id|nct_id|organization|name|phone|email|extension
20187905|NCT04427007|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
20187906|NCT04079972|Dongguk University|Dr.NaNa Keum|+82 10-6793-6654|nak212@mail.harvard.edu|
20157598|NCT00628498|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
20157599|NCT01053507|Clinvest/A Division of Banyan Group, Inc.|Dr. Roger K. Cady|417-841-3673|jtarrasch@clinvest.com|
20157600|NCT01047007|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157601|NCT04099277|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157602|NCT03793621|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157603|NCT04790786|UPMC|Erin McCreary|4845159589|mccrearye3@upmc.edu|
20157604|NCT03759600|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20157605|NCT03257358|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20172763|NCT04221009|James A Haley Veterans' Hospital|Dr. Marc A Silva|813-972-2000|marc.silva1@va.gov|5613
20172764|NCT02154490|SWOG Statistics & Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20172765|NCT02373202|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20172766|NCT03010254|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20172767|NCT02144233|University of Santiago de Compostela. A Coruña. SPAIN|Professor Urbano Santana Penín|+34647344093|urbano.santana@usc.es|
20172768|NCT00187876|University of Florida|Peter Indelicato, MD|352-273-7017|wernegs@ortho.ufl.edu|
20172769|NCT00482612|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20172770|NCT01393704|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
20172771|NCT00464087|Medstar Health Research Institute|Ron Waksman, MD|202-877-2812|ron.waksman@medstar.net|
20172772|NCT00088985|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@UNC.med.edu|
20172773|NCT00418314|St. Jude Medical|Sr. Director Clinical Studies|(408) 522-6410|tshipman@sjm.com|
20172774|NCT01224431|Phoenix Children's Hospital|Angelique Ferayorni|602-546-1910|aferayorni@phoenixchildrens.com|
20172775|NCT02057406|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|jiang001@mc.duke.edu|
20172776|NCT02056782|Cantex|CBertrand|954-315-3660|cbertrand@cantex.com|
20172777|NCT03654651|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
20172778|NCT01401283|Hamburg Eppendorf University Hospital|Daniel A. Reuter, MD|+49-40-7410-0|dreuter@uke.de|
20172779|NCT02433483|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
20172780|NCT02569723|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20172781|NCT02904512|Veterans Affairs Medical Center|Dr. Ilias (Elias) Spanakis|(617) 319-9731|ispanakis@som.umaryland.edu|
20172782|NCT03828357|Abbott|Grant Kim, Director Clinical Programs|8184933147|grant.kim1@abbott.com|
20172783|NCT03219294|Maine Medical Center|Research Coordinator|2076622862|richaj3@mmc.org|
20172784|NCT01963403|UC Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
20172785|NCT03836612|St Thomas' Hospital, London|Dr Peter Irving|020 7188 7188|peter.irving@gstt.nhs.uk|
20187907|NCT06237686|Medical Consultant|Principal Investigator: Søren Meisner, MD|+4520117378|sm_meisner@hotmail.com|
20187908|NCT04734197|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
20187909|NCT04165213|University of Pennsylvania, School of Nursing|Emily Summerhayes, Project Manager|6099233786|esummer@nursing.upenn.edu|
20187910|NCT04464564|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
20187911|NCT05512650|Tufts University|Nancy Baker, Professor|617 627 5562|nancy.baker@tufts.edu|
20187912|NCT04282980|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
20187913|NCT05007080|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187914|NCT05633147|Cinclus Pharma Holding AB|Kajsa Larsson, CMO|+46 706750128|kajsa.larsson@cincluspharma.com|
20218235|NCT01744093|Weill Cornell Medicine|Mei Wang, BS, CCRP|646-962-2672|mew2001@med.cornell.edu|
20157606|NCT00305877|ECOG Statistical Office|Study Statistician|617-632-3012||
20157607|NCT01248793|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
20157608|NCT02332187|University of Kentucky|Gerald Supinski, MD, Professor|859-494-3480|gsupi2@email.uky.edu|
20157609|NCT03886948|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157610|NCT00355030|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157611|NCT00339040|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20157612|NCT00988156|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
20157613|NCT02391311|UAB|Pariya L Fazeli, PhD|205-996-0330|plfazeli@uab.edu|
20157614|NCT03183063|Beaumont Health|Joanne Gondert|248 551-0439|joanne.gondert@beaumont.org|
20157615|NCT00688467|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157616|NCT02163577|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20157617|NCT02970136|University of Miami|Olveen Carrasquillo|305-243-5505|ocarrasquillo@miami.edu|
20157618|NCT00690794|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20172786|NCT02557698|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
20172787|NCT00549302|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172788|NCT03585504|Medical University of South Carolina|Dr. Angela Dempsey|843-762-4500|dempsear@musc.edu|
20157619|NCT01073293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157620|NCT00305448|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20187915|NCT03188692|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
20187916|NCT03370913|BioMarin Pharmaceutical Inc.|Tara Robinson, MD, PhD, Senior Medical Director, Clinical Sciences|415-455-7931|tara.robinson@bmrn.com|
20187917|NCT05883345|Konkuk University Medical Center|Sun-Young Lee|82-2-2030-7747|sunyoung1973.lee@gmail.com|7505
20157621|NCT01343888|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157622|NCT00077974|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20157623|NCT00030147|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
20157624|NCT02217618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157625|NCT02652221|Cincinnati Children's Hospital Medical Center|Andrew T. Trout, MD|513-803-3004|andrew.trout@cchmc.org|
20157626|NCT00003816|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
20157627|NCT04108273|NYU Langone Health|Francisco Castellanos, MD|6467545194|Francisco.Castellanos@nyulangone.org|
20157628|NCT00506142|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
20157629|NCT02213250|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|(001)8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172789|NCT01414114|Amgen, Inc|Study Director|866-572-6436||
20172790|NCT05620563|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20172791|NCT01781403|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
20172792|NCT03590041|University of Colorado Anschutz medical Campus|Dr. Bethany Kwan|303-724-5153|bethany.kwan@cuanschutz.edu|
20172793|NCT03434275|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
20172794|NCT03519932|CooperVision Inc.|Jose A.Vega OD, MSc., FAAO|9256213761|javega@coopervision.com|
20172795|NCT02254486|Norgine Ltd|Lucy Clayton|+44-1895-826669|lclayton@norgine.com|
20172796|NCT01350414|Boston Scientific|Narinder Shargill|408-635-3907|Narinder.Shargill@bsci.com|
20172797|NCT00936585|National Institute of Allergy and Infectious Diseases|Michael Yao, MD|301-594-0593|yaomic@niaid.nih.gov|
20172798|NCT00010374|Synapse Biomedical, Inc.|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
20172799|NCT06185374|NYU Langone Health|Peter Liang, MD|(212) 686-7500|peter.liang@nyulangone.org|5745
20172800|NCT00372112|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172801|NCT02706691|University of Chicago Comprehensive Cancer Center|Technical Director|773-702-0819|pccc_regulatory@bsd.uchicago.edu|
20172802|NCT00356369|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172803|NCT02725710|Duke University|Jeremy M. Weber|919-681-4561|jeremy.m.weber@duke.edu|
20172804|NCT02547454|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20172805|NCT03159624|University of Alabama at Birmingham|Dr. Brad Woodworth|205-801-7858|bwoodworth@uabmc.edu|
20172806|NCT03918447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20172807|NCT03278613|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20172808|NCT01405456|Massachusetts General Hospital|Dr. Steven K. Grinspoon|6177249109|sgrinspoon@mgh.harvard.edu|
20172809|NCT02299297|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
20187918|NCT05683158|Department of Physiotherapy, University of Valencia|PI. Jose Casaña Granell|+34 656-437-371|jose.casana@uv.es|
20187919|NCT04631016|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20172810|NCT05475236|Veterans Health Administration|Dr. Clayton Swanson|3523761611|clayton.swanson@va.gov|107583
20172811|NCT00477971|Mayo Clinic|Dr. Morie Gertz||gertz.morie@mayo.edu|
20172812|NCT05355805|Acelyrin|Donald Betah|(805) 419-3805|Donald.Betah@acelyrin.com|
20172813|NCT05353985|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20172814|NCT00534430|Department of Hematology, City of Hope|Anthony Stein, MD, Clinical Professor|626-537-5748|astein@coh.org|
20172815|NCT00603993|Abbott|Global Medical Services|1-800-633-9110||
20172816|NCT02782780|San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@va.gov|24386
20172817|NCT03395886|Zhongshan Hospital, Fundan university|Mr Zhe Luo|64041990|ec@zs-hospital.sh.cn|
20172818|NCT00460408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172819|NCT02606604|Stony Brook University|Lori Hochman|631-444-1193|lori.hochman@stonybrook.edu|
20172820|NCT01573572|Bausch Health|Study Manager|908-242-8287|sandra.narain@bauschhealth.com|
20172821|NCT02309489|King's College London, UK|Dr Marina Daniele|020 7836 5454|marina.daniele@kcl.ac.uk|
20172822|NCT03303079|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20172823|NCT03315208|Massachusetts General Hospital/Harvard Medical School|Dr. Kate Bentley|617-724-7741|kbentley@mgh.harvard.edu|
20172824|NCT03472469|The University of Texas Health Science Center at Houston|John A. Harvin, MD|(713) 500-7244|John.Harvin@uth.tmc.edu|
20172825|NCT05259696|Palleon Pharmaceuticals|Palleon Clinical Development|857-285-5900|clinical@palleonpharma.com|
20172826|NCT02408315|Indiana University School of Medicine|Dr. David M. Haas|317-880-3949|dahaas@iu.edu|
20172827|NCT03546192|Sanofi Pasteur Inc.|Medical Director|800-633-1610 ext 1#|RegistryContactUs@sanofipasteur.com|
20172828|NCT01200602|Mayo Clinic|Vilmarie Rodriguez, MD|507-284-2695|rodriguez.vilmarie@mayo.edu|
20203082|NCT03026504|Mayo Clinic|Matthew Koster, M.D.|507-284-5800|koster.matthew@mayo.edu|
20157630|NCT02261961|Central Arkansas Veterans Healthcare System|Richard Dennis|501-257-5583|richard.dennis2@va.gov|
20157631|NCT03500211|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
20172829|NCT02648178|The Koop Institute at Dartmouth, Geisel School of Medicine|Dr James Sargent|603-653-9025|James.D.Sargent@dartmouth.edu|
20172830|NCT02205814|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
20157632|NCT04460183|Thirty Respiratory Ltd|Alison Bracchi, MSc|+447763882519|alison.bracchi@30.technology|
20157633|NCT00487981|Boston Scientific|Lyn M. Pimentel, M.B.A.|(661) 949-4174|Lyn.Pimentel@bsci.com|
20157634|NCT01365793|University of California, Davis (UC Davis Health)|Nathan Kuppermann|916-734-1535|nkuppermann@ucdavis.edu|
20172831|NCT01426373|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
20172832|NCT00143403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187920|NCT04967599|University of Southern California|Susan Luczak, PI of study|2137402203|luczak@usc.edu|
20187921|NCT04490109|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20187922|NCT04163991|Horizon Therapeutics USA, Inc.|Ilias Alevizos, PhD, DMD|866-479-6742|clinicaltrials@horizontherapeutics.com|
20187923|NCT03880955|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20187924|NCT03817983|Addenbrookes Hospital, Cambridge, UK|Dr Deepak Jadon|01223 805000|deepak.jadon@addenbrookes.nhs.uk|
20187925|NCT03744676|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20187926|NCT04078152|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20187927|NCT01768013|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
20187928|NCT05990335|Kansas State|Study Director|(785) 532-6850|external+studydirector@nxtech.co|
20187929|NCT04099732|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187930|NCT02624050|Milton S. Hershey Medical Center|Dr. Anthony Bonavia|717-531-6140|abonavia@pennstatehealth.psu.edu|
20187931|NCT02785991|Medtronic Ibérica|Patricia Pascual|636183869|patricia.pascual@medtronic.com|
20187932|NCT03279978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187933|NCT03493542|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20187934|NCT06412965|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187935|NCT03998488|Weill Cornell Medicine|Dr. Randy Longman|646-962-6289|ral2006@med.cornell.edu|
20187936|NCT01756300|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
20187937|NCT04479514|DFCI|Jennifer Huang|6173558937|jennifer.huang@childrens.harvard.edu|
20187938|NCT04244175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20187939|NCT02095691|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
20187940|NCT00887198|Janssen R&D US|SENIOR DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
20187941|NCT05147584|Raydiant Oximetry, Inc.|Laura Kemp|4083751465|laurakemp@raydiantoximetry.com|
20187942|NCT03329937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20187943|NCT04442165|Insitute of Tropical Medicine|Brecht Ingelbeen|+32(0)33455787|bingelbeen@itg.be|
20187944|NCT01223352|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
20187945|NCT05960032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20187946|NCT05830799|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc|+46 31788 05 60|info@vicorepharma.com|
20187947|NCT04173247|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
20187948|NCT02163694|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20187949|NCT03884101|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20187950|NCT05061017|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20218236|NCT02006628|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20187951|NCT04369911|HealthPartners Institute|Amanda Herrmann, PhD|6514956565|amanda.a.herrmann@healthpartners.com|
20187952|NCT05454514|HIDO TECHNOLOGIES, INC.|Charles Gellman, CEO|5108137224|charles@hidohealth.com|
20187953|NCT05496140|UCSF|Lauren M. Haack|415-502-8060|lauren.haack@ucsf.edu|
20187954|NCT05541484|Washington University School of Medicine|Janet McGill, Professor Medicine|314-273-3929|jmcgill@wustl.edu|
20203083|NCT03825042|A.Menarini Industrie Farmaceutiche Riunite Srl|Director of Clinical Operations|0039 055 5680459|pfabrizzi@menarini.it|
20157635|NCT02808429|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20157636|NCT01469039|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823||
20157637|NCT00856609|National Institutes of Health|Dr. Jonathan Krakoff|602-200-5217|jkrakoff@mail.nih.gov|
20157638|NCT01788943|University of Pennsylvania|Jacob Dubroff,M.D., Ph.D., Assistant Professor of Radiology|215-662-3041|jacob.dubroff@uphs.upenn.edu|
20157639|NCT00783432|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|wwheeler@medapharma.us|
20157640|NCT01436110|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157641|NCT03273907|Alcon Research, LLC|CDMA Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20157642|NCT01088503|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157643|NCT00110214|Thomas Jefferson University|William Kevin Kelly, DO||wm.kevin.kelly@jefferson.edu|
20187956|NCT05785130|ChangGung Memorial Hospital|Ya-Ching, Nien|+886 913112012|yaching79@cgmh.org.tw|
20157644|NCT01847092|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20157645|NCT03623698|Imperial College London|Mrs. Natalia Galaz Souza|07751842851|natalia.galaz-souza16@imperial.ac.uk|
20218237|NCT03533374|Aarhus University Hospital|Professor Sandor Beniczky|+4526981536|sbz@filadelfia.dk|
20157646|NCT03604497|University of Alabama at Birmingham|Dr David Schwebel|2059348745|schwebel@uab.edu|
20187957|NCT04157517|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20218238|NCT02384941|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20157647|NCT00811954|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20187958|NCT01536938|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20187959|NCT00329836|Doylestown Hospital|Abraham Ashkenazi, M.D./ Prinicpal Investigator|215-625-2894|aashkenazi@yahoo.com|
20218239|NCT02493777|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
20218240|NCT00468728|Optimer Pharmaceuticals, Inc.|Chief Scientific Officer|1-855-343-4243|medinfo@optimerpharma.com|
20172833|NCT02756689|UAB|Lorie Harper, MD|205-934-5611|lmharper@uabmc.edu|
20172834|NCT01574326|Genzyme Corporation|Trial Transparency Team||Contact-US@sanofi.com|
20187960|NCT04159519|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20187961|NCT04780581|IBSAL|Project manager|+34 923 29 11 00|uicec.coordinacion@ibsal.es|55779
20187962|NCT01651000|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
20187963|NCT02765412|VA Ann Arbor Healthcare System|Angela Larkin|734-845-3612|angela.larkin@va.gov|
20187964|NCT03781089|Duke University Medical Center|Dr. John Middleton|919-684-8111|j.p.middleton@duke.edu|
20187965|NCT03417284|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, MD / Stem Cell Transplantation|713-794-4422|QBashir@mdanderson.org|
20187966|NCT03636490|Columbia University Irving Medical Center|Daichi Shimbo|‭(646) 317-0305‬|ds2231@cumc.columbia.edu|
20187967|NCT02246127|Grupo Español de Tumores Neuroendocrinos y Endocrinos (GETNE)|GETNE Secretary|0034934344412|getne@getne.org|
20187968|NCT03635567|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20187969|NCT03967379|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
20187970|NCT06603766|faculty of medicine Benha University|Dr. Heba Morsy Saad El Din El Ganady|+201111211367|Heba.Aljanadi21@fmed.bu.edu.eg|
20187971|NCT04560179|Stanford University School of Medicine|Erik Jensen, MD, MSCE|267-648-2720|jensene@stanford.edu|
20187972|NCT02506673|Hospital for Special Surgey|Danya DeMeo, Research Assistant|2127742678|demeod@hss.edu|
20187973|NCT04214418|Columbia University|Gulam Manji, MD, PhD|212-304-6357|gam2140@cumc.columbia.edu|
20187974|NCT04323397|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
20187975|NCT03248479|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20187976|NCT04679389|Mayo Clinic|Eva Morava-Kozicz, M.D., Ph.D.|507-266-9140|Morava-Kozicz.Eva@mayo.edu|
20187977|NCT05257603|State University of New York at Buffalo|Dr. Kathleen Parks|(716) 887-3301|kparks@buffalo.edu|
20187978|NCT03076021|University of Washington|Dr. Mary Hebert|206-616-5016|mhebert@u.washington.edu|
20187979|NCT03771612|UCLA|Naomi Eisenberger|3108494330|neisenbe@ucla.edu|
20203084|NCT01158534|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20187981|NCT05334355|Montclair State University|Dr. Evan Matthews, Associate Professor|9736553948|matthewse@montclair.edu|
20187982|NCT04024059|Johns Hopkins University School of Medicine|Kenneth Silverman, Ph.D.|4436176051|ksilverm@jhmi.edu|
20187983|NCT05698368|Stanford University|Dr. Melissa Boswell|(650) 725-4009|boswellm@stanford.edu|
20187984|NCT04494958|APICES|Juan Luis Sanz|91 816 68 04|juanluis.sanz@apices.es|112
20187985|NCT04198701|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
20187986|NCT05933772|CooperVision|Jose A. Vega,OD,MSc,FAAO|925-621-3761|jvega2@coopervision.com|
20187987|NCT04881110|University of Campania Luigi Vanvitelli|Prof. Katherine Esposito, Head of the Division of Endocrinology and Metabolic Diseases|+390815665031|katherine.esposito@unicampania.it|
20187988|NCT01475786|Helixmith|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20187989|NCT01897441|Albert Einstein College of Medicine|Dr. Jesus Anampa Mesias|718-405-8505|janampa@montefiore.org|
20187990|NCT04633278|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20187991|NCT01144455|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20187992|NCT04310423|University of California, Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
20187993|NCT01746979|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20187994|NCT05891275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187995|NCT00942734|University of Texas (UT) MD Anderson Cancer Center|Vali Papadimitrakopoulou, MD||CR_Study_Registration@mdanderson.org|
20187996|NCT04664959|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20187997|NCT01950234|University of Minnesota|Sarah Hikbert|612-624-7745|hilbe010@umn.edu|
20187998|NCT02765854|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Leon Bernal-Mizrachi, MD|336-716-9253|lbernalm@wakehealth.edu|
20187999|NCT04496752|Linus Health|Dr. Sean Tobyne|(617) 433-1777|stobyne@linus.health|
20188000|NCT03662022|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
20188001|NCT05275556|Verily|Dr. Scooter Plowman|650-861-9783|splowman@verily.com|
20188002|NCT04567316|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203085|NCT01058369|Universitätsklinikum Erlangen, Medizinische Klinik 5|Prof. Dr. med. Stefan Krause||stefan.krause@uk-erlangen.de|
20218241|NCT04572243|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20172835|NCT03856164|University of Texas Southwestern|Dr. Olutoyosi Ogunkua|2145578873|olutoyosi.ogunkua@utsouthwestern.edu|
20188004|NCT03547271|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20188005|NCT04835363|University of Malaga|Garcia-perez, Patricia|+34 675447206|terapiaocupacional.patricia@gmail.com|
20188006|NCT04795245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188007|NCT03904576|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188008|NCT05718687|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172836|NCT01919723|University of Alabama at Birmingham|Mehak Goel ,PhD|205-975-4021|mehakgoel@uabmc.edu|
20172837|NCT04502589|Virginia Commonwealth University|Albert Arias, M.D.|(804) 828-5793|albert.arias@vcuhealth.org|
20157648|NCT01016067|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20172838|NCT00911053|Oregon Health and Science University|OHSU IRB|5034948849|irb@ohsu.edu|
20188009|NCT03418740|The Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynchd@pennmedicine.upenn.edu|
20188010|NCT05215054|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
20188011|NCT01499368|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
20188012|NCT03990883|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
20188013|NCT02076009|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20188014|NCT00449748|The University of Texas M. D. Anderson Cancer Cent|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
20157649|NCT02103127|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20157650|NCT00186628|Stanford University Medical Center|David Miklos, MD, PhD; Associate Professor of Medicine (Blood and Marrow Transplantation)|650-725-4626|dmiklos@stanford.edu|
20188015|NCT03944915|University of Chicago|Dr. Ari Rosenberg|855-702-8222|arirosenberg@bsd.uchicago.edu|
20188016|NCT05988398|University of Michigan|Dr. Katie M Edwards|734-647-8812|edkatie@umich.edu|
20188017|NCT04408755|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
20188018|NCT06655818|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20188019|NCT00319046|Actelion Pharmaceuticals Ltd|Cécile Luzy, MSc/Clinical Research Scientist|+ 41 61 565 6386||
20188020|NCT00412607|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
20188021|NCT05757193|Duke University|Senthil Selvaraj, MD|919-660-0730|Senthil.Selvaraj@duke.edu|
20188022|NCT04675034|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20188023|NCT02637609|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
20188024|NCT05836012|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
20188025|NCT05985395|University of Nebraska Medical Center|Windy Alonso|814-577-2941|windy.alonso@unmc.edu|
20188026|NCT03907982|Barts and London NHS trust|Dr Malcolm Finlay, Principal Investigator|+442037658635|malcolm.finlay1@nhs.net|
20188027|NCT04908930|Wake Forest University Health Sciences|Jillian Urban, PhD|336.716.0947|jurban@wakehealth.edu|
20188028|NCT06017115|Universitat Internacional de Catalunya|Dr. Jordi Gargallo|+34 935 04 20 00|jgargallo@uic.es|
20188029|NCT02777593|W.L. Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
20188030|NCT05954546|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188031|NCT06065735|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20188032|NCT02532621|Phraxis, Inc.|Cindy Setum, PhD|612-801-6730|csetum@phraxis.com|
20188033|NCT03522298|Kazia|Jeremy Simpson|+61 400 410 974|jeremy.simpson@kaziatherapeutics.com|
20188034|NCT01992913|Corporal Michael J Crescenz VA Medical Center|Steven L. Sayers, Ph.D.|(215) 823-5196|steven.sayers@va.gov|
20188035|NCT02933489|ECOG-ACRIN|Director Clinical Research Administration|800-227-5463|dhartfeil@acr.org|4765
20203086|NCT04003155|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20188036|NCT05485935|Coloplast A/S|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
20203087|NCT03042611|Elevar Therapeutics, Inc|Elevar Clinical Trials|(801) 303-7440|info-clinicalstudy@elevartherapeutics.com|
20188037|NCT04177771|RxSight|Jeffrey Ha, VP Clinical Affairs|949-521-7870|jha@rxsight.com|
20157651|NCT04207320|University of Chicago|Dr. John Cunningham|773-702-6808|jcunning@bsd.uchicago.edu|
20157652|NCT03434834|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
20157653|NCT02797821|Alexion Pharmaceuticals|Alexion Pharmaceuticals|475-230-2596|ClinicalTrials@Alexion.com|
20172839|NCT00137046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20188038|NCT03250676|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20188039|NCT04626427|Becton Dickinson|Simon Lubek, Clinical Program Manager|+33 6 07 56 66 08|simon.lubek@bd.com|
20188040|NCT02325154|Hospital for Special Surgery, Anesthesiology|Dr. Sean Garvin|2126061036|GarvinS@hss.edu|
20188041|NCT01265537|St. Paul's Hospital|Dr. Jagbir Gill|6046822344|JAGill@providencehealth.bc.ca|64706
20172840|NCT01288469|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
20188042|NCT01612351|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20188043|NCT03697408|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20188044|NCT04595331|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20188045|NCT04300127|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
20188046|NCT05412004|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
20188047|NCT04644029|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188048|NCT05020353|Li Ka Shing Knowledge Institute, St. Michael's Hospital|Sean B. Rourke|(416) 878-2779|sean.rourke@utoronto.ca|
20188049|NCT05132400|NYU Langone Health|Marco Campello, PT, PhD|212-255-6690|Marco.campello@nyulangone.org|
20188050|NCT00640978|UT MD Anderson Cancer Center|Milind Javle, MD/Associate Professor|713-792-2828|mjlim@mdanderson.org|
20188051|NCT02611687|Bioprojet Pharma|Clinical Project Manager|+33 (0)1 47 03 66 23|a.viatte@bioprojet.com|
20188052|NCT03934931|University of California Irvine|Professor Adithya Cattamanchi|415-206-5489|adithya.cattamanchi@uci.edu|
20217972|NCT03648879|National Cancer Institute|Dr. Jeremy L. Davis|240-760-6229|jeremy.davis@nih.gov|
20172841|NCT03782272|PATH|Gwen Ambler, Clinical Research Officer|+1-206-285-3500|gambler@path.org|
20188053|NCT02047500|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20188054|NCT03952520|University of North Carolina at Chapel Hill|Jane Chen, PhD|919-966-2537|janechen@live.unc.edu|
20188055|NCT05643196|NYU Langone Health|Wei Qi|212-961-4492|wei.qi@nyulangone.org|
20188056|NCT04282109|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
20188057|NCT03786926|HUTCHMED Limited|Chao Pan|(+86)15215192478|chaop@hutch-med.com|
20188058|NCT04243759|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
20188059|NCT05875701|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20188060|NCT06664684|İstanbul Bilgi University|Dr. Tugce Ozlu Karahan|+90 212 311 5042|tugce.karahan@bilgi.edu.tr|
20188061|NCT03901534|Columbia University|Sanja Jelic, MD|212-543-8875|sj366@cumc.columbia.edu|
20188062|NCT04819191|Johns Hopkins Bloomberg School of Public Health|Jennifer Wolff, PhD|(410) 502-0458|jwolff2@jhu.edu|
20188063|NCT04602611|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
20188064|NCT05292222|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
20188065|NCT05966766|Tufts Medical Center|Dan Drzymalski, MD|617-913-8168‬‬‬‬‬‬‬‬‬‬‬‬‬‬|dan.drzymalski@tuftsmedicine.org|
20188066|NCT03884439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188067|NCT03351998|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
20188068|NCT04107116|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
20188069|NCT02360371|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
20188070|NCT05886452|Mann Eye Institute|Dr Phillip Brunson|17135802500|Phillip.Brunson@manneye.com|
20188071|NCT04093869|Duke University|Stephanie K. Mabe, MS|919-668-3555|stephanie.mabe@duke.edu|
20188072|NCT02806726|Johnson & Johnson Surgical Vision, Inc.|Priya Janakiraman|1 714 2478628|djanaki1@its.jnj.com|
20188073|NCT04731233|University of Florida|Dr. Charles G. Widmer|352-273-5696|widmer@dental.ufl.edu|
20188074|NCT05129501|University of Nebraska-Lincoln, Nebraska Center for Research on Children, Youth, Families, and Schools/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
20157654|NCT01657305|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
20157655|NCT03763747|OrbusNeich|Stephen M. Rowland, PhD - Vice-President, Research and Development|954-730-0711|srowland@orbusneich.com|
20188075|NCT03092674|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
20188076|NCT01527188|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 33 55 59 29 70|mroux@stallergenes.com|
20188077|NCT03520114|Wake Forest University|Sachin Nalin Vyas, MS,PhD|336-713-4098|svyas@wakehealth.edu|
20188078|NCT03982186|Janssen Sciences Ireland UC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188079|NCT00983307|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maria Werner-Wasik|215 955-6702|maria.werner-wasik@jefferson.edu|
20188080|NCT03512301|Psychology Software Tools, Inc.|Anthony Zuccolotto|412-449-0078|anthony.zuccolotto@pstnet.com|
20203088|NCT00502905|UT MD Anderson Cancer Center|Gabriela Rondon, MD / Assistant Professor|713 745-2294|celsaenz@mdanderson.org|
20188081|NCT05207033|University of Massachusetts Chan Medical School|Elise Stevens, Assistant Professor|(774) 455-6684|elise.stevens@umassmed.edu|56684
20203089|NCT00950690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20188082|NCT03801616|Cedars-Sinai Medical Center|Dr. Alice Chung|3104239331|alice.chung@cshs.org|
20188083|NCT06024642|Imbrium Therapeutics L.P.|Clinical Leader|1-888-827-0622|Medinfo@imbriumthera.com|
20188084|NCT05448014|Umeå University|Inga Dennhag, Associate Professor|+46706217414|inga.dennhag@umu.se|
20188085|NCT00739908|CeNeRx BioPharma Inc.|Mahnaz Asgharnejad, Pharm.D.; Daniel Burch, M.D.|(919) 655 1435; (919) 674 6041|masgharnejad@cenerx.com; danburch@cenerx.com|
20188086|NCT05157841|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20188087|NCT05002738|University of Colorado Anschutz Medical Campus|Eva Dindinger|3037242019|eva.dindinger@cuanschutz.edu|
20203090|NCT00092547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188088|NCT02299349|TriHealth Hatton Research Institute|Angela N Fellner PhD CCRP|513-862-2330|Angie_Fellner@trihealth.com|
20188089|NCT02075554|Globus Medical Inc.|Brandon Bucklen|610-930-1800|bbucklen@globusmedical.com|2517
20188090|NCT00624442|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
20203091|NCT00084682|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
20188091|NCT04933474|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
20188092|NCT01773993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218242|NCT00775606|Rush University Medical Center|Allan R. Tenorio|312-942-3665|allan_s_tenorio@rush.edu|
20157656|NCT00696878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157657|NCT00740181|Brown Univeristy Oncology Research Group|James Butera|401-863-3000|Kayla_Rosati@brown.edu|
20218243|NCT00767338|University of Michigan|Gregory Christman, MD|734-764-8142|growthh@umich.edu|
20218244|NCT03253744|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
20218245|NCT02408120|Emory University|Dr. Priyathama Vellanki|404-251-8957|priyathama.vellanki@emory.edu|
20218246|NCT01134627|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20218247|NCT00754494|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
20218248|NCT00867048|University of Minnesota|Birgit Grund|612-624-8076|birgit@umn.edu|
20218249|NCT01652976|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20157658|NCT01378117|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
20157659|NCT01129206|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii Saab, MD|614-293-6529|Tanio.Saab@osumc.edu|
20188093|NCT04993677|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203092|NCT02901262|UNIMIB, ASST-MONZA San Gerardo Hospital|Prof. Giuseppe Citerio|0039 039 233 4316|giuseppe.citerio@unimib.it|
20203093|NCT01013883|Darlington Memorial Hospital|Dr Rajender singh|01325380100|drrsdogra@yahoo.com|3444
20203094|NCT01371838|AstraZeneca Pharmaceuticals|Melnick, David A / Exec Dir Med Science|+1 302 886 5627|David.Melnick@astrazeneca.com|
20203095|NCT04315363|Northeastern University|Meishan Ai|858-265-7288|ai.me@northeastern.edu|
20203096|NCT01509586|Medical University of South Carolina|Dr. Matthew J. Carpenter|843-876-2436|carpente@musc.edu|
20157660|NCT01374425|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157661|NCT00546481|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20157662|NCT03368066|University of Virginia|Dr. Brian Wentworth|9739436781|bw8xz@hscmail.mcc.virginia.edu|
20188094|NCT04174170|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20188095|NCT04664881|Mayo Clinic|Joerg Herrmann, M.D.|507-255-1267|Herrmann.Joerg@mayo.edu|
20188096|NCT00324415|AMC|Director, AMC Statistical Center|501-526-6712|jylee@uams.edu|
20188097|NCT05419856|4Moving Biotech|Odile Fleurot|03 20 11 80 30|odile.fleurot@4p-pharma.com|
20203097|NCT04013737|Health Protection Research Unit in HCAI and AMR, Imperial College London|Head of Operations|020 3313 2732|head.ops@imperial.ac.uk|
20203098|NCT00641043|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203099|NCT01096771|Indiana University School of Medicine|Dr. William Carlos|3178807819|wcarlos@iu.edu|
20218250|NCT05528861|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20218251|NCT01602172|VA Pittsburgh Healthcare System|Lauren M. Broyles, PhD, RN|412-360-2269|Lauren.Broyles@va.gov|
20218252|NCT03739138|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218253|NCT00767520|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20172842|NCT05860647|HealthPartners Institute Neuroscience Research Center|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
20188098|NCT06102421|Second Faculty of Medicine, Charles University|Mgr. Jakub Katolicky|+420702088258|jakubkatolicky@gmail.com|
20188099|NCT04772534|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20188100|NCT04194450|University of British Columbia|Dr. Jonathan Little|(250) 807-9876|jonathan.little@ubc.ca|
20188101|NCT05265871|Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University|Kefang Lai|18928868231|klai@vip.163.com|
20188102|NCT02295891|Johns Hopkins University|Kristen Rodgers- Research Program Manager, Dept, of Thoracic Surgery|410-955-9047|kpelosk1@jhmi.edu|
20188103|NCT00308997|Yale University School of Medicine|Ralph Hoffman, MD|203-688-9734|Ralph.Hoffman@yale.edu|
20188104|NCT04490356|Duke University Medical Center|Kathryn Starr, Ph.D.|919-660-7571|kathryn.starr@duke.edu|
20188105|NCT03733626|William Beaumont Hospitals|Jad Khalil, MD|(248) 663-1900|jad.khalil@corewellhealth.org|
20188106|NCT03816397|F.I. Proctor Foundation, University of California, San Francisco|Nisha Acharya, MD, MS|(415) 476-6687|nisha.acharya@ucsf.edu|
20188107|NCT00503971|Fundación GECP|Eva Pereira|+34 934302006|secretaria@gecp.org|
20188108|NCT05592223|Fred Hutchinson Cancer Center|Dr. Elizabeth Chandler Church|2066676982|cchurch2@fredhutch.org|
20188109|NCT01220531|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
20188110|NCT01553149|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20188111|NCT05866926|Ferrer|Clinical Operations Head|649442389|nalbareda@ferrer.com|
20188112|NCT00709956|Actelion|Laila Rouault, M.D.|+ 41 61 565 8128|laila.rouault@actelion.com|
20188113|NCT01105091|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
20188114|NCT03215706|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20188115|NCT05267639|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
20188116|NCT03698669|Boston University|Michael Stein, MD|617 358 1956|mdstein@bu.edu|
20203100|NCT02805907|MurciaSalud|Dr. Rubén Andújar-Espinosa|0034669500052|rubemed@hotmail.com|
20203101|NCT02046135|Cohen Children's Medical Center|Dr. James Schneider|7184703330|jschneide2@northwell.edu|
20203102|NCT01933984|Division of Critical Care Medicine, Department of Medicine, Changhua Christian Hospital|Dr. Shin-Hwar Wu|886-4-7238595|126366@cch.org.tw|3971
20203103|NCT00062738|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
20203104|NCT01842464|Western Galilee MC|Menahem Neuman|+972546444033|mneuman@netvision.net.il|
20203105|NCT02544984|The University of Texas Health Science Center at Houston|Ricardo A. Mosquera, MD|(713) 500-5650|Ricardo.A.Mosquera@uth.tmc.edu|
20203106|NCT02416908|Washington University School of Medicine|Geoffrey Uy, M.D.|314-747-8439|guy@wustl.edu|
20203107|NCT01985685|Beth Israel Deaconess Medical Center|Dr. Katherine Berg|617-667-5864||
20203108|NCT01214434|Promius Pharma, LLC|Medical Information Center|888 966-8766|product-complaints@promiuspharma.com|
20203109|NCT03100435|Tufts University|Robert Gyurko|6176366531|robert.gyurko@tufts.edu|
20203110|NCT01651052|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
20203111|NCT03503773|Ablative Solutions Inc|Kate Rumrill, CEO|1 650-688-9743|krumrill@ablativesolutions.com|
20203112|NCT00607828|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
20203113|NCT00425438|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20203114|NCT02134314|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|310-248-8186|noriko.ammerman@cshs.org|
20218254|NCT00594620|The University of Kansas|Jeffrey Holzbeierlein, MD, FACS|913-945-8239|jholzbeierlein@kumc.edu|
20203115|NCT02285010|Mahidol University|Dr.Taniga Kiatchai|+66-2-419-7990|taniga@gmail.com|
20203116|NCT02902809|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20203117|NCT00532259|CureTech Ltd.|Director Clinical Resaerch|+972-8-9324000|talh@curetechbio.com|
20203118|NCT04983940|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr. Ranjth Ramasamy|305-243-6596|Ramasamy@miami.edu|
20203119|NCT05341466|University of Colorado, Boulder|Andrew Q. Tan|303-735-0259|andrew.tan@colorado.edu|
20203120|NCT04156646|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20203121|NCT03511638|Bausch & Lomb|Study Director|510-259-5284|aloncaric@bauschhealth.com|
20203122|NCT01208181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203123|NCT02730247|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20203124|NCT01478347|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20203125|NCT01645930|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20203126|NCT01765712|Nicholas Institute of Sports Medicine and Athletic Trauma|Malachy McHugh Director of Research|2124342714|mchugh@nismat.org|
20203127|NCT01845077|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203128|NCT01004107|Merz North America|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
20203129|NCT00394914|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20203130|NCT04337138|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203131|NCT02092415|Oregon Health & Science University|Jonathan Lindner MD|503 595-8750|lindnerj@ohsu.edu|
20203132|NCT00392444|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@toh.on.ca|70175
20203133|NCT00387660|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20157663|NCT00950651|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20157664|NCT02761642|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20203134|NCT00312377|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20203135|NCT04940598|UAB|Gordon Fisher|2059964114|grdnfs@uab.edu|
20203136|NCT00044044|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20203137|NCT05258058|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
20157665|NCT03783780|Masimo|Tala Harake|1-949-297-7100|studies@masimo.com|
20203138|NCT04286867|Kent State University|William Lechner|8144501093|wlechner@kent.edu|
20203139|NCT02179398|Geneva University Hospital|Dr. Laurence Lacroix|+41223725082|laurence.lacroix@hcuge.ch|
20203140|NCT00603044|The University of Chicago Medicine|Fuad Baroody, MD|(773) 702-4790|fbaroody@surgery.bsd.uchicago.edu|
20203141|NCT01050660|Yale University|Dr. Orly Levit|203-688-2320|orly.levit@yale.edu|
20203142|NCT00649961|Imperial College London|Dr Nazakat Merchant|00447825881907|nazakat.merchant@kcl.ac.uk|
20203143|NCT02519231|University of Washington|Dr. Emily Godfrey|206.685.4895|godfreye@uw.edu|
20203144|NCT00465738|Merz Pharmaceuticals GmbH|Claus Goebel, MD|+49-69-1503-6461|claus.goebel@merz.de|
20203145|NCT02707757|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
20203146|NCT00815308|Shandong Cancer Hospital and Institute|Jinming Yu|86-531-87984729|jn7984729@public.jn.sd.cn|
20203147|NCT00734929|Duke University Medical Center|Dr. Ashraf Habib|9196686265|habib001@mc.duke.edu|
20203148|NCT05136885|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257|healeyalsplatform@mgh.harvard.edu|(HALT ALS)
20203149|NCT02653092|University of Colorado School of Medicine|Dr. Nanette Santoro|303-724-2041|Nanette.Santoro@uanschutz.edu|
20218255|NCT02777918|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
20218256|NCT00757848|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20218257|NCT01338987|National Cancer Institute|Dr. Christopher Kanakry|240-760-6171|christopher.kanakry@nih.gov|
20218258|NCT02071953|University of Pennslyvania|Ricardo Walter|215-898-9164|walterr@dental.upenn.edu|
20218259|NCT00411398|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
20218260|NCT02480582|University of Leeds|Dr Graham Finlayson|0113 343 7601|g.s.finlayson@leeds.ac.uk|
20218261|NCT00720226|Johns Hopkins University School of Medicine|Robert A. Wise|410 550 0545|rwise@jhmi.edu|
20218262|NCT00958126|Seqirus|Clinical Trials Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20218263|NCT03401073|BIDMC|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
20218264|NCT00733369|DePuy Ortho Joint US|Kimberly Dwyer, PhD, CCRA||kdwyer2@its.jnj.com|
20218265|NCT01470612|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218266|NCT01606852|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
20218267|NCT03856593|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
20157666|NCT01044030|Boston Children's Hospital|Louis Vernacchio, MD, MSc|617-919-4283|louis.vernacchio@childrens.harvard.edu|
20157667|NCT02393339|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972507410935|fuxavia@gmail.com|
20188117|NCT05372042|University of Washington|Dr. Kristen Lindgren|206-658-8083|kpl9716@uw.edu|
20203150|NCT01318902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20217973|NCT00466726|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20217974|NCT04403763|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20217975|NCT00350402|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
20217976|NCT01376310|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20217977|NCT04844021|Northwestern University|Dr. Rinad Beidas|312-503-0546|rinad.beidas@northwestern.edu|
20217978|NCT02339740|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20203151|NCT01997567|Rush University Medical Center Department of Anesthesiology|Sandeep Amin, M.D|312-942-6449|Sandeep_Amin@rush.edu|
20203152|NCT02316470|Valneva Austria GmbH|Manager Clinical Research|+43120620|info@valneva.com|0
20203153|NCT01856491|Boston Scientific|Anneleen Viville|0032479983495|anneleen.viville@bsci.com|
20203154|NCT01289392|Associação Fundo de Incentivo à Pesquisa|Dr Teresa Cristina Barros Schutz|55-21-99868033|schutzferraz@gmail.com|
20203155|NCT00733512|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20203156|NCT03314519|Mahidol University|Kasana Raksamanee|66967841010|kasana@gmail.com|
20203157|NCT01912872|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20203158|NCT02778880|Cincinnati Children's Hospital Medical Center|Theresa Frey, MD|513-636-7966|theresa.frey@cchmc.org|
20218268|NCT01602016|University of Arkansas for Medical Sciences|Tracy Gatlin|501-686-6803|tlgatlin@uams.edu|
20218269|NCT04632706|MedinCell S.A.|Joel Richard - Chief Development Officer|00336984590|joel.richard@medincell.com|99
20218270|NCT03078582|Ra Pharmaceuticals, Inc|Sponsor Ra Pharmaceuticals, Inc.|+1 617 401 4060|trials@rapharma.com|
20218271|NCT01045031|Health and Prevention Center, Sanatorium Hera, Vienna, Austria|Dr. Robert Winker|0043(1)-31350|robert.winker@hera.co.at|45666
20218272|NCT01825122|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
20218273|NCT02046525|Washington University in St. Louis|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
20218274|NCT02689063|AFT Pharmaceuticals|Jennifer Zhang -Project Manager|+ 64 9 488 0232|jenniferz@aftpharm.com|710
20218275|NCT02039414|Western Kentucky University|Dr. Rachel Tinius, Assistant Professor|2707455026|rachel.tinius@wku.edu|
20218276|NCT02994355|University of Washington|Dr. R. Scott McClelland|+206-543-4278|mcclell@uw.edu|
20218277|NCT03050918|Vanderbilt University Medical Center|Maame Yaa Yiadom|615-936-0087|maya.yiadom@vumc.org|
20218278|NCT02972502|OhioHealth Research Institute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
20218279|NCT03832738|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
20218280|NCT03852459|Aponia Labs|Kenneth Corroon|917-574-5335|kcorroon@aponialabs.com|
20218281|NCT00430950|Daiichi Sankyo|Global Clinical Leader|908-992-6400|DataSharing@dsi.com|
20218282|NCT02442271|AbbVie|Global Medical Services|800 633-9110||
20218283|NCT01251978|New England Retina Associates|Leslie Hurst- study coordinator|203-288-2020|lhurst@retinamd.com|
20218284|NCT03657108|Icahn School of Medicine at Mount Sinai|Ketan Badani|(212) 241-3919|ketan.badani@mountsinai.org|
20157668|NCT02765399|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
20157669|NCT00768261|Washington University|John G. Csernansky, MD|(312) 926-2323|jgc@northwestern.edu|
20218285|NCT00703508|Virginia Commonwealth University|Dr. Kai Cheang|(804) 828-2257|kicheang@vcu.edu|
20218286|NCT00831623|LomaLindaU|Dr. Jason Slater|909-558-4243|jaslater@llu.edu|
20218287|NCT01064323|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|410-550-5717|hsilber@jhmi.edu|
20218288|NCT00408564|Medical University of South Carolina|Kate Anderton, MPH, CCRP|843-792-2708|anderton@musc.edu|
20157670|NCT00120627|VA San Diego Healthcare System|Jill E. Bormann, PhD, RN, FAAN|858-552-8585|jill.bormann@va.gov|2378
20218289|NCT01564459|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218290|NCT00486018|Genentech, Inc.|Medical Communications|800-821-8590||
20218291|NCT00106938|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
20218292|NCT00631852|Southern Illinois University School of Medicine|Director of Oncology Clinical Trials|217-545-8000|krobinson@siumed.edu|
20218293|NCT02416011|Moffitt Cancer Center|Dr. Thomas Bradon|(813) 745-1750|Thomas.Brandon@moffitt.org|
20218294|NCT02080832|VCU|F. Gerard Moeller, M.D.|804-828-4134|frederick.moeller@vcuhealth.org|
20218295|NCT01448356|Singapore Eye Research Institute|Dr Andrea Petznick|+65 6322|andrea.petznick@seri.com.sg|4512
20218296|NCT03545191|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
20218297|NCT00766831|Medical Affairs|Clinical Research Associate|82-2-2094-4835||
20218298|NCT01392326|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20218299|NCT01862419|Yale University School of Medicine|Francis Perry Wilson, MD MSCE|2037371704|francis.p.wilson@yale.edu|
20218300|NCT00094094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218301|NCT02655016|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20218302|NCT04459715|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20218303|NCT00603291|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20218304|NCT03755336|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
20218305|NCT06029959|University of Washington|Sandeep Khot, MD|206-744-3251|skhot@uw.edu|
20218306|NCT00003138|ECOG Statistical Office|Study Statistician|617-632-3012||
20218307|NCT04495283|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
20218308|NCT05506930|Medical University of South Carolina|Natalie Barnett|(843) 792-5454|barnettn@musc.edu|
20218309|NCT02631876|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20218310|NCT02786277|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
20218311|NCT01013649|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20218312|NCT04285567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20172843|NCT00582166|University of Wisconsin Carbone Cancer Center|Lymphoma/Myeloma Disease Oriented Team|608-265-3794|barnstable@wisc.edu|
20218313|NCT02091141|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20218314|NCT04271735|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
20203159|NCT01666444|Vice President, Clinical Affairs|Kristi Manjarrez|206-689-2256|kmanjarrez@ventirx.com|
20157671|NCT00271544|Medtronic CRDM Clinical Research|Hang Nguyen|800-328-2518|hang.t.nguyen@medtronic.com|62832
20203160|NCT00935857|Northwestern University|Rajesh N. Keswani|312-695-5620|raj-keswani@northwestern.edu|
20203161|NCT01713036|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20203162|NCT00592358|Massachusetts General Hospital|Janet Wozniak, MD|(617)503-1038|jwozniak@partners.org|
20203163|NCT01166659|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20203164|NCT04011436|Universidad Nacional de Colombia|Pt. Luisa Prieto|+57 3202082723|lfprietog@unal.edu.co|
20203165|NCT04760314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20203166|NCT04275310|Virginia Commonwealth University|Eric Benotsch|804-828-0133|ebenotsch@vcu.edu|
20218315|NCT02466230|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
20157672|NCT03096886|University of Pennsylvania|Dr. Yvette Sheline|(215) 573-0082|sheline@pennmedicine.upenn.edu|
20157673|NCT03950856|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157674|NCT03531814|National Cancer Institute|Staci M Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
20157675|NCT02094118|Mayo Clinic|Dr. Daryl Kor|507-255-6051|kor.daryl@mayo.edu|
20157676|NCT03247829|Abbott_Medical_Devices|Dr. Marie-Elena Brett, PhD; Principal Scientist Clinical Research|17815283613|marieelena.brett@abbott.com|
20157677|NCT02722408|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
20157678|NCT00272792|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
20157679|NCT01058239|Massachusetts General Hospital|Jeremy Abramson, M.D|617-724-4000|JABRAMSON@mgh.harvard.edu|
20157680|NCT03121144|Masimo Corporation|Vikram Ramakanth|(949) 297-7000|clinicalresearchdept@masimo.com|
20157681|NCT00427011|Eisai Call Center|Eisai Inc.|888-422-4743||
20157682|NCT00288015|Northwestern University|Mark Agulnik, MD|312-695-6182|magulnik@nm.org|
20157683|NCT00443703|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20157684|NCT04552041|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20157685|NCT03702179|SOGUG|A contact designated by the Sponsor|+34671422325|secretaria@sogug.es|
20157686|NCT02098304|Clark & Watson Dental Practice|Dr Charles Ormond|+44 (0)1324 623445|charlesormond@nhs.net|
20157687|NCT01669902|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157688|NCT00457392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157689|NCT00980148|University of Arkansas for Medical Sciences|Shelly Lensing, Statistician|501-686-8203|sylensing@uams.edu|
20157690|NCT01747915|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157691|NCT01462929|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20157692|NCT02499887|UBMD Emergency Medicine|Heather Lindstrom|716-898-4564|hlindstrom@ecmc.edu|
20157693|NCT01309204|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20157694|NCT02554799|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
20172844|NCT02532972|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736981|Daniel_Lee@meei.harvard.edu|
20172845|NCT04488068|VA San Diego Healthcare System|Mahadevan Rajasekaran, Ph.D.|8585528585|Mahadevan.Rajasekaran@VA.gov|7114
20172846|NCT01606436|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172847|NCT02859454|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@nih.gov|
20172848|NCT00110149|BIDMC|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
20172849|NCT02452398|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20172850|NCT04216017|University of Washington|Dr. Jonah Hebert-Davies|2067443466|jdavies2@uw.edu|
20218316|NCT02072148|Icahn School of Medicine at Mount Sinai|Dr. Raymond L Chai|(212) 844-8775|Raymond.Chai@mountsinai.org|
20218317|NCT00430495|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20218318|NCT00158756|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218319|NCT02400671|University of Washington|Dr. Keshet Ronen|206-685-4363|keshet@uw.edu|
20218320|NCT01421342|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Gary R. Johnson, MS|(203) 932-5711|gary.johnson4@va.gov|3774
20218321|NCT03633448|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20218322|NCT03656874|HealthPartners Institute|Dr. D. Brad Rindal|952.967.5026|D.Brad.Rindal@HealthPartners.com|
20218323|NCT02274844|University of Wisconsin-Madison|Susan Andreae|608-265-8195|sandreae@wisc.edu|
20218324|NCT01507155|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
20218325|NCT00140621|Sanofi|Trial Transparency Team||Contact-US@Sanofi.com|
20218326|NCT02712333|Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
20218327|NCT03463993|University of Zimbabwe|Dr Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
20218328|NCT02566993|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 918466000|clinicaltrials@pharmamar.com|
20218329|NCT02278718|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
20218330|NCT04440449|University of Texas Health San Antonio|Rozmin Jiwani|210-450-8498|jiwani@uthscsa.edu|
20172851|NCT01018186|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172852|NCT02925494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20172853|NCT02845453|Boston Medical Center|Amy Yule, MD|617-414-1936|amy.yule@bmc.org|
20203167|NCT04635735|Memorial Sloan Kettering Cancer Center|Dr. Gunjan Shah, MD|646-608-3734|shahg@mskcc.org|
20218331|NCT03212794|Brigham and Women's Hospital|Joji Suzuki, MD|617-732-5752|Jsuzuki2@bwh.harvard.edu|
20157695|NCT00925002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157696|NCT00002766|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
20157697|NCT01451411|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20157698|NCT00328172|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157699|NCT00558636|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20157700|NCT01990742|University of Rochester|Dr. Helena Temkin-Greener|585-275-8713|Helena_Temkin-Greener@urmc.rochester.edu|
20157701|NCT03443687|University of New Mexico, Dept OBGYN|Dr. Gena Dunivan|5052729712|gdunivan@salud.unm.edu|
20172854|NCT03334448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20157702|NCT02178800|Fred Hutch Cancer Research Center|Gordon Chau|2066672118|gchau@fredhutch.org|
20172855|NCT03235154|Community Research Initiative of New England|Amy E. Colson, MD|6175021700|acolson@crine.org|
20157703|NCT02764996|Mike O'Callaghan Miltary Medical Center|Jill Clark, Senior Research Associate/Research Manager|(702) 653-3298|Jill.M.Clark15.ctr@mail.mil|
20157704|NCT00901303|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
20157705|NCT00099021|Masonic Cancer Center, University of Minnesota|Frank G. Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
20157706|NCT03848416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157707|NCT01100112|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|contact@santarus.com|
20157708|NCT01331681|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20172856|NCT03636061|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20157709|NCT01247064|Cincinnati Children's Hospital Medical Center|Todd Florin|513-636-7966|todd.florin@cchmc.org|
20172857|NCT01922089|Novartis Pharmaceuticals|Study Director|862-778-8300||
20172858|NCT03735433|The Ohio State University|Kara Rood, MD|614-293-8515|Kara.Rood@osumc.edu|
20157710|NCT01580410|Wake Forest University Health Sciences|Dr. Edward Levine|336-716-2763|elevine@wakehealth.edu|
20157711|NCT00658541|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20203168|NCT00907478|Amgen Inc.|Study Director|866-572-6436||
20157712|NCT04828707|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
20203169|NCT04146272|Bernafon AG|Barbara Simon|+41 31 998 15 15|bsim@bernafon.com|1664
20203170|NCT01936649|GE Healthcare|Dr. Jose Zubeldia|011-44-1494-543137|jose.zubeldia@ge.com|
20203171|NCT01591018|University Hospital Ostrava|David Skoloudik|00420597375630|skoloudik@hotmail.com|
20203172|NCT03090620|UColorado|Dr. George Sam Wang|303-724-9967|george.wang@childrenscolorado.org|
20203173|NCT03554005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203174|NCT00631488|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203175|NCT00103194|"ECOG Statistical Office"|"Study Statistician"|617-632-3012||
20203176|NCT03648476|Indiana University|Dawn Neumann|3173292188|dmneuman@iupui.edu|
20203177|NCT02639182|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20218332|NCT00897949|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218333|NCT01763918|Amgen Inc.|Study Director|866-572-6436||
20218334|NCT01553747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20218335|NCT01490931|Univeristy of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD Professor of Pharmacology|215-898-9686|evhersh@pobox.upenn.edu|
20218336|NCT00977431|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218337|NCT03069677|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@uphs.upenn.edu|
20218338|NCT00518882|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20157713|NCT03134326|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20157714|NCT01188967|Massachusetts General Hospital|Maurizio Fava M.D.|617-724-2513|mfava@partners.org|
20157715|NCT04031729|Massachusetts General Hospital|Dr. Tracey Simon|617-724-2401|tgsimon@partners.org|
20157716|NCT00523978|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA - AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
20157717|NCT02553629|Leiden University Medical Center|Prof. Dr. A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
20157718|NCT04577781|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20157719|NCT02148588|Washington University School of Medicine|Simon Haroutounian|3142861715|simon.haroutounian@wustl.edu|314
20157720|NCT02478489|Boston University School of Public Health and School of Medicine|Richard Saitz, MD MPH|(617) 358-1343|rsaitz@bu.edu|
20172859|NCT02988843|Masonic Cancer Center, University of Minnesota|Dr. Shilpa Gupta|612 624 0123|guptash@umn.edu|
20172860|NCT02496611|University of Minnesota|Aaron Kelly PhD|6126253492|kelly105@umn.edu|
20217979|NCT00645944|Yale University|Cenk Tek, M.D.|203-974-7484|cenk.tek@yale.edu|
20218339|NCT04475250|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
20218340|NCT02696031|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
20218341|NCT00597116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20218342|NCT00253981|William Beaumont Army Medical Center|COL Richard Petri, Chief Integrative Pain Management|915-742-3245|richard.petri@amedd.army.mil|
20218343|NCT01829919|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
20172861|NCT02850965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172862|NCT01767155|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
20217980|NCT00738361|Ohio State University Comprehensive Cancer Center|Thomas Olencki, D.O.|614-293-2886|Thomas.Olencki@osumc.edu|
20157721|NCT04103450|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20157722|NCT02259114|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157723|NCT02578901|University of Washington|Dr. Susanne May|206-685-1302|sjmay@uw.edu|
20157724|NCT00244621|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20157725|NCT00587041|Mayo Clinic|Use of Symbiotics to Reduce Urinary Oxalate Excretion|507-266-7960|lieske.john@mayo.edu|
20157726|NCT01847755|Jupiter Medical Center|Dr. Barry Miskin|561-263-5791|clinicaltrials@jupitermed.com|
20157727|NCT01193101|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
20157728|NCT02347085|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20157729|NCT02271529|Cook Research Incorporated|Scott Snyder, Director, Clinical Affairs|765-463-7537|SSnyder@medinst.com|
20218344|NCT02903238|Northwestern University Medical School|Dr. Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
20157730|NCT00956761|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
20172863|NCT02518750|St. Jude Children's Research Hospital|Sima Jeha, MD|901-595-3901|sima.jeha@stjude.org|
20172864|NCT02788357|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
20172865|NCT01365910|Vanderbilt-Ingram Cancer Center|Dr. Jordan Berlin|615-343-4128|jordan.berlin@vanderbilt.edu|
20218345|NCT01553201|National Institute of Neurological Disorders & Stroke|Barbara Karp, MD|301-496-0150|karpb@ninds.nih.gov|
20218346|NCT02743728|University of Minnesota|Dr. Bernadette Gillick|612-626-5898|gillick@umn.edu|
20218347|NCT04588688|University of Michigan|Tobias Else|734-936-1319|telse@med.umich.edu|
20218348|NCT00700817|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20218349|NCT00058214|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20172866|NCT00371137|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
20172867|NCT02013791|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20172868|NCT02170051|Professor of Psychiatry, UC San Diego|Elizabeth W Twamley, PhD|858-642-3848|etwamley@health.ucsd.edu|
20172869|NCT03798483|Oxford University hospital foundation trust|Colin Forde|+441865221540|Colin.Forde@ouh.nhs.uk|
20172870|NCT00276744|SKCCC|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
20172871|NCT02784275|NovMetaPharma Co., Ltd|Peter Lee|+82 (0)2 538 1893|Peter@NovMeta.com|
20172872|NCT01462097|University of Maryland School of Medicine|Stephen Seliger, MD MS|410-605-7000|sseliger@som.umaryland.edu|x55231
20172873|NCT01835587|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20172874|NCT01307007|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610-650-4200|SChowdhury@lpicrd.com|
20157731|NCT02524561|Brigham and Women's Hospital|Dr. Rulla Tamimi|617-525-0862|rulla.tamimi@channing.harvard.edu|
20157732|NCT01077063|Sidney Kimmel Comprehensive Cancer Center at JHMI|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
20157733|NCT03768427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157734|NCT01937520|Rutgers, The State University of New Jersey|Dennis Grech, MD|973 972-5007|grechde@njms.rutgers.edu|
20157735|NCT01644643|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
20157736|NCT02756403|MedStar Washington Hospital Center|Principal Investigator|202-877-7479|peggy.ye@medstar.net|
20157737|NCT00527618|University of Washington, Virology Research Clinic|Tara Perti, MD|(206) 520-4340|tarap@u.washington.edu|
20157738|NCT02099084|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20157739|NCT01490918|The Catholic University of Korea, Seoul St Mary's Hospital|Yoon Hee Choi|82-2-2258-8288|choiyh@catholic.ac.kr|
20157740|NCT00776789|AIIMS|Dr Anu Thukral|01126594605|dranuthukral@yahoo.com|
20157741|NCT02537730|Coopervision Japan|Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
20157742|NCT00648037|Memorial Sloan Kettering Cancer Center|Papadopoulos, Esperanza, MD (Attending)|+1212-639-8276|papadope@mskcc.org|
20157743|NCT02967679|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
20157744|NCT02379195|Center for Cancer Immune Therapy, Herlev Hospital|Dr. Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|
20157745|NCT02404168|University of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
20172875|NCT00387023|UT MD Anderson Cancer Center|Bita Esmaeli, MD / Professor||CR_Study_Registration@mdanderson.org|
20172876|NCT03310775|Kyunghee university hospital, Seoul, South Korea|Dr. Miae Oh|82-10-8929-5048|miae612@naver.com|
20172877|NCT00126568|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Panayiotis Savvides|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
20172878|NCT03064451|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
20172879|NCT00750204|Johns Hopkins University School of Medicine|Roy Brower, M.D.|1 (410) 614-6292|rbrower@jhmi.edu|
20172880|NCT02421315|New York State Psychiatric Institute|Dr. Rachel Marsh|646-774-5774|rachel.marsh@nyspi.columbia.edu|
20172881|NCT04853225|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20172882|NCT01404325|Novartis Pharmaceuticals|Study Director|8627788300||
20172883|NCT02389088|University of California, San Diego|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
20172884|NCT01075204|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954|esther.oppermann@abbott.com|
20172885|NCT01411228|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
20172886|NCT01986855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172887|NCT00848081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20218350|NCT00049842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20157746|NCT01197547|Boston Scientific|Meaghan Wilk|5086834113|wilkm@bsci.com|
20203178|NCT02546856|Servicio de Cardiologıa, Hospital Universitario Galdakao-Usansolo, OSI Barrualde-Galdakao-Osakidetza, Servicio Vasco de Salud, Galdakao, Bizkaia, Spain .BIOCRUCES, Instituto de Investigacion Sanitaria, Bizkaia, Spain|Juana Oyanguren, Nursing graduate, Master in Heart Failure, CV Pathology and Thrombosis Specialist|34 656780945|juanaoy@hotmail.com|
20203179|NCT01097616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203180|NCT00130208|Keryx Biopharmaceuticals|Medical Information|1-844-44-KERYX|medicalinfo@keryx.com|
20203181|NCT00591227|Rush University Medical Center|David Baldwin MD|312-942-6163|david_baldwin@rush.edu|
20203182|NCT03132246|University of Maryland School of Medicine|Dr. Aaron Johnson|410-328-1868|ajohnson1@som.umaryland.edu|
20203183|NCT01733069|Gen-Probe Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
20203184|NCT03268746|Alcon Research|Clinical/Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20203185|NCT00589472|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin|646-422-4470|slovins@mskcc.org|
20203186|NCT01372878|Given Imaging|"Ravit Peled | Biostatistics and Data Management Manager"|+972 (4) 909-7894|ravit.peled@givenimaging.com|7894
20203187|NCT00117338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203188|NCT00546351|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
20203189|NCT01342640|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20203190|NCT02616029|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20203191|NCT02267577|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
20203192|NCT00824538|University of California San Francisco|Hope S Rugo|877-827-3222|clinicaltrials@ucsf.edu|
20203193|NCT00479466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203194|NCT02739698|University Hospital Reina Sofia, Cordoba, Spain|Angela Casado-Adam, MD|0034957010439|angeti@hotmail.com|
20203195|NCT02383719|Convergent Engineering|Study Coordinator|3523784899|carl@conveng.com|113
20203196|NCT02927171|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
20203197|NCT01065480|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|nunesed@nyspi.columbia.edu|
20157747|NCT01953211|University Reproductive Associates|Michael Cho|(201) 288-6330|michaelcho@nyc.com|
20203198|NCT01834326|University of Michigan|Stephen E. Feinberg|734 763 5963|sefein@med.umich.edu|
20157748|NCT04005586|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20218351|NCT03977701|San Diego State University|Dr Jessica Barlow, Principal Investigator|6195943807|jbarlow@sdsu.edu|
20218352|NCT02519621|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20157749|NCT03391882|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20157750|NCT00543985|University of Missouri|Kevin C. Dellsperger, MD, PhD, Professor, Internal Medicine|573-884-2013|dellspergerk@health.missouri.edu|
20157751|NCT01280968|Duke University Medical Center|Alexey G Mukhin, M.D., Ph.D.|Telephone: 919-668-5055|amukhin@duke.edu|
20218353|NCT03676751|UCSF FI Proctor|Pr Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
20218354|NCT00775684|University of Pennsylvania|Professor of Medicine, Director of Translational Research Program|215 746-0025|rickels@pennmedicine.upenn.edu|
20218355|NCT02025751|Evoke Pharma|Chief Medical Officer|8589457189|mcarlson@evokepharma.com|
20157752|NCT00038948|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20157753|NCT02670473|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20157754|NCT01404234|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20157755|NCT01214837|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20157756|NCT00887159|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
20157757|NCT03663855|NYU Langone Health|David Goldfarb, MD|(212) 263-7300|David.Goldfarb@nyulangone.org|
20157758|NCT02259725|USC / Norris Comprehensive Cancer Center|Victoria Soto|3238653000|soto_v@med.usc.edu|
20157759|NCT06164691|University of Pittsburgh|Dr. Matthew Neal|412-647-1158|nealm2@upmc.edu|
20157760|NCT00812955|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
20157761|NCT03500289|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
20157762|NCT02609425|Henry Ford Health System|Sarah Meehan|313-916-9387|smeehan1@hfhs.org|
20157763|NCT01976871|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
20157764|NCT01673646|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20157765|NCT01063348|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
20157766|NCT00269087|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157767|NCT02304159|Southern California Research Center|Dr. Tarek Hassanein|619-319-3993|thassanein@livercenters.com|
20157768|NCT02160288|Massachusetts General Hospital|Dr Liliana Bordeianou|6176430541|lsavitt@mgh.harvard.edu|
20172888|NCT02064868|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20218356|NCT00653991|Annenberg School for Communication and Journalism, University of Southern California|Professor Lynn Carol Miller|310-874-3402|lmiller@usc.edu|
20218357|NCT02181296|University of Pennsylvania|Dr. Nabil M Elkassabany|(215) 662-3793|Nabil.Elkassabany@uphs.upenn.edu|
20157769|NCT00461708|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157770|NCT00501644|UT MD Anderson Cancer Center|Michael E. Garcia, RN, BSN||mgarcia@mdanderson.org|
20157771|NCT02394561|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20157772|NCT01464879|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20157773|NCT02455167|"University of Colorado Denver | Anschutz"|Amanda Wieland, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20172889|NCT00333814|Allergan, Inc|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20172890|NCT02670083|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20172891|NCT00711711|HECVSanté|Pr. Claude Pichonnaz|++41213168126|claude.pichonnaz@hesav.ch|
20172892|NCT01129609|Medtronic|Rianna Rapson|763-526-2170|rianna.k.rapson@medtronic.com|
20172893|NCT01938378|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
20172894|NCT00609492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172895|NCT00720434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172896|NCT02425046|Center for Children's Healthy Lifestyles & Nutrition - Children's Mercy Hospital|Dr. Helena Laroche|(816) 234-9251|hhlaroche@cmh.edu|
20172897|NCT03562481|University of North Carolina at Chapel Hill|Jessica Lee, DDS, MPH, PhD|9195373955|jessica_lee@unc.edu|
20172898|NCT01413191|UT MD Anderson Cancer Center|Dr. Sapna Patel, MD - Associate Professor, Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
20172899|NCT01571427|Oregon Health & Science University|Dr. Hiroko Dodge|(503) 494-6695|dodgeh@ohsu.edu|
20172900|NCT04493281|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20172901|NCT03454581|Federal University of Rio Grande do Sul|PhD Manoela Domingues Martins|55-51-33085011|manomartins@gmail.com|
20172902|NCT02634684|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
20172903|NCT00589914|Johnson & Johnson Pharmaceutical Research & Development LLC|Clinical Leader Psychiatry|1 609 730-2324||
20172904|NCT01737944|Antares Pharma|Jonathan Jaffe, MD; Vice President Clinical Development|1-609-359-3020|jjaffe@antarespharma.com|324
20218358|NCT02939014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20172905|NCT01356966|Emory University|Dr. Jeanie Park|404-727-1386|jeanie.park@emory.edu|
20172906|NCT00660530|University of Illinois College of Pharmacy|Dr. Alan Lau|(312) 996-0894|alanlau@uic.edu|
20172907|NCT02106728|Toronto General Hospital|Dr. Gina Dimitropoulos|416-340-3749|gdimit@ucalgary.ca|
20172908|NCT01967121|Michigan State University|Tracey Covassin|517-353-2010|covassin@msu.edu|
20172909|NCT02289898|Mereo BioPharma Group Plc.|John, Lewicki, Chief Scientific Officer|+44333023300|John.Lewicki@mereobiopharma.com|
20172910|NCT00267046|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-7966|xzhou@mdanderson.org|
20172911|NCT00103142|Duke University Medical Center|Dr. Michael Morse|919-684-5705|michael.morse@dm.duke.edu|
20172912|NCT01979016|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20172913|NCT04983264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172914|NCT01124422|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172915|NCT00938639|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20172916|NCT00142584|Viatris Inc|M. Rachel Kirker, PhD, Director, Clinical Oversight & Inspection Readiness|724-485-6170|rachel.kirker@viatris.com|
20172917|NCT01830699|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
20172918|NCT01354951|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
20172919|NCT04326231|Cognoa|Senior Director of Clinical Research|4082076659|minda.seal@cognoa.com|
20172920|NCT00759954|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20172921|NCT03124875|LimFlow Inc.|Cecilia Petrella|(888) 478-7705|cpetrella@limflow.com|101
20172922|NCT01313936|UCSF Dept of Pediatrics|Steven DuBois, MD|415-476-3831|duboiss@peds.ucsf.ed|
20172923|NCT02875860|Baylor College of Medicine|Dr. Michael Belfort|832-826-7375|belfort@bcm.edu|
20172924|NCT00473642|Retina Specialists of Michigan|Scott Westhouse, DO|616-954-2020|s.westhouse@gmail.com|
20172925|NCT01156311|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20172926|NCT00982592|Perlmutter Cancer Center at NYU Langone|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
20172927|NCT01741701|University of Kansas Medical Center|Dr. Rajesh Pahwa|913-588-6782|rpahwa@kumc.edu|
20172928|NCT01669915|Brigham and Women's Hospital;181 Longwood Ave; Boston, MA 02115|Jae Hee Kang|617-525-2022|nhjhk@channing.harvard.edu|
20172929|NCT04247581|Apple|Health Tech Clinical Operations|866-905-5303|htclinicalquestions@apple.com|
20172930|NCT01025791|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188118|NCT03873805|City of Hope Medical Center|Dr. Tanya Dorff|626 218 8231|tdorff@coh.org|
20188119|NCT03705793|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-362-5296|pawina@wustl.edu|
20188120|NCT00447980|Neurotech USA, Inc.|Patricia Davis, Sr. Director of Clinical Operations|401.333.3880|p.davis@neurotechusa.com|
20218359|NCT01019707|University of California Los Angeles|Edythe D London|310 825 0606|elondon@mednet.ucla.edu|
20157774|NCT00814255|NYUmed|Howard Trachtman|646-501-2663|howard.trachtman@nyumc.org|
20157775|NCT03937479|Verona Pharma Plc|Nancy Herje|+1 646-951-0961|nancy.herje@veronapharma.com|
20157776|NCT02712788|Indiana University|Heather Cero, RN - research cooordinator|317-396-1398|hcero@iupui.edu|
20157777|NCT02411461|Vanderbilt University Medical Center|Ashley Shoemaker, Principal Investigator|6153438116|ashley.h.shoemaker@vanderbilt.edu|
20157778|NCT00940602|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20157779|NCT01463033|Children's National Medical Center|Dr. Pavel Klein, P.I.|301-704-4925|kleinp@epilepsydc.com|
20157780|NCT01074125|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
20157781|NCT01368614|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
20157782|NCT00746187|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
20157783|NCT01904721|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20172931|NCT03033394|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
20172932|NCT03545165|Weill Cornell Medicine|Scott Tagawa MD, Principal Investigator|646-962-2072|guonc@med.cornell.edu|
20203199|NCT00718861|Novartis Pharmaceuticals|Study Director|8627788300||
20218360|NCT04527328|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
20218361|NCT02340221|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20218362|NCT00518622|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20218363|NCT03487848|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20218364|NCT02287909|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
20218365|NCT00515541|Invitrox, Inc|Dr. Don A. Gabriel|(919) 485-4600|dgabriel@invitrox.com|
20218366|NCT04268316|Stanford University|Margot Paul|415-625-3127|mdpaul@stanford.edu|
20218367|NCT00746018|Memorial Sloan Kettering Cancer Center|Nadeem Abu-Rustum, M.D.|212-639-7051|abu-rusn@mskcc.org|
20218368|NCT02132637|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20218369|NCT01030653|University of Michigan|Manjuanth Pai|7346470006|amitpai@med.umich.edu|
20218370|NCT03197558|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
20218371|NCT00353652|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
20218372|NCT01936519|Penn State Milton S Hershey Medical Center|Dr Zakiyah Kadry|717 531 5921|zkadry@pennstatehealth.psu.edu|
20218373|NCT00931268|Q-Med AB|Head of Clinical Development|+46 (0)18 4749000|reception.SEUPP@galderma.com|
20218374|NCT00723645|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20218375|NCT03052322|Fresenius Kabi Swiss BioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
20218376|NCT04920916|University of Virginia Health System|William Petri|434-305-9633|wap3g@virginia.edu|
20218377|NCT00973765|Washington Hospital Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
20218378|NCT01892657|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
20218379|NCT00076804|Johns Hopkins University Center for TB Research|Richard E. Chaisson|4109551755|rchaiss@jhmi.edu|
20218380|NCT00354341|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218381|NCT04295135|Indiana University|Dr. Christopher A. Harle|317 278 3245|charle@iu.edu|
20218382|NCT00334061|Penumbra Inc|Siu Po Sit, PhD Study Coordinator|510 748 3200|siupo.sit@penumbrainc.com|221
20218383|NCT01884064|University of Minnesota|Dr. Teresa Jacobson Kimberley|612-626-4096|tjk@umn.edu|
20218384|NCT01546649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20218385|NCT02312713|University of North Carolina at Chapel HIll|Kelli Allen|919-966-0558|kdallen@email.unc.edu|
20218386|NCT05420012|University of Utah|Josef Stehlik|801-585-9797|josef.stehlik@hsc.utah.edu|
20218387|NCT02684201|University of Pittsburgh|Dr. Lee Fisher, PhD|412-383-1077|lef44@pitt.edu|
20218388|NCT03808740|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
20218389|NCT01901874|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
20218390|NCT01933464|UCSD Dermatology Clincal Trials|Dermatology Clinical Trial Manager|(858)657-8390|dermstudies@ucsd.edu|
20218391|NCT01347866|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218392|NCT02429934|University of California at Los Angeles|Dr. Bevra Hahn|8184869745|bhahn@mednet.ucla.edu|8184869745
20203200|NCT01703819|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
20172933|NCT02927431|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20218393|NCT00869024|University of Minnesota|Dr. Ganesh Raveendran|612-626-4283|ravee001@umn.edu|
20218394|NCT01568866|Amgen Inc.|Study Director|866-572-6436||
20218395|NCT01698775|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218396|NCT03864042|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218397|NCT01244061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218398|NCT02143583|ANERGIS SA|G. DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
20218399|NCT01641133|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218400|NCT03052972|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20218401|NCT03351231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20218402|NCT03020719|Seattle Children's Hospital|Arthur Baines|2068841431|Arthur.Baines@seattlechildrens.org|
20218403|NCT03499119|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20218404|NCT02333487|H. LUndbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20172934|NCT01830972|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
20172935|NCT00673465|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203201|NCT01530399|TMC|Peter Villiger|+19732906340|peter.villiger@themedco.com|
20203202|NCT01302041|Astellas Pharma Global Devlopment, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
20203203|NCT02064439|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20218405|NCT00123955|Wake Forest Baptist Health|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
20218406|NCT01558297|Yale Medical School|Dr. Rachel Barnes|2037856395|rachel.barnes@yale.edu|
20218407|NCT04143243|Baylor College of Medicine|Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
20218408|NCT02218307|University of Miami|Dr. Roy Casiano|305-243-1870|rcasiano@miami.edu|
20172936|NCT01829191|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
20218409|NCT03692312|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
20218410|NCT01408563|Massachusetts General Hospital|Dr. Zachariah DeFilipp|617-643-3944|ZDEFILIPP@mgh.harvard.edu|
20218411|NCT00996931|Sutter Institute for Medical Research|Carol Parise, PhD|916-733-4413|PariseC@sutterhealth.org|
20218412|NCT02246439|RedHill Biopharma Ltd.|Dr. Terry Plasse|+972-(0)3-541-3131|terry@redhillbio.com|
20218413|NCT03439852|University of Hawaii at Manoa, Office of Research Studies|Sharleen Andreshak|808 356 5762|sfa2@hawaii.edu|
20218414|NCT00666848|Vanderbilt University School of Medicine|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
20218415|NCT00289757|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218416|NCT02177136|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20218417|NCT02054130|MedImmune, LLC|Fred Reid|+44 (0) 203 749 6512|information.center@astrazeneca.com|
20218418|NCT01386684|AbbVie|Global Medical Services|800-633-9110||
20218419|NCT00364949|Northwestern University|Dr. Andrea Dunaif|312-503-2902|a-dunaif@northwestern.edu|
20218420|NCT00094458|Centocor Ortho Biotech Services, L.L.C.|Study Director|215 325-7405||
20218421|NCT02130583|Alpert Brown Medical School|Shirley Yen, Ph.D., Principal Investigator|4014441915|Shirley_Yen_PhD@Brown.edu|
20218422|NCT02149290|ZOLL LifeVest|VP of Medical Affairs|412-968-3333|stevens@zoll.com|14400
20218423|NCT00131378|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
20218424|NCT01995266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
20218425|NCT03247517|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
20218426|NCT03310411|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20218427|NCT00619112|UCSF|Nicholas Butowski|4153532966|Butowski@neurosurg.ucsf.edu|
20218428|NCT03623386|Yale School of Medicine|Sule Tinaz, MD, PhD: Associate Professor of Neurology|(877) 925-3637|sule.tinaz@yale.edu|
20218429|NCT03573505|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20218430|NCT02040779|Teva Branded Pharmaceutical Products R&D|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20218431|NCT01385306|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20218432|NCT03949244|Icahn School of Medicine at Mount Sinai|Harriet Lloyd|212-979-4672|hlloyd@nyee.edu|
20218433|NCT02145026|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20218434|NCT01825889|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20218435|NCT05080426|Purdue University|Dr. Ellen Ernst Kossek|(765) 494-6852|ekossek@purdue.edu|
20218436|NCT01570348|FHCRC|Dr. George Georges|(206) 667-6886|ggeorges@fredhutch.org|
20157784|NCT01957865|Massachusetts General Hospital|Jessica Haberer|617 724 0351|jhaberer@partners.org|
20157785|NCT00811720|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20172937|NCT01276353|Clinical Development. JAC PCU. Eisai Co., Ltd.|Naoki Kubota|+81-3-3817-5245||
20157786|NCT02750930|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20157787|NCT00553631|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20157788|NCT01111162|University of Pennsylvania|Pablo Tebas|2153498092|pablo.tebas@uphs.upenn.edu|
20157789|NCT00114127|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
20157790|NCT03188263|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
20157791|NCT00699413|USC|Michael Goran|323.442.3027|goran@usc.edu|
20157792|NCT02779777|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|ko-tip-003@kuraoncology.com|
20157793|NCT00881894|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20157794|NCT00469833|Cincinnati VAMC|David D'Alessio, MD, Section head, Endocrinology, Cincinnati VAMC|513-475-6478|david.d'alessio@va.gov|
20157795|NCT01253369|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
20172938|NCT00553514|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20172939|NCT04952402|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20172940|NCT00726661|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20172941|NCT03327649|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|14052714742|stavros-stavrakis@ouhsc.edu|
20172942|NCT00587639|Mayo Clinic|Dr. Christopher Wall|5072843352|wall.chris@mayo.edu|
20172943|NCT01860651|Hvidovre University Hospital|Dr. Katrine Carlsen|26180513|katrinec@gmail.com|0045
20172944|NCT02695498|Atrium Health Wake Forest Baptist|Rebecca Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
20172945|NCT00160251|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20188121|NCT02720068|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20203204|NCT02433288|AstraZeneca|Traxler, Barry M|+1 301 398 0657|barry.traxler@astrazeneca.com|
20203205|NCT03350750|Johns Hopkins|Jessica Wollett|6673068141|jwollet1@jh.edu|
20203206|NCT00858702|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20203207|NCT00205504|Virginia Commonwealth University|Kai Cheang, Principal Investigator|804-828-9698|kicheang@vcu.edu|
20157796|NCT03289533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157797|NCT00539240|Southern Arizona VA Health Care System|Christopher Wendel, MS|520 792 1450|christopher.wendel@va.gov|1824
20172946|NCT01574612|Meda Pharmaceutical|David Ginsberg, DO|732 564 2200|ginsberg.david@gmail.com|
20203208|NCT01834144|University of Manitoba|Dr. Jonathan McGavock|204-480-1359|jmcgavock@chrim.ca|
20157798|NCT01628523|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wusm.wustl.edu|
20218437|NCT01621191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20218438|NCT01610453|Stavanger UH|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
20172947|NCT02245308|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
20172948|NCT02407704|University of Pittsburgh|Dr. Kirk Erickson|412-624-4533|kiericks@pitt.edu|
20172949|NCT00748033|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
20172950|NCT00064844|Yale University School of Medicine|Ned Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
20172951|NCT00434330|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20172952|NCT01428453|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172953|NCT01996709|Alcon Research, Ltd.|Jessie Lemp, DrPH, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20172954|NCT00850564|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
20172955|NCT02781051|UT Southwestern Medical Center|Chad Rethorst, Associate Professor|2146480153|chad.rethorst@utsouthwestern.edu|
20172956|NCT02564042|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172957|NCT02066233|Mayo Clinic|Dr. Prasad G. Iyer|507-284-6469|Iyer.Prasad@mayo.edu|
20172958|NCT01077856|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172959|NCT05081011|Stanford University|Ashwin K Nayak, MD|(650) 725-5071|aknayak@stanford.edu|
20172960|NCT01961323|Icahn School of Medicine at Mount Sinai|Dr. Partho Sengupta|212-659-8847|partho.sengupta@mountsinai.org|
20203209|NCT02234583|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
20203210|NCT01849250|The University of Texas MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention|713-792-7734|PHBrown@mdanderson.org|
20203211|NCT00367640|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20203212|NCT02631135|UludagU|Hale Aksu Erdost,MD,spesialist|+905323615722|haleaksu78@yahoo.com|
20203213|NCT02367170|University of Florida|PhD in exercise physiology|352 2736105|UFCT-gov@ufl.edu|
20203214|NCT02688842|Shanghai Microport Medical (Company) Co.,Ltd.|Haotian Zhang|+86-21-38954600|zhanght@microport.com|8552
20203215|NCT04504032|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20203216|NCT00771030|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20203217|NCT01839188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203218|NCT00114114|Massachusetts General Hospital|Dr. Ben Leder|617-726-6723|bzleder@partners.org|
20203219|NCT02075255|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
20203220|NCT03792750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20157799|NCT01284959|Chonbuk National University Hospital|Prof. Youngchul Chung|+82-63-250-2185|chungyc@chonbuk.ac.kr|
20157800|NCT01055613|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D.- Research Principle Optometrist|904-443-1290|BPALL@its.jnj.com|
20157801|NCT00363311|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157802|NCT02651545|UBMD Neurology|Michael Jaworski|716-323-0550|mgjawors@buffalo.edu|
20157803|NCT03175731|Qilu Hospital of Shandong University|Prof. Gao|+86-531-82169386|gaoyanjing@sdu.edu.cn|
20157804|NCT02103062|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20157805|NCT01182298|NIAID|Shyam Kottilil||Skottilil@niaid.nih.gov|
20157806|NCT01974284|Yale University School of Medicine|Dr. Glenda Callendar|203-737-2036|glenda.callender@yale.edu|
20157807|NCT02629861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@Tevapharm.com|
20157808|NCT00730886|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20172961|NCT00449046|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172962|NCT01285310|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
20172963|NCT00514540|University of Texas MD Anderson Cancer Center|Lisa Pruitt, Quality Assurance Specialist|713-792-0411|LPruitt@mdanderson.org|
20172964|NCT04468204|Department of Otolaryngology - Head and Neck Surgery|Director of Clinical Research|(843)792-1356|nguyensh@musc.edu|
20172965|NCT01996982|Ascension Seton|Research Enterprise Staff|512-3247991|ra@seton.org|
20172966|NCT03530098|Stanford University|Safwan S Halabi, MD|(650) 721-2850|safwan.halabi@stanford.edu|
20172967|NCT02278250|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20172968|NCT01195415|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
20172969|NCT01442675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20172970|NCT00752232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172971|NCT00555321|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20188122|NCT03094052|University of California, San Francisco|Dr. A. Jo Chien, MD|(415) 885-7577|Jo.Chien@ucsf.edu|
20188123|NCT00124735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20188124|NCT02467270|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20188125|NCT04899778|Cedars-Sinai Medical Center|Dr. Melodie Metzger|310-423-7765|Melodie.Metzger@cshs.org|
20188126|NCT05377411|University of Florida|Dr. Aprinda Queen|(352) 294-8990|aprinda.indahlas@phhp.ufl.edu|
20188127|NCT03718130|GenevaUSA.org|Elissa K. Thomas, Associate Director, Corporate Strategy|248-802-6095|ethomas@genevausa.org|
20188128|NCT01167010|Eurofarma Laboratórios S.A|Sandra Rodrigues (Clinical Research)|1150908600|sandra.rodrigues@eurofarma.com.br|8417
20188129|NCT03340428|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
20203221|NCT01748760|Brown University|Shirley Yen, Ph.D.|401-444-1915|Shirley_Yen_PhD@Brown.edu|
20172972|NCT00005937|NIH National Heart, Lung and Blood Institute|Neal S. Young MD|301-402-1806|youngns@nhlbi.nih.gov|
20172973|NCT00563381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157809|NCT01991483|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203222|NCT00872898|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
20203223|NCT01183546|Human Engineering Research Laboratories|Dr. Alicia Koontz|412-822-3700|alicia.koontz@va.gov|
20203224|NCT00138125|University of California at Los Angeles|Richard J. Pietras, M.D. Ph.D|310 825 9769|rpietras@ucla.edu|
20203225|NCT02351037|Pharmacyclics|Priyanka Mandava, Director of Clinical Operations|408-215-3776|psingh@pcyc.com|
20203226|NCT03176966|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
20157810|NCT04344184|Virginia Commonwealth University|Dr. Alpha Fowler|(804) 519-4369|alpha.fowler@vcuhealth.org|
20157811|NCT02030821|Duke University|Michael Bolognesi, M.D.|919-668-4732|michael.bolognesi@duke.edu|
20157812|NCT02665260|Montefiore Medical center|Dr. Steven Cohen|718-920-8470|dermpharmeinstein@gmail.com|
20157813|NCT01722929|Northwestern University|Murad Alam, MD|312-695-4761|m-alam@northwestern.edu|
20203227|NCT01520922|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20203228|NCT01202110|Cedars-Sinai|Leah Silbert|310 423-3783|Leah.Silbert@cshs.org|
20203229|NCT02269319|MicuRx Pharmaceuticals Inc.|John M. Sall, Global Head of Regulatory|919-670-7803|jsall@micurx.com|
20217981|NCT01807117|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Raj Paspulati|1-800-641-2422|Raj.Paspulati@UHhospitals.org|
20217982|NCT00834899|University of North Carolina at Chapel Hill|Kenneth I. Ataga, MD|919-966-0178|kataga@med.unc.edu|
20217983|NCT04070287|Saint Louis University|Dr. Juliet Iwelunmor|2405280123|juliet.iwelunmor@slu.edu|
20217984|NCT02709486|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172974|NCT01911689|Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College|Dr.XiaoMing Zhang|+86 817 2262218|cjr.zhxm@vip.163.com|
20217985|NCT00572117|Stanford University School of Medicine|Michael J. Ostacher, MD, MPH, MMSc|650-493-5000|ostacher@stanford.edu|
20217986|NCT00489281|Johns Hopkins University|F Javier Bolanos Meade, MD|4106146398|fbolano2@jhmi.edu|
20217987|NCT00606502|Allos Therapeutics, Inc|Medical Monitor|303-426-6262|gweems@allos.com|
20217988|NCT01615887|SUNY University at Buffalo|Ralph Benedict|716-323-0556|benedict@buffalo.edu|
20157814|NCT00716274|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157815|NCT00601367|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20157816|NCT01600287|Postgraduate Institute of Medical Education and Research|Dr G D Puri|00919914209509|gdpuri007@hotmail.com|
20172975|NCT01957644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172976|NCT02730455|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20172977|NCT02733367|Diurnal|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
20217989|NCT00737737|National Institutes of Health Clinical Center|Andrew Mannes, M.D.|301-594-3427|Andrew.Mannes@nih.gov|
20217990|NCT02540447|Mansoura Faculty of Medicine|Amr Mohamed Yassen Ali Badawy|+201001497044|amryassen@hotmail.com|
20217991|NCT02443545|Chiesi Canada Corp.|Fernando Tricta, MD|1-800-854-3534|f.tricta@chiesi.com|7049
20217992|NCT00604201|National Heart Lung and Blood Institute|Childs, William|+1 301 451 7128|childsr@nhlbi.nih.gov|
20217993|NCT01855048|Organization:Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
20217994|NCT03465436|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20217995|NCT01813071|PATH|Jennifer O'Reilly|202-540-4510|joreilly@path.org|
20217996|NCT01769274|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217997|NCT01688726|Alcon Research, Ltd.|Abayomi Ogundele, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20217998|NCT04553913|Atrium Health Wake Forest Baptist|Seiha Kim, DO|336-716-4498|sekim@wakehealth.edu|
20217999|NCT01172821|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157817|NCT03111030|Unviersity of British Columbia|Dr. Kathleen Martin Ginis|250-807-9768|Kathleen_martin.ginis@ubc.ca|
20157818|NCT04021290|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20188130|NCT02954809|University at Buffalo|Dr. Carleara Weiss|716-829-2006|carleara@buffalo.edu|
20172978|NCT05564429|National Institute of Mental Health (NIMH)|Dr Robert Innis|301-594-1368|robert.innis@nih.gov|
20172979|NCT02480439|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20172980|NCT03049280|Intuitive Surgical|Intuitive Surgical Clinical Affairs|408-523-2100|sylvie.akiel-fu@intusurg.com|
20172981|NCT01683383|Stanford University School of Medicine|Krisa P. Van Meurs, M.D.|+1 650 723 5711|vanmeurs@stanford.edu|
20172982|NCT00996307|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20172983|NCT02326025|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20172984|NCT00001723|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN|301-496-4686|yanovskj@mail.nih.gov|
20172985|NCT00536198|Yale University School of Medicine|Kimberly A. Yonkers, M.D.|203-764-5914|Kimberly.Yonkers@yale.edu|
20172986|NCT02643082|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|650-305-2600|creisner@pearltherapeutics.com|
20172987|NCT00881712|University of Florida Proton Therapy Institute|Bradford Hoppe, M.D.|904-588-1800|bhoppe@floridaproton.org|
20172988|NCT01324999|University of North Carolina at Chapel Hill|H. James Ford, MD|(919) 966-2531|hjford@med.unc.edu|
20172989|NCT01294267|Icahn School of Medicine at Mount Sinai, Helmsley Electrophysiology Center|Vivek Y. Reddy, MD|212-241-7114|vivek.reddy@mountsinai.org|
20172990|NCT02505867|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
20172991|NCT00060008|Children's Hospital of Philadelphia|Dr. Michael Fisher|215 590 2800|fisherm@email.chop.edu|
20188131|NCT03910218|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
20218000|NCT00965055|UCSD|Ori Ben-Yehuda|9179697273|obenyehuda@ucsd.edu|
20172992|NCT01307397|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20172993|NCT00560859|University of Pennsylvania|Dr. Susan S. Ellenberg|215-573-3904|sellenbe@upenn.edu|
20218439|NCT02494817|University of Hawaii|Jason W. Mitchell, PhD, MPH|8082196729|jasonmit@hawaii.edu|
20218440|NCT03529461|Bristol Hospital|Makram Gedeon, MD|8605853339|mgedeon@bristolhospital.org|
20218441|NCT02003911|Mount Sinai Kravis Children's Hospital|Dr. Lindsey Douglas|2122416500|lindsey.douglas@mssm.edu|
20218442|NCT00038649|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-794-5783|CR_Study_Registration@mdanderson.org|
20218443|NCT00942331|Memorial Sloan-Kettering Cancer Center|Jonathan Rosenberg, MD|646-422-4461|rosenbj1@mskcc.org|
20218444|NCT02994251|Yale University|Dr. Todd Schlachter|203-785-5885|todd.schlachter@yale.edu|
20218445|NCT00567476|Novartis Pharmaceuticals|Study Director|862 778-8300||
20218446|NCT01155778|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20157819|NCT00553410|International Breast Cancer Study Group (IBCSG)|Meredith M. Regan|+1 617 632 3012|mregan@jimmy.harvard.edu|
20172994|NCT00230607|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20203230|NCT05287893|Medicines for Malaria Venture|Joerg Moehrle|+41 22 555 03 00|info@mmv.org|
20157820|NCT01846702|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157821|NCT01174563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20157822|NCT00444106|Novartis Pharmaceuticals|Study Director|862-778-8300||
20203231|NCT02699515|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|+49
20157823|NCT01634152|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157824|NCT01349114|University of Alabama at Birmingham|David A. Calhoun, MD|205-934-4633|dcalhoun@uab.edu|
20157825|NCT02751814|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20157826|NCT01152437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157827|NCT03848455|Zhujiang Hospital of Southern Medical University|Xiaoya Gao|18680282869|4356975@qq.com|
20157828|NCT03210701|School of Pharmacy, Memorial University|Dr. Debbie Kelly|709 864 7805|dvkelly@mun.ca|
20203232|NCT01240811|University of Pittsburgh|Sharon Achilles, MD, PhD|412-641-1403|achisx@upmc.edu|
20157829|NCT00279214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20157830|NCT01897532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157831|NCT03682965|Pharma Initiatives|Mark Shapiro|9193063675|mshapiro@pharmainitiatives.com|
20157832|NCT00953706|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20157833|NCT01088906|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
20203233|NCT02898207|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
20203234|NCT01842061|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
20203235|NCT03032068|Cleveland Clinic|Jayson Zadzilka|216-445-8023|zadzilj@ccf.org|
20203236|NCT01976819|University Medical Center Groningen and University of Groningen|Prof. Dr. Bernard F.A.M. van der Laan, PhD, MD|0031 (50) 361 27 00|b.f.a.m.van.der.laan@umcg.nl|
20157834|NCT00457626|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20157835|NCT00896012|University at Buffalo|Oleh G. Pankewycz, MD||opankewycz@kaleidahealth.org|
20203237|NCT03918642|VA Greater Los Angeles Healthcare System|Brandon C. Yarns|310-478-3711|brandon.yarns@va.gov|
20203238|NCT05085392|Montana State University|Dr. Lauren Davis|8287736328|laure.davis6@montana.edu|
20203239|NCT01988012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20218447|NCT04017754|Aalborg University Hospital, Gynecologic and Obstetric department|Caroline Nørgaard-Pedersen|+45 41120267|carolinenp94@gmail.com|
20203240|NCT03823937|Sultan.abdulhamid|Tugbaozsoy|+905074583382|tugbaozsoyy@gmail.com|
20203241|NCT01228071|Endo Pharmaceutical, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20203242|NCT02024711|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20203243|NCT02344628|London School of Hygiene and Tropical Medicine|Dr Michael Marks|+447984643424|michael.marks@lshtm.ac.uk|
20203244|NCT06001372|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20203245|NCT03238248|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20218448|NCT03508687|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@med.umich.edu|
20218449|NCT02447926|Northwestern University|Dr. Josh Levitsky|312-695-4837|j-levitsky@northwestern.edu|
20218450|NCT01491035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20218451|NCT02728752|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
20218452|NCT04722601|University of Chicago|Dr. Sonali Smith|855-702-8222|smsmith@bsd.uchicago.edu|
20157836|NCT01783444|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20157837|NCT00552071|Cedars-Sinai Medical Center|Vivian Hwe|4224-315-4489|hwev@cshs.org|
20157838|NCT01900067|Mölnlycke Health Care AB, Surgical Division|Jenny Höglind|0046 31 722 30 00|Jenny.Hoglind@molnlycke.com|
20157839|NCT03557125|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsonsh@musc.edu|
20157840|NCT00937495|University of Wisconsin|Steven Attia, D.O.||sa2@medicine.wisc.edu|
20157841|NCT00441272|National Institute of Allergy and Infectious Diseases|Colleen Hadigan, MD, MPH|301-594-5754|hadiganc@niaid.nih.gov|
20157842|NCT00954447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157843|NCT04592341|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20157844|NCT00692003|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
20157845|NCT01047189|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
20172995|NCT02860169|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20157846|NCT01535287|University of Iowa|Martin Mueller|3193562633|martin-mueller@uiowa.edu|
20157847|NCT00517699|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157848|NCT03341637|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20157849|NCT05547412|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
20172996|NCT00165776|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|+81-3-3817-5245||
20203246|NCT03463265|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
20203247|NCT02241512|UT Southwestern|Dr. David Troendle|214456-8000|david.troendle@utsouthwestern.edu|
20203248|NCT04410783|Washington Univeristy|Brian M Fuller|3147475368|fullerb@wustl.edu|
20203249|NCT02345161|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203250|NCT02284399|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
20203251|NCT00972244|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20218453|NCT02999477|Dana-Farber Cancer Institute|Adrienne Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
20218454|NCT01846273|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20218455|NCT00891839|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20157850|NCT03181971|Stanford University|Anisha Patel, MD|(650) 497-1181|anipatel@stanford.edu|
20157851|NCT02291133|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
20157852|NCT01815424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157853|NCT04723355|Hospital Israelita Albert Einstein|Clinical Trialist|551121515915|karla.santo@einstein.br|
20157854|NCT03374358|Helsinki University Hospital|Dr Jussi Sutinen|+358407480437|jussi.sutinen@hus.fi|
20157855|NCT01127633|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157856|NCT01805687|Cornerstone Therapeutics, Inc.|W. James Alexander, MD, MPH|919-678-6925|jim.alexander@chiesi.com|
20157857|NCT02805790|Stealth BioTherapeutics Inc.|Rekha Sathyanarayana, Executive Director, Clinical Operations|617-762-2579|Rekha.Sathyanarayana@stealthbt.com|
20157858|NCT02189889|UT Southwestern Medical Center|Philip Greilich -PROFESSOR|214/645-8018|PHILIP.GREILICH@UTSouthwestern.edu|
20157859|NCT01244711|Weill Cornell Medical College|james kocsis|212-746-5913|jhk2002@med.cornell.edu|
20157860|NCT00290810|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
20157861|NCT01639469|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20157862|NCT00420381|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157863|NCT02078752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157864|NCT01144143|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
20172997|NCT04973826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172998|NCT00492583|Georgetown University|Daniel J Merenstein, MD|202-687-2745|djm23@georgetown.edu|
20203252|NCT00090285|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203253|NCT03904446|University of Iowa|Cynthia A. Wong, MD|13193563868|cynthia-wong@uiowa.edu|
20157865|NCT00439335|Baylor College of Medicine|Shital Patel, MD|713-798-3793|shitalp@bcm.tmc.edu|
20157866|NCT00512278|Cleveland Clinic|Nizar Zein|216-444-6126|zeinn@ccf.org|
20157867|NCT00753948|James J. Peters VAMC|Joshua Hobson|(718) 584-9000|joshua.hobson@va.gov|3129
20157868|NCT00775268|National Cancer Institute|Dr. Esther Mena|240-760-6111|esther.menagonzalez@nih.gov|
20172999|NCT01897402|JN-International Medical Corporation|Regulatory Affairs Director|4028843477|dr_orten@jn-vaccines.org|
20173000|NCT01209260|University of California San Diego|Jonathan Hsu, MD, MAS|415-476-5706|jonathan.hsu@ucsd.edu|
20188132|NCT05441683|Department of Periodontology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China|Dr. Yan-Min Wu|+86-13757119560|wuyanmin@zju.edu.cn|
20188133|NCT05109871|Liverpool University Hospitals NHS Foundation Trust|Richard Norris|0151529 2534|richard.norris2@liverpoolft.nhs.uk|
20188134|NCT05769634|Icahn School of Medicine at Mount Sinai|Allison C.Waters|(212) 523-8832|allison.waters@mssm.edu|
20188135|NCT00704769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20188136|NCT05374538|VITRAC Therapeutics, LLC|Linda Paradiso, DVM, Chief Development Officer|713-898-8965|linda.paradiso@vitractherapeutics.com|
20188137|NCT04276779|University of Alabama at Birmingham|Dr. Caitlin Clevenger|205-934-7008|cwclev@uab.edu|
20188138|NCT04281498|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
20173001|NCT01648205|University of Rochester|Wojciech Zareba, MD, PhD|5852755391|wojciech_zareba@urmc.rochester.edu|
20203254|NCT02238028|Fudan University|Dr. Haidong Kan|+86-021-54237908|kanh@fudan.edu.cn|
20203255|NCT02834052|AUGUSTA UNIVERSITY MEDICAL CENTER|Dr Asha Nayak|7067216748|anayak@augusta.edu|
20203256|NCT02855411|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20203257|NCT00907881|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157869|NCT00825994|Massachusetts General Hospital|Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
20173002|NCT00203996|The University of Chicago|David A. Ehrmann, MD|(773) 702-6138|dehrmann@medicine.bsd.uchicago.edu|
20188139|NCT04342260|University of North Carolina Lineberger Comprehensive Cancer Center|Amanda Gentry|(336) 655-7743|agentry@email.unc.edu|
20203258|NCT01391312|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20173003|NCT01217840|Stanford University|Sejal Shah MD|6507211811|sshah2@stanford.edu|
20203259|NCT03864237|Brown University School of Public Health|Kate B. Carey|4018636558|kate_carey@brown.edu|
20203260|NCT01848821|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|617-724-8604|dyeh2@partners.org|
20218456|NCT00695435|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20157870|NCT00410189|University of Texas (UT) MD Anderson Cancer Center|Anne S. Tsao, MD / Associate Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
20173004|NCT00897104|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20157871|NCT03723980|Dow University of Health Sciences|Dr. Juzer Shabbir Saifee|92-333-2352134|dr.juzer.shabbir@gmail.com|
20173005|NCT01937559|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
20173006|NCT02167893|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20173007|NCT04818840|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20173008|NCT01804075|Eastern Maine Medical Center|Dr. Mark Brown|207-973-9503|mbrown@emh.org|
20173009|NCT00973739|New York University Langone Medical Center|Matthias Karajannis, MD|212-263-8400|matthias.karajannis@nyumc.org|
20173010|NCT00733408|University of Washington|Jennifer Specht, MD, Associate Professor|(206) 606-1000|jspecht@uw.edu|
20173011|NCT00531232|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20173012|NCT01438424|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20173013|NCT04232124|Vanderbilt University Medical Center|David G. Harrison|6158753049|david.g.harrison@vumc.org|
20173014|NCT02152696|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
20173015|NCT04812964|VA Greater Los Angeles Healthcare System|Dr. Jonathan Jacobs|310-478-3711|jonathan.jacobs2@va.gov|
20173016|NCT02329730|Shanghai Public Health Clinical Center|Shuihua Lu|021-37990333|tubercle@gmail.com|2582
20173017|NCT02423577|President and Chief Scientific Officer|Russell Wilson, PhD|504-896-2789|rbw@autoimmune.com|
20203261|NCT05057988|Stanford University|Dr. Dokyoung Sophia You|650-724-9320|dsyou@stanford.edu|
20188140|NCT03142009|University of New Mexico College of Population Health|Dr. Nina Wallerstein|404-272-4173|nwallerstein@salud.unm.edu|
20188141|NCT03587805|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
20188142|NCT03008382|Virginia Commonwealth University|Dr. Thomas Chelimsky|(804) 628-4859|Thomas.Chelimsky@vcuhealth.org|
20203262|NCT02296346|Huntsman Cancer Institute, University of Utah|Dr. Daniel Couriel|801-213-3082|dan.couriel@hci.utah.edu|
20203263|NCT00850499|Johnson & Johnson Pharmaceutical Research & Development|Andrew Cakana, MD, FRC Path||[ACAKANA@ITS.JNJ.COM|
20203264|NCT02385123|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
20203265|NCT03626415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203266|NCT04498910|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20203267|NCT03881163|Zambon S.p.A|Valentina Vaja|+390266524497|Valentina.Vaja@ZambonGroup.com|
20203268|NCT02057237|Princess Margaret Cancer Centre|Dr. Anthony Joshua|416-946-4501|anthony.joshua@uhn.ca|2520
20203269|NCT02345434|Columbia University|Adam Sacarny|212 305 7084|ajs2102@columbia.edu|
20203270|NCT02221739|Weill Cornell Medical College|Silvia Formenti, M.D.|646-962-4065|formenti@med.cornell.edu|
20203271|NCT01022853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203272|NCT01327339|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203273|NCT03245814|The University of Arizona|Dr. Maggie O'Haire|520-621-6767|maggieohaire@arizona.edu|
20203274|NCT00946270|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD./Professor|713-745-3429|sverstov@mdanderson.org|
20203275|NCT02263365|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
20203276|NCT00510692|S.L.A. Pharma (UK) Ltd|Dr Chris Jordan|+44 (0)1923 681001|cjordan@slapharma.com|
20203277|NCT00945191|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20203278|NCT00784784|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
20218457|NCT00851643|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20218458|NCT00359788|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218459|NCT01869478|Mayo Clinic|Kevin M. Barrett, MD|904-953-9740|Barrett.Kevin@mayo.edu|
20218460|NCT00103402|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
20218461|NCT01393730|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-582-7221|mary_taplin@dfci.harvard.edu|
20218462|NCT02674061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218463|NCT03182582|Stanford University|Geoffrey C. Gurtner, MD|650-736-2776|ggurtner@stanford.edu|
20218464|NCT03334721|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
20157872|NCT00616642|University of California Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
20157873|NCT03856359|Duke University Hospital|Dr. Paul V. Suhocki|919-684-7284|suhoc001@mc.duke.edu|
20157874|NCT01102738|Imperial College London|Dr. Kathleen Sim|(+44) (0)20 7594 3695|k.sim@imperial.ac.uk|
20157875|NCT01212471|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20157876|NCT01881009|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
20157877|NCT03417466|Medtronic Minimed|Fen Peng, Biostatistician|8185763253|fen.peng@medtronic.com|
20157878|NCT05518461|University of Wisconsin - Madison|Dr. Rachel Gicquelais|(608) 890-1837|gicquelais@wisc.edu|
20157879|NCT01886235|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20157880|NCT03326063|Brigham and Women's Hospital|Tanya Laidlaw, MD|617-525-1034|tlaidlaw@bwh.harvard.edu|
20157881|NCT01876381|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20157882|NCT00332696|Novartis Pharmaceuticals|Study Director|862-778-8300||
20157883|NCT00382174|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-280-1992|nturjman@regenerx.com|108
20157884|NCT02750514|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20173018|NCT02345850|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20218465|NCT02646449|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
20218466|NCT02932228|VA Palo Alto Health Care System|Dr Donna Zulman|650-493-5000|Donna.Zulman@va.gov|29113
20218467|NCT04189445|Taiho Oncology, Inc|Taiho Oncology, Inc|609-250-7336|clinicaltrialinfo@taihooncology.com|
20218468|NCT00102518|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
20218469|NCT02960893|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20218470|NCT05142566|Essential Medical LLC (a subsidary of Teleflex, Inc.)|Darra Bigelow, Sr. Manager, Clinical Operations|610-331-7299|darra.bigelow@teleflex.com|
20173019|NCT02758899|Washington University|Wilson Z. Ray|314-747-6145|rayz@wustl.edu|
20173020|NCT02392247|Virginia Commonwealth University|Dr.Bruce Spiess, Principal Investigator|804-828-2267|bruce.spiess@vcuhealth.org|
20173021|NCT02927080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173022|NCT01430091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20173023|NCT01991067|Medical University of Vienna, Department of Medicine I, Division of Infectious Diseases|Assoc. Prof. Dr. Christina Bahrs|+4314040044400|christina.a.forstner@meduniwien.ac.at|
20173024|NCT03134989|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|
20173025|NCT00945139|University of Vermont CC|Dr. Claire Verschraegen|802-656-5487|claire.verschraegen@vtmednet.org|
20173026|NCT00224055|Watson Pharmaceuticals, Inc|Naomi Dahl, PharmD Director, Clinical Affairs||Naomi.dahl@watson.com|
20173027|NCT02068443|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20173028|NCT00664742|Novartis Pharmaceuticals|Study Director|862-778-8300||
20218471|NCT00997139|Northwestern University Department of Dermatology|Clinical Trials Unit Coordinator|312-695-6829|mandybrowning2015@u.northwestern.edu|
20218472|NCT00313443|Unité de Recherches Thérapeutiques. Service de Médecine Interne A. Hôpital Lariboisière. Paris, France|Dr Carmelo Lafuente-Lafuente|+33 1 49 95 63 37|c.lafuente@nodo3.net|
20218473|NCT04718194|Yale|Dr. Dani Chiaramonte|3479310195|danielle.chiaramonte@yale.edu|
20173029|NCT04317066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20173030|NCT02771990|Providence Veterans Affairs Medical Center|Benjamin Greenberg|4012737100|benjamin.greenberg@va.gov|
20173031|NCT02014597|Baylor College of Medicine|Dr. Benjamin Frankfort|713-798-3453|benjamin.frankfort@bcm.edu|
20173032|NCT02825992|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|763-331-4344|steven.mcquillan@acutus.com|
20173033|NCT01780636|UC Irvine|Karen Noblett|714-456-6807|knoblett@uci.edu|
20173034|NCT02279173|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20173035|NCT01164956|Dana-Farber Cancer Institute|Christina K. Ullrich, MD, MPH|617.632.4997|Christina_Ullrich@dfci.harvard.edu|
20173036|NCT00931762|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20173037|NCT01320085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173038|NCT01702454|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173039|NCT00710710|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173040|NCT03510884|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20218474|NCT05713552|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20173041|NCT02282020|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
20218475|NCT04551911|OPKO Health Inc|OPKO Health Inc|305-575-4100|contact@opko.com|
20218476|NCT01215513|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20218477|NCT01383421|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20173042|NCT01500629|Johnson & Johnson Consumer and Personal Products Worldwide|Daniel Qi, MD, PhD, Director, Clinical Research|973 385-2260|dqi6@its.jnj.com|
20173043|NCT00849381|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173044|NCT01622699|Isala|Dr J Bekhof|0384247492|j.bekhof@isala.nl|+31
20173045|NCT02461355|Burke Neurological Institute|Tomoko Kitago, MD|914-368-3169|tok7002@med.cornell.edu|
20173046|NCT04429061|University of Alabama at Birmingham|Dr Carolyn Bolton|966841034|Carolyn.Bolton@cidrz.org|
20173047|NCT02618434|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
20173048|NCT02310464|OBI Pharma, Inc.|Chen-En Tsai, MD, PhD|886 2 27866589|chenentsai@obipharma.com|215
20173049|NCT00885105|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20173050|NCT02772081|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20173051|NCT03267186|Stanford University|Andrew R. Rezvani, MD|650-725-4077|arezvani@stanford.edu|
20173052|NCT01214356|MUSC|Vanessa Diaz, MD MSCR|8438762923|diazva@musc.edu|
20173053|NCT01402544|Univeristy of California, San Diego|Dr. Henry Ferreyra|858-822-7982|hferreyra@ucsd.edu|
20173054|NCT01828281|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
20173055|NCT01442493|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
20173056|NCT02051608|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20173057|NCT01083576|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
20173058|NCT01986985|GE Healthcare|Terri Hanlon, Clinical Affairs Project Manager|609-578-0173|terri.hanlon@GE.com|
20173059|NCT02709785|Saint Louis University|D. Douglas Miley|314-977-8381|ddouglas.miley@health.slu.edu|
20173060|NCT03483051|University of Pennsylvania|Dr. Julio Chirinos|215-200-7779|juliochi@pennmedicine.upenn.edu|
20188143|NCT05073510|BlueDop Medical, Ltd.|Dr. Patrick Kelly|+1 605 521 9831|patrick@bluedopmedical.co.uk|
20173061|NCT00533845|Maimonides Medical center|Danny A Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20173062|NCT01370174|University of Maryland|Dr. Vicki Gray Principal Investigator|4107063778|vicki.gray@som.umaryland.edu|
20173063|NCT00345254|Edith Wolf son Medical Cemter|Samuel Lurie|+972-35028329|drslurie@hotmail.com|
20173064|NCT06316973|Clear Scientific|Piercen Oliver|617-621-8500|poliver@clearsci.com|
20173065|NCT03078647|Candela Corporation|Director of Clinical Marketing|(949) 599-7646|doranr@candelamedical.com|
20173066|NCT01250834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20173067|NCT01348347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173068|NCT01867021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20173069|NCT00640601|AstraZeneca|Gerard Lynch|441625 518062|aztrial_results_posting@astrazeneca.com|
20173070|NCT03681405|Wake Forest Baptist Comprehensive Cancer Center|Meg O'Mara|336-716-9055|megreen@wakehealth.edu|
20173071|NCT03178903|Butler Hospital|Ana M. Abrantes, Ph.D.|4014556440|Ana_Abrantes@Brown.edu|
20173072|NCT01958008|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20173073|NCT03789318|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
20173074|NCT05126901|Shield TX (UK) Ltd.|Clinical Operations, Shield TX (UK) Ltd.|+44 (0) 191 511 8500|info@shieldtherapeutics.com|
20173075|NCT00754624|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20173076|NCT04067544|University of Utah College of Nursing|Lisa Taylor-Swanson|801.585.5486|lisa.taylor-swanson@nurs.utah.edu|
20173077|NCT01529346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173078|NCT01499667|Novartis Pharnaceuticals|Study Director|862-778-8300||
20173079|NCT00460031|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
20173080|NCT02506153|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
20173081|NCT01493570|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173082|NCT00311623|Duke University|Andrew Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
20173083|NCT03103919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20173084|NCT05682326|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173085|NCT03998189|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-4550|aohlmans@wakehealth.edu|
20173086|NCT02959944|Pharmacyclics, LLC|Justin Wahlstrom MD|669-215-7210|jwahlstrom@pcyc.com|
20173087|NCT02005445|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6375|daniel.gottlieb@va.gov|
20173088|NCT01881776|StLukeNY|Dr.Admir Hadzic|212-665-1400|admir@nysora.com|
20173089|NCT02320149|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20173090|NCT00022633|Cleveland Clinic|Dr. Derek Raghavan|216-445-6888|raghavd@cc.ccf.org|
20173091|NCT06133348|University of Alabama at Birmingham Cancer Center|Gabrielle Rocque, MD, MSPH|205-996-9281|grocque@uabmc.edu|
20173092|NCT00487747|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20173093|NCT01359449|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20173094|NCT00330564|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
20173095|NCT02036294|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
20173096|NCT01660698|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
20173097|NCT00429104|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD.PhD./Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
20173098|NCT01907815|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD, Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20173099|NCT02237950|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
20173100|NCT04997161|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20173101|NCT01485770|Jazz Pharmaceuticals|Director, Disclosure & Transparency|(215) 970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20173102|NCT02151253|Duke University Health System|Andrew D. Krystal, MD, MS|919-971-4355|andrew.krystal@duke.edu|
20173103|NCT02485574|Chung-Ang University hospital|Kwang-Sup Song|+82-1037616503|ksong70@cau.ac.kr|
20173104|NCT02663232|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20173105|NCT01214811|Molnlycke Health Care|Viktoria Ahlenius Körner|0046 31 7223000|viktoria.ahleniuskorner@molnlycke.com|
20173106|NCT01408914|Harvard Medical School|Carole Mitnick|617-432-6018|Carole_Mitnick@hms.harvard.edu|
20188144|NCT03109873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Adam Luginbuhl|215-240-0748|adam.luginbuhl@jefferson.ed|
20188145|NCT05180539|Lehigh University|Lucy Napper|610 758 4689|lun214@lehigh.edu|
20188146|NCT03779984|UTexasSouthwestern|David Mercier|214-645-3479|David.Mercier@utsouthwestern.edu|
20188147|NCT00994643|Thomas Jefferson University|Dr. Matthew Carabasi|215-955-8874|matthew.carabasi@jefferson.edu|
20188148|NCT06202560|Institute of dermatology, Thailand|Chinmanat Lekhavat|+66 95-207-2870|chinmanat@gmail.com|
20188149|NCT04518943|VA Puget Sound Health Care System|Dr. Paul Hebert|(206) 277-4165|paul.hebert2@va.gov|
20188150|NCT00968149|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20188151|NCT04757753|SEPTODONT|Dr. Farid BENABDALLAH|+33785662179|clinical-operations@septodont.com|
20188152|NCT04868656|Durham VA Medical Center|Dr. Susan N. Hastings, MD, M.H.Sc|(919) 286-6936|susan.hastings@va.gov|
20188153|NCT03333915|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20188154|NCT02823327|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
20188155|NCT03839446|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
20188156|NCT03872466|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
20218478|NCT00821873|RTI Biologics|Robin Waite, Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
20218479|NCT00134043|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|manisha.shah@osumc.edu|
20218480|NCT04029311|Tohoku University|Dr. Yasue Tanaka|+81227178396|yasue.tanaka.b3@tohoku.ac.jp|
20218481|NCT00729248|Northwestern University|Lorenzo Gallon, MD - Study Principal Investigator|312-695-4457|l-gallon@northwestern.edu|
20218482|NCT01996943|University of California, San Francisco|Dr. Gregory Marcus|(415) 353-2554|Greg.Marcus@ucsf.edu|
20218483|NCT00922272|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20188157|NCT01778686|Rigshospitalet and University of Copenhagen|Gitte Moos Knudsen|+4535456720|gmk@nru.dk|
20188158|NCT04012567|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20218484|NCT00003224|University of Virginia|Craig Slingluff|434-924-1730|cls8h@virginia.edu|
20218485|NCT02588950|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20188159|NCT06059443|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
20188160|NCT05771467|AkdenizU|Dr. Aslı Cetinkaya Yaprak|+0905069228431|ysf20smt@gmail.com|
20188161|NCT05047952|Brain and Cognition Discovery Foundation|Dr. Roger S. McIntyre|416-669-5279|roger.mcintyre@bcdf.org|
20188162|NCT01607853|Leo Pharma A/S|Clinical Trial Disclosure Manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
20188163|NCT04079517|Karolinska Institutet|Per Hall|+4670750 2110|per.hall@ki.se|
20188164|NCT04940624|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20188165|NCT02206828|Medtronic|Djamila Bennat|33474089000|djamila.bennat@medtronic.com|1591
20188166|NCT00113360|UT M. D. Anderson Cancer Center|James Yao, M.D./Associate Professor|713-792-2828|CR_Study_Registration@mdanderson.org|
20188167|NCT04632394|St George's University of London|Dr Michael Waight|020 8672 9944|m2110065@citystgeorges.ac.uk|
20188168|NCT02988193|Optima Integrated Health|Gabriela Voskerician|6502233588|gxv4@case.edu|
20188169|NCT04726410|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
20188170|NCT02231749|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20188171|NCT03705390|CRCTU, University of Birmingham|D3B Trial Mangement Team Leader|+44 (0) 121 371 8027|ALS@trials.bham.ac.uk|
20188172|NCT05988957|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
20188173|NCT02989662|Johns Hopkins University School of Medicine|Mary E McCaul, Ph.D.|4437225728|mmccaul1@jhmi.edu|
20188174|NCT00328783|Thomas Jefferson University|Rani Anne, MD|215-955-6045|Rani.Anne@jeffersonhospital.org|
20188175|NCT00357682|NICE|Prof Janusz A Z Jankowski|07968 479355|prof.jankowski@outlook.com|
20188176|NCT02514915|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126233272|stadtermanbm@upmc.edu|
20188177|NCT03660930|University of Washington|Lee Cranmer, MD, PhD|206-606-7439|ldcranme@fredhutch.org|
20188178|NCT03228719|University of Delaware|Daniel K. White|3028317607|dkw@udel.edu|
20188179|NCT02656706|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-300|BrUOG@BROWN.EDU|
20188180|NCT03725332|University of Kentucky|Wendy Hansen, MD|859-218-0765|wendy.hansen@uky.edu|
20188181|NCT04098276|Johns Hopkins University|Bushra Sabri|+1 (410) 955-7105|bsabri1@jhu.edu|
20188182|NCT04599296|University of Washington|Dr. Mia Hagen, Associate Professor|206-598-3404|smia@uw.edu|
20172676|NCT04208698|CinDome Pharma, Inc.|Director of Clinical Trials|844-531-1834|info@cinrx.com|
20188183|NCT03242915|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20188184|NCT02726386|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director|+33687548073|laurence@neuroderm.com|
20188185|NCT04955431|University of Montana|Dr. John Quindry|406-243-4268|john.quindry@mso.umt.edu|
20188186|NCT03201939|Vanderbilt University Medical Center|C. William Wester|6158750145|william.wester@vumc.org|
20188187|NCT03601897|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
20188188|NCT03598998|City of Hope Medical Center|Dr. Alex Herrera|6263598111|aherrera@coh.org|
20188189|NCT05424718|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@columbia.edu|
20188190|NCT04046549|Horizon Therapeutics USA, Inc.|Todd Wilson, DO|866-479-6742|clinicaltrials@horizontherapeutics.com|
20188191|NCT04319887|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
20188192|NCT04549792|Northwestern University|Principal Investigator|312-503-5944|NUderm-research@northwestern.edu|
20188193|NCT03696433|Vanderbilt University Medical Center|Cassandra Reynolds, BS, CCRC|615-875-9854|cassandra.f.reynolds@vumc.org|
20188194|NCT05495945|University of Michigan|Zirui Huang|(734) 615-2875|huangzu@med.umich.edu|
20188195|NCT05672017|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
20188196|NCT05362474|University of Colorado Denver|Jessica Kendrick|303-724-4837|jessica.kendrick@cuanschutz.edu|
20188197|NCT04039113|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20188198|NCT00353496|Ipsen|Medical Director Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20203279|NCT01004146|University of Texas at Houston Medical School / Dept. of Anesthesiology|Dr. Davide Cattano|713-500-6235|davide.cattano@uth.tmc.edu|
20173107|NCT05989815|Federal University of São Carlos (UFSCar)|Italo Amaral de Oliveira, Principal Investigator|+55 19 99719-0361|italoao@estudante.ufscar.br|
20173108|NCT04583891|University of Virginia|Philip Chow|9146453458|pic2u@virginia.edu|
20173109|NCT01957553|Coloplast|Dr. Birte P.Jakobsen|+45 4911 1395|dkbir@coloplast.com|
20173110|NCT04044716|Atrium Health Wake Forest Baptist|Dr. Carolyn Huffman|336.713.4018|cshuffma@wakehealth.edu|
20173111|NCT01958320|University of California San Francisco|Ronald Clyman, MD PI|415-443-9305|clymanr@peds.ucsf.edu|
20173112|NCT00759811|Instituto de Cardiologia do Rio Grande do Sul|Daniel Medeiros Moreira, MD. MSc.|55 (51) 3219-2802|danielmedeirosmoreira@gmail.com|
20173113|NCT02532933|University Of Denver|Kevin Shelburne|3039021249|kevin.shelburne@du.edu|
20188199|NCT02379351|University of Utah, Department of Obstetrics & Gynecology|Dr. Erin Clark|801-5818425|erin.clark@hsc.utah.edu|
20188200|NCT00945724|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
20203280|NCT02099799|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
20203281|NCT01269034|Albert Einstein College of Medicine|Roger Hicks, Administrative Director for Research - Department of Pediatrics|718-920-7386|roger.hicks@einsteinmed.org|
20203282|NCT03290300|Aerin Medical, Inc.|Scott Wolf, M.D.; Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
20203283|NCT01001494|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20203284|NCT03320512|University of North Carolina at Chapel Hill|Lisa Hightow-Weidman|919-843-0033|lisa_hightow@med.unc.edu|
20203285|NCT01221298|AbbVie|Global Medical Services|800-633-9110||
20203286|NCT04036136|University of North Carollina at Chapel Hill|Gabriel Dichter, PhD|919-364-4275|dichter@med.unc.edu|
20203287|NCT01696877|Johns Hopkins University|Emmanuel S. Antonarakis, M.D., principal investigator|443-287-0553|eantona1@jhmi.edu|
20203288|NCT00515463|Amgen Inc.|Study Director|866-572-6436||
20218486|NCT00866658|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20188213|NCT04732871|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173114|NCT01932112|Seoul St Mary's hospital|Y. Oh, director of clinical trial|82-2-2258-1141|oys@catholic.ac.kr|
20173115|NCT02503735|Massachusetts General Hospital|Dr. Meghan Sise|617-726-5050|MSise@partners.org|
20173116|NCT01714635|Abbott Medical Optics|Kendra Hileman, Ph.D., Director, Clinical Research & Development|714-247-8613|kendra.hileman@amo.abbott.com|
20173117|NCT03672747|Boys Town National Research Hospital|Tony Wilson|531-355-8909|tony.w.wilson@gmail.com|
20173118|NCT04285879|Connecticut Children's|Adam P. Weaver, PT, DPT|860-284-0246|Aweaver@connecticutchildrens.org|
20173119|NCT00824512|Ipsen|Medical Director, Primary Care|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20173120|NCT00071513|Univeristy of Washington|Elizabeth McCauley, PHD, Principal Investigator|206-987-2579|eliz@uw.edu|
20173121|NCT03667924|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
20173122|NCT03358290|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
20173123|NCT02743871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173124|NCT01973166|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20173125|NCT02484729|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20173126|NCT03194698|Mayo Clinic|Joanne F. Shen, M.D.|480-301-8085|Shen.Joanne@mayo.edu|
20173127|NCT04772755|Duke University|Emmanuel B Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
20173128|NCT02480114|Vanderbilt University Medical Center|Derek Smith, DDS, PhD|6159367423|derek.k.smith@vumc.org|
20173129|NCT01535053|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-845-1169|lgedeon@gogstats.org|
20173130|NCT01031069|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173131|NCT00512707|Brigham and Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
20173132|NCT01317160|Karolinska university Hospital|Dr. Paul W. Ackermann|+46851770000|paul.ackermann@karolinska.se|
20173133|NCT05286281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173134|NCT03032705|Tufts University School of Dental Medicine|Dr Gerard Kugel|(617) 636-0870|Gerard.Kugel@tufts.edu|
20173135|NCT03482440|University of Iowa|Anna Stanhewicz|3194671732|anna-stanhewicz@uiowa.edu|
20173136|NCT04405037|Cleveland Clinic Foundation|Dr. Scott Steele|216-444-4715|steeles3@ccf.org|
20173137|NCT01432886|Eisai Co., Ltd.|Tadashi Nakanishi|81-3-3817-5252||5252
20173138|NCT02664441|Seattle Children's Hospital|Christian L. Roth, MD|206-987-5428|christian.roth@seattlechildrens.org|
20173139|NCT05040386|University of Alabama at Birmingham|Anand Iyer, MD, MSPH|2059341968|aiyer@uabmc.edu|
20173140|NCT02560584|Regional Hospitals & Family Health Centers|Dr. J. Stephen Jones|+1-216-442-5060|joness7@cff.org|
20173141|NCT00715078|Dendreon|Shabnam Vaziri|206-455-2323|Svaziri@Dendreon.com|
20173142|NCT02892760|The University of Texas Health Science Center at Houston|Gerard Francisco, MD|713-797-7636|Gerard.E.Francisco@uth.tmc.edu|
20173143|NCT00258882|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
20173144|NCT00386776|Beth Israel Deaconess Medical Center|Dr. Warner V. slack|617 278 8155|wslack@bidmc.harvard.edu|
20173145|NCT00588848|MetroHealth Medical Center|Dr. Dennis Auckley|216-778-7212|dauckley@metrohealth.org|
20173146|NCT00249444|Columbia University|Dr Wilfrid Raby|212-923-3031|rabywil@nyspi.columbia.edu|
20173147|NCT02673489|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20203289|NCT00916721|Massachusetts General Hospital|A. Eden Evins, MD, MPH, Director Center for Addiction Medicine|617-643-4679|a_eden_evins@hms.harvard.edu|
20203290|NCT04331730|Alkahest, Inc.|Head of Communications|(650) 801-0474|trials@alkahest.com|
20188239|NCT05550636|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20188240|NCT04974047|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20188242|NCT03391466|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20203291|NCT01903434|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203292|NCT01469052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203293|NCT03340805|The Children's Hospital of Philadelphia|Dr. Scott L. Weiss, study co-PI|215-590-5505|WeissS@email.chop.edu|
20203294|NCT00404768|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203295|NCT03575468|Consumer Wellness Solutions|Dr. Katrina Vickerman|469-608-4208|katrina.vickerman@optum.com|
20203296|NCT02211495|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20203297|NCT04773041|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|bhavani.x.kashyap@healthpartners.com|
20203298|NCT03729869|Medical University of South Carolina|Lisa Nunn, Program Manager|843-792-0476|jenkinli@musc.edu|
20203299|NCT00128206|University of California, San Francisco|Mary White|415-476-5213|mary.white@nursing.ucsf.edu|
20203300|NCT04220489|UPMC|Jacques E. Chelly, MD, PhD, MBA|412-623-6904|chelje@anes.upmc.edu|
20203301|NCT01597622|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20203302|NCT05047640|University of Miami|Giselle Guerra|3053555803|gguerra@med.miami.edu|
20203303|NCT03132805|Johns Hopkins University|Nicholas S. Ialongo, Principal Investigator|410-493-1252|nialong1@jhu.edu|
20203304|NCT03009539|University of Miami|Guillermo Prado|305-284-2002|gprado@miami.edu|
20203305|NCT03151148|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20203306|NCT00710034|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20203307|NCT00494871|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20203308|NCT04543955|University of Kentucky|Dr. Lowell Anthony|859-323-8043|lowell.anthony@uky.edu|
20203309|NCT05232097|Helsinki University Hospital|Dr. Jari Punkkinen|+358 50 427 9864|jari.punkkinen@hus.fi|
20203310|NCT01172288|Yale University- School of Medicine|Associate Professor|(203)737-4809|michael.bloch@yale.edu|
20203311|NCT01776268|Vanderbilt University Medical Center|James Wynn MD||james.wynn@peds.ufl.edu|
20203312|NCT00871858|Institut Bergonié, Medical Oncology department|Dr. Nathalie Quenel-Tueux|05.56.33.33.33|N.Quenel-Tueux@bordeaux.unicancer.fr|
20203313|NCT01847547|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203314|NCT01188798|St. Jude Children's Research Hospital|Asha Pillai, MD|1-866-278-5833|info@stjude.org|
20203315|NCT02795767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218487|NCT00652028|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20218488|NCT02072824|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218489|NCT02751359|University of California Los Angeles|Dr. Ziva Cooper, Principal Investigator|310-206-9942|zcooper@mednet.ucla.edu|
20218490|NCT02011113|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20218491|NCT01338649|Massachusetts General Hospital|Aleksandar Videnovic|855-644-6387|avidenovic@mgh.harvard.edu|
20218492|NCT02669940|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20218493|NCT03840616|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
20218494|NCT03949803|Universidad de Murcia|Prof. Marta Garaulet Aza|+34868889478|garaulet@um.es|
20218495|NCT05065983|Emergent BioSolutions|Dr. Sufia Muhammad|346-732-7331|muhammads@ebsi.com|
20218496|NCT00986180|Janssen Pharmaceuticals|Vice President, Medical Affairs, Internal Medicine|1 908 218-7250||
20218497|NCT01765582|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218498|NCT03261960|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20218499|NCT04493320|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
20218500|NCT03251963|University of Utah|Christopher Pannucci|801 581 2121|christopher.pannucci@hsc.utah.edu|
20218501|NCT00616941|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20218502|NCT01517659|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20218503|NCT04392583|Smith+Nephew, Inc|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
20218504|NCT03041324|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
20218505|NCT03484117|Massachusetts General Hospital|Dr. Julie Levison, PI|617-724-4698|jlevison@partners.org|
20218506|NCT00003875|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20218507|NCT02303041|Stanford University|Anne Lynn S. Chang/ Associate Professor of Dermatology|650-723-6316|alschang@stanford.edu|
20218508|NCT00886288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218509|NCT00289874|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218510|NCT04972123|University of Wisconsin - Madison Cardiovascular Medicine|Mohamed H. Hamdan, MD, MBA|608-263-4856|mhamdan@medicine.wisc.edu|
20218511|NCT00136318|Kliniken Essen-Mitte, Department of Psychiatry|Professor Dr. Martin Schaefer|+49201-17430001|m.schaefer@kliniken-essen-mitte.de|
20218512|NCT03835325|Eurofarma Laboratórios S.A|Sandra Rodrigues|1150908600|sandra.rodrigues@eurofarma.com.br|8417
20218513|NCT01370213|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
20173148|NCT00082355|NIHCC|Dr Richard Chang|301-402-0256|rchang@cc.nih.gov|
20173149|NCT00759863|Photozig, Inc.|Bruno Kajiyama|650-694-7496|lifezig@photozig.com|3
20173150|NCT00412854|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173151|NCT01084174|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
20173152|NCT01594125|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173153|NCT01484873|Vanderbilt University|Ashley Shoemaker|615-343-8116|ashley.h.shoemaker@vanderbilt.edu|
20173154|NCT01549392|London Health Sciences Hospital|Barbara Fisher|519-685-8650|barbara.fisher@lhsc.on.ca|
20173155|NCT02743806|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20173156|NCT01843751|University of Wisconsin|Randall Brown|608-263-6558|rtbrown@wisc.edu|
20173157|NCT01988103|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20173158|NCT05492942|Boston Medical Center, Internal Medicine|Emily Hurstak, MD MPH|(617) 414 5951|emily.hurstak@bmc.org|
20173159|NCT01141907|Johns Hopkins University|Dr. Cheryl Dennison|443-287-4174|cdennis4@jhu.edu|
20173160|NCT02598076|Yale Comprehensive Epilepsy Center, Department of Neurology, Yale Univseristy School of Medicine|Benjamin Tolchin, MD, MS|347-721-8491|benjamin.tolchin@yale.edu|
20173161|NCT00176826|University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
20173162|NCT01946425|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20173163|NCT04585022|Copenhagen University Hospital Hvidovre, Orthopaedic Department|MD Peter Nyby Hersnaes|+45 40104845|pnhersnaes@gmail.com|
20173164|NCT02775162|OrganOx Ltd|Robert Bovy, VP of Regulatory Affairs, North America|608-556-4429|robert.bovy@organox.com|
20173165|NCT03454893|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
20173166|NCT04876274|School of Pharmacy, Taipei Medical University|Professor Hsiang-Yin Chen|(02)2736-1661|shawn@tmu.edu.tw|6175
20173167|NCT03414424|Bronx VA Medical Center|Noam Y. Harel|718-584-9000|Noam.harel@va.gov|1742
20173168|NCT00877877|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173169|NCT03070782|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20173170|NCT03527966|Virtua Health Inc.|Jillian Hoopes|856-761-3904|jhoopes@virtua.org|
20173171|NCT01948050|Beth Israel Medical Center|Helena Knotkova, PhD|212-844-8541|hknotkov@chpnet.org|
20173172|NCT02288559|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
20173173|NCT00558025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173174|NCT01314443|Ohio State University|Richard Bruno, PhD, RD|614-292-5522|bruno.27@osu.edu|
20173175|NCT05247866|Children's Hospital of Philadelphia|Jonathan Spergel|2155902549|spergel@chop.edu|
20173176|NCT04463719|University of Florida|Naykky Singh Ospina|(352) 273-8655|naykky.singhospina@medicine.ufl.edu|
20173177|NCT02135146|University of Colorado|Nick Naughton, Professional Research Assistant|3037200833|nick.naughton@cuanschutz.edu|
20173178|NCT00333866|Organization: Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20173179|NCT06073119|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20173180|NCT00456547|Northwestern University Feinberg School of Medicine|Dr. Robert J McCarthy, Pharm D|312-926-9015|r-mccarthy@northwestern.edu|
20173181|NCT02393547|Mayo Clinic|Ryan T. Hurt, MD|507-266-1944|nicotineresearch@mayo.edu|
20173182|NCT02979522|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20173183|NCT05185089|NeRRe Therapeutics Ltd|CMO|+44 (0)1438 906960|info@nerretherapeutics.com|
20173184|NCT00667368|University of Alabama at Birmingham|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
20173185|NCT00446290|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20173186|NCT00191789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20173187|NCT05582889|University of New Mexico|Dr. Cindy Blair|5059257907|CiBlair@salud.unm.edu|
20173188|NCT06112756|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20173189|NCT04551092|Quantum Applied Science & Research, QUASAR Inc.|Gayle Guy|858 412 1839|gayle@quasarusa.com|
20173190|NCT01712490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20173191|NCT02423876|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
20173192|NCT01966900|Imperial College London|Dr Tom Cole|+44(0)2033136198|t.cole@imperial.ac.uk|
20173193|NCT03060629|Janssen Vaccines & Prevention B.V|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20173194|NCT01862874|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173195|NCT03748758|Novus Therapeutics|Clinical Director|949-679-1110|study002@novustherapeutics.com|
20173196|NCT01129960|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
20173197|NCT03198234|Stanford|Rajni Agarwal, MD|650-725-9250|rajnia@stanford.edu|
20173198|NCT02032810|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nikhil I. Khushalani|813-745-3437|nikhil.khushalani@moffitt.org|
20173199|NCT01064713|University of Texas (UT) MD Anderson Cancer Center|Agop Y. Bedikian, MD/Professor||CR_Study_Registration@mdanderson.org|
20173200|NCT03228537|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
20173201|NCT01782495|AbbVie|Global Medical Services|800-633-9110||
20173202|NCT01927367|QEII Health Sciences Centre, Halifax, Nova Scotia|Dr. Jafna L Cox|(902) 473-7811|jafna.cox@dal.ca|
20173203|NCT01161862|Department of Biomedical Engineering, Boston University, Boston, Massachusetts.|Edward R. Damiano|(617) 353-9493|edamiano@bu.edu|
20173204|NCT02622321|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20173205|NCT00886899|BridgePoint Medical|VP, Clinical Affairs|763-225-8500|jschultz@bridgepointmedical.com|
20173206|NCT00790855|The University of MD Anderson Cancer Center|Hagop M. Kantarjian, M.D.|713-792-7026|eharriso@mdanderson.org|
20173207|NCT00965718|Yonsei university|Moonjae Chung, MD|82-2-2228-2274|MJCHUNG@yuhs.ac|
20173208|NCT00241280|Johnson & Johnson Vision Care, Inc.|David C. Turner, Ph.D. GLOBAL PLATFORM SR DIRECTOR, R&D|904-443-3500|DTURNER2@its.jnj.com|3479
20173209|NCT00138203|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|(608) 262-8158|amt@medicine.wisc.edu|
20173210|NCT01634360|Eisai Call Center|Eisai Inc.|888-422-4743||
20173211|NCT02402127|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20173212|NCT02260921|Myoscience|Director of Clinical|5109331541||
20173213|NCT01244425|BAXTER INNOVATIONS GmbH|Ildiko Szabo, MD, MBA Medical Director, Biosurgery||ildiko_szabo@baxter.com|
20173214|NCT02999854|Kiadis Pharma Netherlands B.V|Klaudia Traudtner, MD. Head of Safety and Pharmacovigilance.|+31 (0)20 240 52 50|k.traudtner@kiadis.com|
20173215|NCT02848651|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20173216|NCT04140292|Cleveland Clinic Foundation|Maytin, Edward, V|1-866-223-8100|taussigresearch@ccf.org|
20173217|NCT01083368|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
20173218|NCT01705288|Masonic Cancer Center at University of Minnesota|Dr. Peter Argenta|612-626-6283|argenta@umn.edu|
20173219|NCT02835274|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
20173220|NCT01182493|CHU Caen|Prof. Yves Reznik|+33231064585|reznik-y@chu-caen.fr|
20173221|NCT01853826|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173222|NCT03653637|James J. Peters VA Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
20173223|NCT04798768|Boston Scientific|Julie West|651-582-4721|Julie.West@bsci.com|
20173224|NCT05661942|Advocate Health|Michael Cirone, MD|7086841710|michael.cirone@aah.org|
20173225|NCT04202354|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
20173226|NCT02960776|Columbia University Irving Medical Center|Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
20173227|NCT00360828|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
20173228|NCT02081690|Actelion Pharmaeuticals Ltd.|Clinical Trial Disclosure Manager||clinical-trials-disclosure@actelion.com|
20173229|NCT01346839|Michael E. DeBakey VA Medical Center and Baylor College of Medicine|Dr. Hardeep Singh|713-794-8515|hardeeps@bcm.edu|
20173230|NCT00982488|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20173231|NCT04203238|Pennington Biomedical Research Center|Dr. Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
20173232|NCT01134783|University of North Carolina, Chapel Hill|Dr. Leslie A. Lytle|919-843-8171|llytle@email.unc.edu|
20188248|NCT02502266|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20173233|NCT04346537|Boston Scientific|Gena Kantor|1-800-227-3422|gena.kantor@bsci.com|
20173234|NCT00001596|National Human Genome Research Institute|Dr. William A. Gahl|301-402-2739|gahlw@mail.nih.gov|
20218514|NCT00472797|EMD Serono, INc.|Fernando Dangond, MD|781 681 2348|fernando.dangond@emdserono.com|
20203316|NCT02553915|Massachusetts General Hospital|Dr David Mischoulon, Director, Depression Clinical and Research Program, MGH|617-724-5198|dmischoulon@mgh.harvard.edu|
20173235|NCT03867981|The Miriam Hospital|Principal Investigator|401-793-8966|junick@lifespan.org|
20218515|NCT01550744|Janssen Biotech, Inc|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20203317|NCT00700752|Vistakon|Kurt Moody OD|904-443-3088||
20203318|NCT03964415|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20203319|NCT01016483|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
20203320|NCT01302769|99MDG Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20203321|NCT01097330|Population Health Research Institute|Dr. Carlos Morillo|905-527-4322|Carlos.Morillo@phri.ca|40311
20203322|NCT05848245|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
20173236|NCT01694641|Kaali Inst. IVF Center|Dr Peter Kovacs|36-1-202-2802|peterkovacs1970@hotmail.com|
20173237|NCT00289315|Pennington Biomedical Research Center|Lori Steib|(225) 252-5030|Lori.Steib@pbrc.edu|
20173238|NCT00180414|Boston Scientific|Jens Goetzke|+32 2 41|jens.goetzke@bsci.com|67011
20203323|NCT00477451|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20203324|NCT01426386|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20203325|NCT00940927|Nemours Children's Clinic|Kathryn Blake, Pharm.D.|904 858 3806|kblake@nemours.org|
20203326|NCT03694522|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
20203327|NCT02760407|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
20203328|NCT02522377|CLEVELAND CLINIC FOUNDATION|MURAT ALTINAY, MD|2164453359|altinam@ccf.org|
20203329|NCT01158950|University of California, San Francisco|Dr. Jennifer Mitchell|510-985-3522|jennifer.mitchell@ucsf.edu|
20203330|NCT01858428|Spectranetics|Julie Wolfram Smith|763-955-1072|julie.wolframsmith@spnc.com|
20203331|NCT02116972|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20203332|NCT00863928|Virginia Mason Medical Center|Kathryn Dahl, RN|206-341-0578|kathryn.dahl@vmmc.org|
20218516|NCT00436904|Mayo Clinic|Dr. Clive Zent|507-284-5362|zent.clive@mayo.edu|
20218517|NCT02660528|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
20218518|NCT00706381|NIDDK|Kong Chen, Ph.D.|301-451-1636|chenkong@niddk.nih.gov|
20218519|NCT04355663|Third Faculty of Medicine, Charles University|PhDr. Kamila Řasová, Ph.D.|+420604511416|kamila.rasova@gmail.com|
20218520|NCT01026181|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
20218521|NCT03395639|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20218522|NCT01397617|Nobel Biocare Services AG|Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
20218523|NCT00995085|Alcobra Inc|Jonathan Rubin, MD, MBA|610-504-7814|jrubin@alcobra-pharma.com|
20218524|NCT02595008|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20218525|NCT03407118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20218526|NCT01797484|University Heart Centre Hamburg Eppendorf|Dr. Tjark F. Schwemer|+49 40 7410|t.schwemer@uke.de|56800
20218527|NCT02093221|Grifols Therapeutics LLC|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
20218528|NCT03431974|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
20218529|NCT02037165|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218530|NCT02220725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20173239|NCT00463346|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
20173240|NCT01909154|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
20173241|NCT01572909|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20173242|NCT02703909|University of Missouri - Columbia|Terri G. Monk, MD, Principal Investigator|(573)-882-2568|monkt@health.missouri.edu|
20173243|NCT03641651|Zurich University of applied sciences|Prof. Dr. Markus Wirz|+41 58 934|markus.wirz@zhaw.ch|6321
20173244|NCT04779489|UT Southwestern Medical Center|Dr. Solomon Woldu|214-648-9558|solomon.woldu@utsouthwestern.edu|
20173245|NCT00951665|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20173246|NCT03879655|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
20173247|NCT02723084|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20173248|NCT02635828|The Ohio State Universtiy Wexner Medical Center|Director of Neuroanesthesia|6142933559|sergio.bergese@osumc.edu|
20173249|NCT02290509|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20173250|NCT00415909|University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor, Leukemia|713-794-5783|CR_Study_Registration@mdanderson.org|
20173251|NCT05024058|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20173252|NCT00139399|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
20173253|NCT00714389|University of Rochester|Gunhilde Buchsbaum, MD|585-273-3232|gunhilde_buchsbaum@urmc.rochester.edu|
20173254|NCT02734810|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
20173255|NCT00528398|City of Hope National Medical Center|Anthony Stein, M.D.|626-256-4673|AStein@coh.org|82405
20173256|NCT02801942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173257|NCT00127712|Purdue University|James E. Tisdale|317-613-2315|jtisdale@iupui.edu|306
20218531|NCT01673698|ReShape Medical|Director of Clinical Operations|94429-6680|lfong@reshapemedical.com|
20203333|NCT02124798|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203334|NCT02792777|Thomas Jefferson|Kristin L Rising, MD MS|215-503-5507|kristin.rising@jefferson.edu|
20203335|NCT03863496|Ilizarov centre|Sergey Raybukh|+79226716007|rso_@mail.ru|
20173258|NCT00407563|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20203336|NCT02795156|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20173259|NCT02450903|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20203337|NCT01137435|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20203338|NCT02428140|University of Alberta|Dr. Brian Buck|78024819227|bbuck@Ualberta.ca|
20203339|NCT03534271|Rush University|Dr. Jonathan Brady Scott|3129426389|jonathan_b_scott@rush.edu|
20203340|NCT03531957|Asana BioSciencxes, LLC|Pablo Jimenez|9086980782|pablo.jimenez@asanabio.com|
20218532|NCT01297322|Daniel & Daniel Consulting, LLC|Michael A. Daniel, Consulting VP Regulatory Affairs|7753922970|madaniel@clinregconsult.com|
20218533|NCT00712985|Milton S. Hershey Medical Center|Allan Lipton, MD|717-531-5960|alipton@hmc.psu.edu|
20218534|NCT01232491|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20218535|NCT06204887|Recep Tayyip Erdogan University|Dr. Ahter Şanal Çıkman|05069293341|ahter.sanalcikman@erdogan.edu.tr|
20218536|NCT02522403|Universidad Autonoma de Nuevo Leon|Carlos Acosta-Olivo|528183467798|dr.carlosacosta@gmail.com|
20218537|NCT00856973|Sunovion|CNS Medical Director|866-503-6357||
20218538|NCT02664363|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
20218539|NCT01108666|University of Pennsylvania|Dr. Abigail Berman|215-615-3659|Abigail.Berman@uphs.upenn.edu|
20218540|NCT04556552|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
20218541|NCT01553279|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218542|NCT00605865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218543|NCT03955471|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20218544|NCT03012672|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
20218545|NCT01030341|Johns Hopkins Data Coordinating Center|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
20218546|NCT03805100|Xbrane Biopharma AB|Clinical Affairs|+46 85-590 56 00|xbregistry@xbrane.com|
20218547|NCT01884311|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
20218548|NCT02856880|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218549|NCT00793780|Yale University|Erin Sullivan|+1 (203) 974-7317|erin.reutenauer@yale.edu|
20218550|NCT02858492|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20218551|NCT00573157|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20218552|NCT01032018|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
20218553|NCT00937378|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20218554|NCT04425538|Neely Center for Clinical Research, Tufts Medical Center|Director of Clinical Trials|617-636-5000|ncccr@tuftsmedicalcenter.org|3264
20218555|NCT01796912|Imperiwal College London|Dudley Pennell|+44 (0)20 3811 6871|d.pennell@imperial.ac.uk|
20188268|NCT01976936|Columbia University|Mitchell S.V. Elkind, MD, MS, MPhil|212-305-1710|mse13@cumc.columbia.edu|
20188272|NCT06408870|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218556|NCT01388166|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218557|NCT00841906|Sleep Center of Greater Pittsburgh|Sukhdev Grover MD|412-681-7771|Info@SleepCenterOfGreaterPittsburgh.com|
20218558|NCT01196078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20218559|NCT00127036|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
20218560|NCT01280409|University of Texas Health Science Center at Houston|Dr Jerrie Refuerzo|713.500.7780|Jerrie.S.Refuerzo@uth.tmc.edu|
20218561|NCT03275766|University of Bern, University Hospital of Psychiatry, Bern|Prof. Sebastian Walther|+41 632 8979|sebastian.walther@upd.unibe.ch|
20218562|NCT01387581|MelaSciences|Mrinalini Roy|800-729-8849|mishti@melasciences.com|
20218563|NCT01797835|RAND|Dr. Elizabeth D'Amico|3103930411|damico@rand.org|6487
20218564|NCT03001219|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218565|NCT01403064|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20218566|NCT02528123|London Vision Clinic|Prof Dan Z Reinstein|02072214005|dzr@londonvisionclinic.com|
20218567|NCT03760250|University of Pennsylvania|Jenny Wei|2153165151|jenny.wei@pennmedicine.upenn.edu|
20218568|NCT01598350|University of Puget Sound|Julia Looper, PT PhD|253 879 2895|jlooper@pugetsound.edu|
20218569|NCT03733210|Stanford Medicine at Stanford University|Yu-Jin Lee, MD, MS|650-725-4711|yujinlee@stanford.edu|
20218570|NCT03728634|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20218571|NCT00929331|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218572|NCT02963441|IDx LLC|IDx President, Dr. Michael Abramoff|319-248-5620|info@eyediagnosis.net|
20218573|NCT04688931|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
20218574|NCT00361335|Centocor, Inc.|Senior Director Clinical Research|1-800-457-6399||
20218575|NCT04408599|NextCure, Inc|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
20218576|NCT00714493|Centocor Ortho Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-6811|Ddeckto2@its.jnj.com|
20218577|NCT04505293|Duke University|Anthony 'Tony' T. Fuller, MD, MScGH|919-613-1813|anthony.fuller@duke.edu|
20218578|NCT00506129|University of Texas (UT) MD Anderson Cancer Center|Chitra M. Hosing, Professor, Stem Cell Transplantation|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
20218579|NCT02163486|DorkuzEU|Bahar Kuvaki|902324122836|ozbilginsule@gmail.com|
20218580|NCT01284296|University of California, San Francisco|Ronald D. Miller|415 476-9034|millerr@anesthesia.ucsf.edu|
20218581|NCT01400919|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20218582|NCT00251719|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20218583|NCT05227300|Indiana University School of Dentistry|Dr. Kenneth Spolnik|317-274-7280|kspolnik@iu.edu|
20218584|NCT01732874|Nationwide Childrens Hospital|Dr. Christina J. Valentine MD,MS,RD|(614) 722-2000|Christina.Valentine@nationwidechildrens.org|
20218585|NCT02923674|Wake Forest School of Medicine|Barbara Nicklas, MD|336-713-8569|bnicklas@wakehealth.edu|
20218586|NCT04539886|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
20218587|NCT00688376|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20218588|NCT00557076|Edward Hines, Jr VA Hospital|Dr. Theresa Pape|708-202-4953|Theresa.Pape@va.gov|
20218589|NCT02335983|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20218590|NCT01070771|University Hospital Southampton NHS Foundation Trust|Professor Nick Curzen|+44 023 80777222|nick.curzen@uhs.nhs.uk|
20218591|NCT03127644|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20218592|NCT02214420|Scripps Clinic|Dr. Paul Pockros|(858) 554-8879|Pockros.paul@scrippshealth.org|
20218593|NCT04700280|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20218594|NCT00062751|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20218595|NCT03629028|Principal investigator of the research|Şafak Yılmaz Baran, MD|+903224586868|safakyilmazbaran@gmail.com|
20218596|NCT01401257|Hôpital La Timone, Marseille|Pr Shahram ATTARIAN|04 91 38 65|shahram.attarian@ap-hm.fr|79
20218597|NCT03345394|Federal University of Sao Paulo|Dr. André Miguel|+55 11 965884111|aqcmiguel@gmail.com|
20218598|NCT02687360|Columbia Univeristy|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
20218599|NCT02192164|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218600|NCT00673933|Dermatology Institute|Dr Ashish Bhatia|630-942-5040|acbhatia@gmail.com|
20218601|NCT04932941|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
20218602|NCT01583218|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20218603|NCT03168321|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
20218604|NCT02013375|University of Illinois at Chicago|Dr Damiano Rondelli|312-996-6179|drond@uic.edu|
20218605|NCT01856361|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
20218606|NCT01663727|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20218607|NCT01902628|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20218608|NCT01045421|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20218609|NCT00321828|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20218610|NCT02307266|Galderma|Gaëlle Charier|+33 4 93 95 70 68|gaelle.charier@galderma.com|
20218611|NCT03474432|Jesse Brown VAMC|Dr. Mladen Vidovich, study PI|312-996-6730|miv@uic.edu|
20218612|NCT01453894|Northwestern University Feinberg School of Medicine|David W. Baker, MD, MPH|312-503-6400|dbaker1@nmff.org|
20218613|NCT00256984|Ethicon Endo-Surgery|Susan Knippenberg, Clinical Scientist|513 337-3452|sknippen@its.jnj.com|
20218614|NCT00858143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20218615|NCT03853148|Medical University of South Carolina|Teresa Kelechi, Associate Dean for Research and PhD Studies|843-792-4602|kelechtj@musc.edu|
20218616|NCT00090610|Duke University Medical Center|Angeles Alvarez Secord, Director of Gynecologic Oncology Clinical Trials|919-684-3765|secor002@mc.duke.edu|
20218617|NCT00059787|Montefiore Medical Center - New York Cancer Consortium|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
20218618|NCT01248013|Mind-Body Digestive Center|Charles D. Gerson, M.D.|212 496 6161|cgerson@yahoo.com|
20218619|NCT00725530|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20218620|NCT00782821|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
20218621|NCT02667288|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
20218622|NCT04397445|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20218623|NCT01429051|Takeda|Medical Director|+1-800-778-2860|clinicaltrialregistry@tpna.com|
20218624|NCT03921151|Virginia Commonwealth University|Liangsuo Ma, PhD|(804) 828-2871|liangsuo.ma@vcuhealth.org|
20218625|NCT01207648|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20218626|NCT00857792|The University of Chicago Medical Center|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
20218627|NCT03667014|UCSF|Tina Bhutani|4153537800|tina.bhutani@ucsf.edu|
20218628|NCT04421586|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
20218629|NCT01968694|Brigham & Women's Hospital|Dr. Antje M Barreveld|617-243-6298|abarreveld@partners.org|
20218630|NCT00846521|Yale University School of Medicine|Tania Burgurt, MD|203-785-7152|tania.burgurt@yale.edu|
20218631|NCT02792959|Institute Bergonie|Dr. Anne Laure Cazeau, Coordinating Investigator|0556337860|A.Cazeau@bordeaux.unicancer.fr|
20218632|NCT00119067|CDC|Jennifer G Wright||jgwright@cdc.gov|
20218633|NCT03201250|Vanderbilt University Medical Center|Muhamed Baljevic, MD|615-936-8422|muhamed.baljevic@vumc.org|
20218634|NCT02408068|Simbec Research Ltd|Dr G Sharma|0800 691995|contact@simbec.com|
20218635|NCT01780987|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
20218636|NCT04168190|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218637|NCT01640873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218638|NCT03844789|University of Virginia Center for Diabetes Technology|Marc Breton|434-982-6484|mb6nt@virginia.edu|
20218639|NCT02931045|1st Chair and Department of Cardiology, Medical University of Warsaw|Aleksandra Gasecka, MD, PhD|+48225991951|alesandra.gasecka@wum.edu.pl|
20218640|NCT03978091|ARLG - Albany College of Pharmacy and Health Sciences|Thomas Lodise, PharmD, PhD|1 (518) 694-7292|Thomas.Lodise@acphs.edu|
20218641|NCT02477774|University of California, San Francisco|Rahul Seth, MD|415-353-9500|Rahul.Seth@ucsf.edu|
20218642|NCT00257920|Abbott|Medical Information Specialist|1-800-633-9110||
20218643|NCT00770692|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
20218644|NCT00534794|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
20218645|NCT03097588|Department of Pharmacy Services, Oregon health & Science University Hospital|Joseph Bubalo, PharmD (Oncology Clinical Pharmacy Specialist)|5034948007|bubaloj@ohsu.edu|
20218646|NCT01635062|Brigham and Women's Hospital|Dr. Anand Vaidya (Asst Professor of Medicine)|6175258285|avaidya1@partners.org|617
20218647|NCT03828448|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20218648|NCT05069155|University of Pennsylvania|Clinical research coordinator|7574471579|aileen.oon@pennmedicine.upenn.edu|
20218649|NCT02206620|Oregon Health & Science University|Dr. Martina Mancini|5034182602|mancinim@ohsu.edu|
20218650|NCT02150759|Inje University, Haeundae paik hospital|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
20218651|NCT01929031|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218652|NCT05816200|Federal University of Rio Grande do Norte|PhD Cristianne Kalinne Santos Medeiros|+55(84)3342-2341|cristiannekalinne@gmail.com|
20218653|NCT01366443|University of Utah Medical Center, Dept. of OB/GYN|Dr. Michael Draper, MD University of Utah Medical Center, Dept. of OB/GYN|801-581-7647|mike.draper@hsc.utah.edu|
20218654|NCT02394730|University of New South Wales|Sean Emery, Chief Principal Investigator|+61 2 9385 0897|s.emery@unsw.edu.au|
20218655|NCT00731549|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20218656|NCT00588640|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl|646-888-2681|moryln@mskcc.org|
20218657|NCT02384850|GSO Global Clinical Research B.V., EBC Amsterdam, Keizersgracht 62-64, 1015 CS Amsterdam|Dr. Anne L. Kranich|+49 40 44 19 54 60|kranich@gsoglobal.com|
20218658|NCT00507546|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
20218659|NCT01111019|Merck Healthcare, a business of Merck KGaA|Merck KGaA Communication Center|+49 6151 72 5200|service@merckgroup.com|
20218660|NCT01524302|Michigan State University|Dr. Gary E. Stein|517-353-5126|steing@msu.edu|
20218661|NCT00986453|Medtronic Surgical Technologies|Robert Swain, PhD|+1 (603) 294-5428|robert.e.swain@medtronic.com|
20218662|NCT03512262|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
20218663|NCT01299805|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20218664|NCT01418482|Uppsala Akademiska Hospital, Dept. of Plastic Surgery|Fredrik Huss|+46 771 405 405|Fredrik.Huss@surgsci.uu.se|
20218665|NCT00375492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20218666|NCT02664545|Miach Orthopaedics|Rita Paparazzo|1-800-590-6995 x107|rpaparazzo@miachortho.com|
20218667|NCT04062448|Janssen Pharmaceutical K.K.|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218668|NCT04319718|University of Pittsburgh|Dr. Leslie Meyn, Research Assistant Professor|412-641-4233|meynla@mwri.magee.edu|
20173260|NCT00536601|Roswell Park Cancer Institute|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
20218669|NCT00281671|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, MD MPH|312 227 1551|jmcostello@luriechildrens.org|
20218670|NCT02802449|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
20218671|NCT00599521|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
20218672|NCT03882528|Walter Reed Army Institute of Research|Dr. James Moon, Principal Investigator|301-319-9176|James.e.moon.mil@mail.mil|
20218673|NCT01293539|Johns Hopkins|Monica Pearl, M.D.|410-955-8525|msmit135@jhmi.edu|
20218674|NCT00418301|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20218675|NCT00609518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20218676|NCT05855616|Marques de Valdecilla University Hospital|Raquel Pelayo Alonso, Head Nurse of Nephrology, RN|+34 649443488|raquel.pelayo@scsalud.es|
20218677|NCT04032158|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@merckgroup.com|
20218678|NCT04322149|Eledon Pharmaceuticals|Laura Batterman|949-874-3487|lbatterman@eledon.com|
20218679|NCT03716076|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
20218680|NCT02135653|University of Pennsylvania|Dr. Neha Vapiwala|(215) 662-2337|Neha.Vapiwala@pennmedicine.upenn.edu|
20218681|NCT01276301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218682|NCT00912093|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20218683|NCT03687658|Stanford University|Russell Poldrack, PhD|(650) 497-8488|poldrack@stanford.edu|
20218684|NCT00166036|Emory University|Arshed A Quyyumi, MD|404 712 2741|aquyyum@emory.edu|
20218685|NCT00891371|Ipsen|Medical Director, Gastroenterology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20218686|NCT00450619|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
20218687|NCT02034058|Stryker Neurovascular|Alice Lin, Clinical Program Manager|510 413 2673|alice.lin@stryker.com|
20218688|NCT02836496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20218689|NCT03914950|Medical University of Graz, Department of Radiology, Division of Nuclear Medicine|Dr. Susanne Stanzel|+43-316-385-81789|susanne.stanzel@medunigraz.at|
20218690|NCT03052959|Unity Health Toronto|Dr. Aisha Lofters|4163236400|aisha.lofters@utoronto.ca|3832
20218691|NCT04765384|Janssen Vaccines & Prevention B.V.|Vice President Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218692|NCT00629265|Boston Medical Center|Dr. Susan Langmore, PhD, Director of Speech Language Pathology|617-414-1753|langmore@bu.edu|
20218693|NCT02356003|University of Calgary|Frank MacMaster|403-955-2784|fmacmast@ucalgary.ca|
20218694|NCT01684436|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20218695|NCT01775865|University of Iowa|Gary Pierce|319-335-9487|gary-pierce@uiowa.edu|
20218696|NCT01169532|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
20218697|NCT02032706|Advanced Brain Monitoring, Inc.|Daniel Levendowski|760 720 0099|dan@b-alert.com|x6040
20218698|NCT02337959|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
20157885|NCT02230189|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
20157886|NCT03119168|Texas Tech University Health Sciences Center at El Paso|The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma|915-215-4678|antonio.mendoza-ladd@ttuhsc.edu|
20157887|NCT03894891|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
20157888|NCT01313507|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
20157889|NCT00800982|University of California San Francisco|Dr Ethan Levin|4154764019|levine@derm.ucsf.edu|
20157890|NCT01824290|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157891|NCT03046836|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers|8437925807|sellersst@musc.edu|
20157892|NCT01595529|Westat|Dr. Elizabeth Rowley|(919) 941-8325|ElizabethRowley@westat.com|
20157893|NCT02358993|University of Pennsylvania|Dr Uduak Andy|215-662-7709|uduak.andy@pennmedicine.upenn.edu|
20157894|NCT02246010|American University of Beirut|Dr. Mona Nabulsi|9611350000|mn04@aub.edu.lb|5523
20157895|NCT00959907|CBED|Débora Zechmeister do Prado|55 51 30262633|cbed@cbed.org.br|
20157896|NCT03958331|Cincinnati Children's Hospital Medical Center|Dr. Avani Modi|513-636-4864|avani.modi@cchmc.org|
20157897|NCT01911351|NYCHHC Jacobi Medical Center|Dr. Sandra Cunningham|718 918 5250|sandra.cunningham@nbhn.net|
20157898|NCT04422431|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20157899|NCT02015039|National Institutes of Health|Dr. Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
20157900|NCT01900665|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157901|NCT04046939|Knopp Biosciences|Vice President, Clinical and Translational Medicine|4124881776|calman@knoppbio.com|
20157902|NCT01903005|TRY Research|Kent Hoffman, DO|(407) 691-3960|Suboxdoc1@yahoo.com|
20157903|NCT01352286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20157904|NCT00000134|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
20157905|NCT05414175|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20157906|NCT00027560|Memorial Sloan-Kettering Cancer Center|Dr. Hugo Castro-Malaspina|212-639-8197|castro-h@mskcc.org|
20157907|NCT04028648|seca gmbh & co. kg|Kristin Klückmann|040200000232|kristin.klueckmann@seca.com|
20157908|NCT04050384|Nationwide Children's Hospital|Dr. Lance M. Relland|614-722-5971|lance.relland@nationwidechildrens.org|
20157909|NCT03559270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157910|NCT00577278|City of Hope Medical Center|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
20157911|NCT04743011|São Paulo State University (UNESP)|Professor Matheus Bertanha, Ph.D.|+551438801444|matheusbertanha@gmail.com|
20157912|NCT03508674|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20157913|NCT04011592|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|713-486-2837|Sudhakar.Selvaraj@uth.tmc.edu|
20157914|NCT01856322|National Cancer Institute|Dr. Marybeth Hughes|301-594-9341|hughesm@mail.nih.gov|
20157915|NCT01364480|University of Pittsburgh|Debbie Harrington, CCRP, senior research coordinator|4123831355|debbie.harrington@pitt.edu|
20157916|NCT02393859|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20157917|NCT01104402|Johns Hopkins University & University of Washington|Dr. Noah Lechtzin & Dr. Christopher Goss|410-502-7044|nlechtz@jhmi.edu|
20218699|NCT03562559|Vancouver General Hospital|Marcus Tholin|604-875-4111|marcus.tholin@vch.ca|
20218700|NCT05070546|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218701|NCT01227655|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20218702|NCT04982874|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
20218703|NCT00160641|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20218704|NCT02787408|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
20218705|NCT01782482|Alcon Research, Ltd.|Sharon Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20218706|NCT00511992|University of Oklahoma|Ingrid Block, CTO Director|405 271-8001|ingrid-block@ouhsc.edu|
20218707|NCT00985712|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20218708|NCT03736928|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20218709|NCT01194973|Alexion Pharmaceuticals Inc|Alexion Pharmaceuticals Inc||clinicaltrials@alexion.com|
20218710|NCT03096847|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20218711|NCT00359632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218712|NCT01875471|Johnson & Johnson Vision Care|Daria Wicks|1 904 443-1391|RA-VISUS-ClnclStds@its.jnj.com|
20218713|NCT01321008|University of Texas MD Anderson Cancer Center|Bouthaina Dabaja, MD / Associate Professor, Radiation Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
20218714|NCT02324673|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20218715|NCT02749292|Massachusetts General Hospital- Vasculitis and Glomerulonephritis Center|John L Niles|617-726-4132|JLNILES@mgh.harvard.edu|
20218716|NCT01843348|Novartis Pharmaceuticals|Study Director|862-779-8300||
20218717|NCT00251641|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20218718|NCT00876018|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218719|NCT01230892|Emory University|Dr. Habib Samady|404-778-5299|hsamady@emory.edu|
20218720|NCT00679913|Seoul National University Hospital|Sun-Whe Kim, M.D., Ph.D., FACS|82-2-2072-2310|sunkim@plaza.snu.ac.kr|
20218721|NCT00888459|Mayo Clinic|Jon O. Ebbert|507-266-1944|ebbert.jon@mayo.edu|
20218722|NCT00725621|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20218723|NCT01189500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218724|NCT01000493|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218725|NCT00456495|The New York Eye Cancer Center|Clinic Coordinator|212-832-8170|kchin@eyecancer.com|
20218726|NCT01346774|University of Michigan|Betsy Foxman, Hunein F. and Hilda Maassab Professor of Epidemiology|734-764-5487|bfoxman@umich.edu|
20218727|NCT00321594|Department of Clinical Oncology, The Chinese University of Hong Kong|Professor Winnie Yeo|852-2632|winnieyeo@cuhk.edu.hk|2118
20218728|NCT03736213|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
20218729|NCT00609466|Grunenthal|René Allard|49 241 569 3223|Clinical-Trials@grunenthal.com|
20218730|NCT03510182|University of Michigan|Carol Persad|734-615-8112|cpersad@umich.edu|
20218731|NCT01319773|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20218732|NCT05882279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20218733|NCT01334710|Emory University|Dr. Bassel El-Rayes|404-778-1900|belraye@emory.edu|
20218734|NCT03083821|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20218735|NCT00586482|Mayo Clinic|David O. Warner, MD|507-255-4288|warner.david@mayo.edu|
20218736|NCT00290251|NICHD, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
20218737|NCT03303625|Janssen Vaccines and Prevention B.V.|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218738|NCT05392907|INAIL|Ing. Emanuele Gruppioni|+39 051 6936 609|e.gruppioni@inail.it|
20218739|NCT03340064|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20218740|NCT02221037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20218741|NCT01461226|University of Antwerp/Antwerp University Hospital|dr. Luc bruyndonckx|003238213000|luc.bruyndonckx@uza.be|
20218742|NCT02944383|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
20218743|NCT00915928|Odense University Hospital, Odense, Denmark|Frantz Rom Poulsen, Professor, consultant|0045 65413600|frantz.r.poulsen@rsyd.dk|
20218744|NCT02766374|Rutgers - Robert Wood Johnson Medical School|Paul M. Lehrer, PhD|(732) 235-4413|lehrer@rutgers.edu|
20218745|NCT00852969|Tufts Medical Center|Mark Sarnak, MD|617 636-1182|msarnak@tuftsmedicalcenter.org|
20218746|NCT02440022|Becton Dickinson (BD)|Heidi Ronhovde|480-597-8579|Heidi.Ronhovde@bd.com|
20218747|NCT02358343|Center for Biomedical Statistics, University of Washington|Tessa Rue, Biostatistician|206-543-4246|ruet@uw.edu|
20218748|NCT01700049|Mayo Clinic|Dr. Scott Fosko|904-953-2303|fosko.scott@mayo.edu|
20218749|NCT01404078|St John's Research Institute|Dr. Alben Sigamani|+918049467080|alben@sjri.res.in|
20218750|NCT03084367|Philips (Volcano)|Becky Inderbitzen, Global Director, Clinical Development|+1.858.764.1336|becky.inderbitzen@philips.com|
20218751|NCT04325204|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
20218752|NCT00820443|MicroPort Orthepedics|Matt C. Paul, Project Manager|(901) 867-4350|mpaul@ortho.microport.com|
20218753|NCT04710979|University of Minnesota|Dr. Daheia J. Barr-Anderson|240-475-2806|barra027@umn.edu|
20218754|NCT03535675|Johns Hopkins University|Channing Paller; M.D.|4109558239|cpaller1@jhmi.edu|
20218755|NCT02070302|Arizona Arthritis & Rheumatology Research, PLLC|Amanda Santimaw|4806266653|amanda.santimaw@azarthritis.com|
20218756|NCT00307034|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218757|NCT00971841|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20218758|NCT00026221|The Ohio State University Comprehensive Cancer Center|William E. Carson III, MD|614-293-6306|William.Carson@osumc.edu|
20218759|NCT00967044|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD / Assistant Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
20218760|NCT03254602|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
20218761|NCT03309007|UNewMexico|MArk Burge|5052724658|mburge@salud.unm.edu|
20218762|NCT02963311|The Medicines Company|Frank Bosley, Vice-President, Regulatory Operaions|9732906016|frank.bosley@themedco.com|
20218763|NCT01691820|GlaxoSmithKline|GSK Response Center|866-435-7343|biliana.v.nestorova@gsk.com|
20218764|NCT03426566|Wroclaw Medical University|Dr Sutkowska Edyta|0048503077016|edytasutkowska@yahoo.com|
20218765|NCT04442490|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20218766|NCT00333879|Atlanta VA Rehab R&D Center|David Ross|404-321-6111|rosss0128@bellsouth.net|6817
20218767|NCT02044796|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
20218768|NCT02372071|Hadassah Hospital located in Jerusalem, Israel|PROF. BAR-OZ BENJAMIN|02-6774919|baroz@hadassah.org.il|
20218769|NCT01449279|Stanford Cancer Institute|Dr. Susan J Knox|650-725-2720|sknox@stanford.edu|
20218770|NCT02618408|Supernus|Gianpiera Ceresoli-Borroni, PhD, Director of Clinical Research|301-838-2521|gceresoliborroni@supernus.com|
20218771|NCT00063635|Columbia University Medical Center|Joel E. Lavine, MD, PhD||jl3553@columbia.edu|
20218772|NCT01663935|University of Wisconsin, Madison|Dr Michael Struck|608 263-6429|mcstruck@wisc.edu|
20218773|NCT02075671|The George Washington University, Medical Faculty Associates|Dermatology Research Fellow|202-741-2632|knelson@mfa.gwu.edu|
20218774|NCT00894738|Washington University School of Medicine|Dr. Ginger Nicol|(314) 362-2461|nicolg@psychiatry.wustl.edu|
20218775|NCT01249365|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173261|NCT04615923|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20173262|NCT01531374|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20173263|NCT01980914|Gerontology Research Unit|Boris Feldman|6048755115|boris.feldman@vch.ca|
20173264|NCT00449540|Neuralieve|Cynthia Merrell|408-245-6400|cmerrell@neuralieve.com|
20173265|NCT04545866|University of Alabama at Birmingham|Namasivayam Ambalavanan MD|2059344680|nambalav@uabmc.edu|
20173266|NCT01563003|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
20173267|NCT00667004|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20173268|NCT01013701|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20173269|NCT03241342|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20173270|NCT01267812|City of Hope|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
20173271|NCT00556712|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20173272|NCT00848367|Ottawa Hospital Research Institute|Dr. Giorgio Tasca|1-613-737-8085|gtasca@toh.on.ca|
20173273|NCT01059799|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20173274|NCT01537029|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
20173275|NCT00849810|University of Mississippi Medical Center|Professor of Medicine|601-984-5600|DMinor@umc.edu|
20173276|NCT01962207|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173277|NCT04049123|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@llilly.com|
20173278|NCT03036072|Maine Medical Center|Alexa Craig, MD|207-396-6920|craiga@mmc.org|
20173279|NCT02671422|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173280|NCT02289079|University of MInnesota|Dr. Jacob Hutchins|6126249990|hutc0079@umn.edu|
20173281|NCT00662363|Rehabilitation Institute of Chicago|Christina Marciniak|312-238-1000|cmarciniak@ric.org|
20173282|NCT01905657|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188280|NCT05186740|ProVerum|"Vice President, Clinical Affairs |"|"+1-720-472-1504|"|diane@proverummedical.com|
20188283|NCT05595213|BUCA School of Medicine, Endocrinology|Michael F Holick, PhD MD|(617) 358-6139|mfholick@bu.edu|
20188286|NCT03363763|Aucta Pharmaceuticals, Inc.|Dr. Marie Tan|7329129575|Marie.Tan@auctapharma.com|
20157918|NCT00856323|Friends Research Institute, Inc.|Dr. Cathy Reback|323-463-1601|reback@friendsresearch.org|
20188290|NCT02306161|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20173283|NCT04080297|Chief Exceutive Officer|Rob Crombie|+61 3 9657 0731|rcrombie@queoncology.com|
20173284|NCT02744391|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
20173285|NCT05838742|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173286|NCT02607033|Baltimore VA Hosptial|Odessa Addison|4106057000|odessa.addison@va.gov|55393
20173287|NCT06092710|CAndreRenard|CEDRIC GARCION|+33661817274|cedric.garcion.osteo@gmail.com|
20173288|NCT05119569|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20173289|NCT03909178|Massachusetts General Hospital|Dr. Scott Martin|(617) 726-7500|sdmartin@partners.org|
20173290|NCT02623439|University of California, San Diego|Michelle Padilla|(858) 822-5354|CancerCTO@health.ucsd.edu|
20173291|NCT01754623|Florida Hospital Orlando (Formerly at Moffitt Cancer Center)|Ravi Shridhar, M.D., Ph.D.|407-303-5857|ravi.shridhar.md@flhosp.org|
20173292|NCT01880840|Meda Pharmaceutical|Dr.Nancy Ruiz Chief Medical Officer|732 564 2200|nancy.ruiz@meda.us|2390
20173293|NCT04484142|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20157919|NCT01119443|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157920|NCT02329743|Auven Therapeutics|S Weiss|201 486-0396|sid.weiss@auventx.com|
20157921|NCT01428219|University of Michigan Comprehensive Cancer Center|Dr. David C. Smith, M.D.|734-764-3066|dcsmith@umich.edu|
20157922|NCT02071771|Alcon Research, Ltd.|Sr Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20157923|NCT01291108|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20157924|NCT02921295|University of Pittsburgh|Dr. Goeran Fiedler|4126246475|gfiedler@pitt.edu|
20157925|NCT01833494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20157926|NCT03068897|Montefiore|Dr. Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
20157927|NCT01694433|UCLA|Dr. Jenny Kim|310-825-5420|jekim@mednet.ucla.edu|
20157928|NCT03071861|University of Utah|Tara DuPont|8015814178|tara.dupont@hsc.utah.edu|
20157929|NCT00374595|University of Nebraska Medical Center|Jennifer Larsen|(402) 559-4837|jlarsen@unmc.edu|
20157930|NCT03745768|Washington University School of Medicine St. Louis|Pilar Cristancho M.D.|314 362 2413|cristanchopimiento.l@wustl.edu|
20157931|NCT00443118|FUNDASAMIN-Fundacion para la Salud Materno Infantil|Edgardo Szyld MD, MSc|5491144093095|eszyld@gmail.com|
20157932|NCT04512001|Fresenius Kabi SwissBioSim GmbH|Clinical Development|793075735|clinical.development@fresenius-kabi.com|+41
20157933|NCT02776683|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157934|NCT04232943|PATH|Rahsan Erdem, MD, Senior Medical Officer|+1 202 540 4546|rerdem@path.org|
20157935|NCT01773954|Mid Atlantic Retina|Michele Formoso|215-928-3092|research@midatlanticretina.com|
20157936|NCT03391986|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@columbia.edu|
20157937|NCT01664247|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20157938|NCT01553292|University of Manitoba|Dr Yahya Al Ethawi|0012049634721|yalethawi@hsc.mb.ca|
20157939|NCT01718522|Kinder- und Jugendkrankenhaus Auf der Bult|Prof. Dr. Thomas Danne|0511-8115-3331|danne@hka.de|
20157940|NCT01000506|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157941|NCT03064074|Baylor|dianne Nguyen|7137986694|diannen@bcm.edu|
20157942|NCT05018689|Penn State College of Medicine|Dr. Deepa Sekhar|717-531-0003|dsekhar@pennstatehealth.psu.edu|x281334
20157943|NCT01859013|University of Minnesota|Claudia Fox|612-626-6616|lusc0001@umn.edu|
20157944|NCT03091361|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
20157945|NCT02216526|Charité Universitätsmedizin Berlin, Germany|PD Dr. Jan Kottner|+49 (0)30 450 518 218|jan.kottner@charite.de|
20157946|NCT01882465|Johnson & Johnson Vision Care Inc.|Charis Lau, PharmD, OD, FAAO- Principal Research Optometrist|904-433-3500|charislau@gmail.com|
20157947|NCT03824392|aTyR Pharma|Lisa Carey|858 731 8389|clinicaltrials@atyrpharma.com|
20173294|NCT03700671|University of Central Lancashire|Stefan Birkett Lecturer in Exercise Science|01772 893325|sbirkett4@uclan.ac.uk|
20157948|NCT03988426|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
20188305|NCT05162586|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
20188317|NCT02567435|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20188318|NCT02166463|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20188323|NCT02945800|Moffitt Cancer Center|Jonathan Metts, MD|813-745-5616|Jonathan.Metts@moffitt.org|
20188329|NCT05030584|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20188349|NCT03047213|Yale School of Medicine: Medical Oncology|Joseph Kim, MD, Associate Professor of Internal Medicine|(203) 200-4822|joseph.w.kim@yale.edu|
20188355|NCT06139302|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188360|NCT05394844|uwashington|Dr nicole ehrhardt|2404479566|nehrhard@uw.edu|
20188367|NCT02115282|ECOG-ACRIN Cancer Research Group|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
20188373|NCT06393127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188374|NCT02446600|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
20188384|NCT02466971|NRG Oncology|Christopher Purdy on behalf of Wei Deng, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20188410|NCT06415045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
20188417|NCT02101853|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20188418|NCT02112916|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20188442|NCT02890355|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
20188450|NCT02180867|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20188457|NCT04129450|Boston Medical Center|Natalia Morone, MD, MS|617-414-6652|natalia.morone@bmc.org|
20188460|NCT04129164|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20188461|NCT03694262|Medical College of Wisconsin|William Bradley, MD|414-805-6606|wbradley@mcw.edu|
20188462|NCT02757898|Emory University|Dr. John Roback|404-712-1774|jroback@emory.edu|
20188463|NCT03820544|Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Kowalski, MD|215-955-9396|Thomas.Kowalski@jefferson.edu|
20188464|NCT05858905|Shockwave Medical|Josh Popp|1-510-279-4262|jpopp@shockwavemedical.com|
20188465|NCT02752685|NYU Langone Health|Sylvia Adams, MD|212-731-5795|Sylvia.Adams@nyulangone.org|
20188466|NCT02831283|Columbia University|Patrick Lao|2123421351|PJL2133@CUMC.COLUMBIA.EDU|
20188467|NCT04174560|Cincinnati Children's Hospital|Robert Frenck, Jr., MD|513-636-4463|Robert.Frenck@cchmc.org|
20188468|NCT04712903|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20188469|NCT04591080|University at Buffalo|Thikriat Al-Jewair, Program Director|17168296190|thikriat@buffalo.edu|
20188470|NCT03875001|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188471|NCT03782116|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
20188472|NCT05934292|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20188473|NCT04479787|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Udoka.okaro@abbott.com|
20188474|NCT02586974|Città della Salute e della Scienza di Torino - Ospedale Molinette|Dr. Marco Oderda|+393479383465|marco.oderda@libero.it|
20188475|NCT05714059|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
20188476|NCT04899674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188477|NCT03774472|M D Anderson Cancer Center|Debasish Tripathy|713-794-4385|dtripathy@mdanderson.org|
20188478|NCT05648890|Thomas Bata Hospital, Zlin, Czech Republic|Dr. Klára Nekvindová|+420 577 552 280|klara.nekvindova@bnzlin.cz|
20188479|NCT03150862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20188480|NCT05039021|Ethicon Endo-Surgery, Inc.|Senior Director Medical Affair-Endomechanical and Trx|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188481|NCT02719574|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20188482|NCT03027128|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20188483|NCT00630487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20188484|NCT01969916|University of Chicago|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
20188485|NCT00495677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188486|NCT00575016|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20188487|NCT03653364|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20188488|NCT01864538|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilso2112@gmail.com|
20188489|NCT00195403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188490|NCT03983382|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-5154|yua3@mskcc.org|
20188491|NCT03053960|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Lionel Gold|215-955-6215|Lionel.Gold@jefferson.edu|
20188492|NCT02348632|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20188493|NCT01925144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20188494|NCT03744559|Medical University of South Carolina|Dr Michael Saladin|(843) 792-5306|saladinm@musc.edu|
20188495|NCT02879318|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
20188496|NCT04908514|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20188497|NCT04261790|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
20188498|NCT05501548|Johns Hopkins University|Channing Paller, M.D., principal investigator|410-955-8239|cpaller1@jhmi.edu|
20188499|NCT00743951|University of Ottawa, Ottawa Hospital Research Institute|Dawn Stacey|613-737-8899|dstacey@uottawa.ca|73817
20188500|NCT04959812|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|CraigCrandall@texashealth.org|
20203341|NCT02746679|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
20203342|NCT01416610|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20188501|NCT05517902|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medinfo@mnk.com|
20203343|NCT02961764|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20188502|NCT01513122|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
20188503|NCT05787054|Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli|Dr Alessandra Familiari|+393285887422|alessandra.familiari@policlinicogemelli.it|
20188504|NCT02566889|Janssen Scientific Affairs|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188505|NCT03140670|Abramson Cancer Center|Pancreas Research Program Manager|2672575567|mazali@pennmedicine.upenn.edu|
20188506|NCT00220805|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20188507|NCT02325466|Icahn School of Medicine at Mount Sinai|Dr. Robert S. Rosenson|212-241-9101|robert.rosenson@mssm.edu|
20188508|NCT03699163|Imperial College London|Professor George Hanna|02033122124|g.hanna@imperial.ac.uk|
20188509|NCT06336967|University of Pennsylvania|Dr. Heather Nuske, PI|(215) 746-6041|heather.nuske@pennmedicine.upenn.edu|
20188510|NCT02454283|Laguna Pharmaceuticals|Chief Medical Officer|858-405-1429|hdittrich@imager.com|
20188511|NCT01964300|Pediatric Brain Tumor Consortium|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
20188512|NCT00557492|UPMC CancerCenter|Herbert Zeh, MD|4126922852|zehxhx@upmc.edu|
20188513|NCT02524769|Loyola University Chicago|Dr. Elizabeth Mueller|708-216-2180|EMUELLE@lumc.edu|
20188514|NCT02111096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20188515|NCT03621735|University of Michigan|Susan Shore|734-647-2116|sushore@umich.edu|
20203344|NCT03461289|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
20203345|NCT02698423|Geneva University Hospitals|Dr Manuela Viviano|07955 32 272|manuela.viviano@hcuge.ch|
20203346|NCT01553539|Wake Forest University Health Sciences|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
20203347|NCT02749370|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20203348|NCT02101411|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
20203349|NCT01519427|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
20203350|NCT03894904|The University of Texas Health Science Center at Houston|Nischal K. Gautam, MD|(713) 500-6200|Nischal.K.Gautam@uth.tmc.edu|
20203351|NCT03020524|University of Pennsylvania|Regulatory Lead|215.662.4484|psom-ind-ide@pobox.upenn.edu|
20203352|NCT00121810|Hoffmann-La Roche|Medical Communications|800-821-8590||
20203353|NCT02190435|William Beaumont Hospital|Denise Koueiter, MS|248-551-5166|denise.koueiter@beaumont.org|
20188516|NCT04098575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203354|NCT02644525|Laboratory of Parasitic Diseases, NIAID/NIH|Elise O'Connell, MD, Principal Investigator|301-661-0172|oconnellem@mail.nih.gov|
20203355|NCT03028025|VALBHS|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|
20203356|NCT02399475|University of Pennsylvania|Dr. Anne Cappola|2155375359|acappola@pennmedicine.upenn.edu|
20203357|NCT02260193|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
20203358|NCT00935220|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203359|NCT01377467|University Hospital Zürich|Prof. Rudolf P. Wüthrich|+41 44 255 33 84|rudolf.wuethrich@usz.ch|
20203360|NCT01415440|NYSPI|Jonathan Posner, MD|6467745735|jonathan.posner@nyspi.columbia.edu|
20203361|NCT00336492|Johnson & Johnson Pharmaceutical Research and Development|Senior Director, Clinical Research|610-240-8092||
20203362|NCT01781026|Yale University|Harriet Kluger||Harriet.Kluger@yale.edu|
20203363|NCT00633139|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20203364|NCT02160977|Peking University Third Hospital|Dr. Jia-Kuo Yu|86-10-82267392|yujiakuo@126.com|
20203365|NCT03458000|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
20188517|NCT05274321|University of California, San Francisco|Julius Oatts, MD|(415) 353-2800|Julius.Oatts@ucsf.edu|
20188518|NCT03875313|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20188519|NCT04121546|Indiana University School of Medicine|Dr. Michael Bushey|3179637300|mabushey@iu.edu|
20188520|NCT05441449|Spinal Cord Damage research Center, James J. Peters VA Medical Center|Dr. John Handrakis|(718) 584-9000|john.handrakis@va.gov|5439
20188521|NCT00686595|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20188522|NCT06065501|National Cheng Kung University|Professor Miaofen Yen / Professor of Nursing department|886-6-2353535|miaofen@mail.ncku.edu.tw|5823
20188523|NCT06003075|University of Kentucky|Dr. Ralph Zinner|859-562-2864|ralph.zinner@uky.edu|
20188524|NCT06203990|Washington University in St. Louis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
20188525|NCT03286114|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20188526|NCT02956642|University of California San Francisco|Dr. Jenise Wong|415-476-3316|jenise.wong@ucsf.edu|
20188527|NCT05288348|University of Pittsburgh|Francis X Guyette|412 651 1077|guyettef@upmc.edu|
20188528|NCT03304418|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
20188529|NCT01260896|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20188530|NCT00982644|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20188531|NCT00909649|Mansoura university hospital|Elnakeeb Ayman|0106752021|elnakeebayman@yahoo.com|
20188532|NCT00943917|Intarcia Therapeutics, Inc|Michelle Baron MD|510-782-7800|clinicaltrials@intarcia.com|
20188533|NCT01171976|Novartis Pharmaceuticals|Study Director|862-778-8300||
20188534|NCT01318694|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20188535|NCT00003222|University of Virginia|Craig L. Slingluff, MD|434-924-1730|CLS8H@hscmail.mcc.virginia.edu|
20188536|NCT00410423|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|Joanne.Filicko@jefferson.edu|
20188537|NCT01380743|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
20188538|NCT04612244|BSC|Allison Anderson|651-582-5077|allison.anderson@bsci.com|
20188539|NCT02224729|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Joanne Filicko, O'Hara|215-955-8874|joanne.filicko@jeffersron.edu|
20188540|NCT03767335|Menarini Ricerche S.p.A.|Clinical Sciences|+39 05556809990|martine.piccart@bordet.be|
20188541|NCT01313559|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
20188542|NCT02754596|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
20188543|NCT06995755|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
20188544|NCT05856266|Biovitrum|CPL|0795914760|rolf.schlosshauer@sobi.com|
20188545|NCT03213457|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20188546|NCT02951052|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20188547|NCT04227600|JCR Pharmaceuticals|Study Director|+81 797 32 8582|clinical_development@jp.jcrpharm.com|
20188548|NCT04059406|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20188549|NCT04056910|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20203366|NCT00328263|Bio-K+ International Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
20203367|NCT01810991|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20203368|NCT02658656|James J Peters VA Medical Center|Dr. Ann Spungen, Study Chairperson|7185849000|ann.spungen@va.gov|5814
20203369|NCT01118143|University of Tromsø|Professor Jan Bergdahl|+4777649122|jan.bergdahl@uit.no|
20203370|NCT02112448|Advocate Children's Hospital|Jamie Penk|7086845580|jamie.penk@advocatehealth.com|
20203371|NCT04963179|Womed|Director of Clinical Affairs|0785225561|pauline@womedtech.com|+33
20203372|NCT05270694|MaineHealth Institute for Research|Dr. Kathleen Fairfield|207-661-7614|kathleen.fairfield@mainehealth.org|
20203373|NCT01070303|Abbott|Global Medical Services|800-633-9110||
20203374|NCT03121352|University Hospitals|Joseph Baar|216-844-8683|joseph.baar@uhhospitals.org|
20203375|NCT00859898|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
20203376|NCT04230486|Wake Forest School of Medicine|Huai Jiang, PhD|336-695-6460|jianghuai.ws@gmail.com|
20203377|NCT03215264|University of Pennsylvania/ Abramson Cancer Center|Thomas Karasic, MD|2156141858|thomas.karasic@pennmedicine.upenn.edu|
20203378|NCT01397071|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
20203379|NCT02145156|University of Colorado Denver|Julie A. Maertens|303-724-7319|julie.maertens@ucdenver.edu|
20203380|NCT02615535|Spaulding Rehabilitation Hospital|Dr. Ginger Polich|617 952 5000|ginger.polich@mgh.harvard.edu|
20203381|NCT02417233|University of California San Francisco|Dr. Sheri Lippman|415-476-6319|sheri.lippman@ucsf.edu|
20203382|NCT01264965|University of Chicago|Theodore Karrison|773-702-9326|karr@health.bsd.uchicago.edu|
20203383|NCT00532883|NHLBI|Harvey Luksenburg|301-435-0050|luksenburgh@mail.nih.gov|
20203384|NCT03799718|Brainstorm Cell therapeutics|Chief Medical Officer|201-488-0460|Clinical.Trial@brainstorm-cell.com|
20203385|NCT00321984|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20203386|NCT01469013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203387|NCT00076219|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Paul M. Palevsky MD|410-360-3932|paul.palevsky@va.gov|
20203388|NCT01734993|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20203389|NCT03303339|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
20203390|NCT01206595|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20203391|NCT01879618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203392|NCT01797432|University of Minnesota|Maria Hordinsky, MD|612-625-6118|hordi001@umn.edu|
20203393|NCT03809546|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20203394|NCT00487279|St. Jude Medical CRMD|Heidi Hinrichs/Sr. Director, Clinical Operations|(818) 493-3297|hhinrichs@sjm.com|
20203395|NCT00501852|Novartis Pharmaceuticals|Study Director|862-778-8300||
20203396|NCT02679066|Johns Hopkins Bayview|Erik Hasenboehler MD|4105504190|ehasenb1@jhmi.edu|
20203397|NCT01171521|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20203398|NCT01927562|Fractyl|Sarah Hackett|617-596-9522|shackett@fractyl.com|
20203399|NCT00492921|JHU SKCCC|Dr. Javier Bolanos Meade|410-614-6398|Fbolano2@jhmi.edu|
20203400|NCT00652093|Translational Pain Research, University of Rochester Medical Center|Dr. John D. Markman, MD|585-276-3616|john_markman@urmc.rochester.edu|
20203401|NCT04076072|Vanderbilt University Medical Center|Marybeth Carter|615-936-1639|Marybeth.l.carter@vumc.org|
20203402|NCT01422304|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203403|NCT00469014|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Professor, Chair, Stem Cell Transplantation|713-792-3618|CR_Study_Registration@mdanderson.org|
20203404|NCT01566838|Cardiac, Vascular, and Thoracic Surgery Associates|Sandeep Khandhar, MD|703-280-5858|SKhandhar@CVTSA.com|
20203405|NCT00864227|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20203406|NCT02722577|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China|Guodong Niu|+86(10)88398866|guodongniu@fuwai.com|
20203407|NCT03418662|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
20203408|NCT00866294|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203409|NCT03241173|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20203410|NCT00492401|The Ohio State University Comprehensive Cancer Center|William Blum, MD|614-293-9273|William.Blum@osumc.edu|
20203411|NCT01319760|Columbia Presbytarian Hospital, NY|Dr. Ajay Kirtane|212-305-7060|akirtane@columbia.edu|
20203412|NCT00081289|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20203413|NCT01797029|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
20203414|NCT02508701|Purdue University|Stewart Chang Alexander|765-427-9860|alexan90@purdue.edu|
20203415|NCT02167204|University of Washington|Hannah Linden|206-606-2053|hmlinden@uw.edu|
20203416|NCT01863563|Children's Hospital of the Kings Daughters|Craig Derkay, MD|757.668. 9327|Craig.Derkay@chkd.org|
20203417|NCT00530712|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20203418|NCT00734409|Duke University Health System|DaiWai M Olson, PhD RN|(919) 668-3751|Olson006@mc.duke.edu|
20203419|NCT02273323|Unilever R&D Vlaardingen|Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
20203420|NCT04064684|The University of Texas Health Science Center at Houston|Alvaro Jose Coronado Munoz, MD|713-500-5553|Alvaro.J.CoronadoMunoz@uth.tmc.edu|
20203421|NCT00651118|Meda Pharmaceutical|David Ginsberg,..|732 564 2364|david.ginsberg@meda.us|
20203422|NCT03117049|Ono Pharmaceutical Co. Ltd|Medical Information Center|---|clinical_trial@ono.co.jp|
20203423|NCT00839098|Human Engineering Reserach Laboratories|Clinical Coordinator|412-822-3700|annmarie.kelleher@va.gov|
20203424|NCT00798967|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20203425|NCT01354691|Bar Ilan University|Jonathan Rabinowitz, PhD||jonathan.rabinowitz@biu.ac.il|
20203426|NCT03141307|University of Utah|Dr. Bob Wong|801-587-9666|bob.wong@nurs.utah.edu|
20203427|NCT03090737|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20203428|NCT00227877|Boston Children's Hospital - Center for Adolescent Substance Use and Addiction Research|Sion Kim Harris, PhD|857-218-4304|sion.harris@childrens.harvard.edu|
20203429|NCT02517047|Boston Children's Hospital|Dr. Wanda Phipatanakul|6173556117|wanda.phipatanakul@childrens.harvard.edu|
20203430|NCT01452425|UCLouvain|Pr Patrice Forget|3227641821|forgetpatrice@yahoo.fr|
20203431|NCT03103750|Yale School of Medicine|Marc Potenza, PhD, MD|(203) 974-7356|marc.potenza@yale.edu|
20203432|NCT01663740|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20203433|NCT02522481|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
20203434|NCT00410280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203435|NCT03123939|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20203436|NCT01522651|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20203437|NCT03624101|University of Alabama at Birmingham Child Health Research Unit|Heather Hathorne|2055032829|hyhathorne@uabmc.edu|
20203438|NCT04267562|MicroCube, LLC|Dinesh Mody|(510) 651-5000|m@minitouch.us|
20203439|NCT02026908|Northwestern University/Northwestern Memorial Hospital|Samdeep Mouli MD|312-926-5200|s-mouli@northwestern.edu|
20203440|NCT02338076|Rockefeller University|Dr. Emma Guttman|212-327-8333|skhattri@rockefeller.edu|
20203441|NCT00912158|Chest Department, Faculty of Medicine, Assiut University- EGYPT|Dr. Maha K Ghanem, MD, FCCP|+ 2 0127694434|mahaghanem@hotmail.com|
20203442|NCT03459131|Alcon, A Novartis Division|Sr Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20203443|NCT00408421|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20203444|NCT02772965|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-966-1343|michael_kappelman@med.unc.edu|
20203445|NCT03478878|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
20203446|NCT03046472|Maccabi Health services and Wingate college|Neta Vitman|0508955529|vitmanan@gmail.com|
20203447|NCT01614769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203448|NCT02115815|MedImmune, LLC|Judith Falloon, MD|301-398-5000|falloonj@medimmune.com|
20203449|NCT01989546|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
20203450|NCT03960138|University of Missouri|Dr. Brett Froeliger|5738824785|froeligerb@health.missouri.edu|
20203451|NCT04688346|University of Washington|Dr. Travis Nelson|206-290-2899|tmnelson@uw.edu|
20203452|NCT04439838|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203453|NCT01741272|Alberta Health Services|Dr. Robert Balyk|7804395858|rbalyk6@aol.com|
20203454|NCT01958671|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203455|NCT02778867|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
20203456|NCT01290484|Stanford University|Dr. Alfred Lane|650-721-7170|alfred.lane@stanford.edu|
20203457|NCT00960440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203458|NCT03504774|Stanford University School of Medicine|Sayantani B. Sindher, MD|650-521-7237|tina.sindher@stanford.edu|
20203459|NCT01781429|BioMed Valley Discoveries|Brent Kreider, PhD|816-960-4644|bkreider@biomed-valley.com|
20203460|NCT00719576|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
20203461|NCT01035606|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@ucsf.edu|
20203462|NCT01849848|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
20203463|NCT01809262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203464|NCT01505491|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203465|NCT02191917|BioMarin Pharmacuetical Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
20203466|NCT02404155|Maryland Psychiatric Research Center|Dr. Deanna L. Kelly, Pharm.D., BCPP|410-402-6860|dlkelly@som.umaryland.edu|
20203467|NCT01740440|BioMedical Research Ltd|Gary Rainsford|0035391774361|grainsford@bmr.ie|
20203468|NCT02409784|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20203469|NCT01063751|Stryker - Joint Replacement|Filesha Haniff / Clinical Study Manager|1 470.528.9214|filesha.haniff@stryker.com|
20203470|NCT00614666|University of Arizona|Dr. John Galgiani|(520) 626-4968|spherule@email.arizona.edu|
20203471|NCT03408873|Case Western Reserve University and University Hospitals Cleveland Medical Center|Joy Yala, MPH|216-368-0783|jxy790@case.edu|
20203472|NCT01600131|Veterans Health Administration|Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
20203473|NCT02519244|The University of Texas Health Science Center at Houston|Shuo-Hsiu Chang, PT, PhD|713-799-7016|shuo-hsiu.chang@uth.tmc.edu|
20203474|NCT02487745|Johns Hopkins University School of Medicine|Kenneth Silverman|4105502694|ksilverm@jhmi.edu|
20203475|NCT00406315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20203476|NCT01312428|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
20203477|NCT02844582|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20203478|NCT04860713|Maimonides Medical Center|Research Administration Director|718-283-6896|alikourezos@maimonidesmed.org|
20203479|NCT01797783|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-888-451-3937|alcon.medinfo@alcon.com|
20203480|NCT02786355|UBC Department of Anesthesia - BC Women's Hospital|James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
20203481|NCT02202031|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
20203482|NCT02184143|Vanderbilt University Medical Center|Kristin Archer|(615) 322-2732|kristin.archer@Vanderbilt.Edu|
20203483|NCT04412954|Ohio State Univeristy|Sandy Solove|6142478366|solove.3@osu.edu|
20203484|NCT00748826|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20203485|NCT01596842|Dong-A University|Professor|82-51-240-2811|anws@dau.ac.kr|
20203486|NCT02214186|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|M.D. Wallace Andrino da Silva|+551126616787|wallaceandrino@yahoo.com.br|
20157949|NCT00532844|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
20188550|NCT04755595|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|(718) 270-1229|jared.jagdeo@downstate.edu|
20203487|NCT01525849|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|
20203488|NCT00339183|Amgen Inc.|Study Director|866-572-6436||
20203489|NCT00793819|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20203490|NCT00446446|Amgen Inc.|Study Director|866-572-6436||
20203491|NCT02560701|Harvard Pilgrim Health Care Institute|Dr. J. Frank Wharam|(617) 867-4948|jwharam@post.harvard.edu|
20203492|NCT05748925|mansoura urology and nephrology center|Nourelsabah Mohamed Elbialy , consaltant nephrology|01065619243|nourelsabah@mans.edu.eg|
20203493|NCT04392011|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
20203494|NCT00611130|Catalyst Pharmaceutical Partners, Inc.|M Douglas Winship|305-529-2522|dwinship@catalystpharma.com|12
20203495|NCT01765647|University of Alberta|Dory Sample|780-248-5599|dory.sample@ahs.ca|
20203496|NCT03662334|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20203497|NCT01564654|ConforMIS|Marc Quartulli, VP Clinical Affairs|781-345-9191|marc.quartulli@conformis.com|
20203498|NCT00691197|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20203499|NCT00298610|Walter Reed Army Institute of Research|Shon A. Remich, MD|254-733-628-670|sremich@hotmail.com|
20203500|NCT02119104|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203501|NCT01632878|Mylan|Patrick Aubonnet / Medical Director||patrick.aubonnet@mylan.com|
20203502|NCT01558089|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203503|NCT03415464|FACULTY OF SPORT|Vedran Hadzic|+38615207700|vedran.hadzic@fsp.uni-lj.si|728
20203504|NCT02986958|Johns Hopkins Bloomberg School of Public Health|Research Program Manager|410-614-7910|dechava1@jhu.edu|
20203505|NCT02948777|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
20203506|NCT03242928|Novartis Pharma AG|Clinical Disclosure Office|613241111|Novartis.email@Novartis.com|
20203507|NCT03333057|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
20203508|NCT01387295|Herlev University Hospital|Dr Dorte Nielsen|+45 38682344|dorte.nielsen.01@regionh.dk|
20203509|NCT00431847|Philadelphia Veterans Affairs Medical Center|Rollin M Gallagher, MD, MPH|(215) 823-5800|Rollin.Gallagher@va.gov|4907
20203510|NCT00816907|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
20203511|NCT02142894|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
20203512|NCT00717418|Allergan, Inc.|Vice President, GHOSR|714-246-4500|clinicaltrials@allergan.com|
20203513|NCT01024465|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
20203514|NCT00733356|University of California Irvine Child Development Center|Kinberley Lakes|949-824-3009|klakes@uci.edu|
20203515|NCT02836990|University at Buffalo, SUNY|Dr Linda Harris|7168594207|lmharris@buffalo.edu|
20203516|NCT03078608|Kaiser Permanente Northern California|Elaine Kurtovich|510-891-3118|elaine.m.kurtovich@kp.org|
20203517|NCT00723840|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20203518|NCT01747330|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20203519|NCT04004507|Ophthalmic Consultants Of Long Island|Dr. Marguerite McDonald|7342501718|margueritemcdmd@aol.com|
20203520|NCT01400971|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20203521|NCT02535949|Washington University School of Medicine|Dr. Philip Spinella|314-286-0858|pspinella@wustl.edu|
20203522|NCT02137772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203523|NCT00455858|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20203524|NCT02092389|AbbVie|Global Medical Information|1-800-633-9110||
20203525|NCT01844700|Zucker Hillside Hospital, Division of Psychiatry Research|Anil Malhotra, MD|718-470-8281|amalhotra@nshs.edu|
20203526|NCT01242020|Associate Dean for Clinical and Translational Research, College of Physicians and Surgeons|Muredach P. Reilly, MBBCh, MSCE|212-305-9453|mpr2144@cumc.columbia.edu|
20203527|NCT00787332|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
20203528|NCT02273310|The Children's Hospital of Philadelphia/Perleman School of Medicine of The University of Pennsylvania|Lamia Barakat, Ph.D.|267-426-8135|barakat@email.chop.edu|
20203529|NCT03958201|University of Washington|Research Coordinator|206-744-4634|ajames1@uw.edu|
20188551|NCT00319696|Actelion Pharmaceuticals Ltd|Andjela Kusic-Pajic, MD/Clinical Project Team Leader|+41 61 565 64 17||
20188552|NCT02377700|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
20188553|NCT00655499|GERCOR|Regulatory affairs|00331 40 29 85 00|Regulatory.Affairs@gercor.com.fr|
20188554|NCT03373916|University of Michigan|Paul Pfeiffer, MD|734-845-3645|ppfeiffe@med.umich.edu|
20188555|NCT03248492|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo_us@daiichisankyo.com|
20188556|NCT04495621|Menarini Ricerche S.p.A.|Clinical Sciences|+39 0555680|martine.piccart@bordet.be|9990
20188557|NCT03260569|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
20188558|NCT05707351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20188559|NCT00391443|Actelion Pharmaceuticals Ltd|Isabelle Leconte,PhD -Data Science Group Leader, Director|+41 61 565 64 18|isabelle.leconte@actelion.com|
20188560|NCT05545280|Cleveland Clinic Foundation|Kurt Ruetzler, MD|216 636-0561|RUETZLK@ccf.org|
20203530|NCT01595646|Wake Forest School of Medicine|Suzanne Craft, PhD|3366-713-8830|suzcraft@wakehealth.edu|
20203531|NCT00693719|University of Arizona Cancer Center|Dr. Robert Livingston|520/626-4175|rlivingston@azcc.arizona.edu|
20203532|NCT02946229|GE Healthcare|Sean Lucas - Research Manager|1-248-533-5575|sean.lucas@ge.com|
20203533|NCT01161524|Eisai Inc.|Eisai Call Center|888-422-4743||
20203534|NCT00642616|Sanofi|Trial Transparency Team||ContactUS@sanofi.com|
20203535|NCT00339079|Brigham and Women's Hospital|Arthur J. Barsky, MD|617-732-5236|abarsky@partners.org|
20203536|NCT00399802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203537|NCT00542815|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20203538|NCT04946344|Wake Forest University|Dr. Stephen Messier|336-758-3969|messier@wfu.edu|
20203539|NCT04172831|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20203540|NCT01041573|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
20203541|NCT02955186|Yale School of Medicine|Dana Cavallo, Project Coordinator|203-610-9788|dana.cavallo@yale.edu|
20203542|NCT01088815|Johns Hopkins SKCCC|Dr. Ana De Jesus Acosta|443-287-0411|adejesu1@jhmi.edu|7-0411
20203543|NCT02234115|Foresee Pharmaceuticals co., Ltd.|Dr. John Mao||john.mao@foreseepharma.com|
20203544|NCT01618656|Yale University School of Medicine|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@yale.edu|2594
20203545|NCT01276847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203546|NCT01899144|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20203547|NCT02213757|MHRI|Dr. Richter|2028776526|Lee.Ann.Richter@medstar.net|
20203548|NCT00751881|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20203549|NCT04770155|University of Mississippi Medical Center|Director of Clinical Trials|601-815-5000|clinicaltrials@umc.edu|
20203550|NCT02021812|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
20203551|NCT00564629|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
20203552|NCT03634072|Children's Hospital of Philadelphia|Dr Mark Fogel|215-590-7566|fogel@chop.edu|
20203553|NCT01765764|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20203554|NCT00929578|Tufts Medical Center|Alice Gottlieb, MD PhD|617-636-7462|agottlieb@tuftsmedicalcenter.org|
20203555|NCT02307526|James J. Peters VA Medical Center|Jill M. Wecht|7185849000|jm.wecht@va.gov|3122
20203556|NCT01651260|Hollister Incorporated|Malford Cullum|847-918-3975|malford.cullum@Hollister.com|
20203557|NCT02222129|USAF|Richard Knight, MD|+44 1638 528186|richard_b_knight@yahoo.com|
20203558|NCT02144220|University of Rochester|Ray Dorsey, MD|585-275-0663|ray.dorsey@chet.rochester.edu|
20203559|NCT03419533|The University of Adelaide|Prof. Helen Marshall|8161 8115|helen.marshall@adelaide.edu.au|
20203560|NCT01952015|Novartis Pharmaceuticals|Study Director|862-778-8300||
20203561|NCT02239094|Depression Evaluation Service (New York State Psychiatric Institute)|David J. Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
20203562|NCT01597193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203563|NCT03595215|TheraNova|Clinical Research Associate|415-926-8616|akrajcevska@theranova.com|
20203564|NCT03184701|Albert Einstein Healthcare Netwrok|Manisha Verma|2154561026|vermam@einstein.edu|
20203565|NCT04073823|Tactile Medical|Michelle Wetherby|612.230.4576|mwetherby@tactilemedical.com|
20203566|NCT03648996|University of Missouri, School of Medicine|Dr. Camila Manrique, MD|(573) 882-2554|manriquec@umsystem.edu|
20203567|NCT00317941|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20203568|NCT03242759|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203569|NCT00064662|New England Research Institutes|Anne M. Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
20203570|NCT02186795|MUSC|Sylvia Wilson, MD|843-732-2322|wilsosh@musc.edu|
20203571|NCT03008590|VA Boston Healthcare System|Dr Paul Monach, Chief, Rheumatology Section|857-364-5552|Paul.Monach@va.gov|
20203572|NCT03519308|Abramson Cancer Center, University of Pennsylvania|Liudmila Mazaleuskaya/Pancreas Research Program Manager|2674559141|mazali@pennmedicine.upenn.edu|
20203573|NCT00365976|Duke University|Jenny Bridgers, CRC|919-684-0752|jenny.bridgers@duke.edu|
20203574|NCT01963117|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
20203575|NCT01780389|Duke University Medical Center|David Marks, MD|619 668-2859|d.marks@duke.edu|
20203576|NCT01095250|Novartis Pharmaceuticals|Study Director|862-778-8300||
20203577|NCT01000064|Vanderbilt University Medical Center|Dr. Michael G. Tramontana|615-327-7144|Michael.Tramontana@Vanderbilt.Edu|
20203578|NCT02518620|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
20203579|NCT00978445|Cleveland Clinic Foundation|Dr. Heather Gornik|216-445-3689|gornikh@ccf.org|
20203580|NCT02125331|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
20203581|NCT02078713|University of California, San Francisco|Dr. Christine Dehlendorf, Principal Investigator|415-206-8712|christine.dehlendorf.@ucsf.edu|
20203582|NCT02096861|Celltrion, Inc.|BoYoung Choi / Clinical Operation Team Leader|+82-32-850-6594|BoYoung.Choi@celltrion.com|
20203583|NCT00696657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20203584|NCT02601001|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20203585|NCT01790438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203586|NCT00962065|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH|281-863-3000||
20203587|NCT01847638|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
20203588|NCT00950612|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203589|NCT02433210|University of Missouri, Department of Medicine, Division of Nephrology|Dr. Madhukar Misra, MD|573 882-7993|misram@health.missouri.edu|
20203590|NCT01115569|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
20203591|NCT03123354|Masimo Corporation|Vikram Ramakanth|1 (949) 297-7416|clinicalresearchdept@masimo.com|
20203592|NCT02369835|Stanford University|Beth Beadle|650-723-6194|bbeadle@stanford.edu|
20203593|NCT01254604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203594|NCT03074162|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203595|NCT00589888|Emory Univ SOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
20203596|NCT00625365|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
20203597|NCT02969317|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203598|NCT06648161|Kocaeli University|Dr. Resmiye Özdilek|+90 262 303 47 38|resmiyeozdilek@gmail.com|
20203599|NCT05730829|McMaster University|Dr Lisa Carlesso|2896805640|carlesl@mcmaster.ca|
20203600|NCT02880319|DFCI/BWH|Dr. Tracy Balboni|6177327948|tbalboni@bwh.harvard.edu|
20203601|NCT05014776|SKCCC Johns Hopkins Medical Institution|Katherine Bever, MD|443-287-0966|kbever1@jhmi.edu|
20203602|NCT01703286|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203603|NCT02421120|Hartford Hospital|Dr. Joseph L. Kuti, PharmD|860-972-3612|joseph.kuti@hhchealth.org|
20203604|NCT00931892|Beth Israel Deaconess Medical Center|Dr. Ciaran Kelly|617-667-1272|ckelly2@bidmc.harvard.edu|
20203605|NCT01876732|Staten Island University Hospital|Suzanne El-Sayegh|718-226-6158|uviola@siuh.edu|
20203606|NCT00964548|UMASS Medical School|Susanne Muehlschlegel, MD, MPH, Principal Investigator|508-856-4667|susanne.muehlschlegel@umassmemorial.org|
20203607|NCT02531373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203608|NCT02207530|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
20188561|NCT06637774|University of Pittsburgh|James Coyle|4123836608|jcoyle@pitt.edu|
20188562|NCT05155306|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188563|NCT04158141|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20203609|NCT00305006|Teachers College, Columbia University|Dr. Andrew Gordon|212-678-3326|ag275@columbia.edu|
20203610|NCT01996319|Novartis Pharmaceuticals|Study Director|862-778-8300||
20203611|NCT06094296|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20203612|NCT00986258|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
20203613|NCT03332667|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
20203614|NCT04964063|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
20203615|NCT01084499|Asan Medical Center|Principal Investigator||mdlhs@amc.seoul.kr|
20203616|NCT01120093|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20203617|NCT03649321|UT Southwestern Medical Center|Dr. Syed Kazmi|214-648-4180|syed.kazmi@utsouthwestern.edu|
20203618|NCT04929262|Temple University|Margaret Crane|‭(215) 204-7165‬|margaret.crane@temple.edu|
20203619|NCT01488318|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|414-647-5554|stadtermanbm@upmc.edu|
20203620|NCT01455428|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203621|NCT02289755|Allena Pharmaceuticals|VP of Clinical Development|617-467-4577|akausz@allenapharma.com|314
20203622|NCT00751101|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
20188564|NCT04121741|Medical College of WI|Principal Investigator: Jacquelyn P Kulinski|414-955-6896|jakulinski@mcw.edu|
20188565|NCT01084863|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20188566|NCT04505722|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188567|NCT03473223|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
20188568|NCT05827068|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20188569|NCT00319020|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
20188570|NCT03485287|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20188571|NCT01078909|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
20188572|NCT01288443|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
20188573|NCT01596972|Planned Parenthood League of Massachusetts|Director of Clinical Research and Training|617.616.1600|agoldberg@pplm.org|
20188574|NCT04327843|Case Western Reserve University|Kaylee Sarna|(216) 368-3577|kns17@case.edu|
20188575|NCT01639131|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
20188576|NCT00176800|University of Michigan Comprehensive Cancer Center|Dr. Susan Urba, M.D.|734-615-4762|surba@umich.edu|
20188577|NCT02285270|University of Pennsylvania|Daniel Pryma|215-349-5272|daniel.pryma@uphs.upenn.edu|
20188578|NCT00439270|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20188579|NCT04334317|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20188580|NCT01149759|Rockefeller University|Emma Guttman Yassky, MD|212-327-8333|skhattri@rockefeller.edu|
20188581|NCT03183050|Georgetown University|Suzanne O'Neill|202-687-0869|sco4@georgetown.edu|
20188582|NCT02797132|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20188583|NCT01315132|Sidney Kimmel Cancer Center at Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|Neal.Flomenberg@jefferson.edu|
20188584|NCT06199986|University of Chicago|Dr. Ted Skolarus|773 702-0881|tskolarus@bsd.uchicago.edu|
20188585|NCT03433794|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
20188586|NCT01996436|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|Peng.R.Chen@uth.tmc.edu|
20188587|NCT01371994|Astellas Pharma Global Development, Inc.|Medical Director, Urology||clinicaltrials@us.astellas.com|
20203623|NCT02086565|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
20203624|NCT00739297|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203625|NCT00789477|Regeneron|Clinical Trial Management|9148475385|clinicaltrials@regeneron.com|
20203626|NCT02375698|UCT|Dr. Rodney Dawson|27214066850|rodney.dawson@uct.ac.za|
20203627|NCT02680847|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203628|NCT02138578|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-4300|sprattda@med.umich.edu|
20203629|NCT00509873|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20203630|NCT01345786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20203631|NCT04436510|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20203632|NCT01519570|The Ohio State University College of Pharmacy|Stuart Beatty|6146888466|beatty.52@osu.edu|
20203633|NCT02389946|BIOTRONIK, Inc|Amy Culley, Director of Vascular Intervention Clinical Studies|503-451-8034|amy.culley@biotronik.com|
20203634|NCT01605396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203635|NCT03677089|Massachusetts General Hospital - Clinical Coordinating Center|Dr. Karen Kuhlthau|617-724-2842|KKUHLTHAU@PARTNERS.ORG|
20203636|NCT04598165|Women and Infants Hospital of Rhode Island|Jennifer Unger, MD, MPH. Associate Professor, Department of Obstetrics and Gynecology|(401) 274-1122|jennifer_unger@brown.edu|48554
20203637|NCT01323673|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203638|NCT03844633|Ohio State University|Maria Gallo|6146882145|gallo.86@osu.edu|
20203639|NCT01593748|MUSC|Cameron Coggins|843-792-4743|cogginca@musc.edu|
20203640|NCT03596177|MedImmune, LLC|Victoria Parker|+44 747 1357172|information.center@astrazeneca.com|
20203641|NCT03569111|Medtronic|Julie Krzykowski|763-202-3325|Julie.Krzykowski@Medtronic.com|
20203642|NCT01301742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203643|NCT04083222|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
20203644|NCT03625986|Penn State College of Medicine|Dr. Jonathan Foulds|(717) 531-3504|jfoulds@pennstatehealth.psu.edu|
20203645|NCT01937130|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20203646|NCT01850563|Dartmouth-Hitchcock Medical Center|Alan Hartford, MD, PhD, FACR, Professor of Medicine (RadOnc) Director, Radiation Oncology|603-650-6600|Alan.C.Hartford@Hitchcock.org|
20203647|NCT04359823|MUSC|Gabriella Santa Lucia|724-413-8833|santaluc@musc.edu|
20203648|NCT04191967|Univerisity of North Carolina (UNC)|Dr. Chemtai Mungo, MD, MPH|(984) 974-1000|cmungo@email.unc.edu|
20203649|NCT01431144|University of Louisville|Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
20203650|NCT02322892|Beth Israel Deaconess Medical Center|Dr. Lars W. Andersen|6173886343|larswiuffandersen@gmail.com|
20203651|NCT02819310|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
20203652|NCT02046265|University of Pennsylvania School of Nursing|Dr. Anne Teitelman|215-898-1910|teitelm@nursing.upenn.edu|
20203653|NCT01793051|UT MD Anderson Cancer Center|Dr. Robert Orlowski, Professor, Lymphoma-Myeloma|(713) 794-3234|rorlowski@mdanderson.org|
20203654|NCT00059215|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203655|NCT01419275|Stanford University|Dr. Greg Zaharchuk|650-736-6172|susanmir@stanford.edu|
20203656|NCT04985799|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
20203657|NCT02073435|Northwestern University|Donna Woods, MD|312-503-5550|woods@northwestern.edu|
20203658|NCT04494633|Clinical Tools, Inc.|Mary Metcalf, PhD, MPH|(919) 960-8118|metcalf@clinicaltools.com|
20203659|NCT04907539|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
20203660|NCT02311478|University of Utah|Dr. Dave Turok|8015818160|david.turok@hsc.utah.edu|
20203661|NCT03276936|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20203662|NCT03041116|Retrophin, Inc.|Clinical Trial Information Desk|+1-877-659-5518|medinfo@retrophin.com|
20203663|NCT00943319|UChicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
20203664|NCT02043301|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203665|NCT03097328|Dana Farber Cancer Institute|Bradley McGregor, MD|617-632-6328|Bradley_McGregor@DFCI.harvard.edu|
20203666|NCT01798134|Boston Scientific Corporation|Senior Clinical Program Manager|763-494-2172|hansenj2@bsci.com|
20203667|NCT02653976|Solasia Pharma K.K.|Clinical Development Department|+81358438045|clinicaldev@solasia.co.jp|
20203668|NCT02023164|TerSera Therapeutics LLC|Executive Director, Clinical Development|888 600 8116|jnorth@tersera.com|
20218001|NCT00710749|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
20218002|NCT00656968|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3422121|pihsu@isca.vghks.gov.tw|8233
20218003|NCT02985879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20218004|NCT04974619|Moffitt Cancer Center|Dr. Shannon Christy|813-745-8840|Shannon.Christy@moffitt.org|
20218005|NCT03860207|Y-mAbs Therapeutics|Joris Wilms|+45 7026 1414|clinicaltrials@ymabs.com|
20218006|NCT03959527|GARDP|Dr Alison Luckey|+41 22 559 05 39|aluckey@gardp.org|
20218007|NCT01688466|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20218008|NCT06357286|Cornell University|Heather Schofield|6172334775|hws44@cornell.edu|
20218009|NCT05529511|University Hospitals of Derby and Burton NHS Foundation Trust|Hayley Carter|01332254631|hayley.carter1@nhs.net|
20218010|NCT03740113|Univeristy of Virginia|Dr. Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
20218011|NCT02658487|Vanderbilt University Medical Center|Stephen Strickland, MD|(615) 936-8422|stephen.strickland@vumc.org|
20218012|NCT01647958|EndoGastric Solutions|Adrian Lobontiu|650-474-9259|alobontiu@endogastricsolutions.com|
20203669|NCT02436577|AstraZeneca AB|Brilinta Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20203670|NCT03703375|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
20203671|NCT01675011|Boston Scientific|Anastasia Becker - Director of Clinical Trials|763-494-2170|Ana.Becker@bsci.com|
20203672|NCT00615290|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203673|NCT03650452|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20203674|NCT04510194|University of Minnesota|Carolyn Bramante|612-624-0468|jcharles@umn.edu|
20203675|NCT02983981|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
20203676|NCT01523808|Erytech Pharmaceuticals|Director of Clinical Trials|+33 4 78 74 44 38|contact@erytech.com|
20203677|NCT00771407|LifeCell Corporation|Chief Medical Officer|908-947-1104|mfranz@lifecell.com|
20203678|NCT01623531|Department of Anesthesia, Dalhousie University, Halifax, Canada|Dr. Myron Kwapisz|+1 902 473 4326|myron.kwapisz@nshealth.ca|
20203679|NCT00623467|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20203680|NCT04179968|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
20203681|NCT02597673|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
20203682|NCT04184622|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20203683|NCT01134887|Veterans Administration Health Services Research and Development|Richard M. Frankel Ph.D.|317-988-4000|Richard.Frankel@VA.Gov|
20203684|NCT02795988|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
20203685|NCT02834403|Houston Methodist Cancer Center|Polly Niravath, MD|713-441-0629|ccresearch@houstonmethodist.org|
20203686|NCT02341014|Memorial Sloan Kettering Cancer Center|Dr. Steve Horwitz, MD|646-608-2680|horwitzs@MSKCC.ORG|
20203687|NCT03691623|Enanta Pharmaceuticals, Inc.|Guy De La Rosa, MD, Senior Medical Director, Infectious Diseases|+1 857 760 0548|gdelarosa@enanta.com|
20203688|NCT00273858|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203689|NCT02045277|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20203690|NCT02232516|Northwestern University, Feinberg School of Medicine|Dr. Jonathan Moreira|312-695-6180|jonathan.moreira@northwestern.edu|
20203691|NCT05058664|University of Michigan|Ewa Czyz|734 764-9466|ewac@med.umich.edu|
20203692|NCT02606045|University of Pittsburgh|Margaret V. Ragni, MD, PHD|412-209-7480|ragni@pitt.edu|
20203693|NCT01702363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203694|NCT00002663|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
20203695|NCT01351766|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
20203696|NCT01016106|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20203697|NCT00525148|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203698|NCT03015610|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
20203699|NCT01603641|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20203700|NCT03036592|University of Murcia|Prof. Marta Garaulet Aza|868884030|garaulet@um.es|
20203701|NCT05100199|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
20203702|NCT02853331|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203703|NCT03425799|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
20203704|NCT02062151|USF Pediatrics|Laura Weathers|813/844-3046|lweathers@health.usf.edu|
20203705|NCT00257192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20203706|NCT00570739|Daiichi Sankyo, Inc.|John Raia, Senior Director Professional Affairs|(973) 944-2683|jraia@dsi.com|
20203707|NCT00325442|United Therapeutics Corporation|Kevin Laliberte, PharmD; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
20203708|NCT01905397|Duke University Medical Center|Dan Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
20157950|NCT03734822|Nationwide Children's Hospital|Anne May, MD|614-722-4766|Anne.May@nationwidechildrens.org|
20188588|NCT00087685|The University of Texas (UT) MD Anderson Cancer Center|Karen H. Lu, MD, Chair, Gynecologic Oncology & Reproductive Medicine|713-745-8902|CR_Study_Registration@mdanderson.org|
20188589|NCT04018495|Medical College of Wisconsin|Rose Franco, MD|414-955-7040|rfranco@mcw.edu|
20188590|NCT02382003|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
20188591|NCT03857646|Stanford University|Cody Arnold|(650) 723-8772|codya@stanford.edu|
20188592|NCT04529616|RxSight, Inc.|Associate Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|
20188593|NCT05747599|RTIInternational|Yukiko Washio, PhD|9194852794|ywashio@rti.org|
20188594|NCT02500576|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
20188595|NCT06229106|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
20203709|NCT01729598|University of Kentucky|Dr. Gregory A. Jicha|859-323-5550|gregory.jicha@uky.edu|
20157951|NCT01585402|National Heart, Lung, and Blood Institute (NHLBI)|Alessandra Brofferio, M.D.|301.496.2634|alessandra.brofferio@nih.gov|
20157952|NCT04389866|Advanced Dermatology|Dr. Amy Forman Taub|8474596400|drtaub@advdermatology.com|
20157953|NCT01730872|Ora|Keith Lane|9786858900|klane@oraclinical.com|
20157954|NCT01186250|Stanford University|Kiran K. Khush, MD|650-721-3241|kiran@stanford.edu|
20157955|NCT04940130|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick Duffy|301.761.5089|patrick.duffy@nih.gov|
20157956|NCT02240121|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
20157957|NCT01545765|Galderma|Farzaneh Sidou Clinical Project Manager)|00.33.4.93.95.70.70|farzaneh.sidou@galderma.com|
20157958|NCT05501639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157959|NCT00251693|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20157960|NCT01030822|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157961|NCT00401843|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
20157962|NCT01508910|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
20157963|NCT02525679|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157964|NCT01932788|Professor of Pediatrics|Carol,Wagner, MD|843-792-8829|wagnercl@musc.edu|
20157965|NCT01171677|NYUMED|John Rotrosen|212 951 3294|john.rotrosen@nyumc.org|
20157966|NCT02421757|University of Maryland School of Medicine|Dr. Peter Rock|410-328-6933|prock@som.umaryland.edu|
20157967|NCT01646814|PLxPharma|Regulatory Affairs Director|17138421249|regaffairs@plxpharma.com|
20157968|NCT03092479|Geisinger Clinic|Michelle Lent, PhD|5702141004|mrlent1@geisinger.edu|
20157969|NCT04683913|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
20157970|NCT03913130|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
20157971|NCT05653700|Wake Forest University Health Sciences|Kevin Lobdell, MD|704.355.1585|kevin.lobdell@atriumhealth.org|
20157972|NCT01333436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157973|NCT01085214|Massey Cancer Center, Virginia Commonwealth University|Steven Grant, M.D.|804-828-5211|stgrant@vcu.edu|
20157974|NCT01482715|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20157975|NCT02199041|St. Jude Children's Research Hospital|Brandon Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
20157976|NCT02317627|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
20157977|NCT04749914|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20203710|NCT01921270|Emory University|Dr. Stewart Factor|404-728-4952|sfactor@emory.edu|
20203711|NCT00844428|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alxn.com|
20203712|NCT00772967|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203713|NCT01096550|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
20203714|NCT02229864|Abbott Vascular|Latania Chura|503-935-3002|latania.chura@abbott.com|
20203715|NCT00872833|New England Research Institutes, Inc.|Eric Gerstenberger|6179237747|egerstenberger@neriscience.com|
20203716|NCT01713400|H. Lee Moffitt Cancer Center and Research Institute|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
20203717|NCT02345642|Hospital for Special Surgery|Dr. Geoffrey Westrich|212-606-1510|ortizp@hss.edu|
20203718|NCT02588248|UHClevelandMC|L-Menthol Injection as a Novel Technique during Colonoscopy: The MINT-C study|216-844-1000|Richard.wong@UHhospitals.org|6172
20203719|NCT04229446|OsloUH|Primary Investigator Dr. Tone Rustøen|+47 22859229|tone.rustoen@medisin.uio.no|
20203720|NCT00705224|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20203721|NCT02566525|University of Kentucky College of Medicine|Dr. Joseph Zwischenberger, MD|859-323-6013|jzwis2@uky.edu|
20203722|NCT00337467|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20203723|NCT03141086|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20203724|NCT01745627|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20203725|NCT04430582|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173091966|MaryElizabeth.Patti@Joslin.Harvard.edu|
20203726|NCT03607682|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
20203727|NCT04400318|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20203728|NCT01641835|Heidelberg Engineering GmbH|Gerhard Zinser, PhD|+4962216463|Contact@HeidelbergEngineering.com|0
20203729|NCT01109004|The Emmes Corporation|Adam Mendizabal, PhD||amendizabal@emmes.com|
20203730|NCT03805932|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
20203731|NCT05141435|Children's Hospital of Chongqing Medical University|Prof. Shi Yuan|+86 15084335697|shiyuan@hospital.cqmu.edu.cn|
20203732|NCT02410902|Curemark|William E. Gannon, Jr MD, Medical Director|914-824-9716|william.gannon@curemark.com|
20203733|NCT00953043|Mayo Clinic|Dr. Michael Camilleri, Professor of Medicine and Physiology, Gastroenterology|507-266-2305|camilleri.michael@mayo.edu|
20203734|NCT03059810|Johnson & Johnson Vision|Thomas Karkkainen- SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
20203735|NCT00747617|UCSD School of Medicine|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
20203736|NCT03509207|Medical University of Graz|Prof. Edgar Petru|0043 31638581082|edgar.petru@medunigraz.at|
20157978|NCT00403130|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
20157979|NCT00806260|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|day@vivus.com|
20157980|NCT00237042|University of Washington|Dr. Judith Turner|206-543-3997|jturner@u.washington.edu|
20157981|NCT01074931|Abbott|Global Medical Services|1-800-633-9110||
20157982|NCT03132467|UT MD Anderson Cancer Center|Dr. Jennifer Litton, MD- VP, Clinical Research, Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
20157983|NCT05223673|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20157984|NCT04790279|Prisma Health Upstate|Katelyn Pratt|2176223524|katelyn.pratt@prismahealth.org|
20157985|NCT03930771|Weill Cornell Medicine|Rajiv Magge|212-746-6575|ram9116@med.cornell.edu|
20157986|NCT01222117|Grifols Therapeutics|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
20157987|NCT03402932|Western Michigan University|Jing Shen|2693878067|jing.shen@wmich.edu|
20157988|NCT00678288|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20157989|NCT03611881|Massachusetts General Hospital|Elyse Park, PhD, Professor of Psychiatry and Medicine, Harvard Medical School|617.724.6836|epark@mgh.harvard.edu|
20157990|NCT04472650|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20203737|NCT01043185|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20157991|NCT01861665|Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine.|Dr. Glenn Schattman, Associate Professor|646-962-3836|glschatt@med.cornell.edu|
20157992|NCT02549989|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
20157993|NCT00298389|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
20157994|NCT02628444|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20157995|NCT02079909|FUJIFILM Toyama Chemical|Project Manager|+81-3-6427-6245|fftc-clinicaltrial-info1@fujifilm.com|
20157996|NCT01784367|University Medical Center Hamburg-Eppendorf, Germany|Prof. Dr. Stefan Kluge|+49-40-7410|skluge@uke.de|57011
20157997|NCT00720356|Northwestern University|Jeffery Raizer, MD|312-503-4724|Jeffrey.Raizer@nm.org|
20157998|NCT01869634|University of California, Davis Health, Department of Internal Medicine|Dr. David Asmuth, Professor of Medicine|916-734-8695|dasmuth@UCDAVIS.EDU|
20157999|NCT02237001|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
20158000|NCT01713582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158001|NCT04776161|Brigham and Women's Hospital|Candace Feldman, MD, MPH, ScD|617-525-1035|CFELDMAN@BWH.HARVARD.EDU|
20158002|NCT04254692|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
20158003|NCT00342628|PDMI, NICHD, NIH|Feng-Ying (Kimi) Lin, MD, MPH|301-496-0295|link@mail.nih.gov|
20158004|NCT03427814|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158005|NCT03846427|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158006|NCT01334554|Vanderbilt University Medical Center|Cyndya A. Shibao|6159364584|cyndya.shibao@vanderbilt.edu|
20158007|NCT02071901|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Sudipto Mukherjee|1-866-223-8100|TaussigResearch@ccf.org|
20158008|NCT01944020|Columbia University|Ari Shechter|2123424487|as4874@cumc.columbia.edu|
20158009|NCT01979614|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20158010|NCT00661830|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|A. Kaiser|++49(0)6131-179921|kaiser@izks-mainz.de|
20158011|NCT00488514|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158012|NCT03951610|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20158013|NCT03394781|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1829|jill.burns@durect.com|
20158014|NCT04971967|University of North Carolina at Chapel Hill Project - China|Ms. Xumeng Yan|+8615330225941|xumeng_yan@seshglobal.org|
20158015|NCT00052910|Yale Cancer Center|Charles S. Fuchs, MD, MPH|(203) 785-4095|charles.fuchs@yale.edu|
20158016|NCT00938912|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20158017|NCT01475721|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158018|NCT00803738|Perrigo Pharmaceuticals|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
20158019|NCT01048242|University of Pennsylvania|Nalaka Gooneratne|215 349 5938|ngoonera@mail.med.upenn.edu|
20158020|NCT02364037|Washington University School of Medicine|Rachel Paul|3147478176|paulr@wustl.edu|
20158021|NCT01772550|Becton, Dickinson and Company|Randall Jones, MD|801 565-2843|randall_jones@bd.com|
20158022|NCT00559104|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|anademanee@coh.org|62691
20158023|NCT00387088|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158024|NCT00441766|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20158025|NCT02897115|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20158026|NCT03420742|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20158027|NCT03432494|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
20158028|NCT00856635|Teva Pharmaceuticals, Medical Affairs|Scott Kolodny, M.D.|440-327-1811|scott.kolodny@tevapharm.com|
20158029|NCT00437398|Mayo Clinic|Dr. Yogish Kudva|507-284-3964|kudva.yogish@mayo.edu|
20158030|NCT01244035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158031|NCT01162551|CHOP|Susan Rheingold, MD|215-590-2801|cancertrials@email.chop.edu|
20158032|NCT02383862|Regenstrief Institute|Research Coordintor|317-274-9288|tltalib@regenstrief.org|
20203738|NCT01432262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158033|NCT00347932|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
20203739|NCT00165646|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
20203740|NCT04657016|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20203741|NCT05291598|University of Miami Department of Orthopedics|Dr. Victor Hernandez|(305) 689-5195|vhh1@miami.edu|
20203742|NCT01104558|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20158034|NCT00400517|Cleveland Clinic|Dr. Jorge Garcia|2164447774|Garciaj4@ccf.org|
20158035|NCT01023217|Asan Medical Center|Professor Young-Suk Lim|+82-2-3010-5933|limys@amc.seoul.kr|
20158036|NCT01106157|University of Florida|Michael J Haller|3522739264|hallemj@peds.ufl.edu|
20158037|NCT01154335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20158038|NCT02298868|University of Virginia|Dr. Zachary Henry|434-243-2718|zhenry@virginia.edu|
20158039|NCT02141672|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20158040|NCT01194245|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
20158041|NCT01118780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20158042|NCT03962855|University of Massachusetts Medical School|Jeffrey J Rade MD|774-441-6310|jeffrey.rade@umassmed.edu|
20158043|NCT02457247|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20158044|NCT02954887|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20158045|NCT02803203|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-608-3912|YuH@mskcc.org|
20158046|NCT02694601|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20158047|NCT03141255|The University of Chicago|Jonathan D. Paul, MD|(773) 702-9461|jpaul@bsd.uchicago.edu|
20158048|NCT00600067|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
20158049|NCT01684839|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
20158050|NCT01361217|University of Washington|Nina Isoherranen|206-5432517|ni2@uw.edu|
20158051|NCT01220401|University of Tulsa|Dr. Noelle Balliett|918-631-3976|noelle-balliett@utulsa.edu|
20158052|NCT00761345|Fox Chase Cancer Center|Dr. Steven J. Cohen|215-728-4300|steven.cohen@fccc.edu|
20158053|NCT00833027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158054|NCT03069716|Vanderbilt University Medical Center|Dr. Evan L. Brittain|(615) 322-4382|Evan.brittain@vumc.org|
20158055|NCT02878382|University of Sao Paulo Medical School Brazil|Dr Luis Torezan Associate Professor Dermatology|+551138491888|torezanluis@uol.com.br|
20158056|NCT01985022|Emory University|Nathan Call, PhD|404-785-9400|nathan.call@choa.org|
20158057|NCT02481258|Mayo Clinic|Jordan D. Miller, Ph.D.|507-293-0813|Miller.Jordan@mayo.edu|
20158058|NCT02573948|UMR 1058 (Inserm/University of Montpellier/EFS)|NAGOT NICOLAS|+33 4 34 35 91 09|n-nagot@chu-montpellier.fr|
20158059|NCT01673126|Coma Science Group, University of Liège|Aurore Thibaut and Pr Steven Laureys|003243662362|athibaut@ulg.ac.be|
20158060|NCT04421404|UCSF|Dr. Annie Luetkemeyer|415-476-4082|annie.luetkemeyer@ucsf.edu|130
20158061|NCT01876212|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
20158062|NCT03111316|University of Oklahoma Health Sciences Center|Director of Women's Health Research|4052718001|christy-zornes@ouhsc.edu|48137
20158063|NCT02965989|Hospital Universitario 12 de Octubre de Madrid|Ph.D. Ignacio Zaragoza-García|913908000|izaragoz@ucm.es|4646
20158064|NCT01913327|University of California San Francisco|Michael Minzenberg|5104122199|MMinzenberg@mednet.ucla.edu|
20158065|NCT01415583|Massachusetts Eye and Ear Infirmary|Dr. Christopher Hartnick, Division Director, Pediatric Otolaryngology Director, Pediatric Airway, V|617-573-4206|christopher_hartnick@meei.harvard.edu|
20158066|NCT01333722|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20158067|NCT02224508|Group Health Research Institute|Michael Von Korff, ScD|206-287-2874|vonkorff.m@ghc.org|
20158068|NCT00784368|Global Medical Organization; Janssen R&D|Director, Established Products|(609) 730-7674||
20158069|NCT02277249|University of California, Los Angeles|Clinical Instructor - Department of Obstetrics and Gynecology|3107942257|priyabatra@mednet.ucla.edu|
20158070|NCT00628446|Carolinas Healthcare System|Dr. Jesse Lieberman|704-355-0649|Jesse.Lieberman@Carolinashealthcare.org|
20158071|NCT00756275|Brown University|Damaris Rohsenow, PhD|401-863-6665|Damaris_Rohsenow@brown.edu|
20158072|NCT00535769|MGH Curtis|Dr. Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
20158073|NCT00682929|UC Davis Health|Janelle Butters, NP|916-734-6276|jbutters@ucdavis.edu|
20158074|NCT01516632|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|(877) 302-6858|michele@innovativepublichealth.org|1-801#
20158075|NCT01424943|Institute for Families in Society, University of South Carolina|Dr. Cheri Shapiro|803-777-8760|cshapiro@mailbox.sc.edu|
20158076|NCT01435174|University of Michigan College of Pharmacy|Bruce A. Mueller|7346154578|muellerb@umich.edu|
20158077|NCT01482195|King Faisal Specialist Hospital and Research Center|Dr. Fowzan Al Kuraya|+966 11 442 7875|falkuraya@kfshrc.edu.sa|
20158078|NCT00592631|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
20158079|NCT03389308|Castle Creek Pharmaceuticals|Mary C. Spellman, MD|312-847-1291|mspellman@castlecreekpharma.com|
20158080|NCT03975153|Oregon Health & Science University|Teri Greiling, MD, PhD, FAAD|503-494-3376|PRPStudy@ohsu.edu|
20158081|NCT03198767|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20158082|NCT05069649|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20158083|NCT02651116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158084|NCT00705874|Progen Pharmaceuticals Pty Ltd|Director of Clinical Trials|+61 7 32739133|darrynb@progen-pharma.com|
20158085|NCT00041470|University of Washington|Julie Gralow, MD|206-288-2053|pink@u.washington.edu|
20158086|NCT00739310|Maimonides, Department of Pulmonary Medicine|Kathryn Fitzgerald, NP|718-283-7339|kfitzgerald@maimonidesmed.org|
20158087|NCT01061385|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
20158088|NCT03800030|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
20158089|NCT04581785|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20203743|NCT00738543|University of Guanajuato|Alejandro Macias|52 477 7145859|aaeemmhh@yahoo.com|400
20203744|NCT03609658|Wake Forest School of Medicine|Jennifer Gabbard, M.D.|336-716-8028|jgabbard@wakehealth.edu|
20158090|NCT02948582|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20158091|NCT04419467|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20158092|NCT02471313|National Institutes of Health Clinical Center|Dr. Elliot Levy, Staff Clinician, Radiology & Imaging Sciences|301-402-5368|levyeb@cc.nih.gov|
20158093|NCT02706925|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158094|NCT00869167|California Pacific Medical Center|Brandon Lu, M.D., M.S.|415-923-3421|lubs@sutterhealth.org|
20158095|NCT01224236|University of Texas Health Science Center - Houston|Kathleen Kennedy|+1 (713) 500-5651|Kathleen.A.Kennedy@uth.tmc.edu|
20158096|NCT00943631|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
20158097|NCT04684576|University of Washington Department of Rehabilitation Medicine|Dr. Heather Feldner, Study PI|2065433721|hfeldner@uw.edu|
20158098|NCT00530634|City of Hope|Jeff Longmate, Ph.D.|626-256-4673|jlongmat@coh.org|62478
20158099|NCT04615624|University of Hawaii and Hawaii Pacific Health|Melanie Maykin|8089836000|mmaykin@hawaii.edu|
20158100|NCT04571060|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20158101|NCT03301779|Hemanext|William Iselin|7813017446|william.iselin@hemanext.com|
20158102|NCT04410159|UNIVERSITI SAINS ISLAM MALAYSIA|NURUL AZMAWATI MOHAMED|+603 42892400|drnurul@usim.edu.my|2417
20158103|NCT00087698|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20158104|NCT03139032|Arena Pharmaceuticals, Inc.|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
20158105|NCT02073162|The Cleveland Clinic Foundation|Dr. Daniel Sessler|216-444-4900|ds@or.org|
20158106|NCT03943290|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158107|NCT04970069|Cleveland Clinic|Dr. Alparslan Turan|2162172312|turana@ccf.org|
20158108|NCT04342091|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
20158109|NCT04179305|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
20158110|NCT01072136|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
20158111|NCT03192137|InSite Vision|Senior Manager, Clinical Sciences|+91 9987096080|manjiri.desai@sparcmail.com|
20158112|NCT02153489|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20158113|NCT02737501|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20158114|NCT01261975|Bausch & Lomb|Omid Khodai|(949) 521-7894|Omid.Khodai@bausch.com|
20158115|NCT00405288|The Hospital for Sick Children|Dr. Gideon Koren||gkoren@sickkids.ca|
20158116|NCT01070979|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20158117|NCT00142792|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
20158118|NCT00437268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20158119|NCT01569815|Novartis Pharmaceuticals|Study Director|862-778-8300||
20158120|NCT00444925|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20158121|NCT01939145|MGUH Center for Wound Healing and Hyperbaric Medicine|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
20158122|NCT01342094|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20158123|NCT02806414|UCSD Dermatology|Director of Clinical Trials Unit|8586571697|dermstudies@ucsd.edu|
20158124|NCT03198156|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
20158125|NCT02382588|Northwestern Universtiy|Dr. Robert Feder|3126958150|r-feder@northwestern.edu|
20158126|NCT01328743|Brown University|Christopher Kahler|4018636651|christopher_kahler@brown.edu|
20188596|NCT03399500|University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
20158127|NCT02317692|Marquette University|Dr. Alyson Gerdes|414-288-6145|alyson.gerdes@mu.edu|
20158128|NCT04500457|Florida State University|Jesse Cougle|8506458729|cougle@psy.fsu.edu|
20158129|NCT05599100|University of Washington School of Public Health, Department of Health Systems and Population Health|Magaly Ramirez, PhD, MS, MS|206-543-9773|maggiera@uw.edu|
20158130|NCT00810277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20158131|NCT02836470|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
20158132|NCT04551898|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158133|NCT00548197|Iran university of medical Sciences|Mehdi Modarres|009888602217|mmodarres51@yahoo.com|
20158134|NCT01187095|Aarhus University|Yoon Frederiksen|+4587565871|yoonf@psy.au.dk|
20158135|NCT04103112|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
20158136|NCT00288886|Salem Veterans Affairs Medical Center|Steven Lash, Ph.D.|(540)982-2463|Steven.Lash@va.gov|2593
20158137|NCT00456755|Department of Otorhinolaryngology, Head & Neck Surgery, West China Hospital, Sichuan University, China|Zhao Yu||yutzhao@gmail.com|
20158138|NCT04005391|University of Colorado|Margo Harrison|19176555178|margo.harrison@cuanschutz.edu|
20158139|NCT04343092|College of Medicine-University of Baghdad|Faiq I. Gorial|009647801730696|faiqig@gmail.com|
20158140|NCT03358355|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20158141|NCT04072835|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
20158142|NCT01336712|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
20158143|NCT00399568|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20158144|NCT01109108|Boston Medical Center|Stephen I Pelton|617-414-5591|spelton@bu.edu|
20158145|NCT02477527|Midtown Medical Center|Edward W Braun, MD|8139353221|Dr.Braun@DrEdwardBraun.com|
20158146|NCT04567524|Lyndra Therapeutics|Nayana Nagaraj, Senior Medical Director|3023040091|Nnagaraj@lyndra.com|
20158147|NCT01147393|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
20158148|NCT01029912|MetroHealth Medical Center|Dr. Jayme Knutson|2167787342|jsk12@case.edu|216
20158149|NCT00344175|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
20158150|NCT00570323|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
20158151|NCT04263766|Georgia Institute of Technology|Dr. Dobromir Rahnev|6466378219|rahnev@psych.gatech.edu|
20158152|NCT03350451|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20158153|NCT02639247|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20158154|NCT00581048|Vanderbilt University Medical Center|Ryszard Dworski|615-322-3412|ryszard.dworski@Vanderbilt.Edu|
20158155|NCT01891396|Anika Therapeutics, Inc.|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
20158156|NCT03462758|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
20158157|NCT02820844|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20158158|NCT04231097|Massachusetts General Hospital|Christina Luberto, PhD|617-643-9453|cluberto@mgh.harvard.edu|
20158159|NCT02266147|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
20158160|NCT00573391|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20158161|NCT01896687|Virginia Commonwealth University|Dr. Angela Starkweather|8048283986|astarkweathe@vcu.edu|
20158162|NCT00413660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158163|NCT03896477|PATH|Mark Alderson|+ 206.302.4859|malderson@path.org|
20158164|NCT02607124|Cincinnati Childrens Hosptial Medical Center|Renee Doughman|513-636-1699|renee.doughman@cchmc.org|
20158165|NCT01791517|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST, Global Med Affairs|904-443-3500|CColesb@ITS.JNJ.com|3449
20158166|NCT00589797|Aesculap Inc.|Associate Director of Medical and Scientific Affairs|800-258-1946|mikhail.chkolnik@aesculap.com|5173
20158167|NCT01692743|University of Maryland School of Medicine|Raymond K. Cross, MD, MS, AGAF|410-706-3387|rcross@som.umaryland.edu|
20158168|NCT00353301|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848-0655|Thomas.Flaig@ucdenver.edu|
20158169|NCT03230318|Basilea Pharmaceutica International Ltd, Allschwil|Dr Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
20158170|NCT01821326|Shanghai Jiaotong University|Dr.Zhizheng GE|86-68383015|tanwei_1987@163.com|
20158171|NCT04011735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158172|NCT03368196|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20158173|NCT01459666|University Hospitals Cleveland Medical Center|Dr. Kevin Cooper|216-844-3100|Kevin.Cooper@UHhospitals.org|
20158174|NCT01492088|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20158175|NCT00533429|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20158176|NCT02379052|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20158177|NCT00127855|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158178|NCT02343302|Johns Hopkins University|Director of Clinical Trials|410-955-7518|sleung7@jhu.edu|
20158179|NCT01887717|BTG International Inc.|Manager of Clinical Development|613-801-1844|TheraSphereClinical@btgplc.com|
20188597|NCT01983683|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
20188598|NCT05365997|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
20188599|NCT04926740|Lawson Health Research Institute|Kristine Van Aarsen (Research Associate)|5196858500|kristine.vanaarsen@lhsc.on.ca|76089
20188600|NCT04980300|University of Delaware|Daniel White|302-831-7607|dkw@udel.edu|
20188601|NCT04528459|Columbia University|Wakenda K. Tyler, MD, MPH|2123059192|wkt2106@cumc.columbia.edu|
20188602|NCT01347255|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20188603|NCT05709860|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
20188604|NCT02278185|University of Colorado School of Medicine|Dr. Elizabeth R Kessler|720-848-0402|elizabeth.kessler@cuanschutz.edu|
20188605|NCT04530487|M D Anderson Cancer Center|Jeremy S Connors, MD|(713) 792-6624|jsconnors@mdanderson.org|
20188606|NCT04977583|Department of Veterans Affairs|Dr. Grant Huang|(202) 443-5700|CSP@va.gov|
20188607|NCT01617369|University of North Carolina Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
20188608|NCT00557284|IMMUNOe International Research Centers|Dr. Isaac Melamed, principle investigator|303-773-9000|melamedi@immunoe.com|
20188609|NCT01574716|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20188610|NCT01411137|Impax Laboratories, Inc.|Michelle Landolfi, Senior Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
20188611|NCT01143142|University of Colorado|Amanda Dempsey|303-724-6679|amanda.dempsey@ucdenver.edu|
20188612|NCT01268306|Arthur B. Epstein, OD|Dr. Arthur Epstein|424-226-2020|artepstein@yahoo.com|
20188613|NCT03709706|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20188614|NCT01105975|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20188615|NCT00698867|Zimmer Biomet|Kelly Francher, Clinical Affairs Manager|574-371-9783|kelly.francher@zimmerbiomet.com|
20188616|NCT02502526|Alcon, A Novartis Division|Dir Surg Instrumentation, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20188617|NCT03878979|Johns Hopkins University|Dr. Tanguy Seiwert|443-287-8312|tseiwert@jhmi.edu|
20188618|NCT00640159|Baylor College of Medicine/Houston Methodist|William G. Ondo , MD|713-363-8930|wondo@houstonmethodist.org|
20188619|NCT00112359|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
20188620|NCT01218009|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20188621|NCT03170882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20188622|NCT03850899|Indiana University School of Medicine|Samer Gawrieh|(317) 278-9326|sgawrieh@iu.edu|
20188623|NCT03593356|University of California, Irvine|Greg John Duncan|(949) 824-7831|gduncan@uci.edu|
20158180|NCT02592421|University of Texas Health San Antonio|Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
20158181|NCT02655887|Becton Dickinson (BPV)|Megan Hill|480-350-6468|Megan.Hill@bd.com|
20158182|NCT01299389|Janssen Pharmaceutical K.K|Medical director|+81-3-4411-5509||
20158183|NCT02834819|Children's Hospital Colorado/University of Colorado|Cortney Braund, MD|4406696880|Cortney.Braund@childrenscolorado.org|
20158184|NCT04245709|Duke University|Dwight Koeberl, MD,PhD|919-681-9919|dwight.koeberl@duke.edu|
20158185|NCT03637491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158186|NCT02020590|Bone Therapeutics|Chief Medical Officer|+32 71 12 10 00|regulatory@bonetherapeutics.com|
20158187|NCT00598819|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
20158188|NCT01339936|Optometric Technology Group|Dr Michel Guillon|+44 2072224224|mguillon@otg.co.uk|
20158189|NCT02251496|University of Iceland|Dr. Áróra Rós Ingadóttir|8461601|aroraros@landspitali.is|
20158190|NCT00889707|Sophiris Bio Corp (formerly Protox Therapeutics)|Chief Medical Officer|858-255-4711|richard@sophiris.com|
20158191|NCT02185534|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 1000|ClinicalTrialTransparency@astrazeneca.com|
20158192|NCT03465722|Blueprint Medicines|Medical Information Call Center|1-888-258-7768|medinfo@blueprintmedicines.com|
20158193|NCT03542019|University of Jordan|Dr. Ahmad El-Ma'aita|+9626535 5000|a.maaita@ju.edu.jo|
20158194|NCT02041299|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
20158195|NCT02389465|University of Pennsylvania|Dr. Yvette Sheline, McLure Professor of Radiology, Neurology and Psychiatry|(215) 573-0082|sheline@pennmedicine.upenn.edu|
20158196|NCT01635998|Icahn School of Medicine at Mount Sinai|Sam Cammack|(212) 824-8931|sam.cammack@mountsinai.org|
20158197|NCT00846846|Medtronic Cardiovascular|Lisa Bousquette, Director Clinical Research Coronary and Renal Denervation||lisa.r.bousquette@medtronic.com|
20158198|NCT01925768|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20158199|NCT03511001|California State University San Marcos|Dr. Kim Pulvers|760 750 4127|kpulvers@csusm.edu|
20158200|NCT00243191|SARC|SARC, Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
20158201|NCT04339413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20158202|NCT04819113|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158203|NCT00532129|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20158204|NCT03145064|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158205|NCT01396187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158206|NCT01898286|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
20158207|NCT02257242|Brown University Oncology Research Group|BrUOG|4018633000|BrUOG@BROWN.EDU|
20158208|NCT02433496|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
20158209|NCT00551031|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20158210|NCT03460652|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
20158211|NCT02964273|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20158212|NCT01453036|The Catholic University of Korea|Dr. Jin Il Kim|+82-2-3779-2382|jikim@catholic.ac.kr|
20158213|NCT02469701|Brown University Oncology Research Group|Kristen M. Mitchell, CCRP|4018633000|kristen_mitchell@brown.edu|
20158214|NCT00841776|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158215|NCT04245449|Medical University of South Carolina|Michelle Woodbury, PhD|843-792-0651|woodbuml@musc.edu|
20158216|NCT02126319|Fox Chase Cancer Center|Dr. Suzanne M. Miller|215 728-4069|Suzanne.Miller@fccc.edu|
20158217|NCT02462187|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20158218|NCT03688919|University of Michigan School of Public Health|Professor Alison Miller|7346157459|alimill@umich.edu|
20158219|NCT01285024|Cleveland Clinic|President and CEO Cleveland Clinic Florida|216-444-7515|barsouw@ccf.org|
20158220|NCT03885154|University of Kentucky|Kimberly Jones, MD|859-218-5011|kimberly.jones@uky.edu|
20158221|NCT00920556|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158222|NCT00003631|Memorial Sloan Kettering Cancer Center|Dr. Joachim Yahalom|1212-639-5999|yahalomj@mskcc.org|
20158223|NCT03502915|University of North Carolina at Chapel Hill|Kathleen A. Smith, MD|9199665136|ksmith@aims.unc.edu|
20158224|NCT00362882|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20158225|NCT01853462|Aristotle University of Thessaloniki|Lazaros Lazarou||lazarosphysiotherapist@gmail.com|
20158226|NCT01791491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20158227|NCT00955474|Massachusetts General Hospital|John D. Matthews, MD|6177249144|jdmatthews@partners.org|
20158228|NCT00361972|university of utah|kathryn peterson|8015817804|kathryn.peterson@hsc.utah.edu|
20158229|NCT03386435|Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea|Jun-Gol Song, MD, PhD|+82-2-3010-3869|jungol.song@amc.seoul.kr|
20158230|NCT04068922|University of Florida|Dr. Emily Bartley|352-273-8934|ebartley@dental.ufl.edu|
20158231|NCT00625586|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20158232|NCT03542266|Weill Cornell Medical College|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
20158233|NCT02272946|University of California, San Francisco|Priscilla Hsue, MD|628-206-5801|Priscilla.hsue@ucsf.edu|
20158234|NCT00149799|Rhode Island Hospital|Katharine A. Phillips, MD|401-444-1646|katharine_phillips@brown.edu|
20158235|NCT03503396|University of Missouri|Dr. Denis McCarthy|573-882-0426|mccarthydm@missouri.edu|
20158236|NCT01591408|NavalMCSD|Julie Onton|619-553-6228|julie.a.onton.ctr@mail.mil|
20158237|NCT03662282|University of South Florida|Thao Ho|813-844-3437|tho1@usf.edu|
20158238|NCT01176877|Northwestern University, Feinberg School of Medicine, Department of Dermatology|Dr. Steven Nwe, Clinical Research Fellow|312-695-4625|steven.nwe@northwestern.edu|
20203745|NCT00523341|Amgen Inc.|Study Director|866-572-6436||
20158239|NCT00657267|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
20203746|NCT05131880|Universidad Europea de Madrid|Alberto Bermejo Franco|+34912115535|alberto.bermejo@universidadeuropea.es|
20158240|NCT02382991|OTTOBOCK FRANCE|Aurélie LACROIX|0033 (0)7 86 29 52 03|market.access@ottobock.fr|
20203747|NCT00912015|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20158241|NCT03870048|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
20158242|NCT00786422|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20158243|NCT03484429|Central Virginia Veterans Affairs Health Care System|Dr. Denise Lester|804-675-5000|denise.lester@va.gov|
20158244|NCT04466384|Medtronic|Ami Stuart PhD|8017934800|ami.stuart@medtronic.com|
20203748|NCT05137041|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20158245|NCT00943761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203749|NCT02090114|Johns Hopkins University School of Medicine|Samuel Denmeade, M.D.|410-502-8341|denmesa@jhmi.edu|
20203750|NCT01356602|Novartis Pharmaceuticals|Study Director|862-778-8300||
20158246|NCT02268383|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158247|NCT04162470|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20203751|NCT00392171|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20158248|NCT03382912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20158249|NCT04570384|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
20158250|NCT00326001|Biotronik GmbH&Co. KG, Berlin, Germany|Dejan Danilovic|+49 9131 8924 7832|dejan.danilovic@biotronik.com|
20158251|NCT03265145|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158252|NCT04409834|Brigham and Women's Hospital|COVID-PACT Project Manager|(617) 278-0145|covid-pact@bwh.harvard.edu|
20203752|NCT01605071|University of Colorado Denver, Anschutz Medical Campus|Kimberly Cox-York||KIMBERLY.COX-YORK@CUANSCHUTZ.EDU|
20158253|NCT02112656|Imunon, Inc.|Chief Medical Officer|(609) 896-9100|clinical@imunon.com|
20158254|NCT04749745|Butler Hospital|Dr. Shiwen Yuan|2025783000|shiwen_yuan@brown.edu|
20158255|NCT04541667|University of Nebraska Medical Center|Chinenye Dike|402-955-5700|chinenye.dike@unmc.edu|
20158256|NCT03670160|University of Tennessee Medical Center|Janet Parkey, Director - Research Compliance|865-305-6194|jparkey@utmck.edu|
20203753|NCT03499808|SWOG Statistics and Data Management Center|Adam Rosenthal|206-652-9711|adamr@crab.org|
20158257|NCT01365455|Novartis Pharmaceuticals|Study Director|862-778-8300||
20203754|NCT03470922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20203755|NCT01931462|University of Wisconsin|Director of Clinical Research, Department of Surgery|608-262-0540|clinicalresearch@surgery.wisc.edu|
20158258|NCT03965403|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|6179526319|pbonato@partners.org|
20203756|NCT00510224|UCSF|Charles J. Ryan, MD|415-353-9279|ryanc@medicine.ucsf.edu|
20203757|NCT04067765|University of Kansas|Dr. Michael Amlung|785-864-0334|mamlung@ku.edu|
20203758|NCT01881620|Institut Bergonié, Medical Imaging Department|Dr. Anne-Laure Cazeaux, Nuclear physician|05.56.33.78.60|A.cazeaux@bordeaux.unicancer.fr|
20203759|NCT04936724|University of Pennsylvania|Andrew Strasser Ph.D.|215-746-5788|strasse3@pennmedicine.upenn.edu|
20203760|NCT01808118|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20203761|NCT00414310|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair, Leukemia Department|713-792-7026|hkantarjian@mdanderson.org|
20203762|NCT03070730|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|617-632-8454|rfreeman@bidmc.harvard.edu|
20203763|NCT01993329|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203764|NCT05070429|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919-962-3098|lgravens@email.unc.edu|
20203765|NCT02849990|University of Washington|Dr. Michael Schweizer|2066066252|schweize@uw.edu|
20203766|NCT02678741|LumaBridge|Timothy Vreeland, MD|6363465458|tvreeland@lumabridge.com|
20203767|NCT01795898|Janssen Philippines|Medical Affairs Manager|+632-8247901||
20203768|NCT00372190|Radboud University Medical Center|Dr. M.I.J.Withagen|+31 6 51262468|M.I.J.Withagen@umcutrecht.nl|
20203769|NCT04705597|BioAge Labs, Inc.|Patrick Martin, M.D.|215-260-5134|patrick@bioagelabs.com|
20203770|NCT02816710|Department of Ophthalmology, Ruijin Hospital Affiliated Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China.|Dr. Xi Shen|021-64370025|carl_shen2005@126.com|
20203771|NCT00390780|Bioalliance Pharma|Dr Pierre Attali|+33 (0)1 45 58 76 00|pierre.attali@bioalliancepharma.com|
20203772|NCT02440178|seoul national university|Pf. Youngil Koh|82-2-2072-7217|go01@snu.ac.kr|
20203773|NCT01070550|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20203774|NCT01532700|University Health Network|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
20203775|NCT01585961|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
20203776|NCT01258348|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203777|NCT03480282|Beth Israel Deaconess Medical Center|Mara Schonberg|16177541414|mschonbe@bidmc.harvard.edu|
20158259|NCT02292537|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20158260|NCT05393245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158261|NCT03718325|University of Michigan|Dr. Scott Lempka|734-647-9052|NeuromodulationLab@med.umich.edu|
20158262|NCT03073525|Gradalis, Inc|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
20158263|NCT01976299|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|9529558236|mshepard@ospreymed.com|
20158264|NCT03692403|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20203778|NCT03685019|University of Oxford|Thomas Hamilton|01865 227374|thomas.hamilton@ndorms.ox.ac.uk|
20203779|NCT04126603|George Washington University|Sabyasachi Sen|202-994-8560|ssen1@gwu.edu|
20203780|NCT01671085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203781|NCT00637273|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20203782|NCT04465370|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
20203783|NCT00905307|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3924||
20203784|NCT03838367|CytoDyn|Joseph Meidling - Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
20203785|NCT03406104|Gensight Biologics|Magali TAIEL Chief Medical Officer|0762891252|mtaiel@gensight-biologics.com|
20203786|NCT00114972|Boston Scientific|Nic Van Dyck / Senior Program Manager|+ 31 43 356 8328|vandyckn@bsci.com|
20203787|NCT02890329|Dana Farber Cancer Institute|Dr. Jacqueline Garcia|617-632-1906|Jacqueline_Garcia@dfci.harvard.edu|
20203788|NCT01732263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20203789|NCT00231062|Acclarent|Laura England, Manager-Clinical Affairs|650-687-4466|lenglan1@its.jnj.com|
20203790|NCT00668525|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Carl Gommoll, MS|201-427-8000|carl.gommoll@frx.com|
20203791|NCT00590681|University of Chicago|Amanda Spratt|773-834-4031|aspratt@bsd.uchicago.edu|
20203792|NCT01259297|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20203793|NCT02991820|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
20203794|NCT01417780|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
20203795|NCT05022004|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
20203796|NCT02084134|Washington University School of Medicine|Dr. Julie Silverstein|314-747-7006|jsilverstein@wustl.edu|
20203797|NCT02807454|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20203798|NCT05468086|Cedars-Sinai Medical Center|Omer Liran, MD, MSHS|31042333754|omer.liran@cshs.org|
20203799|NCT01165203|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203800|NCT01070784|AstraZeneca|Goran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
20203801|NCT00797459|Medicis|Ron Staugaard|480-291-5652|rstaugaard@medicis.com|
20203802|NCT02815397|Northwestern University|Dr. R Karmali|312-695-6832|reem.karmali@northwestern.edu|
20203803|NCT00085540|Adult Brain Tumor Consortium (ABTC)|Howard Fine, MD|410-955-8837|jfisher@jhmi.edu|
20158265|NCT00672594|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
20158266|NCT02848092|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|513-636-8296|jeff.epstein@cchmc.org|
20158267|NCT00913510|Wellspect HealthCare|Dikran Shamoun|+46313764000||
20158268|NCT05160363|Medicines for Malaria|Senior Director, Program Leadership and Strategy|+41 22 555 03 26|borghinii@mmv.org|
20158269|NCT01349673|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20158270|NCT01665911|Indiana University School of Dentistry|Frank Lippert|317-274-8822|flippert@iu.edu|
20158271|NCT00641108|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
20158272|NCT00118274|University of Virginia|Dr. Craig Slingluff|4349249311|cls8h@virginia.edu|
20158273|NCT01724216|Spectrum Health|Mark Charles DeLano, M.D., Principal Investigator|616-363-7339|delanom@msu.edu|
20158274|NCT00564733|University of Washington|Keith D. Eaton, MD, PhD|2062886249|kdeaton@uw.edu|
20158275|NCT02621476|Kaiser Permanente Northern California|Julie Schmittdiel, PhD, MA|5108913872|Julie.A.Schmittdiel@kp.org|
20158276|NCT01484496|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158277|NCT00506779|University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD|713-745-2565|DGershen@mdanderson.org|
20158278|NCT01645735|Cerexa, Inc|Medical Monitor|(510) 285-9200||
20158279|NCT04105868|University of Pittsburgh|Mary Woody, PhD Assistant Professor of Psychiatry|4123832143|mlw114@pitt.edu|
20158280|NCT01456130|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20158281|NCT00382265|George Washington University|Andrew Meltzer, MD, MS|202-741-2952|ameltzer@mfa.gwu.edu|
20158282|NCT04091048|Medtronic Cardiovascular|Katie Flor, Clinical Research Manager|262 693 6127|katie.j.flor@medtronic.com|
20158283|NCT04908683|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158284|NCT02831855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158285|NCT02688192|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
20158286|NCT00075764|SWOG|Breast Committee Statistician|206-667-4623||
20158287|NCT03012191|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
20158288|NCT02817594|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20158289|NCT02010593|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
20158290|NCT01773967|Cincinnati Children's Hospital Medical Center|Dr. David Schnadower|5138035526|david.schnadower@cchmc.org|
20158291|NCT01135459|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20158292|NCT01531582|University of South Florida, Morsani College of Medicine|Edwin J. Weeber, Ph.D.|(813) 396-9995|eweeber@health.usf.edu|
20158293|NCT02236572|Yale Cancer Center|Lajos Pusztai, MD, DPhil|(203) 200-2328|lajos.pusztai@yale.edu|
20158294|NCT01057693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158295|NCT02413996|IRCCS Istituto Ortopedico Galeazzi, Milano|Davide Tornese|0266214046|davidzai@tin.it|
20158296|NCT00709319|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrstat3@jaeb.org|
20158297|NCT03889028|Clinical University Hospital of Valencia|David Navarro|+34961973500|david.navarro@uv.es|
20203804|NCT01518192|Department of Infectious Diseases, University Medical Center Ljubljana|Franc Strle|+386 1 522 2610|franc.strle@kclj.si|
20158298|NCT00090779|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20158299|NCT02032758|Mayo Clinic in Arizona|Dr. Charles H. Adler|480-301-8100|cadler@mayo.edu|
20203805|NCT00783705|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
20203806|NCT00426751|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203807|NCT01618955|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President-Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
20158300|NCT04345900|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
20158301|NCT04860869|University of Texas Medical Branch|Randall Urban|409-772-5476|rurban@utmb.edu|
20158302|NCT00515528|Department of Medicine|Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
20203808|NCT01200511|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20203809|NCT03288779|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
20158303|NCT01404650|Sarah Cannon Research Institute|Johanna Bendell, MD|877-691-7274|asksarah@sarahcannon.com|
20158304|NCT00590967|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|grigsby@radonc.wustl.edu|
20203810|NCT03403491|patientMpower Ltd|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
20158305|NCT01881789|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20158306|NCT01151020|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20158307|NCT00442416|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20158308|NCT01107964|Milton S. Hershey Medical Center|Dr. David Liang|717-497-9469|dliang12@yahoo.com|
20158309|NCT01737762|Smith and Nephew|Dr Innes Cargill|817-302-3913|innes.cargill@smith-nephew.com|
20158310|NCT00503425|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20158311|NCT02148263|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20158312|NCT00003869|Mayo Clinic|Dr. Edith A. Perez||perez.edith@mayo.edu|
20158313|NCT01964378|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20158314|NCT00326599|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|716-845-4101|alex.adjei@roswellpark.org|
20158315|NCT03364231|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20158316|NCT00585637|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
20158317|NCT01183429|Memorial Sloan Kettering Cancer Center|Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
20158318|NCT04373421|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
20158319|NCT02012218|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20158320|NCT05005273|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
20158321|NCT04685213|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20203811|NCT01355068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158323|NCT03300206|Hologic|Hologic Clinical Research Team|508.263.2900|ClinicalResearch@Hologic.com|
20158324|NCT04566731|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
20203812|NCT00540722|Adult Brain Tumor Consortium (ABTC)|John Fiveash, MD|410-955-8837|jfisher@jhmi.edu|
20203813|NCT00376688|The University of Chicago Comprehensive Cancer Center|Dr. Gini F. Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
20203814|NCT01770353|Ipsen Bioscience, Inc|Medical Director|See email|clinical.trials@ipsen.com|
20203815|NCT02279524|Galmed Research and Development, Ltd.|Medical Director|+972.3.693.8448|clinicaltrial@galmedpharma.com|
20158325|NCT04267926|Department of Veterans Affairs MS Center of Excellence-West and Portland, Oregon Health & Science University|Vijayshree Yadav MBBS, MCR|503-494-3813|yadavv@ohsu.edu|
20158326|NCT04522167|Formycon AG|Public Register Contact|+49 89 864667 100|clinicaltrials@formycon.com|
20158327|NCT02489318|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158328|NCT01306643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20158329|NCT03801928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158330|NCT00348946|Thomas Jefferson University|Judith L. Ross, M.D.|215-955-1648|judith.ross@jefferson.edu|
20158331|NCT02370368|The University of the West Indies, Mona|Dr. Sharmella Roopchand-Martin|876-927-2235|sharmella.roopchandmartin@uwimona.edu.jm|
20158332|NCT05197049|Janssen-Cilag International NV|Senior Medical Leader IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158333|NCT00579553|University of Oklahoma Health Science Center|Andrew Elimian, MD|19146465194|aelimian@aol.com|
20158334|NCT03748641|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158335|NCT04834726|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
20158336|NCT00833443|UCLA|Keith Heinzerling MD|323-461-3106|kheinzerling@mednet.ucla.edu|
20158337|NCT03606486|University of Washington|Dr. Barbara Norquist|206-543-3669|bnorquis@uw.edu|
20158338|NCT00958477|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20158339|NCT03205358|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20158340|NCT03579693|University of Washington|Bryan Kestenbaum, MD|206-685-7343|brk@uw.edu|
20158341|NCT02503085|Reckitt Benckiser Healthcare (UK) Ltd.|Clinical Research Director|+441482 326151||
20158342|NCT01027559|University of Pennsylvania|Dr. Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
20158343|NCT01841021|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lubomir Sokol|813-745-8212|lubomir.sokol@moffitt.org|
20203816|NCT01746732|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203817|NCT02817555|Eastern Health|Andrea Woodland|7097778146|andrea.woodland@easternhealth.ca|
20203818|NCT00137436|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20203819|NCT00701727|Radiant Research|Michael H Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|
20203820|NCT00051558|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20203821|NCT03902366|VA Portland Health Care System|Jennifer Loftis, PhD|503-220-8262|jennifer.loftis@va.gov|57155
20203822|NCT01701583|University of Colorado|Jenny Stitt|303-724-7205|jenny.stitt@ucdenver.edu|
20203823|NCT01441440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inuiries@pfizer.com|
20203824|NCT01345123|Health Dialog|David R Veroff, MPP, SVP Analytic Development|617-406-5219|dveroff@healthdialog.com|
20203825|NCT00883558|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
20203826|NCT01815333|UT MD Anderson Cancer Center|Haesun Choi, MD/ Professor, Abdominal Imaging Department|713-745-4693|hchoi@mdanderson.org|
20203827|NCT00366548|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20158344|NCT01162473|The Children's Hospital of Philadelphia|Rushani W. Saltzman MD|215-590-2549|allergyandimmunology@email.chop.edu|
20203828|NCT01984346|AtriCure|Medical Director of Clinical Education|513-560-5974|SGaynor@atricure.com|
20158345|NCT01144416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20158346|NCT00124072|CTSU, University of Oxford|CTSU Reception|01865 743743|secretary@ctsu.ox.ac.uk|
20203829|NCT00536731|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20203830|NCT01163162|Indiana University|Dr. Rajiv Agarwal|317 988 2241|ragarwal@iu.edu|
20158347|NCT03328832|Kaohsiung Chang Gung Memorial Hospital|Dr. Wang JW|+886-7-7317123|wangjw@adm.cgmh.org.tw|8003
20158348|NCT00873821|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158349|NCT04872569|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
20158350|NCT00742170|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20158351|NCT04417257|Laurent Pharmaceuticals Inc.|Vice president Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
20158352|NCT04951622|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158353|NCT03129464|Cleveland Clinic Florida|Pamela Frazzini Padilla|9546595559f|frazzip@ccf.org|
20158354|NCT05119582|Bispebjerg University Hospital|Prof. Joergen Serup|+1 21424888|joergen.vedelskov.serup@regionh.dk|
20158355|NCT02881775|University of North Carolina at Chapel Hill|Deborah Givens, PhD|919-843-8660|deborah_givens@med.unc.edu|
20203831|NCT00109733|EMD Serono|Sanja Dragnic/Medical Responsible|+7816814017|sanja.dragnic@emdserono.com|
20158356|NCT04581811|UAB Hospital|David Page - PI|205-975-7387|dpage1@uabmc.edu|
20158357|NCT00714948|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20203832|NCT03952468|VA Providence Health Care system|Dr. Jennifer Primack|(401) 273-7100|Jennifer.Primack@va.gov|16295
20158358|NCT02708680|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
20158359|NCT01342926|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158360|NCT02568722|Unity Health Toronto|Dr. Ron Wald|(416) 867-3703|ron.wald@unityhealth.to|
20158361|NCT04792190|University of Rochester|Mehmet Aktas, MD|585-275-4775|mehmet_aktas@urmc.rochester.edu|
20158362|NCT03390504|Janssen Research & Development, LLC|SR DIRECTOR ONCOLOGY CDTL|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158363|NCT00980538|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER EST PRODUCTS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158364|NCT01544348|MedImmune|Claire Birrell, Senior Clinical Scientist|301-398-0000|birrellc@medimmune.com|
20158365|NCT01445847|King Saud University Medical City - College of Medicine|Dr. Khalid Al-Faleh, Chairman, Institutional Review Board|966556031222|kfaleh@ksu.edu.sa|
20158366|NCT00707993|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20158367|NCT03654274|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20158368|NCT02752490|The University of Texas Health Science Center at Houston|Nana-Ama E Ankumah, MD|713-500-6421|Nana.Ama.E.Ankumah@uth.tmc.edu|
20158369|NCT01102491|Joint Reconstruction Center, Seoul National University Bundang Hospital|TK Kim|82-31-787-7196|osktk@snubh.org|
20158370|NCT01265992|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20158371|NCT01837680|Roosevelt Hospital, Mount Sinai Health System|Dr. Kimberly M. Herrera||kimmerher@gmail.com|
20158372|NCT03008070|Inventiva S.A.|Dr Michael Cooreman, Chief Medical Officer|+33380447616|native.public@inventivapharma.com|
20158373|NCT03960684|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20158374|NCT02151786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20158375|NCT02043145|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
20158376|NCT03761056|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20158377|NCT03941483|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20158378|NCT00971282|Galderma|Florence Paliargues|0033 4 92 95 29 57|Florence.Paliargues@Galderma.com|
20158379|NCT02685826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20158380|NCT03154476|Mayo Clinic|Dr. Alexander Egbe|507-284-3725|Egbe.Alexander@mayo.edu|
20158381|NCT01444430|AstraZeneca Research and Development|Carin Jorup, Global Clinical Lead (GCL) SYMBICORT|+46 31 7761000|Carin.Jorup@astrazeneca.com|
20158382|NCT03816176|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20158383|NCT00972023|Barbara Ann Karmanos Cancer Institute|Elaina Gartner|800-527-6266|egartner@seagen.com|
20158384|NCT02595879|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20158385|NCT00600106|Cedars-Sinai Medical Center|C. Noel Bairey Merz|310-423-9680|Noel.BaireyMerz@cshs.org|
20203833|NCT02758717|Lombardi Comprehensive Cancer Center|Bruce D. Cheson, M.D.|507-266-0800|bdc4@georgetown.edu|
20158386|NCT01139411|Weight Control and Diabetes Research Center|Dr. Elissa Jelalian|(401) 793-9716|elissa_jelalian@brown.edu|
20158387|NCT04312932|Nationwide Children's Hospital|Sarah Keim|614-722-2000|sarah.keim@nationwidechildrens.org|
20158388|NCT01537315|University of Arkansas for Medical Sciences|Dumitru Rotaru, MD, PI|501/526-6919|drotaru@uams.edu|
20158389|NCT03323853|University of Arkansas for Medical Sciences|Dr. Michael Wilson|501-686-5515|MPWilson@uams.edu|
20158390|NCT01179984|Bard Peripheral Vascular|Associate Director of Clinical Affairs|480-379-2838|josh.smale@crbard.com|
20158391|NCT01465386|FHCRC|Elihu Estey, MD|206-288-7176|eestey@seattlecca.org|
20158392|NCT02656836|Queen's University Belfast|Augusto Azuara-Blanco|2890976350|a.azuara-blanco@qub.ac.uk|
20158393|NCT02746406|Laborie|Clinical Researcher|9056121170|sbitzos@laborie.com|1755
20158394|NCT02479880|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20158395|NCT00355368|Medical Intensive care unit, University Hospital Basel|Stephan Marsch|+ 41 61 265 2525|smarsch@uhbs.ch|
20158396|NCT01279044|San Francisco Department of Public Health|Dr. Phillip Coffin, Director of Substance Abuse Research Unit|(415) 437 6282|phillip.coffin@sfdph.org|
20158397|NCT01408277|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20158398|NCT02840253|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
20158399|NCT03783962|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
20158400|NCT03346083|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20158401|NCT02763059|King Abdulaziz University|Prof. Maha A Bahammam|00966126400000|mbahammam@kau.edu.sa|
20158402|NCT03369665|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20158403|NCT01816776|Respicardia, Inc.|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
20158404|NCT01775553|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
20158405|NCT03810014|Duke University|Wendy P O'Meara, PhD|919-681-7711|wpo@duke.edu|
20158406|NCT02213068|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
20158407|NCT00633087|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20158408|NCT02534883|St. Louis University|Donald Gregory Ward, MD|314-781-1505|dgreg.ward@health.slu.edu|1
20158409|NCT00886769|Novartis Pharmaceuticals|Study Director|862-778-8300||
20158410|NCT00414076|UT MD Anderson Cancer Center|Coleman,Robert,M.D. / Gyn Onc & Reproductive Medicine|7137923203|RColeman@mdanderson.org|
20158411|NCT00778336|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
20158412|NCT03670355|San Francisco Department of Public Health|Dr. Albert Liu|4154377408|albert.liu@sfdph.org|
20158413|NCT03517436|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
20158414|NCT04181827|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158415|NCT04587869|RAND|Laura Bogart|3103930411|lbogart@rand.org|7281
20158416|NCT02157909|Alcon Research, Ltd.|Head Clinical Development, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20158417|NCT04687917|The Ohio State University|Dr. Bryan R. Garner|6142573462|bryan.garner@osumc.edu|
20158418|NCT04538664|Janssen Research & Development|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158419|NCT03929913|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
20158420|NCT00642707|CytoDyn, Inc.|Kush Dhody|301-956-2536|kushd@amarexcro.com|
20158421|NCT02891226|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20158422|NCT00125788|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
20158423|NCT00947219|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
20158424|NCT00766116|University of California, San Diego|Edward D. Ball, MD|858-822-6600|tball@ucsd.edu|
20158425|NCT03381287|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
20158426|NCT02847169|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20158427|NCT02454530|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158428|NCT03081689|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20158429|NCT02137070|University of Florida|Dr. Ronald Cohen|352-273-6124|roncohen@ufl.edu|
20158430|NCT03533660|University of Pittsburgh|Andrea DiMartini|14122164550|dimartiniaf@upmc.edu|
20158431|NCT00996658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158432|NCT02161536|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|+972 526145354|ravit@motusgi.com|
20158433|NCT04446312|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
20158434|NCT00932035|City of Hope|Carolyn Behrendt, Ph.D.|(626)359-8111|Cbehrendt@coh.org|61148
20158435|NCT02610972|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
20158436|NCT04487080|Janssen Research & Development|Global Medical Head Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158437|NCT02842086|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20158438|NCT03451851|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158439|NCT03581292|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20158440|NCT07214935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20158441|NCT04609553|Rutgers University|Manuel Jimenez, MD, MS|732-235-9300|jimenema@rwjms.rutgers.edu|
20158442|NCT03137771|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20173295|NCT05371509|Mayo Clinic|Umesh Goswami, M.B.B.S., M.D.|480-342-1137|goswami.umesh@mayo.edu|
20158443|NCT02220426|University of North Carolina at Chapel Hill|Rosa Tamara Branca, PhD|9199622229|rtbranca@unc.edu|
20158444|NCT01147965|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20158445|NCT01834287|Brown University|Bess Marcus|4018636850|bess_marcus@brown.edu|
20158446|NCT01650831|Exalenz.Bioscience Ltd.|Avraham Hershkowitz, Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
20158447|NCT02522429|UCLA|Principal Investigator|3108258546|monti@ucla.edu|
20158448|NCT00252512|Minneapolis VA Health Care System|Hildi Hagedorn|612-467-3875|hildi.hagedorn@va.gov|
20158449|NCT05554146|Montefiore Medical Center|Dr. Deepika Slawek|718-920-3786|dslawek@montefiore.org|
20158450|NCT04988295|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158451|NCT01683630|Unversity of Manotiba|Salah Mahmud|204-272-3139|salah.mahmud@umanitoba.ca|
20158452|NCT02197572|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20158453|NCT01947335|Heart Institute (Incor)|Dr. Pedro A. Lemos|+55 11 2661 5000|pedro.lemos@incor.usp.br|
20158454|NCT00901225|Duke University Medical Center|Mitchell E Horwitz, MD, Principal Investigator|919-668-1045|mitchell.horwitz@duke.edu|
20158455|NCT03458325|scPharmaceuticals|Sr. Vice President, Clinical Development and Medical Affairs|(855) 727 4276|jmohr@scpharma.com|
20158456|NCT00175916|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20158457|NCT04024436|Taiho Oncology, Inc|Taiho Oncology, Inc|+1 844-878-2446|medicalinformation@taihooncology.com|
20158458|NCT01169337|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20158459|NCT00540592|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158460|NCT04701411|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20158461|NCT03279237|Massachusetts General Hospital|Dr. Theodore Hong|(617) 726-2000|TSHONG1@mgh.harvard.edu|
20158462|NCT02168101|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANNDLClinicalScience@HCAHealthcare.com|
20158463|NCT05507567|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
20158464|NCT03901963|Janssen Research & Development|Director Clinical Research Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158465|NCT03569878|Department of Psychiatry, University of Washington School of Medicine|Douglas Zatzick|206 744-6701|dzatzick@uw.edu|
20158466|NCT01722994|University of Mississippi Medical Center|Dr. Robert Brodell|601-815-8000|rbrodell@umc.edu|
20158467|NCT02933879|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20158468|NCT01206140|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20158469|NCT01803880|Smith & Nephew, Inc|Stephan Mangin, Director, Global Clinical Strategy|M +1 (512) 913-8192|stephan.mangin@smith-nephew.com|
20158470|NCT03703232|University of Washington|Murray Maitland PT, PhD, Associate Professor|425-286-5278|mmaitlan@uw.edu|
20158471|NCT05226598|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20158472|NCT02959463|The University of Texas MD Anderson Cancer Center|Matthew Stephen Ning, MD, MPH|(832) 710-8779|msning@mdanderson.org|
20158473|NCT01672879|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20158474|NCT02179424|University of Hong Kong|Professor Lam Tai-Hing|39179287|hrmrlth@hku.hk|
20158475|NCT05384834|Emory University|Dr. Holly Gooding|404-778-1429|holly.gooding@emory.edu|
20158476|NCT03951766|Massachusetts General Hospital, Psychiatry Department|Dr. Bettina Hoeppner|6176431988|bhoeppner@mgh.harvard.edu|
20158477|NCT01871545|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
20158478|NCT01523743|Hopital Raymond poincare|Pref. Emmanuel Chartier-kastler|+33 1 42 17 71 29|emmanuel.chartier-kastler@psl.aphp.fr|
20158479|NCT02623972|Dana-Farber Cancer Institute|Filipa Lynce, MD|617-632-4056|Filipa_Lynce@DFCI.HARVARD.EDU|
20158480|NCT05710640|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20158481|NCT04188509|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158482|NCT04847843|University of Utah|Tanya Halliday, PhD, RD|801-213-1364|tanya.halliday@utah.edu|
20158483|NCT02734004|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20158484|NCT05615220|Emalex Biosciences Inc.|Drug Development and Medical Affairs|773 343 0671|mmiller@emalexbiosciences.com|
20158485|NCT02388880|Advanced Circulatory Systems|Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
20158486|NCT04570371|Mayo Clinic|Dr. Andrea Cheville|(507) 284-2747|cheville.andrea@mayo.edu|
20158487|NCT05089292|Icahn School of Medicine at Mount Sinai|Lina Jandorf|(212) 659-5506|lina.jandorf@mssm.edu|
20158488|NCT04229888|Indiana University School of Optometry|Anna Tichenor|812-855-0520|annatich@iu.edu|
20158489|NCT01282866|Laser & Skin Surgery Medical Group Inc.|Suzanne Kilmer, MD|916-456-0400|Study@skinlasers.com|
20158490|NCT00318929|Virginia Commonwealth University|Alan R. Towne, MD|804-282-9869|atowne@mcvh-vcu.edu|
20158491|NCT01541865|Boston Scientific|Angela Schutt, Clinical Trial Manager|763-494-2166|angela.schutt@bsci.com|
20158492|NCT01757301|Richard L. Roudebush VA Medical Center|Erica Evans|317-988-3476|erica.evans2@va.gov|
20158493|NCT00730353|Hoosier Oncology Group|Nasser Hanna, M.D.|317-274-3515|nhanna@iupui.edu|
20158494|NCT01393899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158495|NCT02622295|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
20158496|NCT00049257|Translational Oncology Research International|Dr. Fairooz Kabbinavar, Chief Medical Officer|310 824 1934|FKabbina@mednet.ucla.edu|
20158497|NCT04721158|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
20158498|NCT00132301|VA Puget Sound Health Care System|Dr. Bruce Montgomery|206-277-6878|Robert.Montgomery@va.gov|
20158499|NCT02880228|Mayo Clinic|Shaji K Kumar MD|5072842511|kumar.shaji@mayo.edu|
20158500|NCT03163134|University of Pittsburgh|Benita Valappil|412.864.1744|valappilb2@upmc.edu|
20158501|NCT05110781|University of California, Davis|Principal Investigator|916-734-2790|abewley@UCDAVIS.EDU|
20158502|NCT03674970|Penn State College of Medicine|Patricia Sue Grigson|717-531-5772|pgrigsonkennedy@pennstatehealth.psu.edu|
20158503|NCT04108208|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158504|NCT02101788|NRG Oncology|Linda Gedeon for Austin Miller, PhD|716-845-1169|linda.gedeon@roswellpark.org|
20158505|NCT05111613|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@stryker.com|
20158506|NCT01402869|Loma Linda University|Dr. Lauren Gutenberg|909-558-4690|lgutenberg@llu.edu|
20158507|NCT00841412|Tennessee Valley Healthcare System, GRECC and Vanderbilt University, School of Medicine, Division of Geriatrics, Center for Quality Aging|Sandra F. Simmons, PhD, Associate Professor of Medicine|615-343-6729|Sandra.Simmons@Vanderbilt.edu|
20158508|NCT01142388|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20158509|NCT05730725|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20158510|NCT05265728|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20158511|NCT03687957|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
20158512|NCT03132532|Mayo Clinic|Dr. Steven E. Schild|480-342-4800|sschild@mayo.edu|
20158513|NCT04150913|Massachusetts General Hospital|Director, Cellular Immunotherapy Program|857-367-1486|mghcancercenter@partners.org|
20158514|NCT03052608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158515|NCT04667949|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20158516|NCT02213926|AstraZeneca Clinical -Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20158517|NCT01273038|Coloplast A/S|Director of Medical Affairs|4549111111|dkbir@coloplast.com|
20158518|NCT05887908|Clinical Development Department|Meiji Seika Pharma Clinical Trial Administrator|(+81) 3-3273-3745|clinical-trials@meiji.com|
20158519|NCT02975804|The Hong Kong Polytechnic University|Dr tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
20158520|NCT02630693|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
20158521|NCT04423939|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
20158522|NCT01134614|ECOG Statistical Office|Study Statistician|617-632-3012||
20158523|NCT02661997|VA Boston Healthcare System|Barbara L. Niles, Ph.D.|857-364-4128|barbara.niles@va.gov|
20203834|NCT02759146|Michigan State University|Dr. Gwen Wyatt|517-353-6672|gwyatt@msu.edu|
20203835|NCT00506077|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158524|NCT01766037|Aspire Bariatrics, Inc.|VP Regulatory & Quality|484-200-1031|monica.ferrante@aspirebariatrics.com|
20158525|NCT04503551|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20203836|NCT04332640|Johnson & Johnson Surgical Vision|Head of Clinical Science|7142478200|LVarga17@ITS.JNJ.com|
20203837|NCT00316303|Dartmouth-Hitchcock|Stanley Rosenberg, Ph.D.|603-653-0740|Stanley.d.rosenberg@dartmouth.edu|
20203838|NCT00385268|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
20203839|NCT01293032|Virginia Commonwealth University/Massey Cancer Center|Harry D Bear, MD, PhD|804-828-9325|harry.bear@vcuhealth.org|
20203840|NCT02243527|University of British Columbia|Dr. Jordan A. Guenette|604.682.2344|Jordan.guenette@hli.ubc.ca|62129
20203841|NCT01106534|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20203842|NCT02262039|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
20203843|NCT04174638|Akdeniz University|Dr Sefika Tugba Yangoz|+905058039716|tugbayangoz@gmail.com|
20203844|NCT01831934|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20203845|NCT02641236|Dana-Farber Cancer Institute|Dr. Leslie Lehmann|617-632-4882|Leslie_Lehmann@DFCI.HARVARD.EDU|
20203846|NCT02985450|Carla Coffin|Dr.|403-220-7808|cscoffin@ucalgary.ca|
20203847|NCT00069576|GWU Biostatistics Center|Rebecca Clifton, Ph.D.|(301) 881-9260|rclifton@bsc.gwu.edu|
20203848|NCT05590793|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20203849|NCT04060667|Massachusetts General Hospital|Adeline Boatin|617 724 61320|adeline_boatin@mgh.harvard.edu|
20203850|NCT04488822|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
20203851|NCT03277729|Fred Hutchinson Cancer Center|Mazyar Shadman|206-667-4216|mshadman@fredhutch.org|
20203852|NCT02005601|Hospital for Special Surgery|Dr. Jacques Yadeau|212-606-1206|yadeauj@hss.edu|
20203853|NCT02401555|Bio-Rad Laboratories|David Bhend|425 498 1758|david_bhend@bio-rad.com|
20203854|NCT00443430|University of Washington and Seattle Children's Hospital|Carol Wallace, MD Principal Investigator|206-987-2057|cwallace@u.washington.edu|
20203855|NCT00053846|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20203856|NCT00592501|Massachusetts General Hospital|Annie W. Chan, MD|617-726-5184|AWCHAN@PARTNERS.ORG|
20218776|NCT03579966|Catalyst Pharmaceuticals, Inc.|Gary Ingenito, MD, Chief Medical Officer|3054203200|gingenito@catalystpharma.com|
20218777|NCT01340768|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203857|NCT00279500|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director, Clinical and Scientific Research|8188335089|jdorn@secondsight.com|
20218778|NCT02620150|University of Pennsylvania|Chelsea Voytek|215-746-3711|chelseav@pennmedicine.upenn.edu|
20203858|NCT00933335|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218779|NCT02878486|University of Kansas|Amber Watts, PhD|785-864-2604|amberwatts@ku.edu|
20218780|NCT04049617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20218781|NCT03551496|Boston Scientific|Dana Hromyak|1 216-526-8534|Dana.Hromyak@bsci.com|
20218782|NCT01524679|IZKS of the University Medical Center of the Johannes Gutenberg University Mainz|Christian Ruckes|+49 6131 17|ruckes@izks-mainz.de|9919
20218783|NCT00801099|Swiss Tropical Institute|Franziska Saxer, MD||franziskabrenneke@yahoo.com|
20203859|NCT03880227|The University of Texas at Dallas|Hans Klein|8304562444|hans.klein@utdallas.edu|
20158526|NCT05371054|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
20203860|NCT00504166|University of California San Francisco|Dr. Thomas M. Link|415-353-2450|Thomas.Link@ucsf.edu|
20158527|NCT04930198|Vanderbilt University Medical Center|Dr. Martin Were|(617) 319-6462|martin.c.were@vumc.org|
20203861|NCT00170157|Mayo Clinic|Eugene D. Kwon||kwon.eugene@mayo.edu|
20158528|NCT04158375|Mayo Clinic|Dr. Sreekumaran Nair - Principal Investigator|507-284-2511|nair.sree@mayo.edu|
20158529|NCT01152788|NCIC Clinical Trials Group|Dr. Janet Dancey|1-613-533-6430|jdancey@ctg.queensu.ca|
20158530|NCT04828135|Duke University|Loretta Que|919-681-8551|loretta.que@duke.edu|
20158531|NCT01081262|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
20158532|NCT00415870|UCSD|Project Coordinator|858-534-9329|ldillon@ucsd.edu|
20158533|NCT01272037|SWOG Statistics and Data Management Center|Breast Committee Statistician|206-667-4623|dlew@fredhutch.org|
20158534|NCT01890265|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|067study@fibrogen.com|
20158535|NCT01158820|Department of Anesthesiology & Critical Care|Jeff E Mandel MD MS|2156150553|mandelj@uphs.upenn.edu|
20158536|NCT04585269|Rutgers Cancer Institute|Dr. Katie Devine (PI)|7322357549|katie.devine@rutgers.edu|
20158537|NCT06006078|Cleveland Clinic Foundation|Dr. John Vargo|2164455012|vargoj@ccf.org|
20158538|NCT03462719|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158539|NCT04271540|Brigham and Women's Hospital|Brittany Weber, MD, PhD|6177326291|bweber@bwh.harvard.edu|
20158540|NCT03307785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20158541|NCT04209387|VA Bedford Healthcare System|Mo Modarres, PhD|2164966169|mmodarres@verizon.net|
20158542|NCT05441527|University of Iowa|Dr. Robert Bowers|(319) 467-3199|robert-bowers@uiowa.edu|
20158543|NCT05526521|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20158544|NCT03919929|University of Colorado Anschutz Medical Campus|Melanie Cree, MD, PhD|720-777-5743|melanie.cree@childrenscolorado.org|
20158545|NCT05069012|Beth Israel Deaconess Medical Center|Philip Hess|617-667-3112|phess@bidmc.harvard.edu|
20158546|NCT00100802|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
20158547|NCT01941927|University of California, San Francisco|Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
20158548|NCT03079531|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
20158549|NCT00648648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158550|NCT00325130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20158551|NCT06590441|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
20158552|NCT02683980|Boston Scientific|Clinical Program Manager|612-322-1189|teri.bird@bsci.com|
20158553|NCT03368781|Acutus Medical, Inc.|Steve McQuillan|4422326080|steven.mcquillan@acutus.com|
20158554|NCT00928187|UMI 233 IRD Montpellier|Dr Laura Ciaffi|00237 694926786|lauraciaffi2002@yahoo.fr|
20158555|NCT01144624|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
20158556|NCT02524145|University of Texas Southwestern Medical Center|Dr. Satyam Sarma|214-345-7111|SatyamSarma2@texashealth.org|
20158557|NCT01682356|Washington University School of Medicine|Linda R. Peterson, MD|314-362-4577|lpeterso@wustl.edu|
20158558|NCT05112679|University of Pittsburgh|Sashwati Roy, PI|412 6240422|sar453@pitt.edu|
20158559|NCT05327660|Consumer Wellness Solutions/RVO Health|Dr. Kristina Mullis|765-265-9169|kmullis@rvohealth.com|
20158560|NCT02346903|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
20158561|NCT03440463|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
20158562|NCT00620373|Mayo Clinic|Dr. Deborah J. Rhodes|507-538-1703|rhodes.deborah@mayo.edu|
20158563|NCT01897727|University of Alabama at Birmingham|Dr. Eric Judd|205 934-9281|ejudd@uab.edu|
20158564|NCT01061723|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20158565|NCT00293813|Amgen Inc.|Study Director|866-572-6436||
20158566|NCT02956746|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+886 2 2659 0988|achuang@synermore.com|
20158567|NCT00460655|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158568|NCT00910910|Celgene Corporation|Anne McClain, Senior Manager of Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20158569|NCT01973231|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20158570|NCT01692496|GEIS|Clinical Trial Coordinating Investigator|912866807|secretaria@grupogeis.org|
20158571|NCT05338710|OHSU|Allison Lindauer, PhD, APRN|5034944347|lindauer@ohsu.edu|
20158572|NCT01194219|Celgene Corporation|Anne McClain|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20158573|NCT01081951|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20158574|NCT03377816|University of Haifa|Johanna Czamanski-Cohen|+97246146234|jczamansk@univ.haifa.ac.il|
20158575|NCT05102383|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
20158576|NCT01671956|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20158577|NCT06875284|RTI International|Marni Kan, PhD|919-248-1836|mkan@rti.org|
20158578|NCT06631274|Florida State University|Dr. Lyndsay Jenkins|(850) 644-4592|lnjenkins@fsu.edu|
20158579|NCT03896750|Alliance for Multispecialty Research|William Smith, MD|(865) 305-9100|william.smith@amrllc.com|
20158580|NCT04266912|M.D. Anderson Cancer Center|Timothy A. Yap|713-563-1930|tyap@mdanderson.org|
20158581|NCT05696444|Medtronic|Michele Masters, Sr. Clinical Research Program Manager|4848948925|michele.masters@medtronic.com|
20158582|NCT05200572|University of Rochester|Lee Kehoe, Ph.D.|(585) 276-7686|leekehoephd@gmail.com|
20203862|NCT02650284|Stryker|Alissa Connelly|+61294671000|alissa.connelly@stryker.com|1075
20158583|NCT00316706|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158584|NCT00802997|Baylis Medical|Meghal Khakhar, Director of Regulatory and Scientific Affairs|9056024875|mkhakhar@baylismedical.com|
20158585|NCT04357730|Denver Health Medical Center|Dr. Ernest Moore, Director of Surgical Research|3036021820|ernest.moore@dhha.org|
20158586|NCT03640325|Dana-Farber Cancer Institute|Dr Abby Rosenberg|617.632.5286|abbyr_rosenberg@dfci.harvard.edu|
20158587|NCT03493451|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158588|NCT03046927|University of Mass Medical|Benjamin U. Nwosu, MD|5083406936|bnwosu1@northwell.edu|
20188624|NCT05521516|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|bilfeld@health.ucsd.edu|
20158589|NCT01133756|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20188625|NCT04305327|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20188626|NCT03275285|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20158590|NCT01566149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20158591|NCT02234713|Hospital for Sick Children|Dr. Ann Yeh|416-813-7353|ann.yeh@sickkids.ca|207353
20158592|NCT03574610|Houston Methodist Hospital|Rose Khavari, MD|7134419118|rkhavari@houstonmethodist.org|
20158593|NCT01848977|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
20158594|NCT01032954|Brazilian Center for Studies in Dermatology|Dr Doris Hexsel|555130262633|cientifico@cbed.org.br|
20158595|NCT03501992|Mayo Clinic|Robert M Jacobson, MD|507-250-4576|jacobson.robert@mayo.edu|
20158596|NCT03941873|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20158597|NCT03276728|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials|866-572-6436|MedInfoInternational@amgen.com|
20158598|NCT02415244|University of Iowa Hosptials and Clinics|Kenichi Ueda|3193562633|kenichi-ueda@uiowa.edu|
20188627|NCT00115934|New England Research Institutes|Lynn Sleeper, ScD|617-972-3235|lsleeper@neriscience.com|
20188628|NCT00747565|Abbott Medical Optics, Inc.|Nicholas Tarantino, O.D., Head, Global Clinical Research & Development|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
20188629|NCT06284941|Jiangyan District Hospital of traditional Chinese medicine attached to the Nanjing University of Chinese Medicine|Yang Zhang|15861013918|617405180@qq.com|
20188630|NCT04032106|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
20188631|NCT03400150|BioProtect|Dafna Carmi Yinon|+972 (9) 7731-929|dafna@bioprotect.com|
20188632|NCT04882917|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20188633|NCT00227266|University of Utah|Sandra Reyna, M.D.|801-581-3551|sreyna@genetics.utah.edu|
20188634|NCT00650078|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
20188635|NCT05357989|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
20188636|NCT01663363|Abbott Medical Optics|Ann Murphy, Manager, Clinical Research|619-518-4158|Ann.Murphy@abbott.org|
20188637|NCT04406272|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|patrick_wen@dfci.harvard.edu|
20188638|NCT00979459|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188639|NCT03971539|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188640|NCT00210106|Digestive Tumours Unit, Institut Bergonie|Pr Serge Evrard|s.evrard@brdeaux.unicancer.fr||
20188641|NCT00825344|Johns Hopkins|Dr. Steven P. Cohen|410-955-1818|scohen40@jhmi.edu|
20188642|NCT01675063|Emory University|James Blum|404-778-3482|jmblum@emory.edu|
20188643|NCT03876457|University Hospitals Cleveland Medical Center|Dr. Amrou Sarraj|(216)844-0474|Amrou.Sarraj@UHhospitals.org|
20188644|NCT02422615|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20188645|NCT01036724|CTI Clinical Trials and Consulting|Dr. Tina Hunter, Consulting Statistician to Biosense Webster|513-619-5541|tinah@s2stats.com|
20188646|NCT02967458|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Ethan Halpern|215-955-5345|ethan.halpern@jefferson.edu|
20203863|NCT04590937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158599|NCT02982772|Florida International University|Maria Jose Miguez|561-839-0223|mjmiguez@fiu.edu|
20158600|NCT01234480|Becton Dickinson|Karen Yanson|410-316-4793|karen_a_yanson@bd.com|
20158601|NCT02974140|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20203864|NCT00554294|Research Institute of Child Nutrition, Dortmund|Dr. Mathilde Kersting|0049 231 79221013|kersting@fke-do.de|
20203865|NCT01929044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158602|NCT00617084|Medtronic Bakken Research Center B.V.|Miraida Weldam|+ 31 43 356|miraida.weldam@medtronic.com|6652
20158603|NCT03370419|Wayen State University|Heather Fritz|313-577-9499|heather.fritz@wayne.edu|
20158604|NCT06219967|SUNY Upstate Department of Emergency Medicine|Michael Keenan, MD|315-416-4457|keenanm@upstate.edu|
20158605|NCT05875727|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158606|NCT01530178|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20158607|NCT03844672|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
20203866|NCT00001262|National Institute of Child Health and Human Development|Kaler, Stephen G|+1 301 451 6034|kalers@mail.nih.gov|
20203867|NCT01280123|Northwestern University|Tanya Simuni, MD||TSimuni@nm.org|
20203868|NCT00524745|PATH|Kathleen Neuzil, Principal Investigator|206-285-3500|kneuzil@path.org|4864
20203869|NCT02504892|National Cancer Institute|Dr. Ramaprasad Srinivasan|301-451-2298|srinivasanr@mail.nih.gov|
20203870|NCT00576693|Medical University of South Carolina|Marc I. Chimowitz, MBChB|843-792-3020|mchimow@musc.edu|
20218784|NCT01551888|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20158608|NCT01693250|University of California San Francisco|Dr. Jyu-Lin Chen|415-502-6015|jyu-lin.chen@ucsf.edu|
20158609|NCT02709512|Polaris Pharmaceuitcals Inc|Dr. Mirla Langlois|858-452-6688|mlanglois@polarispharma.com|161
20158610|NCT02155101|University of Liverpool|Professor Anna Maria Geretti|+44(0)151 795 9625|Geretti@liverpool.ac.uk|
20158611|NCT02297815|Children's Hospital of Philadelphia|Dr. Jeffrey Gerber|(267) 426-8775|gerberj@email.chop.edu|
20158612|NCT03650413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20158613|NCT00310375|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203871|NCT01413178|U.T. MD Anderson Cancer Center|Dr. Muzaffar H. Qazilbash / Stem Cell Transplantation and Cellular Therapy|713-745-3219|mqazilba@mdanderson.org|
20158614|NCT04169529|Medtronic|Andy St. Martin|(952) 220-4009|andy.stmartin@medtronic.com|
20158615|NCT03726658|Gate Neurosciences, Inc|Chief Medical Officer|203-247-3895|ron.burch@gateneuro.com|
20158616|NCT00412958|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
20158617|NCT01318135|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20158618|NCT01017042|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20203872|NCT00540449|Janssen Infectious Diseases BVBA|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
20202844|NCT02029430|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20202845|NCT03465735|Mayo Clinic|Waldemar E. Wysokinski, M.D., Ph.D.|507-266-6717|Wysokinski.Waldemar@mayo.edu|
20202846|NCT04661813|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
20202847|NCT04285723|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20202848|NCT03067311|University of North Carolina at Chapel Hill|David Penn, PhD|(919) 843-7514|dpenn@email.unc.edu|
20202849|NCT02903511|"University of Colorado Denver | Anschutz"|Godela Brosnahan, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20202850|NCT00907738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20202851|NCT05363293|Alzamend Inc.|Eve Del Rio, MD, PhD|9736993847|Eve@RioPharma.com|
20203873|NCT03643432|Oxford University Hospitals NHS FT|Jon Room|01865737526|jonathan.room@ouh.nhs.uk|
20203874|NCT00237796|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
20203875|NCT02574312|DePuy Ortho Joint US|Kirstin Cosgrove|800-827-7003|kcosgro1@its.jnj.com|
20203876|NCT05128162|University of Michigan|Kevin Boehnke, PhD|734-998-6939|kboehnke@med.umich.edu|
20203877|NCT00370149|Riley Hospital for Children|Elaine G Cox, MD|317-944-7260|elmcox@iu.edu|
20203878|NCT03022032|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harvard.edu|
20203879|NCT00620321|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20203880|NCT01755195|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
20203881|NCT02340819|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20203882|NCT02856581|Mayo Clinic|Dr. Ivana T. Croghan|507-284-7313|croghan.ivana@mayo.edu|
20202852|NCT02420652|Rutgers Cancer Institute of New Jersey|Biren Saraiya, MD|732-235-3360|saraiybi@cinj.rutgers.edu|
20202853|NCT02452970|EpicentRx, Inc.|Study Director: Bryan Oronsky, Chief Medical Officer|408-569-3202|boronsky@epicentrx.com|
20202854|NCT03726671|University of North Carolina at Chapel Hill|Julie M. Stegall, MSW|704-250-5048|julie_stegall@unc.edu|
20202855|NCT01383200|Bascom Palmer Eye Institute|Dr. Sonia Yoo|305-243-2020|syoo@med.miami.edu|
20202856|NCT02340104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20202857|NCT01040832|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20202858|NCT04510922|University of Cincinnati|Alberto Espay, MD, MSc|5135584050|espayaj@ucmail.uc.edu|
20202859|NCT03692910|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20202860|NCT01322607|Baltimore VA Medical Center (VAHMCS)|Research Specilist|410-605-7156|alyssa.stookey@va.gov|
20202861|NCT00151411|Penn State Hershey|Sandy Eyer|717-531-1540|seyer@hmc.psu.edu|
20202862|NCT01283581|Melinta Therapeutics|Dr. Sue Cammarata|312-724-9401|scammarata@melinta.com|
20202863|NCT00486226|Codman&Shurtleff|Arnaud Nicolas|+33 0 155 004 543|anicolas@its.jnj.com|
20202864|NCT01259492|Novartis Pharmaceuticals|Study Director|8627788300||
20202865|NCT01981122|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
20202866|NCT00117962|Washington University School of Medicine|Dr. Ramaswamy Govindan||rgovinda@dom.wustl.edu|
20202867|NCT03846947|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20202868|NCT00634543|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
20202869|NCT03515538|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
20202870|NCT04243369|Philips|T.J. Battisti|(425) 205-3515|t.j.battisti@philips.com|
20202871|NCT03323307|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
20202872|NCT01954628|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 (604) 629-9223|clinical@aqxpharma.com|
20202873|NCT02740153|Children's National Medical Center|Dr. Nicholas Ah Mew|202-476-5863|nahmew@childrensnational.org|
20202874|NCT01736683|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|800-672-6372|ClinicalTrialsDisclosure@merck.com|
20202875|NCT04021472|VA Bedford Healthcare System|Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
20202876|NCT03069690|University of Pittsburgh Medical Center|Dr. Michele Levine|(412) 647-0703|levinem@upmc.edu|
20202877|NCT00577590|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20202878|NCT00670111|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
20202879|NCT00844883|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20202880|NCT01625169|USC|LaShonda Spencer|323 226-6437|lspencer@usc.edu|
20202881|NCT01857986|Hospitech Respiration|Clinical Trials Manager|+972-3-9191648|adir@hospitech.co.il|5
20188647|NCT00945321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188648|NCT02438137|UMichigan|Tiffany Braley, M.D., M.S.|734-232-1147|tbraley@med.umich.edu|
20188649|NCT04017611|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20188650|NCT00692913|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20188651|NCT02291913|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20188652|NCT03406325|Hong Kong Sanatorium & Hospital|Prof. Tak Hong Lee|28358430|TakHong.Lee@hksh.com|
20188653|NCT01637402|University of California, San Francisco|Dr. Terry Friedlander, MD|415-514-6380|Terence.Friedlander@ucsf.edu|
20188654|NCT00351299|BrighamHospital|Dr. Gerald Weinhouse|617-732-5499|gweinhouse@partners.org|
20188655|NCT04876417|University of Iowa|Thorsten Rudroff, PhD, Associate Professor|(319) 467-0363|thorsten-rudroff@uiowa.edu|
20188656|NCT04868617|Coloplast A/S|Pernille Nonboe|+4549113143|dkpen@coloplast.com|
20188657|NCT01342367|The University of Chicago|Dr. Stanley Liauw|7737026870|sliauw@radonc.uchicago.edu|
20188658|NCT02964741|University of Michigan|Jacqueline Dobson|734-763-8469|contacthope@umich.edu|
20188659|NCT00610558|University of California, Irvine|Dr. Lydia Su|(949) 824-4925|msu@uci.edu|
20188660|NCT01074294|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20188661|NCT01209195|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20188662|NCT00312208|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
20188663|NCT02284113|Pacira Pharmaceuticals, Inc.|Medical Information||MedInfo@Pacira.com|
20188664|NCT04191824|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20188665|NCT01324310|Celgene Corporation|Senior Manager|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20188666|NCT04027439|Verona Pharma|Verona Pharma|+44 (0)203 283 4200|info@veronapharma.com|
20188667|NCT01830595|Minneapolis Medical Research Foundation|Jason Baker|612-873-2705|baker@umn.edu|
20188668|NCT05018143|University of Pennsylvania|Dr. José A. Bauermeister|215-898-3242|bjose@upenn.edu|
20188669|NCT05116774|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20188670|NCT05601882|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20188671|NCT05507970|Medicines for Malaria Venture|Project Director|+41 22 555 03 00|info@mmv.org|
20188672|NCT05464732|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
20188673|NCT05019742|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
20188674|NCT03959423|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
20188675|NCT05617300|HealthPartners Neuroscience Research|Leah Hanson, PhD|6514956352|Leah.R.Hanson@HealthPartners.com|
20188676|NCT05864209|NYU Langone Health|Linda G Kahn, PhD, MPH|(917) 439-8069|linda.kahn@nyulangone.org|
20188677|NCT04207736|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
20188678|NCT02722434|Mayo Clinic|Charles L Loprinzi MD|507/284-2511|cloprinzi@mayo.edu|
20188679|NCT00753337|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20188680|NCT00146172|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20188681|NCT00786864|University of the Witwatersrand|Gina L Fanucchi|+27 11 616 4400|gfanucs@mweb.co.za|
20188682|NCT00712179|Ralph H Johnson VA Medical Center|Dr. Steven A Kautz|843-792-3867|kautz@musc.edu|
20188683|NCT03684590|University of Texas Southwestern|Tiffany Moon, MD|2145345456|tiffany.moon@utsouthwestern.edu|
20188684|NCT02414633|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20188685|NCT02432300|EmotEd, LLC|Dawn Neumann|716-713-5048|dneumann73@gmail.com|
20188686|NCT01211106|Cpl Micheal J Crescenz VA Medical Center|David Oslin, MD|215-823-5894|dave.oslin@va.gov|
20188687|NCT00290537|U.T. M.D. Anderson Cancer Center|Vali Papadimitrakopoulou, MD / Associate Professor|713-792-6363||
20188688|NCT03614663|Zynerba Pharmaceuticals|Stephen O'Quinn, PharmD|919-271-1339|oquinns@Zynerba.com|
20188689|NCT01500200|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20188690|NCT00623194|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20188691|NCT01952366|Sykehuset Innlandet|Dr. Tom Borza|+47 91834607|tom.borza@sykehuset-innlandet.no|
20188692|NCT04860505|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20188693|NCT00857766|GlaxoSmithKline|GSK Response Center|866-435-7343||
20188694|NCT01961609|Novartis Pharmaceuticals|Study Director|862-778-1873||
20188695|NCT01988402|San Antonio Military Medical Center|Jay B Higgs,|2109160797|jay.b.higgs.civ@mail.mil|
20188696|NCT00647400|Abbott|Global Medical Services|800-633-9110||
20188697|NCT01212744|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
20188698|NCT01262339|University of Wisconsin- Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
20188699|NCT02167451|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
20218785|NCT03801265|University of Pittsburgh|Sharad Khetarpal, MD|4126235020|khetarpalsk@upmc.edu|
20188700|NCT00571649|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20188701|NCT01218659|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20188702|NCT00811941|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20188703|NCT03885232|University of Colorado at Anschutz Medical Campus|Sean O'Leary, MD, MPH - Principal Investigator|(303)724-1582|sean.oleary@cuanschutz.edu|
20188704|NCT02397096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20188705|NCT03840902|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20188706|NCT03736564|Mayo Clinic|Dr. Stephen Broski|507-293-6155|broski.stephen@mayo.edu|
20188707|NCT06456723|Imperial College London|Professor Rohini Sharma|0203 313 3720|r.sharma@imperial.ac.uk|
20188708|NCT06688357|University of Florida - Norman Fixel Brain Institute|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
20188709|NCT03029286|Georgetown University|Suzanne O'Neill, PhD|202-687-0869|sco4@georgetown.edu|
20188710|NCT03222609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20188711|NCT05139992|ASH Research Collaborative|Nicole Mortier|866-828-1231|nmortier@ashrc.org|
20188712|NCT03834740|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
20188713|NCT03593226|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
20188714|NCT03891758|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
20188715|NCT03777657|BeiGene|Study Director|877-828-5568|Clinicaltrials@beigene.com|
20188716|NCT03789110|Dana-Farber Cancer Institute|Sara Tolaney|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20188717|NCT03691493|Emory University|Dr. Mylin Torres|404-778-1900|matorre@emory.edu|
20188718|NCT05501600|University of Pittsburgh|Keith Vogt|412-647-3147|vogtkm@upmc.edu|
20188719|NCT02678689|BioMarin Pharmaceutical Inc|Pascal Reisewitz, Global Medical Director, PhD|1-800-983-4587|medinfo@bmrn.com|
20188720|NCT02549352|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20188721|NCT05704725|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20188722|NCT01470144|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD||thomas.pfister@actelion.com|
20188723|NCT00593840|Washington University School of Medicine|Wade Thorstad, M.D.|314-362-8516|thorstad@radonc.wustl.edu|
20188724|NCT01162096|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
20188725|NCT02896907|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. James Posey|215-503-6442|James.Posey@jefferson.edu|
20188726|NCT04503681|Cooper University Health Care|Brian Roberts|856-342-2352|roberts-brian-w@cooperhealth.edu|
20188727|NCT03752684|University of Alabama at Birmingham|John Knight|205-996-2295|johnknight@uabmc.edu|
20188728|NCT01596231|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20188729|NCT03352713|Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine|Dr. Shea Lemley|603-646-7040|behavior.change@dartmouth.edu|
20188730|NCT01812759|UT MD Anderson Cancer Center|Kumar Alagappan,Chair, Emergency Medicine|(713) 745-9911|kalagappan@mdanderson.org|
20188731|NCT00536120|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
20188732|NCT04559698|Yale University School of Public Health|Dr. Zachary Soulliard|646-344-4060|zachary.soulliard@yale.edu|
20188733|NCT03437733|Biosense Webster, Inc.|Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188734|NCT01982682|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Dolores Grosso|215-955-0182|dolores.grosso@jefferson.edu|
20188735|NCT02760654|University of Michigan School of Nursing|Robert Knoerl, Doctoral Student|734-536-9369|rjknoerl@umich.edu|
20188736|NCT01184326|Dana-Farber Cancer Institute|Dr. Mark Pomerantz|617-632-4524|mark_pomerantz@dfci.harvard.edu|
20188737|NCT01084694|Northside Hospital|Dr. Dawn Speckhart, PhD|404-255-1930|dawn.speckhart@northside.com|
20188738|NCT00605306|Novartis Pharmaceuticals|Study Director|862-778-8300||
20188739|NCT01750684|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|acorda@acorda.com|
20188740|NCT01970410|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20188741|NCT00702884|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab|614-293-6529|Tanios.Bekaii-Saab@osumc.edu|
20188742|NCT02185794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20188743|NCT00336505|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
20188744|NCT01092416|Cardiovascular Systems, Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
20188745|NCT00366249|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20188746|NCT01561300|Unilever R&D Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
20188747|NCT00777049|Translational Research in Oncology (TRIO)|Valérie Bee-Muntenau, Director of Project Management|+33 1 58 10 09 09|Valerie.Bee@trioncology.org|
20188748|NCT00246805|Medtronic BRC - Medtronic Italia|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
20188749|NCT03478969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20188750|NCT01185600|University of Miami|Wenche Jy, PhD, Research Associate Professor, Principal Investigator|305-243-6617|wjy@med.miami.edu|
20188751|NCT00724126|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
20188752|NCT01214759|The University of Texas Health Science Center at Houston|Dr. Karen Vigil|(713) 500-6703|Karen.J.Vigil@uth.tmc.edu|
20188753|NCT00739934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188754|NCT03455985|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
20188755|NCT01579318|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
20188756|NCT02555306|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
20188757|NCT00588406|North Shore Long Island Jewish Health System|Dr. Robert Silverman|718-470-7501|rsilverman@nshs.edu|
20188758|NCT03066609|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20218786|NCT03056157|VA Boston Healthcare System|Dr. Brett Litz|(617)5849314|brett.litz@va.gov, litzb@bu.edu|
20188759|NCT03355573|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20188760|NCT01566890|Medical College of Wisconsin Department of Hematology|Joshua Field, MD|414-937-6896|JField@Versiti.org|
20218787|NCT03321630|NYU Langone Health|Paul Oberstein|2127316120|paul.oberstein@nyulangone.org|
20188761|NCT02534285|Technical University Dresden, Dept. of Anaesthesiology|Prof. Dr. Matthias Hübler|+4945814002|matthias.huebler@uniklinikum-dresden.de|
20188762|NCT03983434|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
20188763|NCT00588471|Mayo Clinic|Dr. Amir Lerman|507-255-7760|lerman.amir@mayo.edu|
20188764|NCT04124432|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20188765|NCT01357512|Oulu University Hospital and Univeristy of Oulu|Chief urologist Markku Vaarala|+3588315|markku.vaarala@oulu.fi|2840
20188766|NCT00523419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20188767|NCT01211184|Södertälje Hospital|Robert Hahn|+46855024670|robert.hahn@sodertaljesjukhus.se|4670
20188768|NCT01421667|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20188769|NCT00822120|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
20188770|NCT02999763|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
20188771|NCT04060212|University of Rochester|Matthew Rand|585-275-5459|matthew_rand@urmc.rochester.edu|
20188772|NCT01378416|Eisai Inc.|Yufang Lu, MD PhD|1-888-422-4743||
20188773|NCT03496545|Weill Cornell Medicine|Judy Ch'ang, MD|(212) 746-2596|jhc9010@med.cornell.edu|
20188774|NCT03802994|Ralph H. Johnson VA Medical Center|ACOS/R, R. Amanda C. LaRue|843-789-6707|Rutha.LaRue@va.gov|
20188775|NCT02646618|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
20188776|NCT04474496|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
20188777|NCT01447706|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20188778|NCT00918203|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20188779|NCT00701701|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20188780|NCT00589875|Candel Therapeutics|Garrett Nichols (CMO)|617-916-5445|Gnichols@candeltx.com|
20188781|NCT00859781|Weill Cornell Medicine|Sarah Yuan|6469626040|say7008@med.cornell.edu|
20188782|NCT03357952|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188783|NCT01208974|University of Miami|Cristiane Takita MD|305-243-4337|ctakita@med.miami.edu|
20188784|NCT04057820|University of Arkansas for Medical Sciences|Dr. Songthip Ounpraseuth|5016867233|stounpraseuth@uams.edu|
20188785|NCT04517435|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223 8100|TaussigResearch@ccf.org|
20188786|NCT06191679|Children's Hospital of Philadelphia|Shannon Hammer|2678878580|bresslers@chop.edu|
20188787|NCT03459196|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
20188788|NCT05747014|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
20188789|NCT04989816|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20188790|NCT03987581|Duke University School of Medicine|Angela Kirby|9198247729|angela.caison.kirby@gmail.com|
20188791|NCT02186509|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
20188792|NCT04213807|Anthos Therapeutics|Debra Freedholm|609-439-8246|Deb.f@anthostherapeutics.com|
20188793|NCT00145587|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
20188794|NCT01128595|GlaxoSmithKline|GSK Response Center|866-435-7343||
20188795|NCT00372775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188796|NCT02803749|University of Rochester|Dr. Ruth Schneider|584-341-7500|ruth_schneider@urmc.rochester.edu|
20188797|NCT00890591|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsus.com|
20188798|NCT03234374|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20188799|NCT01436175|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20188800|NCT05405244|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|Kyle_burger@unc.edu|
20188801|NCT03418922|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20188802|NCT03577106|UPMC|Scott Ward|412-683-7105|wards7@upmc.edu|
20188803|NCT00635700|Yale University|Scott W. Woods, M.D.|203-974-7038|scott.woods@yale.edu|
20188804|NCT03601715|Federal University of Santa Catarina|Inaihá Benincá|(+55 48) 3721-6255|inaiha.b@gmail.com|
20188805|NCT02347332|Institut de Recherche Pierre Fabre, Toulouse France|Zahida Issiakhem, Clinical Development Physician|+33 5 34 50 61 71|zahida.issiakhem@pierre-fabre.com|
20188806|NCT01929291|GlaxoSmithKline|GSK Response Center|866-435-7343||
20188807|NCT01478594|AVEO|Medical Director|1.617.588.1960|clinical@aveooncology.com|
20188808|NCT01119755|Hypertension Center, Third Department of Medicine, University of Athens, Greece|George S Stergiou, Associate Professor of Internal Medicine and Hypertension|+302107763117|gstergi@med.uoa.gr|
20188809|NCT01313884|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
20188810|NCT01970007|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20188811|NCT02854436|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188812|NCT04250194|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-2386|fabien.maldonado@vumc.org|
20188813|NCT03893318|University of California, San Diego|Michael Kelly, MD|508-410-9567|mpkelly@ucsd.edu|
20158619|NCT00598507|H. Lee Moffitt Cancer Center and Research Institute|Ronald DeConti, M.D., Principal Investigator|813-745-8466|ronald.deconti@moffitt.org|
20158620|NCT04767061|Weill Cornell Medicine|Princess Osma|646-962-5910|pro4001@med.cornell.edu|
20158621|NCT03782064|Beth Israel Deaconess Medical Center|Emma Logan, Director of Research Nursing|6176675984|eklogan@bidmc.harvard.edu|
20188814|NCT01499849|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781.257.2536|mhuber@tesarobio.com|
20188815|NCT00174252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20188816|NCT01201772|University of Florida|Dominick Angiolillo|904-244-3933|dominick.angiolillo@jax.ufl.edu|
20188817|NCT03938337|O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham|Eddy S. Yang|12059960780|eyang@uab.edu|
20188818|NCT00622700|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20188819|NCT00942266|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20188820|NCT03611556|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20188821|NCT02139436|Spaulding Rehabilitation Hospital|Glen Picard|6177585511|gpicard@partners.org|
20188822|NCT03664011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188823|NCT01693822|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722 4297|apredict-icrctsu@icr.ac.uk|
20188824|NCT02844439|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
20188825|NCT04023175|Atrium Health|Dr. Elizabeth Braxton|8032613377|egwbraxton@gmail.com|
20188826|NCT04187573|Cerus Endovascular, part of Stryker Corporation|Vanessa Sarge|5103292048|vanessa.sarge@stryker.com|
20188827|NCT00317720|UT MD Anderson Cancer Center|Dr. Francisco Esteva|713-563-0742|CR_Study_Registration@mdanderson.org|
20188828|NCT05580003|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188829|NCT03500549|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20188830|NCT00979121|ARDS Network|David A. Schoenfeld, PhD ARDSNet CCC PI|617-726-6111|dschoenfeld@mgh.harvard.edu|
20188831|NCT01913314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20188832|NCT04337931|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
20188833|NCT01738438|Dana-Farber Cancer Institute|Sara Tolaney, MD|617.632.2335|Sara_Tolaney@DFCI.HARVARD.EDU|
20188834|NCT04436289|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
20188835|NCT01532999|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|
20188836|NCT02928172|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|310-423-1682|loani.elvir-lazo@cshs.org|
20188837|NCT02016872|Memorial Sloan Kettering Cancer Center|Dr. Jacob Shin, MD|848-225-6436|shinj2@mskcc.org|
20188838|NCT03280030|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20188839|NCT03211247|DBV Technologies|Pharis Mohideen, MD, Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
20188840|NCT02415127|Horizon Pharma Ireland, Ltd. Dublin, Ireland|Julie Ball, Executive Director Clinical Development & Operations||clinicaltrials@horizonpharma.com|
20188841|NCT00545545|HiberCell|Michele A. Gargano, MSC/ VP Clin Ops and Prg Mngt|651.675.0300|mgargano@hibercell.com|
20188842|NCT02761187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20188843|NCT04153890|West Virginia University School of Nursing|Dr. Ubolrat Piamjariyakul, PhD, RN|3042936729|ubolrat.piamjariyakul@hsc.wvu.edu|
20188844|NCT02868970|Canadian Center for Vaccinology, Dalhousie University|Dr. Jennifer Isenor|902-494-2378|jennifer.isenor@dal.ca|
20188845|NCT03997474|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
20188846|NCT05140902|University of Alabama at Birmingham|Dr. Harrison Kim|205-996-4088|hyunkikim@uabmc.edu|
20188847|NCT05630833|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20188848|NCT03277989|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
20188849|NCT05048394|Point Designs|Becca Connolly|720-600-4753|becca@pointdesigns.com|
20188850|NCT02798471|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20188851|NCT02303392|The Ohio State University Comprehensive Cancer Center|Dr. Jennifer Woyach|614-293-8165|Jennifer.Woyach@osumc.edu|
20188852|NCT03083366|University of Utah|Karena McDonald|801-699-9740|karena.mcdonald@hsc.utah.edu|
20188853|NCT03668899|CairoU|Dr. Amira Farouk|01007192834|Amirafarouk77@gmail.com|
20188854|NCT06056310|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20188855|NCT02702843|Cleveland Clinic Florida|Lo Menzo, M.D.,Emanuele|9546595000|lomenze@ccf.org|
20188856|NCT01779141|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20188857|NCT02261805|Lombardi Comprehensive Cancer Center|Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
20188858|NCT00065182|GlaxoSmithKline|GSK Response Center|866-435-7343||
20188859|NCT02633215|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
20188860|NCT00754325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20188861|NCT03442777|Belgian Healthcare Knowledge Centre|Jillian Harrison|+32 2 287 33 89|jillian.harrison@kce.fgov.be|
20188862|NCT03801148|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20188863|NCT00609869|H. Lee Moffitt Cancer Center and Research Institute|Javier Pinilla-Ibarz|813-745-1387|javier.pinilla@moffitt.org|
20188864|NCT01627561|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20188865|NCT02330588|Department of Pediatrics, University of Alberta|Dr. Geoff Ball|780-248-5490|gdball@ualberta.ca|
20188866|NCT00743574|Yale University|Dr. Lubna Pal|203-737-5619|lubna.pal@yale.edu|
20188867|NCT05230433|Happy Trails Nutrition|Jennifer Meijer|6036505250|jen@htnutrition.com|
20188868|NCT01816971|University of Chicago Medical Center|Andrzej Jakubowiak, MD, PhD|773-702-4005|ajakubowiak@medicine.bsd.uchicago.edu|
20188869|NCT04732000|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
20188870|NCT00754065|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20158622|NCT00363142|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158623|NCT02137447|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|6177248604|dyeh2@partners.org|
20188871|NCT04033445|Janssen Research & Development, LLC|Medical Director IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218788|NCT00140426|University of Colorado School of Medicine, Childrens Hospital Colorado|Jennifer Hagman MD|720-777-2539|jennifer.hagman@childrenscolorado.org|
20218789|NCT00950963|Denver Health|Raymond Estaico, MD|303-860-9900|Ray.Estacio@cpcmed.org|
20218790|NCT01342107|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20218791|NCT00928707|Italfarmaco SpA|Carlo Bianchini, MD|+39 02 6443 2540|c.bianchini@italfarmaco.com|
20158624|NCT00604552|Medtronic Vascular|Angela Parsons|707-591-2293|angela.r.parsons@medtronic.com|
20218792|NCT00132028|SWOG Statistical Center|Study Statistician|206-667-4623||
20218793|NCT02140411|Novartis Pharmaceuticals|Study Director|862-778-1873||
20188872|NCT04497727|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
20158625|NCT00049322|University of California Los Angeles|Carolyn Britten, M.D.|310 829 4971|cbritten@mednet.ucla.edu|
20188873|NCT04353492|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20188874|NCT00776009|Novartis Pharmaceuticals|Study Director|862 778-8300||
20188875|NCT00582972|University of Wisconsin|Dr. Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
20188876|NCT01567605|Simon Fraser University|Dr Victoria Claydon (Principal Investigator)|7787828513|victoria_claydon@sfu.ca|
20188877|NCT00135200|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|(734) 936-5310|mkaminsk@umich.edu|
20188878|NCT02169869|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20188879|NCT02101775|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
20188880|NCT00293397|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20188881|NCT02195232|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
20188882|NCT00503906|UM/Sylvester Comprehensive Cancer CEnter|Stefan Gluck MD|305-243-4909|sgluck@med.miami.edu|
20188883|NCT04035447|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
20188884|NCT03304587|Michigan State University College of Nursing|Dr. Horng-Shiuann Wu, Associate Professor|517-884-4643|wuhorngs@msu.edu|
20203883|NCT02163993|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203884|NCT01252134|Alcon Research, Ltd.|Director of Medical Affairs|888.451.3937|medinfo@alconlabs.com|
20203885|NCT03463941|Duke School of Nursing|Cherie Conley|2166597128|cherie.conley@duke.edu|
20203886|NCT02273050|AstraZeneca|Eva Johnsson, MD, PhD|46 31 7762484|Eva.Johnsson@astrazeneca.com|
20203887|NCT00718419|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20203888|NCT01675531|Seoul ST.Mary's Hospital|Jin-Hyong Kang|82-2-2258-6043|jinkang@catholic.ac.kr|
20203889|NCT00726323|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203890|NCT02528500|W. L. Gore & Associates|Rimma Zakharyan|928 310 6961|rzakhary@wlgore.com|
20203891|NCT00669539|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
20203892|NCT05374408|UNMC|Margaret Emerson|4025596625|margaret.emerson@unmc.edu|
20203893|NCT00376597|The Ohio State University Comprehensive Cancer Center|Electra D. Paskett, PhD|614-293-3917|electra.paskett@osumc.edu|
20203894|NCT00972478|SWOG|Study Statistician|206-667-4623||
20203895|NCT02561000|Tufts Medical Center|Athan Kuliopulos, MD, PhD|617-636-8482|athan.kuliopulos@tufts.edu|
20203896|NCT01234402|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20203897|NCT00365716|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203898|NCT02280291|NYU Langone Health|Nirmal Tejwani|212 598 6599|Nirmal.Tejwani@nyulangone.org|
20203899|NCT05175261|Prolocor, Inc|David J Schneider, MD|8023730071|david.schneider@prolocor.com|
20203900|NCT02918266|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20203901|NCT00148733|University of Bergen|Tor A Strand|90971086|tor.strand@cih.uib.no|
20203902|NCT00358917|Abbott|Medical Information Specialist|800-633-9110||
20203903|NCT00759473|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
20203904|NCT01757704|Lunds University|Dr. Bansi Koul|+4646171649|bansi.koul@skane.se|
20203905|NCT02749721|Rush University Medical Center|Dr. John Zajecka|312-942-5592|John_Zajecka@rush.edu|
20203906|NCT02691247|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
20203907|NCT02552355|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
20203908|NCT01519245|University of Saskatchewan|Dr. Kelsey Brose, Primary Investigator|306-655-1483|kelsey.brose@saskcancer.ca|
20203909|NCT01556633|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20203910|NCT00803244|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20203911|NCT03321929|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
20203912|NCT01253460|The University of Texas MD Anderson Cancer Center|William G Wierda, MD/Professor|713-745-0428|wwierda@mdanderson.org|
20203913|NCT00616239|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
20203914|NCT01052012|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20203915|NCT02873715|University at Buffalo|Leonard H. Epstein, PhD, SUNY Distinguished Professor|716-829-3400|lhenet@buffalo.edu|
20203916|NCT00878228|Hospital for Special Surgery|Dr. David Kim|212-606-1206|KimD@hss.edu|
20203917|NCT01254396|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203918|NCT01461863|Dartmouth-Hitchcock|Dr. Charles Fordham von Reyn|6036505000|fvr@dartmouth.edu|8840
20203919|NCT01555463|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20203920|NCT04333433|Santen, Inc.|Edith van Dijkman|+31683667357|edith.vandijkman@santen.com|
20203921|NCT02026271|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20188885|NCT02029235|Penn State Health Milton S. Hershey Medical Center|Alexander Payatakes, MD|717-531-4805|apayatakes@pennstatehealth.psu.edu|
20188886|NCT02107261|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|2122418748|david.simpson@mssm.edu|
20188887|NCT02431273|Auritec Pharmaceuticals|Sarjan Shah|909-210-9715|sshah@auritecpharma.com|
20188888|NCT00645359|University of Michigan Comprehensive Cancer Center|Dr. Daniel Lebovic, M.D.|734-936-5310|dlebovic@umich.edu|
20188889|NCT02408887|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@mail.nih.gov|
20188890|NCT03333109|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20188891|NCT04088227|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
20188892|NCT05120856|Monash University|Dr Joshua B. B. Garfield|+61 3 8413 8711|joshuag@turningpoint.org.au|
20188893|NCT03160885|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
20188894|NCT05786612|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|004549112057|dkmhla@coloplast.com|
20218794|NCT03584724|Eye Pharma|Elena Meloni|7862187339|elena.meloni@eyepharma.com|
20218795|NCT04988152|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20188895|NCT05890794|AM-Pharma|AM-Pharma Office|31 (0)30 228 92 22|office@am-pharma.com|
20188896|NCT04538352|The Cleveland Clinic Foundation|Research Administrator|(216) 445-4791|jenkink@ccf.org|
20188897|NCT03905694|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20188898|NCT05485805|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20188899|NCT00490139|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20188900|NCT00872729|Horizon Orphan LLC|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
20188901|NCT03664804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20188902|NCT05529992|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20188903|NCT06140290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188904|NCT03301467|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
20188905|NCT05250115|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188906|NCT03758638|Washington University in St. Louis|Rachel Tabak|3149350153|rtabak@wustl.edu|
20188907|NCT01314118|Janssen Services, LLC|Strategic Lead Oncology Tas||ClinicalTrialDisclosure@its.jnj.com|
20188908|NCT01083732|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20188909|NCT00790569|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.ed|
20188910|NCT03244800|MedImmune Limited|Victoria Parker|+44 747 1357152|information.center@astrazeneca.com|
20188911|NCT02941549|Afimmune|Study Director|+3532946380|info@afimmune.com|
20188912|NCT01664741|Johns Hopkins School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
20188913|NCT03451422|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20188914|NCT00918333|Mayo Clinic Cancer Center|Shaji Kumar, MD|507-284-2511|Kumar.shaji@mayo.edu|
20188915|NCT00263757|Mayo Clinic|Dr. Sean M. Caples|507-293-1031|Caples.Sean@mayo.edu|
20188916|NCT00713596|Mayo Clinic|Dr. Oren Friedman|507-538-1392||
20188917|NCT04545619|Biosense Webster, Inc.|Associate Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188918|NCT04384172|University of Michigan|Tim Bruns|734-647-8727|bruns@umich.edu|
20188919|NCT01759862|Stanford University|Paul Grimm|6507237903||
20188920|NCT03631407|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188921|NCT01437319|Johnson &Johnson Vision Care, Inc|Tawnya Wilson, OD Principal Research Optometrist|904-443-3500|TWilson@ITS.JNJ.com|1834
20188922|NCT00983294|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20188923|NCT03473743|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188924|NCT00980954|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20188925|NCT03950817|Maimonides Medical Center|Dr. Sergey Motov (Director of Emergency Medicine Research)|718-283-8693|smotov@maimo.org|
20188926|NCT04614454|Massachusetts General Hospital|Michael Levy|6177267565|mlevy11@mgh.harvard.edu|
20188927|NCT01458366|Sidney Kimmel Cancer Center at Thomas Jefferson University|Joanna Filicko-O'Hara, MD|215-503-7787|Joanna.Filicko@jefferson.edu|
20188928|NCT04647487|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20188929|NCT02787005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188930|NCT01753999|Rutgers Robert Wood Johnson Medical School|Dr. Jag Sunderram|732-235-7038|sunderja@rwjms.rutgers.edu|
20188931|NCT02392234|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20188932|NCT01387516|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
20188933|NCT02972424|Hospital for Special Surgery|Dr. Jeri W. Nieves|2126061604|nievesje@hss.edu|
20188934|NCT03170648|Dana-Farber Cancer Institute|Weidong Lu, MB, MPH, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
20188935|NCT02052440|Denver Veterans Administration Medical Center|Daniel Heppe MD|303 399 8020|daniel.heppe@ucdenver.edu|3940
20188936|NCT03509909|VA San Diego Healthcare System|Ariel J Lang|858-552-8585|ariel.lang@va.gov|5359
20188937|NCT04325828|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188938|NCT05509816|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20158626|NCT03994211|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20188939|NCT02130557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20188940|NCT04066075|University of California Los Angeles|Ava K. Bittner, OD, PhD|310-206-9566|researchatvrc@gmail.com|
20218796|NCT02005887|International Breast Cancer Study Group|Meredith M. Regan|+1 617-632-3012|mregan@jimmy.harvard.edu|
20188941|NCT00309166|GlaxoSmithKline|GSK Response Center|866-435-7343||
20188942|NCT01939288|Imperial College London|Miss Katherine Williams|020 3311 7335|k.williams@imperial.ac.uk|
20188943|NCT03224481|Queen Mary University of London|Professor Padhraig Fleming|02073777397|padhraig.fleming@qmul.ac.uk|
20188944|NCT04801420|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|0
20188945|NCT01675492|Abbott Medical Optics|Director, Clinical Operations|714-247-8628|lachelle.arredondo@abbott.com|
20188946|NCT05349838|Research Organisation (KC) Ltd|Clinical Project Manager|07376618244|WISARD@rokcservices.com|
20188947|NCT00092534|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20188948|NCT04440228|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
20188949|NCT02036970|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20188950|NCT02298842|Terumo BCT|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
20188951|NCT02986789|Masimo Corporation|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
20188952|NCT01171898|Aragon Pharmaceuticals, Inc.|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188953|NCT05802173|Technoderma Medicines|Arthur P. Bertolino MD, PhD, MBA Chief Medical Officer|+1.616.928.1145|arthur.bertolino@innovationderm.com|
20188954|NCT02932410|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188955|NCT00360269|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5215|mcraeal@musc.edu|
20188956|NCT02351791|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
20188957|NCT00048932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20188958|NCT02232737|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
20188959|NCT03849937|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588 1673|kwilliams1@kumc.edu|
20188960|NCT02200705|IceCure Medical|Clinical Trial Manager|+972-4-623-0333|ronitl@icecure-medical.com|
20188961|NCT04779177|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|6464409333|ITCIClinicalTrials@itci-inc.com|
20188962|NCT03738228|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
20188963|NCT02866942|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20188964|NCT06212752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20188965|NCT04162210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20188966|NCT01641900|Massachusetts General Hospital|Dara S. Manoach, Principal Investigator|617-724-6148|dara.manoach@mgh.harvard.edu|
20188967|NCT02568215|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20188968|NCT00371345|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20188969|NCT05579600|Butler Hospital|Sarah Arias|909-753-9444|sarias@butler.org|
20188970|NCT05896267|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20188971|NCT02463448|Beaumont Hospitals|Jennifer Giordano|248-551-3517|jennifer.geiordano@beaumont.org|
20188972|NCT01640951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20188973|NCT04949542|University of Washington (affiliate) / University of North Carolina at Chapel Hill|Dr. Benjamin Buck, Associate Professor|(919) 445-4330|buckbe@uw.edu|
20188974|NCT01536093|Seoul National University College of Medicine|Dr. Juyoung Lee|82-31-787-7301|lamb4122@snu.ac.kr|
20188975|NCT02365597|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188976|NCT02275611|University of North Carolina at Chapel Hill|Dr. Cort A. Pedersen|(919) 966-4447|Cort_Pedersen@med.unc.edu|
20188977|NCT00909324|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20188978|NCT03911271|Rigshospitalet-Glostrup|Niklas Cyril Hansen MD-PhD|+45 31433244|niklas.cyril.hansen@regionh.dk|
20188979|NCT00482911|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-435-7507|sbpso@mail.nih.gov|
20188980|NCT00390884|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20188981|NCT04622332|Sironax|Lisa Fitzgerald, Senior Director Clinical Operation|781-201-3892|Lisa.Fitzgerald@sironax.com|
20188982|NCT05966155|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20188983|NCT04122196|University of Missouri|Eliza DeFroda|573-882-4141|elddmc@health.missouri.edu|
20188984|NCT05036278|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20188985|NCT06122935|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
20188986|NCT03275168|Johns Hopkins University|Dr Maria Trent|4109552910|mtrent2@jhu.edu|
20188987|NCT01946204|Janssen Research & Development, LLC|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188988|NCT03466411|J&J Innovative Medicine|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188989|NCT04375072|The University of Arizona|Hyochol Brian Ahn|520.626.1769|hbrian@arizona.edu|
20188990|NCT02667418|Hines VA|Dr. Stuart Johnson|708--202-8387|Stuart.Johnson2@va.gov|257772
20188991|NCT03498612|University of Washington|Ajay Gopal, MD|206-606-2037|agopal@uw.edu|
20188992|NCT05440344|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20188993|NCT00274261|NICHD|Jason Woo, MD, MPH|301-496-1662|woojj@mail.nih.gov|
20188994|NCT03582475|UCLA / Department of Radiology|Sara Rodriguez|310-794-2877|SaraRodriguez@mednet.ucla.edu|
20188995|NCT02257736|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218797|NCT04771403|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
20218798|NCT01615263|Institut universitaire de cardiologie et de pneumologie de Québec, Laval University|Dr Jean S. Bussières, anesthesiologist, director of research|418 656-4870|jbuss@criucpq.ulaval.ca|
20218799|NCT02458092|US Army Medical Research Unit - Kenya|Nekoye Otsyula|254-722-239-828|notsyula@wrp-ksm.org|
20218800|NCT00621049|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20218801|NCT00686582|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20218802|NCT03323723|Rinovum Subsidiary 2, LLC.|Clinical Development Manager|7242418932|hwhitelam@rinovum.com|
20218803|NCT00899470|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20218804|NCT01144364|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218805|NCT02989168|Global Blood Therapeutics|Nick Vlahakis|16508228756|nvlahakis@gbt.com|
20218806|NCT03456960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20218807|NCT00532935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218808|NCT01301508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218809|NCT01300923|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
20218810|NCT03329079|University of Nebraska Medical Center|Kevin Kupzyk|402-552-7262|kkupzyk@unmc.edu|
20218811|NCT01940497|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218812|NCT02707861|TaiMed Biologics USA Corp.|Manager - Clinical Operations|713-478-2927|bbell@taimedbio.com|
20218813|NCT03123861|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
20218814|NCT02494102|Penn State Health Milton S. Hershey Medical Center|Zyad J. Carr, M.D., FASA|717-531-8521|zcarr@pennstatehealth.psu.edu|
20218815|NCT03554603|Memorial University|Peter Daley MD MSc|7097772089|pkd336@mun.ca|
20158627|NCT02625220|Johnson & Johnson Vision Care Inc.|Benjamin Straker, BAppSc(Optom)(HonS) Principal Research Optometrist|904-443-3500|Bstraker@ITS.JNJ.com|1380
20158628|NCT01140867|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
20158629|NCT01926444|PCC INC.|Patrick Colin|514-586 9297|PCOLIN@VIDEOTRON.CA|
20158630|NCT02100930|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
20158631|NCT03506412|Mayo Clinic|Naveen L. Pereira, M.D.|507-284-8612|Pereira.Naveen@mayo.edu|
20158632|NCT03035864|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20158633|NCT02720523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20158634|NCT02340169|Taro Pharmaceuticals|Senior Director, Clinical Research|+1 914-345-9001|natalie.yantovskiy@taro.com|
20158635|NCT00480740|Children's National Medical Center|Dr. Julia Finkel|202-476-4867|jfinkel@childrensnational.org|
20158636|NCT00577707|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
20158637|NCT03299244|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20158638|NCT03146663|NuCana Plc|Medical and Scientific Affairs Department|01313571116|info@nucana.com|
20158639|NCT00980460|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20158640|NCT00283803|University of Washington|Dr. Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
20158641|NCT01127607|Florida International University|Dr. James Waxmonsky|717 531 8646|jwaxmons@fiu.edu|
20218816|NCT00448136|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218817|NCT02287493|University Medical Center Hamburg-Eppendorf|Dr. Christina König|+49 040 7410 -0|ch.koenig@uke.de|
20218818|NCT03407430|University of North Carolina Medical Center|Dr. Benyam Muluneh|919-966-3213|benyam.muluneh@unchealth.unc.edu|
20158642|NCT02052661|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158643|NCT00662831|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158644|NCT00294671|Amyloidosis Center, Boston Medical Center|Dr. John L. Berk|617-638-4494|jberk@bu.edu|
20158645|NCT01734785|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20188996|NCT03431350|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20188997|NCT03414684|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20188998|NCT02078648|Stemline Therapeutics, Inc.|Clinical Development & Medical Affairs - Solid Tumors|1-973-775-2845|clinicaltrials@menarinistemline.com|
20188999|NCT05379270|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
20189000|NCT01713660|AMO|Carrie Garufis|7145663728|carrie.garufis@amo.abbott.com|
20189001|NCT05579730|Bausch & Lomb|Daniel Donatello|585-338-5306|Daniel.Donatello@bausch.com|
20189002|NCT04306367|Lombardi Comprehensive Cancer Center|Aiwu Ruth He, MD|202-444-2223|Aiwu.R.He@gunet.georgetown.edu|
20189003|NCT03044158|University of California Irvine|Adithya Cattamanchi|714-456-2959|Adithya.Cattamanchi@uci.edu|
20189004|NCT02401815|Cogent Biosciences, Inc.|VP, Head of Clinical Development Operations|617-945-5576|clinops@cogentbio.com|
20189005|NCT00748709|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189006|NCT04660721|Sealantium Medical Ltd.|Prof. Orgad Laub, Chief Executive Officer|+972 0544434387|orgad@sealantium-med.com|
20189007|NCT05483517|Tri-service general hospital|Lai Chia-Ying|87923311|pokerface165@gmail.com|18792
20189008|NCT02751528|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20189009|NCT04218357|Brown University|Carolina Haass-Koffler, PharmD, PhD|4155191385|carolina_haass-koffler@brown.edu|
20189010|NCT04640974|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20189011|NCT04484623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20189012|NCT04257994|St George's, University of London|Dr Angeliki Asimaki|+447484764641|aasimaki@sgul.ac.uk|
20189013|NCT05246709|Columbia University|Seon Mi Jeong|646-317-5238|smj9007@nyp.org|
20218819|NCT03218163|SKCCC|Dr. Philip Imus|4109558873|pimus1@jhmi.edu|
20203922|NCT02275026|Icahn School of Medicine at Mount Sinai|Dr. Joshua Mincer|(917) 922-9475|joshua.mincer@mountsinai.org|
20203923|NCT01585129|WashingtonU|Dr. Anthony Shanks|3179448182|ashanks@iupui.edu|
20203924|NCT00374907|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20203925|NCT01108809|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203926|NCT03395340|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
20203927|NCT01293396|Medical University of Graz|Dr. Norbert Tripolt|0316385|norbert.tripolt@medunigraz.at|78038
20203928|NCT02213198|UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
20203929|NCT03283163|VA Boston Healthcare System|Erica R. Checko (Scioli), PhD|857-364-5696|ericarose.scioli@va.gov|
20203930|NCT04238663|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
20203931|NCT00968253|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20203932|NCT03017924|Cincinnati Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
20203933|NCT03987620|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
20203934|NCT02149836|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
20203935|NCT03860844|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20203936|NCT01128972|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203937|NCT04624932|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
20203938|NCT01678807|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203939|NCT02429427|Imperial College London|Prof Charles Coombes|+44 20 7594 2135|c.coombes@imperial.ac.uk|
20203940|NCT01027910|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
20203941|NCT05306873|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20203942|NCT06787781|university of messina|Dr Fiammetta Iannuzzo|327 628 4688|fiannuzzo@unime.it|
20203943|NCT04920084|Memorial Sloan Kettering Cancer Center|Dr. Urvi Shah, MD, MS|646-608-3713|shahu@mskcc.org|
20203944|NCT01113398|Duke University Medical Center|Katherine B. Peters, MD, PhD|919-684-6173|katy.peters@duke.edu|
20203945|NCT00074412|Statistical Center for HIV/AIDS Research and Prevention|Statistical Research Associate|2066677524|cherron@fhcrc.org|
20203946|NCT02361762|Boston Children's Hospital|Dr. Susan Faja|617-919-4108|susan.faja@childrens.harvard.edu|
20203947|NCT03488472|University of Alabama at Birmingham (UAB)|Drexell Hunter Boggs, MD; Principal Investigator|(205) 934-3411|dboggs@uabmc.edu|
20203948|NCT00028002|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20203949|NCT02491437|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
20203950|NCT02094872|Yale University|Manuel Avedissian, M.D.|203-737-3669|manuel.avedissian@yale.edu|
20203951|NCT04467164|Massachusetts General Hospital, Harvard Medical School|Jill M. Goldstein|617-724-3776|jill_goldstein@hms.harvard.edu|
20203952|NCT02750813|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20203953|NCT02273752|Emory University|R. Donald Harvey, PharmD|404-778-1900|donald.harvey@emory.edu|
20203954|NCT00903032|VA ECHCS|P. Michael Ho|720-857-5115|Michael.Ho@va.gov|
20203955|NCT00750555|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
20203956|NCT03539458|Abbott Vascular Structural Heart|Reshma Rao, Principal Study Clinical Research Associate|651-756-2542|reshma.rao@abbott.com|
20203957|NCT05936385|Nemours Children's Health|Thao-Ly Phan, Associate Professor of Pediatrics|302-331-7342|tphan@nemours.org|
20203958|NCT02042404|EarLens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650 366 9000|slevy@earlenscorp.com|
20203959|NCT03100942|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20203960|NCT01429792|Hoffman-La Roche|Medical Communications|8008218590|genentech@druginfo.com|
20203961|NCT02599766|Swiss TPH|Dr. Karin Hediger|0041795197885|karin.hediger@unibas.ch|
20203962|NCT01617681|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20203963|NCT01883440|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
20203964|NCT01405313|ResMed|Director Medical Affairs|+6128841000|adamb@resmed.com.au|
20203965|NCT05100316|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20203966|NCT00879814|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203967|NCT01428063|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20203968|NCT05761444|Organon Korea Co. Ltd|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20218820|NCT00922987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218821|NCT02811263|University of California, San Francisco|Yvonne W. Wu, MD, MPH|(415) 353-2400|Yvonne.Wu@ucsf.edu|
20189014|NCT05199571|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20189015|NCT03367156|UT MD Anderson Cancer Center|Dr. David Hui- Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20189016|NCT03762850|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
20189017|NCT04803370|Son Llàtzer University Hospital|Joan Bargay Lleonart|34871202000|khaoulahelhaji@gmail.com|
20189018|NCT03002194|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20189019|NCT00442104|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
20189020|NCT00123409|Philadelphia VAMC|David Oslin|2158235894|dave.oslin@upenn.edu|
20189021|NCT04497415|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
20189022|NCT03021993|Medical University of South Carolina|Alan Brisendine, Sponsor-Investigator Support Unit Manager|843-792-9007|brisend@musc.edu|
20189023|NCT00756574|McMaster University|Dr. Mark Loeb|905-525-9140|loebm@mcmaster.ca|26066
20203969|NCT03508622|Children's Hospital Los Angeles|Brenda Manzanarez|323/361-8245|bmanzanarez@chla.usc.edu|
20203970|NCT01005719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20203971|NCT02499146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203972|NCT03161678|University of Maryland, School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
20203973|NCT00752609|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20203974|NCT05114590|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20203975|NCT03347617|Oregon Health and Science University|Amy Huddleston|5034942910|huddlesa@ohsu.edu|
20203976|NCT01425190|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203977|NCT04111276|University of Tennessee|Dr. Michael LaCour|865-974-7684|mlacour@utk.edu|
20203978|NCT01035255|Novartis Pharmaceuticals|Study Director|862-778-8300||
20203979|NCT00584220|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
20203980|NCT00195260|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218822|NCT04969861|Nektar Therapeutics|Study Director|415-482-5300|StudyInquiry@nektar.com|
20203981|NCT01379534|Novartis|Study Director|862-778-8300||
20203982|NCT00829166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20203983|NCT04072237|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
20203984|NCT04985773|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
20203985|NCT02582749|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
20203986|NCT00878072|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20203987|NCT01704781|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
20203988|NCT02379923|Asahi Intecc USA, Inc.|Robert Ricker|408.429.3749|robertr@asahi-intecc.com|
20203989|NCT00872170|New England Research Institutes|Nancy Gee|617-972-3295|ngee@neriscience.com|
20203990|NCT04415489|University of North Carolina at Chapel Hill|Sarah Moustafa, MD|919-908-0000|sarah_moustafa@med.unc.edu|
20203991|NCT00719732|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20218823|NCT04905290|Medtronic|James Burrell, Senior Statistician|18006338766|burrej3@medtronic.com|
20203992|NCT03300752|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
20203993|NCT05113953|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20203994|NCT02626819|Manhattan Campus of the VA NY Harbor Healthcare System|Melanie Jay, MD MS|212-686-7500|melanie.jay@va.gov|5097
20203995|NCT00502307|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20203996|NCT00539253|Johns Hopkins Hospital|Ihab R. Kamel, M.D. PhD|410-955-4567|ikamel@jhmi.edu|
20203997|NCT01998581|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20203998|NCT00255684|Wake Forest|Gordon L. Phillips|604.875.4111|gophilli@wakehealth.edu|67806
20203999|NCT01380106|Boston VA Research Institute, Inc.|Nikhil C. Munshi, M.D.|6176325607|nikhil.munshi@dfci.harvard.edu|
20204000|NCT04346628|Stanford University|Yvonne A. Maldonado, MD|(650) 723-5682|bonniem@stanford.edu|
20204001|NCT01763905|Amgen Inc.|Study Director|866-572-6436||
20204002|NCT01597557|University at Buffalo|Dr. Anne Curtis|716-859-4828|abcurtis@buffalo.edu|
20204003|NCT04149899|Bausch & Lomb Incorporated|Clinical Development|949-416-1194|kevin.kerr@bausch.com|
20204004|NCT03161938|Rigshospitalet|Kristin steinthorsdottir|31666112|kjs@dadlnet.dk|
20204005|NCT02078882|University of California Davis|Christopher L Bowlus|9167348696|clbowlus@ucdavis.edu|
20204006|NCT03165721|National Cancer Institute|Dr. John Glod|240-760-6194|john.glod@nih.gov|
20218824|NCT03295318|Serum Institute of India Pvt. Ltd.|Abhijeet Dharmadhikari|+91-20-26602855|abhijeet.dharmadhikari@seruminstitute.com|2855
20204007|NCT01863849|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
20204008|NCT01457118|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
20204009|NCT02324842|University of Texas Health San Antonio|Eugenio Cersosimo, MD|210-358-7220|cersosimo@uthscsa.edu|
20204010|NCT03540134|University of Virginia|Dr. Jeff Elias|(434) 924-0451|FUSbrain@virginia.edu|
20204011|NCT04341675|University of Cincinnati|Nishant Gupta, MD|513-558-4861|Nishant.Gupta@uc.edu|
20204012|NCT02750800|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20204013|NCT03226223|New York State Psychiatric Institute|Dr. Jermaine Jones|6467746113|jermaine.jones@nyspi.columbia.edu|
20204014|NCT03456713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20204015|NCT01263691|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
20204016|NCT02012608|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
20204017|NCT01202227|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204018|NCT00643487|Upstate Medical University|Thomas V. Smallman|315-464-8618|smallmat@me.com|
20204019|NCT02251704|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20218825|NCT03747601|BIDMC|Daniel Press, MD Chief of Cognitive Neurology Unit|617-667-4074|dpress@bidmc.harvard.edu|
20218826|NCT02788045|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20204020|NCT00630812|Pharmaxis|Brett Charlton|02 94547210|Brett.Charlton@pharmaxis.com.au|
20204021|NCT04889144|Fred Hutchinson Cancer Center|Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
20204022|NCT03430245|Candela Corporation|Director of Clinical Marketing|+1 949.246.7983|doranr@candelamedical.com|
20204023|NCT05628181|University of Michigan|Donovan Maust|734-845-3649|maustd@med.umich.edu|
20204024|NCT04102098|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20158646|NCT02476032|University of Minnesota|Patricia Lenton Director of Oral Health Research Clinic||lento001@umn.edu|
20158647|NCT01308814|University of North Carolina at Chapel Hill|Susan S. Girdler, Ph.D.|919-966-2179|susan_girdler@med.unc.edu|
20158648|NCT01961297|Icahn School of Medicine at Mount Sinai|Dr. Kristina Simonyan|212-241-0656|kristina.simonyan@mssm.edu|
20189024|NCT03304639|University of Pittsburgh Medical Center|Dr. Jason Luke|412-647-2811|lukejj@upmc.edu|
20189025|NCT03516812|University of Washington|Michael Schweizer|206-606-6252|schweize@uw.edu|
20189026|NCT04795167|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
20189027|NCT03660618|University of Iowa Healthcare|Dr. Randy Kardon|319-356-8299|randy-karon@uiowa.edu|
20189028|NCT02313675|University of Pittsbur|John R Fowler, MD|412-605-3245|fowlerjr@upmc.edu|
20189029|NCT03683576|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|Gossamer Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
20189030|NCT02940249|King's College London|Dr Wendy Hall|020 7836 5454|wendy.hall@kcl.ac.uk|
20189031|NCT02628626|Mayo Clinic|Dr. Adil Bharucha|507-284-2687|bharucha.adil@mayo.edu|
20189032|NCT02744066|Magee Womens, UPMC Hamot Hospital|Dr. Michael J. Balsan|814-877-3190|balsanmj@upmc.edu|
20189033|NCT05628103|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
20189034|NCT02990858|CytoDyn|Vice President, Clinical Operations|36009808524|jmeidling@cytodyn.com|
20189035|NCT03492177|Actelion Pharmaceuticals Ltd|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189036|NCT02499328|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20189037|NCT05051982|Indiana University School of Medicine (Dept of Anesthesia)|Dr. Timothy Webb|2196893636|ttwebb@iu.edu|
20189038|NCT01400958|H. Lee Moffitt Cancer Center and Research Institute|Peter A. Forsyth, M.D.|813-745-3063|peter.forsyth@moffitt.org|
20189039|NCT03102034|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20189040|NCT02788019|UT Southwestern Medical Center|Anthony Machi, MD, Assistant Professor|214-648-6400|Anthony.Machi@UTSouthwestern.edu|
20189041|NCT06571058|The Ohio State University Comprehensive Cancer Center|Karen Meade|614-366-5060|Karen.Meade@osumc.edu|
20189042|NCT05663866|Janssen Research & Development LLC|Senior Medical Director Global Medical Affair Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189043|NCT00258830|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20189044|NCT03598907|Department of anesthesiology and intensive care medicine, Charles University and Motol Hospital|prof. Miroslav Durila|+420224435440|miroslav.durila@fnmotol.cz|
20189045|NCT05741528|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|clinicaltransparency@otsuka-us.com|
20189046|NCT00972621|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head, Clinical Research & Development|714-247-8613|kendra.hileman@abbott.com|
20189047|NCT03656718|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20189048|NCT05637970|UCLA|David Tehrani|8583360666|davidmtehrani@gmail.com|
20189049|NCT00489307|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20189050|NCT02307682|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
20158649|NCT02482298|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 10 00||
20189051|NCT05162261|Novoxel Ltd|Dr. Ifat Klein|+972-52-6009860|ifat@novoxel.com|
20189052|NCT02517268|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Harish Lavu|215-955-6888|Harish.Lavu@jefferson.edu|
20189053|NCT04686266|University of Pennsylvania|Lauren Massimo, PhD, CRNP|215-349-5863|lmassimo@upenn.edu|
20189054|NCT03436992|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
20189055|NCT03227861|Janssen Scientific Affairs, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189056|NCT05075395|University of Nebraska Medical Center|Breanna Hetland|402-559-5460|breanna.hetland@unmc.edu|
20189057|NCT05071430|HB Biotech|Tomer Seifan|917-685-7351|tomer.seifan@hbbio.com|
20189058|NCT01958021|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20189059|NCT05810285|Permedicaspa|Lorenzo Banci, study coordinator - clinical affairs|0399514811|lorenzo.banci@permedica.it|
20189060|NCT04649047|Ohio State University College of Nursing|Dr. Mei-Wei Chang|614-247-7211|chang.1572@osu.edu|
20189061|NCT02488408|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
20189062|NCT05037513|University of Kentucky|Dr. Hilary Surratt|8595622458|hilary.surratt@uky.edu|
20189063|NCT05886777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189064|NCT03773107|Levine Cancer Institute|Jim Symanowski, PhD|9804422371|james.symanowski@atriumhealth.org|
20189065|NCT00984815|Horizon Pharma|Amy Y. Grahn, MS|224-383-3012|agrahn@horizonpharma.com|
20189066|NCT05961995|The Ohio State University Hospital|Dr. Thangam Venkatesan|614-293-6255|thangam.venkatesan@osumc.edu|
20189067|NCT07204444|University of Florida|Laura R. Shannonhouse, PhD|352-273-4332|lshannonhouse@coe.ufl.edu|
20189068|NCT02386098|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20189069|NCT02677766|University of Modena and Reggio Emilia|Stefania Costi|+390522522441|stefania.costi@unimore.it|
20189070|NCT01727167|Duke University Medical Center|John J. Freiberger, M.D.|919-684-6726|john.freiberger@duke.edu|
20189071|NCT04083976|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189072|NCT03284359|University of Pennsylvania|Dr. Katherine Courtright|267-978-5083|Katherine.Courtright@pennmedicine.upenn.edu|
20189073|NCT00808834|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20189074|NCT04612868|AEYE Health Inc.|Zack Dvey-Aharon, PhD|8662627343|info@aeyehealth.com|
20189075|NCT00512252|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-454-8304|guy@dom.wustl.edu|
20189076|NCT02357966|XBiotech USA, Inc.|Haritha Pallapotu|512-386-2992|hpallapotu@xbiotech.com|
20218827|NCT05140954|Departments of Global Health and Epidemiology, University of Washington|Kenneth K. Mugwanya, MBChB, MS, PhD|+1 206 520-3800|mugwanya@uw.edu|
20218828|NCT01288053|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
20218829|NCT03188666|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20218830|NCT00144781|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20218831|NCT02068092|Houston Methodist Neal Cancer Center|Jenny Chang|713.790.3333|ccresearch@houstonmethodist.org|
20218832|NCT03696953|Marquette University, College of Nursing|Dr. Lisa Hanson|1-414-288-3841|lisa.hanson@marquette.edu|
20218833|NCT03502707|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218834|NCT00461253|Center for Epidemiology and Health Research, Germany|Dr. Jürgen Dinger|0049 (0) 30 945 101 20|dinger@zeg-berlin.de|
20218835|NCT06262191|Northern Arizona University|PI|928-523-1787|zachary.lerner@nau.edu|
20218836|NCT00541970|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218837|NCT00062010|ECOG Statistical Office|Study Statistician|617-632-3012||
20218838|NCT03758404|MeiraGTx|Program Manager|020 3866 4320|CNGA3@meiragtx.com|
20218839|NCT01687478|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20218840|NCT00292188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20218841|NCT00577395|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20218842|NCT01206101|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20218843|NCT00569530|University of California, San Francisco|Roberta R. Keller, MD|415-514-3192|roberta.keller@ucsf.edu|
20218844|NCT04709835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20218845|NCT01859130|Zimmer Biomet|Clinical Research Specialist|5745497606|tim.swanson@zimmerbiomet.com|
20189077|NCT01779700|Indiana University|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
20189078|NCT01410409|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
20189079|NCT01026805|Interlace Medical, Inc.|John Vozella, V.P. Clinical & Regulatory Affairs|508-875-1343|john@interlacemedical.com|112
20189080|NCT04608409|University of Kentucky|Dr. Frederick Ueland|859-257-1613|frederick.ueland@uky.edu|
20189081|NCT02683174|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
20189082|NCT01082575|Covidien|Fran Haury Clinical Program Manager II|303 305-2314|fran.haury@covidien.com|
20189083|NCT00683800|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189084|NCT04941703|University of Maryland School of Medicine|Wonder Drake|410-710-1412|WDrake@som.umaryland.edu|
20189085|NCT03041233|Abbott|Clinical Scientist|7639541350|emily.jesser@abbott.com|
20189086|NCT04230941|University of Rochester|Allison Magnuson, (Principal Investigator), Associate Professor of Medicine|585-276-7155|allison_magnuson@urmc.rochester.edu|
20189087|NCT02867059|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
20189088|NCT00291694|University of Kansas Medical Center|Dr. Carol Fabian|913-588-3666|cfabian@kumc.edu|
20189089|NCT00853606|Vivus, Inc|Wesley W Day PhD|650-934-5200||
20189090|NCT01273610|City of Hope|Dr. Daneng Li|626-359-8111|danli@coh.org|
20189091|NCT04960813|Columbia University|Kate D. Fitzgerald|646-774-5681|kf2688@cumc.columbia.edu|
20189092|NCT04041219|Mayo Clinic|Heather P. May, Pharm.D.|507-266-7405|May.Heather@mayo.edu|
20189093|NCT01588951|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Margaret Showel, MD|410-614-0675|mshowel1@jhmi.edu|
20189094|NCT01593020|UT MD Anderson Cancer Center|Dr. Valero Vicente, Professor, Breast Medical Oncology|(713) 563-0751|vvalero@mdanderson.org|
20189095|NCT02350634|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|AVD_Clinical_Ops@lists.lilly.com|
20189096|NCT04205487|Florida International University|Adam W. Carrico, PhD|305-348-7887|acarrico@fiu.edu|
20189097|NCT04241848|James J. Peters VA Medical Center, Spinal Cord Damage Research Center|Dr. Ann Spungen|(718) 584-9000|Ann.Spungen@va.gov|5814
20189098|NCT04144868|Affiliated Hospital of Jiujiang University|Zhiying Chen|+86 13767263459|zychenjj@jju.edu.cn|
20189099|NCT01732120|Washington University School of Medicine|Manager of Clinical Trials|3147479781|klima@wustl.edu|
20189100|NCT02766517|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20189101|NCT02972359|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
20189102|NCT02063659|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
20189103|NCT00914966|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20189104|NCT03488719|Saniona A/S|Janus Schreiber Larsen|+45 7070 5225|janus.larsen@saniona.com|
20189105|NCT04724759|Massachusetts General Hospital|Jingping Wang - Principal Investigator|617-643-2729|jwang23@mgh.harvard.edu|
20189106|NCT03477175|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20189107|NCT03371017|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20189108|NCT01855750|Janssen Research & Development, LLC|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189109|NCT04300023|University of Wisconsin - Madison|Kristen Pickett, PhD|(608) 890-2103|Kristen.pickett@wisc.edu|
20189110|NCT05525572|University of Miami, Miller School of Medicine|Thomas A Masterson, III|(305) 243 - 6260|TMasterson@med.miami.edu|
20218846|NCT00903448|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
20218847|NCT03426137|University of Maryland School of Nursing|Research Coordinator|410-706-5975|NRSCollocaLab@umaryland.edu|
20218848|NCT00103311|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20218849|NCT03827564|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20189111|NCT05116163|Brigham and Women's Hospital|Dr. Candace Feldman|617-525-1035|chfeldman@partners.org|
20218850|NCT00270257|Fred Hutchinson Cancer Research Center|Senior Statistical Analyst|206-667-6167|geetha@scharp.org|
20189112|NCT05025384|Vanderbilt University Medical Center|Krista Vermillion|615-875-1921|krista.k.vermillion@vumc.org|
20189113|NCT03425682|Aziyo Biologics, Inc.|Associate Director, Clinical Operations|678-492-4712|srichardson@aziyo.com|
20189114|NCT03610581|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189115|NCT00085982|NIDDK|Rebecca Brown, MD|301-594-0609|brownrebecca@mail.nih.gov|
20189116|NCT05256797|Brigham and Women's Hospital|Shirley Wang|617-525-8376|swang1@bwh.harvard.edu|
20189117|NCT05470114|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20189118|NCT00719888|Fred Hutchinson Cancer Center|Dr. Ann Dahlberg|206-667-1959|adahlber@fredhutch.org|
20218851|NCT01195103|Mayo Clinic|John B Leslie MD|480-301-8000|leslie.john@mayo.edu|
20189119|NCT04577651|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20189120|NCT03861052|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20189121|NCT03376659|Georgetown University|Benjamin Weinberg, MD|202-444-2223|benjamin.a.weinberg@gunet.georgetown.edu|
20189122|NCT00705406|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
20189123|NCT02927249|Dana Farber Cancer Institute|Wendy Chen|617-632-3800|Wendy_chen@dfci.harvard.edu|
20189124|NCT03712371|Medical University of South Carolina, Hollings Cancer Center, Clinical Trials|Alan Brisendine, CCRP, Manager, Sponsor-Investigator Support Unit|843-792-9007|brisend@musc.edu|
20189125|NCT02723929|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
20189126|NCT02362035|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20189127|NCT05462912|UC Davis Orthopaedic Surgery|Eric Giza, MD|916-734-6805|egiza@ucdavis.edu|
20189128|NCT04566861|Johns Hopkins Bloomberg School of Public Health|Dr. Pamela Surkan|4105027396|psurkan@jhu.edu|
20189129|NCT00504023|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@mskcc.org|
20189130|NCT02639637|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153644022|nancy.j.brown@vanderbilt.edu|
20189131|NCT00229658|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20189132|NCT02157116|Duke University|Richard Riedel, MD|919-681-6932|richard.riedel@duke.edu|
20189133|NCT00975585|Vistakon|Sheila Hickson-Curran, MCOptom/ Director, Medical Affairs|904-443-1754||
20189134|NCT01953224|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
20189135|NCT04053270|CLINUVEL PHARMACEUTICAL LIMITED|Dr. Dennis Wright|+ 61 3 9660 4900|mail@clinuvel.com|
20189136|NCT00205179|University of Wisconsin|Dr. Carey Gleason|608-280-7000|ceg@medicine.wisc.edu|
20189137|NCT00463229|McMaster University|Maureen Markle-Reid|905-525-9140|mreid@mcmaster.ca|22306
20189138|NCT00455650|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
20189139|NCT01767467|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189140|NCT01359150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189141|NCT01085513|Given Imaging|director of clinical affairs|+972-4-9097774|Hila.debby@givenimaging.com|
20189142|NCT01787032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189143|NCT02040870|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20189144|NCT04971733|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20189145|NCT04033315|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
20189146|NCT03552276|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20189147|NCT03502447|Sight Sciences, Inc.|VP Medical & Clinical Affairs|877-266-1144|info@sightsciences.com|
20189148|NCT02406092|Hoffman-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20189149|NCT05783843|Wake Forest University School of Medicine|Erin L. Sutfin, PhD|336-713-5282|esutfin@wakehealth.edu|
20189150|NCT00853593|Medtronic, Inc|4396 Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62808
20189151|NCT03890289|"Policlinico S.Orsola-Malpighi - Istituto di Ematologia Seragnoli"|Lisa Argnani|051 214 3827|lisa.argnani@unibo.it|
20189152|NCT02816398|Avenu Medical - Sponsor|Gene Reu|949 276 2483|greu@avenumedical.com|102
20189153|NCT03362190|IVERIC bio, Inc|Hersh Patel, OD / Zimura Medical Director|609-474-6755|clinicaltrials@ivericbio.com|
20189154|NCT00687219|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20189155|NCT04816955|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
20189156|NCT02707198|Whiteside Institute for Clinical Research/St. Luke's Hospital Duluth|Lynsie Radovich, PhD|216-726-7940|lradovic@d.umn.edu|
20189157|NCT01367236|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
20189158|NCT02235298|University of Miami|Gianluca Iacobellis, MD|305-243-3636|giacobellis@miami.edu|
20189159|NCT01595282|PPLM|Principal Investigator|617-616-1600||
20189160|NCT02227706|ETHICON Inc|Patricia Schleckser|9082182244|pschleck@its.jnj.com|
20189161|NCT02823028|University of California Irvine|Professor Cornelia Pechmann|3108920619|cpechman@uci.edu|
20189162|NCT06211530|GE HealthCare|Principal Engineer|+358 (40) 7755194|100012917@gehealthcare.com|
20189163|NCT05807074|University of California, San Francisco|Dr. Merisa Piper, MD|(415) 353-4320|Merisa.Piper@ucsf.edu|
20189164|NCT05785832|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|18583666900|clinicalaffairs@tandemdiabetes.com|
20189165|NCT04038580|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
20189166|NCT05251363|BIOTRONIK, Inc.|Crystal Miller|(503) 475-4984|crystal.miller@biotronik.com|
20189167|NCT04202133|University of Pennsylvanai|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
20189168|NCT04837937|Northwestern University- Feinberg School of Medicine- Division of Geriatrics|Vanessa Ramirez-Zohfeld|+1 312 503 3916|vanessa-ramirez-0@northwestern.edu|
20189169|NCT02328014|Acerta Pharma|Global Clinical Lead|1-877-240-9497|information.center@astrazeneca.com|
20189170|NCT01354444|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
20218852|NCT02621034|Zahedan university of medical sciences|Seyed Roholla Havaei|+989215257093|marty_zl@yahoo.com|
20204025|NCT00610727|Alexza Pharmaceuticals, Inc.|Dave Hasegawa, VP, Device Development|650.947.7031|dhasegawa@alexza.com|
20204026|NCT04742907|Tsumura USA, Inc.|Yu Tanaka, Ph.D., MBA|609-799-2083|Tanaka_yuu@mail.tsumura.co.jp|
20204027|NCT03993691|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20204028|NCT00850759|UAB|David Schwebel|205-934-8745|schwebel@uab.edu|
20204029|NCT03196505|University of California-San Francisco Fresno|Dr. Pearl Ma|5592614500|pma@fresno.ucsf.edu|
20204030|NCT01753076|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204031|NCT02389816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20204032|NCT00300469|Abbott|Medical Information Specialist|800-633-9110||
20204033|NCT01259856|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|212-241-2296|ronald.hoffman@mssm.edu|
20204034|NCT00788775|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20204035|NCT00578864|BAYLOR|Peter Zage, MD|832-824-4615|pezage@txch.org|
20204036|NCT03796091|Green Counseling Services PLLC|Dr. Melinda Green|5154508913|drgreen@greencounselingservice.com|
20204037|NCT01217190|Par Pharmaceutical|Medical Affairs|1-800-828-9393|DrugInfo@strativapharma.com|
20204038|NCT01594476|Oregon Health & Science University|Dr. Maureen Baldwin, MD MPH|(503) 494-9762|schaum@ohsu.edu|
20204039|NCT00938327|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204040|NCT05309369|Medical University of South Carolina|Professor|843 367 4260|mintzerj@musc.edu|
20204041|NCT03007953|Department of Veterans Affairs|Dr. Lynn F. Reinke|206-277-4186|Lynn.Reinke1@va.gov|
20204042|NCT00923910|National Cancer Institute|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
20204043|NCT00418262|University of Oklahoma Health Sciences Center|Mark Wolraich, M.D.|(405) 271-5700|mark-wolraich@ouhsc.edu|45123
20204044|NCT01635933|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20204045|NCT01544595|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20204046|NCT04525222|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
20204047|NCT00601523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20204048|NCT00804193|Perrigo|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
20204049|NCT04072146|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20204050|NCT01617434|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20204051|NCT01193348|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|clinicaltrials@alxn.com|clinicaltrials@alxn.com|
20204052|NCT01721408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204053|NCT04160468|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
20204054|NCT01187901|University of Utah|N. Jewel Samadder|801-213-4211|jewel.samadder@hsc.utah.edu|
20204055|NCT01402284|National Cancer Institute|Dr. Dickran Kazandijian|301-480-8870|kazandijiandg@mail.nih.gov|
20204056|NCT02928406|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20204057|NCT00540436|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218853|NCT02920918|Virginia Commonwealth University|Salvatore Carbone|804 628 3980|scarbone@vcu.edu|
20204058|NCT03302416|Univesity of Pittsburgh|Rajesh Narendran|412-647-5176|narendranr@upmc.edu|
20204059|NCT01745393|Temple University|Bradley Collins|215-204-2849|collinsb@temple.edu|
20204060|NCT01613014|NIAAA|Megan Ryan, Clinical Program Director|3014434225|mryan1@mail.nih.gov|
20204061|NCT05319535|Durham VA Medical Center|Courtney H Van Houtven, PhD|919-286-6936|courtney.vanhoutven@va.gov|
20204062|NCT00905021|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
20204063|NCT00786838|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Senior Medical Director|1 908 704-5779||
20204064|NCT00390364|Sidney Kimmel Comprehensive Cancer Center at JHMI|Manuel Hidalgo, MD (no longer works at Hopkins)|410-502-5328|tbrown55@jhmi.edu|
20204065|NCT02488759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20204066|NCT04038255|University of Miami|Dr. Taghrid Asfar|+1 (901)-371-7229|tasfar@miami.edu|
20204067|NCT05183867|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
20204068|NCT00924352|Vector Oncology (formerly Accelerated Community Oncology Research Network, Inc.)|Vice President of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
20204069|NCT00418834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20204070|NCT01953328|Amgen Inc.|Study Director|866-572-6436||
20204071|NCT02775760|Boston University Chobanian & Avedisian School of Medicine|Karin Schon, Ph.D.|(617) 358-2118|kschon@bu.edu|
20204072|NCT01760941|Virginia Commonwealth University/Massey Cancer Center|Drew Moghanaki, MD, MPH|804-765-5850|Drew.moghanaki@vcuhealth.org|
20204073|NCT00492856|SWOG Statistical Center|SWOG Leukemia Committee Statistician|206-667-4408||
20204074|NCT01915108|assistant professor|Dr. Sangjin Park|82-53-620-3366|apsj0718@naver.com|
20204075|NCT00751530|Community Research Initiative|Project Manager|617 502 1700|pmacht@crine.org|
20204076|NCT01487668|Department of Veterans Affairs, VA Ann Arbor Healthcare System|Amy M. Kilbourne, PhD, MPH|734-845-3452|amy.kilbourne@va.gov|
20204077|NCT03000309|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20204078|NCT04426825|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20204079|NCT02145299|Yale School of Medicine|Dr. Alexandra Lansky|203-737-2142|alexandra.lansky@yale.edu|
20204080|NCT00458406|CTRC, Children's Hospital of Philadelphia|Paul R. Gallagher, MA|215-590-2739|gallagherp@email.chop.edu|
20204081|NCT02424955|Stanford University|Lucas Kas Vitzthum|(650) 498-6000|ccto-website@stanford.edu|
20204082|NCT06150573|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20204083|NCT01071044|Rochester Center for Behavioral Medicine|Joel L. Young, MD|248-608-8800|jyoung@rcbm.net|261
20189171|NCT00093496|Mayo Clinic Cancer Center|Charles Erlichman, M.D.||erlichman.charles@mayo.edu|
20189172|NCT01932970|Amgen Inc.|Study Director|866-572-6436||
20189173|NCT00853580|The University of Alabama at Birmingham|Bruce R. Korf|205.934.9411|bkorf@uabmc.edu|
20189174|NCT01700205|Monell Chemical Senses Center|Julia A. Mennella, PhD|267-519-4880|mennella@monell.org|
20189175|NCT01728324|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189176|NCT00748982|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20189177|NCT03113409|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
20189178|NCT03578965|Washington University School of Medicine|Mary M. Mullen, M.D.|314-655-8750|marymullen@wustl.edu|
20189179|NCT02483468|Ralph H. Johnson VA Medical Center, Charleston, SC & Medical University of South Carolina|Jeffrey J Borckardt, PhD|843.792.3295|borckard@musc.edu|
20189180|NCT03335488|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
20189181|NCT00388726|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20189182|NCT03849066|University of Colorado Denver|James Feinstein, MD, MPH, Principal Investigator|303-724-4186|james.feinstein@cuanschutz.edu|
20189183|NCT00600353|University of Kansas Medical Center|Dr. Omar Aljitawi|913-588-6029|oaljitawi@kumc.edu|
20204084|NCT02534805|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
20204085|NCT02284906|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20204086|NCT03909763|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
20204087|NCT02575079|Emory University|Elizabeth Stenger|404-785-1272|elizabeth.o'brien.stenger@emory.edu|
20204088|NCT01087528|Givenimaging|Hilla Debby/Director of clinical affairs|972490977740|hila.debby@givenimaging.com|77740
20204089|NCT00436969|DePuy Mitek|Aileen Michael|508.828.3337|amichae2@its.jnj.com|
20204090|NCT03116399|Weill Medical College of Cornell University|Sara J. Czaja, PhD|646-962-7141|sjc7004@med.cornell.edu|
20204091|NCT01226420|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
20204092|NCT03196297|Novo Nordisk A/S|Clinical Transparency and Medical Writing (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20204093|NCT02538666|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20204094|NCT04370028|OOO NPF Materia Medica Holding|Mikhail Putilovskiy, MD, PhD|+74952761575|PutilovskiyMA@materiamedica.ru|302
20204095|NCT01043523|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20204096|NCT03382899|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|www.ClinicalTrials.gov@lilly.com|
20204097|NCT01987986|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
20204098|NCT03259334|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20204099|NCT03638947|UIOWA|Randy W. Loftus|6033066475|randy-loftus@uiowa.edu|
20204100|NCT04937816|Boehringer Ingelheim, Call Center|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20204101|NCT01064648|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
20204102|NCT05281523|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20204103|NCT05513391|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20204104|NCT05513053|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20204105|NCT04491877|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20204106|NCT03538652|National Institute on Drug Abuse (NIDA)|Dr. David Epstein|667-312-5092|david.epstein@nih.gov|
20204107|NCT06018350|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
20204108|NCT01096446|OSF Saint Francis Medical Center|Dr. Kamlesh Macwan|309-624-0611|kamlesh.s.macwan@osfhealthcare.org|
20204109|NCT01520324|Cosmo Pharmaceuticals NV|Dr. Richard Jones|+353 18170370|RJones@cosmopharma.com|
20204110|NCT01328249|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
20204111|NCT00748553|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
20204112|NCT00948818|Forest Research Institute|Paul F.C. Eng Ph.D Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
20204113|NCT04253834|Emory University|Dr. Jeffrey Miller|404-252-6104|jeffrey.miller@emory.edu|
20204114|NCT01251276|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204115|NCT02245568|TauRx Therapeutics Ltd|Dr. Diane Downie|+44 1224440905|info@taurx.com|
20204116|NCT02044159|Children's Hospital of Eastern Ontario|Katie O'Hearn, Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
20204117|NCT01111539|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20204118|NCT03628417|Szeged University|Principal Investigator, Assistant Professor|+36-62-545-259|kis.erika.gabriella@med.u-szeged.hu|
20204119|NCT02713230|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-397-2467|MedInfo@pacira.com|
20204120|NCT05619172|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
20204121|NCT00812916|Biosense Webster, EMEA|Nathalie Macours|+32 2 7463076|MNathalie@its.jnj.com|
20204122|NCT00450372|UM/Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4909|lfeun@med.miami.edu|
20204123|NCT00769704|Amgen, Inc.|Study Director|866-572-6436||
20204124|NCT05131451|Johns Hopkins University|Dr. Risa Wolf|4109556463|rwolf@jhu.edu|
20204125|NCT00335504|Mayo Clinic|Dr. Paul Limburg|507-266-9093|limburg.paul@mayo.edu|
20204126|NCT01835496|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
20204127|NCT01856595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204128|NCT03848221|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20204129|NCT01894477|Fred Hutchinson Cancer Research Center|Eileen J Sickle|206-271-7066|esickle@fredhutch.org|
20204130|NCT01706549|Tampere University Hospital|MD Satu Pokkinen|+3583311611|Satu.pokkinen@pshp.fi|
20204131|NCT00681538|GW Pharma Ltd|Richard Potts, Clinical Operations Director|+44 1353 616600|rp@gwpham.com|
20204132|NCT03656926|Zambon S.p.A.|Enrica Bucchioni, M.D., PhD, Global Clinical Development Head|+39 02 665241|clinicaltrials@zambongroup.com|
20204133|NCT00069095|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20204134|NCT02869854|RegionSkane|Mr Peter Nymberg|0705759810|peter.nymberg@med.lu.se|
20204135|NCT05610176|BIOTRONIK SE & Co. KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20204136|NCT00818324|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20204137|NCT01727713|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20204138|NCT01253044|VA San Diego Healthcare System and UCSD|Dr. Ariel Lang|858-246-0631|ajlang@ucsd.edu|
20204139|NCT00987623|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20158650|NCT01685242|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20204140|NCT00962000|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20204141|NCT02702193|University of Miami|Victoria Mitrani|305 284-9139|vmitrani@miami.edu|
20204142|NCT01201798|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20204143|NCT04272216|Clinical Project Manager|Paige Gowen|908-208-3749|paige.gowen@terumomedical.com|
20204144|NCT05174039|Theranexus|Chief Medical Officer|0688941976|marie.sebille@theranexus.com|+33
20204145|NCT01734512|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD|(415) 502-7301|sabine.mueller@ucsf.edu|
20204146|NCT05692154|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20204147|NCT02154750|UC San Diego Health|Gregory Feld, MD|(858) 246-2972|gfeld@health.ucsd.edu|
20204148|NCT01912729|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20204149|NCT00904826|Mayo Clinic|Dr. Sean J. Pittock|507-284-4741|pittock.sean@mayo.edu|
20204150|NCT01429987|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20204151|NCT03860311|UAB|Dr. Stephen Ruffenach|5202707665|stephenruffenach@gmail.com|
20204152|NCT04285346|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20204153|NCT02432287|Albert Einstein College of Medicine|Erika Brutsaert|7188397961|erika.brutsaert@einstein.yu.edu|
20204154|NCT01975272|Maastricht University Medical Centre|Prof. dr. Roy Kruitwagen|0031-3874764|r.kruitwagen@mumc.nl|
20204155|NCT01125176|Weill Cornell Medical College|Richard Furman, MD|646-962-2064|rrfurman@med.cornell.edu|
20204156|NCT00850460|The Rockefeller University Center for Clinical and Translational|Principal Investigator|212 327-8408|trinnamaningatmd@yahoo.com|
20204157|NCT02773914|Göteborg University|Isabelle Andersson Hammar|+4631 786 5719|isabelle.a-h@neuro.gu.se|
20218854|NCT03537274|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204158|NCT00988559|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
20204159|NCT02224846|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20204160|NCT05372575|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204161|NCT03510663|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20204162|NCT03208192|Moscow Clinical Scientific Center|Mikhail Efanov, MD, PhD,|+79161058830|m.efanov@mknc.ru|
20204163|NCT00843622|Fagerström Consulting AB|Dr Karl Fagerström||karl.fagerstrom@swipnet.se|
20204164|NCT02615717|University of Nebraska, Lincoln|Christina Hein, M.A.|7036184722|chein9@gmail.com|
20204165|NCT03230175|TissueTech, Inc.|Nick McCoy, Vice President Clinical Operations|7867340023|nmccoy@tissuetechinc.com|
20204166|NCT02200458|Christie Medical Holdings, Inc.|Clinical Affairs Manager|901-721-0330|christiemedinfo@christiedigital.com|
20204167|NCT04743635|Revelle Aesthetics, Inc.|Rachel Walsh, Senior Manager of Clinical Affairs|6509634498|rwalsh@revelleax.com|
20204168|NCT01954121|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20204169|NCT02796924|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
20204170|NCT01465178|University of Wisconsin|Neil Binkley|608-265-6410|nbinkley@wisc.edu|
20204171|NCT01568905|University of Minnesota Tobacco Research Programs|Dorohty Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20204172|NCT04710862|Syracuse University|Dr. Soren Lowell|315-443-9615|slowell@syr.edu|
20204173|NCT00745368|University of Rochester|Robert DiCenzo|518 694 7228|rob.dicenzo@acphs.edu|
20204174|NCT02364947|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
20204175|NCT00423085|Novartis Pharmaceuticals|Study Director|862-778-8300||
20204176|NCT00853489|Saint Louis University|Dr. Lisa Kaye Cannada|3145778850|LCannada@slu.edu|7
20218855|NCT01969448|Washington University School of Medicine|Marissa J. Tenebaum, M.D.|314-996-8800|tenenbaumm@wustl.edu|
20218856|NCT00974974|Impax Laboratories, Inc.|Michelle Landolfi, Director, Regulatory Affairs|510-240-6402|mlandolfi@impaxlabs.com|
20218857|NCT01959035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20218858|NCT02227147|Dompé|Flavio Mantelli, MD, PhD|02 583831|info@dompe.com|
20218859|NCT01289665|AdventHealth|Dr. Ashley Hill|407-303-1444|Ashley.Hill.MD@adventhealth.com|
20158651|NCT01582009|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20158652|NCT02998684|Medical University of South Carolina|Dr. Jane Joseph|843-792-7683|josep@musc.edu|
20158653|NCT03050450|Johns Hopkins All Children's Hospital (St. Petersburg, FL)|Dr Stacie Stapleton|17274701017|stacie.stapleton@jhmi.edu|
20204177|NCT02326467|Boston Children's Hospital|Celeste Chandonnet|781-216-0050|celeste.chandonnet@childrens.harvard.edu|
20204178|NCT05525975|University of Iowa Health Care|Brendan Patterson|319 678-8451|brendan-patterson@uiowa.edu|
20204179|NCT02405429|University of Iowa|Edward F. Bell, MD|319-356-4006|edward-bell@uiowa.edu|
20218860|NCT03347422|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20218861|NCT03709823|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20218862|NCT03161964|University of Utah|Dr. Anu Sharma|(801) 581-7761|Anu.Sharma@hsc.utah.edu|
20218863|NCT00158600|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20218864|NCT02038907|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20218865|NCT02737332|SPARC|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
20218866|NCT02252718|Medical University of Warsaw|Katarzyna Wojtyniak|(+48) 223179536|wojtyniakkasia@gmail.com|
20218867|NCT01246011|Massachusetts General Hospital|Anne Philip, Data Manager|617 726 0423|alphilip@partners.org|
20218868|NCT03300544|M D Anderson Cancer Center|Arvind Dasari|(713) 792-2828|adasari@mdanderson.org|
20218869|NCT01155024|The Ohio Willow Wood Company|Applied Research Engineer|740-869-3377|mariag@owwco.com|
20218870|NCT01593696|National Cancer Institute|Dr. Nirali N. Shah|240-760-6199|shahnn@nih.gov|
20218871|NCT01936623|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
20218872|NCT02575911|Alcon, A Novartis Division|Global Brand Med Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20218873|NCT01675661|Medical University of South Carolina|Kevin Gray, MD|843-792-6330|graykm@musc.edu|
20218874|NCT00987389|McMaster University, Hamilton, Ontario|Dr. Michael Walsh|905-522-1155|lastwalsh1975@gmail.com|34055
20218875|NCT02992418|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20218876|NCT00289536|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20218877|NCT03246126|NYU Langone Health|Thomas Maldonado|212-263-7311|Thomas.Maldonado@nyulangone.org|
20218878|NCT02468570|BioMarin Pharmaceutical Inc.|Karen Gu/Director, BioStatistics|650-829-4017|kgu@bmrn.com|
20218879|NCT04465630|SIght Sciences, Inc|Kavita Dhamdhere, MD|877-266-1144|kdhamdhere@sightsciences.com|
20218880|NCT01006135|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218881|NCT01912274|Helsinn HealthcareSA|Edwin de Wit - Head of Clinical development|+ 41 919852121|info-HHC@helsinn.com|
20218882|NCT01732484|Medical University of Vienna|Prof. Dr. R. Menapace|+43 699 19660272|rupert.menapace@meduniwien.ac.at|
20218883|NCT01087489|Miami Veterans Affairs Medical Center|Dr. Ninel Gregori, MD|305-575-7000|ngregori@med.miami.edu|3081
20218884|NCT01708590|Bausch Health|Study Director|510-259-5284||
20218885|NCT04740320|Imperial College London|Clinical Project Manager|+442083831284|polly.fox@imperial.ac.uk|
20218886|NCT02272634|Yungjin Pharm. Co., Ltd.|Director of Clinical Trials|82-2-2041-8318|mhlee2017@yungjin.co.kr|
20218887|NCT04620135|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs|+1 908-947-3551|msenchyna@aeriepharma.com|
20218888|NCT01437943|Brigham and Women's Hospital|Anil Chandraker, MD|617-732-7412|achandraker@partners.org|
20218889|NCT00502801|Janssen Scientific Affairs, LLC|Vice President, Data Generation|908 927-2943||
20218890|NCT01565616|Emory University|Lakshmanan Krishnamurti, MD||lakshmanan.krishnamurti@emory.edu|
20218891|NCT03322384|University of California, Davis|Analyst|9167348053|nlogihara@ucdavis.edu|
20218892|NCT03176459|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20218893|NCT00446199|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20218894|NCT04221789|IECS|Dr Fernando Rubinstein|01147778767|frubinstein@iecs.org.ar|
20218895|NCT06077487|University of California, San Francisco|Dr. Brian Anderson|(415) 476-1000|Brian.Anderson@ucsf.edu|
20218896|NCT04385277|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20218897|NCT05101486|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218898|NCT02799095|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
20218899|NCT01933113|Allegheny Health Network|Donald Whiting, MD|412-359-6200|donald.whiting@ahn.org|
20218900|NCT02297438|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218901|NCT04092894|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|7814750572|bsubrama@bidmc.harvard.edu|
20218902|NCT02935686|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218903|NCT02579161|Northwell Health|Dr. Zeph Okeke|516-734-8500|zokeke@northwell.edu|
20218904|NCT00759902|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20218905|NCT02327117|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
20218906|NCT02128217|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20218907|NCT05071313|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218908|NCT01183221|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
20218909|NCT00678041|University of Pittsburgh, UPP13 WH Uro Gynecology - Cor|Gary Sutkin, MD|412--641-1440|gsutkin@mail.magee.edu|
20218910|NCT01700036|University of Michigan Cancer Center|Dr. Pavan Reddy, MD|734-936-8785|reddypr@umich.edu|
20218911|NCT00807248|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20218912|NCT02444793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218913|NCT03996148|Cooper University Hospital|Ludmil Mitrev|(800) 826-6737|mitrev-ludmil@cooperhealth.edu|
20218914|NCT00679926|Oklahoma State University Center for Health Sciences|Johnny Stephens|918-382-3527|johnny.stephens@okstate.edu|
20218915|NCT02504671|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20218916|NCT00210249|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20218917|NCT03222583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20218918|NCT04280705|Organization:NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20218919|NCT03576183|Valneva Austria GmbH|Head Global Medical Affairs|20620|info@valneva.com|0
20218920|NCT02518919|Children's Hospital of Michigan|Dr. Nirupama Kannikeswaran, Associate Professor of Pediatrics and Emergency Medicine|313-745-5260|nkannike@dmc.org|
20218921|NCT04498403|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158654|NCT03592771|Emory University|Ilana Graetz, PhD|404-727-1483|ilana.graetz@emory.edu|
20158655|NCT00735553|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20204180|NCT01392989|Stanford University|Everett Meyer, Assistant Professor of Medicine (Blood and Marrow Transplantation)|650) 725-5816|evmeyer@stanford.edu|
20204181|NCT00441441|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204182|NCT01051986|Seoul National University Hospital|Ki-Bong Kim|+82-2-2072-3482|kimkb@snu.ac.kr|
20204183|NCT02728258|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|gedeonl@nrgoncology.org|
20204184|NCT01725152|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
20204185|NCT00849121|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-265-8131|dm3@medicine.wisc.edu|
20204186|NCT03580382|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
20204187|NCT02808312|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20204188|NCT05151471|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|908-607-1980|information@mt-pharma-us.com|
20204189|NCT04263142|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20204190|NCT01351077|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
20204191|NCT03010423|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20204192|NCT02236546|Vanderbilt-Ingram Cancer Center|Dr. Tom Yankeelov||thomas.yankeelov@utexas.edu|
20204193|NCT00520676|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20204194|NCT03568539|Innovent Biologics (Suzhou) Co., Ltd.|YiBo|+8613382419112|jessica.yi@innoventbio.com|
20204195|NCT03484923|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20204196|NCT03439748|UCLA|Dr. Michelle G. Craske|(310) 825-8403|mcraske@mednet.ucla.edu|
20204197|NCT03696758|UT Southwestern, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
20158656|NCT02705105|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20204198|NCT00312884|Imperial College london|Professor Cowie|0207 349 7716|m.cowie@imperial.ac.uk|
20204199|NCT00115349|UCL Cancer Institute|John Porter, MD, Principal Investigator|+011 (44) 207 679 6224|j.porter@ucl.ac.uk|
20204200|NCT03298412|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20204201|NCT00803010|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-4673|Joseph.Pidala@moffitt.org|2556
20204202|NCT04402008|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
20204203|NCT02780765|Tata Memorial Hospital, Mumbai|Dr Vijaya Patil|+91-2224177000|vijayappatil@yahoo.com|7048
20204204|NCT01028651|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
20204205|NCT01533935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20204206|NCT05631548|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
20204207|NCT04075266|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20204208|NCT05132569|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20204209|NCT01554956|Kedrion SpA|Clinical Trial Manager|+39 05831969231|a.lotti@kedrion.com|
20204210|NCT00913978|Northwestern University|Meltem Yilmaz, MD|312-695-0061|m-yilmaz@northwestern.edu|
20204211|NCT04716933|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20204212|NCT01327651|Fred Hutchinson Cancer Research Center|Maoji Li (Statistical Research Associate)|2066676035|mli2@fredhutch.org|
20204213|NCT03484533|Makerere University Infectious Diseases Institute|Andrew Mujugira|206 520 3800|mujugira@uw.edu|
20204214|NCT03249792|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204215|NCT00216099|Hoosier Cancer Research Network|Jeff Smith|317-921-2050|jsmith@hoosiercancer.org|
20204216|NCT02902172|St. Louis University|Dr. Jennifer Goldkamp|3149772200|jen.goldkamp@health.slu.edu|
20204217|NCT01434472|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
20204218|NCT00138034|Radboud University Medical Center Nijmegen|Professor Doctor F.W.A. Verheugt|+31(0)24-3614533|f.verheugt@cardio.umcn.nl|
20204219|NCT00532948|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20204220|NCT01212172|UC Irvine Dermatology Research Center|Christopher B. Zachary|949 824 7103|czachary@uci.edu|
20204221|NCT00370695|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20204222|NCT03885726|Vapotherm, Inc.|George C. Dungan, II|(267)347-3305|gdungan@vtherm.com|
20204223|NCT03450369|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
20204224|NCT02868216|Cardiologia (Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology|Dra Marcia Moura Schmidt|5551 32333600|mmoura22@terra.com.br|3765
20204225|NCT00809458|UNM Cancer Center|Richard Lauer, MD|505-925-0390|rlauer@salud.unm.edu|
20204226|NCT00660504|Cancer Hospital of Chinese Academy of Medical Sciences|Dr.Sunyan|86-10-87788519|suny@csco.org.cn|
20204227|NCT02439281|U Pittsbutgh, UPMC Children's Hospital|Mihaela Visoiu|4126925260|visoium@upmc.edu|
20204228|NCT03609359|National Cancer Center Hospital East|Dr.Kohei Shitara|(+81)-4-7133-1111|LenvaPembro_core@east.ncc.go.jp|91520
20158657|NCT00422448|Medical University of Graz - Austria|Prof. Dr. Iris Zalaudek|+436763328269|iris.zalaudek@gmail.com|
20204229|NCT01716468|VA Pittsburgh Healthcare System|Jocelyn Tan, MD|412-360-6178|Jocelyn.Tan@va.gov|
20204230|NCT00610935|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20218922|NCT02031458|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20204231|NCT03345836|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20204232|NCT04942483|Imperial College London|Professor Andrew Bush|020 7352 8121|a.bush@imperial.ac.uk|2255
20204233|NCT01943864|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204234|NCT00320385|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204235|NCT02492750|Mayo Clinic|John A Lust MD PhD|507/284-2511|lustj@mayo.edu|
20204236|NCT02965534|University of Applied Sciences Jena|Philipp Hessler|+4916097089677|philipp@hessler.de|
20204237|NCT00748540|MED-EL Corporation|Allison Racey, AuD|888-633-3524|allison.racey@medel.com|
20204238|NCT02915367|Massachusetts General Hospital|Jessica Haberer|617-643-9195|jhaberer@partners.org|
20204239|NCT00722553|Allos Therapeutics, Inc.|Medical Monitor|303-426-6262|gweems@allos.com|
20204240|NCT00436215|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
20158658|NCT04556591|University of Michigan|Dr. Noelle E. Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
20204241|NCT00309777|Kowa Research Europe, Ltd.|Neil Hounslow|01189229004|nhounslow@kowa.co.uk|
20204242|NCT05345691|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5301
20204243|NCT05299983|UC San Diego|Andrea LaCroix|(858) 822-0627|alacroix@ucsd.edu|
20204244|NCT03050359|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20204245|NCT01136668|Hospital for Sick Children|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
20204246|NCT02614287|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20204247|NCT01760993|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204248|NCT05138783|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20204249|NCT03364335|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
20204250|NCT03725202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20204251|NCT01247220|Retina Associates of Florida|Ivan J. Suner, MD|813-875-6373|ivansuner@gmail.com|
20204252|NCT02330549|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20204253|NCT01156597|University of Miami Miller School of Medicine|Armando J. Mendez, Ph.D.|305-243-5342|a.mendez@miami.edu|
20204254|NCT01575197|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
20204255|NCT00050986|University of Texas, M. D. Anderson Cancer Center|W.K. Yung,MD/Clinical Professor, Neuro-Oncology|(713) 794-1285|wyung@mdanderson.org|
20204256|NCT00833248|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20204257|NCT00262080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204258|NCT01361009|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20204259|NCT01826422|IMSS|Dr. Maricela Rodriguez-Cruz|5256276900|maricela.rodriguez.cruz@gmail.com|. 22483
20204260|NCT04549597|Ardelyx|David Rosenbaum|6175134929|drosenbaum@ardelyx.com|
20204261|NCT04009096|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
20204262|NCT02935634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20204263|NCT00210158|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20204264|NCT01773135|Ain Shams University Maternity Hospital|Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams|01003922211|dr.mai_elshahm@yahoo.com|002
20204265|NCT01842308|Mayo Clinic|Suzanne R. Hayman, M.D|(855) 776-0015|hayman.suzanne@mayo.edu|
20204266|NCT02913222|Washington University School of Medicine|Marcie Harris-Hayes, PT, DPT, MSCI, Professor, Physical Therapy and Orthopaedic Surgery|314-286-1435|harrisma@wustl.edu|
20204267|NCT01507584|ucsdmed|Eunice Williams-Steppe|8588221133|emwilliamssteppe@ucsd.edu|
20204268|NCT03521687|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
20204269|NCT02458690|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
20204270|NCT01040208|Sprout Pharmaceuticals|Krista Barbour|9198820850|kbarbour@sproutpharma.com|
20204271|NCT00830037|Indiana University School of Medicine & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
20204272|NCT00740779|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20204273|NCT03392753|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
20204274|NCT03220048|hVIVO|Tim Sharpington|02071480862|t.sharpington@hvivo.com|
20204275|NCT02399813|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
20204276|NCT03280550|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218923|NCT03062228|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
20218924|NCT02910674|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303.724.6713|satish.garg@ucdenver.edu|
20218925|NCT03188718|University of Colorado Denver|Michelle Sobremonte-King, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20218926|NCT02049450|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20204277|NCT03115801|Weill Cornell Medicine|Sharanya Chandrasekhar|6469623110|shc2043@med.cornell.edu|
20204278|NCT02188121|McLean Hospital|Dr. Dost Ongur|617 855 3922|dongur@partners.org|
20204279|NCT00222729|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
20204280|NCT01167595|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
20204281|NCT01915849|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20218927|NCT02381626|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Leng, MD, MPH|646-888-8057|lengj@mskcc.org|
20218928|NCT00394524|Emory University|Guillermo Umpierrez, MD|404-778-1665|geumpie@emory.edu|
20218929|NCT01462318|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20218930|NCT01911897|Vascular Dynamics|Director, Clinical Operations|9492317602|lgreen@vasculardynamics.com|
20218931|NCT02181426|Medical University of South Carolina, Department of Anesthesia and Perioperative Medicine|Research Coordinator for Anesthesia and Perioperative Medicine|843-792-2322|joneswr@musc.edu|
20218932|NCT00369655|Mayo Clinic|Dr. Timothy Hobday|507-284-1159|hobday.timothy@mayo.edu|
20218933|NCT02397408|University of California, Los Angeles|Albert J. Chang, MD, PhD|(310) 82509771|ajchang@mednet.ucla.edu|
20218934|NCT01646138|National Institute of Allergy and Infectious Diseases|Matthew J. Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
20218935|NCT01683838|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
20218936|NCT03397771|Ixaltis|Chief Development Officer|33457260076|svanberg@ixaltis.com|
20218937|NCT03614897|Transcend Medical Group|Alicia Harbison|5708874882|aliciajeanbrown@gmail.com|
20218938|NCT04040322|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
20218939|NCT04078126|AstraZeneca AB|AstraZeneca AB|877-240-9479|information.center@astrazeneca.com|1
20218940|NCT02669758|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20218941|NCT02149108|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218942|NCT01156142|Mayo Clinic|Robert C. Miller, M.D.|507/266-6247|Miller.Robert@mayo.edu|
20218943|NCT00893737|Clinvest|Rebecca Browning|(417) 841-3664|rbrowning@clinvest.com|
20218944|NCT03981419|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20218945|NCT01330459|Oregon Health and Science University|Alison Edelman, MD, Assistant Professor|(503) 494-3666|edelmana@ohsu.edu|
20218946|NCT01231399|City of Hope|Paul Frankel, Ph.D.|(626) 218-5265|pfrankel@coh.org|
20218947|NCT00895947|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
20218948|NCT02623348|University of California, San Francisco|Anoop Sheshadri|415-221-4810|anoop.sheshadri@ucsf.edu|22576
20218949|NCT05472662|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20218950|NCT04647721|Merz Aesthetics|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20218951|NCT02697240|Children's National Medical Center|Suvankar Majumdar|2024763800|smajumdar@childrensnational.org|
20218952|NCT01974440|Janssen Research & Development, LLC|Executive Medial Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218953|NCT02666352|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218954|NCT00857259|Novartis Pharmaceuticals|Study Director|862-778-8300||
20218955|NCT02701413|Northwestern University|Dr. Christina Lewicky-Gaupp|312-472-3874|christina.lewickygaupp@nm.org|
20218956|NCT02138136|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-556-3314|clinicaltrials@mnk.com|
20218957|NCT00535587|Oregon Health & Science University|Kim Dupree Jones|503 494 3837|joneskim@ohsu.edu|
20218958|NCT01359644|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Trials@bms.com|
20218959|NCT04795908|West Virginia University|Jessica Frey|304-598-6127|jessica.frey@hsc.wvu.edu|
20218960|NCT01660334|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218961|NCT00311311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218962|NCT00546572|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218963|NCT00988065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20218964|NCT03979820|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218965|NCT02685202|University of North Carolina at Chapel Hill|Anne E. Sanders, PhD|919-537-3275|anne_sanders@unc.edu|
20218966|NCT01229735|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
20218967|NCT02130882|National Institute of Allergy and Infectious Diseases, NIH|Dr. Amy Klion|301-435-8903|aklion@nih.gov|
20218968|NCT00520286|National Institutes of Health|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20218969|NCT01715064|University of Guelph-Humber|Dr. Daniel Santa Mina|416-798-1331|daniel.santamina@guelphhumber.ca|6065
20218970|NCT00548171|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218971|NCT02257541|Memorial Sloan Kettering Cancer Center|Dr. William Tap, MD|646-888-4163|tapw@mskcc.org|
20218972|NCT03003949|University of North Carolina at Chapel Hill|Susan Girdler, PhD|919-590-0813|rachel_kozik@med.unc.edu|
20218973|NCT02615171|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
20218974|NCT02581007|Northside Hospital|Dr. Melhem Solh|404-255-1930|msolh@bmtga.com|
20218975|NCT04764630|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20218976|NCT00741936|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
20218977|NCT00369382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218978|NCT03110601|Stimgenics|VP of Clinical Affairs|309-662-4321|clinicalSG@stimgenics.com|217
20218979|NCT03935464|University of California San Francisco|Dr. Monica Gandhi|415 260 6709|monica.gandhi@ucsf.edu|
20218980|NCT05730556|Mayo Clinic|Amaal Starling, M.D.|715-537-1345|Starling.Amaal@mayo.edu|
20218981|NCT05011123|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20218982|NCT05742347|Medline Industries, LP|Julie J. Finley|(800) 33-5463|jjfinely@medline.com|
20218983|NCT01670487|Cleveland Clinic|Dr. Sharon Mace|216-445-4598|maces@ccf.org|
20218984|NCT04018664|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20218985|NCT03845296|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20218986|NCT05104073|Penn State College of Medicine|Ian Paul, MD|7175318006|ipaul@pennstatehealth.psu.edu|
20204282|NCT02775864|Columbia University|Dr. Scott Stroup|646-774-8435|Scott.Stroup@nyspi.columbia.edu|
20204283|NCT00619684|Fred Hutchinson Cancer Research Ctr|Dr. William Bensinger|2066674730|wbensing@fredhutch.org|
20204284|NCT02028338|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
20204285|NCT03403504|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
20204286|NCT02094586|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
20204287|NCT01257217|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20204288|NCT02761993|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
20204289|NCT01842620|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204290|NCT00256867|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204291|NCT01442129|Mount Sinai|Deborah D. Ascheim, MD, Associate Professor, Clinical Director of Research, InCHOIR|212-659-9567|deborah.ascheim@mountsinai.org|
20204292|NCT01231633|Long Island Vitreoretinal Consultants|Vincent A. Deramo, MD|5164660390|vaderamo@gmail.com|222
20204293|NCT01930799|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20204294|NCT02916498|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
20204295|NCT00875017|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204296|NCT02689219|IndianaU|Dr. Nabil Adra|(317) 944-5349|nadra@iu.edu|
20204297|NCT03342469|American University|Dr. Kathleen Holton|(202) 885-3797|holton@american.edu|
20204298|NCT01477892|Seoul National University Hospital|Pf. Han-suk Kim|+82-2-2072-0647|kimhans@snu.ac.kr|
20204299|NCT01452126|UNM Department of Anesthesiology|Dr Tim Petersen|5052722610|timpetersen@salud.unm.edu|505
20204300|NCT01921257|Circassia Ltd|VP Clinical Operations|+44 1864 405560||
20204301|NCT01081223|TVAX Biomedical, Inc.|Gary Wood PhD|913-961-1327|gwood@tvaxbiomedical.com|
20204302|NCT00363805|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
20158659|NCT03332173|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20218987|NCT06218823|University of Wisconsin Center for Tobacco Research and Intervention|Associate Director of Research|6082628673|demccarthy@ctri.wisc.edu|
20204303|NCT05515601|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20204304|NCT01689207|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
20204305|NCT01912768|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20204306|NCT02426658|Wake Forest University Health Sciences|Study Nurse|336-716-2121|saverill@wakehealth.edu|
20204307|NCT00524316|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20204308|NCT00088634|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20204309|NCT01199263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|linda.gedeon@roswellpark.org|
20204310|NCT00488033|Intermountain Heart Institute|J.Brent Muhlestein|8015074702|jbrent.muhlestein@imail.org|
20204311|NCT01515306|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20204312|NCT04973228|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20204313|NCT03566108|University of Alabama at Birmingham|Dr. Maria Geisinger, PI, Professor, Director of Advanced Education in Periodontology|205-934-4984|miagdds@uab.edu|
20204314|NCT00683475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20204315|NCT02429258|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|sergey.zhuplatov@astrazeneca.com|
20204316|NCT01694420|Duke University Medical Center|Mehri McKeller, MD|919-668-0242|kara.mcgee@duke.edu|
20204317|NCT00554463|NRG Onocology|Wendy Seiferheld||wseiferheld@nrgonology.org|
20204318|NCT03987919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20204319|NCT03813719|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
20204320|NCT02536170|Emory University|Claudia Morris|404-727-5500|claudia.r.morris@emory.edu|
20204321|NCT00434512|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204322|NCT03303092|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20204323|NCT03222076|MD Anderson Cancer Center|Dr. Ahmed Kaseb|(713) 792-2828|akaseb@mdanderson.org|
20204324|NCT02658994|Human Development Research Foundation|Siham Sikander|+923330590373|sihamsikander@gmail.com|
20204325|NCT03007485|Northwell Health|Dr. Negin Hajizadeh|516-600-1401|Nhajizadeh@northwell.edu|
20204326|NCT01848054|PRA International|Lynn R. Webster, MD|801-892-5140|LRWebsterMD@gmail.com|
20204327|NCT01030458|University of Leuven|Prof. Dr. Jan A Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
20204328|NCT02420223|Medical College of Wisconsin|Dr. Jennifer Knight|866-680-0505|jknight@mcw.edu|
20204329|NCT00208494|DePuy Orthopaedics, Inc.|Jennifer Hoag, MS, Project Leader, Clinical Research|574-372-7399|JHoag2@its.jnj.com|
20204330|NCT00411788|Yale University|Abu-Khalaf, Maysa|(203) 785-4095|maysa.abu-khalaf@yale.edu|
20204331|NCT02874404|University of Nebraska Medical Center|Dr. Matthew Lunning, DO, Associate Professor|402-559-7164|mlunning@unmc.edu|
20204332|NCT00390416|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
20204333|NCT01592409|Centre for Addiction and Mental Health|Dr. Robert Mann, Senior Scientist|416-535-8501|robert.mann@camh.ca|34496
20204334|NCT01219959|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20204335|NCT01728584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204336|NCT01842841|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204337|NCT03207022|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
20204338|NCT02345252|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20158660|NCT01485796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204339|NCT00995345|ActivX Biosciences|Dr. Diane Plotkin, Sr. Director Clinical Development|858-558-5558|dianep@activx.com|
20204340|NCT02336594|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
20204341|NCT00471536|Karmanos Cancer Institute at Wayne State University|Ulka Vaishampayan, M.D.||vaishamu@karmanos.org|
20204342|NCT02651194|AbbVie|Global Medical Services|800-633-9110||
20204343|NCT02403830|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20204344|NCT01980706|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
20204345|NCT02546674|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20204346|NCT03248947|Duke University|Dr. Li-Tzy Wu|919-889-9369|litzy.wu@duke.edu|
20204347|NCT04490265|US Department of Veterans Affairs|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
20204348|NCT01864018|Mayo Clinic|Shaji Kumar|507-284-2511|Kumar.Shaji@mayo.edu|
20204349|NCT01750398|SKCCC at Johns Hopkins|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
20204350|NCT05122650|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20204351|NCT04026412|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20204352|NCT01401010|Michigan State University|Gary E Stein|517-353-5126|Gary.Stein@hc.msu.edu|
20204353|NCT00668434|Kaiser Permanente, Northern California|Dr. Andrew Avins|510-891-3557|andy.l.avins@kp.org|
20204354|NCT03255291|Washington University School of Medicine|Erika Waters, MPH, Ph.D.|314-286-2757|waterse@wustl.edu|
20204355|NCT00634244|ECOG Statistical Office|Study Statistician|617-632-3012||
20204356|NCT04019093|University of Florida|Jeff Boissoneault, PhD|352-273-6147|jboissoneault@phhp.ufl.edu|
20204357|NCT02467387|CardioCell, LLC|Sergey Sikora, President and CEO|760-315-0861|SSIKORA@STEMCARDIOCELL.COM|
20204358|NCT02335216|St. Jude Medical|Roni Diaz|+19723098601|rdiaz@sjm.com|
20204359|NCT01672996|GE Healthcare|Rubin Sheng, MD|609-514-6899|Rubin.Sheng@ge.com|
20204360|NCT03591146|Taiwan Liposome Company|Cynthia Lin|+886 2 2655 7377|cynthia_lin@tlcbio.com|
20204361|NCT02330627|University of California, San Diego|Dr. Charles Taylor|8585349446|c1taylor@ucsd.edu|
20204362|NCT04737031|University of Pennsylvania|Robert Schnoll, PhD|215.746.7143|schnoll@pennmedicine.upenn.edu|
20204363|NCT04369430|Alkahest, Inc.|Clinical Development|(650) 801-0474|trials@alkahest.com|
20204364|NCT00962039|The Ohio State University|John V. Campo|614-581-5984|john.campo@hsc.wvu.edu|
20204365|NCT00444626|Genzyme|Genzyme Medical Information (MedInfo)||medinfo@genzyme.com|
20204366|NCT00008138|SWOG Statistical Center|GYN Committee Statistician|206-667-4623||
20204367|NCT03453151|Duke University|Marat Fudim|(919) 681-5816|marat.fudim@duke.edu|
20204368|NCT00142519|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl, MD|646-888-2681|moryln@mskcc.org|
20204369|NCT02227329|Mayo Clinic|Dr. Ryan Hurt|507-284-4461|Hurt.Ryan@mayo.edu|
20204370|NCT02592629|Penn State Hershey Medical Center|Robert Gallo, M.D.|7175310003|rgallo@pennstatehershey.psu.edu|289222
20204371|NCT01204658|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204372|NCT04594239|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20204373|NCT02100748|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20204374|NCT00091390|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20204375|NCT01686503|Eastern Virginia Medical School|Dr. Stephanie Troy|757-446-8999|troysb@evms.edu|
20204376|NCT02020031|Mayo Clinic|Dr. Mark J. Spanghel|480-301-5685|Spangehl.Mark@mayo.edu|
20204377|NCT02891798|VA Pittsburgh Health System, and University of Pittsburgh|Brian A. Williams, MD, MBA|412-360-1602|brian.williams6@va.gov|
20204378|NCT02669862|Aclaris Therapeutics, Inc.|Judy Schnyder, Senior Director of Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
20204379|NCT02294318|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
20204380|NCT00762372|Baxter Healthcare|Baxter Clinical Trial Disclosures Call Center|(224)948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20204381|NCT02670915|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20204382|NCT00495495|Indiana University School of Dentistry|Domenick T. Zero, DDS MS Principal Investigator|317-274-8822|dzero@iupui.edu|
20204383|NCT02702518|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
20204384|NCT03331666|Columbia University Irving Medical Center|Dr. Nan Wang|212-342-1761|nw30@cumc.columbia.edu|
20204385|NCT05209932|Family Transitions - PTW, LLC|Michele M Porter, PhD - Co-PI/Partner|4802037550|m.marie.porter@gmail.com|
20204386|NCT01409031|University of Colorado, Denver|John Kinsella, MD|303-724-2853|John.Kinsella@ucdenver.edu|
20204387|NCT01504854|Alzheimer's Disease Cooperative Study|Michael Rafii, MD, PhD|858-846-1300|mrafii@ucsd.edu|
20204388|NCT01094730|Johnson & Johnson Vision Care|John R. Buch, O.D., M.S., F.A.A.O., Principal Research Optometrist|1-904-443-1707|jbuch@its.jnj.com|
20204389|NCT02232087|Quotient Clinical Ltd|Pui Leung|44(0)115 974 9000|Pui Leung <Pui.Leung@quotientclinical.com>|
20204390|NCT01958125|electroCore Inc.|Director Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20204391|NCT04096326|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
20204392|NCT02509598|Cardinal Health 414, LLC|Director, Regulatory & Medical Affairs|6147570226|npsmedicalaffairs@cardinalhealth.com|
20204393|NCT04056455|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20204394|NCT02512068|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20204395|NCT04365985|William Beaumont Hospitals|Matthew Sims, MD|248 551-0027|matthew.sims@beaumont.org|
20204396|NCT04891770|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20204397|NCT01952834|Medical College of Wisconsin|Dr. Michael Widlansky|414-955-6755|mwidlans@mcw.edu|
20204398|NCT02110121|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20218988|NCT04732221|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218989|NCT04791969|University of California San Francisco|Glenn-Milo Santos|(415) 476-1435|glenn-milo.santos@ucsf.edu|
20218990|NCT04002063|VHAPTH|Judith A. Callan PhD, RN|412-628-1534|judith.callan@va.gov|
20218991|NCT05327816|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218992|NCT03107026|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20218993|NCT02470390|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
20218994|NCT03596151|Antiviral Research Center, University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
20218995|NCT01685411|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
20218996|NCT01951885|Case Comprehensive Cancer Center|Betty Hamilton MD|866-223-8100|TaussigResearch@ccf.org|
20218997|NCT00824616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218998|NCT04711902|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20218999|NCT05339334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219000|NCT02358135|Keck School of Medicine of University of Southern California|April W. Armstrong, MD, MPH; Associate Dean of Clinical Research|323-865-3871|april.armstrong@med.usc.edu|
20219001|NCT00368979|GlaxoSmithKline|GSK Response center|866-435-7343||
20219002|NCT02238626|MediciNova, Inc.|Director, Scientific Affairs|8583444535|makhay@medicinova.com|
20219003|NCT01659866|Northwestern University|Dr. Anthony Schaeffer|312-908-1615|ajschaeffer@northwestern.edu|
20158661|NCT04830215|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20204399|NCT04360187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204400|NCT04058054|KeraNetics, Inc.|Chris Holder, PhD|336-413-3393|cholder@keranetics.com|
20204401|NCT02203838|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20204402|NCT05091060|Erchonia Corporation|Travis Sammons|3214731251|tsammons@erchonia.com|
20204403|NCT01798706|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20204404|NCT00496873|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
20204405|NCT05896761|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20204406|NCT01318083|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20204407|NCT04747808|MediPrint Ophthalmics, Inc.|Chief Operating Officer|(858) 522-0815|clinical@mediprintlens.com|
20204408|NCT00843310|NYU Cancer Institute|Hearn J. Cho, MD|212-263-9274|hearn.jay.cho@med.nyu.edu|
20204409|NCT03552549|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204410|NCT02739594|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20204411|NCT00041717|Acorda Therapeutics, Inc.|Andrew Blight, Ph.D. Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
20204412|NCT01270581|Mount Sinai School of Medicine|Dr. Andrea Weintraub|212-241-6186|andrea.weintraub@mssm.edu|
20204413|NCT00952289|Incyte Corporation|Study Director|855 463-3463||
20204414|NCT01515176|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
20204415|NCT02932475|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
20204416|NCT00777491|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
20204417|NCT00364845|Amgen Inc.|Study Director|866-572-6436||
20204418|NCT03705962|University of Virginia|Eric McVey|434.243.5382|edm9u@hscmail.mcc.virginia.edu|
20204419|NCT02963714|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
20204420|NCT03855137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20204421|NCT02435277|NuSirt Biopharma|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
20204422|NCT01067508|UCLA Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
20204423|NCT00462020|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
20204424|NCT02065622|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20204425|NCT01249872|University Hospital Of Patras, Greece|Dr Anastasia Zotou|0026130603341|anzotou@hotmail.com|
20204426|NCT03302793|UTHealth|Dr. Sheng Li|713-797-7125|Sheng.Li@uth.tmc.edu|
20204427|NCT04574297|Changhai Hospital|Dr. Zhuan Liao|86-21-31161004|liaozhuan@smmu.edu.cn|
20204428|NCT01687413|Washington University School of Medicine|Jason Rich, M.D.|314-747-3742|richj@wustl.edu|
20204429|NCT05818527|Cairo university|mohamed atfy abdelmotaleb ( PhD student )|01222798922|atfy2002@yahoo.com|
20204430|NCT04237207|Advanced Bionics, LLC|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
20204431|NCT00306917|DePuy Orthopaedics, Inc|Barry Sisson|574-372-7156|BSisson@its.jnj.com|
20204432|NCT02678780|Kapadi|Start Up Unit|+34961452190|maria.rocasalbas@kapadi.com|
20204433|NCT03047993|The University of Texas MD Anderson Cancer Center|Courtney DiNardo/Professor|713-794-1141|cdinardo@mdanderson.org|
20204434|NCT03492463|Duke University|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
20219004|NCT04870138|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|919-843-6893|mmhobbs@med.unc.edu|
20219005|NCT05183217|University of Wisconsin - Madison|Heidi Brown|619-695-4714|heidi.w.brown@kp.org|
20158662|NCT02440139|Virginia Tech|Dr. ShihChung Benedict Lo|301-9215754|benlo@vt.edu|
20158663|NCT03754556|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20204435|NCT06704178|Citruslabs|Patrick Renner|+1 805-876-4484|hello@citruslabs.com|
20204436|NCT00406640|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20204437|NCT04748783|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|919-537-3424|ljacox@live.unc.edu|
20219006|NCT03412396|The University of Texas MD Anderson Cancer Center|Dr. John Davis|(713) 792-3250|johndavis@mdanderson.org|
20219007|NCT03365752|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
20219008|NCT02633488|University of Virginia|Eugene J. Barrett MD PhD|434-924-1263|ejb8x@virginia.edu|
20219009|NCT02713386|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|716-845-1300|purdyc@nrgoncology.org|2296
20219010|NCT01383135|Stanford University|Andrei Iagaru, MD|6507362859|aiagaru@stanford.edu|
20219011|NCT00242619|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
20219012|NCT04941521|The University of Texas Health Science at Houston|Joy M Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
20219013|NCT03167723|Atrium Health Wake Forest|Bradley Thomas MD|704-355-3176|bradley.thomas@atriumhealth.org|
20219014|NCT02122406|University of Pavia|Vittorio Grosso MD|+393332605945|vittorio.grosso@gmail.com|
20219015|NCT01297465|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20219016|NCT02455050|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20219017|NCT03402750|University of Miami|Brian McCabe|305-248-1530|bmccabe@miami.edu|
20219018|NCT02981303|HiberCell|Chief Medical Officer|651.675.0300|CMO@hibercell.com|
20219019|NCT02325518|Alcon, A Novartis Division|Novartis Pharma KK|1-888-451-3937|alcon.medinfo@alcon.com|
20219020|NCT00631449|University of California, San Francisco|Steven Deeks, MD|415-476-4082|Steven.Deeks@ucsf.edu|404
20219021|NCT03393806|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219022|NCT01259115|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
20219023|NCT01971970|Erasmus University Medical Centre - Sophia Childrens Hospital|Professor J.C. Escher|+31107036076|j.escher@erasmusmc.nl|
20219024|NCT00848107|United Therapeutics Corporation|Rex Mauthe, Assoc VP, Regulatory Affairs|(919) 485-8350|RMauthe@unither.com|
20219025|NCT01831765|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20219026|NCT00507130|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
20219027|NCT02524730|Stryker|Britta von den Brincken, Sr. Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
20219028|NCT00859586|NIH NHLBI|Dr. Minoo Battiwalla|301-827-0939|battiwam@nhlbi.nih.gov|
20219029|NCT01772758|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
20219030|NCT00080938|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20219031|NCT01775852|Baylor College of Medicine|Lilian Dindo, PhD|713-791-1414|lilian.dindo@bcm.edu|10296
20219032|NCT00556400|NICHD|Dr. Pamela Stratton|301 496-9079|strattop@mail.nih.gov|
20219033|NCT04561375|Cleveland Clinic|Dr. Daniel Sessler|2168702620|ds@ccf.org|
20219034|NCT00706511|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
20219035|NCT02605993|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
20219036|NCT01025271|University of Pittsburgh|Karin Byers, MD|412-648-6553|dlp5@pitt.edu|
20219037|NCT00121472|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|(781) 852-8334|psood@thoratec.com|
20219038|NCT01383213|IRCCS Fondazione Cà Granda Policlinico Milano|Dr Roberto Cosentini|+390255033618|r.cosentini@gmail.com|3618
20219039|NCT03493386|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219040|NCT04645966|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219041|NCT04146116|University of Wisconsin, Madison|Dr. Marin Schweizer|6082631545|mschweizer@medicine.wisc.edu|
20219042|NCT04645264|Rush University Medical Center|Kern Singh, MD|(312) 432-2435|kern.singh@rushortho.com|
20158664|NCT00211172|Kaiser Permanente Center for Heatlh Research|David H. Smith|503-335-6302|david.h.smith@kpchr.org|
20158665|NCT02509936|"Wuqu' Kawoq | Maya Health Alliance"|Dr Peter Rohloff|6174473034|peter@wuqukawoq.org|
20158666|NCT00770562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20158667|NCT01643408|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20158668|NCT03697161|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|8027525168|tbaumgartner@ovidrx.com|
20158669|NCT00292045|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20158670|NCT04474197|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20158671|NCT00606411|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
20158672|NCT00237666|The Medical Research Network, LLC|Dr. Michael Liebowitz|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
20158673|NCT00624468|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20158674|NCT02346643|St. Jude Medical|Roni Diaz|+1 972 309 8601|RDiaz@sjm.com|
20158675|NCT00635349|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
20158676|NCT01794312|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
20158677|NCT02569476|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158678|NCT01071954|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials||MedInfoInternational@amgen.com|
20158679|NCT00703963|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7068|schaff@mayo.edu|
20158680|NCT01340664|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 908 927-5775||
20158681|NCT03232827|UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR|Dr. Theodore Wagener|405-271-4407|theodore-wagener@ouhsc.edu|50486
20158682|NCT01653587|Santa Casa de Marília|Dr. Pedro Beraldo de Andrade|+551434025561|pedroberaldo@gmail.com|
20189184|NCT04941482|Hanoi Medical University|Dr. Thao Thi Phuong Nguyen|+84916911897|dr.nguyenthiphuongthao.hmu@gmail.com|
20219043|NCT03272464|Massachusetts General Hospital|David M. Miller, MD, PhD|617-726-2667|dmiller4@mgh.harvard.edu|
20219044|NCT02116608|University of Colorado Denver|Jeremy Prager, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20158683|NCT02691416|The Third Central Clinical College of Tianjin Medical University, Tianjin the Third Central Hospital|Dr.Haiyun Wang|13752211206|why819@126.com|
20158684|NCT02528942|Thomas Jefferson University|Yevgeniy Vinogradskiy PhD|2159553605|yevgeniy.vinogradskiy@Jefferson.edu|
20158685|NCT04599803|Verily Life Sciences LLC|Gabriel Kowalsky|9709011616|gabekowalsky@verily.com|
20158686|NCT00881530|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158687|NCT00763256|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
20158688|NCT01637584|UPittsburgh|Dr. Anne Germain|4123832150|germax@upmc.edu|
20158689|NCT04396795|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr Ranjith Ramasamy|305-243-4562|ramasamy@miami.edu|
20158690|NCT02366923|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
20158691|NCT00517010|University of California Davis|Susanna Park MD PhD|916-734-6074|sscpark@ucdavis.edu|
20219045|NCT03468075|University of Iowa, Holden Comprehensive Cancer Center|Clinical Assistant Professor|319-384-9497|varun-monga@uiowa.edu|
20158692|NCT00906178|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1-801#
20158693|NCT00995436|ChestyerfieldNDRH|Jonathan Sandler|01246512106|JonSandler57@gmail.com|
20158694|NCT01232127|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20158695|NCT02725476|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|114
20158696|NCT00289289|Medtronic CRDM Clinical|Jen Lahr||jen.lahr@medtronic.com|
20158697|NCT01445613|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20158698|NCT03666988|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20158699|NCT01166347|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
20158700|NCT05588440|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
20158701|NCT02142803|Dana Farber Cancer Institute|Christine Sceppa McCluskey|617-632-5394|christine_sceppa@dfci.harvard.edu|
20158702|NCT01154452|Memorial Sloan Kettering Cancer Center|Dr. Mrinal Gounder|646-888-4167|gounderm@mskcc.org|
20158703|NCT03706430|Masimo|Dr. William C. Wilson, CMO, SVP|949-297-7000|william.wilson@masimo.com|
20158704|NCT00145626|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
20158705|NCT01392573|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20158706|NCT00436436|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
20158707|NCT02709720|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20158708|NCT00200967|Penn State College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
20158709|NCT05823974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20158710|NCT01541735|Instituto Mexicano del Seguro Social|PhD. Manuel González Ortiz|33 36176000|uiec@prodigy.net.mx|31494
20158711|NCT00626782|Wills Eye Hospital|Prinicipal Investigator|484-434-2700|mpro2020@yahoo.com|
20158712|NCT01238991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158713|NCT03573206|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
20158714|NCT00416494|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
20158715|NCT02222688|University of California, San Diego|Thomas Kipps, MD, PhD|858-534-5400|tkipps@ucsd.edu|
20158716|NCT00276406|Mayo Clinic|Adil E. Bharucha, MD|507-284-6439|bharucha.adil@mayo.edu|
20158717|NCT04248712|Mayo Clinic|Dawn Francis, M.D.|904-953-2254|Francis.Dawn@mayo.edu|
20158718|NCT01966354|Complejo Hospitalario de Navarra|Dr. Mikel Batllori|0034 848422174|mikel.batllori.gaston@cfnavarra.es|
20158719|NCT00332579|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
20158720|NCT02013778|University of Pennsylvania|Gregory Nadolski, MD, Principal Investigator|215-662-7892|gregory.nadolski@pennmedicine.upenn.edu|
20158721|NCT03308968|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20158722|NCT00776594|Dana Farber Cancer Institute|Mary-Ellen Taplin, MD|617-632-6328|Mary_taplin@dfci.harvard.edu|
20158723|NCT03037476|University of Washington|Jason Kilmer, Ph.D.|206-685-4512|jkilmer@uw.edu|
20158724|NCT02141633|University of Miami|Dr Adam Wanner Professor of Medicine Division of Pulmonary and Critical Care Medicine|(305) 243-3045|awanner@med.miami.edu|
20158725|NCT00960401|Winthrop-University Hospital, Division of Hematology and Oncology|Dr. Alexander Hindenburg|516-663-9500|AHindenburg@winthrop.org|
20158726|NCT03053440|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158727|NCT01188551|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
20158728|NCT00391053|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20158729|NCT02248766|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
20158730|NCT02140970|University of Colorado|Dr. Kyle Rove|720 777 5893|kyle.rove@childrenscolorado.org|
20158731|NCT05069597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20158732|NCT02553928|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20158733|NCT02526212|Montefiore Medical Center-Albert Einstein College of Medicine|Aaron Fox, Principal Investigator|718-920-7173|adfox@montefiore.org|
20158734|NCT00040742|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20158735|NCT01434654|St Vincent's Hospital, Sydney|Prof. Bruce Brew|+61 2 8382 1111|b.brew@unsw.edu.au|4100
20158736|NCT00645840|UT Southwestern Medical Center|Perrin White|214 648 6875|perrin.white@utsouthwestern.edu|
20158737|NCT00402324|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20219046|NCT00988442|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 6283313|ACTGCT.Gov@s-3.com|
20189185|NCT03229408|University of Illinois at Chicago|Frank González|(312) 413-1984|frgz12@uic.edu|
20158738|NCT01823198|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation Department|713-792-3618|rchampli@mdanderson.org|
20158739|NCT01119066|Memorial Sloan Kettering Cancer Center|Richard O'Reilly, MD|646-888-2157|oreillyr@MSKCC.ORG|
20158740|NCT02441101|University of Iowa|Barry London|319-356-2750|barry-london@uiowa.edu|
20158741|NCT03012828|Medicines Development Limited|Sally Kinrade, Vice President (Clinical Development)|+613 9629 6111|sally.kinrade@medicinesdevelopment.com|
20158742|NCT01509846|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20158743|NCT03900728|Columbia University Irving Medical Center|Carolyn Westhoff, MD|2123057070|clw3@cumc.columbia.edu|
20158744|NCT03115411|Stanford University School of Medicine|Dr. Subhas Banerjee, MD|650-723-2623|sbanerje@stanford.edu|
20158745|NCT02544750|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20158746|NCT03751371|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
20158747|NCT02484443|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20158748|NCT02969915|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
20158749|NCT02595866|HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute|Kathryn Lurain, M.D.|240-858-3257|kathryn.lurain@nih.gov|
20158750|NCT02520388|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
20158751|NCT01740258|Duke University|Annick Desjardins, MD, FRCPC|919-681-1691|annick.desjardins@duke.edu|
20158752|NCT00418093|Dana-Farber Cancer Institute|Neil Horowitz, MD|617-732-8843|nhorowitz@partners.org|
20158753|NCT03162796|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20158754|NCT02342288|West Virginia University|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
20158755|NCT02375373|University of Florida|Volker Mai, PhD, MPH|352-273-9398|vmai@epi.ufl.edu|
20158756|NCT00407602|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director of Clinical and Scientific Affiars|8188335089|jdorn@secondsight.com|
20158757|NCT00431444|Novartis Pharmaceuticals|Study Director|862-778-8300||
20158758|NCT05007899|Nationwide Children's Hospital|Chelsea Kebodeaux|(614) 722-2250|Chelsea.Kebodeaux@nationwidechildrens.org|
20158759|NCT02368093|Taichung Veterans General Hospital|Der-Yuan Chen|884-4-23592525|dychen@vghtc.gov.tw|3354
20158760|NCT01763333|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158761|NCT02517398|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
20204438|NCT03229759|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
20204439|NCT00500045|Palo Alto Medical Foundation|Renee Kaneshiro|650-853-4744|kaneshr@pamf.org|
20204440|NCT00992446|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20204441|NCT00755846|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20204442|NCT03754933|GeoVax, Inc.|Kelly T. McKee, Jr., MD, MPH|(678) 384-7220|kmckee@geovax.com|
20204443|NCT00734344|University of Alabama at Bimingham|Principal Investigator|996-2371|heaths@uab.edu|
20204444|NCT00818207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204445|NCT02616185|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204446|NCT03621943|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
20204447|NCT01346371|Minnesota Eye Consultants, P.A.|Ahmad Fahmy, OD|612-813-3665|amfahmy@mneye.com|
20204448|NCT03309787|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
20204449|NCT01670656|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204450|NCT00111475|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20204451|NCT01062568|UCSD|Dr. R. Jeffery Chang|858-534-8930|rjchang@ucsd.edu|
20204452|NCT01170117|Columbia Center for Eating Disorders|Dr. Evelyn Attia|646-774-8085|ea12@cumc.columbia.edu|
20204453|NCT01026389|Guerbet|Post M. A. Clinical Unit Manager|+33 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
20204454|NCT01995136|Alcon Japan, Ltd.|Senior Manager, Phase IV|1-888-451-3937|alcon.medinfo@alcon.com|
20204455|NCT03544268|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20204456|NCT02543398|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
20204457|NCT02417870|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
20204458|NCT01830543|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20204459|NCT03496467|Mati Therapeutics|Deepank Utkhede|6046379717|dutkhede@matitherapeutics.com|
20204460|NCT01151046|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20204461|NCT02695524|University of São Paulo|Anamaria Siriani de Oliveira|+551633154415|siriani@fmrp.usp.br|
20204462|NCT01206478|University of Kansas Medical Center|Ann M Davis, PI|913-588-6300|adavis6@kumc.edu|
20204463|NCT02935699|TerSera Therapeutics|Medical Affairs|844-334-4035|tersera@medinfodept.com|
20204464|NCT03913221|University of North Carolina at Chapel Hill|Wesley Jackson, MD, MPH|984-215-3449|wesley.jackson@unc.edu|
20204465|NCT05439460|Stanford University|Chandra Ramamoorthy, MD|(650) 723-5728|chandrar@stanford.edu|
20204466|NCT03446651|Yale School of Medicine|Jeffrey Testani, MD, MTR|(203) 785-7191|jeffrey.testani@yale.edu|
20204467|NCT00798655|University of Pittsburgh|Robert Ferris, MD|412-647-4654|ferrrl@UPMC.EDU|
20204468|NCT00343291|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20204469|NCT00960934|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20204470|NCT02343276|Instituto de Cardiologia de Santa Catarina|Roberto Léo da Silva|55 48 32719077|robertoleo@hotmail.com|
20219047|NCT01830205|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20189186|NCT04200664|Ear Institute, University College London|Dr N Kharytaniuk (Clinical Research Fellow)|02076792000|n.kharytaniuk@ucl.ac.uk|
20189187|NCT02586857|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20158762|NCT03541499|Vanderbilt Vaccine Research Program|Dr. C Buddy Creech|615-3430332|buddy.creech@vanderbilt.edu|
20158763|NCT03554018|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20158764|NCT02131662|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20158765|NCT01618240|Massachusetts General Hospital|Hooman Mirzakhani|617-291-9779|hmirzakhani@partners.org|
20158766|NCT00962871|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20158767|NCT00130039|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
20158768|NCT01928433|Universityhospital Gießen and Marburg, Germany|Prof. Dr. med. Florian Wagenlehner|+49-641-98544516|Florian.Wagenlehner@chiru.med.uni-giessen.de|
20158769|NCT01740687|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20158770|NCT01562886|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
20158771|NCT01016132|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20158772|NCT02132572|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20158773|NCT01198574|South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition|Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar|+62-857-27262672|kyawhtet@gmail.com|
20158774|NCT00556439|Cleveland Clinic|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
20158775|NCT02100423|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Paolo Caimi|1-800-641-2422|paolo.caimi@uhhospitals.org|
20158776|NCT00936663|University of Nebraska Medical Center|Vijay Shivaswamy|402-559-6208|vshivaswamy@unmc.edu|
20158777|NCT03744910|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
20158778|NCT02744612|City of Hope Medical Center|Dr. Alex Herrera, MD|6263598111|aherrera@coh.org|
20158779|NCT04956731|University of California, San Diego|Office of Clinical Trials Administration|858-822-2940|octa@ucsd.edu|
20158780|NCT02220855|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
20158781|NCT03280303|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158782|NCT03419897|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20158783|NCT04105738|University of Massachusetts|Arlene Williams|508-856-5584|arlene.williams@umassmed.edu|
20158784|NCT01945216|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20158785|NCT04473950|University of California, San Francisco|David Andrew Tompkins, MD, MHS|628-206-3645|david.tompkins@ucsf.edu|
20158786|NCT01664117|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20158787|NCT01905943|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20158788|NCT02574078|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20158789|NCT05935878|University of Oxford, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences|Professor David W Murray|+44 01865 27457|david.murray@ndorms.ox.ac.uk|
20158790|NCT03980743|Washington University School of Medicine|Dr. Ginger E. Nicol|314-747-1862|nicolg@wustl.edu|
20158791|NCT03759639|IntraBio Ltd|Taylor Fields, Chief Product Development Officer|+44 8081 641283|tfields@intrabio.com|
20158792|NCT01461499|Shiga University of Medical Science|Steering Committee: Takashi Uzu|81-77-548-2222|takuzu@belle.shiga-med.ac.jp|
20158793|NCT01282242|Massachusetts General Hospital|Lee H. Schwamm, MD|617-724-1597|lschwamm@mgh.harvard.edu|
20158794|NCT01747343|University of Kansas|Brian D. Greer, Ph.D.|386-852-7171|brian.greer@unmc.edu|
20158795|NCT00958360|Hines VA Blind Center|Joan Stelmack, O.D., M.P.H.|708-202-2124|joan.stelmack@va.gov|
20158796|NCT03107052|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20158797|NCT03015363|CardioVascular Research New Brunswick (CVR-NB)|Sohrab Lutchmedial, MD, FRCP(C)|506-648-6101|sohrab.lutchmedial@horizonnb.ca|
20158798|NCT00500357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20158799|NCT02263326|Northwestern University|Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
20158800|NCT00078806|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20158801|NCT02200757|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20158802|NCT01893411|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20158803|NCT02397915|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158804|NCT00368745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20158805|NCT03292874|Cedars Sinai Medical Center|Dr. Hyung L Kim|310-423-4700|kimhl@cshs.org|
20158806|NCT00161616|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20158807|NCT00879034|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
20158808|NCT00933608|NYU School of Medicine|Lidia Glodzik|212.263.5698|Lidia.Glodzik@nyumc.org|
20158809|NCT02331589|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
20158810|NCT02719691|University of Colorado|Jennifer Diamond, MD|303-724-5499|jennifer.diamond@cuanschutz.edu|
20158811|NCT00336284|Biotronik, Inc.|Justin Michalski, M.S. / Clinical Studies Engineer|503-675-2155|justin.michalski@biotronik.com|
20158812|NCT01498744|Ann and Robert H. Lurie Children's Hospital of Chicago|Katherine A Barsness|3122274210|kbarsness@luriechildrens.org|
20158813|NCT01658709|University of Kentucky|Phillip Gribble|8592180885|phillip.gribble@uky.edu|
20158814|NCT00861757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20189188|NCT06193590|Indiana University Health|Dr. Alissa M Conklin|317.944.8231|alconkli@iu.edu|
20189189|NCT03745313|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20204471|NCT00980785|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-256-1901|cmc@medicine.wisc.edu|11691
20204472|NCT04281030|NYU Langone Health|Mia Minen|9294555130|Mia.Minen@nyulangone.org|
20204473|NCT01395368|Washington University in St. Louis|Dr. Jay F. Piccirillo, Professor|314 362-8641|piccirilloj@ent.wustl.edu|
20204474|NCT03474406|Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University.|Asist. Prof. Suratsawadee Wangnamthip|6624197842|suratsawadee.wan@mahidol.ac.th|
20204475|NCT00922194|Sircar Diabetes Clinic|Dr. Amulya R Sircar|+ 91 (522) 2324747|arsircar@yahoo.com|
20204476|NCT04131517|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20204477|NCT00288860|Nationa Center for PTSD Dissemination & Training Division|Craig S. Rosen|650-493-5000|craig.rosen@va.gov|22812
20204478|NCT05142332|University of California San Francsico|Robert Rodriguez|(628) 206-5875|Robert.Rodriguez@ucsf.edu|
20204479|NCT01718509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204480|NCT05906732|Thryv Therapeutics Inc.|VP Clinical Research|514-973-0915|admin@thryvtrx.com|
20204481|NCT02052778|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20204482|NCT02864940|Rush University Medical Center|Michael Chen, MD|312-563-2817|Michael_Chen@rush.edu|
20204483|NCT00004418|Kennedy Krieger Institute|Gerald Raymond|443-923-2750|raymond@kennedykrieger.org|
20204484|NCT04804033|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204485|NCT04124536|University of North Carolina at Chapel Hill|Benjamin Chi, MD, MSc|919-445-4174|bchi@med.unc.edu|
20204486|NCT01879176|Medical University of Vienna|Dr. Martin H. Bernardi|004314040041090|martin.bernardi@meduniwien.ac.at|
20204487|NCT03741725|University of North Carolina, Project-China|Dr. Weiming Tang|+86-15920567132|weiming_tang@med.unc.edu|
20204488|NCT01106625|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
20204489|NCT02496585|Memorial Sloan Kettering Cancer Center|Dr. Zachary Moore, MD, PhD|929-687-0151|moorez@mskcc.org|
20204490|NCT01100307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204491|NCT00997321|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
20204492|NCT00590018|Baylor College of Medicine|Dr. Heather Dickerson|832-826-5637|had@bcm.edu|
20204493|NCT01276457|Novartis Pharmaceuticals|Study director|862 778-8300||
20204494|NCT02065869|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384 1100|clinicaltrials@bellicum.com|
20204495|NCT00527111|US Oncology Network, McKesson Specialty Health|Dr. David McCollum|214-370-1080|david.mccollum@usoncology.com|
20204496|NCT02993224|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20204497|NCT04286412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204498|NCT03827473|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
20204499|NCT01423617|Analyze & Realize|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
20204500|NCT02635737|UHSM|Mr James Harvey|01612914436|james.harvey@uhsm.nhs.uk|
20204501|NCT01552928|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204502|NCT01511419|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20204503|NCT00937768|Mayo Clinic|Dr. R. Jeffrey Karnes|507 284-4430|Karnes.R@mayo.edu|
20204504|NCT04357379|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
20204505|NCT00488618|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
20204506|NCT00659724|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20204507|NCT05366413|Dana-Farber Cancer Institute|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
20204508|NCT04047121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204509|NCT00810459|Philips|Jeff Jasko|412-542-3651|Jeff.Jasko@philips.com|
20204510|NCT02604810|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20204511|NCT00786032|Hines Coordinating Center|Project Manager|708-202-5785|tamara.paine@va.gov|
20204512|NCT02922634|BWH|Dr. Gregory Crosby|617-732-7330|gcrosby@bwh.harvard.edu|
20204513|NCT02723604|Barbara Ann Karmanos Cancer Institute|Dr. Harold Kim|313-576-9543|kimh@karmanos.org|
20204514|NCT01194804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
20204515|NCT02494778|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20204516|NCT01303380|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20204517|NCT02174861|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20204518|NCT01215734|Vanderbilt University|Natasha Halasa, Associate Professor of Pediatrics|615-322-3346|natasha.halasa@vanderbilt.edu|
20204519|NCT00315705|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
20204520|NCT01716533|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204521|NCT02320695|Johnson & Johnson Consumer and Personal Products Worldwide|Christopher Nunez, PhD|973-385-7984|cnunez1@its.jnj.com|
20204522|NCT01393171|Kaiser Permanente|Dr John Nguyen|562-657-2642|john.n.nguyen@kp.org|
20204523|NCT02295735|Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy|PD Dr. Jan Kottner|+4930450518218|jan.kottner@charite.de|
20158815|NCT04397939|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
20158816|NCT01521923|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20158817|NCT00106119|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Kong Chen|3014511636|chenkong@niddk.nih.gov|
20204524|NCT00165841|Eisai Medical Research Inc.|Yufang Lu, Study Director|201-403-2500||
20204525|NCT00797797|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
20204526|NCT02006667|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20204527|NCT01626352|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
20204528|NCT02059213|University of Michigan Rogel Cancer Center|Phillip Palmbos, M.D., Ph.D.|734-936-3591|ppalmbos@umich.edu|
20219048|NCT01460901|Children's Mercy Hospitals and Clinics|Dr. Gary Douglas Myers|8163026817|gdmyers@cmh.edu|7-6817
20219049|NCT00117325|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219050|NCT01941940|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20219051|NCT02523196|University of Colorado Denver|Dr. Amanda Wieland|720-848-2291|amanda.wieland@cuanschutz.edu|
20219052|NCT01733147|Mayo Clinic|Dr. Prasad Iyer|507-293-7911|iyer.Prasad@mayo.edu|
20219053|NCT01745211|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20219054|NCT04394351|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20219055|NCT01106014|Actelion Pharmaceuticals Ltd|Clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
20219056|NCT01972919|Medical College of Wisconsin|Beth Erickson, MD|414-805-4462|BErickson@mcw.edu|
20219057|NCT05367336|Corewell Health Lakeland|Rachelle Pichot; Clinical Research Specialist|240-389-7340|rachelle.pichot@corewellhealth.org|
20219058|NCT04763564|University of North Carolina at Chapel Hill|Hans Herfarth, MD, PhD|9199666806|hherf@med.unc.edu|
20219059|NCT00658658|Amgen Inc.|Study Director|866-572-6436||
20219060|NCT00671918|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
20219061|NCT03182244|Astellas Pharma Inc|Clinical Transparency|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20219062|NCT02492880|Boston Scientific|Director of Clincial Sciences|855-213-9890|BSNClinicalTrials@bsci.com|
20219063|NCT03186781|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20219064|NCT00667810|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219065|NCT01561430|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219066|NCT01736241|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219067|NCT04234984|Department of Anaesthesiology & Pain Medicine, Maastricht University Medical Centre, Postbus 5800, 6202 AZ Maastricht, The Netherlands.|Prof. Dr. Jan Van Zundert|(+32) 475687657|jan.van.zundert@mumc.nl|
20219068|NCT01055132|Johnson & Johnson Vision Care|Ross Franklin|1-904-443-1379|RFrankl1@its.jnj.com|
20219069|NCT00415194|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219070|NCT00969540|Hologenix, LLC|Seth Casden|310-600-3673|seth.casden@celiant.com|
20219071|NCT00271154|Medtronic CRDM|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20219072|NCT01992523|Careggi Hospital|Guido Parodi|00390557947732|parodiguido@gmail.com|
20219073|NCT04536935|University of Washington|Morgan Johnson|715-416-1493|mjohn23@uw.edu|
20219074|NCT05297578|Vaxcyte|Vice President of Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
20219075|NCT03456583|Hologic|Muhammad Waqas|5088267183|Muhammad.Waqas@hologic.com|
20219076|NCT02266134|Kaiser Permanente Washington Health Research Institute|Dr. Cara C. Lewis|206-422-4076|Cara.C.Lewis@kp.org|
20219077|NCT01434186|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
20219078|NCT00831766|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
20219079|NCT02731326|Columbia University|Suzanne Bakken, PhD, RN|212-305-1278|sbh22@columbia.edu|
20219080|NCT01119716|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219081|NCT04380090|Cleveland Clinic Lutheran Hospital|Kathleen Gonzalez|2162174226|gonzalk2@ccf.org|
20219082|NCT00762437|AbbVie|Sally Hallas, RN|209-294-5571|sally.hallas@abbvie.com|
20219083|NCT00302081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20219084|NCT04480710|Hepion Pharmaceuticals Inc|Clinical Operations|732-902-4016|jgreytok@hepionpharma.com|
20219085|NCT02944071|BSC International Medical Trading (Shanghai) Co., Ltd|Junyang Bai|+13671646036|junyang.bai@bsci.com|
20219086|NCT05084963|Revolo Biotherapeutics|Chief Medical Officer|(888) 599-7431|clinicaltrials@revolobio.com|
20219087|NCT03569228|Department of Veterans Affairs|Candice Quinn, Principal Investigator|919-922-8046|candice.quinn@va.gov|
20219088|NCT05442866|MedStar Health Research Institute|Dr. Hunter Groninger|202-877-7445|hunter.groninger@medstar.net|
20219089|NCT03819049|Janssen Research & Development, LLC|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219090|NCT01986010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219091|NCT00115297|UMass|Craig M. Lilly, MD|508-868-5106|craig.lilly@umassmed.edu|
20219092|NCT01335997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219093|NCT00536263|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20219094|NCT00826449|University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, Associate Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
20219095|NCT01103466|Coloplast A/S|Dr. Lis Hentze Poulsen|4549111111|dklhp@coloplast.com|
20219096|NCT01019928|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20219097|NCT02994940|UC Davis Anesthesiology & Pain Medicine|Richard L. Applegate II MD|916-734-5028|rapplegate@ucdavis.edu|
20219098|NCT04300010|UW School of Medicine and Public Health|Eric Cotter, MD|920.362.9221|ecotter@uwhealth.org|
20219099|NCT02331368|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
20219100|NCT00725751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219101|NCT03670264|Children's Hospital of Philadelphia|Dr. Brian Jenssen|215-554-4390|jenssenb@chop.edu|
20219102|NCT02327741|shiraz university of medical sciences|Professor|009836250352|kojurij@yahoo.com|
20219103|NCT02365870|Johns Hopkins University School of Medicine|Dr. Gregory Pontone|(410) 502 - 0477|gpontone@jhmi.edu|
20204529|NCT02152670|Yale University|Gustavo Angarita, MD, Assistant Professor of Clinical Psychiatry|(203) 974-7536|gustavo.angarita@yale.edu|
20204530|NCT02681055|MediciNova, Inc.|Director, Research and Development|8583444535|makhay@medicinova.com|
20204531|NCT00127530|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|914-347-4300|ablight@acorda.com|102
20204532|NCT03712345|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
20204533|NCT05250830|The Ohio State University|Kara Rood|440-321-0264|Kara.Rood@osumc.edu|
20204534|NCT01819311|Florida International University|Jeremy W. Pettit (PI)|305-348-1671|jpettit@fiu.edu|
20204535|NCT00884052|University od California San Diego|Sponsor and Principal Investigator|8588226700|rhaas@ucsd.edu|
20204536|NCT00839423|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20204537|NCT01071096|Clinvest|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
20204538|NCT02585999|Boston Medical Center|Dr. Antonella Lavelanet|6174143745|Katharine.White@bmc.org|
20204539|NCT01332019|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20204540|NCT01369849|Mayo Clinic|Wei Ding, MBBS, PhD||ding.wei@mayo.edu|
20204541|NCT00871377|UCLA School of Medicine|Christopher M. DeGiorgio, MD|310-206-3753|cmd@mednet.ucla.edu|
20204542|NCT00330863|Medical College of Georgia, Georgia Regents University|Peter F. Buckley, MD|706-721-2231|pbuckley@gru.edu|
20204543|NCT00401622|LifeScan Scotland|Mike Grady|(44) 01463 721889|mgrady@its.jnj.com|
20204544|NCT02179515|National Cancer Institute|Dr. James Gulley|301-480-8870|James_Gulley@nih.gov|
20219104|NCT02302859|The University of Texas (UT) MD Anderson Cancer Center|Dr. Lorna McNeill, MPH,PHD/ Chair, Health Disparities Research|713- 563-1103|lmcneill@mdanderson.org|
20219105|NCT00001586|National Cancer Institute, National Institutes of Health|Wyndham H. Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
20204545|NCT02116660|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204546|NCT00848549|Eisai Call Center|Eisai Inc.|888-422-4743||
20204547|NCT02561299|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clintrials_csi@csi360.com|
20204548|NCT01248130|Massachusetts General Hospital|Gagan Joshi, MD|617-726-4651|lkfeinberg@mgh.harvard.edu|
20204549|NCT04168593|USaoPauloGH|Andre Wan Wen Tsai|5511981456449|tsai.andre@gmail.com|
20204550|NCT04183179|Michigan State University College of Nursing|Jiying Ling|5173538591|lingjiyi@msu.edu|
20204551|NCT04087343|The University of Texas Health Science Center at Houston|Jessica Lee, MD, MS, Assistant Professor|713-500-5457|Jessica.Lee@uth.tmc.edu|
20204552|NCT01911845|AbbVie|Global Medical Information|800-633-9110||
20204553|NCT01994226|Keele University|Sponsor|01782|research.governance@keele.ac.uk|734882
20204554|NCT04322994|Stanford University|Dr Thomas Caruso, MD, PhD|6507235728|tjcaruso@stanford.edu|
20204555|NCT02488551|Central Arkansas Veterans Health Care System|Michael Cucciare|501-526-8179|michael.cucciare@va.gov|
20204556|NCT02239770|Penn State College of Medicine|Dr. Patricia Sue Grigson|717-531-5772|psg6@psu.edu|
20204557|NCT01515995|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|mohamed.badawy@utsouthwestern.edu|
20204558|NCT01188564|Pharming Technologies|Anurag Relan, Vice President Clinical Research and Medical Affairs||a.relan@pharming.com|
20204559|NCT04171037|The University of Texas MD Anderson Cancer Center|Gang Zheng, MD|(713) 563-2731|gzheng@mdanderson.org|
20204560|NCT01934894|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
20204561|NCT00039195|Memorial Slaon Kettering|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
20204562|NCT04436822|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
20204563|NCT05118386|Gates Medical Research Institute|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20204564|NCT00369668|University of Florida, Motor Behavior Laboratory|James Cauraugh, Ph.D., PI|352-294-1623|jcaura@hhp.ufl.edu|
20204565|NCT00303108|New York Oncology Hematology, Albany Medical Center|Dr. Rufus Collea|518-262-6696|rufus.collea@usoncology.com|
20204566|NCT04158908|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
20204567|NCT00894413|Johns Hopkins University School of Medicine|Zubair Khan, MD|410-955-3157|zkhan@jhmi.edu|
20204568|NCT03929588|EyeQue|VP Science and Technology|5104558168|noam.sapiens@eyeque.com|
20204569|NCT03054077|Virginia Commonwealth University|Debra Shockey|804-828-3744|dpshockey@vcu.edu|
20204570|NCT00471445|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20204571|NCT02427477|Johnson & Johnson Vision Care Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-443-3500|JBUCH@its.jnj.com|1707
20204572|NCT04715230|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
20204573|NCT00958308|Bio-K+ International. Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
20204574|NCT00654511|Children's National Medical Center|Julia Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
20204575|NCT01468909|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20204576|NCT02389712|Mayo Clinic|Mark A. Frye, M.D.|507-255-7164|MFrye@mayo.edu|
20204577|NCT00304265|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20204578|NCT00311181|St Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
20204579|NCT03534063|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
20204580|NCT00078559|University of Wisconsin - Department of Medicine, Madison, Wisconsin|Arjang Djamali, MD, MS, FASN|608-262-7330|axd@medicine.wisc.edu|
20204581|NCT01313520|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20204582|NCT00506948|University of Texas (UT) MD Anderson Cancer Center|Amin Alousi, MD /Professor, Stem Cell Transplantation|713-745-8613|aalousi@mdanderson.org|
20204583|NCT02395653|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
20204584|NCT00849251|University of Washington|Dr. Pamela Becker|206-616-1589|pbecker@uw.edu|
20204585|NCT00789958|SWOG|SWOG Statistician|206-667-4408||
20219106|NCT01355159|Ottawa Hospital Research Institute|Dr. Mark Walker|6137378899|mwalker@ohri.ca|76655
20219107|NCT00016718|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20158818|NCT02403817|University of California, San Diego|Jeanne Townsend, PhD, Professor of Neurosciences|858-246-1931|jtownsend@ucsd.edu|
20158819|NCT02414607|University of Missouri|Dr. David Beversdorf|(573) 882-6081|beversdorfd@health.missouri.edu|
20158820|NCT00473889|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20219108|NCT02357342|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20219109|NCT01674647|Bayer HealthCare AG|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com|
20158821|NCT02440204|Severance|Dr. Jae Chul Koh|82-010-8702-3931|jaykoh82@gmail.com|
20158822|NCT04908384|University of Washington|Jennifer Sonney|206-685-2161|jsonney@uw.edu|
20158823|NCT01947283|Disparities Research Unit, Department of Medicine, Massachusetts General Hospital|Margarita Alegria|617-724-4987|malegria@mgh.harvard.edu|
20158824|NCT00430989|Bayside health|Professor Paul Myles|+61390762000|p.myles@alfred.org.au|3176
20158825|NCT05002985|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
20158826|NCT03782259|University of Washington|Francis Kim, MD|206-744-8305|fkim@uw.edu|
20158827|NCT04077424|Vanderbilt University Medical Center|Spyros Kalams, MD|6153222035|Joan.e.eason@vumc.org|
20158828|NCT00603941|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20158829|NCT00833469|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
20158830|NCT01642901|MetroHealth Rehabilitation Institute|Christina V Oleson, MD|216-778-4414|coleson@metrohealth.org|
20219110|NCT00944749|National Heart Lung and Blood Institute|Dr Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
20219111|NCT03212521|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20219112|NCT00444457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219113|NCT01401049|NYU School of Medicine|Mitchell Lee, MD|212.263.5071|mitchell.lee@nyumc.org|
20219114|NCT00914459|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219115|NCT01661179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20219116|NCT01602965|Istituto Ortopedico Rizzoli|Mariela Terrafino|0516366694|cristiana.forni@ior.it|0039
20219117|NCT03118570|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20219118|NCT01822574|Mayo Clinic|Robert T. Trousdale, M.D.|507-284-6586|trousdale.robert@mayo.edu|
20219119|NCT03071094|Transgene|Associate Medical Director|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
20219120|NCT02312063|Kansai Electric Power Medical Research Institute|Dr. Daisuke Yabe|+81-6-6458-5821|ydaisuke-kyoto@umin.ac.jp|
20219121|NCT04625426|Tan Tock Seng Hospital|George Glass, Nurse Researcher|+65 6903-5440|glass_george_frederick@ttsh.com.sg|
20219122|NCT01573169|Stroke Unit and Division of Internal and Cardiovascular Medicine University of Perugia, Santa Maria della Misericordia Hospital|Dr. Maurizio Paciaroni|+390755786424|maurizio.paciaroni@unipg.it|
20219123|NCT00321737|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20219124|NCT01079832|Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
20219125|NCT02283294|University of South Florida|David Rose, MD|813-259-8577|drose1@usf.edu|
20219126|NCT00594646|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
20219127|NCT01769339|Janssen Philippines|Medical Affairs Manager|+6328248935||
20219128|NCT01195272|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20219129|NCT03548064|University of Maryland|Wilbur H. Chen, MD, MS|410-706-1188|wchen@som.umaryland.edu|
20219130|NCT04941729|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20219131|NCT00006721|SWOG Statistical Center|Study Statistician|206-667-4623||
20219132|NCT03653507|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20219133|NCT03299088|U of California Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
20219134|NCT03986138|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 (0)6 80 24 93 34|frantz.hebert@guerbet.com|
20219135|NCT04305587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219136|NCT01523457|Yale University|Jill Lacy|+1 (203) 737-1600|jill.lacy@yale.edu|
20219137|NCT01367665|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20219138|NCT02752906|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20219139|NCT01200992|Prometic Biosciences Inc.|Aline Hagerimana, MD, Senior Director Clinical Affairs|(514) 781-0115|a.hagerimana@prometic.com|
20219140|NCT00792935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219141|NCT05984186|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
20219142|NCT03398070|Massachusetts General Hospital|David Perez|6177262000|dlperez@partners.org|
20219143|NCT00197392|Codman & Shurtleff, Inc|J. Thomas Megerian, MD|508.880.8274|jmegeri1@its.jnj.com|
20219144|NCT02622113|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20219145|NCT02369900|Beth Israel Deaconess Medical Center|Michael N. Cocchi MD|617-754-2388|mcocchi@bidmc.harvard.edu|
20219146|NCT01076686|Pacira Pharmaceuticals|Executive Medical Director|203-837-6500|erolo@pacira.com|
20219147|NCT02244918|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
20219148|NCT00673153|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS|(206) 667-3599||
20219149|NCT01916590|UColorado|Colleen Dingmann R.N. Ph.D.|303-724-7494|colleen.dingmann@ucdenver.edu|
20219150|NCT03514641|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
20219151|NCT01345175|Memorial Sloan Kettering Cancer Center|Dr. Philip Paty, MD|212-639-6703|patyp@MSKCC.ORG|
20189190|NCT03292133|Massachusetts General Hospital|Zofia Piotrowska, MD|6176439707|Zofia.Piotrowska@MGH.HARVARD.EDU|
20219152|NCT00505375|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
20219153|NCT00642694|UT Southwestern Medical Center|Dr.Prabha Sunderajan- Assistant Professor|214-645-6964|psunderajan@utsouthwestern.edu|
20219154|NCT04112173|University of Delaware|Jeremy Crenshaw, Ph.D.|302-831-4795|crenshaw@udel.edu|
20219155|NCT04796779|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20219156|NCT02570113|Ablative Solutions Inc|Kate Rumrill|+1 (650) 688-9743|krumrill@ablativesolutions.com|
20219157|NCT02746471|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
20219158|NCT02564211|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219159|NCT00858962|Yale University AIDS Program|R. Douglas Bruce, MD, MA|(203) 737-6133|robert.bruce@yale.edu|
20219160|NCT00622466|The University of Texas Southwestern Medical Center|Dr. Barbara Haley|214-648-4180|barbara.haley@utsouthwestern.edu|
20219161|NCT02551432|Seoul National University Hospital|Bhumsuk Keam|82+10-3231-2208|bhumsuk@snu.ac.kr|
20219162|NCT04492020|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20219163|NCT04594707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20219164|NCT04585789|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219165|NCT01175811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219166|NCT00326963|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20219167|NCT00759187|Colgate Palmolive|William DeVizio- DMD|732-878-7901|William_Devizio@colpal.com|
20219168|NCT01447420|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20219169|NCT03362112|Nanjing First Hospital|Ma Jianhua|8625-52887092|majianhua196503@126.com|
20219170|NCT04562155|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20219171|NCT00851318|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
20219172|NCT01442688|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20219173|NCT02643355|Hennepin Healthcare|Dr. Marc Martel|612-873-7448|Edresearch@hcmed.org|
20219174|NCT05961215|Cedars-Sinai Medical Center|Robert Vescio, MD|3104231825|robert.vescio@cshs.org|
20219175|NCT05187013|George Washington University|Ramin Asgary|(202) 994-6803|raminasgary1@gwu.edu|
20219176|NCT04480021|University of Washington|Dr. Amritha Bhat|206-543-3117|amritha@uw.edu|
20219177|NCT01096368|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20219178|NCT06354998|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20219179|NCT01568320|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20219180|NCT01616953|University of Michigan|Dr. Darnell Kaigler|734-615-4023|dkaigler@umich.edu|
20219181|NCT00762931|electroCore LLC|Clinical Affairs electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
20219182|NCT00816361|MedImmune LLC|Susan Perez MD, MSc|+1 301-398-2827|information.center@astrazeneca.com|
20219183|NCT01394952|Eli Lilly and Company|Chief Medical Officer|800-545-5979|www.ClinicalTrials.gov@lilly.com|
20219184|NCT02440568|University of Illinois at Chicago|Dr. John Quigley|312-413-1300|seanq@uic.edu|
20219185|NCT01031953|Oregon Health & Science University|Dr. Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
20219186|NCT01763684|Zimmer Biomet|Linda Meijer, Clinical Operations Manager|+31786292935|linda.meijer@zimmerbiomet.com|
20219187|NCT02642575|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20219188|NCT01520532|Medtronic AF Solutions|Jay Kelley, Director of Clinical Research|+1.760.827.0076|jay.l.kelley@medtronic.com|
20219189|NCT00643565|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20219190|NCT02562482|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Grace Chen, Deputy Chief, Clinical Trials Program, Vaccine Research Center|240-669-2809|grace.chen@nih.gov|
20219191|NCT00975286|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20219192|NCT01490866|SCRI Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
20219193|NCT04135196|Worcester Polytechnic Institute|Dr. Karen Troy|1-(508)-831-5000|ktroy@wpi.edu|6093
20219194|NCT03201211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219195|NCT01970865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219196|NCT01946191|University of Utah|Dr. Molly Conroy|801-581-8310|Molly.Conroy@hsc.utah.edu|
20219197|NCT01083810|Abbott|Global Medical Services|1-800-633-9110||
20219198|NCT02041091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219199|NCT01855074|Janssen. Pharmaceutical Companies of Johnson and Johnson|Medical Manager Neurosciences|+507-3989740|dmuschet@its.jnj.com|
20219200|NCT01150890|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20219201|NCT03801382|Philips Research|Clinical product lead|+31646802217|daisy.van.minde@philips.com|
20219202|NCT03544879|UC San Diego|Dr. Erik Groessl|858-642-6347|egroessl@ucsd.edu|
20219203|NCT05424042|Wake Forest University School of Medicine|Cynthia Stowe|336-716-0686|cynthia.stowe@advocatehealth.org|
20219204|NCT05091307|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219205|NCT03611543|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs, BSH|(508) 263-8935|ClinicalResearch@Hologic.com|
20219206|NCT05205772|University of North Carolina at Chapel Hill|Miriam Sklerov, MD, MS|984-974-4401|miri@email.unc.edu|
20219207|NCT03047473|Clinique Neuro-Outaouais|Dr Francois Jacques|819-777-2500|francois.jacques@neuro-outaouais.ca|217
20219208|NCT01167257|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
20219209|NCT01480843|Joslin Diabetes Center|Medha Munshi, MD|617-309-4683|medha.munshi@joslin.harvard.edu|
20219210|NCT03283319|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
20219211|NCT00721630|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-5209|trainat@mskcc.org|
20219212|NCT03402555|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
20219213|NCT02213510|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
20219214|NCT03954834|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20189191|NCT03611075|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20219215|NCT04773301|Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Agustín Díaz Álvarez|0034 923291353|adiazal@saludcastillayleon.es|
20219216|NCT03786718|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
20189192|NCT01701401|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20189193|NCT02962102|Brigham and Women's Hospital|Dr. David Leaf|617-525-7612|deleaf@bwh.harvard.edu|
20189194|NCT04827732|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
20189195|NCT04021862|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189196|NCT04057131|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20189197|NCT03835754|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
20204586|NCT00074724|MedStar Health Research Institute|Scientific Center Administrator|301-560-7300|Research@medstar.net|
20204587|NCT02622724|Faron Pharmaceuticals|Chief Medical Officer|+3584005529411|medical@faron.com|
20204588|NCT00296725|New York State Psychiatric Institute|Jonathan W. Stewart, M.D., Principle Investigator|646-774-8070|jws6@cumc.columbia.edu|
20204589|NCT00487084|Northwestern University|Cynthia A. Wong,M.D.|630-472-3555|c-wong2@northwestern.edu|
20204590|NCT00254293|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20204591|NCT04863417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204592|NCT01648452|National Eye Institute|Paul A Sieving, MD, PhD|301-496-2234|ps261o@nih.gov|
20204593|NCT01000727|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204594|NCT03137121|Univ Alabama Birmingham|Rudolph M Navari|574-261-8385|rmnavari@gmail.com|
20204595|NCT03196193|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
20204596|NCT02207478|Shanghai Chest hospital|Dr. Jiayuan Sun|+86 18017321598|jysun1976@163.com|
20204597|NCT02709083|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
20204598|NCT01290445|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219217|NCT00945100|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
20219218|NCT01997216|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20219219|NCT00372411|Dept. of Veterans Affairs, Cooperative Studies Program, West Haven, CT|Peter Guarino, MPH, PhD, Director, WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
20219220|NCT01398514|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
20219221|NCT04208958|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
20219222|NCT02326337|AOTI Ltd.|Dr. Mike Griffiths (Medical Director)|+1(760) 431 4700|mike.griffiths@aotinc.net|
20219223|NCT01570686|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20204599|NCT02568345|Central Hospital, Irmandade da Santa Casa de Misericórdia (ISCM)|Mauro Prado da Silva|+55 11 2176 7000|comissaocientifica@fcmsantacasasp.edu.br|
20204600|NCT01697267|Cambridge University Hospitals NHS Foundation Trust|Prof David Jayne|01223 748062|dj106@cam.ac.uk|
20204601|NCT04410198|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-097Study@fibrogen.com|
20204602|NCT02939937|assistant|dr.alireza gholizade|989112550646|a.gholizade13@yahoo.com|
20204603|NCT02607254|Johns Hopkins University|Dr. Mohammad Khoshnoodi|410-955-5406|mkhoshn1@jhmi.edu|
20204604|NCT02943265|University of Kansas Medical Center|Simon Lee|(913) 588-2689|slee21@kumc.edu|
20204605|NCT03623334|UT Southwestern Medical Center|Sarah Hardee|214-648-1836|sarah.hardee@utsouthwestern.edu|
20204606|NCT00120289|Axio Research, LLC|Ruth McBride|206-577-0212|ruthm@axioresearch.com|
20204607|NCT01590394|Mayo Clinic|Christopher J. Gostout|507-284-7647|gostout.christopher@mayo.edu|
20204608|NCT00782418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204609|NCT00882999|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20204610|NCT01757405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204611|NCT01434641|St. Luke's-Roosevelt Hospital|E. Gordon DePuey, M.D.|212-523-3400|edepuey@chpnet.org|
20204612|NCT00082758|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20204613|NCT00238303|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|galanis.evanthia@mayo.edu|
20204614|NCT01833741|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20204615|NCT00937560|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20204616|NCT00941889|Washington University|Steven Hunt, MD|314-454-7177|hunts@wudosis.wustl.edu|
20204617|NCT00305643|UT MD Anderson Cancer Center|Scott Kopetz, MD, PHD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20204618|NCT00501046|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20204619|NCT02190747|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20204620|NCT01576016|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
20204621|NCT00689819|Wayne State University|Phillip Levy, MD|3139938558|plevy@med.wayne.edu|
20204622|NCT03664193|Weill Cornell Medicine|Josephine Kang|212-746-3607|jok9106@med.cornell.edu|
20158831|NCT02707965|University of Maryland, School of Pharmacy|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
20158832|NCT02943070|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
20158833|NCT00570778|Novartis Pharmaceuticals|Study Director|862-778-8300||
20158834|NCT00711594|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219224|NCT03688282|TheraNova|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
20219225|NCT02906930|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20219226|NCT00910091|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20219227|NCT01908816|Novartis Pharmaceuticals|Study Director|862-778-8300||
20158835|NCT01014767|Tufts Medical Center|Research Administration|617-636-1142|mcoughlin@tuftsmedicalcenter.org|
20219228|NCT02109419|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
20158836|NCT02802293|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
20219229|NCT02628743|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20219230|NCT02534844|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
20219231|NCT00655876|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20158837|NCT00131352|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20158838|NCT03024112|University of Colorado, Denver|Dr. Jason Brainard|720-848-3257|Jason.Brainard@ucdenver.edu|
20158839|NCT02443337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20158840|NCT02096952|Massachusetts General Hospital|Dr. Gahan Joshi|617-726-8392|joshi.gagan@mgh.harvard.edu|
20158841|NCT00253513|OHSU Knight Cancer Institute|Eneida Nemecek, MD|(503) 494-0829|nemeceke@ohsu.edu|
20158842|NCT00988052|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20158843|NCT01313910|UCaliforniaDavis|David Asmuth, MD|9167348695|david.asmuth@ucdmc.ucdavis.edu|
20158844|NCT02446769|Philips|Chuck Cain|412-542-3605|chuck.cain@philips.com|
20158845|NCT04482439|Newsom Eye and Laser Center|T. Hunter Newsom, MD|813-908-2020|hunter@newsomeye.net|
20158846|NCT01103440|Icahn School of Medicine at Mount Sinai|Dr. Annapoorna S Kini|(212) 241-4181|Annapoorna.Kini@mountsinai.org|
20158847|NCT03072043|Moffitt Cancer Center|David Sallman, MD|813-745-6841|David.Sallman@moffitt.org|
20158848|NCT01277822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158849|NCT02923531|X4 Pharmacueticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
20158850|NCT00997984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20158851|NCT01569737|HRA Pharma|Christine Adelbrecht, Clinical Trial Coordinator|+33 1 40 33 32 74|c.adelbrecht@hra-pharma.com|
20158852|NCT02997865|Washington University School of Medicine in St. Louis|Kenneth E. Freedland, PhD|314-286-1311|freedlak@wustl.edu|
20158853|NCT00894699|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20158854|NCT02626156|Medical University of South Carolina|Teresa J. Kelechi|843-792-4602|kelechtj@musc.edu|
20158855|NCT00295646|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
20158856|NCT02243371|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20158857|NCT01736267|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
20189198|NCT02830204|Baylor Scott and White Research Institute|Walter Cerqueira|469-814-3393|walter.cerqueira@bswhealth.org|
20204623|NCT04507867|Universidad Anáhuac México Norte|Dr. Fernando Leal Martínez|+52 5521094339|ferman5@hotmail.com|
20204624|NCT01860534|University of Texas medical Branch, Galveston|Dr. Cara Geary|409-772-2815|cageary@utmb.edu|
20204625|NCT02520518|COLORADO STATE UNIVERSITY|Manager of Research Operations|970-491-2242|Laurie.Biela@colostate.edu|
20204626|NCT00301028|UT MD Anderson Cancer Center|Merrill S. Kies, MD / Professor||CR_Study_Registration@mdanderson.org|
20204627|NCT02175771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20204628|NCT03364673|Dana-Farber Cancer Institute|Alexi Wright, MD, MPH|617-632-2334|alexi_wright@dfci.harvard.edu|
20204629|NCT02208024|University of Cincinnati Cancer Center|Jordan Kharofa, Associate Professor, Department of Radiation Oncology|(513)-584-4073|kharofjr@ucmail.uc.edu|
20204630|NCT00779324|Indiana University School of Medicine|Flora Hammond, MD|3173292106|flora.hammond@rhin.com|
20204631|NCT02207556|Medical College of Wisconsin|Dr. Anita D'Souza|414-805-0637|dsouza@mcw.edu|
20204632|NCT03558555|Icahn School of Medicine at Mount Sinai|Dr. Alopi Patel|(212) 523-6357|Alopi.patel@mountsinai.org|
20204633|NCT00194025|Case Western Reserve University and Unversity Hospitals Case Medical Center|Martha Sajatovic MD|216-844-2808|martha.sajatovic@uhhospitals.org|
20204634|NCT00543569|Astellas Pharma Global Development, Inc. (APGD)|Global Head Global Medical Sciences--Transplant and Immunology/Inflammation||Astellas.resultsdisclosure@astellas.com|
20204635|NCT00862849|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
20204636|NCT00617409|H. Lee Moffitt Cancer Center and Research Institute|Dr. Scott Antonia|813-745-3883|scott.antonia@moffitt.org|
20204637|NCT03615469|Indiana University|Dr. Christine Haedtke|317-274-5358|chaedtke@iu.edu|
20204638|NCT01153763|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204639|NCT00837512|Emory University School of Medicine|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
20204640|NCT01474746|University of California, Davis, MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
20204641|NCT00853333|University of Alabama at Birmigham|Michael Froelich|(205)975-0145|froelich@uab.edu|
20204642|NCT01606761|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20219232|NCT01265433|Sellas Life Sciences|Dr. Dragan Cicic|646-200-5278|info@sellaslife.com|
20158858|NCT01945996|University of Southern California|Elizabeth Burner|3232266667|eburner@usc.edu|
20204643|NCT05086289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20204644|NCT04544709|University of Utah Orthopaedics Center|Heather Littell, Regulatory Coordinator|801-587-5432|u6041929@utah.edu|
20204645|NCT03238235|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
20204646|NCT01814800|ADMA Biologics|Jimmy Mond, M.D., Ph.D|201-478-5552|jmond@admabio.com|
20204647|NCT03807739|Genentech, Inc|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20204648|NCT02371759|University of Belgrade, Faculty of Dental Medicine|DDS PhD Professor Dragica Stojic, DDS PhD Professor Bozidar Brkovic, DDS PhD Marija Milic|+ 381 11 2685 280|brkovic73@yahoo.com|244
20204649|NCT02322320|The Emmes Company|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20204650|NCT00125658|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|carolynn.patten@va.gov|4160
20204651|NCT02876055|Mayo Clinic|Dr. Jason K. Panchamia|507-284-9698|panchamia.jason@mayo.edu|
20204652|NCT00086957|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20204653|NCT00321100|Fox Chase Cancer Center|Dr. Steven Cohen|215-214-1676|steven.cohen@fccc.edu|
20204654|NCT03201198|University of Michigan School of Nursing|Dr. Janet Larson|7346470126|janetlar@med.umich.edu|
20204655|NCT03213626|IndianaU|Dr. Patrick Loehrer|(317) 278-7418|ploehrer@iu.edu|
20204656|NCT01767194|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20204657|NCT02625324|Medtronic|Rianna Rapson - Clinical Study Manager|763-526.2170|rianna.k.rapson@medtronic.com|
20204658|NCT02457182|University of New Mexico|Gregg Kanter, MD|818-599-3456|greggkanter@gmail.com|
20204659|NCT00352755|Washington University School of Medicine|Dr. James Fleshman|314-747-4610|James.Fleshman@BSWHealth.org|
20204660|NCT02397694|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20204661|NCT01116687|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
20204662|NCT00424528|Sepracor Inc|Respiratory Medical Affairs Director|866-503-6351||
20204663|NCT02115113|Novartis Pharmaceuticals|Study Director|862-778-8300||
20204664|NCT02278640|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20204665|NCT00789191|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20204666|NCT02168933|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465||
20204667|NCT03497429|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20204668|NCT01009983|Wake Forest University Health Sciences|Dr. Susan Melin|336-716-2839|smelin@wakehealth.edu|
20204669|NCT03736629|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20204670|NCT00967226|Childrens Research Institute|Nancy M. Bauman MD, Principle Investigator|2024764270|nbauman@cnmc.org|
20204671|NCT05254613|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20204672|NCT02338492|IlluminOss Medical Inc.|Gene DiPoto|401-714-0008|gdipoto@illuminoss.com|202
20204673|NCT03377244|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
20204674|NCT00756886|Surgery - Cardiovascular/Thoracic|Ayesha S. Bryant, MD|(205) 996-7561|abryant@uab.edu|
20204675|NCT00174785|sanofi-aventis|International Clinical Development (ICD), Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20204676|NCT00274768|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-6192|awolff@jhmi.edu|
20204677|NCT00310388|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20204678|NCT05161351|Imperial College London Faculty of Medicine|Agnese Zicari,Quality Assurance Facilitator|+44(0)2075946615|a.zicari08@imperial.ac.uk|
20204679|NCT02082145|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20204680|NCT04732819|Hebrew SeniorLife|Sarah Berry, MD|617-971-5355|sarahberry@hsl.harvard.edu|
20204681|NCT04019275|University of Pittsburgh|Elizabeth Skidmore|412-383-6620|skidmore@pitt.edu|
20204682|NCT02344407|Division of Biostatistics, University of Minnesota|Greg Grandits|612-626-9033|grand001@umn.edu|
20204683|NCT02918409|National Jewish Health|Dr. Milene Saavedra|303-270-2333|saavedram@njhealth.org|
20204684|NCT00677690|Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
20204685|NCT00803543|University of Alabama at Birmingham|Nicholas Van Wagoner|205-934-2840|nvw@uab.edu|
20204686|NCT00503880|University of Nebraska Medical Center|Lori Maness-Harris, MD|402-559-3848|lmaness@unmc.edu|
20204687|NCT03198754|Icahn School of Medicine at Mount Sinai|Heiðdís B. Valdimarsdottir|(212) 659-5678|heiddis.valdimarsdottir@mssm.edu|
20204688|NCT00668200|Novartis Pharmaceuticals|Study Director|8627788300||
20204689|NCT01362686|Regenstrief Insitute|Dr. Noll Campbell|317-274-9051|cambenl@regenstrief.org|
20204690|NCT01496430|Takeda|Medical Director; Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20204691|NCT02108951|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20204692|NCT00932152|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
20204693|NCT01962714|VA Puget Sound Health Care System|David Kearney, MD|206-277-1445|david.kearney@va.gov|
20204694|NCT01151579|Genesys Regional Medical Center|Dr. Fahim Khorfan|810-606-7722|kbarber@genesys.org|
20204695|NCT02991937|NYU Langone Health|Jason Fisher, MD|212-263-7391|Jason.Fisher@nyulangone.org|
20204696|NCT03633227|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
20204697|NCT00400829|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20204698|NCT04836455|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
20219233|NCT01468818|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
20204699|NCT01766336|Transition Therapeutics Ireland Limited|Aleksandar Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20204700|NCT03976531|Institut Bergonié|Pr S Mathoulin-Pélissier|33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20219234|NCT01714232|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20219235|NCT00296231|University of Iowa|Tarah Colaizy||tarah-colaizy@uiowa.edu|
20219236|NCT00338455|Scios R&D, Inc.|Sr. Director Clinical Leader|650 564-5084||
20219237|NCT02176408|NYU Langone Health|Kristin Szuhany|6467545161|kristin.szuhany@nyulangone.org|
20219238|NCT01059344|The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcertive Colitis|Brian G. Feagan et al|Gastroenterology 2013; 145:||149-157
20219239|NCT01739348|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219240|NCT00328016|National Institute on Aging|Jessica McNeeley, Research Fellow|410-558-8110|mcneeleyj@mail.nih.gov|
20219241|NCT01085201|BloodCenter of Wisconsin|Dr. Joshua J. Field|414-937-3848|joshua.field@bcw.edu|
20219242|NCT02699060|IMSechenovMMA|MD, PhD Ivashkin Vladimir Trofimovich|+79252667987|motility_2013@mail.ru|
20219243|NCT00528411|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20219244|NCT03893565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219245|NCT01715571|Johns Hopkins University School of Medicine|Arthur Burnett, MD|410-614-3986|aburnet1@jhmi.edu|
20219246|NCT01687972|Johns Hopkins Univesity School of Medicine|Janice Henderson, MD Assistant Professor|443-287-2783|jhender7@jhmi.edu|
20219247|NCT04558918|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20219248|NCT04658095|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
20219249|NCT02387983|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219250|NCT00077857|Hoffman-LaRoche|Medical Communications|800-821-8590||
20219251|NCT05779943|Emory University|Dr. David Schuster|4047781900|dschust@emory.edu|
20219252|NCT06187909|Department of Anesthesia, Intensive Care, and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt|Yasser Mohamed Reyad Ahmed El-Mansoury|01000286206|yassermoahmed0102107@med.asu.edu.eg|
20219253|NCT05407714|BSC International Medical Trading (Shanghai) Co., Ltd|Associate Clinical Trial Manager|+13671646036|junyang.bai@bsci.com|
20219254|NCT02987959|Fox Chase Cancer Center|Protocol Developer|215-728-4097|ryan.romasko@fccc.edu|
20219255|NCT00673244|Department of Anesthesiology and Critical Care Medicine, George Washington University|Lakhmir S. Chawla|202-994-7903|minkchawla@gmail.com|
20219256|NCT01011179|The Hospital for Sick Children|Dr. Jennifer Stinson|416-813-7654|jennifer.stinson@sickkids.ca|304514
20219257|NCT02205983|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
20219258|NCT03285308|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20219259|NCT02283983|Centre Hospitalier Départemental Vendée|Dr. Frank PRIOU|0251446161|frank.priou@ght85.fr|+33
20219260|NCT03283761|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
20189199|NCT02921555|Grupo Español de Trabajo en Enfermedad de Crohn y colitis Ulcerosa|Dr. Eugeni Domènech|635899553|soporte@geteccu.org|
20189200|NCT04445831|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
20189201|NCT03268421|Cincinnati Children's Hospital|Susmita Kashikar-Zuck, PhD|513-636-6337|susmita.kashikar-zuck@cchmc.org|
20189202|NCT05613907|Leeds Vascular Institute|Dr Assad Khan|0113|assad.khan3@nhs.net|
20189203|NCT05080777|University of Connecticut Center on Aging|Dr. Richard Fortinsky|860-679-8069|fortinsky@uchc.edu|
20189204|NCT04728711|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20189205|NCT04705415|NeurobBo|Sr. Vice President Clinical Operations|8572991035|crinfo@neurobopharma.com|
20189206|NCT01586104|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. David Walterhouse|3122274000|d-walterhouse@northwestern.edu|
20189207|NCT02473276|Columbia University|Richard Smiley|212 305 5006|rms7@cumc.columbia.edu|
20189208|NCT03110575|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
20189209|NCT04701203|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
20189210|NCT05001139|Relife Srl|Prof. Giuseppe Micali|05556809528|lfabbri@relifecompany.it|
20189211|NCT00491894|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20189212|NCT01563185|Horizon Pharma|Julie Ball, Senior Director of Clinical Development & Operations|224-383-3059|jball@horizonpharma.com|
20189213|NCT02842749|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20189214|NCT05293717|University of Rochester|Anna De Benedetto, MD|(585) 275-7546|anna_debenedetto@urmc.rochester.edu|
20189215|NCT05422339|MapHabit|Matt Golden|9143301776|mgolden@maphabit.com|
20189216|NCT04172675|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189217|NCT06072170|Altasciences|Senior Regulatory Affairs Associate|450 973 3155|mgalarza@altasciences.com|112084
20189218|NCT05029284|University of Minnesota|Dr. Emily Kringle|(612) 624-8994|ekringle@umn.edu|
20189219|NCT03070392|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
20189220|NCT02972034|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189221|NCT03009344|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20189222|NCT00378898|Vanderbilt University Medical Center|Dr. Michael Vaezi|615-322-3739|michael.vaezi@vanderbilt.edu|
20189223|NCT02794428|Vanderbilt-Ingram Cancer Center|Douglas Morgan|615-936-7423|drmorgan@uabmc.edu|
20189224|NCT03560323|University of Texas Health -San Antonio|Yuejuan Qin, Assistant Professor|210-358-7200|qiny@uthscsa.edu|
20189225|NCT02534233|Johns Hopkins Hospital|Dr Marcia Canto, Director of Clinical Research|443-287-8083|mcanto1@jhmi.edu|
20189226|NCT01427517|University of Minnesota|Mary Holmay|612-812-5854|holma101@umn.edu|
20189227|NCT01278030|St. Jude Medical|John Gill|818-493-2609|jgill@sjm.com|
20189228|NCT02949297|Endologix, LLC|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
20189229|NCT00458783|Cleveland Clinic|Andra Duncan, MD|216-445-2372|duncana@ccf.org|
20189230|NCT01737398|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20189231|NCT06307457|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219261|NCT02654860|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20219262|NCT03055650|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
20219263|NCT04453202|Janssen Vaccines & Prevention B.V.|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219264|NCT05308368|NC State University|Nitin Sharma|9195130787|nsharm23@ncsu.edu|
20189232|NCT03220724|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20189233|NCT00019604|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
20189234|NCT01379651|Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy|Dr. Iride Dello Iacono|+39 824 771111|iridedello@hotmail.com|
20189235|NCT01545583|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20189236|NCT02522104|Addmedica|Medical director|+33 1 72 69 01 86|corinne.duguet@addmedica.com|
20189237|NCT00454194|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507-284-9265|alex.adjei@roswellpark.org|
20189238|NCT01354145|Bioiberica|Marta Herrero - Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
20204701|NCT02605447|Boston Scientific Corp.|Peter Maurer, Director Clinical Trials|+1 (508) 683|Peter.Maurer@bsci.com|6678
20204702|NCT01479374|Alcon Research, Ltd.|Abhijit Narvekar, MS, MBBS|1-888-451-3937|alcon.medinfo@alcon.com|
20204703|NCT01062074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189239|NCT01556594|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20204704|NCT02045212|Regenera Pharma Ltd|Dr Konstantin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
20204705|NCT03150108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204706|NCT00145249|University of Alabama at Birmingham|Peter G. Pappas, MD|205-934-9951|pappas@uab.edu|
20204707|NCT00515008|tufts medical center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
20204708|NCT03135028|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20204709|NCT02774226|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
20204710|NCT03744780|McGill University|Mallory Frayn, PhD(c)|N/A|mallory.frayn@mail.mcgill.ca|
20204711|NCT03992768|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
20204712|NCT00218036|The University of Texas Health Science Center at Houston|Joy M Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
20219265|NCT00669071|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20219266|NCT00168311|Monash Alfred Psychiatry Research Centre|Professor Paul Fitzgerald|+61 3 9076 6564|p.fitzgerald@alfred.org.au|
20219267|NCT04305496|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20219268|NCT01157897|WRAIR|Donna Tosh|301-319-9332|donna.m.tosh.ctr@mail.mil|
20219269|NCT03276221|Massachusetts General Hospital|Randi M. Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
20219270|NCT00424775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20219271|NCT00681590|University of Miami|Dr. Silvina Levis|305-575-3388|slevis@miami.edu|
20219272|NCT02912650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219273|NCT01795105|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
20219274|NCT01270724|Nationwide Children's Hospital|Megan Blue|614-722-3686|megan.blue@nationwidechildrens.org|
20219275|NCT01791153|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20219276|NCT02876926|Brown University School of Public Health|Dr. Tyler Wray|401-863-6659|tyler_wray@brown.edu|
20219277|NCT00939120|Research institute at Deaconess Clinic|Dr. Paul Siami|812-426-9548|paul.siami@deaconess.com|
20219278|NCT00916136|Vanderbilt|William Obremskey MD MPH|615-936-0112|william.obremskey@vanderbilt.edu|
20189240|NCT01703598|Oregon Health & Science University|Matthew Brodsky MD|503-494-9054|brodskym@ohsu.edu|
20204713|NCT03126539|Johns Hopkins University|Dr. Anna Chien|410-502-7546|CTReP@jhmi.edu|
20204714|NCT03645408|Boston Medical Center/Boston University School of Medicine|Dr. Eric Devine|617-414-1990|eric.devine@bmc.org|
20204715|NCT02596711|UT MD Anderson Cancer Center|Dr. Marcel A. de Dios / Health Disparities Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20204716|NCT01005732|University of Washington|Loren Engrav|206-744-3209|engrav@u.washington.edu|
20204717|NCT04030104|Seno Medical Instruments, Inc.|Vice President of Clinical Operations|210-615-6501|sschaeffer@senomedical.com|
20204718|NCT00632463|ADMA Biologics|Chief Medical Officer|201-478-5552|agrossman@admabio.com|
20204719|NCT00626912|Centre de Recherches du Centre Hospitalier de l'Université de Montréal|Ruby Klink, coordinator|(514) 890 8000|ruby.klink@crchum.qc.ca|25245
20204720|NCT03483506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20204721|NCT02998554|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204722|NCT02366663|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
20204723|NCT02112994|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20204724|NCT02223455|CADRE - Iowa City VAHCS|Heather Reisinger|319-338-0581|heather.reisinger@va.gov|7715
20204725|NCT01683071|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20204726|NCT04211155|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
20204727|NCT03675737|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20204728|NCT02349789|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
20204729|NCT03522350|Weill Cornell Medical College|Nikica Zaninovic, PhD|212-746-5790|nizanin@med.cornell.edu|
20204730|NCT00280150|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20204731|NCT00568958|Yale University School of Medicine|Dr. Stephanie S. O'Malley|203-974-7590|stephanie.omalley@yale.edu|
20204732|NCT01709136|Children's Hospital of Pittsburgh|Dr. Rakesh Sindhi, MD|412-692-6110|rakesh.sindhi@chp.edu|
20204733|NCT03583372|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20204734|NCT02796391|Moffitt Cancer Center|Dr. Vani Simmons|813-745-4816|Vani.Simmons@moffitt.org|
20204735|NCT00831441|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20204736|NCT00377611|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204737|NCT05674344|Masimo Corporation|Chelsea Frank|(949) 297-7000|clinicalresearchdept@masimo.com|
20204738|NCT00111917|National Jewish Health|Lisa Maier, MD|303-398-1983|maierl@njhealth.org|
20204739|NCT04831515|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
20204740|NCT01640925|Houston Methodist Hospital|Dr. Joshua Swan|713-441-0165|jtswan@houstonmethodist.org|
20204741|NCT02156492|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20204742|NCT00748085|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
20204743|NCT02363270|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
20204744|NCT02311309|CHU de Caen|Dr Jean-Luc Hanouz|2 31 06 47 36|hanouz-jl@chu-caen.fr|33
20204745|NCT01319110|Beth Israel Deaconess Medical Center|Dr. Michael Cocchi||mcocchi@bidmc.harvard.edu|
20204746|NCT03837353|NYU Langone Health|David Wise, MD, PhD|(212) 731-5405|David.Wise@nyulangone.org|
20204747|NCT00442013|Johns Hopkins University|Janet Holbrook|443-287-3170|ala-acrc@jhsph.edu|
20204748|NCT03508661|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
20204749|NCT00485589|F. Hoffmann-La Roche AG|Medical Communications|41 616878333|global.trial_information@roche.com|
20204750|NCT04348656|McMaster University/Hamilton Health Sciences|Dr Donald Arnold|905 525 9140|arnold@mcmaster.ca|28603
20204751|NCT01944969|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20204752|NCT03072719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204753|NCT02387372|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204754|NCT01902953|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20204755|NCT01157416|Tulane University School of Medicine|Dr. Michael Scheeringa|5046692322|mscheer@tulane.edu|
20204756|NCT00436566|Mayo Clinic|Dr. Edith A. Perez|507-266-0800|perez.edith@mayo.edu|
20204757|NCT04866303|University of Washington|Clinical Trial Manager|2066169195|cgregor2@uw.edu|
20204758|NCT01954251|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204759|NCT02581111|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@neuro.wustl.edu|
20204760|NCT02504268|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20204761|NCT03025217|Massachusetts General Hospital|Dr. Michelle Dossett|617-643-6034|mdossett@mgh.harvard.edu|
20204762|NCT00511342|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20204763|NCT02432040|University of the Philippines - Philippine General Hospital Section of Dermatology|Dr. Sharlene Chua|2418118|sharlene_chua@yahoo.com|
20204764|NCT00555048|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
20189241|NCT01542255|Dartmouth-Hitchcock|Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
20204765|NCT00718666|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204766|NCT02196038|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
20204767|NCT01580592|Charité - University of Berlin; Dpt. of Dermatology and Allergy|Professor Dr. Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
20204768|NCT00421343|Hebrew SeiorLife|Sarah Berry|617-971-5355|sarahberry@hrca.harvard.edu|
20204769|NCT00360243|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20204770|NCT02569411|St. Michael's Hospital|Dr. Areti Angeliki Veroniki|416-360-4000|averonik@cc.uoi.gr|
20158859|NCT00271856|UCSF Osher Center for Integrative Medicine|Patricia Moran, PhD|415.353.9745|moranp@ocim.ucsf.edu|
20158860|NCT04677543|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
20158861|NCT00854724|BPRL, McLean Hospital|David M. Penetar|617-855-2913|dpenetar@mclean.harvard.edu|
20158862|NCT02159898|Merit Medical, Inc|Casey Holland|7816817983|casey.holland@merit.com|
20158863|NCT01675297|Hanlim Pharma|Clinical Trial Unit|82-2-3489-6297|yrsong@hanlim.com|
20158864|NCT00501592|Intercept Pharmaceuticals, Inc.|Cathi Sciacca, Sr. Director, Clinical Operations|858-652-6800|csciacca@interceptpharma.com|
20158865|NCT01432145|University of Oxford Clinical Trials & Research Governance|Ms Heather House|01865 572245|heather.house@admin.ox.ac.uk|
20158866|NCT01498692|Boston Scientific|Ruth M. Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20158867|NCT04729972|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20158868|NCT00590122|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
20158869|NCT01208324|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
20158870|NCT01701362|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158871|NCT00249808|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20158872|NCT03654040|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20158873|NCT01709110|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20158874|NCT01129765|Advanced Pediatrics|Mary Margaret Thorne|703-938-5555|mthorne@pop.powweb.com|
20158875|NCT03093207|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
20158876|NCT02685566|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20158877|NCT03286829|Saniona A/S|Dr.Kim Krogsgaard, MD, DMSc, CMO|+45 20 14 83 84|kim.krogsgaard@saniona.com|
20158878|NCT00485758|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20158879|NCT04123093|OhioHealth|Dr. Mitch Silver|614-566-1250|mitch.silver@ohiohealth.com|
20158880|NCT00984165|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
20158881|NCT00135330|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20158882|NCT01771991|Sanford Health|Dr Chad Spanos MD|605-328-8200||
20158883|NCT04381052|Columbia University|David J. Cohen, MD|212-305-3273|djc5@cumc.columbia.edu|
20158884|NCT01399229|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
20158885|NCT02229825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20158886|NCT03415581|New York State Psychiatric Institute|Jermaine Jones PhD|6467746113|jermaine.jones@nyspi.columbia.edu|
20158887|NCT03809078|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
20158888|NCT01390298|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
20158889|NCT03645096|UT Southwestern Medical Center|Dr. Sherwood Brown|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
20158890|NCT02544035|National Institute of Child Health and Human Development|Dr. Diane Putnick|301-496-6291|putnickd@mail.nih.gov|
20158891|NCT02888691|Steno Diabetes Center Copenhagen|Dr Signe Schmidt|+4551174785|signe.schmidt@regionh.dk|
20158892|NCT00803361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20158893|NCT03786224|Massachusetts General Hospital|Randi Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
20158894|NCT01539070|Instituto Mexicano del Seguro Social|MPH. Gloria Oliva Martínez Andrade|5556059862|gloria_olivam@hotmail.com|21075
20158895|NCT01437111|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158896|NCT02131311|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
20158897|NCT02623205|Department of Psychiatry, Renaissance School of Medicine at Stony Brook University|Kathryn Hill|904-252-3449|kathryn.hill@stonybrookmedicine.edu|
20158898|NCT01176617|Hospital of the University of Pennsylvania|Dr. Sanjay Dixit|215-615-4337|sanjay.dixit@uphs.upenn.edu|
20158899|NCT02473471|Jordanian University of science and Technology|Dr.Amal Alkebsi|00966552358684|amalkibsi@gmail.com,aalkebsi13@den.just.edu.jo|
20158900|NCT03082677|Memorial Sloan Kettering Cancer Center|Dr. Doris Ponce, MD|646-608-3739|ponced@mskcc.org|
20158901|NCT01667133|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20158902|NCT02371785|Corindus Vascular Robotics|Vice President, Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
20158903|NCT01181804|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20158904|NCT02727816|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20158905|NCT00255723|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
20158906|NCT02749201|maimonides medical center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20158907|NCT03711370|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
20158908|NCT02901249|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|51999185180|afbslima@gmail.com.br|
20189242|NCT00586313|Indiana University Hospital|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
20189243|NCT01979276|Weill Cornell Medical College|Jennifer Hess|646-962-9440|jmh2004@med.cornell.edu|
20189244|NCT03205566|Guy's & St. Thomas' NHS Foundation Trust|Dr Julie Fox|020 7188 7188|julie.fox@gstt.nhs.uk|
20189245|NCT03184987|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20189246|NCT03542305|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189247|NCT01335867|University of Pennsylvania Treatment Research Center|Kyle M. Kampman, M.D.|215 746 2764|kampman@pennmedicine.upenn.edu|
20189248|NCT01619059|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762484
20219279|NCT02900976|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20219280|NCT01408628|University of Kansas Medical Center|Virginia Lewis|913-588-2097|vlewis@kumc.edu|
20219281|NCT01181271|Mass General Hospital|Yi-Bin Chen, MD|617-726-5765|ychen6@partners.org|
20219282|NCT02980874|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20219283|NCT02435836|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20219284|NCT01121666|Five Office Ltd|Dr. Melanie Ruf|+41 44 9324132|clin@five.ch|
20219285|NCT03082664|University of Chicago|Dr. Maritza G. Gonzalez|7737026118|mggonzalez@bsd.uchicago.edu|
20219286|NCT01629966|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20219287|NCT01174082|UT MD Anderson Cancer Center|Qazilbash,Muzaffar,M.D. / Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
20219288|NCT02991430|Scion NeuroStim, LLC|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
20219289|NCT03970837|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219290|NCT02132754|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219291|NCT02304991|University of North Carolina School of Medicine|Edwin Kim, MD, MS|919-962-4960|edwinkim@email.unc.edu|
20219292|NCT04820530|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20219293|NCT01812681|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
20219294|NCT01404923|Laboratoires Mayoly Spindler|Clinical trials Manager|33 134805555|contact_essais_cliniques@mayoly-spindler.fr|
20219295|NCT03190213|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
20219296|NCT03244644|Rebiotix inc, a Ferring Company|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
20219297|NCT01781481|Children's HOspital of Eastern Ontario|Dr. Janice Cohen|613-737-7600|cohen@cheo.on.ca|2497
20219298|NCT00754650|Hoffmann-La Roche|Medical Communications|800 821-8590||
20219299|NCT01007942|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20219300|NCT03825341|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
20219301|NCT04257552|University of Pittsburgh, Magee Womens Research Institute|Dr. Katherine Himes|(412) 641-1805|himekp@upmc.edu|
20219302|NCT00552578|SUNY Buffalo|R Blondell|716-898-4971|blondell@buffalo.edu|
20219303|NCT00470067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20219304|NCT01110135|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20219305|NCT00054665|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
20219306|NCT01243112|Scott & White Healthcare|James Collins, MD|254-724-7508|jbcollins@swmail.sw.org|0612
20219307|NCT00375830|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|650-725-4711|aiagaru@stanford.edu|
20157525|NCT01832610|Medtronic|Thomas Vassiliades, MD - VP MCS Clinical/Medical Affairs|+15085321956|thomas.a.vassiliades@medtronic.com|
20157526|NCT02874092|NYU Langone|Dr. Jeffrey Berger|212-263-0855|Jeffrey.Berger@nyulangone.org|
20157527|NCT01147302|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20204771|NCT02528097|NYU Langone Medical Center|The Office of Clinical Trials|646.754.7431|clinicaltrials@nyumc.org|
20204772|NCT03471767|Duke University|James Davis, MD|919-668-5055|james.m.davis@duke.edu|
20204773|NCT00116857|Washington University School of Medicine|Robert M. Carney, Ph.D.|314-286-1313|carneyr@bmc.wustl.edu|
20204774|NCT00608530|VA San Diego Healthcare System|Joseph H. Atkinson MD, Principal Investigator|858 642 3775|joseph.atkinson@va.gov|
20204775|NCT01952730|Massachusetts General Hospital|Cristina R. Ferrone, MD|617-643-6189|CFERRONE@PARTNERS.ORG|
20204776|NCT01098461|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204777|NCT01514188|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20204778|NCT01019486|University of Colorado, Denver|Robert A. Quaife M.D.|720-848-6562|robert.quaife@ucdenver.edu|
20204779|NCT01277341|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20204780|NCT03134313|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20204781|NCT05373706|University of Washington|Dr. Anne Fairlie|(206) 221-5896|afairlie@uw.edu|
20204782|NCT00540969|Mayo Clinic|Matthew Callstrom, M.D., Ph.D.|5072664532|callstrom.matthew@mayo.edu|
20204783|NCT01975935|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
20158909|NCT01958580|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio - Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
20158910|NCT01169701|Novartis Pharmaceuticals|Study Director|862-778-8300||
20158911|NCT01536561|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158912|NCT00553436|Ethicon Endo-Surgery, Inc|Amy Mahanes, Clinical Research Associate II|513-337-8366|amahanes@its.jnj.com|
20158913|NCT04188834|Georgia Institute of Technology Atlanta|Dr. Annabelle Singer|404.385.4936|annabelle.singer@bme.gatech.edu|
20158914|NCT01030952|Novartis Pharmaceuticals|Study Director|+1-800-244-7668||
20158915|NCT02619591|UMASS Memorial Department of Emergency Medicine|Executive Vice Chairman|508-421-1400|Romolo.Gaspari@umassmemorial.org|
20158916|NCT02455336|James J. Peters VA Medical Center|Michael F. La Fountaine, EdD, ATC, FACSM|718-584-9000|michael.lafountaine@va.gov|3121
20204784|NCT02402218|Johns Hopkins School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
20158917|NCT00391430|NYU Langone|Marylene Cloitre|2122632471|marylene.cloitre@nyulangone.org|
20204785|NCT00430625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20158918|NCT02467192|Hopitaux Universitaires de Geneve|Dr Jerome Stirnemann|+41223729101|jerome.stirnemann@hcuge.ch|
20158919|NCT01955369|Klinikum der Stadt Ludwigshafen|Dr. Joachim Wolf|0049-621|joachim.wolf@diakonissen.de|4200
20158920|NCT00809926|Novartis Pharmaceuticals|Study Director|862-778-8300||
20158921|NCT02530476|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/Associate Professor|713-794-4392|NDaver@mdanderson.org|
20158922|NCT00343564|Cytokinetics,Inc.|Project Manager|650-624-2918||
20158923|NCT01963767|University of South Florida|Dr. Brent Small|813-974-9746|bsmall@usf.edu|
20158924|NCT02521974|FIDEC Corporationa|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
20219308|NCT01085734|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20219309|NCT02651259|Family Health International (FHI 360|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20219310|NCT03756506|Prevent-Plus|Jeff Elbl|314-606-5046|jeff.elbl@prevent-plus.com|
20219311|NCT03678285|University of Wyoming|Dr. Evan Johnson|307-766-5282|ejohns54@uwyo.edu|
20219312|NCT00123474|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20219313|NCT00616629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20219314|NCT01963143|Bio Products Laboratory|Head of Medical Information|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
20219315|NCT00660400|H. Lee Moffitt Cancer Center and Research Institute|Teresa Field, M.D., Ph.D.|813-745-7202|teresa.field@moffitt.org|
20219316|NCT00790335|Washington University in St. Louis|Dr. Suresh Vedantham, Principal Investigator|3143622900|vedanthams@mir.wustl.edu|314
20219317|NCT02421224|University of California, San Francisco|Dr. Justin S. White|415-476-8045|justin.white@ucsf.edu|
20219318|NCT00997204|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20219319|NCT00085423|Dartmouth-Hitchcock|Dr. Marc Ernstoff|603 650 5534|marc.s.ernstoff@hitchcock.org|
20219320|NCT04740814|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20219321|NCT01222286|Innate Pharma|Dr Renaud Buffet|33 4 30 30 30 32|renaud.buffet@innate-pharma.fr|
20158925|NCT01082081|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158926|NCT00670930|Novartis Pharmaceuticals|Study Director|862-778-8300||
20219322|NCT02500641|A. Menarini Industrie Farmaceutiche Riunite SrL|Post-Registration Clinical Trial Responsible|+39 055 5680459|pfabrizzi@menarini.it|
20158927|NCT00921115|University of Kansas Cancer Center|Qamar Khan, MD|(913) 588-6029|QKHAN@kumc.edu|
20158928|NCT03159468|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
20158929|NCT02712983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20158930|NCT03608371|Neumora Therapeutics|Study Contact|8577600900|clinicaltrials@neumoratx.com|
20158931|NCT05360966|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
20158932|NCT01477710|University of Cincinnati|Richard Branson|513-558-6785|bransonrd@uc.edu|
20158933|NCT05258890|Brigham and Women's Hospital|Amar Dhand, MD, PhD|617-732-7432|adhand@bwh.harvard.edu|
20158934|NCT05959447|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20158935|NCT00566982|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20158936|NCT01861704|InSound Medical, Newark, California|Tanya Arbogast, Study Principal Investigator|510-792-4000|Srikant.Mantha@phonak.com|
20158937|NCT00443872|University of Kansas Medical Center|Dr. Kelly Lyons|9135887159|klyons@kumc.edu|
20158938|NCT02789345|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20158939|NCT02978157|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20158940|NCT00694577|Massachusetts General Hospital|Alphonse Taghian|6177261160|ataghian@mgh.harvard.edu|
20158941|NCT00654836|Loyola University|Shelly S. Lo, M.D.|708-327-3154|shlo@lumc.edu|
20158942|NCT00700622|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20158943|NCT00383331|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20158944|NCT02253433|Environmental Health, Baylor College of Medicine|Dr. Winifred J. Hamilton|713-798-1052|hamilton@bcm.edu|
20219323|NCT01948986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20158945|NCT01756573|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
20158946|NCT02008942|PLx Pharma|Ronald Zimmerman, President & CEO|713-842-1249|ron.zimmerman@plxpharma.com|205
20158947|NCT00807586|Minneapolis Heart Institute Foundation|Dr. Daniel Melby|612-863-3900|daniel.melby@allina.com|
20158948|NCT03938103|University of North Carolina at Chapel Hill|Derek Hales, PhD|919-966-6089|derekh@email.unc.edu|
20158949|NCT00392834|University of Arkansas for Medical Sciences|Jeannette Lee, Ph.D.|501-526-6712|jylee@uams.edu|
20158950|NCT03520920|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158951|NCT00372619|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|ResultsReportingCoordinator@childrensoncologygroup.org|
20158952|NCT00066222|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20158953|NCT00405392|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158954|NCT02579421|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
20158955|NCT02767869|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
20158956|NCT03125031|Masimo|Tala Harake||studies@masimo.com|
20158957|NCT03660865|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20158958|NCT05141708|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158959|NCT01703091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20158960|NCT05420961|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20158961|NCT03902392|University of Bari|Thea TM Magrone, BD|+39 080 5478584|thea.magrone@uniba.it|
20158962|NCT00244725|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158963|NCT03799952|University of New Brunswick|Dr. Danielle Bouchard|1 (506) 443-3908|danielle.bouchard@unb.ca|
20158964|NCT03248167|NYU Langone Health|Charles Marmar, MD|646-754-4855|Charles.marmar@nyumc.org|
20158965|NCT02122146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20158966|NCT01107392|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20158967|NCT02584452|Vanderbilt University Medical Center|Christopher Sobey, MD|615-322-4311|christopher.m.sobey@vumc.org|
20158968|NCT00177294|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
20158969|NCT02998671|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20158970|NCT04560686|UT MD Anderson Cancer Center|Dr. Tina Cascone,MD- Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|tcascone@mdanderson.org|
20158971|NCT02846792|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
20158972|NCT01603043|Alcon Research, Ltd.|Yamini Patel, PhD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20158973|NCT04532294|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20158974|NCT03089047|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
20158975|NCT03599518|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20158976|NCT01625416|University of Washington|Dr. Douglas Zatzick|2067446701|dzatzick@uw.edu|
20158977|NCT00375505|Novartis|Study Director|862-778-8300||
20158978|NCT02561481|Univ of Massachusetts Medical School|Andrew Zimmerman, MD|4109350488|andrew.zimmerman@umassmemorial.org|
20158979|NCT01574287|Emory University|Schuster, David|404-712-4859|dschust@emory.edu|
20158980|NCT00429182|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
20158981|NCT03497039|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20158982|NCT02781571|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20158983|NCT00861692|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20158984|NCT02122666|Washington University School of Medicine|Samantha Adamson, MD, PhD|314-362-3500|sadamson@wustl.edu|
20158985|NCT02591472|University of Florida|MaryBeth Horodyski, EdD|352-273-7074|horodmb@ortho.ufl.edu|
20158986|NCT05111002|University of Washington|Lisa E Manhart|206-744-3646|lmanhart@uw.edu|
20158987|NCT02870985|Fuwai Hospital|Prof. Yuejin Yang|008613701151408|yangyjfw@126.com|
20158988|NCT03913013|UCLA Semel Institute for Neuroscience and Behavior|David J. Miklowitz, Ph.D., Principal Investigator|(310) 267-2659|dmiklowitz@mednet.ucla.edu|
20158989|NCT04776720|University of California, San Francisco|Alison Huang, MD, MAS, MPhil|415-353-7900|alison.huang@ucsf.edu|
20158990|NCT03321071|University of South Carolina|R. Glenn Weaver|803-777-5606|weaverrg@email.edu|
20158991|NCT04201639|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20158992|NCT02712996|Vanderbilt University Medical Center|Michael Tramontana,PhD|615-327-7144|michael.tramontana@vumc.org|
20158993|NCT03693144|University of Michigan|Dr. Susan Woolford|734 615-8214|swoolfor@med.umich.edu|
20158994|NCT02227810|Chang Gung memorial hospital|Dr Huang Chung-Chi|88632118800|yhchen@mail.cgu.edu.tw|5233
20158995|NCT01451749|Dongzhimen Hospital,Beijing University of Chinese Medicine|Dr.Jinzhou Tian|86-10-84013380|jztian@hotmail.com|
20158996|NCT00972517|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158997|NCT02311881|GlaxoSmithKline|GSK Response Center|866-435-7343||
20158998|NCT03063606|Yale University|Dr. Carlos Grilo|203-785-7210|carlos.grilo@yale.edu|
20158999|NCT04704713|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
20159000|NCT00790582|Forbes Norris MDA/ALS Center|Giovanna Kushner|415-600-3983|kushneg@cpmcri.org|
20189249|NCT01170208|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
20189250|NCT01351376|Rehabilitation Medicine, New York University School of Medicine|Tara Denham, MD|212 263 8240|Tara.Denham@nyumc.org|
20189251|NCT00176202|University of Illinois at Chicago|Dr Mani Pavuluri|3124130064|mpavuluri@psych.uic.edu|
20159001|NCT02949024|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20159002|NCT01027650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20159003|NCT01527045|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fredhutch.org|
20159004|NCT00912782|Emory University|Monnie Wasse MD/MPH / Associate Professor of Medicine|404-727-1598|hwasse@emory.edu|
20159005|NCT00948857|Center for Human Reproduction|Dr. Norbert Gleicher|212-994-4400|ngleicher@thechr.com|
20159006|NCT03430843|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20159007|NCT03452033|D. Western Therapeutics Institute|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
20159008|NCT05396014|UNC Chapel Hill|Matthew Mauck, MD, PhD|(919) 966-5136|Matt_Mauck@med.unc.edu|
20159009|NCT03062280|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
20159010|NCT04439539|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20159011|NCT02351063|Alere, Inc.|William Arnold, PhD|8588053177|william.arnold@alere.com|
20159012|NCT03372434|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|EThoma39@its.jnj.com|
20159013|NCT05516797|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
20159014|NCT01475643|Valeant Pharmaceuticals NA|Denise Raimondo|9089721885|denise.raimondo@valeant.com|
20159015|NCT03487588|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
20159016|NCT04551963|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20159017|NCT03379259|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20159018|NCT03850093|faculty of medicine- Zagazig university|assistant professor Abeer M. Elnakera|00201005720754|nakera35@hotmail.com|
20159019|NCT02836717|Department of Surgery, Cantonal Hospital St. Gallen|Dr Lukas Marti|+41 71 494 11 11|lukas.marti@kssg.ch|
20159020|NCT01204905|University of Maryland, Baltimore, IHV|Gregory Brogden|410-706-1660|gbrogden@ihv.umaryland.edu|
20159021|NCT04918381|Pulse Biosciences, Inc.|William Knape / VP, Clinical, Regulatory and Quality Affairs|919-757-2033|bknape@pulsebiosciences.com|
20159022|NCT01309997|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
20159023|NCT00282087|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
20159024|NCT03226249|Northwestern University, Feinberg School of Medicine|Jane N. Winter, M.D.|(312) 695-4538|j-winter@northwestern.edu|
20159025|NCT01312805|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
20159026|NCT01532921|Medtronic, Bakken Research Center Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen|+3143356 6566|ber.kleijnen@medtronic.com|
20159027|NCT03462641|University of Michigan|Stiven Roytman|734 998-8400|stivenr@med.umich.edu|
20159028|NCT01804049|VAORD - Portland VA Health Care System|Dr Robert Klein|503-220-8268|kleinro@ohsu.edu|57496
20159029|NCT01231334|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20159030|NCT01260688|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
20159031|NCT00588237|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner|646-888-4219|konnerj@mskcc.org|
20159032|NCT04301934|Mayo Clinic|Johnny Yi, M.D.|480-342-0612|Yi.Johnny@mayo.edu|
20159033|NCT02201329|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159034|NCT01262638|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20159035|NCT04855240|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
20159036|NCT03087604|Wake Forest University Health Sciences|Dr. Sean Dobson|3367168834|sdobson@wakehealth.edu|
20159037|NCT03472495|Virginia Commonwealth University|Tammy Nguyen, PharmD|8046630969|Tammy.Nguyen@vcuhealth.org|
20159038|NCT02110485|Nationwide Children's Hospital|Beth Fischer|614-355-0338|beth.fischer@nationwidechildrens.org|
20159039|NCT01001767|University Hospitals Case Medical Center|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
20159040|NCT02136004|Weill Cornell Medical College|S. Chiu Wong, MD|212-746-4644|scwong@med.cornell.edu|
20159041|NCT00851552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20189252|NCT00731614|San Francisco VA Medical Center|John R. McQuaid, Ph.D.|415-221-4810|john.mcquaid@va.gov|4106
20219324|NCT00475150|University of Wisconsin Comprehensive Cancer Center|Mark B. Juckett, MD||mbj@medicine.wisc.edu|
20219325|NCT02317614|Western Michigan University|Dr. Anthony DeFulio|269-387-4459|anthony.defulio@wmich.edu|
20219326|NCT00750308|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
20219327|NCT00513682|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20219328|NCT04156620|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20219329|NCT02450526|Ipsen|Medical Director||clinical.trials@ipsen.com|
20219330|NCT01753336|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
20219331|NCT04568031|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20219332|NCT01362127|Karolinska Institutet|Fredrik Klevebro|+46858580000|fredrik.klevebro@ki.se|11111
20219333|NCT00228423|University Of Ottawa Heart Institute|Dr. Marc Ruel||mruel@ottawaheart.ca|
20219334|NCT01531738|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20219335|NCT01412372|University of Utah|Dr. Ashok Tuteja|801-581-5679|Ashok.Tuteja@hsc.utah.edu|
20219336|NCT02876575|Medtronic|Melody LaBeau, Director of Clinical Operations|7635262931|melody.a.labeau@medtronic.com|
20219337|NCT00193427|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20219338|NCT04271020|NeoTract, Inc.|Emily Friedland, Director, Global Clinical Affairs|1-610-331-7299|emily.friedland@teleflex.com|
20219339|NCT04682730|University of Pittsburgh|Dr. Deborah Polk, PhD|14126488656|dpolk@pitt.edu|
20219340|NCT02683265|Rhodes Pharmaceuticals L.P.|Inder Chaudhary|401-262-9272|inder.chaudhary@rhodespharma.com|
20219341|NCT00030992|National Cancer Institute, National Institutes of Health|Tito Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
20219342|NCT01233921|Fred Hutchinson Cancer Research Cetner|Dr. Paul J. Martin|206-667-4798|pmartin@fhcrc.org|
20219343|NCT03870477|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
20219344|NCT01708629|Bausch Health|Study Director|510-259-5284||
20219345|NCT02582866|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20219346|NCT03258853|Massachusetts General Hospital|Dr. Melissa Putman|617-726-1847|msputman@mgh.harvard.edu|
20219347|NCT00771745|University of Cincinnati|Dr. Rita Alloway|513-558-1568|Rita.Alloway@uc.edu|
20219348|NCT03567382|University of North Carolina at Chapel Hill|Peyton Thompson, MD, MSCR|919-445-0854|peyton_thompson@med.unc.edu|
20219349|NCT00786994|Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany|Dr Annette Pflugfelder||annette.pflugfelder@med.uni-tuebingen.de|
20219350|NCT02011386|Rigshospitalet, Denmark|Professor Mikkel Østergaard, MD, PhD, DMSc|+45 38633014|mo@dadlnet.dk|
20219351|NCT04555720|Duke University Medical Center|Kyle Mitchell, MD|919-668-2879|kyle.mitchell@duke.edu|
20219352|NCT03753763|Zambon S.p.A.|Director of Clinical Trial - Charlotte Keywood, MD|+39 02 665241|charlotte.keywood@zambongroup.com|
20219353|NCT00719849|Fred Hutchinson Cancer Research Center|Dr. Colleen Delaney|2066671385|cdelaney@fredhutch.org|
20219354|NCT06219278|Candela|Katherine Coleman|508-358-7400|katherinec@candelamedical.com|28533
20219355|NCT02201290|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20219356|NCT03907462|University of California, San Diego|Dr. Job Godino|6195152344|jobg@fhcsd.org|2344
20219357|NCT02370329|Mayo Clinic Arizona|Jeanne M. Palmer, MD|480/342-8000|palmer.jeanne@mayo.edu|
20219358|NCT06378749|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|4013602985|kevers@prochange.com|
20219359|NCT01539135|Tulane University Hospital and Clinics|Dr. Sabrina Bent|5049887137|sabrina.bent@hcahealthcare.com|
20219360|NCT02087995|Dexcom, Inc|Andrew Balo/ EVP|8582000203|abalo@dexcom.com|
20219361|NCT01502410|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20219362|NCT04345601|Baylor College of Medicine|Dr. Laquisa Hill|713-441-1450|LaQuisa.Hill@bcm.edu|
20219363|NCT01811316|Sunstar Americas, Inc.|Akane Takemura|+1-847-794-4276|akane.takemura@us.sunstar.com|
20219364|NCT00699283|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20219365|NCT00805675|Novartis Pharmaceuticals|Study Director|862-778-8300||
20219366|NCT02771795|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20219367|NCT03929757|Janssen Vaccines & Prevention B.V.|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219368|NCT00114166|NRG Oncology, Statistics and Data Management Center - Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
20219369|NCT01154816|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20219370|NCT04715932|Montreal Heart Institute|Dr Jocelyn Dupuis (Principal Investigator)|514 376-3330|jocelyn.dupuis@icm-mhi.org|3477
20219371|NCT02393248|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20219372|NCT03560986|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
20219373|NCT02958982|Rhizen Pharmaceuticals S.A.|Dr. Prajak Barde|+41 32 580 0113|pjb@rhizen.com|
20219374|NCT01749995|General Hospital Groeninge, Kortrijk, Belgium|Dr. Philip Debruyne|+32 056 63 39 00|philip.debruyne@azgroeninge.be|
20219375|NCT01783548|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20219376|NCT03875859|Stanford University|Kavita Yang Sarin|650-804-2899|ksarin@stanford.edu|
20219377|NCT04540406|Notitia Biotechnologies|Clinical Research Associate|732-230-3175|ciarra.williams@notitiabio.com|
20219378|NCT04053465|University at Buffalo|Dr. Riana Pryor|7168295456|rpryor@buffalo.edu|
20219379|NCT01059539|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
20159042|NCT02689206|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20159043|NCT00595881|Children's Hospital of Pittsburgh|Jennifer Marin|412-692-7692|jennifer.marin@chp.edu|
20189253|NCT01160354|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jan Burger, Associate Professor, Leukemia|7137927734|CR_Study_Registration@mdanderson.org|
20159044|NCT01479764|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20189254|NCT03758742|University of Alabama at Birmingham|Dr. Courtney M. Peterson|205-934-0122|cpeterso@uab.edu|
20159045|NCT01916824|Emory University|Boadie Dunlop, MD|404-727-8969|bdunlop@emory.edu|
20159046|NCT00771927|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20159047|NCT03835481|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159048|NCT03020004|Ascletis Pharmaceuticals Co., Ltd|Clinical Trial Disclosures|+86057185389732|yicheng.zhao@ascletis.com|
20159049|NCT00191945|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20159050|NCT02063984|Geisel School of Medicine at Dartmouth Center for Technology and Behavioral Health|Alan J. Budney, Ph.D|603-646-7088|alan.budney@dartmouth.edu|
20159051|NCT04175340|Bausch + Lomb Incorporated|Senior Manager, Clinical Trials|(585) 623-9588|Margaret.Swartzenberg@bausch.com|
20159052|NCT00958347|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
20159053|NCT02146131|Medical University of South Carolina|Kate Taylor|843-792-2297|Talykat@musc.edu|
20159054|NCT02567799|Humanetics Corporation|Michael D. Kaytor|952-400-0406|mkaytor@humaneticscorp.com|
20159055|NCT03292640|Dr. Reddy's Laboratoris, Inc|Srinivas Sidgiddi, Senior Director, Clinical Development|9084585362|srinivassidgiddi@drreddys.com|
20159056|NCT03148379|Medacta USA|Rena Mandino, Director of Clinical Research|352-359-3581|rmandino@medacta.us.com|
20189255|NCT02743819|University of Chicago|Daniel Olson, Clinical Instructor|773-834-4183|daniel.olson2@uchospitals.edu|
20189256|NCT03389802|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
20189257|NCT01706159|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20189258|NCT04119063|Northern Arizona University|Zach Lerner, Associate Professor|928-523-1787|Zachary.Lerner@nau.edu|
20189259|NCT02454959|Pearl Therapeutics, Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20189260|NCT00989196|Octapharma AG|Dr. Sigurd Knaub|+41 554512141|sigurd.knaub@octapharma.com|
20189261|NCT02409680|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
20189262|NCT03789656|Crinetics Pharmaceuticals, Inc|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
20189263|NCT06214052|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20159057|NCT04380753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20159058|NCT05356910|University of California, San Diego|Heather Pines|619-594-2481|hpines@health.ucsd.edu|
20159059|NCT04068948|University of Washington|Travis Nelson|206-543-0980|tmnelson@uw.edu|
20159060|NCT03306433|University of Colorado, SoDM|Clifton Carey|3037241046|clifton.carey@cuanschutz.edu|
20159061|NCT00819156|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20159062|NCT00803595|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20189264|NCT05325294|Medtronic Diabetes|Fang Niu, Sr Statistician|8185763319|fang.niu@medtronic.com|
20189265|NCT01804166|Janssen Scientific Affairs, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189266|NCT02434328|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
20189267|NCT03427463|Medical University of South Carolina|Katherine Hatter, M.D.|(843) 792-5454|herbertk@musc.edu|
20189268|NCT03147287|Dana-Farber Cancer Institute|Project Manager|617-632-3800|ctopm@dfci.harvard.edu|
20189269|NCT00925548|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20189270|NCT02278796|Inselspital University Hospital Bern|Thomas Pabst, Prof Dr. med|+41 31 632 84 30|thomas.pabst@insel.ch|
20189271|NCT03214081|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20189272|NCT02962284|Sun Pharma Global FZE|Harin Mehta|97145520096, 912266455645|clinicaltrials@sparcmail.com, harin.mehta@sparcmail.com|
20189273|NCT04456413|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
20189274|NCT02372799|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20189275|NCT00089609|National Cancer Institute, National Institutes of Health|Ravi Madan, M.D.|301-480-7168|rm480i@nih.gov|
20189276|NCT03706261|Columbia University|Adam M. Brickman, PhD|212-342-1348|amb2139@cumc.columbia.edu|
20189277|NCT05815342|Insulet Corporation|Dr. Trang Ly|9786007628|Tly@insulet.com|
20189278|NCT03116464|VA New York Harbor Healthcare System|Dr. Cory K. Chen|212-686-7500|cory.chen@va.gov|4002
20189279|NCT00747006|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20189280|NCT00357994|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20189281|NCT01655563|Hospital for Sick Children|Dr. Seema Mital|416-813-7418|seema.mital@sickkids.ca|207418
20189282|NCT00345046|Indiana University|Louis B. Cantor|317-278-2651|lcantor@iupui.edu|
20189283|NCT03559205|Keele University|Jonathan Hill|01782 733900|j.hill@keele.ac.uk|
20189284|NCT03150875|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
20189285|NCT04652869|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
20189286|NCT01372085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159063|NCT02953561|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|ndaver@mdanderson.org|
20189287|NCT00562094|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20189288|NCT03689946|Cedars-Sinai Medical Center|Daniel Berman|310-423-4224|daniel.berman@cshs.org|
20159064|NCT01433042|Given Imaging Ltd.|Director of Clinical affairs|+972-4-9097774|Hila.Debby@givenimaging.com|
20159065|NCT00848237|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
20159066|NCT02195700|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20159067|NCT01597908|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20159068|NCT02931838|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20159069|NCT00104728|H. Lee Moffitt Cancer Center and Research Institute|Dr. Eric Haura|813-745-6826|eric.haura@moffitt.org|
20159070|NCT02709577|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
20204786|NCT03375112|Henry Ford Health System|Dr. Michael Charters|1-800-436-7936|mcharte1@hfhs.org|
20204787|NCT02742077|Corindus, Inc.|Clinical Research Manager|(757) 910-4818|tina.ridgeway@corindus.com|
20204788|NCT00243230|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204789|NCT03599141|Indiana University|Heather K. Hardin|317.274.5966|hhardin@iu.edu|
20204790|NCT03136185|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204791|NCT03011840|Tata Memorial Hospital, Mumbai|Dr. Sumitra Bakshi|+912224177058|sumitrabakshi@yahoo.com|
20204792|NCT03738566|Mayo Clinic|Dr. Jeffrey A. Alexander|507-538-0474|Alexander.Jeffrey14@mayo.edu|
20204793|NCT00605722|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20204794|NCT00961662|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
20204795|NCT01042613|St. Jude Children's Research Hospital|Luis Trujillo Huaccho, MD|1-866-278-5833|info@stjude.org|
20204796|NCT00356863|The Gertner Institute for Epidemiology and Health Service Research|Rachel S Dankner, MD, MPH|972-3-5305390|RachelD@gertner.health.gov.il|
20204797|NCT02860845|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
20204798|NCT00836277|University of Pittsburgh Cancer Institute|Weijing Sun, MD|412-864-7764|sunw@upmc.edu|
20204799|NCT00333619|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|cathy.alessi@va.gov|
20204800|NCT03209440|University of Florida|Dr. Diana Wilkie|352-273-6401|diwilkie@ufl.edu|
20204801|NCT02871401|Vanderbilt University Medical Center|Jonathan Kropski MD|615-322-3412|jon.kropski@vumc.org|
20204802|NCT05283863|Case Western Reserve University|Jennifer Sweet, MD|216-844-3192|Jennifer.Sweet@UHhospitals.org|
20204803|NCT01120379|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
20204804|NCT04031404|University of North Carolina at Chapel Hill|Rachel B. Force, PhD|9199669929|rachel_force@med.unc.edu|
20204805|NCT00509496|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20204806|NCT01354353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20204807|NCT01104584|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20189289|NCT01555138|Novartis Pharmaceuticals|Study Director|862-778-8300||
20204808|NCT04017442|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
20204809|NCT02586233|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20204810|NCT01236742|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766 6100|pauline.cho@polyu.edu.hk|
20204811|NCT02373241|University of Alabama at Birmingham|Jeffrey Lebensbugrer|2056389285|jlebensburger@uabmc.edu|
20204812|NCT03575884|Seattle Children's Research Institute|Jason Mendoza, MD, MPH|206.884.1261|Jay.Mendoza@seattlechildrens.org|
20204813|NCT03421964|Virginia Commonwealth University|Nancy Hsu, PsyD, PI|804-327-1166|nancy.hsu@vcuhealth.org|
20204814|NCT02938585|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20204815|NCT02106455|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20204816|NCT01260467|University of Rochester Medical Center|Jennifer Serventi Research Associate|585-276-3971|jennifer_serventi@urmc.rochester.edu|
20204817|NCT03709810|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20204818|NCT02665364|Neovacs|Head of Regulatory Affairs|+33153109300|info@neovacs.com|
20204819|NCT03888391|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20204820|NCT00502320|Lehigh Valley Hospital|Edward R. Norris, MD|610-402-5766|Edward.Norris@lvh.com|
20204821|NCT00838006|Central Arkansas Veterans Healthcare System|Jeff Pyne, MD|501-257-1083|jeffrey.pyne@va.gov|
20204822|NCT02173392|Valeant Pharmaceuticals|Director of Clinical Trials|908|lindsey.mathew@valeant.com|
20204823|NCT03654755|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
20204824|NCT02835677|VA Medical Center|Dr. Linda Nichols, Co-Director Caregiver Center|901 523-8990|linda.nichols@va.gov|5082
20204825|NCT02124707|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20204826|NCT00781599|University of Kansas Medical Center|Dr. Nikki Nollen|(913) 588-3784|NNOLLEN@kumc.edu|
20204827|NCT01202721|Population Health Research Institute|Dr. Tara McCready, Program Director||tara.mccready@phri.ca|
20204828|NCT02740504|ResMed|Paul Phillips|+447789633508|paul.phillips@resmed.com|
20204829|NCT00974051|UColorado|Dr. H Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
20204830|NCT01088438|University of Illinois at Chicago|Dr. Alan Schwartz|312-996-2070|alansz@uic.edu|
20204831|NCT01363713|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20204832|NCT01199055|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20204833|NCT00913133|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
20189290|NCT01613417|Executive Director, MRI|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
20159071|NCT01042158|Johns Hopkins University|Paul Hassoun, MD|410-614-5158|phassoun@jhmi.edu|
20159072|NCT01575808|Toyko Jikei University Hospital|Dr. Takao Ohki|81-090-2478-8304|takohki@msn.com|
20219380|NCT02085135|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
20219381|NCT02971735|Linkou Chang Gung Memorial Hospital|Dr. Li-Ang Lee|886 33281200|5738@cgmh.org.tw|3972
20219382|NCT04091659|University of Pennsylvania|Nicholas A. Giordano, PhD RN|(215) 898-8281|ngio@upen.edu|
20219383|NCT04005352|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20159073|NCT02025634|AdventHealth|Brad Homan|407-303-4270|Brad.Homan.MD@AdventHealth.com|
20159074|NCT00064259|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-405-8404|jsparano@montefiore.org|
20159075|NCT02953093|Albert Einstein College of Medicine|Dr. Nir Barzilai|718-430-3144|nir.barzilai@einsteinmed.edu|
20219384|NCT02695537|University of Alabama at Birmingham|Dr. Martina Bebin, MD|205-934-3866|ebebin@uab.edu|
20159076|NCT01132651|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20219385|NCT04420273|Northwestern University Feinberg School of Medicine|Dr. June Robinson|3129433703|june-robinson@northwestern.edu|
20159077|NCT03054805|Chang Gung Memorial Hospital|Dr. Hsun-Chin Chao|88633281200|chaohero@yahoo.com|8969
20159078|NCT04148482|Massachusetts General Hospital|Sara Cromer|6177247303|scromer@mgh.harvard.edu|
20159079|NCT01519791|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20159080|NCT01525862|Stryker ENT|Principal Clinical Research & Publications Manager|764-463-1598|ellen.omalley@stryker.com|
20159081|NCT00241176|NYU School of Medicine, NYU Child Study Center|Barbara J Coffey, M.D, M.S.|(212)263-3926|barbara.coffey@mssm.edu|
20159082|NCT03206970|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20159083|NCT00375427|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159084|NCT00924001|National Cancer Institute, National Institutes of Health|Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20159085|NCT00070109|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20219386|NCT02849938|Billings Clinic|Patricia M Notario, MD|406-238-2143|pnotario@billingsclinic.org|
20219387|NCT02256436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219388|NCT01696279|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20219389|NCT05788289|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
20219390|NCT02174432|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20219391|NCT02737748|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
20219392|NCT04823975|Huntsman Cancer Institute|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
20219393|NCT02970318|Astrazeneca Clinical Trial|Study Director|1-888-292-9613|information.center@astrazeneca.com|
20219394|NCT03233230|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20219395|NCT01584843|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219396|NCT04126213|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219397|NCT00392236|Feinstein Institute for Medical Research|Delbert Robinson, M.D.|718 470-8195|drobinso@nshs.edu|
20219398|NCT02853370|U.O.C. Haematology - A.O.U. Policlinico Paolo Giaccone, Palermo (Italy)|Dr. Emilio Iannitto|+39 091 6554415|emilio.iannitto@gmail.com|
20219399|NCT02196701|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20219400|NCT03275064|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20219401|NCT00827632|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
20219402|NCT00511095|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
20219403|NCT00753220|Prostate Institute of America|Dr. Duke K. Bahn|888-234-0004|DKBahn@CMHhospital.org|
20219404|NCT01898650|Washington University School of Medicine|Gary Skolnick|13144544005|gskolnic@wustl.edu|
20219405|NCT03923530|NF South Ga VAMC|Dr. Anthony Bavry|352-548-4726|anthony.bavry@va.gov|
20219406|NCT00407758|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
20219407|NCT04154150|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
20219408|NCT03347006|Queen Mary University of London|Professor Jesmond Dalli|+442078828263|j.dalli@qmul.ac.uk|
20219409|NCT02722148|University of North Carolina at Chapel Hill|Dr. Evan S. Dellon|(919) 966-2513|evan_dellon@med.unc.edu|
20219410|NCT05161806|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20159086|NCT03560102|Kantonsspital Winterthur|Christoph A Binkert (Sponsor-Investigator)|+41 52 266 2602|christoph.binkert@ksw.ch|
20159087|NCT00436046|Baylor College of Medicine|Robert Couch, MD|713-798-4474|rcouch@bcm.tmc.edu|
20159088|NCT03588806|University of Pittsburgh|Dr. Ajay D. Wasan|4126658030|wasanad@upmc.edu|
20159089|NCT04904744|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20159090|NCT00716482|SuperSonic Imagine|Research Coordinator|+33 442 99 24 24|sharon.bruce@supersonicimagine.fr|
20159091|NCT02550288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159092|NCT01524224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159093|NCT00456625|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159094|NCT03517371|Center for Neurorehabilitation, College of Health & Rehabilitation, Sargent College, Boston University|Terry Ellis|617-353-2724|tellis@bu.edu|
20159095|NCT02318368|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|(857) 400-0101|Clinical@aveooncology.com|
20189291|NCT03903692|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
20159096|NCT01901614|Oregon Health & Science University|David Huang, MD, PhD|503-494-3000|huangd@ohsu.edu|
20189292|NCT02431741|Faculty Hospital Kralovske Czech Republic|Prof. Dr. Petr Arenberger|+420 267 16 11 11|avemedica@email.cz|
20219411|NCT00855803|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
20219412|NCT00809159|Novartis|Study Director|862-778-8300||
20189293|NCT03732807|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189294|NCT00599196|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20219413|NCT01576874|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20219414|NCT04048343|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
20219415|NCT01672970|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159097|NCT03629223|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20159098|NCT02674464|Johns Hopkins University School of Medicine|Dr. Lisa Cooper, Principal Investigator|4106143659|lisa.cooper@jhmi.edu|
20159099|NCT00783835|Janssen-Cilag Farmaceutica Ltda|Medical Manager|+55 11 30302738||
20159100|NCT01555073|Northwestern University, Feinberg School of Medicine|Antoun Nader, MD|312-695-3045|a-nader2@northwestern.edu|
20159101|NCT01122446|LundU|Helena Elding Larsson, PI|+4640337676|helena.elding_larsson@med.lu.se|
20159102|NCT01369199|University of Pittsburgh|Dr. Steven Belle|412-624-5419|belle@edc.pitt.edu|
20159103|NCT01071252|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159104|NCT01066104|MGH|Dr. Ellen Dutta|6177248256|edutta@mgh.harvard.edu|
20159105|NCT04660552|JelikaLite Corp|Katya Sverdlov, Chief Executive Officer|9175668151|katya@jelikalite.com|
20159106|NCT00470262|Denver VA Medical Center|Dr. Neda Rasouli|303-399-8020|neda.rasouli@ucdenver.edu|4314
20159107|NCT02812238|NHLBI|Dr. Michael N. Sack|301-402-9259|sackm@nih.gov|
20159108|NCT04004221|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20159109|NCT01970241|HCMC|Lisa Fish MD|612-873-2705|lisa.fish@hcmed.org|
20159110|NCT03578926|CooperVision Inc.|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20159111|NCT00992056|University of Miami|Richard A Preston MD MSPH MBA|305 243 5930|rpreston@med.miami.edu|
20159112|NCT00295334|Ben-Gurion University of the Negev|Iris Shai|+972086477443|irish@bgu.ac.il|
20159113|NCT02038946|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20159114|NCT01558596|Minneapolis VA Medical Center|Santiago Garcia, MD|6124673670|santiago.garcia@va.gov|
20159115|NCT00652314|Vascular Solutions, Inc.|Lisa Gallatin, RAC|763-656-4399|lgallatin@vasc.com|
20159116|NCT02548910|Ottawa Hospital Research Institute|Dr. Guillaume Martel|6137378899|gumartel@toh.ca|71053
20159117|NCT00626886|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20159118|NCT02057640|Cleveland Clinic Taussig Cancer Center|Jason Valent, MD|216-445-7238|valentj3@ccf.org|
20159119|NCT01267864|Albert Einstein College of Medicine, Montefiore Medical Center|Benjamin Friedman, MD|718-920-6626|befriedm@montefiore.org|
20159120|NCT00581399|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
20159121|NCT01270880|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath, M.D.|313-576-8715|heathe@karmanos.org|
20159122|NCT01356498|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
20159123|NCT01221753|Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA02215|Robert Haddad, MD|617-632-3090|robert_haddad@dfci.harvard.edu|
20159124|NCT01576939|Stanford University|Quynh Le|650-725-0203|qle@stanford.edu|
20159125|NCT04552288|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
20159126|NCT01831466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159127|NCT02798315|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20159128|NCT00005947|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
20159129|NCT02299141|Washington University School of Medicine|Ramaswamy Govindan|314-362-5654|rgovindan@wustl.edu|
20159130|NCT00434993|Acute Respiratory Distress Syndrome (ARDS) Network|David Schoenfeld, ARDSNet CCC PI|617-726-6111|dschoenfeld@partners.org|
20159131|NCT03335150|VASDHS|Dr. Dawn Schiehser|858-552-8585|Dawn.Schiehser@va.gov|2664
20159132|NCT02991898|Masonic Cancer Center, University of Minnesota|Claudio Brunstein|612-625-3918|bruns072@umn.edu|
20159133|NCT00778167|University of Colorado Denver|Dr. David R. Camidge|720-848-0449|ross.camidge@ucdenver.edu|
20159134|NCT02218697|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189295|NCT00252382|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
20219416|NCT04874636|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20219417|NCT01770392|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219418|NCT04188301|Washington University in St. Louis|Dr. Gary Weil|3144547787|gary.j.weil@wustl.edu|
20219419|NCT03401450|NYU Langone|Dr. Prianka Desai|212-263-5072|prianka.desai@nyulangone.org|
20219420|NCT02642536|VA|Dr. Gina Evans|713-440-4459|gina.evans@va.gov|
20219421|NCT01666197|Novartis Consumer Health SA|Clinical Project Leader|41223635293||
20219422|NCT00620659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219423|NCT01709838|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20219424|NCT00578669|UT Austin School of Nursing|Dr. Richard A. Brown|512-471-8584|brown2@utmail.utexas.edu|
20219425|NCT01193127|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
20219426|NCT03564444|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
20219427|NCT03246646|CMC VA Medical Center|Steven L. Sayers|(215) 823-5196|steven.sayers@va.gov|
20219428|NCT02569112|Venus Concept Ltd.|Dr. Yoni Iger|8889070115|yoni@venusconcept.com|
20219429|NCT02352779|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH. Assistant Professor|585-275-7827|Luke_Peppone@urmc.rochester.edu|
20219430|NCT00529282|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clincal Team Lead|908 927-3785||
20189296|NCT01218048|University of Pittsburgh Cancer Institute|Robert Ferris, MD, PhD|412-623-3205|ferrrl@upmc.edu|
20159135|NCT01059864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159136|NCT00451958|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20159137|NCT02175277|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20159138|NCT03866538|Mayo Clinic|Joseph A. Murray, M.D.|507-284-2631|Murray.Joseph@mayo.edu|
20159139|NCT02482428|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159140|NCT02547038|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20159141|NCT00516893|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
20159142|NCT00284557|Emory University|Anne L. Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
20159143|NCT00301262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20159144|NCT01443364|UCB|UCB Clinical Trial Call Center|+1877 822||9493
20159145|NCT00623233|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159146|NCT00559845|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20159147|NCT00459875|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
20159148|NCT02150057|Andrews Institute for Orthopaedics & Sports Medicine|Dr. Roger Ostrander|850-916-3700|rostrander@flboneandjoint.com|3725
20159149|NCT01696994|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
20159150|NCT00335283|Vanderbilt University Medical Center|Manager, Clinical Trials|615-322-4643|tina.higginbotham@vanderbilt.edu|
20159151|NCT00576628|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20159152|NCT02926027|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
20159153|NCT03645421|AstraZeneca|Global Clinical Lead|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
20159154|NCT00924612|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
20159155|NCT00224120|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20159156|NCT00104416|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159157|NCT02455804|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20159158|NCT04343534|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
20159159|NCT02342691|Forsyth|Hatice Hasturk|617-892-8499|hhasturk@forsyth.org|
20159160|NCT01164891|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20159161|NCT03985943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20159162|NCT00441142|Dana-Farber Cancer Institute|Dr. Eudocia Quant Lee|617-632-2166|eqlee@partners.org|
20159163|NCT00338286|Janssen Research and Development|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20159164|NCT01265563|VA- STVHCS|Dr. Shweta Bansal|2105674700|bansals3@uthscsa.edu|
20159165|NCT03248531|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20159166|NCT01858545|Integra LifeSciences|Manager, Clinical Research|443-766-3869|allison.matthews@integralife.com|
20159167|NCT04075513|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20159168|NCT05398159|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
20159169|NCT05411822|Icahn School of Medicine at Mount Sinai|Mariana Figueiro, PhD|(518) 366-9306|Mariana.Figueiro@mountsinai.org|
20159170|NCT05312697|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20159171|NCT04283656|Thomas Jefferson University|Dr. Walter K. Kraft|(215) 955-9077|Walter.Kraft@jefferson.edu|
20159172|NCT03177512|Bridge HIV, San Francisco Department of Public Health|Albert Liu|628-217-7408|albert.liu@sfdph.org|
20159173|NCT00964002|Department of Medical Oncology, Institut bergonié|Pr Nadine Houede, oncologist||nadine.HOUEDE@chu-nimes.fr|
20159174|NCT02593903|Medical College of Wisconsin|Clinical Research Coordinator|414-337-3441|ebedjeti@mcw.edu|
20159175|NCT02036580|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20159176|NCT01928290|Washington University School of Medicine|Haeseong Park, M.D.|314-747-6268|haeseongpark@wustl.edu|
20159177|NCT01116466|Otto Bock Healthcare Products GmbH|Medical Affairs Manager|004315233786733|Milana.Mileusnic@ottobock.com|
20159178|NCT00976716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159179|NCT04222699|VA Maryland Healthcare System|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
20159180|NCT00617058|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
20159181|NCT02723916|The Ohio State University, College of Nursing|Dr. Susie Breitenstein|6146884614|breitenstein.5@osu.edu|
20159182|NCT03583359|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20159183|NCT00508105|Ottawa Hospital Research Institute|Peter Lapner|613-737-8899|plapner@toh.ca|74700
20159184|NCT02008149|Department of Veterans Affairs|Dr. Gary S. Beaupre|(650) 493-5000|Gary.Beaupre@va.gov|64272
20159185|NCT00703846|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159186|NCT04601532|University of Pittsburgh|Eleanor Shirley, MA CCRC|412-383-7712|shirleye@upmc.edu|
20159187|NCT02566785|University of Nebraska Medical Center College of Nursing|Dr. Rita McGuire|402-472-4712|rita.mcguire@unmc.edu|
20159188|NCT02384044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20189297|NCT03274076|University of Michigan|Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
20219431|NCT00968799|Cantonal Hospital St.Gallen|Sascha Müller, MD|+41 71 494 1317|ulrich.beutner@kssg.ch|
20159189|NCT00837161|Philips Healthcare|Sarah Baxter|425-487-7665|sarah.baxter@philips.com|
20159190|NCT01659996|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20159191|NCT03206918|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20159192|NCT02701764|University of Miami|Dr. Anat Galor|305-450-6050|agalor@med.miami.edu|
20159193|NCT03823287|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159194|NCT00978419|Vanderbilt University Medical Center|Burn Unit Director|(615) 322-4590||
20159195|NCT00475085|University of Rochester|Dr. Charles Heckler|585 273-1141|checkler@urmc.rochester.edu|
20159196|NCT03110029|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
20159197|NCT03281629|Maryland Psychiatric Research Center, University of Maryland School of Medicine|Dr. Xiaoming Du|410 402 6036|xdu@som.umaryland.edu|
20159198|NCT05455580|Hunter-Bellevue School of Nursing, Hunter College, The City University of New York|Tara Heagele, PhD, RN|212-396-7206|th1591@hunter.cuny.edu|
20159199|NCT01321216|American University of Beirut|Dr Ghassan Dbaibo|961-1-350000|gdbaibo@aub.edu.lb|4819
20159200|NCT00782171|Institut Straumann AG - Clinical Research|Institut Straumann AG|+41 61 965 11 11|research@straumann.com|
20189298|NCT03760913|OliPass Corporation|OliPass Call Center|82-2-6488-2200|clinicaltrials.inquiries@olipass.com|
20189299|NCT01006538|King's College Hospital, London|Mr Tim Jackson|+44 2032999000|t.jackson1@nhs.net|1297
20204834|NCT00678587|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204835|NCT03806179|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
20204836|NCT02076321|University of Missouri, Department of Orthopaedics|Dr. Daniel Hoernschemeyer|(573)882-1351|hoernschemeyerd@health.missouri.edu|
20204837|NCT00077610|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20204838|NCT01204255|Virginia Commonwealth University|Thomas J. Smith, MD|804-828-9723|tsmith5@mcvh-vcu.edu|
20204839|NCT00790738|The Zucker Hillside Hospital|Raphael J. Braga, MD|718-4708060|rbraga@nshs.edu|
20159201|NCT05244603|Utah State University|Dr. Sarah Yoho Leopold|6145708258|sarah.leopold@usu.edu|
20159202|NCT03522246|pharmaand GmbH|Medical Information Department|1-800-506-8501|medinfo@pharmaand.com|
20159203|NCT00611442|Carl R Darnall Army Medical Center|Dr. Joel Stengel|2545531804|joel.stengel@us.army.mil|
20159204|NCT00489424|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159205|NCT01558115|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
20159206|NCT01436656|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159207|NCT00880269|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159208|NCT03230890|Atrium Health Wake Forest Baptist|Charles H. Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
20159209|NCT04136548|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
20159210|NCT02516982|Imperial College London|Dr Josip Car|+44(0)2075940799|josip.car@imperial.ac.uk|
20159211|NCT01951586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20159212|NCT02120781|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
20159213|NCT05096247|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20159214|NCT00760435|University of California, San Diego|Dr. Adriana H. Tremoulet|858-246-0012|atremoulet@ucsd.edu|
20159215|NCT00748618|University of Nebraska Medical Center|Fang Yu|(402) 559-9436|fangyu@unmc.edu|
20159216|NCT00466947|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159217|NCT01995526|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159218|NCT03086408|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
20159219|NCT05445921|Washington University School of Medicine, Dept. of Otolaryngology - Head and Neck Surgery|Dr. Andrew Peterson, Resident Physician|314-362-5626|pandrew@wustl.edu|
20159220|NCT01977729|Yale University|Dr. Wendy Silverman|(203) 737-7053|wendy.silverman@yale.edu|
20159221|NCT03286543|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
20159222|NCT03636893|RUIJIN HOSPITAL|Dr BIRENDRA KUMAR SAH|0086-64370045|rjsurgeon@hotmail.com|671302
20159223|NCT00438360|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159224|NCT00758069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20159225|NCT04560816|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20159226|NCT02277691|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20159227|NCT01147250|Sanofi|Trail Transparency Team||Contact-US@sanofi.com|
20159228|NCT02684617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159229|NCT04952597|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20159230|NCT02029755|Taipei medical university hospital|Dr. Hsiao-Chien Tsai|+886-2-27372181|hctsai.anes@gmail.com|8310
20159231|NCT04998318|Duke University Medical Center|Megan Huchko, MD, MPH|(919) 684-8111|megan.huchko@duke.edu|
20159232|NCT00022763|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20159233|NCT04908865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20159234|NCT02141399|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20159235|NCT04445519|Nicox Ophthalmics, Inc.|Doug Hubatsch/Chief Scientific Officer|984-710-5354|hubatsch@nicox.com|
20159236|NCT01345929|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
20159237|NCT00394329|Penn State College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20159238|NCT02819297|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
20159239|NCT02858440|GlaxoSmithKline|GSK Response Center|866-435-7343|lrs54533@gsk.com|
20159240|NCT01670279|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20204840|NCT01357915|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204841|NCT00305253|University of California San Francisco (UCSF)|Suellen Miller|415 597 9394|smiller@globalhealth.ucsf.edu , suellenmiller@gmail.com|
20159241|NCT01407952|Mayo Clinic|Bernard Bendok, MD|3129269441|bendok.bernard@mayo.edu|
20159242|NCT01534351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159243|NCT02702609|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
20159244|NCT04153981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159245|NCT01781806|UCLA CARE Center|Dr. Raphael J. Landovitz|(310) 825-6689|rlandovitz@mednet.ucla.edu|
20159246|NCT02771574|Stanford University School of Medicine|Cindy Lamendola|650-723-3141|clamendola@stanford.edu|
20159247|NCT01780337|Columbia University|William Whang|212-305-8620|ww42@cumc.columbia.edu|
20159248|NCT02091362|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159249|NCT00690430|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159250|NCT00617097|University of California, Davis|Dr. Catherine Cansino|9167346930|Catherine.Cansino@ucdmc.ucdavis.edu|
20159251|NCT02125838|DorkuzEU|Sule Ozbilgin|902324122836|ozbilginsule@gmail.com|
20159252|NCT02565147|The Medicines Company|Global Health Science Center|1.888.977.6326|medical.information@themedco.com|
20159253|NCT00787839|Atlanta VA Medical Center|Lawrence S Phillips, MD|404-728-7608|lawrence.phillips@va.gov|
20159254|NCT03587428|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20159255|NCT00286091|Amgen Inc.|Study Director|866-572-6436||
20159256|NCT01994746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159257|NCT02936869|World Bank|Dr. Adanna Chukwuma|9173712931|adc785@mail.harvard.edu|
20159258|NCT00335738|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20159259|NCT02688270|Covis Pharma|Clinical Trial Interest|18773744177|CTInterest@covispharma.com|
20159260|NCT05066750|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
20159261|NCT00506454|Sepsicure L.L.C.|Vice President|212-606-4352|bianuale@metromediacompany.com|
20159262|NCT03800537|University of North Carolina at Chapel Hill|Desma Jones|919-843-9463|desma_jones@med.unc.edu|
20159263|NCT00902850|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|Robert.Steffen@bausch.com|
20159264|NCT00260832|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20159265|NCT03745638|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20159266|NCT03098433|Virginia Commonwealth University|Francesco S. Celi, MD, MHSc.|804-828-9696|francesco.celi@vcuhealth.org|
20159267|NCT02777203|The Advanced Gyn Surgery Institute|Mary Johnston|6303641112|mjohnston@drcharlesmiller.com|
20159268|NCT03604172|University of Pennsylvania|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
20159269|NCT02676895|GlaxoSmithKline|GSK Response Center|866-435-7343|antonella.s.scire@gsk.com|
20159270|NCT02168062|University of California, San Francisco|Li Zhang, PhD|(415) 476-5339|Li.Zhang@ucsf.edu|
20159271|NCT00182078|Massachusetts General Hospital|Dr. Frederick J. Stoddard Jr., M.D.|6173714762|fstoddard@partners.org|
20159272|NCT00395486|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20159273|NCT01271907|National Cancer Institute, National Institutes of Health|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
20159274|NCT01814046|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
20159275|NCT00564902|James A. Lovell Federal Health Care Center|Dr. Stuart P. Richer|224-610-5440|Stuart.Richer1@va.gov|
20159276|NCT01667250|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20159277|NCT02097719|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20159278|NCT01925040|Kulzer GmbH|Global Scientific Affairs Management|+4915116891006|andrea.leyer@kulzer-dental.com|
20159279|NCT01854775|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20159280|NCT02091531|Memorial Sloan Kettering Cancer Center|Dr. Dana Rathkopf, MD|646-422-4379|rathkopd@mskcc.org|
20159281|NCT00984594|RTI Biologics|Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
20159282|NCT00875485|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159283|NCT01271010|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20159284|NCT01631747|Northwestern University|Mary J. Kwasny|312-503-2294|m-kwasny@northwestern.edu|
20159285|NCT01456195|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20159286|NCT02109432|Pennington Biomedical Research Center|Corby Martin, Associate Professor|225-763-2585|corby.martin@pbrc.edu|
20159287|NCT03304054|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
20159288|NCT02908685|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20159289|NCT02954406|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20159290|NCT04523454|Imperial College London|Dr Rochan Agha-Jaffar|0203 311 3000|Rochan.Agha-Jaffar@nhs.net|21253
20159291|NCT03179982|American University|Caroline Kuo|2028853054|ckuo@american.edu|
20159292|NCT05926544|University of North Carolina at Chapel Hill|Abby Gamble, MA|828-513-0636|abigail_gamble@email.unc.edu|
20159293|NCT04683029|Janssen Pharmaceutical K.K.|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20159294|NCT04299308|University of Kansas Medical Center|Dr. Jill Morris|9139457675|jmorris2@kumc.edu|
20159295|NCT00814580|Ortho-McNeil Janssen Scientific Affair, LLC|Senior Director of Clinical Development, Pain|(908)927-5469|GVorsang@its.jnj.com|
20159296|NCT02551094|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
20159297|NCT04309370|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
20159298|NCT02920528|Lundquist Institute|David Tanen|310-222-3624|dtanen@emedharbor.edu|
20159299|NCT01340625|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20159300|NCT01986231|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
20159301|NCT02377752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159302|NCT00962741|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159303|NCT02003638|University of Pennsylvania|Dr. Emil deGoma|2156156521|emil.degoma@uphs.upenn.edu|
20159304|NCT00654745|Daiichi Sankyo|James McCarthy|732-590-3430|jmccarthy@dsi.com|
20189300|NCT03805672|Oregon Health & Science University|Samantha Underwood|503-494-8481|underwos@ohsu.edu|
20219432|NCT01540773|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
20204842|NCT01785810|Abramson Cancer Center|Michael Gardo|215-615-2232|michael.gardo@uphs.upenn.edu|
20219433|NCT01104779|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
20219434|NCT03867097|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
20219435|NCT01372774|Mayo Clinic|Paul D. Brown, M.D.|(713) 563-2415|brown.paul@mayo.edu|
20219436|NCT00389831|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20219437|NCT01398943|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
20219438|NCT04639713|Novoxel Ltd|Ifat Klein|972-52-6009860|ifat@novoxel.com|
20219439|NCT01580813|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20219440|NCT03190330|Johnson & Johnson Private Limited|Sr. Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219441|NCT02081209|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20219442|NCT04616430|Atossagenetics|Dr. Steven Quay|206.419.4873|steven.quay@atossainc.com|
20219443|NCT00633243|Yale University|R. Douglas Bruce|(203) 737-6133|robert.bruce@yale.edu|
20219444|NCT02022748|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
20219445|NCT02700386|University of Colorado, Denver|Christine Fisher, MD, MPH|720-848-0154|christine.fisher@cuanschutz.edu|
20219446|NCT00379340|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20219447|NCT04347122|KUMC|Kyle Sweeney, MD|913886100|ksweeney2@kumc.edu|
20219448|NCT05538065|Brigham and Women's Hospital|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
20219449|NCT04994483|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
20219450|NCT00112866|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
20159305|NCT03249909|Mölnlycke Health Care|Andrea Marie Picchietti|260 2583879|andrea.picchietti@molnlycke.com|
20204843|NCT02662985|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20204844|NCT03442829|Bournemouth University|Prof. Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
20204845|NCT01486784|Abramson Cancer Center at the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
20204846|NCT02841787|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20204847|NCT03491553|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20204848|NCT02724774|University of Washington|Carol Rhodes, Director of Sponsored Programs|206 543-2139|carhodes@uw.edu|
20204849|NCT03029650|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
20204850|NCT01875367|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20204851|NCT02237157|RenovoRx|Charles Li|(650) 284-4433|charles@renovorx.com|
20159306|NCT00606034|Mountain Diabetes and Endocrine Center|Dr. Wendy Lane, Director of Clinical Research|828-258-2404|mountaindiabetes@msn.com|314
20159307|NCT02078180|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
20159308|NCT05286658|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
20159309|NCT01959178|Bausch Health|Study Director||robert.steffen@bausch.com|
20159310|NCT00935493|Yale University|Christopher van Dyck|203-764-8100|christopher.vandyck@yale.edu|
20159311|NCT00586716|Loma Linda University Medical Center|Dr. Pedro Baron|909-558-6792|PBaron@llu.edu|
20159312|NCT02027311|Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital|Dr. Byung Hyo Cha, Director of ETOMI-1 study|+82-64-740-8050|drhyo@hotmail.com|
20159313|NCT03928418|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
20159314|NCT00745290|Pacira Pharmaceuticals Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20159315|NCT03423238|Wake Forest School of Medicine|Tina Brinkley|336-713-8534|tbrinkle@wakehealth.edu|
20159316|NCT02688829|Microport Medical, Shanghai, China|Dr Zhang Haotian|8621-38954600|zhanght@microport.com|8552
20159317|NCT04470050|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20159318|NCT03640507|Beth Israel Deaconess Medical Center|Cassandra R. Duffy, MD, MPH|617-667-2636|cduffy3@bidmc.harvard.edu|
20159319|NCT01642056|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
20159320|NCT03028129|Federal University of Mato Grosso do Sul|Julio Croda|+5567981229959|julio.croda@ufms.br|
20159321|NCT01076205|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20159322|NCT01145001|Yale University|Dana Cavallo, Assistant Professor|2039747607|dana.cavallo@yale.edu|
20159323|NCT00602225|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
20159324|NCT02993822|NeRRe Therapeutics Limited|Dr. Stephen Pawsey|+44 (0)1438906960|steve.pawsey@nerretherapeutics.com|
20159325|NCT01939977|Hospital Universitari de Bellvitge|Dr. Josep M. Cruzado|0034932607602|jmcruzado@bellvitgehospital.cat|
20159326|NCT02959853|Baylor College of Medicine|Rui Chen|812-239-1855|rui.chen2@bcm.edu|
20159327|NCT01849692|Alcon Research, Ltd.|Clinical Project Group Leader, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20159328|NCT01696981|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
20159329|NCT01962428|General Hospital of Chinese People's Armed Police Forces|huiliang Liu|+8601057976707|lhl518@vip.sina.com|
20159330|NCT00851890|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20159331|NCT03135431|Mayo Clinic|Vanessa Torbenson, M.D.|507-266-9873|Torbenson.Vanessa@mayo.edu|
20159332|NCT05253755|Dermbiont Inc|Joanna Jay|415.819.4816|joanna.j@dermbiont.com|
20159333|NCT02597452|Penn Medicine|Dr. Ari D Brooks|215-829-8461|ari.brooks@pennmedicine.upenn.edu|
20159334|NCT03122145|Holy Cross Hospital|Lauren Tabor Gray|954 542 3429|lauren.tabor@holy-cross.com|
20159335|NCT00281099|Medtronic, Inc.|MVP Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
20159336|NCT04912089|UC San Diego|Jessica Bomyea|858-822-1470|jbomyea@health.ucsd.edu|
20159337|NCT03108521|Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital|Dr. Xingwei Wu and Professor Enwu Long|+8615928017367|wuxw1988@126.com|
20159338|NCT05629312|UZLeuven|Prof. Maria Cadenas|+3216332017|maria.cadenas@uzleuven.be|
20159339|NCT01059357|Wake Forest University Health Sciences|Dr. Joshua Waltonen|3367169068|jwaltone@wakehealth.edu|
20159340|NCT06899737|KDH Research & Communication|Kristen D. Holtz, PhD|4043958711|kholtz@kdhrc.com|
20159341|NCT01308840|University of Rochester|Aram F Hezel|585-275-5823|aram_hezel@urmc.rochester.edu|
20159342|NCT00334737|University of New Mexico|Dr. Robin K Ohls|505-272-6753|rohls@salud.unm.edu|
20159343|NCT00258908|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20159344|NCT03224403|JNJWorldwide|Andrew Myers, MD|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
20159345|NCT01691014|Pfizer ClinicalTrials.gov Call Center, Pfizer, Inc.|Pfizer Inc.|001 800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159346|NCT03372551|Coopervision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|mnguyen@coopervision.com|
20204852|NCT03628508|The Hong Kong Polytechnic University|Dr Amy Fu|8522766 6726|amy.fu@polyu.edu.hk|
20204853|NCT01996748|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
20204854|NCT04539249|Federal Medical Centre, Yenagoa|Dr. Olakunle I. Makinde|08032136315|olakunleife@gmail.com|
20204855|NCT01628016|Hunan Normal University|Dr. Wenhui Yang|+86 731 8873076|yangwh110@163.com|
20159347|NCT00066703|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, PhD Head Trial Activities / Deputy Director|41 31 511 94 00|Heidi.Roschitzki@etop.ibcsg.org|
20159348|NCT01696968|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
20159349|NCT03727646|University of Washington|Dr. Kevin Douglas O'Brien|2065984300|cardiac@uw.edu|
20159350|NCT05280158|University of California, Los Angeles|Yusaku Michael Shino, MD|(310) 866-6327|MShino@mednet.ucla.edu|
20159351|NCT04753658|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159352|NCT05659719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159353|NCT06523010|Bitlis Eren University|Asst. Prof. Ömer Dursun|5426088687|fztomrdrsn@gmail.com|+90
20159354|NCT04812028|University of Minnesota|Gwenyth Fischer|612-625-9950|fisch662@umn.edu|
20159355|NCT05924165|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|(212) 241-1272|Mantu.Gupta@mountsinai.org|
20159356|NCT01681186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159357|NCT05160415|Edgewise Therapeutics, Inc.|Joanne Donovan MD PhD, Chief Medical Officer|720-262-7002|studies@edgewisetx.com|
20159358|NCT01375127|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159359|NCT04308239|Virginia Tech|Michael Madigan|(540) 231-3543|mlm@vt.edu|
20204856|NCT00586924|MedImmune, LLC|Nai Shun Yao, MD|1-301-398-5936|information.center@astrazenea.com|
20159360|NCT00316225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159361|NCT01814878|Janssen Korea/25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Director|82-2-2094-4518||
20159362|NCT02710981|OB-GYN department, Assiut University, Egypt|Essam R. Othman|+201006607801|essamrash@yahoo.com|
20159363|NCT01280058|The Ohio State University Comprehensive Cancer Center|Anne Noonan, MD|614-685-6912|Anne.Noonan@osumc.edu|
20159364|NCT00878254|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
20159365|NCT01132846|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
20159366|NCT00194077|Johns Hopkins University School of Medicine|Robert Findling, MD,MBA Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
20159367|NCT04928885|The University of Illinois at Chicago|Dr. Julie Bobitt, PhD|312.355.0247|jbobitt@uic.edu|
20159368|NCT03470194|U Mass Memorial|Dr Danielle Taylor|508-334-9840|danielle.taylor@umassmemorial.org|
20159369|NCT05332392|Masimo|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
20159370|NCT01268046|Massachusetts General Hospital|Janet Hall, MD|617-877-1112|janet.hall@nih.gov|
20159371|NCT02628405|Accru|Dr Grzegorz S. Nowakowski|507-422-6553|Nowakowski.Grzegorz@mayo.edu|
20159372|NCT01450696|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159373|NCT03818607|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20159374|NCT01334216|Indiana University School of Medicine|Stephen M. Downs, MD, MS|3172780552|stmdowns@iu.edu|317
20159375|NCT01380197|Morehouse School of Medicine|Iris Buchanan|404-398-9578|ibuchanan@msm.edu|
20159376|NCT05730335|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20159377|NCT03915574|UAMS|Nadir Sharawi|5016866119|nelsharawi@uams.edu|
20159378|NCT00883168|Meda Pharmaceuticals, Inc.|David Ginsberg,D.O.|732 564-2364|david.ginsberg@meda.us|
20159379|NCT04027803|BIOCAD|Morozova Maria|+7 (495) 992 66 28|morozovama@biocad.ru|8436
20159380|NCT00615719|VCU|John D. Grizzard|804-828-8569|jdgrizzard@vcu.edu|
20159381|NCT03748706|Cassava Sciences|Lindsay Burns, SVP of Neuroscience|512-501-2484|lburns@cassavasciences.com|
20159382|NCT00842153|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159383|NCT03352141|Zeltiq Aesthetics|Lori Brandt, Director Cinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
20159384|NCT01355679|NMTRC at Spectrum Health|Giselle Sholler, MD|616-267-0334|giselle.sholler@helendevoschildrens.org|
20159385|NCT00142168|DFCI|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
20159386|NCT05319600|University of Vermont|Amy Hughes Lansing, PhD|(802) 656-3801|amy.hughes.lansing@uvm.edu|
20159387|NCT05319899|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20159388|NCT05141175|Duke University|Dr. Anthony Viera|919 681 3178|anthony.viera@duke.edu|
20159389|NCT00787241|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20159390|NCT01032603|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20159391|NCT01104545|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159392|NCT00923351|National Cancer Institute, National Institutes of Health|Dr. John Glod|301-451-0391|john.glod@nih.gov|
20159393|NCT00940290|ITESM|Carlos A. Cuello-García|+52 (81)88882154|carlos.cuello@gmail.com, carlos.cuello@itesm.mx|
20159394|NCT03657134|NYU Langone Health|Lior Jankelson, MD, PhD|212-263-7149|Lior.Jankelson@nyulangone.org|
20159395|NCT01253148|H. Lee Moffitt Cancer Center and Research Institute|Sarah Hoffe, M.D.|813-745-3814|sarah.hoffe@moffitt.org|
20159396|NCT01262560|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20159397|NCT06423456|afyonkarahisar health sciences university hospital|Dr. Betül Ahat|05467240341|drbetula@gmail.com|
20159398|NCT00744380|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
20159399|NCT02443116|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
20159400|NCT04295759|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
20159401|NCT00465972|Duke University School of Medicine|Andrew Krystal, MD, MS, Professor of Psychiatry and Behavioral Sciences|919-681-8742|andrew.krystal@duke.edu|
20159402|NCT00349349|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159403|NCT03028415|Ferring Pharmaceuticals|Global Clinical Compliance|-+1 833-548-1402|DK0-Disclosure@ferring.com|
20159404|NCT02285023|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Prof. Kanokvalai Kulthanan|(662)419-4333|kanokvalai.kul@mahidol.ac.th|
20159405|NCT00295009|DePuy Synthes|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
20159406|NCT01108731|Beth_IsraelMC|Dr Benjamin Natelson|212-844-6747|bnatelson@chpnet.org|
20159407|NCT01063062|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159408|NCT02015481|Bioblast Pharma|Warren Wasiewski|717-368-0780|Warren.wasiewski@bioblastpharma.com|
20159409|NCT00943098|IBSA Institut Biochimique|Barbara Gugliotta, Clincial Research Manager|+41 58 360 10 00|barbara.gugliotta@ibsa.ch|
20159410|NCT00625391|Texas Tech University Health Sciences Center|Dr. Chwan-Li Shen|(806) 743-2815|Leslie.Shen@ttuhsc.edu|
20159411|NCT01352221|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20159412|NCT01088295|University of California, Los Angeles|Jordan E. Lake, M.D., M.Sc.|(310)557-1891|jlake@mednet.ucla.edu|
20159413|NCT03974932|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
20159414|NCT01170273|Miami VA Medical Center|Silvina Levis MD|305-575-3388|silvina.levis-dusseau@va.gov|
20204857|NCT03185455|UPenn|Dr. Adi Hirshberg|917-553-9643|adi.hirshberg@uphs.upenn.edu|
20159415|NCT01673854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20173296|NCT03578367|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20173297|NCT01148745|Dialysis Clinic, Inc.|Dr. Toros Kapoian, M.D., F.A.C.P.|732-940-8368|Toros.Kapoian@dciinc.org|
20204858|NCT04570657|AstraZeneca AB|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20204859|NCT01079962|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20204860|NCT01331239|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20204861|NCT01072539|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204862|NCT00946530|Stanford University|Jerome A. Yesavage, MD|650-493-5000|yesavage@stanford.edu|x64330
20204863|NCT03105700|Dartmouth Hitchcock Medical Center|Krzysztof Bujarski, MD|6036505000|krzysztof.a.bujarski@hitchcock.org|
20204864|NCT02768194|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204865|NCT03095521|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
20204866|NCT01536119|University of Toronto|Jennifer Abbass Dick||jennifer.abbass@mail.utoronto.ca|
20204867|NCT03521193|Centro Cardiologico Monzino, IRCCS|Clinical Trials' Office Chief|+390258002|alessandra.terragni@ccfm.it|675
20204868|NCT01810042|Pusan National University Hospital|Ji Eun Lee|+82-51-240-7957|jlee@pusan.ac.kr|
20204869|NCT04614545|The Cleveland Clinic Foundation|Dr. Marcio Griebeler|216.444.6568|jenkink@ccf.org|
20204870|NCT01454401|Reapplix Blokken 45 3460 Birkerød Denmark|MD, PhD Senior Consultant Magnus Löndahl||magnus.londahl@med.lu.se|
20204871|NCT00369746|New York State Psychiatric Institute|Patrick J. McGrath, M.D.|646-774-8076|mcgrath@nyspi.columbia.edu|
20204872|NCT02560493|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632869|amanda.staiano@pbrc.edu|
20204873|NCT03303040|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
20204874|NCT03379506|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20204875|NCT03006471|INSITITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20204876|NCT03162055|AstraZeneca|Vice President, Inhalation and Oral Respiratory|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20204877|NCT01993615|Madigan Army Medical Center|Daniel Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
20204878|NCT02370498|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173298|NCT00397982|University of Virginia|Craig Slingluff|434 924 1730|cls8h@virginia.edu|
20173299|NCT01024296|Stanford University|Bilal M Shafi, MD|(215) 738-0400|bmshafi@stanford.edu|
20173300|NCT00264641|Hypoglycaemia Research Group|Prof. Birger Thorsteinsson|+4548294829|Birger.Thorsteinsson@regionh.dk|
20173301|NCT01199289|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20173302|NCT03055260|University of Minenesota|Russel Giveans|5042314007|russell.giveans@gmail.com|
20173303|NCT02507505|University of Pennsylvania Perelman School of Medicine|Mark D. Neuman, MD, MSc (Principal Investigator)|215-746-7468|mark.neuman@uphs.upenn.edu|
20173304|NCT00967798|Emory University|Arlene Stecenko, MD|404-712-2657|astecen@emory.edu|
20159416|NCT02316353|CSL Behring|Michelle Hellstern|6102907515|michelle.hellstern@cslbehring.com|
20173305|NCT01409564|Seoul National University Hospital|Prof. Jung Seok Choi|82-2-870-3461|choijs@neuroimage.snu.ac.kr|
20159417|NCT00375674|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1800718|ClinicalTrials.gov_Inquiries@pfizer.com|1021
20159418|NCT05897242|Fred Hutchinson Cancer Center|Jaimee Heffner, Associate Professor|2066677314|jheffner@fredhutch.org|
20173306|NCT00254540|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20159419|NCT00809835|Yale University School of Medicine|Kathleen M. Carroll, Ph.D., Albert E Kent Professor of Psychiatry|203.937.3486|kathleen.carroll@yale.edu|7403
20173307|NCT00225251|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
20159420|NCT02582814|AstraZeneca|A clinical pharmacology and long-term safety study|+819039706431|Yu.Shimizuishi@astrazeneca.com|4669
20159421|NCT03530995|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
20159422|NCT01716039|Alimentiv (Formerly Robarts Clinical Trails)|Dr.Jenny Jeyarajah (Sr. Biostatistician)||jenny.jeyarajah@alimentiv.com|
20173308|NCT03045328|Stanford University|Steven Edward Coutre, Professor of Medicine (Hematology)|650-498-6000|coutre@stanford.edu|
20159423|NCT01668628|The Catholic University of Korea|Dr. Hye Eun Yoon|82-32-280-5886|berrynana@catholic.ac.kr|
20173309|NCT02070692|Oregon Health & Science University|Dr. Katharine Simmons|404-718-6619|simmonka@ohsu.edu|
20159424|NCT02058511|UCSF|Matthias Behrends|415 476 3761|matthias.behrends@ucsf.edu|
20173310|NCT00592839|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
20159425|NCT02643615|The Ohio State University Wexner Medical Center|Dr. Sergio Bergese|6142933559|sergio.bergese@osumc.edu|
20173311|NCT01313767|Clinical Development Team of Medytox Inc.|Medytox Inc.|82-70-8666-6911|hgpark@medytox.com|
20173312|NCT00157950|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173313|NCT01287897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173314|NCT04867850|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
20173315|NCT02902965|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
20173316|NCT00293254|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173317|NCT02259582|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
20173318|NCT02335489|St. Jude Medical|Roni Diaz|+1 972 309 8601|rdiaz@sjm.com|
20173319|NCT01969240|Mayo Clinic|Dr. Erik Hess|507-284-7221|hess.erik@mayo.edu|
20173320|NCT01207765|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
20173321|NCT02653391|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20159426|NCT00801723|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20173322|NCT00503308|UCSF, San Francisco General Hospital|Deborah Cohan, MD|415 206 3658|cohand@obgyn.ucsf.edu|
20159427|NCT04848220|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20173323|NCT02452346|Weill Cornell Medicine|Dr. Sangmin Lee, MD|646-962-2700|sal9053@med.cornell.edu|
20173324|NCT00531050|Novartis Pharmaceuticals|Study Director|862-778-8300||
20173325|NCT01067456|MGH|Dr. Udo Hoffmann|617-726-1255|uhoffmann@partners.org|
20173326|NCT02233309|University of Nebraska Children's Hospital & Medical Center|Jessica K. Goeller, DO|(402) 955-4303|JGoeller@childrensOmaha.org|
20173327|NCT01411696|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20173328|NCT02328755|University of Michigan|John Magenau|734 936-8785|johnmage@med.umich.edu|
20159428|NCT03713398|University of North Carolina at Chapel Hill|Amy Wilson, PhD|919-962-3598|amyblank@email.unc.edu|
20159429|NCT04925076|University of Minnesota|Jeff Boissoneault, PhD|612-624-7357|jboisson@umn.edu|
20173329|NCT00232817|Columbia University|Dr. Pamela Flood|201-370-3933|pamelaflood181@gmail.com|
20173330|NCT00799487|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
20159430|NCT02557100|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20173331|NCT04481750|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20159431|NCT00510718|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159432|NCT01460875|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
20159433|NCT01511614|NIH/NIDA|Dr. Amy Janes|667.312.5164|amy.janes@nih.gov|
20173332|NCT03263442|University of North Carolina - Chapel Hill|Zev Nakamura|984-974-3829|zev_nakamura@med.unc.edu|
20159434|NCT05791565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20159435|NCT02388165|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173333|NCT01463878|Eastern Virginia Medical School|Dr Paul Marik|757-446-8910|marikpe@evms.edu|
20173334|NCT03804879|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20173335|NCT02436889|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
20159436|NCT00705250|Memorial Sloan Kettering Cancer Center|Craig Moskowitz, MD|(212) 639-7992|moskowic@mskcc.org|
20159437|NCT01406938|Novartis Pharmaceutical|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20159438|NCT01289275|UC San Diego, California Smokers' Helpline|Sharon Cummins, Ph.D.|8583001046|scummins@ucsd.edu|
20159439|NCT01576146|Amgen, Inc|Study Director|866-572-6436||
20159440|NCT01558492|Weill Cornell Medicine|Himisha Beltran, MD|646-962-2072|hip9004@med.cornell.edu|
20159441|NCT03454399|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
20159442|NCT01222091|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
20159443|NCT01667224|Clinical Trial Center for Functional Food in Chonbuk National University Hospital|Dr. Soo-Wan Chae|82-63-250-2348|soowan@jbnu.ac.kr|
20159444|NCT01811485|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20159445|NCT01545934|Cal Poly|Suzanne Phelan|805-756-2087|sphelan@calpoly.edu|
20159446|NCT03654404|Dana-Farber Cancer Institute|Hermioni L. Amonoo, Director of Well-Being and Cancer Research Program|617-525-7472|Hermioni_Amonoo@dfci.harvard.edu|
20159447|NCT03299881|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513-236-6799|samlung@elira.com|
20159448|NCT01474772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159449|NCT01822899|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159450|NCT02314156|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
20159451|NCT02846389|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20159452|NCT02321319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20159453|NCT02249091|GSO mbH|Dr Anne L. Kranich|+494044195460|kranich@gsoglobal.com|
20159454|NCT05059301|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20159455|NCT00853242|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20159456|NCT01035463|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
20159457|NCT02516098|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159458|NCT01734395|Jan-Cil Korea|Clinical Research Director|82 2 2094||4518
20159459|NCT01092780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159460|NCT01257230|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159461|NCT02209545|Northwestern Medicine|Dr. Magdy Milad|3126946447|mmilad@nm.org|
20159462|NCT04026009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20159463|NCT02957747|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Suzannah Creech, Ph.D.|254-297-3025|Suzannah.Creech@va.gov|
20159464|NCT01825512|Consorzio per Valutazioni Biologiche e Farmacologiche|Donato Bonifazi|+393936698076|ceo@cvbf.net|
20159465|NCT02466425|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20159466|NCT04181593|OmegaD LLC|Dr. Gregory Smith, MD|3023833948|SGSmith@omegad.com|
20159467|NCT03231917|White River Junction VAMC|Dr Joseph Anderson|8022959363|joseph.anderson@dartmouth.edu|
20159468|NCT01721486|Beaumont Hsopital|Kaveh Aslani, MD|248-898-1907|kaveh.aslani@beaumont.org|
20159469|NCT00582712|University of Wisconsin Carbone Cancer Center|Director of Clinical Research|608-265-0540|clinicalresearch@surgery.wisc.edu|
20159470|NCT01901289|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
20159471|NCT02445014|Mass General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
20159472|NCT01813058|Boston Children's Hospital|susan Goobie, MD, FRCPC|6173667737|susan.goobie@childrens.harvard.edu|
20159473|NCT03585764|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20159474|NCT01581021|University of Mississippi Medical Center|Dr. Lawrence Haber|601-984-6525|lhaber@umc.edu|
20159475|NCT03403361|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
20159476|NCT01932372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159477|NCT05352412|Washington University School of Medicine|Dr. Michael J. Durkin, Principal Investigator|314-454-8225|mdurkin@wustl.edu|
20159478|NCT01917929|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|kevin.barga@stryker.com|
20159479|NCT00673231|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20159480|NCT00810771|VA Ann Arbor Healthcare System, Center for Clinical Management Research|Sarah Hawley, Ph.D.|734-936-8816|sarahawl@umich.edu|
20159481|NCT03594747|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20159482|NCT02470585|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
20159483|NCT02907216|GlaxoSmithKline|GSK Response Center|866-435-7343|kap69137@gsk.com|
20159484|NCT05079347|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
20159485|NCT02095873|University of Warwick|Paul J Thornalley|+442476968594|P.J.Thornalley@warwick.ac.uk|
20159486|NCT00792740|Italfarmaco SpA|Tiziano Oldoni, MD|+39 0264432540|t.oldoni@italfarmaco.com|
20159487|NCT03009162|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159488|NCT00136695|Massachusetts General Hospital|Dr. Benjamin Leder|617-726-6723|bzleder@partners.org|
20159489|NCT02485639|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
20159490|NCT02016716|Amgen Inc.|Study Director|866-572-6436||
20159491|NCT04818216|University of Texas Health San Antonio|Dr. Subrata Debnath, Assistant Professor|210-450-8333|nath@uthscsa.edu|
20159492|NCT04114071|University of Alabama at Birmingham|Dr. Pamela G. Bowen|12059342778|pbowen@uab.edu|
20159493|NCT03479541|Oregon Health and Science University|Dr. Laurie King|5034182602|kingla@ohsu.edu|
20159494|NCT02453750|SickKids|Dr Theo Moraes|416 813 2196|theo.moraes@sickkids.ca|
20159495|NCT02147197|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20159496|NCT03345160|Johns Hopkins School of Medicine|Dr. Robert Wood|410-919-7617|RWood@JHMI.edu|
20173336|NCT01034462|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20173337|NCT00708643|Vistakon|Kurt Moody, O.D. FAOO|904-443-3088||
20173338|NCT00227903|Yale University|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
20173339|NCT04273217|AbViro LLC|Urban Ramstedt|617-818-8112|urban.ramstedt@abviro.com|
20173340|NCT04309656|TB Alliance|Erica Egizi|917-696-4984|erica.egizi@tballiance.org|
20173341|NCT03720470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173342|NCT02311933|Alliance for Clinical Trials in Oncology|Matthew P. Goetz, MD|: 507-284-2511|goetz.matthew@mayo.edu|
20173343|NCT06079320|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173344|NCT03428360|Aquestive Therapeutics|Clinical Project Manager|9089411896|cbuan@aquestive.com|
20173345|NCT03498300|Faculty of Medicine Siriraj Hospital, Mahidol University|Dr. Nalat Sompagdee|+6687-008-7100|pear_nalat@hotmail.com|
20173346|NCT01414855|Genentech, Inc.|Medical Communications|800-821-8590|genetech@druginfo.com|
20173347|NCT04851314|UC Irvine Health|Dr. Robert Ryan Field|7145065703|fieldr@uci.edu|
20173348|NCT00147199|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20173349|NCT03266094|Medtronic|Melody LaBeau, Director of Clinical Operations|763.526.2931|melody.a.labeau@medtronic.com|
20173350|NCT00368355|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
20173351|NCT02727751|Ardelyx|Chief Development Officer|5107451752|drosenbaum@ardelyx.com|
20173352|NCT04061915|New York University|S. Raquel Ramos|212-992-5994|TheHOTIEStudy@gmail.com|
20173353|NCT01322360|Roxane Laboratories, Inc|Anton (Tony) Amann, PhD, Executive Director, Drug Regulatory and Medical Affairs|614-272-4785|Tony.Amann@boehringer-ingelheim.com|
20173354|NCT03473808|Medical University of South Carolina|Amanda Vatinno|8437924840|vatinno@musc.edu|
20173355|NCT03171415|Raziel Therapeutics|Racheli Gueta - Clinical Trials Manager|972-8-9126941|racheli@raziel-therapy.com|
20173356|NCT04059094|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173357|NCT01339429|Brigham and Women's Hospital|Dr. Gita Mody|617-921-8221|gmody@partners.org|
20173358|NCT03057431|Inselspital, Bern University Hospital, Bern, Switzerland|Prof. Daniel Fuster|++41316323144|daniel.fuster@insel.ch|
20173359|NCT03457129|University of Arizona, College of Medicine Phoenix|Stephanie Marsh, MPH, CCRC|602-255-7552|slmarsh@arizona.edu|
20173360|NCT01085591|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
20173361|NCT03649750|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20173362|NCT00459667|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20173363|NCT00396591|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
20173364|NCT00118365|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
20173365|NCT00671502|Meda Pharma US|David Ginsberg, MD Sr Medical Director|732 564 2364|david.ginsberg@meda.us|
20173366|NCT06253806|Washington University, Department of Otolaryngology - Head and Neck Surgery|Nyssa Farrell, MD|314-273-2490|nyssafarrell@wustl.edu|
20173367|NCT03851302|Bronx Veterans Medical Research Foundation|Principal Investigator|718-584-9000 x1742|NOAM.HAREL@VA.GOV|
20173368|NCT04434092|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20173369|NCT00903617|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173370|NCT00475176|National Institute of Diabetes and Digestive and Kidney Diseases, National In|Jay H. Hoofnagle, M.D.|301-496-1333|hoofnaglej@mail.nih.gov|
20173371|NCT01853046|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20173372|NCT05584176|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
20173373|NCT00065507|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20173374|NCT01475331|Milton S. Hershey Medical Center|Dr. Matthew T. Moyer|717-531-3694|mmoyer@pennstatehealth.psu.edu|
20173375|NCT00462761|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20173376|NCT01244906|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
20173377|NCT03480750|National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University|Dr. Yu-Fang Huang|886 6 2353535|yufangh@mail.ncku.edu.tw|5221
20173378|NCT00723892|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800--672-6372|ClinicalTrialsDisclosure@merck.com|
20173379|NCT04532099|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20173380|NCT01194479|Department of Internal Medicine and Endocrinology, Yale University School of Medicine, New Haven, CT|Robert Sherwin, MD|(203) 785-3482|robert.sherwin@yale.edu|
20173381|NCT00498602|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173382|NCT02451839|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20173383|NCT01113801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20173384|NCT02734238|Pennington Biomedical Research Center|Jennifer C. Rood|225-763-2524|jennifer.rood@pbrc.edu|
20173385|NCT01949051|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173386|NCT02935088|Abbott Vascular|Tarn Teraphongphom, Sr. Clinical Scientist|408-9310504|tarn.teraphongphom@abbott.com|
20173387|NCT01506479|University of Pittsburgh|Dr. Charity G. Moore|412-383-6630|cgp22@pitt.edu|
20173388|NCT01846507|Nationwide Children's Hospital|Sarah O'Brien, MD|614-722-3070|sarah.obrien@nationwidechildrens.org|
20173389|NCT01782859|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
20173390|NCT04994522|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20173391|NCT04483011|Bioenergy Life Science, Inc.|Alex Xue, Chief Technology Officer|763-746-0032|alex.xue@bioenergyls.com|3924
20173392|NCT00276159|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
20173393|NCT04356690|Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center|John Mark Sloan, MD|617-638-7002|mark.sloan@bmc.org|
20173394|NCT02426892|UT MD Anderson Cancer Center|Dr. Renata Ferrarotto,MD, Associate Professor, Thoracic-Head & Neck Med Onc|(713) 745-6774|rferrarotto@mdanderson.org|
20173395|NCT03402386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20173396|NCT01896531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20173397|NCT00268996|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173398|NCT02956486|Eisai Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20173399|NCT01905384|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
20173400|NCT03325075|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20173401|NCT00422591|UT MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD|713-792-7734|CR_Study_Registration@mdanderson.org|
20173402|NCT00913003|Northwestern University|Paul Fitzgerald|312-695- 1064|p-fitzgerald2@northwestern.edu|
20173403|NCT02377466|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173404|NCT04210310|NYU Langone Health - Preston Robert Tisch Center for Men's Health|Lawrence Newman, MD|646-754-2000|Lawrence.Newman@nyulangone.org|
20173405|NCT00330616|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173406|NCT00862745|University of California, San Francisco|Dr. Jeanette Brown|415-353-9751|brownj@obgyn.ucsf.edu|
20173407|NCT00697203|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20173408|NCT02617511|University of Manitoba|Dr. Stephen Cornish|204-474-9981|Stephen.Cornish@umanitoba.ca|
20173409|NCT00255047|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20173410|NCT01585194|MD Anderson Cancer Center|Dr. Sapna P. Patel/Associate Professor, Melanoma Medical Oncology|713-792-2921|sppatel@mdanderson.org|
20173411|NCT01333059|Cook Children's Medical Center|Javier Gelvez, MD||Javier.Gelvez@cookchildrens.org|
20173412|NCT01733407|Massachusetts General Hospital|Dr. Florian Eichler|617-643-3799|Feichler@partners.org|
20173413|NCT04152603|Seattle Children's Research Institute|Professor Stephanie Kraft|20688471022068841191|stephanie.kraft@seattlechildrens.org|
20173414|NCT02455531|Carelon Research|Dr. Felicia Trachtenberg|Felicia.Trachtenberg@carelon.c|Felicia.Trachtenberg@carelon.com|
20173415|NCT00530764|GW Pharma Ltd.|Matthew Hersch, Senior Clinical Project Manager|+44 1353 616600|mhersch@gwpham.com|
20173416|NCT03035409|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20173417|NCT02642952|Ramón y Cajal University Hospital|Dr. Andrés Reyes Valdivia|0034 629586239|cauzaza@hotmail.com|
20173418|NCT01405742|University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
20173419|NCT02056340|Beth Israel Deaconess Medical Center|Dr Maureeen Chase, Assistant professor of Emergency Medicine|6177542298|mchase1@bidmc.harvard.edu|
20173420|NCT05740644|Zynex Monitoring Solutions|Clinical Team|888-386-4185|clinical@zynexmonitoring.com|
20173421|NCT04900220|West Virginia University|Dr. Shafic Sraj - Associate Professor|304-293-3007|shafic.sraj@hsc.wvu.edu|
20173422|NCT02028065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173423|NCT00830596|Palmer College of Chiropractic|Christine Goertz, DC, PhD, Principal Investigator|(563) 884-5150|christine.goertz@palmer.edu|
20173424|NCT02107482|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
20173425|NCT00867009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159497|NCT00394251|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20159498|NCT04644276|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20159499|NCT03195660|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
20159500|NCT03367403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159501|NCT00759876|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20159502|NCT01295840|Hospital Universitario Virgen de la Victoria|Dr Javier Alzueta|+34 952 64 15 50|jalzueta@telefonica.net|
20159503|NCT03806556|University of Pittsburgh Medical Center|Meghan McCormick, MD MS|412-692-6938|meghan.mccormick3@chp.edu|
20159504|NCT01707654|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
20159505|NCT00923975|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20159506|NCT01709422|Prince of Songkhla University|Dr. Nisa Netinatsunton|6674451965|nisasan@yahoo.com|9
20159507|NCT01005316|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20159508|NCT00632827|University of California, San Francisco|Lawrence Kaplan, MD|(415) 353-2661|LKaplan@ucsf.edu|
20159509|NCT02925078|University of Michigan|Clinical Research Coordinator|7347633346|aliceou@umich.edu|
20159510|NCT01250184|university of Antioquia, Research Group Rehabilitation in Health|Dr. Luz Helena Lugo, Head of Research Group Rehabilitation in Health|+57 4 2196475|luzh.lugo@gmail.com|
20159511|NCT04528017|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20159512|NCT01126268|The University of Texas Health Science Center at Houston|Dr. Adelaide A Hebert|(713) 500-8339|Adelaide.A.Hebert@uth.tmc.edu|
20159513|NCT01205061|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20159514|NCT00765037|DJO Surgical|Jane M. Jacob - Manager of Clinical Affairs|512-834-6323|jane.jacob@djosurgical.com|
20159515|NCT01320553|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
20159516|NCT01988662|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159517|NCT03425006|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20159518|NCT03560752|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
20159519|NCT01113008|H Virgen de la Victoria|Dr Manuel Jiménez Navarro|951 032 354|jimeneznavarro@secardiologia.es|0034
20159520|NCT02972606|King's College London|Dr Whitney Scott|02071885421|whitney.scott@kcl.ac.uk|
20159521|NCT03503591|Preceptis Medical|Steve Anderson, CEO|612-327-4795|steve@preceptismedical.com|
20159522|NCT00614445|Duchesnay, Inc.|Michael Gallo|450-433-7734|mgallo@duchesnay.com|
20159523|NCT01467037|McGill University Health Centre|Dr Caroline Quach, Pediatric Infectious Diseases Consultant & Medical Microbiologist|514-934-1934|caroline.quach@mcgill.ca|24485
20159524|NCT02126553|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD./Professor|713-563-3534|tkadia@mdanderson.org|
20159525|NCT03831191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159526|NCT01194089|Mayo Clinic|Dr. Toby N. Weingarten|507-255-1612|weingarten.toby@mayo.edu|
20159527|NCT03070171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159528|NCT03374683|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
20159529|NCT02300558|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20159530|NCT01471028|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
20159531|NCT00695955|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20159532|NCT01059682|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20159533|NCT01177553|University of South Florida|Research Coordinator|813-259-8680|obgynclinicalresearch@health.usf.edu|
20159534|NCT01812213|Navidea Biopharmaceuticals|Chief Medical Officer|6149737555|mblue@navidea.com|
20159535|NCT00610857|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|4126486507|tarhiniaa@upmc.edu|
20159536|NCT00158249|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20159537|NCT01626118|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
20159538|NCT00888329|Mayo Clinic|Javier Magrina MD|480-301-8000|magrina.javier@mayo.edu|
20159539|NCT00002540|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
20159540|NCT04826094|Henry M Jackson Foundation for the Advancement of Military Medicine|David Fetterer, MS (Programmer Analyst)|301.500.3818|dfetterer@global-id.org|
20159541|NCT02151903|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
20159542|NCT01864148|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20159543|NCT01500252|UAlberta|Dr. Lauren Beaupre|780-407-3945|lauren.beaupre@albertahealthservices.ca|
20189301|NCT00641537|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20159544|NCT03115827|Vanderbilt University Medical Center|Dr. Katherine McDonell|615-875-7987|katherine.mcdonell@vumc.org|
20159545|NCT00778375|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
20159546|NCT03490292|UW Carbone Cancer Center|Nataliya Uboha, MD, PhD|(608) 265-9966|nvuboha@medicine.wisc.edu|
20159547|NCT01421303|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159548|NCT06003777|Pfizer Inc.|Name or Official Title: Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159549|NCT00904670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159550|NCT01006655|Rambam medical Center|Prof Lea Bentur|xx 972 4 854 3263|l_bentur@rambam.health.gov.il|0502062400
20173426|NCT04474704|The Ohio State University|Maged Costantine, MD|614-293-2222|Maged.Costantine@osumc.edu|
20189302|NCT01801007|MicroVention, Inc., A TERUMO Group Company|Senior Manager, Clinical Quality Compliance and Clinical Operations|714-247-8000|jennifer.jelf@microvention.com|
20189303|NCT00665392|GERCOR|Regulatory Affairs|+33 (0)1 40 29 85 00|regulatory.affairs@gercor.com.fr|
20219451|NCT00554190|Carbylan BioSurgery Inc.|Marcee Maroney, VP Clinical Affairs|650 855 6774|mmaroney@carbylan.com|
20219452|NCT02903030|Nisonger Center|Dr. L. Eugene Arnold, MD, MED. Professor Emeritus College of Medicine|614-685-6701|l.arnold@osumc.edu|
20219453|NCT00977379|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20219454|NCT02603393|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20219455|NCT00699374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219456|NCT02067468|Universidad de Antioquia|Dr Gloria I Sanchez|+57 (4) 219 6062|sanchezg@une.net.co|
20219457|NCT01359969|Pharming Technologies BV|Anurag Relan, MD, VP Clinical Research & Medical Affairs|+31 715247400|a.relan@pharming.com|
20219458|NCT02174419|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20219459|NCT00593736|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20219460|NCT01868893|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20219461|NCT01857271|Albert Einstein Cancer Center|Dr. Haiying Cheng|718-405-8404|hcheng@montefiore.org|
20219462|NCT01853930|Jesse Brown VA Medical Center|Dr. Janet P. Szlyk, PhD|312-997-3644|janet.szlyk@va.gov|
20219463|NCT00110136|Wake Forest CCOP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20219464|NCT00459121|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|313-576-8753|sgadgeel@med.umich.edu|
20219465|NCT04283500|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
20219466|NCT03599271|Intersect ENT|Andrew Campbell PhD, MPH Clinical Affairs Director|6506412100|acampbell@intersectent.com|
20159551|NCT00054327|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Kenneth Cooke MD|216-844-3345|kenneth.cooke@uhhospitals.org|
20219467|NCT01043653|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
20219468|NCT02006693|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20219469|NCT03682224|Southern Illinois University School of Medicine|Sowmy Thuppal, Research Assistant Professor|217-545-2320|sthuppal83@siumed.edu|
20159552|NCT01232504|Department of Hematology, Shanghai Jiao Tong University Affiliated First People's Hospital, China|Chun Wang||wangchun2@medmail.com.cn|
20159553|NCT00613327|Medical Affairs, Janssen Korea|Clinical Research Associate|+82-2-2094-4935||
20159554|NCT00344318|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159555|NCT01014936|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20159556|NCT01153711|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159557|NCT01606176|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20159558|NCT00361231|Massachusetts General Hospital|Dr. Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
20159559|NCT03158740|Connecting Health Innovations|Senior Scientist|8649154636|admin@chi-llc.net|
20159560|NCT01814397|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@med.umich.edu|
20189304|NCT02426138|University of North Carolina at Chapel Hill|Dr. Seth A. Berkowitz|919-966-2276|seth__berkowitz@med.unc.edu|
20189305|NCT03387189|HealthPartners|Kamalini Das|651-293-8233|Kamalini.X.Das@HealthPartners.Com|
20189306|NCT05350501|Enterome|Dr Jan Fagerberg|+33175772785|info@enterome.com|
20189307|NCT00553332|The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute|Tanios Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
20189308|NCT03637296|New York State Psychiatric Institute|Thomas Smith, MD|(646)774-8442|thomas.smith@nyspi.columbia.edu|
20189309|NCT03520036|Mitsubishi Tanabe Pharma Development America, Inc.|Clinical Trials, Information Desk|888-449-2670|information@mt-pharma-us.com|
20189310|NCT01536366|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|jose.rocha@bial.com|
20189311|NCT00873782|University of North Carolina at Chapel HIll|William J. Powers, MD|919 966 8178|powersw@neurology.unc.edu|
20189312|NCT00467272|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|iraad@mdanderson.org|
20189313|NCT06110546|The University of Texas Health Science Center at Houston|Pascal Kingah, MD,MPH|713-500-6828|Pascal.L.Kingah@uth.tmc.edu|
20189314|NCT00145470|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189315|NCT02628106|West China Hospital of Sichuan University|Mr.Zhi-cheng Li|+86 13795581617|wangcaizi2@163.com|
20189316|NCT03160521|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
20189317|NCT03975400|northwell|Michael Birnbaum|718-470-8305|mbirnbaum@northwell.edu|
20189318|NCT03924869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20189319|NCT02734355|Research Institute for Complex Problems of Cardiovascular Diseases, Russia|Dr. Sergey Mamchur|+73842643308|reception@kemcardio.ru|
20189320|NCT04762277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189321|NCT05824559|MEI Pharma|Richard Ghalie, MD CMO|619 990-1153|rghalie@meipharma.com|
20189322|NCT05366751|Sage Therapeutics|Carrie Vaudreuil|+1-857-259-4766|carrie.vaudreuil@sagerx.com|
20189323|NCT02954432|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
20189324|NCT01690624|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189325|NCT05885763|CSL Vifor|Milica Enoiu|+41 58 851 82 64|milica.enoiu@viforpharma.com|
20189326|NCT03024866|Xoft Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
20189327|NCT04912856|Xenon Pharmaceuticals|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
20189328|NCT00647387|Abbott Structural Heart|Ryan Palmer, Director of Clinical Programs|+1 651-202-8362|ryan.palmer@abbott.com|
20159561|NCT00244933|Barbara Ann Karmanos Cancer Institute|Amy Weise, M.D.|313-576-8599|weisea@karmanos.org|
20173427|NCT03128892|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20173428|NCT04570150|UCSD|Dr. Rodney Gabriel|6194710670|ragabriel@health.ucsd.edu|
20173429|NCT01850524|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20173430|NCT00847704|Oregon Health & Science University|Paul J. Cordo|503-418-2520|cordop@ohsu.edu|
20173431|NCT02111850|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
20173432|NCT00195676|Abbott|Global Medical Services|800-633-9110||
20173433|NCT02123745|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
20173434|NCT03334903|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177325500|wfitz@bwh.harvard.edu|
20173435|NCT02879305|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173436|NCT02636868|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9477|psimmons@windtreetx.com|
20173437|NCT03220217|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
20173438|NCT03025542|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20173439|NCT00501293|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com|
20173440|NCT00488345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173441|NCT03626714|Auritec|Sarjan Shah|9092109715|sshah@auritecpharma.com|
20173442|NCT02127567|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
20173443|NCT03518073|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20173444|NCT03045081|University of Washington|Dale J. Langford, PhD; Research Assistant Professor|2066160158|dalejwl@uw.edu|
20189329|NCT05395351|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189330|NCT03850379|Henry Ford Health|Shatha Farhan|3137133910|sfarhan1@hfhs.org|
20159562|NCT04731298|Sobi|Emmanuel Monnet|+41225519156|Emmanuel.Monnet@sobi.com|
20159563|NCT01208961|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20159564|NCT03213938|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
20159565|NCT03641716|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
20159566|NCT02487654|Imperial College London|Professor Prapa Kanagaratnam|+44 20 3313 1000|p.kanagaratnam@imperial.ac.uk|
20159567|NCT04238481|Astellas Pharma Inc|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20159568|NCT02152371|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20159569|NCT00350870|Yale University School Of Medicine Department of Psychiatry|Dr. Kathleen M. Carroll|203-937-3486|kathleen.carroll@yale.edu|7403
20159570|NCT00349921|Wake Forest University Health Sciences|Regina Curry, RN, CCRC|(336) 716-4294|recurry@wfubmc.edu|
20159571|NCT05285644|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
20159572|NCT01101958|ThoraxKlinik, University of Heidelberg|Prof. Dr. F.J.F. Herth|650-216-0176|Felix.Herth@thoraxklinik-heidelberg.de|
20159573|NCT00107900|Daiichi Sankyo, Inc.|Victor Fernandez|732-590-5000|vfernandez@dsi.com|
20159574|NCT02374060|Johns Hopkins University|Elizabeth Sugar, PhD|(410) 614-7837|esugar2@jhu.edu|
20159575|NCT03088930|University of Colorado Cancer Center|Dr. Tejas Patil|7208489264|tajas.patil@cuanschutz.edu|
20159576|NCT00511433|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20159577|NCT01380535|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20159578|NCT03100539|Richard L Roudebush VA Medical Center|Dr. Matthew Bair, Director of Center for Health Information and Communication|317-988-2058|Matthew.Bair@va.gov|
20159579|NCT02596958|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159580|NCT02923830|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20159581|NCT01018134|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
20159582|NCT01751906|Abbott Vascular|Latania Chura / Project Manager|503.935.3002|latania.chura@abbott.com|
20159583|NCT01981863|Stanford University Medical Center|Peter van der Starre|6507236412|pieterva@stanford.edu|
20159584|NCT02242435|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20159585|NCT01110330|Jan-Cil Switzerland|Director Infectious Diseases|41 41 7673477||
20159586|NCT00814697|The NY Memory and Healthy Aging Services|Dr. Gayatri Devi|212-517-6881|gd@nymemory.org|
20159587|NCT00117715|Children's Mercy Hospital|J. Steven Leeder|816-234-3059|sleeder@cmh.edu|
20159588|NCT03289910|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20159589|NCT03990415|University of Missouri|Dr. Dana Duren|(573) 884-7023|durendl@health.missouri.edu|
20159590|NCT03258281|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kpbliden@gmail.com|
20159591|NCT02383420|Carestream Health, Inc.|Susan Pate, Senior Clinical Affairs Manager|585-627-6557|susan.pate@carestream.com|
20159592|NCT03811847|Massachusetts General Hospital|Steven Arnold, MD|617-643-5607|searnold@mgh.harvard.edu|
20159593|NCT02034175|Somnarus Inc|Maria Merchant|4087610884|somnarus@gmail.com|
20159594|NCT03018418|University of Cincinnati Cancer Center|Jordan Kharofa, MD|513-584 4775|kharofjr@ucmail.uc.edu|
20159595|NCT03350035|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20173445|NCT01711177|Université de Montreal|Pierre Forcier|514-343-7468|pierre.forcier@umontreal.ca|
20173446|NCT00911495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189331|NCT03678688|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20189332|NCT00982072|Imperial College NHS Trust|Dr Megan Griffith|02033137309|m.e.griffith@imperial.ac.uk|
20204879|NCT01453569|Shanghai Greenvalley Pharmaceutical Co., Ltd.|Dr. Xianliang Xin|86 21-50504988|xinxianliang@hotmail.com|1370
20173447|NCT00708162|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20173448|NCT00100815|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20173449|NCT04984993|Futura Medical Development Ltd.|Andrew Graham, Senior Clinical Project Manager|+44 1483 685682|Andy.Graham@futuramedical.com|
20173450|NCT02436356|Vanderbilt University Medical Center|Jeffry S. Nyman, Ph.D.|615-936-6296|jeffry.s.nyman@vumc.org|
20173451|NCT02140788|Duke University Health System|Joseph P. McEvoy|919-819-9295|JMCEVOY@gru.edu|
20173452|NCT04577118|iotaMotion, Inc|Laura Chenier|442-325-4171|lchenier@iotamotion.com|
20173453|NCT02611778|bioeq GmbH|Head of Clinical Development|+498024463330|columbus@bioeq.com|
20173454|NCT02746874|Northwestern University|David Walega, MD|312-695-0061|d-walega@northwestern.edu|
20173455|NCT03742154|MUSC|Lisa Coles Program Coordinator|843-876-2291|colesl@musc.edu|
20173456|NCT00003644|NRG Oncology|Linda Gedeon, Christopher Purdy on behalf of Mark Brady, PhD|(716) 845-1169|lgedeon@gogstats.org|
20173457|NCT04249310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173458|NCT01454947|University of Southern California|Jason N. Doctor|213.821.8142|jdoctor@usc.edu|
20173459|NCT02574247|University of Illinois at Urbana-Champaign|Dr. Ian Mertes|217-300-4756|imertes@illinois.edu|
20173460|NCT01382446|SJHMC|Tracy L. Thomas MSN RN CCRN ACNS-BC|602-406-2567|Tracy.Thomas007@dignityhealth.org|
20173461|NCT02536196|Keystone Heart|Pauliina Margolis - CMO|813.530.8200|pauliina.margolis@keystoneheart.com|
20173462|NCT04458909|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20173463|NCT02493621|MUSC|Sylvia Wilson|8437922322|wilsosh@musc.edu|
20173464|NCT00632411|University of Tennessee Health Science Center|Dr. Robert Klesges|901-448-3174|lcolvin1@uthsc.edu|
20173465|NCT00770289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173466|NCT00765375|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
20173467|NCT02545101|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
20173468|NCT02659631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173469|NCT00495170|UT MD Anderson Cancer Center|Dr. Joe Chang / Professor, Radiation Oncology Department|713-563-2337|jychang@mdanderson.org|
20173470|NCT04191499|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20173471|NCT00680745|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20173472|NCT01928329|C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)|Kevan Herold, MD|(203) 785-6507|kevan.herold@yale.edu|
20173473|NCT00811473|AstraZeneca|Gerard Lynch||aztrail_results_posting@astrazeneca.com|
20173474|NCT04127331|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
20173475|NCT02704975|United States Army|Rob Halle|910-689-8887|robhalle@gmail.com|
20173476|NCT02403154|Indiana University|Krista Brown, Clinical Research Coordinator|317-963-1944|brownkm@indiana.edu|
20173477|NCT01119131|VA Portland Health Care System|Amie Hiller, MD|503.721.1091|peterami@ohsu.edu|
20173478|NCT00732615|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20173479|NCT00993291|Vanderbilt University|Fenna Phibbs M.D.|615-936-2025|fenna.phibbs@vanderbilt.edu|
20173480|NCT00003492|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20173481|NCT03566823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20173482|NCT04446377|AI Therapeutics|Peter R. Young/Chief Scientific Officer|203-458-7100|pyoung@ai-thera.com|
20173483|NCT01414075|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
20173484|NCT03847233|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
20173485|NCT01590238|New York Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
20173486|NCT01187043|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20173487|NCT04903626|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20173488|NCT00573534|Columbia University/New York State Psychiatric Instittue|Stephen J. Donovan MD|646 774 8078|sd45@columbia.edu|
20173489|NCT00923598|University of California San Diego|Dr. Brian Ilfeld, Professor of Anesthesiology, In Residence|(858) 444-5949|bilfeld@ucsd.edu|
20173490|NCT00927784|Mount Sinai School of Medicine|Deborah Ascheim, MD, Principal Investigator, Data Coordinating Center|212-659-9567|deborah.ascheim@mssm.edu|
20173491|NCT02457910|Vanderbilt University Medical Center|Vandana Abramson, MD|(615)936-8422|vandana.abramson@vumc.org|
20173492|NCT00467259|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20173493|NCT02196558|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20173494|NCT00576927|Emory University Division of General Medicine and Geriatrics|Dr. Patricia Griffiths|404-321-6111|pcgriff@emory.edu|7138
20173495|NCT04899921|Dana-Farber Cancer Institute|Senior Physician|6176326836|ann_silk@dfci.harvard.edu|
20173496|NCT01457521|Gynuity Health Projects|Elizabeth Raymond|2124481230|eraymond@gynuity.org|
20173497|NCT01706081|Memorial Sloan Kettering Cancer Center|Dr. Ting Bao MD|646-888-0865|baot@mskcc.org|
20204880|NCT03225716|DFCI|Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
20173498|NCT02994979|The New Jewish Home|Dr. Kenneth Boockvar|212-870-5062|kenneth.boockvar@mssm.edu|
20173499|NCT01846611|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20173500|NCT00541034|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|1212-639-7053|brentjer@mskcc.org|
20173501|NCT01988857|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173502|NCT00680043|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20173503|NCT03061331|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20173504|NCT01980875|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20173505|NCT00513474|Massachusetts General Hospital|Bimalangshu R. Dey, MD, PhD||bdey@mgh.harvard.edu|
20173506|NCT01686633|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204881|NCT00848250|Vanderbilt University Medical Center|Mias Pretorius|615-8757402|mias.pretorius@vanderbilt.edu|
20204882|NCT01850745|Liver Section. Hospital del Mar|Professor Ricard Sola|0034932483200|35783@parcdesalutmar.cat|
20204883|NCT03075176|University of Utah John A. Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
20204884|NCT00213980|University of Wisconsin Carbone Cancer Center|Dr. Daniel Mulkerin|608-265-8090|dm2@medicine.wisc.edu|
20204885|NCT03607838|Seikagaku Corporation|General Manager, Clinical Development Department|(81)3-5220-8593|reply@seikagaku.co.jp|
20204886|NCT02411201|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
20204887|NCT00798694|Wills Eye Hospital|Principal Investigator|215-928-3197|ljaykatz@gmail.com|
20204888|NCT05117229|Mayo Clinic|Rafael J. Sierra, M.D.|507-284-2226|Sierra.Rafael@mayo.edu|
20204889|NCT01774344|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20204890|NCT03546413|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20204891|NCT03364608|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
20204892|NCT02951988|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20204893|NCT05836818|University of California San Francisco|Robert Rodriguez|925-457-2145|robert.rodriguez@ucsf.edu|
20204894|NCT02491073|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351||
20204895|NCT01165021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20204896|NCT01419665|Hexal AG / Novartis Pharmaceuticals|Study Director|+41613241111|novartis.email@novartis.com|
20204897|NCT03977727|Texas Diabetes & Endocrinology|Thomas Blevins, MD|512-334-3505|blevins@texasdiabetes.com|1
20204898|NCT03448718|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20204899|NCT00516269|UT MD Anderson Cancer Center|Carmen Escalante, MD / Professor||RABaker@mdanderson.org|
20204900|NCT00926796|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
20204901|NCT01341652|University of Wisconsin Carbone Cancer Center|Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
20204902|NCT02410707|Einstein Healthcare Network|Joseph Herres, DO, Director of Research|215-456-6666|herresjo@einstein.edu|
20204903|NCT02010216|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20204904|NCT01008995|Janssen R&D US|Director, Clinical Research|1 215-793-7646||
20204905|NCT00115804|University of Cincinnati|Dr. Lesley Arnold|513-475-8110|lesley.arnold@uc.edu|
20204906|NCT03689504|Wuqu' Kawoq|Peter Rohloff, Chief Medical Officer|011-502-4958-1253|peter@wuqukawoq.org|
20204907|NCT00621855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20204908|NCT03731364|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
20204909|NCT02953782|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20204910|NCT00665288|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20204911|NCT01934192|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204912|NCT01737840|Akdeniz University|Cenker Eken|00905321593948|cenkereken@akdeniz.edu.tr|
20157528|NCT02121509|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173507|NCT02192814|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
20173508|NCT02530554|Evic Romania|Dr. R Olsavszky|40 21 335 70 91|evicromania@evic.ro|
20189333|NCT01583166|UMass Worcester|Michael Flynn, MD|508-334-9840|michael.flynn@umassmemorial.org|
20189334|NCT01429454|University of California San Diego|Dr. Kristin Cadenhead|(619) 543-6445|kcadenhead@ucsd.edu|
20189335|NCT02000752|Fundación Investigación Biomédica Príncipe de Asturas|Beatriz López Garrido (Midwife)|+34 678210013|bealopega@gmail.com|
20189336|NCT00790699|Texas Diabetes & Endocrinology|Thomas Blevins,MD|5812.334.3505|blevins@texasdiabetes.com|
20189337|NCT01583868|Bausch Health|Study Director||robert.steffen@bausch.com|
20189338|NCT03819543|University of Manitoba|Dr. Marcus Ng|204-787-2684|marcus.ng@umanitoba.ca|
20189339|NCT00047385|Early Detection Research Group, NCI, NIH|Christine D. Berg, M.D.|301-496-8544|bergc@mail.nih.gov|
20189340|NCT03392194|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|SREDLINE@BWH.HARVARD.EDU|
20189341|NCT03865732|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20189342|NCT01509183|Propeller Health|Research Team at Propeller Health|9545369563|leanne.kaye@propellerhealth.com|
20189343|NCT03783936|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
20189344|NCT01009645|Northwestern University|Kenzie Cameron, PhD, MPH|312-503-3910|kcameron@northwestern.edu|
20189345|NCT00620854|Tarsa Therapeutics, Inc.|Thomas Wicks, Ph.D., Vice-President Global RA/QA|267 273 7946|twicks@tarsatherapeutics.com|
20189346|NCT03345979|Alkermes, Inc|Eva Stroynowski|7816097000|eva.stroynowski@alkermes.com|
20189347|NCT04689932|Rockwell Medical|Raymond D Pratt, MD|2489609009|rpratt@rockwellmed.com|
20204913|NCT02118610|Maryland Psychiatric Research Center|Ann Kearns, MS|4104066854|akearns@som.umaryland.edu|
20189348|NCT00734578|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20189349|NCT00999596|Philips Healthcare|Sarah Baxter or Linda Jalbert|425-487-7665 / 978-659-7434|sarah.baxter@philips.com, linda.jalbert@philips.com|
20189350|NCT02095145|University of Wisconsin Carbone Cancer Center|David Jarrard|608-262-0759|jarrard@urology.wisc.edu|
20189351|NCT02085941|Brigham & Women's Hospital/Dana-Farber Cancer Institute|Thomas C. Lee, MD|617-732-7260|tchlee@bwh.harvard.edu|
20189352|NCT03447912|George Washington University|Carla Berg, PhD, MBA, LP|202-994-0168|carlaberg@email.gwu.edu|
20189353|NCT03883724|UPittsburgh|Shachi Tyagi|4126471274|sht55@pitt.edu|
20189354|NCT01477177|Mayo Clinic|Herbert C. Wolfsen, M.D.|904-953-6319|Wolfsen.Herbert@mayo.edu|
20189355|NCT01079806|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20189356|NCT02124304|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
20189357|NCT02788981|University of Chicago|Dr. Nan Chen|773-702-6149|nchen@bsd.uchicago.edu|
20189358|NCT00249769|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20189359|NCT02022657|Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora|Dr. Peter Anderson|3037246821|peter.anderson@ucdenver.edu|
20189360|NCT02909959|University of North Carolina at Chapel Hill|Laura Politte, MD|919-350-1726|lpolitte@wakemed.org|
20189361|NCT00229970|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189362|NCT00843050|Piramal Healthcare Limited|Dr. Alan Hatfield|02230275000|alan.hatfield@piramal.com|5002
20189363|NCT03739866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20173509|NCT01189812|Columbia Northwest Pharmaceuticals|Director of Clinical Operations|425.453.0404|jhobus@nwcrc.net|
20173510|NCT02059057|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|kristi.winterfeldt@bsci.com|
20173511|NCT02200445|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
20189364|NCT03057600|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20189365|NCT02203799|Baylor College of Medicine|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
20189366|NCT02168309|Central Coast Perinatology|Kathryn Sharma|8058980258|katy.jones@gmail.com|
20173512|NCT00587561|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|2039325711|joanna.fiszdon@va.gov|2231
20173513|NCT00959842|Professor|Dr. Greg Shearer|814-867-3040|gcs13@psu.edu|
20173514|NCT03204981|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
20173515|NCT01662908|Daiichi Sankyo, Inc.|Senior Director, CVM TA Development|732-590-5000||
20173516|NCT04244786|New York State Psychiatric Institute|Jeffrey Miller|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
20173517|NCT00613938|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
20173518|NCT00623727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20173519|NCT03745937|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
20173520|NCT02659709|Wills Eye Hospital, Glaucoma Service|Dr. Jonathan S. Myers|215-928-3197|jmyers@willseye.org|
20173521|NCT00312494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20173522|NCT00429507|University of Texas (UT) MD Anderson Cancer Center|Nato Ueno, MD, PhD/Professor, Breast Medical Oncology||CR_Study_Registration@mdanderson.org|
20173523|NCT01104636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173524|NCT00786487|University of Minnesota|Dr. Lisa Chow|612-625-8934|chow0007@umn.edu|
20173525|NCT01710033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173526|NCT01525550|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173527|NCT02877082|Emory University/Winship Cancer Institute|Zaid Al-Kadhimi, MD|404-778-1900|zalkadh@emory.edu|
20173528|NCT03318315|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@som.umaryland.edu|
20204914|NCT02357849|Northwell Health|Dr. Christoph Correll|718-470|ccorrell@northwell.edu|7000
20204915|NCT00403559|Dermatology Specialists, PSC|Joseph F. Fowler, Jr., M.D.|502-583-7546|fowlerjoe@msn.com|184
20173529|NCT00810407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173530|NCT02968563|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20173531|NCT03287804|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
20173532|NCT03179995|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20173533|NCT04008030|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20173534|NCT03108027|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
20173535|NCT03178773|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
20173536|NCT05319795|University Health Network|Professor Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
20173537|NCT02733991|Medtronic Diabetes EMEA|Ohad Cohen M.D., Medical Affairs Director|+972 54 321 1108|ohad.cohen@medtronic.com|
20173538|NCT03035708|National Institute on Alcohol Abuse and Alcoholism|Health Scientist Administrator|301-443-0788|falkde@mail.nih.gov|
20173539|NCT03611790|BioMDg, CRO for VITAL Study|Sigi Caron, President and CEO at BioMDg|(831) 346-6970|sigi@biomdg.com|
20173540|NCT02141997|AbbVie|Global Medical Information|1-800-633-9110||
20173541|NCT01496313|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20173542|NCT03063476|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vanderbilt.edu|
20173543|NCT00451321|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173544|NCT03336853|AOUCareggi|Dr. Riccardo Pace|+390557945608|riccardo.pace@unifi.it|
20173545|NCT03254927|Celldex Therapeutics|Chief Medical Officer|844-723-9363|info@celldex.com|
20173546|NCT00909389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20173547|NCT01528254|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20173548|NCT00737282|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20173549|NCT02763189|Wake Forest School of Medicine|Dr. Michael A. Olympio|3369182132|molympio@wakehealth.edu|
20173550|NCT02049957|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20173551|NCT03557151|Nemours Children's Hospital, Delaware|Melissa A. Alderfer, Ph.D., Center Director & Principal Research Scientist|302-651-6522|melissa.alderfer@nemours.org|
20173552|NCT02810392|Wake Forest School of Medicine|Cheryl Bushnell, MD|336-713-2983|cbushnel@wakehealth.edu|
20173553|NCT00840294|University of Chicago|Scott Eggener|(773) 702-5195|seggener@surgery.bsd.uchicago.edu|
20173554|NCT03383198|Prisma Health|Dr. William R. Hand|864.522.3707|William.Hand@prismahealth.org|
20173555|NCT05392998|Clínica Rementería|Dr. Inés Contreras|34913083838|contreras@clinicarementeria.es|
20173556|NCT01516346|University of Pennsylvania|Julio Chirinos, MD, PhD|215-573-6606|julio.chirinos@pennmedicine.upenn.edu|
20173557|NCT00828347|Department of Nephrology, Kumamoto University Graduate School of Medical Sciences|A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism|+81-96-373-5164|m-adachi@gpo.kumamoto-u.ac.jp|
20173558|NCT02947997|Massachusetts General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
20173559|NCT04868890|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
20173560|NCT02418026|Groupe Hospitalier de la Rochelle Ré Aunis|Mrs Sandrine Delavaux|+33 5 46 45 50 50|saniade@msn.com|
20173561|NCT02669433|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
20173562|NCT00379574|Asan Medical Center, Ulsan University College of Medicine|Dr. Cheolwon Suh|+82-2-3010-3209|csuh@amc.seoul.kr|
20173563|NCT03626623|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
20173564|NCT01190878|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
20173565|NCT02157298|AstraZeneca K.K.|Yuji Ageishi|+81-3-6268-2740|Yuji.Ageishi@astrazeneca.com|
20173566|NCT00989014|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20219470|NCT01119508|UT MD Anderson Cancer Center|Dr. Sapna P. Patel, Assistant Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20219471|NCT00265395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20219472|NCT01996449|UT Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|Wanpen.Vongpatanasin@UTSouthwestern.edu|
20219473|NCT01955837|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20219474|NCT02563106|Synthetic Biologics|Michael Kaleko, MD|(240) 238-3862|mkaleko@syntheticbiologics.com|
20219475|NCT04729309|Hoffmann - LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20219476|NCT01212588|IndianaU|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
20219477|NCT02338193|Woman's Hospital|Dr Karen Elkind-Hirsch, Director of Research|225 231-5278|karen.elkind-hirsch@womans.org|
20219478|NCT01136967|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20219479|NCT04689867|University of Michigan|Lindsay Bornheimer|(734) 615-2915|bornheim@umich.edu|
20219480|NCT01735955|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20219481|NCT02885181|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20219482|NCT03317834|Smith+Nephew, Inc.|Helena Kyriakou|+1 8186995700|Helena.Kyriakou@smith-nephew.com|
20219483|NCT05084716|RAND|Laura Bogart|3103930411|lbogart@rand.org|
20219484|NCT04228783|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219485|NCT00626392|Abbott|Medical Information Specialist|800-633-9110||
20219486|NCT00735306|Duke University|Dr. Brian Czito|919-668-7336|brian.czito@duke.edu|
20219487|NCT03002571|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20219488|NCT03151811|Oncopeptides AB|Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20173567|NCT00883116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20219489|NCT01517373|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159596|NCT04115748|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20159597|NCT00713349|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20189367|NCT01953692|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189368|NCT02022670|University of Colorado Boulder|Dr. Allison DeVan|303-735-6410|allison.devan@colorado.edu|
20189369|NCT05313412|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
20189370|NCT01708278|University of Michigan|Fernando Martinez|(734) 763-2540|fmartine@umich.edu|
20189371|NCT02630966|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20189372|NCT04677738|Morinaga Milk Industry Co., Ltd.|Director of Clinical Trials|+81-46-252-3067|izen-ri138@morinagamilk.co.jp|
20189373|NCT02502461|Dept. of Anesthesia, University of Saskatchewan|Dr. William P. McKay|306 655 1202|bill.mckay@usask.ca|
20189374|NCT03697603|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20189375|NCT03340415|CUHK|Dr Samuel Ling|35052010|samuel-kk-ling@alumni.cuhk.net|
20189376|NCT01683409|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20189377|NCT04218864|Women & Infants Hospital|Dr. Caron Zlotnick|4014743332|czlotnick@butler.org|
20189378|NCT00676091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189379|NCT00692185|New York State Psychiatric Institute|Evelyn Attia, MD|212-543-5923|ea12@columbia.edu|
20189380|NCT00933270|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
20189381|NCT03343704|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189382|NCT01341301|Thomas Jefferson University|Dr. Neal Flomenberg|215-955-8874|neal.flomenberg@jefferson.edu|
20189383|NCT03715946|UPMC Hillman Cancer Center|Barbara Stadterman, MPH|4126475554|stadtermanbm@upmc.edu|
20189384|NCT00302211|Actelion Pharmaceuticals US, Inc.|Gary Palmer SVP, US Medical Affairs|650-624-6900||
20189385|NCT01850355|Massachusetts General Hospital|Dr. Gagan Joshi|617-724-1541|joshi.gagan@mgh.harvard.edu|
20189386|NCT04906057|Cleveland Clinic|Donayja Harris|2164454125|harrisD47@ccf.org|
20189387|NCT03954106|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20189388|NCT05349721|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20189389|NCT06006455|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
20189390|NCT03136159|Loyola University Medical Center|Dr Jean Goodman|7082165459|Jrgoodman@lumc.edu|
20189391|NCT03823703|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
20189392|NCT03137459|Yale School of Medicine|Dr. Terri Fried|203-932-5711|terri.fried@yale.edu|5412
20189393|NCT00985088|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189394|NCT01732757|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20189395|NCT04926857|Medtronic|Nirav Patel|1 (800) 633-8766|nirav.a.patel@medtronic.com|
20189396|NCT00491400|Boston University|Joseph A. Vita, MD|617-638-8700|jvita@bu.edu|
20189397|NCT01767688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189398|NCT00686257|Tufts Medical Center|Nicholas Hill MD|617-636-4288|nhill@tuftsmedicalcenter.org|
20189399|NCT02132949|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20189400|NCT05741450|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
20189401|NCT00887224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20189402|NCT01600482|Vasorum Ltd|Dr James Coleman|00 353 1 4035460|jcoleman@vasorum.ie|
20204916|NCT03637699|Brigham and Women's Hospital|Bonnie Glanz, PhD|617-525-6574|bglanz@bwh.harvard.edu|
20204917|NCT04105244|Frances Payne Bolton School of Nursing, Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP-PC, FAAN|216-534-5844|vab@case.edu|
20159598|NCT03764631|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159599|NCT01200407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159600|NCT01505673|University of Texas Southwestern Medical Center at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20159601|NCT02974855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159602|NCT00633074|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159603|NCT02363972|Avenu Medical|Gene Reu EVP and General Manager|9492762483|greu@avenumedical.com|
20159604|NCT02752633|Landspitali - The National University Hospital of Iceland|Vidar Orn Edvardsson|+3545431000|vidare@landspitali.is|3452
20159605|NCT01843673|Virginia Commonwealth University|Joshua Evans, Ph.D.|804-628-0661|jevans2@mcvh-vcu.edu|
20159606|NCT03275246|Zimmer Biomet|Oliver Schaetti|0041588548901|oliver.schaetti@zimmerbiomet.com|
20204918|NCT04633473|Oregon Research Behavioral Intervention Strategies|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
20204919|NCT04387136|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
20204920|NCT01982773|National Center for Telehealth and Technology|Nigel E. Bush, PhD|253-968-4153|nigel.e.bush.civ@mail.mil|
20204921|NCT02278289|Department of Physical Medicine and Rehabilitation, Taipei Tzuchi Hospital, Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan, ROC|Dr. Yi-Shiung Horng|+886-2-66289779|d97841001@ntu.edu.tw|64515
20204922|NCT01029886|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20159607|NCT02292082|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
20189403|NCT01698918|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20189404|NCT01263132|Merck S.A. de C.V., Mexico, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
20189405|NCT02489357|Johns Hopkins University/Sidney Kimmel Cancer Center|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
20219490|NCT01234922|Wake Forest Baptist Health|William J. Petty, MD|336-716-3313|wpetty@wakehealth.edu|
20219491|NCT01081834|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20219492|NCT00742924|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20219493|NCT01777620|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20219494|NCT01740726|Emory University School of Medicine|Research Coordinator|404-727-4799|sean.carey@emory.edu|
20219495|NCT02701270|Danisco Sweeteners Oy|Kirsti Tiihonen|+358 10 431 050|kirsti.tiihonen@dupont.com|
20219496|NCT03149445|Saniona A/S|Janus Schreiber Larsen|+457070 5225|janus.larsen@saniona.com|
20219497|NCT05594264|University of Delaware|Dr. Yendelela Cuffee|(302) 831-1302|ylcuffee@udel.edu|
20219498|NCT01045135|Akershus University Hospital|Dr.Jette Stær-Jensen, Dr. Franziska Siafarikas|+47-6796000|jett@ahus.no|
20219499|NCT04916444|University of Florida Norman Fixel Institute for Neurological Diseases|Dr. Jun Yu|352-294-5400|jun.yu@neurology.ufl.edu|
20219500|NCT06017479|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti Rahardjo, Sp.U(K), PhD|+62 816-825-226|harrinaerlianti@gmail.com|
20219501|NCT00936897|Amgen Inc.|Study Director|866-572-6436||
20219502|NCT04058067|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20219503|NCT05005312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219504|NCT01283035|DFCI|Joyce Liu, MD, MPH|617-632-5269|joyce_liu@dfci.harvard.edu|
20219505|NCT02955758|Stanford University|Dr. Joel W. Neal|(650) 498-6000|jwneal@stanford.edu|
20219506|NCT05502081|Mansoura University Hospital|Dr. Ahmed Hosny|+2001554658010|ahmedony26@gmail.com|+200115584
20219507|NCT00462124|BioProtect|Galit Itzhaki|+972-9-7731929|galit@bioprotect.co.il|
20219508|NCT02792699|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20219509|NCT04524364|Biosense Webster, Inc.|Associate Director - Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219510|NCT02865460|Miami VA Healthcare System|Nancy Klimas, MD|305-575-7000|nancy.klimas@va.gov|1-4800
20219511|NCT00380744|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219512|NCT00555152|University of Texas (UT) MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention||CR_Study_Registration@mdanderson.org|
20219513|NCT02829294|Eosera Inc|Joseph Griffin PhD|8447327929|info@eosera.com|
20219514|NCT00620555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219515|NCT03796039|University of New Brunswick|Dr. Danielle Bouchard|(506) 443-3908|dboucha1@unb.ca|
20219516|NCT01140503|Stanford University Department of Dermatology|David Fiorentino|650-721-7160|fiorentino@stanford.edu|
20219517|NCT02927366|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20219518|NCT00587990|EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@emmes.com|221
20219519|NCT00206323|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
20219520|NCT03334617|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20219521|NCT03657342|Zambon SpA|Enrica Bucchioni, MD, PhD, Global Clinical Development Senior Director|+3902665241|clinicaltrials@zambongroup.com|
20219522|NCT04314414|Boston Medical Center|Sabrina A Assoumou, MD MPH|(617) 414-5282|sabrina.assoumou@bmc.org|
20219523|NCT03734666|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
20219524|NCT01943110|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
20219525|NCT01910389|New England Research Institutes|Brian Harty|617-972-3224|bhartY@neriscience.com|
20219526|NCT05896202|University of Miami|Marlon L. Wong|3052842670|mwong2@miami.edu|
20219527|NCT04669691|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20219528|NCT01822275|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
20219529|NCT00911807|EBEWE Pharma|Dr. Philipp Novak|01143-7665-8123|philipp.novak@ebewe.com|733
20219530|NCT02103270|The Sean N. Parker Center for Allergy Research at Stanford|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|9544465645|andresap@stanford.edu|
20219531|NCT03918109|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20219532|NCT04430855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20219533|NCT01425723|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
20219534|NCT00186043|Bipolar and Depression Research Program, Stanford University, School of Medicine, VA Palo Alto Health Care System|Trisha Suppes MD, PhD|6504962567|tsuppes@stanford.edu|
20219535|NCT00871741|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219536|NCT04663295|Medtronic MiniMed|Senior Statistician|+18185764034|dz.dai@medtronic.com|
20219537|NCT03610516|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20219538|NCT05958888|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
20219539|NCT03700385|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|kschneider@farapulse.com|
20219540|NCT04241315|On Target Laboratories, Inc.|Tommy Lee|214-289-6422|tlee@ontargetlabs.com|
20159608|NCT00433966|Cardiovascular Research Foundation|Ori Ben-Yehuda, MD, Executive Director, Clinical Trials Center|646-434-4123|obenyehuda@crf.org|
20159609|NCT02570152|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupport@gsk.com|
20159610|NCT01491789|Kennedy Krieger Institute|Dr. Alberrt Recio|443-923-9227|recio@kennedykrieger.org|
20159611|NCT03497975|Trevi Therapeutics, Inc.|Chief Development Officer|203-304-2499|info@trevitherapeutics.com|
20159612|NCT01296711|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|001-844-599-2273|clinicaltrials@ucb.com|
20189406|NCT04693637|AlloVir, Inc|Michelle Matzko, MD, PhD|617-433-2605|mmatzko@allovir.com|
20219541|NCT00658515|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20219542|NCT04086407|Sleep Systems|Director of Operations|978-835-7036|e.lyons@sleepsystems-llc.com|
20219543|NCT01555671|Prof.Dr.Cemil Tascioglu City Hospital|Orhan SAHIN|+90 532 240 00 12|drorhansahin@gmail.com|
20219544|NCT02684630|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
20219545|NCT04590040|UT Health San Antonio|Bennett Amaechi BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
20219546|NCT03047629|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|l.larson@enterininc.com|
20219547|NCT01531439|Children's Mercy Hospital|Dr Ben Pieters|816-234-3464|bjpieters@cmh.edu|
20219548|NCT02813265|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results006@kalarx.com|
20219549|NCT00631657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219550|NCT03035929|Vanderbilt University Medical Center|Grace Henderson, Study Coordinator|615-936-5356|grace.henderson@vumc.org|
20219551|NCT03796598|Richmond VA Medical center|Jasmohan Bajaj|8046755802|jasmohan.bajaj@va.gov|
20219552|NCT01284361|Hollister Incorporated|Malford Cullum PhD/Sr Clin Res Scientist|847-918-3975|malford.cullum@hollister.com|
20219553|NCT04247100|Virginia Commonwealth University|Gisela Chelimsky, MD|804-628-4859|gisela.chelimsky@vcuhealth.org|
20219554|NCT01806571|Mayo Clinic|Aref Al-Kali, M.D.|(507) 538-0591|alkali.aref@mayo.edu|
20219555|NCT02198183|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
20219556|NCT02026687|Dept of anaesthesia, Linköping University Hospital, Sweden|Dr Lena Nilsson|0046101030000|lena.nilsson@regionostergotland.se|
20219557|NCT01957397|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
20219558|NCT00540293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20219559|NCT03537599|The Ohio State University Comprehensive Cancer Center|Dr. Sumithira Vasu|614-293-9869|Sumithira.Vasu@osumc.edu|
20159613|NCT00435227|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20159614|NCT02120300|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20159615|NCT00118248|Washington University School of Medicine|Jeffrey F. Moley, M.D.||moleyj@wustl.edu|
20219560|NCT01823497|Medical College of Wisconsin|Keri R. Hainsworth|414-266-6306|khainswo@mcw.edu|
20219561|NCT00325195|Savient Pharmaceuticals, Inc.|Medical Director|732-418-9300||
20219562|NCT05083585|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219563|NCT00806286|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20219564|NCT03469336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219565|NCT01090921|BVARI|Nikhil C. Munshi, M.D.|857-203-6172|nikhil_munshi@dfci.harvard.edu|
20219566|NCT00686075|MedImmune, LLC.|Filip Dubovsky, Vice President, Clinical Development|301-398-0000|dubovskyf@medimmune.com|
20219567|NCT01108406|Sonitus Medical, Inc.|Lily Woodby, AuD|8668162076|lily@sonitusmedical.com|
20219568|NCT02740699|National Heart, Lung, and Blood Institute at the National Institutes of Health|Dr. Marcus Chen|301.496.0077|chenmy@nhlbi.nih.gov|
20219569|NCT02585934|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
20219570|NCT04713553|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20219571|NCT03544424|University of Manchester|Dr Joanne Taylor|0161 306 6000|joanne.taylor-2@manchester.ac.uk|
20219572|NCT02240030|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
20219573|NCT01716715|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20219574|NCT00849186|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20219575|NCT00417170|Novartis Pharmaceuticals|Study Director|862-778-8300||
20219576|NCT02704403|GENFIT|Carol Addy, MD MMSc|+01 6179536469|clinicaltrial@genfit.com|
20219577|NCT01090752|University Hospital Geneva and Lausanne, Switzerland|Zanchi Anne, MD|0041213140775|azanchidel@hotmail.com|
20219578|NCT01756079|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219579|NCT03597529|Director, Child and Adolescent Headache Program, UCSF Benioff Children's Hospitals|Dr. Amy A. Gelfand|415-502-1914|Amy.Gelfand@ucsf.edu|
20219580|NCT04015908|University of Utah|Dr. Jeffrey D. Swenson|801-581-6393|jeff.swenson@hsc.utah.edu|
20219581|NCT03769714|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
20219582|NCT03464630|Georgia State University|Dr. Kathleen Baggett|404-413-1571|kbaggett@gsu.edu|
20219583|NCT00670202|Brigham and Women's Hospital|Anju Nohria|617-525-7052|anohria@partners.org|617
20219584|NCT00998309|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219585|NCT01316315|N30 Pharmaceuticals Inc.|Janice M. Troha|720-945-7714|janice.troha@n30pharma.com|
20219586|NCT03769207|Stanford University|Marco Perez, Associate Professor of Medicine|(650) 723-9363|mvperez@stanford.edu|
20219587|NCT00735397|Eisai Inc.|Eisai Call Center|888-422-4743||
20219588|NCT06077149|University of Rochester|Ann Falsey, MD|585-922-4339|Ann_Falsey@URMC.Rochester.edu|
20219589|NCT03490344|Memorial Sloan Kettering Cancer Center|Dr. Sham Mailankody, MBBS|646-608-3712|mailanks@mskcc.org|
20219590|NCT04154631|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
20219591|NCT01441947|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-643-5415|sisakoff@partners.org|
20219592|NCT02238795|Jena University Hospital, Center for Clinical Studies|Prof. Dr. Frank M. Brunkhorst|+49 3641 939|frank.brunkhorst@med.uni-jena.de|6687
20219593|NCT02143973|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20159616|NCT00700882|ECOG-ACRIN Statistical Office|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
20159617|NCT00683930|Hoffmann-La Roche|Medical Communications|800-821-8590||
20159618|NCT01832493|Medtronic CRHF|Medtronic SOCR Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
20159619|NCT01732510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159620|NCT00313144|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20159621|NCT01178944|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20159622|NCT00893152|VA HSR&D Center for Mental Healthcare & Outcomes Research|Ellen P. Fischer, PhD|501-257-1711|Ellen.Fischer@va.gov|
20159623|NCT01591954|Department of Biomedical Engineering, Johns Hopkins University|Jeffrey H. Siewerdsen, PhD / Professor of Biomedical Engineering|443-287-6269|jeff.siewerdsen@jhu.edu|
20159624|NCT00656058|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
20159625|NCT00404755|New York State Psychiatric Institute|Jonathan W. Stewart, M.D.|646-774-8000|jws6@columbia.edu|
20159626|NCT05145322|University of Minnesota School of Dentistry|Hooi Pin Chew|6126256975|chew0014@umn.edu|
20159627|NCT06359028|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20159628|NCT04700540|University of Minnesota|Dr. Jude Mikal|385-212-4185|jpmikal@umn.edu|
20159629|NCT02952313|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20159630|NCT04382586|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20159631|NCT02425956|GE Healthcare|Research Manager|262-521-6819|Sandhya.Parameswaran@med.ge.com|
20159632|NCT02265536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159633|NCT03869385|University Hospital of Jena|Prof. Dr. Yasser Sakr|01742191538|yasser.sakr@med.uni-jena.de|0049
20159634|NCT00945529|Nemours Cardiac Center at A. I. duPont Hospital for Children|Ellen Spurrier, MD|302-651-6600|ellen.spurrier@nemours.org|
20159635|NCT00079391|NIH National Heart, Lung and Blood Institute|Minocher Battiwalla|301-402-4170|battiwalla@nhlbi.nih.gov|
20159636|NCT02524275|University of Nebraska Medical Center|Dr. Apar Ganti|402-559-8121|aganti@unmc.edu|
20159637|NCT03763656|Nova Laboratories Ltd|Dr Hussain Mulla, Head of Clinical Development|0116 223 0101|hussain.mulla@novalabs.co.uk|
20159638|NCT00583752|University of Iowa, Holden Comprehensive Cancer Center|David Lubaroff, MD|3193561527|david-lubaroff@uiowa.edu|
20159639|NCT01700959|St. Jude Children's Research Hospital|Tara M. Brinkman, PhD|(901) 595-5683|tara.brinkman@stjude.org|
20159640|NCT00830375|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
20159641|NCT01331837|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159642|NCT01521871|Oslo University Hospital, Rikshospitalet|Dr. Ole Øyen|+4723070000|ooyen@ous-hf.no|
20159643|NCT03407053|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
20159644|NCT03724981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159645|NCT02640625|Oslo University Hospital|Dr. Dag Henrik Reikvam|+4722119881|dagrei@ous-hf.no|
20159646|NCT03284333|Cutera|Margot Doucette|415-357-5518|mdoucette@cutera.com|
20159647|NCT00197145|ViiV Healthcare|GSK Response Center|866-435-7343||
20159648|NCT02370537|AstraZeneca AB|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
20159649|NCT04178993|University of Kentucky|Dr. Craig Rush, Ph.D.|8592575388|crush2@uky.edu|
20159650|NCT04500171|American Samoa Community Cancer Coalition|Va'atausili Tofaeono|648-699-0110|vtofaeono@cancercoalition.as|
20159651|NCT03045406|FadoiFoundation|Giorgio Vescovo|00390685355188|irenezaratti@fadoi.org|
20159652|NCT00882583|FDA|Shanthi Marur|2404026373|shanthi.marur@fda.hhs.gov|
20159653|NCT03596047|Boston Medical Group|Carolina Sandoval - Director Research|+57 3133920816|csandoval@bostonmedical.com.co|
20159654|NCT02589665|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159655|NCT01120236|Department of Medicine, Division of Oncology, University of Washington|Evan Y. Yu, MD||evenyu@u.washington.edu|
20159656|NCT00176488|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20159657|NCT00327015|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20159658|NCT02650804|BPGbio Inc|Head of Clinical Operations|6175880083|clinicaltrials.connect@berghealth.com|
20159659|NCT01159171|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159660|NCT04086693|Beaumont Health|Amit Bahl, MD|248-551-1792|Amit.Bahl@beaumont.edu|
20159661|NCT01892436|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|novartis.email@novartis.com|
20159662|NCT02918396|Johns Hopkins University|Dr. Tarek Zghaib|410-955-5000|tzghaib1@jhmi.edu|
20159663|NCT00837265|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20159664|NCT00583414|Massachusetts General Hospital|Matthew Eagleton, MD|617-726-8279|meagleton@mgh.harvard.edu|
20159665|NCT02222909|Johns Hopkins School of Public Health|Christine Weston|443-287-8039|cweston1@jhu.edu|
20159666|NCT02450383|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
20159667|NCT02759107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159668|NCT02513485|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
20159669|NCT01971463|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
20159670|NCT00420004|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159671|NCT03462927|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
20159672|NCT01942668|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|smirkin@therapeuticsmd.com|1952
20159673|NCT03215758|Novartis Pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
20159674|NCT00611468|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20159675|NCT02357472|Ji Ai Genetics & IVF Institute|Dr.Jing Fu|86-021-63459977|fujing_givf@163.com|
20159676|NCT03931382|Senior Director|John Jacob|604-875-2393|john.jacob@cw.bc.ca|
20159677|NCT00542490|University of Oklahoma|Lisa Landrum, MD|405 271-8001|lisa-landrum@ouhsc.edu|
20219594|NCT03384654|Janssen-Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219595|NCT02800213|San Antonio Uniformed Services Health Education Consortium|Dr. Michael D. April|2109160808|Michael.D.April@post.harvard.edu|210
20219596|NCT04159935|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20219597|NCT01341782|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20219598|NCT02036775|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219599|NCT03541980|Newark Beth Israel Medical Center|Dr Cena Tejani|973 926 7337|ctejani5@gmail.com|
20219600|NCT01222390|Northwestern University|John Y.S. Kim, MD|312-695-0208|jokim@nmh.org|
20219601|NCT01045174|University Hospitals Cleveland Medical Center|Dr. Jerri Rose|216-844-7147|jerri.rose@uhhospitals.org|
20219602|NCT01997229|Alexion Pharmaceuticals, Inc.|Jing-Jing Wang, MD|+1 (475) 230-2596|JingJing.Wang@alexion.com|
20219603|NCT00477295|Eisai Call Center|Eisai Inc.|888-422-4743||
20219604|NCT03039179|Istituto Ortopedico Rizzoli|Head of the Research Nursing Unit|0516366694|cristiana.forni@ior.it|0039
20219605|NCT03276780|University of Alabama at Birmingham, Department of Psychiatry and Behavioral Neurobiology|Dr. Karen Cropsey|205-975-4204|kcropsey@uabmc.edu|
20219606|NCT02304458|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20219607|NCT00390221|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20219608|NCT02351544|The Ohio State University|Dr. Jeffrey Janis|(614) 293-8566|jeffrey.janis@osumc.edu|
20219609|NCT02175576|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
20219610|NCT03582826|MEBO Research|Maria De la Torre, Executive Director|786 228-6880|maria.delatorre@meboresearch.org|
20219611|NCT01413516|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
20219612|NCT01565850|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20219613|NCT05323123|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
20219614|NCT05529472|Abbott Vascular|Ikuko Kishimoto, Principal Clinical Scientist|651.756.4878|ikuko.kishimoto@abbott.com|
20219615|NCT04036799|Hospital for Sick Children|Seema Mital, Staff Cardiologist|416-813-7418|seema.mital@sickkids.ca|
20219616|NCT03589768|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@medicine.umaryland.edu|
20219617|NCT03047330|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
20219618|NCT00000378|New York State Psychiatric Institute|Steven Roose MD|646-774-8661|spr2@columbia.edu|
20219619|NCT05773794|North Carolina A&T State University|Dr. Shengmin Sang|7042505710|ssang@ncat.edu|
20219620|NCT00661895|Creighton Cardiac Center|Tammy Burns, PharmD, Research Manager|402-280-4292|TammyBurns@creighton.edu|
20219621|NCT03376061|Population Health Research Institute|Research assistant|19055212100|Austin.Browne@phri.ca|40582
20219622|NCT00362466|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20219623|NCT00663026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219624|NCT03964649|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219625|NCT03783039|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
20219626|NCT00918138|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20219627|NCT03972163|UMass Chan Medical School|Dr. Jennifer Tjia, Principal Investigator|774-455-3538|jennifer.tjia@umassmed.edu|
20219628|NCT02315196|Cancer Institute of New Jersey|Deborah L Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
20219629|NCT03400943|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20219630|NCT00537303|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20219631|NCT03839823|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20219632|NCT03327792|Yale University|Dr. Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
20219633|NCT00996775|Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System|Michael A. Cucciare, Ph.D.|501-257-1068|michael.cucciare@va.gov|
20219634|NCT01161407|Purdue University|Kathleen M. Hill Gallant|765-494-0101|hillgallant@purdue.edu|
20219635|NCT00952211|UCSD|Dr. Joel Dimsdale||jdimsdale@ucsd.edu|
20219636|NCT01025453|Memorial Sloan Kettering Cancer Center|Dr. Eric Sherman, MD|646-888-4234|shermane@mskcc.org|
20219637|NCT01475097|GE Healthcare|Debra Mansfield|609-514-6329|dabra.mansfield@ge.com|
20219638|NCT03490760|Miami Cancer Institute at Baptist Health, Inc.|Michael Chuong, M.D.|(786) 596-2000|michaelchu@baptisthealth.net|
20219639|NCT04516759|St George Street Capital|Mike Johnson, Managing Director|+447768335460|mike@sgscapital.org|
20219640|NCT03511326|Galderma R&D SNC|CTA Coordinator|+33 0493 95 70 85|cta.coordinator@galderma.com|
20219641|NCT03303196|Children's Hospital of Philadelphia|Lauren Mitteer|267-426-9915|MitteerL@email.chop.edu|
20219642|NCT00867503|University Of Arizona|Dr. Setsuko K Chambers|520/626-0950|schambers@azcc.arizona.edu|
20219643|NCT02287818|TWi Biotechnology Inc.|JingYi Lee|886-2-26571788|jingyi.lee@twibiotech.com|201
20219644|NCT01001988|Sanofi Pasteur|Medical Director|800-633-1610|RegistryContactUS@sanofi.com|
20219645|NCT01844856|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
20219646|NCT03340207|VA Western NY Healthcare System|Dr. Nader D. Nader|716-862-8707|nnader@buffalo.edu|
20219647|NCT00927394|Novartis Pharmaceuticals|Study Directors|862-778-8300||
20173568|NCT03715764|Region Västra Götaland, Närhälsan|PhD-student, Chan-Mei Ho-Henriksson|+46709892821|chan-mei.ho@vgregion.se|
20173569|NCT03445650|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20219648|NCT01221363|Research Centre for Prevention and Health|Mette Aadahl|+45 38663359|mette.aadahl@regionh.dk|
20204923|NCT03294681|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
20204924|NCT00242385|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20159678|NCT04405999|Almazov National Medical Research Centre|Evgeny Mikhaylov|+7(812)7023764|e.mikhaylov@almazovcentre.ru|
20159679|NCT03316118|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
20159680|NCT01106651|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise||ClinicalTrialDisclosure@its.jnj.com|
20159681|NCT03768089|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20159682|NCT02241655|Washington University|Dr. Michael Avidan, MBBCh|314-332-7265|avidanm@wustl.edu|
20204925|NCT03089216|Federal University of Goias|Dr. Terezinha de Jesus Esteves Barata|+55 62 3209-6325|terezinhabarata@yahoo.com.br|
20159684|NCT04154605|Stryker|Robyn Schacherer, Manager Clinical Affairs|763-463-7054|robyn.schacherer@stryker.com|
20159685|NCT03709277|Vanderbilt University Medical Center|Amanda Kibbons|615-875-4745|amanda.m.kibbons@vumc.org|
20159686|NCT00675441|UT MD Anderson Cancer Center|Amin Alousi, MD / Assisstant Professor||CR_Study_Registration@mdanderson.org|
20159687|NCT00869791|Impax Laboratories, Inc.|Michelle Landolfi, PhD. Sr. Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
20159688|NCT00005901|National Institute of Child Health and Human Development|Joan Marini|+1 301 594 3418|marinij@cc1.nichd.nih.gov|
20159689|NCT04154293|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
20159690|NCT02661737|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20159691|NCT03703817|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159692|NCT02493257|The University of Texas Health Science Center at Houston|Dr. Amber U. Luong, Associate Professor and Director of Research|(713) 500-5410|Amber.U.Luong@uth.tmc.edu|
20159693|NCT03194568|Children's Hospital of Philadelphia|Dr. Patrick Cahill|2155901000|cahillp1@chop.edu|
20159694|NCT03927482|The Miriam Hospital|Beth Bock, PhD|4017938020|Beth_Bock@Brown.edu|
20159695|NCT03515551|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
20159696|NCT05818956|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20159697|NCT00920387|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
20159698|NCT02835313|University of Delaware|Dr. Darcy Reisman, PT, PhD, FAPTA|302-831-0508|dreisman@udel.edu|
20159699|NCT04084366|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
20159700|NCT02241733|Edward Hines Jr., VA Hospital|Eileen Collins RN, PhD, Research Nurse Scientist|312-413-5621|ecollins@uic.edu|
20159701|NCT01866111|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
20159702|NCT00157196|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20159703|NCT01252186|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20159704|NCT02791516|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20159705|NCT01439971|Catalyst Biosciences|Chief Medical Officer|1-650-266-8671|hlevy@catbio.com|
20159706|NCT02628600|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
20159707|NCT03236909|MED-EL Corporation|Clinical Research Manager|888-633-3524|research.us@medel.com|
20159708|NCT04283994|University of Washington|Dr. Erin Kross|206-744-4649|ekross@uw.edu|
20159709|NCT01301521|MOMH|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
20159710|NCT03804021|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
20159711|NCT02578680|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20159712|NCT05422365|Biopharma Plasma LLC|Igor Rudenko, Clinical Research Physician|+380503300865|i.rudenko@biopharma.ua|
20159713|NCT04324541|University of North Texas Health Science Center|Leigh Johnson, PhD|817-735-2938|Thanhtruc.Truong@unthsc.edu|
20159714|NCT00306293|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159715|NCT05081167|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
20159716|NCT01842035|University of Alabama at Birmingham|Fadi Hage|2059757123|fadihage@uab.edu|
20159717|NCT00185380|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20159718|NCT00733291|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20159719|NCT02390414|Dana-Farber Cancer Institute|Dr. Gregory A. Abel|6176322304|gaabel@partners.org|
20159720|NCT01089413|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159721|NCT04051710|Aurobindo Pharma|Dr. Joseph Marialouis|9196150585|jmarialouis@aurobindousa.com|4013
20159722|NCT00309140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159723|NCT00470093|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Carol Ann Huff|410-955-8842|huffca@jhmi.edu|
20159724|NCT01610557|National Eye Institute (NEI) at National Institutes of Health (NIH)|Henry E Wiley, MD, Principal Investigator|(301) 451-4260|wileyhe@mail.nih.gov|
20159725|NCT02039219|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
20159726|NCT02226562|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159727|NCT01466660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159728|NCT02750345|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
20159729|NCT00608023|Theratechnologies|Marilyn de Chantal, Global Senior Medical Director|1 438-315-6624|Mdechantal@theratech.com|
20159730|NCT01328535|Mayo Clinic|Roxana S. Dronca, M.D.|507/284-2511|Dronca.Roxana@mayo.edu|
20159731|NCT02652208|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
20159732|NCT03655054|Valencia Technologies|Jacqueline Dister|7604294787|jdister@valenciatechnologies.com|
20159733|NCT04392141|Kermanshah University of Medical Sciences|Prof. Ali Mostafaie|+989188302044|amostafaie@kums.ac.ir|
20159734|NCT05623475|College of Nursing, Taipei Medical University, Taiwan|Kee-Hsin Chen, R.N., Ph.D.|+886-2-27361661|keehsin@tmu.edu.tw|3613
20159735|NCT01054560|Covidien|Director of Clinical Affairs|9498373700||
20159736|NCT00832598|Memorial Sloan Kettering Cancer Center|Dr. Ronald Blasburg, MD|646-888-2211|blasberr@mskcc.org|
20159737|NCT00323960|IRCCS Istituto Giannina Gaslini|Dr. Nicolino Ruperto|+39-010-382854|nicolaruperto@gaslini.org|
20159738|NCT02135029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159739|NCT00712725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159740|NCT03466099|KalVista Pharmaceuticals|Director Clinical|857-999-0075|clinicalinfo@kalvista.com|
20159741|NCT01671293|Universidad del Desarrollo|J. Carola Pérez Ewert|5623279875|janetperez@udd.cl|
20159742|NCT03525600|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20159743|NCT02591537|Northwestern University|Dr. Robert Galiano, Associate Professor of Surgery|312.695.3908||
20159744|NCT01923363|Loma Linda University Medical Center|Dr. Steven Forland|909-558-4000|sforland@llu.edu|43980
20159745|NCT00290771|Novartis Pharmaceuticals|Study Director|862 778-8300||
20159746|NCT05129449|OLYMPUS EUROPA SE & CO. KG|Dr. Peter Teichmann|+49 40 23773|peter.teichmann@olympus.com|7835
20159747|NCT01777217|Century Cancer Centers|Dr. Sanjay Mehta|713-631-8181||
20159748|NCT03814382|Massachusetts General Hospital|Jessica Gerber, DAc.|617-724-1992|jgerber2@mgh.harvard.edu|
20159749|NCT01818258|Organization: Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20159750|NCT02099344|Kaiser Permanente NW|Earl Schuman, MD|503-331-6017|kathleen.ann.arnold@kpchr.org|
20159751|NCT02708849|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
20159752|NCT03802630|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20159753|NCT04420598|Medica Scientia Innovation Research (Medsir)|Alicia García Sanz PhD|611261467|contact.trials@medsir.org|+34
20159754|NCT01221623|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20159755|NCT00661726|NERI|Nancy Gee, TCRN Network Manager|617-972-3295|ngee@neriscience.com|
20159756|NCT00780143|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
20159757|NCT02644096|University of Copenhagen|Chief researcher Britta Hørdam|+ 45 22214383|britta@hordam.dk|
20159758|NCT00322452|AstraZeneca|Gerard Lynch||AZTrial_results_posting@AstraZeneca.com|
20159759|NCT00526656|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Jorge Garcia, MD|216-444-7774|garciaj4@ccf.org|
20159760|NCT04091581|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20159761|NCT02438384|Department of Emergency Medicine, UNC School of Medicine|Tim Platts-Mills, MD|559-240-6073|tim_platts-mills@med.unc.edu|
20159762|NCT03319953|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20159763|NCT02889289|Washington DC VA Medical Center|Dr. Shane Chanpimol|202-745-8000|shane.chanpimol@va.gov|55854
20159764|NCT01795495|Nationwide Children's Hospital|David Martin, MD|6147224200|David.Martin@nationwidechildrens.org|
20159765|NCT03315793|Shionogi|Shionogi Clinical Trial Administrator|+81-6-6209-7885|shionogiclinicaltrials-admin@shionogi.co.jp|
20159766|NCT00790868|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
20159767|NCT01579565|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
20159768|NCT02791191|Eli Lilly and Company|Chief Medical Officer|800-545-5079|Clinicaltrials.gov@lilly.com|
20159769|NCT00678535|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
20159770|NCT02290691|PharmaJet, Inc|Tara Miller, MS, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
20159771|NCT00978380|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20159772|NCT02199314|Cincinnati Children's Hospital Medical Center|John J McAuliffe, MD|1513-636-4408|john.mcauliffe@cchmc.org|
20159773|NCT01461928|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20159774|NCT00731653|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
20159775|NCT02526524|Elcelyx Therapeutics, Inc|Chief Scientific Officer|858-876-1814|info@elcelyx.com|
20159776|NCT00664560|POZEN Inc|Sr VP Clinical Research|919-913-1030|eorlemans@pozen.com|
20159777|NCT02913430|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
20159778|NCT01289353|NYU Langone Health - PCC CTO|Carmen Perez, MD, PhD|212-731-5003|carmen.perez@nyulangone.org|
20159779|NCT01549886|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20159780|NCT00473668|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159781|NCT04569136|National Cheng Kung University|Dr. Kuan-Yin Lin|+886-6-2353535|10802003@gs.ncku.edu.tw|6737
20173570|NCT01361464|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
20173571|NCT01722071|University of Michigan|Tiffany Love, PhD|734-219-3674|tiflove@umich.edu|
20173572|NCT01106898|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
20173573|NCT00818662|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20173574|NCT03021265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173575|NCT01338493|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
20173576|NCT01472081|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20173577|NCT01698801|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20173578|NCT00656474|Glycotex|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
20173579|NCT01614067|University of California, San Francisco|Mitchell Rosen, MD|415-353-7475||
20173580|NCT01505868|UT MD Anderson Cancer Center|Paul Corn, MD PHD- Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
20173581|NCT00775645|SWOG Statistical Center|Study Statistician|206-667-4623||
20173582|NCT02998840|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20173583|NCT02625259|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20173584|NCT03195088|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173585|NCT00665847|Tibotec Pharmaceuticals, Ireland|Senior Director|32 14 641 265|gdsmedt1@its.jnj.com|
20173586|NCT00511667|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173587|NCT03605303|Johnson & Johnson Vision Care Inc.|Brian Pall OD, MS, FAAO - Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
20173588|NCT04702997|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20173589|NCT03274687|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20173590|NCT01188694|University of Washington|Lori Zoellner|206 685-3617|zoellner@u.washington.edu|
20173591|NCT01706003|UT Southwestern Medical Center|Deborah I. Friedman, MD, MPH, Professor of Neurology and Neurotherapeutics and Ophthalmology|2146483517|Deborah.Friedman@utsouthwestern.edu|
20173592|NCT04538066|Synaptogenix, Inc.|Chief Medical Officer|973 242-0005|atuchman@synaptogen.com|
20173593|NCT03182829|DOASENSE GmbH|Harenberg, Job Prof Dr.|+496221825|j.harenberg@doasense.de|9785
20173594|NCT03316131|AstraZeneca RD, Gothenburg|Fredrik Erlandsson|1-877-240-9479|information.center@astrazeneca.com|
20173595|NCT00478569|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20173596|NCT05608005|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20173597|NCT02366845|University of Colorado|Dr. Marc Moss|303-724-6080|marc.moss@cuanschutz.edu|
20173598|NCT05022784|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173599|NCT03020407|Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+6626494000|kmusikatavorn@yahoo.com|83058
20173600|NCT01585428|National Cancer Institute|D. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20204926|NCT00417976|The Ohio State University|Tanios Bekaii-Saab|614-293-9863|Tanios.saab@osumc.edu|
20204927|NCT01022567|Turku University Hospital|Paulina Salminen|+358 2 313 0542|paulina.salminen@tyks.fi|
20204928|NCT01778127|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
20204929|NCT01003080|Montefiore Medical Center|Dr. Sun Jin Kim|718-920-2060|sukim@montefiore.org|
20204930|NCT02720016|VHASDC|Dr. Leslie A. Morland|858-552-4324|Leslie.Morland@va.gov|
20204931|NCT02049749|Children's Hospital of Philadelphia|Dr. Joanne Wood, PI|267-426-3107|woodjo@email.chop.edu|
20204932|NCT00751114|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
20204933|NCT05319080|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
20204934|NCT02358369|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20204935|NCT00448916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204936|NCT03655717|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@mgh.harvard.edu|
20204937|NCT05092971|National Institute of Mental Health (NIMH)|Dr. Maryland Pao|301-435-5770|paom@mail.nih.gov|
20204938|NCT01328158|AbbVie (prior sponsor, Abbott)|AbbVie Japan PMOS Desk|+81-3-4577-1125|abvj-pmos@abbvie.com|
20204939|NCT01208038|Chelsea and Westminster NHS Trust|Dr Kate Maclaran|020 3315 3000|kate.maclaran@nhs.net|
20204940|NCT00430521|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20204941|NCT04552535|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20204942|NCT05108805|Vanderbilt University Medical Center|Dr. Olalekan Oluwole|(615) 936-8422|olalekan.oluwole@vumc.org|
20204943|NCT03342937|Duke University|Dr. Hope Uronis|919-668-1861|hope.uronis@duke.edu|
20204944|NCT00369967|VCUHS|Nicole Karjane|804-828-8614|nkarjane@mcvh-vcu.edu|
20204945|NCT03713957|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20204946|NCT02581865|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20204947|NCT03235817|Anesthesiology|T. Wesley Templeton, MD|336-716-4498|ttemplet@wakehealth.edu|
20204948|NCT02621619|Albany Medical Center|Dr. Andrew Chang|518-262-0042|changa1@amc.edu|
20204949|NCT02282982|AbbVie|Global Medical Services|800-633-9110||
20173601|NCT02699554|University of Washington|Katherine Steele|206-685-2390|kmsteele@uw.edu|
20173602|NCT00788151|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
20204950|NCT00131677|Centers for Disease Control and Prevention (CDC)|Taraz Samandari|404-639-1676|tts0@cdc.gov|
20204951|NCT02924688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20204952|NCT02574858|University of Michigan|Dr. D. Kim Turgeon|734-764-6860|kturgeon@med.umich.edu|
20159782|NCT03257202|Keck Medical Center of USC|Dr. George Hatch|323-442-5860|ghatch.md@gmail.com|
20159783|NCT00129701|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
20159784|NCT03576066|Assembly Biosciences|Linda Bahr, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
20159785|NCT00006164|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|James E. Everhart, MD, MPH, Project Officer|301-594-8878|EverhartJ@extra.niddk.nih.gov|
20159786|NCT00223808|CTVHCS|Charles Burgar, MD|254/743-0085|charles.burgar1@va.gov|
20159787|NCT00365105|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20159788|NCT00635739|Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
20159789|NCT00191724|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20159790|NCT06422364|Indiana University|Dr. Harish Rao, Assistant Professor of Clinical Pediatrics|317-948-7208|harirao@iu.edu|
20159791|NCT03713294|Mayo Clinic|Sikander Ailawadhi|904/953-6468|ailawadhi.sikander@mayo.edu|
20159792|NCT05260073|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20159793|NCT03458910|University of Southern California|Dr. Mara Mather|(213) 821-1868|mara.mather@usc.edu|
20159794|NCT06004895|Aston University|Professor James S Wolffsohn|07833049245|j.s.w.wolffsohn@aston.ac.uk|
20159795|NCT04924530|University of Bath|Professor Javier Gonzalez|01225 38|j.t.gonzalez@bath.ac.uk|5518
20159796|NCT04022226|The University of New Mexico|Dr. Jeremy Miller|5052724490|jermiller@salud.unm.edu|
20159797|NCT03130439|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20159798|NCT01463696|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159799|NCT04726137|Fondazione Penta ETS|Giorgia Dalla Valle|393783022748|giorgia.dallavalle@pentafoundation.org|
20159800|NCT00967694|University of Utah Department of Anesthesiology|Dr. Eric Fox|775-340-0219|ericbfox@yahoo.com|
20159801|NCT05742646|Medical University of South Carolina|Dr. Michelle Nichols|8437928515|nicholmg@musc.edu|
20159802|NCT00152477|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20159803|NCT00425698|Saarland University Medical Centre|Prof. Dr. Danilo Fliser|(49) 6841|indfli@uks.eu|1623526
20159804|NCT02704702|Celerion|Dr.Laura Sterling|1-402-476-2811|laura.sterling@celerion.com|
20159805|NCT00729677|Beth Israel Cancer Center|Victoria Rosenwald, RN MPH|212 844-8285|vrosenwa@chpnet.org|
20159806|NCT03905265|Medicines Development for Global Health Limited|Clinical Project Manager|+61 399122400|MDGH-MOX-2001@medicinesdevelopment.com|
20159807|NCT00960011|The University of Hong Kong|Dr. Joe Fan King Man|852-22553111|drfanj@gmail.com|
20159808|NCT00758264|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159809|NCT00889603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159810|NCT01454505|Alcon Research, Ltd.|Terri Pasquine, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20159811|NCT01818739|The Ohio State University Comprehensive Cancer Center|Floor Backes, MD|614-730-6968|Floor.Backes@osumc.edu|
20159812|NCT02901054|Washington University School of Medicine|Simon Haroutounian, PhD|3142861715|simon.haroutounian@wustl.edu|
20159813|NCT00616018|Denver Health|Jody Green|303-389-1246|jody.green@rmpdc.org|
20159814|NCT03718884|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159815|NCT02609841|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20159816|NCT02839720|UAB Heersink School of Medicine|Bruce R. Korf, MD, PhD|205-996-9487|bkorf@uabmc.edu|
20159817|NCT03306979|Sunnybrook Health Sciences Centre|Dr. Krista Lanctôt, Senior Scientist|416-480-6100|krista.lanctot@sunnybrook.ca|62241
20159818|NCT05248997|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159819|NCT01453205|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
20159820|NCT05593913|Acer Medical Inc.|Regulator Manager|886-2-26960366|AcerMedicalofficial@gmail.com|
20159821|NCT02602275|Biologische Heilmittel Heel GmbH|Head of Clinical Research|+49 7221 501|info@heel.com|0
20159822|NCT01258790|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
20159823|NCT05549232|Hemanext Inc.|Sr. Director, Clinical Affairs|781-301-7474|jill.bagdasarian@hemanext.com|
20159824|NCT03829969|Shanghai Junshi Bioscience Co., Ltd.|Huimei Xie|86-021-50796193|huimei_xie@junshipharma.com|
20159825|NCT04113018|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20159826|NCT05005013|NYU Langone Health|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
20159827|NCT02059499|AMC Statistical Center|Dr Himanshu Joshi, MBBS, MPH, PhD (Assistant Professor)|212-259-9635|himanshu.joshi@mountsinai.org|
20159828|NCT04210245|NGM Biopharmaceuticals|VP, Clinical Operations|(650) 243-5555|ngm282@ngmbio.com|
20159829|NCT06099223|Hartford Hospital|Aseel Walker|860-972-1778|aseel.walker@hhchealth.org|
20159830|NCT02248649|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20159831|NCT02664311|Beth Israel Deaconess Medical Center|Eleanor Greene|617-667-1836|ergreene@bidmc.harvard.edu|
20159832|NCT00722722|Mayo Clinic|Mark Stegall, MD|507-266-2812|Stegall.Mark@mayo.edu|
20159833|NCT00147017|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
20159834|NCT01202188|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159835|NCT00487942|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
20159836|NCT00211757|Montefiore Medical Center|Dr. Eric Hollander|718-920-4287|eholland@montefiore.org|
20159837|NCT03111550|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman,OD, FAAO|+1 714-247-8628|djanaki1@its.jnj.com|
20159838|NCT02461290|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20173603|NCT01985581|Center for Pediatric Excellence|Dr. Judy van Stralen|613-726-7355|judyvanstralen@bellnet.ca|
20159839|NCT01457014|Sleep and Alertness Research Inc.|Sharon A. Chung|416-603-5275|sachung@uhnres.utoronto.ca|
20159840|NCT04027049|Johns Hopkins University|Department of Neurology|410-955-2228|ezink1@jhmi.edu|
20173604|NCT00503009|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219649|NCT02315430|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
20219650|NCT00613886|University of California, Irvine|Chris Nishi Clinical Trials Coordinator|949-824-3238|cnishi@uci.edu|
20219651|NCT00176423|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
20219652|NCT01329549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219653|NCT01775189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219654|NCT01755767|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20219655|NCT04623086|University of Washington|Arthi Thirumalai|206-221-0521|arthidoc@uw.edu|
20219656|NCT00191165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219657|NCT00715624|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20219658|NCT03200912|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8259|USMedInfo@tevapharm.com|
20219659|NCT03007238|City of Hope Medical Center|Dr. Amandeep Salhotra|626-359-8111|asalhotra@coh.org|
20219660|NCT03196635|GE Healthcare|Sara Lam|262-548-2369|sara.j.lam@ge.com|
20219661|NCT00735618|UT MD Anderson Cancer Center|Ying Guo, MD, MS/Associate Professor||jaallo@mdanderson.org|
20219662|NCT01273896|Memorial Sloan Kettering Cancer Center|Modi, Shanu/Medicine (Assistant Attending)|+1646-888-4564|modis@mskcc.org|
20219663|NCT00229723|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20219664|NCT03369197|The Johns Hopkins University|Dr. Laeben Lester|410-955-7519|llester4@jhmi.edu|
20219665|NCT02677714|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20219666|NCT00901576|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20219667|NCT02922738|University of Vermont|Marianne Burke|802-236-0075|marianne.burke@uvm.edu|
20219668|NCT00171951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20219669|NCT00724048|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20219670|NCT02329847|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219671|NCT05034276|University of Utah|Eric Garland|801-581-3826|eric.garland@socwk.utah.edu|
20219672|NCT03365011|Washington University School of Medicine in St. Louis|Jay F. Piccirillo, MD, FACS|(314) 362-8641|piccirij@wustl.edu|
20219673|NCT04180163|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20219674|NCT04730349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20219675|NCT02629354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219676|NCT01246063|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@wustl.edu|
20219677|NCT03155945|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20219678|NCT00810576|UT MD Anderson Cancer Center|Barbara Pro, MD|713-792-2933||
20159841|NCT02650128|Shockwave Medical, Inc.|Beaux Alexander, Vice President Clinical Affairs|510-279-4262|balexander@shockwavemedical.com|145
20159842|NCT03040011|Magee-Womens Hospital of UPMC|Dr. Lauren Giugale, PI|412-641-1498|giugalele@upmc.edu|
20159843|NCT02964559|Emory University|Dr. Michael Lowe|404-778-7215|mlowe3@emory.edu|
20159844|NCT01215643|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20159845|NCT00218634|Mass General Hospital|Steven Safren|617 724 0817|ssafren@partners.org|
20159846|NCT00734604|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159847|NCT01044745|University of Nebraska Medical Center|R. Gregory Bociek, MD|402-559-5388|rgbociek@unmc.edu|
20159848|NCT02890303|Mynosys Cellular Devices, Inc.|Daniel Marinsik|(510) 857-6296|dmarinsik@mynosys.com|
20159849|NCT03086707|Philip Morris Products S.A.|Julia Hoeng, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
20159850|NCT03711929|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20159851|NCT00591149|University of Kansas Medical Center|Chao Huang, MD|913-588-6029|chuang2@kumc.edu|
20159852|NCT02456636|University of Kansas Medical Center|Christie Befort, PhD|913 588-3338|cbefort@kumc.edu|
20159853|NCT02379221|Travis AFB OMFS Clinic|Dr. Jason May|707-423-7085|jason.may.11@us.af.mil|
20159854|NCT02019108|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
20159855|NCT00484393|Fraser Health|Brandi Newby|604-585-5666|brandi.newby@fraserhealth.ca|774374
20159856|NCT01084278|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20159857|NCT02642393|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
20159858|NCT05275010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20159859|NCT02975999|LUrie Children's Hospital|Dr. Jamie Penk, co-investigator|7735773782|jpenk@luriechildrens.org|
20159860|NCT04484649|Columbia University Irving Medical Center|Samantha Garbers-Adams, PhD|212-305-0123|svg2108@cumc.columbia.edu|
20159861|NCT01591837|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20159862|NCT02731820|Istituto Ortopedico Rizzoli|Director of Clinical Trials|+39 051.6366392|ctc@ior.it|
20159863|NCT04478071|The University of Texas Health Science Center at Houston|Bentley J. Bobrow, MD|713-500-7863|Bentley.J.Bobrow@uth.tmc.edu|
20159864|NCT00123162|MS Hershey Medical Center|Richard S Legro MD|717-531-8478|rsl1@psu.edu|
20219679|NCT02013674|ISCI / University of Miami Miller School of Medicine|Marietsy pujol / Senior Regulatory Specialist|305-243-7273|mpujol@med.miami.edu|
20219680|NCT03558061|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20189407|NCT04228952|Masonic Cancer Center|Susan Murphy, PhD|612-624-7633|murph062@umn.edu|
20189408|NCT05553366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20189409|NCT01505166|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
20189410|NCT03187678|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
20189411|NCT01786876|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20189412|NCT00795184|Mauna Kea Technologies|Christophe Bailleul|+ 33 1 70 08 09 74|christopheb@maunakeatech.com|
20189413|NCT03781375|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20189414|NCT02079649|Alcon Research, Ltd.|Clinical Project Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20189415|NCT01034306|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20219681|NCT03483363|The University of Texas Health Science Center at Houston|Nagi Demian, MDDS|(713) 500-5082|Nagi.Demian@uth.tmc.edu|
20189416|NCT00836498|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
20189417|NCT01968967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189418|NCT03489369|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
20189419|NCT02785159|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20189420|NCT04273672|University of Massachusetts Medical School|Kara Smith, MD|5083342527|kara.smith@umassmed.edu|
20189421|NCT02384382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189422|NCT02113449|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189423|NCT01328496|St. Jude Children's Research Hospital|Amr Qudeimat, MD|901-595-8342|amr.qudeimat@stjude.org|
20189424|NCT03960957|QMedAB|Clinical Project Manager|8179615000|aestheticclinicaltrials@galderma.com|
20189425|NCT02091752|Novartis|Study Director|862-778-8300||
20189426|NCT04029090|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml@ml.mt-pharma.co.jp|
20189427|NCT01065779|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20189428|NCT02157948|Amgen Inc.|Study Director|866-572-6436||
20189429|NCT03067948|Johns Hopkins University SOM (Adjunct)|Anne Monroe MD|202-994-0251|amonroe@gwu.edu|
20189430|NCT01604824|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20189431|NCT03617835|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189432|NCT03822832|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189433|NCT04205903|The Ohio State University Comprehensive Cancer Center|Dr. Nicole Williams|(614) 293-0066|Nicole.Williams@osumc.edu|
20189434|NCT04233567|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.Roychowdhury@osumc.edu|
20189435|NCT04248803|TamilNadu MU|Dr Geeth Deepika|9952331820|geethdeepika@gmail.com|
20189436|NCT05352230|UAB|Orlando Gutierrez|2059962736|ogutierrez@uabmc.edu|
20189437|NCT05414682|University of Kansas Medical Center|Dr. Ashley Shaw|913-945-5023|ashaw10@kumc.edu|
20189438|NCT04399837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189439|NCT00003459|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20189440|NCT03088800|Maimonides Medical Center|Sergey Motov, MD|7182836000|smotov@maimonidesmed.org|
20189441|NCT01695291|New York State Psychiatric Institute|Kelsey Hill, Research Coordinator|646-774-5793|Kelsey.Hill@nyspi.columbia.edu|
20189442|NCT00614614|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189443|NCT04745676|University of Rochester Medical Center, Wilmot Cancer Institute|Research Project Manager|585 410 5044|cait_fallone@urmc.rochester.edu|
20189444|NCT05212285|Huadong hospital,Shanghai ,China|Dr.Yinggang Zhu,Dr Ting Zhao|1374321007|robinzyg-zhu@vip.sina.com;vivianzaza@163.com|+86
20159865|NCT04838054|Stony Brook University|Srinivas Rao Myneni Venkatasatya, DDS, PhD|631-632-8739|srinivas.MyneniVenkatasatya@stonybrookmedicine.edu|
20189445|NCT03683030|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189446|NCT04502472|Inova Health Systems|Anne Whitney Brown, MD|7037763067|anne.brown@inova.org|
20189447|NCT02222493|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189448|NCT03132298|Stony Brook University|Jessica Schleider|631-632-4131|jessica.schleider@stonybrook.edu|
20189449|NCT00684242|UT MD Anderson Cancer Center|Sriram Yennurajalingam, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20219682|NCT03433755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20159866|NCT04417218|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
20159867|NCT01074463|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20159868|NCT01345513|Ontario Institute for Cancer Research|Janet E. Dancey|1-613-533-6430|janet.dancey@oicr.on.ca|
20159869|NCT01082874|Population Health Research Institute|P.J. Devereaux, MD, PhD, FRCPC|905-527-4322|philipj@mcmaster.ca|40654
20159870|NCT02808052|Melinta Therapeutics|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
20159871|NCT03549572|Spaulding Rehabilitation Hospital|Yelena Bodien|(617) 643-3956|ybodien@mgh.harvard.edu|
20159872|NCT00803400|Psychiatry Academic Unit at J.A.Fernandez Hospital, University of Buenos Aires Medicine School Department of Mental Health|Dr. Marcelo Rudelir|54 11 48254740|mrudelir@hotmail.com|
20189450|NCT01000805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219683|NCT03936101|Columbia University|Jessica L Giordano, CGC|516-521-5604|jlg2197@cumc.columbia.edu|
20189451|NCT04104022|University of Vermont|Dr. Kelly R. Peck, Ph.D.|8026569610|Kelly.Peck@uvm.edu|
20189452|NCT02808468|University of Washington|Dr. Michele Bedard-Gilligan|206-616-4215|mab29@uw.edu|
20189453|NCT05432986|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
20219684|NCT06913153|Tianjin Medical University|Zhenqiang Song, M.S., Associate Professor and Master's Supervisor|8622-18602276218|Zsong@tmu.edu.cn|
20173605|NCT03878745|Becton Dickinson|Michael Gibney|201-847-6170|Michael.gibney@bd.com|
20173606|NCT01349803|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20173607|NCT02169739|University of California Los Angeles|Latisha Sharma, MD|310-794-6379|lali@mednet.ucla.edu|
20173608|NCT03635957|Horizon Therapeutics Ireland DAC|Paul Peloso, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
20173609|NCT00350636|Watson Laboratories, Inc|Gary Hoel, PhD, Executive Director|801-808-8866|gary.hoel@watson.com|
20173610|NCT01214161|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
20173611|NCT04396990|Vance Thompson Vision|Keeley Boever|6053613937|keeley.boever@vancethompsonvision.com|
20173612|NCT02880189|Mayo Clinic|Dr. Barham K. Abu Dayyeh|507-284-1825|AbuDayyeh.Barham@mayo.edu|
20204953|NCT00882102|The University of Texas MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor|713-563-1586|eharriso@mdanderson.org|
20204954|NCT00868959|Sunovion|Medical Director, CNS|1-866-503-6351||
20173613|NCT01647282|UNMC College of Dentistry|Dr. Amy C. Killeen|402-202-7848|akilleen@unmc.edu|
20204955|NCT02600325|Erasmus MC|Dr. B. J. A. Rijnders|0|b.rijnders@erasmusmc.nl|
20173614|NCT01042236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173615|NCT00826020|University of Nebraska Medical Center|David Mercer|402-559-6955|dmercer@unmc.edu|
20173616|NCT02338960|AMAG Pharmaceuticals|Medical Information|1-877-411-2510||
20173617|NCT02261714|Targovax ASA|Chief Medical Officer|004721398810|contact@targovax.com|
20173618|NCT02522286|Palo Alto Medical Foundation Research Institute|Dr. Ming Tai-Seale|650-853-4779|Tai-SealeM@pamfri.org|
20173619|NCT03889158|University of Illinois at Chicago|Dr. Elizabeth Lefferts|312-996-9607|eschro7@uic.edu|
20173620|NCT03040466|UCSF|Dr. Thomas Chi|415-476-1611|tom.chi@ucsf.edu;manint.usawachintachit@ucsf.edu|
20173621|NCT05584644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173622|NCT03683758|Mountain Health and Performance|Dr. Matthew Wentzell|6043566986|drwentzell@mountainhp.ca|
20173623|NCT01172847|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20173624|NCT01163279|Baycrest Health Sciences|Dr. Deirdre Dawson|416-785-2500|ddawson@research.baycrest.org|2136
20173625|NCT00119392|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20173626|NCT02411292|Division of Plastic Surgery, University of Utah|Dr. Christopher J. Pannucci, M.D., M.S.|801-581-7719|christopher.pannucci@hsc.utah.edu|
20173627|NCT00303498|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173628|NCT00453921|Dartmouth Hitchcock Medical Center|Dr. Laura Flashman|6036505824|Laura.A.Flashman@hitchcock.org|
20173629|NCT02493608|Texas Tech Health Sciences Center|Chadley Copeland|8067434752|chadley.copeland@ttuhsc.edu|
20173630|NCT00174915|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20173631|NCT02232425|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
20173632|NCT03060447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20173633|NCT00665353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20173634|NCT01870583|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
20173635|NCT00583804|MetroHealth Medical Center|Principal Investigator|2169573683|ue.fes.clinicaltrials@gmail.com|
20204956|NCT01122030|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20204957|NCT01205451|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204958|NCT02351258|Johns Hopkins University|Dr. Aaron Milstone|443-287-8932|amilsto1@jhmi.edu|
20204959|NCT00423735|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20204960|NCT00579501|PharmaMar SA, Av de los Reyes 1 Mine Industrial Estate, 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
20204961|NCT01089582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204962|NCT02287402|Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited|Hitoshi Onouchi|+81-6-6204-5116|hitoshi.onouchi@takeda.com|
20204963|NCT02394808|Johnson & Johnson Vision Care Inc.|Tawnya Wilson O.D. SR. MANAGER GLOBAL CLINICAL SALES EDU|443-1834|TWilson@ITS.JNJ.com|
20204964|NCT00209170|University of Miami School of Medicine|Dominique Musselman, MD|404-723-8361|dmusselman@med.miami.edu|
20204965|NCT02130427|University of Pennsylvania|Dr. Wei Zou|800-789-7366|Wei.Zou@pennmedicine.upenn.edu|
20204966|NCT00258427|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
20204967|NCT02108600|University of California, San Francisco|Sindhu Chandran|4153538374|sindhu.chandran@ucsf.edu|
20204968|NCT00734734|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
20204969|NCT01295580|Bioventus, LLC|Director, Regulatory and Clinical Affairs|1-800-396-4325||
20204970|NCT04032171|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20204971|NCT00992784|GlaxoSmithKline|GSK Response Center|866-435-7343||
20204972|NCT00642746|OHSU Knight Cancer Institute|Charles Lopez, MD|503-494-8534|lopezc@ohsu.edu|
20204973|NCT00424294|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204974|NCT01811355|Mayo Clinic, Jacksonville|Dr. Bjorn Oskarsson|9049536896|oskarsson.bjorn@mayo.edu|
20173636|NCT00705081|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20173637|NCT01601626|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20204975|NCT00757484|University of Rochester Medical Center|Dr. Erin Duecy|585-275-4004|erin_duecy@urmc.rochester.edu|
20219685|NCT05065567|SpectrumLakeland|Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
20173638|NCT01623323|OptiNose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
20173639|NCT03045887|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173640|NCT02632552|U.S. Department of Veterans Affairs, Center for Healthcare Organization and Implementation Research (CHOIR)|Timothy P. Hogan, PhD,|508-244-2303|Timothy.Hogan@VA.gov|
20173641|NCT02132767|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
20173642|NCT02074631|University of Minnesota, Masonic Cancer Center|Dr. Kyriakie Sarafoglou|(612) 624-5965|saraf010@umn.edu|
20173643|NCT00778700|Incyte Organization|Study Director|1-855-463-3463|medinfo@incyte.com|
20173644|NCT03914326|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20173645|NCT03274440|Columbia University/New York State Psychiatric Institute|Dr. Reilly Kayser|6467748118|reilly.kayser@nyspi.columbia.edu|
20204976|NCT00976950|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20204977|NCT04124042|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
20204978|NCT04895605|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20204979|NCT02932332|UT MD Anderson Cancer Center|David Hui, MD, Associate Professor/Palliative Care Med|713-792-6258|dhui@mdanderson.org|
20204980|NCT01069523|University of Texas Health Science Center at San Antonio|Steven R.Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
20204981|NCT00473837|Medical Research Council Unit, The Gambia|Mrs Vivat Thomas-Njie|+220-4495442/6|vthomas@mrc.gm|2204
20204982|NCT01025817|Novartis|Study Director|+1 (862) 778-8300||
20204983|NCT01016691|Vistakon|Brian Schwam MD|1-904-443-1482|bschwam@its.jnj.com|
20204984|NCT04533815|University of Alabama|Dr. Lynn Snow|205-201-0312|LSNOW@ua.edu|
20204985|NCT02130258|Massachusetts General Hospital|Dr. Yi Zhang|617-724-6102|yzhang20@partners.org|
20204986|NCT00488592|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
20204987|NCT00441103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20204988|NCT01655823|Wex Pharmaceuticals|Mehran Kavoosi|6046767900|mehrank@wexpharma.com|
20204989|NCT01627067|UT MD Anderson Cancer Center|Dr. Vicente Valero, MD/ Professor, Breast Medical Oncology|713- 563-0751|vvalero@mdanderson.org|
20204990|NCT01700517|Madre Teresa´s Hospital|Dr Lucio Honorio de Carvalho Júnior|+55 31 33398000|luciohcj@gmail.com|
20204991|NCT02632110|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
20204992|NCT03352414|University of California, San Diego|Raymond Diep, Clinical Research Coordinator|(858) 822-5352|rhdiep@health.ucsd.edu|
20204993|NCT01348425|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
20204994|NCT01317667|US Army Medical Research Institute of Infectious Diseases (USAMRIID)|Denise P Clizbe, RN, CCRC|301.619.6869|denise.p.clizbe.civ@mail.mil|
20204995|NCT03615911|University Medical Center Hamburg-Eppendorf|Prof. Marylyn M. Addo|+49 40 7410|m.addo@uke.de|51102
20204996|NCT01968954|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20204997|NCT00064350|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20204998|NCT03600714|NIDDK|Dr. Christopher Koh|301-443-9402|kohchris@mail.nih.gov|
20204999|NCT04597619|Maine Medical Center|David Sobel, MD|207-773-1728|david.sobel@mainehealth.org|
20205000|NCT01935336|U of Colorado, Division of Medical Oncology. Anschutz Medical Campus|Dr. Ross Camidge|7208480300|ross.camidge@cuanschutz.edu|
20205001|NCT00592553|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20205002|NCT01752842|Washington University School of Medicine|Jean E. Schaffer, MD|314-362-8717|jschaff@wustl.edu|
20205003|NCT03260205|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20205004|NCT01743963|Eastern Colorado Health Care System, VA|Liron Caplan, Primary Investigator|7208575103|liron.caplan@ucdenver.edu|
20205005|NCT01968187|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
20205006|NCT01877382|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
20205007|NCT05149040|Helse Bergen|Dr. G.L. Schwarz|0047-55976850|gabriele.leonie.schwarz@helse-bergen.no|
20205008|NCT01617655|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
20205009|NCT05340322|Duke University|Nimmi Ramanujam, PhD|9196605307|nimmi@duke.edu|
20205010|NCT00418964|The Chinese University of Hong Kong|Pauline Lui|852 2632 3072|pauline@ort.cuhk.edu.hk|
20205011|NCT00229203|PharmaMar USA Inc|Claudia Silvia Corrado M.D.|1 212 201 6770|cscorrado@pharmamar.com|
20205012|NCT03457103|NYU Langone|Dr. Anna Norweg|646-501-7777|AnnaMaria.Norweg@nyulangone.org|
20205013|NCT03004469|Polichem S.A.|Francesco Scarci|+41 091 9864 005|francesco.scarci@almirall.com|
20205014|NCT01163253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205015|NCT02492997|Venus Concept Ltd.|Dr. Yoni Iger|888-907-0115|yoni@venusconcpet.com|
20205016|NCT01397552|Upstate Medical University|William Lavelle|315-464-4472|lavellew@upstate.edu|
20205017|NCT00439673|GIMEMA|Alfonso Piciocchi|+39 06.70390521|a.piciocchi@gimema.it|
20205018|NCT00654784|Santhera|Thomas Meier|+4161 906 8964|thomas.meier@santhera.com|
20205019|NCT01722487|Pharmacyclics LLC|Dr. Lori Styles, Medical Monitor|+1 (408) 215-3770|lstyles@pcyc.com|
20205020|NCT00190983|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20205021|NCT04069156|Abbott|Nourdine Chakouri, PhD|(925) 989-5982|nourdine.chakouri@abbott.com|
20205022|NCT04247815|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
20205023|NCT03822871|Cancer Targeted Technology|Dr. Beatrice Langton-Webster, CEO|(206) 617-0699|bealw@cancertargetedtechnology.com|
20205024|NCT00089479|Hoffman-LaRoche|Medical Communications|800-821-8590||
20205025|NCT03943953|Oxford University Hospitals NHS Foundation Trust|Dr Matthew Hotton|01865 234714|matthew.hotton@ouh.nhs.uk|
20205026|NCT01102218|Fresenius Medical Care North America|Christina Kahn, Senior Manager of Clinical Trials|615-345-5542|christina.meng@fmc-na.com|
20205027|NCT00289185|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205028|NCT01742078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205029|NCT01094717|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465|Kristina.Duffin@hsc.utah.edu|
20205030|NCT00576251|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20205031|NCT01124448|Complutense University Madrid|Dr. Juan M Rodríguez|34 91 3943837|jmrodrig@vet.ucm.es|
20205032|NCT01940510|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20205033|NCT00986310|University of California, Davis|Lisa Bateman, MD, FRCPC||lb2863@cumc.columbia.edu|
20205034|NCT03247413|Johns Hopkins University School of Medicine|Akhil Chhatre|443-997-5476|achhatr1@jh.edu|
20205035|NCT03337152|PATH|Gonzalo Domingo|206-285-3500|gdomingo@path.org|
20205036|NCT01021852|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205037|NCT02493426|University of Minnesota|Suma Jacob, MD, PhD|612-624-0018|sjacob@umn.edu|
20205038|NCT02408796|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20205039|NCT00807846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205040|NCT01081873|Abbott|Global Medical Services|800-633-9110||
20159873|NCT00939029|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
20159874|NCT00668382|UMass Medical Scool|Dr. Sheila Noone|508 856 5015|Sheil.Noone@umasmed.edu|
20205041|NCT00441558|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20205042|NCT04799405|Hebrew SeniorLife|Dr. Pascual-Leone|6179715372|apleone@hsl.harvard.edu|
20205043|NCT00603980|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20205044|NCT01029002|Albert Einstein College of Medicine|Dr. Michal Melamed|718-430-2304|michal.melamed@einsteinmed.edu|
20205045|NCT02683525|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
20205046|NCT00711269|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20205047|NCT00906074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219686|NCT03510598|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
20219687|NCT04240392|Yale School of Medicine|Ariadna Forray, MD|203-785-2618|ariadna.forray@yale.edu|
20219688|NCT02155543|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20219689|NCT03665441|Erytech Pharma Inc|Anu Gupta, Senior Study Team Lead|7327424937|anu.gupta@erytech.com|
20219690|NCT00191113|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20219691|NCT05307510|The University of Toledo|Laura Schmelzer|419-530-5068|laura.schmelzer@utoledo.edu|
20219692|NCT02487303|Medical University of South Carolina|Sylvia Wilson|8437921414|wilsosh@musc.edu|
20219693|NCT04003896|Penn State Health|Dr. Nelson Yee|7175310003|nyee@pennstatehealth.psu.edu|280677
20219694|NCT01682863|Novartis Pharmaceuticals|Study Director|862-778-8300||
20205048|NCT02618928|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20205049|NCT04593940|Washington University in St. Louis|William G. Powderly MD|314-454-8276|wpowderly@wustl.edu|
20189454|NCT00551421|Dana-Farber Cancer Institute|Dr. Kimmie Ng|617-632-4150|kimmie_ng@dfci.harvard.edu|
20189455|NCT02271906|UT MD Anderson Cancer Center|George Simon, MD|713-792-7734|GSimon@mdanderson.org|
20219695|NCT00837473|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20189456|NCT00799409|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
20189457|NCT01550952|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
20189458|NCT01970878|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20189459|NCT04323800|The Johns Hopkins University School of Medicine|Shmuel Shoham|410-614-6431|sshoham1@jhmi.edu|
20219696|NCT01635218|Hospital Juárez de México|Dr. Emma del Carmen Macías-Cortés|+52 55 5747 7605|ecmc2008@hotmail.es|
20159875|NCT03305419|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20159876|NCT02210689|Teva Pharmaceuticals USA. Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20159877|NCT00075946|ECOG Statistical Office|Study Statistician|617-632-3012||
20159878|NCT02231892|National Institute on Drug Abuse|Dr. Elliott Stein|443-740-2650|estein@mail.nih.gov|
20159879|NCT03832322|Evergreen General Hospital, Taiwan|Dr. Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
20159880|NCT00799227|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20159881|NCT01191736|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
20159882|NCT02186652|Duke Clinical Research Institute|Chad Livingston|919-668-1935|chad.livingston@duke.edu|
20159883|NCT01179217|Emmaus Medical, Inc|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
20159884|NCT02247011|Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital,Chinese Academy of Medical Science|Dr. Weibo Xia|86-10-6915-5076|xiaweibo@medmail.com.cn|
20159885|NCT04674111|Boston Scientific Corporation|Amy Maurer, Director of Clinical Trials|800-876-9960|amy.maurer@bsci.com|
20159886|NCT00642434|University of New Mexico Health Sciences Center|Dr. Kathleen Colleran|505-272-4658|KColleran@salud.unm.edu|
20159887|NCT01335724|Novartis Consumer Health|Clinical project Leader|+41223635528||
20159888|NCT04470908|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20159889|NCT01974206|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20159890|NCT00053677|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
20159891|NCT03989349|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20159892|NCT02488135|University of Alberta|Scott Murray|587-891-6240|sipmurray@gmail.com|
20159893|NCT01802580|Wake Forest University Health Sciences|Dr. Steve Feldman, Professor of Dermatology, Public Health Scienes, and Pathology|336-716-7740|sfeldman@wakehealth.edu|
20159894|NCT03255967|NYU Langone Health|Abraham Brody|2129927341|Abraham.Brody@nyulangone.org|
20159895|NCT02620878|Università di Padova-Italy|Dr. Daniela Bruttomesso|00390498212183|daniela.bruttomesso@unipd.it|
20159896|NCT00778258|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20159897|NCT04621240|Center for BrainHealth at the University of Texas at Dallas|Erin Venza|972-883-3208|erin.venza@utdallas.edu|
20159898|NCT02406573|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20159899|NCT04448392|UAB|Dr. Nicole Samies|570-271-6440|nsamies2@geisinger.edu|
20159900|NCT00772915|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20159901|NCT01098253|University of Pennsylvania, Perelman School of Medicine|Dr. Hillary R Bogner|215-746-4181|hillary.bogner@uphs.upenn.edu|
20189460|NCT00489554|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205050|NCT04460690|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
20205051|NCT04167306|Addiction BIology Unit - Clinical Trials, Inst Neuroecience and Physiology, Gotheburg University/ Dep of Addictions and Dependency, Sahlgrenska University Hostpital|Andrea de Bejczy|+46313424724|andrea.debejczy@neuro.gu.se|
20205052|NCT02856269|University Hospitals Cleveland Medical Center|Dr. Grace McComsey|216-8442739|Grace.McComsey@UHhospitals.org|
20205053|NCT00127062|Imperial College London|Professor Fan Chung|+44 (0)20 7594 7954|f.chung@imperial.ac.uk|
20205054|NCT03927508|Clinical Reserach Specialist|Pamela Dicamillo|719-400-7463|pdicamillo@ecr-inc.com|
20205055|NCT01253421|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
20205056|NCT00547378|Pelvic Health & Gastric Therapies|Shenita Bolstrom|763-526-8254|shenita.bolstrom@medtronic.com|
20205057|NCT01525927|North Shore LIJ Cancer Institute|Jeffrey Revello Sr. Administrative Manager|516 734 7629|jrevello@nshs.edu|
20205058|NCT04863014|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20205059|NCT00426517|National Institute of Allergy and Infectious Diseases|Kang, Elizabeth|+1 301 402 7567|ekang@niaid.nih.gov|
20205060|NCT02104804|AstraZeneca|Eva Johnsson, MD, PhD, Global Clinical Lead||Eva.Johnsson@astrazeneca.com|
20205061|NCT04501679|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20205062|NCT01032993|BIDMC|Catherine Buettner, MD MPH, Assistant Professor of Medicine|617-754-9600|cbuettne@bidmc.harvard.edu|
20205063|NCT03497026|Auris Health|Scott Rehage|925 6832590|srehage@its.jnj.com|
20205064|NCT04846348|Mayo Clinic|Dr. Joseph Butterfield|507-284-3783|butterfield.joseph@mayo.edu|
20205065|NCT02121756|University of Pittsburgh Department of Medicine|Sharon Riddler, MD|412-383-1675|riddler@pitt.edu|
20205066|NCT04511026|Stanford University|Amer Karam, MD|650-498-6004|amkaram@stanford.edu|
20205067|NCT05027516|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
20205068|NCT04191577|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
20219697|NCT04576923|Indiana University|Samer Gawrieh, MD|317-278-9326|sgawrieh@iu.edu|
20219698|NCT01635283|Jonsson Comprehensieve Cancer Center|Dr. Robert Prins|310-825-7647|rprins@mednet.ucla.edu|
20159902|NCT02867813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20159903|NCT02013206|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20189461|NCT00731692|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20189462|NCT06571695|Loyola University Medical Center|Dr. Dane H. Salazar|773-562-0456|dsalazar@lumc.edu|
20189463|NCT04921358|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20189464|NCT02637063|Oregon Center for Applied Science|Amelia J Birney (PI), Director of Research|541-342-7227|abirney@orcasinc.com|541
20189465|NCT01467934|Columbia University|Melissa Stockwell|212-342-5732|mss2112@columbia.edu|
20189466|NCT00745875|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20189467|NCT02310581|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20189468|NCT02824198|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
20189469|NCT01833455|University of Wisconsin|Stephen Wasmund, PhD|801-587-3740|stephen.wasmund@carma.utah.edu|
20189470|NCT03883828|Montefiore Medical Center|Dr. Beth McLellan|718.862.8840|bmclella@montefiore.org|
20189471|NCT01256359|University of Oxford|Professor Mark Middleton|+44 (0)1865 617331|mark.middleton@oncology.ox.ac.uk|
20189472|NCT00487240|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20189473|NCT01019135|University Health Network & York University|Dr. Sherry L Grace|416.736.2100|sgrace@yorku.ca|22364
20189474|NCT05197452|Research Manager|Dr. Yolanda Cartwright|224-420-0323|yolanda_cartwright@rush.edu|
20159904|NCT01952665|CooperVision|Donald Siegel, OD Principal Investigator|(949) 597-4700|dsiegel@coopervision.com|
20159905|NCT01537081|Reckitt Benckiser LLC|Gail Solomon,MS; Director Clinical Development|973-404-2752|gail.solomon@rb.com|
20159906|NCT01022359|Imperial College London|Neill Duncan|+44 (0 )207 594 7243|n.duncan@imperial.ac.uk|
20159907|NCT01463111|Emory University|Dr. Boadie Dunlop|404-727-8969|bdunlop@emory.edu|
20159908|NCT03817463|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159909|NCT04140695|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
20159910|NCT01559259|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159911|NCT01995669|University of Texas M D Anderson Cancer Center|Dr. Loretta Nastoupil|(713) 792-2860|lnastoupil@mdanderson.org|
20159912|NCT05425732|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20159913|NCT02150551|Children's National Hospital|Catherine Bollard, MD|202-476-4776|cbollard@childrensnational.org|
20159914|NCT04388319|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
20159915|NCT00539513|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
20159916|NCT01328041|ViiV Healthcare|GSK Response Center|866-435-7343||
20159917|NCT00711113|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
20159918|NCT00100230|Retina Foundation of the Southwest|Dennis Hoffman, Ph.D., Sr. Research Scientist|214-363-3911|dhoffman@retinafoundation.org|125
20159919|NCT02200328|Cleveland Clinic Florida|Dr.Alison Schneider|9546595646|schneia2@ccf.org|
20159920|NCT00519376|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159921|NCT02688088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20159922|NCT01245738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159923|NCT00366028|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
20159924|NCT01231321|Abbott|Global Medical Services|800-633-9110||
20159925|NCT04021524|University of Washington|Dr. Jason E. Hsu|(206) 543-3690|jehsu@uw.edu|
20159926|NCT06053541|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159927|NCT03544476|University of Washington|Sarah Iribarren|2065435211|sjiribar@uw.edu|
20159928|NCT00730041|Medtronic Xomed, Inc.|David Hodge|904-281-2774|david.l.hodge@medtronic.com|
20159929|NCT02301546|University of Utah|Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|
20159930|NCT01636063|Baystate Medical Center|David R Kattan|413-794-5256|davidrkattan@gmail.com|
20159931|NCT01801436|Janssen Pharmaceutical Taiwan|Medical Affairs Director|+886-2-23762155||
20159932|NCT01294306|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20159933|NCT02447250|OHSU|Cindy McEvoy, MD|5034940223|mcevoyc@ohsu.edu|
20159934|NCT03632993|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
20159935|NCT00920218|GlaxoSmithKline|GSK Response Center|866-435-7343||
20159936|NCT00873041|Novartis Pharmaceuticals|Study Director|862-778-8300||
20159937|NCT00313313|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20159938|NCT00201448|Virginia Commonwealth University|Stuart Adler|8048281807|sadler@vcu.edu|
20159939|NCT00368836|Carolinas Medical Center|Dr. Jeffrey Kline|704-355-3181|jkline@carolinas.org|
20159940|NCT02141867|South African Surgical Outcomes Study|Prof Bruce Biccard|+27312604328|biccardb@ukzn.ac.za|
20159941|NCT02899650|University of Texas at Austin|Koichiro Hayashi|512-471-8594|k-hayashi@kokugakuin.ac.jp|
20159942|NCT02084706|Brigham and Women's Hospital|Dr. Philip Blazar|617-732-5384|pblazar@partners.org|
20159943|NCT02613117|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20159944|NCT01345591|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
20189475|NCT04237792|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20159945|NCT00090142|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20159946|NCT02442310|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
20159947|NCT01126437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20159948|NCT01418703|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
20173646|NCT01291173|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20173647|NCT00390858|Novartis Pharmaceuticals|Study Director|862-778-8300||
20173648|NCT01230801|BioMarin Pharmaceutical Inc.|Manager, Clinical Operations|415-455-7448|Slava.Titov@bmrn.com|
20173649|NCT00450450|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20173650|NCT01930747|az sint jan brugge|jan mulier|0032486729203|jan.mulier@azsintjan.be|
20173651|NCT05167734|Mayo Clinic|Matthew Warner, M.D.|507-422-1714|Warner.Matthew@mayo.edu|
20173652|NCT01705652|The University of Texas Health Science Center at San Antonio Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1109|swansong@uthscsa.edu|
20173653|NCT01183897|Memorial Sloan Kettering Cancer Center|Brian Kushner MD|212-639-6793|kushnerb@mskcc.org|
20173654|NCT00309842|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
20173655|NCT03564145|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20173656|NCT02811445|Tufts University HNRCA|Michael Lustgarten|617-556-3399|Michael.Lustgarten@tufts.edu|
20173657|NCT02893878|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173658|NCT01386554|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20173659|NCT00353262|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20173660|NCT05286307|NYU Langone Health|Eric J Strauss, MD|646 501-7223|Eric.Strauss@nyulangone.org|
20173661|NCT02759471|CooperVision|Senior Manager Global Medical Scientific Affairs|1-925-621-3761|javega@coopervision.com|
20173662|NCT02554812|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173663|NCT01103284|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
20173664|NCT00696696|NYU Cancer Institute|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
20173665|NCT02642614|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173666|NCT00936910|Children's Hospital of Pittburgh|Dr. William McGhee, Clinical Pharmacy Specialist, Transplant|412-692-5733|william.mcghee@chp.edu|
20173667|NCT01485640|Sunovion|Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20173668|NCT05359666|Irrimax Corporation|Director of Clinical Trials|770-807-3355|cs@irrisept.com|
20173669|NCT02057198|Duke University Medical Center|Daniel Sexton, M.D.|919-684-4596|sexto002@mc.duke.edu|
20173670|NCT02355691|UNC Orthopaedics|Scott Eskildsen, MD|(919) 966-9166|seskilds@unch.unc.edu|
20173671|NCT03540147|University of Texas at Austin|Hirofumi Tanaka|5122324801|htanaka@austin.utexas.edu|
20173672|NCT03232281|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20173673|NCT01403246|GIMEMA|Alfonso Piciocchi|+393203671224|a.piciocchi@gimema.it|
20173674|NCT02345811|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20173675|NCT03633487|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20173676|NCT02489344|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20173677|NCT00605813|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173678|NCT00183092|UCaliforniaSF|Michael Geschwind, MD, PhD|415-476-2901|mgeschwind@memory.ucsf.edu|
20173679|NCT00573755|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
20173680|NCT00870363|University of California Davis Medical Center|David M Asmuth|(916) 734-8695|dasmuth@ucdavis.edu|
20173681|NCT00594997|Brigham and Women's Hospital|Nancy Shadick|617-732-5266|nshadick@partners.org|
20173682|NCT01290640|The University of Tennessee|Dr. Richard Komistek, Professor|865-974-4159|rkomiste@utk.edu|
20173683|NCT04155632|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
20173684|NCT00546637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20205069|NCT01185249|Central DuPage Hospital|Dr. Alice Siehoff, Nurse Scientist|1-630-858-0260|asiehoffrn@msn.com|
20205070|NCT02365584|Ipsen SpA|Medical Director|see email|clinical.trials@ipsen.com|
20205071|NCT01973452|Memorial Sloan Kettering Cancer Center|Dr. Alessia Pedoto, MD|212-639-6840|pedotoa@mskcc.org|
20205072|NCT02193815|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205073|NCT04363437|Maimonides Medical Center|Dr. Felix Yang|7182836000|fyang@maimonidesmed.org|
20205074|NCT00406783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20205075|NCT05294211|Marani Health, Inc.|Vice President, Clinical Affairs|612-718-9699|mindy@maranihealth.com|
20205076|NCT03707158|Boston University|Donna Pincus|(617) 353-9610|dpincus@bu.edu|
20159949|NCT01220973|Rutgers Cancer Institute of New Jersey|Susan Goodin PharmD, FCCP, BCOP|732-235-6783|goodin@cinj.rutgers.edu|
20159950|NCT00006046|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20159951|NCT00596154|Memorial Sloan Kettering Cancer Center|Dr. Christian Grommes, MD|212-610-0344|grommesc@mskcc.org|
20159952|NCT01846663|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
20159953|NCT03691844|Amzell B.V.|Clinical Trial Manager|+41614864000|amzell-disclosure@amzell.com|
20159954|NCT00986401|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20159955|NCT02512874|Mayo Clinic|Dr. Cassie C. Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
20159956|NCT03570918|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@Macrogenics.com|
20159957|NCT02970006|The Ohio State University- Neurological Institute|Vibhor Krishna, MD|6142939274|Vibhor.Krishna@osumc.edu|
20173685|NCT03227029|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20189476|NCT04885998|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20173686|NCT02402309|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20173687|NCT02024867|University at Buffalo|Dr. Lucy Holmes|716-878-7277|LHolmes@upa.chob.edu|
20219699|NCT04314648|RAND|Dr. Allison Ober|3103930411|ober@rand.org|6639
20159958|NCT03888235|University of British Columbia Department of Family Practice|Dr. Helene Bertrand|7782277776|dr.hbertrand@gmail.com|
20159959|NCT01535599|Alcon Research, Ltd.|Sally Scheib, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20159960|NCT03397394|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20159961|NCT03848208|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20159962|NCT02928029|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20159963|NCT01849575|Umea University, Sweden|Dr Margareta Norberg|+46907865544|margareta.norberg@umu.se|
20159964|NCT05427539|Johnson & Johnson Vision Care, Inc. (JJVC)|Ben Straker|1-800-843-2020|bstraker@its.jnj.com|
20159965|NCT00410826|University of Washington|Renato G. Martins, MD, MPH|2062882048|rgmart@uw.edu|
20159966|NCT01907321|University of Florida|Dr. Karen Hegland, PI|352 294-8366|kwheeler@ufl.edu|
20205077|NCT01594294|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
20173688|NCT02865187|Wright State University|Steven R Lindheim|858-740-1083|doclalalindheim@gmail.com|
20205078|NCT01274338|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20205079|NCT01927744|M.D. Anderson Cancer Center|Xiuning Le, MD|713-792-6363|xle1@mdanderson.org|
20205080|NCT03906227|University of North Carolina at Chapel Hill|Anne Froment|919-445-2622|anne_froment@med.unc.edu|
20173689|NCT04267133|University of Rochester|Jean-Philippe Couderc, PhD|585-275-1096|heartjpc@heart.rochester.edu|
20173690|NCT01110707|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20205081|NCT02198651|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20173691|NCT02268864|Janssen Research and Developement, Belgium|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
20173692|NCT02049307|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
20205082|NCT01146951|Eisai Call Center|Eisai Inc.|888-422-4743||
20173693|NCT02612428|Vital Therapies, Inc.|Robert Ashley, Chief Technical Officer|001 858-673-6840|rashley@vitaltherapies.com|
20173694|NCT01510379|The Ohio State University|Kyle A. Perry, MD|614-293-5815|kyle.perry@osumc.edu|
20173695|NCT02064166|Brigham & Women's Hospital|Peter Novak, MD PhD|617-732-8896|pnovak2@bwh.harvard.edu|
20205083|NCT01586026|Bard Access Systems, Inc.|Christopher DiMatteo|801-522-5000|chris.dimatteo@crbard.com|
20173696|NCT00598663|University Children's Hospital Vrazov trg 1 SI-1525 Ljubljana, Slovenia|Tadej Battelino|+386 1 522 50 50|tadej.battelino@mf.uni-lj.si|
20159967|NCT00405509|Allegheny General Hospital|Deborah Gentile, MD|412-359-6654|dgentile@wpahs.org|
20173697|NCT01341964|Population Health Reseach Institute, Hamilton, ON, Canada|Lynda Hill|905-297-3479|Lynda.Hill@phri.ca|40323
20205084|NCT04092816|University of North Carolina at Chapel Hill|Zev Nakamura, MD|984-974-3829|zev_nakamura@med.unc.edu|
20173698|NCT00597766|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3529|rwilson@metrohealth.org|
20205085|NCT01747811|University of Arizona|William Killgore|520-621-0605|killgore@psychiatry.arizona.edu|
20205086|NCT03073213|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20205087|NCT04857593|King's College London|Professor Carmine Pariante|020 78480807|carmine.pariante@kcl.ac.uk|
20205088|NCT05458011|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20173699|NCT00676455|Lahey Clinic|Christopher Wald, MD|781-744-8710|Christopher.Wald@lahey.org|
20173700|NCT04339296|Health Systems Evaluation & Evidence - Alberta Health Services|Research and Evaluation Coordinator|4036489255|armghan.ahmad@albertahealthservices.ca|
20173701|NCT00310791|Children's Hospital Boston|Dr. Catherine Gordon|401-444-4712|cgordon1@lifespan.org|
20173702|NCT01166724|Cleveland Clinic|Dr. Stuart Flechner|216 445-5772|FLECHNS@ccf.org|
20159968|NCT01382303|Ajou University|Kwan Woo Lee|82-31-219-4526|LKW65@ajou.ac.kr|
20159969|NCT02649218|Novartis Pharmaceuticals|Study Lead|+1 (862) 778-8300|novartis.email@novartis.com|
20159970|NCT03354546|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20159971|NCT02244840|Seoul National University Hospital|Professor|82-2-2072-2901|kjparkmd@plaza.snu.ac.kr|
20159972|NCT02438683|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173703|NCT02375113|The University of Texas at San Antonio|Dr. Meizi He|2104585416|meizi.he@utsa.edu|
20173704|NCT03107754|University of Hawaii|Dr. Reni Soon|808-983-6000|rsoon@hawaii.edu|
20173705|NCT00877383|Novartis Pharmaceuticals|Study Director|862 778-8300||
20173706|NCT00459108|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20189477|NCT00910962|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205089|NCT02690207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219700|NCT01305044|Huntsman Cancer Institute|Anita Kinney, PhD, RN|801-585-1151|anita.kinney@hci.utah.edu|
20219701|NCT01392625|ISCI / University of Miami Miller School of Medicine|Joshua M. Hare, MD|305-243-5579|JHare@med.miami.edu|
20219702|NCT00492024|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20219703|NCT03416829|Massachusetts General Hospital|Jarrad H Van Stan|617-643-8410|jvanstan@mghihp.edu|
20157529|NCT00713193|Ohio State University|Spero R Cataland|6142939441|spero.cataland@osumc.edu|
20157530|NCT01143636|Spaulding Rehabilitation Hospital, Boston, MA.|Dr. Felipe Fregni, Director of the Laboratory of Neuromodulation|617.952.6153|info@neuromodulationlab.org|
20157531|NCT01978145|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157532|NCT00322049|U.S. Army Medical Component Armed Forces Research Institute of Medical Services|Wipa Chawachalasai|662-696-2700|wipac@afrims.org|4351
20157533|NCT01250054|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
20157534|NCT01312519|Vidacare Corporation|Senior Director of Science and Clinical|210-375-8500|thomas.philbeck@vidacare.com|
20157535|NCT03372161|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|(650) 386-6709|cambrose@scilexpharma.com|
20159973|NCT04696276|Saint Savvas Hospital of Athens|Maria Bourazani|+302106409000|mbourazani@yahoo.com|
20159974|NCT01585779|Medtronic Coronary and Structural Heart|Shari Benoit|(763) 514-4000|shari.g.benoit@medtronic.com|9749
20159975|NCT01846299|Novartis|Study Director|862-778-8300||
20159976|NCT00082368|National Cancer Institute|Dr. Peter Choyke|301-402-8409|peter_choyke@nih.gov|
20159977|NCT01330628|Spectranetics|Amanda Johnson, VP of Regulatory & Medical Affairs|(719) 447-2000|amanda.johnson@spnc.com|
20159978|NCT00569309|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|Craig.Hofmeister@osumc.edu|
20159979|NCT01740089|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20159980|NCT03703310|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
20159981|NCT01448824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20159982|NCT01760473|New York State Psychiatric Institute|Dr. Sandra Comer|646 774-6146|sdc10@columbia.edu|
20159983|NCT03285958|University of Michigan|Dr. Mary Janevic|734 647 3194|mjanevic@umich.edu|
20159984|NCT03116828|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20159985|NCT03002818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20159986|NCT00966849|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
20159987|NCT00780481|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
20159988|NCT01606787|Memorial Sloan Kettering Cancer Center|Dr. Jonathan Coleman, MD|646-422-4432|colemanj@mskcc.org|
20159989|NCT03015649|Envision Healthcare Scientific Intelligence, Inc.|Women's Imaging Director|9549397729|clinicaltrials@shcr.com|
20159990|NCT05312632|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-10-7409-5623|s-kwon@eisaikorea.com|
20159991|NCT00489736|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20159992|NCT03883165|University of Michigan Medical School|James T Eckner, MD, MS|734-647-5568|jeckner@med.umich.edu|
20159993|NCT00245050|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Vivian von Gruenigen, MD|216-844-5011|vev1@case.edu|
20159994|NCT05526781|Eye Consultants of Atlanta|Dr Joseph Christenbury|14043512220|jchristenbury@eyeconsultants.net|
20159995|NCT02743949|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20159996|NCT01498575|The Children's Hospital of Philadelphia|Dennis Durbin, MD, MSCE|215-590-7331|DURBIND@EMAIL.CHOP.EDU|
20159997|NCT00396006|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20159998|NCT02163967|Weill Cornell Medical College|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
20159999|NCT01215110|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
20160000|NCT03582553|Pennington Biomedical Research Center|Dr. Candida Rebello|225-763-3159|Candida.Rebello@pbrc.edu|
20160001|NCT01425359|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20160002|NCT03172325|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|anjidani.n@orchidpharmed.com|
20160003|NCT03520348|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20160004|NCT01558362|University of Ottawa Heart Institute|Dr. Terrence Ruddy, Principal Investigator|613-696-7267|truddy@ottawaheart.ca|
20160005|NCT03826173|Brown University School of Public Health|David M Williams|4018636248|david_m_williams@brown.edu|
20160006|NCT00380029|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20160007|NCT03639623|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20160008|NCT01229254|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20160009|NCT01694121|Center on Gender Equity and Health at UCSD|Dr. Anita Raj|8588220229|anitaraj@ucsd.edu|
20160010|NCT00932438|University of Louisville|Robert Martin, Md, PhD|602-629-3355|robert.martin@louisville.edu|
20160011|NCT00744978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160012|NCT00503776|Vanderbilt-Ingram Cancer Center|Barbara Murphy, MD|615-343-9444|barbara.murphy@vanderbilt.edu|
20160013|NCT00178919|Vanderbilt University|Italo Biaggioni|615-343-6499|italo.biaggioni@vanderbilt.edu|
20160014|NCT03359785|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20160015|NCT00223977|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
20160016|NCT01895543|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20160017|NCT00735826|Dartmouth-Hitchcock Medical Center|Konstnatin Dragnev, MD Professor of Medicine|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
20160018|NCT03539211|ChristianaCare|Brian Catania|302-838-4700|bcatania@christianacare.org|
20160019|NCT01024972|University of Massachusetts Medical School|Dr. Susanne Muehlschlegel|508-421-5500|susanne.muehlschlegel@umassmemorial.org|
20160020|NCT04077996|Instituto Mexicano del Seguro Social|Dr. Jesus Venegas-Ramírez|3143058373|nefrojesusvr@gmail.com, jesus.venegas@imss.gob.mx|
20160021|NCT03276026|Jefferson|Dr. Adam Thaler|215-901-0749|thaler.adam@gmail.com|
20160022|NCT01083979|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
20205090|NCT01353144|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20205091|NCT03224585|VCU Health|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
20205092|NCT01175213|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20205093|NCT01921634|The Pennsylvania State University, Hershey Medical Center|Andrea Benton, MD|717-531-5394|abenton@pennstatehealth.psu.edu|
20205094|NCT02064205|TNO|W.J. Pasman, PhD|+31888665129|wilrike.pasman@tno.nl|
20205095|NCT03057951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205096|NCT05136170|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20173707|NCT01857232|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-875149|GabrielFox@acaciapharma.com|149
20219704|NCT02351271|Ziemer Ophthalmic Systems AG|Sarah Moyle|970 308 9199|sarah.moyle@ziemergroup.com|
20219705|NCT02201212|Dana Farber Cancer Institute|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
20219706|NCT01839318|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20173708|NCT02062879|UC Health University of Cincinnati Medical Center|Sheila Takieddine|513-585-6195|Sheila.Takieddine@UCHealth.com|
20173709|NCT00056407|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173710|NCT00616655|Sunovion|Eszopiclone Medical Director|866-503-7813|clinicaltrialdisclosure@sunovion.com|
20173711|NCT03761147|Hebrew Univeristy|Anna Shaphir|+972 50 716 7309|shaphira@hadassah.org.il|
20173712|NCT01026792|BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada|Dr. Anna Tinker|604 877 6217|atinker@bccancer.bc.ca|
20173713|NCT01364207|Massachusetts Eye and Ear Infirmary|Dr. Louis R. Pasquale|617-573-4240|aliya_jiwani@meei.harvard.edu|4240
20173714|NCT02626520|Essentia Health|Dr. Bret Friday|218-786-3625|bret.friday@essentiahealth.org|
20173715|NCT00492115|UCSD|Dr. Sonia Ancoli-Israel|858 822 7710|sancoliisrael@ucsd.edu|
20173716|NCT03143569|WASHINGTON UNIVERSITY|Thomas J Graetz|3147474155|graetzt@wustl.edu|
20173717|NCT02045797|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173718|NCT06029673|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
20173719|NCT03730948|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20173720|NCT01786629|Braintree Laboratories, Inc.|John McGowan, Director Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
20173721|NCT00410761|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20173722|NCT02350881|Casa di Cura VIlla Berica|Dr Stefano Fieschi||stefanofieschi@gmail.com|
20173723|NCT02369341|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173724|NCT00674661|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
20173725|NCT00003901|Memorial Sloan Kettering Cancer Center|Valerie Rusch, MD|212-639-5873|ruschv@mskcc.org|
20173726|NCT02707991|Johns Hopkins University|Laura Starbird|9787587909|Lstarbi1@jhu.edu|
20173727|NCT00857220|Sunovion|CNS Medical Director|866-503-6357||
20173728|NCT03187262|Dana-Farber Cancer Institute|Dr. Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
20173729|NCT06273124|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
20173730|NCT01516424|Shang Hai Mental health center|Dr.HuafangLi|13641625395|lhlh_5@163.com|
20173731|NCT01166763|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
20173732|NCT01909479|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20173733|NCT01608659|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20173734|NCT00278655|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
20173735|NCT01092559|GeNO, LLC|Director of Clinical Development|321-785-2613|matthew.rush@genollc.com|
20173736|NCT00383149|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
20173737|NCT03721276|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
20173738|NCT01150981|University of Massachusetts Medical School|Samir Malkani, MD|5088563800|samir.malkani@umassmemorial.org|
20173739|NCT01340898|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173740|NCT02417701|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
20173741|NCT01214629|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20173742|NCT00734903|VA BOSTON|Lisa Najavits, PhD|617-299-1620|lisa.najavits@va.gov; najavits@bu.edu|
20173743|NCT01953120|UCLA|Dr. Suphamai Bunnapradist|3107948516|bunnapradist@mednet.ucla.edu|
20173744|NCT01347008|Federal University of Sao Paulo|Fernando Villela Andrigueti, MD|+55 11 55764239|fernando.andrigueti@usp.br|
20173745|NCT00416078|VAGLAHS at West Los Angeles|Dr. Theodore Hahn|3102684108|thahn@ucla.edu|
20173746|NCT02733588|Joslin Diabetes Center|Mary-Elizabeth Patti, MD|617-309-2665|mary.elizabeth.patti@joslin.harvard.edu|
20173747|NCT01829230|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
20173748|NCT00461682|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173749|NCT03305822|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20173750|NCT01551082|Alliance of Cardiac Vascular and Thoracic Surgeons|Jeremy Smith RN|4236245200|jsmith@actvsurgeons.com|
20173751|NCT03087760|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
20173752|NCT02573857|Medicines for Malaria Venture|Dr Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
20173753|NCT04128267|Vanderbilt-Ingram Cancer Center|Teresa Melton|(615) 936-7423|teresa.melton@vumc.org|
20173754|NCT04501666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20173755|NCT00553150|Mayo Clinic|Jann N. Sarkaria, M.D.|507/284-3559|sarkaria.jann@mayo.edu|
20173756|NCT03204305|Johns Hopkins School of Medicine|Dr. Elise M. Weerts, PhD, Professor|443-550-2781|eweerts@jhmi.edu|
20173757|NCT01165554|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
20173758|NCT03388294|University of North Carolina at Chapel Hill|Linda R. Watson, EdD|919-966-1007|lwatson@med.unc.edu|
20173759|NCT01710254|University of Utah, Dept. of Radiology Research|Edward DiBella, Ph.D.|801-585-5543|edward.dibella@hsc.utah.edu|
20173760|NCT00535223|Atlanta VA Medical Center|David J. Ready,Ph.D.|(404) 321-6111|David.Ready@va.gov|7082
20173761|NCT02953314|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20173762|NCT00735787|Abbott Laboratories|Global Medical Services|1-800-633-9110||
20173763|NCT03251508|UNC Food Allergy Initiative|Edwin Kim, MD, MS|919-537-3193|edwinkim@email.unc.edu|
20173764|NCT00101907|Amgen Inc.|Study Director|866-572-6436||
20173765|NCT01765153|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
20173766|NCT00319644|University of California, San Francisco|Julin Tang, MD|415-206-5274|tangj@anesthesia.ucsf.edu|
20173767|NCT03915496|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173768|NCT02663674|Duke Clinical Vaccine Unit|Emmanuel Walter, M.D., M.P.H.|919-620-5346|walte002@mc.duke.edu|
20205097|NCT03624478|Mayo Clinic|Dr. Carlos Vargas|480-342-1267|Vargas.Carlos@mayo.edu|
20205098|NCT03263117|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|peng.r.chen@uth.tmc.edu|
20205099|NCT02680587|Johns Hopkins University|Dr. Phuoc T. Tran|4106143880|ptran12@jhmi.edu|
20173769|NCT02472795|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
20173770|NCT04166513|Medical College of Wisconsin|Sara Pillay|414-955-4482|Sapillay@mcw.edu|
20173771|NCT04616547|Markey Cancer Center|Dr. Zin Myint|866-340-4488|zin.myint@uky.edu|
20173772|NCT03676218|Institut Bergonié, Bordeaux Comprehensive Cancer Center|Carine Bellera, PhD|+33 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
20173773|NCT04219891|Alcon Research, LLC|Clinical Projects Director, Surgical|8884513937|alcon.medinfo@alcon.com|
20173774|NCT00597012|The Brigham and Women's Hospital|Jeffrey N. Katz, MD, MSc|617-732-5338|jnkatz@bwh.harvard.edu|
20205100|NCT01010854|University of California, San Francisco|Pamela Munster, MD|877-827-3222|clinicaltrials@ucsf.edu|
20173775|NCT05636098|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20205101|NCT01194869|Emory University|Elisavet Paplomata, MD|404-778-1900|elisavet.paplomata@emory.edu|
20173776|NCT00670800|University of Michigan|Yolanda Smith|(734) 936-7401|ysmith@umich.edu|
20173777|NCT03694171|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20205102|NCT01708941|ECOG-ACRIN Statistical Office|Study Statistician|(617) 632-3012|eatrials@jimmy.harvard.edu|
20205103|NCT02226146|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20205104|NCT05464836|MD Anderson Cancer Center|Miriam Garcia, DO|(713) 745-4312|mbgarcia@mdanderson.org|
20173778|NCT03712904|Thomas Jefferson University|Wenyin Shi, MD, PhD|(215) 955-6702|wenyin.shi@jefferson.edu|
20173779|NCT01852942|University of Minnesota|Timothy Schacker, MD|612-626-6577|olso7966@umn.edu|
20173780|NCT04568590|Wake Forest University School of Medicine|Elizabeth Halvorson, MD, MS|336-716-4999|ehalvors@wakehealth.edu|
20173781|NCT02315755|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205105|NCT01522976|SWOG Statistical Center|Leukemia Committee Statistician|206-667-6597|amoseley@fredhutch.org|
20205106|NCT02883049|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20173782|NCT01829516|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
20173783|NCT04708886|Northwestern University Feinberg School of Medicine|Thomas Schnitzer|3125032315|tjs@northwestern.edu|
20173784|NCT00602576|University of Pennsylvania|Dr. Ravi Amaravadi|2157965159|ravi.amaravadi@pennmedicine.upenn.edu|
20173785|NCT00772772|The Rockefeller University|Dr. Mansih Ponda|212-327-7631|mponda@rockefeller.edu|
20205107|NCT01096849|Achaogen, Inc.|Clinical Trials Posting Group||clinical-trials@achaogen.com|
20173786|NCT01372501|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
20205108|NCT04146467|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
20173787|NCT05333900|University of Minnesota|Alexander Khoruts|612-624-2101|khoru001@umn.edu|
20173788|NCT00302042|Northwestern University|Dr. Ronald T. Ackermann|3126036400|r.ackermann@northwestern.edu|
20173789|NCT01277523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173790|NCT03724812|Abbott|Angelic Roach|+1 651 756 3379|angelic.roach@abbott.com|
20205109|NCT01269372|Givenimaging|Hilla Debby/ Director of Clinical Affairs|97299077740|hila.debby@medtronic.com|77740
20205110|NCT01189435|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
20173791|NCT01851720|Johns Hopkins School of Medicine|Alex Coon|410-955-2438|acoon2@jhmi.edu|
20205111|NCT00414960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20173793|NCT02389998|Boston Children's Hospital|Dr Samuel Nurko|6173556055|samuel.nurko@childrens.harvard.edu|
20173794|NCT03525574|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20205112|NCT01449682|Retina Macula Institute|Ron P. Gallemore, M.D., Ph. D.|310) 944-9393|rongallemoremd@gmail.com|
20173795|NCT00905554|Valduce Hospital - Como - Italy|Vittorio Terruzzi, MD|+39031324009|vterruzzi@valduce.it|
20173796|NCT01770379|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20205113|NCT00264849|Novartis Pharmaceuticals|Study Director|862-778-8300||
20205114|NCT05291949|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
20173797|NCT02929823|PPD|Joseph Pollard|+1 910 558 4428|joseph.pollard@ppdi.com|
20173798|NCT05855005|Northwestern University|Kendra Marks|2069991423|kendra.marks@northwestern.edu|
20205115|NCT00099359|Westat|Margaret Camarca, Project Director|301-517-4128|margaretcamarca@westat.com|
20173799|NCT06119529|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20173800|NCT01074450|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20205116|NCT00717366|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20173801|NCT02728895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20173802|NCT02769247|Walter Reed National Military Medical Center|Dr. Shana Miles|318 456 6389|shana.m.miles2.mil@mail.mil|
20173803|NCT00587483|Mayo Clinic|Dr. William Mauermann|507-255-4240|mauermann.william@mayo.edu|
20173804|NCT02150954|Duke University Medical Center|Chad Grotegut , MD||chad.grotegut@dm.duke.edu|
20173805|NCT02621242|University of Washington|Dr. Joanne Stekler|206-744-8312|jstekler@uw.edu|
20173806|NCT00159250|Imperial College London|Francesco Muntoni|+44 02075941872|f.muntoni@ucl.ac.uk|
20205117|NCT00838916|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205118|NCT01927419|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20173807|NCT04344314|Becton, Dickinson and Company|Christopher Rini, Associate Director Translational and Clinical Sciences Center of Excellence|+1 984 389 1186|christopher.rini@bd.com|
20173808|NCT04473937|Massachusetts General Hospital|Chirayu Patel, MD|617-724-9627|CPATEL@MGH.HARVARD.EDU|
20173809|NCT00385996|Weill Cornell Medical College|Nasser Altorki, MD|212-746-5156|nkaltork@med.cornell.edu|
20173810|NCT01086540|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20173811|NCT03164928|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20173812|NCT01998737|Bone Index Finland Ltd.|CTO|+358 45 896 2650|janne.karjalainen@boneindex.fi|
20173813|NCT04631029|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20205119|NCT03488251|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
20173814|NCT00326950|Eisai Call Center|Eisai Inc.|888-422-4743||
20205120|NCT03019744|Fondazione Don Carlo Gnocchi|Dr Maurizio Ferrarin|+390240308305|mferrarin@dongnocchi.it|
20173815|NCT00519818|Diurnal Ltd|Richard JM Ross|0044 114 2712386|r.j.ross@sheffield.ac.uk|
20173816|NCT01053819|University of Alabama at Birmingham|Boni Elewski, MD|205-502-9960|beelewski@gmail.com|
20173817|NCT03777007|Stanford University|Derek F. Amanatullah|(650) 723-2257|dfa@stanford.edu|
20205121|NCT00115765|Amgen Inc.|Study Director|866-572-6436||
20205122|NCT00995670|Zablocki VA Medical Center|Thomas J. Ebert, MD, PhD|414-384-2000|thomas.ebert@va.gov|42429
20173818|NCT02972554|University of North Carolina at Chapel Hill|Dr. Keely A. Muscatell|919-843-9113|kmuscatell@unc.edu|
20173819|NCT00614315|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
20173820|NCT00527943|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205123|NCT00675103|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
20173821|NCT05407675|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20173822|NCT00742001|Terumo BCT|Marty Huntington / Sr Mgr Global Clinical Affairs|+1 (303) 231-4849|Marty.Huntington@terumobct.com|
20173823|NCT00137423|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20173824|NCT00535990|UCSD|Dr. Jonathan Li|6618603471|jzl023@health.ucsd.edu|
20205124|NCT01568424|St. Jude Medical|Poornima Sood|+1.781.852.8334|psood@sjm.com|
20173825|NCT04105998|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
20173826|NCT01050257|Hoffman-LaRoche|Medical Communications|800-821-8590||
20173827|NCT00171223|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20173828|NCT00584558|University of Oklahoma Health Sciences Center|Karen Beckman, MD|405-271-9696|karen-beckman@ouhsc.edu|37536
20173829|NCT02604212|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20173830|NCT00278109|Indiana University School of Medicine|Richard Zellars MD|3179444505|rzellars@iu.edu|
20205125|NCT02006264|Albert Einstein College of Medicine|Marla Keller, MD, Principal Investigator|718-430-3240|marla.keller@einstein.yu.edu|
20173831|NCT02580357|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
20173832|NCT00641862|Harvard T.H. Chan School of Public Health|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
20173833|NCT01270711|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205126|NCT02164513|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173834|NCT00453544|UC San Diego|Dr. Barton Palmer|858-246-0765|bpalmer@ucsd.edu|
20173835|NCT02315170|Raj K M|Raj K Maturi MD|3178171414|maturi.md@midwesteye.com|
20173836|NCT00450333|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20173837|NCT01689701|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
20173838|NCT01277354|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20205127|NCT00810719|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20205128|NCT02773238|University of Washington|Dr. Jing Zeng|206-598-4110|jzeng13@uw.edu|
20173839|NCT00202644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20205129|NCT04095286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173840|NCT02750592|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
20173841|NCT00861146|Yale University School of Medicine|Ned L. Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
20205130|NCT00479557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205131|NCT02509494|Janssen Vaccines & Prevention B.V.|Senior Director Clinical Franchise Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20173842|NCT02981342|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20205132|NCT01511107|Children's Hospital of Pittsburgh of UPMC|Dr. Alejandro Hoberman|412-692-5249|hobermana@upmc.edu|
20173843|NCT01132482|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|Taylor-CousarJ@NJHealth.org|
20173844|NCT01394523|Nationwide Children's Hospital|Tarun Bhalla, MD|6147224200|Tarun.Bhalla@nationwidechildrens.org|
20205133|NCT04752189|Wayne State University|Dr. Andria Eisman, Principal Investigator|313-649-7477|aeisman@wayne.edu|
20173845|NCT00469092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20173846|NCT03642210|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
20173847|NCT01463644|McMaster University|Dr. Parameswaran Nair|905-522-1155|parames@mcmaster.ca|34934
20173848|NCT03756688|Mayo Clinic|Dr. Landon Trost|507-202-1995|landontrost@gmail.com|
20173849|NCT05811234|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
20173850|NCT04499781|NYU Langone Health|Ann-Margaret Navarra, PhD, CPNP-PC|631-638-0859|amd363@nyu.edu|
20173851|NCT01275833|Boston Scientific|Elke Sommerijns|+32479767156|elke.sommerijns@bsci.com|
20160023|NCT03650803|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Holly Marshall|216-844-5330|Holly.Marshall@uhhospitals.org|
20160024|NCT01534260|IndianaU|Dr. Hamid Sayar|(317) 948-7576|ssayar@iu.edu|
20160025|NCT02359045|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20160026|NCT03655301|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20160027|NCT00835198|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20160028|NCT01639339|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160029|NCT00367744|Case Western Reserve University|Dr. Grace McComsey|216 844 3607|mccomsey.grace@clevelandactu.org|
20160030|NCT00793572|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fhcrc.org|
20160031|NCT00895752|Cincinnati Childrens Hospital|Craig Erickson MD|5136366265|craig.erickson@cchmc.org|
20160032|NCT03858335|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
20160033|NCT02063867|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
20160034|NCT00503581|NRG Oncology|Linda Gedeon for James Kauderer|716-845-1169|linda.gedeon@roswellpark.org|
20160035|NCT04376684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160036|NCT01666119|BDSI|Enoch Bortey|919 582 9050|ebortey@bdsi.com|
20160037|NCT05747209|Allegheny General Hospital|Colin Champ, MD|412-734-7605|colin.champ@ahn.org|
20160038|NCT02713997|University of Minnesota|Melena Bellin|612-625-4686|bell0130@umn.edu|
20160039|NCT05487040|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160040|NCT01301066|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@kowaus.com|
20160041|NCT03269968|MedStar Health Reseach Institute|Rachael Overcash|202-877-6093|rachael.overcash@medstar.net|
20160042|NCT04570605|University of Utah School of Medicine|Glen Lau, MD|801-213-2700|Glen.Lau@hsc.utah.edu|
20160043|NCT00868140|Virginia Commonwealth University|Dr. John Nestler|(804) 828-3389|john.nestler@vcuhealth.org|
20160044|NCT02950155|Karolinska Institutet|Prof. Fredrik Piehl|+46 736718101|fredrik.piehl@ki.se|
20160045|NCT03569748|University of Catania|Maria Signorelli|095.378.2636/794|maria.signorelli@unict.it|
20160046|NCT02979093|University of Iowa|Lane Strathearn|3193849464|lane-strathearn@uiowa.edu|
20160047|NCT06107803|Minerva Neurosciences|Joseph Reilly|617-600-7373|JReilly@minervaneurosciences.com|
20160048|NCT05596734|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
20160049|NCT02333396|ChildrensMemorialH|Karen Rychlik, MS|(773) 755-6310|krychlik@luriechildrens.org|
20160050|NCT03219034|Texas A&M University College of Dentistry|Dr. Emet Schneiderman|2148288377|eschneiderman@tamu.edu|
20160051|NCT05470842|UNiversity of East Anglia|Dr Katharina Mattishent|01603286286|k.mattishent@uea.ac.uk|
20160052|NCT01926041|National Taiwan University Hospital & College of Medicine|Dr. Chien-Hsieh Chiang|+88623123456|jiansie@gmail.com|66699
20160053|NCT02136680|University of Maryland Baltimore, School of Medicine|Dr. Carla Alexander|410-328-7129|calexand@medicine.umaryland.edu|
20160054|NCT03559517|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20160055|NCT01311115|University of California, San Francisco|Justin White|415-476-8045|Justin.White@ucsf.edu|
20160056|NCT02320812|jCyte, Inc|Terry O'Neal, Chief Operating Officer|949-243-0688|terry.oneal@jcyte.com|
20160057|NCT02825420|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20160058|NCT04910074|Albert Einstein College of Medicine|Timothy P. Levine, DMD|718-918-5635|timothy.levine@nychhc.org|
20160059|NCT00932620|University of Ioannina|Prof Moses Elisaf|+302651007509|egepi@cc.uoi.gr|
20160060|NCT05243745|HALEON|Haleon Response Center|+441932 95 95 00|ww.clinical-trial-register@haleon.com|
20160061|NCT02998203|Cyprus University of Technology|Dr. Konstantinos C. Makris|00357-25-002398|konstantinos.makris@cut.ac.cy|
20160062|NCT05160168|Theseus Pharmaceuticals (a subsidiary of Concentra Biosciences)|Stew Kroll|(650) 576-9679|skroll@concentrabiosciences.com|
20160063|NCT04187144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160064|NCT02264665|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160065|NCT00789581|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
20160066|NCT01468207|AbbVie|Global Medical Information|1-800-633-9110||
20160067|NCT04385238|Harvard T.H. Chan School of Public Health|Sonia Hernandez-Diaz|6174323942|shernan@hsph.harvard.edu|
20205134|NCT00975195|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205135|NCT03052842|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
20205136|NCT03422133|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20205137|NCT03003403|Duke University|Gary G. Bennett, PhD|919-808-7821|gary.bennett@duke.edu|
20205138|NCT05084053|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20205139|NCT02180724|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20205140|NCT05195359|Resmed Germany Inc|Susanne Fischer / Sr. Manager Clinical Research|+491707854257|susanne.fischer@resmed.de|
20205141|NCT00847938|Clinique Jules Verne|Dr Florent CAPRON|0251171775|florent.capron@mla.fr|33
20205142|NCT05076370|Yale University, Department of Psychiatry|Joao De Aquino, M.D.|203-932-5711|joao.deaquinolima@yale.edu|12916
20205143|NCT02700919|Mereo BioPharma Group|Ian Hodgson, Head of Clinical Operations|+44 3330237300|enquiries@mereobiopharma.com|
20205144|NCT06170866|University of Connecticut|Dr. Cristina Colon-Semenza, Assistant Professor|8604860019|cristina.colon-semenza@uconn.edu|
20205145|NCT03569449|Boston Medical Center, Boston University School of Public Health|Emily Feinberg, ScD, CPNP|617-414-1425|emfeinbe@bu.edu|
20160068|NCT01332188|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20160069|NCT04225676|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20160070|NCT00866034|UMC Utrecht|Ouijdane Hamdine, MD|+31-88-7557524|O.Hamdine@umcutrecht.nl|
20160071|NCT01783574|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|KKMILLER@MGH.HARVARD.EDU|
20160072|NCT03333317|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20160073|NCT03812185|Henry Ford Health System|Yoshihisa Morita|3059784358|moritayoshihisa2016@gmail.com|
20160074|NCT01681069|Analyze & Realize GmBH|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
20160075|NCT04085458|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20160076|NCT01921218|Emory University|Idelberto R. Badell, MD|404-712-6562|ibadell@emory.edu|
20160077|NCT03389555|Beth Israel Deaconness Medical Center Emergency Department|Michae Donnino|(617) 754-2882|mdonnino@bidmc.harvard.edu|
20160078|NCT01885208|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20160079|NCT02130687|Yale University|Nancy J. Brown, M.D.|16153644022|nancy.j.brown@yale.edu|
20160080|NCT03224507|University of Alabama at Birmingham|Luciano J Costa- Principal Investigator|2059349695|ljcosta@uabmc.edu|
20160081|NCT01032291|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20160082|NCT02449889|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20160083|NCT01973387|Janssen Research & Development, LLC|Vice President (VP)||ClinicalTrialDisclosure@its.jnj.com|
20160084|NCT03327220|Pacira CryoTech, Inc.|Kent Jones/ Sr. Director, Quality and Medical Affairs|510-933-1513|kent.jones@pacira.com|
20160085|NCT00693017|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
20160086|NCT00615589|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
20160087|NCT00688324|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@som.umaryland.edu|
20160088|NCT03989427|Melaka-Manipal Medical College|Dr. Rajesh Hosadurga|+6062896662|rajesh.hosadurga@manipal.edu.my|3823
20160089|NCT03176472|Regenacy Pharmaceuticals Inc.|Dr. David Michelson, CMO|2676639826|dmichelson@regenacy.com|
20160090|NCT01972308|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
20160091|NCT03272828|University of Washington|Dr. Mats Kronstrom|425-877-7345|mk33@uw.edu|
20160092|NCT00847665|University Hospital Virgen de las Nieves|Dr. Francisco Manzano|34958020125|fmanzano@mailpersonal.com|
20160093|NCT01562314|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20160094|NCT00585546|University of Michigan|Francis Pagani|734 647-2894|fpagani@med.umich.edu|
20160095|NCT02851797|Italfarmaco SpA|Dr Paolo Bettica, MD and PhD|+3902 66041503|p.bettica@italfarmacogroup.com|
20160096|NCT03077438|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20160097|NCT00813865|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
20160098|NCT02330653|Boston Children's Hospital|Dr. Stacy A. Kahn|617-355-6058|stacy.kahn@childrens.harvard.edu|
20160099|NCT00624585|H. Lee Moffitt Cancer Center and Research Institute|Alan F. List, Executive Vice President & President, Moffitt Medical Group|813-745-6086|alan.list@moffitt.org|
20160100|NCT02256384|Cincinnati Children's Hospital Medical Center|Mario Patino|513-636-4200|mario.patino@cchmc.org|
20160101|NCT01404559|University of South Florida|William S. Quillen|8139749863|wquillen@health.usf.edu|
20160102|NCT04295681|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20160103|NCT04154345|University of Antwerp|Prof. Filip Struyf|32652783|filip.struyf@uantwerpen.be|0032
20172677|NCT02343627|Taro Pharmaceuticals U.S.A. Inc|Senior Director, Clinical|+1 914-345-900|Natalie.Yantovskiy@Taro.com|
20172678|NCT01482884|AstraZeneca|Mark Berner Hansen|+46 31 776 4794|Mark.Berner.Hansen@astrazeneca.com|
20172679|NCT01684007|Alcon Research, Ltd.|Magda Michna, Expert Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20172680|NCT03031678|MED-EL Corporation|Allison Racey|1-888-633-3524|research.us@medel.com|
20172681|NCT00439244|Novartis Pharmaceuticals|Study Director|862-778-8300||
20172682|NCT00590005|Emory University Department of Pediatrics|Dr. Anne Fitzpatrick, Director, Emory Asthma Clinical Research Program|404-727-9112|anne.fitzpatrick@emory.edu|
20172683|NCT04557371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20172684|NCT01154764|Asan Medical Center|Hyeong-Seok Lim MD, Ph.D|+82 2 3010 4613|mdihs@amc.seoul.kr|
20172685|NCT01317030|Bausch & Lomb Incorporated|Robert Steffen, O.D., M.S.|585-338-6399|Robert.Steffen@bausch.com|
20219707|NCT04628793|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219708|NCT02309138|University of Pittsburgh|Director of Center for Research on Health Care Data Center|412-692-2023|dcenter@pitt.edu|
20219709|NCT00819637|Henry Ford Health System, Detroit, Michigan|Richard M Nowak MD|313 881 0023|rnowak1@hfhs.staff|
20219710|NCT03421730|Vectura Limited|Gary Burgess, MD|+44 (0)1249 667700|clinical.enquiries@vectura.com|
20219711|NCT00961402|University of Minnesota|Beth Lewis|612-625-0756|blewis@umn.edu|
20219712|NCT01338870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219713|NCT01955083|Chang Gung Memorial Hospital|Dr. Hsueh-Yu Li|886-3-3281200|hyli38@adm.cgmh.org.tw|3967
20219714|NCT02763826|Medical University or SC|Scott Hutchison, Manager of COBRE Research Operations|843-792-2712|hutchis@musc.edu|
20219715|NCT01559389|Loyola University Medical Center|Elizabeth Mueller, MD|708-216-2180|emuelle@lumc.edu|
20219716|NCT02871492|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
20219717|NCT04546724|Valn|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
20219718|NCT03583086|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
20219719|NCT04113785|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
20219720|NCT00396812|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20219721|NCT00435812|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
20219722|NCT01881984|University of Pittsburgh|Dr. Gerard Vockley|412-692-7746|gerard.vockley@chp.edu|
20219723|NCT03201445|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20219724|NCT02914210|Duke Clinical Research Institute|Janet Bettger, ScD|919-613-0379|janet.bettger@duke.edu|
20219725|NCT01346293|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20219726|NCT02687217|Lady Hardinge Medical College and associated Hospitals|Dr. Swati Sattavan|9891777424|swatisattavan@gmail.com|91
20219727|NCT01844505|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20219728|NCT00128830|Tibotec Pharmaceuticals|Trial Physician|+32-14-607-767||
20219729|NCT02730351|GlaxoSmithKline|GSK Response Center|866-435-7343|sarah.l.west@gsk.com|
20219730|NCT00311402|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219731|NCT00838435|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
20219732|NCT04058249|Stanford University|Protocol Director|650-800-6920|brainstimulationstudy@stanford.edu|
20219733|NCT02472223|Washington University School of Medicine|Mae Gordon|3143623716|gordon.mae@wustl.edu|
20219734|NCT01676415|NORTHWESTERN UNIVERSITY|BRUCE TAN|3126958182|CPRICE2@NM.ORG|
20219735|NCT02754856|University of Texas M D Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
20219736|NCT03735316|Mayo Clinic|James A. Nelson, M.B.B.S.|480-342-1800|Nelson.James1@mayo.edu|
20219737|NCT04874155|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
20219738|NCT00530218|City of Hope National Medical Center|Ricardo Spielberger, MD|626-359-8111|RSpielberger@coh.org|65298
20160104|NCT00210353|International Extranodal Lymphoma Study Group (IELSG)|Prof. Emanuele Zucca MD, Scientific and Medical Director|+41 91 811 9040|ielsg@eoc.ch|
20219739|NCT01798316|Northwell|Director of Clinical Research, Department of Anesthesiology|718-470-7630|odowling@northwell.edu|
20219740|NCT00678886|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219741|NCT03477903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20219742|NCT01147107|University of Hawaii at Manoa John A Burns School of Medicine|Dr. Cecilia Shikuma|8086921328|shikuma@hawaii.edu|
20219743|NCT03496610|Duke University|Hector F. Martinez-Wilson, MD, PhD|919-681-6437|hector.martinez-wilson@duke.edu|
20219744|NCT05330468|Abbott|Director, Clinical Programs Structural Interventions & Cardiac Surgery|(651)-202-8362|ryan.palmer@abbott.com|
20219745|NCT00369317|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
20219746|NCT02365558|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219747|NCT00589329|MetroHealth Medical CEnter|Larraine Presley|216-778-8927|lpresley@metrohealth.org|
20219748|NCT00420459|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
20160105|NCT03368053|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
20160106|NCT04686084|UCLA Oral & Maxillofacial Radiology|Sanjay M Mallya|3108251689|smallya@dentistry.ucla.edu|
20160107|NCT02576041|Allergology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena|Patrizia Pepe, MD|+39. 059 4225449||
20160108|NCT02494518|Cleveland Clinic|Dr. Susan Linder|(216) 445-9815|linders@ccf.org|
20160109|NCT00676520|Abbott Vascular|Ellen Travis|408-845-3000|Ellen.Travis@av.abbott.com|
20160110|NCT04463693|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
20160111|NCT00866047|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20160112|NCT03773133|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
20160113|NCT04659174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20160114|NCT03070223|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20160115|NCT04934800|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
20160116|NCT00516906|3M|J M Heilman|651-733-9897|jmheilman@mmm.com|
20160117|NCT04603495|MorphoSys AG|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
20160118|NCT02187887|RAND|Eric Pedersen|3103930411|ericp@rand.org|6078
20219749|NCT06281171|dfusion Inc.|Lane Edwards, MPH, Project Director|8314402192|Lane.edwards@dfusioninc.com|
20219750|NCT01158573|University of Michigan|Michael Coffey M.D.|734-936-6267|coffeym@umich.edu|
20173852|NCT00227305|AstraZeneca|Seroquel Medical Science Director, MD||AZTrial_Results_Posting@astrazeneca.com|
20173853|NCT02118012|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Christopher Koh, M.D.|(301) 443-9402|kohchris@mail.nih.gov|
20173854|NCT00870896|University of South Florida|Thomas Truncale|813 974 8952|ttruncal@health.usf.edu|
20173855|NCT01770483|SIMS|Prof. Faisal Masud|00923004260213|faisalmasud@hotmail.com|
20173856|NCT04519645|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20173857|NCT03706053|UVA Health|Dr. Alex Kadl|434-243-4851|AK5SC@uvahealth.org|
20173858|NCT03033511|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20160119|NCT05413512|Baylor University|Debroah Holland|(254) 710-1438|Deborah_L_Holland@baylor.edu|
20160120|NCT03645941|Mayo Clinic|Christi A. Patten, MD|507-266-2554|patten.Christi@mayo.edu|
20160121|NCT02684058|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20160122|NCT04319380|London School of Hygiene and Tropical Medicine|Professor Daniel Chandramohan|+447570410351|daniel.chandramohan@lshtm.ac.uk|
20160123|NCT04432064|Indiana University|Prof. Joshua Brown|812 855-9282|jwmbrown@iu.edu|
20160124|NCT05032690|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160125|NCT05151445|Ohio State University College of Nursing|Tara O'Brien|614-292-8045|obrien.782@osu.edu|
20160126|NCT00303446|National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)|Kenneth Fischbeck, M.D.|301-435-9318|kf@ninds.nih.gov|
20160127|NCT04258995|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160128|NCT04580277|Cedars Sinai Inflammatory Bowel Disease Center|Dr. Gil Y. Melmed|310-423-4100|gil.melmed@cshs.org|
20160129|NCT03614416|Bioserenity|Eléonore CAILLET|01 57 27 40 00.|eleonore.caillet@bioserenity.com|
20160130|NCT00450294|Department of Anesthesia|Dr. Amit Chopra|204-880-5370|amitchopra1@live.com|
20173859|NCT04232670|Oregon Health and Science University|Gregory Cote|503-494-4373|coteg@ohsu.edu|
20205146|NCT02263014|The University of Texas (UT) MD Anderson Cancer Center|Dr. Abenaa Brewster, Professor, Clinical Cancer Prevention|713-792-7734|abrewster@mdanderson.org|
20205147|NCT05279898|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-278-8000|bsubrama@bidmc.harvard.edu|
20205148|NCT04393038|Abivax|Study Director|+33 1 53 83 09 63|info@abivax.com|
20205149|NCT05168813|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20205150|NCT01583985|Minneapolis VA Health Care System|Erin Krebs, MD|612-725-2000|erin.krebs@va.gov|
20205151|NCT02275767|Univ of Texas Health Sci Ctr San Antonjio, Dept of Periodontics|Brian L. Mealey DDS, MS|210-567-3567|mealey@uthscsa.edu|
20205152|NCT00571688|University of Alabama at Birmingham|Tracy Manley|205-975-3442|tlmanley@uabmc.edu|
20205153|NCT01048853|The University of Texas MD Anderson Cancer Center|Kathleen Schmeler, MD|(713) 854-9150|kschmele@mdanderson.org|
20160131|NCT00230802|Brigham & Women's Hospital|Erik Alexander, MD|6177325666|ekalexander@partners.org|
20160132|NCT00983515|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
20160133|NCT01746511|University of Rochester|Carl D'Angio|585-273-4911|carol_dangio@urmc.rochester.edu|
20173860|NCT03742037|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
20173861|NCT04447755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20205154|NCT04999969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20205155|NCT03739853|University of Oxford, NDORMS|Laura Coates|+441865737838|laura.coates@ndorms.ox.ac.uk|
20205156|NCT04026178|Chiesi|Metreleptin Clinical Program Lead|+3905212791|clinicaltrials_info@chiesi.com|
20205157|NCT03779334|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20205158|NCT06533475|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20205159|NCT06964165|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20205160|NCT06245044|University of Michigan|Dr. Corey Lester|734-647-8849|lesterca@umich.edu|
20205161|NCT05848323|University of Washington|Lindsey Knowles|2067449640|lmknow@uw.edu|
20205162|NCT04735393|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20205163|NCT01621672|University of Arkansas for Medical Sciences|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
20205164|NCT01735617|Diurnal Ltd.|CEO|+44 (0) 871 716 8848|info@diurnal.co.uk|
20205165|NCT04570332|Highlight Therapeutics Ltd.|M. Quintero, CEO|+34686219355|mquintero@highlighttherapeutics.com|
20205166|NCT03224104|UniversitaetsSpital Zurich - Neurology Clinic|Dr Emilie Le Rhun|+41 762847518|emilie.lerhun@usz.ch|
20205167|NCT05600309|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20205168|NCT06087328|Medical University of South Carolina|Amanda M. Palmer, PhD|843-792-1413|palmeram@musc.edu|
20160134|NCT03842969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20160135|NCT00395291|University of Virginia|W. Kline Bolton, MD|434-924-9692|wkb5s@Virginia.edu|
20160136|NCT01962987|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20173862|NCT04600414|University of Washington|John Fortney, Professor|2066856955|fortneyj@uw.edu|
20173863|NCT00619801|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20189478|NCT00797212|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20189479|NCT01485887|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205169|NCT05822830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20205170|NCT05127044|University of Arkansas for Medical Sciences|Rebecca P Sartini, DNP|5015261580|rpsartini@uams.edu|
20205171|NCT05388656|University of North Carolina at Chapel Hill|Elizabeth Andersen, PhD|(970) 420-4944|elizabeth_andersen@med.unc.edu|
20173864|NCT02172742|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
20173865|NCT01471106|M D Anderson Cancer Center|Dr. Arun K. Banu|(713) 792-2817|barun@mdanderson.org|
20173866|NCT00233103|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
20173867|NCT03855280|Medexus Pharma|Julissa Leon|3125483125|julissa.leon@medexus.com|
20173868|NCT00969150|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20173869|NCT01879332|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20173870|NCT05020990|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
20205172|NCT03201965|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20205173|NCT03368664|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20205174|NCT05612581|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20205175|NCT03589326|Director|Medical|+1-877-825-3327|trialdisclosures@takeda.com|
20205176|NCT05441592|University of Michigan|Edwin Wilkins|734-936-6680|ewilkins@med.umich.edu|
20205177|NCT01371981|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20205178|NCT00118482|University of Calgary|Dr. Robert S. Sheldon|403-2208191|sheldon@ucalgary.ca|
20205179|NCT00125190|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20205180|NCT01586156|Cleveland Clinic|Dr. Serpil Erzurum|216-445-6624|erzurus@ccf.org|
20205181|NCT01423773|Alcon Research|Head, Clinical Trial Management|1-800-241-7629||
20205182|NCT00547638|Ethicon, Inc.|John Lombard, Clinical Research Manager|908 218 2877|jlombar8@its.jnj.com|
20205183|NCT03259490|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205184|NCT00255086|VA Palo Alto Health Care System|Wes Ashford, PhD, MD|650-493-5000|wes.ashford@va.gov|
20205185|NCT00622544|University of MN|Clifford E. Kashtan|646 692 9309|cassi044@umn.edu|
20205186|NCT00434122|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20205187|NCT01963208|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20205188|NCT01842607|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205189|NCT00012012|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20205190|NCT02159469|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
20205191|NCT02034474|NYSPI|Ragy Girgis,MD|6467745553|ragy.girgis@nyspi.columbia.edu|
20205192|NCT03629041|Innoture Ltd|Jemma Burridge, Clinical Project Manager|+44 (0)7799 902476|jburridge@innoture.co|
20205193|NCT01519284|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20205194|NCT01391819|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205195|NCT01262755|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
20205196|NCT01244191|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20205197|NCT05584202|ModernaTX, Inc.|Moderna WeCare Team|866-663-3762|WeCareClinicalTrials@modernatx.com|
20205198|NCT02500368|CooperVision Inc.|Sr. Manager Clinical Research|(925) 730-6754|PChamberlain@coopervision.com|
20205199|NCT01746940|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
20173871|NCT00642941|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
20173872|NCT03051607|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
20205200|NCT03297216|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joan_price@med.unc.edu|
20205201|NCT00781963|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|Cathy.Alessi@va.gov|
20205202|NCT03353753|Deciphera Pharmaceuticals, LLC|INVICTUS Clinical Team|7812096400|clinicaltrials@deciphera.com|
20205203|NCT01830816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20205204|NCT04124692|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20205205|NCT02325687|Hospital for Special Surgery, Anesthesiology Department|Kethy Jules-Elysee|212-606-1206|juleselyseek@hss.edu|
20205206|NCT00205699|Florida Atlantic University|John W. Newcomer|(561) 297-0252|jnewcomer@health.fau.edu|
20205207|NCT03027388|National Cancer Institute|Dr. Eric Burton|240-760-6436|eric.burton@nih.gov|
20205208|NCT03746808|University of North Texas Health Sciece Center|Scott Walters|817-735-2365|scott.walters@unthsc.edu|
20205209|NCT00671723|University of Oklahoma Health Sciences Center|Dr. Houssein Youness|405-271-6173|houssein-youness@ouhsc.edu|
20205210|NCT01754922|VA NJ Health Care System|Dr. Michael Falvo|973-676-1000|Michael.Falvo@va.gov|2423
20205211|NCT01207388|Amgen Inc.|Study Director|866-572-6436||
20205212|NCT01885078|Eli Lilly & Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20205213|NCT02093234|GW Medical Faculty Associates|Richard Katz, MD|202-741-2323|RKatz@mfa.gwu.edu|
20205214|NCT02899377|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
20205215|NCT04321252|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20205216|NCT00611897|Yale School of Medicine, Department of Psychiatry|Handan Gunduz-Bruce, MD|(203) 785-2117|handan.gunduz-bruce@yale.edu|
20205217|NCT00259740|Amgen Inc.|Study Director|866-572-6436||
20205218|NCT01367301|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
20205219|NCT01844830|Loma Linda University|Yiming Li, DDS|909-558-4600|kkellingsworth@llu.edu|
20205220|NCT02500602|Medical University of South Carolina|Sudie Back|843-792-9383|backs@musc.edu|
20205221|NCT03934710|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20205222|NCT03150095|Mayo Clinic|Dr. Cassie Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
20205223|NCT02769351|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49617260893488|jennifer.braun@fmc-ag.com|
20205224|NCT05025787|MGH|Allison Campbell|617-595-8372|acampbell17@mgh.harvard.edu|
20219751|NCT01458106|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
20219752|NCT00073021|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20219753|NCT03835221|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20219754|NCT00612430|Duke University Medical Center|David Reardon, MD|919-668-2329|David_Reardon@DFCI.harvard.edu|
20219755|NCT01088802|Johns Hopkins Medicine|Harry Quon, MD|410-502-3877|hquon2@jhmi.edu|
20219756|NCT01197755|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20219757|NCT00499174|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
20219758|NCT01214915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20219759|NCT00761865|University of Rochester|Benedict DiGiovanni|5852731611|benedict_digiovanni@urmc.rochester.edu|
20219760|NCT03866902|University of Miami|Hudson Santos|3052845812|hsantos@miami.edu|
20219761|NCT02519738|University of Michigan|Ron Hirschl|734 764-6482|rhirschl@med.umich.edu|
20219762|NCT03613727|Virginia Commonwealth University|BMT- CIT Team|804-628-6430|masseybmt@vcu.edu|
20219763|NCT03982199|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20219764|NCT04505956|Vanderbilt University Medical Center - Department of Urology|Nicole Miller, M.D.|(615) 322-3807|nicole.miller@vumc.org|
20219765|NCT02278055|Memorial Sloan Kettering Cancer Center|Dr. Michael Morris, MD|646-422-4469|morrism@MSKCC.ORG|
20219766|NCT04040192|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219767|NCT00469144|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20219768|NCT01994291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219769|NCT00856375|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
20219770|NCT02227446|METRC|Susan Collins|4105028966|scolli21@jhu.edu|
20219771|NCT02121392|University of Chicago Medical Center|Dr. Hue Luu|773-702-6937|hluu@bsd.uchicago.edu|
20219772|NCT01352416|William Beaumont Hospital|Ilana Kutinsky, DO|248-267-5050|ikutinsky@beaumont.edu|
20219773|NCT03904264|Department of Veterans Affairs|Tara Zaugg, AuD / CRH REC Consultant, VISN 20 and REC ICC Clinical Lead, VISN 20|208-422-1000|tara.zaugg@va.gov|
20219774|NCT01054404|Northwestern University|Dr. John F. Bebawy, Assistant Professor of Anesthesiology & Neurological Surgery|312-695-0061|j-bebawy@northwestern.edu|
20219775|NCT02876757|ICES Western|Blayne Welk|5196466000|blayne.welk@sjhc.london.on.ca|
20219776|NCT00118534|VA Puget Sound (Seattle)|Dr. Miles McFall|(206) 764-2177|Miles.McFall@va.gov|
20219777|NCT03016975|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20219778|NCT02901548|Moffitt Cancer Center|Jingsong Zhang, MD, PhD|813-745-6926|Jingsong.Zhang@moffitt.org|
20219779|NCT01006018|Emory University|Mary Rhee, M.D.|404-778-1666|mrhee@emory.edu|
20219780|NCT01497808|University of Pennsylvania|Dr. Amit Maity|(215) 615-6767|maity@uphs.upenn.edu|
20219781|NCT02467478|GW MFA|Sabyasachi Sen|3014616676|ssen1@gwu.edu|
20219782|NCT00258128|Joslin Diabetes Center|Allison B. Goldfine, MD|617-309-2400|allison.goldfine@joslin.harvard.edu|
20219783|NCT01228019|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219784|NCT00276861|Dept. of Oncology Johns Hopkins Singapore Intl Medical Center|Gilberto Lopes MD|656-880-2240|glopes@imc.jhmi.edu|
20219785|NCT02640053|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
20219786|NCT01135186|Stanford University|Dr. Linda Anh B. Nguyen|650-736-5555|nguyenlb@stanford.edu|
20219787|NCT02348723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219788|NCT01268501|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
20219789|NCT02910063|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20219790|NCT04435184|Johns Hopkins University - Baltimore, MD|Dr. Charles Lowenstein|4105020391|clowens1@jhmi.edu|
20219791|NCT04693416|University of Tennessee Health Science Center|Karen Derefinko, PhD|901-448-2526|kderefin@uthsc.edu|
20219792|NCT03750292|University of Rochester|Daniel Croft|(585) 275-4861|daniel_croft@urmc.rochester.edu|
20160137|NCT01967823|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
20219793|NCT00474266|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219794|NCT00048737|UT MD Anderson Cancer Center|Issa Khouri, MD / Professor||rvalverde@mdanderson.org|
20219795|NCT02774642|San Diego VA Healthcare System|Dr. Peter Colvonen|858-552-8585|peter.colvonen@va.gov|2468
20219796|NCT01404832|Dallas VAMC|Stuart Spechler|214-374-7799|sjspechler@aol.com|
20173873|NCT01196923|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
20202882|NCT00318708|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20205225|NCT00156910|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20205226|NCT00379197|University of Minnesota, Dept. Medicine|Dr. Douglas Yee, MD|612-273-5700|yeexx006@umn.edu|
20205227|NCT05301322|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205228|NCT05757427|MVG Industries SAS|Luc Duchesne|+33 (0) 6 70 33 91 20|luc.duchesne91@gmail.com|
20205229|NCT03423979|Urotronic, Inc|Sr. Clinical Project Manager|612-245-6434|jmoland@laborie.com|
20205230|NCT04971785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20205231|NCT00808249|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20205232|NCT01251861|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20205233|NCT03829332|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20205234|NCT05371912|Christiana Care|Mitra Assadi, MD|3026233017|mitra.assadi@christianacare.org|
20205235|NCT02598661|Geron Corp.|Study Director|650-473-7700|mds3001-info@Geron.com|
20205236|NCT01646398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205237|NCT00571519|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20205238|NCT02475850|Yale University|Erich Greene PhD|203-737-3636|erich.greene@yale.edu|
20205239|NCT03434418|Duke University|Thomas Stinchcombe, MD|919-681-9509|thomas.stinchcombe@duke.edu|
20205240|NCT00696436|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20205241|NCT04241146|Children's Hospital of Nevada at UMC|Prashant Jha|702-383-2420|prashant.jha@umcsn.com|
20205242|NCT01517412|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20205243|NCT00218426|University of Pennsylvania|Dr. George E Woody|215-746-7702|woodg@pennmedicine.upenn.edu|
20205244|NCT02716194|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20205245|NCT00363051|Novartis Pharmaceuticals|Novartis Study Director|(862 778-8300||
20205246|NCT01753830|Q-Med AB|Clinical Project Manager|+46 18 4749000|reception.seupp@galderma.com|
20205247|NCT02928380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20205248|NCT03050216|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612 625 3918|bruns072@umn.edu|
20205249|NCT01610076|Mayo Clinic|Kianoush Kashani; Principal Investigator|5072667093|kashani.kianoush@mayo.edu|
20205250|NCT01827930|Institut Bergonié|Pr Simone Mathoulin-Pelissier|05 56 33 33 33|S.Mathoulin@bordeaux.unicancer.fr|
20205251|NCT01895452|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
20205252|NCT01653158|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205253|NCT00980343|Adult Brain Tumor Consortium (ABTC)|Charles J Nock, MD|410-955-8837|jfisher@jhmi.edu|
20205254|NCT00421603|NYSPI|Daniel Brooks|212-740-3205|brooksd@nyspi.columbia.edu|
20205255|NCT00765128|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
20205256|NCT03060083|University of Vermont|Elias M Klemperer|8026561641|elias.klemperer@med.uvm.edu|
20205257|NCT00284739|Kaiser Permanente|Hyo-Chun Yoon, MD,PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
20205258|NCT01231607|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205259|NCT01677507|University of Michigan|Dr. Sayoko Moroi|734-763-3732|smoroi@med.umich.edu|
20205260|NCT02170649|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
20205261|NCT02823600|University of North Carolina at Chapel Hill|Seema Garg, MD, PhD|919-966-5296|sgarg@med.unc.edu, ashton.madison@alumni.duke.edu|
20205262|NCT01309867|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
20205263|NCT05137730|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20205264|NCT01840228|Ohio State University|Dr. Heather Frey|614-688-6798|Heather.Frey@osumc.edu|
20205265|NCT02476357|Lausanne University Hospita! and University of Lausanne|Prof. Dr Med. Maurice MATTER|795561071|maurice.matter@chuv.ch|0041
20205266|NCT00432094|Masonic Cancer Center, University of Minnesota|Dr. Najla El Jurdi|612-625-8942|neljurdi@umn.edu|
20205267|NCT01103778|Rogosin Institute|Dr. Choli Hartono|212-746-1578|chh2001@nyp.org|
20205268|NCT01658579|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
20205269|NCT04580394|Apnimed, Inc.|Clinical Trials|6175008880|clinicaltrials@apnimed.com|
20205270|NCT01464788|McGovern Medical School UTHealth - Houston|Dr. Andrew Barreto|713-500-7002|andrew.d.barreto@uth.tmc.edu|
20205271|NCT00564954|Novartis Pharmaceuticals|Study Director|862-778-8300||
20205272|NCT04397718|Department of Veterans Affairs GLA|Dr. Matthew Rettig|310-478-3711|matthew.rettig@va.gov|44761
20205273|NCT01153893|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205274|NCT05080179|University of Pennsylvania, Perelman School of Medicine|Dr. Erica Dixon|215-573-9987|erica.dixon@pennmedicine.upenn.edu|
20205275|NCT01551758|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205276|NCT02128763|University of Pennsylvania|Maureen G. Maguire, PhD|215-615-1501|maguirem@pennmedicine.upenn.edu|
20205277|NCT03666858|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20202883|NCT00537823|Washington University School of Medicine|David Linehan, M.D.||David_Linehan@URMC.Rochester.edu|
20202884|NCT02873221|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20202885|NCT03811951|University of Illinois at Chicago - College of Pharmacy|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
20202886|NCT01325493|Children's National Health System|Julia Finkel|2024764867|JFINKEL@childrensnational.org|
20202887|NCT01505062|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20202888|NCT01745055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219797|NCT01695863|Aurora Gastroenterology, West Allis WI|Maqsood Khan MD FACG|414-328-8750|mkhangi@yahoo.com|
20219798|NCT01330420|Massachusetts General Hospital|Kathleen Miller, RN|781-485-6176|kmiller16@partners.org|
20219799|NCT01687244|FKD Therapies Oy|David Sawutz, PhD|416-607-9515|david.sawutz@fkdtherapies.com|
20219800|NCT02819050|Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center|Virender Rehan|3102221965|vrehan@labiomed.org|
20219801|NCT00426361|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219802|NCT02373189|Rush University Medical Center|John Burns|13129420379|john_burns@rush.edu|
20160138|NCT00413894|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20160139|NCT01942161|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
20160140|NCT05289271|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160141|NCT01257568|Stryker Orthopaedics|Shaherah Yancy, Director, Clinical Operations|901-650-6601|shaherah.yancy@stryker.com|
20160142|NCT02043197|Abbott|Tatiana V. Vladimirova|+74952584280|tatiana.vladimirova@abbott.com|
20160143|NCT00416715|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20160144|NCT00347438|University of Chicago Medical Center|Dr. Funmi Olopade|773-702-1632|folopade@medicine.bsd.uchicago.edu|
20160145|NCT03334851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160146|NCT00666588|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20160147|NCT04452435|Vicore Pharma|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
20160148|NCT04043234|Infinite Biomedical Technologies, LLC|Chief Executive Officer|(443) 451-7177|rahul@i-biomed.com|
20160149|NCT03106844|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
20189480|NCT02108171|Guangzhou First People's Hospital, Affiliated Hospital of Guangzhou Medical College|Dr. Xiangcai Ruan|+8620-81048306|xc_ruan@hotmail.com|
20189481|NCT02304757|Tenth People's Hospital of Tongji University|Chao Ma|02125078593|mc_7419@hotmail.com|86
20189482|NCT02106884|UZ Leuven|Prof. Dr. Eric Van Cutsem|0032 16 344418|eric.vancutsem@uzleuven.be|
20189483|NCT01607320|Greenville Health System|Bruce Lessey|864-455-1600|blessey@ghs.org|
20189484|NCT03784898|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20189485|NCT02356198|Mayo Clinic|Dr. Dorin T. Colibaseanu, MD|904-953-2596|colibaseanu.dorin@mayo.edu|
20189486|NCT04638816|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
20189487|NCT00087022|Heidelberg Pharma AG (previously Wilex AG)|Head of R&D||info@hdpharma.com|
20189488|NCT01822756|Incyte Corporation|Study Director|1-855-463-3463||
20189489|NCT04111510|Yale School of Medicine|Michael Hurwitz, MD, PhD|(877) 925-3637|michael.hurwitz@yale.edu|
20189490|NCT00544115|City of Hope|Dr. Monzr Al Malki, MD|626359811|malmalki@coh.org|
20189491|NCT03395080|Leap Therapeutics, Inc.|Cynthia Sirard, MD, Chief Medical Officer|+1-617-714-0360|csirard@leaptx.com|
20189492|NCT02060487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189493|NCT02309294|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20189494|NCT01227421|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
20189495|NCT00758550|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20189496|NCT01827839|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189497|NCT05426109|Virginia Tech|Dr. Larson-Meyer|540-231-1025|enette@vt.edu|
20189498|NCT02542943|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189499|NCT03476798|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
20189500|NCT06269003|University of Hawaii Cancer Center|Donghee Nicole Lee, Assistant Professor|8084418184|nlee@cc.hawaii.edu|
20189501|NCT06677203|Asceneuron S.A.|Asceneuron Clinical Research|+41213538245|clinicaltrials.gov@asceneuron.com|
20189502|NCT05865392|University of Colorado|Dr. Danielle M. Ostendorf|3037249203|danielle.ostendorf@cuanschutz.edu|
20189503|NCT04162873|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20189504|NCT04447027|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20189505|NCT05986617|University of Iowa|Victoria Tappa|3193846136|victoria-tappa@uiowa.edu|
20189506|NCT04118894|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
20189507|NCT03496766|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20189508|NCT00768716|Washington State University|Dr Michael H. Court|5093350817|michael.court@wsu.edu|
20189509|NCT03377049|UW School of Medicine and Public Health|Azam Ahmed, MD, FAANS, FACS|608-263-0485|azam.ahmed@neurosurgery.wisc.edu|
20189510|NCT00597376|Rush University Medical Center|Raj C. Shah, MD|312-563-2902|Raj_C_Shah@rush.edu|
20189511|NCT02634307|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20189512|NCT03926026|Nicox Ophthalmics, inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
20189513|NCT01214200|Temple University School of Medicine|Mark Weir, MBChB|215-707-5864|mark.weir@tuhs.temple.edu|
20189514|NCT00667017|University of Texas Southwestern Medical Center|Larry Andeson, MD|214-648-7097||
20189515|NCT01823224|Womack Army Medical Center|Anthony R Plunkett, MD|910-907-6000|anthonyrplunkett@gmail.com|
20189516|NCT01532648|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20189517|NCT03960645|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20189518|NCT01005615|Kennedy Krieger institute|Cristina Sadowsky|443-923-9232|sadowsky@kennedykrieger.org|
20189519|NCT04938453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189520|NCT03292406|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20219803|NCT02828241|Dr. Reddy's Laboratories|Katherine D'Angelo|609-282-1400|kdangelo@drreddys.com|
20160150|NCT02292758|Dana-Farber Cancer Institute|Kimmie Ng, M.D., M.P.H.|(617) 632-4150|Kimmie_Ng@dfci.harvard.edu|
20160151|NCT03622112|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
20160152|NCT01165320|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160153|NCT00385944|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160154|NCT01155466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160155|NCT02075047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160156|NCT00590824|University of Madison Carbone Cancer Center|Paul Sondel, MD, PhD|(608) 263-9069|pmsondel@humonc.wisc.edu|
20160157|NCT03552536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160158|NCT05898672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160159|NCT01114971|Cedars Sinai Medical Center|Proffesor Paul F. White|2147703775|paul.white@cshs.org|
20160160|NCT01778049|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160161|NCT01218958|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
20160162|NCT00515294|Boston University|Jonathan Howland, Professor|617 638 5158|jhowl@bu.edu|
20160163|NCT02959827|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20160164|NCT01025076|Royal Alexandra Hospital/CAMIS|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
20160165|NCT03770728|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20160166|NCT01364558|University of Minnesota|Dr. James Cloyd, Director for Center for Orphan drug research|612-624-4609|cloyd001@umn.edu|
20160167|NCT02778555|Stanford University|Dr. Beth Darnall, Clinical Associate Professor, Division of Pain Medicine|(650) 721-2104|bdarnall@stanford.edu|
20160168|NCT02379988|Peace Health St. Joseph's cancer center|Victor Gonzalez|360-788-8222|vgonzalez1@peachehealth.org|
20160169|NCT00107315|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20160170|NCT02509039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20160171|NCT00945061|University Hospitals Cleveland Medical Center , Case Comprehensive Cancer Center|Dr. Janice A. Lyons, MD|+1 216-844-2536|Janice.Lyons@uhhospitals.org|
20160172|NCT02089464|Nexstim Plc|Vice President, Medical Affairs||jarmo.laine@nexstim.com|
20160173|NCT03943550|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20160174|NCT00096226|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20160175|NCT04262882|University of Texas at San Antonio|Dr. Katelyn Sileo|210-458-7900|katelyn.sileo@utsa.edu|
20160176|NCT04730635|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160177|NCT01327053|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20160178|NCT03172884|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20160179|NCT00721578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157536|NCT01714323|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-4709|nrigotti@partners.org|
20157537|NCT00755807|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157538|NCT02921789|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20157539|NCT01621178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157540|NCT02896257|VA Puget Sound Health Care System|Dr. David Au|206-764-2504|David.Au@va.gov|
20157541|NCT04778592|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
20157542|NCT03423602|Vivasure Medical Ltd|Dr Chris Martin|+353 91 395 442|chris.martin@vsuremed.com|
20157543|NCT01192126|Bausch & Lomb Incorporated|Dr. Robert Steffen OD|585-338-6399|robert.steffen@bausch.com|
20157544|NCT03246087|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20157545|NCT02580877|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8631|cjgreen@benaroyaresearch.org|
20173874|NCT03338855|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
20173875|NCT00455429|Janssen Research and Development, 3210 Merryfield Row San Diego, CA 92121|William Barchuk, M.D.|858-784-3111||
20173876|NCT04948450|National Geriatric Hospital|Dr Nguyen Xuan Thanh|0983277646|xuanthanhbmlk@hmu.edu.vn|
20173877|NCT00471848|European Group for Blood and Marrow Transplantation|Prof. Judith Marsh|+31 (0)71 5265005|a.j.barrois@lumc.nl|
20173878|NCT00529542|Milton S. Hershey Medical Center|Richard S. Legro|717-531-8478|rsl1@psu.edu|
20172686|NCT05109442|Affimed GmbH|Clinical Operations|+49 621 56003-0|trials@affimed.com|
20172687|NCT04216329|National Cancer Institute|Dr. Kevin A. Camphausen|240-760-6205|camphauk@mail.nih.gov|
20172688|NCT01774968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172689|NCT04847557|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20172690|NCT01325584|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
20172691|NCT00524368|Tibotec Pharmaceuticals, Ireland|Medical Leader|+32 015 461 497||
20172692|NCT01955733|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172693|NCT00793598|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20172694|NCT02762266|Stanford University|Erqi Pollom, MD|(650) 498-0484|erqiliu@stanford.edu|
20172695|NCT03758274|University of Rochester|Kenneth R. Conner|585-275-1211|kenneth_conner@urmc.rochester.edu|
20172696|NCT01113983|Edwards Lifesciences|Shin Sakai, PhD||shin_sakai@edwards.com|
20172697|NCT02422511|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
20172698|NCT02961751|University of California, Los Angeles|Jeffrey D. Klausner, MD, MPH|310-267-0409|jdklausner@mednet.ucla.edu|
20172699|NCT00842712|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20172700|NCT02298803|Diabetes Centre, Royal Prince Alfred Hospital|Dr Ted Wu|61295155888|ted.wu@sswahs.nsw.gov.au|
20172701|NCT02299479|Boston Children's Hospital|Garry Steil, PhD|617 355-6000|Garry.Steil@childrens.harvard.edu|
20172702|NCT02785354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205278|NCT00121992|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20160180|NCT01638013|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20160181|NCT02298179|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
20160182|NCT01352442|AcuFocus, Inc.|Eugenia Thomas, OD|949-585-9511|ethomas@acufocus.com|
20205279|NCT00363246|James A. Haley Veterans' Hospital|Andrea M. Spehar, DVM, MPH, JD|813-558-3947|Andrea.Spehar@va.gov|
20160183|NCT02226198|AstraZeneca Plc|Robin Mukherjee|+46 31 776 1000|robin.mukherjee@astrazeneca.com|
20160184|NCT03895632|Medical Physics & Clinical Engineering, Royal Liverpool Hospital|Dr. Tristan Payne|0151 7064225|tristan.payne@nhs.net|
20205280|NCT01608724|Astrazeneca Investment (China) Co., Ltd.|Anya Huang, Brand Physician|+86 21 6030 2032|anya.huang@astrazeneca.com|
20205281|NCT01948388|Arthritis & Rheumatic Disease Specialties|Joanne Sagliani|3059324162|drnbg@rheum-care.com|
20205282|NCT03722784|CooperVision, Inc.|Martine Robie|9256604477|mrobie@coopervision.com|
20205283|NCT00186056|Stanford University|Brent Solvason|650-723-8331|solvason@stanford.edu|
20205284|NCT00910429|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20205285|NCT01317615|Novartis|Study Director|862-778-8300||
20205286|NCT01322646|University at Buffalo|Gregory A. Fabiano, Ph.D.|7166451130|fabiano@buffalo.edu|
20205287|NCT04465396|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20219804|NCT02151877|Advocate Health Care|Chawki Elzein, MD, FACS|7086843029|chawki.elzein@advocatehealth.com|
20160185|NCT04545047|VA Cooperative Studies Program|Project Manager|2062774780|Sarah.Keithly@va.gov|
20160186|NCT01440517|GE Healthcare|Arnold Jacobson, M.D.|1-609-514-6325|Arnold.Jacobson@ge.com|
20160187|NCT00871923|UT MD Anderson Cancer Center|James Welsh,MD- Associate Professor, Radiation Oncology Department|(713) 563-2447|jwelsh@mdanderson.org|
20160188|NCT02263911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160189|NCT05599451|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
20160190|NCT02723006|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20160191|NCT01559922|Suneva Medical, Inc.|Suneva Medical,Inc.||Acne.ScarInfo@sunevamedical.com|
20160192|NCT03638908|UTSouthwestern medical center|Kelly Chin, MD|2146456493|kelly.chin@utsouthwestern.edu|
20160193|NCT02074345|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20160194|NCT03440723|Elm Tree Medical Inc.|CEO|2158050862|evamartin@elmtreemedical.com|
20160195|NCT03392883|Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College|Lisa A. Marsch, PhD|603-646-7092|Lisa.a.marsch@dartmouth.edu|
20160196|NCT01792817|electroCore, LLC|Clinical Affairs|+1 973-355-6683|clinical@electrocorellc.com|
20160197|NCT02994953|Merck KGaA, Darmstadt, Germany|Communication Center|6151 72 5200|service@merckgroup.com|
20160198|NCT01739933|Vanderbilt University Medical Center|Dr. Pratik Pandharipande, Vice Chair Faculty Affairs, PI|6153436268|pratik.pandharipande@vumc.org|
20160199|NCT03356977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160200|NCT01846195|Zynex Monitoring Solutions|Donald Gregg|1-800-495-6670|dgregg@zynex.com|
20160201|NCT01545232|University of Texas Health Science Center - Houston|John Holcomb, M.D.|713-500-5493|John.Holcomb@uth.tmc.edu|
20160202|NCT01247363|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160203|NCT00908115|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160204|NCT01728077|Cares|UCB|+1844599||2273
20160205|NCT01246479|Valneva Austria GmbH|Senior Scientist Clinical Research|+43120620|info@valneva.com|0
20160206|NCT01366612|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20160207|NCT00378599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20160208|NCT03879044|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
20160209|NCT01106859|Purdue Pharma LP|Clinical Leader|800-733-1333||
20160210|NCT01007435|Hoffmann-La Roche|Medical Communications|800 821-8590||
20160211|NCT02545517|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160212|NCT01529515|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20160213|NCT01706497|University Hospitals Leuven (UZ Leuven) and KU Leuven|Prof Dr Geert Meyfroidt, Associate Professor|0032 16 344021|geert.meyfroidt@uzleuven.be|
20160214|NCT00523705|University of Pennsylvania|Ellen Freeman, Principal Investigator|215 662-3329|freemane@mail.med.upenn.edu|
20160215|NCT00746239|Penn State Hershey Medical Center|Ravi Singareddy|717-531-0040|rsingare@gmail.com|
20160216|NCT00642369|Guang Dong Provinical Mental Health Institute|Zhang Bin|86-20-81888553|zhang73bin@hotmail.com|
20173879|NCT03930446|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20189521|NCT03510195|Universiti Putra Malaysia|Dr. Aneesa Abdul Rashid|03-86092956|aneesa@upm.edu.my|
20189522|NCT00022672|Hoffman-LaRoche|Medical Communications|800-821-8590||
20189523|NCT00403494|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
20189524|NCT00639418|MedImmune LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
20189525|NCT01271244|VA NEBRASKA WESTERN IOWA VA HEALTHCARE|SRIRAM RAMASWAMY MD|4029954712|SRIRAM.RAMASWAMY@VA.GOV|
20189526|NCT04658784|Ascension Saint Thomas Medical Group|Dr. Amanda Merriman|615-397-6919|amanda.yacko@gmail.com|
20189527|NCT02575365|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20189528|NCT00343083|University of Maryland Baltimore|Ritesh Kataria|410-328-8018|rkataria@umm.edu|
20189529|NCT05005351|Swing Therapeutics, Inc.|Clinical Project Manager|1 (415) 662-0415|research@swingtherapeutics.com|
20189530|NCT01482325|GE Healthcare|Global Research Manager|414 721 2423|Jeffrey.Conner@ge.com|
20189531|NCT00670488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173880|NCT01566461|Medtronic Endovascular Therapies|Arslan Malik, Sr. Clinical Research Manager||arslan.malik@medtronic.com|
20173881|NCT01997515|Rhode Island Hospital|Director of Research|401-444-4933|mark.kendall@lifesapn.org|
20173882|NCT03055000|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
20173883|NCT04788953|Brigham and Women's Hospital|Dr. Kirsi-Marja Zitting|617-525-8339|kzitting@bwh.harvard.edu|
20173884|NCT02092662|University of Haifa|Sharon Israely|972-523-755-091|sharonis@mh.org.il|
20173885|NCT05074693|University of Houston|Michael Zvolensky, Ph.D.|713-743-8056|mjzvolen@Central.UH.EDU|
20173886|NCT03424265|University of Arkansas for Medical Sciences|Scott Schutzler, R.N.|501-526-5734|seschutzler@uams.edu|
20173887|NCT01422772|Helixmith Co., Ltd.|Jinsub Lee PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
20173888|NCT02422745|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|COSMOS Study Director|1-800-633-6913|cosmostrial@partners.org|
20173889|NCT01899300|Asian Institute of Gastroenterology|Rajesh Gupta, MD|+91 4023378888|drrajeshgupta98@gmail.com|
20173890|NCT00391274|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20173891|NCT01991457|University of Alabama at Birmingham|Dr. Omer Jamy|2059349294|omerjamy@uabmc.edu|
20173892|NCT00894322|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
20173893|NCT00531817|Hoffmann-La Roche|Medical Communications|800-821-8590||
20173894|NCT03965533|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173895|NCT00112593|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
20173896|NCT03447990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20173897|NCT01895855|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
20173898|NCT02738450|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
20173899|NCT03559257|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20173900|NCT00706407|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
20173901|NCT01387347|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
20173902|NCT03251079|Senseonics, Incorporated|Katherine Tweden, PhD|651.335.2205|Katherine.Tweden@senseonics.com|
20173903|NCT02658357|Braeburn|Christine Kampf|6104678728|ckampf@braeburnrx.com|
20173904|NCT01169610|Mayo Clinic|Mark A. Frye, MD|507-255-9391|mfrye@mayo.edu|
20173905|NCT00951808|New England Research Institutes|Hae-Young Kim|617-972-3251|hkim@nerisicence.com|
20173906|NCT02654483|Stanford University|Irene Bailey, CRC|650-721-7149|baileyhi@stanford.edu|
20173907|NCT00423150|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20173908|NCT03439670|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
20173909|NCT01865539|Canandaigua VA Medical Center|Dr. Paul Dougherty, PI|585-463-2673|paul.dougherty@va.gov|
20173910|NCT01603459|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20173911|NCT00196716|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
20173912|NCT00399360|Massachusetts General Hospital|Dr. Steven Grinspoon, Principal Investigator|617-726-3890|sgrinspoon@partners.org|
20173913|NCT02014844|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20173914|NCT01641692|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173915|NCT01474876|AbbVie|Global Medical Information|800-633-9110||
20173916|NCT02291055|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
20173917|NCT01762631|Pennington Biomedical Research Center|Leanne Redman, PhD|2257630947|leanne.redman@pbrc.edu|
20173918|NCT01523886|Herlev Hospital|Mona R Gätke, MD, PH.D.|004538662420|mona.gatke@regionh.dk|
20173919|NCT04035161|Becton Dickinson|Erin Zook, PhD|224-358-5019|erin.zook@bd.com|
20173920|NCT00631566|Infectious Disease Clinical Research Program, USUHS and HJF|Dr. Brian Agan, Deputy Science Director|301-816-8446|bagan@idcrp.org|
20173921|NCT00862446|Vanderbilt University Medical Center|William Walsh|615-322-3476|bill.walsh@vumc.org|
20173922|NCT04640519|Columbia University|Imama Naqvi, MD|646-426-3876|ian2108@cumc.columbia.edu|
20173923|NCT03141281|Florida State University|Dr. Neil Charness|850-644-6686|charness@psy.fsu.edu|
20173924|NCT00733746|Alliance for Clinical Trials in Oncology|Peter Pisters, MD||ppisters@mdanderson.org|
20173925|NCT00657241|SUNYBuffalo|Joseph L. Izzo Jr. M.D.|716-898-5625|jizzo@buffalo.edu|
20189532|NCT02708498|Department of Health Sciences, Lund University|Professor Gerd Ahlström|+46702747767|gerd.ahlstrom@med.lu.se|
20189533|NCT00195819|Abbott|Global Medical Services|800-633-9110||
20189534|NCT01124045|Alcon Research, Ltd.|Pam Kaur, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20189535|NCT03298087|West LA VAMC|Nathanael Kane|3104783711|nathanael.kane@va.gov|46735
20189536|NCT01629589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20189537|NCT00822900|Emergency Neurosciences, Emergency Medicine, Emory University|David W. Wright, Associate Professor, Department of Emergency Medicine, Emory University|404-778-1709|david.wright@emory.edu|
20189538|NCT02234141|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20189539|NCT03418545|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20189540|NCT02251652|Icahn School of Medicine at Mount Sinai|Dr. Gary Goldenberg|212-241-9728|garygoldenbergmd@gmail.com|
20189541|NCT01074242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189542|NCT00109031|Swedish Orphan Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20189543|NCT01957163|GlaxoSmithKline|GSK Response Center|866-435-7343||
20173926|NCT01173718|W. L. Gore & Associates|Debby Pfile, Clinical Research Associate|623-234-5226|dpfile@wlgore.com|
20173927|NCT01367158|Novartis Vaccines|Posting Director||RegistryContactVaccineUS@novartis.com|
20173928|NCT01499563|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinialTrials@itci-inc.com|
20173929|NCT03578081|University of Alabama at Birmingham|Dr Rudolph M. Navari|205-975-2833|rnavari@uabmc.edu|
20173930|NCT03658538|Johns Hopkins University|Dr. Nadia Hansel|410-955-3841|nhansel1@jhmi.edu|
20173931|NCT05198843|University of Texas M D Anderson Cancer Center|Dr. Rachel Layman|(713) 745-8401|RLayman@mdanderson.org|
20173932|NCT02588833|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20173933|NCT03333044|NYU Langone Health|Shinu Mammen|646-501-3484|shinu.mammen@nyulangone.org|
20173934|NCT04709341|Medical University of South Carolina|Samuel Bidwell- Research Manager|843-792-2305|bidwells@musc.edu|
20173935|NCT03649711|University of Arkansas for Medical Sciences|Dr. Nishank Jain, Associate Professor of Medicine|5016865295|njain2@uams.edu|
20173936|NCT02921776|The Ohio State University|Mary Beth Happ, PhD, RN|614-292-8336|happ.3@osu.edu|
20173937|NCT05247229|Department of Medicine, Division of Occupational, Environmental, and Climate Medicine, University of California|Matthew O. Gribble|‭(949) 350-6134‬|matt.gribble@ucsf.edu|
20173938|NCT04537234|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20173939|NCT01721330|Massachusetts General Hospital|Leah Feinberg|617-726-4651|lkfeinberg@mgh.harvard.edu|
20173940|NCT00296374|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20173941|NCT04318080|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20173942|NCT06308822|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20173943|NCT00708942|Photocure|Bjørn Klem, Project Director|+47 22 06 22 10|bk@photocure.no|
20173944|NCT04734652|CAPRISA|Dr Anushka Naidoo|031 655 0668|anushka.naidoo@caprisa.org|0669
20173945|NCT05027438|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD (Principal Investigator)|(412) 360-2806|adam.bramoweth@va.gov|
20173946|NCT00555750|Brigham and Women's Hospital|Dr. John Winkelman, MD, PhD|617-278-0061|jwwinkelman@partners.org|
20173947|NCT01921179|San Francisco VA HCS|Dr Tatjana Novakovic-Agopian|415-753-3888|tatjana.novakovic-agopian@va.gov|
20173948|NCT04693507|Antev Ltd|Carol MacLean|+447525177617|cmaclean@antev.co.uk|
20173949|NCT02710890|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20173950|NCT01190254|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20173951|NCT04146545|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
20173952|NCT01729754|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20173953|NCT00773292|Imperial College London|Graham P Taylor|0207 594 3910|g.p.taylor@imperial.ac.uk|
20173954|NCT04729127|University of Pennsylvania|Melanie Pellecchia|215-746-1950|melanie.pellecchia@pennmedicine.upenn.edu|
20173955|NCT01245270|University of Aberdeen Rowett Institute of Nutrition and Health|Dr Nigel Hoggard|[+44] (0) 1224 438700|N.Hoggard@abdn.ac.uk|
20173956|NCT00542919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20173957|NCT03927612|Indiana University School of Medicine|Clinical Research Specialist|317-274-8670|vrlab@iupui.edu|
20173958|NCT01959542|Brigham and Women's Hospital/Dana-farber Cancer Institute|Dr. Fiona Fennessy|617 632 4891|ffennessy@bwh.harvard.edu|
20173959|NCT03050619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20173960|NCT03202264|McMaster University|Dr. Dee Mangin|905-525-9140|mangind@mcmaster.ca|21219
20173961|NCT03388138|Johnson & Johnson Vision Care, Inc.|Brian Pall O.D, MS, FAAO|1-800-843-2020|bpall@its.jnj.com|
20205288|NCT03730194|University of Nebraska Medical Center|Alyson E Hanish|402-559-6731|alyson.hanish@unmc.edu|
20173962|NCT01528072|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
20173963|NCT02381418|Abbott|Global Clinical Director|+31294477184|serge.vandewitte@abbott.com|
20173964|NCT04014075|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
20173965|NCT01879228|University of Pennsylvannia|Paola Alvarado|215-746-2081|paola.alvarado@pennmedicine.upenn.edu|
20173966|NCT01716013|OptMed|Associate Director of Quality Assurance|(908) 720-2372|nyajnik@optmed.com|
20173967|NCT04741074|Geisinger|Alexander Chang|570-271-8026|achang@geisinger.edu|
20205289|NCT04427917|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173968|NCT02432846|Immunicum Aktiebolag (AB)|Chief Medical Officer|+46 (0)8 732 84 00|info@immunicum.com|
20173969|NCT01516957|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
20173970|NCT01912287|NYU Langone Health|Naomi Simon|646-754-4507|Naomi.Simon@nyulangone.org|
20173971|NCT03226392|Novartis pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
20173972|NCT00937157|Buffalo Neuroimaging Analysis Center|Robert Zivadinov, MD, PhD|716-859-7040|rzivadinov@bnac.net|
20173973|NCT01998633|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20173974|NCT02631850|University of Massachusetts Lowell|Lynne Gauthier|9789345383|lynne_gauthier@uml.edu|
20173975|NCT04098107|Children's Hospital of Philadelphia|Elliot Greenberg|215-590-1527|GREENBERGE@chop.edu|
20173976|NCT01462084|Stanford Sleep Medicine|Michelle Cao, DO, FAASM|(650) 723-6601|michellecao2007@gmail.com|
20173977|NCT03992781|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20173978|NCT01996826|Mass. Eye and Ear|Reza Dana, M.D., M. Sc, MPH|6175734331|Reza_Dana@meei.harvard.edu|
20173979|NCT00695396|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Head of Hematology and Nephrology||pbowers@its.jnj.com|
20173980|NCT02734979|Stanford University|Dr. Stanley G Rockson, Allan and Tina Neill Professor of Lymphatic Research and Medicine|650-725-7571|rockson@stanford.edu|
20173981|NCT00518323|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader (CDTL)|609-730-4530||
20173982|NCT01312818|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612-672-7422||
20173983|NCT02278263|Ko Awatea|Dr Marinus Stowers|+64 276 0044|msto062@aucklanduni.ac.nz|2219
20173984|NCT01514760|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-3264|perrytamarat@uams.edu|43264
20173985|NCT01132547|SunCoast CCOP Research Base at the University of South Florida|Angelina Fink, Research Base Administrator|813-396-9245|angelina.fink@epi.usf.edu|
20173986|NCT02710045|University of Tasmania|Katie Flanagan|+61 3 6777 4081|katie.flanagan@ths.tas.gov.au|
20173987|NCT04318990|Baylor Scott and White Resarch Institute|Sarah Hale|469-814-4845|sarah.hale@bswhealth.org|
20173988|NCT01304966|Queen Sirikit Nation Institute of Thailand|Dr.Pavinee Intakorn|06623548333|pintakorn@yahoo.com|2301
20173989|NCT02290106|Massachusetts General Hospital|Takara Stanley, MD|6177249109|tstanley@mgh.harvard.edu|
20173990|NCT00071760|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20173991|NCT02335099|University of Virginia|Emaad Abdel-Rahman, MD|434-924-5820|ea6n@virginia.edu|
20173992|NCT01288287|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20173993|NCT03519347|NYU Langone Health|David M Charytan, MD, MSc|646-501-9086|david.charytan@nyulangone.org|
20173994|NCT03194555|Allodynic Therapeutics, Inc.|Dr. Annette Toledano, Sponsor-Investigator|+13058956808|annette.toledano@allodynic.com|
20173995|NCT01831154|James A Haley Veterans Hosptial|Dr. Sierra Gower|(813) 972-2000|sierra.gower@va.gov|5946
20173996|NCT03831347|Butler Hospital|Dr. Lisa Uebelacker|401-455-6200|LUebelacker@butler.org|
20173997|NCT01685996|Johns Hopkins University School of Medicine|Dr. Annie Umbricht, M.D.|410-550-1917|annieumbricht@jhu.edu|
20173998|NCT00841087|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20173999|NCT02515045|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
20174000|NCT01412021|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20174001|NCT03255382|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20174002|NCT02448654|Yale University|Elise E. DeVito, Ph.D./ Associate Research Scientist|203-737-4882|elise.devito@yale.edu|
20174003|NCT00238121|University of Chicago Comprehensive Cancer Center|Dr. Gini Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
20174004|NCT02221284|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20174005|NCT00484939|Hoffmann-La Roche|Medical Communications|800 821-8590||
20174006|NCT01556581|Madigan Army Medical Center|Dr. Dan Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
20174007|NCT00449644|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
20174008|NCT03448185|University of Texas Southwestern Medical Center|Eriko Iwatate|214-648-3680|Eriko.Iwatate@UTSouthwestern.edu|
20174009|NCT02226003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174010|NCT02467465|Universidad Complutense de Madrid|Miguel Suárez Varela|+34913941518|misuarezvarela@gmail.com|
20174011|NCT03279692|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
20174012|NCT05986019|Medical University of South Carolina|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
20174013|NCT04262232|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
20174014|NCT01975909|Beth Israel Deaconess Medical Center|Brad Manor, Ph.D.|617-971-5332|bmanor@bidmc.harvard.edu|
20174015|NCT07114198|Inonu|Assistant Professor Merve Bilmez Selen|5457673089|merve.selen@inonu.edu.tr|
20174016|NCT00483379|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20174017|NCT00391989|GIMEMA|Dr. Paola Fazy; Dr. Marco Vignetti|+39 06.70390521|gimema@gimema.it|
20174018|NCT00536107|AstraZeneca|Sharon Chang||aztrial_results_posting@astrazeneca.com|
20174019|NCT00371254|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20174020|NCT00862810|Duke University Health System|Emmanuel Walter MD, MPH|919-620-5346|walte002@mc.duke.edu|
20174021|NCT03329690|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20174022|NCT01817725|Chang Gung Memorial Hospital, Linkou Branch|Dr. Ming-Wei Lai|886-3-3281200|a22141@adm.cgmh.org.tw|8969
20174023|NCT02337907|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174024|NCT00909779|Sunovion|Respiratory Medical Director|1-866-503-6351||
20174025|NCT01592344|Bioness|Charlene Myers, Contractor|9499101655|cahanderson@msn.com|
20174026|NCT00629499|Sarah Cannon Research Institute|Director, Breast Cancer Research|615-329-7274|asksarah@scresearch.net|
20174027|NCT03165110|Ascensia Diabetes|Jane Wallace|(574) 850-1467|jane.wallace@ascensia.com|
20174028|NCT03971188|Washington University in St. Louis|Dr. Charles Goldfarb|(314) 362-3768|goldfarbc@wustl.edu|
20174029|NCT00612924|Terumo|Amanda Isula, Clinical Research Coordinator|800-262-3304|amanda.isula@terumomedical.com|5549
20174030|NCT00730912|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174031|NCT03141242|University of Colorado|Hillary Lum, MD, PhD|3037241911|hillary.lum@cuanschutz.edu|
20174032|NCT02409459|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610.650.4200|mfalone@luitpold.com|844
20174033|NCT00545155|University of Rochester|Manish N. Shah|585-463-2920|manish.shah@rochester.edu|
20189544|NCT04899999|University of Rochester|Dr. Francisco Cartujano Barrera, M.D|(585) 273-1646|francisco_cartujano@urmc.rochester.edu|
20189545|NCT00243867|American Regent Inc.|Manager Medical Writing|631-772-3555|HRathfon@americanregent.com|
20189546|NCT02422524|Duke University|Julius Wilder, MD, PhD|919-668-3063|julius.wilder@duke.edu|
20189547|NCT03212638|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20189548|NCT05182606|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
20219805|NCT02012348|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(585)-657-8390|dermstudies@ucsd.edu|
20219806|NCT03095638|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20189549|NCT02831816|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
20174034|NCT04147455|Emory University|Dr. Kathryn Yount|404-727-8511|kyount@emory.edu|
20174035|NCT03311659|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160217|NCT01180036|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
20160218|NCT04243577|Purdue University|Georgia Malandraki|7654960206|malandraki@purdue.edu|
20160219|NCT01190475|Mereo BioPharma|Jacqueline Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
20160220|NCT00543803|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160221|NCT01779856|Medtronic, plc|RCS Sr. Director of Medical Affairs|763-505-4566|amy.denise.roettger@medtronic.com|
20160222|NCT02680041|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
20160223|NCT00521599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20160224|NCT01610713|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20160225|NCT03119181|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
20160226|NCT01794741|Meda Pharmaceuticals|Dr Nancy Ruiz, MD|732 564 2390|nancy.ruiz@meda.us|
20160227|NCT01774097|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|lemmoye@msn.com|
20160228|NCT00557310|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160229|NCT01180894|Denver Health Hospital|Dr. Fredric Pieracci|303-436-4029|fredric.pieracci@dhha.org|
20174036|NCT00525733|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
20174037|NCT00613015|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
20174038|NCT03632655|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-9600|jch9011@med.cornell.edu|
20205290|NCT02487901|Seoul National Unversity College of Medicine|Chun Kee Chung|+82-2-2072-2357|chungc@snu.ac.kr|
20174039|NCT01179477|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
20205291|NCT02300077|Department of Anesthesiology Washington University in St. Louis|Helga Komen|3148527622|komenh@anest.wustl.edu|
20205292|NCT01255306|"University Hospital Sestre milosrdnice"|Mia Zoric Geber, MD|+385 1 3787 354|mia.zoric-geber@zg.t-com.hr|
20219807|NCT03050060|University of Washington|Dr. Ramesh Rengan, Department Chair|206-598-4100|rengan@uw.edu|
20219808|NCT00510289|Duke University Medical Center|David Rizzieri, MD|919-668-1014|David.Rizzieri@duke.edu|
20219809|NCT03375294|Palo Alto Veterans Affairs|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
20219810|NCT01436799|Gachon University Gil Medical Center|Dr.HJ Kwak|82-32-460-3400|hyun615@gilhospital.com|
20160230|NCT00350363|Stanford|Professor|650-723-6995|cta@stanford.edu|
20160231|NCT04011826|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
20160232|NCT03651856|Medical University of SC|Dr. Gonzalo Revuelta|843-792-7262|revuelta@musc.edu|
20160233|NCT05082428|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160234|NCT01271712|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20160235|NCT05129072|Bausch + Lomb Incorporated|Steffen Robert, Senior Director Clinical Affairs|15853386399|robert.steffen@bauschcloud.com|
20160236|NCT03099174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20160237|NCT04173260|University of Pennsylvania|Dr. Andres Deik|2158297049|adeik@upenn.edu|
20160238|NCT02308163|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
20160239|NCT05235971|University of Michigan|Lara N. Coughlin, Ph.D.|734-936-3101|laraco@med.umich.edu|
20160240|NCT03609385|Charité-Universitätsmedizin Berlin|Dr. Christian Nolte|+4930450560676|christian.nolte@charite.de|
20160241|NCT02118766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160242|NCT03941964|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20160243|NCT03478254|Ciudad Real University Hospital. Castilla La Mancha Health Service.|Angela M. Seco Segura RN, Endocrinology and Nutrition Department.|926278000|amsese@live.com|79510
20160244|NCT00118846|Director, Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
20160245|NCT00726037|Northwestern Medicine Regional Medical Group|Margret Shoup|630-352-5450|MSHOUP@lumc.edu|
20160246|NCT01394692|Johann Wolfgang Goethe University|Dr. Christian Senft|+49 69 63015939|c.senft@med.uni-frankfurt.de|
20160247|NCT04669262|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20160248|NCT05463744|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20160249|NCT03088748|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
20160250|NCT00068250|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20160251|NCT01357161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160252|NCT01824823|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20160253|NCT01660672|University of Rochester Medical Center|Gretchen Birbeck|585-273-4265|Gretchen_Birbeck@URMC.Rochester.edu|
20160254|NCT00098748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20160255|NCT03955250|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|BGaudiano@Butler.org|
20160256|NCT00845039|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160257|NCT00433160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160258|NCT00859339|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20160259|NCT01288612|Mayo Clinic|Prasad G. Iyer|507-284-6469|iyer.prasad@mayo.edu|
20160260|NCT00840060|Lamar University|Monica Harn|409-880-8174|monica.harn@lamar.edu|
20160261|NCT01263015|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160262|NCT00445939|Abbott|Global Medical Services|800-633-9110||
20160263|NCT02154048|Duke University|Steve Melton, MD|919.668.2047|steve.melton@duke.edu|
20160264|NCT04028765|Thomas Jefferson University Health System|Dr. Whitney Bender|4342948416|whitney.bender@jefferson.edu|
20160265|NCT04857437|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160266|NCT02576535|NYU Langone Medical Center|Paul Huang|212-263-6414|Paul.Huang@nyumc.org|
20160267|NCT00504504|University of Texas (UT) MD Anderson Cancer|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
20160268|NCT01691885|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160269|NCT03555981|London School of Hygiene & Tropical Medicine|Dr Helen Brotherton|07481474150|helen.brotherton@lshtm.ac.uk|
20160270|NCT00354107|Children's Oncology Group|Results Reporting Coordinator|3522730558|resultsreportingcoordinator@childrensoncologygroup.org|
20160271|NCT02002936|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
20160272|NCT04035564|"Hospital del Niño de Saltillo Dr. Federico Gomez Santos"|Carlos Sanchez|+528441757244|sanchez.carlos8516@gmail.com|
20160273|NCT00369226|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
20160274|NCT02563860|Montefiore MC|Aleksandra Djukic|7189204378|adjukic@montefiore.org|
20160275|NCT00996281|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20160276|NCT03777709|Mayo Clinic|Dr. LaPrincess Brewer|5072661376|brewer.laprincess@mayo.edu|
20160277|NCT03505788|Ziekenhuis Oost-Limburg|Prof. dr. Wilfried Mullens|+32(0)89327140|wilfried.mullens@zol.be|
20160278|NCT03575065|BeiGene|Study Director|+1 - 877-828-5568|clinicaltrials@beigene.com|
20174040|NCT00189228|University of New Mexico Health Sciences Center|Dr. Mark Schuyler|5059254197|mschuyler@salud.unm.edu|
20174041|NCT04327388|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20174042|NCT04829318|Janssen-Cilag Limited|Director Global Medical Affairs Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20174043|NCT00728130|Simmons Cancer Institute at Southern Illinois University School of Medicine|Director of Clinical Trials|217-545-1946|krobinson@siumed.edu|
20174044|NCT02730299|Gamida Cell|Associate Director, Clinical Operations|+972-073-2064774|aurelie@gamida-cell.com|
20174045|NCT04053023|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20174046|NCT02073279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20174047|NCT01994629|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20174048|NCT03338062|IndianaU|Dr. Ryan Rhome|(317) 944-1367|rrhome@iu.edu|
20174049|NCT01558752|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8899|pbeaule@toh.ca|73265
20174050|NCT01980355|Spectrum Health|G. Paul Wright, MD|6162678540|paul.wright@spectrumhealth.org|
20174051|NCT04340362|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20174052|NCT01601782|University of Michigan|Jon Jacobson, MD|734-936-4365|jjacobsn@umich.edu|
20174053|NCT01519414|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|(614) 293-6196|Paul.Monk@osumc.edu|
20174054|NCT04387435|University of California, Los Angeles|Olujimi Ajijola, MD, Phd|310-206-2235|oajijola@mednet.ucla.edu|
20174055|NCT00975481|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174056|NCT03630120|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
20174057|NCT01519960|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|61 6878333|global.trial_information@roche.com|
20174058|NCT00561080|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174059|NCT02951156|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174060|NCT01092182|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|roschewskimj@nih.gov|
20174061|NCT01166178|Novartis|Study Director|41 61 324 1111||
20174062|NCT00624052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174063|NCT02466555|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
20174064|NCT03839212|University of Miami|Daniel E. Jimenez, Ph.D., Associate Professor|3052432776|dej18@miami.edu|
20174065|NCT02113956|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-5858|michele@innovativepublichealth.org|801
20174066|NCT01498458|University Hospital Heidelberg|Dr. Andreas Schneeweiss|+49 (0)6221 56 36051|andreas.schneeweiss@med.uni-heidelberg.de|
20174067|NCT02446990|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
20174068|NCT01064401|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20174069|NCT03158051|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|608-417-4224|khoppe2@wisc.edu|
20174070|NCT02738151|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20174071|NCT02047747|University of California, San Diego|David Piccioni M.D., Ph.D.|(858) 822-6346|dpiccioni@ucsd.edu|
20174072|NCT01928524|Odense University Hospital|Per Pfeiffer|+45-26283844|per.pfeiffer@rsyd.dk|
20174073|NCT06013176|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
20174074|NCT04199117|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy, Ph.D.|6082655949|demccarthy@ctri.wisc.edu|
20174075|NCT02926924|University of Michigan|Rakesh Patel|734 615-2002|rakeshpa@med.umich.edu|
20174076|NCT04916600|Wayne State University School of Medicine|Dr. Mark Greenwald, Professor|3139933965|mgreen@med.wayne.edu|
20174077|NCT03970733|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
20174078|NCT02341807|Spark Therapeutics|Clinical Director|1-866-647-7275|clinicaltrials@sparktx.com|
20174079|NCT01139450|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20174080|NCT01010906|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174081|NCT02385266|Northwestern University|Camila Bonin Pinto, PhD|3125033971|camila.pinto@northwestern.edu|
20174082|NCT02807350|Jaeb Center for Health Research|Raymond Kraker, Coordinating Center Director|(813)-975-8690|rkraker@jaeb.org|
20174083|NCT03662542|Janssen Research & Development, LLC|Head of Gastroenterology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20174084|NCT01217060|UT MD Anderson Cancer Center|Steven H. Lin, Associate Professor, Radiation Oncology Department|(713) 563-8490|shlin@mdanderson.org|
20174085|NCT01854905|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20174086|NCT02996864|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
20174087|NCT01859494|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20174088|NCT00862186|Seattle Children's Hospital|Catherine Fiona Macpherson, PhD|206-987-2032|catherine.macpherson@seattlechildrens.org|
20174089|NCT02357901|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20174090|NCT04259762|University of New Mexico Health Sciences Center|Dr. Shiraz Mishra|505-925-6085|smishra@unm.edu|
20174091|NCT01203046|Dr. Silvia M. Pinango L|Dr. Silvia M. Pinango L.|+584169267988|pinangosilvia@yahoo.com|
20174092|NCT03453684|"University of Colorado Denver | Anschutz"|Melissa Brooks-Peterson, MD|30372411111|clinicalresearchsupportcenter@ucdenver.edu|
20174093|NCT02063516|tianjinMUGH|Dr. Haiyun Wang|008613752211206|wanghy819@hotmail.com|
20174094|NCT00491387|University of Cincinnati|Myron Gerson MD|5135583974|myron.gerson@uc.edu|
20174095|NCT02293655|Cincinnati Children's Hospital Medical Center|Tanya Froehlich, MD|5136361154|tanya.froehlich@cchmc.org|
20189550|NCT02686658|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
20174096|NCT00413192|Eisai Ltd. Mosquito Way, Hatfield, Hertfordshire, AL 10 9SN|Gitta Irmer Associate Director, Data Quality & Standards Global Regulatory Operations|+44 (0) 845 676 1618||
20174097|NCT03814746|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20174098|NCT05089682|Mayo Clinic|Dr. Gregory A. Worrell|507-538-4880|Worrell.Gregory@mayo.edu|
20174099|NCT00706979|Medical University of South Carolina'|Matthew J. Carpenter|843-792-3974|carpente@musc.edu|
20160279|NCT03617536|Cara Therapeutics|Director of Clinical Trials|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20160280|NCT00113399|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20160281|NCT00396136|Biotronik, Inc.|Clinical Studies|503-451-8050|katerina.demetz@biotronik.com|
20160282|NCT03447314|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160283|NCT01703208|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20160284|NCT00252694|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
20160285|NCT04699032|VectivBio AG|Reda Sheik|+41615513030|clinicaltrials@vectivbio.com|
20160286|NCT04003207|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
20160287|NCT00443053|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160288|NCT00541866|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
20160289|NCT00522418|Cyberonics, Inc|Mark Bunker, Senior Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
20160290|NCT01574157|VA Salt Lake City Healthcare System|Dr. Kalani Raphael, Principal Investigator|801-582-1565|kalani.raphael@va.gov|1794
20160291|NCT04420572|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
20160292|NCT00578877|CONRAD|Jill Schwartz, M.D.|703-276-3913|jschwartz@conrad.org|
20160293|NCT02305017|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20160294|NCT02302092|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20160295|NCT01944098|TeamHealth Anesthesia|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
20160296|NCT01632241|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160297|NCT02251561|Alcon Japan, Ltd.|Director, Clinical & Regulatory Affairs, Division of Medical Affairs||alcon.medinfo@alcon.com|
20160298|NCT01904149|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
20160299|NCT00350272|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20160300|NCT01044212|University of Rochester|Gunhilde Buchsbaum, Division Director Urogynecology|585-273-3233|gunhilde_buchsbaum@urmc.rochester.edu|
20160301|NCT03349645|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20160302|NCT01686750|Johns Hopkins University|Dr. Gregory M.Lucas|410-614-0560|glucas@jhmi.edu|
20160303|NCT02956044|Translational Medicine Group|Program Director|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
20160304|NCT03832114|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20160305|NCT00559468|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160306|NCT01939002|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20160307|NCT00750191|The Center for Clinical Research|Dr. Leonard Kapural|1-336-765-6181|LKapural@ccrpain.com|
20160308|NCT02910401|University of Virginia|Larry Borish, MD|4342436570|lb4@virginia.edu|
20160309|NCT01165112|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20160310|NCT01774253|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
20160311|NCT03802344|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
20160312|NCT02240368|University of Foggia|Alberto Sciusco||alberto.sciusco@gmail.com|
20160313|NCT01010568|Georgetown University Hospital|Bruce D. Cheson|202-444-1212|bdc4@georgetown.edu|
20160314|NCT02793817|Kala Pharmaceuticals, Inc.|Head, Clinical Operations|781-996-5252|Results005@kalarx.com|
20160315|NCT01097642|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
20160316|NCT00871117|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160317|NCT03222973|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20160318|NCT02080481|Cleveland Clinic|Aplarslan Turan, MD|216-445-9857|turana@ccf.org|
20160319|NCT03998670|PEDIG Coordinating Center, Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813 975 8690|rkraker@jaeb.org|
20160320|NCT01444027|University of Washington, School of Nursing|Dr. George Demiris|206-221-3866|gdemiris@uw.edu|
20160321|NCT05538312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160322|NCT03020017|Northwestern University|Priya Kumthekar|312 908 5073|p-kumthekar@northwestern.edu|
20160323|NCT03571672|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
20160324|NCT00428220|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160325|NCT05858450|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20160326|NCT00642174|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160327|NCT01730339|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160328|NCT01065051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20160329|NCT02068846|University of North Carolina at Chapel Hill|Jennifer Webster-Cyriaque, DDS, PhD|(919) 537-3492|jwebster@email.unc.edu|
20160330|NCT01145352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160331|NCT03095027|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20160332|NCT00316693|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174100|NCT01701115|HSS|Dr. Daniel Maalouf|(212) 606-1000|MaaloufD@HSS.EDU|
20174101|NCT00772707|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
20174102|NCT01266460|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20174103|NCT03019107|Liberate Medical|Angus Mclachlan|+1 (833) 203-4663|info@liberatemedical.com|
20174104|NCT00644280|University of California San Francisco|Shan C. Lin, MD|415-353-2608|lins@vision.ucsf.edu|
20174105|NCT02014363|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
20174106|NCT01335581|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20174107|NCT04311424|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20174108|NCT04351087|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
20174109|NCT05517382|Yale University|Claudia-Santi Fernandes|203-785-2885|Claudiasanti.fernandes@yale.edu|
20174110|NCT02155647|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20174111|NCT00967993|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-379|medicalinfo@keryx.com|
20174112|NCT04418999|Illinois College of Optometry|Jennifer Harthan|3129497249|JHarthan@ico.edu|
20174113|NCT03525210|KU Leuven / UZ Leuven|Head of Leuven University Vaccinology Center|+32 16 321 078|luvac@kuleuven.be|
20174114|NCT01374087|Ipsen|Medical Director|use email|clinical.trials@ipsen.com|
20174115|NCT02461225|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20174116|NCT00271947|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
20174117|NCT01786954|Duke Eye Center|Dr Paul Hahn|919-684-5631|paul.s.hahn@duke.edu|
20174118|NCT01522365|Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 (0)31 376 30 00|clinicalresearchmolndal@dentsplysirona.com|
20174119|NCT00651755|University of Texas MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||xzhou@mdanderson.org|
20174120|NCT04170348|CUIMC|Dr. Margaret T. Lee, Professor of Pediatric|212-305-6290|ml653@cumc.columbia.edu|
20174121|NCT01120756|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@va.gov|
20174122|NCT04026048|Memorial University of Newfoundland|Dr. Sheila Garland|(709) 864-4897|sheila.garland@mun.ca|
20174123|NCT00506155|University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
20174124|NCT01467947|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
20174125|NCT03616899|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results011@kalarx.com|
20174126|NCT02517996|Johns Hopkins University School of Medicine|Dr. Tola Fashokun|410-464-6641|bunmi_omo@hotmail.com|
20174127|NCT00679263|Medicinova Inc|Kazuko Matsuda, MD, Vice President Clinical Development|858-373-1500|matsuda@medicinova.com|132
20174128|NCT05104567|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20174129|NCT03479307|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
20174130|NCT01464346|Medtronic Diabetes Clinical Research|Pamela Haworth||pamela.c.haworth@medtronic.com|
20174131|NCT02295995|Durham VA HCS|Dr. Katherine S. Hall|919-286-0411|katherine.hall@duke.edu|6734
20174132|NCT02124863|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@telenet.be|
20189551|NCT00485693|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20189552|NCT05250206|Indizen Optical Technologies (Madrid), Universidad Complutense de Madrid|Director of Clinical Trials|+34 (91) 833 37 86|evachamorro@iot.es|
20189553|NCT02581137|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
20189554|NCT04069247|Chinese University of Hong Kong|Dr. Yun Kwok Wing|+852 39197593|ykwing@cuhk.edu.hk|
20189555|NCT00604890|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
20189556|NCT02969356|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20189557|NCT02678455|University of Vermont|Beth Kirkpatrick MD|802-656-5822|beth.kirkpatrick@med.uvm.edu|
20189558|NCT03187223|Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland|Prof Dr. Thomas Pabst|+41 31 63 2 84 30|Thomas.Pabst@insel.ch|
20189559|NCT04700904|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
20189560|NCT03508700|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
20189561|NCT02556918|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
20189562|NCT06134089|University of Utah|Andy King|801-646-4274|andy.king@utah.edu|
20189563|NCT05643885|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189564|NCT04511702|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20189565|NCT04493424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189566|NCT03062488|Nemours Children's Healthcare System|Carlos A. Archilla, MD|4076507646|carlos.archilla@nemours.org|
20189567|NCT00108355|VA-CT Healthcare System|Guadalupe Garcia-Tsao|203-932-5711|guadalupe.garcia-tsao@yale.edu|2210
20189568|NCT04992273|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20189569|NCT01364597|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20189570|NCT03774849|Candela|Dr. Konika Patel Schallen|5083580357|cie.studyinfo@candelamedical.com|
20189571|NCT03493282|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
20189572|NCT01380145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20174133|NCT02005250|Odense Universitetshospital, afd.M|Prof. Steen Bonnema|+4527339180|steen.bonnema@rsyd.dk|
20174134|NCT04994444|Brown University|Dr. Patricia Cioe|4018636638|patricia_cioe@brown.edu|
20174135|NCT00378209|Dana-Farber Cancer Institute|Dr. Paul Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
20174136|NCT03084081|Cleveland Clinic|Miriam Cremer, M.D.|216-213-6460|cremerm@ccf.org|
20189573|NCT02698475|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20174137|NCT01252940|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20174138|NCT01698463|University of Waterloo|Dr. Lora Giangregorio|(519) 888-4567|lmgiangr@uwaterloo.ca|36357
20174139|NCT01239368|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
20174140|NCT04709575|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20174141|NCT02145039|University of Minnesota Cancer Center|Dr. Claudio Brunstein|612-625-8942|bruns072@umn.edu|
20174142|NCT03181399|Weill Cornell Medicine|Dr. Juan Pascual|(212) 746-3278|jup9003@med.cornell.edu|
20174143|NCT01536379|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174144|NCT02410382|University of Arizona|Dr. Sun K. Yi|(520) 694-7236|sunkyi@email.arizona.edu|
20174145|NCT02064907|Takeda Study Registration Call Center|Takeda|+1-877-825-3327|medicalinformation@tpna.com|
20174146|NCT00265473|Schulze Diabetes Institute, University of Minnesota|Melena D. Bellin, MD|612-625-4686|bell0130@umn.edu|
20174147|NCT06063603|Mayo Clinic|Andrea L. Cheville, MD|507-284-2511|cheville.andrea@mayo.edu|
20174148|NCT04439253|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20174149|NCT03971695|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174150|NCT00939809|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
20174151|NCT04447417|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20174152|NCT01002755|The University of Texas M D Anderson Cancer Center|Ferrajoli,Alessandra M.D.|713-792-2063|aferrajo@mdanderson.org|
20174153|NCT00702403|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
20174154|NCT01341600|University of Maryland School of Medicine|Richard Horenstein M.D., Associate Professor of Medicine|410-706-0154|rhorenst@medicine.umaryland.edu|
20174155|NCT00858442|coaniquem|M Beatriz Quezada.MD|56-2-28734077|investigacion@coaniquem.cl|
20174156|NCT01280552|ImmunoCellular Therapeutics Ltd.|Anthony Gringeri, Ph.D. Senior Vice President Strategic Resources|818 264 2300|anthony.gringeri@imuc.com|
20174157|NCT02016625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174158|NCT02155738|University of Pittsburgh|Halina Zyczynski|412-641-1440|hzyczynski@mail.magee.edu|
20174159|NCT03303404|University of Texas at Austin|Brandon Fico|512-471-8594|bfico@utexas.edu|
20174160|NCT02356783|Hospital for Special Surgery|Robert Griffin, MD, PhD|212-774-2944|griffinr@hss.edu|
20174161|NCT02603809|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 19 77|clinical-trials-disclosure@idorsia.com|
20174162|NCT02953990|Virginia Commonwealth University School of Nursing|Patricia Kinser, PI|804-828-0724|kinserpa@vcu.edu|
20174163|NCT00380978|Department of Anesthesiology; Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20174164|NCT01254227|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20174165|NCT00887354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20174166|NCT00824044|Massachusetts General Hospital|Dr. Amy Farabaugh|617-726-1629|afarabaugh@partners.org|
20174167|NCT01466348|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174168|NCT01291056|University of Utah Department of Obstetrics & Gynecology|Dr. Jessica Pittman|801-339-4103|jessica.pittman@hsc.utah.edu|
20174169|NCT00192504|MedImmune, LLC|Genevieve A. Losonsky, MD/VP Clinical Development|301-398-0000|losonskyG@medimmune.com|
20174170|NCT03989440|ReNetX Bio, Inc.|George D. Maynard, Ph.D., Study Director|2032088925|info@renetx.com|
20174171|NCT02974296|Columbia University|DR. Marta Moreno-Ortega|9142187311|mm4355@cumc.columbia.edu|
20174172|NCT02189473|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
20174173|NCT01955161|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20174174|NCT02784821|University of Florida|Dr. Josef Neu|352-733-0111|neuj@peds.ufl.edu|
20174175|NCT02794103|Université de Montréal|Dr. Sylvie Le May, Professor & Researcher|514 345-4931|sylvie.lemay@umontreal.ca|4938
20174176|NCT04608500|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20174177|NCT03928847|University of California at San Francisco|Harold A. Chapman, M.D.|415-514-1210|hal.chapman@ucsf.edu|
20174178|NCT01881230|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20174179|NCT05123222|Center for Immunization Research|Anna Durbin|667-306-9772|adurbin1@jhu.edu|
20174180|NCT00112502|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Chair Ad Interim, Neuro-Oncology|713-745-3072|jdegroot@mdanderson.org|
20174181|NCT00834210|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20174182|NCT00914810|Minneapolis VA Health Care System|Ken Kunisaki, M.D.|612-467-4400|kunis001@umn.edu|
20174183|NCT02747420|NYU Langone Health|Dr. Benjamin Brucker|+1 646 825 6300|Benjamin.Brucker@nyulangone.org|
20174184|NCT05129488|Bausch & Lomb|Study Director|15853386399|robert.steffen@bausch.com|
20174185|NCT00265343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20174186|NCT02608268|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20174187|NCT01925404|RAND|Deborah Cohen|310 3930411|dcohen@rand.org|
20174188|NCT00706641|Hoosier Cancer Research Network, Inc.|Noah Hahn, MD|317-921-2050|jsmith@hoosiercancer.org|
20174189|NCT03684512|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
20174190|NCT02994732|Biomed Valley Discoveries|Associate Director of Translational Sciences|636-887-6429|Dknoerzer@biomed-valley.com|
20174191|NCT04782856|Uconn Health|Francesco S. Celi, MD, MHSc.|860-679-2715|celi@uchs.edu|
20174192|NCT02535741|Stryker European Operations BV|Doug McGurty|+44(0)1635 500690|doug.mcgurty@stryker.com|
20174193|NCT01030523|Dentsply Sirona Implants|Manager of Global Clinical Research|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
20174194|NCT00426283|Cincinnati Children's Hospital Medical Center|Marc E Rothenberg|513-636-7177|rothenberg@cchmc.org|
20160333|NCT02982018|Johnson & Johnson Vision|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
20160334|NCT03245736|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
20160335|NCT01116024|Medtronic, Inc.|Ryan Palmer, Principal Clinical Research Specialist|763-514-9732|ryan.j.palmer@medtronic.com|49732
20160336|NCT00132691|Center for Presventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania|John H. Kempen, MD, PhD, MUST Trial Vice-Chairman|215-615-1500|john.kempen@uphs.upenn.edu|
20160337|NCT04098367|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20160338|NCT02251717|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20160339|NCT03824405|Botanix Pharmaceuticals|Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
20160340|NCT03515226|University of Washington, Department of Psychiatry & Behavioral Sciences|Dr. Patricia Arean, Director, UW ALACRITY Center|206-221-8692|parean@uw.edu|
20160341|NCT03010137|UC Davis Medical Center|Dr. Yunfeng Xue|408-603-0507|yunxue@ucdavis.edu|
20160342|NCT00322023|Nathan Kline Institute|Dr. Daniel Javitt|845-398-6534|javitt@nki.rfmh.org|
20160343|NCT03920293|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20160344|NCT01952444|Elusys Therapeutics Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
20160345|NCT01477463|Stanford University School of Medicine|Jean Y Tang MD PhD, assistant professor|650-721-7149|baileyhi@stanford.edu|
20160346|NCT03361189|UCLA|Dr. Jeremy P. Moore|310-267-7667|RGoldstein@mednet.ucla.edu|
20160347|NCT03344549|University of Colima|Ari Cisneros Hernández|3335762299|aricisneroshernandez@gmail.com|
20160348|NCT02323126|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20160349|NCT01679600|Bern University of Applied Sciences|Dr. Oliver Stoller|+41344264195|oliver.stoller@bfh.ch|
20160350|NCT00108303|VA|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
20160351|NCT01685801|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20160352|NCT03350256|Abbott|Filippo Agnesi|+19725264860|filippo.agnesi@abbott.com|
20174195|NCT00798369|Novartis Pharmaceuticals|Study Director|862-778-8300||
20174196|NCT03001258|BRAC|Anita Sharif Chowdhury/Research Fellow of BRAC Research and Evaluation Division|+88029846448|anita.sc@brac.net|3719
20174197|NCT02430337|Georgia State University|Shannon Self Brown, PhD|404-413-1283|sselfbrown@gsu.edu|
20174198|NCT02312726|University of New Mexico - Family Planning Research Division|Michel Paves, Research Specialist|505-272-9703|mdaliva@salud.unm.edu|
20174199|NCT01454570|James J Peters VA Medical Center|Dr. Ann Spungen - PI|718-584-9000|ann.spungen@va.gov|5420
20174200|NCT01192282|Groote Schurr Hospital / University of Cape Town|Dr Shahila Tayib|0060195773376|syarq@yahoo.com|
20174201|NCT00117559|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4797|amy.silberbogen@va.gov|
20174202|NCT01892371|The University of Texas MD Anderson Cancer Center|Yesid Alvarado MD./Associate Professor|713-794-4364|yalvarado@mdanderson.org|
20174203|NCT03188094|NYU Langone Health|Jennifer Zanowiak|212 263 0485|Jennifer.Zanowiak@nyulangone.org|
20174204|NCT04007094|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20174205|NCT02653560|UT Southwestern Medical Center|Dr Wanpen Vongpatanasin|2146489078|wanpen.vongpatanasin@utsouthwestern.edu|
20174206|NCT03628703|Cincinnati Children's Hospital Medical Center|Steve W. Wu, M.D.|513-636-4222|steve.wu@cchmc.org|
20174207|NCT04350788|UNC-CH School of Nursing|Biostatistician|919-966-7181|peiran@live.unc.edu|
20174208|NCT01581307|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sarah Hoffe|813-745-4380|sarah.hoffe@moffitt.org|
20174209|NCT02117999|Studio Italiano di Oftalmologia|Marco Lombardo|+39 331 34 38 300|mlombardo@visioeng.it|
20174210|NCT02070744|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20174211|NCT01894581|University of Colorado Denver|Dr. Alex Polotsky|303-724-2001|alex.polotsky@ucdenver.edu|
20174212|NCT03795298|Boston Scientific|Anne Cornaille|+1-800-227-3422|anne.cornaille@bsci.com|
20174213|NCT04383743|University of Washington|Dr. Petros Grivas|2066061943|pgrivas@uw.edu|
20174214|NCT05230693|Medical University of South Carolina|Ennis James, MD|843-792-3769|jamesw@musc.edu|
20174215|NCT05478252|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20174216|NCT03939897|Washington University in St. Louis School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
20174217|NCT03482791|Washington University School of Medicine|Gregory Vlacich, M.D., Ph.D.|314-362-8610|gvlacich@wustl.edu|
20174218|NCT01816893|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
20174219|NCT04475588|Biocon Biologics India Limited|Dr. Subramanian Loganathan|0802808|subramanian.l101@biocon.com|5466
20174220|NCT01327300|University of Florida|Dr. Baharak Moshiree|(352)273-8393|bmoshiree@med.miami.edu|
20174221|NCT03020823|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
20174222|NCT03739112|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20174223|NCT03492099|Johns Hopkins University School of Medicine|Dr. Sophie Lanzkron|4105028642|slanzkr@jhmi.edu|
20174224|NCT00588822|Mayo Clinic|Dr. Benn E. Smith|480-301-6711|bsmith@mayo.edu|
20174225|NCT01948739|Rice University|Marcia K. O'Malley, PhD|(713) 348-3545|omalley@rice.edu|
20174226|NCT04762680|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20174227|NCT02082210|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20174228|NCT03493828|New York Methodist Hospital|Dr Joel Yarmush|(718) 780-3279|joelyarmush@gmail.com|
20174229|NCT01810666|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20174230|NCT02436759|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|9088091423|mvelasco@osmotica.com|
20174231|NCT01727141|Novartis Pharmaceuticals|Study Director|862-778-8300||
20174232|NCT02584504|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20174233|NCT03839511|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
20174234|NCT01290666|University of California, Irvine|Michael J Stamos, MD|888-532-4123||
20174235|NCT00775931|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
20174236|NCT01652664|Alcon Research, Ltd.|Subha Venkataraman, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20174237|NCT00297037|University of Utah|Dr. Christopher Hull|801-581-6465|christopher.hull@hsc.utah.edu|
20174238|NCT00581776|University of Wisconsin- Madison|Brad S Kahl|608-263-1836|bsk@medicine.wisc.edu|
20174239|NCT03538158|Weill Cornell Medicine|Chelsie Burchett|212-746-1417|cob2014@med.cornell.edu|
20174240|NCT03425331|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
20189574|NCT02038049|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20189575|NCT02771366|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
20205293|NCT01179347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205294|NCT00168324|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20205295|NCT01299610|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205296|NCT01337167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205297|NCT02223429|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
20205298|NCT03833817|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
20205299|NCT00884221|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20205300|NCT02097485|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20205301|NCT04172701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205302|NCT02126670|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
20205303|NCT02757092|Chang Gung Memorial Hospital|Respiratory therapist Nai-Ying Kuo|+886077317123|ellen0605@gmail.com|2648
20205304|NCT03363919|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
20174241|NCT01232920|Proctor Foundation, University of California San Francisco|Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
20174242|NCT01413360|Seoul National University Hospital|Jung-Hwan Yoon|+82-2-2072-2228|yoonjh@snu.ac.kr|
20174243|NCT01628601|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20174244|NCT00151320|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
20174245|NCT02246673|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
20174246|NCT01199744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219811|NCT00861198|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20174247|NCT02418468|Novartis Pharmaceuticals|Study Director|862-778-8300||
20174248|NCT02914769|UFRN|Draulio Barros de Araujo|+5584991225987|draulio@neuro.ufrn.br|
20174249|NCT02876900|Noven Pharmaceuticals|George Harb, MD, MPH - Executive Director, Clinical Development|1-551-233-2656|gharb@noven.com|
20174250|NCT04356963|University of Maryland School of Medicine|Dr. Nicholas Morris|410-328-4515|nicholas.morris@som.umaryland.edu|
20174251|NCT02285907|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
20174252|NCT00099437|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20174253|NCT02410954|University of California, San Francisco|Andrew Krystal, MD|(415) 476-7702|andrew.krystal@ucsf.edu|
20174254|NCT02738333|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20174255|NCT00791518|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174256|NCT02488681|Medtronic|Micra CA Study Manager|800-328-2518|rs.micracontinuedaccess@medtronic.com|
20174257|NCT05413369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20174258|NCT02658136|Rigshospitalet|Dr Kiran Mirza|004535451442|KMIR0003@regionh.dk|
20174259|NCT02809677|UT Southwestern Medical Center|Dr. E. Sherwood Brown|24-645-6950|sherwood.brown@utsouthwestern.edu|
20174260|NCT00006101|University of California, Irvine|Dr. Thomas Ahlering|(714) 456-6068|tahlerin@uci.edu|
20174261|NCT00720057|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20219812|NCT02288182|gwd consult · contract research|Dr. Manfred Klasser|+49 (6108) 8256520|manfred.klasser@gwd-consult.de|
20219813|NCT02823652|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20219814|NCT04619992|Hollister Incorporated|Director of Global Clinical Affairs|+1 224-206-2857|sara.wegener@hollister.com|
20174262|NCT04949165|University of Minnesota|Protocol Manager for BLIS|(612)590-2697|telke001@umn.edu|
20174263|NCT04969224|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20174264|NCT01335230|University of Cincinnati, Associate Prof., PI.|Mohamed Tarek M. shata|(513) 558-6110|mohamed.shata@uc.edu|
20174265|NCT01498952|MedImmune LLC|Mohammed Dar|+301-398-0000|information.center@astrazeneca.com|
20174266|NCT02726074|Eisai Inc.|Eisai Korea Inc. Medical department|+82-2-3451-5539|h3-park@eisaikorea.com|
20174267|NCT00579826|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
20174268|NCT01679002|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20174269|NCT05172544|Najít Technologies, Inc.|Dr. Ian Amanna|9717273569|iamanna@najittech.com|
20174270|NCT00454987|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174271|NCT01176266|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
20174272|NCT02642432|AbbVie|Global Medical Services|800-633-9110||
20174273|NCT03999892|Johns Hopkins|Gail Daumit|410 614 6460|gduamit@jhmi.edu|
20174274|NCT01848756|Esanex Inc|Eric Orlemans, Chief Scientific Officer|919-338-2019|eorlemans@esanexpharma.com|
20174275|NCT03245008|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20174276|NCT02075658|UCI Health Department of Urology|Clinical Research Coordinator|714-456-8176|yoonrh@uci.edu|
20174277|NCT01286012|Rockwell Medical|Raymond Pratt, MD CMO|248 960 9009|rd@rockwellmed.com|
20174278|NCT05734443|Virginia Tech|Michael Madigan|5402313543|mlm@vt.edu|
20174279|NCT01602380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20174280|NCT00496756|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
20174281|NCT00877058|Göteborg University|Professor Synneve Dahlin-Ivanoff (Research leader)|+46317865733|synneve.dahlin-ivanoff@gu.se|
20174282|NCT01918761|Cecog|MD Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
20174283|NCT06145542|Zhejiang University|Dr. Xiao Tan|18651218270|xiao.tan@zju.edu.cn|
20174284|NCT03340337|Universidad Maimónides - Universidad Nacional Arturo Jauretche - Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló|Oscar Ronzio|+54-11-4905-1140|ronzio.oscar@maimonides.edu|
20174285|NCT01268111|Mayo Clinic|A J Vinaya Simha|5072664321|simha.aj@mayo.edu|
20174286|NCT04307446|Tufts University|Nancy Baker|617 627 5562|nancy.baker@tufts.edu|
20174287|NCT02094716|Mylan Pharmaceuticals Pvt Ltd|Clinical Sciences Program Lead||prasannac.ganapathi@mylan.in|
20174288|NCT01063764|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20174289|NCT00697515|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20174290|NCT01748643|Ziekenhuis Oost-Limburg|Dr. Pascal Vanelderen|+3289325298|pascal.vanelderen@gmail.com|
20174291|NCT02701647|The Hong Kong Polytechnic University|Chloe Chung|2766|chloe.lh.chung@connect.polyu.hk|7092
20174292|NCT02205333|MedImmune, LLC|Victoria Chiou|301-398-4330|chiouv@MedImmune.com|
20219815|NCT04428333|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219816|NCT02269163|Prometic Biotherapeutics Inc|Director, External Biologics|438-802-3497|clinical@prometic.com|
20174293|NCT02447133|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
20174294|NCT03054870|Cyclomedica Australia Pty Ltd|James McBrayer|+61 2 9541 0411|clinicaltrials@cyclomedica.com|
20174295|NCT02009046|PHI|Norman A. Constantine, Ph.D.|925-284-8118|nconstantine@berkeley.edu|
20174296|NCT01096810|Mount Sinai|Dr. Sundar Jagannath|2122417873|sundar.jagannath@mountsinai.org|
20160353|NCT03960580|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|265-521-0565|john.messina@optinose.com|
20160354|NCT01528891|Children's Hospital of Pittsburgh of UPMC|Peter J. Davis, MD|4126925260|davispj@anes.upmc.edu|
20160355|NCT01437098|Medtronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
20160356|NCT00834990|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20160357|NCT01235923|University of Utah|Robin Ohls|801-581-7052|robin.ohls@hsc.utah.edu|
20160358|NCT00791479|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160359|NCT00773786|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD||rzuwalla@stfranciscare.org|
20160360|NCT00543296|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
20160361|NCT03828422|University Medical Centre Ljubljana|dr. Aleš Blinc, MD, PhD|+38615227124|ales.blinc@kclj.si|
20160362|NCT00934947|UNC Department of Anesthesiology|Samuel McLean|919-966-7315|smclean@aims.unc.edu|
20160363|NCT00585494|University of Wisconsin Madison|Ann Marie Sheehy, M.D., M.S.|608-335-6734|asr@medicine.wisc.edu|
20160364|NCT01920568|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160365|NCT02309645|Ethicon Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20160366|NCT03664674|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20160367|NCT01101971|Queen's University|Dr. Robert Reid|6135332898|reidr@queensu.ca|32898
20160368|NCT01342965|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20160369|NCT01170598|University Health Network|Sara O'Neill|416-597-3422|o'neill.sara@torontorehab.on.ca|7860
20160370|NCT03022097|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20160371|NCT01451931|University of California, San Francisco|Dr. Rebecca Smith-Bindman|415-353-4946|rebecca.smith-bindman@ucsf.edu|
20160372|NCT00607269|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D., Statistician|323-463-1601|jfletcher@friendsresearch.org|
20160373|NCT04270682|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20160374|NCT02388490|Seoul National University Hospital|Tae Min Kim|82+2-2072-3559|gabriel9@snu.ac.kr|
20160375|NCT00855933|The Procter & Gamble Co.|Jon Witt|513-622-2963|witt.jj.2@pg.com|
20160376|NCT00951080|KCI|VP, Global Clinical Development|12102555595|jkhart@mmm.com|
20160377|NCT01960998|Birmingham VA Medcial Center|Kathryn L. Burgio, PhD|205-999-9537|kburgio@uabmc.edu|
20160378|NCT00835640|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20160379|NCT00812006|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
20160380|NCT00235391|Novartis Pharmaceuticals|Study Director|862-778-8300||
20160381|NCT02802241|BIDMC|Judy Nee|6176672193|jnee@bidmc.harvard.edu|
20160382|NCT02927925|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20160383|NCT00580034|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20160384|NCT01182805|University of Michigan|Theodore J. Kolias, MD|(734) 615-4907|tkolias@umich.edu|
20160385|NCT00916058|Weill Cornell Medical College|Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
20160386|NCT02439450|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
20160387|NCT01170065|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160388|NCT02387801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160389|NCT00717522|Celgene Corporation|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20160390|NCT04092907|Harbour Biomed|Nina Shen|18251811067|nina.shen@harbourbiomed.com|
20160391|NCT03551665|Arizona State University|Daniel Peterson|602-543-9373|daniel.peterson1@asu.edu|
20160392|NCT00496483|Veloxis A/S|Christina Sylvest, Sr VP, Global Clinical Development and Operations|+45 20553877|csy@veloxis.com|
20160393|NCT00896363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160394|NCT04143217|Supernus Pharmaceuticals Inc.|Jonathan Rubin, MD, MBA, Senior Vice President/Chief Medical Officer|240-403-5710|jrubin@supernus.com|
20160395|NCT00919867|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20160396|NCT03333252|Weill Medical College of Cornell University|Sara J. Czaja|646-962-7141|sjc7004@med.cornell.edu|
20160397|NCT00457977|University of Minnesota|Sarah Harnden|612-626-9011|sharnden@ccbr.umn.edu|
20160398|NCT04049266|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
20160399|NCT01933230|Cleveland Clinic|Dr. Jose Javier Provencio, Faculty, Neuroinflammation Research Center|216-445-242|provenj@ccf.org|
20160400|NCT04600076|University of Michigan|Katherine Jo Gold|734 998-2499|ktgold@med.umich.edu|
20160401|NCT02891681|Washington University School of Medicine|Quing Zhu, Ph.D.|314-935-7519|zhu.q@wustl.edu|
20160402|NCT02174523|Phase I Clinical Research Unit , Shanghai Xuihui Central Hospital|Dr.Hu Chaoying|021-54036058|cyhu@shxh-centerlab.com|
20160403|NCT01509677|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20160404|NCT00499655|City of Hope|Karen L. Reckamp, M.D.|(626) 256-4673|kreckamp@coh.org|
20160405|NCT00534118|Roswell Park Cancer Institute|Theresa Hahn|716-845-2300|theresa.hahn@roswellpark.org|
20160406|NCT02780856|Calcivis Ltd|Director of Clinical Research|+ 44 131 658 5152|mwillins@calcivis.com|
20160407|NCT01790178|Duke University|Lisa Hobson-Webb|919-668-2277|lisa.hobsonwebb@dm.duke.edu|
20160408|NCT03894969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160409|NCT00589056|University of Pennsylvania|Ramesh Rengan, M.D., Ph.D.|(215) 662-2428|Rengan@xrt.upenn.edu|
20160410|NCT00468676|Dept Psychiatry, University of Washington Medical School|Dr Wayne Katon, Professor and Vice Chair|206-543-7177|wkaton@uw.edu|
20160411|NCT02378298|Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg|Helena Filipsson Nyström|0046-705833398|helena.filipsson@medic.gu.se|
20160412|NCT04762043|Altec, Inc.|Dr. Joshua Kline|5085458212|jkline@altecresearch.com|
20174297|NCT00304356|VA Houston|Daniel Musher|713-794-7386|daniel.musher@va.gov|
20174298|NCT01807897|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6175|daniel.gottlieb@va.gov|
20174299|NCT04120974|Becton, Dickinson and Company|Sandra van Guldener, Director OUS Clinical Affairs|+31646900840|sandra.vanguldener@bd.com|
20174300|NCT02951338|University Health Network|Avril Mansfield|416-597-3422|avril.mansfield@uhn.ca|7831
20174301|NCT00973479|Centocor, Inc.|Director Clinical Research|1-800-457-6399||
20174302|NCT05075850|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
20174303|NCT04256785|Universidad de Granada|Dr. Elena Pita Calandre|+34 958246291|epita@ugr.es|
20174304|NCT01154218|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174305|NCT01265849|CEL-SCI Corporation|John Cipriano, Senior VP Regulatory Affairs, Eyal Talor Chief Scientific Officer|(205) 586-6947|jcipriano@cel-sci.com|
20174306|NCT00362115|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20174307|NCT01172184|Kaohsiung veterans general hospital|Dr. Shih-Hung Hsiao|886-7-3422121|irb@vghks.gov.tw|1518
20174308|NCT01170091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174309|NCT03194321|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
20174310|NCT00271609|National Cancer Institute, National Institutes of Health|Teri Kreisl, M.D.|301-402-3423|kreislt@mail.nih.gov|
20174311|NCT02188589|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20174312|NCT01547000|University of South Florida|Tanya K. Murphy, MD, MS|813-974-2201|tmurphy@health.usf.edu|
20174313|NCT03341533|Mayo Clinic|Dr. Tatnai Burnett|507-538-5783|burnett.tatnai@mayo.edu|
20174314|NCT00643682|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|6176386563|brian.jacobson@bmc.org|
20174315|NCT02084147|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
20174316|NCT03755414|Washington University School of Medicine|Dr. Ramzi Abboud|314-454-8304|rabboud@wustl.edu|
20174317|NCT02153112|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20174318|NCT03168308|University of Texas Southwestern|Tiffany Moon, MD|4694195790|Tiffany.Moon@UTSouthwestern.edu|
20219817|NCT00804713|USUHS|James Mancuso|301-295-3734|james.mancuso@usuhs.edu|
20174319|NCT04039412|Zagazig University-Faculty of Human Medicine|Dr. Ayman Fathy Elsayed|+201125020593|aymanf28@yahoo.com|
20174320|NCT00003641|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20174321|NCT00944450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174322|NCT03019939|The University of Texas MD Anderson Cancer Center|Prithviraj Bose MD/Associate Porfessor|713-792-7747|PBose@mdanderson.org|
20174323|NCT02154581|UT Health San Antonio|Research Compliance Coordinator-Senior|210-567-8554|NijlandK@uthscsa.edu|
20174324|NCT00878709|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20174325|NCT02225743|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsosh@musc.edu|
20174326|NCT01347541|University of Washington School of Medicine|Dr, Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
20174327|NCT02591147|University of Iowa College of Dentistry|Dr. Justine Kolker|(319) 335-7583|justine-kolker@uiowa.edu|
20174328|NCT00768300|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20174329|NCT02664909|UConn Health|Vincent Williams, M.D.|(860) 679-8384|vwilliams@uchc.edu|
20174330|NCT02068222|AbbVie|Global Medical Information|800-633-9110||
20174331|NCT01675128|National Cancer Institute|Dr.Tim Greten|301-451-4723|gretentf@mail.nih.gov|
20174332|NCT03526458|University of Wisconsin, School of Medicine and Public Health, Department of Urology|Shuang Li|6082638336|lis@urology.wisc.edu|
20174333|NCT03011307|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|eisenach@wakehealth.edu|
20174334|NCT01782664|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219818|NCT01208220|LSUShreveport|Dr. Stanley McCallon|318-813-2996|smccal@lsushc.edu|
20219819|NCT00758680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219820|NCT00319982|Brigham and Women's Hospital|Carolyn Ho, MD|617-732-5685|cho@partners.org|
20219821|NCT01094886|Janssen Scientific Affairs, LLC|VP Medical Affairs, Internal Medicine|1 908 218-7250||
20219822|NCT03480386|Mayo Clinic|Roberto P. Benzo, MD|507-284-0561|Benzo.Roberto@mayo.edu|
20219823|NCT00574912|University of Maryland, Baltimore|Dr. Stephen N. Davis|4103282488|sdavis@medicine.umaryland.edu|
20219824|NCT01282723|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
20160413|NCT03006458|CooperVision|Myhanh Nguyen|9257306716|MNguyen@coopervision.com|
20160414|NCT01468233|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20160415|NCT02480166|Stanford University Medical Center|Mindie H. Nguyen, MD, MAS|650-4985691|mindiehn@stanford.edu|
20160416|NCT00457821|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20160417|NCT00842946|Department of Veterans Affairs (formerly Drexel University)|Dr. Erica England|207-239-6323|elengland02@yahoo.com|
20160418|NCT02437409|phenox GmbH|Clinical Affairs|+49 (0)234 36 919|ARTESp@phenox.info|0
20160419|NCT05131971|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160420|NCT02637427|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
20160421|NCT00445211|William Beaumont Hospital|Dr. Justin Trivax|(248)587-2300|Justin.Trivax@beaumont.edu|
20160422|NCT00383643|Stanford University School of Medicine, Dept of Psychiatry|Dr. Jed Black|650 736 4559|jedblack@stanford.edu|
20160423|NCT03549871|Sanofi ( Genzyme, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20160424|NCT01687088|Thomas Jefferson University|Michael J. Marmura, MD|215-955-2243|michael.marmura@jefferson.edu|
20160425|NCT01644695|Institute For Advanced Reconstruction|Dr. Andrew Elkwood, MD|732-741-0970|aelkwood@hotmail.com|
20174335|NCT02404285|Next Science|Matt Myntti PHD, President|9046474161|mmyntti@nextscience.org|
20174336|NCT00698581|UCB|UCB Cares|+1 877 822 9493||
20174337|NCT03760146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174338|NCT01082965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174339|NCT03642717|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174340|NCT02587065|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20174341|NCT03022292|Stein Eye Institute of UCLA|Dr. David Sarraf|310-825-7836|DSarraf@ucla.edu|
20174342|NCT00827983|IBSA Institut biochimique|Clinical trial manager|+41583601000|barbara.cometti@ibsa.ch|
20174343|NCT04056195|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
20174344|NCT02406651|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
20174345|NCT04595513|Cincinnati Children's Hospital Medical Center|Darcy A. Krueger, MD., PhD|513-636-4222|krueger_darcy@cchmc.org|
20174346|NCT01395329|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
20174347|NCT00718328|Johns Hopkins University SOM (former employer during the study)|Neeraj Naval|9042026290|neerajnaval@gmail.com|
20174348|NCT02865915|Millendo Therapeutics US, Inc.|Director of Clinical Operations|734-845-9000|millendo@millendo.com|
20174349|NCT01876485|Department of Veterans Affairs|Dr. LeChauncy Woodard|(713) 440-4441|woodard.lechauncy@va.gov|
20174350|NCT00663052|Wyeth, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174351|NCT06002958|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|(919) 962-1401|kelsey_ludwig@med.unc.edu|
20174352|NCT05497284|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20174353|NCT05760300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20174354|NCT03878446|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20174355|NCT05041322|Spaulding Hospital Cambridge|Jason Hamner|6177585501|jhamner@mgb.org|
20174356|NCT04814433|NYU Langone Health|Thomas Calahan|929-455-5826|Thomas.Calahan@nyulangone.org|
20174357|NCT01331148|Carolinas Healthcare System|Ifeyinwa Osunkwo, MD, MPH, Principal Investigator|980 442 5001|ify.osunkwo@carolinashealthcare.org|
20174358|NCT01545817|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20174359|NCT02967692|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
20174360|NCT00476021|University of Pittsburgh|Principal Investigator|412-641-5496|chenba@upmc.edu|
20174361|NCT00066066|The Forsyth Institute|Ricardo P Teles, DDS, DMSc|617 892-8556|rteles@forsyth.org|
20174362|NCT03752307|University of New Mexico|Corey Ford, M.D., Ph.D.|505-925-4124|cford@salud.unm.edu|
20174363|NCT01230931|The University of Texas Health Science Center at Houston|Catherine G. Ambrose, PhD||Catherine.G.Ambrose@uth.tmc.edu|
20174364|NCT03181828|Children's National|Dr. Nicholas Ah Mew|2025452513|nahmew@childrensnational.org|
20174365|NCT05477875|University of Florida Oaks Eye Center|Yujia Zhou|3522652020|yzhou1996@ufl.edu|
20174366|NCT03054857|King Chulalongkorn Memorial Hospital|Dr.Yada Thongsuk|+66817738629|thongsuk.y@hotmail.com|
20174367|NCT02603432|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174368|NCT04939727|HealthPartners Institute|Dr. Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
20174369|NCT00613028|Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|919-668-1409|reard003@mc.duke.edu|
20174370|NCT05853250|Cleveland Clinic|Nancy M. Albert, PhD, Associate Chief Nursing Officer|216-444-7028|albertn@ccf.org|47028
20174371|NCT01319812|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
20174372|NCT02759120|Weill Cornell Medicine|Elizabeth Peters|646-962-2742|elp2018@med.cornell.edu|
20174373|NCT01633892|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
20174374|NCT02063854|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20189576|NCT02068157|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20174375|NCT03240679|Mayo Clinic|Dr. Kenneth K. Wang|507-284-2691|wang.kenneth@mayo.edu|
20189577|NCT01363128|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD/ Professor|7137924764|ejabbour@mdanderson.org|
20189578|NCT00587171|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H.|813-975-8690|pedig@jaeb.org|
20189579|NCT01303796|Cyclacel Ltd|Mark H. Kirschbaum MD|+1 908 517 7330|mkirschbaum@cyclacel.com|
20189580|NCT02148705|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
20189581|NCT02094534|Orange County Research Center|Joel M. Neutel, M.D., Study Director|714-550-9990|jmneutel@aol.com|
20189582|NCT01737021|Imperial College London|Professor Elena Garralda|+44 (0)20 3312 6085|e.garralda@imperial.ac.uk|
20189583|NCT01673594|Massachusetts General Hospital|Research Regulatory Coordinator|617-726-4651|apulli@mgh.harvard.edu|
20189584|NCT01711294|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
20189585|NCT02605174|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20189586|NCT04250636|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
20189587|NCT02117310|The Ohio State University|Dr. Daniel Prevedello, Associate Professor|(614) 685-1965|daniel.prevedello@osumc.edu|
20189588|NCT01779050|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
20189589|NCT01353274|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189590|NCT00568087|Minneapolis VA Health Care System|Gihyun Yoon, MD|612-467-3996|Gihyun.Yoon@va.gov|
20189591|NCT03737110|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20205305|NCT01827319|CryoLife, Inc.|Scott Capps|800-438-8285|brown.carolyn@cryolife.com|
20174376|NCT00930579|Columbia University|Dawn Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
20205306|NCT01109069|Pharmacyclics|James Dean|669-224-1880|jdean@pcyc.com|
20174377|NCT02255981|Escuela Neijing|Researcher|5744211000|lhgut2001@gmail.com|
20174378|NCT01046682|UHospitalsCleveland|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
20205307|NCT03947255|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20174379|NCT00912990|Rady Children's Hospital San Diego|Dr. Sandeep Khanna|858-966-5863||
20205308|NCT02499575|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|614-895-8747|hyerofac@gmail.com|
20205309|NCT00574119|Vanderbilt University School of Medicine|Marvin W. Kronenberg,M.D.|615 936-7437|marvin.w.kronenberg@vumc.org|
20205310|NCT01206452|University of Kansas Medical Center|Donita Atkins, RN, CCRC|(913) 588-9714|datkins2@kumc.edu|
20174380|NCT02631954|INHA UNIVERSITY HOSPITAL|Sang-Heon Cho, Ph.D.|82-32-890-1122|shcho123@inha.ac.kr|
20174381|NCT06002347|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
20174382|NCT00107198|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20174383|NCT00949325|Johns Hopkins University|David M. Loeb, M.D., Ph.D.|410-502-7247|loebda@jhmi.edu|
20205311|NCT03292952|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
20174384|NCT00751348|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174385|NCT05533632|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20174386|NCT00741039|Memorial Sloan Kettering Cancer Center|Dr. Susan Seo|212-639-3151|seos@mskcc.org|
20174387|NCT01712854|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20174388|NCT03886220|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20174389|NCT00322842|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
20174390|NCT03082599|Carolina Eyecare Physicians, LLC|Dr. Helga P Sandoval, Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
20174391|NCT01340144|Colorado Joint Replacement|Raymond Kim, MD|720-524-1367|raymondkim@ccentura.org|
20174392|NCT03706794|Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|Elizabeth.Seng@einsteinmed.edu|
20174393|NCT01724060|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20174394|NCT00281684|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174395|NCT03098173|Tokyo University|Dr. Ryota Niikura|+81-3-3815-5411|niikura-dky@umin.ac.jp|
20174396|NCT01559012|Città della Salute e della Scienza Ospedale Sant'Anna. Servizio di Medicina Interna|Dr. Aldo Maina M.D. Obstetric Medicine|0039011313|amaina@cittadellasalute.to.it|5735
20205312|NCT04656418|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20205313|NCT02586077|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
20174397|NCT04665050|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174398|NCT00946712|SWOG Statistics & Data Management Center|Lung Committee Statistican|2066675712|jmiao@fredhutch.org|
20174399|NCT00302458|Massachusetts General Hospital|Dr. Thomas Spencer|617-726-1731|spencer@helix.mgh.harvard.edu|
20174400|NCT00853723|UPittsburgh|Mara J Horwitz|4126922848|horwitz@pitt.edu|
20174401|NCT00445965|Memorial Sloan Kettering Cancer Center|Dr. Kim Kramer MD|212-639-6410|kramerk@MSKCC.ORG|
20174402|NCT02447081|Abbott|Ryan Gage, Senior Scientist|651 756 3334|Ryan.Gage@abbott.com|
20174403|NCT01787175|University of Utah Health Care System|Dr. Jonathan Nebeker|801-582-1565|Jonathan.Nebeker@hsc.utah.edu|2458
20174404|NCT05778786|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20174405|NCT02867709|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20174406|NCT01722240|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
20174407|NCT03615105|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
20174408|NCT03313804|University of Kentucky|Dr. John Villano|8593234405|jlvillano@uky.edu|
20174409|NCT01502423|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20174410|NCT00567892|Washington University|Dr. Jay F. Piccirillo|314.362.8641|piccirilloj@ent.wustl.edu|
20174411|NCT02556333|National Institutes of Health, National Institute of Allergy and Infectious Diseases|Alice Pau, Pharm.D., Staff Scientist (Clinical)|301-451-3740|apau@niaid.nih.gov|
20174412|NCT04690751|SK Life Science, Inc.|Executive Director and Head, Clinical Pharmacology|862-271-2645|vvashi@sklsi.com|
20174413|NCT01344161|Tehran University of Medical Sciences|Dr.Farzad Shidfar|09123082922|f-shidfar@tums.ac.ir|
20174414|NCT04364620|Alethia Biotherapeutics ULC|Dr. Julie Laurin, Vice-President, Drug Development|514-581-8125|julie.laurin@alethiabio.com|
20174415|NCT03257631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20174416|NCT02529137|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
20174417|NCT01649375|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20174418|NCT01124604|Neuroscience Department, Clinical Science Department, R&D in Janssen Japan Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
20174419|NCT03102918|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
20174420|NCT04765358|Jaeb Center for Health Research|Robin Gal|813-975-8690|rgal@jaeb.org|
20174421|NCT01660711|NorthShore University/University of Chicago|Dr Robert Marsh|847-5702112|rmarsh@northshore.org|
20174422|NCT03460587|UCLA|Steven C. Cramer, MD|424-522-7273|sccramer@mednet.ucla.edu|
20174423|NCT00952341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205314|NCT01245764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205315|NCT00003476|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20174424|NCT01686841|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
20174425|NCT02066467|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
20174426|NCT01316276|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
20174427|NCT04302389|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
20174428|NCT03056755|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20174429|NCT05230082|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
20174430|NCT04461015|Mayo Clinic|Adrian Vella|507-255-6515|vella.adrian@mayo.edu|
20174431|NCT00464568|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174432|NCT02004028|Verastem Oncology|Clinical Trials|+1-781-292-4204|clinicaltrials@verastem.com|
20174433|NCT03406858|Wayne State University/Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
20174434|NCT00405587|Plexxikon Inc.|Dr. Henry Hsu|510-647-4000|hhsu@plexxikon.com|
20174435|NCT02419742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20205316|NCT00680953|Daiichi Sankyo Co., Ltd.|H. Takami|+81 3 5740 3445|takami.hideo.hs@daiichisankyo.co.jp|
20205317|NCT05343585|Pennington Biomedical Research Center|Chloe Panizza Lozano|(225) 763-2500|cpanizza@hawaii.edu|
20205318|NCT01383109|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
20205319|NCT00944216|Wright State University School of Medicine, Dept of Dermatology|Amy Chen, MD|927-224-3345|amy.chen@wright.edu|
20205320|NCT03039738|Medtronic|Anne Kinney|+1-303-876-8904|anne.r.kinney@medtronic.com|
20205321|NCT00912340|Emory University|Elisavet Paplomata, Principal Investigator|404-778-1900|elisavet.paplomata@emory.edu|
20205322|NCT02062463|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20205323|NCT01743872|Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center|Dr. Vikram S. Kashyap|216-844-1631|vikram.kashyap@uhhospitals.org|
20205324|NCT01509872|Queen's University Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
20205325|NCT00707655|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20205326|NCT02858154|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani|513-736-1814|Neepa.Gurbani@cchmc.org|
20205327|NCT02979301|Mayo Clinic|Dr. Carrie Hruska|507-293-4719|hruska.carrie@mayo.edu|
20205328|NCT02092441|Brooke Army Medical Center|Dr. Michael D. April|210-916-6129|Michael.D.April@post.harvard.edu|
20205329|NCT00600028|Johns Hopkins University School of Medicine|Maureen R. Horton|410-955-4176|mhorton2@jhmi.edu|
20205330|NCT03172481|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
20205331|NCT00830115|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20205332|NCT01925612|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20205333|NCT01396239|Sarepta Therapeutics, Inc.|Edward M. Kaye MD, Interim CEO, SVP & Chief Medical Officer|+1-888-727-3782|clinicaltrials@sarepta.com|
20205334|NCT01107405|Bausch & Lomb Incorporated|Tuyen Ong, MD MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20205335|NCT03495453|NYU Langone Health|Anvar Babaev, MD, PhD|212-263-5656|Anvar.Babaev@nyulangone.org|
20205336|NCT00085917|RCHSPB|John Tierney|301-451-5136|john.tierney@nih.gov|
20205337|NCT00947752|Teva Neuroscience, Inc.|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
20205338|NCT01360762|Institute of Tropical Medicine Antwerp|Johan Van Griensven|+32(0)32476426|jvangriensven@itg.be|
20205339|NCT05590767|Tri-Service General Hospital, National Defense Medical Center|Dr. Lu Yi-Hsiung|+886933429559|luyihsiung@gmail.com|
20205340|NCT02802878|University of Kansas Medical Center|Dr. Neil Segal|913-945-8985|segal-research@kumc.edu|
20205341|NCT01232894|Novartis|Study Director|41 61 324 1111||
20205342|NCT01981967|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20205343|NCT00753935|Vanderbilt_University MC|John A. Oates, MD|615 4343 4847|john.oates@vanderbilt.edu|
20205344|NCT03970395|Azienda Ospedaliera Città della Salute e della scienza di Torino _ Italy|Dr Claudio G Priolo|0039 3471403064|claudiog.priolo@gmail.com|
20205345|NCT00916370|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
20205346|NCT00929734|University of Oslo|Professor Torbjørn Omland|+47 40107050|torbjorn.omland@medisin.uio.no|
20205347|NCT03172520|Mayo Clinic|Eric J. Moore, M.D.|507-284-3853|Moore.Eric@mayo.edu|
20205348|NCT00980980|University of California, Irvine|Dr. Susan Huang|949-824-5073|sshuang@uci.edu|
20205349|NCT02921919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205350|NCT02756650|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20205351|NCT01553916|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4653|clifford.robinson@wustl.edu|
20205352|NCT00230100|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
20205353|NCT03371160|ENvizion Medical (Nutriseal)|Clinical Director|+972-72-2288240|anath@envizionmed.com|
20205354|NCT04348591|Duke University|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
20205355|NCT02038218|DEKK-TEC, Inc.|Dr. Lee Roy Morgan|504-583-6135|lrm1579@aol.com|
20205356|NCT00645567|James A Haley VA, Tampa|John Lloyd|813-624-8986|john.lloyd2@va.gov|
20205357|NCT02648724|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
20205358|NCT01364233|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
20205359|NCT00438399|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|70 51
20205360|NCT00723073|Brigham and Women's Hospital|David Kubiak, Principle Investigator|617-525-8417|dwkubiak@partners.org|
20205361|NCT05522673|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
20174436|NCT00390325|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|Manisha.Shah@osumc.edu|
20189592|NCT03648541|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20189593|NCT01852045|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20189594|NCT02827201|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20189595|NCT01817491|Cleveland Clinic|Michael Macknin, MD|216 444-5512|macknim@ccf.org|
20189596|NCT02124044|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
20189597|NCT00638456|Univeristy of California, San Diego|Dr. Ranjan Dohil|(858) 966-4003|rdohil@ucsd.edu|
20189598|NCT01890954|University of Virginia|Daniel Chernavvsky|434-243-1395|drc2v@virginia.edu|
20189599|NCT03052517|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20189600|NCT00546156|Dana-Farber Cancer Institute|Dr Ian Krop|617-632-2335|ian.krop@dfci.harvard.edu|
20189601|NCT05260437|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20189602|NCT01858688|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Neil Martin, MD|(617) 632-3000|NEMARTIN@PARTNERS.ORG|
20189603|NCT00884806|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20189604|NCT01530334|SPARC CONSULTING SRL|Claudio Iannacone|+39 0243119667|info@sparcconsulting.com|
20189605|NCT01303510|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20189606|NCT00701415|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20189607|NCT04864834|Sandoz|Clinical Disclosure Representative|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
20189608|NCT01676298|Spartan Bioscience Inc.|Dr. Chris Harder|613-228-7756|chris.harder@spartanbio.com|778
20189609|NCT01972776|Novartis|Study Director|862-778-8300||
20189610|NCT01868230|UMass Amherst|Dr. Lisa Chasan-Taber, Principal Investigator|4135451664|lct@umass.edu|
20189611|NCT03672032|University of Iowa Hospitals and Clinics|Dr. Henning Gerke|319-384-6582|henning-gerke@uiowa.edu|
20189612|NCT03162614|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
20189613|NCT02208843|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189614|NCT01321073|The University of Alabama at Birmingham|Robert Bourge, M.D., Professor of Medicine, Radiology, and Surgery|(205)934-7400|bbourge@uab.edu|
20189615|NCT04278833|Stanford University|Clinical Research Coordinator|(650) 723-0003|jessn16@stanford.edu|
20189616|NCT05200416|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
20189617|NCT04224272|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20189618|NCT02609048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20189619|NCT04186247|Amsterdam University Medical Center|Johan Van Limbergen, MD, PhD|+31-20 566 9111|j.e.vanlimbergen@amsterdamumc.nl|
20189620|NCT03769090|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20189621|NCT03964974|University of Michigan|Mark Ilgen|734-845-3646|marki@med.umich.edu|
20189622|NCT02713594|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
20189623|NCT02660086|Massachusetts General Hospital|Dr. Anne Thorndike, Prinicipal Investigator|6177244608|athorndike@mgh.harvard.edu|
20189624|NCT01653509|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189625|NCT00785798|Yale University School of Medicine|Francine Foss, MD||Francine.Foss@yale.edu|
20189626|NCT00326196|Roudebush VAMC|Masoor Kamalesh, MD|317-988-2401|masoor.kamalesh@va.gov|
20189627|NCT05005247|MinervaX|CMO|004553883002|LIO@minervax.com|
20189628|NCT01450007|Mayo Clinic|Dr. David M. Rosenfeld|480-301-7586|Rosenfeld.David@mayo.edu|
20189629|NCT02958553|Ottobock Healthcare|Russ Lundstrom|512-806-2606|russ.lundstrom@ottobock.com|
20189630|NCT01083706|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
20189631|NCT01738698|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20189632|NCT02125292|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20189633|NCT03068312|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
20189634|NCT00273052|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189635|NCT02224755|Abbott|Joyce Chuang/Principal scientist|925-353-5817|joyce.chuang@abbott.com|
20189636|NCT01951703|Clinical Compliance Manager|Jurandir Araujo|904 443-1379|jaraujo7@jnj.com|
20189637|NCT01487954|Case Comprehensive Cancer Center AND Summa Health System|Dr. Charles A. Kunos, MD, PhD|(330) 375-3557|kunosc@summahealth.org|
20189638|NCT02736188|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20189639|NCT00240994|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20189640|NCT02630186|Clovis Oncology, Inc.|Elizabeth Bradley|1-415-409-5495|ebradley@clovisoncology.com|
20189641|NCT00439218|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
20189642|NCT03176407|Ovesco Endoscopy AG|Prof. Dr. T. Gottwald|0049707196528||160
20189643|NCT01428583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189644|NCT05124210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160426|NCT00737568|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20189645|NCT00768755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189646|NCT03142932|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|(443) 287-2969|jgolub@jhmi.edu|
20189647|NCT02128269|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
20189648|NCT00878189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189649|NCT01640288|Duke University School of Medicine, Department of Radiology|H. Cecil Charles, Ph.D.|919-684-7921|cecil.charles@duke.edu|
20189650|NCT04263714|McMaster University|Dr. Stuart Phillips|9055259140|phillis@mcmaster.ca|24465
20174437|NCT02829463|Third Xiangya Hospital of Central South University|Dr. Jinshen He|8613517470997|jinshen.he@hotmail.com|
20174438|NCT00507442|Millennium Pharmaceuticals, Inc|Dixie-Lee Esseltine, MD|(617) 679-7000||
20174439|NCT04434131|University of New Mexico Health Sciences Center|Dr. Michelle Harkins|5052724751|mharkins@salud.unm.edu|
20174440|NCT02672423|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20174441|NCT04236804|University of Pittsburgh|Brian O'Connell|3023997506|oconnellb2@upmc.edu|
20174442|NCT04335279|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
20174443|NCT02808130|Ondokuz Mayıs University Dentalfaculty Periodontology Dep.|Assoc Prof Muge Lutfioglu|+905063073738|mugelutfioglu@hotmail.com|
20174444|NCT00470574|Memorial Sloan Kettering Cancer Center|Teresa Gilewski, MD|(212) 639-2000|gilewskt@mskcc.org|
20174445|NCT01229423|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20174446|NCT02864251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20174447|NCT03506373|Mayo Clinic Jacksonville|Asher Chanan-Khan, MD|904-953-2708|chanan-khan.asher@mayo.edu|
20174448|NCT00885755|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20174449|NCT04196140|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20174450|NCT01820416|Dept. of Communication Sciences & Disorders, University of Iowa|Shawn S Goodman|319-335-8700|shawn-goodman@uiowa.edu|
20174451|NCT02492269|Nationwide Children's Hosp.|Dr. Aymen Naguib|614-722-4200|Aymen.Naguib@nationwidechildrens.org|
20174452|NCT00755131|University of Naples Federico II|Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University|+39081746|vigorito@unina.it|2639
20174453|NCT02120950|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20174454|NCT01852812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174455|NCT00177970|UPittsburgh|Dr. George Arnold|4126212334|arnoldgl@upmc.edu|
20189651|NCT00787176|Northwerstern University|Paloma Toledo|312-472-3585|p-toledo@northwestern.edu|
20189652|NCT05794191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189653|NCT02486939|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
20189654|NCT04278755|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-974-3929|jhbaker@med.unc.edu|
20189655|NCT00895245|University of Washington|Dr. Keith Eaton|206-288-2048|kdeaton@uw.edu|
20189656|NCT02095678|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Vikas Gulani|+1 216-844-3312|Vikas.Gulani@UHhospitals.org|
20189657|NCT00681109|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|(617) 573-4331|Reza_Dana@meei.harvard.edu|
20189658|NCT02706483|Bausch Health|Matt Markovich|908-541-1341|Matthew.Markovich@bauschhealth.com|
20189659|NCT04660799|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20189660|NCT02764970|Medical University of Graz|Assoc. Prof. Dr. Dirk von Lewinski|31638580684|dirk.von-lewinski@medunigraz.at|316
20189661|NCT03131713|Tufts Medical Center|Bichchau Nguyen, Principal Investigato|617-636-1286|bnguyen2@tuftsmedicalcenter.org|
20189662|NCT02144597|Imperial College London|Prof Gary Frost|07872850308|g.frost@imperial.ac.uk|
20189663|NCT00462072|University of Rochester|Rick Barrett|585-275-1647|rick_barrett@urmc.rochester.edu|
20189664|NCT00407888|Medical Oncology University of Washington|Hannah Linden MD FACP|206-288-6989|hmlinden@uw.edu|
20218013|NCT01885182|Mundipharma (China) Pharmaceutical Co. LTD|Clinical study manager|0086-10-65636800|Wei.Zhu@mundipharma.com.cn|6900
20189665|NCT02941692|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
20189666|NCT02382640|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20189667|NCT01560429|Queen's University|Dr. Vidur Shyam|(613) 548-7827|shyamv@kgh.kari.net|
20189668|NCT04939233|Departments of Mechanical Engineering and Electrical and Computer Engineering, Virginia Tech|Dr. Pinhas Ben-Tzvi|NA|bentzvi@vt.edu|
20189669|NCT02506283|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr. Erich Hohenauer|+41813000175|erich.hohenauer@supsi.ch|
20189670|NCT01638000|Astellas Pharma Europe Ltd|Medical Director||Astellas.resultsdisclosure@astellas.com|
20189671|NCT05484661|UT Health San Antonio|Monica Serra|210-949-9759|serram@Uthscsa.edu|
20189672|NCT03787628|UCLA David Geffen School of Medicine|Dr. Edythe London|3106142150|elondon@mednet.ucla.edu|
20189673|NCT00570505|Apollo Endosurgery|Laura Eaton|949-468-9301|laura.eaton@apolloendo.com|
20189674|NCT03016871|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
20189675|NCT07016568|LLC UkrMedGroup|Yevheniia Poliakova|+380502818399|jenyapolyakova@gmail.com|
20189676|NCT03905642|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
20189677|NCT02159989|MD Anderson Cancer Center|Aung Naing|713-563-3885|anaing@mdanderson.org|
20189678|NCT04889989|Ethicon, Inc.|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20189679|NCT05338476|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20189680|NCT02485925|Biosense Webster, Inc.|Kendra McInnis|949-450-7783|kmcinnis@its.jnj.com|
20189681|NCT06922643|Nanogen Biopharmaceutical JSC|Dr. Thuy Phuong Nguyen|+84 903 754 559|phuongthuy@nanogenpharma.com|
20189682|NCT04924608|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20189683|NCT00949117|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Coordinator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
20189684|NCT02014402|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
20189685|NCT00279409|USSF|Laurence Greenhill||larrylgreenhill@gmail.com|
20189686|NCT02542202|UChicago|Rohan Katipally|773-702-0137|Rohan.Katipally@bsd.uchicago.edu|
20189687|NCT00670449|Novartis Pharmaceuticals|Study Director|862 778-8300||
20189688|NCT00413283|Amgen Inc.|Study Director|866-572-6436||
20189689|NCT02002689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20189690|NCT00671853|University Hospitals Cleveland Medical Center|Dr. Kemp Gao|216-844-2865|keming.gao@UHhopsitals.org|
20174456|NCT02916563|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|3037246713|satish.garg@ucdenver.edu|
20174457|NCT02625090|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20174458|NCT02250443|Novartis Pharmaceutical|Study Director|862-778-8300||
20174459|NCT01549964|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20174460|NCT02290821|Novartis Consumer Health|Clinical Research Director Pain, CH Clinical Research & Development Lead|+41225672574||
20174461|NCT02438722|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
20174462|NCT01835743|Coughlin Foot and Ankle Clinic|Michael Coughlin, MD|208-367-3330|thefootmd@gmail.com|
20174463|NCT02449174|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
20174464|NCT02653456|Ra Medical Systems, Inc.|Vice President of Regulatory Affairs and Quality Assurance|877-635-1800|vchester@ramed.com|207
20174465|NCT01520363|Hugo W. Moser Research Institute at Kennedy Krieger , Inc.|Dr. Sakkubai Naidu|443 923 2778|naidu@kennedykrieger.org|
20174466|NCT00178841|Vanderbilt University Dermatology|John Zic, MD|615-322-6485|john.zic@vanderbilt.edu|
20174467|NCT01272830|Clinic Orthopaedic Center|Thomas Bear, MD|330-375-3906|kovacikm@summahealth.org|
20174468|NCT02735551|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20174469|NCT04191382|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20174470|NCT05237206|Alloplex Biotherapeutics|Dr. Sharron Gargosky, Chief Development Offier|+1 503-915-1400|sgargosky@alloplexbio.com|
20174471|NCT01476696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20174472|NCT03038815|Institute for Biomechanics ETH Zürich|Silvio Lorenzetti|078 608 14 84|sl@ethz.ch|
20174473|NCT00620828|Duke UMC|Michael Bolognesi, MD|919-668-4732|bolog002@mc.duke.edu|2
20174474|NCT02918851|Stony Brook Medicine|Dr. Elliott Bennett-Guerrero|6314442979|elliott.bennett-guerrero@stonybrookmedicine.edu|
20174475|NCT03965962|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20174476|NCT00578942|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20174477|NCT01400516|Brigham and Women's Hospital|Daniel H Solomon, MD, MPH||dsolomon@partners.org|
20174478|NCT04439318|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20174479|NCT02485912|University of Oxford|Adrian V Hill, DPhil FRCP||vaccinetrials@ndm.ox.ac.uk|
20174480|NCT00156533|University of Rochester|Wilfred Pigeon|585 275-3374|wilfred_pigeon@urmc.rochester.edu|
20174481|NCT05447156|Masonic Cancer Center|Dana Mowls Carroll, Ph.D., M.P.H.|612-624-4511|dcarroll@umn.edu|
20174482|NCT01541969|University of Nottingham|Professor Deborah Hall, Professor of Hearing Sciences|+44 (0) 115 823 2600|deborah.hall@nottingham.ac.uk|
20174483|NCT01365507|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20174484|NCT01263301|Mennonite Christian Hospital|Ling-Chih Wu MD|88638241234|lingchihwu@yahoo.com|1810
20174485|NCT03265249|Duke University|Alisha Mavis, M.D.|919-684-5068|alisha.mavis@duke.edu|
20174486|NCT01614990|Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System|Jose Garcia, MD, PhD|(206) 764-2984|jg77@uw.edu|
20174487|NCT05630274|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20174488|NCT00525174|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
20174489|NCT02255500|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20174490|NCT01012622|Janssen Korea MAF, Korea|Clinical Research Associate|82-2-2094-4837||
20174491|NCT04254978|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174492|NCT02515942|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20174493|NCT05005390|The University of Texas Health Science Center at Houston|Travis Markham, MD|713-500-6200|Travis.H.Markham@uth.tmc.edu|
20174494|NCT00666757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20174495|NCT02130063|Pharmacosmos|Chief Medical Officer|+45 5948 5959|llt@pharmacosmos.com|
20174496|NCT01723163|Durham Veterans Affairs Medical Center|Dr. Patrick Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
20205362|NCT00302718|VA HSR&D Center for Innovations in Quality, Effectiveness & Safety (IQuESt)|Dr. Laura A. Petersen|713-794-8623|Laura.Petersen@va.gov|
20205363|NCT00349752|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
20205364|NCT00819585|Novartis Pharmaceuticals|Study Director|862-778-8300||
20205365|NCT00738374|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20205366|NCT00632541|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
20205367|NCT03334396|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20205368|NCT00601796|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
20205369|NCT04914377|Novatek Pharmaceuticals|Ahmed Kaseb MD|877-662-8351|akaseb@novatekpharmaceuticals.com|
20205370|NCT02927873|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20205371|NCT01766817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20205372|NCT02902913|University of California, Davis|Roberta R Holt|530-752-4950|rrholt@ucdavis.edu|
20205373|NCT03011450|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20205374|NCT00383721|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20205375|NCT03814590|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20205376|NCT03041909|Global Blood Therapeutics|Margaret Tonda, Sr. Director, Clinical Science|650-741-7761|mtonda@gbt.com|
20205377|NCT03519516|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20174497|NCT02510794|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20174498|NCT04855643|The University of Texas Health Science Center at Houston|Antonio L. Teixeira, MD, PhD, MSc|713-486-2555|Antonio.L.Teixeira@uth.tmc.edu|
20174499|NCT01856790|Yale University School of Medicine|Dr. Jennifer Sherr|203-785-5831|jennifer.sherr@yale.edu|
20174500|NCT02731729|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20174501|NCT01344447|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20174502|NCT03446040|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20174503|NCT00456521|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|Medinfo@Orexigen.com|
20174504|NCT01442363|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
20174505|NCT00076011|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174506|NCT05469100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20174507|NCT06027866|Queen's University Belfast/Western Health & Social Care Trust|Carla McClintock|07706482050|cmcclintock02@qub.ac.uk|
20174508|NCT04343521|Emory University|Gonzalo Vazquez-Prokopec, PhD|404-727-4217|gmvazqu@emory.edu|
20174509|NCT02939560|Medical University of South Carolina|McLeod F. Gwynette, MD|843-792-9162|gwynette@musc.edu|
20174510|NCT03340025|University of Alabama at Birmingham|Benjamin Greene, MD|205-801-7855|bjgreene@uabmc.edu|
20174511|NCT04773158|Indiana University School of Medicine, Pediatrics|William E Bennett, MD|317-944-3774|webjr@iu.edu|
20174512|NCT02420691|UT MD Anderson Cancer Center|Arvind Dasari,MBBS|713-792-2828|adasari@mdanderson.org|
20174513|NCT03002012|University of Minnesota|David Boulware|612-624-1966|boulw001@umn.edu|
20174514|NCT03897179|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20174515|NCT00704535|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20174516|NCT04053101|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
20174517|NCT04415281|University of Florida|Eric Weber|3522737802|ebweber@ufl.edu|
20174518|NCT05694546|University of Maryland Baltimore|Cassidy Claassen|316-727-6185|cclaassen@ihv.umaryland.edu|
20174519|NCT05365750|Kaiser Permanente Colorado|Ingrid A Binswanger, MD, MPH|720-416-7104|ingrid.a.binswanger@kp.org|
20174520|NCT04962009|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
20174521|NCT00768144|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
20174522|NCT01150123|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20174523|NCT05821842|Sound Health Systems, Inc.|Paramesh Gopi|313-509-8237|pgopi@soundhealth.life|
20174524|NCT01466387|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20174525|NCT02530450|UT Health Science Center in San Antonio|Dr. Maria Rayas, Assistant Professor in Pediatric Endocrinology and Diabetes|210-567-5283|rayas@uthscsa.edu|
20174526|NCT01319877|Hoffmann-La Roche|Medical Communications|800-821-8590||
20174527|NCT00832585|Rush University Medical Center - Department of Dermatology|Dr. Michael D. Tharp|312-563-4001|derm@rush.edu|
20174528|NCT01057017|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20174529|NCT02347189|Medtronic|Megan Mueller, Clinical Research Manager|612-916-4771|megan.d.mueller@medtronic.com|
20174530|NCT00091273|University of Virginia|Craig L. Slingluff, MD|434-924-1730|cls8h@virginia.edu|
20174531|NCT02677987|Northwestern University Feinberg School of Medicine|Lisa M. Wu, Ph.D.|(312) 503-7722|lisa.wu1@northwestern.edu|
20174532|NCT04404855|UT Health San Antonio|Michael Liss, MD|210-567-5676|liss@uthscsa.edu|
20174533|NCT00735878|Dartmouth-Hitchcock Medical Center (DHMC)|Konstantin H. Dragnev, MD|(603) 650-6344|konstantin.h.dragnev@hitchcock.org|
20174534|NCT00673179|UT MD Anderson Cancer Center|Peter M. Anderson, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
20174535|NCT03745092|Xuanwu Hospital, Capital Medical University|Pro. Ran Meng|+86-10-83199280|ranmeng2011@pku.org.cn|
20174536|NCT01531387|St. Jude Children's Research Hospital|James M. Boyett, PhD|901-595-4986|james.boyett@stjude.org|
20174537|NCT04248933|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
20174538|NCT03200899|The University of Texas at Austin|Dr. Alexa Stuifbergen|+1 (512) 471-4100|astuifbergen@mail.utexas.edu|
20174539|NCT00302133|University of Miami Miller School of Medicine|Ihsan Salloum, MD, MPH|305 243-7931|isalloum@med.miami.edu|
20174540|NCT01001442|Biotest AG|Iris Bobenhausen|+49 6103 801|iris.bobenhausen@biotest.com|4832
20174541|NCT02753699|Debiopharm International, S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20174542|NCT01412866|DArtmouth-Hitchcock|Mary F. Brunette|603-27105747|mary.f.brunette@dartmouth.edu|
20174543|NCT00549562|Indiana University School of Medicine|David D. Dunn MD|317-944-8164|ddunn@iupui.edu|
20174544|NCT00128921|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20174545|NCT00323115|Dartmouth-Hitchcock Medical Center|Dr. Camilo Fadul|603-653-6312|camilo.e.fadul@hitchcock.org|
20174546|NCT02946047|Mayo Clinic|Dr. Nathan Cummins|507-284-3747|Cummins.Nathan@mayo.edu|
20174547|NCT00699972|Eisai Call Center|Eisai Inc.|888-422-4743||
20174548|NCT03244865|UF Health Department of Anesthesiology|Dr. Tammy Euliano|352-514-7460|teuliano@anest.ufl.edu|
20174549|NCT00902564|H. Lundbeck A/S|Study Director|Email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
20174550|NCT00277212|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20174551|NCT06076694|Clinical Study Center of the First Hospital of Jilin University|TenNor|0512-86861979|info@tennorx.com|
20174552|NCT03336216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20205378|NCT01628250|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine|Dr. Bo Feng|021-64458887|fengbo2022@163.com|
20205379|NCT03287245|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20174553|NCT00922766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219825|NCT00469911|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-0183|groplerr@mir.wustl.edu|
20219826|NCT02062294|Hoffmann-LaRoche|Clinical Operations Department|800-821-8590|switzerland.clinical-research@roche.com|
20174554|NCT00843713|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|Priscilla.Hsue@ucsf.edu|
20174555|NCT02666183|Case Western Reserve University|Sara L. Douglas, PhD, RN, Professor FPB School of Nursing|216-368-0702|sld4@case.edu|
20174556|NCT01231581|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174557|NCT01957462|Coloplast|Daniel Carter|+45 49222523|dkdac@coloplast.com|
20174558|NCT05954052|University of Chicago|Karam Radwan, MD|7738346686|radwan@uchicago.edu|
20174559|NCT03616912|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20174560|NCT02474199|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20174561|NCT03090100|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20174562|NCT00159588|St. Olavs Hospital|Professor Knut Hagen|+47 95401579|knut.hagen@stolav.no|
20174563|NCT00605475|Novartis Pharmaceuticals|Study Director|862 778 8300||
20174564|NCT02596854|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
20174565|NCT04345614|CalciMedica, Inc.|Sudarshan Hebbar, MD|8168387105|sudarshan@calcimedica.com|
20174566|NCT04133168|Boston Scientific|Stephanie Roelke, Clinical Trial Manager|651-582-4000|Stephanie.Roelke@bsci.com|
20174567|NCT02855437|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
20174568|NCT03615326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20174569|NCT05071183|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20174570|NCT02046148|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174571|NCT03970590|VA Bedford Healthcare System Center for Health Organization and Implementation Research|Sarah Cutrona, MD|781-687-2861|sarah.cutrona@va.gov|
20174572|NCT02532647|PAION UK Ltd|Trial Information||reg_paion@paion.com|
20174573|NCT01480076|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20174574|NCT02503332|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20174575|NCT02424383|Becton Dickinson|Sharon Christensen|612-757-0750|Sharon.Christensen@bd.com|
20174576|NCT03559179|HealthPartners Institute|Dr. Rebecca C Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
20174577|NCT00325754|Harbo-UCLA Research and Education Institute|Richard Casaburi|310-22-8249|casaburi@ucla.edu|
20174578|NCT01334723|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205380|NCT02701192|Carolinas Healthcare System|Rachel Seymour, PhD|704-355-2000|Rachel.Seymour@carolinas.org|
20205381|NCT02862548|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20205382|NCT00880763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205383|NCT02267226|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
20205384|NCT02667457|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20219827|NCT00371397|Ohio State University Institute for Behavioral Medicine Research|Janice Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
20219828|NCT02377427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219829|NCT02293863|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20160427|NCT01133626|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20160428|NCT02851407|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
20160429|NCT02124018|First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens|Professor Konstantinos A. Gatzoulis|6944580369|kgatzoul@med.uoa.gr|0030
20160430|NCT01713283|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20160431|NCT00760461|Yale University|Anish A Sheth M.D|203-785-4576|anish.sheth@yale.edu|
20160432|NCT03761394|UMass Chan Medical School|Edith Mensah Otabil|774-455-6574|edith.mensahotabil@umassmed.edu|
20174579|NCT03836963|Edward Hines Jr. VA Hospital|Sandra Kletzel|708-202-5735|sandra.kletzel@va.gov|
20174580|NCT02149173|University of Washington|Hannah M Linden|206-606-2053|hmlinden@uw.edu|
20205385|NCT03330041|University of California, Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
20205386|NCT00989612|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205387|NCT00603733|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20205388|NCT00605696|Albert Einstein College of Medicine of Yeshiva University|Michelle Ng Gong, MD, MS|718 920 5464|mgong@montefiore.org|
20205389|NCT01842646|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
20205390|NCT01057134|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20205391|NCT00751179|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20205392|NCT00915538|Western Sky Medical Research|Lyndon Mansfield MD|915-544-2557|immunman@westernskymed.com|
20205393|NCT01253187|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20205394|NCT02527187|Inmunotek|Dr. Miguel Casanovas/ Medical Director|91 6510010|mcasanovas@inmunotek.com|
20205395|NCT05158179|University of California San Francisco|Yue Ma|415-885-7700|yue.ma@ucsf.edu|
20205396|NCT01293006|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205397|NCT03084718|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20205398|NCT02806947|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20205399|NCT00865189|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20205400|NCT02484898|Medtronic CRHF|Medtronic SEEQ Performance Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
20205401|NCT01978509|Mayo Clinic|Dr. Francisco Ramirez|(480) 301-6990|Ramirez.Francisco@mayo.edu|
20205402|NCT03930641|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20205403|NCT00084929|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
20205404|NCT03641547|OCTO, University of Oxford|Dr Ruth Harman, Trial Manager|01865 617018|octo-CHARIOT@oncology.ox.ac.uk|
20205405|NCT01392053|Universidade de São Paulo|Prof Silvana Quintana|55 16 3602-2813|quintana@fmrp.usp.br|
20205406|NCT00091026|University of Chicago|Hedy Kindler, MD|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
20205407|NCT02513784|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
20205408|NCT00065442|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
20205409|NCT01594333|Brigham & Women's Hospital|Dr. Paul Ridker and Dr. Robert Glynn|617-732-4965|pridker@bwh.harvard.edu|
20205410|NCT01797965|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20205411|NCT00304915|Central Arkansas Veterans Healthcare System|Dr. Jeff Pyne|501-257-1083|jmpyne@uams.edu|
20205412|NCT00712322|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20205413|NCT02242994|Children's National|Dr. Axel Krieger|2024761284|akrieger@childrensnational.org|
20205414|NCT01887587|Medical College of Wisconsin|Ehab Atallah, MD|414-805-8900|eatallah@mcw.edu|
20205415|NCT00973921|Columbia University Medical Center|Giora Weisz MD|212-305 7060|gw2128@mail.cumc.columbia.edu|
20205416|NCT02754830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20205417|NCT02670330|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
20205418|NCT04404010|Precision OS Technology|Dr. Danny P Goel|604-345-0401|danny@precisionostech.com|
20160433|NCT01080768|Novartis Pharmaceuticals|Study Director|862-778-8300||
20160434|NCT04274153|Johns Hopkins SOM Department of GYN/OB|Dr. Jenell Coleman|(410)614-9178|colemanj@jhmi.edu|
20160435|NCT03054350|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
20160436|NCT00772369|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20160437|NCT03510468|Clinical Center|Dr. Joseph Kovacs|+1 301 496 9907|jkovacs@mail.nih.gov|
20160438|NCT03372460|Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System|Dr. Noah S Philip, MD|4012737100|noah_philip@brown.edu|16200
20160439|NCT02499900|Teva Pharmaceutical Industries Ltd.|Director, Clinical Research|+01 215-591-3000|USMedInfo@tevapharm.com|
20160440|NCT03416920|Massachusetts General Hospital|Dr. Pradeep Natarajan|617-724-3526|PNATARAJAN@PARTNERS.ORG|
20160441|NCT02345772|CTCA|Jessica L. Coats, RN|6232073899|jessica.coats@ctca-hope.com|
20160442|NCT03403231|VA Center for Clinical Management Research|Bradley Youles, Project Manager|734-845-5055|Bradley.Youles@va.gov|
20160443|NCT04644796|Missouri Orthopaedic Institute|Angela Atkinson|573-884-1128|avadd9@umsystem.edu|
20160444|NCT02538419|Brigham and Women's Hospital|Dr. Jessie Bakker|617-732-5987|jpbakker@bwh.harvard.edu|
20160445|NCT01071200|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20160446|NCT02071420|University of Iowa|Lucas Carr, PhD|319-353-5432|lucas-carr@uiowa.edu|
20160447|NCT01527513|BIAL - Portela & Cª SA|Director R&D|+351-229866100|clinical.trials@bial.com|
20160448|NCT05894538|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20160449|NCT02794844|Nemours Children's Hospital|James P. Franciosi, MD|407-567-3832|jfrancio@nemours.org|
20205419|NCT02120157|Johns Hopkins University|Heather Symons, MD|410-502-9961|hsymons2@jhmi.edu|
20205420|NCT04368455|Cincinnati Children's Hospital Medical Center|Dr. Francis Real|5136364200|francis.real@cchmc.org|
20205421|NCT00400439|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20205422|NCT01354431|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20205423|NCT04685499|Weill Cornell Medicine|Meyer Cancer Center GI Program Manager|646-962-8189|cdo4001@med.cornell.edu|
20205424|NCT03176277|Ono Pharmaceutical Co., Ltd.|Medical Information Center|Please see email|trials.uk-eu@ono-pharma.com|
20205425|NCT00634114|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20205426|NCT01599754|SFJ Pharmaceuticals|Stewart Hallett|19252011003|stewart.hallett@sfj-pharma.com|
20205427|NCT00702052|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20205428|NCT01577160|Janssen Research & Development|Medical Director|886 2 23762155||
20205429|NCT00101192|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
20205430|NCT03670641|University of Pittsburgh Medical Center (UPMC)|David Rometo, MD|412-586-9700|rometoda@upmc.edu|
20205431|NCT03691610|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20205432|NCT01662297|Yale University/West Haven VAMC|Dr. Albert Arias|2039325711|albert.arias@va.gov|8155
20205433|NCT00242580|Novartis Pharmaceuticals|Study Director|862 778-8300||
20205434|NCT00538980|Weill Cornell Medicine|Richard T. Silver, MD|646-962-2273|rtsilve@med.cornell.edu|
20205435|NCT03282357|Merz Pharmaceuticals GmbH.|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20205436|NCT03550131|University of Washington|Dr. Karen Fredriksen-Goldsen|206-543-5722|fredrikk@uw.edu|
20205437|NCT01318512|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20205438|NCT01788306|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
20205439|NCT01822691|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
20205440|NCT02379390|Sanofi|Trial Transparency Team|800-633-1610|Us@sanofipasteur.com|1
20205441|NCT01559064|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
20205442|NCT04390568|Boehringer Ingelheimv|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205443|NCT03245723|UT Southwestern Medical Center, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
20205444|NCT00077376|ECOG Statistical Office|Study Statistician|617-632-3012||
20218014|NCT03707041|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
20189691|NCT03928743|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20189692|NCT04220983|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
20189693|NCT02822599|Nicklaus Children's Hospital|Jenny Esteves|786-624-2854|jenny.esteves@nicklaushealth.org|
20189694|NCT02007070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189695|NCT00703092|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
20189696|NCT01480258|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189697|NCT06631313|Becton, Dickinson and Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
20189698|NCT01228734|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20189699|NCT00659373|IBCSG|Rudolph Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
20189700|NCT03042767|Emory University|Dr. Miriam Vos|404-727-5383|mvos@emory.edu|
20189701|NCT01934452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205445|NCT03637842|New York State Psychiatric Institute|Christina Brezing, MD|6467748181|christina.brezing@nyspi.columbia.edu|
20205446|NCT01283997|UT MD Anderson Cancer Center|Dr. Sheeba Thomas,Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
20205447|NCT01975246|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205448|NCT00255034|Merck, Sharp & Dohme Corp.|Senior Vice Predsident, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20205449|NCT01263093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205450|NCT00424346|Novartis Pharmaceuticals|Study Director|862-778-8300||
20205451|NCT01494987|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20205452|NCT04807101|Northwestern University|Greg Cohen, MD|312-695-4452|gregcohen@northwestern.edu|
20205453|NCT02254551|Sarah Cannon Development Innovations|Charles Davis, Sr Mgr Regulatory Strategy & Operations|615-524-4341|charles.davis2@scri-innovations.com|
20205454|NCT02759562|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20205455|NCT02293993|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20205456|NCT01957709|Fred Hutchinson Cancer Research Center|Seth Pollack, MD|206-667-6629|spollack@fredhutch.org|
20205457|NCT03587584|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
20205458|NCT00232505|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20205459|NCT01061736|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20205460|NCT00397878|University of Texas MD Anderson Cancer Center|Cathy Eng, MD / Professor|713-792-2828|ceng@mdanderson.org|
20205461|NCT01093755|Mayo Clinic|Prasad Iyer, MD|507-284-0970|Iyer.Prasad@mayo.edu|
20205462|NCT03115112|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20205463|NCT01546285|GE Healthcare|Jeffrey Conner - Global Research Manager|414.721.2423|Jeffrey.Conner@ge.com|
20205464|NCT04019795|Revian, Inc.|John Oakley|919-321-1726|joakley@knowbiollc.com|
20205465|NCT01608490|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|Kristi.Winterfeldt@bsci.com|
20205466|NCT00654953|UAMS|Alison Oliveto, Ph.D.|501-526-8441|olivetoalison@uams.edu|
20205467|NCT01709786|University of Cincinnati|Betty Tsuei, MD|513-558-5661|Betty.Tsuei@uc.edu|
20205468|NCT01170702|Northwestern University Feinberg School of Medicine|Edward Yaghmour|312-695-0693|edward.yaghmour@nm.org|
20205469|NCT00664755|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20205470|NCT00098020|National Institutes of Diabetes, Digestive, and Kidney Disorders|Dr. Jeffery Kopp|301-594-3403|koppj@mail.nih.gov|
20205471|NCT00943488|Carver College of Medicine, University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
20205472|NCT01222572|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Raymond Mak, MD|6177328651|rmak@partners.org|
20205473|NCT02022033|Brown University Oncology Research Group|Howard Safran, MD|401-863-3000|BrUOG@BROWN.EDU|
20205474|NCT01429077|Rehabilitation Institute of Chicago|Leora R. Cherney, PhD|312-238-1117|Lcherney@ric.org|
20205475|NCT00280241|University of Pittsburgh|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
20205476|NCT01413542|Department of Medicine Vanderbilt University Medical Center|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
20205477|NCT03341923|Alcon Japan, Ltd.|Group Manager, Vision Care|+81.3.6899.5061|alcon.medinfo@alcon.com|
20205478|NCT03986190|University of Miami Miller School of Medicine|Dr. Sara St George|305-243-0726|s.stgeorge@med.miami.edu|
20189702|NCT01543204|Amgen Inc.|Study Director|866-572-6436||
20189703|NCT01220999|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20205479|NCT04511819|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20205480|NCT00844649|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20205481|NCT02767856|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
20205482|NCT00239837|University of Oregon|Dr Leslie Leve|541-346-9528|leve@uoregon.edu|
20205483|NCT00536978|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
20202889|NCT00328198|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
20202890|NCT00066781|Mayo Clinic|Matthew Goetz, M.D.|(507) 284-2511|goetz.matthew@mayo.edu|
20202891|NCT02648230|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
20202892|NCT02717546|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574.527.7934|ryan.boylan@zimmerbiomet.com|
20202893|NCT02048878|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
20202894|NCT01720667|University of California San Diego, School of Medicine|Dr. Richard Haas|(858) 822-6700|rhaas@ucsd.edu|
20202895|NCT02984878|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
20219830|NCT02342639|University of Kansas Medical Center|Dr. Jason Stubbs|9135886074|jstubbs@kumc.edu|
20219831|NCT00704847|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+45 22901317|bjr@nordicbioscience.com|
20160450|NCT02323204|University of Iowa/ University of Minnesota|Dr. Marizen R Ramirez|612-624-3143|mramirez@umn.edu|
20160451|NCT00101816|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20160452|NCT04508751|University of California Los Angeles|Dr. Kara Calkins|3108259330|kcalkins@mednet.ucla.edu|
20160453|NCT02752958|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160454|NCT00711490|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyelec@nei.nih.gov|
20160455|NCT03023826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20160456|NCT01646645|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
20160457|NCT00072293|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
20160458|NCT00901511|Fondazione IRCCS Policlinico San Matteo Pavia|Francesca Mariani|+39 0382 503590|fr.mariani@smatteo.pv.it|
20160459|NCT02436668|Pharmacyclics, An AbbVie Company|George Cole|(408) 990-7340|gcole@pcyc.com|
20160460|NCT00167180|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-625-7409|mille011@umn.edu|
20160461|NCT01485380|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|6177247200|oluwaseun.akeju@mgh.harvard.edu|
20160462|NCT01896271|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
20160463|NCT01514240|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
20160464|NCT00509093|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|+1 216-445-9354|advania@ccf.org|
20160465|NCT01103063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160466|NCT05320393|Evolus, Inc.|Rui Avelar|1-949-284-4689|rui.avelar@evolus.com|
20160467|NCT03283098|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20160468|NCT00798317|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
20160469|NCT03115853|Vanderbilt University Medical Center|James Muldowney, MD|615-936-1720|james.muldowney@vanderbilt.edu|
20160470|NCT01069861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160471|NCT01187446|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
20160472|NCT00823212|Boston Scientific Corporation|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20160473|NCT00496197|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160474|NCT04431713|UCL|Professor Foltynie|020 3448 8726|t.foltynie@ucl.ac.uk|
20160475|NCT00149994|Novartis Pharmaceuticals|Study Director|862-778-8300||
20160476|NCT01344538|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
20160477|NCT00297102|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20160478|NCT01655381|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20160479|NCT02324205|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
20160480|NCT04195438|University of Maryland School of Medicine|Dr. Cherif Boutros (Surgical Oncologist)|410-328-7320|cboutros@som.umaryland.edu|
20160481|NCT00868218|University of Bergen|Professor Rebecca Jane Cox|+4755974668|rebecca.cox@uib.no|
20160482|NCT00613925|Oregon health & Science University|Alison Edelman, Associate Professor|503-418-2585|edelmana@ohsu.edu|
20160483|NCT03136497|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20160484|NCT04599959|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160485|NCT00856206|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20160486|NCT02638207|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
20160487|NCT02868034|University of Utah|Julie Fritz|18015872237|julie.fritz@utah.edu|
20160488|NCT04584346|National Institutes of Health|Dr. Debra Ehrlich|301-443-7888|debra.ehrlich@nih.gov|
20160489|NCT00358332|University of Maryland School of Medicine|Christopher V. Plowe|410-706-3082|cplowe@medicine.umaryland.edu|
20160490|NCT03640052|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
20160491|NCT05479097|University of Wisconsin School of Medicine and Public Health|Dr. Sean Duffy|608-263-3111|sean.duffy@fammed.wisc.edu|
20160492|NCT01893372|The Universtiy of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
20160493|NCT01779869|Washington University School of Medicine|Pamela K. Woodard, M.D.|314-362-7130|woodardp@wustl.edu|
20160494|NCT03760016|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
20160495|NCT00957944|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20160496|NCT03232645|Boston Scientific|Clinical Trial Manager|00393421994999|alberto.belligoli@bsci.com|
20160497|NCT01482169|Ochsner Clinic Foundation|Dr. Robert Bober|504-842-4135|rbober@ochsner.org|
20160498|NCT00803517|Samsung Medical Center|Jiwon Lim|82-10-9933-5596|samnyasa@naver.com|
20160499|NCT01369680|Medical University of South Carolina|Dr. Amy-Lee Bredlau|843-792-2957|bredlau@musc.edu|62872
20160500|NCT00759356|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20160501|NCT01657344|Lurie Children's Hospital|Elizabeth Alpern|312-227-6080|ealpern@luriechildrens.org|
20160502|NCT03995680|Swiss Tropical and Public Health Institute|Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
20160503|NCT03385265|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
20160504|NCT03220581|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
20160505|NCT02434354|Abramson Cancer Center|Dr. Tara Mitchell|215-662-7908|tara.mitchell@pennmedicine.upenn.edu|
20160506|NCT03730961|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20160507|NCT01920893|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20174581|NCT04649164|Rush University Medical Center|Dr. Jori Fleisher|3125632900|jori_fleisher@rush.edu|
20174582|NCT03168464|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
20174583|NCT01969812|Atrium Health|Bradley Hurst, M.D.|704-355-3153|brad.hurst@atriumhealth.org|
20174584|NCT04916795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174585|NCT00634088|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20174586|NCT00499096|Department of Veterans Affairs|Dr. Amy M. Kilbourne, PhD, MPH|734-845-3502|Amy.Kilbourne@va.gov|
20174587|NCT01110421|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
20174588|NCT01251380|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20174589|NCT00600756|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
20174590|NCT04503564|Capillary BioMedical, Inc.|Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
20174591|NCT02063737|Carolinas HealthCare System|Dr. Daniel Patterson|704-446-0433|Daniel.Patterson@carolinas.org|
20174592|NCT00439556|UT MD Anderson Cancer Center|Dr. Khouri,Issa,M.D. / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
20174593|NCT01642238|Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon|(212) 241-8484|Juan.Badimon@mssm.edu|
20219832|NCT00416884|Center for Hematologic Malignancies|Center for Hematologic Malignancies|503-494-1551||
20219833|NCT01143766|Indiana University|Gregory A. Cote|317-944-2740|gcote@iupui.edu|
20219834|NCT00213135|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20219835|NCT01328379|Acorda Therapeutics|Vice President - Clinical Development & Medical Affairs|(914) 347- 4300|hhenney@acorda.com|5138
20219836|NCT02886624|Hôpital Saint Antoine|Prof. Karine Lacombe|+33 1 49 28 24 38|karine.lacombe2@aphp.fr|
20219837|NCT00998868|Seoul National University Hospital|Tai Ryoon Han, MD, PhD./Professor|+82-2-2072-3218|tairyoon@snu.ac.kr|
20219838|NCT01027195|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
20219839|NCT02929056|Prisma Health|Dr. Thomas Oliver|864-454-8272|Tom.Oliver@prismahealth.org|
20219840|NCT00402116|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20219841|NCT05048329|NorthShore university HealthSystem|Nirav S Shah|847-570-3542|nshah@northshore.org|
20219842|NCT00324649|Gilead Sciences|Pedro Ferrer|+34 91 771 2478|pedro.ferrer@gilead.com|
20219843|NCT01564537|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20219844|NCT05776862|University of Miami|Mark Nash, PhD|305-243-3628|mnash@med.miami.edu|
20219845|NCT02448706|Northwestern University|Pamela Souza|8474912433|p-souza@northwestern.edu|
20219846|NCT01199471|Abbott|Global Medical Services|800-633-9110||
20219847|NCT02065700|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20219848|NCT03151408|Helsinn Healthcare SA|Francesco Scarci|+41 (0)91 985 1946|francesco.scarci@helsinn.com|
20219849|NCT02784444|Cirius Therapeutics Inc.|Jules Lee|8583336274|jlee@ciriustx.com|514
20219850|NCT03262038|University of Michigan|Elizabeth Putnam|734-763-2435|eread@umich.edu|
20219851|NCT04933968|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
20219852|NCT01724489|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
20219853|NCT05119348|Desmond Tutu Health Foundation|Dr. Philip Smith|+27216501895|Philip.Smith@hiv-research.org.za|
20219854|NCT01664130|Case Comprehensive Cancer Center|Kevin Stephans MD|216-445-8285|stephak@ccf.org|
20160508|NCT03576755|University of California San Francisco|Principal Investigator: Dr. Monika Sarkar|415-502-2656|monika.sarkar@ucsf.edu|
20160509|NCT01767493|Invicro|Stephanie Pizarro|203-990-1613|spizarro@invicro.com|
20160510|NCT00853125|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20160511|NCT03746600|University of Kentucky College of Medicine|Carolyn Lauckner, PhD|989-928-2359|carolyn.lauckner@uky.edu|
20160512|NCT00884039|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
20160513|NCT02648022|Va San Diego Healthcare System|Dr. Samuel B. Ho|858-552-8585|Samuel.Ho2@va.gov|3280
20160514|NCT04209114|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20160515|NCT02403895|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
20160516|NCT00405964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20160517|NCT00937118|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
20160518|NCT01660737|PASCOE Pharamzeutische Präparate GmbH|Jennifer Lebert|0049+(0)641-7960-955|Jennifer.lebert@pascoe.de|
20160519|NCT02981407|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
20160520|NCT02466074|The University of Texas Health Science Center at Houston|John A. Lincoln, MD, PhD|713-500-7016|John.A.Lincoln@uth.tmc.edu|
20160521|NCT01300819|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20160522|NCT05434013|BU School of Public Health|Jennifer Ross, PhD|617 358 1905|jjross@bu.edu|
20160523|NCT03058666|Ony Biotech|James Cummings, MD|7166369096|jcummings@onybiotech.com|
20160524|NCT02818036|University of Pittsburgh|Dr. Tristen Inagaki|412-624-4211|inagaki@pitt.edu|
20160525|NCT04627675|Providence Portland Medical Center|Dr. Rom Leidner|503-215-5696|rom.leidner@providence.org|
20160526|NCT03561701|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
20160527|NCT01319721|State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University|Dr. Shiyou Zhou|+86-020-87331540|zhoushiy@mail.sysu.edu.cn|
20174594|NCT00922883|NHLBI|Cynthia E Dunbar|301-496-5093|dunbarc@nhlbi.nih.gov|
20174595|NCT00867451|Cincinnati Children's Hospital Medical Center|Richard Gilman, Ph.D.|513-636-8172|richard.gilman@cchmc.org|
20219855|NCT04732624|University of Washington/Nepal cleft and burn center|Dr. Raslina Shrestha|+977 9849978888|raslinas@uw.edu|
20219856|NCT03634475|Panoptes Pharma|Study Director|+43 664 851 5865|ssperl@kiorapharma.com|
20219857|NCT00554606|Novartis|Study Director|+41613241111|Novartis.email@novartis.com|
20189704|NCT00603018|UCSD|Walter Kaye, MD/Director, Eating Disorders Program Professor, UCSD Department of Psychiatry|858- 534-8019|wkaye@ucsd.edu|
20189705|NCT02449902|TherapeuticsMD|Shelli Graham, PhD|561-961-1900|Shelli.Graham@TherapeuticsMD.com|
20189706|NCT01365546|Octapharma|Director of Clinical Operations|4152609577|sylvia.werner@octapharma.com|
20189707|NCT03326856|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
20189708|NCT02037568|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9277|biel@ucdenver.edu|
20189709|NCT02684136|HenryFordHS|Timothy Roehrs PhD Study Investigator|313-916-5177|troehrs1@hfhs.org|
20189710|NCT00721734|Amgen, Inc.|Study Director|866-572-6436||
20189711|NCT03861234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189712|NCT00432445|University of Texas (UT) MD Anderson Cancer Center|Dan Gombos, MD/Professor, Ophthalmology|713-792-6920|CR_Study_Registration@mdanderson.org|
20160528|NCT00438854|Massachusetts General Hospital|Philip C. Amrein, M.D.|617-726-8748|pamrein@partners.org|
20160529|NCT00468845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160530|NCT00549900|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160531|NCT03383757|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
20160532|NCT02210832|University of Vermont|Stephen T. Higgins|802-735-6267|stephen.higgins@uvm.edu|
20160533|NCT04790812|The University of Texas Health Science Center at Houston|Harry Gilbert, DDS|713-486-4315|Harry.D.Gilbert@uth.tmc.edu|
20160534|NCT03093636|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|(434) 982-6484|MB6NT@uvahealth.org|
20160535|NCT02754141|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20160536|NCT01430325|Intermountain Healthcare|Lindell K. Weaver, MD|801-408-3623|lindell.weaver@imail.org|
20160537|NCT01175434|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
20160538|NCT00794365|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160539|NCT03538444|Medical University of South Carolina|Gregory Sahlem MD|843-792-5716|sahlem@musc.edu|
20160540|NCT01431014|Chang Gung Memorial Hospital|Lun-Jou Lo, MD,Hye-Young Kim, MD||lunjoulo@cgmh.org.tw|
20160541|NCT00623545|University of Wisconsin-Madison|Dale A Schoeller|608-262-1082|dschoell@nutrisci.wisc.edu|
20160542|NCT04239222|Ottobock SE & Co. KGaA|Clinical Project Manager|+4955278483054|pawel.maciejasz@ottobock.com|
20160543|NCT04283942|Zhongshan Hospital, Fudan University|Dr. Hua Bian|+86 64041990|zhongshan_bh@126.com|
20160544|NCT05494736|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160545|NCT00328653|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
20160546|NCT00937404|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160547|NCT04854031|Boys Town National Research Hospital|Adam Bosen|531-355-5030|adam.bosen@boystown.org|
20160548|NCT00230282|Stanford University|Steven E. Coutre, Associate Professor of Medicine|650-723-6661|coutre@stanford.edu|
20160549|NCT04754230|Stanford University|Zara M. Patel, MD|650-723-5651|zmpatel@stanford.edu|
20160550|NCT01459653|Sandoz GmBH|Andriy Krendyukov, Global Medical Director|+49 8024 4764855|andriy.krendyukov@sandoz.com|
20160551|NCT01691105|Yale School of Medicine|Dr. Steven Bernstein|203-737-3574|steven.bernstein@yale.edu|
20160552|NCT00445848|Swog Statistical Center|Lung Committee Statistican|2066674623|jmoon@fredhutch.org|
20160553|NCT02139878|University of Prince Edward Island|Kim S. Stote PhD, MPH, RD|518-587-2100|Kim.Stote@esc.edu|2873
20160554|NCT00790647|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
20160555|NCT05074888|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20160556|NCT01777542|Boston Children's Hospital|Dr. Mustafa Sahin, Director of Translational Neuroscience Center|617-919-6258|ResearchTNC@childrens.harvard.edu|
20160557|NCT03296137|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD, PhD|+4538686467|anders.kverneland@regionh.dk|
20160558|NCT02270255|McGill University Health Centre|Louis-Martin boucher|5149341934|lmboucher@yahoo.com|44454
20160559|NCT04706273|W. L. Gore & Associates|Eric Novak|314-440-2110|enovak@wlgore.com|
20160560|NCT00899717|University of Santiago de Compostela|Urbano Santana Penín|0034647344093|urbano.santana@usc.es|
20160561|NCT03199053|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20160562|NCT03298984|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|2104147702|Susan.smith@sdponcology.com|
20160563|NCT00970814|NIAAA|Megan Ryan - Clinical Trials Project Manager|301-443-4225|mryan1@mail.nih.gov|
20160564|NCT02403635|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20160565|NCT00359944|Sunovion|Medical Director, CNS|1-866-503-6351||
20160566|NCT00585221|Huntsman Cancer Institute|Director of Clinical Trials|801-213-4241|candace.larson@hci.utah.edu|
20160567|NCT02509052|Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA 91010|Michael Rosenzweig, MD|626-218-2405|mrosenzweig@coh.org|
20160568|NCT02585830|University of Colorado Anschutz Medical Campus|Stacey L. Simon|720-777-5681|stacey.simon@childrenscolorado.org|
20160569|NCT03263923|Case Western Reserve University|Dr. Carol M. Musil|216-368-2545|cmm4@case.edu|
20160570|NCT01323270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160571|NCT05357664|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
20160572|NCT01057225|Mayo Clinic|Joseph Riad Mikhael, M.D.||Mikhael.Joseph@mayo.edu|
20160573|NCT00075725|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20160574|NCT03242772|Duke Center for Autism and Brain Development|Dr. Geraldine Dawson, PhD, PI of Duke Autism Center of Excellence|919-668-0070|geraldine.dawson@duke.edu|
20174596|NCT00788892|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|215-832-3750||
20160575|NCT02023801|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
20174597|NCT01826487|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20174598|NCT01358357|Sunovion Pharmaceuticlas Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20174599|NCT01035944|HemCon Medical Technolgoies|Dr. Jody Oyama|503.245.0459|jody.oyama@hemcon.com|
20174600|NCT02171260|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20174601|NCT02535845|The University of Chicago|Dr. Jasmin Tiro|773-834-4384|jtiro@bsd.uchicago.edu|
20174602|NCT00323492|Gilead Sciences|Camille Aubron-Olivier|+33(0)1 42 737130|camille.aubron-olivier@gilead.com|
20174603|NCT02486042|UC San Diego Health|Sarah Lazar, clinical research manager|(858) 249-1711|slazar@health.ucsd.edu|
20189713|NCT05353296|Columbia University|Carmela Alcantara, PhD|212-851-2187|ca2543@cumc.columbia.edu|
20189714|NCT01989689|Emory University|Arshed Ali Quyyumi MD/FACC|404-727-3655|aquyyum@emory.edu|
20189715|NCT02066636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20160576|NCT02437305|Northwestern Univeristy|Dr. Roopal Kundu|312-926-4926|rkundu@nm.org|
20160577|NCT01560637|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20160578|NCT01185964|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160579|NCT03440918|Vanderbilt University Medical Center|Dr. Sophie Katz|615-343-6190|sophie.e.katz@vumc.org|
20160580|NCT02257177|Galecto|Professor Bertil Lindmark|+4570705210|info@galecto.com|
20160581|NCT01396265|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160582|NCT03444766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20160583|NCT04346108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20160584|NCT01081301|University of Alberta|Dr. Wendy Duggleby|780-492-8660|wendy.duggleby@ualberta.ca|
20219858|NCT03323437|Weill Cornell Medicine|Dr. Dikoma C. Shungu|212-746-2481|dcs7001@med.cornell.edu|
20219859|NCT00843479|Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil|Dr. Bruno Geloneze|+55 19 35218589|bgeloneze@terra.com.br|
20219860|NCT01235195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219861|NCT02119819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20219862|NCT02045147|University of Nebraska Medical Center|Lani Zimmerman|402-472-3847|lzimmerm@unmc.edu|
20219863|NCT04839692|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
20219864|NCT02383810|Helsinn Healthcare SA|Director of Clinical Division|+41 91 9852121|info@helsinn.com|
20219865|NCT01917214|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219866|NCT02861014|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20219867|NCT01837524|Kaiser Center for Clinical and Outcomes Research|Kristina Lewis|404-364-7150|khlewis@wakehealth.edu|
20160585|NCT00724854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20160586|NCT02046226|Halyard Health, Inc.|David T Curd|470-448-5178|david.curd@hyh.com|
20160587|NCT01095653|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20160588|NCT00171925|Novartis Pharmaceuticals|Study Director|862-778-8300||
20160589|NCT02182440|AM-Pharma B.V.|JAcques Arend MD, DiMD, Chief Medical Officer|+31302598836|j.arend@am-pharma.com|
20160590|NCT01799239|Coloplast A/S|Camilla Felsvang Vibjerg, Senior Clinical manager|+45 4911 1990|dkcfv@coloplast.com|
20160591|NCT03754582|Eisai Co., Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20160592|NCT03630198|Vanderbilt Univeristy Medical center|Dr. Brian Drolet|615-322-2918|brian.c.drolet@vumc.org|
20160593|NCT01561755|Icahn School of Medicine at Mount Sinai|Dr. David Simpson|212-241-8748|david.simpson@mssm.edu|
20160594|NCT02680574|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
20160595|NCT01166958|University of Wisconsin Osteoporosis Clinical Research Program|Neil Binkley, MD|608-265-6410|uwosteoporosis@gmail.com|
20160596|NCT01286987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160597|NCT02880514|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20160598|NCT04151628|Shockwave Medical Inc|Randee Randoll, Director Clinical Affairs|1-408-577-7856|rrandoll@shockwavemedical.com|
20160599|NCT00681564|Universidad del Valle|Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).|5723753778|jorge.h.ramirez00@gmail.com|
20160600|NCT02826421|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20160601|NCT04899440|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
20160602|NCT02210221|UZA|Prof. Em. Dr Andrew Maas|0032 3 821 45 37|andrew.maas@uza.be|
20160603|NCT02230761|Topokine Therapeutics, Inc.|Chief Scientific Officer|617 203 2034|CSO@topokine.com|
20160604|NCT03468816|Åby vårdcentral, County council of Östergötland|Dr. Fredrik Iredahl|010-103 00 00|fredrik.iredahl@liu.se|
20160605|NCT02185014|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20160606|NCT00392808|Centro Superior de Investigacion en Salud Publica|Javier Diez-Domingo|+34961925937|diez_jav@gva.es|
20160607|NCT02649855|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|madanr@mail.nih.gov|
20160608|NCT02653495|Rockefeller University|Dr. Ursula Andreo|212-327-7894|uandreo@gmail.com|
20160609|NCT00461305|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20160610|NCT01628614|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20160611|NCT01540409|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
20160612|NCT00953680|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20160613|NCT03966885|Columbia University|Jeremy Kane, PhD, MPH|7179914098|jk4397@cumc.columbia.edu|
20160614|NCT03187834|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
20160615|NCT03710876|Ferring Ventures Ltd|Lindsay Caygill Clinical Trial Manager|+44 (0) 74 213 02230|linsdsay.caygill@trizell.com|
20160616|NCT01007123|Albireo|Dr Mats Ekelund|+46 31 741 14 80|info@albireopharma.com|
20160617|NCT02838901|Wake Forest School of Medicine|Dr. Cheryl Bushnell|336-716-4101|cbushnel@wakehealth.edu|
20160618|NCT00320255|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20160619|NCT00043108|Fox Chase Cancer Center|Dr. Mark Hallman|215-728-2581|Mark.Hallman@fccc.edu|
20160620|NCT03405935|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20160621|NCT04979897|Universidad del Desarrollo|Ana Castro-Avila|+56223279648|anacastro@udd.cl|
20160622|NCT03397134|Minerva Neurosciences|Senior Vice President and Head of R&D|617-600-7378|rkuchibhatla@minervaneurosciences.com|
20160623|NCT03287674|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD|38686467|anders.kverneland@regionh.dk|
20160624|NCT00929773|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20160625|NCT02781792|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
20160626|NCT03061721|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20160627|NCT00118352|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20160628|NCT01224821|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160629|NCT00683917|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20160630|NCT02725879|2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki,|Professor Assimina Galli-Tsinopoulou|+302310994802|agalli@auth.gr|
20219868|NCT03247816|Shield TX (UK) Limited|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20219869|NCT01439009|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
20219870|NCT00926783|Biosense Webster EMEA|Ellen Harris, Sr. Clinical Research Associate, Clinical Operations|(800) 729-9010|eharris@its.jnj.com|
20219871|NCT03257865|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20219872|NCT01661062|University of Michigan Comprehensive Cancer Center|Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
20219873|NCT00717041|University of Rochester|Manish N. Shah, MD MPH|585-275-1198|manish.shah@rochester.edu|
20219874|NCT00873457|Duke University Medical Center|Daphne Friedman, MD|919-684-9220|daphne.friedman@dm.duke.edu|
20219875|NCT01292226|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20219876|NCT00423319|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20219877|NCT03065218|MedStar Health Research Institute|Dr. Douglas Van Nostrand|202-877-0300|douglasvannostrand@gmail.com|
20219878|NCT04181723|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
20219879|NCT00635232|Ligand Pharmaceuticals|Director of Project Management|858-550-7892|hzientek@ligand.com|
20219880|NCT03316378|University of Iowa, Department of Physical Therapy & Rehabilitation Science|Ruth Chimenti, Assistant Professor|319-335-9791|ruth-chimenti@uiowa.edu|
20219881|NCT00960115|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20219882|NCT04853992|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20219883|NCT02351960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20219884|NCT00638027|University of Rochester|Cynthia Irish, RN, MSCN|585-275-6120|cindy_irish@urmc.rochester.edu|
20219885|NCT03014180|Microport CRM|Director of Scientific Communication|0677164209|anne.rousseauplasse@crm.microport.com|
20219886|NCT01284621|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219887|NCT02392351|Boston Scientific|Clinical Trial Manager|970-294-4082|nicole.kilburn@bsci.com|
20160631|NCT04422561|Zagazig University|Dr. Waheed Shouman|+201114812048|shouman66@gmail.com|
20160632|NCT02685748|CPD Dr Laza Lazarevic, Belgrade, Serbia|Pavicevic Dragana|0652207970|gagapavicevic@yahoo.com|+381
20160633|NCT03500172|Johns Hopkins Bloomberg School of Public Health|Dr. Stefan Baral|4105028975|sbaral@jhu.edu|
20160634|NCT01638052|Ann & Robert H. Lurie Children's Hospital of Chicago|Santhanam Suresh, MD|312-227-5147|SSuresh@luriechildrens.org|
20160635|NCT01752400|Massachusetts General Hospital|Alice Shaw, MD, PhD|617-724-4000|ashaw1@mgh.harvard.edu|
20160636|NCT05740332|Medline Industries LP|Director Clinical Operations|630-418-6891|jamiller@medline.com|
20160637|NCT00090233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20160638|NCT04863248|G1 Therapeutics, Inc|Clinical Trial Info|919-213-9835|clinicalinfo@g1therapeutics.com|
20160639|NCT01035346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160640|NCT00027378|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
20160641|NCT05605691|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
20160642|NCT02279719|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
20160643|NCT03541187|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20160644|NCT02701777|Hines VA|Reagan Morehouse|312-238-2993|rmorehouse@sralab.org|
20160645|NCT00869050|Columbia University|Dr. Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
20160646|NCT02098369|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-0637|jakris@uic.edu|
20160647|NCT01690546|Duke University Medical Center|Paolo Mannelli, M.D|919-681-0613|paolo.mannelli@dm.duke.edu|
20160648|NCT03362931|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20160649|NCT01655043|Northwestern University|Dr. James Carr|(312)926-2270|jcarr@northwestern.edu|
20160650|NCT01924442|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-724-2798|Frederic.Grover@ucdenver.edu|
20160651|NCT02229214|VIVUS Inc.|Craig Peterson, Sr. Director, Clinical Research|650-934-5200|ClinicalTrials@vivus.com|
20160652|NCT00246025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160653|NCT00931723|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20160654|NCT02115750|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
20160655|NCT01643850|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20160656|NCT03300024|Johns Hopkins University|Thomas Reifsnyder|410-955-7518|treifsn1@jhmi.edu|
20160657|NCT03305081|TulaneU|Resident of OB/GYN|858-499-2702|sjunya@tulane.edu|
20160658|NCT00570037|Duke University Medical Center|Emmanuel Walter MD, Principal Investigator|919-620-5374|walte002@mc.duke.edu|
20160659|NCT00554619|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160660|NCT01571284|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20160661|NCT04677660|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20160662|NCT04065074|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
20160663|NCT01218100|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|Manfred.stapff@frx.com|
20160664|NCT03964246|Veterans Affairs San Diego Healthcare System|Barton W. Palmer|8582460765|bpalmer@ucsd.edu|
20160665|NCT01118520|Imperial College London|Professor Neil Poulter|+44(0) 20 7594 3446|n.poulter@imperial.ac.uk|
20160666|NCT01089023|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20160667|NCT01070693|Helsinki University Central Hospital|Dr. Georgios Pierides|+358 9 4711|georgios.pierides@hus.fi|
20174604|NCT00566150|Yale University|Dr. Zubin Bhagwagar|203-974-7560|zubin.bhagwagar@yale.edu|
20219888|NCT02099682|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20219889|NCT02802631|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
20219890|NCT02212379|Inserm, Sorbonne Universite, IPLESP|Dr Lambert Assoumou|0142164280|lambert.assoumou@iplesp.upmc.fr|
20219891|NCT00704730|Exelixis, Inc|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20219892|NCT03395405|Northwestern University Feinberg School of Medicine|Michael G Ison|3126954186|mgison@northwestern.edu|
20160668|NCT00904618|Centre Hospitalier Universitaire de Sherbrooke|Louis-Olivier Gagnon|1-819-437-4965|louis.olivier.gagnon@gmail.com|
20219893|NCT04308226|Division of General Internal Medicine, Massachusetts General Hospital|Travis Baggett, MD, MPH|617-643-9314|tbaggett@mgh.harvard.edu|
20219894|NCT00660907|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20219895|NCT01908907|Sanford Health|Lora Black, Senior Director of Clinical Research|605-328-1368|lora.black@sanfordhealth.org|
20219896|NCT04975191|Rutgers University|Dr. Danielle Dick|732-235-5607|Danielle.M.Dick@rutgers.edu|
20219897|NCT00761657|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
20219898|NCT05264129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20219899|NCT04648696|Wake Forest University Health Sciences|John Williamson, PhD|336.713.3431|johnwill@wakehealth.edu|
20219900|NCT03593538|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
20219901|NCT00618332|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
20219902|NCT00359801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20219903|NCT00826007|William Beaumont Hospital|Tamra Dukatz, CRNA, MSN|2489924741|tdukatz@beaumont.edu|
20219904|NCT02420912|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD/Associate Professor|713-745-6080|njain@mdanderson.org|
20219905|NCT02245412|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20219906|NCT01056289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219907|NCT01917916|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219908|NCT01650584|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20219909|NCT00270855|Penn State Hershey Medical Center|Dr. David Gater|7175314263|dgater@hmc.psu.edu|
20219910|NCT01794455|Vanderbilt University|Dr. Warren Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
20219911|NCT05424679|Johns Hopkins Center for Indigenous Health|Dr. Emily Haroz|(410) 449-0051|eharoz1@jhu.edu|
20219912|NCT00450801|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
20219913|NCT04684238|Sedana Medical AB|Ida Sverud|+46 8 124 052 00|medinfo@sedanamedical.com|
20219914|NCT01396512|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20219915|NCT02711878|Emory university|Dr. Eun Ok IM|404-712-9805|eun.ok.im@emory.edu|
20219916|NCT02618759|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20219917|NCT02152605|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219918|NCT00470392|Louis Stokes VA Medical Center and University Hospitals Case Medical Center|Kevin D. Cooper MD|216 844 3111|kevin.cooper@uhhospitals.org|
20219919|NCT02657928|Mayo Clinic|Gerardo Colon-Otero, MD|904/953-2000|gcolonotero@mayo.edu|
20219920|NCT01988129|Brigham and Women's Hospital|Steven W. Lockley PhD|16177324977|slockley@hms.harvard.edu|
20219921|NCT02500043|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20219922|NCT01371747|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20219923|NCT02856555|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20219924|NCT02928055|MetroHealth Medical Center|Richard Wilson, MD|216-778-4414|rwilson@metrohealth.org|
20219925|NCT02094417|Kyowa Kirin Korea Co. Ltd.,|Clinical Development Team, Clinical Development Department|82221912918|kyungmo.lee.m6@kyowakirin.com|
20219926|NCT01473524|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20219927|NCT01171118|University of Rochester|Dr. Suzanne Karan|585-275-5161|suzanne_karan@urmc.rochester.edu|
20219928|NCT01544179|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|haiyi.jiang@astrazeneca.com|
20219929|NCT01386983|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219930|NCT03146962|Weill Cornell Medicine|Dr. Manish Shah, Sponsor-Investigator|646-962-6200|mas9313@med.cornell.edu|
20219931|NCT00049530|ECOG Statistical Office|Study Statistician|617-632-3012||
20219932|NCT02105558|The University of Texas Health Science Center at Houston|Madhumani Rupasinghe, MD|(713) 500-6200|Madhumani.Rupasinghe@uth.tmc.edu|
20219933|NCT03857750|Rigshospitalet|Dr. Matias Vested|+4524464955|matiasvested@gmail.com|
20219934|NCT01696058|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219935|NCT01934335|Holden Comprehensive Cancer Center|Ronald Weigel, MD, PhD|319-353-7474|ronald-weigel@uiowa.edu|
20219936|NCT01421511|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
20219937|NCT05384171|VA Boston Healthcare system|Dr. Dawne Vogt|857-364-5976|dawne.vogt@va.gov|
20219938|NCT00749892|UT MD Anderson Cancer Center|Dr. Arlene O. Siefker-Radtke,Professor, Genitourinary Medical Oncology|(713) 792-2830|asiefker@mdanderson.org|
20219939|NCT04581369|Indiana University|Eric Orman|317-278-1630|esorman@iu.edu|
20219940|NCT00780910|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20219941|NCT01111825|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20219942|NCT04074616|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|713-797-5938|argyrios.stampas@uth.tmc.edu|
20219943|NCT01377987|Brigham and Women's Hospital|Dr. Scott Sands|617 278 0911|sasands@bwh.harvard.edu|
20219944|NCT03150407|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
20219945|NCT00195338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219946|NCT00811928|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20219947|NCT00599053|University of Alabama at Birmingham|Dr. David Randolph|205-934-4680|drandolph@peds.uab.edu|
20219948|NCT04106661|Husson University|William Lindblad, Director of Research and Scholarship|20-7992-1958|lindbladw@husson.edu|
20219949|NCT00233402|Photocure|Yngvil Kloster Thomas|+1 2167732505|ykt@photocure.no|
20219950|NCT06154200|SCCO at MBKU|Dr. Jerry Paugh, Professor Emeritus|7144497487|jpaugh@ketchum.edu|
20219951|NCT03503864|Sun Yat-sen Memorial Hospital|Dr Yang Li|02081332045|drliyang@126.com|
20219952|NCT02639052|Lewis Katz School of Medicine at Temple University|Susan G. Fisher, M.S., Ph.D., Associate Dean and Director, Temple Clinical Research Institute|215-707-3577|susan.fisher@tuhs.temple.edu|
20219953|NCT04572893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20174605|NCT03320564|Wake Forest Baptist Health|Katie Holbrook Bingman|336-713-7765|krholbro@wakehealth.edu|
20174606|NCT02742987|Campus Bio-Medico University|Dr. Fabio Mangiacapra|003906225411612|f.mangiacapra@unicampus.it|
20219954|NCT05038800|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20160669|NCT03410797|University of Pittsburgh|Jacqueline Gartner-Schmidt|412-232-8970|jgs@pitt.edu|
20174607|NCT01308450|BioBDx|Calvin R. Sumner, MD, CMO, Sr. VP for Clinical Development|978-431-5103|calvin_sumner@biobdx.com|
20219955|NCT00121134|DFCI|Dr Harold J. Burstein|617-632-3800|hal_burstein@dfci.harvard.edu|
20160670|NCT03883113|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
20160671|NCT04465877|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
20219956|NCT02478320|M D Anderson Cancer Center|Dr. David Hong|(713) 563-5844|dshong@mdanderson.org|
20160672|NCT00395135|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20174608|NCT04668950|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20174609|NCT03979638|Bellus Health Inc|Senior Director Clinical Development|833-703-0708|lharvey@bellushealth.com|
20219957|NCT00118131|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20219958|NCT02533375|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20219959|NCT00673387|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20219960|NCT00418821|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20219961|NCT03040323|Indiana University Department of Radiology|Jordan Swensson ,MD|317-944-1831|jswensso@iupui.edu|
20219962|NCT02906566|Stanford University|Dr. Anne L. Chang|650-721-7195|alschang@stanford.edu|
20219963|NCT04400682|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
20219964|NCT02105974|GlaxoSmithKline|GSK Response Center|866-435-7343||
20219965|NCT00477633|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20219966|NCT02968849|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20219967|NCT00815360|Retina Associates of Florida, P.A.|Dr. Ivan J. Suner|813-875-6373|ivansuner@gmail.com|
20219968|NCT03785600|VA Portland Health Care System|Jonathan Elliott|503-220-8262|jonathan.elliott@va.gov|53874
20219969|NCT02185690|Princess Margaret Cancer Centre, University Health Network|Dr. Natasha Leighl, Sponsor-Investigator, Division of Medical Oncology|416-946-4645|natasha.leighl@uhn.ca|
20219970|NCT00478244|Masonic Cancer Center, University of Minnesota|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
20219971|NCT00580788|University of Pittsburgh|Mara J Horwitz, MD|4126922848|horwitz@pitt.edu|
20219972|NCT00411411|Gentofte University Hospital|Dr. Kasper Aaboe|+4522170200|kasper@dadlnet.dk|
20219973|NCT03301649|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20219974|NCT01403051|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20219975|NCT00674739|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
20160673|NCT04962230|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219976|NCT00573378|University of Michigan Rogel Cancer Center|Dale L. Bixby, MD|734-936-4991|dbixby@med.umich.edu|
20219977|NCT00887289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20219978|NCT03022084|VA RR&D National Center for Rehabilitative Auditory Research|Dr. James Henry|503-220-8262|James.Henry@va.gov|
20219979|NCT01701011|UMCU|Henrietta Ockhuijsen 1,*, Agnes van den Hoogen, Marinus Eijkemans , Nick Macklon, Jacky Boivin|+31307553628|h.d.l.ockhuysen@umcutrecht.nl|
20219980|NCT02932306|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
20219981|NCT04176406|Duke University|Dr. Lawrence G. Appelbaum|919-613-7664|greg@duke.edu|
20219982|NCT03559400|University of California, San Francisco|David Shearer, MD, MPH, Associate Professor|628-206-8812|david.shearer@ucsf.edu|
20219983|NCT00509366|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
20219984|NCT00282919|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20219985|NCT01327508|Smith & Nephew, Inc.|Cathy Newbill|800-821-5700|cathy.newbill@smith-nephew.com|
20219986|NCT01438996|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
20160674|NCT01598753|University of Washington|Dennis C. Turk, Ph.D.|(206)616-2626|turkdc@uw.edu|
20174610|NCT04993287|NorthShore University HealthSystem|Dr. Nirav Shah|847-657-5959|nshah2@northshore.org|
20174611|NCT02586896|NYU School of Medicine|Michael Bogenschutz|646-501-4026|michael.bogenschutz@nyulangone.org|
20160675|NCT02275117|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20205484|NCT02055430|Cairo University|dr Mohammed Said ElSheemy|01006117755|mohammedshemy@yahoo.com|
20205485|NCT02938052|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
20205486|NCT00669916|Novartis|Study Director|862-778-8300||
20205487|NCT00622869|Novartis Pharmaceuticals|Study Director|862 778-8300||
20160676|NCT02825966|ZOLL|Director, Clinical Operations|4129683333|mosz@zoll.com|
20160677|NCT00832130|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
20160678|NCT02142283|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
20160679|NCT02374814|SUNY Upstate Medical University|Dr. Timothy Endy|315-464-7692|endyt@upstate.edu|
20160680|NCT03093974|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clincaltrials@zambongroup.com|
20160681|NCT02141490|National Cancer Institute|Dr. Ismail B. Turkbey|240-760-6112|turkbeyi@nih.gov|
20160682|NCT01550341|Yale University|Dr. Frederick Altice, Principal Investigator|203-737-2883|frederick.altice@yale.edu|
20160683|NCT00033540|Southwest Oncology Group (SWOG) Statistical Center|Study Statistician|206-667-4623||
20160684|NCT01001546|Durham VA Medical Center - HSRD|Dr. Patrick S. Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
20160685|NCT01253265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160686|NCT03785587|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20160687|NCT00915655|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Leader|+1 609 730-7548||
20160688|NCT00434759|Central Institute of Mental Health, Mannheim, Germany|Prof. Martin Bohus|+49 621 1703 4002|martin.bohus@zi-mannheim.de|
20160689|NCT00495521|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|609-921-7448|kathy.ales@jacobus-pharmaceutical.com|238
20160690|NCT02410824|CooperVision Inc.|Sr. Manager Clinical Research|925-730-6754|pchamberlain@coopervision.com|
20160691|NCT02782325|University of North Carolina at Chapel Hill|Hans Herfarth, MD|919-966-6806|hherf@med.unc.edu|
20160692|NCT01038713|Dartmouth-Hitchcock Medical Center|Timothy Gardner|603-650-6472|timothy.b.gardner@hitchcock.org|
20160693|NCT03777917|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20205488|NCT02821455|University of Edinburgh|E Alexandra Page|7938645122|s1305565@sms.ed.ac.uk|
20205489|NCT04664855|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
20205490|NCT03076190|Stanford University|Dr. Beth Darnall|6507365494|bdarnall@stanford.edu|
20205491|NCT04398199|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mfarris@wakehealth.edu|
20205492|NCT00393913|NYU School o Medicine|Indu Ayappa, PhD|2125628437|indu.ayappa@nyumc.org|
20205493|NCT01518244|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20205494|NCT00870818|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
20205495|NCT00094887|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20205496|NCT04900038|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20219987|NCT01433549|Alcon Research, Ltd.|R. Alan Landers, O.D., M.S., F.A.A.O.|1-888-451-3937|alcon.medinfo@alcon.com|
20160694|NCT00930969|Medtronic Cardiac Rhythm Disease Management|ST Detect Study Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
20219988|NCT01631071|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20160695|NCT00657150|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160696|NCT02966795|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20219989|NCT04497948|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20219990|NCT00696787|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20160697|NCT00432744|University of Florida|Dr. Peter W Stacpoole|352-273-9023|pws@ufl.edu|
20219991|NCT03781037|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
20219992|NCT02549027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20219993|NCT02186834|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
20160698|NCT01401699|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
20219994|NCT01504958|Beth Israel Deaconess Medical Center|Alvaro Pascual-Leone, M.D., Ph.D.|617-667-0203|apleone@bidmc.harvard.edu|
20219995|NCT00127218|The Johns Hopkins Hospital, Department of Medicine, Division of Cardiology|Dr. Joao AC Lima|410-614-1284|jlima@jhmi.edu|
20160699|NCT01460719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160700|NCT02630017|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|maddicott@uams.edu|
20160701|NCT06276881|Dandelion Science|Chief Executive Officer (CEO)|628-777-3477|info@dandelion.science|
20160702|NCT02124512|University of Kentucky|Philip Kern|859-323-2232|pake222@uky.edu|
20160703|NCT00350623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160704|NCT03660228|Dana-Farber Cancer Institute|Gregory A. Abel, MD|617-632-2304|GAABEL@PARTNERS.ORG|
20160705|NCT04126564|Sadhguru Center for a Conscious Planet, BIDMC|Dr. Balachundar Subramaniam|(617)632-8071|bsubrama@bidmc.harvard.edu|
20160706|NCT02536300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20189716|NCT02494336|Johns Hopkins All Children's Hospital|Nicole Chandler, MD|7277674170|nicole.chandler@jhmi.edu|
20189717|NCT00391170|National Heart Lung and Blood Institute|Clara, Joseph|+1 301 402 2399|joseph.clara@nih.gov|
20189718|NCT01989793|Johns Hopkins University|Dr. Jeremy D. Walston, M.D. , Raymond and Anna Lublin Professor of Geriatric Medicine|410-550-1003|jwalston@jhmi.edu|
20189719|NCT02696200|Cincinnati Childrens Hospital|Kim Foss|513-636-5971|kim.foss@cchmc.org|
20189720|NCT03567616|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20189721|NCT00849485|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-3848-5525|clinicaltrialqueries@tevausa.com|
20160707|NCT03315104|Emergent BioSolutions|Dr. Christine Hall|204-275-4200|chall@ebsi.com|4248
20160708|NCT05257148|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
20160709|NCT02769338|Department of Veterans Affairs|Dr. Dawn M. Bravata|317-988-2676|Dawn.Bravata2@va.gov|
20160710|NCT02089113|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20160711|NCT00294645|Medtronic CRDM|CRDM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20160712|NCT00620425|Zogenix, Inc|Edward Smith III, PhD, VP Regulatory Affairs & Product Quality/Safety|510 550 8325|esmith@zogenix.com|
20160713|NCT04942665|University of Florida|Dr. Ali Zarrinpar|(352) 265-0606|ali.zarrinpar@surgery.ufl.edu|
20160714|NCT02061397|University of Pennsylvania|Dr. Vera Krymskaya|215-573-9861|krymskay@pennmedicine.upenn.edu|
20160715|NCT04600505|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20160716|NCT01238835|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
20160717|NCT02250807|Janssen R&D BE|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
20160718|NCT00908648|Gastroenterology Unit, Valduce Hospital - Como - Italy|Dr Vittorio Terruzzi, Director of Gastroenterology Unit|+39031324009|vterruzzi@valduce.it|
20160719|NCT03352557|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20160720|NCT00907803|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
20160721|NCT04612842|Oregon Health & Science University|Dr. Hiroko Kiyoshi-Teo (Assistant Professor)|5034943858|kiyoshi@ohsu.edu|
20160722|NCT05426031|University of Miami|Michael Fabbro II, DO|305-689-1106|mxf790@miami.edu|
20160723|NCT02419131|Massachusetts General Hospital, Harvard Medical School|Dr. Tim Houle|617-724-2111|thoule1@mgh.harvard.edu|
20189722|NCT00556478|Plethora Solutions|Chief Scientific Officer|+44 (0) 20 3077 5400|mail@plethorasolutions.co.uk|
20189723|NCT00526994|CDC|Joanne Klevens|770-488-1386|dzk8@cdc.gov|
20174612|NCT00600938|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20174613|NCT04220411|Arjil Pharmaceuticals LLC.|YEH B, WU|+886-3-573-3608|ybw333@arjilbio.com|
20174614|NCT02680639|Philips|Senior Clinical Development Scientist|(724) 733-5835|chuck.cain@philips.com|
20174615|NCT04646499|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
20174616|NCT02496533|Midwestern Regional Medical Center, Inc.|Jessica Kapustin, RN-C||Jessica.Kapustin@CTCA-Hope.com|
20174617|NCT00947297|Hyperion Therapeutics|Craig James|650-745 7840|craig.james@hyperiontx.com|
20174618|NCT00502697|Vanderbilt University|Melanie Lutenbacher, PhD, MSN, FAAN|615-343-3314|melanie.lutenbacher@vanderbilt.edu|
20174619|NCT02059928|Health Partners|Dr. Ralph J Frascone|6512545304|ralph.j.frascone@healthpartners.com|
20174620|NCT00571259|Satellite Healthcare, Inc.|Veronica Legg, MS: Director of Research Business|360-607-6892|leggv@satellitehealth.com|
20174621|NCT02327429|University of Alberta|Catherine Chan|780-492-9939|cbchan@ualberta.ca|
20174622|NCT02268409|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174623|NCT00489853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20174624|NCT04865354|Alcon Research, LLC|Sr. Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20174625|NCT03873987|Melinta Therapeutics, Inc.|Vice President Clinical Operations|9086171319|kfusaro@melinta.com|
20174626|NCT01465022|University of New Mexico|Eve Espey MD, MPH, Principal Investigator|505 272 6372|eespey@salud.unm.edu|
20174627|NCT00004888|Eastern Cooperative Oncology Group Statistical Office|Study Statistician|617-632-3012||
20174628|NCT00136084|St. Jude Children's Research Hospital|Jeffrey Rubnitz, M.D|1-866-278-5833|info@stjude.org|
20174629|NCT02520011|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|+1-210-414-7702|Susan.smith@sdponcology.com|
20174630|NCT02310919|UCSF Center for Reproductive Health|Dr. Yanett Anaya, Assistant Professor|832-654-8361|Yanett.anaya2@ucsf.edu|
20174631|NCT03239470|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
20174632|NCT02622828|University of Manitoba|Dr. Jacquie Ripat|204-789-3303|jacquie.ripat@umanitoba.ca|
20174633|NCT01921829|University of Pittsburgh|Dr. Kelly Liang|507-269-7812|liangk@upmc.edu|
20174634|NCT04091646|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20174635|NCT03483935|University of Dundee|Prof Charlotte Proby|+44 1382 383289|c.proby@dundee.ac.uk|
20174636|NCT01762943|University of North Carolina at Chapel Hill|Dr. Crystal Schiller|9199664810|crystal_schiller@med.unc.edu|
20174637|NCT00539838|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20174638|NCT02681549|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
20174639|NCT02658890|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20174640|NCT01660893|University of Maryland|Dr. Sharon M. Gordon|410-706-1656|sgordon@dental.umaryland.edu|
20174641|NCT05394025|Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System|Project Manager|503-220-8262|Holly.McCready2@va.gov|51856
20174642|NCT02752191|UCLA|J. Paul Finn|(310) 825-5344|ohrpp@research.ucla.edu|
20174643|NCT03314584|VAORD|Dr. Albert Leung|858-552-8585|ayleung@health.ucsd.edu|3331
20174644|NCT04896658|University of Maryland, Baltimore|Ashraf Badros, MD|410-328-1230|abadros@umm.edu|
20174645|NCT01589445|Ministry of Science and Technology, Government of the People's Republic of Bangladesh|Dr. Masuma Parvin|88 01819141258|acmasuma@gmail.com|
20174646|NCT01420289|Calvary Hospital|Oscar M. Alvarez PhD, Director Center for Curative and Palliative Wound Care|718-518-2577|oalvarez@calvaryhospital.org|
20174647|NCT01752855|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20174648|NCT01100242|University of New Mexico|Richard Lauer, MD|5052725837|rlauer@salud.unm.edu|
20174649|NCT01052207|CHOA/Emory|Dr. Kiran Hebbar|404-785-6135|khebbar@emory.edu|
20174650|NCT02439320|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20174651|NCT02245841|Cleveland Clinic|Anthony Fernandez, MD, PhD|216-445-8776|fernana6@ccf.org|
20174652|NCT03343483|University of Rochester Medical Center|Dr. Kim Van Orden (PI)|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
20174653|NCT01505608|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
20174654|NCT01488097|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|475-230-2596|clinicaltrials@alexion.com|
20174655|NCT01577758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20174656|NCT01293240|Alcon Research|Peter Bergenske|1-800-241-7629||
20174657|NCT04383210|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
20174658|NCT02404350|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
20174659|NCT03261947|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20174660|NCT03969992|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
20174661|NCT01324388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20174662|NCT01405963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20174663|NCT01498640|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20174664|NCT01737047|Imperial College London|Alan Winston|02033121603|a.winston@imperial.ac.uk|1603
20174665|NCT00129129|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174666|NCT03089606|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
20174667|NCT00335972|Cleveland Clinic|Rafi Avitsian, M.D|(216)-444-9735|avitsir@ccf.org|
20174668|NCT00369512|University of Alabama at Birmingham|Eben Rosenthal, MD Department of Surgery Department|(205) 934-9714|erosenthal@uabmc.edu|
20189724|NCT00783952|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-314-2222|rkacmarek@partners.org|
20189725|NCT02170532|Duke University Medical Center|Neil MacIntyre, MD|(919) 681-2720|macin001@mc.duke.edu|
20160724|NCT03060512|AstraZeneca Pharmaceutical LP|Catherine J. Datto, MD, MS, Movantik Medical Head, USMA|+1 302 885 1180|Information.Center@astrazeneca.com|
20174669|NCT02140567|Imperial College Healthcare NHS Trust in London, United Kingdom|Dr. Phang Boon Lim|+44|p.b.lim@imperial.ac.uk|(0)20 3313
20174670|NCT01209442|University of Colorado|Douglas Ney, M.D.|303-724-2184|Douglas.Ney@ucdenver.edu|
20174671|NCT02802592|Johns Hopkins University School of Medicine|Dr. Kenneth Horvath|301-896-3100||
20174672|NCT02882854|Vanderbilt University Medical Center|Stephen Harvey, MD|(615) 936-3198|stephen.harvey@vumc.org|
20174673|NCT00368654|Kaiser Permanente (Current), UC Davis (Previous)|Chai Sue Lee||lam.nguyen@ucdmc.ucdavis.edu|
20174674|NCT00731770|Penn State University|Erin Banta|717-531-6525|ebanta@hmc.psu.edu|1
20174675|NCT00352846|The University of Texas (UT) MD Anderson Cancer Center|Fredrick Hagemeister, MD/Professor||psanjorjo@mdanderson.org|
20174676|NCT00788827|Imperial College London|Professor Charles Pusey|+44 3313 2308|c.pusey@imperial.ac.uk|
20174677|NCT01527682|ASST Spedali Civili di Brescia|Prof. Luciano Quaranta|+39 030 3995|luciano.quaranta@unibs.it|847
20174678|NCT00699556|Yale University|Sherry McKee|(203) 737-3529|sherry.mckee@yale.edu|
20174679|NCT01457885|University of Michigan Comprehensive Cancer Center|Dr. John Magenau, M.D.|734-936-8785|johnmage@umich.edu|
20160725|NCT01648296|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20160726|NCT01672658|Rehabilitation Instititute of Chicago|Arun Jayaraman, PT, PhD|312-238-2091|a-jayaraman@northwestern.edu|
20160727|NCT03831880|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160728|NCT03958656|National Cancer Institute|Dr. James N. Kochendefer|240-760-6062|kochendj@mail.nih.gov|
20160729|NCT02081638|National Institute of Allergy and Infectious Diseases|Dr. Irini Sereti|301-496-5533|isereti@niaid.nih.gov|
20160730|NCT03158012|UCSD Dermatology|Teruaki Nakatsuji|8588227814|tnakatsuji@ucsd.edu|
20160731|NCT02159118|The University of Texas Health Science Center|Chatchawin Assanasen, MD|210-567-7456|assanasen@uthscsa.edu|
20160732|NCT01327274|UCSF Benioff Children's Hospital|Jill Imamura-Ching, RN|415-476-3446|Jill.Imamura-Ching@ucsf.edu|
20160733|NCT00386477|Indiana University School of Medicine|David M. Haas, MD, MS|317-630-7837|dahaas@iupui.edu|
20160734|NCT02446418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160735|NCT02014480|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160736|NCT03114124|UF Health- Jacksonville|Andrea Goosen|904-244-5617|andrea.ggosen@jax.ufl.edu|
20160737|NCT01338610|Alcon Research, Ltd.|Christian Leisner|1-888-451-3937|alcon.medinfo@alcon.com|
20160738|NCT01865812|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
20160739|NCT03089879|GlaxoSmithKline|GSK Response Center|866-435-7343|ass77028@gsk.com|
20160740|NCT02692040|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
20160741|NCT00435162|Novartis Pharmaceuticals|Study Director|862-778-8300||
20160742|NCT01819129|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20160743|NCT00391469|University of Washington|Francis Kim, MD Associate Professor of Medicine|206-744-8712|fkim@u.washington.edu|
20160744|NCT01863134|First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland|Miroslaw Wilczynski|+48 32 20 24 025|miroslaw.wilczynski@cardiosurg.pl|
20160745|NCT00054691|University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD / Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
20160746|NCT02836873|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20160747|NCT02266277|University of Massachusetts Medical School|Dr. Sarah Cutrona|508-856-3086|sarah.cutrona@umassmed.edu|
20160748|NCT00694096|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
20160749|NCT03900923|NYU Langone Health|Francisco X Castellanos, MD|646-754-5194|Francisco.Castellanos@nyulangone.org|
20160750|NCT03190265|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20160751|NCT02599649|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|ggarciam@mdanderson.org|
20160752|NCT02914548|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20160753|NCT00182767|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20160754|NCT00977938|Harvard Clinical Research Institute|Priscilla Driscoll Shempp, Sr. Director Trial Design, Development and Strategy|617.307.5200|pdriscoll@hcri.harvard.edu|
20160755|NCT01310179|University of Alabama at Birmingham|Eben Rosenthal, MD|205-934-9713|erosenthal@uabmc.edu|
20160756|NCT02540330|Atossa Therapeutics, Inc.|Heather Fraser, VP Clinical, Regulatory & CMC|206-707-3088|heather.fraser@atossainc.com|
20160757|NCT03373890|SeattleChildrens|Kristie Bjornson, PT, PhD|206-884-2066|kristie.bjornson@seattlechildrens.org|
20160758|NCT01484834|UNESC|Dr. Antonio Jose Grande|04834312500|grandeto@unesc.net|2571
20174680|NCT04837131|Mayo Clinic|Michael Pham, M.D.|480-301-8318|Pham.Michael@mayo.edu|
20174681|NCT00322335|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174682|NCT00983281|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
20174683|NCT00864474|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174684|NCT00610532|The Ohio State University|Dr. Jim McAuley|614-292-9713|mcauley.5@osu.edu|
20174685|NCT04076644|University of Missouri|Matt Schmidt|573-882-5688|schmidtmw@health.missouri.edu|
20174686|NCT00589108|Mayo Clinic|Dr. Robert T. Trousdale|507-284-3663|trousdale.robert@mayo.edu|
20174687|NCT03256552|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20174688|NCT01713868|Boston University|Michael Corwin, MD||mjcorwin@bu.edu|
20174689|NCT03961100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20189726|NCT02833948|The Heart Center - Rigshospitalet, Copenhagen, Denmark|Ole De Backer, MD, PhD|+45-35457086|ole.debacker@gmail.com|
20219996|NCT01053000|Roger H. Stewart MD PA|Barry Galitzer MD|954-491-0510|barry@galitzer.com|
20219997|NCT00089024|University of Nebraska Medical Center|Jean L Grem|402-552-3233|jgrem@unmc.edu|
20219998|NCT00106964|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20219999|NCT04746794|University of Washington|Faith Beers|206-543-1733|fabeers@uw.edu|
20220000|NCT03207243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160759|NCT02460783|National Institute on Aging|Dimitrios Kapogiannis|+1-202-290-0433|kapogiannisd@nih.mail.gov|
20160760|NCT00747344|Janssen Research & Development, LLC|Director, Clinical Research|215-793-7646||
20160761|NCT02030080|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
20160762|NCT02881112|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
20160763|NCT01371643|NYU Langone Medical Center|David Kleinberg|212 263 6772|David.Kleinberg@nyumc.org|
20160764|NCT02214225|Seqirus|Seqirus Clinical Trial Disclosure Lead||Seqirus.ClinicalTrials@Seqirus.com|
20160765|NCT02170363|St. Jude Medical|Poornima Sood|+17818528334|PSood@sjm.com|
20160766|NCT01861925|Haag Streit AG|Dr. Lucio Robledo, Clinical Trials Biometry|+41 31 978 01 11|lucio.robledo@haag-streit.com|209
20160767|NCT03987932|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
20160768|NCT01605227|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20160769|NCT02129478|The Hospital for Sick Children|Dr. Laura Lee Dupuis|416-813-7654|lee.dupuis@sickkids.ca|309355
20160770|NCT00624819|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160771|NCT02847858|University of California San Francisco|Dr. Kathleen Tebb|415-514-0941|Kathleen.Tebb@ucsf.edu|
20160772|NCT02387164|Skåne University Hospital|Helena Elding Larsson|+4640337676|helena.larsson@med.lu.se|
20220001|NCT03196219|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
20160773|NCT03271047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160774|NCT01416441|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20160775|NCT01243567|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20160776|NCT00526110|The University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD/Professor, GI Medical Oncology|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20160777|NCT01400243|Southern Illinois University Carbondale|David G. Gilbert|618-453-3527|dgilbert@siu.edu|
20160778|NCT01071356|Public Health Institute: Alcohol Research Group|Dr. Douglas Polcin|510-597-3440|dpolcin@arg.org|277
20160779|NCT02278614|Laboratoires Théa|Director of Medical Operations|04 73 98 50 89|J.AUGER@laboratoires-thea.fr|
20160780|NCT04895293|Midwest Eye Institute|Raj K. Maturi, M.D.|317-817-1423|maturi.md@midwesteye.com|
20160781|NCT03762616|Exact Imaging|Dr. Brian Wodlinger|6475279032|bwodlinger@exactimaging.com|
20160782|NCT04030247|Stanford University|Rajesh Dash, MD|650-725-7087|rdash@stanford.edu|
20160783|NCT03559699|Agios Pharmaceuticals, Inc|Medical Affairs|833-228-8474|medinfo@agios.com|
20220002|NCT01422187|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
20220003|NCT00168818|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220004|NCT01056315|Grünenthal|Study Director|+49 (0)-241-569-3223|clinical-trials@grunenthal.com|
20220005|NCT00603837|University of Oklahoma Health Sciences Center|Doug Dannaway, MD|405-271-5215|douglas-dannaway@ouhsc.edu|42048
20220006|NCT04611529|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20220007|NCT02137486|cardiovascular section|taipei city hospital Ren-Ai branch|0088627093600|chenyuehchung.tw@yahoo.com.tw|3741
20220008|NCT00451048|Princess Margaret Hospital|Dr. Karen Yee|416-946-4495|karen.yee2@uhn.on.ca|
20220009|NCT02794597|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
20220010|NCT02538965|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosur|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20220011|NCT00875797|UMCLjubljana|Lidija Kompan, principal Investigator|0038651301781|lidija.kompan@gmail.com|
20220012|NCT02156167|Cochlear|Christiane D'hondt, Clinical Research Specialist|+32 15 76 55 14|cdhondt@cochlear.com|
20220013|NCT03138590|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
20220014|NCT00425373|Novartis Pharmaceuticals|Study Director|862 778-8300||
20220015|NCT00242684|Central Arkansas Veterans Healthcare System|Melinda Bopp, Project Coordinator|501-257-2045|melinda.bopp@va.gov|
20220016|NCT02960490|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20220017|NCT01900561|Department of Veterans Affairs|Dr. Sarah Hawley|734-936-8816|sarahawl@umich.edu|
20220018|NCT01590797|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20160784|NCT00031460|Collaborative Antiviral Study Group|Penelope M. Jester|(205) 934-2424|pjester@peds.uab.edu|
20160785|NCT02968381|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
20160786|NCT01930890|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20160787|NCT01278407|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
20160788|NCT02534935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160789|NCT01596335|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20160790|NCT02209948|MFAR Clinical Research|Pau Doñate|0034934344412|investigacion@mfar.net|
20160791|NCT01176565|University of Minnesota|Adnan I. Qureshi, MD|612-624-2431|qureshai@gmail.com|
20160792|NCT01151761|Stanford University Cancer Center|Dr. Daniel Chang|650-724-3547|dtchang@stanford.edu|
20160793|NCT03602885|DFCI|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
20160794|NCT03911752|University of A Coruña|Thais Pousada García|+34 981 167 000|thais.pousada.garcia@udc.es|5870
20174690|NCT02579265|Fresenius Kabi Deutschland GmbH|Dr. Jean-Marc Lohse, Director Clinical Operations PN NAM & ELAMA|+49 6172 686|Jean-Marc.Lohse@fresenius-kabi.com|4911
20174691|NCT02174848|Chiesi Canada Corp.|Fernando Tricta, MD|416--558-6342|f.tricta@chiesi.com|
20174692|NCT01074164|Northwestern University Department of Dermatology|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20174693|NCT02229318|The Children's Hospital of Philadelphia|Dr Christina Bergqvist, M.D., Study Principal Investigator|+1 215 590 1719|Bergqvist@Email.CHoP.Edu|
20160795|NCT04114604|KITE Research Institute - Toronto Rehabilitation Institute, University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
20205497|NCT00258206|Johns Hopkins University|Dr. Carol Ann Huff|410-955-8842|chuff1@jhmi.edu|
20220019|NCT04893018|Cancer Immunotherapy Trials Network|Clinical Trial Manager|206-667-2541|citn.core.reg@hvtn.org|
20220020|NCT00242632|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
20220021|NCT00627861|The Rogosin Institute|Warren Bobb, N.P.|212-746-9114|wab9006@nyp.org|
20220022|NCT04482387|Cambridge University Hospitals NHS Foundation Trust|Stephen Kelleher|01223217418|research@addenbrookes.nhs.uk|
20174694|NCT00644969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205498|NCT04093258|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|tkarkkai@its.jnj.com|
20205499|NCT00986427|Columbia University Dept of Dermatology|Julian Mackay-Wiggan, MD|212-305-6953|jc299@columbia.edu|
20160796|NCT02285114|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20205500|NCT03784027|University of Cambridge|Prof Roman Hovorka|+44 1223 762 862|rh347@cam.ac.uk|
20205501|NCT02109744|University of Rochester|Jane Liesveld|585 - 275 - 5823|Jane_Liesveld@urmc.rochester.edu|
20205502|NCT04095442|Indiana University Indianapolis|Andrew R. Coggan|3172740656|acoggan@iu.edu|
20205503|NCT01677624|Eisai Co., Ltd.|Shin Maeda|+81-3-3817-5252||
20205504|NCT02658968|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
20205505|NCT03794752|UT Southwestern Medical Center|Peter Chen|12146283837|peter.chen@utsouthwestern.edu|
20205506|NCT01362946|Penn State Hershey Medical Center|Dr. Dan Waschbusch|7175318514|dwaschbusch@hmc.psu.edu|
20205507|NCT03097614|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20205508|NCT00436982|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Eric Garling, PhD, Snr. Director Medical & Scientific Affairs Europe|+31 20 219 2660|Eric.Garling@stryker.com|
20205509|NCT00953225|Ralph H. Johnson VA Medical Center|Sebastiano Gattoni-Celli, M.D.|843-876-5103|gatttonis@musc.edu|
20205510|NCT03864536|UAB|Pariya Wheeler|2052423924|plfazeli@uab.edu|
20205511|NCT02215616|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20205512|NCT04058158|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20205513|NCT01634113|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205514|NCT01598207|Temple University|Dr. Ron Schey|215-707-9900|Ron.schey@tuhs.temple.edu|
20205515|NCT00520299|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20205516|NCT01352845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205517|NCT01956240|Methodist University of Piracicaba|Ms Dayana Patricia Rosa|+55 16 3306-6696|dad_rosa@hotmail.com|
20205518|NCT05197140|University of Arkansas for Medical Sciences|Robert Wolfe|501-526-5769|rwolfe2@uams.edu|
20205519|NCT00278863|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20205520|NCT01009918|University of South Florida|Maya Guglin, MD, PhD|813-259-0600|mguglin@health.usf.edu|
20205521|NCT02310906|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
20205522|NCT00074802|Temple University|Richard G. Heimberg, Ph.D.|215.204.7489|heimberg@temple.edu|
20205523|NCT03819218|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
20205524|NCT00433446|SWOG Statistical Center|Study Statistician|206-667-4623||
20220023|NCT01739699|Northshore University Healthsystem, Evanston Hospital|Dr. Steven Greenberg|8475702760|sbgreenb@gmail.com|
20220024|NCT00314951|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160797|NCT01156389|Shin Poong Pharmaceutical Co., Ltd.|Jangsik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
20160798|NCT03383783|Oral Health Research Institute|Domenick T Zero, DDS, MS|317-274-8822|dzero@iu.edu|
20160799|NCT05039671|Yale University|Dr. Elizabeth Connors|12038150685|elizabeth.connors@yale.edu|
20160800|NCT01318278|Baylor College of Medicine|Dr. Danielle R. Rios|832-826-1380|drrios@texaschildrens.org|
20160801|NCT03837665|University of Kansas Medical Center|Hinrich Staecker, MD, PhD|913-588-6701|hstaecker@kumc.edu|
20160802|NCT02233738|Ralph H. Johnson VA Medical Cneter|Dr. Elizabeth Santa Ana|843-789-7168|Elizabeth.Santaana2@va.gov|
20160803|NCT00096174|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20160804|NCT00330928|InfraReDx, Inc|Director Clinical and Regulatory|781-221-0053|pshah@infraredx.com|
20160805|NCT01309906|Bausch Health|Study Director||robert.steffen@bausch.com|
20160806|NCT03028480|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20160807|NCT01030874|VAORD|Mark Helfand, MD|5032203406|mark.helfand@va.gov|
20160808|NCT00561002|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20160809|NCT03554772|Dr Reddy's Laboratories, Inc.|Srinivas Shenoy B.|6099550249|srinivasshenoyb@drreddys.com|
20160810|NCT03404804|Medical College of Wisconsin|Dr. David Vyles, DO|414-266-2625|dvyles@mcw.edu|
20174695|NCT02449239|Sesen Bio, Inc.|Dr. Rachelle Dillon|204-296-6579|rachelle.dillon@sesenbio.com|
20160811|NCT00711347|Alcon Research, Ltd.|Erin Rogut|813-426-4036|Erin.Rogut@alconlabs.com|
20205525|NCT01188538|Galderma|Farzaneh SIDOU|00 33 4 93 95 70 51|farzaneh.sidou@galderma.com|
20160812|NCT01133405|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20220025|NCT00468650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20220026|NCT02087189|BIOTRONIK SE & Co. KG|Mathias Freudigmann, Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|1248
20220027|NCT03322930|Retina Foundation of the Southwest|Dr. David Birch|214-363-3911|dbirch@retinafoundation.org|105
20220028|NCT00642278|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20220029|NCT00090363|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20220030|NCT03713619|Novarts Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20220031|NCT01758588|Weill Cornell Medicine|Assistant Director of Leukemia and BMT Clinical Trials|646-962-9305|ell2028@med.cornell.edu|
20220032|NCT03344861|on behalf of Concordia Laboratories Inc.|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
20220033|NCT04642365|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220034|NCT02552212|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20220035|NCT02728843|Chiesi Canada Corp.|Caroline Fradette, PhD|1-800-854-3534|c.fradette@chiesi.com|7014
20220036|NCT01671332|University of Wisconsin|Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
20220037|NCT05278650|Duke University|Eleanor McConnell, Ph.D.|919-684-9229|eleanor.mcconnell@duke.edu|
20220038|NCT04080544|The University of Texas at Dallas|Dr. Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
20220039|NCT04967508|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20220040|NCT00459043|DFCI|Robert Haddad|6176326725|robert_haddad@dfci.harvard.edu|
20220041|NCT01392963|Seton Family of Hospitals|Katherine Sebastian|512-324-9999|krsebastian@seton.org|89612
20220042|NCT01689779|Massachusetts General Hospital|Sadeq A. Quraishi, MD|617-726-3030|squraishi@mgh.harvard.edu|
20220043|NCT03758716|Oneness Biotech Co., Ltd.|NienYi Chen PhD|+886 2 2655 8687|nienyichen@onenessbio.com.tw|613
20220044|NCT03156504|Mayo Clinic|Dr. Jennifer Vande Voort|507-255-6782|VandeVoort.Jennifer@mayo.edu|
20220045|NCT03333941|AVITA Medical|VP Clinical Research|661-367-9710|clinicaltrial@avitamedical.com|
20220046|NCT00547586|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20220047|NCT02656069|Xeris Pharamaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
20220048|NCT00741286|Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine|Sang Won Han|82-2-950-8864|swhan@paik.ac.kr|
20220049|NCT01708967|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
20220050|NCT02842073|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
20220051|NCT01333397|Ipsen|Medical Director|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20220052|NCT01085357|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20220053|NCT03100123|Ottawa Hospital Research Institute|Dr. Leslie Skeith|403-944-5246|laskeith@ucalgary.ca|
20220054|NCT04082338|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
20220055|NCT05320887|Wake Forest School of Medicine|Darcy Lockhart, Project Manager I|3367166182|alaverdi@wakehealth.edu|
20220056|NCT04520009|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5724|tor.d.tosteson@dartmouth.edu|
20220057|NCT02910011|University of Florida|Dr. Anna DeBenedetto|352 594 1500|adebenedetto@dermatology.ufl.edu|
20220058|NCT00920790|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
20220059|NCT02460679|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20220060|NCT04411914|Temple University|Mary Morrison, MD, MS|215=707=4037|mary.morrison@temple.edu|
20220061|NCT00706485|Massachusetts General Hospital|Thomas F. DeLaney, M.D.|617-726-6876|tdelaney@mgh.harvard.edu|
20220062|NCT01504997|Shizuoka Cancer Center|Doctor Masanori Tokunaga|81-55098908777|m.tokunaga@scchr.jp|
20220063|NCT01651793|University of Georgia|Dr. Patrick J. O'Connor|706-542-4382|poconnor@uga.edu|
20220064|NCT02015065|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
20160813|NCT02737553|Ege University|Ali Akdemir|+905056748904|md.aliakdemir@gmail.com|
20160814|NCT00089986|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160815|NCT03946124|University of Pennsylvania|Dr. Lily Arya|215-662-3230|larya@pennmedicine.upenn.edu|
20160816|NCT00241631|Imperial College London|Ian M Adcock|+44 (0)20 7594 7840|ian.adcock@imperial.ac.uk|
20160817|NCT00145418|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
20160818|NCT01187004|UTurin|Dr Daniela Pasero|00390116335511|daniela.pasero@unito.it|
20160819|NCT00413920|Novartis Pharmaceuticals|Study Director|862-778-8300||
20160820|NCT02788201|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
20160821|NCT01852825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160822|NCT01854632|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
20160823|NCT02470754|University of California, San Francisco|Natalie Nardone, PhD|415-514-1450|natalie.nardone@ucsf.edu|
20160824|NCT03421743|Savara Inc|Paymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20160825|NCT01457950|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160826|NCT01765426|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20160827|NCT01166373|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20160828|NCT01510184|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|gajanan.Bhat@sppirx.com|
20160829|NCT02310230|University of Vermont Medical Center|Alexander Friend, Clinical Research Coordinator|802-847-4259|alexander.friend@uvmhealth.org|4259
20160830|NCT00712530|Szent Laszlo Hospital, Budapest, Hungary|Dr. Denes Banhegyi|+3614558152|immunol@mail.datanet.hu|
20220065|NCT03203564|Isofol Medical AB|Chief Medical Officer|+46 (0)707646500|karin.ganlov@isofolmedical.com|
20160831|NCT03593681|Boston Scientific|Clinical Trial Project Manager|612-209-9532|blake.hedstrom@bsci.com|
20160832|NCT02078102|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
20160833|NCT00402714|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
20160834|NCT02370641|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
20160835|NCT03109262|Stanford University|Andrei Iagaru, PROFESSOR OF RADIOLOGY (NUCLEAR MEDICINE)|1650-725=4711|aiagaru@stanford.edu|
20160836|NCT03398265|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
20160837|NCT05291936|Johnson & Johnson Vision Care, Inc.|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20160838|NCT01241344|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20160839|NCT02436408|University of Michigan Rogel Cancer Center|Cagri Besirli, MD, PhD|734-232-8404|cbesirli@med.umich.edu|
20160840|NCT01154283|UMichigan|Kirsten Gruis|7346041172|klgruis@gmail.com|
20160841|NCT00042432|Amgen Inc.|Study Director|866-572-6436||
20160842|NCT00320372|Cyberonics, Inc|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|mark.bunker@cyberonics.com|
20160843|NCT01853072|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
20160844|NCT01287221|Mayo Clinic|Dr. Phillip A. Low|507-284-3375|low@mayo.edu|
20160845|NCT02649192|St. Jude Children's Research Hospital|Nehali Patel, MD|866-278-5833|info@stjude.org|
20160846|NCT03849690|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20160847|NCT04432493|Rutgers University|Travis Baker, PhD|18622503351|travis.e.baker@rutgers.edu|
20160848|NCT02761694|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220066|NCT00478426|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2082|amit.oza@uhn.ca|
20220067|NCT00789737|Daiichi Sankyo Pharma Development|Director Metabolic Clinical Development|732-590-5000||
20220068|NCT01189487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220069|NCT04630158|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20220070|NCT05162014|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220071|NCT03136965|University of Wisconsin School of Medicine and Public Health|Kenneth Lee, MD, MBA|(608) 263-9387|klee2@uwhealth.org|
20220072|NCT00390559|Virginia Commonwealth University|Thomas Eissenberg|804.827.4617|teissenb@vcu.edu|
20220073|NCT00575887|Marmara University|Ufuk Abacioglu|902123853100|ufuk@abacioglu.com|
20220074|NCT01210612|University of Toledo Health Science Campus|Phillip Gribble|(419) 530-2691|pgribbl@UTNet.UToledo.Edu|
20220075|NCT02290223|Kaiser NCAL Division of Research|Monique Does, Project Manager|510-891-3612|monique.does@kp.org|
20205526|NCT02267278|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
20205527|NCT02513771|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20205528|NCT01797445|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
20205529|NCT01595438|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
20205530|NCT00550277|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
20205531|NCT00650091|Duke Clinical Research Institute|Kevin J Anstrom|919-668-8902|kevin.anstrom@duke.edu|
20205532|NCT01204697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20205533|NCT01147406|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
20205534|NCT01280266|Seoul National University|Dr. Eun Bong Lee|+82 2 2072-3944|leb7616@snu.ac.kr|
20205535|NCT01784588|Boston Scientific|Teresa Takle-Flach|952-930-6000|Teresa.Takle-Flach@bsci.com|
20205536|NCT04655703|Northwell Health System|Eugene S. Krauss|516-496-2637|ekrauss@northwell.edu|
20205537|NCT00469209|University of Texas M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD/Professor, Stem Cell Transplantation|713-745-3458|mqazilba@mdanderson.org|
20205538|NCT00961441|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20205539|NCT04268004|Nationwide Children's Hospital|Leena Nahata|6147224502|leena.nahata@nationwidechildrens.org|
20205540|NCT01082367|Novartis|Study Director|862-778-8300||
20205541|NCT01453998|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205542|NCT02307838|Novartis Pharmaceuticals|Study Director|862-778-8300||
20205543|NCT00712933|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205544|NCT01148563|Louisiana State Univeristy Health Care Services Division|Dr. Ron Horswell|225-763-2983|rhorsw@lsuhsc.edu|
20205545|NCT01879319|Amgen Inc.|Study Director|866-572-6436||
20205546|NCT01668030|University of Louisville School of Nursing|Dr. Carlee Lehna, Associate Professor|502-852-3913|carlee.lehna@louisville.edu|
20205547|NCT04724733|Washington State University College of Nursing|Julie Postma, Professor, Associate Dean for Research|509-324-7287|jpostma@wsu.edu|
20205548|NCT03067129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20205549|NCT03372603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20205550|NCT04929613|West Virginia University|Keith Zullig, PhD|304-293-1091|kzullig@hsc.wvu.edu|
20205551|NCT00289744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205552|NCT01256983|University Hospital Zürich|Mrs. Hanna Burkahlter|0041 76 371 12 35|hanna.burkhalter@usz.ch|
20205553|NCT00664209|UCaliforniaLA|Jeff Bronstein MD, PhD|310 206-9799|jbronste@mednet.ucla.edu|
20205554|NCT00843843|Rush University Medical Center|Dr. Helen Burgess|3125634785|Helen_J_Burgess@rush.edu|
20205555|NCT00418379|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20205556|NCT00082329|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
20205557|NCT01764256|PATH|Jorge Flores|2028220033|jeflores@path.org|
20205558|NCT00589979|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator|Use e-mail contact|clinicalsite.inquiries@endo.com|
20205559|NCT02029638|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20205560|NCT02451202|Department of Anesthesiology, King Chulalongkorn Memorial Hospital|Dr. Prok Laosuwan|+66 2256 4295|plaospir@yahoo.com|
20205561|NCT01153841|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205562|NCT00830804|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20205563|NCT02792049|Brooke Army Medical Center|Dr. Michael D. April|(210) 916 - 0808|Michael.D.April@post.harvard.edu|
20205564|NCT00779311|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20160849|NCT02652416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160850|NCT00787930|Duke University Medical Center|John Beyer, MD|919-668-0209|john.beyer@dm.duke.edu|
20160851|NCT02395055|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20160852|NCT02513823|Texas Woman's University|Carolyn Moore|713-794-2377|cmoore8@twu.edu|
20160853|NCT01955434|Mayo Clinic|P. Leif Bergsagel, MD|480/301-8335|Bergsagel.leif@mayo.edu|
20160854|NCT01294462|AstraZeneca|Judith Hsia||ClinicalTrialTransparency@astrazeneca.com|
20160855|NCT02743780|Alcon, A Novartis Division|Translational Medicine Expert II, TM-Ophthalmic|1-888-451-3937|alcon.medinfo@alcon.com|
20160856|NCT01357135|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160857|NCT01460407|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20160858|NCT01049802|The Rehabilitation Institute of Chicago|Richard L. Harvey, MD|312-238-1000|rharvey@ric.org|
20160859|NCT04070326|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20160860|NCT01287377|UCSD|Dr. Shu-Hong Zhu|8583001056|szhu@ucsd.edu|
20160861|NCT01216943|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20205565|NCT03428997|Johnson & Johnson Consumer Inc.|Heather Smith|(908) 874-1235|HSmith21@its.jnj.com|
20205566|NCT00769808|Bausch & Lomb Incorporated|Study Director|9083009926|susan.harris@bauschhealth.com|
20160862|NCT02193087|Takeda|Medical Director Clinical Science, Study Official|+1-877-825-3327|trialdisclosures@takeda.com|
20160863|NCT02279498|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
20160864|NCT00737711|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20160865|NCT00624780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205567|NCT01838590|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20205568|NCT05294341|Hershey Medical Center|Dr. Halina Yee; Primary Resident Investigator|7175313503|hyee@pennstatehealth.psu.edu|
20160866|NCT04068519|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20160867|NCT00969761|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160868|NCT03959982|University of Iowa|Dr. Spyridon Fortis|319-356-4419|spyridon-fortis@uiowa.edu|
20160869|NCT00262847|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20160870|NCT00758589|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
20160871|NCT03880838|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
20160872|NCT05013424|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20160873|NCT04411420|Duke University|Leo Brothers|919-668-8322|joseph.l.brothers@duke.edu|
20160874|NCT05693922|University of North Carolina at Chapel Hill|Erin Bondy, PhD|919-843-7694|erin_bondy@med.unc.edu|
20160875|NCT01722292|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20160876|NCT00471887|UCLA|Antoni Ribas, MD|310-206-3928|aribas@mednet.ucla.edu|
20160877|NCT05438602|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20160878|NCT02091284|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 3335-7337|emnpalacios@gmail.com|
20160879|NCT00803413|Hospital das Clínicas - São Paulo University School of Medicine|Mario Fereira Junior|55 11 3069-7691|mariofj@uol.com.br|
20160880|NCT04524455|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20160881|NCT02406443|Renal Physiology Laboratory|University Health Network|416-340-4800|vesta.lai@uhn.ca|8508
20160882|NCT00076336|Novartis Pharmaceuticals|Study Director|862-778-8300||
20160883|NCT03435562|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
20160884|NCT02937766|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20160885|NCT00098722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160886|NCT00308165|Columbia University|Jeffrey N. Bruce, MD|212-305-7346|jnb2@columbia.edu|
20160887|NCT02351349|MUHC|Sameena Iqbal|5146302225|sameena.iqbal@mcgill.ca|1841
20160888|NCT01703117|Icahn School of Medicine at Mount Sinai|Dr. Ana Pereira|212-241-6984|ana.pereira@mssm.edu|
20160889|NCT02583230|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20160890|NCT01340937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160891|NCT00440310|Light Sciences Oncology, Inc.|Vice President of Regulatory Affairs and Clinical Operations|425-957-8986|lisak@lsoncology.com|
20160892|NCT02469415|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
20160893|NCT02119156|GlaxoSmithKline|GlaxoSmithKline|866-435-7343|GSKClinicalSupportHD@gsk.com|1
20160894|NCT02299570|Rebiotix|Assoc. Director of Clinical Research|651-705-8778|Sarah.Mische@Ferring.com|
20160895|NCT03846531|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
20160896|NCT01998893|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20160897|NCT05136898|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
20160898|NCT00867087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160899|NCT00909545|Feinberg School of Medicine, Northwestern University|Tanya Simuni, MD|312-503-2970|TSimuni@nmff.org|
20160900|NCT00529126|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20160901|NCT02334683|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|(212) 241-8748|david.simpson@mssm.edu|
20160902|NCT01891344|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20160903|NCT02969590|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20160904|NCT01414205|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20160905|NCT02498067|University of Chicago|Soo Young Lee|6513430045|sooyoungl@uchicago.edu|
20160906|NCT01229943|Dana-Farber Cancer Institute|Matthew Kulke, MD, MMSc||matthew_kulke@dfci.harvard.edu|
20160907|NCT00320749|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, M.D.|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
20160908|NCT01688843|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
20160909|NCT02342379|University of Texas Health San Antonio|Andrew Brenner, MD, PhD|210-450-5936|brennera@uthscsa.edu|
20160910|NCT00541099|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu|
20160911|NCT00066469|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20160912|NCT00711802|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20160913|NCT02370095|University of North Carolina at Chapel Hill|Wayne H Anderson, PhD|919-445-0351|wayne_anderson@med.unc.edu|
20160914|NCT00581828|University of Wisconsin|Dr Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
20160915|NCT01667562|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20160916|NCT01129882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20160917|NCT02130986|University of Pittsburgh|David T Huang, MD, MPH, Associate Professor|412-647-6818|huangdt@upmc.edu|
20160918|NCT02305849|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|Astellas.resultsdisclosure@astellas.com|
20160919|NCT00355342|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160920|NCT00536874|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
20160921|NCT00997425|James A. Haley VA Hospital, Tampa, FL|Dorothy H. Moore, PhD|813 558-3931|Dorothy.Moore4@va.gov|
20160922|NCT02084238|Peking University People's Hospital|Dr. Jing He|86|hejing1105@126.com|1861170734
20160923|NCT00391391|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20174696|NCT03509675|University of Washington|Stuart Taylor|206-221-3772|stuartt@uw.edu|
20205569|NCT02843178|Stanford University|Mandy Murphy Carroll, Study Coordinator|(650) 509-0004|mandyiam@stanford.edu|
20174697|NCT03898349|VA|Vera Yakovchenko|7816873374|vera.yakovchenko@va.gov|
20205570|NCT00591240|VA Palo Alto Health Care System|Dr. Joseph Liao|650-493-5000|joseph.liao@va.gov|65581
20174698|NCT05620576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20174699|NCT04322396|Gentofte Hospital|Prof. Jens-Ulrik Stæhr Jensen, MD PHD|+4538673057|jens.ulrik.jensen@regionh.dk|
20205571|NCT02762799|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20174700|NCT02826681|American Regent, Inc.|Mark Falone|631.772.3544|mfalone@americanregent.com|244
20174701|NCT01797328|UHLinkopeing|Fredrik H Nystrom|+46101037749|fredrik.h.nystrom@liu.se|
20174702|NCT04296006|University of Kentucky|Joshua Lile, Ph.D.|859-323-6034|jalile2@uky.edu|
20174703|NCT06134817|NYU Langone Health|Bedros Taslakian, MD|332-237-9866|Bedros.Taslakian@nyulangone.org|
20174704|NCT00278954|Bio Products Laboratory|Margaret Stratford Bobbitt|+44 20 8258 2288|Margaret.Stratford-Bobbitt@bpl.co.uk|
20205572|NCT03722472|Access to Advanced Health Institute (AAHI)|Christopher Fox PhD|(206) 381-0883|Christopher.Fox@aahi.org|
20174705|NCT01378221|Heart and Diabetes Center North Rhine-Westphalia, Germany|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
20205573|NCT02420795|UT MD Anderson Cancer Center|Michael Wang, MD, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
20174706|NCT01794806|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
20174707|NCT04452331|University of Illinois Chicago|Dr. Alan Schwartz|3129962070|alansz@uic.edu|
20205574|NCT00949910|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20174708|NCT00076687|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20174709|NCT00826800|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
20174710|NCT03760796|Johns Hopkins University School of Medicine|Dr. Seth Martin|(610) 331 - 3842|smart100@jhmi.edu|
20174711|NCT02836600|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20174712|NCT02211131|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20174713|NCT04493060|Mayo Clinic|Dr. Robert R McWilliams|507-284-2511|mcwilliams.robert@mayo.edu|
20174714|NCT05664490|University of California, San Francisco|Dr. Jennifer Velloza|9173923561|Jennifer.Velloza@ucsf.edu|
20174715|NCT05442554|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20174716|NCT02269280|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Mnaero|713-745-3428|ggarciam@mdanderson.org|
20174717|NCT01990495|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
20174718|NCT01478321|Northwestern University|Karan Dixit, MD|312-695-1301|karan.dixit@northwestern.edu|
20174719|NCT02418195|University of Alabama at Birmingham|Samantha White/ Clinical Trials Manager|12059349189|swwhite@uabmc.edu|
20174720|NCT03167879|RAND Corporation|Dr. Glenn Wagner|310-393-0411|gwagner@rand.org|7698
20174721|NCT01565330|Avid Radiopharmaceuticals|Chief Medical Officer|215-290-0700|clinicaloperations@avidrp.com|
20174722|NCT03095456|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20174723|NCT03583996|HepQuant LLC|Elyse Handley|3037480524|elyse.handley@hepquant.com|
20174724|NCT05389657|University of California, San Francisco|Erin Accurso|415-476-5139|erin.accurso@ucsf.edu|
20174725|NCT02151448|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20174726|NCT04017936|Virginia Commonwealth University|Dr. Jordana Kron, MD|804-828-7565|jordana.kron@vcuhealth.org|
20174727|NCT02039674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174728|NCT01278485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174729|NCT01408030|Cure HHT|James R. Gossage, MD, Medical Director of Cure HHT|706-721-6789|jgossage@augusta.edu|
20174730|NCT02590939|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
20174731|NCT03774433|Dartmouth College|Dr. Lisa Marsch|603-646-7092|Lisa.A.Marsch@dartmouth.edu|
20174732|NCT00108160|VA Ann Arbor Healthcare System|Suzanne F. Bradley, M.D.|734-845-5820|sbradley@umich.edu|55826
20174733|NCT02385084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20174734|NCT05045144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20174735|NCT04903249|Dartmouth-Hitchcock Medical Center|Courtney J. Stevens, PhD, Principal Investigator|603-650-9643|courtney.j.stevens@dartmouth.edu|
20174736|NCT02081079|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20174737|NCT02968979|CHUGAI PHARMA FRANCE|Dr Luz BOBADILLA, Medical Affairs Director|+33 1 56 37 05 28|bobadilla@chugai-pharm.fr|
20174738|NCT00729183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174739|NCT01218555|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
20174740|NCT01359254|The University of Chicago Medicine|Andrew Artz, MD, MS|(773) 834-8980|aartz@medicine.bsd.uchicago.edu|
20174741|NCT02803307|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|carlb@tlcbio.com|
20174742|NCT02678676|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20174743|NCT00851799|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20174744|NCT01449526|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
20174745|NCT04365556|Cincinnati Children's Hospital Medical Center|Rachelle Ramsey|513-803-0415|rachelle.ramsey@cchmc.org|
20174746|NCT00483223|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-726-4920|SISAKOFF@mgh.harvard.edu|
20174747|NCT03722017|Tennessee Valley Healthcare System Nashville Campus|Amanda Mixon, MD MSPH MS|(615) 936-3710|amanda.mixon@va.gov|
20174748|NCT02181556|FFCD|Mrs Karine Le Malicot, Head of biostatistics|+33 3 80 39.34.79|karine.le-malicot@u-bourgogne.fr|
20174749|NCT02376946|TuftsU|Dr. Archana Viswanath|617-636-3578|Archana.Viswanath@tufts.edu|
20174750|NCT05083442|Mayo Clinic Rochester|Dr. Ivana Croghan|507 284-2511|gimresearchstudies@mayo.edu|
20174751|NCT03878316|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
20174752|NCT01554891|Geisel School of Medicine at Dartmouth|Laura A. Flashman, Ph.D.|6036505824|flashman@dartmouth.edu|
20174753|NCT01023581|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20174754|NCT03856437|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
20174755|NCT01176292|Anderson Orthopaedic Research Institute|Dr. William Hamilton|703-619-4411|research@aori.org|
20174756|NCT00997503|Boston Scientific Corporation|Peter Maurer, Director of Clinical Trials|1-508-683-6678|Peter.Maurer@bsci.com|
20174757|NCT01933048|Uniformed Services University of the Health Sciences|Eugene V. Millar, PhD|301-816-8451|emillar@idcrp.org|
20174758|NCT00380393|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174759|NCT02780804|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20174760|NCT02476968|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20174761|NCT01859507|Cairo University. Department of Obstetrics and Gynecology|Abdelmaguid Ramzy|+201008606060|amramzy@gmail.com|
20174762|NCT04476030|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20174763|NCT02404311|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20174764|NCT02155335|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20174765|NCT01536496|Denver Health Medical Center|Ernest E. Moore|303.602.1817|Ernest.Moore@dhha.org|
20174766|NCT02256891|Health Partners|Michael Walsh|(952) 831-8742|michael.walsh@tria.com|
20174767|NCT03865329|Mayo Clinic|Dr. Roberto Benzo|(507) 284-0561|Benzo.Roberto@mayo.edu|
20174768|NCT01746784|N30 Pharmaceuticals|Dr. Steven Shoemaker|720-945-7700|steven.shoemaker@n30pharma.com|
20174769|NCT00526058|B. Braun Medical Inc.|Kevin Minnich, Manager Clinical Affairs/Safety Officer|610-596-2358|kevin.minnich@bbraun.com|
20174770|NCT04171414|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
20174771|NCT04061694|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
20174772|NCT04920123|University of Massachusetts Amherst|Juhyeon Lee|413-404-4732|juhyeonlee@cs.umass.edu|
20174773|NCT03893799|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
20174774|NCT00218296|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20174775|NCT02623803|Mayo Clinic|Dr. Elird Bojaxhi|904-956-3327|bojaxhi.elrid@mayo.edu|
20174776|NCT01742338|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey L. Carson|732-235-7122|jeffrey.carson@rutgers.edu|
20174777|NCT02586493|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174778|NCT03249779|Mayo Clinic|Melissa C. Lipford, M.D.|507-255-9230|Lipford.Melissa@mayo.edu|
20174779|NCT03412084|University of Wisconsin - Madison|Dr. Kelli F Koltyn|608-263-6746|kelli.koltyn@wisc.edu|
20174780|NCT01928862|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20174781|NCT00703885|UCSD|Murray B. Stein MD, MPH|858-534-6451|mstein@ucsd.edu|
20174782|NCT00181207|Johns Hopkins University|Gregory Diette|410-955-3497|gdiette@jhmi.edu|
20174783|NCT02053753|Amgen Inc.|Study Director|866-572-6436||
20174784|NCT02972632|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20174785|NCT02023151|Johns Hopkins University|Sarbjit Saini|4105502191|ssaini@jhmi.edu|
20174786|NCT04064294|Portland VA Health Care System|Dr. Kathryn Chung|(503) 721 -1091|Kathryn.Chung@va.gov|
20174787|NCT03450707|BIDMC|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
20174788|NCT00481195|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
20174789|NCT01451775|boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174790|NCT02932904|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20174791|NCT03999411|University of Miami|Dr. Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
20174792|NCT00337103|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20174793|NCT02016482|AbbVie|Global Medical Services|800-633-9110||
20174794|NCT01289847|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
20174795|NCT03441633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174796|NCT05876273|Center for Diabetes Technology, University of Virginia School of Medicine|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
20174797|NCT03975647|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20174798|NCT03394768|Changi General Hospital|Serene Yeow, Senior Executive, Clinical Trials and Research Unit|+6581258267|serene_yeow@cgh.com.sg|+656426781
20174799|NCT03342742|"University of Colorado Denver | Anschutz"|Kristen Nowak|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20174800|NCT03552575|University of Glasgow|Professor John McMurray|0141 330 2627|john.mcmurray@glasgow.ac.uk|
20174801|NCT04227236|dFusion, Inc.|Regina Firpo-Triplett|831-222-5094|regina.firpo@dfusioninc.com|
20174802|NCT00651573|Cleveland Clinic Foundation|Daniel Sessler, MD|216-4444900|ds@or.org|
20174803|NCT05265260|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20174804|NCT02965703|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
20174805|NCT01471379|UNC Chapel Hill|Dr. Spencer Dorn Associate Professor|919-966-0141|sdorn@med.unc.edu|
20174806|NCT03745144|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
20174807|NCT00589316|Fred Hutchinson Cancer Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
20174808|NCT01883427|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
20174809|NCT01124643|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20174810|NCT01342510|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
20174811|NCT05756790|University of California San Francisco|Dr. Amy Conroy|303-522-9439|amy.conroy@ucsf.edu|
20174812|NCT04128683|University of California San Diego|Dr. Guido Frank|858-246-2053|gfrank@health.ucsd.edu|
20174813|NCT03007394|National Institute on Drug Abuse|David McCann, Ph.D.|301-827-5934|dmccann@nida.nih.gov|
20174814|NCT02901951|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
20174815|NCT00228917|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174816|NCT00409617|Abbott|Global Medical Services|800-633-9110||
20174817|NCT00914862|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20174818|NCT00149747|Stanford Prevention Research Center|Abby C. King|6507252826|king@stanford.edu|
20174819|NCT04649775|Duke University|Loretta Que, M.D.|919-681-8551|loretta.que@duke.edu|
20174820|NCT02457403|The Ohio State University|A James Hanje|614 293 6255|james.hanje@osumc.edu|
20174821|NCT01805024|Santhera Pharmaceuticals|Roxana Drake|+41 61 906 89 29|roxana.drake@santhera.com|
20174822|NCT01085097|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20174823|NCT03615807|Balgrist University Hospital|Professor Ilker UCKAY|+41 44 386 37 05|ilker.uckay@balgrist.ch|
20205575|NCT03287869|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20205576|NCT02455388|Virginia Tech|Dr. Brenda Davy|540-231-6784|bdavy@vt.edu|
20205577|NCT04847141|Sr Manager, Clinical Research, Scientific Innovation Office (SIO)|Mireia Torres|+34 93 5710500|mireia.torres@grifols.com|
20205578|NCT00324740|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20205579|NCT01052831|University of Pennsylvania|Dr. Daniel Weintraub|12153498389|Daniel.Weintraub@uphs.upenn.edu|
20205580|NCT02427750|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20205581|NCT00971425|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205582|NCT01357980|Ipsen|Medical Director Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20205583|NCT02528253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205584|NCT01705964|University of Louisville|Dr. Kerry Caperell|502-629-7212|k0cape01@louisville.edu|
20205585|NCT00094835|Amgen Inc.|Study Director|866-572-6436||
20205586|NCT00387348|Massachusetts General Hospital|William F Pirl, MD|617-724-9151|wpirl@partners.org|
20205587|NCT00505752|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20205588|NCT01149343|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205589|NCT01766219|Wake Forest University Health Sciences|Caio Max Rocha Lima|336-703-4246|crochali@wakehealth.edu|
20205590|NCT04624672|Geisinger Medical Center|Project Manager|570-214-2245|kcunningham1@geisinger.edu|
20174824|NCT00176592|Rutgers New Jersey Medical School|Stuart Cook, MD|973-972-2550|cooksd@njms.rutgers.edu|
20174825|NCT03742141|Icahn School of Medicine at Mount Sinai|Dr. David Steinmetz|646-831-5950|dsteinmetz0@gmail.com|
20174826|NCT03023085|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20174827|NCT00850395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174828|NCT06049043|KDHRC|Andrew Simkus, Research Analyst|7046073567|asimkus@kdhrc.com|
20174829|NCT02180412|University of Texas Medical Branch, Galveston|Dr. Karl Anderson, MD|409-772-9092|kanderso@utmb.edu|
20174830|NCT01113632|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20174831|NCT04654117|Department of Psychology, Michigan State University|Dr. Brooke Ingersoll, Professor|517-432-8412|ingers19@msu.edu|
20174832|NCT01354496|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20174833|NCT01524692|University of Virginia|Dr. Patrick Dillon|4349821495|pmd5b@virginia.edu|
20174834|NCT03190889|The Ohio State University Wexner Medical Center|Nathaniel A. Bates|614-293-9013|nathaniel.bates@osumc.edu|
20174835|NCT04007523|Michigan Medicine|Dr. Phillip Vlisides|734-936-4280|pvliside@med.umich.edu|
20174836|NCT01821534|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20174837|NCT02136576|Tufts University School of Dental Medicine|Dr. Britta Magnuson|617-636-3878|britta.magnuson@tufts.edu|
20174838|NCT02197806|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20174839|NCT03352323|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20174840|NCT00537381|Janssen Research & Development, L.L.C.|Senior Director|908-927-2116||
20174841|NCT05544786|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174842|NCT00500292|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20174843|NCT03065244|Dept. of Pediatrics UCSD School of Medicine|Dr. Jane Burns|858-246-0155|jcburns@health.ucsd.edu|
20174844|NCT03717480|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-6256|vincent_ho@dfci.harvard.edu|
20174845|NCT01708174|Novartis Pharmaceuticals|Study Director|862-778-8300||
20174846|NCT01894152|Abbott Vascular|Roy Leong|+65 (6277) 3202|roy.leong@abbott.com|
20174847|NCT02741700|VA ORD: Birmingham VA Medical Center|Dr. Jasvinder Singh|205-934-3235|jasvinder.md@gmail.com|
20174848|NCT00923559|Dept of Women's and Children's Health, Karolinska Institutet|Björn Salomonsson|+46851777206|bjorn.salomonsson@ki.se|
20174849|NCT01774786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20174850|NCT02268812|Eisai Europe Ltd.|Eisai Medical Services|+44 (0)20 8600 1400||
20174851|NCT04544293|Savara Inc.|Raymond D Pratt, MD FACP|512 614 1848|ray.pratt@savarapharma.com|
20205591|NCT03472040|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20205592|NCT02769832|University of Iowa, Holden Comprehensive Cancer Center|Muhammad Furqan, MD|319-356-1527|muhammad-furqan@uiowa.edu|
20205593|NCT03064568|UTHSCSA|Sally Kabro|210-567-4950|kabro@uthscsa.edu|
20174852|NCT03556579|Johnson & Johnson Vision Care Inc.|John Buch, O.D. F.A.A.O - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
20174853|NCT01144442|Masonic Cancer Center|Peter Argenta, MD|612-626-3111|argenta@umn.edu|
20174854|NCT01951157|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
20174855|NCT00744627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20174856|NCT02268786|Illumina|Tasha Kalista|858-202-4500|tkalista@illumina.com|
20174857|NCT00363779|National Cancer Institute (NCI), National Institutes of Health (NIH)|Thomas Waldmann, M.D.|301-496-6653|Thomas_Waldmann@nih.gov|
20174858|NCT01062555|University of Minenesota|Arthur Matas|612-625-5151|matas001@umn.edu|
20174859|NCT03560531|Zeno Alpha Inc.|Head of Regulatory Affairs|(858) 263-4333|RegLeads@zentalis.com|
20174860|NCT01200797|Vanderbilt-Ingram Cancer Center|Marta A. Crispens, M.D.|615-322-8072|marta.crispens@Vanderbilt.Edu|
20174861|NCT00642668|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20174862|NCT03608774|University of Washington|Julia C. Dombrowski, MD, MPH|206-744-5640|jdombrow@uw.edu|
20174863|NCT01586819|Loyola University Chicago|Rebecca Tung, M.D.|708-216-8000|rtung@lumc.edu|
20174864|NCT02028988|Dana-Farber Cancer Institute|Glenn Bubley MD|617-735-2062|gbubley@bidmc.harvard.edu|
20174865|NCT01063595|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
20174866|NCT01623596|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
20174867|NCT00747435|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
20174868|NCT04059146|University of Iowa|Dr. Ruth Chimenti|319-335-9802|ruth-chimenti@uiowa.edu|
20174869|NCT01324349|Covidien|Vice President, Medical Affairs|203-500-4256|amy.pollack@covidien.com|
20174870|NCT00748215|University of Texas (UT) MD Anderson Cancer Center|Bryan Kee, MD/Assistant Professor, GI Medical Oncology|713-792-2828|bkkee@mdanderson.org|
20174871|NCT02531321|University of Southern California|Dr. Nicole Bender|3234093416|nicole.bender@med.usc.edu|
20174872|NCT01976442|University of Rochester Medical Center|Neil Blumberg MD|(585) 275-3189|neil_blumberg@urmc.rochester.edu|
20174873|NCT01951339|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
20205594|NCT00834886|University of Bergen|Dr. Bjørn Bjorvatn|55586130|bjorn.bjorvatn@igs.uib.no|
20160924|NCT02575118|NORCE|Dr. Trine Lise Lundekvam Berge|+47 56 10 72 12|trbe@norceresearch.no|
20160925|NCT02076399|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20160926|NCT04342689|Yale School of Medicine|Sherry Mansour, MD, MS Assistant Professor|(203) 785-4184|sherry.mansour@yale.edu|
20160927|NCT03503292|Mayo Clinic|Yvette N. Martin McGrew, M.D., Ph.D.|507-255-7481|martin.yvette@mayo.edu|
20160928|NCT01367704|Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center|Dr. Elizabeth Miller|412-692-8504|elizabeth.miller@chp.edu|
20160929|NCT04096820|Queen's University/Kingston General Health Research Institute|Heather McFarlane, Administrative Assistant|613-549-6666|heather.mcfarlane@kingstonhsc.ca|8171
20160930|NCT00475865|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
20160931|NCT01510145|Alcon Research, Ltd|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20160932|NCT05044104|Mayo Clinic|Dr. Vinay Chandrasekhara|207-284-2687|Chandrasekhara.Vinay@mayo.edu|
20160933|NCT02953665|Cedars-Sinai|Vicki Manoukian, Neurology Clinical Research Program Manager|310-423-5067|Vicki.Manoukian@cshs.org|
20160934|NCT02032641|Bascom Palmer Eye Institute|Dr. Sara T. Wester|3053266132|SWester2@med.miami.edu|
20160935|NCT01822535|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
20160936|NCT03190694|University Medical Center Groningen|Prof.dr.H.J. Lambers-Heerspink|+31 50 361 7859|h.j.lambers.heerspink@umcg.nl|
20160937|NCT03582813|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
20160938|NCT01258153|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
20160939|NCT03081858|LIPAC Oncology|Karl Bean|714-900-4412|karl@lipaconcology.com|
20160940|NCT01800318|University of Arkansas for Medical Sciences|Richard W. Hall, professor of pediatrics, co-director of neonatal intensive care unit|501-680-7894|HallRichardw@uams.edu|
20160941|NCT00387647|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
20160942|NCT02032407|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20160943|NCT01309269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20160944|NCT01798641|Johns Hopkins University|Dr. Daniele Rigamonti, MD FACS|410-955-2259|hydrocephalus@jhmi.edu|
20160945|NCT03899064|MC2 Therapeutics|Birgitte Vestbjerg|+44 2077 2575|bve@mc2therapeutics.com|
20160946|NCT00607113|UT MD Anderson Cancer Center|Dr. James Yao|713-792-2828|mjlim@mdanderson.org|
20160947|NCT00340379|Duke University|Frederick Cassidy|919-575-7801|cassi002@mc.duke.edu|
20160948|NCT00628589|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20160949|NCT02418312|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20160950|NCT04214639|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
20160951|NCT04685707|University of Southern Mississippi|Dr. Nuno Oliveira|6012665804|nuno.oliveira@usm.edu|
20160952|NCT04081961|Kazakhstan Academy of Preventive Medicine|Baurzhan Zhussupov|87774822171|baurzhan.zhussupov@gmail.com|
20160953|NCT03037541|Wake Forest University Health Sciences|Joseph Jorizzo, MD|336-716-3775|jjorizzo@wakehealth.edu|
20160954|NCT01610596|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20160955|NCT01987219|NYU School of Medicine|Dr. Horacio Kaufmann|212 263 7225|horacio.kaufmann@nyumc.org|
20160956|NCT01519674|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20160957|NCT04599166|Penn State College of Medicine|Dr. Benjamin Levi|717-531-8778|BHLevi@psu.edu|
20205595|NCT03874351|MJHS Institute for Innovation in Palliative Care, New York, NY|Helena Knotkova, PhD, PhilD|646-784-2262|HKnotkov@mjhs.org|
20205596|NCT00225147|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
20205597|NCT03532776|Dermax|Chauvel Virginie|+32 488 07 04 18|chauvelvirginie07@gmail.com|
20205598|NCT04169113|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
20205599|NCT03625141|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20205600|NCT03250377|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20220076|NCT05293639|Johnson & Johnson MedTech|Reecha Sharma|949.789.3919|rshar120@its.jnj.com|
20220077|NCT02143648|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
20220078|NCT01943994|Sheppard Pratt|Dr. Matthew W. Johnson|443 862 0461|mjohnson3@sheppardpratt.org|
20220079|NCT00813800|Mayo Clinic|Mark Frye, MD|507-255-9391|mfrye@mayo.edu|
20160958|NCT01974752|AstraZeneca|Karin Bowen|+001 301 398 3254|karin.bowen@astrazeneca.com|
20160959|NCT02317809|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20160960|NCT02435680|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20160961|NCT00953524|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20160962|NCT06239441|Hôpital du Sacre Coeur de Montreal|Catherine Lemiere|514 338 2492|catherine.lemiere@umontreal.ca|
20160963|NCT01975519|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
20160964|NCT03784846|Pacific University|Michael Christopher, Ph.D.|503-352-2498|mchristopher@pacificu.edu|
20160965|NCT01310400|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20160966|NCT03180398|Henry Ford Health|Dr. Stephen Brown|3135858415|sbrown1@hfhs.org|
20160967|NCT04709484|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
20160968|NCT02231762|Ipsen|Medical Director||clinical.trials@ipsen.com|
20160969|NCT01394614|Center for Advanced Research in Sleep Medicine|Dr. Jacques Montplaisir|514-388-2693|jy.montplaisir@umontreal.ca|
20160970|NCT01669421|University of Miami|Michael Campos|305-243-3045|mcampos1@med.miami.edu|
20160971|NCT01149486|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20160972|NCT00167102|University of Minnesota|Dr. Maria Hordinsky|612-624-5721|hordi001@umn.edu|
20160973|NCT02740543|NYU Langone Health - Bellevue Hospital|Angeliki Kazeros, MD|212-263-6479|Angeliki.Kazeros@nyulangone.org|
20160974|NCT02961790|Mayo Clinic|Charles L. Loprinzi, M.D|507/284-4565|loprinzi.charles@mayo.edu|
20160975|NCT01007071|Stanford University|Dr. Laurence Katznelson|650-736-9551|katznels@stanford.edu|
20160976|NCT02594098|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
20160977|NCT02042534|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
20160978|NCT05418153|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
20160979|NCT03906656|Ottobock|Russ Lundstrom|6127182025|russ.lundstrom@ottobock.com|
20160980|NCT01036529|Boston Scientific|Valerie Lucero-Cimmarusti|661-949-4745|Valerie.Lucero-Cimmarusti@bsci.com|
20160981|NCT00693472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20160982|NCT03412604|Massachusetts General Hospital|Emiliano Santarnecchi|617-667-0326|esantarnecchi@mgh.harvard.edu|
20160983|NCT01312389|University of Pennsylvania|Director of Clinical Trial Operations|215-662-3324|tracey.thomas@pennmedicine.upenn.edu|
20160984|NCT02989844|University of Minnesota, Masonic Cancer Center|Jeffrey Miller|612-625-7409|mille011@umn.edu|
20160985|NCT00283816|University of Rochester Medical Center|Kathleen M. Hoeger, MD, MPH|585-275-7891|Kathy_Hoeger@urmc.rochester.edu|
20160986|NCT00993499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20160987|NCT01945775|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160988|NCT02876328|National Institute of Allergy and Infectious Diseases (NIAID)|John Tierney, Director of Office of the Clinical Research Policy and Regulatory Operations (OCRPRO)|301.451.5136|JTierney@niaid.nih.gov|
20160989|NCT01256281|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|(212) 824-8056|jeffrey.glassberg@mountsinai.org|
20160990|NCT04883528|Duke University|Stephen J. Greene, MD|919-684-3854|stephen.greene@duke.edu|
20160991|NCT03464422|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
20160992|NCT00085254|Adult Brain Tumor Consortium (ABTC)|Louis Burt Nabors, MD|205-934-1432|bnabors@uab.edu|
20160993|NCT00844805|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20160994|NCT04316741|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
20160995|NCT02726880|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
20160996|NCT00787202|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20160997|NCT01360398|GlaxoSmithKline|GSK Response Center|866-435-7343||
20160998|NCT01453946|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
20160999|NCT00846040|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Kevin Hall, PhD|3014028248|kevinh@niddk.nih.gov|
20161000|NCT00957333|WanFangH|Ruei-Ming Chen|02-27361661|rmchen@tmu.edu.tw|3222
20161001|NCT00858897|Nemours Children's Clinic|Dr. Dominique Darmaun|904-697-3863|ddarmaun@nemours.org|
20161002|NCT03158272|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20161003|NCT03697993|Vaccine Treatment Evaluation Unit (VTEU)|Nadine Rouphael, MD, MSc|(404) 822-1411|nroupha@emory.edu|
20205601|NCT03444870|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220080|NCT01860677|McLean Imaging Center, McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20220081|NCT02785952|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20205602|NCT03728504|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
20205603|NCT02501902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205604|NCT00565058|Aptose Biosciences Inc.|Peter Murray, Director Clinical Development|647-479-9812|pmurray@aptose.com|
20220082|NCT01144715|Kinetic Muscles|James Koeneman, PhD|602-677-5256|jimkoeneman509@gmail.com|
20205605|NCT05506969|Dynavax Technologies|Ouzama Henry, MD|617-686-4796|ohenry@dynavax.com|
20205606|NCT01647464|OHSU|Jonathan Lindner|5034948750|lindnerj@ohsu.edu|
20205607|NCT03329599|Northern California Institute for Research & Education|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
20220083|NCT03553576|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20220084|NCT03020589|University of North Carolina at Chapel Hill|Robert Dupuis, PharmD|919-966-6194|re_dupuis@unc.edu|
20220085|NCT00401986|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|(412) 716-0717|grubbm@bsci.com|
20220086|NCT00351533|University of Vermont|Renee Stapleton, MD PhD|802-656-7975|renee.stapleton@uvm.edu|
20220087|NCT03185013|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20205608|NCT00510068|Novartis Pharmaceuticals|Study Director|862-778-8300||
20220088|NCT02575976|Federal University of Minas Gerais|Professor Raquel Britto|+55 31 99970-4527|r3britto@gmail.com|
20220089|NCT00197496|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
20220090|NCT01881113|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20205609|NCT03886701|Thomas Jefferson University|Dr. Walter K. Kraft|215 955-9077|walter.kraft@jefferson.edu|
20220091|NCT00857584|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20220092|NCT01102374|University of Colorado School of Medicine|Adit Ginde, MD, MPH, Professor of Emergency Medicine|720-848-6777|adit.ginde@ucdenver.edu|
20220093|NCT01104792|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com,|
20220094|NCT01432379|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20220095|NCT01175031|Shanghai Jiao Tong University School of Medicine|Quing Yun Li, MD, PhD|86-21-64314162|liqingyun68@hotmail.com|
20220096|NCT02056392|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20220097|NCT01806506|Department of General, Transplant and Liver Surgery, Medical University of Warsaw|Piotr Kalinowski|0048 22 599 2546|kalip@o2.pl|
20220098|NCT02067273|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20220099|NCT02092467|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220100|NCT01595386|University of Alabama at Birmingham, Pediatric Cardiac Critical Care|Jeffrey Alten, M.D., Director of Clinical and Translational Research Department|205-975-3123|jalten@peds.uab.edu|
20220101|NCT02952898|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
20161004|NCT01048866|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
20205610|NCT01397448|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
20205611|NCT00570531|University of Michigan Comprehensive Cancer Center|Susan Urba, M.D.|734-615-4762|surba@umich.edu|
20161005|NCT02230683|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20161006|NCT04562597|Medical University of South Carolina|Dr. Sylvia Wilson|843-792-2322|wilsosh@musc.edu|
20161007|NCT00524589|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20161008|NCT01266317|University of Pittsburgh|Dr. Michael Donahoe|412-383-2049|donahoem@upmc.edu|
20161009|NCT00046930|ECOG Statistical Office|Study Statistician|617-632-3012||
20161010|NCT01657760|Harbor-UCLA Department of Psychiatry|Todd Zorick|310-781-3400|tzorick@mednet.ucla.edu|
20161011|NCT00799591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161012|NCT02867618|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
20161013|NCT03276052|AstraZeneca|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
20161014|NCT01994863|Coloplast A/S|Director Clinical Affairs||dkdac@coloplast.com|
20161015|NCT03597178|Johnson & Johnson|Brian Pall OD, MS, FAAO- Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
20161016|NCT02370004|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
20161017|NCT01062841|University of Michigan|Lona Mody, MD, MSc|734-764-8942|lonamody@umich.edu|
20161018|NCT02046174|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
20161019|NCT01909180|GE Healthcare|RIchard Petrisko|262-548-4637|richard.petrisko@ge.com|
20161020|NCT00902018|Weill Cornell Medical College|Dr James Bussel|22-746-3474|jbussel@med.cornell.edu|
20161021|NCT03294135|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161022|NCT00186537|Stanford University|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
20161023|NCT02763254|Cell Medica|Dr. Kurt Gunter (Chief Medical Officer)|832-581-4480|Kurt.Gunter@cellmedica.com|
20161024|NCT02963987|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
20161025|NCT01143051|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
20161026|NCT00765882|Forest Research Institute|Paul F.C. Eng, PhD. Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
20161027|NCT01874275|Independent Principal Investigator|Charlotte Stelly-Seitz, MD|713-523-3463|drstellyseitzmd@gmail.com|
20161028|NCT03351114|Duke University|Dr. Adela R. Cardones|9196843110|adela.cardones@duke.edu|
20174874|NCT01538862|Vanderbilt University|Haydar Frangoul, MD, MS|615-342-7339|Haydar.Frangoul@hcahealthcare.com|
20174875|NCT02204748|The University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
20174876|NCT01519882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20174877|NCT02818218|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
20174878|NCT04476537|Columbia University|Gulam Manji, MD|212-342-5162|gam2140@cumc.columbia.edu|
20174879|NCT02280941|University of Ottawa Heart Institute|Dr. Terrence Ruddy|6136967000|truddy@ottawaheart.ca|7267
20174880|NCT04328207|University of Alabama at Birmingham|Cynthia Owsley|2053258635|cynthiaowsley@uabmc.edu|
20174881|NCT00574405|Arkansas Children's Hospital Research Institute|Kathryn Thrailkill, MD|501-364-1430|thrailkillkathrynm@uams.edu|
20174882|NCT02283814|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20174883|NCT03026257|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Clin Dev Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20174884|NCT01398566|The Ohio State University|Lise Worthen-Chaudhari|614-304-1421|liseworthen@gmail.com|
20174885|NCT04380857|Cleveland Eye Clinic|Kathleen Jee, MD|440-526-1974|kjee@midwestvision.com|
20174886|NCT00427635|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20174887|NCT02558790|Massachusetts General Hospital|Craig Surman, MD|617-726-8422|csurman@partners.org|
20174888|NCT00838201|Amgen Inc.|Study Director|866-572-6436||
20174889|NCT01364090|Viral Hepatits Clinical Research Program - The Kirby Institute - UNSW Sydney|Dr. Jason Grebely|+61 2938 50957|Jgrebely@kirby.unsw.edu.au|
20174890|NCT02042924|Masonic Cancer Center, University of Minnesota|Dr. Susanta Hui|626-218-0556|shui@coh.org|
20174891|NCT04033003|University of Michigan, School of Nursing|Jody R. Lori PhD, Associate Dean for Global Affairs, Director, PAHO/WHO Collaborating Center|734-763-0097|jrlori@med.umich.edu|
20174892|NCT01714310|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20174893|NCT02487394|UTMB|William Calhoun, M.D.|409-772-1176|wjcalhou@utmb.edu|
20174894|NCT01018420|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20174895|NCT00265616|CHUV Lausanne|Dr Andrea O. Rossetti|+41 21 314 1190|andrea.rosseti@chuv.ch|
20174896|NCT00826267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174897|NCT04693585|University of California San Francisco|Nadia Diamond-Smith|415-353-4545|nadia.diamond-smith@ucsf.edu|
20174898|NCT03221595|Denver Health Medical Center|Research Coordinator|303-602-6213|Kiara.Leasia@dhha.org|
20174899|NCT02212587|Hospital of Sick Children|Dr. Valerie Waters|416-813-1500|valerie.waters@sickkids.ca|
20205612|NCT00425477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
20174900|NCT00134381|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
20174901|NCT04066426|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
20174902|NCT01675882|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
20174903|NCT02984384|University of Maryland School of Medicine|Robert O'Toole|410-328-6280|rotoole@som.umaryland.edu|
20174904|NCT01117727|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
20174905|NCT02711800|Duke University|Nancy Zucker|9196680075|zucke001@mc.duke.edu|
20174906|NCT02098161|The University of Texas MD Anderson Cancer Center|Naveen Pemmaraju MD/ Associate Professor|713-792-4956|NPemmaraju@mdanderson.org|
20174907|NCT01295515|National Cancer Institute|Dr. Frank Maldarelli|301- 846-5611|frank_maldarelli@nih.gov|
20174908|NCT04938232|Dana-Farber Cancer Institute|Reid Merryman|6176326844|reid_merryman@dfci.harvard.edu|
20205613|NCT02466412|Philip Morris Products S.A.|Steffen Fredersdorf|+41 (58) 242 2182|Steffen.Fredersdorf@pmi.com|
20205614|NCT01868776|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
20205615|NCT02180217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20205616|NCT00776555|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20205617|NCT02553317|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
20205618|NCT03482141|University of California, San Francisco|Mary Norton|(415) 467 4080|mary.norton@ucsf.edu|
20205619|NCT03483116|Murdoch Children's Research Institute|Professor Julie Bines|+61 3 9345 5522|julie.bines@mcri.edu.au|
20205620|NCT01315002|University Hospital Bonn, Department of Psychiatry and Psychotherapy|Prof. Dr. Michael Wagner|004922828716377|michael.wagner@uni-bonn.de|
20205621|NCT02475395|Sandstone Diagnostics|Cheif Science Officer|9253157246|gsommer@sandstonedx.com|925
20174909|NCT03754959|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174910|NCT03869450|Q-Med AB|Clinical Project Manager|+4618 474 9000|reception.seupp@galderma.com|
20174911|NCT00314574|Hoffman-LaRoche|Medical Communications|800-821-8590||
20174912|NCT00449956|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20174913|NCT02882321|The University of Texas MD Anderson Cancer Center|Marina Konopleva MD./Professor|713-794-1628|mkonople@mdanderson.org|
20174914|NCT01446965|University of California, San Francisco|Jeffrey Olgin, MD|415-476-1000|jeffrey.olgin@ucsf.edu|
20174915|NCT00004412|Boston University School of Medicine|Douglas V. Faller, Ph.D., M.D., Susan P. Perrine, M.D.|(617) 638-5639|sperrine@bu.edu|
20174916|NCT02719158|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20174917|NCT03137693|Moffitt Cancer Center|Michael Montejo, MD|813-745-8424|Michael.Montejo@moffitt.org|
20174918|NCT02963493|Oncopeptides|Global Clinical Project Lead|866-596-6626|info@oncopeptides.com|
20174919|NCT03144180|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|9152155103|christina.bracamontes@ttuhsc.edu|
20174920|NCT01142310|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
20205622|NCT02227108|MedImmune LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenea.com|
20161029|NCT02337530|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
20161030|NCT01665430|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20161031|NCT01757561|FirstSunYetSen|Juan-ying Guo|8602087755766(8273)|gjunying@aliyun.com|
20161032|NCT00989235|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20161033|NCT03249935|University of Arkansas for Medical Sciences|Jeannette Lee|501-526-6712|jylee@uams.edu|
20161034|NCT02813668|Emory University|Dr. Mary Beth Weber|404-712-1902|mbweber@emory.edu|
20161035|NCT04662073|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
20161036|NCT01135914|Novartis Pharmaceuticals|Study Director|862-778-8300||
20161037|NCT01053013|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
20161038|NCT00885638|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
20161039|NCT00598078|Jazz Pharmaceuticals|Grace Wang, MD Director Clinical Development and Medical Monitor|650-496-3777||
20161040|NCT01813721|Amgen Inc.|Study Director|866-572-6436||
20161041|NCT04066686|Imperial College Healthcare NHS Trust|Dr Annabelle Lee|02033121077|annabellelee@nhs.net|
20161042|NCT01479595|Novartis|Study Director|862-778-8300||
20161043|NCT02133664|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20161044|NCT00810901|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
20161045|NCT02330523|The McGuire Institute|E. Todd Scheyer DDS, MS|713-783-544|etsperio@swbell.net|
20161046|NCT03366103|Johns Hopkins University/SKCCC|Judy Murray|443-927-3568|jmurra33@jhmi.edu|
20161047|NCT00300482|Abbott|Medical Information Specialist|800-633-9110||
20161048|NCT02120365|Virginia Commonwealth University|Albert Arias|8046286777|albert.arias@vcuhealth.org|
20161049|NCT00343915|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161050|NCT01726673|Feinstein Institute for Medical Research at Northwell Health|Johanna Chang, Senior Research Coordinator|(516) 562-3646|jchang14@northwell.edu|
20161051|NCT02863523|East Carolina University|Dr. Doyle Cummings|252-744-2607|FLOYDS14@ecu.edu|
20161052|NCT01719003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20161053|NCT00882908|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20161054|NCT01275092|Columbia University Medical Center, New York, NY, 10032|Giora Weisz, MD; Director of Clinical Resarch Center for Interven tional Vascular Therapy|212-305-7060|gweisz@crf.org|
20161055|NCT01344629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161056|NCT00048815|Cedars Sinai Medical Center|Mark Hyman Rapaport, M.D.|310-423-2600|mark.rapaport@cshs.org|
20161057|NCT05590000|Abbott|Devyani Nanduri, Senior Director, Clinical & Regulatory Affairs|+16698329450|devyani.nanduri@abbott.com|
20161058|NCT00762996|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
20161059|NCT04610489|Carilion Clinic|John Epling, MD, MSEd|540-581-0123|jwepling@carilionclinic.org|
20161060|NCT03236168|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
20161061|NCT02689076|James J. Peters VA Medical Center|Kimberly M. Judon|718-584-9000|Kimberly.Judon@va.gov|1174
20161062|NCT00837824|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
20161063|NCT00539617|University of California, San Francisco|W. Michael Korn, MD|415-502-2844|michael.korn@ucsf.edu|
20161064|NCT02312765|University of Pennsylvania|Dr Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
20161065|NCT04063787|University of Chicago|Dr. Mary Hammes|773-702-6134|mhammes@bsd.uchicago.edu|
20161066|NCT01816906|Staffordshire University|Professor Nachiappan Chockalingam|+44 1782 295853|n.chockalingam@staffs.ac.uk|
20161067|NCT00746733|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20161068|NCT01527383|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161069|NCT01370837|Maastricht University Medical Center|Kristy Pickwell|+31433877019|k.pickwell@mumc.nl|
20161070|NCT02558400|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
20161071|NCT00456599|University of Michigan|Mark Zalupski, MD|734-615-3969|zalupski@med.umich.edu|
20161072|NCT02246608|Kettering Health Network|Manager, Research Operation and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
20161073|NCT00474617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161074|NCT02191605|Wayne State University, Merrill Palmer Skillman Institute|Dr. Jessica Beatty|3136642518|jbeatty@wayne.edu|
20161075|NCT00734071|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20161076|NCT05275582|VA Center for Integrated Healthcare|Dr. Julie Gass|716-834-9200|julie.gass@va.gov|25429
20161077|NCT00240110|Univeristy of Miami|Dr. Ihsan Salloum|305-243-7931|isalloum@med.miami.edu|
20161078|NCT00203021|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20161079|NCT02080260|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20161080|NCT04699812|Apple Inc.|Clinical Health Product Clinician|866-905-5303|htclinicalquestions@apple.com|
20161081|NCT03204890|Boston Medical Group|Dr. José Pablo Saffon|+573208899777|jsaffon@bostonmedical.com.co|
20161082|NCT03747120|University of Texas Southwestern Medical Center|Dr. Heather McArthur, Professor IM-Hem Onc|214-645-9380|heather.mcarthur@utsouthwestern.edu|
20161083|NCT03627065|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20161084|NCT01688739|Amgen Inc.|Study Director|866-572-6436||
20161085|NCT00996801|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clincaltrialsdisclosure@merck.com|
20161086|NCT00289198|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161087|NCT03369431|University College London|Susan Simmons|+44 7952961881|susan.simmons.16@ucl.ac.uk|
20161088|NCT01062061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220102|NCT00399880|Vanderbilt University Medical Center|Kathryn Goggins, Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
20220103|NCT04844762|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20220104|NCT03722589|Centers for Disease Control and Prevention|Fatimah Dawood, Medical Officer|404-639-0431|hgj0@cdc.gov|
20161089|NCT00490776|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20161090|NCT01694108|Rigshospitalet|Lone Graff Stensballe, Research leader, Pediatrician, PhD|+0045 35459727|lone.graff.stensballe@regionh.dk|
20161091|NCT02151331|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
20161092|NCT01113580|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20161093|NCT01145053|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161094|NCT02088073|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20161095|NCT03684304|University Hospitals|University Hospitals|216-844-1000|info@uhhospitals.org|
20161096|NCT01009346|Johns Hopkins|Ranee Mehra, MD||rmehra1@jhmi.edu|
20161097|NCT00921310|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5737|mbaggstr@dom.wustl.edu|
20161098|NCT02227836|Mayo Clinic|Karthik Ravi, MD|507-284-4824|Ravi.Karthik@mayo.edu|
20161099|NCT02266875|OhioHealth|Dr. Kruti Patel, DO|614-857-7735|kruti.patel@ohiohealth.com|
20161100|NCT02944565|The Ohio State University Comprehensive Cancer Center|Hallie Barr, PharmD BCOP|614-685-5803|Hallie.Barr@osumc.edu|
20161101|NCT02481713|VA Connecticut Healthcare System|Joanna Fiszdon, PhD|2039325711|joanna.fiszdon@va.gov|2231
20161102|NCT00849875|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161103|NCT01304329|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161104|NCT00525629|Beth Israel Deaconess Medical Center|Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20161105|NCT01643876|Université de Montréal|Dr. Elham Emami|5143436111|elham.emami@umontreal.ca|6053
20161106|NCT02469714|Illinois Institute of Technology|Patrick Corrigan|(312)567-6751|corrigan@iit.edu|
20161107|NCT00892606|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
20161108|NCT01735708|Butler Hospital|Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
20161109|NCT01152515|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine|Dr. Shin Ok Koh|82-2-2228-2420|sokoh@yuhs.ac|
20161110|NCT03515941|Baylor College of Medicine|Eunji Jo|713-798-4923|ejo@bcm.edu|
20161111|NCT00276094|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20161112|NCT02759315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161113|NCT01689350|School of Pharmaceutical Sciences, Sun Yat-sen University|Lingyan CHEN, Master candidate|+8615018706960|chlingy@mail2.sysu.edu.cn|
20161114|NCT01406015|Brigham and Women's Hospital|Dr. Rajesh K. Garg||RGARG@bwh.harvard.edu|
20161115|NCT00787137|PanGenetics UK Limited|John Powell|+441763257869|info@pangenetics.com|
20161116|NCT00985907|University of California, San Francisco|Dr. Thomas Martin, MD|(415) 353-9365|Tom.Martin@ucsf.edu|
20161117|NCT00130923|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5747|mary.f.brunette@hitchcock.org|
20161118|NCT00554099|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20161119|NCT03840525|Florida International University|Dr. Gladys Ibanez|305-348-4920|gibanez@fiu.edu|
20161120|NCT02075632|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161121|NCT04240093|Brown University|Jaclyn White Hughto, PhD, MPH|401-863-6580|jaclyn_hughto@brown.edu|
20161122|NCT02839902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20161123|NCT01628367|University of Michigan|Dr. Hom-Lay Wang|734-647-6175|homlay@umich.edu|
20161124|NCT03353922|Neurana Pharmaceuticals|Judy Caron, Chief Operating Officer|(617) 640-5043|jcaron@neuranapharma.com|
20161125|NCT00740714|Weill Medical College of Cornell University|M. Flint Beal, MD|212-746-6575|fbeal@med.cornell.edu|
20161126|NCT03688555|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
20161127|NCT00183963|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|Victoria.Soto@med.usc.edu|
20161128|NCT00886119|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20161129|NCT00394901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20161130|NCT03002623|National Cancer Institute|Dr. Naris Nilubol|301- 451-2355|niluboln@nih.gov|
20161131|NCT02256267|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20161132|NCT00462735|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
20161133|NCT01352741|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223||
20161134|NCT00376805|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
20161135|NCT00259298|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20161136|NCT00645528|Hunter Holmes McGuire VA Medical Center|Sonja K Fredrickson, MD|804-675-5151|sonja.fredrickson@va.gov|
20161137|NCT02916407|Inje University, Haeundae Paik hospital|Dr Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
20161138|NCT05445206|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
20161139|NCT03618628|Washington University School of Medicine|Dr. Mary Hastings|3142861433|hastingsmk@wustl.edu|
20161140|NCT01969500|University of Washington|Dror Ben-Zeev|(206) 685-9655|dbenzeev@uw.edu|
20161141|NCT01741532|ApoPharma Inc.|Caroline Fradette|416-401-7543|cfradett@apopharma.com|
20161142|NCT02463032|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20161143|NCT00613080|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
20161144|NCT00612508|Women's Health Research Unit|Oregon Health & Science University|503-494-3666|whru@ohsu.edu|
20220105|NCT01200069|Rutgers/New Jersey Medical School|Vasanti Tilak, MD|974 972-5254|tilakva@njms.rutgers.edu|
20220106|NCT03408639|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|Anjidani.N@orchidpharmed.com|
20220107|NCT04998851|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220108|NCT00070499|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
20161145|NCT02008357|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20161146|NCT01442064|Genentech|Genentech||ctg-post-d@gene.com|
20161147|NCT02312219|Mass General Hospital|Ahmed Tawakol, MD|617-726-0791|atawakol@mgh.harvard.edu|
20161148|NCT02153346|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161149|NCT01213823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161150|NCT02248740|Virginia Commonwealth Univeristy|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
20161151|NCT01522404|Emory University|Allan I. Levey, MD, PhD|404-727-7220|alevey@emory.edu|
20161152|NCT01591863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161153|NCT04765644|Imperial College London|Dr Ricky Vaja|020 7589 5111|r.vaja@imperial.ac.uk|
20161154|NCT02366767|Stanford School of Medicine|Bruce Buckingham|650-725-9549|buckingham@stanford.edu|
20161155|NCT00579995|University of Nebraska Medical Center|Scott Shurmur, M.D.|402-559-6463|sshurmur@unmc.edu|
20161156|NCT00260065|Eisai Inc.|Eisai Call Center|888-422-4743||
20161157|NCT04559022|UT Southwestern|Research Coordinator|2146458907|jennifer.barillas@utsouthwestern.edu|
20172703|NCT02310568|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172704|NCT02255604|Aarhus Universitets Hospital|Hans Jürgen Hoffmann|7845000|Hans.Jurgen.Hoffmann@ki.au.dk|
20172705|NCT00113217|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor|713-563-7232|ejonasch@mdanderson.org|
20172706|NCT01366521|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172707|NCT03975790|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172708|NCT03824912|Encube Ethicals Pvt Ltd|Dr. Lalatendu Panigrahi, Chief Scientific Officer|+91-22-6264-7002|lalatendu.p@encubeethicals.com|
20172709|NCT00597545|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
20172710|NCT02289690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20172711|NCT01170754|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
20172712|NCT02085785|Department of Veterans Affairs|Dr. Alyson Littman, Research Health Scientist|206-277-4182|alyson.littman@va.gov|
20172713|NCT00779467|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
20172714|NCT02692703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20172715|NCT04626297|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20172716|NCT04118166|Stanford Medicine at Stanford University|Maria Ahern|650-725-6413|mahern@stanford.edu|
20172717|NCT00644995|Group Health Cooperative|Jennifer McClure, PhD|206-287-2737|mcclure.j@ghc.org|
20172718|NCT01427504|University of Colorado|Dr. Jennifer Kiser|303-724-6131|jennifer.kiser@ucdenver.edu|
20172719|NCT00865124|Brigham and Women's Hospital|Gail K. Adler|617-732-5661|gadler@partners.org|
20172720|NCT02743520|University of Miami, Miller School of Medicine|Alberto Ramos, MD, MSPH, FAASM|305-243-8393|a.ramos1@med.miami.edu|
20172721|NCT03950167|UFUK UNIVERSITY|DR MÜGE KESKİN|+905333522090|mugekeskin1@hotmail.com|
20172722|NCT03247530|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
20172723|NCT02533427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20172724|NCT04648631|University of Miami|Hadar Lev-Tov, MD|305-689-2646|hlevtov@med.miami.edu|
20172725|NCT02551731|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20172726|NCT01678911|Rehabilitation Institute of Chicago|Director of the Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
20172727|NCT04649060|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20172728|NCT02602496|University of Nebraska Lincoln|Dr. Devin Rose|402-472-2802|drose3@unl.edu|
20172729|NCT01906008|UT MD Anderson Cancer Center|Dr. James Yao, MD, Director of GI Medical Oncology|(713) 792-2828|jyao@mdanderson.org|
20172730|NCT02117648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172731|NCT01815515|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
20172732|NCT02670837|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
20172733|NCT01985867|The Medical University of Warsaw|Katarzyna Wojtyniak|+48 22 317 94 21|wojtyniakkasia@gmail.com|
20172734|NCT04294472|Vera Therapeutics Inc.|Isabel Gorham, Director of Clinical Operations|(910)200-0532|isabel.gorham@veratx.com|
20172735|NCT02603419|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172736|NCT03552198|KCL|Dr D D'Antoni|NA|donatella.d'antoni@kcl.ac.uk|
20172737|NCT06149247|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
20172738|NCT02289417|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20172739|NCT04786990|Supernus Pharmaceuticals|Joseph T. Hull, PhD|240-403-5324|jhull@supernus.com|
20172740|NCT00923247|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
20172741|NCT01782222|UCB|UCB Cares|+1 877 822 9493||
20172742|NCT02071914|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20172743|NCT01756898|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20172744|NCT01500694|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20172745|NCT02007109|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
20172746|NCT03791489|Stryker ENT|Pr. Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20174921|NCT03387813|Abbott|Fei San Lee, PhD, Sr Clinical Research Scientist|925-694-2109|feisan.lee@abbott.com|
20174922|NCT04534764|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
20174923|NCT03161483|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20174924|NCT00537446|Columbia University Irving Medical Center|Robert Basner, MD||rcb42@cumc.columbia.edu|
20174925|NCT04630093|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
20174926|NCT03925324|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
20174927|NCT00794196|Parc Sanitari Sant Joan de Déu|Dr. Antoni Serrano Blanco|+34936406350|aserrano@pssjd.org|12215
20174928|NCT00259090|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20174929|NCT02129803|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
20174930|NCT01841151|KIND, KBH, Karolinska Institutet|Prof. Sven Bölte|0046703170105|sven.bolte@ki.se|
20174931|NCT00591942|University of Iowa|Dr. Clark Stanford|319-335-7381|Clark-Stanford@uiowa.edu|
20174932|NCT02871739|Massachusetts General Hospital Health Decision Sciences Center|Karen Sepucha|617-724-3350|ksepucha@partners.org|
20174933|NCT03818516|Emory University|David R. Goldsmith, MD|404-727-3735|drgolds@emory.edu|
20174934|NCT04372602|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8491|jdipersi@wustl.edu|
20174935|NCT00594464|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20174936|NCT02907359|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20174937|NCT01625455|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
20174938|NCT04809220|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20174939|NCT05218018|University of Washington|Angela Hanson|206-897-5393|hansonaj@uw.edu|
20174940|NCT03035955|WakeForest|Director of Clinical Trials|336-716-3775||
20174941|NCT02120794|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20174942|NCT00827255|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20174943|NCT00994240|University of Wisconsin-Madison|Clinical Research Administrator|608-287-2640|dbock@dermatology.wisc.edu|
20174944|NCT04681482|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174945|NCT00896337|Boston Scientific|Angela Schutt|763-494-2166|schutta@bsci.com|
20174946|NCT00265512|VA Center for Innovation to Implementation|Todd Wagner|6504935000|todd.wagner@va.gov|22048
20174947|NCT04222712|Tarsier Pharma|COO|+972508371319|zohar@tarsierpharma.com|
20174948|NCT04662801|Yale School of Medicine|Dr Valentina Ivezaj, Assistant Professor of Psychiatry|+1 (203) 785-7807|valentina.ivezaj@yale.edu|
20174949|NCT02323854|Medtronic|Dr. Jaime Kean|303-882-6759|Jaime.m.Kean@medtronic.com|
20174950|NCT00828191|IBSA Institut Biochimique SA|IBSA U.S. Agent|805 376 00 78|cejtwsxx@verizon.net|
20174951|NCT04697693|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
20174952|NCT02910167|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20174953|NCT01418937|GlaxoSmithKline|GSK Response Center|866-435-7343||
20174954|NCT02462967|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
20174955|NCT01828034|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
20174956|NCT03592121|Applied Biology, Inc.|Dr. Andy Goren|(949) 387-4526|andyg@appliedbiology.com|
20174957|NCT03663283|Mayo Clinic|Steven J. Hattrup, M.D.|480-301-8519|hattrup.steven@mayo.edu|
20174958|NCT00579111|Baylor|Rammurti Kamble, MD|713-394-6252|rtkamble@tmhs.org|
20174959|NCT04327999|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20174960|NCT02667483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20174961|NCT00422032|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026|eharriso@mdanderson.org|
20174962|NCT02872116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20205623|NCT02486952|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20205624|NCT00594204|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20205625|NCT00567541|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
20205626|NCT01825655|Virginia Commonwealth University|Santhosh Kumar, MD|804-628-1605|santhosh.kumar@vcuhealth.org|
20205627|NCT01890512|Guidant Europe SA/NV A Boston Scientific Company|Giovanni Raciti|+39 02 26983213|giovanni.raciti@bsci.com|
20205628|NCT01529385|Center for Lower Extremity Ambulatory Research|Ryan Crews, Clinical Scientist|847-578-8437|ryan.crews@rosalindfranklin.edu|
20205629|NCT01401465|Sunovion|Respiratory Medical Director|1-866-503-6351||
20205630|NCT01115738|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205631|NCT04009213|Advanced Medical Solutions|Tina Warburton, Senior Clinical Research Associate|07791742957|tina.warburton@admedsol.com|
20205632|NCT00575094|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20205633|NCT00772382|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20205634|NCT02721251|VA|David Thompson|602-496-0242|david.thompson4@va.gov|
20205635|NCT02921763|Mylan EPD G.K.|Takumi Kanzo|+81-3-5656-0516|takumi.kanzo@viatris.com|
20205636|NCT01369212|University of Pittsburgh|Dr. Abdus Wahed|412-624-3053|wahed@pitt.edu|
20205637|NCT01709981|NYU Langone Health|Dr. Binita Shah|212-263-6631|Binita.Shah@nyulangone.org|
20174963|NCT02346136|MGH Biostatistics|Eric Macklin, PhD|617-724-9828|emacklin@mgh.harvard.edu|
20205638|NCT00862121|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20205639|NCT01582971|Michigan State University|Dr. Gwen Wyatt|517-432-5511|gwyatt@msu.edu|
20205640|NCT02007954|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20205641|NCT01589510|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20205642|NCT01763866|Amgen Inc.|Study Director|866-572-6436||
20205643|NCT05055570|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|majun@mail.ccmu.edu.cn|
20205644|NCT03288493|Poseida Therapeutics|Rajesh Belani, MD, Vice President Clinical Development|858-779-3100|rbelani@poseida.com|
20205645|NCT02415439|ReveraGen BioPharma, Inc.|Eric P. Hoffman, PhD|301-962-1578|eric.hoffman@reveragen.com|
20205646|NCT06076148|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20205647|NCT04860752|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@Edwards.com|
20205648|NCT06025396|Tempero Bio|Director, Clinical Operations|510-250-4750|TMP-301-HNV-101@Temperobio.com|
20205649|NCT01512108|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20205650|NCT01539811|Greenville Health System|Dr. David Cull|8644548295|dcull@ghs.org|
20205651|NCT06422377|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20205652|NCT02017899|GSK Vaccines Institute for Global Health S.r.l.|Dr. Audino Podda|+39 0577 243496|audino.p.podda@gsk.com|
20205653|NCT01985971|University of Pennsylvania|Lilie Lin, MD|215-662-7267|lin@xrt.upenn.edu|
20205654|NCT00646113|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20205655|NCT00804843|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161158|NCT00131456|Columbia University|Dr. Frances R. Levin|212-543-5896|frl2@columbia.edu|
20161159|NCT03809910|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161160|NCT04948307|Orexo US, Inc.|David Capano|9085079909|david.capano@orexo.com|
20161161|NCT00434356|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20161162|NCT02384434|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20161163|NCT05264116|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
20161164|NCT06034652|Integra LifeSciences Corporation|Andrew Tummon, Director, Global Clinical Operations|609-936-5490|andrew.tummon@integralife.com|
20161165|NCT00583791|Abbott|Maren Wagner|6517565585|maren.wagner@abbott.com|
20161166|NCT01330966|George Clinical|Lindsey Munn|901-350-8801|lmunn@georgeclinical.com|
20161167|NCT03769311|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|608-262-4961|jybruce@medicine.wisc.edu|
20161168|NCT02853435|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161169|NCT04172467|Hematology Oncology Kaiserslautern|Prof. Hartmut Link|0631|praxis-link@kabelmail.de|3503709
20161170|NCT02506660|Hospital of Special Surgery|Dr. Richard Kahn|212-774-7274|KahnR@HSS.EDU|
20161171|NCT02961946|Massachusetts General Hospital|Dr. Brian Ghoshhajra|617-726-5954|BGHOSHHAJRA@mgh.harvard.edu|
20161172|NCT01352637|Weill Cornell Medical College|Dr. JoAnn Difede|212 746 3079|jdifede@med.cornell.edu|
20161173|NCT06687824|Manipal University College Malaysia|Heng Sy Xuan|+601110752589|hengsyxuan@hotmail.com|
20161174|NCT04912895|Emory University|Larry Anderson, MD|404-727-1746|larry.anderson@emory.edu|
20161175|NCT02785458|Northwestern University|Dr. Michael S. Wolf, PhD MPH|312-503-5592|mswolf@northwestern.edu|
20161176|NCT01146652|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20161177|NCT00520013|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
20161178|NCT02118597|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20161179|NCT03523273|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
20161180|NCT00273754|University of Texas Medical School/ Houston|Samia Khalil, M.D./ Professor|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
20161181|NCT02590562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20161182|NCT00824005|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
20161183|NCT01866423|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-865-0454|Victoria.Soto@med.usc.edu|
20161184|NCT02255565|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
20161185|NCT02699450|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20161186|NCT00852527|Southern AZ VA Health Care System|Dr. Judith Babcock-Parziale, PI|520-7921450|judith.babcock@va.gov|5698
20161187|NCT00900146|Novartis Pharmaceuticals|Study Director|862-778-8300||
20161188|NCT00700102|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20161189|NCT01811303|RSSL|Rungano Munyuki (Clinical Project Manager)|0118 9184034||
20161190|NCT02525939|DalCor Pharmaceuticals|Dr. Don Black, Chief Medical Officer|‭+1 (609) 613-6637‬|dblack@dalcorpharma.com|
20161191|NCT01635764|AbbVie|Global Medical Services|800-633-9110||
20161192|NCT00933244|University of Wisconsin - School of Medicine & Public Health|Dr. Karen E Hansen|608-265-8162|keh@medicine.wisc.edu|
20161193|NCT01174004|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
20161194|NCT02956850|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20161195|NCT01920152|University of Colorado, Denver|Omer Mei-Dan, MD|3033159900|omer.meidan@cuanschutz.edu|
20161196|NCT02165462|Universidad Católica San Antonio de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
20161197|NCT01995552|India Medtronic Pvt. Ltd.|Vinay Rajan Ph.D|+91 22.3307.4700|vinay.rajan@medtronic.com|
20161198|NCT01515475|Jaeb Center for Health Research|Ray Kraker M.S.P.H.|813-975-8690|rkraker@jaeb.org|
20161199|NCT01968057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20161200|NCT01511809|Ospedale San Raffaele|Dr. Antonella Castagna|00390226437934|castagna.antonella1@hsr.it|
20205656|NCT04327518|Johnson & Johnson Surgical Vision|Director of Clinical Science, Ophthalmic Implants|7142478200|EThoma39@its.jnj.com|
20161201|NCT04957758|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|mmacsai@oysterpointrx.com|
20205657|NCT01966263|Sint Maartenskliniek Nijmegen|Dr Maaike Fenten|31243659111|m.fenten@maartenskliniek.nl|2941
20174964|NCT03735667|Boston Scientific|Sarah Zanon|+41 79 840 7006|sarah.zanon@bsci.com|
20174965|NCT02308735|University of Oklahoma Health Sciences Center|Douglas Dannaway|405-271-5215|douglas-dannaway@ouhsc.edu|42048
20174966|NCT00802412|VA San Diego|Neal Doran, PhD|8585528585|neal.doran@va.gov|2421
20174967|NCT00112242|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof Olivier Michielin|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
20174968|NCT00006478|University of Nebraska Medical Center Division of Oncology/Hematology|Bryan Ludwig, Regulatory Coordinator|402-559-8071|bmludwig@unmc.edu|
20174969|NCT00743652|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20174970|NCT02547129|Mayo Clinic|Dr. Michael J. Taunton|507-284-7692|Taunton.Michael@mayo.edu|
20174971|NCT00805766|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20174972|NCT04120610|Medtronic|Janki Shah|732-266-2503|janki.shah@medtronic.com|
20174973|NCT03373383|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20174974|NCT02159521|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
20174975|NCT00694369|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20174976|NCT00907374|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
20174977|NCT00706836|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
20174978|NCT00544076|City of Hope|Laura Crocitto, M.D.|626-218-3708|lcrocitto@coh.org|
20174979|NCT03131440|Northwestern University|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
20174980|NCT03892460|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
20174981|NCT00746941|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20174982|NCT02508571|Department of Pediatrics, Seoul National University College of Medicine|Dr. Ee-Kyung Kim|82-2-2072-3628|kimek@snu.ac.kr|
20174983|NCT04371380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20174984|NCT00262509|Atlanta VA Rehabilitation R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
20174985|NCT01425879|The Ohio State University|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
20174986|NCT01640366|Smith & Nephew Inc|Rachael Winter, Director of Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
20174987|NCT02739269|The University of Hong Kong|Dr. Raymond Li|+852 22554517|raymondli@hku.hk|
20205658|NCT02150213|Novartis|Study Director|862-778-8300||
20205659|NCT01666145|Carolinas Healthcare System|Principal Investigator|704-446-2772|john.martinie@carolinashealthcare.org|
20205660|NCT01297309|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20205661|NCT01184456|AIDS Healthcare Foundation - Public Health Division|Adam Sukhija-Cohen|(323) 436-8900|adam.cohen@aidshealth.org|
20205662|NCT01804257|Zucker Hillside Hospital, Glen Oaks, NY|John M. Kane MD|(718) 470-8141|psychiatry@nshs.edu|
20205663|NCT00640146|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20205664|NCT01807091|University of Washington|Elihu Estey, MD|206-606-6744|eestey@seattlecca.org|
20205665|NCT04578015|The Ohio State University|Kartik Venkatesh, MD, PhD|614-293-2222|kartik.venkatesh@osumc.edu|
20205666|NCT03024255|Botanix Pharmaceuticals|Anthony Robinson, MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20205667|NCT01415908|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20205668|NCT02685995|University of Pennsylvania|Gregory Nadolski, MD|(215) 662-7892|gregory.nadolski@pennmedicine.upenn.edu|
20205669|NCT02168803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205670|NCT00193219|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20205671|NCT01114373|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-3425|frahbar@emory.edu|
20205672|NCT00868166|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20205673|NCT00240539|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205674|NCT00698035|University of California, San Francisco|Michelle Melisko, MD|415-353-7070|mmelisko@medicine.ucsf.edu|
20205675|NCT02034552|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20205676|NCT02197897|Baylor College of Medicine|Dr. Guilherme Godoy|713-798-4001|godoy@bcm.edu|
20205677|NCT03007719|University of California, San Francisco|Dr. Lawrence Fong|(415) 353-2051|Lawrence.Fong@ucsf.edu|
20205678|NCT00688545|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205679|NCT01878097|University of Kentucky|Dr. Ann Coker|859-323-6758|ann.coker@uky.edu|
20205680|NCT04547998|AVITA|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
20205681|NCT03807245|MinervaX ApS|Dr Per Fischer|+45 20 25 20 38|pbf@minervax.com|
20205682|NCT04116073|Sidney Kimmel Comprehensive Center at Johns Hopkins|Nilo Azad|410-614-9169|nilo.azad@jhu.edu|
20205683|NCT03783442|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20205684|NCT01381718|Children's Hospital Boston/Harvard Medical School|Nicole J. Ullrich, MD, PhD|617-355-3193|Nicole.Ullrich@childrens.harvard.edu|
20205685|NCT02505542|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20205686|NCT00707343|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
20205687|NCT00168064|Yaupon Therapeutics|H. Jeffrey Wilkins, MD|4843247935|hjwilkins@yaupontherapeutics.com|935
20205688|NCT03373110|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
20205689|NCT05489081|Children's Hospital of Philadelphia|Dr. Gwendolyn Lawson|2674266612|lawsong@chop.edu|
20174988|NCT01519453|Johns Hopkins School of Medicine|Dr. Michelle Eakin|410-550-0487|meakin1@jhmi.edu|
20174989|NCT00405548|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
20174990|NCT01709695|Icahn School of Medicine at Mount Sinai|Department of Psychiatry|212-241-6623||
20174991|NCT04652479|Stanford University|Marilyn Tan, MD, FACE|(650) 721-1300|mjtan@stanford.edu|
20174992|NCT00680901|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20220109|NCT00805467|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20174993|NCT00075582|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20174994|NCT01048723|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Zager, M.D.|813-745-1085|jonathan.zager@moffitt.org|
20174995|NCT01148511|Novartis Pharmaceuticals|Study Director|862 778-8300||
20174996|NCT01644175|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
20174997|NCT01177540|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20174998|NCT04448210|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
20174999|NCT00868712|Walter Reed Army Medical Center, Cardiology Service|Todd C. Villines, MD|301-295-7839|todd.villines@us.army.mil|
20175000|NCT02818777|University of Colorado|Dr. Maureen Anne Leehey|303-724-2194|maureen.leehey@ucdenver.edu|
20175001|NCT00656630|The Scripps Research Institute|Barbara J. Mason, Ph.D.-Principal Investigator|858784-7328|mason@scripps.edu|
20175002|NCT04052542|University of Pittsburgh School of Medicine|Timothy D Girard, MD, MSCI|(412) 383-0582|timothy.girard@pitt.edu|
20175003|NCT00856908|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20175004|NCT01667978|Montefiore|Jessica Atrio|718 405 82 60|jatrio@montefiore.org|
20175005|NCT06021951|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20175006|NCT01070316|Cincinnati Children's Hospital Medical Center|Elizabeth Hoskins|(513) 803-7263|elizabeth.hoskins@cchmc.org|
20175007|NCT00543764|BIDMC|Bernard Lee|617-632-7835|blee3@bidmc.harvard.edu|
20175008|NCT05300295|University of Minnesota|Lindsey Weiler, PhD|612-301-9345|lmweiler@umn.edu|
20175009|NCT02013167|Amgen Inc.|Study Director|866-572-6436||
20175010|NCT02138461|MDbackline, LLC|John A. Hovanesian, MD|949 951 9248|jhovanesian@mdbackline.com|
20175011|NCT00842348|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20175012|NCT03200925|Kettering Health Network|Catherine Caponero, DO|937-723-4124|catherine.caponero@ketteringhealth.org|
20175013|NCT01113879|The Ohio State University|Stacy Harnish|614-688-1471|harnish.18@osu.edu|
20175014|NCT00026793|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
20175015|NCT04151290|Cognoa|Senior Director Clinical Research|4082076659|minda.seal@cognoa.com|
20175016|NCT01132495|St. Jude Medical|Sr. Director, Global Clinical Affairs|651-756-5586|jmifek@sjm.com|
20175017|NCT03007758|Prisma Health|Abby Birrell, Study Coordinator|8645222117|abby.birrell@prismahealth.org|
20175018|NCT00082433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20175019|NCT01633320|Edouard Herriot hôspital Anaesthesia and intensive care|Dr Emmanuel Boselli|+334711689|emmanuel.boselli@chu-lyon.fr|
20175020|NCT02276612|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230|GileadClinicalTrials@gilead.com|
20175021|NCT01796197|Dana-Farber Cancer Institute|Beth Overmoyer, MD, FACP|617.632.3800|beth_overmoyer@dfci.harvard.edu|
20175022|NCT04097821|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20175023|NCT00244712|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175024|NCT02776917|University of California, San Diego|Barbara Parker, MD|(858) 657-6100|baparker@health.ucsd.edu|
20175025|NCT02620046|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20175026|NCT00403273|minneapolis VAMC|jasvinder singh|205-504-9559||
20175027|NCT04041869|University of Iowa|Lucas Carr|319-353-5432|lucas-carr@uiowa.edu|
20175028|NCT01336738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175029|NCT01083433|Rainbow Babies and Children's Hospital|Sarah A. MacLeish, DO|216-844-3661|sarah.macleish2@uhhospitals.org|
20175030|NCT02383667|The University of Toledo|Saima Karim, DO|419-383-3697|Saima.Karim@utoledo.edu|
20175031|NCT01332149|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175032|NCT01696435|Massachusetts General Hospital|Dr. Olivia Okereke/Study Principal Investigator|(617) 726-2000|olivia.okereke@mgh.harvard.edu|
20175033|NCT04615949|CardiolRx|Andrea B. Parker, MSc. PhD, Senior Director Clinical Operations|+1 289 9100862|andrea.parker@cardiolRx.com|
20175034|NCT03036566|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
20175035|NCT05458856|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20175036|NCT01852292|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20175037|NCT04320940|Hikma Pharmaceuticals|Amy Schutte|440-201-5010|aschutte@Hikma.com|
20175038|NCT01088646|Givenimaging|Hilla Debby/Director of clinical affairs|97249097774|hila.debby@givenimaging.com|7774
20175039|NCT01572038|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20175040|NCT01888497|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175041|NCT04152447|Massachusetts General Hospital|Dr. Marilyn Heng|617-643-0149|mheng@mgh.harvard.edu|
20220110|NCT01924754|University of California, San Francisco|Dr. Joel Palefsky, MD|(415) 476-8885|Joel.Palefsy@ucsf.edu|
20220111|NCT04320823|Haemonetics Corporation|Jan Hartmann, MD, Vice President of Medical Affairs and Clinical Development|(781) 348 7396|Jan.Hartmann@haemonetics.com|
20175042|NCT04013191|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
20175043|NCT03662100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20175044|NCT02159547|Akdeniz University|Cenker EKEN|00905321593948|cenkereken@akdeniz.edu.tr|
20175045|NCT03711162|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20220112|NCT02899195|PrECOG|Dr. Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
20175046|NCT03034954|University of Michigan|Dr. Annalise Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
20220113|NCT02755649|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20175047|NCT02340299|Charité - Universitätsmedizin Berlin|PD Dr. Christoph Czernik, principal investigator|+49 30 450|christoph.czernik@charite.de|566122
20175048|NCT02431754|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220114|NCT02089659|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220115|NCT01368653|Rutgers, The State University of New Jersey|Danielle E. McCarthy, Ph.D.|608-265-5949|demccarthy@wisc.edu|
20220116|NCT00923273|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20220117|NCT00605540|HC/FMB-Unesp|Renata Ferrari|55 14 38116213|renataferrarifisio@gmail.com|
20220118|NCT00129389|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20220119|NCT05177718|Vumc|Natalizumab and chronic Blood Brain Barrier Breakdown|6159360060|francesca.r.bagnato@VUMC.ORG|
20220120|NCT02691143|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|240-766-0300|jslaski@ssrehab.com|838
20220121|NCT03578549|Univeristy of Michigan|Dr. Darya Dabiri|4198821017|daryad@umich.edu|
20220122|NCT04867174|University of Southern California|Professor Mireille Jacobson|(213) 740-5156|mireillj@usc.edu|
20220123|NCT04414345|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20220124|NCT01831258|SleepMed of South Carolina|Dr Richard Bogan|8777537633|rbogan@sleepmedinc.com|
20220125|NCT02597127|The Medicine's Company|Global Health Science Center|1-888-997-6326|Medical.Information@themedco.com|
20175049|NCT02904057|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20175050|NCT01275066|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|(800) 983-4587|medinfo@bmrn.com|
20175051|NCT02281851|University of Birmingham|Mathew Soden|07800549318|matthewsoden33@gmail.com|
20175052|NCT00394212|Davol Inc., Subsidiary of C.R. Bard|Dawn Heimer, Clinical Research|401-825-8681|Dawn.Heimer@crbard.com|
20175053|NCT00588445|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
20175054|NCT03240133|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20175055|NCT00554671|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|6237
20175056|NCT00116831|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175057|NCT04904185|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
20175058|NCT02945410|Technical University of Munich|Dr. Karsten Koehler|+49 89 289 24488|karsten.koehler@tum.de|
20175059|NCT02061969|Emory University|Saumeth Cardona MD|404-616-4827|scardon@emory.edu|
20175060|NCT00110812|University of Minnesota|Deborah Wentworth|612-726-9005|wentw001@umn.edu|
20175061|NCT02146482|Stanford University|Grant Ognibene|9518343465|grantog@stanford.edu|
20175062|NCT00735371|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20175063|NCT01604343|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20175064|NCT00097721|Eisai Inc|Eisai Call Center|888-422-4743||
20175065|NCT02871375|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20220126|NCT02564887|University of Pittsburgh|Christine Harrison, Clinical Research Coordinator|412-647-9665|harrisonta@upmc.edu|
20220127|NCT01199016|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220128|NCT00561418|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|craig.hofmeister@osumc.edu|
20220129|NCT02318303|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20220130|NCT02667067|NuVasive, Inc.|Nicole Czaplewski|308-660-2021|nczaplewski@nuvasive.com|
20220131|NCT00385008|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220132|NCT02279108|CHU Saint-Etienne|Pr Céline CHAULEUR|04 77 82 86 11|celine.chauleur@chu-st-etienne.fr|+33
20175066|NCT01988571|Wake Forest NCI Community Oncology Research Program Research Base|Lead Biostatistician|336-716-0891|NCORP@wakehealth.edu|
20175067|NCT00980395|University of Arizona|Amy Selegue, NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
20175068|NCT01052545|Michael E. DeBakey VA Medical Center|Barbara Trautner, MD, PhD|713-440-4438|barbar.trautner@va.gov|
20220133|NCT03907657|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|melahat.garipagaoglu@gmail.com|
20220134|NCT02895100|Protagonist Therapeutics, Inc|Director Clinical Development|(+1) 888-899-1543|ptgxclintrials@ptgx-inc.com|
20220135|NCT01120704|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
20220136|NCT00339144|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20220137|NCT03280381|PATH|Dr. Patricia S. Coffey|206-302-4704|pcoffey@path.org|
20220138|NCT04581330|UT Southwestern Medical Center|Dr. Heather Goff|2146484229|heather.goff@utsouthwestern.edu|
20220139|NCT03898908|Grupo Español Multidisciplinar en Melanoma (GEM)|GEM Technical Secretary|0034934344412|secretaria@groupgem.es|
20220140|NCT02655666|Medtronic Minimed|Willam Lv|86-21-20325454|william.lv@medtronic.com|
20220141|NCT00345943|New York State Psychiatric Institute|Dr. Rachel Marsh|6467745774|rachel.marsh@nyspi.columbia.edu|
20220142|NCT00895414|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
20220143|NCT00912925|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
20220144|NCT05199090|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20220145|NCT03485365|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20220146|NCT02181790|Icahn School of Medicine at Mount Sinai|Dr Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
20220147|NCT03661697|University of Miami|Lisa D Grunebaum MD|3052433223|lgrunebaum@med.miami.edu|
20220148|NCT00763061|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20220149|NCT05147324|University of North Carolina at Chapel Hill|Angelica Cristello Sarteau|919-445-1191|angcri@live.unc.edu|
20220150|NCT04988087|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20175069|NCT03792672|Takeda|Medical Director|1-877-825-3327|medicalinformation@tpna.com|
20220151|NCT02752087|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20175070|NCT00453999|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
20175071|NCT02767427|Columbia University|Dr. Kiehyun Daniel Riew, Professor of Orthopedic Surgery|212-932-4410|kr2637@cumc.columbia.edu|
20175072|NCT03608488|SultanAbdulhamid|Tugba OZsoy-Unubol|+905074583382|tugbaozsoyy@gmail.com|
20220152|NCT02458287|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20220153|NCT00843635|University of Miami|Donald T. Weed MD FACS|305-243-9095|dweed@miami.edu|
20220154|NCT03565679|Medline Industries, Inc|Kara Cassady|847-643-3809|kcassady@medline.com|
20220155|NCT00205803|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220156|NCT01024686|U.S. Military Malaria Vaccine Program (USMMVP)|Dr. Michele Spring|301-319-9307||
20175073|NCT01632202|Weill Cornell Medicine|Sr. Research Compliance Specialist|646-962-4065|lao2003@med.cornell.edu|
20220157|NCT03255655|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
20220158|NCT00658021|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20220159|NCT00373698|VA Medical Center, White River Junction, VT|Dr. Paula Schnurr and Dr. Mathew Friedman|802-296-5132|Paula.Schnurr@va.gov; Matthew.Friedman@va.gov|
20220160|NCT01119794|Brown University Oncology Research Group (BrUOG)|Eric Winer, MD|4018633000|kayla_rosati@brown.edu|
20220161|NCT03862755|Shanghai Pulmonary Hospital|Dr. Lei Shen|86-21-65115006|sh_leisen@126.com|2054
20220162|NCT00963560|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
20175074|NCT02127632|DorkuzEU|Anaesthesiology and Reanimation|90.505.525.29.01|ozbilginsule@gmail.com|
20175075|NCT00983216|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20175076|NCT04238728|University of Rochester Medical Center|Julie Ryan, MD|585-276-3862|Julie_Ryan@URMC.Rochester.edu|
20175077|NCT00594061|University of Iowa|Bruce Gantz|319-353-8776|bruce-gantz@uiowa.edu|
20175078|NCT01971853|"University of Colorado Denver | Anschutz"|Director, Clinical Research Administration||clinicalresearchsupportcenter@ucdenver.edu|
20220163|NCT01462773|The Ohio State University Comprehensive Cancer Center|William Carson|614-293-6306|william.carson@osumc.edu|
20220164|NCT02203331|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20175079|NCT04964453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175080|NCT01417481|Instituto Nacional de Enfermedades Respiratorias|Dr. Mario H. Vargas|(+55)54871771|mhvargasb@yahoo.com.mx|
20175081|NCT01907828|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
20175082|NCT00829296|University of Chicago|Dr. George Bakris|773-702-7936|gbakris@medicine.bsd.uchicago.edu|
20175083|NCT01193907|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
20175084|NCT04960228|Lady Davis Institute for Medical Research|Ben Haward, Research Assistant|514-340-8222|ben.haward@ladydavis.ca|23978
20175085|NCT03029624|Valencia Technologies|Stacy Chambliss, Chief of Clinical Trials|661-775-1414|schambliss@valenciatechnologies.com|1002
20175086|NCT01364428|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20175087|NCT01987427|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20175088|NCT01073865|AstraZeneca|Global Clinical Lead|+44 1509 645895|clinicaltrialtransparency@astrazeneca.com|
20175089|NCT04590547|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
20175090|NCT03799484|The University of Texas Health Science Center at Houston|Karina Richani-Reverol, MD|(713) 559-5200|Karina.RichaniReverol@uth.tmc.edu|
20175091|NCT01256593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175092|NCT04414553|University of Colorado|Lisa Ross DeCamp|3037246499|lisa.decamp@cuanschutz.edu|
20175093|NCT02689258|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
20220165|NCT02091466|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Dr. Ricardo Caio Gracco De Bernardis|55-11-21767280|rcaiog@yahoo.com.br|
20220166|NCT01191827|Denver VA Medical Center|Research Biologist|303-724-6232|jason.tregellas@va.gov|
20220167|NCT02542605|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20220168|NCT02682927|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20220169|NCT01178528|IRCCS San Raffaele|G Rosano|0652252309|giuseppe.rosano@sanraffaele.it|
20220170|NCT03462459|University of Wisconsin-Madison|Nasia Safdar, Professor|608-265-1545|ns2@medicine.wisc.edu|
20220171|NCT03739645|Johns Hopkins University|Fred Lenz|443.287.1609|flenz1@jhmi.edu|
20161202|NCT05260333|Baylor College of Medicine|Dr. Leah Antoniewicz, MD-PI|832-8267458|leah.antoniewicz@bcm.edu|
20161203|NCT02360293|VA ORD|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
20161204|NCT02226549|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20161205|NCT01269385|Mayo Clinic|Stephen M. Ansell MD||Ansell.Stephen@mayo.edu|
20161206|NCT02741570|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20161207|NCT01498185|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20161208|NCT00946322|Trauma Recovery Center, Cincinnati VA Medical Center|Jeremiah A. Schumm, PhD, Associate Director|859-572-6717|Jeremiah.Schumm@va.gov|
20161209|NCT01075971|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20161210|NCT02367391|Penn State College of Medicine|Project Coordinator|7175310003|jyingst@phs.psu.edu|289511
20161211|NCT00514020|Vanderbilt-Ingram Cancer Center|Laura Goff, MD|615-936-0059|laura.goff@vanderbilt.edu|
20161212|NCT01688921|PharmaJet, Inc.|Tara Miller, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
20161213|NCT00884910|Netherlands Cancer Institute|Prof Dr FJM Hilgers|+31 20 512 2550|f.hilgers@nki.nl|
20161214|NCT04384107|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161215|NCT00276614|David Geffen School of Medicine at UCLA|Matthew Rettig, M.D.|310-794-3565|mrettig@mednet.ucla.edu|
20220172|NCT02551666|Virginia Tech|Professor Michael L. Madigan, PhD|540-231-3543|mlm@vt.edu|
20220173|NCT01177059|Janssen-Cilag Pty Ltd, Australia|Executive Director Medical & Scientific|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20220174|NCT04051619|Brown University|Carolina Haass-Koffler, PharmD, PhD (PI)|4155191385|carolina_haass-koffler@brown.edu|
20220175|NCT03383523|Drugs for Neglected Diseases Initiative|Jean Yves Gillon|+41229069232|jygillon@dndi.org|
20220176|NCT03132155|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20220177|NCT03120325|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
20220178|NCT02925403|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|vaccinetrials@ndm.ox.ac.uk|
20175094|NCT03317431|Department of Anesthesia,Xinhua hospital affiliated to Shanghai Jiaotong University School of Medicine|Dr.Lai Jiang|021-25078999|jianglaimz@sina.com|
20220179|NCT04778904|Barinthus Biotherapeutics|Chief Medical Officer|+44 (0) 1865 818 808|clinicaltrials@barinthusbio.com|
20220180|NCT03452137|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220181|NCT04138043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20220182|NCT03772717|Emory University|Sumit Verma, MD|404-785-9893|sumit.verma@emory.edu|
20220183|NCT02856802|Upsher-Smith Laboratories, LLC|Clinical Operations|(763) 315-2000|uslinfo@upsher-smith.com|
20220184|NCT00587860|Mayo Clinic|Yuri A. Saito Loftus, M.D., M.P.H.|507-284-5010|saito.yuri@mayo.edu|
20220185|NCT00261443|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20220186|NCT01286753|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220187|NCT02126826|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220188|NCT03092219|Teoxane SA|Clinical Project Manager|+41(0) 22 344 96 36|m.chenet@teoxane.com|
20175095|NCT02356692|CooperVision|Donald Siegel, OD|602 485 3414|dsiegel@coopervision.com|
20175096|NCT04753164|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+18566613721|idorsiaclinicaltrials@idorsia.com|
20175097|NCT02508636|University of California, San Francisco|Dr. Hao Nguyen|(415) 514-5541|Hao.Nguyen@ucsf.edu|
20175098|NCT01025427|University of California, San Francisco|Hiroyu Hatano|415-476-4082|hhatano@php.ucsf.edu|122
20175099|NCT04258605|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
20175100|NCT01017237|University of North Carolina School of Dentistry|Jay Anderson, DDS, MD|919-966-1126|janderson@aims.unc.edu|
20175101|NCT03483675|FHCRC|Kate Chilson|206-667-6069|kchilson@fredhutch.org|
20175102|NCT00181961|Massachusetts General Hospital|Dr. Christina Dording|6177249457|cdording@mgh.harvard.edu|
20220189|NCT03278626|NYU Langone Health - Perlmutter Cancer Center|Jennifer Wu, MD|212-263-3809|Jennifer.Wu@nyulangone.org|
20220190|NCT04971187|M D Anderson Cancer Center|Dr. Xiuning Le|(713) 792-6980|xle1@mdanderson.org|
20220191|NCT00591773|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20220192|NCT02135614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20220193|NCT03831711|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
20220194|NCT03134248|CooperVision|Jose A.Vega OD MSc., FAAO|9256213761|javega@coopervision.com|
20220195|NCT01207583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220196|NCT02679235|University of Sherbrooke|Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20161216|NCT00459537|Novartis Pharmaceuticals|Study Director|862 778-8300||
20161217|NCT03159104|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20161218|NCT01685021|MorphoSys AG|Dr. Sumeet Ambarkhane, Director, Clinical Program Leader|004989899270|sumeet.ambarkhane@morphosys.com|
20161219|NCT02198235|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
20161220|NCT03052530|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
20161221|NCT02410577|Memorial Sloan Kettering Cancer Center|Dr. Joseph Osborne, MD, PhD|212-639-7788|osbornej@mskcc.org|
20161222|NCT04573881|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
20161223|NCT01999218|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161224|NCT00546260|Portola Pharmaceuticals Inc.|Kevin Romanko, Senior Director Clinical Operations|650-246-7305|kromanko@portola.com|
20161225|NCT03780959|Amgen Inc.|Study Director|866-572-6436||
20161226|NCT00664326|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20161227|NCT04787055|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20161228|NCT03647267|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20161229|NCT05079477|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
20161230|NCT03131596|Fuxing Hospital, Capital Medical University, Beijing, China|Dr. Shi Xiaoyu|+86 18618496384|petershi1990@163.com|
20161231|NCT03654885|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20161232|NCT00004445|Louis Stokes Cleveland VAMC|Lisa Lombardo, MPT|216-791-3800|lisa.lombardo2@va.gov|4909
20161233|NCT02753127|Sumitomo Dainippon Pharma Oncology|Keiichi Saito|+1 (617)674-6800|keiichi.saito@SDPOncology.com|
20161234|NCT01670565|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
20161235|NCT00733135|Covidien|Director of Medical Communications|763-591-3047|jean.ahlstrom@covidien.com|
20161236|NCT02499692|The General Hospital of ShenYang Military|Dr Hanyaling|02428851876|hanyl@medmail.com.cn|
20161237|NCT01146288|Rabin Medical Center|Dr Boris Zingerman||borisz@clalit.org.il|
20161238|NCT00353431|Intern Medicine Solothurn, Switzerland|Robert Thomann, MD|+41326274501|endodiab.bss@bluewin.ch|
20220197|NCT02540850|BioChain (Beijing) Science and Technology, Inc.|Dr. Lele Song|86-10-63401580|songlele@biochainbj.com|
20220198|NCT00264550|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
20220199|NCT02246114|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
20220200|NCT02740114|UT MD Anderson Cancer Center|Pedro Ramirez, MD /Professor, Gyn Onc & Reproductive Med|713-745-5498|peramire@mdanderson.org|
20220201|NCT01551030|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@MSKCC.ORG|
20220202|NCT01957761|Ann & Robert H. Lurie Children's Hospital of Chicago|Larry Kociolek, MD, MSCI|312-227-4080|lkociolek@luriechildrens.org|
20220203|NCT02473523|St. Jude Children's Research Hospital|Kirsten Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
20220204|NCT02794246|Univ. of Pennsylvania|Emerging Med|855-216-0098|penncancertrials@emergingmed.com|
20220205|NCT04141930|University of Washington|Research Coordinator|2066165859|jheimo@uw.edu|
20220206|NCT00000620|Wake Forest School of Medicine|Tim Craven / Senior Biostatistician|336-716-6109|tcraven@wakehealth.edu|
20220207|NCT03551821|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
20220208|NCT02368314|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20220209|NCT00958893|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20220210|NCT02010645|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
20220211|NCT01994850|University of Pennsylvania Abramson Cancer Center|Jakub Svoboda, MD|855-216-0098|PennCancerTrials@emergingmed.com|
20220212|NCT05084924|University of North Carolina at Chapel Hill|Justin Riddle, PhD|850-644-9869|justin_riddle@med.unc.edu|
20220213|NCT03774407|Texas Tech|Dr Mirla Avila|8322448072|mirla.avila@ttuhsc.edu|
20220214|NCT00182325|Department of Family Medicine, McMaster University|Dr. Heather Waters|(905) 575-6782|watersh@mcmaster.ca|
20220215|NCT01992185|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
20220216|NCT03225001|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
20220217|NCT01420965|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
20220218|NCT01890434|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20220219|NCT01267994|North Shore-LIJ Health System|Andrea Vambutas, MD, FACS|718-470-7748|vambutas@nshs.edu|
20220220|NCT02950818|University of Michigan School of Public Health|Cathleen Connell|734-647-3189|cathleen@umich.edu|
20220221|NCT04868968|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
20220222|NCT03276078|AstraZeneca PLC|Dr Sami Daoud|1-877-240-9479|Information.centre@astrazeneca.com|
20220223|NCT02552732|Fisher and Paykel Healthcare|Dr Stanislav Tatkov|09 5740100|stanislav.tatkov@fphcare.co.nz|
20220224|NCT03332979|Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London|Dr Kirsten Moore|020 7679 9488|kirsten.moore@ucl.ac.uk|
20220225|NCT01275430|Bard Access Systems, Inc.|Sharon Molotsky|856-266-1327|sharon.molotsky@crbard.com|
20161239|NCT00706329|Children's Hospital Boston and South Shore Hospital|Dr. Neil Feins|6173556915||
20161240|NCT03532932|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20161241|NCT00931801|Community Research Initiative of New England|Calvin J. Cohen MD, MSc, Director of Research|617-502-1700|ccohen@crine.org|
20175103|NCT00799578|Columbia University|Dr. Joel Lavine|212 304 5533|jl3553@columbia.edu|
20175104|NCT01162382|Washington University School of Medicine|Kathy Pierce|314-362-5626|jenkerson_m@wustl.edu|
20175105|NCT01886807|UTSouthwestern Medical Center|Dr. Jeffrey Steiner, PI|214-456-0606|jeffrey.steiner@utsouthwestern.edu|
20175106|NCT01712256|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
20175107|NCT00962104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205690|NCT00400712|Queen's University|Brenda Brouwer|613-533-6079|brouwerb@queensu.ca|
20205691|NCT01181102|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
20205692|NCT03438578|St Olavs Hospital|Erlend Johan Skraastad|0047 79829184|Erlend.Johan.Skraastad@stolav.no|
20205693|NCT01309841|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
20175108|NCT04944901|Scioto Biosciences|Phoevos Hughes, VP Clinical Operations|866-672-4686|phoevos@sciotobiosciences.com|700
20175109|NCT02603835|TherOx, Inc.|Jeffrey L. Creech, Ph.D.|(949) 225-6587|jcreech@therox.com|
20175110|NCT01077804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20175111|NCT04866771|University Of Illinois At Chicago|PRS Training Lead|(312) 996-4995|awards@uic.edu|
20175112|NCT02809430|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
20175113|NCT03567850|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kristopher.Attwood@roswellpark.org|
20175114|NCT01454726|Xuan Wu Hospital of Capital Medical University|Dr. Jianping JIA|0086-10-83198899|jiajp@vip.sina.com|8650
20175115|NCT04200248|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
20175116|NCT01886833|CIDRZ|Dr. Roma Chilengi|+2609173724935|Roma.Chilengi@cidrz.org|
20175117|NCT01661712|2Guy's and St Thomas' NHS Foundation Trust, Lane Fox Respiratory Unit/Sleep Disorders Centre, London, UK|Dr Joerg Steier|020 7188 3430|joerg.steier@gstt.nhs.uk|
20175118|NCT02342704|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20175119|NCT00614913|Radiation Medicine - Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@dominion.llumc.edu|
20175120|NCT00302003|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20175121|NCT01218516|Morphotek (subsidiary of Eisai)|Morphotek (subsidiary of Eisai)|1-888-422-4743|esi_medinfo@eisai.com|
20175122|NCT01539226|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
20175123|NCT02919670|DFCI|Kelly Masone|6176324167|kmasone@partners.org|
20175124|NCT04070833|Brigham and Women's Hospital|Pamela M. Rist|617-278-0835|prist@bwh.harvard.edu|
20175125|NCT02227485|Shiraz University of Medical Sciences|Dr. Mahsa Rostami-Chijan|+989111960300|mahsa_59_2007@yahoo.com|
20175126|NCT02118428|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832|ray.goodrich@terumobct.com|
20175127|NCT02378844|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
20175128|NCT01010282|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20175129|NCT01641367|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20175130|NCT00782210|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175131|NCT03405142|Stanford Medicine at Stanford University|Roan Courtney Raymundo|650-721-4071|rcraymun@stanford.edu|
20175132|NCT00820612|University of Michigan|B. Joseph Elmunzer, MD.|735 615 6652|badihe@umich.edu|
20175133|NCT00436748|Amgen Inc.|Study Director|866-572-6436||
20175134|NCT01610791|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20175135|NCT04883632|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20175136|NCT00850200|University of Florida Proton Therapy Institute|Bradford Hoppe, MD, MPH|904-588-1800|bhoppe@floridaproton.org|
20175137|NCT02319031|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20175138|NCT03917420|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
20175139|NCT02319005|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20175140|NCT03712410|University of Pennsylvania|George Demiris|2158988559|gdemiris@upenn.edu|
20175141|NCT00696137|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
20175142|NCT01371656|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20175143|NCT01874262|AstraZeneca|Susanna Jerström|+46 8 553 260 00||
20175144|NCT01015586|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
20175145|NCT00314236|Piramal Healthcare (Canada) Limited|Alberto Restrepo, MD, Director of Medical and Clinical Affairs|450-686-2437|alberto.restrepo@piramal.com|315
20175146|NCT03621878|imam abdulrahman bin faisal university|Mohammed Alghamdi|+966556852888|mohdg.ios@gmail.com|
20175147|NCT01465464|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20175148|NCT03458130|Eidos Therapeutics|Mark McGovern, Vice President of Clinical Operations|415-887-1471|medinfo@eidostx.com|
20175149|NCT03395314|Yale School of Medicine|Sarah Fineberg, MD, PhD|(203) 974-7265|sarah.fineberg@yale.edu|
20175150|NCT00785486|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
20175151|NCT00775437|AbbVie|Global Medical Information|800-633-9110||
20175152|NCT01183975|Ethicon, Inc.|Birgit Temiz|+49 (0) 40 5297 3144|btemiz@its.jnj.com|
20175153|NCT03316885|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20175154|NCT01102413|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
20175155|NCT04180020|Yale School of Medicine|Sandra Springer, MD|877-554-3578|sandra.springer@yale.edu|
20175156|NCT02244580|Biontech Diagnostics GmbH|Dr. Michael Oed|+49 6131/ 6358030|michael.oed@theracode.de|
20175157|NCT00056563|Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D, Study Investigator|(708) 202-2414|Frances.Weaver@va.gov|
20205694|NCT01441115|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
20220226|NCT02613182|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
20220227|NCT01727726|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
20220228|NCT00863772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220229|NCT00086281|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650-496-3777||
20220230|NCT03149757|University of Minnesota|Keith Horvath|619-594-3346|khorvath@sdsu.edu|
20220231|NCT03456453|University of Kentucky|Michele Staton|859-312-8245|mstaton@uky.edu|
20220232|NCT00896480|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220233|NCT04784533|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20220234|NCT02454127|Tufts Medical Center|Michael Dansinger, MD|617-636-5000|mdansinger@tuftsmedicalcenter.org|
20220235|NCT02777073|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
20220236|NCT03844386|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
20220237|NCT04324073|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|+33(0)1.42.34.89.87|raphael.porcher@aphp.fr|
20220238|NCT01784055|NeoChord, Inc.|Lori E Adels, PhD|1-952-698-7804|ladels@neochord.com|
20220239|NCT00369486|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Adam R. Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
20220240|NCT01659125|Institute of Living|Gretchen J. Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
20220241|NCT05289869|The Ohio State University|Heather Frey, MD, MSCI|614-688-6798|Heather.Frey@osumc.edu|
20220242|NCT01613768|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
20220243|NCT05013008|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20220244|NCT01443728|Columbia University|Gary Brittenham, MD|212-305-7005|gmb31@cumc.columbia.edu|
20220245|NCT04981717|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20220246|NCT03743415|University of Arizona College of Nursing|Terry Badger, PhD|520-626-6058|tbadger@arizona.edu|
20220247|NCT00094861|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20220248|NCT03112642|RutgersSUNJ|William R Grubb MD|7327426528|wrgrubb@aol.com|
20220249|NCT00451204|University of California Los Angeles|Dr. Rhonda Voskuhl|310-206-4636|rvoskuhl@mednet.ucla.edu|
20220250|NCT03760185|Denver Health and Hospital Authority|Dr Cristos Ifantides|303-436-4949|Cristos.Ifantides@dhha.org|
20220251|NCT02242045|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20220252|NCT00866879|Northwestern University|Lorenzo Gallon, MD|3126954457|l-gallon@northwestern.edu|
20220253|NCT02495259|Emory University|Dr. Igor Zhukov|404-268-1404|izhukov@live.com|
20220254|NCT00976911|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20220255|NCT01191944|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220256|NCT05204082|Mayo Clinic|Michael E. Nemergut, M.D., Ph.D.|507-255-7976|Nemergut.Michael@mayo.edu|
20220257|NCT02954991|Mirati Therapeutics|Clinical Operations Director|858-381-5289|LatvenL@Mirati.com|
20220258|NCT00576316|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20220259|NCT02814890|Huashan Hospital, Fudan University, Shanghai|Dr. Jun Zhang|0086-021-52887694|snapzhang@aliyun.com|
20220260|NCT01830790|Duke University|Sharon Fekrat: Associate Professor of Ophthalmology|(919) 681-0341|Sharon.Fekrat@dm.duke.edu|
20220261|NCT02552303|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
20220262|NCT04602546|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
20220263|NCT00253448|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Research Investigator|937-395-8646|douglas.einstein@khnetwork.org|
20220264|NCT01342757|Emory University School of Medicine|Jeffrey J. Olson, MD|404-778-3091|jolson@emory.edu|
20220265|NCT02052011|Yale School of Medicine|Dr. Basmah Safdar|2037853453|basmah.safdar@yale.edu|
20220266|NCT01851330|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20220267|NCT02648932|University of Chicago|Hongtao Liu|773-834-0589|hliu2@medicine.bsd.uchicago.edu|
20220268|NCT01266031|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
20220269|NCT01753557|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20220270|NCT03106987|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
20220271|NCT03336528|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
20220272|NCT01307111|University of New Mexico|Eve Espey, MD, MPH, Principle Investigator|505-272-6372|eespey@salud.unm.edu|
20220273|NCT00682357|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
20220274|NCT00569855|University of Arkansas, Arkansas Children's Hospital, Dept. of Pediatrics|Research Program Manager, Cardiovascular Surgery, Dept. of Pediatrics|501-364-1100|althagekarena@uams.edu|5859
20220275|NCT01275729|University of Chicago|Dr. Jay L Koyner|773-702-4842|jkoyner@uchicago.edu|
20220276|NCT02252406|University of Florida, Jacksonville|Gladys Velarde, MD|904-244-2060|gladys.velarde@jax.ufl.edu|
20220277|NCT03545893|University of Pennsylvania|Arden McAllister, Research Program Manager|215-662-3532|arden.mcallister@pennmedicine.upenn.edu|
20161242|NCT03283150|University of Wisconsin-Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
20161243|NCT01028716|Fred Hutchinson Cancer Center|Rachel Salit|2066671317|rsalit@fredhutch.org|
20161244|NCT00086502|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20161245|NCT05545644|University of New Mexico|Dr. Barbara McCrady|505-925-2388|bmccrady@unm.edu|
20161246|NCT01797380|Duke University Health Systems|Harold Goforth, M.D.|216-636-3999|goforth@ccf.org|
20161247|NCT01842581|Bausch Health Americas, Inc.|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20175158|NCT00811577|Capstone Therapeutics Corp.|Denise Lamon|602-286-5206|dlamon@capstonethx.com|
20175159|NCT04251221|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
20175160|NCT00329407|Boston University|Ofra sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
20175161|NCT02357940|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
20175162|NCT00978068|University of California, San Francisco|Tamara Clark|415-206-8790|tamara.clark@ucsf.edu|
20175163|NCT02442778|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20175164|NCT02482025|VA Greater Los Angeles Healthcare System|Steven R. Simon, MD|310.268.3132|steven.simon2@va.gov|
20175165|NCT04964128|Medtronic|Roseline Re|+33684520425|roseline.re@medtronic.com|
20175166|NCT00446147|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20175167|NCT01965288|CooperVision|Jose A. Vega Sr. Mgr. Global Medical Scientific Affairs|(925) 621-3761|jvega2@coopervision.com|
20175168|NCT03913091|NYU Langone Health|Uchenna O. Umeh, MD|(212) 598-6085|Uchenna.Umeh@nyulangone.org|
20175169|NCT01726738|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20175170|NCT02196324|Menlo Therapeutics Inc. (formerly Tigercat Pharma, Inc.)|Iain Stuart, PhD.|1- 800-775-7936|Iain.Stuart@foamix.com|
20175171|NCT01380184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175172|NCT04243538|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
20175173|NCT00655564|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
20175174|NCT02214277|Claret Medical|Director of Clinical Research|707-528-9300|info@claretmedical.com|
20175175|NCT02131402|Optics Department, University of Valencia 46100 Valencia, Spain|Dr. Robert Montés-Mico O.D., MPhil, PhD|34-9635-44764|robert.montes@uv.es|
20175176|NCT00344773|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20175177|NCT04859868|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|480-301-5351|Pradhan.Gaurav@mayo.edu|
20175178|NCT00500370|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20175179|NCT04804813|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20175180|NCT05627518|Cinclus Pharma AB|Kristofer Katkits Nilsson, Global Trial Manager|+46 7064955|kristofer.katkits@cincluspharma.com|
20175181|NCT05535777|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20175182|NCT02917031|AstraZeneca R&D|AstraZeneca R&D|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20175183|NCT01581593|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
20175184|NCT03003520|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20175185|NCT04982029|Brigham and Women's Hospital|Dr. Joji Suzuki|617-455-7981|jsuzuki2@bwh.harvard.edu|
20175186|NCT03264404|Columbia University|Ruth White, MD, PhD|212-342-5162|raw2168@cumc.columbia.edu|
20175187|NCT02586012|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
20175188|NCT01195467|St Stephen's AIDS Trust|Dr Mark Nelson|02033|mark.nelson@chelwest.nhs.uk|155610
20175189|NCT02388737|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20175190|NCT03252522|Oregon Health & Science University|Jeanette Johnstone, PhD|5034943700|jojeanet@ohsu.edu|
20175191|NCT03299842|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20175192|NCT00071812|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175193|NCT01816139|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20175194|NCT03661814|Icahn School of Medicine at Mount Sinai|Dr. Joel Bauer|914-715-4242|jjb.msh@gmail.com|
20175195|NCT02554656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175196|NCT02400723|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.gould@va.gov|68899
20205695|NCT01906866|Neurim Pharmaceuticals|Dr. Tali Nir|972-7684902|talin@neurim.com|
20205696|NCT00878215|Washington University School of Medicine|William C. Chapman, M.D.|314-362-7792|chapmanw@wustl.edu|
20205697|NCT01969799|Cardeas Pharma|Bruce Montgomery, MD|2069713756|bruce.montgomery@cardeaspharma.com|
20205698|NCT01361919|St. Michael's Hospital|Dr. Paul Dorian|416-864-5104|dorianp@smh.ca|
20205699|NCT03001843|University of Florida|Joshua Sappenfield, MD|352-273-5259|jsappenfield@anest.ufl.edu|
20175197|NCT00358527|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20175198|NCT00749463|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20175199|NCT01381861|TRACON Pharmaceuticals|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
20175200|NCT00913744|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16 751 310|Petra.kozma@thrombogenics.com|
20175201|NCT01344369|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20175202|NCT01127503|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
20175203|NCT00254995|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
20175204|NCT02433834|Pearl Therapeutics, Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
20175205|NCT00283439|Amgen Inc.|Study Director|866-572-6436||
20175206|NCT01632891|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20175207|NCT00935428|OHSU|Dr. John Mayberry|503-494-5300|mayberrj@ohsu.edu|
20175208|NCT00240071|University of Alabama at Birmingham|Carla I Falkson|205-975-2691|cfalkson@uab.edu|
20175209|NCT03341052|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
20205700|NCT01681576|Novartis|Study Director|862-778-8300||
20205701|NCT00178464|St. Christopher's Hospital for Children|Dr. Norma B. Lerner|215 427-5261|norma.lerner@drexelmed.edu|
20175210|NCT01105247|Pharmacyclics|Danelle James|855-427-8846|medinfo@pcyc.com|
20205702|NCT04111107|Tulane University|Stefan Grant, MD|504-988-5800|sgrant6@tulane.edu|
20220278|NCT01256944|Taipei Medical University - WanFang Hospital|Dr. Ming-I Hsu|886-2-2930-7930|hsumigni@yahoo.com.tw|2508
20220279|NCT00005957|Juravinski Cancer Centre at Hamilton Health Sciences|Dr. Timothy J. Whelan|1(905) 387-9495|twhelan@HHSC.CA|
20220280|NCT02047734|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20220281|NCT01174043|IndianaU|Dr. Hamid Sayar|(317)278-6871|ssayar@iu.edu|
20220282|NCT02441660|UT Health San Antonio|Michelle Trbovich|210-617-5300|TrbovichM@uthscsa.edu|18192
20220283|NCT00582010|University of Alabama at Birmingham|Rakesh Patel|205-934-3411|rakeshp@uab.edu|
20220284|NCT02029196|Fontem Ventures|Dr Ana Cravo|+441173322528|AnaMaria.Cravo@fontemventures.com|
20220285|NCT01853332|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
20220286|NCT03495921|Gradalis, Inc.|Clinical and Regulatory Operations|(214) 442-8100|info@gradalisinc.com|
20220287|NCT02289456|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20220288|NCT02892149|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
20220289|NCT03489109|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@nih.gov|
20220290|NCT01547130|Wyckoff Heights Medical Center|Dr Vijaypal Arya|718-326-0400|varyamd@yahoo.com|
20161248|NCT00334282|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220291|NCT03968978|AstraZeneca|Global Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
20220292|NCT02714426|University of Florida|Michael Marsiske, Ph.D.|352.273.5097|marsiske@phhp.ufl.edu|
20220293|NCT01178216|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|3102488186|noriko.ammerman@cshs.org|
20220294|NCT00025259|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20220295|NCT03287843|Ege University Hospital|Erhan Akgun,MD, Proffessor|+902323905050|z.erhan.akgun@ege.edu.tr|
20220296|NCT00908310|GE Healthcare|Debra Mansfield|609-514-6329|debra.mansfield@ge.com|
20220297|NCT02803229|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@cumc.columbia.edu|
20220298|NCT02071849|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
20220299|NCT00555360|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
20161249|NCT01420627|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
20161250|NCT00837876|Vanderbilt-Ingram Cancer Center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
20161251|NCT03558074|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20161252|NCT00506597|The University of Texas (UT) MD Anderson Cancer Center|Robert J. Wells, MD / Professor||CR_Study_Registration@mdanderson.org|
20161253|NCT05242354|Biruni University|Dr Mustafa YILMAZ|+90 533 7129952|myilmaz@biruni.edu.tr|
20161254|NCT01996592|Wake Forest School of Medicine|Jessica L. Booth, MD|336-718-8278|jbooth@wakehealth.edu|
20161255|NCT00870194|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20161256|NCT00707746|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20161257|NCT01685983|Janssen R&D BE|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20161258|NCT02818114|Minneapolis VA Health Care System|J. Irene Harris|612-467-1654|jeanette.harris2@va.gov|
20161259|NCT03035773|Johns Hopkins School of Public Health/SKCCC|Dr. Katherine C. Smith|443.927.3350|ksmit103@jhu.edu|
20161260|NCT01335750|Erdy/Searcy Group|Dr. Gary Andrasko, MS|(614) 459-3363|gandrask@columbus.rr.com|
20161261|NCT02642965|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20161262|NCT04557787|Coloplast A/S|Vice President, Medical Affairs|+454911 1111|clinical-studies@coloplast.com|
20161263|NCT01167907|Wake Forest School of Medicine|Robert S. Weller, MD|336-716-7150|rweller@wakehealth.edu|
20161264|NCT05182580|Orbis International|Dr. Nathan Congdon, Director of Research|646-674-5514|ncongdon1@gmail.com|
20161265|NCT03077698|Xenetic Biosciences Inc|Dr. Curtis Lockshin|781-778-7720|info@xeneticbio.com|
20161266|NCT01439074|Changhai Hospital of Shanghai|Prof Xia, Zhaofan|+86 2181873471||
20161267|NCT01140568|UCSD - Moores Cancer Center|Lara Rose|858-822-6575|ljrose@ucsd.edu|
20161268|NCT00815191|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
20161269|NCT02639338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20161270|NCT03094286|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
20161271|NCT00493636|ACORN Research, LLC|Study Chair|901-435-5570|lschwartzberg@acornresearch.net|
20161272|NCT01893359|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
20161273|NCT01873729|Pediatric Psychopharmacology at Massachusetts General Hospital|Dr. Thomas Spencer|6177243883|tspencer@partners.org|
20161274|NCT01066780|Advanced Bionics, LLC|Kenneth Ripley, Director of Clinical Research|1.661.362.1400|clinical.research@advancedbionics.com|
20161275|NCT04983797|Biosense Webster, Inc.|Associate Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20161276|NCT03099148|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20161277|NCT01842594|Shin Kong Wu Ho-Su Memorial Hospital|Kwan-Hwa Chi|+886-28332211|M006565@ms.skh.org.tw|2612
20161278|NCT01827332|MUSC|Aimee McRae-Clark|843-792-5216|mcraeal@musc.edu|
20161279|NCT03352453|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20161280|NCT01241760|Janssen Infectious Diseases BVBA|Compound Development Team Leader|32 14 64 13 70||
20161281|NCT02725593|Study Information Center|Global Clinical Lead|+1-887-240-9479|information.center@astrazeneca.com|
20161282|NCT04064346|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
20161283|NCT01667146|ANZIC - RC, Monash University|Prof Carol Hodgson|+61 (3) 99030598|carol.hodgson@monash.edu|
20161284|NCT02700165|Zeltiq Aesthetics|Kerrie Jiang, Exective Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20161285|NCT01428336|Cleveland Clinic Foundation|Seenia Peechakara|216 4105901|peechas@ccf.org|
20220300|NCT00103610|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
20220301|NCT02494180|Kwong Wah Hospital|Dr SF Lai|85223322311|lsf087@ha.org.hk|
20220302|NCT00088621|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20220303|NCT00725205|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20220304|NCT01680497|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20220305|NCT05819203|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
20220306|NCT02297698|LumaBridge|Dr. George Peoples|210 557 4291|gpeoples@lumabridge.com|
20175211|NCT00651482|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20175212|NCT01978314|University of Alabama, Birmingham|Dana Victor Rizk, M.D.||drizk@uab.edu|
20175213|NCT02121483|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175214|NCT02086110|University of California, Davis Health System|Dr. Kathleen Angkustsiri|916-703-0278|kangkustsiri@ucdavis.edu|
20175215|NCT01869192|University of Colorado|Anthony Elias, MD|17208480347|anthony.elias@ucdenver.edu|
20175216|NCT01203072|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
20175217|NCT00577512|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20175218|NCT02272413|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175219|NCT01067768|Hospital Pablo Tobón Uribe|Dr. María Victoria Restrepo|57-4-4459315|mrestrepo@hptu.org.co|
20175220|NCT02286193|Group Health Research Institute|Clarissa Hsu, PhD|206-287-4276|hsu.c@ghc.org|
20175221|NCT00423891|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20175222|NCT02852265|University of California, Davis|Dr. Melissa Chen|916-734-6670|mejchen@ucdavis.edu|
20175223|NCT02432716|HealthPartners Neuroscience Research|Clinical Trial Manager|651-495-6363|maria.x.pyle@healthpartners.com|
20175224|NCT00792610|National Taiwan University Hospital|Jan, Chyi-Feng|886-2-23562147|jcf036@ntu.edu.tw|
20175225|NCT01461096|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20175226|NCT01479621|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
20175227|NCT01094548|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20175228|NCT01734551|University of Kentucky|Dr. Henrietta S. Bada, Professor and Vice Chair, Academic Affairs|859-323-1019|hbada2@uky.edu|
20175229|NCT04225923|Nobelpharma Co. Ltd.|Research & Development Divion|81-3-6670-3800|watanabe.tatsuya@nobelpharma.co.jp|
20175230|NCT00855309|Comprehensive Cancer Center of Wake Forest University|LeAnne Kenndy, PharmD|336-713-3416|lakenned@wakehealth.edu|
20175231|NCT01585766|MedImmune|Armando Flor, MD, Director, Clinical Development|301-398-1955|information.center@astrazeneca.com|
20175232|NCT04116710|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|barana@nighthawkbio.com|203
20175233|NCT00582933|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
20175234|NCT01820754|Duke University Medical Center|Neal Ready, MD|919 681-6932|neal.ready@duke.edu|
20175235|NCT01845792|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
20175236|NCT01566448|West Virginia University Hospitals|Aaron Cumpston|304-598-4000|cumpstona@wvumedicine.org|73350
20175237|NCT02376166|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|(212) 659-5599|matthew.galsky@mssm.edu|
20175238|NCT02045511|Johns Hopkins University School of Medicine Dept. Otolaryngology-HNS|Carrie Nieman|3025368362|cnieman1@jhmi.edu|
20175239|NCT00738972|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205703|NCT03956225|Alcon Research, LLC|Sr. CDMA Project Lead, Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
20205704|NCT00321269|Iowa City VA Health Care System|Carolyn Turvey|319 338 0581|Carolyn-Turvey@uiowa.edu|7714
20205705|NCT00805545|University of Florida|Patrick Duff, M.D.|352 273 7673|duffp@ufl.edu|
20205706|NCT01606735|Icon Bioscience, Inc|Wendy Murahashi, MD|6503694049|wendymurahashi@iconbioscience.com|
20205707|NCT00413335|Yale University School of Medicine|Dr. Sonia Caprio, Principal Investigator|203-785-5692|Sonia.Caprio@yale.edu|
20205708|NCT02659605|The University of Texas Health Science Center at Houston|Dr. Pamela D. Berens|(713) 500-6471|Pamela.D.Berens@uth.tmc.edu|
20205709|NCT01929473|IROM CS Co., Ltd.|Tsutomu Takeda|+81-92-738-0500|tsutomu-takeda@irom-cs.co.jp|
20205710|NCT01195363|UTHSCSA|Charles L Bowden, MD|210-567-5393|BowdenC@uthscsa.edu|
20205711|NCT00750165|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|cpaptrial@fphcare.co.nz|7044
20205712|NCT03337139|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
20205713|NCT01871896|University of California San Francisco|Matthew Lin|415 353 2161|Matthew.Lin@ucsf.edu|
20205714|NCT05691829|NYU Langone Health|Fraustina Hsu|646-754-7124|Fraustina.Hsu@nyulangone.org|
20205715|NCT02373371|CHU de Limoges|Project Manager|0555058616|abdeslam.bentaleb@chu-limoges.fr|+33
20205716|NCT00453180|Cincinnati Childrens Hospital|Craig Erickson|513-636-6258|craig.erickson@cchmc.org|
20205717|NCT03326869|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
20205718|NCT03927911|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20205719|NCT00562640|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
20205720|NCT01412151|Massachusetts General Hospital|Steven M. Hersch, MD, PhD|617-726-1254|hersch@helix.mgh.harvard.edu|
20205721|NCT03127852|Centre for Global eHealth Innovation|Dr. Patrick Ware|1 (416) 340 4800|Patrick.Ware@uhn.ca|4765
20205722|NCT01824693|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20220307|NCT04123561|Taiwan Liposome Company|Dr. Tien-Tzu Tai|+886 2 2655 7377|tttai@tlcbio.com|801
20220308|NCT04328961|University of Washington|Ruanne Barnabas|206 520 3800|rbarnaba@uw.edu|
20161286|NCT02423122|EIP Pharma|John Alam||jalam@eippharma.com|
20220309|NCT01621477|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
20220310|NCT03654599|Arizona State University|Dr. Sunny Kim|602-496-6789|Sunny.Kim@asu.edu|
20220311|NCT05833139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220312|NCT03128060|University of Southern California|Susan Enguidanos|(213) 740-9822|enguidan@usc.edu|
20220313|NCT00974922|UCHC|Dr. William White|860-679-2104|wwhite@uchc.edu|
20220314|NCT00287586|Brigham and Women's Hospital|Shalendar Bhasin, MD||Sbhasin@partners.org|
20220315|NCT02640482|AbbVie|Global Medical Services|800-633-9110||
20161287|NCT00552448|TexasTech|Dr. Adaobi Kanu|806 743 7336|adaobi.kanu@ttuhsc.edu|
20161288|NCT00316524|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20161289|NCT05714943|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
20161290|NCT01902459|Ethicon, Inc|Richard Kocharian, MD, PhD|+1 908-218-2013|rkochar1@its.jnj.com|
20161291|NCT02644356|Collinge and Associates, Inc.|William Collinge, PhD, MPH|541-632-3502|william@collinge.org|
20161292|NCT01557881|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
20175240|NCT01228747|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20175241|NCT02036502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220316|NCT00517881|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20220317|NCT00113763|Amgen Inc.|Study Director|866-572-6436||
20220318|NCT02968602|Maryland Psychiatric Research Center|Heidi J Wehring|410-402-6854|hwehring@som.umaryland.edu|
20220319|NCT02462291|University of Verona|Massimo Venturelli - PI|+39 02503 14648|massimo.venturelli@univr.it|
20220320|NCT02129608|Mayo Clinic|Ivana Croghan|507-266-1944|domcro@mayo.edu|
20220321|NCT03300843|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|steven-rosenberg@nih.gov|
20220322|NCT02114385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220323|NCT04204057|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
20220324|NCT03834142|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
20220325|NCT00230178|Sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20220326|NCT01753297|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
20220327|NCT02533180|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20220328|NCT00447876|Ipsen|Medical Director||clinical.trials@ipsen.com|
20220329|NCT01609023|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20220330|NCT03904108|Stony Brook University|Dr. Roger Keresztes|631-638-1000|roger.keresztes@stonybrookmedicine.edu|
20220331|NCT04172597|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
20220332|NCT02646761|University of Pittsburgh|Dr. James J. Irrgang|(412) 383-9865|jirrgang@pitt.edu|
20220333|NCT04797221|Veterans Health Administration|Joseph Simonetti|7207236491|joseph.simonetti@va.gov|
20220334|NCT00486031|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
20220335|NCT03751007|Precigen Actobio T1D, LLC|Sven Blomme|+3292771177|sblomme@actobio.com|
20220336|NCT03717012|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220337|NCT00789035|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220338|NCT01520870|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
20220339|NCT02463357|University of Colorado Denver|Robert Roach||clinicalresearchsupportcenter@ucdenver.edu|
20220340|NCT03509857|Montefiore MC|Dr. Aravind Pothula|9178015577|apothula@montefiore.org|
20220341|NCT01371539|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
20220342|NCT01399658|Dana-Farber Cancer Institute|Martin King, MD|617-732-4332|Martin_King@dfci.harvard.edu|
20220343|NCT02620579|University of Florida|Dr. Samuel S. Wu|3522945910|samwu@biostat.ufl.edu|
20220344|NCT01277159|HSS|Dr. Yadeau|212.606.1206|YadeauJ@hss.edu|
20220345|NCT00796107|Hoffmann-La Roche, Ltd.|Study Director|888-662-6728 (U.S.)|global-roche-genentech-trials@gene.com|
20220346|NCT02681510|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
20220347|NCT00900822|Institut Straumann AG|Clinial Trial Manager|+41 61 965 11 11|info@straumann.com|
20220348|NCT01721317|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220349|NCT01778634|University of Maryland|Rose Marie Viscardi, M.D.|410-706-1913|rviscard@som.umaryland.edu|
20220350|NCT03168334|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
20220351|NCT01072617|BIDMC|Alvaro Pascual-Leone|617-667-0203|apleone@bidmc.harvard.edu|
20220352|NCT03366207|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
20220353|NCT02130622|Dartmouth-Hitchcock|Gastroenterology Research Team Lead|603-653-9033|Jessica.I.Chevalier@hitchcock.org|
20220354|NCT00378573|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
20220355|NCT02806024|University of Washington|Mallory Kremer|206.616.5258|mkremer@uw.edu|
20220356|NCT01654315|The Ohio State University|Dr. Stephen Page|614-292-5490|STEPHEN.PAGE@OSUMC.EDU|614
20220357|NCT03617783|Maryland Psychiatric Research Center|Dr. Robert Buchanan|410-402-7876|rwbuchanan@som.umaryland.edu|
20220358|NCT01898221|Houston Methodist Hospital, Dept of Cardiology|Miguel Valderrabano, MD|713 441 5231|MValderrabano@houstonmethodist.org|
20220359|NCT03837743|DURECT Corporation|Executive Director of Regulatory Affairs|408-777-1829|jill.burns@durect.com|
20220360|NCT00252239|University of Virginia Health System|Dr. E. Clarke Haley, Jr.|434-924-8041|ech@virginia.edu|
20220361|NCT04791514|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
20220362|NCT02257385|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220363|NCT01316302|The Medical Research Network, LLC|Michael R. Liebowitz, M.D.|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
20220364|NCT02288156|UZ Leuven|Prof. Dr. Hellings|016336340|nkogh@uzleuven.be|
20220365|NCT01822366|University of Washington|Dr. Shannon Dorsey|(206) 543-4527|dorsey2@uw.edu|
20161293|NCT02210091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20220366|NCT00767624|STANFORD UNIVERSITY|Rachel Manber, PhD|6504981266|rmanber@stanford.edu|
20220367|NCT00384930|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20220368|NCT02686138|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20161294|NCT00737594|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20161295|NCT01711866|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20161296|NCT01831817|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161297|NCT00897390|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20220369|NCT01449370|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20220370|NCT00534404|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
20161298|NCT00958217|VA San Diego Healthcare System/UCSD|Susan R. Tate, Ph.D., Clinical Psychologist|619-426-9402|srtate@ucsd.edu|
20220371|NCT02996487|Beaumont Hospitals|Maureen Cooney|248 551-0099|maureen.cooney@corewellhealth.org|
20161299|NCT04973696|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ana-Maria Vranceanu|617-724-4977|avranceanu@mgh.harvard.edu|
20161300|NCT01838785|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
20161301|NCT04332614|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20161302|NCT01410812|University of Pennsylvania|Katherine L. Milkman, Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
20161303|NCT00940485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20161304|NCT04555837|The University of Texas MD Anderson Cancer Center|Faye Johnson, MD|(713) 792-6363|fmjohns@mdanderson.org|
20161305|NCT06250738|Rollins School of Public Health|Dr. Andrea Lopez-Cepero|404-727-3956|andrea.a.lopez-cepero@emory.edu|
20161306|NCT02936284|Children's Mercy Hospital, Kansas University|Kai Ling Kong, PhD|816-731-7239|kkong@cmh.edu|
20161307|NCT03859739|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161308|NCT00293709|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220372|NCT02027428|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20220373|NCT01004003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220374|NCT00259272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220375|NCT00563576|Columiba University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
20220376|NCT00315731|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220377|NCT04614246|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20220378|NCT01462812|OptiNose|Sr. Director of Clinical Development|(267) 364-3620|jennifer.carothers@optinose.com|
20220379|NCT03597464|Aurinia Pharmaceuticals|Clinical Trials Information|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20220380|NCT00676780|LSUShreveport|Dr. Jerry W. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
20220381|NCT01374269|Grupo Rehabilitacion en Salud|Dr. Fabio Salinas Duran|5742196475|fabios@une.net.co|
20220382|NCT02125721|NYU Langone Health|David Goldfarb|212 263 0744|David.Goldfarb@nyulangone.org|
20220383|NCT01613313|GerutZ|Dr. Zachary E.Gerut|516 295-2100|Drgerut@drgerut.com|
20220384|NCT00340678|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Dr. Robert Nelson|(602) 200-5205|rnelson@phx.niddk.nih.gov|
20220385|NCT00278889|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20220386|NCT04042376|Janssen Research & Development, LLC|Executive Medical Director Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20220387|NCT01243775|Chonnam National University Hwasun Hospital|Dr. Young-Chul Kim|82-61-379-7614|kyc0923@jnu.ac.kr|
20220388|NCT02260570|Department of Veterans Affairs|Andrew Kayser, MD PhD|925-372-2000|Andrew.Kayser@va.gov|
20220389|NCT03996447|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20220390|NCT05849454|Center for Behavioral Cardiovascular Health|Nadia Liyanage-Don|917-280-3776|nal2151@cumc.columbia.edu|
20220391|NCT02896712|The University of Texas Health Science Center at Houston|Joy Schmitz, PhD|713-486-2867|joy.m.schmitz@uth.tmc.edu|
20220392|NCT01810302|University of Florida|Dr. Spiros Blackburn|(352) 273-9000|spiros.blackburn@neurosurgery.ufl.edu|
20220393|NCT03888066|Vifor Pharma, Inc.|DIAMOND Clinical Study Team|+41 588 518 000|Diamond_Information@viforpharma.com|
20220394|NCT02207634|Amgen Inc.|Study Director|866-572-6436||
20220395|NCT02077140|Medtronic Spine and Biologics|Clinical Affairs|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20220396|NCT00459355|Bedford VA Medical Center|Dr. Kathy Horvath|781-687-2006|Kathy.Horvath@va.gov|
20220397|NCT00836407|The Sidney Kimmel Comprehensive Cancer Center at Johns|Dr. Dung Le||dle@jhmi.edu|
20220398|NCT01762800|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220399|NCT00478062|Johns Hopkins Sidney Kimmel Cancer Center|Yvette Kasamon|4109135018|ykasamon@jhmi.edu|
20220400|NCT01173120|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20220401|NCT02847260|United Therapeutics Corporation|Leigh Peterson, Director, Product Development, Product Development & Global Clinical Operations|919-425-8165|lpeterson@unither.com|
20220402|NCT02906358|The University of Texas Health Science Center at San Antonio|Barbara J Turner|210-562-5551|turner@uthscsa.edu|
20220403|NCT02699684|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20220404|NCT01145508|ECOG Statistical Office|Study Statistician|617-632-3012||
20220405|NCT03624920|Theranexus|Chief Medical Officer|+33680026779|werner.rein@theranexus.fr|
20175242|NCT00847288|Medtronic Cardiac Rhythm Disease Management|OptiVol Care Pathway Clinical Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
20175243|NCT01068509|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
20175244|NCT01429272|Laureate Institute for Brain Research|Jonathan Savitz; Principal Investigator|918 502 5104|jsavitz@laureateinstitute.org|
20175245|NCT02641379|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20175246|NCT01165138|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175247|NCT05516082|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|19256213761|javega@coopervision.com|
20175248|NCT03323658|UT MD Anderson Cancer Center|Priya Thomas,MD-Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
20175249|NCT00615056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175250|NCT04536727|University of Illinois at Chicago|Dr. David Marquez|(312) 996-1209|marquezd@uic.edu|
20175251|NCT00249470|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20175252|NCT00560950|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20175253|NCT02565381|Massachusetts General Hospital|Travis P. Baggett, MD, MPH (Principal Investigator)|617-643-9314|tbaggett@mgh.harvard.edu|
20175254|NCT01558700|Northwestern University|Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
20175255|NCT03369717|Montefiore Medical Center|Nadeem Akbar MD|7189204646|nakbar@montefiore.org|
20175256|NCT05308901|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
20175257|NCT04625803|The First Affiliated Hospital, Zhejiang University School of Medicine|Weijia Fang|+86 87235147|weijiafang@zju.edu.cn|
20175258|NCT05087875|University of Kentucky|Carolyn Lauckner|8595623335|carolyn.lauckner@uky.edu|
20175259|NCT01914666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20175260|NCT03018392|Bone and Joint Clinic of Baton Rouge|Research Projects Director|2254218207|aobrien@bjcbr.com|
20175261|NCT01940120|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-430-1329|chithra.sangli@av.abbott.com|
20175262|NCT03277846|University of Pennsylvania|Michael Perlis|215-746-3577|mperlis@upenn.edu|
20175263|NCT03240575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175264|NCT02488785|Joslin Diabetes Center|Sylvia Rosas|6173092486|sylvia.rosas@joslin.harvard.edu|
20175265|NCT05543928|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20175266|NCT03568942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20175267|NCT01945489|Allergan, Inc|Vice President Medical Affairs|1-877-277-8566|IR-CTRegistration@allergan.com|
20175268|NCT04147442|Bernafon AG|Dr Barbara Simon|+41 31 998 1515|bsim@bernafon.com|1684
20175269|NCT04144166|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
20175270|NCT01489969|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
20175271|NCT02547662|Mayo Clinic|Shaji Kumar MD|507 284 2511|Kumar.Shaji@mayo.edu|
20175272|NCT02223767|Universitätsklinikum Würzburg|Prof. Dr. M Herrmann|093120176650|Herrmann_m@ukw.de|
20175273|NCT01200875|Stanford University|Jason Dragoo, Associate Professor|(650) 721-3430|jdragoo@stanford.edu|
20175274|NCT00934544|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20175275|NCT02643251|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
20175276|NCT02129075|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
20175277|NCT00333229|Novartis Pharmaceuticals|Study Director|862-778-8300||
20175278|NCT01466270|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
20175279|NCT03237234|Shepherd Center|Dr. Edelle C. Field-Fote|404-603-4274|edee.field-fote@shepherd.org|
20175280|NCT02821962|University of Ottawa Heart Institute|Dr. Robert Reid|613-696-7393|breid@ottawaheart.ca|
20175281|NCT01166594|Sunnybrook Health Sciences Centre|Dr Catherine Birt|416 480-5882|catherine.birt@sunnybrook.ca|
20175282|NCT02299050|University of Texas Health San Antonio|Mariam Alatrach|210-358-7220|alatrach@uthscsa.edu|
20175283|NCT02822508|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20175284|NCT00654381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175285|NCT03100825|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20175286|NCT00542750|Medical University of South Carolina|Kevin M. Gray, M.D.|8437920135|graykm@musc.edu|
20175287|NCT00994448|UCLA|Keith Heinzerling MD|310-794-0619|KHeinzerling@mednet.ucla.edu|
20175288|NCT02981381|VA Providence|Noah S. Philip MD|401-273-7100|noah.philip@va.gov|12369
20175289|NCT04164901|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20175290|NCT02638298|Medical University of South Carolina|Dr. Leddy|843-876-1119|leddyl@musc.edu|
20205723|NCT02591238|Peking Union Medical College Hospital.|Prof. Changwei Liu. Director of vascular surgery.|+86 1069152509|aresbill@outlook.com|
20205724|NCT00656084|New York Oncology Hematology|Dr. Lawrence E. Garbo|(518) 489-0044|Lawrence.Garbo@usoncology.com|
20205725|NCT00609804|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20205726|NCT04055467|Johns Hopkins School of Medicine|Dr. Elise Weerts, Professor|410-550-2781|eweerts@jhmi.edu|
20205727|NCT00525785|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|jajani@mdanderson.org|
20205728|NCT03628599|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20175291|NCT05358821|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
20175292|NCT00645333|University of Michigan|Anne F. Schott, MD|1-800-865-1125|canceranswerline@umich.edu|
20175293|NCT00048542|Abbott|Global Medical Services|800-633-9110||
20175294|NCT05847153|Massachusetts General Hospital|Dr. Christine Ritchie|4156721780|csritchie@mgh.harvard.edu|
20175295|NCT06138756|Theranica|Dr Dagan Harris|+972-73-3703649|daganh@theranica.com|
20175296|NCT04476017|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20175297|NCT02704364|NGM Biopharmaceuticals, Inc|Clinical Trial Information and Disclosure|650-243-5555|ngm282@ngmbio.com|
20175298|NCT00846742|St. Jude Children's Research Hospital|Matt Ehrhardt, MD, MS|(901) 595-5913|matt.ehrhardt@stjude.org|
20175299|NCT04063761|Attune Medical|Clinical Research Coordinator|888.534.4873|info@attune-medical.com|
20175300|NCT02775344|Queen Mary Hospital|Dr Manwa Lui|22554647|ellenlui@hku.hk|
20175301|NCT04609020|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
20175302|NCT04627064|Dana-Farber Cancer Institute|Toni Choueiri, M.D|617-6325456|toni_choueiri@dfci.harvard.edu|
20175303|NCT02107599|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20175304|NCT00779103|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20175305|NCT04098458|Medical University of South Carolina|Evan M. Graboyes, MD, MPH (principal investigator)|843-792-0719|graboyes@musc.edu|
20175306|NCT00006489|University of Pennsylvania|Dr. Edna Foa|215-746-3327|foa@mail.med.upenn.edu|
20175307|NCT00578175|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175308|NCT00235872|Abbott|Global Medical Services|800-633-9110||
20220406|NCT01549405|Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital|Dr Derya Özkan|00903125962553|derya_z@yahoo.com|
20220407|NCT02111603|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20220408|NCT02229474|Northumbria Healthcare NHS Foundation Trust|Professor Richard Walker|+441912932709|richard.walker@nhct.nhs.uk|
20220409|NCT00799825|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220410|NCT01109147|Hopital Sainte Marguerite - APHM - Service du Pr. Azorin|Dr. Eric Fakra||eric.fakra@ap-hm.fr|
20220411|NCT00492778|NRG Oncology|Linda Gedeon for Danielle Enserro, PhD.|7168451169|gedeonl@nrgoncology.org|
20220412|NCT01783912|Center for Tobacco Research and Intervention|Bruce Christiansen|608-262-4087|bc1@ctri.wisc.edu|
20220413|NCT01545518|Emory University|Dr. Charles M. Epstein|404-778-3633|cepstei@emory.edu|
20161309|NCT02981524|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
20161310|NCT02677844|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20161311|NCT03458702|Texas Tech University|Dr. Jacalyn McComb|806-834-6306|jacalyn.mccomb@ttu.edu|
20161312|NCT01697462|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20161313|NCT00168103|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
20161314|NCT00545532|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20161315|NCT03630302|Abbott neuromodulation|Erika Ross|972-526-8207|erika.ross@abbott.com|
20161316|NCT05268744|UCSF|Dr. Robert Hendren|(415) 476-7500|robert.hendren@ucsf.edu|
20161317|NCT01133275|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
20161318|NCT01143896|Michael E. DeBakey VA Medical Center|Fasiha Kanwal, MD, MSHS|(713) 440-4495|Fasiha.Kanwal@va.gov|
20161319|NCT01318070|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20161320|NCT01556061|University of Texas at Houston Medical School/ Dept. of Anesthesiology|Dr. Davide Cattano MD PhD|713-500-6235|davide.cattano@uth.tmc.edu|
20161321|NCT04375397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20161322|NCT02568449|Karmanos Cancer Instiute|Dr. Dipesh Uprety|313-576-8722|upretyd@karmanos.org|
20161323|NCT00610441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161324|NCT05810714|The Ohio State University Comprehensive Cancer Center|Dr. Mira Katz|614-293-6603|Mira.katz@osumc.edu|
20161325|NCT03028987|Stanford University School of Medicine, Dept. of Pediatrics|Cornelia Dekker, MD|6507244437|cdekker@stanford.edu|
20161326|NCT01287195|Brigham and Women's Hospital|Scott B. Snapper, M.D., Ph.D.|617-919-4973|ssnapper@partners.org|
20175309|NCT02126969|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
20175310|NCT02153944|National Institute of Mental Health (NIMH)|Dr Maryland Pao|301-435-5770|paom@mail.nih.gov|
20205729|NCT01624506|Ethicon|Janet DeMarchi|612-867-8727|jdemarch@its.jnj.com|
20205730|NCT01016678|Premiere Research Institute|Paul Winner, DO|561-845-0500|pwinner777@aol.com|102
20205731|NCT00132314|VA New England Mental Illness, Research, Education and Clinical Center|Robert Rosenheck, MD|(203) 932-5711|Robert.Rosenheck@va.gov|3723
20205732|NCT01271413|Johns Hopkins University School of Medicine|Dr. Miriam Mintzer|410 550-0529|mmintzer@jhmi.edu|
20205733|NCT01589263|Baylor College of Medicine|Christopher Smith|713-798-4001|cps@bcm.edu|
20205734|NCT03955055|UMass Chan Medical School|Anne Foley, Senior Clinical Research Coordinator|774-442-4098|anne.foley@umassmed.edu|
20205735|NCT00756093|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20205736|NCT04295356|CELLTRION, Inc.|Sung Hyun Kim, Head of Clinical Planning Department|+82 32 850 5778|SungHyun.Kim@celltrion.com|
20205737|NCT02084069|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
20205738|NCT03617913|Mayo Clinic|Parminder Singh, MD|5072555123|Singh.Parminder@mayo.edu|
20205739|NCT02892201|Yale School of Medicine|Barbara Burtness, MD|(203) 200-4622|arbara.burtness@yale.edu|
20205740|NCT05814471|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20205741|NCT03939637|Baylor College of Medicine/ Texas Children's Hospital|Amanda Grimes|832-822-4217|abgrimes@texaschildrens.org|
20205742|NCT04904614|Tufts Medical Center|Dr. Jennifer Chow|617-636-5244|jennifer.chow@tuftsmedicine.org|
20205743|NCT04325906|Rush University|Jie Li, PI|3125634643|jie_li@rush.edu|
20205744|NCT02016898|Duke University Health System|Michael Quist, MD|718-490-7657|michael.quist@duke.edu|
20205745|NCT00365768|Columbia University Medical Center|Julia Glade-Bender, MD|212-305-3379|jg589@cumc.columbia.edu|
20220414|NCT01098474|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175311|NCT05583903|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
20175312|NCT01533246|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
20175313|NCT00354172|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
20175314|NCT01800916|Coloplast A/S|Marian Sinvani|+45 49112356|dkmards@coloplast.com|
20175315|NCT01232296|Novartis Pharmaceuticals|Study Director|862-778-8300||
20175316|NCT02108821|Children's Mercy Hospital, Kansas City|Alka Goyal MD|816-302-3069|agoyal4@stanford.edu|
20175317|NCT00534235|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
20175318|NCT00151814|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20175319|NCT00937547|Instituto de Oncología Dr. Luis Razetti, Caracas Venezuela|Dr. Jorge Sánchez-Lander Corresponding Author|582129870165|animamotrix@live.com|
20175320|NCT01234467|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20175321|NCT04889625|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-904-254-0152|TKarkkai@its.jnj.com|
20175322|NCT05052190|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20175323|NCT00699010|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
20175324|NCT00404352|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20175325|NCT04370691|Abbott|Vinuta Rau|+ 1 408-834-0621|vinuta.rau@abbott.com|
20175326|NCT04152226|Dermbiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
20175327|NCT01112293|AbramsonCC|James Robinson|215-662-8758|jamesrobinson2@pennmedicine.upenn.edu|
20175328|NCT01271868|Aptevo Therapeutics|Dr. David Schaaf|206-859-6655|schaafd@apvo.com|
20175329|NCT00606892|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20175330|NCT06431061|CooperVision Inc.|Jose A Vega, OD,MSc,PhD|925-621-3761|JVega2@coopervision.com|
20175331|NCT04296396|George Washington University Biostatistics Center|MFMU Principal Investigator|301-881-9260|mfmudatasets@bsc.gwu.edu|
20175332|NCT00966238|VaxInnate|Dr. David N. Taylor|609-860-2260|david.taylor@vaxinnate.com|
20175333|NCT02927457|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20175334|NCT04334460|Blade Therapeutics|SVP, Global Regulatory Affairs, Quality, and Safety|(650) 278 4291|dmody@blademed.com|
20175335|NCT03778931|Stemline Therapeutics, Inc.|Carlos A. Garay, MD, Senior Vice President, Clinical Development & Medical Affairs - Solid Tumors|+1-877-332-7967|clinicaltrials@menarinistemline.com|
20175336|NCT00358462|University of Washington|Lisa E. Manhart, PhD - PI|206-744-3646|lmanhart@uw.edu|
20175337|NCT02970968|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20175338|NCT01904604|DAIT/NIAID|Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20175339|NCT02674412|Cleveland Clinic|Scott Gabbard, MD|216 444-6523|gabbars@ccf.org|
20175340|NCT00697346|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20175341|NCT03569371|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
20175342|NCT03643562|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
20175343|NCT04145895|Beaumont Hospitals|Diane Studzinski|2485512570|diane.studzinski@corewellhealth.org|
20175344|NCT01236755|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766-6100|pauline.cho@polyu.edu.hk|
20175345|NCT01481116|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20175346|NCT00805935|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20175347|NCT00386256|VA Greater Los Angeles Healthcare System|Nancy Harada, PhD|310-268-3632|Nancy.Harada@va.gov|
20175348|NCT01691027|Kansas City VA Medical center|Health Scientist|816-861-4700|George.Timberlake@va.gov|52755
20175349|NCT01241903|University of Kentucky|Dr. Susan S. Smyth|(859) 323-2274|ssmyt2@uky.edu|
20175350|NCT03752619|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3623|rwilson@metrohealth.org|
20175351|NCT05040152|The Ohio State University Comprehensive Cancer Center|Xiaochen Zhang|614-293-9600|xiaochen.zhang@osumc.edu|
20175352|NCT03907683|The Pennsylvania State University|Dr David E Conroy|814-863-3451|conroy@psu.edu|
20175353|NCT03400332|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20175354|NCT01188577|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
20175355|NCT02075840|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20161327|NCT00885768|Kidney Reasearch Center, Tehran University of Medical Sciences|Mohammad Reza Khatami MD|00982161192659|khatami@hbi.ir|
20161328|NCT03562793|Richard L. Roudebush VA Medical Center|Dr. Marianne Matthias|317-988-4514|Marianne.Matthias@va.gov|
20161329|NCT02068118|CDM e-Health|Clinical Development Physician|33 (0) 1 39 07 62 86|fralsi-ctpublication@airliquide.com|
20161330|NCT00140842|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
20161331|NCT00283868|University of California, San Diego|Brett C. Meyer, MD|619-543-7760|bcmeyer@ucsd.edu|
20161332|NCT00453973|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20161333|NCT01656629|Johns Hopkins University|Dr. Suzanne Jan De Beur|410-550-0100|sjandebe@jhmi.edu|
20161334|NCT01219933|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20161335|NCT00686842|AMC|Susan Krown, MD, Protocol Chair|301-251-1161|amcpm@emmes.com|
20161336|NCT01443130|University of Maryland School of Medicine|Miriam K. Laufer, MD, MPH|410-706-5333|mlaufer@medicine.umaryland.edu|
20161337|NCT00685373|Novartis Pharmaceuticals|Study Director|862-778-8300||
20161338|NCT02758301|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|6123003066|lindsay.k.werder@medtronic.com|
20175356|NCT04664998|University of Washington|Dr. Renee Heffron|2065203817|rheffron@uw.edu|
20175357|NCT03909165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175358|NCT00414661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220415|NCT03993379|CytomX Therapeutics|Lawrence Lu|(650) 515-3185|clinicaltrials@cytomx.com|
20220416|NCT03094637|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero MD/Professor|713-745-3428|ggarciam@mdanderson.org|
20220417|NCT00711880|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20220418|NCT00704132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20220419|NCT03348163|The University of Texas Health Science Center at Houston|Jordan Elizabeth Lake, MD, Associate Professor|(713) 500-6759|Jordan.E.Lake@uth.tmc.edu|
20220420|NCT04841577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20220421|NCT02054338|Institut de Recherche Pierre Fabre|Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
20220422|NCT00652340|Tragara Pharmaceuticals|Tracy Parrott|858-350-6919|tparrott@tragarapharma.com|
20220423|NCT03682107|Cincinnati Children's Hospital|Dr. Grant Paulsen|513-636-4578|Grant.Paulsen@cchmc.org|
20220424|NCT00879411|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220425|NCT01044264|Perrigo Company|Manager|718-960-0119|jonathan.schwartz@perrigo.com|
20220426|NCT04052334|Moffitt Cancer Center|John E. Mullinax, MD, FACS|813-745-4673|John.Mullinax@moffitt.org|
20220427|NCT05831774|Houston Methodist Hospital|Haley Goble|713-441-3930|hmgoble@houstonmethodist.org|
20220428|NCT00710866|British Columbia Centre for Disease Control|Danuta M Skowronski, MD|604-660-6067|danuta.skowronski@bccdc.ca|
20220429|NCT00337181|Thai Ministry of Public Health|Supachai Rerks-Ngarm|6629659571|supachai@health.moph.go.th|
20220430|NCT01307748|Oregon Health & Science University|Irina Chamine|503.577.6211|fonareva@ohsu.edu|
20220431|NCT02676765|Virginia Commonwealth University|Dr. Brant Ward|804-828-1941|brant.ward@vcuhealth.org|
20220432|NCT01128543|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220433|NCT02391987|Mayo Clinic|Charles J. Bruce|904-953-7227|bruce.charles@mayo.edu|
20220434|NCT01252277|University of Kansas Medical Center|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
20220435|NCT04487067|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220436|NCT03097991|University of South Florida|Dr. James McHale|7278734848|jmchale@usf.edu|
20220437|NCT00246324|LSU Health Sciences Center in Shreveport Department of Neurology|Alireza Minagar, MD|318-813-1481|aminag@lsuhsc.edu|
20220438|NCT00299130|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20220439|NCT02881840|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
20220440|NCT01098487|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220441|NCT02906241|Wayne State University/Karmanos Cancer Institute|Susan Eggly, PhD|313-576-8260|egglys@karmanos.org|
20220442|NCT03301623|Cedars-Sinai Medical Center|Brennan Spiegel|310-423-6467|brennan.spiegel@cshs.org|
20220443|NCT02516553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175359|NCT00654069|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
20220444|NCT01203020|WV Cancer Institute|Abraham Kanate|3049065228|tlr0011@hsc.wvu.edu|
20220445|NCT03532373|Stanford University|Robin Kamal|650-721-7629|rnkamal@stanford.edu|
20220446|NCT03316547|Washington University|Roberta Pineda|314-286-1304|bobbi.pineda@chan.usc.edu|
20220447|NCT00996892|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20220448|NCT01653912|Novartis Pharma AG|Study Director|+41 613241111||
20220449|NCT00708227|Nemours Children's Specialty Care|Kathryn Blake|9046973806|kathryn.blake@nemours.org|
20220450|NCT04007991|Emalex Biosciences, Inc.|Clinical contact|7150562|dkim@emalexbiosciences.com|1847
20220451|NCT01987479|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20220452|NCT05314816|Medical College of Wisconsin|Dr. Kelly Graff|414-266-4123|kegraff@mcw.edu|
20220453|NCT02017015|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20220454|NCT03102606|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
20220455|NCT03104400|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20220456|NCT02013817|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20175360|NCT02130765|Abbott|Senior Clinical Research Scientist|6517562885|amber.miller@abbott.com|
20175361|NCT00915798|UC Irvine|Dr. Jean Gehricke|949-267-0404|jgehrick@uci.edu|
20220457|NCT01125371|Johns Hopkins University|Dr. Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
20220458|NCT01582152|The University of Texas (UT) MD Anderson Cancer Center|Dr. Alfred Yung, Clinical Professor, Neuro-Oncology|713-792-7734|wyung@mdanderson.org|
20220459|NCT02237092|Tver Regional Perinatal Center|Dr. Alexandr Ronenson|011-7-4822-776213|ronensonam@gmail.com|
20220460|NCT03577301|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
20220461|NCT01608061|Functional Neuromodulation|Todd Langevin|7636071214|todd@fxneuromod.com|
20220462|NCT00794339|ACR|Donna Hartfeil|215-717-2765|dhartfeil@acr.org|
20220463|NCT01611857|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
20220464|NCT02439970|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20220465|NCT02934191|Children's Hospital of Philadelphia|Dr. John Germiller|215-590-3440|germiller@email.chop.edu|
20175362|NCT01764607|University of Florida|Priya K Gopalan|352-273-8699|gopalpk@ufl.edu|
20220466|NCT02952586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220467|NCT01931878|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
20175363|NCT00167934|Washington University School of Medicine|Michael Yingling|573-579-1412|yinglingm@wustl.edu|
20220468|NCT00841828|Department of Medical Oncology, Hospital Universitario Virgen de la Victoria|Dr. Emilio Alba||emilioalbac@gmail.com|
20220469|NCT04414618|RedHill Biopharma Ltd.|Vered Katz Ben-Yair|+13474144462|vered@redhillbio.com|
20220470|NCT00362336|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20220471|NCT00658879|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220472|NCT02640690|Atlanta VA Health Care System|Dr. Ursula Kelly|4047272715|ukelly@emory.edu|
20220473|NCT01118975|University of Maryland|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20220474|NCT01645787|Columbia University|Claudia A. Chiriboga, MD, MPH|(212) 305-8549|cac3@columbia.edu|
20220475|NCT04902014|Colorado State University|Dr. Kayla Nuss|9705814824|kayla.nuss@colostate.edu|
20220476|NCT04315506|Duke University|Devon Noonan|919-684-3786|devon.noonan@duke.edu|
20220477|NCT02661217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20220478|NCT00377832|Weill Cornell Medical College|Daniel W. Skupski, MD|718-670-1495|dwskupsk@med.cornell.edu|
20220479|NCT02032680|VA, University of Pittsburgh|Dr. Armando Rotondi|412-360-2494|ArmandoRotondi1@gmail.com|
20220480|NCT03086486|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
20220481|NCT00719615|University of Nebraska Medical Center|Whitney S Goldner, MD|402-559-6205|wgoldner@unmc.edu|
20220482|NCT00687830|Cleveland Clinic Florida|Dr. Shibu Varughese and Dr. Anand Kumar|305-310-1238|akuma003@fiu.edu|
20220483|NCT00626808|MedImmune, LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
20220484|NCT05560386|Icahn School of Medicine at Mount Sinai|Nita Vangeepuram|917-478-2106|nita.vangeepuram@mssm.edu|
20220485|NCT00626561|University of Texas MD Anderson Cancer Center|Michael M. Frumovitz, MD / Professor, Gynecologic Oncology|713-792-9599|CR_Study_Registration@mdanderson.org|
20220486|NCT01598194|UT MD Anderson Cancer Center|Weston,Brian,MD / Gastroenterology Hepatology & Nutrition|713-792-7734|BWESTON@MDANDERSON.ORG|
20220487|NCT01372748|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
20220488|NCT00134901|New York State Psychiatric Institute|Dr Adam Bisaga|(646) 774-6155|bisagaa@nyspi.columbia.edu|
20189727|NCT02397707|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20189728|NCT05169684|Bristol Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20220489|NCT02604407|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20220490|NCT00606632|Heidelberg Pharma AG (former Wilex AG)|Head of R&D||info@hdpharma.com|
20220491|NCT02268877|Denver Health and Hospital Authority|Dr. John Kendall|(303)602-5187|John.Kendall@dhha.org|
20220492|NCT02779166|Northwestern Univeristy Department of Orthopaedic Surgery|Dr. Michael Terry|312-926-4444||
20220493|NCT03908437|University of Pennsylvania, Dpt of Psychiatry, Perelman School of Medicine|Dr. David Metzger, Research Professor, Director of HIV Prevention Research Unit|215-746-7355|dsm@pennmedicine.upenn.edu|
20220494|NCT00442962|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20220495|NCT04238650|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
20220496|NCT03633825|Harvard University|Principal Investigator|617-496-4484|jaroszewski@fas.harvard.edu|
20220497|NCT02756208|Institute of Human Virology|Dr. Mohammad Sajadi|410-7061779|msajadi@ihv.umaryland.edu|
20220498|NCT02585778|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20220499|NCT00356525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220500|NCT02281422|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20220501|NCT02614924|UHCW NHS Trust|Dr Ratidzo Danha|02476 964000|Ratidzo.Danha@uhcw.nhs.uk|25871
20220502|NCT00214383|University of Wisconsin - Madison|Alice Pulvermacher|(608) 262-8448|alice.pulvermacher@chess.wisc.edu|
20220503|NCT01038297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220504|NCT03431493|Johns Hopkins University|Ann Parker, MD, PhD|443-287-2616|aparke36@jhu.edu|
20157546|NCT02903823|Vanderbilt University Medical Center|Peter Konrad, MD PhD - PI|6153439822|peter.konrad@vumc.org|
20157547|NCT01823107|DSM Biomedical|Forde Hansell|484-713-2152|forde.hansell@dsm.com|
20157548|NCT00256126|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20157549|NCT02154061|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20157550|NCT02133573|Children's Hospital of Philadelphia|Dr. J. William Gaynor|215-590-5806|gaynor@chop.edu|
20175364|NCT04514991|University of Pennsylvania- Endodontic Department|Dr. Bekir Karabucak|2158984927|bekirk@upenn.edu|
20175365|NCT03216850|University Hospital Hradec Kralove|Dr. David Astapenko|+420495833218|astapenko.d@seznam.cz|
20175366|NCT01116232|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|404-778-5984|zalkadh@emory.edu|
20175367|NCT03554291|University of Washington|Peter Leary|206-685-2484|learyp@uw.edu|
20175368|NCT02074995|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20175369|NCT01751386|National Institute on Alcohol Abuse and Alcoholism|Lorenzo Leggio|+1 301 435 9398|lorenzo.leggio@mail.nih.gov|
20175370|NCT01398956|UCB Cares|UCB (Study Director)|+1887822||9493
20175371|NCT00451035|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20175372|NCT03274986|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20175373|NCT00603746|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175374|NCT05233566|Washington University School of Medicine|Dr. Bradley Fritz|3142733453|bafritz@wustl.edu|
20175375|NCT01524627|UPenn|Teresa R. Franklin, Ph.D.|215-746-1883|teresafr@mail.med.upenn.edu|
20175376|NCT00969553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175377|NCT00717769|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20175378|NCT01076504|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20175379|NCT03639766|University of Central Florida|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
20175380|NCT01251588|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
20175381|NCT02769702|Washington University School of Medicine|Richard Brasington MD|314-454-7255|rbrasing@wustl.edu|
20175382|NCT03350503|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20175383|NCT04010266|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
20175384|NCT03829046|Icahn School of Medicine at Mount Sinai|Dr. Qinzhong Chen|212-659-8864|qinzhong.chen@mssm.edu|
20175385|NCT02679911|Galderma|Farzaneh SIDOU Clinical Project Manager|0493957051|farzaneh.sidou@galderma.com|33
20220505|NCT01685840|Duke University Health System|G. Michael Felker, M.D.|919-668-8919|michael.felker@duke.edu|
20175386|NCT01399593|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
20175387|NCT02766244|Texas Tech University Health Sciences Center|Dr. Sharmila Dissanaike|8067435609|sharmila.dissanaike@ttuhsc.edu|
20175388|NCT00638885|Atlanta VAMC|J Douglas Bremner MD|404-712-9569|jdbremn@emory.edu|
20175389|NCT02357147|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20175390|NCT04399928|Smith & Nephew|Fleur Derdeyn, Clinical Study Manager|+32497602032|fleur.derdeyn@smith-nephew.com|
20175391|NCT05965349|University of Washington|Dr. Linda Ko|2066854978|lindako@uw.edu|
20175392|NCT03962543|SpringWorks Therapeutics, Inc.|Head of Clinical Operations|8772794870|clinical@springworkstx.com|
20175393|NCT04482179|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
20175394|NCT01302964|Massachusetts General Hospital|Christopher J. McDougle, MD|781-860-1783|cmcdougle@mgh.harvard.edu|
20175395|NCT04718870|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20175396|NCT04127786|Sanofi Pasteur|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
20175397|NCT05124665|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
20175398|NCT03641378|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@mgb.org|
20175399|NCT01433107|Novartis|Clinical Project leader|+41223633111||
20175400|NCT02789176|University of Michigan|Stephanie Rau|734-232-8474|shatchew@med.umich.edu|
20175401|NCT05194020|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
20175402|NCT00596011|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
20175403|NCT02347527|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristina.legget@cuanschutz.edu|
20175404|NCT00348556|Mayo Clinic|Dr. Horng Chen|507-284-8846|chen.horng@mayo.edu|
20175405|NCT00192075|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20175406|NCT01944059|University Cincinnati Physicians Company|Vincent Martin, MD|513-558-7581|vincent.martin@uc.edu|
20175407|NCT01818804|Aalborg University hospital|Salome Kristensen, MD. PhD|+45 97664015|sakr@rn.dk|
20175408|NCT02633956|Intercept Pharmaceuticals, Inc|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20175409|NCT02224872|Johns Hopkins University|Amy DeZern|4105027208|Adezern1@jhmi.edu|
20175410|NCT04118010|Emory University|Dr. Vin Tangpricha|404-727-7254|vtangpr@emory.edu|
20175411|NCT04206293|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20175412|NCT02111252|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
20175413|NCT00430092|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
20175414|NCT01857258|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
20175415|NCT03097653|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Paola Mosconi and Dr. Anna Roberto|+390239014503|donnainformata-mammografia@marionegri.it; paola.mosconi@marionegri.it|
20175416|NCT00706966|University of California San Francisco|Mack Roach, MD|415-353-9855|tdiep@radonc.ucsf.edu|
20175417|NCT01631474|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20175418|NCT03795610|University of California, San Diego|Dr. Assuntina Sacco|(858) 822-6100|agsacco@health.ucsd.edu|
20175419|NCT00559962|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867||
20175420|NCT03047135|Johns Hopkins University|Catherine Handy Marshall, MD|410-955-0231|chm@jhmi.edu|
20175421|NCT00323414|Cleveland Clinic Foundation|Srinivasan Dasarathy MD|216-444-2766|dasaras@ccf.org|
20175422|NCT02659020|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20175423|NCT01077960|EMD Serono|EMD Serono Medical Information|1-888-ASK-SERO (275-7376)||
20175424|NCT05619692|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
20175425|NCT01246791|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
20175426|NCT04049760|Amicus Therapeutics, Inc.|Patient Advocacy|001 609-662-2000|clinicaltrials@amicusrx.com|
20175427|NCT02457598|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20175428|NCT01589302|The Ohio State University Comprehensive Cancer Center|Kami Maddocks, MD|614-293-3507|Kami.Maddocks@osumc.edu|
20175429|NCT02703636|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20175430|NCT00868621|Cleveland Clinic Florida|Gamal M. Ghoniem, MD, FACS|954-659-5188|ghonieg@ccf.org|
20175431|NCT00748956|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-659-9145|adriana.feder@mssm.edu|
20175432|NCT02561130|McMaster University|Natalia McInnes|905-521-2100|natalia.mcinnes@mcmaster.ca|
20175433|NCT02016963|Human Genome Sciences Inc.|GSK Response Center|866-435-7343||
20175434|NCT00384813|Emory University School of Medicine|Marianne Celano, PhD, ABPP|404-778-1536|mcelano@emory.edu|
20175435|NCT01537783|Brigham and Women's Hospital|Scott Weiner, MD, MPH|617-732-5640|sweiner@bwh.harvard.edu|
20175436|NCT03664752|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20175437|NCT02321462|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
20205746|NCT04015440|Walter Reed Army Institute of Research|Jeffrey M Osgood, Ph.D. Associate Director of Military Psychiatry Branch|301-319-7475|jeffrey.m.osgood.mil@mail.mil|
20205747|NCT00992186|Centocor Research & Development, Inc., PA, USA|Senior Director, Early Clinical Development Global Leader|+1-908-927-3159||
20205748|NCT00756496|Siemens Medical Solutions USA, Inc.|Milind Dhamankar|+1 (610) 448-6467|milind.dhamankar@siemens-healthineers.com|
20205749|NCT05127421|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20205750|NCT02235987|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
20205751|NCT01802554|University of California San Diego|Brent T Mausbach, PhD|858-822-7529|BMausbach@ucsd.edu|
20205752|NCT01632735|Azusa Pacific University|Dr. Rachel Gonzales Castaneda|6268156000|rcastaneda@apu.edu|2744
20205753|NCT00574496|Memorial Sloan Kettering Cancer Center|Dr. Miguel-Angel Perales, MD|646-608-3757|peralesm@mskcc.org|
20205754|NCT01848899|NYU Langone Medical Center|Binita Shah|212-263-4235|binita.shah@nyumc.org|
20205755|NCT02815293|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
20205756|NCT02431468|Neurotrope BioScience, Inc.|David Crockford, Vice President, Regulatory Affairs|(973)242-0005|dcrockford@neurotropebioscience.com|
20205757|NCT03180489|Colorado State University|Christopher Bell|9704917522|christopher.bell@colostate.edu|
20205758|NCT00006604|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20205759|NCT01056341|Pierre Fabre Dermatologie|Dr. Jean-Jacques VOISARD - General Manager -|+33 5 63 58 88 00|jean.jacques.voisard@pierre-fabre.com|
20205760|NCT01086150|Albany Medical College|Charles E. Argoff, MD|518 262-0034|argoffc@mail.amc.edu|
20205761|NCT00736580|West Virginia University|Michael Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
20205762|NCT01770691|ConTIPI LTD.|Dr. Elan Ziv|972-4-627-6066|eziv@contipi.com|
20205763|NCT03543358|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20205764|NCT02260648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205765|NCT05128682|Beaumont Hosptials|Jennifer Giordano CRM|248-551-3517|jennifer.giordano@corewellhealth.org|
20205766|NCT02763072|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20205767|NCT00643604|United Therapeutics Corporation|Remodulin Program Leader|919-485-8350|clinicalrecordsmanagement@unither.com|
20205768|NCT03450915|BiondVax Pharmaceuticals ltd.|Chief Scientific Officer & Clinical Management|+97289302529|benyedidia@BiondVax.com|5103
20205769|NCT03095053|Antalya IVF|Kevin Coetzee|090 530 764 3135|kevincoetzee61@yahoo.co.nz|
20205770|NCT01054976|Jan-Cil Korea|Business Unit Director|82 2 2094-4537||
20205771|NCT01164865|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
20205772|NCT00171314|Novartis Pharamaceuticals|Novartis Pharmaceuticals|862-778-8300||
20205773|NCT00377429|Fresenius Biotech|Anne Kuan|781 699 4618|anne.kuan@fresenius-biotech.com|
20205774|NCT02618343|UT Health San Antonio|David Wampler, PhD, LP|210-414-9548|wamplerd@uthscsa.edu|
20205775|NCT02394795|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20205776|NCT05202223|University of Kentucky|Dr. Elizabeth Rhodus|859-257-5562|elizabeth.rhodus@uky.edu|
20205777|NCT02939599|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20205778|NCT01669811|Clinical Statistics & Programming Department, Clinical Science Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
20205779|NCT03828149|Novus Therapeutics|Clinical Director|949-679-1110|study001@novustherapeutics.com|
20205780|NCT01998269|University of North Carolina at Chapel Hill|Dr. Stacy Bailey|919-843-9834|scbailey@unc.edu|
20205781|NCT02559206|Ironwood Pharmaceuticals, Inc.|Nick Omniewski, MPH|(617) 621-8454|nomniewski@ironwoodpharma.com|
20205782|NCT02024204|NYU Langone|Joan Reibman, MD|212-263-6479|joan.reibman@nyumc.org|
20205783|NCT01064076|Cameron Health, Inc. a subsidiary of Boston Scientific|Michael Husby, Clinical Studies Manager|312-402-1877|michael.husby@bsci.com|
20205784|NCT00547898|Valeant Pharmaceuticals|Johnson Varughese|9089271162|christine.hnatko@valeant.com|
20205785|NCT01874119|Saint Louis University|Dr. John Richart|314-577-8854|richartj@slu.edu|
20205786|NCT01002742|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20205787|NCT02670928|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20205788|NCT02678312|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20205789|NCT00700063|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20175438|NCT02469116|Washington University School of Medicine|David G. Mutch, M.D.|314-362-3181|mutchd@wustl.edu|
20205790|NCT02966353|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20175439|NCT04425746|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
20175440|NCT01183169|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20175441|NCT01514396|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
20175442|NCT00692770|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20175443|NCT04248816|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
20175444|NCT04327986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
20175445|NCT00834912|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20175446|NCT03044197|UTexasGalveston|Lori Simon|409-772-1978|lasimon@utmb.edu|
20175447|NCT04492891|Baylor College of Medicine|Michelle Almarez: Clinical Research Manager|713-798-3680|malmarez@bcm.edu|
20175448|NCT00262067|Genentech, Inc.|Medical Communications|800 821-8590||
20175449|NCT00816101|Sheftel Associates Dermatology, LLC|Scott Sheftel, MD|520-293-5757|ssheftel@sheftelderm.com|7106
20175450|NCT02849548|Howard University|Ihori Kobayashi|202-865-7185|ihori.kobayashi@gmail.com|
20175451|NCT00714259|UAB|William Vaughan, MD|20-934-0066|liwilliams@uabmc.edu|
20175452|NCT03750903|Department of Veterans Affairs|Dr. Joe Nocera, PI|404 321 6111|joe.nocera2@va.gov|121662
20175453|NCT00256698|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20175454|NCT00705107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20175455|NCT04477304|University of Southern California|Jason Doctor|(213) 821-8142|jdoctor@usc.edu|
20175456|NCT02777125|University of Tennessee Health Sciences College of Medicine/Le Bonheur Children's Hospital|Mark Snider DO, Principal Investigator|9012875986|marksnider02@hotmail.com|
20175457|NCT05168475|Cambridge University Hospitals NHS Foundation Trust|Professor David Jayne|01223 336816|dj106@cam.ac.uk|
20175458|NCT01589822|Ethicon|Director of Clinical Development|1 908 218-2492|JBatill2@its.jnj.com|
20175459|NCT01140477|Bausch & Lomb, a division of Valeant Corporation|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
20175460|NCT05723770|Bausch & Lomb|Megan Cavet|5852849474|Megan.Cavet@bausch.com|
20175461|NCT01076985|Abbott|Global Medical Services|800-633-9110||
20175462|NCT01982253|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@takeda.com|
20175463|NCT03848845|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20175464|NCT00779675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175465|NCT01569529|University of Illinois at Chicago, Institute for Health Research and Policy|Dr. Robin Mermelstein|312 996-1469|robinm@uic.edu|
20175466|NCT02267629|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor, Director of Rodriguez Translational Therapeutics Lab|650-723-6158|cr2163@stanford.edu|
20175467|NCT02365636|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20175468|NCT03863210|University of Split School of Medicine|Dr. Slavica Jurić Petričević||slavica.juric01@gmail.com|
20175469|NCT05028374|Karmanos Cancer Institute|Dr. Jeffery Zonder|313-576-8732|zonderj@karmanos.org|
20175470|NCT03427658|Bournemouth University|Dr Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
20175471|NCT00355238|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20175472|NCT01454934|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20175473|NCT01956110|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20175474|NCT01163604|jinling hospital|xinfeng Liu|025-84801861|xfliu2@vip.163.com|
20175475|NCT00742313|Duke University Medical Center|Terry Ainsworth, Director, Clinical Research Operations, Education & Training|919-681-7084|terry.ainsworth@duke.edu|
20175476|NCT04587934|Sharp Healthcare|Dr. Anup Katheria|858-939-4170|Anup.Katheria@sharp.com|
20175477|NCT03325166|Oregon Health and Science University|Gerda Teglassy, MD|503-494-4526|tothg@ohsu.edu|
20175478|NCT01633944|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20175479|NCT01436279|Boston Medical Center|Olivera Vragovic|617 414 7304|Olivera.Vragovic@bmc.org|
20220506|NCT03423186|Swedish Orphan Biovitrum AB|Anders Bröijersén, Medical Director|+46 8 697 20 00|anders.broijersen@sobi.com|
20175480|NCT02096458|Takeda Development Center Americas, Inc.|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
20175481|NCT00463060|Good Samaritan Hospital Medical Center|Dr. Johnny Kao|(631) 376-4444|johhny.kao@chsli.org|
20175482|NCT01400841|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
20175483|NCT00701129|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20175484|NCT00910715|UMC Ljubljana, Department of Infectious Diseases|Dr.Dasa Stupica|+386 1 522 2110|cerar.dasa@gmail.com|
20175485|NCT02884089|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20175486|NCT01467076|Wayne State University|Beena Sood, M.D.|313-745-5638|bsood@med.wayne.edu|
20175487|NCT03354429|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20175488|NCT02624284|University of Pennsylvania|Mary Falcone, Ph.D.|215-746-3782|mfalc@pennmedicine.upenn.edu|
20175489|NCT05923229|Washington University School of Medicine|Kerri Rawson|314-273-1053|rawson@wustl.edu|
20220507|NCT04252092|Eksen Sağlık ve Rehabilitasyon|PT,Cansu Hayıroğlu|+905378405948|cansu5309@gmail.com|
20220508|NCT03340974|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
20220509|NCT02374346|Attikon Hospital|P. Matsota|00302105831000|matsota@yahoo.gr|
20220510|NCT03473015|Oxford Heart Centre, Oxford University Hospitals, Oxford, United Kingdom|Professor Adrian Banning|1865 228934|adrian.banning@ouh.nhs.uk|+44
20175490|NCT03064126|Boston Scientific|Cynthia Peterson|763-955-8233|Cynthia.Peterson@bsci.com|
20175491|NCT04508725|Stanford University|Dr. Alice Fan|(650) 498-6000|afan@stanford.edu|
20175492|NCT05288556|Cleveland Clinic|Eric Yudelevich Blumrosen, MD|216 445-6914|YUDELEE@ccf.org|56914
20220511|NCT00396565|Janssen Pharmaceutical K.K.|Director of Clinical R&D Dept. 3|81-3-4411-5652||10118
20220512|NCT00345631|Cordis Corporation, a Johnson&Johnson company|Hans-Peter Stoll, M.D.|908-541-4770|hpstoll@its.jnj.com|
20220513|NCT00517556|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
20220514|NCT01885195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220515|NCT01589497|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20220516|NCT03390426|Duke University Medical Center|William Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
20220517|NCT02593682|University of California, San Francisco|Dr. Andrew Goddard|(317) 274-3960|agoddard@fresno.ucsf.edu|
20220518|NCT03052127|Aura Biosciences|Uma Chandrasekaran, Director, Clinical Development Scientist|706-294-3454|UChandrasekaran@aurabiosciences.com|
20220519|NCT02521376|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20161339|NCT00364533|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-6780||
20220520|NCT03131544|Prostate Laser Center, PLLC|Dr. Ara Karamanian, Medical Director of the Prostate Program|(713) 904-4014|drkaramanian@halodx.com|
20220521|NCT02759692|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO|904 443-1290|BPALL@its.jnj.com|
20161340|NCT00582738|Pharmaceuticals|Novartis|41613241111||
20161341|NCT03412097|Parker University|Dr. Katherine A Pohlman|972 438 6932|kpohlman@parker.edu|7148
20175493|NCT02465528|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20175494|NCT02650986|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
20175495|NCT03817320|TACL|TACL|3233615429|TACL@chla.usc.edu|
20175496|NCT02845752|The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Dr. Harry Rossiter|3102228200|hrossiter@lundquist.org|
20175497|NCT01428193|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
20175498|NCT03762083|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
20175499|NCT02027844|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Deagu, Repulic of Korea|Sun Mee Jung, M.D.|+82-53-620-3368|applejsm@gmail.com|
20175500|NCT03837899|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20175501|NCT01554618|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20175502|NCT00477672|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
20175503|NCT03078946|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
20175504|NCT02722928|The Ohio State University Wexner Medical Center|Juan Fiorda-Diaz Postdoctoral Researcher|6142933559|juan.fiorda@osumc.edu|
20175505|NCT04011410|University of Kentucky College of Medicine|Patrick Hensley|859-562-3223|patrick.hensley@uky.edu|
20175506|NCT02275481|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20175507|NCT01838642|National Cancer Institute|Dr. James Gulley|301-496-4916|gulleyj@mail.nih.gov|
20175508|NCT01495585|National Insitute of DIabetes and Digestive and Kidney Diseases|Dr. Theo Heller|301-402-7147|hellert@mail.nih.gov|
20175509|NCT01215227|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175510|NCT00291668|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20175511|NCT00704028|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20220522|NCT03245827|Saint Louis University|Sandeep Dhindsa|716-977-4911|sandeep.dhindsa@health.slu.edu|
20220523|NCT00553735|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@MEEI.Harvard.edu|
20220524|NCT01954745|Massachusetts General Hospital Cancer Center|Dr. Lipika Goyal|617-724-4000|Lgoyal@partners.org|
20161342|NCT03461406|Instituto Grifols, S.A.|Sandra Camprubi Gimenez|+34670923160|sandra.camprubi@grifols.com|
20161343|NCT01011933|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20161344|NCT01886690|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20161345|NCT01291836|Alere San Diego|William Arnold|858-505-2000|william.arnold@alere.com|
20161346|NCT02900170|Albert Einstein Medical Center|Basma Abdulhadi|215456500|abdulhab@einstein.edu|
20161347|NCT01814670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20161348|NCT00201123|NYU School of Medicine|William Rom MD|212 263-6479|William.Rom@nyumc.org|
20161349|NCT02012686|Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Republic of Korea|Dr Dong Woo Han|82-2-2019-3549|HANESTH@yuhs.ac|
20161350|NCT00966719|Children's Hospital of Eastern Ontario|Dr Catherine Pound|613-737-7600|cpound@cheo.on.ca|
20161351|NCT02945553|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
20161352|NCT01703065|University of Washington|Dr. Celestia Higano, MD|206-606-1152|thigano@u.washington.edu|
20161353|NCT01005212|Houston Methodist Research Institute - Heart Center Research|Bevin Lopez, Clinical Trials Manager|7134413912|balopez@houstonmethodist.org|
20161354|NCT00624416|Pennington Biomedical Research Center|Leanne Redman|225-763-0947|Leanne.Redman@pbrc.edu|
20161355|NCT00160199|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
20161356|NCT01710527|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161357|NCT02124772|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20161358|NCT02827500|Duke Clinical Research Institute|Dr. Robert Mentz|919-668-7121|robert.mentz@duke.edu|
20161359|NCT03343080|Mayo Clinic|Dr. Troy Seelhammer|507-255-6051|seelhammer.troy@mayo.edu|
20161360|NCT03089944|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20161361|NCT01636713|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189729|NCT03539055|Vanderbilt Cardiovascular Research Enterprise|Terry Weyand, MS., CCRP|6153229349|terry.l.weyand@vumc.org|
20175512|NCT00313612|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
20175513|NCT01557400|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20175514|NCT04155008|Montefiore Medical Center|Dr. Justin Tang|718-920-4094|jtang@montefiore.org|
20220525|NCT03764618|Rigel Pharmaceuticals, Inc.|Executive Director, Global Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
20175515|NCT00739752|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
20175516|NCT01393405|University of North Carolina, Chapel Hill, NC|Dr. Hans Herfarth|9199666806|hherf@med.unc.edu|
20175517|NCT01434290|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20220526|NCT04034927|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20220527|NCT02291510|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20220528|NCT03659929|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|1-800-461-7449|david.sequeira@azurity.com|
20220529|NCT04856930|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20220530|NCT01808547|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
20220531|NCT01009814|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20175518|NCT02281552|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175519|NCT01224639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20175520|NCT04365699|NYU Langone Health|Stuart Katz, MD|212-263-3946|Stuart.Katz@nyulangone.org|
20175521|NCT03761732|University of Washington|Lori Zoellner|206 685 3617|ContactUWCATS@uw.edu|
20175522|NCT03925727|Mimetogen Pharmaceuticals|VP Clinical Development|514 924 7484|karen.meerovitch@mimetogen.com|
20175523|NCT02581384|Dana-Farber Cancer Institute|Karen Marcus MD|16177328783|karen_marcus@dfci.harvard.edu|
20175524|NCT00624806|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
20220532|NCT00618371|University of Pittsburgh|Deborah McMahon|412-383-1675|mcmahond@pitt.edu|
20220533|NCT03055624|UCSD|Andrew Picel MD|619-543-3436|apicel@stanford.edu|
20220534|NCT01434810|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
20220535|NCT04036838|ARJ Medical, Inc.|President|813-855-1557|info@gulfcoastscientific.com|
20220536|NCT00979199|CNR Institute of Clinical Physiology, Pisa, Italy and Fondazione Toscana G. Monasterio, Pisa, Italy|Dr. Danilo Neglia|+390503152019|dneglia@ifc.cnr.it|2019
20220537|NCT05676814|Wake Forest University Health Sciences|Scott Coleman, DO|336-716-2712|srcolema@wakehealth.edu|
20220538|NCT02437903|Baumann Cosmetic and Research Institute|Leslie Baumann, MD|(305) 531-5788|studies@derm.net|
20220539|NCT04974749|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20220540|NCT00637494|Corcept Therapeutics|Thaddeus S. Block, MD|(650) 688-8816|tblock@corcept.com|
20220541|NCT00919126|University Hospital Schleswig-Holstein|Prof. Dr. Med Berthold BEIN|+49(0)431-5973 739|bein@anasthesie.uni-kiel.de|
20220542|NCT02559180|Cleveland Clinic Foundation|Rishi P Singh|772-223-5945|singhr@ccf.org|13014
20220543|NCT02075515|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220544|NCT01297985|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
20220545|NCT00741338|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20220546|NCT03593395|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20220547|NCT03713632|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20175525|NCT01574352|USouthernDenmark|professor Lars Bo Andersen|+45 60114380|lars.bo.andersen@hvl.no|
20175526|NCT05677425|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
20175527|NCT04036500|Medical College of Wisconsin|Jenna Sarvaideo, DO|414-955-7069|jsarvaideo@mcw.edu|7069
20175528|NCT02283788|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
20175529|NCT01369875|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20175530|NCT06034496|Center for Applied Brain and Cognitive Sciences|Research Assistant Professor|617-627-1059|kana.okano@tufts.edu|
20175531|NCT02018458|Baylor Scott and White Health|Dr. Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
20175532|NCT00116558|University of Kentucky|Edward J. Kasarskis, M.D., Ph.D.|859-218-5061|ejkas@uky.edu|
20175533|NCT00378014|Novartis Pharmaceuticals|Study Director|862-778-8300||
20175534|NCT00357370|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20175535|NCT01143090|Sunovion Pharmaceuticals Inc|Medical Director, CNS|1-866-503-6351||
20175536|NCT03491150|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20175537|NCT01054703|Acclarent|Laura England, Manager-Clinical Research|650-687-4466|lenglan1@its.jnj.com|
20175538|NCT00117143|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20175539|NCT00548860|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
20175540|NCT00727714|Telemark Hospital|Dr. Anne Kristin M. Fell, MD, PhD|+4735003106|annfel@sthf.no|
20175541|NCT01103934|University of Chicago|Robert M Naclerio, MD|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
20175542|NCT01265446|Novartis Consumer Health, Nyon, Switzerland|Clinical Project Leader|+41223633279|Rowland.Furcha@novartis.com|
20175543|NCT00325234|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20175544|NCT02662387|Loma Linda University Children's Hospital|Dr. Janeth Ejike|9095584000|jejike@llu.edu|44250
20175545|NCT02315768|UCSD|Dr. Thomas Kipps|858-534-5400|tkipps@ucsd.edu|
20175546|NCT02402452|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20175547|NCT02644967|Idera Pharmaceuticals, Inc|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
20189730|NCT03796767|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20175548|NCT02287896|LFB Biotechnologies|Clinical trial Information desk|33169825656|supportqcm@lfb.fr|
20175549|NCT05179421|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
20175550|NCT03746522|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20175551|NCT01639040|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20175552|NCT04135703|The Oho State University|Natasha Slesnick|6142478469|slesnick.5@osu.edu|
20175553|NCT05422053|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
20175554|NCT00486265|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20175555|NCT01452412|Albert Einstein College of Medicine|Michal Melamed, MD|718-430-2496|michal.melamed@einstein.yu.edu|
20189731|NCT00875706|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
20161362|NCT03689244|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20161363|NCT04498377|Evive Biotech|Jianmin Chen|6095124566|jianmin.chen@evivebiotech.com|
20161364|NCT02308488|NYU Langone Health - Perlmutter Cancer Center|Carmen A. Perez, M.D., Ph.D.|212-731-5003|Carmen.Perez@nyulangone.org|
20161365|NCT01541917|Children's Mercy Hospital|Mark Connelly, PhD (Principal Investigator)|816-234-3000|mconnelly1@cmh.edu|3193
20161366|NCT01739803|University of Tennessee College of Pharmacy|Marie Chisholm-Burns|901-448-7141|mchisho3@uthsc.edu|
20161367|NCT02011490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161368|NCT01244633|Psyadon Pharmaceuticals|Dr. Richard Chipkin|3019192020|rchipkin@psyadonrx.com|
20161369|NCT03283436|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
20161370|NCT03759041|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
20161371|NCT02378207|Desmond Tutu HIV Foundation, Cape Town, South Africa|Dr. Linda-Gail Bekker|+27214066959|linda-gail.bekker@hiv-research.org.za|
20161372|NCT01985763|Icahn School of Medicine at Mount Sinai|Dr. Sofya Pintova|212-824-8461|Sofya.Pintova@mountsinai.org|
20161373|NCT00525824|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20161374|NCT02645617|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
20161375|NCT00167661|University of Wisconsin - Madison|Dr. Sharon Bartosh|(608) 265-6020|smbartosh@wisc.edu|
20175556|NCT05132127|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20175557|NCT03013543|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20175558|NCT04087122|Valley Health|Rebekah Smith, RN, BSN|540-536-5547|rsmith3@valleyhealthlink.com|
20175559|NCT02552316|University of Pennsylvania|Junko Takeshita|215-349-5551|Junko.Takeshita@pennmedicine.upenn.edu|
20175560|NCT04382911|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20175561|NCT04521166|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
20175562|NCT02614547|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20175563|NCT00577083|Indiana University|Douglas K Rex, MD|317-948-8741|drex@iu.edu|
20175564|NCT01120210|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Translational Medicine|858.320.3408|wradzisz@its.jnj.com|
20175565|NCT06219915|University of Michigan|Principle Investigator|734-998-8400|pchatkae@umich.edu|
20175566|NCT05320029|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
20189732|NCT03775213|Duke University|Dr. Marc D. Ryser|(919) 684 8294|marc.ryser@duke.edu|
20189733|NCT00786188|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
20189734|NCT01990794|Cardno|Dr. David Galbraith|415-618-3211|david.galbraith@cardno.com|
20189735|NCT01742832|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
20189736|NCT05163353|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20189737|NCT02790281|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20189738|NCT06086028|Tulane University|Leia Y. Saltzman Associate Professor|504-247-1452|lsaltzman@tulane.edu|
20189739|NCT00824408|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189740|NCT04821271|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
20189741|NCT05640167|University of Rhode Island|Dr Christine Clarkin, Principal Investigator|4018742998|chrisclarkin@uri.edu|
20189742|NCT02521493|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20189743|NCT04083781|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20189744|NCT03530631|University of Alabama, Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uabmc.edu|
20189745|NCT00286325|Duke University Medical Center|Dr. Russell P Hall|919-684-3110|hall0009@mc.duke.edu|
20189746|NCT02334215|Friends Research Institute|Robert P. Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
20189747|NCT05615363|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20189748|NCT01836445|Northwestern University|Dr. Brian Mustanski|312-503-5421|brian@northwestern.edu|
20189749|NCT04602728|Emory University|Soumitri Sil, PhD|404-727-2712|soumitri.sil@emory.edu|
20189750|NCT06716632|Gulab Devi Hospital, Lahore|Dr. Zain Himayoun|03043862033|Zain.1080@gmail.com|
20189751|NCT05289037|The Hope Clinic of Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20189752|NCT04937504|Boston Medical Center, Psychiatry Department|Sarah Valentine, PhD|(617) 414-1989|sarah.valentine@bmc.org|
20189753|NCT00070707|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20189754|NCT03690219|Rehabilitation Research Laboratory, University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Ron Clijsen|0041 81 300 01 78|ron.clijsen@supsi.ch|
20189755|NCT04809623|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20189756|NCT01928732|Palo Alto CSPCC|Lisa Zehm|(650) 493-5000|Lisa.Zehm@va.gov|28805
20189757|NCT01185340|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20189758|NCT01719172|Covidien|Julie Totten|781-839-1729|Julie.Totten@Covidien.com|
20189759|NCT01148017|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20189760|NCT01848483|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
20189761|NCT05062161|Columbia University Medical Center|Marwah Abdalla|212 342 1275|ma2947@cumc.columbia.edu|
20189762|NCT01093690|Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University|Suthinee Ithimakin, MD|6624197000|aesi105@yahoo.co.th|4489
20189763|NCT00246129|imperial College Kidney & Transplant Centre|Dr Adam McLean|+44 (0) 208 383 5164|adam.mclean@imperial.nhs.uk|356164
20189764|NCT03740737|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20189765|NCT03469258|Beth Israel Deaconess Medical Center|A. James Moser, MD|(617) 632-1032|ajmoser@bidmc.harvard.edu|
20189766|NCT00770874|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20189767|NCT02236611|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189768|NCT03041090|Saint Louis University|Medhat Osman, MD, PhD - Professor of Radiology, Director of Nuclear Medicine and PET/CT|314-577-8047|medhat.osman@health.slu.edu|
20189769|NCT03403036|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
20189770|NCT01128959|Lundbeck LCC|Lundbeck LLC|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20189771|NCT02338999|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Kaplan, Mariana|+1 301 496 0517|mariana.kaplan@nih.gov|
20189772|NCT02701296|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Sanjay Sinha, MD||sanjaysinha@comcast.net|
20189773|NCT01409837|University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu|Dr. Anthony Mbah, Principal investigator|2348051519065|cmd_unth@yahoo.com|
20189774|NCT01682928|Mednax|Ana Braescu|480-969-5999|ana_braescu@mednax.com|
20189775|NCT01335061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189776|NCT03490032|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20189777|NCT00308308|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20189778|NCT02551224|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20202896|NCT02117050|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20175567|NCT06105528|ProMIS Neurosciences, Inc.|Wendy Luca|617-250-0365|promisclinical@promisneurosciences.com|
20175568|NCT04697628|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175569|NCT00974571|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175570|NCT00393939|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175571|NCT02385799|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
20175572|NCT00547703|Cleveland Clinic Florida|Fernando Castro|954-659-5646|castrof@ccf.org|
20175573|NCT02471521|Seoul National University Hospital|Jin-Tae Kim|82-2-2072-3661|jintae73@gmail.com|
20175574|NCT03985813|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
20175575|NCT02161718|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
20175576|NCT02151526|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20175577|NCT00283933|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20175578|NCT00409292|Dana-Farber Cancer Institute|Brian Wolpin, MD|617-632-3000|brian_wolpin@dfci.harvard.edu|
20175579|NCT02350309|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20175580|NCT01256710|Abbott Medical Devices, Structure Heart Valves|Yunlong (Phil) Zhang, MD, MS, Clinical Consultant|669-203-9308|phil.yl.zhang@abbott.com|
20189779|NCT01021748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189780|NCT01829711|MedImmune, LLC|Priti Patel|+1-650-264-9079|information.center@astrazeneca.com|
20189781|NCT01482091|Albert Einstein College of Medicine/Children's Hospital at Montefiore|Dr. Daniel Fein|718-920-5312|dfein@montefiore.org|
20189782|NCT02935673|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189783|NCT04679675|Kaiser Permanente Washington Health Research Institute|Dr. Beverly Green|206-220-2997|bev.b.green@kp.org|
20189784|NCT00529204|University of California Davis Medical Center|Christopher L. Bowlus, MD|916-734-8986|chris.bowlus@ucdmc.ucdavis.edu|
20189785|NCT01702259|Surgeon's Inc.|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
20189786|NCT03909100|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20189787|NCT03259568|Dept of Neurology, Duke University School of Medicine|Simon W Davis|9195991927|simon.davis@duke.edu|
20189788|NCT04248868|Eminence Clinical Research, Inc.|Christopher A. Schultz|9715067552|cschultz@ecr-inc.com|
20189789|NCT04347941|National University of Ireland, Galway|Dr Bairbre McNicholas|+35391893063|bmcnicholas@nuigalway.ie|
20189790|NCT03128099|Vanderbilt University|Dr. Sohee Park, Project Director|6153223435|sohee.park@vanderbilt.edu|
20189791|NCT00089791|Amgen Inc.|Study Director|866-572-6436||
20189792|NCT02527694|Seoul National University Hospital|So Yeon Kong|82220724412|soyeon.kong@gmail.com|
20189793|NCT02070276|Hôpitaux Universitaires de Genève|Dr. med. Samuele Ceruti|0765661181|samuele.ceruti@me.com|
20189794|NCT02362789|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20189795|NCT00407485|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20189796|NCT00621842|Case Western Reserve University|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
20189797|NCT05074433|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20189798|NCT04397263|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20189799|NCT04806100|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20189800|NCT01235936|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
20189801|NCT02233998|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20189802|NCT00705159|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20189803|NCT03026166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20189804|NCT05270460|Processa Pharmaceuticals Inc.|Dr. Sian Bigora|410-693-6844|sbigora@processapharmaceuticals.com|
20189805|NCT00380250|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20189806|NCT03897699|University of Minnesota|Dr. Kathryn Cullen|612-273-9732|rega0026@umn.edu|
20189807|NCT00680771|University of rochester|Wilfred Pigeon|(585) 275-3374|Wilfred_pigeon@urmc.rochester.edu|
20189808|NCT02691702|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189809|NCT05613088|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20189810|NCT01668719|SWOG Statistics and Data Management Center|Myeloma Committee Statistician|2066674623|rachaels@crab.org|
20189811|NCT04603586|Changhai Hospital|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
20189812|NCT03205488|Northwestern University|Dr. Tanya Simuni|312-503-2970|Tatyana.Simuni@nm.org|
20220548|NCT01524978|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220549|NCT02995408|Massachusetts General Hospital|Karen Kuhlthau, PhD Researcher|6177242842|kkuhlthau@partners.org|
20220550|NCT04237272|Medical University of South Carolina|Dr. Tracy Smith|843 792 5164|smithtra@musc.edu|
20220551|NCT03066258|Regenxbio Inc.|Sherri Van Everen, PharmD/ Vice President of Clinical Development|240.552.8181|svaneveren@regenxbio.com|
20220552|NCT02165735|University of Rochester|Dr. Kevin Fiscella, PI|5853244563|kevin_fiscella@urmc.rochester.edu|
20220553|NCT02784795|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20220554|NCT00101283|ECOG Statistical Office|Study Statistician|617-632-3012||
20220555|NCT02540083|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
20220556|NCT02797171|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20220557|NCT00595309|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
20175581|NCT03023488|Marmara University, School of Medicine, Department of Urology|Dr. Tarik Emre Sener|+905337620712|dr.emresener@gmail.com|
20175582|NCT01205165|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175583|NCT04352140|Mayo Clinic|J. Ross Renew, M.D.|904-956-3325|Renew.J@mayo.edu|
20175584|NCT02681302|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20175585|NCT01736696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175586|NCT00838565|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175587|NCT00458484|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Mitchell Machtay MD|216-844-2530|mitchell.machtay@uhhospitals.org|
20175588|NCT03571516|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20175589|NCT02940327|University of Leicester|Clinical Trials Co-ordinator|0116 250 2427|ha200@le.ac.uk|
20175590|NCT02741115|Mezzion Pharmaceuticals, Inc|Director of Clinical Trials|5734342579|kelly.williams@mezzion.com|
20175591|NCT04976530|CytoSorbents Corp|Weihong Fan|732-329-8885|wfan@cytosorbents.com|
20175592|NCT04602624|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20175593|NCT06425458|Unity Health Toronto|Dr. Naomi Thulien|(416) 864-6060|naomi.thulien@unityhealth.to|77476
20175594|NCT05711927|Columbia University Irving Medical Center|Toni Iurcotta, MD|646-532-8196|ti2241@cumc.columbia.edu|
20175595|NCT03945981|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20175596|NCT00653224|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20175597|NCT00773175|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20175598|NCT00503841|Barbara Ann Karmanos Cancer Institute|Dr. Elaina Gartner|313-576-8724|egartner@seagen.com|
20175599|NCT03285373|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175600|NCT00326612|DIvision of Pediatric Emergency Medicine|Maija Holsti, MD, MPH|801-587-7450|maija.holsti@hsc.utah.edu|
20175601|NCT00419562|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
20175602|NCT00640510|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20175603|NCT01440322|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20175604|NCT03913078|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
20175605|NCT02412631|Mayo Clinic|Dr. Ryan Hurt|(507) 284-2511|gimresearchstudies@mayo.edu|
20175606|NCT00770120|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
20175607|NCT02619409|Medical University of South Carolina|Dr. Eric Bolin|8437922322|bolin@musc.edu|
20175608|NCT02995915|Duke University Medical Center|Angela Kirby, MS|(919) 824-7729|angela.kirby@duke.edu|
20175609|NCT01782313|Northwestern University|Mark Agulnik, MD|312 695 6182|magulnik@nm.org|
20175610|NCT00958776|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
20175611|NCT00480636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175612|NCT02583256|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20175613|NCT04027218|University|Ms. Leticia Carmen Simón López|+34 680721340|leticia.simon25@gmail.com|
20205791|NCT00081328|TODAY Coordinating Center at George Washington University Biostatistics Center|Dr. Kathryn Hirst, Coordinating Center PI|301-881-9260|khirst@bsc.gwu.edu|8025
20175614|NCT02177266|Mayo Clinic|Dr. Jae K. Oh|507-284-6055|oh.jae@mayo.edu|
20175615|NCT02744846|Harvard Pilgrim Health Care Institute|Dr. Jason Block|6178674841|jblock1@partners.org|
20189813|NCT03652610|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20189814|NCT00326183|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20189815|NCT01218594|Sun Yat-Sen University Cancer Center|Ming Chen|86-20-87343640|chenming@sysucc.org.cn|
20189816|NCT01450397|Hospital for Special Surgery|Scott W. Wolfe|212-606-1529|WolfeS@hss.edu|
20189817|NCT02203032|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20189818|NCT02241785|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20189819|NCT01640340|Ohio State University Medical Center|Rachel Layman, MD|614-293-0066|Rachel.Layman@osumc.edu|
20189820|NCT04748341|Lahore school of nursing, University of lahore, Pakistan|Ms. Mishal Liaqat (Principal Investigator)|+923441481666|mishee861@gmail.com|
20189821|NCT00452114|University of Massachusetts Medical School|Stephen Krinzman, Principal Investigator|508-856-1975|stephen.krinzman@umassmed.edu|
20189822|NCT04197713|University of M D Anderson Cancer Center|Dr. Timothy Yap|713) 563-1784|tyap@mdanderson.org|
20189823|NCT05940688|University of Alabama at Birmingham|Dr. Rachel Sinkey|(205) 934-5612|rsinkey@uabmc.edu|
20189824|NCT03365622|University of Rochester Medical Center|Joseph Dooley, MD|5852752141|joseph_dooley@urmc.rochester.edu|
20189825|NCT05376449|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
20189826|NCT06164743|VivaVisionBio|Dr. Joanne Li|(86) 021-58598290|joanne.li@vivavisionbio.com|
20189827|NCT00210236|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Palissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20189828|NCT02831049|National Institute on Drug Abuse (NIDA)|Dr David Epstein|1-667-312-5092|david.epstein@nih.gov|
20189829|NCT04025125|Duke University|Gerald Bloomfield|919-668-8702|gerald.bloomfield@duke.edu|
20205792|NCT00877006|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20205793|NCT01803854|Department of Veterans Affiairs, Office of Research and Development|Dr. Christina D. Williams, Acting Director of Cooperative Studies Program Epidemiology Center Durham|919-286-0411|christina.williams4@va.gov|175464
20205794|NCT05224076|University of Kansas School of Nursing|Dr. Barbara Polivka|6142049915|bpolivka@kumc.edu|
20205795|NCT01807949|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20205796|NCT02666508|UIC College of Dentistry|Kimberly Fasula RDH, MS, MPH|(312) 996-5513|kfasul1@uic.edu|
20175616|NCT03364049|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
20175617|NCT00546715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20175618|NCT00418691|UT MD Anderson Cancer Center|Jeffrey Wefel, PHD/ Associate Professor, Neuropsychology|713-563-0514|jwefel@mdanderson.org|
20175619|NCT01802775|Daiichi Sankyo Development Inc.|Clinical Trial Information|+44 1753482800|info@dsd-eu.com|
20175620|NCT01096784|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20175621|NCT03761628|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
20175622|NCT03307759|Peter MacCallum Cancer Centre|Clinical Research Development and Operations|+61 3 8559 5000|crdo@petermac.org|
20175623|NCT04649151|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20175624|NCT02975934|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
20175625|NCT03362502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175626|NCT03032796|University of California San Francisco|"Joaquin A. Anguera, Associate Professor, Neuroscape | UCSF"|415-502-7322|joaquin.anguera@ucsf.edu|
20175627|NCT00433654|Medtronic, Inc|EnRhythm MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
20220558|NCT00295061|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20175628|NCT03277261|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20175629|NCT02043015|Emory University|Patrick S Sullivan PhD/DVM|404-727-2038|pssulli@emory.edu|
20175630|NCT01403974|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20175631|NCT01990677|Wills Eye|Mitchell Fineman,MD|215-928-3092|research@midatlanticretina.com|
20175632|NCT01494610|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175633|NCT03995953|Implenomics|Sujha Subramanian|(302) 200 8310|sujha.subramanian@implenomics.com|
20220559|NCT01439581|Henry Ford Health System|Robert Behrendt|313-874-9537|Rbehren9@hfhs.org|
20220560|NCT02301390|Icahn School of Medicine at Mount Sinai|Betsy Ellsworth, Research Program Director|212-824-8902|betsy.ellsworth@mountsinai.org|
20220561|NCT00185588|Stanford University|George Albert Fisher, Associate Professor of Medicine, Stanford University|650-725-9057|georgeaf@stanford.edu|
20220562|NCT00398866|Hospital for Special Surgery|Dr. Lisa Mandl|2127742754|MandlL@hss.edu|
20220563|NCT02481869|University of Missouri|Dr. James Cook|5738827615|cookjl@health.missouri.edu|
20220564|NCT00191191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220565|NCT05246670|Geisinger Medical Center|Mellar P. Davis, MD, FCCP, FAAHPM|570-271-7383|mdavis2@geisinger.edu|
20220566|NCT04152291|Wihuri Research Institute|Professor Katariina Öörni|+358 40 7023711|kati.oorni@wri.fi|
20220567|NCT03597295|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
20220568|NCT05124691|Instituto de Salud Global de Barcelona - ISGLOBAL|Jose Muñoz|+34608774071|jose.munoz@isglobal.org|
20220569|NCT05211726|University of Delaware|Christopher Martens|302-831-7270|cmartens@udel.edu|
20220570|NCT03509467|Moffitt Cancer Center|Peter Kanetsky, PhD, MPH|813-745-3988|Peter.Kanetsky@moffitt.org|
20220571|NCT00428116|University of Washington|Grace John-Stewart|206 543 4278|gjohn@uw.edu|
20220572|NCT01141205|Statens Serum Institut|Dr Anders Fomsgaard|+45-32683460|afo@ssi.dk|
20220573|NCT03985852|University of Utah|Dr. Kimberly Kaphingst|801-213-5724|kim.kaphingst@hci.utah.edu|
20220574|NCT01357148|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220575|NCT02495623|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
20220576|NCT04759768|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
20220577|NCT03010683|2nd Cardiology Department, National and Kapodistrian University of Athens, Attikon Hospital|Dr Ignatios Ikonomidis|+30 6944805732|ignoik@gmail.com|
20220578|NCT00537511|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20220579|NCT04324021|Swedish Orphan Biovitrum|Henrick Andersson, Director of Statistical Science|+46760011816|henrik.andersson@sobi.com|
20220580|NCT02006732|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220581|NCT02252354|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20220582|NCT03516513|University of Washington|Michael Pullmann|6158304563|pullmann@uw.edu|
20220583|NCT02064985|Pharmaceutical Product Development, LLC.|Rong Fu|86-021-80135112|rong.fu@ppdi.com|
20220584|NCT02520297|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20220585|NCT01326923|LSU Health Shreveport|J.K. Miller|318 8131406|jmil12@lsuhsc.edu|
20220586|NCT01130597|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20220587|NCT03371459|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
20220588|NCT01325181|Seoul National University Hospital|Jang Won Heo|82220720836|hjw68@snu.ac.kr|
20220589|NCT03694327|MyDigitalStudy|Alankar Gupta, VP, Medical Affairs & Clinical Development|862-485-9279|agupta@clicktherapeutics.com|
20220590|NCT02185053|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20220591|NCT00307437|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215 793-7612||
20220592|NCT03006302|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
20220593|NCT00338728|UT MD Anderson Cancer Center|Dr. Arun,Banu,M.D. / Breast Medical Oncology|713-792-2817|barun@mdanderson.org|
20220594|NCT03859765|Duke University|Sarah A Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
20220595|NCT02374138|Children's Research Institute|Stephen Teach, MD, MPH|202 476 5134|steach@childrensnational.org|
20220596|NCT02933255|National Cancer Institute|Dr. James L. Gulley|301-480-716|gulleyj@mail.nih.gov|
20220597|NCT04803305|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220598|NCT00754546|Dartmouth-Hitchcock Medical Center|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20220599|NCT01862484|The University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-0136|pliszka@uthscsa.edu|
20220600|NCT00721227|Ethicon Endo Surgery, Inc.|Amy Mahanes, Senior Clinical Research Associate|513-337-8366|amahanes@its.jnj.com|
20220601|NCT03207867|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20220602|NCT02638090|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|Jhanelle.Gray@Moffitt.org|
20220603|NCT05292183|Dartmouth-Hitchcock Medical Center|Dr. Krzysztof Bujarski|603 650 5104|krzysztof.a.bujarski@hitchcock.org|
20220604|NCT05573763|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
20220605|NCT03975491|Pennington Biomedical Research Center|Dr. Justin Brown|2257632715|Justin.Brown@pbrc.edu|
20220606|NCT04582149|Emory University|Ofer Sadan, MD, PhD|470-480-6956|ofer.sadan@emory.edu|
20220607|NCT03922529|University of Pittsburgh|Daniel Forman, MD|412-360-2411|formand@pitt.edu|
20220608|NCT01277601|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20220609|NCT03367572|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
20220610|NCT05929651|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20220611|NCT02731638|University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|+1 415 502 2666|jennifer.rose-nussbaumer@ucsf.edu|
20220612|NCT04158245|Tulane University|Brian Lewis|504-988-6300|blewis@tulane.edu|
20220613|NCT02454608|Massachusetts Eye and Ear Infirmary|Benjamin Bleier|(617) 573-6966|Benjamin_Bleier@MEEI.HARVARD.EDU|
20220614|NCT05612685|UCLA|Kristen Choi, Associate Professor|3107947493|krchoi@ucla.edu|
20220615|NCT01887171|Republican scientific and practical center for organ and tissue transplantation|Aliaksej Shcherba|+375293330689|aleina@tut.by|
20161376|NCT03306641|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
20161377|NCT01490294|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20161378|NCT02789410|Mayo Clinic|Dr. Hans P. Sviggum|507-284-9697|sviggum.hans@mayo.edu|
20161379|NCT01751776|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161380|NCT00160654|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20161381|NCT02382848|Penn State University College of Medicine|Dr. Fauzia Mahr|717 531-8133|fmahr@pennstatehealth.psu.edu|
20161382|NCT01858753|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
20161383|NCT02218593|Nemours Children's Health|Director of Clinical Trials|4076507652|kristen.gibbs@nemours.org|
20161384|NCT00528996|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161385|NCT01307462|FHCRC|Guang-Shing Cheng MD|206-667-7074|gcheng2@fhcrc.org|
20161386|NCT02831933|Houston Methodist Neal Cancer Center|Eric Bernicker|713.790.3333|ccresearch@houstonmethodist.org|
20161387|NCT03875664|Atrium Health|Dr. Sarah Evans|704-304-1660|sarah.evans@atriumhealth.org|
20161388|NCT04129411|Mayo Clinic|Dr. Marius Stan|507-284-2463|stan.marius@mayo.edu|
20161389|NCT05065190|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161390|NCT04938037|ErciyesU|Dr. Isa Cuce|+905056263723|dr.icüce@hotmail.com|
20220616|NCT00916643|B. Braun Medical, Inc.|Kevin Minnich|610 596 2358|kevin.minnich@bbraun.com|
20220617|NCT01433055|Maryland Psychiatric Research Center|Deanna L. Kelly, Pharm.D., BCPP|410-402-6861|dkelly@mprc.umaryland.edu|
20220618|NCT04721808|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220619|NCT01728844|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
20220620|NCT00678210|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220621|NCT04825912|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
20220622|NCT03965689|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20220623|NCT01214655|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220624|NCT04933383|Aquilon Pharmaceuticals SA|Clinical Operations|003242292800|clinops@aquilonpharma.com|
20220625|NCT03870880|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
20220626|NCT00180661|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20220627|NCT01383707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220628|NCT00855894|Genentech, Inc.|Medical Communications|800 821-8590||
20220629|NCT02652611|U Maryland|Haley Demyanovich|4107063935|hdemyanovich@som.umaryland.edu|
20220630|NCT01121562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220631|NCT04289363|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
20220632|NCT03790657|Malcom Randall VA Medical Center|David Clark|3523761611|david.clark1@va.gov|105244
20220633|NCT03971474|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20220634|NCT02370238|Dompé Farmaceutici SpA|Dr Pier Adelchi Ruffini, MD|+39 02 583831|info@dompe.it|
20220635|NCT01807065|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20220636|NCT01153425|University of Pennsylvania, Perelman School of Medicine|Felix W. Wehrli, Ph.D.|215-662-7951|wehrli@mail.med.upenn.edu|
20220637|NCT01482312|Alcon Research|Director of Alcon Clinical|1-800-241-7629||
20220638|NCT01699815|Duke University School of Nursing|Virginia C. Muckler|919-684-9307|chris.muckler@duke.edu|
20220639|NCT01295320|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220640|NCT01669603|University of Virginia|Ronald Turner||rbt2n@virginia.edu|
20161391|NCT03350906|Mayo Clinic|Ian R. Lanza, Ph.D.|507-255-8147|Lanza.Ian@mayo.edu|
20220641|NCT04877457|Yale University|Erin Longbrake, MD|203-287-6100|erin.longbrake@yale.edu|
20161392|NCT03323736|Smith+Nephew|Laura England, PhD|(650) 223-6909|laura.england@smith-nephew.com|
20175634|NCT02388997|University of Virginia|Peter W. Heymann|434-982-3654|pwh5a@virginia.edu|
20175635|NCT00006184|National Cancer Institute, National Institutes of Health|Dr, Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
20175636|NCT04688164|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
20175637|NCT00087633|Hoffmann-La Roche|Medical Communications|800-821-8590||
20175638|NCT04707534|University of Oklahoma Health Sciences Center|Manager of Clinical Trials|405-271-6173|Dianne-Belshe@ouhsc.edu|
20175639|NCT01110915|Medtronic, Inc|Advisa MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
20205797|NCT00973622|University of Arkansas for Medical Sciences|Christine Sheffer, PhD|212 650 6860|csheffer@med.cuny.edu|
20205798|NCT00835003|Aarhus University Hospital, Dep. Obstetrics and Gynecology, Aarhus, Denmark|MD, PhD Julie Glavind|+4578450000|julie.glavind@dadlnet.dk|
20205799|NCT01804036|University of Utah|Yoshio Nakamura, PhD|801-585-7690|yn5@utah.edu|
20205800|NCT00830960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205801|NCT03074149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205802|NCT03859960|Fatih Sultan Mehmet Education and Research Hospital|MD. Arzu Atici|+905335621208|arzususinatici@gmail.com|
20205803|NCT03452891|University of Nebraska Medical Center|Amy C Killeen|402-479-6205|akilleen@unmc.edu|
20205804|NCT02855450|Dompè|Flavio Mantelli, MD, PhD|+39 02583831|info@dompe.com|
20205805|NCT05053126|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
20205806|NCT01376245|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205807|NCT05159362|Q2i, LLC|Steven Jenkins, CEO Q2i|646-660-2151|sjenkins@q2i-group.com|
20205808|NCT01335698|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20205809|NCT01170221|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|Philippe.Prokocimer@cubist.com|241
20205810|NCT00739960|UIC|Nadera J Sweiss, MD|312-996-5723|nsweiss@uic.edu|
20205811|NCT00050960|Eisai Call Center|Eisai, Inc.|888-422-4743||
20205812|NCT02171819|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
20175640|NCT03463889|University of California, San Francisco|Dr. Robert Flavell, MD PhD|877-827-3222|Robert.Flavell@ucsf.edu|
20205813|NCT01996904|CM Chungmu Hospital|Sang-Hoon Lhee|+82(2)2068/4525|cmirb@naver.com|
20189830|NCT04535414|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|andrew.blakely@nih.gov|
20189831|NCT03662659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20189832|NCT06943638|"General Oncology Hospital of Kifissia Agioi Anargyroi"|Christine Mavrogiannopoulou, Physiotherapist and Study coordinator|+30 6941464095|x.mavrogiannopoulou@gmail.com|
20189833|NCT05992350|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
20189834|NCT01534052|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|800-888-7704 Ext:5473|astellas.resultsdisclosure@astellas.com|
20189835|NCT01668355|VA|Alexander Young|310-794-7219|alexander.young@va.gov|
20189836|NCT02786966|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20189837|NCT01277302|Genentech, Inc.|Medical Communications|800 821-8590||
20189838|NCT01386632|Sanford Clinical Research|Dr. Steven Powell|605-328-8000|patientquestionsSHDCA@sanfordhealth.org|
20189839|NCT02710669|Vanderbilt University Medical Center|Benjamin Shoemaker, MD|615-322-2318|moore.b.shoemaker@vumc.org|
20189840|NCT03627299|Johns Hopkins University|Christine Durand, MD|410-955-5684|ChristineDurand@jhmi.edu|
20189841|NCT01190124|Hospital de Santa Maria - Centro Hospitalar Lisboa Norte|Doroana, Maria Manuela, M.D.|351 217938043|manuela.doroana@hsm.min-saude.pt|
20189842|NCT01523392|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
20189843|NCT02354417|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
20189844|NCT02005172|University at Buffalo|Deepika Narasimha||deepikan@buffalo.edu|
20189845|NCT01212822|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20189846|NCT03851094|ResMed|Clinical Research Team|800-424-0737|clinicaltrials@resmed.com.au|
20189847|NCT00484198|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20189848|NCT01332266|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20189849|NCT03302091|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189850|NCT01536704|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189851|NCT02392507|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20189852|NCT01802333|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|206-667-4623|amoseley@fredhutch.org|
20189853|NCT00724009|The University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
20189854|NCT02067663|Stanford University School of Medicine|Lisa Goldthwaite|541-515-1825|lgoldthw@stanford.edu|
20189855|NCT01759459|Allina Health|David Gurda|612-863-6566|david.gurda@allina.com|
20189856|NCT01299285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20189857|NCT00486954|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189858|NCT03236779|Head of iPhysio Research Group. Editor-in-Chief Journal of Invasive Techniques in Physical Therapy|Dr. Pablo Herrero Gallego. PT, PhD.|(+34) 646168248|pherrero@usj.es|
20189859|NCT01260883|Seattle Children's Hospital|Anne Lynn MD|206 987-2518|anne.lynn@seattlechildrens.org|
20189860|NCT03070548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
20189861|NCT01836523|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20189862|NCT02309515|Mayo Clinic|Tait D. Shanafelt, MD|507.284.2511|shanafelt.tait@mayo.edu|
20189863|NCT02605876|University of North Carolina at Chapel Hill|Troy Blackburn|9198432021|troyb@email.unc.edu|
20189864|NCT04070105|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
20189865|NCT04026256|Massachusetts General Hospital|Benjamin Leder|617-724-2039|bzleder@mgh.harvard.edu|
20189866|NCT03775915|University of Oxford|Dr Melanie Fleming, Research Associate|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
20189867|NCT00624377|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20189868|NCT03054506|Massachusetts General Hospital|Dr. Kyle Staller|617-726-3080|kstaller@mgh.harvard.edu|
20189869|NCT02245620|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20189870|NCT01102426|Pharma Mar, S.A.|Pharma Mar, S.A.|0034918466000|clinicaltrials@pharmamar.com|
20189871|NCT01393964|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20189872|NCT00148122|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
20189873|NCT00274287|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
20189874|NCT03200574|Corcym S.r.l.|Elisa Cerutti|+393459182413|elisa.cerutti@corcym.com|
20189875|NCT03035942|Pontificia Catholic University of Sao Paulo|Dr. Eduardo Toshiyuki Moro|+5515997728015|edumoro85@gmail.com|
20189876|NCT02538094|Johns Hopkins University SOM|Dr. Tracy Vannorsdall|4105023701|TVannor1@jhmi.edu|
20189877|NCT01989104|Pennington Biomedical Research Center|Dr. William Johnson|225-763-2932|William.Johnson@pbrc.edu|
20189878|NCT01860079|AcibademU|Prof.Dr.Şevket Görgülü|+902623174444|sevket5@yahoo.com|4123
20189879|NCT00718120|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189880|NCT03292692|University of Miami|Dr. Brian Doss|305-284-1101|bdoss@miami.edu|
20205814|NCT00585923|Biomet|Jacquelyn Hughes|973-299-9300|jacquelyn.hughes@biomet.com|3075
20205815|NCT01324622|DePuy Synthes|Allyson Morris|610-719-5298|amorris5@its.jnj.com|
20205816|NCT02219087|OhioHealth|Sara Jordan Clinical Pharmacist for Surgery Services|614-461-8174|sara.jordan@ohiohealth.com|
20205817|NCT00618449|University of California, San Francisco|Julius Schachter, PhD / Emeritus Professor of Laboratory Medicine|+1 (415) 824-5115|Julius.Schachter@ucsf.edu|
20205818|NCT00138424|Collaborative Antiviral Study Group|Penelope Jester, BSN,MPH,CCRC|(205) 877-975-7280|PJester@peds.uab.edu|
20205819|NCT04311177|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
20205820|NCT01912716|Indiana University|Dr. Evan Fogel|317-944-2816|efogel@iu.edu|
20205821|NCT02391350|University of Utah|Dr. Julie Fritz|8015872237|julie.fritz@utah.edu|
20205822|NCT01583452|ITESM - Pediatrics Division|Gabriela López Jaimez|+527211476044|gabylopez7@gmail.com|
20220642|NCT02211417|Dignity Sciences Ltd|Study Director|+353 1 2933590|dsbiopharma.regulatory@dsbiopharma.com|
20220643|NCT01198132|Merck KGaA|Title: Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20220644|NCT01755091|University of Illinois at Chicago|David W. Carley, PhD|312-996-3827|dwcarley@uic.edu|
20220645|NCT03071276|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
20220646|NCT05794503|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
20220647|NCT00509795|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
20220648|NCT04842292|University of Kentucky|Brittany Bissell|8593239308|bdbi223@uky.edu|
20220649|NCT00143247|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20220650|NCT00525798|Nordic Bioscience|Dr. Bente Juul Riis|+45 22901317|bjr@nordicbioscience.com|
20220651|NCT02766283|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
20220652|NCT00805961|Sarah Cannon Research Institute|John D. Hainsworth, MD.|877-691-7274|ASKSARAH@scresearch.net|
20220653|NCT04380961|Janssen Research & Development, LLC|Director 1 Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20220654|NCT00306995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20220655|NCT01496976|Moffitt Cancer Center|Celeste M. Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
20220656|NCT03598790|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20220657|NCT01059786|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
20220658|NCT02905240|Zimmer Biomet|Jennifer Woodell-May, Research Associate Director|5742651885|jennifer.woodell-may@zimmerbiomet.com|
20220659|NCT04021238|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20220660|NCT05789576|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20220661|NCT05026177|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
20220662|NCT06831760|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
20220663|NCT04514679|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5274|tor.d.tosteson@dartmouth.edu|
20220664|NCT03956355|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20220665|NCT03816878|Johns Hopkins University Center for Immunization Research|Kawsar Talaat|410-336-9164|ktalaat1@jhu.edu|
20220666|NCT03355469|Rutgers University|Dr. Steven Malin|848-932-705|steven.malin@rutgers.edu|
20175641|NCT00627679|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|(650) 386-3100|dkellerman@mappharma.com|
20220667|NCT05626231|Boston College School of Social Work|Dr. Maggi Price, PI|541-556-5016|priceml@bc.edu|
20220668|NCT05064384|Boston Scientific|Karen Noblett, MD, Chief Medical Officer|559-250-8082|karen.noblett@bsci.com|
20220669|NCT03765788|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20220670|NCT03203850|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20220671|NCT02717455|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
20220672|NCT00486525|Ohio State University Comprehensive Cancer Center|Janice Kiecolt-Glaser, Principal Investigator|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
20220673|NCT00733005|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20220674|NCT01769456|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20220675|NCT01068548|VANTHCS|Eric Mortensen, MD|214-857-1588|ericm.mortensen@va.gov|
20220676|NCT02185339|Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital|Dr. Sanghyun Hong|82-2-2258-2236|shhong7272@gmail.com|
20220677|NCT01602068|Eyegate Pharmaceuticals, Inc.|Lisa Brandano|781-398-3806|lbrandano@eyegatepharma.com|
20220678|NCT02465398|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
20220679|NCT00599248|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
20175642|NCT02948842|University of South Florida|Lucas Wiegand, MD|813-844-5972|lwiegand@usf.edu|
20175643|NCT04865432|Boston University Chobanian & Avedisian School of Medicine|Michael F. Holick PhD, MD|617-358-6139|mfholick@bu.edu|
20220680|NCT05244122|BrighamHospital|Jeremy Wolfe, Principle Investigator|617-851-1166|jwolfe@bwh.harvard.edu|
20220681|NCT01216735|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
20220682|NCT02969382|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|CLINICALTRIALDISCLOSURE@SUNOVION.COM|
20220683|NCT02090725|Dartmouth-Hitchcock|Jeffrey A. Cohen, MD|603-650-4211|jeffrey.a.cohen@hitchcock.org|
20220684|NCT02037425|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cay, M.D.|417-883-7889|rcady@banyangroupinc.com|
20220685|NCT05256134|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220686|NCT02923232|Pacific University|Dr. Shun-nan Yang|5033522852|shunnan.yang@pacificu.edu|
20220687|NCT01977417|University of Iowa|Gary Pierce, PhD|319-335-9487|gary-pierce@uiowa.edu|
20220688|NCT01692626|West Virginia University|Mohammed Almubarak, MD, Assistant Professor|304-293-4229|malmubarak@hsc.wvu.edu|
20220689|NCT05992623|Inova Schar Heart and Vascular|Brett D. Atwater MD|9192390127|brett.atwater@inova.org|
20220690|NCT02753920|Northwell Health|Marjorie Pilkinton|5166225114|mlpilk@gmail.com|
20220691|NCT03437031|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
20220692|NCT02794870|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20220693|NCT01495702|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20220694|NCT00616421|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
20220695|NCT01427608|Weill Cornell Medicine|Dr. George S. Alexopoulos|(914) 997-5767|gsalexop@med.cornell.edu|
20157551|NCT03758261|University of Pittsburgh Medical Center|Dr. Charles Luke|4127485589|lukecb@upmc.edu|
20175644|NCT05124873|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
20175645|NCT00207142|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
20175646|NCT01857063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175647|NCT04958109|Massachusetts General Hospital|Margaret Lippincott|6177268434|mlippincott@mgh.harvard.edu|
20175648|NCT00531843|UCSF/SF General Hospital|M. Margaret Knudson, MD|415.205.4623|pknudson@sfghsurg.ucsf.edu|
20175649|NCT00715793|University of Pittsburgh|Hussein Tawbi, MD, PhD|713-792-6111|HTawbi@mdanderson.org|
20220696|NCT02422797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20220697|NCT04071405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220698|NCT05044195|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20220699|NCT05445492|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
20220700|NCT02292940|Northern California Kaiser Permanente, Division of Research|Mary Reed, DrPH|510-891-3808|Mary.E.Reed@kp.org|
20220701|NCT03474874|NeXtGen Biologics Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
20175650|NCT00058825|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
20175651|NCT04115358|Marmara University|Prof. Dr. Ali Mentes|+90 2164140545|alimentes@gmail.com|
20189881|NCT02110381|University of Michigan|Dr. Elizabeth Jackson|734-998-7411|lisjacks@med.umich.edu|
20220702|NCT03277066|Noven Pharmaceuticals, Inc.|Gunnar Klauss, MD|1-551-233-2656|gklauss@noven.com|
20220703|NCT03126435|SynCore Biotechnology Co., Ltd.|Albert Lin, Ph.D./Special Assistant to GM|+886-2-2760-3688|JWLin@syncorebio.com|2308
20220704|NCT01375946|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
20220705|NCT03450473|Washington University School of Medicine in St. Louis|Dr. Grant Bochicchio|314-362-9347|gbochicchio@wustl.edu|
20220706|NCT01937871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220707|NCT03154125|FHI 360|Vera Halpern, M.D., Director of Clinical Development|+1 (919) 321-3331|VHalpern@fhi360.org|3117
20220708|NCT00799058|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
20220709|NCT00810511|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20220710|NCT02088697|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20220711|NCT00462904|University of Texas Southwestern Medical Center|Joseph Minei|214-648-3917|joseph.minei@utsouthwestern.edu|
20220712|NCT02652949|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
20220713|NCT00699816|Seoul National University College of Medicine|Jung-Hwan Yoon, MD, PhD|+82-2-2072-2228|yoonjh@snu.ac.kr|
20220714|NCT01569295|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|ClinicalTrialDisclosures@gilead.com|
20220715|NCT02508935|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20220716|NCT02125877|Novartis|Study Director|862-778-8300||
20220717|NCT01973595|University of Florida|Dr. Bobbi Langkamp- Henken|352-392-1991|henken@ufl.edu|205
20220718|NCT03901092|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20220719|NCT04151667|Moffitt Cancer Center|Dr. Rachid Baz|813-745-3163|Rachid.Baz@moffitt.org|
20220720|NCT06101264|University of Connecticut School of Medicine|Prabhath Mannam|8607092371|pmannam@uchc.edu|
20220721|NCT00794508|University of California Los Angeles|Dr. Donald B. Kohn|310-794-1964|dkohn1@mednet.ucla.edu|
20220722|NCT02800642|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20220723|NCT04868500|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20220724|NCT04642404|University of Texas Health Science Center at San Antonio|Vanessa Chrepa, DDS|210-459-3601|vanessa.chrepa@rutgers.edu|
20220725|NCT01941498|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20220726|NCT05299528|Vanderbilt University Medical Center|Daniel Larach, MD|(615) 322-6033|daniel.larach@vumc.org|
20220727|NCT00490841|Abbott Vascular|Ellen Travis|408-845-1512|Ellen.Travis@av.abbott.com|
20220728|NCT04697069|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20220729|NCT02779855|Moffitt Cancer Center|Hatem Soliman, MD|813-745-4985|hatem.soliman@moffitt.org|
20220730|NCT01301729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20220731|NCT00912912|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD/Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
20220732|NCT05422625|William Beaumont University Hospital|Jennifer Giordano RN BSN/ Clinical Research Manager|248-551-3517|Jennifer.Giordano@corewellhealth.org|
20220733|NCT05938621|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
20220734|NCT03686488|Moffitt Cancer Center|Dae Won Kim, MD|813-745-1277|daewon.kim@moffitt.org|
20220735|NCT04205812|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20220736|NCT04559347|The Guthrie Clinic|Poovendran Saththasivam MD|5708874882|Poovendran.Saththasivam@guthrie.org|
20220737|NCT00371033|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
20220738|NCT00221338|University of California San Francisco|Clinical Research Coordinator|4154769489|Christopher.Tang2@ucsf.edu|
20220739|NCT03395288|Washington University|Jerry Lowder, MD|314-362-0063|lowderj@wustl.edu|
20220740|NCT01983566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220741|NCT00181714|Massachusetts General Hospital|Paul Hammerness, MD|617-503-1063|phammerness@partners.org|
20220742|NCT06376682|quantum surgical|MESSNER Laetitia, Chief Clinical officer|+33 (0) 4 48 19 40 50|clinical.department@quantumsurgical.com|
20220743|NCT01625988|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220744|NCT04152863|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220745|NCT01644617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220746|NCT02276807|VA Center for Integrated Healthcare|Dr. Jennifer Funderburk|315-425-4400|Jennifer.Funderburk@va.gov|54703
20220747|NCT00504751|Weill Cornell Medicine|Richard Furman, MD|646.962.2064|amr2017@med.cornell.edu|
20220748|NCT01085760|Mayo Clinic|Dr. Jayant A. Talwalkar|507-538--4877|talwalkar.jayant@mayo.edu|
20220749|NCT03417778|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20220750|NCT04342819|The University of the West Indies|Naveen Seecheran, Senior Lecturer|18687537686|Naveen.Seecheran@sta.uwi.edu|
20220751|NCT02287922|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
20220752|NCT00668317|Hull and East Yorkshire Hospitals Trust|Clinical trials Manager|01482 624067|c.e.wright@hull.ac.uk|
20220753|NCT01565356|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20220754|NCT03345771|NYU Langone Health|Ran Schwarzkopf MD MSc|(646)-501-7300|ran.schwarzkopf@nyulangone.org|
20220755|NCT03606343|Cincinnati Children's Hospital Medical Center|Leanne Tamm, Principal Investigator|513-803-3176|leanne.tamm@cchmc.org|
20220756|NCT00972374|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20220757|NCT00717288|The Ohio State University|Kathleen Dungan, MD|614-292-3800|kathleen.dungan@osumc.edu|
20220758|NCT02411916|Queens Hospital Center|Dr. Aleksandr Fuks|718 883-4035|fuksal@nychhc.org|
20220759|NCT03607487|Incyte Corporation|Incyte Corporation Call Center|1-855-463-3463|medinfo@incyte.com|
20220760|NCT01884337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20220761|NCT02455518|Albany Medical College|Dr. Andrew Chang|2125555555|achang3@yahoo.com|
20220762|NCT03852537|Mayo Clinic|Hemang Yadav, MBBS, MS|507-266-3958|Yadav.Hemang@mayo.edu|
20220763|NCT03203681|University of Miami|Dr. Ranjith Ramasamy|3052433670|ramasamy@miami.edu|
20220764|NCT01027598|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20161393|NCT04872998|University of Utah|Principal Investigator Joel Trinity Associate Professor|801-582-1565|joel.trinity@utah.edu|
20161394|NCT05160766|University Hospital Cologne|Prof. Dr. med. Oliver A. Cornely|0049 221 478 85523|oliver.cornely@uk-koeln.de|
20161395|NCT02654236|IU School of Medicine|Dr. Suthat Liangpunsakul|(317) 988-3232|sliangpu@iu.edu|
20161396|NCT01549873|Nationwide Children's Hospital|David Martin, MD|614-722-4200|David.Martin@nationwidechildrens.org|
20161397|NCT02943915|Moss Rehabilitation Research Institute, Elkins Park, PA, USA|Dylan Edwards|215-663-6554|dylan.edwards@jefferson.edu|
20161398|NCT00701805|Abbott|Global Medical Services|800-633-9110||
20161399|NCT00877370|University of Michigan|Bruce A. Mueller|(734) 615-4578|muellerb@umich.edu|
20161400|NCT00418977|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|katharine.loeb@mssm.edu|
20161401|NCT02262078|Mayo Clinic|Barry A. Borlaug, MD||Borlaug.Barry@mayo.edu|
20175652|NCT02346240|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20220765|NCT04223752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20220766|NCT04759703|Massachusetts General Hospital|John W. Winkelman, MD, PhD|6176436026|JWWINKELMAN@MGH.HARVARD.EDU|
20220767|NCT03071406|Moffitt Cancer Center|Sungjune Kim, MD, PhD|813-745-1898|sungjune.kim@moffitt.org|
20220768|NCT03617458|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
20220769|NCT01350583|H. Lee Moffitt Cancer Center and Research Institute|Robert J. Gillies, Ph.D. - Principal Investigator|813-745-8355|robert.gillies@moffitt.org|
20175653|NCT02942017|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
20175654|NCT04399161|JSS Dental College & Hospital, JSS Academy of Higher Education & Research|Dr. Krupa NC|8105064056|kripa_555@yahoo.com|+91
20175655|NCT03417141|Mayo Clinic|Jason C. Sluzevich, M.D.|904-953-6192|Sluzevich.Jason@mayo.edu|
20175656|NCT02800148|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
20175657|NCT01455012|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20175658|NCT04552587|Medical University of South Carolina|Katherine R. Sterba, PhD, MPH|843- 876-2419|sterba@musc.edu|
20175659|NCT02253810|Hospital for Special Surgery|Dr. Ernest Sink|2126061279|Sinke@hss.edu|
20175660|NCT01467999|NYSPI|daniel brooks|6467746171|daniel.brooks@nyspi.columbia.edu|
20205823|NCT02157506|Bristol-Myers Squibb International Corporation|EU Study Start-Up Unit||clinical.trials@bms.com|
20220770|NCT04186845|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
20220771|NCT05061420|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20220772|NCT01406444|Massachusetts General Hospital|Dr. Karen Klahr Miller|6177263870|kkmiller@mgh.harvard.org|
20220773|NCT01814553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220774|NCT03138655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20220775|NCT02859142|University of Chicago|Andrea King, Ph.D.|7737026181|aking@yoda.bsd.uchicago.edu|
20220776|NCT03290079|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-5553|jonathan.strosberg@moffitt.org|
20220777|NCT00706589|Kiho Moon|Medical Director|+82-2-3287-9009|khmoon@otsuka.co.kr|
20220778|NCT01277211|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220779|NCT03452943|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20220780|NCT03307226|Washington University in St. Louis|Dr. Fred Ssewamala|3149358521|fms1@wustl.edu|
20220781|NCT01199146|University of California, San Francisco|Charles Ryan, MD|415-353-9279|charles.ryan@ucsf.edu|
20220782|NCT01107197|"Department of Clinical Nutrition and Dietetics, Azienda Ospedaliera Maggiore della Carità"|Dr. Federico D'Andrea|+39 0321.373.3275|dietologia@maggioreosp.novara.it|
20220783|NCT05180227|James J Peters VA Medical Center|Dr. Jill Maria Wecht|(718) 584-9000|JM.Wecht@va.gov|3122
20220784|NCT01906515|Cairo University School Of Medicine|Dr Wael N Awada|00201006481958|waoool@hotmail.com|
20220785|NCT00447993|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20220786|NCT02350816|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20220787|NCT04700137|St. Luke's Health System|Dr. Anna K. Radin|208/381-8460|radina@slhs.org|
20220788|NCT02503787|Medtronic Implantable Therapies|Helen Berrier|1-800-633-8766|medtronicneurotrials@medtronic.com|
20220789|NCT04787627|Össur Iceland ehf.|Laurine Roussillon|+354 822 1812|lroussillon@ossur.com|
20220790|NCT00548093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220791|NCT01411527|Rigshospitalet|Anders Juul|+45 3545 5085|Anders.Juul@regionh.dk|
20220792|NCT02716727|University of North Carolina at Chapel Hill|Sumitha Ahmed, DDS|919-537-3946|sumitha_ahmed@unc.edu|
20220793|NCT02924727|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20220794|NCT01464931|Amgen Inc.|Study Director|866-572-6436||
20175661|NCT03900299|Alexandria university|DR. mostafa elsayed|560566541|m_elsayed2009@yahoo.com|+966
20205824|NCT00764478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205825|NCT02702011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20205826|NCT02995330|Johns Hopkins University|"Dr. Samuel R. Denmeade Professor of Oncology| Director Genitourinary Oncology"|410-502-8341|DENMESA@jhmi.edu|
20205827|NCT02407041|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
20205828|NCT02029495|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
20205829|NCT03498287|Pressure Profile Systems|Clinical Trials Manager|310.641.8100|research@wrist-aid.com|
20205830|NCT05515952|University of Arizona|Lisbeth Haaheim|520-626-7755|lhaaheim@arizona.edu|
20205831|NCT01740388|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
20205832|NCT04142216|Demiroglu bilim University|Assistant Professor Nurten Ozen|+905334509382|ozenurten@yahoo.com.tr|
20205833|NCT01641991|Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center|David Bernstein, MD, MA|513-636-7625|david.bernstein@cchmc.org|
20205834|NCT02555657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205835|NCT01948141|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20205836|NCT03700970|Vanderbilt university medical center|Dr. Galen Perdikis|+1 (615) 936-0198|galen.perdikis@vumc.org|
20205837|NCT02396342|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20205838|NCT01578785|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20220795|NCT02936180|McGill University|Ines Colmegna, MD|514-934-1934|ines.colmegna@mcgill.ca|35639
20175662|NCT03465878|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20189882|NCT03803475|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
20189883|NCT01880736|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20189884|NCT01706666|Mayo Clinic Cancer Center|Craig B Reeder, MD|4803018335|Reeder.Craig@mayo.edu|
20189885|NCT01263496|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20189886|NCT05011292|Emory University|Dr. Jean Welsh|404-375-1165|jwelsh1@emory.edu|
20189887|NCT05995977|Karaman Provincial Health Directorate|Handan Altunkan|05367443152|handanaltunkan@gmail.com|
20189888|NCT04181788|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189889|NCT02421679|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
20189890|NCT01458015|Universitätsklinikum Schleswig-Holstein, Campus Kiel; Sektion neurologische Schmerzforschung und -therapie|Prof. Ralf Baron|+4943123911|r.baron@neurologie.uni-kiel.de|
20189891|NCT01276509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20189892|NCT04995601|Recovery Force Health, University of Massachusetts Amherst|Jeff Schwegman (PI), Dr. Karen Giuliano (PI, clinical trial subaward)|317-605-4696; 224-725-0270|kschwegman@recoveryforceusa.com; kkgiuliano@umass.edu|
20189893|NCT04173000|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20189894|NCT00535626|Stryker Orthopedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
20189895|NCT02830893|University of California Irvine|Dr. Steven Cramer|(949) 824-8423|SCCramer@mednet.ucla.edu|
20189896|NCT01567852|University of NewMexico|Dr. Tony Yen|505-272-2610|tyen@salud.unm.edu|
20189897|NCT03332589|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
20189898|NCT00443820|Novartis Pharmaceuticals|Study Director|862-778-8300||
20189899|NCT05139615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189900|NCT03462966|Cedars-Sinai medical center|Mohamad Rashid|310-423-0617|mohamad.rashid@cshs.org|
20189901|NCT04669366|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189902|NCT01808534|IndianaU|Dr. Lawrence H. Einhorn|(317)274-3515|leinhorn@iu.edu|
20189903|NCT01377844|Theracos Sub, LLC|Albert Collinson, Ph.D.|(508) 688-4221|acollinson@theracos.com|
20189904|NCT02494076|University Colorado School of Medicine, Chidren's Hospital Colorado|Nidhya Navanandan, MD|847-636-0817|nidhya.navanandan@childrenscolorado.org|
20189905|NCT02132520|University of Minnesota|Bin He|612-626-1115|binhe@umn.edu|
20189906|NCT02202317|University of Miami Miller School of Medicine|Dr Jason Salsamendi|305-585-7500|jsalsamendi@miami.edu|
20189907|NCT04053699|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20189908|NCT00569166|Mayo Clinic|Dr. Amit Sood|507-538-7623|sood.amit@mayo.edu|8-7623
20189909|NCT02746107|Carol Davila University of Medicine and Pharmacy Bucharest|Professor Cristian Baicus|+40788302355|cbaicus@gmail.com|
20189910|NCT01853384|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20189911|NCT01947491|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
20189912|NCT00704340|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20189913|NCT00929526|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189914|NCT00403845|Novartis Pharmaceuticals|Study Director|862 778-8300||
20189915|NCT03316170|University of Kentucky|Dr. Jessica Burris|+1 859-257-9612|jessica.burris@uky.edu|
20189916|NCT00578344|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
20189917|NCT02169414|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20189918|NCT00321971|Duquesne University School of Nursing|Linda Garand PhD|412-396-6543|garandl@duq.edu|
20189919|NCT03374254|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20189920|NCT04803734|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
20189921|NCT00667953|Penn|Tara C Mitchell|215-662-4000|Tara.Mitchell@pennmedicine.upenn.edu|
20189922|NCT02395692|ABTC|Sr. Research Program Manager|410-955-8837|ABTC@jhmi.edu|
20189923|NCT00854594|Louis Stokes VA Medical Center|Jeneen Shell-Boyd|(216) 791-2300|Jeneen.shell-boyd@va.gov|5831
20189924|NCT00749944|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189925|NCT02547974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20189926|NCT00923078|VA Connecticut Healthcare System|Dr Jason K. Johannesen|2039325711|jason.johannesen@va.gov|2224
20189927|NCT01513902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189928|NCT01999335|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20205839|NCT00895193|University of Kansas Medical Center|Julie-Ann Dutton, MS, RD|(913) 588-4064|jdutton@kumc.edu|
20205840|NCT00599027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205841|NCT00475540|MedStar Health Research Institute|Allie Moses, Manager, Clinical Research Systems and Recruitment Center|301-560-7353|Allison.E.Moses@MedStar.net|
20205842|NCT02714504|Univ Fed Rio de Janeiro|Dr Marcio Nucci|552139382463|mnucci@hucff.ufrj.br|
20205843|NCT02392494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205844|NCT01214317|Isfahan University of medical sciences|Director of clinical trial|+983136202020|etemadifar.m@gmail.com|
20205845|NCT00505895|University of Texas MD Anderson Cancer Center|Muzaffar Qazilbash, MD / Professor, Stem Cell Transplantation|713-745-4371|CR_Study_Registration@mdanderson.org|
20205846|NCT00587769|Mayo Clinic|Jon O. Ebbert|507-284-2511|ebbert.jon@mayo.edu|
20205847|NCT05351710|Florida State University|Dr. Jesse Cougle|8506458729|cougle@psy.fsu.edu|
20205848|NCT00676793|LSU Health, Shreveport|Dr. Jerry w. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
20189929|NCT04766996|Emory University|Kelly Wiltse Nicely, MD|404-727-6946|kelly.wiltse.nicely@emory.edu|
20189930|NCT00080119|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20189931|NCT00508183|Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|74700
20189932|NCT05228834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189933|NCT00564447|Inspire Pharmaceuticals, Inc.|Director of Clinical Research|010-941-9777|kkuhn@inspirepharm.com|
20189934|NCT04405180|University of Pittsburgh|Dr. Daniel Forman|412-864-2507|formand@pitt.edu|
20189935|NCT02988713|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
20189936|NCT03265132|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
20189937|NCT04492475|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20189938|NCT03150758|Cleveland Clinic|Dr. Eric Klein|1-800-223-2273|CancerCenterResearch@ccf.org|
20189939|NCT02359916|Rush University Medical Center|Brad Appelhans, PhD (PI)|312-942-3477|brad_appelhans@rush.edu|
20189940|NCT03938272|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
20189941|NCT00695188|Department of Clinical Pharmacology, Medical University of Vienna|Eva-Luise Hobl|+43 1 40400 2981|eva-luise.hobl@meduniwien.ac.at|
20189942|NCT02074384|Park Nicollet Institute|Dr. Deborah Mullen|952-993-2070|deborah.mullen@parknicollet.com|
20189943|NCT03241810|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
20189944|NCT01323790|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
20189945|NCT00046475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20189946|NCT00266656|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20189947|NCT00703391|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20189948|NCT02114515|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|partner@uic.edu|
20189949|NCT00667732|Oregon Health and Science University|Dr. Matthew Riddle|503-494-0557|riddlem@ohsu.edu|
20189950|NCT01213940|University of South Alabama, Department of Surgery|William O. Richards, MD|251-471-7993|brichards@health.southalabama.edu|
20189951|NCT02725372|Bellerophon Therapeutics Inc|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
20189952|NCT02106325|New York University School of Medicine|Stephen Ross, MD/ Principal Investigator|212 562 4097|Stephen.Ross@nyumc.org|
20189953|NCT02656199|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
20189954|NCT03242863|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
20189955|NCT04852978|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|18447346643|clinicaltrials@regeneron.com|
20189956|NCT04369664|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
20189957|NCT06149416|Stryker Sustainability Solutions|Senior Principal Regulatory Affairs|5602-410-0204|moira.barton@stryker.com|
20189958|NCT02470312|Abbott|Kristin Ruffner, Clinical Program Director|+1 651 756 6717|Kristin.Ruffner@abbott.com|
20189959|NCT00215943|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
20189960|NCT04633200|Environment and Health Group|Patricia Flynn Weitzman|617-455-5976|pat.weitzman@gmail.com|
20189961|NCT02507297|University of Michigan|Leslie Swanson|734-764-2242|lmswan@umich.edu|
20189962|NCT02489799|The Johns Hopkins University School of Medicine|Rebecca Aslakson, M.D., Ph.D.|410-955-9082|raslaks1@jhmi.edu|
20189963|NCT02092285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189964|NCT00087516|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20189965|NCT00278395|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
20189966|NCT04205669|CERMEL|Julian Matthewman|00241 07-98-91-91|julianmatthewman@gmail.com|
20189967|NCT01686152|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20189968|NCT00239642|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|601-650-4200|mfalone@luitpold.com|
20189969|NCT02784834|UC San Diego|Dr. Michael Choi|(858) 534-1765|mychoi@ucsd.edu|
20189970|NCT02143713|AbbVie|Global Medical Services|800-633-9110||
20189971|NCT04264156|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|2154889300|psimmons@windtreetx.com|
20189972|NCT01768572|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20189973|NCT01322386|Stanford University|Kenneth L Cox, MD / Principal Investigator|650-723-5070|KCox@stanfordchildrens.org|
20189974|NCT00949234|UCLA CARE Center|Dr. Raphael Landovitz|310-557-1891|rlandovitz@mednet.ucla.edu|
20189975|NCT03785756|Reckitt Benckiser (Health) Limited|Clinical Project Manager|+44 1482 326151|clinicaldatacontroller@reckitt.com|
20220796|NCT01982812|University of Rochester|Gretchen L. Birbeck|585-273-4265|gretchen_birbeck@urmc.rochester.edu|
20189976|NCT00871494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20189977|NCT02637999|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
20220797|NCT00174954|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20220798|NCT00993421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220799|NCT02215967|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
20220800|NCT03514017|Moffitt Cancer Center|Julio Chavez, MD, MS|813-745-4294|julio.c.chavez@moffitt.org|
20189978|NCT00889863|Novartis Pharmaceuticals|Study Director|862-778-8300||
20189979|NCT03879538|Cleveland Clinic|Alparslan Turan|2162172312|turana@ccf.org|
20189980|NCT03082313|University of Southern California|Beth Smith|13234424072|beth.smith@usc.edu|
20161402|NCT02804750|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20220801|NCT03023176|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
20175663|NCT04656132|NYU Rory Meyers College of Nursing|Margaret M. McCarthy, PhD, RN, FNP-BC|212-992-5796|mmm529@nyu.edu|
20175664|NCT04019041|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20175665|NCT02540954|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20175666|NCT01393743|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20175667|NCT00213148|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20175668|NCT01831232|Fred Hutchinson Cancer Research Ctr|Dr, Mazyar Shadman|206-667-5467|mshadman@fredhutch.org|
20175669|NCT01806896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175670|NCT00245765|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20175671|NCT03080961|CLJI WORLDWIDE|Ty Cross, President & CEO|305-397-8880|tycross@cljiworldwide.com|
20175672|NCT01101841|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
20175673|NCT02381392|Harbor-UCLA Medical Center|Kelly D. Young, MD|310-222-3506|kyoung@emedharbor.edu|
20175674|NCT03756558|Terumo Medical Corporation|Director of Clinical Operations|9085146154|charis.sugden@terumomedical.com|
20175675|NCT02453113|UC Irvine|Kristen Kelly|949 824 5515|kmkelly@uci.edu|
20175676|NCT02896400|Yale School of Medicine|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
20175677|NCT03366077|BioGaia AB|Jenny Palming Clinical research Director|+46 738299900|jp@biogaia.se|
20175678|NCT00634647|National Cancer Institute, National Institutes of Health|Dr. William Dahut|301-435-8183|dahutw@mail.nih.gov|
20175679|NCT02984020|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175680|NCT01700179|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20175681|NCT01896895|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20175682|NCT00667342|St. Jude Children's Research Hospital|Michael Bishop, MD|866-278-5833|referralinfo@stjude.org|
20175683|NCT01207778|University of Utah|Dr. Robin Ohls|505-400-7644|robin.ohls@hsc.utah.edu|
20175684|NCT04015219|BioTissue|Medical Affairs|8882968858|medicalaffairs@biotissue.com|
20175685|NCT01433263|Novartis Pharmaceuticals|Study Director|862-778-8300||
20175686|NCT00646204|Baylor College of Medicine/Houston Methodist|William G. Ondo, MD|713-363-8930|wondo@houstonmethodist.org|
20175687|NCT02582840|AstraZeneca K.K.|Yu Shimizuishi|81 6 7711 4669|Yu.Shimizuishi@astrazeneca.com|
20175688|NCT04031885|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20175689|NCT03107988|New Approaches to Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
20175690|NCT04016324|Medtronic|Rianna Rapson (Prin. Clinical Research Specialist)|763-526-2170|rianna.k.rapson@medtronic.com|
20175691|NCT04709237|Coopervision|Paul Chamberlain|925-251-6682|PChamberlain@coopervision.com|
20175692|NCT02610192|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
20175693|NCT04048460|University of South Florida Department of Communication Sciences & Disorders|Michelle Arnold, AuD, PhD, CCC-A Assistant Professor|(813) 974-1262|mlarnold@usf.edu|
20175694|NCT01344057|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20175695|NCT00145509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20175696|NCT01359592|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
20175697|NCT02881996|Children's Mercy Hospital|Shawn St. Peter|816-234-3000|sspeter@cmh.edu|3575
20175698|NCT01276314|Chang Gung Memorial Hospital, Linko|Drug Hypersensitivity Clinical and Research Center, Laboratory of Dr. Wen-Hung Chung,|886-3-328-1200|kiruamairo@gmail.com|8494
20175699|NCT00749775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175700|NCT00933491|University of Michigan|Tae-Ju Oh|734-647-3320|taejuoh@umich.edu|
20175701|NCT02530294|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20175702|NCT02506816|Medica Scientia Innovation Research (MedSIR)|Director of Operations|0034 932 214 135|alicia.garcia@medsir.org|
20175703|NCT03019627|Dompé|Valeria Motta, PhD|02583831|info@dompe.it|
20175704|NCT01236196|San Francisco VA Medical Center|Dr. Timothy Carmody|415-221-4810|Timothy.Carmody@va.gov|6344
20175705|NCT01340976|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20175706|NCT02953821|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20175707|NCT01067352|Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
20175708|NCT02103478|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20175709|NCT00723606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175710|NCT02566759|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20175711|NCT00976898|Massachusetts General Hospital|Theodore Sunki Hong, MD|617-724-1159|tshong1@mgh.harvard.edu|
20175712|NCT05107128|Sage Therapeutics|Amy Bullock, PhD|617-949-5151|amy.bullock@sagerx.com|
20175713|NCT01740596|CHF Solutions|Audrey Singh|9523454217|audrey.singh@chf-solutions.com|
20175714|NCT01822132|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20175715|NCT01153581|Yale School of Medicine|Nina Stachenfeld|203-562-9901|nina.stachenfeld@yale.edu|219
20175716|NCT01723228|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20175717|NCT02434770|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20175718|NCT00660348|Sidney Kimmel Comprehensive Cancer Center|Michael Erdek, MD|410-502-7388|merdek1@jhmi.edu|
20189981|NCT02404441|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20189982|NCT01918033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175719|NCT01617603|Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road,|Prof. Stephen Atkin, Principal Investigator|+44(0)1482 675312|Stephen.Atkin@hyms.ac.uk|
20175720|NCT04174313|Hospital El Cruce|Nestor Pistillo|054 1142109000|npistillo@yahoo.com.ar|5636
20175721|NCT01282424|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20175722|NCT00528528|Janssen Research & Development, LLC Titusville, NJ|Clinical Leader|609-730-3174||
20175723|NCT03508219|European Cardiovascular Research Institute (ECRI-10)|Ernest Spitzer, MD|0031102062828|e.spitzer@ecri-trials.com|
20175724|NCT04466891|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20175725|NCT00445328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20175726|NCT00316199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20175727|NCT00590954|Memorial Sloan Kettering Cancer Center|Thomas Kaley, MD|212-639-5122|kaleyt@mskcc.org|
20175728|NCT04413929|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20175729|NCT02782949|Mayo Clinic|Dr Paul J. Limburg|507-284-2511|limburg.paul@mayo.edu|
20175730|NCT03316872|Princess Margaret Cancer Centre|Dr. Jennifer J Knox|+1-416-946-2399|jennifer.knox@uhn.ca|
20175731|NCT01966926|University of Minnesota|Dr. Jennifer Linde|612-624-0065|linde074@umn.edu|
20175732|NCT04074317|Xeris Pharmaceuticals Inc.|Dawn Harper, VP Clinical Devlopment|(215) 704-7290|dharper@xerispharma.com|
20175733|NCT06023394|Children's Mercy Kansas City|Dr. Emily Weisberg, pediatric anesthesiologist|9136605813|eweisberg@cmh.edu|
20175734|NCT03548584|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20175735|NCT00533949|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20175736|NCT00727194|Alexion Pharmaceuticals|Alexion Pharmaceuticals|855-752-2356|clinicaltrials@alexion.com|
20175737|NCT04269161|University of Missouri|Roger Fales|5738841564|falesr@missouri.edu|
20175738|NCT01677195|University of Texas Health Science Center at San Antonio / University of California, Davis* current|Dr. Bradley H. Pollock, PI|(530) 752-7250|pbollock@ucdavis.edu|
20175739|NCT04368429|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20175740|NCT03940508|New York University|Dr. Michael A. Lindsey|212-998-5959|michael.lindsey@nyu.edu|
20175741|NCT03633396|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20175742|NCT01012817|Mayo Clinic|Andrea Wahner Hendrickson MD|507-293-0553|WahnerHendrickson.Andrea@mayo.edu|
20175743|NCT02472756|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20175744|NCT02143414|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
20175745|NCT01532362|Jonsson Comprehensive Cancer Center: University of California at Los Angeles|Dr. Jay Moon Lee|(310) 794-7333|jaymoonlee@mednet.ucla.edu|
20175746|NCT02307552|UC Irvine|Thomas Ahlering, MD|714 456-6068|tahlerin@uci.edu|
20175747|NCT00110266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20175748|NCT00978731|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20175749|NCT00293384|Barbara Ann Karmanos Cancer Institute|Muneer Abidi, M.D.|(313) 576-8713|abidim@karmanos.org|
20175750|NCT02871128|Chung Shan Medical University|Dr. You-Cheng Shen|+886-4-24730022|youcheng@csmu.edu.tw|12107
20175751|NCT00548808|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20175752|NCT05044234|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20175753|NCT02940691|Kirby Institute|Professor Jason Grebely|+61 2 9385 0957|jgrebely@kirby.unsw.edu.au|
20175754|NCT05459129|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20175755|NCT04304001|Florida A&M University|Dr. Tanise Jackson, Director of Animal Welfare Research Integrity|850-599-3214|tanise.jackson@famu.edu|
20175756|NCT02102256|University of Southern California|Dr. Laurie Eisenberg|213-764-2826|laurie.eisenberg@med.usc.edu|
20175757|NCT05429203|Stanford University|Subhas Banerjee, MD|(650) 736-5555|subhas.banerjee@stanford.edu|
20175758|NCT02509065|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
20175759|NCT04033159|Dynacure|Dynacure|+33 3 74 95 20 50|info@dynacure.com|
20175760|NCT03523117|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
20175761|NCT03909009|Izmir Katip Çelebi University, Faculty of Medicine|Doç.Dr. Ayhan AŞKIN|00902322444444|ayhanaskin@hotmail.com|1529
20175762|NCT02377089|UCLA Semel Insititute|Andrew F. Leuchter|310-825-0207|afl@ucla.edu|
20189983|NCT02424968|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
20220802|NCT06360081|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161403|NCT02559414|New York University School of Medicine|Jeffrey Berger, MD|212 263 4004|Jeffrey.Berger@nyumc.org|
20161404|NCT04144959|Penumbra, Inc.|Erin Archard, Senior Director of Clinical Research, Vascular|+1 802 377 9715|earchard@penumbrainc.com|
20161405|NCT01973608|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20161406|NCT05970120|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20161407|NCT04692077|HPTN Statistical & Data Management Center|HPTN Statistical Manager|+1 (206) 667-4004|HPTN-Data-Access@scharp.org|
20161408|NCT05149313|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
20161409|NCT01867086|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
20161410|NCT04271475|Actelion Pharmaceuticals Ltd|Clinical Science Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20161411|NCT03493607|Icahn School of Medicine at Mount Sinai|Christina Layton|212-241-6231|christina.layton@mssm.edu|
20161412|NCT00419315|Philadelphia VA Medical Center|David Oslin|215 823 5894|dave.oslin@va.gov|
20161413|NCT03681678|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@corewellhealth.org|
20175763|NCT00499603|The University of Texas MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20220803|NCT00352417|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
20175764|NCT03323099|University of California San Francisco|Dr. Greg Marcus|4154763393|greg.marcus@ucsf.edu|
20175765|NCT05220397|Mayo Clinic|Mark Stegall, M.D.|507-266-2812|stegall.mark@mayo.edu|
20175766|NCT01502644|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
20175767|NCT01409291|Creighton University|Kathleen Packard, PharmD, MS, BCPS (AQ Cardiology)|402-481-3915|kathleenpackard@creighton.edu|
20175768|NCT02052739|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20175769|NCT01526889|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|Novartis.email@novartis.com|
20175770|NCT01573624|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175771|NCT00613509|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20175772|NCT00677807|Novartis Pharmaceuticals|Study Director|862-778-8300||
20175773|NCT01686646|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175774|NCT00314366|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
20175775|NCT03400033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20175776|NCT05409235|Chief Development Officer|D. Scott Edwards, Ph.D.|(339) 234-1333|sedwards@ocuterratx.com|
20175777|NCT00749931|Dune Medical Devices|Clinical Research Manager|+97246178000|shiri@dunemedical.com|
20175778|NCT01458327|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
20175779|NCT03993938|Henry Ford Health System|Trevor Szymanski MD|(313) 622-4168|tszyman1@hfhs.org|
20175780|NCT01524770|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220804|NCT02447744|MGH|Dr. Sara Lazar|617-724-7108|slazar@mgh.harvard.edu|
20220805|NCT01290302|Luitpold Pharmaceutical, Inc|Marsha Simon|631-772-3507|msimon@lpicrd.com|61807
20220806|NCT04140032|UCLA Fielding School of Public Health|Dr. Burt Cowgill|310-794-3569|bcowgill@ucla.edu|
20220807|NCT00615199|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220808|NCT03860974|University of California, San Diego|Brian Ilfeld|8582493660|bilfeld@health.ucsd.edu|
20220809|NCT02653625|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20220810|NCT00064987|Massachusetts General Hospital|Dr. William Crowley|617-724-2470|wcrowley@partners.org|
20220811|NCT00196326|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
20220812|NCT01473407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220813|NCT05223920|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
20220814|NCT00369941|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220815|NCT01027702|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
20220816|NCT00403585|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220817|NCT03514966|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
20220818|NCT02964312|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20220819|NCT04019626|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
20220820|NCT03001453|American Hip Institute|Dr. Benjamin Domb|630-455-7130|drdomb@americanhipinstitute.org|
20220821|NCT02862730|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
20220822|NCT03685344|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|
20220823|NCT02969421|Duke University Medical Center|Tashima Lambert, MD|484-201-9332|dr.tlambert@gmail.com|
20220824|NCT02121652|University at Buffalo School of Nursing|Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
20220825|NCT01103492|University Hospitals Case Medical Center|Jeffrey Marks, MD|216-983-4930|Jeffrey.Marks@uhhospitals.org|
20220826|NCT00261950|Amgen Inc.|Study Director|866-572-6436||
20220827|NCT01023035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220828|NCT02819284|Kala Pharmaceuticals, Inc.|VP Clinical Development|(781) 996-5252|Results007@kalarx.com|
20220829|NCT05584189|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
20220830|NCT02789137|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220831|NCT00445432|Abbott|Global Medical Services|800-633-9110||
20220832|NCT01090414|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20220833|NCT04080739|University of Alabama at Birmingham|Dr. Anthony Morlandt|205-996-2799|morlandt@uab.edu|
20220834|NCT03408171|Geisinger Medical Center|David L. Diehl, MD|570-214-2411|dldiehl@geisinger.edu|
20220835|NCT00247676|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20220836|NCT03594071|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
20220837|NCT05219448|University of Washington|Dr. Donald L. Chi|206-616-4332|dchi@uw.edu|
20220838|NCT01012336|Samsung Medical Center|Pf Duk-Soo Bae|82-2-3410-3519|huna0@naver.com|
20220839|NCT00911300|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220840|NCT03022370|SAMRC|Dr Andrew Gibbs|+27(0)312034899|andrew.gibbs@mrc.ac.za|
20220841|NCT02664181|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223-8100|TaussigResearch@ccf.org|
20220842|NCT00560391|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20220843|NCT03668808|Sansum Diabetes Research Institute|Wendy C Bevier|8056827638|wbevier@sansum.org|207
20220844|NCT02839772|University of Hull|Jill Brooks. PhD student,|01491 839044|jb284@btinternet.com|
20220845|NCT01526655|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
20220846|NCT00280735|UNC Lineberger Comprehensive Cancer|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20220847|NCT02142608|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director X-Ray and Ultrasound|609-514-2262|marialuigia.storto@diag.bracco.com|
20220848|NCT02001987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20220849|NCT01965860|Ghent University|Prof. Dr. Isabelle Van Herzeele|93325108|isabelle.vanherzeele@ugent.be|+32
20220850|NCT00955929|Memorial Sloan Kettering Cancer Center|John Mulhall, MD|646-888-6024|mulhalj1@mskcc.org|
20220851|NCT02064296|University of Michigan|Richard Harris|734-998-6996|reharris@med.umich.edu|
20220852|NCT01894087|University of Michigan|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
20220853|NCT02526667|Evic Romania|Dr. Olsavszky|40 21 335 70 90|research@evic.ro|
20220854|NCT02288325|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20220855|NCT04020887|Washington University School of Medicine|Thaddeus Budelier|314-273-8646|thaddeus.budelier@wustl.edu|
20220856|NCT02040077|Johns Hopkins University School of Medicine|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
20220857|NCT02683421|Navidea Biopharmaceuticals|Bonnie C. Abbruzzese, MS, RD|614-822-2327|babbruzzese@navidea.com|
20220858|NCT04138823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20220859|NCT04036110|University of North Carolina at Chapel Hill|Jia-Rong Wu, PhD, RN|859-323-4712|jiarong.wu2@uky.edu|
20220860|NCT02466685|Northwestern University|Mahdi Arshadi|3123839950|mahdi.arshadi@northwestern.edu|
20220861|NCT02593110|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20220862|NCT03548337|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220863|NCT01061476|Johns Hopkins University|Dr. Susheel Patil|410-550-0574|spatil@jhmi.edu|
20220864|NCT01546454|University of Arizona|Dr. Randy Bogan|520-621-1487|boganr@email.arizona.edu|
20220865|NCT01911273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220866|NCT03017612|Ms.|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
20220867|NCT04895982|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
20220868|NCT02213289|University of Chicago|Daniel Catenacci, MD|2-1000|dcatenac@bsd.uchicago.edu|
20220869|NCT02430038|Imperial College|Professor Christoph Lees|02083831000|christoph.lees@nhs.net|
20220870|NCT05410964|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
20220871|NCT01579747|Univeristy of New Mexico|Nicholas Lam|505 272 2610|nlam@salud.unm.edu|
20220872|NCT00727597|Georegtown University|Dr. Princy Kumar|2024440086|kumarp@georgetown.edu|
20220873|NCT02498613|Yale School of Medicine|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
20220874|NCT04761926|Oticon Medical|Nicole Amichetti, PhD|6093660424|nitc@oticonmedical.com|
20175781|NCT01431703|Shanghai Jiaotong university|Dr Ge zhi zheng|86021-34506250|shenyufeng303@gmail.com|
20175782|NCT02469610|CarmelMC|Dr LEVY FABER Dan|97248250289|DANLf@clalit.org.il|
20175783|NCT04590495|West Virginia University|Toni Marie Rudisill, MS, PhD|304-293-0687|trudisill@hsc.wvu.edu|
20175784|NCT03467425|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20175785|NCT01864291|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
20175786|NCT00712296|Icahn School of Medicine at Mount Sinai|Xiu-Min Li, MD|212-241-1755|Xiu-min.li@mssm.edu|
20175787|NCT01387607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175788|NCT02084628|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20175789|NCT05114005|The Ohio State University Comprehensive Cancer Center|Dr. Lise Worthen-Chaudhari|614-293-6281|wort08@osumc.edu|
20175790|NCT02285504|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20157552|NCT00584857|UAB|J. Michael Straughn, MD|205-934-4986|Michael.straughn@ccc.uab.edu|
20175791|NCT01168024|Osprey Medical|VP Of Clinial Affairs|952-955-8230|mshepard@ospreymed.com|
20220875|NCT05109611|SaNOtize R&D Corp|Chief Science Officer|778-899-0607|chris@sanotize.com|
20220876|NCT00573261|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|weijiang@duke.edu|
20220877|NCT00233948|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
20175792|NCT03091192|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20175793|NCT03853707|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20220878|NCT03573830|BC Children's Hospital Research Institute|Dr. Mariana Brussoni|(604) 875-3712|mbrussoni@bcchr.ubc.ca|
20220879|NCT03284723|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220880|NCT01250210|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
20220881|NCT00764881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20220882|NCT01567462|Emory University|Dr. Kenneth Ogan|404-778-3038|kogan@emory.edu|
20220883|NCT05021900|Rhizen Pharmaceuticals AG|Dr. Prajak Barde|+919820503970|pjb@rhizen.com|
20220884|NCT00886015|JohnHopkins U|Sheila West|410-955-2606|shwest@jhmi.edu|
20220885|NCT03397589|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
20220886|NCT03182933|University of Wisconsin|Laura Zitur - research program manager|6082638118|lzitur@wisc.edu|
20220887|NCT02548156|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220888|NCT06184399|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20220889|NCT01474200|Baxter Healthcare Corporation|Drew Jones, MD, Senior Medical Director|224-270-2659|drew_jones@baxter.com|
20220890|NCT03071692|Kowa Research Institute, Inc.|Director, Clinical Operations|1 (919) 433-1600|CTGResults@KowaUS.com|
20175794|NCT02492451|Zeynep Kamil Research and Teaching Hospital|Selcuk Selcuk|+905321630488|md_sel@hotmail.com|
20175795|NCT01221441|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
20175796|NCT01845155|Deutsches Zentrum für Musiktherapieforschung (Viktor Dulger Institut) DZM e.V. - German Center for Music Therapy Research|Dr. Heike Argstatter|+49-6221-7963960|heike.argstatter@dzm-heidelberg.de|
20175797|NCT01663272|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
20175798|NCT02665481|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20175799|NCT03285646|Regeneron Pharmaceuticals, Inc.|Study Director|844-734-6643|clinicaltrials@regeneron.com|
20175800|NCT03854916|Klein Buendel, Inc.|Dr. David Buller|3035654321|dbuller@kleinbuendel.com|
20175801|NCT01962558|MicroTransponder|VP Clinical Affairs|512-371-4160|studies@microtransponder.com|
20175802|NCT00348205|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20175803|NCT04300296|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20175804|NCT02896127|Novartis PharmaAG|Study Lead|+41613241111|novartis.email@novartis.com|
20175805|NCT00279708|The National Institutes of Health/ The National Heart, Lung, and Blood Institute|Joseph Fontana, MD|301-451-7740|fontanaj@nhlbi.nih.gov|
20175806|NCT03912233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20175807|NCT00326911|ImClone LLC|Chief Medical Officer||ClinicalTrials@ImClone.com|
20175808|NCT01948375|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@aliyun.com.cn|
20220891|NCT00444587|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20175809|NCT03004534|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|030@trioncology.org|
20220892|NCT00582660|University of Alabama at Birmingham|Martin J. Heslin M.D.|205-975-0450|marty.heslin@ccc.uab.edu|
20220893|NCT02229461|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20220894|NCT05273411|University of British Columbia|Jonathan Little, PhD|2508079876|jonathan.little@ubc.ca|
20220895|NCT02738138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20220896|NCT03127514|Amylyx Pharmaceuticals|Amylyx Pharmaceuticals, Head of Clinical R&D|(617) 682-0917|medinfo@amylyx.com|
20220897|NCT00295893|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20220898|NCT02665221|MS Comprehensive Care Center NYU Langone Health|Shannon Haas|646 501 7504|Shannon.Haas@nyumc.org|
20220899|NCT03639779|University of Central Florida College of Medicine|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
20220900|NCT02413229|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20220901|NCT02932462|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20220902|NCT01995513|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20220903|NCT01232452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220904|NCT02454933|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20220905|NCT04362670|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
20220906|NCT04753216|Northwestern University Feinberg School of Medicine|Daniela Matei, MD|312-472-4684|daniela.matei@northwestern.edu|
20220907|NCT01895777|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|8002430127|clintriage.rdg@boehringer-ingelheim.com|
20220908|NCT01342081|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20220909|NCT03044028|Cleveland Clinic|Carlos Higuera|954-659-5430|higuerc@ccf.org|
20220910|NCT04149821|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
20220911|NCT02481206|Zoll|Director of Clinical Affairs|724-968-3333|mosz@zoll.com|
20220912|NCT03648853|UCalifornia San Francisco|Pekka Talke|415 306 3602|pekka.talke@ucsf.edu|
20220913|NCT00839254|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175810|NCT01023659|Centre for Addiction and Mental Heatlh|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|74946
20175811|NCT04537806|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20175812|NCT01873989|Yale University|Dr. Declan Barry|203-285-2708|declan.barry@yale.edu|
20189984|NCT05012462|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
20189985|NCT01976507|Vanderbilt University Medical Center|Christopher Ellis||christopher.ellis@Vanderbilt.Edu|
20189986|NCT01762982|GlaxoSmithKline|GSK Response Center|866-435-7343||
20189987|NCT01794299|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
20189988|NCT03006393|Emory University|Dr. Michael Treadway|(404) 727-3166|mtreadway@emory.edu|
20189989|NCT02161458|University of Pennsylvania|Yvette Sheline, Principal Investigator|215-746-2637|cndslab@pennmedicine.upenn.edu|
20189990|NCT00201825|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-6529|Tanios.Saab@osumc.edu|
20189991|NCT05919732|Nemours|Dr. Gohalem Felema|904-416-5430|gohalem.felema@nemours.org|
20189992|NCT03136861|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20189993|NCT03390166|Mahidol|Punnee Pitisuttithum|6626435599|punnee.pit@mahidol.ac.th|
20189994|NCT03125148|Medical College of Wisconsin|Kulwinder Dua, MD|4149556896|kdua@mcw.edu|
20189995|NCT01735214|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20189996|NCT00257309|Centro Nacional de Investigaciones Cardiovasculares|Héctor Bueno|(+34) 914 531 200|hbueno@cnic.es|4110
20189997|NCT00186446|Stanford University|aimee-noelle swanson|650-736-4559|aimnoe@stanford.edu|
20189998|NCT03692871|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20189999|NCT02852824|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190000|NCT01316913|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190001|NCT05445557|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
20220914|NCT04460560|University of Pennsylvania|K. Rajender Reddy, MD|215-662-4311|ReddyR@pennmedicine.upenn.edu|
20220915|NCT00207883|Children's Healthcare of Atlanta / Emory University|Jana Stockwell, MD|404-785-1600|jana.stockwell@choa.org|
20220916|NCT02359994|Artivion|Priya Patel|678-290-4358|priya.patel@artivion.com|
20220917|NCT04597632|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20220918|NCT01823835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220919|NCT00201409|University of Michigan|Dr. Robert Hyzy|7349365201|rhyzy@umich.edu|
20220920|NCT01320150|Rush University Medical Center|Dr. Robert McCarthy|(312) 563-0448|Robert_J_McCarthy@rush.edu|
20220921|NCT00919854|Janssen R&D US|Senior Director R&D|1 609 730-7548||
20220922|NCT00789997|The Ottawa Hospital Research Institute|Dr Shawn Aaron||saaron@ohri.ca|
20220923|NCT00985491|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3261|pkeating@gidynamics.com|
20220924|NCT01893346|AstraZeneca Pharmaceuticals|Paul Newell, MBBS MRCP MFPM|+44 1625 515727|paul.newell@astrazeneca.com|
20220925|NCT02687529|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
20220926|NCT00464438|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20220927|NCT03020537|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20220928|NCT02296931|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
20220929|NCT01590277|VA Connecticut Healthcare System|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@va.gov|2594
20220930|NCT04386616|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20220931|NCT01377012|Novartis|Study Director|862-778-8300||
20220932|NCT02159079|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
20220933|NCT01319500|Center for Epidemiology and Health Research Berlin|Dr Juergen Dinger|+49 (0)30 945 10145|dinger@zeg-berlin.de|
20220934|NCT02448368|Ardea Biosciences, Inc.|Jesse Hall, MD|(858) 652-6672|JHall@ardeabio.com|
20220935|NCT01632280|Beth Israel Deaconess Medical Center|Dr. Miguel Alonso-Alonso|617-667-0240|malonso@bidmc.harvard.edu|
20220936|NCT01958073|Kaiser Permanente San Diego|Dr. Kimberly Ferrante|6199801439|klf0409@gmail.com|
20220937|NCT01734161|Weill Cornell Medicine|Klaus Kjaer, MD|(212) 746-2953|klk9001@med.cornell.edu|
20190002|NCT04063124|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
20190003|NCT02915783|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20161414|NCT04619004|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
20161415|NCT04979910|Icahn School of Medicine at Mount Sinai|Esther Lee|212-585-6133|esther.lee@mssm.edu|
20190004|NCT02950961|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Alison B Hamilton, PhD MPH|(310) 478-3711|alison.hamilton@va.gov|44157
20190005|NCT03055988|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190006|NCT01971255|National Institute of Allergy and Infectious Diseases|Matthew James Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
20190007|NCT01915914|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190008|NCT00145145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20190009|NCT00428714|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20190010|NCT00309751|Kowa Research Institute Inc|Bill Arana|919 433 1600|barana@kowaus.com|
20190011|NCT01736475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20190012|NCT00513071|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20190013|NCT01479010|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
20190014|NCT00824850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190015|NCT04820491|Virginia Commonwealth University|Jordan Tozer|804-828-5250|jordan.tozer@vcuhealth.org|
20190016|NCT02759575|University of Cincinnati|Vinita Takiar, MD, PhD, Associate Professor|(513)584-8956|Vinita.Takiar@UCHealth.com|
20220938|NCT03086551|University of Waterloo, Waterloo, Ontario, Canada|Sean K Meehan, PhD|5198884567|skmeehan@uwaterloo.ca|39278
20220939|NCT03736031|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|915-215-5103|elp-obgynresearch@ttuhsc.edu|
20161416|NCT05621239|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20161417|NCT06504524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161418|NCT04424225|University of Minnesota|Jessica Nielson|714-904-7939|jnielson@umn.edu|
20161419|NCT01114360|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-2590|frahbar@emory.edu|
20161420|NCT03106415|Mayo Clinic|Saranya Chumsri MD|904-953-2000|Chumsri.Saranya@mayo.edu|
20161421|NCT01804582|University of Maryland, Baltimore|Gloria M. Reeves, M.D.|410-328-3522|greeves@psych.umaryland.edu|
20161422|NCT03476876|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20161423|NCT00159913|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20161424|NCT00385723|Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA|Dr. Janice K. Kiecolt-Glaser|+1 614 293 3499|Janice.Kiecolt-Glaser@osumc.edu|
20161425|NCT01390779|UCSD|Mona Moshtaghi|858 534-6290|momoshta@ucsd.edu|
20161426|NCT03455829|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20161427|NCT03040414|HealthPartners Institute|Amy Becker LaFrance, Sr. Manager, Research Project Management Office|952.967.5079|Amy.B.LaFrance@healthpartners.com|
20175813|NCT00494494|University of North Carolina at Chapel Hill|Kennth L. Cohen, MD|919 843-0292|klc@med.unc.edu|
20175814|NCT01288534|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-9630|sprattda@med.umich.edu|
20175815|NCT01434823|University of Pennsylvania|Dr. Meeta P. Kerlin|215.614.0627|meeta.prasad@uphs.upenn.edu|
20175816|NCT00622427|University of Alabama at Birmingham|Rachel Fargason|205-934-5151|mfargason@uab.edu|
20175817|NCT01993108|University of Michigan|Chandra Sripada|734 232 0281|sripada@umich.edu|
20175818|NCT01299077|Eisai China Inc.|Haibo Song|0086-21-24192864|songhaibo@eisai.com.cn|
20175819|NCT02477020|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20175820|NCT00501540|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
20175821|NCT00519649|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175822|NCT01465802|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175823|NCT02331446|Federal Universisty of Pelotas|Msc. Matheus Pintanel Freitas||matheus.pintanel@hotmail.com|
20175824|NCT04879745|University of Pittsburgh Medical Center|Dr. Mehret Birru Talabi|412-383-8000|birrums@upmc.edu|
20175825|NCT00120042|The University of Western Australia|Dr Jan Dickinson|61-8-93401330|Jan.Dickinson@uwa.edu.au|
20175826|NCT03852316|University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
20175827|NCT04532112|University of Pennsylvania|Dr. Michael Kohanski|2153495766|michael.kohanski@pennmedicine.upenn.edu|
20175828|NCT03592641|Duke University Medical Center|John Strickler, MD|919-668-1861|john.strickler@duke.edu|
20161428|NCT01305655|NOPHO|Dr Jesper Heldrup|+46705172389|jesper.heldrup@skane.se|
20175829|NCT01663259|University of Michigan Rogel Cancer Center|Michelle Mierzwa|734-936-7810|mmierzwa@umich.edu|
20190017|NCT01818063|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edith Mitchell|215-955-8874|edith.mitchell@jefferson.edu|
20190018|NCT04909593|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20190019|NCT01018992|Emory University|Dr. Boadie Dunlop|404-727-8474|bdunlop@emory.edu|
20190020|NCT01825785|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20190021|NCT04721600|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
20190022|NCT01304940|VA ORD|Suzanne Pineles|857-364-5906|suzanne.pineles@va.gov|
20190023|NCT02065895|Boston Children's Hospital|Garry M. Steil, PhD|617-355-7504|garry.steil@childrens.harvard.edu|
20190024|NCT03137784|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20190025|NCT01205126|Janssen Research & Development, LLC|Director, Established Products|+1 609 730 3387;||
20190026|NCT00996164|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20190027|NCT00805792|Mayo Clinic|James F. Meschia, MD|904-953-2903|meschia.james@mayo.edu|
20190028|NCT01773707|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@Yale.edu|
20190029|NCT04328467|University of Minnesota|Radha Rajasingham, MD|612-626-8171|radha@umn.edu|
20190030|NCT01655498|Pelvalon|Director of Clinical|650-276-0130||
20190031|NCT00823966|Pfizer, Inc.|Pfizer ClinicalTraials.gov Call Center|1-800-718-1021|ClinicalTraials.govCallCenter@pfizer.com|
20190032|NCT04471805|University of Iowa, Department of Health and Human Physiology|Thorsten Rudroff, PhD|(319)467-0363|thorsten-rudroff@uiowa.edu|
20190033|NCT01393600|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20190034|NCT01072149|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190035|NCT03800563|Alma Lasers|Dr Meital Grafi-Cohen|+972-523708780|meital.grafi@almalasers.co.il|
20220940|NCT00451178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190036|NCT00950235|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD Principle Investigator|503 335 6751|victor.j.stevens@kpchr.org|
20190037|NCT01163214|Mayo Clinic|Mark J. Spangehl, M.D.|480-342-2377|spangehl.mark@mayo.edu|
20190038|NCT01090739|University of Michigan, Professor of Obstetrics and Gynecology|Dee Fenner, MD, Study Coordinating Investigator|734-647-5866|deef@med.umich.edu|
20190039|NCT00988429|Bial - portela & Cª, S.A.|Head of Clinical Research|+351 22 986 6100|clinical.trials@bial.com|
20190040|NCT00441168|Jan-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492|rangermu@its.jnj.com|
20190041|NCT02964234|University of Illinois at Chicago|Dr. Yamile Molina|312-355-2679|ymolin2@uic.edu|
20190042|NCT00825318|St. Luke's-Roosevelt Hospital Center|James Jones, MD|2125233530|JaJones@chpnet.org|
20190043|NCT01799993|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20190044|NCT04410445|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20190045|NCT01320683|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
20190046|NCT02291861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20190047|NCT04332991|Mass General Hopsital (PETAL Network Coordinating Center)|B.Taylor Thompson, MD|617-726-8854|TTHOMPSON1@mgh.harvard.edu|
20190048|NCT02336958|Helios Kliniken Schwerin|Dr. med. Ronald Seidel|0049 (0)385 5204251|ronald.seidel@helios-kliniken.de|
20190049|NCT03547154|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220941|NCT01260701|SWOG Statistical Center|Study Statistician|206-667-4623||
20220942|NCT00289120|Emory University|Kenneth Ogan|404-778-4898|kogan@emory.edu|
20220943|NCT03631199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20220944|NCT00577863|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220945|NCT04584684|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|847-702-0988|ljacox@live.unc.edu|
20220946|NCT01750190|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|060study@fibrogen.com|
20220947|NCT02955212|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20220948|NCT02009722|Mayo Clinic|Dr. Hans Sviggum|507-581-6083|sviggum.hans@mayo.edu|
20220949|NCT05387889|State University of New York at Buffalo School of Nursing|Dr. Tania Von Visger|7168292201|Taniavon@buffalo.edu|
20220950|NCT02319317|University of Pennsylvania|Catherine McDonald. PhD, RN|2157468355|mcdonalc@nursing.upenn.edu|
20220951|NCT00371436|VA RR&D, NCRAR|James A. Henry, Ph.D.|5032208262|james.henry@va.gov|57466
20161429|NCT03689712|Galera Therapeutics|Megan Holm|484-615-2036|mholm@galeratx.com|
20161430|NCT00689793|Departement of ambulatory care and community medicine, University of Lausanne, Switzerland|Dr Bernard Favrat MD|+41795566183314|Bernard.favrat@chuv.ch|
20161431|NCT00875056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161432|NCT01189292|Department of General, Abdominal and Transplant Surgery, University of Heidelberg|Dr. Ignazio Tarantino||ignazio.tarantino@med.uni-heidelberg.de|
20161433|NCT01483209|Duke University Medical Center|Dr. Cynthia Shortell|919-681-2223|cynthia.shortell@duke.edu|
20161434|NCT00660985|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com|
20161435|NCT02573246|Duke University Health System|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
20161436|NCT01902888|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.208.3365|artscott@wlgore.com|
20220952|NCT01311687|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599||
20175830|NCT03219333|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20175831|NCT01126541|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20175832|NCT03670810|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20175833|NCT01470469|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20175834|NCT04182100|PharmaEssentia Japan KK|Hiroaki Kawase|+81-3-6910-5103|hiroaki_kawase@pharmaessentia.com|
20175835|NCT06285981|Orthofix|Clinical Program Manager|0456719077|danielacangiano@orthofix.it|
20175836|NCT02942979|VA Bedford Medical Center|David Smelson|781-687-2845|david.smelson@va.gov|
20175837|NCT02504372|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175838|NCT03912753|Columbia University|Corina Lelutiu-Weinberger, PhD|212-342-1502|cl4265@cumc.columbia.edu|
20175839|NCT05059600|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20175840|NCT06259331|Supernus|Charlene A. Tucker|(301) 838-2500|ctucker@supernus.com|
20175841|NCT01365273|Monlycke Health Care|Joan Wilson, MSN, MHA, RN|706 504 8997|joan.wilson@molnlycke.com|
20175842|NCT03072134|Northwestern University|Christina Amidei, PhD|13126959124|christina.amidei@nm.org|
20175843|NCT04907032|UAB|Russell Stanley|325-829-8315|russellstanley74@gmail.com|
20175844|NCT02445027|Massachusetts General Hospital|Anna Gao RN.|617-643-6092|tearneylabtrials@partners.org|
20175845|NCT02519712|Memorial Sloan Kettering Cancer Center|Brian Shaffer, MD|212-639-2212|shaffeb1@mskcc.org|
20175846|NCT03037528|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
20175847|NCT04847674|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20175848|NCT02705820|Bank Of Cyprus Oncology Centre|Dr. Harris Charalambous|+35722847300|haris.charalambous@bococ.org.cy|450
20175849|NCT06017089|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
20175850|NCT01188603|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
20175851|NCT00989833|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20175852|NCT00308711|Cytokine PharmaSciences, Inc.|Barbara L. Powers|610-687-1776|bpowers@cytokinepharmasciences.com|214
20175853|NCT02167256|Yale University|Stephen Strittmatter|2037854878|stephen.strittmatter@yale.edu|
20175854|NCT00414388|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD (PI)|847-268-8200|shallmeyer@oncmed.net|
20175855|NCT00411619|Cincinnati Children's Hospital Medical Center|Dr. David Franz|513-636-4222|david.franz@cchmc.org|
20161437|NCT03149003|Sumitomo Pharma Oncology|Sheila Dhaskali|617-674-6800|Sheila.dhaskali@oncology.sumitomo-pharma.com|
20161438|NCT02228343|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
20161439|NCT00701636|LA BioMed at Harbor-UCLA Medical Center|Loren Miller MD|310-222-3813|Lgmiller@ucla.edu|
20161440|NCT00180297|Boston Scientific|Elisabeth Mouton - Clinical Trial Manager|+33 1 39 30 11 90|elisabeth.mouton@bsci.com|
20161441|NCT00973102|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
20161442|NCT01100567|Boston Children's Hospital|Dr. Amy DiVasta, PI|6173553792|amy.divasta@childrens.harvard.edu|
20161443|NCT02449018|Novartis Pharmaceuticals|Study Director|8627781873||
20161444|NCT03335254|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
20161445|NCT01355796|University of Iowa|Janice Launspach|319-356-2047|janice-launspach@uiowa.edu|
20161446|NCT01122108|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|kschmitz@lmarc.com|
20161447|NCT00831701|Department of Urology, University Hospital Zürich, Switzerland|Räto T. Strebel|0041-44-2551111|raeto.strebel@ksgr.ch|
20161448|NCT01440881|University of Florida|Dr. Thomas Beaver|352-273-5501|thomas.beaver@surgery.ufl.edu|
20161449|NCT00693654|Wake Forest University Health Sciences|Alan Fleischer, Jr., MD|336-716-7753|afleisch@wfubmc.edu|
20161450|NCT01977690|Johann Wolfgang Goethe University|Stephan Duetzmann|001491781470479|stephan.duetzmann@gmail.com|
20161451|NCT01274611|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20161452|NCT02290938|RAND|Elizabeth D'Amico|310-393-0411|damico@rand.org|6487
20161453|NCT00168454|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20161454|NCT02769962|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20161455|NCT04927663|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|rahul.aggarwal@ucsf.edu|
20161456|NCT03826342|University of Michigan|Golfo Tzilos Wernette|734-988-3424|gtzilos@med.umich.edu|
20161457|NCT01727011|Centre Antoine Lacassagne|Professeur JM Hannoun-Levi|04.92.03.12.60|jean-michel.hannoun-levi@nice.unicancer.fr|
20161458|NCT02733653|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
20161459|NCT05251753|Wake Forest School of Medicine|Caleb Suggs|3367164171|csuggs@wakehealth.edu|
20161460|NCT00890682|Pacira Pharmaceuticals, Inc|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20161461|NCT02212678|University of Minnesota|Lisa Coles, MS, PhD|4109264788|durh0016@umn.edu|
20161462|NCT02337634|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
20161463|NCT04068610|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20161464|NCT02046070|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20161465|NCT01818284|UT MD Anderson Cancer Center|Chitra Hosing, MD/Professor, Stem Cell Transplantation|713-792-7734|cmhosing@mdanderson.org|
20161466|NCT04030962|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20161467|NCT00306475|Vanderbilt Psychiatric Hospital|Herbert Meltzer, M.D.|615-327-7049|herbert.meltzer@vanderbilt.edu|
20175856|NCT02318693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161468|NCT05991934|Johns Hopkins Bloomberg School of Public Health|Johannes Thrul, PhD|(443) 318-6633‬|jthrul@jhu.edu|
20175857|NCT00689481|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175858|NCT00352612|Johns Hopkins University|Aaron Chen|4109556143|achen33@jhmi.edu|
20175859|NCT02219815|St. Boniface Hospital|Dr. Rakesh Arora|2042581078|rarora@sbgh.mb.ca|
20175860|NCT02742103|CSL Behring|Trial Registration Coordinator|6108784000|clinicaltrials@cslbehring.com|
20175861|NCT02533921|University of Colorado|Benzi Kluger, MD, MS, Principal Investigator|303-724-2194|Benzi.kluger@ucdenver.edu|
20175862|NCT04346615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20175863|NCT01507493|Huazhong University of Science&Technology|Xianwei Zhang|13037154560|znpain@sina.com|
20175864|NCT05226104|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20175865|NCT02349711|Food Science and Human Nutrition Department, University of Florida|Dr. Bobbi Langkamp-Henken|352-294-3721|henken@ufl.edu|
20175866|NCT01516268|Tehran University of Medical Sciences|Dr. Laleh Eslamian|0098218490|leslamian@tums.ac.ir|2415
20175867|NCT01595516|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
20190050|NCT01338506|Medical University of South Carolina|Dr. Sudie Back|843-792-9383|backs@musc.edu|
20190051|NCT02802111|Children's Hospital Los Angeles|Dr. Patrick Ross|323-361-7864|pross@chla.usc.edu|
20190052|NCT00088166|Celtic Pharma Development Services America Inc|Patrick O'Connor, MD, Managing Director Clinical Development|212-616-4050|patrick.oconnor@dev.celticpharma.com|
20190053|NCT02671266|Massachusetts General Hospital/Harvard Medical School|Dr. Angela Fang|617-643-7717|afang@mgh.harvard.edu|
20190054|NCT04884191|CTI BioPharma, Inc.|John Volpone SVP, Strategic Operations|+1 (206) 272-4652|jvolpone@ctibiopharma.com|
20190055|NCT00666705|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20190056|NCT02065609|Washington University School of Medicine in St. Louis|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
20190057|NCT00022490|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu|
20190058|NCT01029704|Theracos, Inc.|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20190059|NCT03845517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190060|NCT01109979|Brigham and Women's Hospital|Ellen Seely, MD|617-732-5012|eseely@partners.org|
20190061|NCT03500406|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
20190062|NCT02580799|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190063|NCT00807599|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun, MD|212-639-3228|hassounh@mskcc.org|
20190064|NCT01328756|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20190065|NCT01262456|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20190066|NCT00257894|Veterans Affairs Medical Center (VAMC), Providence|Damaris J. Rohsenow, Ph.D.|401-863-6648|damaris.rohsenow@va.gov|
20190067|NCT00800176|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190068|NCT00779194|STATE UNIVERSITY OF NEW YORK|Andras Perl|3154644194|perla@upstate.edu|
20205849|NCT02133742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205850|NCT01617187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205851|NCT01265420|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|317-875-9105|tdk@hand.md|
20205852|NCT00538824|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
20205853|NCT02554253|Mayo Clinic|Erica Wittwer|5072559814|wittwer.erica@mayo.edu|
20205854|NCT02664532|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
20205855|NCT04430283|Faraday Pharmaceuticals, Inc.|Clinical Trial Manager|206-492-5310|info@faradaypharma.com|
20205856|NCT03558191|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|0518-82342973|linan.wang@hengrui.com|
20205857|NCT01736254|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205858|NCT01561560|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20205859|NCT03862131|Washington University School of Medicine|Dr. Joshua Mitchell|314-362-1291|jdmitchell@wustl.edu|
20205860|NCT00937794|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20205861|NCT04777214|University of Pennsylvania|Samuel Cason|215-573-4336|sacason@pennmedicine.upenn.edu|
20205862|NCT00597935|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20205863|NCT00800865|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205864|NCT01738737|University of Sao Paulo|Sarah Rubia Ferreira de Meneses|+55(11)470898-71|sarah.meneses@usp.br|
20205865|NCT05263921|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205866|NCT00393068|Sarah Cannon Research Institute|Johanna C. Bendell, MD|615-329-7274|jbendell@tnonc.com|
20205867|NCT00223652|Northwestern University|David C. Mohr|312- 503-1403|d-mohr@northwestern.edu|
20205868|NCT00873288|Northwestern University|Bonnie Spring|312-908-2293|bspring@northwestern.edu|
20205869|NCT00093470|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
20205870|NCT05905601|University of Washington / University of North Carolina at Chapel Hill|Benjamin Buck, Ph.D.|(919) 445-4330|ben.buck@med.unc.edu|
20205871|NCT02514772|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
20205872|NCT03583606|Cincinnati Children's Hospital|Paul Spearman, MD|513-636-4509|paul.spearman@cchmc.org|
20205873|NCT04131933|Ottawa Hospital Research Institute|Dr. Mark Clemons|+1-613-737-7700|mclemons@toh.ca|70170
20205874|NCT00817206|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
20205875|NCT00126581|Dana-Farber Cancer Institute|Pasi Janne, MD, PhD||pjanne@partners.org|
20175868|NCT02096835|Huashan Hospital Fudan University Shanghai, China|Dr.Xiaoyu Yang|086-021-52889999|yangxiaoyu@huashan.org.cn|7693
20205876|NCT00793182|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
20205877|NCT01754207|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20205878|NCT03728140|Reproductive medcine of Jinan central hospatil|Dr. bin wu|+86 053185695203|wb0538@163.com|
20175869|NCT01706952|McGill University Health Centre|Marc A. Tewfik|+15147976673|marc.tewfik@mcgill.ca|
20175870|NCT00023673|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20175871|NCT02453594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175872|NCT02097134|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20175873|NCT00218062|The University of Texas Health Science Center at Houston|Dr Joy M. Schmitz|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
20175874|NCT00721526|NYU Grossman School of Medicine|Michael Bogenschutz|505-999-9325|Michael.Bogenschutz@nyulangone.org|
20175875|NCT00796861|Penn State Health|Dr. Leah Cream|717-531-8870|lcream@pennstatehealth.psu.edu|
20175876|NCT00529386|Dept of Urology, Queen's University|J C Nickel|613 548 2497|jcn@queensu.ca|
20175877|NCT03226652|Imperial College London|Professor M Cowie|+44 (0)207 3518856|m.cowie@imperial.ac.uk|
20175878|NCT05446909|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
20175879|NCT05944250|Stanford University|Dr. Yuri Ikeda|650-647-3485|yurikeda@stanford.edu|
20175880|NCT02665728|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
20175881|NCT02867605|Cleveland Clinic Foundation|Dr. Carol De la Motte|216 444-5374|delamoc@ccf.org|
20175882|NCT00813124|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20175883|NCT00079274|North Central Cancer Treatment Group|Dr. Steven Alberts|507-284-8432|alberts.steven@mayo.edu|
20175884|NCT00767676|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20175885|NCT02082717|Baptist Health South Florida|Diana D'Orazio-Garcia|786-594-9737|DianaDO@baptisthealth.net|
20175886|NCT01830140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20175887|NCT00617240|The University of North Carolina at Chapel Hill|Linmarie Sikich, MD|(919) 972-7500|lsikich@med.unc.edu|
20175888|NCT01611259|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
20175889|NCT03969212|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20175890|NCT02003625|Massachusetts General Hospital|Bimalangshu Dey, MD, PhD|617-724-1124|BDEY@mgh.harvard.edu|
20175891|NCT00075335|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
20175892|NCT01147653|Duke University School of Medicine, Division of Pediatric Blood and Marrow Transplantation|Jesse Troy, PhD||cordbloodtherapyinfo@dm.duke.edu|
20175893|NCT00280566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20175894|NCT00353366|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20175895|NCT01302392|Amgen, Inc.|Study Director|866-572-6436||
20175896|NCT00259857|Medical University of South Carolina|Deborah A Bowlby, MD, Asst.Professor, Pedeiatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
20175897|NCT00670228|sanofi-aventis|Trial Transparency Team||GV-contact-us@sanofi-aventis.com|
20175898|NCT05267054|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20175899|NCT01702233|Biologische Heilmittel Heel|Dr Istvan Zatik|+497221501(0)|istvan.zatik@heel.com|3192
20175900|NCT01552226|St. Joseph Mercy Hospital Ann Arbor|Dr. Robert Cleary|7347128150|Robert.Cleary@trinity-health.org|
20175901|NCT00376168|Protalix Ltd.|Einat Almon|972-4-9889488|einata@protalix.com|137
20175902|NCT05091528|Silverback Therapeutics, Inc.|Chief Scientific Officer|206-456-2900|info@silverbacktx.com|
20175903|NCT02214121|AstraZeneca|Brilinta Global Clinical Lead|+46 31 776 1000|kontakt@astrazeneca.com|
20175904|NCT02375672|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
20175905|NCT00457197|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
20175906|NCT02165111|Johns Hopkins University|Dr. Ricardo J. Bello|4109557566|rbello@jhmi.edu|
20175907|NCT02114879|Washington University|Emily Lenard|314-747-5706|lenarde@wustl.edu|
20175908|NCT02152995|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
20175909|NCT02967367|CHU Saint-pierre|Pr. Marie Bruyneel|00325354219|marie_bruyneel@stpierre-bru.be|
20175910|NCT02751983|Rocky Mountain Mental Illness Research, Education, and Clinical Center|Sean Barnes|720-723-6560|Sean.Barnes2@va.gov|
20175911|NCT01556204|Cleveland Clinic|Tommaso Falcone, M.D.|216-444-1752|falcont@ccf.org|
20175912|NCT03139916|Massachusetts General Hospital|Elizabeth R. Gerstner, MD|617-724-8770|egerstner@mgh.harvard.edu|
20175913|NCT01420081|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175914|NCT00025883|National Institute of DIabetes and Digestive and Kidney Dseases, National Institutes of Health|Dr. Phillip Gorden|301-402-7340|phillipg@mail.nih.gov|
20175915|NCT00218543|COLUMBIA UNIVERSITY|Frances R Levin, MD|212-543-5896|FRL2@COLUMBIA.EDU|
20175916|NCT02448875|Alcon Research|Senior Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20175917|NCT01282216|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
20175918|NCT05093426|Closed Loop Medicine Ltd.|Nihal Noori|07443603405|nihal.noori@closedloopmedicine.com|
20175919|NCT02682420|BD Peripheral Intervention|Courtney Rothwell, Clinical Project Manager|602-830-5544|courtney.rothwell@bd.com|
20175920|NCT04099524|Stanford University|Feng Vankee Lin, PI|6082156005|vankee_lin@stanford.edu|
20175921|NCT03337724|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20175922|NCT00773097|University Pittsburgh|Robert E. Schoen ME|412-648-9115|rschoen@pitt.edu|
20175923|NCT03238911|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20175924|NCT02239536|Seoul ST. Mary's hospital|Bo-In Lee|821083671055|gidoc4u@gmail.com|
20175925|NCT05645432|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20175926|NCT03195478|Bristol-Myers Squibb|Bristol-Myers Squibb Study Directo|1-855-907-3286|Clinical.Trials@bms.com|
20205879|NCT01188096|Atrium Health|Donald L. Durden, MD, PhD|980-442-2048|donald.durden@atriumhealth.org|
20220953|NCT02071225|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220954|NCT05027308|Takeda|Study Director|1-877-825-3327|TrialDisclosures@takeda.com|
20220955|NCT03571828|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20220956|NCT00666328|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
20220957|NCT05534061|University of Oregon|Anne Marie Mauricio, PhD|602-920-7459|amariem@uoregon.edu|
20220958|NCT01412086|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20220959|NCT04347993|Hackensack Meridian Health|Joshua Zenreich|5519965900|joshua.zenreich@hmhn.org|
20220960|NCT02829918|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@Moffitt.org|
20220961|NCT01253902|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20220962|NCT02441686|Dana-Farber Cancer Institute|Emily Benjamin|6176324167|emily_benjamin@dfci.harvard.edu|
20220963|NCT03762239|Barcelona Institute for Global Health (ISGlobal)|Dr. Xavier Basagaña|(+34) 93 214 7306|xavier.basagana@isglobal.org|
20220964|NCT04471428|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20220965|NCT03151304|Helsinn Healthcare|Francesco Scarci, Clinical Operations Manager|+41 (0)91 985 2121|francesco.scarci@helsinn.com|
20220966|NCT00548470|Nathan Kline Institute for psychaitric Research|Robert C Smith MD|845-398-6531|rsmith@nki.rfmh.org|
20220967|NCT02565511|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20220968|NCT01137071|Recepta Biopharma|Director of Clinical Trials|55 11 3709-2140|recepta@receptabio.com.br|
20220969|NCT04807400|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20220970|NCT03656744|HighTide Therapeutics|Chief Medical Officer|314-791-0593|adibisceglie@hightidetx.com|
20175927|NCT02215070|Duke University|Anthony Sung|919-668-1000|anthony.sung@duke.edu|
20220971|NCT01255137|National Cancer Institute, National Institutes of Health|Dr. Tito Fojo|301-496-2631|FojoT@mail.nih.gov|
20220972|NCT01696760|The Ohio State University Comprehensive Cancer Center|Joel Mayerson, MD|614-293-4420|joel.mayerson@osumc.edu|
20220973|NCT01332292|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220974|NCT03295630|Hull University Teaching Hospitals NHS Trust|Dr. Jayne Anderson|01482 875875|jayne.anderson@hey.nhs.uk|5099
20220975|NCT03910673|Duke Vaccine and Trials Unit|Emmanuel Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
20220976|NCT00098774|University of California, San Francisco|James Rubenstein, MD, PhD||jamesr@medicine.ucsf.edu|
20220977|NCT00796757|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20220978|NCT03142191|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20220979|NCT00825786|University of North Carolina, Department of Anesthesiology, University of North Carolina|Priya Kumar, MD|(919) 966-5136|pkumar@aims.unc.edu,|
20220980|NCT03091179|Stanford University|Vladimir Nekhendzy|650-498-4055|nek@stanford.edu|
20220981|NCT01130493|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|(908) 307-2234|Kaihong.Jiang@amneal.com|
20220982|NCT03730207|Medtronic|Jane Zhang|86+18612318110|jane.zhang7@medtronic.com|
20220983|NCT02969044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
20220984|NCT00879086|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
20220985|NCT04728802|Applied Biology, Inc.|Dr. John McCoy|+1 (949)387-4526|johnm@appliedbiology.com|
20220986|NCT04650204|Mayo Clinic|William Tatum, D.O.|507 284-2511|Tatum.William@mayo.edu|
20220987|NCT01330303|GlaxoSmithKline|GSK Response Center|866-435-7343||
20220988|NCT03714919|Nationwide Children's Hospital|Arlyne Thung, MD|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
20220989|NCT02123446|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20220990|NCT04388553|Tuen Mun Hospital|Anyon Chan|24680000|Ca663@ha.org.hk|+852
20220991|NCT00611624|Yale Comprehensive Cancer Center|Kira F. Pavlik, CCRP Clinical Research Coordinator Therapeutic Radiology|(203) 737-2587|kira.pavlik@yale.edu|
20220992|NCT02864355|The Medical University of South Carolina|George Guldan, MD|843-876-5744|guldan@musc.edu|
20220993|NCT04912232|Dartmouth Health|Norman A. Paradis|(603) 650-7254|Norman.A.Paradis@hitchcock.org|
20220994|NCT01070953|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20220995|NCT01957176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20175928|NCT02449356|Xiangya Hospital|Jiali Shao|+8684327413|zwyfeng@163.com|
20205880|NCT00851253|Boston Medical Center|Dr. Minh Tam Truong|617-638-7070|Minh-Tam.Truong@bmc.org|
20205881|NCT02384395|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
20205882|NCT01779648|SMG-SNU Boramae Medical Center|Principal Investigator|+82-10-9988-2691|turejsreal@hanmail.net|
20205883|NCT01618422|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
20205884|NCT03485222|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|(212) 241-8484|juan.badimon@mssm.edu|
20205885|NCT00756678|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20205886|NCT00367341|Emory University School of Medicine|Helen Mayberg, MD|404-727-6740|hmayber@emory.edu|
20205887|NCT02487277|University of California, San Francisco|Dr. Andrew Ko|(415) 353-7286|Andrew.Ko@ucsf.edu|
20205888|NCT05859971|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS, FACS|(608) 262-9060|neuman@surgery.wisc.edu|
20205889|NCT00109005|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
20205890|NCT03004976|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
20205891|NCT01143714|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
20175929|NCT05063734|Oxurion|Clinical Department|+32 16 75 13 10|info@oxurion.com|
20175930|NCT02595567|Washington University School of Medicine|Alexander Chen, Director of Interventional Pulmonology|314-454-8764|achen@dom.wustl.edu|
20175931|NCT01105533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175932|NCT00306592|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20175933|NCT04101526|Moffitt Cancer Center|Dr. Brian Gonzalez|813-745-3219|Brian.Gonzalez@moffitt.org|
20175934|NCT02488629|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
20175935|NCT02652624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20175936|NCT00953329|DukeUMC|Shirley Blalock|919-668-0999|shirley.blalock@duke.edu|
20175937|NCT02099721|Medtronic CRHF|Katy Muckala, Sr. Clinical Research Specialist|(763) 526-1767|katy.a.muckala@medtronic.com|
20175938|NCT01860417|CITOSPIN|Dr. Javier García-Sancho,|0034 983184827|jgsancho@uva.es|
20175939|NCT01403090|BiO2 medical|Luis Angel, MD|2102139778|langel@bio2medical.com|
20175940|NCT01049919|Zimmer Biomet|Hillary Overholser|574-373-2042|hillary.overholser@zimmerbiomet.com|
20175941|NCT00754247|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
20175942|NCT00844545|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
20175943|NCT02039427|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
20175944|NCT03058796|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
20175945|NCT02984995|Daiichi Sankyo Co., Ltd.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20175946|NCT04354831|Medical College of Wisconsin|Mary Beth Graham, MD|414-955-0500|mbgraham@mcw.edu|
20175947|NCT04589559|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
20175948|NCT03217136|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20175949|NCT01401530|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
20161469|NCT05601102|University of Stirling|Professor Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
20175950|NCT02939404|Obesity & Diabetes Clinical Research Section, NIDDK|Douglas C. Chang, MD|602.200.5312|Douglas.Chang@nih.gov|
20175951|NCT05560932|Yale University|Amy C Justice, MD, PhD|203-932-5711|amy.justice2@va.gov|3541
20175952|NCT06640829|The University of Kansas Medical Center|Holly Hull|9135881000|hhull@kumc.edu|
20175953|NCT01350128|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20175954|NCT02915029|University of New Mexico|Dr Vallabh Shah|505-272-9615|vshah@salud.unm.edu|
20175955|NCT01252290|University of Kansas Medical Center|Carol J. Fabian, MD; Professor|913-588-7791|cfabian@kumc.edu|
20175956|NCT02075437|Duke University|Dr. Nancy Zucker|919-668-0075|nancy.zucker@duke.edu|
20161470|NCT05288166|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20161471|NCT03007745|Corporal Michael J. Crescenz VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
20161472|NCT04284813|McLean Hospital/Harvard Medical School|Julie M. McCarthy, PhD|6178553521|jmccarthy@mclean.harvard.edu|
20161473|NCT00300677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20161474|NCT03446053|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
20161475|NCT03968159|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20161476|NCT02459275|University of Miami|Dr. D. Dante Yeh|305-585-1822|dxy154@med.miami.edu|
20161477|NCT02942654|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20161478|NCT01777945|Hoffmann-La Roche|Medical Communications|1-800-821-8590||
20161479|NCT01173029|Universidade Gama Filho|Paulo Robeto Benchimol Barbosa|+55-21-95320182|ecgar@yahoo.com|
20161480|NCT00895661|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20161481|NCT00791557|University Hospitals of Cleveland|Dr. Amanda Suggs, MD|216-844-7546|Amanda.suggs@uhhospitals.org|
20161482|NCT02066129|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
20161483|NCT02322190|National Cancer Institute|Dr. Ronald Gress|240-760-6167|rg26g@nih.gov|
20161484|NCT00357656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20161485|NCT04904809|Abbott Vascular|Sandeep Pingle|858-222-9673|sandeep.pingle1@abbott.com|
20161486|NCT00853840|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20175957|NCT04439240|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20175958|NCT03604692|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
20175959|NCT00727857|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20175960|NCT00637195|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175961|NCT01469065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175962|NCT00203203|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
20175963|NCT00858390|The University of Texas Health Science Center at Houston|G Hergenroeder, Principal Investigator|7135006130|Georgene.W.Hergenroeder@uth.tmc.edu|
20175964|NCT04646616|Drexel University School of Public Health|Dr. Mariana Lazo|2673596058|ml3629@drexel.edu|
20175965|NCT01020019|New York State Psychiatric Institute|Daniel Brooks|646-774-6171|brooksd@nyspi.columbia.edu|
20175966|NCT00835497|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20220996|NCT00224289|Principal Investigator|Bruce Shields, MD|203-785-6288|bruce.shields@yale.edu|
20220997|NCT00489827|Dept Cardiothoracic Surgery, Linköping University Hospital, SE58185 Linköping, Sweden|Rolf Svedjeholm|+46101034825|rolf.svedjeholm@regionostergotland.se|
20175967|NCT00094653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20220998|NCT03048552|Columbia University/New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
20220999|NCT05022212|University of California, San Francisco|Dr Anke Hemmerling, Co-Investigator|4154765878|anke.hemmerling@ucsf.edu|
20221000|NCT02729909|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20221001|NCT02730663|Taewoong Medical Co., Ltd.|JiYoung Ahn/Assistant manager|+82-70-4649-1624|sarahahn@stent.net|628
20221002|NCT06419907|University of Liverpool|Gemma Lewis|01744 646668|gemma.lewis@liverpool.ac.uk|
20221003|NCT03130777|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
20221004|NCT02586688|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
20221005|NCT04856917|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20221006|NCT06389396|Coloplast A/S|Julie Schnipper, Medical Writer|004549111257|dkjuls@coloplast.com|
20221007|NCT01013077|Southern California College of Optometry|William Ridder|714-449-7494|wridder@scco.edu|
20221008|NCT06195930|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20221009|NCT03999996|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20221010|NCT03690388|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20221011|NCT02487966|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
20221012|NCT00266630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221013|NCT03525886|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20221014|NCT05377749|University of North Carolina Lineberger Comprehensive Cancer Center|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
20221015|NCT04909853|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221016|NCT00743717|Los Alamitos Orthopaedic Group|Dr. Perry Secor|805-384-2748|vsarin@kinamed.com|
20221017|NCT01720225|The University of Texas MD Anderson Cancer Center|Elias Joseph MD./Professor|713-792-4764|ejabbour@mdanderson.org|
20221018|NCT01221207|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20221019|NCT00661193|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
20221020|NCT01811472|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20161487|NCT03553498|Albert Einstein College of Medicine|Polly Bijur|718-430-4217|polly.bijur@einsteinmed.org|
20161488|NCT04941807|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
20161489|NCT02968914|AstraZeneca Clinical Study Information Center|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20161490|NCT02713529|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20161491|NCT00047619|University of Calgary|Dr. Chester Ho|(403) 944 4620|chester.ho@albertahealthservices.ca|
20161492|NCT00915148|Stavanger UH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
20161493|NCT01565564|Tianjin Medical University|Dr. Xilin Yang|+86 22 83336727|yangxilin@tijmu.edu.cn|
20161494|NCT03995355|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO - Sr. Principal Research Optometrist|1-800-843-2020|MBishop4@its.jnj.com|
20161495|NCT00094107|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161496|NCT01184417|Alameda County Medical Center|Jonathan Rosenson MD|510-407-6743|jonrosenson@yahoo.com|
20161497|NCT01965899|Medtronic, plc|CRHF Clinical Research|800-328-2518|MedtronicCRMtrials@medtronic.com|
20161498|NCT00535821|Loma Linda University|H. Bryant Nguyen|909-558-4000|hbnguyen@llu.edu|44023
20161499|NCT02698371|University Fernando Pessoa|Prof. Patricia Manarte-Monteiro; Associate Professor|+351 225 071 300|patmon@ufp.edu.pt|
20161500|NCT02525094|MedImmune, LLC|Rene van der Merwe|301-398-2532|information.center@astrazeneca.com|
20161501|NCT02138240|Johns Hopkins University School of Medicine|Kimberly Gudzune|443-287-7238|gudzune@jhu.edu|
20161502|NCT00969436|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161503|NCT01018095|Tulane University|Patricia Kissinger, PhD|5049887320|kissing@tulane.edu|
20161504|NCT00054028|The Ohio State University Comprehensive Cancer Center|Maryam Lustberg, MD|614-293-0066|Maryam.Lustberg@osumc.edu|
20161505|NCT02117349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20161506|NCT02033213|KBC Zagreb|Maja Karaman Ilić, MD PhD|00385 1 2385 122|majakilic1@gmail.com|
20161507|NCT02242981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20161508|NCT02535416|Arrowhead Pharmaceuticals, Inc.|James Hamilton, MD|626-696-3400|jhamilton@arrowheadpharma.com|
20161509|NCT03474081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161510|NCT01176955|Wake Forest Baptist Medical Center|Brad Yentzer|336-716-4735|byentzer@wakehealth.edu|
20161511|NCT01058941|Oregon Health & Science University|Dr. Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20161512|NCT02739321|The Cleveland Clinic|Dr. Thomas Frazier||fraziet2@ccf.org|
20161513|NCT01742065|Kaiser Permanente Center for Health Research|Gloria D. Coronado|503 335 2427|Gloria.D.Coronado@kpchr.org|
20161514|NCT02440789|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20175968|NCT03921411|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20175969|NCT00330551|University of California, Los Angeles|Keith Nuechterlein, PhD|(310) 825-0036|keithn@ucla.edu|
20175970|NCT03697811|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20175971|NCT03120013|University of Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
20175972|NCT02098109|Washington University School of Medicine|Camille Abboud, M.D.|314-454-8304|cabboud@wustl.edu|
20161515|NCT03172130|University of Utah|Krishna Sundar|801-581-7806|krishna.sundar@hsc.utah.edu|
20161516|NCT02349685|SeoulNUBH|Nayoung Kim|+ 82-31-787-7008|nayoungkim49@empas.com|
20161517|NCT01350115|Novartis Pharmaceuticals|Study Director|862-778-8300||
20161518|NCT05565937|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20161519|NCT04544683|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Aaron Conger, MD|801-587-1493|u6007025@umail.utah.edu|
20161520|NCT00151372|Weill Cornell Medical College|George S. Alexopoulos, M.D.|914-997-5767|gsalexop@med.cornell.edu|
20161521|NCT02706197|Program for Clinical Oximetry and Imaging Geisel School of Medicine & Dartmouth Health; Dartmouth College|Periannan (Kupps) Kuppusamy MS, PhD|603-646-5490|Periannan.Kuppusamy@dartmouth.edu|
20161522|NCT02783170|Duke University|Dr. Geeta Swamy|919-681-5220|geeta.swamy@duke.edu|
20161523|NCT00541346|University of Oklahoma Health Sciences Center|Thomas M. Lock, M.D.|405-271-5700|Thomas-Lock@ouhsc.edu|45167
20161524|NCT04253587|UCSF Dept of Neurology|Peter Wais, Principal Investigator|415-502-1212|peter.wais@ucsf.edu|
20161525|NCT02008773|Indiana University Psychotic Disorders Program|Alan Breier, MD|317-880-8495|abreier@iupui.edu|
20161526|NCT04732949|Synairgen|Brooke Clarke, SVP, Head of Communications|02380 512 800|info@synairgen.com|
20161527|NCT01806064|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|233
20161528|NCT03046225|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
20175973|NCT01541826|University of Wisconsin-Madison, Department of Food Science|Dr. Bradley Bolling|608-890-0212|bwbolling@wisc.edu|
20175974|NCT01565291|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20175975|NCT06561217|Emory University School of Medicine|Ravi B. Parikh, MD, MPP|(352) 422-4285|ravi.bharat.parikh@emory.edu|
20175976|NCT02694315|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
20175977|NCT00006916|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20175978|NCT00558103|GlaxoSmithKline|GSK Response Center|866-435-7343||
20175979|NCT02367599|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
20175980|NCT03385239|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20175981|NCT00700011|Texas Oncology - Amarillo|Dr. Seah Lim|806-358-8654|seah.lim@usoncology.com|
20175982|NCT00678561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20175983|NCT00004031|SWOG Statistics and Data Management Center|Study Statistician|2066674623||
20175984|NCT01451424|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20175985|NCT02920983|CooperVision Inc.|Jose Vega, O.D., MSc., FAAO|9256213761|jvega2@coopervision.com|
20205892|NCT01106391|Cordis Corp.|Brandy Maschhaupt, Clinical Project Manager|847-887-5744|brandy.maschhaupt@cardinalhealth.com|
20205893|NCT00150345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20205894|NCT03646760|Henry Ford Health|Steven Keteyian, PhD|313-972-1920|sketeyian1@hfhs.org|
20205895|NCT00555568|CHOIR (Center for Healthcare Organization & Implementation Research|Susan V. Eisen|781-687-2858|susan.eisen@va.gov|
20205896|NCT01588353|XIA Project, Pharmaceuticals Sales Division, Asahi Kasei Pharma Corporation|Norihiro Tateishi, Manager|+81-3-3296-3641|xia_project@om.asahi-kasei.co.jp|
20205897|NCT01409993|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
20161529|NCT01286077|Janssen-Cilag Greece|EMEA Medical Affairs Director|+30 210 8090738||
20161530|NCT04638127|University of Cincinnati|Principal Investigator: Ashley Weber, PhD, RN, RNC-NIC|513-5580132|ashley.weber@uc.edu|
20161531|NCT01282294|Synthes GmbH|Clinical Research Scientist|0041 32 720 44 65|clinicalaffairs.emea@synthes.com|
20161532|NCT02408523|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20161533|NCT04256512|Mayo Clinic|Pooja P. Advani, MBBS|904-953-7291|Advani.Pooja@mayo.edu|
20161534|NCT01733771|Bnai Zion Medical Center|Dr. Samuel Attias|+972524707304|samuel.attias@b-zion.org.il|
20161535|NCT00167388|University of Pittsburgh|Dr. Toby Yanowitz|412-641-4111|yanotd@mail.magee.edu|
20161536|NCT05501795|Bismarck Lasik|Dr Stephen Wexler|701-222-2020|drwexler@bismarcklasik.com|
20161537|NCT02797184|Washington University in St. Louis|Dr. Lauren Park|3143633915|l.park@wustl.edu|
20161538|NCT04831424|Columbia University|Martin Picard|6467748967|mp3484@columbia.edu|
20161539|NCT03199391|Zimmer Biomet|Madison Murphy|5745262059|madison.murphy@zimmerbiomet.com|
20161540|NCT04243330|VA Rocky Mountain MIRECC|Nazanin Bahraini, PhD|720-723-6490|Nazanin.Bahraini@va.gov|
20161541|NCT03921554|Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
20161542|NCT00431951|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
20161543|NCT01789138|Department of Public Health, University of Tartu, ESTONIA|Prof. Anneli Uusküla|+372 7374195|anneli.uuskula@ut.ee|
20161544|NCT00343863|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20161545|NCT05824936|Nemours Children's Hospital|Dr. Abigail Strang|3026516400|astrang@nemours.org|
20161546|NCT00673881|Radiant Research|Michael H. Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|2220
20161547|NCT00096018|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20175986|NCT02908529|Brigham and women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
20175987|NCT04733157|University of Zimbabwe|Dr. Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
20161548|NCT01224444|White River Junction VA|Heiko Pohl|802-295-9363|heiko.pohl@dartmouth.edu|5595
20161549|NCT01221194|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20161550|NCT03119389|University of Maryland|Kerri Thom|410-706-6124|kthom@som.umaryland.edu|
20161551|NCT01342549|Michael E. DeBakey VAMC|Dr. Ricardo Jorge|713-794-7010|ricardo.jorge@va.gov|
20161552|NCT01299571|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161553|NCT00413010|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20161554|NCT00708734|Tampa VA Hospital|Tatjana Bulat|8135583932|tatjana.bulat@va.gov|
20161555|NCT01533922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161556|NCT05432167|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20175988|NCT02553421|ivWatch, LLC|Jason Naramore|855-485-2824|jason.naramore@ivwatch.com|7019
20175989|NCT02056171|Weill Cornell Medicine|Chani Traube|212-746-3056|chr9008@med.cornell.edu|
20175990|NCT00501891|The Preston Robert Tisch Brain Tumor Center at Duke|Annick Desjardins, MD|919-684-6173|annick.desjardins@duke.edu|
20161557|NCT01267175|Medtronic Diabetes|Harold Torunsky|(818) 576 5445|harold.torunsky@medtronic.com|
20161558|NCT02006069|Abbott|Kwangdeok Lee PhD|+19725269673|kwangdeok.lee@abbott.com|
20161559|NCT00958932|National Jewish Health|Dr. Bruce Bender|303-398-1697|benderb@njhealth.org|
20161560|NCT02690649|Parkview Health|Julie Hughbanks|260-266-1444|julie.hughbanks@parkview.com|
20161561|NCT02276547|Neovasc|Lisa Read, Clinical Study Manager|8558025180|lread@neovasc.com|323
20161562|NCT00530920|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161563|NCT03208530|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|(617) 732-5640|kei_ouchi@dfci.harvard.edu|
20161564|NCT00678834|The Ohio State University Wexner Medical Center|Dr. Chandan K. Sen, PhD. Professor and Associate Dean|614-247-7658|chandan.sen@osumc.edu|
20161565|NCT00316888|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
20161566|NCT02314364|Massachusetts General Hospital|Henning Willers, MD|617-726-5184|hwillers@mgh.harvard.edu|
20161567|NCT02144155|UCSD|David Feifel||dfeifel@kadimanp.com|
20161568|NCT00699218|UC Davis|Guohua Xia|916-734-3574|gxia@ucdavis.edu|
20161569|NCT01672866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20161570|NCT02273960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20161571|NCT01789606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161572|NCT01105377|Johns Hopkins Oncology Center|Nilofer S. Azad, M.D.||nazad2@jhmi.edu|
20161573|NCT03295396|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
20161574|NCT01825941|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
20161575|NCT03495102|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20161576|NCT01161537|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20161577|NCT00520910|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
20161578|NCT00358436|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20161579|NCT00668811|MedStar Washington Hospital Center|Dr Kenneth D. Burman|202-877-8109|kenneth.d.burman@medstar.net|
20161580|NCT03938324|Duke University|Sharron Docherty, PhD|919-668-3836|sharron.docherty@duke.edu|
20161581|NCT04558359|University of Kentucky|Alexander Flannery, PharmD, PhD|859-562-2766|alexander.flannery@gmail.com|
20161582|NCT04495868|Emory University|Brian Bobzien, MD|404-616-4226|brian.patrick.bobzien@emory.edu|
20161583|NCT01300351|AstraZeneca China|Guofei Dai|+86 21 60301242|guofei.dai@astrazeneca.com|
20161584|NCT02811913|VA Northeast Ohio Healthcare System|Dr. Svetlana Pundik|(216)791-3800|svetlana.pundik@va.gov|
20161585|NCT02674425|PolyPhotonix|Dr|00441740625|duncan@polyphotonix.com|557
20161586|NCT02258529|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20161587|NCT00443781|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20161588|NCT00430937|Novartis Pharmaceuticals|Study Director|862-778-8300||
20161589|NCT02634606|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|x61987
20161590|NCT01012921|Institut Straumann AG|Julia Dorn|0041619651111|julia.dorn@straumann.com|
20161591|NCT00353873|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161592|NCT03743064|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
20161593|NCT00286221|Johns Hopkins School of Medicine|Dr. Bradford Winters|4109559080|bwinter1@jh.edu|
20161594|NCT00875342|Weil Cornell Medical College|Program director|212 821 0783|jdifede@med.cornell.edu|
20161595|NCT00889200|Butler Hospital|Linda Carpenter, MD|401 455 6349|Linda_Carpenter_MD@Brown.edu|
20161596|NCT03973905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161597|NCT02553538|Massachusetts General Hospital|Dr. Sanja Percac-Lima|617-643-6980|spercaclima@partners.org|
20161598|NCT02648217|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20161599|NCT00106691|GTx, Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
20161600|NCT01754194|Medtronic MITG|Maria Young - Clinical Research Manager|+353 (0)1 4381611|maria.young@medtronic.com|
20161601|NCT00907296|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20161602|NCT02392403|Cochlear|Chris James|+33 534 638 584|cjames@cochlear.com|
20161603|NCT01264614|UNION COLLEGE|Cay Anderson-Hanley, PhD|518-388-6355|andersoc@union.edu|
20161604|NCT02776033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161605|NCT01403376|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
20161606|NCT02616393|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
20175991|NCT00466960|Seattle Cancer Care Alliance|Barbara Goff|206-543-3668|bgoff@u.washington.edu|
20221021|NCT03288714|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
20221022|NCT03280264|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
20221023|NCT02574832|Northwerstern University|Paloma Toledo, M.D.|312-472-3585|p-toledo@northwestern.edu|
20221024|NCT00524420|University of Washington|David H. Avery, MD, Professor|206-744-4527|averydh@u.washington.edu|
20221025|NCT00897910|Barbara Ann Karmanos Cancer Institute|Zaid S. Al-Kadhimi, M.D.|313-576-8022|alkadhiz@karmanos.org|
20221026|NCT02543944|University of Arkansas for Medical Sciences|Dr. Alison H. Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
20221027|NCT00629018|UMC Ljubljana|Prof. Dr. Bojan Vrtovec|+3861 522 2844|bvrtovec@stanford.edu|
20221028|NCT00645970|James A. Haley Veterans' Hospital|Kristin Phillips|813-972-2000|kristin.phillips3@va.gov|6721
20221029|NCT01037452|Novartis|Head New Therapeutic Opportunities|973-503-8000||
20221030|NCT01275846|Detroit Medical Center, Detroit, MI|Ileana L. Piña, MD, MPH, FAHA, FACC|216-225-7385|ilppina@aol.com|
20175992|NCT04973488|"University of Medicine and Pharmacy Victor Babes Timisoara"|Dr. Novacescu Alexandru|+40745064844|novacescu_alex@yahoo.com|
20175993|NCT02026115|University of Florida|Diana J. Wilkie, PhD, RN, FAAN, Professor, Prairieview Trust - Earl and Margo Powers Endowed Profess|352-273-6401|diwilkie@ufl.edu|
20175994|NCT04084769|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20175995|NCT03013491|CytomX Therapeutics, Inc.|Head of Clinical Operations|(650) 515-3185|clinicaltrials@cytomx.com|
20175996|NCT05445128|Ensoma|Ensoma head of regulatory or head of clinical research & development|6127191200|ddietz@ensoma.com|
20175997|NCT06893809|Başakşehir Çam and Sakura City Hospital|Dr. Emine Ozcan|05301592856|dr.emine3419@gmail.com|
20175998|NCT04953442|Baylor College of Medicine|Erica Soltero, PhD|4029100832|soltero@bcm.edu|
20175999|NCT01038778|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
20176000|NCT04740034|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20176001|NCT05648565|The University of Texas Health Science Center at Houston|David Z. Allen|713-500-5427|David.Allen@uth.tmc.edu|
20176002|NCT00368940|Weill Cornell Medicine|Dimitris N. Kiosses, Ph.D.|914-997-4381|dkiosses@med.cornell.edu|
20176003|NCT00991302|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20176004|NCT01707004|UW Carbone Cancer Center|Aric Hall|608-262-1604|achall@medicine.wisc.edu|
20176005|NCT02616250|GALDERMA|Fabien AUDIBERT, Sr CPM|+33 (0) 4 9238 3034|fabien.audibert@galderma.com|
20176006|NCT03085927|Indiana University School of Nursing|Dr. Sheri Robb, MT-BC|317-274-3152|shrobb@iu.edu|
20176007|NCT02573324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20176008|NCT03892889|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20176009|NCT01610700|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20176010|NCT02610868|Solstice Neurosciences|Regulatory Affairs Specialist|502-815-8148|regulatoryaffairs@usworldmeds.com|
20176011|NCT00679341|Genentech, Inc.|Medical Communications|800 821-8590||
20176012|NCT02684591|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
20176013|NCT00654628|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20176014|NCT01797536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176015|NCT05165121|MDHearing|Dr. Sandra Porps|7346572209|slp@mdhearingaid.com|
20176016|NCT01540370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20176017|NCT01532687|OHSU Knight Cancer Institute|Dr. Christopher Ryan|503-494-9000|ryanc@ohsu.edu|
20176018|NCT00403455|Department of Veterans Affairs|Dr. Zhewu Wang|(843) 789-7949|Zhewu.Wang@va.gov|
20176019|NCT03160703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20176020|NCT04805983|Associate Director of the Yale Alzheimer's Disease Research Unit|Adam Mecca, MD, PhD|(203) 785-4736|adam.mecca@yale.edu|
20176021|NCT00226941|Stanford Cancer Institute, Stanford University|George Albert Fisher, Jr, MD, PhD; Colleen Haas Chair, School of Medicine|650-723-2990|georgeaf@stanford.edu|
20176022|NCT01513291|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176023|NCT03732638|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20176024|NCT01358981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20176025|NCT03728582|Johns Hopkins University|Dr. Argye Hillis|(443) 287-4610|argye@jhmi.edu|
20176026|NCT02732847|Memorial University|Reza Tabrizchi|706-864-3381|rtabrizc@mun.ca|
20176027|NCT02738775|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20176028|NCT01018264|University of South Florida|Theresa Zesiewicz, MD, Professor of Neurology|813-974-5909|tzesiewi@health.usf.edu|
20176029|NCT01785524|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
20176030|NCT01060384|University of Nebraska Medical Center|Julie M. Vose|402-559-3848|jmvose@unmc.edu|
20176031|NCT03738826|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
20176032|NCT01859715|University of Colorado|Andrew A Monte, MD||andrew.monte@ucdenver.edu|
20176033|NCT04936685|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20176034|NCT00780572|VA SLC HCS|Director HSR&D|801-582-1565|IDEAS@va.gov|
20176035|NCT04542070|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20190069|NCT02326220|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20221031|NCT00918866|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
20190070|NCT02699099|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20176036|NCT05035017|CooperVision Inc.|Lee Hall BSc PhD MCOptom, FBCLA|925-251-6884|lhall@coopervision.com|
20221032|NCT01472692|UCSD|Department of Medicine|(858) 552-8585||
20221033|NCT03934541|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20221034|NCT02673775|Rutgers, the State University of New Jersey|Andrew Gow, PhD|848-445-4612|gow@pharmacy.rutgers.edu|
20221035|NCT00535405|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221036|NCT03519087|The Ohio State University|Dr. Stephanie Di Stasi|614-685-9779|stephanie.distasi@osumc.edu|
20176037|NCT03049813|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
20176038|NCT01813019|Novartis Pharmaceuticals|Study Director|862-778-8300||
20176039|NCT00427804|Emory University|Vin Tangpricha, M.D., Ph.D.|404-727-7254|vin.tangpricha@emory.edu|
20176040|NCT02164396|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S.- Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|190
20176041|NCT01193556|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20176042|NCT01072682|SeaStar Medical, Inc|Eric Schlorff|8444278100|eric@seastarmed.com|
20176043|NCT01696032|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20176044|NCT02188576|Boston Childrens Hospital|Dr. Susan Goobie, PI|6173557737|susan.goobie@childrens.harvard.edu|
20176045|NCT03025828|Icahn School of Medicine at Mount Sinai|Dr. Kirk Campbell|212-241-6271|kirk.campbell@mssm.edu|
20176046|NCT02203591|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
20176047|NCT05435885|Department of Rehabilitation Medicine, Pusan National University Hospital|Dr. Sanghun Kim|82-51-240-7485|kel5504@gmail.com|
20176048|NCT03306264|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20176049|NCT02143843|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20176050|NCT03029689|Fundació Lluita Contra les Infeccions|Dr. Roger Paredes|(+34) 93 465 7897|rparedes@lluita.org|8209
20176051|NCT01833403|University of Minnesota|Lisa Chow MD|612-625-8934|chow0007@umn.edu|
20176052|NCT02702401|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176053|NCT01228968|Washington University School of Medicine|Gary Skolnick|3143625292|gskolnic@wustl.edu|
20176054|NCT00247728|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
20176055|NCT01462357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20176056|NCT01106456|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
20176057|NCT04292730|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20176058|NCT01527292|University of Louisville, James Graham Brown Cancer Center|Dr. Shiao Woo|502-561-2700|sywoo001@exchange.louisville.edu|
20176059|NCT02549508|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|7044
20176060|NCT01482767|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20176061|NCT00556842|The Centre for Evidence-Based Orthopaedics|Paula McKay|905-521-2100|mckayp@mcmaster.ca|44131
20176062|NCT01247090|Columbia University Medical Center|Anjali Ganda, MD|617-835-3789|ag355@columbia.edu|
20176063|NCT01226719|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20176064|NCT01922024|Curetis USA, Inc.|Clinical Operations|800-659-1221|neil.mucci@curetis.com|
20176065|NCT01868633|University of Iowa|Dr. Unyime Ituk|3193562633|unyime-ituk@uiowa.edu|
20176066|NCT02457325|University of Sao Paulo / Bauru School of Dentistry|Carlos Ferreira Santos|+551432358200|cfsantos@fob.usp.br|
20176067|NCT01574703|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176068|NCT03591575|Chiesi Canada Corp.|Caroline Fradette, PhD|1-(800) 854-3534|c.fradette@chiesi.com|7014
20176069|NCT00862784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176070|NCT01660412|UAMS|James A Ntambi|5015265062|jantambi@uams.edu|
20176071|NCT03551210|R-Pharm|Aleksandr Chernavin, Regional Medical Director|0074959567937|chernavin@rpharm.ru|
20176072|NCT03265119|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20176073|NCT04579679|HUTCHMED International Corporation|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
20176074|NCT01709318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176075|NCT03370341|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
20176076|NCT02383758|Emory University|Dr. Nathan Call||nathan.call@choa.org|
20176077|NCT00273364|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20176078|NCT00646958|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
20176079|NCT04318210|Centers for Disease Control and Prevention|Dr. Allan Taylor|404-639-6120|avt0@cdc.gov|
20176080|NCT00600821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176081|NCT01607905|Karyopharm Therapeutics Inc|Jatin Shah|(617) 658-0600|jshah@karyopharm.com|
20176082|NCT02602288|Temple University|Dr. Stephen Lepore|215-204-9422|slepore@temple.edu|
20176083|NCT00194012|Johns Hopkins University School of Medicine|Robert Findling, MD, MBA, Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
20176084|NCT05036642|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
20176085|NCT01965067|Department of Anesthesiology and Pain Medicine, Hanyang University Hospital|Kyo Sang Kim, MD, PhD|+82-2-2290-8680|kimks@hanyang.ac.kr|
20176086|NCT01379963|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20176087|NCT02066298|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
20176088|NCT02448303|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20176089|NCT00630877|Abbott|Medical Information Specialist|800-633-9110||
20221037|NCT00104572|NIA|Josephine M. Egan,MD, clinical director NIA|410-558-8414|eganj@grc.nia.nih.gov|
20221038|NCT04309617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221039|NCT02290405|National Jewish Health|Bryan Simmons|303-398-1850|SimmonsB@NJHealth.org|
20221040|NCT02016183|Takeda|Medical Director|1-877-825-3327|trialdisclosures@takeda.com|
20221041|NCT03168022|Tonix Pharmaceuticals|Gregory Sullivan, MD||greg.sullivan@tonixpharma.com|
20221042|NCT02171195|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
20221043|NCT00129545|Boston Scientific|Watchman Trial Manager|1-800-227-3422||
20221044|NCT00770328|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
20221045|NCT02463773|University of Minnesota|Roy Cho, MD|612-626-2637|choxx548@umn.edu|
20221046|NCT03541317|University of Michigan|Amy M Kilbourne|734-845-3452|amykilbo@umich.edu|
20190071|NCT02659540|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20221047|NCT02263963|Spectrum Health|Dr. Nezar Jrebi|507-271-8284|jrebi.nezar@hotmail.com|
20221048|NCT02536846|McLean Hospital|Dr. Dost Öngür|617-855-3922|dongur@partners.org|
20221049|NCT03164616|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20190072|NCT01840722|University of Kentucky|Michele Staton, Associate Professor|859-257-2483|mstaton@uky.edu|
20190073|NCT05184062|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20190074|NCT00747149|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20190075|NCT01513447|Northwestern University Feinberg School of Medicine|Cynthia A. Wong, M.D.|312-472-3585|c-wong2@northwestern.edu|
20190076|NCT02534129|ProTechSure Scientific Inc.|L. Michael Glode, MD|303-526-9031|mike.glode@ucdenver.edu|
20190077|NCT03840200|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20190078|NCT05522777|Yakult U.S.A. Inc|Hideyuki Shibata|714-434-6500|hideyuki.shibata@yakultusa.com|
20190079|NCT05489770|EKHUFT|Dr Jane Povey- Research Facilitator|01227766877|jane.povey2@nhs.net|
20190080|NCT05487300|University of Utah|Dr. Guillaume Lamotte|801-585-7575|guillaume.lamotte@hsc.utah.edu|
20190081|NCT03141177|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20190082|NCT05006703|University Hospital Southampton|Professor Graham Roberts|02381 204335|g.c.roberts@soton.ac.uk|
20190083|NCT03565640|Atrium Wake Forest Baptist Health|Sachin Vyas|7865564412|svyas@wakehealth.edu|
20190084|NCT03854734|Penn State College of Medicine|Dr. Jennifer Kraschnewski, Professor of Medicine and Public Health Sciences|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
20190085|NCT02196259|University of Michigan|Dr. Scott Peltier|734-647-8077|spelt@umich.edu|
20190086|NCT00264576|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20190087|NCT02659059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20190088|NCT00092456|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190089|NCT04783389|Connect Biopharma|Dr. Malinda Longphre, PhD, Head of Clinical Operations|+1 510 520 3361|mlongphre@connectpharm.com|
20190090|NCT01241448|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190091|NCT03340961|Dr. Reddy's Lab, INC|Dr. Srinivas Sidgiddi, Senior Director|908-458-5362|Srinivassidgiddi@drreddys.com|
20190092|NCT04311983|Washington University School of Medicine|Matthew Kreuter, Ph.D.|314-935-3701|mkreuter@wustl.edu|
20190093|NCT03331978|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
20190094|NCT00630409|University of Pittsburgh|Leonard Appleman, MD, PhD|412-648-6538|applemanlj@upmc.edu|
20221050|NCT03449446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20221051|NCT01182376|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
20221052|NCT00625872|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221053|NCT02201277|University of California, San Francisco, Interventional Radiology|Maureen Kohi, MD|(415) 353-1300|maureen.kohi@ucsf.edu|
20221054|NCT01512160|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221055|NCT02972892|GE Healthcare|Research Program Integrator|262-290-6037|meghan.terry@ge.com|
20221056|NCT00866359|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20221057|NCT01625091|Unversity of Florida|Dr. Robert Cook|352-273-5869|cookrl@ufl.edu|
20221058|NCT02254265|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
20221059|NCT00768248|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
20221060|NCT03126448|Indiana University Health|Dr. Roman Natoli|713-516-8973|rnatoli@IUHealth.org|
20221061|NCT01547390|University of South Florida|Dr. Anthony Odibo|813-259-0828|aodibo@health.usf.edu|
20221062|NCT04182334|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
20221063|NCT01959295|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20221064|NCT02698033|Massachusetts General Hospital|Wayne Shreffler|6177266147|wshreffler@mgh.harvard.edu|
20221065|NCT04917861|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20221066|NCT01128179|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20190095|NCT04351243|Kinevant Sciences, Inc. on behalf of Kinevant Sciences GmbH|Simon Lowry, MD, Chief Medical Officer|(646) 495-5368|simon.lowry@roivant.com|
20221067|NCT02694328|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20161607|NCT01302054|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190096|NCT00990184|SIBCR|Steven E. Kahn|206-277-5515|skahn@u.washington.edu|
20221068|NCT00134004|Johns Hopkins University|Dr. Ephraim Fuchs|410-419-6479|fuchsep@jhmi.edu|
20221069|NCT07112885|Istanbul University, Department of Orthopedics and Traumatology|Mehmet Yağız Yenigün, MD (Principal Investigator)|+905544383142|mehmet.yenigun@istanbul.edu.tr|
20221070|NCT00720382|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20221071|NCT05192889|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
20221072|NCT05680740|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20221073|NCT06075277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20221074|NCT05355532|Privolzhsky Research Medical University|Ilya Pochinka, MD|+79030561932|pochinka4@yandex.ru|
20176090|NCT02873923|Institut Bergonié|Dr Carine Bellera|33 5 56 33 04 95|c.bellera@brodeaux.unicancer.fr|
20176091|NCT02717949|UT Southwestern Medical Center|Mamta K.Jain, MD|214-648-9914|mamta.jain@utsouthwestern.edu|
20176092|NCT02033005|Imperial College London|Dr Chris Gale|+44 (0) 2033153519|christopher.gale@imperial.ac.uk|
20176093|NCT01639001|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190097|NCT02446015|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20190098|NCT00687297|PrECOG|Study Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
20190099|NCT03695185|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20190100|NCT01672242|University of Maryland School of Medicine|Carl Shanholtz, MD|410.328.8141|cshanhol@som.umaryland.edu|
20190101|NCT05376397|Rutgers School of Public Health|Dr. Devin English, Prinicipal Investigator|19739727212|devin.english@rutgers.edu|
20190102|NCT03029156|Tufts Medical Center|Nicholas S. Hill|617-636-0688|nhill@tuftsmedicalcenter.org|
20190103|NCT01535261|Novartis|Study Director|862-778-8300||
20190104|NCT01137682|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20190105|NCT02791308|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
20190106|NCT02525744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20190107|NCT00472082|Emory University|Kenneth A. Newell, MD, PhD|404-727-2489|kanewel@emory.edu|
20190108|NCT02069379|University of Michigan|Alison Berent-Spillson|(734) 936-4400|berent@umich.edu|
20190109|NCT04421456|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20190110|NCT04617847|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20190111|NCT02206607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190112|NCT03398798|University of North Carolina at Chapel Hill|Christian Piers, DDS, MS, MFA|(828) 433-1242|christian.piers@gmail.com|
20190113|NCT04183491|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20190114|NCT04604652|HighTide Therapeutics|VP Clinical Operations|760-809-3523|cbennett@hightidetx.com|
20190115|NCT02466958|UCLA|Helen Lavretsky, MD|310-794-4619|HLavretsky@mednet.ucla.edu|
20176094|NCT02649972|Memorial Sloan Kettering Cancer Center|Dr. Eli Diamond, MD|212-610-0243|diamone1@mskcc.org|
20176095|NCT00424372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176096|NCT00739336|SUNY Upstate Medical University|Clinical Trials Officer|315-464-5476|Rudesj@upstate.edu|
20176097|NCT00912405|Intersect ENT|James Stambaugh|650-641-2103|jstambaugh@intersectent.com|
20176098|NCT00098839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20176099|NCT00323739|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20176100|NCT02148003|Cleveland Clinic|Nagy Mekhail, MD|216 444-9114|mekhain@ccf.org|
20176101|NCT05022810|HALEON|Marc Renard|+44 7880 182593|marc.m.renard@haleon.com|
20176102|NCT03348904|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20176103|NCT00436280|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176104|NCT04904510|UCLA|Dr. Noah Kojima|(310) 319-4377|nkojima@ucla.edu|
20176105|NCT00087568|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20176106|NCT01034397|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20176107|NCT02002767|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20176108|NCT00812929|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176109|NCT02476565|Vanderbilt University Medical Center|Antonio Hernandez, MD|615 322-4650|antonio.hernandez@vanderbilt.edu|
20176110|NCT04027686|UCLA Periodontics and Implant Surgery|Dr Perry Klokkevold|3108251927|pklokkevold@dentistry.ucla.edu|
20176111|NCT01263873|University Hospitals of Cleveland|Brian Radesic|3309725175|radesic@uakron.edu|
20176112|NCT00672438|Stanford University|Dr. Martin Angst, Professor of Anesthesia|650-498-5109|ang@stanford.edu|
20176113|NCT03915548|MGH Institute of Health Professions|Dr. Kathleen Lyons|617-643-5372|klyons2@mghihp.edu|
20176114|NCT00678691|SUNY Upstate Medical University|Thomas Schwartz|3154643166|schwartt@upstate.edu|
20176115|NCT01150838|University of Virginia|George Politis MD|434-924-2283|GDP8A@hscmail.mcc.virginia.edu|
20190116|NCT03989232|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20190117|NCT01930188|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20190118|NCT00869609|University of Pittsburgh|Trevor J Orchard|412-383-1032|tjo@pitt.edu|
20190119|NCT00337610|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20190120|NCT04012970|Edinburgh Napier Univerisity|Rebecca Hamilton, PhD student|0131 455|rebeccaisabel.hamilton@napier.ac.uk|2350
20190121|NCT04867382|HealthPartners Institute|Stephanie Hooker, PhD, MPH, MS, Principal Investigator|(952) 967-5056|Stephanie.A.HookerShowalter@HealthPartners.com|
20221075|NCT03325101|Mayo Clinic|Matthew Block, MD, PhD|507-266-7446|Block.Matthew@mayo.edu|
20190122|NCT01888484|Clinical Research Management Group|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
20176116|NCT02214147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20221076|NCT05221320|Biomed Valley Discoveries|Deborah Knoerzer, Director Translational Sciences|6368876429|dknoerzer@biomed-valley.com|
20221077|NCT06473519|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20221078|NCT03184571|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
20221079|NCT02514447|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20221080|NCT05351164|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
20221081|NCT03300817|Mayo Clinic|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
20221082|NCT00265759|Baylor College of Medicine|Matthew J. Ellis, MB, BChir, BSc., PhD, FRCP|713 798-1999|Matthew.Ellis@bcm.edu|
20221083|NCT03122730|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
20221084|NCT01581437|Virginia CU|Kenneth Ellenbogen|804-828-7565|kellenbogen@mcvh-vcu.edu|
20221085|NCT03729596|MacroGenics, Inc.|Stephen L. Eck, MD|301-251-5172|info@macrogenics.com|
20221086|NCT03713593|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20221087|NCT05849259|Massachusetts General Hospital|Dr. Christine S Ritchie|415-672-1780|csritchie@mgh.harvard.edu|
20221088|NCT03560037|University of California Davis|Christopher L. Bowlus, MD|916-734-8851|clbowlus@health.ucdavis.edu|
20221089|NCT03620708|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
20221090|NCT05168202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20221091|NCT04483583|University of Florida|Dominick J Angiolillo|904-244-2636|dominick.angiolillo@jax.ufl.edu|
20221092|NCT04011722|Abbott|Nels Engblom|3198533946|nels.engblom1@abbott.com|
20221093|NCT05061134|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20221094|NCT00001521|Clinical Center|Merke, Deborah|+1 301 496 0718|dmerke@nih.gov|
20221095|NCT03176134|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20221096|NCT03915652|Brigham and Women's Hospital|Dr. Candace Feldman|6175251035|cfeldman@bwh.harvard.edu|
20221097|NCT05736861|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20221098|NCT03410056|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20221099|NCT00879255|Department of Veterans Affairs|Leslie A. Morland, Clinical Psychologist|(619) 497-8406|leslie.morland@va.gov|
20221100|NCT05239611|University of Kansas Medical Center|Joel Mermis|913-588-6045|jmermis@kumc.edu|
20221101|NCT00077207|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
20221102|NCT02400996|Sir Ganga Ram Hospital, New Delhi, India|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
20221103|NCT03052751|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20221104|NCT04882241|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicalTrialsDisclosure@msd.com|
20221105|NCT00074308|Abramson Cancer Center of the University of Pennsylvania|Jane Daly|215-662-2812|jane@mail.med.upenn.edu|
20221106|NCT01349192|University of North Carolina, Chapel Hill|Marianne S. Muhlebach, PI|(1) 919 966 1055|Marianne_Muhlebach@med.unc.edu|
20221107|NCT01973439|MRC Clinical Trials Unit at UCL|Trial manager|02076704825|silvia.forcat@ucl.ac.uk|
20221108|NCT02144714|Samsung Bioepis|Samsung Bioepis|+82 31 8061 4534|sbregistry@samsung.com|
20221109|NCT02038010|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
20221110|NCT02262325|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
20221111|NCT02815995|The University of Texas MD Anderson Cancer Center|Dr. Neeta Somaiah|(713) 792-3626|nsomaiah@mdanderson.org|
20221112|NCT01071915|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20221113|NCT01125189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20221114|NCT00114140|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20221115|NCT00110396|Merck Serono SA|Bettina Stubinski/Medical Responsible|+41224143396||
20221116|NCT00387335|University of Chicago|Ezra Cohen|773-702-4137|ecohen@medicine.bsd.uchicago.edu|
20221117|NCT02414958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176117|NCT03204942|National Cancer Institute|Director of Ethical Committee|+201224276580|drsherryfanous@yahoo.com|
20221118|NCT00815880|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
20161608|NCT00857948|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20161609|NCT00084149|University of California, San Diego|Dr. Florin Vaida|619 543-8045|fvaida@ucsd.edu|
20161610|NCT03123614|University of Utah Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
20161611|NCT03757130|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20161612|NCT03619135|University of Iowa College of Dentistry|Dr. Kyle Stein|319-384-5105|kyle-stein@uiowa.edu|
20221119|NCT00245466|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20221120|NCT03885661|University of Pennsylvania|John Millar, PhD|215-898-0638|jsmillar@pennmedicine.upenn.edu|
20221121|NCT05064397|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20221122|NCT02232984|Boston Scientific|Eszter Pais|6515825307|eszter.pais@bsci.com|
20221123|NCT02607046|Department of Veterans Affairs|Dr. Steven Prior|410-605-7000|steven.prior@va.gov|54129
20221124|NCT00769379|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20221125|NCT04408729|Massachusetts General Hospital|Jessica Haberer, MD, MS|617-724-0351|jhaberer@mgb.org|
20221126|NCT03164538|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
20221127|NCT04194645|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221128|NCT03076775|University of North Carolina at Chapel Hill|Ashley Battarbee, MD, MSCR|205-975-2361|anbattarbee@uabmc.edu|
20221129|NCT01776632|San Diego State University|Elva Arredondo|(619) 594-3481|earredon@sdsu.edu|
20221130|NCT04604795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221131|NCT04768686|Hanmi Pharm. Co., Ltd.|Young Su (Bobby) Noh|82-2-410-9277|63forever@hanmi.co.kr|
20221132|NCT03022916|UAB|Director of Clinical Trials, UAB Dermatology|2055029960|Lmroop@uabmc.edu|
20221133|NCT04502212|GE Research|Diane Minas|(518)698-3959|minas@ge.com|
20221134|NCT00111241|Monash University|Prof Susan Davis|+61399030827|susan.davis@monash.edu|
20221135|NCT05934396|University of North Carolina at Chapel Hill|Marisa Marraccini, PhD|919-843-5099|mmarracc@unc.edu|
20221136|NCT02096744|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221137|NCT02216097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221138|NCT02445963|Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC)|Christopher Duplessis, MD|301-319-9047|Christopher.a.duplessis.mil@mail.mil|
20221139|NCT00125515|New York Psychiatric Institute|Dr Adam Bisaga|212-543-6542|bisagaa@nyspi.columbia.edu|
20221140|NCT01449812|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221141|NCT02517463|The University of Hong Kong|Dr. Raymond Li|+852 22553914|raymondli@hku.hk|
20221142|NCT03785327|The University of Texas at Dallas|Dr. Noah Sasson|972-883-2541|nsasson@utdallas.edu|
20221143|NCT03180645|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221144|NCT04208750|Indiana University|Dr. Dawn Meyer|812-855-0559|meyerd@indiana.edu|
20221145|NCT02163057|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20221146|NCT01499095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20221147|NCT04358081|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20221148|NCT00443729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221149|NCT01842438|Australian Catholic University|Prof Liz Forbat, PI|+61 475978476|elizabeth.forbat@acu.edu.au|
20221150|NCT01622257|Assistant professor of Obstetrics & Gynecology, Ain-shams faculty of medicine|Dr. Moustafa Ibrahim|00201001955996|mi_monem@yahoo.com|
20221151|NCT00782626|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
20221152|NCT04054765|play4REAL XR Lab at the Yale School of Medicine|Dr. Kimberly Hieftje|2037872402|kimberly.hieftje@yale.edu|
20221153|NCT01198769|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221154|NCT03242408|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
20221155|NCT02099786|VA RR&D National Center for Rehabilitative Auditory Research|Dr. Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
20221156|NCT03718832|MIT Sloan School of Management|Joseph doyle|6174523761|jjdoyle@mit.edu|
20221157|NCT01996241|London School of Hygiene and Tropical Medicine|Dr Tara Beattie|0044 (0)2079272613|tara.beattie@lshtm.ac.uk|
20221158|NCT01295112|The Emmes Corporation|Traci Clemons|1-301-251-1161|tclemons@emmes.com|10212
20221159|NCT01068262|Merck Sharp and Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221160|NCT04182490|Lumen Bioscience, Inc.|Senior Medical Director|206-899-1904|trials@lumen.bio|
20221161|NCT05024747|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20221162|NCT04428034|UT Health San Antonio|Kylie Meyer, PhD|210-450-5386|meyerk1@uthscsa.edu|
20221163|NCT00245518|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20221164|NCT05262387|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20161613|NCT01439126|Concordia Pharmaceuticals Inc.|John AR McCleery, CPA, CA, Managing Director and CFO|1-246-256-1861|jmccleery@concordiarx.com|
20161614|NCT03242018|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20161615|NCT00687609|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221165|NCT02556801|HAL Allergy|Andrey Larionov, MD, Head of Clinical Development|+31881959189|alarionov@hal-allergy.com|
20221166|NCT04747470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20221167|NCT01942993|Icahn School of Medicine at Mount Sinai|Dr. Philip A Friedlander|212-824-8584|philip.friedlander@mssm.edu|
20221168|NCT02143128|Dept of Anaesthesia and Intensive Care, Akershus University Hospital, Norway|Dr Vladimir Kuklin|98838024|vkuklin@me.com|0047
20161616|NCT02635347|Rutgers-NJ Medical School|Baburao Koneru, MD, MPH|973-972-9599|koneruba@njms.rutgers.edu|
20190123|NCT02102724|Rush University College of Nursing|Barbara Swanson|3129428977|BARBARA_A_SWANSON@RUSH.EDU|
20190124|NCT01326455|UAlberta|Jennifer Fech||jennifer.fech@albertahealthservices.ca|
20190125|NCT02203513|National Cancer Institute|Dr. Jung-min Lee|240-760-6128|leej6@mail.nih.gov|
20190126|NCT01441596|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190127|NCT02008916|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20190128|NCT01528605|Peking University|Xiaoming Lin|010-82805336|linbjmu@bjmu.edu.cn|
20190129|NCT01681511|ICET, Inc.|Dr. Shantha Sarangapani|781-769-6064|Shantha@icetinc.com|
20190130|NCT01156675|Globus Medical|Director, Clinical Affairs|610-930-1800|jmyer@globusmedical.com|1669
20190131|NCT02151994|BIAL-Portela & Ca, S.A.,|Head of Clinical Research|(+351)-22-9866100|clinical.trials@bial.com|
20190132|NCT02432274|Eisai Ltd.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20190133|NCT00090519|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
20190134|NCT00116649|Graceway Pharmaceuticals LLC|Sharon Levy, MD VP Product Development|267-948-0500|sharon.levy@gracewaypharma.com|
20190135|NCT02161146|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20190136|NCT00845520|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
20205898|NCT02677220|Cochlear|Director of Clinical Research|3032647180|loneill@cochlear.com|
20221169|NCT01350271|University of Kelaniya|Dr Balachandran Kumarendran|0094112961140|drbkumaran@gmail.com|
20221170|NCT02906670|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
20221171|NCT00344448|National Institute of Dental and Craniofacial Research|Gabor G Illei, Md, principal Investigator|301 496-4072|illeig@mail.nih.gov|
20221172|NCT04805515|Rutgers Center for Tobacco Studies|Andrea Villanti|732 235 9585|andrea.villanti@rutgers.edu|
20221173|NCT01783886|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20221174|NCT03104855|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
20221175|NCT00940316|Northwestern University|Dr. Al Benson|(312) 695-0184|albenson@nm.org|
20221176|NCT02324582|Southern Illinois University School of Medicine|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
20221177|NCT01924559|Lehigh Valley Hospital|Marna Rayl Greenberg, DO, MPH|484-884-7514|Marna.Greenberg@lvh.com|
20221178|NCT00996489|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20221179|NCT06372210|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20221180|NCT03112473|Department of Rehabilitation Science, The Hong Kong Polytechnic University|Prof. Shamay Ng|27664889|shamay.ng@polyu.edu.hk|
20221181|NCT00523939|Duke University Medical Center|Dr. David Rizzieri|919-668-1040|rizzi003@mc.duke.edu|
20221182|NCT02286843|Memorial Sloan Kettering Cancer Center|Dr. Gary Ulaner, MD, PhD|212-639-7373|carrasj1@mskcc.org|
20221183|NCT00719186|Yale University|Heping Zhang|203-785-5185|rmn-dcc@panlists.yale.edu|
20221184|NCT01855828|Yale University|Lajos Pusztai, MD, DPhil|203-737-6858|lajos.pusztai@yale.edu|
20221185|NCT01866098|Connecticut Mental Health Center|Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7500|cenk.tek@yale.edu|
20221186|NCT03649347|Stress, Trauma, and Anxiety Research Clinic (STARC) at Wayne State University|Kathleen Gorski, Research Coordinator|313-577-9202|kathleen.gorski2@med.wayne.edu|
20221187|NCT04239027|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20221188|NCT03629080|Hookipa Biotech GmbH|Hookipa Front Desk|+43 1 890 63 60 0|office@hookipapharma.com|
20221189|NCT03172494|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20221190|NCT00143390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221191|NCT03417687|Polarean|Laura Sutton|919-206-7900|lsutton@polarean.com|121
20221192|NCT02764151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221193|NCT01450683|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20221194|NCT02614274|University of Missouri|James L. Cook, Director of Research|573-884-4689|cookjl@health.missouri.edu|
20221195|NCT02108912|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
20221196|NCT04977479|National Institute of Allergy and Infectious Diseases|Pamela Frischmeyer-Guerrerio|301-402-9782|pamela.guerrerio@nih.gov|
20221197|NCT02084160|Exalenz|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|
20205899|NCT00965146|Stryker Orthopaedics®|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
20205900|NCT05067452|University of California San Francisco|Dr. Kartika Palar|415-502-8492|kartika.palar@ucsf.edu|
20205901|NCT00067470|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
20205902|NCT01135017|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
20205903|NCT01148693|Tehran medical university of science|Dr. Rasoul sotoudehmanesh|(+98 21) 82414000|r.sotudemanesh@gmail.com|82415000
20205904|NCT03688685|Cadent Therapeutics (A Novartis Company)|Cadent Therapeutics (A Novartis Company)|1-888-669-6682|Novartis.email@novartis.com|
20205905|NCT01504971|ChinaPLAGH|Dr. Weifeng Wang|0086-13911952018|wangwf301@hotmail.com|
20205906|NCT00050622|Florida International University|William E. Pelham, Jr.|305-348-3002|wpelham@fiu.edu|
20205907|NCT02703987|Danone Nutricia Research|Danone Nutricia Research||register.clinicalresearchnutricia@danone.com|
20205908|NCT00936117|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-745-2723|CR_Study_Registration@mdanderson.org|
20205909|NCT04581863|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
20205910|NCT01803711|UConn Health Center|Jayesh Kamath MD PhD|8606796727|jkamath@uchc.edu|
20190137|NCT02613403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221198|NCT00852202|Allergan Sales LLC|Therapeutic Area Head,|877-277-8566|IR-CTRegistration@allergan.com|
20221199|NCT04359797|Vanderbilt University Medical Center|Dr. Edward T. Qian|615-322-2386|edward.t.qian@vumc.org|
20221200|NCT02905032|Mayo Clinci|Peter A. Noseworthy, M.D.|507-255-2446|Noseworthy.Peter@mayo.edu|
20221201|NCT00739063|UT MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD, MS / Associate Professor||CR_Study_Registration@mdanderson.org|
20221202|NCT04927845|Strive Weekly Inc|Dr. Leslie Rith-Najarian, Principal Investigator|3108002143|leslie@striveweekly.com|
20221203|NCT01004744|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
20221204|NCT01682811|Medical College of Wisconsin|Harry T. Whelan MD, Bleser Professor of Neurology|414-266-7544|hwhelan@mcw.edu|
20161617|NCT01617447|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20161618|NCT00780273|University if Rochester Medical Center|Dr. George Romanos|585-276-4149|GeorgiosRomanos@urmc.rochester.edu|
20161619|NCT00121641|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20161620|NCT04468074|University of Colorado, Boulder|Marta Ceko|443-835-6587|Marta.Ceko@colorado.edu|
20161621|NCT00860015|Columbia University|Rober Taub, MD - Vivian and Seymour Milstein Family Prof. of Clinical Medicine||rntaubipod@gmail.com|
20161622|NCT00424268|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20161623|NCT00619489|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20161624|NCT02356887|Toronto western Hospital/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
20161625|NCT01020903|Staten Island University Hospital|Michael Silverberg/Principal Investigator|718-226-6629|msilverberg@siuh.edu|
20161626|NCT05216627|University of Pennsylvania|Daniel Blumenthal|215-746-7155|daniel.blumenthal@pennmedicine.upenn.edu|
20161627|NCT02544373|University of Michigan|Tiffany J. Braley, MD, MS, Associate Professor of Neurology|734-936-6267|tbraley@med.umich.edu|
20161628|NCT02404649|Harvard School of Dental Medicine|Dr. Kevin Guze|6177210707|kevin_guze@hsdm.harvard.edu|
20161629|NCT04075409|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20161630|NCT00162266|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
20161631|NCT04208087|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8593|722_clinical_project_team@seikagaku.co.jp|
20221205|NCT04536376|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@MAYO.EDU|
20161632|NCT01839656|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20161633|NCT00408590|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-2511|galanis.evanthia@mayo.edu|
20161634|NCT02621073|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20161635|NCT01595581|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
20161636|NCT01605942|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20161637|NCT03028636|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
20161638|NCT00495755|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
20161639|NCT01012323|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
20161640|NCT01294163|Radboudumc, Department of Anaesthesiology|Dr. Jan HOFLAND|+31243611111|Jan.Hofland@radboudumc.nl|3658
20161641|NCT04350307|Yale University|Dr. Robin Raju|203-688-8800|robin.raju@yale.edu|
20161642|NCT01120990|Hypertension Center, Third University Department of Medicine, University of Athens|George S Stergiou, MD|+30 210 7763117|gstergi@med.uoa.gr|
20161643|NCT01266590|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20161644|NCT04435600|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20161645|NCT03133221|University of Maryland Greenebaum Comprehensive Cancer Center|Jean Yared, MD|410-328-1230|jyared@umm.edu|
20161646|NCT03298841|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
20161647|NCT03344172|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20161648|NCT02066415|Amgen Inc.|Study Director|866-572-6436||
20161649|NCT02688868|Shanghai Microport Medicine|HT Zhang|+862138954600|zhanght@microport.com|8552
20161650|NCT02989805|Emory University|Benjamin Druss, MD, MPH|404-712-9602|bdruss@emory.edu|
20161651|NCT02771626|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20161652|NCT04094584|University of California, San Francisco|Ralph Wang|(415) 353-4890|ralph.wang@ucsf.edu|
20161653|NCT02713867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20161654|NCT02657564|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
20161655|NCT04135859|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
20161656|NCT03230292|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20161657|NCT04047420|University of Pittsburgh|Sharon Riddler, MD, MPH|4123831741|riddler@pitt.edu|
20161658|NCT01639755|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20161659|NCT01581008|VA Eastern Colorado Health Care System|David Bekelman, MD, MPH|720-857-5088|david.bekelman@va.gov|
20161660|NCT02641522|Benaroya Research Institute|Sarah Robinson/ Administrative Assistant|(206) 342-6931|diabetes@benaroyaresearch.org|
20161661|NCT03629912|Western Kentucky University|Dr. Matthew Shake|270-745-3918|matthew.shake@wku.edu|
20161662|NCT02282904|NIAID|Elizabeth Kang|3014027567|ekang@niaid.nih.gov|
20161663|NCT01852383|New York State Psychiatric Institute|Dr. D.P. Devanand|(646) 774-8658|dpd3@columbia.edu|
20161664|NCT03262116|Massachusetts General Hospital|Dr Steven J. Russell, MD, PhD|617.726.1848|sjrussell@mgh.harvard.edu|
20161665|NCT02365285|Vanderbilt University Medical Center|Cyndya Shibao, MD|615-322-2318|cyndya.shibao@vumc.org|
20161666|NCT02608450|Cassiopea SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20161667|NCT01727791|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161668|NCT03923582|University of Minnesota|Gudrun Kilian|612-624-0358|kilian@umn.edu|
20176118|NCT02100007|MEI Pharma Inc|Richard Ghalie, MD, Sr Vice President Clinical Development|858 369-7116|rghalie@meipharma.com|
20176119|NCT04875520|Nationwide Children's Hospital|Jason G. Newland, MD|614-722-3416|Jason.Newland@nationwidechildrens.org|
20176120|NCT04456699|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20176121|NCT05773287|Duke University|Katherine Collins-Bennett, Ph.D.|919-479-2368|katherine.collins-bennett@duke.edu|
20176122|NCT01468896|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
20176123|NCT04452188|The University of Michigan Health System|Dr. Nathaniel Sznycer-Taub|734-936-8993|nsznycer@umich.edu|
20176124|NCT01495481|University of Pittsburgh|Dr. Gaurav Arora|412-692-6054|gaurav.arora@chp.edu|
20176125|NCT02247349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
20176126|NCT00673452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20205911|NCT00225212|Stanford University Medical Center|Neal Birkett, MS, RAC|650-723-6456|nbirkett@stanford.edu|
20176127|NCT01271543|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
20176128|NCT03495908|The University of Texas Southwestern Medical Center|Dr Pablo F Mora|469-585-0000|pf_mora@yahoo.com|
20176129|NCT02097992|University of Miami|Adam Wanner|(305)243-3045|awanner@med.miami.edu|
20176130|NCT02410811|Cincinnati Children's Hospital Medical Center|Dr. Charles T. Quinn|5138033086|charles.quinn@cchmc.org|
20176131|NCT00554749|Centre for Child and Adolescent Mental Health, Eastern and Southern Norway|Dr. Hanne Kristensen|+4722586000|hanne.kristensen@r-bup.no|
20176132|NCT02353247|University of Louisville|Professor Andrew Scott LaJoie, PhD, statistician on project|502-852-1879|lajoie@louisville.edu|
20176133|NCT02600637|VA Northern California|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
20176134|NCT00480779|University of Pittsburgh|M. Kaye Kramer|4123831286|mkk3@pitt.edu|
20161669|NCT00635089|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20176135|NCT04043312|Hospital of the University of Pennsylvania|Dr. Timothy Markman|267-593-0103|timothy.markman@uphs.upenn.edu|
20176136|NCT04138615|University of Texas Southwestern Medical Center|Dr Craig Crandall|2143454623|craigcrandall@texashealth.org|
20176137|NCT01924169|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
20176138|NCT01930058|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176139|NCT01032135|University of Pennsylvania|James McKay, PhD|215-746-7704|jimrache@mail.med.upenn.edu|
20161670|NCT01304407|Baylor College of Medicine|Dr. Steven Abrams|512-495-4700|sabrams@bcm.edu|
20176140|NCT00806546|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
20176141|NCT02665975|Anglia Ruskin Univeristy|Eldre Beukes|01223698847|eldre.beukes@anglia.ac.uk|2847
20161671|NCT01848847|namik kemal university|cem celik|905324205365|cemcel@yahoo.com|
20176142|NCT01466192|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20176143|NCT05559320|University of Connecticut Department of Kinesiology|Dr. Sudha Srinivasan|(860)-486-6192|sudha.srinivasan@uconn.edu|
20176144|NCT02373124|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
20205912|NCT01519063|Yale University|Dana Cavallo, Assistant Professor|203974-7607|dana.cavallo@yale.edu|
20205913|NCT01357889|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205914|NCT02693691|Abbott|Dr. Marie-Elena Brett|7815283613|marieelena.brett@abbott.com|
20205915|NCT02727660|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
20205916|NCT01567891|Adaptimmune|Clinical Trials Management|215-825-9302|clinicaltrials@adaptimmune.com|6302
20161672|NCT01283542|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20161673|NCT02636946|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20161674|NCT05059977|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20161675|NCT04405245|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
20161676|NCT03443427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20176145|NCT02851108|Heidelberg University|Prof. Dr. Olaf Müller|+49 6221 56 4904|olaf.mueller@urz.uni-heidelberg.de|
20176146|NCT04524403|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
20176147|NCT02517580|Lebanese American University|Dr. Sola Aoun Bahous|+961-1-200-800|sola.bahous@lau.edu.lb|
20176148|NCT00598689|Georgia Regents University|David D. Bogorad, MD, FACS|706-721-1160|dbogorad@gru.edu|
20176149|NCT02343458|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|650-305-2600|creisner@pearltherapeutics.com|
20176150|NCT01913041|Peking Union Medical College Hospital, Anesthesia Department|Dr. Jie Yi|+86 10 69152025|neyil@pumch.cn|
20176151|NCT01513317|Janssen Research & Development|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
20176152|NCT02564198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20176153|NCT02842060|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
20176154|NCT02660359|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
20176155|NCT02506114|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
20176156|NCT04622254|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20176157|NCT03228680|Ferring Pharmaceuticals|Clinical Development Support|-|DK0-Disclosure@ferring.com|
20176158|NCT02167035|Cornerstone Healthcare|Michael Tepedino, MD|336-802-2255|mtepedino@wakehealth.edu|
20176159|NCT02489981|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190138|NCT02807857|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20176160|NCT01743092|Centre for Addiction and Mental Health|Nigel Turner, Ph.D.|416-535-8501|nigel.turner@camh.ca|36063
20176161|NCT03586869|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20176162|NCT00058240|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-3196|John.Byrd@osumc.edu|
20176163|NCT02992899|Emory University|Dr. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
20176164|NCT02370888|Univeristy of Florida Health Cancer Center|Archana Narasanna, Project Manager|(352) 273-6772|PMO@cancer.ufl.edu|
20176165|NCT01332305|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20176166|NCT02074735|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
20176167|NCT03192150|Sun Pharma Global FZE|Head, Clinical development|91 2266455645|Clinical.Trials@sparcmail.com|
20176168|NCT02579616|Eisai Co.,Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20176169|NCT00482391|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
20176170|NCT01448850|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
20176171|NCT02722668|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|612-626-2961|macmi002@umn.edu|
20176172|NCT02664038|VA Connecticut Healthcare System|Morris Bell, Ph.D., Senior Research Career Scientist|203-932-5711|morris.bell@va.gov|2281
20176173|NCT03758040|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
20176174|NCT02606136|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-079DMDStudy@fibrogen.com|
20176175|NCT03296696|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20176176|NCT02713321|Icahn School of Medicine at Mount Sinai|Dr. Victoria Mayer|(212) 659-9194|victoria.mayer@mountsinai.org|
20176177|NCT04694131|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@nih.gov|
20176178|NCT01333488|Memorial Healthcare System|Dr Greg Zorman|954 265 1840|csareli@mhs.net|
20176179|NCT00086580|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20176180|NCT03235024|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20176181|NCT02357576|University of Michigan|Meghan Arnold|734-936-8978|meghanar@umich.edu|
20176182|NCT00261716|VAGLAHS at West Los Angeles|Shirley M. Glynn. Ph.D.|310-268-3939|sglynn@ucla.edu|
20176183|NCT00128180|UNewMexico|Gregory Mertz, MD|5059808601|gmertz@salud.unm.edu|
20176184|NCT00699699|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176185|NCT02047110|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20176186|NCT00705575|Novartis Pharmaceuticals|Study Director|862 778-8300||
20176187|NCT03296163|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
20176188|NCT01632800|Weinberg Medical Physics LLC|Irving Weinberg MD PhD|3013467944|inweinberg@gmail.com|
20221206|NCT06146361|The University of Texas Health Science Center at Houston|Maria E. Fernandez-Esquer, PhD|713-500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
20221207|NCT04952922|The Royal Marsden NHS Foundation Trust|Dr Grainne Brady|0000000000000|grainne.brady@rmh.nhs.uk|
20221208|NCT02603146|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20221209|NCT06082843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221210|NCT01368497|University of Pittsburgh|Dr. Steven Belle|412-624-3758|belle@edc.pitt.edu|
20221211|NCT01130532|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221212|NCT02762929|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
20221213|NCT01383720|Boston Scientific Corporation|Director of Clinical Trials, Valves|408-370-1550||
20221214|NCT02656303|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20221215|NCT02871011|SaNOtize Research & Development Corp.|Dr Chris Miller|778-899-0607|chris@sanotize.com|
20221216|NCT03041311|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20221217|NCT02366689|Farid Ayad|Dr. Farid Ayad|416-473-1189|ayad.farid@gmail.com|
20221218|NCT01290068|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20176189|NCT00354224|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20221219|NCT03283566|Cleveland Clinic Foundation, Department of Endocroine and Metabolism|EMI Research Director|216 445-3757|jenkink@ccf.org|
20221220|NCT00853099|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20221221|NCT01231646|North Shore-LIJ Health System|Connie Lau, MS, CCRC|516-325-7022|clau@nshs.edu|
20221222|NCT01648530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20221223|NCT00934024|MUSC|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
20176190|NCT01000051|MD Anderson Cancer Center|Dr. Popat, Uday / Professor, Stem Cell Transplantation|713-745-3055|upopat@mdanderson.org|
20221224|NCT02719184|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20221225|NCT00200902|Laboratory of Brain, Behavior, and Pharmacology at the University of California Los Angeles|Andrew Leuchter, MD|310-825-0207|jpv@brain.ucla.edu|
20221226|NCT00470535|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20221227|NCT03105518|Brigham and Women's Hospital/Harvard Medical School|Lawrence Tsen, MD|617.732.8216|ltsen@bwh.harvard.edu|
20176191|NCT00821626|Infectious Disease Service, and Travel Clinic, University Hospital of Lausanne, Switzerland|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
20176192|NCT01959581|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
20176193|NCT00005669|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief, Unit on Growth and Obesity|301-496-0858|yanovskj@mail.nih.gov|
20176194|NCT00854581|University of Miami|Juan Carlos Ramos MD|305-243-4909|jramos2@med.miami.edu|
20176195|NCT01339390|Clement J. Zablocki VA Medical Center|Dr. Jeff Whittle|(414) 384-2000|jeffrey.whittle@va.gov|46444
20176196|NCT01446731|Center for Cancer ImmuneTherapy|Per Kongsted, M.D.|+45 38689255|per.kongsted@regionh.dk|
20161677|NCT00576472|St. Jude Children's Research Hospital|Heather Conklin PhD|1-866-278-5833|info@stjude.org|
20176197|NCT00378703|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20176198|NCT02149342|Helsinki university central hospital|Md, PhD Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
20176199|NCT03012386|Vanderbilt University Medical Center|Cyndya Shibao MD|6159364584|cyndya.shibao@vumc.org|
20190139|NCT01094106|Kuopio University Hospital|Matti Reinikainen|+358447176681|matti.reinikainen@kuh.fi|
20190140|NCT01240590|National Cancer Institute|Dr. James Gulley|301-480-7164|gulleyj@mail.nih.gov|
20221228|NCT04108299|NYU Langone Health|Lu Hu|646-501-3438|lu.hu@nyulangone.org|
20221229|NCT02091856|West University of Timisoara|Dr. Bogdan Tudor Tulbure|+040745753061|btulbure@gmail.com|
20221230|NCT04123405|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20221231|NCT01927575|Fujifilm Medical Systems, U.S.A., Inc.|Robert Uzenoff|(203) 602-3664|ruzenoff@fujifilm.com|
20221232|NCT00662649|Novartis Pharmaceuticals|Study Director|862 778-8300||
20221233|NCT01026194|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20221234|NCT01113723|Department of Anesthesiology, Cedars-Sinai Medical Center|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
20221235|NCT05274178|Phonak Audiology Research Center|Principle Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
20221236|NCT02515331|Novartis Pharmaceuticals|Study Director|862-778-8300|novartisemail@novartis.com|
20221237|NCT00124748|Novartis Pharmaceuticals|Study Director|862-778-8300||
20221238|NCT00322712|University of New Mexico|Dr. Fa Chyi Lee|505-925-0405|flee@salud.unm.edu|
20221239|NCT00567008|UPenn|Jennifer Plebani|2152223200|jplebani@mail.med.upenn.edu|152
20221240|NCT01769248|Northwestern University|Srinadh Komanduri|312-695-0484|koman1973@gmail.com|
20221241|NCT00758524|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20221242|NCT04176250|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20221243|NCT01339403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221244|NCT03983980|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20221245|NCT04090125|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20221246|NCT00354913|Duke University Medical Center|Dr. Annick Desjardins|919-681-1691|annick.desjardins@dm.duke.edu|
20221247|NCT03901313|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20221248|NCT01431079|University of Cincinnati|Dr. Manoj Sharma, PI|513-556-3878|manoj.sharma@uc.edu|
20221249|NCT01202175|Univeristy of California, San Diego|Joachim H. Ix, MD, MAS|858-552-7528|joeix@ucsd.edu|
20221250|NCT02790437|Hansa Biopharma AB|Elisabeth Sonesson, Director Clinical Operations|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
20221251|NCT03440840|Nova Southeastern University|Raymond L Ownby, MD, PhD|954-262-1481|ro71@nova.edu|
20221252|NCT01626690|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
20221253|NCT04688671|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
20221254|NCT04720053|Mayo Clinic|Dr. Sanjeev Nanda|507-284-9919|GIMRESEARCHSTUDIES@Mayo.edu|
20221255|NCT01960257|University of California, San Diego|Dr. Sara H. Browne|619 543 8080|shbrowne@health.ucsd.edu|
20161678|NCT03833713|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
20161679|NCT04285489|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|8029
20161680|NCT02576860|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20161681|NCT00477269|Novartis Pharmaceuticals|Study Director|862-778-8300||
20161682|NCT02391961|Louis Stokes VAMC|Alessandro Serra|2167913800|Alessandro.Serra@va.gov|
20161683|NCT02768753|General Hospital of Jinan Military Area|Dr.Qing Qing He，Dr.Gao Feng Ni|15653853675|m15653853675@163.com|
20161684|NCT03984487|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
20161685|NCT01365624|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|610-650-4200|dbregman@lpicrd.com|828
20221256|NCT03749330|Children's Hospital of Philadelphia|Jennifer Walter, MD, PhD, MS Associate Professor of Pediatrics|215-590-1000|walterj1@chop.edu|
20176200|NCT01346267|Wake Forest University School of Medicine|Thomas W. McLean, MD|336-716-4085|tmclean@wfubmc.edu|
20176201|NCT02353091|UCL Ear Institute|Mr Georgios Stavrinos|07856067517|georgios.stavrinos.13@ucl.ac.uk|
20176202|NCT01541930|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
20176203|NCT01957475|Coloplast|Daniel Carter|+45 49112523|dkdac@coloplast.com|
20176204|NCT02915744|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20176205|NCT00813358|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
20176206|NCT04497987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20176207|NCT03665038|Sage Therapeutics|Medical Monitor|(617) 299-8380|medinfo@sagerx.com|
20176208|NCT05346406|Medical College of Wisconsin|Alina G Burek MD|414-337-7050|aburek@mcw.edu|
20176209|NCT03890367|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20176210|NCT02805647|Department of Pediatric Orthopedics and Traumatology Medical University of Bialystok|MichałKarpiński|692224714|gufkarp@gmail.com|+48
20205917|NCT01200160|Abbott Laboratories de México|Carlos A Gonzalez MD, PhD|(5255) 5809-|carlos.gonzalez@abbott.com|7576
20205918|NCT00764946|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205919|NCT01162304|University of Rochester|Joel Kent, MD|585-273-2972|joel_kent@urmc.rochester.edu|
20205920|NCT00413062|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20205921|NCT02176291|University of Pittsburgh|Dr. Jordan F. Karp|412-246-6048|karpjf@upmc.edu|
20205922|NCT03454412|International Clinic of Rehabilitation|Oleh Kachmar|+380324765200|okachmar@ic.reha.lviv.ua|
20205923|NCT01167582|Rutgers University|Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
20205924|NCT03589885|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20205925|NCT01928485|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Lee Ponsky|+1 216-844-4831|lee.ponsky@uhhospitals.org|
20205926|NCT00039741|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20176211|NCT02258152|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
20176212|NCT04011475|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176213|NCT01310413|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176214|NCT02564471|SUNY Upstate Medical University|Dr. Timothy Endy|3154647692|endyt@upstate.edu|
20176215|NCT00941733|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
20176216|NCT01621373|UZ Leuven, NICU|Liesbeth Thewissen, MD, PhD|003216343211|liesbeth.thewissen@uzleuven.be|
20176217|NCT04260191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20176218|NCT01643473|NYU School of Medicine|Antoinette Schoenthaler|212-263-4205|antoinette.schoenthaler@nyumc.org|
20176219|NCT02284828|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20176220|NCT01519518|Liverpool Heart and Chest Hospital|Dr Rod Stables|01512281616|rod.stables@lhch.nhs.uk|1489
20176221|NCT02033889|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176222|NCT03019536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20176223|NCT01312909|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176224|NCT03894449|University of Veterinary & Animal Sciences, Lahore, Pakistan|Dr. Waqas Ahmed|0092-42-99211449|waqas.niaz@uvas.edu.pk|296
20176225|NCT00182689|SWOG Statistical Center|Study Statistician|206-667-4623||
20176226|NCT01640301|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
20176227|NCT00659646|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20176228|NCT03738904|Cedars-Sinai Medical Center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
20176229|NCT02200042|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20176230|NCT01969838|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20205927|NCT00946881|STEBA Biotech|Bertrand Gaillac International Project Leader|+ 33 974197905|b.gaillac@stebabiotech.com|
20205928|NCT03448224|University of Kentucky|Dr. Jerod Stapleton|859.562.2802|jerod.stapleton@uky.edu|
20205929|NCT03103906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20205930|NCT01476748|BWH|Dr. JI Einarsson|617-525-8582|jeinarsson@partners.org|
20205931|NCT04152642|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
20205932|NCT02443571|Blue Earth Diagnostics Ltd.|Chief Medical Officer|+44 (0) 1865 784 186|contact@blueearthdx.com|
20205933|NCT03479216|Derince Training and Research Hospital|Dr. Hande Aytuluk|00905336515650|handegrbz@gmail.com|
20205934|NCT02031432|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20205935|NCT02148211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20205936|NCT02726113|Medical University of South Carolina|Sebastiano Gattoni-Celli, M.D.; Professor of Radiation Oncology|843-876-5103|gattonis@musc.edu|
20205937|NCT03380026|Rochester Skin Lymphoma Medical Group|Clinical Research Coordinator|(585)364-1188|scarroll@roclymphoma.com|
20205938|NCT00859573|University of Arkansas for Medical Sciences|Michael J. Mancino, M.D.|501-526-8442|mjmancino@uams.edu|
20205939|NCT03488238|Masimo Corporation|Cristina Johnson|949-297-7000|clincalresearchdept@masimo.com|
20205940|NCT01316939|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176231|NCT00408993|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20176232|NCT00298896|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
20205941|NCT01432457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161686|NCT03544307|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3774|song-youngpark@unomaha.edu|
20221257|NCT03908125|Senseonics, Inc.|Sr. Director of Clinical Operations|301-407-2946|Kathleen.Davis@senseonics.com|
20221258|NCT02676882|Massachusetts General Hospital Center for Women's Mental Health|Dr. Marlene Freeman|617-643-6403|mfreeman@partners.org|
20221259|NCT01518322|Aerocrine, Inc.|Nancy Herje|919-449-8873|Nancy.Herje@aerocrine.com|
20221260|NCT01269918|Cleveland Clinic|Daniel Sessler, MD|216-445-6500|sesslerd@ccf.org|
20221261|NCT00218387|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
20221262|NCT00856193|Novartis Pharmaceuticals|Study Director|862-778-8300||
20221263|NCT02777372|The Johns Hopkins University School of Medicine|Liisa Hantsoo, Ph.D.|410-502-2334|LHantso1@jh.edu|
20221264|NCT04542057|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
20221265|NCT03897634|Northwestern University|Kendra Marks|847-467-0897|kendra.marks@northwestern.edu|
20221266|NCT03404674|PATH|Rahsan Erdem|202-540-4546|rerdem@path.org|
20221267|NCT04660331|Fred Hutchinson Cancer Center|Dr. Parth Shah|2066676120|pshah@fredhutch.org|
20221268|NCT02765256|University of Pennsylvania|Lindsey Albenberg, DO|267-426-0139|albenbergl@email.chop.edu|
20221269|NCT01487525|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
20221270|NCT01640249|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221271|NCT01870778|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20221272|NCT00065156|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20221273|NCT02577991|Northwestern University Department of Orthopaedic Surgery|Surabhi Bhatt|312-472-6024|surabhi.bhatt@nm.org|
20221274|NCT00115076|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
20221275|NCT02273388|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221276|NCT04331808|Hopital Hotel Dieu (AP-HP)|Dr Raphael Porcher|+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
20221277|NCT02421055|Imperial College London|Dr Nicholas Penney|020 7589 5111|n.penney@imperial.ac.uk|
20221278|NCT00952731|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
20221279|NCT01329900|UT MD Anderson Cancer Center|Issa F Khouri, M.D. / Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
20221280|NCT01184079|University of Pittsburgh Department of Family Medicine|Chyongchiou Jeng Lin, PhD|412/383-2360|cjlin@pitt.edu|
20221281|NCT04233073|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
20221282|NCT00681031|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221283|NCT05329259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221284|NCT02487225|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-7474|Vege.Santhi@mayo.edu|
20221285|NCT01256502|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20221286|NCT01523002|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|
20221287|NCT00773474|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20221288|NCT03220854|Virginia Commonwealth University Massey Cancer Center|Alfredo I Urdaneta|(804) 828-0450|MasseyRadOnc@vcu.edu|
20221289|NCT05101343|Winthrop University|Compliance Coordinator|8033232460|smithmr@winthrop.edu|
20221290|NCT04779879|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20221291|NCT02854527|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221292|NCT05954988|Rein Therapeutics, Inc.|Shawna Evans|1 (737) 802-1989|info@reintx.com|
20221293|NCT05287230|University of South Carolina|Dr. Monique Brown|8037775057|brownm68@mailbox.sc.edu|
20221294|NCT05473182|Grand Valley State Univeristy College of Health Professions|Dr. Lisa K. Kenyon|616-331-5653|kenyonli@gvsu.edu|
20221295|NCT02721732|The University of Texas MD Anderson Cancer Center|Dr. Aung Naing|(713) 563-3885|anaing@mdanderson.org|
20221296|NCT06227052|Queen's Medical Center|Catherine Rault|808-686-4690|crault@hawaii.edu|
20221297|NCT04479852|Sirtsei Pharmaceuticals|Greg Rigdon, PhD|+1 919-949-6862|grigdon@arrivobio.com|
20221298|NCT04589247|Johns Hopkins University|Ranh Voong, MD|4105506597|kvoong1@jhmi.edu|
20221299|NCT02848001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20221300|NCT06379048|Çam and Sakura City Hospital|Dr. Emre Kar|+90 (0212) 909 60 00|emre.kar@sbu.edu.tr|11250
20221301|NCT00118157|Barbara Ann Karmanos Cancer Institute|Sayeh Lavasani, M.D.|(313) 576-8751|lavasans@karmanos.org|
20221302|NCT05989672|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221303|NCT00696423|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221304|NCT03989102|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
20221305|NCT01582490|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
20221306|NCT01783990|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
20221307|NCT01038336|VA RR&D National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Gabrielle Saunders Ph.D.|503-220-2862|gabrielle.saunders@va.gov|56210
20221308|NCT01907490|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20161687|NCT01792518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161688|NCT03263780|Cedars-Sinai Medical Center|Timothy Daskivich, M.D.|310-423-4700|timothy.daskivich@cshs.org|
20161689|NCT04807387|Baylor College of Medicine|Dr Julie Hakim|832-826-7464|julie.hakim@bcm.edu|
20161690|NCT01014455|Mayo Clinic|David O. Warner MD|5072846277|warner.david@mayo.edu|
20161691|NCT00249613|UCLA Integrated Substance Abuse Programs|Michael Prendergast|310-267-5503|mlp@ucla.edu|
20221309|NCT04544241|Charles R. Drew University of Medicine & Science|Sharon Cobb|323-568-3329|sharoncobb1@cdrewu.edu|
20221310|NCT03411031|Moffitt Cancer Center|Dr. Melissa Alsina|813-745-7202|Melissa.Alsina@moffitt.org|
20221311|NCT00818766|Brigham & Women's Hospital|David Oxman, MD|215-503-1198|doxman2001@yahoo.com|
20221312|NCT04515147|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
20221313|NCT03503669|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
20221314|NCT04793711|Primus Pharmaceuticals, Inc.|Clinical Project Manager|4802506689|msanstead@primusrx.com|
20161692|NCT00806442|Brigham and Women's Hospital|Elliot Israel, MD|617-732-2801|eisrael@partners.org|
20161693|NCT02621398|Cancer Institute of New Jersey|Salma Jabbour, MD|732-235-8675|jabbousk@cinj.rutgers.edu|
20161694|NCT01497613|University of Miami Miller School of Medicine|Dr. Sara J. Czaja|305-355-9068|sczaja@med.miami.edu|
20161695|NCT00128713|New England Research Institutes|Susan Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
20161696|NCT00475215|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161697|NCT00424190|Cerexa|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
20161698|NCT00351273|University of South Florida|John D. Carter, M.D.|(813) 974-2681|jocarter@health.usf.edu|
20161699|NCT02241187|Memorial Sloan Kettering Cancer Center|Dr. Kenneth Yu, MD|646-888-4188|YuK1@mskcc.org|
20161700|NCT00199888|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20161701|NCT02030288|VA Boston Healthcare System|Nicholas Livingston|857-364-6360|nicholas.livingston@va.gov|
20161702|NCT05219669|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
20161703|NCT00330668|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
20161704|NCT02920957|CooperVision Inc|Sr.Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20161705|NCT00558272|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20161706|NCT00569868|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|5015266990|pettynathanm@uams.edu|2461
20161707|NCT03442296|Johns Hopkins University School of Medicine|Dr. Carrie Nieman|410-502-6965|cnieman1@jhmi.edu|
20161708|NCT03684694|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
20161709|NCT01280695|Metabolic Solutions Development Company|Jerry Colca, PhD|269.343.6732|jcolca@msdrx.com|
20161710|NCT05011513|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161711|NCT03667690|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
20161712|NCT04802187|Massachusetts General Hospital|Madeline Davies|617-726-6653|medavies@mgh.harvard.edu|
20161713|NCT04327024|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20161714|NCT05101798|Icahn School of Medicine at Mount Sinai|Orli Weiss|9086700847|orli.weiss@icahn.ismms.edu|
20161715|NCT00837759|NIDDK, National Institutes of Health|Dr. Rana Malek|3015945288|malekr@mail.nih.gov|
20161716|NCT01882868|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20161717|NCT01073930|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20161718|NCT01022424|Otsuka Pharmaceutical Co.,Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20161719|NCT00720343|Stanford University|Pamela Flood, M.D.|201-370-3933|pflood@stanford.edu|
20161720|NCT03459365|Cleveland Clinic|Carlos Higuera|954 659-5430|higuerc@ccf.org|
20161721|NCT04037254|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20161722|NCT03320330|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20161723|NCT02198794|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20161724|NCT01885910|DermResearch, PLLC|Dr. Leon Kircik|502-451-9000|wedoderm@yahoo.com|
20161725|NCT01918332|Yonsei University Healthcare System Severance Hospital|Prof. YangSoo Jang|82-2-6924-3109|yejung@lgls.com|
20161726|NCT02905006|Cares|UCB|+1877 822|UCBCares@ucb.com|9493
20161727|NCT05063539|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20161728|NCT02017522|University of Michigan|Venkatesh Murthy, MD||vlmurthy@umich.edu|
20161729|NCT05856227|Basilea Pharmaceutica International Ltd, Allschwil|Marc Engelhardt, MD, Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20161730|NCT01751139|GlaxoSmithKline|GSK Response Center|435-7343|GSKClinicalSupportHD@gsk.com|866
20161731|NCT04736628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161732|NCT00759525|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
20161733|NCT02428205|University of Missouri|Dr David Beversdorf|5738826081|beversdorfd@health.missouri.edu|
20161734|NCT00527319|Oxford Pharmaceutical Resources, Inc.|Dr. Richard Guarino|973-256-0600|Guarino@oxfordpharm.com|
20161735|NCT04908280|University of Rochester|Christopher T Richardson MD, PhD|585 - 275 - 7546|crichardson@urmc.rochester.edu|
20161736|NCT00680368|Loma Linda VA Healthcare System|T. Michael Kashner, PhD, PI|909 825-7084|michael.kashner@va.gov|2853
20161737|NCT00483041|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
20161738|NCT03779503|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20161739|NCT00864851|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20221315|NCT02760004|UMass Chan Medical School / UMass Memorial Health|Nancy Byatt, Tenured Professor of Psychiatry, ObGyn, and Population & Quantitative Health Sciences|508.856.5812|Nancy.Byatt@umassmemorial.org|
20161740|NCT03826199|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
20161741|NCT03242252|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20161742|NCT01116427|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20161743|NCT02211313|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
20161744|NCT02717130|Thriving Mind South Florida|John W. Newcomer, M.D., President & CEO|305-860-0653|jnewcomer@thrivingmind.org|
20221316|NCT00128401|National Institute of Mental Health|Cameron, Jennifer Ann|+1 301 402 9356|cameronj@mail.nih.gov|
20221317|NCT00970593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221318|NCT01561716|University of Rochester|Dr. Isabel D Fernandez|585-275-9554|Diana_Fernandez@URMC.Rochester.edu|
20221319|NCT00545714|Hoffmann-La Roche|Medical Communications|800--821--8590|global-roche-genentech-trials@gene.com|
20221320|NCT02045446|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214/645-7603|puneeth.iyengar@utsouthwestern.edu|
20221321|NCT03889886|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
20221322|NCT00276484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20221323|NCT01121250|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
20221324|NCT02423200|EIP Pharma|John Alam|617-945-0794|jalam@eippharma.com|
20221325|NCT01525329|Cleveland Clinic|Dr. Edward Maytin|216-445-6676|maytine@ccf.org|
20221326|NCT01690117|University of Leipzig, Medical Faculty, Clinic and Policlinic for Psychiatry and Psychotherapy|Prof. Dr. Hermann-Josef Gertz|0049 (0)341 97 24420|Hermann-Josef.Gertz@medizin.uni-leipzig.de|
20221327|NCT00397462|Binghamton University, SUNY|Professor Kenneth McLeod|(607)777-5779|kmcleod@binghamton.edu|
20221328|NCT03624192|AVITA Medical|VP, Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
20221329|NCT00100828|SKCCC at Johns Hopkins|Arlene Forastiere|410-955-9818|af@jhmi.edu|
20161745|NCT03344640|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20161746|NCT00110461|Otsuka Pharmaceutical Development & Commercialization, Inc.|Andy Forbes||andy.forbes@otsuka-us.com|
20161747|NCT00657371|UT MD Anderson Cancer Center|Robert S. Bresalier, MD / Professor||CR_Study_Registration@mdanderson.org|
20161748|NCT00537407|Debiopharm International S.A.|Jean-Maurice Dumont, Vice President Medical Affairs|4121 321 01 11|jean-maurice.dumont@debiopharm.com|
20161749|NCT00652899|University of Minnesota, Dept. Ob/Gyn|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
20161750|NCT01943552|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161751|NCT01600053|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
20161752|NCT02715726|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20161753|NCT02445573|Guang'anmen hospital of China Academy of Chinese Medical Sciences|Dr. Huanfang Xu|+86 10 8800 1124|huanfang_xu@126.com|
20161754|NCT01565941|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
20161755|NCT02855944|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20161756|NCT02478580|University Of Texas Southwestern Medical Center|Dr. Enas Kandil|214-590-8509|Enas.Kandil@UTSouthwestern.edu|
20161757|NCT02358044|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161758|NCT04728594|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20161759|NCT01455220|University of South Florida|Dr.Tuan Vu/ Dr. Derrick Robertson|813-974-6378|droberts@health.usf.edu|
20161760|NCT00267150|Novartis Pharmaceuticals|Study Director|862-778-8300||
20161761|NCT02718040|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
20161762|NCT04881747|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20161763|NCT00521222|Columbia University Irving Medical Center|Marjorie Slankard, MD|212-326-8410|ms53@columbia.edu|
20161764|NCT00499408|Comprehensive Cancer Center of Wake Forest University|K.C. Balaji, MD|336-716-5690|kbalaji@wakehealth.edu|
20161765|NCT01378429|Sunovion|Respiratory Medical Director|866-503-6351||
20161766|NCT02504931|UT Health San Antonio|Dr. John Roache|210-562-5406|roache@uthscsa.edu|
20161767|NCT02265796|Malcom Randall VA Medical Center|Dr. Anthony Bavry|352-376-1611|anthony.bavry@va.gov|6325
20161768|NCT02014584|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161769|NCT00483002|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161770|NCT01969435|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
20161771|NCT01706588|The School of Dentistry, University of Birmingham|Prof. Thomas Dietrich|+44-121-46 65494|t.dietrich@bham.ac.uk|
20161772|NCT00582998|University of Alabama at Birmingham|Asya Love, RN|205-996-6781|asyalove@uab.edu|
20161773|NCT01597635|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161774|NCT00652951|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161775|NCT01192568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20161776|NCT02593825|Duquesne University|Regina Harbourne, Primary Investigator|4026570538|harbourner@duq.edu|
20161777|NCT02100969|University of Kansas Medical Center|Dr. Mazen Dimachkie|913-588-6970|mdimachkie@kumc.edu|
20161778|NCT06359080|JelikaLite Corp|Katya Sverdlov, Chief Operating Officer|9175668151|katya@jelikalite.com|
20161779|NCT00511134|Yale University|Andrea H. Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
20161780|NCT01949090|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161781|NCT00707954|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20161782|NCT00599755|Merck Sharp and Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161783|NCT01306656|Columbia University|Shonni Silverberg, MD|212-305-6291|sjs7@cumc.columbia.edu|
20161784|NCT01778426|Medtronic|Neuromodulation, Clinical Study Management||medtronicneurotrials@medtronic.com|
20161785|NCT01364740|Stanford University|Clete A. Kushida, MD, PhD|650-721-7560|clete@stanford.edu|
20161786|NCT05532891|Imperial College London|Dr Emma Rose McGlone|07949565678|e.mcglone@ic.ac.uk|
20161787|NCT00417963|C.R. Bard Inc.|Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|2644
20161788|NCT00477152|Baxter Halthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
20161789|NCT01023672|Mayo Clinic|Dr. Bradley F. Boeve|507-266-4106|bboeve@mayo.edu|
20176233|NCT02880371|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176234|NCT03394391|Babcock University|Dr. Olumide ABIODUN|07038569725|olumiabiodun@gmail.com|7038569725
20176235|NCT01560624|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
20176236|NCT00451282|Children's Hospital of Philadelphia|Nancy Kassam-Adams|215-590-3118|nlkaphd@mail.med.upenn.edu|
20176237|NCT01565993|Hospital Universitario Severo Ochoa|Dra Elvira Quintanilla|34 914818000|elviramquintanilla@hotmail.com|8326
20176238|NCT04086472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176239|NCT01241734|Hackensack Meridan Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
20176240|NCT02252081|Nashville Campus TVHS|Dr. Adriana Hung|6153274751|adriana.hung@va.goc|6731
20176241|NCT00048724|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20176242|NCT04116229|Washington University School of Medicine|Sarah Eisenstein, Associate Professor in Psychiatry|3143627107|seisens@wustl.edu|
20176243|NCT02595684|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20176244|NCT04574362|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176245|NCT00642304|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20176246|NCT01646671|Novartis Pharmaceuticals|Study Director|+1-862-778-8300||
20176247|NCT02178475|Amgen Inc.|Study Director|866-572-6436||
20176248|NCT01430585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176249|NCT00779766|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176250|NCT01420302|Department and Laboratory of Intensive Care Medicine KULeuven/UZLeuven|Professor Greet Van den Berghe|003216344017|greet.vandenberghe@kuleuven.be|
20176251|NCT03054909|University of Minnesota, Masonic Cancer Center|Dr. Melissa Geller|+1 612-626-3111|gelle005@umn.edu|
20176252|NCT01132144|University of Sao Paulo|Dr. Wellington P Martins|55162231|wpmartins@gmail.com|
20176253|NCT01412424|Cedars-Sinai Medical Center|Shlomo Melmed, MD|310 423-4691|melmed@csmc.edu|
20176254|NCT01274637|Ottawa Hospital Research Institute|Dr. Marc Rodger|6137388899|mrodger@ohri.ca|
20176255|NCT01194297|University of Rochester|Dr. Carl D'Angio|585-275-2972|carl_dangio@urmc.rochester.edu|
20176256|NCT01824303|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20176257|NCT03759223|VA Center for Integrated Healthcare|Dr. Paul King, Clinical Research Psychologist|716-862-6038|paul.king2@va.gov|
20176258|NCT00811564|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20176259|NCT02075320|UNC School of Medicine Department of Radiology|Dr. Yueh Lee|(919) 537-3730|yueh_lee@med.unc.edu|
20176260|NCT01397695|UCSD|Research Compliance and Integrity|(858) 822-4939|ctgov@ucsd.edu|
20176261|NCT03773757|Indiana University|Dr. Greg Sachs|317-278-5570|sachsg@iu.edu|
20176262|NCT02660918|Christiana Care Health System|Dr. Matthew Hoffman Chair Department of OB/GYN|302 733 3350|mhoffman@christianacare.org|
20176263|NCT03487913|Centessa Pharmaceuticals|Milena Kanova, MD, Vice President, Clinical Operations|+44 7780 430583|Milena.Kanova@centessa.com|
20176264|NCT02985736|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
20176265|NCT00382733|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20176266|NCT00179413|BIDMC|Dr. Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
20176267|NCT00550836|Mayo Clinic|Steven R. Alberts, M.D.||alberts.steven@mayo.edu|
20176268|NCT02144675|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20176269|NCT00439140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20176270|NCT01458171|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20176271|NCT02270060|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
20176272|NCT00578565|Mayo Clinic|Eric. L. Matteson, M.D.|507-284-8450||
20176273|NCT01192152|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20176274|NCT02709395|Wellspect HealthCare|Head of Medical Affairs, Markus Wittebo|+46 31 376 40 00|markus.wittebo@wellspect.com|
20176275|NCT01559311|St. Jude Medical (Hong Kong) Ltd|Clinical Project Leader Asia|29967605|lyim@sjm.com|
20176276|NCT05013905|Prometheus Biosciences, Inc.|Study Director|858-422-4300|mm@prometheusbiosciences.com|
20176277|NCT01849588|Massachusetts General Hospital|Dr. Andrew Zhu|617-724-4000|azhu@partners.org|
20176278|NCT00515827|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20176279|NCT03181542|Penn State Hershey Medical Center|Dr Priti Dalal|717-531-6597|pdalal@pennstatehealth.psu.edu|
20176280|NCT01009099|Edward Hines Jr., VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
20176281|NCT01856543|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum|914-367-7273|gelblumd@mskcc.org|
20176282|NCT01712984|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20176283|NCT02261818|Johns Hopkins University|Dr Jin Hui Joo|4105502282|jjoo1@jhmi.edu|410
20176284|NCT03223298|Weill Cornell Medicine|Dr. Gwendolyn S. Reeve|(212) 746-5175|gsr9001@med.cornell.edu|
20176285|NCT01265953|Oregon Health & Science University|Dr.Jackilen Shannon|503-418-9860|shannoja@ohsu.edu|
20205942|NCT04507776|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176286|NCT01151553|Emory University|Dr. Heather Bloom|404-321-6111|heather.bloom@emory.edu|6391
20176287|NCT01032694|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205943|NCT02911818|The University of Pennsylvania Center for Weight and Eating Disorders|Dr. Thomas Wadden|215-746-5046|wadden@pennmedicine.upenn.edu|
20205944|NCT01136746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221330|NCT01176513|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
20221331|NCT04583735|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
20221332|NCT01215136|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
20221333|NCT02308124|SNUH|Jung-Ick Byun|+8224406254|mr830611@gmail.com|
20221334|NCT00708110|ViiV Healthcare|GSK Response Center|866-435-7343||
20221335|NCT01994785|Cleveland Clinic|John Vargo|216 445-5012|vargoj@ccf.org|
20221336|NCT01042093|Towson Orthopaedic Associates|David F. Dalury, MD|410-337-7900|ddalury@gmail.com|1221
20221337|NCT02435524|London School of Hygiene & Tropical Medicine|Dr Veronique Filippi|+44 (0)20 7927 2874|veronique.filippi@lshtm.ac.uk|
20221338|NCT05275920|NYU Langone Health|Amrita Mukhopadhyay, MD|212-263-7751|amrita.mukhopadhyay@nyulangone.org|
20221339|NCT00243412|Hoffman-LaRoche|Medical Communications|800-821-8590||
20190141|NCT02739100|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
20190142|NCT01075152|University of Minnesota|Dr. David R Boulware|6126249996|coat.trial@gmail.com|
20190143|NCT01079949|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20190144|NCT02144285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190145|NCT01529632|Novartis Pharmaceuticals|Study Director|862-778-8300||
20190146|NCT00452452|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20190147|NCT04445337|University of Nebraska Medical Center|Michael Lankhorst|402-559-4081|michael.lankhorst@unmc.edu|
20190148|NCT03346200|KARMA project, Karolinska Institute|PI Professor MD Per Hall|+46 8 524 85000|Per.hall@ki.se|
20190149|NCT02713217|Central Arkansas Veterans Healthcare System|Richard R. Owen, MD|5012574802|richard.owen2@va.gov|
20190150|NCT04620733|CymaBay Therapeutics, Inc.|CymaBay Study Director|1-510-293-8800|medinfo@cymabay.com|
20190151|NCT02221934|Neuros Medical, Inc.|Nick Hargus, PhD. Vice President of Clinical and Medical Affairs|440-951-2565|nhargus@neurosmedical.com|
20190152|NCT01921166|AtriumHealth|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|brad.hurst@atriumhealth.org|
20190153|NCT00230009|Wayne State University|Steven J. Ondersma, ,PI|313-577-6680|s.ondersma@wayne.edu|
20190154|NCT04555694|Cleveland Eye Clinic|Dr. Thomas Chester, OD|440-526-1974|tchester@midwestvision.com|
20190155|NCT00451906|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20190156|NCT01250717|BIDMC|Glenn Bubley MD, Director of GU ONC|617-735-2062|gbubley@bidmc.harvard.edu|
20190157|NCT01578278|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20190158|NCT02121808|Laval University|Jean S. Bussières|418 656-8711|jbuss@criucpq.ulaval.ca|
20190159|NCT02164578|Medical Clinic III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany|Dr. Frank Pistrosch|0049 351 458|frank.pistrosch@uniklinikum-dresden.de|5955
20190160|NCT03924193|Yale University School of Medicine|Dr. Valentina Ivezaj|2037857807|valentina.ivezaj@yale.edu|
20190161|NCT00647699|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
20190162|NCT03029585|US Biotest, Inc.|Gere S. diZerega, MD, Responsible Medical Officer|1-805-595-1300|gere.dizerega@usbiotest.com|
20190163|NCT02165202|PATH|Heather Kelly|650-392-2510|hkelly@path.org|
20190164|NCT01689740|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20190165|NCT01420328|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Husam Ghanim|7169574325|ghanim@buffalo.edu|
20190166|NCT03835416|Durham VA Medical Center|Dr. Connie Bales, Assoc. Director, GRECC|919-286-0411|connie.bales@va.gov|6780
20190167|NCT01975701|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novatis.com|
20190168|NCT02753075|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190169|NCT01301183|Massachusetts General Hospital|Madhu Misra|6177265790|mmisra@mgh.harvard.edu|
20190170|NCT02152384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190171|NCT02958826|University of Missouri|Dr. Hope Gole|573-882-8030|golehk@health.missouri.edu|
20190172|NCT00603798|Graceway Pharmaceuticals|Sharon F Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
20190173|NCT04540952|Atrium Health|Dr. Paul Marshburn|704-619-2537|Paul.Marshburn@atriumhealth.org|
20190174|NCT01062165|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
20190175|NCT04361617|Wake Forest University Health Sciences|Lindsay Reynolds, PhD|336.713.1134|lireynol@wakehealth.edu|
20190176|NCT02067000|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|7044
20190177|NCT02005484|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190178|NCT00825734|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20190179|NCT04534738|University of Maryland Baltimore|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
20190180|NCT02584257|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
20190181|NCT02137785|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
20190182|NCT01670877|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
20190183|NCT00417885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190184|NCT02309892|Helix BioPharma Corp.|Brenda Lee, Director, Clinical Operations|416 642 1807|blee@helixbiopharma.com|
20190185|NCT01584648|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20190186|NCT04812977|Hayatabad Medical Complex, Peshawar|Yousaf Jamal Mahsood|091921714047|yousaf82@hotmail.com|
20221340|NCT04589663|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20221341|NCT00041132|SWOG Statistical Center|Study Statistician|206-667-4623||
20221342|NCT00736632|Washington University in St. Louis|Dr. Carlos Bernal-Mizrachi|314-362-0947|cbernal@wustl.edu|
20221343|NCT00995774|Washington DC Veterans Affairs Medical Center|Peter Lum, PhD|202-319-5181|lum@cua.edu|
20176288|NCT03843502|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
20176289|NCT02866682|University of California, Los Angeles (UCLA)|Dr. Suphamai Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
20176290|NCT02837744|Axio Biosolutions Pvt. Ltd.|Shailee Mehta, Clinical Research Manager|9879009940|shailee.m@axiobio.com|
20221344|NCT01808573|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|424-248-6500|clinicaltrials@pumabiotechnology.com|
20176291|NCT01750268|San Francisco VA Health Care System/University of California, San Francisco|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
20176292|NCT02086591|University of Rochester|Carla Casulo|585-273-3258|carla_casulo@urmc.rochester.edu|
20176293|NCT01923181|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20176294|NCT02944578|Emory University|Dr. Lisa Flowers|404-251-8931|flowe2@emory.edu|
20176295|NCT01878604|Central South University|Shuiping Zhao|86-731-85295806|zhaosp@medmail.com.cn|
20176296|NCT02932891|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20221345|NCT02513212|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20176297|NCT03511521|Northwestern University Feinberg School of Medicine|Dr. Mark Molitch, Principal Investigator|3125034130|molitch@northwestern.edu|
20176298|NCT00577122|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
20190187|NCT02009332|Aadi Bioscience|Berta Grigorian|818-416-8378|bgrigorian@aadibio.com|
20190188|NCT01912599|University of North Carolina|Jean-Claude Mwanza, MD, MPH, PhD|919-843-4917|jean-claude_mwanza@med.unc.edu|
20190189|NCT03798756|Keele University|Mrs Sarah Lawton|01782 734887|s.a.lawton@keele.ac.uk|
20221346|NCT03953612|Yale School of Medicine|Verica Milivojevic, PhD|203-737-5201|verica.milivojevic@yale.edu|
20221347|NCT00489255|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20221348|NCT03485352|Federal University of Uberlandia|Mrs Cibele Crispim|55 34 3218-2084|cibelecrispim@gmail.com|
20221349|NCT02028676|Medical Research Council|Professor Ann Sarah Walker|+44 20 7670 4726|rmjlasw@ucl.ac.uk|
20221350|NCT01244503|Virginia Commonwealth University|Arun J Sanyal|804 828 6314|asanyal@mcvh-vcu.edu|
20221351|NCT03691727|University of Iowa|David Hasan|319-384-8669|david-hasan@uiowa.edu|
20221352|NCT01982955|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20221353|NCT01191450|Eurofarma Laboratórios S.A|Eurofarma Laboratórios S.A|50 11 5090-8415|fernanda.martinez@eurofarma.com.br|
20221354|NCT03493685|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
20221355|NCT04452669|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
20221356|NCT04408183|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
20221357|NCT06418529|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161790|NCT02504580|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
20161791|NCT00448747|Aeterna Zentaris|Nicola Ammer|+496942602|nammer@aezsinc.com|3472
20161792|NCT01085435|Boston Scientific|Jens Goetzke|1-800-227-3422|jens.goetzke@bsci.com|
20161793|NCT04473664|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20161794|NCT00789672|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
20161795|NCT02704689|Stryker|Jennifer Warnke|(201) 749-8000|jennifer.warnke@stryker.com|
20161796|NCT01646203|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20161797|NCT00450073|Emory University|Vin Tangpricha|4047277254|vin.tangpricha@emory.edu|
20161798|NCT01100528|Cleveland Clinic, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|866-223-8100|CancerCenterResearch@ccf.org|
20161799|NCT03842683|Steno Diabetes Center North Denmark|Dr. Morten Hasselstrøm Jensen|+4522226964|mhj@hst.aau.dk|
20161800|NCT01557959|Wake Forest Baptist Health|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
20161801|NCT00551291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20161802|NCT01177969|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
20161803|NCT00996346|University of New Mexico Cancer Center|Monte Shaheen, MD / Study Principal Investigator|505-925-0404|MoShaheen@salud.unm.edu|
20161804|NCT01475162|Medical College of Wisconsin|William R. Drobyski|414-456-4941|wdrobysk@mcw.edu|
20161805|NCT00490022|University of Washington|Dr. Stephanie Page, PhD, MD|206.616.0483|page@u.washington.edu|
20161806|NCT01504204|Wake Forest University Health Sciences|Irma M Richardsom, MHA|336-716-2903|irichard@wakehealth.edu|
20161807|NCT00903331|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
20161808|NCT03426631|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
20161809|NCT00654004|Oregon Health & Science Univeristy|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
20161810|NCT00444067|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20161811|NCT04971941|Harvard School of Dental Medicine|Dr. Jeffry R Shaefer|(781) 718-6793|jeffry_shaefer@hms.harvard.edu|
20161812|NCT00710385|Substance Abuse|Sandra D. Comer|646-774-6146|sdc10@columbia.edu|
20161813|NCT01264770|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20161814|NCT01325714|Houston Center for Innovations in Quality, Effectiveness, and Safety|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
20161815|NCT02528357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161816|NCT04039867|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20161817|NCT01008969|University of California, San Francisco|Youngho Seo, PhD|415-353-9464|youngho.seo@ucsf.edu|
20161818|NCT01848366|William Beaumont Hospital|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.org|
20190190|NCT00042939|ECOG Statistical Office|Study Statistician|617-632-3012||
20176299|NCT00440271|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176300|NCT00456092|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20176301|NCT01268644|UT Southwestern Medical Center|Dr. Abhimanyu Garg|2146482895|abhimanyu.garg@utsouthwestern.edu|
20176302|NCT00883389|University of Maryland, School of Medicine|Dr. Jeffrey C. Fink, Associate Professor, Nephrology|410-328-5720|jfink@medicine.umaryland.edu|
20176303|NCT01600040|Massachusetts General Hospital|Andrea Russo, MD|617-726-7941|alrusso@mgh.harvard.edu|
20176304|NCT00113516|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20176305|NCT05421078|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20176306|NCT02409615|Nemours/A I duPont Hospital for Children|Karen Sacks, MSN PNP|302-651-5649|ksacks@nemours.org|
20176307|NCT02170727|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20176308|NCT00414050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1 800 672 6372|ClinicalTrialsDisclosure@merck.com|
20176309|NCT00539526|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20176310|NCT03097068|Vitreo-Retinal Associates, P.C.|Louis C. Glazer, MD|1-616-285-1200|glazerlc@vrapc.com|
20176311|NCT02802345|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176312|NCT00057746|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
20176313|NCT01109316|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20176314|NCT01936259|Zimmer Biomet, Inc.|Director of Clinical Operations|800-613-6131|clinicaldirector@zimmerbiomet.com|
20176315|NCT00799812|BD|Erin Zook|847-362-9047|erin.zook@bd.com|
20176316|NCT00395044|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20176317|NCT04378933|Mayo Clinic|R. Robert Auger, M.D.|507-266-1066|Auger.Raymond1@mayo.edu|
20176318|NCT03511560|Columbia University|Amanda Alonso|212-342-0261|aa2974@cumc.columbia.edu|
20176319|NCT03075644|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20176320|NCT04942938|Centura Health|Dr. Courtney Ellerbusch|3039058272|courtneyellerbusch@centura.org|
20176321|NCT01362907|Alcon Research|Joachim Nick, Dipl. Ing. (FH)|+49 6022 240 520|joachim.nick@cibavision.com|
20176322|NCT03022617|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
20176323|NCT02978690|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176324|NCT01706250|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176325|NCT03286140|Imperial College London|Professor Alun Davies|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
20176326|NCT01826825|Brigham and Women's Hospital|Deborah J. Culley, M.D., Principal Investigator|6177327330|dculley@bwh.harvard.edu|
20176327|NCT03254134|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190191|NCT00795639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205945|NCT03154294|Avera Cancer Institute|Dr. Casey Williams|605-322-3588|Casey.Williams@avera.org|
20205946|NCT00092677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20205947|NCT00749268|Covidien|Jessica Carlson, Clinical Project Manager|(203) 821-4734|jessica.carlson@covidien.com|
20205948|NCT02814448|Cleveland Clinic|Dr. Miriam Cremer|216-312-0618|cremerm@ccf.org|
20205949|NCT00010803|University of Virginia|Steven T. DeKosky MD|434-924-5118|SD3ZC@hscmail.mcc.virginia.edu|
20205950|NCT04671342|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
20205951|NCT00806078|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
20205952|NCT03351478|Lexicon Pharmaceuticals, Inc|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20205953|NCT03911869|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20205954|NCT03554850|Stryker Neurovascular|Fei Qin|+8613524821775|fei.qin@stryker.com|
20205955|NCT00985738|University of Colorado Hospital|Dr. Al Baha Barqawi|303-724-2722|AL.BARQAWI@UCDENVER.EDU|
20205956|NCT02236273|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
20205957|NCT02119026|Medical University Vienna, Internal Med. I, Dep. of Oncology|Werner Scheithauer, MD|+43 1 40400|werner.scheithauer@meduniwien.ac.at|54620
20205958|NCT00812604|University of Hong Kong|Dr. Ricky Wing Kit Wong, Associate professor in orthodontics|852-2859 0554|fyoung@hkucc.hku.hk|
20205959|NCT01373918|University of California, Los Angeles|Dr. Kara L. Calkins|310 825-9330|KCalkins@mednet.ucla.edu|
20205960|NCT00340834|Novartis Pharmaceuticals|Study Director|862-778-8300||
20205961|NCT00291499|IBSA Institut biochimique|Project Leader|0041 58360100|rd@ibsa.ch|
20205962|NCT00129740|The University of Texas MD Anderson Cancer Center|Cortes,Jorge E, MD./Professor|713-794-5783|jcortes@mdanderson.org|
20205963|NCT02451488|Mayo Clinic|Dr. James Jakub|507-284-3629|Jakub.James@mayo.edu|
20205964|NCT02786836|UT Southwestern Medical Center at Dallas|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
20205965|NCT02849184|Jichi Medical University School of Medicine|Professor Kazuomi Kario|+81-285-58-7538|kkario@jichi.ac.jp|
20205966|NCT01387074|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20205967|NCT04426890|Celltrion. Inc|Yunju Bae/Head of Clinical Planning 1 Department|+82 32 850 4160|Yunju.bae@celltrion.com|
20205968|NCT02373163|PREVENCION|Josefina Medina-Lezama|+5154251269|jmedinal2911@gmail.com|
20205969|NCT01532570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20205970|NCT05034614|Mayo Clinic|Danielle J. O'Laughlin, P.A.-C., M.S.|507-284-5164|OLaughlin.Danielle@mayo.edu|
20205971|NCT03892707|Woerwag Pharma LLC|Anna Shagako, Clinical Trials Manager/ Authorized Person of Pharmacovigilance|+7 (495) 382 85 56|anna.shagako@woerwagpharma.ru|
20205972|NCT04263363|UCLA|Dr. Eilon Gabel, MD|310-267-8693|EGabel@mednet.ucla.edu|
20176328|NCT02563028|Hospital for Special Surgery|Valeria Rotundo|212-774-7885|rotundov@hss.edu|
20176329|NCT00075829|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20176330|NCT00799617|University of Pennsylvania, Perelman School of Medicine|Peter J. Snyder, MD|215-898-0208|pjsnyder@upenn.edu|
20176331|NCT04545515|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20176332|NCT02501096|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20176333|NCT01848990|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20176334|NCT00685932|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbank, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
20176335|NCT00096044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20176336|NCT02442830|UMass Medical School|Principal Investigator|(774) 442-4098|David.Cave@umassmemorial.org|
20176337|NCT01552772|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20176338|NCT00895180|Sidney Kimmel Comprehensive Cancer Center|Dr. Jaishri Blakely|(410) 955-8893||
20176339|NCT03851016|University of Houston|Dr. Theresa C. Chrisman|713-447-3334|tkchrisman@comcast.net|
20176340|NCT03878134|NIH Clinical Center|Dr. Elizabeth Jones Chief, Radiology and Imaging Sciences|3012634853|ejones@cc.nih.gov|
20176341|NCT00853658|Novartis Pharmaceuticals|Study Director|862-778-8300||
20176342|NCT03090256|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20176343|NCT00586469|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176344|NCT02553746|424 Army General Hospital|Georgios Kotsovolis|+306948182743|gskotsos@gmail.com|
20176345|NCT01227512|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20176346|NCT04055116|Geisinger|Gayatri Malik, MD|15702716355|gmalik1@geisinger.edu|
20176347|NCT04150224|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
20176348|NCT02774681|Northwestern University|Massimo Cristofanilli, MD|312-503-5488|Massimo.cristofanilli@nm.org|
20176349|NCT01394926|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|Paulsherwin@ge.com|
20176350|NCT00512096|UT MD Anderson Cancer Center|Cherie A. Perez||caperez@mdanderson.org|
20176351|NCT02489227|Coherus BioSciences, Inc.|Barbara K. Finck, MD|650-649-3530|bfinck@coherus.com|
20176352|NCT03212963|Sun Pharma Advanced Research Company Ltd.|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
20176353|NCT01312766|IBSA Institut Biochimique SA|Dr. Barbara Cometti, Senior Clinical Research Manager, IBSA|+41 58 360 10 00|barbara.cometti@ibsa.ch|
20176354|NCT01069289|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20176355|NCT00298038|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20176356|NCT02696096|Butler Hospital|Dr. Michael Stein|401-455-6652|michael_stein@brown.edu|
20176357|NCT02556710|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20176358|NCT00827372|IndianaU|Kathy Miller, MD|317-944-0920|kathmill@iupui.edu|
20176359|NCT02139644|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20176360|NCT01010984|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
20176361|NCT01076400|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176362|NCT02160873|Florida State University|Dr. Michael J. Ormsbee|(850) 645-5000|mormsbee@fsu.edu|
20176363|NCT02766608|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
20176364|NCT02080091|Alimera Sciences, Ltd.|Andrew Joyson - Associate Director, Clinical Operations Europe|+44 1252 354 026|Andrew.Joyson@alimerasciences.com|
20176365|NCT00158379|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
20176366|NCT02391948|University of Washington|Sarah Westcott McCoy PT, PhD, FAPTA|206-616-8601|westcs@uw.edu|
20176367|NCT02348489|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20176368|NCT00201006|University of Florida|Michael G. Perri, PhD|352 273-6214|mperri@ufl.edu|
20176369|NCT03151265|dorsaVi Ltd|Sangeeth Wanasinghage|+61 1800 367 728|support@dorsavi.com|
20176370|NCT00509197|Hôpital du Sacré-Coeur de Montréal|Dr Catherine Lemiere|514 338 2796|catherine.lemiere@umontreal.ca|
20176371|NCT01383681|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20176372|NCT00938431|UCB|Study Director|+1877 822 9493||
20176373|NCT01353339|St Paul's Hospital|Dr. John S. Gill|604-806-8970|jgill@providencehealth.bc.ca|
20176374|NCT00423436|UT MD Anderson Cancer Center|Charles S Cleeland, PhD, Professor||asaleeba@mdanderson.org|
20176375|NCT03738865|Xeris Pharmaceuticals, Inc.|Chelsea Boundy|312-517-1466|cboundy@xerispharma.com|
20176376|NCT01529645|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20176377|NCT00274716|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176378|NCT04193202|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176379|NCT02212730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176380|NCT00854087|SCTI Research Foundation|Dr. Tarek Hassanein|6195220330|thassanein@livercenters.com|
20176381|NCT01777997|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20205973|NCT04190186|University of Rochester|David Huang, MD|585 275 5391|david_huang@urmc.rochester.edu|
20205974|NCT02141217|GlaxoSmithKline|GSK Response Center|866-435-7343||
20205975|NCT01665768|Johns Hopkins University|Douglas Gladstone, MD|4109558781|dgladst1@jhmi.edu|
20205976|NCT04603391|University of Florida|John S. Markowitz, Pharm.D.|(352) 273-6262|jmarkowitz@cop.ufl.edu|
20176382|NCT01694706|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176383|NCT00975975|IndianaU|Dr. Robert Nelson|317-944-0920|ronelson@iu.edu|
20176384|NCT01733368|Hospital Clinico Universitario Virgen de la Victoria|Dr. Javier Alzueta Rodríguez|951 03 20 00|jalzueta@telefonica.net|
20176385|NCT02514252|UT MD Anderson Cancer Center|Suresh K. Reddy, MD/Professor, Palliative Care Med|(713) 794-5362|sreddy@mdanderson.org|
20176386|NCT01416194|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176387|NCT03358576|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
20176388|NCT00723801|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
20176389|NCT01222494|Washington University|Dr. Ginger Nicol|314-362-2461|nicolg@wustl.edu|
20176390|NCT01174030|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20176391|NCT00047463|Vanderbilt University|Beth Malow/Principal Investigator|615-322-0283|beth.malow@vanderbilt.edu|
20176392|NCT01490060|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|(713) 792-7966|CR_Study_Registration@mdanderson.org|
20176393|NCT03161314|Physical Therapy Faculty, Mahidol University|Asst.Prof.Dr. Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|20804
20176394|NCT03698773|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|hsc-anesthesiology@salud.unm.edu|
20176395|NCT02399085|MorphoSys AG|Lisa Walz|+49 89 89927 26240|Lisa.Walz@morphosys.com|
20176396|NCT03304379|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20176397|NCT02873104|Cutera|Lourdes Moldre, NP|415-971-5118|lmoldre@cutera.com|
20176398|NCT01298063|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176399|NCT00245557|McLean Hospital|Brent Forester MD|617-855-3622|bforester@mclean.harvard.edu|
20176400|NCT01752933|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20176401|NCT03282955|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
20176402|NCT01121211|Massachusetts General Hospital|Dr. Anne Klibanski|6177263870|aklibanski@partners.org|
20176403|NCT00179647|Celgene Corporation|Robert D. Knight, M.D.|908-673-9749|rknight@celgene.com|
20176404|NCT00835406|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20176405|NCT04524962|Cartesian Therapeutics, Inc.|Hafsa Kamboh|4127585340|hafsa@cartesiantx.com|
20176406|NCT02550652|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
20176407|NCT02486406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20176408|NCT01744730|Duke Clinical Research Institute, Duke University School of Medicine|Kevin Watt, MD|919-668-8556|kevin.watt@dm.duke.edu|
20176409|NCT03062891|University of Notre Dame|Dan Denis|6178066484|ddenis@nd.edu|
20205977|NCT01899677|Zeynep Kamil Maternity and Children's Education Training Hospital|Ozge Serce (Investigator, MD)|+905323270375|ozge_serce@hotmail.com|
20205978|NCT02759861|University of Nebraska Medical Center|Mark Mailliard|402-559-8126|mark.mailliard@unmc.edu|
20205979|NCT02151682|Grünenthal GmbH|Clinical Trial Helpdesk|+49-(0)241-569|clinical-trials@grunenthal.com|3223
20176410|NCT03678181|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
20176411|NCT00333606|Ernst Moritz Arndt University of Greifswald|Taras Usichenko, director of the trial|+493834865828|taras@uni-greifswald.de|
20176412|NCT01037790|University of Pennsylvania|Jennifer Louie, Program Manager|267-414-6179|Jennifer.Louie2@pennmedicine.upenn.edu|
20176413|NCT00850031|AcuFocus, Inc|Eugenia Thomas, Director Clinical Trials|949/585-9511|nthomas@acufocus.com|129
20176414|NCT03149237|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
20176415|NCT04587193|Virginia Commonwealth University|Brian Berman|800-762-6161|brian.berman@vcuhealth.org|
20176416|NCT02707640|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20176417|NCT05419947|Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Luis Muñoz Bellvís|0034 923 29 11 00|luismb@usal.es|
20176418|NCT01157533|The University of Texas (UT) MD Anderson Cancer Center|Ara Vaporciyan, MD, BS/ Professor||CR_Study_Registration@mdanderson.org|
20190192|NCT03349476|Icahn School of Medicine at Mount Sinai|Stephanie Harcum|(212) 824-8927|stephanie.harcum@mountsinai.org|
20190193|NCT04417907|Stanford University|Kimford Meador|650-721-5552|kmeador@stanford.edu|
20190194|NCT00674765|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
20190195|NCT00248794|VA Connecticut Healthcare System|Gary Bryson|860-594-6348|gary.bryson@va.gov|
20190196|NCT03449979|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
20190197|NCT03195127|University of Maryland, Baltimore|Avelino C. Verceles, M.D., M.S.|4103288141|avercele@medicine.umaryland.edu|
20190198|NCT01762345|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
20190199|NCT00244751|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190200|NCT00068107|Baylor Research Institute|Dr. Raphael Schiffmann|214-820-4533|raphael.schiffmann@baylorhealth.edu|
20190201|NCT03288506|Queen's University Belfast|Dr Paul Best|0289097|p.best@qub.ac.uk|3256
20190202|NCT04658888|Penn State Health Milton S Hershey Medical Center|Dr. Christina Scartozzi|484-650-0885|Cscartozzi@pennstatehealth.psu.edu|
20190203|NCT03400579|University of North Carolina at Chapel Hill|Mehul Patel, PhD|919-843-7307|mehul_patel@med.unc.edu|
20190204|NCT02644122|University of California, San Diego|Ezra Cohen, MD|(858)822-5800|ecohen@ucsd.edu|
20190205|NCT02773732|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20190206|NCT02579915|McLean Hospital|Courtney Beard|16178553557|CBEARD@MCLEAN.HARVARD.EDU|
20190207|NCT02067819|Weill Cornell Medicine|Shannon Bennett, PhD|646-962-2820|smb9017@med.cornell.edu|
20190208|NCT00805441|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20190209|NCT01782209|University of Alabama at Birmingham|Richard J. Whitley, MD|205.638.2530|rwhitley@peds.uab.edu|
20190210|NCT02935894|USDA, ARS Western Human Nutrition Research Center|Dr. John W. Newman|530-752-1009|john.newman@ars.usda.gov|
20161819|NCT01175395|University of Illinois at Chicago|Jennifer I Lim MD|312-413-0704|jennylim@uic.edu|
20161820|NCT01927055|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
20161821|NCT03002454|Winnipeg Regional Health Authority|Dr. Sandor Demeter|1 (204) 787-3375|sdemeter@hsc.mb.ca|
20161822|NCT02477553|Indiana University|Peter H. Schwartz, M.D., Ph.D.|317-278-4037|phschwar@iu.edu|
20161823|NCT03449433|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20161824|NCT02745535|Institute of Human Virology, University of Maryland|Dr. Eleanor Wilson|1(410)706-1710|eleanor.wilson@ihv.umaryland.edu|
20161825|NCT01291277|Yale School of Medicine|Dr. Loren Laine|203-937-3462|loren.laine@yale.edu|
20161826|NCT00849108|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|cesare.orlandi@lantheus.com|
20161827|NCT00716742|Allergan, Inc.|Vice President, Global Health Outcomes Strategy and Research|714-246-4500|clinicaltrials@allergan.com|
20161828|NCT02963701|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161829|NCT03480009|University of Pittsburgh|Principal Investigator, MD MPH|412-641-5496|fpr@upmc.edu|
20161830|NCT01548742|Minneapolis VA Medical Center|Kelvin O. Lim, MD (Principal Investigator)|612-467-3323|kolim@umn.edu|
20161831|NCT00637572|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20161832|NCT01345682|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161833|NCT00896649|Boston Medical Center|Gustavo Mercier, House Radiologist|617-638-6610|gustavo.mercier@bmc.org|
20161834|NCT00795288|Washington University|Michael Diringer|314-362-2999|diringerm@wustl.edu|
20161835|NCT01075984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161836|NCT02495454|Fondazione Italiana Linfomi ONLUS|Dr. Luigi Marcheselli - FIL statistician|059 4223873|lmarcheselli@filinf.it|
20161837|NCT03652675|Columbia University / New York State Psychiatric Institute|Jennifer C Elliott, PhD|646 774 7953|jce2130@cumc.columbia.edu|
20161838|NCT01638559|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20161839|NCT00712582|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
20161840|NCT00491374|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20161841|NCT02539511|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
20161842|NCT01181674|McMaster University|Dr. Natalia McInnes (nee Yakubovich)|905-521-2100|natalia.mcinnes@mcmaster.ca|
20161843|NCT01274429|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20161844|NCT01399008|Metabolex|Mary Jean Stempien, M.D., Acting Chief Medical Officer|510-293-8800|mjstempien@metabolex.com|
20161845|NCT03907033|Mayo Clinic|Dr. Johnny Yi|480-342-0612|Yi.Johnny@mayo.edu|
20161846|NCT00370838|Johns Hopkins University|Dr. Harvey Singer|410-955-7212|hsinger@jhmi.edu|
20161847|NCT00007644|Minneapolis VA Medical Center|Timothy Wilt, MD|612-467-2158|timothy.wilt@va.gov|
20161848|NCT04046250|Tosk, Inc.|Emile Youssef, MD, PhD|312.244.0068|eyoussef@tosk.com|
20161849|NCT00709878|Northwestern University|Mario Lacouture, MD|212-610-0079|LacoutuM@mskcc.org|
20161850|NCT00575965|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617 632 5880|steven_treon@dfci.harvard.edu|
20161851|NCT03268941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20161852|NCT01216683|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20161853|NCT01629953|VA North Texas Health Care System|James LePage, Ph.D. Chief Research and Development|214-857-0240|james.lepage@va.gov|
20161854|NCT00344500|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
20161855|NCT01329848|Western University of Health Sciences|Dr. Chris Chase|909 706-3882|cchase@westernu.edu|
20161856|NCT02252965|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20161857|NCT01387464|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
20161858|NCT02615691|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20161859|NCT01854268|University of Florida|Alexandra E. Brandimore, M.A. CCC/SLP|352-273-3711|aessman@ufl.edu|
20161860|NCT04279613|Yale University|Dr. Kevan Herold|203-785-6507|kevan.herold@yale.edu|
20161861|NCT04051827|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20161862|NCT02888743|Department of Data Science, Dana-Farber Cancer Institute|Anita Giobbie-Hurder, MS (Study biostatistician)|617-632-2193|agiohur@ds.dfci.harvard.edu|
20161863|NCT01424566|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
20161864|NCT02484950|Rush University Medical Center|Brian Cole|(312) 432-2818|Brian.cole@rushortho.com|
20161865|NCT03675516|Momentum Data|Dr Andrew McGovern|+447531221970|andy.mcgovern@momentumdata.co.uk|
20161866|NCT01079936|University of Texas (UT) MD Anderson Cancer Center|Muzaffar H. Qazilbash, Professor, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
20161867|NCT02335424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161868|NCT02712424|Geisel School of Medicine|Dr C Fordham von Reyn|6036505000|fvr@dartmouth.edu|
20161869|NCT02723175|Medical University of South Carolina|Jeffrey Borckardt|843-792-3295|borckard@musc.edu|
20161870|NCT04109976|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20161871|NCT00906958|ResMed Ltd|Alison Wimms|+44 7901332675|alison.wimms@resmed.com|
20161872|NCT04054999|Mayo Clinic|Sher-Lu Pai, M.D.|904-956-3327|Pai.SherLu@mayo.edu|
20161873|NCT02598128|Alcresta Therapeutics, Inc.|Russell G. Clayton, D.O., Chief Medical Officer|215.813.5100|rclayton@alcresta.com|
20161874|NCT03134183|Virginia Commonwealth University|Frances Casey, MD|804-828-5076|frances.casey@vcuhealth.org|
20176419|NCT02277626|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
20176420|NCT02648698|Department of Hysteroscopic Centre, Fuxing Hospital, the Eighth Clinical Medical College, Capital Medical University, Beijing, China|Dr. Dongmei Song|13651294056|echosdm@163.com|86
20176421|NCT03143829|University of Central Floroda|Victoria Loerzel|407-823-0762|victoria.loerzel@ucf.edu|
20176422|NCT02181530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20176423|NCT00966940|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
20176424|NCT01326780|Valeant|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
20176425|NCT01774903|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
20176426|NCT00924950|UCSF|Tina Bhutani|4154763396|tinabhutanimd@gmail.com|
20176427|NCT01602315|Novartis Pharmaceuticals|Study Director|862-778-8300||
20176428|NCT00593372|UAMS Medical Center|Gary McCullough|501-852-7886|garyhmccullough@uams.edu|
20176429|NCT00127790|Universityy of Rochester|Wilfred Pigeon, PhD|(585) 275-3374|wilfred_pigeon@urmc.rochester.edu|
20176430|NCT00961259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20176431|NCT00843791|OREGON HEALTH & SCIENCE UNIVERSITY|Dr. Jonathan Q Purnell|5034941056|purnellj@ohsu.edu|
20176432|NCT01252251|Memorial Sloan Kettering Cancer Center|Dr. Michael Postow, MD|646-888-4589|PostowM@mskcc.org|
20176433|NCT01324024|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20176434|NCT05711069|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
20176435|NCT02691455|The University of Texas Health Science Center at Houston|Robert M. Feldman, MD|(713) 559-5239|Robert.M.Feldman@uth.tmc.edu|
20176436|NCT01257204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20176437|NCT02057757|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. John Beigel|301-451-9881|jbeigel@niaid.nih.gov|
20176438|NCT00563797|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
20176439|NCT02809976|Tufts Medical Center|David Romarin, MD Prinicpal Investigator|617 636 7462|drosmarin@tuftsmedicalcenter.org|
20176440|NCT00530023|Director, Program Management, Clinical Research|Harold Torunsky|8185765445|harold.torunsky@medtronic.com|
20176441|NCT00211081|Emory University|Dr. Willam Mahle|404-785-6000|wmahle@emory.edu|
20176442|NCT00982189|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
20176443|NCT03755765|Department of Family Medicine, Georgetown University Medical Center|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
20176444|NCT02104557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176445|NCT03091751|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
20176446|NCT04455893|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
20176447|NCT01158222|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20176448|NCT01161329|UppsalaU|Karin Hellström|+46184714762|karin.hellstrom@neuro.uu.se|
20176449|NCT00111228|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20176450|NCT00962429|Oregon Health and Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
20176451|NCT02464969|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20176452|NCT02863354|Retina Consultants of Houston|Dr. Charles C. Wykoff|713-524-3434|ccwmd@houstonretina.com|
20176453|NCT01611571|Columbia University Medical Center|Marcella Walker MD|212-342-5351|mad2037@columbia.edu|
20176454|NCT00724451|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20176455|NCT01599650|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20176456|NCT00720876|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
20176457|NCT00286949|Michael E. DeBakey VA Medical Center|Laura Marsh, M.D., Principal Investigator|713-794-8907|laura.marsh2@va.gov|
20176458|NCT03402243|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20176459|NCT02737566|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
20176460|NCT05038137|Medical University of South Carolina|Dr. Karanchi|(843) 792-2529|karanchi@musc.edu|
20205980|NCT04150562|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
20176461|NCT00622635|Novartis Pharmaceuticals|Study Director|862 778-8300||
20176462|NCT00281840|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
20176463|NCT00733343|Department of Cardiology, Imperial College London, Dovehouse St., London SW3 6LY, United Kingdom|Martin R. Cowie, MD|+44 (0)20 7589 0|m.cowie@imperial.ac.uk|5111
20176464|NCT02185768|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20176465|NCT03383588|Montefiore Medical Center|Dr Catherine Igel|718-405-8200|cigel@montefiore.org|
20176466|NCT03027466|National Cancer Institute|William Klein|2402766972|kleinwm@mail.nih.gov|
20176467|NCT01858194|Icahn School of Medicine at Mo|Betsy Ellsworth, Research Program Director|212 824 8902|betsy.ellsworth@mountsinai.org|
20176468|NCT02158039|Mayo Clinic|Dr. Mark Topazian|507-284-7602|topazian.mark@mayo.edu|
20205981|NCT02988219|Warsaw Medical University|Dr. Karolina Dobronska|48 22 502 17 21|karolinapladzyk@gmail.com|
20205982|NCT01306032|National Cancer Institute|Dr. Alice Chen|301-435-0517|chenali@mail.nih.gov|
20205983|NCT01522443|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20161875|NCT03274804|Universitätsklinikum Heidelberg, NCT|Dr. Georg Martin Haag|+49 (0) 6221 56|GeorgMartin.Haag@med.uni-heidelberg.de|4801
20161876|NCT04040621|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161877|NCT00845065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20161878|NCT02299076|VAL HEALTH, LLC|Daniel Astrachan|2033769388|dastrachan@valhealth.com|
20161879|NCT01198509|New York University School of Medicine|Steven B. Abramson, MD|212-263-8003|StevenB.Abramson@nyumc.org|
20161880|NCT00181610|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
20161881|NCT01994993|Duke University Medical Center|Michael Cohen-Wolkowiez, M.D|9196688812|michael.cohenwolkowiez@duke.edu|
20161882|NCT02228096|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20161883|NCT00499746|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
20161884|NCT01969721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161885|NCT00790478|University of Tennessee|Paul Terry|(865) 305-9341|pterry@utmck.edu|
20161886|NCT02383433|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Davendra Sohal|+1 216-444-8258|sohald@ccf.org|
20161887|NCT02208349|St Vincent Hospital|Jestin Carlson|8144525000|jcarlson@svhs.org|
20161888|NCT04311463|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161889|NCT00952614|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
20161890|NCT01102894|University of Minnesota|Dr. Joanne Slavin|612-624-7234|jslavin@umn.edu|
20161891|NCT04023682|University of Iowa Hospitals and Clinics|Sundara Reddy, MBBS|(319) 356-2108|sundarareddy-durgempuditripura@uiowa.edu|
20176469|NCT01196871|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20205984|NCT03260894|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20205985|NCT00706394|Endologix|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
20205986|NCT00290589|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
20205987|NCT00318565|Biosense Webster|Christine Liu|9098398608|cliu10@its.jnj.com|8608
20205988|NCT00691093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20205989|NCT03123055|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
20205990|NCT06444165|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
20205991|NCT03814005|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20205992|NCT01896856|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Nilofer Azad|410-614-9169|nazad2@jhmi.edu|
20205993|NCT04446299|Braintree Laboratories, Inc.|Head of R&D, GI|7819646710|studydirector@sebelapharma.com|
20205994|NCT01700985|Therapeutics Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20205995|NCT00134017|Johns Hopkins University|Leo Luznik, MD|4105027732|luznile@jhmi.edu|
20205996|NCT02584868|Centre Hospitalier Universitaire Brugmann|Philippe Van der Linden, MD, PhD|+32 2 477 23 30|philippe.vanderlinden@chu-brugmann.be|
20205997|NCT01192204|The Ohio State University|Susan R, Mallery DDS, PhD|614 292-5892|mallery.1@osu.edu|
20205998|NCT02940626|X4 Pharmaceuticals (merged with Arsanis)|Vice President, Clinical Operations|(857) 529-8300|rnd@x4pharma.com|
20205999|NCT03488914|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
20206000|NCT01767519|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20206001|NCT00293423|University of California, Davis|Dr. Orin Bloch||obloch@ucdavis.edu|
20206002|NCT00507416|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
20206003|NCT03571256|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20206004|NCT00868452|Sunovion|Medical Director, CNS|1-866-503-6351||
20206005|NCT01673191|Retinal Consultants of Arizona|Dr. Pravin Dugel|602-222-2221|PDugel@gmail.com|
20206006|NCT03141372|Cleveland Clinic Florida|Sara Farag, Fellow in Minimally Invasive Gynecologic Surgery|8147691904|faragsara@gmail.com|
20206007|NCT02247401|AbbVie|Global Medical Services|800-633-9110||
20206008|NCT01714817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20206009|NCT00476996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20206010|NCT00904995|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
20206011|NCT00675558|Columbia University Medical Center|Paul D. Berk, MD|2120-305-4491|pb2158@columbia.edu|
20206012|NCT04218799|University of Maryland School of Medicine|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
20206013|NCT01769469|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20206014|NCT02750267|Center for Diabetes Technology|Dr. Daniel R. Chernavvsky|4342431395|drc2v@virginia.edu|
20206015|NCT02447458|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
20206016|NCT02790463|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
20206017|NCT00798577|Alcon Labs|Alcon Clinical|1.888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20206018|NCT01425229|University of Heidelberg|Prof. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
20206019|NCT03148756|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20206020|NCT01376362|National Institutes of Health|Hatice Nida Sen, Principal Investigator, National Eye Institute|(301) 402-3254|senh@nei.nih.gov|
20206021|NCT00638924|Unicamp|Juliana Gomes Zabatiero||juzabatiero@yahoo.com.br|
20206022|NCT02259127|MRC CTU at UCL|Prof Diana M Gibb (Chief Investigator)|+44 (0) 207 670 4700|diana.gibb@ucl.ac.uk|
20206023|NCT05406440|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161892|NCT01599741|Philips|Thijs Grunhagen|+31 6 11645166|thijs.grunhagen@philips.com|
20161893|NCT00440830|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
20221358|NCT05126693|KU Leuven|Prof. dr. Kaat Desloovere|+32 486 40 13 73|kaat.desloovere@kuleuven.be|
20221359|NCT05525520|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20221360|NCT02732730|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
20221361|NCT05878093|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20221362|NCT04100018|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20221363|NCT00711243|Northwestern University|Mary Mulcahy (MD)|312.695.6182|Mary.Mulcahy@nm.org|
20221364|NCT03514459|University of Washington|Dr. McKenna Eastment|5742101120|mceast@uw.edu|
20221365|NCT02892955|Abbott|Joyce Chuang|9253535817|joyce.chuang@abbott.com|
20221366|NCT01962103|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20221367|NCT01321749|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D.|8683198127|jixm70@hotmail.com , Jixm@ccmu.edu.cn|
20176470|NCT01079234|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20221368|NCT03825939|NYU Langone|Dr. Jan Koenig|516-678-2232|Jan.Koenig@nyulangone.org|
20176471|NCT01485601|Medytox Inc.|Young Ryu|+82-2-6901-5890|young.ryu@medytox.com|
20221369|NCT04179838|Northwestern University|Thorsten Kahnt|3125032896|thorsten.kahnt@northwestern.edu|
20221370|NCT03456102|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
20221371|NCT01495000|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221372|NCT04004481|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
20221373|NCT01608100|Abbott Diagnostics Division|Karla Grasso, Clinical Research Manager|1 224-667-5602|karla.grasso@abbott.com|
20221374|NCT03805386|Mayo Clinic Arizona|Principal Investigator, Dr Johnny Yi|14803420612|yi.johnny@mayo.edu|
20221375|NCT04937881|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
20221376|NCT04055740|University of Chicago|Dr. Andrew Beaser|(888) 824-0200|abeaser@bsd.uchicago.edu|
20221377|NCT01277783|Medtronic Bakken Research Center B.V.|Mireille van Ginneken, Principal Clinical Research Specialist|+31433566801|mireille.vanginneken@medronic.com|
20221378|NCT00780338|RAND|Matthew Chinman|412 683-2300|chinman@rand.org|4287
20221379|NCT03347110|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20221380|NCT01004354|University of Massachusetts Medical School|Benjamin U Nwosu, MD|5083347872|benjamin.nwosu@umassmemorial.org|
20221381|NCT00811733|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221382|NCT00793871|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221383|NCT02500589|Durahm VA Health Care System|Jennifer Gierisch|919-286-0411|jennifer.gierisch@va.gov; j.gierisch@duke.edu|176936
20221384|NCT00291317|Children's Specialized Hospital|Frank Castello|732 258 7065|fcastello@childrens-specialized.org|
20221385|NCT00890617|Barbara Ann Karmanos Cancer Institute|Dr. Frank A. Baciewicz|(313) 993-0580|FBaciewi@dmc.org; baciewic@karmanos.org|
20221386|NCT00262028|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20221387|NCT00613171|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20221388|NCT01197911|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20221389|NCT03282916|Columbia University Irving Medical Center|Dr. Davangere P Devanand|646-774-8658|dpd3@cumc.columbia.edu|
20221390|NCT01526057|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221391|NCT00571324|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
20221392|NCT03354598|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
20221393|NCT02553772|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
20221394|NCT00786409|University of Chicago|Linda Wagner-Weinter, MD|773-702-2245|lww@uchicago.edu|
20221395|NCT00610129|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy|646-888-4185|ReidyD@mskcc.org|
20221396|NCT00950365|Montefiore Medical Center|Roman Perez-Soler, MD|(718) 405-8505|RPEREZSO@montefiore.org|
20221397|NCT00141778|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
20221398|NCT04599075|University of Massachusetts Chan School of Medicine|Dr. Gianna Wilkie|7743642523|Gianna.Wilkie@umassmemorial.org|
20221399|NCT03051672|Dana-Farber Cancer Institute|Dr. Sara Tolaney|6176323800|sara_tolaney@dfci.harvard.edu|
20221400|NCT01328184|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221401|NCT00692692|Vanderbilt University Medical Center|Jason Wendel, MD|615-936-0160|jason.wendel@vanderbilt.edu|
20221402|NCT02360215|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20221403|NCT05016960|VA San Diego Healthcare System|Dr. Erin Almklov|858-552-8585|erin.almklov@va.gov|3907
20221404|NCT05579782|Medical College of Wisconsin|Tracy Wang, MD|414-955-1459|tswang@mcw.edu|
20221405|NCT05655546|Scripps Research|Julia Moore Vogel|8587842275|immunocare@scripps.edu|
20221406|NCT02218463|University of Missouri-Kansas City School of Medicine|Dr. Tazim Dowlut-McElroy, M.D., M.S.|816-404-5150|tdowlut@cmh.edu|
20221407|NCT03700125|Barts Health NHS Trust|Dr Simon Finney|02073777000|simon.finney2@nhs.net|
20221408|NCT02059512|First Pavlov State Medical University of St. Petersburg|Vladimir V Komok, Ph.D|8-904-632-19-00|vladimir_komok@mail.ru|
20221409|NCT04576507|New York State Psychiatric Institute|Caroline A. Arout, Ph.D.|646-774-6167|caroline.arout@nyspi.columbia.edu|
20221410|NCT04467840|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
20221411|NCT04470518|Leuven Unit Health Technology Assessment Research, KU Leuven|Tine De Burghgraeve, PhD|+3216377276|tine.deburghgraeve@kuleuven.be|
20221412|NCT05201794|Janssen Research & Development, LLC|Senior Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20190211|NCT02033174|IiSGM|Dr Alvarez-Sala|+34 915868287|luisantonio.alvarezsala@salud.madrid.org|
20206024|NCT02088541|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20206025|NCT05742841|Wake Forest School of Medicine|Nick Ashburn|336-716-4646|n.ashburn@wakehealth.edu|
20221413|NCT03848715|UCLA|Dr. Chloe Boyle|310 794 9383|ccboyle@mednet.ucla.edu|
20221414|NCT04653454|Mayo Clinic|Adrian Dumitrascu M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
20221415|NCT02763046|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20221416|NCT00080912|NCIC Clinical Trials Group|Dr. Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
20221417|NCT00086684|Janssen R&D US|SENIOR DIRECTOR CLINICAL LEADER|1 609 730-4529||
20221418|NCT02826486|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
20190212|NCT03659136|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20221419|NCT01067105|Sunovion|Respiratory Medical Director|1-866-503-6351||
20221420|NCT01917682|Corindus, Inc.|John Van Vleet, VP of Clinical and Regulatory Affairs|(260)615-8892|john.van_vleet@siemens-healthineers.com|
20221421|NCT02521415|Carolinas Medical Center|Dr. Stacy Reynolds|704-355-3181|stacy.reynolds@carolinashealthcare.org|
20221422|NCT02203357|Peking University Health Science Center|Dr. Hui Zhuang|86-10-82801617|zhuangbmu@126.com|
20221423|NCT02439216|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
20221424|NCT02094300|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|SSnyder@medinst.com|
20221425|NCT01111318|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221426|NCT02493660|Stryker Company|Colleen Roden, Director, Clinical Operations|1 931 267 2041|colleen.roden@stryker.com|
20221427|NCT03073876|City University of New York - Queens College and The Graduate Center|Nancy S. Foldi, PhD; Professor|718.997.3253|nfoldi@qc.cuny.edu|
20221428|NCT01050530|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20221429|NCT04505969|Barau Dikko Teaching Hospital, Kaduna State University|Study Principal investigator|+2348066664042|abubakarabdulkareem8@gmail.com|
20221430|NCT02288312|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20221431|NCT01276041|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
20221432|NCT00725491|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20221433|NCT01094704|UNC-Chapel Hill|Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
20221434|NCT02070965|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
20221435|NCT00942357|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD. and Helen Huang, MS.|716-845-1169|lgedeon@gogstats.org|
20221436|NCT02023983|Municipal Hospital Ostrava|dr. Kamil Novobílský|+420 59 619 2660|k.novobilsky@mnof.cz|
20221437|NCT02105467|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221438|NCT01321879|UT MD Anderson Cancer Center|Dr. Issam I. Raad/ Chair, Infectious Diseases|713- 792-7943|iraad@mdanderson.org|
20221439|NCT01288807|UCSD|Tobias Moeller-Bertram (PI)|7603211315|moellerbertram@yahoo.com|
20221440|NCT00958828|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20221441|NCT02687451|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20190213|NCT03786471|University of California Los Angeles|Jenny Summapund|3233660667|jsummapund@mednet.ucla.edu|
20190214|NCT03976102|Dr. Reddy's Laboratories Ltd.|Head - Clinical Development|91-40-4464-4000|RI-01-006@drreddys.com|
20190215|NCT02834624|University of Missouri-Columbia|Dr. Naomi Lauriello|573-882-2272|lauriellon@health.missouri.edu|
20190216|NCT05066230|Kodiak Sciences Inc|Chief Medical Officer|1 (650) 281-0850|ClinOps@kodiak.com|
20190217|NCT03072238|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20190218|NCT00112827|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20190219|NCT01562275|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190220|NCT01863368|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20190221|NCT04371471|NumaHealth international|Dr. Kamyar Hedayat|+33660404192|khedayat@numahealth.com|
20190222|NCT00515112|The University of Chicago|Dr. Walter Stadler|773-702-4400|wstadler@medicine.bsd.uchicago.edu|
20190223|NCT01366976|Vanderbilt University School of Medicine|Mias Pretorius|16153220758|mias.pretorius@vanderbilt.edu|
20190224|NCT00307489|Gilead Sciences, Inc.|Stephen J. Rossi, PharmD|650-522-4212|stephen.rossi@gilead.com|
20190225|NCT04425252|Clear Creek Bio, Inc.|Vice President Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
20190226|NCT01458288|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
20190227|NCT00304278|Southern Illinois University|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
20206026|NCT04134728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206027|NCT00110591|CytoDyn, Inc.|Joe Meidling|360-980-8524|jmeidling@cytodyn.com|
20206028|NCT00962754|Princess Amalia Children's Clinic, Isala Klinieken|Dr. J. Bekhof|0031-38-4245050|j.bekhof@isala.nl|
20206029|NCT01711541|Alliance for Clinical Trials in Oncology|Everett E. Vokes, M.D.|773-702-9306|evokes@medicine.bsd.uchicago.edu|
20206030|NCT03943446|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206031|NCT00905268|The National Hospital, University College London|Prof. Nicholas William Wood|020 7837 3611|n.wood@ucl.ac.uk|
20206032|NCT01281189|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20206033|NCT05355818|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20206034|NCT01175590|Bausch & Lomb Inc.|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20206035|NCT01019252|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@mgh.harvard.edu|
20206036|NCT03154307|Miami Neuroscience Institute|Clinical Research Administrator|17865961825|starlieb@baptisthealth.net|
20221442|NCT02321111|University of Texas Health San Antonio|Laurie Che Kelly|210-617-5300|che@uthscsa.edu|14731
20221443|NCT00707239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221444|NCT03104192|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
20221445|NCT01778530|National Cancer Institute|Dr. Joohee Sul|301-402-6298|Joohee_Sul@nih.gov|
20221446|NCT03472014|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20221447|NCT01400477|University of Colorado|Dr. Robert Freedman|393 724 1000|robert.freedman@ucdenver.edu|
20221448|NCT03652051|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
20221449|NCT01958437|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|7347639259|bhampste@med.umich.edu|
20221450|NCT02394600|Kingston General Hospital|Dr. Anne Ellis|613-548-2336|ellisa@kgh.kari.net|
20221451|NCT02569801|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20221452|NCT00428246|Indiana University|Rajiv Agarwal|317-988-2241|ragarwal@iupui.edu|
20221453|NCT02200055|General Surgery, Naval Medical Center Porstmouth|Dr. Christopher Oxner|757-953-2495|christopher.r.oxner.mil@mail.mil|
20221454|NCT03442751|Glaukos|Valerie Smith|9493679600|VSmith@glaukos.com|
20221455|NCT00656656|University of Lübeck|Prof. Dr. Detlef Zillikens|+49-451-500-41500|detlef.zillikens@uksh.de|
20221456|NCT01928472|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20221457|NCT00981812|University of Cincinnati Medical Center|Mary Mahoney, MD|513-584-4396|mary.mahoney@uchealth.com|
20221458|NCT02603887|UT MD Anderson Cancer Center|Dr. Elisabet Manasanch/ Assistant Professor, Lymphoma-Myeloma|713-745-8092|eemanasanch@mdanderson.org|
20221459|NCT04442464|Mayo Clinic|Cherie B. Nau, O.D.|507-284-4152|Nau.Cherie@mayo.edu|
20221460|NCT01308424|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
20221461|NCT00948155|University of Pennsylvania|Andrew A. Strasser, Ph.D., Associate Professor|215 746 5788|strasse3@mail.med.upenn.edu|
20221462|NCT03411863|James J. Peters VAMC|Dr. Noam Y. Harel|718-584-9000|noam.harel@va.gov|1742
20221463|NCT05767905|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221464|NCT05966506|The University of Texas Health Science Center at Houston|Nitha Mathew Joseph, PhD, RN, CNE, CGNC|713-500-2165|Nitha.Mathew@uth.tmc.edu|
20221465|NCT01903798|SCIRE|Executive Director, Southern California Institute for Research and Education|562-826-8000|Sabry.Eassa@va.gov|5747
20221466|NCT00307086|H. Lee Moffitt Cancer Center|Mellisa Alsina, MD|813-745-6886|Melissa.Alsina@moffitt.org|
20221467|NCT03618017|University of Michigan Rogel Cancer Center|Lauren Wallner, Ph.D.|734-232-0788|lwallner@med.umich.edu|
20206037|NCT03657810|Charleston Laboratories, Inc.|Bernard P. Schachtel, MD, Chief Scientific Officer|561.379.8726|bschachtel@charlestonlabs.com|
20206038|NCT03325556|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-|medicalinformation@acadia-pharm.com|2897
20206039|NCT01705587|University of Pittsburgh|Susan Greenspan, MD|412-692-2477|greenspn@pitt.edu|
20206040|NCT02227849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20206041|NCT00762268|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
20206042|NCT00081939|The Myeloma Institute, University of Arkansas for Medical Sciences|Director of Clinical Trials and Regulatory Affairs|501-526-6990|npetty@uams.edu|
20206043|NCT04897594|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
20206044|NCT04526067|University of Texas Health Science Center in San Antonio|Dawn Velligan, PhD|210-567-5508|velligand@uthscsa.edu|
20206045|NCT03515213|University of California, Irvine|Leslie Thompson|9498243990|lmthomps@hs.uci.edu|
20206046|NCT01457924|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206047|NCT01329341|James A Haley Veterans Hospital|Stephanie McGovern|813-558-3964|stephanie.mcgovern@va.gov|
20206048|NCT00448760|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD, Professor|305-243-4909|bardalan@med.miami.edu|
20206049|NCT01226706|Gynecology, Regina Qu'Appelle Health Region|Dr. Corrine Jabs|(306) 586-3120|corrinejabs@hotmail.com|
20206050|NCT03017846|Albert Einstein College of Medicine|Anthony Guzman, MD|7189208352|anguzman@montefiore.org|
20206051|NCT01789346|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20206052|NCT00618995|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206053|NCT01213264|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206054|NCT02375984|Saint John's Cancer Institute (formerly John Wayne Cancer Institute)|Lisa van Kreuningen|3105827053|lisa.vankreuningen@providence.org|
20206055|NCT05014542|Family Medicine Practice Svijetlana Perculija Durdevic, MD, Ninska 10, Sesvete|Svijetlana Perculija Durdevic, MD, family medicine specialist, acupuncturist|00385913302507|svijetlana.perculija.durdevic@outlook.com|
20206056|NCT01438307|UAB|Francisco Robert, MD|205-934-5077|paco@uab.edu|
20206057|NCT02307318|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
20206058|NCT02378883|Medtronic Neurovascular|Darren Lacour, Sr. Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
20206059|NCT01707368|LEO Pharma GmbH|Tobias Anger, Medical Advisor|+49 610 220 1258|TANDE@leo-pharma.com|
20206060|NCT00810810|Bloodworks Northwest (formerly Puget Sound Blood Center)|Karen Nelson, PhD., Vice President Laboratories|206-689-6549|knelson@bloodworksnw.org|
20206061|NCT02563925|Memorial Sloan Kettering Cancer Center|Dr. Shanu Modi, MD|646-888-5243|modis@MSKCC.ORG|
20206062|NCT00282867|University of Virginia|Karen C. Johnston, MD, MSc|434 924-5323|kj4v@virginia.edu|
20206063|NCT01342952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206064|NCT04024072|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
20221468|NCT00312338|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20221469|NCT03757819|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
20221470|NCT03490110|Veterans Affairs|Dr. Anthony Chen|925-372-2530|anthony.chen@va.gov|
20206065|NCT00426556|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20206066|NCT02494440|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20206067|NCT03970824|CELLTRION, Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
20221471|NCT01015534|Instituto Nacional de Cancerologia de Mexico|Carlos Gamboa Vignolle/ Radiation Oncologist|0155556280400|cswgamboa@yahoo.com|441
20206068|NCT01488409|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
20221472|NCT01125917|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20221473|NCT05824754|University of Michigan|Inbal Billie Nahum-Shani|7346609626|inbal@umich.edu|
20221474|NCT02015611|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8217|dhouston@wakehealth.edu|
20221475|NCT04421131|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
20221476|NCT00858494|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
20221477|NCT01875978|China Medical University Hospital|Dr. Dalong Chen|+886-227919696|my686chen@gmail.com|1205
20221478|NCT01169350|University of Washington|Dr. Janet F. Eary|206-598-6244|jeary@uw.edu|
20221479|NCT04870710|BIDMC|Dr. Paulo Lizano|617-754-1227|plizano@bidmc.harvard.edu|
20221480|NCT04201197|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20221481|NCT05724589|Institute of Dermatology, Thailand|Dr. Supawee Phanmamuang|6623545222|dewsupawee@gmail.com|
20221482|NCT01611779|Siesta Medical, Inc.|Michael Kolber|408-320-9424|mkolber@siestamedical.com|
20221483|NCT03475992|MVG Industries|Luc Duchesne|0033169298156|luc.duchesne@mvg-world.com|
20221484|NCT04075487|VA Maryland Health Care System, Geriatric Research, Education, and Clinical Center|Dr. Beth Hogans, M.D., Ph.D., Neurologist|410-605-7000|beth.hogans@va.gov|
20221485|NCT05411991|University Hospital Brussels - Vrije Universiteit Brussel|Prof. Dr. Frederik H. Verbrugge|024749657|frederik.verbrugge@uzbrussel.be|+32
20221486|NCT00725283|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221487|NCT00116779|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20221488|NCT03743051|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
20221489|NCT00711087|Baylor College of Medicine|Christopher P. Smith, MD, MBA, MSS|713-798-7498|cps@bcm.edu|
20221490|NCT01422200|Cincinnati Children's Hospital Medical Center|Dr. Brenda Wong|5136364222|brenda.wong@cchmc.org|
20221491|NCT00840749|Accuray Inc|study admin|4087164608|ccheung@accuray.com|
20221492|NCT01936844|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
20221493|NCT01656460|Brown University Oncology Research Group (BrUOG)|Thomas DiPetrillo, MD|4018633000|kayla_rosati@brown.edu|
20221494|NCT01113892|Getinge Group|Elizabeth Bulger|603 880 1433|Elizabeth.Bulger@getinge.com|5368
20221495|NCT04584502|Geisel School of Medicine|Sarah Lord, Ph.D.|6036467089|sarah.e.lord@dartmouth.edu|
20221496|NCT03535740|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20221497|NCT04481035|Cincinnati Children's Hospital Medical Center|Donald L. Gilbert MD|513-636-4222|donald.gilbert@cchmc.org|
20221498|NCT05807828|1. Academic Orthopaedic Department, Aristotle University Medical School, General Hospital Papageorgiou 2. Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-AUTh|Eustathios Kenanidis - Assistant Professor of Orthopaedic Surgery & Traumatology|6973693693|ekenanidis@auth.gr|
20206069|NCT00105560|Massachusetts General Hospital|Dr. Nancy Tarbell, Pediatric Radiation Oncologist|617-724-1836|NTARBELL@mgh.harvard.edu|
20206070|NCT04569799|Penn State Health College of Medicine|Kathryn McGillen, M.D.|717-531-0003|kmcgillen@pennstatehealth.psu.edu|
20206071|NCT01315847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206072|NCT00979017|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
20206073|NCT03086317|Emory University|Dr. Wissam Jaber, Assistant Professor|4046861000|wissam.jaber@emory.edu|
20206074|NCT03699631|Froedtert and the Medical College of Wisconsin|William Drobyski, MD|414-805-6700|wdrobyski@mcw.edu|
20206075|NCT00964158|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206076|NCT01182337|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
20206077|NCT03101514|the first affiliated hospital of Harbin medical university|Dr. Zhi-Ping Liu|+8613936034546|as150001@aliyun.com|
20206078|NCT01021813|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206079|NCT02270684|University of Southern California|Dr Christopher Powers|3234422900|powers@usc.edu|
20206080|NCT02581982|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mgoodman@wakehealth.edu|
20206081|NCT00405821|NIAID|Steven Reynolds|256-772-220-087|sjreynolds@niaid.nih.gov|
20206082|NCT04962503|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager|Tel: +61 3 9660 4900|mail@clinuvel.com|
20206083|NCT02372097|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206084|NCT02608229|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
20206085|NCT01033487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206086|NCT00862654|Galderma|Farzi Sidou, Clinical Project Manager|+33 4 93 95 70 51|farzaneh.sidou@galderma.com|
20206087|NCT03954444|Teva Pharmaceuticals Development Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20206088|NCT03812588|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
20206089|NCT03094832|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206090|NCT00442767|Montefiore Medical Center|Dr. Rubina Heptulla|718-920-4664|rheptull@montefiore.org|
20206091|NCT01181778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20206092|NCT02674685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221499|NCT05198518|Icahn School of Medicine at Mount Sinai|Alfred Marc C Iloreta Jr, MD|(212) 241-9410|alfred-marc.iloreta@mountsinai.org|
20221500|NCT02766335|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20221501|NCT00501995|Johns Hopkins University|Gwen Leatherman,R.N.,M.S.|410-550-8582|gleathe@jhmi.edu|
20221502|NCT03645863|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20221503|NCT02396511|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
20221504|NCT01841593|SSAT Research, Chelsea & Westminster Hospital|Dr. Marta Boffito|+442033155601|marta.boffito@chelwest.nhs.uk|
20221505|NCT01651078|Monteris Medical|Nissa Mollema (Clinical Operations Manager)|763-253-4710|nmollema@monteris.com|
20221506|NCT03125798|Wielkoposkie Centrum Pulmonologii i Torakochirurgii|Dr Piotr Gabryel|+48616654249|piotrgabryel@gmail.com|
20221507|NCT02635984|AU Medical Center / University of Georgia College of Pharmacy|Dr. Amber Clemmons, Clinical Pharmacist - BMT/Hematology & Clinical Associate Professor|706-721-6493|aclemmons@augusta.edu|
20221508|NCT03164551|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20221509|NCT01515423|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20221510|NCT02501928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221511|NCT03737357|Institut Straumann|Anaïs Robert, Clinical Trial Leader|+41799258750|anais.robert@straumann.com|
20221512|NCT00951496|NRG Oncology|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
20221513|NCT02020278|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20221514|NCT00838526|Eisai Inc.|Eisai Medical Information, Eisai|+1 888 274 2378|esi_medinfo@eisai.com|
20221515|NCT01555697|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
20221516|NCT04429945|James A Haley Veterans Hospital|Dr. Christopher Fowler|619-647-4470|christopher.fowler3@va.gov|
20221517|NCT04338022|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20221518|NCT02466321|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
20221519|NCT02189837|Amgen Inc.|Study Director|866-572-6436||
20221520|NCT04851873|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20221521|NCT02198963|Mercury Street Medical|Dr. John Pullman|(406) 723-1375|john.pullman@mecurystmed.com|
20206093|NCT02661464|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20206094|NCT00903370|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
20206095|NCT00719862|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|WWheeler@medapharma.us|
20206096|NCT01184846|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20206097|NCT01999946|NYU Langone Health|Joshua Lee, MD MS|646-501-3552|joshua.lee@nyulangone.org|
20206098|NCT01987349|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20206099|NCT01770145|US WorldMeds|Regulatory Associate, Clinical Operations|5028158130|rgerlach@usworldmeds.com|
20206100|NCT04268303|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20206101|NCT00355134|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206102|NCT02979444|Northwestern University Feinberg School of Medicine|Darius Tandon, PhD|410-852-0399|dtandon@northwestern.edu|
20206103|NCT00741104|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20206104|NCT04306900|Trishula Therapeutics, Inc.|Executive Director|1-650-509-5732|info@trishulatx.com|
20206105|NCT03621189|Chang Gung Memorial Hospital|Dr. Hsing Chang Ni|886975365663|alanni0918@yahoo.com.tw|
20206106|NCT01135394|University of Maryland School of Medicine|Soren Snitker, MD, PhD|4107061511|ssnitker@som.umaryland.edu|
20206107|NCT04432376|Hill Dermaceuticals|Dr. Rosario G Ramirez, Medical Director|4073231887|nini.ramirez@hillderm.com|
20206108|NCT00379236|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20206109|NCT00801892|University of Pittsburgh|E. Chasens, PhD|412-624-9380|chasense@pitt.edu|
20206110|NCT00438464|University of Texas (UT) MD Anderson Cancer Center|Jeri Kim, MD / Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20206111|NCT00728936|Idera Pharmaceuticals, Inc|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20206112|NCT01601704|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
20206113|NCT01090102|University of California, San Francisco|Dr. Ma Somsouk|415-206-6480|somsoukma@medsfgh.ucsf.edu|
20206114|NCT03518034|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20206115|NCT00546429|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
20206116|NCT02273037|The Hospital for Sick Children|Dr. Diego G. Bassani|+14168137654|diego.bassani@sickkids.ca|303033
20206117|NCT02062398|BlueWind Medical|Amit Korner, VP Clinical Research|+972.74.7218905|amit.korner@bluewindmedical.com|
20206118|NCT00601146|DFCI|Andrea Ng|617-732-6310|ang@lroc.harvard.edu|
20206119|NCT00415519|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20206120|NCT01619488|Nemours Childrens Health Delaware|Kirk W Reichard, MD, MBA, Surgical Director|302-651-5999|kreichar@nemours.org|
20206121|NCT00510484|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
20206122|NCT01590212|University of Glasgow|Prof. Phil Wilson|+44 (0)1463 255892|p.wilson@abdn.ac.uk|
20206123|NCT02533401|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20206124|NCT01324128|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
20206125|NCT03819764|The Cleveland Clinic Foundation|Dr. Susan Linder, PT, DPT, PhD|216-445-9815|linders@ccf.org|
20176472|NCT03509948|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20176473|NCT03221257|University of California, Los Angeles|Dr. Michael D. Roth|3102067389|mroth@mednet.ucla.edu|
20176474|NCT02281136|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Manager of Clinical Research|9147608796|Anna.Houlihan@sunpharma.com|
20176475|NCT05402995|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20176476|NCT00205712|Washington University School of Medicine|John Newcomer, MD|314-362-3153|newcomerj@wustl.edu|
20176477|NCT01071512|University of Chicago|Dr. Adil Javed|773.834.0558|ajaved@neurology.bsd.uchicago.edu|
20176478|NCT02188485|University of Rochester|Kim Van Orden, PhD|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
20176479|NCT00437034|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20176480|NCT03146650|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
20176481|NCT01815671|Specialists in Gastroenterology, LLC|Leonard Weinstock, MD|314-997-0554|lw@gidoctor.net|102
20176482|NCT01130740|Center for Health Services Reserach in Primary Care, Durham VAMC|Kelli D. Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
20176483|NCT02047604|Valeant Pharmaceuticals|VP Clinical Services|9089271162|christine.hnatko@valeant.com|
20176484|NCT00983814|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20176485|NCT02517905|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20176486|NCT04114058|Cedar Sinai -Kerlan Jobe|Dr. Michael Banffy|(310) 665-7200|Michael.Banffy@cskerlanjobe.org|
20176487|NCT02710526|Braeburn Inc|Sonnie Kim|6104678718|sonnie@braeburnrx.com|
20176488|NCT01994395|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
20176489|NCT00459134|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20176490|NCT00829621|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20176491|NCT03995758|Indiana University School of Medicine|Dr. Marcelino Rivera|3179622485|maeriver@iu.edu|
20176492|NCT01755416|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20176493|NCT01976845|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Dr. Ronald H Wender|3104231682|ronald.wender@cshs.org|
20176494|NCT00441337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20176495|NCT03655236|Sun Pharma Advanced Research Company Limited|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
20176496|NCT04356716|Columbia University|Suzanne Daly, RN, BSN|212 305 9535|sd2798@cumc.columbia.edu|
20176497|NCT01818336|AllerQuest|Dr. Franklin Adkinson Jr., MD-Vice President, Chief Medical Officer|410-550-2051|fadkinson@allerquest.com|
20176498|NCT04258839|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20176499|NCT02293005|UT MD Anderson Cancer Center|Dr. Anne Tsao, MD- VP, Academic Affairs, CAO Office|(713) 792-6363|astsao@mdanderson.org|
20176500|NCT03328897|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20176501|NCT02192684|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
20176502|NCT00608829|W.L. Gore and Associates|Abe Letter|928 864 3113|aletter@wlgore.com|
20176503|NCT03189914|Rexahn|Doug Swirsky/ Chief Executive Officer|12402685300|swirskyd@rexahn.com|
20176504|NCT00612066|University of California, Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
20176505|NCT00982319|Sidney Kimmel Comprehensive Cancer Center|Dr. Kala Visvanathan|410-614-1112|kvisvan1@jhu.edu|
20176506|NCT03779997|University of Washington|Judith I. Tsui|206-744-1835|tsuij@uw.edu|
20176507|NCT03603964|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20176508|NCT01591746|Mayo Clinic|Dr. Valerie Lemaine, MD, MPH|507-284-2736|lemaine.valerie17@gmail.com|
20176509|NCT02248922|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20176510|NCT05051241|Zhejiang GenFleet Therapeutics Inc.|Yuting Peng|+86 21 6882 1388|ytpeng@genfleet.com|
20176511|NCT02480621|Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital|Dr. Adam Driesman|2033315938|Adam.Driesman@nyumc.org|
20176512|NCT05468398|University of California, Irvine|Navid Alem, MD / Principal Investigator|(949) 413-4950|alemn@hs.uci.edu|
20176513|NCT04632940|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-094DMDStudy@fibrogen.com|
20176514|NCT00684424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20176515|NCT02181231|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
20176516|NCT02520531|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
20176517|NCT02442700|Ramathibodi Hospital, Mahidol University|Asita Wongprikorn, MD|664236949|wongprikorn@yahoo.com|
20176518|NCT01723904|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20176519|NCT00752908|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20176520|NCT00059475|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-6375|nciirbadmin@mail.nih.gov|
20176521|NCT00887341|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190228|NCT01448447|Mercy|Dr. Robert Frazier|314-251-6844|Robert.Frazier@mercy.net|
20190229|NCT04025762|University of Cambridge|Dr Charlotte Boughton|+441223769066|cb2000@medschl.cam.ac.uk|
20190230|NCT00759798|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
20190231|NCT01286311|Northwestern University|Stephen D. Persell, MD MPH|312-503-6464|spersell@nmff.org|
20221522|NCT01876446|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20190232|NCT03034863|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
20190233|NCT01381549|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206126|NCT00881361|Mayo Clinic|Judy C. Boughey, MD|507-284-3629|boughey.judy@mayo.edu|
20206127|NCT06000501|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
20206128|NCT03496662|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
20206129|NCT00493467|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma|713-563-1509|fsamaniego@mdanderson.org|
20206130|NCT03819478|Wake Forest University Health Sciences|Ashley Weaver, PhD|336-716-0944|asweaver@wakehealth.edu|
20221523|NCT04277962|University of Texas Medical Branch Galveston|Dr. Antonio Saad Director of Clinical Research Division|409-772-0982|afsaad@utmb.edu|
20221524|NCT02473926|University of Colorado - Anschutz Medical Campus|Dr. Amy Huebschmann|3037242268|amy.huebschmann@cuanschutz.edu|
20221525|NCT02757326|Duke University Medical Center, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy|Yubin Kang, M.D., Principal Investigator|(919) 668-2331|yubin.kang@duke.edu|
20221526|NCT00683657|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20221527|NCT00202930|UPMC Children's Hospital of Pittsburgh|Jean M. Tersak, M.D.|412-692-8570|jean.tersak@chp.edu|
20221528|NCT03008174|Johns Hopkins University|Vinciya Pandian|4436553482|vpandia1@jhu.edu|
20221529|NCT03423940|Rutgers, The State University of New Jersey|Brian D. Greer, Ph.D., BCBA-D|848-800-8505|brian.greer@rutgers.edu|
20221530|NCT03200717|Novartis Pharmaceuticals|Study director|+1 862-778-8300|novartis.email@novartis.com|
20221531|NCT03629184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20221532|NCT01461538|Seattle Genetics, Inc.|Chief Medical Office|855-473-2436|medinfo@seagen.com|
20221533|NCT02085447|University Hospitals Cleveland Medical Center|Dr. Martha Sajatovic|2168442808|martha.sajatovic@uhhospitals.org|
20221534|NCT03552380|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20221535|NCT02046603|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20221536|NCT03447743|University of Kentucky|Dr. Michele Staton|859-312-8245|mstaton@uky.edu|
20221537|NCT02461160|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20221538|NCT01112059|UAB|Amit Gaggar, MD|934-5400|agaggar@uab.edu|
20221539|NCT03672227|REGENTS OF THE UNIVERSITY OF MICHIGAN|Dr. Katherine Bauer|(734)763-2546|kwbauer@umich.edu|
20221540|NCT05620082|University of Southampton|Dr Samantha J Meredith|0238120|s.j.meredith@soton.ac.uk|4656
20221541|NCT04665765|City of Hope Medical Center|Dr. Alex Herrera , MD|6263598111|aherrera@coh.org|
20221542|NCT01410097|Wake Forest University|Stephen B. Kritchevsky, PhD|336-713-8548|skritche@wakehealth.edu|
20221543|NCT02572570|University of North Carolina at Chapel Hill|Ricardo Walter, DDS, MS|9195373596|walterr@unc.edu|
20221544|NCT01417156|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221545|NCT01866826|NCI|Frank Maldarelli, MD|301-846-5611|fmalli@mail.nih.gov|
20221546|NCT00742209|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20221547|NCT00776035|Washington University School of Medicine|Linda R. Peterson, MD, Professor of Medicine and Radiology|314-362-4577|lpeterso@wustl.edu|
20221548|NCT04620746|Johns Hopkins University School of Medicine|Jonathan Zenilman|410-550-9080|jzenilm1@jh.edu|
20221549|NCT03473925|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221550|NCT02756611|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20221551|NCT03135015|Housey Healthcare ULC|Project Manager|2486637000|info@housey.com|
20221552|NCT01223378|Bausch & Lomb|H DeCory, PhD|585-338-8161|heleen.decory@bausch.com|
20206131|NCT01074658|Medronic Bakken Research Center|Hanne Gonnissen|+3143356|hanne.gonnissen@medtronic.com|6734
20206132|NCT00091962|University of Pittsburgh School of Medicine|Dr. Bruce L Rollman, Principal Investigator|(412) 692-2659|rollmanbl@upmc.edu|
20206133|NCT00432562|Adventrx Pharmaceuticals|Chief Executive Officer|858-768-6325|culley@adventrx.com|
20221553|NCT00124917|National Cancer Institute|Dr. Deborah Citrin|301-496-5457|Debra_Citrin@nih.gov|
20221554|NCT03518008|Alcon Research|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20221555|NCT04941131|King Abdulaziz University|Dr Zuhair Natto|9666943899|znatto@kau.edu.sa|
20221556|NCT00476190|Dana Farber Cancer Institute|Dr. Dan DeAngelo|6175828410|Daniel_Deangelo@dfci.harvard.edu|
20221557|NCT03123068|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
20221558|NCT04782076|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20221559|NCT00462917|Brigham and Women's Hospital and Harvard Medical School|Robert C. Green, MD, MPH|617-264-5838|rcgreen@genetics.med.harvard.edu|
20221560|NCT02860546|Taiho Oncology, Inc.|Taiho|844-878-2446|medicalinformation@taihooncology.com|
20221561|NCT03997851|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
20221562|NCT00281957|SWOG Statistical Office|SWOG melanoma statistician|206-667-4408||
20221563|NCT03787134|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
20221564|NCT00619060|University of Arizona|Steve Stratton,PhD Chairman of Scientific Review Comittee|(520) 626-9295|SStratton@uacc.arizona.edu|
20221565|NCT00822692|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
20221566|NCT03420521|Johns Hopkins University|Dr. Christine Hann|410-502-0678|chann1@jh.edu|
20221567|NCT03281876|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221568|NCT02208089|Moorfields Eye Hospital NHS Foundation Trust|Mr Bruce Allan|02075662320|bruce.allan@ucl.ac.uk|
20221569|NCT02443740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206134|NCT00416312|Johns Hopkins University, School of Medicine|George Sgouros, Ph.D.|410 614 0116|gsgouros@jhmi.edu|
20206135|NCT02146248|OHSU|Jeffrey T. Jensen|503-629-4058|jensenje@ohsu.edu|
20206136|NCT00425100|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20206137|NCT04406389|Weill Cornell Medicine|Dr. Maria T. DeSancho|646-962-2065|mtd2002@med.cornell.edu|
20206138|NCT02559713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206139|NCT04428359|BP Koirala Institute of Health Sciences|Dr. Bibisha Baaniya|9841744777|cul.bibisha@gmail.com|+977
20206140|NCT03539861|University of Michigan|Lenar Yessayan|734-763-9041|lenar@med.umich.edu|
20206141|NCT02682030|Cedars Sinai Medical Center - 8700|Dr. Ashraf Elsayegh|3105560335|ashraf.elsayegh@cshs.org|
20206142|NCT01374217|Carolinas HealthCare System|Nilanjan Ghosh, MD|9804422000||
20206143|NCT03418051|University of North Carolina at Chapel Hill|Erik Wikstrom|9199622260|wikstrom@unc.edu|
20206144|NCT02486211|University of Pittsburgh|Dr. Jon Rittenberger|4126479489|rittjc@upmc.edu|
20206145|NCT03695393|Boston Medical Center and BU School of Medicine|Karsten Lunze, MD|617-638-6933|lunze@bu.edu|
20206146|NCT04169061|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
20206147|NCT04585451|PainQx|VP R&D|6179817753|bd@painqx.com|
20206148|NCT00673894|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
20206149|NCT00493974|University of Minnesota|Sarah Lindberg|612-626-9011|slindberg@umn.edu|
20206150|NCT02807363|Enteris Biopharma Inc.|Paul Shields, Ph.D|9734533520|pshields@enterisbiopharma.com|
20206151|NCT02188719|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20206152|NCT00966693|UT MD Anderson Cancer Center|Weber,Donna M.,M.D. / Lymphoma/Myeloma|713-792-2860|dmweber@mdanderson.org|
20206153|NCT00192036|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20206154|NCT03371732|Institute Bergonie|Dr. Marion Barrault Couchouron, Coordinating Investigator|0556337805|m.barrault@bordeaux.unicancer.fr|
20206155|NCT01861054|Dompé Farmaceutici|Pier Adelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
20206156|NCT00555906|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206157|NCT02193828|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20206158|NCT03219567|Duke University|Anthony Kuo, M.D.|919-684-3799|anthony.kuo@duke.edu|
20206159|NCT00889681|Medtronic- AF Solutions|Dana Wigert- Sr. Clinical Research Specialist|763-526-2802|dana.wigert@medtronic.com|
20206160|NCT04176445|Hospital Moinhos de Vento|PT Douglas Neves|(51) 9.98975514|nevesfisioup@gmail.com|
20206161|NCT01829217|Dana-Farber Cancer Institute|Principal Investigator: Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
20206162|NCT04046341|Children's Hospital of Philadelphia|Marsha Wallace|2155900119|wallacem@chop.edu|
20206163|NCT04377672|Johns Hopkins University|Sanjay K. Jain|4105028241|sjain5@jhmi.ed|
20206164|NCT03162458|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761571|PutilovskiyMA@materiamedica.ru|302
20206165|NCT01637870|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbanks, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
20206166|NCT00405652|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206167|NCT05109702|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
20206168|NCT02713789|Urovant Sciences GmbH|JP Nicandro, PharmD|833-219-5557|clinicaltrials@urovant.com|
20206169|NCT01305213|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
20176522|NCT02015234|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|212 980 9155|greg.sullivan@tonixpharma.com|117
20206170|NCT00744848|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20206171|NCT00976248|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
20206172|NCT00719953|Sourazky Tel-Aviv Medical Center|Professor N. Vaisman|972-3-6974807|vaisman@tasmc.health.gov.il|
20206173|NCT02947022|UNC Chapel Hill, Department of Radiology|Clinical Research Manager|919-966-4997|rad_research@med.unc.edu|
20206174|NCT04021706|Tufts University|Bess Dawson-Hughes|6175563066|bess.dawson-hughes@tufts.edu|
20206175|NCT01375647|University of Vermont|Dorothy M Dickson, MSc|802 656 9296|dorothy.dickson@med.uvm.edu|
20206176|NCT04884945|Indiana University School of Medicine, Pediatrics|Stacy Keller|3172786127|stasulli@iu.edu|
20206177|NCT02332798|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20176523|NCT01591681|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|jdrfapp2@jaeb.org|
20206178|NCT00595868|University of Vermont|John R. Hughes, MD|802-656-3195|john.hughes@uvm.edu|
20221570|NCT00456300|Montefiore Medical College|Rubina Heptulla|832824000|rubhep@gmail.com|
20221571|NCT00978874|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
20176524|NCT01649856|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20221572|NCT03098082|Indiana University School of Medicine|Jeffrey J. Easler, MD|3179440980|jjeasler@iu.edu|
20221573|NCT02452476|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+39 0521 2791|clinicaltrials_info@chiesi.com|
20221574|NCT03567980|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
20206179|NCT01102140|University of Michigan|Dr. Jennifer Cowger|7345464911|jennifercowger@gmail.com|
20206180|NCT02354092|Oregon Health & Science University|Ob/Gyn Regulatory Specialist, Women's Health Research Unit|503-494-3666|whru@ohsu.edu|
20206181|NCT03788967|Senior Vice President Clinical Development|Angela Talley|857-242-1575|atalley@sperotherapeutics.com|
20206182|NCT01625611|Yale University|Dr. Krishnan-Sarin|203.974.7595|nicholas.franco@yale.edu|
20206183|NCT00233324|University of Alabama|Waldemar A. Carlo, M.D|(205) 934-4680|wcarlo@peds.uab.edu|
20206184|NCT02137837|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|dlew@fredhutch.org|
20221575|NCT02575833|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20176525|NCT02138214|University of Wisconsin, Madison|Dr. Rebecca Sippel|608-263-1387|sippel@surgery.wisc.edu|
20176526|NCT00832429|M D Anderson Cancer Center|Sara Hull|713-563-4598|sehull@mdanderson.org|
20176527|NCT00627406|Fertility Clinic Regional Hospital Skive|Dr. Peter Humaidan|+45 78 44 57 60|peter.humaidan@viborg.rm.dk|
20176528|NCT00235989|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20176529|NCT01331694|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176530|NCT01129141|NCRAR, VA RR&D|James A. Henry, Ph.D.|503.220.8262|james.henry@va.gov|57466
20176531|NCT01334866|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
20176532|NCT00178191|University of Rochester|Michael Flynn|585-273-3232|Michaelk_flynn@urmc.rochester.edu|
20176533|NCT00495716|University of Washington Virology Research Clinic|Clinic Director|206-520-4340|vrc@uw.edu|
20176534|NCT04519658|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
20176535|NCT01427296|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
20176536|NCT03367312|Duke University School of Medicine|Dr. Sudarshan Rajagopal|919-684-6237|sudarshan.rajagopal@duke.edu|
20176537|NCT05267171|Universidad de Oviedo|Claudia Leirós Díaz|663571819|claudia_leiros@hotmail.com|
20176538|NCT02076412|Rigel|Anne-Marie Duliege, MD|6506241100|clinicaltrials@rigel.com|6506241100
20176539|NCT00958880|Southern Methodist University|Jasper Smits, Ph.D.|214-768-4310|jsmits@smu.edu|
20190234|NCT02981953|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20190235|NCT02889900|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazenca.com|
20190236|NCT02556606|Michael E. DeBakey VA Medical Center|Marijn Lijffijt, PhD|3618274395|marijn.lijffijt@bcm.edu|
20190237|NCT01690000|Aarhus University|Anne Kristine Amstrup|4578467681|anne_kristine_am@hotmail.com|
20221576|NCT02139137|SDSU/UCSD Joint Doctoral Program in Clinical Psychology|Jessica Bomyea|8585528585|jbomyea@ucsd.edu|3720
20221577|NCT03367819|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20221578|NCT02633787|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20221579|NCT00550459|Otsuka Pharmaceutical Development & Commercialization, Inc.|Frank Czerwiec, MD, PhD; Sr. Director, Global Clinical Development|(240) 683-3523|frank.czerwiec@otsuka.com|
20221580|NCT02404805|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Dr. Jennifer Kiser|(303) 724-6131|jennifer.kiser@ucdenver.edu|
20221581|NCT01742897|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
20221582|NCT03793608|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20221583|NCT04211831|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20221584|NCT00967330|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20221585|NCT01243957|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221586|NCT02771977|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
20221587|NCT02698163|UCLA School of Dentistry|Dr. Eric Sung|(310) 206-6407|esung@dentistry.ucla.edu|
20221588|NCT05373108|University of California, Los Angeles|Rushi V. Parikh, MD|(310) 825-9011|RParikh@mednet.ucla.edu|
20221589|NCT01133067|Dept. of Radiation Oncology, Tata Memorial Hospital|Dr. J.P. Agarwal|+91 22 24177000|agarwaljp@tmc.gov.in|7164
20221590|NCT00752128|Medtronic Bakken Research Center B.V.|Marianne Wanten|+3143356|marianne.wanten@medtronic.com|6815
20221591|NCT00610428|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20221592|NCT00349973|University of Maryland, Baltimore|Dr. Elliot Hong, Prinicipal Investigator|410-402-6828|ehong@som.umaryland.edu|
20221593|NCT04135937|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
20221594|NCT02548143|LFB USA|Kerry Biron, Director US Clinical Operations|508.370.5166|kerry.biron@lfb-usa.com|
20221595|NCT02409927|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20221596|NCT04871776|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@partners.org|
20221597|NCT05493501|EQRx International|EQRx Clinical Trials|(650) 779-2300|clinicalstudies@eqrx.com|
20221598|NCT00619723|Psychoneuroendocrine Research Group|Dr. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
20221599|NCT06389487|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221600|NCT04004403|University of Illinois Chicago|Krista Varady|3129967897|varady@uic.edu|
20221601|NCT01168232|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20221602|NCT06497699|Ocumension Therapeutics (Shanghai) Co., Ltd|Director of Clinical Trials|2289 3653|clinicalop@ocumension.com|3653
20221603|NCT04510090|Escient Pharmaceuticals|Kristin Taylor, Sr VP, Head of Clinical Development|(858) 617-8220|clinicaltrials@escientpharma.com|
20221604|NCT01749826|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
20176540|NCT01971346|University of Michigan|Heather Chubb|734-936-6394|hdchubb@med.umich.edu|
20190238|NCT04785794|FluGen|Pamuk Bilsel, CSO|608-442-6562|pbilsel@flugen.com|
20190239|NCT00813709|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20190240|NCT01215253|University of Rochester|Wojciech Zareba|585-275-5391|wojciech.zareba@heart.rochester.edu|
20190241|NCT00759681|Greenville Memorial Hospital|David Cull, MD|864-455-9825||
20190242|NCT04387773|Oregon Health & Science University|Dr. Amie Hiller|503-494-7772|peterami@ohsu.edu|
20190243|NCT03146845|Smith & Nephew, Inc.|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
20190244|NCT03403153|Department of Veterans Affairs|Dr, Suzannah Creech Ph.D|254-297-3025|suzannah.creech@va.gov|
20190245|NCT02721147|Fox Chase Cancer Center|Dr. Jennifer Reese, Assistant Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20176541|NCT01122511|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20176542|NCT00955266|Brigham & Women's Hospital|Michael Nurok|617-899-5961|mnurok@gmail.com|
20190246|NCT00185692|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
20190247|NCT01722097|Herlev Hospital, University of Copenhagen, Department of Anaesthesiology|Dr. Matias Vested Madsen|+45 38683868|matias.vested.madsen@regionh.dk|
20190248|NCT00711022|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
20190249|NCT01757288|UT Southwestern Medical Center|Dr. Yuanyuan Zhang|214-648-6764|Yuanyuan.Zhang@UTSouthwestern.edu|
20190250|NCT00722865|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20190251|NCT02825550|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|3624/5603
20190252|NCT00700999|Jesse Brown VA Medical Center|Dr. K Luan Phan|312-569-7161|Kinh.Phan@va.gov|
20190253|NCT02379078|St. Michael's Hospital (Unity Health Toronto)|Dr. Catherine Yu|(416) 360-4000|catherine.yu@unityhealth.to|
20190254|NCT01125436|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
20190255|NCT01694199|Regenesis Biomedical, Inc.|Dr. Rick Isenberg|877-970-4970|isenberg@regenesisbio.com|
20190256|NCT00761267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190257|NCT04144088|Chung Shan Medical University Hospital|Dr. Cheng Chung Wei|+886-4-24739595|wei3228@gmail.com|34718
20190258|NCT01777932|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20190259|NCT03936699|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513.236.6799|samlung@elira.com|
20190260|NCT03400748|Spiration, Inc.|Lauri DeVore|425-636-5464|lauri.devore@olympus.com|
20190261|NCT01419184|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
20190262|NCT01414192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190263|NCT01469585|University of Hawaii|Investigator|808-203-6500|blissk@hawaii.edu|
20190264|NCT01604122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190265|NCT03031782|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20190266|NCT00424476|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190267|NCT03979040|VA Finger Lakes Health Care System|Dr. Nik Allan - Study Statistician|(850) 274-0567|Nicholas.Allan@osumc.edu|
20190268|NCT03032965|University of Michigan|Hamid Ghanbari|734-963-7141|ghhamid@med.umich.edu|
20190269|NCT03541369|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20190270|NCT02978183|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
20190271|NCT02279732|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20190272|NCT01790659|Instituto Conmemorativo Gorgas de Estudios de la Salud|Nestor Sosa, MD, FACP|507-527-4950|drnsosa@gmail.com|
20190273|NCT01894503|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20190274|NCT03072862|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20190275|NCT02513667|UT Southwestern Medical Center|Dr. Sawsan Rashdan|214-648-4180|Sawsan.Rashdan@UTSouthwestern.edu|
20190276|NCT03347396|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20190277|NCT01297595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190278|NCT01047709|University of Michigan|Devin Brown, MD|7349369075|devinb@umich.edu|
20190279|NCT01331408|Galderma Uppsala|Head of Medical Affairs|+46 (0)18 474 9000|receptionen.SEUPP@galderma.com|
20190280|NCT01673256|St. Jude Medical Inc.|Kyle Brunner|651.756.3482|kbrunner02@sjm.com|
20190281|NCT01670526|Hines CSPCC|Tom Sindowski|708-202-5858|tom.sindowski@va.gov|
20190282|NCT00392197|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20190283|NCT04182217|Université d'État d'Haïti|Axler JEAN PAUL, Author|+50943776900|jeanpaulaxler@hotmail.com|
20190284|NCT01970527|University of Washington Medical Center|Dr. Ramesh Rengan|206-598-4100|rengan@uw.edu|
20190285|NCT01974102|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
20190286|NCT04914897|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20190287|NCT03020914|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
20190288|NCT03624023|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
20190289|NCT01053897|Garnet BioTherapeutics, Inc.|Gerri Henwood, CEO|484-395-2440|ghenwood@garnetbio.com|
20190290|NCT01131325|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20190291|NCT03761849|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20190292|NCT03840993|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
20190293|NCT04271254|University of North Carolina Lineberger Comprehensive Cancer Center|David Lalush|9195137671|dlalush@email.unc.edu|
20190294|NCT00473512|Janssen R & D|Senior Director, Clinical Research|(310) 943-8040||2917
20190295|NCT02662023|University of California, San Diego|Brian M. Ilfeld, MD, MS||bilfeld@ucsd.edu|
20190296|NCT01828476|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
20190297|NCT00267956|Centocor Research & Development, Inc|Senior Director Clinical Research|1-800-457-6399||
20190298|NCT01263223|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221605|NCT01922037|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20221606|NCT05085834|University Hospitals Cleveland Medical Center|Grace McComsey|216-368-3731|Grace.McComsey@uhhospitals.org|
20221607|NCT04673149|GeneOne Life Science|Chief Medical Officer|6106576351|dkane@genels.us|
20221608|NCT03657797|Nicox Ophthalmics Inc.|Doug Hubatsch / Chief Scientific Officer|832-360-3022|hubatsch@nicox.com|
20190299|NCT02246647|Mayo Clinic|Madhusudan Grover, MBBS|507-253-5384|Grover.Madhusudan@mayo.edu|
20190300|NCT02416973|Regenesis Biomedical Inc.|Heather Vander Ploeg|602-428-7041|Heather.VanderPloeg@regenesisbio.com|
20176543|NCT01687166|Boston Scientific|Clinical Trial Manager|617-218-3849|weismanm@bsci.com|
20176544|NCT02755831|Naval Medical Center San Diego|CAPTAIN Dennis Spence, NC, USN, PhD, CRNA|6199161680|dennis.l.spence.mil@mail.mil|
20176545|NCT02296112|Vanderbilt University Medical Center|Douglas Johnson, MD|(615) 936-8422|douglas.b.johnson@vumc.org|
20176546|NCT02316717|Immuron|Neta Tobis, Clinical Director|+972549277334|neta@immuron.com|2549277334
20206185|NCT01978600|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20206186|NCT01181141|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
20206187|NCT00118911|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@partners.org|
20206188|NCT05507580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20206189|NCT03395223|Provepharm SAS|Emilie HUYGHUES|+33 6 20 58 28 27|emilie.huyghues@provepharm.com|
20206190|NCT00763243|Indiana University School of Medicine|William Kronenberger, Ph.D.|317-944-8162|wkronenb@iupui.edu|
20206191|NCT03005041|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206192|NCT01248364|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206193|NCT01555905|University of Florida|D. Barbara Smith|3522945315|bksmith@ufl.edu|
20176547|NCT00298831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206194|NCT02293096|"University of Colorado Denver | Anschutz"|Andrew Monte, MD, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20161894|NCT02145351|Mayo Clinic|Barry A. Borlaug, M.D.|507-255-4152|Borlaug.Barry@mayo.edu|
20206195|NCT01117012|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20206196|NCT02781454|University of Washington|Dr. Michael D. Weiss|206-598-7688|mdweiss@uw.edu|
20176548|NCT01516879|Amgen Inc.|Study Director|866-572-6436||
20206197|NCT03219892|Xuanwu Hospital|Piu Chan|010-83198677|pbchan@hotmail.com|
20206198|NCT05425719|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
20206199|NCT03796182|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20206200|NCT04682353|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20206201|NCT02849626|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20206202|NCT01185704|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20206203|NCT01313208|Amgen Inc.|Study Director|866-572-6436||
20206204|NCT01957787|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
20206205|NCT03258632|Department of Veterans Affairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|23336
20176549|NCT02052466|Cleveland Clinic Foundation|Dr. Eric Ricchetti|2164456915|ricchee@ccf.org|
20176550|NCT01720069|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
20176551|NCT00508742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176552|NCT04568122|Stanford University BioEngineering|Manu Prakash, PhD|(650) 725-3731|manup@stanford.edu|
20176553|NCT01613339|Orebro county council|Dr. Anette Forsberg|+46-19-602 5788|anette.forsberg@orebroll.se|
20176554|NCT01228929|University of Rochester|Dr. James V. Aquavella|585-275-8944|james_aquavella@urmc.rochester.edu|
20176555|NCT00594256|Nathan Kline Institute|Joshua Kantrowitz MD|845-398-5503|jkantrowitz@nki.rfmh.org|
20176556|NCT01910064|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
20176557|NCT02002494|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
20176558|NCT02460224|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20176559|NCT04160260|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20176560|NCT03837496|Massachusetts General Hospital|Jamie Jacobs, PhD|617-643-1777|jjacobs@mgh.harvard.edu|
20176561|NCT01974050|Columbia University|Melissa S. Stockwell|212-342-5732|mss2112@cumc.columbia.edu|
20176562|NCT00236938|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
20176563|NCT00965848|Medical Affairs, Janssen-Cilag Ltd.,Thailand|Medical Affairs Director|662-792-7200||
20176564|NCT00813761|Vistakon|Kristy Canavan, OD|1-904-443-1474|kcanava2@its.jnj.com|
20206206|NCT00187889|University of Florida|Dr. Carl J. Pepine|352-273-9082|carl.pepine@medicine.ufl.edu|
20206207|NCT03505749|VA Portland Health Care System|Dr. Vanessa Somohano, Postdoctoral Research Fellow|503-220-8262|vanessa.somohano@va.gov|
20206208|NCT01151540|Eisai Co., Ltd.|Customer Joy Department. EJ|8133817-3700|_ML_CLNCL@hhc.eisai.co.jp|
20206209|NCT03846219|Immunic AG|Andreas Muehler, MD|+4917678738359|andreas.muehler@imux.com|
20206210|NCT00180271|Boston Scientific|Jill Leigh|800 227 3422|jill.leigh@bsci.com|
20206211|NCT01392378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206212|NCT02679807|University of Virginia|Ronald Turner|434-981-9141|rbt2n@virginia.edu|
20206213|NCT02322411|University of Wisconsin - Madison|Dr. Nicole Pulia|6082561901|npulia@wisc.edu|11697
20206214|NCT01285791|Hadassah Medical Organization|Dr Ido Mizrahi|+972-2-5844550|idomiz17@gmail.com|
20206215|NCT04350905|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
20206216|NCT02671461|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20206217|NCT01412060|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20206218|NCT00629525|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
20206219|NCT00004732|Mayo Clinic|Thomas G. Brott, MD - Principal Investigator|904-953-0556|Brott.thomas@mayo.edu|
20206220|NCT01183312|Emory University School of Medicine|Dr. Lynn Marie Trotti|404-728-4752|lbecke2@emory.edu|
20161895|NCT03180307|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
20161896|NCT00428207|Joslin Diabetes Center|Howard Wolpert, MD|6173092665|howard.wolpert@joslin.harvard.edu|
20161897|NCT01563172|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161898|NCT01154751|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
20161899|NCT02986854|GlaxoSmithKline|GSK Response Center|866-435-7343|mb116236@gsk.com|
20176565|NCT01767792|The University of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.4010|bkorf@uabmc.edu|
20176566|NCT01891734|Department of Veterans Affairs San Diego|Kathleen Grubbs|808-383-9757|kathleen.grubbs@va.gov|
20176567|NCT04551105|Virginia Tech|Study Director of Clinical Trials|+1 (301) 820-5225|dcben0@gmail.com|
20176568|NCT04176796|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
20206221|NCT01688635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176569|NCT02927691|Teachers College, Columbia University|Michelle Troche|212-678-3953|mst2139@tc.columbia.edu|
20176570|NCT00320281|Craig Hospital|Dr. Gary Maerz|303-789-8220|adannels@craighospital.org|
20206222|NCT04491240|MC Dinasty|Tyumina Olga|+78462039808|centr123@bk.ru|201
20206223|NCT00367432|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20206224|NCT05567393|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206225|NCT00358501|Jazz Pharmaceuticals|Head of Clinical Development|650.496.3777||
20176571|NCT03042312|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20176572|NCT01856140|Seoul National University College of Medicine|Dr. Sang Yoon Lee|028702673|rehabilee@gmail.com|
20176573|NCT02805257|University of California, San Francisco|Ying Han, MD, PhD|415-476-3321|ying.han@ucsf.edu|
20176574|NCT04331366|Emory University|Jeffery Miller, MD|404-778-7200|jeffrey.miller@emory.edu|
20176575|NCT01043874|Novartis Pharmaceuticals|Study Director|862-778-8300||
20176576|NCT03574129|University of Washington|Dr. Irene Njuguna|2065191275|irenen@uw.edu|
20176577|NCT00672477|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
20176578|NCT02886572|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
20176579|NCT02451748|University of Illinois at Chicago|Shiva Shahrara, PhD|312-413-7529|shahrara@uic.edu|
20176580|NCT03087591|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-5772|ptriozzi@wakehealth.edu|
20176581|NCT01519713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20176582|NCT00875394|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20176583|NCT01933334|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20176584|NCT01531959|Beth Israel Deaconess Medical Center|Matthias Eikermann|6176327034|meikerma@bidmc.harvard.edu|
20176585|NCT02082522|At the request of Concordia Laboratories Inc.|Dr. Michelle Depot||michelle.depot@advanzpharma.com|
20176586|NCT01863446|Mass General Hospital|Elizabeth Klerman|617-643-2424|ebklerman@hms.harvard.edu|
20176587|NCT00491244|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-2-23123456|jacque_liu@mail2000.com.tw|63572
20176588|NCT03095417|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
20176589|NCT02571452|San Francisco VA Healthcare System|Dr. Shira Maguen|415-221-4810|Shira.Maguen@va.gov|22511
20176590|NCT02821104|Nationwide Children's Hospi|Robert Hoffman|614-722-4425|robert.hoffman@nationwidechildrens.org|
20176591|NCT03795922|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20176592|NCT01416805|University of South Florida|Dr. Eric Storch|727-767-8230|Eric.Storch@bcm.edu|
20176593|NCT03653429|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
20176594|NCT02708745|Seattle Children's Hospital|Dr. Doug Opel|206-987-2000|douglas.opel@seattlechildrens.org|
20176595|NCT04408963|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20176596|NCT01700946|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
20176597|NCT01168934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176598|NCT03056690|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20176599|NCT01159067|City of Hope National Medical Center|Dr. Vinod Pullarkat|626-256-4673|vpullarkat@coh.org|82405
20176600|NCT03074734|TobaccoFree Research Institute Ireland|Professor Luke Clancy|+353868364337|lclancy@tri.ie|
20176601|NCT05580575|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
20176602|NCT02617589|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20176603|NCT01975389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176604|NCT02127307|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-5431347|jose.zubeldia@ge.com|
20176605|NCT03333746|The Ohio State University Comprehensive Cancer Center|Dr. Yvonne Efebera|614-293-7243|Yvonne.Efebera@osumc.edu|1278
20176606|NCT01312961|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20176607|NCT04796831|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20176608|NCT04187196|Atrium Health|Elijah Beaty, MD, MPH, FACC|704-403-6100|Elijah.Beaty@atriumhealth.org|
20176609|NCT00183872|USC/Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
20176610|NCT00595582|LSU Health Sciences Center, Shreveport LA|Dr. James Patterson/Professor|318-813-2070|jpatte@lsuhsc.edu|
20176611|NCT02797262|University of California, Los Angeles|Research Scientist|3105917541|statue22@gmail.com|
20206226|NCT02540772|San Rafael University Hospital|Monica Triviño Mosquera|34958275700|monica.trivino@sjd.es|
20206227|NCT02177175|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-7932|yua3@mskcc.org|
20206228|NCT01924299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20206229|NCT00605072|University of Southern California|Dr. Ihab Hajjar|323-226-6720|ihajjar@usc.edu|
20206230|NCT05064332|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206231|NCT00888615|NRG Oncology|Christopher Purdy on behalf of James Kauderer|(716)845-1300|purdyc@nrgoncology.org|2296
20206232|NCT00141037|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20206233|NCT00637377|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20206234|NCT01293084|Johns Hopkins Univeristy|Beth Laube Professor|410-502-5791|blaube@jhmi.edu|
20206235|NCT04186663|University of California San Francisco|Dr. Hellene Ellenikiotis|408-313-0166|hellene.ellenikiotis@ucsf.edu|
20206236|NCT01549223|Brigham and Women's Hospital|Lawrence Tsen, MD|617-732-8216|ltsen@partners.org|
20206237|NCT01626989|Philips|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
20206238|NCT02437487|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|(617) 945-9626|mtrucksis@serestherapeutics.com|
20206239|NCT02293902|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20206240|NCT03801356|Cleveland Clinic|Dr. Michael Steinmetz|216-445-5754|STEINMM@ccf.org|
20176612|NCT01600586|Vanderbilt University|Olena Chorna|850-508-5571|olena.chorna@vanderbilt.edu|
20176613|NCT04409041|Washington University|Dr. Caroline Mann|(314) 996-8010|cmann@wustl.edu|
20176614|NCT01978184|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
20176615|NCT02460198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176616|NCT00931307|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20176617|NCT00691210|Columbia University Medical Center|Owen A. O'Connor, MD, Ph.D.|212-326-5720|oo2130@cumc.columbia.edu|
20176618|NCT01208233|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176619|NCT01181895|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176620|NCT00555438|CHU SAINT-ETIENNE|Pr patrick MISMETTI|33(1)477127788|patrick.mismetti@chu-st-etienne.fr|
20176621|NCT01578044|VA Eastern Colorado Health Care System|P. Michael Ho|720-857-2115|michael.ho@va.gov|
20176622|NCT02758236|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
20176623|NCT05789875|UCSF|Dr. Parya Saberi|415-502-1000|parya.saberi@ucsf.edu|17171
20176624|NCT00023452|CDC|Dr Elsa Villarino|404-639-5340|mev1@cdc.gov|
20176625|NCT02287415|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20176626|NCT01940705|VA RR&D National Center for Rehabilitative Auditory Research|Gabrielle Saunders, PhD|503-220-8262|Gabrielle.Saunders@va.gov|56210
20176627|NCT02447991|Mayo Clnic|Jeffrey Staab, MD|507-293-9438|staab.jeffrey@mayo.edu|
20176628|NCT01693601|Icahn School of Medicine at Mount Sinai|John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
20176629|NCT01003418|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176630|NCT02770391|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Moshe Ornstein,|18662238100|taussigresearch@ccf.org|
20176631|NCT00019682|Indiana University Health|Dr Douglas Schwartzentruber|317-948-6873|dschwart@iuhealth.org|
20176632|NCT03333486|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20176633|NCT01612546|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20176634|NCT02276495|UC Irvine Health Department of Anesthesiology & Perioperative Care|Dr. Joseph Rinehart|714-456-7415|jrinehar@hs.uci.edu|
20176635|NCT03246529|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
20176636|NCT02143518|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
20176637|NCT00452335|Sucampo Pharma Americas, Inc.|VP, Clinical Development|301-961-3400|info@sucampo.com|
20176638|NCT02283528|Emory University|Dr. Gary Francis Bouloux|404-778-4500|gfboulo@emory.edu|
20176639|NCT03136068|UCSF|Director of Clinical Trials|414-206-8715|abby.sokoloff@ucsf.edu|
20176640|NCT01946711|Pari Pharma|Friedrich gruber|+4989742846|friedrich.gruber@pari.com|76
20176641|NCT01337089|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
20176642|NCT04419493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176643|NCT00524134|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20176644|NCT01577706|McLean Hospital|Dr. J. Eric Jensen|617-855-3366|ejensen@mclean.harvard.edu|
20176645|NCT01782131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176646|NCT01627249|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrstat2@jaeb.org|
20176647|NCT00796718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20176648|NCT03266588|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20176649|NCT00736242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176650|NCT02627677|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20176651|NCT00317772|UT MD Anderson Cancer Center|Diane C Bodurka,Chief Education & Training Ofc, Education & Training|(713) 745-3358|dcbodurka@mdanderson.org|
20176652|NCT01040871|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
20176653|NCT04175262|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176654|NCT01176591|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
20176655|NCT01073618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176656|NCT02696850|WashingtonU|Dr. Jay F. Piccirillo, Principal Investigator|(314) 362-8641|piccirij@wustl.edu|
20176657|NCT03041415|Stanford University|Principal Investigator|6507235082|king@stanford.edu|
20176658|NCT00673049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176659|NCT02621606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206241|NCT00713284|California Pacific Medical Center|Dr. V. Ram Peddi|415-600-1000|peddir@sutterhealth.org|
20206242|NCT00462488|Sesen Bio|Rachelle Dillon, Ph.D.|204-452-7126|rachelle.dillon@sesenbio.com|308
20206243|NCT05711862|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
20206244|NCT02061748|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206245|NCT02848313|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20206246|NCT03788616|Faculty of dentistry, Ain Shams University|Dr. Marina Fakhry assistant lecturer of pediatric dentistry|01273731722|Dr.marina.fakhry@gmail.com|+02
20206247|NCT03510910|NYU Langone Health|Thomas Youm, MD|212-348-3636|Thomas.Youm@nyulangone.org|
20206248|NCT01673490|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206249|NCT03062267|University of Washington|Principal Investigator|(206) 685-9655|dbenzeev@uw.edu|
20206250|NCT03382262|Flexion Therapeutics|Scott Kelley MD, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
20176660|NCT02044510|Lawson Research Institute|Mary McKibbon|5196466367|mary.mckibbon@sjhc.london.on.ca|
20176661|NCT01175824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176662|NCT03455855|Boston Scientific|Dr Haotian Zhang|+8617621154031|haotian.zhang@bsci.com|
20176663|NCT02979535|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20176664|NCT04820673|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20176665|NCT00587587|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
20176666|NCT01162005|Seoul National University Children's Hospital|Hee Gyung Kang|+82-2-2072-0658|pedneph@snuh.org|
20176667|NCT03226067|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|Desk: +46 556659-9766|richard.philipson@calliditas.com|
20176668|NCT00767000|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176669|NCT03103282|3-D Matrix Europe SAS|Florian REBECA|+33617587769|frebeca@puramatrix.com|
20176670|NCT02039505|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20176671|NCT00693992|University of Pittsburgh|Mark A. Socinski, M.D.||socinskima@upmc.edu|
20176672|NCT01343082|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20176673|NCT00856024|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClincialTrialsDisclosure@merck.com|
20176674|NCT03614793|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
20176675|NCT00633984|Boston University|Dr. Stefan G. Hofmann|617 353 9233|shofmann@bu.edu|
20176676|NCT02554773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20176677|NCT02496884|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20176678|NCT00097591|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176679|NCT02312310|Columbia University Medical Center|Scott A. Small, MD|212-305-1269|sas68@columbia.edu|
20176680|NCT01168999|University of Florida|Dr. Joel Bialosky|352-273-8636|bialosky@phhp.ufl.edu|
20176681|NCT04317586|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
20176682|NCT01276327|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176683|NCT00807092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20176684|NCT01794949|Emory University|Henry Liberman, MD|404-686-2503|hliberm@emory.edu|
20176685|NCT03003676|Targovax|Dr. Lone H. Ottesen, Chief Development Officer|+44 7920567911|lone.ottesen@targovax.com|
20176686|NCT05209191|REAL Prevention LLC|Dr. Michael L. Hecht|18143601893|HECHTPSU@GMAIL.COM|
20176687|NCT00759967|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@ohri.ca|82534
20176688|NCT03766646|University Hospital Southampton|Dr Patrick Butler|81205662|patrick.butler@uhs.nhs.uk|+44 (0)23
20176689|NCT01229228|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
20176690|NCT03264157|Bio Products Laboratory|Head of Medical Affairs|1-844-4BPLUSA|MedInfo@bpl-us.com|
20176691|NCT00009737|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20176692|NCT01163682|Columbia University Irving Medical Center|Dawn Hershman|212-342-5162|dlh23@cumc.columbia.edu|
20176693|NCT01734746|MaastrichtUMC|R.F.P.M. Kruitwagen|+31433874767|r.kruitwagen@mumc.nl|
20176694|NCT04279925|Plastic Surgery Division of Surgery Department of Cipto Mangunkusumo Hospital Jakarta / Faculty of Medicine Universitas Indonesia|Prasetyanugraheni Kreshanti, MD|08158732424|pras_md@yahoo.com|
20176695|NCT01931839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20176696|NCT02710630|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20176697|NCT03224468|Massachusetts General Hospital|Jodi Gilman, PhD|617-643-7293|jgilman1@mgh.harvard.edu|
20176698|NCT01978119|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176699|NCT00812812|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176700|NCT01877421|Oral Health Research Institute, Indiana University School of Dentistry|Domenick T. Zero, DDS, MS|240-457-0668|dzero@iu.edu|
20176701|NCT00908960|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
20176702|NCT01158924|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20176703|NCT04165291|Yale University Child Study Center|Carla Stover|12037853486|carla.stover@yale.edu|
20176704|NCT01343160|W.L. Gore & Associates|Rizwan Afzal|623-234-5408|rafzal@wlgore.com|
20176705|NCT03047447|Bristlecone Health, Inc,|Dr. Kelly Gibas, Director or Clinical Trials|(763) 424-2474|kgibas@bristleconefitness.com|
20176706|NCT00432380|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176707|NCT01071395|Rush University of Medical Center|Dr. Christopher G. Goetz|312-942-8016|cgoetz@rush.edu|
20176708|NCT02669329|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20176709|NCT03704376|The University of Texas Health Science Center at Houston|Lane Bailey, PhD, PT|713-704-6794|lane.bailey@uth.tmc.edu|
20176710|NCT03422003|Dana-Farber Cancer Institute|Dr. Rinaa Punglia|617-632-3591|rpunglia@mgb.org|
20176711|NCT01404312|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20176712|NCT01722331|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20176713|NCT01154166|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176714|NCT04265755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20176715|NCT01375049|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20176716|NCT01575561|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20176717|NCT02840877|Boston Medical Center|Karen Jacobson, MD MPH|617-414-5213|karen.jacobson@bmc.org|
20176718|NCT01172938|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|clinicaltrialdisclosure@celgene.com|
20161900|NCT02530996|Salt Lake VAMC and University of Utah|Dr. Tracy Frech|801 213 2312|tracy.frech@hsc.utah.edu|
20161901|NCT00718770|University of Colorado School of Medicine|Joshua Klopper, MD|303-724-3921|joshua.klopper@ucdenver.edu|
20176719|NCT00003498|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20161902|NCT04484207|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
20161903|NCT01624090|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@nih.gov|
20161904|NCT00772109|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20161905|NCT00752726|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161906|NCT01403116|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
20161907|NCT01895309|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
20161908|NCT00042666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176720|NCT02956629|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161909|NCT04232215|Mayo Clinic|Yvonne S. Butler Tobah, M.D.|507-284-0210|ButlerTobah.Yvonne@mayo.edu|
20161910|NCT02454153|Johns Hopkins University|Naresh M. Punjabi|410-550-6487|npunjabi@jhmi.edu|
20161911|NCT01555125|Novartis Pharmaceutical|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20161912|NCT02651220|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20161913|NCT04268745|New York University|Dr. Anat Lubetzky|2129989195|anat@nyu.edu|
20161914|NCT01086852|Bio Products Laboratory|Miranda Norton|020 8 957 2661|miranda.norton@bpl.co.uk|
20161915|NCT00447122|BrUOG|Howard Safran, MD|4018633000|BrUOG@brown.edu|
20161916|NCT01447121|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3062|carmine.greene@ascensia.com|
20161917|NCT02409342|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20161918|NCT02048371|SARC|SARC|734-930-7600|sarc@sarctrials.org|
20161919|NCT00279812|Institute of Food Research|Dr Charlotte Armah|01603 255 000|charlotte.armah@ifr.ac.uk|5360
20176721|NCT04188041|Kent Hospital|Daria Szkwarko, PI|401-921-7981|szkwarkd@gmail.com|77981
20161920|NCT05327361|University of Miami|Enzo Berardesca|3052434472|exb743@med.miami.edu|
20206251|NCT02940860|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20206252|NCT04914819|University of Pennsylvania|Dr. Jennifer Lewey|215-662-7700|jennifer.lewey@pennmedicine.upenn.edu|
20206253|NCT03404219|Boston University|Dr. Daniel Fulford|(617) 358-6723|dfulford@bu.edu|
20161921|NCT01439373|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161922|NCT04576897|Indiana University|Samer Gawrieh|317-278-9326|sgawrieh@iu.edu|
20161923|NCT03834220|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20161924|NCT00574548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161925|NCT02593318|University of Kansas Medical Center|Russell H. Swerdlow, MD|9135885000|rswerdlow@kumc.edu|
20161926|NCT02020408|UCSD Department of Psychiatry|Walter H. Kaye, MD|858-534|wkaye@ucsd.edu|8019
20161927|NCT01174173|Northwestern University|Sanjiv J. Shah, MD|3129262926|sanjiv.shah@northwestern.edu|
20161928|NCT02107157|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20161929|NCT00527332|Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden|Dr Preben Kjolhede|+46101030000|Preben.Kjolhede@lio.se|3187
20161930|NCT02069119|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20161931|NCT02720692|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
20161932|NCT02503501|HealthPartners Neuroscience Research|Clinical Research Manager|651-495-6363|aleta.l.svitak@healthpartners.com|
20206254|NCT02715804|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
20206255|NCT03961295|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20206256|NCT00948194|University of Colorado Denver|Nick Naughton|303-724-0833|nick.naughton@cuanschutz.edu|
20161933|NCT01740401|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20161934|NCT03878758|Becton Dickinson|Michael Gibney|201-847-6170|michael.gibney@bd.com|
20161935|NCT00765063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161936|NCT03614325|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|6177543189|bpogara@bidmc.harvard.edu|
20206257|NCT01759160|First Affiliated Hospital of Sun Yat-sen University|Dr. Xia Feng|008613688877856|fengxiar@yahoo.cn|
20206258|NCT02905825|Exalenz Bisocience|Avraham Hershkowitz|972-8-9737513|avrahamh@exalenz.com|
20206259|NCT00662389|Apsara Medical Corporation|Eve Conner, Ph.D. Consultant|510 566-2495|eaconner@sbcglobal.net|
20206260|NCT01709708|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
20206261|NCT01527110|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206262|NCT02657434|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20206263|NCT01858597|The first Affiliated Hospital of Sun-Yat Sen University|Director of Clinical Trials|86-020-28823388|zsyyyb@mail.sysu.edu.cn|
20206264|NCT00511108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20206265|NCT02698566|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20206266|NCT02147691|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20206267|NCT04866823|Wake Forest School of Medicine|Morgana Mongraw-Chaffin|13367133108|mmongraw@wakehealth.edu|
20161937|NCT00321464|Amgen Inc.|Study Director|866-572-6436||
20161938|NCT01673620|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161939|NCT01206582|Mayo Clinic|Dr. Adil E. Bharucha|507-284-6439|bharucha.adil@mayo.edu|
20161940|NCT02522325|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
20206268|NCT01392742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20176722|NCT00701389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176723|NCT05282004|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20176724|NCT04808609|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
20176725|NCT01993719|National Cancer Institute|Dr. Stephanie L. Goff|240-760-6214|stephanie.goff@nih.gov|
20176726|NCT00618657|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20176727|NCT00365859|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20176728|NCT02461589|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20176729|NCT04713748|Duke Clinical and Translational Science Institute|Douglas Wixted|919-668-0515|douglas.wixted@duke.edu|
20176730|NCT01557946|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
20176731|NCT00406029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176732|NCT04067141|CooperVision, Inc.|Jose A. Vega, O.D., MSC., FAAO|9256213761|javega@coopervision.com|
20176733|NCT01219738|University of Miami|Eliana Mendes|(305) 243-2568|e.mendes@miami.edu|
20176734|NCT01038921|Emory University|Dr. Abinav Goyal|404-727-8758|agoyal4@emory.edu|
20176735|NCT01709227|Stanford University|David Kwiatkowski|650-721-3290|david.kwiatkowski@stanford.edu|
20176736|NCT04695691|Cutera|Director Clinical Research|415-657-5518|mdoucette@cutera.com|
20176737|NCT02639884|Masimo Corporation|Vikram Ramakanth|9492977416|vramakanth@masimo.com|
20176738|NCT00559897|Barbara Ann Karmanos Cancer Institute|Dr. Shirish Gadgeel|313-576-8753|gadgeels@karmanos.org|
20176739|NCT03295201|Marmara University|Dr. Kardelen Gencer Atalay|5324404887|kardelengencer@gmail.com|532
20176740|NCT00572572|Hoosier Cancer Research Network|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20176741|NCT01831089|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology Business Unit.|+34 91 846 60 00|clinicaltrials@pharmamar.com|
20176742|NCT00889421|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
20176743|NCT01958918|Novartis Pharma AG|Study Director|+41613241111|Novartis.email@novartis.com|
20176744|NCT01597687|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176745|NCT02114892|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
20176746|NCT01243450|Cu-Tech, LLC|William J. Cunningham, MD|(973) 331-1620|wcunningham@cu-tech.com|
20176747|NCT02013765|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20176748|NCT02061345|Imperial College, London|Prof Pat Price|02075895111|p.price@imperial.ac.uk|
20176749|NCT04479618|BenskinL|Linda Benskin, PhD, RN, Independent Researcher|+1 (512) 659-0812|lindabenskin@utexas.edu|
20176750|NCT04023695|Vanderbilt University|Brian Drolet, MD|(615) 322-2350|brian.c.drolet@vumc.org|
20176751|NCT01134900|The University of Texas Health Science Center at Houston (UTHealth)|Allison B. McCoy, PhD|713-500-6931|allison.b.mccoy@uth.tmc.edu|
20176752|NCT00659269|University of New Mexico|Zoneddy Dayao, MD|5059250404|zdayao@salud.unm.edu|
20176753|NCT02832674|ThermiGen LLC|Toni Fournier, Sr. VP New Products|214-888-0634|TFournier@Thermi.com|
20176754|NCT00718042|Abbott Laboratories|Associate Director Clincal Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
20176755|NCT04327934|John B. Pierce Laboratory/Yale School of Medicine|Nina Stachenfeld|203 562 9901|nina.stachenfeld@yale.edu|219
20176756|NCT02443298|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
20176757|NCT01047683|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
20176758|NCT04627727|BIDMC|Judy Nee, mD|617-667-2193|jnee@bidmc.harvard.edu|
20176759|NCT04847050|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
20176760|NCT03735420|National University of Natural Medicine|Ryan Bradley, ND, MPH|5035521862|rbradley@nunm.edu|
20176761|NCT00833924|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
20176762|NCT01485861|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20176763|NCT03835260|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
20176764|NCT01260922|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20176765|NCT02822794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20176766|NCT00466323|VA VISN 5 Mental Illness Research, Education and Clinical Center|Amy Drapalski, Ph.D.|410-637-1855|amy.drapalski@va.gov|
20176767|NCT05101252|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|(904)254-0152|TKarkkai@its.jnj.com|
20176768|NCT02266381|The First Affiliated Hospital of Guangzhou Medical University|Dr. Guohua Zeng|0086-20-34294163|gzgyzgh@vip.sina.com|
20176769|NCT03732248|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
20176770|NCT00733824|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
20176771|NCT02658851|Apyx Medical|Kari Larson|8012440058|kari.larson@apyxmedical.com|
20176772|NCT01243944|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20176773|NCT01384539|University of Colorado|Dr. Jessica Kendrick|303-602-5012|Jessica.Kendrick@ucdenver.edu|
20176774|NCT01166984|AtoxBio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
20176775|NCT01714024|UNC School of Dentistry|Steven Offenbacher, DDS, PhD, MMSc|919-537-3205|steven_offenbacher@unc.edu|
20176776|NCT01731171|Sheppard Pratt Health System|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
20190301|NCT01113541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206269|NCT01998958|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20206270|NCT02432703|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20176777|NCT01736852|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20176778|NCT00403546|Massachusetts General Hospital|Donald C. Goff, MD||Donald.Goff@nyumc.org|
20176779|NCT02604589|William Beaumont Hospital|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
20176780|NCT00793910|Carl R. Darnall Army Medical Center|Matthew Kuhnle, DO|216-965-3518|matthew.kuhnle@us.army.mil|
20176781|NCT01504438|Duke University|James Nunley II, M.D.|919-684-4033|james.nunley@duke.edu|
20176782|NCT02610140|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20176783|NCT03362515|Thomas Jefferson University|Dr. Mindy Rabinowitz|215-955-6784|mindy.rabinowitz@jefferson.edu|
20176784|NCT04523129|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
20176785|NCT06748040|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20176786|NCT04621500|Medical University of South Carolina|Stephen J. Savage, MD|18437925787|savages@musc.edu|
20176787|NCT03809182|Pontificia Universidad Católica de Chile|Mauricio Ibacache MD|+56984421425|mibacach@med.puc.cl|
20176788|NCT03794089|VA Center for Integrated Healthcare|Dr. Robyn L. Shepardson|315-425-4400|Robyn.Shepardson@va.gov|53956
20176789|NCT00116805|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20176790|NCT01760954|AbbVie|Global Medical Services|800-633-9110||
20176791|NCT02487563|Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University|Yaqiong Tang|+86 18896588075|tangyaqiong@suda.edu.cn|
20176792|NCT02744534|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
20176793|NCT03821376|Indiana University|Jordan Swensson, MD|317-944-1831|jswensso@iu.edu|
20176794|NCT00071487|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176795|NCT02391402|Portland VA|Megan Callahan|503-220-8262|megan.callahan@va.gov|50525
20176796|NCT02318329|Five Prime Therapeutics|Medical Lead|415-365-5600|FPA144@fiveprime.com|
20176797|NCT03971617|Stony Brook University Medical Center|Sandra Skinner|631-444-7513|sandra.skinner@stonybrookmedicine.edu|
20176798|NCT02032901|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20176799|NCT02855060|Atrium Health|Rachel Seymour|74-355-6969|rachel.seymour@atriumhealth.org|
20176800|NCT04088097|Yale University|Dr Janet Lydecker|2037374299|janet.lydecker@yale.edu|
20176801|NCT01126593|Orlando Orthopaedic Center|Dr. Randy Schwartzberg|(407) 254-2500|orlandosportsdoc@yahoo.com|
20176802|NCT03057119|Florida State University|Katie Kloss|9045716395|katie.kloss@med.fsu.edu|
20176803|NCT03556761|University of Pennsylvania|Dr Lisa Levine|215-662-6913|lisa.levine@pennmedicine.upenn.edu|
20176804|NCT00353704|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
20176805|NCT01037309|Prosensa|Fiona Lawrence|+31(0)713322100|f.lawrence@prosensa.nl|
20176806|NCT02530619|Northwestern University, Feinberg School of Medicine|Brady L. Stein, MD|312-695-6832|bstein@nmff.org|
20176807|NCT01282710|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
20176808|NCT00786916|Akron Children's Hospital|Michael D. Reed, Pharm.D.|330-543-3193|MReed@chmca.org|
20176809|NCT01807585|Medtronic Endovascular|Melissa Hasenbank, Clinical Research Director|707-525-0111|melissa.hasenbank@medtronic.com|
20176810|NCT03021759|University of Pennsylvania|Rebecca Pepe|215-360-0951|peper@pennmedicine.upenn.edu|
20176811|NCT01854554|UT MD Anderson Cancer Center|Dr. Caroline Chung, MD- VP, Chief Data Officer, Data Impact & Governance|(713) 745-5422|cchung3@mdanderson.org|
20176812|NCT02504645|ImmuPharma|CEO|+33 6 18 22 16 50|robert.zimmer@immupharma.com|
20176813|NCT00359762|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20176814|NCT02819726|Archigen Biotech Ltd|Medical Director|+44(0)20 3749 5000|info@archigenbio.com|
20176815|NCT02829034|University of Pennsylvania|Yuchi Han, PI of the study|215-615-3417|yuchi.han@uphs.upenn.edu|
20176816|NCT02652780|GenSight Biologics|Regulatory Affairs|176217220|ipengue@gensight-biologics.com|0033
20176817|NCT02613481|Yardley Dermatology Associates, PC|Director of Clinical Trials|2155796155|rfried@yardleyderm.com|
20176818|NCT01033747|Novartis Pharmaceuticals|Study Director|862 778-8300||
20176819|NCT02647658|University of Pittsburgh|Dr. Charity Patterson|412-383-4812|cgp22@pitt.edu|4123834812
20176820|NCT00803023|Jazz Pharmaceuticals|Director of Clinical Development|650-496-3777||
20206271|NCT00724815|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
20206272|NCT01628393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20206273|NCT00561340|University of Nebraska Medical Center|Christopher Kratochvil|402-552-6005|ckratoch@unmc.edu|
20206274|NCT01989754|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20206275|NCT02186457|Indiana University School of Medicine|Dr. Michael House|3179440113|michouse@iupui.edu|
20206276|NCT01369225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206277|NCT01229891|National nutrition and food technology institute|T Neyestani|0982122376471|neytr@yahoo.com|
20206278|NCT00105183|Fresenius Biotech|Regulatory Affairs|781 699 4618|anne.kuan@fresenius-biotech.com|
20206279|NCT02135900|Staten Island University Hospital|Michel Chalhoub, MD|7182269000|chalhoubmichel@gmail.com|
20206280|NCT04702984|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20206281|NCT03167541|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research|+44 (0) 1482326151|clinicalrequests@rb.com|
20206282|NCT01467661|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20206283|NCT03037307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206284|NCT00270998|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20206285|NCT01118715|Athens Orthopedic Clinic|Dr. Michael Shuler|706-549-1663|mshuler@athensorthopedicclinic.com|
20206286|NCT01855945|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20206287|NCT02156804|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20176821|NCT01542528|Yale University|Dr. James Leckman|203-785-5880|james.leckman@yale.edu|
20176822|NCT02202135|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
20176823|NCT02256111|Duke University|Michael Harrison, MD|919-668-4615|michael.harrison@duke.edu|
20176824|NCT04177693|Yale University|Dr. Heping Zhang|2037855185|heping.zhang@yale.edu|
20176825|NCT04382326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176826|NCT01762761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20176827|NCT00995449|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
20176828|NCT00534352|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
20176829|NCT04788147|RefleXion|Debradenise Brooks|16504828435|dbrooks@reflexion.com|
20176830|NCT00293540|International Breast Cancer Research Foundation|Richard R. Love, MD|608-698-7881|richardibcrf@gmail.com|
20176831|NCT00781326|University of Pittsburgh|Ellen Whyte, MD|412 246 5066|whyteem@upmc.edu|
20176832|NCT01144338|Astrazaneca Inc.|Peter Ohman|1(301)398-0120|Peter.Ohman@astrazeneca.com|
20176833|NCT02401672|Medical University of South Carolina|Xingbao Li, MD|843-792-5729|lixi@musc.edu|
20176834|NCT04796610|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
20176835|NCT01410110|Yale University School of Medicine|Morris Bell, Ph.D.|203-932-5711|morris.bell@yale.edu|2281
20176836|NCT01814722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176837|NCT01070810|BIDMC|Michael W Donnino|617-754-2295|mdonnino@bidmc.harvard.edu|
20176838|NCT02418546|Massachusetts General Hospital|Dr. Anne-Marie Wills|6177265532|awills@mgh.harvard.edu|
20176839|NCT05061446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176840|NCT02661828|Emory University|Boadie Dunlop, MD|404-727-8474|vcruz@emory.edu|
20176841|NCT02799082|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
20176842|NCT04496258|University of Denver|Kateri McRae|3038713632|Kateri.McRae@du.edu|
20176843|NCT02678039|Dartmouth-Hitchcock|Mark P. Yeager, MD|603-650-5922|mark.p.yeager@hitchcock.org|
20176844|NCT00861341|University of Rochester, Wilmot Cancer Center|Charles Francis, MD|585-275-3761|Charles_Francis@urmc.rochester.edu|
20176845|NCT00006411|JCHR|Roy W. Beck, MD, PhD|813-975-8690|cds@jaeb.org|
20176846|NCT01825408|UNC Department of Otolaryngology|Dr. Adam Zanation||adam_zanation@med.unc.edu|
20176847|NCT01218997|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
20176848|NCT04382612|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20176849|NCT01328002|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20176850|NCT03149328|University of Alberta|Dr. Kara Schick-Makaroff|1-780-492-9043|kara.schickmakaroff@ualberta.ca|
20176851|NCT01222585|Duke Clinical Research Institute|Michael Cohen-Wolkowiez, MD|919668-8812|michael.cohenwolkowiez@dm.duke.edu|
20176852|NCT01443442|SCCO at MBKU|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
20176853|NCT01306617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20176854|NCT03077165|IlkosTherapeutic Inc.|Monique Champagne|450-680-3381|mchampagne@ilkostherapeutic.com|2910
20176855|NCT00766415|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
20176856|NCT01114516|Northwestern University Feinberg School of Medicine|Dr. Emily Miller|3124724685|emily-miller-1@northwestern.edu|
20176857|NCT00061048|National Cancer Institute, National Institutes of Health|Thomas A. Waldmann, M.D.|301-496-6653|Thomas.Waldmann2@nih.gov|
20176858|NCT02755935|Cochlear Americas|Ginger Grant, AuD|410-375-0883|ggrant@cochlear.com|
20176859|NCT01632579|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176860|NCT03779841|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20176861|NCT00898677|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176862|NCT00234884|Abbott|Global Medical Services|1-800-633-9110||
20176863|NCT01016834|Zogenix|Judith Myers, Senior Director Clinical Operations|510-550-8300|jmyers@zogenix.com|
20176864|NCT00836875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176865|NCT00734305|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20176866|NCT03119766|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20176867|NCT02562755|SillaJen Biotherapeutics Inc.|Kyoung Soo Ha, Senior Medical Director|+1-415-281-8886|ksha@kr.sillajen.com|
20176868|NCT02034578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20176869|NCT00129987|Imperial College London|Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
20176870|NCT01159938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176871|NCT00581945|Study Director|Novartis Pharmaceuticals|862-778-8300||
20176872|NCT02621983|Atlanta VA Medical Center|Dr. Erica Duncan|404-321-6111|erica.duncan@va.gov|207532
20161941|NCT01755455|Dartmouth-Hitchcock Medical Center|Alex H. Gifford, M.D.|603-650-5533|alex.h.gifford@hitchcock.org|
20161942|NCT02081599|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20161943|NCT01840527|Massachusetts General Hospital Cancer Center|Ryan Sullivan|6177244000|rsullivan7@mgh.harvard.edu|
20161944|NCT02146001|University of Pittsburgh|Dr. Bethany Barone Gibbs|412-383-4002|bbarone@pitt.edu|
20161945|NCT01356628|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Avnish Bhatia|215-955-8874|avnish.Bhatia@jefferson.edu|
20161946|NCT00306527|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20161947|NCT00785980|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20176873|NCT01138124|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176874|NCT00982020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176875|NCT00466193|Purdue Pharma LP|Clinical Leader|800-733-1333||
20176876|NCT02525133|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20176877|NCT01614210|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
20176878|NCT01181921|Jan-Cil Spain|COUNTRY MEDICAL DIRECTOR|+34 91 7228043||
20176879|NCT02317575|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20176880|NCT03326999|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-6426|christina.jeng@mountsinai.org|
20221609|NCT00413699|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176881|NCT02548962|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
20176882|NCT04831736|NYU Langone Health|Lisa Doan, MD|212-201-1004|Lisa.Doan@nyulangone.org|
20176883|NCT00652457|University of California, San Diego|Jody Corey-Bloom, MD, PhD|858-249-0574|jcoreybloom@ucsd.edu|
20176884|NCT02159482|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
20176885|NCT02753751|Yale University|Francis P. Wilson|2037376095|francis.p.wilson@yale.edu|
20176886|NCT02828111|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|clinical@pellepharm.com|
20221610|NCT02115269|Abbott|Jean-Pascal Berrou, Global Medical Director CNS/Pain|+41614870457|jean-pascal.berrou@abbott.com|
20176887|NCT04096560|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20176888|NCT04071951|Cedars-Sinai Medical Center|Joshua Pevnick|310.423.4683|pevnickj@cshs.org|
20176889|NCT01459796|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20176890|NCT00701051|Baltimore VA Medical Center|Steven J. Prior, PhD|410-605-7000|steven.prior@va.gov|4129
20176891|NCT03634579|Emory University|Sherif Nour|404-778-3800|sherif.nour@emoryhealthcare.org|
20176892|NCT05857527|Medical University of South Carolina|Kelly McGloon|8437926443|mcgloon@musc.edu|
20176893|NCT02543346|Kingston General Hospital|Dr. Anne Ellis|6135482336|ellisa@kgh.kari.net|
20176894|NCT01748994|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
20176895|NCT02141516|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20221611|NCT02810457|Centus Biotherapeutics Limited|Clinical Trial Information|+353 1 609 7100|Clinical-Trial@centusbio.com|
20221612|NCT01402570|University of Michigan|Claire Z. Kalpakjian|734-763-0153|clairez@umich.edu|
20221613|NCT04074941|Marcus Institute, Hebrew SeniorLife|Shivani Sahni, PhD|6179715382|shivanisahni@hsl.harvard.edu|
20221614|NCT03642262|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20221615|NCT01557504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221616|NCT01365819|UCLA, Dept of Family Medicine|Dr. Steve Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|
20221617|NCT02750618|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20221618|NCT04144413|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20221619|NCT01103180|University of Chicago|Dr. Emil Coccaro|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
20221620|NCT01760304|Brigham and Women's Hospital|Dr. Miguel Divo|8573070311|mdivo@bwh.harvard.edu|
20221621|NCT04552795|UT Health San Antonio|Bess Frost, PhD|210-562-5037|bfrost@uthscsa.edu|
20221622|NCT01332487|GlaxoSmithKline|GSK Response Center|866-435-7343||
20176896|NCT03251924|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20221623|NCT03499067|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20221624|NCT02440464|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20221625|NCT00324987|SWOG Statistical Center|SWOG Statistician|206-667-4408||
20221626|NCT01299103|Chicago Center for Facial Plastic Surgery|Dr. Steven Dayan|(312) 335-2070|sdayan@drdayan.com|
20221627|NCT00860795|University of Washington|James A Taylor, MD|206-616-1206|uncjat@u.washington.edu|
20221628|NCT01199939|Janssen Pharmaceuticals|SENIOR MEDICAL DIRECTOR|1 609 730-2931||
20221629|NCT00882518|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20221630|NCT03238651|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20221631|NCT01960413|Vanderbilt University Medical Center|Michael DeBaun, MD MPH|(615) 875-3040|m.debaun@vumc.org|
20221632|NCT00791778|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20221633|NCT01285362|Columbia Universty|Dr Mercedes Martinez|212-305-3438|mm2479@cumc.columbia.edu|
20221634|NCT04886596|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221635|NCT01074944|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20221636|NCT00194779|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20221637|NCT02348112|Coloplast Corp.|Liz Driessen|1-800-258-3476|usedri@coloplast.com|
20221638|NCT02103855|Indiana University|Jeanne Chen|317-944-3570|jchen@iuhealth.org|
20221639|NCT03714828|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
20221640|NCT03560128|Indiana University|Study Coordinator|317-948-0724|rlahr@iu.edu|
20221641|NCT01998841|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20221642|NCT02586155|Resverlogix Corp.|Sr. Director of Clinical Operations|403.254.9252|clinicaltrials@resverlogix.com|
20221643|NCT02552121|Genmab A/S|Genmab|7020 2728|clinicaltrials@genmab.com|+45
20221644|NCT00972595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221645|NCT01263938|University of Pennsylvania School of Medicine|Dr. Ronald Collman|215-898-0193|collmanr@pennmedicine.upenn.edu|
20221646|NCT01522456|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Associate Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
20221647|NCT04052620|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20221648|NCT01500473|Children's Hospital Los Angeles|Thomas Keens|3233612101|tkeens@chla.usc.edu|
20221649|NCT02201784|Jawaharlal Nehru Medical College, AMU, Aligarh, India|Dr. Manazir Athar|+918868056469|drmanazirathar@gmail.com|
20221650|NCT02072980|Alcon Research, Ltd.|Cecile Maissa, Global Brand Medical Affairs Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20221651|NCT00193050|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
20221652|NCT02431364|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20221653|NCT00061932|Montefiore Medical Center|Rutvi Patel|718-379-6861|rupatel@montefiore.org|
20221654|NCT00916383|Teikoku Pharma USA, Inc.|Director of Clinical Trials|(408) 501-1821||
20221655|NCT02899962|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20221656|NCT00258960|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34 916 592 870|geicam@geicam.org|
20221657|NCT00473590|Hoffman-LaRoche|Medical Communications|800-821-8590||
20221658|NCT04778475|Medical University of South Carolina|Sinead Farrelly DPT|843-792-3069|farrelsi@musc.edu|
20221659|NCT01245283|UF&Shands Orthopaedics and Sports Medicine Institute|Kevin R. Vincent, M.D. Ph.D.|352-273-7458|vincekr@ortho.ufl.edu|
20221660|NCT00395161|University of Utah|Jeri Burr, MS, RN-BC, CCRC|801-587-7753|jeri.burr@hsc.utah.edu|
20221661|NCT02153983|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
20221662|NCT01610492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221663|NCT00580502|NYULMC|Heekoung Youn|2122632174|younh01@nyumc.org|
20221664|NCT03093259|Abivax|Sharon Skare|+33 (0) 1 53 83 08 41|sharon.skare@abivax.com|
20221665|NCT01757275|AstraZeneca|Huifang Chen|+86 21 60301335|ariel.chen@astrazeneca.com|
20221666|NCT01821807|Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation|Dr. Ruslan Abdullayev|+905063010833|ruslan_jnr@hotmail.com|
20221667|NCT04446247|Owlet Baby Care, Inc|Madison Kenley, Clinical Research Director|801-552-8383|mkenley@owletcare.com|
20221668|NCT01401452|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20221669|NCT00584454|UAMRIID Division of Medicine|LTC Robert Rivard, MD|301-619-8244|robert.g.rivard.mil@mail.mil|
20221670|NCT00254592|University of California Irvine Medical Center|Rita S. MEHTA, MD|(714) 456-5153|rsmehta@uci.edu|
20221671|NCT01459783|University of California Los Angeles|Joshua Chodosh or Barbara Vickrey|310-206-7671|jchodosh@mednet.ucla.edu|
20221672|NCT02601014|University of Minnesota Division of Hematology, Oncology and Transplantation|Emmanuel Antonarakis, MD|612-301-2180|anton401@umn.edu|
20221673|NCT01168427|Medtronic - CRDM|RIO Clinical Research Specialist.|1-800-328-2518|MedtronicCRMtrials@medtronic.com|63277
20161948|NCT00528801|Children's Hospital of Oakland and Research Institute|Elliott Vichinsky, MD|510-428-3651|evichinsky@mail.cho.org|
20161949|NCT02207491|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20161950|NCT00387725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161951|NCT04724967|University of Miami|Robert Kirsner|305-689-2646|rkirsner@med.miami.edu|
20161952|NCT02429791|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221674|NCT02456740|Amgen Inc.|Study Director|866-572-6436||
20221675|NCT00858273|Nemours Children's Clinic|Dominique Darmaun, MD|(904) 697 3674|ddarmaun@nemours.org|
20221676|NCT00625820|University of Michigan|Rajiv Saran, MD|734-763-6611|rsaran@umich.edu|
20221677|NCT00982657|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20161953|NCT04201093|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20221678|NCT00070564|SWOG Statistical Center|Breast Committee Statistician|206-667-4623|jmiao@fredhutch.org|
20221679|NCT04796961|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20161954|NCT00007020|Retrophin, Inc.|Retrophin Medical Information|+1 8776595|medinfo@retrophin.com|518
20161955|NCT00881504|Georgetown University Medical Center|Dr. John L Marshall|202-444-7064|marshalj@georgetown.edu|
20221680|NCT03018288|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
20221681|NCT03593473|University of North Carollina at Chapel Hill|Alison Stuebe, MD, MSc|919-966-1601|astuebe@med.unc.edu|
20221682|NCT06700512|WSAUDAS|Dr. Veronika Littmann|+4991313080|Veronika.littmann@wsa.com|
20221683|NCT01490086|Reviva Pharmaceuticals, Inc.|Marc Cantillon, M.D|408-960-2209|mcantillon@revivapharma.com|
20221684|NCT05825404|Penn State University|Ying-Ling Jao|8148655634|yuj15@psu.edu|
20221685|NCT01127256|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
20221686|NCT00679211|Genentech, Inc.|Medical Communications|800-821-8590||
20221687|NCT00931528|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
20221688|NCT01730053|Regeneron Pharmaceuticals|Clinical Trial Management||clinicaltrials@regeneron.com|
20221689|NCT01470248|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
20221690|NCT01741311|University of Connecticut|Michael Copenhaver|8602083632|michael.copenhaver@uconn.edu|
20221691|NCT05842967|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20221692|NCT01051310|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
20221693|NCT00572936|University of Nebraska Medical Center|Carol Toris, PhD|402-559-1852|ctoris@unmc.edu|
20221694|NCT01173523|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468||
20221695|NCT01634048|Imperial College|Professor Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
20221696|NCT02806908|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20221697|NCT04429503|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20221698|NCT05516108|University of Pittsburgh|Emily K Lindsay, PhD|412-601-0585|emily.lindsay@pitt.edu|
20221699|NCT00709995|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20221700|NCT02392481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221701|NCT03565900|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221702|NCT01999920|NYSPI|Franklin Schneier, MD|6464774-8041|fschneier@nyspi.columbia.edu|
20221703|NCT02058069|MAKO Surgical Corp.|Michael Conditt|7132408675|michael.conditt@stryker.com|
20221704|NCT02222922|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221705|NCT01254643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221706|NCT03359850|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221707|NCT01280643|Fox Chase Cancer Center|Dr. Crystal Denlinger|215-214-1676|crystal.denlinger@fccc.edu|
20221708|NCT02090088|Amgen Inc.|Study Director|866-572-6436||
20221709|NCT01629511|UT MD Anderson Cancer Center|Dr. Chitra Hosing|713-792-8750|cmhosing@mdanderson.org|
20221710|NCT03290378|Avenue Therapeutics|VP of Clinical Operations and Program Management|781-652-4514|mryan@avenuetx.com|
20221711|NCT03817125|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20221712|NCT02002221|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20221713|NCT00942084|Duke Clinical Research Institute|P. Brian Smith, MD MPH MHS|919-668-8951|brian.smith@duke.edu|
20221714|NCT01366417|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
20221715|NCT01087918|UZurich|Hubertus van Hedel, PhD|+41 44 762 52 91|hubertus.vanhedel@kispi.uzh.ch|
20221716|NCT01037218|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20221717|NCT02568072|St George's, University of London|Dr Andrew D'Silva|020 7188 7188|adsilva@nhs.net|51554
20221718|NCT01302743|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|702-653-3298|jill.clark.3.ctr@us.af.mil|
20221719|NCT00897715|VA Tennessee Valley Healthcare System.|Adriana Hung|615-873-7480|adriana.hung@va.gov|
20221720|NCT01268553|Los Angeles Biomedical research INst at Harbor-UCLA|Dr. Ronald Oudiz|310-222-3560|roudiz@labiomed.org|310
20221721|NCT00513240|Baylor College of Medicine|Dr. Dean B. Andropoulos|832-826-5831|dra@bcm.edu|
20221722|NCT02714218|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20221723|NCT01930162|Novartis Pharmaceuticals|Study Director|862-778-8300||
20221724|NCT02550561|University of California, Irvine|Phuong Linh Huynh, CRC|7144566155|plhuynh@hs.uci.edu|
20221725|NCT01564693|SAPIENZA UNIVERSITY OF ROME|PROF. ALESSANDRO LAVIANO|+390649973902|alessandro.laviano@uniroma1.it|
20221726|NCT00774163|Tulane University School of Public Health and Tropical Medicine|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
20221727|NCT03957200|University of manitoba|Dr Helen Pymar|204-787-4184|hpymar@hsc.mb.ca|
20221728|NCT02285361|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221729|NCT01283464|Johns Hopkins Dermatology|Dr. Anna L. Chien|4105027546|ctrep@jhmi.edu|
20221730|NCT03051100|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20221731|NCT01778855|UCLA|David S Liebeskind, MD|310-794-6379|dliebeskind@mednet.ucla.edu|
20221732|NCT02059135|LFB USA|Laura Massey, Sr. Clinical Project Manager|508-370-5157|laura.massey@lfb-usa.com|
20161956|NCT01276223|Alcon Research|Director of Alcon Clinical|1-888-451-3937||
20221733|NCT02289729|AbbVie|Global Medical Services|800-633-9110||
20221734|NCT00931411|Innovaderm Research|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20221735|NCT01949662|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
20221736|NCT02291237|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20221737|NCT07034820|Nimsai Academia|Cem Atabiner, Principal Investigator|05324593292|cem.atabiner@kecioutdoor.com.tr|
20221738|NCT00729937|Olive View-UCLA Medical Center|David A. Talan, MD|818-364-3107|dtalan@ucla.edu|
20221739|NCT03207386|University of Nebraska Lincoln|Dr. Katie Edwards|6034223207|katie.edwards@unl.edu|
20161957|NCT05011058|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
20161958|NCT02596230|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161959|NCT01571232|Retina Macula Institute|Ron P. Gallemore M.D., Ph.D.|310-944-9393|rongallemoremd@gmail.com|
20221740|NCT01478373|Novartis Pharmaceuticals|Study Director|862-778-8300||
20221741|NCT01199380|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
20221742|NCT01408043|Case Comprehensive Cancer Center|Navneet Majhail|216-444-2199|majhain@ccf.org|
20221743|NCT03741400|Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
20221744|NCT02624180|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
20221745|NCT02833337|Centro de Implantologia, Cirugia Oral y Maxilofacial|Alberto Monje|+41798836264|amonjec@umich.edu|
20221746|NCT01256879|U of Maryland|James Polli, Professor|410-706-8292|jpolli@rx.umaryland.edu|
20221747|NCT00397514|University of British Columbia|Dr. Shubhayan Sanatani|6048752345|ssanatani@cw.bc.ca|7955
20221748|NCT00445146|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@Gilead.com|
20221749|NCT00640315|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20221750|NCT00266279|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|bcccto@louisville.edu|
20221751|NCT00725920|Federal University of Sao Paulo|Marcelo F Mello|55 11 50822860|mf-mello@uol.com.br|
20221752|NCT02623725|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
20221753|NCT01615367|Massachusetts General Hospital|Dr. Louisa Sylvia|617-643-4804|lsylvia2@partners.org|
20221754|NCT04720105|Icahn School of Medicine at Mount Sinai|Hassan Hamade|212-844-8811|hassan.hamade@mountsinai.org|
20221755|NCT02892331|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virgina.edu|
20221756|NCT03717155|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20221757|NCT02286713|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20221758|NCT02654054|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20221759|NCT01333592|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
20221760|NCT06018129|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
20221761|NCT05120193|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
20221762|NCT04748510|Perth Hip & Knee|Dr Serene Lee, Orthopaedic Research Officer|64891720|research@hipnknee.com.au|
20221763|NCT02325973|Abbott Medical Italia|Vanoni Benedetta, Abbott Clinical Site Lead|+39340571064|benedetta.vanoni@abbott.com|
20221764|NCT02513160|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20221765|NCT01279317|Maastricht University Medical Centre|Drs. Jan-Willem van Dijk|+31(0)433881394|janwillem.vandijk@maastrichtuniversity.nl|
20221766|NCT03241862|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20221767|NCT03428958|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
20221768|NCT03874117|VA Palo Alto|Tammy Sirich|6504935000|tsirich@stanford.edu|
20221769|NCT05012098|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
20221770|NCT05258773|Sensorion|Chief Medical Officer|+33 4 67 20 77 30|contact@sensorion-pharma.com|
20221771|NCT04514692|Stanford University|Dr. Elizabeth Kidd|(650) 723-6171|ekidd@stanford.edu|
20221772|NCT05364931|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20221773|NCT02243605|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
20221774|NCT03103087|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20221775|NCT03511105|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221776|NCT00075816|The EMMES Corporation|Adam Mendizabal|301-251-1161|amedizabal@EMMES.com|
20221777|NCT01823328|Hennepin Healthcare|Audrey Hendrickson|612-873-9528|Audrey.Hendrickson@hcmed.org|
20221778|NCT03077737|Northwestern University|Dr. Brian Hitsman, PhD|312-503-2074|b-hitsman@northwestern.edu|
20221779|NCT02019472|Janssen-Cilag International N.V.|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20221780|NCT00513695|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|Jennifer Specht, MD|(206) 288-6889|jspecht@uw.edu|
20221781|NCT02157935|AstraZeneca|Tor Skärby||tor.skarby@astrazeneca.com|
20221782|NCT03192488|Indiana University|Robert Chapman|812-856-2452|rfchapma@indiana.edu|
20221783|NCT00867529|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
20221784|NCT03588910|Montefiore Medical Center|Dr. Kari Plewniak|718-920-5157|kplewnia@montefiore.org|
20221785|NCT02547428|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20221786|NCT02302833|The University of Texas MD Anderson Cancer Center|Dr. Camilo Jimenez|(713) 792-2841|cjimenez@mdanderson.org|
20221787|NCT06192589|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
20221788|NCT03664232|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20221789|NCT02717507|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20221790|NCT05017246|Washington University School of Medicine|Dr. Premal H Thaker|314-747-3604|thakerp@wustl.edu|
20221791|NCT01662778|Imperial College London|Dr Omar Usmani||o.usmani@imperial.ac.uk|
20221792|NCT02562066|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
20221793|NCT02003209|NSABP Foundation|Judy Langer, Director of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20206288|NCT00389441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221794|NCT00638508|Maimonides Medical Center|Kalpana Tyagaraj, M.D.|718-283-9162|Kalpana_tyagaraj@msn.com|
20221795|NCT00485264|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20221796|NCT03500198|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
20221797|NCT01514461|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20221798|NCT00654095|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20190302|NCT02132676|VA Ann Arbor Healthcare System Center for Clinical Management & Research|Dr. Michele Heisler|734-845-3502|mheisler@umich.edu|
20190303|NCT01580306|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190304|NCT01494467|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
20190305|NCT02450747|Johnson & Johnson Vision Care Inc.|Tom Karkkainen O.D., M.S., F.A.A.O- Sr. Research Principal Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
20190306|NCT04184271|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
20190307|NCT03386344|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20190308|NCT01516710|Oslo University Hospital|Dr. Aasmund A. Fretland|004723070100|aafret@ous-hf.no|
20221799|NCT04650217|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|brr8@cumc.columbia.edu|
20190309|NCT01280721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
20190310|NCT01180400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20190311|NCT05188248|NYU Langone|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
20190312|NCT01182285|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
20190313|NCT03209492|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20190314|NCT01525875|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
20190315|NCT03481725|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|m1medeiros@health.ucsd.edu|
20190316|NCT01894620|University of Manitoba|Dr Zahra Moussavi|204 474-7023|Zahra.Moussavi@umanitoba.ca|
20190317|NCT02877680|Baylor College of Medicine|Marisa Hilliard, Associate Professor of Pediatrics|832-824-7209|marisa.hilliard@bcm.edu|
20190318|NCT01133678|University of Chicago|Everett Vokes, MD|(773) 702-6227|evokes@medicine.bsd.uchicago.edu|
20190319|NCT03424187|Imperial College London|Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
20190320|NCT00879710|Medical College of Wisconsin|Srividya Kidambi, MD, MS|414-955-4843|skidambi@mcw.edu|
20190321|NCT01864200|BTG|Shirley Steiner, Director of Clinical Operations|610 943 3631|shirley.steiner@btgplc.com|
20190322|NCT02077374|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20190323|NCT02514824|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
20206289|NCT00049504|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.gov|
20206290|NCT00636441|Duke University Medical Center|P. Kelly Marcom, M.D.|919-684-3877|marco001@mc.duke.edu|
20190324|NCT03576118|Ajou University Hospital|Dr. Jong Yeop Kim|+82312195574|kjyeop@ajou.ac.kr|
20190325|NCT02170207|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206291|NCT00334204|University of Mississippi|Tibor Fulop, M.D./Associate Professor of Medicine|601 984-5670|tfulop@umc.edu|
20206292|NCT00983359|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
20206293|NCT00844285|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20206294|NCT01586806|Hospital for Special Surgery|Dr. Mary Chisholm|2126061206|chisholmm@hss.edu|
20206295|NCT03288324|Cincinnati Childrens Hospital Medical Center|Hermine Brunner|(513) 636-6320|hermine.brunner@cchmc.org|
20218015|NCT00784524|Masonic Cancer Center, University of Minnesota|Dr. Douglas Yee|612-626-8487|yeexx006@umn.edu|
20218016|NCT00118378|New York State Psychiatric Institute|Dr. Judith Rabkin|212.543.5762|jgr1@columbia.edu|
20218017|NCT01432574|H. Lee Moffitt Cancer Center and Research Institute|Anna Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
20218018|NCT02516410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20218019|NCT01252719|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
20218020|NCT04051684|Montefiore Medical Center|Dr. Karina Gritsenko|718-920-7246|kgritsen@montefiore.org|
20218021|NCT01475253|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20218022|NCT03135899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218023|NCT04146363|Eli Lilly and Company|Chief Medical officer|800-549-5929|ClinicalTrials.gov@lilly.com|
20218024|NCT06141824|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218025|NCT03660241|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218026|NCT02914236|Aerin Medical, Inc.|Scott Wolf, M.D., Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
20218027|NCT02676284|Zambon S.A.U.|Antonio Esteras, MD|+34 93 544 64 00|antonio.esteras@zambongroup.com|
20218028|NCT00735917|University of Colorado Cancer Center|Wells A. Messersmith, M.D.||wells.messersmith@ucdenver.edu|
20218029|NCT00708708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218030|NCT00856830|Univeristy of Alabama at Birmingham|Francisco Robert, MD, Department of Medicine, Division of Hematology and Oncology|205-934-5077|pacorobertuab@cs.com|
20218031|NCT02473783|Tri-Service General Hospital, National Defense Medical center|Dr. Chin-bin Yeh|886-2-87923311|chinbinyeh@gmail.com|17387
20218032|NCT03768726|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218033|NCT01286558|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161960|NCT02478164|Dana-Farber Cancer Institute|Eudocia Q. Lee, MD, MPH|617-632-2166|eqlee@partners.org|
20161961|NCT00802893|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20161962|NCT00320424|GlaxoSmithKline|GSK Response Center|866-435-7343||
20161963|NCT03123328|Masimo Corporation|Director, Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
20161964|NCT02251938|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
20221800|NCT00595621|Texas Tech|Irene Sarosiek, MD, AGAF, FACG, CCRP|915.215.5254|Irene.sarosiek@ttuhsc.edu|
20221801|NCT00268450|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20221802|NCT02502149|Bioverativ|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
20176897|NCT00153101|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20161965|NCT04909229|Yale University|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
20161966|NCT05138549|Prisma Health|Harley T. Davis|8032969533|pamela.davis2@prismahealth.org|
20161967|NCT00231413|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20161968|NCT01659255|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20161969|NCT03316950|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20221803|NCT02548832|INSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA|Esperanza Martinez Abundis|3310585200|esperanzamartnezabundi@yahoo.com|34211
20161970|NCT02809053|Archigen Biotech Ltd|Medical Director|+44 (0)20 3749 5000|info@archigenbio.com|
20161971|NCT02411929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20161972|NCT01722435|Centre for Interdisciplinary Addiction research of Hamburg University ZIS|Prof. Dr. Jens reimer|+4940741057900|reimer@uke.de|
20161973|NCT02565810|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
20221804|NCT02968576|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@ucdenver.edu|
20161974|NCT02049138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20176898|NCT03169153|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20176899|NCT01440946|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
20221805|NCT01998919|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20176900|NCT03299192|Kaiser Permanente|Rene Hawkes, Project Manager|206-287-2073|rene.j.hawkes@kp.org|
20176901|NCT03291613|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
20176902|NCT00658112|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
20221806|NCT01068860|Novartis Pharmaceuticals|Dr. Tom Thuren/Global Brand Medical Director|862-778-1828|tom.thuren@novartis.com|
20221807|NCT05263908|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221808|NCT02961595|University of Tampere|Hanna Viskari||hanna.viskari@uta.fi|
20221809|NCT01433471|NYU Langone Medical Center|Martin Wolff|(646) 329-7259|martin.wolff@nyumc.org|
20221810|NCT03711188|Immodulon Therapeutics Ltd|Clinical Trial Information Desk,|0044 0203137 6346|info@immodulon.com|
20221811|NCT04784091|Tarsus Pharmaceuticals|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
20221812|NCT03875508|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20221813|NCT02137252|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Fremonta Meyer, MD||flmeyer@partners.org|
20221814|NCT04460911|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20221815|NCT00063934|UTMDACC|Francisco Esteva, MD, PHD / Professor|713-792-2817|Francisco.Esteva@nyumc.org|
20221816|NCT04341363|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
20172747|NCT03572062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172748|NCT01858389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20172749|NCT01691781|Brigham and Women's Hospital|Anand Vaidya|6175258285|avaidya1@partners.org|
20172750|NCT03978520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20172751|NCT02818569|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|617-724-7200|ojohnsonakeju@partners.org|
20172752|NCT01918085|Coloplast|Henrik Sigaard Knoth|+ 45 4911 3469|dkhsk@coloplast.com|
20172753|NCT01118221|MVAHS|Robert M Jackson, MD|305-575-3548|robert.jackson4@va.gov|
20172754|NCT01580618|Kaiser Permanente|Hyo-Chun Yoon, MD, PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
20172755|NCT03501069|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20172756|NCT00580606|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
20221817|NCT00489866|Durham VAMC|Christine E. Marx, MD|9192860411|marx0001@mc.duke.edu|7426
20221818|NCT00923013|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|kreitmar@mail.nih.gov|
20221819|NCT03933904|Center for Cytokine Storm Treatment & Laboratory (CSTL), University of Pennsylvania|Dr. David Fajgenbaum|215-614-0935|davidfa@pennmedicine.upenn.edu|
20221820|NCT05366010|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20221821|NCT01108718|Beth Israel Medical Center|Diana Vu|212-844-6747|dvu@bethisraelny.org|
20221822|NCT05317312|Viatris|Susanne Vogt|004906172|susanne.vogt@viatris.com|88801
20172757|NCT00240162|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20172758|NCT03655691|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
20172759|NCT03694821|UConn Health|Director of Outcomes, Research & Quality|860-679-4932|mcote@uchc.edu|
20172760|NCT04102020|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
20172761|NCT01730833|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20172762|NCT04419714|Wesper/Tatch|Amir Reuvent|5754482824|amir@wesper.co|
20221823|NCT00837148|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20221824|NCT02301169|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
20221825|NCT04535141|University of North Carolina Lineberger Comprehensive Cancer Center|Jonathan Ptachcinski PharmD, BCPS, BCOP|+1 919-966-9786|Jonathan.Ptachcinski@unchealth.unc.edu|
20190326|NCT03122860|Biosplice Therapeutics, Inc.|Christopher Swearingen, PhD, VP of Biometrics|858.926.2952|chris.swearingen@biosplice.com|
20221826|NCT01422213|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20190327|NCT01138657|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20190328|NCT02841449|University of Bath|Dr Harriet Carroll|+447706548573|hac38@bath.ac.uk|
20190329|NCT02159352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20190330|NCT00529529|Novartis Pharmaceuticals|Study Director|862 778-8300||
20190331|NCT01214109|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190332|NCT01020435|Palmer College of Chiropractic|Christine M Goertz, DC, PhD (Study Principal Investigator)|563-884-5150|christine.goertz@palmer.edu|
20190333|NCT01000649|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20190334|NCT03132571|Yale School of Medicine, Department of Psychiatry|Dr. Cenk Tek|(203) 974-7500|cenk.tek@yale.edu|
20190335|NCT00346398|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20190336|NCT02607956|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20190337|NCT01916109|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20190338|NCT02354144|Division of Cancer Epidemiology, Department of Oncology, McGill University|Dr. Eduardo Franco|514-398-6032|eduardo.franco@mcgill.ca|
20190339|NCT00103857|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20190340|NCT01856569|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190341|NCT02707952|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20190342|NCT00696241|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20190343|NCT03065400|Icahn School of Medicine at Mount Sinai|Mikaela Dougherty|212-241-8839|Mikaela.dougherty@mssm.edu|
20190344|NCT03060525|University of Rochester|Dr. Steven Barnett|585-273-2548|steven_barnett@urmc.rochester.edu|
20190345|NCT02147093|Johnson & Johnson Vision Care INC.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
20190346|NCT02302157|Lineage|Avi Ben Shabat, MD|+972-509105205|avi@cellcure.co.il|
20190347|NCT02189759|University of Alabama at Birmingham|Manimaran Ramani|2054731425|mramani@peds.uab.edu|
20190348|NCT01147471|Virginia Commonwealth University|Ajai K Malhotra, MD|804-827-2409|akmalhot@mcvh-vcu.edu|
20190349|NCT04000399|University of Pittsburgh|Stephanie D. Stepp, PhD|4127155447|steppsd@upmc.edu|
20190350|NCT03020498|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20190351|NCT03890484|University of Washington|Dr. Jessica Canning|206.221.4430|jrcannin@uw.edu|
20190352|NCT00518206|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20190353|NCT01294644|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20190354|NCT02188459|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@pennmedicine.upenn.edu|
20190355|NCT02548585|MedImmune, LLC|Philip Ambery|+44 (0) 1223 895997|information.center@astrazeneca.com|
20190356|NCT02612285|Esanex Inc|Eric Orlemans PhD||eorlemans@esanexpharma.com|
20190357|NCT02399111|Northwell Health System|Dr. Kambhampaty Krishnasastry|516-233-3643|kkrishna@northwell.edu|
20190358|NCT00853957|Novartis Pharmaceuticals|Study Director|862-778-8300||
20190359|NCT02942771|University of Kentucky|Dr. Linda Van Eldik|(859) 257-5566|linda.vaneldik@uky.edu|
20190360|NCT04919499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206296|NCT00788697|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
20206297|NCT01998880|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20206298|NCT02248857|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
20206299|NCT02261883|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20206300|NCT01664858|University of Leeds|Professor John P Greenwood|+44 (0)113 3925481|j.greenwood@leeds.ac.uk|
20206301|NCT03549117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206302|NCT00014911|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20206303|NCT04199793|Vanderbilt University Medical Center|Sandip Zalawadiya, MBBS|6159368187|sandip.k.zalawadiya@vumc.org|
20206304|NCT03820726|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206305|NCT01011218|Stanford University Medical Center|Oxana RG Palesh, MD, PhD; Assistant Professor of Psychiatry and Behavioral Sciences|650-725-7011|oxana.palesh@stanford.edu|
20206306|NCT00345540|Novelos Therapeutics, Inc.|Vice President, Clinical Development|617-244-1616|hpalmin@novelos.com|
20206307|NCT01938001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20206308|NCT01576120|Given Imaging|"Ravit Peled | Clinical Trials Manager"|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
20206309|NCT01569087|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
20206310|NCT00107172|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
20206311|NCT02688153|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
20206312|NCT03140722|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
20206313|NCT01742091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221827|NCT03762265|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20190361|NCT04343716|University of Alabama at Birmingham|Dr. Robert Sorge|2059348563|rsorge@uab.edu|
20190362|NCT01437540|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20221828|NCT01805089|DFCI|Dr. Wendy Chen|617-632-3800|wychen@partners.org|
20190363|NCT00608959|Cadence Pharmaceuticals, Inc|Catherine J Hardalo, MD Vice President, Anti-Infectives Clinical Development|858 4361439|chardalo@cadencepharm.com|
20190364|NCT01416285|Chang Gung Memorial Hospital|CHAO-HUNG WANG, MD|+886-2-24313131|bearty54@gmail.com|2923
20190365|NCT01005602|University of Illinois at Chicago|Dr. Robert J. DiDomenico|(312) 413-4654|rdidom1@uic.edu|
20190366|NCT01248715|University Louisville|Dr. Paula Peyrani|502-852-3905|paula.peyrani@louisville.edu|
20190367|NCT02416102|University of Miami|Matthias Salathe, MD|913-588-6000|msalathe@kumc.edu|
20190368|NCT01919489|Emory University|Dr. Francisco Pasquel|404-778-1695|fpasque@emory.edu|
20190369|NCT01540474|Walter Reed Institute of Research|Jason W. Bennett|3013199477|jason.w.bennett.mil@mail.mil|
20190370|NCT00857311|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20190371|NCT01587703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20190372|NCT00828139|SWOG Statistical Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
20190373|NCT01714947|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20190374|NCT04751929|Dana-Farber Cancer Institute|Atish Choudhury, MD PhD|6176326328|atish_choudhury@dfci.harvard.edu|
20161975|NCT00491608|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
20221829|NCT02857816|Medtronic Pelvic Health & Gastric Therapies|Beth Michaud / Sr. Principal Clinical Research Specialist|763.526.8102|beth.m.michaud@medtronic.com|
20190375|NCT01123356|Medical University of South Carolina|Clinical Trials Network Manager|843-792-1753|adraleta@musc.edu|
20190376|NCT03015961|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20190377|NCT00376259|Novartis Pharmaceuticals|Study Director|862-778-8300||
20190378|NCT03734588|Spark Therapeutics|Tiffany Chang, MD, MAS Clinical Development Lead, Hematology|Please Email|Tiffany.chang@sparktx.com|
20190379|NCT00930644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20221830|NCT01149863|Emory University|Dr. Harvey|404-778-4381|rdharve@emory.edu|
20190380|NCT01877720|Seoul National University College of Medicine|Dr. Han-Suk Kim|82-2-2072-1696|kimhans@snu.ac.kr|
20161976|NCT00257660|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
20190381|NCT02962609|Istanbul University|Duygu Gözen (Associate Professor)|+902124400000|dgozen@istanbul.edu.tr|27082
20190382|NCT02068352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20221831|NCT03326193|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221832|NCT02845700|Florida State University|Dr. Wen Li|850-645-1409|wenli@neuro.fsu.edu|
20221833|NCT01964976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20221834|NCT03918629|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190383|NCT01732419|Maxima Medical Center|Dr. J. Kraal|+31612520944|j.kraal@mmc.nl|
20190384|NCT02740517|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
20190385|NCT01129011|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
20190386|NCT01012999|University of Utah|Robert Stephen, MD|801-587-7653|rlstephen@comcast.net|
20190387|NCT03745651|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20190388|NCT04175834|Providence Health & Services|Chiayi Chen, Director of WC/PBSI Clinical Research Program|503-216-1012|Chiayi.Chen@providence.org|
20190389|NCT01322347|Rockwell Medical|Senior Director, Clinical Research & Development|248-960-9009|rd@rockwellmed.com|
20190390|NCT04883541|Üsküdar Üniversitesi|Assistant Professor Tuğba YILMAZ ESENCAN|+905057084946|tugba.yilmazesencan@uskudar.edu.tr|
20190391|NCT01369147|Emory University|Thomas Ziegler, MD|404-727-7351|tzieg01@emory.edu|
20190392|NCT02823574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.gov|
20190393|NCT00590759|W. L. Gore and Associates, Inc.|Robert Makowsky|6232345784|rmakowsk@wlgore.com|
20190394|NCT01567150|Hollister Incorporated|Director, Global Clinical Affairs|8479183996|ginger.salvadalena@hollister.com|
20190395|NCT03711279|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|+86-18036618962|qianna.zhan@hengrui.com|
20221835|NCT00607321|Medtronic Cardiovascular|K Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20190396|NCT02542696|Sumitomo Pharma America, Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20190397|NCT02410278|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20221836|NCT01891864|Sandoz|Dr Guido Wuerth - Global Program Medical Director|+4980244762925|guido.wuerth@sandoz.com|
20221837|NCT02483676|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Steven Kittner|410-706-0414|skittner@som.umaryland.edu|
20221838|NCT05479435|Istanbul Medipol University|Arzu Abalay|+905075891917|arzuabalay@hotmail.com|
20190398|NCT03693989|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20221839|NCT05081063|Loma Linda University Health|Kaushik Mukherjee|9096515948|kmukherjee@llu.edu|
20221840|NCT00955617|Guerbet|Emilie Huchet|+33 1 45 91 50 00|emilie.huchet@guerbet-group.com|7688
20221841|NCT04199104|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20221842|NCT03796988|University of Miami|Hadar Lev-Tov, Assistant Professor|305-243-4472|hltevtov@med.miami.edu|
20221843|NCT04563754|Baylor College of Medicine|Dr. Sharmila Anandasabapathy|713-798-8105|Sharmila.Anandasabapathy@bcm.edu|
20221844|NCT04023396|Abivax|Associate Director Clinical Operations|+33630031132|laurence.desroys@abivax.com|
20221845|NCT03150329|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
20221846|NCT04075825|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20190399|NCT01190436|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20161977|NCT04897607|Christiana Care Health System|Dr. Scott Siegel|302-623-4500|ssiegel@christianacare.org|
20190400|NCT00113529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20190401|NCT00648895|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
20190402|NCT01077284|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20190403|NCT04626128|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
20190404|NCT00841321|Portland VA Medical Center Multiple Sclerosis Center of Excellence|Dennis Bourdette, MD|503-220-8262|dennis.bourdette@va.gov|54594
20190405|NCT02137603|All Children's Hospital Johns Hopkins Medicine|Dr. Nicole Chandler|727-767-4170|Nicole.Chandler@jhmi.edu|
20190406|NCT02632747|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190407|NCT00379210|University of Pennsylvania|Amishi Jha|215-898-8011|apjha@psych.upenn.edu|
20190408|NCT03444155|Otto Loewi Research Center, Chair of Physiological Medicine, Medical University of Graz, Austria|Dr. Willibald Wonisch|00436505299540|willibald.wonisch@medunigraz.at|
20190409|NCT02574286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20190410|NCT03875729|Sanofi|Clinical and Translational Medicine Lead|1-703-344-2992|laura.knecht@sanofi.com|
20190411|NCT05303324|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20190412|NCT04085614|Philips Medical Systems Nederland B.V.|Peter Eshuis|+31628739280|peter.g.eshuis@philips.com|
20190413|NCT00952523|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
20221847|NCT03220204|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
20221848|NCT02861586|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221849|NCT00728260|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
20221850|NCT04581824|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221851|NCT04796909|The Hong Kong Polytechnic University|Dr. Chi-Wen Chien, Associate Professor|+85227666703|will.chien@polyu.edu.hk|
20221852|NCT04162847|Washington University in St. Louis School of Medicine|Dr. Denise Wilfley|3142862079|wilfleyd@wustl.edu|
20221853|NCT04815083|photonamic GmbH & Co. KG|Vice President Clinical Development & Regulatory Affairs|+49 (0)4101 78539 09|info@photonamic.de|
20221854|NCT01892501|Institute Bergonie|Dr. Dominique Bechade, Coordinating Investigator|0556337805|d.bechade@bordeaux.unicancer.fr|
20221855|NCT03070236|Dana-Farber Cancer Institute (DFCI)|Ann H. Partridge, MD, MPH|617-632-3800|Ann_Partridge@dfci.harvard.edu|
20161978|NCT03781791|Enterin|Richard Larson, MD Chief Medical Officer|505-469-2670|r.larson@enterininc.com|
20161979|NCT00413374|Brigham and Women's Hospital|Research Coordinator|617-732-6984|arao2@partners.org|
20161980|NCT00552760|Lehigh Valley Hospital|Edward R. Norris, MD|(610) 402-5766|Edward.Norris@lvh.com|
20161981|NCT03022981|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20161982|NCT03615066|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20161983|NCT00924404|University of Iowa|Lakshmi Durairaj|319-353-7968|lakshmi-durairaj@uiowa.edu|
20161984|NCT02437084|Stanford University School of Medicine|Dr Joshua W. Knowles, MD, PhD; Assistant Professor, Cardiovascular Medicine|650-723-1431|knowlej@stanford.edu|
20161985|NCT01571453|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20161986|NCT00129961|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20161987|NCT01985360|NYU Langone Health|Sripal Bangalore|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
20161988|NCT00721175|Khon Kaen University|Assist. Prof. Apichat Sangchan|66850004651|apichaz@yahoo.com|
20161989|NCT03294629|Sleep Center, Taoyuan Chang Gung Memorial Hospital|Ning-Hung, Chen|+886-3-3281200|ninghung@yahoo.com.tw|2281
20161990|NCT03691779|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20161991|NCT03897036|Senhwa Biosciences|Jason Huang, MD / Chief Medical Officer and Acting Chief Executive Officer|(858) 552-6808|jasonhuang@senhwabio.com|112
20161992|NCT00721539|Stanford|Edward Damrose, MD, associate professor|650-725-6500|edamrose@stanford.edu|
20161993|NCT00225784|Dartmouth-Hitchcock|J. Marc Pipas, MD|603-650-9474|J.Marc.Pipas@hitchcock.org|
20161994|NCT03869333|PATH|Rahsan Erdem|+1 202 540 4546|rerdem@path.org|
20161995|NCT01459913|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20161996|NCT01915823|Meda Pharmaceuticals|Dr.Nancy Ruiz,MD|7325642390|nancy.ruiz@meda.us|
20161997|NCT01064687|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20161998|NCT02966015|Clinical operations,Medical Affairs|Head of clinical operations|+45 49113267|dkphl@coloplast.com|
20161999|NCT00509171|London Health Sciences Centre|Emil H. Schemitsch, MD, FRCS|5196633349|emil.schemistch@lhsc.on.ca|
20162000|NCT02039856|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|(818) 891-7711|elizabeth.yano@va.gov|36031
20162001|NCT02540291|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20162002|NCT00896441|Stanford University|Mike Greicius|650-723-8331|greicius@stanford.edu|
20162003|NCT01304589|University of Tennessee Health Science Center|Dr. Candace Brown|901-412-4341|csbrown@uthsc.edu|
20162004|NCT01441466|Princess Amlia Children's Clinic, Isala|Jolita Bekhof|+31384245050|j.bekhof@isala.nl|
20162005|NCT02423980|Xeris Pharmaceuticals, Inc.|Martin Cummins, VP Drug Development|512-498-2675|mcummins@xerispharma.com|
20162006|NCT01729494|University of Cincinnati|Rita R. Alloway, Pharm.D., Director of Clinical Trials|513-558-1568|rita.alloway@uc.edu|
20162007|NCT02666105|University of Minnesota|Manish Patel, DO|612-625-2654|patel069@umn.edu|
20176903|NCT00983580|Mayo Clinic|Frank A. Sinicrope, M.D.||sinicrope.frank@mayo.edu|
20221856|NCT01439802|Albert Einstein College of Medicine|Dr. Erika Levi|718-405-8260|elevi@montefiore.org|
20221857|NCT06160609|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221858|NCT03036657|Oregon Health & Science University|Alexandra Dimitrova, PI|503-494-0766|dimitroa@ohsu.edu|
20221859|NCT02383017|Onnit Labs|Vince Kreipke|3176954359|Vkreipke@onnit.com|
20221860|NCT00927589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20221861|NCT02695446|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
20221862|NCT02386319|Herlev Hospital|Dr. Anders Gram-Hanssen|004526225318|anders.gram-hanssen@regionh.dk|
20221863|NCT01651117|Corporal Michael J. Crescenz VA Medical Center|Judith A. Long, MD|215-898-4311|judith.long@va.gov|
20221864|NCT01342471|National Cancer Institute|Jeremy Steeves Ph.D.|(865)-308-3506|jeremy.steeves@nih.gov|
20221865|NCT02088177|NYSPI|Dr. Frances R. Levin||frl2@cumc.columbia.edu|
20221866|NCT01774760|Turku University Hospital, Turku, Finland|Prof. Heikki Minn|+35823130000|heikki.minn@tyks.fi|30149
20221867|NCT01641640|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20221868|NCT00289848|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20221869|NCT01545648|University of California, San Francisco|Hope Rugo, MD|877-827-3222|cancertrials@ucsf.edu|
20221870|NCT01234350|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20221871|NCT03103438|Biocad|Nadezhda Kravtsova|+7 (812) 380 49 33|kravtsovana@biocad.ru|
20221872|NCT01894919|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20221873|NCT02792517|Amgen Inc.|Study Director|866-572-6436||
20221874|NCT01823861|London School of Hygiene and Tropical Medicine|Dr. Chris Smith|07974562199|christopher.smith@lshtm.ac.uk|
20221875|NCT02570308|Immunocore, Ltd|Nicola McKelvie|484-534-5261|nicola.mckelvie@immunocore.com|
20221876|NCT02069015|Wayne State University|Julie Gleason-Comstock|313-577-6681|jgleason@med.wayne.edu|
20221877|NCT02182492|Department of ENT of Tongji Hospital Tongji Medical College Huazhong University of Science and Technology|Dr. Zheng Liu|86 027 83663807|zhengliuent@hotmail.com|
20221878|NCT03335475|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
20221879|NCT02411656|The University of Texas MD Anderson Cancer Center|Bora Lim, MD|(713) 745-0689|blim@mdanderson.org|
20221880|NCT06481709|APR Applied Pharma Research s.a.|Giorgio Reiner Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
20221881|NCT05921903|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20221882|NCT03305848|Regions Hospital|Benjamin A Willenbring, MD|651-254-3563|benjamin.a.willenbring@healthpartners.com|
20221883|NCT00789854|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20221884|NCT05365451|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
20221885|NCT02224157|AstraZeneca AB|Stefan Ivanov|000000000|information.center@astrazeneca.com|
20221886|NCT05906628|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20221887|NCT06811155|hospital universitario virgen de la victoria|eva cabrera cesar|646905201|evacabreracesar@gmail.com|
20221888|NCT01320293|University of North Carolina|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
20221889|NCT00470470|Memorial Sloan-Kettering Cancer Center|Dr. Richard Carvajal|646-888-4161|carvajar@mskcc.org|
20221890|NCT01532934|University of Rochester|Marc T. Swogger, Ph.D.|585-275-7418|marc_swogger@urmc.rochester.edu|
20221891|NCT03483012|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20221892|NCT00793455|Northwestern University|Kenzie A. Cameron, PhD, MPH|312-503-3910|k-cameron@northwestern.edu|
20221893|NCT02574598|Instituto Nacional de Cancerología|Dr. Oscar Arrieta|(52) 55-5628-0400|ogar@unam.mx|71101
20221894|NCT01597778|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20221895|NCT02749617|Hematology Research Program (HRP)|Director of HRP|6048754111|alee14@bccancer.bc.ca|22958
20221896|NCT04910100|BLP Management Group LLC|Barry Butler|813-766-9539|bbutler@blpmgmt.com|
20221897|NCT02329015|Long Island University|Marshall Hagins PhD, PT|3478048512|mhagins@liu.edu|
20221898|NCT04740918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20221899|NCT01710787|Jean Brown Research|Adam D. Marberger, DDS|801-261-2000||
20221900|NCT01941615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
20221901|NCT04314037|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20221902|NCT00273182|Medtronic, Inc.|InSync Registry Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
20221903|NCT02490631|Vanderbilt University Medical Center|Elizabeth Card|615-875-4611|elizabeth.b.card@vumc.org|
20221904|NCT00856492|SWOG Statistical Center|Breast Committee Statistician|206-667-4623||
20176904|NCT00433992|Case Western Reserve University|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
20176905|NCT01603875|Queen Saovabha Memorial Institute|Dr. Terapong Tantawichien|66225201614|terapong_tantawichien@hotmail.com|125
20176906|NCT04737538|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20176907|NCT01652716|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
20176908|NCT03735862|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
20176909|NCT01514318|DJO Surgical|Dr. Jane M. Jacob|512-834-6323|jane.jacob@djoglobal.com|
20176910|NCT01337297|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
20176911|NCT02778204|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20221905|NCT03832686|Stanford University|Heather Starmer, MD|650-529-5903|hstarmer@stanford.edu|
20221906|NCT03323398|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20221907|NCT02235454|Duke University|Sanjay Asrani|919-684-8656|sanjay.asrani@duke.edu|
20176912|NCT04122443|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20206314|NCT00612339|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
20176913|NCT01072201|Colgate Palmolive Co|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
20176914|NCT00360334|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20176915|NCT01916304|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20176916|NCT01898793|Washington University School of Medicine|Amanda Cashen, M.D.|314-434-8323|acashen@wustl.edu|
20176917|NCT04666441|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20176918|NCT03390907|Penn State Milton S. Hershey Medical Center|Dr. John Levenick|717-531-3834|jlevenick@pennstatehealth.psu.edu|
20176919|NCT01578551|Johns Hopkins University|David Ettinger, MD|410-955-8847|ettinda@Jhmi.edu|
20176920|NCT02780349|Gardia Medical|Vardit Segal Ph.D|972-4-6277166|vardit@gardiamedical.com|
20176921|NCT04028388|Modra Pharmaceuticals|M. Keessen|+31202050188|info@modrapharmaceuticals.com|
20176922|NCT02584309|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
20176923|NCT02841644|Atrium Health|Vice Chair of Research|7043552000|Rachel.Seymour@atriumhealth.org|
20176924|NCT02430077|UT Southwestern Medical Center|Abhimanyu Garg|2146482895|Abhimanyu.garg@utsouthwestern.edu|
20176925|NCT00818441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176926|NCT02199691|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext 1#|Contact-US@sanofi.com|
20176927|NCT02969928|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
20176928|NCT04286594|McLean Hospital|Dr. Staci Gruber|617-855-2762|gruber@mclean.harvard.edu|
20176929|NCT01736566|Brigham and Women's Hospital|Carrie Blout, Genetic Counselor Project Manager|617-264-5837|carrie.blout@gmail.com|
20176930|NCT01209624|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20176931|NCT03403634|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@Roswellpark.org|
20176932|NCT03964454|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
20176933|NCT05955560|Becton, Dickinson & Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
20176934|NCT01539291|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20176935|NCT04450264|Icahn School of Medicine at Mount Sinai|Dr. Jamilia Sly|212-824-7813|jamilia.sly@mssm.edu|
20176936|NCT00822510|University of Arizona College of Nursing|Terry Badger, PhD, PMHCNS-BC, FAAN|520-626-6058|tbadger@email.arizona.edu|
20176937|NCT03985423|Sobi|Radmila Kanceva, MD|+4686972000|radmila.kanceva@sobi.com|
20176938|NCT01045447|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20176939|NCT03320070|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medInfo@mnk.com|
20176940|NCT00272168|VA Central Office|Wendy Tenhula, Ph.D.|202-461-4167|Wendy.Tenhula@va.gov|
20176941|NCT01075321|Mayo Clinic|Craig B. Reeder MD|480.301.8000|Reeder.Craig@mayo.edu|
20176942|NCT01800877|Centre de Recherche du CHUS|Marie-Hélène Masse|819-346-1110|marie-helene.masse3@usherbrooke.ca|14173
20176943|NCT00003457|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20176944|NCT02246998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20176945|NCT02473614|University of California at Irvine|Dr. Kelli Sharp|9495107968|ksharp@uci.edu|
20176946|NCT01075074|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
20176947|NCT02416791|Neurostimulation Laboratory, Hospital das Clínicas/São Paulo University, Brazil|Professor Adriana Bastos Conforto|+55 11 2661-7955|adriana.conforto@hc.fm.usp.br|
20176948|NCT00562159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20176949|NCT01992536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20176950|NCT03669081|University of Utah|Eryberto Martinez|801-581-2563|eddie.martinez@utah.edu|
20176951|NCT00389324|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
20176952|NCT02519504|Emory University|Judith Fridovich-Keil, PhD|404-727-3924|jfridov@emory.edu|
20176953|NCT03936244|Hospital Universitario Fuenlabrada|Dr. Hugo Otaola Arca|+56 9 4108 9452|hugotaolarca@hotmail.com|
20176954|NCT03551938|University of Michigan|Dr. Rob Stephenson|734-763-1188|rbsteph@med.umich.edu|
20176955|NCT01925183|Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna|Markus Peck-Radosavljevic (Principal Investigator)|+43 1 40400|markus.peck@meduniwien.ac.at|47440
20176956|NCT01114646|Hartford Hostpial|Arben Ademi, CCRP|860-972-3561|arben.ademi@hhcealth.org|
20176957|NCT01046110|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20176958|NCT00905580|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
20176959|NCT01233817|Department of Physical Medicine and Rehabilitation, School of Medicine, University of Utah|Aga Lewelt MD, Principal Investigator|801-518-4572|aga@genetics.utah.edu|
20206315|NCT03750240|NYU Langone Health|Guillaume Madelin, PhD|(212) 263-3343|guillaume.madelin@nyulangone.org|
20206316|NCT03706040|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20206317|NCT00927758|Sandoz|Study Director|609-627-8889|yaping.zhu@sandoz.com|
20206318|NCT03125018|Masimo|Tala Harake||studies@masimo.com|
20206319|NCT00439725|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20206320|NCT01544478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206321|NCT03030183|Ra Pharmaceutical, Inc|Sponsor Ra Pharmaceutical, Inc|1 617 401 4060|trials@rapharma.com|
20206322|NCT00212758|Oregon Health & Science University|Dr. Amira Al-Uzri|503-494-7327|aluzria@ohsu.edu|
20176960|NCT01202773|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221908|NCT03641469|Green Sun Medical|James A. Arthur|720-202-3621|jarthur@greensunmedical.com|
20221909|NCT01618344|Hunstman Cancer Institute|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
20221910|NCT04692103|UWashington|Hannah Linden, MD|206-606-2053|hmlinden@uw.edu|
20176961|NCT01430130|Neodyne Biosciences|Kristin Prosak|650-543-7129|kprosak@neodynebio.com|126
20176962|NCT03525834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20176963|NCT02703844|University of Kent|David Wilkinson|+44 (0)1227 824772|d.t.wilkinson@kent.ac.uk|
20176964|NCT00801684|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
20176965|NCT01184014|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
20176966|NCT00614939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20176967|NCT00840970|Intersect ENT|Chris Lewis, VP Clinical Affairs|423-598-6681|clewis@intersectent.com|
20176968|NCT03465540|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20176969|NCT00504829|Life Cycle Pharma|H. Eugene Griffin, MS, DVM|646-200-8505|ggr@lcpharma.com|
20176970|NCT01854827|University of Michigan|DCC PI|734-936-3585|mageej@med.umich.edu|
20176971|NCT04443218|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20176972|NCT02660944|Resolve Therapeutics LLC|James Posada|(208)7277010|jp@resolvebio.com|
20176973|NCT02843568|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
20176974|NCT03586999|University of Colorado|Brad Haverkos, MD|7208488698|brad.haverkos@cuanschutz.edu|
20176975|NCT00088218|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
20176976|NCT01701375|Johns Hopkins University|Ivana Gojo, MD|410-502-7726|Igojo1@jhmi.edu|
20176977|NCT02807597|UT Southwestern Medical Center|Dr. Samuel Achilefu|314-362-8599|Samuel.Achilefu@UTSouthwestern.edu|
20176978|NCT00096941|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20176979|NCT02073968|Montefiore Medical Center / Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
20176980|NCT01645709|CaloSyn Pharma Inc.|Stephen Snowdy, PhD|404-863-8892|ssnowdy@ansleyvc.com|
20176981|NCT01525082|Stanford University|Shaheen Shagufta, Clinical Assistant Professor|650-725-6454|sshaheen@stanford.edu|
20176982|NCT04111497|Fred Hutchinson Cancer Center|Dr. Stephanie Lee|206-667-6190|sjlee@fredhutch.org|
20176983|NCT03880578|Klinikum Lüdenscheid|Professor Rolf Larisch, Director|‭+49 2351 46|rolf.larisch@klinikum-luedenscheid.de|3311
20176984|NCT02255110|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20176985|NCT02328326|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Dr. Ann-Marie Rosland|4123602259|Ann-Marie.rosland@va.gov|
20176986|NCT02209324|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20176987|NCT03105362|Boston Children's Hospital|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
20176988|NCT01785602|Novartis|Study Director|862-778-8300||
20176989|NCT02749903|Memorial Sloan Kettering Cancer Center|Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
20176990|NCT03127228|University of Michigan|Dr. Chin-Wei Wang|734-763-2105|jeffwa@umich.edu|
20176991|NCT02041429|Dana-Farber Cancer Institute|Beth Overmoyer, MD|617.632.380|Beth_Overmoyer@DFCI.HARVARD.EDU|
20176992|NCT03424681|Mind Research Network|Dr. Claire Wilcox|5052725028|cwilcox@mrn.org|
20176993|NCT01175226|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
20176994|NCT05204134|Tandem Diabetes Care|Supervisor Clinical Operations|+18778016901|clinicalaffairs@tandemdiabetes.com|
20176995|NCT00389818|AMC|Ronald Mitsuyasu, MD|310-557-1803|rmitsuya@mednet.ucla.edu|
20176996|NCT01312467|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
20176997|NCT02752048|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3294-4527|toiawase@taiho.co.jp|
20176998|NCT01431508|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20176999|NCT00132769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177000|NCT00129259|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20177001|NCT01092195|National Institutes of Health|Pamela Stratton MD|301-435-4068|strattop@mail.nih.gov|
20177002|NCT01609556|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20177003|NCT00139997|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
20177004|NCT02788175|NIAID|Dr. Michael C. Sneller|301-496-0491|MSNELLER@niaid.nih.gov|
20177005|NCT00162136|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20177006|NCT00774995|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177007|NCT03117387|LUMC|Maarten Honing|+31715264038|g.h.m.honing@lumc.nl|
20177008|NCT00428610|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177009|NCT01543256|Boston Scientific|Evelyne Ho|+1 508-683-4140|Evelyne.Ho@bsci.com|
20177010|NCT00262834|SKCCC|Vered Stearns|4432876489|vstearn1@jhmi.edu|
20177011|NCT01054729|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20177012|NCT00659165|Univ NM|Mark Burge|505-272-4658|mburge@salud.unm.edu|
20177013|NCT01790750|University of Florida|Curt DeGroff|(352) 273-7831|degroffc@peds.ufl.edu|
20177014|NCT02352493|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|Clinicaltrials@alnylam.com|
20177015|NCT02162810|UPMC Children's Hospital of Pittsburgh|Karen Kenyon, research coordinator|4126923058|kenyonkl@upmc.edu|
20177016|NCT00706121|SWOG Statistical Center|SELECT/S0000D Statistician|206-667-4623||
20177017|NCT02546544|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
20221911|NCT03879135|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20177018|NCT01921348|University of MS Medical Center|Gailen D. Marshall, Jr., MD, PhD, Director, Division of Clinical Immunology and Allergy|6018155527|gmarshall@umc.edu|
20177019|NCT02223390|Duke University (Currently at Columbia University)|Kathleen Sikkema, PhD|212-305-8236|ks3364@cumc.columbia.edu|
20177020|NCT01465334|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
20177021|NCT01994486|UNIVERSITY OF FLORIDA|Giuseppe (Joseph) Morelli, MD|352-273-9467|GIUSEPPE.MORELLI@MEDICINE.UFL.EDU|
20177022|NCT03963895|Aronora, Inc.|Norah Verbout, Ph.D.|503-964-0250|norah.verbout@aronorabio.com|
20177023|NCT00795600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20177024|NCT04729803|palo alto university|Dr. Mikael Rubin|650-433-3805|mrubin@paloaltou.edu|
20177025|NCT05734846|CooperVision Inc.|Percy Lazon de la Jara BOptom PhD|+1-925-251-6682|PLazon@coopervision.com|
20221912|NCT03985800|Department of Psychiatry, University of Pittsburgh|Eva Szigethy, Co-Principal Investigator, Adjunct Professor of Psychiatry, Staff Psychiatrist|412-667-0416|szigethye@upmc.edu|
20177026|NCT01248884|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221913|NCT05277922|Vicore Pharma AB|Cecilia Ganslandt|+46 705 797075|info@vicorepharma.com|
20221914|NCT06025721|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
20162008|NCT02885246|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
20162009|NCT02806960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20162010|NCT01769196|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20162011|NCT00126776|Minneapolis VAMC|Kathryn Rice MD|612 725 2000|kathryn.rice@va.gov|4400
20221915|NCT04173507|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20162012|NCT03603106|Guerbet|Jing Hao, MD|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20162013|NCT01272869|Coloplast A/S|Director Medical Affairs|4549111111|dkbir@coloplast.com|
20162014|NCT00771615|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162015|NCT02455076|Emory University|Guillermo Umpierrez|(404)778-1665|geumpie@emory.edu|
20162016|NCT00859937|University of Chicago Comprehensive Cancer Center|Dr. Stuart Wong|773-702-9311|swong@mcw.edu|
20162017|NCT03908476|Abbott|Marie Fahey|+15122864398|Marie.fahey@abbott.com|
20162018|NCT05194267|UCSD|Jean-Phillipe Miron|514-890-8000|jmiron@health.ucsd.edu|26489
20221916|NCT02832687|CHRISTUS St. Vincent Regional Medical Center|Dr. Michal Gajewski, DO|(505) 913-3361|Michal.Gajewski@stvin.org|
20162019|NCT02868229|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20162020|NCT00687102|Wake Forest University Health Sciences|Sally A. Shumaker, PhD|336-71696934|sshumake@wakehealth.edu|
20162021|NCT02540668|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20162022|NCT03270891|University of Michigan|Laurie Buis|734-998-5694|buisl@med.umich.edu|
20162023|NCT05779007|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20162024|NCT06225466|University of Texas Southwestern Medical Center|Dr. Proshad Efune|2144566393|proshad.efune@utsouthwestern.edu|
20162025|NCT05147662|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20162026|NCT04394715|Yale University|Nihar Desai|203-767-6399|nihar.desai@yale.edu|
20162027|NCT04676867|DalCor Pharmaceuticals|David Kallend|+1 514-508-5099|dkallend@dalcorpharma.com|
20162028|NCT00549770|Novartis Pharmaceuticals|Study Director|862-778-8300||
20162029|NCT02294734|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162030|NCT00548717|Dana Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|Corey_Cutler@dfci.harvard.edu|
20162031|NCT05375214|Johns Hopkins University|Kevin Li|443-475-0671|kevinli@jhmi.edu|
20162032|NCT00908037|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162033|NCT04596085|Natural Supplements LLC|Dr. Mahir Abduldaim|+966557880299|maherdaim@yahoo.com|
20162034|NCT00025155|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20162035|NCT05086510|AinShamsU|Dr. Mohammad Gamal|2001114115331|mdgamal92@gmail.com|
20162036|NCT01944345|Wenzel Spine, Inc.|Director, Quality & Regulatory Affairs|5123148271|bnowatzke@wenzelspine.com|
20162037|NCT04079881|Wash Univ School of Medicine|Janet McGill, MD|(314) 362-8681|jmcgill@wustl.edu|
20162038|NCT03945019|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
20162039|NCT01462877|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20162040|NCT01407523|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20162041|NCT00141115|New York State Psychiatric Institute|John J. Mariani|2125435987|jm2330@columbia.edu|
20177027|NCT02334800|Pfizer Inc.|Pfizer ClinicalTrail.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177028|NCT00575588|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20177029|NCT00736996|University of Colorado|Robert S. Schwartz, M.D.|303-724-1919|robert.schwartz@ucdenver.edu|
20177030|NCT02667912|Tomsk National Research Medical Center of the Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
20177031|NCT01984398|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20177032|NCT03834194|University of Virginia, School of Medicine|Dr. Rebecca Krukowski|9014482426|wae4mq@virginia.edu|
20177033|NCT01343407|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177034|NCT04079933|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20190414|NCT01029925|University of California Los Angeles Jonsson Comprehensive Cancer Center|Edward Garon, MD|310 586 2098|egaron@mednet.ucla.edu|
20162042|NCT00084487|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
20162043|NCT01561963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20162044|NCT04598269|Aclaris Therapeutics, Inc.|Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20177035|NCT02187016|Silverstone Research Group|Pejjmon Amini, DMD|702-901-444||
20177036|NCT01986829|Washington University School of Medicine|Brian Van Tine, M.D.|314-362-5817|bvantine@wustl.edu|
20177037|NCT02504866|Clinical Center|Damiano, Diane|+1 301 451 7544|damianod@cc.nih.gov|
20177038|NCT01229436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177039|NCT01775137|Novartis Pharmaceuticals|Study Director|862-778-8300||
20177040|NCT02059148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177041|NCT03231371|University of Michigan|Bryan Goldstein||Bryan.Goldstein@cchmc.org|
20177042|NCT03054844|Columbia University|Dr. Daniel Tsze|212-305-9825|dst2141@columbia.edu|
20177043|NCT00437489|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20177044|NCT01286818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177045|NCT03321981|Merus N.V.|Executive Director Clinical Trials|+16174014499|USenquiries@merus.nl|
20177046|NCT00877448|BiondVax Pharmaceuticals Ltd.|Tamar Ben-Yedidia, PhD|972-8-9302529|benyedidia@BiondVax.com|
20177047|NCT01385059|City of Hope Medical Center|Dr. Sumanta Kumar Pal|626-359-8111|SPal@coh.org|
20177048|NCT00022516|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
20177049|NCT04689737|Fundació de Lluita contra la SIDA, les Malalties Infeccioses i la Promoció de la Salut i La Ciència|Dr. Jose Molto Marhuenda|+34 934657897|jmolto@lluita.org|
20177050|NCT03321019|University of Florida|Dr. Karen Hegland|3522948366|kwheeler@ufl.edu|
20177051|NCT04934670|Xenikos BV (no longer in business)|Ypke van Oosterhout, custodian of Sponsor|+31 611 0177 611|ypke@me.com|
20177052|NCT03895853|UT MD Anderson Cancer Center|Joseph L. Nates, Professor, Critical Care& RespiratoryCare|(713) 792-5040|jlnates@mdanderson.org|
20177053|NCT03067441|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20177054|NCT01592708|UNC Chapel Hill|Dr. Jay Anderson, PI|919-966-5136|janderson@aims.unc.edu|
20177055|NCT02921412|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|JVega2@coopervision.com|
20177056|NCT01528228|A.T. Still University|Corey Luebbering|660.626.2147|coreyluebbering@atsu.edu|
20177057|NCT02056301|Baylor College of Medicine|Chris Glover, MD, MBA|832-824-5800|cdglover@bcm.edu|
20177058|NCT03452917|University of Washington|Francis Kim|206-897-5264|fkim@u.washington.edu|
20177059|NCT01194674|National Institutes of Health|H. Nida Sen, Principal Investigator, National Eye Institute|301-402-3254|senh@nei.nih.gov|
20177060|NCT03433456|University of Alabama at Birmingham|Dr. Gareth Dutton|205.934.6876|gdutton@uabmc.edu|
20177061|NCT01242527|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20177062|NCT03373591|Montefiore Medical Center|Diego Camacho, MD|718-920-4800|dicamach@montefiore.org|
20177063|NCT01198600|Alcon Research|R. Alan Landers, O.D., M.S., F.A.A.O.|1-800-241-7629||
20177064|NCT04177108|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20177065|NCT01427712|Medical affairs|Medical affairs manager|+81-3-5656-0516|takumi.kanzo@viatris.com|
20177066|NCT00784043|MED-EL Corporation|Jennifer Bulls|1-888-633-3524|research.us@medel.com|
20177067|NCT01143259|Intermountain Healthcare|Matthew Peters RN MS|801-442-3703|matthew.peters@imail.org|
20177068|NCT00099983|VA Connecticut HCS|John Krystal, MD|203-937-4790|john.krystal@yale.edu|
20177069|NCT02641080|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
20177070|NCT00803634|The Medicines Company|Jason Campagna|973-290-6199|jason.campagna@themedco.com|
20177071|NCT04307186|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20177072|NCT02854540|Stanford School of Medicine|Dr. Marlyanne Pol-Rodriguez|650-721-7144|mpr@stanford.edu|
20157553|NCT01832727|Amgen, Inc|Study Director|866-572-6436|medinfo@amgen.com|
20177073|NCT03835533|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20190415|NCT05265247|HALEON|Haleon Response Center|+4407880182593|ww.clinical-trial-register@haleon.com|
20157554|NCT02348203|University of Arizona|Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
20157555|NCT02633735|HealthPartners Institute|Elyse Kharbanda|952-967-5038|elyse.o.kharbanda@healthpartners.com|
20157556|NCT04436744|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157557|NCT01133847|University of Texas Health Science Center Houston|Dr. Carolyn Denton|713-500-3891|carolyn.a.denton@uth.tmc.edu|
20157558|NCT01120405|Population Health Research Institute - Mc Master University, Hamilton CANADA|Yannick LE MANACH, MD, PhD|0012892606840|Yannick.Lemanach@phri.ca|
20157559|NCT02961244|Dokuz Eylul University Medicine Faculty, General Surgery Department|Ali Kadir Degirmenci|+902324122901|alikadir@hotmail.com|
20157560|NCT03789292|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
20157561|NCT00967616|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20157562|NCT01696643|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
20157563|NCT00575666|UMass Medical School|Xiaoduo Fan, MD, MPH, MS|508-856-3881|Xiaoduo.Fan@umassmed.edu|
20157564|NCT00508482|Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences|Dr. Zhishun Liu|0086-010-88001124|liuzhishun@aliyun.com|
20157565|NCT01227057|VASDHS|Catherine Ayers|8585528585|catherine.ayers1@va.gov|2976
20157566|NCT01205503|Markey Cancer Center Biostatistics Shared Resource Facility|Emily Dressler, PhD|859 323-3076|emilydressler@uky.edu|
20157567|NCT02742129|Duke Clinical Research Institute|Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
20157568|NCT02850978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157569|NCT00570713|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
20157570|NCT04016714|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157571|NCT03722810|BIHAM, University of Bern|Prof. Michael Harris|+44 1761 241366|michael.harris@biham.unibe.ch|
20221917|NCT00210210|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials' Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20221918|NCT04231825|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
20221919|NCT01662635|Thoracic Oncology Unit. Instituto Nacional de Cancerología|Oscar Gerardo Arrieta-Rodríguez|+52 55 56280400|ogar@unam.mx|832
20221920|NCT03861390|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
20221921|NCT03428152|Derince Training and Research Hospital|Dr|+905336515650|handegrbz@gmail.com|
20221922|NCT00754130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221923|NCT01836471|Novaratis Pharmaceuticals|Study Director|862-778-8300||
20221924|NCT05506046|Georgia State University|Lyudmila Popova|404-413-9338|lpopova1@gsu.edu|
20221925|NCT00191477|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20221926|NCT02479451|Mass General Hospital|Sagar Nigwekar|5857298636|sagarnigs@gmail.com|
20221927|NCT00381862|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
20221928|NCT01275365|Brigham and Women's Hospital|Shalendar Bhasin, MD|617-525-9040|Sbhasin@partners.org|
20221929|NCT03776357|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
20221930|NCT01169064|Vanderbilt University Medical Ctr., Dept OB/GYN|Dr. Kelly Bennett; Director of Maternal Fetal Medicine|6153436275|kelly.a.bennett@vanderbilt.edu|
20162045|NCT03040986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
20162046|NCT02177838|Rutgers Cancer Institute of New Jersey|Sung Kim, MD|732-235-3986|sk1375@cinj.rutgers.edu|
20162047|NCT00803062|NRG Oncology Statistics and Data Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20162048|NCT00737633|Vivus, Inc|Wesley W Day, PhD|650-934-5200|day@vivus.com|
20162049|NCT00377364|UT Southwetern Medical Center at Dallas|E.Sherwood Brown, M.D., Ph.D.|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
20162050|NCT02925728|Centre Hospitalier Départemental Vendée|Sylvie VERBRUGGHE|0251446161|sylvie.verbrugghe@ght85.fr|
20162051|NCT03101085|University of Kansas Medical Center|Dr. Russell Swerdlow|913-588-0970|rswerdlow@kumc.edu|
20162052|NCT00955513|Novartis Consumer Health|Clinical Project Leader Pain category|+41223635528||
20162053|NCT00695864|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
20162054|NCT01879072|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20162055|NCT02108691|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
20162056|NCT01776723|H Lee Moffitt Cancer Center & Research Institute|Eric Padron, MD|813-745-3907|Eric.Padron@Moffitt.org|
20162057|NCT00626405|Mayo Clinic|Svetomir Markovic, M.D., Ph.D.|5072840527|markovic.svetomir@mayo.edu|
20162058|NCT02147769|Stanford University|Valerie Chock, MD|650-723-5711|vchock@stanford.edu|
20162059|NCT05498467|Department of Dermatology and Allergy - Herlev-Gentofte Hospital|Kelvin Yeung|38673243|kelvin.yeung@sund.ku.dk|0045
20162060|NCT01264419|Silk Road Medical, Inc.|Richard Ruedy, Exec VP Clinical Affairs|408-828-7281|ric@silkroadmed.com|
20162061|NCT02100475|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20162062|NCT00119366|Fred Hutchinson Cancer Research Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
20162063|NCT02692755|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
20162064|NCT00527982|UT MD Anderson Cancer Center|Waun K. Hong, MD/Professor||CR_Study_Registration@mdanderson.org|
20162065|NCT01939366|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20162066|NCT00680797|VA Greater Los Angeles|Dr. Cathy Lee|310-478-3711|cathy.lee2@va.gov|42627
20162067|NCT04680975|Sanofi (Kadmon, a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20162068|NCT03909152|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
20162069|NCT05346653|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
20162070|NCT04541628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20162071|NCT02781480|MeiraGTx|Chief Medical Officer|+1 973 609-2156|robert.zeldin@meiragtx.com|
20162072|NCT03950492|WVU Rockefeller Neuroscience Institute|James Mahoney, PhD|304-293-5323|james.mahoney@hsc.wvu.edu|
20162073|NCT01192412|St. George's, University of London|Dr. Laura A. Magee|+442086729944|LMagee@sgul.ac.uk|52621
20162074|NCT00151476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20162075|NCT00383942|Loyola University|Scott Graziano, M.D.|708-216-6288|sgrazia@lumc.edu|
20162076|NCT03433417|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
20162077|NCT02917733|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162078|NCT04099511|University of Missouri|Dr. Gregory Petroski|(573) 884-2119|petroskig@health.missouri.edu|
20162079|NCT00687674|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20162080|NCT06151288|Vaxcyte, Inc.|Study Director: Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
20162081|NCT00759408|Brigham and Women's Hospital|Anju Nohria, MD|617-525-6852|ANOHRIA@PARTNERS.ORG|
20162082|NCT01240200|Emory University School of Medicine|Christopher Newton, MD|404-355-4393|cnewton@atlantadiabetes.com|
20162083|NCT06328660|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
20162084|NCT03194438|State University of New York at Buffalo School of Nursing|Tania Von Visger, APRN, PhD, PCCN|7168292201|Taniavon@buffalo.edu|
20162085|NCT02708485|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
20162086|NCT02387294|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
20162087|NCT00997620|Westernsky|Lyndon E Mansfield, MD|915-544-2557|immunman@westernskymed.com|
20221931|NCT01286467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177074|NCT03238001|Digital Cognition Technologies|SVP, Clinical Affairs|6174331777|aholway@digitalcogtech.com|
20177075|NCT03115424|Mayo Clinic|Adrian Vella, M.D.|507-266-1387|vella.adrian@mayo.edu|
20177076|NCT03791398|BrUOG|Brown University Oncology Research Group|401-863-3000|BrUOG@Brown.edu|
20177077|NCT03176693|University of California Los Angeles|Masha Livhits, MD|310-206-0585|mlivhits@mednet.ucla.edu|
20177078|NCT02207829|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177079|NCT00766376|Palomar Medical Technologies, Inc.|Director of Regulatory Affairs|781-993-2414|stimberlake@palomarmedical.com|
20177080|NCT01418209|Brigham and Women's Hospital|Hadine Joffe, MD, MSc|617-732-4906|hjoffe@partners.org|
20177081|NCT00101101|H. Lee Moffitt Cancer Center and Research Institute|Sophie Dessureault, M.D., Ph.D.|813-745-1965|sophie.dessureault@moffitt.org|
20177082|NCT01800903|Coloplast A/S|Trine Møller Senior Clinical Manager|+45 4911 2174|dktrm@coloplast.com|
20177083|NCT01976416|Indiana University|Dr Chandy John|317-274-8940|chjohn@iu.edu|
20177084|NCT01110239|University Miami|Sebastian Koch|305 243-6733|skoch@med.miami.edu|
20177085|NCT00080223|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20177086|NCT01127438|Eisai Call Center|Eisai Inc.|888-422-4743||
20177087|NCT04452344|Rutgers University School of Dental Medicine|Cecile A. Feldman, DMD|973-972-4634|feldman@rutgers.edu|
20177088|NCT02939105|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20177089|NCT04292301|SpinTech MRI|Rana El Hachem|2487126789|rana@spintechmri.com|
20177090|NCT01751022|Medtronic|Shelby Li|+17635262704|shelby.li@medtronic.com|
20177091|NCT01968434|Clalit HS|Prof. Herman Avner Cohen|00972 3-939-8203|hermanc@clalit.org.il|
20177092|NCT03154710|Weprom|Dr Katell LE DU|241682940|k.ledu@cjb72.org|0033
20177093|NCT02180646|University of Missouri|Dr Jill Kanaley|573-882-2519|kanaleyj@missouri.edu|
20177094|NCT03082963|University of Miami|Dr Jeffrey Goldberger|305-243-4356|j-goldberger@miami.edu|
20177095|NCT01438411|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
20177096|NCT02212028|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20177097|NCT02280044|Johns Hopkins Bloomberg School of Public Health|David A Sack|443 287 8795|dsack1@jhu.edu|
20177098|NCT02105116|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20177099|NCT04837482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20177100|NCT01175382|University of Alabama at Birmingham|Dr. Kathryn Burgio|205-558-7064|kburgio@uabmc.edu|
20177101|NCT00844194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177102|NCT02377986|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
20177103|NCT03017508|Yale University|Angeli Landeros|203-737-4809|angeli.landeros@yale.edu|
20177104|NCT03907501|UCSD School of Medicine|Dr. Christine Tara Peterson|7033959377|chpeterson@health.ucsd.edu|
20177105|NCT01659021|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20177106|NCT01381172|Impulse Dynamics (USA) Inc|Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
20177107|NCT01751568|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 544-7040|mallen@fhi360.org|11246
20177108|NCT03447769|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20177109|NCT00797667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177110|NCT02673697|Corcym|Elisa Cerutti|+39 3459182413|elisa.cerutti@corcym.com|
20177111|NCT00583492|Henry Ford Health System|Benjamin Movsas|313-516-2319|bmovsas1@hfhs.org|
20221932|NCT01058642|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20177112|NCT01351740|British Columbia Centre for Excellence in HIV/AIDS|Dr Marianne Harris|1-604-806-8771|mharris@cfenet.ubc.ca|
20177113|NCT03259035|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
20177114|NCT03473886|Massachusetts General Hospital|Rachel A. Millstein|617-724-2047|RAMILLSTEIN@mgh.harvard.edu|
20177115|NCT00817089|UPENN|David Oslin|215 823 5894|oslin@upenn.edu|
20177116|NCT03783923|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20177117|NCT00723177|NYSPI/Columbia University|Sandra Comer PhD|646 774-6146|SDC10@columbia.edu|
20177118|NCT02291718|Duke University Medical Center|Dr. Lynne Koweek|919-684-8111|lynne.koweek@duke.edu|
20177119|NCT00823082|GrifolsTherapeutics Inc.|Michael Ken Woodward, BSc, M.Sc|+1 919-316-6675|michael.woodward@grifols.com|
20177120|NCT01767116|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20177121|NCT02096055|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
20177122|NCT05799495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20177123|NCT03694548|Emory University|Dr. Nitya Bakshi|404-727-3149|nitya.bakshi@emory.edu|
20177124|NCT00305058|Montefiore Medical Center|Andrew Chang, MD|718-920-6626|achang3@yahoo.com|
20177125|NCT04102501|Retrotope|Mark G. Midei, MD, VP Medical Affairs|4103715357|mark@retrotope.com|
20177126|NCT02338362|Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada|Dr. Graham Trope|1-416-603-5117|graham.trope@uhn.ca|
20221933|NCT01833481|University of Tennessee|Dr. Richard D. Komistek|8659742093|rkomiste@utk.edu|
20177127|NCT01669343|Princess Margaret Hospital|Dr. David Cescon|416-946-2000|dave.cescon@uhn.on.ca|
20177128|NCT00439777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20177129|NCT00661492|US Oncology|Dr. Mark T. Fleming|757-827-9400|Mark.Fleming@USONCOLOGY.COM|
20177130|NCT01024387|Dana-Farber Cancer Institute|Matthew H. Kulke, MD|617.632.5136|Matthew_Kulke@dfci.harvard.edu|
20190416|NCT02399449|University of Maryland Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
20177131|NCT03855189|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177132|NCT06281548|University of North Carolina-Chapel Hill|Adams Sibley|423-227-9198|asibley@live.unc.edu|
20177133|NCT00586105|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20177134|NCT00754845|Canadian Cancer Trials Group|Senior Biostatistician|6135336430|dtu@ctg.queensu.ca|
20177135|NCT00503685|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177136|NCT03099382|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Shiwei Sun; Project Manager|+86-18036618554|shiwei.sun@hengrui.com|
20221934|NCT00423878|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
20221935|NCT01060072|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20221936|NCT01416636|SciPharm SàRL|Bianca Tan||b.tan@scipharm.eu|
20221937|NCT01147068|Protein Sciences Corporation|Dr. Ruvim Izikson, M.D.|203-599-6064|rizikson@proteinsciences.com|163
20221938|NCT03181633|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20221939|NCT02641093|University of Cincinnati|Trisha Wise-Draper, MD, PhD|513 558 2826|wiseth@ucmail.uc.edu|
20221940|NCT02755285|Fujifilm Medical Systems USA, Inc.|Randy Vader|(360) 356-6821|randy.vader@fujifilm.com|
20221941|NCT00699998|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20221942|NCT01406574|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
20221943|NCT03093701|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
20221944|NCT00946920|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20221945|NCT03482973|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|0706
20221946|NCT04616612|Indiana University|Dr. Rebecca Bartlett Ellis|3172740047|rjbartle@iu.edu|
20221947|NCT01451463|The Ohio State University|Sandra K Kostyk, MD, PhD|6142934969|sandra.kostyk@osumc.edu|
20221948|NCT00524940|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
20162088|NCT01554514|Washington University|Dr. Elaine Majerus|314-362-8866|emajerus@wustl.edu|
20162089|NCT01423916|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20162090|NCT02903394|Duke University|Kengyeh Chu|919-681-2093|ken.chu@duke.edu|
20162091|NCT03157583|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20162092|NCT01395277|University of Texas at Austin|Dr. R. Matthew Brothers|512-232-6016|r.m.brothers@austin.utexas.edu|
20162093|NCT03096873|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20162094|NCT05236712|Univcersity of Washington|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
20162095|NCT00628147|SF VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
20162096|NCT02636712|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
20162097|NCT01581619|Massachusetts General Hospital|Alphonse Taghian, MD, PhD|617-726-7559|ATAGHIAN@mgh.harvard.edu|
20162098|NCT00290498|U.T. MD Anderson Cancer Center|Dr. Luis E. Fayad / Lymphoma/Myeloma|7137922860|lefayad@mdanderson.org|
20162099|NCT04122170|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
20162100|NCT02250664|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
20162101|NCT03957876|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD, MPH|216-444-0506|mukhers2@ccf.org|
20162102|NCT03847909|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20162103|NCT04268173|University of Wisconsin-Madison|Dr. Ryan Westergaard|(608) 265-7927|rpw@medicine.wisc.edu|
20162104|NCT00869401|Mayo Clinic|Nadia Laack M.D.|5072844561|laack.nadia@mayo.edu|
20162105|NCT01147900|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162106|NCT00975143|Cipher Pharmaceuticals Inc.|Julia Chan, RAC|905-602-5840|jchan@cipherpharma.com|326
20162107|NCT01375608|NIH, NHLBI, MCHB|Dr Matthew Hsieh|301-402-7687|matthewhs@nhlbi.nih.gov|
20162108|NCT00581360|Clinical Research Services, UPCI|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
20162109|NCT03129360|NYU Langone Health|Donald Goff, MD|646.485.4843|Donald.Goff@nyulangone.org|
20162110|NCT00545103|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20162111|NCT01953913|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20162112|NCT01353911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162113|NCT02219503|AbbVie|Global Medical Services|800-633-9110||
20162114|NCT00082381|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20162115|NCT03249103|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20162116|NCT02925741|Cleveland Clinic|Mary Montague|216-444-1878|montagm@ccf.org|
20162117|NCT01786252|Michigan State University|Dr. Asgerally Fazleabas|(517) 884-6031|asgi@hc.msu.edu|
20162118|NCT00494507|University of Rochester|Robert Griggs, MD|585-275-3707|robert_griggs@urmc.rochester.edu|
20162119|NCT00295932|Memorial Sloan Kettering Cancer Center|Dr. Carol Portlock|212-639-8109|portlocc@mskcc.org|
20162120|NCT00109577|University of Calgary|Dr. Bonnie Kaplan|403-955-7363|kaplan@ucalgary.ca|
20162121|NCT00587847|North Shore-Long Island Jewish Health System|Kanti Rai, MD|(718) 470-4050|krai@nshs.edu|
20162122|NCT02613169|University of Washington|Dr. Sylvia M. LaCourse|206-616-5978|sylvial2@uw.edu|
20162123|NCT00343382|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-1623|cloprinzi@mayo.edu|
20162124|NCT03729245|Nektar Therapeutics|Study Director|4154825300|StudyInquiry@nektar.com|
20177137|NCT01802411|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|Pacira Pharmaceuticals, Inc.|MedInfo@pacira.com|
20177138|NCT01337245|University of Arizona|Senior Regulatory Coordinator|520-621-6417|regulatory@arizona.edu|
20177139|NCT03930745|University of Alabama at Birmingham School of Medicine|Jeanne Marrazzo, MD, MPH|205-975-5500|jmarrazzo@uabmc.edu|
20177140|NCT02670629|"Servicio de Ortopedia y Traumatología . Hospital Universitario José Eleuterio González"|Dr. Adriana Hernández|8112901288|adrianahl@gmail.com|
20177141|NCT04095858|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177142|NCT01344460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20177143|NCT03285477|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20177144|NCT01343706|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177145|NCT03483623|David Grant Medical Center, Clinical Investigation Facility, Travis AFB, CA|Lt Col Laurie Migliore|707-423-7280|laurie.a.migliore.mil@mail.mil|
20177146|NCT00560833|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162125|NCT04032080|Baylor Scott & White Health|Joyce O'Shaughnessy, MD|214-818-8472|joyce.oshaughnessy@usoncology.com|
20177147|NCT01085318|EMD Serono, Inc.|Fernando Dangond, MD FAAN|781-681-2348|fernando.dangond@emdserono.com|
20177148|NCT01059617|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177149|NCT02116322|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
20177150|NCT00852397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177151|NCT03861000|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
20177152|NCT05932290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162126|NCT00884832|Mayo Clinic|Dr. Adil E. Bharucha|507-266-9156|bharucha.adil@mayo.edu|
20177153|NCT03864614|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20177154|NCT00910481|King's College London|Professor Divaka Perera|02071887188|divaka.perera@kcl.ac.uk|
20177155|NCT00136955|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20177156|NCT02239510|TriHealth Hatton Research Institute|Jenni Steinbrunner|513-862-4033|jenni_steinbrunner@trihealth.com|
20162127|NCT02096263|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177157|NCT01787604|MeshalkinRI|Dmitry|+79069090505|dmhvan@mail.ru|
20177158|NCT00074282|ECOG-ACRIN Statistical Office|Study Statistician|617 632 3012|eatrials@jimmy.harvard.edu|
20177159|NCT00464542|University of Pittsburgh|Thomas Cherpes|412 692 5930|cherpestl@upmc.edu|
20177160|NCT01319396|ResMed|Paul Phillips|+353 1 716 3755|paul.phillips@resmed.com|
20177161|NCT03859323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20177162|NCT01682460|CCLR|Research Manager|519-888-4742|cclr2@sciborg.uwaterloo.ca|
20177163|NCT01203189|Saint Louis Univ Hospital|Aibing Mary Guo, M.D., Assistant Professor|3142563430|aguo@slu.edu|
20221949|NCT02964247|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20221950|NCT03759392|Cytokinetics, Inc.|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
20162128|NCT03322423|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-904-443-3402|TKarkkai@its.jnj.com|
20162129|NCT02337725|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20162130|NCT04891107|Boston University Department of Physical Therapy & Athletic Training|Terry Ellis PT, PhD, FAPTA|617-353-7571|tellis@bu.edu|
20162131|NCT03098745|CooperVision Inc.|Dr.Jose A.Vega O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20162132|NCT00500760|Amgen Inc.|Study Director|866-572-6436||
20162133|NCT03178669|InDex Pharmaceuticals|Karin Arnesson, Clinical Trial Manager|+46 8 122 038 57|karin.arnesson@indexpharma.com|
20162134|NCT01600092|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221951|NCT01288079|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20221952|NCT01530464|Duke University Medical Center|Dr. Thies Schroeder|919 681 4721|thies.schroeder@duke.edu|
20162135|NCT02914561|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20162136|NCT03332160|Tactile Medical|Heather Smith|612.800.5539|HSmith@tactilemedical.com|
20162137|NCT01008462|Fred Hutchinson Cancer Research Center|Dr. Mohamed L. Sorror|(206) 667-6298|msorror@fredhutch.org|
20221953|NCT01709500|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20162138|NCT03445390|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
20162139|NCT02964585|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|202-741-2233|ssen1@email.gwu.edu|
20162140|NCT03517566|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20162141|NCT01183468|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20221954|NCT03170544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162142|NCT00303511|Emory University|Dr. Wendy Book|404-778-5545|wbook@emory.edu|
20162143|NCT00454649|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177164|NCT02055352|Novartis Pharmaceuticals|Study Director|862-778-8300||
20177165|NCT05349617|Bavarian Nordic A/S|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
20177166|NCT01763567|Medtronic, Inc.|Julie Sekella|818-576-5000|Julie.Sekella@medtronic.com|
20177167|NCT03811912|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20190417|NCT02516202|Fred Hutchinson Cancer Research Center|Dr. Katherine A. Guthrie|2066675595|kguthrie@fredhutch.org|
20190418|NCT00871715|University of Southern California|Carolee Winstein, Principal Investigator|3234422903|winstein@usc.edu|
20177168|NCT04401579|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20177169|NCT00489970|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177170|NCT01863680|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20177171|NCT00618514|Image Guided Surgery Associates|Robert Worthington-Kirsch|(610) 327-7236|kirsch@igsapc.com|
20177172|NCT01093794|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20177173|NCT00566228|Mayo Clinic|Luis F. Porrata, M.D.|507/284-2511|Porrata.Luis@mayo.edu|
20177174|NCT02740127|UT MD Anderson Cancer Center|Bobby Bellard, Assistant Professor, Anesthesiology & PeriOper Med|(713) 794-1461|bbellard@mdanderson.org|
20177175|NCT02707055|National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Lorenzo Leggio, M.D., PhD|+1 443 740 2801|lorenzo.leggio@nih.gov|
20177176|NCT00414700|TiGenix n.v.|Nel Van Lommel, MSc, Manager Clinical Operations Europe, TiGenix n.v.|+3216396060|nel.vanlommel@tigenix.com|
20177177|NCT00902304|Novartis Pharmaceuticals|Study Director|862-778-8300||
20177178|NCT02492100|Massachusetts General Hospital|Areej El-Jawahri|248-763-3912|ael-jawahri@partners.org|
20177179|NCT05706506|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20177180|NCT03832010|Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
20177181|NCT00987467|Johns Hopkins University, Wilmer Eye Institute|Esen Akpek, MD, Associate Professor of Ophthalmology, Wilmer Eye Institute|410-955-5214|esakpek@jhmi.edu|
20177182|NCT02646423|University of California, San Francisco|Miriam Kupperman, PhD, MPH|415-502-4089|miriam.kupperman@ucsf.edu|
20177183|NCT04564833|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
20177184|NCT00086346|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20177185|NCT02807948|Abbott|Adam M.Cline, MD, MSc.- Principal Scientist|818-493-2025|adam.cline@abbott.com|
20177186|NCT03523533|University of New Mexico Health Sciences Center (HSC)|Dr. Tim Petersen|5052722610|timpetersen@salud.unm.edu|
20177187|NCT00440050|Oregon Health and Sciences University/Portland VA Medical Center, Portland, Oregon.|Joseph Quinn, MD|503-494-6976|quinnj@ohsu.edu|
20177188|NCT01303627|Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital 1. Anesthesiology|Derya Özkan MD|0903125962553|derya_z@yahoo.com|
20177189|NCT01576536|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|mike.stein@vanderbilt.edu|
20177190|NCT02066857|Emory University|Claude Jarrett, M.D.|404-778-8099|CJarrett@wilmingtonhealth.com|
20221955|NCT02387840|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Deborah Runkin Gold|1-800-641-2422|CTUReferral@UHhospitals.org|
20177191|NCT02203019|Texas Tech University|Dr Kenneth Nugent|18067436847|kenneth.nugent@ttuhsc.edu|
20177192|NCT04450823|Global Surgery Amsterdam|Dr Matthijs Botman|0031648073683|matthijsbotman@gmail.com|
20177193|NCT04495712|VA Portland Health Care System|Merritt Raitt MD|503-220-8262|merritt.raitt@va.gov|57571
20177194|NCT02511431|NIDDK|Christopher Koh, MD|301-443-9402|christopher.koh@nih.gov|
20177195|NCT00462384|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20177196|NCT01131312|National Cancer Institute|Dr. Mark Schiffman|240-276-7259|schiffmm@nih.gov|
20177197|NCT04040985|Smith and Nephew|Michael Howarth|07540268240|michael.howarth@smith-nephew.com|+44
20177198|NCT03879798|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
20177199|NCT03526900|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20177200|NCT03893448|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177201|NCT02785406|The University of Texas Health Science Center at Houston|Scott Lane|713-486-2535|Scott.D.Lane@uth.tmc.edu|
20177202|NCT01776645|Stanford University|Dr. Sean Mackey|650-724-2795|smackey@pain.stanford.edu|
20177203|NCT00856583|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20177204|NCT01944046|Duke University|Linmarie Sikich, M.D.|919-681-0026|linmarie.sikich@duke.edu|
20177205|NCT03023891|Vanderbilt University Medical Center|Vivian Kawai|(615) 322-3304|vivian.k.kawai@vumc.org|
20177206|NCT04289753|Northwestern University|Stephen D. Persell, MD, MPH, FACP|3125036464|spersell@nm.org|
20177207|NCT01985126|Janssen Research & Development, LLC|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20177208|NCT00366626|Medical University of South Carolina|Dr. Raymond F. Anton, Distinguished University Professor|843-792-1226|antonr@musc.edu|
20177209|NCT02371369|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20177210|NCT01757964|University of Washington|David Suskind MD Professor of Pediatrics|206-987-2521|Jani.Klien@seattlechildrens.org|
20177211|NCT01587651|Daiichi Sankyo Medical Affairs|Fred Lipkin|973-944-2216|flipkin@dsi.com|
20177212|NCT00127673|Case Western Reserve University|Dr. Norah C Feeny|2163682695|ncf2@case.edu|
20177213|NCT00358735|Medical Compression Systems|Clifford W Colwell, M.D Scripps Clinic|972-4-6266630|Jbarak@mcsmed.com|412
20177214|NCT03864900|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
20177215|NCT01866709|ZS Pharma, Inc|Henrik Rasmussen, MD, PhD|443-699-5230|hrasmussen@zspharma.com|
20177216|NCT05003791|University of Illinois Chicago|Dr. Madison Goodyke|6166446417|mbuurs2@uic.edu|
20177217|NCT01422070|Università degli Studi di Ferrara|Dr Maurizia Capuzzo|+393355932642|cpm@unife.it|
20177218|NCT03191903|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
20221956|NCT00226577|Karmanos Cancer Institute|Gerold Bepler, M.D., Ph.D. via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
20177219|NCT02358889|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
20177220|NCT01027793|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
20177221|NCT00927927|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
20177222|NCT02379585|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
20177223|NCT02897141|Columbia University|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
20177224|NCT02936076|The Miriam Hospital|Dr. Jessica Unick|401-793-8966|junick@lifespan.org|
20177225|NCT03135522|The Johns Hopkins University School of Medicine|Dr. Robert A. Wise, M.D.|410-905-5688|rwise@jhmi.edu|
20177226|NCT00499369|SWOG|Study Statistician|206-667-4623||
20177227|NCT01898195|Department of Population Health, New York University School of Medicine|Donna Shelley, MD, MPH/ Vice Chair for Research; Associate Professor of Population Health and Medici|646-501-2526|Donna.Shelley@nyumc.org|
20177228|NCT03283670|Washington University|Ben Palanca, MD PhD|314 273-9076|palancab@wustl.edu|
20177229|NCT02331992|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 5740123|cpaptrial@fphcare.co.nz|
20177230|NCT00724347|VANCHCS|David L. Woods, Ph.D.|925-372-2571|David.Woods@va.gov|
20177231|NCT01688336|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20177232|NCT00612313|UT Southwestern Medical Center|Dr. Graham Emslie and Dr. Betsy Kennard|214-456-5900|beth.kennard@utsouthwestern.edu|
20177233|NCT00527566|National Jewish Health|Michael Wechsler|617-285-4987|wechslerm@NJHealth.org|
20177234|NCT01773226|Zimmer Biomet|Linda Korthout, Scientific Affairs Specialist|+31.610.072.853|Linda.Korthout.external@zimmerbiomet.com|
20177235|NCT01429259|Hartford Hospital|Joseph L. Kuti, Pharm.D.|860-972-3612|joseph.kuti@hhchealth.org|
20177236|NCT00746954|Louis Stokes DVA Medical Center|Kingman P. Strohl MD|216-7913800|kingman.strohl@va.gov|
20177237|NCT00993447|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20177238|NCT00970502|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
20177239|NCT02041195|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20177240|NCT03564496|NYU Langone|Matthew Lustberg|929 455 5090|matthew.lustberg@nyulangone.org|
20177241|NCT00674986|Hoffman-LaRoche|Medical Communications|800-821-8590||
20177242|NCT01880424|AstraZeneca|Peter Zeng|+86 21 6030 1867|peter.zeng@astrazeneca.com|
20177243|NCT01787617|Pennington Biomedical Research Center|Dr. Robert Newton|225-763-3034|Robert.Newton@pbrc.edu|
20177244|NCT03521635|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177245|NCT01230593|Icahn School of Medicine at Mount Sinai|Albert Wu MD PhD|2125184524|albert.wu@mssm.edu|
20177246|NCT04495374|Universidade Federal de Alfenas|Profa. Dra. Larissa Helena Lobos Torres Pacheco|3537011805|larissa.torres@unifal-mg.edu.br|55
20177247|NCT03727750|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177248|NCT00111657|Duke University Medical Center|John S. Sundy, MD, PhD|919-684-2347|john.sundy@duke.edu|
20177249|NCT01054820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177250|NCT00321919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20177251|NCT02624804|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20177252|NCT02590354|Institute of Tropical Medicine Antwerp|Dr. Eric Florence|+32 3 247 66 42|eflorence@itg.be|
20177253|NCT00996996|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177254|NCT00760929|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
20177255|NCT02099838|Huazhong University of Science and Technology|Dr. Yu|027-83662883|xfyu188@163.com|
20177256|NCT01227889|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177257|NCT04121962|Johns Hopkins Bloomberg School of Public Health|Dr. Karin Tobin|4105025368|ktobin2@jhu.edu|
20177258|NCT00774787|Rigel Dermatology|Darrell Rigel|212-684-5964|dsrigel@prodigy.net|
20177259|NCT02019719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177260|NCT04535037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20177261|NCT01319318|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20177262|NCT02731131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20177263|NCT02509624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20177264|NCT02348216|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20177265|NCT01055639|VA San Diego Healthcare System|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
20177266|NCT00765245|Vanderbilt-Ingram Cancer Center|Dr. Nishitha Reddy|800-811-8480|nishitha.reddy@vanderbilt.edu|
20221957|NCT02044380|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20221958|NCT00420420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20221959|NCT02208362|City of Hope Medical Center|Dr. Christine Brown|626-256-4673|CBrown@coh.org|83977
20221960|NCT02290444|University at Buffalo|Curtis Wojcik, Lab Coordinator|7163230551|cmwojcik@buffalo.edu|
20221961|NCT00868530|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177267|NCT04483479|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|r.larson@enterininc.com|
20221962|NCT01609790|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20177268|NCT01197950|Universty of Skovde|Professor Lena Mårtensson|+46500448000|lena.martensson@his.se|
20177269|NCT02553330|Incyte Organization|Study Director|855-463-3463|medinfo@incyte.com|
20177270|NCT02896855|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20177271|NCT01205685|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
20221963|NCT06954493|SCYNEXIS, Inc|David Angulo, MD|(201) 884 - 5471|david.angulo@scynexis.com|
20221964|NCT00739882|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
20221965|NCT04021914|Emory University|Dr. Jeffrey N. Siegelman|4042518868|jsiegelman@emory.edu|
20221966|NCT02844543|Stanford University|Dr. Jamshid Ghajar, MD, PhD|(650) 725-5562|acrevelt@stanford.edu|
20221967|NCT00955409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177272|NCT02169674|Vaccine Evaluation Center|Director of Vaccine Evaluation Center|604-845-2422||
20177273|NCT01666002|Stanford University|Jean Tang MD PhD, assistant professor|650-723-6316|tangy@stanford.edu|
20177274|NCT05053087|Mayo Clinic|Benjamin K. Wilke, M.D.|904-953-2405|Wilke.Benjamin@mayo.edu|
20177275|NCT04171700|University of Pennsylvania|Kim Reiss Binder|1 215 360 0735|Kim.ReissBinder@uphs.upenn.edu|
20177276|NCT02585895|Amgen Inc.|Study Director|866-572-6436||
20177277|NCT01452269|University of Rochester|Dr. Steven Barnett||steven_barnett@urmc.rochester.edu|
20177278|NCT01243333|Huntsman Cancer Institute Research Compliance Officer|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
20177279|NCT01169467|Duke University Medical Center|Dr. Keith Dombrowski|(919)|keith.dombrowski@dm.duke.edu|
20177280|NCT03108924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177281|NCT04634604|Jaeb Center for Health Research|Ray Kraker|8139758690|rkraker@jaeb.org|
20177282|NCT02127164|University of Arizona|Andrew Tang, MD|520-626-5056|traumaresearch@arizona.edu|
20177283|NCT01173848|Cleveland Clinic|Dr. James Simon|216-445-4891|simonj2@ccf.org|
20177284|NCT02265705|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20177285|NCT04030416|seca gmbh & co. kg|Kristin Klückmann|+49(40)200000|kristin.klueckmann@seca.com|232
20177286|NCT00346034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20177287|NCT04000165|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Dr. Swee Lay Thein, Chief of Sickle Cell Branch|301.402.6699|sweelay.thein@nih.gov|
20177288|NCT03660683|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|301-461-6676|ssen1@email.gwu.edu|
20177289|NCT00941603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177290|NCT02079805|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20177291|NCT00383435|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20177292|NCT01753193|MedImmune, LLC|Raj Tummala|+1 301-398-0548|information.center@astrazeneca.com|
20221968|NCT00803790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20221969|NCT04710576|Syndax Pharmaceuticals|Chief Medical Officer|781-419-1400|clinicaltrials@syndax.com|
20221970|NCT00637312|Orthofix|Ruba Sarris|214-937-2256|rubasarris@orthofix.com|
20221971|NCT02068508|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20177293|NCT00583557|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177294|NCT02682264|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20177295|NCT02347761|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20177296|NCT02942160|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20177297|NCT01255358|EryDel spa|Clinical Study Coordinator|+39 02 36504470|guenter.janhofer@erydel.com|
20177298|NCT03950739|United Therapeutics Corp.|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20177299|NCT03625570|Louisiana State University Health Sciences Center - New Orleans|Dr. Noelle G. Moreau|504-568-4291|nmorea@lsuhsc.edu|
20177300|NCT03264989|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20177301|NCT03370887|AstraZeneca|Global Clinical LEad|1-877-240-9479|information.center@astrazeneca.com|
20177302|NCT01343056|University of Pittsburgh|Linda Siminerio, PhD|412-864-0158|simineriol@upmc.edu|
20177303|NCT00345579|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177304|NCT03029208|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20177305|NCT01863017|University of Kansas Medical Center|Merlin G Butler|9135881800|mbutler4@kumc.edu|
20177306|NCT01732835|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
20162144|NCT03385330|Children's Hospital of Philadelphia|Dr. Sara DeMauro|445-225-6400|demauro@chop.edu|
20221972|NCT00813150|Jan-Cil Germany|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
20162145|NCT00086411|University of Pennsylvania|Peter Gariti, Ph.D.|215-222-3200|gar1iti@mail.med.upenn.edu|0
20162146|NCT00375167|Queens University|Dr. Terry Krupa|613-533-6236|terry.krupa@queensu.ca|
20162147|NCT01078168|Clinic of Psychiatry and Psychotherapy, University Medical Center JGU Mainz|Prof. Dr. Andreas Fellgiebel|+49-6131-17-7363|Andreas.Fellgiebel@unimedizin-mainz.de|
20162148|NCT01962870|Stanford University|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
20162149|NCT03109184|NORTHEASTERN UNIVERSITY|DR. CHRISTIE RIZZO|(617) 373-2486|C.RIZZO@NORTHEASTERN.EDU|
20221973|NCT02024607|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
20221974|NCT05423093|Johns Hopkins University|Rheanna Platt|410-550-8753|rplatt1@jhmi.edu|
20162150|NCT00602420|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20162151|NCT01735981|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
20162152|NCT01237613|Orthopedic Foot and Ankle Center|Terrence M. Philbin, DO|614-895-8747|ofacresearch@orthofootankle.com|111
20177307|NCT03207750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20177308|NCT02334748|Novartis Pharma AG|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
20177309|NCT02493361|University of California, San Francisco|Dr. Katy Tsai|(415) 402-5483|katy.tsai@ucsf.edu|
20221975|NCT03593525|The Hospital for Sick Children|Dr. Lillian Sung|416 813 5287|lillian.sung@sickkids.ca|
20221976|NCT05537233|Indiana University School of Medicine|Viral N Shah, MD|317-278-6017|shahvi@iu.edu|
20221977|NCT05338489|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20162153|NCT02315560|University of Pittsburgh|Dr. Heidi Stephany|412-692-7932|heidi.stephany@chp.edu|
20162154|NCT01041287|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
20162155|NCT01209078|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162156|NCT00924508|UCSF|John Koo, MD|415-476-6281|john.koo@ucsfmedctr.org|
20177310|NCT02388321|Maimonides Medical Center|Sergey Motov, MD (Prinicipal Investigator)|718-283-8693|smotov@maimonidesmed.org|
20177311|NCT00289341|Rockefeller University|Mayu Frank|212-327-7443|frankm@rockefeller.edu|
20177312|NCT01568047|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
20177313|NCT01276587|Columbia University|Margaret Lee, MD|212-305-6290|ml653@cumc.columbia.edu|
20177314|NCT03329352|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
20177315|NCT01618838|Georgetown University Hospital|Dr. Sean Collins|202-444-3062|spc9@gunet.georgetown.edu|
20177316|NCT02679690|University of Pittsburgh|Sheryl Ondrejko, DNP||sherylannmarieo@gmail.com|
20177317|NCT01286259|University of California, San Francisco|Steven G. Deeks|(415) 476-4082|Steven.Deeks@ucsf.edu|
20177318|NCT02308033|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
20177319|NCT02582905|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
20177320|NCT00499889|UT MD Anderson Cancer Center|Richard E. Champlin, MD/Professor|713-792-8848|pmcadams@mdanderson.org|
20177321|NCT00345397|Medical College of Wisconsin and Zablocki VAMC Milwaukee, WI|Mary F. Otterson, MD; Professor of Surgery|414-384-2000|Motterso@mcw.edu|4-1619
20177322|NCT03325712|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177323|NCT01297062|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20177324|NCT03823651|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
20177325|NCT01850004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20177326|NCT05350449|University of Nevada Las Vegas|Dr. Nirmala Lekhak|702-895-5983|nirmala.lekhak@unlv.edu|
20177327|NCT01046643|The University of Michigan|Dr. Yolanda Smith|(734) 936-7401|ysmith@med.umich.edu|
20177328|NCT03009110|Indiana University School of Medicine|Graham Hogg|317-962-0415|gahogg@iu.edu|
20177329|NCT01175668|Baystate Medical Center|Rachana Singh, MD|413-794-2400|rachana.singhmd@bhs.org|
20162157|NCT03464019|Milestone Pharmaceuticals Inc.|Cameron Szakacs_PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
20162158|NCT00767806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162159|NCT00372697|Novartis Pharmaceuticals|Study Director|862 778-8300||
20221978|NCT05857488|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
20162160|NCT01815840|Hoffmann-La Roche|Medical Communications|800 821-8590||
20162161|NCT00901199|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|510-428-3172|ashutosh.lal@ucsf.edu|
20221979|NCT03851406|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
20221980|NCT01217112|GW Research Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223266800|rp@gwpharm.com|
20221981|NCT02596971|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20221982|NCT01401361|St. Jude Medical|Nancy Ouch|+19497695041|NOuch@sjm.com|
20206323|NCT02574481|Boston Scientific|Nicole Kilburn|970-294-4082|Nicole.Kilburn@bsci.com|
20221983|NCT00595920|Opexa Therapeutics, Inc.|Kenny Frazier, VP of Clinical Development and Regulatory Affairs|281-775-0660|kfrazier@opexatherapeutics.com|
20221984|NCT00351468|Novartis|Study Director|862-778-8300||
20221985|NCT00611923|Weill Cornell Medical College and Yale School of Medicine|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
20221986|NCT04565145|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
20221987|NCT03096314|Massachusetts General Hospital|Nancy Ringwood, CCC Project Manager|617-724-9836|nringwood@mgh.harvard.edu|
20221988|NCT02764762|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20221989|NCT00887575|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20221990|NCT03318861|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
20221991|NCT00917852|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20221992|NCT00471081|GlaxoSmithKline|GSK Response Center|866-435-7343||
20221993|NCT02844933|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
20221994|NCT01479465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20221995|NCT02739789|Stony Brook University|Dr. David Hsu, Assistant Professor of Psychiatry|(631) 638-1522|david.hsu@stonybrookmedicine.edu|
20221996|NCT01129440|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
20162162|NCT03221842|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20162163|NCT00704288|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20206324|NCT01461824|The Research Institute at Nationwide Children's Hospital|Dr. Andrea Bonny|614-722-2450|andrea.bonny@nationwidechildrens.org|
20206325|NCT01105936|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206326|NCT01089751|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20177330|NCT00874029|Halt Medical, Inc|Laura Kemp, Sr. VP Clinical Affairs|408-375-1465|lkemp@haltmedical.com|
20177331|NCT00283504|CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS|MARIPAZ MORALES MD|7576688255|MARIPAZ.MORALES@CHKD.ORG|
20177332|NCT03198000|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD, MPH|(973) 255-8701|AParikh1@its.jnj.com|
20177333|NCT01761747|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-6335|phammerman@partners.org|
20177334|NCT02937545|Duke University School of Medicine|Susanne B Haga|919-684-0325|susanne.haga@duke.edu|
20177335|NCT02007577|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
20190419|NCT01794689|Johns Hopkins University|Dr. Michael T. Smith, PhD|410-550-7000|msmith62@jhmi.edu|
20190420|NCT01697956|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20190421|NCT01964547|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20190422|NCT01115309|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20190423|NCT05700851|University of Nottingham|Prof. Maarten Taal|01332224618|m.taal@nottingham.ac.uk|
20190424|NCT03246724|Boston Medical Center|Marissa Fiorello, Clinical Research Manager|617-414-8848|Marissa.Fiorello@bmc.org|
20190425|NCT02978716|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
20190426|NCT00589628|Duke Health Systems|Dr. C. Egla Rabinovich|919-668-0238|egla.rabinovich@duke.edu|
20190427|NCT01862159|Region Örebro län, Sweden AND Örebro University, Sweden|Dr Erik Stenberg|+46196021000|erik.stenberg@regionorebrolan.se|
20221997|NCT02393950|Orion Corporation|Clinical Trials Information Desk|+358104261|clinicaltrials@orionpharma.com|
20221998|NCT05486091|Anxiety Disorders Center|Gretchen Diefenbach, Ph.D.|860-545-7396|gretchen.diefenbach@hhchealth.org|
20221999|NCT00370552|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20222000|NCT01607450|Indiana University|Kieren J Mather MD FRCPC|317-278-7826|kmather@iu.edu|
20222001|NCT01062425|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20222002|NCT00663793|University of Washington|John K Amory, MD, MPH|206-616-1727|jamory@u.washington.edu|
20222003|NCT01468337|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
20222004|NCT00395629|Novartis Pharmaceuticals|Study Director|862-778-8300||
20222005|NCT03534687|University of Michigan|Jacob Haus|734 647-2790|jmhaus@umich.edu|
20222006|NCT01686373|University of South Carolina|Dr. Julius Fridriksson|1-803-777-5931|jfridrik@sc.edu|
20222007|NCT00314340|UC Davis Medical Center|Barth Wilsey MD|916-843-7165|blwilsey@ucdavis.edu|
20222008|NCT01967862|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20222009|NCT04973267|Brown University - SPH|Tyler Wray, PhD|4018636659|tyler_wray@brown.edu|
20222010|NCT03751098|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
20222011|NCT01592786|Forest Research Institute|Joel Trugman, MD|201-427-8000|Joel.Trugman@frx.com|8681
20222012|NCT03810092|CHD VENDEE|Romain DECOURS|02 51 44 65 72|romain.decours@ght85.fr|+33
20222013|NCT01841047|Institut Bergonié|Pr Guy KANTOR||G.Kantor@bordeaux.unicancer.fr|
20222014|NCT01639157|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
20222015|NCT04578535|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20222016|NCT00235755|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222017|NCT03839628|The University of Utah|Micah Drummond|801-213-2737|micah.drummond@hsc.utah.edu|
20222018|NCT03447639|Beaumont Hospital|Director of Urology Research|248.551.0804|Deborah.Hasenau@Beaumont.org|
20222019|NCT03440229|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|james.lewis@pennmedicine.upenn.edu|
20222020|NCT02280200|University of Minnesota|Ryan Mays PhD, MPH, MS|612-625-0430|rjmays@umn.edu|
20222021|NCT01306305|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20222022|NCT04030299|The University of Iowa|Dr. Yu-Hsaing Wu|(319) 335-9758|yu-hsiang-wu@uiowa.edu|
20177336|NCT02626715|UPMC Children's Hospital of Pittsburgh|Dr. Randy Windreich|412-692-5055|randy.windreich@chp.edu|
20177337|NCT02504294|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
20177338|NCT00864032|University of California Davis Comprehensive Cancer Center|Dr. Robert J. Canter|916-734-5907|robert.canter@ucdmc.ucdavis.edu|
20177339|NCT01059760|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
20177340|NCT02252211|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20177341|NCT00659633|University of Alabama at Birmigham|Dr. Michael Froelich|205-975-3328|mfroelich@uabmc.edu|
20177342|NCT00968669|MedImmune|Joe Parker, MD|301-398-0000|parkerJ@medimmune.com|
20177343|NCT01953926|Puma Biotechnology, Inc.|Sr Director, Clinical Operations|4242486500|clinicaltrials@pumabiotechnology.com|
20177344|NCT03836287|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20177345|NCT02255175|UNC School of Medicine|Crystal Edler Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
20177346|NCT00986999|University of Hawaii|Cecilia M. Shikuma M.D.|808 692-1328|shikuma@hawaii.edu|
20177347|NCT01949480|University of Pittsburgh|Dr. Anna Uskova, Principal Investigator|412) 623-2167|UskoAA@anes.upmc.edu|
20177348|NCT00144339|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177349|NCT02100072|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20177350|NCT04644328|Massachusetts Institute of Technology|Esther Duflo|617-258-7013|eduflo@mit.edu|
20177351|NCT03330834|Sun Yat-sen University Cancer Center|Dr.Yuxiang Ma|86 020 87343894|mayx@sysucc.org.cn|
20190428|NCT01138969|KaohsiungVGH|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
20222023|NCT03539302|InCarda Therapeutics|VP Clinical Operations|510-422-5522|propst.meisa@incardatherapeutics.com|111
20222024|NCT01927120|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Betts|813-745-5410|brian.betts@moffitt.org|
20222025|NCT04507464|University of Illinois at Chicago|Dr. Ulf Bronas|3123555886|bronas@uic.edu|
20222026|NCT01853215|Vidacare Corporation|Larry J. Miller, MD|210-375-8500|larry.miller@vidacare.com|
20177352|NCT04798586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177353|NCT00968617|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20177354|NCT04433767|Vanderbilt University Medical Cdenter|Warren Taylor, MD, Director of the DIvision of Geriatric Psychiatry|615-322-1073|warren.d.taylor@vumc.org|
20177355|NCT00298233|Oxford University Clinical Research Unit|Dr. Jeremy Farrar|+84 839237954|info@oucru.org|
20177356|NCT00819182|Indiana University|Janet S Carpenter, PhD, RN, FAAN|317-278-6093|carpentj@iupui.edu|
20177357|NCT00167544|Nationwide Children's Hospital Clinical Research Institute|Dr. Nehal Parikh|614-355-6657|nehal.parikh@nationwidechildrens.org|
20177358|NCT00288587|Cleveland Clinic Foundation|Leighann Cesar, RN|216-445-6551|cesar1@ccf.org|
20177359|NCT01434602|National Cancer Institute|Dr. Mark R. Gilbert|240-760-6023|mark.gilbert@nih.gov|
20177360|NCT01835626|University of California, San Francisco|Dr. Sue Yom|(415) 353-9893|Sue.Yom@ucsf.edu|
20177361|NCT01108081|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
20177362|NCT01764945|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177363|NCT00648908|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
20177364|NCT05077267|Bavarian Nordic A/S|Bavarian Nordic Call Center|+1-844-422-8274|medical.information_us@bavarian-nordic.com|
20177365|NCT02944877|University of California, Irvine|Dr. Sean Young|714-413-2347|syoung5@hs.uci.edu|
20177366|NCT04747977|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
20177367|NCT00690521|University of New Mexico Health Sciences|Joe Anderson|505-272-3664|janderson@salud.unm.edu|
20177368|NCT03819660|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
20177369|NCT01136291|Department of Obstetrics and Gynecology - University of Campinas|Fernanda Garanhani de Castro Surita|+551935219304|surita@unicamp.br|
20177370|NCT02545907|Leeds Institute of Clinical Trials Research|Alexandra Pitchford|0113 343 9077|medcatal@leeds.ac.uk|
20177371|NCT01573702|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20177372|NCT03165045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177373|NCT01827904|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-360-9900|nadira@insightec.com|
20177374|NCT04773015|GE Healthcare|Paul Sherwin, MD, PhD|609 510 3686|PaulSherwin@ge.com|
20177375|NCT02908269|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20177376|NCT00142909|Yale University School of Medicine|Rajita Sinha, Ph.D|203-737-5805|rajita.sinha@yale.edu|
20177377|NCT03971643|InflaRx|Prof. Dr. Niels C. Riedemann|+49-(0) 3641-508 180|niels.riedemann@inflarx.de|
20177378|NCT01870843|Xian-Janssen Pharmaceutical Ltd|Associate TA Manager||ClinicalTrialDisclosure@its.jnj.com|
20177379|NCT02265237|AbbVie|Global Medical Information|800-633-9110||
20177380|NCT00650546|Department of Gastroenterology, San Antonio Uniformed Services Health Consortium|Patrick R Kenney, DO||pat.kenney@us.army.mil|
20177381|NCT01178853|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
20177382|NCT03550313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177383|NCT00839072|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20177384|NCT01682837|UT Southwestern Medical Center at Dallas|John Poindexter|2146486857|john.poindexter@utsouthwestern.edu|
20177385|NCT04782323|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20177386|NCT04369469|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20177387|NCT01165281|Janssen Pharm KK Japan|Medical Director|＋81-3-5509||
20177388|NCT02863991|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
20177389|NCT01154634|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20177390|NCT00364858|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20177391|NCT01307501|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
20177392|NCT00363766|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177393|NCT00558285|Novartis Pharmaceuticals|Study Director|862-778-8300||
20177394|NCT02596451|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20177395|NCT03151434|Indiana University Department of Anesthesiology|Dr. Yar Luan Yeap|3172740275|yyeap@iupui.edu|
20177396|NCT02345512|National Health Service Greater Glasgow & Clyde|Ms Jennifer Crockett|0141 276 4900|jennifer.crockett@ggc.scot.nhs.uk|4912
20177397|NCT01660906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20177398|NCT01538745|SAUSHEC|Josh Miller|210-916-7111|joshmillersr@gmail.com|
20177399|NCT03478891|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20177400|NCT01489579|Kaiser Permanente|Alicia Cymbala|303-972-5384|Alicia.A.Cymbala@kp.org|
20177401|NCT04827576|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20177402|NCT04295564|OHSU|Dr. Cindy McEvoy|503-494-0223|mcevoyc@ohsu.edu|
20177403|NCT02527798|Duke University|Leigh Gosnell|919-668-1280|leigh.gosnell@duke.edu|
20177404|NCT04745169|Baylor College of Medicine|Elizabeth Lorenz, MD|713-798-2694|elizabeth.lorenz@bcm.edu|
20177405|NCT00639717|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik|734-764-3243|jelevine@umich.edu|
20177406|NCT02062502|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177407|NCT00724282|University of Chicago|Andrea Eiring|773-702-3657|aeiring@bsd.uchicago.edu|
20177408|NCT01808690|University of Colorado Denver/Children's Hospital Colorado|Dr. Kristen J Nadeau|720-777-2855|Kristen.Nadeau@childrenscolorado.org|
20177409|NCT04396834|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
20177410|NCT01024569|University of Illinois at Chicago|Judith A Cook|312-355-3921|jcook@uic.edu|
20177411|NCT02053350|UVirginia|Dr. Cirle Warren|(434) 924-5242|CA6T@hscmail.mcc.virginia.edu|
20177412|NCT01747772|Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital|Anthony E. Samir MD||asamir@partners.org|
20177413|NCT02244944|University of Kentucky|Gregory Graf|8592574749|Gregory.Graf@uky.edu|
20177414|NCT00492349|University of Maryland|L. Elliot Hong, M.D.|410-402-6828|ehong@mprc.umaryland.edu|
20177415|NCT01928719|Penn State College of Medicine|Nicolle Krebs|717-531-5673|nkrebs@pennstatehealth.psu.edu|
20177416|NCT02367911|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
20177417|NCT00263666|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177418|NCT00896168|Xian-Janssen Pharmaceutical Ltd|Director of Medical Affairs|(8610) 5821 8359||
20177419|NCT01490632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177420|NCT00381966|Johns Hopkins University|Daniel Song|401-502-5875|dsong2@jhmi.edu|
20177421|NCT05732454|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177422|NCT01153633|B. Braun Medical AG|Medical Scientific Affairs Manager|+41 58 258 55 47||
20177423|NCT00384085|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
20177424|NCT03846024|University of Vermont|Ethan Jones|802-656-9437|ethan.d.jones@med.uvm.edu|
20177425|NCT03725982|Institute of Occupational and Social Medicine and Health Services Research|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
20177426|NCT03319277|Cleveland Clinic|Emily RW Davidson, M.D.|812-272-2380|dr.emily.rose@gmail.com|
20177427|NCT02346383|CCAMP|J Kelby Hutcheson MD|8642956399|khutchesonmd@carolinapain.com|
20177428|NCT01944631|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177429|NCT00838110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177430|NCT01003899|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177431|NCT00352365|SWOG|Study Statistician|206-667-4623||
20190429|NCT00689351|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20177432|NCT01262651|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
20177433|NCT02811861|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20177434|NCT04743908|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
20177435|NCT02692248|MFAR|Responsable person designated by the sponsor|+34934344412|investigacion@mfar.net|
20177436|NCT01512225|Sunnybrook Research Institute|Dr. Elizabeth Asztalos|416-480-6100,|elizabeth.asztalos@sunnybrook.ca|87791
20177437|NCT04969783|Masonic Cancer Center|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
20177438|NCT00512135|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20177439|NCT03422250|IRCCS Centro San Giovanni di Dio Fatebenefratelli|Michela Pievani|+39 030 35011|mpievani@fatebenefratelli.eu|
20177440|NCT03812146|VA Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|Kyle.Possemato@va.gov|53551
20177441|NCT00377819|Amgen Inc.|Study Director|866-572-6436||
20177442|NCT03388619|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
20177443|NCT00467870|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20177444|NCT01917526|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
20177445|NCT02261363|University of Nevada, Reno|Jennifer Pearson|7756825005|jennipearson@unr.edu|
20177446|NCT01517802|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20177447|NCT01206738|University of Aberdeen|Prof Shaun Treweek||streweek@mac.com|
20177448|NCT03774186|Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus|Dr. Sarit Polsky|303-724-8575|sarit.polsky@cuanschutz.edu|
20177449|NCT03740490|Stephenson Cancer Center, University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
20177450|NCT03268811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20177451|NCT02031276|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
20177452|NCT01148810|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20177453|NCT01235910|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
20177454|NCT02880852|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20177455|NCT02165722|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
20177456|NCT05423509|University of New Mexico Health System|Selina Silva, MD|505-272-4107|ssilva@salud.unm.edu|
20177457|NCT06390098|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
20177458|NCT02417246|UF|Dr. Larisa H Cavallari|352-273-8245|lcavallari@cop.ufl.edu|
20177459|NCT03535649|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20177460|NCT00317239|Luitpold Pharmaceuticals, Inc.|Mark Falone|610-650-4200|mfalone@luitpold.com|
20177461|NCT04408469|Yale University School of Public Health|Dr. Danielle Chiaramonte|646-429-9407|danielle.chiaramonte@yale.edu|
20177462|NCT04321460|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20177463|NCT01308749|Duke University Center for Autism and Brain Development|Linmarie Sikich, MD|9196810026|linmarie.sikich@duke.edu|
20177464|NCT01301963|CCCC|Hien Duong, MD|216-445-5531|duongh@ccf.org|
20177465|NCT02824913|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
20177466|NCT03058679|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|lewisjd@pennmedicine.upenn.edu|
20177467|NCT01098006|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177468|NCT00599326|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
20177469|NCT00784810|Napp Pharmaceuticals Ltd|Director of Medical Affairs|01223 424444||
20177470|NCT04137380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20177471|NCT00779246|Christiana Care Health System|Marci Drees, MD, MS|302-733-5602|mdrees@christianacare.org|
20177472|NCT03579459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177473|NCT04844281|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
20177474|NCT02844946|Baylor College of Medicine|Dr. Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
20177475|NCT02806986|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20177476|NCT00407537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177477|NCT06027216|Schepens Eye Research Institute, Mass Eye and Ear|Eli Peli|617-912-2597|eli_peli@meei.harvard.edu|
20177478|NCT02745626|University of Connecticut Health|Dr. Madhur Upadhyay, Director Orthodontic Clinic, Assistant Professor|860-679-3729|maupadhyay@uchc.edu|
20162164|NCT01055314|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20177479|NCT00413413|Novartis Pharmaceuticals|Study Director|862 778-8300||
20177480|NCT01040130|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177481|NCT00096135|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20177482|NCT04537923|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20162165|NCT00568126|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
20162166|NCT04395690|Aula Dental Avanzada|G. Esteve-Pardo|965215755|guillem@clinicaesteve.com|
20162167|NCT04512976|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
20162168|NCT02702414|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177483|NCT01261611|Ipsen Innovation|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20177484|NCT04690855|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
20177485|NCT01615731|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20177486|NCT03586648|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
20177487|NCT02395120|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
20177488|NCT00377234|Hoffmann-LaRoche|Medical Communications|800-821-8590||
20177489|NCT01997398|Barrow Neurlogical Institute / St. Joseph's Hosptial & Medical Center|Francisco A. Ponce, MD|602-406-3242||
20177490|NCT01159691|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20177491|NCT03822533|Region Västra Götaland, Närhälsan|Chan-Mei Ho-Henriksson, PhD-student, RPT|+46709892821|chan-mei.ho@vgregion.se|
20177492|NCT02489500|Boston Medical Center|Vaishali Sanchorawala, MD|6176388261|sfenness@bu.edu|
20177493|NCT02863926|Indiana University School of Medicine|Kristen Wanczyk / Certified Clinical Research Nurse Coordinator|317-7988-9548|keevans@iu.edu|
20177494|NCT00511862|BTG International Canada Inc.|Director of Clinical Operations|613-801-1880|TheraSphereClinical@btgplc.com|
20177495|NCT04726709|University of Idaho|Dr. Rajal Cohen|2088856324|rcohen@uidaho.edu|
20177496|NCT00085410|Fox Chase Cancer Center|Assistant Professor, Medical Oncology|215-214-1676|crystal.denlinger@fccc.edu|
20177497|NCT03073603|University of Colorado School of Medicine|John R. Corboy, MD|13037242187|john.corboy@cuanschutz.edu|
20177498|NCT02312739|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|HSC-familyplanningresearch@salud.unm.edu|
20177499|NCT00823719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177500|NCT02357836|UT Southwestern Medical Center|Dr. David Gerber|214-648-4180|David.Gerber@UTSouthwestern.edu|
20177501|NCT04757649|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
20177502|NCT03750487|Partnership to End Addiction|Sarah Dauber, Vice President|212-841-5270|sdauber@toendaddiction.org|
20177503|NCT00344682|UMass Medical School|Dr. Kristina Deligiannidis|508-856-5928|kristina.deligiannidis@umassmemorial.org|
20177504|NCT04827212|Northeastern University|Dr. Dinesh John|(801) 230-6320|d.john@northeastern.edu|
20177505|NCT00574080|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|PettyNathanM@uams.edu|2461
20177506|NCT02995967|UAB|Joseph Malek|2059965466|jmalek@uabmc.edu|
20177507|NCT00563784|UT MD Anderson Cancer Center|Dr. Steven H. Lin/Radiation Oncology|713-563-8490|shlin@mdanderson.org|
20177508|NCT03434119|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20177509|NCT04360824|University of Iowa Hospitals & Clinics|Dr. Usha Perepu|1-319-356-2195|usha-perepu@uiowa.edu|
20177510|NCT00304070|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20177511|NCT00320216|Centocor Research & Development, Inc.|Senior Director Clinical Research|1-800-457-6399||
20177512|NCT03421197|Dr Reddy's Laboratories|Srinivas Sidgiddi, Sr Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
20177513|NCT00148343|Case Western Reserve University/MetroHealth Medcial Center|Lynne Sheffler, MD|216-957-3570|lsheffler@metrohealth.org|73556
20177514|NCT00353275|UT Health Science Center at Houston|Dr. Lillian S. Kao|713-566-5095|Lillian.S.Kao@uth.tmc.edu|
20177515|NCT02528214|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20177516|NCT01380327|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20177517|NCT05046795|Viatris|Dik WH Ng, PhD|+44 (0)1304 626895|dik.ng@viatris.com|
20162169|NCT00597493|Duke University Health System|David Reardon, MD|617-632-2166|David_Reardon@DFCI.harvard.edu|
20162170|NCT03446456|University of Maryland School of Nursing|Rachel Massalee|4107068244|rmassalee@umaryland.edu|
20162171|NCT04369950|The University of Texas Health Science Center at Houston|Linden Lee, MD, Assistant Professor|(713) 500-6200|Linden.O.Lee@uth.tmc.edu|
20162172|NCT00989963|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director||info@lungbiotechnology.com|
20162173|NCT02408263|HSS|Dr. Gungor|212.606.1206|GungorS@hss.edu|
20162174|NCT00612560|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20162175|NCT00765570|Summa Health System|Tracy Mondello, MS|330-375-6131|mondellot@summahealth.org|
20162176|NCT01529034|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
20162177|NCT04588389|UMass Chan Medical School|Dr Alexander Chan for Eman Nada, MD|7743030338|alexander.chan@umassmemorial.org|
20162178|NCT02227394|Zambon S.p.A.|Luca Raiteri, MD|+39 02 6652461|luca.raiteri@zambongroup.com|
20162179|NCT00658814|SWOG|Study Statistician|206-667-4623||
20190430|NCT03075878|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20162180|NCT01141478|Loma Linda University Medical Center|Diane Scavone, research coordinator|909 558-3636|dscavone@llu.edu|33670
20190431|NCT01986348|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20190432|NCT02158806|University of Auckland|Professor Andrew Jull|+64 9 923 4259|a.jull@auckland.ac.nz|
20162181|NCT02981966|UTexas_SanAntonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
20162182|NCT05026853|University of Michigan|Dr. Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
20162183|NCT03836677|AstraZeneca AB|AstraZeneca AB|1-877-240-9479|information.center@astrazeneca.com|
20177518|NCT01127178|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20177519|NCT05348681|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
20177520|NCT01470027|Weill Cornell Medicine|Dr. Dikoma C. Shungu, Professor of Physics in Radiology|2127462481|dcs7001@med.cornell.edu|
20177521|NCT03646513|Smith+Nephew, Inc.|Andrew Copey|+61.490.503.157|andrew.copley@smith-nephew.com|
20177522|NCT00782340|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20177523|NCT04174521|Vanderbilt University Medical Center|Bryan Shepherd|615-343-3496|bryan.shepherd@vumc.org|
20177524|NCT02388633|OregonHSU|Jonathan Lindner, MD|5034949191|lindnerj@ohsu.edu|
20177525|NCT00759109|Merck Sharp and Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20177526|NCT00780962|Beth Israel Deaconess Medical Center|Nathan I. Shapiro, MD, MPH|617-754-2323|nshapiro@bidmc.harvard.edu|
20177527|NCT01660763|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20177528|NCT01910519|Emory University|Nadine Rouphael MD|404-712-1435|nroupha@emory.edu|
20177529|NCT04266028|Desentum Oy|Head of Clinical Operations|+358400224892|Info@desentum.fi|
20177530|NCT00952653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177531|NCT00380068|Gilead Sciences Inc|Martine Allard, PhD; Senior Clinical Research Scientist|650-524-3898|martine.allard@gilead.com|
20177532|NCT01458574|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177533|NCT02125786|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|8662785833|referralinfo@stjude.org|
20177534|NCT02279641|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
20177535|NCT04964089|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
20177536|NCT01494051|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
20177537|NCT01664078|Cordis US Corp|Jennifer Lee|+1-669-699-6851|jennifer.lee02@cordis.com|
20177538|NCT02877485|Stanford Facial Plastic and Reconstructive Surgery|Sam P. Most MD|650-736-3223|smost@stanford.edu|
20177539|NCT01915563|Althaia Xarxa Assistencial Universitaria de Manresa|Dr Rafael Fernandez|34.8732550|rfernandezf@althaia.cat|3730
20177540|NCT02259608|Radboud UMC|Rob Arts|0031 24|rob.jw.arts@radboudumc.nl|36 67206
20177541|NCT01812044|Duke University Medical Center|Laura Enyedi, M.D.|919-684-2038|laura.enyedi@dm.duke.edu|
20177542|NCT02720484|Northwestern University|Devalingam Mahalingam|312.472.0564|mahalingam@northwestern.edu;|
20177543|NCT05070897|Hôpital Européen Georges Pompidou|Pr Elena Paillaud|0156093310|elena.paillaud@aphp.fr|
20177544|NCT05039268|Macquarie University|Richard Gan|+61 2 9812 3739|richard.gan@mq.edu.au|
20177545|NCT01617629|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
20177546|NCT01663636|Center for Global Health, University of Colorado|Dr. Edwin J. Asturias|3037246282|edwin.asturias@ucdenver.edu|
20177547|NCT03832946|Galecto Biotech aps|Hans Schambye - Chief Executive Officer|+4526373726|info@galecto.com|
20177548|NCT02715765|University of Minnesota|Kelvin Lim|612-273-9803|kolim@umn.edu|
20177549|NCT02060890|University of California, San Francisco|Nicholas Butowski MD Professor of Neuro-Oncology|414-353-2966|Thelma.Munoz@ucsf.edu|
20177550|NCT02838017|NorthShore University HealthSystem|Lena Braginsky|2245952705|lena.braginsky.mfm@gmail.com|
20177551|NCT01692197|UT MD Anderson Cancer Center|Borthakur,Gautam MD|713-563-1586|CR_Study_Registration@mdanderson.org|
20177552|NCT02120924|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
20206327|NCT03300258|University of Wisconsin, Madison|Peter Adamczyk|(608) 263-3231|peter.adamczyk@wisc.edu|
20162184|NCT01732913|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20162185|NCT03233438|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20162186|NCT03831945|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
20162187|NCT00614484|Professor of Radiation Medicine, Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@llu.edu|
20177553|NCT01884350|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20162188|NCT01300455|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177554|NCT03510481|NIAID/LMIV|Dr. Patrick Duffy|301-761-5089|patrick.duffy@nih.gov|
20177555|NCT02756624|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20177556|NCT03588572|Guangzhou General Hospital of Guangzhou Military Command|Dr.Yan Liu|0086-02088654756|yanliu@139.com|0086
20177557|NCT02663817|University of Miami|Dr. Ivaylo Mihaylov|305-243-8223|i.mihaylov@med.miami.edu|
20177558|NCT02099006|University of Rochester|Adrienne Bonham MD|(585) 273-3314|adrienne_bonham@urmc.rochester.edu|
20177559|NCT01308580|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20162189|NCT03074682|Yale University|Dr. Marc Auerbach|203-688-3333|marc.auerbach@yale.edu|
20162190|NCT00694304|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20162191|NCT02438813|Allergan, Inc|Medical Director/ Epidemiologist|714-246-4500|clinicaltrials@allergan.com|
20162192|NCT00576576|Emory|Dr. Habib Samady|4047781237|hsamady@emory.edu|
20162193|NCT03135210|University of Minnesota|Amanda Sharp|(612) 626-4691|sharp@umn.edu|
20162194|NCT00552409|University of Washington|Dr. Ian de Boer|206-616-5403|deboer@u.washington.edu|
20162195|NCT04018313|Celltrion. Inc|Keumyoung Ahn/Head of Clinical Planning 2 Department|+82 32 850 4190|Keumyoung.ahn@celltrion.com|
20162196|NCT01270256|University of Chicago|Dr. Robert M Naclerio|773-702-0080|rnackeri@surgery.bsd.uchicago.edu|
20162197|NCT02879578|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20177560|NCT03712917|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
20162198|NCT04566692|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
20162199|NCT00671437|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
20177561|NCT01438541|Molnlycke Health Care AB|Tina Kjellén|+46317223098|tina.kjellen@molnlycke.com|
20177562|NCT02091167|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios, Coordinator of Clinical Trials|+55 27 3335-7337|emnpalacios@gmail.com|
20177563|NCT03096782|University of Texas MD Anderson Cancer Center|Amanda Olson, MD / Stem Cell Transplantation|713-745-1505|alolson@mdanderson.org|
20177564|NCT02250612|Sylentis|Clinical Trials Department||info@sylentis.com|
20177565|NCT05356221|Oticon Medical|Dr. Nicole Amichetti|+1 609-366-0424|nitc@oticonmedical.com|
20177566|NCT01286779|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20177567|NCT02862106|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
20177568|NCT00377676|VeroScience|Richard Scranton|401 816-0525|richard_scranton@veroscience.com|
20177569|NCT04153409|Lateral Pharma Pty Ltd|Mr David Kenley|+61400151490|dk@lateral-pharma.com|
20177570|NCT01617421|Clinical Center|Middleton, Kimberly|+1 301 496 9083|middletonk@mail.nih.gov|
20177571|NCT01754714|Abbott|Associate Director Clinical Services|+31 29-44-79-196|taco.baardman@abbott.com|
20177572|NCT05857163|TenNor Therapeutics (Suzhou) Limited.|Guozhu Geng|0512-86861990|guozhu.geng@tennorx.com|
20177573|NCT01972061|University of Pittsburgh|Dr. Christopher Chermansky|412-6418385|chermanskycj2@upmc.edu|
20177574|NCT01866410|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20177575|NCT00093145|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20177576|NCT01310036|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20177577|NCT00553267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177578|NCT04389840|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20177579|NCT02078284|Pugent Sound Blood Center|Sherrill Slichter|206-292-6541|sjslichter@psbc.org|
20177580|NCT02365467|Medtronic|Alexa Glandon, Medtronic Clinical Study Manager|12624087021|alexa.a.glandon@medtronic.com|
20177581|NCT02043782|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
20177582|NCT00709722|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
20177583|NCT04667117|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20177584|NCT03359096|University of Pennsylvania|Raj C. Dedhia, MD, MSCR|215-349-5009|Raj.Dedhia@pennmedicine.upenn.edu|
20177585|NCT01306162|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177586|NCT01947946|AZ-PPD|Steven Fox|441480716682|steven.fox@ppdi.com|
20177587|NCT00833989|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177588|NCT01805297|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6060|sonny-icks@dmei.org|
20177589|NCT02952924|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20177590|NCT01226745|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20177591|NCT01435577|Grünenthal GmbH|Director of Clinical Trials|+241 569 3223||
20177592|NCT02830594|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20177593|NCT01156701|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177594|NCT02232893|Tsumura USA Inc|Yu Tanaka|609-799-2083|Yu Tanaka <tanaka_yuu@mail.tsumura.co.jp>|
20177595|NCT01298128|Mount Sinai Hospital|Dr. Kimberly Liu|416-586-5367|kliu@mtsinai.on.ca|
20177596|NCT01090453|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177597|NCT00522275|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20177598|NCT02666950|Mayo Clinic|Lisa Sproat, M.D.|480/301-8000|Sproat.Lisa@mayo.edu|
20177599|NCT03867734|University of Washington|Lindley A. Barbee, MD, MPH|206-744-2595|lbarbee@uw.edu|
20177600|NCT03965052|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20177601|NCT00884585|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20177602|NCT03970109|National Institutes of Health|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
20177603|NCT04323436|Novartis|Study Director|862-778-8300|Novartis.email@novartis.com|
20177604|NCT01365494|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20177605|NCT03351049|University of Pittsburgh|David Brienza|412.624.6383|dbrienza@pitt.edu|
20177606|NCT01700816|Massachusetts General Hospital|Carlos Fernandez Robles MD|6176432410|cfernandez-robles@mgh.harvard.edu|
20177607|NCT03832192|care.coach|Principal Investigator|8554374569|pi@care.coach|2
20177608|NCT02663128|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20177609|NCT01253343|Cincinnati Children's Hospital Medical Center|Dr. Drew Barzman|513-636-4788|drew.barzman@cchmc.org|
20177610|NCT01842789|Acessa Health, Inc.|Laura Kemp, Clinical Affairs Consultant|4083751465|lkemp@acessahealth.com|
20177611|NCT00450424|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|Kristen.Sorice@fccc.edu|
20177612|NCT02267382|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@mycovia.com|
20177613|NCT02730819|Mayo Clinic|Dr. Jason Sluzevich|904-953-9453|Sluzevich.Jason@mayo.edu|
20177614|NCT02121847|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20177615|NCT02142049|Pharmacyclics, LLC|Director of Clinical Operations|408-774-0330|Clinical_Directors@pcyc.com|
20177616|NCT01410448|Novartis Pharmaceuticals|Study Director|862-778-8300||
20177617|NCT02535065|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
20177618|NCT01781572|Pfizer|Study Director|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177619|NCT04198662|University of California, San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20177620|NCT03156023|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20177621|NCT00932893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177622|NCT02526693|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
20206328|NCT00247273|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20222027|NCT02107131|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|
20162200|NCT05098509|Radius Pharmaceuticals, Inc.|Ellie Ratigan|617-444-1800|scout015@radiuspharm.com|
20162201|NCT04033068|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177623|NCT03009045|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Loren G. Miller|310-222-5623|lgmiller@ucla.edu|
20177624|NCT01585103|Mayo Clinic|Dr. Jeffrey Alexander|507-284-1825|Alexander.Jeffrey14@mayo.edu|
20177625|NCT01349569|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
20177626|NCT03581305|NIH/CC|Dima Hammoud, Senior investigator|3014023041|hammoudd@cc.nih.gov|
20177627|NCT01798927|UT Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
20177628|NCT00626522|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
20177629|NCT03165526|Abbott Medical Device|Courtney Weiler|224 430 4918|ClinicalTrials.gov_SH_Inquiries@abbott.com|
20177630|NCT04389762|Professor Lu Neurological Clinic|Professor Lu|+886-3-396-0388|lucs.clinic@gmail.com|
20177631|NCT00328510|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-7679|Maria.Werner-Wasik@jeffersonhospital.org|
20177632|NCT00780208|Medical University of South Carolina|Aimee McRae-Clark, Professor|843-792-5216|mcraeal@musc.edu|
20177633|NCT01412944|Novartis|Study Director|862-778-8300||
20177634|NCT01990950|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
20177635|NCT02349295|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20177636|NCT02061384|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
20177637|NCT06111742|Boston Children's Hospital, Harvard Medical School|Harrison Pravder|516-426-8166|hpravder@meei.harvard.edu|
20177638|NCT01914926|Maimonides Medical Center|Christian Fromm, MD; Director of Research|718-283-6391|cfromm@maimonidesmed.org|
20177639|NCT03489304|Perelman School of Medicine|Dr. Matthew Kayser|215 898 8298|kayser@pennmedicine.upenn.edu|
20177640|NCT02239679|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|Anna.Houlihan@sunpharma.com|
20177641|NCT02716974|Johns Hopkins University School of Medicine|Kenneth Pienta|410-502-3137|kpienta1@jh.edu|
20177642|NCT02605954|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20177643|NCT02301143|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20177644|NCT03214367|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20177645|NCT03508843|University of Alabama at Birmingham|Dr David Schwebel|1-205-934-8745|schwebel@uab.edu|
20177646|NCT04717596|Abigail Wexner Research Institute|Dr. Elise Berlan|6147222458|elise.berlan@nationwidechildrens.org|
20177647|NCT03555396|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
20177648|NCT02536508|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20177649|NCT01889420|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
20177650|NCT00130533|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20177651|NCT00574587|Montefiore Medical Center|Markenya Mirander|718-862-8840|MMIRANDE@montefiore.org|
20177652|NCT02040116|Wake Forest Baptist Medical Center|LeAnne Kennedy|336-713-3400|lakenned@wakehealth.edu|
20177653|NCT01592435|Carestream Health, Inc.|Susan Pate, MS, RN, RAC, Senior Manager, Clinical Affairs|585-627-6557|susan.pate@carestream.com|
20177654|NCT02384759|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20177655|NCT01605617|Mayo Clinic|Dr. Jeffrey L. Cornella|480-342-2867|cornella.jeffrey@mayo.edu|
20177656|NCT00347308|The New York Eye & Ear Infirmary|Anthony P. Sclafani, MD|212-979-4200|asclafani@nyee.edu|
20177657|NCT02014116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20177658|NCT00121238|University of Michigan Comprehensive Cancer Center|Maha Hussain, M.D.|(734)936-8906|mahahuss@med.umich.edu|
20177659|NCT03043664|Duke University Medical Center|Michael Morse, MD|919-668-1861|michael.morse@duke.edu|
20177660|NCT01540851|Brigham and Women's Hospital|Elena Losina, PhD|617-732-6928|elosina@partners.org|
20177661|NCT00325468|Amgen Inc.|Study Director|866-572-6436||
20177662|NCT03593655|Stellenbosch University, Centre for Medical Ethics and Law|Gonasagrie Nair|27-21-938-7050|gnair@sun.ac.za|
20177663|NCT03732209|Fralin Biomedical Research Institute at VTC|Jeffrey Stein|540-526-2124|jstein1@vtc.vt.edu|
20177664|NCT02864082|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
20177665|NCT04139317|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20177666|NCT03621696|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
20177667|NCT00412087|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
20177668|NCT01109992|Brigham and Women's Hospital|Sharmila Dorbala|617-732-6215|sdorbala@partners.org|
20177669|NCT00690755|James A. Haley VA Research Department|Robert Farese, MD|813-972-2000|Robert.Farese@va.gov|
20177670|NCT01390246|University of Texas Medical Branch|Dr. Tatiana Nanovskaya, PhD|409-772-3908|tnnanovs@utmb.edu|
20177671|NCT00214136|University of Wisconsin Carbone Cancer Center|Dr. Mark A. Ritter|608-263-8500|ritter@humonc.wisc.edu|
20177672|NCT04287920|Mayo Clinic|Douglas (Doug) A. Simonetto, M.D.|507-284-4824|Simonetto.Douglas@mayo.edu|
20177673|NCT02310750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20177674|NCT03085563|Children's Hospital Colorado|Paul Szefler, MD, FAAP|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20177675|NCT03447782|Boston Children's Hospital|Dr. Alyssa Lebel|7812161960|alyssa.lebel@childrens.harvard.edu|
20177676|NCT01934218|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|yuko.shibata@seikagaku.co.jp|
20177677|NCT03538626|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20177678|NCT04575428|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
20177679|NCT02911948|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20177680|NCT03021187|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20177681|NCT00718718|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20177682|NCT02467777|Fox Valley Orthopaedic Institute|Vishal Mehta|6305841400|vmehta@fvortho.com|
20177683|NCT03394924|Enanta Pharmaceuticals, Inc.|Nathalie Adda|+1 6176070705|nadda@enanta.com|
20177684|NCT02276482|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177685|NCT03277313|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20177686|NCT01311102|Harbor-UCLA Medical Center|Dr. Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
20177687|NCT02005471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20177688|NCT00801827|Vanderbilt_University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
20177689|NCT00627705|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
20177690|NCT03431168|UAB|Dr. Jodie Dionne|2059756530|jdionne@uabmc.edu|
20177691|NCT00253864|Ottawa Hospital Research Institute|Clinical Research Coordinator|613-737-8899|kmcilquham@ohri.ca|79839
20177692|NCT04697758|AsclepiX Therapeutics|Dr A Shojaei|8005723545|ashojaei@asclepix.com|
20177693|NCT00360529|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
20177694|NCT00443547|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20177695|NCT00791765|Amgen Inc.|Study Director|866-572-6436||
20177696|NCT04575896|Johns Hopkins University|Niraj Desai, MD|410-614-8297|ndesai13@jhmi.edu|
20177697|NCT00924287|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
20177698|NCT02498483|Columbia University|Jennifer Woo Baidal|212-342-2962|jw3286@cumc.columbia.edu|
20177699|NCT04704375|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
20177700|NCT01625897|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20177701|NCT00156065|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20177702|NCT01432366|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177703|NCT02891187|UNewMexico|Dr. Jennifer Thompson|16366790301|jthompson626@gmail.com|
20177704|NCT04546581|University of Minnesota|James Neaton|612-626-9040|neato001@umn.edu|
20177705|NCT01275625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177706|NCT03929029|Dana Farber Cancer Institute|Dr. Patrick A. Ott|6175829030|patrick_ott@dfci.harvard.edu|
20177707|NCT04579757|HUTCHMED Limited|Nicky Murray|+44 7738 881999|nicolam@hutch-med.com|
20177708|NCT02207816|GlaxoSmithKline|GSK Response Center|866-435-7343|cc781166@gsk.com|
20177709|NCT01780922|Washington State Unviversity|Boon P. Chew|5093351427|boonchew@wsu.edu|
20177710|NCT02473952|Grifols Therapeutics, LLC|Rhonda Griffin, BSN|919-316-6693|Rhonda.Griffin@Grifols.com|
20177711|NCT00958919|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20177712|NCT02606838|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20177713|NCT00237744|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|jjd17@case.edu|6603
20177714|NCT04955639|Pivot Health Technologies Inc.|Craig Fujii, Sr. Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
20177715|NCT01369342|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
20177716|NCT02727894|Institution for Clinical and Experimental Medicine|Jan Král|+420605273008|jan.kral@centrum.cz|
20177717|NCT04320069|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20177718|NCT03204279|Helsinn Healthcare SA|Edwin de Wit - Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
20177719|NCT00924885|Vitrolife|Director of clinical investigations|0046708228063|thardarson@vitrolife.com|
20177720|NCT02508480|Boston University|Dr. Zlatka Russinova|617-353-3549|zlatka@bu.edu|
20177721|NCT04969250|University of Minnesota|Melissa Skeans, Statistician/Protocol Manager|612-626-9011|tico@insight-trials.org|
20177722|NCT03305016|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
20177723|NCT02119416|SUNYBuffalo|Jennifer Temple|716-829-5593|jltemple@buffalo.edu|
20177724|NCT02278328|Children's Hospital of Philadelphia|Timothy Roberts, Professor|267 426 0307|robertstim@email.chop.edu|
20177725|NCT01059565|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20177726|NCT03927950|Department of Psychiatry, University of Tartu|Eduard Maron|+3727318812|eduard.maron@kliinikum.ee|
20177727|NCT03263429|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20177728|NCT01618864|Iluminage|Director of Clinical Affairs|+972 547 800 260|doranr@iluminagebeauty.com|
20177729|NCT05177770|Coherus BioSciences|Allison Intondi, Vice President, Clinical Operations|800-794-5434|ClinicalTrials@Coherus.com|
20177730|NCT00958035|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20177731|NCT03585244|Foundation for Prader-Willi Research|Theresa Strong, PhD - Director of Research Programs|888-322-5487|theresa.strong@fpwr.org|702
20177732|NCT02105948|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177733|NCT01140191|Walter Reed National Military Medical Center (WRNMMC)|COL Glenn W. Wortman|301-295-6400|glenn.wortmann@amedd.army.mil|
20162202|NCT04042727|Stony Brook University|Andreas KAlogeropoulos|4045124463|Andreas.Kalogeropoulos@stonybrookmedicine.edu|
20177734|NCT02955511|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|3104231682|ofelia.elvir-lazo@cshs.org|
20177735|NCT03273946|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20190433|NCT01898299|New York State Psychiatric Institute|Joshua Kantrowitz|6467746738|jk3380@cumc.columbia.edu|
20177736|NCT01308918|Institut universitaire de cardiologie et de pneumologie de Quebec|Nathalie Gagne|418 656-8711|nathalie.gagne@criucpq.ulaval.ca|2645
20177737|NCT01220557|Forschungsinstitut der Diabetes Akademie Mergentheim|Norbert Hermanns, PhD|+49 7931 594|hermanns@diabetes-zentrum.de|553
20177738|NCT02558010|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
20177739|NCT00430768|UMASS Medical School|Dr. Terry Flotte|(508) 856-2107|Terry.Flotte@umassmed.edu|
20177740|NCT00762320|Phoenix Children's Hospital|Laura Clarke-Steffen, PhD, RN|602-933-0234|lclarke@choenixchildrens.com|
20177741|NCT02199028|Stanford University|Dr Bruce Buckingham|(408) 356-0911|buckingham@stanford.edu|
20177742|NCT01881126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20177743|NCT00867217|University of Kansas Medical Center|Dr. Bruce Kimler|(913) 588-4523|bkimler@kumc.edu|
20177744|NCT04072159|Arizona State University, College of Health Solutions|Dr. Alexis Koskan (Assistant Professor)|602-827-2792|alexis.koskan@asu.edu|
20177745|NCT01177904|IVI Madrid|Dr. Graciela Kohls|91 180 29 00|graciela.kohls@ivi.es|
20177746|NCT00695669|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177747|NCT05045625|Albany Medical College|Clinical Research Coordinator|518-262-2367|khazeno@amc.edu|
20177748|NCT03421691|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20177749|NCT00047879|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
20177750|NCT03980470|University Hospital Zurich|Dr Ronny R. Buechel|+41442551059|ronny.buechel@usz.ch|
20177751|NCT01196975|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177752|NCT03738150|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177753|NCT03762135|University of Michigan|Dr. Susan Woolford|734-615-8214|swoolfor@med.umich.edu|
20177754|NCT01548690|University of Texas Southwestern Medical Center|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
20177755|NCT01117311|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
20177756|NCT00105027|The EMMES Corporation|Paul C. VanVeldhuisen, Ph.D.|301-251-1161|score@emmes.com|
20177757|NCT05244525|The University of Texas Health Science Center at Houston|James M. Gregory, MD|(713) 486-7500|James.M.Gregory@uth.tmc.edu|
20177758|NCT00110617|Novartis Pharmaceuticals|Study Director|862-778-8300||
20177759|NCT02657226|The University of Pittsburgh|Dr. John Kellum|4123834202|kas287@pitt.edu|
20177760|NCT03708198|UVA Health|William Manson, MD|4349242283|wcm6m@virginia.edu|
20177761|NCT00045110|Adult Brain Tumor Consortium|Lauren E Abrey, MD|410-955-8837|jfisher@jhmi.edu|
20177762|NCT01932164|Hospital Sirio Libanes|Dra Daniela Franco Bueno|+5511997900159|dbuenousp@gmail.com|
20177763|NCT03680755|Temple University Kornberg School of Dentistry|Associate Dean for Research & Chair Department of Oral Health Sciences|215-707-1773|marisol.tellez.merchan@temple.edu|
20177764|NCT03662750|Imperial College London|Prof Roland Veltkamp|020 3311 7296|r.veltkamp@imperial.ac.uk|
20177765|NCT05872035|Apple|Rajiv Kumar, MD|8669055303|htclinicalquestions@apple.com|
20177766|NCT03843788|Rutgers, The State University of New Jersey|Dr. Adrienne Simonds|8565667190|simondad@shp.rutgers.edu|
20177767|NCT03069482|Duke University Psychiatry & Behavioral Sciences|Dr. Roger Vilardaga|9196813441|roger.vilardaga@duke.edu|
20177768|NCT01461668|University of California Irvine|Raveena Singh|949-824-9285|ravsingh@uci.edu|
20177769|NCT01009931|Rutgers Cancer Institute of New Jersey|Tatiana Zelinskaya|(732) 235-9837|zelinsta@cinj.rutgers.edu|
20177770|NCT01760239|HealthPartners Institute|Elyse Kharbanda, MD MPH|952-967-5038|Elyse.O.Kharbanda@healthpartners.com|
20177771|NCT01983293|Abbott|Clay Cohorn|1 972 309 8087|clay.cohorn@abbott.com|
20177772|NCT02434692|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20177773|NCT03147248|Celltrion. Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
20177774|NCT03750552|Theravance Biopharma Inc|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20177775|NCT02062632|Mayo Clinic|Terence T. Sio, MD, MS|507/284-2511|sio.terence@mayo.edu|
20177776|NCT02156674|Masonic Cancer Center, University of Minnesota|Elizabeth Braunlin MD, PhD|612 626 2755|braun002@umn.edu|
20177777|NCT00581230|UT Medical School at Houston|Carin A. Hagberg|713-500-6222|carin.a.hagberg@uth.tmc.edu|
20177778|NCT00773968|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20177779|NCT01562756|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
20177780|NCT02241967|Ralph H. Johnson VA Medical Center|Jeffrey Borckardt, Ph.D|843-792-3295|Jeffrey.Borckardt@va.gov|
20177781|NCT04517396|University of Pennsylvania|Katherine Greene|215-662-7580|katherine.greene@pennmedicine.upenn.edu|
20177782|NCT02008890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20177783|NCT02332720|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190434|NCT02383043|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
20177784|NCT03240588|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20177785|NCT01449305|isRed Pharma & Biotech Research Corporation|Mirror Hsieh|886-8-7628188|mingrong@bioisred.com|
20162203|NCT01181258|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
20162204|NCT02540265|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
20162205|NCT01972789|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
20162206|NCT00971295|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20162207|NCT04836247|University of Delaware|Valerie Earnshaw|302-831-4772|earnshaw@udel.edu|
20162208|NCT04016077|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162209|NCT00988364|Baylor College of Medicine|Dr. Chu-Huang Chen|832-355-9026|chu-huang.chen@bcm.edu|
20162210|NCT02474407|SK Bio-pharmaceuticals Co, Ltd|Lee Min Jae, Associate Manager||minj.lee@sk.com|
20162211|NCT01887353|Intermountain Healthcare|T. Jared Bunch|8015074701|jared.bunch@imail.org|
20162212|NCT00609739|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
20190435|NCT01303744|Cerespir|Richard Margolin|(646) 202-2562|rmargolin@cerespir.com|
20162213|NCT01178268|Abbott Vascular|Dana Haudek|928-925-4054|dana.haudek@av.abbott.com|
20162214|NCT00592124|Johns Hopkins University|Craig W. Hendrix, MD|1 410 955-9707|chendrix@jhmi.edu|
20162215|NCT00649428|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
20162216|NCT04599465|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20162217|NCT00258817|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20162218|NCT00495625|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
20162219|NCT00856726|University of Alabama at Birmingham|Orlando Gutierrez|205-996-2736|ogutierrez@uabmc.edu|
20162220|NCT02702180|Savara Inc|Raymond D. Pratt, MD, PACP - Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20162221|NCT03267888|Emory University|Mohammad K Khan|404-778-3473|m.k.khan@emory.edu|
20162222|NCT02893917|Yale School of Medicine: Medical Oncology|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
20162223|NCT00679172|Emergent Product Development Gaithersburg|Dr. Tim Babinchak|(240) 631-3585||
20162224|NCT00793169|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
20162225|NCT03392649|Univerisity of Chicago Medicine|Dr. Gaurav Upadhyay|773-702-9461|gupadhyay@medicine.bsd.uchicago.edu|
20162226|NCT02241343|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20162227|NCT00753454|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
20190436|NCT00760877|Novartis|Study Director|862-778-8300||
20162228|NCT05249569|UT Southwestern Medical Center|Dr. David Hsieh|214/648-4180|david.hsieh@utsouthwestern.edu|
20162229|NCT03927144|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20162230|NCT03858530|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
20162231|NCT01463072|City of Hope|Dr. Mina Sedrak|626-359-8111|msedrak@coh.org|
20162232|NCT02271945|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
20162233|NCT01452919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162234|NCT00615030|Novartis Pharmaceuticals|Study Director|862-778-8300||
20162235|NCT01359943|Novartis Pharmaceuticals|Study Director|862-778-8300||
20162236|NCT03781505|Aga Khan University|Dr. Muhammad Saad Yousuf|+92213486|saad.yousuf@aku.edu|4253
20177786|NCT02091726|University of New England|Peter S. Millard, MD, PhD|2072992131|pmillard@mac.com|
20177787|NCT01227681|Buddhist Tzu Chi General Hospital Hualien|Dr. Chen Shin-Yuan|+886-3-8561825|william.sychen@msa.hinet.net|2151
20177788|NCT02047045|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
20177789|NCT04066114|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20177790|NCT00803647|NSABP Foundation|Diana Gosik, Director Department of Site and Study Management|412-339-5333|diana.gosik@nsabp.org|
20177791|NCT00856856|Abbott Vascular International BVBA|Susan Veldhof|31653428610|susan.veldhof@av.abbott.com|
20177792|NCT00728819|Penn Medicine|Associate Professor of Radiology|2156627892|ITKINMAX@GMAIL.COM|
20177793|NCT00434057|Electro-Optical Sciences, Inc.|Joanna Adrian / Director, Clinical Operations and Medical Affairs|(914)591-3783|adrian@eosciences.com|732
20177794|NCT04829344|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
20177795|NCT00455195|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20177796|NCT03814889|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
20177797|NCT02117570|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20177798|NCT02148250|University of Minnesota|Elizabth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
20177799|NCT00922428|Pascoe pharmazeutische Präparate GmbH|Anja Braschoss|0049 641 7960100|KlinischeForschung@pascoe.de|
20177800|NCT03403725|Menarini Ricerche SPA|Corporate Director of Clinical Sciences|+39 055 56809933|acapriati@menarini-ricerche.it|
20177801|NCT03701555|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20177802|NCT00546728|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20177803|NCT00373334|Braintree Laboratories, Inc.|Clinical Operations Manager|781-843-2202|jmcgowan@braintreelabs.com|
20177804|NCT02539342|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
20190437|NCT01605435|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
20162237|NCT00065806|Duke University Medical Center|Laura Schanberg, MD|919-684-6575|laura.schanberg@duke.edu|
20162238|NCT03002311|WASHINGTON UNIVERSITY MEDICAL SCHOOL|Brian F. Gage, MD|3144548697|bgage@wustl.edu|
20162239|NCT00308074|University of Massachusetts Medical School|Dr. Jean A. Frazier|508-856-5896|ChildResearch@umassmed.edu|
20177805|NCT04447404|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1417|jill.burns@durect.com|
20162240|NCT02092311|OMID FERTILITY CENTER|Dr.Navid Pooyan|00989124474032|navidpooyan@yahoo.com|
20162241|NCT00652080|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
20177806|NCT04723576|RAND|Lisa S. Meredith|310.393.0411|seidel@rand.org|7365
20177807|NCT01064739|Vanderbilt University|Dr. Emily Garland|615 936 1748|emily.garland@vanderbilt.edu|
20177808|NCT02962687|Durham VA HSR&D|Susan N Hastings|919-286-6986|susan.hastings@va.gov|
20177809|NCT04258020|OhioHealth|Dr. Kiran Devulapally|614-566-9143|kiran.devulapally@ohiohealth.com|
20177810|NCT02097472|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20177811|NCT04004611|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20177812|NCT04323852|Shahid Beheshti Medical School|Dr. ََAfshin Zarghi|021-22439781|Mpajouhesh@sbmu.ac.ir|
20177813|NCT04022668|Yeditepe University|Emre Aslanger|0216578000|mr_aslanger@hotmail.com|4240
20177814|NCT03834779|UT Southwestern Medical Center|Dr. Ank Nijhawan|214-648-2777|ank.nijhawan@utsouthwestern.edu|
20177815|NCT04118348|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20177816|NCT01519206|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20177817|NCT02297308|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
20177818|NCT04738643|University of Pennsylvania|Robert Schnoll, PhD|215-746-7143|schnoll@pennmedicine.upenn.edu|
20177819|NCT03579563|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
20177820|NCT04597190|University of Washington|John Fortney|2066856955|fortneyj@uw.edu|
20177821|NCT04349553|Prokarium|Kristen Albright|+44 (0) 7375 124 275|kristen.albright@prokarium.com|
20177822|NCT03526250|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20177823|NCT04420221|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20190438|NCT00711555|University of Illinois|Sandra Cuellar|312-996-6985|scuell1@uic.edu|
20177824|NCT02219932|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20177825|NCT00990652|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
20177826|NCT04618718|Protembis GmbH|Karl von Mangoldt|+49 241 9903 3621|kvm@protembis.com|
20177827|NCT04159688|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
20177828|NCT01988246|Cole Eye Institute - Cleveland Clinic|Rishi Singh, MD|216-445-9497|singhr@ccf.org|
20177829|NCT03543826|University of Washington|Adrienne James|206-744-4634|ajames1@uw.edu|
20177830|NCT01272934|Novartis Consumer Health|Clinical Project Leader|0041223635228||
20177831|NCT05219877|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti|+62 816-825-226|harrinaerlianti@gmail.com|
20177832|NCT01201629|OKC VA Medical Center|Dr. Meheroz H. Rabadi|405-456-5298|meheroz.rabadi@va.gov|
20177833|NCT01358526|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20177834|NCT04558346|University of Kansas Medical Center|Dr. Michael Rippee|913-945-7486|mrippee@kumc.edu|
20177835|NCT01462344|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177836|NCT01962974|Janssen Pharmaceuticals|STRATEGIC LEAD||ClinicalTrialDisclosure@its.jnj.com|
20177837|NCT03086447|Johnson & Johnson Vision|Kristy Canavan- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1474|KCANAVA2@its.jnj.com|
20177838|NCT00581529|University of Michigan Comprehensive Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
20177839|NCT00809757|Sunovion|Respiratory Medical Director|1-866-503-6351||
20177840|NCT00659334|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
20177841|NCT01174342|Meir Medical Center|Amit Meshi|+972523580222|amitmeshi@gmail.com|
20177842|NCT01629329|EINSTEIN MEDICAL CENTER|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
20177843|NCT01592643|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
20177844|NCT01218438|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20177845|NCT05819749|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
20177846|NCT05912400|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|IWen@uams.edu|24024
20177847|NCT01092338|Children's Hospital of Philadephia|Virginia Stallings|215-590-1664|stallingsv@email.chop.edu|
20177848|NCT02522494|Jesse Brown VA Medical Center|Howard S. Gordon, MD|(312) 569-7331|howard.gordon2@va.gov|
20177849|NCT05645354|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD,MSc,DrPH-NHSN|713-500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
20177850|NCT03248739|Wake Forest University School of Medicine|Kyle Fargen|336-716-8641|kfargen@wakehealth.edu|
20177851|NCT03461003|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
20177852|NCT01795833|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
20177853|NCT00852631|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
20177854|NCT00765843|Rosalind Franklin University of Medicine and Science|Ryan Crews|847-578-8437|ryan.crews@rosalindfranklin.edu|
20177855|NCT02508311|James J Peters VA Medical Center|Gregory Schilero|7185849000|gregory.schilero@va.gov|6701
20190439|NCT01298219|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20190440|NCT02024477|The George Washington University|Dr Saby Sen|202-994-8560|ssen1@gwu.edu|
20190441|NCT00090064|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20190442|NCT04820023|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|+82-31-8092-3280|Clinicaltrials.gov_inquiries@bridgebiorx.com|
20190443|NCT01020487|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20177856|NCT00448539|Eisai Inc.|Eisai Medical Information|1 8882472378|esi_medinfo@eisai.com|
20190444|NCT04049578|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190445|NCT02400749|Innovaderm Research Inc.|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
20177857|NCT04862143|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20177858|NCT02370602|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20190446|NCT02240810|Boston Scientific|Director, Clinical Trials|508-683-6678|peter.maurer@bsci.com|
20177859|NCT02103439|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20177860|NCT03349710|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20177861|NCT00695903|Cubist Pharmaceuticals|Medical Director||ellie.hershberger@cubist.com|
20177862|NCT02696317|Alcon, A Novartis Division|Sr. Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20177863|NCT01343368|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-8094|smith719@umn.edu|
20177864|NCT04256733|University of Montana|Dr. Laurie Slovarp|406-243-2107|laurie.slovarp@umontana.edu|
20177865|NCT04542343|CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE|DR. MOHSEN BAZARGAN|323-357-3655|mohsenbazargan@cdrewu.edu|
20177866|NCT01296568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177867|NCT00321854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177868|NCT01816594|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20177869|NCT00413153|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
20177870|NCT00454051|Novartis Pharmaceuticals|Study Director|862-778-8300||
20177871|NCT01571362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177872|NCT03117738|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
20177873|NCT03966157|Saint Louis University|Dr. Samuel J. Burton|3147500811|s.burton.1818@gmail.com|
20177874|NCT01669629|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|904 443-1032|kosborn@its.jnj.com|
20177875|NCT01221597|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20177876|NCT02504073|Kantonsspital Baselland Standort Bruderholz|Alexandra Bellwald|0041797429755|alexandra.bellwald@ksbl.ch|
20177877|NCT04420689|Alume Biosciences|Chief Medical Officer|858-922-3966|brett.berman@alumebiosciences.com|
20177878|NCT01877538|Department of Nuclear Medicine & PET Center, Aarhus University Hospital|Dr. Per Borghammer|+0045 23818581|perborgh@rm.dk|
20177879|NCT01347333|Mercy Research|Michelle McFarland, MPH, CHRC|314-251-8827|michelle.mcfarland@mercy.net|
20177880|NCT02366338|Mugla Sitki Kocman University|Ozcan Basaran|+902522120724|basaran_ozcan@yahoo.com|
20177881|NCT01292928|Boston Scientific Corporation|Philip Ghizoni, Clinical Trial Manager|763-255-0036|Philip.Ghizoni@bsci.com|
20177882|NCT04530448|West Virginia University|Ankit Sakhuja, MD|304.598.6092|ankit.sakhuja@hsc.wvu.edu|
20177883|NCT01491854|Novartis Pharma AG|Study Director|862-778-8300|novartis.email@novartis.com|
20177884|NCT02212574|Johns Hopkins University|Dr. Kenneth Cohen|(410) 614-5055|kcohen@jhmi.edu|
20177885|NCT02703350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177886|NCT02898974|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
20177887|NCT01026974|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20177888|NCT00303966|University of Chicago|Dr. Wendy Stock|773-834-8982|wstock@medicine.bsd.uchicago.edu|
20177889|NCT01715805|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20177890|NCT04936230|Weill Cornell Medicine|Himanshu Nagar, MD|212-746-3704|hnagar@med.cornell.edu|
20177891|NCT02647359|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20177892|NCT04642638|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20177893|NCT00511004|NIAID|Thomas B. Nutman|301-496-5398|tnutman@niaid.nih.gov|
20177894|NCT02388386|Scripps Clinic Medical Group|Sanjeev Bhavanni MD|6196601842|bhavnani.sanjeev@scrippshealth.org|
20177895|NCT01672801|Boston IVF|Alan Penzias|781-434-6500|apenzias@bostonivf.com|
20177896|NCT01673802|University of Alabama at Bimringham|John V. Thomas, MD; Principal Investigator|205-996-4132|jvthomas@uabmc.edu|
20177897|NCT02935062|Federal University of Santa Maria|Márcia Keske-Soares|55 55 999726370|marcia-keske.soares@ufsm.br|
20177898|NCT02384954|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20177899|NCT01692340|The Ohio State University|Steven K. Clinton, MD PhD|614-293-2886|steven.clinton@osumc.edu|
20177900|NCT01733056|Emory University|Dr. Robert Swerlick|404-727-3669|rswerli@emory.edu|
20177901|NCT01546194|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
20177902|NCT00836641|Goethe University Childrens Hospital|Prof Markus Rose|0049-696301|Markus.Rose@kgu.de|5754
20177903|NCT02372396|Veterans Medical Research Foundation|Dr. Ariel Lang|858-552-8585|ajlang@ucsd.edu|5359
20177904|NCT02890381|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20177905|NCT04313634|Mayo Clinic|Sundeep Khosla, M.D.|507-255-6663|khosla.sundeep@mayo.edu|
20177906|NCT03825380|Laboratoires Théa|Corentin LE CAMUS|0473981414|Corentin.LECAMUS@theapharma.com|
20177907|NCT00680316|Genentech, Inc.|Medical Communications|800-821-8590||
20190447|NCT01945593|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20190448|NCT00228813|Emory University|Kuang-Yueh Chiang, MD|404-785-0858|kchian2@emory.edu|
20177908|NCT01762046|Massachusetts General Hospital|Jose C. Florez, MD, PhD|6176433308|jcflorez@partners.org|
20190449|NCT00507429|OXiGENE, Inc.|Peter Langecker, MD, PhD|650 635 7008|plangecker@oxigene.com|
20206329|NCT04209530|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20190450|NCT00506025|University of California Irvine Medical Center|Deborah A. Wing, MD|714-456-5967|dwing@uci.edu|
20190451|NCT01574105|Saskatoon Health Region|Mark Rosin|306-655-2128|mark.rosin@sasktoonhealthregion.ca|
20190452|NCT04714359|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20206330|NCT03276572|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
20206331|NCT00607919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20177909|NCT03595904|Icahn School of Medicine at Mount Sinai|Dr. Sarah Miller|212-824-7783|Sarah.Miller@mssm.edu|
20177910|NCT01581281|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
20177911|NCT02087163|Align Technology|Allison Mossing|4084701056|amossing@aligntech.com|
20177912|NCT02298192|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20177913|NCT01995123|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health; William S Middleton Memorial Veterans Hospital|Jessica Cook, PhD|608-265-9775|jwcook@ctri.wisc.edu|
20177914|NCT04764396|University of Michigan|Eileen Carpenter|734-615-3948|eicarpen@med.umich.edu|
20177915|NCT03230916|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177916|NCT00383448|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
20177917|NCT01128413|Washington University School of Medicine|Dr. Chris Holthaus|314-747-5994|holthauscv@wustl.edu|
20177918|NCT02587351|University of Minnesota|John Connett|612-626-9010|john-c@umn.edu|
20177919|NCT01218646|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20177920|NCT00722761|MGH Curtis|Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
20177921|NCT02693665|Children's National Medical Center|Dr. Maureen E. Lyon, PhD, Professor of Pediatrics, Principal Investigator|703-346-2873|mlyon@childrensnational.org|
20177922|NCT02075593|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20177923|NCT01496352|Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD, VP, Drug Development|609-375-9855|kallenby@drreddys.com|
20177924|NCT02010060|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
20177925|NCT04414696|Kaiser Permanente|Lyndsay Avalos|5108210300|lyndsay.a.avalos@kp.org|
20177926|NCT00660010|Abbott Laboratories|Global Medical Services|800-633-9110||
20177927|NCT00726752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177928|NCT01177098|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20177929|NCT06167031|Tzu Chi University|Associate professer Mei-Lin Hsieh|886933513291|shaer@gms.tcu.edu.tw|
20177930|NCT03870763|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20177931|NCT00778648|Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany|Dr. Stephanie Roll|+49 30 450 529023|stephanie.roll@charite.de|
20177932|NCT02120027|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
20177933|NCT01002872|Northshore University Healthsystem|Dr Stuart Sprague|847-570-1761|ssprague@northshore.org|
20177934|NCT03393000|Diffusion Pharmaceuticals Inc|Vice President of Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
20177935|NCT01773070|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20177936|NCT01471054|Oncology Service, Wills Eye Hospital|Arman Mashayekhi, MD|215-928-3105|arman_mash@yahoo.com|
20177937|NCT01843192|Ethicon, part of Johnson & Johnson|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20177938|NCT01559844|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20177939|NCT02181803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177940|NCT00951041|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177941|NCT01259713|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20177942|NCT01578993|Semprus BioSciences|Ulla Wallin, Director of Clinical Research|1-617-577-2205|ulla.wallin@semprusbio.com|
20177943|NCT02388724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20177944|NCT01217073|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20177945|NCT00620750|New York University School of Medicine|Marc Gourevitch, MD, MPH|212-263-8553|marc.gourevitch@nyumc.org|
20177946|NCT04477187|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20177947|NCT02564523|Janssen Vaccines & Prevention B.V|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20177948|NCT01552213|Stanford University, School of Medicine|Anna Girsen, Research Operations Manager|(650) 725-5720|agirsen@stanford.edu|
20177949|NCT03905655|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
20177950|NCT02566031|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20190453|NCT03884478|Loyola Marymount University|Dr. Sarah C. Boyle, Senior Research Scientist|3105686681|sarah.boyle@lmu.edu|
20190454|NCT02213094|UNC at Chapel Hill|Kim Boggess MD Principal Investigator|919-966-1601|kboggess@med.unc.edu|
20177951|NCT03031938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177952|NCT02479412|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20177953|NCT03317002|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20177954|NCT02732938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177955|NCT01613248|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20177956|NCT01636882|Viralytics Ltd|Mark Grose|1 647 821 7673|mark.grose@viralytics.com|
20177957|NCT03280121|Daniel and Daniel Consulting, LLC|Cynthia Harris, Director of Clinical Trials|775-392-2975|cindy@clinregconsult.com|
20177958|NCT01631630|National Institute on Alcohol Abuse and Alcoholism|Diazgranados, Nancy|+1 301 435 9386|nancy.diazgranados@nih.gov|
20177959|NCT01981564|Johns Hopkins University School of Medicine, Department of Pediatrics|Dr. Arlene Butz|410-614-5963|abutz@jhmi.edu|
20177960|NCT02162420|Masonic Cancer Center|Christen Ebens, MD, MPH|612-624-4511|ebens012@umn.edu|
20190455|NCT01807234|Johns Hopkins University School of Medicine|Dr. B. Lee Peterlin|410-550-9550|hnitchi1@jhmi.edu|
20222028|NCT02696291|Emergent Product Development Gaithersburg, Inc.|Tim Babinchak, MD|(240) 631-3585|tbabinchak@ebsi.com|
20162242|NCT03722524|AO Servier|Natalya LOGUNOVA|+7 495 9370700|Natalya.LOGUNOVA@servier.com|
20162243|NCT00663403|University of Michigan College of Pharmacy|Bruce A. Mueller|7347636629|muellerb@umich.edu|
20162244|NCT02649894|Becton Dickinson|Dawn Heimer|2018476800|dawn.heimer@bd.com|
20177961|NCT03638141|Sidney Kimmel Comprehensive Center|Ana De Jesus-Acosta|4432870411|adejesu1@jh.edu|
20177962|NCT03996473|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20177963|NCT03759873|University of Texas Medical Branch, Division of Cardiovascular Medicine|Dr. Diann Gaalema|409-772-1533|digaalem@utmb.edu|
20177964|NCT05725005|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
20177965|NCT06116591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177966|NCT05585307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20177967|NCT00233493|University Hospitals Cleveland Medical Center Center for Medical Mycology|Dr. Mahmoud Ghannoum|216-844-8580|Mahmoud.Ghannoum@case.edu|
20177968|NCT01391962|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
20177969|NCT06476366|Department of Dermatology, Emirates Military Hospital|Dr Ahsan Tameez-ud-din|051-9293480|ahsantameezuddinmalik@gmail.com|312
20177970|NCT03726346|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7675
20177971|NCT00054353|Fred Hutch|Marco Mielcarek, MD||mmielcar@fredhutch.org|
20177972|NCT03449030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20177973|NCT00388414|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20177974|NCT01404572|Bristol-Myers Squibb (BMS)|BMS Study Director||Clinical.Trials@bms.com|
20177975|NCT03282890|UConn|Dr. Michael Copenhaver|860-208-3632|michael.copenhaver@uconn.edu|
20177976|NCT00700401|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20177977|NCT00682734|Montefiore Medical Center|Benjamin Friedman|718 920 6626|befriedm@montefiore.org|
20177978|NCT00295750|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20177979|NCT01650259|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20177980|NCT00626431|Abbott|Global Medical Services|800-633-9110||
20177981|NCT01683864|University Clinic of Tübingen|Prof. Alfred Königsrainer|0049 7071 2983290|silvia.wagner@med.uni-tuebingen.de|
20177982|NCT00355082|GlaxoSmithKline|GSK Response Center|866-435-7343||
20177983|NCT02522715|Oregon Health & Science University|Rachel Slottke, Program Manager|503-494-6117|slottker@ohsu.edu|
20177984|NCT02073331|Aziyo Biologics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
20177985|NCT01359735|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20177986|NCT03006328|NYU Langone Health|Sandra Wittleder, PhD|212-263-4149|sandra.wittleder@nyulangone.org|
20177987|NCT01778465|Western University|Clinical Trials Program Coordinator|+15196466100|taciano.rocha@sjhc.london.on.ca|61125
20177988|NCT00724971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20177989|NCT01003249|Wake Forest University Health Sciences|Dr. Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
20177990|NCT00147966|UCSD|Arthur Kavanaugh|858-657-7040|akavanaugh@ucsd.edu|
20177991|NCT00955877|Washington University in St. Louis School of Medicine|Diego Morales|3144544688|d.morales@wustl.edu|
20177992|NCT02132611|Cardiovascular Systems, Inc.|Clinical Project Manager|651-259-1600|clinicaltrials_csi@csi360.com|
20177993|NCT03943095|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20177994|NCT03387852|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20177995|NCT02194621|RBHS-Rutgers School of Dental Medicine, Oral Biology Department|Daniel Fine, DMD|973-972-3728|finedh@sdm.rutgers.edu|
20177996|NCT04631666|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
20177997|NCT02763384|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-747-8439|guy@wustl.edu|
20177998|NCT02493127|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
20177999|NCT02037347|Yale University|Brett King MD|203-785-4092|brett.king@yale.edu|
20178000|NCT02096900|Loma Linda University|Amgad H. Hanna, MD|909-558-4475|ahanna@llu.edu|
20178001|NCT03143218|London School of Hygiene and Tropical Medicine|Professor Brian Greenwood|+442072994707|brian.greenwood@lshtm.ac.uk|
20178002|NCT00670774|Mayo Clinic|Dr. Mark D. Stegall|507-284-6275|Stegall.Mark@mayo.edu|
20178003|NCT00866840|Rutgers Cancer Institute of New Jersey|James Goydos, MD|(732) 235-7593|goydosjs@cinj.rutgers.edu|
20178004|NCT02474927|University of Pittsburgh|John McDyer|(412) 624-8915|mcdyerjf@upmc.edu|
20178005|NCT02599194|Stanford University|Andrei H. Iagaru|(650) 725-4711|aiagaru@stanford.edu|
20178006|NCT03919422|Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital|Dr. Junfen Zhang, director of the clinical trial|+8618930173689|zhangjunfeng@sjtu.edu.cn|
20178007|NCT03034577|The University of Melbourne|Prof Colin Royse|+61408467548|Colin.Royse@unimelb.edu.au|
20178008|NCT04177758|Rush University Medical Center|Anne DeBenedetti, MSc|312-432-2468|anne.debenedetti@rushortho.com|
20178009|NCT00374842|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178010|NCT00808808|MedImmune, LLC|Seth Toback, MD|301-398-0000|tobacks@medimmune.com|
20178011|NCT01913600|Medtronic, Coronary & Structural Heart Clinical|Lisa Bousquette, Clinical Research Director|707-591-2967|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20178012|NCT02653482|Saint Luke's Hospital of Kansas City|Program Manager, Cardiometabolic Research|8166957561|DEFINE-HF@saint-lukes.org|
20178013|NCT04657211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178014|NCT05054816|Sonova Canada|Jinyu Qian, PhD; VP Sonova Innovation Centre Toronto|647-262-4826|jinyu.qian@sonova.com|
20178015|NCT06273774|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20178016|NCT04560166|Y-mAbs Therapeutics|Chief Operating Officer|+4570261414|clinicaltrials@ymabs.com|
20178017|NCT00976599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178018|NCT00844857|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190456|NCT01074229|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
20190457|NCT02163499|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20190458|NCT02991118|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20190459|NCT01958346|Teamhealth Anesthesia|Devanand Mangar MD|813-844-4434|devanandmangar@teamhealth.com|
20190460|NCT02562521|Yale University School of Medicine|Dr. Krysten Bold|2039747603|krysten.bold@yale.edu|
20190461|NCT00963924|Nathan Klein Institute for Psychiatric Research|Dr. Donald C Goff|646-754-4843|donald.goff@nyumc.org|
20190462|NCT00446095|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20190463|NCT02627794|Cedars-Sinai Medical Center|Dr. Martin L. Hopp|310-657-7704|marty@towerent.com|
20190464|NCT00657709|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20190465|NCT00886834|University of Utah, Department of Obstetrics and Gynecology|Dr. David Turok|801-581-7647|david.turok@hsc.utah.edu|
20190466|NCT02764320|Mayo Clinic|Dr. Todd J. Schwedt|480-301-9443|Schwedt.Todd@mayo.edu|
20190467|NCT00753896|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20190468|NCT01280656|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20190469|NCT02959866|St. Michael's Hospital|Anne Rucchetto, Research Coordinator|416-864-6060|rucchettoa@smh.ca|76155
20190470|NCT03150589|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20190471|NCT01405508|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20190472|NCT00476957|Medtronic Bakken Research Center|Dr. Frank van Leeuwen, Director Clinical Research Coronary and Renal Denervation|+31 43 3566622|frank.van.leeuwen@medtronic.com|
20190473|NCT00999336|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20190474|NCT00409747|NIH/NIMH/PDN Branch|Dr. Susan Swedo|301-496-5323|swedos@mail.nih.gov|
20190475|NCT01141075|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20190476|NCT02006641|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20190477|NCT02132195|Emory University|Dr. Greenbaum|404-712-6374|LGREEN6@emory.edu|
20190478|NCT01287832|St. John Hospital and Medical Center|Leonard Johnson MD|3133438823|leonard.johnson@stjohn.org|
20190479|NCT04749797|University of Pennsylvania|Timothy Lucas|(215) 662-3487|Timothy.Lucas@pennmedicine.upenn.edu|
20190480|NCT00632736|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190481|NCT00537914|Sandoz|Clinical Disclosure Representative|+4980249080|sandoz.disclosure@sandoz.com|
20190482|NCT02312258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20190483|NCT01766206|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
20190484|NCT01662505|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190485|NCT01313663|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190486|NCT04588207|University of Pittsburgh School of Medicine|Dr. Helbert Rondon Berrios, Professor of Medicine|4126473120|rondonberriosh@upmc.edu|
20190487|NCT01661972|Duke University Medical Center|John Strickler, M.D.|919-668-1861|john.strickler@duke.edu|
20190488|NCT04348357|Texas Tech University Health and Science Center El Paso|Dr Steven Radtke|2177254940|dr.radtke@gmail.com|
20190489|NCT00623714|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20190490|NCT02367794|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190491|NCT01695044|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
20190492|NCT02340806|Northwestern University|Elizabeth Lange, MD|312-472-3585|elizabeth.lange@northwestern.edu|
20190493|NCT01186809|Asst Papa Giovanni XXIII|Prof Alessandro Rambaldi|+390352673681|arambaldi@asst-pg23.it|
20222029|NCT04707573|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
20190494|NCT04895085|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
20190495|NCT02591056|Regulatory Insight, Inc.|Elvira Cawthon, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20190496|NCT05379400|NYU Langone Health|Sharine Wittkopp|646-501-7733|Sharine.Wittkopp@nyulangone.org|
20190497|NCT01922102|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20190498|NCT00365599|H. Lee Moffitt Cancer Center and Research Institute|Susan Minton, D.O.|813-745-3806|susan.minton@moffitt.org|
20190499|NCT06182631|SUNY Buffalo|Jill Fenenll|716-323-0220|jillfenn@buffalo.edu|
20190500|NCT01345253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20190501|NCT04077437|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20190502|NCT05361304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, OD, MS, FAAO|800-843-2020|jbuch@its.jnj.com|
20190503|NCT00476151|EpiCept Corporation|Chief Medical Officer|914-606-3500|deverton@epicept.com|
20190504|NCT01286870|Mentor Worldwide, LLC|Laura Vellucci|(805) 879-6000|lvelucci@its.jnj.com|
20190505|NCT01074099|Harvest Technologies|Director of Clinical Operations|508-732-7530|CLI2011communication@harvesttech.com|
20190506|NCT03557307|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
20190507|NCT01383616|Hospital for Special Surgery|Brian Rebolledo, MD|212-606-1172|rebolledob@hss.edu|
20190508|NCT04239911|Weill Cornell Medicine|Dr. Madeline Sterling|646-962-5029|mrs9012@med.cornell.edu|
20190509|NCT03456856|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20190510|NCT02043652|CDC|Alexande Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
20190511|NCT03823794|Guy's & St Thomas' NHS Foundation Trust|Carsten Flohr|020 7188 8884|carsten.flohr@kcl.ac.uk|
20190512|NCT03262389|Mayo Clinic|Michael C. Roarke, M.D.|480-342-0988|Roarke.Michael@mayo.edu|
20190513|NCT01052272|University of Alabama at Birmingham|Louis . J. Dell'Italia, M.D|205-934-3969|Dell'Italia@PHYSIOLOGY.UAB.EDU|
20190514|NCT02955225|Rush University Medical Center|Dr. Markus Wimmer, Director Motion Analysis Laboratory|(312) 942 2789|markus_a_wimmer@rush.edu|
20206332|NCT01660230|ZZ Biotech, LLC|Kent Pryor, PhD, MBA, Chief Operating Officer||kpryor@zzbiotech.com|
20206333|NCT02580240|Subei People's Hospital|QQLv|18051063899|bonhomie2014@163.com|
20178019|NCT00570674|Dana-Farber Cancer Institute|Roy B. Tishler, MD|617.632.5734|RTISHLER@LROC.HARVARD.EDU|
20178020|NCT01877408|University of New England|Dr. Peter Millard|2078663503|pmillard@mac.com|
20206334|NCT00646581|UMass Medical School|Matthew Goodnow|508-856-2494|matthew.goodnow@umassmed.edu|
20206335|NCT00527072|Janssen Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-5711||
20206336|NCT02007252|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206337|NCT00608881|Massachusetts General Hospital|Dr. Merit Cudkowicz|617-726-0813|mcudkowicz@partners.org|
20206338|NCT02954952|Masimo Corporation|Director of Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
20206339|NCT02100410|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20206340|NCT01707095|University of Colorado|Thomas Robinson|303-724-2728|thomas.robinson@ucdenver.edu|
20206341|NCT00810043|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
20206342|NCT02001688|Kamada Ltd|Head of Clinical Operations|+972-72-2219172|sharonc@kamada.com|
20206343|NCT01089569|International Diabetes Center|Dr. Richard M. Bergenstal|952-993-1913|richard.bergenstal@parknicollet.com|
20178021|NCT02621931|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20206344|NCT00445341|National Cancer Institute, National Institutes of Health|Kieron Dunleavy, M.D.|301-435-1007|DunleavK@mail.nih.gov|
20206345|NCT03051217|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20206346|NCT02864706|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20206347|NCT00641706|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|Galanis.evanthia@mayo.edu|
20206348|NCT05441540|UNC School of Medicine|Benjamin Succop|8284439726|benjamin_succop@med.unc.edu|
20206349|NCT01359046|Mayo Clinic|Dr. John Gebhart|507-266-7711|gebhart.john@mayo.edu|
20206350|NCT01349972|University of North Carolina, Lineberger Comprehensive Cancer Center|Joshua Zeidner|(919) 962-5164|Joshua_Zeidner@med.unc.edu|
20206351|NCT04539262|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20206352|NCT01788150|Svelte Medical|Betsy Lowry|19082642181|blowry@sveltemedical.com|
20206353|NCT03673956|Mayo Clinic|Dr. Garret W. Choby|507-284-2533|Choby.Garret@mayo.edu|
20206354|NCT02021071|Philips|Rami Nachabe, PhD|+1-513-926-1486|Rami.Nachabe@philips.com|
20206355|NCT01902004|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Helen Lavretsky|(310)794-4619|hlavretsky@mednet.ucla.edu|
20162245|NCT00719680|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20178022|NCT00920426|ViiV Healthcare|GSK Response Center|866-435-7343||
20206356|NCT04075396|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20162246|NCT02911142|National Cancer Institute|Dr. Ramya Ramaswami|240-506-1088|ramya.ramaswami@nih.gov|
20162247|NCT01286740|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20162248|NCT03266172|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178023|NCT01292603|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20162249|NCT04921332|University of Pittsburgh|Erica Osborn DNP, CRNP|814-282-9793|elo25@pitt.edu|
20162250|NCT02435706|Columbia University College of Dental Medicine|Elena Sanz Miralles, DDS, PhD|212-342-3008|ecs2181@cumc.columbia.edu|
20162251|NCT04856904|Galderma R&D, Inc.|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20162252|NCT00847015|Memorial Sloan Kettering Cancer Center|Dr. M. Catherine Pietanza|646-888-4203|pietanzm@mskcc.org|
20162253|NCT00902174|Novartis Pharmaceuticals|Study Director|862-778-8300||
20162254|NCT00454584|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215-793-7612||
20162255|NCT01716104|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Director of Clinical Research and Medical Information|+74952761571|PutilovskiyMA@materiamedica.ru|302
20162256|NCT02895945|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20178024|NCT03282981|VA Northern California Health Care System|Dr. Sara Dahle and Dr. Rosyln Rivkah Isseroff|916-843-7151|sara.dahle@va.gov|
20178025|NCT02345031|Autifony Therapeutics Ltd|Clinical Project Manager|+44 1438 906860|info@autifony.com|
20178026|NCT01641978|Hospital Universitario de Getafe|Susana Arias Rivera|+34916839360|susana.arias@salud.madrid.org|2459
20178027|NCT02358603|Department of Cardiology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine|Dr. Zhao, Jianrong||drzjr@126.com|
20178028|NCT03576547|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./Professor|713-745-0394|fravandi@mdanderson.org|
20178029|NCT01912612|University of Michigan Rogel Cancer Center|Lynn Henry, MD, PhD|734-936-9868|norahh@med.umich.edu|
20178030|NCT01588184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20178031|NCT00907153|Penn State Hershey Medical Center|Dr. Nazia Raja-Khan|717-531-8395|nrajakhan@psu.edu|
20178032|NCT02460991|Boston Scientific|Kristi Winterfeldt|763-494-1165|kristi.winterfeldt@bsci.com|
20178033|NCT02277106|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20178034|NCT05762835|University of California at Davis|Dr. Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
20178035|NCT00485485|UT MD Anderson Cancer Center|Anne Tsao, M.D. / Associate Professor|713-792-6363|mejprice@mdanderson.org|
20178036|NCT03667053|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
20178037|NCT00515502|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178038|NCT01869491|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
20178039|NCT01910129|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20178040|NCT00965523|Eisai|Tatsuo Watanabe, Study Director|+81-3-3817-5252||
20178041|NCT02363738|University Health Network|Dr. Roger McIntyre|416-603-5279|roger.mcintyre@uhn.ca|
20178042|NCT02187991|Sarah Cannon Development Innovations, LLC|Taqi Mohammad|713-870-2175|taqi.mohammad@scri.com|
20178043|NCT01939028|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Chad Michener|216-444-6601|michenc@ccf.org|
20178044|NCT00875836|MUSC|Dr. Aimee McRae-Clark|843.792.5216|mcraeal@musc.edu|
20178045|NCT00322348|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20178046|NCT01289912|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
20178047|NCT00802854|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178048|NCT02293044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20178049|NCT00989287|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178050|NCT02512575|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20178051|NCT01047839|Valneva Austria GmbH|Senior Scientist Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
20178052|NCT01857531|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
20178053|NCT02576067|Icahn School of Medicine at Mount Sinai|Zahi Fayad, PhD|212-824-8471|zahi.fayad@mssm.edu|
20178054|NCT02726451|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20178055|NCT03570619|University of Michigan Rogel Cancer Center|University of Michigan Cancer Center Admin|7349369499|ClinicalTrialsgov_CCAdmin@umich.edu|
20178056|NCT04773587|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20178057|NCT02372409|Washington University School of Medicine|Andrew Cluster, M.D.|314-454-6018|acluster@wustl.edu|
20178058|NCT01808313|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178059|NCT00477191|Department of Dermatology, Mass General Hospital|Alexa Boer Kimball, MD MPH|617-726-0149|akimball@partners.org|
20178060|NCT01289067|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|(212) 604-6010|bobby.liaw@mountsinai.org|
20178061|NCT04656847|Sevier|Medical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|
20178062|NCT03301051|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20178063|NCT00622167|Massachusetts General Hospital|Iris McNulty, RN|617 726 2612|imcnulty@partners.org|
20178064|NCT00572234|University of Nebraska Medical Center|Kathleen Grant|402-995-4347|kathleen.grant2@va.gov|
20178065|NCT05893992|Sonova|Dr. Jonathan Vaisberg|9057456785|jonathan.vaisberg@sonova.com|
20178066|NCT00435370|Baylor College of Medicine|Dr. Thomas R. Kosten|(713) 794-7032|kosten@bcm.edu|
20178067|NCT00746603|Weill Cornell Medicine|Jennifer Levine, MD|212-305-9770|jel9022@med.cornell.edu|
20178068|NCT01965834|University of Miami|Denise Pereira MD|305-243-4909|dpereira2@med.miami.edu|
20178069|NCT00158743|BTG International Inc|Suzanne Ward Pharm D|610-278-1660|suzanne.ward@btgplc.com|
20178070|NCT01681589|NYU Langone Health|Prin Amorapanth, MD, PhD|212-263-6037|Prin.Amoropanth@nyulangone.org|
20178071|NCT02352948|AstraZeneca|Medical Science Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20178072|NCT00679939|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178073|NCT01428765|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178074|NCT00074035|The Ohio State University Medical Center|Sherif S. Farag, M.D., Ph.D.||farag-1@medctr.osu.edu|
20178075|NCT02269670|Emory University|Dr. Suchita Pakkala|404-686-3496|suchita.pakkala@emoryhealthcare.org|
20178076|NCT05374421|Erchonia Corporation|Clinical Affairs Manager|864-531-0064|tsammons@erchonia.com|501
20178077|NCT05023304|Vance Thompson Vision|Director of Clinical Trials|1-605-371-7075|keeley.boever@vancethompsonvision.com|
20178078|NCT04370054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178079|NCT05672628|The University of Texas Health Science Center at Houston|Seema S Aggarwal, PhD, APRN, AGNP-C|713-500-9946|Seema.S.Aggarwal@uth.tmc.edu|
20178080|NCT01962493|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178081|NCT06660823|Ain Shams University|Dr.Mohammed Abd Al Jawad,Professor of cardiac surgery|+201111219461|mohammed_abdaljawad@med.asu.edu.eg|
20178082|NCT02979639|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178083|NCT01429532|SunYat-senU|Prof. Yizhi Liu|+86-20-87330341|Reviewborad_SYsU@163.com|
20178084|NCT00240487|The Children's Hospital of Philadelphia|Richard Lin|2155905505|linr@email.chop.edu|
20162257|NCT04003987|Indiana University School of Medicine|Yar Yeap|(317) 274-0275|yyeap@iupui.edu|
20178085|NCT01096992|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|CR_Study_Registration@mdanderson.org|
20178086|NCT04098939|Aarhus University Hospital|Søren Helbo Skaarup|+4528911869|soeska@rm.dk|
20178087|NCT02062359|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20190515|NCT02074709|University of Texas Southwestern Medical Center|Irina Gasanova|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
20162258|NCT01946126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20178088|NCT02985866|University of Virginia Center for Diabetes Technology|Boris Kovatchev, PhD|434-982-0602|mc7m@virginia.edu|
20178089|NCT03272633|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD|732-235-4523|strairrk@cinj.rutgers.edu|
20178090|NCT04386096|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20178091|NCT05457608|CooperVision|Jose A. Vega,OD,MSc,FAAO|9256213761|jvega2@coopervision.com|
20178092|NCT04402866|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20178093|NCT03647501|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20178094|NCT01016769|Memorial Sloan Kettering Cancer Center|Dr. David Pfister, MD|646-888-4237|pfisterd@mskcc.org|
20178095|NCT04149405|OndokusMU|Feyza Otan Özden|+905322535106|feyza_otan@yahoo.com|
20178096|NCT01362140|Amgen Inc.|Study Director|866-572-6436||
20178097|NCT00492284|QLT Inc.|Medical Information Department|1-800-663-5486|medaff@qltinc.com|
20178098|NCT01474681|Novartis Pharmaceuticals|Study Director|862-778-8300||
20178099|NCT01972516|Dana-Farber Cancer Institute|Susana Campos, MD|617-632-5269|susana_campos@dfci.harvard.edu|
20178100|NCT02195986|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
20178101|NCT02571218|IRCCS Policlinico San Donato|Giuseppe Ciconte|+39 02 52 77 42 60|g.ciconte@gmail.com|
20178102|NCT00319098|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178103|NCT02834780|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20178104|NCT03150056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178105|NCT02415400|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20178106|NCT03335033|Mayo Clinic|Matthew W. Urban|507-284-3703|Urban.Matthew@mayo.edu|
20178107|NCT00395876|Genentech, Inc.|Medical Communications|800-821-8590||
20178108|NCT02270450|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066674623|karnold@fredhutch.org|
20178109|NCT00601926|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|614-293-2886|Paul.Monk@osumc.edu|
20178110|NCT01968213|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20178111|NCT04458948|UNM HSC|Cristina Beato|505-272-1734|CBeato@salud.unm.edu|
20178112|NCT01392560|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178113|NCT02081846|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
20178114|NCT03282227|Zosano Pharma Corporation|Donald Kellerman, PharmD, Sr. VP, Clin Dev and Med Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
20178115|NCT02937168|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20178116|NCT02154763|The Ottawa Hospital|Dr.Joseph Mamazza|613-798-5555|jmamazza@toh.on.ca|
20178117|NCT02491671|Hospital Universitario de Salamanca|Dr. Marcelo Jiménez|923291100|mfjl@usal.es|
20178118|NCT02251990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178119|NCT03265600|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6132|zschuman@cha.harvard.edu|
20178120|NCT00535730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178121|NCT02293538|Alcon Research, Ltd.|Global Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20178122|NCT00856050|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
20178123|NCT02439710|Institute for Policy Advancement Ltd|Mark W Skinner|+1-202-253-8342|mskinnerdc@gmail.com|
20178124|NCT00936858|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
20178125|NCT05525494|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20178126|NCT00584727|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
20178127|NCT02464449|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
20178128|NCT00729833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178129|NCT00092131|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20178130|NCT02341417|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20178131|NCT02820623|Northwestern University|Rinad Beidas, PhD|312-503-0546|rinad.beidas@northwestern.edu|
20178132|NCT03858803|Portland State University|Dr. Janet S. St. Lawrence|971-978-7801|janetsstlawrence@gmail.com|
20178133|NCT03736434|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
20178134|NCT04598152|The Ohio State University College of Medicine|Jay Fournier, PhD|614-293-9600|jay.fournier@osumc.edu|
20178135|NCT03674177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178136|NCT00714168|University of Pittsburgh|John M. Jakicic, PhD|412-383-4001|jjakicic@pitt.edu|
20178137|NCT04988308|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20178138|NCT03341910|Dr. Reddy's Laboratories, Inc|Dr. Srinivas Sidgiddi, Sr. Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
20178139|NCT02625623|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20178140|NCT00744653|Copenhagen University Hospital Herlev|MD Louise Wichmann Matthiessen|+ 45 38 68 98 58|louise.wichmann.matthiessen@gmail.com|
20178141|NCT03826667|Smith+Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
20178142|NCT00596440|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
20178143|NCT03077724|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
20178144|NCT02313428|University of Pittsburgh|Sashwati Roy|412-648-8297|sar543@pitt.edu|
20190516|NCT00096278|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20178145|NCT05183022|University of Alabama at Birmingham|Andrew D. Pucker, OD, PhD|1-920-579-2900|apucker@uab.edu|
20178146|NCT00799292|Mt Sinai School of Medicine, Department of Obstetrics and Gynecology|Charles Ascher-Walsh MD, MPH|212-241-2827|charles.ascher-walsh@mssm.edu|
20178147|NCT01738984|University of Hawaii, School of Nursing and Dental Hygiene|Cheryl Albright|8089569716|cherylal@hawaii.edu|
20162259|NCT03429543|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20162260|NCT01818492|Sobi AB|Carl Johan Treutiger|46 76 00 11 815|CarlJohan.Treutiger@sobi.com|
20162261|NCT02025439|Edward Hines VA Hospital|Theresa Bender-Pape|708-202-4953|Theresa.BenderPape@va.gov|
20162262|NCT02345330|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
20162263|NCT03077204|Ascension Texas Spine and Scoliosis|Devender Singh, Research Scientist|512 324 3580|dpsingh@ascension.org|15916
20162264|NCT00454181|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
20162265|NCT01054625|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20162266|NCT02976103|Dana-Farber Cancer Institute|Donna Berry, PhD, RN|617-632-1909|donna_berry@dfci.harvard.edu|
20162267|NCT00079677|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20162268|NCT00565136|Boston Urogynecology Associates|Peter Rosenblatt, MD; Director of Urogynecology|(617) 354-5452|prosenbl@mah.harvard.edu|
20162269|NCT01218399|Astra Zeneca|Elena Pizzi|+1 302 885 2677|Elena.Pizzi@astrazeneca.com|
20162270|NCT00412074|Medical University of South Carolina|Carol Wagner|18437922112|wagnercl@musc.edu|
20162271|NCT00989781|UCSD|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
20162272|NCT01399268|HSS|Dr. Jules|212.606.1206|JulesK@hss.edu|
20162273|NCT00651625|University of New Mexico|Wilmer L. Sibbitt, MD, Principal Investigator|505 272-4761|wsibbitt@salud.unm.edu|
20162274|NCT00409344|Massachusetts General Hospital|Ulrich Schmidt, MD PhD|617-724-6490|uschmidt@partners.org|
20162275|NCT05096312|East Avenue Medical Center|Dr. Monqiue Lianne Lim-Ang|0287100957|moniquelianne.lim@gmail.com|
20162276|NCT01805037|Northwestern University, Feinberg School of Medicine|Barbara Pro, MD|312-695-6180|barbara.pro@northwestern.edu|
20162277|NCT03927404|University of Pittsburgh|Dr. Sashwati Roy|412-648-8297|sar453@pitt.edu|
20162278|NCT01229449|Reckitt Benckiser Healthcare International|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20162279|NCT02641067|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162280|NCT03203291|Columbia University Irving Medical Center|Sunil Agrawal, PhD|(212) 854-2841|sunil.agrawal@columbia.edu|
20162281|NCT03157037|Linköping University|Professor Mårten Segelmark|+46 70 287 19 44|marten.segelmark@liu.se|
20162282|NCT02102399|Federal University of Bahia|Lilian Paternostro|+55 (71) 8191-9730|lilian_fono@hotmail.com|
20162283|NCT04349033|Wayne State University|Dr. Mark A. Lumley, Professor|3135772247|mlumley@wayne.edu|
20162284|NCT00534833|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20162285|NCT00324233|Coloplast A/S|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
20162286|NCT01707381|Bausch + Lomb|Heleen DeCory, Ph.D.|(585) 338-8161|Heleen.DeCory@bausch.com|
20162287|NCT01704456|UBC|Dr Lori Brotto|604-875-4111|lori.brotto@vch.ca|68898
20162288|NCT00498355|University of California San Francisco|Dr. Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
20162289|NCT00410605|Univerisity of Wisconsin Carbone Cancer Center|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
20162290|NCT04583956|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20162291|NCT03908970|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20162292|NCT04407234|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20162293|NCT02008227|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20162294|NCT00742417|Instituto Grifols S.A.|Mireia Torres|+34935710500|mireia.torres@grifols.com|12273
20162295|NCT00627367|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
20162296|NCT00965575|Cincinnti Childrens|Sejal Jain|513-636-4222|sejal.jain@cchmc.org|
20162297|NCT00757822|Central Arkansas Veterans Healthcare System|Dr. Muhammad Jaffar|501-688-9310|Muhammad.Jaffar@va.gov|
20162298|NCT02814175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20162299|NCT01912339|Boston Scientific Corporation|Kevin Hagelin, Clinical Program Manager|(800) 328-3881|kevin.hagelin@bsci.com|
20162300|NCT01754493|New York State Psychiatric Institute|Roberto Lewis-Fernandez|646-774-8102|rlewis@nyspi.columbia.edu|
20162301|NCT02489942|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0217|clintriage.rdg@boehringer-ingelheim.com|
20162302|NCT01272635|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
20162303|NCT04996251|Northwell Health (previously) now at Advocate Aurora Health|Dr. Vini Chopra Konowitz|859-905-8782|vinichopra924@gmail.com|
20178148|NCT03910413|The University of Alabama at Birmingham|Andrew Smith|205-934-4080|andrewdennissmith@uabmc.edu|
20178149|NCT00610116|Department of Cardiology and Rhythmology, Augusta Hospital, Duesseldorf, Germany.|Joachim Winter, MD|+49 (0) 2118|joachim.winter@uniklinik-duesseldorf.de|1173
20178150|NCT03100617|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
20178151|NCT00955357|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20178152|NCT01258608|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178153|NCT00676182|James A. Haley Veterans' Hospital|Dr. Kris Siddharthan|813-558-3950|Krishnaswami.Siddharthan@va.gov|
20178154|NCT04250727|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
20178155|NCT01393782|George Washington University Medical Faculty Associates|Clinical Trials Unit, Department of Anesthesiology and Critical Care Medicine|202-715-4750|mseneff@mfa.gwu.edu|
20178156|NCT02943408|Veterans Affairs Rocky Mountain (VISN 19) Mental Illness Research Education and Clinical Center (MIRECC)|Dr. Samantha Hack|720-234-2017|samantha.hack@va.gov|
20178157|NCT01106833|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20178158|NCT01911403|Hospital de Sao Joao, E.P.E.|Dr. Paulo Morgado|+351 22 551 2100|vilaresmorgado@iol.pt|
20178159|NCT01621126|Massachusetts General Hospital|Dr. Jon J.P. Warner, Chief of Shoulder Service MGH, Harvard Professor of Orthopaedics.|617-724-3140|jwarner@mgh.harvard.edu|
20178160|NCT01949311|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|1-844-734-6643|clinicaltrials@regeneron.com|
20178161|NCT02338154|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20178162|NCT04279314|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20178163|NCT00692094|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
20178164|NCT03166618|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20206357|NCT00047853|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
20206358|NCT02260388|University of Kansas Medical Center|Dr. Richard Barohn|9139459943|rbarohn@kumc.edu|
20178165|NCT01925950|Soligenix, Inc.|Dr. Richard Straube|609-538-8200||
20206359|NCT00305604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178166|NCT00798720|University of Wisconsin|Abigail Mapes, Thoracic Oncology Research Program Manager|(608) 262-8158|acmapes@medicine.wisc.edu|
20178167|NCT03137303|University of Illinois at Chicago|Min J. Joo, MD MPH|312-996-8039|joo@uic.edu|
20178168|NCT03561090|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
20178169|NCT00373399|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
20178170|NCT03663231|University of Rochester|Ralph Saunders|585-275-1141|ralph_saunders@urmc.rochester.edu|
20178171|NCT02007291|Federal University of Minas Gerais|Luís Felipe José Ravic de Miranda|55-31-3225-2337|ravicmiranda@gmail.com|
20178172|NCT01433354|Novartis Pharmaceuticals|Study Director|862--778--8300||
20178173|NCT05098054|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20178174|NCT02015676|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20178175|NCT01618162|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20178176|NCT00476476|Dana-Farber Cancer Institute|Neil Horowitz MD|617.732.8843|NHOROWITZ@mgh.harvard.edu|
20178177|NCT04794803|Dompé Farmaceutici|Dr Maria De Pizzol, BSc|+39 02 583831|clinops@pec.dompe.it|
20178178|NCT01426191|xiangbei welman pharmacuticol CO.,LTD|Directer of clinical trials|020-38868707|gap@welman.com.cn|
20178179|NCT00971048|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20178180|NCT01189279|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20178181|NCT03321396|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|6202
20178182|NCT02964416|Aga Khan University|Dr Asma Abdus Salam|+92-21-34864715|asma.salam.azhar@gmail.com|4639
20178183|NCT01654549|Tehran University of Medical Sciences|Dr Raika Jamali|982163120000|jamalira@tums.ac.ir|411
20178184|NCT01507220|The Ohio State University|Sergio Bergese, MD|(614) 293-9027|bergese.1@osu.edu|
20178185|NCT00937924|University of California, Irvine|Dr. Kenneth Chang|714-456-6187|kchang@uci.edu|
20178186|NCT01763931|SKCCC at Johns Hopkins|Vered Stearns, MD|410-614-1361|HopkinsBreastTrials@jhmi.edu|
20178187|NCT04650555|Humanetics Corporation|Michael D Kaytor, PhD|952-400-0405|mkaytor@humaneticscorp.com|
20178188|NCT00845663|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20178189|NCT03806270|Yeditepe U|Dr. Ferda F. Kartufan|+902165784000|ferdasozer@gmail.com|4754
20178190|NCT04460742|University of Rochester|Adam Simning|585-474-9534|adam_simning@urmc.rochester.edu|
20178191|NCT01043432|Rocky Mountain MIRECC|Lisa A. Brenner|303-399-8020|lisa.brenner@va.gov|2571
20178192|NCT02633137|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
20178193|NCT03152526|Miltenyi Biotec|Clinical Project Manager|617-218-0055|lorenb@miltenyibiotec.com|
20178194|NCT04307004|University of Alabama at Birmingham|Emily B. Levitan, Professor and Vice Chair|(205) 975-7680|elevitan@uab.edu|
20178195|NCT05545072|Emory University|Thomas S Edwards, MD Assistant Professor, Rhinology and Skull Base Surgery Division|4045017710|thomas.edwards@emory.edu|
20178196|NCT02395042|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20178197|NCT01324271|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20206360|NCT00753623|MGH Center for Translational Pain Research|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
20206361|NCT03332303|Prasco LLC|Senior Director, Quality Assurance|513-618-3333|b.inskeep@prasco.com|
20206362|NCT03495817|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20178198|NCT02807558|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|tcrowell@syros.com|
20178199|NCT01972841|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|astellas.resultsdisclosure@astellas.com|
20178200|NCT01360606|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20178201|NCT04818346|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20178202|NCT03695172|Duke University Medical Center|Amanda Kumar, MD|919-681-4607|amanda.kumar@duke.edu|
20178203|NCT02734212|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
20178204|NCT02076152|Massachusetts General Hospital|Elizabeth Gerstner, MD|617-724-2887|EGERSTNER@PARTNERS.ORG|
20178205|NCT04313881|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20178206|NCT00727272|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20178207|NCT00651664|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20178208|NCT00688636|Univerisity of Pittsburgh|Research Coordinator|412-648-9173|goldbyreffnerka@upmc.edu|
20178209|NCT01572727|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20178210|NCT04053764|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20178211|NCT04732286|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20178212|NCT01954017|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director of Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
20178213|NCT03346759|University of Michigan|Jason Bell, MD|7342323897|jasonbel@med.umich.edu|
20178214|NCT01680328|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20178215|NCT01453595|Memorial Sloan Kettering Cancer Center|Dr. Martin Voss|646-422-4631|vossm@mskcc.org|
20178216|NCT03166761|Vanderbilt University Medical Center|Byron Schneider|(615)936-7708|byron.j.schneider@vumc.org|
20178217|NCT03969654|Zimmer Biomet, Inc.|Director of Clinical Operations|8006136131|Clinicaloperations@zimmerbiomet.com|
20178218|NCT00765193|Department of Dermatology, Medical University of Graz-Austria|Iris Zalaudek, MD|+436763328269|iris.zalaudek@medunigraz.at|
20178219|NCT01864564|University of Texas at Austin|Lorie M. Harper, MD, MSCI|512-324-7036|lorie.harper@austin.utexas.edu|
20178220|NCT03373604|Columbia University|Patrick Lao, PhD|212-342-1399|pjl2133@cumc.columbia.edu|
20178221|NCT00710424|GW Pharm Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20178222|NCT00003508|Burzynski Research Institute, Inc|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20178223|NCT02160314|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
20178224|NCT00593567|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20178225|NCT02993445|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
20178226|NCT01946542|Duke University Medical Center|William Kraus|919-684-2063|william.kraus@duke.edu|
20178227|NCT00871689|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
20178228|NCT00590902|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
20178229|NCT00785291|UCSF Comprehensive Cancer Center|Hope Rugo, M.D.||hrugo@medicine.ucsf.edu|
20178230|NCT02119260|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178231|NCT01986881|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178232|NCT02057874|Vanderbilt University Medical Center|Professor of Surgery and Cancer Biology|615-936-2956|lee.gorden@vanderbilt.edu|
20178233|NCT04205630|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
20178234|NCT00886340|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
20178235|NCT03224182|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20178236|NCT02481310|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@northwestern.edu|
20178237|NCT04953390|Sonova USCS|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
20178238|NCT01698684|Vivus, Inc.|Wesley W Day, PhD|650-934-5200||
20178239|NCT02925455|Case Western Reserve University and MetroHealth System|Michael Fu|215-368-0355|mjf24@case.edu|
20178240|NCT00686166|SWOG Statistical Center|SWOG Statistician|206-667-4408||
20178241|NCT01514448|Novartis Pharmaceuticals|Study Director|862-778-8300||
20178242|NCT02314624|Evidence Based Practice Institute|Linda Dimeff, PhD|206-384-7371|linda.dimeff@jasprhealth.com|
20178243|NCT03595579|Axsome Therapeutics, Inc.|Amanda Jones, PharmD, Senior Vice President of Clinical Development|212-332-3223|ajones@axsome.com|
20178244|NCT03912259|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20178245|NCT00360308|Eisai Call Center|Eisai Inc.|888-422-4743||
20178246|NCT04786444|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
20190517|NCT02865083|Saint Louis University|Jennifer Goldkamp, MD|314-977-2574|jgolka2@slu.edu|
20190518|NCT02105688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190519|NCT01358175|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20190520|NCT00237718|Vanderbilt University|T. Alp Ikizler, MD||alp.ikizler@vanderbilt.edu|
20190521|NCT04908488|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20206363|NCT00326417|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20178247|NCT02071173|Boston Scientific|Kelly Aspinwall|1-800-CARDIAC|kelly.aspinwall@bsci.com|
20178248|NCT00386880|Doylestown Hospital|Abraham A. Ashkenazi, MD-Principal Investigator|215-625-2894|aashkenazi2001@yahoo.com|
20178249|NCT03430674|Indiana University|Jamie Renbarger, MD|317-944-8784|jarenbar@iu.edu|
20206364|NCT00435994|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
20178250|NCT02436265|Indiana University|Aali shah MD|317-944-9981|ashah9@iuhealth.org|
20222030|NCT05207865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222031|NCT02546986|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20162304|NCT01543776|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20162305|NCT03626545|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20190522|NCT00329771|Doylestown Hospital, Pennsylvania|Abraham A. Ashkenazi, M.D./Principal Investigator|215-625-2894|aashkenzai2001@yahoo.com|
20190523|NCT01107912|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190524|NCT02432183|KU Leuven|Dominique MA Bullens|3216341338|dominique.bullens@kuleuven.be|
20190525|NCT01124916|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
20190526|NCT00887471|SUNY Downsate Medical Center|Nira A Goldstein, MD|718-270-1638|ngoldstein@downstate.edu|
20190527|NCT05756647|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo, MD|314-362-8641|piccirj@wustl.edu|
20190528|NCT02469155|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20190529|NCT00595959|Spectranetics Inc|Thomas M. Rasmussen V.P. Clinical Affairs|719-447-2471|thomas.rasmussen@spnc.com|
20190530|NCT03014726|Urotronic, Inc.|Ian Schorn, Vice President of Clinical Affairs|320.282.6312|schorni@urotronic.com|
20190531|NCT02428595|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
20190532|NCT00901459|Duke Center for Nicotine and Smoking Cessation Research|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@mc.duke.edu|
20190533|NCT04765046|Medtronic|Ami Stuart|8017934800|ami.stuart@medtronic.com|
20190534|NCT03529942|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
20190535|NCT02314000|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
20190536|NCT00636168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20190537|NCT03015220|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20190538|NCT02291549|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20190539|NCT01180959|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD- Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
20190540|NCT01468597|Medical University of Graz|Elisabeth Mahla, MD|0043 316 385 13027|elisabeth.mahla@medunigraz.at|
20190541|NCT00912964|Astellas Pharma Global Development, Europe|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
20190542|NCT04447287|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20190543|NCT00613405|Medical University of South Carolina|Aimee McRae-Clark, PharmD|843-792-5126|mcraeal@musc.edu|
20190544|NCT00655824|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190545|NCT00960206|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
20190546|NCT00507767|MD Anderson Cancer Center|Dr. Vassiliki Papadimitrakopoulou, Professor|713-792-6363|vpapadim@mdanderson.org|
20162306|NCT04274556|Demiroglu Bilim University|Nurten OZEN|+90 212 213 64 86|ozenurten@yahoo.com.tr|
20162307|NCT03387020|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
20162308|NCT00434642|Hoffman-LaRoche|Medical Communications|800-821-8590||
20162309|NCT02421588|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
20162310|NCT04532931|Shin Poong Pharm. Co., Ltd.|Shin Poong Pharm. Co., Ltd.|82-2-2189-3478|bwon@shinpoong.co.kr|
20162311|NCT04071158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162312|NCT01178099|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162313|NCT02703480|Tufts University School of Dental Medicine|Associate Professor|6176366659|yumi.ogata@tufts.edu|
20162314|NCT02473367|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162315|NCT04816721|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
20162316|NCT03445559|VA New York Harbor Healthcare System|Dr. Danil V. Makarov|212-686-7500|Danil.Makarov@Va.gov|
20162317|NCT02466009|University of Rochester|Aram Hezel|585-275-5823|Aram_Hezel@urmc.rochester.edu|
20162318|NCT02176161|NYU Langone Health|Aaron Katz, MD|516-535-1900|Aaron.Katz@nyulangone.org|
20162319|NCT02678923|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
20162320|NCT00455143|Icahn School of Medicine at Mount Sinai|Department of Anesthesiology|212-241-7473||
20162321|NCT02004977|University of Minnesota|Dr. Susie Nanney|612-626-6794|msnanney@umn.edu|
20162322|NCT05222555|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20162323|NCT00300365|University of Pennsylvania|Dr. Richard L. Dunbar|(215) 315-3378|richard.dunbar@uphs.upenn.edu|
20178251|NCT04969198|University of Wisconsin-Madison|Jesse Kaye|608-262-8885|jtkaye@ctri.wisc.edu|
20178252|NCT04391023|University of Iowa|Dr. Alexandra Courtney Fietsam|N/A|alexandra-fietsam@uiowa.edu|
20178253|NCT03256162|Trinity College Dublin|Dr Bronagh Gallagher|01 249|bgallag@tcd.ie|3200
20178254|NCT03074630|AmsterdamUMC|Erik van Bommel|+31 20 4444444|e.vanbommel@amsterdamumc.nl|
20178255|NCT04009291|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
20178256|NCT01270347|Horizon Pharma USA, Inc|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
20178257|NCT02085408|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20178258|NCT02189798|Advanced Bionics|Michelle Caulfield, Senior VP, Global Quality Assurance and Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
20178259|NCT03842995|Hudson Alpha Institute for Biotechnology|Greg Cooper, PhD|2563279490|gcooper@hudsonalpha.org|
20178260|NCT05553808|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178261|NCT01518868|Bausch Health|Study Director||robert.steffen@bausch.com|
20222032|NCT01415518|AstraZeneca|Goran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
20222033|NCT03944668|HealthPartners Neuroscience Research|Amanda Herrmann, PhD|651-495-6356|amanda.a.herrmann@healthpartners.com|
20222034|NCT02445248|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20222035|NCT03190993|Pennington Biomedical Research Center|John Apolzan|225-763-2827|john.apolzan@pbrc.edu|
20222036|NCT00127231|Johns Hopkins University School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
20222037|NCT00471822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222038|NCT04570670|Banner Life Sciences LLC|Thomas Lategan, PhD|3368990959|thomas.lategan@bannerls.com|
20222039|NCT00083382|UAMS Myeloma Institute|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
20222040|NCT03426124|Boston Scientific|Leslie Cass|206-641-4529|Leslie.Cass@bsci.com|
20222041|NCT04335123|Kansas University Medical Center|Dr Matthias Salathe|9135886000|msalathe@kumc.edu|
20222042|NCT02677753|University of Louisville|Dr. Sean Francis|5025617260|sean.francis@louisville.edu|
20222043|NCT00957801|University of Texas Medical Branch|Randall J Urban, Professor and Chair, Internal Medicine|409-772-1176|rurban@utmb.edu|
20222044|NCT03124368|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20222045|NCT01120808|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
20178262|NCT02273141|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
20178263|NCT01556438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178264|NCT00529399|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
20178265|NCT02672111|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
20178266|NCT02486328|Ufuk University Faculty of Medicine|Dr Perihan Ekmekçi|+903122044000|erdogduperi@gmail.com|
20178267|NCT06242444|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20178268|NCT03317977|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
20178269|NCT02635880|Cutera|Ginger Pocock|4156575702|gpocock@cutera.com|
20178270|NCT02046980|Daegu Kyungbook Dizziness society|Dr. Hyun Ah Kim|+82-53-250-7475|kha0206@dsmc.or.kr|
20178271|NCT03206203|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20178272|NCT03998618|Indiana University|Dr. Catherine Mosher|317-274-6769|cemosher@iu.edu|
20178273|NCT01483924|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
20178274|NCT00003298|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20178275|NCT01386528|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20178276|NCT00335322|Kirby Institute|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
20178277|NCT03369444|University College London|Pratima Chowdary|+44(0)20 7472 6835|p.chowdary@ucl.ac.uk|
20178278|NCT04330638|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
20222046|NCT02626026|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20222047|NCT01909934|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20162324|NCT01274520|Columbia University College of Physicians and Surgeons - Center for Liver Disease and Transplantation|James V. Guarrera, MD, FACS|(212)305.3839|jjg46@cumc.columbia.edu|
20162325|NCT01374178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162326|NCT01422824|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20162327|NCT01641822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20162328|NCT02760810|Johnson & Johnson Vision Care Inc.|Andrea Le, OD, MBA - Manager, Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
20162329|NCT02421601|Seikagaku Corporation|Clinical Development Department|(81)3-5220-8948|kyoichi.osano@seikagaku.co.jp|
20162330|NCT03222414|Vanderbilt University Medical Center|Laura Sorabella||laura.sorabella@vumc.org|
20162331|NCT02522442|Sleep Therapy & Research Center|Eric Powell, Ph.D.|(210) 614-6000|powell.eric@sleeptrc.com|
20162332|NCT00470418|James J Peters VA Medical Center|Dr. Hillel Grossman|718-584-9000|hillel.grossman2@va.gov|5752
20162333|NCT00599638|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162334|NCT03006887|Eisai, Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20162335|NCT00462748|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20162336|NCT01729208|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
20162337|NCT02428413|Teleflex|Thomas Philbeck, PhD, MBA, Senior Director of Global Research and Scientific Services|210-581-7778|thomas.philbeck@teleflex.com|
20162338|NCT04882787|Sonova|Jinyu Qian, Director Innovation Centre Toronto|905-677-1167|jinyu.qian@sonova.com|5873
20162339|NCT03689855|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-747-7948|danielmorgensztern@wustl.edu|
20162340|NCT01438177|Perlmutter Cancer Center|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
20162341|NCT02772978|University of California at San Francisco|Andrew Kayser, MD PhD|415-502-7332|Andrew.Kayser@ucsf.edu|
20162342|NCT02851823|Izmir Katip Celebi University, Dentistry Faculty|Assoc.Prof.Dr. Mehmet Sağlam|+90 530 324 99 48|dtmehmetsaglam@gmail.com|
20162343|NCT00771056|Northwell Health (formerly North Shore LIJ Health System)|Kanti R Rai, MD|(718)470-4050|krai@nshs.edu|
20162344|NCT04943432|University of North Carolina at Chapel Hill|Catherine Paquette, MA, MPS|919-962-5082|cpaq@live.unc.edu|
20162345|NCT02986802|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3755|De-Kun.Li@kp.org|
20178279|NCT01410773|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20162346|NCT02684188|University of Montana|Tom Seekins, Ph.D.|2432654|TOm.Seekins@UMontana.edu|406
20178280|NCT01041638|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20178281|NCT03152552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20178282|NCT00567242|University of Florida|Bruce Crosson, PhD / Professor|352-273-6617|nossorc1@phhp.ufl.edu|
20190547|NCT00663819|CMU College of Medicine|Dr. Anthony Senagore|989-790-1001|anthony.senagore@cmich.edu|
20190548|NCT01502813|University of Utah, Diagnostic Neuroimaging Lab|Deborah Yurgelun-Todd, Ph.D.|801-587-1538|Deborah.Yurgelun-Todd@hsc.utah.edu|
20190549|NCT00725959|Colorado School of Public Health|Dr. Sheana Bull|303-724-1238||
20190550|NCT02470806|Smith & Nephew, Inc.|Natasha Schappell, CCRP|817-302-3949|natasha.schappell@smith-nephew.com|
20190551|NCT03032198|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
20190552|NCT00866619|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222048|NCT06180122|Imperial College Healthcare NHS Trust|Sophie Connolly|02033117322|sophie.connolly1@nhs.net|
20222049|NCT00380874|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20222050|NCT03380429|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20222051|NCT02816736|Duke Clinical Research Institute|Kevin J. Anstrom, Ph.D., Director of Biostatistics|919-668-8902|kevin.anstrom@duke.edu|
20190553|NCT02934932|Duke University|Dr. Steven Szabo|919-681-8742|steven.szabo@duke.edu|
20190554|NCT02892019|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20190555|NCT01229176|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
20190556|NCT00882050|University of Pennsylvania|Kim Lacy, RN BSN|215-893-7234|kim.lacy@uphs.upenn.edu|
20190557|NCT01159600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190558|NCT00946998|University of Texas Southwestern Medical Center|Susan Hedayati, MD, Professor of Medicine|214-645-6106|susan.hedayati@utsouthwestern.edu|
20190559|NCT01857362|Swedish Orphan Biovitrum|Dr Erik Brouwer, Medical Director|+4686972000|erik.brouwer@sobi.com|
20190560|NCT03833934|Addario Lung Cancer Medical Institute (ALCMI)|Ericka Izzo, Clinical Project Manager|941-713-1225|eizzo@alcmi.org|
20190561|NCT01330953|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190562|NCT01279447|Northwestern|Lawrence Hsu, MD|312 9262000|larryphsu@gmail.com|
20190563|NCT00674609|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20190564|NCT00234832|Abbott|Global Medical Services|800-633-9110||
20190565|NCT00538629|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162347|NCT00428844|Cubist Pharmaceuticals, Inc.|Ed Campanaro, VP Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
20190566|NCT02301299|Northwestern University|Erin Wymore|3125033243|erin.wymore@northwestern.edu|
20190567|NCT03512041|Washington University School of Medicine|Catherine E Lang|314-286-1945|langc@wustl.edu|
20190568|NCT00555620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190569|NCT05203822|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20190570|NCT04343989|NYU Langone Health|Bonnie Lonze, MD, PhD|212-263-3865|bonnie.lonze@nyulangone.org|
20190571|NCT03320941|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20190572|NCT00447499|Ipsen|Bert Bakker, MD, PhD.|+1 650 238 1669|bert.bakker@ipsen.com|
20190573|NCT05087849|UCSF|Ayan Kusari|4153537800|ayan.kusari@ucsf.edu|
20190574|NCT01767376|GlaxoSmithKline|GSK Response Center|866-435-7343||
20190575|NCT03360071|John Hopkins University School of Medicine|Jody Tversky, MD|410-550-2300|hoddin1@jhmi.edu|
20190576|NCT00946088|Stanford University School of Medicine|Deirdre Lyell, MD|(650) 384-5107|deirdre.lyell@stanford.edu|
20190577|NCT00896389|University of Maryland, Baltimore|Dr. Yen Pei Christy Chang|410-706-6737|cchang@som.umaryland.edu|
20190578|NCT03184519|IVIValencia|LAURA CARACENA (STUDY COORDINATOR)|034 963050900|laura.caracena@ivirma.com|
20190579|NCT02755948|Imperial College London|Professor Christopher Chiu|(0)20 8383 2301|c.chiu@imperial.ac.uk|
20190580|NCT00584909|UAB|J. MIchael Straughn, MD|205-934-4986|Michael.Straughn@ccc.uab.edu|
20190581|NCT03345407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20190582|NCT00065611|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
20190583|NCT02092909|Idera Pharmaceuticals|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20190584|NCT03436797|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20190585|NCT05104242|University Hospitals of Derby & Burton NHS Foundation Trust, Royal Derby Hospital|Catherine Johnson|01332 789354|catherine.johnson16@nhs.net|
20190586|NCT01597856|VA Connecticut/ Yale University|Christina Lazar|203-932-5711|Christina.Lazar@Yale.edu|4833
20190587|NCT01508117|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
20190588|NCT00963105|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20190589|NCT04930263|National Yang Ming Chiao Tung University|Mrs Cheng-Chen Chou|28267176|chou8278@gmail.com|
20190590|NCT01989156|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20190591|NCT00850993|Mallinckrodt Pharmaceuticals|Medical Information Call Center|1-800-844-2830|clinicaltrials@mnk.com|5
20190592|NCT03839355|Mayo Clinic|Dr. Malini Madhavan|507-255-4152|Madhavan.Malini@mayo.edu|
20190593|NCT01852175|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
20190594|NCT02951702|St. Luke's Hospital|Ryan Medas, Pharm.D.|314-205-6053|ryan.medas@stlukes-stl.com|
20222052|NCT00218023|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
20222053|NCT01707290|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20222054|NCT01198470|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|1669
20222055|NCT02949973|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20190595|NCT05866887|Dana-Farber Cancer Institute|Maimouna Oumar|617-632-3000|maimouna_sy@dfci.harvard.edu|
20190596|NCT03816202|Integra LifeSciences|Andrew Tummon, Director, Global Clinical Trials|609-936-5490|andrew.tummon@integralife.com|
20222056|NCT00586703|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20222057|NCT02774941|Children's Health - Children's Medical Center, Dallas|Clinical Research Coordinator - Respiratory Care Dept|214-456-1367|gerald.moody@childrens.com|
20222058|NCT00806403|Sahlgren's University Hospital/S, Gothenburg|Lars Grip||lars.grip@vgregion.se|
20178283|NCT04084314|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20178284|NCT03336619|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
20178285|NCT01300546|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
20178286|NCT02271386|The Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|2674262304|fiks@email.chop.edu|
20178287|NCT01316926|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178288|NCT02649868|Clinical Center|Wood, Bradford|+1 301 496 7739|bwood@mail.cc.nih.gov|
20178289|NCT00983073|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
20178290|NCT00234065|Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.|Masahiko Abe, Director Cardiovascular Projects|+81-6-6943-7722|abems@otsuka.jp|2545
20178291|NCT05557942|Aerovate Therapeutics|Toll Free Number|(888) 373-8110|clinicaltrials@aerovatetx.com|
20178292|NCT03776136|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20178293|NCT02258477|University of Colorado, Anschutz Health and Wellness Center|Dr. James Hill|303-724-9974|james.hill@ucdenver.edu|
20178294|NCT01839734|The Ruth M. Rothstein CORE Center|Dr. Gregory Huhn|312-572-4575|ghuhn@cookcountyhhs.org|
20178295|NCT05245864|UAMS|Arny A. Ferrando|501-526-5711|AFerrando@uams.edu|
20178296|NCT03576768|Medical University of South Carolina|Colleen Hanlon, PhD|843-792-9888|hanlon@musc.edu|
20178297|NCT01760889|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20178298|NCT03035292|Cambridge University Hospitals NHS Trust|Dr Stephen Kelleher, Director of R&D|01223 217418|r&denquiries@addenbrookes.nhs.uk|
20178299|NCT01808950|Galderma Spirig|Dr. Francine Santoro|+41623878720|francine.santoro@galderma.com|
20178300|NCT01907191|Saint Francis Hospital and Medical Center|Sanjay Sinha, MD|860-714-6654|ssinha3300@gmail.com|
20178301|NCT01718028|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D.|1-888-451-3937|alcon.medinfo@alcon.com|
20178302|NCT01549613|University of Cincinnati, Dept. of Emergency Medicine|George J. Shaw, MD, PhD|513-558-8098|shawge@ucmail.uc.edu|
20178303|NCT02216123|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178304|NCT02131272|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20178305|NCT00381940|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20178306|NCT03162224|Global Clinical Lead|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20178307|NCT05159622|George Washington University|Uriyoan Colon-Ramos|202994 1899|uriyoan@gwu.edu|
20178308|NCT04162769|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20178309|NCT00324870|Johns Hopkins University|Michael Carducci, MD|410-614-6337|carducci@jhmi.edu|
20178310|NCT00725452|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20178311|NCT02163733|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20178312|NCT02723864|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
20178313|NCT03148470|University of Fribourg|Prof. Dr. Jean-Marie Annoni|++4126 306 3802|jean-marie.annoni@unifr.ch|
20178314|NCT00713648|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20178315|NCT00082173|Johns Hopkins University|Dr. Richard Chaisson|410-955-1755|rchaiss@jhmi.edu|
20178316|NCT01733732|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20178317|NCT00746590|BTG International Ltd.|Claire Daugherty|+1 801 556 8882|claire.daugherty@btgplc.com|
20178318|NCT01738750|University of Utah|Dr. Eric Scaife|801-662-2950|eric.scaife@imail2.org|
20178319|NCT00464815|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178320|NCT02526654|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20178321|NCT01402141|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Baek-Hwan Cho, MD|82-63-250-1579|chobh@jbnu.ac.kr|
20178322|NCT02633800|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|CTRinfo@DSI.com|
20178323|NCT01030861|Benaroya Research Institute|Carla Greenbaum, MD|206-342-6933|cjgreen@benaroyaresearch.org|
20178324|NCT00254982|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20178325|NCT00000392|NIMH|Benedetto Vitiello, MD - Supervisory Medical Officer|301-443-3357|bvitiell@mail.nih.gov|
20178326|NCT02836418|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20178327|NCT03643952|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178328|NCT01358968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178329|NCT00209417|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
20178330|NCT00487162|UMDNJ-NJMS|J. Jeffrey Freda, MD, MBA|973 972-5007|jjfreda@umdnj.edu|
20178331|NCT00815295|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
20178332|NCT04052204|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
20178333|NCT00363675|Shrines Hospitals for Children - Boston|Mary Jo Baryza, Diredtor of Therapeutic Services|617-371-4749|mbaryza@shrinenet.org|
20178334|NCT01803074|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178335|NCT00789438|Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinukum Schleswig-Holstein, Campus Kiel|Christoph Ilies M.D.|+49-431-597|christoph.ilies@anaesthesie.uni-kiel.de|2991
20206365|NCT03096444|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
20222059|NCT01882985|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
20206366|NCT00628758|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
20206367|NCT04179786|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
20206368|NCT03310580|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director, Global Clinical Operations|(908) 947-3543|nramirez@aeriepharma.com|
20206369|NCT03644108|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20206370|NCT00376246|UCSD Medical Center|Ori Ben-Yehuda, MD|619-543-2814|obenyehuda@ucsd.edu|
20206371|NCT03205982|Columbia University|Rebecca Schnall, PhD, MPH|212-342-6886|rb897@columbia.edu|
20206372|NCT00877604|Fondazione Istituto Neurologico Carlo Besta|Alberto Albanese|+39 02 2392 4552|alberto.albanese@unicatt.it|
20206373|NCT00994162|Smith+Nephew|Rachael Winter|+44 1482 673475|rachael.winter@smith-nephew.com|
20206374|NCT02983799|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20206375|NCT02025829|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
20206376|NCT00607126|DAvdi Geffen School of Medicine at UCLA|Barbara Giesser,MD|310-825-7313|bgiesser@mednet.ucla.edu|
20206377|NCT01495923|The Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
20206378|NCT02677623|Columbia University|Nisha Philip, Clinical Research Manager|212-305-4973|np2173@cumc.columbia.edu|
20206379|NCT03136367|Dartmouth College|Marie-Anne Durand|603-667-8601|marie-anne.durand@dartmouth.edu|
20206380|NCT00201760|The Ohio State University Comprehensive Cancer Center|Kari Kendra, MD|614-293-7956|Kari.Kendra@osumc.edu|
20206381|NCT01999348|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20206382|NCT03175562|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206383|NCT01230749|Janssen R&D US|Director, Translational Medicine|1 908 927-7881||
20206384|NCT03366844|Cedars-Sinai Medical Center|Stephen Shiao, MD, PhD|310-423-2836|Stephen.Shiao@cshs.org|
20222060|NCT00765102|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20222061|NCT03197389|University Hospitals Leuven|Prof. Dr. Ann Smeets|003216340903|hanne.vos@uzleuven.be|
20222062|NCT04129125|Imperative Care|Didem Aksoy, Senior Director of Clinical Affairs|650-644-8293|daksoy@imperativecare.com|
20222063|NCT02547012|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20222064|NCT04846400|University of Michigan|David A Zopf, MD|734-936-5730|davidzop@med.umich.edu|
20222065|NCT04132973|The University of Sheffield|Elaine Clarke|01142226533|e.n.clarke@shef.ac.uk|
20222066|NCT04383327|NYU Langone Health|Keng-Yen Huang, PhD, MPH|646-501-2879|Keng-Yen.Huang@nyulangone.org|
20222067|NCT01210560|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20222068|NCT05271175|Cyprus rTMS|Georgios Mikellides|0035799430330|george.mikellides@gmail.com|
20222069|NCT00991887|Carolinas Medical Center|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
20222070|NCT00226499|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222071|NCT04143373|Tehran UMS|Dr. Nariman Nikparto|+989124969058|n-nikparto@razi.tums.ac.ir|
20222072|NCT03888469|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20222073|NCT04564092|GE Healthcare|Yongqing Tang, MD PhD|189-1820-3986|Yongqing.Tang@ge.com|
20222074|NCT02859337|Oregon Health & Science University|Dr. A Edelman|503-418-2585|edelmana@ohsu.edu|
20222075|NCT02816346|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20222076|NCT02362360|Coloplast|Head of Clinical Operations|0045 49111990|dkcfv@coloplast.com|
20222077|NCT04146012|Accidentals Inc. (Formally Artegraft Inc.)|Tony Calandra, President|973.540.1250|arc@mcguggan.com|
20222078|NCT01546025|Brown University|Suzanne Colby|4018636655|Suzanne_Colby@brown.edu|
20222079|NCT05425927|SyntheticMR|Erik Lange|+46(0)70-331 56 78|erik.lange@syntheticmr.com|
20222080|NCT02996227|Cleveland Clinic|Fabio Rodriguez|215 444-9950|rodrigf3@ccf.org|
20222081|NCT03296813|Duke University|Robert Mentz, MD|919-668-7121|robert.mentz@duke.edu|
20222082|NCT03349060|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222083|NCT00485732|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222084|NCT05022667|University of Michigan Medical Center|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
20222085|NCT02512302|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20222086|NCT04067050|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
20222087|NCT00659711|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
20222088|NCT01644240|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
20222089|NCT03207776|Atrium Health|Dr. Jason Roberge|704-898-3855|Jason.Roberge@AtriumHealth.org|
20222090|NCT02342678|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
20222091|NCT00460603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206385|NCT02480998|The catholic university of Korea, Seoul ST. Marry's Hospital|Dr.Dong-suck Lim, CI|+82-2-2258-7327||
20206386|NCT02687711|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20206387|NCT00191386|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222092|NCT03003962|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20222093|NCT03871543|Johnson & Johnson Vision Care, Inc.|Ross Franklin|1 800-843-2020|RFRANKL1@its.jnj.com|
20222094|NCT01839708|Ohio State University|Mei-Wei Chang|(614) 292-4041|chang.1572@osu.edu|
20178336|NCT03644186|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki|+41 31 511 94 00|TOUCH-monitoring@etop.ibcsg.org|
20178337|NCT03712891|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20178338|NCT02701985|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20178339|NCT01953081|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
20178340|NCT01625221|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
20178341|NCT01988779|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
20178342|NCT00377403|Washington University in St Louis|Jane Garbut,MD|314-454-8613|jgarbutt@dom.wustl.edu|
20178343|NCT01284426|Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University|Professor Orathai Jirapongsananuruk, Director of Clinical Trials|024197000|siojr@mahidol.ac.th|
20178344|NCT00417079|sanofi-aventis|International Clinical Development Study Director||GV-Contact-us@sanofi-aventis.com|
20178345|NCT00694603|Massachusetts General Hospital|Dr. Lecia Sequist|617-724-4000|lvsequist@partners.org|
20178346|NCT00969501|Georgia Institute for Clinical Research, LLC|Arnold Weil, MD|770-421-2030|research@lowbackpain.com|
20178347|NCT01922076|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20178348|NCT01022762|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20178349|NCT00802074|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
20178350|NCT00827918|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178351|NCT02979262|Yale University Child Study Center|Dr. Carla Stover|2037853486|carla.stover@yale.edu|
20178352|NCT03743038|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20178353|NCT01565707|Astellas Pharma Europe B.V.|Medical Director, Medical Science - Urology||Astellas.resultsdisclosure@astellas.com|
20178354|NCT05207813|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20178355|NCT00617344|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
20178356|NCT03591068|Optinose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
20178357|NCT01417026|Children's Hospital of Philadelphia|Robert Schultz, PhD|267-426-7540|schultzrt@email.chop.edu|
20178358|NCT02959996|Massachussetts General Hospital|Malavika Prabhu|6177249028|mprabhu@mgh.harvard.edu|
20178359|NCT01261338|University of Cincinnati|Ronald J. Jandacek, PhD, Principal Investigator|513-558-5492|ronald.jandacek@uc.edu|
20178360|NCT01329029|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20178361|NCT06854601|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
20178362|NCT02794285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20178363|NCT03252587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20178364|NCT04124926|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
20178365|NCT01250977|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|215-746-7173|albeldab@pennmedicine.upenn.edu|
20178366|NCT02167074|Erasmusm MC University Medical Center Rotterdam|Dr. P. van Riet|0031648237608|p.vanriet@erasmusmc.nl|
20178367|NCT02578238|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20178368|NCT02013622|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20178369|NCT04224155|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
20178370|NCT05130970|CSL Behring LLC|Trial Registration Coordinator|610 878 4000|clinicaltrials@cslbehring.com|+1
20178371|NCT04235036|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20178372|NCT01640808|Pharmaceutical Division, Clinical Administration Dept.|Administrator of clinical trial information||ctrdinfo@kowa.co.jp|
20178373|NCT00989768|Brazilian Center for Studies in Dermatology|Juliana de Souza|+55 51 3026 2633|pesquisa@cebd.org.br|
20178374|NCT02192502|Cleveland Clinic|Dr. Andra Duncan|216-538-6944|duncana@ccf.org|
20178375|NCT01381692|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20178376|NCT01904448|University of North Carolina at Chapel Hill|Craig A. Buchman, MD, FACS|314-362-7395|buchmanc@wustl.edu|
20178377|NCT03896035|VANTHCS|Una Makris, MD (PI)|2148570240|una.makris2@va.gov|
20178378|NCT03819491|Consult Med Iasi|Dr. Delia Reurean-Pintilei|+40232233387|drdeliapintilei@gmail.com|
20178379|NCT01506193|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178380|NCT01388816|Proprietary Products, Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD|609-375-9855|kallenby@drreddys.com|
20178381|NCT00743366|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|reslabsurc@gmail.com|
20178382|NCT03160027|University of California, San Francisco & San Francisco VA Medical Center|Dr. Linda Chao|14152214810|linda.chao@ucsf.edu|24386
20218034|NCT00362817|The Ohio State University Medical Center and James Cancer Hospital & Solove Research Inst.|Herbert Newton,|614-293-4448|newton.12@osu.edu|
20178383|NCT01798550|Emory University|Christine Kempton MD, MSc|404-778-1900|ckempto@emory.edu|
20218035|NCT01787279|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20218036|NCT00836719|LSU Health Sciences Center-New Orleans|Jesus Lovera MD|5045686700|jlover@lsuhsc.edu|
20218037|NCT01191242|Intermountain Heart Institute|John Carlquist, PhD|8014081028|john.carlquist@imail.org|74707
20218038|NCT00140413|Children's Hospital Los Angeles|Dr. Mark Borchert|323-361-6219|mborchert@chla.usc.edu|
20218039|NCT02694549|CaveoMed GmbH|Albertus M. Scheule, MD, PhD, MBA|+49(0)7071-53982-10|albertus.scheule@caveomed.com|
20218040|NCT01005706|Medical University of South Carolina|Charles F. Bratton, MD|843-792-4003|brattocf@musc.edu|
20218041|NCT01567826|Icahn School of Medicine at Mount Sinai|Dr. Pedro R. Moreno||pedro.moreno@mountsinai.org|
20178384|NCT02308748|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
20178385|NCT01994954|University of Massachusetts Medical School|Dr. Lawrence Rhein|508-334-6206|Lawrence.Rhein@umassmemorial.org|
20178386|NCT00449176|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20178387|NCT00675766|West Los Angeles Veterans Association|Dr. Charles Hinkin|310-478-3711|chinkin@ucla.edu|44214
20178388|NCT02576678|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20178389|NCT02472964|Mylan Inc|Clinical Program Manager|412-651-9530|gail.tribble@mylan.com|
20178390|NCT02045238|Hospital Universitario - Sao Paulo University|Dr. Mateus Deckers Leme|X551130919200|mateusdl@gmail.com|9451
20178391|NCT01454583|Foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen, Germany|Professor Dr. Uwe Zeymer|+49 621 503 2813|Uwe.Zeymer@t-online.de|
20178392|NCT04434560|Duke University|Sarah Sammons, MD|919-684-4563|sarah.sammons@duke.edu|
20178393|NCT01749982|Columbia University|Megan N Hall|212-305-3161|mh2825@columbia.edu|
20178394|NCT01967732|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20178395|NCT03028974|Stanford University|Cornelia Dekker, MD|650-724-4437|cdekker@stanford.edu|
20178396|NCT01687257|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20178397|NCT03085485|University of Alabama at Birmingham|Bo Liu|(205) 975-7868|boliu@uabmc.edu|
20178398|NCT01302119|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
20178399|NCT01662882|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20178400|NCT01775904|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178401|NCT04891419|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20178402|NCT01055769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178403|NCT02235493|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
20178404|NCT00490646|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20178405|NCT01178086|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20178406|NCT02137369|Emory University|Dr. Dunlop|404-727-8969|bdunlop@emory.edu|
20178407|NCT04184791|Feinstein Institute for Medical Research at Northwell|Dr. Ritesh Ramdhani|516-325-7000|rramdhani@northwell.edu|
20178408|NCT00126438|GE Healthcare|Jose Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
20178409|NCT01420848|University of São Paulo|Leonice Fumiko Sato Kurebayashi|(5511 991126023)|fumie_ibez@yahoo.com.br|
20178410|NCT02899728|Dana- Farber Cancer Institute|Jacob Sands, MD|617-632-6049|Jacob_Sands@DFCI.HARVARD.EDU|
20178411|NCT02680054|Oxford University Hospitals NHS Trust|Dr Rachel Besser|01865 741741|rachel.besser@ouh.nhs.uk|
20178412|NCT02626780|The GID Group|Director of Clinical Affairs|3039524901|GIDAA-01@thegidgroup.com|
20178413|NCT04304833|University of Arkansas for Medical Sciences|Judith Weber|5012961982|weberjudithl@uams.edu|
20178414|NCT01116934|JWGUniversity|Prof. Dr. Peter Eickholz|+49-69-6301|eickholz@med.uni-frankfurt.de|5642
20178415|NCT00613951|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20178416|NCT01437449|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
20178417|NCT05540522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178418|NCT03754803|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178419|NCT04951336|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
20178420|NCT04348604|Case Western Reserve University|Joy Yala, Data Manager|216-368-0783|jxy790@case.edu|
20222095|NCT00350207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222096|NCT03214224|Penn State College of Medicine|Andrew Geronimo|717-531-0003|geronimo@psu.edu|282576
20222097|NCT03802825|Kaiser Permanente Center for Health Research|Dr. Stephanie L. Fitzpatrick, Senior Investigator|502-345-1476|Stephanie.L.Fitzpatrick@kpchr.org|
20222098|NCT03982511|Central Michigan University|Sarah Domoff, PhD|989-774-6461|domof1se@cmich.edu|
20222099|NCT01313897|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
20222100|NCT01837901|Okuvision GmbH|Dr. R. Schippert|+49 7121 15935|ruth.schippert@okuvision.de|50
20222101|NCT01051960|University of California, Los Angeles|Rajan Saggar, MD|(310) 794-9718|rsaggar@mednet.ucla.edu|
20222102|NCT00360282|University of Pittsburgh|Joseph M. Furman, MD, PhD|(412) 647-2115|furmanjm@upmc.edu|
20222103|NCT00661557|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222104|NCT03396653|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
20222105|NCT01293695|Baylor University|Dr. Gary Elkins, Director of the Mind-Body Medicine Research Laboratory|254-296-0643|gary_elkins@baylor.edu|
20222106|NCT00607620|University of Washington|Douglas Zatzick, MD|206-744-6701|dzatzick@uw.edu|206
20222107|NCT01082328|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20222108|NCT00031590|Childrens Hospital of Philadelphia|Peter Phillips|215-590-1000|phillipsp@email.chop.edu|
20222109|NCT01568892|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222110|NCT02962492|State University of NY at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
20162348|NCT00488826|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20178421|NCT02097108|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
20178422|NCT06675500|Ain Shams University|Dr.Sarah Elghareeb,lecturer of Anesthesia and ICU|+201012434690|Sarahhamdy@med.asu.edu.eg|
20178423|NCT00127608|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178424|NCT05520138|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178425|NCT04133831|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
20178426|NCT00680407|Meda Pharmaceuticals, Inc.|Associate Director, Clinical Research and Operations||michael.purzycki@meda.us|
20178427|NCT00506493|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
20178428|NCT04171102|University of Cagliari|Prof. Dr. Giuseppe Amato|337963197|amatomed@gmail.com|
20178429|NCT01751126|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
20178430|NCT00915031|University of California, Irvine|Linda Huynh|7144567354|lindamh@uci.edu|
20178431|NCT01253525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178432|NCT00265980|Professor of Pediatrics and Medicine at the Columbia University|Michael Rosenbaum, MD|212-305-9949|mr475@cumc.columbia.edu|
20178433|NCT04050865|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
20178434|NCT01466985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178435|NCT05616962|Primus Pharmaceuticals, Inc.|Director of Clinical Trials|480-483-1410|info@primusrx.com|
20178436|NCT00857207|Malcom Randall VAMC|Julia Kay Waid-Ebbs, Health Science Specialist|352-871-0282|Julia.Waid-Ebbs@va.gov|
20178437|NCT03073148|Tangible Science|Director of Research and Development|650-241-1045|kelly@tangiblescience.com|108
20178438|NCT00643916|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20178439|NCT01143688|National Jewish Health|Michael E. Wechsler M.D.|617-285-4987|wechslerm@NJHealth.org|
20178440|NCT03078270|George Washington University|Daniel Lieberman, M.D.|202-741-2899|dlieberman@mfa.gwu.edu|
20178441|NCT00447057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178442|NCT00440531|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20178443|NCT00385580|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20178444|NCT00677833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178445|NCT02606279|Wake Forest University Health Sciences|Katherine Schafer, Assistant Professor Internal Medicine|13367166342|kschafer@wakehealth.edu|336
20178446|NCT04493216|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178447|NCT02172755|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
20178448|NCT00985725|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20178449|NCT00993655|Canadian Cancer Trials Group|Senior Biostatistician|6135336430||
20178450|NCT03151005|Department of Endocrinology, Xinqiao Hospital, Army Military Medical University|Min Long, MD|023-68763255|longmin_casper@163.com|
20178451|NCT05090709|Edinburgh Napier University|Dr Rebecca Hamilton|0131455|rebeccaisabel.hamilton@napier.ac.uk|2350
20178452|NCT04977050|University of New Mexico|Dr. Akshay Sood|505-272-4751|ASood@salud.unm.edu|
20178453|NCT03318523|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20178454|NCT02858050|Saint Michael's Medical Center|Jihad Slim, MD|9738772663|jsmdsmmc@gmail.com|
20178455|NCT00863655|Novartis Pharmaceuticals|Study Director|862-778-8300||
20178456|NCT02261493|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
20178457|NCT01597050|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20178458|NCT00483184|Nobel Ilac San ve Tic. A.S.|Hasan Zeytin MD., Ph.D.|+90 216 6336012|hasan.zeytin@nobel.com.tr|6012
20178459|NCT02065336|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20178460|NCT00530855|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20178461|NCT01627327|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178462|NCT03901326|People's Liberation Army General Hospital|Dr Junjie Yang|13581662680|fearlessyang@126.com|86
20178463|NCT02161133|Veterans Affairs New Jersey Healthcare System|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
20178464|NCT01515410|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
20178465|NCT02081573|University of Pittsburgh School of Nursing|Judith A. Callan|412-383-5321|callanja@pitt.edu|
20178466|NCT00868439|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20178467|NCT00423176|Merck, Sharp & Dohme Corp.|Senior Vice Presdient, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20178468|NCT03871595|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178469|NCT00224874|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20178470|NCT00911534|Eisai Call Center|Eisai Inc.|888-422-4743||
20178471|NCT02477111|Cordis, A Cardinal Health Company|Jennifer Lee, Clinical Project Manager|669-699-6851|jennifer.lee02@cordis.com|
20178472|NCT01328574|National Cancer Institute|Dr. Andrea Apolo|301-451-1984|apoloab@mail.nih.gov|
20178473|NCT00554970|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20178474|NCT00113568|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20178475|NCT00452387|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20178476|NCT00736645|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20178477|NCT04403698|Study Principal Investigator Ghent Universitary Hospital|Prof. dr. Ruth Wittoek|+329 332 25 20|Ruth.Wittoek@Ugent.be|
20178478|NCT01181050|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
20178479|NCT04899349|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20178480|NCT01018394|Mayo Clinic|Dr. Jon Ebbert|507-266-1944|nicotineresearch@mayo.edu|
20178481|NCT03792126|University Hospitals Dorset NHS Foundation Trust|Louise Johnson|0300 019 4473|Louise.Johnson@uhd.nhs.uk|
20218042|NCT02062801|Sharp HealthCare|Dr. David R. Gambling|858-395-5668|david.gambling@sharp.com|
20178482|NCT00683644|University of Iowa|richard tyler|319 356 2471|rich-tyler@uiowa.edu|
20190597|NCT04501614|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20222111|NCT02179892|Emory University|Dr. Colette Curtis|404-778-3900|ccurti3@emory.edu|
20222112|NCT02375971|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20222113|NCT02755103|Medical University of South Carolina|Therese K Killeen PhD, Principal Investigator|843-792-5232|killeent@musc.edu|
20222114|NCT04177095|Massachusetts General Hospital|Hannah Gilligan, MD|617-726-2000|hgilligan@mgh.harvard.edu|
20222115|NCT00777296|Insmed Incorporated|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
20222116|NCT00658723|ETHICON, Inc.|Jonathan Batiller, Director Clinical Development|908-218-2819|JBatill2@its.jnj.com|
20222117|NCT03437863|Department of Digital Health Research (previously Center for Shared Decision Making and Collaborative Care Research)|Head of Research and Development|+47 23 03 31 67|elin.borosund@rr-research.no|
20178483|NCT04322682|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514 376-3330|jean-claude.tardif@icm-mhi.org|3612
20178484|NCT01027000|Dana Farber Cancer Institute|Edwin P. Alyea, MD||edwin_alyea@dfci.harvard.edu|
20178485|NCT02238379|Yale University|Dr. Helena Rutherford|203-737-3408|helena.rutherford@yale.edu|
20178486|NCT04123067|Penn State Hershey Medical Center|Dr. Kerstin Bettermann|717-531-1803|kbettermann@pennstatehealth.psu.edu|
20178487|NCT00441090|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20178488|NCT01441102|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20178489|NCT00605280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178490|NCT00518115|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178491|NCT00843167|Oregon Health & Science University|Dr. Jackilen Shannon|541-706-6861|shannoja@ohsu.edu|
20178492|NCT00127101|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20178493|NCT01662310|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20178494|NCT04302350|The First Affiliated Hospital of Nanjing Medical University|Dr.cunming Liu|13951890866|cunmingliu@njmu.edu.cn|
20178495|NCT00833638|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178496|NCT01400503|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20178497|NCT01669122|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178498|NCT03762473|University of Alabama at Birmingham|Graham Towns, MD|(205)934-1801|gtowns@uabmc.edu|
20178499|NCT02962908|PepTcell Ltd (trading as SEEK)|Dr Olga Pleguezuelos, Chief Scientific Officer|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
20178500|NCT03543254|St. Olavs Hospital HF|Knut Hagen|+4795401579|knut.hagen@ntnu.no|
20178501|NCT02077166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20178502|NCT03519854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178503|NCT05132699|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6742|straud@uthscsa.edu|
20178504|NCT03195010|FHCRC|Dr Bethany Samuelson Bannow|5034949925|samuelsb@ohsu.edu|
20178505|NCT01951625|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20178506|NCT00655980|University of Chicago Medicine|Principal Investigator|7737022544||
20178507|NCT01367262|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178508|NCT03163758|Peking Union Medical College Hospital|Dr. Weihong Zhang|01069159581|ZhangWeiHong@pumch.cn|
20178509|NCT03962894|University of Florida|Jennifer Fishe|904-244-4046|Jennifer.Fishe@jax.ufl.edu|
20178510|NCT04918784|Acera Surgical, Inc.|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
20222118|NCT01139125|Georgia Regents University|Peter F. Buckley, MD|706-721-2231|PBuckley@gru.edu|
20178511|NCT01712009|Amgen Inc.|Study Director|866-572-6436||
20178512|NCT02822222|RMJ Holdings LLC d/b/a RMJH Rx|Russell Jaffe, M.D., Chief Executive Officer|(703) 840-4440|rjaffe@rmjholdings.com|
20178513|NCT00428090|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178514|NCT00361140|Moffitt Cancer Center|Dr. Teresa Field|(813) 745-7202|Teresa.Field@moffitt.org|
20178515|NCT00184548|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20178516|NCT02690974|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20178517|NCT00746122|Imperial College London|Professor Janet Powell|44-2033117312|j.powell@imperial.ac.uk|
20178518|NCT02184611|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178519|NCT00160680|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20178520|NCT01922115|UNC Chapel Hill|Dr. Elizabeth Geller|919-966-4717|elizabeth_geller@med.unc.edu|
20178521|NCT03232983|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20178522|NCT01615328|Seoul National University Bundang Hospital|Jin-Sup Yeom|82-31-787-7190|highcervical@gmail.com|
20178523|NCT01992380|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20178524|NCT04294966|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20178525|NCT01137474|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
20178526|NCT04109703|Soovu Labs|Charles Chabal, MD|206-579-4910|Chuck@Soovu.com|
20178527|NCT05072080|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
20178528|NCT04867369|NYU Langone Health|Arthur Hertling, MD|212-598-6085|arthur.hertling@nyulangone.org|
20178529|NCT05554237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222119|NCT05697809|Oxular Ltd|Friedrich Asmus, MD, Chief Medical Officer|617 882 7179|friedrich.asmus@ocular-cc.com|
20222120|NCT02199964|Baylor College of Medicine|Stephen Pflugfelder, M.D.|713-798-6100|stevenp@bcm.edu|
20178530|NCT01839110|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
20178531|NCT04575467|Caliway Biopharmaceuticals Pty Ltd|Candra Chou|886226971355|candra.chou@caliway.com|1317
20178532|NCT00930293|University of Pittsburgh|Jill M. Cyranowski, PhD|412-246-5588|cyranowskijm@upmc.edu|
20190598|NCT02555397|Henry Ford Health System|Shyam Nyati|734-272-1751|snyati1@hfhs.org|
20190599|NCT04529941|Cedars-Sinai Medical Center|Dr. Peng-Sheng Chen|310-967-2707|Peng-Sheng.Chen@cshs.org|
20190600|NCT01240785|Department of Obstetrics and Gynecology, Turku University Central Hospital|Dr Kristiina Tertti|+358 2 3130000|kristiina.tertti@tyks.fi|
20190601|NCT00237809|Yale University|Dr. Deepak Cyril D'Souza|203-932-5711|deepak.dsouza@yale.edu|2594
20190602|NCT00872339|New England Research Institutes|Felicia Trachtenberg|6179723120|ftrachtenberg@neriscience.com|
20190603|NCT01107795|University of Alabama at Birmingham|Dr. Kirk Withrow|(205) 801-7874|kwithrow@uabmc.edu|
20190604|NCT02417376|GCD Indore|Dr Divya Singh Hada|+918720898289|dr_dshada@yahoo.com|
20190605|NCT01127737|Northwestern University|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
20190606|NCT02138838|Amgen Inc.|Study Director|866-572-6436||
20190607|NCT02736175|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20190608|NCT02010684|University of California Los Angeles|Dr. Jeanne Miranda|310-794-3710|mirandaj@ucla.edu|
20190609|NCT04520321|Trefoil Therapeutics.com|Thomas M Tremblay, RN, BSN|4153053491|ttremblay@trefoiltherapeutics.com|
20190610|NCT01884571|Emory University|Jonathan Glass, MD|404-727-3507|jglas03@emory.edu|
20190611|NCT00091572|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20190612|NCT01045057|Atos Medical AB|Director of Clinical Affairs|+1 352 870 0872|Corina.van.As@atosmedical.com|
20190613|NCT01199302|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20190614|NCT04433091|Vanderbilt University Medical Center|M.Benjamin Shoemaker,MD MSCI|615-322-2318|moore.b.shoemaker@vumc.org|
20190615|NCT05480410|Fundación Universitaria María Cano|Physiotherapy professor|+573206728934|catalinaloperamuneton@fumc.edu.co|
20190616|NCT05356130|Kaiser Permanente Center for Health Research|Greg Clarke, PhD|503-335-2400|greg.clarke@kpchr.org|
20190617|NCT04851587|University of Florida|Emily Bartley|352-273-8934|EBartley@dental.ufl.edu|
20190618|NCT02880293|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
20190619|NCT03239899|National Institutes of Health|Avindra Nath, MD|301-496-1561|avindra.nath@nih.gov|
20190620|NCT02802176|University of California, San Francisco|Marcelle Cedars, MD, Director, Division of Reproductive Endocrinology|(415) 353-7475|Marcelle.Cedars@ucsf.edu|
20190621|NCT02109172|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20190622|NCT03409276|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20190623|NCT03605745|Boston Scientific|Kaitlyn Rainbow, Clinical Research Associate|952-930-6627|kat.rainbow@bsci.com|
20190624|NCT01272388|Washington University School of Medicine|Brian R. Lindman, MD|314-747-3617|brlindman@wustl.edu|
20190625|NCT01107717|University of Texas Health Science Center at San Antonio|Muhammad Abdul-Ghani, MD|210-557-1157|abdulghani@uthscsa.edu|
20190626|NCT04454125|University of Pittsburgh|Dr. Franziska Rosser|412-692-8429|franziska.rosser2@chp.edu|
20190627|NCT04694300|University of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD. Professor of Oral Surgery and Pharmacology|215-898-9686|evhersh@upenn.edu|
20190628|NCT00113334|University of Texas (UT) MD Anderson Cancer Center|Edward Kim, MD, BS / Assistant Professor|713-792-6363|CR_Study_Registration@mdanderson.org|
20190629|NCT03490942|Xeris Pharmaceuticals|B J. Witkin|919-412-6483|bwitkin@xerispharma.com|
20190630|NCT01193283|NIH NHLBI|Dr. Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
20190631|NCT00830284|Boston Children's Hospital|John Kheir|6179194712|john.kheir@childrens.harvard.edu|
20190632|NCT01183013|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190633|NCT00547456|North Shore LIJ Health System|Rubin Cohen, MD|516-465-5400|rocohen@nshs.edu|
20190634|NCT02256553|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190635|NCT04739306|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4190|keumyoung.ahn@celltrion.com|
20190636|NCT01951105|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
20190637|NCT02727998|Yale School of Medicine|Dr. Ilan Harpaz-Rotem|(203) 937-4760|ilan.harpaz-rotem@yale.edu|
20190638|NCT03651271|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20190639|NCT05072795|Medical University of South Carolina|Dr. Andreana Benitez|843-876-8479|benitez@musc.edu|
20190640|NCT00138645|Pennington Biomedical Research Center|Corby K. Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
20190641|NCT00821093|Novartis Pharmaceuticals|Study Director|862 778-8300||
20190642|NCT01601821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190643|NCT00212888|OHRI|Dr. Jonathan B Angel|613-737-8442|JANGEL@toh.ca|
20190644|NCT01901302|Cubist Pharamceuticals|Vice President Clinical Research|1.781.860.8660||
20190645|NCT02010021|Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
20190646|NCT00834483|Rush University Medical Center|Dr. Brett R. Levine|312-432-2466|brettlevine@gmail.com|
20190647|NCT02812706|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20206388|NCT03077243|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
20206389|NCT03984812|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20190648|NCT02465632|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20222121|NCT02172664|Indiana University School of Dentistry|Dr. Jeffrey Platt|3172747229|jplatt2@iu.edu|
20222122|NCT05267236|Midwest Evaluation and Research|Midwest Evaluation and Research|620-208-6143|mer@midwestevaluation.com|
20222123|NCT04760626|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20222124|NCT02452944|Department of Anesthesiology, Gachon University Gil Hospital|Mi Geum Lee|82-32-460-3637|mikeum2@gilhospital.com|
20178533|NCT01152580|Duquesne University|Dr. Paula Witt-Enderby, Professor of Pharmacology and Toxicology|412-396-4346|wittp@duq.edu|
20178534|NCT01570829|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20178535|NCT00850473|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20178536|NCT00526123|Tufts Medical Center|Dr. Klemens B. Meyer|617-636-9421|kmeyer@tuftsmedicalcenter.org|
20178537|NCT02677116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20178538|NCT03182868|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
20178539|NCT03342638|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20178540|NCT02654808|Columbia University|Dr. Timothy Ryntz|212-305-4973|ter2111@cumc.columbia.edu|
20178541|NCT01680848|Dental PBRN Japan|Director of the Dental PBRN Japan|+81-93-285-3022|info@dentalpbrn.jp|
20178542|NCT02275065|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20178543|NCT02186210|Seoul National University Hospital Dept of Anesthesiology|Dr Yunseok Jeon|82-2-2072-2465|jeonyunseok@gmail.com|
20178544|NCT03213158|University of Wisconsin - Madison|Fahid Aziz, MD|(608) 262-5420|faziz@wisc.edu|
20178545|NCT01684748|Virginia Polytechnic Institute & State University|Elaina Marinik, Ph.D.|5402318299|emarinik@vt.edu|
20178546|NCT01826812|The Wilmer Eye Institute, Johns Hopkins|Dr. Esen K. Akpek|410-955-5214|esakpek@jhmi.edu|
20178547|NCT01955954|Palo Alto Health Sciences, Inc|Debra Reisenthel|9255948404|debra@pahealthsciences.com|
20178548|NCT01921296|University of Michigan Hospital|Dr. Norah Lynn Henry, Associate Professor of Internal Medicine|734-936-4991|norahh@umich.edu|
20178549|NCT01569438|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178550|NCT01207102|Duke University Medical Center|Dr Kimberly Blackwell|919-6681748|black034@mc.duke.edu|
20178551|NCT03649230|Purdue Pharma (Canada)|Graeme Donnelly|905.837-6498|graeme.donnelly@purdue.ca|
20178552|NCT01693068|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20178553|NCT00579280|University of South Florida College of Medicine|David V. Sheehan, MD, MBA|813-974-4544|dsheehan@health.usf.edu|
20178554|NCT04126408|northwell health|northwell health|5165620100|trebeiz@northwell.edu|
20178555|NCT00295022|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20178556|NCT01551199|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 791-1414|ellen.teng@va.gov|25513
20178557|NCT00734630|Forest Laboratories, Inc.|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
20178558|NCT01239030|Rhodes Pharmaceuticals|Akwete Adjei, PhD|401-202-9408|Akwete.Adjei@pharma.com|
20178559|NCT00977665|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20178560|NCT01330433|Loma Linda University, Dept of Cardiovascular and Thoracic Surgery|Research Coordinator|909-558-4355|vayermiller@llu.edu|
20178561|NCT00668902|Indiana University School of Medicine|Zeruesenay Desta|+1 (317) 274-2823|zdesta@iu.edu|
20178562|NCT03084666|University of Alabama at Birmingham|Brant Wagener, MD, PhD|12059346007|bwagener@uabmc.edu|
20178563|NCT01201057|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
20178564|NCT04259086|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20178565|NCT03240692|Stanford University|Dr. Nolan Williams|650-800-6920|nolanw@stanford.edu|
20178566|NCT02300220|Imperial College London|Professor Jadwiga Wedzicha|02075947947|j.wedzicha@imperial.ac.uk|
20178567|NCT02291614|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20178568|NCT01159054|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-6660|kzandinejad@partners.org|34769 page
20178569|NCT03088826|Maimonides Medical Center|Sergey Motov|718283600|smotov@maimonidesmed.org|
20178570|NCT02432105|Alcon, A Novartis Division|Clinical Scientific Director, GCRA - Global Clinical Development|1-888-451-3937|alcon.medinfo@alcon.com|
20178571|NCT00683826|Columbia University Medical Center|Henry N. Ginsberg MD, Gissette Reyes Soffer MD|2123059298|gr2104@columbia.edu|
20178572|NCT04365660|Stanford University|Dr. Kristen Ganjoo, MD|650-498-6000|kganjoo@stanford.edu|
20178573|NCT01311674|Emergent Biosolutions|Christine Hall, Sr. Director Clinical Research||chall@ebsi.com|
20178574|NCT02012491|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|Courtney.Schreiber@uphs.upenn.edu|
20178575|NCT02430194|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20178576|NCT03969719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178577|NCT05608629|Icahn School of Medicine at Mount Sinai|Dr. Benjamin H Natelson|(212) 844-6665|Benjamin.Natelson@mountsinai.org|
20178578|NCT02130193|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178579|NCT01212770|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20178580|NCT02243943|LUMC|Prof Dr A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
20178581|NCT00829387|VA Connecticut Healthcare System|Rebecca Czlapinski|203-932-5711|rebecca.czlapinski@va.gov|3357
20178582|NCT03036163|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
20178583|NCT00707031|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20222125|NCT03193853|Baylor Scott and White Health|Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
20222126|NCT06684951|AlNahrain university|Omaima Ismail Khalaf|9647831475217|khokh7871@gmail.com|
20222127|NCT01787292|Health Science Specialist|Dr. Keith McGregor|4043216111|keith.mcgregor2@va.gov|126792
20178584|NCT00941330|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
20178585|NCT02747238|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
20178586|NCT00541450|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||clinicaltrialsdisclosure@spcorp.com|
20178587|NCT02858895|Medicenna Therapeutics Inc|Rosemina Merchant - Chief Development Officer|604-340-3081|nmerchant@medicenna.com|
20178588|NCT05338333|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20222128|NCT01827111|UT MD Anderson Cancer Center|Adi Diab, MD-Associate Professor, Melanoma Medical Oncology|(713) 745-7336|adiab@mdanderson.org|
20222129|NCT02962648|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20178589|NCT01475136|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178590|NCT01266642|UT MD Anderson Cancer Center|Dr. Benjamin Smith, Professor, Radiation Oncology Department|(713) 563-2380|bsmith3@mdanderson.org|
20178591|NCT03854461|Queen's University Belfast|Prof. Jayne Woodside|+44 (0)28 9097 8942|j.woodside@qub.ac.uk|8942
20178592|NCT01323530|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20178593|NCT01194570|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20178594|NCT02673398|City of Hope|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
20178595|NCT04333420|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
20178596|NCT00289887|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178597|NCT01266850|Vanderbilt University Medical Center|Kathryn M. Edwards, MD|615-322-3078|kathryn.edwards@vanderbilt.edu|
20178598|NCT01437124|Wirral NHS Trust|Hussain Kazi|0151 678 6111|hussainkazi@nhs.net|
20178599|NCT04128293|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178600|NCT02035332|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
20178601|NCT04177680|Matinas BioPharma|Dr. James J Ferguson, MD|(908) 505-0964|jferguson@matinasbiopharma.com|
20178602|NCT04924283|Medical University of South Carolina|Christine Hahn|843-518-2875|hahnc@musc.edu|
20178603|NCT02030015|University of Minnesota|Jeanine Jarnes, PharmD|612-626-5131|utzx0002@umn.edu|
20178604|NCT00365391|Wayne State University|Philip A. Philip, M.D., Ph.D., F.R.C.P.||philipp@karmanos.org|
20222130|NCT03267212|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
20178605|NCT01332227|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20178606|NCT00514943|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178607|NCT03764449|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20178608|NCT05745142|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178609|NCT01100255|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
20178610|NCT03751631|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
20178611|NCT00833560|Jan-Cil Germany|Therapeutic Areas Director|+49 2137 955-492||
20178612|NCT00499031|NRG Oncology Statisics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gmail.com|
20178613|NCT00414817|Kaiser Permanente, Center for Health Research|Dr. William Vollmer, Senior Investigator|503-335-6755||
20178614|NCT00477230|CardioFocus, Inc.|Burke T. Barrett, Study Director|508 658-7200|bbarrett@cardiofocus.com|
20178615|NCT03382782|Illinois Institute of Technology|Dr. Lindsay Sheehan, Co-Investigator|312-567-7983|lsheehan@iit.edu|
20178616|NCT01316510|UC Davis|Mark Underwood|916-734-8672|munderwood@ucdavis.edu|
20178617|NCT01785680|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manary@kids.wustl.edu|
20178618|NCT03409666|Zimmer Biomet|Lisette Smid|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
20178619|NCT01791725|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20178620|NCT00512148|Tengion declared bankruptcy in 2014|Tengion declared bankruptcy and there is no results contact|There is no Tengion phone||
20178621|NCT01866943|Hospital for Special Surgery|Research Fellow|917-843-6655|berlinerz@hss.edu|
20178622|NCT01355588|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20178623|NCT01666951|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
20178624|NCT02366910|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
20178625|NCT05276830|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20178626|NCT02623322|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
20178627|NCT03284788|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
20178628|NCT03563716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20178629|NCT03775200|Compass Pathways|Medical Director|07443136539|info@compasspathways.com|
20178630|NCT04605978|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20178631|NCT03813238|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20178632|NCT02583425|Dr. Reddy's|Director, Clinical Development|609-375-9900||
20178633|NCT03104699|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
20178634|NCT01690130|Medical University of South Carolina|TMS in Nicotine Craving|8437925729|lixi@musc.edu|
20178635|NCT01644734|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222131|NCT01560975|NYEE|Dr. Robert Ritch|+1 212 477 7540|ritchmd@earthlink.net|
20178636|NCT02462876|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
20178637|NCT01786512|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20178638|NCT02450331|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20222132|NCT05691712|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20222133|NCT05303194|The University of Texas Medical Branch|Rafael Samper-Ternent|8322057994|rasamper@utmb.edu|
20222134|NCT04837196|Astellas Pharma Inc|Clinical Transparency|08008887704|astellas.resultsdisclosure@astellas.com|
20178639|NCT03581981|Atlanta VAHCS|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|203122
20222135|NCT01289678|Brody School of Medicine|Paul R. Walker, MD|2527441888|walkerp@ecu.edu|2527441888
20222136|NCT02174627|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20222137|NCT01267019|VA Greater Los Angeles, VISN 22 MIRECC|Michael F. Green, PhD|(310) 268-3376|mgreen@ucla.edu|
20222138|NCT02729025|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20222139|NCT05573464|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20222140|NCT04632927|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
20222141|NCT05734157|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
20222142|NCT04846569|Brown University|Jennifer Pellowski|4018635453|jennifer_pellowski@brown.edu|
20162349|NCT01549977|Takeda|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20178640|NCT02080871|W.L. Gore & Associates|Hector R Novoa|928-864-3867|hnovoa@wlgore.com|
20178641|NCT03384173|University of Wisconsin, Madison|Matthew Harer|608-417-6236|mwharer@wisc.edu|
20178642|NCT03509974|Cochlear|George Cire|+13038855440|gcire@cochlear.com|
20178643|NCT00464646|NSABP Foundation, Inc.|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
20178644|NCT01040858|Portland VA Healthcare System|Dr. Daniel Storzbach|503-220-8262|Daniel.Storzbach@va.gov|56497
20178645|NCT02606903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178646|NCT02157779|Providence VA Medical Center|M. Tracie Shea, PhD|401-273-7100|MaryTracie.Shea@va.gov|6248
20178647|NCT01291498|Oxford University Hospitals NHS Trust|Mr Radu Mihai||radu.mihai@ouh.nhs.uk|
20178648|NCT02548455|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
20178649|NCT01292876|University of Pittsburgh|Maria Alexander, Office Manager|412-624-5308|alexanderm3@upmc.edu|
20178650|NCT01175850|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
20178651|NCT04528069|Alcon Research, LLC|Director of Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20178652|NCT02525874|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20178653|NCT01814371|Washington University School of Medicine|Stephanie Fritz, MD, MSCI|3144544115|fritz.s@wustl.edu|
20178654|NCT01692782|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20178655|NCT04158050|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
20178656|NCT01016938|Universtity of Maryland School of Medicine|Warren D'Souza, PhD, MBA|410-328-7159|wdsouza@umm.edu|
20178657|NCT03945188|Arena Pharmaceuticals, a wholly owned subsidiary of Pfizer|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20178658|NCT01982240|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20178659|NCT04341116|I-Mab Biopharma US Ltd|Claire Xu|3177558242|Claire.Xu@i-mabbiopharma.com|
20178660|NCT00338884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178661|NCT00781391|Daiichi Sankyo, Inc.|James Hanyok, Sr. Director|732-590-5000|jhanyok@dsi.com|
20178662|NCT04535947|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
20178663|NCT00995501|Cleveland clinic|Daniel Sessler, MD|216-445-4900|sesseld@ccf.org|
20178664|NCT03616184|University of Nebraska Medical Center|Vijaya Bhatt|402-559-8008|vijaya.bhatt@unmc.edu|
20178665|NCT02396745|Allegheny Singer Research Institute|Mara Yerk, Administrative Director|412-389-3059|mara.yerk@ahn.org|
20178666|NCT04111757|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
20178667|NCT02133534|Duke University Medical Center|Research Practice Manager|919 681 6819|bixby001@duke.edu|
20178668|NCT02355002|Massachusetts General Hospital|Drs. Joan Camprodon and Sabine Wilhelm|6177265340|jcamprodon@mgh.harvard.edu|
20178669|NCT04321239|University of Michigan|Mary Janevic|734 647 3194|mjanevic@umich.edu|
20178670|NCT04322604|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20178671|NCT00850889|Allergan, Inc.|Steven P. James, MD, VP, Global Medical Affairs|714-246-4500|james_steven@allergan.com|
20178672|NCT02003352|Brain Synergy Institute|Frederick R Carrick|321-868-6464|drfrcarrick@post.harvard.edu|
20178673|NCT00053989|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716084505819|theresa.hahn@roswellpark.org|
20178674|NCT03205371|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20178675|NCT01851174|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
20178676|NCT02921997|Vanderbilt Vaccine Research Program|C. Buddy Creech, MD, MPH|615-343-0332|buddy.creech@vanderbilt.edu|
20178677|NCT04575051|University of Pittsburgh|Dr. Catherine Palmer|412-383-6565|cvp@pitt.edu|
20178678|NCT03492281|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20178679|NCT03624504|Medtronic (Shanghai) Management Co., Ltd.|Weifan Sun, Clinical Study Manager|021-20325267|weifan.sun@medtronic.com|86
20178680|NCT02958969|BWH|Gregory Piazza|6177326984|gpiazza@bwh.harvard.edu|
20162350|NCT00006400|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
20162351|NCT01705106|University of Chicago|Manish R. Sharma, MD|773-834-0312|msharma@bsd.uchicago.edu|
20162352|NCT00671606|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, ND/Assistant Professor||tjohnsto@mdanderson.org|
20203022|NCT02584634|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178681|NCT02363946|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|6263043400||
20178682|NCT01292239|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
20178683|NCT00765388|Coloplast A/S|Seema Suchdev Wrisberg|+4549113519|dkssw@coloplast.com|
20178684|NCT01846182|Central Texas Veterans Health Care System|Charles J. Foulks, M.D., ACOS/R|254 743 2643|Charles.Foulks@va.gov|
20178685|NCT03923933|Head of Nephrology Hospital General de México|Rafael Vadez-Ortiz M.D. PhD|+52 2789-2000|rafavaldez@gmail.com|1253
20178686|NCT00587964|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Beal|212-639-5159|bealk@mskcc.org|
20178687|NCT03030222|Saint Luke's Hospital of Kansas City|Study Manager|816-932-9858|EMBRACE-HF@saint-lukes.org|
20178688|NCT01830127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178689|NCT03156660|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
20178690|NCT01302847|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|MPAACT.ctgov@fstrf.org|
20178691|NCT01371851|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
20178692|NCT00450411|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20178693|NCT05725317|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20178694|NCT00344461|University of Maryland, Institute Of Human Virology|Charles E. Davis, Jr., MD|410-706-4608|cdavis@ihv.umaryland.edu|
20178695|NCT02339831|Brigham and Women's Hospital|Wolfgang Fitz MD|617-732-9500|wfitz@partners.org|
20178696|NCT00671931|Cincinnati Children's Hospital|Mohamed Mahmoud, MD Principal Investigator|513 636-7426|mohamed.mahmoud@cchmc.org|
20178697|NCT00951275|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20178698|NCT02813070|GE Healthcare|Paul Sherwin, M.D., PhD|+1-774-843-3888|PaulSherwin@ge.com|
20178699|NCT03645759|Michael E. Debakey VA Medical Center|Dr. Gina Evans|832-269-3048|gina.evans@va.gov|
20178700|NCT00818753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178701|NCT01389973|Janssen, R&D, LLC, Spring House, PA|Senior Director, Clinical Development, Immunology||ClinicalTrialDisclosure@its.jnj.com|
20178702|NCT00725296|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20178703|NCT02693743|University of Arkansas for Medical Sciences|Favrin Smith|1 (501) 526-8488|SmithFavrinM@uams.edu|
20178704|NCT03360942|Dartmouth-Hitchcock Medical Center|Cristina Ferrazzano Yaussy, MPH, CCRP, Research Regulatory Affairs Specialist|603-650-5333|Cristina.Ferrazzano.Yaussy@hitchcock.org|
20178705|NCT04907942|Click Therapeutics|Shaheen Lakhan, MDPhD, FAAN Study Chair|Not applicable|Science@clicktherapeutics.com|
20178706|NCT00254202|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20178707|NCT02459574|Imperial College London|Prof. Prapa Kanagaratnam|02033123783|p.kanagaratnam@imperial.ac.uk|
20178708|NCT04427202|University of Chicago Medicine|Mai T. Pho, MD MPH|773-834-3689|mpho@bsd.uchicago.edu|
20178709|NCT00251745|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20178710|NCT05501860|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
20222143|NCT00838903|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222144|NCT04225715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20178711|NCT00636649|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
20178712|NCT04508699|San Diego State University|AVP for Research Support Services|619-594-5938|rss@sdsu.edu|
20178713|NCT04866017|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20178714|NCT03355326|Indiana University, School of Medicine|Dr. Alan Ladd, Principle Investigator|317-274-4606|aladd@iupui.edu|
20178715|NCT01377480|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178716|NCT00876915|University of Rochester|Charles Francis, MD|(585) 275-5823|charles_francis@urmc.rochester.edu|
20178717|NCT01111123|Mount Siani School of Medicine Department of Dermatology|Jason Emer, MD|2122413288|jason.emer@mssm.edu|43288
20178718|NCT01735201|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20178719|NCT02063230|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20178720|NCT01203930|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20178721|NCT01835262|Maimonides Medical Center|Antonios Likourezos|718-283-6896|alikourezos@maimonidesmed.org|
20178722|NCT03014674|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178723|NCT00605293|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20178724|NCT00234052|Northwestern University|Clinical Trials Office|312-695-1301||
20178725|NCT01410474|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20178726|NCT02428296|Children's National Medical Center|Dr. Kim Keppler-Noreuil|2024766287|kkepplerno@childrensnational.org|
20178727|NCT00828984|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
20178728|NCT00420199|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20178729|NCT05095272|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick E. Duffy; Lab Chief|240.381.1317|patrick.duffy@nih.gov|
20178730|NCT03610464|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
20178731|NCT01826227|Memorial Sloan Kettering Cancer Center|Dennis Chi, MD|212-639-5016|chid@mskcc.org|
20178732|NCT03294330|Penn State College of Medicine|Colette Pameijer|717-531-5272|cpameijer@pennstatehealth.psu.edu|
20178733|NCT04139564|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
20222145|NCT00683618|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20222146|NCT01002989|Hypertension Center, Third University Department of Medicine, Sotiria Hospital|George S. Stergiou, MD, FRCP, Associate Professor of Medicine|+30 2107763117|gstergi@med.uoa.gr|
20222147|NCT01611935|University of Pennsylvania|Dr. Carrie Sims|215-588-5154|carrie.sims@uphs.upenn.edu|
20178734|NCT01624948|UCSF|Allison Webber MD|415 353 8382|allison.webber2@ucsf.edu|
20222148|NCT05177484|Royal Wolverhampton NHS Trust|Group Research Sponsorship Manager|01902|rwh-tr.sponsorshipofresearch@nhs.net|695065
20222149|NCT02549859|University of Chicago|Ms. Lani Leong, Research Coordinator|7738341688|lani@neurology.bsd.uchicago.edu|
20222150|NCT00729612|The Ohio State University|Gregory Otterson, MD|614-293-2887|Greg.Otterson@osumc.edu|
20222151|NCT02506868|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20222152|NCT04537078|Elshatby University Maternity Hospital|Dr. Aly Hussein|002-0119448000|emam_aly@me.com|
20222153|NCT00444535|Novartis Pharmaceuticals|Clinical Disclosure Office|8620778-8300||
20222154|NCT03922308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20222155|NCT00942578|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
20222156|NCT01704495|AstraZeneca|Medical Science Director Bengt Larsson||ClinicalTrialTransparency@astrazeneca.com|
20222157|NCT01256450|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20222158|NCT03866512|University of Exeter|Dr Marlou Dirks|+44 1392 725496|m.dirks@exeter.ac.uk|
20222159|NCT03328507|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
20222160|NCT00832455|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20222161|NCT05209867|University of Florida|Dr. Simone Marini|3522948951|simone.marini@ufl.edu|
20222162|NCT00323453|Santa Barbara Cottage Hospital|Laura Isaacs (Research Quality Assurance & Integrity Analyst) on behalf of Dr. Kenneth Waxman (PI)|805-324-9255|lisaacs@sbch.org|
20222163|NCT03876743|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
20218043|NCT01612884|Indiana University School of Medicine|Rolf Kreutz, MD|3179620500|rkreutz@iu.edu|
20218044|NCT03923699|Washington University School of Medicine|Thomas Kannampallil|(314) 273-7801|thomas.k@wustl.edu|
20218045|NCT03575871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218046|NCT02017860|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20218047|NCT06005597|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20218048|NCT03998436|Novalead Pharma Pvt. Ltd.|Supreet K. Deshpande|7066233033|supreet@novaleadpharma.com|
20218049|NCT00971737|Johns Hopkins University|Leisha Emens, MD, PhD||emensle@jhmi.edu|
20218050|NCT00251225|University of Pittsburgh Cancer Institute|Leonard J. Appleman, MD, PhD|412-648-6507|applemanlj@upmc.edu|
20218051|NCT02224573|Greenwich Biosciences|Medical Enquiries|1-833-424-6724|medinfo@greenwichbiosciences.com|
20218052|NCT00252174|McLean Hospital at time of study|John H. Halpern, M.D.|6179065063|jhalpern@recoverycoa.com|
20218053|NCT02546362|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
20218054|NCT01138826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218055|NCT05206448|University of Iowa|Rachel Mejia, DO|319-356-3143|rachel-mejia@uiowa.edu|
20218056|NCT03360916|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
20218057|NCT00754442|University of Maryland School of Medicine|Elizabeth A Streeten, MD|410-328-6219|estreete@medicine.umaryland.edu|
20218058|NCT01557842|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
20218059|NCT05560763|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
20218060|NCT01835379|Smith & Nephew, Inc.|Vice President, Medical & Clinical Affairs|817-302-3914|jaime.dickerson@smith-nephew.com|
20218061|NCT06972251|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|allison.lewinski@va.gov|
20222164|NCT03889418|Ochsner Health|Principal Investigator|504-842-8256|eboni.pricehaywood@ochsner.org|
20222165|NCT05002790|University Hospitals Coventry &Watwickshire NHS Trust|Cyprian Mendonca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25874
20222166|NCT00092118|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20222167|NCT02314026|Exalenz Bioscience|Clinical trial manager|97289737513|avrahamh@exalenz.com|
20222168|NCT01139775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222169|NCT04306211|Indiana University|John M. DeWitt, MD|317-944-0980|jodewitt@iu.edu|
20222170|NCT03296527|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20222171|NCT01597973|University of Michigan|Jolene Daniel|732 235-7713|jd1557@rwjms.rutgers.edu|
20222172|NCT02723344|Eastern Colorado Health Care System, Rocky Mountain MIRECC|Dr. Lisa A Brenner|720-723-6488|lisa.brenner@va.gov|
20222173|NCT03473184|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
20222174|NCT01326845|Novartis Pharmaceuticals|Study Director|862-778-8300||
20222175|NCT02524847|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
20222176|NCT04352101|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
20222177|NCT01268527|Eisai Medical Research Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20222178|NCT02794727|Mayo Clinic|Sanjeev Nanda, MD|507-284-2511|nanda.sanjeev@mayo.edu|
20222179|NCT01008605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222180|NCT00908544|MUC Research GmbH|Dr. phil. Eva Wolf|+49 (0)89-558703-0|Eva.Wolf@MUCResearch.de|
20222181|NCT01213966|Faculty of Tropical Medicine|Professor Sasithon Pukrittayakamee|(662) 354-9400-19|yon@tropmedres.ac|1435
20222182|NCT05192239|Colorado State University|Christopher Bell, Associate Professor|(970) 491-7522|christopher.bell@colostate.edu|
20222183|NCT03223350|Henry Ford Hospital|Dr. Joseph Miller, associate research director|313-916-5419|jmiller6@hfhs.org|
20222184|NCT00740636|Memorial Sloan Kettering Cancer Center|Dr. Maria C. Pietanza|646-888-4203|PietanzM@mskcc.org|
20222185|NCT00204490|University of Texas Medical Branch Galveston|Dr. Lee Jane W. Lu|409-772-1730|llu@utmb.edu|
20222186|NCT03477006|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
20222187|NCT02245516|Kala Pharmaceuticals Inc|VP, Clinical Development||results004@kalarx.com|
20222188|NCT00682786|Washington University School of Medicine|Benjamin R. Tan, M.D.|314-362-3560|btan@dom.wustl.edu|
20222189|NCT00762710|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
20222190|NCT04762160|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20222191|NCT01370629|Correvio International|Head of Clinical Development|+41 (0) 22 907 79 70|info@correvio.com|
20222192|NCT02817763|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
20222193|NCT01047527|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
20222194|NCT05142722|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20222195|NCT02141438|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20222196|NCT03896503|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20222197|NCT00437021|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
20222198|NCT01880554|Institut Bergonie|Derek Dinart||d.dinart@bordeaux.unicancer.fr|
20222199|NCT05161481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20222200|NCT01174823|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20222201|NCT00529087|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20222202|NCT02954601|Oramed|Chief Scientific Officer|+972-2-566-0001|miriam@oramed.com|
20222203|NCT00318474|Saint Joseph's Hospital and Medical Center|Ron Hogg, M.D.|602-406-3246|ronhogg@gmail.com|
20222204|NCT01775813|University of Colorado School of Medicine|Dr. Megan Kelsey|720-777-0991|megan.kelsey@childrenscolorado.org|
20222205|NCT05251337|Indiana University Health|Alyson Keen|3173413060|akeen2@iuhealth.org|
20222206|NCT01735916|Medtronic|MIRACLE EF Study Manager|(763) 514-4000|medtroniccrmtrials@medtronic.com|
20222207|NCT02004366|Emory University|Priyathama Vellanki|404-778-1665|priyathama.vellanki@emory.edu|
20222208|NCT03158038|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
20222209|NCT01067781|Valneva Austria GmbH|Head Clinical Developement|0043120620|info@valneva.com|0
20222210|NCT00708552|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222211|NCT01904526|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
20222212|NCT04878432|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222213|NCT03971071|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20222214|NCT03334435|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20222215|NCT03922321|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
20222216|NCT00495391|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
20222217|NCT02712320|Foresee Pharmaceuticals Co., Ltd.|Dr. John Mao|+886 2-2655-2658|john.mao@foreseepharma.com|
20178735|NCT02249819|Northwell Health|Johanna Chang, Senior Research Coordinator|(516)562-3646|jchang14@northwell.edu|
20222218|NCT03313180|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20222219|NCT01697748|University of South Florida|Dr Sheila Connery, Associate Professor Obstetrics and Gynecology|813-259-8542|sconnery@health.usf.edu|
20178736|NCT00002558|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
20222220|NCT00553839|Stanford University|Chandra Ramamoorthy, MBBS, FRCA|650-723-5728|chandrar@stanford.edu|
20222221|NCT03376789|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
20222222|NCT01118741|Johns Hopkins University|Michael Carducci, MD|410-614-3977|carducci@jhmi.edu|
20206390|NCT04038385|William Paterson University, Sociology Department|Jennifer Di Noia, PhD, Principal Investigator|19737203714|dinoiaj@wpunj.edu|
20206391|NCT02038790|Indivior, Inc.|Global Director Clinical Development|804-379-1090||
20206392|NCT02431793|Northwestern University|Dr. Danielle McCarthy|312-926-7532|d-mccarthy2@northwestern.edu|
20206393|NCT01818986|University of Texas Southwestern Medical Center Dallas|Dr. Raquibul Hannan|214-645-7696|raquibul.Hannan@UTSouthwestern.edu|
20206394|NCT02286726|The University of Texas MD Anderson Cancer Center|Ghayas Issa C. MD./Assistant Professor|713-745-6798|GCIssa@mdanderson.org|
20206395|NCT02683707|JohnsHopkinsU|Dr J William McEvoy|4109555000|jmcevoy1@jhmi.edu|
20206396|NCT03537092|University Of Pittsburgh|Leslie Meyn, PhD|412-641-4233|meynla@mwri.magee.edu|
20206397|NCT03170258|Duke University|R. Alison Adcock, MD, PhD|919-681-7486|alison.adcock@duke.edu|
20206398|NCT01563107|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
20206399|NCT02707601|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20206400|NCT01769612|Institut Pasteur of Tunis|Afif Gen Salah, MD, PhD|011-216-71-792-429|noemailavailable@no.com|
20206401|NCT03907969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20206402|NCT01333098|Washington University School of Medicine|Eric Lenze, MD|314-362-5154|lenzee@wustl.edu|
20206403|NCT01391468|China Medical University|II-Kuan Wang|88975681050|ikwang@seed.net.tw|
20206404|NCT00063986|ECOG Statistical Office|Study Statistician|617-632-3012||
20206405|NCT03669146|The Ohio State University College of Optometry|Ann Morrison|614-570-3416|morrison.421@osu.edu|
20206406|NCT01488188|International Vaccine Institute|Dr. Jae Seung Yang|82-2-881-1198|jsyang@ivi.int|
20222223|NCT05188261|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
20206407|NCT01783470|NIDDK / NIH|Aaron M. Cypess, MD, PhD, MMSc|301-435-9267|aaron.cypess@nih.gov|
20206408|NCT01675141|National Cancer Institute|Dr. Dickran Kazandijian|301-451-2677|kazandijiandg@nih.gov|
20222224|NCT02025725|Evoke|Chief Medical Officer|858-345-1494|mcarlson@evokepharma.com|206
20222225|NCT02946463|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20222226|NCT05581641|BioNTech SE|BioNTech clinical trials patient information|61319084|patients@biontech.de|+49
20222227|NCT01924689|BioMed Valley Discoveries, Inc.|Brent Kreider|816-960-4644|bkreider@biomed-valley.com|
20222228|NCT00468819|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20222229|NCT02492867|University of Michigan Rogel Cancer Center|ClinicalTrials.gov CC Admin|734-936-9499|clinicaltrialsgov_ccadmin@med.umich.edu|
20222230|NCT02692859|jiangsuPCDCP|Kai Chu|18915999781|chukai19812007@163.com|
20222231|NCT00122382|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
20222232|NCT01591096|SeattleChildrens|Catherine Amlie-Lefond MD|206-987-2078|calefond@seattlechildrens.org|
20222233|NCT01831635|Queen's University Belfast|Dr Lesley Anderson|02890632315|l.anderson@qub.ac.uk|
20222234|NCT01276860|Arkansas Children's Hospital|Clinical Research Coordinator|501-364-2018|boswelljl@archildrens.org|
20222235|NCT05966584|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2380|markovaa@mskcc.org|
20222236|NCT03576326|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
20222237|NCT05086744|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20222238|NCT02999269|University of New Mexico|Dr. Chris Abbott, Division Chief Neuromodulaton, Department of Psychiatry|505272223|cabbott@salud.unm.edu|
20222239|NCT03100864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222240|NCT00382200|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal, MD, PhD|646-608-3746|rampalr@mskcc.org|
20222241|NCT01120184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20222242|NCT03096418|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
20222243|NCT00536939|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20222244|NCT01894841|Providence VAMC|Jennifer Primack|401 273-7100|jennifer.primack@va.gov|6295
20222245|NCT02235064|Cooper University Health System|Dr. Richard L Fischer|856-342-2491|fischer-richard@cooperhealth.edu|
20222246|NCT03532425|University of Alberta|Dr. Stephen D. Shafran|780-407-6945|sshafran@ualberta.ca|
20178737|NCT03046212|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
20178738|NCT01260350|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20178739|NCT00558428|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178740|NCT00626028|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20178741|NCT05224050|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
20178742|NCT04385368|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20178743|NCT00617981|Celsion Corporation|Nicholas Borys, M.D. Senior Vice President and Chief Medical Officer|609-896-9100|nborys@celsion.com|
20178744|NCT02123108|University of California Los Angeles|Dr. Fady M. Kaldas|310-825-8138|FKaldas@mednet.ucla.edu|
20178745|NCT00716092|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178746|NCT02219048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178747|NCT02436330|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-624-9188|alc@uic.edu|
20178748|NCT02054806|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178749|NCT01132326|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20178750|NCT00677235|Bard Peripheral Vascular|John Van Vleet|1-800-321-4254|John.VanVleet@CRBard.com|
20178751|NCT00952367|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178752|NCT02230956|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20178753|NCT04273139|Dana-Farber Cancer Institute|Jorge J. Castillo, Md|617-632-2681|jorgej_castillo@dfci.harvard.edu|
20178754|NCT03575325|Moffitt Cancer Center|Bijal D. Shah, MD, MS|813-745-4294|Bijal.Shah@moffitt.org|
20178755|NCT05711641|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|Dr. Tatiane Vacaro Campos|+551126617585|tati_vacaro@hotmail.com|
20178756|NCT03574597|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20178757|NCT02355743|BloodCenter of Wisconsin, Medical College of Wisconsin|Lynn Malec|414-257-2424|lynn.malec@bcw.edu|
20178758|NCT00762450|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
20178759|NCT02862457|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20178760|NCT04496219|University of Washington|Dr. Sarah Psutka, MD, MS|206-598-4294|spsutka@uw.edu|
20178761|NCT00951483|Loyola University Chicago|Angelos Halaris, MD, PhD|708-216-3275|ahalaris@lumc.edu|
20178762|NCT03565887|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
20178763|NCT03364751|Philip Morris Products S.A.|Christelle Haziza, Director Clinical Science & Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20178764|NCT02975973|Baylor College of Medicine|Raymond Cho|713-798-7781|Raymond.Cho@bcm.edu|
20178765|NCT02413580|Grifols Therapeutics LLC|Rhonda Griffin|9193166693|Rhonda.Griffin@grifols.com|
20178766|NCT03804710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178767|NCT04542018|University of Michigan|Prashant Singh, MBBS|734-647-1191|singhpr@med.umich.edu|
20178768|NCT03583554|Baylor College of Medicine and Michael E. DeBakey VA Medical Center|Dr. Marijn Lijffijt, Assistant Professorq|713-798-5642|marijn.lijffijt@bcm.edu|
20178769|NCT03178266|ZipLine Medical|Wendy Winters, Clinical Project Manager|4085061866|wwinters0@gmail.com|
20178770|NCT01215292|University of Washington|Mara Roth, MD|206-221-0519|mylang@uw.edu|
20178771|NCT00262821|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20178772|NCT00528775|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20178773|NCT04540874|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178774|NCT01777854|UH|Carissa Wentland DO|320-392-4737|carissa.wentland@gmail.com|
20178775|NCT02080468|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
20178776|NCT00205348|University of Wisconsin-Madison|Dr. Herbert Chen|608-263-1387|chen@surgery.wisc.edu|
20178777|NCT02732366|University of Pittsburgh, Department of Physical Therapy|Christine M. McDonough, Assistant Professor of Physical Therapy|4123834603|cmm295@pitt.edu|
20178778|NCT01297959|Excited States/Exoxemis, Inc|Jackson T Stephens, Jr|(402) 884-2316|sstephens@exoxemis.com|
20190649|NCT04791917|University of Florida Department of Clinical and Health Psychology|Jeff Boissoneault, PhD|352-273-6200|jboissoneault@phhp.ufl.edu|
20190650|NCT00910871|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
20206409|NCT00109772|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20206410|NCT01659268|College of Nursing at Ribeirão Preto, University of Sao Paulo|Cesar Eduardo Pedersoli|55(16)3602-3421|cesinhajardel@ig.com.br|
20206411|NCT00813917|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
20206412|NCT01498588|Emory University|Keerthi Gogineni, MD, MSHP|404-778-1801|keerthi.gogineni@emory.edu|
20206413|NCT03168841|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
20206414|NCT03364491|George Washington University Biostatistics Center|Principal Investigator, MFMU|301-881-9260|mfmudatasets@bsc.gwu.edu|
20206415|NCT03043807|Johns Hopkins University|Kenneth Pienta|4105023137|kpienta1@jh.edu|
20206416|NCT00792701|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
20206417|NCT00615914|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206418|NCT00802867|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20222247|NCT01220466|Abbott Medical Optics|Amelia Saliba, Sr. Manager, Clinical Research|408-273-4158|amelia.saliba@amo.abbott.com|
20206419|NCT01156532|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20206420|NCT01809197|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20206421|NCT03228394|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20206422|NCT02157103|Emory University|William L. Read, MD, Principal Investigator|404-778-1900|william.l.read@emory.edu|
20206423|NCT01525667|Pluristem Ltd.|Dr.Esther Lukasiewicz Hagai|+972-972-74-710-8600|estherl@Pluristem.com|694
20206424|NCT00294684|NIDDK|Ed Doo||dooe@niddk.gov|
20206425|NCT02443805|Stallergenes Greer|Martine Le Gall, Director of Clinical Development|+33 1 55 59 25 56|martine.legall@stallergenesgreer.com|
20206426|NCT00968708|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20206427|NCT02708966|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
20206428|NCT01515488|Maricopa Integrated Health System|Madhumita Sinha, MD, MHSM|602-344-5404|madhumita_sinha@dmgaz.org|
20206429|NCT03407170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222248|NCT04227197|Massachusetts General Hospital|Brian G Skotko, MD, MPP, Principal Investigator|(617) 643-3196|bskotko@mgh.harvard.edu|
20222249|NCT04547985|Weill Cornell Medicine|Dr. Holly G. Prigerson|646-962-9655|hgp2001@med.cornell.edu|
20222250|NCT01379768|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
20222251|NCT03446027|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
20222252|NCT03097341|Aronora, Inc.|Christina U. Lorentz, PhD, Senior Scientist and Project Manager|503-964-0250|christina.lorentz@aronorabio.com|
20222253|NCT01209949|Galderma Laboratories, L.P.|Norman Preston|817-961-5360|Norman.Preston@galderma.com|
20222254|NCT06188715|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20222255|NCT03808948|Charité - Universitätsmedizin Berlin|Prof. Dr. med. Kai Schmidt-Ott|+4930450614671|Kai.schmidt-ott@charite.de|
20222256|NCT02075203|SATVI|Dr. Mark Hatherill|+27214066145|mark.hatherill@uct.ac.za|
20222257|NCT03566199|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD.|(415) 502-7301|Sabine.Mueller@ucsf.edu|
20222258|NCT00568451|Mayo Clinic Cancer Center|Svetomir N. Markovic M.D., Ph.D.|507-284-2511|markovic.svetomir@mayo.edu|4-2511
20222259|NCT05266053|Indiana University|Dr. Lisa Mims - Principal Investigator|7733074863|lamims@iupui.edu|
20222260|NCT05344560|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20222261|NCT02996968|TriHealth Inc.|Abigail Shatkin-Margolis, MD|513-463-4300|Abigail_Shatkin-margolis@trihealth.com|
20222262|NCT00391768|Collaborative Antiviral Study Group|Penelope Jester|877-975-7280|PJester@peds.uab.edu|
20222263|NCT01620138|Universidade Federal do Rio de Janeiro|Monica Gadelha|+552139382323|mgadelha@hucff.ufrj.br|
20222264|NCT05005507|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20222265|NCT01072773|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20178779|NCT01667432|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20222266|NCT02556775|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20222267|NCT01719367|Florida Electrophysiology Associates|Matthew Kolek, MD|(561) 434-0353|info@heartrhythmexperts.com|
20222268|NCT02792062|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20222269|NCT01549587|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
20222270|NCT03197038|University of Illinois at Chicago|Dr. Ulf Bronas|312-355-5886|bronas@uic.edu|
20222271|NCT01565889|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20222272|NCT02166333|Johns Hopkins University|Dr. Lawrence Appel|410-955-4156|lappel@jhmi.edu|
20222273|NCT02269098|Medstar Health Research Institute|Michelle F Magee, MD|202-877-0351|michelle.f.magee@medstar.net|
20222274|NCT03523520|University of Missouri Health Care|Dr. Kara B. Goddard|5738841605|goddardk@health.missouri.edu|
20222275|NCT01766076|Makarere University|Damalie Nakanjako|41407000|dnakanjako@gmail.com|249
20222276|NCT03644342|Baylor College of Medicine|Michelle S. Ludwig, MD, MPH, PhD|713-566-3662|Michelle.Ludwig@bcm.edu|
20222277|NCT01845441|University Hospitals Cleveland Medical Center|Dr. Kristine Blackham|216-403-2705|kristine.blackham@gmail.com|
20222278|NCT00359424|University of Cincinnati Academic Health Center|Joseph P. Broderick|513-558-5429|broderjp@ucmail.uc.edu|
20222279|NCT02259010|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20222280|NCT02462603|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20222281|NCT02716714|Korea University Ansan Hospital|Ilhwan Kim|+82314125986|kumcihk@korea.ac.kr|
20222282|NCT03218995|Sarepta Therapeutics, Inc.|Medical Director|800-690-2003|clinicaltrials@sarepta.com|
20222283|NCT02045264|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20222284|NCT01445730|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-4717 1990|marja-riitta.taskinen@helsinki.fi|
20222285|NCT03134144|Institute of Occupational and Social Medicine and Health Services Research, University of Tübingen|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
20222286|NCT01167140|Myoscience|Francis Rogers Palmer III, MD|650-474-2600|thenry@myoscience.com|
20222287|NCT03805412|University of Washington Diabetes Institute|Dr. Nicole Ehrhardt|202-741-3422|nehrhard@uw.edu|
20162353|NCT04667104|Janssen Research & Development, LLC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20162354|NCT02933502|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20190651|NCT00349713|University of Bamako|Mahamadou A. Thera, MD, MPH, Professor|223-20-22-81-09|mthera@icermaili.org|
20190652|NCT01005914|Oregon Health & Science University|Dr. Brandon Hayes-Lattin|503-494-1551|hayeslat@ohsu.edu|
20190653|NCT01755598|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20222288|NCT00848718|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190654|NCT04016415|Milton S. Hershey Medical Center, Penn State Hershey College of Medicine|Dr. Nazia T Raja-Khan, M.D., M.S., Associate Prof, Dept of Medicine, Div. of Endocrin & Diabetes|717-531-8395|nrajakhan@pennstatehealth.psu.edu|
20190655|NCT00828178|Johns Hopkins University School of Medicine|Dr. Michelle Petri|410-955-9114|mpetri@jhmi.edu|
20190656|NCT02429115|Penn State College of Medicine - Penn State Health|Nasrollah Ghahramani|7175318156|nghahramani@pennstatehealth.psu.edu|
20190657|NCT02260154|Abbott|Tatiana V. Vladimirova MD, PhD|+7 495-258-4280|tatiana.vladimirova@abbott.com|
20190658|NCT03547167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222289|NCT01769573|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
20222290|NCT02389829|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
20222291|NCT00571727|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20222292|NCT03817190|DS Biopharma|Study Director|+35312933590|info@dsbiopharma.com|
20222293|NCT05514873|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20222294|NCT03525678|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20222295|NCT04495946|Wake Forest University School of Medicine|Marc Kowalkowski, PhD|704-355-9902|marc.kowalkowski@advocatehealth.org|
20222296|NCT01068678|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20222297|NCT02565628|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222298|NCT04170738|Icahn School of Medicine at Mount Sinai|Iliyan Ivanov|(212) 523-1924|iliyan.ivanov@mssm.edu|
20222299|NCT03055338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222300|NCT03058705|University of Rochester|Edward Messing, MD|585-275-0998|edward_messing@urmc.rochester.edu|
20222301|NCT03752970|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222302|NCT03976362|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20222303|NCT04767282|Michigan State University|Amy Custack, Associate Professor|8106005656|saxeamym@msu.edu|
20222304|NCT00824772|Inje University|Kye-Min Kim, Associate Professor, Dept of Anesthesiology & Pain Medicine|82-2-950-1168|kyemin@paik.ac.kr|
20222305|NCT02767011|Charleston Area Medical Center Research Institute|Mike Broce|304-388-9923|mike.broce@camc.org|
20222306|NCT00730483|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20222307|NCT02955355|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20222308|NCT02992236|Nephrology University Erlangen Germany|Prof Dr Rroland Schmieder|+49 9131 8536207|roland.schmieder@uk-erlangen.de|
20222309|NCT03817853|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20222310|NCT04268771|Dr. Reddy's Laboratories Ltd.|Head-Clinical Development|91-40-4464-4000|RI-01-007@drreddys.com|
20222311|NCT02841995|Sanofi ( Kadmon, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20222312|NCT00717912|Biofortis|Doctor|0240205799|info@mxns.com|
20222313|NCT01051596|Georgetown University|Michael Pishvaian, MD, PhD|202-444-2223|pishvaim@georgetown.edu|
20222314|NCT03809663|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20222315|NCT01703260|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20222316|NCT02531308|Northwestern University|Dr. R Karmali|312-695-0686|reem.karmali@northwestern.edu|
20222317|NCT02721277|University of Florida|Josef Neu, MD|352-273-8985|neuj@peds.ufl.edu|
20222318|NCT00630825|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222319|NCT02275819|VA Boston Healthcare System|Dr. Jayashri Aragam|617-323-7700|Jayashri.Aragam@va.gov|
20222320|NCT01346059|Beaumont Health|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
20222321|NCT01354652|AsanMC|Dr. Han Chu Lee|82230103915|hch@amc.seoul.kr|
20222322|NCT02211209|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20222323|NCT00749073|Vertos Medical|VP Clinical, Regulatory, Quality|9493490008|cmyers@vertosmed.com|216
20222324|NCT00558701|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
20222325|NCT01464424|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20222326|NCT01808066|CogCubed|Chief Medical Officer|612-250-9737|monika@cogcubed.com|
20222327|NCT00745901|North America Pharmaceutical (Ortho-McNeil Janssen Scientific Affairs, LLC)|Chief Scientific Officer|1-888-526-5060||2915
20222328|NCT00758290|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20162355|NCT03208088|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen SR Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20222329|NCT00884117|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190659|NCT00736502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190660|NCT00645411|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20190661|NCT01307800|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190662|NCT02674399|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
20190663|NCT02255474|The Ohio State University|Dr. Jeffrey Walline|614-247-6840|walline.1@osu.edu|
20190664|NCT02394912|Volcano|VP Clinical Trials|858-720-8731|jonathan.batiller@philips.com|
20190665|NCT00860457|Lombardi Comprehensive Cancer Center, Georgetown University Hospital|Dr. Bruce D. Cheson|202-444-7932|bdc4@georgetown.edu|
20190666|NCT01082159|Vertos Medical|VP Clinical Research|949-349-0008|cmyers@vertosmed.com|216
20190667|NCT01175980|Barbara Ann Karmanos Cancer Institute|Dr. Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
20190668|NCT03444298|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
20162356|NCT00605345|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20190669|NCT03016091|Davidoff Cancer Center at Rabin Medical Center|Shlomit Yust-Katz MD|92739378002|shlomit2@clalit.org.il|
20190670|NCT04520256|The Miriam Hospital|Dr. J. Graham Thomas|(401) 793-8154|jthomas4@brownhealth.org|
20190671|NCT01730118|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20190672|NCT04206397|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
20190673|NCT02680314|Montefiore Medical Center|Peter Bernstein, MD|718-904-2767|pbernste@montefiore.org|
20190674|NCT02101554|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190675|NCT00668746|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
20190676|NCT04179799|University of Florida|Emily Fox|352-273-6500|ejfox@phhp.ufl.edu|
20190677|NCT02232009|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
20190678|NCT02409732|Dartmouth-Hitchcock Medical Center|Dr. Michael Shane Chapman Section Chief of Dermatology|603-650-3106|Michael.Shane.Chapman@hitchcock.org|
20190679|NCT00168805|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190680|NCT04175392|Beaumont Hospitals|Kirsten Gage, CRM|947-521-8519|kirsten.gage@beaumont.org|
20190681|NCT03075449|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190682|NCT01532830|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
20190683|NCT01613599|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190684|NCT02991456|Duke University|James Herndon II, Ph.D.|919-668-8145|james.herndon@duke.edu|
20190685|NCT03503188|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190686|NCT01699178|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
20190687|NCT04407442|University of California, San Francisco|Dr. Alfred Chung|(415) 353-2421|Alfred.Chung@ucsf.edu|
20222330|NCT02798380|Hallux, Inc.|Thomas M Tremblay, RN BSN, Vice President of Clinical Affairs|(415) 305-3491|ttremblay@halluxinc.com|
20222331|NCT00952068|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20222332|NCT02022202|Mayo Clinic|Matthew P. Goetz MD and Judy C. Boughey MD|507-284-2511|Goetz.Matthew@mayo.edu|
20222333|NCT03957473|Penumbra, Inc.|Study Manager|+1 415-601-9561|apascua@penumbrainc.com|
20222334|NCT04390763|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20222335|NCT03831932|The Ohio State University Comprehensive Cancer Center|Dr. Dwight Owen|614-685-2039|Dwight.Owen@osumc.edu|
20222336|NCT02170220|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20222337|NCT01956773|Duke University Medical Center|Dr. Lori A. Orlando, Director Program in Precision Medicine|919-660-6606|orlan002@duke.edu|
20222338|NCT01383174|University of California San Francisco|Dr. Anna Maria Napoles|415-476-6290|anapoles@ucsf.edu|
20222339|NCT01153815|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222340|NCT00126750|VA Bedford CHOIR|Dr. Thomas Houston II|781-687-2884|thomas.houston2@va.gov|
20222341|NCT01786993|St. Jude Medical|Director of Clinical Studies|972-309-8000|ccohorn@sjm.com|8087
20222342|NCT00450437|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
20222343|NCT01890122|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20222344|NCT02040805|University of California, San Francisco|Dr. Kevin L. Delucchi|415-476-4180|kevin.delucchi@ucsf.edu|
20222345|NCT03591874|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
20222346|NCT01225250|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20222347|NCT00071110|University of Pittsburgh|Benoit H. Mulsant, MD|(416) 535-8501|benoit_mulsant@camh.net|3655
20222348|NCT01759602|Johns Hopkins University|Michael Levy, MD, PhD|443-287-4412|mlevy@jhmi.edu|
20222349|NCT00503698|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20222350|NCT03807544|Theranova|Director of Clinical Trials|14159268616|clindquist@theranova.com|
20222351|NCT03194542|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20222352|NCT03655405|a. Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
20222353|NCT00030901|SWOG Statistical Center|Study Statistician|206-667-4623||
20222354|NCT01806051|Children's Hospital Los Angeles|Linda Randolph, M.D.|323-361-2178|lrandolph@chla.usc.edu|
20222355|NCT02576847|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20190688|NCT00321555|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|robert_kreitman@nih.gov|
20222356|NCT02021929|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
20190689|NCT02066389|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20222357|NCT03757312|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
20222358|NCT02573597|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
20162357|NCT02126839|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20162358|NCT00422383|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190690|NCT00762853|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
20190691|NCT02684435|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20190692|NCT01664806|University of Colorado School of Medicine|Dr. Thomas Robinson|303-724-2728|thomas.robinson@Ucdenver.edu|
20190693|NCT03905512|Selecta Biosciences, Inc.|Study Director|617-923-1400|ptraber@selectabio.com|
20190694|NCT03293238|Andrews Research & Education Foundation|Dr. Joshua Hackel|850-916-8796|jghackelmd@yahoo.com|
20190695|NCT00070317|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
20190696|NCT02502019|Biom'Up|Dr. William Spotnitz, Chief Medical Officer|352-514-5009|wspotnitz@gmail.com|
20190697|NCT03560206|University of Kentucky|Misook Chung, PhD|(859) 323-8024|misook.chung@uky.edu|
20190698|NCT03987074|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20190699|NCT03100370|Rice University|Marcia O'Malley, PhD|713-348-3545|omalleym@rice.edu|
20190700|NCT05062343|Brigham and Women's Hospital|Sarah Little|6174557372|selittle@bwh.harvard.edu|
20190701|NCT00508144|The University of Texas (UT) MD Anderson Cancer Center|Ralph Zinner, MD/Thoracic & Head and Neck Medicine|713-792-7734|CR_Study_Registration@mdanderson.org|
20190702|NCT00442507|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5740|dmorgens@dom.wustl.edu|
20190703|NCT01084772|Smith & Nephew, Inc.|Stuart Pratt|+1 (901) 497-0365|stuart.pratt@smith-nephew.com|
20190704|NCT00835328|The Children's Hospital of Philadelphia|Diva D. Deleon, MD,MSCE|215-590-3420|deleon@email.chop.edu|
20190705|NCT02009865|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
20190706|NCT01517282|MorphoSys|Roman Korolkiewicz|+49 89 89927 208|roman.korolkiewicz@morphosys.com|
20190707|NCT00525915|University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
20190708|NCT00267774|Stanford University|William F. Fearon, MD|650 725-2621|wfearon@stanford.edu|
20190709|NCT01078402|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20190710|NCT03677986|Johns Hopkins University School of Medicine|Kenneth Silverman, Professor|4105502694|ksilverm@jhmi.edu|
20190711|NCT02332889|University of Louisville|Nancy Alsip|5028522905|nancy.alsip@louisville.edu|502
20190712|NCT01892007|NIHR Nottingham Biomedical Research Centre, University of Nottingham|Dr Helen Henshaw|+44 (0)115 8232606|helen.henshaw@nottingham.ac.uk|
20190713|NCT00424502|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20190714|NCT01634165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190715|NCT02135445|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20190716|NCT00635609|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20190717|NCT04097535|Imperial College London|Professor Eric Aboagye|02083833759|eric.aboagye@imperial.ac.uk|
20190718|NCT03070301|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
20190719|NCT03556891|Valencia Technologies|Jackie Dister|7604294787|jdister@valenciatechnologies.com|
20190720|NCT05492786|Geisinger health|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
20190721|NCT03154827|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
20190722|NCT00729053|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20190723|NCT00489489|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
20190724|NCT06091982|National Cardivascular Center Harapan Kita|Prieta Adriane MD|+62 21 5684093|prietaadriane@gmail.com|7406
20190725|NCT03978130|NYU Langone Health|John Dodson, MD|6465012714|john.dodson@nyulangone.org|
20190726|NCT03523897|Virtua Health|Dr. Jeremy Reid|8008967326|jreid@reconstructiveortho.com|
20190727|NCT05349123|Mayo Clinic|Roberto P Benzo|507-284-0561|benzo.roberto@mayo.edu|
20190728|NCT02136797|Memorial Sloan Kettering Cancer Center|Dr. Kevin Curran, MD|212-639-5836|currank@mskcc.org|
20190729|NCT04523571|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20190730|NCT04198428|HealthPartners Institute|Dr. Rebecca Rossom, Co-Principal Investigator|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
20190731|NCT04396860|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20190732|NCT03344458|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
20190733|NCT02169089|University Hospitals Cleveland Medical Center|Dr. Sanjay Rajagopalan|216-844-5191|Sanjay.Rajagopalan@uhhospitals.org|
20190734|NCT03696342|Medical Affairs Operations Chief|Dr. Alejandra Sanchez-Rios|33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
20190735|NCT01309802|Southern Illinois University School of Medicine|Research Administrator|217-545-2531|surgeryresearch@siumed.edu|
20190736|NCT01816165|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicaresearchsupportcenter@ucdenver.edu|
20190737|NCT00553800|Hossein.Borghaei@fccc.edu|Hossein Borghaei|215-214-4297|Hossein.Borghaei@fccc.edu|
20190738|NCT03960437|Columbia University|Thomas L.Nickolas, MD, MS|212-305-9847|tln2001@cumc.columbia.edu|
20190739|NCT01838499|AstraZeneca|Humphrey Gardner MD FCAP|+1 781 839 4523|Humphrey.Gardner@astrazeneca.com|
20162359|NCT00411632|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
20190740|NCT03614923|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
20190741|NCT01882088|Federal research Center of Nutrition and Biotechnology|Dr Sergey Morozov, Senior Reseracher, Dpt Gastroenterology and Hepatology|+74996131091|morosoffsv@mail.ru|
20190742|NCT00125619|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|patten@phhp.ufl.edu|4160
20190743|NCT01585597|Emory University|Christopher Horn|404 387 7320|cmhorn@emory.edu|
20190744|NCT01493947|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
20190745|NCT02030847|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
20190746|NCT01074437|Seattle childrens research institute|Jonathan Perkins, Prinicipal Investigator|206-987-1927|jonathan.perkins@seattlechildrens.org|
20190747|NCT01189370|University of Kansas Cancer Center|Dr. Peter Van Velduizen|913-945-5059|SWILLIAM@kumc.edu|
20190748|NCT00641797|Lehigh Valley Health Network|Regina Sacco, DPT, BA, BHSC|610-969-0300|Regina_R.Sacco@lvhn.org|
20190749|NCT01103141|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
20190750|NCT00427297|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
20190751|NCT00422162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190752|NCT02741297|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
20190753|NCT05274906|Fred Hutchinson Cancer Center|Marian L. Neuhouser, Principal Investigator|206-667-4797|mneuhous@fredhutch.org|
20190754|NCT00848198|TearLab, Inc.|Michael Berg, VP of Regulatory|858-795-6887|mberg@TearLab.com|
20190755|NCT02062827|The University of Alabama at Birmingham|James Markert, MD|(205) 934-7171|jmarkert@uabmc.edu|
20190756|NCT04463004|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-628-1215|antonio.abbate@vcuhealth.org|
20190757|NCT02604199|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20190758|NCT02100189|OHSU|John Hunter, MD|503-494-4937|hunterj@ohsu.edu|
20190759|NCT02342275|Sichuan University|Yi jJi|+86 02885423453|jijiyuanyuan@163.com|
20190760|NCT01648491|Beaumont Hospital - Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.org|
20190761|NCT02213458|University of California, San Francisco|Dr. Katherine Possin|(415) 476-1889|katherine.possin@ucsf.edu|
20190762|NCT05607147|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|7328247241|subramga@sdm.rutgers.edu|
20190763|NCT01721109|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
20190764|NCT02632045|Columbia University|Melissa Accordino, MD|212-342-5162|mkg2134@cumc.columbia.edu|
20190765|NCT05878522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206430|NCT00587834|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
20190766|NCT01842360|Inmunotek S.L|Miguel Casanovas|34691490175|mcasanovas@inmunotek.com|
20190767|NCT05740371|Mitsubishi Tanabe Pharma GmbH|Clinical Trials, Information Desk|Please email|regulatory@mt-pharma-eu.com|
20190768|NCT02051972|Abbott Medical|Nicole Harbert|1-972-526-4841|nicole.harbert@abbott.com|
20190769|NCT03800602|Emory University|Olumide B. Gbolahan MBBS, MSc|404-778-0032|ogbolah@emory.edu|
20190770|NCT00617708|SWOG|Study Statistician|206-667-4623||
20190771|NCT02907489|Cairo university|Mohamed Omaia Ahmed|00201224474609|mohamed.omaia@dentistry.cu.edu.eg|
20190772|NCT02561195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190773|NCT04990388|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20190774|NCT01885559|Mayo Clinic|Dr. Vicente Torres||torres.vicente@mayo.edu|
20190775|NCT00780741|Jaeb Center for Health Research|Ray Kraker, Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20190776|NCT01867307|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20190777|NCT03820024|UNC Lineberger|Leslie Clark|919-966-5996|leslie_Clark@med.unc.edu|
20190778|NCT00676195|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
20190779|NCT04588246|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20190780|NCT05927753|Bruno Vision|Richard E Lippman|301-580-3931|richard.lippman@gmail.com|
20190781|NCT00612716|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
20190782|NCT03473665|Columbia University|Runsheng Wang|212-305-4308|rw2646@cumc.columbia.edu|
20190783|NCT03782545|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20190784|NCT02011568|University of Ottawa Heart Institute|Dr Michel Le May|613-696-7000|mlemay@ottawaheart.ca|14646
20190785|NCT00396409|Novartis Pharmaceuticals|Study Director|862-778-8300||
20190786|NCT02069366|Wayne State University|Dr. Christine Rabinak|(313) 577-9875|rabinak@wayne.edu|
20190787|NCT01537900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190788|NCT03314233|Childrens Hospital of Philadelphia|Dr. Elizabeth Foglia|215-590-1653|foglia@email.chop.edu|
20190789|NCT01797705|DeVilbiss Healthcare|Jim Froehlich|814-443-7692|Jim.Froehlich@devilbisshc.com|
20190790|NCT01838447|Children's Hospital of Eastern Ontario|Katie O'Hearn, PICU Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
20190791|NCT01114217|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20190792|NCT06247488|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|(913) 389-7961|david.sequeira@azurity.com|
20190793|NCT02186587|University of Missouri - Department of Orthopaedic Surgery|Sonny B. Bal, MD, PI|573-882-6762|BalB@health.missouri.edu|
20190794|NCT03785210|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
20190795|NCT00460434|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20190796|NCT02722278|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
20190797|NCT00561678|Icahn School of Medicine at Mount Sinai|Dr. Stacie Deiner|212-241-7749|stacie.deiner@mountsinai.org|
20190798|NCT03708744|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
20190799|NCT00460577|Novartis Pharmaceuticals|Study Director|862-778-8300||
20190800|NCT04043806|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20190801|NCT02790788|National and Kapodistrian University of Athens|Associate Professor in Intensive Care Medicine|00302132043307|sdmentzelopoulos@yahoo.com|
20222359|NCT04955691|Yale school of Medicine|Laura Nally|203-785-5831|laura.nally@yale.edu|
20222360|NCT05795153|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20222361|NCT03760744|Vanderbilt Medical Center|Dr. Manus J. Donahue|615.322.8350|mj.donahue@vumc.org|
20222362|NCT03668119|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20222363|NCT03769168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20222364|NCT05336227|University of Alabama at Birmingham|Byron Lai|205.638.9790|blai@uabmc.edu|8-9725
20222365|NCT04050462|NYU Langone Health|Nina Beri, MD|212-731-5770|nina.beri@nyulangone.org|
20222366|NCT04042467|Vanderbilt University Medical Center|Filoteia Popescu|615-875-9083|filoteia.popescu@vumc.org|
20222367|NCT03375918|UMass Chan Medical School|Jennifer Tjia|774-455-3538|jennifer.tjia@umassmed.edu|
20222368|NCT03507608|Johns Hopkins SOM, Dept of Radiation Oncology|Dana Kaplin|443-690-7007|dkaplin1@jh.edu|
20222369|NCT05468164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20222370|NCT03827291|Duke University|Amanda Kumar, MD|919-681-6437|amanda.kumar@duke.edu|
20222371|NCT04795466|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20222372|NCT04652726|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222373|NCT04286269|University of Minnesota|Sonya Wang|612-301-1454|sgwang@umn.edu|
20222374|NCT01135381|University of California San Francisco (UCSF); University of Alabama at Birmingham (UAB)|Dr. Christine Ritchie|415-514-0605|christine.ritchie@ucsf.edu; critchie@uab.edu|
20222375|NCT01102257|Mount Sinai School of Medicine|Dr. Penny Asbell|(212) 241-7977|penny.asbell@mssm.edu|
20222376|NCT04066244|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222377|NCT02979587|Medtronic|Lindsey Gustafson, Clinical Study Manager|7635262782|lindsey.m.gustafson@medtronic.com|
20222378|NCT01467713|Takeda|Medical Director, Clinical Science|1-877-825-3327|trialdisclosures@takeda.com|
20222379|NCT02525783|Stryker|Matt Venegoni|612-297-0939|matthew.venegoni@stryker.com|
20178780|NCT01054768|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|5104283172|ashutosh.lal@ucsf.edu|
20222380|NCT00866281|Novartis Pharmaceuticals|Study Director|862-778-8300||
20222381|NCT01100086|Purdue Pharma L.P.|Stephen Harris, M.D.|203-588-7592|Stephen.Harris@Pharma.com|
20222382|NCT02275546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222383|NCT02527746|Evivebiotech|Catrina Wang / Senior Medical Director|021-61760866|catrina.wang@evivebiotech.com|
20222384|NCT02918565|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
20222385|NCT02612623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222386|NCT00333983|VA Maryland Health Care System, Baltimore|Dr. Susan S. Conroy|(410) 605-7000|susan.conroy@va.gov|3213
20222387|NCT03204786|Stanford University|Antonio Hardan, MD|(650)736-1235|autismdd@stanford.edu|
20222388|NCT00449865|University of Rochester|Karl Kieburtz, Director of CTSI|585-275-0553|Karl.kieburtz@chet.rochester.edu|
20222389|NCT00406367|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
20222390|NCT00171210|Novartis Pharmaceuticals|Study Director|862-778-8300||
20222391|NCT00253435|Chidlren's Hospital Los Angeles|Araz Marachelian, MD, NANT Medical Director|323-3691-5687|amarachelian@chla.usc.edu|
20222392|NCT03187301|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20222393|NCT01808963|UC Davis Medical Center|Dr. Neal Fleming|916-734-5394|nwfleming@ucdavis.edu|
20222394|NCT03252535|Cellavita|Cristiane Valverde Wenceslau|+55 (19) 3829.0849|cristiane.valverde@cellavitabrasil.com.br|
20222395|NCT00304096|University of Virginia|Kimberly Bullock, PhD and David Brenin, MD|434-924-0180|kb9d@virginia.edu|
20222396|NCT02158585|DENT Neurosciences Research Center|Dr. Jennifer Cox|716-250-7002|jcox@dentinstitute.com|
20222397|NCT00461630|Clinical Trial Service Unit, University of Oxford|Professor Jane Armitage|+44 (0)1865 743743|thrive@ctsu.ox.ac.uk|
20222398|NCT02546375|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222399|NCT01965756|Massachusetts General Hospital|Dr. Steven E. Arnold MD|617-643-5607|SEARNOLD@mgh.harvard.edu|
20222400|NCT00442897|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20222401|NCT04498182|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
20222402|NCT02104219|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
20222403|NCT01788631|Dana-Farber Cancer Institute|Dr. David G. Nathan|61746322155|David_Nathan@dfci.harvard.edu|
20222404|NCT00891020|Hoffman-LaRoche|Medical Communications|800-821-8590||
20222405|NCT03291080|Nova Laboratories|Dr Hussain Mulla|+44 (0) 116 223 0100|hussain.mulla@novalabs.co.uk|
20222406|NCT01932060|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
20222407|NCT01339260|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
20222408|NCT02667704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222409|NCT00320710|Novartis|Study Director|862-778-8300||
20222410|NCT04545008|Prisma Health|Dr. Julie Martin - Director, Cancer Research|864-455-3667|julie.martin@prismahealth.org|
20222411|NCT00506415|Novartis|Study Director|862 778 8300||
20222412|NCT00997373|UC Davis|Lloyd H. Smith MD, PhD|916-734-6945|lhsmith@ucdavis.edu|
20222413|NCT04578457|Sonova AG|Juliane Raether|+41 58 928 01 01|juliane.raether@sonova.com|
20178781|NCT02471651|California Retina Consultants|Dr. Gabriel Gordon|8059631648|gabe@californiaretina.com|3034
20178782|NCT02048072|Cantonal Hospital of St. Gallen|Jochen Vehoff|0041714941111|jochen.vehoff@kssg.ch|
20222414|NCT03123393|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20222415|NCT05245526|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
20222416|NCT00427648|NorthShore Health|Frank F. Tu|8475702521|ftu@northshore.org|
20222417|NCT02230904|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20190802|NCT01622088|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20222418|NCT02069041|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20222419|NCT01464333|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20222420|NCT01069510|Oregon Health and Science Univ.|Dr. Craig Broberg|503-494-7400|brobergc@ohsu.edu|
20222421|NCT01514292|Dexcom, Inc|Andy Balo, SVP, Regulatory, Clinical and Biometrics|8582000200|abalo@dexcom.com|
20222422|NCT00463047|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
20222423|NCT03283787|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
20190803|NCT02499497|Brigham and Women's hospital|Dr. Shalender Bhasin, Principal Investigator|617 525 9150|sbhasin@bwh.harvard.edu|
20222424|NCT00426166|University of Toledo|Dr. Martin Skie|419-383-3515|martin.skie@utoledo.edu|
20222425|NCT00739661|Genentech, Inc|Medical Communications|800-821-8590||
20222426|NCT02198664|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20190804|NCT03166215|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20222427|NCT02632409|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20222428|NCT05600283|Mayo Clinic|Dr. Kathy MacLaughlin|507-266-4648|maclaughlin.kathy@mayo.edu|
20222429|NCT02883062|Washington University School of Medicine|Dr. William Gillanders|314-747-0072|gillandersw@wustl.edu|
20190805|NCT01357564|Center of Innovation on Disability and Rehabilitation Research, Department of Veterans Affairs; St. Catherine University, Department of Occupational Therapy|Dr. Paul Arthur|3176881499|pbarthur824@stkate.edu|
20190806|NCT04362176|Vanderbilt University Medical Center|Todd Rice, M.D., MSc|615-343-8010|vcc@vumc.org|
20190807|NCT02438410|Mayo Clinic|Dr. Darrell Pardi|(507) 538-1827|pardi.darrell@mayo.edu|
20190808|NCT00658632|Eisai Inc.|Eisai Medical Services|888-422-4743||
20190809|NCT04374435|University of California, Irvine|Anand Ganesan, MD, Professor|949-824-0606|aganesan@uci.edu|
20190810|NCT04551053|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20190811|NCT02971683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20190812|NCT04206501|University of Rochester Medical Center|Spencer Z. Rosero, M.D.|5852752756|spencer_rosero@urmc.rochester.edu|
20190813|NCT02091102|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20190814|NCT01158716|Cardiovasular RS|Theodoros Zografos|+306956161001|theodoroszografos@gmail.com|
20190815|NCT02423447|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
20190816|NCT05615870|University of Arkansas for Medical Sciences|Jing Jin|501-214-2236|JJin@UAMS.edu|
20190817|NCT00927849|Mansoura university hospital|ayman elnakeeb|0020106752021|elnakeebayman@yahoo.com|
20190818|NCT03266419|Asan Medical Center|Dr. Byung-Moon Choi|82-2-3010-1704|byungmoonchoi7@gmail.com|
20190819|NCT02993926|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20190820|NCT01760876|Queen Mary Hospital,University of Hong kong|Prof. Stephen Wai-luen LEE|(852) 22555409 or 28181314|prof.stephenlee@gmail.com ; kongsl@hku.hk|
20190821|NCT05777772|University of Washington|Dr. Elizabeth Phelan|(206) 520-5000|phelane@uw.edu|
20190822|NCT04604899|jCyte, Inc.|Chief Strategy Officer|9492430687|media@jcyte.com|
20190823|NCT00732498|University of Arizona|NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
20190824|NCT03000829|Intermountain Health|Dr. Ithan Peltan|801-507-6556|ithan.peltan@imail.org|
20190825|NCT03394508|Karolinska Institutet|Jon Konradsen|+46704242058|jon.konradsen@ki.se|
20190826|NCT00267865|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|yarchoar@nih.gov|
20190827|NCT03458416|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
20190828|NCT00083122|Mayo Clinic Cancer Center|Keith C. Bible, M.D, Ph.D.||Bible.Keith@mayo.edu|
20190829|NCT03122548|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
20190830|NCT02819141|Mayo Clinic|Dr. Linda L. Chlan, Professor of Nursing|507-255-7859|chlan.linda@mayo.edu|
20190831|NCT00409006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190832|NCT01742949|Hopital Bichat-Claude Bernard|Dr Marie-Pia D'Ortho|+33140258080|marie-pia.dortho@bch.aphp.fr|
20190833|NCT03050372|Medical University of South Carolina|Thomas W. Uhde, M.D.|843-792-0028|uhde@musc.edu|
20190834|NCT02123797|Baptist Cancer Center|Dr. Raymond Osarogiagbon|901-752-6131|Raymond.Osarogiagbon@bmg.md|
20190835|NCT05030467|Brigham and Women's Hospial|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
20190836|NCT05878990|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
20190837|NCT01933776|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20190838|NCT00984334|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
20190839|NCT00331799|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
20222430|NCT04426006|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20222431|NCT03193684|UTHSCSA|Dr. Muhammad Abdul-Ghani|210 567 6691|abdulghani@uthscsa.edu|
20222432|NCT00720213|Sleepcare Diagnostics|Shahrokh Javaheri, MD|513-459-7750|javaheri@snorenomore.com|
20222433|NCT00097448|Massachusetts Eye and Ear Infirmary|Dr. Steven Rauch|617-573-1166|steven_rauch@meei.harvard.edu|
20222434|NCT00620945|Cleveland Clinic|Muhammad A. Mumtaz, MD|216 444 9125|mumtazm@ccf.org|
20190840|NCT02889809|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20190841|NCT05065918|The University of Arkansas for Medical Sciences|Jocelyn Anderson|501-686-7712|andersonjocelyn@uams.edu|
20222435|NCT00920439|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178783|NCT01648270|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20178784|NCT03456700|Mayo Clinic|Aminah Jatoi MD|507/284-2511|Jatoi.Aminah@mayo.edu|
20178785|NCT04154787|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20178786|NCT03053050|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20178787|NCT03703466|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20178788|NCT01602536|University of California, Irvine|Cornelia Pechmann|310-892-0619|cpechman@uci.edu|
20178789|NCT01321554|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20178790|NCT01865708|Children's Healthcare of Atlanta|Dr. Jana Stockwell|404-785-1868|jana.stockwell@choa.org|
20178791|NCT02355067|Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
20178792|NCT01553318|Wake Forest Baptist|dennis ang|336-716-4209|dang@wakehealth.edu|
20178793|NCT02238925|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency||tom.chmielewski@jazzpharma.com|
20178794|NCT02178059|AstraZeneca R&D|Göran Eckerwall, Medical Science Director|1-800-236-9933|Goran.Eckerwall@astrazeneca.com|
20178795|NCT04149925|Lexington Medical Inc.|Annette Dunn|480-313-8505|annette@lexington-med.com|
20178796|NCT02586025|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20178797|NCT03597568|University of I|Dr. Diana Jalal|319-338-0581|diana-jalal@uiowa.edu|
20178798|NCT03722927|Wake Forest Baptist Health|Dr. Christopher Runyan|336-716-4171|crunyan@wakehealth.edu|
20178799|NCT00999466|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20178800|NCT05443659|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
20178801|NCT03255824|Montefiore Medical Center|Dr. Patrick Nolan|718-405-8195|pnolan@montefiore.org|
20178802|NCT05072457|Hearts for Hearing|Lead Investigator|405-548-4335|phonakaudiologyresearch@gmail.com|
20178803|NCT02001194|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
20178804|NCT01091155|novoGI|Eran Choman, VP Clinical Affairs & Statistics|+972 9 8603000|eran.choman@novogi.com|
20178805|NCT03040713|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20178806|NCT02281448|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20178807|NCT00772590|Kirby Institute, University of New South Wales|Sean Emery|+612 938509900|semery@kirby.unsw.edu.au|
20178808|NCT02565914|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20178809|NCT00361374|Massachusetts General Hospital|Dr David Mischoulon, Director of Research, Depression Clinical and Research Program|617-724-5198|dmischoulon@partners.org|
20178810|NCT01782443|DFCI|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
20178811|NCT02570126|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178812|NCT01335204|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20178813|NCT00831779|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20178814|NCT02872701|On Target Laboratories|Tim Biro|216-533-3082|tbiro@ontargetlabs.com|
20178815|NCT00187226|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|901-595-3604|thomas.merchant@stjude.org|
20178816|NCT04683926|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
20178817|NCT00941993|Acclarent|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
20178818|NCT01040260|University of California, San Francisco|Dr. Timothy Carmody|(415) 221-4810|Timothy.Carmody@ucsf.edu|26344
20178819|NCT00885092|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20178820|NCT05120115|MetroHealth Hospital|James Sulzer|5125419036|jss280@case.edu|
20178821|NCT01113502|Abramson Cancer Center of the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
20178822|NCT01144026|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
20178823|NCT01970982|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20178824|NCT01146496|University of Edinburgh|Michael Eddleston|01312426776|m.eddleston@ed.ac.uk|
20178825|NCT00708916|New York University School of Medicine|Andrew Franks, MD, Principal Investigator|212-263-5244|andrew.franks@nyumc.org|
20178826|NCT04270292|Demiroglu Bilim University|Nurten OZEN|+90 (212) 275 75 82|ozenurten@yahoo.com.tr|
20178827|NCT01133158|GELTAMO|Francisco Javier Peñalver|91 621 98 24|fjpenalver@fhalcorcon.es|
20178828|NCT01984684|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
20178829|NCT02681614|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Bryan Traughber|+1 216-884-2516|bryan.traughber@uhhospitals.org|
20190842|NCT04203199|Wake Forest University Health Sciences|Colleen Hanlon, PhD|844-386-7001|DeepTMS@brainsway.com|
20190843|NCT03149887|UPittsburgh|Dr. Steven L. Orebaugh|412-877-5832|orebaughsl@anes.upmc.edu|
20190844|NCT00113880|MedImmune, LLC|Chris Ambrose, MD, Sr Director, Medical Affairs|301-398-0000|ambrosec@medimmune.com|
20190845|NCT02630147|University of Sherbrooke Hospital Research Center, QC, Canada|Dr Jean-Paul Praud|819-346-1110|jean-paul.praud@usherbrooke.ca|14851
20190846|NCT01634620|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
20190847|NCT01107353|Roxane Laboratories, Inc.|Anton (Tony) Amann, PhD., Executive Director, DRAMA|614-272-4785|tony.amann@boehringer-ingelheim.com|
20190848|NCT03034772|Wills Eye Physicians, Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
20190849|NCT01136733|Eisai Medical Inc.|Eisai Medical Services|1-888-422-4743||
20190850|NCT01745380|University of Pennsylvania School of Dental Medicine|Elliott V. Hersh, Principal Investigator|215-898-9686|evhersh@pobox.upenn.edu|
20190851|NCT02368691|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20190852|NCT02660034|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20178830|NCT00420992|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
20178831|NCT02835339|Oregon Health and Science University|Kathleen Brookfield, MD, PhD, MPH|503-494-2101|brookfie@ohsu.edu|
20178832|NCT01077544|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
20178833|NCT03786952|Ohio Northern University|Phillip Zoladz|419-772-2142|p-zoladz@onu.edu|
20178834|NCT03923959|LancasterGH|Halle Becker|7175441401|halle.becker@pennmedicine.upenn.edu|
20178835|NCT04918147|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20178836|NCT01362439|Janssen-Cilag SpA, Cologno Monzese, Milan - Italy|Therapeutic Area Medical Manager|+39 0225101||
20178837|NCT00673309|University of Texas Medical Branch|Tina Mack-Moshay- ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
20178838|NCT04040751|Emory University|Sarah Blanton, PT, DPT|404-712-2222|sblanto@emory.edu|
20178839|NCT04212091|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20178840|NCT02712905|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20178841|NCT03721965|Incyte Corporation|Incyte Corporation Call Center|(0)330 100 3677|globalmedinfo@incyte.com|
20178842|NCT04085328|Alcon Research, LLC|Expert CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20178843|NCT00689221|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20178844|NCT01029054|University of Michigan Hospital|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
20178845|NCT01812655|Arkansas Children's Hospital|Debra Jeffs, PhD, RN, Principal Investigator|501-364-3239|jeffsda@archildrens.org|
20178846|NCT00036569|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@mail.nih.gov|
20178847|NCT04435665|NFlection|Director of Clinical Operations|7078532199|comara@nflectionrx.com|
20178848|NCT02454101|AinShamsU|ahmed kotb|0100868199|ahmedmkotp@hotmail.com|+2
20178849|NCT00419263|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|(919) 859-1302||
20178850|NCT02342886|TB Alliance|Leandra Lombard, Director, Clinical Operations|+27 87 700 3900|Leandra.Lombard@tballiance.org|
20178851|NCT01328080|Johns Hopkins Dermatology|Ginette Okoye, MD, Director of Ethnic Skin Program|410-502-7546|ctrep@jhmi.edu|
20178852|NCT00765674|Novartis Pharmaceuticals|Study Director|862 778-8300||
20178853|NCT03015402|University of Pittsburgh|Dr. Michael Risbano, Director of Advanced Cardiopulmonary Exercise Testing Program|412-692-2210|risbanomg@upmc.edu|
20222436|NCT01252095|Progen Pharmaceuticals Ltd|Director of Clinical Development|+61 7 32739133||
20178854|NCT03138096|Radboud University Medical Center|Dr. M.B.B. McCall|+31642166480|Matthew.McCall@radboudumc.nl|
20178855|NCT01813474|AstraZeneca|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
20222437|NCT01420068|Noden Pharma DAC|Ciara Walsh|+ 353 1 9121573|cwalsh@nodenpharma.com|
20178856|NCT00316082|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20178857|NCT01011829|University of California, Los Angeles|Steve Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
20178858|NCT01995461|Marshfield Clinic Research Foundation|Dr. Rachel Stankowski|715-389-3442|stankowski.rachel@mcrf.mfldclin.edu|
20178859|NCT00540124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178860|NCT02671032|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
20178861|NCT01163097|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
20178862|NCT02510144|University of Maryland Baltimore|Dr. Mohit Gilotra|(301) 502-4102|mgilotra@som.umaryland.edu|
20178863|NCT03311373|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20178864|NCT02115633|RxFunction, Inc.|Lars Oddsson, PhD|8572340382|loddsson@rxfunction.com|
20178865|NCT04557930|Dartmouth-Hitchcock|Dr. Amber E. Barnato|603-646-5609|Amber.Barnato@dartmouth.edu|
20178866|NCT00374322|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178867|NCT01112579|Medtronic Cardiac Rhythm and Heart Failure|DEFEAT-HF Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
20178868|NCT00902694|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20178869|NCT04969263|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|extension
20178870|NCT00175825|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20222438|NCT01753310|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
20222439|NCT00867659|Virginia Center for Reproductive Medicine|Dr Fady Sharara|7034377722|fsharara@vcrmed.com|
20222440|NCT04495829|Woolfson Eye Institute|R. Doyle Stulting, MD, PhD|(770) 255-3330|dstulting@icloud.com|
20222441|NCT02976129|VHsquared|Chief Medical Officer|+44 (0)1223 837650|info@vhsquared.com|
20178871|NCT04098406|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
20178872|NCT01357616|Alcon Research, Ltd.|Mandy Ye, Head, Clinical Trial Management, Asia|1-888-451-3739|alcon.medinfo@alcon.com|
20178873|NCT03432364|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
20178874|NCT00522301|Memorial Sloan Kettering Cancer Center|Dr. William Tew|646-888-4220|teww@mskcc.org|
20178875|NCT01490502|The Johns Hopkins University School of Medicine|Sandra D. Cassard, ScD|443-287-4353|scassar1@jhmi.edu|
20178876|NCT04186780|Universidade de Sorocaba|Dr. Luciane Cruz Lopes|+ 55 15 2101-7104|luciane.lopes@prof.uniso.br|
20178877|NCT01699022|SPARC|Dr. Shravanti Bhowmik|02266455645|shravanti.bhowmik@sparcmail.com|5626
20222442|NCT02712554|Charleston Laboratories, Inc.|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
20222443|NCT02188147|ZOLL|Vice President Medical Affairs|412-968-3333|stevens@zoll.com|4400
20222444|NCT02503540|Cole Eye Institute Cleveland Clinic Foundation|Dr.Justis P. Ehlers|2166360183|ehlersj@ccf.org|
20178878|NCT02066402|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
20178879|NCT00152464|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20178880|NCT02258139|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
20222445|NCT01662492|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20178881|NCT04465357|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
20222446|NCT07091916|Medtronic Japan Co., Ltd.|Takuto Yamamoto|+818046716498|takuto.yamamoto@medtronic.com|
20178882|NCT04452292|University of Kentucky|Dr. Charles Kunos|859-323-2354|charles.kunos@uky.edu|
20178883|NCT03039595|Oxford Univeristy Hospitals NHS Foundation Trust|Dr Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
20178884|NCT00917579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20178885|NCT00754338|Centre for Contact Lens Research|Craig A Woods, Research Manager|1 519 888 4567|cawoods@sciborg.uwaterloo.ca|36547
20178886|NCT04020341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178887|NCT04886479|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
20178888|NCT04555096|Galera Therapeutics|Judy Schnyder, SVP Clinical Operations and Data Management|2155937119|jschnyder@galeratx.com|
20178889|NCT00382824|Lahey Hospital & Medical Center|Jordan Jara|7817442958|jordan.jara@lahey.org|2958
20178890|NCT04475549|Cyclerion Therapeutics, Inc.|Cyclerion Clinical Development|1-857-327-8778|info@cyclerion.com|
20178891|NCT05163418|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20178892|NCT04495179|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
20178893|NCT00162370|Lantheus Medical Imaging|Director, Clinical Operations|978-671-8118|Sandra.Monte@lantheus.com|
20178894|NCT00569582|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20178895|NCT03905330|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20178896|NCT02612311|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20178897|NCT01596582|Boston Medical Center|Paul C. Schroy III, MD, MPH|671-638-8335|paul.schroy@bmc.org|
20178898|NCT01428076|BTG International Inc.|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
20178899|NCT00387673|Miami VA Healthcare System|Kristina Beekhuizen|305-575-7000|Kristina.Beekhuizen@va.gov|
20178900|NCT00862134|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
20178901|NCT02191267|Brigham and Women's Hospital|Dr. Martha Shenton|617-699-6152|shenton@bwh.harvard.edu|
20178902|NCT02216773|Imperial College London|Professor Long Jiao|+44 2033133937|l.jiao@imperial.ac.uk|
20178903|NCT00796302|Ohio State University|Michael Aman|614-688-4196|Aman.1@osu.edu|
20178904|NCT02652481|Boston Scientific|Clinical Trial Manager|+32479983495|anneleen.viville@bsci.com|
20178905|NCT02124265|Johns Hopkins University School of Medicine|Carisa Cooney|443-287-4629|ccooney3@jhmi.edu|
20178906|NCT00101933|Medtronic Neuromodulation|Jim Vollhaber, Clinical Study Manager|763-526-8093|medtronicneurotrials@medtronic.com|
20178907|NCT04510675|Princeton Consumer Research Corp.|Principal Investigator|727-576-7300|bd@princetonconsumer.com|
20178908|NCT00810264|BIOTRONIK|Clinical Studies Engineer Group Manager|800-547-0394|celestial@biotronik.com|
20178909|NCT01563536|AbbVie|Global Medical Services|800-633-9110||
20178910|NCT04653766|Bioxodes|Medical Writer|+32 (0)71 239 602|stephanie.demoulin@bioxodes.com|
20178911|NCT01270126|Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of Medical Psychology, Magdeburg, Germany|Prof. Bernhard A. Sabel|0049 3916721800|bernhard.sabel@med.ovgu.de|
20178912|NCT00538590|Hospital of Universität Köln|Thomas Dietlein, Ph. D., MD|+49 221 4785862|thomas.dietlein@uk-koeln.de|4300
20178913|NCT00567190|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20178914|NCT06030414|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
20178915|NCT01522417|Medicure|Kyle Brown|204-594-3411|kbrown@medicure.com|
20178916|NCT01352598|Mercy|Jaymeson Stroud, MD|314-251-6844|Jaymeson.Stroud@mercy.net|
20178917|NCT00058123|North American Brain Tumor Consortium|Susan Chang, MD|410-955-8837|jfisher@jhmi.edu|
20178918|NCT00636610|Genentech, Inc.|Medical Communications|800-821-8590||
20178919|NCT00313820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20190853|NCT03863184|Weill Cornell Medicine|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
20190854|NCT01403805|Department of Dentistry, Yubari Kibounomori, Japan|Dr. Masahiro Hatta|+81-123-52-4339|masahiro.hatta@hotmail.co.jp|
20190855|NCT00147745|Daiichi Sankyo, Inc|John Raia, Senior Director, Professional Affairs|(973) 944-2683|jraia@dsi.com|
20190856|NCT00103116|UKentucky|Edward Hirschowitz|8596081981|eahirs2@uky.edu|
20190857|NCT00815347|University of Connecticut Health Center|MArk Metersky, MD|860-679-3582|metersky@nso.uchc.edu|
20190858|NCT00724750|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
20190859|NCT00510783|Emory|Brittney Copeland|404-616-0301|bcopel3@emory.edu|
20190860|NCT00316121|Advanced Technologies and Regenerative Medicine, LLC|Manny Lazaro, Director, Clinical Affairs|508-828-2741|mlazaro@its.jnj.com|
20190861|NCT01318356|Radboud university medical center|S.P. Keijmel, MD PhD|0031243611111|stephan.keijmel@radboudumc.nl|
20190862|NCT01979211|University of Cincinnati Cancer Center|Vinita Takiar, Associate Professor, MD|513-584-4775|vinita.takiar@uc.edu|
20190863|NCT03045302|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
20190864|NCT00134056|University of Southern California Norris Comprehensive Cancer Center|Dr. David I Quinn|3238653956|diquinn@med.usc.edu|
20190865|NCT02035345|Massachusetts General Hospital|Dr. Aleena Banerji|6177263850|abanerji@mgh.harvard.edu|
20190866|NCT00742560|AbbVie|Global Medical Services|800-633-9110||
20190867|NCT01536795|Institut Pasteur, Tunisia|Afif Ben Salah, MD|011-216-71-792-429|afif.bensalah@pateur.rns.tn|
20190868|NCT04985604|Day One Biopharmaceuticals, Inc.|Study Director|1-650-484-0899|clinicaltrials@dayonebio.com|
20190869|NCT04598776|CeraRoot CLINIC|Dr. Josep Oliva-Ochoa. Director of Clinical Trials|+34 935950247|josep.oliva@cerarootclinic.com|
20190870|NCT00348283|Abbott|Medical Information Specialist|800-633-9110||
20222447|NCT02747108|VA Center for Clinical Management Research|Jeffrey Kullgren, MD, MS, MPH - Principal Investigator|(734) 845-3502|jkullgre@med.umich.edu|
20178920|NCT00182754|Mayo Clinic|Aminah Jatoi, M.D|507-284-4918|jatoi.aminah@mayo.edu|
20178921|NCT00506064|UT MD Anderson Cancer Center|Una Srejic, MD / Professor|713-792-6914|CR_Study_Registration@mdanderson.org|
20206431|NCT00126672|Dana-Farber Cancer Institute|Dabora Sandra L MD|(617) 732-5500|sandy.dabora@gmail.com|
20206432|NCT00660075|Laval University|Patrick Couture|418-654-2106|patrick.couture@crchul.ulaval.ca|
20206433|NCT01001234|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206434|NCT01150760|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206435|NCT00125372|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@hitchcock.org|
20206436|NCT01851863|Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China|Sheng-Liang Chen, MD|86-21-58752345|slchenmd@hotmail.com|
20178922|NCT00553696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206437|NCT02076334|University University Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
20178923|NCT00686881|Merck Sharp & Dohme Corp..|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20178924|NCT02085252|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206438|NCT03379376|Wake Forest University Health Sciences|Meg O'Mara - Study Coordinator|336-716-5440|megreen@wakehealth.edu|
20178925|NCT01460940|The Ohio State University Comprehensive Cancer Center|Dr. Kristie Blum|614-293-4590|Kristie.Blum@osumc.edu|
20178926|NCT02925676|UNEEG medical|Clinical Research Associate|+45 25657550|clinical@uneeg.com|
20178927|NCT02460692|University of California, San Diego|Thomas D. Marcotte, PhD|619-543-5044|tmarcotte@health.ucsd.edu|
20178928|NCT03260868|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20178929|NCT01298999|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
20178930|NCT02151266|Emory University|Dr. Gary|404-727-8360|ragary@emory.edu|
20178931|NCT03987841|University of Alabama at Birmingham|Caroline Presley|205-934-7609|capresley@uabmc.edu|
20178932|NCT04839965|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
20178933|NCT00981084|University of Missouri - Kansas City|Dr. Jared Bruce|401-499-4043|brucejm@umkc.edu|
20178934|NCT02291679|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
20178935|NCT02276222|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20178936|NCT02170025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20178937|NCT02543658|First affilitated hospital of Nanchang university|Wenhua He|+8613879182642|hewenhua@ncu.edu.cn|
20178938|NCT01139190|PLx Pharma LLC|Ronald Zimmerman, CEO & President|713-842-1249|ron.zimmerman@plxpharma.com|205
20178939|NCT03896009|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20178940|NCT00437645|Novartis Pharmaceuticals|Study Director|862 778-8300||
20178941|NCT03966053|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|5165623757|avlachos@northwell.edu|
20178942|NCT04586569|Boston Children's Hospital|Dr. Linda Bulich|617-355-7737|linda.bulich@childrens.harvard.edu|
20222448|NCT05151744|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20222449|NCT05228470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178943|NCT03675451|Weill Cornell Medicine|Junaid Niaz|212.746.5793|mjn3001@med.cornell.edu|
20178944|NCT02127372|Duke University Medical Center|Gordana Vlahovic, MD|919-681-4047|Gordana.vlahovic@dm.duke.edu|
20178945|NCT03548207|Janssen Research & Development, LLC|Vice President Research and Development, Cellular Therapy|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20178946|NCT01756352|Brigham and Women's Hospital|Marcelo DiCarli, MD|(617) 732-6290|mdicarli@bwh.harvard.edu|
20178947|NCT00415610|University of Minnesota|Adnan I Qureshi, MD|612-624-2431|qureshai@gmail.com|
20178948|NCT00337272|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20178949|NCT03043079|University of Pennsylvania|Dr. John P Fischer|2156627300|john.fischer2@uphs.upenn.edu|
20178950|NCT04539821|VA Connecticut Healthcare System|Dr. Brent Moore|203-435-2243|brent.moore@va.gov|
20178951|NCT04635579|University of Washington|Dr Scott Telfer|2062292022|telfers@uw.edu|
20178952|NCT04493931|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178953|NCT03338894|Atlantic Children's Health/Atlantic Health Outpatient|Dr. Alycia Leiby|973--971-5676|alycia.leiby@atlantichealth.org|
20178954|NCT00378352|National Institute on Aging, NIH|Edward Lakatta, M.D.|410-558-8218|lakattae@grc.nia.nih.gov|
20178955|NCT00266825|University of Kansas Medical Center|Dr. Susan Carlson|913-588-5359|SCARLSON@kumc.edu|
20178956|NCT00430248|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20178957|NCT01127646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178958|NCT03466086|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
20178959|NCT01754467|Northwestern University|Christine Pellegrini, PhD|312-503-1395|c-pellegrini@northwestern.edu|
20178960|NCT01970462|Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
20178961|NCT04208516|UPMC|Jeremy Kearns, MD|412-623-5296|kearnsjt@upmc.edu|
20178962|NCT05763628|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
20178963|NCT00319748|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
20178964|NCT04721925|University of Michigan|Erin Bonar|7347647936|erinbona@med.umich.edu|
20178965|NCT03002610|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
20178966|NCT03802123|ImaginAb|Director, Regulatory Affairs|: +1.310.730.5869|ethomas@imaginab.com|
20178967|NCT00658567|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
20178968|NCT04860518|Faron|Dr Juho Jalkanen|+358407071046|juho.jalkanen@faron.com|
20178969|NCT03468933|Tulane University|Dr. Fayez Kheir|504-988-3541|fkheir@tulane.edu|
20178970|NCT06134180|Case Western Reserve Unviersity|Kylie Meyer|2163681928|knm77@case.edu|
20178971|NCT01936857|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20222450|NCT04053868|University of California San Francisco|Dr. Neal Benowitz|628-206-8324|neal.benowitz@ucsf.edu|
20222451|NCT05731700|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
20178972|NCT02279043|University of California, San Francisco|Edith Fox|4152062544|edith.fox@ucsf.edu|
20178973|NCT01939548|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20178974|NCT00490282|The University of Texas (UT) MD Anderson Cancer Center|Adam Garden, MD/Radiation Oncology Department|(713) 563-2300|agarden@mdanderson.org|
20178975|NCT00774579|Imperial College Healthcare London|Prof. Desmond Johnston|020 3312 1253|desmond.johnston@imperial.ac.uk|
20178976|NCT00976352|University of Florida|Dr. Barry Byrne, Professor and Associate Chair|352-273-6563|bbyrne@ufl.edu|
20178977|NCT01494584|GlaxoSmithKline|GSK Response Center|866-435-7343||
20178978|NCT01499082|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20178979|NCT01786967|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
20178980|NCT02574910|UT Southwestern Medical Center|Dr Perrin White|2146489246|perrin.white@utsouthwestern.edu|
20178981|NCT02963974|University of North Carolina at Chapel Hill|Lisa Park, AuD, CCC-A|984-215-2871|lisa_park@med.unc.edu|
20178982|NCT05380947|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20178983|NCT01188109|Emory University|Shishir K. Maithel, MD|404-778-1900|smaithe@emory.edu|
20206439|NCT01611298|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
20178984|NCT01256567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20178985|NCT02563496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20178986|NCT02306759|The Brooklyn Hospital Center|Director, Emergency Medicine Clinical Research Program|718-250-6250|bsin@tbh.org|
20178987|NCT02721082|U. Kansas Medical Center|Dr. Kimber Richter|9134490157|krichter@kumc.edu|
20178988|NCT00251862|Boston Medical Center|Dr. Paul C. Schroy III|617-638-8335|paul.schroy@bmc.org|
20178989|NCT02453685|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20178990|NCT02925611|PGIMER|Dr. Steve Joys|7087617352|stevejoys@gmail.com|91
20178991|NCT00416182|Vermont Children's Hospital at Fletcher Allen Health Care|Dr. Thomas Lahiri, Principal Investigator|802-847-8600|thomas.lahiri@vtmednet.org|
20178992|NCT00522626|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
20178993|NCT01723722|Eastern Maine Medical Center|Dr Mark S Brown|207-973-8670|mbrown@emh.org|
20178994|NCT01169675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20178995|NCT02354664|University of Florida|Barbara Smith, Assistant Professor|352-294-5315|bksmith@phhp.ufl.edu|
20178996|NCT02816138|Vanderbilt University Medical Center|Warren D. Taylor, MD|6153221073|warren.d.taylor@vanderbilt.edu|
20178997|NCT02355028|Alcon, A Novartis Division|Clinical Scientist, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
20178998|NCT04102579|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20178999|NCT05899686|UCaliforniaSF|Pekka Talke|4153063602|pekka.talke@ucsf.edu|
20179000|NCT00572195|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
20179001|NCT01525602|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20179002|NCT02532179|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20179003|NCT01077830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179004|NCT00806234|Johns Hopkins University|Dr. Mark Riddle|410-302-6120|mriddle1@jhmi.edu|
20179005|NCT01337674|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179006|NCT03076970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20179007|NCT00789815|Chung Gung Memorial Hospital|Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
20179008|NCT00119405|Case Western Reserve University|Grace McComsey|216-844-3607|mccomsey.grace@clevelandactu.org|
20179009|NCT00800839|The University of Texas (UT) MD Anderson Cancer Center|Amin M. Alousi, MD/Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
20179010|NCT04676425|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179011|NCT04958785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|GileadClinicalTrials@gilead.com|GILEAD-0
20179012|NCT01224925|UiT The Arctic University of Norway (Tromsø university)|Associate professor Rita Kundzina|+4777649118|rita.kundzina@uit.no|
20179013|NCT00791843|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
20179014|NCT02018445|SeaSpine|Sara Tish Mikoczi|760-216-5652|tish.mikoczi@seaspine.com|
20179015|NCT00949884|Daiichi Sankyo, Inc.|Robert Dubiel, PharmD|973-944-2963|bdubiel@dsi.com|
20179016|NCT00245102|Memorial Sloan-Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20179017|NCT03717402|Dana-Farber Cancer Institute|Andrea C. Enzinger, MD|617-582-7335|Andrea_Enzinger@DFCI.HARVARD.EDU|
20222452|NCT04541017|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
20222453|NCT05400655|Centers for Disease Control and Prevention|Dr. Laura Steinhardt, PhD, MPH|1 6467641472|LSteinhardt@cdc.gov|
20222454|NCT02088554|Medtronic|Jessica Halverson, Director of Clinical Research|(800) 633-8766|rsperigonpivotaltrial@medtronic.com|
20179018|NCT02565901|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20179019|NCT01857882|University Health Network|Dr. Toni Zhong|416-340-3858|toni.zhong@uhn.ca|
20179020|NCT02293395|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20179021|NCT04639193|University of California San Diego|Dr Chris Schmickl|8582462154|cschmickl@health.ucsd.edu|
20179022|NCT01023568|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20222455|NCT01754350|JohannWGUH|Johannes Rieger|+4969630187711|j.rieger@uni-tuebingen.de|
20222456|NCT01256164|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20222457|NCT02974686|Washington University|Dr. R. Delos Santos|314-362-8351|delossantos@wustl.edu|
20222458|NCT02283268|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20179023|NCT00224770|Johns Hopkins University|Dr. Daniel F. Hanley|(410) 614-6996|dhanley@jhmi.edu|
20179024|NCT01106430|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20179025|NCT01341977|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20179026|NCT00662857|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20179027|NCT00989092|Amgen Inc.|Study Director|866-572-6436||
20179028|NCT03586583|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20179029|NCT02832622|Abbott|Kwangdeok Lee, PhD|1-972-526-9673|kwangdeok.lee@abbott.com|
20179030|NCT02173548|Virginia Commonwealth University|Antonio Abbate, MD, PhD|(804) 828-0513|antonio.abbate@vcuhealth.org|
20222459|NCT01739231|PATH|Richard Walker|202-822-0033|rwalker@path.org|
20179031|NCT04141774|UW School of Medicine and Public Health|Dr. Vivek Prabhakaran, MD, PhD|(608) 265-5269|vprabhakaran@uwhealth.org|
20179032|NCT03822117|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20179033|NCT01610427|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179034|NCT05131165|RAND Corporation|Sebastian Linnemayr|310-393-0411|slinnema@rand.org|6734
20222460|NCT00570141|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|917-900-4000|bert.slade@healthpoint.com|
20179035|NCT01478009|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Chang-Seop Lee|82-63-276-8284|lcsmd@jbnu.ac.kr|
20222461|NCT01135329|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Yvette Kasamon|410-955-8839|ykasamo1@jhmi.edu|
20222462|NCT00981214|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20222463|NCT02309411|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20179036|NCT02298361|OCHIN, Inc.|Jennifer E. DeVoe, MD, DPhil|503-943-2618|devoej@ohsu.edu|
20179037|NCT01798394|University of Minnesota|Nicole Tosun|612-624-5439|tosun004@umn.edu|
20179038|NCT03247790|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20179039|NCT03320018|Stony Brook Medicine|Christine Pol|6314449083|christiana.pol@stonybrookmedicine.edu|
20179040|NCT02691182|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
20179041|NCT03026790|University of Minnesota|Erin Krebs|612-629-7558|Erin.Krebs@va.gov|
20222464|NCT03270657|Duke University|Dr. Dennis Turner|919-684-7777|dennis.turner@duke.edu|
20179042|NCT02563002|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20179043|NCT03856515|M.D. Anderson Cancer Center|Jason Robinson|713-792-2265|nicotinestudy@mdanderson.org|
20179044|NCT02650219|St Joseph Hospital Marseille|Dr Christine Serratrice|0041798731474|cserratrice@hotmail.fr|
20179045|NCT02094443|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20179046|NCT05453110|Baylor University Keller Army Community Hospital Division 1 Sports Physical Therapy Fellowship|Dr. Kelly M. Scott|509-595-7263|kmsid119@gmail.com|
20179047|NCT05906368|UPMC, University of Pittsburgh|Dr. Katherine Grace Lim|412-641-1778|limkg2@upmc.edu|
20179048|NCT03387579|Indiana University School of Medicine|Dr. Katie Huff|3179449395|huffka@iupui.edu|
20179049|NCT01291784|Icahn School of Medicine at Mount Sinai|Dr. John O. Mascarenhas|212-241-6756|john.mascarenhas@mssm.edu|
20179050|NCT04504331|Stanford Medicine at Stanford University|Jennifer Lee Caswell-Jin, MD|1-310-332-6541|caswell@stanford.edu|
20179051|NCT04570436|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
20179052|NCT01274182|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
20179053|NCT01822587|MUSC|Michael Saladin|843-792-5306|saladinm@musc.edu|
20179054|NCT00691938|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
20179055|NCT03882879|Rush University Medical Center|Dr. Jori Fleisher|13125632900|jori_fleisher@rush.edu|
20179056|NCT00594854|Pozen Inc.|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
20179057|NCT01250990|University of Pennsylvania|Richard L Dunbar|215-662-9024|richard.dunbar@uphs.upenn.edu|
20179058|NCT03172702|AstraZeneca|Global Clinical Lead|+18772409479|information.center@astrazeneca.com|
20179059|NCT03292146|Massachusetts General Hospital|Karen K. Miller, MD|617-724-7388|KKMILLER@mgh.harvard.edu|
20222465|NCT00455403|Wash. Univ. School of Medicine|Janet McGill, MD|314-362-8681|jmcgill@wustl.edu|
20222466|NCT00459862|Mayo Clinic|Julian Molina, M.D, Ph.D.||Molina.julian@mayo.edu|
20222467|NCT02535026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20179060|NCT02954354|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20222468|NCT01343043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179061|NCT03039023|Cleveland Clinic Foundation|Jennifer Wilcox|216-636-6153|kirsopj@ccf.org|
20179062|NCT04852055|Brown University|Project Director|(401) 863-7345|ellen_mccreedy@brown.edu|
20222469|NCT00925704|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20222470|NCT00216125|Hoosier Cancer Research Network|Georgia Gould|3176385842|ggould@hoosiercancer.org|10
20222471|NCT05340764|Washington University School of Medicine GI Division|Dr. Chien-Huan Chen|3143623201|chen330@wustl.edu|
20222472|NCT00502242|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222473|NCT03207815|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20222474|NCT01671007|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222475|NCT03877068|Emory University|Guillermo E. Umpierrez, MD|404-778-1665|geumpie@emory.edu|
20222476|NCT01812109|University of Texas Southwestern Medical Center|Dr. Linda Baker|214/456-2480|Linda.baker@childrens.com|
20222477|NCT01966120|Biofrontera Bioscience GmbH|Clinical Trial Department,|+49 2148763226|ameluz@biofrontera.com|
20222478|NCT01346696|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20222479|NCT04630002|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20222480|NCT05541003|Robert Wood Johnson|Dr. Keerthana Kesavarapu|6784690425|kk1132@rwjms.rutgers.edu|
20222481|NCT02182843|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
20222482|NCT00375973|University of Cincinnati College of Medicine|Lesley M. Arnold, M.D.|513-558-7700|lesley.arnold@uc.edu|
20206440|NCT00411086|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20222483|NCT05333601|Nemours Children's Health|Dr. Kimberly Canter|3026514501|kimberly.canter@nemours.org|
20222484|NCT02215369|Angiodynamics|Ariel Bloch|7742453646|abloch@angiodynamics.com|
20222485|NCT04548193|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|Chong.Wang@roswellpark.org|
20222486|NCT02042014|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20222487|NCT01011816|formerly Spinal Restoration, Inc|Jeff Doerzbacher||jdoerzbacher@renascentmed.com|
20222488|NCT01216241|University of Rochester|Dr. Robert F. Betts|585-275-5871|robert_betts@urmc.rochester.edu|
20222489|NCT01155180|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20222490|NCT01681212|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20222491|NCT00343044|Benaroya Research Institute at Virginia Mason|Thomas Malpass, M.D., Principal Investigator|206-223-6193|thomas.malpass@vmmc.org|
20222492|NCT05047211|UTMB Galveston|Dr Antonio Saad Director of PRD|4097721795|antalar@me.com|
20222493|NCT01511978|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|6099217447|kathy.ales@jacobus-pharmaceutical.com|231
20222494|NCT02187198|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski, PhD|203-932-5711|elizabeth.ralevski@yale.edu|4282
20222495|NCT00561392|Novartis Pharmaceuticals|Study Director|862 778-8300||
20222496|NCT03321968|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20222497|NCT03822468|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20222498|NCT01532518|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
20222499|NCT01575834|Amgen Inc.|Study Director|866-572-6436||
20222500|NCT02155283|Radiancy Ltd|Dr. Daniele Perl-Treves, Clinical Director|972-97757556|daniele@radiancy.com|
20222501|NCT00232739|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
20222502|NCT00470717|UHClevelandMC|Dr. Lydia Furman|216-844-8260|Lydia.Furman@uhhospitals.org|
20222503|NCT01741688|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20222504|NCT01548040|Theragen Inc.|Richard Pearce|901 634 0544|richard.pearce@theragen.com|
20222505|NCT02282813|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
20222506|NCT00410813|SWOG Statistical Center|SWOG Breast Committee Statistician|206-667-4623||
20222507|NCT04278417|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222508|NCT06509438|EspadPharmed|Hamidreza Kafi|+989129232594|Kafi.h@orchidpharmed.com|
20222509|NCT01262872|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222510|NCT01000155|Brigham&Women's Hospital|Maureen Okam, MD, MPH|617-732-5048|mokam@partners.org|
20222511|NCT02092298|UT MD Anderson Cancer Center|Brian Badgwell,Professor, Surgical Oncology|713-745-3715|csentonn@mdanderson.org|
20222512|NCT00365794|University of Southern California|Fred Sattler, MD|323-409-4635|fsattler@usc.edu|
20222513|NCT02554682|Children's Hospital of Philadelphia|Dr. Carol Ford|267-426-3938|fordc@email.chop.edu|63938
20222514|NCT02169271|UT MD Anderson Cancer Center|Dr. Therese Bevers / Clinical Cancer Prevention Department|713-745-8048|tbevers@mdanderson.org|
20222515|NCT02174510|Shanghai Xuhui Central Hospital, Drug Clinical Trial Institution|Prof.Hu Chaoying|13816319160|cyhu@shxh-centerlab.com|
20222516|NCT01991743|Northwestern University|Dr. Robert J McCarthy|312-695-4976|r-mccarthy@northwestern.edu|
20222517|NCT05286450|Sohag University|dr magdy mohamed amin|(093)- 4602963|portal@med.sohag.edu.eg|
20222518|NCT03126968|University of Maryland|Robert M. Reed|4103288141|rreed@som.umaryland.edu|
20222519|NCT04010240|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Antoine Italiano|0556333333|a.italiano@bordeaux.unicancer.fr|
20222520|NCT00570687|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20222521|NCT00975611|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
20222522|NCT01682226|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
20222523|NCT03771898|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20222524|NCT03263936|Therapeutic Advanced in Childhood Leukemia and Lymphoma|Ellynore Florendo|323-361-3022|eflorendo@chla.usc.edu|
20222525|NCT05343000|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
20222526|NCT03123120|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222527|NCT03135548|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222528|NCT02632175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20222529|NCT04623216|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
20222530|NCT04998136|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20222531|NCT03521154|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20222532|NCT05386680|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222533|NCT04526639|University of Massachusetts Lowell|Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
20222534|NCT01624740|Boston Scientific|Nitzan Mekel-Bobrov, PhD|661-949-4537|Nitzan.Mekel-Bobrov@bsci.com|
20222535|NCT03773172|Columbia University Irving Medical Center|Henry Ginsberg, MD|212-305-9562|hng1@cumc.columbia.edu|
20222536|NCT05088460|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20222537|NCT04659863|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222538|NCT00298272|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20222539|NCT00915018|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20222540|NCT00457002|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20222541|NCT04168112|SightMD|Dr. Alanna Nattis|631-957-2816|anattis@sightmd.com|
20222542|NCT01598064|National Cheng Kung University Hospital|Dr. Po Lin Chen|886-2353535|n939492@mail.hosp.ncku.edu.tw|4733
20222543|NCT00454246|Hoffman-LaRoche|Medical Communications|800-821-8590||
20222544|NCT02898597|University of Massachusetts Boston|Dr. Sun Kim|617-287-6831|sun.kim@umb.edu|
20222545|NCT05326529|University Hospital of Derby and Burton|Charlotte Smith|01283 593150|charlotte.smith79@nhs.net|3150
20222546|NCT00154284|Novartis Pharmaceuticals|Study Director|862-778-8300||
20222547|NCT00326716|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
20162360|NCT01108523|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20162361|NCT05399290|Michigan State University|Erika Malana|5173038716|malanaer@msu.edu|
20162362|NCT00761527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20162363|NCT03831100|Medical University of South Carolina|Evan Graboyes|843-792-0719|graboyes@musc.edu|
20162364|NCT04566601|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20162365|NCT02625844|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20162366|NCT03047031|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20162367|NCT01450098|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162368|NCT00610311|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20162369|NCT03229109|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
20162370|NCT04207749|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20162371|NCT05126836|University of Minnesota|Dr. Markus Meyer|612.625-9538|meye3249@umn.edu|
20162372|NCT03416127|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20162373|NCT00567359|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|LVSEQUIST@PARTNERS.ORG|
20162374|NCT02397057|American Regent, Inc|Mark A. Falone, MD MPH|6317723544|mfalone@americanregent.com|61844
20162375|NCT02870101|UCLA David Geffen School of Medicine and Fielding School of Public Health|Jeffrey D. Klausner, MD, MPH|310-557-2273|JDKlausner@mednet.ucla.edu|
20162376|NCT00793325|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179063|NCT04672941|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222548|NCT00684411|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617.632.6633|EDJACOBSEN@PARTNERS.ORG|
20222549|NCT02126579|University of Virginia|Craig Slingluff, MD; Professor, Department of Surgery; Program Director, UVA Cancer Center|4349249311|cls8h@virginia.edu|
20222550|NCT01780038|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
20222551|NCT01317095|Thomas Jefferson University|Hitoshi Hirose, Professor of Surgery|2159556925|Hitoshi.Hirose@jefferson.edu|
20179064|NCT00045305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20222552|NCT03168711|Massachusetts General Hospital|Dr. Sabrina Paganoni|617-724-3914|spaganoni@mgh.harvard.edu|
20222553|NCT04509076|San Diego State University|D. Keith Horvath, Professor of Psychology|619-594-3346|khorvath@sdsu.edu|
20222554|NCT04029584|University of California, San Francisco|Leslie Benet, PhD|(415) 476-3853|leslie.benet@ucsf.edu|
20222555|NCT04381728|WOMED|Pauline Chirouze|0785225561|pauline@womedtech.com|+33
20222556|NCT03137160|The Ohio State University- Dermatology|Dr. Benjamin Kaffenberger, MD|6143463399|Benjamin.Kaffenberger@osumc.edu|
20222557|NCT02588612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20222558|NCT02348918|Allegro Ophthalmics, LLC|Director of Clinical Research|949-940-8130|info@allegroeye.com|
20222559|NCT03448419|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222560|NCT02147834|North Florida South Georigai Veteran Health System|Anthony A Bavry, M.D.|352-548-6000|anthony.bavry@va.gov|104726
20222561|NCT04025879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20222562|NCT03482635|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222563|NCT04577807|Istari Oncology|Head of Operations|919-245-7662|info@istarioncology.com|
20222564|NCT03175536|Harvard Medical School and Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|6178674893|alison_galbraith@harvardpilgrim.org|
20222565|NCT00979654|MedImmune, LLC|Jerry Green|1-888-483-7729|rtpsafety@ppdi.com|
20222566|NCT00413582|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
20222567|NCT03830333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222568|NCT00722137|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20222569|NCT01129557|Columbia University Medical Center, Division of Nephrology|Andrew Bomback, MD|212-305-5020|asb68@columbia.edu|
20222570|NCT01486446|Xenon Pharmaceuticals Inc.|Dr. Y Paul Goldberg|604 484 3300|pgoldberg@xenon-pharma.com|
20222571|NCT01367886|Washington University School of Medicine|H. Henry Lai, MD|314-362-8295|laih@wudosis.wustl.edu|
20222572|NCT01938092|University of Missouri-Columibia, Dept. Ob/Gyn|Erma Z. Drobnis, Associate Director, Research Success Center|573-817-3124|drobnise@health.missouri.edu|
20222573|NCT00985504|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222574|NCT00574704|Cytos Biotechnology AG|Head of Clinical Develpment|+41 44 733 4|info@cytos.com|7 47
20222575|NCT01465412|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222576|NCT03711786|University of North Carolina at Chapel Hill|Brian Pence, PhD|919-966-7430|bpence@unc.edu|
20222577|NCT04390113|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
20222578|NCT01611883|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222579|NCT02689154|Children's Hospital of Los Angeles|Dr. Alaina Vidmar|323-361-3385|avidmar@chla.usc.edu|
20222580|NCT03379727|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20222581|NCT02757053|Heartland Regional Medical Center dba Mosaic Life Care|Clinical Research Development Manager|816 271 7937|Linda.Schumacher@mymlc.com|
20222582|NCT02418182|University of Alabama at Birmingham|Deidre Gunn, Assistant Professor|205-934-1030|ddowns@uabmc.edu|
20222583|NCT00734994|Duke University, Division of Urology|Brant A. Inman, MD, MS|919 684-1322|brant.inman@duke.edu|
20222584|NCT02431676|Johns Hopkins University|Dr. Jessica Yeh|410-614-4316|hyeh1@jhmi.edu|
20222585|NCT01622673|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222586|NCT05009602|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
20222587|NCT03782792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222588|NCT05271370|CytoDyn|Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
20222589|NCT06045325|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
20222590|NCT03048747|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20222591|NCT00833105|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
20222592|NCT03656068|Pinnacle Clinical Research|Stephen Harrison, MD|210-982-0320|stephenharrison87@gmail.com|
20222593|NCT05253573|University of Oklahoma Stephenson Cancer Center|Thanh Cong Bui, MD, DrPH|1-405-271-8001|thanh-c-bui@ouhsc.edu|50559
20222594|NCT01344824|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20222595|NCT03417557|CooperVision|Myhanh Nguyen, Sr. Optometrist|19257306716|MNguyen@coopervision.com|
20222596|NCT04506463|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|Clinical.Trial@sunpharma.com|5689
20222597|NCT04229095|The Scripps Research Institute|Dr. Barbara J. Mason, Ph.D. Professor|(858 784-7324|mason@scripps.edu|
20222598|NCT01085630|HealthPartners Cancer Care Center|Arkadiusz Z. Dudek M.D., Ph.D.|651 254-3321|Arkadiusz.Z.Dudek@HealthPartners.Com|
20222599|NCT01237041|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
20222600|NCT02366637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222601|NCT01609010|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20222602|NCT01543178|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
20222603|NCT02770170|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222604|NCT04376346|Centers for American Indian and Alaska Native Health, University of Colorado Anschutz Medical Campus|Carol Kaufman|303-880-7795|carol.kaufman@cuanschutz.edu|
20222605|NCT03581123|University of Washington|Eric Meier, Study Biostatistician|206-450-0020|emeier11@uw.edu|
20222606|NCT04195685|VA Pacific Islands Healthcare System|Dr. Judy Carlson|808-433-6677|judy.carlson@va.gov|
20222607|NCT00162981|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20222608|NCT00300235|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
20222609|NCT01323517|Memorial Sloan Kettering Cancer Center|Dr. Charlotte Ariyan, MD|212-639-6280|ariyanc@mskcc.org|
20222610|NCT03351608|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222611|NCT02877004|Mayo Clinic|Dr. Ivana Croghan|507-266-1944|nicotineresearch@mayo.edu|
20222612|NCT01593670|Masonic Cancer Center, University of Minnesota|Dr. Erica Warlick|612-625-5467|ewarlick@umn.edu|
20222613|NCT02044302|Yale Center for Clinical Investigations|Katisha Brown CPC|(203) 737-7495|katisha.brown@yale.edu|
20222614|NCT01987089|Crescenz VA Medical Center|Subhajit Chakravorty|(215)-823-5800|Subhajit.Chakravorty@va.gov|
20222615|NCT04557215|Cedars-Sinai Medical Center|Mohamad Rashid|310.423.7302|mastprogram@cshs.org|
20222616|NCT04994691|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20222617|NCT01684423|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20222618|NCT02249728|Prana Biotechnology|Dr Dianne Angus|+61 393494906|info@pranabio.com|
20222619|NCT01342770|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-2511|wigle.dennis@mayo.edu|
20222620|NCT02220764|Zahnärztliche Prothetik|Dr. Konstantinidis Ioannis|+49 351 458 4231|ioannis.konstantinidis@uniklinikum-dresden.de|
20222621|NCT05000164|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
20222622|NCT03020992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20222623|NCT02861807|University of New Mexico|Katie Witkiewitz|505-277-4121|katiew@unm.edu|
20179065|NCT02386995|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
20179066|NCT06213701|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
20179067|NCT00453986|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179068|NCT04450108|Bosch Healthcare Solutions|Dr. Klaus Müller, Study director|+49 160 90816081|klaush.mueller@de.bosch.com|
20179069|NCT01031810|New York State Psychiatric Institute|Dr. Patrick J. McGrath|(646) 774-8076|mcgrath@nyspi.columbia.edu|
20179070|NCT01024608|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20179071|NCT02669784|Milton S. Hershey Medical Center|Rekha Cherian, M.D.|717-531-6735|rcherian@pennstatehealth.psu.edu|
20179072|NCT01880723|University of Arizona|Courtney Wheatley|507-266-2696|wheatley.courtney@mayo.edu|
20179073|NCT02821403|The Hong Kong Polytechnic University|Dr. Tsz Wing Leung|27664268|jeffrey.TW.leung@polyu.edu.hk|
20179074|NCT03289234|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml@ml.mt-pharma.co.jp|
20179075|NCT02412137|Texas Scottish Rite Hospital for Children|Dr. Brandon Ramo|2145597755|brandon.ramo@tsrh.org|
20179076|NCT04913363|University of Virginia|Jennifer Roe|434-982-4567|jjr4b@virginia.edu|
20179077|NCT04506970|Mayo Clinic|Mauro Schenone|5072840210|schenone.mauro@mayo.edu|
20179078|NCT04295005|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20179079|NCT00608582|VA Boston Healthcare System and Boston University School of Medicine|Margaret Naeser, PhD|857-364-4030|mnaeser@bu.edu|
20179080|NCT02240108|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
20179081|NCT00297115|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20179082|NCT02124889|WakeForest|Dr. Adolfo Fernandez|336-716-6099|afernand@wakehealth.edu|336
20179083|NCT02472652|Thomas D Gazda MD PC|Thomas D Gazda MD|480 518 6299|goodgazda@yahoo.com|
20179084|NCT02713711|UC de Maule|Professor Gabriel Nasri Marzuca Nassr|56 71 203463|gmarzuca@gmail.com|
20179085|NCT00998400|University of Bologna|Professor Chiara Rafanelli|0039 051 2091847|chiara.rafanelli@unibo.it|
20179086|NCT03704584|Emory University|Dr. Charles Daly|404-919-6168|charles.a.daly@emory.edu|
20179087|NCT03185832|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
20179088|NCT01083641|University of Wisconsin Carbone Cancer Center|Dr. Kari Wisinski|608-262-2876|kbwisinski@medicine.wisc.edu|
20179089|NCT03439189|Exalenz Bioscience|Clinical trial manager|00 972 546605412|avrahamh@exalenz.com|
20179090|NCT03412812|University of Alabama at Birmingham|Dr. John Fiveash|205-975-0224|jfiveash@uabmc.edu|
20179091|NCT01777321|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179092|NCT03837509|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20179093|NCT04280653|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
20179094|NCT00455975|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
20179095|NCT01267292|The University of Texas Health Science Center at Houston|Scott Lane, PhD|713-486-2535|Scott.D.Lane@uth.tmc.edu|
20179096|NCT03315143|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20179097|NCT02799784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179098|NCT01804816|Cleveland Clinic Foundation|Dr. W.H. Wilson Tang, MD|(216) 444-2121||
20179099|NCT01050816|Eulji General Hospital|Lee Gyeong Tae|+82-11-214-3323|lkt2408@hanmail.net|
20179100|NCT03086330|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20179101|NCT02360319|Vanguard Research Group|Patrica Marcy|3474398035|pmarcy@northwell.edu|
20179102|NCT01256411|Novartis Pharmaceuticals|Study Director|862-778-8300||
20179103|NCT01445652|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20179104|NCT00929162|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20179105|NCT01701414|Dept of Emergency Medicine, Rhode Island Hospital|Francesca Beaudoin MD, MS|401-444-2577|fbeaudoin@lifespan.org|
20179106|NCT00117676|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20179107|NCT00952822|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20179108|NCT02643862|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
20179109|NCT01281644|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20179110|NCT01755702|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179111|NCT01319799|Sahlgrenska University Hospital,Cardiothoracic Anesthesia, 41345 Gothenburg ,SWEDEN|Dr Bjorn Reinsfelt|0046702954263|bjorn.reinsfelt@gu.se|
20179112|NCT01965782|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20179113|NCT03673306|IRCCS Ospedale Policlinico San Martino, Genoa, Italy|Matteo Lambertini|+39 010 555 4254|matteo.lambertini@unige.it|
20179114|NCT03701399|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20179115|NCT03440372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20179116|NCT00448448|University of Iowa Dept of Orthopaedics and Rehabilitation|Dr. Lori A. Dolan|319-356-1075|lori-dolan@uiowa.edu|
20179117|NCT03945292|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
20179118|NCT02684006|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179119|NCT04642898|University of Kentucky|Dr. Sauer-Zavala|859-562-1571|ssz@uky.edu|
20162377|NCT00414518|University of Colorado Denver|Michelle A. Barron|303-724-4939|michelle.barron@ucdenver.edu|
20179120|NCT04280562|David Putrino|Icahn School of Medicine at Mount Sinai|212-824-8369|david.putrino@mountsinai.org|
20179121|NCT02968420|Vaccine Evaluation Center|Dr. Manish Sadarangani|604-875-2422|msadarangani@bcchr.ubc.ca|
20179122|NCT01368965|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20162378|NCT00581867|University of Kansas Medical Center|Dr. Jeffrey Burns|(913) 588-0555|jburns2@kumc.edu|
20179123|NCT02618967|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20222624|NCT01006122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222625|NCT03493854|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20222626|NCT02094352|HSS|Dr. Richman|212.517.4481|RichmanD@HSS.EDU|
20179124|NCT02676375|Department of Psychiatry, University of California San Diego|Dr. Arthur Brody|8585528585|abrody@ucsd.edu|3775
20222627|NCT02422446|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|Ldjousse@rics.bwh.harvard.edu|
20222628|NCT00529308|Yale University|Dr. Angeli Landeros-Weisenberger||angeli.landeros-weisenberger@yale.edu|
20222629|NCT04123496|Medical University of South Carolina|Donna Robers, MD|843-792-9343|Robertdr@musc.edu|
20222630|NCT03365635|Penn Presbyterian Medical Center|Michael R. Rudnick, MD|215-662-8738|rudnickm@uphs.upenn.edu|
20222631|NCT05343364|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20222632|NCT03331796|Veterans Affairs Palo Alto Health Care System|Joy L Taylor, PhD|650-776-3385|joyt@stanford.edu|
20222633|NCT04709562|Vapotherm Inc|Kathy Gerich|(585) 469-6753|kgerich@vtherm.com|
20222634|NCT00660517|Meda Pharmaceuticals|David Ginsberg, D.O.|7325642364|david.ginsberg@meda.us|
20222635|NCT01791894|Stanford University School of Medicine, Department of Dermatology|Jean Y Tang MD PhD|650-721-7149|baileyhi@stanford.edu|
20222636|NCT01391858|UTexas Southwestern Medical Center|Babatunde Ogunnaike|(214) 590|Babatunde.Ogunnaike@UTSouthwestern.edu|8536
20222637|NCT02268916|VA Ann Arbor|Pearl Lee, MD|734-845-3182|Pearl.Lee2@va.gov|
20222638|NCT04205643|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
20222639|NCT03146806|Emory University|Vinita Singh, MD|404-686-2410|vinita.singh@emory.edu|
20222640|NCT03337087|Accru|Dr. Tanios Bekaii-Saab|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
20222641|NCT04526288|Fred Hutchinson Cancer Center|Dr. Filippo Milano, Director of FHCC Cord Blood Transplant Program|206.667.5925|fmilano@fredhutch.org|
20222642|NCT00594165|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20222643|NCT04830969|University at Buffalo|Lu Li|7168296284|lli59@buffalo.edu|
20222644|NCT01422889|Boston Scientific|Peter Maurer, MPH; Director, Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
20222645|NCT01580670|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20222646|NCT00996125|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222647|NCT00488644|UT MD Anderson Cancer Center|Victor Levin, MD, BS / Professor||kuhunter@mdanderson.org|
20222648|NCT04331067|Washington University School of Medicine|Andrew Davis, M.D.|314-273-3581|aadavis@wustl.edu|
20222649|NCT04926831|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222650|NCT02003404|Loyola University of Chicago|Dr James Swan, MD|708-485-1271|jswan@lumc.edu|
20222651|NCT03859427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20222652|NCT00673439|James Graham Brown Cancer Center|Goetz H Kloecker, MD, MSPH|502/562-4358|ghkloe01@exchange.edu|
20222653|NCT01804946|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
20222654|NCT03103152|Queen Mary University, London.|Professor Jack Cuzick, Director of The Wolfson Institute|+44 (0)207 882 3504|j.cuzick@qmul.ac.uk|
20222655|NCT03474965|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222656|NCT03208166|Medical University of South Carolina|Marc Chimowitz, MD|843-792-3020|mchimow@musc.edu|
20222657|NCT03100903|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222658|NCT04659993|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Katie.Duckworth@advocatehealth.org|
20222659|NCT01295671|Boston Children's Hospital|Dr. David Ludwig|617-355-4878|david.ludwig@childrens.harvard.edu|
20222660|NCT01944878|Hallym University College of Medicine, Chuncheon Sacred Heart Hospital|Dr. Chang Seok Bang|+82-33-240-5000|cloudslove@naver.com|
20222661|NCT01436370|Department of Internal Medicine, University of Iowa|Jack Stapleton, MD|319-356-3168|jack-stapleton@uiowa.edu|
20222662|NCT02395848|McMaster University|Christine Lee|2505191898|clee@mcmaster.ca|
20222663|NCT01754129|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20222664|NCT02276560|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20222665|NCT00616343|Loma Linda University|Dr. David Swope|909-558-4908|Thamilton@llu.edu|
20179125|NCT04559568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20179126|NCT03678545|Cincinnati Children's Hospital Medical Center|Regina Yearout|513-517-2108|regina.yearout@cchmc.org|
20179127|NCT05103384|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
20179128|NCT05608499|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
20179129|NCT00514735|Medtronic|Linda Nelson, Director of Clinical Research|763-526-2891|linda.k.nelson@medtronic.com|
20222666|NCT01033032|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20222667|NCT02609607|University of Pittsburgh Medical Center|Dr. David Levinthal|14123030525|levinthald@upmc.edu|
20179130|NCT02865720|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20222668|NCT00651261|Dana Farber Cancer Institute|Richard Stone, MD||rstone@partners.org|
20222669|NCT02314260|kasr EL alini|Dr Ahmed Kamel|0201120022332|dr.ahmed.m.kamel@gmail.com|
20179131|NCT02660827|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
20179132|NCT01422408|Knight Cancer Institute, Oregon Health & Science University|Emile Latour|503-418-9601|latour@ohsu.edu|
20179133|NCT02953938|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20179134|NCT02038894|Cincinnati Children's Hospital Medical Center|Dr. Mario Patino|5132538190|mario.patino@cchcm.org|
20179135|NCT03124979|Masimo|Tala Harake||studies@masimo.com|
20222670|NCT02027545|VA Ann Arbor Healthcare System|Sameer D. Saini, MD, MS|734-845-5865|sameer.saini@va.gov; sdsaini@med.umich.edu|
20222671|NCT04610346|Jefferson Moss Rehabilitation Research Institute|Sharon Antonucci, Ph.D CCC-SLP, C-AAIS|215-663-6561|sharon.antonucci@jefferson.edu|
20222672|NCT03892642|OU Health Stephenson Cancer Center|Associate Professor|405-271-6900|kelly-stratton@ouhsc.edu|
20222673|NCT03309943|Duke University School of Medicine|Jason A. Oliver, Ph.D.|(919) 668-0093|Jason.A.Oliver@duke.edu|
20222674|NCT02344238|Medical University of South Carolina|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
20222675|NCT01483963|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20222676|NCT05028790|University of Houston|David A Berntsen, OD PhD|713-743-5836|dberntsen@uh.edu|
20222677|NCT02019264|Eisai Ltd|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20222678|NCT02414243|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
20179136|NCT04274894|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20179137|NCT03848403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20179138|NCT00168038|CSL Behring|Clinical Trial Disclosure Manager||clinicaltrials@cslbehring.com|
20179139|NCT00490256|Emory University|Paul Kirshbom, MD|404-785-6330|pkirshb@emory.edu|
20179140|NCT04198805|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
20179141|NCT04188067|Massachusetts General Hospital|Dr. Alexandra Touroutoglou PhD|6176436348|ATOUROUTOGLOU@mgh.harvard.edu|
20179142|NCT03599349|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 865|clinicaltrials@merz.com|
20179143|NCT05007392|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20222679|NCT01297517|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20222680|NCT01609296|Medtronic|Kristel Wittebols Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
20222681|NCT00386360|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20222682|NCT00628212|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20179144|NCT00803452|University of Louisville|Professor Douglas Borchman|502 852 7435|borchman@louisville.edu|
20179145|NCT04648150|Hopital fondation Rothschild|Dr Amélie YAVCHITZ|+33148036454|ayavchitz@for.paris|
20179146|NCT01774149|Norwegian Center for Integrated Care and Telemedicine|Dr. Stein Olav Skrøvseth|+4795805841|stein.olav.skrovseth@telemed.no|
20179147|NCT01659151|Moffitt Cancer Center|Amod Sarnaik, M.D.|813-745-8581|Amod.Sarnaik@moffitt.org|
20179148|NCT05878197|Ghent University|drs. Anke Adriaansen|0471028622|anke.adriaansen@ugent.be|
20179149|NCT00939484|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
20179150|NCT04233372|Hospital Clínic of Barcelona|Dr. Alexy Inciarte|+34932275400|ajinciar@clinic.cat|
20179151|NCT03938454|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20179152|NCT01090310|Novartis|Study Director|862-778-8300||
20179153|NCT00695786|UT MD Anderson Cancer Center|Felipe Samaniego,MD/Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
20179154|NCT01410058|University of Zimbabwe College of Health Sciences|Tsitsi G Monera-Penduka|307148|moneratg@yahoo.co.uk|
20179155|NCT03027414|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
20179156|NCT01364922|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20179157|NCT02542839|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
20179158|NCT04244396|Abbott_Medical_Devices|Emily Jesser Clinical Research Scientist II|6514482520|emily.jesser@abbott.com|
20179159|NCT01787097|Imperial College|Dr Omar S Usmani|+44 (0)20 7351 8051|o.usmani@imperial.ac.uk|
20179160|NCT05178121|University of Washington|Doyanne Darnell|206-744-9108|darnelld@uw.edu|
20179161|NCT01953003|Institut de Recherche Pierre Fabre, Toulouse France|Karim Keddad, Head of Medical Unit|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
20179162|NCT02512679|Children's Hospital Los Angeles|Neena Kapoor, M.D.|343-361-2434|nkapoor@chla.usc.edu|
20179163|NCT00553501|University of Vermont, Vermont Cancer Center|Barbara Grant, MD||barbara.grant@vtmednet.org|
20179164|NCT02597907|Kyungpook National University|Dr Younghoon Jeon|82534205871|jeon68@gmail.com|
20179165|NCT03701295|Johns Hopkins University|ETCTN Grants Administrative Manager|410-955-4044|jmurra33@jhmi.edu|
20179166|NCT01464021|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20179167|NCT04672096|Neuronoff, Inc.|Jasmine Wilson|408-858-2612|jasmine@neuronoff.com|
20179168|NCT03391765|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20179169|NCT00944658|Imperial College London|Peter Taylor|+44 (0) 2075941872|jrco@imperial.ac.uk|
20179170|NCT01255592|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20179171|NCT01272960|University of Alabama School of Medicine|Dr. Lorie Harper|205-975-0515|lmharper@uabmc.edu|
20179172|NCT00963911|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
20179173|NCT03496974|XBiotech|Ashley Otero, Corporate and Clinical Relations Manager|512-386-2930|aotero@xbiotech.com|
20179174|NCT00838682|The Catholic University of Korea, Uijeongbu St. Mary's Hospital|Hiun-Suk Chae|82-31-820-3019|chs@catholic.ac.kr|
20179175|NCT00990964|Medtronic, Inc.|Attain Success Clinical Trial Leader|800-328-2518|medtronicCRMtrials@medtronic.com|62864
20179176|NCT03202472|Jonsson Comprehensive Cancer Center|Mark Glover|310 794-8742|mglover@mednet.ucla.edu|
20179177|NCT03928028|Children's Hospital of Philadlephia|C. Alix Timko|2674265467|timkoc@chop.edu|
20179178|NCT02012192|Medical University of Innsbruck|Prof. Dr. Nicole Concin|+43 512 504|nicole.concin@i-med.ac.at|81433
20190871|NCT04453709|University of Massachusetts Amherst|Kalpana Poudel-Tandukar, Associate Professor|413-545-5095|kalpana@umass.edu|
20190872|NCT02282761|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20179179|NCT02802501|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20222683|NCT02914613|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
20222684|NCT00546377|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens, Associate Attending|+1212-639-7053|brentjer@mskcc.org|
20206441|NCT04294095|Colorado School of Public Health|Jenn Leiferman|303-724-4386|jenn.leiferman@cuanschutz.edu|
20206442|NCT02629614|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
20206443|NCT02224638|Swedish Covenant Hospital|Nancy Chaiken|847-372-3500|nchaiken@comcast.net|
20206444|NCT01406652|Geneva University Hospitals|Dr.med Ilker Uçkay|+412237123311|ilker.uckay@hcuge.ch|
20190873|NCT00515281|University of Chicago|Michael D. Schreiber, MD|773-702-6205|mschreiber@bsd.uchicago.edu|
20206445|NCT00861380|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206446|NCT00089102|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20206447|NCT01998399|Vanderbilt University|Gordon Bernard, Professor of Medicine, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@Vanderbilt.Edu|
20206448|NCT00971633|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20206449|NCT01269047|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20206450|NCT00795509|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206451|NCT00970268|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20206452|NCT01079195|Abbott|Global Medical Services|1-800-633-9110||
20206453|NCT03984838|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
20206454|NCT02320214|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20206455|NCT02146833|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20206456|NCT03726333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
20206457|NCT01060098|Imperial College London|Sonya Abraham|+44 (0)20 3313 4114|s.abraham@imperial.ac.uk|
20206458|NCT02971007|Matinas Biopharma|Director Clinical Development|9082953235|jjohnson@matinasbiopharma.com|
20206459|NCT05302804|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
20206460|NCT01807611|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|866-278-5833|referralinfo@stjude.org|
20206461|NCT01419015|Edwards Lifesciences|Aya Saeki||Aya_Saeki@edwards.com|
20206462|NCT02911519|SAMEIN|Dr. Jenny Garcia|+57 4 219 6014|jenny.garcia@udea.edu.co|
20206463|NCT00653328|Vanderbilt-Ingram Cancer Center|Marta Crispens, M.D.|800-811-8480|marta.crispens@vanderbilt.edu|
20206464|NCT01237223|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206465|NCT02057276|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
20206466|NCT02516150|Massachusetts General Hospital|Courtney Balliro|617-726-1242|cballiro@partners.org|
20206467|NCT03943888|Seoul National University Hospital|Dr. Sang-Hwan Ji|+82-2-2072-3661|taepoongshin@gmail.com|
20206468|NCT00064077|NRG Oncology|Angela Kuras on behalf of Michael Sill and Helen Huang|716-845-5702|kurasa@nrgoncology.org|
20206469|NCT02256345|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
20206470|NCT02052141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20206471|NCT00879437|Baylor College of Medicine|Jack Su|8328224306|jmsu@txch.org|
20206472|NCT00268463|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20206473|NCT03000686|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206474|NCT02920450|University of Florida Heath Cancer Center|Protocol Development Manager|352-273-8128|clh1230@ufl.edu|
20206475|NCT01921452|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|49-6151-72-5200|service@merckgroup.com|
20206476|NCT02291445|Maastricht University (Medical Center)|Z. Weerts||z.weerts@maastrichtuniversity.nl|
20206477|NCT05097157|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20206478|NCT00770224|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
20206479|NCT01112982|University of South Florida|John Carter, M.D|813-974-2473|mpatelli@health.usf.edu|
20206480|NCT04206670|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20206481|NCT01170949|University Charité Berlin|Markus Magerl|+4930450618304|markus.magerl@charite.de|
20206482|NCT01296698|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20206483|NCT02801006|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20206484|NCT03639987|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20206485|NCT01614912|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20222685|NCT04332081|NYU Langone|David Lee|212-263-3293|David.lee@nyulanogne.org|
20222686|NCT02744430|Baylor College of Medicine|Perla Ramirez|713-798-8514|Perla.Ramirez@bcm.edu|
20222687|NCT03850496|Imperial College London|Dr Tristan Lane, Clinical Lecturer|02033117317|tristan.lane@imperial.ac.uk|
20222688|NCT03090958|UNC-Chapel Hill|Lisa Hightow Weidman, MD|919 966 2536|lisa_hightow@med.unc.edu|
20222689|NCT01417741|OHSU department of APOM|Dr. Christine Martin, assistant professor|503 494 7641|martich@ohsu.edu|
20222690|NCT00676364|Lehigh Valley Health Network|Jenny Boucher|610-402-8844|jenny.boucher@LVH.com|
20222691|NCT05209464|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
20222692|NCT03821259|University of Edinburgh/NHS Tayside|Klaudia Suchorab|+44 1738 621151|klaudia.suchorab@nhs.net|
20222693|NCT00869999|Massachusetts General Hospital Cancer Center|Jeffrey Barnes, MD|617-724-4000|jabarnes@partners.org|
20190874|NCT03590847|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
20190875|NCT06312566|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20190876|NCT03747575|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20190877|NCT03010878|Colorado State University|Dr. Arlene Schmid|9704917562|arlene.schmid@colostate.edu|
20190878|NCT02924051|University of Kentucky|Dr. Frances Hardin-Fanning|(859) 257-4866|fdbowe2@uky.edu|
20206486|NCT00996593|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206487|NCT01202760|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222694|NCT03858998|Weill Cornell Medicine|Dr. Robert Peck|(646) 962-8140|rnp2002@med.cornell.edu|
20222695|NCT03363776|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
20222696|NCT04157348|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20222697|NCT02527434|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20222698|NCT00568061|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20222699|NCT05027451|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|misty.stevens@intervexion.com|
20222700|NCT04316104|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
20222701|NCT02693002|University of Kentucky|Dr. Gretchen Wells, PI||gretchen.wells@uky.edu|
20222702|NCT02266797|NYU Langone Medical Center|Michael Gerling|(718) 630-8600|Michael.Gerling@nyumc.org|
20222703|NCT01753570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20222704|NCT03546491|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20222705|NCT02062450|TORNIER SAS|Nathalie TRETOUT|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
20222706|NCT02555228|MOHH Holdings|Dr Song Mingjun|86337635|mingjun.song0950c@gmail.com|
20222707|NCT02203721|Abbott Medical Optics|Kendra Hileman, Ph.D., Director of Clinical Research and Development|714-247-8613|kendra.hileman@abbott.com|
20222708|NCT04745689|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20222709|NCT00153179|Brigham and Women's Hospital|Mark A. Creager|603-650-8283|Mark.A.Creager@hitchcock.org|
20222710|NCT02438423|Georgia Tech|Mark Prausnitz, PhD|404-894-5135|prausnitz@gatech.edu|
20222711|NCT02640664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20222712|NCT00314327|NSLIJ|Delbert Robinson, M.D.|718-470-8195|Drobinson@nshs.edu|
20222713|NCT01408303|AstraZeneca Pharmaceuticals|Torbjörn Lundström||ClinicalTrialTransparency@astrazeneca.com|
20222714|NCT02571673|Memorial Sloan Kettering Cancer Center|Dr. Talya Salz, PhD|646-227-3646|salzt@mskcc.org|
20222715|NCT00669669|Fred Hutch Cancer Research Center|Hans-Peter Kiem, M.D., Ph.D.|206.667.4425|hkiem@fredhutch.org|
20222716|NCT00715273|University of Washington|Xue-Qiao Zhao|206-744-8305|xueqiao@uw.edu|
20222717|NCT01205776|Abbott Vascular|Rhonda Hensley, Clinical Project Manager|+1 828-559-0080|rhonda.hensley@abbott.com|
20222718|NCT03334344|Ceevra|Russ Yoshinaka|415-926-9434|ryoshinaka@ceevra.com|
20222719|NCT04031846|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222720|NCT01644292|University of Manitoba|Ed Giesbrecht|204-977-5630|Ed.Giesbrecht@med.umanitoba.ca|
20222721|NCT00695292|Sarah Cannon Research Institute|Dr. David Spigel|615-329-7274|askSARAH@scresearch.net|
20222722|NCT00693498|University of Rochester|Jill M. Cholette MD, Principle Investigator|585-275-8138|Jill_Cholette@urmc.rochester.edu|
20222723|NCT04541589|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20222724|NCT02727478|Karolinska Instituet|Dr Breiffni Leavy|+46852488814|breiffni.leavy@ki.se|
20222725|NCT02633293|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20222726|NCT01017874|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222727|NCT00808210|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
20222728|NCT02017210|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
20222729|NCT01953302|Varazdin General Hospital|Alen Pajtak|+38542393053|alen.pajtak@obv.hr|
20222730|NCT00778817|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
20222731|NCT02356588|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20222732|NCT01418378|DePuy Synthes|Dave Whalen|574-372-7028|dwhalen@its.jnj.com|
20222733|NCT03150719|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20222734|NCT01790984|University of Surrey|Professor Bruce A.Griffin|+44 0483 689724|b.griffin@surrey.ac.uk|
20222735|NCT04742400|National Institutes of Health|Daniel Reich, MD|301-496-1801|reichds@ninds.nih.gov|
20222736|NCT00383760|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
20222737|NCT01691560|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222738|NCT01051791|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20222739|NCT00288626|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20222740|NCT03097757|Montefiore Medical Center|Roger Hicks|718-862-1751|roger.hicks@einsteinmed.org|
20222741|NCT01372618|NYU Langone|David Kleinberg|646 501 7504|david.kleinberg@nyumc.org|
20222742|NCT00245128|OHSU Knight Cancer Institute|Dr. Michael Mauro|503-494-1080|maurom@ohsu.edu|
20190879|NCT01229527|Department of Anesthesia and Intensive Care|Dr. Massimo Agostoni|+39.02.2643.2656|agostoni.massimo@hsr.it|
20190880|NCT00914732|Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
20190881|NCT02130401|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|bacllc@earthlink.net|
20190882|NCT00321672|NeurogesX|Trudy Vanhove, VP Clinical Development|650-393-7444|tvanhove@neurogesx.com|
20222743|NCT01081769|Janssen-Cilag Germany|EMEA Medical Affairs Director Psychiatry||ClinicalTrialDisclosure@its.jnj.com|
20222744|NCT04005404|Helios Center for Research and Innovation|Director Prof. Dr. Petra Thürmann|0049 (0)202 896-1851|petra.thuermann@helios-gesundheit.de|
20222745|NCT00558467|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222746|NCT00507455|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20206488|NCT00871572|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222747|NCT00931255|UMaryland|Abdolreza Haririan, MD|410-328-5720|ahariria@medicine.umaryland.edu|
20222748|NCT01372995|Emory University|Jenny Han, MD|404-616-0821|jehan2@emory.edu|
20222749|NCT00746889|UCSD|Jeannie Chao|858-657-7040|j5chao@ucsd.edu|
20222750|NCT03038867|Weill Cornell Medical College|Research coordinator|212-746-5385|mac4015@med.cornell.edu|
20222751|NCT02403479|St. Joseph's Healthcare London|Dr. Leigh Sowerby|519-646-6143|leigh.sowerby@sjhc.london.on.ca|
20222752|NCT00789373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222753|NCT02461966|Tanta university|Sherief Abd-Elsalam|00201095159522|sherif_tropical@yahoo.com|
20222754|NCT03782012|William Jewell College|Dr. Amy Elizabeth Barth|816-415-7622|bartha@william.jewell.edu|
20222755|NCT01964222|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
20222756|NCT03612596|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
20222757|NCT01019694|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222758|NCT01050582|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Clinical Leader|609-730-6581||
20222759|NCT01831076|University of Colorado|Anthony Elias|720-848-0347|anthony.elias@ucdenver.edu|
20222760|NCT04244084|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20179180|NCT04525547|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20179181|NCT00800202|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20179182|NCT01768832|Washington University in St. Louis|Dr. Gammon M. Earhart|314-286-1407|earhartg@wustl.edu|
20179183|NCT00715650|Yale University|Dr. Marc Rosen|203-932-5711|marc.rosen@yale.edu|2575
20179184|NCT02641392|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|amcclain@celgene.com|
20179185|NCT02052310|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1200|063study@fibrogen.com|
20179186|NCT03518125|BARDA|Susan Hollingsworth/Regulatory Operations Specialist|202-691-2040|Susan.Hollingsworth@hhs.gov|
20179187|NCT04452877|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20179188|NCT01505387|Analyze & Realize|Felix Alt|+49 30 40008100|Falt@a-r.com|
20179189|NCT01301391|CLIOSS S.r.l.|Dr. Davite Cristina|+39 0031 58|regulatory@clioss.com|1482
20179190|NCT00595504|Massachusetts General Hospital|David C. Henderson, M.D.|617-912-7800|dchenderson@partners.org|
20179191|NCT01949870|AstraZeneca|Dr Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20179192|NCT00293267|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179193|NCT02182973|University of Louisville|Paula Radmacher|5028525532|paula.radmacher@louisville.edu|
20179194|NCT01235546|University of Alabama at Birmingham, Maternal & Fetal Medicine|Alan Tita, MD|205-934-9616|atita@uab.edu|
20179195|NCT01123382|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
20179196|NCT02740049|Imperial College London|Dr Coen Wiegman|+44(0)2075947846|c.wiegman@imperial.ac.uk|
20179197|NCT02274857|Abbott|Clinical Program Director|651-756-6717|kristin.ruffner@abbott.com|
20179198|NCT00948298|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
20179199|NCT02403180|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20179200|NCT04225533|Serpin Pharma, LLC|Dr. Cohava Gelber|7033433258|cgelber@serpinpharma.com|
20179201|NCT04026529|Omaha VA Medical Center|Dr. Debra Romberger|4025597539|debra.romberger@va.gov|
20179202|NCT03338829|University of Minnesota|Sarah A. Wernimont MD, PhD|612-301-3408|swernimo@umn.edu|
20179203|NCT02340026|The Children's Hospital of Philadelphia|Laura A. Prosser, PT, PhD|215-590-2495|ProsserL@chop.edu|
20179204|NCT03628287|City University of New York, School of Public Health|Denis Nash, PhD|347-331-6554|denis.nash@sph.cuny.edu|
20179205|NCT03088267|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
20179206|NCT05417620|Johns Hopkins Bloomberg School of Public Health|Dr. Sheree Schwartz|443-983-2564|sschwartz@jhu.edu|
20179207|NCT04393441|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20179208|NCT02782169|University of Hawaii|Family Planning Department|808-983-6000|hawaiimedab@gmail.com|
20179209|NCT04003610|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20179210|NCT00771810|Tarix Pharmaceuticals|Elizabeth Wagner|6178760223|elizabeth.wagner@tarixpharma.com|
20179211|NCT00765232|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
20179212|NCT05198466|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20179213|NCT00226239|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
20179214|NCT06223373|Wake Forest University Health Sciences|Kristen Faith Nicholson, PhD|704-355-2000|Kristen.Nicholson@advocatehealth.org|
20179215|NCT01165775|Stanford School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
20179216|NCT03421808|Medical University of South Carolina|Mark S. George, MD|18438765142|georgem@musc.edu|
20179217|NCT03764774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20179218|NCT04574882|University of Pennsylvania|Director of Research|2674280125|digitalhealth@pennmedicine.upenn.edu|
20179219|NCT05809596|Boston Scientific|Nicole Kelly, Clinical Trial Manager|1-800-CARDIAC|Nicole.Kelly2@bsci.com|
20222761|NCT00795002|The Sidney Kimmel Comprehensive Cancer Center|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
20222762|NCT00026494|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
20222763|NCT01455597|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20179220|NCT06916468|University Hospitals Cleveland Medical Center|Dr. Bryan Carroll|(216)844-8200|Bryan.Carroll@UHhospitals.org|
20179221|NCT03770494|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20190883|NCT03163472|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
20190884|NCT00512902|University of California at Los Angeles|Dr. Daniel Furst, Carl M Pearson Professor of Rheumatology|310-794-9504|defurst@mednet.ucla.edu|
20179222|NCT04922554|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20179223|NCT01345630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179224|NCT01289418|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
20179225|NCT00551070|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20179226|NCT01352585|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20179227|NCT00605202|Oulu University Hospital, Department of Internal Medicine|Janne Hukkanen|+358-8-315 6212|janne.hukkanen@oulu.fi|
20179228|NCT04682119|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20179229|NCT03364348|Stanford Medicine at Stanford University|Sinyoung Park|650-721-4485|sinyoung@stanford.edu|
20179230|NCT01580072|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
20179231|NCT01746095|Savara Inc.|Head of Clinical Development|+45 7930 1414|info@savarapharma.com|
20179232|NCT02459262|MinervaX ApS|Per Fisher DPhil|+45 20 25 20 38|pbf@minervax.com|
20179233|NCT01904864|Baylor College of Medicine|Jacquelyn M. Powers, MD||jacquelyn.powers@bcm.edu|
20179234|NCT03724487|Case Western Reserve University|Dr. Carolyn Still, Assistant Professr|216-368-6338|cwh11@case.edu|
20179235|NCT00832767|Covidien|Jessica Carlson|203-821-4734|jessica.carlson@covidien.com|
20179236|NCT00549757|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20179237|NCT02629991|Albert Einstein College of Medicine|Bonnie Taylor|7188397530|botaylor@montefiore.org|
20179238|NCT01814748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179239|NCT00939874|St Vincents Hospital|Professor Andrew Carr|+61 2 8382 3359|andrew.carr@svha.org.au|
20179240|NCT00330174|Medical University of South Carolina|Susan Sonne, PharmD, BCPP|843.792.5221|sonnesc@musc.edu|
20179241|NCT01032733|University of Florida|Stephen Anton|352-273-7514|santon@ufl.edu|
20179242|NCT02316769|Vanderbilt University|Bret Alvis|6159365836|bret.d.alvis@vanderbilt.edu|
20179243|NCT00834106|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179244|NCT00330915|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20179245|NCT00645164|DFB Pharmaceuticals|Herbert B. Slade MD, FAAAAI|817.302.3919|bert.slade@dfbpharmaceuticals.com|
20179246|NCT05656040|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20179247|NCT05288660|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20179248|NCT01895972|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
20179249|NCT04751942|Univeristy Hosptials Cleveland Medical Center|Rachael Kilkenny|216-545-4850|Rachael.Kilkenny@UHhosptials.org|
20179250|NCT02954523|Georgetown University|Chul Kim|12024442223|Chul.Kim@gunet.georgetown.edu|
20179251|NCT03531320|InnoPharmax Inc.|Staff of Medical Affairs|886-2-8797-7607|yuan.lin@innopharmax.com|
20179252|NCT03365154|Libra Medical|Phil Zhang, MD|6692039308|pzhang@libramed.com|
20179253|NCT00724152|VA Connecticut Healthcare System|Dr. Caroline Schmidt, Co-investigator|203-932-5711|Caroline.Schmidt@va.gov|3391
20179254|NCT00386022|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
20179255|NCT03371082|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
20179256|NCT03266770|University Hospitals Cleveland Medical Center|Dr. Kyle Scarberry|(216)844-3009|Kyle.Scarberry@UHhospitals.org|
20179257|NCT02440633|Otsuka Pharmaceutical Co., Ltd.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
20179258|NCT01160848|Photocure ASA|Project Director|+47 22062210|pf@photocure.no|
20179259|NCT02657031|University Medical Center Emergency Department|Dr. Tony Zitek|7022247124|zitek10@gmail.com|
20179260|NCT03078816|UCSF Movement Disorders|Aaron Viser|415 353 9453|aaron.viser@ucsf.edu|
20179261|NCT02114151|Janssen Infectious Diseases - Diagnostics BVBA|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
20179262|NCT04209075|NIDDK|Dr. Stephanie Chung|301-402-2122|Stephanie.Chung@NIH.gov|
20179263|NCT02638948|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
20179264|NCT04639128|The Permanente Medical Group|Dr. Adrian Hinman|510-454-7292|adrian.d.hinman@kp.org|
20179265|NCT06821412|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
20179266|NCT01218126|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179267|NCT02411565|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hye Sook Chon|813-745-7205|hyesook.chon@moffitt.org|
20179268|NCT01860703|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
20179269|NCT00072761|Vanderbilt University School of Medicine|Michael R. DeBaun, MD, MPH|615-875-3040|m.debaun@vanderbilt.edu|5-3040
20179270|NCT02532556|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20179271|NCT00696410|University of Michigan|Jennifer Cowger, MD, Assistant Professor|734 936-5265|jennmatt@med.umich.edu|
20179272|NCT04898231|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
20179273|NCT03184792|University of Washington|Dr. Fatma Inanici|2067872692|finanici@uw.edu|
20179274|NCT02495025|University of California Los Angeles|Principal Research Manager, Health Services Research Program|310-825-8624|lindseythompson@mednet.ucla.edu|
20190885|NCT01549951|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
20190886|NCT00738400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20190887|NCT04313985|Stanford University|Geoffrey Gurtner|(520) 626-2222|gurtner@surgery.arizona.edu|
20190888|NCT01542502|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@vcu.edu|
20190889|NCT01052714|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
20190890|NCT00990314|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
20179275|NCT03818672|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
20179276|NCT02134587|School of Pharmaceutical Scientes of Universidade Estadual Paulista Júlio de Mesquita Filho, Araraquara, SP (Brazil)|Fabiana Rossi Varallo|5516997629496|varallo.f.r@gmail.com|
20179277|NCT00265889|Case Comprehensive Cancer Center|Brian Bowell, MD|216-444-6922|bolwelb@ccf.org|
20179278|NCT00303862|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20179279|NCT01001052|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20179280|NCT05238233|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
20179281|NCT02778100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20179282|NCT00825266|Stanford University|Roham Zamanian|650-725-5495|roham.zamanian@stanford.edu|
20179283|NCT00860379|Shriners Hospitlas for Children|Maggie Dylewski Begis|617-872-8567|mdylewski@shrinenet.org|
20179284|NCT01515748|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20179285|NCT03221387|Lewis Katz School of Medicine at Temple University|Adam Nester, JD, MS|215-707-1986|coisom@temple.edu|
20179286|NCT02365519|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
20179287|NCT01971723|Florida State University|Dr. Michael J. Ormsbee|(850) 644-4793|mormsbee@fsu.edu|
20179288|NCT00657618|WRAIR|Roseanne A. Resnner, MD|301-295-6400|rose.resnner@us.armyh.mil|
20179289|NCT05774197|Harvard Medical School|Desiree Azizoddin, PsyD|4052718001|desiree_azizoddin@dfci.harvard.edu|50516
20179290|NCT05460325|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20179291|NCT05073133|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20179292|NCT05002218|Columbia University Irving Medical Center|Scott Barbuto, MD|518-275-9588|sb3779@cumc.columbia.edu|
20179293|NCT04120233|University of Kentucky|Dr. Linda J. Van Eldik|1-859-257-5566|linda.vaneldik@uky.edu|
20179294|NCT04981678|MaineHealth, Department of Anethesiology|Lead Research Coordinator|207-662-2862|janelle.richard@mainehealth.org|
20179295|NCT01984697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179296|NCT03810534|University of North Carolina at Chapel Hill|Mark Toles, MPH|919-966-5684|mtoles@email.unc.edu|
20179297|NCT03092375|UF Hepatology Research at CTRB|Lauren Morelli|3522739508|LAUREN.MORELLI@MEDICINE.UFL.EDU|
20179298|NCT00949715|Medtronic CRDM|Rachael Rose|763-526-2332|rachael.k.rose@medtronic.com|
20179299|NCT00861614|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20179300|NCT02243280|AbbVie|Global Medical Services|800-633-9110||
20179301|NCT01807156|Emory University|Bassel El-Rayes, MD|404-778-1900|bassel.el-rayes@emoryhealthcare.org|
20179302|NCT04372628|Vanderbilt University Medical Center|Clinical Trials Operations Manager|(615) 875-3080|kelly.walsh@vumc.org|
20179303|NCT01493687|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
20179304|NCT05067439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179305|NCT00705133|UC Los Angeles|Rajan Saggar|310-206-6766|rsaggar@mednet.ucla.edu|
20179306|NCT03135535|Baylor College of Medicine|Prof.|17137987536|bijan.najafi@bcm.edu|
20179307|NCT02323646|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20179308|NCT00521144|Memorial Sloan-Kettering Cancer Center|Dr. Lee Krug|646 888 4201|krugl@mskcc.org|
20179309|NCT01370525|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
20179310|NCT01207570|The Hong Kong Polytechnic University|Dr. Marco Pang|85227667156|Marco.Pang@inet.polyu.edu.hk|
20179311|NCT04791761|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
20179312|NCT01705496|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
20179313|NCT01559948|Texas Woman's University|Dr. Kelli Brizzolara|214-689-7722|kbrizzolara@twu.edu|
20179314|NCT00180479|Abbott Vascular|Ellen Travis, Clinical Science|408-845-1512|Ellen.Travis@av.abbott.com|
20179315|NCT00526630|University of Cincinnati|Alberto Espay, MD|513-403-4600|alberto.espay@uc.edu|
20179316|NCT05168579|University of Pittsburgh|Dr. Deepika Mohan|404-375-9325|dem73@pitt.edu|
20179317|NCT00840801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179318|NCT01242748|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20179319|NCT00335452|sanofi-aventis|Trial Information Transparency Team||GV-Contact-us@sanofi-aventis.com|
20179320|NCT02736825|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20179321|NCT02943941|Medtronic Inc|Verla Laager|(800) 328.2518|verla.l.laager@medtronic.com|
20179322|NCT00790452|UT MD Anderson Cancer Center|Victor A Levin, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
20179323|NCT02940574|KU Leuven|Prof. Dr. Kaat Alaerts|16 37 64 46|kaat.alaerts@kuleuven.be|+32
20179324|NCT03687190|Changhua Christian Hospital|Chung-Min Chiu|*886-982-506-067|shongdiah@gmail.com|
20179325|NCT01750879|Massachusetts General Hospital|Dr. Wayne Shreffler|617-726-6147|WSHREFFLER@mgh.harvard.edu|
20179326|NCT04810221|Life Meter Srl|Dr. Fernando De Benedetto/President|+39 391 4334 090|fernando.debenedetto@lifemetersrl.com|
20179327|NCT03642938|Duquesne University (now at University of Texas at Dallas)|Benedict Kolber|972-883-7225|Benedict.kolber@utdallas.edu|
20179328|NCT00105235|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20222764|NCT00441129|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20179329|NCT01964326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179330|NCT02347657|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20222765|NCT01737710|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20222766|NCT00812981|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222767|NCT00999609|Spark Therapeutics|Clinical Director||clinicaltrials@sparktx.com|
20222768|NCT00694473|Massachusetts General Hospital|Steven J Russell, M.D. PhD|617-726-8722|sjrussell@mgh.harvard.edu|
20222769|NCT02818946|Duke University|Sujata Ghate, MD|919-684-2711|sujata.ghate@duke.edu|
20222770|NCT04666259|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222771|NCT04178122|VA Boston Healthcare System|Morgan Danowski|617-595-5385|morgan.danowski@va.gov|
20222772|NCT02677922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20222773|NCT02905981|Rockwell Medical|Ray Pratt, MD|248 960-9009|rpratt@rockwellmed.com|405
20190891|NCT02168855|University of Arkansas|Dr. Brian Primack|479-575-3208|bprimack@uark.edu|
20222774|NCT02105987|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222775|NCT03004638|MedImmune LLC|Richard George|+1-301-398-5681|information.center@astrazenea.com|
20222776|NCT03926117|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20222777|NCT02705365|Massachusetts General Hospital|Sanja Percac-Lima, MD, PhD|617-643-6980|spercaclima@partners.org|
20222778|NCT01699373|Changi General Hospital|Dr Lim Yean Chin|+65 68503831|yean_chin_lim@cgh.com.sg|
20222779|NCT00086138|JHU|Paul Rosenberg|410-550-9883|prosenb9@jhmi.edu|
20222780|NCT02359955|Shanghai No. 9 People's Hospital|Dr. Haixin Qian|13501961651|drqian8167@126.com|
20222781|NCT02748356|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
20222782|NCT05107492|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190892|NCT02704156|Changhai Hospital affiliated to Naval Medical University|Huojun Zhang|86-021-31162207|chyyzhj@163.com|
20190893|NCT03584282|University of Washington|Dr. Joanne Stekler, Primary Investigator|(206) 744-8312|jstekler@uw.edu|
20190894|NCT00604461|H. Lee Moffitt Cancer Center and Research Institute|Tawee Tanvetyanon, M.D.|813-745-3050|tawee.tanvetyanon@moffitt.org|
20190895|NCT03689452|Icahn School of Medicine at Mount Sinai|Dr. Danielle P. Dubin|212-731-3311|DPDubin121@gmail.com|
20190896|NCT02676778|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20190897|NCT04992494|NYU Langone Health|Amanda Shallcross|646-501-3426|Amanda.Shallcross@nyulangone.org|
20190898|NCT01430299|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
20190899|NCT06466655|University of Delaware|Jody Greaney, PhD|3028312193|jgreaney@udel.edu|
20190900|NCT03214198|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20190901|NCT03686176|Johns Hopkins University|Therese Canares|4109964711|tcanare1@jhmi.edu|
20190902|NCT00515879|Boston University|Dr. Stefan G. Hofmann, Ph.D., Professor of Psychology|617 353 9233|shofmann@bu.edu|
20190903|NCT01154699|University of California San Diego|Robert L. Owens|8586575258|rowens@ucsd.edu|
20190904|NCT04295499|Unicon Optical Co., Ltd.|Dr. Jimmy Chou|+88635775586|ra@uniconvision.com.tw|1307
20190905|NCT03282071|The University of Hong Kong|Dr. Yuying Sun|(852)39179144|gyysun@hku.hk|
20190906|NCT00308113|University of Pittsburgh|Dr. Paula R. Clemens|412-648-9762|pclemens@pitt.edu|
20190907|NCT04448561|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20190908|NCT01613807|Sansum Diabetes Research Institute|Dr. Kristin Castorino|8056827640|kcastorino@sansum.org|256
20190909|NCT01612221|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
20190910|NCT04413149|Peking Union Medical College Hospital|Dr. Shi Juhong|+86-13701178492|Shijh@pumch.cn|
20190911|NCT01044901|The University of Chicago|Dr. Amit Patel, MD|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
20190912|NCT02661490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20190913|NCT02878590|InnoMed Healthscience|Javier Collazo|9547739656|jcollazo@innomedhs.com|
20190914|NCT03322514|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20190915|NCT01184859|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20190916|NCT00961298|Allegheny General Hospital|Alicia Kaplan MD|412-330-4069|akaplan@wpahs.org|
20190917|NCT00814632|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
20190918|NCT02004132|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20190919|NCT00282828|Rush University Medical Center|Mark Pollack, M.D.|312-942-5372|mark_pollack@rush.edu|
20190920|NCT02514577|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
20190921|NCT02388932|Cleveland Clinic, Case Comprehensive Cancer Center|Shlomo Koyfman, MD|216-444-7552|koyfmas@ccf.org|
20190922|NCT02132598|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
20190923|NCT00627523|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190924|NCT01093976|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
20190925|NCT00376935|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20190926|NCT00406276|Emory University|Dr.Suresh Ramalingam, MD|404-778-5378|ssramal@emory.edu|
20222783|NCT05236764|Baylor College of Medicine|Dr. Erin Morales|832-826-0860|erin.moralesubico@bcm.edu|
20222784|NCT05870371|Musculoskeletal Research Laboratory (MRL) of Physiotherapy Department University of West Attica, Athens, Greece|Dr. George Georgoudis|+30-210-5387487|physiolab@uniwa.gr|
20222785|NCT01873846|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
20222786|NCT03308097|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
20222787|NCT01099618|Emory University SOM|Dawn Smiley|4047781665|dsmiley@emory.edu|
20157572|NCT03708367|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan, PhD|+1 408 5335282|skasthur@ITS.JNJ.com|
20190927|NCT01038128|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
20190928|NCT02186015|Loyola University Chicago|Patricia Sheean|708-216-0344|psheean1@luc.edu|
20190929|NCT02333071|AMAG Pharmaceuticals|Medical Information|1-877-411-2510|amag@druginfo.com|
20222788|NCT00564850|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
20179331|NCT03708588|Aurora Health Care|Suhail Allaqaband, MD|414-469-3491|suhail.allaqaban@aah.org|
20179332|NCT02416492|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
20179333|NCT01621880|Sun Yat-sen Memorial Hospital, Sun Yat-sen University|Yamei Tang|08613556001992|yameitang@hotmail.com|
20179334|NCT01662063|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20179335|NCT01422135|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
20179336|NCT01477853|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179337|NCT00248781|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20179338|NCT00677352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179339|NCT01532128|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20179340|NCT00580814|UCaliforniaIrvine|Tim Wigal, Ph.D., director UCI CHild Development Center|949-824-1812|tlwigal@uci.edu|
20179341|NCT04044456|Malcom Randall VAMC|Health Science Specialist|352-376-1611|julia.waid-ebbs@va.gov|105224
20179342|NCT01972529|Eisai Inc|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
20179343|NCT01201811|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20179344|NCT00715429|University of Wisconsin School of Pharmacy|Dr. Mary Elliott|608-695-7501|meelliott@pharmacy.wisc.edu|
20179345|NCT04899245|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
20179346|NCT02073461|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
20179347|NCT03188055|University of Wisconsin, Madison|Margaret Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
20179348|NCT03017079|THE SECOND AFFILIATED HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE|Dr|18817821529|hm198699@126.com|
20179349|NCT03657277|University of Iowa|Nicole Brogden|3193358752|nicole-brogden@uiowa.edu|
20179350|NCT04349280|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179351|NCT04549363|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179352|NCT02286089|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20179353|NCT01387139|Ucolorado|Keith Weisz|303-724-2592|keith.weisz@childrenscolorado.org|
20179354|NCT03520322|University of Rochester Medical Center|Otolaryngology Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
20179355|NCT00791323|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20179356|NCT04620681|Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
20179357|NCT02235545|Abbott|Nicole Harbert, Program Director|1 972-526-4841|nicole.harbert@abbott.com|
20179358|NCT04647032|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
20179359|NCT02093663|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20179360|NCT00508404|Amgen Inc.|Study Director|866-572-6436||
20179361|NCT03662074|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-0230|saverill@wakehealth.edu|
20179362|NCT01424930|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20179363|NCT01566331|University of Padua|Dr. Erich Cosmi|+393398146745|ecosmi@hotmail.com|
20179364|NCT03685396|Azienda Ospedaliera San Paolo - Università degli Studi di Milano|Dr.Fulvio Gatti|3396441920|fudy@libero.it|
20179365|NCT01197508|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20179366|NCT01078155|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20179367|NCT03286751|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20179368|NCT01119768|AstraZeneca|Gerard Lynch||az_trials_posting@astrazeneca.com|
20179369|NCT01059643|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20179370|NCT01820559|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20179371|NCT01069354|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
20179372|NCT00166296|Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona|Crisanto Diez-Quevedo|+34934978814|cdiezquevedo.germanstrias@gencat.cat|
20179373|NCT03477279|University of North Carolina at Chapel Hill|Nora Rosenberg, PhD, MSPH|919-843-6580|nora_rosenberg@unc.edu|
20179374|NCT04035200|Imbrium Therapeutics|Medical Information|1-888-726-7535|Purduemedinfo@pharma.com|
20179375|NCT02277990|Medtronic|Daniel Lexcen, Sr. Clinical Program Manager|+17635269702|daniel.lexcen@medtronic.com|
20179376|NCT03351738|MedImmune, LLC|Richard George|+1-301-398-5681|information.center@astrazeneca.com|
20179377|NCT03997513|VA Pittsburgh Healthcare System|Dr. Jessica Bon Field|412-360-6823|jessica.field@va.gov|
20179378|NCT03821337|VA Medical Center|Program Manager|843-792-0476|lisa.nunn@va.gov|
20179379|NCT05479604|Mayo Clinic|Amar Miglani, M.D.|4803422929|miglani.amar@mayo.edu|
20179380|NCT02202746|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20179381|NCT03138733|Basilea Pharmaceutica|Dr Marc Engelhardt, MD|+41 79 701 0551|marc.engelhardt@basilea.com|
20179382|NCT04723823|University of Pittsburgh|Debbie Harrington, CCRP|412-383-1355|debbie.harrington@pitt.edu|
20179383|NCT05107960|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20179384|NCT03459287|Cerus Corp|Richard Benjamin, M.D., Ph.D.|925 288 6000|rbenjamin@cerus.com|
20179385|NCT03641313|Vanderbilt-Ingram Cancer Center|Jordan Berlin|6153434128|jordan.berlin@vumc.org|
20179386|NCT03033225|Mayo Clinic|Kenneth K. Wang, MD|507-284-2511|wang.kenneth@mayo.edu|
20179387|NCT00946296|UMass Medical School|Dr. Giles Whalen|508-334-5202|Giles.Whalen@umassmemorial.org|
20179388|NCT04283448|Montana State University|Mary P Miles|406 994-6678|mmiles@montana.edu|
20179389|NCT03434678|Memorial Sloan Kettering Cancer Center|Dr. Florence Grant, MD|212-639-8829|moses-gf@mskcc.org|
20179390|NCT05735587|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
20179391|NCT06060457|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20222789|NCT05682729|University of Dayton|Mary Wagner|9372292775|mwagner8@udayton.edu|
20179392|NCT02061202|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|212-241-3650|jeffrey.glassberg@mountsinai.org|
20222790|NCT05096403|Swedish Orphan Biovitrum AB|Luis López Lazaro|46733319155|luis.lopezlazaro@sobi.com|
20222791|NCT00652626|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20222792|NCT04003636|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20222793|NCT02058537|Temple University Hospital|Ron Schey|215-540-0120|Ron.schey@tuhs.temple.edu|
20222794|NCT02582242|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20157573|NCT01677988|Medical University of South Carolina|Paul O'Brien, MD|843-792-4271|obrienpe@musc.edu|
20179393|NCT01533493|Massachusetts General Hospital|Joseph Biederman|617-724-1743|jbiederman@partners.org|
20179394|NCT01456299|Ajou University|Dr.Kim|82-32-460-3400|kjyeop@ajou.ac.kr|
20179395|NCT00525525|University of California San Francisco|Michael D. Prados, MD, FACP|415-353-2383|pradosm@neurosurg.ucsf.edu|
20179396|NCT05614089|University of Pittsburgh|Dr. Jing Luo, MD, MPH, Associate Professor of Medicine|412-383-3559|luoj@pitt.edu|
20179397|NCT05163522|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179398|NCT01712477|Michigan State University|Chet A Morrison, M.D.|9897901001|chet.morrison@cmich.edu|
20179399|NCT02521285|UT MD Anderson Cancer Center|Robert S. Bresalier, MD- Professor, Gastroenterology Hepat & Nutr|(713) 745-4340|rbresali@mdanderson.org|
20179400|NCT02499679|HeartFlow|Sarah Mullen|650-241-1221|smullen@heartflow.com|
20179401|NCT05701995|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20179402|NCT00406133|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D., Director|813-975-8690|rbeck@jaeb.org|
20179403|NCT04880395|Fundación Huésped - Buenos Aires|Dr. María Inés Figueroa|+54 11 2120-9999|maria.figueroa@huesped.org.ar|
20179404|NCT04686422|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20179405|NCT00227617|UCSF Helen Diller Family Comprehensive Cancer Center|Dr. Emily Bergsland|415-885-7810|Emily.Bergsland@ucsf.edu|
20179406|NCT01542957|Universitat de Barcelona|Prof. Guillem Feixas|0034 933125100|gfeixas@ub.edu|
20179407|NCT00689026|Georgia Regent University|Dr. Sherman M. Chamberlain, Professor of Medicine|706-721-2238|schamberlain@gru.edu|
20179408|NCT01666808|Emory University|Dr. Ashesh Jani|404-778-3827|abjani@emory.edu|
20179409|NCT03933826|University of Washington|Dr. John Gore|206-543-9926|cistopm@uw.edu|
20179410|NCT04992546|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20179411|NCT04506775|UMass Chan Medical School|J. Aaron Scott, DO|774-303-4156|jamesaaron.scott@umassmemorial.org|
20179412|NCT00818116|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20179413|NCT03934736|Dynavax Technologies Corporation|Robert Janssen, MD, Senior Vice President & Chief Medical Officer|5106650414|rjanssen@dynavax.com|1414
20179414|NCT00500903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20179415|NCT05096156|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD MS, Principal Investigator|16142928858|OPT-EyeStudies@osu.edu|
20179416|NCT01648348|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-1370|galanis.evanthia@mayo.edu|
20179417|NCT00995072|ECIR|Benjamin Epstein, PharmD|904-854-1354|benjamin.epstein@eastcoastresearch.net|
20179418|NCT03063294|Veterans Affairs Greater Los Angeles Healthcare System|David Avram Ganz, MD, PhD|310-478-3711|David.Ganz@va.gov|
20179419|NCT05340855|Mayo Clinic|Christi A Patten, Ph.D.|507-266-2554|patten.Christi@mayo.edu|
20179420|NCT03407794|University of North Florida|Andrea Arikawa|9044798995|andrea.arikawa@unf.edu|
20179421|NCT01811212|The Ohio State University Compreshive Cancer Center|Manisha Shah, MD|614-366-6994|manisha.shah@osumc.edu|
20179422|NCT03419364|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
20179423|NCT00552084|Vanderbilt University Medical Center|Dr. C Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
20179424|NCT01338025|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20179425|NCT00566579|Department of OBGYN, Faculty of Medicine, Khon Kaen University, 40002, THAILAND|Bandit Chumworathayi|66818733327|bunchu@kku.ac.th|
20179426|NCT03779906|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director Medical Planning and Management X-ray products|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
20179427|NCT02553460|Lucile Packard Children's Hospital|Tanja A. Gruber, MD, PhD|(650) 723-5535|tagruber@stanford.edu|
20179428|NCT01936896|Virginia Commonwealth University|Antonio Abbate|8048280513|antonio.abbate@vcuhealth.org|
20179429|NCT04737109|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20179430|NCT02287350|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
20179431|NCT01582789|CooperVision, US|Don Siegel, OD|623-544-3877|dsiegel@coopervision.com|
20179432|NCT02276066|University of Florida Board of Trustees Contracts & Grants|Mark S. Segal|352-273-5357|segalms@medicine.ufl.edu|
20179433|NCT05050578|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20179434|NCT05377359|Sonova|Bilal Sheikh, Research Audiologist|2268083260|bilal.sheikh@sonova.com|
20179435|NCT03386032|The Procter & Gamble Company|Laurie Moulton, M.S., Statistical Group Scientist|+1-513-544-3636|moulton.lt@pg.com|
20179436|NCT03276637|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
20179437|NCT04082442|Johns Hopkins University|Thorsten Leucker, MD|410-502-0469|tleucke1@jhmi.edu|
20179438|NCT02710292|Alcon Japan Ltd.|Clinical Manager|1-888-451-3937|alcon.medinfo@alcon.com|
20179439|NCT03122119|Star Spine and Sports|Dr. Douglas Hemler, Prinical Investigator|3035701834|dhemler@starcolorado.com|
20179440|NCT01920282|Virginia Tech|Dr. Kevin Davy|(540) 231-3487|kdavy@vt.edu|
20190930|NCT01533181|H. Lee Moffitt Cancer Center and Research Institute|Dr. Alberto Chiappori|813-745-2158|alberto.chiappori@moffitt.org|
20222795|NCT00300885|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20179441|NCT02803125|VA Boston Healthcare System|Anica Pless Kaiser, PhD|857-364-5309|Anica.PlessKaiser@va.gov|
20179442|NCT02364180|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
20179443|NCT01783418|Ste-Justine's Hospital|Catherine Malboeuf-Hurtubise, Post-doctoral fellow|514-343-6111|catherine.malboeuf-hurtubise@umontreal.ca|4594
20179444|NCT00089141|Fred Hutchinson Cancer Research Center (FHCRC)|Paul J. Martin, M.D.|206-667-4798|pmartin@fhcrc.org|
20179445|NCT00508261|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222796|NCT00603902|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20222797|NCT02101736|The University of Alabama at Birmingham|Karen Cole-Plourde, Program Director -NFCTC|(205) 514-1317|kplourde@uab.edu|
20222798|NCT00459290|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
20162379|NCT01329939|North Shore - Long Island Jewish Health System; Hofstra North Shore-LIJ School of Medicine|Dr. Sherry Farzan, Attending Physician, Assistant Professor of Medicine and Pediatrics|5166225070|sfarzan@nshs.edu|
20162380|NCT01966445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20222799|NCT03691207|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
20179446|NCT02901626|Christiana Care Health System, Department of Obstetrics & Gynecology|Matthew Hoffman, MD, MPH|(302) 301-3350|mhoffman@christianacare.org|
20179447|NCT04082884|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
20179448|NCT01007656|PingTung Christian Hospital Ruiguang Branch|Dr. Choo-Aun Neoh|886-8-736-8686|neohca@gmail.com|5310
20179449|NCT04857034|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20179450|NCT00387894|University of California San Francisco|Michael Prados, MD|415-353-7500|PradosM@neurosurg.ucsf.edu|
20179451|NCT00659490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20179452|NCT05674890|University of Iowa Hospitals and Clinics Department of Ophthalmology and Visual Sciences|Dr. Andrew Pouw|3193562928|andrew-pouw@uiowa.edu|
20179453|NCT00827541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179454|NCT01649232|Spanish Neurometrics Foundation|Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation|+34 634548720|moises.aguilar@gmail.com|
20179455|NCT02421666|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|2157078823|grace.ma@temple.edu|
20179456|NCT00246337|Merck Sharp & Dohme Corp|Vice President of Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
20179457|NCT00338598|Yale University|Elizabeth Ralevski Assistant Professor of Psychiatry|+1 203-932-5711|elizabeth.ralevski@yale.edu|4282
20179458|NCT03525548|Vertex Pharmaceuticals Incorporated|Medical Monitor|617 341 6777|medicalinfo@vrtx.com|
20179459|NCT01226511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20179460|NCT02032212|Imperial Tobacco Group|Tanvir Walele|0044 177 933 7589|tanvir.walele@uk.imptob.com|
20179461|NCT02579876|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
20179462|NCT01537302|Austin Heart|Matthew Selmon, MD|512-788-2692|matthew.selmon@hcahealthcare.com|
20179463|NCT00106184|University of Pittsburgh|Chester V. Oddis, MD|412-383-8861|cvo5@pitt.edu|
20179464|NCT02162680|Duke University Medical Center|Julia Aucoin, DNS|1 919 613 6406|julia.aucoin@dm.duke.edu|
20179465|NCT02313909|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20179466|NCT01583686|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
20179467|NCT00643123|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
20179468|NCT05292534|Sonova|Dr. Ieda Ishida|6472847562|ieda.ishida@sonova.com|
20179469|NCT01538472|University of Texas (UT) MD Anderson Cancer Center|Issa Khouri, MD / Professor, Stem Cell Transplant|713-745-2803|CR_Study_Registration@mdanderson.org|
20179470|NCT02309112|University of Oxford|Marcy McCall, Lead Researcher|+441865 289300|marcy.mccall@kellogg.ox.ac.uk|
20222800|NCT01202578|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20162381|NCT00524017|SKCCC|Dr. Zubair Khan|4109553157|zkhan@jhmi.edu|
20162382|NCT00117793|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
20162383|NCT01753401|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20162384|NCT01463202|Center for Family Planning Research|Principal Investigator|412-641-5496|fpr@upmc.edu|
20162385|NCT02825212|Icahn School of Medicine at Mount Sinai|Dr. Peter D. Gorevic|212-241-0968|peter.gorevic@mountsinai.org|
20222801|NCT01134107|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20222802|NCT00687271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222803|NCT05483686|ISA Associates, Inc.|Dr. Samantha Leaf|703-739-0880|sleaf@isagroup.com|4
20222804|NCT05780983|Wake Forest University Health Sciences|Jaime M Hughes, PhD, MPH, MSW|336-716 -0835|jane.hughes@wfusm.edu|
20222805|NCT04747886|Cedars-Sinai Medical Center|Dr. Sarah-Jeanne Salvy|310-423-6423|sarah.salvy@cshs.org|
20222806|NCT03777436|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20222807|NCT00685399|Novartis Pharmaceuticals|Study Director|862-778-8300||
20222808|NCT01998932|Imperial College London|Miss Sarah Onida|: +44 (0) 20 3311 7335|s.onida@imperial.ac.uk|
20222809|NCT00656292|Mayo Clinic|Michael J. Brown, M.D.|507-284-6317|Brown.Michael3@mayo.edu|
20222810|NCT03674112|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20162386|NCT03286283|Apyx Medical (formerly Bovie Medical Corporation)|Shawn Roman/Vice President of Research and Development|1-727-384-2323|shawn.roman@apyxmedical.com|
20162387|NCT03688100|Cedars-Sinai Medical Center|Dr. Waguih IsHak|310-423-3515|Waguih.IsHak@cshs.org|
20222811|NCT03451591|University of Edinburgh|Prof Joanna Wardlaw|0131 465 9599|joanna.wardlaw@ed.ac.uk|
20222812|NCT00214786|Baylor University Medical Center|Dr. Marlon Levy|214-820-2050|Marlon.Levy@baylorhealth.edu|
20179471|NCT02133872|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
20179472|NCT02923739|M D Anderson Cancer Center|Dr. Anil Sood|713-745-5266|asood@mdanderson.org|
20179473|NCT02573402|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|(713) 797-5007|Argyrios.Stampas@uth.tmc.edu|
20179474|NCT02623855|UCSF Benioff Children's Hospital Oaland|Dr. Nooshin Razani, Principal Investigator|415-428-3129|nrazani@mail.cho.org|
20179475|NCT00948974|Drexel University|Evan Forman|215.553.7113|evan.forman@drexel.edu|
20179476|NCT02231177|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20179477|NCT03581084|UCSF Airway Clinical Research Center|Ariana Lowman|14155141539|ariana.baum@ucsf.edu|
20179478|NCT02857426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20179479|NCT01155154|SUNY Downstate Medical Center|Shahriar Zehtabchi|718-245-2973|shahriar.zehtabchi@downstate.edu|
20179480|NCT02634788|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20179481|NCT00758459|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20179482|NCT01238640|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhaue@its.jnj.com|
20179483|NCT02831257|Massachusetts General Hospital|Scott Plotkin|617-724-5369|splotkin@mgh.harvard.edu|
20179484|NCT00611858|Dana-Farber Cancer Institute|Jeffrey Meyerhardt, MD, MPH|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
20179485|NCT02703922|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
20179486|NCT00717860|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20179487|NCT04058353|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20179488|NCT01266447|NRG Oncology|Linda Gedeon, Clinical Data Coordinator|716-845-1169|lgedeon@gogstats.org|
20179489|NCT01728792|Takeda|Takeda Study Registration Call Center, Central Contact|+1-877-825-3327|medicalinformation@tpna.com|
20179490|NCT03559218|KeraNetics|Ryan Clohessy, PhD|4102513940|rclohessy@keranetics.com|
20179491|NCT04277455|Mercy Research|Dr. Johnson Thomas|417-888-5660|johnson.thomas@mercy.net|
20179492|NCT02760056|OHSU|Anna Orban|503-494-3549|orban@ohsu.edu|
20179493|NCT01679301|Philips Respironics|Chuck Cain|+1 724 7335835|chuck.cain@philips.com|
20179494|NCT01042509|Hospital Universitario|Dr. David Gomez-Almaguer|5281-83488510|hematohu@yahoo.com|
20179495|NCT01564368|American College of Radiology|Senior Director Clinical Research Administration|215-574-3150|info@acr.org|
20179496|NCT00691808|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug safety|281-863-3000||
20179497|NCT01802437|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
20179498|NCT02228967|San Diego State University Research Foundation|Mark B. Reed/Professor and Interim Associate Dean|619-594-6664|mreed@sdsu.edu|
20179499|NCT00520975|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
20179500|NCT01446666|Asan Medical Center, University of Ulsan College of Medicine|Professor Young-Suk Lim|+82-02-3010-5933|limys@amc.seoul.kr|
20179501|NCT00238433|Oregon Health & Science University|Richard Maziarz, MD|503-494-6365|maziarzr@ohsu.edu|
20179502|NCT00053495|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
20179503|NCT00409682|Abbott|Global Medical Services|800-633-9110||
20179504|NCT05711537|Wake Forest School of Medicine|Heather Columbano, MD|336-716-4498|hcolumba@wakehealth.edu|
20179505|NCT01896869|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
20179506|NCT01691833|Carolinas Healthcare System|Dr. Rachel Seymour|704-355-2000|Rachel.Seymour@carolinas.org|
20179507|NCT03319537|Memorial Sloan Kettering Cancer Center|Dr. Marjorie Zauderer, MD|646-608-3790|zauderem@mskcc.org|
20179508|NCT00252538|VA Long Beach Healthcare System|Peter Hauser|562 826 8000|peter.hauser2@va.gov|2629
20179509|NCT04710927|University Malaya Kuala Lumpur, Malaysia|Dr Tengku Nurfarhana Nadirah Tengku Hamzah|0379674802|tengkunurfarhana@um.edu.my|4865
20179510|NCT00118716|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179511|NCT00801801|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
20179512|NCT00855062|Harvard School of Public Health|Sachiko Miyahara|617-432-2837|miyahara@sdac.harvard.edu|
20179513|NCT03357614|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
20179514|NCT00530062|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20179515|NCT03059901|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
20179516|NCT00454571|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
20179517|NCT01376323|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179518|NCT04681729|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20179519|NCT02436811|Universidade Federal do Paraná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
20179520|NCT03595332|Northern Arizona University|Dr. Hendrik de Heer|9285231499|dirk.deheer@nau.edu|
20179521|NCT02227875|Mylan, Inc.|Keri L. Vaughan, Director Global Clinical Operations, General Medicine||keri.vaughan@mylan.com|
20179522|NCT04209725|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20179523|NCT03494166|University of Arizona College of Nursing|Terry Badger, PhD (MPI) and Alla Sikorskii, PhD (MPI)|520-626-6058|tbadger@arizona.edu|
20179524|NCT02470494|Earlens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650-739-4447|Suzanne.Levy@Earlens.com|
20179525|NCT00855595|Intendis GmbH|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20179526|NCT01780935|Novartis Pharmaceuticals|Study Director|862-778-8300||
20190931|NCT01837719|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20179527|NCT01844284|Abbott Vascular|Hajime Kusano|408-845-1626|hajime.kusano@av.abbott.com|+1
20179528|NCT00723099|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
20179529|NCT02755597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20179530|NCT03643224|Medtronic CAS|Josman Suri|7635050262|josman.suri@medtronic.com|
20179531|NCT02098538|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
20179532|NCT04252742|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20179533|NCT04179032|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179534|NCT06289192|Johns Hopkins University|Alejandra Ellison-Barnes|n/a|aelliso6@jhmi.edu|
20179535|NCT02753595|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20179536|NCT01570868|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20179537|NCT02453581|Qeensland Institute of Medical Research|Dr James McCarthy|+61 7 3845 3796|James.McCarthy@qimr.edu.au|
20179538|NCT03937219|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20179539|NCT03899753|Montefiore Medical Center|Konrad Gruson, MD|3475774412|kgruson@montefiore.org|
20179540|NCT02515279|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20179541|NCT01800968|Duke Clinical Research Institute|Adrian Hernandez, MD|919-668-7515|adrian.hernandez@duke.edu|
20179542|NCT02257099|UBMD Orthopaedics and Sports Medicine|John Marzo, MD|7168292982|jmmarzo@buffalo.edu|
20179543|NCT03185481|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179544|NCT02303184|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20179545|NCT02620917|University of Padova|Daniela Bruttomesso|0039 049/8212183|daniela.bruttomesso@unipd.it|
20179546|NCT02044991|Loyola University|Colleen Fitzgerald, M.D., M.S.|708-216-2180|cfitzgerald@lumc.edu|
20179547|NCT00701038|The Ohio State Universtiy|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
20179548|NCT01398280|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
20179549|NCT00057551|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
20179550|NCT03371940|Indiana University School of Medicine|Dr. Mary de Groot|317-278-1965|mdegroot@iu.edu|
20179551|NCT02362048|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20179552|NCT05099926|Columbia University Irving Medical Center|Dr. Andrea T. Duran|212-342-4491|atd2127@cumc.columbia.edu|
20179553|NCT04475432|Tarsus Pharmaceuticals, Inc.|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
20179554|NCT00504426|Headwuarters of New Product Evaluation and Development, Otsuka Pharmaceutical Co., Ltd.|IMAOKA, Kyoji, Operatin Officer, Gemeral Manager|+81-3-6361-7366||
20179555|NCT04029129|UConnHealth|Dr. Douglas Brugge|860-679-8814|brugge@uchc.edu|
20179556|NCT02003508|Melbourne Sexual Health Centre|A/Prof Marcus Chen|+613 93416260|mchen@mshc.org.au|
20179557|NCT00031486|University of Alabama at Birmingham|Penny Jester|(877) 975-7280|pjester@peds.uab.edu|
20179558|NCT03685591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179559|NCT01714804|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
20179560|NCT01685138|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20179561|NCT02068495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20179562|NCT03988166|Teleflex|Ricardo De Medeiros, Director Scientific Clinical Affairs|612.812.5008|ricardo.demedeiros@teleflex.com|
20179563|NCT00944047|University of Kansas Cancer Center|Dr. Qamar Khan|(913) 588-6029|ctnursenav@kumc.edu|
20179564|NCT02220894|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179565|NCT05390970|University of Iowa Healthcare|Dr. Annah J. Vollstedt|712-253-1627|annah-vollstedt@uiowa.edu|
20179566|NCT03538015|University of Utah|Dr. Owen Chan|801-581-7755|ochan@u2m2.utah.edu|
20179567|NCT00698646|Novartis Pharmaceuticals|Study Director|862-778-8300||
20179568|NCT00511875|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
20179569|NCT01349920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179570|NCT01951638|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20179571|NCT03479697|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
20179572|NCT00766675|Janssen Pharmaceutics Taiwan|Medical Affairs Director|+886-2-23762155||
20179573|NCT03308825|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
20179574|NCT02044848|Novartis Pharmaceuticals|Study Director|862-778-8300||
20179575|NCT00045708|Johns Hopkins - Adult Brain Tumor Consortium (ABTC)|Director Adult Brain Tumor Consortium|410-955-8837|jfisher@jhmi.edu|
20179576|NCT00278538|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20179577|NCT00685945|Vanderbilt University|Dr. Mias Pretorius|615-343-0665|mias.pretorius@vanderbilt.edu|
20179578|NCT03183388|Yale School of Medicine|Dr. Hilary Blumberg|203-785-6180|hilary.blumberg@yale.edu|
20179579|NCT04716413|Montefiore Medical Center|Dr. Naum Shaparin|718-920-4316|nshapari@montefiore.org|
20179580|NCT01493960|Index Pharmaceuticals|Dr Thomas Knittel|0046 8 508 847 31|thomas.knittel@indexpharma.com|
20179581|NCT00249249|Kowa Research Europe, Ltd.|Dr Neil Hounslow|+44 118 922 9004|nhounslow@kowa.co.uk|
20179582|NCT01679236|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
20179583|NCT05418777|William Beaumont Hospitals|Maureen Cooney, RN Clinical Research Manager|2485510099|maureen.cooney@corewellhealth.org|
20179584|NCT03935217|Lupin Pharmaceuticals|Director of Clinical Operations|443-301-3146|jackieshaw@lupin.com|
20179585|NCT00847405|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20179586|NCT02259517|Duke University|Jonathan Posner, MD|1 919 684 2403|jonathan.posner@duke.edu|
20179587|NCT02305381|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20222813|NCT02560922|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20222814|NCT02684097|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
20222815|NCT00462709|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20222816|NCT02064816|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20222817|NCT04468347|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20222818|NCT01732458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222819|NCT04339062|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617-632-3090|glenn_hanna@dfci.harvard.edu|
20222820|NCT03218826|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20222821|NCT01197534|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20222822|NCT05630287|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
20222823|NCT04873869|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
20222824|NCT02589639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222825|NCT00703157|Medtronic Bakken Research Center, Coronary and Structural Heart Disease Management|Ber Kleijnen|+31 (0) 43 356 6566|ber.kleijnen@medtronic.com|
20222826|NCT00347009|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222827|NCT02522884|Intact Vascular, Inc.|Joseph C. Griffin, III|4842531048|JGriffin@intactvascular.com|1043
20222828|NCT04495751|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|hklepin@advocatehealth.org|
20222829|NCT03289754|restor3d, Inc.|Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
20222830|NCT04873934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222831|NCT00708461|University of Minnesota|Jennifer A. Linde, Ph.D.|612-624-0065|linde074@umn.edu|
20222832|NCT01786161|Massachusetts General Hospital|Hsin Lin|6177241314|hlin13@mgh.harvard.edu|
20222833|NCT00580151|University of Texas-Galveston|Walter Meyer, M.D.|409-770-6718|wmeyer@utmb.edu|
20222834|NCT01934582|United Therapeutics Corp.|Global Medical Information|919-425-8350|clinicaltrials@unither.com|
20222835|NCT03584854|University of Chicago|Dr. Naida Cole|773-702-6700|nmcole@bsd.uchicago.edu|
20222836|NCT02907177|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20222837|NCT01453088|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20222838|NCT02968173|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20222839|NCT02670525|Dana-Farber Cancer Institute|Dr. Yana Pikman|6176324754|yana_pikman@dfci.harvard.edu|
20222840|NCT01796392|Pulmonx Corporation|Narinder Shargill|650-216-0108|nshargill@pulmonx.com|
20222841|NCT02505217|University of Vermont|David J Schneider, MD|802-656-8955|david.schneider@uvm.edu|
20222842|NCT04639219|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20222843|NCT04681066|CalciMedica|Sudarshan Hebbar (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
20179588|NCT00514683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20179589|NCT01163643|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20179590|NCT04998604|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20179591|NCT00642902|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20179592|NCT00429663|Boston Medical Center|Paul Tornetta III, MD|617-414-6295|paul.tornetta@bmc.org|
20179593|NCT05383417|University of California San Diego Health|Dr. Andrew Vahabzadeh-Hagh|858-249-4070|avahabz@health.ucsd.edu|
20179594|NCT02466646|Marmara University Faculty of Dentistry, Department of Periodontology|Prof. Dr. Basak Dogan|00905332621170|basak.sdogan@gmail.com|
20179595|NCT03953898|Yale School of Medicine|Rory Shallis, MD|(203) 200-4363|rory.shallis@yale.edu|
20179596|NCT03261271|University of Kansas Medical Center|Dr. Jill Hamilton-Reeves|913-588-7650|jhamilton-reeves@kumc.edu|
20179597|NCT03420781|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20179598|NCT05267600|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20179599|NCT04067401|University of Rochester Medical Center, Psychiatry Dept|Dr. Peter Wyman|5852733372|peter_wyman@urmc.rochester.edu|
20179600|NCT02167217|Washington University School of Medicine|Anne M. Connolly, MD FAAN|314-362-6981|connollya@wustl.edu|
20179601|NCT01889186|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20179602|NCT01804101|Fred Hutchinson Cancer Center|Dr. Roland B. Walter|206-667-3599|rwalter@fredhutch.org|
20222844|NCT00953654|The University of Georgia|Matthew P. Herring, PhD|706-542-4381|mph8@uga.edu|
20222845|NCT03111940|Oxford Heart Centre, John Radcliffe Hospital|Prof Adrian Banning|01865 228934|Adrian.Banning@ouh.nhs.uk|
20222846|NCT03517540|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20179603|NCT02657317|University of Texas Health Science Center at San Antonio|Donald McGeary, PhD|210-567-5454|mcgeary@uthscsa.edu|
20179604|NCT02856113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20179605|NCT01960725|Duke University School of Medicine|Dr. Dennis Clements|919-684-7790|dennis.clements@duke.edu|
20179606|NCT02110901|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
20179607|NCT02489110|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
20179608|NCT03467932|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
20179609|NCT01058304|Health Services Research & Development, Durham VAMC|Kelli D. Allen|919-286-0411|kelli.allen@va.gov|7090
20206489|NCT01654523|University of Michigan|Joseph Himle - Professor|7343303258|himlej@umich.edu|
20222847|NCT01205269|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20179610|NCT02496767|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20179611|NCT02889133|Columbia University Medical Center|Dr. Eldad Hod|212-305-4109|eh2217@cumc.columbia.edu|
20179612|NCT04711603|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
20179613|NCT01089374|Dartmouth-Hitchcock Medical Center|Dr. Richard Barth|603-650-9479|Richard.J.Barth.Jr@hitchcock.org|
20179614|NCT01591382|Brigham and Women's Hospital|Dr. Srdjan S. Nedeljkovic||snedeljkovic@partners.org|
20179615|NCT02969837|University of Chicago|Member of the Biostatistics Lab|773.702.2453|slee@health.bsd.uchicago.edu|
20179616|NCT05887947|University of Kansas Medical Center|Eleanor Leavens|913-945-7875|eleavens@kumc.edu|
20179617|NCT02597036|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20179618|NCT04421092|Medical University of South Carolina - Department of Otolaryngology|Shaun A. Nguyen, MD - Director of Clinical Research|8437921356|nguyensh@musc.edu|
20179619|NCT06351371|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20222848|NCT01207687|Johns Hopkins Comprehensive Neurofibromatosis Center|Dr. Jaishri Blakeley|410-614-3853|jblakel3@jhmi.edu|
20222849|NCT00987337|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20222850|NCT01801865|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
20222851|NCT02134015|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|DataSharing@dsi.com|
20222852|NCT01022307|VANCHCS|David L. Woods, Chief Clinical Neurophysiology|925-372-2571|David.Woods@va.gob|
20222853|NCT03867201|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20162388|NCT04783077|University of Minnesota|Susan Telke|6125902697|telke001@umn.edu|
20162389|NCT01141491|MabVax Therapeutics, Inc.|Dave Hansen|858.259.9405|dhansen@mabvax.com|301
20162390|NCT02453555|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20162391|NCT03045341|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
20162392|NCT02409719|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
20162393|NCT02479139|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
20162394|NCT00764673|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
20162395|NCT00849862|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20162396|NCT01727336|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162397|NCT00619099|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
20162398|NCT00885482|Catholic University of S. Heart|Andrea De Luca|+390630155366|deluca.andrea@fastwebnet.it|
20162399|NCT00084656|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20162400|NCT01532869|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20162401|NCT01026220|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20162402|NCT00778895|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162403|NCT04684992|Cairn Diagnostics|Chief Scientist and Compliance Officer|615-376-5464|cwilliams@cairndx.com|
20162404|NCT03776461|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20162405|NCT02953886|University of Michigan|Emily Yanca|734-763-3988|emthorpe@umich.edu|
20162406|NCT02163421|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20162407|NCT01009086|Janssen Research & Development, LLC|Director, Clinical Research|1-800-526-7736||
20162408|NCT01389323|BristolMyers Squibb|BristolMyers Squibb Study Director||Clinical.Trials@bms.com|
20162409|NCT02647346|Podimetrics Inc|Brian Petersen|860-558-9204|brian@podimetrics.com|
20162410|NCT01192828|University of Colorado Denver|Dr. Johan Van Hove, Primary Investigator|303-724-2338|johan.vanhove@childrenscolorado.org|
20162411|NCT03040115|University of Cincinnati|Elizabeth Kopras, Senior Research Associate|513-558-7205|koprasej@uc.edu|
20162412|NCT02533726|Stanford University School of Medicine|Dr David Pickham|650 701 6830|dpickham@stanford.edu|
20162413|NCT01147848|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222854|NCT04138498|Cingulate Therapeutics|VP of Clinical Operations and Regulatory Affairs|913-942-2304|hmitzel@cingulatetherapeutics.com|
20162414|NCT01919216|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
20179620|NCT01849263|Washington University School of Medicine|Nancy L. Bartlett, M.D.||nbartlet@dom.wustl.edu|
20162415|NCT01417455|Instituto de Medicina Molecular|João Eurico Fonseca|+351217999544|jecfonseca@gmail.com|47221
20179621|NCT04359784|Fred Hutchinson Cancer Center|Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
20179622|NCT04130802|Oculis SA|Chief Development Officer|0041 21 711 39 70|info@oculis.com|
20179623|NCT00438880|Mayo Clinic Cancer Center|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
20179624|NCT01345721|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20179625|NCT00985010|Materno-Perinatal Hospital of the State of Mexico|Hugo Mendieta Zerón|+52-722-2176605|mezh_74@yahoo.com|
20179626|NCT02390531|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
20179627|NCT02618616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20179628|NCT04225988|Cedars Sinai Medical Center|Dr. Edmund Huang, MD|310-423-2641|edmund.huang@cshs.org|
20179629|NCT05361655|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20179630|NCT04839354|Emory University|Claudia Morris, MD|404-785-7141|claudia.r.morris@emory.edu|
20179631|NCT05650164|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20179632|NCT00284141|Sanofi|Trial Transparency Team||Contact-Us@Sanofi.com|
20179633|NCT00201864|The Ohio State University|Ewa Mrozek|614-293-7956|Ewa.Mrozek@osumc.edu|
20179634|NCT00071721|Alzheimer's Disease Cooperative Study|Paul Aisen|858-622-2028|paisen@ucsd.edu|
20179635|NCT02882711|The University of Texas Health Science Center at Houston|Salih Selek, M.D.|713-741-3936|salih.selek@uth.tmc.edu|
20179636|NCT02597790|David Geffen School of Medicine at UCLA|Kara Chew, MD, MS|310-825-0796|kchew@mednet.ucla.edu|
20179637|NCT00299000|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
20179638|NCT02412501|Medtronic Coronary/Structural Heart|Beth Moe, Clinical Study Manager|763-526-1184|beth.moe@medtronic.com|
20179639|NCT01160484|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
20179640|NCT01782742|Cleveland Clinic Lou Ruvo Center for Brain Health|Jeffrey Cummings, MD, ScD|702.483.6029|cumminj@ccf.org|
20179641|NCT00803101|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20179642|NCT01909570|University Hospital Virgen de las Nieves|Dr. Ana Clavero|0034958020482|anaclaverogilabert@gmail.com|
20179643|NCT02790073|Sanifit|Rekha Garg MD MS|18582815978|rekha.garg@sanifit.com|
20179644|NCT04170686|University of Pennsylvania|Dr. Melissa G. Hunt|610-529-8055|mhunt@psych.upenn.edu|
20179645|NCT03328143|Aurora Neuroscience Innovation Institute|Richard A Rovin, MD|4143851922|richard.rovin@aurora.org|
20179646|NCT02882282|MD Anderson Cancer Center|Renata Ferrarotto, MD|713-792-6363|rferrarotto@mdanderson.org|
20179647|NCT02487498|Novartis Pharmaceuticals|Study Director|862-778-1873||
20222855|NCT05763875|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222856|NCT01777282|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222857|NCT02186873|Johnson&Johnson|Senior Director Clinical Development, Immunology General||ClinicalTrialDisclosure@its.jnj.com|
20222858|NCT03694002|SWOG Statistics and Data Management Center|Study Statistician|2066672894|mhsieh@fredhutch.org|
20222859|NCT05678959|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20222860|NCT04850989|National University of Singapore|Nur Hani Zainal|+65 6516 3749|hanizainal@nus.edu.sg|
20222861|NCT04722315|Kennedy Krieger Institute|Dr. Jacqueline Harris|6672054295|harrisjac@kennedykrieger.org|
20222862|NCT01481766|Hospital for Sick Children, Toronto, Canada|Dr. Patricia Parkin|416-81307654|patricia.parkin@sickkids.ca|
20222863|NCT00347958|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20222864|NCT03868930|VA Boston Healthcare System|Dr. Catherine B. Fortier|857-364-4361|Catherine.Fortier@va.gov|
20222865|NCT06047366|Indiana University School of Dentistry|Dr. Ken Spolnik|317-274-7280|kspolnik@iu.edu|
20222866|NCT04033237|University of Vermont|Sarah H. Heil, PhD|802-656-8712|Sarah.Heil@uvm.edu|
20222867|NCT04704050|Tulane University|Nassir Marrouche|504-988-2025|nmarrouche@tulane.edu|
20222868|NCT02151851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20222869|NCT02159053|Novartis Pharmaceuticals|Study Director|8627788300||
20222870|NCT01540487|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20222871|NCT00617890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222872|NCT03503370|Baltimore VA Medical Center|Dr. Mary-Claire Roghmann|(410) 706-0062|Mary-Claire.Roghmann@va.gov|
20222873|NCT03483961|Emergent BioSolutions|Sharmila Rajendran|650-486-0244|rajendras@ebsi.com|
20179648|NCT00676130|Brigham and Women's Hospital|Daniel J. Pallin, MD, MPH|617-525-6614|dpallin@partners.org|
20179649|NCT01861574|Medical University of South Carolina|JEFFREY J BORCKARDT|(843)792-3295|borckard@musc.edu|
20179650|NCT00331344|Oakland Medical Center|Andrea Harzstark, M.D.|510-752-6789|andrea.l.harzstark@kp.org|
20222874|NCT02640950|Sheppard Pratt Health System|Director of Clinical Research|4109383125|saaronson@sheppardpratt.org|
20222875|NCT04545489|Durham VA Health Care System|Dr. Hayden Bosworth, PhD|919-286-0411|Hayden.Bosworth@va.gov|177101
20222876|NCT01234870|Northwestern University|Dr. James Carr|(312)695-4218|jcarr@northwestern.edu|
20222877|NCT04134767|Rollins School of Public Health at Emory University|Dr. Hannah LF Cooper|404-727-0261|hcoope3@emory.edu|
20222878|NCT00638404|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
20222879|NCT02453334|American Regent, Inc|Mark A. Falone, MD MPH|631-772-3544|mfalone@americanregent.com|61844
20222880|NCT02362672|Nektar Therapeutics|Medical Affairs||StudyInquiry@nektar.com|
20190932|NCT01703988|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20157574|NCT00928772|VAMC|Grigory Chernyak, MD|405-326-1885|grigory.chernyak@va.gov|
20190933|NCT02995733|Brigham and Women's Hospital|Dr. Elliot Israel|617-732-8110|eisrael@bwh.harvard.edu|
20222881|NCT02693106|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20179651|NCT04538144|Institute for Exercise and Environmental Medicine|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
20179652|NCT01342458|University of Sao Paulo|Dr. Francis Trombini-Souza|55 11 3091 8426|trombinisouza@usp.br|
20179653|NCT01181726|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20222882|NCT00184717|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20222883|NCT03126630|Mayo Clinic|Dr. Aaron Mansfield|(507) 284-2511|mansfield.aaron@mayo.edu|
20222884|NCT06028438|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20222885|NCT05625802|University of Michigan|Christopher Fung|734-763-4091|chfung@med.umich.edu|
20222886|NCT02829320|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179654|NCT00229957|McMaster University|Dr. Julie Richardson|905-525-9140|jrichard@mcmaster.ca|27811
20179655|NCT01222195|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
20179656|NCT02696564|School of Medicine, Johns Hopkins University|Robert A. Wise, M.D.|410-550-0545|rwise@jhmi.edu|
20179657|NCT03633929|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
20179658|NCT01520402|Mount Sinai School of Medicine|Dr. Daniella Kadian-Dodov|(212) 241-9454|daniella.kadian-dodov@mssm.edu|
20179659|NCT01722162|Washington University School of Medicine|Manik A. Amin, M.D.|314-362-9115|manikamin@wustl.edu|
20179660|NCT02487810|Fostering Improvement in End-of-Life Decision Science (FIELDS) Program|Beth Cooney, Assistant Director of FIELDS Program|215-573-9461|elcooney@exchange.upenn.edu|
20179661|NCT01257880|Swedish Medical Center|Jill T. Jesurum, Ph.D.|206-683-1505|jill.jesurum@swedish.org|
20179662|NCT00077064|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20179663|NCT02252432|Cedars Sinai Medical Center|Ofelia Loani Elvir Lazo, MD|310-423-1682|Loani.Elvir-Lazo@cshs.org|
20179664|NCT01281202|National Institute on Drug Abuse|David McCann, Ph.D.|301-443-2999|dmccann@nida.nih.gov|
20179665|NCT03759834|Mayo Clinic|Matthew Carlson, M.D., M.B.A.|507-284-8532|Carlson.Matthew@mayo.edu|
20179666|NCT04859660|University of Arizona|Martina Gabra|520-626-6636|mgabra2@gmail.com|
20179667|NCT03217747|M D Anderson Cancer Center|Aung Naing|713-563-1930|anaing@mdanderson.org|
20179668|NCT03996291|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20179669|NCT03248375|Icahn School of Medicine at Mount Sinai|Dr. Edward Kim|(212) 241-7409|Edward.Kim@mountsinai.org|
20179670|NCT04098250|Mayo Clinic|Todd Schwedt, M.D.|480-301-9721|Schwedt.Todd@mayo.edu|
20179671|NCT00633464|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20222887|NCT01954056|University of New Mexico|Dr. Kristi Watterberg|505-272-8609|KWatterberg@salud.unm.edu|
20179672|NCT00394355|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20179673|NCT04278625|Nationwide Children's Hospital|Dr. Peter Winch|614-722-5936|peter.winch@nationwidechildrens.org|
20179674|NCT02612064|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179675|NCT00079001|Massachusetts General Hospital|Matthew Smith, MD, PhD||smith.matthew@mgh.harvard.edu|
20179676|NCT05070416|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20179677|NCT05805657|University of California, Berkeley|Dr. Allison Harvey, Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
20179678|NCT03764072|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20179679|NCT02080780|Ventrus Biosciences|Ventrus|646-706-5208|VEN307@ventrusbio.com|
20179680|NCT02686034|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
20179681|NCT00459342|The University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, MD / Associate Professor|713-792-7734|fmjohns@mdanderson.org|
20179682|NCT00542880|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20179683|NCT00696384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20179684|NCT01678131|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179685|NCT03513757|Medical College of Wisconsin|Susan Taylor MD|414-266-3560|sutaylor@mcw.edu|
20222888|NCT03070600|University of Washington|Grace John-Stewart|206-543-4278|gjohn@uw.edu|
20222889|NCT00105079|Hoffman-LaRoche|Medical Communications|800-821-8590||
20222890|NCT02182115|University of Minnesota|Dr. Susan Kline|612-626-3662|kline003@umn.edu|
20222891|NCT01464593|Celsion Corporation|Chief Medical Officer|609-896-9100|nborys@celsion.com|
20222892|NCT02053766|The University of Texas Health Science Center at Houston|Maria Matuszczak|713 -500-5075|maria.matuszczak@uth.tmc.edu|
20222893|NCT02464163|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20222894|NCT00775229|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
20222895|NCT02476578|CLALIT HEALTH SERVICES|Dr. Nir Tsabar|+97246049512|NIR.TSABAR@CLALIT.ORG.IL|
20222896|NCT03491462|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20222897|NCT04938180|AmMax Bio., Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
20222898|NCT00423332|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20222899|NCT00885664|University of Cincinnati|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
20222900|NCT02035202|UCSD|Colin Depp|858 822 4251|cdepp@ucsd.edu|
20222901|NCT02653144|Montefiore Medical Center|Dr. Amaresh Vydyanathan|7189204316|avydyana@montefiore.org|
20222902|NCT00942890|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
20222903|NCT00911612|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
20179686|NCT00941798|Novartis Pharmaceuticals|Study Director|862-778-8300||
20222904|NCT02097238|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20222905|NCT01106911|University of Pittsburgh|Dr. Jules H. Sumkin|412-641-1976|jsumkin@upmc.edu|
20179687|NCT04251884|Ospedale Regionale di Lugano|Dr. Francesco Mongelli|+41764706297|francesco.mongelli@mail.com|
20179688|NCT04179721|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
20179689|NCT01489189|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
20179690|NCT07069764|National Institute of Laser Enhanced Sciences (NILES), Cairo University|DR.hala shaaban attiyah|01012894478|std.halashaaban@niles.edu.eg|
20179691|NCT04081220|UT HEALTH MAYS CANCER CENTER|Dr Zohra Nooruddin|2013362409|nooruddinz@uthscsa.edu|
20179692|NCT00856167|University of Arizona|Dr. Cheryl Ritenbaugh, Principal Investigator|520-822-6710|ritenbau@email.arizona.edu|
20179693|NCT03284112|Columbia University|Dr. James M. Noble|212-342-4126|jn2054@columbia.edu|
20179694|NCT01529008|Bone Therapeutics|Chief Medical Officer|+32 493 09 73 66|Regulatory@bonetherapeutics.com|
20222906|NCT03728348|Exact Sciences|Alexandra Massoud, Sr. Director of Clinical Affairs|608.284.5700|clinicaltrials@exactsciences.com|
20179695|NCT00332332|Amgen Inc.|Study Director|866-572-6436||
20179696|NCT01382602|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20179697|NCT03091673|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
20179698|NCT04389333|National Clinical Research Center for Digestive Diseases Department of Gastroenterology|Dr. Zhuan Liao|21-31161004|liaozhuan@smmu.edu.cn|+86
20179699|NCT04425902|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179700|NCT01191840|Duke University Health System|Vance Fowler|919-668-8044|fowle003@mc.duke.edu|
20179701|NCT04669600|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
20179702|NCT01544998|Mayo Clinic|Horng Chen, MD, Professor of Medicine|507-284-8846|chen.horng@mayo.edu|
20179703|NCT02128646|University of Kansas Medical Center|Michael Moncure, MD|913-588-1240|mmoncure@kumc.edu|
20179704|NCT03171480|The Ohio State University|Kara Rood, MD|440-321-0264|kara.rood@osumc.edu|
20179705|NCT01373931|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20179706|NCT01995539|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20179707|NCT00530803|Montefiore Medical Center|Associate Professor, Dept of Pediatrics|718-741-2460|cskae@montefiore.org|
20179708|NCT01932697|Mayo Clinic|Daniel J. Ma, M.D.|507/284-3261|Ma.Daniel@mayo.edu|
20179709|NCT00141739|Blood and Marrow Transplant Program, University of Michigan|Dr. John E. Levine|734-936-8456|jelevine@med.umich.edu|
20179710|NCT00828308|BrUOG|Anthony Mega, MD|4018633000|BrUOG@brown.edu|
20179711|NCT00860067|MedImmune LLC, an affiliate of AstraZeneca AB|Judith Falloon, MD/ Sr. Dir. Clinical Development|301-398-0000|falloonj@medimmune.com|
20179712|NCT01282801|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20179713|NCT01862796|National Institute of Diabetes Digestive and Kidney Diseases/NIH|Dr. Marci E. Gluck|602-200-5317|gmarci@mail.nih.gov|
20179714|NCT03815019|University of Kansas Medical Center|Ann Davis, PhD, MPH, ABPP, Director, Center for Children's Healthy Lifestyles & Nutrition|(913) 588-1227|adavis6@kumc.edu|
20179715|NCT05398796|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
20179716|NCT06199934|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179717|NCT04270747|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20179718|NCT05960097|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179719|NCT01784068|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20179720|NCT04708223|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20179721|NCT02063828|Wake Forest NCORP Research Base|Emily Dressler, PhD|336 716-0891|ncorp@wakehealth.edu|
20179722|NCT03483038|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20179723|NCT04987762|Purdue Pharma L.P.|Clinical Leader|1-800-745-7445|nelson.sessler@imbriumthera.com|
20179724|NCT01064297|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179725|NCT01091948|Cleveland Clinic Foundation|Dr. Basem Abdelmalak|216-444-3746|abdelmb@ccf.org|
20179726|NCT03210155|Texas A&M University Corpus Christi|Dr. Christina Murphey|316.825.3747|christina.murphey@tamucc.edu|
20179727|NCT00755040|Vanderbilt Ingram Cancer Center|Madan Jagasia, M.D.|(615) 936-8422|madan.jagasia@vanderbilt.edu|
20179728|NCT03034018|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
20179729|NCT00586170|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
20179730|NCT01089231|Leibniz Universität Hannover|M. Sc. Simone Schmidt|+49 (511) 762 5931|Schmidt@nutrition.uni-hannover.de|
20179731|NCT00316173|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179732|NCT04552743|Stanford Medicine at Stanford University|Khanh Nguyen|650-721-2372|khanhpn@stanford.edu|
20179733|NCT00558064|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20179734|NCT03152084|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20179735|NCT02027402|Seoul St Mary's hospital|Teaho Hong|821052065266|gshth@catholic.ac.kr|
20179736|NCT00982930|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20179737|NCT00112580|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20179738|NCT02624739|ResMed|Paul Phillips|01 906 8861|paul.phillips@resmed.com|
20179739|NCT05597722|University of Pittsburgh|Dr. Eva Szigethy|412-667-0416|szigethye@upmc.edu|
20179740|NCT00404495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179741|NCT04108000|Emory University|Professor Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
20179742|NCT04411849|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
20179743|NCT03904043|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
20179744|NCT05559866|Mayo Clinic|Dr. Omar Ghanem|507-284-2095|ghanem.omar@mayo.edu|
20179745|NCT05619003|Coloplast|Senior Scientific Manager|+45 49112880|dkcpov@coloplast.com|
20179746|NCT03538951|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
20179747|NCT06238999|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20179748|NCT06615544|Ivoclar Vivadent AG|Head of Department Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20179749|NCT00811382|BIOTRONIK|Mathias Freudigmann|+49(0)30 68905 - 1248|mathias.freudigmann@biotronik.com|
20179750|NCT07018999|Department of Anaesthesiology & Perioperative Medicine, Hong Kong Children's Hospital|Dr. Vansie Kwok, Consultant|+852-96737367|kv314@ha.org.hk|
20179751|NCT03444376|Clinical Development|• Project Lead|+82-2-6098-2756|yoonjeong.choi@genexine.com|
20179752|NCT06027619|Cleveland Clinic, Dermatology and Plastic Surgery Institute, Case Comprehensive Cancer Center|Edward V Maytin|(216) 445-6676|maytine@ccf.org|
20222907|NCT01814696|Partners Healthcare Connected Health Innovation|Kamal Jethwani, MD, MPH|617-724-3410|kjethwani@partners.org|
20179753|NCT01746043|UT MD Anderson Cancer Center|Lin,Steven H,M.D. Ph.D. / Radiation Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20179754|NCT00710606|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
20222908|NCT05653479|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|1 917-499-0789|sumathi.sivapalasingam@upstreambio.com|
20179755|NCT03168295|University of Texas Health San Antonio|Carolina Solis-Herrera|(210) 567-6691|solisherrera@uthscsa.edu|
20222909|NCT00984542|Vanderbilt-Ingram Cancer Center|Leora Horn, MD|615-936-2033|leora.horn@vanderbilt.edu|
20222910|NCT00425750|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.|615-343-4677||
20222911|NCT02293512|VA Portland Healthcare System|Erin Martz, PhD|503.220.8262|erin.martz@va.gov|56006
20222912|NCT01757184|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20222913|NCT01959464|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
20222914|NCT03515811|Medtronic|Andrea DiScipio, Senior Clinical Research Specialist|781-491-5350|andrea.l.discipio@medtronic.com|
20222915|NCT00237458|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20179756|NCT01887470|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20179757|NCT06369779|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20179758|NCT01682213|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman, MD|646-888-4162|chapmanp@mskcc.org|
20179759|NCT01264380|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20179760|NCT01147822|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@Novartis.com|
20162416|NCT02837042|UAB|Gurudatta Naik, Scientist 3|205-996-5530|alkanand@uab.edu|
20179761|NCT01860586|Mid-Atlantic Retina|Dr. Jason Hsu, Principal Investigator|215-928-3092|jshu@midatlanticretina.com|
20222916|NCT01276756|Cairo University|Dr. Hany Shehab|00201111111071|h.shehab@drshehab.com|
20179762|NCT01751230|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|leanne.redman@pbrc.edu|
20179763|NCT00261495|Janssen Pharmaceutica NV|EMEA Medical Affairs Director Analgesia|+49 4107 312356|kpappert@its.jnj.com|
20179764|NCT03474107|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20179765|NCT01916655|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
20179766|NCT01330316|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20179767|NCT01337986|Washington Univerisity St. Louis|Robert Naismith, MD|314-747-5576|naismithr@wustl.edu|
20179768|NCT02287584|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20179769|NCT02269371|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|7026533298|jill.clark.3.ctr@us.af.mil|
20179770|NCT01492686|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20179771|NCT04711356|London School of Hygiene & Tropical Medicine|Dr Daniela Manno, clinical trial coordinator and responsible physician|+44 20 7927|daniela.manno@lshtm.ac.uk|2092
20179772|NCT03430063|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20179773|NCT03124199|Hospital Universitario de la Princesa|Mercedes Ramas|913093911|mercedesramas@gmail.com|
20179774|NCT02798211|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20179775|NCT03086018|Bernafon AG|Julie Tantau|+41 31 998 1646|juta@bernafon.com|
20179776|NCT01782872|Hospital for Special Surgery|Dr. Jacques YaDeau|212774224|yadeauj@hss.edu|
20179777|NCT01892345|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20179778|NCT02080195|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Javier Bolaños Meade, MD|410-614-6398|fbolano2@jhmi.edu|
20179779|NCT03505476|University of Iowa|Dr. Jennifer Hrabe Clinical Associate Professor|319-384-7359|jennifer-hrabe@uiowa.edu|
20179780|NCT02748694|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20179781|NCT04219618|The University of Texas Health Science Center at Houston|Igor D. Gregoric, MD|713-486-6714|Igor.D.Gregoric@uth.tmc.edu|
20179782|NCT00659984|NANT Consortium|NANT Operations Center|323-361-5687|nantops@chla.usc.edu|
20179783|NCT01005303|Belfast Health and Social Care Trust|Dr Nick McKeag|02895048487|nick.mckeag@belfasttrust.hscni.net|
20179784|NCT04026165|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20179785|NCT01059630|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
20179786|NCT03170375|VA Ann Arbor Health System|Scott Hummel|734-845-5283|scott.hummel@va.gov|
20179787|NCT00441701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179788|NCT05028426|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Vivien Fontaine|+33546455050|recherche.clinique@ght-atlantique17.fr|
20222917|NCT05868577|Atrium Health Wake Forest Baptist|Michael Jones, DPM|704-355-2000|michael.jones4@advocatehealth.org|
20179789|NCT00621543|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5368|sarah_betstadt@urmc.rochester.edu|
20179790|NCT03155932|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20179791|NCT02206217|School of Optometry, The Hong Kong Polytechnic University|Prof. Carly Sin Yin Lam|2766 6091|carly.lam@polyu.edu.hk|
20179792|NCT03607825|Minnetronix Neuro|Director of Clinical Trials|651-917-4060|info@cerevention.com|
20179793|NCT01287611|DrLutfi|Dr. Cem Turan|00905323513423|cemturan@gmail.com|
20179794|NCT00763958|University of Alabama at Birmingham|Dr. Karen Cropsey|205-917-3786|kcropsey@uab.edu|205
20179795|NCT02192970|University of Wisconsin - Madison|Michael M Altaweel, MD|(608) 263-7290|mmaltaweel@wisc.edu|
20179796|NCT03299686|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20179797|NCT02709005|University of Iowa Hospitals and Clinics|Patricia Winokur, MD|319-384-4590|patricia-winokur@uiowa.edu|
20179798|NCT02348684|Medical College of Wisconsin|Dr. Carmen Bergom|414-805-4365|cbergom@mcw.edu|
20222918|NCT02630251|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
20179799|NCT03720938|Abant Izzet Baysal University|Dr. Halil Ibrahim Atasoy|90 532 599 89 53|halilibrahimatasoy@gmail.com|
20179800|NCT03532308|Yale University School of Medicine|Michael S. Leapman, MD|(203) 785-2815|michael.leapman@yale.edu|
20179801|NCT00499863|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
20179802|NCT00691132|University of Minnesota|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
20222919|NCT04586244|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20179803|NCT01923805|Cleveland Clinic|Alison Klika; Research Program Manager, Adult Reconstruction|216-444-4954|klikaa@ccf.org|
20179804|NCT01060553|Veteran Affairs New Jersey Health Care System|Thomas W. Findley, MD, PhD|973-676-1000|thomas.findley@va.gov|2713
20162417|NCT03596450|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20179805|NCT03160287|University of Washington|Oleg Zaslavsky|2066163242|ozasl@uw.edu|
20179806|NCT01498822|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20179807|NCT04707196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20222920|NCT01334229|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
20222921|NCT03564119|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20179808|NCT01462162|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20179809|NCT03485911|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20222922|NCT00634036|University of Pittsburgh|Dr. Fernando Holguin|412-692-2817|holguinf@upmc.edu|
20222923|NCT03896022|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
20222924|NCT04573322|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
20222925|NCT02915705|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20222926|NCT01500382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179810|NCT03333928|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
20179811|NCT02881008|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
20179812|NCT04037436|University of Waterloo|The MoveStrong program for promoting balance and functional strength training and adequate protein i|519-888-4567|lmgiangr@uwaterloo.ca|46357
20179813|NCT01375205|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-3968|simpsone@ohsu.edu|
20179814|NCT01674621|Radius Health Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
20179815|NCT01148862|Medtronic|Thomas P Troub|818-576-3142|thomas.troub@medtronic.com|
20179816|NCT05031078|Emory University|Dr. Erin Scherer|404-712-6904|erin.margaret.scherer@emory.edu|
20179817|NCT01220869|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20179818|NCT03750006|VA Kansas City Healthcare System|Bruce Troen|913-574-4896|bruce.troen@va.gov|
20179819|NCT01108458|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
20179820|NCT01486615|B. P. Koirala Institute of Health Sciences|Dr Krishna Pokharel|0977-9841986321|drkrishnapokharel@gmail.com|
20179821|NCT01686165|University of Arizona Cancer Center|Daniel Persky, M.D.|520-626-8908|dpersky@uacc.arizona.edu|
20179822|NCT03921346|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
20179823|NCT00939731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179824|NCT00970216|Chang Gung Memorial Hospital|Chau-Ting Yeh|88633281200|chautingy@gmail.com|8121
20179825|NCT01392300|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20179826|NCT02938169|Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine|Dr. Juseok Ryu|+82-10-4382-2328|jseok337@snu.ac.kr|
20179827|NCT05056870|Johnson & Johnson Vision Care, Inc.|Benjamin Straker-Principal Research Optometrist|1-800-843-2020|bstraker@its.jnj.com|
20179828|NCT05044325|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179829|NCT00755222|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20179830|NCT00742079|Massachusetts General Hospital|Jennifer Gottlieb, PhD|617-912-7800|jgottlieb2@partners.org|
20179831|NCT02243202|Janssen Research & Development, LLC|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20179832|NCT04382924|Algernon Pharmaceuticals|Dr. Christopher Bryan|2045572308|cbryan@algernonpharmaceuticals.com|
20179833|NCT02659787|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20179834|NCT00582946|EarLens Corporation|Sunil Puria|650-366-9000|spuria@earlenscorp.com|
20179835|NCT04207840|Amphastar Pharmaceuticals, Inc.|Amphastar Pharmaceuticals, Inc.|(909) 980-9484|info@amphastar.com|
20179836|NCT02173054|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Papapit Tuchinda|+662-419-4333|papapitt@gmail.com|
20179837|NCT01114204|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20179838|NCT05582304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R Buch|1-800-843-2020|jbuch@its.jnj.com|
20179839|NCT00991341|New England Research Institutes|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
20179840|NCT02401464|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20179841|NCT03036384|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
20179842|NCT03010462|Nexstim Plc|Vice President, Medical Affairs|+358927271710|jarmo.laine@nexstim.com|
20179843|NCT00817999|Creighton University|Tammy Burns, PharmD|402-280-4292|TammyBurns@creighton.edu|
20179844|NCT02799472|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179845|NCT02007434|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20179846|NCT01321541|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
20179847|NCT04074590|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20179848|NCT01355458|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20179849|NCT06097676|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
20179850|NCT00792103|NuPathe Inc.|Mark Pierce, MD PhD|484-567-0130|mpierce@nupathe.com|
20179851|NCT03745222|Celgene Corporation|Anne McClain|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
20179852|NCT02535364|Juno Therapeutics|Dr. Nikolaus Trede|206-566-5886|Nick.Trede@junotherapeutics.com|
20179853|NCT00571701|Northwell Health (previously known as NorthShore-LIJ Health System)|Dr. Bettie Steinberg|516-562-1159|bsteinbe@northwell.edu|
20179854|NCT01247428|Micell Technologies|Dennis Donohoe, MD, Chief Medical Advisor|919-313-2102|ddonohoeconsult@gmail.com|
20179855|NCT01112228|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20179856|NCT02660801|UQTR|Pr Martin Descarreaux|819-376-5011|martin.descarreaux@uqtr.ca|3791
20179857|NCT04766086|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20179858|NCT01959347|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20222927|NCT06868654|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20222928|NCT04015518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157575|NCT01822665|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179859|NCT03541044|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179860|NCT00560612|Durham VA Medical Center|Christine Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
20179861|NCT04581200|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
20179862|NCT03131960|MicroTransponder Inc.|Study Director|8556289375|studies@microtransponder.com|
20222929|NCT00550745|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222930|NCT00764660|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179863|NCT01625923|University of Michigan|Allen Lee|734-936-9454|allenlee@umich.edu|
20179864|NCT02918500|University of Ottawa Heart Institute|Dr. Andrew Pipe|613-696-7000|apipe@ottawaheart.ca|
20179865|NCT04404478|Ohio State University|Dr. Holly Jones|760-415-6147|jones.7935@osu.edu|
20179866|NCT01215357|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
20179867|NCT01859793|Medical College of Wisconsin|Michael E. Widlansky|414-955-6806|mwidlans@mcw.edu|
20179868|NCT05414318|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
20179869|NCT02192775|University of Arkansas for Medical Sciences|Brittany Lehman|501-686-8274|blehman@uams.edu|
20179870|NCT02255032|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20179871|NCT02037438|Stanford University|Dr. Clete Kushida|650-721-7560|clete@stanford.edu|
20179872|NCT03056534|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20179873|NCT06131294|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20179874|NCT02675465|Amicus Therapeutics, Inc.|MedInfo|001 609-662-2000|MedInfoUSA@amicusrx.com|
20179875|NCT01856530|Boston University|Dr. Stefan G. Hofmann|617-353-9233|shofmann@bu.edu|
20179876|NCT00728962|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20179877|NCT04954586|McMaster University|Dr. Lisa Carlesso|9055259140|carlesl@mcmaster.ca|23811
20179878|NCT00532155|Sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
20179879|NCT02134925|University of Pittsburgh|Robert E. Schoen, M.D., M.P.H|412-864-7078|rschoen@pitt.edu|
20179880|NCT04027348|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
20179881|NCT02158884|Major Extremity Trauma and Rehabilitation Consortium|Susan Collins (Study Manager)|410 502 8966|scolli21@jhu.edu|
20179882|NCT02498834|University of North Carolina at Chapel Hill|Betsy Sleath, PhD|(919) 962-0079|betsy_sleath@unc.edu|
20179883|NCT01949779|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
20179884|NCT00140205|BIDMC|Dr. Christos mantzoros|6176671656|cmantzor@bidmc.harvard.edu|
20179885|NCT02202434|Boston Scientific|Amy Maurer|508-683-6647|amy.maurer@bsci.com|
20179886|NCT03237858|Boston Scientific|Joe Hobbs, Clinical Trial Manager|612-206-4703|JOE.HOBBS@BSCI.COM|
20179887|NCT02623816|MetroHealth Medical Center|Nisheet Waghray|2167785736|nwaghray@metrohealth.org|
20179888|NCT04858802|Medtronic plc|Xiaomin Deng|707-566-1311|Xiaomin.deng@medtronic.com|
20179889|NCT01886963|Carolinas HealthCare System|Dr. Todd Heniford|7043551813|todd.heniford@carolinashealthcare.org|
20179890|NCT03610737|Vertos Medical|Angie Lee|949-349-0008|alee@vertosmed.com|
20179891|NCT01610154|Fuwai Hospital|Dr. Hui Wang|86-010-88396587|wh_endo@163.com|
20179892|NCT02337517|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
20179893|NCT02013388|Nivalis Therapeutics, Inc.|Nivalis Therapeutics, Inc. (Formerly N30 Pharma)|720-945-7700|steven.shoemaker@nivalis.com|
20179894|NCT03243422|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919 962-3098|lgravens@email.unc.edu|
20179895|NCT01083654|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
20179896|NCT00864708|NF/SG VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
20179897|NCT00215540|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
20179898|NCT03145766|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20179899|NCT01391325|Ardea Biosciences, Inc.|Vice President, Clinical Research and Development|858.652.6587|sbaumgartner@ardeabio.com|
20179900|NCT02801669|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20179901|NCT00571961|Yale University AIDS Program|R. Douglas Bruce, MD, MA, MSc|(203) 737-6133|robert.bruce@yale.edu|
20179902|NCT04461795|Clinvest Research|Jim Sly|417-841-3673|jsly@clinvest.com|
20179903|NCT00615264|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
20179904|NCT00185640|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
20179905|NCT00058422|Memorial Sloan Kettering Cancer Center|Paul A. Hamlin, M.D.|646-608-1667|hamlinp@mskcc.org|
20179906|NCT01134601|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citind@mail.nih.gov|
20179907|NCT01817374|UAB Radiology Research|Marianne Vetrano|205-934-4080|mvetrano@uabmc.edu|
20179908|NCT03154281|Avera Cancer Institute|Dr. Casey Williams|6053223588|Casey.Williams@avera.org|
20179909|NCT03863522|Johns Hopkins University|Dr. Sara Sukumar|4106142479|saras@jhmi.edu|
20179910|NCT02884414|Stanford University|Jennifer Hledik|650-493-5000|jerhart@stanford.edu|62388
20179911|NCT02396537|University of Alabama at Birmingham|Dr. Christopher Pruitt|2056389587|cpruitt@peds.uab.edu|
20179912|NCT01982435|Cleveland Clinic Foundation|Dr. Justis Ehlers|216-636-0183|Ehlersj@ccf.org|
20179913|NCT00871403|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179914|NCT00304512|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20179915|NCT00985985|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179916|NCT00927355|Emory|Dr. George Beck|404-686-1000|gbeck@emory.edu|
20179917|NCT01572389|Department of Veteran Affairs|Aanand, Naik, MD|713-794-8541|anaik@bcm.edu|
20222931|NCT01131455|ColumbiaOG|Vicki L Jones, Research Coordinator|573-443-2402|v.jones@columbiaorthogroup.com|4391
20179918|NCT03315936|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20179919|NCT02914314|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20179920|NCT00125593|Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford|Professor Colin Baigent|+44 1865 743743|colin.baigent@ctsu.ox.ac.uk|
20179921|NCT01597505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179922|NCT03728972|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz MD, PhD|646-608-3714|hultcram@mskcc.org|
20179923|NCT04543188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179924|NCT02487472|GlaxoSmithKline|GSK Response Center|866-435-7343|lzr30020@gsk.com|
20179925|NCT00462280|University of California, Irvine|Dr. Kenneth G. Linden|714-456-3719|kglinden@uci.edu|
20179926|NCT01313286|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20179927|NCT04843930|Weill Cornell Medicine|Lindsay Victoria, PhD|646-962-3973|liv3002@med.cornell.edu|
20179928|NCT00947661|Sun Pharma Advanced Research Company|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
20179929|NCT02036645|AstraZeneca Pharmaceuticals|Michael Pomfret, Project Director, IMED Neuroscience||Clinicaltrialstransparency@astrazeneca.net|
20179930|NCT02010632|Khon Kaen University|Miss Nontaya Nakkam|66862642540|nonna_na@hotmail.com|
20179931|NCT04241094|Center for Care Delivery & Outcomes Research|Laura Meis, PhD|651-467-4516|laura.meis@va.gov|
20179932|NCT01669798|Duke University Medical Center|Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
20179933|NCT01802086|SormlandCC|Beatrice Olsson Duse|0704948359|bod257@hotmail.com|
20179934|NCT03125005|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20179935|NCT05918978|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20179936|NCT00622180|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
20179937|NCT02280239|Providence Health Care|Vininder Kour Bains|604-682-2344|VBains@providencehealth.bc.ca|62207
20179938|NCT06387472|Mayo Clinic|Matthew Hall, M.D.|904-953-6412|Hall.Matthew@mayo.edu|
20179939|NCT02439749|Medtronic|Pamela McKenna, Sr. Principal Clinical Research Specialist|(773) 597-5241|pamela.m.mckenna@medtronic.com|
20179940|NCT02332590|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20179941|NCT00279201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20179942|NCT00916032|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20179943|NCT01995487|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20179944|NCT04204200|Centre Hospitalier de Ham|Dr. Jean-Francois Cazeneuve, Surgeon|06 62 29 24 51|jfc.laon@gmail.com|0033
20179945|NCT03466918|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
20179946|NCT04226365|Penn Medicine / Lancaster General Hospital|Halle Becker, MPH, Research Project Manager|7175441777|Halle.Becker@pennmedicine.upenn.edu|
20179947|NCT06412146|Children's Mercy Research Institute|Sophie MacColl|8166011485|risingT1DE@cmh.edu|
20179948|NCT03881696|DAIT/NIAID|Director, Clinical Research Operations Program|202-604-9855|DAITClinicalTrialsGov@niaid.nih.gov|
20179949|NCT01061333|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179950|NCT01105702|Perlmutter Cancer Center at NYU Langone|Michael Gruber, MD|212-731-5577|michael.gruber@nyumc.org|
20179951|NCT02228395|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20179952|NCT04343586|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
20179953|NCT02648971|Wake Forest University|Dr. John Hubbard|336-998-1297|jhubbard@wakehealth.edu|
20179954|NCT03802864|Weill Cornell Medicine|Russell Hayden|2127465566|rph9002@med.cornell.edu|
20179955|NCT02569437|Icahn School of Medicine at Mount Sinai|Dr. Benjamin Malkin||Benjamin.D.Malkin@kp.org|
20179956|NCT01856712|University of Wisconsin|Randall Brown|6082636558|rtbrown@wisc.edu|
20179957|NCT02255357|new york psychiatric institute|wilfrid raby, m.d.|2129233031|wilfrid.raby@nyspi.columbia.edu|
20179958|NCT00509236|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179959|NCT01641926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20179960|NCT01691521|GlaxoSmithKline|GSK Response Center|866-435-7343||
20179961|NCT02343003|Halyard Health|David Curd|470-448-5178|david.curd@hyh.com|
20179962|NCT03954743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20179963|NCT01153269|Abbott|Global Medical Services|1-800-633-9110||
20179964|NCT02281760|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
20179965|NCT02635724|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20179966|NCT04048863|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
20179967|NCT00100932|Eisai|Dr. Peter Tarassoff|888-422-4743||
20179968|NCT01159743|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20179969|NCT00829686|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
20179970|NCT02387996|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20179971|NCT02424591|NYU School of Medicine|John Ard, MD|212.263.5072|john.ard@nyumc.org|
20179972|NCT01446796|Duke University Medical Center|Michel Khouri, MD|919 684 8111|michel.khouri@duke.edu|
20179973|NCT00818363|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20179974|NCT00312702|Walter Reed Army Institute of Research|James F. Cummings, MD|301-319-9312|james.cummings@us.army.mil|
20179975|NCT00770432|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20190934|NCT02720198|Duke University Medical Center|Dr. Narei Hong|984-215-8493|narei.hong@duke.edu|
20190935|NCT04879823|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
20190936|NCT03897075|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20190937|NCT04468633|Duke University|Andrew Gross, MD|919-684-8656|andrew.gross@duke.edu|
20190938|NCT01843920|Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
20190939|NCT01498445|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
20222932|NCT03548779|University of North Carolina at Chapel Hill|Jonathan Berg, MD, PhD|919-966-7043|jonathan_berg@med.unc.edu|
20222933|NCT06360588|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20222934|NCT00754234|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
20179976|NCT01453348|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20222935|NCT04432831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20222936|NCT05336630|Dartmouth-Hitchcock Medical Center|Dr. Timothy B. Gardner|603-653-9033|timothy.b.gardner@hitchcock.org|
20222937|NCT01623310|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
20222938|NCT00356603|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222939|NCT00734162|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20222940|NCT00566020|GlaxoSmithKline|GSK Response Center|866-435-7343||
20222941|NCT00596687|Emory Univ SOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
20222942|NCT01262287|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
20222943|NCT00932373|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20222944|NCT06098339|CooperVision Inc.|José A. Vega, O.D., MSc., PhD, FAAO|925-621-3761|JVega2@coopervision.com|
20162418|NCT04058886|University of North Carolina at Chapel Hill|Kim Faurot, PhD|919-966-8586|faurot@med.unc.edu|
20162419|NCT01069705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20162420|NCT03624127|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20162421|NCT00915551|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20162422|NCT04390841|Biotronik (Beijing) Medical Device Limited|Senior Clinical Study Project Manager|+86 10 6522 3851-863|lan.chen@biotronik.com|
20162423|NCT02999633|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20162424|NCT03262441|Fred Hutchinson Cancer Research Center|Dr. Joshua Schiffer|(206)667-7359|jschiffe@fredhutch.org|
20162425|NCT01545050|CSL behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20162426|NCT02607228|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20162427|NCT03235089|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
20162428|NCT01860950|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
20162429|NCT01204216|Research Service, Cincinnati VA Medical Center|Robert M Cohen, MD, Physician,|5136748676|robert.cohen@uc.edu|
20162430|NCT03665688|UTMB Galveston|Antonio Saad Director of Clinical Research Division|409 772 0982|afsaad@utmb.edu|
20162431|NCT04775264|AtriAN Medical Ltd|Barry O'Brien|+353872934292|barry.obrien@atrianmedical.com|
20162432|NCT01196416|Memorial Sloan Kettering Cancer Center|Dr. Mark Dickson|646-888-4164|DicksonM@mskcc.org|
20162433|NCT02280317|Valirx plc|Dr Suzanne Dilly|+44 2476796496|suzanne.dilly@valirx.com|
20162434|NCT00727558|Vistakon|Kurt Moody OD, FAAO/ Director|904-443-3088|kmoody1@its.jnj.com|
20162435|NCT01717326|Merck Sharp & Dohme Corp.|Results Point of Contact* Name or Official Title Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162436|NCT01123707|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20162437|NCT03281304|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162438|NCT01114438|GI Dynamics|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
20162439|NCT02508324|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
20162440|NCT00123604|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20162441|NCT02577016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162442|NCT00566254|Eisai Call Center|Eisai Inc.|888-422-4743||
20162443|NCT00687531|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20162444|NCT02301624|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20179977|NCT00633919|ALK-Abelló S.A.|Santiago Martín - Trial Manager|+34 913276127|santiago.martin@alk-abello.com|
20179978|NCT01673893|Cardiovascular Institute of the South Clinical Research Corporation|Deanna K. Benoit, LPN, CCRC|985-876-0300|deanna.benoit@cardio.com|5613
20179979|NCT02756832|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20179980|NCT01991821|Acacia Pharma|Dr Gabriel Fox|01223875130|GabrielFox@acaciapharma.com|149
20179981|NCT03579290|Yale University|Theresa Babuscio Data Manager|203-737-5430|theresa.babuscio@yale.edu|
20179982|NCT01566630|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20179983|NCT01781390|Mesoblast, Inc.|Kenneth Borow, MD (Lead, Global Cardiovascular Development)|(212) 880-2060|Ken.Borow@Mesoblast.com|7951
20179984|NCT04559282|Cochlear|Therese Agat|+46766498562|tagat@cochlear.com|
20222945|NCT02273063|Neuromodulation Research Clinic|Director|401-455-6200|Linda_Carpenter_MD@Brown.edu|
20162445|NCT03210961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20179985|NCT00622713|Novartis Pharmaceuticals|Study Director|862-778-8300||
20222946|NCT05125848|Zynex Monitoring Solutions|ZMS Clinical|(800) 495-6670|clinical@zynexmonitoring.com|
20222947|NCT03831113|University of Pittsburgh|Dr Steve Caritis|412 641 4874|scaritis@mail.magee.edu|
20162446|NCT02467582|SAKK|Regulatory affairs|+41 31 389 91 91|regulatory@sakk.ch|
20162447|NCT00703924|Institute Pasteur Tunisia|Afif Ben Salah, MD, PhD|216-71-792-429|afif.bensalah@pasteur.rns.tn|
20162448|NCT05388617|Cynosure|Jamie Trimper|9782564200|jamie.trimper@cynosure.com|
20162449|NCT01031979|Ralph H. Johnson VAMC|Dr. Peter Tuerk|(843) 789-6188|peter.tuerk@va.gov|
20162450|NCT00301418|Feinstein Institute for Medical Research|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
20222948|NCT02492984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162451|NCT03592368|University of Colorado, Anschutz Medical Campus|Joel Stoddard|(720) 777-5702|joel.stoddard@cuanschutz.edu|
20162452|NCT02566590|University of Utah|Micah Drummond|8015877764|micah.drummond@hsc.utah.edu|
20162453|NCT01248741|British Columbia Cancer Agency|Dr Juanita Crook|2507123958|jcrook@bccancer.bc.ca|
20162454|NCT01593592|Tropical Medicine Departement, Faculty of Medicine, Zagazig University, Egypt|Dr Mohamed Emara|+2 0100 272 4482|emara_20007@yahoo.com|
20162455|NCT03335774|Nivagen Pharmaceuticals|Dr Vishal S Narang|+919820020278|vnarang@nivagen.com|
20162456|NCT03354273|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
20162457|NCT01971008|Innsbruck Medical University|Prof. Dr. Klaus Seppi|004351250481498|klaus.seppi@tirol-kliniken.at|
20162458|NCT03775512|Biosense Webster, Inc.|Franchise Medical Manager|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20162459|NCT02277925|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
20162460|NCT00705367|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20162461|NCT00244101|Vermont Oxford Network|Roger F. Soll, MD|802 865 4814|roger.soll@uvmhealth.org|212
20162462|NCT01959139|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
20162463|NCT02629822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162464|NCT03679624|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
20162465|NCT00741013|Washington University School of Medicine|Delphine L. Chen|314-362-7029|chend@mir.wustl.edu|
20162466|NCT00082407|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20162467|NCT00858208|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162468|NCT02352753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20162469|NCT00539305|University of Washington|Monique Cherrier PhD.|206-277-3594|cherrier@u.washington.edu|
20162470|NCT00607867|Minneapolis VA Health Care System, Metabolic Research Labortory|Mary C. Gannon, Ph.D.|6124672895|ganno004@umn.edu|
20162471|NCT01440816|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
20162472|NCT04120363|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
20162473|NCT04302545|King Edward Medical University, Lahore, Pakistan|Shazia Saaqib|+92-3214708583|shaziasaaqib@gmail.com|
20162474|NCT02516592|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20162475|NCT03068754|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20162476|NCT01110382|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
20162477|NCT00077649|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20162478|NCT00881465|University of South Florida|Eric Storch, Ph.D.|7277678230|estorch@health.usf.edu|
20162479|NCT00590577|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader, Paliperidone|609-730-4530||
20162480|NCT01300260|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162481|NCT02128074|Keryx Biopharmaceuticals, Inc|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
20162482|NCT00908466|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
20162483|NCT04373746|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
20162484|NCT00418574|Menarini Ricerche SpA|Clinical Research Director||abagovomab@menarini-ricerche.it|
20190940|NCT02592434|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190941|NCT03082196|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-251-6831|drmilgrom@silverarrest.com|
20190942|NCT00105521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20190943|NCT03912298|University of Pennsylvania|Peggy Compton|2158986679|pcompton@nursing.upenn.edu|
20190944|NCT00385697|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
20190945|NCT00442559|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190946|NCT01368874|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20190947|NCT02815709|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20190948|NCT02732899|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20222949|NCT02282631|Institute of Health and Society, Newcastle University|Dr Samuel Ginja|+44191208|samuel.ginja@newcastle.ac.uk|4565
20222950|NCT04134429|insel Gruppe AG|Dr. med. Christa König|+41 31 632 21 11|christa.koenig@insel.ch|
20222951|NCT02669901|Univesity of New Mexico School of Medicine|Dr. Joanna Katzman, Principal Investigator|(505) 272-2321|JKatzman@salud.unm.edu|
20222952|NCT03981900|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162485|NCT03001778|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
20162486|NCT00235716|Dept. of Veterans Affairs Cooperative Stduies Program|Peter Guarino, PhD, Director WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
20162487|NCT03238924|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
20190949|NCT01426217|Dartmouth-Hitchcock Medical Center|Randy Loftus, MD|(603) 650-6177|Randy.W.Loftus@hitchcock.org|
20157576|NCT04540367|Houston Methodist Hospital|Bradley Lambert|8326872483|bslambert@houstonmethodist.org|
20179986|NCT01108757|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
20179987|NCT01719237|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
20179988|NCT03338621|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
20179989|NCT00989586|The Ohio State University Comprehensive Cancer Center|Beth Christian|614-293-8858|beth.christian@osumc.edu|
20179990|NCT04203537|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
20179991|NCT05375955|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20179992|NCT05454410|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
20179993|NCT05261191|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20179994|NCT05004688|Mass General|Kayla McEachern|617 643 5265|kmceachern2@mgh.harvard.edu|
20179995|NCT00895622|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20179996|NCT03879408|Johnson & Johnson Consumer, Inc.|ASSOCIATE DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20179997|NCT01320943|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20179998|NCT04616014|Oramed, Ltd.|Chief Scientific Officer|972-2-566-0001|miriam@oramed.com|
20179999|NCT02227316|UCLA Department of Radiological Sciences|Director of Clinical Research|310-794-8995|schaabane@mednet.ucla.edu|
20180000|NCT01081041|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180001|NCT03489057|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan, PhD|+1 919-966-8450|xianming@email.unc.edu|
20180002|NCT02034708|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
20180003|NCT00654901|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20180004|NCT02552238|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
20180005|NCT05158296|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
20180006|NCT01986101|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20180007|NCT03324880|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20180008|NCT00652938|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180009|NCT03020225|BGU|Prof. Iris Shai|+972 52-579-3040|irish@bgu.ac.il|
20180010|NCT01412801|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20180011|NCT01547299|Medivation, Inc.|William Novotny, MD, Sr. Director, Clinical Development|415- 983-3066|william.novotny@medivation.com|
20180012|NCT01742364|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
20180013|NCT02272725|Stanford University School of Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
20180014|NCT04739761|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20180015|NCT02584725|Columbia University Irving Medical Center|Robert Maniker, MD|212-305-9876|rm3046@cumc.columbia.edu|
20180016|NCT03941015|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|18710168703@163.com|
20180017|NCT01966003|Amgen Inc.|Study Director|866-572-6436||
20180018|NCT00674570|San Francisco VA Health Care System|Sabra Inslicht, Ph.D.|415-221-4810|sabra.inslicht@ucsf.edu|23341
20180019|NCT00633932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20180020|NCT00482274|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|503 494-2897|eilersk@ohsu.edu|
20180021|NCT04836858|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20180022|NCT03215901|Boston University|Jacob Bor, Assistant Professor|617-358-2176|jbor@bu.edu|
20180023|NCT04887948|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180024|NCT00787319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180025|NCT03075904|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20180026|NCT01287520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180027|NCT01800201|University of Pennsylvania|Noora Marcus|215-746-4429|noora.marcus@uphs.upenn.edu|
20180028|NCT00708435|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20180029|NCT01737684|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180030|NCT03921190|University of Jordan|Dr. Ahmad El-Ma'aita|+9625355000|a.maaita@ju.edu.jo|
20180031|NCT05061537|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20180032|NCT02924324|Memorial Sloan Kettering Cancer Center|Dr. Ellen Basu, MD, PhD|212-639-5204|BasuE@mskcc.org|
20180033|NCT04503096|Medical University of South Carolina|Andreana Benitez PhD|(843) 876-8479|benitez@musc.edu|
20180034|NCT01480596|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180035|NCT01576367|Novartis Pharmaceuticals|Study Director|862-778-8300||
20180036|NCT00988221|Hoffman-La Roche|Medical Communications|800 821-8590||
20180037|NCT00595270|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar.kastner@intercell.com|0
20180038|NCT00632281|University of Florida|Bridget Fitzgerald, Clinical Research Coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
20180039|NCT03592277|Saint Francis Hospital and Medical Center|David Shapiro, MD, MHCM, FACS, FCCM CMO of Saint Francis Hospital and Medical Center|860-833-5673|dshapiro@trinityhealthofne.org|
20180040|NCT00954733|Northwestern University|Gildaasio De Oliveira, M.D.|312-472-3573|gjr@northwestern.edu|
20180041|NCT01346514|VA Puget Sound|Carol Malte|206.277.3780|carol.malte@va.gov|
20180042|NCT00909480|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20180043|NCT00861601|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180044|NCT02299258|The First People's Hospital of Yuhang District|Dr.Ding Shi|+8657189369162|shidingyuhang@163.com|
20180045|NCT03982043|University of Pittsburgh|Tina R. Goldstein, Ph.D.|4122465604|goldtr@upmc.edu|
20180046|NCT01725386|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20180047|NCT00879996|SUNY Buffalo|Dr. Richard Blondell|716-898-4971|blondell@buffalo.edu|
20180048|NCT02786264|Yale School of Medicine|Dr. Robert Schonberger|2037852802|robert.schonberger@yale.edu|
20180049|NCT00993824|International Diabetes Center|Roger Mazze PhD|952-993-3796|rmazze@aol.com|
20180050|NCT03434457|Douglas Mental Health University Institute|Dr Patricia Pelufo Silveira|1514-761-6131|patricia.silveira@mcgill.ca|3928
20180051|NCT02413463|Faculty of Medicine, Cairo University|Ahmed Awadein, MD|201223911743|ahmedawadein@yahoo.com|
20180052|NCT01973036|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
20180053|NCT01821417|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS MS|2059344506|ngeurs@uab.edu|
20180054|NCT04772053|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20180055|NCT04146896|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20180056|NCT02118337|MedImmune, LLC|Farzana Walcott|+1 301-398-3063|information.center@astrazeneca.com|
20180057|NCT04296890|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20180058|NCT02583763|Region Östergötland / University of Linköping|Olov Änghagen PhD student|+461047246|olov.anghagen@regionostergotland.se|
20180059|NCT00724464|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
20180060|NCT01931735|VA Palo Alto Research|Jessica Asay|650-493-5000|asay@stanford.edu|65971
20180061|NCT02719990|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
20180062|NCT02404389|Novartis Pharmaceuticals|Study Director|862-778-8300||
20180063|NCT00335257|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|0049(0)30 945 10120|dinger@zeg-berlin.de|
20180064|NCT00717314|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20180065|NCT05076149|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20180066|NCT05096208|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180067|NCT00782496|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20180068|NCT00584935|UAB Department of Dermatology|Wendy Cantrell, CRNP|205-502-9960|wcantrell@uabmc.edu|
20180069|NCT01481545|National Cancer Institute of Naples|Dr. Antonio Avallone|+39 081 5903629|a.avallone@istitutotumori.na.it|
20180070|NCT00117156|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
20180071|NCT01919970|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
20180072|NCT04043962|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
20180073|NCT00584402|University of Califonia, Davis|John McGahan, M.D.|(916)734-0519|john.mcgahan@ucdmc.ucdavis.edu|
20180074|NCT01987817|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20180075|NCT02402296|Al-Azhar University- Faculty of dental medicine (Girls branch)|Professor Hala Helmi Hazzaa|00201014129297|hala.hazzaa@yahoo.com|
20180076|NCT01576718|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20180077|NCT01874145|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20180078|NCT04631705|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
20180079|NCT05741385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180080|NCT05690776|Zimmer Biomet|Julie Nicoux|+33672613502|julie.nicoux@zimmerbiomet.com|
20180081|NCT01816763|VA Palo Alto|Karl Lorenz MD MSHS, Principal Investigator|6504935000|kalorenz@stanford.edu|
20180082|NCT00975221|Amgen Inc.|Study Director|866-572-6436||
20180083|NCT02783820|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
20180084|NCT00856934|CHUV - CPR|Dr. Wassim Raffoul|+41 21 314 25 05|Wassim.Raffoul@chuv.ch|
20180085|NCT01186328|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20180086|NCT01862991|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20180087|NCT02026232|Washington University School of Medicine|Dr. Janet McGill|314-273-3929|jmcgill@wustl.edu|
20180088|NCT03075501|University of Illinois at Chicago|Emma Childs|312-355-2726|echilds@uic.edu|
20180089|NCT02762981|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20180090|NCT02970032|University of Utah Health|Corinne Bertolaccini, PharmD|801-581-2167|Corinne.Bertolaccini@hsc.utah.edu|
20180091|NCT02392611|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20180092|NCT02357290|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
20180093|NCT03800979|Institute of Dermatology|Dr. Chinmanat Lekhavat (My old last name is Tangjaturonrusamee.)|+660847607474|chinmanat@hotmail.com|
20180094|NCT00605319|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
20180095|NCT02991482|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki|+41 31 511 94 00|Heidi.Roschitzki@etop-eu.org|
20180096|NCT01250119|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20180097|NCT01213043|Grifols Therapeutics Inc.|Benjamin King, PhD||ben.king@grifols.com|
20180098|NCT02670538|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20180099|NCT01155830|University of Utah|Dr. Christian Yost|801/581-7052|christian.yost@hmbg.utah.edu|
20180100|NCT02887989|Cedars-Sinai Health System|Garth Fuller|3236003890|garth.fuller@cshs.org|
20180101|NCT05648357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20180102|NCT00255346|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Department Chair|713-792-7026|hkantarjian@mdanderson.org|
20180103|NCT00674323|Novartis Pharmaceuticals|Study Director|862-778-8300||
20180104|NCT01678443|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
20222953|NCT03611777|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180105|NCT00805493|Emotion and Development Branch, NIMH-IRP|Kenneth Towbin, M.D., Chief Clinical Child and Adolescent Psychiatry|301-402-4403|Kenneth.Towbin@nih.gov|
20180106|NCT01676532|St.Michael's Hospital|Sloane Freeman|416-864-6060|freemansl@smh.ca|77042
20222954|NCT01369030|Pamlab, Inc.|Lori W Barrentine, MS, PA-C, Director of Clinical Affairs|985-867-5788|lbarrentine@pamlab.com|
20222955|NCT06152224|UW School of Medicine and Public Health|Ushma Patel, MD|(608) 287-5898|upatel@uwhealth.org|
20180107|NCT02045433|UT Southwestern/Simmons Cancer Center-Dallas|Dr.Kevin Albuquerque|2146458499|Kevin.Albuquerque@UTSouthwestern.edu|
20180108|NCT01559454|University at Buffalo|Dr. Ricahrd Blondell|716-816-7237|blondell@buffalo.edu|
20180109|NCT02207725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20180110|NCT03395808|Avenue Therapeutics|Micheal Ryan, VP Clinical|781-652-4514|mryan@avenuetx.com|
20180111|NCT03645967|Medline Industries, LP|Keri Jorgenson|2243014670|kajorgenson@medline.com|
20180112|NCT00548132|Washington University School of Medicine|Bernard C. Camins, MD|3144548351|bcamins@dom.wustl.edu|
20180113|NCT01187914|Arrhythmia Research Center, University of Utah|Dr. Kavitha Damal, Clinical research Manager|8012133775|kavitha.damal@carma.utah.edu|
20180114|NCT02110732|Helsinki University Hospital|Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
20180115|NCT02948959|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20180116|NCT02312856|CERENOVUS|Christopher Hendricks|415-656-6565|chendric@its.jnj.com|
20180117|NCT01932294|University of Alabama at Birmingham|RongBing Xie|205-975-3624|rongbingxie@uabmc.edu|
20180118|NCT04415151|Yale School of Medicine|Hyung Chun, MD, FAHA|(203) 785-6012|hyung.chun@yale.edu|
20180119|NCT01778946|Vanderbilt University Medical Center|Dr. Paul Newhouse|6159360928|paul.newhouse@vanderbilt.edu|
20180120|NCT02150837|Medifast|Chris Coleman|410-504-8161|ccoleman@choosemedifast.com|
20180121|NCT00409786|University of Pittsburgh|Kathleen McTigue|412-692-2940|mctiguekm@upmc.edu|
20180122|NCT00638235|Eastern Virginia Medical School|Dr. James C Lukban, Professor & Director Division of urogynecology|7574467900|lukbanjc@evms.edu|
20180123|NCT02211534|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
20180124|NCT02608905|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
20180125|NCT00597714|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20180126|NCT01350141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180127|NCT00810082|Dartmouth College|Dr. Jon D. Lurie, MD, MS|603-653-3575|Jonathan D. Lurie <Jonathan.D.Lurie@hitchcock.org>|
20180128|NCT01488708|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180129|NCT01588990|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20180130|NCT02367716|Cardiac Rhythm Management, Abbott Medical Devices|Clay Cohorn, Clinical Program Director|+19723098087|clay.cohorn@abbott.com|
20180131|NCT01473381|Forest Research Institute|Suresh Durgam, MD Clinical Asset Lead for Vilazodone - Senior Director - Clinical Development|201 427-8000|suresh.durgam@frx.com|8172
20180132|NCT00539643|Memorial Sloan Kettering Cancer Center|Dr. Anne Covey, MD|212-639-6746|coveya@MSKCC.ORG|
20180133|NCT02341456|AstraZeneca|Lone Ottesen|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
20180134|NCT03587142|Temple University|Dr. Henry Parkman|(215) 707-7579|henry.parkman@temple.edu|
20180135|NCT03673462|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20180136|NCT02768662|Otonomy, Inc.|Otonomy Medical information Center|1-844-686-4636|medinfo@otonomy.com|
20180137|NCT02352363|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
20180138|NCT02481375|University of British Columbia|Crystal Karakochuk|604 822 0421|crystal.karakochuk@ubc.ca|
20180139|NCT03528174|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
20180140|NCT03002038|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
20180141|NCT05436912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20180142|NCT01616576|Advanced Bionics, LLC|Cedric Navarro, Vice President of Regulatory/Clinical Affairs and Quality|(661) 362-1963|Clinical.Research@advancedbionics.com|
20180143|NCT00979602|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180144|NCT02904902|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20180145|NCT03885011|Orasis|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
20180146|NCT02712398|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
20180147|NCT00699140|Instituto Grifols, S.A|Marta Carretero, PhD, Clinical Project Leader|+ 34 93 571 22 00|marta.carretero@grifols.com|
20180148|NCT04750655|University of California, San Francisco|Ying Han|(415) 353-2020|ying.han@ucsf.edu|
20222956|NCT04181606|The Pennsylvania State University|Dr. David Proctor|(814)863-0724|dnp3@psu.edu|
20222957|NCT02509507|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20180149|NCT00094211|Stanford University|Dr. Abby C. King|650-725-5394|king@stanford.edu|
20180150|NCT03564782|Istari Oncology|W. Garrett Nichols, MD MS|919-245-7662|info@istarioncology.com|
20180151|NCT02002182|Baylor College of Medicine|Dr. Andrew Sikora|7137983909|Andrew.Sikora@bcm.edu|
20180152|NCT02835846|Loyola University Chicago|Alan J Wolfe|7082165814|awolfe@luc.edu|
20180153|NCT03787680|University of Michigan Rogel Cancer Center|Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20180154|NCT05400746|University of Oxford|Dr. Angela M Minassian|01865611424|angela.minassian@bioch.ox.ac.uk|
20180155|NCT03724396|University of California San Diego|Dr. Dawn Eichen|858-249-1123|deichen@ucsd.edu|
20180156|NCT01490125|Novartis|Study director|41 61 324 1111||
20180157|NCT04522180|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionisph.com|
20180158|NCT05807919|University of Mihcigan|Prashant Singh|734-647-9252|singhpr@med.umich.edu|
20180159|NCT06334042|Hacettepe University Department of Anesthesiology and Intensive Care|Oguzhan Kahveci, MD|+903123051207|kahveci.oguz@hotmail.com|
20180160|NCT04571099|Philips Clinical & Medical Affairs Global|Marijke van Vlimmeren|+31 6 31042408|marijke.van.vlimmeren@philips.com|
20180161|NCT03635489|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20180162|NCT01368900|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20180163|NCT02492854|Boston Medical Center|Jeffrey Siracuse, MD|617-638-8488|Jeffrey.Siracuse@bmc.org|
20180164|NCT01786902|Asan Medical Center|Dr. Hanwook Yoo|82-2-3010-3374|hwyoo@amc.seoul.kr|
20180165|NCT00361439|University of Chicago|Jayant Pinto, MD|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
20180166|NCT00674466|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
20180167|NCT02277743|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20180168|NCT01224158|Johnson & Johnson Consumer and Personal Products Worldwide|Director Oral Health, Medical Affair & Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20180169|NCT00429494|The University of Texas (UT) MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD, PhD / Professor||CR_Study_Registration@mdanderson.org|
20180170|NCT00976703|Metrohealth Medical Center|Kelly S Gibson, MD|216-778-5498|kgibson@metrohealth.org|
20180171|NCT03289481|Clinical Research|Caroline Knight|2079218959|CKnight@pbmc.org|
20180172|NCT02209636|Rocky Mountain VA Medical Center|Anna Jovanovich, MD|303-724-8677|anna.jovanovich@va.gov|
20180173|NCT01900054|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20180174|NCT01108835|The Chinese University of Hong Kong|Fanny Ko|85226323133|fannyko@cuhk.edu.hk|
20180175|NCT03285295|Abbott Laboratories|George Chen (Associate Director Clinical Affairs)|224-668-9185|george.chen@abbott.com|
20180176|NCT02075021|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
20180177|NCT02796274|Santhera Pharmaceuticals|Vanessa Dos Reis Ferreira|+41 61 906 89 50|office@santhera.com|
20180178|NCT00957931|University of California, San Francisco|Dr. Sandhya Kharbanda, MD||Sandhya.Kharbanda@ucsf.edu|
20180179|NCT00857805|Loma Linda University Health|David Bush, MD, Professor Radiation Medicine|909 558 1000|DBush@llu.edu|88056
20180180|NCT01289041|Novartis Pharmaceuticals|Study Director|862-778-8300||
20180181|NCT01062763|Dept. of Endocrinology, Odense University Hospital|Dr. Ib A. Jacobsen|+45 27203135|ib.abildgaard@rsyd.dk|
20180182|NCT01403441|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
20180183|NCT03926065|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
20180184|NCT03260127|VA San Diego Healthcare System|Laura Crocker|8586426484|laura.crocker@va.gov|
20180185|NCT01129531|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20180186|NCT02714868|Department of Occupational Therapy, Boston University|Dr. Jessica Kramer, Assistant Professor, PI|617-353-2702|kramerj@bu.edu|
20180187|NCT00369681|Johns Hopkins University|Dr. Yvette Kasamon|410-955-8839|ykasamon@jhmi.edu|
20180188|NCT00981474|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20180189|NCT01010477|Rutgers-Robert Wood Johnson Medical School|Jill Williams, MD, Principal Investigator|7322354341|Jill.williams@rutgers.edu|
20180190|NCT02508532|Blueprint Medicines|Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
20180191|NCT00500240|UT MD Anderson Cancer Center|Khanh D Vu, MD/ Associated Professor|713-745-4516|eharriso@mdanderson.org|
20180192|NCT00301080|Northwestern University|Clinical Research Office|312-695-1301|cancertrials@northwestern.edu|
20180193|NCT03502616|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180194|NCT01581840|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20222958|NCT00302848|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
20222959|NCT02074358|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20222960|NCT03337113|Kent State University|William Lechner|814-450-1093|wlechner@kent.edu|
20180195|NCT04000594|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20180196|NCT01622010|St. Boniface Hospital|Kelly Codispodi BMR PT|204-237-2138|kcodispodi@sbgh.mb.ca|
20180197|NCT02055157|BioMarin Pharmaceutical Inc.|Alice Hunstman-Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
20180198|NCT03976466|ISSEMyM Instituto de Seguridad Social del Estado de Mexico y Municipios|Julio Carlos Vélez de Lachica, Head of the orthopedics department at Regional Hospital Tlalnepantla|5526269200|activeknee@gmail.com|2100
20180199|NCT01557322|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180200|NCT02247336|William S Middleton Memorial Veterans Hospital|Corrine Voils, PhD|608-256-1901|corrine.voils@va.gov|12208
20180201|NCT00943306|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
20180202|NCT00733499|DePuy Ortho Joint US|Tamiko Magee-Rodgers, PhD||TMageeRo@its.jnj.com|
20180203|NCT00733980|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180204|NCT02739347|Baylor College of Medicine|Raymond Cho|7137987781|Raymond.Cho@bcm.edu|
20180205|NCT01552954|Department of Internal Medicine, Seoul National University Bundang Hospital|Ho Jun Chin|+82-10-7360-7025|mednep@snubh.org|
20180206|NCT00779779|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180207|NCT01395823|Dialysis Clinic Inc|Karen Majchrzak|615-342-0483|karen.majchrzak@dciinc.org|
20180208|NCT00070135|The Ohio State University|Steven Devine, MD||steven.devine@osumc.edu|
20162488|NCT03576716|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
20180209|NCT03300570|Fox Chase Cancer Center|David Weinberg, M.D., M.Sc.|215-214-1424|david.weinberg@fccc.edu|
20222961|NCT00725153|Alcon Research, Ltd.|Jessie Lemp, MS|817-615-2739|Jessie.Lemp@alconlabs.com|
20180210|NCT03188120|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180211|NCT01769170|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20180212|NCT01472874|Yale|Dr. Schilsky|203-785-2565|michael.schilsky@yale.edu|
20180213|NCT01126060|Samsung medical center|Dr. Man Ki Chung|82-2-3410-1845|manki.chung@samsung.com|
20180214|NCT02070484|OhioHealth|Josepha Shehadi, MD|614-220-5648|joseph@drshehadi.com|
20180215|NCT02658630|VA Pittsburgh Healthcare System|George F. Wittenberg|412-648-4178|GeoWitt@Pitt.edu|
20180216|NCT01521884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180217|NCT02821819|Instituto Bernabeu|Dr. Juan Carlos Castillo|+34650562634|jcastillo@institutobernabeu.com|
20180218|NCT00658138|University of Bologna, Italy|Professor Giovanni Dondi dall'Orologio|+39 051-2088132|gdondi@alma.unibo.it|
20180219|NCT04182880|Cali Biosciences|Chief Medical Officer|12038376500|e.onel@calibiosciences.com|
20180220|NCT03389477|Washington University School of Medicine|Douglas Adkins, M.D.|(314) 362-4471|dadkins@wustl.edu|
20180221|NCT03522077|Aurora Health Care|Dr. Muhammad Fuad Jan|414-649-3491|fuad.jan@aah.org|
20180222|NCT02239380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180223|NCT04366726|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
20180224|NCT01353222|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
20180225|NCT03857230|IVFarma LLC|General Manager|+7(499)6455342|info@ivfarma.ru|1
20180226|NCT01654601|The Catholic university of Korea|Won-myung Bahk. M.D. PhD.|82-2-3779-1051|wmbahk@catholic.ac.kr|
20180227|NCT02636270|Cincinnati Childrens Hospital Medical Center|Philippe Backeljauw|513-636-8444|philippe.backeljauw@cchmc.org|
20180228|NCT01119898|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20180229|NCT01806584|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20180230|NCT01833143|Memorial Sloan Kettering Cancer Center|Gregory Riely, MD, PhD|646-608-3913|rielyg@mskcc.org|
20180231|NCT03021668|Johns Hopkins Hospital|Dr. Matthew J. Weiss|4106143368|mweiss5@jhmi.edu|
20180232|NCT00909428|Loyola University Chicago|Mary P FitzGerald|708-216-2170|mfitzg8@lumc.edu|
20180233|NCT02217280|Missouri Orthopaedic Institute|Dr. Christina Goldstein|573-884-9022|goldsteincl@health.missouri.edu|
20180234|NCT01015976|University of North Dakota - Neuropsychiatric Research Institute|James L. Roerig PharmD, BCPP|701 365 4919|jroerig@nrifargo.com|
20180235|NCT00116844|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180236|NCT03995784|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
20180237|NCT02907814|Rutgers New Jersey Medical School|Dr. Elliot Crane|973-972-2020|cranees@njms.rutgers.edu|
20180238|NCT00583622|The University of Texas MD Anderson Cancer|Yago Nieto, MD, PhD / Professor||celsaenz@mdanderson.org|
20180239|NCT01786330|University of Kansas School of Medicine - Wichita|Zachary Kuhlmann, DO|316-685-7234|zkuhlmann@kumc.edu|
20180240|NCT02172625|Georgia State University|Dr. Gerald S. Zavorsky|404-413-1271|zavorsky@gsu.edu|
20180241|NCT02053077|MUG|Thomas Pieber|004331638512383|thomas.pieber@medunigraz.at|
20180242|NCT04834817|University of California, Irvine|Dr. Kristen Kelly, Professor and Chair, Dept. of Dermatology|949-824-5515|kmkelly@hs.uci.edu|
20180243|NCT02417532|The Chris Moody Centre|Nick Birch|+44 1604 215440|nickbirch@doctors.org.uk|
20190950|NCT01648699|Janssen Philippines|Medical Affairs Manager|+632-8248935||
20190951|NCT02267746|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
20190952|NCT01812837|UC Davis|Dr. Raja Sivamani|9167035145|rksivamani@ucdavis.edu|
20190953|NCT03720717|University of Alabama at Birmingham|Timothy J Ness MD PhD, Professor Emeritus|2059079743|tness@uabmc.edu|
20190954|NCT05008224|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20190955|NCT05234632|Smith & Nephew, Inc.|Dr Rochelle O'Hara|+44 1923 477218|Rochelle.OHara@smith-nephew.com|
20190956|NCT04799587|Northwestern University|Paul Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20190957|NCT00728884|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20190958|NCT05263492|Virginia Commonwealth University Massey Cancer Center|Massey IIT Research Operations|804-628-6430|masseyepd@vcu.edu|
20190959|NCT03680092|University of California, San Diego|Dr. Dimitrios Tzachanis|(858) 822-6600|dtzachanis@health.ucsd.edu|
20190960|NCT03345420|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
20190961|NCT05216835|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20190962|NCT05179603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20190963|NCT03861078|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
20190964|NCT01075815|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20190965|NCT00596960|VAMC|Eric Dieperink, MD|612-467-3964|eric.dieperink@va.gov|
20190966|NCT02058992|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20190967|NCT01292005|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-2175|vege.santhi@mayo.edu|
20190968|NCT02916745|on behalf of Concordia Laboratories Inc./Advanz Pharma|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
20190969|NCT03005106|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
20190970|NCT01855399|VA HSRD: CCMR Ann Arbor and University of Michigan Medical School|Dr. Michele Heisler|(734) 845-3614|mheisler@umich.edu|
20190971|NCT03019289|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20190972|NCT00936065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20190973|NCT02389894|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
20190974|NCT04617574|Holyoke Medical Center Weight Management Program|Bariatric Clinical Administrator|(413) 535 - 4759|davidson_elana@holyokehealth.com|
20180244|NCT02241720|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
20180245|NCT02764775|Fort Worth Independent School district|Dr. Julie Brown|214-725-8232|jbrown18@twu.edu|
20180246|NCT01265030|Maine Medical Center|Dr. Aaron Weiss, Principal Investigator|2073967565|Aaron.Weiss@mainehealth.org|
20180247|NCT01992549|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
20190975|NCT01429285|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
20190976|NCT02070640|The Ohio State University Wexner Medical Center|Associate Professor|614-293-3230|raaja.narula@osumc.edu|
20190977|NCT02168153|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|Long_C@palmer.edu|
20190978|NCT01288729|Stanford Childrens Health|Bruce Buckingham|650725-6549|buckingham@stanford.edu|
20190979|NCT01754389|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
20190980|NCT01819233|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Nicole Simone|215-955-6702|nicole.simone@jefferson.edu|
20190981|NCT03602053|PATH|Dr Niraj Rathi, MD; Senior Medical Officer|+91 11 4064 0000|nrathi@path.org|
20190982|NCT01769352|Johns Hopkins University School of Medicine|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
20190983|NCT05129592|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|3017128357|cweiger2@jhmi.edu|
20190984|NCT04203225|Harbor-UCLA Medical Center|Kelly D. Young, MD|424-306-5431|kyoung3@dhs.lacounty.gov|
20190985|NCT03672188|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20190986|NCT01234675|Cleveland Sleep Research Center|Mansoor Ahmed, MD|4402438044|sleepresearchcenter@yahoo.com|
20190987|NCT03997409|Vanderbilt University Medical Center|Dr. Sara Duffus|+1 (615)322-7427|sara.duffus@vumc.org|
20190988|NCT01753323|Novartis Pharmaceuticals|Study Director|862-778-8300||
20190989|NCT02115542|Moffitt Cancer Center|Richard Kim, MD|813-745-1432|Richard.Kim@moffitt.org|
20190990|NCT01870999|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800-562-3974||
20190991|NCT01636258|The Cleveland Clinic|Adam M. Bernstein MD|216-448-8538|bernsta2@ccf.org|
20190992|NCT03416335|Sumitomo Pharma America|Reyna Bishop|617-674-6800|reyna.bishop@us.sumitomo-pharma.com|
20190993|NCT00116584|ULouisville|Dr. In Kim|502-629-7212|in.kim@louisville.edu|
20190994|NCT03327051|Stanford University|Aida Habtezion|650-736-5555|aidah@stanford.edu|
20190995|NCT02798861|University of Pittsburgh|Andres Duarte-Rojo|412-647-7922|duarterojoa@pitt.edu|
20190996|NCT00907517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20190997|NCT02795819|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|877-462-7739|AskMassey@vcu.edu|
20190998|NCT02465866|Charleston Laboratories, Inc|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
20190999|NCT02023099|AbbVie|Global Medical Services|800-633-9110||
20191000|NCT00203502|University of Arkansas for Medical Sciences|Dr. Issam Makhoul|5016868274|MakhoulIssam@uams.edu|
20191001|NCT01469819|Texas Tech University Health Sciences Center El Paso|Dr. Irene Sarosiek|(915)215-5254|irene.sarosiek@ttuhsc.edu|
20191002|NCT01695993|University of Rochester Medical Center|Joseph A. Roscoe, PhD Associate Research Professor|585 275-9962|joseph_roscoe@urmc.rochester.edu|
20191003|NCT04117711|Applied Therapeutics, Inc|Riccardo Perfetti, MD|2122209226|rperfetti@appliedtherapeutics.com|
20191004|NCT04057937|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20191005|NCT02029521|Intermountain Healthcare|Clark Bishop|385 224 7343|clark.bishop@imail.org|
20191006|NCT01072396|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191007|NCT00472199|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191008|NCT01540071|Io Therapeutics, Inc.|Martin E. Sanders, M.D.|(650) 219-5973|msanders@io-therapeutics.com|
20191009|NCT02446912|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20191010|NCT01268488|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|914-333-6280|carmine.greene@ascensia.com|
20191011|NCT00828542|Sao Paulo University|Dr. Milena Bastos Brito|551636022814|milenabastos@usp.br|
20191012|NCT01106586|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20222962|NCT00644917|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20222963|NCT00758485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20222964|NCT00921557|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20222965|NCT01566539|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
20180248|NCT01495221|Vitreous Retina Macula Consulatants of New York|Jason S. Slakter, MD|212-861-9797|mail@vrmny.com|
20180249|NCT00767104|Wake Forest University Health Sciences|Alan Fleischer, Jr. MD|336-716-3775|Afleisch@wfubmc.edu|
20180250|NCT00840996|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20180251|NCT04022889|Cerus Corporation|Carol Moore|9258766819|cmoore@cerus.com|
20180252|NCT03047174|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
20180253|NCT03015116|Landstuhl Regional Medical Center|Dr. Ann Kobiela Ketz|8022656263|annketz@gmail.com|
20180254|NCT01015807|Univerisity of Washington|Dr. Laurent Bollag|+12063277328|bollag@uw.edu|
20180255|NCT00708526|University of Utah|Dwayne Westenskow, PhD|801-581-2478|Dwayne.Westenskow@hsc.utah.edu|
20180256|NCT02949921|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20180257|NCT01175148|Mary Babb Randolph Cancer Center|Pam Bunner, Clinical Research Specialist|304-598-4511|bunnerp@wvuhealthcare.com|
20180258|NCT00431184|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
20191013|NCT01757171|Weill Cornell Medical College|Navjot Kaur, GI Program Manager|646-962-9350|nak2028@med.cornell.edu|
20180259|NCT00519896|University of Washington|Renato G Martins|206-288-2048|rgmart@uw.edu|
20180260|NCT00750282|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
20180261|NCT01077362|Janssen Research & Development, LLC|Senior Director, Clinical Research|1-800-526-7736||
20222966|NCT03259425|Huntsman Cancer Institute|Data Manager, Research Compliance Office|8015850601|compliance@hci.utah.edu|
20180262|NCT02387216|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
20180263|NCT04359771|faculty of medicine, Cairo University|Dr. Ahmed Abdelbaki|00201066642728|a.abdelbaki@kasralainy.edu.eg|
20180264|NCT02306265|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
20180265|NCT02917265|Oklahoma Medical Research Foundation|Aikaterini Thanou, MD|405-271-7805|aikaterini-thanou@omrf.org|
20180266|NCT01187329|Cleveland Clinic|Andra E. Duncan, M.D|216-445-2372|DUNCANA@ccf.org|
20180267|NCT01216163|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180268|NCT03597035|University Hospitals Cleveland Medical Center|Sanjay Rajagopalan|216-844-5125|Sanjay.Rajagopalan@UHhospitals.org|
20180269|NCT03107377|Evofem|Chief Medical Officer|858-550-1900|kculwell@evofem.com|
20180270|NCT02914379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20180271|NCT00453102|University of Miami|Izidore S. Lossos|305-243-4785|ilossos@med.miami.edu|
20180272|NCT03154944|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
20180273|NCT01782963|Massachusetts General Hospital|Noopur Raje, MD|617-724-4000|NRAJE@mgh.harvard.edu|
20180274|NCT04249219|University of Massachusetts Chan Medical School|Elise Stevens|(774) 455-6684|elise.stevens@umassmed.edu|56684
20180275|NCT05652036|Houston Methodist Hospital Department of Urology|Dr. Rose Khavari|713-441-6455|rkhavari@houstonmethodist.or|
20180276|NCT02237508|Zambon SpA|Isabella Salerio, PhD|+39 02665241|clinicaltrials@zambongroup.com|
20180277|NCT01650519|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20180278|NCT01737281|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
20180279|NCT05458024|University of North Carolina at Chapel Hill|Sam McLean, MD, MPH|+1 (919) 843-5931|samuel_mclean@med.unc.edu|
20222967|NCT04724538|P. Hertsen Moscow Oncology Research Institute|Mariia Sedova, MD|+79253093463|mariya.sedova58@gmail.com|
20222968|NCT01282372|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20222969|NCT00713258|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
20222970|NCT01322490|Bavarian Nordic A/S|Program Lead, Clinical Operations|+ 45 3326|info@bavarian-nordic.com|8383
20222971|NCT01431716|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD, Senior Clinical Scientist|+41 61 565 5932|thomas.pfister@actelion.com|
20222972|NCT02199795|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|
20222973|NCT04972110|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
20222974|NCT03620643|The Royal Marsden NHS Foundation Trust|Clinical Trial Manager|02078082887|rolo.trial@rmh.nhs.uk|
20222975|NCT05310071|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20222976|NCT02418949|Shirley Ryan AbilityLab|Alexander Barry|3122381435|abarry@sralab.org|
20222977|NCT02343939|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20222978|NCT00460811|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
20222979|NCT02097745|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20222980|NCT03480542|Hackensack Meriden Health|Cole McCoy|551-204-5529|cole.mccoy@hmhn.org|
20222981|NCT03278223|Visioncare Research Ltd.|Mr Thomas Boyes, Clinical Project Manager|+441252 718719|t.boyes@visioncare.co.uk|223
20222982|NCT02099110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20222983|NCT01435304|Maine Medical Center|Dr. Robert S Kramer|207-662-1486|Kramer@mmc.com|
20222984|NCT02977572|INTENSIVE CARE UNIT. HOSPITAL GENERAL UNIVERSITARI CASTELLO|Dr. Alberto Belenguer Muncharaz|0034-964-725000|belengueralberto8@gmail.com|
20222985|NCT03527589|Merit Medical|Casey Holland|6178420251|casey.holland@merit.com|
20222986|NCT02683928|Ichnos Sciences SA|Study Director|2013314000|clinicaltrialsdisclosuredesk@ichnossciences.com|
20222987|NCT01014169|Boston University School of Medicine/Boston Medical Center|Dr Caroline Kistin|617-414-3642|caroline.kistin@bmc.org|
20222988|NCT00523848|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20222989|NCT00086619|Massachusetts General Hospital|Robert Neer, MD|617-726-6723|rneer@partners.org|
20222990|NCT00489918|Zosano Pharma Inc.|Don Kellerman, VP of Clinical Development and Medical Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
20222991|NCT02748213|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20222992|NCT00913263|Dept. of Surgery, Tampere University Hospital, Tampere, Finland|Teuvo Tammela, Professor|+358-3-31164621|teuvo.tammela@uta.fi|
20222993|NCT00961350|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
20222994|NCT05908526|University of Maryland, Baltimore|Emerson Wickwire, PhD|410-706-4771|ewickwire@som.umaryland.edu|
20222995|NCT04818034|University of California, San Francisco|Marshall Stoller|415-514-0918|victoria.hogue@ucsf.edu|
20222996|NCT01760655|Tevogen Bio|Dolores Grosso|848-256-5751|dolores.grosso@tevogen.com|
20222997|NCT03100968|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
20222998|NCT04738474|University of Washington|Jill Steiner|2062218240|jills8@uw.edu|
20222999|NCT04973176|University Hospitals Coventry and Warwickshire NHS Trust|Dr Cyprian Mendonnca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25784
20223000|NCT01515865|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20180280|NCT04986085|Grupo Español de Tumores Neuroendocrinos y Endocrinos|A responsible Person Designated by the Sponsor|0034934344412|investigacion@mfar.net|
20180281|NCT02954458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20180282|NCT01905046|City of Hope|Victoria Seewaldt, M.D.|6262564674|vseewaldt@coh.org|67321
20180283|NCT05672680|Icahn School of Medicine at Mount Sinai|Celia Divino|(212) 241-3348|celia.divino@mountsinai.org|
20223001|NCT01450306|Hartford Hospital|Dr David Tolin|860-545-7685|david.tolin@hhchealth.org|
20180284|NCT00747123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20223002|NCT04687137|Shire|Study Director|: +1 866 842 5335|ClinicalTransparency@shire.com|
20223003|NCT02510664|Baylor College of Medicine|Marisa Hilliard PhD, Principal Investigator|832-824-7209|marisa.hilliard@bcm.edu|
20180285|NCT03267680|University of Southern California|Tali Homsey|3238650430|tali.homsey@med.usc.edu|
20180286|NCT01778556|NIDDK|Dr. Rebecca Brown|301-594-0609|brownrebecca@mail.nih.gov|
20223004|NCT00735969|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype|(301) 402-5115|mg228m@nih.gov|
20180287|NCT00116272|Amgen Inc.|Study Director|866-572-6436||
20223005|NCT02801617|Laboratorios Sophia|Dr. Oscar Olvera|(33) 3001 4200|oscar.olvera@sophia.com.mx|1074
20223006|NCT02110758|National Committee for Quality Assurance|Sarah Hudson Scholle|202-955-1726|scholle@ncqa.org|
20223007|NCT04090060|Medical college of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
20180288|NCT00576732|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609 730 2317||
20180289|NCT00920023|Massachusetts General Hospital|Ralph Weissleder|6177268226|RWEISSLEDER@MGH.HARVARD.EDU|
20223008|NCT02176655|Clinvest/A Division of Banyan Group Inc.|Heather Manley|417-841-3664|hmanley@clinvest.com|
20223009|NCT06110494|University of Pennsylvania|Dr. Bekir Karabucak Chair of the Department of Endodontics|215-898-4927|bekirk@upenn.edu|
20223010|NCT00435708|Queen's University Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
20223011|NCT02490371|QEHHongKong|Dr. Helen LUK|852-9208 5366|clkyz02@ha.org.hk|
20223012|NCT03915587|University of Colorado|Sarkis Chris Derderian|720-777-6163|sarkis.derderian@childrenscolorado.org|
20223013|NCT01718535|Mount Sinai Services Inc.|Azar Azad|416-856-8545|aazad@mtsinai.on.ca|
20223014|NCT01605552|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
20180290|NCT01235403|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20180291|NCT02978443|Georgetown University|Suthee Rapisuwon|202-877-6583|Suthee.Rapisuwon@medstar.net|
20180292|NCT02296190|Milestone Pharmaceuticals|Francis Plat _MD_Chief Medical Officer|514-336-0444|fplat@milestonepharma.com|225
20180293|NCT02087501|Endospan|Jessica Kleine||j.Kleine@endospan.com|
20180294|NCT00094328|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20180295|NCT03682705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20180296|NCT01483937|BalanceSense LLC|Karen L. Atkins PhD PT|407 625 9680|atkins.balancesense@gmail.com|
20180297|NCT02213328|Desmond Tutu HIV Foundation|Dr Katherine Gill|+2721 785 3121|katherine.gill@hiv-research.org.za|
20180298|NCT00265330|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20180299|NCT00990340|Teva Neuroscience|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
20180300|NCT04615182|TransMedics Inc.|Laura Damme, VP Clinical Affairs|9785520900|ldamme@transmedics.com|
20180301|NCT01336621|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180302|NCT03571737|Brody School of Medicine @ East Carolina University|Dr. Jennifer Stahl|2527442570|stahlj@ecu.edu|
20180303|NCT00280826|National Eye Institute|Robert Nussenblatt, MD, MPH|301-496-3123|drbob@intra.nei.nih.gov|
20180304|NCT02139358|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
20180305|NCT04485130|University of California, San Francisco|Dr. Sulggi Lee|415-735-5127|sulggi.lee@ucsf.edu|
20180306|NCT00402337|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
20180307|NCT02178566|Inova Health Systems|Christopher King, MD|7037763067|christopher.king@inova.org|
20180308|NCT02934620|Ohio State University, College of Public Health|Maria Gallo|16146882145|gallo.86@osu.edu|
20180309|NCT04557826|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
20223015|NCT01163851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223016|NCT00648115|VA North Texas Health Care System|James LePage|210-857-0240|james.lepage@va.gov|
20180310|NCT01474213|Department of Anaesthetics, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine|Dr. Jiang Hong|86-21-13512122883|hr310@vip.sina.com.cn|
20180311|NCT02130284|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20180312|NCT00682643|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180313|NCT01875185|Johns Hopkins University School of Medicine|RhondaLyn McLean|(215) 662-4949|rhondalyn.mclean@uphs.upenn.edu|
20180314|NCT03565068|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180315|NCT05778526|The Hong Kong Polytechnic University.|Dr. Ka Po Wong|64860214|portia.wong@polyu.edu.hk|
20180316|NCT00085202|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|info@stjude.org|
20180317|NCT01985828|Advocate Health|Geraldine Lara|8477238239|geraldine.lara@aah.org|
20180319|NCT03238300|Medical University of South Carolina|Lindsay M. Squeglia, PhD|843-792-5451|squegli@musc.edu|
20180320|NCT02917941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20180321|NCT01893827|NYU Langone Health|Mia Malone|646-501-3577|mia.malone@nyulangone.org|
20180322|NCT00399763|Denver Health|Christian Thurstone, M.D.|303-436-6006|christian.thurstone@dhha.org|
20180323|NCT04064242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20180324|NCT03536546|Department of Veterans Affairs|Paul N Pfeiffer, MD MS|(734) 769-1000|Paul.Pfeiffer@va.gov|
20180325|NCT04512066|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20180326|NCT00859651|Columbia University|Katherine Crew, MD|212-305-1732|kd59@cumc.columbia.edu|
20180327|NCT00445679|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20180328|NCT00311155|Daiichi Sankyo Pharma Development|Sr. Director, Regulatory Operations|732-590-5032|hmkessler@dsi.com|
20180329|NCT00612222|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20180330|NCT02419547|Brigham and Women's Hospital|Douglas Shook, MD, Chief, Divison of Cardiac Anesthesia|617-732-8219|dshook@bwh.harvard.edu|
20180331|NCT01567943|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
20180332|NCT01478113|Massachusetts General Hospital|Maren Nyer|617-643-4897|mnyer@partners.org|
20180333|NCT01703702|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20180334|NCT02294630|Wayne State University|Beena G. Sood, MD, MS|313-745-5638|bsood@med.wayne.edu|
20180335|NCT00628901|Boston Scientific|Ana Becker / Sr. Clinical Program Manager|651-581-4605|Ana.Becker@bsci.com|
20180336|NCT00815035|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20180337|NCT01767935|Wake Forest University Health Sciences|Dr. David Childs|336-716-2471|dchilds@wakehealth.edu|
20180338|NCT04399356|Tufts Medical Center|Dorothy Dulko, PhD - Research Project Director|(617) 636-5009|ddulko@Tuftsmedicalcenter.org|
20180339|NCT03812536|Ohio State University|Dr. Syed Husain|6142938772|syed.husain@osumc.edu|
20180340|NCT03148236|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
20180341|NCT01735396|Tisch Cancer Center, Icahn School of Medicine at Mount Sinai|Dr. Matthew David Galsky|212-689-5412|matthew.galsky@mssm.edu|
20180342|NCT00572624|Washington University School of Medicine|Dr. Linda Peterson, M.D.|314-362-4577|lpeterso@dom.wustl.edu|
20180343|NCT02201056|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20180344|NCT02081950|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
20180345|NCT00818961|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
20180346|NCT01286441|Santalis Pharmaceuticals|Dr. Paul Castella Ph.D.|210-399-2316|paulc@santalispharma.com|101
20180347|NCT01436201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180348|NCT01435655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180349|NCT00524225|University of Pittsburgh|Dr. Margaret Ragni, Professor of Medicine|412-209-7288|ragni@dom.pitt.edu|
20180350|NCT00110890|Amgen Inc.|Study Director|866-572-6436||
20180351|NCT01686581|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20180352|NCT01975220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180353|NCT02839343|Mayo Clinic|Frank Sinicrope|5072664338|Sinicrope.Frank@mayo.edu|
20180354|NCT01870388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180355|NCT01852058|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20180356|NCT03619590|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
20180357|NCT00263328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180358|NCT01199926|Purdue University|Dr. Dorothy Teegarden|765-494-8791|teegarden@purdue.edu|
20180359|NCT01226914|Medical University of South Carolina - Department of Otolaryngology - Head and Neck Surgery|Shaun A. Nguyen, MD, FAPCR|8437921356|nguyensh@musc.edu|
20180360|NCT02613221|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20180361|NCT01301274|Intensive Care Unit - Hospital Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
20180362|NCT00661661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180363|NCT03879603|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Julie E. Ledgerwood, DO (Study Chair)|301-594-8502|ledgerwood@mail.nih.gov|
20180364|NCT03403426|Reflow Medical|Isa Rizk|9494810399|info@reflowmedical.com|
20180365|NCT00626366|University of Nebraska Medical Center|Erin K O'Brien|402-559-6463|irbora@unmc.edu|
20180366|NCT03520400|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
20180367|NCT01933880|Xi'an Janssen Pharmaceutical Ltd.|Director - CNS & Pain, CDMA, China R&D and SA|+86 10 5821-8307||
20180368|NCT00510458|Stryker Orthopaedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
20180369|NCT02569710|Alios BioPharma, Inc|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20180370|NCT01125722|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20180371|NCT03474549|Rapid-Medical|Dr. Walid Haddad- Chief Clinical Officer|+972 72 2503331|walid@rapid-medical.com|
20180372|NCT00834808|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20180373|NCT03573908|Ironwood Pharmaceuticals, Inc.|Vanessa Chong|(617) 374-3923|vchong@ironwoodpharma.com|
20180374|NCT04006925|Stanford University|Emmanuel During|212-844-8888|Emmanuel.During@mountsinai.org|
20180375|NCT01755143|Medtronic Cardiac Rhythm and Heart Failure|5076MRI Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
20180376|NCT00045435|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|206-667-4961|bsandmai@fhcrc.org|
20180377|NCT00674622|University of Pittsburgh School of Medicine Department of Psychiatry|Ronald Glick, MD|412-623-3023|glickrm@upmc.edu|
20180378|NCT00738101|Baylor College of Medicine|Dr. Muralidhar H Premkumar|8328267980|premkuma@bcm.edu|
20180379|NCT01292070|Tunitas Therapeutics|Nolan Sigal, MD, PhD, CEO, Tunitas Therapeutics|(650) 887-4747|nsigal@tunitastherapeutics.com|
20180380|NCT00051168|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20180381|NCT04236258|Brigham and Women's Hospital|Dr. Elizabeth Yoselevsky|314-413-1254|eyoselevsky@bwh.harvard.edu|
20191014|NCT00428441|University of Insubria|Dr. Walter Ageno|+39 0332 278831|agewal@yahoo.com|
20191015|NCT00094497|University Hospital of Wuerzburg, Germany|Martin Fassnacht|+49-931-201-39021|fassnacht_m@ukw.de|
20191016|NCT05216952|University of North Carolina at Chapel Hill|Jill Hagey, MD, MPH|919-966-5280|jmhagey1@ad.unc.edu|
20191017|NCT01014013|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20162489|NCT00559988|Biotronik, Inc|Crystal Miller|503-451-8051|crystal.miller@biotronik.com|
20223017|NCT01073605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223018|NCT03018080|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20223019|NCT00740792|Meda Pharmaceuticals|David Ginsberg,D.O.|7325642364|david.ginsberg@meda.us|
20223020|NCT01921322|Medtronic Diabetes|John Shin, PhD|818-576-4019|john.shin@medtronic.com|
20223021|NCT02417142|UMass Medical School|Xiaoduo Fan, MD, MPH|(508) 856 -3881|xiaoduo.fan@umassmed.edu|
20223022|NCT04632069|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
20223023|NCT04042623|Aravive|Dr. Reshma Rangwala, Chief Medical Officer|936-355-1910|rrangwala@aravive.com|
20223024|NCT02573181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223025|NCT03412734|TriHealth Inc.|Catrina Crisp, MD MSc|513-463-4300|Catrina_Crisp@trihealth.com|
20223026|NCT03431831|University of Nebraska Medical Center|Trina Aguirre|308-632-0410|taguirre@unmc.edu|0412
20223027|NCT01620190|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
20223028|NCT00179660|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20223029|NCT03935425|Flint Rehab|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
20223030|NCT00402688|Ortho-McNeil Janssen Scientific Affairs, LLC|Therapeutic Area Lead, Anti-Infective Franchise|908-927-5220||
20223031|NCT03980145|Indiana University|Peter Altenburger|3172780703|paltenbu@iu.edu|
20223032|NCT02892110|MUSC|Amanda Wagner, Program Manager|843-792-0484|wagne@musc.edu|
20223033|NCT00835224|James J Peters VAMC|Dr. Jill M. Wecht|718 584-9000|jm.wecht@va.gov|3122
20223034|NCT05393869|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
20223035|NCT02730403|NYU Grossman School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyulangone.org|
20223036|NCT04922255|University of Pittsburgh|Megan Bradley, MD|2487701681|megsbrad2010@gmail.com|
20223037|NCT00014495|Memorial Sloan Kettering Cancer Center|Dr. Martin Tallman|212-639-3842|tallmanm@mskcc.org|
20223038|NCT01342523|University of Wisconsin|Stevens Smith, PhD|608-262-7563|sss@ctri.wisc.edu|
20223039|NCT00556946|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
20223040|NCT02929589|MOMMC|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
20223041|NCT02755467|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20223042|NCT02091089|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20223043|NCT04668248|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
20223044|NCT03187730|NYU Langone|Elizabeth Vargas|310-486-9775|elizabeth.varagas@nyulangone.org|
20223045|NCT00994461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223046|NCT00461773|The Christ Hospital|Gina G. Chung, MD|(513) 564-7771|gina.chung@thechristhospital.com|
20223047|NCT04571645|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20223048|NCT03723850|University of Chicago|Dr. David Gallo|773-702-8829|dgallo@uchicago.edu|
20223049|NCT03147690|Boston Children's Hospital|Dr. David Mooney, MD MPH|617-355-7800|david.mooney@childrens.harvard.edu|
20223050|NCT00591565|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
20223051|NCT02811965|Lincoln Memorial University|Jennifer Savage, DNP, APN, FNP-BC||jennifer.savage@lmunet.edu|
20223052|NCT01863667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223053|NCT03627546|Weill Cornell Medicine|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
20223054|NCT01992172|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
20223055|NCT00615550|Columbia Laboratories|George W Creasy MD|973-486-8797|Gcreasy@columbialabs.com|
20223056|NCT01537042|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20223057|NCT02741076|Janssen Pharmaceuticals, Inc.|John Han, Associate Director, Statistics|484-354-3547|jhan9@its.jnj.com|
20223058|NCT01779440|Dartmouth-Hitchcock|Mary F. Brunette, MD|603-229-5419|Mary.F.Brunette@hitchcock.org|
20223059|NCT01115244|Vanderbilt University Medical Center|Mary Beth Cole|(615) 322-6485||
20223060|NCT01329380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20223061|NCT02965573|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20223062|NCT00315458|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
20223063|NCT01209520|University of Miami|Ikechukwu Akunyili MD|305-243-6626|IAkunyili@med.miami.edu|
20223064|NCT02508077|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20223065|NCT05864612|Wake Forest University Health Sciences|Heidi Munger-Clary, MD, MPH, FACNS, FAES|336-716-7110|heidi.mungerclary@advocatehealth.org|
20223066|NCT03960008|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
20223067|NCT03056638|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
20223068|NCT02530125|Northwestern University|Winter, Jane MD|312 695 4033|Jwinter@nm.org|
20223069|NCT00468481|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20223070|NCT03187418|Centre Hospitalier de l'Universite de Montreal (CHUM)|Dr. Michael Marchand, MD|514-890-8000|michael.marchand-gareau@umontreal.ca|
20223071|NCT00728468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223072|NCT01568034|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
20223073|NCT01637922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223074|NCT04392375|The Ohio State University|Kara Rood, MD|440-321-0264|Kara.Rood@osumc.edu|
20223075|NCT02498444|Stanford University|Jeffrey Feinstein, MD|6507252297|jeff.feinstein@stanford.edu|
20223076|NCT03656692|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20223077|NCT01841762|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani / Associate Director, Clinical Operations|6508086586|scott.tsurutani@actelion.com|
20180382|NCT00709059|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20180383|NCT01396317|Hospital for Special Surgery|Dr. Robert Spiera|212-774-2048|spierar@hss.edu|
20180384|NCT03315130|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20180385|NCT00524030|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180386|NCT02914132|ExThera Medical Corporation|Sr. Director of Regulatory and Clinical Affairs|9258392079|erdie@extheramedical.com|
20180387|NCT02707692|UC San Diego|David (Davey) Smith|619-300-9638|d13smith@health.ucsd.edu|
20180388|NCT02944656|Emory University|Tiffany Hailstorks, MD, MPH|404-778-1385|tiffany.p.hailstorks@emory.edu|
20180389|NCT04398537|University of Alabama at Birmingham|Stefanie Woodard|205-996-4132|swoodard@uabmc.edu|
20180390|NCT03535337|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
20180391|NCT00552786|National Taiwan University|Dr. Yue-Liang Guo|+886-2-33228216|leonguo@ntu.edu.tw|
20180392|NCT04684641|Yale University|Dr. Jonathan Koff|475-224-8167|jon.koff@yale.edu|
20180393|NCT03549234|University of California San Diego|Matthew Swisher, MD|415-314-4099|matthew.swisher@gmail.com|
20180394|NCT02243631|Zablocki VA Medical Center|Dr. Ann Rosenthal , MD ACOS/Research|414-384-2000|ann.rosenthal@va.gov|41430
20180395|NCT03117517|Khyber Medical University|Dr. Mohsin Shah (Associate Professor)|3429620074|mohsin.ibms@kmu.edu.pk|+92
20180396|NCT01959945|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20180397|NCT01590771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180398|NCT02019563|The Hospital for Sick Children|Trang Nguyen|6473300825|trang.nguyen@easternhealth.ca|
20180399|NCT01785628|China Medical University Hospital|The chief, Department of Neurology|8864-22052121|d8079@mail.cmuh.org.tw|5035
20180400|NCT02200939|Smith+Nephew, Inc.|Laura England, Sr. Director Global Clinical Strategy|+1 650 223 6941|Laura.England@smith-nephew.com|
20180401|NCT02746575|Washington University|Principal Investigator|7737022544||
20180402|NCT04867785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20223078|NCT01270464|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20223079|NCT02448537|Massachusetts General Hospital|Gregory Cote, M.D., Ph.D|617-724-4000|gcote@partners.org|
20223080|NCT04725812|Cedars-Sinai Medical Center|Professor of Medicine, Cedars-Sinai Medical Center|310-423-7608|sananth.karumanchi@csmc.edu|
20223081|NCT05778851|PAVmed Inc., Lucid Diagnostics Inc.|Victoria T. Lee, MD CMO, SVM Clinical Affairs|425.218.6535|VTL@PAVmed.com|
20223082|NCT05656534|The Ohio State University|Dr. Stephanie Gorka|614-366-1027|stephanie.gorka@osumc.edu|
20223083|NCT00742963|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20180403|NCT01486758|Washington University in St. Louis|Dr. Avraham Beigelman (PI)|314-454-2694|beigelman_a@kids.wustl.edu|
20180404|NCT02494921|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
20180405|NCT03239873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180406|NCT02169895|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20180407|NCT03585296|Aclaris Therapeutics|Executive Director Clinical Operations|4843242144|jschnyder@aclaristx.com|
20180408|NCT03270514|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Kathirvel Subramaniam, MD, MPH, FASE|724-799-5852|subramaniamk@upmc.edu|
20180409|NCT03980184|Yale University|Rajita Sinha, PhD, Study PI|203-737-5805|rajita.sinha@yale.edu|
20180410|NCT00462670|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
20180411|NCT02002884|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20180412|NCT02966002|University of Michigan|Adam Lubert|734-764-5177|luberta@med.umich.edu|
20180413|NCT01662531|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20180414|NCT02291432|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20180415|NCT02596022|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
20180416|NCT02145078|Barbara Ann Karmanos Cancer Institute|Gerold Bepler|(313)576-8670|beplerg@karmanos.org|
20180417|NCT03327402|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20180418|NCT02134119|University of Georgia|Jamie Cooper|7065424903|jamie.cooper@uga.edu|
20180419|NCT01454830|The Pennsylvania State University|Amy M. Sawyer, PhD|814-863-1020|ams24@psu.edu|
20180420|NCT00872430|Hospital de Clínicas de Porto Alegre|Dr. Paulo Dornelles Picon|55 xx 51 21018752|paulopicon@gmail.com|
20180421|NCT00584805|USAMRIID Medical Division|Anthony Cardile, D.O.|301-619-8833|anthony.cardile.mil@mail.mil|
20180422|NCT03195465|Loma Linda University School of Allied Health Professions|Amy Sadek, PhD Rehabilitation Science|951-212-2104|asadek@llu.edu|
20162490|NCT01455194|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20180423|NCT03097861|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20180424|NCT01785563|University of Iowa|Tarah T. Colaizy|3193255640|tarah-colaizy@uiowa.edu|
20180425|NCT01616771|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
20180426|NCT00744328|Northwestern University|Research Study Coordinator|312-695-8441|emily.pinheiro@northwestern.edu|
20180427|NCT00154310|Novartis Pharmaceuticals|Study Director|862-778-8300||
20180428|NCT04041440|Customized Learning Exercises for Aural Rehabilitation|Chief Operating Officer|314 399-9943|chris@amptify.com|
20223084|NCT00839800|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20180429|NCT02247804|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20223085|NCT03421210|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
20223086|NCT02973503|CHU Clermont-Ferrand|Armand Abergel|+33473750523|aabergel@chu-clermontferrand.fr|
20223087|NCT04478695|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20180430|NCT00517075|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
20180431|NCT03447730|Synlogic|Andrew Marsh, Head Clinical Operations|617-401-9975|andrew.marsh@synlogictx.com|9135
20180432|NCT01962025|Ottawa HRI|Dr. Deborah Zimmerman|613-722-7000|dzimmerman@toh.ca|
20180433|NCT05737433|Hepion Pharmaceuticals Inc|Jill Greytok|732-902-4000|jgreytok@hepionpharma.com|
20180434|NCT01350505|VA Palo Alto Health Care System|Dr. Jamie Zeitzer|650-493-5000|jamie.zeitzer@va.gov|62410
20180435|NCT00868699|Sunovion|Medical Director, CNS|1-866-503-6351||
20180436|NCT04251065|SC Ematologia - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - Trieste|Prof. Francesco Zaja|+ 39 040 3992015|francesco.zaja@asugi.sanita.fvg.it|
20180437|NCT01054573|Janssen Research & Development, LLC|Medical Leader|1 609 730-3174||
20180438|NCT05266963|Vanderbilt University Medical Center|Dan Moore, M.D., Ph.D.|615-322-7247|daniel.moore@vumc.org|
20180439|NCT00152009|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20180440|NCT01306201|Covidien|Ulf Borg, Director of Clinical Affairs|303-305-2400|ulf.borg@covidien.com|
20180441|NCT04702568|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20180442|NCT00393523|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20180443|NCT02912468|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
20180444|NCT04091360|Verona Pharma|Medical Science Director|6464130307|margot.macdonald-berko@veronapharma.com|
20180445|NCT03452176|Massachusetts General Hospital|Dr. Michael Levy|617-726-0412|mlevy11@mgh.harvard.edu|
20180446|NCT00779558|Stanford University|Alan Schroeder|408 885-5260|alan.schroeder@hhs.sccgov.org|
20180447|NCT00423852|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, Assistant Attending|+1646-422-4491|Feldmand@mskcc.org|
20180448|NCT00980005|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180449|NCT04145037|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
20180450|NCT01756560|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
20180451|NCT01916941|University of New Mexico|Dr. Claire Wilcox|505-272-2333|cewilcox@salud.unm.edu|
20180452|NCT00098254|National Cancer Institute|Giuseppe Giaccone, M.D., PH.D.|301-496-4916|giacconeg@mail.nih.gov|
20180453|NCT02224482|Fox Chase Cancer Center|Dr. Suzanne Miller|215-728-4069|Suzanne.Miller@fccc.edu|
20180454|NCT00744263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180455|NCT00910520|Allergan, Inc|Therapeutic Area Head,|714-246-4500 ext:|clinicaltrials@allergan.com|
20180456|NCT00211237|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20180457|NCT01121172|4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki|Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology|00302310991537|agalli@auth.gr|
20180458|NCT04078035|University of Pittsburgh|Dr. Anna Marsland|14123705622|marsland@pitt.edu|
20180459|NCT03758118|IRCCS Fondazione Bietti|Dr, Vincenzo Parisi|+390686356727|vmparisi@gmail.com|
20180460|NCT05644353|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20180461|NCT03929562|University of Michigan|Anne C. Fernandez|734-232-0521|acfernan@med.umich.edu|
20180462|NCT01036022|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180463|NCT03482505|Masimo|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
20180464|NCT00855010|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20180465|NCT02969525|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20180466|NCT03445065|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20180467|NCT02089230|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
20180468|NCT01598298|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
20180469|NCT00186498|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
20180470|NCT03469284|UT MD Anderson Cancer Center|Dr. Carlos Roldan, Associate Professor, Pain Medicine|(713) 563-7402|croldan@mdanderson.org|
20180471|NCT04567693|Montefiore Medical Center|Dr. Jonathan Ross|718-920-7064|joross@montefiore.org|
20180472|NCT02134210|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
20223088|NCT02875613|UC San Diego - Moores Cancer Center|Dr. Assuntina Sacco|858-822-5210|agsacco@ucsd.edu|
20180473|NCT01596283|Memorial Sloan Kettering Cancer Center|Dr. Mary Fischer MD|212-639-6745|fischerm@mskcc.org|
20180474|NCT03722264|Virginia Commonwealth University|Eser Tufekci, DDS, PhD|804-828-9326|etufekci@vcu.edu|
20180475|NCT02608489|Soonchunhyang University Hospital|Dr. JinKwon Chung|82-2-709-9354|schcornea@schmc.ac.kr|
20180476|NCT01411501|Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences|Liu Zhishun|8610-010-88001124|liuzhishun@aliyun.com|
20180477|NCT00708721|Huntsman Cancer Institute|Dr. Paul Shami|801-585-0100|paul.shami@hci.utah.edu|
20180478|NCT04105972|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20223089|NCT01136356|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
20223090|NCT02347774|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20223091|NCT00927862|Intermountain Healthcare|Dr. Jeffrey L. Anderson, Director of CV Research and Professor of Medicine|801-507-4704|jeffrey.anderson@imail.org|
20180479|NCT02687412|SichuanCHRI|Dr Cui Ling|+8618181422637|cuiling1985@qq.com|
20223092|NCT04306965|Tufts Medical Center|Study Coordinator|617-636-1579|courtney.donovan@tuftsmedicine.org|
20223093|NCT00820248|Canadian Cancer Trials Group|Wendy Parulekar|613-533-6430|wparulekar@ctg.queensu.ca|
20180480|NCT00553202|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20180481|NCT01671839|Merz Pharmaceuticals|Public Disclosure Manager|+49 69 1503 0|clinicaltrials@merz.com|
20180482|NCT00041756|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20180483|NCT01749501|William Beaumont Hospital|Dr. Martin Espinosa|248-898-0633|Martin.espinosa@beaumont.edu|
20223094|NCT01309360|Helios-Kliniken Schwerin|Dr.med.Ronald Seidel|0049 (0)385 520-4251|ronald.seidel@helios-kliniken.de|
20223095|NCT02901067|Denver Health Medical Center|Study Coordinator, James Chandler|303-602-3798|james.chandler@dhha.org|
20223096|NCT01562782|The Rogosin Institute|Lisa Hudgins, M.D.|646-317-0805|lih2013@nyp.org|
20223097|NCT02993250|Janssen Pharmaceutical K.K., Japan|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20223098|NCT00776295|H. Lee Moffitt Cancer Center|Mohamed Kharfan Dabaja, MD|961-1350000|MK143@aub.edu.lb|5350
20223099|NCT02307279|Gelesis|Harry Leider, MD, MBA|(443)934-4906|hleider@gelesis.com|
20180484|NCT04048759|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
20180485|NCT00509002|The University of Texas (UT) MD Anderson Cancer Center|George R Blumenschein Jr, MD, Professor, Thoracic/Head & Neck Med. Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20180486|NCT01111838|Memorial Sloan Kettering Cancer Center|Dr. Andrea Cercek|646-888-4189|CercekA@mskcc.org|
20180487|NCT02444663|University of Oxford|Thomas Hamilton, Clinical Research Fellow|01865227696|thomas.hamilton@ndorms.ox.ac.uk|
20180488|NCT00553098|Fred Hutch Cancer Research|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
20180489|NCT01299090|Moy, Fincher, Chipps Medical Group|Lisa Chipps, MD|(310) 274-5372|lchipps@ucla.com|
20180490|NCT01872910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20180491|NCT01540565|NRG Oncology|Christopher Purdy on behalf of Mike Sill|(716)845-1300|purdyc@nrgoncology.org|2296
20180492|NCT02091739|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20180493|NCT03469349|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20180494|NCT01422369|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
20180495|NCT03771157|University of Rochester|Michael Brady|585-276-3203|michael_brady@urmc.rochester.edu|
20180496|NCT02086162|Dartmouth-Hitchcock|Dr. Mary F. Brunette|603-229-5419|mary.f.brunette@hitchcock.org|
20180497|NCT03349268|University of Michigan|Keith Kaye|732 235-9312|kk1116@rwjms.rutgers.edu|
20180498|NCT01827254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180499|NCT01834222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180500|NCT02207439|University of Pennsylvania|Alexander Lin, MD|215-662-3198|alexander.lin2@pennmedicine.upenn.edu|
20180501|NCT04785326|Dong-A ST|Clinical Research Manager|02-920-1111|imspring@donga.co.kr|
20180502|NCT02641249|University of California|Dr. Kalpashri Kesavan|3108256304|KKesavan@mednet.ucla.edu|
20180503|NCT00692406|DukeUMC|Dr. F. Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
20180504|NCT02597933|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180505|NCT04205929|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
20180506|NCT00817804|Respironics California|Adam Seiver|760-703-6993|adam.seiver@philips.com|
20180507|NCT01097915|University of Cagliari|Iole Tomassini Barbarossa, Associate Professor|+390706754144|tomassin@unica.it|
20180508|NCT04599101|William Beaumont Hospitals|Christine Batchelder, Research Nurse Manager|2488981075|christine.batchelder@corewellhealth.org|
20180509|NCT05288023|University of California San Francisco|Kieran O'Brien|(415) 476-1442|kieran.obrien@ucsf.edu|
20180510|NCT02235701|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20180511|NCT00525265|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
20180512|NCT01913639|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
20180513|NCT01805882|National Institute of Allergy and Infectious Diseases|Shyam Kottilil MD|+1 410 706 4872|Skottilil@ihv.umaryland.edu|
20180514|NCT00130793|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180515|NCT01515189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20223100|NCT00356148|Marmara University School of Medicine|Prof. Bahadir M Gulluoglu|902164256565|bmgulluoglu@marmara.edu.tr|4012
20180516|NCT01013792|HCA Retreat Hospital, Institute of Plastic and Reconstructive Surgery|Joseph V. Boykin, Jr., MD|804-353-8100|joseph.boykin@HCAhealthcare.com|
20180517|NCT02100722|Stanford University|William Fearon, MD|650-725-2621|wfearon@stanford.edu|
20180518|NCT02300285|Boston Children's Hospital|Michael SD Agus, MD|617 355-5849|michael.agus@childrens.harvard..edu|
20180519|NCT02541383|Intergroupe Francophone du Myélome|Chief Executive Officier|+33 1 40 21 24 02|ifmclinicaltrials@myelome.fr|
20180520|NCT03500640|University of Pittsburgh School of Medicine|Elizabeth M. Venditti PhD, Associate Professor of Psychiatry and Epidemiology|4123025228|vendittiem@upmc.edu|
20180521|NCT05777174|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
20180522|NCT01447849|TexasTech|Dr. Jerzy Sarosiek, Director, Mol. Medicine Research|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
20180523|NCT01970787|Laser Surgery Care|Stephen E Goldstone|212-242-6500|segmd@prodigy.net|
20180524|NCT01905254|Universitiy Clinic Hamburg eppendorf|PD Dr. Ulrike Denzer|040741055380|u.denzer@uke.de|
20180525|NCT01087996|The EMMES Corporation|Adam Mendizabal|301 251 1161|amendizabal@emmes.com|221
20180526|NCT04395183|University of Utah|Brent Kious, MD, PhD|801-585-1418|brent.kious@hsc.utah.edu|
20191018|NCT02305797|Cardinal Health Regulatory Sciences|Director of Regulatory Affairs and Product Development|913.451.3955|david.rhein@cardinalhealth.com|
20191019|NCT03508830|University of California, San Francisco|Dr. Greg J. Haro|415-353-7502|greg.haro@ucsf.edu|
20191020|NCT02391714|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|skaur@salud.unm.edu|
20223101|NCT02484456|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
20223102|NCT01053663|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20223103|NCT02737930|University of Rochester|Bogachan Sahin|(585) 275-2530|bogachan_sahin@urmc.rochester.edu|
20223104|NCT04594070|University of Texas Medical Branch Galveston|Dr. Melody Safarzadeh|9082854962|mesafarz@utmb.edu|
20180527|NCT01008475|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20180528|NCT02668016|Imperial College London|Professor Darrel Francis|0207 594 9647|d.francis@imperial.ac.uk|
20180529|NCT01044576|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
20180530|NCT00971750|Gundersen Lutheran Health System|Dr. Shanu Kothari|608-775-2331|snkothar@gundluth.org|
20180531|NCT01657266|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Clinical trials Director|52+ (33) 30 01 42 00|leopoldo.baiza@sophia.com.mx|
20180532|NCT05093049|Apyx Medical|Senior Director of Clinical Affairs|801-244-0058|kari.larson@apyxmedical.com|
20180533|NCT01316770|NIDCR/NIH|Ilias Alevizos|3014966207|alevizosi@mail.nih.gov|
20180534|NCT02260401|University of Washington|Dr. Janna Friedly|206-744-3000|friedlyj@uw.edu|
20180535|NCT00736489|AstraZeneca|Carin Jorup, MSD||ClinicalTrialTransparency@astrazeneca.com|
20180536|NCT02205801|The University of Chicago Medicine & Biological Sciences|Dr. Raymond H. Grogan|773-702-7125|rgrogan@surgery.bsd.uchicago.edu|
20180537|NCT01583101|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
20180538|NCT01974700|Indiana University|Dr. Aaron Cohen-Gadol|317-396-1300|ACohen@goodmancampbell.com|
20180539|NCT02234063|Icahn School of Medicine at Mount Sinai|Dr. Carol R. Horowitz|212-659-9564|carol.horowitz@mssm.edu|
20180540|NCT00402194|Indiana University|Dr. Kieren Mather|317-278-7826|kmather@iu.edu|
20180541|NCT01555164|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20180542|NCT03443713|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
20180543|NCT04686279|Johns Hopkins University|Dr. Craig Hendrix|410-955-9707|chendrix@jhmi.edu|
20180544|NCT04255342|University of Iowa|Chris Barwacz|(319) 384-3002|chris-barwacz@uiowa.edu|
20180545|NCT01672853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20180546|NCT01620567|Tufts University|Elizabeth J. Johnson, PhD|617.556.3204|elizabeth.johnson@tufts.edu|
20180547|NCT00976482|ospedale S Orsola- Malpighi, Bologna, Italy|dr Mauro Biffi|+393337661449|mauro.biffi@aosp.bo.it|
20180548|NCT00720902|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
20180549|NCT02959671|University of Minnesota|Thorsten Gruenheid, DDS, PhD|612-625-3903|tgruenhe@umn.edu|
20162491|NCT02891382|Universidad Peruana Cayetano Heredia|Dr. J Jaime Miranda|+511 241 69 78|Jaime.Miranda@upch.pe|
20180550|NCT03366220|The University of Texas Health Science Center at Houston|Dr. Lillian S Kao|(713) 500-6280|Lillian.S.Kao@uth.tmc.edu|
20180551|NCT03462706|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
20180552|NCT03463915|University of Louisville|Sean Francis|502-561-7260|Sean.francis@louisville.edu|
20180553|NCT01334944|Cumberland Pharmaceutical Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
20180554|NCT02341287|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
20180555|NCT02254408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20180556|NCT01097395|University of Colorado|Jennifer Kiser|3037246131|jennifer.kiser@cuanschutz.edu|
20180557|NCT00584701|UCSF|Robert Hendren, DO|415-476-7198|robert.hendren@ucsf.edu|
20180558|NCT01161472|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180559|NCT01449240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20180560|NCT02914184|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20180561|NCT00798174|Washington University in St. Louis|Dr. Timothy W. Smith|314-286-1501|tsmith@wustl.edu|
20180562|NCT00768430|Baylor College of Medicine|Dr. Sanjay Mathew|7137911414|sjmathew@bcm.edu|5439
20180563|NCT00802659|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8525|jbradley@radonc.wustl.edu|
20180564|NCT03355755|Ekso Bionics|Leslie Van Hiel|4042268017|leslie.vanhiel@gmail.com|
20180565|NCT03093428|Dana Farber Cancer Institute|Atish Choudhury|617-632-6328|achoudhury@partners.org|
20180566|NCT04042285|Hull University Teaching Hospitals NHS Trust|Louise Hitchman|01482 311925|l.hitchman@nhs.net|
20180567|NCT05340751|Hospital for Special Surgery|Dr. Friedrich Boettner|2127742127|BoettnerF@hss.edu|
20180568|NCT00067990|University_of_Minnesota|Hassan N. Ibrahim, MD|(612) 624-9444|ibrah007@umn.edu|
20180569|NCT02176421|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20180570|NCT02406885|The Johns Hopkins University School of Medicine|Dr. Brent Petty|410-955-8181|bpg@jhmi.edu|
20180571|NCT03810313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20180572|NCT03820323|University of Washington|Rena C. Patel|206-520-3800|rcpatel@uw.edu|
20180573|NCT01617005|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20180574|NCT01320735|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20180575|NCT02307513|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20180576|NCT01560260|Sarcoma Alliance for Research through Collaboration (SARC)|Kristen Nuyen, Research Project Manager|734-930-7600|sarc@sarctrials.org|
20180577|NCT05952297|University of Utah|Dr. Kelly Baron|8015857588|kelly.baron@utah.edu|
20180578|NCT01458990|Hunter Holmes McGuire VA Medical Center|Jasmohan Bajaj|804 675 5802|jasmohan.bajaj@va.gov|
20180579|NCT01107743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180580|NCT00308737|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20162492|NCT02516228|Philips|Sr. Clinical Operations Manager|3034753417|pat.olsen@philips.com|
20162493|NCT03916484|University of North Carolina at Chapel Hill|Kate Muessig, PhD|850-644-3299|kmuessig@fsu.edu|
20180581|NCT01225822|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180582|NCT01290822|Columbia University|Henry M. Spotnitz, MD|(212) 305-6191|hms2@columbia.edu|
20162494|NCT00788710|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20180583|NCT01003639|University of Iowa Hospitals and Clinics|Dr. Michael Wall|319-353-3942|michael-wall@uiowa.edu|
20180584|NCT03501693|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20180585|NCT00284089|Novartis Pharmaceuticals|Study Director|862 778-8300||
20180586|NCT00089895|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20180587|NCT02778399|Clinical Operations|Medical Responsible|+41 (0)22 552 1560|clinicaltrials@obseva.ch|
20180588|NCT00578721|UC Irvine Health - Chao Family Comprehensive Cancer Center|Jason Zell, DO, MPH, MS|714-456-5153|jzell@hs.uci.edu|
20180589|NCT03501043|MossRehab|Stella Lee|215-663-6665|leest@einstein.edu|6665
20223105|NCT00708214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180590|NCT00405639|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
20180591|NCT02081456|Cayuga Medical Center|Dr. Michael Costello, PT, DSc, OCS, MTC|607-252-3500|mcostellopt@gmail.com|
20180592|NCT00612534|AcelRx|Pamela Palmer, MD PhD|650-216-3500|ppalmer@acelrx.com|
20180593|NCT02101918|UT MD Anderson Cancer Center|Dr. Daniel M. Halperin/ GI Medical Oncology|713-792-2828|DMHalperin@mdanderson.org|
20180594|NCT01508013|East Tennessee State University|Dr. Joel Hillhouse|423-439-4332|hillhous@etsu.edu|
20180595|NCT02487095|National Cancer Institute|Dr. Anish Thomas|240-760-7343|thomasa6@nih.gov|
20180596|NCT02117934|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
20180597|NCT03108157|ProcreaTec|Dr. Alexandra Izquierdo, Medical and Scientific Director at ProcreaTec|0034651879266|endoscratchtrial@gmail.com|
20180598|NCT03557086|Massachusetts General Hospital|Dr. Nneka Ufere|617-643-3408|nneka.ufere@mgh.harvard.edu|
20180599|NCT01279343|Washington University School of Medicine|Jeanine Carbone MD|314-362-8523|jfcarbone@hotmail.com|
20180600|NCT04534114|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20180601|NCT03287414|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20180602|NCT02759185|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
20223106|NCT03852264|University of Arizona|Dr. Evan MacLean|520-621-0386|evanmaclean@arizona.edu|
20223107|NCT02073448|Galderma K.K|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
20223108|NCT01413750|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20223109|NCT03124407|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
20223110|NCT03660189|The MetroHealth System|Dr. Chloe Castro|2167784527|ccastro@metrohealth.org|
20223111|NCT03761030|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
20223112|NCT05708976|University of California San Francisco|Ashley E. Mason, PhD|4155146820|ashley.mason@ucsf.edu|
20180603|NCT03245255|Thomas Jefferson University|Jaydev Dave|2158684795|dave.jaydev@mayo.edu|
20180604|NCT04765735|Medtronic|Janelle Blum|262-289-8419|janelle.blum@medtronic.com|
20180605|NCT01960530|Diurnal Limited|Dr John Porter|02920 682069|info@diurnal.com|
20223113|NCT05753904|University of Missouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
20223114|NCT00183885|USC/Norris Comprehensive Cancer Center|Victoria Soto|(323) 865-0451|victoria.soto@med.usc.edu|
20223115|NCT00608777|DermResearch, PLLC|Leon Kircik, M.D.|502-5451-9000|wedoderm@yahoo.com|
20223116|NCT01045187|Xoft, Inc.|Kelly W Elliott RN, MS|408-419-2428|Kelliott@xoftinc.com|
20223117|NCT00396656|Novartis Pharmaceuticals|Study Director|862 778-8300||
20223118|NCT01537926|UTHealth Science Center at Houston|Dr. Ali J. Marian|713-500-2310|Ali.J.marian@uth.tmc.edu|
20223119|NCT00504712|Barnsley Hospital NHS Foundation Trust|Professor TH Jones|01226 431684||
20223120|NCT01303172|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0) 20 3137 6346|info@immodulon.com|
20223121|NCT02821754|Principal Investigator|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
20223122|NCT03635515|University of Minnesota|Ronald Ordinola Zapata DDS, MS, PhD|(612) 624-9900|rordinol@umn.edu|
20223123|NCT00514215|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
20223124|NCT00554515|Beth Israel Deaconess Medical Center|David F. McDermott, MD||dmcdermo@bidmc.harvard.edu|
20223125|NCT00766636|University of Texas MD Anderson Cancer Center|Jason B. Fleming, MD / Surgical Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
20223126|NCT02060838|Nationwide Children's Hospital|Aymen Naguib, MD|(614) 722-0596|Aymen.Naguib@nationwidechildrens.org|
20223127|NCT01731119|UNC-Chapel Hill|Dr. Linmarie Sikich||linmarie_sikich@med.unc.edu|
20223128|NCT01017536|Aeras|Bernard Landry|301-547-2900|blandry@aeras.org|
20223129|NCT01385137|SWOG Statistical Center|Study Statistician|206-667-4623||
20223130|NCT02837731|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20223131|NCT01119859|Hoffmann-La Roche|Medical Communications|800 821-8590||
20223132|NCT01294241|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
20223133|NCT02644668|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20223134|NCT02835625|Cancer Registry of Norway|Prof. Solveig Hofvind|+47 22928828|solveig.hofvind@kreftregisteret.no|
20223135|NCT03850483|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223136|NCT04325568|New York University|Dr. Lawrence Yang|(212) 992-6334|lawrence.yang@nyu.edu|
20180606|NCT04472377|Hygeia Touch Inc.|Lance Yang|+886-3-6675616|cyyang@hygeiatouch.com|
20180607|NCT01022073|San Francisco VA Medical Center|William J. Marks, Jr., M.D.|415-750-2100|William.Marks@va.gov|
20223137|NCT01164579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223138|NCT02215200|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8361|cjgreen@benaroyaresearch.org|
20180608|NCT01122381|Vetarans Administration Pittsburgh Healthcare System|Kathy Gardner MD|(412) 360-6185|kathy.gardner@va.gov|
20223139|NCT00302328|Glostrup Hospital|Ulrik Christensen|+4538634825|bisan@regionh.dk|
20223140|NCT01288937|Columbia University|Thomas H. Brannagan, MD|(212) 305-0405|tb2325@cumc.columbia.edu|
20180609|NCT02395133|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20180610|NCT00962247|SUNY Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
20180611|NCT01536184|Child Development Clinic SSCY Centre|Dr. Ana Hanlon-Dearman|204-258-6628|ahdearman@hsc.mb.ca|
20180612|NCT01861522|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20223141|NCT04511520|National medical research center for therapy and preventive medicine|Dr. Maria Makhinova|+79104803524|longtimeaftertomorrow@gmail.com|
20223142|NCT00912743|Astra Zeneca LLP|Angela Sawyer, Clinical Delivery Director|+44 1625 512397|angele.sawyer@astrazeneca.com|
20223143|NCT04157296|University of Michigan|Yanni Liu|734-936-9275|yanniliu@med.umich.edu|
20223144|NCT02237196|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20223145|NCT02049905|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20223146|NCT00862823|University of Alabama at Birmingham|Jennifer King|205-934-2696|jenking@uab.edu|
20223147|NCT00619892|UCSF Fresno|Andrew Goddard, M.D.|559-499-6580|agoddard@fresno.ucsf.edu|
20180613|NCT02073097|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Brian T. Hill|1-866-223 8100|TaussigResearch@ccf.org|
20180614|NCT00386308|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20180615|NCT01336634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20180616|NCT01200030|The Hong Kong Polytechnic University|Dr. Shamay Ng|(852) 2766-4889|Shamay.Ng@polyu.edu.hk|
20180617|NCT02265224|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
20180618|NCT00247624|August Health University|Vaughn McCall|706-721-3141|wmccall@augusta.edu|
20180619|NCT02567825|UPMC Children's Hospital of Pittsburgh|Alejandro Hoberman, MD|412-999-3277|hobermana@upmc.edu|
20180620|NCT04741802|Duke University|Nia S. Mitchell, MD, MPH|919-668-7202|nia.s.mitchell@duke.edu|
20180621|NCT03101241|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
20180622|NCT01381874|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20180623|NCT04488003|Biomed Valley Discoveries|Caroline Emery, PhD|816-960-4615|cemery@biomed-valley.com|
20180624|NCT01248962|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
20180625|NCT01003184|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20180626|NCT00557622|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180627|NCT04848662|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20180628|NCT02551744|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20180629|NCT02991144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20180630|NCT03151395|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20180631|NCT04475848|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20180632|NCT02494206|Memorial Sloan Kettering Cancer Center|Dr. Babak Mehrara MD|212-639-3099|mehrarab@mskcc.org|
20180633|NCT04394845|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
20180634|NCT03961009|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
20180635|NCT05796518|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0031|mnjenkin@wakehealth.edu|
20180636|NCT01535274|University of Michigan|Dr. Paul Picton|734-936-4280|ppicton@umich.edu|
20180637|NCT02690077|Advocate Aurora Health|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aah.org|
20180638|NCT02667886|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
20180639|NCT00594217|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342436911|cm2hq@virginia.edu|
20180640|NCT04186403|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20180641|NCT01407354|University Maryland Rehabilitation and Orthopaedic Institute|Paula Richley Geigle PT PhD|410 448 6773|pgeigle@umm.edu|
20180642|NCT02223754|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optemtrist|904-443-3500|TKarkkai@its.jnj.com|3402
20180643|NCT01298921|Geisinger Health System|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
20180644|NCT00515437|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
20180645|NCT04999644|Johns Hopkins University School of Medicine|Justin Strickland|4105501975|jstric14@jhmi.edu|
20180646|NCT01807650|Amryt Pharma|Head of Clinical Development|+353 1 518 0200|medinfo@amrytpharma.com|
20180647|NCT01373450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180648|NCT02946918|UT Southwestern Medical Center|Dr. Alex Tessnow-ASSOC PROFESSOR|214/648-3685|Alex.Tessnow@UTSouthwestern.edu|
20180649|NCT02716038|Columbia University Irving Medical Center|Catherine A. Shu, MD|212-305-3997|cas2145@cumc.columbia.edu|
20180650|NCT00069784|sanofi|Trial Transparency Team||Contact_US@sanofi.com|
20180651|NCT02654990|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
20180652|NCT04466215|The Scripps Research Institute|Dr. Barbara J.. Mason, Ph.D.|(858) 784-7324|mason@scripps.edu|
20180653|NCT02669095|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
20180654|NCT03621202|Saranas, Inc.|Zaffer Syed|833-375-9273|zaffer@saranas.com|
20180655|NCT00697190|Vistakon|John Buch OD|904-443-1707||
20180656|NCT00886639|Schön Klinik BGL|Dr. Klaus Kenn|0865293|iheinzelmann@schoen-kliniken.de|1540
20180657|NCT00926003|Michigan State University|Dr. Michael J. Boivin|5174324204|Michael.Boivin@hc.msu.edu|
20180658|NCT01986361|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
20223148|NCT00291876|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180659|NCT01871558|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20180660|NCT03203694|University of Missouri|Jaume Padilla|(573) 882-7056|padillaja@missouri.edu|
20180661|NCT02281526|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20180662|NCT01709305|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180663|NCT01103960|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180664|NCT03396432|Children Hospital of Philadelphia|Dr. John Fiadjoe, PI|267-426-2961|fiadjoej@email.chop.edu|
20180665|NCT02294474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20180666|NCT00267696|The Ohio State University Comprehensive Cancer Center|Larry Copeland, MD|614-293-8697|Larry.Copeland@osumc.edu|
20180667|NCT03221660|Ivoclar Vivadent AG|Dr. med. dent. Lukas Enggist, Dentist internal clinic (Principal Investigator)|+423 235 34 46|lukas.enggist@ivoclarvivadent.com|
20180668|NCT03104647|Shaare Zedek Medical Center|Dr. Yair Barzilay, PI|+972-2-6555166|barzilay@szmc.org.il|
20180669|NCT00118898|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20180670|NCT05473000|The University of British Columbia|Dr. Michael Koehle|604-822-3838|michael.koehle@ubc.ca|
20223149|NCT00288366|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
20180671|NCT01338012|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
20180672|NCT02714205|University of California, San Francisco|Mike Schembri, Data Systems Analyst|415-353-7161|michael.schembri@ucsf.edu|
20180673|NCT05879198|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
20180674|NCT03813147|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20180675|NCT01693692|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20180676|NCT02805595|Beth Israel Deaconess Medical Center|Martina Porter - Associate Directory of Dermatology Research|6176675834|mporter3@bidmc.harvard.edu|
20180677|NCT04934137|University of Texas Medical Branch|Dr. Melissa Morrow|409-266-0344|memorrow@utmb.edu|
20180678|NCT01167179|Radboud University Nijmegen Medical Center|Jacqueline de Leeuw MSc|+31243614925|j.deleeuw@kno.umcn.nl|
20180679|NCT04602494|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|aeevins@mgh.harvard.edu|
20180680|NCT01806740|Guerbet|Corinne Dubourdieu, Head of Clinical Projects|+33145915000|corinne.dubourdieu@guerbet.com|
20180681|NCT04666922|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191021|NCT02097056|Eisai Korea Inc.|Youngji Pyo|+82-2-3451-5533|y-pyo@eisaikorea.com|
20191022|NCT01446042|Trimel Pharmaceuticals Corp.|Natalia Tkachenko, MD Director Clinical Affairs|9054641755|ntkachenko@trimelpharmaceuticals.com|
20223150|NCT00857896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223151|NCT02907918|Washington University School of Medicine|Foluso O. Ademuyiwa, M.D., MPH|314-454-8313|bisiademuyiwa@wustl.edu|
20223152|NCT02308540|PATH|Dr. Steve Lamola|1-206-285-3500|slamola@path.org|
20180682|NCT01382940|Hoffmann-La Roche|Medical Communications|800 821-8590||
20180683|NCT01517243|Dartmouth College|Lionel Lewis|1-603-650-8685|lionel.d.lewis@dartmouth.edu|
20180684|NCT00983489|Deen Dayal Upadhaya Hospital, New Delhi|Dr Kanchan Sharma|919417938224|psaiims@yahoo.co.in|
20180685|NCT02105636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20180686|NCT00291655|UCB Pharma|UCB Clinical trial call center|+1 877 822 9493||
20180687|NCT00871819|Boston Scientific|Nitzan Mekel-Bobrov, Ph.D.|(661) 949-4537|Nitzan.Mekel-Bobrov@bsci.com|
20180688|NCT05197257|University of Colorado|Dr. Bennett Chin|720-848-0000|Bennett.Chin@cuanschutz.edu|
20180689|NCT02802319|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
20180690|NCT04651114|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
20180691|NCT01966796|Far Eastern Memorial hospital|Dr. Ping-huai Wang|886-2-89667000|pinghuaiwang@gmail.com|2816
20180692|NCT01923896|Emory University|William G. Sharp Ph.D.|404-419-5162|wgsharp@emory.edu|
20180693|NCT02410967|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
20180694|NCT03545113|Wake Forest University Health Sciences|Mariana Murea, MD|336-716-5777|mmurea@wakehealth.edu|
20180695|NCT00235443|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20180696|NCT02032173|Novartis Pharmaceuticals|Study Director|862-778-1873||
20180697|NCT05082142|Northwestern University|Nicholas Dean (current fellow)|7806906285|nicholas.dean@northwestern.edu|
20180698|NCT02010697|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
20180699|NCT00474929|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
20180700|NCT00819403|Univ Maryland|Dr Michael Miller|410 328-6299|mmiller@medicine.umaryland.edu|
20180701|NCT03661996|Centrexion Therapeutics Corporation|Clinical Operations|617-837-6911|info@centrexion.com|
20180702|NCT03321513|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
20180703|NCT03029247|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
20180704|NCT02593305|University of Iowa|Dr. Darren P. Casey|3193841009|darren-casey@uiowa.edu|
20180705|NCT01993017|Center for Behavioral Cardiovascular Health|Ian Kronish, MD, MPH, Principal Investigator|212-342-1335|ik2293@columbia.edu|
20180706|NCT00068380|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20180707|NCT01976364|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180708|NCT02757521|Washington University|Ben J Palanca, MD PhD MSC|314-286-0132|palancab@wustl.edu|
20180709|NCT01190215|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191023|NCT03906240|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Adam McGuire|254-297-5173|adam.mcguire@va.gov|
20180710|NCT00003511|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20223153|NCT01091662|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
20223154|NCT04109391|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
20223155|NCT02156908|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|josh.kantrowitz@nki.rfmh.org|
20223156|NCT01371110|Baylor College of Medicine (previously Icahn School of Medicine at Mount Sinai)|Wayne Goodman|713-798-4945|wayne.goodman@bcm.edu|
20223157|NCT00945035|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223158|NCT02049814|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20223159|NCT00954941|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-794-5783|eharriso@mdanderson.org|
20223160|NCT02023411|PGIMER|Dr Ashu Rastogi|9781001046|ashuendo@gmail.com|
20223161|NCT03533114|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20223162|NCT05478135|Prova Health|Dr Jack Halligan|07742161980|jack.halligan@provahealth.com|
20223163|NCT00693238|University of Florida|Randal Henderson, MD, MBA|904-588-1800|rhenderson@floridaproton.org|
20223164|NCT01028014|University of Alabama at Birmingham|Dr. William Jerod Greer|205-934-7874|wjgreer@uab.edu|
20223165|NCT02411396|Johns Hopkins University School of Medicine|Sophie Lanzkron, MD, MHS, Associate Professor of Medicine and Oncology|410-502-8642|slanzkr@jhmi.edu|
20223166|NCT01631149|Leiden University Medical center|Dr. Albert Dahan|3171 526 2301|a.dahan@lumc.nl|
20223167|NCT00436475|Tufts Medical Center|Dr. Anastassios G. Pittas|617-636-5689|apittas@tuftsmedicalcenter.org|
20223168|NCT02016105|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
20223169|NCT00090493|University of Arkansas for Medical Sciences - MIRT|Frits van Rhee, MD, PhD|(501) 686-8230|vanrheefrits@uams.edu|
20223170|NCT02071706|GE Healthcare|Yvonne Celestial|+33625023857|MarieYvonne.CELESTIAL@ge.com|
20223171|NCT01214083|VA Connecticut Healthcare System|Gihyun Yoon, MD|203-932-5711|gihyun.yoon@va.gov|7421
20180711|NCT00462722|University of Colorado Anschutz Medical Campus|Catherine Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
20223172|NCT01908829|Astellas Pharma Europe Ltd|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
20223173|NCT02865499|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
20223174|NCT02247440|Institut de Recherche pour le Developpement|Gonzague Jourdain|+66818830065|Gonzague.Jourdain@ird.fr|
20223175|NCT02792192|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20223176|NCT02320058|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20223177|NCT00661609|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20223178|NCT01430403|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20223179|NCT03522714|Northwestern University|Peter Ullrich, Clinical Research Coordinator|3129267037|peter.ullrich@nm.org|
20223180|NCT04481789|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20223181|NCT02477332|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20223182|NCT02743936|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April@post.harvard.edu|
20223183|NCT02880475|Mundipharma (China) Pharmaceutical Co. , Ltd|Junjiao Ma|01065636711|Junjiao.Ma@mundipharma.com.cn|
20223184|NCT00900159|Brigham and Women's Hospital; Harvard Medical School|Dr. Orfeu M. Buxton|617-507-9177|Orfeu_Buxton@HMS.Harvard.edu|
20223185|NCT01075256|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223186|NCT04321356|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
20223187|NCT02115581|Children's Medical Center|Giv Heidari-Bateni MD/MPH|3142991984|givhb@yahoo.com|
20223188|NCT01877642|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7777|ClinicalTrialsInfo@alexza.com|
20223189|NCT02593097|Mayo Clinic|Amaal J. Starling, M.D.|480-301-6574|Starling.Amaal@mayo.edu|
20223190|NCT03759587|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20223191|NCT00006178|National Institutes of Health|Dr. Allan D. Kirk||allank@intra.niddk.nih.gov|
20223192|NCT00665431|Pozen|Sr VP Clinical Research|919 913 1030|eorlemans@pozen.com|
20223193|NCT00454363|UT MD Anderson Cancer Center|Dr. James Yao, MD/Professor, GI Medical Oncology, Study Principal Investigator|713-792-2828|jyao@mdanderson.org|
20223194|NCT01578239|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20223195|NCT01669863|Hannover Medical School|Dr Marius Hoeper|00495115323530|hoeper.marius@mh-hannover.de|
20180712|NCT03472287|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman/Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
20180713|NCT01395043|Aalborg Hospital|Dr Nils Bjerregaard|004522860649|niheb@rn.dk|
20180714|NCT02342314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180715|NCT01683994|National Cancer Institute|Dr. William Dahut|240-760-6070|william_dahut@nih.gov|
20180716|NCT00999661|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20180717|NCT00917267|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20180718|NCT03728153|Massachusetts General Hospital|Farrah Mateen|16177248653|fmateen@mgh.harvard.edu|
20180719|NCT02960763|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20180720|NCT02250521|The University of Texas Health Science Center at Houston|Carin A. Hagberg, MD|713-500-6200|Carin.A.Hagberg@uth.tmc.edu|
20180721|NCT00312858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223196|NCT02461433|Johns Hopkins University|Mahmoud Malas|410-550-4546|bmalas1@jhmi.edu|
20223197|NCT02434146|University of Wisconsin Carbone Cancer Center|Margo L Hoover-Regan|608-263-6200|mhooverregan@pediatrics.wisc.edu|
20223198|NCT02703467|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20180722|NCT03638635|Inova Health System|Erica Emery|703-776-7615|erica.emery@inova.org|
20180723|NCT01603420|The Proton Collaborative Group|Corey Woods|630-836-8668|cwoods@pcgresearch.org|
20180724|NCT02318719|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20180725|NCT00252590|VA San Diego Healthcare/University of California, San Diego|Dr. Susan Tate|619-426-9402|srtate@ucsd.edu|
20180726|NCT00432835|University of Mississippi Medical Center|Thomas L. Abell, MD, Professor of Medicine|6019844540|tabell@umc.edu|
20180727|NCT00289770|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180728|NCT00423293|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20180729|NCT02430818|Washington University School of Medicine|Evan Schwarz|3147473690|schwarze@wustl.edu|
20180730|NCT00674115|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20180731|NCT01014975|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
20180732|NCT00936481|Vanderbilt Universit|Kanika Bagai, MD, Assistant Professor|6153220283|kanika.bagai@vanderbilt.edu|
20180733|NCT01971580|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
20180734|NCT02632786|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
20180735|NCT04250337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20180736|NCT00136812|Stanord University|Judith Prochaska, PhD, MPH; Associate Professor|650-724-3608|JPro@stanford.edu|
20180737|NCT04498247|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180738|NCT00669903|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20180739|NCT01678820|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180740|NCT00245856|University of Oklahoma Health Sciences Center|Suman Rathbun MD|4052714742|suman-rathbun@ouhsc.edu|44773
20180741|NCT01539863|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
20180742|NCT03662997|Molnlycke Health Care|David Pham|678-231-9655|david.pham@molnlycke.com|
20180743|NCT00007475|National Institute of Diabetes & Digestive & Kidney Diseases|Jeffrey B. Kopp, MD|+1 (301) 594-3403|jbkopp@nih.gov|
20180744|NCT01719224|Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital|Matthias Eikermann, MD, PhD|617-643-7735|meikermann@partners.org|
20180745|NCT03000673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20180746|NCT01472562|Weill Cornell Medicine|Jia Ruan M.D, Ph.D|646.962.2064|amr2017@med.cornell.edu|
20180747|NCT01512745|Fudan University Shanghai Cancer Center, Shanghai; PLA Cancer Centre, The 81 Hospital of PLA, Nangjing|Co-Director of Clinical Trials|021-64433755|fudanlijin@163.com,qinsk@csco.org.cn|
20180748|NCT02357810|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
20180749|NCT00258180|Johns Hopkins School of Medicine|Maria Oliva-Hemker MD|410-955-8769|moliva@jhmi.edu|
20180750|NCT00152971|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180751|NCT00675506|Massachusetts General Hospital|Steven K. Grinspoon MD|617-726-3890|sgrinspoon@partners.org|
20180752|NCT04986982|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
20180753|NCT03679767|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20162495|NCT02518191|Shanghai 6th People's Hospital Affiliated to Shanghai Jiao Tong University|Dr. ZONG|86 (21) 24058549|tigerzong@msn.com|
20162496|NCT01990859|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20162497|NCT02262754|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162498|NCT01727414|Cincinnati Children's Hospital|Tanya Froehlich|5136361154|tanya.froehlich@cchmc.org|
20162499|NCT04079114|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
20162500|NCT01227005|University of Texas Health Science Center-Houston|Bryan A. Cotton, MD, MPH|713-500-7354|bryan.a.cotton@uth.tmc.edu|
20162501|NCT01431391|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
20162502|NCT00629798|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|646-608-3738|tamarir@mskcc.org|
20162503|NCT02554981|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20162504|NCT00753363|Baltimore VAMC|Dr. Alice Ryan|410-605-7851|aryan@grecc.umaryland.edu|
20162505|NCT02292706|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20162506|NCT01229722|Dimagi Inc.|Dr. Vikram Kumar|6176492214|information@dimagi.com|
20162507|NCT01990612|Northwestern University|Dr. William Grobman|312-472-4661|w-grobman@northwestern.edu|
20162508|NCT02725866|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20162509|NCT03595527|Centre hospitalier de l'Université de Montréal|Valréie Martel-Laferrière, MD|5148908000|valerie.martel-laferriere.med@ssss.gouv.qc.ca|
20162510|NCT02413047|Indiana University|Dr. Matthew Bohm, DO (Principal Investigator)|3179485136|mbohm@iu.edu|
20162511|NCT02188849|Institute of Nutrition and Food Technology University of Chile|Sandra Hirsch MD|+56 229781485|shirsch@inta.uchile.cl|
20162512|NCT04365452|Indiana Univiersity|Theresa Joyce, Quality Improvement Consultant, Research Complaince|3172921882|tajoyce@iu.edu|
20162513|NCT00812565|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201-604-1155|michael.eppolito@octapharma.com|
20162514|NCT01369732|Yonsei University College of Medicine|Dr. Yon Hee Shim|82220193547|tren125@yuhs.ac|
20162515|NCT01793883|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
20162516|NCT02353728|Weill Cornell Medical College|Dr.Ellen K.Ritchie|646-962-2700|ritchie@med.cornell.edu|
20162517|NCT00895310|University of California Davis|Analyst|9167340294|pkaujla@ucdavis.edu|
20162518|NCT00659230|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|3819
20162519|NCT00547521|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20180754|NCT05229653|NYU Langone Health|Kathy Huang, MD|(212) 545-5400|Kathy.Huang@nyulangone.org|
20180755|NCT01845974|Advocate Medical Group Cardiology|Scott M. Miller MD|847-698-5500|scott.miller@advocatehealth.com|
20191024|NCT02724423|Neurelis, Inc.|Sunita Misra, M.D. Medical Director|(832) 257-1975|smisra@neurelis.com|
20191025|NCT02713698|Centro Hospitalar do Porto|Ana Maria Araujo|22 2077549|amfariaaraujo@gmail.com|1280
20191026|NCT03287947|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
20191027|NCT03317288|UT Southwestern Medical Center|Dr. Yi-Ting Tzen|2146481786|Yi-Ting.Tzen@UTSouthwestern.edu|
20191028|NCT01132378|Heekin Institute for Orthopaedic Research|R. David Heekin MD, FACS|904-634-0640|drheekin@heekinortho.com|
20191029|NCT03869541|Imperial College London|Huw Woodbridge|+44 (0)20 7594 3192|h.woodbridge@imperial.ac.uk|
20191030|NCT05287178|University of Oregon|Yoel Everett|541-346-7054|yeverett@uoregon.edu|
20191031|NCT00288353|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
20191032|NCT03867396|University of Colorado Anschutz SOM|Dr. Melinda Anderson|303-724-9316|melinda.anderson@cuanschutz.edu|
20191033|NCT03941769|The University of Texas MD Anderson Cancer Center|Gheath Al-Atrash, M.D. / Stem Cell Transplantation|713-792-7734|galatras@mdanderson.org|
20223199|NCT02934698|MUSC|Patrick Flume|843-792-3167|flumepa@musc.edu|
20191034|NCT00145496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20191035|NCT02228889|The Ohio State University Wexner Medical Center|Dr. Jeffrey Janis|(614) 297-2913|jeffrey.janis@osumc.edu|
20191036|NCT05957198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191037|NCT03138499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20191038|NCT01334606|BD Medical - Diabetes Care|Laurence J. Hirsch. Medical Director|201-847-6513|laurence_hirsch@bd.com|
20191039|NCT02312245|Mayo Clinic|S. John Weroha, M.D., Ph.D.|(507) 284-2511|weroha.saravut@mayo.edu|
20191040|NCT00448344|VA Connecticut|Dr. Lori Bastian|860-667-6853|lori.bastian@va.gov|
20191041|NCT00410150|Cincinnati Children's Hospital Medical Center|Dr. Derek Wheeler|513-636-4239|derek.wheeler@cchmc.org|
20191042|NCT02680145|Mayo Clinic|Dr. John A. Occhino|(507) 538-5883|Occhino.John@mayo.edu|
20191043|NCT01123200|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
20191044|NCT01178281|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20191045|NCT01232569|Hoffmann-La Roche|Medical Communications|800 821-8590||
20191046|NCT02956122|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20191047|NCT02652390|Hässleholm Hospital, Hässleholm, Sweden|Dr. Isam Atroshi|+46443091260|Isam.Atroshi@skane.se|
20191048|NCT01064882|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20191049|NCT01537120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191050|NCT00392704|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20191051|NCT05335005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191052|NCT00515697|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191053|NCT00644332|Gilead Sciences|Emmanuelle Bellemin, Senior Manager, Regulatory Affairs||emmanuelle.bellemin@gilead.com|
20191054|NCT03694210|Interscope, Inc.|Alexis James Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
20191055|NCT00443755|Mayo Clinic|K. Sreekumaran Nair, MD, Ph.D.|507-255-3605|nair@mayo.edu|
20191056|NCT01654445|University of Calgary, Department of Clinical Neurosciences|Shelagh B Coutts and Michael D Hill|4039448065|michael.hill@ucalgary.ca|
20191057|NCT02706834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20223200|NCT02654977|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@umich.edu|
20191058|NCT01896921|University of Maryland|Gregg Brogden|4107061660|gbrogden@ihv.umaryland.edu|
20191059|NCT01862614|The Ohio State University College of Dentistry|Dr. John Nusstein, Professor|614-292-3596|nusstein.1@osu.edu|
20191060|NCT04441996|Emory University|Cheryl Maier MD, PhD|404-712-2795|cheryl.maier@emory.edu|
20191061|NCT00678899|Cochlear Americas|Ginger Grant/Clinical Project Manager|410-375-0883|ggrant@cochlear.com|
20191062|NCT03451292|Instituto Grifols, S.A.|Mireia Torres|+34 93 5710500|approach_preciosa@grifols.com|
20191063|NCT04385849|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20191064|NCT01375777|Amgen Inc.|Study Director|866-572-6436||
20191065|NCT00355784|University of Michigan, Ann Arbor, Michigan|Jeffrey F. Horowitz|734-647-1076|jeffhoro@umich.edu|
20191066|NCT02543294|UT MD Anderson Cancer Center|Dr. Anecita P. Fadol,PHD/Associate Professor, Department of Nursing|713-792-8397|afadol@mdanderson.org|
20191067|NCT00730925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191068|NCT02103816|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20191069|NCT04362111|University of Alabama at Birmingham|Walter Winn Chatham MD|205-612-7402|wchatham@uabmc.edu|
20191070|NCT02504502|Geisinger Health System|Alanna Kulchak Rahm, PhD|570-214-5093|akrahm@geisinger.edu|
20191071|NCT01509040|University of Washington Harborview Center for Pre Hospital Emergency Care|Dr. Graham Nichol|206-521-1728|nichol@uw.edu|
20191072|NCT02475733|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191073|NCT02131155|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191074|NCT01887418|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-329-3020|jjaffe@antarespharma.com|324
20191075|NCT00475735|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191076|NCT03132753|Chestnut Health's Lighthouse Institute; Chicago, Illinois|Dennis Watson|224-534-0114|dpwatson@chestnut.org|
20223201|NCT00150488|Queen Unviersity|J. Curtis Nickel|613 548 2497|jcn@queensu.ca|
20223202|NCT01266291|University of Pennsylvania|John Pollard, MD|215-873-5909|john.pollard@uphs.upenn.edu|
20162520|NCT05066165|Intellia Therapeutics|Trial Manager|833-888-0387|clinicalscience@intelliatx.com|
20223203|NCT03291431|Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences|Dr. Timothy C. Durazzo/Project PI|650-493-5000|tdurazzo@stanford.edu|62982
20223204|NCT03508726|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
20223205|NCT01113385|Children's National|Asha Moudgil MD, Professor of Pediatrics|202-476-5058|amoudgil@childrensnational.org|
20223206|NCT01517763|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|
20223207|NCT00178685|University of Rochester|Dr. Geoffrey Williams|585-530-2050|geoffrey_williams@urmc.rochester.edu|
20223208|NCT04112043|University of Florida|Dr. Robert Mankowski|352-294-5055|r.mankowski@ufl.edu|
20223209|NCT00181285|University of Illinois at Chicago|Jerry A. Krishnan|312-413-0637|jakris@uic.edu|
20223210|NCT01750697|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20223211|NCT01057810|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20223212|NCT02088905|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
20223213|NCT00267969|Centocor Research & Development, Inc.|Dir. Clinical Research|1-800-457-6399||
20223214|NCT04075682|University of South Carolina|Dr. James F. Thrasher|803.777.4862|thrasher@sc.edu|
20223215|NCT00744965|UT Southwestern Medical Center|Kenneth J. Leveno, MD|214-648-2316|kenneth.leveno@utsouthwestern.edu|
20223216|NCT00887315|Department of Health Studies, University of Chicago|Dr. Sang Mee Lee|773-834-6765|slee@health.bsd.uchicago.edu|
20223217|NCT00821964|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
20223218|NCT00832572|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20223219|NCT00384839|Texas Oncology, P.A|Dr. Guru Sonpavde|(281) 332-7505|Guru.Sonpavde@USOncology.com|
20223220|NCT00443079|UCSDMED|Dr. Heather Patton|619-543-2470|hpatton@ucsd.edu|
20223221|NCT00863343|Meso Scale Diagnostics, LLC.|Dennis Mertz, Director Regulatory and Clinical Affairs|240 631-2522|dmertz@mesoscale.com|2809
20223222|NCT01421225|Boston Children's Hospital|Garry Steil (Assistant Prof. of Pediatrics)|617-355-7504|garry.steil@childrens.harvard.edu|
20223223|NCT02649439|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
20223224|NCT04081610|Laboratorios Sophia|Dr. Alejandra Sanchez-Rios|+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|1190
20223225|NCT02714595|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20223226|NCT00497289|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
20223227|NCT02257489|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223228|NCT04606394|PRISM|Gary T Ferguson, M.D.|248-514-6063|garytferguson@msn.com|
20223229|NCT01896128|Burke Rehabilitation Hospital|Pasquale Fonzetti MD|(914) 597-2502|pfonzett@burke.org|
20223230|NCT00955955|Massachusetts General Hospital- Depression Clinical and Research Program|Dr. George Papakostas- Director of Treatment Resistant Depression Studies|617-726-6697|gpapakostas@partners.org|
20223231|NCT00863356|HemCon Medical Technologies|V.P., Clinical Affairs|971.223.4904|jody.oyama@hemcon.com|
20223232|NCT01996254|SPR Therapeutics, Inc.|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
20223233|NCT01339923|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20223234|NCT00637000|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
20223235|NCT01855243|Cairo University|Eman Said Sayed|01001186079|gaviota_3011@hotmail.com|002
20223236|NCT00943150|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20223237|NCT01860040|Western Regional Medical Center|Director of Clinical Research|6232073000|jessica.coats@ctca-hope.com|
20223238|NCT01931995|Massachusetts General Hospital|Dr. Mark Eldaief|6177261728|MELDAIEF@PARTNERS.ORG|
20223239|NCT04513080|Talkspace|Aarthi Padmanabhan|240-273-6191|aarthi.padmanabhan@talkspace.com|
20223240|NCT02477826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20223241|NCT00828568|Taro Pharmaceuticals USA|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
20223242|NCT00403481|Daiichi Sankyo|John J. Raia, R.Ph, Pharm. D.|1-877-437-7763|druginfo@dsus.com|
20223243|NCT00799474|The University of North Carolina at Chapel Hill, Gillings School of Global Public Health|Dr. Noel Brewer, PhD|919-966-3282|ntb1@unc.edu|
20223244|NCT03139578|Johnson & Johnson Vision|Anna Sulley BSc MCOptom FAAO|+44 1344864043|asulley1@its.jnj.com|
20223245|NCT04657198|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20223246|NCT03793842|Michigan Medicine|Robert Hyzy, MD|734-936-5201|rhyzy@med.umich.edu|
20162521|NCT00680459|Baystate Medical Center|Dr. Christine McKiernan|413-794-5370|Christine.McKiernan@bhs.org|
20180756|NCT05408468|University Hospitals Cleveland Medical Center|Dr. Grant Pignatiello|216-368-4480|gap54@case.edu|
20223247|NCT04087720|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
20223248|NCT01166438|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
20180757|NCT01960075|Medical University of South Carolina|Jordan Elm, PhD Biostatistician|843-876-1605|elmj@musc.edu|
20180758|NCT04235582|Aurora Health Care|Mindy Waite, Behavioral Health Research Scientist|414-773-4323|mindy.waite@aah.org|
20180759|NCT00663117|Pennsylvania State University, College of Medicine Hershey, PA 17033|Jill P Smith, MD Professor of Medicine, Gastroenterology Division|717-531-3694|jsmith2@psu.edu|
20180760|NCT01158378|HyperBranch Medical Technology, Inc|Michael Carnahan, PhD|919-433-3329|michaelc@hyperbranch.com|
20180761|NCT02769065|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20180762|NCT03017235|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DKO-Disclosure@ferring.com|
20180763|NCT00437125|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180764|NCT02248961|R-Pharm|Boris Berezhanskiy, Medical Advisor|0074959567937|berezhanskiy@rpharm.ru|2468
20162522|NCT02376179|Nationwide Children's Hospital|Kris Jatana, MD|614-722-6032|Kris.Jatana@nationwidechildrens.org|
20180765|NCT03518658|CRHF Clinical|Keith Holloman|763-526-1545|keith.holloman@medtronic.com|
20180766|NCT02531295|University of California, San Francisco|Sulggi Lee, MD PhD|415-735-5127|sulggi.lee@ucsf.edu|
20223249|NCT03340454|NYU Langone Health|Yi-Ling Tan|646-501-3489|yi-ling.tan@nyulangone.org|
20223250|NCT01464164|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|516-562-1506|avlachos@northwell.edu|
20223251|NCT03682848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20223252|NCT03000010|University of Michigan|G. Ying Li|734-936-5715|yingyuli@med.umich.edu|
20223253|NCT02347813|University of Rochester|Alice Pentland, MD|585-275-1998|alice_pentland@urmc.rochester.edu|
20223254|NCT01134939|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180767|NCT00649389|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20180768|NCT04662671|EmitBio, Inc.|Chief Scientific Officer|(919) 321-1734|nstasko@emitbio.com|
20180769|NCT00453310|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
20180770|NCT04551196|Washington University School of Medicine|David Leonard, MD, Principal Investigator|314-454-2136|dsleonard@wustl.edu|
20180771|NCT00244374|University of California, San Francisco|Dr. Paula J. Lum|415-476-4082|plum@php.ucsf.edu|411
20180772|NCT00603265|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20180773|NCT00525135|University of California San Francisco|UCSF PRS Administrator|415-502-3212|Elaine.Cooperstein@ucsf.edu|
20180774|NCT04399551|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20180775|NCT04502056|JPAL North America|Tristan Loisel|6307476739|tloisel@povertyactionlab.org|
20180776|NCT00010439|Medical University of South Carolina|Deborah A Bowlby, M.D., Assistant Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
20180777|NCT01112514|Massachusetts General Hospital|Andrew T. Chan|617 726 3212|achan@partners.org|
20180778|NCT01118455|Cyberonics, Inc.|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
20180779|NCT01973491|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20180780|NCT02721641|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20180781|NCT01863043|University of Florida|Dr. Leslie Parker|352 215 9360|parkela@ufl.edu|
20180782|NCT03377790|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20180783|NCT01987596|Barbara Ann Karmanos Cancer Institute|Dr. Maxim Yankelevich|313-745-5515|myankele@med.wayne.edu|
20180784|NCT01928225|University of Colorado|Cynthia Frinhaber|720-848-0000|cynthia.firnhaber@cuanschutz.edu|
20180785|NCT00854295|Zimmer Biomet|Erin Osborn|574-371-9884|erin.osborn@zimmerbiomet.com|
20180786|NCT00709592|Virginia Commonwealth University|Amir A Toor, MD|804-828-4360|atoor@mcvh-vcu.edu|
20180787|NCT01231841|Cleveland Clinic Foundation|Jaroslaw Maciejewski, MD PhD, Principal Investigator|216-445-5962|maciejj@ccf.org|
20223255|NCT03817229|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|5136364864|avani.modi@cchmc.org|
20223256|NCT01030289|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
20223257|NCT01186692|Medtronic|Susan Patterson|763.526.1544|susan.patterson@medtronic.com|
20223258|NCT00757042|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20223259|NCT03319732|RVL Pharmaceuticals, Inc.|Vice President Regulatory Affairs and Quality|908-809-1300|regulatory@rvlpharma.com|
20223260|NCT00481351|Universidade de São Paulo|Otavio Celeste Mangili, MD|+554499928818|otaviomangili@yahoo.com.br|
20223261|NCT04892706|Bausch Health Americas, Inc|Study Director|908-541-8664|alison.magnotti-nagel@bauschhealth.com|
20223262|NCT03232931|Emory University|Dr. Nathalie Maitre|404-712-8920|nathalie.linda.maitre@emory.edu|
20223263|NCT04925557|State University of New York at Buffalo|Dr. Robert Zivadinov|716-248-2140|rzivadinov@bnac.net|
20223264|NCT05488470|Division of Cardiology at the Rhode Island and Miriam Hospital, Warren Alpert School of Medicine, Brown University|Antony Chu, M.D., FACC, FAHA, FHRS, FACP, Director of Complex Ablation - Arrhythmia Services Section|401-444-8689|antony_chu@brown.edu|
20223265|NCT01941745|"Tufts Medical Center | Division of Newborn Medicine"|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
20223266|NCT00068393|ECOG Statistical Office|Study Statistician|617-632-3012||
20223267|NCT01190410|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20223268|NCT00893997|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
20223269|NCT04556084|Medical College of Wisconsin|Michael Burke|4149554198|mmburke@mcw.edu|
20223270|NCT04797611|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
20223271|NCT03867409|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
20223272|NCT03300505|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20223273|NCT05119595|B.Braun Aesculap|Diana Kupferschmid, Study Manager of B. Braun|0049746195|studies@aesculap.de|0
20223274|NCT00251303|National Institute of Mental Health, Pediatrics and Developmental Neuroscience Branch|Dr. Susan E. Swedo|301-496-5323|swedos@mail.nih.gov|
20223275|NCT01108341|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20223276|NCT04402138|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
20223277|NCT04390503|Columbia University|Jessica Justman, MD|212-342-0537|jj2158@cumc.columbia.edu|
20223278|NCT01068730|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20223279|NCT02799667|Tufts Medical Center|Ashley T. Peterson, MD, Study Coordinator|617-636-5000|apeterson@tuftsmedicalcenter.org|2382
20180788|NCT02674490|Johns Hopkins University School of Medicine|Dr. Argye Hillis, MD|4109552228|argye@jhmi.edu|
20191077|NCT00084747|UCLA|Dr. Gary Schiller|310-206-5755|gschiller@mednet.ucla.edu|
20202897|NCT00175006|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20223280|NCT00379080|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
20223281|NCT01222520|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223282|NCT02285166|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20223283|NCT03219840|The University of Texas Health Science Center at Houston|Flavia S. Lakschevitz, DDS, PhD, MSc|604-822-3863|flavia.lakschevitz@dentistry.ubc.ca|
20223284|NCT03423173|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20223285|NCT03348930|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
20223286|NCT02920008|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
20223287|NCT01862250|University of Toronto|Estelle B. Gauda|416-813-4908|estelle.gauda@sickkids.ca|
20223288|NCT00179777|University of Helsinki|Professor Mikael Knip|+3582941 25222|mikael.knip@helsinki.fi|
20223289|NCT03457116|NYU Langone Health|Judy Lee, MD|(646) 501-7906|Judy.Lee@nyulangone.org|
20223290|NCT00839527|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223291|NCT02549287|Georgia State University|Dr. Daniel Whitaker|404-413-1282|dwhitaker@gsu.edu|
20223292|NCT00638222|The University of Toledo, HSC|Christopher Cooper, MD|419.383.6030|christopher.cooper@utoledo.edu|
20223293|NCT00427921|Abbott Laboratories|Medical Information Specialist|Phone: (800) 633-9110||
20223294|NCT00520533|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20223295|NCT03502070|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
20223296|NCT01218087|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
20223297|NCT02568189|Icahn School of Medicine at Mount Sinai|James W Tsung MD, MPH|212 241 6272|james.tsung@mountsinai.org|
20223298|NCT04200651|New York Eye Surgery Center; University of Colorado|Dr. Nicholas Tan|3476175971|tannicholas97@gmail.com|
20223299|NCT00691444|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
20223300|NCT02547220|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20223301|NCT04201574|Allysta Pharmaceuticals, Inc.|Clinical Trial Admin|(510) 560-6592|clinicaltrial.admin@allysta.com|
20223302|NCT02887183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20223303|NCT01031680|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20223304|NCT04471194|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
20223305|NCT01029782|Interior Health|Dawn Dalen|250-862-4449|dawn.dalen@interiorhealth.ca|
20223306|NCT03649932|University of Texas Medical Branch|Dr. Sunil Jain|4097722815|amnahqasim@gmail.com|
20223307|NCT02195869|Pharmacyclics LLC, An AbbVie Company|Manuela Juretic, Associate Director, Clinical Operations|(408) 215.3628|mjuretic@pcyc.com|
20223308|NCT00767455|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20223309|NCT01921101|University of Illinois at Chicago|Dr. Carol Braunschweig, Professor|3129962575|braunsch@uic.edu|
20191078|NCT03410953|UICEC, Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL), Plataforma SCReN, Salamanca, Spain|Ricardo López-Pérez, PhD. Study Coordinator and Manager of Clinical Trial|923 291100|ricardo.lopez@scren.es|55779
20191079|NCT05319756|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
20191080|NCT00720629|H. Lee Moffitt Cancer Center and Research Institute|Lia Perez, M.D.|813-745-7202|lia.perez@moffitt.org|
20191081|NCT00296504|ViiV Healthcare|GSK Response Center|866-435-7343||
20191082|NCT02162771|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
20191083|NCT01078571|Abbott|Global Medical Services|1-800-633-9110||
20191084|NCT03594266|BiotronikUS|Crystal Miller|503-475-4984|crystal.miller@biotronik.com|
20191085|NCT00166361|Mayo Clinic|Dr. Lance A. Mynderse|507-284-1250|mynderse.lance@mayo.edu|
20191086|NCT01047306|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20191087|NCT01878253|Zimmer Biomet Inc|Clinical Operation Director|574-371-9823|Bill.Bourdeau@zimmerbiomet.com|
20191088|NCT00472056|UT MD Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor||mvpacheco@mdanderson.org|
20191089|NCT03647709|St Elizabeth Medical Center|Dr Andrew Wickline|315-735-4496|awickline23@gmail.com|
20191090|NCT01818245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191091|NCT04393779|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20223310|NCT03456804|Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8717|heathe@karmanos.org|
20223311|NCT02729051|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20180789|NCT02440594|University of Pennsylvania|Shahrzad Mavandadi|215-823-5211|shahrzad.mavandadi@va.gov|
20180790|NCT03154359|Children's Mercy Hospital|James Steven Leeder, PharmD, PhD|816-731-7116|sleeder@cmh.edu|
20180791|NCT00152763|University Health Network, Toronto General Hospital|Dr. Jane Irvine|(416) 736-5115|jirvine@yorku.ca|22444
20180792|NCT02951351|Mayo Clinic|Margaret M. Reynolds, MD|507-284-2733|margaretmmreynolds@gmail.com|
20180793|NCT02006420|University of Michigan|Dinesh Khanna|734-763-7182|khannad@umich.edu|
20180794|NCT03765762|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20180795|NCT00389974|Princess Margaret Hospital, Toronto, Canada|Dr. Helen Mackay|(416) 946-2253|helen.mackay@uhn.ca|
20180796|NCT00474175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180797|NCT00467142|Institut Bergonié|Pr Yves Becouran||y.becouarn@bordeaux.unicancer.fr|
20223312|NCT00596817|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20223313|NCT03063437|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|majdi@openbiome.org|
20180798|NCT01619787|SUNYBuffalo|Leonard H. Epstein|716-829-3400|ckk@buffalo.edu|
20180799|NCT01034579|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20180800|NCT03321006|NYP Institute|Dr. Katharine Brewster|646 774 6380|Katharine.Brewster@nyspi.columbia.edu|
20180801|NCT00749125|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
20180802|NCT02357043|Remington-Davis Inc.|Dr. Ian Baird|6144872560|hbaird@remdavis.com|
20180803|NCT02979626|University of Colorado Denver|Dr. Suchitra Rao|7207771234|suchitra.rao@childrenscolorado.org|
20180804|NCT01336959|Mereo BioPharma|Dr. Ian Hodgson|+44 333 0237300|enquiries@mereobiopharma.com|
20180805|NCT01737996|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180806|NCT00058019|University of Chicago Medical Center|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
20180807|NCT00985543|St Stephens Centre, Chelsea and Westminster Hospital|Dr Marta Boffito|+44 2088 466 507|marta.boffito@chelwest.nhs.uk|
20180808|NCT02693834|Baylor Institute for Rehabilitation|Priya Karakkattil, PT PhD|469-888-5172|Pjke7991@gmail.com|
20180809|NCT01468922|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
20180810|NCT01923389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162523|NCT02454478|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20162524|NCT02227667|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
20162525|NCT00389493|New York State Psychiatric Institute|Dr. Helen Blair Simpson|646-774-7000|kimeldo@nyspi.columbia.edu|
20162526|NCT00791089|University of Michigan|Hakan Oral|734 936-6868|oralh@med.umich.edu|
20162527|NCT01959841|Maruho Co.,Ltd. Kyoto R&D Center|linical Development Dept.|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20162528|NCT00860171|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
20162529|NCT00780416|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20162530|NCT03304119|Hôpital Privé Antony|V Chassaing|+33 1 46 74 37 00|vchassaing92@gmail.com|
20162531|NCT00666224|Teva Pharmaceutical Industries, Ltd.|Yossi Gilgun, PhD, Global Clinical Leader|972-9-863-1491|yossi.gilgun@teva.co.il|
20162532|NCT02170870|Mayo Clinic|Dr. Adil E. Bharucha, Principal Investigator|507-284-2687|bharucha.adil@mayo.edu|
20162533|NCT01128192|Veterans Medical Research Foundation|Principal Investigator|858-552-8585|rrhenry@ucsd.edu|
20162534|NCT03521141|Vanderbilt University Medical Center|Stephen King|615-875-9394|stephen.king@vumc.org|
20162535|NCT05443256|University of New Mexico|Dr. James F. Cavanagh|5052773890|jcavanagh@unm.edu|
20162536|NCT00482625|Weill Cornell College of Medicine|Dr. Steven Lipkin|212-774-7160|stl2012@med.cornell.edu|
20162537|NCT01078363|Stanford University|William F. Fearon, M.D.|650 725-2621|wfearon@stanford.edu|
20162538|NCT00746863|UNC Hospitals|Gena Dunivan, MD|919-966-4717|gdunivan@med.unc.edu|
20162539|NCT00655629|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20162540|NCT01610336|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20162541|NCT01193114|The Ohio State University|Dr. Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
20162542|NCT01559675|Cedars Sinai Medical Center|Dr. Phillip Fleshner|310-289-9224|pfleshner@aol.com|
20162543|NCT01963845|University of California, San Diego|Rohit Loomba, MD professor of Medicine|858-543-2230|roloomba@ucsd.edu|
20162544|NCT00193180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20162545|NCT01393639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162546|NCT01832155|University of Minnesota|Corjena Cheung, Assistant Professor|612-624-5198|corjena@umn.edu|
20162547|NCT01369641|Thomas Jefferson University|David Cognetti, MD|215-955-6670|David.Cognetti@jefferson.edu|
20162548|NCT00842543|Nemours Children's Clinic|J. Atilio Canas MD|9046973600|jcanas@nemours.org|3674
20162549|NCT03738891|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
20162550|NCT00896025|University of Texas Southwestern Medical Center|William M. Lee, MD|214-645-6111|william.lee@utsouthwestern.edu|
20162551|NCT03100058|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20162552|NCT02718716|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20162553|NCT02942485|University of Helsinki|Dr. Svetlana Vakkilainen|+358407693375|svetlanakostjukovitch@gmail.com|
20162554|NCT01317901|Aptevo Therapeutics|Scott C. Stromatt|206-859-6675|sstromatt@apvo.com|
20162555|NCT01991522|St. Michael's|Dr. Samir C. Grover|416-864-5628|samir.grover@utoronto.ca|
20162556|NCT03194646|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20162557|NCT02141360|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
20162558|NCT00510744|University of Pittsburgh|Stephen O'Keefe|412 648 7217|sjokeefe@pitt.edu|
20162559|NCT00098306|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162560|NCT00129467|Portland Veterans Affairs Medical Center|Dr. Linda Ganzini|(503) 220-8262|linda.ganzini@va.gov|56492
20162561|NCT01331291|Massachusetts General Hospital|Tracy T. Batchelor, MD|617-643-1938|tbatchelor@mgh.harvard.edu|
20162562|NCT01424228|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20162563|NCT00932165|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20162564|NCT00439374|Northwestern University Medical School|William Grobman, MD|312-472-4661|w-grobman@northwestern.edu|
20162565|NCT00293020|BioDelivery Sciences International|Andrew Finn, Pharm.D.|919-582-9050|AFinn@bdsi.com|
20180811|NCT00759772|Massachusetts General Hospital|Pouneh K. Fazeli, MD|617-726-3870|pkfazeli@partners.org|
20162566|NCT00666965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20162567|NCT03037983|Palo Alto VA|Jong Yoon|510-220-7086|jhyoon1@stanford.edu|
20180812|NCT01568827|The Ohio State University|Dr. Joseph Kitzmiller|6142928438|joseph.kitzmiller@osumc.edu|
20180813|NCT02761629|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20180814|NCT00562978|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|ANademanee@coh.org|82405
20180815|NCT03767634|Imperial College London|Dr Chris Gale|+44 (0)20 3315 3519|christopher.gale@imperial.ac.uk|
20180816|NCT00936221|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20180817|NCT01348776|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
20180818|NCT02459080|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20180819|NCT04362137|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20180820|NCT00771875|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
20180821|NCT01121484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180822|NCT04112940|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|4165973422|tri-swallowinglab@uhn.ca|7802
20206490|NCT02026206|Pusan Natinal University Yangsan Hospital|Professor Yong-Il Shin|82-55-360-2872|rmshin01@gmail.com|
20223314|NCT04138953|Emory University|Michael Borich, DPT, PhD|404-712-0612|michael.borich@emory.edu|
20162568|NCT01122849|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162569|NCT01894022|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162570|NCT02697188|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|212
20162571|NCT01124955|Federal University of São Paulo|Tatiana Molinas Hasegawa|55 115576 4239|tatianamolinas@hotmail.com|
20162572|NCT02249182|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20162573|NCT03274518|University of São Paulo|Dr. Bruno Caldin da Silva|+5511997620521|bruno.caldin@hc.fm.usp.br|
20162574|NCT00692419|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Steven D. Weisbord MD|412-360-3911|steven.weisbord@va.gov|
20162575|NCT05090852|UPenn|Natasha Mirza, MD|215 662 2979|natasha.mirza@pennmedicine.upenn.edu|
20162576|NCT00504894|Weill Cornell Medicine|Kane Pryor|(212) 746-2953|kap9009@med.cornell.edu|
20162577|NCT00148941|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20162578|NCT03244826|Dana-Farber Cancer Institute|Dr. Gregory Abel (Principal Investigator)|617-632-1906|gregory_abel@dfci.harvard.edu|
20162579|NCT03050320|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
20162580|NCT02673684|Defense and Veterans Center for Integrative Pain Management|Mary McDuffie|301-400-4242|mmcduffie@dvcipm.org|
20162581|NCT04356040|Abbott|Anne Sarver|6517563813|anne.sarver@abbott.com|
20162582|NCT01092663|KineMed, Inc.|Carine Beysen, PhD|510-655-6525|cbeysen@kinemed.com|123
20162583|NCT01008904|Virginia Commonwealth University|Thomas J. Smith, MD|410-955-2091|tsmit136@jhmi.edu|
20162584|NCT00360568|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20162585|NCT01008449|UAB|Principal Investigator|205-934-3411|dana_figueroa_marzilli@hotmail.com|
20162586|NCT01220180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162587|NCT01067469|UT MD Anderson Cancer Center|Dr. John F de Groot/Chair Ad Interim, Neuro-Oncology|713- 745-3072|jdegroot@mdanderson.org|
20162588|NCT01338857|New York University Langone Medical Center|Matthias A. Karajannis, MD|212-263-9630|matthias.karajannis@nyumc.org|
20162589|NCT04016844|University of Iowa|Dr.Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
20162590|NCT01364389|Novartis Pharmaceuticals|Study Director|862-778-8300||
20162591|NCT01534195|Ora|Keith Lane|9786896500|klane@oraclinical.com|
20162592|NCT00241904|Johns Hopkins University|Dr. Jerilyn Allen|410-614-4882|jallen1@jhu.edu|
20162593|NCT03968848|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20180823|NCT02130453|The University of Texas MD Anderson Cancer Center|Nicolas Palaskas, MD|(713) 745-1942|nlpalaskas@mdanderson.org|
20180824|NCT00930943|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
20180825|NCT02204579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20180826|NCT00539279|VA San Diego Healthcare System|Steven R. Thorp, Ph.D., ABPP|(858) 552-8585|Steven.Thorp@va.gov|2468
20180827|NCT04591977|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|7175310003|jmoss1@pennstatehealth.psu.edu|323429
20180828|NCT00405353|UCLA|Dr. Rhonda Voskuhl|(310) 206-4636|rvoskuhl@mednet.ucla.edu|
20180829|NCT02906683|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
20180830|NCT02781506|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
20180831|NCT02326844|National Cancer Institute|Dr. Jung-Min Lee|301-443-7735|leej6@mail.nih.gov|
20180832|NCT01340482|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20180833|NCT02593539|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20180834|NCT02835443|Enspire DBS Therapy, Inc.|Director of Clinical Trials|123-456-7890|info@enspiredbs.com|
20180835|NCT02444988|Vanderbilt University Medical Center|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
20180836|NCT02791490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180837|NCT01189890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191092|NCT03802513|VA RR&D National Center for Rehabilitative Auditory Research|Principal Investigator|503-220-8262|sarah.theodoroff@va.gov|
20191093|NCT00538616|Duke University|Dr. Carmelo Graffagnino|919/681-3751|Carmelo.Graffagnino@duke.edu|
20191094|NCT01591655|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20191095|NCT00274846|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
20191096|NCT02032420|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
20180838|NCT00077636|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20180839|NCT00592319|Trustee of Boston Univ. Medical Campus|Dr. Zhi Wang|617-414-1590|zwang@bu.edu|
20223315|NCT03225105|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20180840|NCT01045122|University of Rochester Medical Center|Dr. Suzanne Karan|585-275-5161|Suzanne_Karan@urmc.rochester.edu|
20180841|NCT01017120|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223316|NCT01399047|University of Rochester Medical Center|Erika Augustine, MD, MS|585-275-2808|erika_augustine@urmc.rochester.edu|
20180842|NCT00335725|IBSA instutut Biochimique SA|IBSA Clinical Research Manager|+41 58 360 1000|sd@ibsa.ch|
20223317|NCT00836888|Ono Pharmaceutical Co. Ltd|Ohyama Yukiya||y.ohyama@ono.co.jp|
20223318|NCT02046005|Brigham and Women's Hospital|Dr. Elizabeth Karlson|617-732-5078|ekarlson@bwh.harvard.edu|
20223319|NCT03652636|Indiana University|Jordan Swensson, MD|317-944-1837|jswensso@iu.edu|
20180843|NCT02122341|USC Intitute of Urology|Dr. Matthew Dunn|323-865-3700|mdunn@med.usc.edu|
20223320|NCT04019613|Mayo Clinic|Dr. Brandon M. Wiley|507-255-1051|Wiley.Brandon@mayo.edu|
20180844|NCT01642602|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20223321|NCT02986282|Warsaw Medical University|Dr Jacek Lewandowski|5992828|jlewandowski@wum.edu.pl|+48 22
20223322|NCT01283334|Emory University|Nabil F. Saba, MD|404-778-1900|nfsaba@emory.edu|
20223323|NCT03467217|Johns Hopkins Bloomberg School of Public Health|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
20223324|NCT00784238|Clinical Research Team, Medical Affairs Korea|Senior Clinical research Associate|82-2-2094-4804||
20223325|NCT03806933|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20223326|NCT02919423|University of Arkansas for Medical Sciences|Merideth Addicott, Assistant Professor|501-526-8436|maddicott@uams.edu|
20223327|NCT01736397|Keryx Biopharmaceuticals|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
20180845|NCT02961881|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20223328|NCT05088603|Atrium Health Wake Forest Baptist Health Department of Neurosurgery|Dr. Kyle Fargen|336-716-6702|kfargen@wakehealth.edu|
20223329|NCT02989246|Children's Hospital Los Angeles|Dr Robinder Khemani, Associate Director of Research ACCM|323-361-2376|rkhemani@chla.usc.edu|
20180846|NCT00569803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20180847|NCT01993823|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+39933946470|ejimenezv@salvatbiotech.com|
20180848|NCT01355419|CHU St Pierre|Dr Marie Bruyneel|00325354219|Marie_BRUYNEEL@stpierre-bru.be|
20180849|NCT05033743|Indiana University School of Medicine|Chemen M. Neal, Associate Professor|3172789639|chmtate@iupui.edu|
20180850|NCT01622348|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20180851|NCT00791921|Professor, Department of Allergy and Rheumatology, Division of Internal Medicine, Graduate School of Medicine, University of Tokyo|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
20180852|NCT02392767|Dr. Loges + Co. GmbH|Dr. Birgit Goyvaerts|0049-4171-707182|goyvaerts@loges.de|
20180853|NCT01592695|University of Iowa|Mark Vander Weg, PhD|319-338-0581|mark-vanderweg@uiowa.edu|7717
20180854|NCT00422799|Dana-Farber Cancer Institute|Irene M. Ghobrial|(617) 632-4218|Irene_Ghobrial@DFCI.HARVARD.EDU|
20180855|NCT01965158|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
20180856|NCT04542226|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|Phone: +7(495) 730-75-45 ext.|DodonovNS@petrovax.ru|125
20180857|NCT01047475|Microbio / Sophie Chang|Director of Clinical Trials|886-2-2570-5596|sophie_chang@fountainmab.com|556
20180858|NCT04537897|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180859|NCT00919893|Clinic for urology and pediatric urology, JL-University, Giessen, Germany|Dr. F.M.E. Wagenlehner|0049 641 9944518|wagenlehner@AOL.com|
20180860|NCT00453479|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180861|NCT01580098|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
20180862|NCT01532817|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20180863|NCT03029780|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20180864|NCT00197028|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180865|NCT00178256|University of Rochester|Yuhchyau Chen MD, PhD|585-275-5575|yuhchyau_chen@urmc.rochester.edu|
20180866|NCT03308058|University of Nebraska Medical Center|Jane Meza|402-559-6825|jmeza@unmc.edu|
20180867|NCT03066622|Regions Hospital|Meghan O'Brien|651-254-5303|meghan.e.obrien@healthpartners.com|
20180868|NCT01763788|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20180869|NCT00641719|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180870|NCT03303469|The University of Alabama at Birmingham|Janis O'Malley|205-934-6504|jomalley@uabmc.edu|
20206491|NCT00735670|University of Michigan Spinal Cord Injury System|Dr. Denise G Tate|734 763-0971|dgtate@umich.edu|
20223330|NCT00730730|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20223331|NCT01868438|Medicines for Malaria Venture|Stephan Duparc|+41 22 799 4070|duparcs@mmv.org|351
20223332|NCT02497040|uludag university|Dr.Banu Otlar Can|+905323827044|botlar@hotmail.com|
20223333|NCT03260244|Abbott|Associate Director, Clinical Research, Electrophysiology|651-756-3813|anne.sarver@abbott.com|
20223334|NCT01177293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223335|NCT00956592|Oregon Health & Science University|Michael Aziz|503-494-5581|azizm@ohsu.edu|
20180871|NCT01622543|The Ottawa Hospital - Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
20223336|NCT03528369|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
20223337|NCT02162719|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20223338|NCT03555565|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20223339|NCT02230696|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20180872|NCT00345384|Baylor Research Institute|President Baylor Research Institute|214-820-3296|researchclinicaltrials@baylorhealth.edu|
20180873|NCT00885352|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223340|NCT03138252|University Hospitals Cleveland Medical Center|Dr. Alison Bauer|216-844-3787|alison.bauer@uhhospitals.org|
20180874|NCT00365378|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223341|NCT00076752|National Cancer Institute, National Institutes of Health|Dr. Steven Pavletic|301-402-4899|pavletis@mail.nih.gov|
20223342|NCT00394836|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180875|NCT03278886|Boston Medical Center|Dr. Jeffrey Samet|617-414-7444|jsamet@bu.edu|
20180876|NCT03560258|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20180877|NCT01460160|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20180878|NCT03893825|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20223343|NCT02593526|UNewMexico|Mark Unruh|5052728800|MLUnruh@salud.unm.edu|
20180879|NCT01316341|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage@boehringer-ingelheim.com|
20180880|NCT04161807|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical @Regulatory Affairs|0542220121|daganh@theranica.com|
20180881|NCT02006121|Britannia Pharmaceuticals|Medical Director|+44 1189209500|reception@britannia-pharm.com|
20180882|NCT04229030|Raziel Therapeutics|Racheli Gueta, Director of Clinical trials|97289126941|racheli@raziel-therapy.com|
20180883|NCT02354859|University of Washington|Christopher H. Goss, Professor of Medicine and Pediatrics|206-543-3166|goss@uw.edu|
20180884|NCT00000143|Johns Hopkins School of Public Health|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
20180885|NCT01989598|Princess Margaret Cancer Centre|Dr. Suzanna Trudel|4169464501|Suzanne.Trudel@uhn.ca|4566
20180886|NCT02340520|UConn Health|Nausherwan Burki, MD||nburki@uchc.edu|
20180887|NCT03428126|MD Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
20180888|NCT00884754|London Health Sciences Centre|Philip Jones|519-685-8500|philip.jones@lhsc.on.ca|36306
20180889|NCT03176238|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20180890|NCT03556358|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
20180891|NCT00315588|University of Miami Miller School of Medicine Miami Fl|Dr. Rodolfo Alejandro|305 243 5324|ralejand@med.miami.edu|
20180892|NCT01351025|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
20180893|NCT02066896|Federal University of Sao Paulo|Tania Sales de Alencar Fidelix|11991346992|fidelixtania@gmail.com|11
20223344|NCT00527644|University of Missouri Health Care|Bruce Ramshaw, M.D.|5738841925|kadysj@health.missouri.edu|
20223345|NCT00977704|Medicis R&D Clinical Research Department|Head of Clinical Trials||ClinicalTrialsQuery@Medicis.com|
20223346|NCT00610155|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223347|NCT03325816|Georgetown University|Chul Kim, MD|202-444-2223|Chul.Kim@gunet.georgetown.edu|
20180894|NCT00513786|The Ohio State University Comprehensive Cancer Center|Dr. David O'Malley|614-293-3873|David.O'Malley@osumc.edu|
20180895|NCT05067933|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
20180896|NCT01065350|Mayo Clinic|Nathan J. Smischney, MD|507-255-6032|smischney.nathan@mayo.edu|
20180897|NCT03331185|University of Manitoba|Dr. Jonathan Bouwer|204 898 1132|jfbouwer@gmail.com|
20180898|NCT02875834|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20180899|NCT03697980|Medtronic Cardiac Rhythm and Heart Failure|CRM/MCS Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
20180900|NCT05200936|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
20223348|NCT03192306|Benu BioPharma, Inc.|Dr. Eric Morrel, VP Clinical Research|5082085634|emorrel@benubio.com|
20223349|NCT04932655|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD|512-501-2444|eschoen@cassavasciences.com|
20223350|NCT00083759|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20223351|NCT03645395|Molecular Templates, Inc.|Study Director|862-204-7184|trials@mtem.com|
20223352|NCT00892151|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20223353|NCT02429778|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.Gould@va.gov|68899
20223354|NCT02475265|Massachusetts General Hospital|Dr. Pouneh Fazeli|617-726-3870|pkfazeli@partners.org|
20223355|NCT02751450|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223356|NCT01598090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20223357|NCT02324504|Boston Children's Hospital|Dr. Michael Agus|617 355-5849|michael.agus@childrens.harvard.edu|
20162594|NCT00360724|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
20162595|NCT01959243|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
20180901|NCT01282476|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20223358|NCT04002115|Penn State Health|Dr. Seema Naik|7175310003|snaik@pennstatehealth.psu.edu|289626
20180902|NCT01542541|BIDMC|Dr Alan Moss|6176673197|amoss@bidmc.harvard.edu|
20180903|NCT01288781|UWalesBangor|Mr Justin Stevan Lawley|00441248382810|pepa16@bangor.ac.uk|
20180904|NCT00670462|University of Minnesota|Robert W. Jeffery PhD|612-626-8580|jeffe001@umn.edu|
20180905|NCT04424290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20180906|NCT02936037|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33180401440|frederic.sedel@medday-pharma.com|
20180907|NCT02949674|Instituto Mexicano del Seguro Social|Dr. Juan Lopez|+5257473500|juanlopez110@hotmail.com|25538
20180908|NCT00548041|Temple University Hospital|Dr. Ellen Tedaldi|215-707-2000|ellen.tedaldi@tuhs.temple.edu|
20180909|NCT01087723|The Medicines Company|Global Health Science Center|800-388-1183||
20180910|NCT01868035|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180911|NCT02550132|Université du Québec à Trois-Rivières|Dr Martin Descarreaux DC, PhD|18193765011|martin.descarreaux@uqtr.ca|3791
20180912|NCT01617083|University of South Florida Rothman Center|Study Coordinator|7277678393|ebrenna1@health.usf.edu|
20223359|NCT01377922|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
20223360|NCT02858583|University of Alberta|Georg Schmölzer|780-735-4647|schmolze@ualberta.ca|
20223361|NCT00853645|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
20223362|NCT03831360|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|LUebelacker@butler.org|
20223363|NCT04615403|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
20223364|NCT03170362|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
20223365|NCT02145260|Brigham and Women's Hospital|Finnian Mc Causland|6177326432|fmccausland@bwh.harvard.edu|
20223366|NCT01972438|National Institutes of Health|Manuel B. Datiles, III, MD, Principal Investigator, NEI|301-594-7052|DatilesM@nei.nih.gov|
20223367|NCT02171234|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
20223368|NCT02157376|AstraZeneca|Barry Traxler||barry.traxler@astrazeneca.com|
20223369|NCT01052480|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
20223370|NCT00529373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development,|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223371|NCT01094574|Stanford School of Medicine|Martin Angst, MD, Professor, Dept. of Anesthesia, Stanford SOM|650-498-5109|ang@stanford.edu|
20223372|NCT01074268|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20223373|NCT00966992|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|pgrigsby@radonc.wustl.edu|
20223374|NCT00603473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223375|NCT00733421|Foot & Ankle Surgical Centre|Jan Jakobsson PI, MD, PhD, Professor|46702500960|jan.jakobsson@ki.se|
20223376|NCT01523782|ERYTECH Pharma|Denise Tilton, Global Head Clinical Operations & Program Management|+1 857-706-1587|dtilton@erytech.com|
20223377|NCT04185220|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
20223378|NCT03771560|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
20223379|NCT00687544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20223380|NCT00789698|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
20223381|NCT01870973|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
20223382|NCT00389532|Sanofi pasteur Inc|Medical Director||RegistryContactUS@sanofipasteur.com|
20162596|NCT01345669|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20162597|NCT00516165|Massachusetts General Hospital|Dr.Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
20162598|NCT01549925|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
20162599|NCT00554372|SillaJen Biotherapeutics, Inc.|Manager, IP, Contracts, Translational Research|415 281 8886|tchiaverotti@sillajen.com|
20162600|NCT03343626|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20162601|NCT02175979|Catharina Hospital|dr Misha Luyer|+31402399111|misha.luyer@catharinaziekenhuis.nl|
20162602|NCT01107665|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20180913|NCT01912222|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
20180914|NCT01432535|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20180915|NCT00543400|Momenta Pharmaceuticals|Jim Roach, MD Chief Medical Officer|617-491-9700|jroach@momentpharma.com|
20180916|NCT01414413|Liverpool School of Tropical Medicine|Dr Peter MacPherson|0044151 705 3100|p.macpherson@liv.ac.uk|
20180917|NCT03223272|UAB|Physician|4346545260|dacalhou@sentara.com|
20180918|NCT00451217|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180919|NCT01129336|Novartis Pharmaceuticals|Study Director|862-778-8300||
20180920|NCT03664739|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20180921|NCT01582880|Massachusetts Eye and Ear Infirmary|Dr. Joseph Ciolino, MD|617-573-4437|joseph_ciolino@meei.harvard.edu|
20180922|NCT04668989|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|jvega2@coopervision.com|
20180923|NCT00574990|Salt Lake City VA HSRD IDEAS 2.0 Center of Innovation|Dr. Charlene Weir|801-582-1565|charlene.weir@utah.edu|5114
20180924|NCT01235975|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180925|NCT03354325|University of Utah|Eric Coon|801-662-3645|Eric.Coon@hsc.utah.edu|
20180926|NCT01798186|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20180927|NCT00101660|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20180928|NCT00708305|GlaxoSmithKline|GSK Response Center|866-435-7343||
20180929|NCT04711460|University of MN|Joan D. Lund|612-273-9115|Lund1687@umn.edu|
20223383|NCT02702388|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20223384|NCT00602836|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
20223385|NCT01729338|Duke University Medical Center|Gwynn Long|919-668-0838|gwynn.long@duke.edu|
20180930|NCT00282815|University of Michigan|Devin Brown, MD|734-936-9075|devinb@umich.edu|
20180931|NCT00192023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20180932|NCT01421589|Massachusetts General Hospital|Hideo Makimura, MD, PhD|617-726-8277|hmakimura@partners.org|
20180933|NCT00251927|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20180934|NCT00658697|DFCI|Rana R. McKay, MD|6176323237|rana_yehia@dfci.harvard.edu|
20180935|NCT01170884|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20180936|NCT00452413|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20223386|NCT01806961|Sipirig AG|Dr. Francine Santoro|+41 62 387 87 87|francine.santoro@galderma.com|87 20
20223387|NCT04532619|University of Oregon|Camille C. Cioffi|541-525-4886|ccioffi@uoregon.edu|
20223388|NCT00679029|University of Nebraska|Elizabeth Reed|(402) 559-5388|ereed@unmc.edu|
20223389|NCT01976650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20162603|NCT01487265|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
20180937|NCT00332605|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
20180938|NCT01614847|Northeastern State University Oklahoma College of Optometry|Thomas O. Salmon, OD, PhD, Professor|918-444-4011|salmonto@nsuok.edu|
20180939|NCT02765490|Janssen Research & Development, LLC|Trial Physician, Medical Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20180940|NCT03237013|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
20180941|NCT04548531|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@mgh.harvard.edu|
20180942|NCT01466764|Stanford University|Gary Peltz|650-721-2487|gpeltz@stanford.edu|
20180943|NCT00258440|Oregon Health and Science Univeristy|Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
20180944|NCT00737061|Hologic, Inc.|Edward Evantash, MD, Medical Director, Vice President Medical Affairs|508-263-8475|edward.evantash@hologic.com|
20180945|NCT02378402|Department of Radiology, Chang Gung Memorial Hospital|Gigin Lin, MD, PhD|886-3-3281200|giginlin@cgmh.org.tw|2575
20180946|NCT01035333|Albany College of Pharmacy and Health Sciences|Dr Margaret Malone|518 694 7275|margaret.malone@acphs.edu|
20180947|NCT00706784|MGH|Alexandra B. Kimball, MD|617-726-5066|akimball@partners.org|
20180948|NCT00734214|McMaster University|Dr. Karen Choong|905-5212100|choongk@mcmaster.ca|75617
20180949|NCT00447954|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20180950|NCT04195880|Providence VAMC|Vincent Mor, Principal Investigator|4012737100|vincent_mor@brown.edu|6259
20180951|NCT02061696|Borgess Heart Institute|Frank Saltiel, MD|269-381-3963||
20180952|NCT04613882|Coopervision|Jose A. Vega, OD, MSc, FAAO|9256213761|javega@coopervision.com|
20180953|NCT00621296|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20180954|NCT02415998|University of Iowa|Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
20180955|NCT00384059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180956|NCT01774071|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|646-888-2212|LarsonS@MSKCC.ORG|
20180957|NCT00381641|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
20180958|NCT04921969|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20180959|NCT04287868|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
20223390|NCT02260869|Lumbrera LLC|David Cedeno|3098266974|dclumbrera@gmail.com|
20180960|NCT01811563|Duke University Medical Center|Samuel Wellman, MD|919-681-4055|samuel.wellman@duke.edu|
20180961|NCT01267825|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
20180962|NCT00806624|Daiichi Sankyo.,LTD|Atsushi Nonogaki, Manager|81-80-3029-7553|nonogaki.atsushi.zz@daiichisankyo.co.jp|
20180963|NCT01804673|Clinic for Anaesthesiology, Intensive Care Unit and Pain Therapy at the Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 33, 48149 Munster.|Head|+49 251 / 83 - 4 72 52||
20180964|NCT01857934|St. Jude Children's Research Hospital|Sara M. Federico, MD|866-278-5833|referralinfo@stjude.org|
20180965|NCT01024959|Gen-Probe, Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
20180966|NCT00313911|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20180967|NCT03384953|Osher Center for Integrative Medicine|Dr. Lindsey C. McKernan|615-320-7770|lindsey.mckernan@vumc.org|
20180968|NCT00636792|Millennium Pharmaceutical Inc|Carol Satler|(617) 551-3729||
20180969|NCT01912781|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20180970|NCT00773955|Washington University|Maria Q. Baggstrom, M.D.||Mbaggstr@im.wustl.edu|
20180971|NCT04789577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20180972|NCT01275196|Novartis Pharmaceuticals|Study Director|862-778-8300||
20180973|NCT01027364|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
20223391|NCT00769067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20180974|NCT03119610|UT Health San Antonio|Sara Espinoza, MD|210-617-5197|espinozas2@uthscsa.edu|
20180975|NCT00535743|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20180976|NCT00114634|NICHD, NIH|Forbes D Porter|301-435-4432|fdporter@mail.nih.gov|
20180977|NCT03283696|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20180978|NCT02223065|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
20180979|NCT00684762|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20180980|NCT02104830|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
20180981|NCT05150587|Alfasigma|Nicola Gargano - Senior Clinical Scientist|0039 (0)6 91395072|nicola.gargano@alfasigma.com|
20223392|NCT05127330|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|bgaudiano@butler.org|
20180982|NCT01165840|Texas Tech University HSC|Ronald Hall|214-358-9009|ronald.hall@ttuhsc.edu|
20180983|NCT00249496|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20180984|NCT00439179|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20180985|NCT04957732|University of Florida Shands Emergency Department|Richard Petrik, MD, Clinical Assistant Professor|352-265-5911||
20180986|NCT06173570|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20180987|NCT01232465|North Shore|Dennis Marchesi|516-562-1761|dmarches@nshs.edu|
20180988|NCT01844115|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20180989|NCT00758160|Janssen Pharmaceutical, Taiwan|Medical Affairs Director|+886-2-23762155||
20180990|NCT00545363|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20180991|NCT00366301|Brigham and Women's Hospital|Aruna Pradhan|617-732-8777|apradhan@partners.org|
20180992|NCT01372605|University of North Carolina-Chapel Hill|Dr. Brian Pence|9199667446|bpence@unc.edu|
20180993|NCT01108510|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20180994|NCT00210119|Institut Bergonie|Dr Gabriel Etienne||g.etienne@bordeaux.unicancer.fr|
20180995|NCT00951509|Human Engineering Research Labs|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
20180996|NCT01361620|George Washington University|Dr. Timothy McCaffrey|(202) 994-8919|mcc@email.gwu.edu|
20180997|NCT01830881|Oregon Health and Science University|Lisa Bayer, MD|503-494-3666|whru@gmail.com|
20180998|NCT03125941|rigshospitalet|kristin steinthorsdottir, md|31666112|kjs@dadlnet.dk|
20180999|NCT00582491|Yale University School of Medicine|Peter Morgan, MD, PhD|203-974-7515|Peter.Morgan@yale.edu|
20181000|NCT01193582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181001|NCT01425632|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20181002|NCT00350701|University at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
20181003|NCT01448421|keystoneheart|Karen Jaffe, VP RA./QA/CA|97246158005|karen.jaffe@keystoneheart.com|8005
20181004|NCT02289989|Rutgers Robert Wood Johnson Medical School|Amy Pappert, MD|732-235-7765|papperas@rwjms.rutgers.edu|
20181005|NCT00406419|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
20181006|NCT01775930|UT MD Anderson Cancer Center|Dr. Eric Jonasch, MD / Professor, Genitourinary Medical Oncology|713- 563-7232|ejonasch@mdanderson.org|
20181007|NCT03487718|University of Kentucky|Ridge Preservation with Leukocyte Platelet Rich Fibrin: A Clinical, Radiographic, and Histomorphomet|8593236193|firasayafi@uky.edu|
20181008|NCT03915951|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181009|NCT05064735|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20181010|NCT01396395|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20181011|NCT03691948|Medical University of South Carolina|Jenna L. McCauley, PhD, Assistant Professor of Psychiatry|8437923922|mccaule@musc.edu|
20181012|NCT01370005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181013|NCT02009696|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
20181014|NCT02120664|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20181015|NCT03916744|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20223393|NCT04981470|neuroloop|Clinical Affairs|+497611543390|study@neuroloop.de|
20223394|NCT00078767|Allegheny Singer Research Institute|Judith Cohen, MD||judith.cohen@ahn.org|
20223395|NCT03233529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223396|NCT03396315|Columbia University|Mariana Bucovsky|12123057225|mb3523@cumc.columbia.edu|
20223397|NCT01828983|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
20181016|NCT02460263|Outset Medical, Inc|Clinical Operations|(669) 231-8200|clinical@outsetmedical.com|
20181017|NCT04524598|Limbix Health|Janel Shelton-DeMagnus, Research Operations Manager|8885462495|janel@limbix.com|709
20181018|NCT02301156|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20181019|NCT00525603|The University of MD Anderson Cancer Center|William G. Wierda, MD/Associate Professor|713-745-0428|eharriso@mdanderson.org|
20181020|NCT02638623|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
20181021|NCT00180713|Imperial College London|Professor Martin R Wilkins|+44 (0)20 8383 2049|m.wilkins@imperial.ac.uk|
20181022|NCT00479089|The University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20181023|NCT00735449|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20181024|NCT05295732|LEO Pharma A/S|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20181025|NCT00550550|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20181026|NCT00977769|Oslo University Hospital|Professor Leiv Arne Rosseland|+4723070000|lrossela@ous-hf.no|
20181027|NCT03311230|University of Pennsylvania|Joseph Harrison|2157461249|joseph.harrison@uphs.upenn.edu|
20181028|NCT01302938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181029|NCT00171873|KKS Marburg|Carmen Schade-Brittinger|0049-6421-2866458|carmen.brittinger@kks.uni-marburg.de|
20181030|NCT04536571|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20181031|NCT02780622|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20181032|NCT01283321|University of Maryland|Dr. Kenichi Tanaka|412-328-0205|ktanaka@anes.umm.edu|
20181033|NCT01076283|Brown University|Lorenzo Leggio, MD|401-863-1000|lorenzoleggio@gmail.com|
20181034|NCT02708433|University of North Carolina at Chapel Hill|Raymond P. White, Jr. DDS, PhD|919-537-3944|ray_white@unc.edu|
20181035|NCT00799643|Joslin Diabetes Center|Allison B.Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
20181036|NCT01518946|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@shire.com|
20181037|NCT03857841|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20181038|NCT01060020|Washington University School of Medicine|Brian R. Lindman, MD, Assistant Professor of Medicine|314-747-3617|brlindman@wustl.edu|
20181039|NCT04249336|Dow University of Health Sciences|Syed Jaffar Abbas Zaidi|00923412481371|jaffar.zaidi@duhs.edu.pk|
20181040|NCT01242176|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181041|NCT00871351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20181042|NCT00398398|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20181043|NCT02291289|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20181044|NCT00154063|Eisai Call Center|Eisai Inc.|888-422-4743||
20181045|NCT03483077|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181046|NCT01258660|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20181047|NCT02136498|Group Health Research Institute|Principle Investigator|206-287-2737|mcclure.j@ghc.org|
20181048|NCT04192630|Bausch + Lomb Incorporated|Anya Loncaric, Executive Director, Global Clinical Operations|(310) 770-7750|Anya.Loncaric@bauschcloud.com|
20181049|NCT01208415|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
20181050|NCT01115491|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20181051|NCT03856996|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20181052|NCT01840319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181053|NCT01586338|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20181054|NCT04071470|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
20181055|NCT03306043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181056|NCT01544491|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20181057|NCT01799720|Universidad Miguel Hernández|Dr. Elena García García|965222025|egarcia@umh.es|2025
20181058|NCT01644396|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20181059|NCT04131959|CytoSorbents|CytoSorbents|732-329-8885|info@cytosorbents.com|
20181060|NCT01304082|Massachusetts General Hospital|Brian Wainger|617-726-8810|bwainger@partners.org|
20181061|NCT02733042|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20181062|NCT02838628|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20181063|NCT01356667|UCLA, Integrated Substance Abuse Programs|Dr. Daniel Dickerson|562-277-0310|daniel.dickerson@ucla.edu|
20181064|NCT01018563|Eisai Medical Information|Eisai Medical Information|888 422 4743|esi_medinfo@eisai.com|
20181065|NCT02344537|New York State Psychiatric Institute|Brian Fallon, MD|6467748052|brian.fallon@nyspi.columbia.edu|
20181066|NCT00798486|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20206492|NCT04354155|Johns Hopkins All Children's Hospital|Anthony Alexander Sochet|17277672912|anthony.sochet@jhmi.edu|
20223398|NCT02207803|Virginia Commonwealth University|Dr. Paul Perrin|8048273894|pperrin@vcu.edu|
20181067|NCT01468532|Barbara Ann Karmanos Cancer Institute|Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
20181068|NCT00589550|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
20181069|NCT05525286|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
20181070|NCT00960752|UT MD Anderson Cancer Center|Michael Davis, PHD., Chair, Melanoma Medical Oncology|713-792-3454|mdavies@mdanderson.org|
20181071|NCT04844970|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
20181072|NCT05490329|Florida State University|Lisa Hightow-Weidman, MD, MPH|8506443296|lhightowweidman@fsu.edu|
20181073|NCT03169881|University of Utah|Robin K Ohls, MD|801-581-7052|robin.ohls@hsc.utah.edu|
20181074|NCT00856661|H. Lundbeck A/S|study director||LundbeckClinicalTrials@Lundbeck.com|
20181075|NCT03936777|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20181076|NCT02306122|Brown University|Joanne Michaud|401-863-9317|joanne_michaud@brown.edu|
20181077|NCT01642082|NRG Oncology|Linda Gedeon, BA, CCRP Clinical Research Coordinator|716-845-1169|lgedeon@gogstats.org|
20181078|NCT01811940|NYSPI|Frances R. Levin, M.D.|646-774-6137|Frances.levin@nyspi.columbia.edu|
20181079|NCT03734991|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
20181080|NCT02322814|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20191097|NCT01395914|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
20181081|NCT03012061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191098|NCT01920178|Cambridge Health Alliance|Paul M. Heffernan, D.P.M.|617-665-2556|pheffernan@challiance.org|
20181082|NCT04152343|Dartmouth-Hitchcock Medical Center|Dr. Eric Hoffer, Director of Interventional Radiology|603 650 7417|hoffer@hitchcock.org|
20181083|NCT00118092|Karmanos Cancer Institute at Wayne State University|Elisabeth Iljas Heath, M.D.||heathe@karmanos.org|
20181084|NCT00591864|Mayo Clinic|Amy Lynn Conners MD|(507) 284-2511|MBI@mayo.edu|
20191099|NCT03023878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20162604|NCT01618695|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
20162605|NCT02291419|Cleveland Clinic|Dr. Venu Menon|216-445-5390|menonv@ccf.org|
20162606|NCT01115673|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20181085|NCT02459093|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
20181086|NCT03519243|BIOCAD|Linkova Iuliia|+7 (495) 992 66 28|linkova@biocad.ru|930
20223399|NCT00594100|W. L. Gore & Associates|Andrew Garcia|(800) 437-8181|AGarcia@WLGore.com|
20223400|NCT04286581|University of Minnesota|Dr. Jacob Hutchins, MD|612-624-9990|hutc0079@umn.edu|
20223401|NCT00160706|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20223402|NCT00748189|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20223403|NCT04696055|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20223404|NCT03969901|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20223405|NCT04411810|NYU Langone Health|David Polsky, MD, PhD|212-263-9087|David.Polsky@nyulangone.org|
20223406|NCT01920958|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20223407|NCT05406479|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
20223408|NCT02028767|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223409|NCT01284348|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223410|NCT00140244|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20223411|NCT00638716|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
20223412|NCT03567005|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20223413|NCT02589626|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223414|NCT02564900|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
20223415|NCT01089608|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
20223416|NCT05338502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20223417|NCT03575793|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20223418|NCT01127451|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20223419|NCT02111577|SOTIO a.s.|Prof. Radek Spisek, M.D., Ph.D.|+420 2241 75101|spisek@sotio.com|
20223420|NCT01014988|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223421|NCT00729157|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
20223422|NCT00886743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223423|NCT03055897|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
20223424|NCT01663285|University of Michigan Comprehensive Cancer Center|Dr. Ajjai Alva|734-647-8921|ajjai@umich.edu|
20223425|NCT03521115|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
20223426|NCT02261948|Centro Cardiologoco Monzino|Piergiuseppe Agostoni|02 5800|piergiuseppe.agostoni@ccfm.it|2772
20223427|NCT01913535|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@mgh.harvard.edu|
20223428|NCT03655470|Brown University|Anthony Spirito, PI|4014441929|anthony_spirito@brown.edu|
20223429|NCT03063086|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20223430|NCT04590586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20223431|NCT01893281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20223432|NCT01316211|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
20223433|NCT05481125|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20223434|NCT02244463|Dana-Farber Cancer Institute|Kartik Sehgal, MD|(617) 632-3090|Kartik_Sehgal@dfci.harvard.edu|
20223435|NCT01769508|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20223436|NCT00910208|Albert Einstein College of Medicine|Polly Bijur, PhD|718-430-4217|polly.bijur@einstein.yu.edu|
20223437|NCT03615144|Memorial Sloan Kettering Cancer Center|Maria Cancio, MD|212-639-7196|canciom@mskcc.org|
20223438|NCT02587598|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
20223439|NCT04709692|University of Kentucky|R. Kiplin Guy|859-257-5290|kip.guy@uky.edu|
20223440|NCT04431908|Yale School of Medicine|Dr. R. Peter Manes|(203) 785-5430|rpeter.manes@yale.edu|
20223441|NCT02726906|UC San Diego|Judy Pa, PhD|858-246-1333|jpa@ucsd.edu|
20223442|NCT00791661|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223443|NCT03605862|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
20223444|NCT00697463|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
20223445|NCT03307252|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223446|NCT03482453|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20223447|NCT00251238|Radboud University Nijmegen, The Netherlands|Dr. SJH Bredie, MD, PhD|0031 24 3618819|bas.bredie@radboudumc.nl|
20223448|NCT00604591|Columbia University|Edward D. Huey, MD|212-305-1134|edh2126@cumc.columbia.edu|
20223449|NCT00869622|VA Boston Healthcare System|Antonio A. Lazzari, M.D., Ph.D|(857) 364-6381|Antonio.Lazzari@va.gov|
20223450|NCT01314872|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223451|NCT03214380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20223452|NCT03788434|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
20223453|NCT01905553|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20223454|NCT01070095|St. Michael's Hospital|Dr. Samir Gupta|(416) 864-6060|guptas@smh.ca|2252
20223455|NCT00655707|ImperialC|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
20223456|NCT03692325|Dana-Farber Cancer Institute|Glenn Hanna, MD|617-632-3090|gjhanna@partners.org|
20223457|NCT02817516|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20223458|NCT00664859|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
20223459|NCT00348595|Johns Hopkins University School of Medicine|Mario Eisenberger|(410) 614-3511|eisenma@jhmi.edu|
20223460|NCT04481191|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223461|NCT00546117|Washington University|Judith Lieu, MD|314-454-6162|lieuj@wustl.edu|
20223462|NCT01323153|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20223463|NCT01560234|AstraZeneca R&D|Ajay Aggarwal||ClinicalTrialTransparency@astrazeneca.com|
20181087|NCT01164228|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20223464|NCT02317276|UCSF Dermatology|Sarah Arron, MD, PhD|415-353-9684|Sarah.Arron@ucsf.edu|
20223465|NCT01665157|National Taiwan University Hospital|Han-Mo Chiu, M.D., Ph.D.||hanmochiu@ntu.edu.tw|
20223466|NCT04292912|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20223467|NCT00280397|Eisai Co., Ltd.|Akihiko Tsuruoka|+81-3-3817-5252||5252
20223468|NCT06175026|Stanford University|Dr. Anna H. Grummon, PhD|(650) 644-7366|agrummon@stanford.edu|
20223469|NCT04347564|Augenheilkunde Lindenthal|Daniela Claessens|017229227962|daniela.claessens@gmx.de|
20223470|NCT02225860|Tufts Medical Center|Ronald D. Perrone|6176362372|rperrone@tuftsmedicalcenter.org|
20223471|NCT00555464|Medical College of Wisconsin|Beth Drolet, MD|414-955-2817|sjoachim@mcw.edu|
20223472|NCT01250873|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20223473|NCT02278939|University of California San Francisco, School of Nursing|Dr. Melinda Sarmiento Bender and Dr. Yoshimi Fukuoka|(415) 514-3151|melinda.bender@ucsf.edu; yoshimi.fukuoka@ucsf.edu|
20223474|NCT02669836|Washington University|David D. Limbrick MD|314-454-3212|T.Meehan@wustl.edu|
20223475|NCT02423343|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20223476|NCT01665950|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
20223477|NCT04826965|Duke University|Suhail Mithani, MD|919-681-8390|suhail.mithani@duke.edu|
20223478|NCT00626821|Coloplast|Helle Aaes Senior Scientific Manager|+45 49112949|dkheaa@coloplast.com|
20223479|NCT00756236|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
20223480|NCT04903496|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223481|NCT01940887|Ophthotech Corp.|Keith Westby|212-845-8200|Keith.Westby@ophthotech.com|
20223482|NCT01062113|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20223483|NCT01290679|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20223484|NCT00562302|Angiotech|Thomas Doyle|352.338.0440|tdoyle@angio.com|
20223485|NCT04791319|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20223486|NCT01704651|Mayo Clinic|Dr. Jamie N. Bakkum-Gamez|507-266-8661|Bakkum.Jamie@mayo.edu|
20223487|NCT00679289|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20223488|NCT00937040|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
20223489|NCT01131169|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
20223490|NCT00634803|Yale University|Richard S. Schottenfeld, M.D.|203-974-7349|richard.schottenfeld@yale.edu|
20223491|NCT00778869|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20223492|NCT00364923|Allos Therapeutics, Inc|Michael Saunders, M.D.|303-426-6262|msaunders@allos.com|
20223493|NCT02209519|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|jschwebk@uabmc.edu|
20223494|NCT01985932|University of Pennsylvania|Curtiland Deville, MD|215-662-2428|deville@uphs.upenn.edu|
20223495|NCT03474731|University of Kentucky|Dr. Nancy Schoenberg|(859) 323-8175|nesch@uky.edu|
20181088|NCT02090634|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
20181089|NCT01965938|Vanderbilt University School of Medicine|Dr. Bret Alvis, MD|615-343-6268|bret.d.alvis@vanderbilt.edu|
20181090|NCT03757234|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20181091|NCT00610701|University of Missouri|Brett D. Crist, MD|5738826562|cristb@health.missouri.edu|
20181092|NCT01152294|Massachusetts General Hospital|Karen Sepucha, Ph.D.|617-724-3350|ksepucha@partners.org|
20181093|NCT01744860|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20181094|NCT02736968|University of California, San Diego|Sharon Reed, MD|858-822-2808|slreed@ucsd.edu|
20223496|NCT02401048|Pharmacyclics|Emily Liu|(669) 224-1899|aliu@pcyc.com|
20223497|NCT01826513|University of Western Australia|Prof. David Hillman & Prof. Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
20181095|NCT02578914|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20181096|NCT03342053|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20181097|NCT02961374|Cancer Prevention Network (CPN) - Mayo Clinic College of Medicine|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
20223498|NCT02887248|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20181098|NCT00735644|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20181099|NCT01586312|Instituto de Biología y Genética Molecular (IBGM)|Professor Javier Garcia-Sancho|34 983 423 084|jgsancho@ibgm.uva.es|
20223499|NCT02397122|Kirikkale University|Dr. H. Gencay Keceli|+905326714377|monsieur_gencay@yahoo.com|
20181100|NCT02041923|University of Illinois at Chicago|Rosemary White-Traut|312-996-7935|rwt@uic.edu|
20181101|NCT01861457|Medical University of South Carolina|Shaun A. Nguyen, MD, Associate Professor- Director of Clinical Research|8437921356|nguyensh@musc.edu|
20181102|NCT02274649|Shepherd Center|Michael Jones, PhD, Director Research|4043507595|mike_jones@shepherd.org|
20206493|NCT01686958|Profound Medical|Mathieu Burtnyk|647-476-1350|mburtnyk@profoundmedical.com|408
20223500|NCT00765336|Medicis Global Services Corporation|Director of Clinical Trials||ClinicalTrials@Medicis.com|
20223501|NCT00478777|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20162607|NCT03043391|Istari Oncology|W. Garret Nichols, MD MS|919-245-7662|info@istarioncology.com|
20162608|NCT01732770|Amgen Inc.|Study Director|866-572-6436||
20162609|NCT00491491|Chaim Sheba Medical Center|Dr Avichai Shimoni|972 3 530 5303|ashimoni@sheba.health.gov.il|
20162610|NCT01350232|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|jef001@jefferson.edu|
20162611|NCT00125957|McLean Hospital|Dr. Beth Murphy|617-855-2000|bmurphy5@partners.org|2297
20162612|NCT03828617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181103|NCT01928680|Chinese Academy of Medical Science|Dr. Qiao Li|86-18500027849|liqiaopumc@qq.com|
20162613|NCT01271725|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20162614|NCT01721226|George Washington University|Dr. Irene Kuo|202-994-0367|ikuo@gwu.edu|
20162615|NCT02950480|University of California, San Francisco|Dr. Pamela Munster|(415) 885-7810|pamela.munster@ucsf.edu|
20162616|NCT03251937|Boston Scientific|Director of Clinical Sciences|661 949 4350|roshini.jain@bsci.com|
20181104|NCT02023879|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20162617|NCT03828331|VA Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
20162618|NCT03121365|The Children's Hospital of Phiadelphia|Dr. James Guevara|215-590-1130|Guevara@email.chop.edu|
20162619|NCT03653988|University of Iowa Hospitals and Clinics|Melinda Seering, M.D.|(319) 384-8466|melinda-seering@uiowa.edu|
20162620|NCT01835223|Roswell Park Cancer Institute|Katy Wang, Statistician, M.A.|716-845-1300|katy.wang@roswellpark.org|6269
20181105|NCT00874432|University of Wisconsin - Madison|Dr. Arjang Djamali|(608) 262-9306|axd@medicine.wisc.edu|
20162621|NCT03149055|Memorial Sloan Kettering Cancer Center|Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
20162622|NCT02630472|UPenn|Nithin D. Adappa, Principal Investigator|215-662-2360|Nithin.Adappa@uphs.upenn.edu|
20181106|NCT03713021|Washington University School of Medicine|Ryan Jackson, M.D.|314-362-0365|jackson.ryan@wustl.edu|
20162623|NCT01279616|Nationwide Children's Hospital|Kristy Ott|614-722-6313|kristy.ott@nationwidechildrens.org|
20162624|NCT00413036|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20162625|NCT00183625|Semel Institute at UCLA|Stephen R. Marder, M.D.|310-268-3647|marder@ucla.edu|
20162626|NCT05979922|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
20162627|NCT03400163|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20162628|NCT01483183|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20181107|NCT05256381|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
20206494|NCT02486367|University Hospitals Cleveland Medical Center|Dr. David Zidar|216-791-3800|daz21@case.edu|
20206495|NCT04197986|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|Proof302.ct@qedtx.com|
20223502|NCT00305084|Clinical Operations|MolMed S.p.A.|0039 02212771|clinical.operations@molmed.com|
20223503|NCT04105218|University of Colorado Anschutz Medical Campus|Clinical Research Support Center|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20223504|NCT00926848|University of Nebraska Medical Center|Bernice Yates|402-861-1713|bcyates@unmc.edu|
20223505|NCT00153543|CDC/Arctic Investigations Program|Karen Miernyk|9077293453|kmiernyk@cdc.gov|
20223506|NCT04678232|Case Western Reserve University|Norah Feeny, PhD|(216) 368-2695|ncf2@case.edu|
20223507|NCT00842023|Western University of Health Sciences|Dr. Sheryl L. Chow|9094695379|schow@westernu.edu|
20223508|NCT01323387|Synthes Spine|Clinical Research Associate|610-719-5942|knappk@synthes.com|
20223509|NCT00511914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20223510|NCT00570063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223511|NCT01554527|University of Michigan|Dr. Ronald Chervin|734-647-9064|chervin@med.umich.edu|
20223512|NCT00550043|Incyte Corporation|Study Director|1-855-463-3463||
20223513|NCT02073929|Center of Endocrinology and Metabolism, Dept. of Internal Medicine, Herlev Gentofte Hospital, Denmark|Professor Jens Faber|+4538689016|jens.faber@regionh.dk|
20223514|NCT01483027|Boston Scientific|Chantal Laframboise|+1 613 882 0876|chantal.laframboise@bsci.com|
20223515|NCT00972816|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20223516|NCT01770366|Baystate Medical Center|Sofija Zagarins|413-794-2876|sofija.zagarins@baystatehealth.org|
20223517|NCT00593684|Baylor Health Care System|Furgan Moin, MD|214-820-7604|Furgan.Moin@baylorhealth.edu|
20223518|NCT03625466|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20223519|NCT04082572|M.D. Anderson Cancer Center|Michael J. Overman, MD|(713) 792-2828|moverman@mdanderson.org|
20223520|NCT00809471|Vivus, Inc|Wesley W Day PhD|650-934-5200||
20223521|NCT01058993|University of Washington|David D. Dale, MD|206-543-7215|dcdale@u.washington.edu|
20223522|NCT00831311|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20223523|NCT03448575|Kaiser Permanente Washington Health Research Institute|Robert Penfold, PhD|206-316-7544|robert.b.penfold@kp.org|
20223524|NCT00287872|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
20223525|NCT02780713|AstraZeneca AB|AZD9496 Global clinical leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20223526|NCT01931475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20223527|NCT03461952|Canadian Cancer Trials Group|Janet Dancey|613-533-6430|jdancey@ctg.queensu.ca|
20223528|NCT03991299|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
20223529|NCT00860535|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162629|NCT00239928|Pfizer, Inc.|Pfizer Clinical Trails.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20162630|NCT03276546|Queen's University, Belfast|Professor Margaret Cupples|07714233204|m.cupples@qub.ac.uk|
20181108|NCT04635059|Medical College of Wisconsin|Deepak Kilari, MD|414-805-4600|dkilari@mcw.edu|
20181109|NCT01946243|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20223530|NCT00930774|National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Dr. Gabrielle H Saunders|503-220-8262|gabrielle.saunders@va.gov|56210
20223531|NCT03200704|Novadaq Technologies ULC, now a part of Stryker|Colleen Roden, Director of Clinical Sciences and Operations|931-267-2041|colleen.roden@stryker.com|
20223532|NCT01680861|Miami Transplant Institute|Jeffrey Gaynor, Ph.D. biostatistician||jgaynor@med.miami.edu|
20223533|NCT00654875|Novartis Pharmaceuticals|Study Director|862-778-8300||
20223534|NCT01011465|Harvard School of Public Health|Dr. Laura Kubzansky|617-432-3589|lkubzans@hsph.harvard.edu|
20223535|NCT03921840|Johns Hopkins University|Junxin Li|4105022608|jli248@jhu.edu|
20223536|NCT02042950|UT MD Anderson Cancer Center|Dr. Hun Ju Lee/ Assistant Professor, Lymphoma/Myeloma|(713) 794-1829|hunlee@mdanderson.org|
20223537|NCT02935179|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
20223538|NCT00882778|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20223539|NCT00832871|University of New Mexico Comprehensive Cancer Center|Dr. Fa-chyi Lee|505-925-0405|FLee@salud.unm.edu|
20181110|NCT00440180|University of Utah|Marie Gibson|801-213-2845|marie.gibson@hsc.utah.edu|
20223540|NCT01683266|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
20181111|NCT01702428|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181112|NCT04995497|University of Iowa Healthcare|Archit Sharma, M.D.|(319) 384-7911|archit-sharma@uiowa.edu|
20223541|NCT03766165|Johns Hopkins University; Indiana University|Dr. Larissa Jennings Mayo-Wilson|1-812-856-0902|ljmayowi@iu.edu|
20223542|NCT02217410|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20223543|NCT01254318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181113|NCT02091869|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-1538|perrytamarat@uams.edu|41538
20181114|NCT01533714|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20181115|NCT01560377|Novadaq Technologies, Inc.|Alicia Wilton|1.905.629.3822|awilton@novadaq.com|209
20181116|NCT02572817|National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
20181117|NCT03959592|Duke University|Alessandro Jammal, M.D., Ph.D.|919-684-0202|alessandro.jammal@duke.edu|
20181118|NCT02201446|Department of Burn Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, People's Republic of China|Guo-sheng Wu|+86 18019359841|drwuguosheng@sina.cn|
20181119|NCT01234649|Woman's Hospital|Dr Karen Elkind-Hirsch|225 231-5275|karen.elkind-hirsch@womans.org|2
20223544|NCT01080118|Northwestern University Feinberg School of Medicine|Dr. Gildasio DeOliveira|312-472-3573|g-jr@northwestern.edu|
20223545|NCT02295020|LSUHSC-NO -Orthopaedic Department|Dr. Vinod Dasa|(504) 412-1700|vdasa@lsuhsc.edu|
20223546|NCT03628339|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20223547|NCT00355147|VA Stroke QUERI Center, Roudebush VAMC|Teresa Damush, Ph.D.|317-988-4277|Teresa.Damush@va.gov|
20223548|NCT02793674|Presbyterian Hospital|Thomas Weiler, MD|505-724-7044|tweiler@gmail.com|
20223549|NCT01146379|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
20223550|NCT03557931|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20181120|NCT00896454|Amgen Inc.|Study Director|866-572-6436||
20181121|NCT00566943|Synovis Surgical Innovations|Lesa Hobright-Turner, Director Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
20181122|NCT00580229|University of South Florida|John D. Carter, M.D.|813-974-2681|jocarter@health.usf.edu|
20181123|NCT01461993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181124|NCT02228525|Memorial Sloan Kettering Cancer Center|Dr. Eytan Stein, MD|646-608-3749|steine@mskcc.org|
20181125|NCT00680056|UNIFESP|Danilo Berton|55-11-55718384|dcberton@gmail.com|
20181126|NCT03056859|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
20181127|NCT01821898|Baylor College of Medicine/Texas Children's Hospital|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
20181128|NCT04193293|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20181129|NCT04719013|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
20181130|NCT03904693|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20181131|NCT04654468|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20181132|NCT06390826|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20181133|NCT01155661|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181134|NCT01597388|AstraZeneca|Julie Charlton|+ 01625-582828|ClinicalTrialTransparancy@astrazeneca.com|
20181135|NCT04396535|Mayo Clinic|Dr. Konstantinos Leventakos|507-284-2511|leventakos.konstantinos@mayo.edu|
20181136|NCT05832437|Columbia University School of Nursing|Maureen George|212-305-1175|mg3656@cumc.columbia.edu|
20181137|NCT04159415|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20181138|NCT02400437|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
20181139|NCT00337662|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20181140|NCT02088632|Jefferson Headache Center|Clinical research manager|2159552680|mary.hopkins@jefferson.edu|
20181141|NCT00882921|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20162631|NCT03041896|MCRA|Glenn Stiegman|2025525800|gstiegman@mcra.com|
20191100|NCT02849509|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206496|NCT03380624|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|fogt.78@osu.edu|
20181142|NCT05027074|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20162632|NCT04869358|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20223551|NCT02449798|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0935|Gina.Gilbert@crbard.com|
20223552|NCT01721096|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20223553|NCT01355575|Imperial College London|Dr Jeremy Cobbold|+44 1865228756|jeremy.cobbold@ndm.ox.ac.uk|
20223554|NCT02685358|VA Palo Alto Health Care System|Eric Kuhn, PhD|650-493-5000|eric.kuhn@va.gov|23160
20223555|NCT01707108|Rambam Health Care Campus|Director of Trial|+97247772983|j_horwitz@rambam.health.gov.il|
20223556|NCT01088672|Stryker NV|Amelia Saliba, AIS Clinical Program Manager|510-413-2500|aisstudies@stryker.com|
20223557|NCT02438826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20223558|NCT00675428|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20223559|NCT02805179|University of Michigan|Michelle Kim, MD|734-936-4300|michekim@med.umich.edu|
20223560|NCT02380261|Alcon, a Novartis company|Dir Clinical Operations - LACAR, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20223561|NCT03388645|National Institute of Allergy and Infectious Diseases|Lesia Dropulic|+1 301 496 7675|dropulicl@niaid.nih.gov|
20223562|NCT00552396|Innate Pharma|Dr Renaud Buffet Senior Director, Clinical Development and Translational Research|+33430303032|renaud.buffet@innate-pharma.fr|
20223563|NCT00482677|Canadian Cancer Trials Group|Keyue Ding|613-5336430|kding@ctg.queensu.ca|
20223564|NCT00101166|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sophie Dessureault|813-745-1965|sophie.dessureault@moffitt.org|
20223565|NCT00686829|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223566|NCT01732640|Johns Hopkins University|Hao Wang|410-614-3426|hwang76@jhmi.edu|
20223567|NCT04574908|Wake Forest University Health Sciences|Portable Hemodynamic Monitoring on Hosp Units|336.716.4498|akhanna@wakehealth.edu|
20223568|NCT00712543|Cumberland Pharmaceuticals Inc.|Bryan Voss, Ph.D.|615-255-0068|bvoss@cumberlandpharma.com|
20223569|NCT03687684|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20223570|NCT02428309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20223571|NCT02863445|Oregon Health and Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
20223572|NCT04520997|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20223573|NCT02981082|University of Pittsburgh|Dr. Robert Lafyatis|412-648-7040|lafyatis@pitt.edu|
20223574|NCT00199797|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20223575|NCT02195622|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
20223576|NCT03190668|University of Florida|Christoph Seubert, MD|352-273-8960|cseubert@anest.ufl.edu|
20181143|NCT04150029|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
20181144|NCT06536465|Recursion Pharmaceuticals, Inc.|Recursion Pharmaceuticals|385-374-1724|clinicaltrials@recursionpharma.com|
20181145|NCT02364713|Mayo Clinic|Evanthia Galanis|507-266-0584|galanis.evanthia@mayo.edu|
20223577|NCT00504725|Duke University Medical Center|Andrew Shaw MD|9192866938|andrew.shaw@duke.edu|
20181146|NCT01032044|Mayo Clinic, Jacksonville, Florida, USA|Dr Michael B. Wallace|904 953-7630|wallace.michael@mayo.edu|
20181147|NCT01233609|Foundation Fighting Blindness Clinical Research Institute|Chief Drug Development Officer|410 423 0581|pzilliox@blindness.org|
20181148|NCT01567865|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20181149|NCT00309608|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181150|NCT00127413|VA Boston Healthcare System|John D. Otis|8573645740|john.otis@va.gov|
20181151|NCT01051063|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181152|NCT04885530|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20181153|NCT04213989|Laser Lipo and Vein Center|Thomas Wright, MD|636-397-4012|info@laserlipoandveins.com|
20181154|NCT00963989|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
20181155|NCT01439087|Massachusetts General Hospital|Gary Tearney, MD, PhD|617-724-2979|GTEARNEY@PARTNERS.ORG|
20181156|NCT03390036|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
20181157|NCT01086605|Mayo Clinic|Alvaro Moreno-Asptia, M.D.|507/284-1159|morenoaspitia.alvaro@mayo.edu|
20181158|NCT00744237|Forest Laboratories, Inc|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
20181159|NCT01984424|Amgen Inc.|Study Director|866-572-6436||
20181160|NCT01807221|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20181161|NCT06017999|Xgene Pharmaceutical|Director of Clinical Trials|+886-2-2528-0580|emily.chen@xgenepharm.com|
20181162|NCT04338581|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20181163|NCT01089556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181164|NCT01649596|Genesys Regional Medical Center|Surgeon|810-606-6500|twasfie@gmail.com|
20181165|NCT00594906|University of Rochester|Dr. J. Edward Puzas|(585) 275-3664|edward_puzas@urmc.rochester.edu|
20181166|NCT02165904|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
20181167|NCT02564055|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181168|NCT01375959|Albert Einstein College of Medicine|Dr. Jill Crandall|718-430-3765|jill.crandall@einstein.yu.edu|
20181169|NCT01394250|The Chidren's Hospital of Philadelphia|Deb Potts|215-590-7098|pottsd@email.chop.edu|
20223578|NCT00378508|Yale University|Kevan Herold, MD|203-785-6507|kevan.herold@yale.edu|
20162633|NCT04047979|Emory University|Dr. Nadine Rouphael|404-712-1435|nroupha@emory.edu|
20191101|NCT00763919|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
20223579|NCT01435018|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20223580|NCT01694069|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20181170|NCT02310126|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
20223581|NCT05225298|Stanford University|Shuchi Anand, MD, MS|650-725-2207|sanand2@stanford.edu|
20223582|NCT01450826|Duke University Medical Center|Mary Lou Affronti, DNP, RN, MHSc, ANP|9196845301|mary.affronti@duke.edu|
20181171|NCT02524054|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|6176670572|rbanzett@bidmc.harvard.edu|
20223583|NCT02223650|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
20181172|NCT02222896|Microbac|Dr. Bashir|703-925-9366|muhammad.bashir@microbac.com|
20181173|NCT02441946|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181174|NCT02111213|Stanford University|Principal Investigator|6507232880|desparza@stanford.edu|
20181175|NCT01613027|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20181176|NCT00299195|Memorial Sloan Kettering Cancer Center|Dr. Jay Boyle, MD|212-639-2906|boylej@mskcc.org|
20181177|NCT02153359|Johns Hopkins University|Dr. Sonali Bose|410-550-2708|kladson1@jhmi.edu|
20181178|NCT02354963|IIS La Fe|Dr Cesar Diaz-Garcia|961 24 67 00|cesar.diaz@ivirma.com|
20181179|NCT04267614|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181180|NCT01463293|Fonterra Research Centre|Dr James Dekker|+64 6 350 6323|james.dekker@fonterra.com|
20181181|NCT02707523|UAB|Dr. Michele Kong, PI|205-6389387|mkong@peds.uab.edu|
20181182|NCT00779584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181183|NCT01896115|Boston Scientific|Stephen Carcieri, PhD|661-949-4756|Stephen.Carcieri@bsci.com|
20181184|NCT02590068|The Rockefeller University|Dr. Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
20181185|NCT03632434|University of East London|Professor Cynthia Fu|07563 240193|c.fu@uel.ac.uk|
20181186|NCT01182727|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
20181187|NCT04297241|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
20181188|NCT00886262|Medical University of South Carolina|Dr. Scott Reeves|843-792-5699|reevess@musc.edu|
20181189|NCT04038346|University of Pittsburgh Children's Hospital of Pittsburgh|Desiree Neville|412-692-7692|desiree.neville@chp.edu|
20181190|NCT01844193|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
20181191|NCT00786474|Duke University Medical Center|Thomas Ortel, MD, PhD, Principal Investigator|919-684-5350|thomas.ortel@duke.edu|3
20181192|NCT01868074|University of Iowa|Neil Segal, M.D., M.S.|3193560737|segal-research@uiowa.edu|
20181193|NCT03688711|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
20181194|NCT02667444|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20181195|NCT05415124|NYU Langone Health|Melissa Debordeaux, MD|(212) 263-7300|Melissa.Debordeaux@nyulangone.org|
20181196|NCT04175912|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20181197|NCT02303626|BioCryst Pharmaceuticals, Inc|VP Clinical Development|(+1) 919 859 1302|clinicaltrials@biocryst.com|
20206497|NCT01078558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20181199|NCT05376371|University or Wisconsin-Madison|Ryan Westergaard|6082657927|rpw@medicine.wisc.edu|
20181200|NCT05407311|Clarity Pharmaceuticals|Dr. Othon Gervasio, Chief Medical Officer|+61 (0)2 9209 4037|info@claritypharmaceuticals.com|
20181201|NCT00715741|University of Utah|Harriet Hopf, MD|801-205-1013|Harriet.Hopf@hsc.utah.edu|
20181202|NCT03797326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20181203|NCT04908449|Medical College of Wisconsin|Dr. Anne L. Castro|(414) 805-8700|anncastro@mcw.edu|
20181204|NCT00147225|University of Texas MD Anderson Cancer Center|Dr. Saroj Vadhan-Raj|713-792-7966|svadhanr@mdanderson.org|
20181205|NCT06385483|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20181206|NCT05569954|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20181207|NCT04386746|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Max Kates, MD|4105028130|mkates@jhmi.edu|
20181208|NCT05819619|Hackensack Meridian Health|Melissa M. Figueroa, MD, MPH, FACOG|551-996-8400|melissa.figueroa@hmhn.org|
20181209|NCT00802737|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181210|NCT03864926|University of Wisconsin Hospital and Clinics|Sandesh Parajuli, MD, MBBS|(608) 265-0152|sparajuli@medicine.wisc.edu|
20181211|NCT00445601|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|206-667-2933|ctangen@fredhutch.org|
20181212|NCT01091428|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20181213|NCT00214903|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|+49 (0) 30 945 101 20|dinger@zeg-berlin.de|
20181214|NCT02543723|East Carolina University|Essie Torres|252-328-1818|torrese@ecu.edu|
20181215|NCT01625910|University of Minnesota, Department of Family Medicine and Community Health|Steven D. Stovitz, MD, MS|612-310-2344|sstovitz@umphysicians.umn.edu|
20181216|NCT02391038|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20181217|NCT02959138|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20206498|NCT00992602|University of Washington|Maciej M. Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
20206499|NCT02481596|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
20181218|NCT02873286|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20181219|NCT01327547|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181220|NCT00329719|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072842511|jaeckle.kurt@mayo.edu|
20181221|NCT03918239|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@takeda.com|
20181222|NCT02930122|University of Kentucky|Dr. Cale Jacobs|859-218-3065|cale.jacobs@uky.edu|
20181223|NCT00358215|Amgen Inc.|Study Director|866-572-6436||
20181224|NCT01681368|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
20181225|NCT01026909|Seattle Children's Hospital|Dr Klane White|206-987-5678|klane.white@seattlechildrens.org|
20181226|NCT03076359|Vanderbilt University|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
20181227|NCT02040792|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20181228|NCT01757665|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Program Management|949-250-2500|aya_westbrook@edwards.com|4035
20181229|NCT00956540|Hospital Virgen de la Salud|Dr. Gonzalo Hernández|0034629625428|ghernandezm@telefonica.net|
20181230|NCT02771210|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20181231|NCT01311362|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4966215639197|gerd.mikus@med.uni-heidelberg.de|
20181232|NCT01576055|W.L. Gore & Associates|Thomas Sabin|928-864-3153|tsabin@wlgore.com|
20181233|NCT01930435|UCSF|Dr. Sue Yom|415-353-7175|yoms@radonc.ucsf.edu|
20181234|NCT04012814|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
20181235|NCT04397523|Institute for Transfusion Medicine of RNM|Assoc. Prof. Dr. Rada M. Grubovic Rastvorceva, MD MSci PhD, CMO|+38923226923|drgrubovic@gmail.com|
20181236|NCT02694640|University of South Carolina|Dr. Bernardine Pinto|8037779272|pintob@mailbox.sc.edu|
20162634|NCT04865237|Imperial College London|Professor Christopher Chiu|02083832301|c.chiu@imperial.ac.uk|
20181237|NCT00832338|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
20181238|NCT00601718|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20181239|NCT04241575|The Chinese University of Hong Kong|Dr Vincent Wong|+85235054205|wongv@cuhk.edu.hk|
20181240|NCT01865617|Fred Hutchinson Cancer Research Center|Dr. Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
20181241|NCT02226172|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181242|NCT00502996|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20181243|NCT02500979|AstraZeneca|Dr. Peter Ohman|+1 (301) 398-0120|Peter.Ohman@astrazeneca.com|
20181244|NCT02132533|UT Southwestern Medical Center|Chet Edward Wells, MD|214-648-2316|dawn.wilson@utsouthwestern.edu|
20181245|NCT04422639|University of Arkansas for Medical Sciences|Assistant Director of Cancer Clinical Trials|501-686-8274|bscanlan@uams.edu|
20181246|NCT01964521|The Norfolk & Norwich University Hospitals NHS Foundation Trust|Dr Ketan Dhatariya|+44 1603 286286|ketan.dhatariya@nnuh.nhs.uk|
20181247|NCT02593032|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@pennmedicine.upenn.edu|
20181248|NCT00119262|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20181249|NCT00988351|Malcom Randall VA|Dr. Richard B. Berry|3522621575|Richard.Berry@medicine.ufl.edu|
20181250|NCT03853317|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20181251|NCT00183456|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
20181252|NCT00787722|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20181253|NCT01088529|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20181254|NCT01265823|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20181255|NCT01263106|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181256|NCT03599986|DataClin|Medical Writer|(+2) 01001566602|mariam.abdalla@dataclin.com|
20181257|NCT04858295|University of Pennsylvania|Dr. Sarah Schrauben|267-324-7588|sarahsch@upenn.edu|
20181258|NCT00654940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20181259|NCT04435795|Research Institute of the McGill University Health Center|Dr Nicole EZER|514-934-1934|nicole.ezer@mcgill.ca|76192
20162635|NCT03550404|Pacific Institute for Research and Evaluation|Cathleen Willging|505-765-2328|cwillging@pire.org|
20162636|NCT00820222|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20162637|NCT02690714|Prometic Biotherapeutics Inc.|Senior Director, Clinical Development|301-549-9761|clinical@prometic.com|
20162638|NCT01361178|University of Pittsburgh|Andrej Petrov, MD|412-648-6215|petrovaa@upmc.edu|
20162639|NCT01399866|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
20162640|NCT02013245|Centre Hospitalier Universitaire Vaudois (CHUV)|Dr. François Spertini, Associate Professor, Division Immunology & Allergy|+41 21 31 40 799|Francois.Spertini@chuv.ch|
20162641|NCT05392803|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
20162642|NCT03036189|Montana State University|Suzanne Held|4069946321|suzanne@montana.edu|
20162643|NCT04534881|Saint Louis University|Sandeep Dhindsa|13149774911|sandeep.dhindsa@health.slu.edu|
20162644|NCT02713659|The Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
20181260|NCT02240589|Indiana University School of Medicine|Flora Hammond, MD|317-329-2106|flora.hammond@rhin.com|
20181261|NCT00373295|New York State Psychiatric Institute|Dr. Margaret Haney|646-774-6129|reslabsurc@gmail.com|
20181262|NCT04176133|Mayo Clinic|Robert J. Pignolo, MD, PhD|507-255-8716|Pignolo.Robert@mayo.edu|
20181263|NCT01238575|Emory University|Lawrence Scahill, MSN, PhD||lawrence.scahill@emory.edu|
20191102|NCT02374476|Icahn School of Medicine at Mount Sinai|Dr. Srinivas R Dukkipati|(212) 241-7114|srinivas.dukkipati@mountsinai.org|
20181264|NCT00883103|Baystate Medical Center|Oz Harmanli, MD|4137945608|oz.harmanli@baystatehealth.org|
20181265|NCT00654329|Children's National Medical Center|Julia C. Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
20223584|NCT05167370|Cincinnati Children's Hospital Medical Center|Dr. Sonata Jodele|(513) 636-5917|Sonata.Jodele@cchmc.org|
20181266|NCT01744496|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20223585|NCT01767506|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
20223586|NCT02656290|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Aya_Westbrook@edwards.com|
20223587|NCT01608087|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223588|NCT00908791|Norris Cotton Cancer Center|Burton Eisenberg, MD, Deputy Director, Norris Cotton Cancer Center|603-653-3613|Burton.L.Eisenberg@Dartmouth.edu|
20223589|NCT02461524|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
20223590|NCT00880581|Stanford University|Ronald Levy|6507256452|levy@stanford.edu|
20223591|NCT00981669|Instituto Butantan|Alexander Roberto Precioso|+5511-2627-9372|alexrp@butantan.gov.br|9372
20223592|NCT01943851|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20223593|NCT02062710|Montefiore Medcial Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
20223594|NCT04984278|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20223595|NCT03535194|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20181267|NCT00479037|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
20223596|NCT01289639|VA Puget Sound Health Care System|Kristina Utzschneider|206-277-3568|kutzschn@u.washington.edu|6-3568
20181268|NCT00267111|Mount Sinai Hospital|Dr. Vibhuti Shah|416-586-4816|vshah@mtsinai.on.ca|
20162645|NCT00223704|Vanderbilt University|Mias Pretorius, Associate Professor of Anesthesiology and Clinical Pharmacology|615-8757402|mias.pretorius@vanderbilt.edu|
20162646|NCT01630889|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|059study@fibrogen.com|
20162647|NCT02974842|nVision Medical|Surbhi Sarna|408 655 3577|surbhi@nvisionmedical.com|
20162648|NCT01854281|University Hospital Motol|Jakub Honek, MD|+42022443|jakub.honek@gmail.com|4901
20162649|NCT01000324|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162650|NCT01068158|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20162651|NCT02355210|University of Nebraska-Lincoln|Heather Rasmussen, Assistant Professor|402-472-1373|hrasmussen2@unl.edu|
20162652|NCT01368081|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20162653|NCT01424033|University of Michigan|Jan Stevens|7349365566|janstev@med.umich.edu|
20162654|NCT01853605|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20162655|NCT00238238|Meyer Cancer Center, Weill Cornell Medical College|John P Leonard, M.D.||jpleonar@med.cornell.edu|
20162656|NCT04978818|Johns Hopkins School of Public Health|Dr. Laura Hammit|4436510000|lhammitt@jhu.edu|
20162657|NCT04517643|Johns Hopkins Medicine|Robert Hobbs|410-502-1229|rhobbs3@jhmi.edu|
20162658|NCT01007838|UWalesBangor|Danielle Kirkman|00 44 1248 388254|pepa03@bangor.ac.uk|
20162659|NCT02277119|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
20162660|NCT04699461|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20162661|NCT02478255|Duke University|Bastiaan Driehuys, PhD (Professor of Radiology)|919 684-7786|bastiaan.driehuys@duke.edu|
20162662|NCT00767767|Weill Cornell Medicine|Kane Pryor|(212) 746-2969|kap9009@med.cornell.edu|
20162663|NCT03068767|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Chief of internal medicine department|+886-2-6628-9779|uld888@yahoo.com.tw|2317
20162664|NCT01730586|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-7734|MOverman@mdanderson.org|
20162665|NCT00061633|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20162666|NCT01431963|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162667|NCT03253328|Washington University School of Medicine|Mohamed A Zayed|314-362-5648|zayedm@wustl.edu|
20162668|NCT02964767|SinghRK|Dr. Ranjan K Singh|91+9431263911|dr_ranjankumarsingh@yahoo.com|
20162669|NCT01370265|Mayo Clinic|Dr. Panithaya Chareonthaitawee|507-284-1648|chareonthaitawee.panithaya@mayo.edu|
20162670|NCT02611817|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20162671|NCT03077919|RTI International|Kristine L. Rae Olmsted, MSPH|919-541-8035|krolmsted@rti.org|
20162672|NCT00826618|University of Miami|Thomas A. Albini, MD|3054825006|talbini@med.miami.edu|
20162673|NCT03032263|Wake Forest University Health Sciences|Dr. Thomas Templeton|336-716-4285|ttemplet@wakehealth.edu|
20162674|NCT06831513|UT Southwestern Medical Center - School of Health Professions|Dara Spivey, CPO, LPO|(214) 645-8250|dara.spivey@utsouthwestern.edu|
20181269|NCT03772314|Emory University|Dr. Lynn Marie Trotti|404-712-7240|lbecke2@emory.edu|
20218062|NCT00949988|UCSD Moores Cancer Center|Kimberly Aguilar, Clinical Trials Manager|858-534-5201|k1aguilar@ucsd.edu|
20162675|NCT05148806|NHS Blood and Transplant|Gillian Powter Trial Manager|44 7590 353091|gillian.powter@nhsbt.nhs.uk|
20162676|NCT01363661|ECSOR|Jacques Bruhwyler, Project Manager|3267444093|Jacques.Bruhwyler@ecsor.com|
20181270|NCT02796963|UNC Project-China|Dr. Weiming Tang|+86-21-83755824|weimingtangscience@gmail.com|
20191103|NCT05431543|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
20218063|NCT01980342|Johns Hopkins University School of Medicine|Jenny Robinson, MD MP FACOG|4105500337|mailto:jrobin87@jhmi.edu|
20218064|NCT01929395|Dartmouth Hitchcock Medical Center|Dr Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
20218065|NCT00484419|Daiichi Sankyo Inc.|John Raia, Director, Professional Affairs|973-630-2683|jraia@dsus.com|
20218066|NCT03604341|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
20218067|NCT01453413|Taking Control of Your Diabetes|Dr. Steven Edelman, MD|858-755-5683|svedelman@vapop.ucsd.edu|
20218068|NCT01829113|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20181271|NCT01290536|University of California San Francisco|Nicholas Fidelman, MD|1-415-353-1300|Nicholas.Fidelman@ucsf.edu|
20181272|NCT00110513|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Affairs|508-370-5257|denise.tilton@gtc-bio.com|
20181273|NCT01927718|UT MD Anderson Cancer Center|Qaiser Bashir, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|QBashir@mdanderson.org|
20181274|NCT00240526|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181275|NCT01716208|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20181276|NCT02029040|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|Mohamed.Badawy@UTsouthwestern.edu|
20181277|NCT02649322|Orlando Health|Daryl C. Osbahr, MD|321.843.4800|Daryl.Osbahr@orlandohealth.com|
20223597|NCT04304235|The University of British Columbia|J Mark Ansermino|1 604 875 2711|anserminos@yahoo.ca|
20223598|NCT01916681|University of Pennsylvania|Dr. Lisa Levine|2156626913|lisa.levine@uphs.upenn.edu|
20223599|NCT02821338|US Food and Drug Administration|Office of Generic Drugs, Center for Drug Evaluation and Research|240-402-7920|genericdrugs@fda.hhs.gov|
20223600|NCT04429555|Medicinova Inc|Malath Makhay|8582468680|makhay@medicinova.com|
20223601|NCT04967885|Dartmouth College|Elizabeth Saunders|6036467006|elizabeth.c.saunders@dartmouth.edu|
20223602|NCT00723008|U.S. Army Institute of Surgical Research|LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS|210-916-3527|Elizabeth.Mann@us.army.mil|
20223603|NCT05835011|Taiho Oncology, Inc.|Taiho Central|844-878-2446|medicalinformation@taihooncology.com|
20223604|NCT00187681|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
20223605|NCT00823043|Vistakon|Arthur Shedden MD|904-443-1557||
20181278|NCT01017653|Preston Robert Tisch Brain Tumor Center|Annick Desjardins||annick.desjardins@dm.duke.edu|
20181279|NCT01630590|UT MD Anderson Cancer Center|Dr. Paul Corn, Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
20181280|NCT01752413|Memorial Blood Centers|Jed B Gorlin MD, MBA|651-332-7284|Jed.Gorlin@innovativeblood.org|
20181281|NCT02366936|Duke University Health System|Dr. William Malcolm|919-681-4913|william.malcolm@duke.edu|
20181282|NCT01751113|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181283|NCT01551303|Massachusetts General Hospital|Dr. Elizabeth Hoge|617-724-0859|ehoge@partners.org|
20181284|NCT02878213|EPD Solutions|Chen Sagy Bross|+972-50-5560073|chensb@epd-medical.com|
20181285|NCT00656916|UT MD Anderson Cancer Center|Lara Bashoura, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20181286|NCT02512510|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20181287|NCT04110366|Imperial College London|Dr Ryan Thwaites|(0044) 0203 3125730|r.thwaites@imperial.ac.uk|
20181288|NCT02471404|AstraZeneca|Eva Johnsson, MD, PhD|+46 (0)31776 24 84|ClinicalTrialTransparency@astrazeneca.com|
20181289|NCT01927731|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
20181290|NCT01464255|Clinical Research Center, University of California, Berkeley, School of Optometry|Thao N Yeh, O.D.|(510) 642-9649|thaoyeh@berkeley.edu|
20181291|NCT03299062|University of Arkansas for Medical Sciences|Rohit Dhall, MD|6025033193|rdhall@uams.edu|
20181292|NCT00849680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
20181293|NCT00785538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181294|NCT03897205|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
20181295|NCT04276090|University of Kentucky|Dr. Michael Cavnar|859-323-8920|michael.cavnar@uky.edu|
20181296|NCT04642469|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20181297|NCT02917577|UCalgary|Heinrike Schmeling|4039553194|schmelingresearch@albertahealthservices.ca|
20181298|NCT02066532|Columbia University Irving Medical Center|Dawn Hershman, MD|212-305-5098|dlh23@cumc.columbia.edu|
20181299|NCT05033080|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20181300|NCT04485546|Dompé Farmaceutici S.p.A|Sarah Wilting, OD MS|833-366-7387|usmedinfo@dompe.com|
20181301|NCT03560245|Neurotropebioscience, Inc|Alan J. Tuchman, MD, Acting Chief Medical Officer|973-242-0005|atuchman@neurotrope.com|
20181302|NCT01381952|Karolinska University Hospital|Dr. Söderman|+46851774037|michael.soderman@karolinska.se|
20181303|NCT03662360|Clinica Luganese Moncucco|Dr. Med. Pio Fontana|0041919608712|pioeugenio.fontana@moncucco.ch|
20181304|NCT02302066|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20181305|NCT03777865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181306|NCT01722318|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20181307|NCT04694482|ASST Monza|Dr. Alice Caldiroli|+3495009941|a.caldiroli@asst-monza.it|
20181308|NCT01378520|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20181309|NCT05259774|Relife Srl|Lia Fabbri|05556809528|lfabbri@relifecompany.it|
20181310|NCT00461292|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20181311|NCT02180438|University of Washington|Dr. Geoffrey S Gottlieb. MD PhD (PI)|1-206-616-2631|gottlieb@uw.edu|
20181312|NCT02058290|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
20181313|NCT01238549|VAORD|Dr. Ann Spungen|718-584-9000|ann.spungen@va.gov|5814
20181314|NCT00785707|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
20181315|NCT03295266|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181316|NCT00105586|Washington University in St. Louis|Eric Lenze|314-362-1671|lenzee@wustl.edu|
20181317|NCT02262260|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20181318|NCT00675415|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
20181319|NCT01794117|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
20181320|NCT00405704|UNC Chapel Hill|Dr. Myra Carpenter, Senior Investigator|919-962-3245|myra_carpenter@unc.edu|
20223606|NCT02655510|Mayo Clinic|Vijay Shah, M.D.|507-284-3917|Shah.Vijay@mayo.edu|
20223607|NCT01867710|Janssen Pharmaceutica N.V|Medical Affairs Director||ClinicalTrialDisclosure@its.jnj.com|
20223608|NCT01471340|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223609|NCT00526669|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223610|NCT03499899|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20223611|NCT04501640|Astellas Pharma China, Inc.|Clinical Trial Disclosure|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
20223612|NCT01981954|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
20223613|NCT02274870|Northwell Health|Director of Research, Anesthesiology|718-470-7630|odowling@northwell.edu|
20223614|NCT00887783|Dept. Oncology, Odense University Hospital|Dr. Olfred Hansen, Professor, Ph.D.|+4524241588|olfred.hansen@rsyd.dk|
20223615|NCT01975571|University of Iowa|Dr. Camille Dunn|3193538776|camille-dunn@uiowa.edu|
20223616|NCT00489086|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
20223617|NCT03341143|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20223618|NCT01609543|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20191104|NCT03247985|Mayo Clinic|Dr. David R. Farley|507-284-7565|farley.david@mayo.edu|
20191105|NCT01945086|Janssen Research & Development, LLC.|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20191106|NCT01391234|University of Virginia Department of Radiation Oncology|Dr. Paul Read|(434) 924-5191|PWR3U@hscmail.mcc.virginia.edu|
20191107|NCT04853394|University of Illinois Chicago|Mary E. Mackesy-Amiti|312-355-4892|mmamiti@uic.edu|
20191108|NCT00318591|Coloplast|Anna Karina Busch, Intl. Senior Scientific Manager|+45 49112350|dkakb@coloplast.com|
20191109|NCT00748098|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20191110|NCT04212299|University of Illinois Chicago|Andrew Sawers|312-996-1427|asawers@uic.edu|
20191111|NCT03537014|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20191112|NCT05022472|UCSD|Dr. Britt Skaathun|619-543-5011|bskaathun@health.ucsd.edu|
20191113|NCT05579769|St. Jude Children's Research Hospital|Dr. Ashok Srinivasan|8662785833|referralinfo@stjude.org|
20191114|NCT00088452|Cincinnati Children's Hospital Medical Center|Tracy Glauser, MD|513-636-8854|tracy.glauser@cchmc.org|
20191115|NCT02629419|Matinas BioPharma|Theresa Matkovits, PhD|862-812-1436|tmatkovits@matinasbiopharma.com|
20191116|NCT02055053|Lahey Clinic|dmitry nepomnayshy MD|781 744 8576|dmitry.nepomnayshy@lahey.org|
20191117|NCT02515656|Laboratoire Innotech International|Director of Medical Affairs|+33 (0)1 46 15 29 00||
20191118|NCT04044352|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-4946|kneuzil@som.umaryland.edu|
20191119|NCT01100268|Columbia University Department of Psychiatry|Dr. Carolyn Rodriguez|(646) 774-8061|cr2163@columbia.edu|
20191120|NCT02176356|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20191121|NCT00926952|Innovaderm Research Inc.|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20191122|NCT03643705|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
20191123|NCT01654289|University of Wisconsin|Bruce Barrett MD PhD|608-263-2220|bruce.barrett@fammed.wisc.edu|
20191124|NCT01732627|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20191125|NCT02137239|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20191126|NCT01994538|Minneapolis VA Health Care System|Dimitri Drekonja, MD, MS|612 467 4183|dimitri.drekonja@va.gov|
20191127|NCT04864236|UCLA Anesthesiology|John Shin MD, Associate Clinical Professor|310-267-6629|JShin@mednet.ucla.edu|
20191128|NCT02744898|NYU Langone Health|Franco Muggia, MD|212 263 2172|Franco.Muggia@nyulangone.org|
20191129|NCT04908800|Kyorin Pharmaceutical Co.,Ltd|Yoji Mimaki|+81-3-3525-4788|ml-kyorin_clinicaltrials.gov@mb.kyorin-pharm.co.jp|
20191130|NCT00157209|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20191131|NCT03751280|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20191132|NCT04474691|New York University|Tara McAllister|212-992-9445|tkm214@nyu.edu|
20191133|NCT01323309|Memorial Sloan Kettering Cancer Center|Dr. William Breitbart, MD|646-888-0020|breitbaw@MSKCC.ORG|
20191134|NCT01348763|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
20191135|NCT00310050|Wake Forest University Health Sciences|Dr. William Blackstock|3367136501|ablackst@wakehealth.edu|
20191136|NCT00685659|University of Pennsylvania|James R. McKay, Ph.D.|215-746-7704|jimrache@mail.med.upenn.edu|
20191137|NCT04422210|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20191138|NCT00449033|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20191139|NCT05045638|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20191140|NCT01109602|Colorado State University, Department of Occupational Therapy|Arlene Schmid, PhD, OTR|970-491-7562|arlene.schmid@colostate.edu|
20191141|NCT01190228|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20191142|NCT03613363|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20191143|NCT00581009|University of California Irvine|Dr. Joseph Wu|7142252212|jcwu@uci.edu|
20191144|NCT00739024|Swedish Headache Center|Pat Barrodale, RN|206-215-3502|pat.barrodale@swedish.org|
20191145|NCT00832650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191146|NCT03219216|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20191147|NCT02332824|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20191148|NCT00440037|Kyowa Kirin Co., Ltd.|Research & Development Planning Department , Research & Development Division||clinical.info.jp@kyowakirin.com|
20191149|NCT00498797|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20191150|NCT03928821|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20191151|NCT02784535|Vanderbilt University Medical center|Dr Cyndya Shibao|615-322-2318|cyndya.shibao@vumc.org|
20162677|NCT00724984|Pharmacyclics|Dr. Thorsten Graef|855-427-8846|pharmacyclics@medcomsol.com|
20181321|NCT02696902|MedImmune, LLC|Mark Esser|+1 301 3986849|information.center@astrazeneca.com|
20181322|NCT01741454|University of Wisconsin School of Medicine & Public Health|Shuang Li (Linda)|608.263.8336|lis@urology.wisc.edu|
20181323|NCT02401308|St. Joseph's Hospital and Medical Center|Lisa Arnold - Operations Manager Neurosurgery Clinical Research|602-406-9593|lisa.arnold@dignityhealth.org|
20181324|NCT02998021|University of Pittsburgh|Alicia Koontz, PhD|4128223700|akoontz@pitt.edu|
20181325|NCT01734434|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20181326|NCT06211296|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
20181327|NCT01040780|Cancer Hospital, Chinese Academy of Medical Sciences|Yan Sun, M.D.|0086-010-87788519|zhangheping@csco.org.cn|
20181328|NCT03681639|Zimmer Biomet|Esther Foo|+41792894930|esther.foo@zimmerbiomet.com|
20181329|NCT03677128|Duke University|Kristin Schroeder, MD MPH|919-668-6288|kristin.schroeder@duke.edu|
20181330|NCT00619476|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20181331|NCT01222832|SEMC|Peter catalano|617-789-5004|peter.catalano@steward.org|
20181332|NCT01554982|Keryx|Lisa Loram|919-434-6195|lisa.loram@keryx.com|
20181333|NCT00678444|UPittsburgh|Dr. Jerry Lowder|314-747-1402|lowderj@wudosis.wustl.edu|
20181334|NCT04448236|Haven of Hope hospital, Hospital Authority|Dr. Lau Chung Wai|27038888|lcw431@ha.org.hk|
20181335|NCT02354924|Mackay Memorial Hospital_Taipei|Dr. Huey-Chuan Cheng|886-2-25433535|hccheng@ms2.mmh.org.tw|
20181336|NCT00900627|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
20181337|NCT00962585|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
20181338|NCT02821832|National Institute of Allergy and Infectious Diseases|Dr. Clif E. Barry 3rd|301-693-4665|cbarry@niaid.nih.gov|
20181339|NCT02254421|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20181340|NCT00867490|Novartis Pharmaceuticals|Study Director|862 778-8300||
20181341|NCT00358150|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20181342|NCT03685708|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
20181343|NCT00179010|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
20181344|NCT03748979|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20181345|NCT02682498|UC Irvine Health|Joseph Rinehart|714-456-5059|jrinehar@uci.edu|
20181346|NCT02823964|Anthera Pharmaceuticals|Nicole Ramza|510-856-5600|info@anthera.com|
20181347|NCT04800757|The University of Texas Health Science Center at Houston|Maria Eugenia Fernandez-Esquer|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
20181348|NCT05462652|Big Health, Inc.|Jessica Lake|(510) 244-3753‬|research@bighealth.com|
20181349|NCT03410914|Sunnybrook Health Sciences Centre|Dr. Paul Karanicolas|4164806100|paul.karanicolas@sunnybrook.ca|4774
20181350|NCT00855868|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20181351|NCT03537261|Massachusetts General Hospital Lurie Center|Lisa Nowinski, PhD|781-860-1700|lnowinski@mgh.harvard.edu|
20181352|NCT01177813|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181353|NCT01729728|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20181354|NCT04011384|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
20181355|NCT02001974|Dompé Farmaceutici|Pieradelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
20181356|NCT00993317|Korea Otsuka Pharmaceutical|Eun Young Cho, Clinical Trial Manager|+82-2-3287-9233|hyerim@otsuka.co.kr|
20181357|NCT00672958|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20181358|NCT01380990|UCL Institute of Child Health|Dr Claire Booth|+44207 905 2198|C.Booth@ucl.ac.uk|
20181359|NCT02374593|Riley Hospital for Children|Dr. Erica Eugster|317 944-3889|eeugster@iu.edu|
20181360|NCT01990820|NorthShore University HealthSystem|Dr. Mark Gerber|847-504-3300|mgerber@northshore.org|
20181361|NCT01009047|Janssen Research & Development, LLC|Senior Director, Clinical Leader|+1-609-730-2436||
20181362|NCT02141659|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206500|NCT01216397|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181364|NCT01812005|The Ohio State University James Comprehensive Cancer Center|Kristie Blum, MD|614-293-7807|Kristie.Blum@osumc.edu|
20181365|NCT00305864|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20181366|NCT01450787|Coa Research Foundation|Kenneth A Beckman, MD|614-506-4720|kenbeckman22@aol.com|
20181367|NCT02836613|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20181368|NCT03881059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20181369|NCT05284019|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20181370|NCT02743793|DAIT/NIAID|Director, Clinical Research Operations Program|13015947669|DAITClinicalTrialsGov@niaid.nih.gov|
20181371|NCT02065570|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20181372|NCT01231503|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181373|NCT02697006|Fresenius MCD|Dr. Anja Derlet-Savoia|+49 6172 608 2801|Anja.Derlet@fmc-ag.com|
20181374|NCT03119571|University of Minnesota|Demetri Yannopoulos, MD|6126261382|yanno001@umn.edu|
20181375|NCT01146574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20181376|NCT03053492|Medical University of South Carolina|Michelle Woodbury|843-792-1671|woodbuml@musc.edu|
20181377|NCT04267575|Jerome Canady Research Institute for Advanced Biological and Technological Sciences|Jerome Canady, M.D.|301-270-0147|drjcanady@gwu.edu|
20181378|NCT03382600|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206501|NCT01875510|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
20206502|NCT02281344|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
20206503|NCT01360229|University of Colorado School of Medicine|Dr. Benzi Kluger|3037242194|benzi.kluger@ucdenver.edu|
20206504|NCT04671615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206505|NCT01455415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206506|NCT00587301|NYU Langone Health|Christine Ren Fielding, MD|2122633166|christine.ren-fielding@nyulangone.org|
20206507|NCT00351819|Brigham and Women's Hospital|Dr. Shehzad Basaria|617-525-9150|sbasaria@partners.org|
20206508|NCT01400139|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20206509|NCT00418717|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20206510|NCT02867163|University of New Mexico|Dr. David Siegel|505-272-2610|dsiegel@salud.unm.edu|
20206511|NCT00249795|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20206512|NCT01804114|NSUHS|Michael Ujiki, MD|8475701700|rpulido@northshore.org|
20206513|NCT00719537|William Beaumont Hospital|John Uckele|2485510610|john.uckele@beaumont.edu|
20206514|NCT03380000|Penn State University|David N. Proctor|8145715234|dnp3@psu.edu|
20223619|NCT02218736|Duke Clnical Research Institute|Kathy Hijek, Associate Director of Clinical Operations|919-668-8700|kathy.hijek@duke.edu|
20223620|NCT03879525|Wake Forest School of Medicine|Heidi Munger Clary, MD, MPH|336-716-7110|hmungerc@wakehealth.edu|
20223621|NCT03834766|Tris Pharma, Inc.|Antonio Pardo|19175149058|apardo@trispharma.com|
20223622|NCT00565643|Lehigh Valley Health Network|Daniel Kiefer|484-664-7521|daniel_g.kiefer@lvhn.org|
20223623|NCT03702010|Hospital Universitario de Salamanca|Dr. Francisco José Sánchez Montero|923291100|fjsmontero@saludcastillayleon.es|
20223624|NCT03933618|Albany Medical Center|Dr. Charles Welliver|518-262-3341|wellivr@amc.edu|
20223625|NCT02196688|Hutchison Medipharma Ltd|Dr. Songhua Fan|+86 21 2067 3058|songhuaf@hmplglobal.com|5058
20223626|NCT01137110|Washington University|Dr Theresa Human|314-747-8799|theresa.human@bjc.org|
20223627|NCT00422695|Rutgers School of Dental Medicine|Eli Eliav|973 972 7210|eliavel@sdm.rutgers.edu|
20223628|NCT04192071|University of Florida|Melissa Vilaro, Assistant Professor|352-2733525|mgraveley@ufl.edu|
20223629|NCT02553499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223630|NCT01582178|Vitkovice Hospital|Premysl Falt, MD|+420595633|faltprem@centrum.cz|205
20223631|NCT01726270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223632|NCT02948751|Columbia University|Kevin Kalinsky, MD|212-305-0170|kk2693@columbia.edu|
20223633|NCT00582608|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak|212-639-7623|modaks@mskcc.org|
20223634|NCT02819973|Duke Clinical Research Institute|Kevin Thomas, MD|919-668-8700|kevin.thomas@duke.edu|
20223635|NCT03478644|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20223636|NCT01965366|Emory University|Dr. Barbara Rothbaum|404-712-8866|brothba@emory.edu|
20223637|NCT04152837|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
20223638|NCT00586820|Mayo Clinic|Dr. Amir Lerman|507-255-6670|lerman.amir@mayo.edu|
20223639|NCT03010800|Oklahoma University Health Science Center|Dr. Robert Hurst|405-271-3930|Robert-Hurst@ouhsc.edu|
20223640|NCT04463251|R-Pharm|Sergey Grishin, Director, Dep. of Clinical Development and Medical Expertise in Autoimmune Diseases|0074959567937|sa.grishin@rpharm.ru|1506
20223641|NCT03763929|Diffusion Pharmaceuticals Inc|Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
20223642|NCT01827267|Puma Biotechnology|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20223643|NCT03070002|Northwestern University|MASSIMO CRISTOFANILLI, MD|312-503-1114|massimo.cristofanilli@nm.org|
20223644|NCT02754427|University of British Columbia|Dr. Kristin Campbell|604-827-4704|kristin.campbell@ubc.ca|
20223645|NCT03689374|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20223646|NCT05367973|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
20223647|NCT01351480|AARDS Research, Inc.|Norman B Gaylis, MD|305-652-6676|drnbg@rheum-care.com|
20223648|NCT04250350|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20223649|NCT03937908|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
20223650|NCT03205761|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20223651|NCT00636194|Bausch & Lomb|Robert Steffen OD|(585) 338-6399|robert.steffen@bausch.com|
20223652|NCT03470012|cyberDERM|Danielle Fendrick|610-325-0881|dfendrick@cyberderm-inc.com|
20223653|NCT02163226|UT MD Anderson Cancer Center|Dr. Quynh-Nhu Nguyen, MD,Associate Professor, Radiation Oncology Department|(713) 563-2450|qnnguyen@mdanderson.org|
20223654|NCT01585324|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20223655|NCT00653133|I-Flow Corporation|Alan Dine Director of Clinical Research|513-253-8033|alan.dine@kcc.com|
20223656|NCT05318092|AngioDynamics, Inc.|Elizabeth Manning|339-237-2765|liz.manning@angiodynamics.com|
20223657|NCT03854370|Wright State University|Dr. Geoffrey Towers|937-208-2850|geoffrey.towers@wright.edu|
20223658|NCT02796352|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|(412) 647-5554|stadtermanbm@upmc.edu|
20223659|NCT01300338|Mayo Clinic|Dr. Frederick North|507-284-5164|North.Frederick@mayo.edu|
20223660|NCT00101036|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20223661|NCT02579343|Counseling and Psychological Services|Adam McCabe|239-590-7950|amccabe@fgcu.edu|
20206515|NCT01142193|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|Bob.Anders@upsher-smith.com|
20206516|NCT01425749|University of Virginia|Craig L Slingluff Jr|434-924-1730|cls8h@virginia.edu|
20223662|NCT00381238|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223663|NCT00061373|NIH/NINDS and University of Texas Southwestern, Clinical Research Institute of Austin|Steven Warach, MD, PhD; Principal Investigator|512-324-8383|swarach@seton.org|
20223664|NCT02806544|Vanderbilt University|Laila Agrawal|615-322-4967|laila.saied@vanderbilt.edu|
20223665|NCT00843037|University Health Network|Dr. Jennifer Knox, PI|(416) 946-2000|jennifer.knox@uhn.ca|5131
20181379|NCT02874066|National Taiwan University Hospital|Chen-Hua Liu|+886-972651880|jacque_liu@mail2000.com.tw|
20181380|NCT03141528|Inselspital|Dr. Tina Pedersen|+4522125797|tinaheidipedersen@yahoo.dk|
20223666|NCT00722566|Johnson & Johnson Pharmaceutical Research & Development|Helgi Van de Velde, M.D., Ph.D.||HVDVELDE@ITS.JNJ.COM|
20181381|NCT00967018|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20181382|NCT01850082|VA Boston Healthcare System|Marco Zenati, M.D.|857-203-6815|Marco.Zenati@va.gov|
20181383|NCT01680458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181384|NCT03406702|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20181385|NCT00601003|Beat Childhood Cancer|Giselle Sholler, MD|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
20223667|NCT00401544|Amgen Inc.|Study Director|866-572-6436||
20223668|NCT00382590|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-745-3428|eharriso@mdanderson.org|
20223669|NCT00425061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223670|NCT03436693|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20223671|NCT02173522|University of Miami|Shivank Bhatia|305-243-7500|sbhatia1@med.miami.edu|
20223672|NCT03834974|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
20223673|NCT04720911|UMass Chan Medical School|Dr. Celine Larkin|5084211436|celine.larkin@umassmed.edu|
20223674|NCT00090220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223675|NCT00941863|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20223676|NCT02394340|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
20223677|NCT00737204|New York State Psychiatric Institute|Judith G. Rabkin, Ph.D., M.P.H.|(646) 774-8075|jgr1@columbia.edu|
20223678|NCT03315286|Weill Cornell Medicine|Dr. George Varghese, Principal Investigator|646-962-3376|giv9006@med.cornell.edu|
20223679|NCT02828124|Bristol Myers-Squibb|Phase 1/2 Study of BMS-986183 in Subjects with Advanced Hepatocellular Carcinoma|Please email|Clinical.Trials@bms.com|
20223680|NCT01590121|Imperial College London|Dr. Claire Shovlin, Principal Investigator|+44 208 383 1178|c.shovlin@imperial.ac.uk|
20223681|NCT00747474|Taiwan Liposome Company, Ltd.|Shu Chi Hsu|650-872-8816|shuchi@tlcbio.com|102
20223682|NCT02829723|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20223683|NCT02989649|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20223684|NCT00256854|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181386|NCT03729024|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20181387|NCT02768558|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
20181388|NCT00514046|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
20181389|NCT00655551|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
20181390|NCT02956434|VA Boston Healthcare System|Dr. Johanna Thompson-Hollands|857-364-2311|johanna.thompson-hollands@va.gov|
20181391|NCT02049710|Carnegie Mellon University, Social and Decision Sciences|Mandy Lanyon, Research Associate II|4122683249|mandy@cmu.edu|
20181392|NCT03391960|3M|Helen Han|651-737-9234|mhan3@mmm.com|
20181393|NCT00581113|Virginia Commonwealth University|Martha D. Wellons|804-628-1939|mwellons@vcu.edu|
20181394|NCT01818141|Hartford Hospital|Dr. David P. Nicolau, PharmD, FCCP, FIDSA|860-972-3941|david.nicolau@hhchealth.org|
20181395|NCT02169830|Saint Louis University|Dr. Anthony A Mikulec|314-977-8884|anthony.mikulec@health.slu.edu|
20181396|NCT03204695|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20181397|NCT04834362|National Institute of Neurosciences and Hospital, Dhaka|Dr. Mashfiqul Hasan|+8801816268746|mashfiqul.hasan@nins.gov.bd|
20181398|NCT02555371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181399|NCT03095599|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
20181400|NCT00299689|James Graham Brown Cancer Center, University of Louisville|Dr. Jason Chesney|502/852-3679|jaches03@exchange.louisville.edu|
20181401|NCT00968838|The University of Texas M D Anderson Cancer Center|Dr. Emil J. Freireich MD/Professor|713-792-2660|eharriso@mdanderson.org|
20181402|NCT00742885|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181403|NCT04781647|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
20181404|NCT01755689|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181405|NCT02609659|AbbVie|Global Medical Services|800-633-9110||
20181406|NCT01432015|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
20181407|NCT01155388|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20181408|NCT01004250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181409|NCT03943589|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
20181410|NCT04329104|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
20181411|NCT03884231|Abbott|Tucker Tomlinson|+1/ 972 526 9646|tucker.tomlinson@abbott.com|
20191152|NCT03740919|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20162678|NCT00303485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20181412|NCT01853254|Hoffmann-La Roche|Medical Communications|800 821-8590||
20181413|NCT00830947|OrthoAccel Technologies, Inc.|Zaffer Syed, Director of Clinical & Regulatory Affairs|(832) 803-0339|zsyed@orthoaccel.com|
20191153|NCT02214017|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
20181414|NCT02462083|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
20181415|NCT02802020|Boston Scientific Corporation|Brian Vatcher|+1-508-683-5274|brian.vatcher@bsci.com|
20181416|NCT01474512|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181417|NCT03888885|The Chinese University of Hong Kong|Dr. Sum Kim Wai Raymond|+852 39436091|kwsum@cuhk.edu.hk|
20181418|NCT03092960|Stanford University|Lisa Goldman Rosas|(650) 721-8415|lgrosas@stanford.edu|
20181419|NCT02766673|Children's Hospital of Philadelphia|Natalie Napolitano, MPH, RRT-NPS, FAARC|215-590-1708|napolitanon@email.chop.edu|
20162679|NCT01468350|Acorda Therapeutics, Inc.|Vice President - Clinical Development & Medical Affairs|914-347-4300|hhenney@acorda.com|
20162680|NCT02133781|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20162681|NCT01378325|AUBMC|Sahar Siddik-Sayyid|9611350000|ss01@aub.edu.lb|6380
20162682|NCT04120402|Eupraxia Pharmaceuticals Ltd.|Chief Scientific Officer|250-590-3968|amalone@eupraxiapharma.com|
20162683|NCT01496469|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20162684|NCT00635167|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edouard Trabulsi|215-955-1000|edouard.trabulsi@jefferson.edu|
20162685|NCT00630344|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
20162686|NCT01357551|Durham VA Medical Center|Dr. Corrine Voils|9192860411|corrine.voils@va.gov|5196
20162687|NCT06292130|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
20162688|NCT03274414|Memorial Sloan Kettering Cancer Center|Dr. Marc Cohen, MD|212-639-3769|cohenm2@mskcc.org|
20162689|NCT00891228|NICHD|H. Trent MacKay, MD, MPH|301-435-6988|mackayt@mail.nih.gov|
20162690|NCT02381015|Wake Forest University Health Sciences|Dr. Aubrey R. Turner|336-918-3585|aubreyturner@gmail.com|
20162691|NCT00118742|Hoffmann-La Roche|Medical Communications|800-821-8590||
20162692|NCT00904488|UNC Eshelman School of Pharmacy|Dr. Jo Ellen Rodgers|(919) 962-2249|jerodgers@unc.edu|
20162693|NCT02688985|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20162694|NCT02445326|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20162695|NCT01964963|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20162696|NCT00930553|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20162697|NCT01726582|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-955-1412|stsai@mcw.edu|
20162698|NCT01235234|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20162699|NCT00921843|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20162700|NCT03704688|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Arbour|646-608-3792|arbourk@mskcc.org|
20162701|NCT00787189|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20162702|NCT00847886|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug Safety|281-863-3000||
20162703|NCT02462720|BTG International Inc.|Lynn Allen|425-410-3152|lynn.allen@btgplc.com|
20162704|NCT00972530|Department of Research and Development County Council of Gavleborg/Uppsala University|Dr Tomas Weitoft|+46 26 154388|tomas.weitoft@lg.se|
20162705|NCT03397342|Montefiore Medical Center|Dr. Madhur Garg|718-920-4140|mgarg@montefiore.org|
20162706|NCT03250182|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20162707|NCT01068769|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
20162708|NCT01458418|Children's Mercy Hospital|Corey Schurman|8162343000|crschurman@cmh.edu|
20162709|NCT03671304|UT Southwestern Medical Center|Dr. Muhammad Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
20162710|NCT00596830|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162711|NCT00887926|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162712|NCT02097030|CooperVision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
20162713|NCT00774800|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
20162714|NCT01059994|University of Texas Medical Branch|Melinda Sheffield-Moore|4097728126|melmoore@utmb.edu|
20162715|NCT04016259|The University of Texas Health Science Center at Houston|"Hyochol Brian Ahn, PhD, RN, MSN, Associate Professor"|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
20162716|NCT01336023|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20162717|NCT04496453|Emory University|Lavanya Vasudevan, Ph.D., M.P.H., C.P.H.|404-727-3956|lavanya.vasudevan@emory.edu|
20162718|NCT04294147|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20162719|NCT02332291|Vanderbilt University Medical Center|Warren D. Taylor, MD, MHSc|615-322-1073|warren.d.taylor@vumc.org|
20162720|NCT00881647|University of California, San Francisco|Thomas C. Neylan, MD|415-750-6961|thomas.neylan@ucsf.edu|
20162721|NCT03916081|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20162722|NCT01240135|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20162723|NCT00699335|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20162724|NCT02726022|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20162725|NCT02841241|Intermountain Medical Center|Office of Research|8015077000|officeofresearch@imail.org|
20181420|NCT02360774|Beth Israel Deaconess Medical Center|Jody Dushay|6176671996|jdushay@bidmc.harvard.edu|
20181421|NCT03268590|Case Western Reserve University|Michael John Decker, PhD|216-368-2467|mjd6@case.edu|
20181422|NCT00531011|Abbott Vascular, Italy|Maria Jose' M. Lopera|+39-02-516251|mariajose.lopera@av.abbott.com|
20181423|NCT05719285|Cleveland Clinic Foundation|Dr. Lauren Gleich|701-330-1669|LAURENGLEICHDO@GMAIL.COM|
20162726|NCT02828020|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20181424|NCT02173535|Johnson & Johnson Vision Care Inc.|Charis Lau, Pharm.D., O.D., FAAO|(904) 443-1293|MLau87@ITS.JNJ.com|
20223685|NCT02353442|São Carlos Fedetal University|Dayana Rosa|+55 16 33066695|dad_rosa@hotmail.com|
20181425|NCT04204772|University of Minnesota, Department of Medicine|Armin Rashidi, MD, PhD|612-624-0123|arashidi@umn.edu|
20181426|NCT03875495|Genenta Science|Chief Medical Officer|+39 02 2643 3982|info-trial@genenta.com|
20181427|NCT00227760|Princess Margaret Cancer Centre - University Health Network|Dr. Srikala Sridhar|416-946-2249|srikala.sridhar@uhn.ca|
20181428|NCT00859508|Synthes USA HQ, Inc.|Heidi Hausner, Clinical Research Manager|610-719-5707|hausner.heidi@synthes.com|
20181429|NCT00600743|St. Luke's/Roosevelt Hospital|Harry R. Kissileff|212-523-4200|hrk2@columbia.edu|
20181430|NCT02368002|University of Minnesota|Nancy Sherwood|612-625-4567|sherw005@umn.edu|
20181431|NCT00579982|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181432|NCT03192215|Columbia University|Mitchell S.V. Elkind, MD, MS, FAHA/ Randolph S. Marshall, MD, MS (trial investigators)|212-305-1710/ 212-305-8389|mse13@cumc.columbia.edu, rsm2@cumc.columbia.edu|
20181433|NCT02038764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181434|NCT01306175|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181435|NCT04844918|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20181436|NCT02731313|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20181437|NCT04716881|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
20181438|NCT00363896|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20181439|NCT01558674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181440|NCT00924469|Janssen Research & Development, LLC 10990 Wilshire Blvd, Suite 1200 Los Angeles, CA 90024|Senior Director, Clinical Research|(310) 914-2917||
20181441|NCT00630058|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20181442|NCT01651936|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
20181443|NCT03044353|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181444|NCT01079143|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20181445|NCT02162992|H. Germans Trias i Pujol|Dr. Roger Villuendas|+34 4978398|rogervilluendas@hotmail.com|
20181446|NCT00981825|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20181447|NCT03285113|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
20181448|NCT02965144|Rigshospitalet|Karin Piil|0045612078067|Karin.Piil@regionh.dk|
20181449|NCT01076088|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181450|NCT01757067|University of Maryland Medical Center|Dr. Timm-Michael Dickfeld|410-328-7801|Tdickfel@som.umaryland.edu|
20181451|NCT02643979|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
20181452|NCT02207374|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20181453|NCT00322374|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20181454|NCT01000376|Eisai|Dr. Peter Tarassoff|888-422-4743||
20181455|NCT02372058|Albert Einstein Medical Center located in Philadelphia, Pennsylvania, USA|Dr. David L. Schutzman|215-456-6698|schutzmand@einstein.edu|
20181456|NCT01994720|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00||
20191154|NCT00985621|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191155|NCT01911819|Loma Linda University|Prof. Joseph Kan|(909) 558-4980|jkan@llu.edu|
20191156|NCT03953079|Graybug Vision|Executive Director, Biostatistics|650-459-4235|pdinh@graybug.vision|
20191157|NCT01732406|Massachusetts General Hospital|Dr. Karen Miller|617-726-3870|kkmiller@partners.org|
20191158|NCT04394624|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20191159|NCT00939211|AstraZeneca|Gerard Lynch|+441509645895|clinicaltrialtransparency@astrazeneca.com|
20191160|NCT00603278|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191161|NCT00991185|duke|brian smith|919668951|brian.smith@duke.edu|
20191162|NCT04743999|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
20191163|NCT01721759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20191164|NCT01195584|General Hospital Amstetten|Wolfgang Senker, MD|+43 7472 6040|wolfgang.senker@aon.at|6611
20191165|NCT00924833|Istituto Auxologico Italiano|Gianfranco Parati, Professor|+3961911|gianfranco.parati@unimib.it|2949
20191166|NCT02577315|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191167|NCT00417989|Medtronic|Scott Lee, M.D.|8185764204|scott.w.lee@medtronic.com|
20191168|NCT01636778|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191169|NCT01245699|Maricopa Integrated Health System|Bentley J Bobrow, MD|602-364-0580|bentley.bobrow@azdhs.gov|
20191170|NCT01846988|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani, Assistant Professor|(513) 736-1814|Neepa.Gurbani@cchmc.org|
20191171|NCT00990821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191172|NCT03530345|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
20191173|NCT04150250|PATH|Gwen Ambler|206-285-3500|gambler@path.org|
20191174|NCT01436045|HealthPartners Institute for Education and Research|Michael H Rosenbloom, MD|6512547900|michael.h.rosenbloom@healthpartners.com|
20223686|NCT03613909|Cochlear Ltd|Marian Jones, Principal Investigator|+61498008181|mjones@cochlear.com|
20223687|NCT03990571|The University of Texas M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
20223688|NCT03514485|Children's Hospital of Philadelphia|Tyra Bryant-Stephens, MD|215-590-5261|stephenst@chop.edu|
20223689|NCT02798289|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20223690|NCT03075891|Galderma|Rajeev Chavda|0033492382928|rajeev.chavda@galderma.com|
20181457|NCT03912220|Johns Hopkins University|Dr. Ahmet Hoke|410-955-2227|ahoke1@jh.edu|
20181458|NCT00762021|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20181459|NCT04394247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181460|NCT04318093|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20181461|NCT01719900|University of Calgary|Dr. Raylene Reimer|14032208218|reimer@ucalgary.ca|
20181462|NCT02559609|UConn Health|Sheia Alessi|860-679-1849|salessi@uchc.edu|
20181463|NCT00591123|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Zev Wainberg, MD|310-829-5471|zwainberg@mednet.ucla.edu|
20181464|NCT02855164|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20181465|NCT00876460|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181466|NCT00383240|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20181467|NCT02044458|Aurora Health Care, Inc.|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aurora.org|
20181468|NCT01919996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181469|NCT02924389|Emory University|Cecile Lahiri, MD|404-616-6306|cdelill@emory.edu|
20181470|NCT01642186|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-824-6566|abou-alg@mskcc.org|
20181471|NCT01668147|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20181472|NCT01118962|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20181473|NCT01938664|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
20181474|NCT03985098|University of Houston|Susan Abughosh|832-842-8395|smabughosh@uh.edu|
20181475|NCT02516579|Addmedica|Medical director|+33172690186|corinne.duguet@addmedica.com|
20181476|NCT01383993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181477|NCT04764929|Columbia University|Patrick Wilson, MD|212-305-8458|ptw2107@cumc.columbia.edu|
20181478|NCT02137538|Stanford University|E Kirk Neely|650-723-5791|neely@stanford.edu|
20181479|NCT02338713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20181480|NCT05258747|Sandoz|Sandoz Disclosure Office|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
20181481|NCT01254565|Amgen, Inc|Study Director|866-572-6436||
20181482|NCT02726399|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
20181483|NCT04747275|Children's Mercy|Max Feldt|816-960-8892|mmfeldt@cmh.edu|
20181484|NCT02774343|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
20181485|NCT02206152|University of Minenesota|Elizabeth Seaquist, MD|612-624-9176|chape044@umn.edu|
20181486|NCT02080520|Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
20181487|NCT00390455|Dana-Farber Cancer Institue|Harold Burstein, M.D.||hburstein@partners.org|
20181488|NCT05641077|Cleveland Clinic|Lannah Lua-Mailland|216-314-2163|lual@ccf.org|
20181489|NCT00794820|University of Texas (UT) MD Anderson Cancer Center|Susan O'Brien, MD/ Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20181490|NCT05022602|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
20181491|NCT04076020|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
20181492|NCT01591460|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20181493|NCT03679013|Inova Fairfax Hospital|Ramesh Singh, MD|(703)776-8025|ramesh.singh@inova.org|
20181494|NCT01930643|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|+886-975837711|jeff01@mmh.org.tw|
20181495|NCT00432679|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181496|NCT00610675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181497|NCT01824082|University of California San Diego|Brian M. Ilfeld|858-822-0776|bilfled@health.ucsd.edu|
20181498|NCT00684983|Mayo Clinic|Paul Haluska Jr MD PhD|507-284-1159|haluska.paul@mayo.edu|
20181499|NCT02379117|UNottingham|Dr Gordon Moran|44 [0]115 9249924|Gordon.Moran@nottingham.ac.uk|70608
20181500|NCT01686932|Novartis|Study Director|862-778-8300||
20181501|NCT01284140|University of Iowa|Brian K. Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
20181502|NCT01598428|Shandong University|Dr.Yang Gao|0086-543-89268587|pinkapples@126.com|
20181503|NCT04147260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181504|NCT01555021|Massachusetts General Hospital, Boston, MA|John D. Matthews, M.D., M.Sc.|617-643-9095|jmatthews@partners.org|
20181505|NCT02708238|"Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II"|Annamaria Staiano|00390817462679|staiano@unina.it|
20181506|NCT01313923|UC Irvine Dermatology Research Center|Sergei A. Grando, MD, PhD, DSc|9498242713|sgrando@uci.edu|
20181507|NCT01388530|David Geffen School of Medicine at UCLA|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20191175|NCT01184755|Rutgers - Robert Wood Johnson Medical School|Lynn Clemow, PhD|732-235-6972|lynn.clemow@rutgers.edu|
20191176|NCT02442622|NYU Langone Health|Steve Vanlew, PhD|646-501-7707|Steve.Vanlew@nyulangone.org|
20206517|NCT04644484|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+86-512-87658266|xjli@synermore.cn|8077
20206518|NCT04366713|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
20206519|NCT00156013|Oncology Specialists|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
20162727|NCT03688620|GlaxoSmithKline|Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccines|877-379-3718|GSKClinicalSupportHD@gsk.com|
20181508|NCT01990300|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20181509|NCT02420327|University of Maryland School of Medicine|Dr. Britta Hahn|410-402-6112|bhahn@som.umaryland.edu|
20181510|NCT02204293|Helios Fachklinik Vogelsang-Gommern GmbH, Germany|Prof. Dr Eugen Feist|+49 30 450 513 192|eugen.feist@charite.de|
20223691|NCT02004886|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223692|NCT00638443|University of Rochester|John Markman, MD|585-340-8926|maria_frazer@urmc.rochester.edu|
20223693|NCT05831644|Vicore Pharma AB|Director Clincial Operations|+46 (0) 31 788 05 60|info@vicorepharma.com|
20223694|NCT05819086|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Regulatory Manager|608-262-7568|mark.zehner@ctri.wisc.edu|
20223695|NCT02258373|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
20223696|NCT01343277|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20206520|NCT00677560|Queen Mary University of London|Dr Harpal Singh Kalsi|07872492181|h.kalsi@qmul.ac.uk|
20223697|NCT01894100|University of North Carolina at Chapel Hill|Yvonne M. Golightly, PT, PhD|919-966-0566|golight@email.unc.edu|
20223698|NCT01094301|SPRTherapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
20223699|NCT00135512|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223700|NCT05476250|Masimo Coporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20223701|NCT04013672|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
20223702|NCT00430573|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
20223703|NCT00688662|Medical University of South Carolina|Dr Peter Cotton|8438767217|cottonp@musc.edu|
20206521|NCT00631540|Cook Incorporated|Scott Snyder, PhD|765-463-7537|ssnyder@medinst.com|
20206522|NCT00807014|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206523|NCT04034043|IRCSS Istituto Ortopedico Rizzoli|Federico Giardina|+390516366418|federico.giardina@ior.it|
20206524|NCT00523614|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
20206525|NCT02091921|University of Southern California|Leonardo Clavijo, MD|3234426130|lclavijo@usc.edu|
20206526|NCT03307629|Noxopharm|Lorena Figueroa, Director clinical Operations|+612 9144 2223|lorena.figueroa@noxopharm.com|
20206527|NCT03296787|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206528|NCT02483078|CytoDyn|Joseph Meidling Senior Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
20206529|NCT02853032|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
20206530|NCT04876599|Massachusetts General Hospital|Dr. Daniel Hall|‭+1 (704) 517-7273‬|dhall7@mgh.harvard.edu|
20206531|NCT01379924|Boston Children's Hospital|Dr. Joanne Cox|6173557701|joanne.cox@childrens.harvard.edu|
20206532|NCT03700736|University of Connecticut|Dr. Molly Waring|860-486-1446|molly.waring@uconn.edu|
20206533|NCT04532918|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20206534|NCT03682055|Cullinan Oncology|Phill Gallacher|+1 617 710 9127|pgallacher@cullinanoncology.com|
20206535|NCT01826448|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20206536|NCT00880100|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 263||
20206537|NCT02225925|Johns Hopkins University|Daniel Song|410-502-5875|dsong2@jhmi.edu|
20206538|NCT00402285|University of California, San Francisco|Peter Carroll, MD|415-353-7098|pcarroll@urology.ucsf.edu|
20206539|NCT02431702|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20206540|NCT03551626|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20206541|NCT03967847|University Hospitals Cleveland Medical Center|John Strony, MD|908-268-3663|john.strony@uhhospitals.org|
20206542|NCT01017549|iCAD, Inc. Xoft, Inc|Michael A. Patz MBA, RAC, Senior Director Clinical Affairs|603-882-5200|mpatz@icadmed.com|7308
20206543|NCT00443846|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206544|NCT03304262|University of New Mexico|Sarah Pirio Richardson|505-272-3342|spiriorichardson@salud.unm.edu|
20206545|NCT03744598|patientMpower Ltd|Chief Scientific Officer|353872599131|colin@patientmpower.com|
20223704|NCT04740827|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20223705|NCT02147158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20223706|NCT03425396|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20162728|NCT01515046|The University of Iowa|Joseph J. Cullen, MD, FACS|319-353-8297|joseph-cullen@uiowa.edu|
20162729|NCT01183065|Memorial Sloan Kettering Cancer Center|Ho, Alan, MD, PhD (Assistant Attending)|+1646-888-4235|HoA@mskcc.org|
20162730|NCT00416455|NRG Oncology Statistics and Data Management Center|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20162731|NCT02456857|MD Anderson Cancer Center|Dr. Clinton Yam|(832) 589-8343|cyam@mdanderson.org|
20162732|NCT05546229|Cari Health Inc.|Chief Medical Officer|619 2343725|drcarr@carihealth.com|
20162733|NCT01983774|Columbia University|Emily DiMango, MD|212-305-0631|ead3@cumc.columbia.edu|
20162734|NCT01339897|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
20162735|NCT00365274|The University of Texas (UT) MD Anderson Cancer Center|Michelle Fanale, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
20162736|NCT03696589|Teachers College, Columbia University|Lori Quinn|212-678-3424|lq2165@tc.columbia.edu|
20162737|NCT03657095|Lung Biotechnology PBC Study Director|Lung Biotechnology PBC|301-608-9292|info@lungbiotechnology.com|
20191177|NCT00383500|Stanford University|Stanley G. Rockson|650-725-7571|rockson@stanford.edu|
20191178|NCT03051984|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
20191179|NCT01557699|SERUM INSTITUTE OF INDIA LIMITED|Dr Prasad Kulkarni|+912026602384|drpsk@seruminstitute.com|
20191180|NCT01002547|Malcom Randall VA Medical Center|Dr. Kenneth Cusi|352-273-8662|Kenneth.Cusi@va.gov; Kenneth.Cusi@medicine.ufl.edu|
20191181|NCT03273283|Hospital Clínic de Barcelona|Pol Bruguera Soler|628162567|pbruguer@clinic.cat|
20191182|NCT00710814|Columbia University|Judith Korner, M.D., PhD|2123053725|jk181@cumc.columbia.edu|
20223707|NCT03033602|VA Boston Healthcare System & Boston University School of Medicine|Dr. Denise Sloan, Professor of Psychiatry|857-364-6333|dsloan@bu.edu|
20181511|NCT00614198|Center for Autisme|Lennart Pedersen|44982355|lpe@centerforautisme.dk|
20181512|NCT01225835|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20181513|NCT03051659|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
20181514|NCT01266993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181515|NCT02589392|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
20181516|NCT02293837|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20181517|NCT04779242|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20181518|NCT02087150|Acclarent|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
20181519|NCT00925782|University of Kansas Medical Center|Omar Aljitawi, M.D., Assistant Professor of Medicine|913-588-6029|oaljitawi@kumc.edu|
20181520|NCT00780442|Medical University of South Carolina|Dr. Kimber L. Price|843-792-4847|pricekl@musc.edu|
20181521|NCT01272882|ChristianaCHS|Gerard Fulda|302-733-4260|gfulda@christianacare.org|
20181522|NCT00318149|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181523|NCT00219141|Novartis Pharmaceuticals|Study Director|862 778-8300||
20181524|NCT02216422|AbbVie|Global Medical Services|800-633-9110||
20181525|NCT01012973|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20181526|NCT02061761|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20181527|NCT02341144|Johns Hopkins All Children's Hospital|Nicole Chandler|7277674170|nicole.chandler@jhmi.edu|727
20181528|NCT02913521|Egeen|Kalev Kask|16504690600|kalev.kask@egeeninc.com|
20181529|NCT02138747|Astellas Pharma US, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
20181530|NCT00183443|Stanford University|Dr. Patricia Suppes|6504935000|tsuppes@Stanford.edu|62567
20181531|NCT04793464|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
20181532|NCT00547105|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
20181533|NCT00903786|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
20181534|NCT00220961|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
20181535|NCT00459303|National Taiwan University Hospital|Fung-Rong Hu|+886223123456|fungronghu@ntuh.gov.tw|2131
20181536|NCT00401102|Iona College|Dr. Colleen Jacobsonn|646-207-3563|cjacobson@iona.edu|
20181537|NCT01414426|UChicago|Dr. Alexander Pearson|855-702-8222|apearson5@medicine.bsd.uchicago.edu|
20181538|NCT00845871|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20181539|NCT01857622|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
20181540|NCT02076074|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8610|izoberi@wustl.edu|
20181541|NCT03380780|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20181542|NCT01374802|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181543|NCT01291225|Center for Injury Research and Policy|Dr. Gary Smith|614-355-5850|Gary.Smith@Nationwidechildrens.org|
20181544|NCT01267253|NRG Oncology|Linda Gedeon for Wei Deng,PhD|716-845-1169|lgedeon@gogstats.org|
20181545|NCT00064025|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@norgoncology.org|
20181546|NCT02468934|SPR Therapeautics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
20181547|NCT01234766|Dartmouth-Hitchcock Medical Center|Frederick Lansigan, MD|603-650-4628|Frederick.Lansigan@hitchcock.org|
20181548|NCT01370603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181549|NCT00518713|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20181550|NCT01515345|Kaiser Franz Josef Hospital|Univ.Prof. Dr Günter Christ|+43160191|guenter.christ@wienkav.at|2508
20181551|NCT00547911|National Institutes of Health|Dr. David Goldstein|301-496-1115|goldsteind@ninds.nih.gov|
20181552|NCT00003458|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20181553|NCT02133924|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-3429|john.levine@mssm.edu|
20181554|NCT02413190|Kennedy Krieger Institute|Dr. Kathryn Wagner|443-923-9525|wagnerk@kennedykrieger.org|
20181555|NCT01644474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20181556|NCT00050089|VAMC Bronx|Dr. Sheldon Brown|(718) 584-9000|sheldon.brown@va.gov|6666
20181557|NCT01097460|Merrimack Pharmaceuticals|Dr. Victor Moyo|1-617-441-1094|vmoyo@merrimackpharma.com|
20181558|NCT01163747|Hoffman-LaRoche|Medical Communications|800-821-8590||
20181559|NCT01404611|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
20181560|NCT01216293|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20181561|NCT00513019|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
20181562|NCT00377741|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20181563|NCT01500226|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781-257-2536|mhuber@tesarobio.com|
20181564|NCT02176928|University of Miami|Shirin Shafazand, MD, MS|305-243-7888|sshafazand@med.miami.edu|
20181565|NCT00225420|Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20181566|NCT00360555|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
20191183|NCT00705614|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181567|NCT02018861|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20181568|NCT02748564|Cancer Institute of New Jersey|Adam Berger, MD|215-235-8079|ab2047@cinj.rutgers.edu|
20191184|NCT00925288|Johns Hopkins University|Dr. Brandon Brown|949-266-4401|bbrown@jhsph.edu|
20181569|NCT00504348|Tokyo Medical and Dental University|Kazuki Takada, M.D.|81-3-3813-6111|takada.rheu@tmd.ac.jp|
20181570|NCT00224133|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20181571|NCT00709891|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20181572|NCT03699124|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
20181573|NCT00506285|Psychiatry Research Clinic|Barrie K. Marchant|801 585-6663|barriemarchant@aol.com|
20223708|NCT01441765|Beth Israel Deaconess Medical Center|Dr. David Avigan, Principal Investigator|617-667-9920|davigan@bidmc.harvard.edu|
20181574|NCT01305356|Wright Medical|Justin Moss|615-236-4984|Justin.Moss@wright.com|
20181575|NCT00551213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181576|NCT01890967|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181577|NCT01861301|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
20181578|NCT00593554|IndianaU|Dr. Sherif Farag|317-278-0460|ssfarag@iu.edu|
20181579|NCT03685747|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
20181580|NCT03796689|University of California, San Fransico|Dr. Mark Pletcher, Professor|415-514-8008|mark.pletcher@ucsf.edu|
20181581|NCT00795132|University of Utah|Dr. Michael Pulsipher|801-588-2680|michael.pulsipher@hsc.utah.edu|
20181582|NCT02561455|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20181583|NCT00262743|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
20181584|NCT00415493|ASTHMA Inc.|Principal Investigator|(510) 620-5714|dennis.shusterman@cdph.ca.gov|
20181585|NCT05584657|Iterum Therapeutics|Senior Vice President and Head of Clinical Development|8606614035|saronin@iterumtx.com|
20181586|NCT05454449|National Yang-Ming Chiao-Tung University|Yi-Fen Shih, Ph.D Department of Physical Therapy and Assistive Technology|+886-2-28267340|yfshih@nycu.edu.tw|
20181587|NCT02701582|NYU School of Medicine|Marc Bloom, MD, PHD|305 689-2388|mbloom@miami.edu|
20181588|NCT01033773|MedStar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
20181589|NCT01950273|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181590|NCT00472186|Dupage Chidlren's ENT & Allergy|Manali Amin, MD|630-785-0367|manali.amin@gmail.com|
20181591|NCT02367014|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
20181592|NCT02264574|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
20181593|NCT02900781|Texas Tech University Health Sciences Center|Nancy Swinford CCRC|8067432569|nancy.swinford@ttuhsc.edu|
20181594|NCT04254679|McGill University|Dr. Julio F. Fiore Jr|514 934-1934|julio.fiorejunior@mcgill.ca|35655
20181595|NCT00478608|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20181596|NCT04496414|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|
20181597|NCT02406261|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20181598|NCT03039543|Seoul National University Bundang Hospital|Dr. Junghee Ryu, Associate Professor|82-31-787-7497|jinaryu74@gmail.com|
20181599|NCT03230864|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20181600|NCT01861756|Aristotle University Thessaloniki|Dr. Apostolos Tsapas||atsapas@auth.gr|
20181601|NCT01458249|Eisai Co., Ltd.|Sun Asami|+81-3-3817-5252||5252
20181602|NCT02056119|Rush University Medical Center|David Vines, PhD, RRT|3129424408|david_vines@rush.edu|
20181603|NCT01316692|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-875-8359|jeff.sosman@vanderbilt.edu|
20181604|NCT03220737|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
20181605|NCT00178620|The University of Texas Health Science Center at Houston|Dr. Richard W. Smalling|713-500-6559|richard.w.smalling@uth.tmc.edu|
20181606|NCT00176865|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
20181607|NCT03121534|The University of Texas MD Anderson Cancer Center|Philip Thompson MD.|713-745-5732|PAThompson2@mdanderson.org|
20181608|NCT00681187|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20181609|NCT01600950|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181610|NCT04230980|Weill Cornell Medical College|Grace Tan, Clinical Research Coordinator|212-746-3208|grt2008@med.cornell.edu|
20181611|NCT02269943|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20181612|NCT03541642|Temple University|Dr. Sarah Bass|215-204-5110|sbass@temple.edu|
20181613|NCT03523871|NYU Langone Health|Luis Angel, MD|646-501-0119|Luis.Angel@nyulangone.org|
20181614|NCT01952301|Perio Health Professionals, PLLC|Dr. Michael K. McGuire|713-783-5442|mkmperio@swbell.net|
20181615|NCT00972179|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20181616|NCT03055832|TearFilm Innovations, Inc.|Rob Thornhill|844-458-9776|rthornhill@tearfilm.com|
20181617|NCT03619174|Viveve|Vice President, Clinical & Medical Affairs|720-696-8173|clinicalaffairs@viveve.com|
20181618|NCT00792428|Beth Israel Deaconess Medical Center|Gottfried Schlaug, MD, PhD|617-632-8917|gschlaug@bidmc.harvard.edu|
20181619|NCT04285229|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20181620|NCT03216902|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
20181621|NCT03228017|NYU Langone|Dr. Michael Garshick|212-263-0855|michael.garshick@nyulangone.org|
20181622|NCT01872949|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
20181623|NCT02969031|Dana-Farber Cancer Institute|Julie Goldman|617-632-5563|Julie_Goldman@dfci.harvard.edu|
20181624|NCT01556763|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
20181625|NCT02258464|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20181626|NCT04170296|Endo Pharmaceuticals|David Hernandez, MD|800-462-3636|clinicaltrials@endo.com|
20191185|NCT02081196|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20191186|NCT00434577|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191187|NCT00097708|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650 - 496 - 3777||
20191188|NCT01921114|AngioDynamics|Alicia Conway|774-249-8707|aconway@angiodynamics.com|
20191189|NCT01904019|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
20191190|NCT00635570|Department of Obstetrics and Gynecology, The University of Chicago|Melissa Gilliam|773-834-0840|mgilliam@babies.bsd.uchicago.edu|
20191191|NCT01101464|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20191192|NCT00383630|Columbia University|Yoshifumi Naka, MD, PhD|(212) 305-0828|yn33@columbia.edu|
20191193|NCT00332488|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20191194|NCT02552810|University of Valencia|Dr. Luigi Canullo|+39 347 6201976|luigicanullo@yahoo.com|
20191195|NCT04816708|Duke University|Christopher E. Cox, MD|919-681-7232|christopher.cox@duke.edu|
20191196|NCT00197119|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191197|NCT04483791|EVP, Clinical Research|Candace Elek, M.S.|408-913-5468|celek@elixirmedical.com|
20191198|NCT01503515|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20191199|NCT04050722|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191200|NCT01350102|Penn State Milton S. Hershey Medical Center|Nell Blake, DPM|(717) 531-5638|nblake@pennstatehealth.psu.edu|
20191201|NCT01828593|Entera Health|Senior Director, Clinical Research|515-963-7565|audrey.shaw@enterahealth.com|
20191202|NCT03087851|Dep. of Endocrinology and Internal Medicine, Aarhus University Hospital|MD Anne Sophie Sølling|78 45 54 75|annesoel@rm.dk|
20191203|NCT01502787|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
20191204|NCT00377312|University of Pittsburgh|Mara J Horwitz|412-692-2848|horwitz@pitt.edu|
20191205|NCT02775214|Riley Hospital for Children at Indiana University Health|Dr Nicole Horn|3179449981|nhorn@iuhealth.org|
20191206|NCT00762723|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
20191207|NCT02794441|Children's Hospital of Eastern Ontario Research Institute|Dr. Roger Zemek|6137377600|rzemek@cheo.on.ca|3931
20191208|NCT00084409|University of Colorado Denver|Robert Keith, M.D.|303-399-8020|robert.keith@ucdenver.edu|3182
20191209|NCT01572493|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
20191210|NCT00609245|Vanderbilt University Medical Center|Bassel Abou-Khalil, MD|615-936-0060|bassel.abou-khalil@vanderbilt.edu|
20191211|NCT01090076|Changi General Hospital|Mr Alvin Wong|68504627|alvin_wong@cgh.com.sg|
20191212|NCT01116440|Mereo BioPharma Group Plc.|William Moore|+44333023300|WM@mereobiopharma.com|
20191213|NCT01103271|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-0838|mfava@partners.org|
20191214|NCT01763346|University or Southern California|Dr. Thomas Buchanan|3234794319|buchanan@usc.edu|
20191215|NCT00411463|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
20191216|NCT00253019|Emory University|Carrie Cwiak, MD, MPH|404-778-1696|ccwiak@emory.edu|
20191217|NCT00694564|UC San Diego|Dr. Jeannie Huang|858-576-1700|jshuang@ucsd.edu|7322
20191218|NCT02402465|University of Chicago|Fuad Baroody, MD|773-702-4790|fbaroody@surgery.bsd.uchicago.edu|
20191219|NCT01284634|GW Research Ltd|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20191220|NCT02236598|Duke University Health System|Ranee Chatterjee Montgomery, M.D.||ranee.chatterjee@duke.edu|
20191221|NCT01484314|Brigham and Womens Hospital/ Dana Farber Cancer Institute|Dr. Nancy Berliner|617-732-5840|nberliner@parnes.org|
20191222|NCT00605384|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20191223|NCT01955720|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191224|NCT03334747|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20191225|NCT00191984|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191226|NCT03303521|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20191227|NCT04086576|University of Pennsylvania|Jessie Hemmons|215-746-8255|jhemmons@pennmedicine.upenn.edu|
20191228|NCT00005908|National Cancer Institute, National Institutes of Health|JoAnne Zujewski, M.D.|301-435-9207|zujewskij@mail.nih.gov|
20191229|NCT00578929|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20191230|NCT04736602|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20191231|NCT01379521|Novartis Pharmaceuticals|Study Director|862-778-8300||
20191232|NCT00938041|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223709|NCT00940823|Prism Eye Institute|Dr. Iqbal Ike K. Ahmed|905-456-3937|ike.ahmed@utoronto.ca|
20191233|NCT03042559|Loma Linda University|Dr. Everett Lohman III|9095584632|elohman@llu.edu|83171
20191234|NCT01855997|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20191235|NCT01536535|Connecticut Childrens|Dr. Jeffrey Hyams|8605459532|jhyams@connecticutchildrens.org|
20191236|NCT02389725|Mayo Clinic|Dr. Tobias Kummer|507-255-4399|kummer.tobias@mayo.edu|
20191237|NCT03866434|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20191238|NCT01485991|Janssen IDV - Janssen Dx|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
20191239|NCT02538471|Weill Cornell Medicine|Dr. Silvia Formenti|212-746-3608|formenti@med.cornell.edu|
20223710|NCT00170625|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
20191240|NCT01475370|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20191241|NCT00125853|Imperial College London|Professor Neil Poulter|+44 2075943445|n.poulter@imperial.ac.uk|
20191242|NCT02522299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191243|NCT01257698|Mid Atlantic Retina|Jason Hsu MD|215-928-3092|jhsu@midatlanticretina.com|
20191244|NCT02488070|Stanford University|Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
20191245|NCT00050167|UT MD Anderson Cancer Center|Aman Buzdar, M.D./Professor||agmadrig@mail.mdanderson.org|
20191246|NCT03418701|University of Florida|Dr. Lori Bilello, Project Manager|904-244-9202|Lori.bilello@jax.ufl.edu|
20191247|NCT02038803|Rush University Medical Center|Dr. Robert Balk|3129426744|Robert_Balk@rush.edu|
20191248|NCT04754594|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20191249|NCT01261793|Care|UCB|+1844599|UCBCares@ucb.com|2273
20191250|NCT03305458|Medical University of South Carolina|Dr. Tatiana Davidson|8437921866|davidst@musc.edu|
20191251|NCT01370564|Medtronic|Todd Fonseca, VP Clinical|763-526-8151|todd.fonseca@medtronic.com|
20191252|NCT02684942|Chulabhorn hospital|Saengrawee Thanthong|+662-576-6021|saengrawee81@gmail.com|
20191253|NCT02406859|James J. Peters VAMC|Dr. Mark Korsten|718-741-4675|mark.korsten@va.gov|6753
20191254|NCT01786551|Brigham and Women's Hospital|Gail K Adler|617-732-5661|gadler@partners.org|
20191255|NCT04890158|Montefiore Medical Center|Dr. Alecia Thompson-Branch|718-904-4105|alethomp@montefiore.org|
20191256|NCT03868735|Rush University|Dr. J. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
20191257|NCT04357964|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|(615) 343-7592|alp.ikizler@vumc.org|
20191258|NCT00733226|Kecioren Education and Training Hospital|Cem Hasan RAZİ|090 312 3659000|cemrazi2@gmail.com|1139
20191259|NCT02561078|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20191260|NCT00043186|Amgen Inc.|Study Director|866-572-6436||
20191261|NCT00958711|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20191262|NCT03722485|3M|Sher-ree Beekman|262-409-5112|sbeekman@mmm.com|
20191263|NCT02151643|Shield Therapeutics|Mark Sampson|+44 (0) 207 186 8500|msampson@shieldtx.com|
20191264|NCT00197106|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191265|NCT01189617|Johnson & Johsnon Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|9285-277-0715|jhauze@its.jnj.com|
20191266|NCT02640807|Revimmune|Dr Michel Morre, DVM, Chief Scientific Officer|+33(0)603357060|m.morre@revimmune.com|
20191267|NCT00520403|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20191268|NCT01145417|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191269|NCT01797562|Allerderm(dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|
20191270|NCT03930238|University of Iowa|Jacob Simmering|319-384-1107|jacob-simmering@uiowa.edu|
20191271|NCT01370018|Institute for Human Genetics and Biochemistry|Cynthia L. Bristow, MS, PhD|6314446238|cynthia.bristow@alpha1biologics.com|
20191272|NCT02406495|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20191273|NCT01525641|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191274|NCT03772041|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20191275|NCT02204319|ProHealth Care|Linda LaBorde PT|262-928-5139|linda.laborde@phci.org|
20191276|NCT00383747|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
20191277|NCT03544229|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20191278|NCT02143310|FontemVentures|Tanvir Walele|01779337589|tanvir.walele@fontemventures.com|
20191279|NCT05012397|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
20191280|NCT00404547|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20191281|NCT00679549|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
20191282|NCT01136798|The University of Chicago|Eve Van Cauter, PhD|773-834-4001|evcauter@bsd.uchicago.edu|
20191283|NCT01093183|University of Nebraska Medical Center|James Schwarz, MD|402-559-5166|jkschwarz@unmc.edu|
20191284|NCT01614899|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20191285|NCT02350127|San Francisco VA|Dr. Deborah Barnes, PI|415-221-4810|deborah.barnes4@va.gov|24221
20191286|NCT03152409|Brigham and Women's Hospital|Dr. Jessica Harder|6177326753|jaharder@bwh.harvard.edu|
20191287|NCT03575572|University of Utah|Stephanie Goldstein|801 587-7572|stephanie.goldstein@hsc.utah.edu|
20191288|NCT04405089|Minneapolis VA Medical Center|Dr. Shalamar Sibley, MD, MPH|612-467-1727|Shalamar.Sibley@va.gov|
20191289|NCT03048058|Wake Forest University Health Sciences|Irma M. RIchardson, MHA;|336-716-2903|irichard@wakehealth.edu|
20191290|NCT01247922|Astellas Pharma Global Development, Inc.|Sr. Medical Director||Astellas.resultsdisclosure@astellas.com|
20191291|NCT02588027|University of California, San Francisco|Dr. Jennifer Tangtiphaiboontana|5622095440|Jennifer.Tangtiphaiboontana@ucsf.edu|
20191292|NCT04372186|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genetech@druginfo.com|
20191293|NCT04736472|University of Pennsylvania|Sony Tuteja, PI|215-573-7834|Sony.Tuteja@PennMedicine.upenn.edu|
20191294|NCT02116582|Astellas Pharma Europe B.V.|Executive Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
20191295|NCT01876823|Columbia Psychiatry|Dr. Gregory Pelton, MD|(646) 774-8669|ghp4@columbia.edu|
20191296|NCT02256488|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20191297|NCT02268526|Novartis Pharmaceuticals|Study Director|8627788300||
20191298|NCT00975130|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20191299|NCT00577096|University of Arkansas for Medical Sciences|Elizabeth Ann Coleman|501-661-7902|colemanelizabetha@uams.edu|
20191300|NCT03562117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191301|NCT04964297|Weill Cornell Medical Center|Dr. Mehraneh Jafari|+1 646 962 2270|mdj9003@med.cornell.edu|
20191302|NCT02418819|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181627|NCT00932646|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181628|NCT00653263|UArkansas|Michael J Mancino|501-526-8442|mjmancino@uams.edu|
20181629|NCT00776100|Mayo Clinic|Steven E. Schild, M.D.|507-538-1760|sschild@mayo.edu|
20181630|NCT02285595|Sonendo, Inc.|Director of Clinical Research|9496678036|clinical@sonendo.com|
20181631|NCT01960790|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20181632|NCT00195715|Abbott|Global Medical Services|1-800-633-9110||
20181633|NCT03844321|Massachusetts General Hospital|Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
20181634|NCT03421496|Radius Health|Bruce Mitlak, MD; Head of Discovery Science and Chief Medical Officer|617-444-1943|bmitlak@radiuspharm.com|
20181635|NCT00544544|McLean Hospital|Brian P. Brennan, M.D.|617-855-2911|bbrennan@partners.org|
20181636|NCT02452866|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
20181637|NCT02955277|Assuta Hospital Systems|Dr. Zvi Buckman|+97237462520|Bukman_tz@mac.org.il|
20181638|NCT04212169|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20181639|NCT02819479|Norton Neuroscience Institute|Shervin R. Dashti, MD, PhD, Principal Investigator|502-394-6390|shervin.dashti@nortonhealthcare.org|
20181640|NCT02968940|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
20181641|NCT01406860|University of Iowa Hospitals and Clinics|Brett Faine|3193108067|brett-faine@uiowa.edu|
20181642|NCT02722941|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-8156|Taiga.Nishihori@moffitt.org|
20181643|NCT04006366|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
20181644|NCT04430335|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-9055|megreen@wakehealth.edu|
20181645|NCT03123263|TTUHSC-El Paso|Sumit Gaur|9152155200|sumit.gaur@ttuhsc.edu|
20181646|NCT01080196|University of Utah|Dr Paul LaStayo|8019719298|paul.lastayo@health.utah.edu|
20181647|NCT03988374|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|6098061200|annhita.ghassemi@churchdwight.com|
20181648|NCT01335308|University of Michigan|Ken Resnicow|734 647 0212|kresnic@umich.edu|
20181649|NCT03249376|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20181650|NCT00627042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181651|NCT01154036|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181652|NCT02086552|Mayo Clinic|Francis K Buadi, MD|507/284-2511|Kumar.Shaji@mayo.edu|
20181653|NCT03954158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181654|NCT00634322|BTG International (Protherics)|VP Clinical Development, BTG International|610-943-3632|janet.rush@btgplc.com|
20181655|NCT04102540|University of Colorado College of Nursing|Dr. Samantha Stonbraker|3037248281|Samantha.Stonbraker@CUAnschutz.edu|
20181656|NCT00906503|Barbara Ann Karmanos Cancer Institute|Barbara Ann Karmanos Cancer Institute|313-576-9370|davisv@karmanos.org|
20181657|NCT02339389|Brigham and Women's Hospital|Bhavani Kodali|6175258449|bkodali@partners.org|
20181658|NCT01567163|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181659|NCT03405662|University of California, San Francisco & San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@ucsf.edu|24386
20181660|NCT00280293|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
20181661|NCT00581256|University of Michigan Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
20181662|NCT01348854|Abbott Medical Optics|Carrie Garufis|714-247-8200|carrie.garufis@amo.abbott.com|
20181663|NCT01720797|University of Florida|Calogero Dolce, DDS, PhD|352-273-5700|cdolce@dental.ufl.edu|
20181664|NCT04524104|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
20181665|NCT00983619|MedImmune, LLC|Shahram Rahimian|800-236-9933|information.center@astrazeneca.com|
20181666|NCT00724061|Northwestern University|Dr. Timothy Kuzel|312-695-6180|cancertrials@northwestern.edu|
20181667|NCT01183650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181668|NCT00088205|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20181669|NCT04827134|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181670|NCT01048606|Université de Sherbrooke|Pr Isabelle Dionne, Ph.D., vice-dean to research and graduate studies|1-819-821-8000|isabelle.dionne@usherbrooke.ca|63327
20181671|NCT02443103|IndianaU|Dr. Kathy Miller|317-948-3855|kathmill@iu.edu|
20181672|NCT03657264|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
20181673|NCT03358329|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20181674|NCT02982720|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
20181675|NCT01448525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20181676|NCT03875911|UCLA Jules Stein Eye Institute|Dr. Joseph Caprioli|310-825-6323|caprioli@jsei.ucla.edu|
20181677|NCT02144519|University of South Carolina|Michael W Beets|8037773003|beets@mailbox.sc.edu|
20181678|NCT02343575|Stanford University|Yelizaveta Sher, MD|650-736-0459|ysher@stanford.edu|
20181679|NCT03824938|Columbia University Irving Medical Center|Victoria M. Leavitt, MD|212-342-1351|vl3227@cumc.columbia.edu|
20181680|NCT05126459|Loma Linda University Health|Dr. Jung-Wei Chen|909 558 1000|JWChen@llu.edu|
20181681|NCT00287469|Armed Forces Research Institute of Medical Services|Mrigendra P. Shrestha MD|662-644-4888|shrestham@afrims.org|
20181682|NCT00065468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181683|NCT05515679|Hopeful Aging|Michael Skrajner|4404777881|info@hopefulaging.com|
20181684|NCT02571439|Maimonides Medical Center|Dr Kalpana Tyagaraj|7182836000|KTyagaraj@maimonidesmed.org|
20181685|NCT02501135|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
20181686|NCT02019602|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20181687|NCT00683449|MediciNova, Inc.|Kazuko Matsuda, MD PhD MPH, Vice President, Clinical Development|858-373-1500|matsuda@medicinova.com|132
20181688|NCT01448044|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20181689|NCT01058863|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20181690|NCT00507026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162738|NCT00761202|Allergan, Inc.|Vice President Medical Affairs - Europe|(714)246-4500|clinicaltrials@allergan.com|
20162739|NCT00492336|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
20181691|NCT03653416|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
20181692|NCT00658736|Cleveland Clinic|Dr. Tyler Stevens|216 445-1996|stevent@ccf.org|
20181693|NCT02788006|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20181694|NCT02682563|AmsterdamUMC|Erik van Bommel|+31 20 444 2264|e.vanbommel@amsterdamumc.nl|
20181695|NCT01991197|Clinical Research Centre, St Vincent's University Hospital, Dublin, Ireland|Dr Maeve Lynch||maeve.lynch2@hse.ie|
20181696|NCT03553940|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
20181697|NCT01010217|UT MD Anderson Cancer Center|Dr. Stefan O Ciurea, Associate Profeddor of Stem Cell Transplantation|713-745-0146|sciurea@mdanderson.org|
20181698|NCT05822921|Virginia Tech|Dr. Angela Scarpa|540-231-2615|ascarpa@vt.edu|
20181699|NCT03277378|Abbott|Robyn Capobianco, PhD|+1 512 286 4274|robyn.capobianco@abbott.com|
20181700|NCT02397265|Imperial College London|Nick Oliver|020 7594 2460|nick.oliver@imperial.ac.uk|
20181701|NCT04714216|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
20181702|NCT01682538|Swedish Orphan Biovitrum|Medical Director|+4686972000|erik.brouwer@sobi.com|
20181703|NCT01868789|Orthopedic Foot and Ankle Center|Dr. Gregory Berlet|6148958747|ofacresearch@orthofootankle.com|
20181704|NCT01349829|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20181705|NCT00777803|Merz Pharmaceuticals GmbH|Matthias Zerm|+49 69 1503|matthias.zerm@merz.de|865
20181706|NCT00528190|Ottawa Hospital Research Institute|Shawn Aaron|613-737-8259|saaron@ohri.ca|
20162740|NCT03043651|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
20162741|NCT02980133|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20162742|NCT02596945|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20181707|NCT01995357|Coloplast A/S|MD, Medical Director|+45 4911 1395|dkbir@coloplast.com|
20181708|NCT04129580|Penn State Milton S. Hershey Medical Center|Dr Sarah Kawasaki|7175311000|skawasaki@pennstatehealth.psu.edu|
20181709|NCT02435511|University of Chicago|Dr. Stacy Lindau|7738348986|slindau@bsd.uchicago.edu|
20181710|NCT02711995|Weill Cornell Medicine|Katerina Andreadis|646-962-9883|kaa2055@med.cornell.edu|
20181711|NCT00322868|Case Western Reserve University|Michael W Konstan, MD|2168443267|michael.konstan@case.edu|
20181712|NCT04006795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181713|NCT01852162|University of Florida|Dominick Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
20181714|NCT03248570|University of California, San Francisco|Dr. David Oh, MD|(415) 476-1000|David.Oh@ucsf.edu|
20181715|NCT01603940|Hospital Universitario Pedro Ernesto (UERJ)|Ronaldo Altenburg Gismondi, MD, PhD|+5521996092383|ronaldogismondi@gmail.com|
20181716|NCT00163215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181717|NCT00739583|Johns Hopkins University|Simon C Mears|410-550-0101|smears1@jhmi.edu|
20181718|NCT01809210|AstraZeneca|Dr Gabriella Mariani , MD|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
20181719|NCT00590980|University of Illinois at Chicago|Sepideh Amin-Hanjani, MD|312-996-4842|hanjani@uic.edu|
20181720|NCT00827944|Derriford Hospital, Department of Surgery|Pr. Andrew KINGSNORTH|+44 175 276 3017|Andrew.Kingsnorth@phnt.swest.nhs.uk|
20181721|NCT04975789|University of Wisconsin - Madison, School of Nursing|Maichou Lor, PhD, RN|608-265-4248|mlor2@wisc.edu|
20181722|NCT01489020|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
20181723|NCT03294213|Ambu A/S|Anna Lundgaard|+4529643748|aclu@ambu.com|
20181724|NCT02451930|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20191303|NCT04374253|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20223711|NCT01082211|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20223712|NCT04999163|Procyrion, Inc.|Sr. Director, Clinical Affairs|650-208-1118|tami@procyrion.com|
20223713|NCT01106677|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
20223714|NCT03875092|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20223715|NCT04114357|Indiana University|Heba M Ismail|317-278-8326|heismail@iu.edu|
20223716|NCT03693612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20223717|NCT04364802|University of Kentucky|Alexandra Kejner|859-323-6741|aeke234@uky.edu|
20223718|NCT01669174|Novartis Pharmaceuticals|Study Director|862-778-8300||
20223719|NCT01953601|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223720|NCT01246349|The Hospital for Sick Children|Beverly Walpole|416. 813 7654|bwalpole@uoguelph.ca|328363
20223721|NCT02991729|UNC School of Medicine Maternal Fetal Medicine|Laura Carlson, MD|8643503140|lauramosbycarlson@gmail.com|
20223722|NCT05537441|Yale University|Daniella Meeker|(213)926-2658|daniella.meeker@yale.edu|
20223723|NCT04310397|The University of Texas MD Anderson Cancer Center|Rodabe Amaria, MD|(713) 792-2921|rnamaria@mdanderson.org|
20223724|NCT00723255|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20223725|NCT00614523|Amgen Inc.|Study Director|866-572-6436||
20223726|NCT03962790|Johnson & Johnson Vision Care|Brian Pall, Director Clinical Science, Vision Care|1-800-843-2020|bpall@its.jnj.com|
20223727|NCT02877095|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-309-5544|rachel.e.olson@duke.edu|
20181725|NCT02485353|IndianaU|Hamid Sayar, MD|317-948-7576|ssayar@iu.edu|
20181726|NCT04758403|BIDMC|Adnan Majid|617-632-8386|tsipresearchstaff@bidmc.harvard.edu|
20181727|NCT04411940|Cycle Pharmaceuticals|Head of Global Regulatory Affairs & Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
20181728|NCT00839917|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181729|NCT03354637|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
20181730|NCT02774265|University of Maryland Medical Center|Dr. Bryce Haac|410-328-3495|bhaac@som.umaryland.edu|
20181731|NCT01300559|Duke University Medical Center|Steven E. Hill, M.D.|681-6614|hill0012@mc.duke.edu|
20181732|NCT02268552|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20181733|NCT00997243|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center|Alison Walker, MD|614-293-3196|Alison.Walker@osumc.edu|
20223728|NCT03966924|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
20223729|NCT01934517|U of Montreal|Vincent Peloquin|514-343-6056|vincent-claude.peloquin@umontreal.ca|
20223730|NCT02153671|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20223731|NCT00452673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20223732|NCT04638881|Stanford University School of Medicine|Dr. Richard K. Kim|3475869661|rkwkim@stanford.edu|
20223733|NCT01322594|MedImmune, Limited|Ed Piper|+44 (0) 1223 471 471|pipered@medimmune.com|
20223734|NCT02064270|University of Missouri, Department of Orthopaedic Surgery|Stacee Clawson, Research Manager|5738849017|clawsons@health.missouri.edu|
20223735|NCT01949844|Cedars-Sinai Medical Center|Dr. Behzad Sharif, Assistant Professor|310-423-7758||
20223736|NCT02048826|University of California at Irvine|Prof. David Reinkensmeyer|949-824-5218|dreinken@uci.edu|
20181734|NCT01754779|UT Southwestern Medical Center|Dr. Naim Maalouf|214/648-2954|naim.maalouf@utsouthwestern.edu|
20181735|NCT03415022|New York State Psychiatric Institue|Dr. Franklin Schneier|646-774-8041|Franklin.Schneier@nyspi.columbia.edu|
20181736|NCT03226457|University of Dundee|Dr Natalie Mordi (Principle Investigator)|+ 44 (0) 1382 383 667|n.a.mordi@dundee.ac.uk|
20181737|NCT03583541|Washington University in St. Louis|Fred Ssewamala|3149358521|fms1@wustl.edu|
20181738|NCT00884286|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
20181739|NCT01196104|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20181740|NCT00409240|Providence VAMC|Wen-Chih Wu, MD|401-273-7100|wen-chih.wu@va.gov|6237
20181741|NCT04655313|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20181742|NCT03781960|University of Pennsylvania Hospital|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
20181743|NCT00594932|Oklahoma Medical Research Foundation|Joan T Merrill M.D.|405 271 7805|joan-merrill@omrf.org|
20181744|NCT01094171|GlaxoSmithKline|GSK Response Center|866-435-7343||
20181745|NCT01536145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181746|NCT02444234|University of Southern California|Paul M Beringer, Pharm.D.|323-442-1402|beringer@usc.edu|
20181747|NCT05199233|Mayo Clinic Rochester|Dr. Ivana T. Croghan|507 284-2511|gimresearchstudies@mayo.edu|
20181748|NCT00736073|DUMC|Dr. Martin Poleski|9196841817|martin.poleski@dm.duke.edu|
20181749|NCT02563834|Indiana University|Dr. Kieren J Mather|317-278-7826|kmather@iu.edu|
20181750|NCT01364727|Stanford University Medical Center|Heather A Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
20181751|NCT00688259|VA Greater Los Angeles Healthcare System at West Los Angeles|Shirley M. Glynn, Ph.D.|3102683939|shirley.glynn@va.gov|
20181752|NCT00939796|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20181753|NCT01676220|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
20181754|NCT04227340|St. Jude Children's Research Hospital|Belinda Mandrell, PhD, RN|(901) 595-4209|belinda.mandrell@stjude.org|
20181755|NCT00445263|SAMU 93|Pr Frédéric Lapostolle|0033148964454|frederic.lapostolle@avc.aphp.fr|
20181756|NCT00393094|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
20181757|NCT00549822|Massachusetts General Hospital|Dr. Paul Goss|617-724-3118|pgoss@mgh.harvard.edu|
20181758|NCT00570258|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
20181759|NCT03050398|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20181760|NCT03018106|Emory University|Gina Northington, MD|(404) 778-5770|gina.northington@emory.edu|
20181761|NCT04242875|Carolina Eyecare Physicians|Director of Research|8438813937|hsandoval@cepmd.com|
20181762|NCT04675242|Nicox Ophthalmics, Inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
20181763|NCT02611830|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20181764|NCT03687450|Brigham and Women's Hospital|Julia Loewenthal, MD|6177325500|jloewenthal@bwh.harvard.edu|
20181765|NCT03567993|UMass Chan Medical School|Dr. Rajani Sadasivam|508-456-8923|rajani.sadasivam@umassmed.edu|
20181766|NCT02036515|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181767|NCT01823614|Central Research Institute for Epidemiology|Dmitry Kireev|+74959749646|dmitry.kireev@pcr.ru|2227
20181768|NCT01671748|Cardiff and Vale University Health Board|Dr Judith White|02920744771|judith.white3@wales.nhs.uk|
20223737|NCT00384748|University of Georgia|Neale Chumbler, PhD|706-369-5975|chumbler@uga.edu|
20181769|NCT02601937|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
20181770|NCT03615482|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181771|NCT04404257|William Beaumont Hospitals|Dr. Simon Dixon, MD|248-898-4198|simon.dixon@beaumont.edu|
20181772|NCT03114995|Cardiovascular Center, Seoul National University Bundang Hospital|Dr. Tae-Jin Youn|+82-31-787-7031|ytjmd@snubh.org|
20181773|NCT04223154|Wake Forest University School of medicine|Colleen A. Hanlon, Ph.D.|336-716-5465|chanlon@wakehealth.edu|
20181774|NCT02662244|UCSD|Dr. Arisa Ortiz|858-657-1697|dermstudies@ucsd.edu|
20181775|NCT02466126|Department of Veterans Affairs, Micheal E. DeBakey VAMC|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
20181776|NCT00315627|University of Miami Miller School of Medicine|Dr. Rodolfo Alejandro|305 243-5324|ralejand@med.miami.edu|
20181777|NCT01115998|University of Oklahoma Health Sciences Cetner|Director of Sponsored Programs|405-271--2090|mary-cotter@ouhsc.edu|
20181778|NCT02718417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181779|NCT01023308|Novartis Pharmaceuticals|Study Director|862-778-8300||
20181780|NCT03905811|University of Iowa|Jordan Schultz|3193849388|jordan-schultz@uiowa.edu|
20181781|NCT01646320|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
20181782|NCT02892409|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20181783|NCT01330043|Stanford University|Dr. Sean P. David|401-265-2275|spdavid@stanford.edu|
20181784|NCT01440049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181785|NCT00447330|Duke University Medical Center|Brant Hamel|919-668-1861|brant.hamel@duke.edu|
20181786|NCT02971891|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20181787|NCT02748512|Axiom|Kelley Collins-Winters, RTR, BS, MBA|469-667-6655|kelleyc@axiom.cc|
20181788|NCT04963764|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Todd Florin|312-227-6080|edpneumoniaresearch@luriechildrens.org|
20181789|NCT02411591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20181790|NCT02491892|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20181791|NCT01405794|University of Utah|Dr. Mark Munger|801-581-6165|mmunger@hsc.utah.edu|
20181792|NCT04496167|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
20181793|NCT03088137|IVFarma LLC|Mikhail Polzikov (PhD)|+74996455342|mikhail.polzikov@ivfarma.ru|1
20181794|NCT00598481|Fondazione Telethon|Fondazione Telethon||cvezzali@telethon.it|
20181795|NCT04612049|University of Montreal|Dr Danielle Levac|5148639108|danielle.levac@umontreal.ca|
20181796|NCT00918749|Warner Chilcott|Grexan Wulff, Manager, Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20181797|NCT00136916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20181798|NCT02397460|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181799|NCT02501759|OHSU Knight Cancer Institute|Fegus Coakley|503-494-2333|coakleyf@ohsu.edu|
20181800|NCT02213055|The Deirdre Imus Environmental Health Center at HackensackUMC|Project Manager, Environmental Research|551-996-8071|dimuscenter@hackensackumc.org|
20181801|NCT00231894|Nathan Kline Institute ofr Psychiatric research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
20181802|NCT03190083|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nidhi Sharma|+1 216-444-9014|sharman2@ccf.org|
20181803|NCT02025205|Pulmonx|Narinder Shargill, Vice President, Global Medical and Clinical Affairs|650-216-0108|nshargill@pulmonx.com|
20181804|NCT01767129|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
20181805|NCT01024751|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.reindel@bausch.com|
20181806|NCT00955903|Wake Forest School of Medicine|Jamy Ard, MD|3367169837|jard@wakehealth.edu|
20181807|NCT04033991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181808|NCT03020095|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
20181809|NCT01628510|Washington University|Roberta Pineda|314-286-1304|pineda_r@kids.wustl.edu|
20181810|NCT01656759|Rush University|Sean Kearns|708-236-2664|sean_m_kearns@rush.edu|
20181811|NCT04707391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181812|NCT04374565|University of Virginia|Dr. Jeffrey Sturek|434-284-1776|JMS3HK@hscmail.mcc.virginia.edu|
20181813|NCT03246672|William S Middleton Memorial Veterans Hospital|Dr. Corrine Voils|608-262-9636|corrine.voils@va.gov|
20181814|NCT01932996|University of Minnesota|Rebekah Pratt|612-625-1196|rjpratt@umn.edu|
20181815|NCT02923895|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181816|NCT03983993|Emory University|Olatunji Alese|404-778-6639|olatunji.alese@emory.edu|
20181817|NCT02500316|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20181818|NCT01406717|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
20181819|NCT03257995|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20181820|NCT02040090|Kamada|Eran Schenker, VP Medical Director|+972-8-9406472|Erans@kamada.com|
20191304|NCT02814279|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
20191305|NCT01207453|Brigham and Women's Hospital|Yvonne C Lee, MD, MMSc|617-732-8736|ylee9@partners.org|
20191306|NCT00676663|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|+1-858-888-3798|kmadigan@syndax.com|
20223738|NCT04470544|Mayo Clinic|Alan Haruo Bryce, M.D.|(480)301-8335|Bryce.Alan@mayo.edu|
20223739|NCT00823069|Medicis|Mary Sanstead|480-291-5926|msanstead@medicis.com|
20162743|NCT03738618|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20181821|NCT02554435|California State Polytechnic University, Pomona|Dr. Zakkoyya Lewis|5628819950|drkoyyalewis@gmail.com|
20223740|NCT00712881|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20223741|NCT00068367|SWOG Statistical Center|Study Statistician|206-667-4623|sarcoma@crab.org|
20223742|NCT02879617|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20223743|NCT02222545|Omeros Corporation|Clinical Trial Manager|(206) 676-5000|ctinfo@omeros.com|
20223744|NCT04807205|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20223745|NCT00537316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20223746|NCT04533412|Icahn School of Medicine at Mount Sinai|Alex D. Federman, MD, MPH|(212) 824-7565|alex.federman@mountsinai.org|
20223747|NCT05113979|OnPointVision|Lynne Archer|949-749-4170|larcher@onpoint-vision.com|
20223748|NCT05875025|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20223749|NCT00968981|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20223750|NCT02233296|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20223751|NCT04259424|Medical University of South Caroina|Ryan Ross|843-792-3477|rossre@musc.edu|
20223752|NCT00784303|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20223753|NCT01878084|Alexandria University|Prof. Mona K. Marei|002-03-4858353|mona.marei@gmail.com|
20223754|NCT01876784|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20181822|NCT01614574|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20223755|NCT02643849|SRS Medical|Director of Clinical Trials|800-345-5642|info@srsmedical.com|
20223756|NCT01194531|Natera (formerly Gene Security Network)|Nina Wemmer, MS,CGC, Study Coordinator|650-249-9090|nwemmer@natera.com|
20223757|NCT03891862|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20223758|NCT02410798|Synapse Biomedical|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
20223759|NCT05093530|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
20223760|NCT00373958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223761|NCT01777568|Cleveland Clinic|Kurz, M.D., Andrea|(216) 445-9924|KURZA@ccf.org|
20223762|NCT05229952|University of Alabama at Birmingham|Dr Sonia Fargue|2059756932|sfargue@uab.edu|
20223763|NCT00492648|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223764|NCT00282113|University of California Davis|Mark A. Underwood MD|916-734-5061|mark.underwood@ucdmc.ucdavis.edu|
20223765|NCT03382834|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|3016283313|ACTGCT.Gov@s-3.com|
20223766|NCT02387957|Ophthotech Corp.|Denise Teuber|646-753-8461|denise.teuber@ophthotech.com|
20223767|NCT02294396|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
20223768|NCT02949843|Wake Forest Baptist Comprehensive Cancer Center|William Petty|3367163313|wpetty@wakehealth.edu|
20223769|NCT02120833|Johnson & Johnson Consumer and Personal Products Worldwide|Chirstopher Nunez, PhD/Study Director|973-385-7984 USA EST|cnunez1@its.jnj.com|
20223770|NCT03613649|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
20223771|NCT03429244|Indianan University School of Medicine|Jennifer Lehman|3179489575|jgeck@iu.edu|
20181823|NCT02875561|University of Colorado|Dr. Saketh Guntupalli|303-724-2024|saketh.guntupalli@cuanschutz.edu|
20223772|NCT00474201|National Institutes of Health|Scott Penzak|301-496-2997|sp286u@nih.gov|
20181824|NCT01168674|Tufts Medical Center|Dr. Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
20181825|NCT02584855|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20181826|NCT02337478|Wake Forest University Health Sciences|Timothy Pardee, MD, Ph.D.|336-716-5440|tpardee@wakehealth.edu|
20181827|NCT00895843|University of Manchester|Mr Sin L Yong|01612756806|sin.l.yong@manchester.ac.uk|
20181828|NCT02329600|Faculty of Oral and Dental Medicine Cairo University|Dr. Noha Ayman Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
20181829|NCT04374500|Umeå University, Umeå, Sweden|Stefan Söderberg|+46 70 319 38 03|stefan.soderberg@umu.se|
20223773|NCT01500187|University of Health Science Center|Franklin Garcia-Godoy DDDS, MS PhD||fgarciagodoy@gmail.com|
20223774|NCT00750139|Merz Pharmaceuticals, LLC|Associate Medical Director- Dermatology|800-334-0514||
20223775|NCT00595517|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20223776|NCT00658775|Eisai Call Center|Eisai Inc.|888-422-4743||
20223777|NCT02521051|Massachusetts General Hospital|Justin Gainor, MD|617-724-4000|jgainor@partners.org|
20223778|NCT02784613|San Diego Sexual Medicine|Irwin Goldstein|619-265-8865|dr.irwingoldstein@gmail.com|
20223779|NCT01551264|Washington University School of Medicine|Matthew Dobbs MD|561-844-5255|mdobbs@paleyinstitute.org|
20223780|NCT01435460|Bausch & Lomb, Incorporated|Tuyen Ong|(973) 360-6389|tuyen.ong@bausch.com|
20223781|NCT01706939|Icahn School of Medicine at Mount Sinai|Dr. Marshall R Posner|(212) 659-5461|marshall.posner@mssm.edu|
20223782|NCT01046903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223783|NCT05020665|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
20223784|NCT01868022|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20223785|NCT03297645|Virginia Commonwealth University|Robin S. Everhart, PhD|(804) 828-7249|reverhart@vcu.edu|
20223786|NCT02504827|University of Southern California|Paul Beringer|323-442-1402|beringer@usc.edu|
20223787|NCT03386994|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223788|NCT02842580|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20181830|NCT01607411|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223789|NCT02965729|Pennington Biomedical Research Center|Dr. Amanda Staiano|225-763-2729|amanda.staiano@pbrc.edu|
20223790|NCT00725361|StanfordU|Lorinda Chung|650-736-0727|shauwei@stanford.edu|
20181831|NCT03262701|Loma Linda University School of Dentistry|Yoon Jeong Kim|(909) 558-4610|yjkim02d2@llu.edu|
20223791|NCT06366087|BARDA|Michael D. Schwartz, MD MPH/Division of CBRN Countermeasures|(202)-260-0849|Michael.Schwartz@hhs.gov|
20181832|NCT04387162|Atlanta VA Medical Center|Amy Rodriguez|404-321-6111|amy.rodriguez@va.gov|
20181833|NCT03171168|Montefiore Medical Center|Matthew Bartels|(914) 597-2332|MBARTELS@montefiore.org|
20181834|NCT03786094|Spexis AG|Christian Zwingelstein|+41 61 567 16 00|info@spexisbio.com|
20181835|NCT02906202|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20181836|NCT01987830|Massachusetts General Hospital|Dr. Elizabeth Gerstner|(617) 726-2000|EGERSTNER@mgh.harvard.edu|
20181837|NCT01706965|New York State Psychiatric Insititute|Marlene Carlson|646-774-8436|marlene.carlson@nyspi.columbia.edu|
20181838|NCT03698864|Processa Pharmaceuticals|Mary G. Nyberg, VP Clinical Operations|443-776-3133|mnyberg@processapharmaceuticals.com|
20181839|NCT00057811|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20181840|NCT04131907|Laborie Medical Technologies|Jill Moland|800-522-6743|jmoland@laborie.com|
20181841|NCT00859131|Medical University of South Carolina|Kenneth Chavin, MD, PhD|843-792-3368|chavinkd@musc.edu|
20181842|NCT03428815|University of Pittsburgh|Dr. Goeran Fiedler|14126246475|gfiedler@pitt.edu|
20181843|NCT02404493|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
20181844|NCT01700348|Philips Oral Healthcare, Inc|Marcia Delaurenti, Clinical Project Manager|425-908-1212|marcia.delaurenti@philips.com|
20181845|NCT03796013|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20181846|NCT03958630|National Institute of Mental Health|Innis, Robert|+1 301 594 1368|robert.innis@nih.gov|
20181847|NCT01736358|Montefiore Medical Center|Dr.David Hoenig||dhoenig@montefiore.org|
20181848|NCT04157686|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20181849|NCT03038672|Mayo Clinic|Stephen Ansell|(507)284-5096|ansell.stephen@mayo.edu|
20223792|NCT03717051|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
20223793|NCT00860249|Northwestern University, Department of General Internal Medicine|Kenzie A. Cameron, PhD, MPH|312-503-3910|K-Cameron@northwestern.edu|
20223794|NCT00519428|NYSPInstitute|Jonathan W. Stewart, M.D.|212-543-5745|jws6@columbia.edu|
20223795|NCT01168908|Kennedy Krieger Institute|Kathryn Wagner, MD, PhD|443-923-9525|wagnerk@kennedykrieger.org|
20223796|NCT01275755|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20223797|NCT03653351|Washington University in Saint Louis|Eric Lenze MD|314-362-5154|lenzee@wustl.edu|
20223798|NCT02703272|Janssen Research & Development, LLC|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20223799|NCT02651155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20223800|NCT00976820|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223801|NCT01098500|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223802|NCT03452488|Biophytis S.A.|Cendrine Tourette|+331 44 27 33 00|cendrine.tourette@biophytis.com|
20223803|NCT04016779|Supernus|Joseph Hull, Ph.D., Director Clinical research|240-403-5324|jhull@supernus.com|
20223804|NCT00330343|JHU|Myron Yaster|9552393|myaster1@jhmi.edu|
20223805|NCT00281632|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223806|NCT06586788|Indiana School of Medicine|Dr. Rebecca McNally Keehn|(317) 274-2121|mcnallyr@iu.edu|
20223807|NCT02980341|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20223808|NCT01369108|3M Oral Care Solutions Division|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
20223809|NCT01813214|Lombardi Comprehensive Cancer Center|Dr Michael Atkins|202-687-2795|mba41@georgetown.edu|
20223810|NCT04748458|IRCCS Istituto Ortopedico Rizzoli|Dr Francesco Castagnini|+390516366418|francescocastagnini@hotmail.it|
20223811|NCT02050919|OHSU Knight Cancer Institute|Christopher Ryan, MD|503-494-8487|ryanc@ohsu.edu|
20223812|NCT02691936|Cleveland Clinic Foundation|Dr. Marie Fidela Paraiso|216-444-3428|PARAISM@ccf.org|
20223813|NCT00749684|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20181850|NCT04423393|Vir Biotechnology, Inc.|Study Inquiry|(415) 906-4324|clinicaltrials@vir.bio|
20181851|NCT05220501|Sunnybrook Health Sciences Centre|Dr. Laurence Klotz|+1. 416 480 4673|Laurence.Klotz@sunnybrook.ca|
20181852|NCT02692235|AWFiS|Robert Olek|+48 58 5547392|robol@awf.gda.pl|
20181853|NCT05160025|Rutgers University|Dr. John Palmieri, Study Coordinator|9733562378|john.palmieri@rutgers.edu|
20181854|NCT00107380|SWOG Statistical Center|Study Statistician|206-667-4623||
20181855|NCT03673098|Massachusetts General Hospital|Dr. Christina Psaros|617-726-7458|cpsaros@mgh.harvard.edu|
20181856|NCT01268059|MedImmune, LLC|Mohammed Dar, MD, Vice President & Head, Clinical Development, Oncology|+1 301-398-0000|information.center@astrazeneca.com|
20181857|NCT03660943|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
20181858|NCT03850444|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181859|NCT01021878|Pontifícia Universidade Católica do Paraná|Dr. Roberto Pecoits-Filho and Dr. Thyago P. Moraes|554132713150|r.pecoits@pucpr.br|
20181860|NCT01155726|Alcon Research|Director of Clinical Trials|1-800-241-7629||
20181861|NCT05305040|AlloVir, Inc.|Kevin Anderson|617-433-2605|kanderson@allovir.com|
20181862|NCT01195675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181863|NCT02424344|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20181864|NCT01174550|Duke University Medical Center|Dr. Pamela Douglas|919-668-8700|pamela.douglas@duke.edu|
20181865|NCT01536262|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181866|NCT00412516|PATH|Anthony A Marfin, Director Japanese Encephalitis Vaccine Introduction and Sustainability Project|2062853500|aamarfin@path.org|
20181867|NCT05257837|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
20181868|NCT01781611|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405-822-2336|joan-merrill@omrf.org|
20223814|NCT03696108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181869|NCT03639675|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20181870|NCT02459587|Veterans Health Administration|Dr. Mark Ilgen|7349366266|mark.ilgen@va.gov|
20181871|NCT04731714|Washington University School of Medicine|Kevin J. Black, M.D.|314-362-5041|kevin@wustl.edu|
20181872|NCT05343455|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
20223815|NCT05239494|University of Alabama at Birmingham|Andrew Pucker, OD, PhD|920-579-2900|andrewpucker@hotmail.com|
20223816|NCT01053962|Synergy Pharmaceuticals Inc|Dr. Laura Barrow/Senior Vice President Clinical Development|212-297-0020|lbarrow@synergypharma.com|
20223817|NCT04798989|Tisento Therapeutics|Clinical Research|1-857-259-5371|hello@tisentotx.com|
20223818|NCT02892422|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20223819|NCT03089697|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
20223820|NCT02693171|United Therapeutics Corp.|Odette Jordan, MD, PMP|919-425-5606|ojordan@unither.com|
20181873|NCT03468426|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181874|NCT02139982|The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University|Dr. Ting Li|008613587876896|liting1021@aliyun.com|
20181875|NCT02472314|Wayne State University School of Medicine and Cleveland Clinic Florida|Vani J. Sabesan, MD|131375138489|sabes001@gmail.com|
20181876|NCT05794997|Brigham and Women's Hospital|Rishi J Desai, PhD|6172780932|rdesai@bwh.harvard.edu|
20181877|NCT04466618|Mayo Clinic|Dr Adrian Vella|5072843754|vella.adrian@mayo.edu|
20181878|NCT00109928|SWOG Statistical Center|Study Statistician|206-667-4623||
20181879|NCT01041508|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20181880|NCT01734850|CSL Behring|Trial Registration Coordinator|484-878-4000|clinicaltrials@cslbehring.com|
20181881|NCT00750893|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20181882|NCT00661258|Boston University Center for Global Health and Development|Dr. Lora Sabin|617-414-1272|lsabin@bu.edu|
20181883|NCT01083160|Abbott|Global Medical Services|1-800-633-9110||
20181884|NCT01951092|Alpert Medical School of Brown University/The Miriam Hospital|Aadia Rana, MD|401-793-4680|arana@lifespan.org|
20181885|NCT01712789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20181886|NCT01708187|Orthopedic Foot and Ankle Center|Gregory Berlet, MD|614-895-8747|ofacresearch@orthofootankle.com|
20181887|NCT00788255|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
20181888|NCT01152554|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20181889|NCT02117544|Alcon Research, Ltd|Clinical Project Lead, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20181890|NCT03486899|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20181891|NCT01439711|Duke University Medical Center|E. Shelley Hwang MD MPH|919-684-6849|shelley.hwang@duke.edu|
20191307|NCT01114334|Denver Health and University of Colorado Denver|Dr. Robert D. Keeley|303-602-8270|robert.keeley@dhha.org|
20191308|NCT00998517|Washington University in St. Louis|Indi Trehan|5039284634|itrehan@wustl.edu|
20191309|NCT04382053|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@novartis.com|
20191310|NCT04623996|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
20191311|NCT01399905|Oregon Health and Science University|John G. Nutt, MD|503-494-9054|nuttj@ohsu.edu|
20191312|NCT00672100|William Beaumont Hospital|Craig T. Hartrick, MD|248-964-3440|chartrick@beaumont.edu|
20191313|NCT00513292|University of Texas MD Anderson Cancer Center, Houston, TX, USA|Aman U. Buzdar, MD|713-792-2817|abuzdar@mdanderson.org|
20191314|NCT02135419|University of California, San Francisco|Dr. Joel Palefsky|(415) 476-1574|joel.palefsky@ucsf.edu|
20191315|NCT00714688|Janssen-Cilag Germany|EMEA Medical Affairs Director|+49 2137 955258||
20191316|NCT01123642|VISN 17 Center of Excellence for Research on Returning War Veterans|Sandra B. Morissette, Ph.D.|254-297-5170|sandra.morissette@va.gov|
20191317|NCT00651937|The University of Texas (UT) MD Anderson Cancer Center|Dr. Richard E Champlin,MD/Chair, Stem Cell Transplantation|713- 203-8632|rchampli@mdanderson.org|
20191318|NCT02924350|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191319|NCT02137499|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20191320|NCT00848393|Nationwide Children's Hospital|Aymen Naguib, MD|6147220596|Aymen.Naguib@nationwidechildrens.org|
20191321|NCT00575367|Inspire Pharmaceuticals, Inc.|Karen Kuhn/ Director|919 941-9777|kkuhn@inspirepharm.com|
20191322|NCT02288364|Duke University Medical Center|Jay A. Baker, MD|919-684-7645|jay.baker@duke.edu|
20191323|NCT00443898|Novartis Pharmaceuticals|Study Director|862-778-8300||
20191324|NCT03619889|Universidad Complutense de Madrid|Dra. Gema Serrano-Hernanz|669332986|gema.serrano.hernanz@gmail.com, gemase01@ucm.es|
20191325|NCT00755716|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
20191326|NCT03681353|Duke University Medical Center|Angela Kirby, MS|919-286-0411|angela.kirby@duke.edu|175526
20191327|NCT00726388|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223821|NCT01167881|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181892|NCT02408549|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20181893|NCT01146808|Columbia University Medical Center|Robert S. Brown Jr., MD, MPH|(212) 305-3839|tt2103@columbia.edu|
20181894|NCT01833117|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20181895|NCT01232556|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181896|NCT02448719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20181897|NCT02225275|The University of Texas MD Anderson Cancer Center|Dr. Alessandra Ferrajoli MD/ Professor|173-792-2063|aferrajo@mdanderson.org|
20181898|NCT00597870|Lundquist Institute of BioMedical Studies|Rodney A. White, MD|3109635230|rawhite@ucla.edu|
20181899|NCT01473420|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20181900|NCT02308501|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
20181901|NCT04172987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20181902|NCT02186938|MUSC|Dr Hand|843-792-5442|handw@musc.edu|
20181903|NCT01603121|Eastern Virginia Medical School|Dr. David Lieb, Principal Investigator|7574465910|liebdc@evms.edu|
20181904|NCT00577720|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20181905|NCT02410161|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20181906|NCT03862482|Université de Montréal|Dr. Aldo Joseph Camarda|514-343-7124|aj.camarda@umontreal.ca|
20181907|NCT00738530|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20181908|NCT04179461|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
20181909|NCT03100838|USFDA|Dr. Minori Kinjo|240-40269118|minori.kinjo@fda.hhs.gov|
20181910|NCT01347645|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20181911|NCT00184028|USC/Norris Comrpehensive Cancer Center|Barbara Gitlitz, MD|323-865-3906|Gitlitz@usc.edu|
20181912|NCT01141660|Eastern Virginia Medical School|Cristina Baldassari|7576689853|baldassc@yahoo.com|
20181913|NCT01438229|St. Jude Medical|Steven Madej|651-756-2230|smadej@sjm.com|
20181914|NCT00209027|Emory University|Erica Duncan|404-321-6111|erica.duncan@va.gov|7532
20181915|NCT03785340|Ocugen|Vijay Tammara, VP, Strategic regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
20181916|NCT04963062|University of Wisconsin School of Medicine and Public Health|Shuang Li|608.263.8336|lis@urology.wisc.edu|
20181917|NCT00670982|Dana-Farber Cancer Institute|Harold J. Burstein, MD|617-632-2335|hal_burstein@dfci.harvard.edu|
20181918|NCT03749460|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
20181919|NCT02406209|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20181920|NCT01500746|Northwestern University|Dr. Elliot Hirsch|312-695-6022|elliot-hirsch@md.northwestern.edu|
20157577|NCT01685684|Collegium Pharmaceutical|Clinical Scientist|+1.781.232.0764|clinicaltrials@collegiumpharma.com|
20157578|NCT00606489|Cumberland Pharmaceuticals|Amy Rock, Doctor of Philosophy (Ph.D.)|6152550068|arock@cumberlandpharma.com|
20157579|NCT00907621|Department of General practice, University of Oslo|Dr. Holgeir Skjeie|+4722850550|Holgeir.Skjeie@medisin.uio.no|
20157580|NCT04089020|Children's Mercy Kansas City|Jordan Carlson, PhD.|816-234-9240|jacarlson@cmh.edu|
20157581|NCT01563055|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223822|NCT01992653|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20223823|NCT00977314|Sonitus Medical, Inc.|Clinical Trials Manager|8668162076|lily@sonitusmedical.com|
20181921|NCT01349660|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
20223824|NCT01303406|National Hospital for Neurology and Neurosurgery|Dr Paola Giunti|020 3448 3141|violet.le-fevre@uclh.nhs.uk|
20223825|NCT02107859|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20181922|NCT01591161|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20223826|NCT02344251|MUSC|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
20223827|NCT00671528|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20223828|NCT03767153|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
20223829|NCT00556933|Wright State University, Dayton, Ohio|R. Brian Stevens, MD, PhD|937-545-4817|rbstevens1@icloud.com|
20223830|NCT03887442|TTCC Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|Carmen Montalbán, Manager|+34676154172|ttccmanager@yahoo.com|
20223831|NCT06343467|TRIA Orthopedic Center|Megan Reams; Director of Orthopaedic Research|(952) 806-5329|megan.reams@tria.com|
20223832|NCT01628198|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20223833|NCT00022698|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20223834|NCT03318497|UT Southwestern Medical Center|Kelli Key, PhD|214-648-8152|Kelli.Key@UTSouthwestern.edu|
20223835|NCT01743560|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20223836|NCT02119455|University of Connecticut- Division of Orthodontics|Dr. Flavio Uribe|8606792550|furibe@uchc.edu|
20223837|NCT00877487|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20223838|NCT01516008|Janssen Research & Development, L.L.C.|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20223839|NCT01217476|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
20223840|NCT02118727|University of Missouri Health Care|Richard Barohn, MD|573-882-3693|rbarohn@health.missouri.edu|
20223841|NCT03129945|University of California, Irvine|Judith Chung|714-456-8695|judithc@hs.uci.edu|
20223842|NCT00813813|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20223843|NCT00986921|Boston University Department of Obstetrics and Gynecology|Director of Clinical Research|617-414-5175|rstudy@bmc.org|
20223844|NCT04445714|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20181923|NCT00556374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20223845|NCT02805660|Mirati Therapeutics|Tavette Neskorik, Senior Director, Clinical Science|858-332-3552|neskorikt@mirati.com|
20223846|NCT01684943|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
20223847|NCT06137131|Ghent University|Dr. Iris Meerschman|+32499294636|iris.meerschman@ugent.be|
20162744|NCT01332253|Senior Manager, Clinical Operations|Byron Kaelin|615-255-0068|bkaelin@cumberlandpharma.com|250
20181924|NCT00847301|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20181925|NCT00996580|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20223848|NCT01493284|St Jude Medical|Sr Clinical Scientist|4159179696|alicia.kimber@abbott.com|
20223849|NCT04965311|OHSU Knight Cancer Institute|Dr. Brett Sheppard|503-494-9169|sheppard@ohsu.edu|
20223850|NCT01672710|Institute for Health and the Environment, University at Albany|David O. Carpenter MD|518-525-2660|dcarpenter@albany.edu|
20223851|NCT02122887|Bar Ilan University|Moran Influs|972-35317943|moran.influs@gmail.com|
20162745|NCT03499314|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
20181926|NCT05708846|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|dheart@humanitcare.com|
20181927|NCT00641186|Baylor College of Medicine|Christine Hunter|713-798-3951|chunter@bcm.edu|
20181928|NCT02218489|Kala Pharmaceuticals, Inc|VP, Clinical Development|781-996-5252|Results003@kalarx.com|
20181929|NCT00519636|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223852|NCT03725761|Wisconsin Institutes for Medical Research|Joshua M Lang, MD, MS|(608) 265-8131|jmlang@medicine.wisc.edu|
20223853|NCT03634033|Grand Valley State University|Dr. Sandra Spoelstra|616-331-5905|spoelsts@gvsu.edu|
20223854|NCT01397786|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20223855|NCT04432090|AdventHealth, Orlando|Richard Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
20223856|NCT00743730|Medical College of Wisconsin|Keri R. Hainsworth, PhD, Research Director|414-266-6306|khainswo@mcw.edu|
20223857|NCT02836236|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20223858|NCT01953874|ResMed|Adam Benjafield|(858)836-6782|adam.benjafield@resmed.com|
20223859|NCT00811317|Massachusetts General Hospital|Steven Russell|6177261848|sjrussell@mgh.harvard.edu|
20223860|NCT00174967|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20223861|NCT04420585|Montefiore Medical Center|Dr. Kerry Morrone|718-741-2342|kmorrone@montefiore.org|
20223862|NCT00477750|Mayo Clinic|Dr. Vivek Roy||roy.vivek@mayo.edu|
20223863|NCT03558152|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20223864|NCT00601172|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223865|NCT02219581|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
20223866|NCT04434469|Genetech|Medical Communications|800-821-8590|genentech@druginfo.com|
20162746|NCT00872599|Vanderbilt University|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
20223867|NCT01579045|Vistakon/Johnson & Johnson Vision Care|Katherine Osborn Lorenz, OD MS|904-443-3123|kosborn@its.jnj.com|
20181930|NCT00950937|Hospital de Clínicas de Porto Alegre|Pedro Dall'Ago|555133038751|pdallago@pq.cnpq.br|
20223868|NCT00840307|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20181931|NCT01254890|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
20223869|NCT04184362|SFVA|Joannalyn Delacruz, Ph.D.|415-375-5748|Joannalyn.Delacruz@va.gov|
20223870|NCT01470651|New York State Psychiatric Institute-Research Foundation for Mental Hygene|Judith Rabkin|646-774-8075|jgr1@cumc.columbia.edu|
20223871|NCT01936181|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
20162747|NCT04794270|Johnson & Johnson VIsion Care, Inc.|Benjamin Straker - Principal Research Optometrist|1-904-312-0604|bstraker@its.jnj.com|
20181932|NCT01824472|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
20181933|NCT01815736|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20181934|NCT03363659|Advocate Aurora Health|Manager of Oncology research|414 778 4345|karen.cheek@aah.org|
20181935|NCT03872388|MD Anderson Cancer Center|Carlos Barcenas, MD|(713) 794-5098|chbarcenas@mdanderson.org|
20181936|NCT05516342|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
20181937|NCT01929993|Fundação Oswaldo Cruz|Dr Fábio Russomano|55 21 25541815|fabiorussomano@gmail.com|
20181938|NCT01866475|Teleflex|Tatiana Puga|2104451794|tatiana.puga@teleflex.com|
20181939|NCT03531905|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20181940|NCT01036087|UT MD Anderson Cancer Center|Dr. Naoto Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
20181941|NCT03251144|University of California Los Angeles|Theodoros Kelesidis|3108257875|tkelesidis@mednet.ucla.edu|
20181942|NCT02054247|Eskisehir Osmangazi University|Dr. Onur Armagan|00902222392979|dronurarmagan@hotmail.com|
20181943|NCT01625338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20181944|NCT00787943|Northwestern University|Amy Paller, MD|312-695-3721|apaller@northwestern.edu|
20181945|NCT02033993|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
20181946|NCT04990687|UAB|Samantha White|205-934-1989|swwhite@uabmc.edu|
20181947|NCT00108524|Durham VAMC|William S Yancy, Jr. MD, MHSc|919-286-0411|william.yancy2@va.gov|7770
20181948|NCT01349907|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181949|NCT05818540|Bleep, LLC|Stuart Heathington|919-619-7170|stuart@bleepsleep.com|
20181950|NCT01477749|Dendreon Pharmaceuticals, Inc.|Lynn Ngo|206-274-6763|lngo@dendreon.com|
20181951|NCT01969162|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20181952|NCT02096081|Merz North America, Inc.|Michelle Widmann|919-582-8238|Michelle.Widmann@merz.com|
20181953|NCT04004208|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20181954|NCT04463615|City of Hope Medical Center|Dr. Christiane Querfeld|6263598111|cquerfeld@coh.org|
20181955|NCT00839982|FCHRC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@seattlecca.org|
20181956|NCT01310868|University College London|GALA-5 Trial Coorinator|0207 679 9898|ctc.sponsor@ucl.ac.uk|
20181957|NCT00305682|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
20181958|NCT01628874|Children's Hospital Colorado|Dr. Ryan Caltagirone|303-521-8563|ryan.caltagirone@childrenscolorado.org|
20181959|NCT00873093|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20181960|NCT01848834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181961|NCT01342029|Cedars-Sinai Medical Center|C.Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
20181962|NCT00813111|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20181963|NCT03259373|Harvard Pilgrim Health Care|Richard Platt, MD|(617) 867-4912|Richard_Platt@harvardpilgrim.org|
20181964|NCT00885495|University of Cincinnati College of Medicine|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
20181965|NCT04504916|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20181966|NCT01368211|Transfusion Service Rigshospitalet - Dept of Immunology, Copenhagen Denmark|Dr. Pär Johansson|+45 35452030|per.johansson@rh.regionh.dk|
20181967|NCT01513967|Regenera Pharma Ltd|Dr Konstatin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
20181968|NCT02334527|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20181969|NCT01563978|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44-1625-512415|dave.goldstraw@astrazeneca.com|
20181970|NCT05764239|Synlogic|Clinical Operations|(617) 401-9975|info@synlogictx.com|
20181971|NCT04630756|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20181972|NCT04178551|VA Connecticut Healthcare System|William C. Becker, MD|203-932-5711|william.becker4@va.gov|2427
20181973|NCT05593211|Anthem Biotechnologies|Jeremy D. Ollerenshaw, Ph.D.|770.337.2390|ollerenj@anthembiotech.com|
20181974|NCT04343222|University of Wisconsin - Madison|Maxwell Wingelaar|231-233-6051|mwingelaar@uwhealth.org|
20181975|NCT03077620|Washington University in St Louis School of Medicine|Dr. Brendan Lucey|314-747-3805|luceyb@wustl.edu|
20181976|NCT03225846|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20181977|NCT04248465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20181978|NCT03621982|ADC Therapeutics|Yvan LeBruchec|+41799110551|Yvan.LeBruchec@adctherapeutics.com|
20181979|NCT00238420|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20181980|NCT00442286|CVRx|Vice President of Clinical Research|763-416-2876|lgalle@cvrx.com|
20191328|NCT01530477|GE Healthcare|Yi Xia|1 (608) 221-1551|Yi.Xia@ge.com|500-3045
20191329|NCT00382408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
20191330|NCT00917462|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, MD, PhD|646-888-4183|ilsond@mskcc.org|
20223872|NCT00900757|Duke University Medical Center|Mary Lou Affronti|919-684-6239|mary.affronti@dm.duke.edu|
20223873|NCT01489254|Synthon BV|VP Clinical Development|+3124727700|clinicaltrials@synthon.com|
20181981|NCT02922985|University of Texas Medical Branch|Emily Hadley|4022028626|ehadley15@gmail.com|
20181982|NCT05221749|Alexandria University|Nour Ammar|4868066|nour.ammar@alexu.edu.eg|201
20181983|NCT04140890|Wayne State University|Dr. Yi-Ling Hu|3142039991|ha1124@wayne.edu|
20181984|NCT01053637|BAYLOR COLLEGE OF MEDICINE|Corrie E. Chumpitazi|832 824-1353|corriec@bcm.edu|
20181985|NCT02102464|TearScience, Inc.|VP Clinical and Regulatory Affairs|919-467-4007|regulatory@tearscience.com|
20181986|NCT02388074|bioAffinity Technologies Inc.|Bijal Karia, PhD Director of Research|2107485287|bk@bioaffinitytech.com|
20181987|NCT00915902|Nemours Alfred I. duPont Hospital for Children|Research Coordinator|302-651-6686|cprosper@nemours.org|
20181988|NCT01778062|Novartis Pharmaceuticals|Study Director|862-778-8300||
20181989|NCT04039503|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20181990|NCT02413684|Duke Asthma, Airway and Allergy Center|Njira Lugogo|919-613-5707|njira.lugogo@duke.edu|
20181991|NCT03387514|UW School of Medicine and Public Health|Steve Cho, MD|608-263-5585|cho85@wisc.edu|
20181992|NCT04436796|Sansum Diabetes Research Institute|Jordan Pinsker|805-682-7640|jpinsker@sansum.org|
20181993|NCT01159535|University of Washington|Dr. Sarah Bowen|(206) 543-3452|swbowen@uw.edu|
20181994|NCT00118144|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20181995|NCT04069221|Medicines for Malaria Venture|Dr Myriam El Gaaloul, PharmD|+41 22 555 0377|elgaaloulm@mmv.org|
20181996|NCT00245011|Sidney Kimmel Comprehensive Cancer Center|David M. Loeb, M.D., Ph.D., Director, Musculoskeletal Tumor Program|410.502.7247|loebda@jhmi.edu|
20181997|NCT04701593|Virginia Tech|Dr Vishak John|(540) 855-5100|vishakjohn@vt.edu|
20181998|NCT00462644|Wake Forest University, Department of Surgery|Amy N. Hildreth, MD||ahildret@gmail.com|
20181999|NCT03040687|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
20182000|NCT03317379|New York State Psychiatric Institute|Lisa Ranzenhofer, PhD|240 671 9040|lr2840@cumc.columbia.edu|
20182001|NCT02846558|Johns Hopkins Department of Neurology|Dr. Ellen Mowry, M.D., M.C.R.|410-502-0675|emowry1@jhmi.edu|
20182002|NCT04445155|University of South Florida|Dr. Ukamaka Oruche|813-396-2524|orucheu@usf.edu|
20182003|NCT02018315|University of Texas Southwestern Medical Center|Juan Pascual, M.D., Ph.D.|214-648-3550|juan.pascual@utsouthwestern.edu|
20182004|NCT02359019|Barbara Ann Karmanos Cancer Institute|Dr. Ammar Sukari|313-576-8778|sukaria@karamanos.org|
20182005|NCT00904150|Centre for Neuroscience and Trauma, Queen Mary, University of London|Professor Anne MacGregor|+44 7774 868628|e.macgregor@qmul.ac.uk|
20182006|NCT03280563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20182007|NCT04213846|University of Washington|Christine Lee, Ph.D.|206-543-6574|leecm@uw.edu|
20182008|NCT02107274|Ministry of Health of Malaysia|Dr. Albert Iruthiaraj L. Anthony|+60174633410|albert5409@yahoo.com|
20182009|NCT03961256|Mayo Clinic|Mark D. Stegall, M.D.|507-266-2812|Stegall.Mark@mayo.edu|
20182010|NCT02708641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20182011|NCT03158948|INOTREM SA|Executive VP Research and Medical Sciences|30 62 86 51|jjg@inotrem.com|+33 (0)6
20182012|NCT04730947|Mayo Clinic|Dr. Barry A. Borlaug|507-293-2762|borlaug.barry@mayo.edu|
20182013|NCT03861728|University of Miami|Wendy Lee|305-326-6434|wlee@miami.edu|
20182014|NCT00354029|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
20182015|NCT01021332|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||astellas.resultsdisclosure@astellas.com|
20182016|NCT04648891|Mayo Clinic|David G. Lott, M.D.|480-342-2983|Lott.David@mayo.edu|
20191331|NCT03939793|Penn Center for Community Health Workers|Director of Evaluation|267-624-5465|molly.knowles@pennmedicine.upenn.edu|
20223874|NCT02233101|Rush University Medical Center|Craig J. Della Valle, MD|312-432-2350|craigdellavalle@rushortho.com|
20223875|NCT02737631|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20182017|NCT05087095|Virginia Commonwealth University|Ashlee Loughan, PhD, LCP|804-828-9815|ashlee.loughan@vcuhealth.org|
20182018|NCT01923428|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
20182019|NCT04320615|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20182020|NCT02107443|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_COACH@URMC.Rochester.edu|
20182021|NCT01400893|CytoPherx, Inc|H. David Humes|734-997-7055|dhumes@cytopherx.com|302
20182022|NCT00946647|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20182023|NCT03057834|Wake Forest University School of Medicine|Candace Parker-Autry, MD|336-716-3779|candace.parkerautry@wfusm.edu|
20182024|NCT02683993|Boston Scientific|Teri Bird|6123221189|teri.bird@bsci.com|
20182025|NCT03990363|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20182026|NCT01544582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182027|NCT00550173|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182028|NCT01728805|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
20182029|NCT00107744|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|504-988-5165|jhe@tulane.edu|
20182030|NCT01875861|Central Arkansas Veterans Healthcare System|Dr. Richard Owen|(501) 257-1710|Richard.Owen2@va.gov|
20182031|NCT00810641|KONOS|Treatment of apogeotropic HC BPPV|82 10 5538 6565|ohsun@jbnu.ac.kr|
20182032|NCT01556243|Mayo Clinic|Judy Boughey|507-266-9997|Boughey.Judy@mayo.edu|
20182033|NCT01388543|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
20182034|NCT03703206|University of Pennsylvania|Nabil Elkassbany, MD|2158236700|nabil.elkassabany@uphs.upenn.edu|
20182035|NCT02325713|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20182036|NCT01213173|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20182037|NCT02253316|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
20182038|NCT02353832|University of Texas Southwestern|Michael Folkert, M.D., Ph.D.|214-645-8525|Michael.Folkert@utsouthwestern.edu|
20182039|NCT02684903|University of Oregon|Dr. Elizabeth Skowron|541-346-9329|eskowron@uoregon.edu|
20182040|NCT03824535|Stanford University|Dr. Carina Mari Aparici|650-497 9280|drmari@stanford.edu|
20182041|NCT02841267|Hugo W. Moser Research Institute at Kennedy Krieger Inc.|Dr. Kathryn R. Wagner|443-923-9525|wagnerk@kennedykrieger.org|
20182042|NCT01950390|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20182043|NCT02699190|The Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
20182044|NCT02385721|Boryung Pharmaceutical Co., Ltd|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
20182045|NCT00731042|3M Company|Chou Eyberg|651-737-0934|cieyberg1@mmm.com|
20182046|NCT03374072|Boston University|Dr. Gael Orsmond|(617)353-2703|gorsmond@bu.edu|
20182047|NCT01672983|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20182048|NCT00802841|Novartis|Study Director|862-778-1873||
20182049|NCT02174198|Columbia University|Nurit Bittner, DDS, MS, Dip.ABP|212-342-2763|nb2203@cumc.columbia.edu|
20182050|NCT00432159|Depuy Synthes|Lynn Wilson|508-880-8109|lwilso45@its.jnj.com|
20182051|NCT02823990|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20182052|NCT04096365|AtaCor Medical, Inc.|Alan Marcovecchio, Vice President, Clinical Affairs|949 391 2252|alan@atacor.com|
20182053|NCT00920374|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182054|NCT01939158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182055|NCT05310084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182056|NCT05373901|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20182057|NCT02065245|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305-243-5579|JHare@med.miami.edu|
20182058|NCT01518257|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20182059|NCT02331940|University of Crete|Director of Clinical Trials|2810394824|izolthi@gmail.com|0030
20182060|NCT01460381|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182061|NCT01824446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20182062|NCT01033643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182063|NCT03527277|University of California, Davis|Kimber Stanhope|5302190914|klstanhope@ucdavis.edu|
20182064|NCT02091063|Columbia University|Jennifer Amengual, MD|212-305-0591|jea2149@cumc.columbia.edu|
20182065|NCT02652130|Mesoblast, Inc.|Christopher James, VP, Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
20182066|NCT03930186|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20182067|NCT04569240|Cleveland Clinc|Andrea Parianos|216-445-8354|debsa@ccf.org|
20182068|NCT00765661|Veloxis|Christina Sylvest, Sr VP Global Clinical Development & Operations|45 20553877|csy@veloxis.com|
20182069|NCT05205941|MMV|Benoit Bestgen|+41797651868|bestgenb@mmv.org|
20182070|NCT01600703|University Health Network|Dr. Gary Lewis|416-340-4270|gary.lewis@uhn.ca|
20182071|NCT02633891|BVAMC|Dr. Lindsay Zilliox|410-328-3100|lzilliox@som.umaryland.edu|
20182072|NCT00344370|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
20182073|NCT02013687|Fraunhofer USA Center for Molecular Biotechnology|Dr. Jessica Chichester, Senior Scientist Immunology|302-369-3635|jessica.chichester@fhcmb.org|
20182074|NCT01782326|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182075|NCT02559817|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20182076|NCT03389893|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
20182077|NCT02874846|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20182078|NCT00388362|Stanford University|Laura Johnston, MD|650-723-0822|janices1@stanford.edu|
20223876|NCT04603482|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
20182079|NCT02335268|GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH|Dr. Carsta Köhler|+49 351 25933|info@gmiho.de|100
20182080|NCT02859597|Montefiore Medical Center|Dr.Jay Berger|7189204316|jberger@montefiore.org|
20182081|NCT05768945|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20182082|NCT04894903|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
20182083|NCT01670500|DFCI|Project Manager|617-632-2257|CTOPM@dfci.harvard.edu|
20182084|NCT01112696|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
20182085|NCT01822353|Helsinki University Hospital, Helsinki, Finland|Paula Kauppi, Chief Specialist|+358504286802|paula.kauppi@hus.fi|
20182086|NCT02550873|Promedior Inc.|Renu Gupta, MD, Chief Medical Officer|856-722-9824|rgupta@promedior.com|
20182087|NCT01857323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20182088|NCT03873246|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20182089|NCT04209790|Geisinger|Regulatory Project Manager|570-214-2462|khassanzadeh@geisinger.edu|
20182090|NCT05617040|Barinthus Biotherapeutics|Chief Medical Officer|+44 1865 818808|enquiries@barinthusbio.com|
20182091|NCT04562779|Denver Health & Hospital Authority|Dr. Dale Terasaki|303-602-6922|dale.terasaki@dhha.org|
20182092|NCT03173248|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33155726000|scientificinformation@servier.com|
20182093|NCT00075803|NHLBI|Nancy DiFronzo, PhD|301-435-0065|difronozon@nhlbi.nih.gov|
20182094|NCT05567952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182095|NCT05194735|Alaunos Therapeutics, Inc.|Jaymes Holland|6502732627|jholland@alaunos.com|
20182096|NCT02651103|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
20182097|NCT01616563|Metabolic Syndrome Canada|Rupinder Dhaliwal|613 484 3830|rupinder.dhaliwal@metsc.ca|
20182098|NCT01106287|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182099|NCT00072475|University of Minnesota|Pankaj Gupta, M.D.||gupta013@umn.edu|
20182100|NCT02123966|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
20182101|NCT01097655|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20182102|NCT01421771|University of New Mexico Health Sciences Center|Samiha Mateen|505-272-6057|smateen@salud.unm.edu|
20182103|NCT02028884|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20182104|NCT02403674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20182105|NCT00826280|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
20182106|NCT03487666|Georgetown University|Candace Mainor, MD|202-444-2223|Candace.Mainor@gunet.georgetown.edu|
20182107|NCT03201757|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
20182108|NCT05559047|Bleep, LLC|Stuart Heatherington|919-619-7170|stuart@bleepsleep.com|
20182109|NCT00765362|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|1323
20182110|NCT00412867|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20182111|NCT00664521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20182112|NCT02800928|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
20182113|NCT01853163|Navitas Life Sciences GmbH|Managing Director|+49 (0) 69-66 80 30-0|marty.boom@navitaslifesciences.com|
20182114|NCT05570747|Bleep, LLC|Stuart Heatherington, Founder and Executive Chairman of Bleep|(919) 619-7170|stuart@bleepsleep.com|
20182115|NCT01521949|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
20182116|NCT02886728|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20182117|NCT02029703|Cleveland Clinic|M. Elaine Husni, MD, MPH|216-445-1853|HUSNIE@CCF.ORG|
20182118|NCT02988375|Henry Ford Health|Dr. Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
20182119|NCT00180687|Imperial College London|Dr. Nawar Alkhamesi|442033121110|n.alkhamesi@imperial.ac.uk|
20182120|NCT04990440|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20182121|NCT03712098|SUNY Buffalo|Rebecca Ashare|7168296273|rlashare@buffalo.edu|
20182122|NCT02537444|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20182123|NCT01341080|Rush University Medical Center|Deborah A Hall MD PhD|312-563-2900|Deborah_A_Hall@rush.edu|
20182124|NCT04830514|University of Arkansas for Medical Sciences|David D. Church, Ph.D., Assistant Professor|5015265709|dchurch@uams.edu|
20182125|NCT01275053|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
20182126|NCT02954575|Octapharma AG|Cristina Solomon|+41 (0)55 451 21 89|Cristina.Solomon@octapharma.com|
20182127|NCT01066156|Cambridge Health Alliance|Igor Elman|(617) 665-1000|ielman@challiance.org|
20182128|NCT04081298|Fred Hutchinson Cancer Center|Heather Greenlee|206-667-4502|hgreenlee@fredhutch.org|
20223877|NCT00732758|Children's Hospital of Pittsburgh|Kumaravel Rajakumar|412-692-5822|rajakumark@upmc.edu|
20223878|NCT01552915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20223879|NCT06191393|Aptitude Medical Systems, Inc|Brad Killingsworth|2814674855|brad.killingsworth@aptitudemedical.com|
20223880|NCT01023841|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20182129|NCT01054911|University of Alabama in Birmingham, Comprehensive Cancer Center|Dr. James Posey, MD|205-934-0916|jposey@uabmc.edu|
20182130|NCT01008722|University of California, San Diego|Dr. Sanjiv Narayan (Professor of Medicine, Principal Investigator)|(650) 498-8161|sanjiv1@stanford.edu|
20182131|NCT00146640|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20182132|NCT02059161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182133|NCT02511561|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20182134|NCT01723826|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20182135|NCT01627340|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182136|NCT04305236|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20182137|NCT04183192|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
20182138|NCT00429702|SunCoast CCOP Research Base|SunCoast CCOP Research Base Lead Biostatistician|18009091242|ccop@epi.usf.edu|
20182139|NCT05049616|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|(713) 500-6421|michal.f.bartal@uth.tmc.edu|
20182140|NCT02916862|Florida International University|Cristina Palacios|3053483235|crpalaci@fiu.edu|
20182141|NCT03160079|University of California, San Diego, Moores Cancer Center|Dr. James Mangan|858-822-6600|jmangan@health.ucsd.edu|
20182142|NCT01107730|Attikon Hospital|Ioannis K. Toumpoulis|00306977243942|toumpoul@otenet.gr|
20182143|NCT05893797|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20182144|NCT04770220|Alzheon|Aidan Power|(508) 861-7709|aidan.power@alzheon.com|
20182145|NCT04955626|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
20182146|NCT00850720|Children's Healthcare of Atlanta|Kiran Hebbar, MBBS|404-785-1600|kiran.hebbar@choa.org|
20182147|NCT00003509|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20182148|NCT03658811|Toyos Clinic|Dillon O'Brien|6153274015|dobrien@toyosclinic.com|6
20182149|NCT04951479|UPMC|Anish Ghodadra, MD|4126470104|ghodadraa@upmc.edu|
20182150|NCT01638468|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
20182151|NCT04060680|Medtronic|Drew Turk, Clinical Research Specialist|7633580375|drew.turk@medtronic.com|
20182152|NCT03706690|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20182153|NCT02711826|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20182154|NCT01133860|IRCCS Policlinico San Matteo Foundation|Prof. Carlo Balduini|0039.0382.502580|c.balduini@smatteo.pv.it|
20182155|NCT00729690|Rush University|Asokumar Buvanendran|(312) 942-3685|asokumar@aol.com|
20182156|NCT02169219|Massachusetts General Hospital, Division of Rheumatology|Dr. John Stone|617-643-2140|adfernandes@mgh.harvard.edu|
20182157|NCT02886936|University of Pennsylvania|Jessica Kenia, Research Coordinator|215-893-2678|jessica.kenia@pennmedicine.upenn.edu|
20182158|NCT02507219|Laureate Institute for Brain Research|Dr. Martin Paulus|918-502-5120|mpaulus@laureateinstitute.org|
20182159|NCT02320721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20182160|NCT02419755|St. Jude Children's Research Hospital|Tanja A. Gruber, MD, PhD|901-595-2252|tanja.gruber@stjude.org|
20182161|NCT00852137|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20182162|NCT05397470|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20182163|NCT06403605|ETS Wound Care, LLC|Donald Buck, MD|410-490-5998|dbuck@etswoundcare.com|
20182164|NCT00394095|University of Cincinnati|Melissa DelBello, MD|513-558-4489|melissa.delbello@uc.edu|
20182165|NCT05737550|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
20182166|NCT01256476|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
20182167|NCT02600429|clinical operation|Director of clinical operation||swkang@regentreellc.com|
20182168|NCT02401529|King Fahd General Hospital|Dr Faris Ahmed Bahammam|00966554699544|dr_farisbahammam@yahoo.com|
20182169|NCT01414036|Boston Medical Center|Karen E. Lasser|617-414-6688|karen.lasser@bmc.org|
20182170|NCT01598987|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182171|NCT00924664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182172|NCT02941146|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20182173|NCT01450943|VA Northern California Health Care System|Sara Dahle, D.P.M., M.P.H.|916-843-7151|Sara.dahle@va.gov|
20182174|NCT05153174|University of Rochester Medical Center|Dr Thu H. Le, MD, FAHA - Chief of Nephrology|585-273-4259|thu_le@urmc.rochester.edu|
20182175|NCT03303105|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20182176|NCT02023944|Bedford Veterans Hospital|Maureen K. O'Connor|781-687-2830|maureen.oconnor@va.gov|
20182177|NCT04822298|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20182178|NCT04351750|National Cheng Kung University|Dr. Kuan-Yin Lin|+88662353535|10802003@gs.ncku.edu.tw|5931
20182179|NCT01333943|Hospital for Special Surgery|David H. Kim, MD|(212) 606-1206|KimD@HSS.EDU|
20182180|NCT01789203|Methodist Hospital|Samir Patel|267-808-0577|spatel2@houstonmethodist.org|
20182181|NCT00951561|Another Way Products|Charles Tepper|917-538-6894|charles_tepper@yahoo.com|
20182182|NCT05176353|University of Michigan|Owen Albin, MD|734.232.1871|oalbin@med.umich.edu|
20182183|NCT01254305|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20182184|NCT04365413|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Lacey McNally|405-325-0789|lacey-mcnally@ouhsc.edu|
20182185|NCT02037061|Cleveland Clinic|Dr. Cecile Unger|216-444-0542|ungerc@ccf.org|
20182186|NCT03019458|Sunshine Care Foundation|Dr. Patrick Acuna|+63 947 959-1851|patrick_acuna@hotmail.com|
20223881|NCT04240457|ChicagoArbor Eye Care|David Lubeck, MD|708-798-6633|david.lubeck@chicagoarboreye.com|
20182187|NCT00557505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182188|NCT00031447|Collaborative Antiviral Study Group|Penelope M Jester|205-934-2424|pjester@peds.uab.edu|
20182189|NCT01636362|Molnlycke Health Care AB|Joan Wilson|706 504 8997|joan.wilson@molnlycke.com|
20182190|NCT02521259|Seoul National University Bundang Hospital|Dr. YEA JI LEE|+821086307701|ladydaisy82@naver.com|
20182191|NCT00519779|The Ohio State University|Dr. Janice Kiecolt-Glaser|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
20182192|NCT03330119|Main Line Health System|Dr. Norman Brest|484-476-2325|brestn@mlhs.org|
20182193|NCT01561079|Johns Hopkins University School of Medicine|Dr. Lauren M Jansson|410-550-5438|ljansson@jhmi.edu|
20182194|NCT01323660|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182195|NCT02118714|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20182196|NCT00229619|NIH National Heart, Lung and Blood Institute|Adrian Wiestner MD, NHLBI|301-594-6855|wiestnera@nhlbi.nih.gov|
20182197|NCT00570661|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
20182198|NCT01700673|Johns Hopkins University School of Medicine, Division of Hematologic Malignancies|Jonathan Webster, MD|4106149106|jwebst17@jhmi.edu|
20182199|NCT01734382|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20182200|NCT01052662|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
20182201|NCT00401817|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
20182202|NCT02015663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20182203|NCT00479674|Duke University Medical Center|Dr. Kimberly Blackwell|919-668-1748|black034@duke.edu|
20182204|NCT02071095|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20182205|NCT03293485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182206|NCT01852955|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
20182207|NCT01272011|Malcom Randall VAMC|Dr. Nicole Tester|352-376-1611|ntester@phhp.ufl.edu|7507
20182208|NCT06096181|Cedars-Sinai Medical Center|Glenn Tan, MD|310-423-5841|Glenn.Tan@cshs.org|
20182209|NCT02240680|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20182210|NCT01657032|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Pieścik-Lech|+48-22-45-23-309|hania@ipgate.pl|
20182211|NCT03633903|Laureate Institute for Brain Research|Namik Kirlic, PhD|918-502-5747|nkirlic@laureateinstitute.org|
20182212|NCT05968482|Amzell BV|Chief Executive Officer|+31235560460|amzell-disclosure@amzell.com|
20182213|NCT00525057|UT MD Anderson Cancer Center|Patrick Lin, MD/Professor, Orthopaedic Oncology|(713) 745-0088|plin@mdanderson.org|
20182214|NCT01925170|Mayo Clinic|Dr. Deborah Rhodes|507-284-7971|rhodes.deborah@mayo.edu|
20182215|NCT01077024|University of Cincinnati Addiction Sciences Division|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
20182216|NCT02034435|Vanderbilt University Medical Center|Dr. James M. Luther, MD|(615) 936-3420|james.luther@vumc.org|
20182217|NCT00628628|The University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
20182218|NCT02839681|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
20182219|NCT02300311|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20182220|NCT02687919|University of Iowa|Amanda Irish||amanda.k.irish@gmail.com|
20182221|NCT00419003|Baylor College of Medicine|Dr. Sanjay Mathew|7137985439|sjmathew@bcm.edu|
20182222|NCT00772928|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20182223|NCT01653847|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
20182224|NCT02165124|Johns Hopkins Univesity|Dr. Clifford Weiss|4106141046|cweiss@jhmi.edu|
20182225|NCT00768599|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
20182226|NCT00801242|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20182227|NCT01845636|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
20182228|NCT02015195|Division of Emergency Medicine, Department of Surgery, Stanford University School of Medicine|Paul Auerbach, MD|650.725.9445|auerbach@stanford.edu|
20182229|NCT00131911|Mayo Clinic Cancer Center|Timothy J. Hobday M.D.||Hobday.timothy@mayo.edu|
20182230|NCT02554513|VASLCHCS|Dr. Shannon Mauszycki|801-582-1565|shannon.mauszycki@utah.edu|
20182231|NCT02760862|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
20182232|NCT01606189|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20182233|NCT01354938|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954||
20182234|NCT01167023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182235|NCT03981055|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
20182236|NCT01577732|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182237|NCT03803774|National Cancer Institute|Dr. Vassiliki Saloura|240-760-6352|vassiliki.saloura@nih.gov|
20182238|NCT02491411|SKCCC at JHU|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
20182239|NCT04034238|National cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
20182240|NCT02062905|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
20182241|NCT01819415|Maisonneuve-Rosemont Hospital|Dr. Flavio Rezende|514-867-2990|frezendef@hotmail.com|
20182242|NCT01207934|Washington University School of Medicine|Samuel Klein, MD|3143628708|sklein@wustl.edu|
20182243|NCT02307123|Tampere University Hospital|Toni Pakkanen, MD|358408227209|toni.pakkanen@icloud.com|
20182244|NCT00751790|Debiopharm S.A.|Eija Lundström|+41 21 3210111|elundstrom@debiopharm.com|
20182245|NCT03302910|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
20182246|NCT01106976|VAAAHS|Nicolaas Bohnen|7349988400|Nicolaas.Bohnen@va.gov|
20182247|NCT02949518|Hospital for Special Surgery|Dr. Ellen Soffin|212-606-1206|soffine@hss.edu|
20182248|NCT03560141|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20182249|NCT05677867|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182250|NCT04170023|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20182251|NCT02783482|Green Cross Corporation|Clinical Project Manager|82 31 260 9472|sungsil.lee@gccorp.com|
20182252|NCT00953160|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
20182253|NCT01330355|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
20182254|NCT03836664|University of Kansas Medical Center|Dr Dipika Aggarwal, Clinical Assistant Professor|9139459926|daggarwal@kumc.edu|
20182255|NCT03566680|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20182256|NCT02724020|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20182257|NCT00425503|Baylor College of Medicine|Dr. Teresa Hayes - Associate Professor|713-794-7368|thayes@bcm.edu|
20182258|NCT02179918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182259|NCT00276250|Emory University|Nicole Turgeon, MD|404-727-3257|nturgeo@emory.edu|
20182260|NCT03189134|Boston Children's Hospital|Aditya K. Kaza, MD|617-355-7932|aditya.kaza@cardio.chboston.org|
20182261|NCT03890120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20182262|NCT04537949|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20182263|NCT04003974|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20182264|NCT02400307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20182265|NCT03248440|Senju USA, Inc.|Takahiro Ogawa, PhD|+1 818 719 7190|ogawataka@senju-usa.com|
20182266|NCT00905060|University of California, Davis|Dr. Orin Bloch, MD||obloch@ucdavis.edu|
20182267|NCT03023332|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
20182268|NCT01657682|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20182269|NCT02150044|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20182270|NCT01719861|Stanford University Medical Center|Joel Neal, MD, PhD; Assistant Professor of Medicine|650-725-3081|jwneal@stanford.edu|
20182271|NCT00958009|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
20182272|NCT02284464|Hospital Regional Universitario de Málaga|Dr. Domingo Hernandez|951291174|domingohernandez@gmail.com|
20182273|NCT00087490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182274|NCT00761774|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20182275|NCT00755755|PregLem S.A.|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
20182276|NCT01318811|Vanderbilt_Univeristy MC|Dr. Thomas Golper|615-322-5914|thomas.golper@vumc.org|
20182277|NCT02402764|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hyo Sook Han|813-745-8960|hyo.han@moffitt.org|
20182278|NCT00483262|Dana-Farber Cancer Institute|Irene Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
20182279|NCT04992442|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20182280|NCT02303574|AstraZeneca|Bengt Larsson|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20182281|NCT01359410|Washington University School of Medicine|William Hawkins, M.D.|314-362-7046|hawkinsw@wustl.edu|
20182282|NCT05590910|UT Health San Antonio-Faculty; Texas Woman's University-Student|Jorgie Ann Contreras|2107235319|contrerasj6@uthscsa.edu|
20182283|NCT00994279|Wake Forest NCI NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20182284|NCT00577629|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
20182285|NCT02774213|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
20182286|NCT01449721|Christiana Care Health System|Ryan Arnold, MD, Director of Research, Emergency Medicine|302-733-5108|ryarnold@christianacare.org|
20182287|NCT03864133|Wake Forest University Health Sciences|Keith Walter, MD|336-716-3937|kwalter@wakehealth.edu|
20182288|NCT02668432|University of Texas Health San Antonio|Bethany Kalich, PharmD|210-883-1177|kalich@uiwtx.edu|
20182289|NCT03888365|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
20182290|NCT00114959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20182291|NCT04019561|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20182292|NCT05781490|Lument AB|Dr Jan Marsal|+46709822008|jan.marsal@med.lu.se|
20182293|NCT02044419|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
20182294|NCT03212365|University of Utah|Christopher Pannucci, MD|801 581 2121|christopher.pannucci@hsc.utah.edu|
20182295|NCT03713645|Temple University Hospital, Inc.|Adam Diamond, PharmD, BCPS, FAST|215-280-8041|adam.diamond@tuhs.temple.edu|
20182296|NCT00333138|Novartis pharmaceuticals|Study director|862-778-8300||
20182297|NCT01342887|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS||rwalter@fredhutch.org|
20223882|NCT00844480|Northwestern University|Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20223883|NCT02858180|Duke University|Andrew Muir, MD|919-684-2052|muir0002@duke.edu|
20223884|NCT01570634|Salient Pharmaceuticals Incorporated|Richard scruggs|7135899859|rscruggs@salientpharmaceuticals.com|
20182298|NCT01031043|Georgia Regents University|Gregory N. Postma MD|706-721-6100|gpostmat@gru.edu|
20223885|NCT01054196|Weill Cornell Medicine|Roger Pearse, M.D. PhD|646-962-6500|rnp2001@med.cornell.edu|
20182299|NCT04880161|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
20182300|NCT01354106|cyberDERM|Dr. Gary Grove|610-325-0112|GGrove@cyberderm-inc.com|
20182301|NCT00465361|Children's Mercy Hospitals and Clinics|Sarah S. Nyp|816-234-3000|ssnyp@cmh.edu|
20182302|NCT01511536|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20223886|NCT02223546|Medical University of Graz|Gerald Seidel, MD|+43 316 385 12394|gerald.seidel@medunigraz.at|
20223887|NCT00179673|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
20223888|NCT02388815|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
20182303|NCT02357758|London Health Sciences Centre|Dr. Sumit Dave|519.685.8439|Sumit.Dave@lhsc.on.ca|
20223889|NCT00319592|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20182304|NCT02297503|Galderma|Maria Norberg|+46184891267|maria.norberg@galderma.com|
20223890|NCT01512446|Ruhr-Universität Bochum|Johannes Pfeilschifter, MD||Johannes.Pfeilschifter@rub.de|
20223891|NCT03421145|3M Health Care Business Group|Manager of Biostatistics|6518152737|swalters@mmm.com|
20223892|NCT01820572|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20223893|NCT00288600|Fundação Oswaldo Cruz|Maria Elisabeth Moreira|552125541911|bebeth@iff.fiocruz.br|
20182305|NCT02021461|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
20182306|NCT02703532|Emory University|Sarah Blanton, PT, DPT, NCS, FNAP|404-712-2222|sblanto@emory.edu|
20182307|NCT01161160|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182308|NCT03738241|Baylor College of Medicine|Hana El Sahly, MD, FIDSA|713-798-2058|hana.elsahly@bcm.edu|
20182309|NCT01244763|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
20182310|NCT03169361|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20182311|NCT02788656|Brigham and Women's Hospital|Akshay Desai|617-732-7046|adesai@bwh.harvard.edu|
20182312|NCT02263885|InSightec|Nadir Alikacem, PhD|214-630-2000|nadira@insightec.com|
20182313|NCT04446975|UNMC|Dr. Karsten Bartels|(402) 559-4081|anesthesiology.research@unmc.edu|
20182314|NCT02459964|UT MD Anderson Cancer Center|Sai-Ching J. Yeung, MD, Professor, Emergency Medicine|(713) 745-9911|syeung@mdanderson.org|
20182315|NCT00550732|Merck Sharp & Dohme Corp.|Senior Vice President, Globalo Clinical Development||ClinicalTrialsDisclosure@merck.com|
20182316|NCT02435901|Northwell Health System Cohen Children's Medical Center of NY|Indira Sahdev, MD|7184703460|isahdev@northwell.edu|
20182317|NCT01813422|Amgen Inc.|Study Director|866-572-6436||
20182318|NCT01653743|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20182319|NCT03748771|University of California San Diego|Dr. Rakesh Bhattacharjee|858-966-5846|rlbhattacharjee@ucsd.edu|
20182320|NCT00811187|Montefiore Medical Center|Research Program Administrator|718-405-8526|fheitor@montefiore.org|
20182321|NCT02825043|University of Oklahoma Health Sciences Center Dept. of Medicine|Clinical Trials Manager|(405)271-6651|research@ouhsc.edu|
20182322|NCT00329303|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20182323|NCT02444143|University of Illinois at Chicago|Dr. Patricia West-Thielke|312-996-5695|pwest@uic.edu|
20182324|NCT00083174|Canadian Cancer Trials Group|Senior Biostatistician|613-533-6430|dtu@ctg.queensu.ca|
20182325|NCT03582137|University of Colorado|Maureen Leehey, MD|3037248288|maureen.leehey@cuanschutz.edu|
20182326|NCT03704298|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20223894|NCT03600194|Philips|Jeff Jasko|412-542-3836|jeff.jasko@philips.com|
20223895|NCT04439214|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
20223896|NCT02235077|Duke Clinical Research Institute|Adrian Hernandez, MD|919 668 7515|adrian.hernandez@duke.edu|
20223897|NCT03852628|RTI International|PASA Core Leadership|919-541-6002|shirsch@rti.org|
20223898|NCT02964208|Abbott|Ryan Gage|+1 612 805 6398|ryan.gage@abbott.com|
20223899|NCT00957268|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20223900|NCT02036840|Nationwide Children's Hospital|Ralph Beltran, MD|614-722-4200|Ralph.Beltran@nationwidechildrens.org|
20223901|NCT01758731|University of Colorado, Denver|Dr. David Raben|303-724-3027|david.raben@ucdenver.edu|
20223902|NCT01923298|The University of Arizona Cancer Center|Dr. Pavani Chalasani|520-626-0191|pchalasani@uacc.arizona.edu|
20223903|NCT02572076|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
20223904|NCT02778074|Linkoping University|Dr Peter Johansson|0460700896548|peter.b.johansson@liu.se|
20182327|NCT00832260|Hospital Universitari i politecnic La Fe|Dr. José Olagüe|+34 961 24 40 00|jolague@terra.com|
20182328|NCT00859014|University of Texas Health Science Center|Dr. Sean I. Savitz, Professor and Director of Stroke|713.500.7083|sean.i.savitz@uth.tmc.edu|
20223905|NCT03699280|Imperial College London|Ms Nandita Deo|07939360357|nandita.deo@gmail.com|
20223906|NCT02396420|South Florida Medical Imaging|Cynthia Toot ARNP|954-267-6626|cynthia.toot@holy-cross.com|
20223907|NCT00569673|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
20182329|NCT00162942|Otsuka America Pharmaceutical, Inc|Tao Wang|240-683-3213|tao.wang@otsuka-us.com|
20182330|NCT04796935|Elevate Clinical Consulting|Keri Urwin|919-247-8845|kurwin@elevateclinicalconsulting.com|
20182331|NCT00410384|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182332|NCT01253200|Boston Scientific|Timothy Meyer; Director of Clinical Trials|651 581 3425|Timothy.meyer@bsci.com|
20182333|NCT02049437|University Hospitals Cleveland Medical Center|Marijke Frederix, PhD|(216) 844-0383|marijke.frederix@UHhospitals.org|
20182334|NCT02706626|Criterium, Inc.|Tom Stinchcombe|9196819509|Thomas.stinchcombe@duke.edu|
20182335|NCT01055782|Specialist Doctors Rolighedsvej|Lene Hendel MD|+4545819090|lene@hendel.dk|
20182336|NCT01163149|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
20182337|NCT01192295|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20223908|NCT03518619|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|Ana_Abrantes@Brown.edu|
20223909|NCT01273623|Boston Scientific|Susanna Kennedy|763.494.2601|susanna.kennedy@bsci.com|
20223910|NCT01640379|Johns Hopkins University|Dr. Maria Trent|4109552910|mtrent2@jhmi.edu|
20182338|NCT00630539|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20202898|NCT02052960|Glycotope GmbH|Senior Director Clinical Department|0049309489|contact@glycotope.com|2600
20182339|NCT01253980|Poisons Information Centre, Red Cross War Memorial Children's Hospital and University of Cape Town|Dr Kate Balme|+27 21 658 5308|kate.balme@uct.ac.za|
20182340|NCT01700530|University of Missouri|John P. Thyfault, PhD|573-874-9728|thyfaultj@missouri.edu|
20182341|NCT02953548|GW Research Ltd|Medical Enquires|+44 01223 238170; 1877886281|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20182342|NCT01023178|Stanford University|Sejal Shah MD|6507235791|sshah2@stanford.edu|
20182343|NCT00310362|MInneapolis VA Health Care System|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
20182344|NCT03453385|Medical University of South Carolina (MUSC)|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
20182345|NCT02806336|Baltimore VA Geriatric Research Education and Clinical Center|Dr. Leslie Katzel|4106057248|leslie.katzel@va.gov|
20182346|NCT04159896|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
20182347|NCT05705167|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
20182348|NCT04529538|PATH|Chris Gast, Ph.D.|206-285-3500|cgast@path.org|
20182349|NCT02223182|DBV Technologies|Pharis Mohideen, MD Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
20182350|NCT03552978|San Francisco Veterans Affairs Medical Center|Ellen Herbst, MD|415-221-4810|Ellen.Herbst@va.gov|24926
20182351|NCT00231179|Children's Hospital of Philadelphia|Jerilynn Radcliffe, PhD|215-590-7446|Radcliffe@email.chop.edu|
20182352|NCT02206685|Baylor College of Medicine|Kim P. Nguyen, MD, Principal Investigator|832-824-5907|kpnguyen@texaschildrens.org|
20182353|NCT01345292|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20182354|NCT01385280|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
20182355|NCT01893320|The University of Texas MD Anderson Cancer Center|Naval Daver MD, Associate Professor|713-794-4392|NDaver@mdanderson.org|
20182356|NCT05406791|University of Illinois at Chicago|Colleen Stiles-Shields, PhD|312-413-1128|ecss@uic.edu|
20182357|NCT00515086|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182358|NCT02373813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20182359|NCT02967016|Rutgers SUNJ|Dr. Antonio Gonzalez|4133869415|ajantoni@gmail.com|
20182360|NCT02068729|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
20182361|NCT01447914|University of Texas (UT) MD Anderson Cancer Center|Robert Orlowski, MD, PhD / Professor, Department of Lymphoma/Myeloma|713-792-2860|ROrlowski@mdanderson.org|
20182362|NCT05967442|Advocate Christ Medical Center|Marc McDowell|708684800|marc.mcdowell@aah.org|
20182363|NCT01764386|Orexigen Therapeutics, Inc.|Executive Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20182364|NCT02271594|BD|Dr. Ken Strauss|32475380454|kenneth.strauss@bd.com|
20182365|NCT00495469|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182366|NCT03815916|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
20182367|NCT04454567|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
20182368|NCT03748264|Philips|Jeff Jasko|4125423651|Jeff.Jasko@philips.com|
20182369|NCT01123161|Cedars-Sinai Medical Center|Dr. Patrick Lyden|310-423-5166|lydenp@cshs.org|
20182370|NCT00926393|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20182371|NCT03311854|Sobi AG|Veronica Asnaghi, MD|+41 61 201 13 20|veronica.asnaghi@sobi.com|
20182372|NCT01276535|Westlake Dermatology|Gregory A. Nikolaidis, MD|512-328-3376|karen@westlakedermatology.com|
20182373|NCT00305760|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
20182374|NCT00106431|Celgene Corporation|Elizabeth Faust, PhD, Vice President, Clinical Research Services|617/583-1300|EFaust@Celgene.com|
20182375|NCT00707863|Indiana Uiniveristy|Amit Anand MD|3172747422|aanand@iupui.edu|
20182376|NCT02223689|Medline Industries, Inc.|Lori Rotolo|8476434640|lrotolo@medline.com|
20182377|NCT02851511|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
20182378|NCT00051311|National Cancer Institute|Dr. Ronald Gress|240-760-6167|Ronald_Gress@nih.gov|
20182379|NCT02256969|Massachusetts Eye and Ear Infirmary|Assistant Professor of Ophthalmology|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|6060
20182380|NCT01427907|Fresenius Medical Care, North America|Mayuri Thakuria MD (MBBS), MPH|781-699-4645|mayuri.thakuria@fmc-na.com|
20182381|NCT04337489|Imperial College London|Fahad Iqbal|020 3312 6666|f.iqbal@imperial.ac.uk|
20182382|NCT01328587|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
20182383|NCT03413605|Center for Asian Health, Lewis Katz School of Medicine, TempleUniversity|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
20182384|NCT00674492|Center for Healthcare Organization and Implementation Research|Jack A. Clark, PhD|781.687.2937|Jack.Clark@va.gov|
20182385|NCT00335153|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20182386|NCT04038099|UT Southwestern Medical Center|Christina Hicks, MS, APRN, WHNP-BC, FAUNA|2146453848|christy.hicks@utsouthwestern.edu|
20182387|NCT03688542|Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
20182388|NCT02724787|James A. Haley Veterans' Hospital|Dr. Shannon Miles|813-972-2000|shannon.miles@va.gov|6728
20182389|NCT01113463|University of Texas MD Anderson Cancer Center|Charles A. Conrad, MD / Professor, Neuro Oncology|713-792-2883|CR_Study_Registration@mdanderson.org|
20182390|NCT02478359|Kaiser Permanente|Huong Q2 Nguyen, Research Scientist|626-564-3935|huong.q2.nguyen@kp.org|
20182391|NCT00372528|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20223911|NCT03489707|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
20223912|NCT00325156|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223913|NCT04064411|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
20223914|NCT03395184|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182392|NCT01818700|Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University school of medicine, Seoul Korea|Dr. Whan Eoh|82-2-3410-3491|w.eoh@samsung.com|
20182393|NCT02412761|The University of Texas Health Science Center at Houston|Joyce P. Samuel, MD, MS|(713) 500-5670|Joyce.P.Samuel@uth.tmc.edu|
20182394|NCT01417000|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
20182395|NCT02987829|Tracon Pharmaceuticals Inc.|Charles Theuer, MD PhD|8585500780|ctheuer@traconpharma.com|
20182396|NCT00562965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182397|NCT01911221|Novartis Vaccines and Diagnostics|Posting Director||RegistryCpontactVaccinesUS@novartis.com|
20182398|NCT03379233|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20182399|NCT00965484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182400|NCT00848211|Thymon LLC|Gideon Goldstein, MD, PhD|(973) 467-9558|gidgold@gmail.com|
20182401|NCT02531438|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
20182402|NCT01124617|Neuroscience department, clinical science department, R&D in Janssen Japan, Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
20182403|NCT00945477|Illinois CancerCare, P.C.|James Knost, M.D.|309-243-3000|jknost@illinoiscancercare.com|
20182404|NCT04653051|Zimmer Biomet|Georgia Tsapara|+41 79 94 54936|georgia.tsapara@zimmerbiomet.com|
20182405|NCT00558753|Rush University Medical Center|Asokumar Buvanendran, M.D.|(312) 942-3685|asokumar@aol.com|
20182406|NCT04582045|HealthPartners Institute|Linda M. Loes|952-967-7862|linda.m.loes@healthpartners.com|
20182407|NCT00487721|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848 0655|Thomas.Flaig@ucdenver.edu|
20182408|NCT00783718|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20182409|NCT00696293|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
20182410|NCT01027871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182411|NCT04833855|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20182412|NCT03782727|Cardiff and Vale University Health Board|Dr Rachel Abbott|02920743181|rachel.abbott@wales.nhs.uk|
20182413|NCT02405390|Nicklaus Children's Hospital|Jose M. Vargas Loayza, M.D.|786-624-3588|jose.vargas-loayza@mch.com|
20182414|NCT04887285|Northwestern University|Steven P. Cohen|312-695-2500|steven.cohen@northwestern.edu|
20182415|NCT04640571|University of Maryland, Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
20182416|NCT04515797|Massachusetts General Hospital|Dr. Raymond Chung|6177247562|Chung.Raymond@mgh.harvard.edu|
20182417|NCT01688102|The Rockefeller University|Dr. Manish Ponda|212-327-7631|mponda@rockefeller.edu|
20182418|NCT03437668|UCaliforniaLA|Stephen R Marder|3102670221|smarder@mednet.ucla.edu|
20182419|NCT02099539|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20182420|NCT05812794|The University of Texas Health Science Center at Houston|Stuart Mason Fraser, MD|713-500-7142|Stuart.M.Fraser@uth.tmc.edu|
20182421|NCT03473756|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20182422|NCT03714022|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20182423|NCT01007552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|groman@appliedstats.com|847
20182424|NCT04482855|University of Pennsylvania School of Nursing|Dr. Jie Deng|2155734729|jiedeng@nursing.upenn.edu|
20182425|NCT00663962|Queen's University|Pregabalin and Post-thoracotomy pain|(613) 548-7827|zamoraj@kgh.kari.net|
20182426|NCT04207255|Medical University of South Carolina|Alan Brisendine|(843) 792-9007|brisend@musc.edu|
20182427|NCT03253653|San Diego State University Research Foundation|Dr. Nada Kassem|619-370-7488|Nkassem@sdsu.edu|
20182428|NCT05927480|HealthPartners Institute|Sandy Vang, Director of Research Administration at Regions Hospital|1-651-254-6961|sandy.x.vang@healthpartners.com|
20182429|NCT02624778|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20182430|NCT01955382|NIAID/NIH|Dr. Rick M. Fairhurst, Principal Investigator|301-761-5077|rfairhurst@niaid.nih.gov|
20182431|NCT04610684|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
20182432|NCT02395185|Shriners Hospital for Children|Rebecca Davis|859-268-5705|rfdavis@shrinenet.org|
20182433|NCT03575962|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20182434|NCT01876043|Institut Bergonié|Dr Antoine ITALIANO|+33556333333|a.italiano@bordeaux.unicancer.fr|
20182435|NCT04940390|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
20182436|NCT05458102|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20182437|NCT05336123|Brown University|Dr. Lauren Weinstock|401-455-6304|Lauren_Weinstock@brown.edu|
20182438|NCT00715390|The Children's Hospital of Philadelphia|Ronald Litman, DO|215-590-5091|litmanr@email.chop.edu|
20182439|NCT03835546|Fundació Lluita contra la SIDA|Jose A. Muñoz-Moreno|+34 93 497 84 14|jmunoz@flsida.org|
20182440|NCT00350532|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4498|jimeisenach@gmail.com|
20182441|NCT00112723|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
20182442|NCT04170764|TriHealth|Dr. Emily Aldrich|513-463-4300|Emily_Aldrich@trihealth.com|
20182443|NCT01598025|Memorial Sloan Kettering Cancer Center|Dr. Richard O'Reilly, MD|646-888-2157|oreillyr@mskcc.org|
20182444|NCT04531540|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20182445|NCT03239210|NYU Langone Health|Nicolette Recchia|845-398-6563|nicolette.recchia@nyulangone.org|
20191332|NCT00702338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191333|NCT03341312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20182446|NCT02664220|McGovern Medical School, University of Texas Health Sciences Center at Houston|Dr. Kuojen Tsao|713-500-7300|Kuojen.Tsao@uth.tmc.edu|
20182447|NCT01575860|Abramson Cancer Center of the University of Pennsylvania|Jakub Svoboda, MD. Study Principal Investigator|855-216-0098|PennCancerTrials@emergingmed.com|
20182448|NCT01403987|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|617-6386563|brian.jacobson@bmc.org|
20182449|NCT00180674|Imperial College London|Prof Mark Thursz|+44 (0)20 3312 1903|m.thursz@imperial.ac.uk|
20182450|NCT00278564|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
20182451|NCT01094743|Johnson & Johnson Vision Care|Huan Sheng, MD, PhD|1-904-443-3440|HSheng2@its.jnj.com|
20182452|NCT03606460|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20182453|NCT00003377|Gynecologic Oncology Group Statistical & Data Center|Melissa Leventhal|(716)845-5702|mleventhal@gogstats.org|
20182454|NCT00427973|Massachusetts General Hospital Cancer Center|Andrew X. Zhu, MD|617-643-3415|azhu@partners.org|
20182455|NCT02584790|Pamela Youde Nethersole Eastern Hospital|Dr Wong Kai Chuen|(852) 64600771|wkc568@ha.org.hk|
20182456|NCT05142228|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
20182457|NCT04541186|89bio, Inc.|Entrigue Study Team|1-415-432-9270|Ct.gov_SHTG@89bio.com|
20182458|NCT04878172|Cynosure|Jamie Trimper|9788776342|jamie.trimper@cynosure.com|
20182459|NCT01902901|Kaiser Permanente Center for Health Research|Katrina Goddard|503-335-6353|katrina.ab.goddard@kpchr.org|
20182460|NCT01079598|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
20182461|NCT00058058|American College of Radiology Imaging Network|Senior Director of Protocol Management||Donna Hartfeil <dhartfeil@acr.org>|
20182462|NCT01605136|Clinuvel Inc.|Dr. Dennis Wright|646 527 7310|Dennis.Wright@clinuvel.com|170
20182463|NCT01072929|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20182464|NCT01414166|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182465|NCT03682536|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20182466|NCT04824131|HPTN Statistical & Data Management Center|HPTN Statistical Manager|1206-667-4004|HPTN-Data-Access@scharp.org|
20182467|NCT05489224|CELLTRION, Inc.|Head of Clinical Planning Department 3|+82-32-850-4167|jeehye.suh@celltrion.com|
20182468|NCT04794062|Good Samaritan Hospital, TriHealth|Leonid Khokhlov, MD|5138858974|leonkhokhlov@gmail.com|
20182469|NCT03686384|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
20182470|NCT03008122|Saint Louis University|Sarah George, MD|314-977-9035|sarah.george@health.slu.edu|
20182471|NCT00610883|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
20182472|NCT02338609|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
20182473|NCT04883346|Section on Growth and Obesity, NICHD, NIH|Jack A. Yanovski, MD, PhD|301-496-0858|yanovskj@mail.nih.gov|
20182474|NCT04736056|Duke University|Hannah Fisher, PhD|919-416-3471|hannah.fisher@duke.edu|
20182475|NCT02148718|AbbVie|Global Medical Services|800-633-9110||
20182476|NCT03289455|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
20182477|NCT00333788|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
20182478|NCT00935792|Mayo Clinic|Timothy Call, M.D.|5076682050|Call.Timothy@mayo.edu|
20191334|NCT01812707|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
20191335|NCT01631825|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20191336|NCT01514630|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
20191337|NCT03568708|CIncinnati Children's Hospital Medical Center|Dr. Halley Wasserman|513-803-3815|halley.wasserman@cchmc.org|
20191338|NCT03861429|University of Utah|Dr. Gail Towsley|801-585-9085|gail.towsley@nurs.utah.edu|
20191339|NCT00511147|Grifols Therapeutics Inc|Henry Li, PhD|1 + 919 316 6042|henry.li@grifols.com|
20191340|NCT00809783|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191341|NCT00529555|Sunstar Americas, Inc|Marie Wilson, Clinical Program Manager|773-481-3327|marie.wilson@us.sunstar.com|
20191342|NCT02133066|Children's Hospital of Philadelphia|Aaron Chen|2674260383|chena2@email.chop.edu|
20191343|NCT03229356|Johns Hopkins University|Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
20191344|NCT05372913|Woebot Health|Dr. Athena Robinson|(415) 209-5642|athena@woebothealth.com|
20191345|NCT03193216|Medical University of South Carolina|Dr. Puja Elias, Associate Professor, PI for study|8438764269|eliasps@musc.edu|
20191346|NCT03275402|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
20191347|NCT01514864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20191348|NCT05135156|University of Washington|Dr. Kathleen J. Ramos|2065430393|ramoskj@uw.edu|
20191349|NCT02986659|Atrium Health Wake Forest Baptist|Jingzhong Ding, PhD|336-713-8601|jding@wakehealth.edu|
20191350|NCT00647998|Hospital of the University of Pennsylvania|Steven Messe, MD|2156623363|messe@mail.med.upenn.edu|
20191351|NCT01956071|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
20191352|NCT01259440|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
20223915|NCT01817582|Bausch & Lomb Incorporated|Director of Clinical Operations||Jon.Williams@bauschhealth.com|
20191353|NCT02254681|Allina Health|Srinevas K. Reddy|612-863-8716|laura.rockwell@allina.com|
20191354|NCT02469077|Vanderbilt University Medical Center|Stephen Bruehl, Ph.D.|615-936-1821|stephen.bruehl@vumc.org|
20223916|NCT03053063|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20223917|NCT04223635|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20191355|NCT01059526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20223918|NCT02060058|Kaohsiung Medical University Hospital|Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine|+886-7-3121101|hsmonyan@gmail.com|6770
20223919|NCT01188876|Massachusetts General Hospital|Marcela del Carmen, MD, MPH|617-724-4800|MDELCARMEN@mgh.harvard.edu|
20182479|NCT02956967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182480|NCT02322775|AstraZeneca Research and Development|Mitchell Goldman, Global Clinical Leader Benralizumab|301 398 0323|Mitchell.Goldman@astrazeneca.com|+1
20182481|NCT02538679|Cedars Sinai Medical center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
20182482|NCT01521143|Prima BioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
20182483|NCT03050294|Wake Forest Baptist Health|Steven R. Feldman|336-716-7740|sfeldman@wakehealth.edu|
20182484|NCT00819234|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20182485|NCT04438785|Grupo Hospitalario Quironsalud|Francisco Jesus Gonzalez|0034645014593|fgonzasan@gmail.com|
20182486|NCT04011033|BeijingYouan Hospital|Lu Jun|+86-010-83997153|lujun98@ccmu.edu.cn|
20182487|NCT01823341|Jaeb Center for Health Research|Judy Sibayan, MPH, CCRP|813-975-8690|jsibayan@jaeb.org|
20182488|NCT02027935|University of Texas MD Anderson Cancer Center|Dr. Adi Diab|(713) 745-7336|adiab@mdanderson.org|
20182489|NCT05174065|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20182490|NCT00689104|Astellas Pharma Europe B.V.|Director Medical Science||ClinicalTrials.Disclosure@us.astellas.com|
20182491|NCT04873817|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Devyani.Nanduri@abbott.com|
20182492|NCT00216320|Innovative Neurotronics|Director of Clinical Research|512-721-1922|hrogers@ininc.us|
20182493|NCT00924560|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20182494|NCT00593320|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8502|jbradley@radonc.wustl.edu|
20182495|NCT00604786|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
20182496|NCT03323151|ECOG-ACRIN Statistical Center|Opeyemi Jegede, Statistician|617-582-7613|ojegede@ds.dfci.harvard.edu|
20182497|NCT00665561|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182498|NCT02337361|Public Health Institute/Alcohol Research Group|Madhabika B. Nayak|510-898-5849|mnayak@arg.org|
20182499|NCT01641861|Khon Kaen University|Dr. Kemporn Kitsahawong|66-910-566-996|kkempo@kku.ac.th|
20182500|NCT01101542|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182501|NCT00701311|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
20182502|NCT00814489|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182503|NCT01974687|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182504|NCT01515319|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
20182505|NCT01449929|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182506|NCT03015740|M D Anderson Cancer Center|Dr. Pavlos Msaouel|713-563-4585|PMsaouel@mdanderson.org|
20182507|NCT02153788|Duke University Medical Center|Andrew Krystal, MD|919-681-8742|andrew.krystal@duke.edu|
20182508|NCT04672460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquires@pfizer.com|
20182509|NCT01032850|University of New Mexico Cancer Center|Dr. Yehuda Patt, MD|505-925-0405|yzpatt@salud.unm.edu|
20182510|NCT00079937|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182511|NCT02949271|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
20182512|NCT01207908|Cincinnati Children's Hospital Medical Center|Dr. Meilan Rutter|513-636-4744|meilan.rutter@cchmc.org|
20182513|NCT02092987|Columbia University Medical Center|Jose Luchsinger|212-305-4730|jal94@cumc.columbia.edu|
20182514|NCT00852475|Baltimore VAMC and University of Maryland Medical Center|Michael Miller, MD|4103286299|mmiller@medicine.umaryland.edu|
20182515|NCT00498186|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20182516|NCT03929302|UT Southwestern Medical center|Namrata Das|2146082836|Namrata.Das@utsouthwestern.edu|
20182517|NCT00367237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20182518|NCT01175707|Cubist Pharmaceuticals|Vice President, Clinical Research|781-860-8318||
20182519|NCT02321540|UT MD Anderson Cancer Center|Dr. John V. Heymach, Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
20182520|NCT00372567|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182521|NCT02347943|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
20182522|NCT01873287|Children's Hospital of Eastern Ontario|Dr. Roger Zemek|613-737-7600|rzemek@cheo.on.ca|
20182523|NCT00303303|Carolinas Medical Center|William Kerns II MD Program Directorm Medical Toxicology|704-355-5297|rkerns@carolinas.org|
20182524|NCT00691028|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20182525|NCT03085017|Loma Linda University Health Care|David G. Rabkin, MD FACS|909-558-4354|drabkin@llu.edu|
20182526|NCT00402883|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20182527|NCT01528124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182528|NCT00451698|Medical College of Wisconsin|Dr. Steven Zangwill|414-266-2380|szangwill@chw.org|
20182529|NCT03825393|Tokat State Hospital|Dr.Sevil Okan|5308211797|doctorsevil@yahoo.com|
20182530|NCT01169519|Duke University Medical Center|Dr. Kevin Hill|919-668-8305|kevin.hill@duke.edu|
20182531|NCT00582790|University of Wisconsin Carbone Cancer Center|Study coordinator|(608) 263-7107|uwcccgu@medicine.wisc.edu|
20182532|NCT02374957|Wake Forest University Health Sciences|Dr. Matthew Edwards|336-716-9343|medwards@wakehealth.edu|
20223920|NCT03617770|University of Illinois at Chicago|Dr. Pamela Martyn-Nemeth|3129967903|pmartyn@uic.edu|
20182533|NCT02390557|Massachusetts General Hospital, Mongan Institute for Health Policy|Lisa I. Iezzoni, MD, MSc|6176430657|liezzoni@mgh.harvard.edu|
20182534|NCT01950260|Mayo Clinic|Dr. Marius N. Stan|507-284-2463|stan.marius@mayo.edu|
20182535|NCT01882062|Inserm U1127|Dr Fanny MOCHEL|+33 (0)1 5727 46 78|fanny.mochel@upmc.fr|
20182536|NCT03283553|Johns Hopkins University|Research Program Manager|410-614-7910|dechava1@jhu.edu|
20182537|NCT03686683|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
20182538|NCT03255941|FHI 360|Mario Chen|919 544 7040|mchen@fhi360.org|11399
20223921|NCT00356135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182539|NCT00372060|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20182540|NCT02865434|Navidea Biopharmaceuticals|Bonnie Abbruzzzese|6147937500|babbruzzese@navidea.com|
20223922|NCT03963232|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20182541|NCT01579578|AstraZeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
20223923|NCT03512210|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|301-628-3348|ACTGCT.gov@fstrf.org|
20223924|NCT02551770|GWD Consult|Dr. Manfred Klasser|+49 6108 825 65 20|manfred.klasser@gwd-consult.de|
20182542|NCT01004263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182543|NCT01770860|Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.|Associate Director, Clinical Research|973-385-7984||
20182544|NCT01528709|Lynn Heart and Vascular Institute, Boca Raton Regional Hospital|Dr. Alexander Kulik|5619556300|alex_kulik@yahoo.com|
20182545|NCT01237678|ImmunoGen Inc.|Dr. Richard Bates, Sr. Manager, Publications|781 895 0196|Richard.Bates@immunogen.com|
20182546|NCT01034111|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182547|NCT02726178|Sainte Justine university hospital center|Dr. Anne Monique Nuyt|514 3454931|anne-monique.nuyt@recherche-ste-justine.qc.ca|3971
20182548|NCT05124899|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20182549|NCT00438971|Rush University|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
20182550|NCT03432533|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20182551|NCT01648283|Washington University School of Medicine|Evan D. Kharasch, MD, PhD|314-362-8796|kharasch@wustl.edu|
20182552|NCT00372970|Temple University|Frank Friedenberg|215-707-9900|frank.friedenberg@temple.edu|
20182553|NCT04880070|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20182554|NCT00578227|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182555|NCT01511250|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20182556|NCT00980278|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
20182557|NCT03610633|Medical University of South Carolina|Laura Lohnes|843-792-7709|lohnes@musc.edu|
20182558|NCT01763047|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD., M.S., F.A.A.O- Senior Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
20182559|NCT01112735|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|734-646-8214|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20182560|NCT02148809|HospitalSS|Dr. Friedrich Boettner|2127742127|boettnerf@HSS.edu|
20182561|NCT00916006|LEO Pharma|Dr. Torsten Skov|+4520736294|tosdk@leo-pharma.com|
20182562|NCT01051778|Cairo university|Usama .M .Fouda|+20123595106|umfrfouda@yahoo.com|
20182563|NCT03419780|University of Pennsylvania|Dr Rebecca Hamm|215-662-6913|rebecca.feldmanhamm@pennmedicine.upenn.edu|
20182564|NCT02929108|Washington University School of Medicine|Debra Oliver, Ph.D.|314-747-5361|oliverd@wustl.edu|
20182565|NCT01008748|UT MD Anderson Cancer Center - Clinical Research Operations|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
20182566|NCT00052962|National Cancer Institute, National Institutes of Health|Marybeth Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
20182567|NCT04654351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20182568|NCT03643965|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
20182569|NCT06268301|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20182570|NCT02820051|UANL|Dr. Julio E. González-Aguirre|82204444|jeglza111@gmail.com|229
20182571|NCT04536025|University of Colorado|Dr. Chelsey Anderson|12069926861|chelsey.anderson@cuanschutz.edu|
20182572|NCT01222247|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
20182573|NCT02084082|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20182574|NCT00832780|University of New Mexico Comprehensive Cancer Center|Ben Liem, MD|505-272-0086|BLiem@salud.unm.edu|
20182575|NCT02655653|Montefiore Medical Centr|Dr. Jonathan Leff|7189205409|jleff@montefiore.org|
20182576|NCT03298113|3M Healthcare Business Group|Nancy Klinger, Clinical Manager|651 736|nmklinger@mmm.com|5825
20182577|NCT05121675|Perelman School of Medicine|Dr. Heather Nuske|2153495537|Heather.Nuske@Pennmedicine.upenn.edu|
20182578|NCT04447820|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20182579|NCT03298815|University of Utah|Catherine Lee, MD|206-667-4922|Catherine.Lee@hci.utah.edu|
20182580|NCT02451423|University of California, San Francsico|Dr. Lawrence Fong, MD|(415) 514-3160|lawrence.fong@ucsf.edu|
20182581|NCT00764868|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20182582|NCT03658629|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20182583|NCT01221181|Columbia University Medical Center|Andrew Bomback, MD, MPH|212-305-0320|asb68@cumc.columbia.edu|
20182584|NCT00429793|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20182585|NCT01394991|Johnson and Johnson PRD|Clinical Development Team Lead|1 908 218 6097||
20182586|NCT03073005|Northwestern University|Dr. Jeffrey H Barsuk|312-926-5924|jbarsuk@nm.org|
20182587|NCT02427646|LHSC|Dr. Mandar Jog|519-685-8500|mandar.jog@lhsc.on.ca|76708
20182588|NCT03824236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206546|NCT02980692|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20182589|NCT04091672|AVITA Medical|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
20182590|NCT05296629|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
20182591|NCT02268396|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20182592|NCT01304706|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
20182593|NCT02655692|Yale University|John Krystal|203.785.6396|john.krystal@yale.edu|
20182594|NCT00716079|The George Institute for Global Health|Professor Craig Anderson|+612 9993 4521|canderson@georgeinstitute.org.au|
20182595|NCT04978363|University of Iowa|Molly Pacha|319-290-7596|molly-pacha@uiowa.edu|
20182596|NCT00940017|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20182597|NCT01684046|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20182598|NCT05080192|University of Pennsylvania|Seavmeiyin Kun|215-917-0115|seavmeiyin.kun@pennmedicine.upenn.edu|
20182599|NCT03614130|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20182600|NCT03371108|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
20182601|NCT05805059|Coopervision|Jose A. Vega,OD,MSc,FAAO, PhD|925-621-3761|jvega2@coopervision.com|
20182602|NCT05328973|M.D. Anderson Cancer Center|Neil Bailard, MD|713-597-1687|nbailard@mdanderson.org|
20182603|NCT02596906|Center for BrainHealth, The university of Texas at Dallas|Dr. Namrata Das|9728833266|Namrata.Das@utdallas.edu|
20182604|NCT03570255|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20182605|NCT00790062|University of Alabama at Birmingham|Alan T. N. Tita, MD|(205) 934-9616|atit@uab.edu|
20182606|NCT02680756|Shield Therapeutics|Jackie Mitchell MA DPhil|0044 752 565 6885|jmitchell@shieldtx.com|
20182607|NCT00480441|Treatment Research Center|Dr. Marina Goldman, Principle Study Investigator|215 222 3200|marinag@mail.med.upenn.edu|104
20182608|NCT03681691|Wake Forest University Health Science|Christina Hugenschmidt, PhD|336.713.4190|chugensc@wakehealth.edu|
20182609|NCT00748969|LA Biomed at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1972|lpolgreen@labiomed.org|
20182610|NCT02334306|MedImmune, LLC|Gabor Illei|+1 240 558 0038 118|information.center@astrazenea.com|
20182611|NCT00465985|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182612|NCT01687270|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20182613|NCT03302156|UW School of Medicine and Public Health|Elizabeth Sadowski, MD|608-263-9028|esadowski@uwhealth.org|
20182614|NCT03532178|UCaliforniaSF|Dr. Chanhung Lee|4154762131|chanhung.lee@ucsf.edu|
20182615|NCT01608971|Heart and Diabetes Center NRW|Andreas Koster|0043 5731 3284|akoster@hdz-nrw.de|
20182616|NCT03278028|Aclaris Therapeutics|Executive Director, Clinical Operations|+1(484) 329-2144|jschnyder@aclaristx.com|
20182617|NCT03635112|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20182618|NCT00463151|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20182619|NCT05349084|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
20182620|NCT00972543|Merck Serono S.A., a division of Merck KGaA|Medical Responsible|+49-6151-75-5200|service@merckgroup.com|
20182621|NCT00293462|University of California, San Francisco|Marylin J. Dodd, RN, PhD, FAAN|415-476-2191|Marylin.dodd@ucsf.edu|
20182622|NCT00688688|Astellas Pharma Global Development, Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
20182623|NCT04296942|National Cancer Institute|Dr. Fatima H. Karzai|301-480-7174|fatima.karzai@nih.gov|
20182624|NCT02341534|BIOTRONIK SE & Co. KG|Sascha Mrosk, Senior Clinical Project Manager|15168901308|sascha.mrosk@biotronik.com|0049
20182625|NCT04034121|Elixir Medical|Candace Elek, Executive Vice President, Clinical Research|408-636-2020|celek@elixirmedical.com|
20182626|NCT00714233|University of Rochester|Kathleen M Hoeger MD MPH|5852757891|Kathy_hoeger@urmc.rochester.edu|
20182627|NCT00530777|University of Washington|Dr. Carey Farquhar|206-543-4278|cfarq@uw.edu|
20182628|NCT02359058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182629|NCT03163992|Samsung Medical Center|Jeeyun Lee|8223410-1779|jyunlee@skku.edu|
20182630|NCT01582243|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182631|NCT03382821|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
20182632|NCT01805323|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20182633|NCT00797225|AbbVie|Global Medical Services|800-633-9110||
20182634|NCT02408965|UCSF|Jennifer Kerns|4152068715|Jennifer.kerns@ucsf.edu|
20182635|NCT02096003|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
20182636|NCT03178201|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
20182637|NCT02783950|University of Michigan|Todd Morgan, MD|734-647-8902|tomorgan@med.umich.edu|
20182638|NCT01767909|Wake Forest School of Medicine|Suzanne Craft, PhD, Project Director for Clinical Trial|(336) 713-8830|suzcraft@wakehealth.edu|
20182639|NCT01723774|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
20182640|NCT04348370|Texas A&M University College of Medicine|Jeffrey D. Cirillo|979-436-0343|jdcirillo@tamu.edu|
20182641|NCT05302791|University of Montana|Dustin Slivka|406-243-2389|dustin.slivka@umontana.edu|
20182642|NCT03663712|Duke University|Dan G. Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
20182643|NCT04956692|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20182644|NCT03541603|Tenax Therapeutics, Inc.|Stuart Rich, MD; Chief Medical Officer|919 855 2100|s.rich@tenaxthera.com|
20182645|NCT03486197|University of Washington/Fred Hutch Cancer Center Proton Therapy|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
20182646|NCT01016353|KCI|Senior Director, Global Clinical Development|(210) 255-5595|jane.hart@kci1.com|
20182647|NCT04863898|RTI International|Laura Nyblade, Fellow|202-728-1961|lnyblade@rti.org|
20182648|NCT03285711|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20223925|NCT05033262|The University of Pennsylvania School of Nursing|Emily Summerhayes|6099233786|esummer@nursing.upenn.edu|
20182649|NCT02431533|Pharmabiotix, Inc|Mark Cobb|214-327-4712|cobbcoinc@aol.com|
20182650|NCT02303743|Hospital Germans Trias i Pujol|Dr. Vicente Lorenzo-Zúñiga García|+34-934978866|vlorenzo.germanstrias@gencat.cat|8443
20182651|NCT02234310|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
20223926|NCT05270395|University of Kentucky|Dr. McLouth|859-562-2526|laurie.mclouth@uky.edu|
20182652|NCT00235495|University of Miami|Dr. Myron D. Ginsberg|305-243-6103|MGinsberg@med.miami.edu|
20223927|NCT03527264|Brown Oncology Research Group|Don S. Dizon, MD|4018633000|BrUOG@Brown.edu|
20223928|NCT01515462|Fondazione Telethon ETS|Sean Russell|+39 02 2022 17210|srussell@telethon.it|
20182653|NCT03251378|HUTCHMED International|William Schelman, MD, PhD|973-306-4490|albertof@hutch-med.com|+1
20182654|NCT05051540|University of Miami|Hadar Lev-Tov, MD|305-243-1953|hlevtov@med.miami.edu|
20182655|NCT04996069|Tufts University School of Dental Medicine|Mabi Singh|6176363931|mabi_l.singh@tufts.edu|
20182656|NCT00615433|Sunovion Pharmacetuicals Inc.|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20182657|NCT04739423|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
20182658|NCT03194776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20182659|NCT01939938|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
20182660|NCT02963597|Albert Einstein Healthcare Network|Dr Sunil Sharma|2154566950|sharmasu@einstein.edu|
20182661|NCT00308061|University of Bamako Faculty of Medicine, Mali|Mahamadou A. Thera, MD MPH|223-222-1809|mthera@mrtcbko.org|
20182662|NCT00741273|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
20182663|NCT00783692|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20182664|NCT03750656|University of Kansas Medical Center|Dr. David Duchene|(913) 588-8721|dduchene@kumc.edu|
20182665|NCT03005288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20182666|NCT00209274|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-421-6994|chithra.sangli@av.abbott.com|
20182667|NCT02753530|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20182668|NCT01114620|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182669|NCT01125774|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182670|NCT01734811|Inmunotek|Medical Director|916 510 010|mcasanovas@inmunotek.com|
20223929|NCT05129293|Trinity Health Of New England|Mandell Center Research Team|860-714-3005|MSResearch@TrinityHealthOfNE.org|
20223930|NCT00784550|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223931|NCT00743288|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
20223932|NCT05903924|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
20223933|NCT00688701|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20182671|NCT01290094|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20182672|NCT01786343|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
20182673|NCT03230006|Center for Anxiety and Related Disorders, Boston University|Dr. Todd Farchione|6173539610|tfarchio@bu.edu|
20182674|NCT01712685|National Cancer Institute|Dr. Adam Metwalli|301-435-6237|metwallia@mail.nih.gov|
20182675|NCT01871285|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20182676|NCT00929305|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20223934|NCT00029536|Beth Israel Deaconess Medical Center|Dr. Andrew G. Herzog|781-431-0277|aherzog@bidmc.harvard.edu|
20223935|NCT02715700|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223936|NCT04166591|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
20223937|NCT03030989|University of Chicago|Randee Estes, Study Coordinator|773-702-1209|restes@medicine.bsd.uchicago.edu|
20223938|NCT02730377|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20223939|NCT03917472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20223940|NCT01154296|Department of Sociomedical Sciences/Mailman School of Public Health/Columbia University|Lisa Metsch, PhD, Stephen Smith Professor and Chair of Sociomedical Sciences|212-305-3577|lm2892@columbia.edu|
20223941|NCT02759055|HealthPartners Institute|Patrick J O'Connor|952-967-5034|Patrick.J.OConnor@HealthPartners.Com|
20223942|NCT00765895|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
20223943|NCT01470781|McLean Hospital/Harvard Medical School|Dr. Kathryn Lewandowski|617-855-2886|klewandowski@mclean.harvard.edu|
20223944|NCT00970632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182677|NCT01489176|University of Nebraska Medical Center|Thomas R Porter|402-559-5156|trporter@unmc.edu|
20182678|NCT05541497|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
20182679|NCT01796665|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20182680|NCT01565538|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|020-87343439|wsysums@163.net|
20182681|NCT00359619|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223945|NCT00697541|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20162748|NCT02510001|University of Oxford Clinical Trials and Research Governance (CTRG)|Heather House|01865 572245|heather.house@admin.ox.ac.uk|
20182682|NCT01251614|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20182683|NCT00049517|ECOG Statistical Office|Statistician|617-632-3012||
20223946|NCT01429064|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
20182684|NCT01419717|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20182685|NCT02857283|UNC Center for Environmental Medicine, Asthma and Lung Biology|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
20182686|NCT00093795|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20182687|NCT00613301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20182688|NCT00961805|Federal University of Sao Paulo|Andreia S Baptista, PT|551155764239|deiasalvador1@yahoo.com.br|
20182689|NCT04094064|University of Virginia Center for Diabetes Technology|Dr. Meaghan Stumpf|(434) 982-4351|MMS5CF@hscmail.mcc.virginia.edu|
20223947|NCT01871402|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20223948|NCT04594941|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
20223949|NCT00231114|Asthmatx, Inc.|Narinder S Shargill, PhD|408-419-0100||
20223950|NCT02005692|Leaf Healthcare, Inc.|Barrett Larson, MD, Chief Medical Officer|650-701-3652|barrett.larson@leafhealthcare.com|
20223951|NCT01194999|Barrie Urology Associates - The Male/Female Health and Research Centre|Joseph A Zadra, MD CM FRCSC|705-727-0551|joezadra@rogers.com|
20223952|NCT02682823|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20223953|NCT03781583|University of Michigan Medical School|James Weiland|734-764-9793|weiland@umich.edu|
20182690|NCT04188288|Yale University|Kathleen Garrison, PhD|203-737-6232|kathleen.garrison@yale.edu|
20182691|NCT02790606|C.R. Bard|Talar Saber, Clinical Project Manager|480-379-2839|talar.saber@crbard.com|
20191356|NCT01732588|MMV|Dr Fiona Macintyre|+41 22 799 4060|macintyref@mmv.org|4078
20191357|NCT02005029|Virginia Commonwealth University|Dr. Leslie Cloud|804-662-5304|leslie.cloud@vcuhealth.org|
20191358|NCT02621047|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20191359|NCT03690921|M D Anderson Cancer Center|Dr. Emma Holliday|713-563-2340|EBHolliday@mdanderson.org|
20191360|NCT00735462|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
20191361|NCT00475787|Canandaigua VA Medical Center|Paul Dougherty, DC|585-463-2673|paul.dougherty@va.gov|
20191362|NCT04748445|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191363|NCT03327571|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20191364|NCT00139659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20191365|NCT02943109|Ohio State University College of Medicine|Prof. Ann Scheck McAlearney|614-293-8973|Ann.McAlearney@osumc.edu|
20191366|NCT01209936|University of Southern California|Dr. David Erceg|(323) 442-2900|erceg@usc.edu|
20191367|NCT02382913|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20191368|NCT00024102|University of North Carolina|Hyman Muss, MD||hyman.muss@gmail.com|
20191369|NCT01078376|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20191370|NCT02502487|West China Hospital, Department of Anesthesiology|Dr. Guizhi Du, Associate professor|+86 18980602213|du_guizhi@yahoo.com|
20191371|NCT01150500|Study Manager|Hiroko Ookubo|+81-3-6430-7017|hiroko.ookubo@medtronic.com|
20191372|NCT05021757|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
20191373|NCT03799289|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
20191374|NCT04089332|University of Wisconsin - Madison|Dr. William Schrage|608-262-7715|william.schrage@wisc.edu|
20191375|NCT05401149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20182692|NCT02735915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191376|NCT00006099|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20191377|NCT06016127|Albany Saratoga Centers for Pain Management|Kasandra Cliff|518-371-6772|khopkins@northwayspc.com|
20191378|NCT04281875|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
20182693|NCT00946114|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182694|NCT00723294|Weill Cornell Medicine|Rache M. Simmons, MD|(212) 821-0870|rms2002@med.cornell.edu|
20182695|NCT01211665|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20182696|NCT02333630|Nationwide Children's Hospital|David Stukus, MD|614 722-4808|david.stukus@nationwidechildrens.org|
20182697|NCT05349864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182698|NCT00984282|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20182699|NCT02223793|University of Oslo|Karianne Svendsen|+4795026445|karianne.svendsen@medisin.uio.no|
20182700|NCT00315055|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20182701|NCT02359435|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20182702|NCT00496379|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-2335|nlin@partners.org|
20182703|NCT00623506|Durham VA Medical Center|Christine E. Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
20182704|NCT01289119|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20191379|NCT00734851|DukeUMC|Andrew J. Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
20191380|NCT01524887|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20191381|NCT00170950|Novartis Pharmaceuticals|Study Director|862 778-8300||
20191382|NCT02648282|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng MD, PhD|410-502-6241|lzheng6@jhmi.edu|
20191383|NCT04387201|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|713-500-6641|absalon.d.gutierrez@uth.tmc.edu|
20191384|NCT04320602|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20223954|NCT05139303|University of Kentucky College of Dentistry Division of Orofacial Pain|Dr. Isabel Moreno Hay|8593233440|imo226@uky.edu|
20223955|NCT01938430|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20223956|NCT03875482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20223957|NCT01302444|Rhode Island Hospital|James R Klinger, MD||jklinger@lifespan.org|
20223958|NCT02822573|Wake Forest NCORP Research Base|Lead Biostatistician (Emily Dressler, PhD)|336-716-0891|NCORP@wakehealth.edu|
20223959|NCT04143594|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20223960|NCT01023256|MorphoSys|Roman Korolkiewicz|+498989927|Roman.Korolkiewicz@morphosys.com|208
20223961|NCT00308087|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
20223962|NCT01044290|HSRD, Durham VAMC|Karen Steinhauser, PhD|919 668-2148|karen.steinhauser@duke.edu|
20223963|NCT04323306|MMV|Benoit Bestgen|+41 79 765 18 68|bestgenb@mmv.org|
20223964|NCT01878812|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223965|NCT01646021|Janssen-Cilag International NV|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20223966|NCT00438100|The University of Tokyo|Tempei Miyaji|+81-3-5800-9086|tmiyaji@m.u-tokyo.ac.jp|
20223967|NCT02581475|Shandong University Qilu Hospital|Dr. Yanqing Li|+86-531-82169236|liyanqing@sdu.edu.cn|
20223968|NCT01967706|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20223969|NCT00725608|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
20182705|NCT01704846|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20182706|NCT02912195|Alameda Health System|Andrew Herring|510 437-8356|aherring@alamedahealthsystem.org|
20182707|NCT01515956|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
20182708|NCT00530335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182709|NCT01244984|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182710|NCT01360840|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20182711|NCT04668144|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904244206|francesco.franchi@jax.ufl.edu|
20182712|NCT01366196|Hss|Dr. Michael Urban|(212) 606-1000|UrbanM@hss.edu|
20182713|NCT02282527|Grifols Therapeutics Inc.|Henry Li|1-919-316-6042|henry.li@grifols.com|
20182714|NCT01872611|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
20182715|NCT03537651|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20182716|NCT03569813|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
20182717|NCT03163511|Vertex Pharmaceuticals, Inc|Gautham Marigowda|617-961-0568|gautham_marigowda@vrtx.com|
20182718|NCT03669042|Artivion, Inc.|Karen Sylvester|7704193355|karen.sylvester@artivion.com|
20182719|NCT04639947|Duke Eye Center|Dr. Sanjay Asrani|+1 919 684 8656|sanjay.asrani@duke.edu|
20182720|NCT04001114|University of Maryland|Britta Hahn, Ph.D.|410-402-6112|bhahn@som.umaryland.edu|
20182721|NCT03057132|Cancer Treatment Centers of America|Joseph Rudolph, BSN, RN, CWOCN, DWC|(215) 537-4678|Joe.Rudolph@ctca-hope.com|
20182722|NCT04436029|Cartesian Therapeutics|Chief Medical Officer|(301) 348-8698|trials@cartesiantx.com|
20182723|NCT02696785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20182724|NCT01258387|Acorda Therapeutics, Inc.|Anthony Caggiano, MD, PhD|914-347-4300|tcaggiano@acorda.com|5150
20182725|NCT02487446|Novartis Pharmaceuticals|Study Director|862-778-1873||
20182726|NCT01822821|Cleveland Clinic|Nicole Zimmerman|216-636-9449|zimmern2@ccf.org|
20182727|NCT02320253|MGH Diabetes Center|Dr. Deborah J. Wexler|617-726-8767|dwexler@mgh.harvard.edu|
20182728|NCT05750745|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20182729|NCT05064761|Galderma Research and Development, LLC (GLLC)|Clinical Project Manager|+1 817-961-5000|aestheticclinicaltrials@galderma.com|
20182730|NCT05780047|Million Marker Wellness, Inc.|Carol Kwiatkowski, VP of Research|510-305-5690|carol@millionmarker.com|
20182731|NCT01925781|Creighton University|Director of Clinical Trials|402-280-4961|sandrabyers@creighton.edu|
20182732|NCT03590743|Mayo Clinic|Robert D. McBane, II M.D.|507-266-3964|mcbane.robert@mayo.edu|
20182733|NCT02696226|Cleveland Clinic|Dr. Douglas Johnston|216-444-5613|JOHNSTD3@ccf.org|
20182734|NCT02698436|JNJWorldwide|Lisa Fitzgerald|+1 908-904-6235|lfitzge6@its.jnj.com|
20182735|NCT00097370|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182736|NCT02081365|Maurice H. Kornberg School of Dentistry, Temple University|Marisol Tellez M. BDS, MPH, Ph.D|215-707-1773|marisol@temple.edu|
20182737|NCT02230579|Medicines for Malaria Venture|Dr Cristina Donini - Associate Director|00 41 22 555 03 12|doninic@mmv.org|
20182738|NCT00062868|Baylor College of Medicine|Dr. Helen E. Heslop|832-824-4662|hheslop@bcm.edu|
20182739|NCT01324882|UConn Health Center|Joseph Anderson|8022959362|joseph.anderson@dartmouth.edu|6003
20182740|NCT04949399|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20182741|NCT00670540|University Hospital Grenoble|Jean-Luc Bosson|33 4 76 76 50 40|jean-luc.bosson@imag.fr|
20182742|NCT01866917|Montefiore Medical Center|Ja Hyun Shin|718-920-5157|JASHIN@montefiore.org|
20182743|NCT03896230|Hackensack Meridian Health|Gabrielle L. Procopio, Pharm.D., BCPS|551-996-4368|Gabrielle.Procopio@hmhn.org|
20182744|NCT02613897|University of Texas Health San Antonio|Yuejuan Qin|210-617-5300|qiny@uthscsa.edu|
20182745|NCT01140347|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182746|NCT00901485|Royal Brompton Hospital|Miss Julia Kelly|+44 2073528121|j.kelly@rbht.nhs.uk|4183
20182747|NCT01959880|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20182748|NCT01919619|M D Anderson Cancer Center|Issa Khouri, MD / Stem Cell Transplantation Department|713-792-8750|ikhouri@mdanderson.org|
20223970|NCT01021761|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
20223971|NCT00614120|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20223972|NCT03047720|Indiana University|Dr Benjamin Whittam|317.944.8896|bwhittam@iupui.edu|
20182749|NCT00587288|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20182750|NCT01306331|Evofem|Clinical Operations|858-550-1900|clinicaloperations@evofem.com|
20182751|NCT04669249|PRO Health Group|Dr. Steven Proctor|305-814-7762|sproctor@prohealthgroup.net|
20182752|NCT03127358|Albert Einstein College of Medicine|Julia Arnsten, MD|718-920-6641|jarnsten@montefiore.org|
20182753|NCT00887640|Duke University Medical Center|Dr. Andrew Armstrong|919-668-8108|andrew.armstrong@dm.duke.edu|
20182754|NCT00409708|Novartis Pharmaceuticals|Study Director|862 778-8300||
20182755|NCT02213900|Indiana University|Babar Khan, MD|317-274-9132|bakhan@iu.edu|
20191385|NCT00497198|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20191386|NCT01816685|Duke University|Andrew Krystal|(919) 668-1212|andrew.krystal@dm.duke.edu|
20191387|NCT02720185|University of Wisconsin Carbone Cancer Center|Kari Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
20191388|NCT00381888|Masonic Cancer Center, University of Minnesota|Levi S. Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
20191389|NCT01410084|Wake Forest School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
20191390|NCT01589523|Cincinnati Children's Hospital Medical Center|Ken Setchell, PhD|5136364548|kenneth.setchell@cchmc.org|
20191391|NCT00961896|Novartis|Study Director|862-778-8300||
20191392|NCT00506922|UT MD Anderson Cancer Center|Marcos de Lima, MD / Professor|713-745-3219|bmcmullin@mdanderson.org|
20191393|NCT00792259|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
20191394|NCT00371462|Edward Hines Jr., VA Hospital|Associate Chief of Staff for Research|708-202-5689|eileen.collins@va.gov|
20191395|NCT03721978|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20191396|NCT05244226|Duke University|Lisa Einhorn, MD|919-681-4877|lisa.einhorn@duke.edu|
20191397|NCT01997437|Kuban State Medical University|Dr. Paolo Macchiarini|+7(928)-268-80-00|pmacchiarini@ksma.ru|
20191398|NCT04397614|University of Oklahoma Health Sciences Center|Krista Kezbers|405-271-8001|krista-kezbers@ouhsc.edu|45042
20191399|NCT00555997|Massachusetts General Hospital|Dr. George Papakostas|617-726-6697|gpapakostas@partners.org|
20182756|NCT02685293|Pearl Therapeutics Inc.|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20191400|NCT02507687|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20191401|NCT02675998|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20191402|NCT00275301|University of Minnesota|S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
20191403|NCT02097849|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20191404|NCT01540162|National Medical University Odessa|Prof. Mykola L. Aryayev, MD & PhD|+380 48 740 5249|nataly_kononenko@ukr.net|
20223973|NCT01154088|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223974|NCT05010512|Alcon Research, LLC|Associate Director, Clinical Projects - CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20223975|NCT05129137|Unither Pharmaceuticals|Non-Clinical and Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
20223976|NCT01084668|Abbott|Global Medical Services|800-633-9110||
20223977|NCT01118624|Spectrum Pharmaceuticals|Pankaj Sharma, MD|949-743-9264|pankaj.sharma@sppirx.com|
20182757|NCT00088465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191405|NCT00598871|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
20223978|NCT01869699|University of California, San Francisco|Dr. Hildy Schell-Chaple|415-353-1039|hildegarde.schell-chaple@ucsf.edu|
20223979|NCT05028075|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
20223980|NCT01475851|GlaxoSmithKline|GSK Response Center|866-435-7343||
20223981|NCT01576276|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|jkong2@mgh.harvard.edu|
20223982|NCT02447497|3M|Nancy Klinger|651 491 9433|nmklinger@mmm.com|
20223983|NCT01322035|University of South Alabama, Department of Surgery|Dr. William O. Richards|251-471-7993|brichards@health.southalabama.edu|
20223984|NCT00727844|Tuberculosis Research Section, LCID, NIAID, NIH|Dr. Clifton Barry|301-451-9554|cbarry@niaid.nih.gov|
20223985|NCT04569968|Bolu Abant İzzet Baysal University|Tamer ÇANKAYA|5335519171|tamercankaya@hotmail.com|+90
20223986|NCT03912818|Stanford University|Sandy Srinivas|650-725-2078|sandysri@stanford.edu|
20223987|NCT03861871|NYU Langone Health|Latoya King|646 558 083|latoya.king@nyulangone.org|
20182758|NCT00448864|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20223988|NCT00979420|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223989|NCT04676451|Penn State Hershey Medical Center|Amy Longenecker|717-531-1513|alongenecker@pennstatehealth.psu.edu|
20223990|NCT04257032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20223991|NCT00602459|Ohio State University|John Byrd, M.D.||john.byrd@osumc.edu|
20223992|NCT01295827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223993|NCT01668173|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal|212-639-2194|RampalR@mskcc.org|
20223994|NCT00684320|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|(619) 229-3740|namir@mail.sdsu.edu|
20223995|NCT00072280|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20223996|NCT00746564|St. Jude Medical|Director, Clinical Studies|1-800-733-3455|tshipman@sjm.com|
20223997|NCT00322231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20223998|NCT03226769|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20223999|NCT02439814|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
20224000|NCT02640677|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20224001|NCT00537576|University of California, San Francisco|Anke Hemmerling, Project Director|415-597-4963|ahemmerling@globalhealth.ucsf.edu|
20224002|NCT04679311|Washington University School of Medicine|Steven Weintraub MD|314-652-4100|weintraub@wustl.edu|55298
20224003|NCT02255305|NorthShore UH|Jennifer Grant|847-570-2420|jgrant@northshore.org|
20224004|NCT02706886|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20224005|NCT04934189|Hunter College of the City University of New York|Danielle S. Berke, Ph.D.|212-772-5550|db2800@hunter.cuny.edu|
20224006|NCT03309657|University of Queensland Center for Clinical Research|Prof. Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
20224007|NCT03320850|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20182759|NCT01390857|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224008|NCT03192995|University of California at San Francisco|Dr. Glenn-Milo Santos, Associate Professor|415-867-1151|glenn-milo.santos@ucsf.edu|
20224009|NCT05210101|Brigham and Women's Hospital|Sophia Koo, MD|6175258418|skoo@bwh.harvard.edu|
20224010|NCT03506568|Devers Eye Institute|Dr. Robert Kinast|503-413-8202|robertkinast@gmail.com|
20224011|NCT01286168|Mayo Clinic|Dr. Amy C. Degnim|507-284-6357|Degnim.Amy@mayo.edu|
20224012|NCT01424514|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224013|NCT06207149|Vanderbilt University|Meghan Burke|6153431014|meghan.burke@vanderbilt.edu|
20182760|NCT02757885|Emory University|Professor of Pediatrics, Dr. Suhag H. Parikh|4047853240|suhag.parikh@emory.edu|
20182761|NCT02485964|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
20182762|NCT01474538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20182763|NCT01456780|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
20182764|NCT01501929|University of Texas Southwestern|Wanpen Vongpatanasin|2146482103|Wanpen.Vongpatanasin@UTSouthwestern.edu|
20182765|NCT02688621|University of Vermont|Doris Ogden|802-656-1960|doris.ogden@uvm.edu|
20182766|NCT02359838|Dana-Farber Cancer Institute|Gregory A. Abel|617-632-2304|gregory_abel@dfci.harvard.edu|
20182767|NCT04565249|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
20182768|NCT00886613|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182769|NCT04760444|University of Michigan School of Social Work|Dr. Jaclynn Hawkins|(734) 647-4072|jachawk@umich.edu|
20182770|NCT01982760|Case School of Medicine|Dr. Bahman Guyuron|440-461-7999|bguyuron@guyuron.com|
20162749|NCT04042324|Rockwell Medical, Inc|Raymond Pratt, MD|248 960 9009|rpratt@rockwellmed.com|405
20182771|NCT00821236|Durrie Vision|Brigette Ellis|913-491-3330|bellis@durrievision.com|7255
20224014|NCT02487771|University of Kansas Medical Center|Susan Carlson, PhD|(913) 588-5359|SCARLSON@kumc.edu|
20182772|NCT03587194|Psoriasis Treatment Center of Central New Jersey|Ashley Reed|6094434500|ashley.reed@schweigerderm.com|
20224015|NCT04598451|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
20224016|NCT02653170|Michigan State University|Dr. Mathew Reeves|517-353-8623|reevesm@msu.edu|
20224017|NCT02002533|University of Rochester|Gary Morrow|585-275-9961|gary_morrow@urmc.rochester.edu|
20224018|NCT02147522|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
20224019|NCT03796442|Seoul National University Hospital|Prof. Ho Young Hwang|00-82-2-2072-3020|scalpel@snu.ac.kr|
20224020|NCT02893553|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
20162750|NCT01504841|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20162751|NCT04756804|Zurex Pharma, Inc.|VP, Reg Affairs|608.203.9090|customercare@zurexpharma.com|
20162752|NCT04440813|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
20162753|NCT04648683|Vanderbilt University Medical Center|Carrie Brintz|615-875-9885|carrie.brintz@vumc.org|
20162754|NCT01362894|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
20162755|NCT00291018|DePuy Synthes Spine|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
20162756|NCT01626092|Masonic Cancer Center, University of Minnesota|Weston P Miller, MD|612-626-2778|mill4991@umn.edu|
20182773|NCT01104103|The University of Texas Health Science Center at Houston|Dr. Richard Bradley|713-500-7878|Richard.N.Bradley@uth.tmc.edu|
20162757|NCT02219334|Baylor College of Medicine|Shabana Yusuf/Associate Professor of Pediatrics|832-824-5388|syusuf@bcm.edu|
20162758|NCT05362058|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20162759|NCT00711971|University of Michigan|Ellen Mozurkewich, Adjunct Assistant Professor|(734) 546-2772|emozurkewich@salud.unm.edu|
20182774|NCT00282438|Northwestern University|Dr Richard Burt, Chief, Division of Immunotherapy, Department of Medicine|312-695-4960|rburt@northwestern.edu|
20182775|NCT02397889|Icahn School of Medicine at Mount Sinai|Adriana Feder|212-659-9279|adriana.feder@mssm.edu|
20182776|NCT01125202|New York University School of Medicine|Mary Ann Sevick, ScD|6465012621|mary.sevick@nyumc.org|646
20182777|NCT00875641|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182778|NCT03404609|Stanford University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
20182779|NCT01454362|Queen Mary University of London|Dr Hayden McRobbie|0207 882 7260|researchamendments@bartsandthelondon.nhs.uk|
20182780|NCT04500821|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
20182781|NCT01928940|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182782|NCT02954055|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
20182783|NCT01363479|Helsinn Healthcare SA|Marco Palmas MD, Head of Clinical Development|+41919852121|marco.palmas@helsinn.com|
20182784|NCT00587132|Mayo Clinic|Dr. Naoki Takahashi|507-284-7249|takahashi.naoki@mayo.edu|
20182785|NCT01352507|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162760|NCT03606187|SGX Medical|VP of Clinical Affairs|6613108409|wpark@sgxmedical.com|
20162761|NCT01566500|Columbia University|Marie Chesaniuk|212-854-0127|mc3333@columbia.edu|
20162762|NCT04774926|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20162763|NCT02524158|VA San Diego|Dr. Erik J. Groessl|858-552-8585|erik.groessl@va.gov|6347
20162764|NCT02638168|Penn State Health Milton S Hershey Medical Center|Raman Baweja, MD, MS|7175318134|rbaweja@pennstatehealth.psu.edu|
20162765|NCT01635881|Boston Scientific|Andrey Nersesov, Clinical Trial Manager|1-508-683-4988|Andrey.Nersesov@bsci.com|
20162766|NCT01973998|Lewis Katz School of Medicine Temple University|Michael R. Jacobs - Director of Research Development|2157072242|michael.jacobs@tuhs.temple.edu|
20162767|NCT00646399|Biosynexus|Irwin Scher, MD|301-330-5800|irwinscher@biosynexus.com|
20182786|NCT01119703|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182787|NCT03999944|FRESCA Medical|Vice President, RA/CA/QA|949-542-3535|mlmooney@frescamed.com|
20182788|NCT00884611|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
20182789|NCT02095158|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20182790|NCT00941031|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182791|NCT00631917|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182792|NCT00883350|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
20182793|NCT01076335|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20182794|NCT02939183|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20191406|NCT01194271|The University of Texas (UT) MD Anderson Cancer Center|Padmanee Sharma, Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20191407|NCT01750086|Massachusetts General Hospital|Dr. Joy Tsai|617-726-6723|jntsai@mgh.harvard.edu|
20191408|NCT01983462|University of Iowa|Gary Pierce, PhD|3193359487|gary-pierce@uiowa.edu|
20191409|NCT00349622|MGH|Merit Cudkowicz|617-724-1873|mcudkowicz@partners.org|
20191410|NCT00508274|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20191411|NCT03296566|University of British Columbia|Dr. Marette Lee|604.875.5608|Marette.Lee@vch.ca|
20191412|NCT03065205|University of Colorado|Heather Hoch MD|720-777-4108|heather.hoch@childrenscolorado.org|
20191413|NCT00821119|Instituto Materno Infantil prof. Fernando Figueira|Jucille Meneses|55 (81) 2122-4100|jmeneses@elogica.com.br|4135
20191414|NCT00550771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20191415|NCT01243411|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20191416|NCT03022578|UT MD Anderson Cancer Center|Dr. Barbara O'Brien, MD/Associate Professor, Neuro-Oncology|(713) 794-4380|bjobrien@mdanderson.org|
20206547|NCT02665468|VA-CHOIR|Dr. Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
20182795|NCT01740557|M D Anderson Cancer Center|Dr. Rodabe Amaria M.D.|(713) 792-2921|rnamaria@mdanderson.org|
20182796|NCT00490555|University of Washington|Dr. Stephanie Page|2066160483|page@u.washington.edu|
20191417|NCT00805285|University of Maryland, Baltimore|Raymond Cross, MD, MS|410-706-3387|rcross@medicine.umaryland.edu|
20191418|NCT00839306|Eisai Inc.|Eisai Medical Services|888-422-4743||
20191419|NCT01066897|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
20191420|NCT01763645|BIOCAD|Feder Krykov|+7 (812) 380 4933|kryukov@biocad.ru|8552
20191421|NCT02396758|Boston Scientific|Nancy O'Connell|763-494-2706|nancy.oconnell@bsci.com|
20191422|NCT02110225|Dompé farmaceutici s.p.a.|Flavio Mantelli, MD, PhD|+39 02 583831|clinical.trials@dompe.com|
20191423|NCT02176018|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
20224021|NCT02086448|University of Pittsburgh|Dr. Francesca Facco|412-641-1220|Faccof@upmc.edu|
20191424|NCT00265096|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
20191425|NCT00774306|Thomas Jefferson University|Dr. Scott Mintzer|215-955-1222|scott.mintzer@jefferson.edu|
20191426|NCT03022045|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20191427|NCT03436433|Duke Neurosugery|Claudia E. Pamanes, MPH, CCRP|9196680897|claudia.pamanes@duke.edu|
20191428|NCT01126879|Northwestern University|William Catalona, MD|312-695-1301|WCatalona@nm.org|
20191429|NCT00126555|University of Texas MD Anderson Cancer Center|Randal S. Weber, MD / Head & Neck Surgery|7137927734|rsweber@mdanderson.org|
20191430|NCT01780545|Hoosier Cancer Research Network|Clinical Data Manager|3176345842|hcrndm@hoosiercancer.org|41
20191431|NCT01443546|Weill Cornell Medical College|Ina Cholst, MD|646-962-3025|icholst@med.cornell.edu|
20191432|NCT00498433|Novartis Pharmaceuticals|Study Director|862-778-8300||
20191433|NCT01212952|Mayo Clinic|Martha Q. Lacy, M.D.|(507) 284-8430|lacy.martha@mayo.edu|
20191434|NCT01264887|Grünenthal GmbH|Director Clinical Trials|+49 241 569|clinical-trials@grunenthal.com|3223
20191435|NCT04531813|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20191436|NCT02171130|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191437|NCT00591409|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191438|NCT00858507|Providence VA Medical Center|Thomas O'Toole, MD|4012737100|thomas.otoole@va.gov|
20191439|NCT02853305|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191440|NCT04772313|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
20191441|NCT01836198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20191442|NCT03187353|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
20191443|NCT02754310|iLumens|Dr David Drummond|+0033144494848|david.drummond@ilumens.org|6
20191444|NCT00935649|PathoLase|David M Harris, PhD, Research Director|510-502-3345|bmcinc@comcast.net|
20191445|NCT03794609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224022|NCT01968356|3M Health Care|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
20191446|NCT02205476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191447|NCT03840278|Massachusetts General Hospital Diabetes Research Center|Courtney A Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
20191448|NCT03805698|Cedars-Sinai Medical Center|David Kulber, MD, PI|3104235900|david.kulber@cshs.org|
20191449|NCT02359552|Cleveland Clinic Lou Ruvo Center for Brain Health|Dr. Aaron Ritter|702-483-6049|rittera@ccf.org|
20191450|NCT02391116|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20191451|NCT01747629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20191452|NCT01770509|The Department of Dermatology, Sheba Medical Center|Dr. Shoshana Greenberger|972-3-5302443|shoshana.greenberger@sheba.health.gov.il|
20191453|NCT02033499|University of North Carolina at Chapel Hill|Dr. Katrina Donahue|919-966-5090|Katrina_Donahue@med.unc.edu|
20191454|NCT04593641|Celltrion Inc.|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
20191455|NCT03427177|Fox Chase Cancer Center|Dr. Linda Fleisher|215-214-3757|Linda.Fleisher@fccc.edu|
20191456|NCT00794573|Jewish General Hospital / McGill University|Mark Eisenberg, MD MPH|5143408222|mark.eisenberg@ladydavis.ca|
20191457|NCT01294358|National Cancer Institute|Dr. Udo Rudloff|301-496-3098|udo_rudloff@nih.gov|
20191458|NCT03356145|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20191459|NCT02963922|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20191460|NCT00702234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191461|NCT02150109|Ascensia Diabetes Care|Jane Wallace, Deputy Director Clinical Trials|574-257-3063|jane.wallace@ascensia.com|
20191462|NCT02181400|Sydney Eye Hospital|Maria Willilams|02 9382 7309|maria.williams@sydney.edu.au|
20191463|NCT04763863|Coloplast AB|Catarina Sternhufvud|+46 (0)705 56 10 97|secast@coloplast.com|
20191464|NCT00905255|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20191465|NCT03479502|Vanderbilt_University MC|Rosemary Sanders, Research Coordinator|16155930171|Rosemary.a.sanders@vumc.org|
20191466|NCT01332318|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20191467|NCT02040532|MGH Center for Women's Mental Health|Dr. Lee Cohen|617-724-0816|lcohen2@partners.org|
20191468|NCT02363933|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
20191469|NCT00500539|Novartis Pharmaceuticals|Study Director|862-778-8300||
20191470|NCT01808144|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
20191471|NCT03993054|University of Miami|Sara St. George|305-243-0726|s.stgeorge@med.miami.edu|
20191472|NCT04341584|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|:+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
20191473|NCT04853238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20224023|NCT01579084|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20224024|NCT01482065|Johns Hopkins University|Dr. Seva Polotsky, M.D., PhD|410-550-6386|vpolots1@jhmi.edu|
20206548|NCT03862495|Skin Disease Hospital of Southern Medical University|Deputy Chief Physician Li Changchang|18585239166|lichch8@mail2.sysu.edu.cn|
20206549|NCT04397796|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20206550|NCT01057862|Yale University|Dr. Marc N Potenza|2037373553|marc.potenza@yale.edu|
20206551|NCT01661946|Queen's University Department of Ophthalmology|Dr. Sanjay Sharma|613-544-3400|sanjay_sharma60@hotmail.com|2227
20206552|NCT03363165|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20206553|NCT02255760|MedImmune LLC|Hasan S. Jafri, MD, Senior Director, Clinical Development|301-398-0000|jafrih@medimmune.com|
20206554|NCT00618813|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20206555|NCT00003838|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
20182797|NCT00603538|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182798|NCT04794179|University of Utah Healthcare|Richard Gurgel MD, PI|801-585-1626|Richard.Gurgel@hsc.utah.edu|
20206556|NCT00425113|National Institute of Allergy and Infectious Diseases|Ray Chen|301-443-5816|ray.chen@nih.gov|
20182799|NCT03109015|Duke University|Michael Harrison, MD|919-668-8108|michael.harrison@duke.edu|
20182800|NCT01096056|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206557|NCT04737759|Boston College|Dr. Karen Lyons|6175526379|karen.lyons@bc.edu|
20206558|NCT01484561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182801|NCT01110174|PI has left the institution, all efforts to locate PI have been exhausted.|PI has left the institution, all efforts to locate PI have been exhausted.||steve.martinez@ucdmc.ucdavis.edu|
20206559|NCT03371251|Boston Pharmaceuticals, Inc.|Etienne Dumont, MD|(484) 986 8699|clinicaltrials@bostonpharmaceuticals.com|
20206560|NCT00291187|Vanda Pharmaceuticals Inc.|Marlene Dressman, PhD.|202-734-3462|marlene.dressman@vandapharma.com|
20206561|NCT04362813|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20206562|NCT00961116|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20206563|NCT01981109|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
20206564|NCT02023268|Laboratoires Théa|Dr Pascale Pouliquen|04 73 98 14 36|p.pouliquen@laboratoires-thea.fr|
20224025|NCT01942486|University of Utah|Bradley Katz|8015871079|bradley.katz@hsc.utah.edu|
20206565|NCT01153672|University of Washington|Hannah M. Linden, MD|206-288-6989|hmlinden@u.washington.edu|
20206566|NCT00615459|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206567|NCT01363258|UAB School of Nursing|Rita Jablonski|205-975-9019|rjablonski@uabmc.edu|
20224026|NCT03728426|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Dr. Amy Sherman|6175253575|acsherman@bwh.harvard.edu|
20224027|NCT02637895|University of Miami Miller School of Medicine|Dr. Philip Harvey|305 243 4094|pharvey@med.miami.edu|
20224028|NCT02161484|University of Pittsburgh|Dr. Rita Merman, P.I.|41256322137|MermanRB@upmc.edu|
20182802|NCT03507309|Imperial College Healthcare NHS Trust|Dr Amit Kaura|020 3312 6666|amit.kaura@nhs.net|
20182803|NCT04816526|Cartesian Therapeutics|Dr. Milos Miljkovic, Chief Medical Officer|4436335855|milos@cartesiantx.com|
20182804|NCT01737268|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration|+81-3-3244-0512|Astellas.resultsdisclosure@astellas.com|
20182805|NCT01155999|Laboratoires Thea|Pascale Pouliquen (Medical director)|0473963614|p.pouliquen@laboratoires-thea.fr|
20182806|NCT01190176|GlaxoSmithKline|GSK Response Center|866-435-7343|pr266560@gsk.com|
20182807|NCT02909101|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
20206568|NCT00918346|Santen Oy|Auli Ropo|+358405012416|auli.ropo@santen.fi|
20206569|NCT03238352|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20182808|NCT02189863|Alcon Research, Ltd.|Global Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20182809|NCT03697460|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-6479|Mangold.Aaron@mayo.edu|
20182810|NCT03369951|Northwestern University of Feinberg School of Medicine|Richard G. Wunderink, MD|312-695-1878|r-wunderink@northwestern.edu|
20182811|NCT02266329|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
20182812|NCT02178436|Karmanos Cancer Institute|Mohammed Najeeb Al Hallak M.D.|313-576-8718|alhallakm@karmanos.org|
20182813|NCT00365417|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
20182814|NCT00725010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20182815|NCT03499600|George Mason University|Dr. Amanda Sanchez|703-993-1354|asanch49@gmu.edu|
20182816|NCT00569946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182817|NCT00797862|Novartis Pharmaceuticals|Study Director|862- 778- 8300||
20182818|NCT01743729|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20182819|NCT05074498|Truebinding, Inc|Dongxu Sun|650-847-1117|info@truebinding.com|
20182820|NCT01240356|The University of Texas Health Science Center at Houston|James C. Grotta, MD|+1 (713) 500-7088|james.c.grotta@uth.tmc.edu|
20182821|NCT05642000|University of California San Diego|Rebecca Fielding-Miller|8583810603|rfieldingmiller@health.ucsd.edu|
20182822|NCT00172185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20182823|NCT04048135|89bio, Inc.|Clinical Director|1-858-261-8838|bio89-100-002@89bio.com|
20182824|NCT01677936|Louisville Metabolic and Atherosclerosis Research Center|Kathy Schmitz RN|502.515.5672|kschmitz@lmarc.com|
20182825|NCT03837028|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
20182826|NCT00157014|Astellas Pharma Canada, Inc|Associate Director, Scientific Affairs||clinicaltrials@us.astellas.com|
20182827|NCT01362491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191474|NCT02548754|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|4052714742|stavros-stavrakis@ouhsc.edu|
20206570|NCT00928512|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20206571|NCT04153929|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206572|NCT04083794|Spaulding Rehabilitation Hospital Cambridge|Dr. Adina E. Draghici|617-758-5508|adraghici@mgh.harvard.edu|
20206573|NCT02157168|University of Arizona|Dr. Ada Wilkinson-Lee, Co-Investigator|(520) 626-7766|adaw@email.arizona.edu|
20206574|NCT02971293|AstraZeneca|Dr Ioannis Psallidas, MD, PhD|1-877-240-9479|Information.centre@astrazeneca.com|
20206575|NCT00729326|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20206576|NCT03104985|State Scientific Center of Laser Medicine, Russia, Moscow|Sergey Moskvin|+7-905-770-1860|7652612@mail.ru|
20206577|NCT01235728|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206578|NCT02810951|Castle Creek Biosciences|Chief Medical Officer|(484) 713-6000|medinfo@castlecreekbio.com|
20206579|NCT03199638|Nemours Children's Health|Dr Dominique Darmaun, PI|904 6973674|ddarmaun@nemours.org|
20206580|NCT03097029|Children's Hospital of Philadelphia|Dr. Nina Sainath|267.426.1736|sainathn@email.chop.edu|
20206581|NCT01669642|washington university in st louis|SRI SANKAR CHINTA PI|3144544661|schinta@wustl.edu|
20206582|NCT01854593|Department of Ophthalmology, Surugadai Hospital of Nihon University|Dr. Ayumu Manabe|+81-3-3293-1711|ayumu.m76@gmail.com|429
20206583|NCT01125293|Dana-Farber Cancer Institute|Irene Ghobrial|617-632-4101|irene_ghobrial@dfci.harvard.edu|
20206584|NCT00936299|University of Colorado Denver|Paula Riggs, MD|303.724.2235|paula.riggs@ucdenver.edu|
20206585|NCT00260429|Auxilium Pharmaceuticals, Inc.|Greg Kaufman, MD; Senior Director of Clinical Development|484 321 5900|gkaufman@auxilium.com|5920
20206586|NCT00659126|Oregon Health and Science University|Amy Huddleston|5034945626|huddlesa@ohsu.edu|
20206587|NCT02228564|Becton Dickinson|Spark Yamanoglu|480-597-8604|Spark.yamanoglu@bd.com|
20206588|NCT01324687|University of Rochester|Manish N. Shah|585-276-6565|manish_shah@urmc.rochester.edu|
20206589|NCT03383627|Northwell Health|Lubaina Presswala, DO|516-708-2540|lpresswala@northwell.edu|
20206590|NCT02633046|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20206591|NCT04128527|Ambu|Signe Toräng|31267089|sito@ambu.com|
20224029|NCT01892709|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
20224030|NCT05356533|University of Washington|Jennifer Cadigan|206-543-5689|cadiganj@uw.edu|
20224031|NCT00635453|Universidade Federal de Ciências da Saúde de Porto Alegre|Dr. Marcia Vitolo|+555133038798|marciavitolo@hotmail.com|
20191475|NCT02972242|WRNMMC Cardiology|Hampton Crimm|301-295-4500|hampton.a.crimm.mil@mail.mil|
20191476|NCT03098797|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20191477|NCT00509821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191478|NCT02628964|NYU Langone Health|Donna Shelley, MD MPH|917-494-4210|donna.shelley@nyulangone.org|
20191479|NCT03443063|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20191480|NCT00552513|Population Health Research Institute|TIMACS Project Office|19055244322|timacs@phri.ca|
20191481|NCT01341444|Medstar Georgetown University Hospital|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
20191482|NCT05012280|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
20191483|NCT02229396|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20191484|NCT00082641|University of Nebraska|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
20191485|NCT03245762|University of Florida|Jennifer Miller, MD|352-265-7337|millejl@peds.ufl.edu|
20191486|NCT03935932|University of Pittsburgh|Tim Corcoran, Associate Professor|4126922210|corcorante@upmc.edu|
20191487|NCT02679079|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20191488|NCT03924947|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20191489|NCT03009019|BioDelivery Sciences (a subsidiary of Collegium Pharmaceutical)|Director, Scientific Communications|913-940-1789|tkunkel@collegiumpharma.com|
20191490|NCT01441583|Boston Scientific|Clinical Trial Manager|+18002273422|jens.goetzke@bsci.com|
20191491|NCT05376787|F2 Labs|Wendy Fuster|3013682586|wfuster@f2labs.com|
20191492|NCT05060237|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
20191493|NCT01057888|University of Rochester, Deparentment of Pediatrics|Dr. Peter Szilagyi|585 275-5798|peter_szilagyi@urmc.rochester.edu|
20191494|NCT01697592|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191495|NCT00666835|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20191496|NCT00899379|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191497|NCT01906658|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20191498|NCT01797822|Baylor College of Medicine|Stephen Pflugfelder|713-798-6100|stevenp@bcm.edu|
20191499|NCT03319719|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20191500|NCT00744796|University of Texas Southwestern Medical Center|Dr. Vinod Mootha|214-648-3837|peter.chen@utsouthwestern.edu|
20191501|NCT02581189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20191502|NCT02253147|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
20191503|NCT02223871|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure desk||clinical-trials-disclosure@idorsia.com|
20191504|NCT01939405|MGH|Dr. Nicolas Oreskovic|6177260593|noreskovic@mgh.harvard.edu|
20191505|NCT00396097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224032|NCT02091375|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20182828|NCT01257503|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
20182829|NCT02933320|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20182830|NCT01996644|Washington University|Cheri Levinson|5023456483|cherialevinson@wustl.edu|
20182831|NCT03647475|Medtronic Coronary/Renal Denervation (C/RDN)|Cecile Mahoney, Sr. Clinical Research Specialist|763-505-1057|cecile.c.mahoney@medtronic.com|
20182832|NCT04577183|RedDress Medical|Clinical Trial Manager|1-800-674-9615|alon@reddress.co.il|
20182833|NCT01721564|Royal Prince Alfred Hospital, Sydney, Australia|Prof David Celermajer|+61 2 9515 6519|david.celermajer@email.cs.nsw.gov.au|
20182834|NCT03106025|Loma Linda University Medical Center|Dr. Stephanie Tseeng|9095584000|ttseeng@llu.edu|
20182835|NCT03079375|OdenseUH|Lene V. Ravn-Nielsen clinical pharmacist|+4523467925|lene.ravn-nielsen@rsyd.dk|
20182836|NCT02321748|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20182837|NCT02072226|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20182838|NCT01492309|UPenn|Deborah Kim, MD|6107261020|drkim@upenn.edu|
20182839|NCT03255018|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20182840|NCT03557385|Duke Clinical Research Institute|Marjan Cobbaert|9196995638|mr157@duke.edu|
20182841|NCT04381494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20182842|NCT01711918|University of Iowa|Dr. Ron Schey|3193849756|ron-schey@uiowa.edu|
20182843|NCT02749045|University of Pittsburgh Medical Center|Prem Soman, MD, PhD|412 647 3435|somanp@upmc.edu|
20182844|NCT00507208|University of Alabama at Birmingham|William Carroll, MD|205-934-9713|wcarroll@uabmc.edu|
20182845|NCT02002819|UCLA Mary S. Easton Center for Alzheimer's Disease Research|Dr. Keith Vossel|310-794-3665,|neuroeaston@mednet.ucla.edu|
20182846|NCT02243007|Massachusetts General Hospital|David P. Ryan, MD|6177240245|dpryan@mgh.harvard.edu|
20182847|NCT02950545|University of Virginia|Principal Investigator|434-924-8021|djc4f@virginia.edu|
20182848|NCT03101592|David Geffen School of Medicine at UCLA|Dr. Risa Hoffman, MD, MPH; Director of GHP; Associate Professor of Clinical Medicine|310 825-7225|rhoffman@mednet.ucla.edu|
20182849|NCT03398356|Wroclaw Medical University|Dr Edyta Sutkowska|+48/503077016|edytasutkowska@yahoo.com|
20182850|NCT01522339|Cincinnati Children's Hospital Medical Center|Jean Tkach|513-636-7166|jean.tkach@cchmc.org|
20182851|NCT00647348|University of London|Professor Jeremy Chataway, Chief Investigator|07974752295|j.chataway@ucl.ac.uk|
20182852|NCT00619151|Sorin Group USA, Inc.|Barbara Mathews Director Clinical and Medical Affairs|512-435-3602|Barbara.mathews@sorin.com|
20182854|NCT02775617|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
20182855|NCT02419521|Medtronic Coronary Structual Heart|Beth Moe, Clinical Study Manager||beth.moe@medtronic.com|
20182856|NCT01941316|Cancer Research and Biostatistics|Director of Quality and Regulatory Compliance|206-839-1782|lisau@crab.org|
20182857|NCT02775435|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20182858|NCT00100659|Johns Hopkins University School of Medicine|Kathleen B. Schwarz, M.D.|410-955-8769|kschwarz@jhmi.edu|
20182859|NCT04555044|Organization: Baxter Healthcare|Name/Official Title: Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20182860|NCT01675830|Boston Children's Hospital|Karen Sakakeeny|617-355-6369|Karen.Sakakeeny@childrens.harvard.edu|
20182861|NCT05487703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182862|NCT02403323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20182863|NCT03582956|Yale University|Michelle Van Name|2037855831|michelle.vanname@yale.edu|
20182864|NCT00197236|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182865|NCT03885596|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
20182866|NCT03360422|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
20182867|NCT01835899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20182868|NCT02616263|Washington University in St. Louis, School of Medicine, Program in Physical Therapy|Dr. Mary Hastings, Professor|3142107108|hastingsmk@wustl.edu|
20182869|NCT01859195|The Miriam Hospital|Principal Investigator|401-793-4775 or 401-793-8180|scu-uvin@lifespan.org; kate.guthrie@lifespan.org|
20182870|NCT05015478|Icahn School Of Medicine at Mount Sinai|Mariana Figueiro PhD|212-241-6500|Mariana.Figueiro@mountsinai.org|
20182871|NCT04319094|Mass General Hospital|Dr. Jin hui Joo|410-724-5317|jhjoo@mgh.harvard.edu|
20182872|NCT04081545|Virginia Mason Medical Center|Christine Oryhan|206-223-6980|christine.oryhan@virginiamason.org|
20182873|NCT00654238|Abramson Cancer Center at the University of Pennsylvania|Dr. Marcia Brose|215-746-6344|brosem@mail.med.upenn.edu|
20182874|NCT00614744|Brown University, Women & Infants Hospital of Rhode Island|Abbot Laptook|401-274-1122|alaptook@wihri.org|47421
20182875|NCT02141581|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20182876|NCT02414828|Aeras|Ann Ginsberg, Chief Medical Officer|301-547-2912|aginsberg@aeras.org|
20182877|NCT01779375|George Washington University Biostatistics Center|Sharon Edelstein|3018819260|sharone@bsc.gwu.edu|
20182878|NCT01245413|Lægehuset, Skodsborg Strandvej 125A, 2942 Skodsborg, Denmark|Dr. Claus Hyldahl|4545801331|hyldahl@info.dk|
20191506|NCT03461211|Horizon Pharma USA, Inc.|Roxann Becco|866-479-6742|clinicaltrials@horizontherapeutics.com|
20191507|NCT03807700|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191508|NCT02720081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191509|NCT03209050|mmc medical international services|Clinical Research Organization and Trial Manager|9492805700|laura22@mmc-medical.com|
20191510|NCT02316847|SK Bio-pharmaceuticals Co, Ltd|MinJae Lee, Associate Manager||minj.lee@sk.com|
20191511|NCT00397020|UCSD Medical Center|Dr. David Feifel|619-543-2485|dfeifel@ucsd.edu|
20191512|NCT03371485|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20191513|NCT00349388|Atlantic Health System|Dr. Joel Rosh|973-971-5676|joel.rosh@atlantichealth.org|
20191514|NCT01061775|Children's Hospitals and Clinics of Minnesota|Dr. Jennifer Abuzzahab|651-220-6867|jennifer.abuzzahab@childrensmn.org|
20191515|NCT02567227|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
20191516|NCT03746483|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589-7020|info@firstwavebio.com|
20191517|NCT04349124|Duke University|Brenna Hughes, M.D.|919-668-0843|brenna.hughes@duke.edu|
20191518|NCT02498418|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20191519|NCT00957671|University of Texas Medical Branch|Randall Urban, MD|409-772-1176|rurban@utmb.edu|
20191520|NCT01026103|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
20191521|NCT00762502|Johnson & Johnson Vision Care, Inc.|John Buch, OD|1-904-443-1707|RA-Visus-ClnclStds@its.jnj.com|
20191522|NCT00924209|National Cancer Institute, National Institutes of Health|Caryn Steakley, Deputy Clinical Director|240-858-3749|steaklec@nih.gov|
20191523|NCT02625922|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20191524|NCT01518517|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
20191525|NCT01239056|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20191526|NCT03840148|Venatorx Pharmaceuticals, Inc.|Paul McGovern, MD|484-329-8615|mcgovern@venatorx.com|
20191527|NCT03615404|Duke University Medical Center|Principal Investigator|919-684-0000|pedsneuronc@duke.edu|
20191528|NCT00257556|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20191529|NCT01074034|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
20191530|NCT03849300|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20191531|NCT01774929|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
20191532|NCT04839289|Sonova USCS|Lisa Standaert|331-702-0173|lisa.standaert@phonak.com|
20191533|NCT01544153|Truth Initiative|Amanda L. Graham, PhD|202-454-5938|agraham@truthinitiative.org|
20191534|NCT02127892|Children's Hospital Los Angeles|Neena Kapoor, M.D.|323-361-2546|nkapoor@chla.usc.edu|
20191535|NCT00390806|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191536|NCT01879735|Dept. of Nuclear Medicine & PET-center, Dept. of Hepatology and Gastroenterolgy. Aarhus University Hospital|Susanne Keiding M.D., Associate professor, D.Sc.|+45 7846 3031|susanne@pet.auh.dk|
20191537|NCT00884793|UCSF|Steven Yukl|415-221-4810|steven.yukl@ucsf.edu|3930
20191538|NCT03169530|Beth Israel Deaconess Medical Center|Kenneth Mukamal, MD, MPH|617 754-1401|kmukamal@bidmc.harvard.edu|
20191539|NCT01032200|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20191540|NCT00067808|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026||
20191541|NCT00727259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191542|NCT01021683|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
20191543|NCT00663923|Tabriz University of Medical Sciences|Mohammad R sedghipour,MD|+98 411 3306619|sedghipm@yahoo.com|
20191544|NCT02319304|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
20191545|NCT01804140|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20191546|NCT02785900|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20191547|NCT00547300|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20191548|NCT01596699|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
20191549|NCT04130061|University of Utah|Vikas Sharma, MD|801-581-5311|vikas.sharma@hsc.utah.edu|
20191550|NCT02270463|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|1-877-332-7967|clinicaltrials@menarinistemline.com|
20191551|NCT04990973|Columbia University Irving Medical Center|Dr. Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
20191552|NCT00637247|AmpliMed Corporation|Robert Dorr|520-626-7892|bdorr@azcc.arizona.edu|
20191553|NCT00111839|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
20191554|NCT02312622|Stanford University|Joel W. Neal, MD PhD, Assistant Professor of Medicine (Oncology)|(650) 498-4696|jwneal@stanford.edu|
20191555|NCT00871143|Institute of Psychiatry|Dr. David Veale|0203 228 3461|david.veale@kcl.ac.uk|
20191556|NCT02499835|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD|608-263-4198|dm3@medicine.wisc.edu|
20191557|NCT05109117|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20191558|NCT01751451|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher, MD|646-888-4878|scherh@MSKCC.ORG|
20191559|NCT03972137|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
20191560|NCT02973477|University of Michigan|Lynn Ang|734-232-8058|angly@med.umich.edu|
20191561|NCT05110014|Wake Forest Baptist Health Sciences|Study Coordinator|336-713-3103|eswright@wakehealth.edu|
20191562|NCT01860807|UCLA|Keith Heinzerling MD|310-319-4700|kheinzerling@mednet.ucla.edu|
20191563|NCT01947153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191564|NCT02381652|Anika|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
20224033|NCT05896527|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20224034|NCT02355821|RGNKC|Ekaterina Dudinskaya, head of age-related metabolic and endocrine disorders laboratory|+79031914690|katharina.gin@gmail.com|
20224035|NCT00507819|The Children's Hospital of Philadelphia|David J. Goldberg, MD|267-426-8143|goldbergda@email.chop.edu|
20224036|NCT01187771|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
20191565|NCT01340300|Dana-Farber Cancer Institute|Meyerhardt, Jeffrey,M.D.,M.P.H.|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
20224037|NCT03261674|VA Palo Alto|Dr Ansgar Furst; Rayma Williams|(650) 339-4015|ansgar.furst@va.gov; rayma.williams@va.gov|
20224038|NCT01883817|University of Cincinnati|Director Clinical Research Management|513-558-8621|gayathri.kavikondala@uc.edu|
20224039|NCT02045862|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
20224040|NCT00623935|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
20224041|NCT03961061|Wake Forest Health Sciences|Justin B. Moore, PhD|336-716-3702|jusmoore@wakehealth.edu|
20162768|NCT02540993|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20162769|NCT00844558|University of Iowa|Neil Segal|3193560737|segal-research@uiowa.edu|
20162770|NCT00588094|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
20162771|NCT04569357|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20162772|NCT03514433|Boston Medical Center|Tracy A Battaglia, MD, MPH|617 638 7428|Tracy.Battaglia@bmc.org|
20162773|NCT02202538|Parker Hannifin Corporation|Ryan Farris|(216) 896-3335|ryan.farris@parker.com|
20162774|NCT01457846|Astrazeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
20162775|NCT01846741|Cyberonics, Inc.|Bita Najimipour, Clinical Study Manager|(281) 228-7370|bita.najimipour@cyberonics.com|
20162776|NCT01853878|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162777|NCT03997825|Relievant Medsystems|Diane Sahr, VP of Clinical Research|(650) 368-1000|dsahr@relievant.com|
20162778|NCT00383162|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162779|NCT00767819|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20162780|NCT01153698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20162781|NCT01323140|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20182879|NCT05968079|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20182880|NCT02738840|Abbott|Robyn A Capobianco|+1 512 934 3941|robyn.capobianco@abbott.com|
20182881|NCT01801449|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Montealegre, Gina|+1 301 761 7747|montealegrega@mail.nih.gov|
20182882|NCT01171924|Curis, Inc.|Associate Director of Regulatory Affairs|(617) 503-6548|lsaunders@curis.com|
20182883|NCT00256308|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
20182884|NCT02165605|UT Southwestern Medical Center|Sarmistha Sen|214-645-1477|Sarmistha.Sen@UTSouthwestern.edu|
20182885|NCT00762463|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182886|NCT00531479|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224042|NCT04507256|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20224043|NCT00631410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224044|NCT00979875|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
20224045|NCT01945970|Unilever R&D Research Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@gmail.com|
20224046|NCT00782184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224047|NCT02738879|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224048|NCT00890084|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224049|NCT01438294|Universidade Nove de Julho|Evelim Leal de Freitas Dantas Gomes, PhD PT|5511976333349|evelimfreitas@hotmail.com|
20224050|NCT01346189|University of Pennsylvania and Department of Veteran Affairs|Dr. Kevin G. Volpp||volpp70@wharton.upenn.edu|
20224051|NCT03330262|Barron Associates|Principal Research Scientist|434-973-1215|barron@barronassociates.com|125
20162782|NCT03029091|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513 636-7177|marc.rothenberg@cchmc.org|
20162783|NCT00604045|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
20182887|NCT03766438|Mayo Clnic|Mark Wieland, MD, MPH|507-284-1195|wieland.mark@mayo.edu|
20182888|NCT04358549|FUJIFILM Pharmaceuticals U.S.A., Inc.|Clinical Research Manager|No phone at site|fphucontact@fujifilm.com|
20182889|NCT02909439|Stony Brook Medicine|Ramon Abola, Clinical Associate Professor|631-444-2975|ramon.abola@stonybrookmedicine.edu|
20182890|NCT00785772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182891|NCT04867902|Massachusetts General Hospital|Dr. Emily Feig|617-724-9140|efeig@mgh.harvard.edu|
20182892|NCT05355116|University of Winchester|Dr James Belsey|(+44) 07799040556|KneeResearch@pm.me|
20182893|NCT02501629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20182894|NCT02004613|Cleveland Clinic Foundation|Dr. Alparslan Turan|216-445-9857|turana@ccf.org|
20191566|NCT01656486|Carolinas Medical Center|David Iannitti, MD|704-446-2772|david.iannitti@carolinashealthcare.org|
20191567|NCT02642159|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20191568|NCT04194541|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
20191569|NCT00588341|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|(646) 888-4162|chapmanp@mskcc.org|
20191570|NCT01954771|Beijing Anzhen Hospital|Dr.Yingsheng Zhou|0086-010-64456185|zys626@aliyun.com|
20191571|NCT02886234|The Miriam Hospital|Dr. Michael Carey|401793-8218|michael_carey@brown.edu|
20162784|NCT00465647|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
20182895|NCT00868231|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20182896|NCT03120676|Memorial Sloan Kettering Cancer Center|Dr. Anas Younes, MD|212-639-5059|younesa@mskcc.org|
20191572|NCT03635775|University of Wisconsin Madison|Bernadette Gillick|612-625-3645|bgillick@wisc.edu|
20182897|NCT01168401|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
20182898|NCT00672256|Duke University Medical Center|Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
20182899|NCT01801930|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20182900|NCT01335789|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5216|mcraeal@musc.edu|
20182901|NCT03783533|University of Washington|Dr. Jessica Jenness|206-616-7967|jennessj@uw.edu|
20224052|NCT00205868|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20224053|NCT01075646|Department of Anesthesia, Reanimation Bellvitge University Hospital|Noelia Fustran|932607323|nfustran@bellvitgehospital.cat|
20224054|NCT01730534|AstraZeneca|Global Study Leader|+49 4103 708 3792|Sandra.ranft@astrazeneca.com|
20224055|NCT01520558|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
20224056|NCT01676896|UTexasAustin|Sharon Horner|512-471-7951|shorner@mail.nur.utexas.edu|
20224057|NCT01647516|Celgene Corporation|Anne McClain, Senior Manager|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
20224058|NCT01323595|Weill Cornell Medical College|Chairman, Department of Urology|212 746-5491|pnschleg@med.cornell.edu|
20224059|NCT01613222|GEHealthcare|Jeffrey Conner|414-477-8374|Jeffrey.Conner@ge.com|
20224060|NCT01895608|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
20224061|NCT03505593|ENvizion Medical|Clinical Director|+972-72-2288240|anath@envizionmed.com|
20224062|NCT02319174|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
20224063|NCT00405522|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
20224064|NCT02855359|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20224065|NCT03155178|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
20224066|NCT04712019|3M|Biostatistics Manager|651-382-2876|swalters@mmm.com|
20224067|NCT04525079|Celltrion Inc|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
20224068|NCT02347891|Northwell Health|Principal Investigator|5167082550|gmarder@northwell.edu|
20224069|NCT02195310|KCI Europe Holding B.V.|Daniela Weichert, PhD|+353 (0) 860436155|daniela.weichert@acelity.com|
20224070|NCT02541669|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20224071|NCT04739722|Geneoscopy Inc.|Chief Medical and Science Officer|314-887-7777|contact@geneoscopy.com|
20224072|NCT00834639|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20162785|NCT04118595|University of North Carolina at Chapel Hill|Michelle Meyer, PhD|919-966-6539|mlmeyer@unc.edu|
20162786|NCT04146935|Yale School of Medicine|Dr. Karl Insogna|203-785-3272|karl.insogna@yale.edu|
20162787|NCT01371305|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20162788|NCT04038567|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
20162789|NCT02220712|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20162790|NCT03533244|Allgenesis Biotherapeutics|Tan Nguyen|+886-2-8787-1232|tan.nguyen@allgenesis.com|
20162791|NCT00760838|Ghent University Hospital|dr. Brusselle Guy|003293322604|guy.brusselle@uzgent.be|
20162792|NCT01817959|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20162793|NCT04450329|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20162794|NCT03937960|University of Alabama at Birmingham|Dr. Bhuvana Sunil|2056389107|dr.bhuvana.s@gmail.com|
20162795|NCT02561221|Pennington Biomedical Research Center|Dr. Peter T. Katzmarzyk, Associate Executive Director of Population and Public Health Sciences|225-763-2536|doctors@pbrc.edu|
20162796|NCT02387008|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidget_jenkins@unc.edu|
20162797|NCT03368235|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20162798|NCT04356352|Wake Forest University Health Sciences|Michael Norton, MD|336-716-8791|mnorton@wakehealth.edu|
20162799|NCT00781859|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
20162800|NCT01138501|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20162801|NCT00622388|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162802|NCT00348309|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162803|NCT01743040|UCLA Biomed|Joseph Thomas, MD|310-222-2544|jthomas@labiomed.org|
20162804|NCT01894243|AstraZeneca|Anitra Fielding - Senior Research Physician||ClinicalTrialTransparency@astrazeneca.com|
20162805|NCT00828750|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162806|NCT04006392|Erchonia Corporation|Clinical Affiairs|888.242.0571|tsammons@erchonia.com|501
20162807|NCT01299116|FHI 360|Dr. David Hubacher|919 544 7040|dhubacher@fhi360.org|11223
20162808|NCT01620944|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20162809|NCT04378114|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
20162810|NCT00830180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162811|NCT01832532|Cincinnati Children's Hospital Medical Center|Raouf Amin, MD|(513) 636-7945|Raouf.Amin@cchmc.org|
20162812|NCT00392990|Northwestern University|Leo Gordon, MD||l-gordon@northwestern.edu|
20162813|NCT04331002|University of Kentucky|Dr. Austin Stone|859-218-3131|austin.stone@uky.edu|
20162814|NCT01078844|Johns Hopkins University School of Medicine|Eric Samstad, MD|410-550-0171|esamsta1@jhmi.edu|
20182902|NCT00360126|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182903|NCT00810303|Department of Clinical Pharmacology|Danilo Wegner|+4903834865640|dwegner@uni-greifswald.de|
20162815|NCT00991406|Cleveland VAMC|Elizabeth Hardin|216-791-3800|Elizabeth.HardinvandenBogert@va.gov|4698
20182904|NCT01720043|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
20224073|NCT01783639|Gardia Medical|Dr. Vardit Segal|+972-4-6277166|Vardit@Gardiamedical.com|106
20224074|NCT03729570|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
20224075|NCT00805870|Western Michigan University|Dr. Christopher C. Cheatham|269-387-2542|chris.cheatham@wmich.edu|
20224076|NCT00278148|Case Comprehensive Cancer Center|Dr. Nathan Pennell|21684459281|penneln@ccf.org|
20224077|NCT03998163|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20224078|NCT02083185|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20224079|NCT03419598|University of Bath|Professor Richie Gill|01225 383627|r.gill@bath.ac.uk|
20191573|NCT05562583|Northwestern University|Judith Tedlie Moskowitz|312-503-7712|judith.moskowitz@northwestern.edu|
20191574|NCT01675050|University of Michigan|Ismaeel Hashemi, M.D. Principal Investigator|6169165566|ismaeel.hashemi@gmail.com|
20191575|NCT01961921|Alnylam Pharmaceuticals Inc|Chief Medical Officer|1-877-256-9526|Clinicaltrials@alnylam.com|
20191576|NCT01820637|Boston Scientific|Lieve Cornelis, Clinical Trial Manager|+ 32 476-840-183|Lieve.Cornelis@bsci.com|
20191577|NCT00583115|Indiana University|Ronald Mark Payne MD|317-278-6329|rpayne@iu.edu|
20191578|NCT00264498|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20191579|NCT02382406|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20191580|NCT04543942|The Ohio State University|Dr. Jessica Weafer|859-533-9878|jessica.weafer@osumc.edu|
20191581|NCT00179478|University of California San Diego|Revere P Kinkel MD (PI)|619-543-5295|rkinkel@ucsd.edu|
20191582|NCT00360971|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20191583|NCT02520414|Boston Scientific|Meaghan Wilk Clinical Project Manager|5086834113|meaghan.wilk@bsci.com|
20191584|NCT02506881|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20191585|NCT00741468|Repros Therapeutics Inc.|Jennifer Wike|281-719-3402|jwike@reprosrx.com|
20191586|NCT03722836|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
20191587|NCT02391545|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20191588|NCT02016690|AbbVie|Global Medical Services|800-633-9110||
20191589|NCT01222078|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191590|NCT05756348|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
20191591|NCT01363297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191592|NCT00495612|Genentech, Inc.|Medical Communications|800 821-8590||
20191593|NCT02189122|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
20191594|NCT02264353|University of California, San Diego|Atul Malhotra, MD|(858) 657-6159|amalhotra@ucsd.edu|
20191595|NCT04896502|Arkansas Children's Hospital|Robbie Pesek, MD|501-364-3149|rdpesek@uams.edu|
20191596|NCT02656745|Click Therapeutics|Director of Scientific Affairs|646-844-2158|brian@clicktherapeutics.com|
20191597|NCT03340766|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20191598|NCT03847389|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|4073231887|nini.ramirez@hillderm.com|
20191599|NCT02864147|Clinical Research Team Leader, Gynecologic Oncology, Yale Cancer Center|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
20191600|NCT02269917|Janssen Research & Development|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20191601|NCT00240097|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
20191602|NCT02383927|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-001@kuraoncology.com|
20191603|NCT00818519|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20191604|NCT00981578|InSightec|Nadir Alikacem|214.360.2000|nadira@insightec.com|
20191605|NCT02865135|Dana Farber Cancer Institute (DFCI)|Kartik Sehgal, MD|617-632-3090|Kartik_Sehgal@dfci.harvard.edu|
20191606|NCT01393314|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
20191607|NCT04374019|University of Kentucky|Susanne Arnold MD|8592579568|smarno0@uky.edu|
20191608|NCT01180790|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20191609|NCT00655668|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20191610|NCT02335242|Stanford University|Jean Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
20191611|NCT03873038|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191612|NCT04222088|Research Institute for Tropical Medicine|Dr. Fe Esperanza Caridad J. Espino|63288072628|fe.espino2019@gmail.com|343
20191613|NCT00595764|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
20191614|NCT00585910|Massachusetts General Hospital|Kerry Brodziak|617-503-1043|kbrodziak@partners.org|
20191615|NCT00464737|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20191616|NCT02825849|UCSF|Heather Huddleston|415-353-3040|heather.huddleston@ucsf.edu|
20191617|NCT00789399|Prairie Education and Research Cooperative|Chief Operating Officer|217 492 9104|jchambers@prairieresearch.com|
20191618|NCT00580047|University of Nebraska Medical Center|Lynn Mack|402-559-6208|lmack@unmc.edu|
20191619|NCT02820298|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20224080|NCT00570349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20224081|NCT00985959|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
20224082|NCT03055494|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20224083|NCT05443594|Boston Scientific|Thomas Stoltz|651-582-4000|Thomas.Stoltz@bsci.com|
20224084|NCT03197467|AIO-Studien-gGmbH|AIO-Studien-gGmbH Help Desk|0049-30-8145344|info@aio-studien-ggmbh.de|31
20224085|NCT06229132|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
20191620|NCT01189136|Women & Infants Hospital of Rhode Island|Charles R. Rardin, MD|401 453-7560|crardin@wihri.org|
20191621|NCT01894256|AstraZeneca|Dr Anitra Fielding|+44 1625 582828|anitra.fielding@astrazeneca.com|
20191622|NCT00546884|University of Minnesota|John Song MD MPH MAT|612-624-8936|songx006@umn.edu|
20191623|NCT00141271|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20191624|NCT02133131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20162816|NCT03824587|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20191625|NCT02316171|Viralytics|Mark Grose|+1 905 593 2891|Mark.Grose@viralytics.com|
20162817|NCT00986362|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
20162818|NCT01300572|Fred Hutchinson Cancer Research Center|Brenda Sandmaier, MD|(206) 667-4961|bsandmai@fredhtuch.org|
20162819|NCT02160145|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Devlopment|609 524 6788|clinicaltransparency@otsuka-us.com|
20162820|NCT02006979|University of Alberta|Dr. Amy Kirkham, Postdoctoral Research Fellow|7804926874|amy.kirkham@ualberta.ca|
20162821|NCT00375518|Memorial Sloan Kettering Cancer Center|Dr. David Amar|212-639-6798|amard@mskcc.org|
20162822|NCT03170193|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20162823|NCT06037408|Emphycorp, Inc.|Dr. Alain Martin|(908) 237-1561|al.martin.hq@emphycorp.com|
20162824|NCT03052816|UH Hospitals Cleveland Medical Center/MetroHealth Medical Center at time of study protocol|Andrey Petrikovets MD|323 243 9091|andrepetrikovets@yahoo.com|
20162825|NCT01211340|University of Missouri|Debra Parker Oliver|573-884-5301|oliverdr@missouri.health.edu|
20162826|NCT03755661|Boston University|LaNeia Thomas|617-358-6346|laneia@bu.edu|
20182905|NCT01516892|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20182906|NCT03613129|Bateman Horne Center|Lucinda Bateman, MD|(801) 359-7400|LBateman@batemanhornecenter.org|
20182907|NCT00938340|Penn State University|Penny Kris-Etherton||pmk3@psu.edu|
20182908|NCT00711646|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20191626|NCT01772147|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224086|NCT01296542|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
20224087|NCT04338269|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20224088|NCT03681990|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
20224089|NCT02424630|Chuncheon Sacred Heart Hospital|Dr Jung-Taek Hwang|82 33 240 5197|drakehjt@hanmail.net|
20224090|NCT02031640|Teva Branded Pharmaceutical Products, R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20224091|NCT01895270|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
20224092|NCT03085238|MTrap|Vice President, RA/QA/CA|3013258537|cmitchell@m-trap.com|
20224093|NCT01279070|Parc Sanitari Sant Joan de Déu|Dr. Aida Farreny|+34 936406350|afarreny@pssjd.org|2373
20224094|NCT01741792|Amgen, Inc.|Study Director|866-572-6436||
20224095|NCT00761280|Isarna Therapeutics GmbH, formerly Antisense Pharma GmbH|Medical Officer|+49-89-890831|info@isarna-therapeutics.com|0
20224096|NCT00949403|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20182909|NCT00269399|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
20182910|NCT03441360|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20182911|NCT03396835|Masimo Corporation|Tala Harake|949-297-7137|studies@masimo.com|
20182912|NCT01451814|Brown University School of Public Health|Dr. Christopher Kahler|401 863-6651|Christopher_Kahler@brown.edu|
20182913|NCT03439124|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
20182914|NCT02467491|University of Florida|Dr. Vincenzo Valiani|352-2835906|vincio86@gmail.com; v.valiani@ufl.edu|
20182915|NCT04353037|UnitedHealth Group R&D / Optum Labs|Mike Lahm, Director Data Science|302-379-0209|MichaelLahm@uhg.com|
20182916|NCT03710564|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20182917|NCT02993471|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20182918|NCT04939428|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20182919|NCT05096117|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|3014430788|falkde@mail.nih.gov|
20182920|NCT00877851|Queen's University, Belfast|Prof Michelle McKinley|+44(0)2890632685|m.mckinley@qub.ac.uk|
20182921|NCT03424239|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|ewyu@mgh.harvard.edu|
20182922|NCT00770211|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
20182923|NCT02982928|Nationwide Children's Hospital|Ahsan Syed, MD|614-722-4200|Ahsan.Syed@nationwidechildrens.org|
20182924|NCT00318656|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182925|NCT01446003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224097|NCT02256982|Massachusetts General Hospital|Ted Hong, MD|617-726-6050|tshong1@partners.org|
20224098|NCT03614078|PRCL Research Inc|Caroline Fortier|1-514-708-4417|caroline.fortier@prclresearch.com|
20224099|NCT03886519|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
20224100|NCT04964544|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20224101|NCT03875274|BPKIHS|Dr. Pankaj Baral|9856037077|pankajbaral7@gmail.com|
20224102|NCT03829618|Penn State Hershey Medical Center|Zoulfira Nisnevitch-Savarese, M.D.|717-531-6597|znisnevitchsavarese@pennstatehealth.psu.edu|
20224103|NCT02833844|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20224104|NCT05129475|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224105|NCT01899742|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224106|NCT02662764|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20224107|NCT04874233|Prism Clinical Research|Amy Eastenson, MD|1-651-641-2900|aeastenson@prismresearchinc.com|
20224108|NCT00387751|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
20224109|NCT02809859|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|7044
20224110|NCT00089778|National Cancer Institute (NCI), National Institutes of Health (NIH)|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
20224111|NCT00177307|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
20224112|NCT01104246|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20224113|NCT04789291|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224114|NCT03783130|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20224115|NCT01867294|Mayo Clinic|Aminah Jatoi, M.D.|507.284.1623|jatoi.aminah@mayo.edu|
20224116|NCT01223469|St. Jude Medical/Endosense|Hendrik Lambert PhD, VP of Clinical and Regulatory Affairs||Hendrik.Lambert@endosense.com|
20224117|NCT00380081|Purdue Pharma LP|Clinical Leader|800-733-1333||
20224118|NCT00070018|SWOG Statistical Center|Study Statistician|206-667-4623||
20224119|NCT04756128|Methodist Hospital|Daniel Delaney, PharmD|952-993-5442|daniel.delaney@parknicollet.com|
20224120|NCT00669552|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
20224121|NCT00574249|Abbott|Medical Information Specialist|1-800-633-9110||
20224122|NCT03197870|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
20224123|NCT01508130|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20224124|NCT01680159|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20224125|NCT02200536|Damascus University|Assistant Professor Easter Joury|00963955650456|easterjoury@icloud.com|
20224126|NCT02783729|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20224127|NCT05600270|Lahey Hospital and Medical Center|Neev Mehta|781-744-1933|neev.n.mehta@lahey.org|
20224128|NCT04021121|University of California, San Francisco|Dr. Felicia Chow|(628) 206-4449|felicia.chow@ucsf.edu|
20224129|NCT02458768|LG Life Sciences|Jonghee Jin|82-2-6924-3122|jonghee@lgls.com|
20224130|NCT02288091|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
20224131|NCT02773212|University of Illinois at Chicago|Dr. Margaret Wardle|(312)413-5564|mwardle@uic.edu|
20224132|NCT01330394|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
20224133|NCT03843632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182926|NCT03905135|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
20182927|NCT02806895|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20182928|NCT02042443|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408||
20182929|NCT02735187|Philips Light & Health|Dr. Joerg Liebmann|+ 49-(0)1733715907|joerg.liebmann@philips.com|
20182930|NCT01007149|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182931|NCT02784704|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
20182932|NCT01913340|University of California San Francisco|Yvonne Wu, MD MPH||wuy@ucsf.edu|
20182933|NCT05010304|University of Texas Southwestern|Dr Timothy Chow|2144569093|timothy.chow@utsouthwestern.edu|
20182934|NCT03568162|Ichnos Sciences SA|Ichnos Sciences Clinical Trials Administrator|315-583-1249|clinicaltrials@ichnossciences.com|
20182935|NCT00768066|The EMMES Corporation|Adam Mendizabal, Biostatistician|301-251-1161|amendizabal@emmes.com|221
20182936|NCT04831775|The University of Texas at Austin|Dr. Heather Cuevas|5124226059|hcuevas@mail.nur.utexas.edu|
20182937|NCT00337818|GlaxoSmithKline|GSK Response Center|866-435-7343||
20182938|NCT00336232|Tufts University|Sarah Booth, PhD|617-556-3231|sarah.booth@tufts.edu|
20182939|NCT04783415|City of Hope Medical Center|Dr. Alexey Danilov|626-359-8111|adanilov@coh.org|
20182940|NCT03115346|VA Hospital|Dr. Mark Eid|502-295-8961|mark.a.eid01@gmail.com|
20182941|NCT01796977|Halyard Health, Inc.|Director of Clinical Affairs|470-448-5352|david.curd@hyh.com|
20182942|NCT02376933|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
20182943|NCT00389519|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
20182944|NCT03425539|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
20182945|NCT01080131|Novartis Pharmaceuticals|Study Director|862 778-8300||
20182946|NCT02014558|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20182947|NCT05579886|CooperVision Inc.|José A. Vega OD, MSc, FAAO, PhD|19256213761|javega@coopervision.com|
20182948|NCT00299702|Ortho-McNeil, Inc. N America Pharm CNS/IM|Therapeutic Area Lead|609-730-3693||
20182949|NCT01560949|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|(713) 792-2828|gvaradha@mdanderson.org|
20182950|NCT00751036|Novartis Pharmaceuticals|Study Director|862-778-8300||
20182951|NCT04580407|Director|Study|+1-877-825-3327|TrialDisclosures@takeda.com|
20182952|NCT03921528|Scholar Rock|Clinical Trials Coordinator|833-724-7625|clinicaltrials@scholarrock.com|
20182953|NCT02530151|Northwestern University|Michael Terry, MD|312-472-6488|mterry@nm.org|
20182954|NCT01562743|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-6361-7366||
20182955|NCT01374490|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20182956|NCT04155424|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20191627|NCT02025647|NCS Pearson|Dr. Paul E Williams, Sr. Research Director|952-681-4553|paul.e.williams@pearson.com|
20182957|NCT02449044|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20182958|NCT02162446|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20182959|NCT03618095|Boston Scientific|Amy Maurer|800-876-9960|amy.maurer@bsci.com|
20224134|NCT03403751|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
20224135|NCT05036668|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20182960|NCT05526911|TB Alliance|Antonio Lombardi|917.601.0024|antonio.lombardi-consultant@tballiance.org|
20224136|NCT02105246|San Francisco VA Healthcare System|Dr. Mary Whooley|415-221-4810|mary.whooley@va.gov|
20224137|NCT01623037|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulaory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20224138|NCT00789256|Dartmouth-Hitchcock Medical Center|Marc Gautier, MD - Principal Investigator|603-650-5529|marc.gautier@hitchcock.org|
20224139|NCT00471718|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
20224140|NCT01446237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224141|NCT01931956|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
20224142|NCT02272842|Innlandet Hospital Trust|Tor Strand|+4790971086|tors@me.com|
20224143|NCT02663102|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20224144|NCT04089904|University of Chicago|Theodore Karrison (Research Professor)|7737029326|tkarrison@health.bsd.uchicago.edu|
20224145|NCT00321698|Portland VAMC|Dr. Mark Garzotto|541-728-0665|garzotto@ohsu.edu|
20224146|NCT03666533|Department of Veterans Affairs Northeast Ohio Healthcare system|Dr. Svetlana Pundik|216-791-3800|svetlana.pundik@va.gov|63732
20224147|NCT02017717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20224148|NCT04488419|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
20224149|NCT03339726|JNJWorldwide|Steven Sacavage, PharmD, Associate Director, Global Pain & Allergy Clinical Research|215 273-8568|ssacavag@its.jnj.com|8568
20224150|NCT02210247|Pacira Pharmaceuticals Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20224151|NCT03960021|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20224152|NCT02203851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20224153|NCT04630249|The Medical University of South Carolina|Constance Guille|843-792-6489|guille@musc.edu|
20224154|NCT02817698|Yale University|Marc Grasso|2037377074|marc.grasso@yale.edu|
20182961|NCT05025449|Emory University|Laura Oh, MD|404-778-1709|laura.oh@emory.edu|
20182962|NCT01537133|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
20182963|NCT03379740|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20182964|NCT01260662|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
20182965|NCT03049111|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
20182966|NCT00248612|Center for Anxiety and Related Disorders at Boston University|Todd J. Farchione, PhD|617 353 9610|tfarchio@bu.edu|
20182967|NCT00991276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182968|NCT01268891|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20182969|NCT03615001|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
20182970|NCT01688973|City of Hope National Medical Center|Przemyslaw W. Twardowski, MD|626-256-4673|ptwardowski@coh.org|68218
20182971|NCT01124162|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20182972|NCT02022462|University of Southern California|Dr. John Brekke|213-740-0297|brekke@usc.edu|
20224155|NCT02360631|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
20182973|NCT01702896|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20182974|NCT04371536|Baylor College of Medicine|Dr. Jacquelyn Powers|832-824-7330|jmpowers@txch.org|
20182975|NCT00908947|BD/Bard|Talar Saber, Senior Project Manager, Clinical Affairs|1.480.379.2839|Talar.Saber@crbard.com|
20182976|NCT02712099|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20182977|NCT02534896|SPARC|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
20182978|NCT02796092|GITMI (University of Zaragoza)|Prof. Alicia Laborda|0034 976 76 15 49|alaborda@unizar.es|
20182979|NCT02446223|Cosmetic Laser Dermatology/West Dermatology Research|Clinical Research Coordinator|858 657 1004|IGuiha@CLderm.com|
20182980|NCT00920686|NeurAxon, Inc|Thomas Lategan, PhD|417 673 6697|tlategan@neuraxon.com|
20182981|NCT03006341|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20182982|NCT00742274|W.L. Gore and Associates|Jennifer Gorman|928-864-3381|jgorman@wlgore.com|
20182983|NCT00073957|Beth Israel Deaconess Medical Center|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
20182984|NCT02219490|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20182985|NCT02347917|Sumitomo Dainippon Pharmaceutical|Clinical Research (Oncology)|e-mail only|cc@ds-pharma.co.jp|
20182986|NCT02974010|NeuroRx|Martin Brecher|+1 484 254 6134|mbrecher@neurorxpharma.com|
20182987|NCT02280655|Emory University|Dr. John D. Roback|404-712-1774|jroback@emory.edu|
20182988|NCT04088188|MD Anderson|Shubham Pant|832-803-5306|spant@mdanderson.org|
20182989|NCT03124108|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
20182990|NCT02266810|Intersect ENT|James Stambaugh (VP, Clinical Affairs)|650-641-2103|jstambaugh@intersectent.com|
20182991|NCT00578617|Mayo Clinic|Kristi Monahan|507-255-6676|CABANA@mayo.edu|
20182992|NCT01219855|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
20182993|NCT01670019|Duke University|John Beyer, M.D.|919-668-0209|john.beyer@dm.duke.edu|
20182994|NCT05650333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Centre|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20182995|NCT01129778|Stanford University|W. Ray Kim, MD, Chief of Gastroenterology and Hepatology|650-725-6511|wrkim@stanford.edu|
20182996|NCT02524288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20182997|NCT00517933|Duke Clinical Research Institute|Kevin J Anstrom, PhD|919-668-8902|kevin.anstrom@duke.edu|
20182998|NCT04807517|Massachusetts General Hospital Lurie Center for Autism|Lurie Center Research Manager|781-860-1711|luriecenterresearch@mgh.org|
20182999|NCT05096884|Hackensack Meridian Health|Jana Tancredi|5519962353|Jana.Tancredi@hmhn.org|
20183000|NCT03781804|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|267-521-0565|John.Messina@optinose.com|
20183001|NCT03717194|Seoul National University Bundang Hospital|Soo Lim|+82-31-787-7035|limsoo@snu.ac.kr|
20183002|NCT04678830|CytoDyn Inc.|Bernie Cunningham, PhD|(360) 980-8524|bcunningham@cytodyn.com|
20183003|NCT05550337|Teva Pharmaceuticals, Inc.|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20183004|NCT01836458|Novartis Pharmaceuticals|Study Director|862-778-8300||
20183005|NCT03184428|Eyestylianides ophthalmology center|Christoforos Stylianides|0035725320244|Info@eyestylianides.com|
20183006|NCT00561574|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183007|NCT00445692|Fred Hutch Cancer Research Center|Leona A. Holmberg, MD, PhD|206-667-6447|lholmber@fredhutch.org|
20183008|NCT03860077|Brown University|Dr. Rachel Cassidy|4018636621|rachel_cassidy@brown.edu|
20183009|NCT02147990|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20183010|NCT00430677|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20183011|NCT02639429|The University of Texas Health Science Center at Houston|Mesk Alrais, MD|(713) 566-5735|Mesk.A.Alrais@uth.tmc.edu|
20183012|NCT02040844|Circassia Ltd|VP Clinical Operations|+44 1865 405560|info@circassia.com|
20183013|NCT00946192|Massachusetts General Hospital and Harvard Medical School|Madhu Misra, MD; Chief, Pediatric Endocrine|6177245602|mmisra@mgh.harvard.edu|
20183014|NCT03181724|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
20183015|NCT03032159|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
20183016|NCT00681811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20183017|NCT02068885|Boston Children's Hospital|Cara Ebbeling, PhD, Co-Director, New Balance Foundation Obesity Prevention Center|617-919-3457|Cara.Ebbeling@childrens.harvard.edu|
20183018|NCT00828919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183019|NCT05567159|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20183020|NCT04159506|VA Connecticut Healthcare System|Steve Martino, Ph.D.|203-932-5718|Steve.Martino@va.gov|7418
20183021|NCT02501811|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
20183022|NCT00662909|Astellas Pharma Global Development, Inc.|Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
20183023|NCT01311648|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20183024|NCT02702921|Ethicon Endo Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
20183025|NCT01107626|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20183026|NCT01760291|Boston Scientific|Director of Clinical Trials|18002273422|peter.maurer@bsci.com|
20183027|NCT03467724|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
20183028|NCT04310579|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20183029|NCT02052648|Lumos Pharma Corporation|Lumos Pharma, Inc.|515-598-2921|clinical.trials@lumos-pharma.com|
20183030|NCT01325870|Advanced Circulatory|Clinical Research Associate|651-403-5606|nburkhart@advancedcirculatory.com|
20183031|NCT02236559|McGovern Medical School at The University of Texas Health Science Center at Houston|Dr. Pratik Doshi, MD||pratik.b.doshi@uth.tmc.edu|
20183032|NCT02049866|Columbia University|Mariana Bucovsky|212-305-7225|mb3523@cumc.columbia.edu|
20183033|NCT01117480|AbbVie|Global Medical Information|800-633-9110||
20183034|NCT03721016|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20183035|NCT03700658|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20183036|NCT02488317|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
20183037|NCT00817635|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20183038|NCT03533036|UCLA|Dr. Aparna Sridhar, Associate Clinical Professor|3107947274|asridhar@mednet.ucla.edu|
20183039|NCT00003656|Weill Cornell Medical College|Sharon Singh|(646) 962-9340|shs4011@med.cornell.edu|
20183040|NCT04969822|Vitrolife A/S|Mr. Jørgen Berntsen|+4551542005|jberntsen@vitrolife.com|
20183041|NCT00763282|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
20183042|NCT02060279|Nemours Children's Specialty Care|Dr. Amanda Lochrie|904-697-3698|alochrie@nemours.org|
20183043|NCT00335556|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20183044|NCT02365298|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan|904-443-3449|CColesb@ITS.JNJ.com|
20183045|NCT03736785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20183046|NCT00728845|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20183047|NCT00320489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183048|NCT03441984|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20183049|NCT05457842|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20224156|NCT02677038|M D Anderson Cancer Center|Dr. Milind Javle|713-792-5434|mjavle@mdanderson.org|
20183050|NCT00996372|Sprout Pharmaceuticals|VP, Clinical Development|9198820850|clinicaltrials@sproutpharma.com|
20183051|NCT02107014|University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
20183052|NCT03058783|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20183053|NCT00295867|UCSF Helen Diller Family Comprehensive Cancer Center|Hope S. Rugo|415-353-7618|hrugo@medicine.ucsf.edu|
20183054|NCT03852433|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20183055|NCT00746330|Novartis Pharmaceuticals|Study Director|862-778-8300||
20183056|NCT01981850|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183057|NCT01467700|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20224157|NCT02523924|Johns Hopkins University|Steven Rowe, MD|4105028052|srowe8@jhmi.edu|
20224158|NCT03671564|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
20224159|NCT04521621|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20183058|NCT03523962|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
20183059|NCT03727854|Seoul National University Hospital|Professor|82-2-2072-2217|ymchomd@snu.ac.kr|
20183060|NCT01078246|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183061|NCT04210024|University of Kentucky|Dr. Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
20183062|NCT00121199|SWOG Statistical Center|Study Statistician|206-667-4623||
20183063|NCT03168438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20183064|NCT04432974|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia|Dr. Massimiliano Paltenghi|(+39) 3487046844|massimiliano.paltenghi@spedalicivili.brescia.it|
20183065|NCT05191797|University of Washington|Rafael Santana-Davila|2066062190|rafaelsd@uw.edu|
20183066|NCT01018511|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
20183067|NCT04523181|Golden Biotechnology Corporation|Dr. Howard Cheng|+886228086006|howard@goldenbiotech.com|826
20183068|NCT01649427|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
20183069|NCT05822440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20183070|NCT02387749|Cairo university, faculty of medicine|Dina Mohammed Riad Ebrahim Abdelmagid|+201112052600|drdina_m@hotmail.com|
20183071|NCT02809911|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
20224160|NCT02609100|Washington University School of Medicine in St. Louis|Dr. Vladimir M. Kushnir|314-362-3685|vkushnir@wustl.edu|
20224161|NCT01460654|Massachusetts General Hospital|Dr. Benjamin Leder|6177266723|bzleder@partners.org|
20224162|NCT02777970|Menarini Ricerche|Dr. Angela Capriati (Clinical Sciences Director)|+39 055 5680|acapriati@menarini-ricerche.it|9933
20224163|NCT02319967|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|chicagotrial@uic.edu|
20224164|NCT05845567|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
20183072|NCT01113515|NovaLead Pharma Pvt. Ltd.|Supreet Deshpande|+91-866-965-6660|supreet@novaleadpharma.com|12
20183073|NCT02482233|Royal Columbian Hospital / University of British Columbia|Dr. Susan Ming Lee|604-520-4253|susanlee.anesthesia@gmail.com|
20183074|NCT04888585|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20183075|NCT04927975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20183076|NCT00630864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224165|NCT00742872|American University of Beirut Medical Center|Dr. Ala Sharara|+961-3-350000|as08@aub.edu.lb|
20183077|NCT03719677|Wayne State University|Heather Fritz|313-664-2627|Heather.fritz@wayne.edu|
20183078|NCT03059992|SCYNEXIS, Inc.|Dr. David Angulo, SCYNEXIS CEO|201-884-5471|david.angulo@scynexis.com|
20183079|NCT00147043|Imperial College London|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
20183080|NCT01645111|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
20183081|NCT04057196|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
20183082|NCT01118377|Hoffmann-La Roche|Medical Communications|800 821-8590||
20183083|NCT02085356|University of Miami Miller School of Medicine|Violeta Rodriguez|3052432188|vjrodriguez@med.miami.edu|
20183084|NCT00739102|Cordis Corporation, a Johnson & Johnson company|Patricia Schleckser, Director Medical Affairs|908-541-4564|pschleck@its.jnj.com|
20183085|NCT01062126|Abbott (Previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim1@abbott.com|
20183086|NCT00646451|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
20183087|NCT02232178|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20183088|NCT01149681|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
20183089|NCT01167426|Teva Pharmaceuticals Medical Affairs|Thomas Smith, MD|816-508-5128|tom.smith@tevapharm.com|
20183090|NCT01524536|National Institute of Allergy and Infectious Diseases|Paneez Khoury|+1 301 402 3773|khouryp@niaid.nih.gov|
20183091|NCT04176458|Northwestern University|Daniel Ganger, MD|3126954496|daniel.ganger@nm.org|
20183092|NCT02131324|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
20183093|NCT00891618|University of Texas MD Anderson Cancer|Michael Wang, MD / Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
20183094|NCT04582877|Zurich Medical|Charles Chan|(612) 889-9412|cchan@zurichmed.com|
20183095|NCT01970943|Massachusetts General Hospital|Dr David Borsook, study PI|6172817135|david.borsook@childrens.harvard.edu|
20183096|NCT02595398|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20183097|NCT03601507|University of Arizona Cancer Center|Ricklie Julian, MD|520-694-2873|rickliej@arizona.edu|
20183098|NCT01664104|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183099|NCT03061513|Weill Cornell Medical College|Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
20183100|NCT00683410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183101|NCT03761784|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20183102|NCT00586339|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183103|NCT01081145|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20183104|NCT01103973|Boston IVF|Alice D. Domar, PhD|781-434-6500|domar@domarcenter.com|
20183105|NCT01830842|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|MAddicott@uams.edu|501
20183106|NCT03235349|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20183107|NCT03394027|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navmed.nci.nih.gov|
20191628|NCT02093897|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20191629|NCT03480919|Hospital for Special Surgery|Jonathan Kirschner|6467146327|kirschnerj@hss.edu|
20191630|NCT04572997|Prof. Dr. Kristian Reich|Prof. Dr. Kristian Reich|+49 1722701941|kreich@jerucon.com|
20206592|NCT01496274|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20206593|NCT02758613|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20206594|NCT00721617|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20224166|NCT01917812|Johns Hopkins University School of Medicine|Dr. Seth S Martin|410-955-7376|smart100@jhmi.edu|
20224167|NCT01968707|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
20224168|NCT05178641|Procter & Gamble Co.|Dr. Susanna Brink, Clinical Scientist|+49 6196 89 4474|brink.s@pg.com|
20224169|NCT05803096|Beth Israel Medical Center|Dr. Heidi Rayala|16176673739|hrayala@bidmc.harvard.edu|
20224170|NCT01083186|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20224171|NCT02474589|SIGA Technologies|Dennis E Hruby, PhD, Chief Scientific Officer|541-753-2000|dhruby@siga.com|
20224172|NCT01740128|James J. Peters VAMC|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
20224173|NCT02658734|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20224174|NCT02231879|LMI/NIAID/NIH|Dr. David H. McDermott|301-761-6647|dmcdermott@niaid.nih.gov|
20224175|NCT00459706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224176|NCT00189306|Graceway Pharmaceuticals|Medical Director|267-984-0400|jim.lee@gracewaypharma.com|
20224177|NCT02017912|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
20224178|NCT03640481|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20224179|NCT00535847|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20162827|NCT02566317|Arizona State University|Matthew Buman, PhD|602-827-2289|mbuman@asu.edu|
20162828|NCT01016600|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20191631|NCT02956278|University of California San Francisco|Kathy Giacomini, PhD|415-514-4363|kathy.giacomini@ucsf.edu|
20191632|NCT01967719|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20191633|NCT02329223|Novartis|Study Director|862-778-8300||
20191634|NCT04588519|Spark Biomedical, Inc.|Navid Khodaparast, PhD|832-280-4756|navid.khodaparast@sparkbiomedical.com|
20191635|NCT03067610|University of Texas Southwestern Medical Center|Dr. David Sher|214/645-7607|david.sher@utsouthwestern.edu|
20191636|NCT01226485|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20191637|NCT00796614|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191638|NCT00740597|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
20191639|NCT00932659|Duke University|Patrick Pun, MD, MHS|919-660-6865|patrick.pun@duke.edu|
20191640|NCT01157351|Janssen Research & Development|Director, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20191641|NCT00746785|The Mind Reseach Network|Kent Hutchison, Ph.D.|505-272-5028|khutchison@mrn.org|
20191642|NCT01231464|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191643|NCT03449134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191644|NCT00993798|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20191645|NCT00957996|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
20191646|NCT02983877|Case Western Reserve University|Dr. Jennifer Levin|2168445057|jennifer.levin@uhhospitals.org|
20191647|NCT02503982|Schneider Children's Medical Center of Israel|Dr. Liat Ashkenazi-Hoffnung|972-3-9253681|LiatA3@clalit.org.il|
20191648|NCT01502306|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
20191649|NCT01960348|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|medinfo@alnylam.com|
20191650|NCT01580995|VAORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|
20191651|NCT01821729|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
20191652|NCT02916706|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20191653|NCT00970320|Ostfold Hospital Trust|Dr Hege Hølmo Johannessen|+4799721345|hege.holmo.johannessen@so-hf.no|
20191654|NCT01709123|Louisiana State University Health Science Shreveport|Sushil K. Jain, PhD|318.675.6086|sushil.jain@lsuhs.edu|
20191655|NCT01902381|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|bpowell@wakehealth.edu|
20191656|NCT04140266|Hans Rosling Center for Population Health|Jen Balkus|260 616 6614|jbalkus@uw.edu|
20191657|NCT00791102|University of Chicago|Robert Naclerio, MD|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
20191658|NCT03511378|Lupin Ltd. (Lupin Research Park), Pune, India|Dr. Chirag Shah, Director|91-20-67917368|chiragshah@lupin.com|
20191659|NCT02762500|Lycera Corp.|H. Jeffrey Wilkins, MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
20191660|NCT01701271|Bio Basic Europe|Prof. Fulvio Marzatico|(39) 0382 - 506390|fulviomk@unipv.it|
20191661|NCT00730847|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191662|NCT00280683|UCaliforniaDavis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
20191663|NCT04517877|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
20191664|NCT03018223|Moffitt Cancer Center|Nelli Bejanyan, MD|813-745-7208|Nellie.Bejanyan@moffitt.org|
20191665|NCT00329550|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20191666|NCT01223963|Q-Med AB|Chief Medical Officer|+46 18 4749000|reception.seupp@galderma.com|
20191667|NCT00666198|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191668|NCT05153499|Finch Therapeutics|CEO|617-229-6499|info@finchtherapeutics.com|
20162829|NCT01937260|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
20191669|NCT05786521|University of Texas Health Science Center San Antonio|TIffany M Cortes, MD|210-450-3333|cortest@uthscsa.edu|
20191670|NCT01369706|Deutsches Herzzentrum München|Prof. Dr. Christof Kolb|+49891218|kolb@dhm.mhn.de|2020
20206595|NCT03549429|Tufts Medical Center|Dr. Dan Drzymalski|‪617-913-8168|ddrzymalski@tuftsmedicalcenter.org|
20224180|NCT05007041|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
20224181|NCT04889157|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224182|NCT01546168|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20224183|NCT01902758|University of Montana|Director of the Montana Center for Work Physiology and Exercise Metabolism|406-243-2117|brent.ruby@mso.umt.edu|
20224184|NCT00423189|Retina Consultants of Houston|David M. Brown|713-524-3434|dmbmd@houstonretina.com|
20224185|NCT01844206|Columbia University|Dr. Allison Lee|305-582-6077|al3196@cumc.columbia.edu|
20224186|NCT05028413|University of Pennsylvania|Associate Professor Mucio C. Delgado, MD, MS|215-74-826|mucio.delgado@pennmedicine.upenn.edu|
20224187|NCT02747849|UPittsburgh|Rajeev Chaudhry, MD|412-692-7932|rajeev.chaudhry@chp.edu|
20224188|NCT03488849|InnoVital Systems|Chief Medical Officer|2022862328|amit@innovitalsystems.com|
20224189|NCT01618019|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
20224190|NCT01542034|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20224191|NCT03845491|Stryker Neurovascular|Sr. Clinical Project Manger|510-413-2500|lisa.park@stryker.com|
20224192|NCT00901017|Institut Straumann AG|Marc Quirynen, Professor|+4161965|michael.hotze@straumann.com|1235
20224193|NCT00978250|National Cancer Institute|Dr. James Doroshow|240-781-3320|jim_doroshow@nih.gov|
20224194|NCT00387010|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20224195|NCT02071810|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20224196|NCT00520481|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20224197|NCT04586634|Coloplast|Director of Clinical Strategy|+4549111111|clinical-studies@coloplast.com|
20224198|NCT00381043|University of North Carolina at Chapel Hill|Dr. J.C. Garbutt|919-966-4652|jc_garbutt@med.unc.edu|
20224199|NCT02847494|Montefiore Health|Benjamin W. Friedman, MD|17189206626|befriedm@montefiore.org|
20224200|NCT02468154|Istituto Ortopedico Rizzoli|Luisa Veronesi|0516366694|cristiana.forni@ior.it|0039
20224201|NCT02841280|Indiana University|Dr. Rajiv Agarwal|3179882241|ragarwal@iu.edu|
20224202|NCT04553471|Washington University School of Medicine|Pamela Samson, M.D.|314-747-1786|psamson@wustl.edu|
20224203|NCT05152966|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
20224204|NCT01340027|Astellas Pharma Europe, B.V.|Medical Director||Astellas.resultsdisclosure@astellas.com|
20191671|NCT03220776|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
20191672|NCT03226353|CooperVision|Jose A. Vega OD MSc FAAO|(925) 621- 3761|javega@coopervision.com|
20191673|NCT02747121|Helsetilsynet|Dr Einar Hovlid|+4721529900|eho@helsetilsynet.no|
20191674|NCT02166047|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20191675|NCT04318587|University of Pittsburgh|Naomi Ryssel|412-335-9688|agostinonr@upmc.edu|
20191676|NCT02490878|MD Anderson Cancer Center|Caroline Chung, MD|(713) 745-5422|cchung3@mdanderson.org|
20191677|NCT03280108|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20224205|NCT00833482|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20224206|NCT02496091|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20224207|NCT05685264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224208|NCT01290978|cyberDERM Clinical Studies|Dr. Gary Grove|610-325-0112||
20224209|NCT02342197|Kasr El-Aini Hospital|Nawara Mohamed|0223654060|nawaram@kasrelaini.edu.eg|002
20191678|NCT01187407|Eli Lilly and Company|Chief Medical Officer|800-545-597||
20224210|NCT01746420|Wright Medical|Justin Moss|615-236-4984|justin.moss@wright.com|
20224211|NCT02600845|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20224212|NCT02341495|Loyola University Medical Center|Dr. Elizabeth Henry|708-327-3153|ehenry@lumc.edu|
20224213|NCT04383938|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20183108|NCT05887323|Abbott|Director of Clinical Research|9725269673|kwangdeok.lee@abbott.com|
20183109|NCT00658411|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
20183110|NCT01481935|University of Maryland School of Medicine|Anthony D. Harris, MD MPH|410-706-0064|aharris@epi.umaryland.edu|
20183111|NCT01560143|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
20183112|NCT01639443|West Los Angeles VA / Cedars-Sinai Medical Center|Jennifer Talley Soares|(310) 478-3711|jennifer.soares@va.gov|83240
20183113|NCT01248221|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
20183114|NCT04305912|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
20183115|NCT00928200|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20183116|NCT01268566|MedImmune, LLC, an affiliate of AstraZeneca|A Phase 2 Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme|1-877-240-9479|information.center@astrazeneca.com|
20183117|NCT00601965|Veterans Medical Research Foundation|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
20183118|NCT02138916|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
20183119|NCT01348087|Novartis Pharmaceuticals|Study Director|862-778-8300||
20183120|NCT00555581|Hospital for Special Surgery|Robert F. Spiera|212-774-2048|spierar@hss.edu|
20183121|NCT00117988|UT MD Anderson Cancer Center|Dr. Anas Younes, MD / Professor||etubbs@mdanderson.org|
20183122|NCT03822351|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20183123|NCT02237079|Tulane University|Dr. Franck Mauvais-Jarvis|504-988-5990|fmauvais@tulane.edu|
20183124|NCT02929069|Yale University|John Pachankis, PhD|(203) 785-3710|john.pachankis@yale.edu|
20183125|NCT02708862|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
20224214|NCT04161079|Medtentia International Ltd Oy|Olli Keränen / Chief Executive Officer|+358 50 3567090|ok@medtentia.com|
20224215|NCT02515994|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., F.A.A.O. Principle Research Optometrist|904-443-1474|KCANAVA2@its.jnj.com|
20224216|NCT00326781|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
20224217|NCT04045132|The Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
20224218|NCT01632150|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20224219|NCT05027048|Stanford|Dr. Jessica Ansari|650-723-5349|jansari@stanford.edu|
20224220|NCT02879994|Jonsson Comprehensieve Cancer Center|Dr. Edward Garon|(310)586-2098|egaron@mednet.ucla.edu|
20224221|NCT02143791|Abbott|Devyani Nanduri|+1 510 561 4328|devyani.nanduri@abbott.com|
20224222|NCT04112160|UT Southwestern Dept of Urology|Dr. Brett Johnson|214-645-3526|brett.johnson@utsouthwestern.edu|
20224223|NCT03051516|Fred Hutchinson Cancer Center|Margaret M. Madeleine, PhD|206-667-4630|mmadelei@fredhutch.org|
20224224|NCT01272141|Emory University School of Medicine|William Read, MD|1-888-946-7447|william.l.read@emory.edu|
20224225|NCT04327661|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
20224226|NCT02111785|Department of Neurosurgery, University of Virginia Health System|Dr. Daniel Raper|4349823244|raper@virginia.edu|
20224227|NCT03960866|Ocuphire Pharma, Inc.|Mina Sooch|248-681-9815|msooch@ocuphire.com|
20224228|NCT00981045|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20224229|NCT00759785|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224230|NCT02416193|Loyola University Chicago|Mary Byrn, R.N., Ph.D.|(773) 508-8973|mbyrn@luc.edu|
20224231|NCT01013844|Northwestern University Department of Dermatology|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
20224232|NCT01608815|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20224233|NCT02062944|Northwestern University|Josh Levitsky|312 695 4413|josh.levitsky@nm.org|
20224234|NCT02122770|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20224235|NCT01041976|Edith Nourse Rogers Memorial VA|Lisa Mueller|781-687-3192|Lisa.Mueller@va.gov|
20224236|NCT02850016|The Rockefeller University|Marina Caskey|212-327-7396|mcaskey@rockefeller.edu|
20224237|NCT00711828|Mayo Clinic|Craig B. Reeder, M.D.||Reeder.Craig@mayo.edu|
20224238|NCT00715728|Vienna General Hospital/University of Vienna|Olga Plattner, Medical Doctor|43-1-40-400-4103|olga.plattner@meduniwien.ac.at|
20224239|NCT01258075|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20224240|NCT02939716|University of Nottingham|Robin Spiller|01158231090|robin.spiller@nottingham.ac.uk|
20224241|NCT00976209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20224242|NCT01252563|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224243|NCT03826628|AFT Pharmaceuticals Ltd.|Ioana Stanescu|+64 9 488 0232|ioana.stanescu@aftpharm.com|712
20224244|NCT02951533|Janssen-Cilag GmbH|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20224245|NCT02029989|UMN, College of Pharmacy|Dr. Mark E. Schneiderhan|8452540458|meschnei@d.umn.edu|
20224246|NCT00271011|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
20224247|NCT02880865|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
20224248|NCT00756561|University of Washington, Dept. of Medicine|Mara Roth, MD|(206) 221-0519|mylang@u.washington.edu|
20224249|NCT02224820|Dept of Transplant Surgery, Uppsala University Hospital|Dr. Tomas Lorant|+46 70 677 29 01|tomas.lorant@surgsci.uu.se|
20224250|NCT03045276|Children's Hospital of Philadelphia|Dr. Sandra Amaral|2678443097|amarals@chop.edu|
20224251|NCT03724877|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224252|NCT03492398|Seoul National University Hospital|Inseung Jeon|82-2-2072-1920|isjeon0127@snu.ac.kr|
20224253|NCT03951064|University of North Carolina at Chapel Hill|Jackson Pettee|984-215-6872|jackson_pettee@med.unc.edu|
20183126|NCT06044948|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|8884513937|alcon.medinfo@alcon.com|
20183127|NCT03788291|University of Rochester|Paul Barr, MD|585-273-3258|paul_barr@urmc.rochester.edu|
20183128|NCT02081391|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|Clinical-Trials@grunenthal.com|3223
20183129|NCT01458275|Sunovion|Respiratory Medical Director|1-866-503-6351||
20183130|NCT01729871|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20183131|NCT03971357|Price Vision Group|Marianne Price|317-814-2990|mprice@cornea.org|
20183132|NCT01555762|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20183133|NCT01333514|Rush University Medical Center|Chung-Kay Koh|8475305230|chungkay@gmail.com|
20183134|NCT00112112|MedImmune, LLC|Raburn Mallory|301-398-0000|malloryr@medimmune.com|
20183135|NCT00836810|University of Bristol|Professor John Kirwan|+44 117 342 2904|John.Kirwan@Bristol.ac.uk|
20183136|NCT00819910|Brooke Army Medical Center|Ahmad Slim, MD|2109164717|ahmad.slim@us.army.mil|
20183137|NCT01912495|Erasmus MC|B.J.A.Rijnders|0031107034529|b.rijnders@erasmusmc.nl|
20183138|NCT00871429|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20183139|NCT03102242|Mayo Clinic|Helen J. Ross, MD|4803018000|Ross.Helen@mayo.edu|
20183140|NCT01137292|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191679|NCT01713998|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20191680|NCT03638258|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20191681|NCT01287416|University of Manitoba|Shay-Lee Bolton|204-787-5082|sbolton@hsc.mb.ca|
20191682|NCT02694198|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
20191683|NCT00607789|Lindner Center of HOPE|Susan McElroy, MD|513-536-0718|susan.mcelroy@lindnercenter.org|
20191684|NCT01313299|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20183141|NCT03663101|Ipsen Innovation SAS|Medical Director|see email|clinical.trials@ipsen.com|
20183142|NCT01311713|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20183143|NCT04549051|Albert Einstein College of Medicine|Sayed Wahezi, M.D.|718-920-7246|swahezi@montefiore.org|
20183144|NCT01772719|University of Louisville, James Graham Brown Cancer Center|James Graham Brown Cancer Center, Clinical Trials|502-562-3429|ctobcc@louisville.edu|
20183145|NCT00477412|UT MD Anderson Cancer Center|Michael Wang, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
20183146|NCT00731211|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20183147|NCT02931396|University of Pittsburgh|Alicia Koontz|4128223700|akoontz@pitt.edu|
20183148|NCT05460663|University of New Mexico, College of Nursing|Stephen H. A. Hernandez, PhD, RN, FAAN|505-272-0756|shhernandez@salud.unm.edu|
20183149|NCT03068468|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20183150|NCT02555449|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20183151|NCT02466516|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20183152|NCT03712930|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20183153|NCT03895034|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20183154|NCT01510912|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
20183155|NCT03784963|The University of Chicago|Dr. Ann Nguyen, MD|773-702-9396|anguyen3@medicine.bsd.uchicago.edu|
20183156|NCT03181958|Children's Hospital of Chongqing Medical University|Dr.Yuan Shi|+86 23 68757731|shiyuan@hospital.cqmu.edu.cn|
20183157|NCT02695290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183158|NCT01144949|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
20183159|NCT00349908|Codman & Shurtleff|J. Thomas Megerian, MD|508.828.8274|jmegerian1@its.jnj.com|
20183160|NCT02891629|EyeFree Assisting Communication|Or Retzkin, CEO|+972526490093|or@eyecontrol.co.il|
20183161|NCT00151996|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20183162|NCT00959920|Loyola University Medical Center|Dr. Sarita Massey|708-354-9250|smassey@lumc.edu|
20183163|NCT00109967|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.||ansell.stephen@mayo.edu|
20183164|NCT04148937|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20183165|NCT03107611|Mylan Pharmaceuticals Pvt Ltd|Prasanna C Ganapathi, Clinical Sciences Program Lead|+91 9148448200|PrasannaC.Ganapathi@mylan.in|
20183166|NCT02753413|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183167|NCT01020838|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
20183168|NCT02175212|Hospital Universitario de la Princesa; Health Research Institute IIS from Hospital Universitario de la Princesa|Dr. Almudena Zapatero|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
20183169|NCT01908634|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
20183170|NCT01570751|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20183171|NCT01072357|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
20183172|NCT01876511|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20183173|NCT00315120|University of North Texas Health Science Center-The Osteopathic Research Center|John C. Licciardone, DO, MS, MBA|817-735-2028|john.licciardone@unthsc.edu|
20183174|NCT01048788|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20183175|NCT05419557|Inova Health System|Dr. Elyssa Wood|5714728649|elyssa.wood@inova.org|
20183176|NCT00588666|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20224254|NCT00796705|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20224255|NCT03376256|University of Miami|Dr. Ralf Gebhard|3055858365|rgebhard@med.miami.edu|
20224256|NCT02251106|University of Alberta|Dr. Greg Kawchuk|780-492-6891|greg.kawchuk@ualberta.ca|
20224257|NCT02375555|Dana Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
20224258|NCT02267772|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD, Associate Professor|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
20224259|NCT01565369|Avid Radiopharmaceuticals|Chief Medical Officer|215-798-0700|clinicaloperations@avidrp.com|
20224260|NCT02294175|James A. Haley Veterans Hospital and Clinics|Dr. Linda Cowan|813-558-3932|linda.cowan@va.gov|
20224261|NCT01901653|AbbVie Stemcentrx|Senior Director, Clinical Operations|(650) 827-4879|isobel.lakatos@abbvie.com|
20224262|NCT02548351|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20183177|NCT01233050|Penn Medicine|Dr. Najjia Mahmoud, MD, Cheif of Colorectal Surgery|(215) 662-2078|najjia.mahmoud@uphs.upenn.edu|
20183178|NCT01771666|Stanford University|Dr. Irene Wapnir|650-724-1953|Wapnir@stanford.edu|
20183179|NCT00601848|University of Pennsylvania|Keith A Cengel, MD, PhD|(215) 615-5312|cengel@pennmedicine.upenn.edu|
20183180|NCT04304534|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20183181|NCT00464672|Novartis Vaccines and Diagnostics|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com|
20183182|NCT02299635|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183183|NCT00601640|University of Arizona/Arizona Cancer Center|Joanne Jeter, MD|520.626.9295|jjeter@azcc.arizona.edu|
20183184|NCT02047461|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
20183185|NCT00015457|National Institutes of Health|Barbara I Karp, MD|301-496-0150|karpb@ninds.nih.gov|
20183186|NCT04974489|University of North Carolina, Chapel Hill|M. Justin Byron, PhD|(919)966-3292|jbyron@unc.edu|
20183187|NCT01710514|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20183188|NCT03404843|Colorado State University|Frank Dinenno|970-491-3203|frank.dinenno@colostate.edu|
20183189|NCT02701361|Duke University Health System|Christopher Cox|9196817232|christopher.cox@duke.edu|
20183190|NCT01078233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183191|NCT02718118|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
20183192|NCT00097253|The Ohio State University, Department of Psychiatry|Janice K. Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
20183193|NCT02430532|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20183194|NCT01190150|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20183195|NCT04469218|Lineus Medical|CEO|844-546-3728|vance@lineusmed.com|
20183196|NCT02750709|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
20183197|NCT03256344|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20183198|NCT04490148|Penn State College of Medicine|Dr. Andrew Geronimo|717 531 0003|ageronimo@pennstatehealth.psu.edu|282576
20183199|NCT01879371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183200|NCT02606734|Osprey Medical|Michele Shepard|952-955-5236|mshepard@ospreymed.com|
20183201|NCT00580801|Janssen Research & Development, LLC, Titusville, NJ|Clinical Leader|609-730-3174||
20183202|NCT00502593|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183203|NCT02121418|University of Washington|Dr. Pamela Becker|206-606-7273|pbecker@u.washington.edu|
20183204|NCT00880906|Vanderbilt University|Michael Vaezi, MD, PhD|615-322-3739|michael.vaezi@vanderbilt.edu|
20183205|NCT01534910|Los Angeles Biomedical Research Institute|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
20183206|NCT00544440|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024|Senior Director|310-943-8040||2917
20183207|NCT01460342|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183208|NCT03586167|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20183209|NCT00591838|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4633|clifford.robinson@wustl.edu|
20183210|NCT03237936|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
20183211|NCT02512042|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
20183212|NCT02001714|Beaumont Health|Ananias C. Diokno, MD||ananias.diokno@beaumont.edu|
20183213|NCT04163458|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20183214|NCT01335932|FHCRC|Dr.Michael Boeckh|206 667-6706|mboeckh@fredhutch.org|
20183215|NCT00952718|ChangGungMH|Dr. Liaw MY|+8867317123|myliaw1@yahoo.com.tw|8199
20183216|NCT04109118|Boston Medical Center and BU School of Medicine|Tae Woo Park, MD|617-414-1906|taewoo.park@bmc.org|
20183217|NCT03563053|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
20183218|NCT00813488|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
20183219|NCT02926937|Lexicon Pharmaceuticals, Inc,|Medical Affairs|338-6064|medical-information@lexpharma.com|(510)
20183220|NCT01559090|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20183221|NCT04985383|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
20183222|NCT03677375|Masimo|Tala Harake|9492977000|studies@masimo.com|
20191685|NCT01919398|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20191686|NCT01350388|University of Utah|Srinivasan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
20183223|NCT00126113|National Center for Rehabilitative Auditory Research|Gabrielle Saunder Ph.D.|503-220-8262|gabrielle.saunders@va.gov|56210
20183224|NCT01143077|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
20191687|NCT01064856|AbbVie|Global Medical Services|800-633-9110||
20183225|NCT00124982|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20206596|NCT02910219|Georgetown University|Sandra M. Swain, MD, FACP, FASCO|202-687-4600|Sandra.Swain@georgetown.edu|
20206597|NCT02096042|The University of Texas (UT) MD Anderson Cancer Center|Nitin Jain, MD/Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20206598|NCT03406715|Moffitt Cancer Center|Alberto A. Chiappori, MD|813-745-4541|Alberto.Chiappori@moffitt.org|
20206599|NCT00845507|University of Cincinnati|Dr. DelBello|513-558-2989|Melissa.Delbello@uc.edu|
20206600|NCT02690168|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
20206601|NCT02762708|Mayo Clinic|Meera Shah, MB, ChB|507-284-0106|Shah.Meera@mayo.edu|
20206602|NCT01062009|UCSF Benioff Childrens Hospital Oakland|Natalie Cvijanovich, MD|510-428-3784|NCvijanovich@mail.cho.org|
20206603|NCT01961089|Ziemer Ophthalmic Systems AG|Dr. Gregor Schmid|+41323327154|gregor.schmid@ziemergroup.com|
20206604|NCT01468701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206605|NCT01068717|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20206606|NCT02758119|iLumens|David Drummond|0033144494848|david.drummond@ilumens.org|6
20206607|NCT01822223|University of Alabama at Birmingham|Michael S. Reddy, DMD, DMSc|2059344720|mreddy@uab.edu|
20206608|NCT02679781|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+97226776135|fuxavia@gmail.com|
20224263|NCT01744184|University Hospitals Dorset NHS Foundation Trust|Dr Simon McLaughlin|01202303626|Simon.McLaughlin@uhd.nhs.uk|
20224264|NCT00792688|Glycotex, Inc.|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
20224265|NCT02091986|AstraZeneca|Global Clinical Lead Göran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
20224266|NCT00125242|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@health.utah.edu|1363
20224267|NCT00606554|Boston University School of Medicine|Allan Walkey, MD, MSc|617-638-4860|alwalkey@bu.edu|
20224268|NCT01664949|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20224269|NCT02727777|UT MD Anderson Cancer Center|Dr. Jason R. Westin/Lymphoma/Myeloma|713-792-3750|jwestin@mdanderson.org|
20224270|NCT01738503|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20224271|NCT01490073|University of Washington|Elizabeth Micks|206-616-4939|emicks@uw.edu|
20224272|NCT01662791|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|DiBaise.John@mayo.edu|
20224273|NCT01187498|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
20224274|NCT02807506|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
20224275|NCT00965341|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO / Assistant Professor|713-745-4192|HMoreno@mdanderson.org|
20224276|NCT01970475|Amgen Inc.|Study Director|866-572-6436||
20224277|NCT02234596|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,|646-888-4186|janjigiy@mskcc.org|
20224278|NCT00688935|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
20224279|NCT05072106|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit,|0034918466000|AEincoming@pharmamar.com|
20224280|NCT00626236|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
20224281|NCT04240886|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20224282|NCT01089933|OHRI|Dr Michelle Chiu|613-798-5555|mchiu@toh.ca|14169
20224283|NCT04743804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20224284|NCT00771264|Uroplasty, Inc.|Susan Holman, Cheif Operating Officer|952-426-6143|susan.holman@uroplasty.com|
20224285|NCT01944670|Skeletal Dynamics, LLC|Ana Escagedo|305-596-7585|AEscagedo@SkeletalDynamics.com|
20224286|NCT01131884|University of Rochester|K.Rao Poduri, M.D., Chair of Physical Medicine & Rehab|585-275-6978|kr_poduri@urmc.rochester.edu|
20224287|NCT04063657|University of California, Davis|Dr. Christopher Kreulen|(916) 734-6805|ckreulen@ucdavis.edu|
20224288|NCT03408444|Johnson & Johnson Vision Care, Inc.|Xu Cheng - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
20224289|NCT04984681|University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
20224290|NCT01214252|Covidien|Annie Choi|781-839-1756|annie.choi@covidien.com|
20224291|NCT01473394|Forest Research Institute, Inc.|Carl Gommoll|201 427-8000||
20224292|NCT03391232|Treos Bio|Chef Scientific Officer|+3615500826|eniko.toke@treosbio.com|
20224293|NCT00552032|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20224294|NCT04430738|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162830|NCT00954993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183226|NCT05273801|Shirley Ryan AbilityLab|Dr. Miriam Rafferty|3122387233|mrafferty@sralab.org|
20183227|NCT04257058|Emory University|Dr. Jordan Marchak|404-727-2293|jgillel@emory.edu|
20183228|NCT04476472|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20183229|NCT00821184|Lahey Clinic|John T. Stoffel, MD|781-744-5481|John.T.Stoffel@lahey.org|
20183230|NCT02030028|University of Pittsburgh|Dr. Dana Ascherman (Principal Investigator)|14123838123|DAscher@pitt.edu|
20183231|NCT02734056|Brigham|Bhavani Kodali|6175258449|kodali@zeus.bwh.harvard.edu|
20183232|NCT01249092|Cleveland Clinic|Claudia O. Zein, MD|216-444-0421|zeinc@ccf.org|
20183233|NCT00802919|Nathan Kline Institute for Psychiatric Research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
20183234|NCT02657629|HackensackUMC|Nicole Spillane MD|917-446-6656|nspillane@hackensackumc.org|
20183235|NCT04866407|Rutgers RWJMS|Dr Sydney Asselstine|6469403587|sydneyasselstine@gmail.com|
20183236|NCT02001623|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
20183237|NCT03669354|Southern California University Of Health Sciences|Anupama Kizhakkeveettil|(562) 475-5158|anu@scuhs.edu|
20206609|NCT04209400|VBI Vaccines Inc.|Dr Francisco Diaz-Mitoma|613-297-3304|fdiazmitoma@vbivaccines.com|
20183238|NCT02786771|Partners Connected Health Innovation|Odeta Dyrmishi - Acting Project Manager|6177243605|odyrmishi@partners.org|
20183239|NCT01063036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20183240|NCT01977612|Washington University School of Medicine|Lindsay Kuroki, M.D.|314-362-2368|kurokil@wustl.edu|
20224295|NCT02091960|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20224296|NCT04178824|Icahn School of Medicine at Mount Sinai|Allan Geliebter PhD|212-523-4574|Allan.Geliebter@mountsinai.org|
20224297|NCT03794661|Abbott Medical Devices Neuromodulation|Binith Cheeran|+15122864262|binith.cheeran@abbott.com|
20224298|NCT04810247|The Miriam Hospital|Dr. KayLoni Olson|401-793-8971|kayloni.olson@lifespan.org|
20224299|NCT01995175|GlaxoSmithKline|GSK Response Center|866-435-7343|lr24921@gsk.com|
20224300|NCT01877551|Washington University School of Medicine|Dr. Dominic Reeds|3143628430|dreeds@wustl.edu|
20224301|NCT00984061|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20224302|NCT00535782|Hoffman-LaRoche|Medical Communications|800-821-8590||
20224303|NCT04777201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20224304|NCT02697890|TuftsUSDM|Y. Natalie Jeong|6176366531|natalie.jeong@tufts.edu|
20224305|NCT02691013|University of California San Diego|Dr. Robert Owens|858-657-5258|rowens@ucsd.edu|
20224306|NCT06017752|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
20183241|NCT02715258|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20224307|NCT02357706|Charite Department of Sleepmedizin|Prof Dr med Ingo Fietze|+49 30 450 513 122|ingo.fietze@charite.de|
20224308|NCT02327403|Massachusetts General Hospital|Dr. Leonardo V Riella, MD, PhD|6176436266|LRIELLA@MGH.HARVARD.EDU|
20224309|NCT00880230|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20224310|NCT02275780|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20224311|NCT03369067|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20224312|NCT01054300|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224313|NCT00135798|University Colorado, Denver|Gregory T. Everson, M.D., Director of Hepatology|720-848-2245|greg.everson@UCDenver.edu|
20224314|NCT00738881|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D|507/538-1760|alex.adjei@roswellpark.org|
20224315|NCT01282164|Cleveland Clinic|Dr. Amir H. Hamrahian|216-445-8555|hamraha@ccf.org|
20224316|NCT01663779|Yale School of Medicine|Kevin M. Schuster|203-785-2572|kevin.schuster@yale.edu|
20224317|NCT03409107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20224318|NCT01185509|Dana-Farber Cancer Institute|Ian Krop, MD, PhD|617.632.6973|Ian_Krop@dfci.harvard.edu|
20224319|NCT00916344|BIOTRONIK SE & Co.KG|Dr. Evelyn Diessel|+49 (0) 30 68905|evelyn.diessel@biotronik.com|1231
20224320|NCT02946073|Braeburn|Susan Franks, SVP, Head of Regulatory Affaires|6104678719|sfranks@braeburnrx.com|
20224321|NCT01588457|UT Health San Antonio|Charles Bowden, MD|2105675393|bowdenc@uthscsa.edu|
20183242|NCT04208243|Children's Hospital Colorado|Dr. Jennifer Raybin|720-777-3407|jennifer.raybin@childrenscolorado.org|
20183243|NCT02955069|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20224322|NCT03991013|University of Cape Town|Prof Graeme Meintjes|+27 (0) 21 4066075|Graeme.Meintjes@uct.ac.za|
20224323|NCT00108485|Diabetes Research Institute|Dr. Ronald Goldberg|305-243-6574|RGoldber@med.miami.edu|
20224324|NCT00343785|Fred Hutchinson Cancer Research Center|Dr. Rainer Storb, Director Transplantation Biology|2066676839|rstrob@fredhutch.org|
20224325|NCT00828074|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20224326|NCT01203826|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
20224327|NCT01537068|NYSPI|David Hellerstein MD|646-774-8000|desdesk@nyspi.columbia.edu|
20224328|NCT03099694|Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing|Prof. Shi Yuan|13508300283|15084335697@163.com|
20224329|NCT02046395|Tulane University|Vechi Batuman|(504)988-5346|vbatuma@tulane.edu|
20224330|NCT02537431|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
20224331|NCT03641326|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
20183244|NCT00943605|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20183245|NCT00913913|Dartmouth-Hitchcock Medical Center|Dr. Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
20183246|NCT00918957|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20183247|NCT01720446|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20206610|NCT00771173|Loyola University Chicago|Dr. Linda Brubaker|708-216-3960|lbrubaker@lumc.edu|
20183249|NCT01956669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20183250|NCT01131494|University Federal of Bahia|Natalie Argolo Ponte|55 31 3274 5579|natyargolo@hotmail.com|
20183251|NCT03768856|Cleveland Clinic, Case Comprehensive Cancer Center|Dr Shlomo Koyfman|1-800-223-2273|TaussigResearch@ccf.org|
20183252|NCT02145182|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
20183253|NCT00016913|Department of Medicine, Memorial Sloan-Kettering Cancer Center|Wm. Kevin Kelly, DO||kellyw@mskcc.org|
20183254|NCT01196988|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206611|NCT01602549|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162831|NCT00704938|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20183255|NCT03999554|FluGen|Pamuk Bilsel, CSO|6084426562|pbilsel@flugen.com|
20206612|NCT05200455|Dartmouth-Hitchcock Medical Center|Dr. Barbara Jobst|6036505000|Barbara.C.Jobst@hitchcock.org|
20183256|NCT04012853|WJB Dorn VA Medical Center|Dr. X. Michelle Androulakis Chief of Neurology|803-776-4000|xiao.androulakis@va.gov|4077
20183257|NCT01695317|St. olavs Hospital|Dr. knut Hagen|95401579|knut.hagen@stolav.no|
20183258|NCT03055767|"University of California, Irvine | Dept. of Anesthesiology & Perioperative Care"|Shalini Shah, MD|(949) 824-7246|ssshah1@hs.uci.edu|
20183259|NCT02228408|New York University Medical Center|David Charytan|(646) 501-9086|david.charytan@nyulangone.org|
20183260|NCT00618540|University of Minnesota, Pediatric BMT|Dr. Angela Smith, MD|612-626-2778|smith719@umn.edu|
20183261|NCT01466881|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|hongli@fredhutch.org|
20183262|NCT01101165|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
20183263|NCT04580303|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
20183264|NCT01444287|Vistakon|Noel Brennan|1 904 4433494|nbrenna2@its.jnj.com|
20183265|NCT02427737|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant sponsoring site-PIs); CEO|617 734 9087|drevlang@ComfortTalk.com|
20183266|NCT01134575|The University of Texas MD Anderson Cancer Center|Hagop M. Kantarnian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
20183267|NCT01456936|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183268|NCT02317705|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
20183269|NCT03095508|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
20183270|NCT01674569|Tyrogenex, Inc|Sr Vice President, Development|240-403-7153|Dan@tyrogenex.com|
20183271|NCT01599325|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20183272|NCT03879642|Nemours Children's Health-Jacksonville|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
20183273|NCT01878890|Institut Bergonié|Dr Guilhem Roubaud|33 5 56 33 33 33|g.roubaud@bordeaux.unicancer.fr|
20183274|NCT04054661|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
20183275|NCT00578214|Mayo Clinic|Dr. Clark C. Otley|507-284-3579|otley.clark@mayo.edu|
20183276|NCT05674370|Mayo Clinic|Dr. Matthew Binicker|507-284-3697|binnicker.matthew@mayo.edu|
20183277|NCT02020018|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7066|schaff.hartzell@mayo.edu|
20224332|NCT00794040|Mood, Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health|Dr Argyris Stringaris|(301) 443-8019|argyris.stringaris@nih.gov|
20224333|NCT04696354|Philips|Danielle Op den Kamp, Sr Manager Clinical Operations|+31 (0)627218737|Danielle.op.den.kamp@philips.com|
20224334|NCT03005327|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
20224335|NCT04687072|Argenx|Regulatory manager|Please email|regulatory@argenx.com|
20224336|NCT01263782|UT MD Anderson Cancer Center|Dr. George Simon, Thoracic/Head & Neck Med Onc|713-794-4740|GSIMON@MDANDERSON.ORG|
20224337|NCT00915876|University of Michigan|Amy Pai|7346470005|amypai@med.umich.edu|
20224338|NCT02782065|Boston Children's Hospital|Leah Abecassis|6173552299|leah.abecassis@childrens.harvard.edu|
20224339|NCT04545567|University of Virginia|Mark DeBoer|1 434 924 0123|mdd5z@virginia.edu|
20224340|NCT03979807|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224341|NCT04009668|University of Michigan|Dr. Zubin Modi|(734) 232-6798|modiz@med.umich.edu|
20224342|NCT02419612|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
20224343|NCT03626363|Michigan Technological University|Kelly Kallio, Assistant Vice President of Sponsored Programs|9064872226|kmkallio@mtu.edu|
20224344|NCT00533702|Eli Lilly and company|Chief Medical Officer|800-545-5979||
20224345|NCT01095978|Abbott|Global Medical Services|1-800-633-9110||
20224346|NCT00960986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20224347|NCT01984892|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20224348|NCT04464720|University of California San Francisco|Dr. Stephanie M Holm|415-514-0878|stephanie.holm@ucsf.edu|
20224349|NCT00342563|Yale University School of Medicine|Dr. Elizabeth Ralevski|+1 203-932-5711|elizabeth.ralevski@yale.edu|x4282
20224350|NCT02156895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224351|NCT04413552|Indivior, Inc.|Global Director, Clinical Development|804-594-4488|TrialDisclosure@Indivior.com|
20224352|NCT03476174|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
20224353|NCT03955081|OLYMPUS EUROPA SE & CO. KG|Peter Teichmann, PhD|+49 40 23773|peter.teichmann@olympus.com|7835
20183278|NCT00567164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20183279|NCT04044664|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20183280|NCT02005666|Cadila Healthcare Limited|Mr Anuj K Saini|02717623666|Anuj.Saini@zyduscadila.com|314
20183281|NCT00478556|UAB Hospital Radiology|Lisa Nelson|205-934-4015|lnelson@uabmc.edu|
20183282|NCT01982643|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
20183283|NCT01744691|Pharmacyclics, Inc.|Dr. Alvina Chu|855-427-8846|medinfo@pcyc.com|
20183284|NCT02086708|Massachusetts General Hospital|Dr. Uzma Shah|617-726-1450|USHAH@mgh.harvard.edu|
20183285|NCT04588480|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20183286|NCT01859312|National Institute of Child Health and Human Development (NICHD)|Deborah P. Merke, MD, MS|301-496-0718|DMerke@cc.nih.gov|
20183287|NCT00853827|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20183288|NCT01506362|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
20183289|NCT00290732|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
20224354|NCT01794793|RECORDATIGROUP|Mario Maldonado, MD / Head of Clinical Development Global Endocrinology|+41798030344|maldonado.m@recordati.com|
20224355|NCT05013788|The University of Texas Health Science Center at Houston|Monica Kodakandla, MD|713-500-5666|RMonica.Kodakandla@uth.tmc.edu|
20183290|NCT00843193|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183291|NCT00542386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20183292|NCT02982213|Northwestern University|Feyce Peralta, MD|312-472-3585|feyce.peralta@northwestern.edu|
20183293|NCT01104415|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
20183294|NCT03227757|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
20224356|NCT04852679|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20224357|NCT03728985|W.L. Gore and Associates|Rizwan Afzal|1-623-234-5408|rafzal@wlgore.com|
20224358|NCT01294696|Merck Sharp & Dohme Corp|Vice President, Late Stage Group Development Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224359|NCT05633992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20224360|NCT02417961|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
20224361|NCT05079750|University of Oxford|Dr. Paola Cicconi|01865 611425|paola.cicconi@ndm.ox.ac.uk|
20224362|NCT05091346|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20224363|NCT00197002|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224364|NCT02345265|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|Joyce_Liu@dfci.harvard.edu|
20224365|NCT03569293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20224366|NCT04843761|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
20224367|NCT04769466|LifeBio|Lisbeth Sanders|937-303-4574|beth@lifebio.com|
20224368|NCT04542499|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20224369|NCT02142361|Optometry Research Group (GIO)|Robert Montés-Mico O.D., MPhil, PhD Optometry|34-9635-44764|robert.montes@uv.es|
20224370|NCT04281784|University of Washington|Janaki Torrence, Research Coordinator|206-402-7357|jtorrenc@uw.edu|
20224371|NCT04035434|CRISPR Therapeutics AG|Annie Weaver, PhD: Study Director|+1 617-315-4600|info@crisprtx.com|
20224372|NCT04488497|Weill Cornell Medicine|Dr. Iris Navarro Millan|646-962-7875|vam4007@med.cornell.edu|
20224373|NCT02111746|The University of Texas Health Science Center at Houston|Dr. Kristofer M Charlton-Ouw|(713) 486-5100|Kristofer.CharltonOuw@uth.tmc.edu|
20224374|NCT01849068|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
20224375|NCT02210286|Stanford University|Alison Myoraku|6507244559|myoraku@stanford.edu|
20224376|NCT05185622|Santhera|Dr Shabir Hasham|+41 61 906 89 50|Shabir.Hasham@santhera.com|
20224377|NCT02659514|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|9497886700|shanta.chawla@sppirx.com|
20224378|NCT05283135|Oregon Medical Research Center, PC|Benjamin Ehst, MD, PhD|5032451525|behst@oregonmedicalresearch.com|
20224379|NCT00348790|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
20224380|NCT04186806|3M Health Care|Elaine Egging/Project Manger|651-737-0263|eegging@mmm.com|
20224381|NCT03687372|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20224382|NCT02614222|The Cooper Health System|Dr. Ronak Desai|856-342-2000|desai-ronak@cooperhealth.edu|
20224383|NCT03602391|University of Texas at Arlington|JEREMY A FORSBERG|8172722105|ogcs@uta.edu|
20224384|NCT00984139|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224385|NCT02725580|Amicus Therapeutics|Amicus Therapeutics Patient Advocacy|+1 609-662-2000|clinicaltrials@amicusrx.com|
20224386|NCT00878969|Vanderbilt University|T. Alp Ikizler, MD|615-343-6104|alp.ikizler@vanderbilt.edu|
20224387|NCT00655733|Hutchison MediPharma|Hua Mu,Senior Vice President of Clinical Research and Development|861 3564487805|huam@hmplglobal.com|
20224388|NCT02035748|Alcon, a Novartis company|EMEA Medical Affairs Lead, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20224389|NCT00258349|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20224390|NCT01088243|National Jewish Health|Dr. Lisa A. Maier|303-398-1983|MaierL@NJHealth.org|
20224391|NCT01152359|VA Medical Center|William S. Yancy, Jr.|919-286-0411|william.yancy2@va.gov|7770
20224392|NCT02262000|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20224393|NCT01007136|University of Texas Southwestern|Timea Hodics, M.D.||Timea.Hodics@UTSouthwestern.edu|
20224394|NCT02370667|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
20224395|NCT00705718|Medtronic|Karla Betz, Principal Clinical Research Specialist|763-526-2737|karla.h.betz@medtronic.com|
20224396|NCT02954653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224397|NCT03054064|Parker Hannifin Corporation|Ryan J. Farris, Ph.D., P.E.|2168963335|ryan.farris@parker.com|
20224398|NCT01890226|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
20224399|NCT01459718|Novartis Pharmaceuticals|Study Director|862-778-1873||
20224400|NCT01500213|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|862.228.2483|mhuber@tesarobio.com|
20224401|NCT00785213|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20224402|NCT02386345|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
20224403|NCT02612610|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224404|NCT00669019|University of Chicago|Dr. Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
20183295|NCT03297112|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
20224405|NCT02003963|Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632729|amanda.staiano@pbrc.edu|
20224406|NCT00176644|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20224407|NCT01801280|Charité University Hospital - Department of Nephrology|Olesja Rissling|+49 30 450 514 153|olesja.rissling@charite.de|
20183296|NCT01144468|University Health Network|Dr. Angela Cheung|416-340-4841|jscher@uhnresearch.ca|
20183297|NCT02960659|NIDDK|Dr. Stephanie Chung|301-402-2122|stephanie.chung@nih.gov|
20183298|NCT04199728|Penn State College of Medicine|Dr. Scott Bunce|215-510-8295|sbunce@pennstatehealth.psu.edu|
20183299|NCT02703714|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
20183300|NCT05365633|University of Oklahoma|Dr. Julia McQuoid|405-271-8001|julia-mcquoid@ouhsc.edu|1
20183301|NCT01331824|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|212-241-6756|matthew.galsky@mssm.edu|
20183302|NCT01606124|Mayo Clinic|Frank A. Sinicrope, M.D.|507-284-2511|sinicrope.frank@mayo.edu|
20183303|NCT01091454|Mayo Clinic|Alvaro Moreno-Aspitia MD|507-284-1159|morenoaspitia.alvaro@mayo.edu|
20183304|NCT03179787|Otsuka Pharmaceutical Co., Ltd.|Section Chief of Pharmacovigilance|+81-3-6717-1400|Sugimoto.Yuna@otsuka.jp|
20183305|NCT00661778|Hoffmann-La Roche|Medical Communications|800 821-8590||
20183306|NCT02008292|Yale University|Dr. Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
20183307|NCT00427557|MD Anderson Cancer Center|Dr. Partow Kebriaei|713-563-5174|celsaenz@mdanderson.org|
20183308|NCT03667547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183309|NCT04460898|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183310|NCT03223883|University of Iowa Carver College of Medicine|Dr. Diana Jalal|319-356-3500|diana-jalal@uiowa.edu|
20183311|NCT05298111|Universiti Sultan Zainal Abidin|Ms Ong Ying Qian|+60142186195|oyq0109@gmail.com|
20183312|NCT02380742|Loyola University|Brendan Martin, Biostatistician|708-216-8051|bmartin5@luc.edu|
20183313|NCT00580073|University of Wisconsin-Madison|CRA|608-265-4347|smccarthy@medicine.wisc.edu|
20183314|NCT03518112|The University of Texas MD Anderson Cancer Center|Dr. Elias Joseph Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
20183315|NCT02220478|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
20183316|NCT01729819|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20183317|NCT02987543|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20183318|NCT02076919|Alcon Research, Ltd.|Principal Clinical Scientist, CA CSI ID|1-888-451-3937|alcon.medinfo@alcon.com|
20183319|NCT01280591|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20183320|NCT02263508|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20183321|NCT02504619|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
20183322|NCT01259102|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
20183323|NCT01803646|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
20183324|NCT01541358|David Geffen School of Medicine at UCLA|Andrew Quon, MD|310-983-1419|AQuon@mednet.ucla.edu|
20183325|NCT00930813|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
20183326|NCT05790408|Northwestern University|Angelo P. Tanna|3129088152|atanna@northwestern.edu|
20183327|NCT01064817|Promedior, Inc.|Elizabeth G. Trehu, MD|781-538-4203|btrehu@promedior.com|
20183328|NCT00558363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183329|NCT03102710|Massachusetts General Hospital, Harvard Medical School|Jian Kong, Principal Investigator|617-726-7893|jkong2@mgh.harvard.edu|
20183330|NCT01368406|Programa de Esquizofrenia PROESQ UNIFESP|Cecilia Attux|551155733599|cattux@gmail.com|
20183331|NCT01313182|New York University School of Medicine|Dr. Michael Phillips|212 263 4316|michael.phillips@nyumc.org|
20183332|NCT02759731|National Cancer Institute|Dr. Steven Pavletic|240-760-6174|pavletis@mail.nih.gov|
20183333|NCT00606580|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
20183334|NCT01833065|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20183335|NCT00434278|Genentech, Inc.|Medical Communications|800-821-8590||
20183336|NCT00927823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183337|NCT00828672|UZ Leuven|Prof. Dr. Eric Van Cutsem|+32 16 34 42 18|Eric.VanCutsem@uzleuven.be|
20183338|NCT00906698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183339|NCT02430181|Eiger BioPharmaceuticals, Inc|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20183340|NCT00001575|National Cancer Institute|Thomas Waldmann M.D.|301-496-6653|waldmann@nih.hhs.gov|
20183341|NCT00831792|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-7734|PCORN@MDANDERSON.ORG|
20183342|NCT01242085|VA Palo Alto HCS|Steven T Woolson, MD|650-493-5000|steven.woolson@va.gov|66101
20183343|NCT01178762|National Taiwan University Hospital|Yan-Ming Chen / Yu-Chih Hou|886-2-2312-3456|louice1070@gmail.com|62131
20183344|NCT02377362|GLWL Research Inc|Study Director||choruspharma@lists.lilly.com|
20183345|NCT01549652|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
20183346|NCT03068611|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
20183347|NCT03247543|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
20183348|NCT01097343|St. Vincent Medical Group|Dr. Joseph S. Rossi|765 482 0656|jrossi@thecaregroup.com|
20183349|NCT00964119|University of Wisconsin - Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
20183350|NCT02059980|University of Wisconsin-Milwaukee|Dr. Han Joo Lee|414-229-5858|leehj@uwm.edu|
20183351|NCT05365386|Novoxel Ltd|Dr. Ifat Klein|+972.52-6009860|ifat@novoxel.com|
20183352|NCT05196737|Medical University of South Carolina|Gretchen Seif, PT, DPT, MHS, OCS, FAAOMPT|(843) 792-9345|seif@musc.edu|
20183353|NCT03722446|University of Michigan - Department of Anesthesiology|Dr. Carlo Pancaro|617-435-5403|cpancaro@med.umich.edu|
20224408|NCT01546571|Polynoma|Clinical Program Director|5418405451|karihatten@polynoma.com|
20224409|NCT05127304|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224410|NCT01866657|University Hospitals Cleveland Medical Center|Dr. Edwin Avery|440-391-0690|Edwin.avery@uhhospitals.org|
20224411|NCT01421186|MorphoSys AG|Dr Winrich Rauschning, Clinical Project Lead (external)|+4989 89927|winrich.rauschning@external.morphosys.com|0
20224412|NCT01880086|Weill Cornell Medical College|Dr. Peter N. Schlegel|2127465491|pnschleg@med.cornell.edu|
20224413|NCT04360174|Ocular Therapeutix|Chief Medical Officer|7813574000|clinicalaffairs@ocutx.com|
20224414|NCT00214149|UW Hospital and Clinics|Diana Trask, research coordinator for study|608-263-9528|trask@humonc.wisc.edu|
20224415|NCT01323010|University of Sao Paulo|Dr Fabio Pereira Muchão|+5511 983835563|fabiomuchao@gmail.com|
20224416|NCT03973918|ABTC Consortium|Director of ABTC Consortium|410-955-8837|jfisher@jhmi.edu|
20224417|NCT05174949|University of Oklahoma Health Sciences Center|Dr. Yuan Yang (Principal Investigator) C/o Dr. Shirley James (Project Biostatistician)|4052712131|shirley-james@ouhsc.edu|46812
20224418|NCT04351373|Mayo Clinic|Dr. Matthew Carlson|507-284-8532|Carlson.Matthew@mayo.edu|
20224419|NCT04537910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20224420|NCT00896181|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
20224421|NCT00351741|USAISR|Principal Investigator|210-916-3054|kevin.chung@us.army.mil|
20224422|NCT01123941|Novartis Vaccines Institute for Global Health|Dr. Audino Podda, MD|+39 0577 243496|audino.podda@novartis.com|
20224423|NCT04281901|Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.|Domen Vozel, M.D., Saba Battelino, M.D., PhD.|+386 (0)1 522 83 07|domen.vozel@kclj.si|
20224424|NCT03338803|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224425|NCT05168878|University of Colorado|Dr. Maya Haasz|7204789231|maya.haasz@childrenscolorado.org|
20224426|NCT05083923|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20224427|NCT02751879|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224428|NCT03802565|Neurana Pharmaceuticals, Inc.|Randall Kaye, MD - Chief Medical Officer|858-732-0708|rkaye@neuranapharma.com|
20224429|NCT04065451|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
20224430|NCT01996410|OhioHealth|John Elliott|614-566-3643|John.Elliott@ohiohealth.com|
20224431|NCT02251548|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
20224432|NCT04654754|Rush University|Dr. Jie Li|3125634643|jie_li@rush.edu|
20224433|NCT04616573|Sight Sciences, Inc.|Kavita Dhamdhere, MD, PhD|877-266-1144|kdhamdhere@sightsciences.com|
20224434|NCT03839459|University of Rochester Medical Center|Brea Lipe, MD|(585) 275-4099|Brea_Lipe@URMC.Rochester.edu|
20224435|NCT03036098|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20224436|NCT02276053|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20224437|NCT01632904|Incyte Corporation|Study Director|855 463-3463||
20224438|NCT00715104|Dendreon Corporation|Lynn Ngo|206-274-6763|lngo@dendreon.com|
20183354|NCT00635817|Abbott|Global Medical Services|800-633-9110||
20183355|NCT02908464|Beth Israel Deaconess Medical Center|Brian O'Gara, MD, MPH|617-754-3189|bpogara@bidmc.harvard.edu|
20183356|NCT02163915|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20183357|NCT02234128|Lung Bioengineering Inc.|Michael Roberts, Director Regulatory Affairs|2406502261|mroberts@lungbioengineering.com|
20183358|NCT04622527|Mayo Clinic|Dr. Ivana Croghan|507-284-2511|gimresearchstudies@mayo.edu|
20183359|NCT01090024|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183360|NCT00149630|Baylor College of Medicine|Thomas R. Kosten, M.D.|(713) 794-7032|kosten@bcm.edu|
20183361|NCT00567879|Novartis|Study Director|862-778-8300||
20183362|NCT00777556|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20183363|NCT03720990|University of Nebraska Medical Center|William Rizzo|402-559-2560|wrizzo@unmc.edu|
20183364|NCT00377455|Georgetown University|Dr. Virginia Steen|202-444-6200|steenv@georgetown.edu|
20183365|NCT02628093|Weill Cornell Medicine|Koianka Trencheva|646-9622342|kivanova@med.cornell.edu|
20183366|NCT03284411|Medtronic|SCS Dosing Clinical Research Study Team|800-633-8766|rs.scsdosing@medtronic.com|
20183367|NCT01883492|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
20183368|NCT03265210|Weill Cornell Medicine|Dimitris Kiosses, PhD|914-997-4381|dkiosses@med.cornell.edu|
20183369|NCT00796068|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206-667-5925|fmilano@fredhutch.org|
20183370|NCT03357341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20183371|NCT00686517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20183372|NCT02162667|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20183373|NCT01693614|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20183374|NCT02156687|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
20183375|NCT00420316|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224439|NCT02956447|Massachusetts General Hospital|Dr. Stephanie Seminara|617-724-5390|MGHKisspeptinResearch@partners.org|
20224440|NCT02907593|Oregon Health & Science University|Dr. Cindy McEvoy|5034945598|mcevoyc@ohsu.edu|
20224441|NCT05103176|University of Michigan|Dr. Michael Vesia, Assistant Professor|734 763-3905|mvesia@umich.edu|
20183376|NCT02281318|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183377|NCT01281813|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20183378|NCT05257798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206613|NCT00878644|University of Utah|Marianne Gildea, BSN, MS; Director of THAPCA Trials|801-608-4907|marianne.gildea@hsc.utah.edu|
20183379|NCT00812877|Oregon Health & Science University|Dr. Thomas J. Hilton|503.494.8672|hiltont@ohsu.edu|
20206614|NCT00547729|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
20206615|NCT01280812|UC San Francisco|Yoshimi Fukuoka, PhD, RN, FAAN|415-476-8419|yoshimi.fukuoka@ucsf.edu|
20206616|NCT00681291|LifeCell|Donna Jacobs|908-809-7856|djacobs@lifecell.com|
20206617|NCT00086385|University of California, San Francisco|Sharon M. Hall, PhD|415-476-7574|sharon.hall@ucsf.edu|
20206618|NCT01149772|Michael E. DeBakey VA Medical Center|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
20206619|NCT03424044|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
20206620|NCT02935595|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|(713) 486-2500|Sudhakar.Selvaraj@uth.tmc.edu|
20206621|NCT00442611|Stanford University|Dr. Lorinda Chung|(650)493-5000|shauwai@stanford.edu|6242
20206622|NCT00784459|Washington University|Dr Jonathan Green|314-747-3591|jgreen@wustl.edu|
20206623|NCT01376388|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206624|NCT02108223|Sisli etfal training anf research hospital|Fatma yazıcı yılmaz|+905079234033|fatmayazc@gmail.com|
20206625|NCT02252068|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
20206626|NCT02568852|Haseki-156|Dr.Turgut Donmez|00905347400967|surgeont73@hotmail.com|
20206627|NCT02471586|Abbott|Kristina M Gibbens, Senior Clinical Project Manager|+1 651-756-3859|Kristina.gibbens@abbott.com|
20206628|NCT06103591|EmStop, Inc.|Phil Ebeling, CEO|763-227-9954|phil.ebeling@emstopeps.com|
20183380|NCT00703911|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20206629|NCT01510834|Pacific Health Research and Education Institute|Laurel King, PhD|808-564-5711|laurel.king@va.gov|
20206630|NCT04839393|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206631|NCT00671970|Dana Farber Cancer Institute|Dr. David Reardon|(617) 632-2166|David_Reardon@DFCI.HARVARD.EDU|
20206632|NCT01510028|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20206633|NCT00633893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20206634|NCT02741310|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20206635|NCT05091918|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
20206636|NCT01766986|University Hospital Hamburg-Eppendorf|Dr. Matthias Reeh|+49015222816521|m.reeh@uke.de|
20206637|NCT01100658|Masonic Cancer Center, University of Minnesota|Alicia Kunin-Batson|612-624-6931|kunin003@umn.edu|
20206638|NCT01784211|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20206639|NCT02668952|Dept of Anesthesiology, University of New Mexico|Neal Gerstein, MD|5052722610|ngerstein@salud.unm.edu|
20206640|NCT00239356|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20206641|NCT02044822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20206642|NCT03417505|Tangible Science|Dr. Kelly Mabry|650-241-1045|kelly@tangiblescience.com|108
20206643|NCT05686044|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
20206644|NCT00364819|University of California Davis|Christopher L. Bowlus, MD|916-734-8986|clbowlus@ucdavis.edu|
20206645|NCT03437044|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
20206646|NCT00391807|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20206647|NCT02351739|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20206648|NCT01998438|Fuwai Hospital|Dr. Hongwen Ji|+86 13701229553|jihongwen@hotmail.com|
20206649|NCT03725293|Beaumont Hospitals|Amit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
20206650|NCT02143141|Wake Forest School of Medicine|Dr. Jessica Booth|3367188278|jbooth@wakehealth.edu|
20206651|NCT04965116|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
20206652|NCT01975675|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20206653|NCT00224003|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
20183381|NCT02082158|National Center for Occupational Health and Infection Control|Aaron Eagan|352-376-1611|aaron.eagan@va.gov|4973
20183382|NCT02274493|UT MD Anderson Cancer Center|Dr. Jesse C Selber / Professor, Plastic Surgery|713-794-1297|jcselber@mdanderson.org|
20183383|NCT03131206|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
20183384|NCT00286741|Durham VA Medical Center|David Edelman|919-286-6936|dedelman@duke.edu|
20183385|NCT00957229|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
20183386|NCT00543725|Janssen Infectious Diseases BVBA|Medical Leader|32 14 641418||
20206654|NCT01575899|Buddhist Tzu Chi General Hospital|Dr. Ming-Cheh, Chen|+886-910-521003|MingCheh_chen@tzuchi.com.tw|
20206655|NCT02807844|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20206656|NCT00709124|Johns Hopkins University School of Medicine|Dr Dale Needham|(410) 955-3467|dale.needham@jhmi.edu|
20206657|NCT00373490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206658|NCT00108953|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20206659|NCT00753688|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206660|NCT03803202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206661|NCT01367860|IOT/HC University of SãoPaulo|Dr. Alexandre Cristante Fogaça|+55 11 2661-6951|aacristante@uol.com.br|
20206662|NCT02925312|Medstar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
20206663|NCT02766907|TissueTech|VP Medical Affairs|8882968858|hsheha@tissuetechinc.com|
20206664|NCT00701441|Ohio State University|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
20206665|NCT00537680|Santhera Pharmaceuticals|Dr Thomas Meier|+41619068964|thomas.meier@santhera.com|
20183387|NCT01250002|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
20183388|NCT02322216|Alcon, a Novartis Company|Clinical Project Lead, GCRA-Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20183389|NCT02410291|Sunnybrook Health Sciences Centre|Krista Dawdy, Clinical Educator|416 480 6104|krista.dawdy@sunnybrook.ca|
20183390|NCT03608670|Medtronic Cardiac Rhythm Management|CRM Clinical Research|+1 800 328 2518|rs.medtronicCRMtrials@medtronic.com|
20183391|NCT01651949|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224442|NCT05128773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20224443|NCT04697056|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20224444|NCT01451164|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
20224445|NCT01668966|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20224446|NCT04495816|Icahn School of Medicine at Mount Sinai|Dr. David Lerner|212-241-9410|david.lerner2@mountsinai.org|
20224447|NCT02901275|Johns Hopkins University School of Medicine|Dr. Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
20224448|NCT06137703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224449|NCT01527487|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20224450|NCT01384019|Seoul national university Bundang hospital|Dr. Chang-Hwan Yoon|+82-31-787-7052|changhwanyoon@snubh.org|
20224451|NCT01695330|Oncotherapeutics|Dr. James Berenson|310-420-9649|jberenson@berensonocology.com|
20224452|NCT00640653|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
20224453|NCT00597506|Duke University Medical Center|Herbert Hurwitz, MD|919-668-1861|herbert.hurwitz@duke.edu|
20224454|NCT02961062|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20224455|NCT03199612|Montefiore Einstein|Omar Saeed|718-920-2626|osaeed@montefiore.org|
20183392|NCT00678795|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20183393|NCT01191086|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|bob.anders@upsher-smith.com|
20183394|NCT01636206|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20183395|NCT02057718|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20183396|NCT01320072|Montefiore Medical Center|Dr. Elina Jerschow, attending physician|9173625291|ejerscho@montefiore.org|
20183397|NCT00434018|VACO|Dr. Shirley Groer|202-553-9899|Shirley.Groer@va.gov|
20183398|NCT04059237|Stanford University|Catherine Benedict, PhD|650-498-9111|cbenedict@stanford.edu|
20183399|NCT00608907|Johnson & Johnson Pharmaceutical Research & Development|Helgi van de Velde, MD, PhD||HVDVELDE@ITS.JNJ.COM|
20183400|NCT00906035|Upenn|Emile Mohler, MD|215-573-6606|Emile.Mohler@uphs.upenn.edu|
20183401|NCT03058991|Boston University Charles River Campus|Dr. Michael Otto|617-353-9610|mwotto@bu.edu|
20183402|NCT01689519|Hoffmann-La Roche|Medical Communications|800 821-8590||
20183403|NCT01787240|MGH|Dr. Cristina Cusin|617 726 6421|ccusin@partners.org|
20183404|NCT01161563|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
20183405|NCT00559949|UNC Lineberger Comprehensive Cancer Center|Dr. David Neil Hayes|919-966-3786|hayes@med.unc.edu|
20183406|NCT03320096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20183407|NCT01992354|GE Healthcare|John Strohmeyer|+1 609 865 7423|john.strohmeyer@ge.com|
20183408|NCT01559506|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
20183409|NCT00835380|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183410|NCT00917865|Emory University|David Schuster, MD|404-712-4859|dschust@emory.edu|
20183411|NCT03098966|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20183412|NCT01582945|Massachusetts General Hospital|Dr. Cristina Cusin|6177266421|ccusin@mgh.harvard.edu|
20183413|NCT01726023|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.Wilson2@astrazeneca.com|
20183414|NCT00816829|Solvay Pharmaceuticals|Sven Voet, Global Communication|+32 (0) 2 509 69 77|sven.voet@solvay.com|
20183415|NCT03643211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183416|NCT04858425|First Wave BioPharma|VP, Regulatory, QA & Compliance|19194491484|AChandler@FirstWaveBio.com|
20183417|NCT05457491|Mayo Clinic|Saranya P. Wyles, M.D., Ph.D.|507-284-5475|Wyles.Saranya@mayo.edu|
20183418|NCT04536077|Washington University School of Medicine|Roheena Z. Panni, M.D.|314-362-7046|roheenazpanni@wustl.edu|
20183419|NCT04798521|Oregon Health & Science University|Dr. P. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20183420|NCT02443792|U of Cape Town|Dr. Justin Shenje|0027788938497|justintshenje@gmail.com|
20183421|NCT04550039|Shirley Ryan AbilityLab|Katherine Enzler, Physical Therapist|312-238-2941|kenzler@sralab.org|
20183422|NCT04548622|Yale University Department of Psychiatry|Dr. Philip R. Corlett PhD|(203) 974-7866|philip.corlett@yale.edu|
20183423|NCT02908620|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
20183424|NCT01155869|Providence VA Medical Center|Peter Friedmann|401-273-7100|peter.friedmann@va.gov|6240
20183425|NCT01843465|Clinique Pasteur, Toulouse, France|Dr Serge Boveda|(33) 5 62 21 16 45|sboveda@clinique-pasteur.com|8819
20183426|NCT02824432|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20183427|NCT00967369|UT MD Anderson Cancer Center|Dr. Michelle A Fanale / Associate Professor, Lymphoma/Myeloma|713-792-2860|MFANALE@MDANDERSON.ORG|
20183428|NCT05824351|Duke University|Amy Barto, MD|919-684-1817|amy.barto@duke.edu|
20183429|NCT00828945|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183430|NCT04164563|Brigham and Women's Hospital|Dr. Jeremy T. Smith|6177325322|jsmith42@bwh.harvard.edu|
20224456|NCT02938949|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
20224457|NCT00371644|VA North Texas Health Care System|Dr. Alina Suris|2148572312|alina.suris@va.gov|
20224458|NCT00526331|UT MD Anderson Cancer Center|Gabriel Mena, MD / Professor||CR_Study_Registration@mdanderson.org|
20191688|NCT01780584|Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita|Dr Eva M Marwali, Principal Investigator|+62215684085|evamarwali@yahoo.com|2807
20191689|NCT04783519|University of Washington|Mary Larimer|(206) 543-3513|larimer@uw.edu|
20191690|NCT00645099|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
20191691|NCT01201915|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20191692|NCT03406507|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
20191693|NCT00381797|St. Jude Children's Research Hospital|Shengjie Wu|(901) 595-2859|shengjie.wu@stjude.org|
20191694|NCT00684203|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191695|NCT01699698|Kyushu University|Dr. Taketo Matsunaga|092-642-5444|mtaketo@surg1.med.kyushu-u.ac.jp|
20191696|NCT00719212|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+33 (1) 58 10 08 89|matthieu.rupin@trioncology.org|
20191697|NCT00837096|Acelity|VP, Global Clinical Affairs|210-255-5595|jane.hart@acelity.com|
20191698|NCT00488319|Johnson & Johnson Research & Development, LLC|Director Clinical Research|1-609-730-6771||
20191699|NCT01982786|Canadian cancer trials group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
20191700|NCT01011049|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20191701|NCT00352053|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20191702|NCT02435381|Baylor College of Medicine|Christopher D. Verrico Ph.D.|713-791-1414|Cverrico@bcm.edu|26020
20191703|NCT01490359|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
20191704|NCT04150341|Theravance Biopharma US, Inc|Nathan Pfeifer|001 (650) 808-3711|npfeifer@theravance.com|
20191705|NCT00875615|University of Miami Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4981|lfeun@med.miami.edu|
20191706|NCT03713073|The University of Texas Health Science Center at Houston|Chun-Teh Lee, DDS, DMSc, MS|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
20191707|NCT01907113|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191708|NCT00833898|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9279|biel@ucdenver.edu|
20191709|NCT02176382|Massachusetts General Hospital|Dr. Joy Tsai|6177266723|jntsai@mgh.harvard.edu|
20191710|NCT02209610|VAORD|Dr Markus Amann|801-582-1565|markus.amann@hsc.utah.edu|4358
20191711|NCT00387959|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
20191712|NCT03897049|dfusion, Inc|Tamara Kuhn, Vice President & Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
20191713|NCT03441789|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20191714|NCT03168425|Vanderbilt University Medical Center|Sarah Osmundson, MD|+1 (615) 343-5700|sarah.osmundson@vumc.org|
20191715|NCT01960114|McNeil Consumer Healthcare|Rajesh Mishra, MD, PhD/Vice President, Medical/Clinical Affairs, Global OTC|215-273-8569 USA EST|rmishr16@its.jnj.com|
20191716|NCT01176435|University of Minnesota|C. Gail Summers, MD|612-625-6469|summe001@umn.edu|
20191717|NCT02845375|Leiden University Medical Center|Dr Albert Dahan|+31715262301|a.dahan@lumc.nl|
20191718|NCT01177137|Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health|Roberta W. Scherer, Director Data Coordinating Center|410 502 4636|rschere1@jhu.edu|
20191719|NCT04970381|Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Prof. Yan Liang|+8618801287180|fwyy2803@163.com|
20191720|NCT02959177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20191721|NCT03389451|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
20191722|NCT02215954|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20191723|NCT02460562|Faculty of Dentistry, Thammasat University|Dr. Kritirat Kiatsirirote|662-9869213-5|kkritirat@yahoo.com|7150
20191724|NCT01951261|Hospital Puerta de Hierro|Dra Patricia Mínguez Clemente|911916859|drapat3@gmail.com|
20191725|NCT01924806|Smith & Nephew|Henry Jaimes|01923-477-164|henry.jaimes@smith-nephew.com|
20191726|NCT00999141|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
20191727|NCT03690284|University of Texas Southwestern|Clinical Research Coordinator|3106127741|matthew.oh@utsouthwestern.edu|
20191728|NCT04098497|University of Wisconsin - Madison|Amy Cochran|(608) 262-0772|cochran4@wisc.edu|
20191729|NCT02046941|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
20191730|NCT03455218|Medical College of Wisconsin|Robert Niebler, MD|4142663360|rniebler@mcw.edu|
20191731|NCT00297778|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191732|NCT02996097|Johns Hopkins School of Medicine|Dr. Ginette Okoye|9142158980|ginette.okoye@howard.edu|
20191733|NCT02201771|Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Yunpeng Zhu|008613816819346|zypB1014@rjh.com.cn|
20191734|NCT03569475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20191735|NCT02109107|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20191736|NCT03697083|University of Pennsylvania|Katherine K. Milkman Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
20191737|NCT01643902|Johns Hopkins University School of Medicine|Victor C. Urrutia|410-955-2228|vurruti1@jhmi.edu|
20191738|NCT03078751|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20191739|NCT02515097|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
20191740|NCT00853021|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
20191741|NCT03613454|University of Alabama at Birmingham|Dr. AJ Gunn|205-975-4850|agunn@uabmc.edu|
20224459|NCT01043705|Medtronic plc|Lynn Landborg, Clinical Research Manager|763 526 2877|lynn.landborg@medtronic.com|
20224460|NCT00581542|University of Rochester, Strong Mem orial Hospital|Franci Gigilotti|585 275-0588|francis_gigilotti@urmc.rochester.edu|
20224461|NCT05020366|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
20224462|NCT00392496|Sunnybrook Health Sciences Centre|Dr. Rena Buckstein|416-480-5847|rena.buckstein@sunnybrook.ca|
20224463|NCT04150705|Washington University School of Medicine|Tyler Fraum, M.D.|314-362-2928|tylerjfraum@wustl.edu|
20224464|NCT04050124|NYU Langone Health|Scott Gorenstein, MD|5166638498|Scott.Gorenstein@nyulangone.org|
20224465|NCT04601103|3M Health Care Business Group|Brenda Coalwell, Clinical Affairs Manager|16517362456|bccoalwell1@mmm.com|
20224466|NCT03336268|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
20224467|NCT06011161|VISN 2 Center of Excellence for Suicide Prevention|Dev Crasta|585-364-8119|Dev.Crasta@va.gov|
20224468|NCT04442269|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20224469|NCT03559868|Yale University, Yale School of Medicine|Mehal Wajahat MD, DPhil|877.925.3637|wajahat.mehal@yale.edu|
20224470|NCT00430352|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20224471|NCT04326439|Emory University|Dr. Himalee Sabnis|404-727-3285|hsabnis@emory.edu|
20224472|NCT05805085|CooperVision Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
20224473|NCT02291601|Bioscience Labs|C Beausoleil|460-782-5498|cbeausoleil@biosciencelabs.com|
20224474|NCT05870956|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224475|NCT00347919|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224476|NCT01597375|Brigham and Women's Hospital|Tanya Laidlaw|617-525-1034|tlaidlaw@bwh.harvard.edu|
20224477|NCT03379753|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
20224478|NCT01032239|Medtronic Clinical Neuromodulation|Alessandra Calabrese, PhD||alessandra.calabrese@medtronic.com|
20224479|NCT02738255|Brigham and Women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
20224480|NCT00624195|UCSD|Dr. Ron Ellis|619-543-5079|roellis@ucsd.edu|
20224481|NCT01508052|Gachon University|Dr.Kwak|82324603400|hyun615@gilhospital.com|
20224482|NCT04535531|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20224483|NCT04713592|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20224484|NCT00654992|Seoul National University Bundang Hospital|Effect of erythropoietin in kidney after cardiac surgery|82-31-787-7014|kyna@snubh.org|
20224485|NCT02225366|UT MD Anderson Cancer Center|Dr. Rodabe Amaria,MD, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|rnamaria@mdanderson.org|
20224486|NCT01190267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224487|NCT01056198|Healthpoint Biotherapeutics|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
20224488|NCT04017832|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20224489|NCT01382225|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20224490|NCT02426749|University of Manitoba|Dr Zahra Moussavi|204 474 7023|Zahra.Moussavi@umanitoba.ca|
20224491|NCT01852201|Medical University of SC|Jonathan Lena, MD|843-792-9226|lena@musc.edu|
20224492|NCT02513498|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
20224493|NCT02484651|Universidade Aberta, Mathematics Section|Prof. Catarina S Nunes|+351 300 001 705|cnunes@bio-mathematics.org|
20224494|NCT01419080|Saint Luke's Hospital of Kansas City|John Spertus|816-932-8270|jspertus@saint-lukes.org|
20224495|NCT03040804|Montefiore Medical Center|Steven R. Cohen, MD, MPH|7189208352|srcohen@montefiore.org|
20224496|NCT02266472|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20224497|NCT01077739|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20224498|NCT00877071|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
20224499|NCT05723328|Hackensack Meridian Carrier Clinic|Zachary D. Fischer PhD, MT-BC|908-281-1324|Zachary.Fischer@hmhn.org|
20183431|NCT02698241|Medtronic CRHF Clinical Research|Joe Hobbs Clinical Research Specialist|800-633-8766|joe.hobbs@medtronic.com|
20183432|NCT04969991|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
20183433|NCT03645031|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
20183434|NCT00482729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20183435|NCT01546155|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
20183436|NCT02930343|JIPMER|Dr Pooja Belani|8940482248|drpoojabelani@gmail.com|
20183437|NCT02899000|Galderma Laboratories, LP|Dr. Jean Philippe York, Medical Affairs Manager|1-817-961-5468|jp.york@galderma.com|
20183438|NCT03224299|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
20183439|NCT03646669|Icahn School of Medicine at Mount Sinai|Maria Peralta|212-274-7571|Maria.peralta@mountsinai.org|
20183440|NCT00309452|Yale University|Vinod H. Srihari|2039747816|vinod.srihari@yale.edu|
20183441|NCT02814643|AstraZeneca|Mitchell Goldman MD, PhD|+1 610 457 5585|Mitchell.Goldman@astrazeneca.com|
20183442|NCT03686813|Duke University|Richard Moon, M.D.|919-684-8762|richard.moon@duke.edu|
20183443|NCT02614560|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20183444|NCT00549848|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
20183445|NCT00130780|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris, Attending|+1646-888-4205|krism@mskcc.org|
20224500|NCT05537792|Georgia Institute of Technology|Dr. Aaron Young|404.385.5306|aaron.young@me.gatech.edu|
20224501|NCT03495154|Medtronic|Alyssa Sutch, Senior Clinical Research Specialist|612-214-9756|alyssa.m.sutch@medtronic.com|
20224502|NCT05376241|University of Colorado|Laura Scherer|303-724-5749|laura.scherer@cuanschutz.edu|
20224503|NCT05773781|University of Liverpool|Mr Jason Fleming|0151 529 5259|Jason.Fleming@liverpool.ac.uk|
20224504|NCT02059434|AstraZeneca|AstraZeneca Clinical Study Information Center||ClinicalTrialTransparency@astrazeneca.com|
20224505|NCT00929474|St. Jude Medical|Manager of Clinical Studies|818-493-2522|klee3@sjm.com|
20224506|NCT03201874|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
20224507|NCT03050541|University of Chicago|Office of Clinical Research|(773) 834-1238|tkyeo@bsd.uchicago.edu|
20183446|NCT05193318|Metrohealth Hospital System (formerly employee of Medical University of South Carolina)|Eric Dobson, MD (principal nvestigator)|513-504-2091|edobson@metrohealth.org|
20224508|NCT04644185|Sinocelltech Ltd.|Dr.|13522038372|yuanxin_chen@sinocelltech.com|
20224509|NCT01702532|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224510|NCT03790618|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20224511|NCT00842075|UColorado|Dr. H. Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
20224512|NCT00546455|UCSD|MARIO CHOJKIER|858-552-8585|mchojkier@gmail.com|7283
20224513|NCT00345878|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224514|NCT02102100|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehemt.sofuoglu@yale.edu|4809
20224515|NCT04076059|Astellas Pharma China, Inc|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|China only
20224516|NCT02677896|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
20224517|NCT03902522|CytoDyn|Joseph Meidling|13609808524|jmeidling@cytodyn.com|
20224518|NCT02729038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20224519|NCT05363072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224520|NCT03719287|3M|Helen Han|651-737-9234|mhan3@mmm.com|
20224521|NCT01128218|SIU Medicine|Barbara Lokaitis, BA, CCRP / Senior Clinical Research Coordinator|217.545.9737|blokaitis@siumed.edu|
20224522|NCT03536949|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
20224523|NCT02160847|Georgia State University|Dr. Jenelle Shanley Chatham|404-413-1340|jshanley@gsu.edu|
20224524|NCT04329091|UNIVERSITY OF CHICAGO|Al McAuley, Clinical Research Manager|7738343274|amcauley1@bsd.uchicago.edu|
20224525|NCT04106089|Rutgers University Camden|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
20224526|NCT00741091|Boston Scientific Corporation|Todd Kornmann, Specialist, Prin Reg Affairs|763-494-1348|Todd.Kornmann@bsci.com|
20224527|NCT01801358|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
20224528|NCT03787303|Aultman Hospital|Shruti Trehan MD|3303634162|trehanshruti4@gmail.com|
20224529|NCT00108342|Department of Veterans Affairs - VAGLA|Nina G. Schneider, Ph.D., Principle Investigator|310-268-3059|ngs@ucla.edu|
20224530|NCT01210495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224531|NCT03141983|University of Pennsylvania|Natalie Kuzla|2672524208|nkuzla@pennmedicine.upenn.edu|
20224532|NCT00767039|Boston Medical Center|Alan Fujii MD (PI)|617-4414-3735|Alan.Fujii@bmc.org|
20224533|NCT01826370|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224534|NCT01575275|Cleveland Clinic|Dr. Michael Vogelbaum|2164448564|vogelbm@ccf.org|
20224535|NCT04416737|Stanford University|Dr. Rayhan Lal|650-725-2908|inforay@stanford.edu|
20224536|NCT03332628|University of Iowa|Nicole Brogden, Associate Professor|(319) 335-8752|nicole-brogden@uiowa.ed|
20224537|NCT01472757|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
20224538|NCT02619396|John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust|Dr Milena Leo|0186522055|milena.leo@ouh.nhs.uk|
20224539|NCT02833935|McGill University|Shane Sweet|514-398-4184|shane.sweet@mcgill.ca|09903
20224540|NCT02505334|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20224541|NCT02543892|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20224542|NCT00081731|University of Toledo|Christopher Cooper, MD|419-383-6297|christopher.cooper@utoledo.edu|
20224543|NCT01259375|Huntsman Cancer Institute|Dr. Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
20224544|NCT00628095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224545|NCT03124121|Guy's & St Thomas' Hospital|Dr Mark Samaan|07740637713|mark.samaan@gstt.nhs.uk|
20224546|NCT00478699|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
20224547|NCT04060199|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
20224548|NCT01005888|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20224549|NCT02635542|University of Chicago|Rebecca M Gerlach, MD|773-702-6700|rgerlach@dacc.uchicago.edu|
20224550|NCT01065714|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20224551|NCT01260272|L-MARC Research center|Kathy Schmitz, Site Manager|502 214 3990|kschmitz@lmarc.com|
20224552|NCT01629290|University of Michigan School of Dentistry|Danika Downey, DDS|330-877-8783|danika.downey@gmail.com|
20183447|NCT02846415|School of Nursing, The Hong Kong Polytechnic University|Dr Daphne Cheung|+852 27664534|cheungdaphne@polyu.edu.hk|
20183448|NCT00667693|Cleveland Clinic Foundation|Daniel I Sessler, MD|216-445-8396|sesslerd@ccf.org|
20183449|NCT03383887|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
20183450|NCT00300456|Abbott|Medical Information Specialist|800-633-9110||
20183451|NCT05097573|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20183452|NCT00742573|New York State Psychiatric Institute|Mark Olfson, MD, MPH|646-774-6413|mark.olfson@nyspi.columbia.edu|
20224553|NCT00656851|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
20224554|NCT03584464|Medtronic, plc|Alissa Anderson, Clinical Study Manager|7075912434|alissa.anderson@medtronic.com|
20224555|NCT04424966|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
20224556|NCT03932331|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20224557|NCT03782298|Smtih + Nephew, Inc|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
20224558|NCT01797081|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20224559|NCT00359736|Miami VAHS|Dr. Robert M Jackson, ACOS/R|305-575-3548|robert.jackson4@va.gov|
20206666|NCT01225172|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20224560|NCT02057419|The Miriam Hospital|Dr Kate Guthrie, Principal Investigator, Project WISH Lead Investigator|401-793-8180|kate.guthrie@brownhealth.org|
20224561|NCT05513703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20206667|NCT03001310|MeiraGTx|Program Manager|0044 (0)20 3866 4320|CNGB3@meiragtx.com|
20224562|NCT02767492|Hawkins Foundation|Kyle Adams|864 454-7458|kyle.adams@hawkinsfoundation.com|
20206668|NCT03404518|Loma Linda University Health System|Khanh Nguyen, MD|909-558-8558|khanguyen@llu.edu|
20206669|NCT01347632|CONRAD|Andrea Thurman|757-446-7444|thurmaar@evms.edu|
20206670|NCT03693404|NYU Langone Health|Philipp Leucht, MD|646-501-0291|philipp.leucht@nyulangone.org|
20206671|NCT01576406|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224563|NCT01793688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206672|NCT00651313|Columbia Laboratories, Inc.|George W. Creasy, MD Vice President, Clinical Research|973-486-8797|gcreasy@columbialabs.com|
20206673|NCT03328624|SALSA@USC|Research Coordinator|323-442-5528|dhuyvett@usc.edu|
20206674|NCT00892957|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
20224564|NCT03649178|Vanderbilt University Medical Center|C. Michael Stein MD|615-936-3420|michael.stein@vumc.org|
20206675|NCT01760187|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|8572425142|alison.long@aegerion.com|
20206676|NCT05151367|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
20206677|NCT01962688|Icahn School of Mediine at Mount Sinai|Dr. Jagat Narula|212-241-4122|jagat.narula@mountsinai.org|
20206678|NCT04482244|Dana-Farber Cancer Institute|Dr. Manan Nayak|617-632-5096|manan_nayak@dfci.harvard.edu|
20224565|NCT03003494|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206679|NCT02823080|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
20206680|NCT00676208|Louis Stokes VA Medical Center|Michelle Davidson|(216) 791-2300|michelle.davidson@va.gov|2338
20224566|NCT05238025|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20224567|NCT01638312|Kaohsiung Medical University Chung-Ho Memorial Hospital|JihJin Tsai, MD|886-7-3121101|jijits@cc.kmu.edu.tw|6358
20224568|NCT02754674|Samsung Medical Center|Wang, JoonHo|82-2-3410-3507|mdwang88@gmail.com|
20224569|NCT02135107|Eisai Co., Ltd. and EA Pharma Co., Ltd.|Public Relations Group (EA Pharma Co., Ltd.)|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
20224570|NCT03083561|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20224571|NCT05523011|Paracrine Therapeutics Private Limited|Lai Ruenn Chai|+6593375977|ruennchai.lai@paracrinetherapeutics.com|
20224572|NCT02278120|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20224573|NCT03197324|Theracos Sub, LLC|Albert Collinson, Ph.D.|508-688-4221|acollinson@theracos.com|
20224574|NCT00102531|Insmed|Margaret Galluzzi|(908) 977-9900|Margaret.Galluzzi@Insmed.com|
20224575|NCT00288067|University of Washington|Dr. Ajay Gopal|206-288-2035|agopal@uw.edu|
20224576|NCT00954512|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224577|NCT05685732|Corium, LLC|Ronald Tashjian|6172337474|rtashjian@corium.com|
20224578|NCT02640404|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20224579|NCT05250102|Medline Industries, LP|Julie J. Finley|(800) 633-5463|jjfinley@medline.com|
20224580|NCT04908202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20224581|NCT05397171|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20224582|NCT02100670|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224583|NCT00538512|University of Michigan School of Public Health|Arnold S. Monto, MD|734-764-5453|asmonto@umich.edu|
20224584|NCT01390428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224585|NCT00642603|Genentech, Inc.|Medical Communications|800-821-8590||
20224586|NCT05897827|University of Pittsburgh|Robert W. S. Coulter|412-624-0647|robert.ws.coulter@pitt.edu|
20224587|NCT01004406|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
20224588|NCT02928770|Stanford University|Clete A. Kushida, M.D., Ph.D.|6507217560|clete@stanford.edu|
20224589|NCT01752634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20224590|NCT01196936|University of Alabama at Birmingham|Dr. Smita Bhatia|(205) 638-2120|sbhatia@peds.uab.edu|
20224591|NCT06474078|Chang Gung Memorial Hospital|Dr. Chun Bing Chen|03-3281200|chunbing.chen@gmail.com|8494
20224592|NCT05562934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20224593|NCT04216784|Rush University Medical Center|Lance Lineberger|312-942-5126|Lance_Lineberger@rush.edu|
20224594|NCT00962949|Vanderbilt University Medical Center|Hossam Mustafa|615-343-6499|adcresearch@vanderbilt.edu|
20224595|NCT05409131|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20224596|NCT04250714|Boston Scientific|Nele Cielen - Clinical Trial Manager|0032470991143|nele.cielen@bsci.com|
20224597|NCT05741346|BioCryst Pharmaceuticals Inc.|Study Director|+001 919859 1302|clinicaltrials@biocryst.com|
20224598|NCT03711058|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|610-614-9169|nazad2@jhmi.edu|
20224599|NCT05573672|Canadian College of Naturopathic Medicine|Monique Aucoin|416 498 1255|maucoin@ccnm.edu|223
20206681|NCT00669032|Tedec-Meiji Farma, S.A.|R&D Director|918870980|m.gimeno@tedecmeiji.com|
20191742|NCT04167085|David Geffen School of Medicine at UCLA|Justin P. McWilliams, MD, FSIR|(310) 267-8773|jumcwilliams@mednet.ucla.edu|
20191743|NCT03249272|Duke Cardiovascular Magnetic Resonance Center|Han Kim, MD|9196683539|han.kim@duke.edu|
20191744|NCT02273180|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20191745|NCT02154516|Smith and Nephew|Clinical Study Manager|0499905851|stephanie.rufo@smith-nephew.com|+61
20191746|NCT00966641|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
20191747|NCT03859622|Karl Landsteiner Institute of General Medicine|Dr.med.Gustav Kamenski|+4322832226|kamenski@aon.at|
20191748|NCT02965599|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191749|NCT01431105|UC San Diego|Adriana Tremoulet|858-246-0012|atremoulet@ucsd.edu|
20191750|NCT02946788|Timber Pharmaceuticals|Alan Mendelsohn, MD|12673004249|amendelsohn@timberpharma.com|
20191751|NCT04435522|Rhode Island Hospital|Philip Chan, M.D.|401-793-4859|philip_chan@brown.edu|
20191752|NCT02868788|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
20191753|NCT02799745|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20202899|NCT03849560|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
20202900|NCT00807664|Coloplast|Dr Birte Petersen Jacobsen|004549110000|DKBIR@coloplast.com|1395
20202901|NCT01396525|AbbottVascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
20202902|NCT03739983|University of Wisconsin Carbone Cancer Center|Ryan Spencer, MD, MS|608-265-1700|rjspencer2@wisc.edu|
20202903|NCT01753518|Mayo Clinic|Dr. Margaret Dow|507-266-8008|dow.margaret@mayo.edu|
20202904|NCT00940342|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
20202905|NCT00553787|Vivus, Inc|Wesley W Day PhD|650-934-5200|day@vivus.com|
20202906|NCT01088412|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20202907|NCT00793104|RI Biologics|Robin Waite , Clinical Projects Director|386-418-8888|rwaite@rtix.com|
20202908|NCT00754767|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
20202909|NCT03494725|DuPont Nutrition and Biosciences|Elaine Patterson, Ph. D.|+358-40-4827-626|elaine.patterson@dupont.com|
20202910|NCT02619253|IndianaU|Dr. Nabil Adra|317-278-7728|nadra@iu.edu|
20202911|NCT00514449|Western Psychiatric Institute and Clinic|Dr. Konasale Prasad|412-586-9014|prasadkm@upmc.edu|
20202912|NCT04083144|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|4165358501|bernard.lefoll@camh.ca|33111
20202913|NCT01363843|BrUOG|William Sikov, MD and Kimberly Perez, MD|4018633000|kayla_rosati@brown.edu|
20202914|NCT01811030|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20202915|NCT01462292|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202916|NCT02333045|Emory University|Anandi Sheth, MD|404-616-6240|ansheth@emory.edu|
20202917|NCT00206518|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
20202918|NCT02335450|Oakland University|Beth Black|248-364-8694|bblack@oakland.edu|
20202919|NCT04538950|Mayo Clinic|John P. Bois, M.D.|507 284-4072|Bois.John@mayo.edu|
20202920|NCT01748695|Brigham and Women's Hospital|Dr. Christine N. Sang, Director of Translational Pain Research|617-525-7246|csang@partners.org|
20202921|NCT00847561|The Johns Hopkins University School of Medicine|Dr. Golda Ginsburg|410-955-1544|gginsbu@jhmi.edu|
20202922|NCT01707147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202923|NCT04435769|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202924|NCT02489630|Virginia Tech SOM / Carilion Clinic (prior)|Dr Karen J Bowers, co-PI|678-591-7280|bowerskj@gmail.com|
20202925|NCT01056523|Jewish General Hospital|Dr. Assouline|514-340-8222|sarit.assouline@mcgill.ca|8434
20202926|NCT03429556|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20202927|NCT03165981|Duke University|Dr. Emmanuel B. Walter|919-620-5346|chip.walter@duke.edu|
20202928|NCT06384989|The Ohio State University|Julie Mansfield|614-366-2101|julie.mansfield@osumc.edu|
20202929|NCT05243550|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
20202930|NCT01894516|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
20202931|NCT05652660|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202932|NCT02605863|University of Rochester|Edward Messing, ND|585-275-0998|edward_messing@urmc.rochester.edu|
20202933|NCT01486316|Medtronic, Inc|Rachael Rose, Clinical Research Specialist|763-526-2332|rachael.k.rose@medtronic.com|
20202934|NCT00112151|Univeristy of Colorado at Denver|Dr. Robert S. Schwartz, Head, Division of Geriatric Medicine|303-724-1919|robert.schwartz@ucdenver.edu|
20183453|NCT00657280|Stanford Hospital and clinics|Dr. Michael Fowler Director of the Heart Failure|650-721-5540|mfowler@stanford.edu|
20183454|NCT00975806|Celgene Corporation|Anne McClain,Senior Manager|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
20183455|NCT00246012|Centocor, Inc.|Senior Director|908-927-2116||
20183456|NCT04889664|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-585-4661|adriana.feder@mssm.edu|
20183457|NCT04181632|Nemours Children's Health System (North Florida/JAX)|Jennifer Pfieffer|904 383 0414|jennifer.pfieffer@nemours.org|
20183458|NCT03636451|University of California, San Diego|Sheila Mody|8583294464|smody@health.ucsd.edu|
20183459|NCT01806714|University of Rochester|Dr. Cynthia Rand|585 275-9316|cynthia_rand@urmc.rochester.edu|
20183460|NCT02155829|USUHS|Dr. David M. Benedek|(301) 295-3294|david.benedek@usuhs.edu|
20202935|NCT01777438|UZ Leuven|Dr Hellings|+32 16 332338|peter.hellings@uzleuven.be|
20202936|NCT01792986|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
20202937|NCT00375934|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
20202938|NCT03191396|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20183461|NCT01919697|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20183462|NCT04107805|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183463|NCT03408860|University of Kentucky|Shannon Sauer-Zavala|858-218-4082|ssz@uky.edu|
20183464|NCT00404079|Oslo University Hospital Ullevaal|Project Manager: Philip Wilkens|004723016140|philip.wilkens@medisin.uio.no|
20183465|NCT00771849|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20183466|NCT00614406|Oregon Health and Sciences University|Allison Edelman, MD, MPH|503-494-5949|edelmana@ohsu.edu|
20183467|NCT01972152|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Drug Development|512-498-2675|mcummins@xerispharma.com|
20183468|NCT01669148|Massachusetts General Hospital|Thomas J. Brady, MD|6177268294|tbrady@mgh.harvard.edu|
20183469|NCT03861169|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|818-687-3310|trodriguez@sightsciences.com|
20183470|NCT02596035|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20183471|NCT00509769|Genentech, Inc.|Medical Communications|800 821-8590||
20183472|NCT04173572|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
20183473|NCT02873754|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
20183474|NCT01253226|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183475|NCT00988637|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Dierctor|817-961-5358|ron.gottschalk@galderma.com|
20183476|NCT00414206|CoMentis, Inc.|Carl Grove|650-869-7600|cgrove@comentis.com|
20183477|NCT01543685|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
20183478|NCT01391013|Jan-Cil Italy|Therapeutic Area Medical Manager|39 02 2510589||
20183479|NCT02685033|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20183480|NCT00708097|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183481|NCT00603447|Amgen, Inc.|Study Director|866-572-6436||
20183482|NCT04341298|Avulux|Dr. Charles Posternack, President|833-288-5890|cposternack@avulux.com|
20183483|NCT03425643|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20183484|NCT03141788|3M|Elaine Egging|651-737-0263|eegging@mmm.com|
20183485|NCT04133363|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS, MS, Interim Dean, Principal Investigator|205-9344506|ngeurs@uab.edu|
20183486|NCT01838200|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20183487|NCT04415333|North Carolina A&T State University|Marc Cook, PhD|336-285-3547|mdcook@ncat.edu|
20183488|NCT03523702|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
20183489|NCT01210820|AMO Development, LLC|Carrie Garufis|714-566-3728|carrie.garufis@amo.abbott.com|
20183490|NCT01875250|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
20183491|NCT02749968|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
20183492|NCT00538213|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183493|NCT03140176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183494|NCT03196167|Yale University|Amit Bardia|2038436469|amit.bardia@yale.edu|
20183495|NCT00470626|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
20183496|NCT02689349|Envoy Medical Corp.|Elizabeth Anderson, Ph.D.|(1) 651-788-3017|landerson@envoymedical.com|
20183497|NCT01549314|Massachusetts General Hospital Endocrine Unit|Dr. Melissa Putman|857-218-5017|msputman@partners.org|
20183498|NCT00486759|Hoffmann-La Roche|Medical Communications|800 821-8590||
20183499|NCT01025843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183500|NCT00516503|Mayo Clinic|Debra Barton, R.N., Ph.D.||Barton.debra@mayo.edu|
20183501|NCT01649791|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20183502|NCT00771667|Janssen Research and Development, US|Director, Clinical Research|610-651-6554||
20183503|NCT01897233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20183504|NCT00332644|University of Wisconsin|Piper, Megan E|608-265-5472|mep@ctri.medicine.wisc.edu|
20183505|NCT00565110|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
20183506|NCT04033432|Northwestern University|Maha Hussain, MD|312-908-5487|mhussain@northwestern.edu|
20183507|NCT03110458|Sensorion|Director of Regulatory Affairs|+33 4 67 20 77 30|contact@sensorion-pharma.com|
20183508|NCT00738699|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20183509|NCT01213706|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
20183510|NCT00868192|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
20183511|NCT03201809|UC Davis|Dr. Granger Wong, Chief and Professor of Plastic Surgery|(916) 734-7289|gwong@ucdavis.edu|
20183512|NCT00422201|HRA Pharma|Head of Clinical Research|0033140331130|s.durand@hra-pharma.com|
20183513|NCT01120275|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
20183514|NCT02087306|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20183515|NCT02736799|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
20183516|NCT01156116|University of Chicago|Esra Tasali|773-702-1497|etasali@medicine.bsd.uchicago.edu|
20183517|NCT00197015|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183518|NCT04511650|EyePoint Pharmaceuticals, Inc.|Dario Paggiarino, MD|8589670016|dpaggiarino@eyepointpharma.com|
20183519|NCT02050308|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
20183520|NCT01186848|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20183521|NCT01490580|NICU, CHI Créteil|Dr Xavier Durrmeyer|+33145175433|xavier.durrmeyer@chicreteil.fr|
20183522|NCT02526680|Wills Eye Hospital Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20224600|NCT04765722|McMaster University|Dr. Imran Satia|905 5212100|satiai@mcmaster.ca|76228
20224601|NCT03596671|BlueWind Medical|Medical Affairs|612-203-5739|peter.rodine@bluewindmedical.com|
20183523|NCT04615299|John Dingell VA Medical Center|Dr Padmavathi Patel|313-576 2731|Padmavathi.Patel@va.gov|
20183524|NCT03593070|Rush University College of Nursing|Dr. Olimpia Paun|3129426996|olimpia_paun@rush.edu|
20224602|NCT05906836|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20183525|NCT04979988|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183526|NCT03098030|United Therapeutics Corporation|Program Manager, Oncology|919-485-8350|kmaher@unither.com|
20183527|NCT03310983|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
20183528|NCT03612804|VA Puget Sound Health Care System|Steven B Zeliadt|206-277-4175|Steven.Zeliadt@va.gov|
20183529|NCT01656304|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
20183530|NCT04391309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20183531|NCT00881335|Shanghai Tenth People's Hospital, Tongji University|Zhang Xiangyu|86-21-66307174|xiangyu62@126.com|
20183532|NCT01615809|Fundaciò per la Recerca i la Docencia sant Joan de Deu|Rosa Maria morales Palau|936009751|rmorales@fsjd.org|
20183533|NCT00554801|Portland VA Medical Center|Marjorie R. Leek|503-220-8262|Marjorie.Leek@va.gov|54525
20183534|NCT05826431|UW Medicine Multiple Sclerosis Center|Dr. Kevin Alschuler, Director of Rehabilitation Research|206-668-8413|kalschul@uw.edu|
20183535|NCT02104765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183536|NCT01624168|Appalachian State University|Dr. Karen Caldwell, Professor|828-262-6045|caldwellkaren@appstate.edu|
20183537|NCT02357784|Northwestern University|Dr. Margaret Mueller|13124723874|mgmueller@nm.org|
20183538|NCT00462943|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20183539|NCT04222959|San Diego State University Research Foundation|Elizabeth Reed|508-212-1517|ereed@sdsu.edu|
20183540|NCT03392532|Alcon, A Novartis Division|CDMA Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20183541|NCT04173962|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-4640|james.murrough@mssm.edu|
20183542|NCT02289560|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-630-9900|nadira@insightec.com|
20183543|NCT02540213|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183544|NCT01673113|Massachusetts General Hospital|Dr. Lilit Garibyan|617-726-6168|lgaribyan@partners.org|
20183545|NCT00038103|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20183546|NCT02987335|Albert Einstein College of Medicine|Dr Meredith Hawkins|718.430.3186|meredith.hawkins@einsteinmed.org|
20183547|NCT01981356|Center for Innovation to Implementation, VA Palo Alto HCS|Matthew Boden, Ph.d.|650-493-5000|Matthew.Boden@va.gov|27529
20183548|NCT01670110|Mayo Clinic|Marie C. Hogan, M.D., Ph.D.|507-284-3479|Hogan.Marie@mayo.edu|
20183549|NCT02555631|Albert Einstein College of Medicine|Dr. Elizabeth Walker|718-430-3242|elizabeth.walker@einstein.yu.edu|
20183550|NCT01751724|University of Miami|Eduardo Bancalari M.D., Director Division of Neonatology|3055856408|ebancalari@miami.edu|
20183551|NCT03981549|The Emmes Company, LLC|Principal Investigator of the TRUST Data Coordinating Center|301-251-1161|trust@emmes.com|
20183552|NCT05012644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183553|NCT02465359|University of South Florida|Tuan H. Vu, MD|813-974-9413|tvu6@usf.edu|
20191754|NCT02542410|BOSTON CHILDREN'S HOSPITAL|DR. AMY DIVASTA|6173556000|amy.divasta@childrens.harvard.edu|
20191755|NCT02517528|AbbVie|Global Medical Services|800-633-9110||
20191756|NCT04298099|Baylor College of Medicine|Karla Wyatt-Thompson|8328245800|karla.wyatt@bcm.edu|
20191757|NCT01268098|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20191758|NCT00665132|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
20191759|NCT01093599|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
20191760|NCT01703845|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191761|NCT04333732|Washington University School of Medicine in Saint Louis|Professor Michael S. Avidan|+1-(314)-273-2456|avidanm@wustl.edu|
20191762|NCT01845649|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20191763|NCT00248534|North American Brain Tumor Consortium|Lauren Abrey, MD|410-955-3657|jfisher@jhmi.edu|
20191764|NCT01222533|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191765|NCT03418493|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20191766|NCT02028247|Baylor College of Medicine|Dr. Eric Storch|7137983579|eric.storch@bcm.edu|
20191767|NCT00526097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191768|NCT00966979|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
20191769|NCT01318317|City of Hope|Dr. Lwaliw Popplewell|626-359-8111|lpopplewell@coh.org|
20191770|NCT03713281|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20191771|NCT05566886|Corsano Health B.V.|Clinical Research Manager|+31 61 640 7778|info@corsano.com|
20191772|NCT00630552|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20191773|NCT03226106|Eastern Colorado VA Medical Center|Cory Christiansen, PT, PhD|303-724-9101|cory.christiansen@cuanschutz.edu|
20191774|NCT01084239|Massachusetts Genderal Hospital Biostatistics Center|Pearl Zakroysky|617 724 0309|pzakroysky@partners.org|
20191775|NCT00721214|Massey Cancer Center|John M. McCarty, MD|804-828-4360|jmccarty@vcu.edu|
20224603|NCT04982575|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20183554|NCT01278862|3M HCBG Clinical Operations|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
20191776|NCT00983905|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
20191777|NCT00494026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191778|NCT02466243|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
20191779|NCT00405912|Mayo Clinic|Dr. Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
20191780|NCT03730662|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20191781|NCT01309243|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20191782|NCT00632931|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20191783|NCT01402063|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20191784|NCT03712449|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20191785|NCT01592396|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20191786|NCT04491006|Athira Pharma|Hans Moebius, CMO|1-866-725-0930|clinicaltrials@athira.com|
20191787|NCT03192202|Columbia University Irving Medical Center (CUIMC)|Ahmed Sawas, MD|212-305-0591|as4386@cumc.columbia.edu|
20191788|NCT01940523|Hospital for Special Surgery|David Mayman MD|212.774.2024|maymand@hss.edu|
20191789|NCT00902226|H. Lundbeck A/S|Study Director|email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
20191790|NCT00451555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20183555|NCT02952261|Shanghai Pulmonary Hospital affiliated to Tongji university|Dr. Chang Chen|+86 13816869003|chenthoracic@163.com|
20183556|NCT00798265|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20183557|NCT03354390|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator|301-451-7128|childsr@nhlbi.nih.gov|
20183558|NCT01185522|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20183559|NCT00954707|Cordis Corporation, a Johnson & Johnson company|Amy Orlick, Associate Director|908-541-4347|aorlick@its.jnj.com|
20183560|NCT02962674|seleon gmbh|Annegret Genger|+49 175 934 91 83|Annegret.Genger@seleon.de|
20183561|NCT00669461|University of Arkansas for Medical Sciences|Muhannad Heif, MD|5016500215|mmheif@gmail.com|
20183562|NCT00364286|The University of Texas MD Anderson Cancer Center|Susan O'Brien, MD/ Professor|713-792-7543|eharriso@mdanderson.org|
20183563|NCT00628862|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20183564|NCT00531518|Maine Medical Center Research Institute|William R McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
20183565|NCT01227278|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
20183566|NCT04020718|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@mgh.harvard.edu|
20183567|NCT03546907|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20183568|NCT02620761|Medical College of Wisconsin|Jeffrey Segar|14143377702|jsegar@mcw.edu|
20183569|NCT03720210|Mayo Clinic|Marius N. Stan, M.D.|507-266-3769|Stan.Marius@mayo.edu|
20183570|NCT01551056|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20183571|NCT02174562|Thomas Jefferson University|Barry Rovner, MD|215-503-1243|Barry.Rovner@Jefferson.edu|
20183572|NCT03336450|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20183573|NCT00798096|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20183574|NCT03670602|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
20183575|NCT03557333|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
20183576|NCT00864682|Virginia Mason Medical Center|Joseph M. Neal, MD|206-223-6980|anejmn@vmmc.org|
20183577|NCT00957658|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
20183578|NCT02469064|Universidad del Valle|Dr Lina Marcela Sandoval Moreno|316 478 0808|linamarce48@gmail.com|
20183579|NCT01585038|Indiana University School of Medicine|Samir K Gupta, Md, MS|317-274-7926|sgupta1@iu.edu|
20183580|NCT02046616|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183581|NCT04420195|NYU Langone Health|Tyler C Lewis|646-501-4222|Tyler.lewis@nyulangone.org|
20183582|NCT01833832|National Cancer Institute|Dr. Jeremy Davis|240-760-6229|jeremy.davis@nih.gov|
20183583|NCT00130637|National Eye Institute, NIH|H. Nida Sen, MD, MHS|301-435-5139|senh@nei.nih.gov|
20183584|NCT00942149|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
20183585|NCT01591616|Virginia Commonwealth University, School of Dentistry|Tegwyn H. Brickhouse, DDS, PhD|(804) 827-2699|thbrickhouse@vcu.edu|
20183586|NCT01959412|Novartis Pharmaceuticals|Study Director|862-778-8300||
20183587|NCT00158054|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
20183588|NCT03038399|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
20183589|NCT04567888|Twill|Eliane M. Boucher, PhD (Sr Director of Research Strategy)|(800) 264-6428|eliane@twill.health|
20183590|NCT00414648|Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati|Francis X. McCormack, MD|513-558-4831|mccormfx@ucmail.uc.edu|
20183591|NCT01194258|Halozyme Therapeutics|Vice President, Endocrinology Clinical Development|858-794-8889||
20183592|NCT00619645|University of California Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
20183593|NCT02026258|UConn Health|Flavio Uribe|8606793656|furibe@uchc.edu|
20183594|NCT00383188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191791|NCT00922441|Boryung Pharmaceutical|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
20224604|NCT05711381|Hanmi Pharmaceutical Co., Ltd.|Moon Hee Lee, MD|+82 2 410 9062|mhlee7@hanmi.co.kr|
20183595|NCT04246762|R-Pharm|Marina Beloukhova, Scientific advisor|0074959567937|beloukhova@rpharm.ru|2129
20183596|NCT00410124|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
20183597|NCT00597519|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
20183598|NCT05484726|Fatima Memorial Hospital Shadman Lahore|Assistant Professor Dr Rafia Gul|00923064620027|docrafiagul@gmail.com|
20183599|NCT03396913|Lumenis|Yair Manor, Clinical Director|+972-52-3763416|yair.manor@lumenis.com|
20183600|NCT02781584|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20183601|NCT03028363|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20183602|NCT00782639|Bracco Diagnostics, Inc|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
20183603|NCT04771273|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183604|NCT04436120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183605|NCT00331162|Wake Forest University Health Sciences|Dr. Alan Farney|336-716-6510|afarney@wakehealth.edu|
20183606|NCT03328949|Shockwave Medical, Inc.|Beaux Alexander, Vice President of Clinical Affairs|510-279-4262 ext. 145|balexander@shockwavemedical.com|
20183607|NCT01697319|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
20183608|NCT01421654|ResMed|Amy Blase/Clinical Research Manager|858-836-6715|amy.blase@resmed.com|
20183609|NCT00392678|Joslin Diabetes Center|Allison B. Goldfine, MD co-investigator|617-309-2643|allison.goldfine@joslin.harvard.edu|
20183610|NCT01944319|Peking University Third Hospital|Dr. Qingtao ZHOU|86-10-82265562|zhouqingtaobysy@sina.com|
20183611|NCT04026620|University of North Carolina at Chapel Hill|Julie Hasken, PhD|704-250-5000|julie_hasken@unc.edu|
20183612|NCT00604721|UNC Lineberger Comprehensive Cancer Center|Bert. H. O'Neil, Associate Professor, Clinical Research|919-966-4431|bert_oneil@med.unc.edu|
20183613|NCT04776213|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20183614|NCT00556543|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
20183615|NCT01838551|Strongbridge Biopharma|Chief Medical Officer|14845890392|f.cohen@strongbridgebio.com|
20183616|NCT00906282|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
20183617|NCT03395353|Shionogi|Corporate Communications Department|+81-6-6209-7885|shionogiclintrials-admin@shionogi.co.jp|
20183618|NCT02013037|Cedars Sinai Smidt Heart Institute|Dr. Jignesh Patel|310-248-8300|jignesh.patel@cshs.org|
20183619|NCT00726596|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
20183620|NCT02743078|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
20183621|NCT02195713|Theranova, LLC|Devyani Nanduri|415-926-8616|dnanduri@theranova.com|
20183622|NCT00357396|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
20183623|NCT04002973|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20183624|NCT02488980|Penn State Hershey Infectious Diseases|Jose Stoute, MD|800-243-1455|noemail@no.com|
20183625|NCT05174013|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20183626|NCT02034916|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183627|NCT04008836|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
20183628|NCT00588965|MetroHealth Medical Center|Dr. Elizabeth Kaufman|216-778-2349|ekaufman@metrohealth.org|
20183629|NCT01234532|University of Maryland, Baltimore|Katherine Tkaczuk, M.D.|410-328-2565|ktkaczuk@umm.edu|
20183630|NCT03748433|Imperial College London|Professor Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
20183631|NCT01183533|University of Texas Health Science Center at Houston|Sean I. Savitz, MD|713-500-7083|sean.i.savitz@uth.tmc.edu|
20183632|NCT04842604|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20183633|NCT03036735|Steward Health Care|Dr Peter Catalano|617-789-5004|peter.catalano@steward.org|5004
20183634|NCT00344019|BIDMC|Director of Clinical Trials|6176678800|dcutlip@bidmc.harvard.edu|
20183635|NCT02503202|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183636|NCT00478335|University of Colorado Denver|Melissa Cadnapaphornchai, MD|720776263|melissa.cadnapaphornchai@ucdenver.edu|
20183637|NCT01191788|RAND Corporation|Katherine Watkins|(310) 393-0411|kwatkins@rand.org|6509
20183638|NCT05252871|Western University of Health Sciences|Frank Spors|9097063883|fspors@westernu.edu|
20183639|NCT01245439|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20183640|NCT00217672|University of California, Los Angeles|Sara Hurvitz, M.D.|310-829-5471|shurvitz@mednet.ucla.edu|
20183641|NCT03673943|RadioMedix Inc|Ebrahim Delpassand|7134999733|edelpassand@radiomedix.com|
20183642|NCT01852019|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888-779-MDCO|jayne.prats@themedco.com|1510
20183643|NCT00208507|DePuy Orthopaedics, Inc|Dave Whalen|574-372-7028|DWhalen@its.jnj.com|
20183644|NCT00001304|National Institute of Child Health and Human Development|WINER, Karen|+1 301 435 6877|winerk@mail.nih.gov|
20183645|NCT00436644|Mayo Clinic|Dr. Paul Haluska|507-266-2123|haluska.paul@mayo.edu|
20183646|NCT04364269|Vifor Pharma, Inc.|CSL Vifor|+41 588 518 000|VIT2763-THAL-201.study@viforpharma.com|
20183647|NCT00878722|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20183648|NCT00972504|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183649|NCT02878330|MedImmune, LLC|M. Pamela Griffin|+1 301-398-4059|information.center@astrazeneca.com|
20183650|NCT02476890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224605|NCT04322539|HUTCHMED International|William Schelman, MD, PhD|+1-973-306-4490|williams@hutch-med.com|
20206682|NCT01607073|Gillette Children's Specialty Healthcare|Beverly Wical, MD|(651) 229-3870|BWical@gillettechildrens.com|
20206683|NCT00642018|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20206684|NCT01410799|University of Pennsylvania|Dr. Anne Cappola|215-573-5359|acappola@upenn.edu|
20206685|NCT02564029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206686|NCT04126031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206687|NCT00617656|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
20206688|NCT01946412|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20206689|NCT00131664|Dr. Anatoly Langer, Chair CHRC, Canadian Heart Research Centre|Dr. Robert Josse|416-977-8010|langera@chrc.net|
20206690|NCT00789724|VCU Pauley Heart Center|Antonio Abbate, MD, PhD|8048280513|aabbate@mcvh-vcu.edu|
20206691|NCT00323310|Bracco Diagnostics Inc|Usha Halemane/Executive Director|609-514-2578|usha.halemane@diag.bracco.com|
20206692|NCT00446641|Asan Medical Center, University of Ulsan College of Medicine|Professor Sun U. Kwon|82-2-3010-3960|sukwon@amc.seoul.kr|
20206693|NCT03565991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206694|NCT00899600|Dartmouth-Hitchcock Medical Center|Dr. Randy Loftus|6036504642|randy.w.loftus@hitchcock.org|
20206695|NCT03542149|Medicines for Malaria Venture (MMV)|Dr. Helen Demarest|: +41 22 555 03 24|demaresth@mmv.org|
20206696|NCT02009930|David Grant Medical Center, Travis Air Force Base|Dr. Elijah Burton|707-423-7950|elijah.j.burton2.mil@mail.mil|
20206697|NCT02468804|University of Colorado Denver|Isabelle Buard, PhD|(303)472-5973|Isabelle.Buard@cuanschutz.edu|
20206698|NCT02959970|Almirall LLC|Ayman Grada|610-840-7107|ayman.grada@almirall.com|
20206699|NCT00666536|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206700|NCT00488059|Hoffmann-La Roche|Medical Communications|800-821-8590||
20206701|NCT02933372|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
20206702|NCT03008187|Menarini Ricerche|Angela Capriati, MD|+39 055 56 80 9990|acapriati@menarini-ricerche.it|
20206703|NCT03805971|Centre hospitalier universitaire de Liège|Dr Olivier Bonhomme|003243667881|obonhomme@chuliege.be|
20206704|NCT01155193|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20206705|NCT03613818|Boise State Universtiy|Dr. Diana Doumas|2084261219|dianadoumas@boisestate.edu|
20206706|NCT00254163|Ocala Oncology|Dr. Craig Reynolds|(352) 732-4032|Craig.Reynolds@USOncology.com|
20206707|NCT03012594|Northwell health|Dr.Larry Miller|5165620334|lmiller7@northwell.edu|
20206708|NCT01480232|Massachusetts General Hospital-Center for Addiction Medicine|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
20206709|NCT01952288|VA Puget Sound Health Care System|Rebekah J. Rein, JD|206-764-2711|rebekah.rein@va.gov|
20206710|NCT03962634|Virginia Commonwealth University|Parthasarathy Madurantakam|804-828-4953|madurantakap@vcu.edu|
20206711|NCT01355497|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
20206712|NCT00994760|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666|clinicaltrials@nycomed.com|0
20206713|NCT01001572|Novartis Pharmaceuticals|Study Director|862 778-8300||
20206714|NCT01094808|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
20206715|NCT00369278|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206716|NCT02967172|University of Iowa|Michael Willey, MD|319-384-8452|michael-willey@uiowa.edu|
20206717|NCT02025530|University of Manchester|Professor Alexander Heazell|+441612766484|alexander.heazell@manchester.ac.uk|
20206718|NCT05364437|Imperial College London|Gary Frost|07872850308|g.frost@imperial.ac.uk|
20206719|NCT04586673|University of Oxford|Dr Paola Cicconi|01865611425|paola.cicconi@ndm.ox.ac.uk|
20206720|NCT04583969|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20206721|NCT00563368|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
20206722|NCT01061567|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206723|NCT01831804|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206724|NCT01819506|Ralph H Johnson VAMC|Michelle Woodbury|843-792-1671|Woodbuml@musc.edu|
20206725|NCT01592006|University of Chicago Medical Center|Dr. Helen S. Te|773-702-2395|hte@medicine.bsd.uchicago.edu|
20206726|NCT00228943|Indiana University|Janet S. Carpenter|317-278-6093|carpentj@iupui.edu|
20224606|NCT03617861|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
20224607|NCT00623597|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20206727|NCT00176878|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20206728|NCT00114218|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|lgedeon@gogstats.org|
20206729|NCT01927887|Massachusetts General Hospital|Mukesh Harisinghani|6176432009|mharisinghani@partners.org|
20206730|NCT01040845|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20224608|NCT01846221|Columbia University|Allison Lee, MD - Assistant Professor of Anesthesiology|212-342-2028|al3196@cumc.columbia.edu|
20183651|NCT00082810|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
20183652|NCT03495713|Abramson Cancer Center at Penn Medicine|John P. Plastaras, MD, PhD|855-216-0098|PennCancerTrials@emergingmed.com|
20206731|NCT04445688|Apnimed, Inc|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
20183653|NCT01147380|University of Miami|Dr. Seigo Nishida|305-355-5760|snishida@med.miami.edu|
20206732|NCT00299416|UT-Houston Health Science Center, Department of Neurology|James C. Grotta, MD|713-500-7088|james.c.grotta@uth.tmc.edu|
20206733|NCT00442260|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20206734|NCT02074904|UPENN|Timothy Pond, MPH|215-746-1959|timpond@pennmedicine.upenn.edu|
20206735|NCT00466661|Medical University of South Carolina|Bryan K. Tolliver, M.D., Ph.D. (Principal Investigator)|(843) 792-4869|tollive@musc.edu|
20206736|NCT01963780|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
20183654|NCT02979899|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
20183655|NCT01321606|William S. Middleton Memorial Veterans Affairs Medical Center|Dr. Nasia Sardar|608-256-1901|nasia.safdar@va.gov|17800
20206737|NCT01749800|Spaulding Rehabilitation Hospital|Paolo Bonato|+1-617-952-6319|pbonato@partners.org|
20183656|NCT00117663|Group Health Research Institute|Diana Buist PhD, Principal Investigator|206-287-2931|buist.d@ghc.org|
20183657|NCT04286529|Mayo Clinic|Rajiv Kumar, MD|507-284-0020|rkumar@mayo.edu|
20224609|NCT04599933|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
20224610|NCT02663752|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20224611|NCT01779167|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
20224612|NCT02963558|Wake Forest University School of Medicine|D Clark Files, MD|336-716-8898|dfiles@wakehealth.edu|
20224613|NCT02339155|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183658|NCT02341625|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20183659|NCT05325853|American Genomics, LLC|Dr. Martin Uram|973-885-3447|aschupp@cmcturnkey.com|
20183660|NCT01839877|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20183661|NCT01544062|University of Washington|Srdjan Jelacic, MD|(206) 598-3777|sjelacic@uw.edu|
20183662|NCT03368001|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|615-936-0280|blythe.corbett@vumc.org|
20183663|NCT01093534|Astellas Pharma Europe Ltd.|Director Medical Affairs - Urology||clinicaltrials@us.astellas.com|
20183664|NCT00811057|University of Mississippi Medical Center|Dr. Rick Martin|601-815-7035|rmartin@umc.edu|
20183665|NCT00768651|Faculty of Medicine and Dentistry, University of Alberta|Peter Senior, MD, PhD - Professor of Medicine, Medical Director-Clinical Islet Transplant Program,|780-407-1480|peters@islet.ca|
20183666|NCT00281918|Hoffmann-LaRoche|Medical Communications|800-821-8590||
20183667|NCT02124460|Massachusetts General Hospital|Dr. Elsie Taveras|617-726-8555|elsie.taveras@mgh.harard.edu|
20183668|NCT00995709|Novartis Pharmaceuticals|Study Director|862-778-8300||
20183669|NCT01199237|University of California, San Francisco|Rachel Eshima McKay|415-502-1715|eshimar@anesthesia.ucsf.edu|
20183670|NCT03008915|Columbia University|Dr. Carrie Pistenmaa|212-342-4162|"cp2346@atcumc.columbia.edu"|
20183671|NCT00712166|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
20183672|NCT01773122|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20183673|NCT01769391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183674|NCT03386929|Worldwide Innovative Network (WIN) Association|Fanny Wunder, Project Manager|0033604090029|fanny.wunder@winconsortium.org|
20183675|NCT01975467|Sonoma Orthopedics|Rick Epstein|8479872516|repstein@sonomaorthopedics.com|
20183676|NCT02837237|KBP Biosciences Co., Ltd.|Vincent J. Benn|2677996545|vince.benn@kbpbiosciences.com|
20183677|NCT01144182|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
20183678|NCT03772964|University of Pittsburgh|Dr. Brian Zuckerbraun|(412) 647-3065|zuckerbraunbs@upmc.edu|
20183679|NCT01286402|University of Texas Health Science Center at Houston|Angela Stotts, PhD, PI|713-500-7590|Angela.L.Stotts@uth.tmc.edu|
20183680|NCT02317016|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20183681|NCT03906968|MUSC|Dr. Zachary M. Soler|(843) 792-3531|solerz@musc.edu|
20183682|NCT03121950|The Ohio State University|Deb Kegelmeyer|614-293-0214|kegelmeyer.1@osu.edu|
20183683|NCT03693742|BC Cancer - Vancouver|Study Manager|(604) 877-6000,|hsaprunoff@bccancer.bc.ca|
20183684|NCT00589667|Memorial Sloan-Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
20183685|NCT02804594|University of California San Francisco|Emmanuelle Waubant, MD|415 514 2468|Emmanuelle.Waubant@ucsf.edu|
20183686|NCT03538041|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20183687|NCT02126878|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20183688|NCT02425449|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
20183689|NCT01070888|Boston Children's Hospital|Wanda Phipatanakul|857-218-5336|wanda.phipatanakul@childrens.harvard.edu|
20183690|NCT02631148|Brigham and Women's Hosptial|Dr. Ciaran McMullan|617 732 5500|mcmullcj@gmail.com|
20183691|NCT00487578|Clinvest|M.E. Beach|(417) 841-3618|mbeach@clinvest.com|
20183692|NCT02378714|Northwestern University|Dr. Brian Hitsman|312-504-5834|b-hitsman@northwestern.edu|
20183693|NCT02525796|Brigham and Women's Hospital|Anand Vaidya|16177325666|anandvaidya@bwh.harvard.edu|
20183694|NCT00726999|Medical College of Wisconsin|Lynn Rusy, MD|414-266-2555|lrusy@chw.org|
20183695|NCT00955825|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20224614|NCT02176083|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
20183696|NCT02729701|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
20183697|NCT03597100|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
20183698|NCT00816751|UC San Diego Health|Jessica M. Kingston, MD|858-249-1204|jkingston@ucsd.edu|
20183699|NCT00393848|UAMS|Arny Ferrando|501-526-5711|aferrando@uams.edu|
20183700|NCT02192606|Brigham and Women's Hospital|Jon I. Einarsson|617-732-5500|jeinarsson@partners.org|
20183701|NCT02550197|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20183702|NCT04763044|Procter & Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20183703|NCT01458210|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183704|NCT02224924|Memorial Sloan Kettering Cancer Center|Dr. Amgad Moussa MD|212-639-3690|moussaa@mskcc.org|
20183705|NCT01616654|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20206738|NCT00661570|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
20206739|NCT02754661|Medtronic GIH (Given Imaging LTD)|Liron Bar Yaakov, Senior Manager Clinical Affairs|972-526060466|liron.baryaakov@medtronic.com|
20183706|NCT00610688|Cincinnati Children's Hospital Medical Center|Dr. Adekunle Dawodu|513-636-1966|Adekunle.Dawodu@cchmc.org|
20206740|NCT01000025|NCIC Clinical Trails Group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
20206741|NCT04423757|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206742|NCT02738580|IVIValencia|DR. ERNESTO BOSCH|+34 963050900|Ernesto.Bosch@ivirma.com|
20206743|NCT00158223|Icahn School of Medicine at Mount Sinai|Dr. Joseph I. Friedman|631-761-3607|joseph.friedman@mssm.edu|
20206744|NCT01250756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206745|NCT02999100|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206746|NCT03595384|Emory University|Jennifer K Frediani PhD, RD|404-727-3766|jfredia@emory.edu|
20206747|NCT00293241|Medtronic Bakken|Lidwien Vainer|+31 433566752|lidwien.vainer@medtronic.com|
20206748|NCT00583661|Berlin Heart Inc.|Robert Kroslowitz, CEO|1-281-863-9700|kroslowitz@berlinheart.com|
20206749|NCT01270958|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206750|NCT02142504|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206751|NCT02352103|Vattikuti Urology Institute, Henry Ford Hospital|Deepansh Dalela, MD|3139162600|ddalela1@hfhs.org|
20206752|NCT04114539|Emalex Biosciences, Inc.|Sr. Director of Clinical Operations|1847|dkim@emalexbiosciences.com|7150562
20206753|NCT03124901|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20206754|NCT00617591|H. Lee Moffitt Cancer Center and Research Institute|Rachid Baz, M.D.|813-745-8212|rachid.baz@moffitt.org|
20206755|NCT01711658|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20206756|NCT00166517|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206757|NCT02918656|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
20206758|NCT00842361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20206759|NCT02186561|Medtronic Neurovascular, Clinical Affairs|Senior Project Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
20206760|NCT03094611|The University of Texas MD Anderson Cancer Center|Elias Jabbour, MD./ Professor, Leukemia|713-792-4764|ejabbour@mdanderson.org|
20206761|NCT04285853|Emory University|Dr. John Xerogeanes|404-778-7202|jxeroge@emory.edu|
20206762|NCT01072448|Novartis Pharmaceuticals|Study Director|862 778-8300||
20206763|NCT02119468|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|62405
20206764|NCT01877941|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|art.wallace@va.gov|3732
20206765|NCT03179410|Duke University|Andrew Armstrong, M.D.|919-668-8797|andrew.armstrong@duke.edu|
20206766|NCT02460978|AstraZeneca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20206767|NCT02562989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206768|NCT00588523|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley, MD|212-639-7523|kaleyt@mskcc.org|
20206769|NCT00841269|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
20206770|NCT00088972|SWOG|Study Statistician|206-667-4623||
20183707|NCT01772420|Albert Einstein College of Medicine|Dr. Amit K. Verma|718-430-8761|amit.verma@einsteinmed.edu|
20183708|NCT05334758|BioTeke USA|Chang Turkmani|202-679-2112|chang@themegaco.com|
20183709|NCT02178540|Novartis Pharmaceuticals|Study Director|862-778-8300||
20183710|NCT00932022|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20183711|NCT03888755|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20183712|NCT02903836|Wockhardt|Dr Manishkumar D Shah|02226534444|manish.shah@wockhardt.com|6893
20183713|NCT01872819|University of Washington|Dr. Pamela Becker|206-288-7273|pbecker@u.washington.edu|
20183714|NCT04379713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183715|NCT03808883|Case Western Reserve University|Sarah Fulton, MA, RA, Begun Center, Jack, Joseph and Morton Mandel School of Applied Social Science|216-368-0429|sarah.fulton@case.edu|
20183716|NCT04628572|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183717|NCT02470949|University of Florida|Michelle Cardel, PhD, RD|(352) 273-9703|mcardel@ufl.edu|
20183718|NCT01595854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183719|NCT04365400|Afimmune|Study Director|+3532946380|info@afimmune.com|
20183720|NCT02371746|Envisia Therapeutics, Inc.|Kristin Blackwell, Consultant, Regulatory Affairs & Quality Assurance|919-219-6448|kristin.blackwell@envtx.com|
20183721|NCT02613364|University of Rochester Medical Center|Dr. Karen Mustian, Study PI|585-275-0557|karen_mustian@urmc.rochester.edu|
20183722|NCT01909336|HIMFG|Claudia Montserrat Flores Robles|(52) 5566756686|montseflores@hotmail.com|
20183723|NCT01235949|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183724|NCT00754936|Weill Cornell Medicine|George S Alexopoulos|914-997-5767|gsalexop@med.cornell.edu|
20183725|NCT01114945|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
20183726|NCT00371566|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183727|NCT02914522|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20206771|NCT01459068|Johns Hopkins Bloomberg School of Public Health|Courtland Robinson|4104155266|crobinso@jhsph.edu|
20206772|NCT02023112|AbbVie|Global Medical Information|800-633-9110||
20206773|NCT00360685|Moffitt Cancer Center|Janelle Perkins, PharmD|813-745-7226|Janelle.Perkins@moffit.org|
20206774|NCT01449955|UT Southwestern/VA North Texas|Dr. Alina Suris|214-857-0334|alina.suris@va.gov|
20224615|NCT03226678|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20224616|NCT01279564|Rambam Health Care Campus|Dr. Michal Barak|972 4 8542487|m_barak@rambam.health.gov.il|
20224617|NCT03427268|Pharmamar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology, Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20224618|NCT01813734|Massachusetts General Hospital|Dr. Alice Shaw|617-724-4000|ASHAW1@mgh.harvard.edu|
20224619|NCT01643798|Medical University of South Carolina|Joseph Taylor|8437295729|taylorjj@musc.edu|
20224620|NCT03327948|Axonics, Inc.|Gita Ghadimi|9497516412|gita.ghadimi@axonics.com|
20224621|NCT03870529|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
20224622|NCT02045732|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224623|NCT01349322|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20224624|NCT05014815|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20224625|NCT04247880|University of Washington|Dr. Marissa Baker|206 616 4709|bakermg@uw.edu|
20224626|NCT04516343|Biomotum|Chief Science Officer|(800) 566-2531|zach@biomotum.com|
20224627|NCT03833804|UW School of Medicine and Public Health|Majid Afshar, MD|608-263-1792|mafshar@medicine.wisc.edu|
20224628|NCT06303167|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20224629|NCT03506945|University of California San Diego|Brent Mausbach|8588227529|bmausbach@ucsd.edu|
20224630|NCT03385304|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
20224631|NCT01097421|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191792|NCT02685007|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20191793|NCT01887990|University of Cincinnati|Cheryl McCullumsmith|513-5588022|cheryl.mccullumsmith@uc.edu|
20191794|NCT00468858|GSK|Faina Rose, PhD|610-664-8986|faina.v.rose@gsk.com|
20191795|NCT00543101|Community Research Initiative of New England (CRINE)|Clavin Cohen MD|617 502 1700|ccohen@crine.org|
20191796|NCT01885936|Duke University|Dwight Koeberl, M.D., Ph.D.|919-681-9919|dwight.koeberl@duke.edu|
20191797|NCT00991029|Medical University of South Carolina|Dr. Jordan Elm|843-876-1605|elmj@musc.edu|
20191798|NCT00317603|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
20191799|NCT00523549|Novartis Pharmaceuticals|Study Director|862-778-8300||
20191800|NCT02487251|Michigan State University|Holly E. Brophy-Herb, PI|517-355-3397|hbrophy@msu.edu|
20191801|NCT00427778|Queen's University|Dr Marie-Andree Harvey|613-548-6115|harveym@queensu.ca|
20191802|NCT00321321|Gentofte Hospital, University of Copenhagen|Dr. Kasper Aaboe|+4539978474|Kasper@dadlnet.dk|
20191803|NCT00439647|Novartis Pharmaceuticals|Novartis Study Director|862-778-8300||
20191804|NCT00843115|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20191805|NCT00225277|Takeda Global Research and Development Center Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20191806|NCT03432650|Hospital for Special Surgery, Anesthesiology|Dr. Stephen Haskins|212-606-1036|haskinss@hss.edu|
20191807|NCT00677092|University of Massachusetts Medical School|Jonathan Kay, MD|508-793-6936|jonathan.kay@umassmemorial.org|
20191808|NCT00784277|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20191809|NCT01093222|SWOG|Study Statistician|206-667-4623||
20191810|NCT02222337|Lombardi Comprehensive Cancer Center, Georgetown University|Kristi Graves, PhD|202-687-1591|Kristi.Graves@georgetown.edu|
20191811|NCT00187135|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|866-278-5833|referralinfo@stjude.org|
20191812|NCT03927222|Duke University|Mustafa Khasraw, MD|919-684-5301|mustafa.khasraw@duke.edu|
20191813|NCT03723915|Northwestern University, Feinberg School of Medicine|Devalingam Mahalingam MD, PhD Associate Professor, Division of Hematology and Oncology|312-695-6929|mahalingam@nm.org|
20191814|NCT00640042|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
20191815|NCT00549042|Covidien|Alfredo Bozzini, MD|314-654-2000|Alfredo.Bozzini@covidien.com|
20191816|NCT03039088|Rheumatology department, Cochin Hospital, APHP|Doctor Anna MOLTO|0158412617|anna.molto@aphp.fr|
20191817|NCT00655083|Menarini Group- Clinical Research|Angela Capriati, Clinical research Director|+ 39-055 56809990|acapriati@menarini-ricerche.it|
20191818|NCT01212484|NYU Medical Center|Horacio Kaufmann, MD; director of Dysautonomia Center|212 263 7225|horacio.kaufmann@nyumc.org|
20191819|NCT04289714|Royal Brompton Hospital|Sukeshi Makhecha|0207-3528121|s.makhecha@rbht.nhs.uk|4375
20191820|NCT03106337|Massachusetts General Hospital|Antonia Stephen, MD||ASTEPHEN@PARTNERS.ORG|
20191821|NCT06135675|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
20191822|NCT01592383|University of Chicago|Hedy Kindler|7737020360|hkindler@medicine.bsd.uchicago.edu|
20191823|NCT00560313|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20191824|NCT00835510|Taro Pharmaceuticals|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
20191825|NCT00356993|Addictions Program|Dr. Peter Selby|416-535-8501|peter_selby@camh.net|77432
20224632|NCT02634268|VA Puget Sound Health Care System|Margaret Collins|206.764.2085|margaret.collins@va.gov|
20224633|NCT01120249|SWOG|Melissa Plets|206.667.2707|mplets@fredhutch.org|
20224634|NCT01701193|University of Saskatchewan|Roger Pierson, PhD|306-884-1059|roger.pierson@usask.ca|
20224635|NCT02720744|Flamel Ireland Limited|Jennifer Gudeman|+1 (314) 750-2751|jgudeman@avadel.com|
20191826|NCT00853372|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20224636|NCT01482962|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20224637|NCT02407457|Endologix, Inc.|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
20191827|NCT00467298|VA Puget Sound Health Care System-Seattle|Cynthia M. Dougherty|206 764 2205|cynthia.dougherty@va.gov|
20191828|NCT01644188|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20224638|NCT02174913|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
20224639|NCT01230424|Tufts Medical Center|Dr. Timothy McAlindon|6176365610|tmcalindon@tuftsmedicalcenter.org|
20224640|NCT03502018|Maimonides Medical Center|Dr. Kevin Kang|718-283-8805|kkang@maimonidesmed.org|
20224641|NCT04489381|Romark, L.C.|Jessica Fulgencio|8132828544|jessica.fulgencio@romark.com|
20183728|NCT00177216|University of Pittsburgh|Jean Miewald|412-246-6406|miewaldjm@upmc.edu|
20183729|NCT03399370|The Medicines Company|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
20183730|NCT01224678|University of Vermont|Marie E. Wood, M.D|802-656-5452|marie.wood@uvm.edu|
20183731|NCT04318444|Columbia University|Jon T. Giles, MD|212-305-6327|jtg2122@cumc.columbia.edu|
20183732|NCT01264718|Medica Research Institute|Dr. Glenn Flores, Distinguished Chair of Health Policy Research|952-992-3367|Glenn.Flores@medica.com|
20183733|NCT03545984|Cleveland Clinic|Dr. Maged Argalious|+12164452064|ARGALIM@ccf.org|
20183734|NCT01768676|Vivus|Wesley D Day, PhD|650-934-5200||
20183735|NCT02023125|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183736|NCT03183518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20183737|NCT04248829|Yuhan Corporation|Dongmin Kim|+82-2-828-0523|clinicaltrials@yuhan.co.kr|
20183738|NCT02132702|Clinic for Spinal Cord Injuries, Rigshospitalet, University of Copenhagen|Carsten Bach Baunsgaard|1111111111|carsten.bach.baunsgaard@regionh.dk|
20183739|NCT02251613|Alcon Japan, Ltd.|Hironari Sakaguchi, Phase IV Clinical & Regulatory Affairs, Japan|+81 3 6899 5054|Hironari.Sakaguchi@alcon.com|
20183740|NCT01867580|KCI, an Acelity Company|Anthony Tate, RN, BSN|210-515-4060|anthony.tate@kci1.com|
20183741|NCT01304147|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-7574|james.murrough@mssm.edu|
20183742|NCT01244828|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183743|NCT04520165|CHU-Uliege|Dr Florence Schleich|003243667881|fschleich@chuliege.be|
20183744|NCT05233085|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20183745|NCT05052983|Galderma Research & Development|Sponsor|(817) 961-5000|clinical.studies@galderma.com|
20183746|NCT01942707|Universidade Federal de São Paulo|Dr. Heraldo Carlos Borges Inforzato|55-13-997112644|heraldo@litoral.com.br|
20183747|NCT02812966|Advocate Aurora Research Institute|Director, Clinical Trials Research Cardiovascular and Multiple Specialties|708-860-7792|laura.wrona@aah.org|
20183748|NCT01066923|University of Pittsburgh|Clifton Callaway|412-647-3078|callawaycw@upmc.edu|
20191829|NCT03756168|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20183749|NCT05208359|Loyola University Chicago|Sungha Kang|7735082712|skang@luc.edu|
20183750|NCT05147233|OCULIS Operations SàrI|Sharon Klier, M.D., M.S., M.P.H, Chief Development Officer|+41 21 711 3970|info@oculis.com|
20183751|NCT04670822|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
20183752|NCT04411082|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
20183753|NCT02577523|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director||laurence@neuroderm.com|
20183754|NCT02787694|University of Alabama at Birmingham|David A. Brown, PT, PhD|205-975-2788|dbrownpt@uab.edu|
20183755|NCT00150176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20183756|NCT02385669|University of Virginia|Craig L. Slingluff, Jr. MD|434-924-9311|cls8h@virginia.edu|
20183757|NCT02810080|ZOLL|Nathan Burkhart|763.367.0462|nburkhart@zoll.com|
20183758|NCT03923491|Brown University School of Public Health|Dr. Alison Tovar|401-863-7327|alison_tovar@brown.edu|
20183759|NCT01169311|Covidien|Tam LaFleur|203-821-4744|tam.lafleur@covidien.com|
20183760|NCT00753012|Massachusetts General Hospital|Dr. Paul Hammerness|(503)617-1040|phammerness@partners.org|
20183761|NCT01027286|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
20183762|NCT00545844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20183763|NCT00094809|Amgen Inc.|Study Director|866-572-6436||
20183764|NCT01329328|University of Verona|Prof. Carlo Zancanaro|+390458027155|carlo.zancanaro@univr.it|
20183765|NCT02699970|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
20183766|NCT02507336|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
20183767|NCT01596751|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
20183768|NCT01370694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183769|NCT05372094|Sonova US|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20183770|NCT02957539|VA Puget Sound Health Care System|Paul Hebert|2062774165|paul.hebert2@va.gov|
20183771|NCT02242773|University of Miami|Sanoj Punnen, MD|+1 (305) 2436596|s.punnen@med.miami.edu|
20183772|NCT01565928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183773|NCT01119950|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
20183774|NCT04897737|UCLA|Dr. Dvora Joseph Davey, PI|310-701-1526|dvoradavey@ucla.edu|
20183775|NCT01986686|Stony Brook Medicine|Roberto Bergamaschi, MD, PhD|631-638-2215|roberto.bergamaschi@stonybrookmedicine.edu|
20183776|NCT00139737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183777|NCT02925195|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
20183778|NCT03264248|University of Pittsburgh|Dr. Jonathan Pearlman|412-822-3685|jlp46@pitt.edu|
20183779|NCT03525119|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20183780|NCT01713530|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20183781|NCT01256034|Chiba University Graduate School of Medicine|Dr. Katsunori Furukawa|+81-43-226-2269|k-furukawa@umin.ac.jp|
20183782|NCT00758602|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183783|NCT03939819|Emory University|Dr. Elizabeth Hechenbleikner|404-778-3712|elizabeth.hechenbleikner@emory.edu|
20183784|NCT05046132|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20183785|NCT04089488|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
20183786|NCT02148133|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20183787|NCT00855465|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20183788|NCT00079183|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
20183789|NCT01157182|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20224642|NCT02865590|Department MESVA - University of L'Aquila|Enrico Marchetti DDS, PhD|+39862433304|enrico.marchetti@univaq.it|
20224643|NCT01549041|DukeUMC|Joseph P McEvoy, MD|9198199295|JPMCEVOY@DUKE.EDU|
20224644|NCT02336360|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20224645|NCT03814720|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Alicia T Widge, M.D.|301-451-8715|alicia.widge@nih.gov|
20224646|NCT05098067|Women and Infants Hospital|Dr. Lauren Murphy|2107222589|lmmurphy@wihri.org|
20224647|NCT02872857|The University of Texas Health Science Center at Houston|HuiMahn Alex Choi, Associate Professor|713-500-5638|Huimahn.A.Choi@uth.tmc.edu|
20224648|NCT00850096|CPEX Pharmaceuticals, Inc.|Chief Medical Officer|603-658-6100||503
20224649|NCT03117881|University of Alabama at Birmingham|Dr. Tapan Mehta|205) 975-9171|tapan@uab.edu|
20224650|NCT04946552|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
20224651|NCT00308750|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20224652|NCT01358578|Novartis|Study Director|862-778-8300||
20224653|NCT03605849|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20224654|NCT02304380|University of North Carolina at Chapel Hill|Renée Ferrari, PhD|(919) 843-1341|rferrari@unc.edu|
20224655|NCT00328094|Beth Israel Deaconess Medical Center, Boston, MA|Dr. Balachundhar Subramaniam, MD MPH|6177542675|bsubrama@bidmc.harvard.edu|
20183790|NCT03743246|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20183791|NCT00530842|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183792|NCT02534350|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20183793|NCT01161498|Amgen, Inc.|Study Director|866-572-6436||
20183794|NCT02807493|University of Minnesota|James Gambucci|612-625-7448|gambu001@umn.edu|
20183795|NCT01493778|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20183796|NCT01227707|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183797|NCT05819190|Pharmndev Experts|Dr Bernard Gout Organization|+41798659000|Email:bgout@pharmndev.ch|
20183798|NCT04495634|University of North Carolina at Chapel Hill|Doreen Steed, R.T. (R)(M)|919-966-0188|doreen_steed@med.unc.edu|
20183799|NCT03105128|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20183800|NCT03468920|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20183801|NCT00823979|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183802|NCT03523091|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@beaumont.org|
20183803|NCT00741988|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20183804|NCT02885311|Northwell Health|Dr. Jonathan Morgenstern|(516) 837-1694|jmorgenste@northwell.edu|
20183805|NCT01001078|Maisonneuve-Rosemont Hospital|Nikola Joly, M.D.|+1 514 252 3426|nikola.joly@umontreal.ca|
20183806|NCT02685488|University of Arizona|Dr. John J.B. Allen|(520) 621-7448|john.jb.allen@arizona.edu|
20183807|NCT05019729|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20183808|NCT01597128|University of Kentucky Medical Center|J. Scott Roth, M.D.|859-323-6346|arockich@uky.edu|246
20183809|NCT03254394|Washington University in St Louis|Simon Haroutounian, PhD. Associate Professor|3132861715|sharout@wustl.edu|
20183810|NCT00208767|Emory University School of Medicine|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
20183811|NCT02930590|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
20183812|NCT00536380|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20183813|NCT00387465|SKCCC|John Wrangle, MD|843-792-7789|wrangle@musc.edu|
20183814|NCT03418324|Cedars-Sinai Medical Center|Edwin Posadas, MD|310-423-7600|Edwin.Posadas@cshs.org|
20183815|NCT00907218|MassGH|Dr. Timothy Wilens|617-724-5226|twilens@partners.org|
20183816|NCT04884737|UCLA School of Nursing|Barbara Bates-Jensen, PhD, RN, FAAN|626-437-8543|batesjen@sonnet.ucla.edu|
20183817|NCT00290706|Northwestern University|Leo Gordon|312-695-4520|l-gordon@northwestern.edu|
20183818|NCT04066738|Oxford University Hospitals NHS Foundation Trust|Prof. Tim Betts|01865 220256|ep.doctors@ouh.nhs.uk|
20183819|NCT00605033|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20183820|NCT01196429|NRG Oncology Statistics and Data Management Center - Buffalo|Linda Gedeon for William Brady PhD|716-845-5702|lgedeon@nrgoncology.org|
20183821|NCT03768206|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
20183822|NCT04181307|NYU Langone Health|Andrea B. Troxel, ScD|646-501-3654|andrea.troxel@nyulangone.org|
20183823|NCT00849147|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20183824|NCT04517864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183825|NCT01049503|Bauru Dental School/University of São Paulo|Dr. Marília Buzalaf|+55 14 32358346|mbuzalaf@fob.usp.br|
20183826|NCT00028769|SWOG Statistical Center|Study Statistician|206-667-4623||
20183827|NCT01199783|Herz- und Diabeteszentrum NRW|PD Dr. Bernd Stratmann|+495731973768|bstratmann@hdz-nrw.de|
20183828|NCT01499134|Thomas Jefferson University|Danielle Duffy MD|215 955 5050|Danielle.Duffy@jefferson.edu|
20183829|NCT01198275|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr. Savina Nodari|00390303996|nodari@med.unibs.it|587
20183830|NCT00391846|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20183831|NCT03624413|Emory University|Brian C. Zanoni, MD|404-727-0284|brian.christopher.zanoni@emory.edu|
20183832|NCT00970307|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183833|NCT01811706|University of Florida|Dr. Guangbin Xia, Assistant Professor|352-273-5550|guangbin.xia@neurology.ufl.edu|
20183834|NCT02452918|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
20183835|NCT03823300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183836|NCT00943735|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20183837|NCT00486330|Yale University AIDS Program|R. Douglas Bruce|2037374040|robert.bruce@yale.edu|
20183838|NCT00813904|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
20183839|NCT01405924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183840|NCT02506257|AMC Amsterdam|Dr. IJE van Der Muelen|020 - 566 9111|TtT@amc.uva.nl|
20183841|NCT00964366|GlaxoSmithKline|GSK Response Center|888-435-7343||
20183842|NCT02393716|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
20183843|NCT03760419|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
20183844|NCT01924767|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20183845|NCT01193153|Janssen Scientific Affairs, LLC, Titusville, NJ|Director of Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20183846|NCT01648140|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183847|NCT01678196|Minneapolis VA Healthcare Service Center|Christopher Erbes, PhD|612-725-2000|christopher.erbes@va.gov|2125
20183848|NCT01377623|UMDNJ-New Jersey Medical School|Alex Bekker|973-972-5007|alex.bekker@nyumc.org|
20183849|NCT01740817|University of Texas Health Science Center at San Antonio|Dr. Nicolas Musi|200-562-6152|musi@uthscsa.edu|
20183850|NCT01988233|University of Illinois Chicago|Dr. David X. Marquez|3129961209|marquezd@uic.edu|
20183851|NCT00470106|VA Greater Los Angeles|Michael F. Green, PhD|(310)2693376|michael.green6@va.gov|
20183852|NCT03781336|National Institutes of Health|Psychologist|3014027360|amelir@mail.nih.gov|
20183853|NCT03987451|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20183854|NCT01183780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183855|NCT00982033|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
20183856|NCT00770965|Novartis|Study Director|862-778-8300||
20183857|NCT00128193|Colorado State University, Department of Microbiology, Immunology and Pathology|Patrick J. Brennan, Ph.D.|970-491-6700|patrick.brennan@colostate.edu|
20183858|NCT04673851|University of North Carolina at Chapel Hill|Bryan Stiles, MA|919-590-5811|stilesb@unc.edu|
20191830|NCT01929876|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20191831|NCT01542398|Queen's University, Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
20191832|NCT03991988|Emory University|Dr. Ihab Hajjar|4047121763|ihajjar@emory.edu|
20191833|NCT01355978|Clinical Research Consuting|Richard J. Morishige, MS, RRT|510-606-0374|rjmorishige@gmail.com|
20191834|NCT04349644|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|(615) 936-0280|blythe.corbett@vumc.org|
20191835|NCT05006417|UW School of Medicine and Public Health|Michael Suer, MD|(608) 265-3207|suer@rehab.wisc.edu|
20191836|NCT01169636|UT MD Anderson Cancer Center|Dr. Christopher Flowers, MD/ Chair, Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
20191837|NCT02396953|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
20191838|NCT00510198|Medtronic CRDM Clinical Research and Reimbursement|Clinical Trial leader|7635262788|ming.duanmu@medtronic.com|
20191839|NCT02994784|Boston Medical Center and BU School of Medicine|John M Sloan, MD|617-638-7519|mark.sloan@bmc.org|
20191840|NCT02179853|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
20191841|NCT01649557|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20191842|NCT02149524|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
20191843|NCT04151706|Stanford University|Dr. Robert Lowsky|(650) 723-0822|rlowsky@stanford.edu|
20191844|NCT03029234|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20191845|NCT02541942|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20191846|NCT02544113|Cleveland Clinic|Dr. Bijan Eghtesad|216 444-9898|eghtesb@ccf.org|
20191847|NCT00583050|Massachusetts General Hospital|Matthew Eagleton, M. D.|617-726-8279|MEAGLETON@mgh.harvard.edu|
20191848|NCT02847637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20191849|NCT04765553|Swedish Orphan Biovitrum AB|Veronica Asnaghi|+41 61 508 72 13|Veronica.Asnaghi@Sobi.com|
20183859|NCT00880048|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224656|NCT01911780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224657|NCT00985426|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
20191850|NCT01746108|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191851|NCT03430050|MUSC|Dr. Sherman|843-792-8174|shermanb@musc.edu|
20206775|NCT01203787|UNIVERSITY OF FLORIDA|Roniel Cabrera, MD|352-273-9468|RONIEL.CABRERA@MEDICINE.UFL.EDU|
20206776|NCT01601470|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206777|NCT02079519|Hoffmann-La Roche|Medical Communications|800 821-8590||
20206778|NCT03627494|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206779|NCT00959894|UNC School of Medicine|Michelle Floris-Moore, M.D., M.S.|919-966-2537|mfloris@med.unc.edu|
20206780|NCT01689324|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20206781|NCT00405275|VA Nebraska-Western Iowa Health Care System|James R. O'Dell, MD|402-559-7288|jrodell@unmc.edu|
20206782|NCT03870893|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
20206783|NCT01308853|Akademikliniken, Stockholm, Sweden|Dr. Per Hedén|+46 8 614 54 00|per.heden@ak.se|
20206784|NCT03689699|Columbia University|Mark N. Stein, MD|212 305 5874|mns2146@cumc.columbia.edu|
20206785|NCT00693420|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20206786|NCT03300427|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20206787|NCT00053014|SWOG statistical office|SWOG leukemia statistician|206-667-4408||
20206788|NCT02853123|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206789|NCT01473355|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20206790|NCT03250624|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20206791|NCT01894555|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
20206792|NCT00106249|CUNY|Dr. Antonio Mantovani|212-650-5417|amantovani@med.cuny.edu|
20206793|NCT01810289|University of California at San Francisco|Dr. Elvin Geng|415-476-4082|elvin.geng@ucsf.edu|409
20206794|NCT02809118|Auris Medical|RAM|0041 61 201 13|ra@aurismedical.com|50
20206795|NCT01235338|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20206796|NCT01597440|Children's National Health System|Dr. Mendel Tuchman||mtuchman@childrensnational.org|
20206797|NCT00509028|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20206798|NCT00948428|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20206799|NCT04241120|HabitAware|Sameer Kumar|2489904720|sameer@habitaware.com|
20183860|NCT01069341|The University of Medicine and Dentistry of New Jersey|Dr. Neelakshi Bhagat|973-972-2032|bhagatne@umdnj.edu|
20183861|NCT02326649|UCSD|Christopher Davis|8589665855|cdavis@rchsd.org|5668
20183862|NCT00373269|Temple University|Dr. Nina T. Gentile|215-707-8402|ngentile@temple.edu|
20183863|NCT02950558|University of Cincinnati|Jun-Ming Zhang, MD, MSc|5135582427|jun-ming.zhang@uc.edu|
20183864|NCT01184508|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183865|NCT01269736|Yale University|Professor Marjorie Funk, PhD, RN|(203) 737-2346|marjorie.funk@yale.edu|
20183866|NCT02861937|Krishnadevaraya college of dental sciences|Dr. Rudrakshi C|080-28467083|drrudrakshi@rediffmail.com|
20183867|NCT00319436|Yale University School of Medicine, Department of Psychiatry and Yale Child Study Center|Nancy Suchman, Ph.D., Associate Professor|203-937-3486|nancy.suchman@yale.edu|7430
20206800|NCT01495689|Ottawa Hospital Research Institute|Smita Pakhale|613-737-8899|spakhale@ohri.ca|79428
20183868|NCT00790790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183869|NCT03253913|University of Cincinnati|Nishant Gupta, MD|5135584831|nishant.gupta@uc.edu|
20183870|NCT02808338|Philips|Clinical Operations Manager|14125423669|jeremy.powers@philips.com|
20183871|NCT02194933|Otsuka Data Transparency Organization|Global Clinical Development||DT-inquiry@otsuka.jp|
20183872|NCT02053363|Rady Children's Hospital|Michael P Kelly|858-576-1700|mkelly5@rchsd.org|223750
20183873|NCT02000817|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206801|NCT05516134|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
20206802|NCT01843205|University of Kentucky|Craig R. Rush, Ph.D.|(859) 257-5388|crush2@email.uky.edu|
20206803|NCT00517413|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20206804|NCT00606177|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20162832|NCT00265317|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20206805|NCT00136357|The Center for Mind-Body Medicine|Dr. James Gordon|202-966-7338|jgordon@cmbm.ort|
20206806|NCT01502761|University of Southern California|Dr. William J Mack|323 442 7512|william.mack@med.usc.edu|
20224658|NCT02052596|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206807|NCT01838655|National Institutes of Health|Brian Brooks, MD, PhD, Principal Investigator, NEI|301-451-2238|brian.brooks@nih.gov|
20206808|NCT02603172|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20224659|NCT00558896|Mayo Clinic|Dr. Martha Lacy||lacy.martha@mayo.edu|
20206809|NCT00927576|VANCHCS|Dr. David L. Woods|925-372-2571|dlwoods@ucdavis.edu|
20206810|NCT00441727|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20183874|NCT00166166|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
20183875|NCT00739765|New York State Psychiatric Institute|John C. Markowitz, M.D.|646 774-8098|jcm42@cumc.columbia.edu|
20224660|NCT00182728|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20183876|NCT01323777|Alcon Japan, Ltd.|Group Manager, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20183877|NCT04210180|Rose Research Center|Jed E. Rose, Ph.D.|9193282345|jed.rose@roseresearchcenter.com|
20206811|NCT02133001|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20206812|NCT04211961|University of Galway|Dr. Alberto Alvarez-Iglesias|+35391524411|alberto.alvarez-iglesias@universityofgalway.ie|
20206813|NCT03210220|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82-32-460-3636|jjchoi2@gilhospital.com|
20224661|NCT00250458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20224662|NCT00001656|National Institute of Mental Health|Judith L. Rapoport, M.D.|301-496-6080|rapoporj@mail.nih.gov|
20224663|NCT00667186|University of Cincinnati College of Medicine|Michael S. Lyons|513-558-0890|lyonsme@ucmail.uc.edu|
20224664|NCT00201240|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20224665|NCT01135069|Spear Pharma|K.L. Spear M.D.|239-433-3442|spear@spearpharma.com|
20224666|NCT03258008|UT MD Anderson Cancer Center|Dr. John Heymach, PHD-Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
20224667|NCT01629823|ALA-ACRC|Janet T Holbrook, PhD, MPH|443-287-3170|jholbro1@jhu.edu|
20224668|NCT01199822|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20224669|NCT00525902|Oregon Health & Science University|Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
20224670|NCT02258542|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
20224671|NCT00480493|University of Massachusetts, Worcester|Susan Sullivan-Bolyai|508-856-4185|susan.sullivan-bolyai@umassmed.edu|
20224672|NCT04027075|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
20224673|NCT02844907|Durham VAMC|David D'Alessio, MD|919-684-5778|david.dalessio2@va.gov|
20183878|NCT03538054|The University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
20191852|NCT00797511|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20191853|NCT03036150|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|Information.center@astrazeneca.com|
20191854|NCT04458181|University of Minnesota|Amy R. Krentzman|612-625-2312|akrentzm@umn.edu|
20191855|NCT01990664|Johnson & Johnson Vision Care, Inc.|Jurandir Araujo, Clinical Compliance Manager|9044431379|jaraujo7@its.jnj.com|
20191856|NCT00931918|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20191857|NCT00809341|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Lode Swinnen|410-955-8603|lswinne1@jhmi.edu|
20191858|NCT01219777|The Ohio State University Comprehensive Cancer Center|Ritu Salani, MD, MBA|614-293-3873|Ritu.Salani@osumc.edu|
20191859|NCT02975297|The University of Texas Health Science Center at Houston|Luba Yammine, PhD, APRN, FNP-C, Associate Professor|(713) 500-2005|Luba.Yammine@uth.tmc.edu|
20191860|NCT00570921|University of Kentucky|Dr. Mara D. Chambers|866-340-4488|mdcham2@email.uky.edu|
20191861|NCT00711997|BioCancell Ltd.|Monique Ben-Am, M.Sc.|+972-2-5486533|monique.ben-am@biocancell.com|
20191862|NCT04731675|AmMax Bio, Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
20191863|NCT02856490|Joylux|Colette Courtion|206.219.6444|sophia@joylux.com|
20191864|NCT01182103|Kaohsiung Chang Gung Memorial Hospital|Tiao-Lai Huang|886-7-7317123|a540520@adm.cgmh.org.tw|8753
20191865|NCT01163955|Glinn and Giordano Physical Therapy|W. Brian Monroe, Doctor of Physical Therapy|661-832-9737|tandbmonroe@hotmail.com|
20191866|NCT03891641|University of North Carolina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
20191867|NCT01372202|SKCCC|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
20191868|NCT00096681|Desmond Tutu HIV Centre|Prof LG Bekker|+2721 633 6599|Linda-Gail.Bekker@hiv-research.org.za|21
20191869|NCT00745121|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20191870|NCT03628456|International Biophysics Corporation|VP of Engineering and Quality|512-804-0046|quality@biophysicscorp.com|
20191871|NCT01723514|Amgen Inc.|Study Director|866-572-6436||
20191872|NCT01547247|Digestive Diseases Center, Vítkovice Hospital, Ostrava, Czech Republic|Přemysl Falt MD|+420602689561|faltprem@centrum.cz|
20191873|NCT01281917|University of Wisconsin Carbone Cancer Center|Lymphoma Disease Oriented Team|608-265-5542|neils@wisc.edu|
20191874|NCT04016805|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20191875|NCT04491084|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-405-8550|nitin.ohri@einsteinmed.edu|
20191876|NCT00740870|Medtronic|Karla Mezera|612-306-4325|karla.p.mezera@medtronic.com|
20191877|NCT00607997|Sunesis Pharmaceuticals, Inc.|Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
20191878|NCT03041298|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
20191879|NCT01376297|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
20191880|NCT04414397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20191881|NCT03640754|MenoGeniX|Debra Duke|303-995-7979|debra.duke@menogenix.com|
20191882|NCT05329402|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
20191883|NCT01478256|George John MD|George John|5028949757|grjohn777@yahoo.com|
20191884|NCT01204775|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
20191885|NCT00276016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20191886|NCT01679613|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191887|NCT01374971|Nathan Wei, MD, PA dba Arthritis Treatment Center|Nathan Wei, MD|301-694-5800|nwei@arthritistreatmentcenter.com|
20191888|NCT03735147|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20191889|NCT00509925|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20191890|NCT00951171|WIHRI|Andrew S Blazar, MD Principal Investigator|401-274-1122|ablazar@WIHRI.org|8461
20191891|NCT00919061|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa|646-888-4184|abou-alg@mskcc.org|
20191892|NCT00092521|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191893|NCT01878383|University of Alabama at Birmingham|David Kimberlin, MD|205.638.2530|DKimberlin@peds.uab.edu|
20191894|NCT03464383|Wake Forest University School of Medicine|Heidi M. Munger Clary, MD, MPH Associate Professor of Neurology|336-716-7110|hmungerc@wakehealth.edu|
20191895|NCT03475056|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20191896|NCT00113269|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
20191897|NCT00837590|Indiana University|Dr. Kieren Mather|317-278-2187|kmather@iupui.edu|
20191898|NCT01904136|Samer Srour, MD / Stem Cellular Transplantation Department|UT MD Anderson Cancer Center|713-794-4354|ssrour@mdanderson.org|
20191899|NCT01947517|Queen's University|Dr. Stephanie Baxter|613 544 3310|baxters@baxtereyemd.com|
20191900|NCT05446714|al-azhar university|dr. mohamed shendy|01223303833|Shendy_ortho@azhar.edu.eg|
20191901|NCT02276638|Nidek|Head, Regulatory Affairs|(800) 223-9044|support@nidek.com|
20191902|NCT02742532|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
20191903|NCT02418845|Lupin Pharmaceuticals Inc|Gregory Kaufman, MD|908.603.6062|gregorykaufman@lupin.com|
20191904|NCT00460564|GlaxoSmithKline|GSK Response Center|866-435-7343||
20191905|NCT01522703|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
20191906|NCT00943618|UT MD Anderson Cancer Center|Paul M. Cinciripini, BS,MS,PHD/Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
20191907|NCT06142578|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
20191908|NCT01990313|Stanford University|Chioma Anidi|6507236709|chioma.anidi@stanford.edu|
20191909|NCT02412111|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20191910|NCT00487552|MED Institute, Inc.|Scott Snyder, Ph.D., Manager, Biostatistics and Data Management, Senior Statistician|765-463-7537|ssnyder@medinst.com|
20191911|NCT02624869|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20191912|NCT01917006|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20191913|NCT02158247|The Catholic University of Korea|Dr. Oh Saecheol|+88-42-220-9046|oscane0822@gmail.com|
20191914|NCT01318538|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
20191915|NCT00053352|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20191916|NCT02154477|SLU|sandeep dhindsa|314-977-4911|dhindsa@slu.edu|
20191917|NCT02741713|Wake Forest Baptist Health|Dr.Jon Wells Reynolds|336-715-9695|jreynold@wakehealth.edu|
20191918|NCT01388478|University of Kansas Medical Center|Jeffrey Burns, M.D., M.S.|913-588-0555|KUAMP@kumc.edu|
20191919|NCT01037413|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191920|NCT05215418|Vivus LLC|Lan Nguyen|650-934-5246|clinical@vivus.com|
20191921|NCT00619983|Wake Forest School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
20191922|NCT03201900|Eisai, Inc.|Inquiry Service.|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20191923|NCT02971228|Zealand Pharma A/S|Kim Mark Knudsen|+45 5060 3780|KMKnudsen@zealandpharma.com|
20191924|NCT02367105|Michael E DeBakey VA Medical Center|Dennis T Villareal, MD|713-794-7156|dennis.villareal@va.gov|
20191925|NCT01233999|Emory University|Dr. Suephy Chen|404-778-3084|schen2@emory.edu|
20191926|NCT02560389|University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison|Josh Cisler|608-263-6100|jcisler2@wisc.edu|
20191927|NCT00550446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191928|NCT02716298|CooperVision|Senior Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
20191929|NCT01321723|Unigene Laboratories, Inc.|Nozer Mehta, PhD. Chief Scientific Officer|(973) 265-1100|nmehta@unigene.com|
20191930|NCT02246218|Horizon Therapeutics, LLC|Colleen Canavan, Director|866-479-6742|clinicaltrials@horizonpharma.com|
20191931|NCT01859611|ELECTRONIC ENGINEERING EL.EN. SPA|ALESSANDRO BIZZARRI STUDY DIRECTOR|+390558826807|A.BIZZARRI@ELEN.IT|
20191932|NCT04081389|Roswell Park Comprehensive Cancer Center|Kristopher Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
20191933|NCT01537185|Comprehensive Clinical Development Northwest|Dr. Royce Morrison|206 285 3500|ckeech@path.org|
20191934|NCT04074343|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
20191935|NCT00827775|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
20191936|NCT00992719|Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Duke University School of Medicine|Geeta K. Swamy, M.D.|919-681-5220|geeta.swamy@duke.edu|
20191937|NCT01670188|Mayo Clinic|Dr. Alejandro Rabinstein|507-284-4741|Rabinstein.Alejandro@mayo.edu|
20191938|NCT00866918|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20191939|NCT00802438|UW Madison|Gina Crisafi, BS|608-265-4554|gmc@medicine.wisc.edu|
20191940|NCT00096109|Barbara Ann Karmanos Cancer Institute|Elaina Gartner, M.D.|(425) 527-4398|egartner@seagen.com|
20191941|NCT02906696|The University of Texas MD Anderson Cancer Center|Philip Thompson, MD/Assistant Professor|713-792-7430|PAThompson2@mdanderson.org|
20191942|NCT02101268|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191943|NCT02831998|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
20191944|NCT00819013|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20191945|NCT05324007|University of Chicago|Dr. Hyesung Grace Hwang|(773) 834-9791|hyesung@uchicago.edu|
20191946|NCT00839332|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191947|NCT01200485|UT MD Anderson Cancer Center|Saroj Vadhan, MD/Professor, Cytokine & Supportive Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20191948|NCT06080438|University of Miami|Principal investigator|305-326-6434|wlee@med.miami.edu|
20191949|NCT01564953|Aarhus University Hospital|Dr. Sarah Hashim Ali Hussein|0045 42660308|sarsuri@hotmail.com|
20191950|NCT03589300|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
20206814|NCT01444898|Children's Hospital Los Angeles|Dr. Mitchell Geffner|323-361-7032|mgeffner@chla.usc.edu|
20206815|NCT03235726|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20206816|NCT01263314|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206817|NCT00282568|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
20206818|NCT00324272|John Radcliffe Hospital|Mr. Henk Giele, Consultant Plastic & Reconstructive Surgeon|01865 231 056|henk.giele@orh.nhs.uk|
20206819|NCT00990249|The University of Texas (UT) MD Anderson Cancer Center|Partow Kebriaei, MD/Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
20206820|NCT01548417|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
20206821|NCT00602771|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
20206822|NCT02873208|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
20206823|NCT00415584|Montefiore Medical Center|Dr. Maria Coco|718-920-4136|mcoco@montefiore.org|
20206824|NCT02640755|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
20206825|NCT03434041|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20206826|NCT00444080|University of Virginia|Peter A. Netland, MD, PhD|434-982-1086|pan9c@virginia.edu|
20206827|NCT02057068|Atlanta Department of Veterans Affairs Medical Center CVNR|Patricia C. Griffiths, PhD|6783615462|pcgriff@emory.edu|
20206828|NCT02420990|Center on Addiction|Dr. Aaron Hogue|212-841-5278|ahogue@centeronaddiction.org|
20206829|NCT03326583|George Washington Medical Faculty Associates|Dominic Raj|(202) 741-2296|draj@mfa.gwu.edu|
20206830|NCT03447821|Cosmo Technologies Ltd.|Richard Jones|+353 18170370|RJones@cosmopharma.com|
20206831|NCT04685538|Sintetica SA|Anna Guaita|+41 (0)91 640 42 50|aguaita@sintetica.com|
20206832|NCT01784614|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20206833|NCT01505114|Fred Hutchinson cancer Research center|Chunyuan Wu|206-667-5567|cwu@scharp.org|
20206834|NCT03168555|Zealand University Hospital|Dr. Christian Borup, coordinating investigator|+4523328035|chrbo@regionsjaelland.dk|
20206835|NCT02165072|Texas Tech university Health Sciences Center, Lubbock, TX|Dr Kenneth Nugent|(806) 743-6847|Kenneth.nugent@ttuhsc.edu|
20206836|NCT01732107|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20206837|NCT03882723|Rush University Medical Center|Dr. David Vines|3129424408|David_Vines@rush.edu|
20206838|NCT02959190|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20206839|NCT01522768|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
20206840|NCT01421069|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206841|NCT01641081|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20206842|NCT00444964|Children's Mercy Hospital|Jaylene Weigel|816-701-1359|jweigel@cmh.edu|
20206843|NCT01015820|Mayo Clinic|Dr. Michael B. Wallace|904-953-6970|wallace.michael@mayo.edu|
20206844|NCT01313078|National Cancer Institute, National Institutes of Health|Elise Kohn, M.D.|301-496-9336|kohne@mail.nih.gov|
20206845|NCT03136484|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20206846|NCT04399980|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
20206847|NCT00044655|NYSPI|Nancy H. Covell, Ph.D.|6469450227|covelln@nyspi.columbia.edu|
20183879|NCT00667745|Bipolar Clinic and Research Program at|Dr. Andrew Nierenberg, Director of the Bipolar Trials Network|617-724-0837|ANIERENBERG@PARTNERS.ORG|
20206848|NCT01115517|Robert Cizik Eye Clinic|Dr. Nan Wang|713-559-5200|nwang@cizikeye.org|
20206849|NCT01176240|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20206850|NCT03906136|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20206851|NCT04772469|University of California San Francisco|Dr. Carol Camlin|5109679558|Carol.Camlin@ucsf.edu|
20206852|NCT01389076|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
20206853|NCT00394277|Hoffmann-La Roche|Medical Communications|800-821-8590||
20206854|NCT02371980|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206855|NCT00922974|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20206856|NCT02944513|Brigham and Women's Hospital|Dr. Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
20206857|NCT02314598|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
20206858|NCT00937326|GlaxoSmithKline|GSK Response Center|866-435-7343||
20206859|NCT02578992|Tri-Service General Hospital|Dr. Wei-Hung Chan|+886-2-87927128|whcken@gmail.com|
20206860|NCT00790218|Can-Fite BioPharma|Sari Fishman, Director of Clincal Trials|972528998666|sari@canfite.co.il|
20206861|NCT02443155|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20206862|NCT00505518|Massachusetts General Hospital|Albert Yeung|617-724-5138|ayeung@partners.org|
20206863|NCT00302055|Northwestern University|Dr. Ronald T Ackermann|(312) 503-6400|r.ackermann@northwestern.edu|
20206864|NCT02279160|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
20183880|NCT02351180|Washington University in St. Louis|Ramsey Hachem, MD|3144548766|rhachem@wustl.edu|
20183881|NCT02754479|DuPage Medical Group|Kelly Stankiewicz, MD FAAD|(630) 547-5040|kjstanki@gmail.com|
20183882|NCT02666742|Kansas City Heart Rhythm Institute|Donita Atkins|913-253-3064|Donita.Atkins@hcahealthcare.com|
20183883|NCT02299336|Retina Consultants of Houston|Dr. Charles C. Wykoff|7135243434|ccwmd@houstonretina.com|
20206865|NCT00189436|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|412-359-4099|dskoner@hsc.wvu.edu|
20206866|NCT00731666|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
20206867|NCT00088595|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206868|NCT03180294|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20206869|NCT02058706|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
20206870|NCT02650193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206871|NCT01951326|RedHill Biopharma|Reza Fathi, Senior VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
20206872|NCT04083404|Queen Margaret University|Dr Susan Prior|44 (0)131 474 0000|sprior@qmu.ac.uk|
20206873|NCT00179998|Nationwide Children's Hospital|Dr. Robert Castile|614-355-6670|robert.castile@nationwidechildrens.org|
20206874|NCT05935982|University of Alabama at Birmingham (UAB)|Byron Lai, PhD|205-638-9790|byronlai@uab.edu|8-9725
20206875|NCT00420342|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20206876|NCT00810095|MindFrame, Inc .|Dr. Thomas J. McCarthy|949-204-0806|tmccarthy@mindframeinc.com|
20183884|NCT01910636|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20206877|NCT05301803|CathVision ApS|Clinical Research Manager|+4531324745|kpf@cathvision.com|
20206878|NCT01599806|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
20206879|NCT02023918|UCSF|Dr. Ethan Weiss|4155140819|ethan.weiss@ucsf.edu|
20206880|NCT03436147|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
20206881|NCT03006926|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20206882|NCT03689972|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20183885|NCT01359371|VA Center for Clinical Management Research Health Services|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
20206883|NCT02417064|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20206884|NCT01192100|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
20206885|NCT01235507|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20206886|NCT01082588|Massachusetts General Hospital|Dr. David Henderson|617-912-7800|dchenderson@partners.org|
20206887|NCT02017704|SKCCC @ Johns Hopkins Medicine|Amol Narang, MD|410-955-7390|anarang2@jhmi.edu|
20206888|NCT01587274|Montefiore Health|Benjamin W. Friedman, MD|7189206626|befriedm@montefiore.org|
20206889|NCT02475629|TaiMed Biologics USA Corp.|Manager - Clinical Services|(949) 331-3225|bbell@taimedbio.com|
20206890|NCT00643097|Duke University Medical Center|Dr. John H. Sampson|919-684-9041|john.sampson@duke.edu|
20206891|NCT01095666|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20206892|NCT00588380|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
20206893|NCT03383614|DNDi|Jean Yves Gillon|+41.22.906.92.32|jygillon@dndi.org|
20183886|NCT02106442|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20206894|NCT01511640|University of Kentucky College of Medicine|Joshua Lile, Ph.D., Professor|8593236034|jalile2@uky.edu|
20206895|NCT03297944|University of Kentucky|Marion Coe|859-257-6488|mcoe07@gmail.com|
20202939|NCT01438710|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
20206896|NCT01577628|Innovaderm Research|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
20206897|NCT00841672|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206898|NCT02709109|Parion Sciences|Alison Church|919-313-1183|achurch@parion.com|
20206899|NCT01787799|Boston Scientific|Peter Maurer, MPH; Director of Clinical Trials|508-683-6678|peter.maurer@bsci.com|
20206900|NCT01928082|The University of Chicago|Murray J. Favus|(773) 702-6138|mfavus@medicine.bsd.uchicago.edu|
20206901|NCT04010370|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
20206902|NCT01815580|Fred Hutchinson Cancer Center|Ann Duerr|206 667 7938|aduerr@fredhutch.org|
20206903|NCT02573233|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20206904|NCT00214487|Dr. Thomas Aller, Optometrist Inc.|Dr. Thomas Aller|650 871-1816|cptreyes@earthlink.net|
20206905|NCT02228824|University of Pittsburgh|Dr. Saul Shiffman|412-567-1761|shiffman@pinneyassociates.com|
20206906|NCT01814826|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20206907|NCT03034057|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206908|NCT03339401|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20206909|NCT02566109|Wake Forest University Health Sciences|Gregory Hundley, MD|336-716-0607|ghundley@wakehealth.edu|
20206910|NCT03032250|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-1432|cnightin@wakehealth.edu|
20206911|NCT01240304|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
20206912|NCT01993667|University of Utah|Dr. Scott McIntosh, MD, MPH|801-581-2730|Scott.McIntosh@hsc.utah.edu|
20206913|NCT03561246|Brooks Rehabilitation Clinical Research Center|Mark G. Bowden - PI|904-345-6626|mark.bowden@brooksrehab.org|
20206914|NCT03619837|University of Southern California|Norah Terrault|323-442-5100|terrault@usc.edu|
20206915|NCT02650895|OncoImmune, Inc.|Dr. Pan Zheng|2027516823|pzheng@oncoimmune.com|
20206916|NCT02988401|Johns Hopkins University|Dr. Ellen Mowry|4106141522|Emowry1@jhmi.edu|
20206917|NCT00981682|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20206918|NCT00983242|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlpharma.com|
20202940|NCT00893113|Chesapeake Urology Research Associates|Ronald Tutrone, MD|443.471.5742|hthomas@cua.md|
20202941|NCT02133235|NTUH|YJ Cheng|886-2-23123456|chengyj@ntu.edu.tw|62158
20202942|NCT03270085|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
20202943|NCT02114203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202944|NCT01518699|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20202945|NCT02110108|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20202946|NCT02123017|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20224674|NCT00550862|Intercept Pharmaceuticals|Dr. David Shapiro|858-652-6800|dshapiro@interceptpharma.com|
20224675|NCT03207074|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
20224676|NCT00109876|Rhode Island Hospital/Alpert Medical School|Damian E. Dupuy, MD|401 - 444 - 5184|ddupuy@lifespan.org|
20224677|NCT00455520|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
20224678|NCT02335749|Zeltiq Aesthetics|Kerrie Jiang, Director Clinical Affairs|925-621-7462|kerrie.jiang@allergan.com|
20224679|NCT01683422|Loma Linda University Health|Gary Yang|909 558 4000|gyang@llu.edu|88056
20224680|NCT00986986|University of Hawaii at Manoa|Dominic Chow|(808)737-2751|dominicc@hawaii.edu|
20224681|NCT02303990|University of Pennsylvania|Dr. Amit Maity|215) 662-3759|maity@uphs.upenn.edu|
20224682|NCT03235115|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20224683|NCT00492817|The University of Texas MD Anderson Cancer Center|Amol J. Ghia, MD|(832) 628-7357|ajghia@mdanderson.org|
20224684|NCT02719938|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
20224685|NCT00955968|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20224686|NCT01455181|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20224687|NCT05020899|Boston Medical Center|Lisa Quintiliani, PhD|617-638-2777|lisa.quintiliani@bmc.org|
20224688|NCT00565669|Carolina Eye|Helga Sandoval||hps@cepmd.com|
20224689|NCT01068626|University of Gothenburg|Kristjan Karason|+46 31 342 7554|kristjan.karason@gu.se|
20224690|NCT01785849|Amgen Inc.|Study Director|866-572-6436||
20224691|NCT01940900|Ophthotech Corp.|Denise Teuber||denise.teuber@ophthotech.com|
20224692|NCT03098498|Department of Periodontology, University Hospital Wuerzburg|Dr. Yvonne Jockel-Schneider|49-931-201-72620|jockel_y@ukw.de|
20224693|NCT02431806|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20224694|NCT00742508|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224695|NCT01177709|Nathan Kline insistute for Psychiatric Research|Robert C smith MD|845-298-6531|rsmith@nki.rfmh.org|
20224696|NCT04972968|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20224697|NCT01698879|CETLAM|Dr. Jordi Sierra|+34 93 434 44 12|jsierra@santpau.cat|
20224698|NCT04120584|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
20224699|NCT03619902|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20224700|NCT04450407|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20224701|NCT04542421|u of colorado|Dr Anna Maw|720-848-4289|anna.maw@cuanschutz.edu|
20224702|NCT00474045|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20224703|NCT02009397|University of Louisville, James Graham Brown Cancer Center|Dr. Jason Chesney|502-562-3429|jason.chesney@louisville.edu|
20224704|NCT00581347|University of Rochester Medical Center|Peter Szilagyi|585-275-5798|peter_szilagyi@urmc.rochester.edu|
20224705|NCT02987374|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20224706|NCT00287989|MSKCC|Charles M. Rudin, MD, PhD.|646-888-4527|rudinc@mskcc.org|
20224707|NCT00808639|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard.edu|
20224708|NCT00655473|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20224709|NCT00710684|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224710|NCT00514904|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224711|NCT01317797|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20224712|NCT02584998|CMC VAMC|Emily Carter Paulson, MD MSCA|215-823-5880|emily.paulson@va.gov|
20224713|NCT01306045|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@nih.gov|
20224714|NCT04198584|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-966-6732|donna_evon@med.unc.edu|
20224715|NCT04550832|LigaChem Bioscience, Inc.|Seonghye Cheon|+82)02-6952-0689|scheon@ligachembio.com|
20224716|NCT04823130|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20224717|NCT03312595|Acera Surgical, Inc.|Chief Science Officer|844-879-2237|information@acera-surgical.com|
20224718|NCT03315455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20224719|NCT04439357|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20224720|NCT05175131|Abbott|Suntje Sander-Struckmeier, PhD|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
20224721|NCT02407132|University of Arkansas for Medical Sciences|Dr. Pearl McElfish|479-713-8680|pamcelfish@uams.edu|
20224722|NCT02672332|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20157582|NCT00902330|Virginia Commonwealth University|Debra Lyon, RN, PhD, FNP|804-828-7743|delyon@vcu.edu|
20183887|NCT01303835|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
20183888|NCT02355158|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
20202947|NCT02773758|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202948|NCT01592851|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202949|NCT00521339|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20202950|NCT01819935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202951|NCT03060577|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20202952|NCT02940886|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20202953|NCT02392208|University of Michigan|Dr. Bruce A. Mueller|734-763-6629|muellerb@med.umich.edu|
20202954|NCT02889510|Dynamic Science S.L|Anna Royo|+34680603119|a.royo@dynasolutions.com|
20202955|NCT02988986|Houston Methodist Hospital|Dr. Jenny Chang, Director of Houston Methodist Cancer Center|713-441-0681|jcchang@houstonmethodist.org|
20202956|NCT01650779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20206919|NCT02918721|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20206920|NCT05283499|Rutgers University School of Dental Medicine|Cecile A. Feldman|973-972-4634|feldman@rutgers.edu|
20206921|NCT02408484|Octapharma|Sigurd Knaub|55 451 21 41|sigurd.knaub@octapharma.com|+41 (0)
20206922|NCT02436915|Institute for Aging Research, Hebrew SeniorLife|Brad Manor|617-971-5332|bradmanor@hsl.harvard.edu|
20206923|NCT04830839|Cincinnati Children's Hospital Medical Center|Professor|+15136363370|shari.wade@cchmc.org|
20183889|NCT01212757|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20206924|NCT01117181|Johns Hopkins|Anne Casper, MA|410-955-8183|ashankli@jhsph.edu|
20206925|NCT00863317|Richmond Emergency Physicians Inc|Frank Petruzella|773 447-2489|fpetruzella@gmail.com|
20206926|NCT04480749|LSHTM|Michael Marks|020 7636 8636|michael.marks@lshtm.ac.uk|
20206927|NCT00216086|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20206928|NCT00809614|Novartis|Study Director|862-778-8300||
20206929|NCT01080625|SNUH|Chul-Woo Jung/ Assistant professor|82-2-2072-0640|spss@snuh.org|
20206930|NCT01224106|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20206931|NCT00728728|VHA Durham|Christine E. Marx, MD|9192860411|christine.marx@va.gov|3626
20206932|NCT03053401|Akron Children's Hospital|Dr. Rami Karroum|330-543-8823|rkarroum@akronchildrens.org|
20206933|NCT00839436|NIAID|Dr. Virginia Sheikh|3014357939|sheikhv@niaid.nih.gov|
20206934|NCT01440972|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
20206935|NCT03933215|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20183890|NCT00573833|Memorial Sloan Kettering Cancer Center|Dr. Josh Yoshiya Yamada, Assistant Attending|+1212-639-2950|yamadaj@mskcc.org|
20183891|NCT04493242|Direct Biologics, LLC|Dr. Amy Lightner|512-354-7124|alightner@directbiologics.com|
20206936|NCT05784129|Janssen Pharmaceuticals, Inc, US Medical Affairs|Medical Director Gastroenterology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20206937|NCT00407550|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
20224723|NCT01458951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224724|NCT03384784|University of Pennsylvania|Rebecca Ashare|215.746.7143|rlashare@pennmedicine.upenn.edu|
20224725|NCT00585013|Baylor College of Medicine|Paul Checchia MD|832-826-5011|checchia@bcm.edu|
20224726|NCT04392167|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
20224727|NCT01573767|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224728|NCT00473824|ADMA Biologics, Inc.|Rebecca Avila|561-989-5853|reavila@admabio.com|
20224729|NCT02560623|Mayo Clinic|Dr. Prasad G. Iyer|507-293-7911|iyer.Prasad@mayo.edu|
20224730|NCT05216991|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
20224731|NCT01661933|The Prince Charles Hospital|Dr John Croese. The Chief Investigator|+61733716164|jcroese@bigpond.com|
20224732|NCT02657577|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
20183892|NCT04722003|Emory University Vaccine and Treatment Evaluation Unit (VTEU)|Varun K. Phadke, MD|404-712-9046|varun.phadke@emory.edu|
20183893|NCT03351075|KU Leuven|Prof. An De Groef|+32 16 342 171|an.degroef@kuleuven.be|
20183894|NCT03175172|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
20183895|NCT03169244|University of North Carolina at Chapel Hill|James C. Garbutt, MD|919-445-0205|jc_garbutt@med.unc.edu|
20183896|NCT02974634|University of Pennsylvania|Dr. Robert Krouse|215-615-4573|robert.krouse@pennmedicine.upenn.edu|
20183897|NCT00550394|University of Cincinnati|Melissa DelBello, MD, MS|513-558-2989|delbelmp@uc.edu|
20183898|NCT04860258|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
20183899|NCT02496702|Technical University of Denmark, Center for Playware|Jari Due Jessen|+45 45 25 39 29|jdje@elektro.dtu.dk|
20183900|NCT01400776|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20183901|NCT04035668|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20183902|NCT01012388|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
20183903|NCT02937831|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20183904|NCT03426228|Fakih IVF|Dr. Ayla Coussa|+971501403866|A.coussa@warwick.ac.uk|
20183905|NCT02027558|VA Greater Los Angeles Healthcare System|Cathy Alessi, MD|818-891-7711|Cathy.Alessi@va.gov|39311
20183906|NCT00831272|University of Pennsylvania|David Oslin|215 823 5894|oslin@upenn.edu|
20183907|NCT00114244|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20183908|NCT02694978|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20183909|NCT01613716|Cleveland Clinic Foundation|Sunil K. Srivastava, MD|216-636-2286|srivass2@ccf.org|
20191951|NCT02569632|Children's Hospital Oakland Research Institute (CHORI)|Dan Granoff, MD (Principal Investigator)|510-428-3000|dgranoff@chori.org|7640
20191952|NCT00673127|Beth Israel Deaconess|Steven Balk|617-735-2065|sbalk@bidmc.harvard.edu|
20191953|NCT01678898|Protalix Ltd|Raul Chertkoff|+972-4-9028100|raul@protalix.com|
20191954|NCT00776984|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191955|NCT03030599|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20191956|NCT00068718|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20191957|NCT00230971|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20191958|NCT04380688|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20191959|NCT01879085|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR, Clinical Trials Administrator|412-647-5554|stadtermanbm@upmc.edu|
20206938|NCT02238782|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
20224733|NCT00230022|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
20224734|NCT01967641|New York State Psychiatric Institute|Dr. Maria A. Sullivan, M.D., Ph.D|646-774-6152|mas23@columbia.edu|
20224735|NCT00723190|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20224736|NCT00454818|Celladon Corporation|Jeffrey J. Rudy, Vice President|1 858-366-4288|jrudy@celladon.net|
20224737|NCT03181503|Galderma|Clinical Operations|(0) 4 93 95 70 70|Clinical.Studies@galderma.com|+33
20183910|NCT03848910|Hearing CRC Melbourne|Professor Robert Cowan|+61 3 9035 5347|r.cowan@unimelb.edu.au|
20183911|NCT01376089|GE Healthcare|Lauren Lim, PharmD|1-626-356-1937|lauren.lim@ge.com|
20183912|NCT03854253|Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia|Dr. Stanislav Sapozhnikov|+79091919191|stas_ss@bk.ru|
20183913|NCT00419094|UCB, Inc.|Study Director|+1 877 822 9493||
20183914|NCT00701896|Ohio State University|Dr. Philip Diaz|6142934925|diaz.3@osu.edu|
20183915|NCT03020745|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20183916|NCT00743444|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20183917|NCT02680457|Instituto de Terapéutica Experimental y Clínica, Universidad de Guadalajara|Dr. Manuel González Ortiz|+52 3310585200|uiec@prodigy.net.mx|34212
20224738|NCT01892085|University of Florida|Leslie Parker|352 215 9360|Parkela@ufl.edu|
20183918|NCT00989937|UCSD|David Feifel||dfeifel@kadimanp.com|
20183919|NCT00203216|Thomas Jefferson University/Jefferson Headache Center|Dr. William Young, Principal Investigator|215-955-2243|William.B.Young@Jefferson.Edu|
20183920|NCT03287622|University of Michigan|Dr. Terri Voepel-Lewis|734-646-6803|terriv@umich.edu|
20183921|NCT02057692|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
20183922|NCT01192542|Johnson and Johnson Vision Care|Brian Pall, O.D., M.S. F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
20183923|NCT00355914|Pain Management Center of Paducah, Paducah, KY|Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|100
20183924|NCT02633358|China Medical University Hospital, Taichung, Taiwan|Dr. Da-Long Chen, director of cardiac intensive care unit|0952122027|my686chen@gmail.com|
20183925|NCT02513238|Rigshospitalet|Principal Investigator, Mesrix|26276374|c.gronhoj@gmail.com|
20183926|NCT03622580|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20183927|NCT00354640|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
20183928|NCT00590707|Johns Hopkins|frederick Sieber|410-550-0942|fsieber1@jhmi.edu|
20183929|NCT01930045|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183930|NCT00241644|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183931|NCT03804918|Imperial College London|Dr Gehan Soosaipillai|+44 20 3312 6666|gsoosaip@ic.ac.uk|7651
20183932|NCT01087762|Cares|UCB|+1887822||9493
20183933|NCT02311972|Duke University|Dr. Robin B. Dail|919-684-3786|robin.dail@duke.edu|
20183934|NCT01563354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20183935|NCT05340244|GE Healthcare|Tracy Grzendzielewski|414-218-6167|tracy.grzendzielewski@ge.com|
20183936|NCT03621761|University of Michigan|Tiffany Braley|734-232-1147|tbraley@med.umich.edu|
20183937|NCT01050569|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
20183938|NCT03387319|Emory University|Kimberly R Jacob Arriola, PhD, MPH|404-727-2600|kjacoba@emory.edu|
20183939|NCT01122901|Adult Brain Tumor Consortium|David Peereboom, MD|410-955-8837|jfisher@jhmi.edu|
20183940|NCT00756730|Community Research initiavte|Dr. Daniel Skiest|413 794 5376|Daniel.Skiest@baystatehealth.org|
20183941|NCT00639002|Incyte Corporation|Study Director|855 463-3463||
20183942|NCT02509585|Cardinal Health|LaTosha Eligon|913-661-3896|latosha.eligon@cardinalhealth.com|
20183943|NCT05190419|UNION therapeutics A/S|UNION therapeutics A/S|+4561777435|clinicaltrials@uniontherapeutics.com|
20183944|NCT03210402|Medtronic Inc|Mike Bennett, Clinical Study Manger|262-362-1956|mike.s.bennett@medtronic.com|
20183945|NCT04470193|University of Utah|Flory Nkoy, MD, MS, MPH|801-662-3660|flory.nkoy@hsc.utah.edu|
20183946|NCT04663802|University of Pennsylvania|Dr. Meeta Prasad Kerlin (PI)|215-746-0446|prasadm@pennmedicine.upenn.edu|
20183947|NCT02517307|Oregon Health & Science University|Melanie Gillingham, PhD|503-494-1682|gillingm@ohsu.edu|
20183948|NCT03863834|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
20183949|NCT00145041|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
20183950|NCT02770248|Alcon, A Novartis Division|Field Medical, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
20183951|NCT01837641|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20183952|NCT01579916|MedImmune, LLC|Raburn Mallory, MD/Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
20183953|NCT03264456|University of Alabama at Birmingham|Samuel Galgano|2059341388|samuelgalgano@uabmc.edu|
20183954|NCT03360396|Boston Scientific Corporation|Jessica Stockwell|612-618-1136|Jessie.Stockwell@bsci.com|
20183955|NCT01123083|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183956|NCT00961636|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20183957|NCT00939991|Duke University Medical Center|Katherine Peters, MD, PhD|919-684-3914|katherine.peters@dm.duke.edu|
20183958|NCT02486588|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
20183959|NCT00329732|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@jefferson.edu|
20183960|NCT02551055|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20183961|NCT05328297|Janssen Research & Development|Senior Director Clinical Sciences Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20183962|NCT04513522|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20183963|NCT04541303|Univ of Mo|Brianna Castillo MD|813-765-1619|briannacastillo.md@gmail.com|
20183964|NCT01613118|Travere Therapeutics, Inc.|Jula Inrig, MD|1-445-529-6312|Jula.Inrig@travere.com|
20224739|NCT01573325|Northwestern Memorial Hospital|Rebecca Duke DNP, MSN, NP-BC Transplant Surgery Nurse Practitioner|3126951686|rduke@nmh.org|
20224740|NCT03448939|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20224741|NCT01541839|University of Alberta|Dr. Erin Wright|780-407-7656|erin.wright@me.com|
20224742|NCT03488225|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
20191960|NCT03579680|University of Michigan|Ted Skolarus|Ph: (734) 845-3506|tskolarus@uchicago.edu|
20224743|NCT01472965|St. Jude Children's Research Hospital|Joshua Wolf, MBBS, BA|901-595-1475|joshua.wolf@stjude.org|
20224744|NCT01393132|Wayne State Univeristy, Detroit, MI|Gabriel Sosne, MD|248-594-6702|gsosne@med.wayne.edu|
20224745|NCT04631107|Apnimed, Inc.|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
20224746|NCT02525536|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20224747|NCT01797159|The SKCCC at Johns Hopkins|The SKCCC at Johns Hopkins|4109556980|kjansen3@jhmi.edu|
20224748|NCT00475878|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.edu|
20191961|NCT05294328|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
20191962|NCT04267393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20191963|NCT02056873|Univeristy of Florida|Dr. Michael Okun|3522945400|okun@neurology.ufl.edu|
20191964|NCT03339271|Mayo Clinic|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
20191965|NCT01936324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20191966|NCT03119688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20191967|NCT02705625|Medivir|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
20191968|NCT00863798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191969|NCT04867707|University of Missouri|Dr. Luis Martinez|(573) 882-3244.|martinezlemusl@umsystem.edu|
20191970|NCT04238520|The Ohio State University|Dr. Xi Chen, Associate Professor|614-2920474|chen.13047@osu.edu|
20191971|NCT01470599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191972|NCT00195442|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20191973|NCT02041221|SPARC|Dr Shravanti Bhowmik|+91 22 66455645||
20191974|NCT02190552|Neuravi Limited|Mairsil Claffey|0035391394123|mclaffey@neuravi.com|
20191975|NCT02637856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20191976|NCT02509312|Beth Israel Deaconess Medical Center|John J. Kowalczyk, MD|617-667-3112|jkowalcz@bidmc.harvard.edu|
20191977|NCT02815735|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20191978|NCT01508832|University of California San Francisco|Ronald D Miller, MD|415 476-9034|millerr@anesthesia.ucsf.edu|
20191979|NCT02122549|ZOLL|Vice President of Medical Affairs|412-968-3333|stevens@zoll.com|14400
20191980|NCT00702650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20191981|NCT00988533|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20191982|NCT00661544|U.T. M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD / Associate Professor|713-745-3458||
20191983|NCT00943722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20191984|NCT01036165|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
20191985|NCT03082898|Vanderbilt University|Dr. Michael Goldfarb|615 343 6924|michael.goldfarb@vanderbilt.edu|
20191986|NCT00307164|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20191987|NCT01848067|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jianqing Lin|(215) 955-8874|jianqing.lin@jefferson.edu|
20206939|NCT02580591|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191988|NCT01649297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191989|NCT01685047|St Jude Medical|Karolien Timmermans|0032 497 51 39 21|ktimmermans@sjm.com|
20191990|NCT02601105|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
20191991|NCT01732926|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20191992|NCT02434523|Boston Medical Center|Dr. Jacob Pieter Noordzij|617-638-8124|Pieter.Noordzij@bmc.org|
20191993|NCT00676897|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
20191994|NCT01049984|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20191995|NCT01040403|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20191996|NCT00292981|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
20191997|NCT01983553|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
20191998|NCT00594178|Dept of PM&R; University of Arkansas for Medical Sciences|Thomas S. Kiser|501-221-1311|kiserthomass@uams.edu|
20191999|NCT01035047|Wake Forest Baptist Medical Center|Erin Harper|336-716-2059|erharper@wakehealth.edu|
20192000|NCT02005393|FujiFilm Medical Systems USA|Robert Uzenoff: Executive Director of Clinical Science|(203) 602-3664|ruzenoff@fujifilm.com|
20192001|NCT02840916|Kaohsiung Chang Gung Memorial Hospital|Dr. Wen-Long Hu|+886-7-731-7123|oolonghu@gmail.com|2334
20192002|NCT04191148|Medpace|Clinical Trial Manager|513-630-0130|E.Plummer@Medpace.com|
20192003|NCT00726713|Pamlab Inc.|Page Young, Clinical Project Manager|985-867-5788|pyoung@pamlab.com|
20206940|NCT01801124|Maimonides Medical Center|Mark Kronefeld, MD|(718) 283-8816||
20206941|NCT00732641|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20206942|NCT03979872|University of Utah|Dr. Yelena Wu|801-213-5653|yelena@utah.edu|
20206943|NCT00865046|VA Pittsburgh Healthcare System|Dr. Debra K. Weiner|412-360-2920|debra.weiner@va.gov|
20206944|NCT00481988|Division of Experimental Therapeutics, NY State Psychiatric Organization|Peter Bulow MD, Assistant Professor of Clinical Psychiatry|(212) 543 5664|pb2182@columbia.edu|
20206945|NCT00654420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206946|NCT00250497|University_of_Minnesota|Dr. Dianne Neumark-Sztainer, Professor|612-624-0880|neuma011@umn.edu|
20206947|NCT01673425|VA National Center for Occupational Health & Infection Control|Lewis Radonovich|352-376-1611|Lewis.radonovich@va.gov|4988
20206948|NCT01525420|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.||jbricker@fhcrc.org|
20206949|NCT02242760|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20206950|NCT03011775|Ukrainian Medical Stomatological Academy|Prof. Igor Kaidashev|+380505858953|kaydashevip@gmail.com|
20206951|NCT01451398|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20206952|NCT00422669|Medtronic, Inc.|Optimize RV Trial Leader|1-800-328-2518|medtroniccrmtrials@medtronic.com|
20206953|NCT00927264|Johns Hopkins University|Cynthia Rand, Ph.D.|410-550-0487|crand@jhmi.edu|
20206954|NCT02219997|Alcon Research, Ltd.|Global Brand Med Affairs Lead, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
20206955|NCT05103475|Veterans Health Administration|Bella Etingen, PhD|214-857-0240|Bella.Etingen@va.gov|
20224749|NCT00096993|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20206956|NCT00924729|Johns Hopkins University|Walter J. Stark, M.D./Professor of Ophthalmology|410-955-5490|wstark@jhmi.edu|
20206957|NCT00196196|Codman & Shurtleff, Inc.|Jandira Ramos, MPH|508-828-3127|jramos8@its.jnj.com|
20206958|NCT02917629|UW Carbone Cancer Center|Dr. Howard Bailey|800-622-8922|clinicaltrials@cancer.wisc.edu|
20206959|NCT00718523|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+331 58 10 08 89|matthieu.rupin@trioncology.org|
20206960|NCT03271307|University of California Los Angeles|Dr. Kathryn Dovel|7143303416|KDovel@mednet.ucla.edu|
20206961|NCT00910728|AstraZeneca|Dr Gregory Curt, MD|+1 301 398 0109|Gregory.Curt@astrazeneca.com|
20206962|NCT01042938|University of Rochester Medical Center|Julie L Ryan, PhD, MPH (PI)|585-276-3862|julie_ryan@urmc.rochester.edu|
20206963|NCT03997760|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20206964|NCT03032510|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
20206965|NCT00856986|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20206966|NCT03061812|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20206967|NCT05041062|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20206968|NCT04018612|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
20206969|NCT00361218|Massachusetts General Hospital|John W. Denninger, MD, PhD|617-726-2985|jdenninger@partners.org|
20206970|NCT01983878|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20206971|NCT02671760|Sequential Medicine Ltd|Head of Product Development|617-818-2735|tadahl@outlook.com|
20206972|NCT02999191|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20206973|NCT01745913|Weill Cornell Medical College|Koen van Besien, MD|2127462646|kov9001@med.cornell.edu|
20206974|NCT03418064|CooperVision|Jose A. Vega, O.D., MSc., FAAO|19256213761|jvega2@coopervision.com|
20206975|NCT00136838|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
20206976|NCT04454138|Prism Eye Institute|Ronaldo Santiago|905-456-3937|ronaldo.santiago@prismeye.ca|267
20206977|NCT01883804|Barbara Davis Center for Diabetes, University of Colorado School of Medicine|Dr. Aaron Michels|303-724-1923|aaron.michels@ucdenver.edu|
20206978|NCT01802515|Yale University|Dr. Mehmet Sofuoglu, Principal Investigator|203 937-4809|mehmet.sofuoglu@yale.edu|
20224750|NCT01828216|Chinese University of Hong Kong|David SC Hui|852 2632 2211|dschui@cuhk.edu.hk|
20224751|NCT00435487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20224752|NCT00835679|Vanderbilt-Ingram Cancer Center|Emily Chan, MD|615-343-4677|emily.chan@vanderbilt.edu|
20224753|NCT02560324|University of Pennsylvania|Principal Investigator|215-746-5789|rlashare@pennmedicine.upenn.edu|
20224754|NCT03596723|Kala Pharmaceuticals, Inc|VP Clinical Development|781-996-5252|Results010@kalarx.com|
20224755|NCT00191282|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20224756|NCT01717482|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-8462|Wigle.Dennis@mayo.edu|
20224757|NCT04756154|3M|Linda Olson|651-736-3586|lkolson2@mmm.com|
20224758|NCT03589976|NYU Langone Health|Jose-Alberto Palma, MD, PhD|212-263-7225|JoseAlberto.PalmaCarazo@nyulangone.org|
20224759|NCT02776644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224760|NCT02089334|Rexahn Pharmaceuticals Inc.|Doug Swirsky/ Chief Executive Officer|240-268-5300|swirskyd@rexahn.com|
20224761|NCT04778059|US Biotest, Inc.|Dr. Gere diZerega|8055951300|gere.dizerega@usbiotest.com|
20224762|NCT02832375|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224763|NCT01312233|Spine Institute for Quality|Christine M Goertz, DC, PhD (Study Principal Investigator)|301-335-0071|cgoertz@spineiq.org|
20183965|NCT01072006|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
20224764|NCT06350461|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
20224765|NCT03430895|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4770|funts@mskcc.org|
20224766|NCT00084318|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20224767|NCT03597009|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20157583|NCT00165789|Eisai Call Center|Eisai Inc.|888-422-4743||
20183966|NCT05219253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20183967|NCT03086369|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20183968|NCT04668339|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
20183969|NCT02986178|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
20183970|NCT00178399|University of Rochester|Michael Milano|585-273-4096|michael_milano@urmc.rochester.edu|
20183971|NCT01124188|UPMC Late Life Depression|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
20183972|NCT01645098|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
20183973|NCT01324453|Minneapolis Heart Institute Foundation|Jane Fox|6128636289|jane.fox@allina.com|
20183974|NCT00708032|Johnson & Johnson Vision Care, Inc.|Kathy Osborn, OD|+1 904 443-1032|clinicalstudies@its.jnj.com|
20183975|NCT01904071|Maimonides Medical Center|Dr. Eitan Dickman, Director of EM Ultrasound|718-283-6057|edickman@maimonidesmed.org|
20183976|NCT02064959|The University of Texas Health Science Center at Houston|Georgene W. Hergenroeder, Ph.D., Associate Professor|713-500-6230|lisa.h.schmitt@uth.tmc.edu|
20183977|NCT02711839|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
20183978|NCT02477670|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|SDube@avanir.com|
20183979|NCT01759264|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20183980|NCT02630719|Truman Medical Center|Sean Gratton MD|816-404-5275|sean.gratton@tmemed.org|
20183981|NCT03262935|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
20183982|NCT02567656|Rhizen Pharmaceuticals S.A.|Prajak Barde MD|+41 32 580 0113|pjb@rhizen.com|
20183983|NCT03951649|UAB|Rachel Sinkey|(205) 934-5611|rsinkey@uabmc.edu|
20183984|NCT02441036|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20183985|NCT00612586|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20183986|NCT01901276|Columbia University Medical Center|Daniel Freedberg, MD, MS|212-305-1021|def2004@cumc.columbia.edu|
20183987|NCT00395018|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20183988|NCT00761930|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
20183989|NCT03257813|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|3001 4200|ricardo.llamas@sophia.com.mx|1059
20183990|NCT03478696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20183991|NCT03615924|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20183992|NCT00716144|GlaxoSmithKline|GSK Response Center|866-435-7343||
20183993|NCT00909363|Weill Cornell Medicine|Dr james B Bussel|917-291-5091|jbussel@med.cornell.edu|
20183994|NCT03280836|Penn State University|Dr. Kathleen Sturgeon|7175314530|kms99@psu.edu|284676
20183995|NCT01989910|Taipei Veterans General Hospital|Dr. WEN-WEI KU|+886228751997|stephaneku@gmail.com|
20183996|NCT01891968|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD|713-745-3428|CR_Study_Registration@mdanderson.org|
20183997|NCT04141917|University of Washington|Dr. Helen Chu|206-685-8702|helenchu@uw.edu|
20183998|NCT02954848|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20183999|NCT01802632|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
20184000|NCT04349150|Massachusetts General Hospital|Daniel C. Chung, MD|6177263544|chung.daniel@mgh.harvard.edu|
20184001|NCT03383146|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20184002|NCT05382104|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20184003|NCT03506880|The Pennsylvania State University|Dr. Rob Turrisi|814-865-7808|rturrisi@psu.edu|
20184004|NCT02336438|Bassett Healthcare Network|Dr. Amy Freeth|607-547-3273|amy.freeth@bassett.org|
20184005|NCT01317420|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184006|NCT05686421|Wills Eye Hospital|Joel Schuman, MD FACS|215-928-3197|JSchuman@willseye.org|
20184007|NCT00857649|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20184008|NCT02498769|Duke University Health System|Dr. Joseph P Mathew Professor of Anesthesiology and Chairman Department of Anesthesiology|919-681-6646|joseph.mathew@duke.edu|
20184009|NCT02533167|Wake Forest Health Sciences|Ashley Tonidandel, MD|336-718-8278|atonidan@wakehealth.edu|
20184010|NCT00367055|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184011|NCT04707313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20184012|NCT02459899|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20184013|NCT01591733|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
20184014|NCT03586544|The Ohio State University|Dharini Bhammar|614-866-9467|dharini.bhammar@osumc.edu|
20184015|NCT01832506|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20192004|NCT00498615|Johns Hopkins University|Gwen Leatherman, R.N.|410-550-8582|gleathe@jhmi.edu|
20192005|NCT03247738|University of Florida College of Medicine, Jacksonville|Dominick J. Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
20192006|NCT00129649|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
20192007|NCT02482935|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20192008|NCT04952701|CooperVision|Jose Vega|9256402964|JVega2@coopervision.com|
20192009|NCT02212301|Johnson & Johnson Vision Care Inc.|Tawnya Wilson OD|904-443-3500|TWilson@ITS.JNJ.com|1834
20192010|NCT00413634|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20184016|NCT00539292|The Hospital for Sick Children|Dr Jacob C Langer|416-813-7340|jacob.langer@sickkids.ca|
20184017|NCT02165761|W.L. Gore and Associates, Inc.|Suzy Palmer, CCRP|928-864-3670|supalmer@wlgore.com|
20184018|NCT00176839|University of Minnesota Masonic Cancer Center|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
20192011|NCT01262118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20206979|NCT01906476|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
20206980|NCT04821960|Northwestern University|James W. Griffith|3125035345|j-griffith@northwestern.edu|
20206981|NCT01041404|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20206982|NCT01931150|Memorial Sloan Kettering Cancer Center|Dr. Mario Lacouture|646-888-6014|LacoutuM@mskcc.org|
20206983|NCT01248585|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
20206984|NCT04968353|Virginia Commonwealth University School of Dentistry, Orthodontics|Steven J Lindauer|8048289326|sjlindau@vcu.edu|
20206985|NCT01685203|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20206986|NCT02896192|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20206987|NCT00410904|Barbara Ann Karmanos Cancer Institute|Shirish M. Gadgeel, M.D.|313-576-8753|gadgeels@karmanos.org|
20206988|NCT01696396|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20206989|NCT02712008|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20206990|NCT01731990|Novartis Pharmaceuticals|Study Director|862-778-8300||
20206991|NCT04374149|Prisma Health|Dr. Julie Martin, Director of Cancer Research|(864) 455-3667|julie.martin@prismahealth.org|
20206992|NCT05569850|DIBINE, University of Bologna|Prof. Lorenzo Breschi|+393482210664|lorenzo.breschi@unibo.it|
20206993|NCT02177786|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20206994|NCT01305941|UNC Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20206995|NCT03950440|University Hospitals Leuven|Dr. Danny Feike Hoogma|003216344270|danny.hoogma@uzleuven.be|
20206996|NCT02892734|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
20206997|NCT02043509|University of East Anglia|Dr Joanne Emery||joanne.emery@uea.ac.uk|
20224768|NCT01550705|University of Utah|John D. Phillips, Ph.D.|801-581-6650|john.phillips@hsc.utah.edu|
20224769|NCT01378377|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20224770|NCT01645891|EO2 Concepts|Dr. Mark Q Niederauer|2103387703|m.niederauer@eo2.com|
20224771|NCT00754520|Zimmer Biomet|Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
20224772|NCT00138073|Massachusetts General Hospital|Jaime Chang|617-726-9069|jchang4@partners.org|
20224773|NCT03026530|Region Ostergotland|Dr. Kihlstedt Pasquier|0046101041000|ebba.kihlstedt.pasquier@regionostergotland.se|
20224774|NCT03301740|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
20224775|NCT00334633|University of Alabama at Birmingham|jane R Schwebke, MD|205-975-5665|schwebke@uab.edu|
20224776|NCT01173055|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
20224777|NCT00456508|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20224778|NCT04814368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20224779|NCT04530591|Hospital of the University of Pennsylvania|Jacob Brenner, Assistant Professor of Medicine|215-662-2222|Jacob.Brenner@pennmedicine.upenn.edu|
20224780|NCT04216589|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20224781|NCT03721835|Smith+Nephew, Inc.|Karlie Morgan|+1.512.496.7507|Karlie.Morgan@smith-nephew.com|
20224782|NCT01690910|St. Joseph Mercy Hospital|Amy Burghardt|734-712-2027|amy.burghardt@stjoeshealth.org|
20224783|NCT01254851|Loyola University Medical Center|Linda Brubaker|708-216-4033|lbrubaker@lumc.edu|
20224784|NCT02294461|Astellas Pharma Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20224785|NCT04676412|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20224786|NCT01371877|University of Nebraska Medical Center|Dr. Jill Poole|402-559-4087|japoole@unmc.edu|
20224787|NCT05932225|Alcon Research, LLC|Clinical Trial Lead, CDMA Trial Management Operations|1-888-451-3937|alcon.medinfo@alcon.com|
20224788|NCT01027897|Grady Health System|Prasad Abraham|404-616-3246|pabraham@gmh.edu|
20184019|NCT00299741|Massachusetts General Hospital|Dr. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
20184020|NCT00324038|Napp Pharmaceutical Ltd|Dr Paul Schofield, Medical Director|01223424444|info@contact-clinical-trials.com|
20184021|NCT03070483|Loyola University Chicago|Dr. Holly Kramer|7083279039|hkramer@lumc.edu|
20184022|NCT02031471|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20184023|NCT01215695|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
20184024|NCT00361283|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
20192012|NCT00578318|Georgetown University Medical Center|Alfiee M. Breland-Noblem Ph.D., MHSc|2026872392|ab2892@georgetown.edu|
20192013|NCT02025985|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20192014|NCT00527514|Daiichi Sankyo|John Raia|(973) 630-2683|jraia@dsus.com|
20192015|NCT03041701|National Cancer Institute|Dr. Christine Heske|240-760-6197|christine.heske@nih.gov|
20192016|NCT00920699|Johns Hopkins University|Christopher A. Ross M.D. Ph.D.|410-614-0011|caross@jhmi.edu|
20192017|NCT00001941|National Cancer Institute, National Institues of Health|Thomas Waldmann, M.D.|301-496-6653|tawald@mail.nih.gov|
20192018|NCT03175198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192019|NCT02630706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20206998|NCT04724291|George Washington University|Dr. Andrew C. Meltzer|2027412952|ameltzer@mfa.gwu.edu|
20206999|NCT03189563|Dong-A ST|Xiaofei Du|82-2-92-8457|duxiaofeicat@donga.co.kr|
20224789|NCT02667626|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
20224790|NCT04527003|MSHersheyMC|Dr. Kristin Riley|7175316647|kriley1@pennstatehealth.psu.edu|
20224791|NCT00033657|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20184025|NCT00430300|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184026|NCT02205307|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
20184027|NCT02041104|Mlinotest d. d.|Ana Velikonja|0038651321785|anaa.velikonja@gmail.com|
20184028|NCT00546871|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20184029|NCT01713946|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20207000|NCT00608244|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
20207001|NCT02748785|Seoul National University Hospital|Eun Bong Lee|+82-2-2072-4399|leb7616@snu.ac.kr|
20207002|NCT01957215|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207003|NCT01670825|Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
20207004|NCT04697888|Children's Mercy Hospital|Joel Lim, MD - Principal Investigator|(816)234-3000|jlim@cmh.edu|
20207005|NCT02613338|University of Tennessee|Adrija Sharma, Principal Investigator|8659747684|adrija.sharma@utk.edu|
20207006|NCT00698139|Columbia University|Dr. Paolo C. Colombo|212-305-2638|pcc2001@columbia.edu|
20224792|NCT02332239|Department of Emergency Medicine, Alpert Medical School, Brown University|Megan L. Ranney, MD, MPH, FACEP|401-444-2557|megan_ranney@brown.edu|
20184030|NCT04036058|Wm. S. Middleton Memorial VA Hospital|Linda McKinley|608-256-1901|linda.mckinley2@va.gov|
20184031|NCT03284957|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20184032|NCT02945332|Texas Tech University|Dr. Nikhil Dhurandhar|806 834-6446|nikhil.dhurandhar@ttu.edu|
20184033|NCT03544515|Columbia University College of Dental Medicine|Philip Y. Kang, DDS|212-342-5244|pyk2104@cumc.columbia.edu|
20184034|NCT01393119|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
20184035|NCT01266265|United Therapeutics Corporation|Nicole Leedom|919-425-5870|nleedom@unither.com|
20184036|NCT01580293|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20184037|NCT01134562|Amgen, Inc|Study Director|866-572-6436||
20184038|NCT00768664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184039|NCT02544152|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20184040|NCT00423098|Novartis Pharmaceuticals|Study Director|862-778-8300||
20184041|NCT02320123|UT Southwestern Medical Center|Dr. Ramona Rhodes|214-648-9012|ramona.rhodes@utsouthwestern.edu|
20184042|NCT02284555|Destiny Pharma|Director of Projects|+44 (0)1273 704440|medinfo@destinypharma.com|
20184043|NCT02694835|Alcon, A Novartis Division|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20184044|NCT00534937|Allegheny General Hospital|Dr. Satish Muluk|(412) 359-3714|muluk@usa.net|
20184045|NCT00941655|National Cancer Institute, National Institutes of Health|Dr. Udo Rudloff|301-496-3098|Udo.Rudloff@nih.gov|
20184046|NCT03290248|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20184047|NCT01815008|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
20184048|NCT00004124|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|(206) 667-4623|ctangen@fredhutch.org|
20184049|NCT00446550|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
20184050|NCT02698891|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-3800|nlin@partners.org|
20184051|NCT00516386|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
20184052|NCT02383472|Boston Children's Hospital|Dr. William Meehan|781-216-1328|William.Meehan@childrens.harvard.edu|
20184053|NCT02013830|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20184054|NCT01111526|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lia Perez|813-745-3665|lia.perez@moffitt.org|
20184055|NCT02200523|Cleveland Medical Devices|Sarah Weimer|216-791-6720|sweimer@clevemed.com|
20184056|NCT04424641|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
20184057|NCT00597038|UCSF Helen Diller Family Comprehensive Cancer Center|Adil Daud, Director, Melanoma Clinical Research|415-353-7392|adaud@medicine.ucsf.edu|
20184058|NCT04238429|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
20184059|NCT03245580|Parkview Mirro Research Center|Christina Zelt RN|2602664153|christina.zelt@parkview.com|
20184060|NCT01171625|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20184061|NCT03557008|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20184062|NCT00186186|Stanford University|Dr. Terence Ketter, Chief Bipolar Disorder Clinic|650-723-2515|tketter@stanford.edu|
20184063|NCT00807144|Imperial College Healthcare NHS Trust|Adam McLean|+44 020 8383 5164|adammclean@nhs.net|
20184064|NCT05882812|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
20184065|NCT03959241|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20184066|NCT03192046|UtexasSouthwestern|Staci Shearin|214-648-6564|staci.shearin@utsouthwestern.edu|
20184067|NCT01505881|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184068|NCT01194154|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20184069|NCT00842257|Massachusetts General Hospital|Dr. David Patrick Ryan, Chief, Hem/Onc|617-974-4545|DPRYAN@mgh.harvard.edu|
20184070|NCT01596504|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20184071|NCT02314117|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20184072|NCT04439799|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-6596|Ramasamy@miami.edu|
20184073|NCT00949975|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20207007|NCT03597503|Supernus|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
20184074|NCT04347954|Stanford University|Jayakar Nayak, MD, PhD|(650) 723-5281|jnayak@stanford.edu|
20184075|NCT03368937|University of Virginia|Sue Brown|434-982-0206|sab2f@virginia.edu|
20224793|NCT01576003|Cincinnati Children's Hospital Medical Center|Conrad R. Cole, MD|513-636-6155|conrad.cole@cchmc.org|
20224794|NCT01928797|Brigham and Women's Hospital|Dr. Bhavani Kodali|617-732-8220|BKODALI@BWH.HARVARD.EDU|
20184076|NCT02969863|MGH|Courtney Balliro, BS RN CDE|617-726-1242|cballiro@partners.org|
20224795|NCT03280225|Central Arkansas Veterans Healthcare System|Dr. Sara J. Landes|501-257-3385|sara.landes@va.gov|
20224796|NCT01440569|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20224797|NCT01044758|Johns Hopkins University School of Medicine|Gregory Krauss, M.D.|(410) 955-2822|gkrauss@jhmi.edu|
20224798|NCT02584959|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20224799|NCT00204477|University of Texas Medical Branch Galveston|Leejane W. Lu|(409)772-1011|llu@utmb.edu|
20224800|NCT03660475|Penn State Hershey Medical Center|Joseph Sassani, MD, MHA|717 531 8783|jsassani@pennstatehealth.psu.edu|
20224801|NCT01966068|Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|267-426-2304|fiks@email.chop.edu|
20224802|NCT02345460|Case Comprehensive Cancer Center|Dr. Davendra Sohal|216-444-8258|sohald@ccf.org|
20224803|NCT00129727|Massachusetts General Hospital|Richard T Penson MD MRCP|617-726-5867|rpenson@partners.org|
20224804|NCT01553240|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
20224805|NCT01239212|Cincinnati Children's Hospital Medical Center|Dr. Stephanie Merhar|513-636-4200|stephanie.merhar@cchmc.org|
20224806|NCT01037127|GlaxoSmithKline|GSK Response Center|866-435-7343||
20224807|NCT00656487|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20224808|NCT02637713|Montefiore Medical Center|Dr. Erin Moran-Atkin|718-920-4800|emoran2@montefiore.org|
20224809|NCT02847182|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
20224810|NCT02345889|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
20224811|NCT04325698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224812|NCT04253782|Yale School of Medicine|Daniel Joseph, MD|(203) 785-4404|daniel.joseph@yale.edu|
20224813|NCT00962091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20224814|NCT00003910|ECOG Statistical Office|Study Statistician|617-632-3012||
20224815|NCT02086682|Mayo Clinic|Dr. Marie Hogan|507-266 -1963|Hogan.Marie@mayo.edu|
20224816|NCT02044874|Arena Pharmaceuticals, Inc|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
20224817|NCT02889835|UAB School of Dentistry|Nathaniel Lawson DMD PhD|205-975-8302|nlawson@uab.edu|
20224818|NCT01834716|Mayo Clinic|Neill Graff-Radford|9049537103|graffradford.neill@mayo.edu|
20224819|NCT05072964|FARAPULSE|Allison Anderson|651-582-5077|Allison.Anderson@bsci.com|
20224820|NCT02987972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224821|NCT01726036|TriHealth|Rachel G. Sinkey MD - PI|513-862-6918|pam_plummer@trihealth.com|
20224822|NCT01047332|Brigham and Women's Hospital|Dr. David L. Carr-Locke, MD, FRCP||dcarrlocke@chpnet.org|
20224823|NCT00291161|Houston HSRD Center of Excellence|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
20224824|NCT03521817|Pennington Biomedical Research Center|John W Apolzan|225-763-2827|john.apolzan@pbrc.edu|
20224825|NCT03153982|University of California, San Francisco|WIlliam Ryan, MD|(415) 502-1877|William.Ryan@ucsf.edu|
20224826|NCT00778102|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20224827|NCT01328548|McMaster University|Dr. Mark Loeb|905 515 9140|loebm@mcmaster.ca|26679
20224828|NCT04149574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20224829|NCT04506905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224830|NCT00073983|SARC|SARC Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
20224831|NCT04010747|Boston Medical Center & BU Chobanian & Avedisian School of Medicine|Emily R Kline, PhD|401-206-0586|emily.kline@bmc.org|
20224832|NCT03976323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20224833|NCT03200847|University of Colorado Hospital|Dr. Martin McCarter|13037242725|martin.mccarter@cuanschutz.edu|
20224834|NCT03800836|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20224835|NCT02000882|US Oncology Research|Taqi Mohammad|7138702175|taqi.mohammad@mckesson.com|
20224836|NCT00549601|Novartis Pharmaceuticals|Study Director|862-778-8300||
20224837|NCT02389374|Menzies School of Health Research|Benedikt Ley|889468643|benedikt.ley@menzies.edu.au|
20224838|NCT00908596|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20224839|NCT00224406|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20184077|NCT03608839|State University of Campinas (UNICAMP)|Dr Rodrigo Pessoa Cavalcanti Lira|551935217396|alayf@hotmail.com|7396
20184078|NCT01794936|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20184079|NCT03920215|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20184080|NCT03320434|Ora, Inc|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
20184081|NCT03024606|Saint Louis University|Research Nurse|314-977-2090|jathompson@slu.edu|
20184082|NCT02547922|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20184083|NCT01867632|MUHC|Dr. Mirko Gilardino|514.934.1934|Mirko.Gilardino@muhc.mcgill.ca|
20184084|NCT00102063|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
20184085|NCT01118338|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20184086|NCT02739035|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|5072665895|schouten.gabriel@mayo.edu|
20184087|NCT00833365|University of Utah|Dr. Gary Chan|801-587-7508|gary.chan@hsc.utah.edu|
20184088|NCT00940992|Solgel|Ofra Levy-Hacham, Ph.D, VP of Quality Assurance|972-8-9313433|ofra.levy-hacham@sol-gel.com|3802
20224840|NCT01842906|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
20184089|NCT03165175|Naval Health Research Center|Suzanne Hurtado|619-553-7806|suzanne.l.hurtado.civ@mail.mil|
20184090|NCT02950896|Washington University School of Medicine|Heather McKenzie|3142862628|heather.mckenzie@wustl.edu|
20184091|NCT00630786|Amgen Inc.|Study Director|866-572-6436||
20184092|NCT02020616|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20184093|NCT00147277|Medtronic Italia S.p.A.|Laura Manotta|003902241371|laura.manotta@medtronic.com|
20184094|NCT00839540|Michigan State University|Dr. Gary E.Stein, Pharm.D.|517-353-5126|steing@msu.edu|
20184095|NCT02885350|Helsinki University Central hospital/Women's hospital/anaesthesia|Dr Antti Vaananen|358504271850|antti.vaananen@hus.fi|
20184096|NCT01378065|Coloplast Corp|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
20224841|NCT01556997|Symplmed Pharmaceuticals LLC|Jeff Feldstein, Sr. Vice President and CMO|888-552-9769|feldstein@symplmed.com|
20224842|NCT01010009|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
20184097|NCT00688519|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184098|NCT01063517|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
20192020|NCT00661466|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20192021|NCT03083093|LUMC|F.A. Klok, MD PhD|003171 526 9111|f.a.klok@LUMC.nl|
20192022|NCT01544309|Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University|Hisao Ogawa, Ph.D; Study Chair|+ 81 963735175|ogawah@kumamoto-u.ac.jp|
20192023|NCT00702273|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192024|NCT01123512|Benvenue Medical, Inc.|Barbara S. Lindsay, Vice President Clinical & Regulatory Affairs|408-454-9300|blindsay@benvenuemedical.com|
20192025|NCT02551692|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
20192026|NCT01091519|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192027|NCT00621946|The University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|Sherwood.Brown@UTSouthwestern.edu|
20192028|NCT01196741|University of Glasgow|Prof Iain McNeish, Professor of Gynaecological Oncology|+44 (0)141 330 3968|iain.mcneish@glasgow.ac.uk|
20192029|NCT01227928|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192030|NCT04582864|Washington University School of Medicine|Dr. Matthew Christopher|314-273-0286|christopherm@wustl.edu|
20192031|NCT02207322|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
20192032|NCT00605566|Princess Margaret Cancer Centre|Dr. Lillian Siu||lillian.siu@uhn.ca|
20192033|NCT04396847|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
20192034|NCT03864341|NYU Langone Health|Kelly Doran, MD, MHS|(212) 263-5850|Kelly.doran@nyulangone.org|
20192035|NCT01066936|Smith & Nephew|Tracey Brengola|978-319-2702|tracey.brengola@smith-nephew.com|
20192036|NCT04334668|Cleveland Clinic|Dr. W. H. Wilson Tang|216-444-2121|tangw@ccf.org|
20192037|NCT02416713|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
20192038|NCT04156399|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
20192039|NCT04831047|Bascom Palmer Eye Institute|Wendy W. Lee MD|305-243-6434|wlee@med.miami.edu|
20192040|NCT01333111|Novo Nordisk A/S|Global Clinical Regstry (GCR, 1452)||clinicaltrials@novonordisk.com|
20192041|NCT00624013|Charles Drew University of Medicine and Science|Diana Echeverry, MD, Principal Investigator|3235634800||
20192042|NCT00847132|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|jhuffman@partners.org|
20192043|NCT03993457|UTexasSouthwestern|Maria Monastirsky|214-648-0174|maria.monastirsky@utsouthwestern.edu|
20192044|NCT01772823|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20192045|NCT02895360|Basilea Pharmaceutica International Ltd.|Thomas Kaindl, MD, Global Medical Director, Oncology|+41615671505|Thomas.Kaindl@basilea.com|
20192046|NCT02262364|Zimmer Biomet|Jennifer Woodell-May, PhD||jennifer.woodell-may@zimmerbiomet.com|
20192047|NCT01271036|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|928-277-0715|jhauze@its.jnj.com|
20192048|NCT00337285|Shire Pharmaceutical Development, Inc.|Timothy Whitaker||twhitaker@shire.com|
20192049|NCT00997932|University of North Carolina School of Medicine|Dr. G Stuart|919-962-4880|gstuart@med.unc.edu|
20192050|NCT01004185|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20192051|NCT03214250|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
20192052|NCT01649505|Oregon Health and Science University|Dr. Juliana Hansen|503-494-4834|hansenju@ohsu.edu|
20192053|NCT00616577|Loma Linda University|Charles Lee, MD|909-558-9408|thamilton@llu.edu|
20192054|NCT01376050|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20192055|NCT05694533|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
20192056|NCT00496626|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192057|NCT04582669|Montefiore Medical Center|Haley Heibel, MD|(718) 920-8352|hheibel@montefiore.org|
20192058|NCT01874665|Ariad Pharmaceuticals|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
20192059|NCT02090998|Rutgers/RWJMS|william grubb md|7322357827|grubbwr@rwjms.rutgers.edu|
20192060|NCT02647788|University of Pennsylvania|Dr. Benjamin Gray|215-294-9650|Benjamin.Gray@uphs.upenn.edu|
20192061|NCT01274559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192062|NCT03245619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20192063|NCT02832284|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412 749 1423|grubbm@bsci.com|
20192064|NCT04752033|Mayo Clinic|Dr. Joseph Pleticha|5073588378|Pleticha.joseph@mayo.edu|
20192065|NCT00776659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192066|NCT01167192|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
20224843|NCT01361113|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20224844|NCT01250171|Novartis Pharmaceuticals|Study Director|862 778-8300||
20224845|NCT03309696|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
20192067|NCT03231969|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
20192068|NCT01336205|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20192069|NCT02314104|St. Barnabas Medical Center|Dr. Eric Liberman|917-696-1370|eliberma@montefiore.org|
20192070|NCT03503162|Motus GI|Director of Clinical Operations|954-541-8000|anniec@motusgi.com|
20192071|NCT02835092|Medifast|Linda Arterburn, VP Scientific & Clinical Affairs|443-379-5191|linda.arterburn@medifastinc.com|
20192072|NCT00025506|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20192073|NCT00713206|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20192074|NCT02547441|Clinical Development Dept.|Maruho Co., Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20192075|NCT01657877|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192076|NCT01532635|Thomas Jefferson University|Neal Flomenberg, MD|215-955-8874|Neal.Flomenberg@jefferson.edu|
20192077|NCT00905034|University of Texas (UT) MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor, Leukemia|713-563-1586|CR_Study_Registration@mdanderson.org|
20192078|NCT04148521|Atrium Health|Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
20192079|NCT01978236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20192080|NCT00634920|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20192081|NCT03029611|UWashington (University of Washington)|Director of Clinical Operations|206-616-2305|childj@u.washington.edu|
20192082|NCT01527500|Novartis Pharmaceuticals|Study Director|862-778-8300||
20192083|NCT00372255|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192084|NCT02864342|AstraZeneca|Medical Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20192085|NCT02573883|Medstar Health Research Institute|Dr. Cheryl Iglesia|202-877-6526|cheryl.iglesia@medstar.net|
20192086|NCT02341599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192087|NCT01125566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192088|NCT01560585|University Hospitals Cleveland Medical Center - Cleveland, OH|Alan J Lerner,MD|1 216 464 6449|alan.lerner@uhhospitals.org|
20192089|NCT00519285|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20192090|NCT02970305|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20192091|NCT01729923|University of Washington|Dr. Stacey Cohen, Principal Investigator|206-606-6658|shiovitz@uw.edu|
20192092|NCT01813305|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
20192093|NCT00988117|UCaliforniaSF|Dr. Bruce Miller|415-476-5569|bmiller@memory.ucsf.edu; kpossin@memory.ucsf.edu|
20192094|NCT04088500|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20192095|NCT00574171|UW Carbone Cancer Center|Dr. William Schelman|608-265-4347|wrs@medicine.wisc.edu|
20192096|NCT01355471|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20192097|NCT02930837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192098|NCT00006436|National Caner Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
20192099|NCT01071317|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
20192100|NCT02592486|Department of Pulmonary Medicine, Kameda Medical Center|Kei Nakashima, Associate Chief|81-4-7092-2211|kei.7.nakashima@gmail.com|8614
20192101|NCT02617667|Novaliq GmbH|Dr Sonja Krösser, VP Preclinical and Clinical Development|+49 6221 50259-0||
20192102|NCT01502371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192103|NCT03777553|Durham Veterans Affairs Medical Center|Elizabeth Van Voorhees|919-886-5542|elizabeth.vanvoorhees@va.gov|
20192104|NCT01554371|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
20192105|NCT02811302|Medtronic - MITG, RGI|Melanie Crystal, Sr. Clinical Program Manager|720-435-5737|melanie.crystal@medtronic.com|
20192106|NCT02598934|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192107|NCT02481934|Hospital universitario 12 de octubre|Alejandra Leivas PhD|+34917792612|alejandraleial@gmail.com|4612
20192108|NCT00960505|University of Illinois Chicago|Krista Varady, PhD, Associate Professor|3129967897|varady@uic.edu|
20192109|NCT03749616|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20192110|NCT03302559|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20192111|NCT03390933|MetroHealth System|Dr. Ashwini Sehgal|216-778-8484|axs81@case.edu|
20192112|NCT01932762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192113|NCT00695136|Pediatrics & Developmental Neuroscience Branch, NIMH|Susan E. Swedo, MD|301-496-5323|swedos@mail.nih.gov|
20192114|NCT03469492|Yale School Of Medicine|Elizabeth Sanchez Rangel, MD|203-737-6067|elizabeth.sanchezrangel@yale.edu|
20192115|NCT01726049|University Hospital Groningen, NL|E.S. Hoendermis, MD, PHD|0031503616161|e.s.hoendermis@umcg.nl|
20192116|NCT01811498|Northwell Health|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
20192117|NCT02668198|Mayo Clinic|Dr. Michael B. Wallace|904-953-2221|wallace.michael@mayo.edu|
20192118|NCT02202109|University of Miami|Dr. Erin Kobetz|3052436185|ekobetz@med.miami.edu|
20192119|NCT06178718|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
20192120|NCT00320398|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192121|NCT04190225|Brown University|Dr. Shira Dunsiger, Biostatistician|401-863-6747|shira_dunsiger@brown.edu|
20184099|NCT03622593|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20184100|NCT05674136|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20184101|NCT02983617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20184102|NCT02860286|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
20184103|NCT00711958|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20184104|NCT02107339|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
20184105|NCT02296424|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
20184106|NCT00071799|Celgene Corporation|CL Beach||CLBeach@celgene.com|
20184107|NCT00814346|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20184108|NCT03941912|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20184109|NCT05136443|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
20184110|NCT01241435|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20192122|NCT01057251|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|manfred.stapff@frx.com|8686
20162833|NCT00801229|Massachusetts General Hospital|Joseph Biderman, MD|617-726-1746||
20184111|NCT00326924|Ottawa Hospital Research Institute|Dean Fergusson, Senior Scientist|613-737-8480|dafergusson@ohri.ca|
20224846|NCT02949908|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20224847|NCT05070468|Alborz University of Medical Sciences|Dr. Masoumeh Farahani|09123783823|drfarahani73@yahoo.com|
20224848|NCT02607280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20224849|NCT00078949|NCIC|Seninor Biostatistician for LY12|613-533-6000|bechen@ctg.queensu.ca|77703
20224850|NCT00577005|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
20224851|NCT01004432|Janssen Scientific Affairs, LLC|Study Director|215-325-4209|rdehorat@its.jnj.com|
20224852|NCT00590538|The Children's Hospital of Philadelphia|Ronald Rubenstein, MD, PhD|1-215-590-1281|rubensteinr@email.chop.edu|
20224853|NCT02309723|Tufts Medical Center|Dr.Yue Zhong, Project Director of Center for the Evaluation of Value and Risk in Health|6176361424|yzhong@tuftsmedicalcenter.org|
20224854|NCT01125813|Octapharma AG|Dr Sigurd Knaub|41 55 451 21 41|sigurd.knaub@octapharma.ch|
20224855|NCT02539134|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20224856|NCT01143064|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
20224857|NCT02453282|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20224858|NCT00323037|CTI Clinical Trial and Consulting Services|Sandy Stagge, RN, BSN|513-619-1837|sstagge@ctifacts.com|
20224859|NCT02327013|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20224860|NCT02380859|Dartmouth-Hitchcock Medical Center|Stephen L. Lee, MD PhD|603-650-5104|stephen.l.lee@hitchcock.org|
20224861|NCT01565668|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20224862|NCT04258254|University of Delaware|Anjana Bhat, Study PI|4435238680|abhat@udel.edu|
20224863|NCT02255552|Sarepta Therapeutics, Inc.|Medical Director|+1-800-690-2003|clinicaltrials@sarepta.com|
20224864|NCT01447446|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20224865|NCT02063178|University of Tennessee Health Science Center|Rebecca Krukowski|9014482426|rkrukows@uthsc.edu|
20224866|NCT04829331|Acera Surgical|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
20224867|NCT01313494|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20224868|NCT03747302|Norris Cotton Cancer Center|Dr. Ardis Olson|603-643-2385|Ardis.Olson@dartmouth.edu|
20224869|NCT01032070|Astellas Pharma Global Development, Inc|Senior Medical Director, Medical Oncology||ClinicalTrials.Disclosure@us.astellas.com|
20224870|NCT00583375|Wright Medical|Stephen Roach|615-656-7466|Stephen.Roach@wright.com|
20224871|NCT00738062|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20224872|NCT02772276|MediBeacon|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
20224873|NCT02248974|Baylor College of Medicine|Dr. Jennifer Blumenthal-Barby|(713) 798-3785|jennifer.blumenthal-barby@bcm.edu|
20224874|NCT00894790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224875|NCT04093492|Medical College of Wisconsin|Dr. Mir A Basir|414-266-6820|mbasir@mcw.edu|
20224876|NCT01118988|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|310-825-0731|LZeltzer@mednet.ucla.edu|
20224877|NCT00087126|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
20224878|NCT01432275|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
20224879|NCT01839799|University of Pennsylvania|Jennifer Louie, Program Manager|215-220-9668|Jennifer.Louie2@pennmedicine.upenn.edu|
20224880|NCT01836809|Virginia Commonwealth University|Keyur Shah, MD|804-828-4571|kshah@mcvh-vcu.edu|
20224881|NCT01935700|Kaohsiung Medical University Hospital|Dr. Zu-Yau Lin|88677317123|linzuyau@yahoo.com.tw|
20224882|NCT01935128|University of Toledo Medical Center|Michael A. Rees, MD, PhD|419 383-3961|michael.rees2@utoledo.edu|
20224883|NCT00231283|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
20224884|NCT00772005|Cephalon, Inc.|Vice President, Clinical Research, CNS/Pain|1-800-896-5855||
20224885|NCT01225289|Tehran University of Medical Sciences|The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patien|+98 912 2182815|sjafarirad@gmail.com|
20224886|NCT02203162|Montefiore Medical Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
20224887|NCT00336323|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Name/Official Title: Adam Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
20224888|NCT03526055|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
20224889|NCT01162122|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20224890|NCT01001806|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
20224891|NCT00878605|VA Greater Los Angeles Healthcare System|Dr. Zhaoping Li, Section Chief|310-268-3528|zhaoping.li@va.gov|
20184112|NCT02221219|University of Kentucky|Research Protocol Manager/Clinical/UKHC|(859) 257-1000|hong.huang@uky.edu|
20184113|NCT00596167|Indiana University School of Medicine|Brian Decker MD, PharmD|317-278-2868|bsdecker@iupui.edu|
20184114|NCT03193619|Becton, Dickinson, and Company|Anna Lovas|952-239-0548|anna.lovas@bd.com|
20184115|NCT00762606|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20184116|NCT03557658|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20184117|NCT01147341|michael schiff|Michael schiff|303 773 8429|michael.schiff@me.com|
20184118|NCT05565391|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184119|NCT04296227|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
20184120|NCT02716324|The Children's Hospital of Philadelphia|James Guevara, MD MPH|2155901130|guevara@email.chop.edu|
20184121|NCT00888979|UConn Health|Cheryl Oncken|860-679-3425|oncken@uchc.edu|
20184122|NCT05641311|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20192123|NCT04544865|Ethicon Endo-Surgery|SENIOR DIRECTOR OF CLINICAL AFFAIRS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20192124|NCT02973802|Apitope International|CEO|+44(0)1291 635511|info@apitope.com|
20192125|NCT01850823|Teva Pharmaceuticals Inc., USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20192126|NCT01751165|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192127|NCT03752242|BioMimetix|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
20192128|NCT01387815|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20184123|NCT01568918|Mayo Clinic|Michelle Clarke, M.D.|(507) 284-5317|Clarke.Michelle@mayo.edu|
20184124|NCT04301986|UNC Center for Esophageal Diseases & Swallowing|Ariel E. Watts, Assistant Director of Clinical Trial Operations|919-962-7316|ariel_watts@med.unc.edu|
20184125|NCT00922207|HoffmannLa Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20184126|NCT03299816|Johns Hopkins University School of Medicine|Deidra C. Crews, MD, ScM|410-502-0518|dcrews1@jhmi.edu|
20184127|NCT01733238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20184128|NCT02311907|Mayo Clinic|Charles L. Loprinzi M.D.|507/284-1623|cloprinzi@mayo.edu|
20184129|NCT00367991|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
20184130|NCT03515304|Johns Hopkins University - Baltimore, MD|Dr. Thorsten Leucker|4105020469|tleucke1@jhmi.edu|
20184131|NCT01271452|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20184132|NCT02203630|Vanderbilt University Medical Center|Raj Keriwala|615-322-3412||
20184133|NCT03684265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184134|NCT02570295|Swiss Federal Institute of Sport Magglingen SFISM|Dr. Thomas Wyss|+41 58 467 64 16|thomas.wyss@baspo.admin.ch|
20184135|NCT00717626|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
20184136|NCT02806869|University of Michigan|Dr. Duxin Sun|734-615-8740|duxins@med.umich.edu|
20184137|NCT04001517|EIP Pharma|Dr. John Alam|6176698426|johnjalam@gmail.com|
20184138|NCT02705586|VA Portland Health Care System|Dr. Amie Hiller|503 721 1091|peterami@ohsu.edu|
20184139|NCT02045836|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184140|NCT05575375|The Miriam Hospital|Emily Gathright|4017938271|emily.gathright@brownhealth.org|
20184141|NCT02798835|Department of Anesthesia and Perioperative Care, Vancouver General Hospital, Vancouver, BC, Canada.|Dr. Steven Lee|6048754111|steven.lee2@vch.ca|61534
20184142|NCT01576523|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20184143|NCT01996917|Columbia University|Christine Rohde, MD|212-342-3707|chr2111@cumc.columbia.edu|
20184144|NCT00739141|Memorial Sloan Kettering Cancer Center|Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
20184145|NCT03687892|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
20184146|NCT04221438|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20184147|NCT05673720|Florida State University|Geraldine Martorella, Hyochol Ahn|850-645-9758|gmartorella@fsu.edu|
20184148|NCT01585558|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20184149|NCT00997386|University of Arizona Cancer Center|Program Coordinator|52-626-0301|aselegue@email.arizona.edu|
20184150|NCT00762619|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
20184151|NCT00617201|University of Kentucky|Dr. Sharon Walsh|859-257-2684|sharon.walsh@uky.edu|
20184152|NCT01350804|Novartis|Study Director|862-778-8300||
20184153|NCT02878850|Duke University|Miriam Treggiari|9196819933|miriam.treggiari@duke.edu|
20184154|NCT01286272|Alliance for Clinical Trials in Oncology|Kristie A. Blum, MD|614-293-8858|kristie.blum@osumc.edu|
20184155|NCT04001829|ECOG-ACRIN Biostatistics Center|Study statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20184156|NCT05011396|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
20184157|NCT03253848|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20184158|NCT06331403|Massachusetts General Hospital|Lucy Finkelstein-Fox, PhD|617-726-6300|lfinkelsteinfox@mgh.harvard.edu|
20184159|NCT04480827|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|972.3.693.8448|yossigs@galmedpharma.com|
20184160|NCT04218110|Eurofins EVIC|Commercial Manager|+40 213357090|luciachirita@eurofins.com|
20184161|NCT00002842|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|
20184162|NCT02015546|Duke University Medical Center|Dr. Ashwin Patkar|919-681-0613|ashwin.patkar@duke.edu|
20184163|NCT05855655|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
20184164|NCT04580160|Vesper Medical|Joseph C. Griffin, III|4848926340|Jgriffin@vespermedical.com|
20184165|NCT01337635|Medical College of Wisconsin|Yvonne Chiu, MD|414-955-2818|ychiu@mcw.edu|
20184166|NCT01113931|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20184167|NCT03176654|Loma Linda University Health|Everett Lohman, PhD. Professor||elohman@llu.edu|83171
20184168|NCT01307267|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184169|NCT01402531|UCSD|Department of Surgery|(858) 657-5291||
20184170|NCT02568644|Universidade Federal de Minas Gerias|Dr. Antonio Lucio Teixeira||altexr@gmail.com|
20184171|NCT04956575|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20184172|NCT03593876|University of Pittsburgh|Dr. Elizabeth Skidmore|(412) 383-6617|skidmore@pitt.edu|
20184173|NCT00432458|Mayo Clinic|Dr. Thomas Witzig||witzig@mayo.edu|
20184174|NCT00854906|University of Arkansas for Medical Sciences|Richard Harper|501 526-6000|harperricharda@uams.edu|2616
20202957|NCT00052429|Memorial Sloan Kettering Cancer Center|Dr. Suzanne Wolden|212-639-5148|woldens@mskcc.org|
20184175|NCT04147897|University of Washington|Dror Ben-Zeev, Professor|206-685-9655|dbenzeev@uw.edu|
20184176|NCT04527549|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20184177|NCT03718767|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
20184178|NCT01290224|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
20184179|NCT00346333|Harvard Medical School|Eliot L. Berson, M.D.|617-573-3600|marilyn_sullivan@meei.harvard.edu|
20184180|NCT03460756|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20184181|NCT04333758|Tan Tock Seng Hospital Pte Ltd|Ms Lim Chien Joo|9035249|Chien_Joo_LIM@ttsh.com.sg|
20184182|NCT03963583|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
20184183|NCT03946670|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20184184|NCT02425111|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20184185|NCT06315907|Pennington Biomedical Research Center|Professor|+1 (225) 763-2585|corby.martin@pbrc.edu|
20184186|NCT05019144|Medical University of South Carolina|Dr. Aaron P. Lesher|843-408-6782|leshera@musc.edu|
20184187|NCT00588770|ECOG-ACRIN Cancer Reserch Group Statistical Office|Study statistician|6176323012|eatrials@jimmy.harvard.edu|
20184188|NCT00843882|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20184189|NCT00256243|Chao Family Comprehensive Cancer Center|Dr. Rita Mehta|(714) 456-5153|rsmehta@uci.edu|
20184190|NCT00792948|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|(206) 667-4623||
20184191|NCT06129045|Black Hills State University|Ashley Pfeiffer|6053815370|ashley.pfeiffer@bhsu.edu|
20184192|NCT01582269|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20184193|NCT05076266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20184194|NCT03401489|San Francisco VA Medical Center|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
20184195|NCT03516942|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20184196|NCT01426269|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
20184197|NCT03675581|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184198|NCT00799396|University of Maryland School of Medicine|Alan R Shuldiner, MD|410-706-1623|ashuldin@medicine.umaryland.edu|
20184199|NCT01867216|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20184200|NCT03454529|Karmanos Cancer Institute|Michael Simon,MD|313. 576-8727|simonm@karmanos.org|
20184201|NCT06258785|Endeavor Health|Dr. Claudia Paya Ten|847-570-4729|claudia.payaten@endeavorhealth.org|
20184202|NCT00114101|Roswell Park Cancer Institute|Philip McCarthy, MD||philip.mccarthy@roswellpark.org|
20184203|NCT05764161|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20184204|NCT00831415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20184205|NCT05694065|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Fenghua Ding|+00 86 21 64370045|ruijindfh@126.com|
20184206|NCT03861767|UPMC|Matthew D. Neal, MD FACS|412-647-1158|nealm2@upmc.edu|
20184207|NCT01145885|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184208|NCT03184558|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
20184209|NCT05299606|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20184210|NCT02880241|Medicines for Malaria Venture (MMV)|Dr Stephan Duparc, Chief Medical Officer|+41 22 555 0351|duparcs@mmv.org|
20184211|NCT00057837|ECOG Statistical Office|Study Statistician|617-632-3012||
20184212|NCT02537522|Johnson & Johnson Vision Care Inc.|Andrea Le, OD -Manager Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
20184213|NCT04303156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184214|NCT02570711|Acerta Pharma, LLC|Priti Patel, MD, Vice President - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20184215|NCT05001945|Mineralys Therapeutics|David Rodman, MD Chief Medical Officer|1-888-378-6240|drodman@mineralystx.com|
20184216|NCT00585533|Huntsman Cancer Institute/University of Utah|Wallace Akerley, MD|801-585-5986|wallace.akerley@hci.utah.edu|
20184217|NCT03482011|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20184218|NCT00468052|UMDNJ|Anuradha Patel, MD|973 972-5254|patelan@umdnj.edu|
20184219|NCT02709655|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20184220|NCT02248480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20184221|NCT04795752|Sight Sciences, Inc|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
20184222|NCT00800605|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
20184223|NCT06218251|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
20184224|NCT05797155|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
20184225|NCT00026312|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20184226|NCT02445391|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
20184227|NCT02322840|Medtronic|Yetunde Ishola (Clinical Study Manager)|734-221-8182|yetunde.a.ishola@medtronic.com|
20184228|NCT05672030|Brigham and Women's Hospital, Allergy and Clinical Immunology|Tanya M. Laidlaw, MD, Associate Professor of Medicine|6177329850|tlaidlaw@partners.org|
20184229|NCT05793112|Massachusetts General Hospital|Dr. Qian Yuan|6172435466|QYUAN@mgh.harvard.edu|
20184230|NCT03215927|University of Pittsburgh|Rohit Aggarwal|4123838123|aggarwalr@upmc.edu|
20184231|NCT03779048|University of Pennsylvania|Dr. Jena Tronieri|2157465045|jena.tronieri@pennmedicine.upenn.edu|
20184232|NCT00465816|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184233|NCT02207972|Mount Sinai West|Dr Barbara Orlando MD and PI|2125236915|barbara.orlando@mountsinai.org|
20207008|NCT03690674|Seattle Children's Research Institute|Dr. Pooja Tandon|206-884-1130|pooja.tandon@seattlechildrens.org|
20207009|NCT02027272|University of Mississippi Medical Center|James N. Martin, Jr.|601-984-5358|jnmartin@umc.edu|
20207010|NCT00688623|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20207011|NCT02000219|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
20207012|NCT02667236|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
20207013|NCT01605890|Hopital Bichat-Claude Bernard, AP-HP, Paris, France|Pr Sophie Matheron|+33140257883|sophie.matheron@aphp.fr|
20207014|NCT01780324|Seattle Children's Hospital|Neil Uspal, MD|206-987-2599|neil.uspal@seattlechildrens.org|
20207015|NCT04037462|VA Ann Arbor Healthcare System|Dr. Nithya Ramnath|(734) 845-5800|Nithya.Ramnath@va.gov|
20224892|NCT02787057|Peking University First Hospital|Dr. Jie Dong|+86 010 66551708|jie.dong@bjmu.edu.cn|
20224893|NCT03442699|Hartford Hospital/Institute of Living|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
20224894|NCT01914159|Dept of Ophthalmology, University of Bonn, Bonn, Germany|Tim U. Krohne, MD, FEBO|+49 228 287|krohne@uni-bonn.de|15505
20224895|NCT02292186|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20224896|NCT01443494|Intensive Care Unit, Zhongda Hospital, Southeast University|Jingyuan Xu|86-025-83262550|xujingyuanmail@163.com|
20224897|NCT02978859|Columbia University|Benjamin Izar|212 304 5871|bi2175@cumc.columbia.edu|
20224898|NCT00150800|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20224899|NCT01790828|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224900|NCT00754208|University of Nebrasa Medical Center|Joan Daughton|402-552-6006|jdaughton@childrensomaha.org|
20224901|NCT02326298|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20224902|NCT01768845|West Virginia Universtiy|Michael Craig, MD|304-293-4980|craigm@wvumedicine.org|
20224903|NCT01472939|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20224904|NCT03180515|Stanford School of Medicine|Bronte-Stewart Lab|6507236709|hbsmovlab@gmail.com|
20224905|NCT02718248|Ottawa Hospital Research Institute|Sarah MacLean|6137378899|samaclean@ohri.ca|73011
20224906|NCT02523235|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
20224907|NCT02604550|Emory University|John Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
20224908|NCT01404208|MGH|Dr. Daniel Geller|617 724 5141|dan.geller@mgh.harvard.edu|
20224909|NCT02570139|3M Critical and Chronic Care Solutions Division|Anne Swearingen, Manager, Clinical Operations|651 736 7826|aswearingen@mmm.com|
20224910|NCT00908076|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
20224911|NCT02609724|UZ Leuven|Prof. Nele Devoogdt|0032 16 34 25 15|nele.devoogdt@uzleuven.be|
20224912|NCT03077659|NanOlogy, LLC|Gere S. diZerega, MD|805-595-1300|gere.dizerega@usbiotest.com|
20224913|NCT03769675|Mayo Clinic|Narayan R. Kissoon, M.D.|507-284-4961|Kissoon.Narayan@mayo.edu|
20224914|NCT04068688|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
20224915|NCT01099774|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20224916|NCT02554318|Medical Faculty Wijaya Kusuma Surabaya|Dr. Budhi Setiawan|+6287751644522|nehesa@gmail.com|
20224917|NCT00006305|University of Pittsburgh|Dr. Maria Brooks|4126241618|brooks@edc.pitt.edu|
20224918|NCT00662558|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20224919|NCT05765253|Argon Medical Devices|Danyel Carr|469-731-1421|Danyel.Carr@argonmedical.com|
20224920|NCT00396877|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
20224921|NCT02945254|Brigham and women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
20224922|NCT00783224|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20224923|NCT01711619|Medtronic|Global Clinical Study Manager||medtronicneurotrials@medtronic.com|
20224924|NCT00334802|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20224925|NCT02470403|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20224926|NCT03422159|Community Medical Center Department of Critical Care, Department of Nephrology|Jose Iglesias, DO|732-557-8070|jiglesias23@gmail.com|
20224927|NCT02348359|Brace Pharma Capital|Vice President, Clinical and Regulatory|240-403-7153|info@Tyrogenex.com|
20224928|NCT03436199|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20224929|NCT01881087|Fundación Valle del Lili|Dr. Fredy Ariza, MD., MSc., PhD(a).|+57 3319090|fredyariza@hotmail.com|4122
20224930|NCT02631070|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20224931|NCT02669914|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovindan@wustl.edu|
20224932|NCT04742309|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20224933|NCT00503997|Vanderbilt-Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
20224934|NCT00085098|Children's Oncology Group|Results Coordinator|(626) 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20224935|NCT01195844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20224936|NCT04812795|University of Pennsylvania|Dr. Andy Tan|2157466546|andy.tan@asc.upenn.edu|
20224937|NCT00980018|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20224938|NCT02565706|William Paterson University|Jennifer Di Noia|973.720.3714|dinoiaj@wpunj.edu|
20224939|NCT03887117|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20224940|NCT02020512|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20224941|NCT00483704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184234|NCT00818454|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184235|NCT03573518|Botanix Pharmaceuticals|Head of Development|+1 445 300 3403|trials@botanixpharma.com|
20184236|NCT01112670|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
20184237|NCT01765543|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20207016|NCT04402385|Yale School of Medicine|Olga Grechukhina, MD: Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences|(203) 785-3091|olga.grechukhina@yale.edu|
20184238|NCT00507689|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20207017|NCT00608894|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
20184239|NCT02138006|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
20184240|NCT01188499|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|Jeffrey.Skolnik@tetralogicpharma.com|141
20184241|NCT00424762|University of Texas Southwestern Medical Center at Dallas|Dr. Darren K. McGuire|214 645 7520|darren.mcguire@utsouthwestern.edu|
20207018|NCT01518309|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20207019|NCT00038142|The University of Texas (UT) MD Anderson Cancer Center|Dr. Eugenie S. Kleinerman, Professor, Pediatrics - Research|713-792-8110|ekleiner@mdanderson.org|
20224942|NCT03627416|Jagiellonian University Medical College|Dr. Jakub Antczak|+48 795 421 153|jantczak@uj.edu.pl|
20224943|NCT05727306|University of Sheffield|Andrew G. Messenger|+44 114 222 2000|a.g.messenger@sheffield.ac.uk|
20224944|NCT00948506|University of Pennsylvania|Joy Wan|2157466364|joy.wan@uphs.upenn.edu|
20224945|NCT03912428|National Institute of Mental Health|Dr. Robert Innis|+1 301 594 1368|robert.innis@nih.gov|
20224946|NCT03233204|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20224947|NCT02814227|University of Michigan|J. Todd Arnedt, PhD|734-615-8666|tarnedt@med.umich.edu|
20224948|NCT02520427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20224949|NCT00793624|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224950|NCT00157248|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224951|NCT03191864|Ellodi Pharmaceuticals (Formerly Adare Pharmaceuticals)|Senior Director Clinical Operations and Medical Affairs|(609) 450-1312|karol.knoop@ellodipharma.com|
20224952|NCT01447927|University Hospitals of Cleveland, Case Medical Center|Dr. Amitabh Chak|216-844-5385|Amitabh.chak@case.edu|
20224953|NCT02342548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224954|NCT04231396|BioSpeech|K. Lindaas, Principal Investigator|(503) 522-6276|kirstylindaas@biospeech.com|
20224955|NCT00595114|Brigham and Women's Hospital|Dr. Bruce D. Levy|617-525-5407|blevy@partners.org|
20224956|NCT00616603|Loma Linda University Department of Anesthesiology|Patricia Moore, CCRP|909-558-8493|pamoore@llu.edu|
20224957|NCT04108988|Yale School of Medicine|Dr. Kimberly Hieftje|(203) 737-3301|kimberly.hieftje@yale.edu|
20224958|NCT02570321|UCSF, Proctor Foundation|Sarah Abedelrahman, Research Data Analyst|2135093817|sarah.abdelrahman@ucsf.edu|
20224959|NCT04679051|Texas Tech University|Joaquin U Gonzales|806 834 5944|joaquin.gonzales@ttu.edu|
20224960|NCT01886781|University of Stellenbosch, South Africa|Cheryl Stevenson|0827514411|cheryl@retaildc.co.za|
20224961|NCT01522235|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|6176328454|rfreeman@bidmc.harvard.edu|
20224962|NCT01985958|University of Pennsylvania|Edgar Ben-Josef, M.D.|215-662-3932|Edgar.Ben-Josef@uphs.upenn.edu|
20224963|NCT00934856|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20224964|NCT00195494|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20224965|NCT00513357|University of Texas MD Anderson Cancer Center|Dr. Egidio Del Fabbro|713-563-4157|ammarin@mdanderson.org|
20224966|NCT03019003|Massachusetts General Hospital Cancer Center|Dr. Sara Pai, MD, PhD|6178779118|sara.pai@mgh.harvard.edu|
20224967|NCT00926536|Stanford University|Dr Nishita Kothary|6504986020|kothary@stanford.edu|
20224968|NCT03301844|NTC srl|Alessandro Colombo|+39 02 4385 0490|alessandro.colombo@ntcpharma.com|
20224969|NCT05087966|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
20224970|NCT01267201|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20224971|NCT00501059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20224972|NCT02124759|UTHSC San Antonio|Dr. Nicolas Musi|630-5001|musi@uthscsa.edu|210
20224973|NCT03653091|Fractyl Health, Inc.|Sarah Hackett, Sr. Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
20224974|NCT04249622|Mayo Clinic|Saranya Chumsri, MD|904-953-2000|Chumsri.Saranya@mayo.edu|
20224975|NCT04250298|Medical University Graz|Dr. Camilla Drexler-Helmberg|0043316385|camilla.drexler@uniklinikum.kages.at|83066
20224976|NCT03604705|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20224977|NCT03689543|National Institute of Mental Health|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
20224978|NCT00932451|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184242|NCT00723450|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184243|NCT01135511|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184244|NCT00971789|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20184245|NCT00545077|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20184246|NCT03260140|VA Puget Sound Health Care Sysem|Margaret P. Collins|206.764.2085|margaret.collins@va.gov|
20184247|NCT00831675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20184248|NCT05283395|Alcon Research, LLC|Scientific Advisor, Clinical R&D|1-888-451-3937|alcon.medinfo@alcon.com|
20184249|NCT01063972|University of Kansas Medical Center|Sharon Fitzgerald, MPH|913-588-3488|sfitzgerald@kumc.edu|
20224979|NCT01451632|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20224980|NCT00585715|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
20224981|NCT04891406|Imperial Tobacco Ltd|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.co|
20224982|NCT01634659|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20224983|NCT02968433|Stanford University|Dr. Helen Bronte-Stewart|650-723-6709|hbsmovlab@gmail.com|
20224984|NCT01294371|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20224985|NCT05619536|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
20224986|NCT00875433|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20224987|NCT04272606|University of Iowa|Catherine Olinger|319-384-5892|catherine-olinger@uiowa.edu|
20224988|NCT00637806|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
20224989|NCT00725101|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20224990|NCT01592292|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20224991|NCT00885742|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20224992|NCT01319851|Emory University|Dr. John Horan|404-785-1272|jthoran@emory.edu|
20224993|NCT00622336|Celgene Corporation|Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
20224994|NCT00819780|Amgen Inc.|Study Director|866-572-6436||
20224995|NCT02923245|Brown University|Almaz Dessie, MD||almaz@brown.edu|
20224996|NCT01764997|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20224997|NCT00787917|Novartis Pharmaceuticals|Study Director|862 778-8300||
20224998|NCT05530980|University of South Carolina College of Nursing|Dr. Demetrius Abshire|803-576-6262|abshired@mailbox.sc.edu|
20224999|NCT02172040|Kitov Pharmaceuticals, Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
20225000|NCT01463267|Kent State University|Joel Hughes|3306727721|jhughes1@kent.edu|
20225001|NCT00684749|University of Minnesota|Umar Choudry/Bruce Cunningham|6126250697|choud008@umn.edu|
20225002|NCT00082017|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
20225003|NCT04438499|Laborie Medical Technologies|Adele Campbell|16032558251|ACampbell@laborie.com|
20225004|NCT02093390|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20225005|NCT05670314|University of Nottingham|Dr Afroditi Kouraki|0115 8231676|afroditi.kouraki1@nottingham.ac.uk|+44
20225006|NCT01777139|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225007|NCT02542293|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20225008|NCT03030118|Penn State Hershey College of Medicine|Nancy J Olsen MD, Professor of Medicine|717-531-4921|nolsen@pennstatehealth.psu.edu|
20225009|NCT04529850|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
20225010|NCT00310466|ALK-Abelló A/S|Kim Simonsen, Senior Director|+4545747576||
20225011|NCT00593606|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20184250|NCT00712335|Inje University|Dr. Chang-Keun Kim|82-2-950-8832|kimck@paik.ac.kr|
20225012|NCT04643964|The Ohio State University|Dr. Daniel Strunk|6146884891|strunk.20@osu.edu|
20225013|NCT02638129|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
20225014|NCT00869557|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20225015|NCT02397291|"University of Colorado Denver | Anschutz"|Henry Galan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20225016|NCT00114738|National Cancer Institute|Dr. Wyndham Wilson|301-435-2415|wyndham_wilson@nih.gov|
20225017|NCT02971800|CHU de Québec|Dr Philippe Laberge|+1(418)525-4444|philippe.laberge@fmed.ulaval.ca|
20225018|NCT01149421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225019|NCT04566133|National Cancer Institute|Dr. Tim F. Greten|2407606114|gretentf@mail.nih.gov|
20225020|NCT00176436|Maryland Psychiatric Research Center|M. Patricia Ball, R.N., C.,M.S.|410-402-7663|pball@mprc.umaryland.edu|
20225021|NCT00355706|Pain Management Center of Paducah|Laxmaiah Manchikanti, MD|2705548373|drm@asipp.org|100
20225022|NCT03738800|Mayne Pharma|Mayne Pharma|1 252 752 3800|us.medicalinformation@maynepharma.com|
20225023|NCT04395391|Exact Sciences|Alexandra Massoud, Vice President of Clinical Affairs|608-284-5700|clinicaltrials@exactsciences.com|
20225024|NCT02223819|Columbia University|Shaheer A. Khan, DO|212-342-5162|sk4488@cumc.columbia.edu|
20225025|NCT04339179|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
20225026|NCT01917344|Boston Children's Hospital|Susan Waisbren, P.h.D|617-355-7346|susan.waisbren@childrens.harvard.edu|
20225027|NCT02956057|Tomas Bata Hospital|Kojecky Vladimir|+420577552512|kojecky@bnzlin.cz|
20225028|NCT00565916|Washington University School of Medicine|Dr. Robert Gropler MD|314-747-3878|groplerr@mir.wustl.edu|
20225029|NCT03435224|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20184251|NCT03401112|Imara Inc.|Imara Clinical Operations|617-206-2020|info@imaratx.com|
20225030|NCT00367484|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Bettina Stubinski/Senior Medical Director|+49 6151 72 5200|service@merckgroup.com|
20225031|NCT04472026|University Of Florida|Naykky Singh Ospina|352) 273-8656|naykky.singhospina@medicine.ufl.edu|
20184252|NCT01264679|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20225032|NCT02382796|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225033|NCT00624559|University of Delaware|Dr. William Farquhar|302-831-6178|wbf@udel.edu|
20184253|NCT03475316|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
20225034|NCT04007107|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20225035|NCT04526574|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184254|NCT00424645|UT MD Anderson Cancer Center|Saroj Vadhan, MD||CR_Study_Registration@mdanderson.org|
20184255|NCT01179334|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20184256|NCT04177394|Abbott|Melody Dong|4086434617|melody.dong@abbott.com|
20184257|NCT00258895|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20184258|NCT00547118|Maryland Psychiatric Research Center|Dr. Robert W. Buchanan|410-402-7876|rwbuchanan@mprc.umaryland.edu|
20184259|NCT01335542|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
20184260|NCT01595321|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
20184261|NCT01390402|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
20184262|NCT04789408|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20184263|NCT05841680|Florida International University|Jeremy Pettit|3053481671|jpettit@fiu.edu|
20184264|NCT03602911|West Virginia University|Rusha Patel, MD|4052717559|Rusha-Patel@ouhsc.edu|
20184265|NCT01170026|Department of Psychiatry and Human Behavior, The Alpert Medical School of Brown University|Dr. Anthony Spirito|401-369-2435|anthony_spirito@brown.edu|
20184266|NCT02098343|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20225036|NCT01678885|Pennington Biomedical Research Center|Corby Martin, Ph.D.|225-763-2585|corby.martin@pbrc.edu|
20225037|NCT00426660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225038|NCT00980174|Amgen Inc.|Study Director|866-572-6436||
20225039|NCT05873335|Gabi SmartCare|Edouard Carton|472537844|edouard.carton@gabismartcare.com|
20225040|NCT00329641|SWOG Statistical Office|SWOG Melanoma Statistician|206-667-4408||
20225041|NCT01075399|Certus International, Inc.|Edward M. Aten, MD, President|603.627.1212|eaten@certusintl.com|
20225042|NCT01153620|B. Braun Medical, Centre of Excellence|Medical Affairs Manager|+41 58 258 55 47||
20225043|NCT03329248|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20225044|NCT00987402|University Hospital, Geneva|Stephan Harbarth MD|+41-22-372.3357|stephan.harbarth@hcuge.ch|
20225045|NCT03000530|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20225046|NCT01523704|Fujita Health University School of Medicine|Eiichi Watanabe, MD, PhD|+81-562-93-2312|enwatan@fujita-hu.ac.jp|
20225047|NCT01430624|Medical University of South Carolina|Heidi Resnick, Ph.D.|843-792-2945|resnickh@musc.edu|
20225048|NCT01362517|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20225049|NCT00798018|Department of Anesthesiology, West China Second Hospital|Han Huang|80-028-8550-3753|huanghan1981@hotmail.com|
20225050|NCT01285492|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20225051|NCT03379792|AdventHealth Translational Research Institute|Richard E. Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
20225052|NCT01121536|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20225053|NCT03646149|VA Greater Los Angeles|Sonya Gabrielian, MD, Investigator|310-478-3711|sonya.gabrielian@va.gov|49853
20225054|NCT01273155|National Cancer Institute|Naoko Takebe, M.D., Ph.D.|240-781-3398|Takeben@mail.nih.gov|
20225055|NCT01256385|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
20225056|NCT00401960|Weill Medical College|K Rhee|6469626224|kyr9001@med.cornell.edu|
20225057|NCT02649426|ReCor Medical Inc.|Chief Clinical Officer|+1-650-420-8048|hreeve-stoffer@recormedical.com|
20225058|NCT01606202|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20225059|NCT00306787|Novartis Pharmaceuticals|Study Director|862-778-8300||
20225060|NCT01438814|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225061|NCT01666210|Ocular Therapeutix, Inc.|Eric Ankerud|781-357-4013|eankerud@ocutx.com|
20162834|NCT03826186|University of Iowa Hospitals and Clinics|Vice Chair for Research|319-335-9595|donna-hammond@uiowa.edu|
20162835|NCT02300259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162836|NCT02737475|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20162837|NCT00385138|The Medicines Company|Meredith Todd|973.290.6088|meredith.todd@themedco.com|
20162838|NCT03928717|Providence College|Dr. Nick Tarantino|4018651612|ntaranti@providence.edu|
20162839|NCT02255461|St. Jude Children's Research Hospital|Jie Huang|9015955750|jie.huang@stjude.org|
20184267|NCT05515562|Wake Forest University Health Sciences|John Williamson, PharmD|336.713.3431|johnwill@wakehealth.edu|
20184268|NCT05314634|National Taiwan Normal University|Ruei-Hong Li|+886988163220|rueihongli@gmail.com|
20184269|NCT02582593|University of Florida|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
20184270|NCT03785782|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20184271|NCT03889925|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
20184272|NCT03762668|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20184273|NCT00773370|VA Medical Center, Baltimore Maryland|Mary Stuart, ScD, VA Research Investigator|410-455-2084|stuart@umbc.edu|
20184274|NCT01924975|University of Iowa Hopspital & Clinics|Satoshi Hanada/Clinical Assistant Professor|3193561219|satoshi-hanada@uiowa.edu|
20184275|NCT04483856|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
20184276|NCT02613871|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20184277|NCT01786564|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
20184278|NCT00494442|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20184279|NCT00604019|RUSH University Medical Center|Gourang Patel, PharmD|312-942-4258|gourang_p_patel@rush.edu|
20184280|NCT01241292|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20184281|NCT03145480|Northwell Health|Jacqueline Barrientos, MD|516-470-4050|jbarrientos@northwell.edu|
20184282|NCT03034915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20184283|NCT03593213|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20184284|NCT01831791|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184285|NCT00494780|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184286|NCT01190007|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184287|NCT01254019|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184288|NCT03061474|University of California, Irvine|Dr. Joshua Grill|(949) 824-5905|jgrill@uci.edu|
20184289|NCT03109795|University of Iowa|Professor|319-335-9487|gary-pierce@uiowa.edu|
20162840|NCT01336413|VHA Durham|Christine E. Marx, MD MA|9192860411|christine.marx@va.gov|3626
20184290|NCT00845832|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20184291|NCT01391130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20184292|NCT00189202|University of Michigan|Dr. Akinlolu Ojo, Professor of Medicine|734 9364890|aojo@umich.edu|
20184293|NCT00668863|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184294|NCT04153435|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
20184295|NCT00869323|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
20184296|NCT00908830|University of Michigan Health System|Linda Stuckey, Pharm.D|734-936-8129|lindastu@med.umich.edu|
20184297|NCT01068743|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20184298|NCT00638963|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20184299|NCT00846066|Childrens Mercy Hospital|Nasreen Talib MD, MPH.|816-234-3242|ntalib@cmh.edu|
20184300|NCT00588809|The University of Chicago Medicine|Olatoyosi Odenike, MD|(773) 702-6149|todenike@medicine.bsd.uchicago.edu|
20184301|NCT01755949|Mayo Clinic|Joseph L. Blackshear, Principal Investigator|904-953-7279|blackshear.joseph@mayo.edu|
20184302|NCT01647438|Northwestern University|Dr. Namratha Kandula, Principal Investigator|312-503-6470|nkandula@nm.org|
20184303|NCT04925765|University of Pittsburgh Medical Center|Dr. Katherine Grace Lim|4126411777|limkg2@upmc.edu|
20184304|NCT01214824|Abbott Diabetes Care|Director Global Clinical and EMEA Regulatory Affairs|01993863164|joe.bugler@abbott.com|
20184305|NCT00834834|NYSPI|Barbara Stanley, Ph.D.|6467747582|stanley@nyspi.columbia.edu|
20184306|NCT00373529|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20184307|NCT00442117|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclcosure@merck.com|
20184308|NCT04009577|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20184309|NCT01600729|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20184310|NCT00748410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184311|NCT01071993|University of Oklahoma|Mazen Abu-Fadel, MD|405-271-4742|mazen-abufadel@ouhsc.edu|
20184312|NCT00305695|NRG Oncology|Linda Gedeon on behalf of James Kauderer, MA, BS|716-845-1169|linda.gedeon@roswellpark.org|
20184313|NCT01649180|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
20184314|NCT00841035|University of Alabama at Birmingham|Research Nurse Supervisor of Clinical trials|(205)975-0450|jhrichardson@uabmc.edu|
20184315|NCT04970342|National Advanced Driving Simulator, University of Iowa|Timothy Brown, Ph.D.|3193354785|timothy-l-brown@uiowa.edu|
20184316|NCT01625013|University of California, San Francisco|Anthony Luke, MD|4155146120|Anthony.Luke@ucsf.edu|
20184317|NCT02601170|Tri-service general hospital|Dr. Tsung-Ying Li|886-2-87927166|doc31141@gmail.com|
20184318|NCT02763124|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
20184319|NCT00385801|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
20184320|NCT02247063|University of Michigan|Thiago Nascimento|734-615-9390|Nasci@umich.edu|
20184321|NCT01190566|Seoul National University Hospital|Woo Kyung Moon|82-2-2072-2584|moonwk@snu.ac.kr|
20184322|NCT01123928|Zhongshan Ophthalmic Center|Dr. Nathan Congdon|13925056342|ncongdon1@gmail.com|
20184323|NCT04178941|Children's Hospital of Philadelphia|Chris Bonafide, MD, MSCE|267-426-2901|bonafide@chop.edu|
20184324|NCT01810263|Seoul National University Bundang Hospital|Nam-Jong Paik|82-031-787-7731|njpaik@snu.ac.kr|
20184325|NCT01121549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184326|NCT03995069|Ralph H. Johnson VA Health Care System|Principal Investigator|8434671373|NaJin.Seo@va.gov|
20192129|NCT00913523|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Senior Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20184327|NCT03619226|Coloplast A/S|Julie Schnipper, Medical Writer|49111257|dkjuls@coloplast.com|
20184328|NCT03215095|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
20184329|NCT00304031|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20184330|NCT00493649|US Oncology Research, McKesson Specialty Health|Dr. Stephen E Jones|832-381-7580|steve.jones@usoncology.com|
20184331|NCT01662336|AbbVie (prior Sponsor Abbott)|Global Medical Services|800-633-9110||
20184332|NCT02189252|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
20184333|NCT00566735|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
20184334|NCT04603924|Robert Homolka|Sr. Vice President Clinical Operations|8572991035|bob.homolka@neurobopharma.com|
20184335|NCT01175317|Maastricht University Medical Center|Kostan Reisinger|0031433881494|k.reisinger@maastrichtuniversity.nl|
20184336|NCT02164240|DFCI|Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
20184337|NCT00686855|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
20184338|NCT01731041|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
20184339|NCT01668940|The Hospital for Sick Children|Dr Shinya Ito, Principal Investigator|4168135776|shinya.ito@sickkids.ca|205776
20184340|NCT02731755|University of Reading|Prof Jeremy Spencer|+44(0) 1183788724|j.p.e.spencer@reading.ac.uk|
20225062|NCT02273908|Medical Affairs, Pfizer Japan Inc.|Study Director : Koichi Fujii, MD|81-3-5309-9370|koichi.fujii@pfizer.com|
20225063|NCT00369161|Novartis Pharmaceuticals|Study Director|862-778-8300||
20184341|NCT01460446|Hoffmann-La Roche|Medical Communications|800 821-8590||
20225064|NCT04908475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20225065|NCT01440387|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225066|NCT01870297|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
20225067|NCT01739764|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20225068|NCT00337779|Teva Pharmaceutical Industries, Ltd.|Chen Duksin, MD|972-9-863-4642|chen.duksin@teva.co.il|
20225069|NCT00404924|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20225070|NCT03887429|Promentis Pharmaceuticals|Chad Beyer|(414) 238 2992|cbeyer@promentispharma.com|
20225071|NCT03303391|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
20225072|NCT03008278|Yale School of Medicine|Michael Cecchini, MD|(203) 200-4422|michael.cecchini@yale.edu|
20184342|NCT00516321|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225073|NCT01074255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225074|NCT00422422|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20225075|NCT01389258|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20225076|NCT02477709|Afferent Pharmaceuticals, Inc.|Chief Medical Officer|650-286-1276|info@afferentpharma.com|
20225077|NCT02943785|Daiichi Sankyo|Contact for Clinical Trial Information|+ 1 908-992-6400|CTRinfo@dsi.com|
20225078|NCT03313310|UNC Chapel Hill, ATN Coordinating Center|Betty Rupp|919-962-6603|brupp@email.unc.edu|
20184343|NCT02139046|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20225079|NCT01281956|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
20225080|NCT01361867|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
20184344|NCT01292252|University of California, San Francisco|Shane Burch, MD|415-353-4487|Shane.Burch@ucsf.edu|
20184345|NCT00373386|Research Institute at Nationwide Children's hospital|Robert P. Hoffman MD|614-722-4425|robert.hoffman@nationwidechildrens.org|
20192130|NCT01202409|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-745-4317|moverman@mdanderson.org|
20225081|NCT01593254|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20225082|NCT00456261|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20225083|NCT02918552|University of Pittsburgh|Tara Sheila Stakich|412-864-2082|tss54@pitt.edu|
20225084|NCT04395274|Ohio State University Comprehensive Cancer Center|Dr. Alayna Tackett|614-558-2679|alayna.tackett@osumc.edu|
20225085|NCT02680834|TactileMedical|Clinical Research Director|612-540-5267|astone@tactilemedical.com|
20225086|NCT01362244|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20225087|NCT02681757|Children's Hospital Colorado|Choi Young Mee MD|7207770859|youngmeeyoungmee@gmail.com|
20225088|NCT01650545|University of Maryland|Aldo Tullio Iacono|410 328 4351|aiacono@umm.edu|
20225089|NCT02539654|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20225090|NCT00602290|University of California, Los Angeles|Dr. Helen Lavretsky|310-794-4619|hlavretsky@mednet.ucla.edu|
20192131|NCT01774019|Boston Scientific|Andrea Burbage|15086834387|Andrea.Burbage@bsci.com|
20225091|NCT01709864|Novartis Pharmaceuticals|Study Director|862-778-8300||
20225092|NCT02517021|Helsinn Healthcare SA|Dr. Ruben Giorgino|+41 91 985 2121|ruben.giorgino@helsinn.com|
20225093|NCT01911793|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
20225094|NCT03334422|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225095|NCT01313221|Amgen Inc.|Study Director|866-572-6436||
20192132|NCT00553605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225096|NCT03246061|Relievant Medsystems|Chris Hilker, Sr. Director Clinical Affairs|(650) 368-1000|chilker@relievant.com|
20225097|NCT00401401|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20225098|NCT02864316|Sidney Kimmel Comprehensive Cancer Center|Patrick Forde, MBBCh|410-955-3974|pforde1@jhmi.edu|
20162841|NCT04240574|Rosalind Franklin University|Jacque Ortiz|847-578-8423|jacquelyn.ortiz@rosalindfranklin.edu|
20192133|NCT03206476|Universidad de Guadalajara|Dra. Gabriela Macedo Ojeda|(+52) 3310585200|gabriela.macedo@cucs.udg.mx|33900
20192134|NCT01085812|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20192135|NCT02561806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20192136|NCT01322009|University of Pittsburgh|Robert Clark|412-692-7260|clarkrs@ccm.upmc.edu|
20192137|NCT00394589|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20225099|NCT04710368|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
20225100|NCT05459558|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
20225101|NCT03278847|Imperial College London|Dr Chris Gale, Reader in Neonatal Medicine|+44 203 3153519|christopher.gale@imperial.ac.uk|
20162842|NCT01858740|Fred Hutchinson Cancer Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
20184346|NCT01925469|University of Pennsylvania|Dr. Emelia Bachman|443-955-9195|emeliacleo@gmail.com|
20225102|NCT01887288|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
20207020|NCT00364832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20207021|NCT00762528|Colgate Palmolive Company|William DeVizio, DMD|732-878-7901|william_Devizio@colpal.com|
20207022|NCT01266070|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20207023|NCT01838213|Vestre Viken Hospital Trust|Arne Søraas, PhD|+4790652904|arne@meg.no|
20207024|NCT04882072|Janssen Pharmaceutical K.K.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207025|NCT03185819|Janssen-Cilag International NV|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207026|NCT03097133|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207027|NCT00371540|Indiana University School of Medicine|Kara Wools-Kaloustian|317-274-7936|kwools@iu.edu|
20207028|NCT02910089|Astrazeneca Pharmaceuticals|Susan Thomas, MD|302-886-5589|Susan.Thomas2@astrazeneca.com|
20207029|NCT00732238|Michael E DeBakey VA Medical Center-Baylor College of Medicine|Rabih Darouiche|713-841-3882|rdarouiche@aol.com|
20207030|NCT02939976|Duke University Medical Center|David Kong, M.D.|919-668-8946|David.F.Kong@duke.edu|
20207031|NCT04080752|Janssen Research & Development, LLC|BE-R and D-Research Physician - Seni|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207032|NCT01585168|Yale University|Dr. Godfrey Pearlson|(860) 545-7757|Godfrey.Pearlson@hhchealth.org|
20207033|NCT01194414|Hoffman-LaRoche|Medical Communications|800-821-8590||
20207034|NCT03605836|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20207035|NCT00954824|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
20207036|NCT02977507|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20207037|NCT01188460|OHRI|Dr. Keith Wilson||kewilson@toh.ca|
20207038|NCT00744692|Duke University Medical Center|Dr. Suhag Parikh|919-668-1100|suhag.parikh@dm.duke.edu|
20207039|NCT00356057|BIOTRONIK, Inc.|Katerina de Metz, Director Clinical Studies|5036752169|katerina.demetz@biotronik.com|
20207040|NCT01620593|UT Health San Antonio Cancer Center|Sukeshi Arora, MD|210-450-1015|aroras@uthscsa.edu|
20207041|NCT00838383|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207042|NCT01000818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207043|NCT00741260|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20207044|NCT02565615|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207045|NCT03920865|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20207046|NCT05563714|University of Michigan|Dr. Jacob E. Kurlander, MD, MS|734-660-4883|jkurland@umich.edu|
20207047|NCT01351064|IUSM|Aaron Carroll|3172789696|aaecarro@iu.edu|
20207048|NCT02120352|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207049|NCT02427100|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor, Associate Professor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
20207050|NCT01610206|University of Virginia|Linda Duska, MD|434-982-1719|lrd5d@virginia.edu|
20207051|NCT03536923|Renovia, Inc|Chief Medical Officer, Dr. Samantha Pulliam|866-735-8424|sjpulliam@renoviainc.com|
20207052|NCT01929707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20207053|NCT01332097|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
20207054|NCT00431496|Amgen Inc.|Study Director|866-572-6436||
20207055|NCT02343952|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20207056|NCT01915095|Hines VA|Audrey Wilson|3122383637|awilson03@sralab.org|
20207057|NCT02067533|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
20207058|NCT00845845|The University of Illinois Chicago|Scott Cotler, M.D. Professor of Medicine|708-216-3789|scotler@lumc.edu|
20207059|NCT00383708|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
20207060|NCT00318370|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
20207061|NCT00464711|Massachusetts General Hospital|Dr. Dan Iosifescu||diosifescu@partners.org|
20207062|NCT01750840|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
20207063|NCT01997281|Seoul National University College of Medicine|Youn Min Cho, M.D, PhD|+82-2-2072-1965|ymchomd@snu.ac.kr|
20207064|NCT02448914|LobSor Pharmaceutical AB|Roger Bolsöy, CEO|+46 (0) 72 222 44 08|roger.bolsoy@lsmgroup.se|
20207065|NCT00560794|Amgen Inc.|Study Director|866-572-6436||
20207066|NCT01237301|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
20207067|NCT01372813|National Cancer Institute, National Institutes of Health|Marston Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
20218069|NCT00355472|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
20218070|NCT03453840|University of California San Francisco|Liusheng Huang (Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
20218071|NCT03581214|Washington University in St Louis|Nandini Raghuraman|3144548181|nraghuraman@wustl.edu|
20218072|NCT01341587|University of Maryland Baltimore|*Administrator, Division of Gerontology|4107062406|cquinn@som.umaryland.edu|
20218073|NCT05472116|University of Minnesota|Jonathan Strutt|(314) 578-8045|strutt@umn.edu|
20218074|NCT04740931|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218075|NCT01534637|Comprehensive Cancer Center of Wake Forest University|James Lovato, MS|336-713-4172|jlovato@wakehealth.edu|
20218076|NCT02377921|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20218077|NCT02854059|Hansa Biopharma AB|Elisabeth Sonesson (Director Clinical Operations)|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
20218078|NCT00706355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207068|NCT04507360|University of Washington|Tim Althoff|206-543-4243|althoff@cs.washington.edu|
20207069|NCT03140488|University of Arizona|Meghan Hill|+64273095220|meghan.hill@auckland.ac.nz|
20207070|NCT01131078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20207071|NCT04315298|Regeneron Pharmaceuticals, Inc.|Clinical Trials Adminstrator|844-734-6643|clinicaltrials@regeneron.com|
20207072|NCT01199198|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante,MD/Chair, General Internal Med|(713) 745-4516|cescalan@mdanderson.org|
20207073|NCT00736385|Duke University Medical Center|Christopher Kigongo|919-668-6579|christopher.kigongo@duke.edu|
20207074|NCT03267511|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207075|NCT01594749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207076|NCT00364351|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20207077|NCT00653068|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20207078|NCT02444936|Cleveland VA|Dr. David Canaday|216-368-8901|dxc44@case.edu|
20207079|NCT03552289|Cook Research Incorporated|Alan Saunders|765-463-7537|Alan.Saunders@CookMedical.com|
20207080|NCT03654560|United Health Products, Inc.|Gerard Abate, MD Chief Medical Officer|(386) 627-1598|G.Abate@unitedhealthproductsinc.com|
20207081|NCT00209092|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emory.edu|
20207082|NCT01726504|Guang An Men Hosptial of China Academy of Chinese Medical Sciences|Liu Zhishun|86 13651016313|liuzhishun@hotmail.com|
20207083|NCT02037204|UMC Utrecht|Prof. Daniel Saris|000000000000000000|d.saris@umcutrecht.nl|
20207084|NCT01119963|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
20207085|NCT03938636|Navidea Biopharmaceuticals|Chief Medical Officer|614-822-2320|mrosol@navidea.com|
20207086|NCT02579863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192138|NCT03700372|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|cschneider@farapulse.com|
20207087|NCT03531762|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20225103|NCT01092637|National Perinatal Epidemiology Unit, University of Oxford|Clinical Trials Unit|+44 1865 289700|ctu@npeu.ox.ac.uk|
20225104|NCT02921750|Mölnlycke Health Care|Maria Åberg Håkansson|+46 31722 3000|maria.aberghakansson@molnlycke.com|
20225105|NCT04703270|St George's, University of London|Dr Sarah Sturrock|020 8672 9944|ssturroc@sgul.ac.uk|
20225106|NCT03292458|Massachusetts Eye and Ear|Prof. Kristina Simonyan|617-573-6016|kristina_simonyan@meei.harvard.edu|
20162843|NCT03386487|Yale University|Dr. Deepak Cyril D'Souza, M.D.|203-932-5711|deepak.dsouza@yale.edu|2594
20225107|NCT02278367|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20225108|NCT00810017|MedStar Health Research Institute|Scientific Center Administrator, Oncology Research|(301) 560-7300|Research@MedStar.net|
20225109|NCT02368210|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
20225110|NCT01492101|Nektar|Alison Hannah, MD||AHannah@nektar.com|
20225111|NCT00316914|Mayo Clinic|Dr. Axel Grothey|507-184-2779|grothey.axel@mayo.edu|
20225112|NCT01675154|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-8295|abhimanyu.garg@utsouthwestern.edu|
20192139|NCT03409731|Abbott medical device|Hajime Kusano|+1 408-845-1626|hajime.kusano@abbott.com|
20192140|NCT01114672|Winthrop University Hospital|Mary Schanler, Principal Investigator|5156639028|mschanler@winthrop.org|
20192141|NCT04672798|University of Pittsburgh|Dr. Stephanie Stepp|412-715-5447|steppsd@upmc.edu|
20192142|NCT01710800|Walter Reed National Military Medical Center|Dr. Fouad J. Moawad|(301) 400-1551|Fouad.Moawad@us.army.mil|
20192143|NCT02427958|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20192144|NCT00812838|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
20192145|NCT01530659|Neurotech USA, Inc.|Neurotech, Sr. Director of Clinical Operations|629-333-5804|p.davis@neurotechusa.com|
20192146|NCT00953862|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
20192147|NCT02287883|University of California, Berkeley|Patricia Ramsay, Project Drector|(510)643-8063|pramsay@berkeley.edu|
20192148|NCT03416621|Duke Cancer Institute|Dr. Kathryn I Pollak|919-681-4757|kathryn.pollak@duke.edu|
20192149|NCT00545571|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192150|NCT03367910|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
20192151|NCT01193218|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192152|NCT00363649|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
20192153|NCT01013740|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20192154|NCT00979745|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
20192155|NCT03811834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20192156|NCT00576823|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20192157|NCT01242371|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
20192158|NCT03360110|CooperVision|Myhanh Nguyen, OD, Manager of Clinical Research|19257306716|MNguyen@coopervision.com|
20192159|NCT00510146|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20192160|NCT03188536|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20192161|NCT01930214|Cardiovascular Systems Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
20192162|NCT00025662|NHLBI|A. John Barrett|301-402-4170|barrettjj@mail.nih.gov|
20192163|NCT01748045|Tufts Medical Center|Dr. Christiane Dammann|617-636-8738|cdammann@tuftsmedicalcenter.org|
20192164|NCT02132117|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20192165|NCT04947436|University of Texas Health San Antonio|Dr. Donna Gardner|210-450-8479|dgardner62001@gmail.com|
20207088|NCT00446797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20207089|NCT02019758|University of North Carolina at Chapel Hill|Evan S. Dellon, MD MPH|919-966-2513|edellon@med.unc.edu|
20207090|NCT01973972|Duke University|William S. Yancy, Jr.|919-681-2863|yancy006@mc.duke.edu|
20184347|NCT00779870|Imperial College London|Prof Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20225113|NCT05323994|Sevier|Denis Morozov|8-495-93707-00|denis.morozov@servier.com|
20184348|NCT01582100|Northwestern University|Christine Ebert Nelson|3126954513|c-ebert@northwestern.edu|
20184349|NCT01040689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184350|NCT05876949|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
20184351|NCT02334436|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
20184352|NCT04589689|Stanford University|Jessie Wong, PhD|6507361517|wongjj@stanford.edu|
20207091|NCT00257322|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
20225114|NCT01253668|Merck|Dr. Stephen Keefe|215-220-9693|stephen.keefe@merck.com|
20225115|NCT00766467|Dana-Farber Cancer Insitute|Eudocia Quant Lee, MD|617-632-2166|eqlee@partners.org|
20184353|NCT01665092|Univeristy of Mississippi Medical Center|Alan Jones|601-384-5586|aejones@umc.edu|
20184354|NCT00463788|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20184355|NCT00360698|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
20184356|NCT01692938|Stanley M. Truhlsen Eye Institute|Quan Nguyen, MD Director of the Stanley M. Truhlsen Eye Institute|402-559-4276|quan.nguyen@unmc.edu|
20184357|NCT04598321|Brown University Oncology Research Group (BrUOG)|Assistant Director|401-863-3000|BrUOG@brown.edu|
20184358|NCT02755116|Icahn School of Medicine at Mount Sinai|Dr. Jaime B. Hyman|212-241-7473|Jaime.hyman@mountsinai.org|
20184359|NCT02423291|"Institute of Hematology L. e A. Seràgnoli, AOU Policlinico S.Orsola-Malpighi Via Massarenti, 9 - 40138 Bologna Italy"|MD Vittorio Stefoni|+39 0512143680|vittorio.stefoni2@unibo.it|
20184360|NCT01510717|Alcon Research, Ltd.|Magda Michna, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20184361|NCT02476409|University of North Carolina at Chapel Hill|Amanda Lee|919-843-9936|akg72@med.unc.edu|
20184362|NCT02555215|Biogen|Medical Director, Overall Study Officials|866-633-4636|clinicaltrials@biogen.com|
20184363|NCT01595061|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
20184364|NCT00529789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20184365|NCT03189589|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20184366|NCT03194958|Washington University in St. Louis|Matthew Kreuter|314-935-3701|mkreuter@wustl.edu|
20184367|NCT00317226|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
20184368|NCT00959946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184369|NCT00356265|University of Michigan|Crystal Gadegbeku||crystal.Gadebeku@tuhs.temple.edu|
20184370|NCT02971488|Hospital Universitario Infanta Leonor|Pablo Ryan|0034616832148|pablo.ryan@salud.madrid.org|
20184371|NCT02348658|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20184372|NCT00237770|James J Peters VA Medical Center|Dr. Jill M. Wecht, principal Investigator|718 584-9000|jm.wecht@va.gov|3122
20184373|NCT03293498|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20184374|NCT00159783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20184375|NCT04975308|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20184376|NCT02538107|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20184377|NCT01278394|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
20184378|NCT00818805|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20184379|NCT01236560|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20184380|NCT02471755|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Dr.Xiaoxu Liu|+86 10 8800 1124|liuxiaoxu_lxx@163.com|
20184381|NCT05216510|Tonix Pharmaceuticals|Herb Harris, MD, PhD|(862) 904-0355|herb.harris@tonixpharma.com|
20184382|NCT05323734|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20184383|NCT05061693|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20184384|NCT01568073|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20184385|NCT01499654|Northwestern University|Edwin Wu, MD|847-535-7270|ed-wu@northwestern.edu|
20184386|NCT00658996|Bausch & Lomb Incorporated|Gerard Cairns, PhD, MCOptom|(585) 338-5170|gerard.cairns@bausch.com|
20192166|NCT03719378|Colorado Joint Replacement|Rose Johnson, CCRP Research Lead|3032602940|roseannjohnson@centura.org|
20192167|NCT03352882|University of Pennsylvania|Kimberly A. Forde, MD, PhD - Principal Investigator|(215) 349-8222|kforde@pennmedicine.upenn.edu|
20192168|NCT02161185|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
20192169|NCT03790878|Duke University|Katherine (Kibby) McMahon|917-880-1551|Kibby.McMahon@duke.edu|
20192170|NCT00582114|Professor of Medicine|Dr. Rajiv Agarwal|317-988-2241|ragarwal@iu.edu|
20192171|NCT00118703|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192172|NCT00953212|Maine Medical Center|Dr. Robert Kramer|207-662-2923|KRAMER@mmc.org|
20192173|NCT01209286|Amgen Inc.|Study Director|866-572-6436||
20192174|NCT01349036|Daiichi Sankyo Inc.|Study Director|908-992-6400|CTRinfo@dsi.com|
20192175|NCT03796208|University of Kentucky|Kristin Ashford, PhD, Study MPI|859-257-9333|khashf0@uky.edu|
20207092|NCT04072575|Janssen Research & Development, LLC|Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20192176|NCT05127018|Peking University School of Stomatology|Xi Gong|15201304426|gongx31480528@163.com|
20225116|NCT02777944|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
20225117|NCT00259285|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20225118|NCT00985517|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
20225119|NCT01420679|Spectrum Pharmaceuticals, Inc|Gajanan Bhat|949-743-9219|gajanan.Bhat@sppirx.com|
20225120|NCT00943670|Hoffman-LaRoche|Medical Communications|800-821-8590||
20225121|NCT01777295|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225122|NCT00956631|Vertos Medical|VP of Clinical, Regulatory and Quality|9493490008|cmyers@vertosmed.com|216
20225123|NCT00717275|University of Florida|Dr. Erin M. Dunbar|352-273-9000|edunbar@neurosurgery.ufl.edu|
20225124|NCT03769194|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
20225125|NCT01996657|Wuhan Asia Heart Hospital|Dr.Litao Zhang|+862765796888|zhengleetau@qq.com|8204
20225126|NCT00312572|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20225127|NCT03878875|Imperial|Hemna Santilale|020|hemna.santilale@nhs.net|
20225128|NCT01133288|Kennedy Krieger Institute|Eric Levey, M.D.|443-923-9148|levey@kennedykrieger.org|
20225129|NCT00551161|North Shore-LIJ Health System|Marc L. Gordon,MD|516-562-3492|MLGordon@nshs.edu|
20225130|NCT00416793|UT MD Anderson Cancer Center|Gauri Varadhachary, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
20225131|NCT01672294|VA HSRD Durham VA Medical Center|Karen Steinhauser, PhD|9196682148|karen.steinhauser@va.gov|
20225132|NCT03170609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225133|NCT03083769|Southern Medical University|Dr. Liang Li|86 20 61648510|liliang@smu.edu.cn|
20225134|NCT01904903|MedStar|Allison Moses|301-256-2728|Allison.E.Moses@medstar.net|
20225135|NCT00719914|Brigham and Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
20225136|NCT00634049|Astellas Pharma Global Development, Inc.|Vice President, Medical Head ID/IM/TX|(224) 205-8800|Astellas.resultsdisclosure@astellas.com|
20225137|NCT00314132|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225138|NCT01260584|Daiichi Sankyo|Brian Baker|973-944-2712|bbaker@dsi.com|
20225139|NCT05708703|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
20225140|NCT00586508|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225141|NCT02079636|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225142|NCT03434249|SOFAR S.p.A|LAURA PATRUCCO|+390202 909 362291|laura.patrucco@sofarfarm.it|
20225143|NCT03325894|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20225144|NCT03482167|University of Delaware|Christopher R. Martens, Ph.D.|302-831-7270|cmartens@udel.edu|
20225145|NCT02167815|Nemocnice Podlesí|MuDr Jan Stryja|+420 558 304 111|Jan.stryja@atlas.cz|
20225146|NCT04612777|New York State Psychiatric Institute|Dr. Michael Compton|4043759231|mtc2176@cumc.columbia.edu|
20225147|NCT05497960|IMPACTIV (Vivo)|Eric Levitan|770-331-3208|eric@teamvivo.com|
20225148|NCT04148287|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20225149|NCT01131065|Instituto Grifols, S.A.|Michael Woodward, BSc, M.Sc|+34 935712200|michael.woodward@grifols.com|
20225150|NCT00824382|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225151|NCT02407054|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225152|NCT00415597|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
20225153|NCT01043562|Vanderbilt University (current institution)|Dr. Andrew E. Radbill|615-322-7447|andrew.radbill@vanderbilt.edu|
20225154|NCT04102865|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20225155|NCT02824562|UAB|Jessica Merlin|2059967894|jmerlin@uabmc.edu|
20184387|NCT02994654|AVITA Medical|VP Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
20225156|NCT02168777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20225157|NCT01663857|Eli Lilly and Company|Chief Medical Officer|800-575-5979|Clinicaltrials.gov@lilly.com|
20225158|NCT01172808|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225159|NCT03529799|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
20225160|NCT03315962|UCSF|Gabe Chamie|(415) 476-4082|gabriel.chamie@ucsf.edu|
20225161|NCT01066793|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20225162|NCT01520519|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
20225163|NCT03774394|University of Florida|Francesco Franchi, MD|+1-904-244-2060|francesco.franchi@jax.ufl.edu|
20225164|NCT02697916|Duke University; Duke Clinical Research Institute|W. Schuyler Jones, MD|919-668-8917|schuyler.jones@duke.edu|
20225165|NCT00994214|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20184388|NCT00605904|NIAAA, NIH|Markus Heilig|301.435.9386|mheilig@mail.nih.gov|
20184389|NCT03603717|Department of Veterans Affairs, Center of Excellence for Suicide Prevention|Wilfred Pigeon, PhD|(585) 393-7918|wilfred.pigeon2@va.gov|
20184390|NCT01353963|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184391|NCT05777785|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
20184392|NCT02188420|University of Minnesota|Kate Frost|612-626-0637||
20225166|NCT02020837|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
20225167|NCT04987931|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225168|NCT00290693|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
20184393|NCT05644444|Reckitt Benckiser Health Limited|Clinical Study Manager|+44 (0)1482 326151|ClinicalRequests@reckitt.com|
20225169|NCT05625477|Zhuhai Trinomab Pharmaceutical Co., Ltd.|Wenxi Xiang|18083065921|xiangwenxi@trinomab.com|
20225170|NCT01692002|Imperial College London|Prof Gary Frost Head of Section for Nutrition Research|07872850308|g.frost9296@gmail.com|
20184394|NCT04817670|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
20184395|NCT02639286|NIDDK|Dr. Rebecca Brown|301-594-0609|rebecca.brown@nih.gov|
20184396|NCT02396316|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20184397|NCT05636332|Philips|Tiffani Bowers|724-989-3072|tiffani.bowers@philips.com|
20184398|NCT02135679|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
20184399|NCT00085436|Dartmouth-Hitchcock Medical Center|Dr. Marc S. Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
20184400|NCT00714714|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director Clinical Operations|949-973-1153|David.Linberry@valeant.com|
20184401|NCT01185561|Loyola University|Sue Penckofer, Ph.D.|708-216-9303|spencko@luc.edu|
20184402|NCT01078116|Abbott|Global Medical Services|1-800-633-9110||
20184403|NCT02616900|eSight Corporation|Rob Hilkes|613 276-4145|rhilkes@eSightcorp.com|
20184404|NCT02242487|Acorda Therapeutics|Dr. Charles Oh, Senior Vice President - Clinical Development|914-326-5455|coh@acorda.com|
20184405|NCT01296815|Centro de Investigación en. Enfermedades Infecciosas|Gustavo Reyes-Teran|52 55 56667985|gustavo.reyesteran@gmail.com|
20184406|NCT00508924|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20184407|NCT02369484|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
20184408|NCT02178241|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20225171|NCT04849416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225172|NCT01450072|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
20184409|NCT02252042|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225173|NCT02370056|Cleveland Clinic|Dr. Emre Gorgun|216 444-1244|GORGUNE@ccf.org|
20184410|NCT00979992|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Administration and Operations|716-845-5702|kurasa@nrgoncology.org|
20184411|NCT04532528|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184412|NCT02658240|UT Southwestern Medical Center|Irina Gasanova|4694191997|Irina.Gasanova@UTSouthwestern.edu|
20184413|NCT03691428|Yale|Dr. Joan Monin|203785-2895|joan.monin@yale.edu|
20184414|NCT01460290|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
20184415|NCT02527148|Stryker South Pacific|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
20184416|NCT03698708|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
20184417|NCT02448446|South Coast Retina Center|Dr. Julie Gasperini|5629847024|jgasperini@gmail.com|
20184418|NCT01254188|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20184419|NCT04283552|Washington University School of Medicine|Richard L. Wahl, M.D.|314-362-7100|rwahl@wustl.edu|
20184420|NCT02384070|Odessa Heart Institute / Permian Research Foundation|Fernando Boccalandro MD FACC FSCAI|432-3373117|Fboccalandro@echd.org|
20184421|NCT02202499|H. Lee Moffitt Cancer Center and Research Institute|Dr. Thomas Brandon|813-745-1750|thomas.brandon@moffitt.org|
20184422|NCT00376363|University of North Carolina|Donald Budenz|919-843-0297|donald_budenz@med.unc.edu|
20184423|NCT01059877|QuietMind Foundation|Marvin Berman, PhD|610.940.0488|marvinberman@quietmindfdn.org|
20184424|NCT00640250|Institute of Clinical Research, Department of Dermoto Venerology and Allergy Center|Evy Paulsen, MD|+45 65 41 27 08||
20184425|NCT02957136|Duke University Health System|Christopher Polage|919-668-5008|christopher.polage@duke.edu|
20184426|NCT01667796|Johns Hopkins|Ellen Mowry|4106141522|vitamindtrialms@jhmi.edu|
20184427|NCT01836133|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20184428|NCT02200770|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20184429|NCT01124734|Penn State Cancer Institute|Joseph Drabick, MD|717 531 5059|jdrabick@pennstatehealth.psu.edu|
20184430|NCT00634621|GE Healthcare|Emilio Moreno Carretero, M.D.|011-34-9166-30970|Emilio.Morenocarretero@ge.com|
20184431|NCT00886145|James J. Peters VA Medical Center|William A. Bauman|718-584-9000|william.bauman@va.gov|5428
20184432|NCT01837966|NYU School of Medicine|Associate Professor ; Res Program Dir/Medical Dir Day Surgery; Vice Chair for Education|212.263.5072|michael.wajda@nyumc.org|
20184433|NCT01202955|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
20184434|NCT00392054|Population Health Research Institute|Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC, FHRS|905-527-4322|Carlos.Morillo@phri.ca|40311
20184435|NCT02928224|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184436|NCT02115139|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
20184437|NCT00468910|Northwestern University|Dr. Seema Khan|312-503- 4236|skhan@nm.org|
20184438|NCT01909778|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184439|NCT00919763|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
20184440|NCT00664430|Abbott|Global Medical Services|800-633-9110||
20184441|NCT04740164|The University of Texas MD Anderson Cancer Center|Dr. Katherine Hagan|(713) 794-5945|khagan@mdanderson.org|
20184442|NCT01152190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20184443|NCT00891176|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184444|NCT00433199|Abbott|Global Medical Services|800-633-91110||
20184445|NCT00357097|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184446|NCT03505099|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
20184447|NCT00732381|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20207093|NCT02498392|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20225174|NCT03749499|University of Chicago Illinois|Heather M. Prendergast MD, MS, MPH, Professor, Department of Emergency Medicine|3124131214|hprender@uic.edu|
20225175|NCT02667587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20225176|NCT05940077|Tufts University|Dr. Evan Papa|617-636-4056|evan.papa@tufts.edu|
20225177|NCT00388297|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
20225178|NCT01048905|Emory University School of Medicine|Claudia R. Morris MD, FAAP|404-727-5500|claudia.r.morris@emory.edu|
20225179|NCT03933020|The University of Texas Health Science Center at Houston|Rohini D. Samudralwar, MD|(832) 325-7077|Rohini.D.Samudralwar@uth.tmc.edu|
20225180|NCT02696434|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20225181|NCT01586871|University of Minnesota|Aaron Kelly PhD|612-626-3492|kelly105@umn.edu|
20162844|NCT00734968|University of Missouri|Daniel Jackson MD|573 499 6041|jacksondl@health.missouri.edu|
20162845|NCT04207060|Mayo Clinic|Dr. Santhi Swaroop Vege|(507) 266-6931|vege.santhi@mayo.edu|
20162846|NCT01067144|Stanford University|Dr. Ian Carroll|(650) 723-6411|ic38@stanford.edu|
20162847|NCT00626444|Thomas Jefferson University|Daniel Monti, MD|215-955-4410|Daniel.Monti@jefferson.edu|
20162848|NCT01871441|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Neal Flomenberg|215 955-0182|dolores.gross@jefferson.edu|
20162849|NCT01835158|Harvard|Toni K. Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
20162850|NCT00296140|Roudebush VA Medical Center|Dr. Linda Williams|317-988-2715|Linda.Williams6@va.gov|
20162851|NCT01856582|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD/Associate Professor of Pediatrics|513-803-9063|Rebecca.Marsh@cchmc.org|
20162852|NCT00475904|EpiCept Corporation|Chief Medical Officer|914-606-3500|sallard@epicept.com|
20162853|NCT00880191|Mayo Clinic|Debra L. Barton RN, PhD, AOCN|507/284-1623|barton.debra@mayo.edu|
20162854|NCT00939562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20162855|NCT01919801|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20162856|NCT01843062|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20225182|NCT01004718|University of Pennsylvania|Ellen Napier, CRNP|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
20225183|NCT04103034|Band Therapeutics|Tia DeFeo-Fraulini|7819186561|tia.defeo-fraulini@bandtherapeutics.com|
20225184|NCT04105010|Dizal Pharmaceuticals|Rika Chen|862161095875|clinicaltrials@dizalpharma.com|
20225185|NCT01810705|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
20225186|NCT00427999|Novartis Pharmaceuticals|Study Director|862-778-8300||
20225187|NCT03570554|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20225188|NCT01642485|Richmond Pharmacology Ltd|Dr Jorg Taubel|+44(0)2086645200|j.taubel@richmondpharmacology.com|
20225189|NCT00676572|Imperial College London|Professor Kian Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20225190|NCT01966419|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
20225191|NCT03114657|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20225192|NCT01179737|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20225193|NCT00115037|UPENN|David Oslin, MD|215-823-5894|oslin@upenn.edu|
20225194|NCT01546038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225195|NCT01398410|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
20225196|NCT04245202|Ege University Medical Faculty Hospital|Dr. Aykut Eşki|05303009760|aykuteski1984@gmail.com|
20225197|NCT00231309|Emory University|Kuang-Yueh Chiang, MD|404-785-1441|kuang-yueh.chiang@choa.org|
20225198|NCT03515629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20225199|NCT01254721|SM&M Korea|Hui Jung Sin / Clinical Project Leader|82-2-2188-2165|ClinicalTrialTransparency@astrazeneca.com|
20225200|NCT00424021|Gilead Sciences, Inc.|Karen L Miller, PhD|650-524-3892|KarenL.Miller@gilead.com|
20225201|NCT03597022|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20225202|NCT05385224|EnteraSense Ltd.|David Collins, Director of Technical Operations|091 750 246|david@enterasense.com|
20225203|NCT01069315|McMaster University|Paula McKay, Manager|9055274322|mckayp@mcmaster.ca|44131
20225204|NCT00553358|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@Novartis.com|
20225205|NCT01832818|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
20225206|NCT03209518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20225207|NCT00236899|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20225208|NCT01897792|UAB Department of Anesthesiology|Jean-Francois Pittet, MD|205-996-4755|jpittet@uabmc.edu|
20225209|NCT02366403|War Related Illness and Injury Study Center, VA Palo Alto Healthcare System|Peter Bayley, PhD|650 493-5000|peter.bayley@va.gov|68653
20225210|NCT03013985|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
20225211|NCT00791492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225212|NCT02322333|Clinvest Research|Jim Sly MS|4178413673|jsly@clinvest.com|
20225213|NCT00076999|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225214|NCT04964986|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
20225215|NCT05821296|Dermosciences France|Sara Bayo Rodriguez|638966321|clinicaltrials@dermaceutic.com|0033
20225216|NCT01217385|American College of Radiology|Donna Hartfeil, Director Protocol Management|215-717-2765|dhartfeil@acr.org|
20225217|NCT00090987|AMC|Jeannette Y. Lee, Director of Statistical Center|(501) 526-6712|jylee@uams.edu|
20225218|NCT00990665|St. Jude Medical|Clay Cohorn: Director, Clinical Study Management|972 309 8087|ccohorn@sjm.com|
20225219|NCT02603562|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20162857|NCT01677858|Amgen Inc.|Study Director|866-572-6436||
20225220|NCT00796744|US Biotest|Dr. Shelagh Verco|805-595-1300|shelagh.verco@usbiotest.com|
20225221|NCT01534208|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20184448|NCT00457691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184449|NCT01420549|Aché Laboratórios Farmacêuticos S. A.|Antonio Carlos Amedeo Vattimo|+55 11 26088111|antonio.vattimo@ache.com.br|
20184450|NCT04584099|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20184451|NCT04786457|University of Maryland, Baltimore, Center for Vaccine Development and Global Health|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
20184452|NCT03073941|Zimmer Biomet|Chiara Griffoni, Clinical Project Senior Lead|+41 79 560 16 28|chiara.griffoni@zimmerbiomet.com|
20184453|NCT04951310|University of Pennsylvania|Dr. Katherine Milkman|215-573-9646|bcfg@wharton.upenn.edu|
20184454|NCT01188655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184455|NCT00925899|Bispebjerg Hospital|Lise Pedersen|004535312305|lise.pedersen.01@regionh.dk|
20184456|NCT00683696|Biotronik, Inc.|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
20184457|NCT00089544|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20184458|NCT00227994|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
20184459|NCT01823536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20184460|NCT03648762|VA Pittsburgh Healthcare System|Daniel E. Forman, MD|(412) 360-2917|Daniel.Forman@va.gov|
20184461|NCT04112069|Mass. General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
20184462|NCT01391832|University of Texas at Dallas|Dr. John Hart, Jr.|972-883-4853|jill.ritter@utdallas.edu|
20184463|NCT01154985|Mochida Pharmaceutical Company Ltd.|Hironori Sato, Director|+81-3-3225-6331|hnsato@mochida.co.jp|
20184464|NCT00589277|Yale University School of Medicine|Benjamin Toll, Ph.D. Associate Professor of Psychiatry|(203) 974 5767|benjamin.toll@yale.edu|
20184465|NCT03345901|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20184466|NCT00722046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184467|NCT00925587|Amgen Inc.|Study Director|866-572-6436||
20184468|NCT00490802|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
20184469|NCT01556724|University of Pittsburgh|Susan Sandusky|412-383-1036|sis127@pitt.edu|
20184470|NCT01149369|Johns Hopkins Data Coordinating Center|Katherine Yates|443-287-0082|kyates1@jhu.edu|
20184471|NCT03644849|Saint Louis University|Dr. Ramona Behshad|314-977-9721|ramona.behshad@health.slu.edu|
20184472|NCT02755805|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
20184473|NCT02593149|Pursuit Vascular, Inc.|Laurie Lynch, PhD|6124249006|llynch@pursuitvascular.com|
20184474|NCT01140048|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184475|NCT03520413|Durham Veterans Affairs Medical Center|Matthew Crowley, MD|919-286-0411|matthew.crowley@va.gov|
20184476|NCT04054635|University of Manitoba|Dr. Robert J. Schroth|204-977-7764|robert.schroth@umanitoba.ca|
20184477|NCT00891930|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
20184478|NCT03040661|Inova Heart and Vascular Institute|Vineet Kumar|(703) 289-9400|vineet.kumar@inova.org|
20192177|NCT01215032|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
20192178|NCT03120949|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
20192179|NCT01705145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20192180|NCT00312845|Johnson & Johnson Pharmaceutical Research & Development|Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.||YElsaye1@ITS.JNJ.COM|
20192181|NCT00316589|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20192182|NCT03594045|Massachusetts General Hospital|Dr. Rachel Rosovsky|617-724-4000|RPROSOVSKY@mgh.harvard.edu|
20192183|NCT01283971|Hoffman-LaRoche|Medical Communications|800-821-8590||
20192184|NCT03325608|NYU Langone Health|Joshua Chodosh, MD, MSHS, FACP|212-263-6768|Joshua.Chodosh@nyumc.org|
20192185|NCT02154347|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20192186|NCT02188784|Duke Clinical Research Institute|Dr. Adrian Hernandez|919-668-7515|adrian.hernandez@duke.edu|
20192187|NCT05041439|Massachusetts General Hospital|Dr. Julie H Levison|(617) 724-4698|jlevison@mgb.org|
20192188|NCT02917421|Weill Medical College|Dr.Silvia Formenti|212-746-3608|shc2043@med.cornell.edu|
20192189|NCT00664105|Vanderbilt-Ingram Cancer Center|Vicki Keedy, M.D.|(615) 322-4967||
20192190|NCT02185105|CooperVision, Inc|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
20192191|NCT01343251|St John Hospital and Medical Center|Dr. Robert Provenzano|313-886-8787|Rprovenzano@scsp.net|
20192192|NCT03006185|Bispebjerg Hospital|Emily Wenande|+4540505590|emilycathrinew@hotmail.com|
20192193|NCT03984513|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
20192194|NCT01468077|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192195|NCT04843579|Weill Cornell Medicine|Multiple Myeloma Program Manager|646-962-9376|hyk4001@med.cornell.edu|
20192196|NCT03834623|Moffitt Cancer Center|Nikhil Khushalani, MD|813-745-3437|Nikhil.Khushalani@moffitt.org|
20192197|NCT00004146|Adult Brain Tumor Consortium|Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
20192198|NCT03024996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20192199|NCT00478647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20192200|NCT01009762|Statens Serum Institut|Professor Anders Fomsgaard|+45-32683460|afo@ssi.dk|
20192201|NCT02363998|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
20192202|NCT00477464|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192203|NCT00639769|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.||barbara.murphy@vanderbilt.edu|
20192204|NCT00784147|TaiMed Biologics, Inc.|Stanley T. Lewis, Jr., MD|949-769-6543|stlewis@taimedbiologics.com|108
20192205|NCT03677245|University of Mississippi Medical Center|Dr. Meredith Flowers|662-386-5926|mmflowers@umc.edu|
20225222|NCT02046772|Hospital Universitario Príncipe de Asturias|Antonio Rodríguez Miguel|+34 91 887 81 00|antonio.hupa@gmail.com|2610
20184479|NCT00439569|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
20184480|NCT01224015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20184481|NCT00857545|NRG Oncology|Linda Gedeon for Wei Deng PhD|716-845-1169|lgedeon@gogstats.org|
20184482|NCT01943916|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
20184483|NCT01576484|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20184484|NCT00581854|University of Wisconsin|Brad S Kahl, MD|608-263-1836|bsk@medicine.wisc.edu|
20184485|NCT05444244|University of Wisconsin School of Medicine and Public Health|Andrea Gilmore-Bykovskyi|6082623057|algilmore@wisc.edu|
20184486|NCT03823911|Institute of Human Virology, University of Maryland School of Medicine|Dr. Poonam Mathur|410-706-4745|pmathur@ihv.umaryland.edu|
20184487|NCT03302741|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
20184488|NCT04923724|Washington University School of Medicine|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
20184489|NCT00958633|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|yatham@mail.ubc.ca|
20184490|NCT01243619|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon MD, PhD|617-732-8564|hmamon@lroc.harvard.edu|
20184491|NCT00233519|University of Rochester Medical Center|Richard T. Moxley, III MD|585-275-5006|RichardT_Moxley@urmc.rochester.edu|
20184492|NCT00094575|VAMC Minneapolis, MN|Dr. Frank A. Lederle|612-725-2158|Frank.Lederle@va.gov|
20184493|NCT04305405|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20184494|NCT03072953|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20184495|NCT00206375|Texas Children's Hospital, Baylor College of Medicine|Dr. MJ Redondo (designated by the institution to enter results)|832-822-1019|redondo@bcm.edu|
20184496|NCT05714696|Florida State University College of Medicine|Dr. Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
20192206|NCT04912700|Beaumont Hospitals|Ahmit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
20184497|NCT00837616|Nemours Children's Clinic|Dr. Nelly Mauras|(904) 697-3674|nmauras@nemours.org|
20184498|NCT02674750|Curis, Inc.|Reinhard von Roemeling, M.D., Senior Vice President, Clinical Development|617-503-6500|rvonroemeling@curis.com|
20184499|NCT01685606|Brown University Oncology Research Group (BrUOG)|Dr. Peter Quesenberry|4018633000|kayla_rosati@brown.edu|
20184500|NCT01787760|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
20184501|NCT03512756|Tyme, Inc.|Study Director|617-674-9069|Maria.Loushin@TymeInc.com|
20184502|NCT05470868|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
20184503|NCT04250883|Radboud umc|Dr. Michiel Warle|024-3613808|michielwarle@radboudumc.nl|
20184504|NCT00402896|The University of Texas (UT) MD Anderson Cancer Center|Carlos A. Jimenez, MD/Professor, Pulmonary Medicine||CR_Study_Registration@mdanderson.org|
20184505|NCT01318382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20184506|NCT01599104|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
20184507|NCT00019747|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20184508|NCT00687167|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20184509|NCT02271854|Novartis Consumer Health a GSK Consumer Healthcare company|Director Clinical Research pain category|+413635528||
20184510|NCT01308567|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20184511|NCT03344536|Memorial Sloan Kettering Cancer Center|Dr. Komal Jhaveri MD|646-888-5145|jhaverik@mskcc.org|
20184512|NCT01571596|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20184513|NCT01437605|Moffitt Cancer Center|Dr. Nikhil Khushalani|813-745-3437|Nikhil.Khushalani@Moffitt.org|
20184514|NCT00434304|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184515|NCT02663297|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
20184516|NCT01636687|Novartis Pharmaceuticals|Study Director|+1-862-778-8300|Novartis.email@novartis.com|
20184517|NCT02771899|Columbia University Medical Center|Dr. Lawrence Lenke|2129324410|ll2989@columbia.edu|
20184518|NCT03835819|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
20184519|NCT01269749|University of Florida|Dr Scott Rivkees|352-273-9001|srivkees@ufl.edu|
20184520|NCT02918279|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20184521|NCT00636207|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184522|NCT02888080|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20184523|NCT01641198|Université de Montréal|Dr. Aldo-Joseph Camarda|(514) 343-7124|aj.camarda@umontreal.ca|
20184524|NCT00980330|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20184525|NCT00568854|Los Angeles County Department of Public Health|Dr. Alicia Chang|213-745-0846|alchang@ph.lacounty.gov|
20184526|NCT00666276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184527|NCT01039688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184528|NCT02594735|GWU Myositis Center|Dr. Rodolfo Curiel|202-741-2488|rcuriel@gwu.edu|
20184529|NCT01296191|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
20184530|NCT04567407|Boston Children's Hospital|Roland Brusseau MD|857-218-4814|roland.brusseau@childrens.harvard.edu|
20184531|NCT03844269|Akili Interactive Labs, Inc.|Minny Suh|857-254-4444|minny@akiliinteractive.com|
20192207|NCT03357471|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20225223|NCT03578146|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20184532|NCT00665444|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
20184533|NCT00475319|Dermatologicals & Ophthalmologicals, Otsuka Pharmaceutical Co., Ltd.|Eiji Murakami|+81-6-6231-6067||
20184534|NCT00101010|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Alma Rodriguez, MD, Lymphoma||CR_Study_Registration@mdanderson.org|
20184535|NCT00346151|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20184536|NCT03897348|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
20207094|NCT02473289|Janssen Research & Development, LLC|ASSOCIATE DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20184537|NCT03737240|University of Miami Miller School of Medicine|Dr. Rodolfo Galindo|305-243-7707|Rodolfo.galindo@miami.edu|
20184538|NCT01369498|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20184539|NCT01394510|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kutzschn@uw.edu|6-3568
20184540|NCT02539108|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20184541|NCT01852071|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
20184542|NCT01240330|Venous Health Systems, Inc.|Director of Quality Assurance & Operations|(650)646-3327|rlaguna@venoushealth.com|104
20184543|NCT00535145|Ortho-McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
20207095|NCT02244619|Kettering Health Network|Skip Hickman, RPH|(937) 762-1339|skip.hickman@ketteringhealth.org|
20207096|NCT03135262|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: BH39147|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
20207097|NCT00383266|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5740|mbaggstr@dom.wustl.edu|
20207098|NCT03745989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207099|NCT02728206|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20207100|NCT01620658|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute, Research and Outcomes|786-596-3505|raulh@baptisthealth.net|
20207101|NCT03960658|Minneapolis VA Health Care System|Dr. Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
20207102|NCT02918318|Janssen Pharmaceutical K.K., Japan|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207103|NCT01782885|Universidad Autónoma de Nuevo León|M Sc Mario Simental-Mendía|+52 (81) 8329 4174|mario.simental@gmail.com|
20207104|NCT04146038|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD, PhD|732-235-4523|strairrk@cinj.rutgers.edu|
20207105|NCT01704976|BUAS|Slavko Rogan (Study Chair)|+41 31 848 35 56|slavko.rogan@bfh.ch|
20207106|NCT00633360|Brigham & Women's Hospital|Dr Hadine Joffe|617-732-4906|hjoffe@partners.org|
20207107|NCT01098032|Clinica Mediterranea|Dr. Carlo Briguori, Principal Investigator|+390817259|carlobriguori@clinicamediterranea.it|764
20207108|NCT03136913|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
20207109|NCT00610207|Cook Biotech, Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
20207110|NCT03241589|VHA|Sara Peracca|415-750-2091|sara.peracca@va.gov|
20207111|NCT02069704|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
20207112|NCT03378973|Hospital for Special Surgery|Ronald Emerson, MD|2127742742|emersonr@hss.edu|
20207113|NCT01478581|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
20207114|NCT00638274|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-82748|ppan@wakehealth.edu|
20207115|NCT03634228|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/ Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
20207116|NCT02809846|Scripps TSRI|Lase Ajayi|785.218.1643|tajayi@scripps.edu|
20207117|NCT01594411|CardioDx, Inc.|EJ Fernandez, MD, CCRP - Sr. Manager Clinical Affairs|650-383-3350|jkuo@cardiodx.com|
20207118|NCT01262599|Columbia University Medical Center|Dr. Christine Rohde|(212) 342-3707|chr2111@columbia.edu|
20207119|NCT00437203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225224|NCT03959488|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20225225|NCT01463358|Casa di Cura san Pio XI|Massimo Santini MD FESC FACC|+390666494491|m.santini@rmnet.it|
20225226|NCT01211483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20225227|NCT02284568|Teva Pharmaceutical Industries Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20225228|NCT00460265|Amgen Inc.|Study Director|866-572-6436||
20225229|NCT00365209|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
20225230|NCT02600767|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
20225231|NCT00904839|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225232|NCT01688141|University of Leicester|Professor Nigel Brunskill|+44 116 258 8043|njb18@le.ac.uk|
20225233|NCT04521114|CytoDyn Inc.|Joseph Meidling, Senior Director - Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
20225234|NCT02854605|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20225235|NCT00568334|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162858|NCT01331109|Forest Research Institute|Robert Palmer, MD|1-201-427-8200|robert.palmer@frx.com|8218
20225236|NCT01897571|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
20225237|NCT01797094|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20225238|NCT03217968|CEFALY Technology|Clinical Trial Department director|+3243676722|info@cefaly.com|
20225239|NCT00625404|FHI 360|Jennifer Deese, Principal Investigator|919-544-7040|jdeese@fhi360.org|11292
20225240|NCT05268016|Meiji Pharma USA Inc.|Meiji Pharma USA Inc. Study Lead|+1 201-777-7133|mpu.contact@meiji.com|
20162859|NCT00066963|Professor, S/D- PREV/REST|Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
20207120|NCT00479167|Rush University Medical Center|Stephanie Gregory, MD|312-942-5982|stephanie_gregory@rush.edu|
20207121|NCT02650440|Coordination of Improvement of Higher Level Personnel - CAPES|Thais A. Rodrigues, MS, PT.|55 (61) 2022-6002|faleconosco@capes.gov.br|
20207122|NCT02384993|University of Wisconsin - Madison|Ozioma C. Okonkwo|(608) 265-4479|ozioma@medicine.wisc.edu|
20207123|NCT00880607|Children's Hospital of Colorado, University of Colorado|Mindy Cohen, MD FAAP, Assistant Professor, Department of Anesthesiology||Mindy.cohen@childrenscolorado.org|
20207124|NCT04129086|The University of Texas Health Science Center at Houston|John Andrew Harvin, MD|713-500-7292|John.Harvin@uth.tmc.edu|
20207125|NCT01628042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207126|NCT01004159|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20207127|NCT02481440|The Third Affiliated Hospital of Sun Yat-sen University|Li-Min Rong M.D., Director of Clinical Trials|862085252900|ronglimin@21cn.com, ronglm@mail.sysu.edu.cn|
20207128|NCT04483544|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
20207129|NCT01183104|Japan Association for Diabetes Education and Care|Prof. Yasuo Terauchi|+81-3-3514-1721|terauchi-tky@umin.ac.jp|
20207130|NCT01636453|Penumbra, Inc.|Michaella Corso|(510) 748-3200||
20207131|NCT01977040|Mednax. Inc|Kimberly Maurel|714593-9171|kimberly_maurel@mednax.com|
20207132|NCT01685060|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20207133|NCT00634751|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
20207134|NCT02828644|Akili Interactive Labs|Kathryn Jenkins|7742666693|kjenkins@akiliinteractive.com|
20207135|NCT02996110|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20207136|NCT00524043|Johnson & Johnson Pharmaceutical Research & Development|Clinical Team Leader, Paliperidone|609 730-2436||
20225241|NCT05656885|CooperVision Inc.|Dr. Jose A Vega OD, MSc, FAAO|+19256213761|javega@coopervision.com|
20225242|NCT03411902|Wake Forest School of Medicine|Kristen Beavers|336-758-5855|beaverkm@wfu.edu|
20225243|NCT04482036|Eskenazi Health|Jessica Broughton|317-903-6276|jessica.broughton@eskenazihealth.edu|
20225244|NCT00713661|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
20225245|NCT00270231|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
20225246|NCT01432561|University of California San Diego|Dr. Ranjan Dohil, P.I.|619-471-9554|rdohil@ucsd.edu|
20225247|NCT04208321|ICON Early Phase Services, LLC|Dr. Cassandra Key, Senior Medical Director|210-283-4120|Cassandra.key@iconplc.com|
20225248|NCT00574795|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20225249|NCT00672841|University of Utah|Kimberly E. Hanson, MD, MHS|801.585.2867|kim.hanson@hsc.utah.edu|
20225250|NCT02638259|Sandoz|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
20225251|NCT04299048|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225252|NCT02569086|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45|krisoebr@rm.dk|78452845
20225253|NCT01717391|The University of Iowa|John M. Buatti, MD|319-356-2699|john-buatti@uiowa.edu|
20225254|NCT03677934|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
20225255|NCT02952872|Wayne State University|Dr. Emily Grekin|313-577-2820|grekine@wayne.edu|
20225256|NCT04769739|Evergreen General Hospital|Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
20225257|NCT00045734|Adult Brain Tumor Consortium (ABTC)|Patrick Wen, MD|410-955-8837|jfisher@jhmi.edu|
20225258|NCT02069093|Novartis Pharmaceuticals|Study Director|862-778-8300||
20192208|NCT03294941|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
20225259|NCT05972941|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
20225260|NCT02624388|UVA Health|William Petersen|434-924-8499|wcp3g@uvahealth.org|
20225261|NCT03290547|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20225262|NCT00561470|sanofi-aventis|International Clinical Development Study Director||contact-us@sanofi.com|
20225263|NCT02315872|Providence Health & Services|Lynette Currie|503-216-1034|lynette.currie@providence.org|
20225264|NCT00335959|SWOG Statistical Center|Study Statistician|206-667-4623||
20225265|NCT01889355|AgaMatrix, Inc|Senior Clinical Research Technician|603-328-6035|krocha@agamatrix.com|
20225266|NCT00737893|Johns Hopkins Brady Urological Institute|Dr. Hiten Patel|410-502-7710|hiten.patel@lumc.edu|
20225267|NCT01001598|Boston Children's Hospital|Colin A. Sieff|617 919-4241|colin.sieff@childrens.harvard.edu|
20225268|NCT02722837|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20225269|NCT02450552|Massachusetts General Hospital - Neurological Clinical Research Institute|Protocol Investigator|617-726-2000|Brian.Wainger@MGH.HARVARD.EDU|
20225270|NCT04877535|Washington University School of Medicine|Christopher King|(314) 362-8649|christopherking@wustl.edu|
20192209|NCT04051242|University of Pittsburgh|J. Peter Rubin, MD Principal Investigator and Endowed Chair of Plastic Surgery|412-383-8080|rubipj@UPMC.EDU|
20192210|NCT00374088|University of Michigan - Pediatric Cardiology|Ranjit Aiyagari, MD|734-647-8761|ranjita@umich.edu|
20192211|NCT04545476|Vanderbilt University Medical Center|Karen Arnaud|615-322-6485|karen.arnaud@vumc.org|
20192212|NCT00241969|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
20192213|NCT00130728|Genentech, Inc.|Medical Communications Specialist|800-821-8590|genentech@druginfo.com|
20192214|NCT02301364|Memorial Sloan Kettering Cancer Center|Christian Grommes, MD|212-639-4058|grommesc@mskcc.org|
20207137|NCT02253394|Brigham and Women's Hospital|Dr. Bradley Maron|617-525-4857|bmaron@bwh.harvard.edu|
20207138|NCT01092364|Duke University Medical Center|Dr. Laura P. Svetkey|919-660-6626|laura.svetkey@dm.duke.edu|
20225271|NCT00925652|Dana-Farber Cancer Institute|Erica Mayer MD MPH|617-632-2335|emayer@partners.org|
20207139|NCT00054756|NIDDK|Dr Joanna Klubo-Gwiezdzinska|301-496-1211|joanna.klubo-gwiezdzinska@nih.gov|
20207140|NCT01536418|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207141|NCT02734849|Allakos, Inc.|Henrik Rasmussen, MD, PhD, Chief Medical Officer|1 6505975002|hrasmussen@allakos.com|
20207142|NCT04210232|Johnson & Johnson Surgical Vision|Eugenia K. Thomas|+1 657 2903260|EThoma39@its.jnj.com|
20207143|NCT02658149|Beaumont Health|Dr. James Verner|1(248)551-9722|jverner1@aol.com|
20207144|NCT00711412|Northwestern University|Dr. Mary Mulcahy|312 695 6182|Mary.Mulcahy@nm.org|
20207145|NCT01525745|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
20207146|NCT04358991|University of Pittsburgh|Dr. Ryan Shields, Associate Professor of Medicine|412-864-3745|shieldsrk@upmc.edu|
20207147|NCT00794469|Hadassah Medical Organization|Gal Dubnov-Raz|+972+54-4570250|gal-d@bezeqint.net|
20207148|NCT02458352|University Hospital Zurich|Dr. Ronny Buechel|0041442551059|ronny.buechel@usz.ch|
20207149|NCT02527564|Stanford University|Po W. Wang|650-723-2483|wangp0@stanford.edu|
20207150|NCT00628134|University of Pittsburgh|Tim Corcoran, Ph.D.|412-624-8918|corcorante@upmc.edu|
20207151|NCT04097028|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
20207152|NCT03687827|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20207153|NCT01156363|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20207154|NCT03285490|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20207155|NCT04944758|University of British Columbia|Dr. Raymond Lam|6048227325|r.lam@ubc.ca|
20207156|NCT04989504|Mayo Clinic|Dr. Kimberly Corbin|855-776-0015|corbin.kimberly@mayo.edu|
20207157|NCT00617162|Abbott|Lyndahl Himes, Sr. Clinical Research Scientist|+1 214 998 1137|lyndahl.himes@abbott.com|
20207158|NCT00735072|University of California, San Francisco|Peter W. Hunt, MD|(415) 476-4082|phunt@php.ucsf.edu|345
20207159|NCT00911144|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207160|NCT01291511|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20207161|NCT04521920|Duke University|Dr. Mehri McKellar|(919) 613-6129|mehri.mckellar@duke.edu|
20207162|NCT00047008|NRG Oncology|Wendy Seiferheld||SeiferheldW@nrgoncology.org|
20207163|NCT02773368|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20207164|NCT01929018|University of Colorado Denver, Anschutz Medical Campus|Dr. Cory Christiansen|303.724.9101|cory.christiansen@ucdenver.edu|
20207165|NCT00748865|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20207166|NCT01366534|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207167|NCT02748525|The University of Texas Health Science Center at Houston|Isis Gayed, MD|713-704-1787|isis.w.gayed@uth.tmc.edu|
20207168|NCT01047436|Xidea Solutions Limited|Dr D Bendel||daryl@xideasolutions.com|
20207169|NCT05784103|University of Pittsburgh|Dr. Surya Gnyawali, PhD|6143712027|scg92@pitt.edu|
20207170|NCT02635867|University of Illinois at Chicago|Adriana Semprum-Clavier|312-966-3535|asemprum@uic.edu|
20225272|NCT01343667|W. L. Gore & Associates|Bryan Randall, Clinical Biostatistician|928-864-4832|BRandall@WLGore.com|
20225273|NCT00810446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225274|NCT05079230|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20225275|NCT01524783|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20225276|NCT00100841|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
20225277|NCT03164265|University of Pittsburgh|Dr. Angus Thomson|(412) 624-6392|thomsonaw@upmc.edu|
20225278|NCT01876979|OMFS & HD|Department Chair|302-320-6458|dmeara@christianacare.org|
20225279|NCT00106639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225280|NCT02240069|University of Montana|Curtis Noonan|406-243-4957|curtis.noonan@umontana.edu|
20225281|NCT01096589|Centre for Reasearch and Implementation of Clinical Practice (CRICP)|Prof. Christine Moffatt, Principal Investigator|+44 20 73 51 14 11|christine.moffatt@cricp.org.uk|
20225282|NCT01294007|ATEC Spine|Saba Pasha, Director Clinical Research & Data Science|760-356-6639|spasha@atecspine.com|
20225283|NCT00721279|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225284|NCT00900731|Novartis Pharmaceuticals|Study Director|862 778-8300||
20225285|NCT03806231|Intermountain Healthcare|Molly Adams, Clinical Research Project Coordinator|(801)507-7030|molly.adams@imail.org|
20225286|NCT02919267|Institut universitaire de cardiologie de de pneumologie de Québec|Dr Jean Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
20225287|NCT03467763|Memorial Sloan Kettering Cancer Center|Dr. James Flory|6468883790|floryj@mskcc.org|
20225288|NCT02227368|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
20225289|NCT03046056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20225290|NCT05243563|USA Health|Catera Duhon|251-415-1598|cduhon@health.southalabama.edu|
20225291|NCT00441363|VeroScience|Donna Cowan|401 816-0525|donna_cowan@veroscience.com|
20225292|NCT01043094|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
20225293|NCT02437188|Baylor College of Medicine|Dr. Lilian Dindo, Assistant Professor|713-440-4637|lilian.dindo@bcm.edu|
20225294|NCT00499343|U.T. M.D. Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor|713-792-8750||
20207171|NCT04904640|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini, MD|+390516366418|francesco.castagnini@ior.it|
20225295|NCT00888290|Albert Einstein College of Medicine|Michal Melamed|718-430-2496|michal.melamed@einsteinmed.org|
20207172|NCT00564265|Hospital de La Serena|Dr. Marcelo A. Beltran|56 - 51 - 485923|beltran_01@yahoo.com|
20207173|NCT04254796|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|olga.tymofiyeva@ucsf.edu|
20207174|NCT01976975|McLean Hospital|David Crowley|6178554432|djcrowley@mclean.harvard.edu|
20184544|NCT01444417|Amgen Inc.|Study Director|866-572-6436||
20184545|NCT04018924|Emoled|Duccio Rossi Degl'Innocenti|+39 0550751981|d.rossi@emoled.com|
20184546|NCT02214160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20184547|NCT02423798|Medtronic Minimed|Odile O'Sullivan, Clinical Trial Manager|8184763319|odile.osullivan@medtronic.com|
20184548|NCT00275392|James H. Quillen VAMC|Courtney D. Hall, PhD|423-926-1171|courtney.hall@va.gov|7518
20184549|NCT04221828|US Biotest, Inc.|Gere S. diZerega, MD|18055951300|gere.dizerega@usbiotest.com|
20184550|NCT01430611|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20184551|NCT02204982|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20184552|NCT01968226|Cleveland Clinic|Dr. Balaji Tamarappoo|216-444-6765|tamarab@ccf.org|
20184553|NCT00566527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184554|NCT00457743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20184555|NCT02261467|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
20184556|NCT01576952|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
20184557|NCT00794118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207175|NCT02463227|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s3.com|
20184558|NCT04090190|Mass General Brigham|Vatche Minassian, MD, MPH|(617) 732-4838|vminassian@bwh.harvard.edu|
20207176|NCT01933399|MUSC|David Morrisette, PhD|843-792-2940|morrisdc@musc.edu|
20207177|NCT01024920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207178|NCT00926185|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20207179|NCT02861118|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20207180|NCT01452191|University of Nottingham|Professor Denise Kendrick||denise.kendrick@nottingham.ac.uk|
20207181|NCT03236506|University of Dundee|Professor John Dillon|01382 383017|j.f.dillon@dundee.ac.uk|
20225296|NCT04767529|Akero Therapeutics, Inc.|Kitty Yale|(650) 487-6488|harmonystudies@akerotx.com|
20225297|NCT01056913|St John of God Hospital Vienna|Bernhard Dauser (MD)|+43121121|bernhard.dauser@gmail.com|5098
20225298|NCT02598778|MMC - Dentistry|Kakanantadilok, Nuntiya|(888) 700-6623|nkakanan@montefiore.org|
20225299|NCT02290925|Faculty of Medicine & Allied Sciences, Rajarata University of Sri Lanka|Professor Sisira Siribaddana|+94777326940|sisira.siribaddana@gmail.com|
20225300|NCT01716520|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225301|NCT00253370|ECOG Statistical Office|Study Statistician|617-632-3012||
20184559|NCT00028093|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C W|3014961333|hoofnaglej@extra.niddk.nih.gov|
20184560|NCT00940537|Washington University School of Medicine|Gary Skolnick|314-362-5292|gskolnic@wustl.edu|
20184561|NCT01597258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184562|NCT00933400|American College of Radiology|Communications Director|215-574-3150|nfredericks@acr.org|
20184563|NCT01415349|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20184564|NCT01764464|University of Rochester|John Markman|585-276-3616|john_markman@urmc.rochester.edu|
20184565|NCT02079844|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20184566|NCT01401023|Michigan State University|Dr. Gary Stein, Pharm D|517-353-5126|steing@msu.edu|
20184567|NCT02515305|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20184568|NCT02531113|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
20225302|NCT00791037|University of Washington|Dr. Mary L. Disis|206-543-8557|ndisis@u.washington.edu|
20184569|NCT00981630|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20184570|NCT04120454|The Ohio State University Comprehensive Cancer Center|Dr. Asrar Alahmadi|614-293-6786|Asrar.Alahmadi@osumc.edu|
20184571|NCT02576574|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20184572|NCT05262738|University of Texas at Austin, Dell Medical School|Alexander Saucedo, MD|210-845-7571|alexander.saucedo@ascension.org|
20184573|NCT02374463|Baltimore VA Medical Center|Leslie Katzel, MD, PhD|410-605-7248|leslie.katzel@va.gov|
20184574|NCT01318967|Wake Forest School of Medicine|Michael Rocco, MD|336-716-4650|mrocco@wfubmc.edu|
20184575|NCT01305252|Stanford University School of Medicine|Roham Zamanian, MD, FCCP|650- 725-5495|zamanian@stanford.edu|
20184576|NCT04676334|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
20184577|NCT03795194|Phoenix Children's|Research Coordinator|6029331858|zhunteman@phoenixchildrens.com|
20184578|NCT00774397|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184579|NCT00077675|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20184580|NCT02499159|Inova Health System|Devon Collins|703-776-4096|Devon.Collins@inova.org|
20184581|NCT04425863|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
20184582|NCT02601820|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-260-4062|donna_evon@med.unc.edu|
20184583|NCT01599793|University of Chicago|Russell Szmulewitz, MD|773-702-7609|rszmulew@medicine.bsd.uchicago.edu|
20184584|NCT00083551|UAMS Myeloma Institute|Bart Barlogie|501-526-6990|barlogiebart@uams.edu|2420
20207182|NCT00023712|Gynecologic Oncology Group(GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20207183|NCT02667392|VAORD|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov; dkrose@phhp.ufl.edu|105238
20225303|NCT00998205|University of Missouri-Columbia|Anand Chockalingam|573-882-2296|chockalingama@missouri.edu|
20207184|NCT01570309|Jacobi Medical Center|Dr Seth I Sokol|718-918-5735|seth.sokol@nbhn.net|
20184585|NCT02564744|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20184586|NCT00687856|University of Pittsburgh|John Gorcsan MD|4126476570|gorcsanj@upmc.edu|
20184587|NCT02966275|MGH|Courtney Balliro BS, RN, CDE|617-726-1242|cballiro@partners.org|
20184588|NCT03122236|University of Florida|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
20184589|NCT04530149|Maimonides Medical Center|Research Administration Director|7182836896|alikourezos@maimo.org|
20184590|NCT00829036|Atlanta VA Rehab R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
20184591|NCT00277355|Massachusetts General Hospital|Merit Cudkowicz, MD, MSc|617-726-1873|mcudkowicz@partners.org|
20184592|NCT02765100|Weill Cornell Medicine|James H Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
20184593|NCT00538759|Minneapolis Heart Institute Foundation|Lisa Tindell, Director of Clinical Operations|6128633816|Lisa.Tindell@allina.com|
20184594|NCT01514149|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
20184595|NCT00808405|University of Washington|Connie Celum, MD, MPH|206-520-3824|ccelum@uw.edu|
20184596|NCT02675244|Icahn School of Medicine at Mount Sinai|Annetine Gelijns|212-659-9567|annetine.gelijns@mountsinai.org|
20184597|NCT04040296|Yale University|Abinet Aklilu|203-737-1787|abinet.aklilu@yale.edu|
20184598|NCT01956032|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20184599|NCT02652442|James H Quillen VAMC|Research Health Science Specialist|(423) 926-1171|courtney.hall@va.gov|7518
20184600|NCT01571557|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20184601|NCT01177670|Hologic, Inc.|Edward Evantash, MD|508-263-8475|edward.evantash@hologic.com|
20184602|NCT00391898|Novartis Pharmaceuticals|Study Director|862 778-8300||
20184603|NCT00749749|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|Innocoll|484-406-5211|ctucker@innocoll.com|
20184604|NCT01035658|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20184605|NCT00309907|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20184606|NCT00244855|Fred Hutchinson Cancer Research Center|Dr. David Maloney|206-667-5616|dmaloney@fredhutch.org|
20184607|NCT00869258|Columbia University|Robert Fine, MD|212-305-1168|rlf20@columbia.edu|
20184608|NCT01396837|RedDress|Saron Sirota, Clinical Team Leader|+972-54-5800765|sharon@reddress.co.il|
20225304|NCT02635009|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20184609|NCT02529995|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+44 1625 231825|Yuri.Rukazenkov@astrazeneca.com|
20184610|NCT01883908|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20184611|NCT01316263|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20184612|NCT01075217|Bracco Diagnostics Inc|Usha Halemane|609.514.2578|Usha.Halemane@diag.bracco.com|
20184613|NCT01911169|Medical University of South Carolina|Dr. James Oates|843-789-6797|oatesjc@musc.edu|
20184614|NCT00364013|Amgen Inc.|Study Director|866-572-6436||
20184615|NCT00293293|Moffitt Cancer Center|Patricia L. Judson, M.D.|813-745-1600|Patricia.Judson@moffitt.org|
20184616|NCT01149512|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
20184617|NCT03873337|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
20184618|NCT01574807|Division of Endodontics|Dr. John Nusstein|614-292-3596|nusstein.1@osu.ed|
20184619|NCT02512965|Canadian Cancer Trials Group|Dr. Keyue Ding|16135336430|kding@ctg.queensu.ca|77705
20184620|NCT00835770|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20184621|NCT01185782|Merck Serono Co., Ltd., Japan, an affiliate of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20184622|NCT02507752|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20184623|NCT00149838|MUSC|Mark S. George, MD, Professor|8438700368|georgem@musc.edu|
20184624|NCT01061151|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20184625|NCT00523237|Stanford University|Philip Grant, MD|650-723-2804|pmgrant@stanford.edu|
20184626|NCT01691690|Nationwide Children's Hospital|Dr. Arlyne Thung|(614) 722-4200|Arlyne.Thung@NationwideChildrens.org|
20184627|NCT00939510|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
20184628|NCT03903822|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184629|NCT01390818|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
20184630|NCT04594759|Medical University of South Carolina|Dr. Samantha Karlin|(843)- 714-0146|karlin@musc.edu|
20184631|NCT03994705|Cartesian Therapeutics|Dr. Vera Sarkodie Medical Director,|617-231-8085|vera.sarkodie@cartesiantx.com|
20184632|NCT01395758|ArQule, Inc.|Brian Schwartz, MD Chief Medical Officer|781-994-0300|ClinicalTrials@arqule.com|
20184633|NCT01514734|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20184634|NCT00696618|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)641-8762|ejfuchs@jhmi.edu|
20184635|NCT00042224|Northshore LIJ Health System|Georgios Petrides, M.D.|718-470-8569|GPetride@NSHS.EDU|
20184636|NCT01041417|Emory University School of Medicine|Dr. Arshed Quyyumi|4047273655|aquyyum@emory.edu|
20225305|NCT05869864|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
20225306|NCT00981058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225307|NCT05916131|University of Michigan|Yu Kuei Lin, MD|734-232-1573|yuklin@med.umich.edu|
20192215|NCT03029819|Georgia State University School of Public Health|Claire Spears|4044139335|cspears@gsu.edu|
20192216|NCT01449747|The Catholic University of Korea|Dr. Ji Hyun Kim|82-2-961-4534|kjhyun@catholic.ac.kr|
20225308|NCT01973335|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge, researcher|0473924199|frederik.verbrugge@zol.be|+32
20207185|NCT04857892|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207186|NCT01311895|Montefiore Medical Center|Dr. Andrew Chang|718-920-6626|achang3@yahoo.com|
20207187|NCT00655811|University of Miami|Gil Yosipovitch, MD, Professor|305-243-5121|gyosipovitch@med.miami.edu|
20207188|NCT03304912|Drexel University|Alexis Roth, PhD, MPH|267.359.6123|alexisroth@drexel.edu|
20207189|NCT00368472|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20207190|NCT01044056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207191|NCT04095793|Theravance Biopharma|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
20207192|NCT00044213|Mount Sinai Medical Center|Gervasio A. Lamas, M.D.|305-674-2162|Gervasio.Lamas@msmc.com|
20207193|NCT00118404|The University of Texas Southwestern Medical Center|Dr. Robin B. Jarrett, Professor of Psychiatry|214-648-5345|Robin.Jarrett@UTSouthwestern.edu|
20207194|NCT01154322|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
20207195|NCT02590640|"University of Colorado Denver | Anschutz"|Director, Research Services|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20207196|NCT00045487|University of Texas Health Science Center San Antonio|Alain Mita, MD|210-450-5094|goodwine@uthscsa.edu|
20207197|NCT01167153|Novartis Pharmaceuticals|Study Director|862-778-8300||
20207198|NCT00098865|DFCI|Mark W. Kieran, MD, PhD|617-632-4907|mark_kieran@dfci.harvard.edu|
20207199|NCT03050307|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20207200|NCT00439309|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20207201|NCT01998906|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20207202|NCT02367859|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
20207203|NCT00429572|UT MD Anderson Cancer Center|Naoto Ueno, MD, PhD/Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
20207204|NCT01665872|Yale University|Dr. Megan Smith|2037648655|megan.smith@yale.edu|
20207205|NCT00987727|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20207206|NCT01678313|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
20207207|NCT01789255|University of Michigan Comprehensive Cancer Center|Pavan Reddy, M.D.|734-647-5954|reddypr@umich.edu|
20207208|NCT02128958|Can-Fite BioPharma|Pnina Fishman, PhD, CEO|972-3-924-1114|pnina@canfite.co.il|
20184637|NCT03473340|University of Michigan|VIbha Lama|734-936-5010|vlama@med.umich.edu|
20184638|NCT00203411|Translational Research in Oncology|Dr. Arash Naeim|310 267-6810|anaeim@mednet.ucla.edu|
20207209|NCT02565576|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20207210|NCT00939341|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|28062
20207211|NCT01131130|Bausch + Lomb|Dr. Robert Steffen|585-338-6399|robert.steffen@bausch.com|
20207212|NCT01268943|Chinese Academic Medical Sciences|Dr. Jing Jin|010-87788503|tangyu.pumc@gmail.com|
20207213|NCT02437162|Johnson&Johnson|SENIOR DIRECTOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207214|NCT03981744|Janssen Pharmaceutical K.K.|PRODUCT DEVELOPMENT PORTFOLIO LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207215|NCT02782104|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207216|NCT03464136|Janssen Scientific Affairs, LLC|DIRECTOR MEDICAL AFFAIRS MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207217|NCT04338321|Janssen-Cilag International NV|Europe, Middle East, Africa (EMEA) Medical Advisor Spravato|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207218|NCT02438787|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207219|NCT03412565|Janssen Research & Development, LLC|GLOBAL MEDICAL HEAD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207220|NCT03375203|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207221|NCT03107793|Janssen-Cilag International N.V.|European Medicines Agency (EMEA) Advisor-Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207222|NCT02808507|Johns Hopkins Bloomberg School of Public Health|Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
20207223|NCT00262639|Medical University of South Carolina|Raymond F. Anton, M.D.|843-792-1226|antonr@musc.edu|
20207224|NCT06181708|Imperial College Healthcare NHS Trust|Emma Flint|02033117322|e.flint1@nhs.net|
20207225|NCT00246376|Baylor College of Medicine|Ashok Balasubramanyam, MD, Prinicipal Investigator|713-798-8654|ashokb@bcm.edu|
20207226|NCT01872897|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
20207227|NCT02418585|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207228|NCT02040857|Dana-Farber Cancer Institute|Project Manager|617-632-5313|ctopm@dfci.harvard.edu|
20207229|NCT04159701|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207230|NCT02845440|Massachusetts General Hospital, Center for Addiction Medicine|A. Eden Evins|6177333131|aeevins@mgh.harvard.edu|
20207231|NCT01849562|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20207232|NCT00329784|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20207233|NCT04599972|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
20207234|NCT00638690|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Research|310-914-2915||
20207235|NCT02348840|Emory University|Gari D. Clifford, DPhil|404-727-0229|gari.clifford@emory.edu|
20225309|NCT00506714|Arthritis Foundation|Meika A. Fang, MD|310-478-3711|meika.fang@va.gov|84503
20225310|NCT02305446|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20225311|NCT02289105|Fostering Improvement in End-of-Life Decision Science Program|Dr. Scott Halpern|215-5739461|shalpern@exchange.upenn.edu|
20184639|NCT03949335|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|ethoma39@its.jnj.com|
20184640|NCT01351272|Universitätsklinikum Würzburg|Prof. Dr. M. Herrmann|093120176650|Herrmann_m@ukw.de|
20184641|NCT01212991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184642|NCT00632424|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
20184643|NCT05135000|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20184644|NCT04623008|Ohio State University College of Nursing|Mei-Wei Chang, PhD|614-247-7211|chang.1572@osu.edu|
20184645|NCT03568422|Canadian Cancer Trials Group|Pierre-Olivier Gaudreau|6135336430|p-ogaudreau@ctg.queensu.ca|
20184646|NCT03439891|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
20184647|NCT02763319|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20184648|NCT04926181|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 476-1000|Rahul.Aggarwal@ucsf.edu|
20184649|NCT03936660|Duke Clinical Research Institute|Chris Granger, MD|9196688700|christopher.granger@duke.edu|
20184650|NCT03803605|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-2537|cynthia_gay@med.unc.edu|
20184651|NCT00233090|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
20184652|NCT01875848|VACT West Haven HealthCare System|William, Becker M.D|203-932-5711|william.becker4@va.gov|2247
20184653|NCT00840177|SWOG Statistical Center|S0919 Statistician|2066674623|amoseley@fredhutch.org|
20184654|NCT02407249|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
20184655|NCT01622868|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20184656|NCT00542789|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20184657|NCT02584829|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
20184658|NCT00687713|National Institute on Drug Abuse|Ann Anderson, MD|301-827-5916|aanderso@nida.nih.gov|
20207236|NCT00373880|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
20184659|NCT03538717|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184660|NCT01424397|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184661|NCT02767765|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20184662|NCT01951170|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20184663|NCT00804648|Vistakon|Arthur Shedden MD|904-443-1557||
20184664|NCT01647581|VA|Linda Feagins|214-587-1603|linda.feagins@austin.utexas.edu|
20184665|NCT01105117|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
20184666|NCT00585052|University of Iowa|Raymond Hohl, MD|319-335-6564|rhohl@pennstatehealth.psu.edu|
20184667|NCT03631433|OSU|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
20184668|NCT00446459|University of Washington|Dr. Connie L. Davis|206-598-7162|cdavis@u.washington.edu|
20162860|NCT00988091|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20162861|NCT00773747|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162862|NCT04260347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184669|NCT01965665|Duke University Medical Center|Michael Kerzner, DMP|919-613-4449|michael.kerzner@duke.edu|
20184670|NCT00858117|Northwestern University|Olga Frankfurt, MD|312 695 6180|o-frankfurt@northwestern.edu|
20184671|NCT00253890|Butler Hospital|Dr. Michael D. Stein, MD|401-455-6646|mstein@butler.org|
20184672|NCT02355275|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@gmail.com|838
20184673|NCT02115828|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
20184674|NCT03531840|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
20184675|NCT02267824|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
20184676|NCT03074331|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20184677|NCT03451721|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
20184678|NCT00960141|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20184679|NCT04086966|University of Alabama at Birmingham|April Riddle|(205)934-6504|ariddle@uabmc.edu|
20184680|NCT02933944|Targovax|Chief Medical Officer|+ 47 21398810|contact@targovax.com|
20184681|NCT00995904|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20184682|NCT05274217|University of Washington|Teresa Evans-Campbell|206-543-6075|tecamp@uw.edu|
20184683|NCT06243796|Nakhon Phanom hospital|Dr.Kriengkrai Prasert|+6642199222|gpsiam28@gmail.com|1091
20184684|NCT03144674|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20184685|NCT00736853|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K.|Medical Director|+81-3-4411-5509||
20184686|NCT01199705|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20184687|NCT01616459|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184688|NCT03394885|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|angeles.secord@duke.edu|
20184689|NCT04980755|University of Plymouth|Dr Joseph Lanario|01752 764403|joseph.lanario@plymouth.ac.uk|
20162863|NCT02669212|National Institutes of Health|Dr. Brian Walitt|202-549-7669|brian.walitt@nih.gov|
20184690|NCT01926977|Sierra Eye Associates|Arshad Khanani M.D., Vitreo-Retinal Diseases and Surgery|775-329-0286|arshad.khanani@gmail.com|
20184691|NCT00801983|University of Pittsburgh|Dr. Nancy Baker|412 383-6607|nab36@pitt.edu|
20184692|NCT02270645|University of Miami|Keyvan Nouri|3052433380|knouri@med.miami.edu|
20184693|NCT03149991|Massachusetts General Hospital|Dr. Rebecca Hock|617-872-3711|rhock@mgh.harvard.edu|
20184694|NCT04411056|The Guthrie Clinic|Praneet Madabhushi MD|5708874882|praneeth.madabhushi@guthrie.org|
20184695|NCT03702842|University of Florida|Emily J Fox, Research Associate Professor|352-273-6085|ejfox@phhp.ufl.edu|
20184696|NCT02631603|LMU/ Haunersches Kinderspital|Prof. Dr. med. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
20207237|NCT01987752|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
20184697|NCT03122886|Mayo Clinic|Aminah Jatoi, MD|507/284-2511|Jatoi.Aminah@mayo.edu|
20207238|NCT00626340|University of Pennsylvania|Dr. Cynthia Neill Epperson|215-573-8871|cepp@mail.med.upenn.edu|
20184698|NCT05985044|Johns Hopkins University School of Nursing|Dr.Binu Koirala|707-225-2166|bkoiral1@jhu.edu|
20207239|NCT01347073|Hyperion Therapeutics, Inc.|Craig James R.N. Associate Dir. UCD Clinical Operations|(650) 745- 7480|craig.james@hyperiontx.com|
20207240|NCT00621244|Novartis Pharmaceuticals|Study Director|862-778-8300||
20207241|NCT01466062|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20207242|NCT00865202|University of Colorado|Thomas Robinson MD|303-724-2728|thomas.robinson@ucdenver.edu|
20207243|NCT02865928|Northwell Health|Louis Ballas|718-470-5827|lballas@northwell.edu|
20207244|NCT03531710|United Neuroscience|Medical Director|+1 (972) 809-0481|info@unitedneuroscience.com|
20207245|NCT03152110|University of Pittsburgh|Alicia Koontz|412-822-3700|akoontz@pitt.edu|
20207246|NCT01925014|The LOCAT Group|Kyoung Ho Lee|82317877607|kholeemail@gmail.com|
20207247|NCT01690988|Washington University School of Medicine|Dr. Michael Avidan|314-747-4155|avidanm@wustl.edu|
20207248|NCT02705352|Massachusetts Eye and Ear|Shyana Harper|6173915982|Shyana_harper@meei.harvard.edu|
20207249|NCT01634100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207250|NCT00552344|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20207251|NCT00471276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207252|NCT00744991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207253|NCT01662986|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207254|NCT01487863|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
20225312|NCT01636947|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225313|NCT00935064|University of Delaware/Christiana Care Health System|Dr. Raelene E. Maser|302-831-8400|rmaser@udel.edu|
20225314|NCT00445744|FHCRC|H. Joachim Deeg MD|206 667 4409|jdeeg@fhcrc.org|
20225315|NCT03943823|The University of Texas Health Science Center at Houston|Sunbola Ashimi, PhD|713-500-6410|Sunbola.S.Ashimi@uth.tmc.edu|
20225316|NCT01522131|The University of Texas Health Science Center at Houston|Rosemary Thomas, DMD, MS|713-486-4074|rosemary.thomas@uth.tmc.edu|
20225317|NCT03724084|The Ohio State University Comprehensive Cancer Center|Dr. James Blachly|614-293-7484|James.Blachly@osumc.edu|
20225318|NCT02454075|Trio Medicines|Dr Malcolm Boyce|020 8961 4130|mboyce@hmrlondon.com|
20225319|NCT02719353|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20184699|NCT04163328|UAB|Dr. Kelly K. Nichols|205-975-9935|nicholsk@uab.edu|
20225320|NCT02651415|BC Cancer|Dr. Barbara Melosky|604-877-6000|bmelosky@bccancer.bc.ca|
20225321|NCT03956615|Vrije Universiteit Brussel|Dr. Matthias D'Huyvetter|+3224776013|afspraak_nucleaire@uzbrussel.be|
20225322|NCT00412217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20225323|NCT01069419|UCB Clinical Trial Call Center|UCB (Study Director)|+1887 822 9493||
20225324|NCT02202044|University of Colorado|Tracey MacDermott|303-724-2757|Tracey.MacDermott@ucdenver.edu|
20225325|NCT00824434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20184700|NCT03312907|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20184701|NCT03189524|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20225326|NCT03673345|University of Rochester|Jennifer Nayak, MD, PI|5852750526|Jennifer_nayak@urmc.rochester.edu|
20184702|NCT04879524|Queen Mary University of London|P Chaichanavichkij|020 7882 8752|p.chaichanavichkij@qmul.ac.uk|
20184703|NCT01780298|Philip Morris Products S.A.|Julia HOENG, PhD|+41 (58) 242 2214|clinicaltrials.pmi@pmi.com|
20184704|NCT03873779|Zeltiq|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20184705|NCT03113617|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
20184706|NCT04252586|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20184707|NCT01714492|The University of Tennessee|Richard Komistek, Ph. D.|8659744159|rkomiste@utk.edu|
20184708|NCT03740009|UNC School of Medicine|Crystal Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
20225327|NCT05153148|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20225328|NCT00232596|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225329|NCT01712334|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20225330|NCT01253174|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20225331|NCT02267135|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|trialandresults.registries@novartis.com|
20225332|NCT01863498|Children's Mercy Kansas City|Dr. Shawn St. Peter|816-234-3575|sspeter@cmh.edu|
20225333|NCT00932698|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20184709|NCT01236001|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20184710|NCT02988817|Genmab A/S|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
20184711|NCT03926039|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
20184712|NCT01406223|Duke University Medical Center|Principal Investigator|919-668-3987|francis.mcclernon@duke.edu|
20207255|NCT01975376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207256|NCT02564068|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
20225334|NCT00131365|InSightec|Nadir Alikacem|214.630.2000|nadira@insightec.com|
20225335|NCT04608344|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20184713|NCT05082935|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
20184714|NCT02122445|Sport and Spine Rehab Clincal Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
20184715|NCT02869334|Nathan Kline Institute|Dr. Daniel Javitt|8453986534|javitt@nki.rfmh.org|
20184716|NCT01937507|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
20184717|NCT04530747|Pennington Biomedical Research Center|Prachi Singh|12257633151|prachi.singh@pbrc.edu|
20184718|NCT03292913|RTI International Institute|Megan Lewis|206-268-3613|melewis@rti.org|
20184719|NCT02379819|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20184720|NCT03950622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184721|NCT01839331|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
20184722|NCT03752151|Medtronic, Plc|Dana Wigert, Sr Prin Clinical Research Specialist|+17635262802|dana.wigert@medtronic.com|
20184723|NCT04056624|East Carolina University, Department of Public Health|Stephanie Jilcott Pitts|252-744-5572|jilcotts@ecu.edu|
20184724|NCT00548418|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
20207257|NCT04401904|UT Health San Antonio|Carolina Solis-Herrera, MD|210-567-4900|solisherrera@uthscsa.edu|
20184725|NCT03977935|Changhai Hospital|Investigator of Clinical Trials|15021569528|1372971347@qq.com|
20184726|NCT03029598|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
20184727|NCT01047241|Copenhagen University Hospital, Rigshospitalet|Sponsor's contact person Bettina Nygaard Nielsen|+45 35459546|bettina.nygaard.nielsen@regionh.dk|
20207258|NCT01614795|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20184728|NCT02092116|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
20184729|NCT00770757|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@dom.wustl.edu|
20184730|NCT00350792|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20184731|NCT04470375|University of South Dakota|Dr. Kory Zimney|16056586373|kory.zimney@usd.edu|
20184732|NCT04762875|Ensoma|Elizabeth Hook|617-766-3917|ehook@ensoma.com|
20184733|NCT01792830|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20184734|NCT01943799|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20184735|NCT01691326|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20184736|NCT03811574|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20184737|NCT01832480|Tulane University School of Public Health and Tropical Medicine|Patricia Kissinger, Ph.D.|504-988-7320|kissing@tulane.edu|
20184738|NCT01542229|Charleston VAMC|Dr. Anouk L. Grubaugh|843-789-5853|grubaugh@musc.edu|
20184739|NCT03639558|University of Nottingham/Psychiatric Hospital of the Cross|Dr. Joseph Dib|07748668553|joseph.elie.dib@gmail.com|
20184740|NCT05510245|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184741|NCT02414204|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Timmy Lee|205-934-3589|txlee@uab.edu|
20184742|NCT00995150|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
20184743|NCT01373346|Gangnam severance hospital|Seung Ho Choi, M.D., Ph.D.|82-2-2019-3374|choish@yuhs.ac|
20184744|NCT01198028|MD Anderson Cancer Center|Dr. Bonnie Glisson, MD,Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|bglisson@mdanderson.org|
20184745|NCT01186198|Abbott Medical Devices|Jessie Coe|224 668 5360|Jessie.coe@abbott.com|
20184746|NCT02665988|Houston Methodist Hospital|Dr. Alok Madan|832-930-1662|amadan@houstonmethodist.org|
20207259|NCT00655057|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
20207260|NCT00179517|Beth Israel Deaconess Medical Center|Andrew G Herzog MD,MSc|781-431-0277|aherzog@bidmc.harvard.edu|
20207261|NCT00565812|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207262|NCT01308294|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof. Olivier Michielin, MD PhD|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
20207263|NCT00946023|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
20207264|NCT00260195|RAND Corporation|Lisa Jaycox|703-344-8236|jaycox@rand.org|5118
20207265|NCT00614991|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
20207266|NCT02623699|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20207267|NCT00033371|University of Texas (UT) MD Anderson Cancer Center|Patrick Lynch, MD/Professor, Gastroenterology/Hepatology|713-794-5073|plynch@mdanderson.org|
20207268|NCT00251589|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184747|NCT00970359|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho|646-888-4235|hoa@mskcc.org|
20184748|NCT01565148|University of Nebraska|Quan Dong Nguyen|4025592020|quan.nguyen@unmc.edu|
20184749|NCT00262730|Adult Brain Tumor Consortium Central Office- Johns Hopkins|Director of Adult Brain Tumor Consortium|410-955-3657|jfisher@jhmi.edu|
20184750|NCT01170962|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20184751|NCT03942042|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20184752|NCT02918071|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
20184753|NCT06630390|University of Rochester Medical Center|Mark Oldham|585-275-3592|mark_oldham@urmc.rochester.edu|
20207269|NCT00323427|Portland VA Medical Center|Mitchel Turbin, Ph.D.|503-220-8262|bonnie.becker@va.gov|54525
20207270|NCT02493868|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218079|NCT02510014|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
20218080|NCT02463799|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-8341|eantona1@jhmi.edu|
20218081|NCT04179019|Brigham and Women's Hospital|Anand Vaidya|6177325666|anandvaidya@bwh.harvard.edu|
20162864|NCT03549104|University of Illinois at Chicago|Pamela Martyn-Nemeth|312-996-7903|pmartyn@uic.edu|
20184754|NCT02788773|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
20184755|NCT03632941|Duke University|Michael Morse, M.D.|919-681-3480|michael.morse@duke.edu|
20184756|NCT04688450|Massachusetts General Hospital|Dr. Andrew Tomas Reisner|617-726-2241|areisner@mgh.harvard.edu|
20184757|NCT02544074|The Ohio State University|Douglas Scharre, MD|614-293-4969|Doug.Scharre@osumc.edu|
20184758|NCT04498052|University of Utah|Kensaku Kawamoto, MD, PhD, MHS / Associate Chief Medical Information Officer|801-581-4080|kensaku.kawamoto@utah.edu|
20184760|NCT05286385|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61294286555|cltd-prs-admin@cochlear.com|
20184761|NCT02581215|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20184762|NCT05930782|MMV Medicines for Malaria Venture|Dr Anne Claire Marrast|+41 22 555 03 00|marrasta@mmv.org|
20184763|NCT04270526|Mount Auburn Hospital|William Winkelman|617-354-5452|william.winkelman@mah.harvard.edu|
20184764|NCT02541565|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
20184765|NCT02566902|University of California - San Diego|Mike Gardiner, MD|8589668036|magardiner@ucsd.edu|
20184766|NCT01108003|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20184767|NCT04425629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20184768|NCT00232180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184769|NCT02748317|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
20184770|NCT00414544|Cosmeta, A Gel-Del Technolgies Company|Dr. David B. Masters|651 209-0707|dmasters@gel-del.com|
20184771|NCT04259450|Affimed GmbH|Clinical Operations|+49 62216530770|trials@affimed.com|
20184772|NCT03452189|NYU Langone Health|Dr. Jerome Lowenstein|+1 212 263 5635|Jerome.Lowenstein@nyulangone.org|
20184773|NCT03390296|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
20184774|NCT02724592|University of Greifswald|Dr. Mohammad Alkilzy|0049-17623399340|alkilzym@uni-greifswald.de|
20184775|NCT01950780|Columbia University Dept of Dermatology|Director of Clinical Research Dermatology|2123056953|jc299@cumc.columbia.edu|
20184776|NCT00639860|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
20184777|NCT04723394|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20184778|NCT00371787|Centre for Contact Lens Research|Dr. Craig Woods|1-519-888-4567|cawoods@uwaterloo.ca|36547
20184779|NCT01972724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20184780|NCT04977700|Klein Buendel, Inc.|Julia Berteletti|303-565-4321|jberteletti@kleinbuendel.com|
20184781|NCT01900249|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20184782|NCT01065506|The University of Texas at Austin|Jasper Smits|512-475-8095|smits@utexas.edu|
20184783|NCT01546753|University of Arkansas for Medical Sciences|Dr. Stacie Jones|(501) 364-1060|JonesStacieM@uams.edu|
20184784|NCT03036813|Global Blood Therapeutics|Margaret Tonda, PharmD, Sr. Director, Clinical Science|(650) 741-7761|mtonda@gbt.com|
20184785|NCT01102231|IFCT|Communications Officer|+33156811045|contact@ifct.fr|
20184786|NCT05946551|Emory University|Tiffany Walker, MD Assistant Professor|404-778-1621|tiffany.austin.walker@emory.edu|
20184787|NCT00311363|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20184788|NCT01697969|Alcon Research, Ltd.|Danyel Crout Carr, MS, CCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20184789|NCT05360901|Brigham and Women's Hospital|Jessica M. Lipschitz|617-732-6548|jlipschitz@bwh.harvard.edu|
20184790|NCT05609032|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
20184791|NCT03764475|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20184792|NCT04110743|University of California Davis|Dr. Lorenzo Nardo|916-731-9004|lnardo@ucdavis.edu|
20184793|NCT01759771|Ralph H. Johnson Veterans Affairs Medical Center|Stephen J. Savage, MD, Chief Section of Urology|843 789 7330|savages@musc.edu|
20184794|NCT02528188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184795|NCT05368831|NorthSea Therapeutics BV|CLIENT TO PROVIDE|31 035760 65 05|info@northseatherapeutics.com|
20184796|NCT00529659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20184797|NCT03887650|Hartford Hospital|Dr. Kevin Finkel|860-972-1778|Kevin.Finkel@hhchealth.org|
20184798|NCT01503749|Seoul National University Hospital|Pf. Jung-Hwan Yoon|82-2-2072-2228|yoonjh@snu.ac.kr|
20184799|NCT04200365|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
20184800|NCT02101190|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20192217|NCT00702546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184801|NCT01499199|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192218|NCT02725008|New York Presbyterian - Brooklyn Methodist Hospital|Christopher P Kelly|718.780.5040|chk9064@nyp.org|
20192219|NCT01020747|Massachusetts General Hospital|Monica Tettamanti|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
20225336|NCT05249127|Clarity Pharmaceuticals|Dr Othon Gervasio, Chief Medical Officer|+61 2 9209 4037|info@claritypharmaceuticals.com|
20225337|NCT02908074|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
20225338|NCT02073565|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
20225339|NCT03646305|York University|Keisha C. Gobin, MA|416-736-2100|kgobin@yorku.ca|33153
20225340|NCT01554176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225341|NCT02436031|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
20225342|NCT02607306|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20225343|NCT02333383|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20225344|NCT00463840|New York University Cancer Institute|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
20225345|NCT01653327|Dartmouth-Hitchcock Medical Center|Dr. Thomas Davis|1-603-650-8626|Thomas.H.Davis@hitchcock.org|
20225346|NCT04284930|Cleveland Clinic|Risal Djohan|216 312-6146|djohanr@ccf.org|
20225347|NCT02301039|Sarcoma Alliance for Research Through Collaboration|Research Manager|734-930-7600|sarc@sarctrials.org|
20225348|NCT04683939|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20225349|NCT03765229|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
20225350|NCT01160380|Oncotherapeutics|Director of Clinical Operations|310-623-1200|lthulin@oncotherapeutics.com|
20225351|NCT02510820|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20225352|NCT03089853|University of Alabama at Birmingham|Surya P Bhatt|205-934-5555|sbhatt@uabmc.edu|
20225353|NCT00642954|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225354|NCT02913105|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20225355|NCT01317004|Novartis Pharmaceuticals|Study Director|862-778-8300||
20225356|NCT04114656|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20225357|NCT02661061|Trinity College Dublin|Dr Martha Finnegan|0863638264|mfinneg@tcd.ie|
20225358|NCT03052920|Washington University in St. Luis|Jill B Firszt, PI|314-362-4760|FirsztJ@wustl.edu|
20225359|NCT01980628|Pharmacyclics, LLC|Isaiah Dimery, MD, Senior Medical Director|408-215-3579|idimery@pcyc.com|
20225360|NCT02578940|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
20225361|NCT00525876|UT MD Anderson Cancer Center|Issa F. Khouri, MD/ Professor||celsaenz@mdanderson.org|
20225362|NCT00693485|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20225363|NCT04513899|University of California, Irvine, Sue & Bill Gross School of Nursing|Dr Adeline Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
20162865|NCT01806675|Stanford University|Sanjiv Sam Gambhir, Professor for Clinical Investigation in Cancer Research and Professor|650-725-6175|sgambhir@stanford.edu|
20192220|NCT01149876|MGH|Dr. Molly Wanner|617-726-2914|harvardskinstudies@partners.org|
20192221|NCT02175745|Stanford University|Erik Mittra, MD, PhD|650-736-2859|emittra@stanford.edu|
20192222|NCT00983892|Ann Arbor Veterans Administration|Maria J. Silveira MD MA MPH|734-763-4550|mariajs@med.umich.edu|
20192223|NCT00808899|St. Jude Children's Research Hospital|Wayne L. Furman|1-866-278-5833|info@stjude.org|
20192224|NCT03028012|University of Utah Physical Medicine and Rehabilitation Orthopedics|Dr. Daniel Cushman|8015852373|heidi.hansen@hsc.utah.edu|
20192225|NCT03181282|Washington University in St. Louis|Ryan Duncan|314-273-1052|duncanr@wustl.edu|
20192226|NCT02624375|University of Washington|Dr. Christine Johnston, Associate Professor|206 520 4340|cjohnsto@uw.edu|
20192227|NCT00569010|The University of MD Anderson Cancer Center|Jean-Pierre Issa, M.D./Professor|713-745-2260|eharriso@mdanderson.org|
20192228|NCT04525456|NUS|Study administrator|+65 6601 7766|lsixtc@nus.edu.sg|
20192229|NCT03448536|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20192230|NCT02736955|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20192231|NCT01424189|Alcon Research, Ltd.|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20192232|NCT04688086|NIRAMAI Health Analytix Private Limited|Dr Sathiakar Collison|+919810823838|sathiakar.collison@niramai.com|
20192233|NCT01203956|Sleep Medicine Associates of Texas|Leon Rosenthal, MD|214-750-7776|LRosenthal@sleepmed.com|
20192234|NCT00513461|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
20192235|NCT01329419|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192236|NCT02920021|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
20192237|NCT04522778|UPMC|Ryan St. Pierre-Hetz|3154369898|stpierrehetzre@upmc.edu|
20192238|NCT00069277|Eisai Inc|Eisai Call Center|888-422-4743||
20202958|NCT00073333|University of Central Florida|Deborah C. Beidel, Ph.D.|407-823-3254|deborah.beidel@ucf.edu|
20162866|NCT03078855|University of Rochester|Michael Brady, PhD|585-275-5830|michael_brady@urmc.rochester.edu|
20202959|NCT00915005|UT MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
20225364|NCT02217800|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
20225365|NCT01937715|Pfizer Inc.|Pfizer ClincialTrials.gov Call Center|+18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225366|NCT00632632|Weill Cornell Medical College|JoAn Difede, PhD|212 746 3079|jdifede@med.cornell.edu|
20225367|NCT01698268|Beaumont Health|Kaveh Aslani, MD|248-898-81905|kaslani@beaumont.org|
20225368|NCT04757805|Nationwide Children's Hospital|Giorgio Veneziano, MD|614-722-4200|Giorgio.Veneziano@nationwidechildrens.org|
20225369|NCT02469168|Walter Reed National Military Medical Center|Jody Richardson, MSN, RN|301-295-7798|jody.richardson.ctr@usuhs.edu|
20225370|NCT00298363|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20225371|NCT00135356|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20225372|NCT00153816|Geisel School of Medicine at Dartmouth|Leila A. Mott, Statistical Analyst|603-650-3447|Leila.A.Mott@Dartmouth.EDU|
20225373|NCT03282591|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
20225374|NCT01533688|UOklahoma|Dr. Mohammad Madhoun|405-456-326-|mohammad-madhoun@ouhsc.edu|
20225375|NCT02263729|University of Pittsburgh|James J. Irrgang|412-383-9865|jirrgang@pitt.edu|
20225376|NCT04591015|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
20225377|NCT06046209|CooperVision, Inc.|Lee Hall|+19252516684|lhall@coopervision.com|
20225378|NCT04525131|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
20225379|NCT06226649|National Cheng Kung University|Mr. Chun-Yi Ho|886-6-2353535|eggman0011@gmail.com|5852
20225380|NCT02553798|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20225381|NCT00983541|Huntsman Cancer Institute|Christopher Anker, MD|801-213-4241|candace.larson@hci.utah.edu|
20225382|NCT03706469|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20225383|NCT01955109|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
20225384|NCT01167634|University of Pennsylvania School of Medicine|Laurie Norton|2155738799|lanorton@mail.med.upenn.edu|215
20225385|NCT02614131|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225386|NCT00911586|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
20225387|NCT00310076|Comprehensive Cancer Center of Wake Forest University|Greg Russell, MS|336-716-5449|grussell@wakehealth.edu|
20225388|NCT00089635|Amgen Inc.|Study Director|866-572-6436||
20225389|NCT02603107|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20225390|NCT00032630|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-393-2863|Frederick.Grover@ucdenver.edu|
20225391|NCT04103515|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
20225392|NCT00821015|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20225393|NCT01887678|Biologische Heilmittel Heel GmbH|Christine Frank, PhD, Global Clinical Project Manager|+49 7221 501 3188|christine.frank@heel.com|
20192239|NCT01225159|Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand|Dr.Panthila Rujirojindakul, Staff|+66 74 45 1651|rpanthi@medicine.psu.ac.th|
20192240|NCT02230306|University of Pittsburgh Cancer Institute|Melissa Burgess, MD|412-623-7277|burgessma@upmc.edu|
20192241|NCT05400226|Vergent Bio|Maggie Neptune|+1-510-410-9124|mneptune@vergentbio.com|
20192242|NCT01145547|Legacy Health System|W. Kenneth Ward|503-413-5171|kenward503@msn.com|
20192243|NCT01770314|Inflexxion|Emil Chiauzzi|617-614-0429|echiauzzi@inflexxion.com|
20192244|NCT03512288|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192245|NCT01078584|Abbott|Global Medical Services|800-633-9110||
20192246|NCT01208870|SUNY Buffalo|Leonard H. Epstein, Ph.D.|716-829-3400|lhenet@buffalo.edu|
20192247|NCT01121185|MassBiologics|Director Clinical Affairs|617-474-3000|MBLclinicaldirector@umassmed.edu|
20192248|NCT00424177|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192249|NCT01393613|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20192250|NCT01618227|Massachusetts General Hospital|Neal Chen|617-726-4700|nchen1@partners.org|
20192251|NCT04236245|Venclose, Inc.|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
20192252|NCT00654615|Wake Forest University Health Sciences|Zhongyu Li, MD, PhD, Professor - Department of Orthopaedic Surgery|336-716-9520|zli@wakehealth.edu|
20192253|NCT00474383|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024.|Senior Director|310-943-8040||2917
20192254|NCT01482819|Johnson & Johnson Vision Care|Daria Wicks, Senior Clinical Research Manager|904-443-1391|RA-ClnclStds@its.jnj.com|
20192255|NCT03110692|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
20192256|NCT00562484|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20192257|NCT02672514|Herzzentrum Coswig|Dr. Jessica Vogler|+491749740710|j_vo@web.de|
20192258|NCT00702520|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192259|NCT00942188|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20192260|NCT02250183|Allegheny Health Network-West Penn Hospital Burn Center|Ariel M. Aballay, MD|412-578-1836|Ariel.Aballay@AHN.org|
20192261|NCT03282799|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
20192262|NCT03614676|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20192263|NCT02080403|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
20192264|NCT01999972|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225394|NCT01044589|Cleveland Clinic|Dr. Massarat Zutshi|(216) 444-3540|zutshim@ccf.org|
20162867|NCT00391027|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20184802|NCT01692730|University of Rochester|Scott McIntosh|585-275-0511|scott_mcintosh@urmc.rochester.edu|
20184803|NCT01199575|University of California, San Diego|Thomas Kipps, MD PhD|858-534-5400|tkipps@ucsd.edu|
20225395|NCT02410213|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
20184804|NCT01849055|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225396|NCT01017601|Mayo Clinic|Julian Molina, M.D, Ph.D.|507-284-1328|Molina.julian@mayo.edu|
20225397|NCT00187278|St Jude Medical|Pascale Ducloux, Clinical Manager|+3227746709|pducloux@sjm.com|
20225398|NCT01857102|Johnson and Johnson Vision Care Inc.|Kathrine E. Osborn, OD, MS, FAAO- DIRECTOR GLOBAL STRATEGIC CLAIMS|904-443-1032|KOSBORN@its.jnj.com|
20225399|NCT01115556|Vitreous Retina Macula Consultants of New York|K. Bailey Freund, MD (or Galyna Ganieva, Research Manager)|212-861-9797|gganieva@vrmny.com|6929
20184805|NCT00223795|VA Greater Los Angeles Healthcare System|Meika A. Fang, MD|310-268-4503|meika.fang@va.gov|
20184806|NCT00475501|Geriatric Research Education and Clinical Center|Stephen Borst, Ph.D|352-374-6114|stephen.borst@va.gov|5033
20184807|NCT01819883|Massachusetts General Hospital|Karen Miller|617-726-3870|KKMiller@MGH.Harvard.edu|
20184808|NCT02139943|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20184809|NCT02299375|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184810|NCT03226899|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
20184811|NCT02047981|UCSF F.I. Proctor Foundation|Ying Lin|4155144709|ying.lin@ucsf.edu|
20184812|NCT00704184|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184813|NCT00716859|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20184814|NCT00700336|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
20184815|NCT02701257|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
20184816|NCT03762213|Arkansas Children's Hospital|Dr. Saumya V Joshi|501-364-4619|svjoshi@uams.edu|
20184817|NCT00411216|Emory|Susan J Herdman, PT, PhD|4047120612|sherdma@emory.edu|
20184818|NCT01550549|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20184819|NCT00590369|Cleveland Clinic|Nancy M. Albert PhD, RN|216-444-7028|albertn@ccf.org|
20184820|NCT03350542|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
20184821|NCT01251354|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20184822|NCT03546608|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20184823|NCT00130117|BIDMC|Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
20184824|NCT02460900|NIH|National Heart, Lung and Blood Institute--Josh Fessel|3018275514|josh.fessel@nih.gov|
20184825|NCT03422276|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
20184826|NCT05165485|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20184827|NCT04888637|University of Arkansas for Medical Sciences (UAMS)|University of Arkansas for Medical Sciences (UAMS)|501-526-6876|ORRAClinicalTrials-govadmin@uams.edu|
20184828|NCT04520061|Mass General Hospital|Lisa Morse|617-724-2000|lgmorse@partners.org|
20184829|NCT02279095|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20184830|NCT05938413|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
20184831|NCT04922021|LEO Pharma A/S|Disclosure Specialist|+4544945888|disclosure@leo-pharma.com|
20184832|NCT05686408|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20184833|NCT03133182|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20184834|NCT03314753|Medtronic|Study Project Manager (CSM)|00491742122|petra.kremer@medtronic.com|081
20184835|NCT01285999|Cardiovascular Institute and Fu Wai Hospital|Dr. Runlin Gao|+861068314466|gaorunlin@citmd.com|
20184836|NCT03237481|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20184837|NCT03481777|Aarhus University Hospital|Dr. Rolf Blauenfeldt|0045 78450000|rolfblau@rm.dk|
20184838|NCT03591770|Boston Medical Center|Sharmeel K. Wasan, MD|(617) 638-6116|sharmeel.wasan@bmc.org|
20184839|NCT04139668|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|33111
20184840|NCT03718065|Medical University of South Carolina|Dr. Constance Guille|843-792-6489|guille@musc.edu|
20225400|NCT02648477|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20184841|NCT04300647|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20184842|NCT04046848|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20184843|NCT05386238|Rush University Medical Center|Melissa Crane|312-563-0269|melissa_m_crane@rush.edu|
20184844|NCT04907474|Eyenovia, Inc.|Michael Rowe|833-393-6684|mmrowe@eyenovia.com|
20184845|NCT05055778|University of Virginia|Kara P. Wiseman, MPH, PhD|434-243-8126|kara.wiseman@virginia.edu|
20184846|NCT03190174|Sarcoma Oncology Research Center|Erlinda M. Gordon, MD/Principal Investigator|310-552-9999|egordon@sarcomaoncology.com|
20184847|NCT04714320|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20184848|NCT01353313|University of New Mexico Health Sciences|Kristi Watterberg|505-272-8609|kwatterberg@salud.unm.edu|
20184849|NCT04755660|National Taipei University of Nursing and Health Sciences|Dr. Tingru Lin|886-2-28227101|tingru@ntunhs.edu.tw|3150
20184850|NCT02879162|Canadian Cancer Trials Group|Dr. Janet Dancey|6135336000|jdancey@ctg.queensu.ca|75606
20184851|NCT02824029|Karmanos Cancer Institute|Dr. Dipenkumar Modi, MD|313-576-8782|modid@karmanos.org|
20184852|NCT03043599|H Lee Moffitt Cancer Center & Research Institute|Bradford Perez, MD|813-745-8234|Bradford.Perez@moffitt.org|
20184853|NCT01164098|University of Miami|George W. Burke, M.D.|3053555315|gburke@med.miami.edu|
20184854|NCT00610649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184855|NCT00332241|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@BMS.com|
20184856|NCT00802464|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184857|NCT03567252|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
20184858|NCT04512482|Indiana University School of Dentistry, Department of Orthodontics|Kelton T. Stewart, Department Chair|317-278-1087|keltstew@iu.edu|
20184859|NCT01939899|Millennium Pharmaceuticals, Inc.|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
20184860|NCT01537419|Center for Family Intervention Science, Drexel University|Guy Diamond, Ph.D.|215-571-3420|gd342@drexel.edu|
20184861|NCT02706717|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20184862|NCT03401190|CalciMedica, Inc.|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
20184863|NCT00106080|Department of Veterans Affairs, Health Services Research and Development|David H. Au, MD, MS|206-764-2430|david.au@va.gov|
20184864|NCT01414738|UT Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|ROBERT.TIMMERMAN@UTSouthwestern.edu|
20184865|NCT04204993|Imperial College London|Professor Chris Chiu|+44 (0)20 8383 2301|c.chiu@imperial.ac.uk|
20184866|NCT01266122|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|617-724-0817|ssafren@partners.org|
20184867|NCT00421889|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20184868|NCT00978042|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20184869|NCT00529516|GlaxoSmithKline|GSK Response Center|866-435-7343||
20184870|NCT03224390|Duke University|Dr. Eric Green|9196817289|eric.green@duke.edu|
20184871|NCT00703820|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
20184872|NCT02639910|MorphoSys AG|Peter Kelemen MD, PhD - Director, Clinical Program Leader|+498989927|peter.kelemen@morphosys.com|26856
20184873|NCT00761605|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2-2094-4804||
20184874|NCT00741455|Dartmouth-Hitchcock Medical Center|Darcie Findley|603-650-4595|darcie.l.findley@hitchcock.org|
20184875|NCT01319617|UCSD|Felipe Medeiros|858 82245-92|fmedeiros@glaucoma.ucsd.edu|
20184876|NCT03689920|Boston Scientific|Director of Clinical Sciences|661-949-4350|roshini.jain@bsci.com|
20184877|NCT01985334|Novartis Pharmaceuticals|Study Director|862-778-8300||
20184878|NCT00546754|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20184879|NCT00396084|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D.|(216) 368-1949|jlj@case.edu|
20184880|NCT04556981|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20184881|NCT05113771|Denovo Biopharma|Julie Doostzadeh, Executive Director|858-799-1021|jdoostzadeh@denovobiopharma.com|709
20184882|NCT02574455|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20184883|NCT02189915|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
20184884|NCT01763970|SKCCC at Johns Hopkins|Matthew Ladra,MD|(202) 537-4788|mladra@jhmi.edu|
20184885|NCT03631550|Neurolief Ltd.|Michal Kedar-Datel|+972-52-6659806|michal.kedar-datel@neurolief.com|
20184886|NCT03565315|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20184887|NCT01083316|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
20184888|NCT04515641|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184889|NCT01239316|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
20184890|NCT03276871|Cleveland Clinic|Aldo Fafaj|2162195943|fafaja@ccf.org|
20184891|NCT04578496|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
20184892|NCT01029587|Johns Hopkins University|Benjamin Philosophe|443-287-7178|bphilosophe@jhmi.edu|
20184893|NCT04585191|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|5108213969|Richard.W.Grant@kp.org|
20184894|NCT01701986|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, MD, PhD/ Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
20184895|NCT04917588|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
20184896|NCT02237417|Otsuka|Wilt, Timothy|240.683.3095|timothy.wilt@otsuka-us.com|
20184897|NCT04156581|Hospital for Special Surgery|Dr. Justas Lauzadis|212-774-2946|lauzadisj@hss.edu|
20184898|NCT03602612|National Cancer Institute|Dr. James Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
20184899|NCT05786391|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
20184900|NCT02476695|Wuxi HISKY Medical Technologies Co., Ltd.|Peng Lu|13816688340|yixuebu@fibrotouch.com|
20184901|NCT05057897|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20184902|NCT04524390|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
20184903|NCT04751526|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
20184904|NCT03088813|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
20184905|NCT03079024|University of Minnesota|Melissa Fisher|(612) 273-9812|mafisher@umn.edu|
20184906|NCT03613740|University of Guadalajara|PhD. Karina G. Pérez Rubio|+52 1 3310585200|karina.prubio@academicos.udg.mx|
20184907|NCT04279574|Solventum US LLC|Paula Myhre|6513842714|pemyhre1@solventum.com|
20184908|NCT03575052|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|58-261|medicalinformation@acadia-pharm.com|2897
20184909|NCT04188379|argenx BV|Regulatory Manager|+32 9 310 3400|regulatory@argenx.com|
20192265|NCT02210208|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
20192266|NCT01171183|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
20192267|NCT01101334|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20192268|NCT03440047|Mayo Clinic|Dr. Nayantara Coelho-Prabhu|(507)284-2407|CoelhoPrabhu.Nayantara@mayo.edu|
20207271|NCT02407236|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207272|NCT05849441|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
20207273|NCT00093756|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507/284- 9265|alex.adjei@roswellpark.org|
20207274|NCT01627782|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20207275|NCT00643448|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20207276|NCT02168660|UT Southwestern Medical Center|Dr Perrin C White, Professor of Pediatrics|2146486875|perrin.white@utsouthwestern.edu|
20207277|NCT02177812|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207278|NCT00089999|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207279|NCT03695471|Mayo Clinic|Jason Sluzevich|904-953-6402|Sluzevich.Jason@mayo.edu|
20207280|NCT02145754|University Medical center Ljubljana, Infectious Diseases Department|Daša Stupica|+386 1 522 21 10|dasa.stupica@kclj.si|
20207281|NCT00430027|University of Colorado, Denver|Dr. Tracey Schefter|720-848-0100|Tracey.Schefter@ucdenver.edu|
20207282|NCT00464620|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20207283|NCT01572844|GW Medical Faculty Associates|Alison Ehrlich, MD, Chair of Department of Dermatology|202-741-2625|aehrlich@mfa.gwu.edu|
20207284|NCT05724069|Alfasigma|Sara Manzoni|3473778218|sara.manzoni@alfasigma.com|
20207285|NCT01193049|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207286|NCT00864539|National Nutrition and Food Technology Research Institute|Dr. Tirang R. Neyestani|(+9821)22376471|neytr@yahoo.com|
20207287|NCT01847560|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225401|NCT05604794|University of Toronto|Dr Chris Lo|65 6709 3003|chris.lo@utoronto.ca|203
20225402|NCT00090584|New England Research Institutes|Anne Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
20225403|NCT02735096|Innervo Technology|Dr. Hui Tang|5732896776|htang@innervotech.com|
20225404|NCT00438802|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
20225405|NCT00497770|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20225406|NCT01080391|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20225407|NCT04493151|Center for Anti-Infective Research and Development, Hartford Hospital|Dr. Joseph L. Kuti, PharmD, FIDP, FCCP|(860) 972-3612|Joseph.Kuti@hhchealth.org|
20225408|NCT05749068|Silicon Valley Gastroenterolgy|Dr. George Triadafilopoulos|(650) 988-7530|info@siliconvalleygi.com|
20225409|NCT01938989|Alcon Research, Ltd.|Melvin Sarayba, Franchise Head Cataract, GMA|1-888-451-3937|alcon.medinfo@alcon.com|
20207288|NCT00592176|University of Alabama at Birmingham|Dr. Tyler Hall, M.D.|205-325-8310|tandrewhall@yahoo.com|
20225410|NCT02073656|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20225411|NCT01605032|Albert Einstein College of Medicine/Montefiore Medical Center|Ira Braunschweig, MD|718-920-4057|IBRAUNSC@montefiore.org|
20207289|NCT01680991|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20207290|NCT06073054|University of Iowa|Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
20207291|NCT00068822|Mayo Clinic|David F. Kallmes, M.D.|507-266-3350|kallmes.david@mayo.edu|
20207292|NCT00981292|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
20207293|NCT01408732|University of Minnesota|Holly Boyer, MD|612-725-2000|boyer011@umn.edu|
20207294|NCT03377452|VA Greater Los Angeles Healthcare System|Jennifer Martin, PhD|818-891-7711|jennifer.martin@va.gov|36080
20207295|NCT00424099|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD- Chair, Palliative Care Med|(713) 792-6084|ebruera@mdanderson.org|
20207296|NCT00764322|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20207297|NCT03345342|Janssen Research & Development, LLC|Compound Development Team Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207298|NCT03277105|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207299|NCT03321526|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207300|NCT01989572|ECOG Statistical Office|Study Statistician|617-632-3012||
20207301|NCT02280096|Instituto Mexicano del Seguro Social. Unidad de Investigación Médica en Enfermedades Neurológicas.|Dr. Israel Grijalva|(01152) 5555780240|igrijalvao@yahoo.com|
20207302|NCT00285649|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
20207303|NCT00693693|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
20207304|NCT02465489|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
20207305|NCT02972593|Indiana University School of Medicine Department of Orthopaedic Surgery|Dr. Brian H. Mullis|317-963-1966|bmullis@iupui.edu|
20207306|NCT00554853|UMichigan|PPAR-gamma agonist, rheumatoid arthritis and cardiovascular disease|734-936-7905|makaplan@umich.edu|
20207307|NCT02203916|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20207308|NCT03696576|Emory University|Sandeep Shelly|404-686-4206|SSHELLY@emory.edu|
20207309|NCT01137006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20207310|NCT00312728|Hoffman-LaRoche|Medical Communications|800-821-8590||
20207311|NCT01922986|University of Minnesota|James R. Carey|612-626-2746|carey007@umn.edu|
20207312|NCT00338806|NYSPInstitute|Dr. Helen Verdeli|212 543 5262|verdelih@nyspi.columbia.edu|
20207313|NCT00438490|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
20207314|NCT01819194|Vistakon|Daria Wicks|904-443-1391|RA-VISUS-ClnclStds@its.jnj.com|
20207315|NCT00045630|SWOG Statistical Center|Study Statistician|206-667-4623||
20207316|NCT04449276|CureVac AG|Clinical Trial Information|+49 6976805870|clinicaltrials@curevac.com|
20207317|NCT03054740|Aultman Health Foundation|Jane Sewell|330 363 0000|Jane.Sewell@aultman.com|3334
20207318|NCT00701103|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207319|NCT01378299|Michael E. DeBakey VA Medical Center|Reina Villareal, MD|713-794-7534|reina.villareal@va.gov|
20207320|NCT02046382|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
20207321|NCT00456885|BIDMC|Jody Dushay|6177353343|jdushay@bidmc.harvard.edu|617
20207322|NCT01448707|Janssen Research & Development, LLC|EMEA Medical Affairs Program Lead||ClinicalTrialDisclosure@its.jnj.com|
20207323|NCT04266158|The Ohio University|College of Medicine Office of Research Compliance Team|6145886811|comresearchcompliance@osumc.edu|
20207324|NCT03595449|Mayo Clinic|Shari A. Ochoa, M.D.|480-301-6479|Ochoa.Shari@mayo.edu|
20207325|NCT02820038|University of North Carolina at Chapel Hill|Susan J. Blalock, PhD|919-962-0080|s_blalock@unc.edu|
20207326|NCT03215667|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
20225412|NCT01969084|Beth Israel deaconess Medical Center|Aristidis Veves|617 632 7075||
20207327|NCT04319445|Wake Forest University Health Sciences|Rebecca E Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
20207328|NCT00441480|The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer|Prof. Dror Harats|972-3-5302940|dror@vbl.co.il|
20207329|NCT01922739|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20207330|NCT00422240|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20207331|NCT01927068|Spectranetics LLC, now part of Philips Image Guided Therapy|Associate Director, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
20207332|NCT04489940|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center,|+49 6151725200|service@emdgroup.com|
20207333|NCT01624467|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20207334|NCT02725268|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20207335|NCT04498468|Johns Hopkins Wilmer Eye Institute|Michael Lin, BA, Research coordinator|8653851192|mlin60@jhu.edu|
20207336|NCT01838304|University of Pennsylvania|Vice-Chair of Research|(215) 662-3766|roderic.eckenhoff@uphs.upenn.edu|
20207337|NCT02104141|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
20207338|NCT03674541|Brigham and Women's Hospital|Dr. David Systrom|6175431554|dsystrom@bwh.harvard.edu|
20207339|NCT00262314|EMD Serono, Inc.|Fernando Dangond, M.D., Medical Responsible|+1 781 681 2348||
20207340|NCT05104749|Sonoran University of Health Sciences|Elizabeth Rice Principal Investigator|4809700000|e.rice@sonoran.edu|
20207341|NCT03964493|TenNor Therapeutics Limited|Zhenkun Ma, PhD / CEO|+1(646) 775-1861|zhenkun.ma@tennorx.com|
20207342|NCT02963766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225413|NCT02054910|University of Alabama at Birmingham|Jaypal Ramesh|205-975-9564|jramesh@uab.edu|
20225414|NCT02920177|University of Michigan|Jordyn Sessel|734-615-0934|jsessel@med.umich.edu|
20207343|NCT01947647|Ralph H. Johnson VAMC|Daniel Gros, PHD|843-789-7311|daniel.gros@va.gov|
20225415|NCT04907227|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207344|NCT02224274|UMC Ljubljana|Marko Noc|+386 1 522 22 96|marko.noc@mf.uni-lj.si|
20207345|NCT00887068|UT MD Anderson Cancer Center|Dr. Richard E. Champlin, MD/ Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20207346|NCT00499460|Clinical Research Division, Fred Hutchinson Cancer Research Center|Danny D. Shen, Member (Retired)|206-685-2920|ds@uw.edu|
20207347|NCT00901394|University of Chicago|Principal Investigator|7737022544||
20207348|NCT02290340|MedImmune, LLC|M. Pamela Griffin|301-398-4095|information.center@astrazeneca.com|
20207349|NCT03209362|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|taku.hosaka@seikagaku.co.jp|
20207350|NCT03039569|University of Nebraska-Lincoln|Weiwen Chai|402-472-7822|wchai2@unl.edu|
20207351|NCT03991468|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
20207352|NCT00616772|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20207353|NCT03186261|Faculty of Dentistry, Cairo University|Ali Mostafa Shamaa|+201005276468|alishamaa@hotmail.com|
20207354|NCT02859558|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20207355|NCT01432756|Boston Children's Hospital|Laura Bogart|857-218-4073|laura.bogart@childrens.harvard.edu|
20207356|NCT01357720|Crucell Switzerland AG|Medical Affairs Director|+41(0)319086111|info@crucell.com|
20207357|NCT00365872|H. Lee Moffitt Cancer Center and Research Institute|Scott J. Antonia, M.D., Ph.D.|813-745-3883|scott.antonia@moffitt.org|
20207358|NCT00863434|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
20207359|NCT01116661|University of California San Francisco|Mitch Berger, MD; Director of Neurosurgery|415-353-7500|Mtich.Berger@ucsf.edu|
20225416|NCT03723070|Boston Scientific|Clinical Trial Manager|+32 470 991143|nele.cielen@bsci.com|
20225417|NCT03053427|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
20225418|NCT03816644|Albert Einstein College of Medicine|Dr. Joe Verghese|7184303808|joe.verghese@einsteinmed.edu|
20225419|NCT01801241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
20184910|NCT04928001|Montana State University|Dr. Katey T. Franklin|406-570-6056|katey.franklin@montana.edu|
20184911|NCT01693120|Medtronic AF Solutions|Bob Hokanson, Clinical Research Manager|763.526.2811|robert.hokanson@medtronic.com|
20184912|NCT01741363|Department of Internal Medicine, National Taiwan University Hospita|Han-Mo CHIU|+886-2-23123456|hanmochiu@ntu.edu.tw|63354
20184913|NCT03827304|Sheffield Hallam University|Ivan Phelan|+44 114 225 6955|i.phelan@shu.ac.uk|
20184914|NCT05406258|Shirley Ryan AbilityLab|Dr. Megan O'Brien, PhD|312-238-2289|mobrien02@sralab.org|
20184915|NCT02411084|ADIENNE S.A|Renata Palmieri|+41.91.210.47.22|renata.palmieri@adienne.com|
20184916|NCT03624972|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20184917|NCT03112174|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20184918|NCT02036424|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20184919|NCT04987021|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
20184920|NCT01534494|New York University Grossman School of Medicine|Michael Bogenschutz|5059999325|Michael.Bogenschutz@nyulangone.org|
20184921|NCT05137236|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20184922|NCT00924807|St. Luke's Roosevelt Hospital Center|Seth Cohen, MD|212-523-7289|secohen@chpnet.org|
20184923|NCT00825630|Sharon Hospital|Dr. Haim Shirin|0097239372231|haims3@clalit.org.il|
20184924|NCT02880137|Mayo Clinic|Dr. Jonathan Johnson|507-255-7013|johnson.jonathan@mayo.edu|
20184925|NCT03504423|Cornerstone Pharmaceuticals Inc.|Sanjeev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
20184926|NCT00431834|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
20184927|NCT02622568|University of Texas Southwestern|Dr. Nnenna Agim|2144561631|Nnenna.Agim@childrens.com|
20184928|NCT01643616|HELIOS-Kliniken Schwerin, Germany|Dr. Ronald Seidel|0049 385 5204251|ronald.seidel@helios-kliniken.de|
20184929|NCT00324350|University of California, San Francisco|Dr. Ann Schwartz|415-514-8000|aschwartz@psg.ucsf.edu|
20184930|NCT00439413|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20184931|NCT02647905|Senseonics|Vice President, Clinical Sciences|3015157260|katherine.tweden@senseonics.com|
20184932|NCT03285542|Cleveland Clinic|Viktor Krebs|216-445-3843|krebsv@ccf.org|
20184933|NCT05119855|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20184934|NCT04059042|University of Kansas Medical Center|Dr. Rebecca Lepping|913-588-0287|rlepping@kumc.edu|
20184935|NCT05848817|Mann Eye Institute|Phillip Brunson|1-713-580-2500|brunsonphillip@gmail.com|
20184936|NCT02597920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20184937|NCT00642850|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20184938|NCT02168400|University of Minnesota|Jazmin Camchong|(612) 625-3330|camch002@umn.edu|
20184939|NCT03733028|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
20184940|NCT00335036|Children's National|Charles Berul, MD|202-476-5710|cberul@childrensnational.org|
20184941|NCT05489484|Guna S.p.a.|Vincenzo Miranda (Clinical Research Manager); Kamilia Laarej (TSU&CRA)|02 280.18.(358)-(359)|v.miranda@guna.it; k.laarej@guna.it|
20184942|NCT03833661|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20184943|NCT03756571|Seattle Children's Research Institute|Kristie Bjornson, PT, PhD|206-884-2066|Kristie.bjornson@seattlechildrens.org|
20184944|NCT01625104|University of Michigan|Eva Kline-Rogers MS, RN|734 9985909|evakline@med.umich.edu|
20184945|NCT01290341|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
20225420|NCT03240406|Albert Einstein College of Medicine|Dr. Yasmin Mossavar-Rahmani|718-430-2136|yasmin.mossavar-rahmani@einsteinmed.edu|
20184946|NCT04247074|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
20184947|NCT01796236|Ear Nose Throat, University Medical Center Utrecht, Utrecht|Professor Robert Stokroos|0031 8875 56644|R.J.Stokroos@umcutrecht.nl|
20184948|NCT00785512|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
20225421|NCT00756600|Boston Children's Hospital Anesthesia Foundation|Dr Mary Ellen McCann|6173557737|mary.mccann@childrens.harvard.edu|
20184949|NCT00895531|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
20184950|NCT01195883|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|DS@OR.org|
20225422|NCT00703326|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225423|NCT03364036|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20225424|NCT01393106|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20225425|NCT03041467|Medtronic|Phally Roffe, Clinical Study Manager|763.526.0350|phally.s.roffe@medtronic.com|
20225426|NCT01238341|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20225427|NCT01084148|Orfagen|Clinical Project Manager|0033 5 34 50 64 62|caroline.miklaszewski@orfagen.com|
20225428|NCT02474355|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20225429|NCT02330172|Seoul national university Bundang Hospital|Eunsu Choi|821032990658|potterydoll@hanmail.net|
20225430|NCT00734656|University of Connecticut Health Center|Jonathan Covault|860-679-7560|jocovault@uchc.edu|
20225431|NCT02287688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20225432|NCT03214679|University School of Medicine, New York|Ben Eckhardt|212-562-1000|benjamin.eckhardt@nyumc.org|
20225433|NCT01601067|VA San Diego|Sonya Norman, PhD|858-552-8585|sonya.norman@va.gov|
20225434|NCT03083353|The University of Texas at Austin|Sara Reedy|512-232-4319|Sarah.Fella@austin.utexas.edu|
20225435|NCT02509078|Mass General Hospital (PETAL Clinical Coordinating Center)|Katie Oldmixon|617-726-4777|coldmixon@mgh.harvard.edu|
20225436|NCT02686814|Medtronic|Jessica Halverson, Clinical Research Director|(800) 633-8766|rs.perigonjapantrial@medtronic.com|
20225437|NCT01888653|Columbia University Medical Center/New York State Psychiatric Institute|Yuval Neria|6467748092|yuval.neria@nyspi.columbia.edu|
20184951|NCT02943590|MassGH|Tomas Neilan|617726200|tneilan@partners.org|
20225438|NCT01760447|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225439|NCT02030886|Yale School of Medicine|Dr James Liu|+1 203 785 2020|liu.ji@yale.edu|
20225440|NCT03341936|Dana Farber Cancer Institute|Glenn J. Hanna, MD|6176326799|GJHANNA@partners.org|
20225441|NCT02368886|Mayo Clinic Arizona|Tanios Bekaii-Saab, M.D.|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
20225442|NCT02485418|University of Texas Southwestern|Deryk Walsh, MD|2144566393|deryk.walsh@utsouthwestern.edu|
20225443|NCT00858468|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225444|NCT02131636|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20225445|NCT02173379|Abbott Vascular|Kelly A. Stockelman, PhD|720-951-8649|Kelly.Stockelman@abbott.com|
20184952|NCT05330234|Imperial College London|Mr Gianpaolo Fusari|--|g.fusari@imperial.ac.uk|
20184953|NCT00440011|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
20184954|NCT02808585|PhaseBio|Dr. John Lee, Chief Medical Officer|6109816500|john.lee@PhaseBio.com|
20184955|NCT01429350|Penumbra, Inc.|Michaella Corso|510-995-2079|mcorso@penumbrainc.com|
20184956|NCT03960463|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20184957|NCT05568615|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20184958|NCT05194917|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Dr. Adrienne Johnson|608-262-8673|aljohnson43@ctri.wisc.edu|
20184959|NCT03817684|Tetra Therapeutics|CEO|616-224-0084|info@tetratherapeutics.com|
20184960|NCT05505045|University of Missouri|Anna Boone, PhD|573-882-7023|booneae@umsystem.edu|
20184961|NCT05540535|New York University|Liraz Arie|3478661117|la1816@nyu.edu|
20184962|NCT03346538|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20184963|NCT05672667|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
20184964|NCT02217904|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20184965|NCT01903811|SWOG Statistical Center|S1304 Statistician|2066674623|rachaels@crab.org|
20184966|NCT04540913|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
20184967|NCT00444600|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
20184968|NCT05132478|UW School of Medicine and Public Health|Corrine Voils, PhD|(608) 262-9636|voils@surgery.wisc.edu|
20184969|NCT05608564|School Of Dental Medicine, University Of Belgrade, Department of Periodontology and Oral Medicine|Assistant Professor Dr. Iva Milinkovic|+381642041811|iva.milinkovic@gmail.com|
20184970|NCT02549170|Shire|Study Director|+18668425335|ClinicalTransparency@shire.com|
20184971|NCT03051165|Emory University|Raj Dedhia, MD, MS|(404) 778-3381|raj.dedhia@emory.edu|
20184972|NCT02561702|University of Rochester|David Herrmann|585-275-4568|david_herrmann@urmc.rochester.edu|
20184973|NCT00520546|German Federal Armed Forces Hospital, Ulm|Major Medical Corps Dr. Markus Hartenbach|0049 731 1710 1851|markushartenbach@bundeswehr.org|
20184974|NCT03076515|Theranica Bio-Electronics Ltd|Dagan Harris|+972723909755|daganh@theranica.com|
20184975|NCT00595790|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
20184976|NCT03988023|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20184977|NCT02101281|Dompé|Flavio Mantelli, MD, PhD|+39 513138|info@dompe.it|
20207360|NCT00777257|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225446|NCT00674479|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD/Professor|713-745-0394|fravandi@mdanderson.org|
20184978|NCT00174382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20184979|NCT00194714|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
20184980|NCT00529100|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20184981|NCT03733119|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
20184982|NCT02253537|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
20184983|NCT03231358|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
20184984|NCT03684044|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20184985|NCT03703336|POLYVAC|Nguyen Thuy Huong, Ph.D, Vice Director|+84 912514309|huong72us@yahoo.com|
20184986|NCT00595413|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20184987|NCT00807937|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20184988|NCT00533910|Hunter Holmes McGuire VAMC|Jasmohan Bajaj|804 675 5802|jasmohan@gmail.com|
20225447|NCT04997265|Vanderbilt University Medical Center|Whitney Gannon|6109095789|whitney.gannon@vumc.org|
20184989|NCT04629950|Department of Dermatology, Weill Cornell Medicine|Dr. Richard D. Granstein|(646) 962-7546|rdgranst@med.cornell.edu|
20184990|NCT03233633|Connecticut Hospice|Jim Prota, Director of Pharmacy|203-848-0660|jprota@hospice.com|
20184991|NCT02088853|Göteborgs University|Professor Lars Fandriks|+46313424123|lars.fandriks@gastro.gu.se|
20225448|NCT00631163|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20184992|NCT03337399|Massachusetts General Hospital/Harvard Medical School|Jennifer Temel|617-724-4000|jtemel@mgh.harvard.edu|
20184993|NCT00603954|CHU de Liège|Dr. Frédéric Baron|003243667201|f.baron@ulg.ac.be|
20184994|NCT02708108|Childrens Hospital Los Angeles|Dr Etan Orgel|13233612121|eorgel@chla.usc.edu|
20184995|NCT02568683|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20225449|NCT00004088|City of Hope|Brenda Williams, Senior Director, Clinical Trials Office|626-218-2702|bwilliams@coh.org|
20184996|NCT00891436|Rush University Medical College|James N. Moy, M.D.|312-942-6176|jmoy@rush.edu|
20184997|NCT02214550|NorthShore University HealthSystem|Dr. Frank Tu|8475702520|ftu@northshore.org|
20184998|NCT00580866|Vanderbilt|William Obremskey|6159363630|william.obremskey@Vanderbilt.Edu|
20184999|NCT00609336|University of Washington|Andrew Coveler, MD|206-288-7509|acoveler@uw.edu|
20225450|NCT04344535|Stony Brook University|Elliott Bennett-Guerrero|6314446026|elliott.bennett-guerrero@stonybrookmedicine.edu|
20185000|NCT02477605|Alcon, A Novartis Division|Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20185001|NCT01388361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20185002|NCT01061034|Assaf Harofeh medical center|Dr. Keren Doenyas-Barak|972-57-7346651|kerendoenyas@gmail.com|
20185003|NCT01061671|University of Minnesota|Sarah Lindberg|612-626-9011|sharnden@ccbr.umn.edu|
20185004|NCT00856739|Stanford University, Palo Alto Veterans Hospital|Dr. Thomas P. Andriacchi, Ph.D.|650-723-8024|tandriac@stanford.edu|
20225451|NCT00939471|Acclarent, Inc.|Laura England, Manager-Clinical|650-687-4466|lenglan1@its.jnj.com|
20192269|NCT01181609|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20225452|NCT02555930|Imperial College London|Dr Harriet Kemp|+44 20 3315 8816|h.kemp@imperial.ac.uk|
20192270|NCT01722045|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator||clinicaltrials@regeneron.com|
20192271|NCT00612352|Yale University|Ismene Petrakis||ismene.petrakis@yale.edu|
20225453|NCT01010399|Franco Felizarta, MD|Franco Felizarta, MD|661-324-3128|felizarta@pol.net|
20192272|NCT02161406|University of Michigan DCC (SABER)|Dr. Cathie Spino|734-615-5469|spino@umich.edu|
20192273|NCT01339299|Fertility Clinic Regional Hospital Skive|Prof, M.D. Peter Humaidan|+45 78445760|peter.humaidan@viborg.rm.dk|
20192274|NCT00263211|Department of Medicine Div. of Oncology, Washington University School of Medicine St. Louis MO|Katherine Weilbacher, M.D,|Fax: 314-454-8973|kweiblac@dom.wustl.edu|
20225454|NCT00419159|Novartis Pharmaceuticals|Study Director|862-778-8300||
20225455|NCT02117713|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20225456|NCT01094782|Massachusetts General Hospital|Dr. Lucy Chen|6177246102|mghpainresearch@partners.org|
20192275|NCT02034162|Janssen R&D US|DIRECTOR CLINICAL LEAD||ClinicalTrialDisclosure@its.jnj.com|
20192276|NCT00760513|University Hospital Southampton|Professor CD Byrne|02381205006|c.d.byrne@soton.ac.uk|
20192277|NCT03379545|NYU Langone Health|Joseph Zuckerman, MD|212-598-6674|Joseph.Zuckerman@nyulangone.org|
20192278|NCT00848510|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20192279|NCT04333147|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20225457|NCT00678470|University of California at San Francisco|John Koo MD|4154764701|john.koo@ucsfmedctr.org|
20225458|NCT00957905|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-422-4491|feldmand@mskcc.org|
20225459|NCT02083653|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
20225460|NCT04292639|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
20192280|NCT04606199|University of California San Francisco|Dr. Stefanie Mayer|7345450698|Stefanie.mayer@ucsf.edu|
20192281|NCT03596242|Wake Forest School of Medicine|Claudia L. Campos, MD|ccampos@wakehealth.edu|ccampos@wakehealth.edu|
20225461|NCT01987232|Amgen Inc.|Study Director|866-572-6436||
20225462|NCT02028169|AbbVie|Global Medical Services|800-633-9110||
20225463|NCT04164004|Stanford University|Alexander Sandhu|9097671214|ats114@stanford.edu|
20225464|NCT05822648|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
20192282|NCT00706914|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
20225465|NCT03564795|KeraNetics|Luke Burnett|336.725.0621|lburnett@keranetics.com|
20225466|NCT02770768|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
20185005|NCT00419341|CSL Behring|Clinical Trial Disclosure Manager|Use email contact.|clinicaltrials@cslbehring.com|
20185006|NCT00282971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20185007|NCT00513526|AMC|Group Statistician|501-526-6712|jylee@uams.edu|
20185008|NCT01925339|University of Michigan|Dr. Hom-Lay Wang|734-763-3383|homlay@umich.edu|
20185009|NCT01985542|Helsinki University Hospital|Dr. Sanna Salmi|+358505431421|sanna.salmi@helsinki.fi|
20185010|NCT04474314|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
20225467|NCT02208050|St. Vincent's University Hospital|Professor Christopher McGuigan|+35312214209|C.McGuigan@svhg.ie|
20185011|NCT06336629|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20185012|NCT04043455|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20185013|NCT01998984|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20185014|NCT03025789|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41795431713|ovalverde@dndi.org|
20185015|NCT04656925|Washington State University|Abigail Bowen|(425) 736-1354|abigail.bowen@wsu.edu|
20185016|NCT04440176|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185017|NCT01631214|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20185018|NCT05288283|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20225468|NCT00477607|VA RR&D National Center for Rehbilitative Auditory Research|Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
20185019|NCT04153565|Merck Sharp& Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20185020|NCT02991807|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
20225469|NCT00474786|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225470|NCT00432276|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20185021|NCT02300298|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185022|NCT03285763|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20225471|NCT00467961|NIH NHLBI|Minocher Battiwalla, MD|301-827-0939|minoo.battiwalla@mail.nih.gov|
20185023|NCT00402246|Medtronic, Inc|CONNECT Clinical Trial Specialist||medtronicCRMtrials@medtronic.com|
20185024|NCT04071756|Dana-Farber Cancer Institute|Nicole LeBoeuf, MD, MPH|617-632-6571|nicole_leboeuf@dfci.harvard.edu|
20185025|NCT03628885|Indiana University|Dr. Gregory Zimet|3172748812|gzimet@iu.edu|
20185026|NCT01808339|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185027|NCT00265200|James Graham Brown Cancer Center, University of Louisville|Goetz H Kloecker, MD|502-562-4358|ghkloe01@louisville.edu|
20185028|NCT02932579|University of Rochester Eastman Institute for Oral Health|Yanfang Ren, Professor|5852735588|yanfang_ren@urmc.rochester.edu|
20185029|NCT00111813|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20185030|NCT02283749|Brown University Oncology Research Group (BrUOG)|Kayla Rosati|14018633000|kayla_rosati@brown.edu|
20185031|NCT00818246|RoseLab Skin Optics Laboratory|Dr Daniel Barolet|(514) 343-4444|daniel.barolet@mcgill.ca|
20185032|NCT00574834|University of Maryland Baltimore|Stephen N. Davis, MBBS- Principal Investigator|410-328-2488|sdavis@medicine.umaryland.edu|
20185033|NCT02121002|Amneal Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amneal.com|
20185034|NCT01007396|Samsung Medical Center|Won-Jung Koh|82-2-3410-3429|wjkoh@skku.edu|
20225472|NCT02429310|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
20225473|NCT02678000|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20162868|NCT03422536|University of Arizona Cancer Center|Rachel Jarrett|5206260375|rjarrett@email.arizona.edu|
20225474|NCT02604173|Stanford University|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
20162869|NCT00532298|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185035|NCT00409838|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20185036|NCT04788641|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20185037|NCT01250769|Philips Healthcare, Office of Medical and Health Affairs|Director of Clinical Operations|425 908-1208|wendy.jenkins@philips.com|
20185038|NCT03283371|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20185039|NCT00243503|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185040|NCT00914589|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20185041|NCT01919450|Cardiovascular Imaging Technologies, LLC|Timothy M. Bateman, MD|816-531-2842|tbateman@cvit.com|
20185042|NCT00093015|Amgen Inc.|Study Director|866-572-6436||
20185043|NCT00296036|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
20185044|NCT03403413|Loui9s Stokes Cleveland VAMC|Dr. Stephen Selkirk|440-552-0493|stephen.selkirk@va.gov|
20185045|NCT03501264|University of Pittsburgh, Graduate School of Public Health|James Egan|412-624-2255|jee48@pitt.edu|
20185046|NCT03951805|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20185047|NCT01198145|Mayo Clinic|Robert C. Miller, M.D., M.S.||miller.robert@mayo.edu|
20185048|NCT03830866|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20185049|NCT03049969|NYU Langone Health|Leigh Charvet, MD|9294555141|Leigh.Charvet@nyulangone.org|
20185050|NCT00510887|Duke University Medical Center|Dr. David Rizzieri|919-668-1000|rizzi003@mc.duke.edu|
20192283|NCT00916305|London School of Hygiene & Tropical Medicine|Clare Gilbert|+44 207 958 8332|clare.gilbert@lshtm.ac.uk|
20192284|NCT04067843|University Hospital Zurich|Dr. Yvonne Achermann|+41442553402|yvonne.achermann@usz.ch|
20185051|NCT00194896|University of Washington|Jerry P. Palmer, MD|206-764-2495|jpp@u.washington.edu|
20185052|NCT00068601|SWOG Statistics and Data Management Center|Cancer Survivorship Committee Statistician|206-667-4623||
20185053|NCT02570022|Henry Ford Hospital|Dr. Kelechi Okoroha|8324239895|krokoroha@gmail.com|
20185054|NCT01877343|University of Florida|Dr. Curt DeGroff|352-273-7770|degroffc@peds.ufl.edu|
20185055|NCT01136486|North Shore LIJ|Dr. Rosemarie Basile|718 226-6501|rbasile1@siuh.edu|
20185056|NCT02692417|University of Michigan|Dr. Tim Bruns|(734) 647-8727|bruns@umich.edu|
20225475|NCT01324570|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stacy.baldridge@pharma.com|
20185057|NCT02409667|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20185058|NCT01205048|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20185059|NCT01255670|Helsinki University Central Hospital|Dr. Karin Blomgren|+358504271579|karin.blomgren@hus.fi|
20225476|NCT02360475|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185060|NCT03892564|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
20185061|NCT03664960|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20185062|NCT00903162|Dana-Farber Cancer Institute|Ann Partridge, MD, MPH|617.632.3800|ann_partridge@dfci.harvard.edu|
20185063|NCT02960204|Histogen Inc.|Mark Hubka, Executive Director, Medical Affairs|858-526-3109|mhubka@histogen.com|
20185064|NCT03087708|VA Long Beach Health Care System|Dr. Pankaj Gupta|562-826-8000|pankaj.gupta@va.gov|
20185065|NCT03997916|University Hospitals Cleveland Medical Center|Eric Yeh, MD|216-844-1867|eric.yeh@uhhospitals.org|
20185066|NCT01207492|Dana-Farber Cancer Institute|Andrew Wagner, MD, PhD|617.632.5204|andrew_wagner@dfci.harvard.edu|
20185067|NCT02769858|University of Michigan|Dr. Leslie Swanson|734-239-2248|LMSwan@med.umich.edu|
20225477|NCT00316862|Memorial Sloan-Kettering Cancer Center|David H. Ilson, M.D., Ph.D.||ilsond@mskcc.org|
20185068|NCT04242940|Oticon Medical|Manager of Clinical Affairs|609-366-0424|studyinfo@oticonmedical.com|
20185069|NCT01304277|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20185070|NCT03783026|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20185071|NCT04814186|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185072|NCT04919590|Truth Initiative|Dr. Amanda Graham|202-525-6473‬|vapestudy@truthinitiative.org|
20225478|NCT00207727|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
20225479|NCT03759366|Alexion Pharmaceuticals Inc.|Alexion Europe SAS European Clinical Trial Information|7 87148158|clinicaltrials.eu@alexion.com|
20225480|NCT05362695|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
20225481|NCT00539032|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225482|NCT04459598|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20225483|NCT00986947|Johns Hopkins University School of Medicine|Andrew Singer, MD|410-550-6484|registerclinicaltrials@jhmi.edu|
20225484|NCT01669785|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|260-755-1099||
20225485|NCT02978885|Columbia University|Gebhard Wagener, MD|212-305-6494|gw72@cumc.columbia.edu|
20185073|NCT01853748|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
20185074|NCT03342027|University of Chicago|Dr. Seth Himelhoch|773-834-4314|seth.himelhoch@bsd.uchicago.edu|
20185075|NCT01643070|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
20185076|NCT04941287|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20185077|NCT02980276|University of Galway|Professor Fidelma Dunne|+35391492117|fidelma.f.dunne@universityofgalway.ie|
20185078|NCT03657212|University of California, Irvine|Dr Sara Mednick|8589457904|mednicks@uci.edu|
20185079|NCT00003042|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20185080|NCT03990649|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20185081|NCT05773313|Mayo Clinic|Nathan Delafield, M.D.|480-574-1920|Delafield.Nathan@mayo.edu|
20185082|NCT03050814|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|julius.strauss@nih.gov|
20185083|NCT01443845|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20185084|NCT02014129|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20185085|NCT01471691|Thomas Hanscom AMC|Thomas O'Hearn MD|310-829-3303|tohearn@gmail.com|
20185086|NCT01854385|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
20185087|NCT01610297|Novartis|Study Director|862-778-8300||
20185088|NCT01929759|Boston Medical Center, Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
20185089|NCT01121991|EMD Serono Canada Inc., an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+1-888-737-6668|david.sciberras@emdserono.com|5248
20185090|NCT02590432|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20185091|NCT03399604|Liquidia Technologies|Chief Medical Offier|919-328-4400|safety@liquidia.com|
20185092|NCT01188369|Aarhus University Hospital|Dr. Peter Juhl-Olsen|+4578451199|peter.juhl-olsen@ki.au.dk|
20185093|NCT01828554|University of Madison Carbone Cancer Center|Kari B. Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
20185094|NCT05052996|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20185095|NCT02131597|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/ Professor|713-745-3428|ggarciam@mdanderson.org|
20185096|NCT05782231|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
20185097|NCT01561989|Roswell Park Cancer Institute|Dr. Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
20185098|NCT01736215|Janssen Cilag Thailand|Medical Affairs Director|+6627927232||
20185099|NCT03447249|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20202960|NCT00471380|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20202961|NCT02397655|Xuanwu hospital, Capital medical university|Dr. Yang Hua|86-10-83198923|dryanghua99@163.com|
20202962|NCT02747043|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20185100|NCT01248936|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20185101|NCT03485950|UT MD Anderson Cancer Center|Issam Raad,MD - Chair, Infectious Diseases|(713) 792-7943|iraad@mdanderson.org|
20185102|NCT00988858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225486|NCT00866333|Syndax Pharmaceuticals, Inc.|Michael L. Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
20185103|NCT00567489|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20185104|NCT00593866|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
20225487|NCT02669082|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20185105|NCT03359889|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185106|NCT03799783|University Hospital Padova|Angela Amigoni, MD|339 8333765|Angela.amigoni@aopd.veneto.it|++39
20225488|NCT04918355|University of Colorado|Heather Tolle|303-724-9924|heather.tolle@cuanschutz.edu|
20185107|NCT02020252|University of Chicago Medicine|Toni M Cipriano|574-339-0652|tcipriano@uchicago.edu|
20225489|NCT04852276|National Institute of Allergy and Infectious Diseases (NIAID)|Emily Ricotta, PhD|240-550-3474|emily.ricotta@nih.gov|
20185108|NCT02793154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20185109|NCT04732338|Hackensack Meridian Health|Alphonsa Thomas, DO|7328364504|Alphonsa.Thomas@hmhn.org|
20185110|NCT04426500|Icahn School of Medicine at Mount Sinai|Dr. Reza Mehrazin|(212) 241-4812|reza.mehrazin@mountsinai.org|
20185111|NCT02372253|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Anath Shalev, MD|205-996-4777|shalev@uab.edu|
20185112|NCT01803555|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20185113|NCT00629850|Texas State Respiratory Care Department|Chris Russian, Associate Professor|512-245-3794|cr23@txstate.edu|
20185114|NCT01923480|Baxter Healthcare|Aparna Valluru, Clinical Project Manager|224.270.6063|Aparna_Valluru@baxter.com|
20185115|NCT01551355|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster|212-241-3852|valentin.fuster@mssm.edu|
20225490|NCT03850691|Masonic Cancer Center, University of Minnesota|Evidio Domingo-Musibay, MD|612-625-9604|musib024@umn.edu|
20225491|NCT02732015|UT MD Anderson Cancer Center|Saroj Vadhan,MD-Clinical Professor, Cytokine & Supportive Oncology|713-792-7966|svadhanr@mdanderson.org|
20225492|NCT05437640|University of Alabama at Birmingham|Dr. Christine Ferguson|205-934-7773|cfergus2@uab.edu|
20225493|NCT05206734|Royal Hospital for Children and Young People, Edinburgh|Richard K Russell|0131 312 0431|richard.russell@nhs.scot|
20225494|NCT04228965|Medical University of South Carolina|Erin A. McClure, Principal Investigator|843-792-7192|mccluree@musc.edu|
20225495|NCT03015194|National Heart Lung and Blood Institute (NHLBI)|Robert Lederman, M.D. Principal Investigator, NIH, NHLBI|301.402.6769|ledermar@nhlbi.nih.gov|
20225496|NCT02707172|Kaohsiung Medical University|Dr. Ming-Tsang Wu|+886-7-3121101|e_encourage@yahoo.com|2315
20225497|NCT05251064|University of Virginia|Dr. Mark Miller|(434) 243-7778|mdm3p@uvahealth.org|
20225498|NCT01754766|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20225499|NCT00433017|Novartis Pharmaceuticals|Study Director|862 778-8300||
20225500|NCT01306214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225501|NCT01937884|University of Arizona|Dr. Katri Typpo|5206265485|ktyppo@email.arizona.edu|
20225502|NCT00894244|Northwestern University|Dr. Murad Alam|(312) 695-6785|m-alam@northwestern.edu|
20225503|NCT02826577|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
20225504|NCT03924505|RTI International|Dr. Barrot H Lambdin|628-200-6707|blambdin@rti.org|
20225505|NCT03003000|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225506|NCT02447575|Baylor College of Medicine|Dr. Nicola Hanania|(713) 873-3454|hanania@bcm.edu|
20225507|NCT04933617|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
20225508|NCT03743402|University of Washington|Dr. Mark Sullivan|2066853184|sullimar@uw.edu|
20225509|NCT02191046|Thammasat university|Dr.Araya Satdhabudha|0813414900|araya221@gmail.com|662
20225510|NCT02147067|Emory University|Habib Samady, MD|(404) 778-1237|hsamady@emory.edu|
20225511|NCT02572856|University of Washington Medical Center|David Flum, MD|206 616-5440|daveflum@uw.edu|
20225512|NCT00428922|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-0066|Bhuvaneswari.Ramaswamy@osumc.edu|
20225513|NCT02536781|Khon Kaen University|Faculty of Pharmaceutical Science|+66-43-362092|lsucharat@gmail.com|
20225514|NCT03423147|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
20225515|NCT00508157|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20225516|NCT02910726|Memorial Sloan Kettering Cancer Center|Neeta Pandit-Taskar, MD|1-833-MSK-KIDS|pandit-n@mskcc.org|
20225517|NCT01952080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20225518|NCT02258334|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225519|NCT00862459|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20225520|NCT00770133|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20185116|NCT01094184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20185117|NCT04766034|NYU Langone Health|Pasquale Rummo, MPH, PhD|914-316-5907|Pasquale.rummo@nyulangone.org|
20185118|NCT00823472|UMC Utrecht|Prof. dr. B.C.J.M. Fauser|+31-88-7557524|b.c.fauser@umcutrecht.nl|
20185119|NCT04019444|The Hope Clinic of the Emory Vaccine Center|Varun K. Phadke, MD|404-712-9046|vphadke@emory.edu|
20185120|NCT01996605|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
20185121|NCT04220229|City of Hope|Lee Cranmer, MD, PhD|626-256-4673|lcranmer@coh.org|
20225521|NCT00564395|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20162870|NCT00479856|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225522|NCT00687882|Johns Hopkins All Children's Hospital|Dr. Neil A Goldenberg, Associate Dean of Research|727-767-3674|neil@jhmi.edu|
20225523|NCT01236326|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-0727|mea9008@med.cornell.edu|
20207361|NCT00638651|University of Miami|Dr. Keyvan Nouri|305-243-3380|knouri@med.miami.edu|
20225524|NCT01625689|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
20225525|NCT00889187|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon, MD, PhD|617-732-8564|HMAMON@LROC.HARVARD.EDU|
20225526|NCT03092934|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20207362|NCT02996305|Ovid Therapeutics|Adera Matthews, MD|570 620 6290|madera@ovidrx.com|
20225527|NCT01782352|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
20225528|NCT01333956|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
20225529|NCT02134353|Pharmaxis|Dr Brett Charlton|+61 2 9454 7200|Brett.Charlton@pharmaxis.com.au|210
20225530|NCT01732471|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20207363|NCT02973997|University of Colorado, School of Medicine|Bryan Haugen, M.D.|507-266-0800|bryan.haugen@ucdenver.edu|
20225531|NCT01953432|Michael E. DeBakey VA Medical Center|Daryl Shorter, MD|713-798-4870|shorter@bcm.edu|
20207364|NCT01431521|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207365|NCT00444951|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225532|NCT03426436|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
20225533|NCT02892513|Medical College of Wisconsin|Carrie Y. Peterson, MD, MS|414-955-5783|cypeterson@mcw.edu|
20225534|NCT00655681|University of New Mexico Carrie Tingley Hospital|Elizabeth A. Szalay MD|505 272-5214|eszalay@salud.unm.edu|
20225535|NCT05011890|University of North Carolina Lineberger Comprehensive Cancer Center|Gita Mody|+1 919-966-3382|gita_mody@med.unc.edu|
20225536|NCT04776018|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20225537|NCT00326170|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
20225538|NCT00093847|Massachusetts General Hospital|Dr George Papakostas, M.D.|6177266697|gpapakstas@partners.org|
20225539|NCT00394433|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
20185122|NCT04992390|P1vital Products Ltd|Dr Amy Beckenstrom|+44(0)1865 522 030|abeckenstrom@p1vital.com|
20185123|NCT01827787|Dana-Farber Cancer Institute|Dr. Erica Mayer|617-632-2335|Erica_Mayer@dfci.harvard.edu|
20225540|NCT00594386|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20225541|NCT03417024|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
20225542|NCT03168919|St. Jude Children's Reaserch Hospital|Asim K. Bag, MD Bag|9015953347|asim.bag@stjude.org|
20225543|NCT01085136|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225544|NCT02195427|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
20225545|NCT01210144|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20225546|NCT03260426|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
20225547|NCT00083720|ImClone, LLC|Chief Medical Officer||ClinicalTrials@imclone.com|
20225548|NCT00386425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225549|NCT04226495|University of Nebraska Medical Center|Jeffrey Songster|308-520-2847|jeffrey.songster@unmc.edu|
20225550|NCT00435019|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20225551|NCT03557684|UCLA|Joshua H. Cho, MD, PhD|3104286218|hjcho@mednet.ucla.edu|
20225552|NCT00505661|UT MD Anderson Cancer Center|John Kavanagh, MD / Professor|713-792-2933||
20225553|NCT01093651|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
20225554|NCT03611582|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20225555|NCT01783821|Mayo Clinic|Dr. Emir Festic|904-953-9758|Festic.Emir@mayo.edu|
20225556|NCT01907217|St Patrick's University Hospital|Prof Declan McLoughlin|+353 1 2493343|d.mcloughlin@tcd.ie|
20225557|NCT01764659|UMMC MSGCC|Howard Zhang, PhD|(410)706-6510|hzhang@umm.edu|
20225558|NCT01210352|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
20225559|NCT00422292|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225560|NCT02440854|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225561|NCT03338569|University of Minnesota|Ronald Reilkoff, MD|612-624-0999|rreilkof@umn.edu|
20225562|NCT02243046|Global Research Consultants|Dr. Franklin Garcia-Godoy|954-888-9102|fgarciagodoy@gmail.com|
20225563|NCT04607980|Amgen Inc.|Study Director|8665726436|medinfo@amgen.com|
20225564|NCT01854879|Cochlear Americas|Lori O'Neill Director of Research|(303) 790-9010|loneill@cochlear.com|
20225565|NCT02012959|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20225566|NCT04542278|University of Wisconsin - Madison School of Medicine and Public Health|Dawn Elfenbein, MD, MPH, FACS|(608) 263-1387|elfenbein@surgery.wisc.edu|
20225567|NCT01859949|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225568|NCT01344759|Cincinnati Children's Hosptial Medical Center|Dr. Mohamed Mahmoud|513-636-4408|Mohamed.Mahmoud@cchmc.org|
20225569|NCT01890759|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225570|NCT01080976|BIDMC|Charles Safran|617-278-8170|csafran@bidmc.harvard.edu|
20225571|NCT00810498|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
20225572|NCT04494425|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20185124|NCT03807778|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20225573|NCT01270321|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
20225574|NCT03151083|VA Connecticut Healthcare System|Dr. Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
20225575|NCT04003623|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20207366|NCT03637959|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
20225576|NCT02918097|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|5551999185180|afbslima@gmail.com.br|
20225577|NCT04640038|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
20225578|NCT02242019|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20225579|NCT04316260|Medical University of South Carolina|Noelle Natale|843-876-2426|natalen@musc.edu|
20207367|NCT00366444|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
20207368|NCT04984876|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20225580|NCT01744483|Oregon Health Science & Science University|Dr Miriam Treggiari|(503) 494-8311|treggiar@ohsu.edu|
20225581|NCT01190189|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20225582|NCT03915626|University of Maryland, Baltimore School of Pharmacy|Dr. Audra L. Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20225583|NCT05025332|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
20225584|NCT01026818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225585|NCT04575584|Merck Sharp & Dohme, LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225586|NCT02634801|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225587|NCT00940576|University of Jena, Institute of Nutrition, Department of Nutritional Physiology Jena, Thuringia, Germany|Gerhard Jahreis, Prof. Dr.|+(49)3641/949610|gerhard.jahreis@uni-jena.de|
20225588|NCT02335346|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225589|NCT01548768|Columbia University Irving Medical Center|Dr. Joan Bathon, MD|212-305-6327|jmb2311@cumc.columbia.edu|
20225590|NCT02907619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207369|NCT02204410|Massachusetts General Hospital|Dr. Timothy Wilens|(617)643-3481|twilens@mgh.harvard.edu|
20225591|NCT03326518|Lument AB|Dr Thomas Fork|+46 705336996|thomas.fork@lumentab.com|
20225592|NCT01375374|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20207370|NCT04829734|Multi Radiance Medical|Douglas Johnson, ATC, EES, CLS - Chief Science Officer, Clinical and Scientific Affairs|440-542-0761|info@multiradiance.com|
20207371|NCT02000622|AstraZeneca|Medical Science Director|1-877-240-9479|clinicaltrialtransparency@astrazeneca.com|
20207372|NCT01405027|Chronic Liver Disease Foundation|Dr. Fred Poordad|732-381-8887|poordad@txliver.com|
20225593|NCT01908582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225594|NCT01829997|RTI Surgical|Kristina Shine|386-418-8888|kshine@rtix.com|4404
20207373|NCT01462045|University of New Mexico|Sang Hwan Kim, PhD/Lead Investigator|5057954545|sanghk@gmail.com|
20225595|NCT02065518|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
20225596|NCT03108066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20207374|NCT05085327|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20225597|NCT00564278|Columbia Univ Med Center and New York State Psychiatric Institute|Roberto Lewis-Fernandez, MD, Professor of Psychiatry CUMC - NYSPI|646-774-8102|rlewis@nyspi.columbia.edu|
20225598|NCT00560703|Organization: Galderma R&D, Inc|Michael Graeber|609-409-7701|clinicaltrials@galderma.com|
20225599|NCT06439095|Van Yuzuncu Yil University Faculty of Dentistry|Dr. Burçin Avcı, Assistant Professor|+90 5359558140|burcinavci@yyu.edu.tr|
20207375|NCT02462122|Bausch Health|Study Director||anyaloncaric@bauschhealth.com|
20225600|NCT02339974|Henry Ford Health|Dr. Brian O'Neill|313-970-6483|boneil3@hfhs.org|
20225601|NCT03484403|Dallas VA Medical Center|Dr Thiru Annaswamy|214-857-0273|thiru.annaswamy@va.gov|
20225602|NCT04278924|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20225603|NCT04847232|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20225604|NCT03798327|Icahn School of Medicine at Mount Sinai|Dr. Nathan Goldstein|212-844-1712|Nathan.goldstein@mssm.edu|
20225605|NCT02476916|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
20225606|NCT05600036|Alumis Inc.|SVP, Development Operations|(650) 231-6625|clinicaltrials@alumis.com|
20225607|NCT00715520|Emory University|Dr. Cathrin Buetefisch|4047121894|cathrin.buetefisch@emory.edu|
20225608|NCT02570750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225609|NCT04122625|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20225610|NCT02697591|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20225611|NCT01939223|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
20185125|NCT05094141|UT Southwestern Medical Center|Dr. Sarah Rebstock|214-456-8106|sarah.rebstock@utsouthwestern.edu|
20207376|NCT04403802|Cedars-Sinai Medical Center|Dr. Arash Asher|310-423-1218|arash.asher@cshs.org|
20225612|NCT01294748|Micell Technologies|Jeffrey Mifek, VP Clinical Affairs|919-313-2102|jmifek@micell.com|
20185126|NCT04708509|The Ottawa Hospital|Dr. Andrew Seely|613-737-8899|aseely@toh.ca|74052
20225613|NCT01853696|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
20225614|NCT02867202|the 1st affiliated hospital of Wenzhou Medical University.|the 1st affiliated hospital of Wenzhou Medical University.|0886-0577-88069525|zfy983023@hotmail.com|
20185127|NCT04870645|M D Anderson Cancer Center|Jason Johnson, MD|713-792-8443|jasonjohnson@mdanderson.org|
20185128|NCT04192747|Elixir Medical Corporation|Tina Cordaro, Sr. Director, Clinical Trials|585-360-7270|tcordaro@ElixirMedical.com|
20207377|NCT01938391|NYU Langone Medical Center|Anvar Babaev, MD, PHD, FACC, FSCAI|212-263-5656|anvar.babaev@nyumc.org|
20207378|NCT05241470|Stuart Therapeutics|Brian Del Buono, Executive Vice President|7034025866|brian@stuarttherapeutics.com|
20207379|NCT02334813|University Hospital Essen, Germany|Prof. Dr. Ulrich Dührsen|+49 201 723|ulrich.duehrsen@uk-essen.de|2417
20207380|NCT01077193|Ethicon-Endo Surgery, Inc.|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
20207381|NCT00911326|Navidea Biopharmaceuticals|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
20207382|NCT04283773|Assiut Univercity|Demonstrator at pathology department|00201033986747|omar011523@med.au.edu.eg|
20207383|NCT06048809|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20225615|NCT00438256|Massachusetts General Hospital|Theodore Hong, MD|617-724-1159|TSHONG1@mgh.harvard.edu|
20225616|NCT01656187|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
20225617|NCT02798120|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
20225618|NCT03292471|VA Pittsburgh/California State University, East Bay|Dr. Michelle Gravier|510 885-3215|michelle.gravier@csueastbay.edu|
20225619|NCT03611101|Exalenz Bioscience|Clinical Trial Manager|+972-8-9737513|avrahamh@exalenz.com|
20225620|NCT03838510|San Francisco Department of Public Health, University fo California San Francisco|Phillip Coffin, MD, MIA|628-217-6282|phillip.coffin@sfdph.org|
20207384|NCT02784496|The University of MD Anderson Cancer Center|Prithviraj Bose, MD/Professor|713-792-7747|PBose@mdnaderson.org|
20225621|NCT00466206|UCSF-Benioff Children's Hospital|Michael Harrison, MD|415 476-2538|pedsurg@ucsfmedctr.org|
20225622|NCT01964716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225623|NCT02540161|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
20225624|NCT03913104|University of California, San Francisco|Natalie Morris|(415) 353-4724|natalie.morris@ucsf.edu|
20225625|NCT01370616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225626|NCT00462449|Department of Physical Medicine and Rehabilitation University of Pittsburgh|Dr. Michael C. Munin|412-648-6848|muninm@upmc.edu|
20225627|NCT01693185|Konkuk University Medical Center|Dr. Tae-Yop Kim, Professor of Anesthesiology|82-2-2030-5445|taeyop@gmail.com|
20225628|NCT03292614|Dietrich-Bonhoeffer-Klinikum|Ulrike Holland|+49 395 775 3427|aug-st2@dbknb.de|
20225629|NCT03780972|ONL Therapeutics|Director of Clinical Operations|(734) 412-8787|info@onltherapeutics.com|
20225630|NCT01712308|The University of Texas MD Anderson Cancer|Prithviraj Bose MD/Associate Professor|713-792-7747|PBose@mdanderson.org|
20225631|NCT03725033|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20225632|NCT03742258|Northwestern University|Dr. Reem Karmali, MD|(312) 695-0711|reem.karmali@northwestern.edu|
20225633|NCT02503254|Philip Morris Products S.A.|Cam Tuan Tran|+41 (58) 242 2620|CamTuan.Tran@pmi.com|
20225634|NCT02638051|Clifford Hospital|Prof. Clifford LK Pang, President of Clifford Hospital|(8620) 34710038|cpang@cliffordgroup.com|
20225635|NCT01380691|Eli Lilly Company|Chief Medical Officer|800-545-5979||
20225636|NCT01048099|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20225637|NCT01731470|Beaumont Hospital, Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.edu|
20225638|NCT00358956|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20225639|NCT03678675|Tufts Medical Center|Jean Hostage|617-636-4549|jeanhostage@gmail.com|
20225640|NCT04392219|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
20162871|NCT01578577|Northwestern University|Dr. Stephen Persell|312-503-6464|spersell@nm.org|
20225641|NCT03300050|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
20225642|NCT03594955|Sanofi-Aventis Research & Development|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20225643|NCT01110967|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
20225644|NCT01066663|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|l 617-632-4894|Jennifer_Brown@dfci.harvard.edu|
20225645|NCT01090050|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
20225646|NCT03539484|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20225647|NCT02232061|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20225648|NCT00571103|University of Iowa Carver College of Medicine|Dr. Donald W Black|319-3534431|donald-black@uiowa.edu|
20225649|NCT03735407|CheckCap|Clinical Director|972-4-8303401|daniella.bleistein@check-cap.com|
20225650|NCT04400656|Imperial College London|Ms Puja Jadav|0203 311 5473|p.jadav@imperial.ac.uk|
20225651|NCT06010732|Indiana University School of Dentistry|Domenick T. Zero|3179877507|dzero@iu.edu|
20225652|NCT04401202|King Abdulaziz University|Dr. Abdulrahman Koshak|0543292333|aekoshak@kau.edu.sa|
20225653|NCT03491397|University of California Los Angeles|Siddharth A. Padia, MD|310-825-2992|SPadia@mednet.ucla.edu|
20225654|NCT02714036|MEDICINOVA, INC|Director, Research and Development|858-373-1500|clinicaltrialinfo@medicinova.com|
20225655|NCT03141034|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
20225656|NCT01006590|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20225657|NCT03332095|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20225658|NCT00178646|UTHealth|Gerard E. Francisco|7137975246|Gerard.E.Francisco@uth.tmc.edu|
20225659|NCT04942210|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20225660|NCT03688802|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20225661|NCT05697627|University of Michigan|Hannah Becker|(734) 764-2580|hcbecker@umich.edu|
20225662|NCT01410240|Baxter BioScience|Maurice Bagot D'Arc, MD, Sr Medical Director Medical Affairs , BioSurgery||maurice_bagot_d'arc@baxter.com|
20225663|NCT04348500|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
20225664|NCT02776670|Alcon, A Novartis Division|Head, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20207385|NCT04960202|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225665|NCT03699540|University of Kentucky|Shanna Babalonis, Ph.D.|859-257-1881|babalonis@uky.edu|
20225666|NCT02066727|Tianjin Medical University General Hospital|Dr Yuechun LU|15902233666|luyuechun@sina.com|
20225667|NCT05460078|Atrium Health|Dr. Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
20225668|NCT02722746|University of Florida, College of Medicine|Dr. Terrie Vasilopoulos|3522738910|tvasilopoulos@anest.ufl.edu|
20225669|NCT00895934|Fred Hutchinson Cancer Research Center|Roland B. Walter, MD, PhD|206-667-3599|rwalter@fhcrc.org|
20225670|NCT02636699|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
20225671|NCT00624832|Novartis Pharmaceuticals|Study Director|862-778-8300||
20225672|NCT04379700|NYU Langone Health|Bedros Taslakian, MD|212-263-5898|bedros.taslakian@nyulangone.org|
20207386|NCT02158728|Medtronic|Clinical Research Specialist L. Vainer|+31 43 3566752|lidwien.vainer@medtronic.com|
20225673|NCT04595279|Johns Hopkins University|Matthew Johnson|410-550-0056|mwj@jhu.edu|
20225674|NCT03624569|The Ohio State University|Richard Bruno, Principal Investigator|6142925522|bruno.27@osu.edu|
20225675|NCT00957424|Roswell Park Cancer Institute|Richard O'Connor|716-845-4517|richard.oconnor@roswellpark.org|
20225676|NCT01038752|Optimum Therapeutics|Dr. M. Guillaume Wientjes||gwientjes@optimumtx.com|
20225677|NCT02053259|Arizona State University|Dr. Marc Adams|602-827-2470|marc.adams@asu.edu|
20225678|NCT02343380|University of Turin|Dr Simona Bo|0039116335543|simona.bo@unito.it|5541
20225679|NCT02700698|University of Arkansas for Medical Sciences; Arkansas Children's Research Institute|Elisabet Borsheim, PhD|501-364-3053|EBorsheim@uams.edu|
20225680|NCT00703118|Tibotec|Medical Leader|1 609 730-3174||
20225681|NCT04165135|Hoffmann-La Roche|Medical Communications|800 821 8590|genentech@druginfo.com|
20225682|NCT00530790|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225683|NCT03714776|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
20225684|NCT00423358|University of Wisconsin|Karen E Hansen, MD, MS|608-263-3457|keh@medicine.wisc.edu|
20225685|NCT00915603|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20225686|NCT05053035|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
20225687|NCT03319810|Sutter Institute for Medical Research|Carol Parise, PhD, Research Scientist|(916) 887-4744|PariseC@sutterhealth.org|
20225688|NCT01618916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225689|NCT03004924|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20225690|NCT02005627|Imperial College London|Stephen R Durham|+44207-351-8024|s.durham@imperial.ac.uk|
20225691|NCT04000360|The Cleveland Clinic Foundation|Dr. Jay L. Alberts|440-708-3735|albertj@ccf.org|
20225692|NCT02865811|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
20225693|NCT03014622|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
20225694|NCT01119846|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225695|NCT01243294|Coloplast A/S|Pia Nordmand, Clinical Trial Manager|+4549113250|dkpialn@coloplast.com|
20225696|NCT00048997|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20225697|NCT03763058|Centre d'Evaluation et Traitement de la Douleur|Dr Guilhem Parlongue|00262262912037|guilhem_parlongue@hotmail.com|
20225698|NCT00048165|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20225699|NCT00212264|University of Alabama at Birmingham|Patricia S Goode, MD|2055587064|pgoode@uabmc.edu|
20225700|NCT02051335|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20225701|NCT01084538|Abbott|Global Medical Services|1-800-633-9110||
20225702|NCT00803205|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20225703|NCT03973697|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20225704|NCT01490697|Massachusetts General Hospital|Roger K. Pitman, MD|617-726-5333|roger_pitman@hms.harvard.edu|
20225705|NCT00379808|University of Florida|Dr Julie Johnson, PI|352-273-6007|johnson@cop.ufl.edu|
20225706|NCT03409120|University of Alabama at Birmingham|Christopher Gonzalez|2059753732|clg17@uab.edu|
20225707|NCT04779606|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20225708|NCT02442206|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20225709|NCT01225926|Alcon Research, Ltd.|Manoj Venkiteshwar, Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20225710|NCT03972501|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
20225711|NCT01741350|University of Connecticut|Dr. Michael M. Copenhaver, Ph.D.|860 208-3632|michael.copenhaver@uconn.edu|
20225712|NCT01709409|OHRI|Dr. Brigitte Lemyre|613-737-8899|blemyre@toh.on.ca|71882
20192285|NCT01475461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192286|NCT04184349|The University of Texas Health Science Center at Houston|Olga Pewelek, MD|713-500-6227|Olga.I.Lyuksyutova@uth.tmc.edu|
20192287|NCT01980524|Medical University of Vienna|Dr. Peter Wolf|004314040043110|peter.wolf@meduniwien.ac.at|
20192288|NCT01880697|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20192289|NCT04035577|Northwestern University|Dr. Emily Lattie|3125033741|emily.lattie@northwestern.edu|
20192290|NCT02591862|Akari Therapeutics plc|Chief Scientific Officer|02080040261|miles.nunn@akaritx.com|
20192291|NCT00505414|Grünenthal GmbH|Director of Clinical Trials|+49 (0)241 569 3223|Clinical-Trials@grunenthal.com|
20192292|NCT00846768|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225713|NCT02412878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20225714|NCT02190721|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|USMedInfo@tevapharm.com|
20225715|NCT04571385|Acesion Pharma|Birgitte Vestbjerg|+45 20772575|bve@acesionpharma.com|
20225716|NCT04046263|"University of Colorado Denver | Anschutz"|Jessica Kendrick, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20225717|NCT01212159|Temple University School of Medicine|Alfred A. Bove|215-707-9259|alfred.bove@tuhs.temple.edu|
20225718|NCT04676152|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20225719|NCT01928199|Washington University in St. Louis|Rowena Delos Santos|314-362-8351|delossantos@wustl.edu|
20225720|NCT00755261|SKCCC, Johns Hopkins University|Christian Meyer, M.D., Ph.D.|4105025940|cmeyer13@jhmi.edu|
20225721|NCT02081014|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP Drug Development|512-498-2675|mjcummins@xerispharma.com|
20225722|NCT00591019|University of Arkansas for Medical Sciences (UAMS)|Dr John Dornhoffer|501 686-5140|dornhofferjohnl@uams.edu|
20225723|NCT00004500|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
20225724|NCT03517449|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20225725|NCT05835063|University of Michigan|Melissa Cousino|(734) 936-4220|melcousi@med.umich.edu|
20225726|NCT01918072|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Donna L. Washington, MD, MPH|310-478-3711|donna.washington@va.gov|49479
20225727|NCT02893423|Maimonides Medical Center|Kalpana Tyagaraj|718-283-1753|KTyagaraj@maimonidesmed.org|
20225728|NCT04677387|University of North Carollina at Chapel Hill|Delesha Carpenter, PhD, MSPH|828-250-3916|dmcarpenter@unc.edu|
20225729|NCT00269477|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20225730|NCT00431067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225731|NCT00938587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225732|NCT00548249|Rockwell Medical|Richard C. Yocum, MD|858-229-8585|ryocum@rockwellmed.com|
20192293|NCT04353817|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20192294|NCT04358068|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20192295|NCT00338949|UCSD/VA San Diego|Jonathan Meyer MD|8589640777|jmmeyer@ucsd.edu|
20192296|NCT05674292|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|501
20192297|NCT01841112|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192298|NCT00878553|Somnus Therapeutics, Inc|Dr. Christine Blumhardt, Chief Regulatory Officer|617-710-0928|cblumhardt@somnusthera.com|
20192299|NCT02143063|UConn Health|Sheila Alessi, PhD|860-679-1849|salessi@uchc.edu|
20192300|NCT00859976|Zimmer Biomet|Clinical Project Lead||Maggie.Shen@zimmerbiomet.com|
20192301|NCT02062645|Novartis Pharmaceuticals|Study Director|862-778-8300||
20192302|NCT00461123|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20192303|NCT02604342|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20192304|NCT02024750|University of Wisconsin School of Medicine and Public Health|Elizabeth Cox|608-263-9104|ecox@wisc.edu|
20192305|NCT01612767|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
20207387|NCT03558828|Rush University College of Nursing|Manju Daniel|312.942.3460|manju_n_daniel@rush.edu|
20185129|NCT05873062|Autifony Therapeutics Ltd|Head of Clinical Project Management|+447909228562|Alice.Sharman@autifony.com|
20185130|NCT06546657|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
20185131|NCT01216176|University of Miami|Joyce Slingerland MD PhD FCRP(C)|305-243-7265|jslingerland@med.miami.edu|
20225733|NCT01912352|Seoul National University|Dr. Jae-Won Kim|822-2072-3648|adore412@paran.com|
20225734|NCT01660802|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20225735|NCT02759835|National Cancer Institute|Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
20225736|NCT01404949|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
20225737|NCT01505179|UCSD MED CLINICAL TRIALS|Denise Barnard, MD|858 246-2996|dbarnard@ucsd.edu|
20225738|NCT01267422|Department of Ophthalmology, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology|Bin Li|+86-13638673626|libin-12@163.com|
20225739|NCT00284154|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20225740|NCT04527978|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20225741|NCT00055497|Abbott|Global Medical Services|800-633-9110||
20225742|NCT02104167|Zimmer Biomet|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
20225743|NCT00731731|Mayo Clinic|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
20225744|NCT01429441|ThromboGenics N.V.|Dr. Petra Kozma-Wiebe|+32 16 751 497|petra.kozma@thrombogenics.com|
20225745|NCT00595101|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20225746|NCT01606748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225747|NCT04100590|New York State Psychiatric Institute|Caroline A Arout, PhD|646-774-6167|caroline.arout@nyspi.columbia.edu|
20225748|NCT00006110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20225749|NCT00621517|East Tennessee State University|Max Bayard MD|802-524-8805|mmbayard3@gmail.com|
20225750|NCT01863732|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20225751|NCT03084315|University of Minnesota|Anne Joseph, MD, MPH|612-625-3789|lagre010@umn.edu|
20225752|NCT01313351|Rapid Pathogen Screening, Inc|Robert Sambursky, MD|9415581853|rob.sambursky@lumosdiagnostics.com|
20225753|NCT03884985|University of Rochester|Martina Poletti|(585) 275-4801|martina_poletti@urmc.rochester.edu|
20225754|NCT02906033|Helsinki University Hospital|MNSc Maria Pulkkinen|+358 50 427 2678|maria.pulkkinen@hus.fi|
20225755|NCT02664922|University of California, Los Angeles|Jennifer Scovotti|310.206.4484|jscovotti@mednet.ucla.edu|
20225756|NCT00094536|Cooper Surgical|Chief Medical Officer|203-601-5200|Robert.Auerbach@coopersurgical.com|
20225757|NCT02655419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225758|NCT01900431|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20225759|NCT00624650|OHSU|Samantha Ruimy|5034940724|ruimy@ohsu.edu|
20225760|NCT03782974|USANA Health Sciences|Dr. Jeremy Tian|01-801-954-7658|jeremy.tian@usanainc.com|
20225761|NCT00714753|Mayo Clinic|Thomas M. Pisansky, M.D.||Pisansky.Thomas@mayo.edu|
20225762|NCT03704948|University of Iowa|Lisa S. Segre|13193357079|lisa-segre@uiowa.edu|
20225763|NCT01726621|Medtronic MiniMed, Inc|Clinical Research Manager|8185765171|julie.sekella@medtronic.com|
20225764|NCT04504175|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20225765|NCT00448812|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|+1 (412) 716-0717|grubbm@bsci.com|
20225766|NCT01687283|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225767|NCT02092649|University of Guelph|Sebastian Jannas-Vela MSc|(519)-824-4129|sjannas@uoguelph.ca|53907
20225768|NCT01533948|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20225769|NCT01153009|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20225770|NCT00410072|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20225771|NCT01291264|University of California, San Francisco|Dr. Julius Schachter, Professor of Laboratory Medicine|415 824 5115|julius.schachter@ucsf.edu|
20225772|NCT03307837|Concentric Analgesics|Dr. John Donovan, President and Founder|415-676-8940|JOHN@CONCENTRICANALGESICS.COM|
20225773|NCT03525808|Boston Scientific|Ornela Gjata|(508)-683-4155|Ornela.Gjata@bsci.com|
20225774|NCT00904917|Children's Hospital of Philadelphia|Rhonda C. Boyd, Ph.D.|215-590-3945|boydr@email.chop.edu|
20225775|NCT00762034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225776|NCT02107313|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
20225777|NCT02830074|John D. Dingell VA Medical Center|Dr. M.Safwan Badr, MD, Ph.D.|3135763548|m.badr@va.gov|
20185132|NCT04847479|University of Pennsylvania|Robert Gross|215-898-2437|grossr@pennmedicine.upenn.edu|
20225778|NCT01031004|Vistakon|John Buch/Principal Research Optometrist|904-443-1707||
20225779|NCT01641471|Cleveland Clinic - Section of Adult Reconstrution|Research Program Manager|216-444-4954|klikaa@ccf.org|
20225780|NCT02788188|National Institute of Allergy and Infectious Diseases|Davey, Richard|+1 301 496 8029|rdavey@niaid.nih.gov|
20225781|NCT02815267|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20185133|NCT01600014|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20185134|NCT02975505|University of California, San Francisco Division of Nephrology|Dr. Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
20185135|NCT04278586|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6056|zschuman@cha.harvard.edu|
20185136|NCT02791230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192306|NCT01891890|Emory University|David Loring, PhD|404-778-5943|dloring@emory.edu|
20225782|NCT01108237|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
20225783|NCT02178358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20225784|NCT00948922|H. Lee Moffitt Cancer Center and Research Institute|Dr. Melissa Alsina|813-745-7202|melissa.alsina@moffitt.org|
20225785|NCT02784288|University of Michigan|Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
20207388|NCT01250899|University of California, Los Angeles|Dr Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
20207389|NCT00673816|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
20207390|NCT05129124|Bausch + Lomb Incorporated|Jill Schafer|0000000|Jill.Schafer@bausch.com|
20185137|NCT05233098|Boston Scientific|Jessie Stockwell, Sr. Clinical Trial Specialist|6126181136|jessie.stockwell@bsci.com|
20185138|NCT04076293|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|8224100377|jiyeon.kang@hanmi.co.kr|
20185139|NCT04201834|University of Rochester|Ruth Schneider, MD|585-341-7500|Ruth_schneider@urmc.rochester.edu|
20185140|NCT03089125|Massachusetts General Hospital|Joseph A. Greer, Ph.D.|617-643-2143|jgreer2@mgh.harvard.edu|
20185141|NCT04104321|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|0543314054|yossigs@galmedpharma.com|
20185142|NCT04038957|Sumitomo Pharma America Inc|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20207391|NCT02234050|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
20185143|NCT04065048|Case Western Reserve University|Abigail Raffner Basson, Principal Investigator & Study Coordinator|2163276003|axb860@case.edu|
20207392|NCT03774875|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20185144|NCT04354337|University of Washington|Weichao Yuwen|2536924478|wyuwen@uw.edu|
20207393|NCT02352090|Helsinki University Central Hospital|Oskari Heikinheimo|+358 50 4271533|oskari.heikinheimo@helsinki.fi|
20207394|NCT03630185|The University of Texas Health Science Center at Houston|Stuart A Harlin, MD|713-486-5131|Stuart.A.Harlin@uth.tmc.edu|
20207395|NCT00796003|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
20185145|NCT03554265|University of Texas Medical Branch|Randall Urban, MD|409-772-5476|rurban@utmb.edu|
20207396|NCT05179057|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
20185146|NCT02652260|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20185147|NCT02723955|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20185148|NCT04999085|University of North Carolina Lineberger Comprehensive Cancer Center|Christopher E. Jensen, MD, MSCR|+1 984-987-1072|cejensen@med.unc.edu|
20185149|NCT00880425|Thomas Jefferson University|Jessica Ailani, MD/ Headache Fellow|631-807-8194|Jessica.Ailani@gmail.com|
20185150|NCT05056246|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20207397|NCT02968277|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
20207398|NCT03733132|Mayo Clinic|K Sreekumaran Nair, M.D., Ph.D.|507-255-2415|Nair@mayo.edu|
20185151|NCT05857644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185152|NCT05096819|Oxford University Hospitals|Dr Elizabeth Orchard|01865 741166|elizabeth.orchard@ouh.nhs.uk|
20207399|NCT01775800|The Rogosin Institute|Dr. Nathaniel Berman|212-746-9766|nab2009@nyp.org|
20185153|NCT03324984|Montefiore Medical Center|Dr. Elilary Montilla Medrano|929-263-3302|emontill@montefiore.org|
20185154|NCT03845829|Department of Vascular Surgery, Shanghai Ninth People's Hospital|Kaichuang Ye|+86-021-2327166|ykaichuang@163.com|
20207400|NCT03146403|Genocea|Jennifer LaVin|617-876-8191|jennifer.lavin@genocea.com|
20185155|NCT02152137|Mayo Clinic|Robert C. Smallridge, M.D.|904-953-2392|smallridge.robert@mayo.edu|
20185156|NCT04878354|ALK-Abelló A/S|Senior Director, Clinical Data Science|+4545747576|clinicaltrials@alk.net|
20185157|NCT03358875|BeiGene|Study Director|1-877-828-5568|Clinicaltrials@beigene.com|
20207401|NCT00077922|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
20185158|NCT03599648|University of Oregon|Dr. Laura Lee McIntyre|541-346-7452|llmcinty@uoregon.edu|
20185159|NCT03363854|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
20185160|NCT06382064|The Ohio State University College of Optometry|Dr. Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
20185161|NCT06194214|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207402|NCT02182999|Department of Orthopedic Surgery, Medical University of Innsbruck|Dr. Matthias Braito|0043 512 504|matthias.braito@gmail.com|81214
20207403|NCT05241288|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
20207404|NCT02252588|University of Minnesota|Christine Wendt, MD|612-624-0999|wendt005@umn.edu|
20207405|NCT02575300|H. Lee Moffitt Cancer and Research Center|Dr. Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
20207406|NCT02736929|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
20185162|NCT05687903|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20207407|NCT00605358|Weill Cornell Medicine|Dr. Jo Anne Sirey|9149974333|jsirey@med.cornell.edu|
20185163|NCT04847999|University of British Columbia|Dr Jonathan Little|2508786893|jonathan.little@ubc.ca|
20185164|NCT02879448|Abbott Medical|Jordan Anderson, Clinical Scientist|651 756 3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
20185165|NCT03717415|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
20185166|NCT04300231|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|317-274-0275|yyeap@iupui.edu|
20207408|NCT02148952|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
20185167|NCT04431050|Imperial|Joan Nanan|+44 (0)20 7594 9000|j.nanan@imperial.ac.uk|
20207409|NCT04007367|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20207410|NCT01764022|BIOCAD|Dr. Mariia Shustova|+7812380 49 33|shustova@biocad.ru|651
20207411|NCT03645811|University of Health Science|Dr. Demet İnangil|+905303021160|demet.inangil@sbu.edu.tr|
20207412|NCT01215786|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20207413|NCT04555811|University of Minnesota, Masonic Cancer Center|Veronika Bachanova MD, PhD|612-625-5469|bach0173@umn.edu|
20185168|NCT02386553|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20185169|NCT03128359|City of Hope Medical Center|Dr. Monzr M.Al Malki, MD|6263598111|malmalki@coh.org|
20207414|NCT04731922|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20225786|NCT02757625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185170|NCT02006758|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
20225787|NCT02131233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225788|NCT00645671|Bausch & Lomb|Dr. Tuyen Ong|(973) 360-6389|Tuyen.Ong@bausch.com|
20185171|NCT02740231|Bone Therapeutics|Dr Olivier Godeaux Medical Officer|+32 71 12 10 00|jta.koa1@bonetherapeutics.com|
20185172|NCT03655262|UCLA|Michelle Craske, Ph. D|(310) 825 8403|mcraske@mednet.ucla.edu|
20225789|NCT02095197|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
20185173|NCT04328727|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20225790|NCT02020135|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
20225791|NCT01597492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225792|NCT01204918|Yale University|Gerard Sanacora, PhD, MD: Professor of Psychiatry; Director, Yale Depression Research Program|(203) 974-7535|gerard.sanacora@yale.edu|
20225793|NCT01963091|MUSC|Dr. Moran-Santa Maria|843-792-8187|moranm@musc.edu|
20225794|NCT01280682|Department of Endocrinology, First Affiliated Hospital of Nanjing Medical University|Yang Tao|+86-13851498409|dryangtao@sina.com|
20225795|NCT00849290|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
20225796|NCT01178814|Columbia University Irving Medical Center|Mark Heaney, MD|646-317-5199|mlh2192@cumc.columbia.edu|
20225797|NCT01687387|Innate Pharma|Director Clinical Operations|+33043030|info@innate-pharma.fr|30
20225798|NCT03760458|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20225799|NCT00750919|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225800|NCT01464619|The Children's Hospital of Philadelphia|James Guevara, MD, MPH|215-590-1130|guevara@email.chop.edu|
20225801|NCT02612688|Brown University|Jessica A. Ogarek, Senior Biostatistician|401-863-9356|jessica_ogarek@brown.edu|
20225802|NCT04006509|University of Florida|Leslie A. Parker|352 273 6384|parkela@ufl.edu|
20225803|NCT00080483|University of Pennsylvania|Peter J. Snyder M.D.|215-898-0208|pjs@mail.med.upenn.edu|
20225804|NCT00602446|Masonic Cancer Center, University of Minnesota|Linda J. Burns, MD|612-624-8144|burns019@umn.edu|
20162872|NCT01763606|Memorial Sloan Kettering Cancer Center|Dr. Lisa DeAngelis, MD|212-639-8000|deangell@mskcc.org|
20225805|NCT00002525|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20225806|NCT00459368|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454||
20185174|NCT04583423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225807|NCT02651688|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20225808|NCT02112877|Boston Scientific|Nancy O'Connell, Sr. Clinical Research Manager|763-494-2706|nancy.oconnell@bsci.com|
20225809|NCT00625183|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20225810|NCT02740335|Clinical Research Management Group|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
20225811|NCT02279745|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20225812|NCT00380718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225813|NCT01349933|Mayo Clinic|Brigette Buig-Yue Ma, MBBS, FRACP||brigette@clo.cuhk.edu.hk|
20225814|NCT01578499|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20225815|NCT02033200|Vivus Inc|VP of Development|650-934-5200||
20225816|NCT01706575|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20225817|NCT02912455|Cleveland Clinic|Dr. Sangeeta Kashyap|(216) 445-2679|kashyas@ccf.org|
20225818|NCT02670382|Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University|Dr. Stefania Lamon-Fava, Scientist I|617-556-3105|stefania.lamon-fava@tufts.edu|
20225819|NCT02230540|Rigshospitalet, Department of Urology|Per Bagi, MD|+45 3545 8310|Per.bagi@regionh.dk|
20225820|NCT03244618|Unilever|Dr Jane Matheson|+44 (0)1516413633|jane.matheson@unilever.com|
20225821|NCT02949141|Patan Academy of Health Science|Darlene R House, MD|+977 9810339799|dhouse@iupui.edu|
20225822|NCT01810783|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
20225823|NCT00630747|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20225824|NCT03858894|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
20225825|NCT04503668|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20225826|NCT03403621|Mayo Clinic|Dr. Alexander Meves|507-284-3668|Meves.Alexander@mayo.edu|
20225827|NCT00395642|BIOTRONIK, Inc.|Katerina de Metz (Director, Clinical Studies)|800-547-0394|katerina.demetz@biotronik.com|
20185175|NCT02238483|AstraZeneca|Ziad Taib|+46 708 46 73 56|ziad.taib@astrazeneca.com|
20185176|NCT00390299|Mayo Clinic|Evanthia Galanis, M.D.|+1 (507) 266-0584|Galanis.Evanthia@mayo.edu|
20185177|NCT04661410|The WELL Center|Dr. Adrienne Juarascio|443-801-8093|asj32@drexel.edu|
20185178|NCT00331136|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
20185179|NCT00536341|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20185180|NCT00533546|University of Rochester|Curtis Benesch, M.D., M.P.H.|585 275-2530|curtis_benesch@urmc.rochester.edu|
20185181|NCT03750968|University of Utah John A. Moran Eye Center|Paul Bernstein, MD, PhD|801-581-4069|Paul.Bernstein@hsc.utah.edu|
20185182|NCT02178098|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20225828|NCT02993354|Montefiore Medical Center|Dr. Peter Bernstein|718-904-2767|pbernste@montefiore.org|
20225829|NCT02061683|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20207415|NCT04238689|Radboudumc, Department of Medical Microbiology|Dr. Matthew B.B. McCall|+31 024 361 1111|matthew.mccall@radboudumc.nl|
20185183|NCT00957242|University of Chicago Hospital|Imre Noth, MD, Associate Professor of Medicine|773-834-1832|inoth@medicine.bsd.uchicago.edu|
20185184|NCT03101371|University of Colorado, Anshcutz Medical Campus|Saketh Guntupalli, MD|303-724-2033|saketh.guntupalli@cuanschutz.edu|
20207416|NCT00981747|University of Iowa|Dr. Alicia Gerke|319-356-1616|alicia-gerke@uiowa.edu|
20207417|NCT03489850|University of California Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
20207418|NCT03242590|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
20185185|NCT05028582|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20207419|NCT02033850|'L. Sacco' Department of Biomedical and Clinical Sciences University of Milan|Prof. Leonardo Pantoni, Principal Investigator|0039-02-50319865|leonardo.pantoni@unimi.it|
20207420|NCT01437267|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
20207421|NCT03934203|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20225830|NCT01078298|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185186|NCT04939246|Miami Cancer Institute at Baptist Health, Inc.|Director, Concept Development & Data Management|(786) 527-9546|mciresearchconceptandprotocoldev@baptisthealth.net|
20225831|NCT03489941|Bausch & Lomb|Heleen DeCory|(585) 338-8161|heleen.decory@bausch.com|
20185187|NCT02576509|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20185188|NCT03398148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20185189|NCT00212355|Nobelpharama|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
20185190|NCT05769595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20225832|NCT00659776|Oregon Health and Science University|Amy Huddleston|503-494-2910|huddlesa@ohsu.edu|
20225833|NCT00628927|University of Cincinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
20225834|NCT01298141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20225835|NCT02379273|Cochlear Americas|Aaron J Parkinson, PhD, Principal Clinical Project Manager|3035242563|aparkinson@cochlear.com|
20225836|NCT01421147|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225837|NCT00136214|BIDMC|Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
20225838|NCT00171158|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20225839|NCT02232477|Lundquist Institute|Dr. Agnes Chen|424-306-7635|ahchen@lundquist.org|
20225840|NCT02757352|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20225841|NCT01268189|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
20225842|NCT00497146|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20225843|NCT01471444|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20225844|NCT01240902|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20225845|NCT03738163|Mölnlycke Health Care|Sabrina Chowdhury|+44 (0)7769 907654|sabrina.chowdhury@molnlycke.com|
20225846|NCT01214668|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225847|NCT02769312|Providence VA Medical Center, Center for Neurorestoration and Neurotechnology|Dr. Noah S. Philip|401-273-7100|noah.philip@va.gov|6235
20225848|NCT01681095|William Beaumont Hospital|Marc P. Sakwa, M.D.|248/898-0123|marc.sakwa@beaumont.org|
20225849|NCT01602679|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342430329|cm2hq@virginia.edu|
20225850|NCT02496039|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
20225851|NCT03297021|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@mountsinai.org|
20225852|NCT02734862|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
20225853|NCT00790556|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225854|NCT00255840|CIPRA-SA|Dr Ian Sanne|+27 11 276 8800|isanne@witshealth.co.za|
20225855|NCT03247322|Medical University of South Carolina|David Taber, PharmD, MS|843-792-3368|taberd@musc.edu|
20225856|NCT00339833|National Institutes of Health|Jonathan Krakoff, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|6022005217|jkrakoff@mail.nih.gov|
20225857|NCT00217581|Barbara Ann Karmanos Institute|Philip A. Philip, M.D., Ph.D., F.R.C.P|(313) 576-8746|philipp@karmanos.org|
20225858|NCT02829047|Vibrant Gastro|Clinical trials manager|046663322|service@vibrantgastro.com|
20225859|NCT01005901|Novartis Pharmaceuticals|Study Director|862-778-8300||
20225860|NCT00760487|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20225861|NCT00496587|The University of Texas MD Anderson Cancer Center|Dr. Nazir Tannir/|713-792-7734|CR_Study_Registration@mdanderson.org|
20225862|NCT00482170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225863|NCT01134263|Sanofi Pasteur|Trial Transparency Team||Contact-US@sanofi.com|
20225864|NCT01557517|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20225865|NCT00162097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20225866|NCT02819440|Vanderbilt University Medical Center|Evan Brittain|6153224382|evan.brittain@vumc.org|
20225867|NCT01701505|Big Grins Pediatric Dentistry|Dr. Gregory D. Evans, DDS|970-407-1020|greg@biggrinswithdrgreg.com|
20225868|NCT02445859|The Universit yof Leeds|Andrew Kirby|0044 113 3923989|a.kirby@leeds.ac.uk|
20225869|NCT02007278|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20185191|NCT06241794|Hitit University faculty of medicine|Guvenc Dogan|06342193000|guvencdogan@gmail.com|
20207422|NCT00838695|VAnderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
20207423|NCT01810380|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
20207424|NCT00608842|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
20207425|NCT01390038|Tornier/Wright Medical|Josh Myers|9529217119|josh.myers@wright.com|
20207426|NCT03799627|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
20207427|NCT02637804|CooperVision Inc.|Director, Professional Service|+81 3 5449 6619|Taku.Muraoka@jp.coopervision.com|
20207428|NCT00441012|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207429|NCT00814307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207430|NCT01256918|Dr. Ram Manohar Lohia Hospital|Dr. Praveen Kumar Malik|00919810405681|praveenk002@yahoo.com|
20207431|NCT02482389|Duke University Health System|Joan Cahill|(919) 668-5211|joan.cahill@duke.edu|
20207432|NCT00550290|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
20207433|NCT02569398|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207434|NCT00695500|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
20207435|NCT03039192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207436|NCT04888507|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20207437|NCT00636155|Duke University Medical Center|Mark Lanasa, MD, PhD|919-286-6897|mark.lanasa@duke.edu|
20207438|NCT00766142|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
20207439|NCT00400946|Dana-Farber Cancer Institute|Lewis B. Silverman, MD|617.632.6191|Lewis_Silverman@dfci.harvard.edu|
20207440|NCT04685408|Case Western Reserve University|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
20207441|NCT05643170|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20207442|NCT00142818|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
20207443|NCT02358863|Lombardi Comprehensive Cancer Center (LCCC)|John Marshall, MD|202-444-7064|marshalj@georgetown.edu|
20207444|NCT00438191|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
20207445|NCT06436300|Washington State University|Clemma Muller|612-327-7237|clemma.muller@wsu.edu|
20207446|NCT03765736|Duke Cancer Institute|John Strickler, MD|(919) 668-6608|john.strickler@duke.edu|
20207447|NCT02632344|Massachusetts General Hospital|Dr. Sara Pai, Principal Investigator|617-726-5251|sarapaimdphd@gmail.com|
20207448|NCT05426460|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
20207449|NCT02855086|Stanford University Medical Center|Gordon Li, MD, Associate Professor of Neurosurgery|650-721-1020|gordonli@stanford.edu|
20207450|NCT00589602|Cleveland Clinic|Jarek Maciejewski, MD|216-445-5962|maciejj@ccf.org|
20207451|NCT01804842|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20207452|NCT02869451|Duke University Medical Center|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
20207453|NCT00413777|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20207454|NCT03008889|Emory University|Dr. Lawrence Scahill|404-785-9336|lawrence.scahill@emory.edu|
20207455|NCT04288089|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20207456|NCT02219516|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
20207457|NCT04246489|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20225870|NCT01557868|American Orthopaedic Society for Sports Medicine|Dr. Barton Mann|847-292-4900|bart@aossm.org|
20225871|NCT00795769|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20225872|NCT04475718|Orange Square Designs|Lisa Marceau|4014284197|lisa@orangesquare.com|
20225873|NCT03304184|University of Michigan|Elizabeth Van Tubergen|2487045640|evantub@umich.edu|
20225874|NCT03230838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225875|NCT00435188|Durham VA Research and Development|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
20225876|NCT00521885|Lehigh Valley Health Network|Leslie Baga, Director of Research|610 402 1285|Leslie.Baga@lvhn.org|
20225877|NCT01915771|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
20225878|NCT00497055|San Francisco Department of Public Health|Phillip O. Coffin, Director of Substance Use Research|415-437-6282|phillip.coffin@sfdph.org|
20225879|NCT00575510|Mayo Clinic|Dr. Carmen Radecki Breitkopf|507-266-0969|radeckibreitkopf.carmen@mayo.edu|
20225880|NCT03420222|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20225881|NCT02334384|Eastern Virginia Medical School|Kenji Cunnion|7574465125|cunniokm@evms.edu|
20225882|NCT02603926|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
20225883|NCT03469999|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
20225884|NCT03439462|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
20225885|NCT02820181|The First Hospital of Shanxi Medical University|Dr.Jun Tian|+8618612270351|zguotian@126.com|
20225886|NCT04424914|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225887|NCT00460746|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|rfalcon@its.jnj.com|
20225888|NCT00822328|Cheng Hsin Rehabilitation Medical Center|Dr.Yi-Hsien Lin|+886-2-28264400|d49311001@ym.edu.tw|5750
20225889|NCT01778751|Durham Veterans Affairs Medical Center|Dr Matthew J Crowley|919-286-6936|matthew.crowley@va.gov|
20207458|NCT00557323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20207459|NCT00058188|Northwestern University|Clinical Trials Office|312-695-1301||
20185192|NCT03661359|University of Toledo|Heather Klepacz, M.D, Principle Investigator|419-383-6754|heather.klepacz@utoledo.edu|
20185193|NCT03012841|Medtronic|Mary Sauline, Clinical Research Specialist|440-596-3529|mary.k.sauline@medtronic.com|
20207460|NCT01520688|Allegheny Health Network|Deborah Gentile, MD|412-359-4099|dgentile@ahn.org|
20207461|NCT00498368|Mayo Clinic|Dr. Fernando Fervenza|507-255-3712|Fervenza.Fernando@mayo.edu|
20207462|NCT02266004|University of Miami|Corneliu Luca, MD|305-243-6732|cluca@med.miami.edu|
20207463|NCT01791465|Vanderbilt University Medical Center|John Koethe MD|615-343-0533|john.r.koethe@vanderbilt.edu|
20207464|NCT03289052|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20207465|NCT00537771|AstraZeneca|James J. Armbrust|+44 1625 518062|ClinicalTrialTransparency@astrazeneca.com|
20207466|NCT04246541|University Hospitals Cleveland Medical Center|Dr. Michael Karns|216-844-7200|michael.karns@uhhospitals.org|
20207467|NCT01744041|Washington University - School of Medicine|Dr. Shannon Lenze|3143622752|slenze@wustl.edu|
20207468|NCT03949621|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20207469|NCT00414973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20207470|NCT03813199|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
20207471|NCT01501162|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
20207472|NCT04247828|Altec Inc.|Dr. Paola Contessa|508-545-8236|pcontessa@altecresearch.com|
20207473|NCT01512693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207474|NCT02044367|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207475|NCT00491751|Boston University School of Medicine|Naomi M. Hamburg, MD|617-638-7462|nhamburg@bu.edu|
20207476|NCT02150460|National Eye Centre, Kaduna. Nigeria|Dr Aminatu Ali AbdulRahman|+2348037878367|aaaminatu@yahoo.com|
20207477|NCT02699125|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
20207478|NCT02939651|Fox Chase Cancer Center|Namrata Vijayvergia|+1 215-214-4283|Namrata.Vijayvergia@fccc.edu|
20207479|NCT04445051|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
20207480|NCT01451983|Cleveland Clinic Center for Autism|Thomas W. Frazier, PhD|216-448-6440|fraziet2@ccf.org|
20207481|NCT00570362|St.Mary's Hospital, College of Medicine, The Catholic University of Korea|Jung-Il Moon|82-2-3779-2114|jimoon@catholic.ac.kr|1243
20207482|NCT02092324|OHSU|Dr. Kim-Hien Dao|503-494-5074|daok@ohsu.edu|
20207483|NCT02512276|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20207484|NCT00398138|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak, Attending|+1212-639-5518|maslakp@mskcc.org|
20207485|NCT03256136|Massachusetts General Hospital|Dr. Jessica Lin|617-724-1134|jjlin1@partners.org|
20207486|NCT04973085|University of Vermont|Adam Sprouse Blum, MD|8028478050|Adam.Sprouse-Blum@uvmhealth.org|
20207487|NCT03190967|National Cancer Institute|Dr. Stanley Lipkowitz, PhD|240-760-6129|lipkowis@navmed.nci.nih.gov|
20207488|NCT01316380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207489|NCT03054298|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20207490|NCT03073200|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207491|NCT05116683|Columbia University|Benjamin Izar, MD|212-304-5871|bi2175@cumc.columbia.edu|
20207492|NCT01474889|UPenn|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
20207493|NCT00802880|Washington University School of Medicine|Brian Van Tine, M.D., Ph.D.|314-362-5817|bvantine@dom.wustl.edu|
20207494|NCT04964557|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
20207495|NCT01186003|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20207496|NCT02571972|Retina Service of Wills Eye Hospital, Mid Atlantic Retina|Dr. Jason Hsu|215-928-3092|jhsu@midatlanticretina.com|
20207497|NCT03559192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207498|NCT00615420|BC Cancer|Dr. Philippa Hawley|(604) 877-6000|phawley@bccancer.bc.ca|67-2752
20207499|NCT01673373|Getinge|Sr. Clinical Trial Manager|603-864-5219|inka.vesela@getinge.com|
20207500|NCT00424840|University of Massachusetts Medical School|Dr. William Walsh|508-334-5539|William.Walsh@umassmemorial.org|
20207501|NCT01145833|University of CA, San Diego Center for Healthy Eating and Activity Research|Kerri Boutelle, Principal Investigator|858-534-8037|kboutelle@ucsd.edu|
20207502|NCT04924114|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20207503|NCT03287830|Columbia University|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
20225890|NCT00394771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20225891|NCT02839876|Duke University Medical Center|Dr. Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
20225892|NCT02721017|University of California San Francisco Department of Surgery|Dr. Benjamin Padilla|415-476-3642|Benjamin.Padilla@ucsf.edu|
20185194|NCT03954184|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|todd.molfenter@wisc.edu|
20185195|NCT03397108|The Hospital for Sick Children|Dr. Shinya Ito|4168135776|shinya.ito@sickkids.ca|
20185196|NCT05104697|Emma Pendleton Bradley Hospital|Dr. Kristen Benito|401-432-1054|kbenito@lifespan.org|
20185197|NCT04898023|University of Missouri Healthcare|Ryan Camden|(575) 882-4141|camdenr@health.missouri.edu|
20185198|NCT04468776|CPMCRI|Dr. Katie Stone|(510) 427-4562|katie.Stone@ucsf.edu|
20185199|NCT05613205|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20185200|NCT03569176|Stanford University|Dr. Dennis P. Wall|650-497-9214|dpwall@stanford.edu|
20185201|NCT03103321|Mayo Clinic|Jon C. Tilburt, MD|5072661105|tilburt.jon@mayo.edu|
20185202|NCT02488863|University o fFlorida|Eric Weber|352-273-7802|ebweber@ufl.edu|
20225893|NCT03816007|VA San Diego Healthcare System|Dr. Erik Groessl|858-642-6347|erik.groessl@va.gov|
20225894|NCT01428115|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20225895|NCT02620384|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
20225896|NCT02071082|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20225897|NCT00742027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20225898|NCT02798354|Children's Hospital at Montefiore and Albert Einstein College of Medicine|Dr. Michael Rinke|718-741-2597|mrinke@montefiore.org|
20225899|NCT01051440|Steward St. Elizabeth's Medical Center|Tara Lauriat|617-789-2404|tara.lauriat@steward.org|
20225900|NCT01833936|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|6148958747|ofacresearch@orthofootankle.com|
20225901|NCT00385827|Janssen Research & Development|Director||ClinicalTrialDisclosure@its.jnj.com|
20225902|NCT04227405|University of Maryland|Dr. Mariana Falconier, Associate Professor|301-405-4004|marianak@umd.edu|
20225903|NCT04985942|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
20225904|NCT01305772|Duke University Medical Center|Neal Ready,MD|919-681-6932|neal.ready@dm.duke.edu|
20225905|NCT03536663|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|781-699-4203|ChiangHong.Ho@fmc-na.com|
20225906|NCT01523834|Azienda Sanitaria Universitaria Integrata di Udine (A.S.U.I. Udine) - SOC Clinica Ematologica|Dr. Francesco Zaja, Co-Investigator of the Study|+39 0432559604|francesco.zaja@asuiud.sanita.fvg.it|
20225907|NCT02135016|First Hospital of CMU|Dr. Jun Wang|8602483283100|wjun2000@hotmail.com|
20225908|NCT03252145|University of California, San Francisco|Betty Smoot, DPTSc, PT|(707) 494-8262|Betty.Smoot@ucsf.edu|
20225909|NCT03488563|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20225910|NCT01088711|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225911|NCT01441245|Department of Internal Medicine, University of Siena, Le Scotte hospital, Siena, Italy|Alberto Palazzuoli MD, Cardiology Unit|+39577585363|palazzuoli2@unisi.it|
20225912|NCT00582426|Novartis|Study Director|1-800-778-8300||
20225913|NCT03543176|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20225914|NCT02626000|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20225915|NCT02164318|Duke University Medical Center|Dr. Jeffrey Lawson|919-681-2533|lawso006@mc.duke.edu|
20225916|NCT00662311|Departments of Radiation Oncology and Global Health University of Washington Medical Center|Shilpen Patel|206-598-4100|shilpenp@uw.edu|
20225917|NCT02508103|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
20225918|NCT01964989|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20225919|NCT02499263|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20225920|NCT04126317|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20225921|NCT00424593|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225922|NCT04096001|Stanford Prevention Research Center, School of Medicine, Stanford University|Judith J Prochaska, PhD|650-724-3608|jpro@stanford.edu|
20225923|NCT02693717|UT MD Anderson Cancer Center|Jianjun Gao, MD PHD, Associate Professor, Genitourinary Medical Oncology|(713) 563-4195|jgao1@mdanderson.org|
20225924|NCT05114564|CooperVision|José A. Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
20225925|NCT00493311|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
20225926|NCT02779075|Mayo Clinic|Adrian Vella|507-202-8490|vella.adrian@mayo.edu|
20225927|NCT04957212|Cinnagen Co.|Dr.Nasim Anjidani|0989125477964|anjidani.n@orchidpharmed.com|
20225928|NCT02813473|ECRI|Ron van Amsterdam|+31102062802|RvAmsterdam@cardialysis.nl|
20225929|NCT02787681|Loma Linda University|H. Bryant Nguyen, MD|909-558-4000|hbnguyen@llu.edu|
20225930|NCT03260790|Mayo Clinic|Avni Y. Joshi, M.D., M.S.|507-284-3165|Joshi.Avni@mayo.edu|
20225931|NCT00789685|Faron Pharmaceuticals Limited|Dr Ilse Piippo, MD|+358 2469 5151|ilse.piippo@faronpharmaceuticals.com|
20225932|NCT02791438|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20225933|NCT01603394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162873|NCT04406649|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
20162874|NCT04164732|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20162875|NCT00661622|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
20162876|NCT04493203|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20162877|NCT00773773|Memorial Sloan Kettering Cancer Center|Dr. Paul Tempst, PhD|212-639-8923|liljah@mskcc.org|
20162878|NCT04067609|Yale School of Medicine|Dr Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
20162879|NCT04765202|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20162880|NCT04929249|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20162881|NCT01620762|Circassia Ltd|VP Clinical Operations|+44 1865 405560||
20162882|NCT00705146|VIHA|Helia Sillem MScOT|2507557611|helia.sillem@viha.ca|
20162883|NCT00095173|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20162884|NCT01623869|Memorial Sloan-Kettering Cancer Center|Sandra Pierina D'Angelo, M.D.||dangelos@mskcc.org|
20225934|NCT02669667|MedImmune|Rene van der Merwe|+44 (0)1223 898263|information.center@astrazeneca.com|
20225935|NCT01215435|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20162885|NCT01868334|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
20162886|NCT03777319|The Abigal Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-722-5615|kevin.flanigan@nationwidechildrens.org|
20185203|NCT06629454|University of Pennsylvania|Doraid Jarrar|2156627878|doraid.jarrar@pennmedicine.upenn.edu|
20185204|NCT01704079|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
20185205|NCT05273723|Northwell Health|Karina Davidson|(516) 562-3467|kdavidson2@northwell.edu|
20185206|NCT05846646|ImmuneSensor Therapeutics, Inc.|Patrick Widhelm, Senior Director Clinical Operations and Project Management|830-730-8176|pwidhelm@immunesensor.com|
20185207|NCT00505934|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20185208|NCT01296646|University of North Carolina at Chapel Hill|James C. Garbutt, M.D., Professor of Psychiatry|919-966-4652|jc_garbutt@med.unc.edu|
20207504|NCT05505734|Avillion Life Sciences|Chief Medical Officer|+44 (0)203 764 9530|contact@avillionls.com|
20207505|NCT00435929|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
20207506|NCT02155712|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
20207507|NCT05180721|Yale|Robin Whittemore|203-432-7000|robin.whittemore@yale.edu|
20207508|NCT03575351|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20207509|NCT00976963|University of Washington|Ann Stapleton|‪(206) 880-3464‬|stapl@uw.edu|
20207510|NCT01328769|University of Utah|Paul Hopkins|801-585-8139|paul.hopkins@utah.edu|
20207511|NCT01688999|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
20207512|NCT02768103|VA Palo Alto Health Care System|Dr Johanson|408-250-1982|lisa.johanson29@gmail.com|
20207513|NCT02951455|University of Illinois Urbana Champaign|Liliane Windsor|2173001782|lwindsor@illinois.edu|
20207514|NCT03039790|Takeda (Note: This product was divested to HilleVax in 2022)|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20207515|NCT03003130|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
20207516|NCT01236768|Agile Therapeutics|Lisa Flood, Associate Director of Clinical Operations|609-683-1880|lflood@agiletherapeutics.com|
20207517|NCT01855425|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
20207518|NCT01957085|Lewis Katz School of Medicine|Robert L. Bettiker, MD/MGA, Principle Investigator|215.707.1982|robert.bettiker@temple.edu|
20207519|NCT02128919|Nathan Kline institute for Psycghatric Research|Robert C Smith MD|845-398-6531|rsmiith@nki.rfmh.org|
20207520|NCT02108522|AlloVir|Iain Fraser, MD|833-409-2281|ClinicalTrials@allovir.com|
20207521|NCT02283840|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20207522|NCT01025232|Retinal Consultants of Houston|David M. Brown, MD Director of Clinical Research|713-394-7534|dmbmd@houstonretina.com|
20207523|NCT01600105|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
20207524|NCT03748420|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
20207525|NCT01263444|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20207526|NCT01611662|Fox Chase Cancer Center|Elizabeth Plimack, MD|215-728-3889|Elizabath.Plimack@fccc.edu|
20207527|NCT00372489|Affymax|VP, Clinical Development|650-812-8700|info@affymax.com|
20207528|NCT03330106|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20207529|NCT01004874|Duke University Medical Center|Dr. Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
20207530|NCT03441594|Pennington Biomedical Research Center|Candice A. Myers|12257632849|candice.myers@pbrc.edu|
20162887|NCT02951429|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20207531|NCT00623766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20207532|NCT00486889|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20207533|NCT00893763|University of South Florida|Cindy L. Munro, APRN, PhD|813-974-7597|cmunro2@health.usf.edu|
20207534|NCT02324049|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
20207535|NCT02159365|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20207536|NCT02618512|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
20207537|NCT03198728|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
20207538|NCT00285246|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley, Ph.D., Research Physiologist|781-687-2273|karen.quigley@va.gov|
20162888|NCT01620528|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20162889|NCT03256253|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
20162890|NCT02161757|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20162891|NCT00391625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20162892|NCT03664765|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
20162893|NCT01623739|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
20162894|NCT02019875|University of Washington|Kenneth Thummel|206-543-0819|thummel@u.washington|
20162895|NCT01628965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20162896|NCT00330681|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20162897|NCT00847197|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162898|NCT01366885|OHSU|Dr. Gene Stubbs|503-939-7351|stubbsgene@comcast.net|
20185209|NCT02134951|New York State Psychiatric Institute|Marlene Carlson|646-774-8436|mc157@columbia.edu|
20207539|NCT04051944|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20225936|NCT00840034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20225937|NCT05811026|Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan|Dr. Chang-Ming Huang|+886-2-23123456|daniel510791@gmail.com|262141
20162899|NCT03845738|Dentsply IH AB d.b.a Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 31 376 30 00|annakarin.lundgren@dentsplysirona.com|
20207540|NCT03083470|US Biotest, Inc.|Gere diZerega, MD; President & CEO|805-595-1300|gere.dizerega@usbiotest.com|
20207541|NCT03077711|Lehigh Valley Health Network|Dr. Carolyn Botros, DO|4845917480|carolyn.botros@lvhn.org|
20207542|NCT01526928|Clovis Oncology|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20207543|NCT00736450|University of Nebraska Medical Center|Julie Vose|402-559-3848|jmvose@unmc.edu|
20207544|NCT04157751|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207545|NCT00427791|UT MD Anderson Cancer Center|Dr. Partow Kebriaei, Associate Professor|713-792-2648|ytdinh@mdanderson.org|
20207546|NCT01395966|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
20207547|NCT03446612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207548|NCT02901080|Electromedical Products International, Inc.|Science and Education Director|8174583295|josh@epii.com|
20207549|NCT00333970|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|203-932-5711|joanna.fiszdon@va.gov|2231
20207550|NCT04925947|Weill Cornell Medicine|Barbara Ma|646-962-6444|btm9003@med.cornell.edu|
20207551|NCT00899678|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20207552|NCT03787095|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20207553|NCT03150199|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
20207554|NCT03148795|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207555|NCT03338036|University of Western Ontario|Dr Jim Dickey, Associate Professor|519-661-2111|jdickey@uwo.ca|87834
20207556|NCT00815776|Ascentia Health, Inc.|Lawrence G. Clayton, M.A., Study Director|(815) 484-9258|LGClayton@aol.com|
20207557|NCT03924427|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20207558|NCT03028467|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207559|NCT02253160|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer - BBT|303-232-6800|Ray.Goodrich@terumobct.com|
20207560|NCT00149890|Novartis Pharmaceuticals|Study Director|862-778-8300||
20207561|NCT01387594|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20207562|NCT01365091|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20207563|NCT00392951|Children's Hospital of Philadelphia|David T. Teachey, MD|267-426-5802|teacheyd@email.chop.edu|
20207564|NCT03298048|UTexas_Houston|Dr. Herbert DuPont|713-500-9366|herbert.l.dupont@uth.tmc.edu|
20207565|NCT01435122|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jonathan R. Strosberg|813-745-3636|jonathan.strosberg@moffitt.org|
20207566|NCT02406027|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207567|NCT01990703|University of Utah, Department of OBGYN|Dr. David Turok|801-581-6170|david.turok@hsc.utah.edu|
20207568|NCT03277794|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
20207569|NCT04852666|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-843-5908|michael_kappelman@med.unc.edu|
20207570|NCT04021628|St George's, University of London|Dr Shari Sapuan|02086729944|ssapuan@sgul.ac.uk|5382
20207571|NCT03671148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20207572|NCT02209259|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
20207573|NCT03878160|Massachusetts General Hospital|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
20207574|NCT00533780|Stanford University|Kathy Turner, RN, NP|650-724-6850|kathyt@stanford.edu|
20207575|NCT03887052|Kestra Medical Technologies, Inc.|Laura Gustavson, VP Clinical Marketing|14255264759|laura.gustavson@kestramedical.com|
20207576|NCT02365506|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20207577|NCT04574570|IRCCS Istituto Ortopedico Rizzoli|Dr Stefano Zaffagnini|+3905163665706366111|stefano.zaffagnini@unibo.it|
20207578|NCT01058395|Wayne State University|Dr. Jay Meythaler|(313) 375-7226|jmeythal@med.wayne.edu|
20207579|NCT01266876|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20207580|NCT05016037|Vanderbilt University Medical Center|Dr. Stephen Camarata|(615) 579-5608|stephen.camarata@vumc.org|
20207581|NCT01899768|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207582|NCT04043416|The University of Ottawa|Katherine Reilly|613-562-5800|kreilly@uottawa.ca|8238
20207583|NCT04098016|Duke University|Dr. Melissa Kay|7812493062|melissa.kay@duke.edu|
20207584|NCT01196091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20207585|NCT04476108|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207586|NCT02213081|Northwestern University|Dr. Serdar Bulun|312-472-3980|Serdar.Bulun@nm.org|
20207587|NCT00355615|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20207588|NCT04259346|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20207589|NCT00085644|Abbott|Global Medical Services|800-633-9110||
20207590|NCT01302691|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207591|NCT02829775|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20207592|NCT00062647|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20207593|NCT00390429|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20207594|NCT01039428|KDL|Study Director|818058844243|toiawase@advance-cro.co.jp|
20207595|NCT01313039|University of Miami Sylvester Comprehensive Cancer Center|Judith Hurley MD|305-243-6462|JHurley@med.miami.edu|
20207596|NCT01678560|Yale University|Meir Kryger, MD|203-815-0914|meir.kryger@yale.edu|
20207597|NCT02201472|Cincinnati Children's Hospital|Dr. Stephanie Merhar|513-803-5180|stephanie.merhar@cchmc.org|
20207598|NCT01300767|Alcon Research|Director of Clinical Trials|1-800-241-7629||
20207599|NCT00117572|UC San Diego Moores Cancer Center|Dr. Ezra E.W. Cohen||ecohen@ucsd.edu|
20207600|NCT00997555|Hurley Medical Center|John Alfred Carr, MD|810-262-4993|heartandbones@yahoo.com|
20192307|NCT01161628|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
20225938|NCT02870205|Glenmark Pharmaceuticals Ltd|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20225939|NCT01945294|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20225940|NCT03383692|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20225941|NCT01420016|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
20225942|NCT03557476|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20225943|NCT01156051|Children's Specialized Hospital|Thomas A Rugino MD|732-797-3826|trugino@childrens-specialized.org|
20225944|NCT01897766|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225945|NCT00793546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225946|NCT02101359|Laboratoires Thea|Medical director|33-4-73-98-14-36|p.pouliquen@laboratoires-thea.fr|
20225947|NCT00494221|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20225948|NCT03040427|Cleveland Clinic Foundation|Dr. Wael A. Jaber|216.444.8305|jaberw@ccf.org|
20225949|NCT00732680|Mayo Clinic|Rizwan Siwani, MBBS|507-284-9155|siwani.rizwan@mayo.edu|
20225950|NCT03755518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20225951|NCT03172364|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20225952|NCT01714609|Yale University|Dr. Garcia-Tsao|(203) 737-6063|guadalupe.garcia-tsao@yale.edu|
20192308|NCT00984698|University of Arizona|Dr. Patricia Haynes, Assistant Professor|5206261855|thaynes@email.arizona.edu|
20192309|NCT01143883|University of South Florida|Jorge E. Marcet, M.D.|813-844-4545|jmateka@health.usf.edu|
20192310|NCT00806598|The University of Texas MD Anderson Cancer Center|Tapan Kadia, MD/Assistant Professor|713-563-3534|eharriso@mdanderson.org|
20192311|NCT02196168|London Health Sciences centre|Dr.Eric Winquist|519-685-8500|Winquist@lhsc.on.ca|
20192312|NCT00770588|AstraZeneca|Gerard Lynch|52564555|aztrial_results_posting@astrazeneca.com|86 21
20192313|NCT05288504|Avalo Therapeutics, Inc.|Garry Neil, MD|610.254.4201|gneil@avalotx.com|
20192314|NCT01220856|Dompé SpA|Luisa Daffonchio, PhD|+39 583831|daffonchio@dompe.it|
20192315|NCT00361842|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20192316|NCT04206384|CAO Group|VP, Quality & Regulatory|801-256-9282|info@caogroup.com|
20192317|NCT02212197|Camurus AB|Clinical Trial Manager||info@camurus.com|
20192318|NCT03015181|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
20192319|NCT01688895|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-241-7699|hetanshi.naik@mssm.edu|
20192320|NCT01077622|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192321|NCT01260142|Eisai Call Center|Eisai Inc.|888-422-4743||
20192322|NCT03927742|University of Minnesota|Rachel Vogel|612-624-6928|isak0023@umn.edu|
20192323|NCT03822377|Cardiology Clinic, Sassari University Hospital, Sassari, Italy|Prof. Guido Parodi|0039|parodiguido@gmail.com|792830626
20192324|NCT02356484|Lausanne University Hospital|Pr. Nicolas Demartines|0041213142424|demartines@chuv.ch|
20192325|NCT00618917|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20192326|NCT00496834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192327|NCT01503164|Johns Hopkins University|Naresh Punjabi|410-550-6384|npunjabi@jhmi.edu|
20192328|NCT01042145|Washington University School of Medicine|Dr. Jane Garbutt|314-454-8613|jgarbutt@dom.wustl.edu|
20192329|NCT04088136|Georgia Institute of Technology|Dr. Christopher Hertzog|404-894-6774|ch18@gatech.edu|
20192330|NCT01177228|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
20192331|NCT00356759|McMaster University|Dr. Sam Schulman|19055270271|schulms@mcmaster.ca|44810
20192332|NCT04159805|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20192333|NCT03821064|Medical University of South Carolina|Evan Graboyes (PI)|843-792-0719|graboyes@musc.edu|
20192334|NCT01314014|James P. Wilmot Cancer Center, University of Rochester|Paul M. Barr, MD|585-273-3258|Paul_Barr@urmc.rochester.edu|
20192335|NCT02998918|University of South Carolina|Mark Sarzynski|8037779510|sarz@mailbox.sc.edu|
20192336|NCT02473913|University of Chicago|Stephanie Valle|773-834-3778|svalle@yoda.bsd.uchicago.edu|
20192337|NCT01568021|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20192338|NCT04013932|University of North Carolina at Chapel Hill|Joy Noel Baumgartner|919.923.8534|joy.baumgartner@unc.edu|
20192339|NCT00749671|Baystate|James R. Cook MD|413-794-4492|james.cook@bhs.org|
20192340|NCT05399082|Mayo Clinic|Ryan M. Kern, M.D.|507-266-3958|Kern.Ryan@mayo.edu|
20192341|NCT00771238|Nebraska Medical Center|Joyce Black, PhD, RN|402-559-6573|JBlack@unmc.edu|
20192342|NCT03371706|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
20192343|NCT00497874|Pro-Change Behavior Systems, Inc.|Deborah A. Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
20192344|NCT04260464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192345|NCT01004029|Covis Pharma|Clinical Trial Interest|1-877-374-4177|CTInterest@covispharma.com|
20192346|NCT02826798|VBI|Bebi Yassin-Rajkumar|613-749-4200|byassin-rajkumar@vbivaccines.com|151
20192347|NCT02806505|Hoffmann-La Roche|Medical Communications|800-821-8590|global.trial_information@roche.com|
20192348|NCT00803777|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20225953|NCT02732327|Allergan|David Melnick, MD|201-427-8554|Melnick_David@Allergan.com|
20192349|NCT00384865|Penn|Steven Kawut|215-573-0258|kawut@upenn.edu|
20225954|NCT02306694|Oregon Health & Science University|Dr. Jayson Taylor|503-494-8716|taylojas@ohsu.edu|
20225955|NCT00603382|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225956|NCT00583102|University of Iowa|Raymond Hohl, MD|319-356-8110|rhohl@pennstatehealth.psu.edu|
20225957|NCT02183909|University of California, San Francisco|Janet Myers, PhD, MPH, MA|415-502-1000|janet.myers@ucsf.edu|14626
20225958|NCT02320227|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20225959|NCT01665677|Medical College of Wisconsin|Dr. Medhi Hamadani|414-805-6800|mhamadani@mcw.edu|
20225960|NCT01180049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225961|NCT01738191|Medical University of South Carolina|Dr. Vanessa Hinson|843-792-9115|hinsonvk@musc.edu|
20225962|NCT02483572|University of Nebraska Medical Center|Wayne Fisher|4025598863|wfisher@unmc.edu|
20225963|NCT00350779|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclsoure@merck.com|
20225964|NCT00528372|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
20225965|NCT02006056|Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto|Dr. Edward Chow|416-480-4974|edward.chow@sunnybrook.ca|
20225966|NCT02770846|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
20225967|NCT02432144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20225968|NCT02946489|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
20225969|NCT01483599|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20225970|NCT02109445|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225971|NCT00958412|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20225972|NCT00966355|Korea University College of Medicine|Prof. Soon Ho Um|+82-2-920-5019|umsh@korea.ac.kr|
20225973|NCT02552888|Tulane School of Medicine|Dr. Jing Chen|5049886110|jchen@tulane.edu|
20225974|NCT03630705|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20225975|NCT01290952|Azienda Ospedaliera Luigi Sacco|Dr. Massimo Lemma|0039 0239042876|lemma.massimo@hsacco.it|
20225976|NCT02688764|Vifor Fresenius Medical Care Renal Pharma France|Milica Enoiu / Clinical Research Manager|+41588518264|milica.enoiu@viforpharma.com|
20225977|NCT02113007|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
20225978|NCT00885378|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20225979|NCT04076319|USC Suzanne Dworak-Peck School of Social Work|Dr. Benjamin Henwood|+1 (213) 821-0496|bhenwood@usc.edu|
20225980|NCT01054222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225981|NCT00824655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20225982|NCT03504189|Nuvo Group|VP Clinical|+972-3-6242266|adar.shani@nuvocares.com|1630
20225983|NCT03091738|Virginia Commonwealth University|Jasmohan Bajaj, MD|804-828-4060|jasmohan.bajaj@vcuhealth.org|
20225984|NCT02665741|University of California, Davis|Dr. Sooraj Tejaswi|916-734-7215|stejaswi@ucdavis.edu|
20225985|NCT01267929|Postgraduate Studied Program, faculty of medicine, Thammasat University|Miss Namfon Mahasup|+66 867733596|namfon_pt@yahoo.com|
20207601|NCT01188811|Oregon Health & Science University|Rebecca Spain, MD, MSPH|503-494-5759|spainr@ohsu.edu|
20225986|NCT01467271|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
20225987|NCT01515566|University of Texas MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC / Asst. Professor, Palliative Care and Rehabilitation Medicine|713-792-6085|CR_Study_Registration@mdanderson.org|
20225988|NCT02085070|Yale Cancer Center|Director, Clinical Trials Office|12037372572|Joyce.Tull@yale.edu|
20225989|NCT03084302|University of Pittsburgh|Bethany Barone Gibbs, Associate Professor, University of Pittsburgh|412-383-4002|bbarone@pitt.edu|
20225990|NCT01411319|University of Miami|Alan Pollack, MD, PhD|305-243-4916|apollack@med.miami.edu|
20225991|NCT01579669|Portland State University|Christina Nicolaidis, MD, MPH|5037259603|nicol22@pdx.edu|
20225992|NCT04948827|Camino Pharma|Gonul Velicelebi|858-201-2901|gonul@caminopharma.com|
20225993|NCT03441685|Vanderbilt University Medical Center|Dr. C. Melanie Schuele|615-936-5256|melanie.schuele@vanderbilt.edu|
20225994|NCT00527124|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath|313-576-8715|heathe@karmanos.org|
20225995|NCT00660595|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20225996|NCT01148459|GlaxoSmithKline|GSK Response Center|866-435-7343||
20225997|NCT02985021|VA Puget Sound HCS|Dr. Bruce Montgomery, PI|2062776878|rbmontgo@uw.edu|
20225998|NCT04854057|Spaulding Rehabilitation|Dr. Randy Trumbower|6179526822|randy.trumbower@mgh.harvard.edu|
20225999|NCT01679028|Tasly Pharmaceuticals, Inc.|Dr. Henry SUN|240-744-6225|henrysunusa@gmail.com|
20226000|NCT00177866|University of Pittseburgh|George Arnold, MD|412 621-2334|Arnoldgl@upmc.edu|
20226001|NCT01951573|Alcon Research, Ltd.|Mary Fahmy, Head, Clinical Development, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20226002|NCT04399889|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
20226003|NCT01537835|Denver Health and Hospital Authority|Marisha Burden, MD|303-602-5011|Marisha.Burden@dhha.org|
20226004|NCT01152996|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20226005|NCT03077607|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226006|NCT00460239|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
20226007|NCT03610334|Inflectis Bioscience|Dr Anne Visbecq (Chief Medical Officer)|0630632020|annevisbecq@inflectisbioscience.com|33
20162900|NCT00825812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20226008|NCT00519584|Cleveland Clinic|K. C. Cummings III, MD|216-444-1016|cummink2@ccf.org|
20162901|NCT03597061|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
20185210|NCT02461628|Duke University|Wendy O'Meara, PhD|16099103091|wpo@duke.edu|
20185211|NCT02015520|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20185212|NCT06027229|UW School of Medicine and Public Health|Dr. Freddy Caldera, DO, PhD, MS|(608) 263-1995|fcaldera@medicine.wisc.edu|
20185213|NCT04630301|Johns Hopkins University|Dr. Jeffrey Thiboutot|410-502-2533|jthibou1@jhmi.edu|
20226009|NCT05259917|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
20226010|NCT00592592|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
20226011|NCT03585712|HRA Pharma|Agnes Hemon|0140337092|a.hemon@hra-pharma.com|
20226012|NCT02886884|University of Miami|Dr. Joshua M. Hare, MD|305-243-5579|jhare@med.miami.edu|
20226013|NCT01096680|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20226014|NCT02697734|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20226015|NCT02324699|Icahn School of Medicine at Mount Sinai|Dr. Bruce Sands|212-241-8100|bruce.sands@mssm.edu|
20226016|NCT03970200|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20226017|NCT01607346|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226018|NCT01098162|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20226019|NCT01605825|Acorda Therapeutics, Inc.|Study Director|914-347-4300||
20185214|NCT06459401|Boston University|Ashlyn Aiello|617-500-3645|ajma@bu.edu|
20185215|NCT00998881|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20185216|NCT01261052|Legacy Health System|Dr. W Kenneth Ward|503-413-5171|kenward503@msn.com|
20185217|NCT04149002|Duke University|Sarahn M. Wheeler, MD|(919) 684-6327|sarahn.wheeler@duke.edu|
20207602|NCT01602744|Tel Aviv University|Dvora Frankenthal|0097235326835|shai_f@zahav.net.il|
20185218|NCT04704284|Mayo Clinic|Julie Guerin, M.D.|507-293-3698|Guerin.Julie@mayo.edu|
20207603|NCT00654368|Amgen Inc.|Study Director|866-572-6436||
20226020|NCT00830518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20226021|NCT04333225|Baylor Scott & White Research Institute|Peter A. McCullough, MD, MPH|2148412000|peteramccullough@gmail.com|
20207604|NCT00559013|Synovis|Lesa Hobright-Turner, Director of Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
20207605|NCT04228445|Provepharm, Inc.|Senior Director of Clinical Operations|6106018605|todd.koch@provepharm.com|
20207606|NCT02583360|The Research Institute at Nationwide Children's Hospital|Sudarshan Jadcherla MD|614-355-6433|sudarshan.jadcherla@nationwidechildrens.org|
20207607|NCT00606294|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
20207608|NCT03418376|Hasselt University|Dr. Charly Keytsman|+32477611122|charly.keytsman@uhasselt.be|
20207609|NCT01976624|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
20207610|NCT02774291|Albert Einstein College of Medicine/Montefiore medical center|Braunschweig, Ira|718-798-7474|ibraunsc@montefiore.org|
20207611|NCT00471315|Medical University of South Carolina|Peter Cotton, MD|(843) 792-6999|CottonP@MUSC.edu|
20207612|NCT00108277|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
20207613|NCT00460525|Department of Epidemiology of Parasitic Diseases, University of Bamako|Mahamadou A. Thera, MD, MPH|223-222-8109|mthera@mrtcbko.org|
20207614|NCT04757376|CELLTRION, Inc.|Head of Clinical Planning Department|+82 32 850 4167|jeehye.suh@celltrion.com|
20207615|NCT01307046|Merch Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207616|NCT00609167|Mayo Clinic|Dr. A. Keith Stewart||stewart.keith@mayo.edu|
20207617|NCT03898323|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
20207618|NCT01547806|National Cancer Institute|Dr. Jennifer Kanakry|301-451-3787|kanakryja@nih.gov|
20207619|NCT00712270|Kettering Health Network|Manager, Research Operations and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
20207620|NCT02574520|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20207621|NCT01611311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207622|NCT02550093|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
20207623|NCT00886691|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20207624|NCT01251315|Charles R Drew University of Medicine and Science|Dr .Naureen Tareen|323-568-3359|aaant@aol.com|
20207625|NCT03935594|Vanderbilt university medical center|Dr. Salam AlKassis|(615)322-2350|salam.al.kassis@vumc.org|
20207626|NCT03954704|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20207627|NCT03017040|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
20207628|NCT00985140|Stanford University Cancer Center|Richard T. Hoppe, MD Henry S. Kaplan Harry Lebeson Professor of Cancer Biology|(650) 723-5510|hoppe@stanford.edu|
20207629|NCT01388491|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20207630|NCT04035473|Athenex|Regional Project Manager|+886-277039399|lmeiying@athenex.com|
20207631|NCT00514592|Umeå University|Dr Elias Johansson|+46907850000|elias.johansson@neuro.umu.se|
20207632|NCT02735044|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20207633|NCT02308709|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20207634|NCT01682759|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207635|NCT00397891|Wyeth|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207636|NCT00412113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20207637|NCT00864123|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
20207638|NCT02058251|Medical University of South Carolina|Dr. Sudie Back|843-792-5915|backs@musc.edu|
20207639|NCT01190020|University of Iowa|Robert Summers, MD|319-356-2130|robert-summers@uiowa.edu|
20207640|NCT00796224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20207641|NCT04511338|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|1-781-249-8216|chianghong.ho@fmc-na.com|
20207642|NCT03227224|Janssen Research & Development, LLC|SENIOR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207643|NCT04195750|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20207644|NCT03782376|Janssen-Cilag Ltd.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207645|NCT03219476|Medical College of Wisconsin|Lubna Chaudhary|414-805-4600|lchaudhary@mcw.edu|
20207646|NCT00360672|UT MD Anderson Cancer Center|Gautam Borthakur, M.D./Associate Professor|713-563-1586|eharriso@mdanderson.org|
20207647|NCT06535932|Philips|Sarah Bass|240-278-0838|sarah.bass@philips.com|
20207648|NCT02254304|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20207649|NCT01226472|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20207650|NCT05166603|US Department of Veterans Affairs|Dawn M. Bravata, MD|3179882676|dawn.bravata2@va.gov|
20207651|NCT02531633|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207652|NCT04193605|School of Nursing at the University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
20207653|NCT04992507|The Ohio State University Comprehensive Cancer Center|Dr. Aslam Ejaz|614-293-7171|aejaz@uic.edu|
20207654|NCT01852591|H. Lee Moffitt Cancer Center and Research Institute|Frederick Locke, M.D.|813-745-3509|frederick.locke@moffitt.org|
20226022|NCT02155322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226023|NCT02036541|Allergan plc|Rupali Nangia|714-246-6020|rupali.nangia@allergan.com|
20226024|NCT01836185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162902|NCT00895453|Vienna Medical School|Armin Witt MD|+43140400|armin.witt@meduniwien.ac.at|2821
20185219|NCT02346526|Massachusetts General Hospital|Philip Saylor, MD|617-724-5197|psaylor@mgh.harvard.edu|
20185220|NCT01381406|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185221|NCT01066026|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|55 51 30262633|cientifico@cbed.org.br|
20185222|NCT03930420|University of Washington|Margaret Hannon, PhD|206-616-7859|peggyh@uw.edu|
20185223|NCT03635151|University of Cincinnati College of Nursing|Tamilyn Bakas|513-558-2254|tamilyn.bakas@uc.edu|
20185224|NCT01172418|University of Miami|George W. Burke, M.D.|305-355-5315|gburke@med.miami.edu|
20185225|NCT02538341|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis|205-975-2176|jrcurtis@uabmc.edu|
20207655|NCT05706623|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
20207656|NCT03728881|Division of Cancer Epidemiology and Genetics, NCI|Aimée R. Kreimer, PhD|240.276.7102|kreimera@mail.nih.gov|
20207657|NCT05379686|Steno Diabetes Center Copenhagen|Dr|+45 39 68 08 00|SDC-FP-Stenoinfo@regionh.dk|
20207658|NCT04517253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207659|NCT04428580|Stanford University|James Lock, MD, PhD|(650) 498-9111|jimlock@stanford.edu|
20207660|NCT04651777|Western Universtiy|Dr. Grace E Parraga|519-931-5365|gparraga@robarts.ca|
20226025|NCT02356107|University of Utah|Brent Kious, MD, PhD|(801) 581-4888|Brent.Kious@hsc.utah.edu|
20226026|NCT00523809|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
20226027|NCT00808470|University of Texas at Dallas|Dr. Colleen Le Prell|214-905-3018|colleen.leprell@utdallas.edu|
20226028|NCT01454414|University of North Carolina at Chapel Hill|Dr. Meagan Vaughn|9196986208|meagan.vaughn@unc.edu|
20226029|NCT00586898|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|Scherh@mskcc.org|
20226030|NCT00636961|Novartis Pharmaceuticals|Study Director|862-778-8300||
20226031|NCT00868751|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
20226032|NCT01218971|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
20226033|NCT02179749|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
20226034|NCT01841567|Klinik und Poliklinik für Orthopädie und Unfallchirurgie der Uniklinik Köln|Dr Kourosh Zarghooni|+49 2247887294|kourosh.zarghooni@uk-koeln.de|
20226035|NCT01327313|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20226036|NCT01573754|University of Texas Medical Branch Galveston|Dr. Karl Anderson|409-772-4661|kanderso@utmb.edu|
20226037|NCT01994902|Coloplast A/S|Medical Director|+45 49111395|dkbir@coloplast.com|
20226038|NCT00182000|Massachusetts General Hospital|Sabine Wilhelm, PhD|6177246146|swilhelm@partners.org|
20226039|NCT00727090|Northwestern University|Andrew M Naidech|312-503-3592|a-naidech@northwestern.edu|
20192350|NCT02820597|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20192351|NCT01053247|Fougera Pharmaceuticals Inc|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20192352|NCT03458728|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
20192353|NCT01572298|UTHSCSA Periodontics|Dr. Brian Mealey|210-567-3589|mealey@uthscsa.edu|
20192354|NCT01788475|Lahey Medical Center|Christine Gould PAC, MS|9785384412|christine.gould@lahey.org|
20192355|NCT00908349|Supernus Pharmaceuticals, Inc|Janet K. Johnson, PhD|301-838-2623|jjohnson@supernus.com|
20185226|NCT02321514|Abbott|Karine Miquel, PhD|+32 479 600 107|karine.miquel@abbott.com|
20192356|NCT01789840|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
20218082|NCT03377023|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|jhanelle.gray@moffitt.org|
20218083|NCT04141696|National Institute of Nursing Research (NINR)|Dr. Leorey Saligan, PhD.|+1 301 451 1685|saliganl@mail.nih.gov|
20218084|NCT05626803|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
20218085|NCT04583163|Hackensack Meridian Health|Tania Zielonka|5519964452|tania.zielonka@hmhn.org|
20218086|NCT01000610|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218087|NCT05218109|University of Florida|Sarah Bottari, M.S.|(352) 273-6455|sbottari@ufl.edu|
20218088|NCT00595335|Mayo Clinic|Dr. Rebecca S. Bahn|507-284-2462|bahn.rebecca@mayo.edu|
20218089|NCT01959490|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
20218090|NCT04859699|University of Washington|Linda K. Ko|+1 206 707-5624|lindako@uw.edu|
20162903|NCT04167137|Synlogic|Aoife Brennan, MB, BCh, BAO, MMSc|(857) 999-0767|aoife@synlogictx.com|
20162904|NCT02634827|Mayo Clinic|Aref Al-Kali, MD|507-538-0871|AlKali.Aref@mayo.edu|
20162905|NCT00400569|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
20162906|NCT01849419|University of Chicago|Dr. Harriet de Wit|(773) 702-3560|hdew@uchicago.edu|
20162907|NCT02714283|Oregon Health & Science University|Emily Henkle, PhD, MPH|503-494-6226|henkle@ohsu.edu|
20162908|NCT02461745|Southern California Permanente Medical Group|Division of Clinical Trials Research|(626) 564-5667|clinical.trials@kp.org|
20162909|NCT03848949|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
20162910|NCT00997594|Mie University|Dr. Koichiro Yamakado|+81-59-231-5029|yama@clin.medic.mie-u.ac.jp|5630
20162911|NCT03712787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20162912|NCT01865448|Unidad de Apoyo a la Investigacion. Hospital Rio Hortega|Dr. Daniel de Luis|983420400|dadluis@yahoo.es|83523
20162913|NCT00952081|UMDNJ|Alex Bekker, MD, PhD|973-972-5007|bekkeray@umdnj.edu|
20207661|NCT06048367|West China Hospital of Sichuan University|Professor. Yongsheng Wang|18980602258|wangys@wchscu.cn|
20162914|NCT00439296|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20162915|NCT00931606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162916|NCT04255862|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20162917|NCT05111249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20162918|NCT05128578|University of Pittsburgh|Shari Rogal|412-360-6177|rogalss@upmc.edu|
20162919|NCT00871338|GlaxoSmithKline|GSK Response Center|866-435-7343||
20162920|NCT02391363|Baylor College of Medicine|Melinda A. Stanley, PhD|713-794-8841|mstanley@bcm.edu|
20162921|NCT03004911|School of Medicine at the University of Sao Paulo|Amélia Pasqual Marques|+55 11 3091 7451|pasqual@usp.br|
20162922|NCT00799266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20162923|NCT01702025|Department of Health and Exercise Science|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
20162924|NCT02679755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162925|NCT01061359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162926|NCT00725049|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20162927|NCT02610777|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20162928|NCT00732875|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20162929|NCT02324283|Juntendo University|Dr. Izumi Kawagoe|+81338133111|ikawago@juntendo.ac.jp|
20162930|NCT00660179|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
20162931|NCT00581581|University of Rochester|Ronnie Guillet, MD, PhD|585-275-6209|ronnie_guille@urmc.rochester.edu|
20162932|NCT05224453|Prince Sattam bin Abdulaziz University|Dr. Gopal Nambi|0501878382|physio_gopal@rediffmail.com|
20162933|NCT04171219|M.D. Anderson Cancer Center|Aung Naing, MD|713-563-3885|anaing@mdanderson.org|
20207662|NCT04088331|Boston Scientific|Winnie Chen|952-930-6000|Winnie.Chen@bsci.com|
20207663|NCT01994109|Solstice Neurosciences|Regulatory Affairs Associate||regulatoryaffairs@usworldmeds.com|
20207664|NCT00576147|Baylor College of Medicine|Claudia Robertson|(713) 798-8932|claudiar@bcm.edu|
20207665|NCT02136134|Janssen R&D US|Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207666|NCT05674838|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20207667|NCT03070119|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20207668|NCT03137888|Emory University|Dr. Hui-Kuo Shu|4047781900|hgshu@emory.edu|
20207669|NCT02974621|Massachusetts General Hospital|Isabel Arillaga-Romany, MD PhD|877-442-3324|iarrillaga@mgh.harvard.edu|
20207670|NCT00732472|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207671|NCT02159768|National University Hospital|Senior Consultant|+65 67724200|eugene_liu_hc@nuhs.edu.sg|
20226040|NCT01142947|Center for Individualized and Genomic Medicine Research, Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|kwillia5@hfhs.org|
20226041|NCT04378569|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20226042|NCT01048944|Southern Illinois University Carbondale|David G. Gilbert, Ph.D.|618-45303558|dgilbert@siu.edu|
20226043|NCT01844817|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
20226044|NCT01128400|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
20226045|NCT02362425|National Institute of Nursing|Katherine Meileur Chief, Neuromuscular Symptoms Unit|301-435-1503|meilleurk@mail.nih.gov|
20226046|NCT00596453|Johns Hopkins Medical Institutions|Misop Han, M.D.|410-502-7454|mhan1@jhmi.edu|
20226047|NCT04750278|Foresee Pharma|Chief Medical Officer|408-823-4807|yisheng.lee@foreseepharma.com|
20226048|NCT03026283|Northwell Health|Pamela Noack|212 434 4926|pnoack@northwell.edu|
20226049|NCT03231397|Washington University School of Medicine|Dr. Sean J. English|(314) 362-5707|sjenglish@wustl.edu|
20162934|NCT02380443|Mirror Biologics, Inc|Dr. Michael Har-Noy|7602167494|harnoy@mirrorbio.com|
20162935|NCT02974257|BIDMC|Dr. Katherine Berg|617-754-2281|kberg@bidmc.harvard.edu|
20162936|NCT01015781|VA RR&D, NCRAR|James A. Henry, Ph.D., Principal Investigator|5032208262|james.henry@va.gov|57466
20207672|NCT04870099|Indiana University|Prof. Lorenzo Lorenzo-Luaces, Assistant Professor|8123456193|lolorenz@indiana.edu|
20207673|NCT03715205|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20207674|NCT03342404|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20226050|NCT03782571|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|904 443-3402|TKarkkai@its.jnj.com|2126
20207675|NCT01863901|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
20207676|NCT03733249|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
20207677|NCT00850135|Stanford University School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
20207678|NCT02253992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20207679|NCT03323086|The Miriam Hospital|Dr. Michael Carey|401 793 8218|michael_carey@brown.edu|
20207680|NCT02515851|University Louisville|Nancy Alsip|502-852-2610|nlalsi01@exchange.louisville.edu|
20207681|NCT03676465|University of Virginia|Dr. Mark DeBoer|(434) 924-5956|deboer@virginia.edu|
20207682|NCT01866306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207683|NCT00796549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207684|NCT01836029|VentiRx|Kristi Manjarrez|206 689 2256|kmanjarrez@ventirx.com|
20207685|NCT03523715|University of Southern California|Begum Ozel, MD|562-657-2961|ozel@usc.edu|
20207686|NCT00606229|Otsuka Pharmaceutical CO., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20207687|NCT02139280|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603.650.4628|Kenneth.R.Meehan@hitchcock.org|
20207688|NCT01332851|Family and Child Nursing, University of Washington|Dr. Monica Oxford|206-685-6107|mloxford@uw.edu|
20207689|NCT03299166|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20207690|NCT01425853|Bioiberica|Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
20207691|NCT00422903|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207692|NCT00801138|Cleveland Clinic Foundation|Daniel I Sessler, MD|2164458396|sesslerd@ccf.org|
20207693|NCT01947894|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207694|NCT01249157|Memorial Sloan Kettering|Dr. Maxine Jochelson|646-888-4507|JochelsM@mskcc.org|
20207695|NCT03796195|Northwestern University|David Walega, MD|3126952500|d-walega@northwestern.edu|
20207696|NCT02996994|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
20207697|NCT02392468|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207698|NCT03630016|Owlet Baby Care, Inc.|Madison Kenley, CCRP, BS|801-552-8383|mkenley@owletcare.com|
20207699|NCT01562678|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|617-667- 8630|cmantzor@bidmc.harvard.edu|
20207700|NCT02470429|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20207701|NCT00090766|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20207702|NCT00804986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20207703|NCT00959699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20207704|NCT03887286|University of Miami|Mary Sokoloski|305 585-6683|msokoloski@med.miami.edu|
20207705|NCT01885104|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207706|NCT02858713|Department of Dermatology, Odense University Hospital|M.D. Mathias Tiedemann Svendsen|+45 61265827|m_tiedemann@hotmail.dk|
20207707|NCT00126425|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
20207708|NCT01895634|Johnson & Johnson K.K. Medical Company|Depertment Chief, Clinical Operation|+81-3-4411-6789|yikeda5@its.jnj.com|
20207709|NCT03325010|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20207710|NCT02402881|The Johns Hopkins University|Elliott R Haut, MD PhD|410-502-3122|ehaut1@jhmi.edu|
20207711|NCT00926263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207712|NCT04350372|Abbott Structural Heart|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
20207713|NCT02460172|ZipLine Medical|Wendy Winters, Clinical Project Manager|408-506-1866|wwinters0@gmail.com|
20207714|NCT00113555|Uromedica|Timothy Plouffe|763-999-7048|tplouffe@uromedica-inc.com|
20207715|NCT03864627|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20207716|NCT00112840|University of Miami - Sylvester Comprehensive Cancer Center|Jaime Merchan, M.D.||jmerchan2@med.miami.edu|
20207717|NCT00683774|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
20207718|NCT02875366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20207719|NCT03595176|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
20207720|NCT03374891|"University of Colorado Denver | Anschutz"|Daniel Matlock, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20207721|NCT01201967|Massachusetts General Hospital|Jeff C. Huffman, MD|6177242910|jhuffman@partners.org|
20207722|NCT02497287|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207723|NCT02422186|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207724|NCT03074318|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
20207725|NCT01712776|Cleveland Clinic|Dr. Sharon E. Mace, Director of Research, ESI|(216) 445-4598|maces@ccf.org|
20207726|NCT01030757|University of New Mexico|Ben Liem, MD|505-272-0086|bliem@salud.unm.edu|
20207727|NCT01952041|University of Washington School of Medicine|Dror Ben-Zeev, PhD|(206) 685-9655|dbenzeev@uw.edu|
20226051|NCT00950729|Centre hospitalier universitaire de Sherbrooke (CHUS)|François Cabana|1-819-346-1110|francois.cabana@usherbrooke.ca|14233
20226052|NCT01944644|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
20226053|NCT00168428|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20207728|NCT03650387|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
20226054|NCT05381454|University of Texas Southwestern Medical Center|Theodoros Kelesidis|2146488979|Theodoros.Kelesidis@UTSouthwestern.edu|
20207729|NCT01370499|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20185227|NCT01215344|Vanderbilt-Ingram Cancer Center|Madan Jagasa, M.D.|(6150 936-8422|madan.jagasia@vanderbilt.edu|
20185228|NCT00393484|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20185229|NCT00879060|Tufts Medical Center|Martin Maron, MD|(617) 636-8066|mmaron@tuftsmedicalcenter.org|
20185230|NCT03294499|Imperial College Healthcare NHS Trust|Dr Farai Nyatsanza|n/a|farai.nyatsanza@nhs.net|
20185231|NCT04767698|Johns Hopkins University, School of Medicine|Dimitrios Ladakis|410-614-1522|dladaki1@jhmi.edu|
20185232|NCT01381471|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185233|NCT00780234|Rocky Mountain Regional VA Medical Center|Robert L. Keith, MD|720-857-5120|robert.keith@ucdenver.edu|
20185234|NCT00132964|Hospital for Sick Children|Kathy Boutis|4168138982|kathy.boutis@sickkids.ca|
20185235|NCT00088413|National Cancer Institute|Dr. James Gulley|301-480-8870|james_gulley@nih.gov|
20185236|NCT04011631|SMART Clinical Products|Ellie Coumans|+31 (0)6 53 82 70 16|e.coumans@smartclinicalproducts.com|
20185237|NCT02382744|Department of Anesthesia, St. Paul's Hospital/Providence Health Care|Dr. Stephan Schwarz, Director of Research|(604) 806-8337|stephan.schwarz@ubc.ca|
20226055|NCT01826981|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20226056|NCT03457818|Columbia University|Dr. Mishaela Rubin|2019528237|mrr6@cumc.columbia.edu|
20226057|NCT01393522|Mercy Health Research|Timothy R. Smith, MD|314-251-8895|Timothy.Smith@mercy.net|
20226058|NCT01796301|Amgen Inc.|Study Director|866-572-6436||
20226059|NCT00667563|AMC|Jeannette Y. Lee|5015266712|jylee@uams.edu|
20226060|NCT01041274|NYU Langone Medical Center|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
20226061|NCT02028780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226062|NCT00777335|University of California Los Angeles (UCLA) / Cancer International Research Group (CIRG) (Translational Research in Oncology TRIO) Inc.|Dr. Richard Finn|+ 1 310 586 2091|RFinn@mednet.ucla.edu|
20226063|NCT00264290|University of California, San Francisco|Peter W. Hunt, M.D.|415-476-4082|phunt@php.ucsf.edu|345
20226064|NCT00707980|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20226065|NCT02163681|University of Missouri|Talissa Altes, MD|573-882-1026|altest@health.missouri.edu|
20226066|NCT02455453|Washington University School of Medicine|Farrokh Dehdashti, M.D.|314-747-1604|dehdashtif@wustl.edu|
20185238|NCT01044303|East Carolina University|Dr. Paul Bolin|252-744-3773|bolinp@ecu.edu|
20185239|NCT02539225|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20185240|NCT01411592|University of Kiel|Dr. Martin Sasse, D.M.D., Assistant Professor|+494315972874|sekretariat@proth.uni-kiel.de|
20185241|NCT00212134|Stanford University School of Medicine|Scott R Lambert, MD, Study Chairman|650-498-4242|lambert7@stanford.edu|
20185242|NCT01109524|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20185243|NCT01553058|University of Pennsylvania|Suzette Baez VanderBeek, MPH|215-662-3514|suzettev@upenn.edu|
20185244|NCT00194610|University of Washington|Claire Yang, MD|206-744-6384|cyang@uw.edu|
20185245|NCT02318134|First Affiliated Hospital of Nanchang University|Dr. Ling Ding|15279196058|2495802456@qq.com|
20185246|NCT05123742|Rutgers School of Dental Medicine|Cecile A. Feldman, DMD, MBA|9739724634|feldman@sdm.rutgers.edu|
20207730|NCT00887822|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20207731|NCT05815758|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20207732|NCT03661983|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20207733|NCT02903966|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207734|NCT01320033|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20207735|NCT02045979|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207736|NCT00963469|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207737|NCT00585104|University of Utah Health Sciences Center|Andrew D. Michaels, MD|(801) 585-5971|Andrew.Michaels@hsc.utah.edu|
20207738|NCT00782756|Memorial Sloan Kettering Cancer Center|Dr. Philip Gutin|212-639-8556|gutinp@mskcc.org|
20207739|NCT03979495|Massachusetts General Hospital|Dr. Jennifer Haas|617-724-1832|jhaas@mgh.harvard.edu|
20207740|NCT00354484|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20207741|NCT00378534|NIH NHLBI OCD DIR ORIC|Sara Hauffe, RN Protocol Liaison|301-827-2720|sara.hauffe@nih.gov|
20207742|NCT04969900|Principal Investigator|Dr. Leanne Free|303-724-8576|leanne.free@cuanschutz.edu|
20207743|NCT03691649|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20207744|NCT03537937|Pragmatic Critical Care Research Group|Chair of the Steering Committee|(615) 322-3412|matthew.w.semler@vumc.org|
20226067|NCT00649792|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
20226068|NCT06363292|Laboratorios Sophia|Alejandra Sanchez Rios|+ 52 33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
20226069|NCT04217317|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-5878|dfunes@wakehealth.edu|
20226070|NCT02087943|CelgeneCorp|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|amcclain@celgene.com|
20226071|NCT02716506|Kanta-Häme Central Hospital|Dr Nina Mattsson|+358407338307|nina.mattsson@fimnet.fi|
20226072|NCT03836209|PrECOG|Li Chen, MS; Statistician|857-284-3670|Li Chen <lic@ds.dfci.harvard.edu>|
20226073|NCT03739710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20226074|NCT01753115|Emergent BioSolutions|Robert Hopkins, MD, MPH & TM, FACP, FIDSA, Medical Monitor|301-944-0136|HopkinsR@ebsi.com|
20185247|NCT00031694|Montefiore Medical Center-New York cancer Consortium|Joseph Sparano|718-405-8404|jsparano@montefiore.org|
20185248|NCT01976312|Novartis|Study Director|862-778-8300||
20185249|NCT03010631|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20226075|NCT03642067|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20226076|NCT03124160|FHI 360|David Hubacher|+1-919-321-3459|dhubacher@fhi360.org|
20226077|NCT04313400|Amarex Clinical Research, LLC|Dr. Ahmad Bayat, Sr Director II, Regulatory Affairs|301-956-2523|ahmadb@amarexcro.com|
20226078|NCT01263717|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
20226079|NCT05753735|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Nikola Anusic, Protocol Study Coordinator|216-421-5986|a.nikolau@icloud.com|
20226080|NCT01461473|Stanford University|Clete A. Kushida, M.D., Ph.D.|650-721-7560|clete@stanford.edu|
20226081|NCT01784926|Oslo University Hospital|Dr. Olav Kristianslund|+4723015168|olav.kristianslund@medisin.uio.no|
20226082|NCT00329745|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226083|NCT01534416|Icahn School of Medicine at Mount Sinai|Dr. Rachel L. Barr Grzesh|212-241-2995|rachel.barr@mssm.edu|
20226084|NCT03224624|VA San Diego Healthcare System|Dena Rifkin|8585528585|dena.rifkin@va.gov|2784
20226085|NCT01884545|NYU Rory Meyers College of Nursing|Allison A. Vorderstrasse, DNSc, APRN, FAAN|212-998-5786|allisonvorderstrasse@nyu.edu|
20226086|NCT01424241|Columbia University Medical Center|Pamela Freda, MD|212-305-2254|puf1@columbia.edu|
20226087|NCT02782377|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
20226088|NCT01648920|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA. Director, Clinical Development and Medical Affairs|919-449-8873|nancy.herje@aerocrine.com|
20226089|NCT00303472|Amgen Inc.|Study Director|866-572-6436||
20226090|NCT05537428|Yale University|Philip Corlett|2039747866|philip.corlett@yale.edu|
20226091|NCT03360214|Columbia University|Sherene Ishtihar|212-342-3681|si2271@cumc.columbia.edu|
20226092|NCT01249833|Trial Management Group Inc.|Joanne Morris, Clinical Research Quality Manager|4169297717|joanne@tmginvestigators.com|
20226093|NCT03796676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226094|NCT00535392|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20226095|NCT02828137|Inha University Hospital|Dr. Sung Woo Kwon|821031133363|kwonswdr@gmail.com|
20226096|NCT00262002|Novartis Vaccine and Diagnostics S.r.l|Posting Director||RegistryContactVaccineUS@novartis.com|
20226097|NCT01085084|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20226098|NCT02749799|Dr. Reddys Laboratories Inc|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20226099|NCT02070978|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20226100|NCT03951753|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20226101|NCT04633291|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
20226102|NCT01905592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20226103|NCT01037816|Hisamitsu Pharmaceutical Co., Inc.|Yoshinobu Higashi, Section Manager, International Regulatory Affairs|+81-3-5293-1712|Yoshinobu_Higashi@hisamitsu.co.jp|
20226104|NCT02371668|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
20226105|NCT03417752|VA Center of Excellence for Suicide Prevention|Elizabeth Karras, PhD|585-393-7285|elizabeth.karras-pilato@va.gov|
20226106|NCT02771860|University Gent|Prof. dr. Ruth Wittoek|+3293322522|anuschka.vandenbogaert@uzgent.be|
20226107|NCT00314808|Duke University|Deborah H. Allen, MSN, RN, CNS, FNP-BC, AOCNP|(919) 681-4719|allen079@mc.duke.edu|
20226108|NCT04304508|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20207745|NCT04423718|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20226109|NCT00699400|EMD Serono, Inc.|Mary C. Mahony, PhD, HCLD (AAB)|781.681.2438|mary.mahony@emdserono.com|
20226110|NCT01775787|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
20226111|NCT01299896|Vanderbilt University|Dr. Hilary A. Tindle|615-875-9726|hilary.tindle@vanderbilt.edu|
20226112|NCT04474054|FARAPULSE|Christopher (Kit) Schneider|617-686-7661|christopher.schneider@bsci.com|
20226113|NCT05725824|University of Arizona|Dr. Bryan Wong|5206268549|bryanwong@arizona.edu|
20226114|NCT01502956|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20226115|NCT01616758|Oncternal Therapeutics|Mary Bretimeyer|8582092082|mbreitmeyer@oncternal.com|208
20226116|NCT01466075|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20226117|NCT00199849|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20226118|NCT04727528|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20226119|NCT04656301|NY State Psychiatric Institute|Dr. Franklin Schneier|6467748041|franklin.schneier@nyspi.columbia.edu|
20226120|NCT00576524|Children's Hospital of Philadelphia|Marsha Wallace|(215) 590-0119|wallacem@email.chop.edu|
20226121|NCT01662856|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
20226122|NCT03479008|Unversity of Michigan|Dr. Benjamin Bassin|734 763-2134|bsbassin@med.umich.edu|
20226123|NCT01704755|AbbVie (prior sponsor, Abbott)|Global Medical Information|800 633-9110||
20226124|NCT02872909|University of Dundee|Professor Sally Ibbotson|01382 383499|s.h.ibbotson@dundee.ac.uk|
20226125|NCT02187029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226126|NCT01188668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226127|NCT03571607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226128|NCT02937636|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20162937|NCT00398567|Puma Biotechnology, Inc|Senior Director, Clinical Operations|+1 424 248 6500|clinicaltrials@pumabiotechnology.com|
20207746|NCT00425945|Stanford University School of Medicine|Dr. Randall Stafford|650-724-2400|rstafford@stanford.edu|
20226129|NCT00770913|Eisai Co.,Ltd. Eisai Product Creation Systems|Tomoki Kubota, Study Director|+81-3-3817-3908|t2-kubota@hhc.eisai.co.jp|
20226130|NCT00596102|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 20620|info@valneva.com|0
20226131|NCT00359294|PharmaMar USA Inc|Responsible medical officer|1 212 201 6770|ccoronado@pharmamar.com|
20226132|NCT00583011|University of Oklahoma Health Science Center|Andrew Elimian, MD|9142317323|aelimian@aol.com|
20226133|NCT04208412|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
20226134|NCT02946021|Tactile Medical|Jill Christensen|(612) 355-5123|jchristensen@tactilemedical.com|
20226135|NCT01090141|Unknown|Tawanda Gumbo||Unknown@utsouthwestern.edu|
20226136|NCT01348100|Novartis Pharmaceuticals|Study Director|862 778-8300||
20226137|NCT01129804|UConn Health|Mark D. Litt, PhD; Principal Investigator|860-679-4680|litt@uchc.edu|
20185250|NCT01538719|Boston University School of Medicine|Eric A Stratton, Sr. Clinical Research Manager|6174142507|eas@bu.edu|
20226138|NCT02347072|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-350-2600|creisner@pearltherapeutics.com|
20185251|NCT02556138|Mayo Clinic|Dr. Kymberly Watt|507-266-1686|Watt.Kymberly@mayo.edu|
20185252|NCT00475241|VA Ann Arbor Healthcare System|Dr. Sheila A.M. Rauch|734-845-3545|sherauch@med.umich.edu|
20185253|NCT02807779|University of California, San Francisco|Warren Gasper, MD|415-353-4366|warren.gasper@ucsf.edu|
20185254|NCT06024174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20185255|NCT03757949|SWOG|Danika Lew|206-667-2272|dlew@fredhutch.org|
20185256|NCT03725722|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20226139|NCT01608672|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20226140|NCT02259699|University of California, Irvine|Dr. Lari Wenzel|949-824-3926|lwenzel@uci.edu|
20226141|NCT00777062|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
20226142|NCT01134393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226143|NCT03658642|Yale School of Medicine|Ted Melnick, MD, MHS Associate Professor of Emergency Medicine and of Biostatistics (Health Informat|(203) 785-5174|edward.melnick@yale.edu|
20226144|NCT00098670|The Ohio State University|Dr. Thomas Lin||thomas.lin@osumc.edu|
20226145|NCT01808222|Emory University|David Schuster MD|404-712-4859|dschust@emory.edu|
20226146|NCT03290391|Boston Medical Center and BU Chobanian & Avedisian School of Medicine|Jeffrey Samet, MD MA MPH|(617) 414-7288|jsamet@bu.edu|
20226147|NCT03762681|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20226148|NCT02548949|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226149|NCT01396551|Varian Medical Systems|Julie Allen|206-330-2605|julie.allen@varian.com|
20226150|NCT00524680|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20226151|NCT01146561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226152|NCT02801370|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20226153|NCT04318132|Nidek.co., ltd.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
20226154|NCT01124370|Respicardia|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
20226155|NCT00073008|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226156|NCT01926197|Stanford Medicine at Stanford University|Samantha Wong|650-498-8495|swong8@stanford.edu|
20226157|NCT03628716|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
20226158|NCT00856843|Braintree Laboratories, Inc.|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
20226159|NCT00829829|Regeneron Pharmaceuticals, Inc. Phone:|Clinical Trial Management||clinicaltrials@regeneron.com|
20226160|NCT02984267|Arizona Anesthesia Consultants|Dr. Thomas Vernon|480-570-7082|tvernon@azanesthesia.net|
20226161|NCT02685072|Yale School of Public Health|Kimberly Yonkers, MD|(203) 764-6621|kimberly.yonkers@yale.edu|
20226162|NCT01342172|Icahn School of Medicine at Mount Sinai|Dr. Matthew Galsky|212-241-8816|matthew.galsky@mssme.edu|
20226163|NCT01289574|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
20226164|NCT03402230|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
20226165|NCT03885999|The Chinese University of Hong Kong, Department of Surgery, Prince of Wales Hospital|Dr. Kaori Futaba|0085264630121|kfutaba@surgery.cuhk.edu.hk|
20226166|NCT02452554|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20226167|NCT03634813|Yale School of Medicine|Robert B. Schonberger, Director of Clinical Scientist Track Program|203-785-3941|robert.schonberger@yale.edu|
20226168|NCT02669043|Massachusetts General Hospital|Dr.Cristina Cusin|617-726-6421|ccusin@partners.org|
20226169|NCT03884270|Loyola University Chicago|Dr. Sarah Kinsinger|708-216-0464|sarah.kinsinger@lumc.edu|
20226170|NCT02919007|Home Skinovations|Dr Liora Levi|+97249097470|LioraL@silkn.com|
20226171|NCT00467558|University of Minnesota|Jon E. Grant, MD|612-273-9736|grant045@umn.edu|
20226172|NCT04679948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226173|NCT02636439|Wake Forest School of Medicine|Dalane W. Kitzman, MD|336-716-3274|dkitzman@wakehealth.edu|
20226174|NCT02494401|University of New Mexico|Janet Poole|(505) 272-1753|JPoole@salud.unm.edu|
20226175|NCT05188729|Verrica Pharmaceuticals|Susan Cutler, VP Medical Affairs|484-773-089|scutler@verrica.com|
20226176|NCT03646487|University of Illinois Chicago|Mary Dawn Koenig, PhD, RN, FACNM|312-996-7982|marydh@uic.edu|
20226177|NCT01732445|Mayo Clinic|Ruben A. Mesa, M.D.|480/301-8335|mesa.ruben@mayo.edu|
20226178|NCT00520767|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
20226179|NCT00376532|Thomas Jefferson University|David J. Whellan MD|215 955 2636|david.whellan@jefferson.edu|
20226180|NCT01133704|Dendreon Corporation|Kathleen Picha|206-265-4545|kpicha@dendreon.com|
20226181|NCT02207400|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185257|NCT04310735|The Pennsylvania State University|Stephen Wilson|8148656219|sjw42@psu.edu|
20185258|NCT03398200|University of Rochester|Omar Aljitawi, MD|(585) 275-4099|Omar_Aljitawi@URMC.Rochester.edu|
20185259|NCT01649271|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207747|NCT02881151|Stanford University School of Medicine|Dr. Jaimie Henderson|+1 (650) 723-5574|henderj@stanford.edu|
20207748|NCT03315702|Department of Anesthesia, Xinhua hospital affiliated to Shanghai Jiaotong University School of medicine|Dr. Lai Jiang|021-25078999|jianglaimz@sina.com|
20207749|NCT03258593|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
20207750|NCT00732654|Johns Hopkins University|Corinne Keet|4109555883|pediatricallergy@jhmi.edu|
20207751|NCT05618808|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20207752|NCT03381274|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20207753|NCT04284787|Yale School of Medicine|Amer Zeidan, MBBS Professor of Internal Medicine (Hematology)|(203) 200-4363|amer.zeidan@yale.edu|
20207754|NCT01874353|AstraZeneca|Global Clinical Program Lead|1-877-240-9479|information.center@astrazeneca.com|
20207755|NCT00911183|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
20207756|NCT04228276|Palo Alto VA|Dr. Jong Yoon|6504935000|jong.yoon@va.gov|
20207757|NCT03825536|University of California, San Francisco|Sulggi A. Lee|415-735-5127|sulggi.lee@ucsf.edu|
20207758|NCT06085443|YSLAB|Mélody DUTOT|33 (0)2.98.53.30.03|melody.dutot@yslab.fr|
20207759|NCT02559115|Memorial Sloan Kettering Cancer Center|Dr. Hebert A. Vargas Alvarez , MD|646-888-5410|vargasah@mskcc.org|
20207760|NCT00557362|University of California San Francisco Proctor Foundation|Tom M/ Lietman|4155022662|tom.lietman@ucsf.edu|
20207761|NCT02756845|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20207762|NCT04732780|Imperial College London|Dr Vicky McKechnie|02083830689|vicky.mckechnie@nhs.net|
20207763|NCT00772889|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207764|NCT01563406|Rush University Medical Center|Mary Hayden, MD|3129428727|mhayden@rush.edu|
20207765|NCT05559203|University of Stirling|Prof Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
20207766|NCT01937624|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Kyle Cassas|864-454-7422|kcassas@ghs.org|
20207767|NCT00255008|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20207768|NCT02092168|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20207769|NCT00707486|HemCon Medical Technologies|Staci McAdams|(503)245-0459|staci@hemcon.com|103
20207770|NCT03296072|GlaxoSmithKline|GSK Response Center|866-435-7343 Ext:|GSKClinicalSupportHD@gsk.com|
20207771|NCT02421146|Psychiatry Research, The Zucker Hillside Hospital|Andrea Joanlanne|7184708898|ajoanlanne@northwell.edu|
20207772|NCT04474366|University of California, San Francisco|Esther Kim|415-353-9392|Esther.kim@ucsf.edu|
20207773|NCT03398824|Boston Children's Hospital|Akiko Shimamura|617-919-6946|akiko.shimamura@childrens.harvard.edu|
20207774|NCT05307523|University of Washington|Reham A. Abuatiq, Research coordinator and a PhD candidate|6198309638|rabuat@uw.edu|
20207775|NCT03144089|University of Iowa Hospitals and Clinics|Ron Abrons, MD|(319) 353-8061|ron-abrons@uiowa.edu|
20207776|NCT03858686|Foresee Pharmaceuticals|Yisheng Lee, MD, Chief Medical Officer|4088234807|yisheng.lee@foreseepharma.com|
20207777|NCT04412668|aTyR Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20207778|NCT01868594|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20207779|NCT00356434|Johns Hopkins Univ|Abimbola Aina|410-955-8496|aaina1@jhmi.edu|
20207780|NCT06853210|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
20207781|NCT02116361|Allergan, Inc|Arlene Lum, PMP|714-246-5548|lum_arlene@allergan.com|
20207782|NCT02659098|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207783|NCT04363944|University at Buffalo|Dr. Jeanne Langan|17168292905|jlangan@buffalo.edu|
20207784|NCT03517722|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI.|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207785|NCT03573804|Dartmouth-Hitchcock|Timothy B Rooney, MD, PI|603-650-5000|timothy.b.rooney@hitchcock.org|
20207786|NCT01425307|The University of Texas School of Public Health|Barry Robert Davis|713-500-9515|barry.r.davis@uth.tmc.edu|
20207787|NCT03649815|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
20207788|NCT00952419|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20207789|NCT00758576|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20207790|NCT01592773|Forest Research Institute|Joel Trugman, MD|201-427-8681|Joel.Trugman@frx.com|
20207791|NCT04418427|Adverum Biotechnologies|Study Medical Director|650-656-9323|clinicaltrials@adverum.com|
20207792|NCT01293123|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
20207793|NCT04495673|University of Minnesota|Kelvin Lim|(612) 626-6772|kolim@umn.edu|
20207794|NCT03738878|Yale University|Nancy J. Brown|2037854672|nancy.j.brown@yale.edu|
20207795|NCT01888965|Georgetown Lombardi Comprehensive Cancer Center|John L Marshall|202 444 7064|marshalj@georgetown.edu|
20207796|NCT04076579|University of Michigan Rogel Cancer Center|Clinical Trials Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20207797|NCT03793010|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
20207798|NCT03770689|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20207799|NCT03040479|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20207800|NCT01736176|AbbVie|Global Medical Services|800-633-9110||
20207801|NCT00186121|Stanford University Medical Center|Melinda Telli, MD|650-724-9533|mtelli@stanford.edu|
20185260|NCT01489813|Emory University|Omer Kucuk|404-778-4729|okucuk@emory.edu|
20207802|NCT00417248|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20207803|NCT01569568|Children's National Medical Center|Dr. Andrea Gropman|202-476-2120|agropman@childrensnational.org|
20226182|NCT03638466|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
20192357|NCT01937195|Evangelical Community Hospital|Norman R. Anderson|570-222-2000|nanderson@evanhospital.com|
20226183|NCT03251482|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20226184|NCT04508647|University of Colorado Hospital|Manali Kamdar, MD|720-848-6400|manali.kamdar@cuanschutz.edu|
20226185|NCT02447328|AstraZeneca Korea|Karin Otter, MD, PhD|+82 2 2188 0968|Karin.Otter@astrazeneca.com|
20226186|NCT00707967|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226187|NCT02155309|Henry Jackson Military Foundation for Naval Medical Research Unit - Dayton|Daniel Geyer, MPH|(937) 938-3922|daniel.geyer.1.ctr@us.af.mil|
20226188|NCT00006244|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20226189|NCT01220726|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
20226190|NCT02511132|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
20192358|NCT02263040|Mount Sinai Hospital, Toronto|Dr. Allison McGeer|416-586-3118|allison.mcgeer@sinaihealthsystem.ca|
20192359|NCT00511836|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
20192360|NCT00030823|Memorial Sloan Kettering Cancer Center|Dr. Teresa Gilewski|646-888-4557|gilewskt@mskcc.org|
20192361|NCT01755546|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
20192362|NCT01114139|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20192363|NCT03376555|Penn State University|Professor Lacy Alexander|8148671781|lma191@psu.edu|
20192364|NCT02536742|International Breast Cancer Study Group|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
20192365|NCT04629443|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20192366|NCT03954223|Children's Hospital Los Angeles|Alaina Vidmar, MD|323-361-3385|avidmar@chla.usc.edu|
20192367|NCT02431455|Lahey Hospital and Medical Center|Haddon Pantel|3013566674|Haddon.Pantel@Lahey.org|
20192368|NCT03468179|Vanderbilt University|Sean S. Davies|6153225049|sean.davies@vanderbilt.edu|
20192369|NCT00858247|Mayo Clinic|Seema Kumar, MD|507-284-3300|kumar.seema@mayo.edu|
20192370|NCT02512861|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
20192371|NCT01172639|University Hospitals Leuven|Prof. Dr. Patrick Verschueren|+32 16 34 25 41|patrick.verschueren@uzleuven.be|
20226191|NCT01649362|Centre Hospitalier de Luxembourg|Dr Manon Bache|+352 4411 3157|manon.bache@hotmail.com|
20226192|NCT02030119|Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
20226193|NCT03746405|Duke University|Dr Lysianne Beynel|919-681-1157|lysianne.beynel@duke.edu|
20226194|NCT02753816|Spectrum Health|Dr. Betsy Steensma|(616) 391-5701|elizabeth.steensma@spectrumhealth.org|
20226195|NCT00112918|Hoffman-LaRoche|Medical Communications|800-821-8590||
20226196|NCT02372383|UColorado|Dr. Stacey Martiniano|7207776181|stacey.martiniano@childrenscolorado.org|
20226197|NCT01999985|H. Lee Moffitt Cancer Center and Research Institute|Thoracic CRO, attn: Dr. Ben Creelan|813-745-3050|ben.creelan@moffitt.org; thoraciccro@moffitt.org|
20226198|NCT03130959|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20226199|NCT02384538|AbbVie|Global Medical Services|800-633-9110||
20226200|NCT03042910|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226201|NCT00313586|ECOG Statistical Office|Study Statistician|617-632-3012||
20226202|NCT02087670|Universidad de Antioquia|Jesus Alberto Plata Contreras|5742196478|rehabilitacionsalud@siu.udea.edu.co|
20226203|NCT00479115|Cincinnati Children's Hospital Medical Center|Stella Davies, MBBS, PhD, MRCP|513-636-1371|Stella.Davies@cchmc.org|
20226204|NCT04472494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20226205|NCT03519919|CooperVision.Inc|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20226206|NCT03076996|FHI 360|Dr. Lisa Dulli|919-544-7040|ldulli@fhi360.org|11396
20226207|NCT01027468|Medical University of Vienna|Assoc.Prof.PD.Dr.Stefan Sacu|+43404001|stefan.sacu@meduniwien.ac.at|7937
20226208|NCT00988000|Imperial College|Professor Martyn Partridge|+44 (0)20 7594 7959|m.partridge@imperial.ac.uk|
20226209|NCT02144077|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32 66|ameluz@biofrontera.com|
20226210|NCT01909973|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20226211|NCT01462305|Philips|Sr. Clinical Development Scientisit|+41 79 460 0622|fatima.sertkuniyoshi@philips.com|
20226212|NCT00169104|Dartmouth-Hitchcock Medical Center / Norris Cotton Cancer Center|Gary N. Schwartz MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
20226213|NCT00368459|Stanford University|Victor Henderson|650-723-5456|vhenderson@stanford.edu|
20226214|NCT01457417|Healthcare Pharmaceuticals, Inc|Cynthia Sirard, MD|617-714-0357|CSirard@hcven.com|
20226215|NCT00715299|VAHSRD and Medical University of South Carolina|Steve Kautz, PhD, Principal Investigator|843-792-3867|kautz@musc.edu|
20226216|NCT02020889|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226217|NCT01540981|UNMC|Joyce Black|(402) 559-6573|jblack@unmc.edu|
20226218|NCT00809094|Stanford University|Dr. Carol Conrad|650-723-8325|cconrad@stanford.edu|
20226219|NCT02094326|Hospital Virgen de la Macarena|Dr. Federico Navarro Sarabia|+34 955 00 80 00|federico.navarro.sarabia@gmail.com|
20226220|NCT02620683|University of North Carolina Chapel Hill|Dr Raymond P. White Jr|919-537-3944|ray_white@unc.edu|
20226221|NCT01535443|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medial Director|+52 (33)30014200|lbaiza@sophia.com.mx|
20192372|NCT02447432|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226222|NCT00232557|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20226223|NCT00893074|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
20185261|NCT05644002|Rutgers, the State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
20207804|NCT00934791|Mayo Clinic|Dr. Patrick G. Dean|507-266-6953|dean.patrick2@mayo.edu|
20185262|NCT04842500|Vanderbilt University|Dr. Joseph Lambert|615-343-0824|joseph.m.lambert@vanderbilt.edu|
20185263|NCT06180967|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20185264|NCT05756075|Radboudumc|Drs. D. de Graaf|+31243613450|debbie.degraaf@radboudumc.nl|
20185265|NCT03433469|University of California, San Francisco|Dr. Collin M. Blakely, MD, PhD|(415) 502-6959|collin.blakely@ucsf.edu|
20185266|NCT04605198|University of California, Los Angeles|Dr. Dana Rose Garfin, Associate Professor|415-407-9498|dgarfin@ucla.edu|
20185267|NCT02605837|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20185268|NCT05075408|Galderma Research & Development, LLC|Sponsor|8179615000|aestheticclinicaltrials@galderma.com|
20185269|NCT01727518|Ludwig Boltzmann Institute for Lung Health|Dr Robab Breyer-Kohansal|+436505398439|Robab.Breyer-Kohansal@lunghealth.lbg.ac.at|
20226224|NCT02260817|Decatur Memorial Hospital, Decatur, IL|Thomas H. Tarter, M.D., Ph.D - Director, Urologic Oncology, Cancer Care Specialists of Illinois|(217) 876-6600|ttarter@ccsci.net|
20185270|NCT05419505|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
20185271|NCT05683392|Tandem Diabetes Care, Inc|Supervisor, Clinical Affairs|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
20185272|NCT02780388|Viela Bio|Viela Bio Clinical Operations|+1 240-558-0038|ClinicalTrials@VielaBio.com|
20185273|NCT04527146|UPenn|Rachel Paul, Genetic Counselor|215-490-5816|rachel.paul3@pennmedicine.upenn.edu|
20185274|NCT05107401|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
20185275|NCT01563341|Mayo Clinic|Ryan J. Uitti, MD|904-953-2000|uitti.ryan@mayo.edu|
20185276|NCT04337372|University of Florida|Lisa Scott|352-273-2125|lscott@ufl.edu|
20185277|NCT05307783|Merit Medical|Vicky Brunk|(385) 766-9152|vicky.brunk@merit.com|
20185278|NCT04883645|Medical University of South Carolina|Dr. Angela J. Yoon|8437924496|yoona@musc.edu|
20185279|NCT00977691|National Heart Lung and Blood Institute|Courtney Fitzhugh, MD, Investigator|+1 301 402 6496|courtney.fitzhugh@nih.gov|
20185280|NCT03460236|Stanford University|Christine Hoang, Clinical Research Coordinator|650-721-7630|c1hoang@stanford.edu|
20226225|NCT02826161|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
20226226|NCT04435808|The University of New Mexico School of Medicine|Walter Dehority|5052725535|wdehority@salud.unm.edu|
20226227|NCT03299101|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
20226228|NCT05347966|UBC|Dr. Haakon Nygaard|604-827-0600|haakon.nygaard@ubc.ca|
20226229|NCT02488018|Addis Ababa University [Office telephone +251011-655-1927]|Abera Belay (PhD Candidate)|Mobile +251911840655|ab.berabelay@gmail.com|
20226230|NCT00351936|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
20226231|NCT03882957|Geisel School of Medicine (Dartmouth College)|Diane Gilbert-Diamond|603-646-5403|diane.gilbert-diamond@dartmouth.edu|
20226232|NCT03337048|Coloplast A/S|Vice President, Medical Affairs|+45 49111111|clinical-studies@coloplast.com|
20185281|NCT03890913|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20226233|NCT01819844|Massachusetts General Hospital|Steven J. Russell|617-726-8722|sjrussell@partners.org|
20226234|NCT04399538|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192373|NCT00156923|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
20192374|NCT01585298|Novartis Pharmaceuticals|Study Director|862-778-8300||
20192375|NCT00014222|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
20192376|NCT03398421|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20192377|NCT01009138|Research Institute of the Diabetes Academy Mergentheim|Dr. Bernhard Kulzer|+49 7931|kulzer@diabetes-zentrum.de|594151
20192378|NCT00874497|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20192379|NCT00644878|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20192380|NCT00948610|UCLA|Michael R. Irwin|3108258281|mirwin1@ucla.edu|
20192381|NCT00665223|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20192382|NCT00591591|ISS, Inc., Champaign Illinois|Antonios Michalos|217-359-8681|antonios.michalos@iss.com|
20192383|NCT00002597|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20192384|NCT01419977|Duke University Medical Center|Nirmish Shah, MD|919-684-5350|nirmish.shah@duke.edu|
20192385|NCT01426113|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20192386|NCT03579433|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20192387|NCT01494545|Alcon Research, Ltd|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20192388|NCT00468130|Rutgers University|Sherie Novotny, MD|7322354119|novotnsl@ubhc.rutgers.edu|
20192389|NCT00436956|National Cancer Institute|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
20192390|NCT02485899|BioMarin Pharmaceutical, Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
20192391|NCT03245463|Hospital for Special Surgery|Dr. James Wyss|2126061731|wyssj@hss.edu|
20192392|NCT03517111|Arizona State University|Dr. Sonia Vega-López|602-496-3350|sonia.vega.lopez@asu.edu|
20192393|NCT00912223|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20192394|NCT02719743|GlaxoSmithKline|GSK Response Center|866-435-7343|ct427449@gsk.com|
20192395|NCT01438840|Eisai Call Center|Eisai Inc.|888-422-4743||
20192396|NCT02601209|Memorial Sloan-Kettering Cancer Center|William D. Tap, MD|646-888-4156|tapw@mskcc.org|
20185282|NCT03494504|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20192397|NCT00193596|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20192398|NCT02261285|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
20207805|NCT02353806|University of Texas Southwestern Medical Center|Jamie Morgan, MD|214-645-3838|jamie.morgan@utsouthwestern.edu|2147665011
20185283|NCT04881162|Silk Road Medical|Heather Smith|763-335-5160|hsmith@silkroadmed.com|
20185284|NCT04832360|University of Georgia|Dr. Michelle vanDellen|706-542-8991|mvd@uga.edu|
20185285|NCT04869982|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20185286|NCT04608045|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
20185287|NCT05833789|Vanderbilt University Medical Center|Michael McGill|615-322-0128|michael.g.mcgill@vumc.org|
20185288|NCT02473250|Columbia University Irving Medical Center|Martin Lan MD PhD|646 774 7610|martin.lan@nyspi.columbia.edu|
20185289|NCT06023082|Citruslabs|Patrick Renner|(805) 292-0714|hello@citruslabs.com|
20185290|NCT03584516|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20185291|NCT05986565|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|
20185292|NCT04500301|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
20185293|NCT00448240|Henry Ford Health System|Tiffany Pearce, Director of Clinical Trials|313-575-8046|tpearce1@hfhs.org|
20185294|NCT00670046|UTHSCSA|Ron Rodriguez, MD, PhD|2105675643|rodriguezr32@uthscsa.edu|
20185295|NCT06146374|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
20185296|NCT03755141|Korea university Guro hospital|In Hae Park|+82-2-2626-3172|parkih@korea.ac.kr|
20207806|NCT02425891|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20185298|NCT01285635|University of Michigan Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
20185299|NCT04759833|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20185300|NCT03446157|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|919-445-4208|Melahat_Canter@med.unc.edu|
20185301|NCT01619410|University of Pennsylvania|Michael Z. David/Assistant Professor|215-662-6932|michdav@pennmedicine.upenn.edu|
20185302|NCT03405714|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20185303|NCT02462759|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20185304|NCT04110054|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20185305|NCT03693937|Sensus Healthcare|Isabelle Raymond|561-922-5808|iraymond@sensushealthcare.com|
20185306|NCT01000480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20185307|NCT00570700|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20185308|NCT02410018|IMBiotechnologies Ltd|President|780-945-6609|mstewart@tbwifi.ca|
20185309|NCT02374307|OsloMet - Oslo Metropolitan University|Maria Bjerk|+4767236683|maria.bjerk@oslomet.no|
20185310|NCT00632203|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20185311|NCT02641912|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185312|NCT04452318|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20185313|NCT02554786|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20185314|NCT00604669|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20185315|NCT01695954|NYU School of Medicine|Carlos Malvestutto, MD, MPH|212-263-3570|carlos.malvestutto@nyumc.org|
20185316|NCT03921866|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185317|NCT02395978|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
20185318|NCT03794024|Cleveland Clinic|Robert Bolash|216-444-3134|bolashr@ccf.org|
20185319|NCT03032406|University of Pennsylvania|Dr Angela DeMichele|2156624000|angela.demichele@pennmedicine.upenn.edu|
20185320|NCT03351699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20185321|NCT05644730|Ideal Medical Technologies|Dr. Leon DeJournett/Chief Medical Officer|8283379960|leondej@idealmedtech.com|
20185322|NCT03330795|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
20207807|NCT04124952|SightTrust Eye Institute|Andrew Shatz, MD|877.878.7890|ashatz@sighttrust.com|
20207808|NCT02306928|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45 7845 2845|krisoebr@rm.dk|
20185323|NCT05018910|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
20185324|NCT00539734|Prince of Songkla University|Patama Bhurayanontachai|66-74-451380|tpatama@hotmail.com|
20185325|NCT01771731|University of California San Francisco|Donald I. Abrams, MD|415-476-4082|Donald.Abrams@ucsf.edu|444
20185326|NCT00065260|NIH NHLBI|Dr. Bhavisha Patel|301.402.3477|bhavisha.patel@nih.gov|
20185327|NCT03161327|Saint Louis University|Dr. Keith Pereira|314-268-5782|keith.pereira@health.slu.edu|
20185328|NCT00490100|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
20185329|NCT03498196|Baylor College of Medicine|Jennifer M. Taylor, MD, MPH|713-797-7670|Jennifer.Taylor@bcm.edu|
20185330|NCT01037985|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185331|NCT05239182|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20185332|NCT01609218|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20185333|NCT00774852|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20207809|NCT00166504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20185334|NCT04428112|UCSF|Dr. Veronica Yank|415-476-9654|veronica.yank@ucsf.edu|
20185335|NCT05158153|University of California, San Francisco|Dr. Ian McCoy|415-476-2172|ian.mccoy@ucsf.edu|
20192399|NCT01702519|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192400|NCT02383407|George Washington University|Dr. Mohamad Koubeissi|202-741-2533|mkoubeissi@mfa.gwu.edu|
20185336|NCT05134337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20185337|NCT04592198|Xiamen LP Pharmaceutical Co.,Ltd|Matthew H Nieder|(415) 516-9498|matthew@lppharma.com|
20185338|NCT03481660|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
20185339|NCT01259401|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|9173
20185340|NCT00186992|St. Jude Children's Research Hospital|Matthew Krasin, MD|(901) 595-3226|matthew.krasin@stjude.org|
20185341|NCT03683069|Brigham and Women's Hospital|Gordon H. Williams, Professor of Medicine|617-223-1611|gwilliams@bwh.harvard.edu|
20185342|NCT05696080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20185343|NCT05768373|Solventum|Helen Han|6517856568|mhan3@solventum.com|
20185344|NCT05478525|Glyscend Therapeutics|Ashish Nimgaonkar, MD|6175483513|ashish.nimgaonkar@gmail.com|
20185345|NCT01991977|Mayo Clinic|Nadia N. Laack, MD|507/284-2511|Laack.Nadia@mayo.edu|
20185346|NCT04799197|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
20185347|NCT03845465|Vanderbilt University Medical Center|Sarah Jaser, PhD|6153436775|sarah.jaser@vumc.org|
20185348|NCT05656911|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20185349|NCT03547908|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20185350|NCT01536886|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20185351|NCT04541043|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
20185352|NCT04607044|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20185353|NCT05403801|Dana Farber Cancer Institute|Desiree Azizoddin|(617) 632-3000|desiree_azizoddin@dfci.harvard.edu|
20185354|NCT03416023|OstomyCure AS|Johan Järte|+46 706 524 532|jjaerte@ostomycure.com|
20185355|NCT03651895|Imperial College|Farne Hugo|+44 (0)20 7589 5111|h.farne@imperial.ac.uk|
20185356|NCT02837510|University of Pennsylvaina|James Loughead PhD|215-746-6827|loughead@pennmedicine.upenn.edu|
20185357|NCT03857620|University of Texas MD Anderson Cancer Center|George J. Chang, MD, MS|713-563-1875|gchang@mdanderson.org|
20185358|NCT03271151|Anesthesiology Critical Care & Pain Management|Dr. Jacques Yadeau|2127742224|Yadeauj@hss.edu|
20185359|NCT04118452|University of California, Los Angeles & Kaiser Permanente School of Medicine|Dr. Paul Chung, Professor and Principal Investigator|626-710-0389|paul.j.chung@kp.org|
20207810|NCT03057106|Canadian Cancer Trials Group|Dr. Keyue Ding|1-613-533-6430|kding@ctg.queensu.ca|77705
20185360|NCT03215030|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20185361|NCT03438188|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
20185362|NCT03433339|Lindner Center of HOPE/ University of Cincinnati Department of Psychiatry and Behavioral Neurosciences|Dr. Francisco Romo-Nava|513-536-0725|romofo@ucmail.uc.edu|
20185363|NCT05952076|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20185364|NCT05332340|Biozeus Biopharmaceutical S.A.|Joaquim Herzog de Oliveira Knox|+55 (21) 25239089|joaquim.knox@biozeus.com.br|
20185365|NCT04143061|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20185366|NCT04970407|Ipsen Innovation|Laurent Pons/Clinical Pharmacology Director|see email|clinical.trials@ipsen.com|
20185367|NCT02960230|University of California, San Francisco|Dr. Sabine Mueller, MD PhD|(415) 502-1600|Sabine.Mueller@ucsf.edu|
20185368|NCT03602014|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
20185369|NCT03401853|University of Washington|Stephen Smith, MD|(206) 606-6546|ssmith50@fredhutch.org|
20185370|NCT01898494|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20185371|NCT05540002|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
20185372|NCT03289039|Dana-Farber Cancer Institute|Jose Pablo Leone, MD|617-632-3800|josep_leone@dfci.harvard.edu|
20207811|NCT03261037|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20207812|NCT03139435|Wake Forest Baptist Comprehensive Cancer Center|Roy Strowd|336-713-5440|rstrowd@wakehealth.edu|
20207813|NCT02481986|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
20207814|NCT01944462|Thomas Jefferson University|Laura T. Pizzi, PharmD, MPH; Principal Investigator|215-955-1159|laura.pizzi@rutgers.edu|
20207815|NCT01222767|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20207816|NCT00723489|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20207817|NCT03657576|The University of Alabama at Birmingham|James Markert, MD|2059347171|jmarkert@uabmc.edu|
20207818|NCT04437511|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207819|NCT05032755|Duke University Medical Center|Maggie Sweitzer|919-668-0094|maggie.sweitzer@duke.edu|
20207820|NCT02498600|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|linda.gedeon@roswellpark.org|
20207821|NCT05298774|Yale University|Dr. Ira Leeds|(203)785-2616|ira.leeds@yale.edu|
20207822|NCT01319045|UCLA|Jamil Aboulhosn|310-825-5950|jaboulhosn@mednet.ucla.edu|
20226235|NCT00893971|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|605-305-2600|creisner@pearltherapeutics.com|
20226236|NCT00492232|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20226237|NCT00410059|UT MD Anderson Cancer Center|Vice President Clinical Research/Clinical Research Operations|713-792-7734|CR_Study_Registration@mdanderson.org|
20226238|NCT02756364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20226239|NCT02223364|Mayo Clinic|Dr. Sandra L. Kopp|507-284-6637|Kopp.Sandra@mayo.edu|
20185373|NCT02819843|Memorial Sloan Kettering Cancer Center|Dr. Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
20162938|NCT02967510|ITF Research Pharma SLU|Javier Suárez Almarza|+34 916572323|jsuarez@itfsp.com|
20185374|NCT04732494|BeiGene, Ltd.|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20185375|NCT03055858|Abbott Laboratories|Ebony Kargbo|612-209-8185|Ebony.Kargbo@abbott.com|
20185376|NCT04761302|University of Puerto Rico: Department of Orthopedic Surgery|Dr. Hans Hess|787-365-5755|hans.hess1@upr.edu|
20185377|NCT01718743|University of Texas M D Anderson Cancer Center|Dr. Krina Patel|(713) 792-6662|kpatel1@mdanderson.org|
20226240|NCT01416155|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20185378|NCT02728557|University of Haifa|Prof. Sigal Zilcha-Mano|972-4-8249047|sigalzil@gmail.com|
20185379|NCT03416010|The Ohio State University|Dr. Bernadette Melnyk|6142924844|melnyk.15@osu.edu|
20185380|NCT03625323|Immutep|Immutep CMO|+ 49 30 88716843|regulatoryaffairs@immutep.com|
20185381|NCT03948763|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20185382|NCT01426412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20185383|NCT05021133|UMass Chan Medical School|Mayuko Ito Fukunaga|5088561975|mayuko.itofukunaga@umassmed.edu|
20185384|NCT02376790|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20162939|NCT01177189|Salt Lake City VAMC|Van Reese|801 582 1565|van.reese@hsc.utah.edu|
20185385|NCT03014453|Shengjing Hospital of China Medical University|Dr. Shucheng Zhang|862496615|zhangshucheng76@126.com|57911
20185386|NCT05450458|RodillaActiva Medical Center|Dr. Julio Carlos Vélez de Lachica|5215518338063|activeknee@gmail.com|
20185387|NCT03148496|The University of Texas Health Science Center at Houston|Julie Holihan, MD|713-500-7188|Julie.L.Holihan@uth.tmc.edu|
20185388|NCT02141074|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20185389|NCT01070069|Endologix|Elisa Hebb|949-598-4628|ehebb@endologix.com|
20185390|NCT00041938|Columbia University|Dr. J.L.P. (Seamus) Thompson|212-342-1252|jlt12@columbia.edu|
20185391|NCT00262301|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
20185392|NCT03101930|Vanderbilt University Medical Center|Dr. James M. Luther, MD MSCI (Principal Investigator)|(615) 936-3420|james.luther@vumc.org|
20185393|NCT03201562|Presbyopia Therapies, LLC|Jerry Horn, MD|(847)-772-8885|visionxcl@icloud.com|
20185394|NCT00001277|NIDDK|Dr. Smita Jha|301-827-1930|smita.jha@nih.gov|
20185395|NCT04484935|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20185396|NCT02150967|QED Therapeutics, Inc.|David van Veenhuyzen, Vice President, Clinical Development|1 650 391-9740|david.vanveenhuyzen@bridgebio.com|103
20185397|NCT04048382|San Diego State University|Dr. Aaron J. Blashill|6195942245|ajblashill@sdsu.edu|
20185398|NCT03640949|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
20185399|NCT05368558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20185400|NCT03744312|Columbia University|Patrick J. Lao, PhD|212-305-9079|pjl2133@cumc.columbia.edu|
20185401|NCT04579380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185402|NCT03821844|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
20185403|NCT03913195|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
20185404|NCT05307978|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20185405|NCT05166135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185406|NCT04855760|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
20185407|NCT04840199|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20185408|NCT03517553|University of Iowa|Dr Bradley S. Dixon|319-356-1626|bradley-dixon@uiowa.edu|
20185409|NCT02201108|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20185410|NCT05215847|Aardvark Therapeutics|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
20192401|NCT00746356|St. Jude Medical|Ashish Oza, Clinical Studies Director|818 362 6822|aoza@sjm.com|3648
20192402|NCT01263925|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20226241|NCT03078127|University of North Carolina at Chapel Hill|Scott Donaldson, MD|984-974-9198|scott_donaldson@med.unc.edu|
20192403|NCT03536702|MS Hershey Medical Center|Monika Joshi, MD, MRCP|717-531-8678|muj14@psu.edu|
20226242|NCT03597139|Aurinia Pharmaceuticals|Mary Palmen|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20226243|NCT00477204|University of Colorado Denver|David Maahs, MD, PhD|303-724-2323|david.maahs@ucdenver.edu|
20226244|NCT04811664|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20226245|NCT02717442|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20162940|NCT04878211|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20162941|NCT00328614|Thomas Jefferson University|Edouard Trabulsi, MD|215-955-1000|Edouard.Trabulsi@jefferson.edu|
20162942|NCT01687101|Thomas Jefferson University, Jefferson Headache Center|Stephen D Silberstein, MD|215-955-2243|bruce.smith@jefferson.edu|
20162943|NCT05274269|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20162944|NCT02206035|Froedtert and the Medical college of Wisconsin|William Drobyski, MD|414-456-4941|wdrobysk@mcw.edu|
20162945|NCT02936843|The University of Michigan|Rodica Pop-Busui, MD, PhD|Phone 734-647-9809|rpbusui@med.umich.edu|
20162946|NCT03668613|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20192404|NCT03605368|Children's Hospital of Philadelphia|Julia Parish-Morris|267-426-7540|parishmorrisj@chop.edu|
20192405|NCT01726517|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20192406|NCT03765164|QURE Healthcare|Director of Clinical Trials|415-321-3388|qureadmin@qurehealthcare.com|
20207823|NCT00081263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
20185411|NCT03830177|Northwestern University|Lucy Bilaver, PhD|312-503-5618|l-bilaver@northwestern.edu|
20185412|NCT04586920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20185413|NCT00753987|SickKids|Felix Ratjen|4168137500|felix.ratjen@sickkids.ca|
20185414|NCT05136404|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
20185415|NCT02553642|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4718|funts@mskcc.org|
20185416|NCT04600752|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20185417|NCT03732820|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20185418|NCT03928522|Washington University|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
20185419|NCT02885636|Mayo Clinic|Dr. Barry Borlaug|507-284-8846|borlaug.barry@mayo.edu|
20185420|NCT04287985|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
20185421|NCT01340066|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
20185422|NCT02789020|University of Florida|David Vaillancourt|3522941770|vcourt@ufl.edu|
20185423|NCT04349072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20185424|NCT01363492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20185425|NCT01691079|University of California, San Francisco|Mona Luke-Zeitoun, MD||lukezeitounm@peds.ucsf.edu|
20185426|NCT03771352|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
20185427|NCT00011986|Gynecologic Oncology Group Statistical and Data Center|Linda Gedeon, BS, CCRP|716-845-1169|lgedeon@gogstats.org|
20185428|NCT03338816|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20185429|NCT02376530|SUNYBuffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
20185430|NCT00445315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185431|NCT05187442|National Taiwan University|PIAO-YI CHIOU, doctoral|+886-2-23123456|piaoyi@ntu.edu.tw|288427
20185432|NCT01948661|E.O. Ospedali Galliera|Andrea DeCensi|010563|andrea.decensi@galliera.it|4501
20185433|NCT03271489|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20192407|NCT02484547|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20192408|NCT01665599|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20192409|NCT01494298|Mercer University College of Pharmacy|Gina Ryan Clinical Professor|678.547.6222|ryan_gj@mercer.edu|
20192410|NCT00514813|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20192411|NCT02979613|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20192412|NCT01138098|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192413|NCT00420147|University of Delaware|Todd Royer|302-831-4351|royer@udel.edu|
20192414|NCT04944784|Cytokinetics|Cytokinetics MD|6506242929|medicalaffairs@cytokinetics.com|
20192415|NCT01568112|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20192416|NCT04510948|Department of Medicine, Yale School of Medicine|Mary Tinetti, MD|203-688-5238|MARY.TINETTI@yale.edu|
20192417|NCT01479270|MetroHealth Medical Center|Robert Pollard|216-778-4444|rpollard@metrohealth.org|
20192418|NCT00891046|Novartis Pharmaceuticals|Study Director|862--778--8300||
20192419|NCT00362375|SisterLove, Inc.|Dazon Dixon-Diallo, Executive Director|404-505-7777|ddiallo@sisterlove.org|
20192420|NCT04984239|University of Pittsburgh|William Evans|412-383-6943|will.evans@pitt.edu|
20192421|NCT02034019|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
20192422|NCT04523207|Janssen Research & Development, LLC|Group Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20192423|NCT03113383|Vanderbilt University Medical Center|Thomas C Naslund, MD|5-322-2343|thomas.naslund@vumc.org|
20192424|NCT02122172|University of Chicago|Dr. Peter O'Donnell|(773) 702-7564|podonnel@bsd.uchicago.edu|
20192425|NCT03062449|Dartmouth Health|Aleksandra C. Stark|(603) 650-5104|Aleksandra.C.Stark@hitchcock.org|
20192426|NCT03765398|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
20192427|NCT04702893|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192428|NCT00408928|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
20192429|NCT02948569|University of Missouri|Dr. Elizabeth Parks|15738825864|parksej@missouri.edu|
20192430|NCT05145439|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
20192431|NCT01951378|Seton Family of Hospital|Director Pediatric Fellowship|512-324-9999|a.a@abc.com|
20192432|NCT00543062|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20192433|NCT03831854|Cleveland Clinic|Dr Kamal Maheshwari|216-318-7235|maheshk@ccf.org|
20192434|NCT03927690|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20192435|NCT04026399|Medical University of South Carolina|Na Jin Seo|8437920084|seon@musc.edu|
20192436|NCT03248141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192437|NCT00675792|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20192438|NCT01844726|Northwestern University|Dr. James Reilly|312-503-4809|james.reilly@northwestern.edu|
20218091|NCT04718545|Goteborg University|Dr Olivier Carcuac|317863124|olivier.carcuac@gu.se|+46
20185434|NCT06061081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20185435|NCT02252172|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20185436|NCT05575076|Cassava Sciences|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
20185437|NCT03380390|Aclaris Therapeutics|Dr. David Gordon|484-540-6273|dgordon@aclaristx.com|
20192439|NCT04205955|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066677685|karnold@fredhutch.org|
20192440|NCT03898960|CERENOVUS|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218092|NCT04843566|Weill Cornell Medicine|Jim Hu|2127463418|jch9011@med.cornell.edu|
20218093|NCT04963569|NHS Lothian/University of Edinburgh|Dr John (Jack) Cafferkey|0|j.cafferkey@ed.ac.uk|
20185438|NCT02886286|University Hospitals Cleveland Medical Center|Salim M. Hayek, MD, PhD|2168442685|salim.hayek@uhhospitals.org|
20185439|NCT01127373|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
20185440|NCT02633267|University of Michigan|Dr. Joseph Himle|(734) 615-0611|himlej@umich.edu|
20185441|NCT02290613|Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital|Prof. Dr. med. E. Grünig|+49 6221 396|ekkehard.gruenig@med.uni-heidelberg.de|8053
20207824|NCT01267955|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
20207825|NCT03233308|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
20207826|NCT01996865|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20207827|NCT04571684|University of Kansas Medical Center|Principal Investigator|913-945-7709|skessler2@kumc.edu|
20207828|NCT04430036|University of Texas Health Science Center at San Antonio|Robert Svatek, MD|210-567-5643|svatek@uthscsa.edu|
20207829|NCT01842334|Beth Israel Deaconess Medical Center|Dr. Kevin P Hill, Director of the Division of Addiction Psychiatry|617-667-1504|khill1@bidmc.harvard.edu|
20207830|NCT00376675|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
20207831|NCT01833026|University of Illinois at Chicago|Min Joo|3129968039||
20207832|NCT00995215|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
20207833|NCT00942422|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
20207834|NCT01930487|Ocular Vascular Research Center, Indiana University School of Medicine|Brent Siesky, PhD, Assistant Director|317-278-0177|bsiesky@indiana.edu|
20207835|NCT00423592|Gilead Sciences, Inc.|Annemarie Vance|650-524-3829|Annemarie.Vance@gilead.com|
20207836|NCT03296280|South Texas Veterans Health Care System / UT Health San Antonio|Nilam Soni|210-949-9454|sonin@uthscsa.edu|
20207837|NCT02005510|University of Washington|Dr. Rachel Winer|2066165081|rlw@uw.edu|
20207838|NCT00002981|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|212-639-7373|LarsonS@MSKCC.ORG|
20207839|NCT01300949|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
20207840|NCT01833806|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs & CRO|(214) 630-2000|nadira@insightec.com|
20207841|NCT05083949|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207842|NCT00056550|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Development|508-370-5257|denise.tilton@gtc-bio.com|
20207843|NCT00322387|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20207844|NCT00195624|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
20207845|NCT01894776|Ottawa Hospital Research Institute|Dr. Bill Cameron|613-737-8899|bcameron@toh.ca|78923
20207846|NCT00320190|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20207847|NCT00102804|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20207848|NCT02094664|UCLA Mattel Children's Hospital|Dr. Diana Chen|3108255930|dychen@mednet.ucla.edu|
20207849|NCT04330989|University of North Carolina at Chapel Hill|Benjamin Chi|9194454147|bchi@med.unc.edu|
20207850|NCT02299206|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
20207851|NCT00691054|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
20207852|NCT04673630|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20207853|NCT02141854|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20207854|NCT03128307|Zyppah|Jonathan Greenburg, DDS|(818) 414- 4817|jgreenburg@outlook.com|
20207855|NCT00121485|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|781 852 8334|psood@thoratec.com|
20207856|NCT02386605|Greater Los Angeles VA Healthcare System|Dr. Felice Reddy|3104783711|felice.reddy@gmail.com|
20207857|NCT00908895|Département d'orthopédie, CHA-Pavillon Enfant-Jésus Québec|Dr Stéphane Pelet, MD, PhD|418-649-0252|stephane.pelet.ortho@gmail.com|3165
20207858|NCT02710422|University of Miami|Sanoj Punnen MD, MAS|305-243-6596|s.punnen@med.miami.edu|
20207859|NCT02608099|Baim Institute for Clinical Research|Director of Trial Design and Development|617-307-5200|TrialDesignandDevelopmentStaff@baiminstitute.org|
20207860|NCT00416572|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|scheier@cmu.edu|
20207861|NCT01654224|University of Pittsburgh|David Nace, MD, MPH|412 692-2366|naceda@upmc.edu|
20226246|NCT00382109|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20185442|NCT00522951|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20185443|NCT02713126|Mayo Clinic|Dr. Barry Borlaug|507-255-1051|borlaug.barry@mayo.edu|
20185444|NCT00100698|Massachusetts General Hospital|Janet Lo|617-724-9109|jlo@partners.org|
20185445|NCT01017146|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185446|NCT01747486|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
20226247|NCT05052697|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226248|NCT02724410|Atrium Health|Dr. B. Todd Heniford|704-355-3168|Todd.Heniford@atriumhealth.org|
20226249|NCT01900899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226250|NCT02860507|Merck Pharmaceuticals|Chadwick Neal / Medical Affairs Director|2056010605|chadwick.neal@merck.com|
20226251|NCT02772809|University of Pennsylvania|Michelle J Johnson|215 893-2665|johnmic@pennmedicine.upenn.edu|
20226252|NCT00723697|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
20226253|NCT00534105|Baystate Medical Center|Glenn Markenson MD|413-794-8073|glenn.markenson@bhs.org|
20226254|NCT02774005|Santhera Pharmaceuticals (Switzerland) Ltd|Head of Regulatory Affairs EU|+41 6190689|julien.gaudias@santhera.com|50
20226255|NCT00978341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20207862|NCT03763942|Emory University|Dr. Jeb Jones|404-712-2275|jeb.jones@emory.edu|
20207863|NCT02145429|University of Pittsburgh|Charles F. Reynolds, MD|(412) 246-6414|reynoldscf@upmc.edu|
20207864|NCT02200510|CincinnatiChildrens|Lori Crosby|5136365380|lori.crosby@cchmc.org|
20207865|NCT03662789|Oslo University Hospital|Dr. Lars Gullestad|0047 97644772|lars.gullestad@medisin.uio.no|
20207866|NCT03598140|UTexas Southwestern|Dr. Joshua Gaston|817-637-8043|drgaston@outlook.com|
20226256|NCT03035916|China-Japan Unit Hospital of Jilin University|Dr. Guoqing Zhao|0435-84995117|zhaogq65@126.com|
20226257|NCT01451554|Mayo Clinic|Jon O. Ebbert, MD|507-255-3965|ebbert.jon@mayo.edu|
20226258|NCT01402986|MedImmune, LLC|Meena Jain, MB BChir, Director, Clinical Development,|301-398-0000|JainM@medimmune.com|
20226259|NCT02634983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20226260|NCT03178851|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20185447|NCT01256840|UCLA Department of Psychology|Dr. A. Janet Tomiyama|3102066875|tomiyama@psych.ucla.edu|
20226261|NCT02226120|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20226262|NCT00076258|UT Southwestern Medical Center|Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
20226263|NCT00661453|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
20226264|NCT00401193|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20226265|NCT02526160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20226266|NCT00398216|Daiichi Sankyo, Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
20226267|NCT00570960|University of Virginia|Patrick G. Northup, M.D.|434-924-0000|northup@virginia.edu|
20226268|NCT01962948|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20226269|NCT03396822|University of Maryland School of Medicine|Daniel Harrison|410-328-5605|dharrison@som.umaryland.edu|
20226270|NCT03372382|McGovern Medical School, University of Texas, Health Science Center at Houston|Dr Jenifer Dinis, MD|713 500 6421|jenifer.dinis@uth.tmc.edu|
20226271|NCT02849704|Children's Hospital of Philadelphia|Virginia Stallings, MD|267.425.1633|stallingsv@email.chop.edu|
20226272|NCT02579382|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20226273|NCT01952418|Massachusetts General Hospital|Norman Nishioka, MD|6177264422|NNISHIOKA@PARTNERS.ORG|
20226274|NCT03188523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226275|NCT00412932|Daiichi Sankyo|John Raia|973-630-2683|jraia@dsus.com|
20226276|NCT02259400|"AOU G. Martino Universitary Hospital of Messina"|Dr. Vincenzo Salvo|+39 0902212132|salvovincenzo@virgilio.it|
20226277|NCT01247675|Ascendis Pharma A/S|Michael Beckert, MD|(+49) 172-155-2596|mb@ascendispharma.com|
20226278|NCT05886907|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20226279|NCT01763203|Icahn School of Medicine at Mount Sinai|Dr. Barbara Vickrey; Chair of Neurology|2122415698|barbara.vickrey@mssm.edu|
20226280|NCT02187861|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20226281|NCT02756819|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20226282|NCT03083808|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
20226283|NCT01491841|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20226284|NCT02933528|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20226285|NCT00741598|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
20226286|NCT01301079|Federal University of Sao Paulo|Plínio da Cunha Leal|55-98-8852-2021|pliniocunhaleal@hotmail.com|
20226287|NCT04105842|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20226288|NCT02700425|The University of Chicago|Dr. Gaurav A. Upadhyay, MD|773-702-5988|gupadhyay@medicine.bsd.uchicago.edu|
20226289|NCT01639703|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
20226290|NCT02768792|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20185448|NCT01084707|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20226291|NCT01690299|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
20226292|NCT01882803|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20226293|NCT01563913|VA Portland Health Care System|Kathryn Chung, MD|5037211091|Kathryn.Chung@va.gov|
20226294|NCT00551174|Hoffmann-La Roche|Medical Communications|800-821-8590||
20226295|NCT00551525|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20226296|NCT04676724|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20226297|NCT00287729|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
20162947|NCT02106494|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
20185449|NCT00087139|ECOG Statistical Office|Study Statistician|617-632-3012||
20207867|NCT05304611|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
20207868|NCT03993119|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207869|NCT00963820|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20185450|NCT00976495|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20185451|NCT02272816|Centre for Experimental Cancer Medicine, Barts Cancer Institute, QMUL|Project Lead|02078828277|bci-carpet@qmul.ac.uk|
20185452|NCT05171777|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20185453|NCT04154384|Emory University|Mara L. Schenker|404-778-1550|mara.schenker@emory.edu|
20162948|NCT00709618|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226298|NCT01515696|Medical University of Vienna|Nadja Haiden M.D.|+431404003232|nadja.haiden@meduniwien.ac.at|
20226299|NCT00657657|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226300|NCT02521792|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20226301|NCT00398047|Wake Forest University Health Sciences|Ralph D'Agostino Jr., Ph.D.|113-716-3483|rdagosti@wfubmc.edu|
20226302|NCT00237692|Center for Primary Care, HSRD COIN|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
20226303|NCT00123682|VA New York Harbor Healthcare System|Dr. Scott Sherman, PI|212-686-7500|scott.sherman@va.gov|7386
20226304|NCT00090870|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20226305|NCT03021317|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
20226306|NCT01151345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226307|NCT02588092|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20226308|NCT03883477|Cedars-Sinai Medical Center, Department of Orthopedic Surgery|Clinical Trial RN|3104235900|rodriquezsv@csmns.org|
20226309|NCT03853291|Weill Cornell Medicine|Dr. Catherine Riffin, Assistant Professor of Psychology in Medicine|646.962.7160|acr2213@med.cornell.edu|
20226310|NCT01658904|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
20226311|NCT01961167|W. L. Gore & Associates|Melissa Zambeck|928-856-4900|mzambeck@wlgore.com|
20226312|NCT03148067|University of Sao Paulo|Physician|551126616900|priscila.rosalba@hc.fm.usp.br|
20226313|NCT02934555|Beth Israel Deaconess Medical Center|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
20226314|NCT01183416|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
20226315|NCT02984644|University of Texas Health Science Center at San Antonio|Dr. Eugenio Cersosimo|210-358-7200|cersosimo@uthscsa.edu|
20226316|NCT04074330|Takeda|Medical Director|1-877-825-3327|TrialDisclosures@takeda.com|
20226317|NCT03124537|Brandeis University|Alycia Bisson|781 736 3284|lifespanlab@brandeis.edu|
20207870|NCT02354690|National Center for Cancer Immune Therapy|Inge Marie Svane|0045386889339|inge.marie.svane@regionh.dk|
20226318|NCT03338244|UC San Francisco - Proctor Foundation|Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
20226319|NCT03301831|Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP|(216) 368-3082|vab@case.edu|
20226320|NCT04485637|University of Southern California|Wandi Bruine de Bruin|4126385875|wandibdb@usc.edu|
20226321|NCT00913770|Yale University|Gail D'Onofrio, MD, MS|203-785-4404|gail.donofrio@yale.edu|
20226322|NCT02348008|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20226323|NCT01446250|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20226324|NCT03268005|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20226325|NCT00248833|WRAIR|Paul B. Keiser|866-856-3259|clinical1@na.amedd.army.mil|
20226326|NCT02427802|Innocoll|Lesley Russell, MBChB, MRCP, Chief Medical Officer|484-406-5206|lrussell@innocoll.com|
20226327|NCT05346237|University hospital Osijek|Željka Laksar Klarić|+38598666494|zeljka.l.klaric@gmail.com|
20226328|NCT00802672|Perrigo Company|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
20226329|NCT04336475|Cukurova University|Dr Nihan Cuzdan, MD, principal investigator|05052706846|nihancuzdan@hotmail.com|
20226330|NCT03304106|Cochlear Limited|Laura Chenier, Clinical Project Manager|422-325-4171|lchenier@cochlear.com|
20226331|NCT01990573|Washington University School of Medicine|Dr. Anshuman Sharma|314-457-3147|sharma.a@wustl.edu|
20226332|NCT04560868|Kaiser Permanente Washington Health Research Institute|Director, Investigative Science|206-287-2737|jennifer.b.mcclure@kp.org|
20226333|NCT01983826|University of Iowa|Dr. Darren P. Casey||darren-casey@uiowa.edu|
20226334|NCT01763827|Amgen Inc.|Study Director|866-572-6436||
20226335|NCT02906579|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
20226336|NCT00759655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226337|NCT02179047|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
20226338|NCT02213380|The second affiliated hospital and Yuying children's hospital of Wenzhou medical university|Ting Li|008613587876896|liting1021@aliyun.com|
20226339|NCT02090777|Duke Eye Center|Jullia Rosdahl MD PhD|919-684-8850|jullia.rosdahl@duke.edu|
20226340|NCT03063619|M D Anderson Cancer Center|Dr. Banu Arun|(713) 792-2817|barun@mdanderson.org|
20226341|NCT01490840|Novartis|Study Director|862-778-8300||
20226342|NCT03331263|Medline Industries, Inc.|Senior Regulatory Affairs Specialist|8476433515|aminarcik@medline.com|
20226343|NCT03639857|University of Central Florida College of Medicine|Dr. David Weinstein|407-266-4900|david.weinstein@ucf.edu|
20226344|NCT01025284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20226345|NCT01703169|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
20226346|NCT00905567|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20226347|NCT02542397|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
20226348|NCT00389467|Georgetown University|Chelsea S. Kidwell, MD|202-687-7302|ck256@georgetown.edu|
20185454|NCT01136876|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
20185455|NCT05321069|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20226349|NCT02362191|University of North Carolina at Chapel Hill|David Rubinow, MD|919-445-0220|drubinow@med.unc.edu|
20226350|NCT01473940|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
20185456|NCT01241916|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
20226351|NCT00547248|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226352|NCT00534248|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
20185457|NCT02412748|Rush University College of Nursing|Dr. Wrenetha Julion, Professor|3129426272|Wrenetha_A_Julion@rush.edu|
20185458|NCT04128319|Xenikos|Eric van Hooren, Chief Development Officer|+31 6 109 345 84|e.vanhooren@xenikos.com|
20185459|NCT00839241|Astra Tech AB|Head of Clinical Research Area Health Care|+46317761000||
20185460|NCT00972439|USC/Norris Comprehensive Cancer Center|Celeste Pearce, Ph.D.|323 865 0437|cpearce@usc.edu|
20185461|NCT01227265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20185462|NCT01967836|Ascension Wisconsin|Dr Maureen Greene|414-447-2716|maureen.greene@ascension.org|
20185463|NCT03481816|National Cancer Institute|Dr. Marijo Bilusic|240-760-6064|marijo.bilusic@nih.gov|
20207871|NCT05064007|Johns Hopkins University|Dr. Junxin Li|4105022608|junxin.li@jhu.edu|
20207872|NCT04556175|Northern Arizona University|Dr Julie Baldwin|928-523-6566|Julie.Baldwin@nau.edu|
20207873|NCT04430894|Dana-Farber Cancer Institute|Elizabeth K. O'Donnell, MD|617-632-3000|Elizabeth_ODonnell@DFCI.HARVARD.EDU|
20207874|NCT05549505|Arvinas Estrogen Receptor, Inc|Arvinas Estrogen Receptor, Inc.|475-345-3366|clinicaltrialsARV-471@arvinas.com|
20207875|NCT06408818|innovation Research and Training|Dr. Tracy Scull|9194937700|tscull@irtinc.us|
20207876|NCT00854061|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20207877|NCT05492877|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20207878|NCT02871791|Dana-Farber Cancer Institute|Sara Tolaney, MD MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
20207879|NCT02782364|University Hospital of South Manchester|Karen Telford|01612916654|karen.telford@uhsm.nhs.uk|
20207880|NCT04209634|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20207881|NCT00608491|Duke University|Jenny Ibarra|9192363291|jenny.ibarra@duke.edu|
20207882|NCT00515099|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20207883|NCT00592072|Yale School of Medicine|Dr Robert Sherwin|203-785-6222|robert.sherwin@yale.edu|
20207884|NCT03369704|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20207885|NCT05333289|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20207886|NCT03148899|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
20207887|NCT02010567|UNC Lineberger|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20207888|NCT00118040|University of Wisconsin|Howard H. Bailey, M.D.|608-263-8624|hhbailey@wisc.edu|
20207889|NCT02750501|Alcresta Therapeutics, Inc.|"Madhumalli (Molly) Sarkar, MD, PhD, Head of Clinical Development"|617 431 8866|msarkar@alcresta.com|
20207890|NCT03685643|University of Hong Kong|Dr Wong Chi Wai William|(852) 2518-5650|wongwcw@hku.hk|
20207891|NCT01738594|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@nm.org|
20207892|NCT03797144|Medtronic|Clinical Research Specialist|+39 3450225929|francesca.molineris@medtronic.com|
20207893|NCT00403390|Children's Hospital Boston|Jeremi Carswell, MD|617-355-7476|Jeremi.Carswell@childrens.harvard.edu|
20207894|NCT02943668|Fred Hutch Cancer Research Center|Dr. Bart Scott|206.667.1990|bscott@fredhutch.org|
20207895|NCT02711553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207896|NCT00778310|University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
20207897|NCT00572728|ACRIN|Ben Herman|401.863.9188|bherman@stat.brown.edu|
20207898|NCT01529450|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
20207899|NCT03457636|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20207900|NCT02724111|Korea University Guro Hospital|Dr Byung Gun Lim|82-2-2626-1437|bglim9205@korea.ac.kr|
20207901|NCT00533351|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20207902|NCT01828567|Durham VA Center of Innovation in Primary Care|Eugene Z Oddone, MD, MPSc|919-286-0411|eugene.oddone@va.gov|
20207903|NCT02614261|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20207904|NCT03512275|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207905|NCT02369211|Brigham and Women's Hospital|James Webber|(617) 732-6877|jwebber1@partners.org|
20207906|NCT03399786|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20207907|NCT01855919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20207908|NCT03455530|University of Arizona|Dr. Paloma Beamer|520-626-0006|pbeamer@arizona.edu|
20226353|NCT02020369|LFB USA Inc.|Jeffry Lawrence, MD, Vice President, Clinical Development|+1.508.370.5113|jeffry.lawrence@lfb-usa.com|
20207909|NCT01747447|Brigham and Women's Hospital|Meryl S LeBoff, M.D.|1-800-388-3963|vitalstudy@partners.org|
20207910|NCT01183728|Instituto de Biología y Genética Molecular (IBGM)|Dr. Javier García-Sancho|+34 98 318 48 27|jgsancho@ibgm.uva.es|
20207911|NCT01054339|Applied Genetic Technologies Corp.|Ellery D. Mangas|386-462-7106|emangas@agtc.com|
20207912|NCT00740116|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
20207913|NCT03037489|Medivir AB|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
20207914|NCT02499172|Johns Hopkins Bloomberg School of Public Health|Dr. Mohammad Ali|410-502-3154|mali25@jhu.edu|
20207915|NCT01111331|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207916|NCT00724243|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20207917|NCT01842282|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
20226354|NCT03132415|University of Pennsylvania|Jose Bauermeiser|215-898-9993|bjose@upenn.edu|
20185464|NCT02269475|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
20226355|NCT00315614|University of Miami|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
20185465|NCT01704196|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20207918|NCT00908050|Baylor College of Medicine/Houston Methodist|William Ondo, MD|713-363-8390|wondo@houstonmethodist.org|
20207919|NCT01997892|Amgen Inc.|Study Director|866-572-6436||
20207920|NCT04806165|Washington University in St. Louis School of Medicine|Ellen E. Fitzsimmons-Craft|314-286-2074|fitzsimmonse@wustl.edu|
20207921|NCT02943577|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20207922|NCT01355224|Boston University School of Public Health|Dr. Catharine Wang|617-638-5187|clwang@bu.edu|
20207923|NCT00939055|EndoGastric Solutions|Senior Director Clinical Affairs|650-823-9093|gsahyun@endogastricsolutions.com|
20207924|NCT00584987|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
20207925|NCT03502941|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
20207926|NCT03225833|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20207927|NCT00808028|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207928|NCT04465240|University of Southern California|Daniel A. Hackman, Ph.D.|(213) 821-3112|dhackman@usc.edu|
20207929|NCT02274311|Hospital das Clinicas da Faculdade de Medicina da USP|Dr. Felipe Henning Gaia Duarte|+5511987550990|drfelipegaia@outlook.com|
20207930|NCT00508001|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20207931|NCT03093350|Baylor College of Medicine|Shaun Bulsara|713-798-8014|sbulsara@bcm.edu|
20207932|NCT05085275|USRC Kidney Research|Stephanie Brillhart, Senior Director Regulatory Compliance|303-881-9451|stephanie.brillhart@usrenalcare.com|
20207933|NCT02912572|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
20207934|NCT00729560|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
20207935|NCT00829010|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207936|NCT02432690|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
20207937|NCT01023516|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20207938|NCT00369564|Nemours Children's Clinic|Scott Bradfield, MD|904-697-3793|sbradfie@nemours.org|
20207939|NCT02060903|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20207940|NCT00137267|Bedford VA Medical Center|Dr. David Smelson|781-687-2845|david.smelson@va.gov|
20207941|NCT00638989|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20207942|NCT03288311|Vanderbilt University Medical Center|Jonathan Casey, Assistant Professor of Medicine|6158754681|Jonathan.d.Casey@vumc.org|
20207943|NCT00853112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207944|NCT01553591|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20207945|NCT01426009|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20207946|NCT02283333|Ralph H. Johnson VA Medical Center|Dr. Ron Acierno, PI|843-364-1667|ron.acierno@va.gov|
20207947|NCT00513370|Abbott|Medical Information Specialist|1-800-633-9110||
20207948|NCT01856855|University of Alabama at Birmingham (UAB)|John Fiveash, MD|(205) 975-0224|jfiveash@uabmc.edu|
20207949|NCT00809055|Brigham and Women's Hospital|Dr. Terrie Inder|617-525-6650|tinder@partners.org|
20207950|NCT04099836|Duke University Medical Center|Dr. Thomas Stinchcombe|919-681-9509|Thomas.stinchcombe@duke.edu|
20207951|NCT01550315|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
20207952|NCT00397631|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207953|NCT02661256|NYU-Winthrop Hospital|Nazeeh Hanna, MD|6314211424|nazeehhanna@gmail.com|
20226356|NCT02224612|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
20226357|NCT00697593|Merck Serono S.A., a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20226358|NCT03498313|University of Illinois at Chicago|Dr. Tory Eisenlohr-Moul, Assistant Professor of Psychiatry|859-317-0503|temo@uic.edu|
20226359|NCT04026750|High Point Clinical Trials Center|Melanie Fein, MD|1-336-841-0700|mfein@highpointctc.com|2530
20226360|NCT02630563|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
20226361|NCT04812184|Indiana University School of Medicine|Nicholas Pettit|18653688599|nrpettit@iu.edu|
20226362|NCT02239640|Medtronic|Oscar Bolanos|949-527-0822|Oscar.bolanos@medtronic.com|
20226363|NCT00929994|Toronto Rehab|Dr.|4169781739|dina.brooks@utoronto.ca|
20226364|NCT05076604|Washington University School of Medicine|Matthew Schill|3147470707|schillm@wustl.edu|
20226365|NCT02061813|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20226366|NCT01705080|Abbott|Steven Madej|651-756-2230|smadej@sjm.com|
20226367|NCT00206427|Baylor Breast Cancer|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.tmc.edu|
20226368|NCT00281697|Genentech, Inc.|Medical Communications|800 821-8590||
20226369|NCT00632125|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20226370|NCT00828061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20226371|NCT01400906|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226372|NCT02075008|Novartis Pharmaceuticals|Study Director|862-778-8300||
20226373|NCT00572455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226374|NCT04446429|Applied Biology|Director of Clinical Trials|+1-949-387-4526|monican@appliedbiology.com|
20162949|NCT04042909|Brown University|Kate B. Carey|4018636558|kate_carey@brown.edu|
20162950|NCT01077401|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
20207954|NCT01878175|Durham VA Medical Center|Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
20207955|NCT01796106|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
20226375|NCT05205005|Harry S. Truman Memorial Veterans' Hospital|Harry S. Truman Memorial Veterans' Hospital Research Service|573- 814-6000|Camila.Manrique-Acevedo@va.gov|56550
20207956|NCT01108068|University of Maryland School of Medicine|Elizabeth Streeten, MD|410-328-3335|estreete@som.umaryland.edu|
20207957|NCT04107935|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
20207958|NCT00836953|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20207959|NCT02268942|Medtronic Cardiac Rhythm and Heart Failure|Mary Jacoski|+15087390909|mary.v.jacoski@medtronic.com|
20207960|NCT02201251|Janssen Research & Development, LLC|Director - Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20207961|NCT05393570|UTSW - O'Donnell School of Public Health|Sarah E. Messiah|(972) 546-2919|Sarah.Messiah@UTSouthwestern.edu|
20207962|NCT03531918|Fred Hutchinson Cancer Center|Roland Walter, Member of Clinical Research Division|206-667-3599|rwalter@fredhutch.org|
20207963|NCT05259800|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20207964|NCT04048876|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20207965|NCT02996500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207966|NCT02332876|University of San Diego, California|Dr. Sheri Hartman|8585349235|sjhartman@ucsd.edu|
20207967|NCT02415595|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20207968|NCT03580525|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20207969|NCT01637090|Boston Medical Center|Adam Lerner, MD|617-638-8265|adam.lerner@bmc.org|
20207970|NCT04063865|Indiana University|Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
20207971|NCT01700140|SymBio Pharmaceuticals|Nobuyuki Koseki|+81-3-5472-1127||
20207972|NCT01060124|Medical affairs, Janssen Korea, Ltd.|CRA|82220944835||
20207973|NCT01183481|Sunnybrook Health Sciences Centre|Dr. Edward Chow|416-480-4998|edward.chow@sunnybrook.ca|
20207974|NCT01708915|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20207975|NCT01045551|Columbia University Medical Center|Julian Mackay-Wiggan, MD, MS|212-305-6953|jc299@cumc.columbia.edu|
20207976|NCT03231228|B. Braun Medical Inc.|Diana Valencia MD|610-596-2875|diana.valencia@bbraunusa.com|
20207977|NCT01222416|Vanderbilt-Ingram Cancer Center|A Bapsi Chakravarthy, MD Program Director, Radiation Oncology|615-322-2555|babsi.chak@vanderbilt.edu|
20207978|NCT01744340|BrUOG-Brown University Oncology Research Group|Howard Safran, MD|4018633000|kristen_mitchell@brown.edu|
20207979|NCT00518336|GlaxoSmithKline|GSK Response Center|866-435-7343||
20207980|NCT04337203|Wake Forest Baptist Comprehensive Cancer Center|Carol Kittel|336-399-3832|c.kittel@wakehealth.edu|
20207981|NCT00461851|Yale University Yale Cancer Center|Dr Michael Hurwitz|2037371600|Hari.deshpande@yale.edu|
20207982|NCT01493024|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20207983|NCT03031327|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20226376|NCT00909220|Northwestern University|Jackie Gollan, Ph.D. Associate Professor of Psychiatry and Behavioral Sciences|312-695-6121|j-gollan@northwestern.edu|
20226377|NCT01449864|University of Pennsylvania|John Plastaras, MD, PhD|267-972-3539|plastaras@uphs.upenn.edu|
20226378|NCT00694356|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226379|NCT02082769|Department of Endocrinology, Xijing Hospital, Fourth Military Medical University|Qiuhe Ji|+86-29-84775213|qiuheji@hotmail.com|
20226380|NCT01308463|Zimmer Biomet|Kelly Francher|574-371-9783|kelly.francher@zimmerbiomet.com|
20226381|NCT01042392|Novartis Pharmaceuticals|Study Director|862-778-8300||
20226382|NCT03117361|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
20226383|NCT00587795|Mayo Clinic|Dr. David Dennison|507-284-7405|Dennison.David@mayo.edu|
20226384|NCT00943592|University of Chicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
20226385|NCT02072941|University of California San Francisco|Dr. Rebecca Sudore|(415) 221-4810|rebecca.sudore@ucsf.edu|23475
20226386|NCT01247350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20226387|NCT03476642|Penn State MS Hershey College of Medicine-PennState Health|Dr. Sanjib Adhikary|717-531-6140|sadhikary@pennstatehealth.psu.edu|
20226388|NCT02438280|University of Washington|Dr. Greg Huang, Professor and Chair of Orthodontics|(206) 616-6996|ghuang@uw.edu|
20226389|NCT02982863|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226390|NCT02457195|The Pennsylvania State University College of Medicine|Dr. Piotr Janicki|7175315680|pjanicki@pennstatehealth.psu.edu|
20226391|NCT05359952|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20226392|NCT05980013|Zynex Monitoring Solutions|ZMS Clinical|888-386-4185|clinical@zynex.com|
20226393|NCT03066778|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226394|NCT02091414|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20226395|NCT03146741|University of Pennsylvania|Dr. Peter Reese|215-900-3782|peter.reese@uphs.upenn.edu|
20226396|NCT02589847|Rebiotix, Inc.|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
20226397|NCT00902746|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
20226398|NCT05050448|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
20226399|NCT05391555|University of California San Francisco|Rachel Eshima McKay|415-476-9035|rachel.eshima@ucsf.edu|
20226400|NCT02081001|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP for Drug Development|512-498-2675|mcummins@xerispharma.com|
20226401|NCT04274075|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20185466|NCT03582722|Emory University|Michele Marcus, PhD, MPH|404-727-8010|mmarcus@emory.edu|
20207984|NCT00669240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20207985|NCT03276494|Ohio State University|Thomas Lawson|614-366-7312|thomas.lawson@osumc.edu|
20226402|NCT01765569|Organization: Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20185467|NCT04994509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20185468|NCT03638427|Stanford University|Paul Blumenthal, MD|(650) 725-6035|gynresearch@stanford.edu|
20185469|NCT04402294|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
20185470|NCT04459416|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng, MD, PhD|646-608-8556|dengg@MSKCC.ORG|
20185471|NCT02525692|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
20185472|NCT05510232|Hospital for Special Surgery|Dr. Peter Fabricant|(212) 606-1996|fabricantstaff@hss.edu|
20185473|NCT02380612|AVITA Medical|VP Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
20185474|NCT02721381|Michigan State University|Dr. Brooke Ingersoll|517-930-2275|ingers19@msu.edu|
20185475|NCT03611153|Mayo Clinic|Dr. Barry A. Borlaug|507-255-2200|borlaug.barry@mayo.edu|
20226403|NCT01030718|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20185476|NCT00979576|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185477|NCT05794763|Stanford University|Dr. Eric Stice|6507237885|estice@stanford.edu|
20185478|NCT03805594|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|Rahul.Aggarwal@ucsf.edu|
20185479|NCT03424811|University of Pennsylvania|Tanja Kral|(215) 573-7512|tkral@nursing.upenn.edu|
20185480|NCT05931861|Laboratoires Théa|Clinical Affairs Director|0473981436|Corentin.LECAMUS@theapharma.com|
20185481|NCT00567398|Vantive|Clinical Trials Disclosure Group|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20185482|NCT03229811|Fresenius Medical Care|Dr. Amaka Eneanya|267-769-5455|amakaeneanya@gmail.com|
20185483|NCT05265312|Johns Hopkins University School of Medicine|Dr. Eva Tseng|410-583-2774|etseng3@jhmi.edu|
20185484|NCT04247542|Acurx Pharmaceuticals, Inc.|Robert J DeLuccia|914-949-3898|rjdeluccia@acurxpharma.com|
20185485|NCT05145257|Citruslabs|Patrick Renner|4242450284|hello@citruslabs.com|
20185486|NCT04905407|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
20226404|NCT00423813|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
20226405|NCT01386944|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
20226406|NCT02974803|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
20226407|NCT01904032|Loyola University Chicago|Sue Penckofer, Ph.D., F.A.A.N.|773-508-8949|spencko@luc.edu|
20226408|NCT00531947|Mylan Specialty L.P.|Kim Portland, Ph.D.|908.542.2636|kimberly.portland@mylan.com|
20226409|NCT02611765|Baylor College of Medicine|Jose Serpa-Alvarez|713 798-7910|jaserpaa@bcm.edu|
20226410|NCT02432209|Yale School of Public Health|Fangbai Sun|2037855185|fangbai.sun@yale.edu|
20226411|NCT02383355|Radboudumc|Wouter van der Heijden|0031 24 3616980|wouter.vanderheijden@radboudumc.nl|
20226412|NCT00305565|Cyberonics Inc.|Mark Bunker Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
20226413|NCT02446847|The Rockefeller University|Dr. Marina Caskey, Associate Professor of Clinical Investigation|212-327-7396|mcaskey@rockefeller.edu|
20226414|NCT00502853|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20226415|NCT03681184|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20226416|NCT02787083|Philadelphia Urosurgical Associates, PC|Kristene E Whitmore MD|215-704-1457|bladder1@aol.com|
20226417|NCT03162328|Philips|Gary Garcia|6085129475|gary.garcia@philips.com|
20226418|NCT03852498|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
20226419|NCT00980655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226420|NCT03939533|CRMG|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
20185487|NCT05178810|Ferrer|Clinical Operations Head|+34 649 442 389|nalbareda@ferrer.com|
20185488|NCT05568004|Ege University Faculty of Medicine Sport Medicine Department|Dr. Yunus Emre Meydanal|905068046512|yemremeydanal@gmail.com|
20192441|NCT00548847|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
20226421|NCT00357890|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
20226422|NCT02672176|University of California, Davis|Heather M. Young, Principal Investigator|916-734-4745|hmyoung@ucdavis.edu|
20226423|NCT03117634|Singapore National Eye Center|Gemmy Cheung, Principal Investigator|+65 6322 8335|gemmy.cheung.c.m@singhealth.com.sg|
20226424|NCT02823470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20226425|NCT03565874|Department of Child and Adolescent Psychiatry, University Hospital of Lausanne|Dr. Sébastien Urben|+41 21 314 7492|sebastien.urben@chuv.ch|
20226426|NCT01073163|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20226427|NCT00703677|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
20226428|NCT04441788|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
20226429|NCT00753298|Astra Tech AB|Head of Therapeutic Area Health Care|+46317763000||
20226430|NCT03859648|MED-EL Corporation|MED-EL Corporation|919-314-1437|research.us@medel.com|
20226431|NCT02315664|Arthritis Research Canada|Dr. Linda Li, Professor, University of British Columbia|604-207-4020|lli@arthritisresearch.ca|
20192442|NCT03463577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20192443|NCT00236184|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
20192444|NCT01101997|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20192445|NCT00469456|Forest Research Institute, a subsidiary of Forest Laboratories Inc.|Stephen Graham, PhD|201-427-8156|stephen.graham@frx.com|
20185489|NCT05968495|Pearl Plastic Surgery|Christopher Nichols, MD|360-878-9300|cnichols@pearlplasticsurgery.com|
20192446|NCT01743521|Kirby Institute|A/Prof Gail Matthews|+61 (0)2 9385 0900|gmatthews@kirby.unsw.edu.au|
20192447|NCT00913068|Capital District Health Authority|Dr. Ricardo A. Rendon|9024736604|rrendon@dal.ca|
20226432|NCT01677182|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20226433|NCT02501161|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20226434|NCT00995722|University Of Miami|Dr. Benatar|305-243-6480|MBenatar@med.miami.edu|
20226435|NCT00667992|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20226436|NCT00762762|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
20226437|NCT02748057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226438|NCT03834025|University of North Carolina at Chapel Hill|Marisa Domino, PhD|919-966-3891|domino@unc.edu|
20226439|NCT04541329|University of California, San Francisco|Raymond Cho, MD, PhD|415 353 7800|rashes@ucsf.edu|
20226440|NCT02793947|University of Iowa Hospitals and Clinics|Dr. Michael Willey|319-384-8452|michael-willey@uiowa.edu|
20226441|NCT02096276|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20226442|NCT01563198|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant)|617 734 9087|drevlang@gmail.com|
20226443|NCT01310127|Discover Vision Centers|Melissa Toyos, MD|816-478-1230|mtoyos@discovervision.com|
20226444|NCT01465230|Yale University|Dr. Terri Parker|203-737-5312|terri.parker@yale.edu|
20226445|NCT02014519|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226446|NCT01738919|Aarhus University Hospital|Janni Kjaergaard Thillemann|+45 28137303|teamjanni@gmail.com|
20226447|NCT00947310|University of Rochester, Heart Research Follow-up Program|Dr. Arthur J. Moss|585-275-5391|arthur.moss@heart.rochester.edu|
20226448|NCT02532257|The University of Texas MD Anderson Cancer Center|Loretta Nastoupil, MD|(713) 792-2860|lnastoupil@mdanderson.org|
20226449|NCT02849171|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
20226450|NCT02090283|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
20226451|NCT04727736|UPMC Hillman Cancer Center|Barbara M Stadterman, Clinical Research Manager - Regulatory|412-647-5554|stadtermanbm@upmc.edu|
20226452|NCT00459810|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|(503) 494-2897|eilersk@ohsu.edu|
20226453|NCT02964338|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20226454|NCT00621257|children's Hospital Boston|Helen Pappa, MD, MPH, Principal Investigator|617-355-6058|helen.pappa@childrens.harvard.edu|
20226455|NCT01867515|VA Portland HCS, RR&D National Center for Auditory Rehabilitative Research|Michelle R. Molis, PhD|503-220-8262|michelle.molis@va.gov|55574
20226456|NCT01255904|Baylor College of Medicine|Jason Reynolds|(210) 704-2680|jmreynol@bcm.edu|
20226457|NCT03258645|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226458|NCT00184002|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
20226459|NCT02171429|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20226460|NCT00320242|Beth Israel Deaconess Medical Center and Harvard Medical School|Dr. David K. Simon, Associate Professor of Neurology|617-735-3251|dsimon1@bidmc.harvard.edu|
20226461|NCT00558012|University of Pittsburgh|Dr. Susan Greenspan|412-692-2477|greenspn@pitt.edu|
20226462|NCT01724177|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20226463|NCT04846270|Essity Hygiene and Health AB|Fredrik Agholme|+4670323634|fredrik.agholme@essity.com|
20226464|NCT00700375|Osaka General Medical Center|Prevention on Conrast-Induced Nephropathy With Bolus Injection of Sodium Bicarbonate|81-6-6692-1201|u_hiromichi@yahoo.co.jp|
20226465|NCT00581061|University of California, Irvine|Doug Skarecky|714-456-6744|dwskarec@uci.edu|
20226466|NCT02821416|AstraZeneca|Maria Jison|001-202-577-6213|Maria.Jison@astrazeneca.com|
20226467|NCT02256917|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
20226468|NCT00540644|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
20226469|NCT01869777|Wake Forest University Health Sciences|Principal investigator|336-716-5440|tpardee@wakehealth.edu|
20226470|NCT03549598|Mayo Clinic|John P. Bois, M.D.|507-284-3545|Bois.John@mayo.edu|
20226471|NCT04819438|Zambon S.p.A.|Dr. Mathias Knecht, Chief Medical Officer|+41.91.960.4187|mathias.knecht@zambongroup.com|
20226472|NCT02869893|Cincinnati Children's Hospital Medical Center|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
20226473|NCT00705341|Johns Hopkins University|Anne Capser|410-955-8183|ashankli@jhsph.edu|
20226474|NCT02237989|Eskisehir Osmangazi University|Dr. Fulya Bakılan|+905057737335|fulyabakilan@gmail.com|
20226475|NCT03665077|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
20226476|NCT00435461|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226477|NCT01472822|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jeong-Hwan Seo, MD|82-63-276-8284|vivaseo@jbnu.ac.kr|
20226478|NCT00205660|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
20226479|NCT01768559|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20226480|NCT00837967|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20226481|NCT02681458|Islamic Azad University of Mashhad|Dr. Hassan Yazdanfar|00985136631004|hasanyazdanfar@yahoo.com|
20226482|NCT02504320|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20226483|NCT01737879|Amgen Inc.|Study Director|866-572-6436||
20226484|NCT00685360|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20226485|NCT01504672|Umeå University|Dr. Maria Gustafsson|0046703978717|maria.gustafsson@umu.se|
20226486|NCT04978337|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20226487|NCT02497404|Weill Cornell Medical College|Sebastian Mayer, MD|646-962-7950|sam2033@med.cornell.edu|
20226488|NCT01408901|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20226489|NCT00845676|San Francisco General Hospital/UCSF|Brad Hare, MD|415-476-4082|chare@php.ucsf.edu|556
20226490|NCT00681265|Eyeon Therapeutics, Inc.|David M. Kleinman||dave@eyeontherapeutics.com|
20185490|NCT05271903|University of Utah|Melissa Watt|801-587-2100|melissa.watt@hsc.utah.edu|
20185491|NCT05444192|University of Central Lancashire|Dr Graham Chapman|01772894949|gchapman2@uclan.ac.uk|
20185492|NCT04522713|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
20207986|NCT04610827|Mayo Clinic|Julie M. Baughn, M.D.|507-293-1031|Baughn.Julie@mayo.edu|
20207987|NCT00364611|Sanofi-aventis|Trial Transparency Team||Contact-us@sanofi.com|
20207988|NCT01562379|Johns Hopkins Bloomberg School of Public Health|Parul Christian|1-410-955-1188|pchrist1@jhu.edu|
20207989|NCT03350724|The University of Texas Health Science Center at Houston|Jennifer James, DMD, MS|713-486-4383|Jennifer.D.James@uth.tmc.edu|
20207990|NCT02134912|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
20207991|NCT01935622|Virginia Commonwealth University|Antonio Abbate|8048280513|aabbate@vcu.edu|
20207992|NCT04097925|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
20207993|NCT02636049|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
20207994|NCT03702439|Imperial Prostate|David Eldred-Evans|020 7594 7773|d.eldred-evans@imperial.ac.uk|
20207995|NCT02059174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20207996|NCT02306148|University of Sao Paulo - School of Medicine|Dr Isabel Sacco|0055 11 996431511|icnsacco@usp.br|
20207997|NCT04397757|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
20207998|NCT01901809|Johns Hopkins University School of Medicine|Kavita Sharma, MD|410-955-7670|ksharma8@jhmi.edu|
20207999|NCT02776904|University of Arkansas for Medical Sciences|Dr. Charlotte Yates|501-450-5542|cyates@uca.edu|
20208000|NCT04167514|CSL Behring|Clinical Study Disclosure Manager|1- 610-878-4697|clinicaltrials@cslbehring.com|
20208001|NCT00290355|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208002|NCT03345849|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20208003|NCT00033514|Medical University of South Carolina|Carolyn Britten|843-792-4271|britten@musc.edu|
20208004|NCT03595982|Icahn School of Medicine at Mount Sinai|Dr. Melissa Chu Lam|520-360-8807|melissachu.md@gmail.com|
20208005|NCT01228084|Oregon Health & Science University, Knight Cancer Institute|Joshi Alumkal, MD|503-494-1091||
20208006|NCT03577028|Harpoon Therapeutics|Medical Director|1-650-452-728|HPN4241001@harpoontx.com|
20208007|NCT01599585|National Center for Telehealth and Technology|Larry D. Pruitt, PhD|253-968-2946|larry.d.pruitt21.civ@mail.mil|
20208008|NCT04564027|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
20208009|NCT00777036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20208010|NCT04632589|University of Iowa|Anna Stanhewicz, PhD|3194671732|anna-stanhewicz@uiowa.edu|
20208011|NCT05827978|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20208012|NCT05564039|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
20162951|NCT00894361|PI/study coordinator retired due to personal family health matters and study sponsor then withdrew funding. Study terminated and no data was collected or analyzed from any participant.|Terence J. Gioe, M.D.||tjgioe@gmail.com|
20162952|NCT02920749|Department of Anaesthesiology and Intensive Therapy, University of Pecs|Dr. Timea Bocskai|36 72 507374|bocskai.timea@pte.hu|
20162953|NCT00286494|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20162954|NCT04776317|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
20185493|NCT01532388|Karolinska Institutet|Dr Kristina Sinadinovic|+46812345735|kristina.sinadinovic@socialstyrelsen.se|
20185494|NCT00792636|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185495|NCT01046136|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
20185496|NCT04579250|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20185497|NCT01154192|UC San Diego School of Medicine|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
20185498|NCT01376700|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20192448|NCT04269434|Instituut van Tropische Geneeskunde Antwerpen|Dr. Chris Kenyon|+3232470786|ckenyon@itg.be|
20192449|NCT02767609|Loma Linda University medical Center|Brenda Bartnik Olson|909-558-4000|bbartnik@llu.edu|85216
20192450|NCT01772563|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192451|NCT00832000|University of Kansas Medical Center|Richard J. Barohn, MD|913-588-6095|rbarohn@kumc.edu|
20192452|NCT01898442|University of Florida - Jacksonville|Dominick J. Angiolillo, MD, PhD|9042443933|dominick.angiolillo@jax.ufl.edu|
20192453|NCT01435798|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
20192454|NCT03974100|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20192455|NCT00690378|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20192456|NCT00935259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192457|NCT03318783|Oregon Health and Science University|Ross Martini|4013386803|martinir@ohsu.edu|
20192458|NCT03990298|Hospital of the University of Pennsylvania, Dept of Otorhinolaryngology, Head & Neck Surgery|Erica Thaler, MD|215-662-4533|erica.thaler@pennmedicine.upenn.edu|
20192459|NCT01690923|ResMed Ltd|Xueling Zhu, Clinical Consultant|61288842265|xueling.zhu@resmed.com.au|
20192460|NCT01721746|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20192461|NCT03467698|UT Dallas|UT Dallas IRB DIrector|972-883-4506|amanda.boone@utdallas.edu|
20192462|NCT00623363|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20192463|NCT01062269|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|HBaysMD@aol.com|
20192464|NCT03004586|UT MD Anderson Cancer Center|George Eapen,MD/ Professor, Pulmonary Medicine|(713) 563-4256|geapen@mdanderson.org|
20208013|NCT04566445|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20208014|NCT04785144|Kaiser Permanente Washington|Lisa Jackson|206-442-5216|lisa.a.jackson@kp.org|
20208015|NCT04453722|Cleveland Clinic|Daniel I. Sessler, Professor & Chair|216-445-6500|DS@CCF.org|
20208016|NCT01263470|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20208017|NCT00610714|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20208018|NCT01327573|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
20208019|NCT01108263|Georgetown University|Dr. John Steinberg, Principal Investigator|202-444-0793|zr40@georgetown.edu|
20208020|NCT00712712|Institute Bergonie|Dr. Jean Palussière|05 56 33 37 50|j.palussiere@bordeaux.unicancer.fr|
20208021|NCT02055872|McMaster University|Simon Oczkowski|905 521 2100|oczkowsj@mcmaster.ca|42442
20208022|NCT01029691|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
20208023|NCT02591511|Taipei medical university|Dr. Chia-Yun Lin|+886919986391|windoct@hotmail.com|
20208024|NCT01104922|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor; ClinicalTrials.gov Admin|412-647-5554|stadtermanbm@upmc.edu|
20208025|NCT03501979|University of Alabama at Birmingham|Dr. Erica Stringer-Reasor|205-975-2914|esreasor@uabmc.edu|
20208026|NCT05245071|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20208027|NCT01602822|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
20208028|NCT02329860|clinical operation|Zexiang.huang/ project manager|13811725417|zexiang.huang@hengrui.com|
20208029|NCT03369340|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20208030|NCT01076270|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4730|wbensing@fredhutch.org|
20208031|NCT04005755|AFT Pharmaceuticals|Jennifer Zhang -Project Leader|+ 64 9 488 0232|jenniferz@aftpharm.com|710
20208032|NCT02599441|University at Buffalo|Research coordinator|7162043209|mk67@buffalo.edu|
20208033|NCT01228149|Dept. of Ophthalmology, University Medical Center Mainz|Dr. Dr. Katrin Lorenz|00496131174069|lorenz@augen.klinik.uni-mainz.de|
20208034|NCT02005211|AstraZeneca|Vice President, Neuroscience iMed||ClinicalTrialTransparency@astrazeneca.com|
20208035|NCT01917136|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
20208036|NCT04589832|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
20208037|NCT02202161|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208038|NCT00832091|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-208-9191|nturjman@regenerx.com|108
20208039|NCT00952588|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20208040|NCT04554394|Pulse Biosciences, Inc.|William A. Knape|(919) 757-2033|bill.knape@pulsebiosciences.com|
20208041|NCT01766401|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20208042|NCT01021553|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208043|NCT01950364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20208044|NCT00935701|Kennedy Krieger Institute|Lana Warren|4439239312|WarrenL@kennedykrieger.org|
20208045|NCT04055844|University of Minnesota, Masonic Cancer Center|Mark Juckett , MD|612-676-4200|juck0001@umn.edu|
20208046|NCT04716010|University of North Carolina at Chapel Hill|Lindsey Smith Taillie, PhD|(919) 445-8313|taillie@unc.edu|
20208047|NCT00679380|Santarus, Inc.|Michael Huang, M.D., Senior Medical Director|858-314-5700|contact@santarus.com|
20208048|NCT01099761|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208049|NCT01347840|Ethicon Endo-Surgery, Inc.|Amy Mahanes|513-337-8366|amahanes@its.jnj.com|
20208050|NCT00928304|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
20208051|NCT01359111|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
20208052|NCT04223778|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20208053|NCT00703729|CU Sports Medicine|Dr. Eric McCarty|303-441-2118|cyndi.long@ucdenver.edu|
20208054|NCT03053180|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20208055|NCT01928186|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20208056|NCT00511706|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20208057|NCT02972658|AstraZeneca|AstraZeneca Information Center|877-240-9479|information.center@astrazeneca.com|
20208058|NCT03958149|Imperial College Healthcare NHS Trust|Key investigator|02033121077|annabellelee@nhs.net|
20208059|NCT00621764|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20208060|NCT02583399|Cumberland Pharmaceuticals Inc.|Sr. Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
20208061|NCT00686699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208062|NCT01693562|MedImmune, LLC|Ashok Gupta|+13013981287|information.center@astrazeneca.com|
20192465|NCT00927901|Novartis Pharmaceuticals|Study Director|862 778-8300||
20192466|NCT02344173|Abbott|Principal Clinical Research Scientist|6517564067|eric.grovender@abbott.com|
20192467|NCT03738397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20192468|NCT02881047|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|leahyd@uphs.upenn.edu|
20192469|NCT03783546|Dana-Farber Cancer Institute|Weidong Lu, MB, MPh, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
20192470|NCT05275023|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20208063|NCT02759939|Dartmouth College|Rachel Thompson|6036530860|rachel.thompson@dartmouth.edu|
20208064|NCT00087594|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20192471|NCT01664897|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD./Professor|713-794-5783|jcortes@mdanderson.org|
20208065|NCT00768040|Novartis Pharmaceuticals|Study Director|862-778-8300||
20208066|NCT00551200|Hyperion Therapeutics|Sr. Vice President and Chief Medical Officer, Bruce F. Scharschmidt|(650) 745-7851|bruce.scharschmidt@hyperiontx.com|
20208067|NCT03347279|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
20208068|NCT01646151|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20208069|NCT02530281|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20208070|NCT03558503|UroGen Pharma|Elyse Seltzer, MD|1-646-492-8518|elyse.seltzer@urogen.com|
20208071|NCT02094612|Kaiser Permanente Division of Research|Monique Does, Project manager|510-891-3612|monique.does@kp.org|
20208072|NCT01542632|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20208073|NCT03991936|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
20208074|NCT01866839|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
20208075|NCT02773849|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
20208076|NCT05306964|University of Pittsburgh|Raghavan Murugan, MD, MS, FRCP, Principal Investigator|412-647-8499|muruganr@ccm.upmc.edu|
20208077|NCT01685372|University of Colorado School of Medicine|Donna Curtis, MD, MPH|720-777-6981|donna.curtis@childrenscolorado.org|
20208078|NCT02477800|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20208079|NCT00129376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20208080|NCT02061540|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
20208081|NCT01948518|Cleveland Clinic|Umur Hatipoğlu, MD|216-636-5344|HATIPOU@ccf.org|
20208082|NCT02289833|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20208083|NCT04509024|Carnegie Mellon University|Dr. Seth Wiener, Associate Professor|412-268-5669|sethw1@cmu.edu|
20208084|NCT02561273|University of Nebraska Medical Center|Matthew Lunning|402-559-7164|mlunning@unmc.edu|
20208085|NCT02723019|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
20208086|NCT03597789|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-5082|djjones@email.unc.edu|
20208087|NCT00958191|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
20208088|NCT00611767|Yale University School of Medicine|Dr. Ismene L. Petrakis, Professor of Psychiatry|203-932-5711|Ismene.petrakis@yale.edu|2244
20208089|NCT01642004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20208090|NCT02718625|Smith & Nephew, Inc.|Natasha Schappell, Clinical Study Manager|817-302-3949|Natasha.Schappell@smith-nephew.com|
20208091|NCT00598806|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20208092|NCT01818765|Oxford university hospitals NHS Foundation Trust|Dr James Gamble|+441865221012|drjgamble1@jhpg.net|
20208093|NCT02417129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208094|NCT00952133|NYU Langone Medical Center|Jeanna Blitz, MD|212-263|jeanna.viola@nyumc.org|0667
20208095|NCT01603628|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20208096|NCT01969565|Emory University|Jonathan Kaufman, MD|404-778-1900|jlkaufm@emory.edu|
20208097|NCT03667573|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
20208098|NCT02877134|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20208099|NCT01197794|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
20208100|NCT01055457|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D.- PRINCIPAL RESEARCH OPTOMETRIST, Clin Ops|904-443-3500|KCANAVA2@its.jnj.com|
20208101|NCT02187224|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
20226491|NCT03275389|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20226492|NCT01790516|Inova Health Care System|Dr John Deeken, PI|703 776 8161|john.deeken@inova.org|
20226493|NCT03749109|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20226494|NCT03034135|Cantex Pharmaceuticals|Stephen Marcus MD|9543153660|smarcus@cantex.com|
20226495|NCT02014051|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
20226496|NCT02576977|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226497|NCT02957357|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
20226498|NCT01196377|Vanderbilt University School of Medicine|Dr. Donald H Arnold|6155790516|don.arnold@vanderbilt.edu|
20226499|NCT03159299|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
20226500|NCT02489448|Yale School of Medicine|Lajos Pusztai, MD, DPhil Professor of Medicine (Medical Oncology)|(203) 737-8309|lajos.pusztai@yale.edu|
20226501|NCT04152083|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20226502|NCT03280056|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
20226503|NCT04254081|University of California, San Diego|UCSD Family Planning Research|(858) 329-4464|familyplanningresearch@health.ucsd.edu|
20226504|NCT01135524|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20226505|NCT02762071|Johns Hopkins University|Uma Srikumaran|443-546-1550|us@jhmi.edu|
20226506|NCT00807612|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20226507|NCT04607135|Duke University|Kathy Nightingale, Ph.D.|919-660-5175|kathy.nightingale@duke.edu|
20226508|NCT03465709|Apellis Pharmaceuticals. Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20208102|NCT00835276|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20226509|NCT04892446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20226510|NCT04167189|PhenoSolve|Lynn Feldman|617-879-1670|lynn@phenosolve.com|
20226511|NCT03193047|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20226512|NCT02328937|Johnson & Johnson Vision Care Inc.|Tawnya Wilson - PRINCIPAL RESEARCH OPTOMETRIST|+1 904 443-1834|TWilson@ITS.JNJ.com|
20226513|NCT01210222|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20226514|NCT05593770|Research Organization (KC) Ltd|Clinical Project Manager|+44 (0) 7494 795 982|nectar@rokcservices.com|
20226515|NCT01309451|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
20226516|NCT04865419|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20226517|NCT00547157|Amgen Inc.|Study Director|866-572-6436||
20226518|NCT04186221|TransMedics, Inc.|Laura Damme, VP Clinical Affairs|978-552-0900|ldamme@transmedics.com|
20226519|NCT01654263|Group Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|Jackson.L@ghc.org|
20226520|NCT00972283|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20226521|NCT00282152|Vanderbilt University Medical Center|David Charles, MD||david.charles@Vanderbilt.Edu|
20226522|NCT00585325|University of Wisconsin-Madison|Cindy Schmitz, RN, MS, NP|608-262-2664|CSchmitz@uwhealth.org|
20162955|NCT05438576|Mayo Clinic|Demilade Adedinsewo, M.B, Ch.B.|904-953-0859|adedinsewo.demilade@mayo.edu|
20226523|NCT03092791|Takeda|Senior Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20226524|NCT02182830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226525|NCT01990768|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
20226526|NCT00154375|Novartis Pharmaceuticals|Study Director|862-778-8300||
20226527|NCT04672044|Birmingham VA Medical Center|Research Integrity Officer|2059338101|latanya.higginbottom@va.gov|337436
20226528|NCT00334295|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20226529|NCT01588405|United Therapeutics|Nicole Leedom|919-425-5870|nleedom@unither.com|
20226530|NCT01181947|St. Antonius Ziekenhuis|Dr. Robin Heijmen|0031306092047|r.heijmen@antoniusziekenhuis.nl|
20226531|NCT03715452|Osprey Medical, Inc.|Vice President of Clinical Affairs|952.955.8236|kknish@ospreymed.com|
20226532|NCT00792116|Baylor|Craig Johnston|713-798-2068|caj@bcm.edu|
20226533|NCT02453256|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20226534|NCT01216332|Vanderbilt|Dr. Natasha Halasa|6153223346|natasha.halasa@vanderbilt.edu|
20226535|NCT03479944|Alcon Japan Ltd.|Group Manager, Surgical, Alcon Japan|03-6899-5061|alcon.medinfo@alcon.com|
20226536|NCT00729300|Baylor College of Medicine|Christopher Verrico|713-791-1313|verrico@bcm.edu|26020
20226537|NCT01066871|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20226538|NCT04162795|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20226539|NCT01440634|UT Southwestern Medical Center|Dr. Carlos H Timaran|2146450533|timaran1@msn.com|
20226540|NCT02029274|Novartis Pharmaceuticals|Study Director|862-778-8300||
20226541|NCT01124292|Georgia Institute of Technology|Dr. Maysam Ghovanloo|404-385-7048|mgh@gatech.edu|
20226542|NCT01680653|Stanford University|Dr. Bruce Buckingham|650-725-6549|bbendo@stanford.edu|
20226543|NCT03373461|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20226544|NCT03020550|University of California, Davis|Michelle Dossett, MD, PhD|916-734-5367|mdossett@ucdavis.edu|
20226545|NCT01972464|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
20226546|NCT04530838|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226547|NCT00803712|Amgen Inc.|Study Director|866-572-6436||
20226548|NCT02588586|The Rockefeller University|Dr. Marina Caskey, Professor of Clinical Investigation|2123277396|mcaskey@rockefeller.edu|
20226549|NCT02484092|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226550|NCT02861664|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20226551|NCT00905632|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226552|NCT02609386|Eterna Therapeutics|VP of Quality|212-582-1199|info@eternatx.com|
20226553|NCT00610168|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226554|NCT01588158|Massachusetts General Hospital|Neal Chen, MD||nchen1@partners.org|
20226555|NCT02820870|VA Center for Clinical Management Research|Jeremy Sussman, MD, MS - Principal Investigator|(734) 845-5200|jeremysu@med.umich.edu|
20226556|NCT00878800|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20226557|NCT03318003|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
20226558|NCT01266824|Children's Hospital of Philadelphia|Dr. Amy Cohen|215-590-1000|cohenam@email.chop.edu|
20226559|NCT01101750|MedStar Health Research Institute|Veronica Gomez-Lobo, MD|202-877-4099|veronica.gomez-lobo@medstar.net|
20226560|NCT02693262|University of California, San Diego|Jonathan Hsu, MD, MAS|858-246-2972|jonathan.hsu@ucsd.edu|
20226561|NCT01029262|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1588|clinicaltrialdisclosure@celgene.com|
20226562|NCT01753713|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-844-5060|ahluwam@ccf.org|
20226563|NCT02620787|Center for Anti Infective Research and Development|Dr. David P. Nicolau|(860) 972-3941|david.nicolau@hhchealth.org|
20226564|NCT01896193|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20226565|NCT05612217|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
20162956|NCT02881762|University of Maryland, Baltimore|Dr Lydia Tang|14107066567|lydiatang@ihv.umaryland.edu|
20162957|NCT00465088|Abbott|Global Medical Services|800-633-9110||
20162958|NCT04054375|Northwestern University School of Medicine|Dr. Senda Ajroud-Driss|(312) 944-0063|s-ajroud@northwestern.edu|
20226566|NCT02959918|Selecta Biosciences, Inc.|Dr. Peter Traber|713-540-9776|ptraber@selectabiosciences.com|
20226567|NCT01549340|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20226568|NCT02585713|Mayo Clinic|Robert D. McBane, M.D.|507/284-4565|Mcbane.robert@mayo.edu|
20208103|NCT04922710|AdventHealth Research Institute|Kirk Erickson, Director of Translational Neuroscience|412-576-3724|kirk.erickson@adventhealth.com|
20208104|NCT01010776|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
20208105|NCT01736930|Jaeb Center for Health Resesarch|Roy W. Beck, MD, PhD|813-975-8690|jdrfapp2@jaeb.org|
20208106|NCT00678249|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|john.reviere@crbard.com|
20208107|NCT00721357|Ralph H Johnson VAMC|Chris Gregory|(843)792-1078|Christopher.Gregory@va.gov|
20208108|NCT00374127|New York State Psychiatric Institute at Columbia University Medical Center|Dr. Meg Haney, Professor of Neurobiology|6467746153|meg.haney@nyspi.columbia.edu|
20208109|NCT00928499|University of California, Irvine|Karen Noblett, MD|714-456-8564|knoblett@uci.edu|
20208110|NCT00703781|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
20208111|NCT05954065|Erchonia|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
20208112|NCT05325333|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
20208113|NCT03893630|University of Kentucky|Dr. John M. O'Brien|8592575158|john.obrien2@uky.edu|
20208114|NCT04540627|mAbxience Research SL|Director of Clinical Trials|+34917711500|susana.millan@mabxience.com|
20208115|NCT01465958|Grifols Therapeutics Inc|Henry Li, PhD|800-20-2807|henry.li@grifols.com|
20208116|NCT03109418|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
20208117|NCT02043704|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
20208118|NCT02785588|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
20208119|NCT06115681|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208120|NCT00211536|Sr. Clinical Research Manager|John Shin|818-576-4019|john.shin@medtronic.com|
20208121|NCT01004861|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20208122|NCT00003389|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
20208123|NCT02554721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20208124|NCT01662752|St Mark's Hospital|Professor Robin Kennedy|+44(0)2082354046|robin.kennedy@nhs.net|
20208125|NCT04657003|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20208126|NCT00935766|Denver Health Medical Center|Carlin Long, MD|303-602-3899|carlin.long@dhha.org|
20208127|NCT01823991|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nagi Kumar|813-745-6885|nagi.kumar@moffitt.org|
20208128|NCT05158244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208129|NCT04334876|Indiana University|Courtney Rowan|317-944-7065|coujohns@iu.edu|
20208130|NCT02184520|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
20208131|NCT02185040|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|866-260-1599|ClinicalTrialDisclosure@Celgene.com|
20208132|NCT01792024|University of Chicago|Dr. Aytekin Oto|773-834-7424|aoto@radiology.bsd.uchicago.edu|
20208133|NCT00811395|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
20208134|NCT00170846|Novartis Pharmaceuticals|Study director|862-778-8300||
20208135|NCT00528840|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20208136|NCT02079311|Universitätsklinikum Gießen und Marburg GmbH|Prof Alexander Torossian|(+49) 06421 - 286 9864|alexander.torossian@med.uni-marburg.de|
20208137|NCT01714336|Mayo Clinic|Dr. Mark Pagnano|507-284-2511|pagnano.mark@mayo.edu|
20208138|NCT04995666|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20208139|NCT01756833|University of Maryland School of Medicine|Michael L. Terrin, MDCM, MPH, Contact Principal Investigator|410-706-6139|mterrin@som.umaryland.edu|
20208140|NCT01523613|University of Michigan|Dr. Mathilde Peters||mcpete@umich.edu|
20208141|NCT00808132|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185499|NCT00727909|VA TVHS|Gene W. Bratt, Ph.D.|615-873-6068|gene.bratt@va.gov|
20208142|NCT02795182|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20208143|NCT03442933|Universidad Europea de Madrid|Gerson Garrosa Martín|+34 663 294 774|g.garrosa@gmail.com|0034
20208144|NCT00398086|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20208145|NCT00696774|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20208146|NCT00890201|Hospital de La Serena|Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna|56 51 485923|beltran_01@yahoo.com|
20208147|NCT00033293|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20208148|NCT02087241|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
20208149|NCT02181504|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20208150|NCT01671605|Vanderbilt University Medical Center|Valentina Kon|6153224883|valentina.kon@vanderbilt.edu|
20208151|NCT00887913|Syneron Medical Ltd|Hanit Brenner-Lavie|972-73-244-2200|hanitb@syneron.com|581
20226569|NCT01150903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20162959|NCT02932748|University of Kansas Medical Center|Anna M. Gorczyca, PhD|913-588-9077|agorczyca@kumc.edu|
20226570|NCT03173456|Department of Emergency Medicine Albert Einstein Coll of Med|Dr. Polly Bijur|914-661-4707|polly.bijur@einsteinmed.org|
20226571|NCT01733121|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20226572|NCT04736069|Ufuk University|Nihan Cüzdan|5052706846|nihancuzdan@hotmail.com|
20226573|NCT03061188|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
20208152|NCT00598585|Charles R. Drew University|Theodore C. Friedman MD PhD|3106685197|theodorefriedman@cdrewu.edu|
20185500|NCT01696773|The Ohio State University|Steven J. Schwartz|614-292-2934|schwartz.177@osu.edu|
20208153|NCT01200758|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20208154|NCT03341728|University of North Caroilina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
20208155|NCT00461552|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
20208156|NCT01289028|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20208157|NCT02031627|Tactile Medical|Susy Peters, Clinical Trial Manager|612-540-7175|speters@tactilemedical.com|
20208158|NCT01229410|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20208159|NCT00384449|Oregon Health & Science University|Dr. Christina J. Flaxel|(503) 418-3352|flaxelc@ohsu.edu|
20208160|NCT06022224|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20208161|NCT01855867|The Fenway Institute|Dr. Kenneth Mayer, Medical Research Director|6179276374|kmayer@fenwayhealth.org|
20208162|NCT03116841|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20208163|NCT03267576|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20208164|NCT01846208|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
20208165|NCT01268514|Medtronic|Andrea DiScipio, Clinical Research Associate|781-491-5350|andrea.l.discipio@medtronic.com|
20208166|NCT01432938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20208167|NCT01424306|Fred Hutchinson Cancer Research Center|Mario Kratz|206-667-7362|mkratz@fredhutch.org|
20208168|NCT00369928|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20208169|NCT01875874|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
20208170|NCT00407420|University of Bristol|Julian Hamilton-Shield|00441173420183|j.p.h.shield@bristol.ac.uk|
20208171|NCT03344562|University of Texas Southwestern Medical Center|Dr. Amy Mathews - ASSISTANT PROFESSOR|214/645-1719|Amy.Mathews@UTSouthwestern.edu|
20208172|NCT02736474|Shanghai Mental Health Center|Chief Physician Dr Du. Jiang Du|86-21-64387250|dujiangdou@163.com|
20208173|NCT02463331|Clinic Hospital of University of Sao Paulo|Lydia Teófilo de Moraes Falcão|55-81-996486935|lydiatmf@yahoo.com.br|81
20208174|NCT02382276|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20208175|NCT05439876|School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan|Shao-Yu Tsai|(02)23123456#288904|stsai@ntu.edu.tw|
20208176|NCT04191096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208177|NCT03285061|Brigham & Women's Hospital|Dr. Christopher Chiodo|617-983-7363|cchiodo@bwh.harvard.edu|
20208178|NCT02683668|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
20208179|NCT00387829|Intergra LifeSciences|Director of Medical Affairs|609-275-0500|clinicalaffairs-neuro@integralife.com|
20208180|NCT02442765|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20208181|NCT02385292|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20208182|NCT03818399|Virginia Commonwealth University|Roy Sabo, PhD|804-828-3047|roy.sabo@vcuhealth.org|
20208183|NCT00141297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226574|NCT00573872|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
20226575|NCT02609984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226576|NCT00613379|Cytodyn, Inc.|Dr. Nader Pourhassan|360-980-8524|npourhassan@cytodyn.com|
20226577|NCT02404610|Hennepin Healthcare|Audrey Hendrickson|6128739528|audrey.hendrickson@hcmed.org|
20226578|NCT02306850|Saint Louis University|John Richart, MD|314-577-8854|john.richart@health.slu.edu|
20226579|NCT02420262|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20226580|NCT00941304|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20226581|NCT03293394|Spedali Civili di Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
20226582|NCT00086450|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster, M.D., Ph.D.|212-860-1056|valentin.fuster@mssm.edu|
20226583|NCT00784719|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226584|NCT00074815|Duke University School of Medicine|Jeffrey Sapyta, PhD|919-668-0069|jeffrey.sapyta@duke.edu|
20226585|NCT01436227|M.D. Anderson Cancer Center|Eric Jonasch, MD|713-792-2830|ejonasch@mdanderson.org|
20226586|NCT05446142|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226587|NCT00889915|Duke Clinical Research Institute - Duke University School of Medicine|John S. March, MD, MPH|919-668-7818|john.march@duke.edu|
20226588|NCT02098395|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20226589|NCT01310582|Clinical Research Group|Kirtanaa Voralu, Associate Director Research Management|215-255-7878|kirtanaa.voralu@drexelmed.edu|7878
20226590|NCT01509612|Medical University of Vienna|Michael Frass, MD|+436645453040|office@ordination-frass.at|
20226591|NCT03774888|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
20226592|NCT04633226|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20226593|NCT02536105|Massachusetts General Hospital|Dr. Thomas Spencer|617-724-5600|spencer@helix.mgh.harvard.edu|
20226594|NCT04585243|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
20226595|NCT06329687|Oyster Point Pharma Inc|Marian Macsai, MD|3122592477|marian.macsai@viatris.com|
20226596|NCT02733341|The Royal Wolverhampton NHS Trust|Professor James Cotton|01902307999|jamescotton@nhs.net|
20226597|NCT04156906|The Children's Hospital of Philadelphia|Stella Chou, MD|215-590-0947|chous@chop.edu|
20226598|NCT05415462|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20226599|NCT01408719|Agriculture and Agri-food Canada|Dr. Nancy Ames|204-474-7187|nancy.ames@agr.gc.ca|
20226600|NCT00290654|Masonic Cancer Center, University of Minnesota|Todd Tuttle, M.D.|612-625-2991|tuttl005@umn.edu|
20185501|NCT04752163|The University of MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
20185502|NCT05623345|Acelyrin Inc.|Clinical Trials Information Desk|+18054564393|clinicaltrials@acelyrin.com|
20185503|NCT05384730|University of Southampton|Dr Samantha Meredith|0238120|s.j.meredith@soton.ac.uk|4656
20208184|NCT02987205|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
20208185|NCT02646891|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20208186|NCT00848172|NINDS|Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
20208187|NCT00103207|ECOG Statistical Office|Study Statistician|617-632-3012||
20208188|NCT03442595|MedStar Health|Dr Michelle F Magee, Director MedStar Diabetes Institute|202-877-2383|michelle.f.magee@medstar.net|
20208189|NCT00779116|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20208190|NCT01947127|Faculty of Medicine, Chulalongkorn University|Khrongwong Musikatavorn, M.D.|+6622564553|kmusikatavorn@yahoo.com|
20208191|NCT01562327|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20208192|NCT00706264|Hospital Vall d'Hebron|Maria M Goya|934893085|maria.goya@vhir.org|4652
20208193|NCT02447952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20208194|NCT04084210|University of Wisconsin- Madison|Megan Piper, PhD, Director of Research Professor|608-265-5472|mep@ctri.wisc.edu|
20208195|NCT02246309|Center for Human Reproduction|Dr. David Barad, Director of Clinical Research|2129944400|dbarad@theCHR.com|212
20208196|NCT01795716|Shanghai Jiaotong University School of Medicine Ruijin Hospital|Dr. Zhou Li|13816510379|lizhou999_999@yahoo.com|
20208197|NCT00998985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208198|NCT01100762|University of Maryland, Baltimore|Gad Alon, PhD, PT|410-706-7733|galon@som.umaryland.edu|
20208199|NCT02152540|DVBIC, VA Palo Alto/Stanford School of Medicine|Dr. Maheen M. Adamson|6502136307|madamson@stanford.edu|
20208200|NCT01012037|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208201|NCT00415623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20208202|NCT01369069|University of Virginia|Karen C. Johnston, MD|434 924-5323|kj4v@virginia.edu|
20208203|NCT02573012|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20208204|NCT00882362|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20208205|NCT02096471|The Univ of Alabama at Birmingham|Gary Cutter, PhD|205.975-5048|cutterg@uab.edu|
20208206|NCT01809327|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20208207|NCT01635244|University of Michigan|David Bach, MD|734-615-4907|dbach@med.umich.edu|
20208208|NCT01401101|RAND Corporation|Lisa S. Meredith, PhD|310.393.0411|seidel@rand.org|7365
20208209|NCT01555541|University of California, San Francisco|Charalambos Andreadis, MD, MSCE, Associate Professor of Clinical Medicine|877-827-3222|cancertrials@ucsf.edu|
20208210|NCT02871570|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208211|NCT04396106|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
20208212|NCT02520141|M D Anderson Cancer Center|Milind Javle|(713) 792-5434|mjavle@mdanderson.org|
20208213|NCT01628718|Massachusetts Veterans Epidemiological Research and Information Center|Brett T. Litz, PhD|617-584-9314|litzb@bu.edu|
20208214|NCT02313506|Arthritis Research Canada|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
20208215|NCT02168816|Loyola University Medical Center|Michael Pinzur, M.D.|708-216-4993|mpinzu1@lumc.edu|
20208216|NCT03714256|Permobil|Vice President of Research and Innovation|+46703836763|karin.leire@permobil.com|
20208217|NCT00945594|University of Oklahoma Health Sciences Center|Lieschen Quiroz, MD|405-271-8787|lieschen-quiroz@ouhsc.edu|
20208218|NCT01066546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208219|NCT03860181|Medical University of South Carolina|Josef Eichinger, MD|843-876-0111|eichinge@musc.edu|
20208220|NCT03258762|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20208221|NCT00060333|Mayo Clinic|Barbara A. Pockaj, MD|507/284-3559|pockaj.barbara@mayo.edu|
20208222|NCT02545049|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20208223|NCT01586962|Novartis|Clinical Project Leader|+41223633111||
20208224|NCT03300557|University of Minnesota/Masonic Cancer Center|Britt Erickson|612-626-6283|bkeric@umn.edu|
20208225|NCT04960397|University of Maryland|Dr. James D. Campbell|410-706-5328|jcampbel@som.umaryland.edu|
20208226|NCT01394211|University of Arizona Cancer Center|Program Coordinator|5206260301|aselegue@email.arizona.edu|
20208227|NCT02020304|Wake Forest School of Medicine|Vernon H Ross MD|336-718-8278|vhross@wakehealth.edu|
20208228|NCT02469597|Northwell Health- Cohen Children's Medical Center|Dr. Kristy Williamson|718-470-7640|kwilliam12@nshs.edu|
20208229|NCT02308839|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20208230|NCT04144140|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20208231|NCT01749930|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
20208232|NCT04735432|argenx BV|Regulatory Manager|+32 9 310 34 00|regulatory@argenx.com|
20208233|NCT01066819|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20226601|NCT00544908|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
20226602|NCT02651337|Alcyone LifeSciences|Director of Clinical Operations|9787091946|jmcguire@alcyonels.com|
20226603|NCT02137226|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226604|NCT02998996|Eurocine Vaccines AB|Anna-Karin Maltais|+46 76 233 81 62|annakarin.maltais@eurocine-vaccines.com|
20208234|NCT02408016|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
20226605|NCT04270695|China Medical University|Ms Weng|0975127007|chuyu0608@gmail.com|
20185504|NCT00411151|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|M. Kabisch|++49 (0)6131-179922|kabisch@izks-mainz.de|
20185505|NCT02191085|University of Calgary|Dr. Sachin Pendharkar|403-210-8617|sachin.pendharkar@ucalgary.ca|
20185506|NCT01881412|Rhode Island Hospital and Brown University|Dr. Aris Garro|401-480-8682|arisgarro1@gmail.com|
20208235|NCT03502265|University of Southern California|Beth Smith|323-361-4670|beth.smith@usc.edu|
20208236|NCT00718887|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20208237|NCT00775138|Insmed|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
20208238|NCT03557801|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615 343 1187|lucy.b.spalluto@vumc.org|
20208239|NCT00535236|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208240|NCT04880642|Vicore Pharma|CEO Carl-Johan Dalsgaard|+46 (0) 317880560|info@vicorepharma.com|
20208241|NCT02390323|Hospital for Special Surgery|Semih Gungor|212-606-1206|gungors@hss.edu|
20208242|NCT01671176|Oticon Medical LLC|Ravi Sockalingam|9082023524|rsoc@oticomedical.com|
20208243|NCT02275052|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208244|NCT00561795|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208245|NCT02807376|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20208246|NCT00846027|Hoffmann-La Roche|Medical Communications|800 821-8590||
20208247|NCT00041119|Dana-Farber Cancer Institute|Lawrence N. Shulman, M.D.|(617)-632-2277|Lawrence_Shulman@dfci.harvard.edu|
20208248|NCT03228836|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20208249|NCT00948389|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
20208250|NCT01619176|CNR IAC|DR. Christine Nardini|+393386947833|christine.nardini.rsrc@gmail.com|
20208251|NCT02967562|King's College London|Professor Anne Greenough|02032999000|anne.greenough@kcl.ac.uk|
20208252|NCT04652102|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
20208253|NCT00886587|Johnson & Johnson Consumer Inc|Amisha Parikh-Das, PhD/Study Director|973 385-2863 USA EST|AParikh1@its.jnj.com|
20208254|NCT03062605|UCLA|Dr. Vladimir W. Spolsky|310-794-0700|vspolsky@dentistry.ucla.edu|
20208255|NCT02405091|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20208256|NCT01009333|Medtronic Neuromodulation|Maureen McGuire, Sr. Program Manager|763-526-8425|maureen.mcguire@medtronic.com|
20208257|NCT02139176|UNC Chapel Hill/UNC Project Lilongwe|Nora Rosenberg, PhD|+265 (0)99 109 0676|Nora_Rosenberg@unc.edu|
20208258|NCT01056601|Masonic Cancer Center, University of Minnesota|Arkaduisz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20208259|NCT00247962|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20208260|NCT01955005|Iowa City VA Health Care System|Carolyn L Turvey|319 338 0581|Carolyn.Turvey@VA.Gov|7714
20208261|NCT02815982|University of South Florida|Dr. Marilyn Stern|8139740966|mstern1@usf.edu|
20208262|NCT01469637|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20208263|NCT01371721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208264|NCT00545584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208265|NCT03514394|University of Washington|Morgan Johnson|17154161493|mjohn23@uw.edu|
20208266|NCT00135694|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20208267|NCT02584660|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20208268|NCT04623255|University College London|Prof Marie Scully|+ 44 (0)20 3447 9884|m.scully@ucl.ac.uk|
20208269|NCT02120469|City of Hope|Dr. Yuan Yuan|626-359-8111|yuyuan@coh.org|
20208270|NCT01040728|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208271|NCT02583711|Imperial College London|Ms Aliza Abeles|07834987667|aliza.abeles@gmail.com|
20208272|NCT02237898|Yale School of Medicine|Dr. Megan Smith|(203) 764-8655|megan.smith@yale.edu|
20208273|NCT02282930|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
20208274|NCT01601873|The University of Texas Health Science Center at Houston|Kristofer Charlton-Ouw, MD|(713) 486-5117|Kristofer.CharltonOuw@uth.tmc.edu|
20208275|NCT03196973|Laboratorios Salvat, S.A.|Medical Director|933946400|ejimenez@svt.com|
20208276|NCT03516227|National Defense Medical Center, Taiwan|Dr. Yu-Ju Chen|886-287923100|judychen37@gmail.com|18762
20208277|NCT00125268|Mayo Clinic|Dr. Matthew A. Butters|480-301-7745|butters.matthew@mayo.edu|
20208278|NCT00925522|St. Jude Medical|Nancy Ouch, Project Manager|949.769.5041|nouch@sjm.com|
20208279|NCT00671515|University Hospitals Cleveland Medical Center|Dr. Joseph Calabrese|216-844-2865|Joseph.Calabrese@UHhospitals.org|
20208280|NCT02985684|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
20208281|NCT02449915|TriHealth Inc.|Jennifer Yeung, DO|513-463-4300|Jennifer_Yeung@trihealth.com|
20208282|NCT01436357|University of New Mexico and Johns Hopkins University|Kimberly Page, Ph.D., M.P.H. and Andrea Cox, M.D., Ph.D.|505-272-2520, 410-502-2715|pagek@salud.unm.edu, acox@jhmi.edu|
20208283|NCT00656799|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20208284|NCT05281094|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
20208285|NCT00631969|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20226606|NCT00882661|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
20226607|NCT00003896|SWOG Statistical Center|Gynecologic Committee Statistician|206-667-4623||
20226608|NCT02373137|Kaiser Permanente / University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|650-299-2111|Jennifer.Rose-Nussbaumer@kp.org|
20226609|NCT01398358|University of Michigan|Julie Lumeng, MD|jlumeng@umich.edu|jlumeng@umich.edu|
20208286|NCT00957034|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20185507|NCT05751785|The Geneva Foundation|Ms. Elizabeth Metzger, Senior Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
20226610|NCT02022735|University of Miami|Corneliu Luca, MD, PhD|305-243-6732|cluca@med.miami.edu|
20226611|NCT00985686|Canadian Institute of Natural and Integrative Medicine|Dr. John Toews|4032200022|j.toews@cinim.org|111
20226612|NCT03134911|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226613|NCT01087203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226614|NCT00537290|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
20226615|NCT02559570|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20226616|NCT04388176|Vicore Pharma AB|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
20226617|NCT02364076|Georgetown University Medical Center -Lomabardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
20226618|NCT01064362|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226619|NCT00360009|University of Florida Department of Neurology|Michael Okun, M.D.|352-273-5550|okun@neurology.ufl.edu|
20226620|NCT00184093|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
20226621|NCT05095311|Indiana University|Curtis Goss, Student Investigator|8178080085|csgoss13@gmail.com|
20226622|NCT02588664|Wake Forest University Health Sciences|Dr. Pamela W. Duncan|(336) 716-5068|pduncan@wakehealth.edu|
20208287|NCT02390167|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20208288|NCT00805194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208289|NCT02009501|Mount Sinai St. Luke's|Dr. John C. Lantis II||JLantis@chpnet.org|
20208290|NCT01722552|Boston University School of Public Health|Dr Lora Sabin|617-414-1272|lsabin@bu.edu|617
20208291|NCT01488994|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20208292|NCT01072500|Wake Forest School of Medicine|Michael Miller|336-716-6837|mmiller@wakehealth.edu|
20208293|NCT02908841|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
20208294|NCT01611558|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20208295|NCT02465957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20208296|NCT01520727|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20208297|NCT03798366|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20208298|NCT01245972|ucsdmed|S. Brian Jiang|8586571663|s2jiang@ucsd.edu|
20208299|NCT04005885|CooperVision. Inc|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
20208300|NCT01412333|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20208301|NCT00366106|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20208302|NCT00750867|University of Massachusetts Medical School|Dr.Peter Novak|508-334-4973|novakp@ummhc.org|
20208303|NCT00474539|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20208304|NCT03018340|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20208305|NCT01836549|University of Tennessee Health Science Center|Dr. Mehmet Kocak|9014482937|mkocak1@uthsc.edu|901
20208306|NCT00676806|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
20208307|NCT00266799|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20208308|NCT02192190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20226623|NCT02308371|University of North Carolina|Dr. Melissa Hines|901-652-6138|mhinesthomas@gmail.com|
20226624|NCT00534638|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226625|NCT04229771|William Beaumont Hospital|Dr. Dianne Schlachter, Staff Physician|248-551-2020|dianne.schlachter@beaumont.org|
20226626|NCT02903420|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
20226627|NCT03866278|Massachusetts General Hospital|Principal investigator|6176709739|patrick.purdon@MGH.HARVARD.EDU|
20226628|NCT00227019|Stanford University|Heather Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
20226629|NCT02500719|University of Arkansas for Medical Sciences|Dr. Keith A. Bush|501.526.8347|kabush@uams.edu|
20226630|NCT00990509|University of Arizona|Chelsea Kidwell, MD|(520) 626-7159|ckidwell@neurology.arizona.edu|
20226631|NCT02710084|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|212-659-9134|alexander.kolevzon@mssm.edu|
20226632|NCT00181883|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
20226633|NCT05305989|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20226634|NCT03031340|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
20226635|NCT03335813|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. John Greskovich|1-866-223-8100|taussigresearch@ccf.org|
20226636|NCT00652145|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
20162960|NCT01415401|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader|1-888-451-3937|alcon.medinfo@alcon.com|
20162961|NCT00994422|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20208309|NCT02607865|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20226637|NCT01639144|Center for Research & Grants, Baptist Health South Florida|Gary M. Kiebzak, Ph.D., Co-investigator and Clinical Research Administrator|786-268-6224|garyk@baptisthealth.net|
20226638|NCT01520207|Brigham and Women's Hosptial|Dr. Finnian Mc Causland|6177326432|fmccausland@partners.org|
20226639|NCT00472732|Children's Research Institute|Andrea Gropman, M.D.|202-476-2120|agropman@childrensnational.org|
20226640|NCT00305227|University of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
20226641|NCT00856791|Onconova Therapeutics, Inc.|Francois E. Wilhelm, MD, PhD|609 281-7086|fwilhelm@onconova.us|
20226642|NCT03492437|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20208310|NCT03227692|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
20208311|NCT01657253|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Director of Clinical Trials|52+ 33 30014200|leopoldo.baiza@sophia.com.mx|
20208312|NCT01970540|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
20208313|NCT00242710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208314|NCT00579527|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
20208315|NCT00381706|Dana Farber Cancer Institute|Peter Enzinger, M.D.||peter_enzinger@dfci.harvard.edu|
20208316|NCT00203294|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@Jefferson.edu|
20226643|NCT03872843|Wake Forest|Dr. Jorge Gutierrez|336-716-2011|jgutierrez@wakehealth.edu|
20192472|NCT02083679|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20192473|NCT04814992|University of Pennsylvania|Dr. Peggy Compton|2158988283|pcompton@nursing.upenn.edu|
20192474|NCT00557349|University of Missouri|Archana Ramaswamy, MD|573-884-4003|ramaswamya@health.missouri.edu|
20192475|NCT01817712|VA Cooperative Studies Program|Tassos C. Kyriakides, Ph.D, Biostatistician|203-932-5711|tassos.kyriakides@va.gov|3771
20192476|NCT01831726|Novartis Pharmaceuticals|Study Director|862-778-8300||
20192477|NCT01669720|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20192478|NCT01075100|US Oncology Research, McKesson Specialty Health|Dr. Cynthia Osborne|214-370-1057|Cynthia.Osborne@usoncology.com|
20192479|NCT00731588|University of Iowa|John A. Widness, M.D.|319-356-8102|john-widness@uiowa.edu|
20192480|NCT01329185|University of Minnesota|Dr. Priya Verghese, Director of Pediatric Kidney Transplantation|6126262922|pverghes@umn.edu|0
20192481|NCT02388347|MedImmune LLC|Rene van der Merwe||information.center@astrazeneca.com|
20192482|NCT03898700|Thomas Jefferson University|Dr. MJ Mulcahey|215-503-2888|maryjane.mulcahey@jefferson.edu|
20192483|NCT00701909|University of California, San Francisco|Dr. Kathleen Puntillo, RN, PhD|415 819 2655|kathleen.puntillo@ucsf.edu|
20192484|NCT00971997|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20192485|NCT04009629|University of Kansas Medical Center|Dr. Eric Vidoni|913-588-0555|kuamp@kumc.edu|
20192486|NCT00761956|Zimmer, Inc|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
20192487|NCT01928693|Cornea Consultants of Nashville|Ira Shivitz MD|615-320-7200|jhatley@corneaconsultants.net|
20192488|NCT02022111|Emory University|Mohammed Kumail Ali, MD|404-727-9776|mkali@emory.edu|
20192489|NCT04398368|Mayo Clinic|Stephen A. Boorjian, M.D.|507 422-5516|Boorjian.Stephen@mayo.edu|
20192490|NCT02808975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20192491|NCT03602586|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20192492|NCT01083199|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
20192493|NCT02106195|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
20192494|NCT03568812|Tropical and Infectious Disease Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Indonesia|Dr dr. Erni Juwita Nelwan, Ph.D, Sp.PD-KPTI|+62811961229|ejnelwan@yahoo.com|
20192495|NCT05252845|Mahidol-Oxford Tropical Medicine Research Unit (MORU)|Professor Lorenz von Seidlein|+66-(0)2-3549170|Lorenz@tropmedres.ac|
20192496|NCT01296763|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Thomas Brown|410-502-5328|tbrown55@jhmi.edu|
20192497|NCT00634842|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20192498|NCT03194867|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20192499|NCT00464945|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20192500|NCT01010204|Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center|K.N. Roy Chengappa, Md|412-246-5006|chengappakn@upmc.edu|
20192501|NCT01513330|Coloplast A/S|Director of Clinical Trials|+45 4911 3595|dkbir@coloplast.com|
20192502|NCT01519778|Cubist Pharmaceuticals|Carisa De Anda, Phd, Vice President Clinical Research|8583522639|carisa.deanda@cubist.com|
20192503|NCT02693704|EPFL|Gilles Courtois|0041216932631|gilles.courtois@epfl.ch|
20192504|NCT02367430|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
20192505|NCT03021551|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
20192506|NCT03539068|Department of Veterans Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
20192507|NCT04585737|Orlando Immunology Center|Wendy Wert, Clinical Research manager|4076473960|wwert@oicorlando.com|
20192508|NCT00541671|Christiana Care Health System|Deb Marco|302-733-4130|DMarco@christianacare.org|
20192509|NCT00551135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192510|NCT04799418|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
20192511|NCT01379703|Abbott|Global Medical Services|1-800-633-9110||
20192512|NCT04731142|Imperial College London|Dr Jack Halligan|+447742161980|j.halligan@imperial.ac.uk|
20192513|NCT02669407|Duke University|Marat Fudim, M.D.|919-684-8111|marat.fudim@duke.edu|
20192514|NCT00704171|Covidien|Jennifer L. Doyle, Global Director of Clinical Affairs|781-839-1770|jennifer.doyle@covidien.com|
20226644|NCT05133323|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20192515|NCT00078728|The Johns Hopkins University School of Medicine|Golda Ginsburg, PhD,Professor|410-955-1544|gginnsbu@jhmi.edu|
20192516|NCT03634839|Yale University|Dr. Suchitra Krishnan-Sarin|(203)974-7595|suchitra.krishnan-sarin@yale.edu|
20208317|NCT02364999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208318|NCT02541994|Ochsner Health Services|Dr. Andrew Lawton|504-842-3995|andrew.lawton@ochsner.org|
20226645|NCT02697214|The Cleveland Clinic|Marc Gillinov, MD|216 445-8841|GILLINOM@ccf.org|
20208319|NCT03427528|Northwestern University, CCH|Dr. Darius Tandon|+1 312 503 3398|dtandon@northwestern.edu|
20208320|NCT00550615|University of Nebraska Medical Center|Julie M Vose|402-559-348|jmvose@unmc.edu|
20208321|NCT04180475|University of Virginia|John Stankovic|434-982-2275|jas9f@virginia.edu|
20208322|NCT01948791|Novartis Pharmaceuticals|Study Director|862-778-8300||
20208323|NCT02555722|CooperVision Inc.|Senior Manager, Clinical Research|925-730-6754|PChamberlain@coopervision.com|
20208324|NCT00702949|Mayo Clinic|Charles Loprinzi, M.D.|507/284-1623|cloprinzi@mayo.edu|
20208325|NCT03525613|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20208326|NCT00374452|VA Palo Alto Health Care System|Mary K. Goldstein, MD|650-493-5000|mary.goldstein@va.gov|1,1,62105
20208327|NCT00389805|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20208328|NCT01315873|New York University School of Medicine|Michael Grossbard, MD|646 501 9305|Michael.Grossbard@nyumc.org|
20208329|NCT01756391|Boston Children's Hospital|Wanda Phipatanakul|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
20208330|NCT00523744|Novartis Pharmaceuticals|Study Director|862-778-8300||
20208331|NCT03117309|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20208332|NCT01003067|Hirslanden Bern|Prof. Christoph A. Maurer|+41 31 335 33 33|christoph.maurer@hin.ch|
20208333|NCT02076243|Icahn School of Medicine at Mount Sinai|Dr. Philip Friedlander|212-824-8584|philip.friedlander@mssm.edu|
20208334|NCT00542425|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
20208335|NCT00193128|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20208336|NCT00590031|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, Attending|+1646-888-4183|ilsond@mskcc.org|
20208337|NCT01610414|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208338|NCT01402375|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-6626|achang3@yahoo.com|
20208339|NCT02176005|Da Volterra|Dr. Annie Ducher, Chief Medical Officer|+33 1 58 39 32 20|annie.ducher@davolterra.com|
20208340|NCT03726749|MGH|Dr Sebastian Unizony|617-726-7938|sunizony@mgh.harvard.edu|
20208341|NCT04957745|Schepens Eye Research Institute of Massachusetts Eye and Ear|Dr. Jaehyun Jung|6179122525|jaehyun_jung@meei.harvard.edu|
20208342|NCT00826540|Mayo Clinic|Dr. Axel Grothey, M.D.|(507) 284-4430|grothey.axel@mayo.edu|
20208343|NCT02802735|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20208344|NCT01166386|Carolinas Healthcare System, Carolinas Medical Center|Dr. Janet Niemeier|704 355 2046|janet.niemeier@carolinashealthcare.org|
20208345|NCT01564485|University of California, Irvine|Ashwini Erande, Clinical Coordinator|714 456 7025|aerande@uci.edu|
20208346|NCT00852761|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208347|NCT03922711|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20208348|NCT02390362|The Research Institute at Nationwide Children's Hospital|William E. Smoyer, MD.|6147222683|william.smoyer@nationwidechildrens.org|
20208349|NCT04009824|University of Maryland School of Medicine - Center for Vaccine Development|Dr. Matthew Laurens|410-706-5328|mlaurens@som.umaryland.edu|
20208350|NCT01024946|Memorial Sloan Kettering Cancer Center|Dr. Lee Krug|646-888-4201|krugl@mskcc.org|
20208351|NCT03147495|PLA Institute of Orthopaedics, Xijing Hospital, Fourth Military Medical University, No.17, Changle West Road, Xincheng District, Xi'an, Shanxi Province, China|Dr. Cheng Huang|0086-57427754027|jfj113hc@163.com, jfj906hc@163.com|
20208352|NCT02483611|University of Sao Paulo|Dra Waynice Neiva de Paula Garcia|551636021000|waynicegarcia@gmail.com|2211
20208353|NCT02608892|Children's Hospital of Eastern Ontario|Dr Denise Harrison|613-737-7600|dharrison@cheo.on.ca|4140
20208354|NCT03032523|Yale University|Laura Nally, MD, Instructor in Pediatrici Endocrinology|9728324734|laura.nally@yale.edu|
20208355|NCT04840849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20208356|NCT02590406|Institut universitaire Cardiologie et Pneumologie de Québec|Dr Jean S Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
20208357|NCT00957723|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
20208358|NCT00877890|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20208359|NCT00984009|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20208360|NCT00281528|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20208361|NCT02178592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20208362|NCT05592145|Atrium Health Wake Forest Baptist|Renea Jennings RN,BSN,CCRP|336-716-4417|rjenning@wakehealth.edu|
20208363|NCT02036476|Dana-Farber Cancer Institute|Dr. Robert Haddad|617.632.3090|ROBERT_HADDAD@DFCI.HARVARD.EDU|
20208364|NCT01893879|Stanford University|Leslie Roche, RN|650-723-1396|lesroche@stanford.edu|
20208365|NCT01579162|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
20208366|NCT01984294|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20208367|NCT02746991|EyePoint Pharmaceutical|Flavio Leonin Jr., MD|617-972-6024|fleonin@eyepointpharma.com|
20208368|NCT03049852|Cloudbreak Therapeutics, LLC|Dr, Jinsong Ni|9496789752|Ni-Jinsong@cloudbreaktherapeutics.com|
20208369|NCT02610231|Kyowa Kirin|Development Devision - Project Management Department|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20208370|NCT01431794|Johns Hopkins University School of Medicine|Dr. Ana De Jesus-Acosta|443-287-0411|adejesu1@jhmi.edu|
20208371|NCT01134328|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20208372|NCT02140762|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20208373|NCT02709889|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20208374|NCT00537810|Yale University School of Medicine|Dr. Carlos Grilo|2037852792|carlos.grilo@yale.edu|
20208375|NCT03452397|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20208376|NCT01711359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20208377|NCT02698176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226646|NCT02459197|Tools4Patient|Chief Scientific Officer|+32 71 91|alvaro.pereira@tools4patient.com|94 00
20226647|NCT00577772|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|dibaise.john@mayo.edu|
20226648|NCT01761643|UC San Diego|Mike Duszynski|6195438080|mduszynski@health.ucsd.edu|
20226649|NCT00856999|Oregon Health & Sciences University|Roger Dailey, MD, FACS|503-494-3020|daileyr@ohsu.edu|
20226650|NCT02465437|Corbus Pharmaceuticals, Inc.|John Skutnik, MS|781-562-9853|jskutnik@corbuspharma.com|
20226651|NCT00003483|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20226652|NCT00103662|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20226653|NCT01354197|Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand|Kaweesak Chittawatanarat|053-935533|kchittaw@gmail.com|
20226654|NCT00105989|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20226655|NCT01369745|Zalicus|Margaret Lee,PhD|617-301-7142|mlee@zalicus.com|
20226656|NCT02754518|University of Chicago|Sara Kalantari, MD|773-834-6853|skalantari@medicine.bsd.uchicago.edu|
20226657|NCT00613821|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
20162962|NCT04124705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20226658|NCT02051790|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20162963|NCT02093962|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
20162964|NCT05758402|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20162965|NCT01636986|Alcon Research, Ltd.|Jami Kern, PhD|1-888-452-3937|alcon.medinfo@alcon.com|
20162966|NCT04867733|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
20162967|NCT01716455|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20162968|NCT00395850|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20162969|NCT00820872|Mayo Clinic|Alvaro Moreno-Aspitia, M.D.|(904) 953-7291|morenoaspitia.alvaro@mayo.edu|
20162970|NCT03197922|Emory University|Nathan Call, PhD|404-785-9428|ncall@emory.edu|
20162971|NCT01987583|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
20162972|NCT01844778|Novartis|Study Director|862-778-8300||
20162973|NCT05261009|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-4498|dhenshaw@wakehealth.edu|
20162974|NCT01736618|Boston Scientific - Rhythm Management|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
20162975|NCT02762331|Virginia Commonwealth University|Donald Brophy, PharmD|(804) 827-1455|dbrophy@vcu.edu|
20162976|NCT00211887|Icahn School of Medicine at Mount Sinai|Dr. Fred D. Lublin|212-241-6854|fred.lublin@mssm.edu|
20162977|NCT00965419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162978|NCT04254666|University of Massachusetts Chan Medical School|Carol Curtin|774-455-6527|carol.curtin@umassmed.edu|
20162979|NCT02798978|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20162980|NCT02475278|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20162981|NCT01946152|UT MD Anderson Cancer Center|Michael Wang,MD/ Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
20162982|NCT02346461|National Human Genome Research Institute|Carrillo, Nuria|+1 301 402 2324|nuria.carrillo@nih.gov|
20162983|NCT03688074|AstraZeneca|Globall Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
20162984|NCT03056339|The University of Texas MD Anderson Cancer Center|Dr. Loretta Nastoupil, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-792-2860|lnastoupil@mdanderson.org|
20226659|NCT02302846|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
20226660|NCT00411450|Amgen Inc.|Study Director|866-572-6436||
20226661|NCT00397189|Neurim Pharmaceuticals|VP clinical and regulatory affairs|+972-3-6499340|Talin@neurim.com|
20226662|NCT01059773|Janssen-Cilag France|EMEA THERAPEUTIC AREA LEADER|+33 6 15167408||
20226663|NCT00235573|University of Florida|Gail Kauwell|352-392-1991|gkauwell@ufl.edu|227
20226664|NCT02258217|OhioHealth Research Institute|Anand Gupta|614-788-3868|anand.gupta@ohiohealth.com|
20226665|NCT00141518|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20226666|NCT01806168|Vancouver Coastal Health / Vancouver General Hospital|Kawai Leong, MD, MSc, FRCPC|604-875-8289|kawai.leong@vch.ca|
20226667|NCT03410992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20226668|NCT01001910|Montefiore Medical Center|Clinical Supervisor|718-405-8395|bkhaksari@montefiore.org|
20226669|NCT00614874|Creighton University School of Medicine|Dr. Tammy Wichman|402-449-4486|wichman@creighton.edu|
20226670|NCT03904420|Cochlear Limited|Laura Chenier|+14423254171|lchenier@cochlear.com|
20226671|NCT01468454|Children's Hospital of Philadelphia - Department of Radiology|Lisa J. States, MD|267-245-7146|states@chop.edu|
20226672|NCT01100723|University of Colorado|Dr. David M. Spiegel|303-724-7797|david.spiegel@ucdenver.edu|
20226673|NCT02104427|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7072|lwchang@taigenbiotech.com|1227
20226674|NCT01462630|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20226675|NCT02134795|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
20226676|NCT00844090|Omaha VA Medical Center|Cyrus Desouza MD|402-995-5506|cyrus.desouza@va.gov|
20226677|NCT01048541|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
20226678|NCT00718094|University Louisville|Gerald Dryden, MD|502-852-0156|gwdryd01@louisville.edu|
20226679|NCT02600611|Motif BioSciences|David Huang|936-577-5770|david.huang@motifbio.com|
20226680|NCT03167255|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
20226681|NCT00396383|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20208378|NCT02253173|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|sebastian.mirkin@therapeuticsmd.com|1952
20208379|NCT02561572|Sheffield Teaching Hospitals NHS Foundation Trust|Dr Matthew Wiles|00441142712381|matthew.wiles@sth.nhs.uk|
20208380|NCT00805142|Janssen R&D, 1125 Trenton-Harbourton Road, Titusville, PA 18902, USA|Senior Director, Clinical Leader|609-730-6777||
20208381|NCT00424463|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20208382|NCT01265719|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208383|NCT00027027|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20208384|NCT00290329|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208385|NCT02132169|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
20208386|NCT00959192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208387|NCT01967134|IAVI|Dr. Dereck Tait|27214424991|dtait@iavi.org|
20208388|NCT04607291|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
20208389|NCT00305773|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Steven Gore, MD||gorest@jhmi.edu|
20208390|NCT02679222|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20208391|NCT00570089|Cedars-Sinai Medical Center|C. Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
20208392|NCT00945945|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20208393|NCT00816062|Medtronic|Rianna Rapson|7635262170|rianna.k.rapson@medtronic.com|
20208394|NCT01716585|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20208395|NCT01672827|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|paulsherwin@ge.com|
20208396|NCT03288987|Aryogen|Dr. Nasim Anjidani (Director of Medical- Clinical Trials)|009809125477964|anjidani.n@orchidpharmed.com|
20208397|NCT04235959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20208398|NCT01143116|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
20208399|NCT03055806|Ixchelsis Limited|Chief Medical Officer|44 (0) 1227-832760|ian.osterloh@ixchelsis.com|
20208400|NCT04601194|Indiana University|Michelle Salyers|317-274-2904|mpsalyer@iu.edu|
20208401|NCT04905563|Le Bonheur Children's Hospital|Lindsey Locke, MSN|(901) 287-8931|lindsey.locke@lebonheur.org|
20208402|NCT01797302|University of Pittsburgh School of Medicine|Kumaravel Rajakumar|412-692-5822|kumaravel.rajakumar@chp.edu|
20208403|NCT00568399|Washington University School of Medicine|James Delmez, MD|314 362 7207|jdelmez@dom.wustl.edu|
20208404|NCT03574987|University of Bath|Professor Javier Gonzalez|0122538|j.t.gonzalez@bath.ac.uk|5518
20208405|NCT04586127|Wake Forest University School of Medicine|Dr. Emily Haines|(336) 716-5170|ehaines@wakehealth.edu|
20208406|NCT02381795|Clinvest Research|Clinical Data Manager|417-883-7889|jsly@clinvest.com|
20208407|NCT00932399|Seattle Epidemiologic Research and Information Center|Alyson Littman|206-277-4182|alyson.littman@va.gov|
20208408|NCT02176226|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
20208409|NCT03894501|Rutgers Robert Wood Johnson Medical School|Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
20208410|NCT01173874|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|646-774-8436|mcarlson@nyspi.columbia.edu|
20208411|NCT02089191|Alcon Research, Ltd.|Global Medical Affairs Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20208412|NCT01038635|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20208413|NCT01227252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20208414|NCT04542525|Alcon Research, LLC|Director of Clinical Projects, Surgical|+1-817-909-6199|jessie.hull@alcon.com|
20208415|NCT01034709|QIAGEN|Kevin Modarress, PhD Senior Manager Regulatory Affairs Operations NA, Regulatory Affairs|301-944-7103|kevin.modarress@qiagen.com|
20208416|NCT04050540|University of Washington, Department of Global Health|Jenell Stewart|206 520 3866|jenells@uw.edu|
20208417|NCT01060150|Medical Affairs / Janssen-Cil Korea|Clinical Research Director|82-2-2094-4518||
20208418|NCT02516306|Encore Vision, Inc|Jerry M. Stein, Ph.D.|817-292-6963|summercreekc@gmail.com|
20208419|NCT02736149|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
20208420|NCT01566981|Department of family medicine, Medical Faculty in Ljubljana|Dr. Rade Iljaž|'386 31 300- 381|radeiljaz@gmail.com|
20208421|NCT01351415|Hoffmann-La Roche|Medical Communications|888-6821-8590|genentech@druginfo.com|
20208422|NCT01365195|Cedars Sinai Medical Center|Research project Advisor|310-423-1682|Ofelia.Elvir-Lazo@cshs.org|
20208423|NCT00824746|Chonnam National University Hwasun Hospital|Young-Chul Kim, MD, PhD|82-61-379-7614|kyc0923@jnu.ac.kr|
20208424|NCT03480360|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|(603) 650-4628|Kenneth.R.Meehan@hitchcock.org|
20208425|NCT00472043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20208426|NCT02975206|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
20208427|NCT01981096|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|susmita.kashikar-zuck@cchmc.org|
20208428|NCT01225211|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20208429|NCT02067104|University of Arizona|Amy Selegue|520-626-0301|aselegue@email.arizona.edu|
20208430|NCT00806494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208431|NCT01901679|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
20208432|NCT02067806|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20208433|NCT01066637|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20208434|NCT00554840|Maryland Psychiatric Research Center|Elaine Weiner, M.D.|410-402-7694|eweiner@mprc.umaryland.edu|
20218094|NCT00493779|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20185508|NCT02638337|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20185509|NCT00274469|AstraZeneca|Jasmine Lichfield|07585404954|jasmine.lichfield@astrazeneca.com|
20185510|NCT04238247|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Michelle Macy|312-227-6676|mmacy@luriechildrens.org|
20185511|NCT04950127|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20185512|NCT01711632|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
20185513|NCT04315181|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
20208435|NCT03474172|Guangdong Provincial Hospital of Chinese Medicine|Director of department of Clinical Epidemiology|+862081887233|darongwu@163.com|35842
20185514|NCT03833167|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20185515|NCT02860130|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20208436|NCT00795717|Tufts University School of Medicine|Christine A. Wanke, MD|617-636-3811|christine.wanke@tufts.edu|
20208437|NCT00211692|VA San Diego Healthcare System|Samuel B. Ho, MD, Chief GI Section|858-552-8585|samuel.ho2@va.gov|2631
20208438|NCT00410514|Astellas Pharma Global Development, Inc. (APGD)|Associate Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
20185516|NCT01467427|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20208439|NCT02691468|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
20208440|NCT04227119|Emory University|Anand Shah, MD|404-712-4063|anand.d.shah@emory.edu|
20208441|NCT01021423|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20208442|NCT02886338|TMU|Fat-Moon, Suk|29307930|fmsuk@tmu.edu.tw|7923
20208443|NCT00394654|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
20208444|NCT03756285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20208445|NCT00807456|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
20208446|NCT01800162|University of Pennsylvania|Dr. Kurt Barnhart|215-662-2974|KBarnhart@uphs.upenn.edu|
20208447|NCT00286156|Cleveland Clinic|Dr William Braun Consultant Staff Nephrology, Cleveland Clinic|216/444/6995|braunw@ccf.org|
20208448|NCT06334055|Masimo Corporation|Ahmed Alghazi, M.B.Ch.B|949-297-7000|studies@masimo.com|
20208449|NCT03458234|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|(205) 934-5670|ammcdonald@uabmc.edu|
20208450|NCT01801189|Legacy Weight and Diabetes Institute|Dr. Valerie Halpin|503-413-7557|vhalpin@lhs.org|
20208451|NCT00498706|Northwestern University|Dr. David C. Mohr|312-503-1403|d-mohr@northwestern.edu|
20208452|NCT01497665|Angiochem Inc.|Betty Lawrence, Vice President, Development|514-788-7800|blawrence@angiochem.com|205
20208453|NCT01021293|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208454|NCT04728815|Duke University|Scott Compton, Ph.D.|919-668-0063|compt004@duke.edu|
20208455|NCT05315297|Stanford University School of Medicine|Dr. Raymond Chou, MD|650-723-5256|raymond.chou@stanford.edu|
20208456|NCT02033369|NYSPI|Franklin Schneier, MD|646-774-8041|fschneier@nyspi.columbia.edu|
20208457|NCT01503229|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20208458|NCT04335929|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
20208459|NCT03999203|Queen's University Belfast|Professor Liam Heaney|02890976376|l.heaney@qub.ac.uk|
20208460|NCT01319539|Columbia University Medical Center|Kevin Kalinsky, MD|212-305-1945|kk2693@cumc.columbia.edu|
20208461|NCT02534324|Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+66818390511|Khrongwong.m@chulahospital.org|
20208462|NCT01138995|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
20208463|NCT02889861|Immunocore, LLC|Chris Holland, Executive Director Head of Biometrics|1-267-589-9204|chris.holland2@immunocore.com|
20208464|NCT03993314|University of Alabama at Birmingham|Dr. Mark Powell|205-934-6007|mfpowell@uabmc.edu|
20208465|NCT01041027|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8086|dykuo@montefiore.org|
20208466|NCT02377674|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
20208467|NCT02146274|Duke University School of Medicine|Vice Dean of Clinical Research|919-684-4979|awindham@duke.edu|
20208468|NCT03521089|Mayo Clinic|Dr. Yonas Geda|480-301-6934|geda.yonas@mayo.edu|
20208469|NCT02039687|Araim Pharmaceuticals, Inc.|Chief Medical Officer|914-762-7586|info@araimpharma.com|
20208470|NCT01349491|University of Oklahoma Health Sciences Center|Stavros Stavrakis|405-271-9696|stavros-stavrakis@ouhsc.edu|37539
20208471|NCT01432236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208472|NCT05064449|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20208473|NCT02049385|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
20192517|NCT01127321|MedImmune, LLC.|David Close, Director, Clinical Development|301-398-0000|closeda@medimmune.com|
20192518|NCT01588366|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20192519|NCT00719043|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192520|NCT00302159|National Cancer Institute, national Institutes of Health|Kevin Camphausen, M.D.|301-496-5457|camphauk@mail.nih.gov|
20192521|NCT00813098|Lexicon Pharmaceuticals, Inc.|Clinical Project Manager|281-863-3000||
20192522|NCT03470545|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20192523|NCT01664923|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192524|NCT00364377|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
20192525|NCT03672175|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20192526|NCT00336817|Upittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
20208474|NCT00532441|Hoosier Cancer Research Network, Inc.|Dr. EG Chiorean, MS|317-921-2050|jsmith@hoosiercancer.org|
20208475|NCT00443534|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208476|NCT05466240|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
20208477|NCT00303329|Novartis Pharmaceuticals|Study Director|862-778-8300||
20208478|NCT00413231|Medtronic Vascular, Inc.|PJ Belmont, Clinical Research Specialist|707-480-3025|PJ.Belmont@Medtronic.com|
20208479|NCT03474380|HSRD ADAPT|Courtney Van Houtven|919-286-6936|courtney.vanhoutven@va.gov|
20208480|NCT00626327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20208481|NCT01710709|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
20208482|NCT04446039|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20208483|NCT00542321|University of Texas Health Science Center at Houston|Sandra K. Hanneman, PhD, RN, FAAN|713-500-2030|Sandra.K.Hanneman@uth.tmc.edu|
20208484|NCT01731951|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
20208485|NCT00253747|University of CIncinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
20185517|NCT03811535|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20208486|NCT02452034|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208487|NCT00431132|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20208488|NCT00672139|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
20208489|NCT03727802|Toray Industries, Inc|Clinical Trials Information Desk|+81-3-3245-8576|clinical-trials.toray.mb@mail.toray|
20208490|NCT00256204|Teva Branded Pharmaceutical Products R&D|Dennis Ahern, MS, Director|215-293-6339|dennis.ahern@tevausa.com|
20226682|NCT03538691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20226683|NCT01909141|Cairo University|Dr. Ghada Abdel Fattah|00201006513305|ghadaabdelfatah2007@yahoo.com|
20226684|NCT00481767|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185518|NCT02371395|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
20185519|NCT05494788|Cardiol Therapeutics Inc.|Andrea B. Parker, MSc., PhD, Senior Director of Clinical Operations|+1 289 9100862|andrea.parker@cardiolrx.com|
20185520|NCT05480943|VA Sierra Nevada Healthcare System|Elisabeth Mates, MD,PhD, Principal investigator|775-786-7200|Elisabeth.Mates@va.gov|5273
20185521|NCT02672033|Jonsson Comprehensieve Cancer Center|Dr. Percy Lee|310 825-9771|percylee@mednet.ucla.edu|
20185522|NCT00976937|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20185523|NCT03069313|Cleveland Clinic Florida|Zeina Nahleh, MD (previoulsy PI at Texas Tech university HSC-EP)|9546595840|nahlehz@ccf.org|
20185524|NCT04218266|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20185525|NCT01637246|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20185526|NCT00620698|Beth Israel Deaconess Medical Center|Seward Rutkove|617-667-8130|srutkove@bidmc.harvard.edu|
20185527|NCT03432858|WellSpan Health|Clinical Research Associate|(717) 851-7634|cbush@wellspan.org|
20185528|NCT01011946|University of Chicago|Dr. Daniel Appelbaum|(773) 834-2012|dappelbaum@radiology.bsd.uchicago.edu|
20185529|NCT04820686|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
20185530|NCT01424670|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20185531|NCT00761189|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
20226685|NCT01366638|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
20185532|NCT04377308|The University of Toledo Department of Psychiatry|Cheryl McCullumsmith, M.D., Ph.D.|419-383-5669|cheryl.mccullumsmith@utoledo.edu|
20185533|NCT01494922|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185534|NCT02759016|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192527|NCT04068051|Axsome Therapeutics, Inc.|Caroline Streicher, Vice President, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20192528|NCT01086384|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192529|NCT01196819|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
20192530|NCT03854019|The University of Texas Health Science Center at Houston|Erin Furr Stimming, MD|713-500-7033|Erin.E.Furr@uth.tmc.edu|
20226686|NCT00636636|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
20192531|NCT02632812|Galeno Desenvolvimento de Pesquisas Ltda.|Gilberto De Nucci, PhD, principal investigator|55.19.32516928|denucci@gilbertodenucci.com|
20192532|NCT02872311|Marshfield Clinic Research Institute|Project Manager|715-389-5088|king.jennifer@marshfieldresearch.org|
20192533|NCT03045809|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
20192534|NCT02725567|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20226687|NCT00524173|NIDDK|Marc Ghany, MD|301-402-5115|marcg@intra.niddk.nih.gov|
20226688|NCT01237327|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226689|NCT03300180|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
20185535|NCT03988842|Cedars-Sinai Medical Center|Victor Tapson|919-971-6441|Victor.Tapson@cshs.org|
20185536|NCT02891915|Vanderbilt Vaccine Research Program|Dr. C. Buddy Creech|615-343-0332|buddy.creech@vanderbilt.edu|
20192535|NCT01129115|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|kuamp@kumc.edu|
20192536|NCT04626271|Healthy.io|Dr. Danielle Jeddah (Director of Clinical Development) OR Jennifer Kachel Acobas (Director of RA)|0543111050, 0528345562|danielle.jeddah@healthy.io, jennifer.acobas@healthy.io|
20226690|NCT04233671|The University of Alabama|Dr. Mercy Mumba|205-348-6317|mnmumba@ua.edu|
20192537|NCT01747837|Icahn School of Medicine at Mount Sinai|Sam Commack|212-824-8931|sam.cammack@mountsinai.org|
20192538|NCT00751634|Northwestern University|Dr. Andrew Naidech|312-503-3335|a-naidech@northwestern.edu|
20192539|NCT00817336|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|jk3380@cumc.columbia.edu|
20192540|NCT03671239|University of Pennsylvania|Jose A. Bauermeister, PhD|215-898-9993|bjose@nursing.upenn.edu|
20192541|NCT02019641|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@mail.nih.gov|
20192542|NCT01246050|VA Medical Center Nashville|Henry Ooi|615-8736373|henry.ooi@va.gov|
20192543|NCT03856047|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20192544|NCT03410108|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20185537|NCT01522924|University of Louisville|Dr. Jacqueline Singleton|502-852-2611|jasing02@louisville.edu|
20226691|NCT00461097|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
20192545|NCT00937521|Novartis Vaccines|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com|
20226692|NCT01554163|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226693|NCT01941537|Rockefeller University|James Krueger|2123277730|kruegej@rockefeller.edu|
20226694|NCT00857961|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20226695|NCT02557516|Innate Pharma|Dr. Agnes BOYER-CHAMMARD, Medical Director|+33430303030|Agnes.BOYER-CHAMMARD@innate-pharma.fr|
20226696|NCT01243177|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20226697|NCT00669318|Mayo Clinic Cancer Center|Timothy G. Call MD||call.timothy@mayo.edu|
20226698|NCT01431313|University of Pittsburgh|Marc A. Simon, MD|4128023131|SIMONMA@UPMC.EDU|
20226699|NCT05554640|Johnson & Johnson Vision Care (JJVC)|John R. Buch, O.D., M.S.|1-800-843-2020|jbuch@its.jnj.com|
20226700|NCT01239394|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20226701|NCT02603211|Temple University|Chang-hee Won|2152046158|cwon@temple.edu|
20185538|NCT00709098|Actelion Pharmaceuticals Ltd|Laila Rouault, MD/International Clinical Leader|+ 41 61 565 8128||
20185539|NCT00352976|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2961|macmi002@umn.edu|
20185540|NCT03939312|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20185541|NCT04881175|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20185542|NCT02119650|Incyte Corporation|Study Director|855 463-3463||
20185543|NCT02730871|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20185544|NCT04623775|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20185545|NCT05928624|Columbia University|Giuseppe Cullaro, MD MAS|8454067438|gc2576@cumc.columbia.edu|
20185546|NCT03978637|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20185547|NCT01959698|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20185548|NCT04924062|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20185549|NCT03899961|Oslo University Hospital|Leiv Arne Rosseland|92204274|lrossela@ous-hf.no|+47
20185550|NCT04491968|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman, Associate Professor|7322358569|cooperna@rwjms.rutgers.edu|
20185551|NCT02428192|DFCI|Dr. Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
20185552|NCT04112316|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
20185553|NCT04093362|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
20185554|NCT03535727|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, M.D.|443-287-0002|Dle@jhmi.edu|
20185555|NCT03055377|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20192546|NCT02023905|University of California, San Francisco|Dr. Jennifer Clarke, MD MPH|(415) 353-2167|Jennifer.Clarke@ucsf.edu|
20192547|NCT01185171|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
20192548|NCT03559829|Associate Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
20192549|NCT01729845|Fred Hutch Cancer Research Center|Dr. Anna Halpern|2066676233|halpern2@uw.edu|206
20192550|NCT00573651|The MetroHealth System|Nora G Singer|216-778-2138|nsinger@metrohealth.org|
20192551|NCT01837797|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20192552|NCT03797989|University of Oxford|Dr. Angela Minassian|07973684040|angela.minassian@bioch.ox.ac.uk|
20192553|NCT04052997|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
20192554|NCT00953199|Penn State Hershey Medical center|Abraham Mathew MD|717 531 3834|amathew@hmc.psu.edu|
20192555|NCT00097669|VITATOPS|Clinical Trial Coordinator|+61892247004|julia.o'dea@health.wa.gov.au|
20226702|NCT00524771|Center for Epidemiology and Health Research, Germany|Dr. Juergen Dinger|0049 (0)30 945 101 20|dinger@zeg-berlin.de|
20192556|NCT05250960|TriHealth|Rachel Baker|513-569-6191|Rachel_Baker2@trihealth.com|
20208491|NCT02177942|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226703|NCT03407417|University of Florida|Dr. Benjamin Lok|352-214-9829|lok@ufl.edu|
20226704|NCT03743025|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
20185556|NCT04505774|University of Pittsburgh|Dr. Stephen Wisniewski|412-383-4696|stevewis@pitt.edu|
20185557|NCT01938547|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20192557|NCT00934700|Imperial College London|Research Integrity Officer|+44 020 7594 1872|jrco@imperial.ac.uk|
20192558|NCT02364609|UC Davis Comprehensive Cancer Center|Leslie Garcia, Data Research Supervisor|916-734-0156|lesgarcia@ucdavis.edu|
20192559|NCT03049306|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
20226705|NCT01960465|Jesse Brown VAMC|Dr. Bharati Prasad|312-569-6343|bharati.prasad@va.gov|
20208492|NCT01234337|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20208493|NCT01309646|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208494|NCT02365961|Hawkins Foundation|Hawkins Foundation Research Coordinator|864 454 7458|info@hawkinsfoundation.com|
20208495|NCT01646346|Yale University|Dr. Suzanne Evans, MD, MPH|(203) 785-5175|suzanne.evans@yale.edu|
20208496|NCT02130635|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208497|NCT01142791|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20208498|NCT04111185|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
20208499|NCT05375838|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20208500|NCT00866606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208501|NCT00807989|Yonsei University Severance Hospital|Dr. Yoon||BILEE@yuhs.ac|
20208502|NCT03675685|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20208503|NCT00392210|University of Rochester|Michael K. Flynn, MD|585-273-3232||
20208504|NCT01987609|UCSD Medicine|Director of Clinical Trials Unit|858-657-8322|dermstudies@Ucsd.edu|
20208505|NCT01279954|Oregon Health & Science University|Eric Suler, MD|503-494-5023|suhlere@ohsu.edu|
20208506|NCT01512849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20208507|NCT01385098|Houston Methodist Hosptial|Sherman Vadim|713-441-5514|vsherman@tmhs.org|
20208508|NCT00122317|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
20208509|NCT07072962|Baylor College of Medicine|Bijan Najafi|424-467-7127|najafi.bijan@gmail.com|
20208510|NCT01084096|NICHDGlobal|Dr. Elizabeth McClure, Data Coordinating Center PI|919-316-3773|mcclure@rti.org|
20226706|NCT00791700|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226707|NCT03672344|BioStream Technologies, LLC|Michael Farber|856-222-1122|farberm@biostreamtech.com|
20226708|NCT00996034|Yale University|Irina Esterlis, Ph.D.|203-932-5711|irina.esterlis@yale.edu|3109
20226709|NCT01720524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226710|NCT02493452|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
20226711|NCT00158262|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
20226712|NCT00527826|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226713|NCT03628378|Columbia University Irving Medical Center|Jeffrey A. Geller, MD|212-305-1120|jg2520@cumc.columbia.edu|
20226714|NCT02105285|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
20226715|NCT01421641|Oregon Health & Science University|Paula Bednarek|(503) 418-4500|bednarek@ohsu.edu|
20226716|NCT00883415|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
20226717|NCT02420119|HaEmek Medical Center|Dr.Frieda Wolf|97246495476|friedawolf@hotmail.com|
20226718|NCT02364388|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
20226719|NCT03231306|UAB|Coretta Thomas, Scientist & Data Manager for NF Consortium|2059758629|coretta@uab.edu|
20226720|NCT01808261|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226721|NCT02264210|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|86-20-87343439|wangsy@sysucc.org.cn|
20226722|NCT04501952|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20226723|NCT02080364|vTv Therapeutics LLC|Ann Gooch PhD,RAC,CCRP; Vice President Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
20226724|NCT00991289|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20226725|NCT01456143|Mt Sinai|Brett Miles||Brett.Miles@mountsinai.org|
20226726|NCT01850394|Faculty of Medicine, Ramathibodi Hospital, Mahidol University|Dr. Paphon Sa-ngasoongsong|66-2-2011589|chan3s@hotmail.com|
20226727|NCT00436826|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20226728|NCT03509181|McLean Hospital|Courtney Beard|617-855-3557|cbeard@mclean.harvard.edu|
20185558|NCT03564600|University of Pittsburgh School of Medicine|Professor Debra K. Weiner, M.D.|4124016811|dweiner@pitt.edu|
20185559|NCT04823611|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20185560|NCT02226341|Columbia University|Anca Askanase MD, MPH|212 305 0856|ada20@cumc.columbia.edu|
20185561|NCT04716634|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20226729|NCT04550364|Universoty of Oslo|Psychologist and PhD Bente Sommerfeldt|004793221280|bsommerfeldt@gmail.com|
20226730|NCT04060797|Zhongda Hospital Affiliated to Southeast University|Dr. Gaojun Teng|13805175100|gjteng@vip.sina.com|
20226731|NCT00110357|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20185562|NCT02793687|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
20185563|NCT03467542|Terumo Neuro|Robert Gash|714-247-8000|robert.gash@microvention.com|
20185564|NCT01673984|Ipsen|Medical Director, Uro-Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20185565|NCT00150813|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20185566|NCT01820260|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20185567|NCT04424927|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20192560|NCT03151551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20192561|NCT05896696|A.Stein Regulatory Affairs Consulting Ltd.|Ahava Stein|+972-9-7670002|ahava@asteinrac.com|
20208511|NCT05604781|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
20208512|NCT02885506|Medicines for Malaria Venture|Dr Cristina Donini|0041 22 555 0312|doninic@mmv.org|
20185568|NCT03727061|Roswell Park Compressive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|adrienne.groman@roswellpark.org|
20185569|NCT02365766|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20185570|NCT05166811|University of Utah|Dr. Michael D. Johnson|(801) 935-0503|mike.johnson@hsc.utah.edu|
20185571|NCT04058626|Imperial College London/ Imperial College Healthcare NHS Trust|Mr Pasha Normahani|020 3312 6666|p.normahani@imperial.ac.uk|switch
20185572|NCT05272852|BostonScientific|Karin Froidcourt|+0032471636566|Karin.Froidcourt@bsci.com|
20185573|NCT02991534|VA Greater Los Angeles Healthcare System|Dr. Bevanne Bean-Mayberry|818-891-7711|bevanne.bean-mayberry@va.gov|36009
20185574|NCT02155010|Haeundae paik hospital, Inje University|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
20185575|NCT04791709|University of Miami|Dr. Daniel Jimenez|305-243-2776|dej18@miami.edu|
20185576|NCT02724956|UT MD Anderson Cancer Center|Carin Hagberg, MD/Chief Academic Officer, CAO Office|713-792-5888|chagberg@mdanderson.org|
20185577|NCT00650104|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185578|NCT00894543|University of Pennsylvania School of Medicine|Dr. Ellen W. Freeman|215-349-5521|freemane@mail.med.upenn.edu|
20226732|NCT04004260|Lamar University|Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 821 9443|vmanchaiah@lamar.edu|
20226733|NCT03382418|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20226734|NCT02360280|Minneapolis VA Medical Center|Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
20226735|NCT05464420|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20226736|NCT01383018|Boston Scientific|Amanda Vail, Clinical Project Manager|612-749-5366|amanda.vail@bsci.com|
20185579|NCT04048681|Beth Israel Deaconess Medical Center|Dr. Olivia Farr|6176678636|ofarr@bidmc.harvard.edu|
20185580|NCT02808676|Lawson Health Research Institute|Dr. Manuel Montero-Odasso|519-685-4292|manuel.monteroodasso@sjhc.london.on.ca|42179
20185581|NCT03385629|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
20185582|NCT02919449|Vyriad|Alice Bexon MD Chief Medical Officer|+1-617-417-7300|alice.bexon@bexonclinical.com|
20185583|NCT02058108|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20185584|NCT03144518|University of Nottingham|Dr Kieran Ayling|+44 1158466908|kieran.ayling@nottingham.ac.uk|
20185585|NCT01989455|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
20185586|NCT00999167|Horizon Therapeutics, Inc.|Julia Egofske||clinicaltrials@horizonpharma.com|
20185587|NCT00448669|National Institutes of Health|Dr. Michael Thigpen|1-240-669-2877|michael.thigpen@nih.gov|
20185588|NCT05512962|Oxular Limited|Friedrich Asmus, MD|'+1 631 292 1207|friedrich.asmus@oxular.com|
20185589|NCT04838613|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20185590|NCT04970654|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20185591|NCT02137850|Novo Nordisk A/S|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
20185592|NCT00136435|Dana Farber Cancer Institute|Dr. Dan DeAngelo|617-582-8410|Daniel_Deangelo@dfci.harvard.edu|
20185593|NCT02794480|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185594|NCT00632749|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185595|NCT04999592|MaineHealth Maine Medical Center - Portland|David J. Gagnon, PharmD - Principal Investigator|207-662-0111|dgagnon@mmc.org|
20185596|NCT01748916|University of Hohenheim|Dr. Ralf Schweiggert|0049-711-459-22995|ralf.schweiggert@uni-hohenheim.de|
20185597|NCT02671435|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20185598|NCT04095104|University of Colorado School of Medicine|Jaime Moore, MD MPH|303-724-8419|jaime.moore@cuanschutz.edu|
20185599|NCT03169894|Avalo Therapeutics, Inc.|Garry Neil, MD|908-720-2691|gneil@avalotx.com|
20185600|NCT01721291|Imperial College London|Dr Omar Usmani|+440(0) 207351 8051|o.usmani@imperial.ac.uk|
20185601|NCT01091168|INSTITUT DE RECHERCHE PIERRE FABRE|Dr Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
20185602|NCT03767517|University of Alabama at Birmingham|Dr. Ronit Elk|205-996-1702|relk@uabmc.edu|
20185603|NCT03448458|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
20185604|NCT06377358|University of Malaga|José Rioja Villodres|(+34) 952 137 278|jose.rioja@uma.es|
20185605|NCT01303445|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185606|NCT03236441|UT Southwestern Medical Center|Oladipupo Olafiranye, MD, MS|2148572923|oladipupo.olafiranye@utsouthwestern.edu|
20185607|NCT04059354|University of Wisconsin - Madison, Waisman Center|Houri K. Vorperian, PhD, Senior Scientist Emerita|608-213-3257|vorperian@waisman.wisc.edu|
20185608|NCT03888989|Stanford University|Philip Grant|650-521-3540|pmgrant@stanford.edu|
20185609|NCT02396199|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20185610|NCT06072404|University of Palermo|Prof. Olga Di Fede|00393294030298|olga.difede@unipa.it|
20185611|NCT04899115|University of Michigan|Patricia Bloom, MD|734-647-5944|ppbloom@med.umich.edu|
20185612|NCT04868110|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
20185613|NCT03263026|DeNovo Biopharma|Gracielli Hage-Kautz, Associate Director Clinical Operations|858-799-1021|gkautz@denovobiopharma.com|746
20185614|NCT03379168|University of New Mexico Health Sciences Center|Dustin Richter, MD; Vice Chair of Research|505-272-4107|DLRichter@salud.unm.edu|
20185615|NCT05320432|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20185616|NCT05343390|University of North Carolina at Chapel Hill|Nora E. Rosenberg, PhD|(919) 966-3761|nrosenbe@email.unc.edu|
20185617|NCT05806788|UT Health San Antonio|Dr. Lisa Smith Kilpela|210-450-8121|kilpela@uthscsa.edu|
20185618|NCT03737058|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
20192562|NCT00143598|Centre for Clinical Epidemiology, Jewish General Hospital|Dr. Susan R Kahn|514-340-8222|susan.kahn@mcgill.ca|7587
20192563|NCT03900715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20192564|NCT01639742|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20192565|NCT02370251|University of Oklahoma|Kimberly Ernst, MD|405-271-5215|kimberly-ernst@ouhsc.edu|42039
20192566|NCT04469465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20192567|NCT04120376|Children's Hospital of Philadelphia|Dr. Cynthia Mollen|2153701217|mollenc@chop.edu|
20192568|NCT02053610|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192569|NCT00429143|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
20192570|NCT03427060|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
20192571|NCT00781937|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20192572|NCT01150045|Alliance for Clinical Trials in Oncology|Jeffrey A. Meyerhardt, MD, MPH|617-632-6855|jmeyerhardt@partners.org|
20192573|NCT03124693|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20192574|NCT01663506|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192575|NCT02431052|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20192576|NCT02094898|Mayo Clinic|William V. Bobo, M.D.|507-538-9041|Bobo.William@mayo.edu|
20192577|NCT03520075|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
20192578|NCT01439854|University of Texas Health San Antonio|Muhammad Abdul-Ghani|210-557-1157|abdulghani@uthscsa.edu|
20192579|NCT00328562|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-6702|Maria.Werner-Wasik@jeffersonhospital.org|
20192580|NCT03305809|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20192581|NCT00816556|Mayo Clinic|Maire Brid MacBride MB BCh|507-538-2271|MacBride.Maire@mayo.edu|
20192582|NCT04014790|REGiMMUNE|Chief Executive Officer|+81-80-7022-7536|kenzo@regimmune.com|
20192583|NCT03546816|Menlo Therapeutics Inc.|Iain Stuart, PhD|1- 800-775-7936|Iain.Stuart@foamix.com|
20208513|NCT01864746|German Breast Group (GBG) Forschungs GmbH|Prof. Dr. Sibylle Loibl|+49 6102 7480|penelope@gbg.de|0
20208514|NCT01005966|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208515|NCT01451203|Astellas Pharma Inc|Vice President, Japan/Asia Clinical Development||Astellas.resultsdisclosure@astellas.com|
20208516|NCT02493712|Holy Stone Healthcare Co., Ltd|YUCHIH, Chen|886287975966|ivychen@hshc.com.tw|272
20208517|NCT02528643|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
20208518|NCT04492514|University of Cincinnati|Clinical Research Director|513-584-0156|mcmahasn@ucmail.uc.edu|
20208519|NCT01640353|SI-BONE, Inc.|Daniel Cher, MD, Vice President of Clinical Affairs|650-269-5763|dcher@si-bone.com|
20208520|NCT01524900|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208521|NCT03758612|TB Alliance|Majda Benhayoun|347-601-8225|majda.benhayoun@tballiance.org|
20208522|NCT04450394|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20208523|NCT00001151|NIH|Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|3014965051|marxs@mail.nih.gov|
20208524|NCT03891199|West Virginia University|Brock A. Lindsey, MD|304-293-1317|blindsey@hsc.wvu.edu|
20208525|NCT01192139|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20208526|NCT03812224|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20208527|NCT00303719|Masonic Cancer Center, University of Minnesota|Erica Warlick, MD|612-625-8942|ewarlick@umn.edu|
20208528|NCT01641952|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20208529|NCT04853368|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20208530|NCT00612573|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20208531|NCT05386368|Atrium Health Wake Forest Baptist|Joseph Molnar MD|336-716-4171|jmolnar@wakehealth.edu|
20208532|NCT01822886|"Policlinico S.Orsola-Malpighi - Institute of Hematology L. e A. Seràgnoli, University of Bologna, Via Massarenti, 9-40138 Bologna, Italy"|Zinzani Pier Luigi/Argnani Lisa|+39 0516364042|pierluigi.zinzani@unibo.it/lisa.argnani@unibo.it|
20208533|NCT03633461|Oyster Point Pharma, Inc.|Jeffery Nau|609-382-9035|jnau@oysterpointrx.com|
20208534|NCT01880320|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
20208535|NCT04495166|Medical School of the University of Sao Paulo|Daniel Fatori|5511 96162-6183|daniel.fatori@gmail.com|
20208536|NCT02176031|Dana-Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|CSCUTLER@PARTNERS.ORG|
20208537|NCT03938857|Duke University|Mara L. Becker, MD, MSCE|919-613-1942|mara.becker@duke.edu|
20208538|NCT02516605|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20208539|NCT02643420|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20208540|NCT02127970|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20208541|NCT01639599|Seoul St.Mary's Hospital,|Young Eun Moon|822-2258-6163|0910momo@naver.com|
20208542|NCT04138758|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208543|NCT00923481|National Cancer Institute, National Institutes of Health|Dr. Shivaani Kummar|301-435-5402|kummars@mail.nih.gov|
20208544|NCT02988115|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20208545|NCT00104299|DAIT/NIAID|Associate Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20226737|NCT00438204|Barbara Ann Karmanos Cancer Institute|Antionette J. Wozniak, M.D., F.A.C.P.|(313)576-8752|wozniakt@karmanos.org|
20226738|NCT02472886|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20192584|NCT02438371|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
20185619|NCT05535257|Mayo Clinic Florida|Suzanne Langley OTR/L|9044724288|langley.suzanne@mayo.edu|
20185620|NCT05415410|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
20185621|NCT04848974|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD/Professor|713-563-3534|tkadia@mdanderson.org|
20208546|NCT05102734|Perelman School of Medicine at the University of Pennsylvania|Dr. John C. Greenwood|18568167172|john.greenwood@pennmedicine.upenn.edu|
20208547|NCT00275834|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
20208548|NCT02630459|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20208549|NCT00125138|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20208550|NCT01694667|University of California, San Francisco|Stephen Bent|415-221-4810|Stephen.Bent@ucsf.edu|3457
20208551|NCT00348686|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20208552|NCT02911324|Columbia University/New York State Psychiatric Institute|Reilly Kayser, MD|646-774-8118|reilly.kayser@nyspi.columbia.edu|
20208553|NCT01258738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208554|NCT02418000|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
20208555|NCT00689611|Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University|Dr. Mark J. Eisenberg|514.340.8222|mark.eisenberg@mcgill.ca|3564
20185622|NCT01549899|University of Arizona|Daniel J. Taylor, Ph.D.|5206219289|danieljtaylor@arizona.edu|
20185623|NCT04711135|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20185624|NCT05050682|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185625|NCT02664558|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20185626|NCT03578536|Minneapolis VA Health Care System|Andrew Hansen, PhD|612-467-2910|Andrew.Hansen2@va.gov|
20185627|NCT02345720|Johnson & Johnson Vision Care Inc.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
20185628|NCT02538900|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
20185629|NCT02874534|University of North Carolina at Chapel Hill|Gabriel S. Dichter, PhD|9194450132|dichter@med.unc.edu|
20185630|NCT04431726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20185631|NCT04281485|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185632|NCT01095796|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20185633|NCT04004325|FORMA Therapeutics, Inc.|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20185634|NCT02926911|Duke university|Dr. Shelley Hwang|919-668-6688|shelley.hwang@duke.edu|
20185635|NCT00731341|Galil Medical|Joy Benson, CRA|651-287-5112|joy.benson@galilmedical.com|
20185636|NCT03517969|Dana Farber Cancer Institute|Dr. Atish D Choudhury|617-6326328|atish_choudhury@dfci.harvard.edu|
20185637|NCT02140645|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185638|NCT04854096|NS Pharma, Inc.|Medical Affairs|+1-201-986-3860|trialinfo@nspharma.com|
20185639|NCT06647238|Atrium Health|Lyndsi Roland|828-434-5434|lyndsi.roland@advocatehealth.org|
20185640|NCT02965846|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
20185641|NCT02814838|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20185642|NCT00593489|Lawson Research Institute|Dr. Stewart Harris|519 858-5028|sharris1@uwo.ca|
20185643|NCT00901901|BAYER|Therapeutic Area Head|(+)1-888-84-22937|clinical-trials-contact@bayer.com|
20185644|NCT00073749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185645|NCT00715884|Cordis|Amy Orlick, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com|
20185646|NCT00611559|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185647|NCT00879333|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20185648|NCT00215787|Head and Neck Surgery Associates|Scott Phillips|317-926-1056|sphillips@hnsaonline.com|
20185649|NCT03547999|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20185650|NCT05048186|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
20185651|NCT00951379|University of Texas (UT) MD Anderson Cancer Center|University of Texas MD Anderson Phase I/II Prevention Consortium||CR_Study_Registration@mdanderson.org|
20192585|NCT01161446|University of Washington|Dr. David Katz|206-744-5877|dkatz7@u.washington.edu|
20192586|NCT00810342|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
20192587|NCT01852032|UC Davis|John Brock Staff Research Associate|916-734-3101|jmbrock@ucdavis.edu|
20192588|NCT03065933|McLean Hospital|Elizabeth S. Liebson, M.D.|617-855-2284|eliebson@partners.org|
20192589|NCT04504630|UT Southwestern Medical Center|Christian LoBue, PhD|2146484658|Christian.LoBue@utsw.edu|
20192590|NCT02330562|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20192591|NCT01547117|Vanderbilt University Medical Center|Alfredo Gamboa, MD|6158751003|alfredo.gamboa@vumc.org|
20192592|NCT00258362|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
20192593|NCT00568698|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
20208556|NCT00724594|Medical University of South Carolina|Dr. Dorothea Jenkins|843-792-4341|jenkd@musc.edu|
20208557|NCT00490815|Alimera Sciences, Inc|Kathleen Billman, Senior Director of Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
20208558|NCT01508221|University of Cincinnati|Alison Kastl|513-584-0436|Kastla@ucmail.uc.edu|
20208559|NCT04383665|Keck School of Medicine of University of Southern California|Dr Darrin Lee|(323) 442-5720|darrinjl@usc.edu|
20185652|NCT00738023|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20192594|NCT01777126|Pharmacy Department, University Hospitals Leuven & Department of Pharmaceutical and Pharmacological Sciences, KULeuven, Belgium|Peter Declercq|003216342340|peter.declercq@uzleuven.be|
20185653|NCT02467166|University of California, San Diego Health System|Gregory K. Feld, MD, Director CCEP|(858) 246-2972|gfeld@health.ucsd.edu|
20185654|NCT02742519|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20185655|NCT01872078|AstraZeneca Pharmaceuticals LP|Martin L. Scott, MD/PhD|781-472-5130|martin.scott@astrazeneca.com|
20185656|NCT03912831|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20185657|NCT00766649|National Eye Institute|Wai T. Wong|(301) 905-7301|wongw@nei.nih.gov|
20185658|NCT03242148|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
20208560|NCT01904760|Department of Anesthesiology, Peking University School and Hospital of Stomatology, Beijing, China|Xudong Yang|8610-82195287|kqyangxudong@163.com|
20208561|NCT04056325|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20208562|NCT03128372|Medtronic|Julia Katilius|1 303-305-2278|julia.z.katilius@medtronic.com|
20208563|NCT04249076|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
20208564|NCT00783263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20185659|NCT03859869|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20185660|NCT05239039|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185661|NCT03690206|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
20185662|NCT05511467|Medical University of South Carolina|Principal Investigator|(843) 792-3435|heisek@musc.edu|
20185663|NCT03152786|Wake Forest School of Medicine|Ashok Hemal, MD|336-716-5694|ahemal@wakehealth.edu|
20185664|NCT04499950|SKCCC|Jennifer Sheng|410-614-0762|jsheng7@jhmi.edu|
20185665|NCT04955717|USC|Dr. Jeffrey D. Klausner|415-876-8901|jdklausner@med.usc.edu|
20185666|NCT02349412|Massachusetts General Hospital Cancer Center|Jennifer Temel, MD|(617) 724-0453|jtemel@partners.org|
20185667|NCT04533022|Vicore Pharma AB|Chief medical officer Bertil Lindmark|+46 707661505|info@vicorepharma.com|
20185668|NCT02163447|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
20185669|NCT06240091|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
20185670|NCT03897686|RCBIOFORM|Julia Melentyeva Commercial Director|+7 (495) 223-70-95|md@bioform.ru|
20185671|NCT05415436|The University of Toledo Medical Center|Kristi Baker BSN, RN|4193836223|kristi.baker@utoledo.edu|
20185672|NCT03264131|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu Canter|919-962-0000|Melahat_Canter@med.unc.edu|
20185673|NCT04030130|Medical University of South Carolina|Evan Graboyes, MD, MPH|843-792-0719|graboyes@musc.edu|
20185674|NCT02597946|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185675|NCT04995484|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20185676|NCT03743636|Northwestern University|Mary M. McDermott, MD|312-503-6419|mdm608@northwestern.edu|
20185677|NCT05485922|Coloplast, Clinical strategies|Medical Writer|+4549112057|dkmhla@coloplast.com|
20185678|NCT06190678|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20185679|NCT05038566|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
20185680|NCT05535062|Neuronetics|Neha Goyal|763-528-1599|neha.goyal@neurostar.com|
20185681|NCT03285321|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20185682|NCT05194969|University of North Carolina at Chapel Hill|Christopher J. Sayed, MD|984-974-3900|christopher_sayed@med.unc.edu|
20185683|NCT00739648|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
20185684|NCT05996744|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20185685|NCT02840474|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
20185686|NCT03192891|Brigham and Women's Hospital|Raymond Y. Kwong, MD MPH|8573071960|rykwong@bwh.harvard.edu|
20185687|NCT04850807|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
20185688|NCT03739996|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|ACTG Network Coordinating Cent|ACTGCT.gov@fstrf.org|
20208565|NCT00106626|Merck & Co., Inc.|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20185690|NCT05387447|University of Nebraska Medical Center|Marcia Shade|402-559-6641|marcia.shade@unmc.edu|
20185691|NCT04178733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20185692|NCT05126862|University of Virginia School of Nursing|Jessie Gibson, PhD, RN|434-924-0107|js6zn@virginia.edu|
20185693|NCT03655132|VA Bedford Healthcare System|Dr. Erin D. Reilly|781-724-4191|Erin.Reilly@va.gov|
20185694|NCT04119284|Nemours Hospital for Children|Suken Shah, MD, Orthopedics Department Chair|3025472557|suken.shah@nemours.org|
20185695|NCT02651324|Albany medical center|Farzana Afroze|518-262-4300|afrozef@amc.edu|
20185696|NCT01974245|Federal University of São Paulo|Dr. Lilian Cuppari|+551159048499|lcuppari@uol.com.br|
20185697|NCT05919082|LEO Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
20185698|NCT05653856|Curium|Darcy Denner|314-506-3511|Solar@curiumpharma.com|
20185699|NCT02697136|Abionyx Pharma|Constance Peyrottes|+33673045380|cpeyrottes@abionyx.com|
20208566|NCT00721136|Johns Hopkins Medical Institutions|Charles Henrikson, MD|503 494 7400|chenriks@jhmi.edu|
20208567|NCT00732199|John D. Dingell VA Medical Center|Susmita Chowdhuri|313 576 1000|susmita.chowdhuri@va.gov|3685
20208568|NCT01747928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208569|NCT04335552|Duke University|Jason Stout, MD, MHS|919-668-0826|jason.stout@dm.duke.edu|
20208570|NCT00405756|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20185700|NCT02500758|Universidad Complutense de Madrid|Dr. Ricardo Becerro de Bengoa Vallejo|914590409|ribebeva@enf.ucm.es|
20208571|NCT02404792|University of Colorado|Kristine Erlandson (PI)|303-724-4941|kristine.erlandson@ucdenver.edu|
20208572|NCT02870348|Instituto Grifols SA|Sandra Camprubi|+34935710049|sandra.camprubi@grifols.com|
20208573|NCT01051856|Mayo Clinic|Florencia G. Que, MD|507-284-6178|que.florencia@mayo.edu|
20208574|NCT00107536|The Ohio State University Comprehensive Cancer Center|Tanio Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
20208575|NCT01117428|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
20208576|NCT02519777|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20208577|NCT02195531|Philips Research|Senior Scientist|+31628041122|Joyca.lacroix@philips.com|
20208578|NCT00602043|University of Pennsylvania|Dr. David Mankoff|(2015) 615-3687|david.mankoff@uphs.upenn.edu|
20208579|NCT04912297|Finnish Institute for Health and Welfare|Dr. Merit Melin, Research manager||merit.melin@thl.fi|
20208580|NCT01284127|Johns Hopkins University|Michael Levy|443-287-4612|mlevy@jhmi.edu|
20208581|NCT01878786|MedStar Georgetown Transplant Institute|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
20226739|NCT00320788|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator||clinicaltrials@regeneron.com|
20208582|NCT01683058|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20208583|NCT04062240|Mayo Clinic|Dr. Matthew Ritter|507-255-5123|Ritter.Matthew@mayo.edu|
20208584|NCT01057394|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
20208585|NCT01195636|Xenon Pharmaceuticals Inc.|Dr. Paul Goldberg, VP Clinical Development|604-484-3300|pgoldberg@xenon-pharma.com|
20208586|NCT03961529|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20208587|NCT01612494|Washington University School of Medicine|Dr. Angela Lumba-Brown|314-362-4325|lumba_a@kids.wustl.edu|
20208588|NCT03459794|University of Georgia|Dr Adrian Wolstenholme|706 542 2404|adrianw@uga.edu|
20208589|NCT03481634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20208590|NCT02169466|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
20208591|NCT03490734|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|kyle_burger@unc.edu|
20208592|NCT02350660|University of Virginia|Department of Medicine and Pediatrics|434.924.0000|spc7w@virginia.edu|
20208593|NCT01849289|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20208594|NCT00660816|CCCC|Dr. Afshin Dowlati|216-844-1228|afshin.dowlati@uhhospitals.org|
20208595|NCT00641745|Sunovion|Josephine Cucchiaro, PhD; Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20208596|NCT04733664|Richard L. Roudebush VA Medical Center|Dr. Arjun D. Sinha|---|adsinha@iu.edu|
20208597|NCT02599324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20208598|NCT02109939|Assurex Health|Lindsey Burns|5137015068|lindsey.burns@myriad.com|
20208599|NCT01058356|Pharmbio Korea Co., Ltd.|Korea Association for the Study of Intestinal Disease (KASID)|82-2-587-2551|pharmbio@hotmail.com|
20208600|NCT02993783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20208601|NCT02582151|Lawson Health Research|Blayne Welk|5196466000|lawson@lawsonresearch.ca|
20208602|NCT01309581|Mount Sinai School of Medicine|James Murrough|212 241 7574|James.Murrough@mssm.edu|
20208603|NCT01899729|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20208604|NCT01454531|ALK-ABELLÓ|ALICIA MARIN|+34 913276127|amaes@alk.net|
20208605|NCT01914510|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
20208606|NCT01277666|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208607|NCT00027846|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20208608|NCT01354964|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einsteinmed.org|2903
20208609|NCT00711009|Abbott|Global Medical Services|800-633-9110||
20208610|NCT01062230|Huntsman Cancer Institute at the University of Utah Medical Center|Maurizio Zangari, MD Principal Investigator|801-585-3229||
20226740|NCT03414229|Memorial Sloan Kettering Cancer Center|Dr. Sanda D'Angelo, MD|646-888-4159|dangelos@mskcc.org|
20226741|NCT03576924|University of British Columbia|Dr. Mary Jung|1-250-807-9670|mary.jung@ubc.ca|
20226742|NCT04533438|Aerin Medical|Sr. Manager of Clinical Operations|312-888-0441|tdang@aerinmedical.com|
20226743|NCT00271219|Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Johns Hopkins University School of Medicine|Dr. Hendree Jones|919-485-2664|hjones18@jhmi.edu|
20226744|NCT05568797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20226745|NCT00099632|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20226746|NCT03131687|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20226747|NCT02797678|Philips Respironics|Senior Data Manager|7243877949|Jeff.Jasko@philips.com|
20226748|NCT05137002|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
20226749|NCT01670045|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20226750|NCT00768287|Medexus Pharma, Inc.|Clinical Trial Manager|1-312-548-3125|julissa.leon@medexus.com|
20226751|NCT03046953|CRCTU Birmingham|C Morland Cinical Trial Coordinator|+44 121 371 7862|avail-t@trials.bham.ac.uk|
20226752|NCT03828214|College of St. Scholastica|Dr. Alexandra Borstad|614-395-1708|aborstad@css.edu|
20226753|NCT04283253|UNIVERSITY OF PITTSBURGH|George Wittenberg|4126484178|GEOWITT@PITT.EDU|
20226754|NCT02716584|VA Greater Los Angeles Healthcare System|Dr. Robert Kern|310-478-3711|Robert.Kern2@va.gov|49229
20226755|NCT00420628|Bausch & Lomb|Timothy Comstock OD|(585) 338-6631|tcomstock@bausch.com|
20208611|NCT01459016|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20226756|NCT01830933|University of California, San Francisco|Celia P. Kaplan, Professor|415-502-5601|celia.kaplan@ucsf.edu|
20208612|NCT04259749|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
20208613|NCT00303602|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20208614|NCT00620126|University of Maryland. Baltimore|PI|410-706-3387|rcross@medicine.umaryland.edu|
20208615|NCT00784225|SWOG Statistical Center|SELECT/S0000B Statistician|2066674623|adarke@fredhutch.org|
20208616|NCT02551874|AstraZeneca|Global Clinical Lead|+46 (0)31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20208617|NCT00313716|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
20208618|NCT02491463|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208619|NCT01491802|Queen's University|Kathy Webb|613-549-6666|kw2@queensu.ca|4950
20208620|NCT00663208|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20208621|NCT03500302|Johns Hopkins University|Allison Hays|443-287-6827|ahays2@jhmi.edu|
20208622|NCT02399345|AbbVie|Global Medical Information|800-633-9110||
20185701|NCT02923180|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Emmanuel Antonarakis|410-502-8341|eantona1@jhmi.edu|
20185702|NCT05198310|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20185703|NCT04436107|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
20185704|NCT04116736|Johnson & Johnson Vision Care (JJVC)|Graeme Young|+44(0) 1252 718719|g.young@visioncare.co.uk|
20185705|NCT03526354|UMass Chan Medical School|Dr. Xiaoduo Fan|5088566463|xiaoduo.fan@umassmed.edu|
20185706|NCT01101451|NRG Oncology|Helen Huang on behalf of Wei Deng Ph.D.|7168452318|huangh@nrgoncology.org|
20192595|NCT00412880|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208623|NCT00039377|Roswell Park Cancer Institute|Meir Wetzler, M.D.||meir.wetzler@roswellpark.org|
20208624|NCT02873598|University of Colorado Cancer Center|Dr. Sana Karam|7208480141|sana.karam@cuanschutz.edu|
20218095|NCT01131299|NIH NHLBI|Dr. Marcelo Amar|301-402-0521|mamar@mail.nih.gov|
20218096|NCT01300624|Brain Rehabilitation Research Center, Malcom Randall VA, Gainesville, FL|Lisa Edmonds, PhD|352.262.4465|lisa.annamarie.edmonds@gmail.com|
20218097|NCT01398059|University of Prince Edward Island|Dr. Travis Saunders|902-566-0641|trsaunders@upei.ca|
20218098|NCT05017974|University of California, San Francisco|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
20218099|NCT02148913|Corewell Health|Esther Peariso|616-486-0358|esther.peariso@corewellhealth.org|
20218100|NCT01287039|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20218101|NCT03301532|University of Texas Southwestern Medical Center|Dr. Juan Pascual|214-648-3550|juan.pascual@utsouthwestern.edu|
20218102|NCT00262041|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20218103|NCT00834652|Washington University School of Medicine|Patrick J. Lustman, Ph.D.|3142861320|lustmanp@psychiatry.wustl.edu|
20218104|NCT01173471|AstraZeneca|Stuart McIntosh||ClinicalTrialTransparency@astrazeneca.com|
20218105|NCT04132336|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20218106|NCT01011075|University of Pittsburgh Cancer Institute|Julie E. Bauman, MD|412-648-6507|baumanje@upmc.edu|
20218107|NCT00946348|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|603-650-7549|alan.i.green@dartmouth.edu|
20218108|NCT04060719|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218109|NCT04319159|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
20218110|NCT00894517|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20218111|NCT02100319|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20218112|NCT02370914|Stanford University|Dr. Paul Auerbach|(650) 725-9445|auerbach@stanford.edu|
20218113|NCT04136951|Columbia University|Maxim Topaz, PhD, Elizabeth Standish Gill Associate Professor of Nursing|6462760460|mt3315@cumc.columbia.edu|
20218114|NCT01478828|The SKCCC at Johns Hopkins|Dr. Phuoc Tran|410-614-6477|tranp@jhmi.edu|
20218115|NCT05611996|Massachusetts General Hospital|Dr. Jin Hui Joo|6177245317|jhjoo@mgh.harvard.edu|
20218116|NCT04479475|Johns Hopkins University|Haneefa Saleem, PhD, MPH|443-287-5130|haneefa.saleem@jhu.edu|
20218117|NCT01122316|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
20218118|NCT00296491|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218119|NCT03451006|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
20218120|NCT02547766|University of Utah|Associate Director of Clinical Trials|801-581-5318|heather.thiesset@hsc.utah.edu|
20218121|NCT04317313|Second Affiliated Hospital, School of Medicine, Zhejiang University|Dr. Xiaohui Zhang|+86-571-87767188|zhanghui4127@zju.edu.cn|
20218122|NCT05444543|University Hospitals Cleveland Medical Center|Dr. Thomas Sferra|(216)844-1765|Thomas.Sferra@UHhospitals.org|
20218123|NCT03847194|Seattle Children's Research Institute|Joyce Yi-Frazier|2068841456|joyce.yi-frazier@seattlechildrens.org|
20218124|NCT00768118|Barbara Ann Karmanos Cancer Institute|Fazlul Sarkar, Ph.D.|(313) 576-8327|sarkarf@karmanos.org|
20218125|NCT01144403|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20218126|NCT03891329|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20218127|NCT02654587|OSE Immunotherapeutics|Chief Medical Officer Immuno-Oncology|+33 2 28 29 10 10|contact@ose-immuno.com|
20218128|NCT01825837|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20218129|NCT00904748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218130|NCT02096588|SKCCC SOM Onc Breast and Ovarian Cancer|Dr. Karen Smith ; Clinical Associate|2026606500|ksmith60@jhmi.edu|
20218131|NCT00176631|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20218132|NCT00589849|Creighton University|Dr. Aryan Mooss|402-280-4566|aryanmooss@creighton.edu|
20185707|NCT05386069|Prisma Health|Manager OBGYN Research|864-455-1510|patti.parker@prismahealth.org|
20226757|NCT00656175|UCLA CARE Center|Dr. Jordan Lake|310-557-9679|jlake@mednet.ucla.edu|
20185708|NCT03580369|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
20226758|NCT02497937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20185709|NCT04923347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20226759|NCT01616160|Massachusetts General Hospital|Daniel L. Hamilos, M.D.|617-726-5090|dhamilos@partners.org|
20185710|NCT06066541|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20185711|NCT04052516|NorthSea Therapeutics BV|Chief Scientific Officer|31 035760 65 05|info@northseatherapeutics.com|
20185712|NCT03819686|Emory University|Dr. Kimberly Jacob Arriola|404)-727-2600|kjacoba@emory.edu|
20185713|NCT04788537|University of Pennsylvania|Edward S Brodkin, MD|1-215-746-0118|ebrodkin@pennmedicine.upenn.edu|
20226760|NCT01903993|Hoffmann-La Roche|Medical Communications|800 821|genentech@druginfo.com|8590
20185714|NCT03157167|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
20185715|NCT03697070|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
20185716|NCT04842643|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20226761|NCT03620383|Oregon Health & Science University|Ramsey Al-Hakim, MD|503-494-7660|alhakim@ohsu.edu|
20185717|NCT03484702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20185718|NCT04286282|University of Minnesota|Sarah Lofgren|612-624-9996|Lofg0020@umn.edu|
20185719|NCT01226979|SKCCC at Johns Hopkinis|Amol Narang, MD|(410) 955-7390|anarang2@jhmi.edu|
20185720|NCT01894061|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. David Peereboom|1-866-223-8100|TaussigResearch@ccf.org|
20185721|NCT02387853|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20185722|NCT05141903|Prolacta Bioscience|Dr. David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
20226762|NCT03790865|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
20226763|NCT01540513|University of Wisconsin Carbone Cancer Center|Dr. Lance Hall|608-263-5585|lhall@uwhealth.org|
20226764|NCT02273362|Mayo Clinic|Kenneth K. Tanabe, M.D.|507-284-2511|ktanabe@partners.org|
20226765|NCT03283930|National Institute of Mental Health (NIMH)|Dr. Daniel Pine|+1 301 594 1318|daniel.pine@nih.gov|
20226766|NCT00805129|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
20226767|NCT01868165|Imperial College London|Dr Ruth Peters|07950289662|r.peters@imperial.ac.uk|
20226768|NCT00571662|University of Nebraska Medical Center|R Gregory Bociek|402-559-5388|rgbociek@unmc.edu|
20185723|NCT02278562|VA TN Valley Healthcare System|Alp Ikizler MD|615-322-5000|alp.ikizler@vanderbilt.edu|
20226769|NCT01429298|Department of Emergency Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
20226770|NCT01839916|University of Chicago|Dr. Hongtao Liu|773-834-1736|hliu2@medicine.bsd.uchicago.edu|
20226771|NCT03471832|CooperVision|Jose A.Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
20226772|NCT02385110|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
20226773|NCT01888952|CTRC@UTHSCSA|Anand Karnad, MD|210-450-1000|karnad@uthscsa.edu|
20226774|NCT02271217|Acorda Therapeutics|Holly Roberts, Executive Medical Director|914-326-5000|hroberts@acorda.com|
20226775|NCT01971567|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
20226776|NCT01223404|University of Maryland School of Medicine|Dr. Britta Hahn|4104026112|bhahn@mprc.umaryland.edu|
20185724|NCT02630823|Washington University School of Medicine|Premal Thaker, M.D., MSc.|314-362-1740|thakerp@wustl.edu|
20185725|NCT04272619|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|kristen.sorice@fccc.edu|
20208625|NCT04067310|Instituto Nacional do Câncer|Director of Clinical Trials|+552132076549|cecilia.silva@inca.gov.br|
20208626|NCT01249404|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
20208627|NCT03890731|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20208628|NCT02058940|The University of North Carolina at Chapel Hill|Nicole R. Pinelli|919-962-1641|nickipinelli@unc.edu|
20208629|NCT03308799|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
20208630|NCT01494753|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
20208631|NCT00053482|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
20208632|NCT01539720|Planned Parenthood of the St. Louis Region and Southwest Missouri|Director of Research|314-531-7526|research@ppslr.org|384
20208633|NCT00298766|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
20208634|NCT02600715|University of Kansas School of Medicine-Wichita|Jennifer Duong, MPH, Research Associate|316-962-3126|jduong@kumc.edu|
20208635|NCT02500901|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
20226777|NCT00707057|SCOLR Pharma Inc|Stephen Turner, VP and Chief Technical Officer|425-368-1050|sturner@scolr.com|1001
20226778|NCT02492165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20226779|NCT02750332|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
20226780|NCT02937740|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
20226781|NCT04194489|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie.petrenko@rochester.edu|241
20226782|NCT00983645|Loma Linda University Medical Center Transplantation Institute|Dr. Pedro Baron|909-558-3636|pbaron@llu.edu|36792
20185726|NCT03854578|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185727|NCT02287311|Baylor College of Medicine|Dr. Rayne Rouce|832-824-4647|rouce@bcm.edu|
20208636|NCT00656136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208637|NCT01273207|National Heart Lung and Blood Institute|Dr Richard Childs|+301-451-7128|childsr@nhlbi.nih.gov|
20208638|NCT02990325|Abivax|Sophie Biguenet|+33 (0) 1 53 83 08 41|sophie.biguenet@abivax.com|
20208639|NCT00821886|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20208640|NCT01345162|IRCCS Policlinico S Matteo|Dr Massimo Allegri|00390382502627|massimo.allegri@unipv.it|
20208641|NCT02242305|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226783|NCT01000987|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
20226784|NCT04147247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208642|NCT03547960|Imperial College London|Gary Frost|2075940959|g.frost@imperial.ac.uk|
20208643|NCT00611351|University of Nebraska Medical Center|Lori Maness-Harris|402-559-3848|lmaness@unmc.edu|
20208644|NCT03018028|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20208645|NCT02532998|AstraZeneca AB|AZD9977 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20208646|NCT02065479|University of Florida|Dr. Dominick Angiolillo|904-244-3378|dominic.angiolillo@jax.ufl.edu|
20208647|NCT03243981|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
20208648|NCT01483378|NYU Langone Medical Center|Dr. Elisabeth J. Cohen|212-263-3262|elisabeth.cohen@nyumc.org|
20208649|NCT01077310|Yale School of Medicine|Principle Investigator|203-737-2883|sandra.springer@yale.edu|
20208650|NCT01957111|University of Pennsylvania|Philip Gehrman|215-746-3578|gehrman@exchange.upenn.edu|
20208651|NCT00362440|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20208652|NCT03644173|Hackensack meridian Health|Manager, Investigator Initiated Research Program|5519961244|Elli.GournaPaleoudis@hmhn.org|
20208653|NCT03500419|Mayo Clinic|Matthew (Matt) J. Ziegelmann, M.D.|507-266-3982|Ziegelmann.Matthew@mayo.edu|
20208654|NCT02625610|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20208655|NCT01783223|Hennepin Healthcare Department of Emergency Medicine|Director of Research|6128733000|james.miner@hmced.org|
20208656|NCT01396486|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
20208657|NCT00082628|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20208658|NCT03986671|Powell Mansfield Inc.|Chris Studer|6198101000|cstuder@powellmansfield.com|
20208659|NCT02074436|Emory University|Dr. Ana Antun|404-778-1900|ana.antun@emoryhealthcare.org|
20208660|NCT01694966|Cosmo Technologies Ltd|R&D Manager|111111111|rjones@cosmopharma.com|11111
20208661|NCT00994890|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208662|NCT00792922|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
20208663|NCT03323385|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
20208664|NCT00699582|Eisai Call Center|Eisai Inc.|888-422-4743||
20208665|NCT04422951|Stanford University|Thomas N. Robinson, MD, MPH|(650) 723-5331|tom.robinson@stanford.edu|
20208666|NCT00352027|St. Jude Children's Research Hospital|Jamie Flerlage, MD|901-595-0392|jamie.flerlage@stjude.org|
20208667|NCT04491591|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
20208668|NCT00412425|UT MD Anderson Cancer Center|Agop Bedikian, MD Professor||asreckew@mdanderson.org|
20208669|NCT02505269|Massachusetts General Hospital|Dr. Jeremy Abramson|617-724-4000|JABRAMSON@mgh.harvard.edu|
20208670|NCT03099304|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
20208671|NCT02692560|Kaiser Permanente Washington Health Research Institute|Dori Rosenberg, PhD, MPH|206-287-2532|rosenberg.d@ghc.org|
20208672|NCT01529827|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20208673|NCT03810053|University of Arkansas for Medical Sciences|Matthew Henry|5016868274|mhenry3@uams.edu|
20208674|NCT00715949|The Children's Hospital of Philadelphia|Michael L. Nance|215-590-5932|nance@email.chop.edu|
20208675|NCT00420212|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20208676|NCT01326910|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist Clinical Quality Systems and Process|928-277-0715|jhauze@its.jnj.com|
20208677|NCT03701061|Emory University|Nadine Rouphael|404-712-1435|nroupha@emory.edu|
20208678|NCT02274766|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20208679|NCT02607735|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20208680|NCT00869375|OUHSC|J. Emilio Exaire MD|405 271 4742|jose-exaire@ouhsc.edu|44744
20208681|NCT00606021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20226785|NCT03397121|The Medicines Company|Vice President - Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
20208682|NCT01202643|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
20208683|NCT01347931|Clinical Reseach Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
20208684|NCT03414372|University of North Carolina at Chapel Hill|Bryce Stamp, MPH|919-966-7430|bstamp@ad.unc.edu|
20208685|NCT03479203|University of Pennsylvania|Felix W.Wehrli, PhD|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
20208686|NCT01603615|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20208687|NCT00836342|Clinical Unit for Research Trials in Skin, Massachusetts General Hospital|Kristen Corey|617-726-1302|kcorey1@partners.org|
20208688|NCT03287960|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20208689|NCT03927703|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20208690|NCT01398176|UFlorida|Dr. Susan S. Percival|352-392-1991|percival@ufl.edu|201
20208691|NCT01871870|Legacy Health System|Dr. Ken Ward|971-570-2632|kenward503@msn.com|
20185728|NCT05461131|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
20185729|NCT04538417|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
20208692|NCT00519090|Novartis Pharmaceuticals|Study Director|862-778-8300||
20185730|NCT05693610|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
20208693|NCT01977651|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20185731|NCT04549168|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
20185732|NCT05519228|ZimmerBio|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
20185733|NCT04204278|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20185734|NCT00676715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20185735|NCT02249949|Georgetown University|Michael J. Pishvaian, MD, PhD|202-444-2144|pishvaim@georgetown.edu|
20185736|NCT04414644|University of Pennsylvania|Kelly Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
20185737|NCT04469036|UC Davis Health|Raynald Dizon|9167344736|rodizon@ucdavis.edu|
20185738|NCT02728076|Froedtert and the Medical college of Wisconsin|Adam Currey, MD|414-805-4462|acurrey@mcw.edu|
20185739|NCT05106257|Rush University Medical Center|Amanda R. Mathew, PhD|(312 563-1273|amanda_mathew@rush.edu|
20208694|NCT03287089|Atrium Health|Dina Bastawros, MD|336-718-1970|dina.bastawros@gmail.com|
20208695|NCT00667381|University of California, Irvine|Arnold Seto|714-456-6699|aseto@uci.edu|
20208696|NCT01646255|UCB|Study Director|+1877 822||9493
20208697|NCT01072656|Cleveland Clinic|Dr Andre Machado|216-444-4270|machada@ccf.org|
20208698|NCT02430389|Northwester University|Laura B. Hemmer, M.D.|312-695-0061|l-hemmer@northwestern.edu|
20208699|NCT01681836|University of Pittsburgh|Dr. Kara Hughan|412-692-5170|kara.hughan@chp.edu|
20208700|NCT00742391|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20208701|NCT02394028|Hoffmann La-Roche|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy|800 821-8590|genentech@druginfo.com|
20208702|NCT00205374|University of Wisconsin-Madison|J. Scott McMurray, MD|608-262-7181|mcmurray@surgery.wisc.edu|
20208703|NCT02239562|University of Miami|Christopher O'Brien|305-243-2329|CObrien@med.miami.edu|
20208704|NCT01205646|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
20208705|NCT01241318|"Ariadne Labs|BWH & HSPH"|Katherine Semrau (Epidemiologist, co-PI)|6177805311|ksemrau@ariadnelabs.org|
20208706|NCT02355665|JNJWorldwide|Andrew Myers, MD, Director, Clinical Research|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
20208707|NCT04129242|The Medical University of SC|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
20208708|NCT03194256|Brown University|Suzanne Colby|4028636621|suzanne_colby@brown.edu|
20208709|NCT03480841|University of North Carolina at Chapel Hill|Dr. Linda Beeber|(919) 966-8148|beeber@email.unc.edu|
20208710|NCT01362049|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|(802) 847-7633|Sharon.Henry@uvm.edu|
20208711|NCT03198884|SIHF Healthcare|John Verna|618-337-8153|jverna@sihf.org|
20208712|NCT00852124|UMARYLAND|Alessio Fasano|617-726-1450|afasano@partners.org|
20208713|NCT02417935|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20208714|NCT01228435|Massachusetts General Hospital|Lecia Sequist|617-726-7812|lvsequist@partners.org|
20208715|NCT02850276|Icahn School of Medicine at Mount Sinai|Dr. Jessica Robinson-Papp|212-241-8390|jessica.robinson-papp@mssm.edu|
20208716|NCT04815291|Merit Medical Systems Inc.|Casey Holland|6178420251|casey.holland@merit.com|
20208717|NCT02183792|University of Southern California School of Pharmacy|Tien Ng, Pharm.D.|3234421840|tienng@usc.edu|
20208718|NCT02910492|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20208719|NCT00989664|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208720|NCT02994043|University of Colorado Denver|Jamie Laurin|303-724-3183|JAIME.LAURIN@CUANSCHUTZ.EDU|
20208721|NCT00095836|Massachusetts General Hospital|John Clark, MD|617-724-4000|jrclark@partners.org|
20208722|NCT01158885|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20185740|NCT05054374|Memorial Sloan Kettering Cancer Center|Dr. Ezra Rosen, MD, PhD|646-888-6955|rosene1@mskcc.org|
20185741|NCT01707030|Department of Veterans Affairs|Dr. Micheal Cucciare|501-257-1068|Michael.Cucciare@va.gov|
20208723|NCT00962780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185742|NCT04437433|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20185743|NCT04245501|University of Denver|Michelle Rozenman, Ph.D., Director, BRAVE Lab & Associate Professor, Department of Psychology|303-871-6448|michelle.rozenman@du.edu|
20208724|NCT01813149|Cleveland Clinic Foundation|Michael Stanton Hicks, MD|216-445-3497|stantom@ccf.org|
20185744|NCT03526861|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20208725|NCT02363322|NIAID/LIR|Dr. Richard T. Davey, Jr.|301-496-8029|rdavey@niaid.nih.gov|
20208726|NCT02269709|University of Michigan|Frank W. DiPaola, MD|734-763-9650|dipaolaf@med.umich.edu|
20185745|NCT03610490|M D Anderson Cancer Center|Amir A Jazaeri, MD|713-792-8578|aajazaeri@mdanderson.org|
20208727|NCT02504424|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|
20208728|NCT04098172|First Affiliated Hospital of Xi 'an Jiaotong University|Dr. Ning Guo|13991229101|drnguo@gmail.com|+86
20208729|NCT00426842|James J Peters VAMC|Dr. Jill M. Wecht|718-584-9000|jm.wecht@va.gov|3122
20208730|NCT00090844|Division of Hematology & Oncology, University of California, San Francisco|Pamela Munster, MD|415-476-1000|Pmunster@medicine.ucsf.edu|
20185746|NCT05767437|University of Valencia|Jose casaña Granell|677361782|jose.casana@uv.es|
20185747|NCT00601900|Memorial Sloan-Kettering Cancer Center|Maura Dickler, M.D.||dicklerm@mskcc.org|
20208731|NCT00982111|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20226786|NCT00327340|OncoGenex Pharmaceuticals|Monica S. Krieger, PhD|425-686-1558|mkrieger@oncogenex.com|
20185748|NCT06064916|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
20185749|NCT03295734|UAB|Thomas W. Buford, PhD|205-996-3008|twbuford@gmail.com|
20185750|NCT02323321|TransMedics Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
20185751|NCT00446225|Fundación GECP|Eva Pereira|+34934302006|epereira@gecp.org|
20185752|NCT05741489|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
20185753|NCT01057433|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
20185754|NCT05268302|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
20185755|NCT06041139|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
20185756|NCT02317783|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah|
20185757|NCT04093752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20185758|NCT06207058|Tricore|Medical Director|505-938-8461|michael.crossey@tricore.org|
20185759|NCT06155721|Badalona Serveis Assistencials|Jose Ferrer Costa|+34 937407482|jfcosta@bsa.cat|
20185760|NCT04277936|Vanderbilt University Medical Center|Stephan Heckers|6159222665|stephan.heckers@vumc.org|
20208732|NCT01070381|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20185761|NCT02057939|Duke University|Andrew Armstrong, MD ScM|919-668-4615|andrew.armstrong@duke.edu|
20208733|NCT01230827|Johnson & Johnson Pharmaceutical Research & Development|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20185762|NCT03527160|Cincinnati Children's Hospital Medical Center|Dr. Stuart Goldstein|513-636-2209|stuart.goldstein@cchmc.org|
20185763|NCT02910713|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20208734|NCT01032265|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@jll.se|
20185764|NCT04430634|Nerudia|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
20185765|NCT04442126|Numab Therapeutics AG|Josephine Adams|00447712295851|j.adams@numab.com|
20208735|NCT01854918|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20185766|NCT06450405|University of California, San Diego|Antoni Duleba|858-657-7000|aduleba@health.ucsd.edu|
20208736|NCT00673075|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
20208737|NCT00574340|University of Maryland, Baltimore|Dr. Stephen N. Davis|410-328-2488|sdavis@medicine.umaryland.edu|
20226787|NCT02418234|Hangzhou first people's hospital|Prof. Shenglin Ma|086057156007664|mashenglin@medmail.com.cn|
20208738|NCT02146352|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
20226788|NCT02915159|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20226789|NCT04534517|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20226790|NCT00823264|Emory University|Dr. Brent Morgan|404-616-4403|bmorg02@emory.edu|
20226791|NCT01714544|Promius Pharma|Director Clinical Operations|609-282-1404|jfraser@drreddys.com|
20226792|NCT03180957|University of Oxford|Professor Jagdeep Nanchahal|+44(001865 612633|jagdeep.nanchahal@kennedy.ox.ac.uk|
20226793|NCT03557918|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20226794|NCT04575090|UTSouthwestern Medical Center|Zahid Ahmand, MD|214-648-2377|zahid.ahmad@utsouthwestern.edu|
20226795|NCT03373760|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20226796|NCT01093586|Case Comprehensive Cancer Center|Brenda Cooper MD|216-844-3213|brenda.cooper@uhhospitals.org|
20226797|NCT00613366|Oregon Health & Science University|Dr. Alison Edelman|503.494.5949|edelmana@ohsu.edu|
20226798|NCT01968811|Sahlgrenska university Hospital|Dr Marcus Langenskiöld|+46 709 433160|marcus.langenskiold@vgregion.se|
20226799|NCT03868839|University of Massachusetts Medical School|Xiaoduo Fan|5088563881|xiaoduo.fan@umassmed.edu|
20226800|NCT01716663|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
20226801|NCT00872521|Jan-Cil Australia|Regional Medical Affairs Director Asia Pacific|61 427564369||
20226802|NCT03006562|Johns Hopkins Brady Urological Institute|Dr. Mohamad Allaf|410-955-6100|mallaf@jhmi.edu|
20226803|NCT02644278|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20226804|NCT01089127|Novartis Pharmaceuticals|Study Director|862 778-8300||
20226805|NCT00572260|Duke University Health System|Yong Choi, Clinical Research Coordinator|919-684-7584|yong.choi@duke.edu|
20226806|NCT00059228|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
20226807|NCT00511810|University of Cincinnati|Robert McNamara, PhD|513-558-5601|robert.mcnamara@uc.edu|
20226808|NCT02427841|OHSUKCI|Dr. Gina Vaccaro|503-216-6300|vaccarog@ohsu.edu|
20226809|NCT01464190|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
20226810|NCT02592447|H Lee Moffitt Cancer Center and Research Institute|Heather Jim, PhD|813-745-6369|Heather.Jim@moffitt.org|
20226811|NCT03861780|Bioscience Laboratories|Principal Investigator II/Training Coordinator|(406) 587-5735|cduley@biosciencelabs.com|110
20226812|NCT03929263|Oklahoma State University|Kara Kerr|9186971478|kara.kerr@okstate.edu|
20226813|NCT01096160|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226814|NCT01460732|Hypertension Center, Third University Department of Medicine|George S. Stergiou|0030 210 7763117|gstergi@med.uoa.gr|
20226815|NCT00627497|Medtrionic spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20226816|NCT01300247|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20226817|NCT00922116|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20185767|NCT04774380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20185768|NCT05338086|mAbxience Research S.L.|Susana Millan , PhD|(+34) 917.711.500|Susana.Millan@mabxience.com|
20208739|NCT02918006|Vaxart, Inc.|Sean Tucker, PhD, Chief Scientific Officer|650-550-3502|stucker@vaxart.com|
20185769|NCT03940703|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20185770|NCT03217565|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20185771|NCT05113966|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20208740|NCT02936206|Icahn School of Medicine at Mount Sinai|Dr. Amy Tiersten|212-241-3300|amy.tiersten@mssm.edu|
20185772|NCT05386355|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
20208741|NCT02510885|Duke Eye Center|Dr. Priyatham Mettu|919-684-9010|priyatham.mettu@duke.edu|
20208742|NCT03091920|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
20208743|NCT00453349|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20185773|NCT01939275|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
20208744|NCT03373006|HALO Diagnostics|Chief Research Officer|760-766-2047|bernadette@halodx.com|
20185774|NCT03625882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20208745|NCT00381810|Genentech, Inc.|Medical Communications Specialist|800 821-8590|genentech@druginfo.com|
20208746|NCT01513460|Novartis Pharmaceuticals|Study Director|862-778-8300||
20208747|NCT00367380|Malaria Vaccine and Drug Development|Sócrates Herrera MD, principal investigator|(572) 5216232 - 5574929|sherrera@inmuno.org|
20185775|NCT04712994|University of Washington|Anjuli Wagner|9784602331|anjuliw@uw.edu|
20185776|NCT05110495|University of Oxford|Dr Simon Lord|01865 227212|simon.lord@oncology.ox.ac.uk|
20185777|NCT03679611|Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network|Dr. Jean Wong, MD, FRCPC.|416-603-5800|tojean.wong@uhn.ca|3635
20208748|NCT00489216|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20185778|NCT00579124|Children's Hospital of Philadelphia|Patricia Hankins|215 590 5168|hankinsp@chop.edu|
20185779|NCT03896516|National Institute on Drug Abuse (NIDA)|Dr Lorenzo Leggio, M.D., Ph.D.|1-667-312-5188|lorenzo.leggio@nih.gov|
20185780|NCT05783219|University of Louisville Medical Center|Rodger Rothenberger|(502) 588-7660|Rodger.rothenberger@louisville.edu|
20185781|NCT03739450|UT Southwestern Medical Center|Dr. Shannon Juengst|8328480674|Shannon.Juengst@UTSouthwestern.edu|
20185782|NCT02682316|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
20208749|NCT00149227|Department of Cardiology, Kyoto Prefectural University of Medicine|Prof. Hiroaki Matsubara|+81-75-251-5511|matsubah@koto.kpu-m.ac.jp|
20208750|NCT02828982|University of Michigan|Dr. Deanna Gates|(734) 647-2698|gatesd@umich.edu|
20185783|NCT03984695|KUMCRI|Jaime Caldwell|913-588-1261|spa@kumc.edu|
20185784|NCT05595629|Women & Infants Hospital of Rhode Island|Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|
20185785|NCT02662062|ANZUP|Dr Anthony Uccellini - ANZUP Research fellow|61 2 9046 8954|trials@anzup.org.au|
20185786|NCT05374837|Rutgers School of Public Health|Shauna Downs|973-972-7212|sd1081@sph.rutgers.edu|
20185787|NCT05406921|AMGA|Elizabeth Ciemins, PhD, SVP Research|4062813275|eciemins@amga.org|
20185788|NCT02829814|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
20185789|NCT04831281|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
20185790|NCT05249439|Imperial College London|Professor Tricia Tan|44 207 594 9048|t.tan@imperial.ac.uk|
20185791|NCT02097420|Abbott|Vinny Podichetty, Clinical Program Director|+1 779-209-9425|vinny.podichetty@abbott.com|
20185792|NCT05059262|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
20185793|NCT04864912|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20185794|NCT06320964|University of California, San Francisco|Nadia Diamond-Smith, PhD, MS|(415) 502-5800|nadia.diamond-smith@ucsf.edu|
20185795|NCT03606642|HonorHealth Research Institute|Joanne Saczynski, MSN, RN, ACRP-CP|480-323-1046|jsaczynski@honorhealth.com|
20185796|NCT05021640|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20185797|NCT04737772|RVO Health|Helena Berlin|702-620-4965|hberlin@rvohealth.com|
20208751|NCT02312934|Vanderbilt University Medical Center|Dr. Paul A. Newhouse|(615) 327-7009|paul.newhouse@vumc.org|
20208752|NCT00701064|VA|Shawn Youngstedt|803-767-3208|shawn.youngstedt@asu.edu|
20226818|NCT06060496|University of Kentucky|Gopalkumar Rakesh, MD|8592579402|gopalkumar.rakesh@uky.edu|
20185798|NCT02549339|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20226819|NCT02028507|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20185799|NCT05691309|Children's Hospital of Philadelphia|Dr. Kevin Downes|215-590-4024|downeskj@chop.edu|
20226820|NCT02258659|University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
20226821|NCT03990051|Glia, LLC|Wei-wei Chang, PhD; President|(617) 794-8922|chang@gliacell.com|
20185800|NCT04301778|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng, MD PhD|646-239-3110|Lzheng6@jhmi.edu|
20226822|NCT00272844|Boston Children's Hospital|Dr. Mira Irons|617-355-2449|mira.irons@childrens.harvard.edu|
20185801|NCT04820855|University of New Mexico Health Sciences Center|Dr. Angela Dao|5059678428|angela.dao@gmail.com|
20185802|NCT04838262|The University of Texas at Arlington|Dr. Jody Greaney|8172727891|jody.greaney@uta.edu|
20185803|NCT04539574|M.D. Anderson Cancer Center|Max Wintermark, MD|713-792-0845|mwintermark@mdanderson.org|
20185804|NCT05695989|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20208753|NCT02475564|Hospital de Clínicas de Porto Alegre, RS|Dr. Ricardo Francalacci Savaris|+55 51 33598653|rsavaris@hcpa.edu.br|
20226823|NCT03060291|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
20185805|NCT04179149|Ponce Research Institute, Ponce Health Sciences University|Dr. Idhaliz Flores|787-840-2575|iflores@psm.edu|2206
20185806|NCT02384317|ChemoCentryx|Study Director|650-210-2900|medinfo@amgen.com|
20185807|NCT04382898|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20208754|NCT03395704|La Jolla Pharmaceutical Company|Stew Kroll, MA|650-576-9679|skroll@ljpc.com|
20208755|NCT01156012|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
20185808|NCT05229120|Henry Ford Health|Julia Felton, PhD|704-995-7832|jfelton4@hfhs.org|
20185809|NCT05134350|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20185810|NCT04950192|Philips IGTD|Rashmi Ram, Director of Clinical Development|719-464-6326|rashmi.ram@philips.com|
20208756|NCT01665040|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|rjain@bsci.com|
20185811|NCT05956002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208757|NCT00508469|Alcon France|Severine Durier, PharmD|+33 1 47 10 48 43||
20185812|NCT02307565|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
20185813|NCT04936035|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20185814|NCT04401800|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20185815|NCT05751382|Dentsply Sirona Implants and Consumables|AnnaKarin Lungren Dr.|0046 702 666 492|annakarin.lundgren@dentsplysirona.com|
20185816|NCT05849051|UNC Lineberger Comprehensive Cancer Center|Adam O Goldstein|919-270-6491|AOG@med.unc.edu|
20185817|NCT05873751|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185818|NCT03926819|Hillhurst Bio|President and CEO|858 232 9495|admin@hillhurstbio.com|
20185819|NCT04391894|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20208758|NCT03922945|VIVUS|Sr. Director, Clinical Research|650-934-5200|clinical@vivus.com|
20208759|NCT00750360|GlaxoSmithKline|GSK Response Center|866-435-7343||
20185820|NCT01889199|University of California, Los Angeles|Daniel A. Dumesic, MD|310-794-5542|DDumesic@mednet.ucla.edu|
20185821|NCT04450342|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20185822|NCT05633407|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20208760|NCT00772031|The EMMES Corporation|Anne S Lindblad, PhD|301 251 1161|alindblad@emmes.com|105
20208761|NCT03419741|Medical University of SouthCarolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
20185823|NCT03526874|Children's Hospital of Philadelphia|Dr. Christina Szperka|12155901719|szperka@chop.edu|
20208762|NCT04354870|NYU Langone Health - Bellevue Hospital|H. Michael Belmont, MD|646-501-7400|Michael.Belmont@nyulangone.org|
20185824|NCT00220740|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20185825|NCT01762059|Massachusetts General Hospital|Dr. Steven J. Russell|617-726-1848|sjrussell@mgh.harvard.edu|
20185826|NCT04757610|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
20226824|NCT00618826|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
20185827|NCT02318901|WRMC|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20226825|NCT05171270|University of Oxford|Professor Laura Coates|07870257823|laura.coates@ndorms.ox.ac.uk|
20185828|NCT03811366|Hospital das clínicas- Faculdade de Medicina da Universidade São Paulo|Dra Joyce Hisae Yamamoto|41988263757|vmsakata@yahoo.com.br|
20185829|NCT04774237|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
20185830|NCT04455035|The University of Texas Health Science Center at Houston|Brett Chiquet, DDS, PhD, Associate Professor|7135008220|Brett.T.Chiquet@uth.tmc.edu|
20185831|NCT00753090|Zimmer Biomet|Lisette Smid|0623956378|lisette.smid@zimmerbiomet.com|
20185832|NCT05574426|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
20185833|NCT06143670|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20185834|NCT03747484|Fred Hutchinson Cancer Center|Joshua Veatch|206.667.5108|jveatch@fredhutch.org|
20185835|NCT02815813|Dartmouth-Hitchcock|Dr. Kelly Aschbrenner|603-440-7722|kelly.a.aschbrenner@dartmouth.edu|
20185836|NCT04563793|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20226826|NCT01509664|New York Obesity Nutrition Research Center|Dr Allan Geliebter|212-523-4184|ag58@columbia.edu|
20185837|NCT00837369|University of Nebraska Medical Center|Thomas Porter|402-559-5151|trporter@unmc.edu|
20185838|NCT04521478|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185839|NCT02643667|Washington University School of Medicine|Dr. Russell K. Pachynski|314-286-2341|rkpachynski@wustl.edu|
20185840|NCT05058391|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20185841|NCT02790931|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
20185842|NCT03833245|University of Utah|Gerald Cochran, PhD|801-213-0799|jerry.cochran@hsc.utah.edu|
20185843|NCT05161715|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20185844|NCT03775109|Imperial College, London|Professor Mark Thursz|+44 (0) 203 3126454|m.thursz@imperial.ac.uk|
20185845|NCT03347383|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
20185846|NCT04030169|Lykos Therapeutics|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|877-627-7722|trialdata@lykospbc.com|
20185847|NCT04690673|Helsinki and Uusimaa Hospital District, Pain clinic|Dr Johanna Kujala|+358400780411|johanna.kujala@helsinki.fi|
20185848|NCT05549726|UCSF|Tamara Clark|415-517-3444|tamara.clark@ucsf.edu|
20226827|NCT02855567|Icahn School of Medicine at Mount Sinai|Dr. Charles Ascher-Walsh|212-241-2827|Charles.ascher-walsh@mssm.edu|
20185849|NCT04173663|Vanderbilt University Medical Center|Julie Lounds Taylor, PhD, principal investigator|615-343-5659|julie.l.taylor@vumc.org|
20185850|NCT03931291|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20226828|NCT01556932|Virginia Commonwealth University/ Hospice & Pallative Medicine|Devon S. Flecher, MD|804-828-9723|dsfletcher@mcvh-vcu.edu|
20185851|NCT04402489|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|Please E-mail|information@mt-pharma-us.com|
20208763|NCT03384316|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|straussjy@nci.nih.gov|
20185852|NCT06391177|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20226829|NCT03956030|Penn State Health, Milton S. Hershey Medical Center|Dr. Christina DeAngelis|717-531-5994|cdeangelis2@pennstatehealth.psu.edu|3763
20226830|NCT02256839|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
20226831|NCT01843803|Department of Veterans Affairs|Frances M Weaver|708-202-5866|frances.weaver@va.gov|
20226832|NCT01861002|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Roy Leong, BA, CCRP|323-361-5132|rleong@chla.usc.edu|
20226833|NCT05285787|Epizon Pharma|John Rudy|2127551000|jrudey@epizonpharma.com|
20185853|NCT03328702|University of California, Davis|Dr. Peter Belafsky|8582053366|pcbelafsky@ucdavis.edu|
20226834|NCT03138577|Weill Cornell Medical College|Dr. Tiffany Tedore|212-746-2725|tft9001@med.cornell.edu|
20226835|NCT01051817|Novartis Pharmaceuticals|Study Director|862-778-8300||
20226836|NCT04346199|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20226837|NCT00627926|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20226838|NCT02401035|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226839|NCT00869128|Shoham Geriatric Medical Center, Pardes Hana, Israel|D. Garfinkel , MD|Tel: 972-4-6375667|dorong@shoham.health.gov.il|
20226840|NCT05259163|Evolution Optiks|Raul Mihali|2039815480|raul.mihali@evolutionoptiks.com|
20226841|NCT05251233|Washington University School of Medicine|Natasha Leigh-Matijakovich, M.D.|314-362-7147|leigh@wustl.edu|
20226842|NCT00103285|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20226843|NCT00452439|University of Texas (UT) MD Anderson Cancer Center|Maria Cabanillas, Associate Professor, Endocrine Neoplasia and HD|(713) 563-0764|mcabani@mdanderson.org|
20226844|NCT01381926|UAB|Dr. Amy Warriner|205-996-4004|awarriner@uabmc.edu|
20226845|NCT03974802|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20226846|NCT02624947|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20226847|NCT01550510|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
20226848|NCT03107182|University of Chicago|Ari Rosenberg|773-702-8222|arirosenberg@bsd.uchicago.edu|
20226849|NCT05787860|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
20226850|NCT06785090|College of Medicine, University of Baghdad|Enas Sabeeh|09647704294077|inas.abd2206m@comed.uobaghdad.edu.iq|
20226851|NCT01065558|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
20226852|NCT03654729|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46732344698|kristina.sjoblom@egetis.com|
20226853|NCT01449734|CSCC Germany, Jena University Hospital|Christiane Hartog, MD|+49 3641 9323171|christiane.hartog@med.uni-jena.de|
20226854|NCT02675764|Medical University of South Carolina|Dr. Na Jin Seo|8437920084|seon@musc.edu|
20226855|NCT00052078|Johns Hopkins University|John Walkup|212-746-1891|jtw9001@med.cornell.edu|
20226856|NCT00335517|University of Rochester|Glenn Rectine, MD|585-275-8780|glenn_rectine@urmc.rochester.edu|
20226857|NCT04780815|ImperialBrands PLC|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.com|
20226858|NCT02245815|Instituto Mexicano del Seguro Social|Dra. Guadalupe Gómez Rodríguez|477 75 23 166|lupitaneonato@gmail.com|
20226859|NCT01919164|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20226860|NCT01398852|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
20226861|NCT00588146|Mayo Clinic|Karen L. Swanson, D.O.|507-255-3214|swanson.karen@mayo.edu|
20226862|NCT02100839|Linear Clinical Research Ltd|Dr. Janakan Krihnarajah, MBBS (Hons), FRACP|800 393 8820|JKrishnarajah@linear.org.au|
20226863|NCT03442725|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
20226864|NCT01543568|Retina Consultants of Houston|David Brown, MD|713-524-3434|dmbmd@houstonretina.com|
20226865|NCT03440619|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20226866|NCT00463801|Novartis Pharmaceuticals|Study Director|862-778-8300||
20226867|NCT03272347|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20162985|NCT01363908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20185854|NCT03636503|Dana-Farber Cancer Institute|Caron Jacobson, MD|617-632-6404|caron_jacobson@dfci.harvard.edu|
20226868|NCT00940888|Saint Jude Medical|Grant Kim, Director Clinical Studies|818-493-3147|gkim@sjm.com|
20185855|NCT03089398|Icahn School of Medicine at Mount Sinai|Dr. Emilia Bagiella|212-659-9580|emilia.bagiella@mountsinai.org|
20185856|NCT05439603|Ancora Bio, Inc dba EmbarkNeuro|Chief Medical Officer|610 871-4891|info@embarkneuro.com|
20226869|NCT00578279|Indiana University Medical Center|Julia K. LeBlanc, MD|(317) 948-8125|juleblan@iupui.edu|
20226870|NCT02250300|Froedtert and the Medical college of Wisconsin|Mehdi Hamadani, MD|414-805-4600|mhamadani@mcw.edu|
20226871|NCT03512353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20226872|NCT03569098|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20185857|NCT03818191|Mayo Clinic|Victor Karpyak, MD, PhD|(507)284-8891|karpyak.victor@mayo.edu|
20185858|NCT04630262|DePuy Synthes|Kelly Francher, Staff Clinical Research Scientist|574-241-6581|kfranche@its.jnj.com|
20192596|NCT01288209|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
20192597|NCT01496365|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20192598|NCT00565266|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20208764|NCT03428230|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20208765|NCT02194699|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20208766|NCT02719028|Golden Biotechnology Corp|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
20226873|NCT03939923|West Virginia University|Director of Research in Department of Anesthesiology|304-598-4122|david.scalzo@hsc.wvu.edu|
20185859|NCT01195831|Leo Pharma|Malin Jaernkrants|+4544945888|malin.jaernkrants@leo-pharma.com|
20185860|NCT04703322|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20185861|NCT03262779|Yale School of Medicine|Scott Gettinger, MD|(203) 200-5864|scott.gettinger@yale.edu|
20185862|NCT01180634|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
20185863|NCT04419168|University of Pittsburgh|Dr. Charles Jonassaint|412-586-9850|cjonassaint@pitt.edu|
20185864|NCT04640961|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20185865|NCT03713086|CureVac|CureVac SE|+49 (0) 697680587-0|clinicaltrials@curevac.com|
20185866|NCT05009251|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
20185867|NCT01582711|CDC|Andrey Borisov, MD, MPH, Study Director|(404) 639-3311|pha5@cdc.gov|
20226874|NCT01666912|UNC_ChapelHill|Amy G. Bryant, Assistant Professor|919-843-5633|amy_bryant@med.unc.edu|
20226875|NCT03782987|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20185868|NCT02784509|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20185869|NCT06311084|Imperial College London|Dr Martina Di Simplicio|0208 383 4162|m.di-simplicio@imperial.ac.uk|
20185870|NCT03988634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20185871|NCT04049747|Imperial College London|Ms Puja Jadav|020 7594 7773|p.jadav@imperial.ac.uk|
20185872|NCT04299009|Pittsburgh VA Healthcare System|Isabella Soreca|412 3606815|Isabella.Soreca@va.gov|
20185873|NCT04356027|Abbott|Tarn Teraphongphom, Principal Clinical Research Scientist|+1 (408) 931-0504|tarn.teraphongphom@abbott.com|
20185874|NCT04092387|University of Vermont|Stephen T. Higgins, PhD|802-735-6267|stephen.higgins@uvm.edu|
20185875|NCT05061095|Lineberger Comprehensive Cancer Center|Dr. Daniel Richardson|(919) 966-4432|daniel_richardson@med.unc.edu|
20185876|NCT03414814|Seoul National University Hospital|Ji-Sook Kim|821025866440|kbj3075814@snu.ac.kr|
20185877|NCT03161379|Sidney Kimmel Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
20185878|NCT05449795|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
20226876|NCT00308516|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20226877|NCT02581488|Smith and Nephew|SR. Clinical Study Manager, US Global Clinical Operations|+1 817-302-3959|Darrell.Lange@smith-nephew.com|
20226878|NCT02749227|Columbia University|Pamela U. Freda, MD|212-305-2254|puf1@cumc.columbia.edu|
20185879|NCT03393975|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20185880|NCT03315754|Memorial Sloan Kettering Cancer Center, New York, NY, USA|Jonathan Coleman, MD|+1-646-422-4432|colemanj@mskcc.org|
20185881|NCT04089371|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20226879|NCT03782181|University of Balearic Islands|José Mingorance|+34677602465|josea.mingorance@uib.es|
20185882|NCT03932682|Seqirus|Clinical Trial Disclosure Manager|+1 855 358 8966|seqirus.clinicaltrials@seqirus.com|
20185883|NCT01772472|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20185884|NCT03361748|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20185885|NCT04572750|VA Palo Alto Health Care System|Keith Humphreys, PhD|(650) 493-5000|keith.humphreys@va.gov|
20226880|NCT01587105|Seattle Children's Hospital|Rita Mangione-Smith, MD, MPH|2068848242|Rita.Mangione-Smith@seattlechildrens.org|
20185886|NCT02520063|UAB|Erica Stringer-Reasor|2059759375|esreasor@uabmc.edu|
20185887|NCT05005221|University of Michigan|Manjunath Pai|734/647-0006|amitpai@med.umich.edu|
20185888|NCT02485834|Weill Medical College of Cornell University|Manish A. Shah MD|646-962-6200|mas9313@med.cornell.edu|
20185889|NCT05691452|Vanderbilt University School of Nursing|Dr. Chorong Park|6153436075|chorong.park@vanderbilt.edu|
20185890|NCT03604263|Medtronic CRHF|Krestyn Thomas|6123236613|krestyn.j.thomas@medtronic.com|
20226881|NCT01957579|MedImmune, LLC|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
20185891|NCT05902793|The Second Affiliated Hospital of Zhejiang University School of Medicine|Dr. Zhijun Pan|0571-87783777|zepzj@163.com|
20192599|NCT01015677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20226882|NCT02726789|Replicor Inc.|Chief Scientific Officer|514 733 1998|availlant@replicor.com|
20226883|NCT01000974|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226884|NCT03365934|JNJWorldwide|Amisha Parikh-Das|973-255-8701|aparikh1@its.jnj.com|
20226885|NCT01307891|University of Alabama at Birmingham|Andres Forero, M.D.|205-934-7167|aforero@uab.edu|
20226886|NCT04611542|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Dr. Jeremy Jones|541-484-2123|jeremy.jones@influentsin.com|
20226887|NCT00377637|Hoffman-LaRoche|Medical Communications|800-821-8590||
20226888|NCT01965002|Stanford Univeristy Medical Center|Pejman Ghanouni, MD, PhD|650-498-4485|ghanouni@stanford.edu|
20226889|NCT00493012|Heart and Diabetes Center North Rhine-Westfalia|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
20226890|NCT04085601|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20192600|NCT02706951|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20192601|NCT03491215|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
20192602|NCT02720211|Axon Optics|Director of Clinical Trials|8012304851|bradley.katz@hsc.utah.edu|
20192603|NCT00424554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20192604|NCT02988349|Sichuan University|Dr. Xin Xu|86-28-85503494|xin.xu@scu.edu.cn|
20226891|NCT02121795|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|ClinicalTrialDisclosures@gilead.com|
20162986|NCT02644343|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
20192605|NCT02172950|CSL Behring|Clinical Trial Disclosure Manager|use email contact|clinicaltrials@cslbehring.com|
20226892|NCT04155463|Boise State University|Dr. Cynthia Curl|208-426-3924|cynthiacurl@boisestate.edu|
20208767|NCT01191190|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
20208768|NCT01753765|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
20208769|NCT01667731|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20208770|NCT00561912|UT MD Anderson Cancer Center|Ana M. Aparicio, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20208771|NCT00577382|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20208772|NCT02049476|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Jennifer E. Thorne, MD, PhD; Professor of Ophthalmology & Epidemiology,Director of Ocular Immunology|410-955-2966|jthorne@jhmi.edu|
20208773|NCT03007472|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
20208774|NCT00649220|Merz Pharmaceuticals GmbH|Manager Public Disclosure|+49 69 1503 865|matthias.zerm@merz.de|
20208775|NCT00525499|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
20208776|NCT01111058|University of Chicago|Everett Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
20208777|NCT02790476|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
20208778|NCT01729559|Scripps Mercy Hospital|Steven R. Shackford, MD|619-299-2600|shackford.steven@scrippshealth.org|
20208779|NCT01028131|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
20208780|NCT02906644|Duke University|Clinical Research Coordinator|(919) 668-5055|al.salley@duke.edu|
20208781|NCT04646668|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
20208782|NCT03672006|Medical College of Wisconsin|Dr. Shelia Hanson|414-266-3728|shanson@mcw.edu|
20208783|NCT00608426|Center for Chronic Disease Outcomes Research|Steven Fu, Director|612-467-1979|steven.fu@va.gov|
20162987|NCT03437577|University of Minnesota|Susan Marino|612-624-2964|marin007@umn.edu|
20185892|NCT05121740|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|91 846 60 00|virologytrials@pharmamar.com; clinicaltrials@pharmamar.com|
20185893|NCT04847544|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20208784|NCT00761891|Department of Pharmacology, School of Medicine, Vanderbilt University|Olivier Boutaud, PhD|615-343-7398|olivier.boutaud@vanderbilt.edu|
20208785|NCT00777790|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20208786|NCT01453439|Massachusetts General Hospital|Dr. Sabine Wilhelm, Ph.D.|+1(617)724-6146|swilhelm@mgh.harvard.edu|
20208787|NCT01014442|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20208788|NCT02074059|Windtree Therapeutics, Inc.|Executive Director, Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|9477
20208789|NCT03520842|Stanford University|Heather Wakelee|(650) 498-6000|ccto-website@stanford.edu|
20208790|NCT02512094|Faculty of Medicine Siriraj Hospital, Mahidol University|Panai Laohaprasitiporn||panailao@gmail.com|
20208791|NCT02764229|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
20208792|NCT00804596|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20208793|NCT01973205|Novartis|Clinical Project Leader|9735038000||
20208794|NCT02135848|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208795|NCT00147082|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
20208796|NCT02030067|Processa Pharmaceuticals|Director Drug Development and Regulatory Affairs|443-631-6614|pfranks@processapharmaceuticals.com|
20208797|NCT00265382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20208798|NCT02543801|Kootenai Health|Director of Research Programs|2086254223|salbritton@kh.org|
20208799|NCT02347124|Kaiser Permanente Washington Health Research Institute|Dr. Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
20208800|NCT02358876|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
20208801|NCT01455064|Abbott Diabetes Care|Shridhara A. Karinka, Ph.D., Director of Clinical Affairs|510-749-6393|SHRIDHARA.ALVA@ABBOTT.COM|
20185894|NCT05816551|Institute for Exercise and Environmental Medicine|Craig Crandall, PhD, Primary Investigator|214-345-4623|craigcrandall@texashealth.org|
20185895|NCT04311996|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
20185896|NCT02379156|James J. Peters VA Medical Center|John P. Handrakis|718-584-9000|John.Handrakis@va.gov|3129
20185897|NCT03676582|Sheffield Teaching Hospitals NHS Trust|Lise Sproson|07753827428|Lise.Sproson@nihr.ac.uk|
20185898|NCT03744936|Mayo Clinic|Dr. Victor Montori|507-284-1920|montori.victor@gmail.com|
20185899|NCT05993078|Tianjin Medical University General Hospital|Jiayue Ding|18518347837|sjnkzz2@163.com|
20185900|NCT05062265|Atlantic Orthopaedic|Dr. Ashley Suttmiller|7573213300|suttmilera@atlanticortho.com|6283
20185901|NCT04172441|Zealand Pharma A/S|Charlotte Teglman Schiøler|+45 5060 3722|cschioler@zealandpharma.com|
20185902|NCT04674358|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20185903|NCT05418296|Mentia|Dr Mandy Salomon|4156326872|mandy@mentia.me|
20185904|NCT05382936|Stemline|Carlos Garay, M.D.|877-332-7967|clinicaltrials@menarinistemline.com|
20185905|NCT03101904|Bangor Univeristy|Dr Jamie Hugo Macdonald|+44 1248 38|j.h.macdonald@bangor.ac.uk|3272
20185906|NCT05114460|New York State Psychiatric Institute|Jermaine Jones PhD: Research Scientist/Associate Professor|646 774-6113|jermaine.jones@nyspi.columbia.edu|
20185907|NCT03692611|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
20185908|NCT00616967|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|vstearn1@jhmi.edu|
20185909|NCT02910583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20208802|NCT04269629|Department of Dermatology and Venerology|Assoz.-Prof. Dr. Gunter Sturm|+4331638580318|gunter.sturm@medunigraz.at|
20208803|NCT04118127|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20208804|NCT01376908|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
20192606|NCT04962698|Georgia Institute of Technology|Prof. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
20192607|NCT00853229|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
20192608|NCT02586415|Stanford University/School of Medicine|Dr. Gregory Albers|650-723-4448|albers@stanford.edu|
20192609|NCT02777242|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
20192610|NCT00255944|University of Colorado|Dr. Sheana Bull|3037241238|sheana.bull@ucdenver.edu|303
20192611|NCT05178979|Boston College|Katelyn Sileo|617-552-3205|sileoka@bc.edu|
20192612|NCT03124550|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
20192613|NCT02299427|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
20192614|NCT00511797|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20192615|NCT01121913|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20192616|NCT03269695|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192617|NCT00104637|Columbia University|David J. Lederer, MD|212-305-7771|dl427@columbia.edu|
20192618|NCT01313624|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20192619|NCT01017263|Duke UMC|Scott Kollins, PhD|9196810014|scott.kollins@dm.duke.edu|
20192620|NCT03849768|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
20192621|NCT02447718|IWK Health Centre|Dr. Karina Top|902-470-6343|karina.top@dal.ca|
20192622|NCT00239681|AstraZeneca|Torbjorn Lundstrom||ClinicalTrialTransparency@astrazeneca.com|
20192623|NCT03121612|Arnolda Consulting|Dr Gaston Arnolda|+61 2 8068 4963|gaston.arnolda@gmail.com|
20192624|NCT02654132|Bristol Myers-Squibb|Bristol Myers-Squibb Study Director|Please email|Clinical.Trials@bms.com|
20192625|NCT01880437|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192626|NCT03713320|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
20192627|NCT00909532|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20192628|NCT01209598|Memorial Sloan Kettering Cancer Center|Mark Dickson, MD|646-888-4164|dicksonm@mskcc.org|
20192629|NCT00085566|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|scherh@mskcc.org|
20192630|NCT01174264|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20192631|NCT00358007|Thomas Jefferson University|Pramila Rani Anne, MD|215-955-6702|Pramila.Anne@jefferson.edu|
20192632|NCT02111863|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
20192633|NCT00087555|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
20192634|NCT05523219|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
20192635|NCT03772613|Mayo Clinic|Dr. Shahyar M. Gharacholou|904-956-8400|Gharacholou.Shahyar@mayo.edu|
20192636|NCT00661713|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20192637|NCT04522206|NYU LAngone Health - Long Island|Muhammad B. Tariq, M.D|602-363-1134|Muhammad.Tariq2@nyulangone.org|
20192638|NCT02657954|VA San Diego Healthcare System|Dr Elizabeth Twamley|858-642-3848|elizabeth.twamley@va.gov|
20192639|NCT05146206|Community and Patient Preference Research (CaPPRe)|Dr Lili Toh|+61 452551409|lili.toh@cappre.com.au|
20192640|NCT01660256|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20192641|NCT02232399|University of Gothenburg|Prof. Albert Gyllencreutz Castellheim|+46708979820|albert.castellheim@gu.se|
20192642|NCT01184885|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
20192643|NCT02489734|Children's Hospital of Fudan University|Dr. Xuan Wang|021-18017591058|13818318679@139.com|
20192644|NCT04599855|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20192645|NCT04294667|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20192646|NCT02165397|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
20192647|NCT03297398|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20192648|NCT03481556|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20192649|NCT01316887|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192650|NCT00611715|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
20192651|NCT00107978|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20192652|NCT01841697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192653|NCT01624298|Johns Hopkins University|Stephanie Skavenski|+260966674841|sskavenski@yahoo.com|
20192654|NCT00350298|MassBiologics|Director of Clinical Affairs|617-474-3000|MBLClinicalDirector@umassmed.edu|
20192655|NCT04198948|University of Sarajevo|Associate Professor Tanja Dujic, PhD|+38733586194|tanja.dujic@ffsa.unsa.ba|
20192656|NCT00233389|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20192657|NCT01809899|Georgetown University Medical Center|Mary Ann Dutton|2026871997|mad27@georgetown.edu|
20192658|NCT02208037|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20192659|NCT01777490|HSR&D/COIN, Durham VAHCS|Courtney Van Houtven|(919)286-6936|Courtney.VanHoutven@va.gov|
20226893|NCT00113295|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
20226894|NCT01936363|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20226895|NCT02372344|AstraZeneca Pharmaceuticals|Stefan C Carlsson, MD, PhD, Global Clinical Lead|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20192660|NCT03634306|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|David.Levine@Mercy.net|
20192661|NCT02312206|Prothena Biosciences|Wendy Curlin|(650) 837-8550|clinicaltrials@prothena.com|
20192662|NCT00585975|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
20192663|NCT04915131|Bloom Technologies NV|Managing Director|+14156038067|julien@bloomlife.com|
20208805|NCT02142712|University of New Mexico - Neurology Department|Dr. Vishnumurthy Shushrutha Hedna|505-272-3342|Drshushrutha@gmail.com|
20208806|NCT02853318|Roswell Park Comprehensive Cancer Institute|Katy Wang, Statistician, M.A.|7168451300|katy.wang@roswellpark.org|6269
20208807|NCT02646332|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|williamhsup@yahoo.com.tw|78233
20185910|NCT04263311|NYU Langone Health|Jennifer Zanowiak|(646) 501-3502|Jennifer.Zanowiak@nyulangone.org|
20208808|NCT00780676|University of Texas (UT) MD Anderson Cancer Center|Stacy Moulder, MD/Associate Professor, Breast Medical Oncology|713-792-2360|CR_Study_Registration@mdanderson.org|
20185911|NCT03958955|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20185912|NCT04673929|The Royal Marsden Hospital|Professor Vinidh Paleri|02078082732|vinidh.paleri@rmh.nhs.uk|
20185913|NCT04638829|Sobi,Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
20185914|NCT05082909|Imperial College London|Dr Timothy Rawson|07891750151|antibiotic.research@imperial.ac.uk|
20185915|NCT04088630|Wake Forest University School of Medicine|Carol Kittel, Senior Biostatistician|336-399-3832|c.kittel@wakehealth.edu|
20185916|NCT02954341|CHU de Lille - Institut Coeur Poumon|Dr Pascal De Groote|33 (0)3 20 44 50 38|Pascal.DEGROOTE@chu-lille.fr|
20185917|NCT03381261|Weill Cornell Medicine|Dr. Lisa Gfrerer|646.962.4250|lig4013@med.cornell.edu|
20185918|NCT04024813|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20185919|NCT04140708|Vanderbilt University Medical Center|Dr. Daniel Claassen|615-322-6103|daniel.claassen@vumc.org|
20185920|NCT02900924|Veryan Medical|Nick Yeo|+441403258984|nick.yeo@veryanmed.com|
20185921|NCT05536440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185922|NCT02589275|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20185923|NCT00931710|Novartis Pharmaceuticals|Study Director|862-778-8300||
20185924|NCT05671029|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
20185925|NCT03338790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20185926|NCT03822845|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
20185927|NCT02386371|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20185928|NCT04410042|St. Jude Children's Research Hospital|Michael D. Neel, MD|901-259-1600|mneel@orthosouth.org|
20185929|NCT01494662|Dana-Farber Cancer Institute|Rachel Freedman, MD|617-632-3800|Rachel_Freedman@dfci.harvard.edu|
20185930|NCT04072822|Indiana University School of Medicine|Samer Gawrieh, MD|(317) 278-9326|sgawrieh@iu.edu|
20185931|NCT05481320|UC Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
20185932|NCT02811679|Massachusetts General Hospital|Jeffrey Barnes, MD, PhD|6177244000|JABARNES@mgh.harvard.edu|
20185933|NCT06365086|University of Texas at Austin|Sara Hussain, PhD|5122322686|sara.hussain@austin.utexas.edu|
20185934|NCT05611073|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
20185935|NCT05319860|University of Miami|Dr. Debbie Anglade|305-284-2388|d.anglade@miami.edu|
20185936|NCT04314895|NanOlogy, LLC|Mark Mitchell|8179004074|mark.mitchell@dfb.com|
20185937|NCT03941860|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20185938|NCT05328648|University of North Carolina at Chapel Hill|Emilia Goland, MMSc|919-966-2017|emilia_goland@unc.edu|
20185939|NCT03113422|Dana-Farber Cancer Institute|Mr Opeyemi Jegede|(617) 582-7613|ojegede@jimmy.harvard.edu|
20185940|NCT03930342|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
20185941|NCT02596126|Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P (CNIC)|Antonio J Quesada, PhD|+34 914531200|aquesada@cnic.es|(#1163)
20185942|NCT00084552|Fox Chase Cancer Center|Eric Horwitz|215-728-2995|Eric.Horwitz@fccc.edu|
20185943|NCT03717506|Gage Development Company|Gage Development Clinical Trials|1-847-999-0600|clinicalinfo@capstonedevservices.com|
20185944|NCT03748342|UT Southwestern Medical Center|Dr. Tiffany Moon|469/419-5790|Tiffany.Moon@UTSouthwestern.edu|
20185945|NCT05792423|MGH|Anthony Samir|6176432009|asamir@mgh.harvard.edu|
20185946|NCT02471638|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
20185947|NCT01328262|Haukeland University Hospital|Elin Opheim Netland|+4755976050|elin.opheim.netland@helse-bergen.no|
20185948|NCT04578912|University of Minnesota|Christine Conelea|(612) 261-3127|cconelea@umn.edu|
20185949|NCT04593472|Johns Hopkins Bloomberg School of Public Heath|Dr. Jennifer Wolff|4105020458|jwolff2@jhu.edu|
20185950|NCT03648840|Indiana University - Indianapolis|Dr. Martin H. Plawecki, MD, PhD|317 944 8164|mplaweck@iu.edu|
20185951|NCT03158805|Lindner Center of HOPE|Susan McElroy|5135360700|susan.mcelroy@lindnercenter.org|
20185952|NCT03703700|Center for Reproductive Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Dr. Dongzi Yang|8602081332233|yangdz@mail.sysu.edu.cn|
20185953|NCT05063994|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
20185954|NCT04236856|Corindus|Clinical Scientist|6173012445|hamid.rai@siemens-healthineers.com|
20185955|NCT04975880|Quanta Dialysis Technologies|Dr. Paul Komenda|(204) 510-5219|paul.komenda@quantadt.com|
20185956|NCT04638998|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
20185957|NCT03692676|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192664|NCT03082612|Emory University|Dr. Jill Hamilton|404-727-8749|jill.b.hamilton@emory.edu|
20208809|NCT01882439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20208810|NCT00527722|UT MD Anderson Cancer Center|Sanjay Gupta, MD|713-563-7341|srao@mdanderson.org|
20208811|NCT02909504|University Hospitals Cleveland Medical Center|Dr. Keming Gao, MD, PhD|2168442865|keming.gao@UHhospitals.org|
20226896|NCT05225558|LigaChem Biosciences, Inc.|Seonghye Cheon|+82)2-6952-0689|scheon@ligachembio.com|
20226897|NCT03200548|University of Michigan|Suzanna Zick|734-998-9553|szick@med.umich.edu|
20185958|NCT04868227|University of Edinburgh|Professor Malcolm Dunlop|+44 (0) 131 651 8602|malcolm.dunlop@ed.ac.uk|
20185959|NCT04490915|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20185960|NCT04725240|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20185961|NCT03222128|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
20185962|NCT02312960|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20185963|NCT02207062|University of Washington|Dr. Ajay Gopal, Professor|206-606-2037|agopal@uw.edu|
20208812|NCT02055976|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185964|NCT04060355|Emory University, School of Nursing|Kenneth Hepburn, PhD|404-712-9286|khepbur@emory.edu|
20185965|NCT01140880|Friends Research Institute, Inc.|Dr. Cathy J. Reback|323-463-1601|reback@friendsresearch.org|
20185966|NCT05680675|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
20185967|NCT04421378|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20185968|NCT02927769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20185969|NCT02807636|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20185970|NCT03175029|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
20185971|NCT03164980|NOGGO e.V.|Jasmin Yamamoto|+49 30 4036865 32|jasmin.yamamoto@noggo.de|
20185972|NCT05227209|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
20185973|NCT05633953|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
20185974|NCT06093659|Imperial Brands PLC|Tasnim Abusalem|+44 (0) 117 332 2343|tasnim.abusalem@impbrands.com|
20185975|NCT01253824|Nobelpharama|Department director of clinical development department 1|+81-23-5651-1177|murakami@nobelpharma.co.jp|
20208813|NCT00751335|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAP.trial@fphcare.co.nz|7044
20208814|NCT00362297|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
20185976|NCT00512070|VA Puget Sound Health Care System|Amanda Wood, PhD|253-583-1652|amanda.wood@va.gov|
20208815|NCT00684073|Schering-Plough|Head, Clinical Trials Registry and Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20208816|NCT01869686|Amgen Inc.|Study Director|866-572-6436||
20208817|NCT03512028|Washington University School of Medicine|Catherine Lang|314-286-1945|langc@wustl.edu|
20208818|NCT00983827|University of Utah|Dr. Steven Edgley|801-581-4695|carma.hyde@hsc.utah.edu|
20208819|NCT05414422|Perception Neuroscience|Clinical Trials Group|+49 (0) 89 2153 9035|clinicaltrials@perceptionneuroscience.com|
20208820|NCT02728804|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|adarke@fredhutch.org|
20208821|NCT00198042|Hospital for Special Surgery|Scott Rodeo, MD|212-606-1000|rodeos@hss.edu|
20208822|NCT02098733|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20208823|NCT01078389|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20208824|NCT00103376|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20208825|NCT02927990|Philips Medical Systems B.V.|Pim van Lochem|+31 (0)634322891|pim.vanlochem@philips.com|
20208826|NCT01091116|Menarini-Ricerche|Clinical Research Director|+39-055-56809990||
20208827|NCT01160458|National Cancer Institute, National Institutes of Health|Dr. Raffit Hassan, M.D.|301-451-8742|hassanr@mail.nih.gov|
20208828|NCT00182793|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20208829|NCT02155660|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
20208830|NCT03730987|University of Miami|Dr. Victoria Behar-Zusman|305-2849139|vbehar-zusman@miami.edu|
20208831|NCT02505945|Torax Medical|Adam Ahlstrom|651-361-8900|aahlstro@its.jnj.com|
20226898|NCT00875563|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
20208832|NCT00386152|Centocor Ortho Biotech Services, LLC|Nephrology Therapeutic Area, Medical Lead|215-325-4176||
20208833|NCT02996981|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
20208834|NCT03258710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20208835|NCT03451630|UPMC Center for High-Value Health Care|Kelly Williams, PhD, MPH|412-454-1198|williamsk17@upmc.edu|
20208836|NCT01756846|University Medical Center Utrectht|Dr. Judith Poldervaart|008875 55105|j.poldervaart@umcutrecht.nl|
20208837|NCT01521260|University Medical Center Groningen - Center for dentistry and oral hygiene|Y.C.M. de Waal|+31 50-3639051|y.c.m.de.waal@umcg.nl|
20226899|NCT02896569|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20185977|NCT00961571|Georgetown University, Department of Medicine and Oncology|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
20185978|NCT05524233|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20185979|NCT03070184|The University of Alabama at Birmingham|Nehal Vekariya, MS - Clinical Research Coordinator III|2059347173|nvekariya@uabmc.edu|
20185980|NCT05327101|Abbott Medical Devices|Stephanie Delgado|818-493-3285|stephanie.delgado1@abbott.com|
20208838|NCT00565721|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
20208839|NCT02813681|University of Texas Medical Branch|Denise Wilkes|409-772-1221|dwilkes@utmb.edu|
20208840|NCT02500706|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20226900|NCT00313846|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20226901|NCT03257436|BostonScientific|Sharda Mehta|6785967330|sharda.mehta@bsci.com|
20226902|NCT00970489|Harvard School of Public Health|Namasha Schelling|617-432-1734|nschelling@hsph.harvard.edu|
20226903|NCT02659943|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@nih.gov|
20226904|NCT01305811|New England School of Acupuncture|Lisa Conboy|6175581788|lconboy@nesa.edu|145
20208841|NCT00529152|ApoPharma|Dian Shaw, Manager Clinical Research|416-401-7283|dshaw@apotex.com|
20226905|NCT01723072|Novartis Pharmaceuticals|Study Director|1-888-669-6682||
20208842|NCT01497899|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20208843|NCT02026193|Rambam health Care campus|Dr Shahar Kol , Director IVF Unit|97247773232|skol@rambam.health.gov.il|
20208844|NCT02499380|PneumRx|Jörg Rennecke|+49 211 5422750|medical.services@btgplc.com|
20208845|NCT01874288|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
20185981|NCT05337748|University of Pretoria|Professor De Wet Swanepoel|+27827824009|dewet.swanepoel@up.ac.za|
20208846|NCT04212221|Zai Lab (Shanghai) Co.,Ltd.|Medical Director|+86 4008201022|medinfo@zailaboratory.com|
20208847|NCT03845504|Stanford University|Director, Research Development, Integrity and Strategy|(650) 736-4559|aimnoe@stanford.edu|
20208848|NCT03681808|Bausch & Lomb|Study Director|585-338-6399|Robert.Steffen@bausch.com|
20208849|NCT03123549|NuVasive, Inc.|Jessica Fulwider|7037721455|jfulwider@nuvasive.com|
20185982|NCT02506959|The University of Texas MD Anderson Cancer Center|Yago Nieto, MD / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderosn.org|
20185983|NCT03818659|University of California, San Francisco|Dr. Mark Pletcher|415-514-8008|mark.pletcher@ucsf.edu|
20185984|NCT03453619|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20185985|NCT04969419|Momentum Data Ltd|Dr Andrew McGovern|+44 7531221970|andy.mcgovern@momentumdata.co.uk|
20208850|NCT05223478|Ocuphire|Drey Coleman VP of Clinical Operations|8134041993|dcoleman@ocuphire.com|
20208851|NCT03370133|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20208852|NCT00636506|American Medical Systems|Men's Health Clinical Affairs|952-930-6328|Karen.Seybold@ammd.com|
20208853|NCT03742271|Johnson & Johnson Vision Care Inc.|John Buch OD F.A.A.O- Sr. Principal Research Optometrist|+1 904 443-1707|JBUCH@its.jnj.com|
20208854|NCT01624974|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208855|NCT03607994|Wake Forest Baptist Health|Catherine Tegeler - Project Manager|336-716-9341|categele@wakehealth.edu|
20208856|NCT00498927|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212 639 7523|omuroa@mskcc.org|
20208857|NCT01408862|Institute of Medical Research (UBA-CONICET)|Dr. Carlos Jose Pirola|541145148701|cpirola@ciudad.com.ar|167
20208858|NCT03125902|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20208859|NCT01775995|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
20208860|NCT01997333|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
20208861|NCT00890396|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
20208862|NCT04411472|AM-Pharma|AM-Pharma Office|+31 (0)30 22 89 222|office@am-pharma.com|
20226906|NCT01841970|Medtronic Surgical Innovations|Study Director, Clinical Research|508-452-4028||
20208863|NCT05060003|Washington University School of Medicine|George Ansstas, M.D.|314-362-5677|gansstas@wustl.edu|
20208864|NCT00440232|Jefferson Headache Center/Thomas Jefferson University|Stephen D. Silberstein, M.D.|215-955-2243|stephen.silberstein@jefferson.edu|
20208865|NCT01558791|National Center for PTSD|Dr. Jessica Hamblen, PI|802-296-5132|Jessica.Hamblen@va.gov|5389
20208866|NCT01747655|AbbVie|Global Medical Information|1-800-633-9110||
20208867|NCT02275559|UMass Chan Medical School|Dr James Carmody|5088561205|james.carmody@umassmed.edu|
20208868|NCT03769753|Memorial Sloan Kettering Cancer Center|T. Peter Kingham, MD|212-639-5260|kinghamp@mskcc.org|
20208869|NCT02699632|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
20208870|NCT01657903|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208871|NCT01259388|Birmingham VA Medical Center|Dr. John Rinker|205-934-2402|John.Rinker@va.gov|
20208872|NCT03529162|Saint Louis University|Sarah Dawson, Research Nurse|314-977-4106|sarah.dawson@health.slu.edu|
20208873|NCT00620815|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20208874|NCT01888367|Promius Pharma, LLC, Dr. Reddy's Laboratories|VP, Drug Development|609-375-9855|kallenby@drreddys.com|
20208875|NCT00591786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208876|NCT03969589|VISN 5 MIRECC|Amy Drapalski|443-421-6273|amy.drapalski@va.gov|
20208877|NCT00517634|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208878|NCT03143855|Virginia Commonwealth University|Dr. F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
20208879|NCT03417999|Children's Hospital of Philadelphia|Dr. Kelly Grogan|410-279-6994|grogank@chop.edu|
20208880|NCT02185729|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20208881|NCT02514889|UCLA Fielding School of Public Health, 650 Charles Young Drive, Los Angeles, CA 90095|William J. McCarthy, Ph.D., Professor|310-794-7587|wmccarth@ucla.edu|
20208882|NCT00396266|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20208883|NCT00422942|Hoffmann-LaRoche|Medical Communications Organization|800-821-8590|genentech@druginfo.com|
20208884|NCT02978339|Mayo Clinic|John E. Eaton, M.D.|507-284-3917|Eaton.John@mayo.edu|
20208885|NCT00695318|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
20208886|NCT00939094|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20208887|NCT02705755|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20208888|NCT05453006|University of Minnesota|Christina Bliss Barsness|612-625-7179|blis0015@umn.edu|
20208889|NCT01906489|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
20226907|NCT03478371|Procter & Gamble Co|Jan Streicher-Scott, PhD, RPh|513-634-5584|streicherscott.jl@pg.com|
20226908|NCT03428100|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
20208890|NCT00195702|Abbott|Global Medical Services|800-633-9110||
20185986|NCT05862870|UConn Health|Mark D. Litt, PhD|860-679-4680|Litt@uchc.edu|
20208891|NCT03721549|WCCT Global|Erin Flynn, Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
20226909|NCT04693078|Shaare Zedek Medical Center|Dr. Dan Meir Livovsky|+34603833576|danlivo@yahoo.com|
20208892|NCT04823494|GN|Todd Fortune|763-772-5566|tfortune@gnresound.com|
20208893|NCT03691831|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20208894|NCT02198040|Universidad de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
20208895|NCT04524663|Stanford University|Dr. Julie Parsonnet, MD|(650) 725-4561|parsonnt@stanford.edu|
20208896|NCT03359811|UT MD Anderson Cancer Center|Dr. Juan Cata, MD, Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
20208897|NCT01080794|Beth Israel Deaconess Medical Center|Dr. Alvaro Pascual-Leone|(617) 667-0203|apleone@bidmc.harvard.edu|
20208898|NCT01189201|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208899|NCT01682876|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
20162988|NCT00536471|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20162989|NCT01703507|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
20162990|NCT04273893|University of Virginia|UVA Radiation Oncology Clinical Research Coordinator|434-243-0008|UVARADONCClinicalTrials@uvahealth.org|
20162991|NCT05613257|Cedars Sinai Medical Center|Joel Arnold|310-423-9839|joel.arnold@cshs.org|
20208900|NCT00578331|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20208901|NCT03852901|National Institute on Aging|Josephine M. Egan, MD, Clinical Director|410-558-8414|eganj@mail.nih.gov|
20208902|NCT00911508|Mayo Clinic|Dr. Douglas L. Packer|507-255-6263|CABANA@mayo.edu|
20208903|NCT03374982|University of Nebraska Medical Center|Zachary Houser|402-980-9633|zach.houser@unmc.edu|
20208904|NCT00240331|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20208905|NCT01409382|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|55-21-999737500|sclapauch@gmail.com|
20208906|NCT01233076|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
20208907|NCT04308668|University of Minnesota|David Boulware, MD, MPH|6125552020|covid19@umn.edu|
20208908|NCT01266967|GlaxoSmithKline|GSK Response Center|866-435-7343||
20208909|NCT04563845|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20208910|NCT01020812|Stanford University|Daniel T Chang|650-723-6171|dtchang@stanford.edu|
20208911|NCT01519700|Sandoz|Dr. Roumen Nakov, Global Programme Medical Director|+49 8024 4764704|roumen.nakov@sandoz.com|
20208912|NCT00960323|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20208913|NCT01522963|University of Minnesota|Michael Kotlyar|6126251160|kotly001@umn.edu|
20208914|NCT03824704|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20208915|NCT02083406|Medicines for Malaria Venture (MMV)|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
20208916|NCT02577107|Novartis Pharmaceuticals|Study Director|862-778-8300||
20208917|NCT00218439|University of Minnesota College of Pharmacy|Dr. Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20208918|NCT00883896|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208919|NCT00991458|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20208920|NCT03306589|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
20208921|NCT00731094|VA Pittsburgh Healthcare System|Kelly Hyman Burkitt, PhD|412-360-2202|Kelly.Burkitt@va.gov|
20208922|NCT03380091|University of California, San Francisco|Heather Huddleston|(415) 353-3040|Heather.Huddleston@ucsf.edu|
20208923|NCT01182480|Denver Health and Hospital Authority|Andrew W. Steele, MD, MPH, MSc|303-602-9773|andy.steele@dhha.org|
20208924|NCT01980056|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
20208925|NCT00535262|Depression Evaluation Service, New York State Psychiatric Institute|Deborah A. Deliyannides, M.D. Research Psychiatrist|(212) 543-5734|deliiyan@nyspi.columbia.edu|
20208926|NCT01707667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20208927|NCT03802331|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208928|NCT01196793|Imperial College London NHS Trust|Dr Hermione Lyall|02033126965|hermione.lyall@nhs.net|
20208929|NCT00368069|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20208930|NCT03010358|OHSU Knight Cancer Institute|Bria Thurlow|503-494-4292|thurlow@ohsu.edu|
20208931|NCT02675933|Dell Children's Medical Center of Central Texas|Dr. Catherine Yee|5123240000|ceyee@ascension.org|86878
20208932|NCT00958282|University of Minnesota|Dr. Marc Mooney|6129916875|moon0078@umn.edu|
20208933|NCT00859495|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
20208934|NCT01220024|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20208935|NCT00174460|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208936|NCT02467504|Peking university People's Hospital|Prof. Zhanguo Li|+86-13810001444|13810001444@163.com|
20208937|NCT00083616|Amgen Inc.|Study Director|866-572-6436||
20208938|NCT01199952|University of California, San Francisco|Director for Research Operations|415-206-2476|abby.sokoloff@ucsf.edu|
20208939|NCT01474993|UMass Medical School|Andrew Zimmerman, M.D.|508-856-3279|Andrew.Zimmerman@umassmemorial.org|
20208940|NCT01853397|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
20226910|NCT01118663|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20162992|NCT05380505|NYU Langone Health|Marie Bragg, PhD|646-501-2717|Marie.Bragg@nyulangone.org|
20162993|NCT02783599|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20208941|NCT02132312|Omeros Corporation|Omeros Clinical Trial Information|ctinfo@omeros.com|ctinfo@omeros.com|
20208942|NCT01632345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208943|NCT00089505|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20226911|NCT04039204|Wake Forest University School of Medicine|Bruce Lessey, Ph.D., M.D.|336-713-0380|blessey@wakehealth.edu|
20226912|NCT01189461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226913|NCT01242241|Baylor College of Medicine|Dr. Olutoyin A. Olutoye|832-824-5800|oao@bcm.edu|
20208944|NCT01724021|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20226914|NCT02282163|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound Programs|1-609-514-2506|Melda.Dolan@diag.bracco.com|
20226915|NCT03472521|Stanford University|Dr. Pamela Flood, MD, MA|201-370-3933|pflood@stanford.edu|
20226916|NCT00678015|University of California, San Francisco|Dr. Terence Friedlander|415-353-7171|terence.friedlander@ucsf.edu|
20226917|NCT00391872|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20226918|NCT01409915|"University of Colorado Denver | Anschutz Medical Campus"|John O'Shaughnessy, MS, Clinical Research Services Principal Professional|3037247924|john.oshaughnessy@cuanschutz.edu|
20226919|NCT04826484|Johns Hopkins University School of Medicine|Andrew T. Gabrielson, MD|410-955-5000|atg@jhmi.edu|
20208945|NCT02543918|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
20208946|NCT03503617|Flint Rehabilitation Devices|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
20208947|NCT03570476|University of Washington|Dr. Bruce Montgomery, PI|206-598-0860|rbmontgo@uw.edu|
20208948|NCT02041533|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20208949|NCT00545740|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20208950|NCT02117024|Clinical Development|Lori McDermott|919-794-8950|lmcdermott@heatbio.com|
20208951|NCT03138798|Icahn School of Medicine at Mount Sinai|Dr. Eric Bergh|908-625-8148|eric.bergh@mssm.edu|
20208952|NCT02380703|Baylor College of Medicine|Mark Kunik, MD, MPH, Primary Investigator|713-794-8639|mkunik@bcm.edu|
20208953|NCT00266695|Chromaderm|info@chroma-derm.com|info@chroma-derm.com||
20208954|NCT00245635|Montefiore Medical Center, Albert Einstein College of Medicine|Eric Hollander, MD|7189204287|eholland@montefiore.org|
20208955|NCT01373294|H. Lee Moffitt Cancer Center and Research Institute|Dr. Mayer Fishman|813-745-8311|mayer.fishman@moffitt.org|
20208956|NCT01920061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20208957|NCT00877929|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20208958|NCT03245372|Hospital Universitario Virgen del Rocío, Servicio Andaluz de Salud|Dr. Alejandro Domínguez-Blanco|0034660762856|aledguez@gmail.com|
20208959|NCT02155725|LFB Biomédicaments|Medical Director France|33 169827229|zitounis@lfb.fr|
20226920|NCT00511173|Creighton University|Christopher Destache|402-280-4744|destache@creighton.edu|
20226921|NCT00215644|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20226922|NCT05122624|Johns Hopkins Bloomberg School of Public Health|Dr. Yeonsoo Baik|410-955-2378|ybaik3@jh.edu|
20226923|NCT01476267|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20226924|NCT00758498|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
20226925|NCT04403113|Marmara University|Assoc. Prof Gonul Acar|5323778878|gonulacar34@gmail.com|+90
20226926|NCT01516736|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
20226927|NCT02781818|UNC Dermatology|Dr. Christopher Sayed|984-974-3900|christopher_sayed@email.unc.edu|
20226928|NCT01877668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20226929|NCT01302418|QIAGEN|Tony Lam|301-944-7090|tony.lam@qiagen.com|
20226930|NCT01697800|Johns Hopkins Medicine|Zubair Khan|410-955-3157|zkhan@jhmi.edu|
20226931|NCT00954122|AstraZeneca|Gerard Lynch|4415 09645895|clinicaltrialtransparency@astrazeneca.com|
20226932|NCT02485483|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20226933|NCT01851655|University of Florida|Dr. Terese Chmielewski|352-273-6104|tchm@ufl.edu|
20226934|NCT02291029|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20226935|NCT00522548|University of Pennsylvania|Roy Bloom, MD|215-662-4643|roy.bloom@uphs.upenn.edu|
20226936|NCT00666211|Vanderbilt-Ingram Cancer Center|Nancy Wells, Director of Nursing Research Patient Care Svcs|615-322-6184|nancy.wells@vanderbilt.edu|
20226937|NCT02881658|The University of Hong Kong|Dr Cheung Ching Lung|(852)28315085|lung1212@hku.hk|
20226938|NCT02999789|University of California, San Francisco|Eddie Cruz-Romero, MD, MPH|(628) 206-2837|Edward.Cruz@ucsf.edu|
20226939|NCT01065571|University of Illinois at Chicago|Joanne Tobacman, MD|312-569-7826|jkt@uic.edu|
20226940|NCT04878055|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20226941|NCT02907463|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
20226942|NCT00433550|Mayo Clinic|Robert R. McWilliams, M.D.||mcwilliams.robert@mayo.edu|
20226943|NCT00447772|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
20226944|NCT02862080|The University of Texas Health Science Center at Houston|Marcie Kern, PT, MSPT|713-799-6995|neurorecoveryresearch@memorialhermann.org|
20226945|NCT05438277|Campbell Foundation|Research Manager|9017595413|mknack@campbell-foundation.org|
20226946|NCT02849743|The Children's Hospital of Philadelphia|Dr. Shana McCormack|(215) 590-3174|mccormacks1@chop.edu|
20208960|NCT00337935|Centocor Ortho-Biotech LLC.|Vice President, Medical Affairs|800.457.6399||
20208961|NCT01884675|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226947|NCT03064113|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20192665|NCT01006616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20208962|NCT02361307|Mahidol University|Piyapat Dajpratham|6624197508|piyapat.daj@mahidol.ac.th|
20226948|NCT02050334|Chemigen|Consultant|317 293-0852|farlowds@yahoo.com|
20192666|NCT00736125|Duke University Medical Center|Dr. Terri Monk|919-286-6938|terri.monk@duke.edu|
20192667|NCT04974723|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
20192668|NCT02877732|Stanford Concussion and Brain Performance Center/ Stanford Emergency Medicine|Dr. Jamshid Ghajar|(650) 725-5562|jghajar@stanford.edu|
20192669|NCT00992992|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192670|NCT00952848|Virginia Commonwealth University|Thomas J. Smith, MD, FACP|410-955-2091|tsmit136@jhmi.edu|
20208963|NCT00329433|Washington University School of Medicine|Michael S. Avidan, MBBCh|314-747-4155|avidanm@wustl.edu|
20208964|NCT01336647|Hatchtech Pty Ltd|Clinical Manager|+61 3 9092 0490|tahveninen@hatchtech.com.au|
20208965|NCT00953849|Ralph H. Johnson VA Medical Center, Charleston, SC|M. Rita I. Young, Ph.D.|843-792-9953|rita.young@va.gov|
20208966|NCT04156802|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
20208967|NCT00692198|Johns Hopkins Bloomberg School of Public Health|James Tonascia, PhD|410-955-8175|jtonasc1@jhu.edu|
20208968|NCT03233009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20208969|NCT01101321|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20208970|NCT00134563|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
20208971|NCT02406586|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20208972|NCT02839330|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20208973|NCT02615158|University of Maryland School of Medicine|Dr. Maureen Black|410-706-2136|mblack@som.umaryland.edu|
20208974|NCT03558230|Medical University of South Carolina|Dr. Na Jin Seo|843-792-0084|seon@musc.edu|
20208975|NCT03339999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20192671|NCT02250534|University of Vermont|Stephen T. Higgins, PhD, Professor, Department of Psychiatry|802-735-6267|stephen.higgins@uvm.edu|
20208976|NCT01856920|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@immunitybio.com|
20208977|NCT03028324|University of Miami|Joyce Rios Gomes-Osman|305-284-2632|j.gomes@miami.edu|
20208978|NCT02545270|Department of Anesthesiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev Denmark|MD. G. G. Nervil||gustavnervil@gmail.com|
20208979|NCT02515890|University of Pittsburgh|Keith M. Vogt, MD., PhD.|412-999-8570|vogtkm@upmc.edu|
20208980|NCT00661362|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20208981|NCT01654666|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D|8683198127|jixunming@vip.163.com|
20208982|NCT04805892|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6464001204|jstega@optonline.net|
20208983|NCT00014560|Dartmouth Hitchcock|Dr. Pamela Ely|603-653-9071||
20208984|NCT02195895|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20208985|NCT03432819|RAND Corporation|Laura Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
20208986|NCT04382066|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|+34 91 846 60 00|clinicaltrials@pharmamar.com|
20208987|NCT01430559|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192672|NCT03197025|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@mail.nih.gov|
20192673|NCT00217022|Mayo Clinic, Rochester MN|Dr. Darrell Pardi|507-538-1231|pardi.darrell@mayo.edu|
20192674|NCT00458393|University of California, San Francisco|David Glidden|415-514-8009|david.glidden@ucsf.edu|
20192675|NCT02625571|Penn State College of Medicine|Dr. Brian Allen|717-531-4100|ballen1@pennstatehealth.psu.edu|323492
20192676|NCT01253447|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
20208988|NCT04225026|Galera Therapeutics|Judy Schnyder, Sr. Vice President, Clinical Operations|484-870-9625|jschnyder@galeratx.com|
20208989|NCT00579059|Biomet, LLC|Megan Lawson, Clinical Research Specialist|1-800-348-9500|megan.lawson@biomet.com|1183
20208990|NCT00779506|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20208991|NCT03982069|University of Pittsburgh|Dr. Katherine Williams|412-383-1979|kvw3@pitt.edu|
20208992|NCT01218477|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20208993|NCT00787527|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD/ Associate Professor|713-792-2860|yoki@mdanderson.org|
20208994|NCT03970330|MSHersheyMC|Dr. Kristin Riley|717-531-6447|kriley1@pennstatehealth.psu.edu|
20208995|NCT03137433|University of Minnesota|Aaron Kelly, PhD|612-626-3492|kelly105@umn.edu|
20208996|NCT04051320|University of North Carolina at Chapel Hill|Crystal Schiller, PhD|919-966-5243|crystal_schiller@med.unc.edu|
20208997|NCT03485976|Oregon Health & Science University, Department of Dermatology|Teri Greiling, MD, PhD|503-494-8452|PRPStudy@ohsu.edu|
20208998|NCT02452892|Tal Medical|Dr. Atul Pande, MD, Chief Medical Officer||apande@talmedical.com|
20208999|NCT01005875|University of Alabama at Birmingham|Dr. Kimberly Keene|2-5-934-5670|kkeene@uab.edu|
20209000|NCT00078715|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos A. Zarate, Jr.|301-451-0861|zaratec@mail.nih.gov|
20209001|NCT00606931|Naviscan Inc|Judith E Kalinyak, MD, PhD, Medical Director|858-587-3641|jkalinyak@naviscan.com|108
20209002|NCT00286234|Sanford School of Medicine, University of South Dakota|Dr. William Harris|16052716917|bill@omegaquant.com|2
20209003|NCT04241627|University of Southern California Keck School of Medicine Department of Pediatrics|Caitlin Sayegh|13233617748|cssayegh@chla.usc.edu|
20226949|NCT03874013|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20226950|NCT01411852|Resuscitation Outcomes Consortium|Susanne May, PhD, Principal Investigator|206-685-1302|sjmay@uw.edu|
20209004|NCT01205399|C. R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
20226951|NCT01715948|Capital Health|Dr. Manohar Bance|902-473-5975|m.bance@dal.ca|
20192677|NCT02108652|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192678|NCT03035318|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
20192679|NCT03311269|Vascular Inisights, LLC|Ms. Lorraine Hanley, MBA|617-519-1109|lorraine.hanley@merit.com|
20192680|NCT02564718|Bayer|Therapeutic Area Head|+1-888-84-22937|clinical-trials-contact@bayer.com|
20192681|NCT03845075|Saniona A/S|Janus Schreiber Larsen|7070 5225|janus.larsen@saniona.com|+45
20192682|NCT01560871|Texas Woman's University|Dr. Suh-Jen Lin|214-689-7718|slin@twu.edu|
20192683|NCT02669615|Medical College of Wisconsin|Parameswaran Hari|4148054600|phari@mcw.edu|
20192684|NCT02271230|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|ldjousse@rics.bwh.harvard.edu|
20192685|NCT01130168|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209005|NCT01468844|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20209006|NCT04745065|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|401-360-2980|kevers@prochange.com|
20209007|NCT04490499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209008|NCT01843933|Yale University|Melissa Langhan|2037377413|melissa.langhan@yale.edu|
20209009|NCT00819052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209010|NCT03524664|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie_petrenko@urmc.rochester.edu|241
20209011|NCT02694562|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
20209012|NCT00807768|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
20209013|NCT01522391|Pergamum AB|Margit Mahlapuu PhD, Assoc. Prof. in Molecular Medicine|+46 70 631 01 09|margit.mahlapuu@pergamum.com|
20209014|NCT00758420|BTG International Inc.|David Wright MBBS|610-943-3538|david.wright@btgplc.com|
20209015|NCT01835964|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20209016|NCT01140646|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
20209017|NCT03006276|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
20209018|NCT04126187|Gainesville Eye Associates|Clayton Blehm, MD|17705324444|claytonblehm@gmail.com|
20209019|NCT02720627|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20209020|NCT03815006|Manchester University NHS Foundation Trust|Dr Lala Leelarathna|01612766706|lalantha.leelarathna@manchester.ac.uk|
20209021|NCT02612194|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20209022|NCT02539160|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
20209023|NCT01681004|SI-BONE, Inc.|Daniel Cher, Vice President of Clinical Affairs|408-207-0700|dcher@si-bone.com|
20209024|NCT00372905|Northwestern University|Jane Winter, MD|312 695 4033|Jwinter@nm.org|
20209025|NCT02218424|Ann & Robert H. Lurie Children's Hospital of Chicago|Hubert Benzon, MD; Primary Investigator|312-227-5122|hbenzon@luriechildrens.org|
20209026|NCT00490477|University of Turin, Italy|V. M. Ranieri, MD|00390116334001|marco.ranieri@unito.it|
20209027|NCT01148836|Cleveland Clinic|Jacqueline Sharp, CNP|216-636-0000|pylej@ccf.org|
20209028|NCT01922336|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82 31 8061 4534|sbregistry@samsung.com|
20209029|NCT03726320|NYU Langone Health|Danil Makarov|212-263-4961|Danil.Makarov@nyulangone.org|
20209030|NCT02679560|UC Davis|Dr. Ian Brown|(916)734-1279|iebrown@ucdavis.edu|
20209031|NCT02028182|Allerderm(dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smarthealth.com|
20209032|NCT01519648|National Hematological Society|Professor Galina A Klyasova|+7(495)6125181|klyasova.g@blood.ru|
20209033|NCT01684930|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
20209034|NCT01277757|University of Texas (UT) MD Anderson Cancer Center|Funda Meric-Bernstam, MD/Chair, Investigational Cancer Therapeutics|713-563-4347|fmeric@mdanderson.org|
20209035|NCT03808298|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20209036|NCT01004822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209037|NCT01858701|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20209038|NCT00187655|UCSF|Richard Castro, MD|4155144363|Rich.Castro@ucsf.edu|
20209039|NCT01115166|Department of Anaestesilogy and Intensive Care|Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
20209040|NCT01801475|Stanford University|Dr. David R Drover|6507250364|ddrover@stanford.edu|
20209041|NCT01786707|University of Miami School of Medicine|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
20209042|NCT00421928|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20209043|NCT00444028|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20209044|NCT02022566|Lunds university|Physical therapist Therese Jönsson|0046703360721|therese.jonsson@med.lu.se|
20209045|NCT02138227|Temple University|Dr. Laura Siminoff|(215) 204-8726|lasiminoff@temple.edu|
20209046|NCT00346476|Desmond Tutu HIV Centre|Prof LG Bekker|+27216506966|Linda-Gail.Bekker@hiv-research.org.za|
20226952|NCT01129245|Oregon Health and Science University|Alison Edelman|503-494-5949|edelmana@ohsu.edu|
20226953|NCT01026948|University of Liverpool|Professor Zarko Alfirevic|00 44(1)51 702|zarko@liverpool.ac.uk|4100
20226954|NCT01951118|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
20192686|NCT01305473|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
20209047|NCT01881867|Cancer Immunotherapy Trials Network|CITN Director|206-667-4141|mcheever@fredhutch.org|
20209048|NCT04120116|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
20209049|NCT00965458|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20209050|NCT02223637|GlaxoSmithKline|GSK Response Center|866-435-7343|geetha.x.kamath@gsk.com|
20209051|NCT05111548|University of Michigan|Dr. Cynthia Burton|734-615-9821|czburton@med.umich.edu|
20209052|NCT01846039|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20209053|NCT00594958|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
20209054|NCT03330275|Johnson & Johnson Vision Care, Inc.|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
20209055|NCT01855607|Columbia University Irving Medical Center|Dawn L. Hershman, MD, MS, FASCO|212 305-1945|dlh23@columbia.edu|
20209056|NCT02181634|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|pcata@jimmy.harvard.edu|
20209057|NCT02528331|Duke University|Richard Weiner, MD, PhD|919-681-8742|weine002@duke.edu|
20209058|NCT02392078|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
20209059|NCT02079077|University of Manitoba|Keith Fowke|204-789-3296|keith.fowke@umanitoba.ca|
20209060|NCT01425268|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|9003
20226955|NCT02989402|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20226956|NCT03505372|Beth Israel Deaconess Medical Center|Dr Jordana Phillips|617 667 1630|jphilli2@bidmc.harvard.edu|
20226957|NCT01852513|The University of Chicago|Dr. Jayant Pinto, PI|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
20226958|NCT02487797|Northwestern University, Yale University|Dr. Moeun Son|475-414-5328|moeun.son@yale.edu|
20226959|NCT02824627|University of Nebraska Medical Center|Soonjo Hwang|402-552-6351|soonjo.hwang@unmc.edu|
20226960|NCT01938846|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20226961|NCT02477358|University of Nebraska Medical Center|Elisabeth Easley|530-524-6020|eleasley@gmail.com|
20226962|NCT01689441|Brigham and Women's Hospital|David Leaf, MD, MMSc|617-732-5500|deleaf@partners.org|
20226963|NCT00964028|GlaxoSmithKline|GSK Response Center|866-435-7343||
20226964|NCT01603407|University of Rochester|Robert Griggs|585-275-6072|robert_griggs@urmc.rochester.edu|
20226965|NCT03705286|Duke University|Miriam Treggiari|919-681-9933|miriam.treggiari@duke.edu|
20226966|NCT01074177|Massachusetts General Hospital|Lecia Van Damn Sequist|617-724-4000|lvsequist@partners.org|
20226967|NCT02106351|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20226968|NCT01514383|Medline Industries, Inc|Ed Drower, Clinical Project Director|847-643-3874|edrower@medline.com|
20226969|NCT01401543|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20226970|NCT00069823|Johns Hopkins University|Ellen Brown|443-287-3170|ala-acrc@jhsph.edu|
20226971|NCT03560869|University of Delaware|William B. Farquhar|302-831-6178|wbf@udel.edu|
20226972|NCT01801111|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20226973|NCT01210482|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20226974|NCT01223937|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20226975|NCT05176717|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
20226976|NCT03284853|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. Vice President, Clinical Development & Medical Affairs.|+1 908 947 3551|msenchyna@aeriepharma.com|
20226977|NCT00765817|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20226978|NCT00765947|Novartis Pharmaceuticals|Study Director|862-778-8300||
20226979|NCT02143024|UC Davis Department of Psychiatry and Behavioral Sciences|Ladson Hinton, MD|(916) 734-3485|lwhinton@ucdavis.edu|
20226980|NCT02308228|University of Kentucky|Douglas Long|859-323-5438|DELONG2@UKY.EDU|
20226981|NCT06597084|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
20226982|NCT01043133|USUHS|Ronald W. Gimbel|301-295-3077|rgimbel@usuhs.mil|
20226983|NCT01545141|Roswell Park Cancer Institute|Kris Attwood|716-845-2300|Kristopher.attwood@roswellpark.org|
20226984|NCT01575756|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
20226985|NCT03999749|NYU Langone Health|Janice Mehnert, M.D.|212-731-5431|janice.mehnert@nyulangone.org|
20226986|NCT00255164|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20226987|NCT03677869|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20226988|NCT05219968|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
20226989|NCT02735473|University of Minnesota|Jeffrey R Wozniak|612-273-9741|jwozniak@umn.edu|
20226990|NCT04587336|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|Allison.Lewinski@va.gov|174048
20226991|NCT04776928|University of Michigan|Jennifer Waljee|(734) 936-8925|filip@med.umich.edu|
20226992|NCT00913081|University of Pennsylvania|Richard L. Dunbar, MD, PI|609 413-1067|richard.dunbar@uphs.upenn.edu|
20226993|NCT01781208|Cincinnati Children's Hospital Medical Center, Department of Radiology|Jonathan Dillman, MD|513 803-7114|jonathan.dillman@cchmc.org|
20226994|NCT04391179|University of Michigan|Jason Knight, MD, PhD|734-763-3031|jsknight@med.umich.edu|
20226995|NCT03334188|"University of Colorado | School of Medicine | ACCORDS"|Dr. Larry Allen, Professor of Medicine|303-724-4713|larry.allen@cuanschutz.edu|
20226996|NCT04218279|University of Pittsburgh|P. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
20226997|NCT00716807|UCSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
20226998|NCT03442088|University Hospitals Cleveland Medical Center|Dr. Neil Korman, Director Clinical Trials Unit|216-844-8200|Neil.Korman@UHhospitals.org|
20226999|NCT01001520|University of Pennsylvania|Caryn Lerman, PhD|215-746-7141|clerman@mail.med.upenn.edu|
20227000|NCT02541422|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
20227001|NCT00357877|Kaiser Permanente Data Coordinating Center|Dr. William Vollmer|503-335-6755|william.vollmer@kpchr.org|
20209061|NCT00719706|McLean Hospital|Dr. Brian Brennan|617-855-2911|bbrennan@partners.org|
20227002|NCT04668209|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
20209062|NCT00682539|Department of Ophthalmology, Medical University Vienna|Dr. Katharina Kriechbaum|00431 40400 79480|katharina.kriechbaum@meduniwien.ac.at|
20227003|NCT03570047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227004|NCT01351090|Luitpold Pharmaceuticals, Inc.|David Bregamn, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20227005|NCT00028262|National Institute of Child Health and Human Development|Dr. Anil Mukherjee|+1 301 496 7213|mukherja@exchange.nih.gov|
20227006|NCT00268983|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227007|NCT01719380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227008|NCT00848757|Yale University School of Medicine|Michelle Van Name|203-785-5831|michelle.vanname@yale.edu|
20227009|NCT01064414|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20227010|NCT02532374|Philip Morris Products S.A.|Loyse Felber Medlin|+41 (58) 242 2686|Loyse.FelberMedlin@pmi.com|
20227011|NCT04553666|University of Rochester Medical Center|Dr. Nikesha Gilmore, Assistant Professor|1-585-275-1275|nikesha_gilmore@urmc.rochester.edu|
20227012|NCT00716456|Memorial Sloan Kettering Cancer Center|Dr. Gregory J. Riely|646-888-4199|rielyg@mskcc.org|
20227013|NCT05926648|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20227014|NCT03861091|Wake Forest Baptist Comprehensive Cancer Center|Biostatistician|336-716-5440|blevine@wakehealth.edu|
20227015|NCT02038179|University of Alabama at Birmingham|Dr. Elizabeth Rahn|205-996-6552|elizabethrahn@uabmc.edu|
20227016|NCT03626701|AVITA Medical|Elizabeth Kirshner|661-877-6869|ekirshner@avitamedical.com|
20227017|NCT00807885|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
20227018|NCT03489343|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
20227019|NCT00327717|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affairs|81-3-3817-3914||
20227020|NCT01912950|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20227021|NCT03242941|Medtronic|Lilian Kornet|+31433566710|lilian.kornet@medtronic.com|
20227022|NCT01630135|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227023|NCT04767373|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20227024|NCT01502033|Mayo Clinic|Dr. Paul Croarkin|(507) 293-2557|croarkin.paul@mayo.edu|
20227025|NCT02658669|VA San Diego Healthcare System|Dr. Henry Orff|(858) 642-6492|Henry.Orff@va.gov|
20227026|NCT00186485|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
20227027|NCT02247739|Pharming Group NV|VP Clinical Research & Medical Affairs||a.relan@pharming.com|
20227028|NCT02550743|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD, Principal Investigator|14018633000|kayla_rosati@brown.edu|
20162994|NCT00694018|VA Ann Arbor Center for Clinical Management Research|Sarah L. Krein, PhD, RN|734-845-3621|sarah.krein@va.gov|
20162995|NCT00856544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227029|NCT01246895|Piramal Healthcare (Canada) Limited - Bio-Orthopaedics Division|David Castelo, Clinical Research Manager|450-686-2437|david.castelo@piramal.com|313
20227030|NCT03804268|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20227031|NCT00838097|Amgen Inc.|Study Director|866-572-6436||
20227032|NCT01156805|Hospital General de Granollers|Dr. Esteve Llargues|938425000|ellargues@fhag.es|2675
20227033|NCT03311841|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227034|NCT00121719|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20227035|NCT01472445|Stanford University|Melinda Telli, Associate Professor of Medicine (Oncology)|650-724-9533|mtelli@stanford.edu|
20227036|NCT01705977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227037|NCT02017093|University of Haifa|Prof. Eli Carmeli|972-4-8288-397|ecarmeli@univ.haifa.ac.il|
20227038|NCT02288819|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge|0473924199|frederik.verbrugge@zol.be|+32
20227039|NCT00765856|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20227040|NCT02039778|Mount Sinai Beth Israel|Dr. Rahul Parikh|732-253-3939|parikhrr@cinj.rutgers.edu|
20227041|NCT01715233|Baylor University Medical Center Dallas Texas|Ronan J. Kelly MD MBA|214-820-2828|Ronan.Kelly@bswhealth.org|
20227042|NCT03065647|University of Michigan|Robert Neumar|734-936-0253|neumar@umich.edu|
20227043|NCT01678664|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20227044|NCT00826150|BioCancell Ltd.|VP Clinical|+97225486553|monique.ben-am@biocancell.com|
20227045|NCT02981914|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|karrisont@nrgoncology.org|
20227046|NCT03801642|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
20227047|NCT00753675|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20227048|NCT01462110|Johnson & Johnson Consumer Inc.|Michael Lynch|908-433-6423|mlynch23@ITS.JNJ.com|
20227049|NCT04457362|NYU Langone Health|Nader Paksima|2122632193|Nader.Paksima@nyulangone.org|
20227050|NCT05279131|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
20227051|NCT00594230|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20227052|NCT00333710|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4707|amy.silberbogen@va.gov|
20227053|NCT02149264|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20227054|NCT01877161|Seoul National University Bundang Hospital|Nam-Jong Paik|031-787-7731|njpaik@snu.ac.kr|7731
20227055|NCT00401518|Globus Medical|Director of Clinical Affairs|610-930-1800|jmyer@globusmedical.com|
20227056|NCT00672633|Boston Children's Hospital|Dr. Stavroula Osganian, Principal Investigator|8572184728|stavroula.osganian@childrens.harvard.edu|
20227057|NCT00929344|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
20185987|NCT04321031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185988|NCT04080531|Emory University|Craig C. Hofmeister, MD, MPH|404-778-0519|craig.hofmeister@emory.edu|
20227058|NCT02499120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20185989|NCT03143153|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20185990|NCT05448651|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|917-499-0789|sumathi.sivapalasingam@upstreambio.com|
20185991|NCT05551195|Woebot Health|Kate Martin|(415) 209-5642|kate@woebothealth.com|
20185992|NCT04251299|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
20185993|NCT05470400|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20185994|NCT03940963|Axogen|Stacy Arnold, VP of Product Development and Clinical Research|770-833-2570|sarnold@axogeninc.com|
20185995|NCT01198366|Aeras|Product Director|301-547-2919|blandry@aeras.org|
20185996|NCT04812535|InflaRx GmbH|Dr. Camilla Chong, CMO|+49 3641-508-180|camilla.chong@inflarx.com|
20185997|NCT03436745|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
20185998|NCT03661840|University of Colorado Hospital|Elissa Kolva, MD|7208488090|elissa.kolva@va.gov|
20185999|NCT03846505|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers, Lab Manager|8437925807|sellersst@musc.edu|
20186000|NCT05592418|AIM ImmunoTech Inc.|Diane Young|352-448-7797|diane.young@aimimmuno.com|
20186001|NCT05569252|Daiichi Sankyo|Contact for Clinical Trial Information|9089926400|CTRinfo_us@daiichisankyo.com|
20186002|NCT03665597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20186003|NCT04831216|University of Arkansas for Medical Sciences|Krista Langston|479-713-8000|KNLangston@uams.edu|
20186004|NCT04663087|University of Alabama at Birmingham|Dr. Jan Jansen|205-975-3030|jjansen@uabmc.edu|
20186005|NCT05371652|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186006|NCT03978871|University of Illinois, Urbana-Champaign|Dr. Karen Rudolph|217-333-8624|krudolph@illinois.edu|
20186007|NCT03095274|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
20186008|NCT01361711|Northwestern University|Shuo Ma, MD, PhD|312-908-5250|shuo-ma@northwestern.edu|
20186009|NCT03964350|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20186010|NCT05529966|Stanford University|Robert T. Chang, MD|650-725-5743|christyr@stanford.edu|
20186011|NCT04222660|Iowa City VA Healthcare System|Dr. Mark Yorek|13193380581|mark.yorek@va.gov|637696
20186012|NCT02187003|Biossil Inc.|Head of Regulatory|978-245-7397|debora@biossil.ai|
20186013|NCT05159583|University of California, Berekeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20186014|NCT04280445|Trent Doctorate in Clinical Psychology Programme, University of Nottingham, UK|Dr Daniell De Boos|+44 (0)115 84 67523|danielle.deboos@nottingham.ac.uk|
20186015|NCT04833777|University of Saskatchewan|Dr. David Sauder|306-955-9800|sauderdave@gmail.com|
20186016|NCT05098795|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
20186017|NCT03394846|University of South Carolina|Robert Glenn Weaver|8037775605|weaverrg@mailbox.sc.edu|
20186018|NCT05543746|University of North Carolina at Chapel Hill|Rachel Kozik|919-590-0813|rachel_kozik@med.unc.edu|
20186019|NCT03149315|Johns Hopkins University School of Medicine|Melanie Dispenza, MD, PhD|410-550-1815|mdispen1@jhmi.edu|
20186020|NCT04600323|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|jessica.kendrick@cuanschutz.edu|
20186021|NCT03841669|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
20186022|NCT03205800|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
20186023|NCT02193958|FUJIFILM Pharmaceuticals U.S.A, Inc.|Vice President of Clinical Operations|(617) 945-3763|fphucontact@fujifilm.com|
20186024|NCT05264376|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
20186025|NCT04501861|Cleveland Clinic Foundation|Dr. Mariya Geube|216-444-2779|Geubem@ccf.org|
20186026|NCT04234698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186027|NCT04083235|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20186028|NCT01007591|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20186029|NCT02724878|Dana-Farber Cancer Institute|Toni Choueiri|617-632-5456|toni_choueiri@dfci.harvard.edu|
20186030|NCT03779204|Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|naomi.thulien@unityhealth.to|
20186031|NCT04258709|University of Pittsburgh|Dr. Jill Demirci|412-648-9236|JVR5@pitt.edu|
20186032|NCT02592330|Massachusetts Eye and Ear|Michael Cheung, MS, CCRP (Clinical Research Project Manager)|617-573-6981|mcheung0@meei.harvard.edu|
20186033|NCT03090152|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|2126061036|JulesElyseeK@HSS.EDU|
20186034|NCT05150860|San Diego State University|Assistant Vice President for Research Support Services|(619) 594-5938|rgulizia@sdsu.edu|
20186035|NCT05634226|Children's Hospital of Pittsburgh|Dr. Tarek Alsaied|5136521226|tarek.alsaied84@gmail.com|
20186036|NCT02729311|University of California, San Francisco|Deborah Barnes, PhD|415-221-4810|Deborah.Barnes@ucsf.edu|4221
20186037|NCT05324124|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20186038|NCT04034251|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|blakelyam@nih.gov|
20186039|NCT05034952|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20186040|NCT02287610|Horizon Pharma Ireland, Ltd.|Mike Marshall, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
20186041|NCT04950660|Children's Mercy Kansas City|Anne Stuedemann MSN, RN, CPNP|8162343693|astuedemann@cmh.edu|
20186042|NCT02111798|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
20186043|NCT05493787|Geisinger|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
20227059|NCT02541409|Johns Hopkins University Bloomberg School of Public Health|Dr. Shruti Mehta|443-287-3837|smehta@jhu.edu|
20192687|NCT01283022|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20192688|NCT04354168|Boston University Chobanian & Avedisian School of Medicine, Family Medicine|Brian Jack, MD|617-414-6207|brian.jack@bmc.org|
20192689|NCT01781832|Cincinnati Children's Hospital Medical Center|Ethan Smith, MD|513 636-4200|Ethan.Smith@cchmc.org|
20192690|NCT02287233|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20192691|NCT02804399|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001800781021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192692|NCT01774305|Yonsei Univ. Health System, Gangnam Severance Hospital|Dr. Jeongsoo Lee|+82-2-2019-6092|ration99@yuhs.ac|
20192693|NCT01157377|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20192694|NCT01795859|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20192695|NCT00904722|The University of Texas (UT) MD Anderson Cancer Center|Sattva S. Neelapu, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
20192696|NCT01743976|Wake Forest School of Medicine|James C. Eisenach|336-716-4182|jimeisenach@gmail.com|
20192697|NCT02072421|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
20192698|NCT01801982|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192699|NCT00727506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192700|NCT01482429|Federal University of Uberlândia|Liliane Barbosa da Silva Passos|553432182150|lilibsp@yahoo.com.br|
20192701|NCT03561597|KKWCH|Dr Chew Chu Shan Elaine|63946042|elaine.chew.c.s@singhealth.com.sg|
20192702|NCT04887506|Tavanta Therapeutics|Head, Clinical Development|+1 833776 8963|info@tavanta.com|
20192703|NCT02636608|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20227060|NCT01845597|Rebound Research and Education Foundation.|Pamela Fairchild|3604498728|pfairchild@reboundmd.com|
20227061|NCT01289548|Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology|Hua zheng|00862783663173|huaz1980@hotmail.com|
20192704|NCT03506347|Mayo Clinic|Dr. Mark Spangehl|480-342-2948|Spangehl.Mark@mayo.edu|
20227062|NCT02359110|Penn State Milton S. Hershey Medical Center|Timothy Deimling, M.D.|717-531-3503|tdeimling@pennstatehealth.psu.edu|
20227063|NCT00956839|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow|Professor Eesh Bhatia|00915222494382|ebhatia@sgpgi.ac.in|
20227064|NCT00994110|Memorial Sloan Kettering Cancer Center|Dr. Peter Allen|212-639-5132|allenp@mskcc.org|
20227065|NCT01914393|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20227066|NCT01111565|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20227067|NCT02824224|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20227068|NCT02683239|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20227069|NCT03846544|Brussels IVF|Dr Liese Boudry|024779857|liese.boudry@uzbrussel.be|
20227070|NCT00368108|Eisai Call Center|Eisai Inc.|888-422-4743||
20227071|NCT04131712|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
20227072|NCT02363387|Johns Hopkins University School of Medicine|Kenneth Silverman|443-617-6051|ksilverm@jhmi.edu|
20227073|NCT00815997|NPO International TRI Network|Sigeru Saito, MD, Principal Investigator|+81-467-461717|saito@shonankamakura.or.jp|10490
20227074|NCT02299388|Tulane University|Dr. Tina Thethi|504-988-5044|tthethi@tulane.edu|
20227075|NCT04613739|Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|617-867-4893|alison_galbraith@harvardpilgrim.org|
20192705|NCT01437488|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jean Hoffman-Censits|215 955-8874|jean.hoffman-censits@jefferson.edu|
20192706|NCT04562896|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20192707|NCT06124131|Tulane University|Laura Perry|504-988-8906|lperry5@tulane.edu|
20192708|NCT04594733|MUSC|Research Coordinator|843-792-1869|nitchie@musc.edu|
20192709|NCT01024036|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
20192710|NCT03459612|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20192711|NCT02176837|Hope Pharmaceuticals|Craig Sherman, MD|4806071970|sherman@hopepharm.com|
20192712|NCT00691678|Columbia University|Dawn L. Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
20192713|NCT01251887|NIAAA/NIA|Ramsden, Christopher|+1 410 558 8369|ramsdence@mail.nih.gov|
20192714|NCT00566345|Ology Bioservices|Sr. Manager, Clinical & Regulatory Operations|386-418-8751|angie.kimbler@ologybio.com|
20192715|NCT01190449|Weill Cornell Medicine Cornell University|Cara Rosenbaum, MD|(646) 962-6500|car9156@med.cornell.edu|
20192716|NCT04811339|University of Cincinnati|Dr. Bruce Yacyshyn|513-633-8715|yacyshbr@ucmail.uc.edu|
20192717|NCT03972397|The University of Texas Health Science Center at Houston|Anthony L Estrera, MD|713-486-5100|anthony.l.estrera@uth.tmc.edu|
20192718|NCT00903760|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|713-745-3428|ggarciam@mdanderson.org|
20192719|NCT01177956|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20192720|NCT02531867|Alexion|Medical Director|(781) 357-9900|clinicaltrials@alexion.com|
20192721|NCT02330276|Va San Diego Healthcare System|Robert R. Henry, MD|8585528585|rrhenry@outlook.com|3648
20192722|NCT01256671|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20192723|NCT04411186|Medical University of South Carolina|Dr. David Gutman, M.D., MBA, Associate Professor of Anesthesiology|843-792-5454|gutman@musc.edu|
20192724|NCT01266018|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20192725|NCT01780454|Massachusetts General Hospital|Dr. David Sachs|617-726-4065|David.Sachs@tbrc.mgh.harvard.edu|
20192726|NCT02641587|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
20227076|NCT00003537|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20209063|NCT02257970|Stanford University, School of Medicine|Dr. Stanley Rockson|650-725-7571|rockson@stanford.edu|
20209064|NCT00508872|UT MD Anderson Cancer Center|Eddie Abdalla, MD/Assistant Professor|713-792-6940||
20209065|NCT01256424|Photocure|Vice President Research and Development|+47 22062210|ifh@photocure.no|
20209066|NCT04871451|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
20209067|NCT04594213|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20209068|NCT03764813|Fondazione Policlinico Gemelli IRCCS|luciana teofilili medical director of the UNICATT cord blood bank|39 06 30154180|luciana.teofili@unicatt.it|
20209069|NCT02206776|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|650-723-4095|ocdresearch@stanford.edu|
20209070|NCT02898662|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20209071|NCT02109731|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
20209072|NCT04462731|University of Pennsylvania|Ya-Hsin Yu|215-898-4927|yayu@upenn.edu|
20209073|NCT00779142|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu|
20209074|NCT00672490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20209075|NCT03698370|Stanford University|Dr. Andrei Iagaru, MD|650-728-4711|aiagaru@stanford.edu|
20209076|NCT04738123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20209077|NCT00486720|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20209078|NCT01294319|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Dr. Lynnette Nieman|301-496-4000|niemanl@mail.nih.gov|
20209079|NCT00302731|University of Kansas Medical Center|Jeanne A Drisko, MD, CNS, FACN|913-588-6208|jdrisko@kumc.edu|
20209080|NCT02780869|Biom'up|Rachel Hoffman, Vice President Clinical Operations North America|404-702-9253|r.hoffman@biomup.com|
20209081|NCT01610752|Pennington Biomedical Research Center|Dr. Leanne M. Redman|2257630947|leanne.redman@pbrc.edu|
20209082|NCT02208466|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
20209083|NCT00283062|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20209084|NCT03702166|UT Health San Antonio|John Moring, PhD|(210) 562-6716|moringj@uthscsa.edu|
20209085|NCT01333865|Massachusetts General Hospital|Gagan Joshi, MD|617-724-2344|joshi.gagan@mgh.harvard.edu|
20209086|NCT00554229|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20209087|NCT00784836|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
20209088|NCT02613910|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209089|NCT00434876|Philadelphia VAMC|Subhajit Chakravorty|215-823-5800|Subhajit.Chakravorty@va.gov|3405
20209090|NCT03539900|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
20209091|NCT02843282|University of Texas at Dallas, Center for BrainHealth|Erin Venza, Research Clinician|972-883-3208|erin.venza@utdallas.edu|
20209092|NCT00224952|The Children's Mercy Hospital|J. Steven Leeder Pharm D, PhD|816-234-3059|sleeder@cmh.edu|
20209093|NCT02681094|AstraZeneca|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20209094|NCT00987558|Bial - Portela & Cª, S.A.|Head of Clinical Research||jose.rocha@bial.com|
20209095|NCT02210559|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-069Study@fibrogen.com|
20209096|NCT02546193|Mayo Clinic|VanessaTorbenson, M.D.|507-266-9873|torbenson.vanessa@mayo.edu|
20209097|NCT00310440|Nor Consult, LLC|Lead Clinical Research Associate|2066076861|p15@nor-consult.com|
20209098|NCT01287403|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, MD, PhD|+41217858054|maurice.beaumont@rdls.nestle.com|
20209099|NCT00148109|University of Michigan Comprehensive Cancer Center|Dr. Rashmi Chugh|(734) 936-5710|rashmim@umich.edu|
20209100|NCT01098266|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
20209101|NCT01733758|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209102|NCT02557308|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
20209103|NCT02357394|University of Kansas Health System, Dept of OBGYN|Dr. Gene Lee|9135886201|glee@kumc.edu|
20209104|NCT03911401|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20209105|NCT02918968|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20209106|NCT01589185|Aridis Pharmaceuticals, Inc.|Lynne Deans, M.T.|408-385-1742|deansl@aridispharma.com|
20209107|NCT00886626|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20209108|NCT00917553|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
20209109|NCT01616173|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale MD|312-695-3045|ryrahangdale@hotmail.com|
20209110|NCT01905241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
20209111|NCT04680273|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20209112|NCT03172026|University of California Los Angeles|Dr. Bruce H. Dobkin|310-206-6500|BDobkin@mednet.ucla.edu|
20209113|NCT04168775|University of North Carolina at Chapel Hill|Michael B. Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
20227077|NCT01051557|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|kaleyt@mskcc.org|
20227078|NCT02958787|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, MD|734-232-5244|sprattda@umich.edu|
20227079|NCT00130689|Dana-Farber Cancer Institute|Jennifer Ang Chan, MD, MPH|617-632-6315|jennifer_chan@dfci.harvard.edu|
20227080|NCT00766597|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20192727|NCT01165177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209114|NCT00504595|Novartis Pharmaceuticals|Study Director|862-778-8300||
20209115|NCT01177943|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20227081|NCT00943397|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20209116|NCT04652245|Meda Pharma GmbH & Co. KG (A Viatris Company)|Christine Kolb|+496172888|christine.kolb@viatris.com|2511
20227082|NCT01254656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227083|NCT01178125|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20227084|NCT02948829|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20227085|NCT01004978|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20227086|NCT00369915|NIMH/NIH|Maura Furey, PhD|301-594-7773|mfurey@mail.nih.gov|
20227087|NCT00814138|University of Kansas Medical Center|Richard J. Barohn, MD/ Chairman of Neurology|913-588-6094|rbarohn@kumc.edu|
20227088|NCT02381678|Guangdong General Hospital|Dr. Huiming Guo (Chief in Cardiac Surgical Department)|86-13609089789|guohuiming@vip.tom.com|
20227089|NCT01050946|Medical College of Wisconsin|Jeanne Palmer,MD|414-805-6800|jpalmer@mcw.edu|
20227090|NCT00583908|Vistakon|Kurt Moody, OD FAAO|904-443-3088|kmoody1@its.jnj.com|
20227091|NCT01749410|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20227092|NCT00270296|Harvard TH Chan School of Public Health|Dr. Roger Shapiro|617-432-2334|rshapiro@hsph.harvard.edu|
20227093|NCT01447407|NovaDigm Therapeutics, Inc.|John P. Hennessey, Jr.|12676405189|john_hennessey@novadigm.net|
20227094|NCT00580957|Vanderbilt University|Italo Biaggioni, M.D. Professor of Medicine|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
20227095|NCT01348139|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20227096|NCT02762084|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|Info@Pellepharm.com|
20227097|NCT01015326|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
20192728|NCT02007200|University of Michigan Comprehensive Cancer Center|Gregory T. Wolf, M.D.|800-865-1125|gregwolf@umich.edu|
20227098|NCT02254772|Stanford Univeristy Medical Center|Ronald Levy, MD, Professor of Medicine|650-725-6452|levy@stanford.edu|
20227099|NCT01765296|CrystalGenomics, Inc.|Chief Medical Officer|+82-31-628-2871|sang-yoon.lee@cgxinc.com|
20227100|NCT01619852|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
20227101|NCT04556760|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
20227102|NCT01805895|Augusta University|Dr Jeffrey Switzer|7067211691|jswitzer@augusta.edu|
20227103|NCT03677635|King's College London|Dr Clementine Edwards|07557866053|clementine.edwards@kcl.ac.uk|
20227104|NCT00954681|NYSPI/Columbia University|John J. Mariani|6467746140|john.mariani@nyspi.columbia.edu|646
20227105|NCT03075267|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20227106|NCT02168491|Medical University Vienna, Austria|Prof. Dr. Michael Krebs|+ 43 1 40400|michael.krebs@meduniwien.ac.at|43120
20227107|NCT00809445|Columbia University, Mailman School of Public Health|Dr. Lisa Metsch|212-305-3577|lm2892@columbia.edu|
20227108|NCT03335800|Associate Professor of Medicine, Stanford University|Minang (Mintu) Turakhia, Associate Professor of Medicine, Stanford University|(650) 493-5000|mintu@stanford.edu|
20227109|NCT01566604|Novartis|Study Director|862-778-8300||
20227110|NCT01204203|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
20227111|NCT01610037|Novartis Pharmaceuticals|Study Director|862-778-8300||
20227112|NCT00972959|"Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital of Athens,"|Prof. M. A. Dimopoulos|0030 210 3381511|mdimop@med.uoa.gr|
20227113|NCT00705757|Summa Health System ( at the time of the trial)|Deepak P. Edward, MD|330-780-0399|deepak.edward@gmail.com|
20227114|NCT00661089|The Rehabilitation Institute of Chicago|Dr. Christina Marciniak|312-238-1000|cmarciniak@ric.org|
20227115|NCT03877744|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
20227116|NCT01443858|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
20227117|NCT05017272|Q2i LLC Telephone: 646-660-2151 Email: sjenkins@q2i-group.com|Steve Jenkins|646-660-2151|sjenkins@q2i-group.com|
20227118|NCT03361306|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20227119|NCT00321906|The University of Chicago|Edward Garrity, MD|(773) 834-1119|egarrity@uchicago.edu|
20227120|NCT02778152|The Research Institute at Nationwide Children's Hospital|Dr. Peter Minneci|614-722-3066|peter.minneci@nationwidechildrens.org|
20227121|NCT01272908|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192729|NCT03598699|AxeroVision, Inc.|Dr. Achim Krauss|+1 (484) 238-6255|achim.h.krauss@gmail.com|
20192730|NCT01657799|AbbVie|Global Medical Services|800-633-9110||
20192731|NCT04182113|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
20192732|NCT01646385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192733|NCT01777334|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192734|NCT02440334|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. John Eisenbrey|(215) 503-5188|john.eisenbrey@jefferson.edu|
20192735|NCT04611347|University of Virginia|Brent DeGeorge, MD|434.982.4263|BD6U@uvahealth.org|
20192736|NCT00727415|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20192737|NCT00345800|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
20192738|NCT00756457|Ithaca College|Jeff Houck, PhD|585-340-9619|jhouck@ithaca.edu|
20192739|NCT01973062|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-444-6145|ahluwam@ccf.org|
20192740|NCT02113410|Florida Atlantic University|Dr. Juyoung Park|561-297-4537|jpark14@fau.edu|
20192741|NCT04593823|scPharmaceuticals|Dr. John Mohr, PharmD; Sr VP Clinical Development and Medical Affairs|7813017220|jmohr@scpharma.com|
20192742|NCT05043883|CathVision|Mads Matthiesen|+4531470730|mem@cathvision.com|
20192743|NCT02980705|Sun Pharma Advanced Research Company Limited|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
20192744|NCT00263575|Strakan Pharmaceuticals Ltd|Fiona Miller|01896 66868|fiona.miller@prostrakan.com|
20192745|NCT00537329|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20192746|NCT02420041|Naval Medical Center San Diego|LCDR Ian M Fowler, MD|619-532-8954|ian.m.fowler.mil@mail.mil|
20227122|NCT02221648|Yale University School of Medicine|Bahman Jabbari M.D, , Professor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
20227123|NCT00149396|Medigene|Associate Director Regulatory Affairs|858-586-2252|p.larson@medigeneusa.com|
20227124|NCT01168921|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
20227125|NCT02937623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227126|NCT00810069|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227127|NCT00719160|Yale University|Karl L. Insogna, M.D.|203-737-2871|Karl.insogna@yale.edu|
20227128|NCT01466361|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227129|NCT02358031|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20227130|NCT05664581|AbbVie|Global Medical Services|001 8006339110|abbvieclinicaltrials@abbvie.com|
20227131|NCT03101150|King Fahd Medical City|Consultant Obstetritian and Gynecologist|00966539417217|amali@kfmc.med.sa|
20227132|NCT02772666|Mashhad University of Medical Sciences|Dr. Amirhossein Vejdani|+9151105411|amirhosein_vejdani@yahoo.com|
20227133|NCT01317641|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
20227134|NCT00715559|Mount Sinai School of Medicine|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
20227135|NCT02019550|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20227136|NCT00675987|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
20227137|NCT02787304|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
20227138|NCT04771013|GIMUNICAH|Héctor M. Ramos-Zaldívar|+56934988958|hramos@unicah.edu|
20227139|NCT01450319|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20227140|NCT00823134|ResMed Germany Inc|Oliver Munt|0899901|oliver.munt@resmed.de|00
20227141|NCT00078403|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20227142|NCT00419757|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20227143|NCT02100280|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
20227144|NCT03045653|Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative innovation center for Cancer Medicine|Zhongyu Yuan|+8613798027658|yuanzhy@sysucc.org.cn|
20227145|NCT00193414|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20227146|NCT00379834|West Virginia University|Dr. Tony Realini|3045986926|realinia@wvuhealthcare.com|
20227147|NCT01519817|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
20227148|NCT02922153|AtriCure|Nfii Ndikitum|513-644-8192|nndikintum@atricure.com|
20186044|NCT03761537|LEO Pharma A/S|Disclosure|44 94 58 88|disclosure@leo-pharma.com|+45
20227149|NCT01116921|Unviersity of Minnesota|Kari D. Roberts, MD|612-625--9577|rober694@umn.edu|
20227150|NCT01325350|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20227151|NCT03429348|University of Arizona|Jeff Burgess, MD., MS, MPH, Assoc Dean of Research|520-626-4918|jburgess@email.arizona.edu|
20227152|NCT01716806|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20227153|NCT03506438|Duke|Christopher Cox|9196817232|christopher.cox@duke.edu|
20227154|NCT01128296|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
20227155|NCT03979066|Columbia University|Gulam Manji, MD, PhD|212-305-0592|gam2140@columbia.edu|
20227156|NCT02806713|University of Massachusetts UMass Memorial|Michael K Flynn|(508) 856-5152|michael.flynn@umassmemorial.org|
20227157|NCT01195779|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227158|NCT00552695|Stony Brook U|Adam Singer|631-444-7857|adam.singer@stonybrook.edu|
20227159|NCT01401595|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, Ph.D.|215-898-2823|kca@mail.med.upenn.edu|
20227160|NCT00521365|AstraZeneca|Gerard Lynch|09645895|ClinicalTrialTransparency@astrazeneca.com|4415
20227161|NCT01718483|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20227162|NCT03049501|University of Miami|David Loewenstein|305-355-7016|dloewenstein@miami.edu|
20227163|NCT04547140|Grifols Therapeutics LLC|Rhonda Griffin, Clinical Program Leader/Director|+1 919 757 1744|Rhonda.griffin@grifols.com|
20227164|NCT00873730|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20227165|NCT01116037|Medtronic|Ryan Palmer|+17635149732|ryan.j.palmer@medtronic.com|
20227166|NCT01265394|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
20227167|NCT00115778|Columbia University Medical Cetner|Selim Arcasoy, MD|212-305-7771|sa2059@columbia.edu|
20227168|NCT03870334|NImmune|Project Management|(540) 944-4545|pm@nimmun.com|
20227169|NCT02185417|Boston VAHCS|Dr. Sarah Leatherman|857-364-4201|sarah.leatherman@va.gov|
20227170|NCT00249873|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
20227171|NCT00412841|NYULMC|Dr. H. Michael Belmont|212-598-6518|michael.belmont@nyumc.org|
20227172|NCT01781962|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20227173|NCT01167569|Rutgers RWJMS|Alan Spotnitz, MD|732-235-9806|spotnitz@rwjms.rutgers.edu|
20227174|NCT05417412|San Diego State University|Dr. V. Robin Weersing|619-594-8892|robin.weersing@sdsu.edu|
20227175|NCT01576575|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20227176|NCT01668836|Heart Institute (InCor), University of São Paulo Medical School|Antonio de Padua Mansur - Associate Professor|55-11-26615387|apmansur@usp.br; apmansur@yahoo.com|
20227177|NCT02895035|Penn State Hershey Eye Center|Seth Pantanelli|717-531-5690|spantanelli@pennstatehealth.psu.edu|
20227178|NCT00274742|Amgen Inc.|Study Director|866-572-6436||
20227179|NCT02697071|Lewis Gale Medical Center|Corey Heitz, MD|5406322364|coreyheitzmd@gmail.com|
20227180|NCT02256696|Vanderbilt University|Dr. Kelly Dooley|(615) 322-8972|kelly.e.dooley@vumc.org|
20227181|NCT02572453|Dana-Farber Cancer Institute|Jillian Foreman|1-877-338-7425|jillianM_foreman@dfci.harvard.edu|
20227182|NCT01951417|Galderma Labratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
20209117|NCT00967473|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
20209118|NCT02816255|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
20209119|NCT00026559|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
20209120|NCT04047472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20209121|NCT01303159|Weill Cornell Medical College|Michel Kahaleh|646-962-4797|mik9071@med.cornell.edu|
20209122|NCT01016912|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
20209123|NCT00733096|Johns Hopkins School of Medicine|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
20209124|NCT00914940|Fred Hutchinson Cancer Research Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
20209125|NCT00496782|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20209126|NCT02735382|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Mark Zehner, MS|6082627568|mark.zehner@ctri.wisc.edu|
20209127|NCT00760994|VA Puget Sound Health Care System|Tracy Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
20209128|NCT01288911|Astellas Pharma Global Development, Inc. (APGD)|Executive Medical Director||Astellas.resultsdisclosure@astellas.com|
20209129|NCT02431559|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20209130|NCT05489146|University of Pittsburgh|Amit Sethi, Associate Professor, Department of Occupational Therapy,|4123836619|asethi@pitt.edu|
20209131|NCT00955682|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209132|NCT03820388|University of California Davis|Dr. Hong Liu|916-734-5031|hualiu@ucdavis.edu|
20209133|NCT00469391|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
20209134|NCT03523390|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20209135|NCT02260791|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|+44 1896 668 173|Clinical-Trials@fk-b.com|
20227183|NCT00977613|Beth Israel Cancer Center|Victoria Rosenwald|212 844-8285|vrosenwa@chpnet.org|
20227184|NCT00382785|University of Delaware|Paula Klemm, PhD, RN, OCN|(302) 831-8501|klemmpa@udel.edu|
20227185|NCT03742986|NYU Langone Health - Perlmutter Cancer Center|Maryann Kwa, MD|(212) 731-6364|maryann.kwa@nyulangone.org|
20227186|NCT01598610|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20227187|NCT02925858|Jewish General Hospital|Dr Matthew Cameron|514-340-8222|matthew.cameron@mcgill.ca|25701
20227188|NCT03360019|University of Florida|Glenn Smith|352-273-6556|glennsmith@ufl.edu|
20227189|NCT04878120|University of Virginia|Dr. Chiara Fabris|4344220240|cf9qe@virginia.edu|
20227190|NCT00520039|West Virginia School of Osteopathic Medicine|Dr. Karen Steele|(304)667-4255|ksteele@osteo.wvsom.edu|
20227191|NCT00223665|University of Washington|Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
20227192|NCT00325819|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|jackson.L@ghc.org|
20227193|NCT00534417|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20227194|NCT02058589|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227195|NCT02049983|Levita Magnetics International Corp|Alberto Rodriguez-Navarro, MD|6506557625|info@levita.com|
20227196|NCT00490971|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609-730-2436||
20227197|NCT00593450|CATT Research Group|Dr. Maureen Maguire|215-615-1501|maguirem@mail.med.upenn.edu|
20209136|NCT01680835|Medtronic|Jennifer Seamans, M.S., Clinical Research Program Manager|763-398-7455|jennifer.l.seamans@medtronic.com|
20227198|NCT06450457|The University of Texas Health Science Center at Houston|Kaitlin Benjamin, PT, DPT|610-639-0431|Kaitlin.Benjamin@memorialhermann.org|
20227199|NCT04754542|University of Colorado Denver|Eric Engebretson|3037244518|eric.engebretson@cuanschutz.edu|
20227200|NCT04570709|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|Melahat_Canter@med.unc.edu|
20227201|NCT01212094|NINDS, NIH|Dr. Bibiana Bielekova, Prinicipal Investigator|301-402-4488|bibiana.bielekova@nih.gov|
20227202|NCT01490892|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Flemming Forsberg|215-955-4870|flemming.forsberg@jefferson.edu|
20227203|NCT03621956|Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
20227204|NCT05541939|Vogenx|Chief Scientific Officer|919-659-5677|info@vogenx.com|
20227205|NCT04789382|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20227206|NCT04980014|Takeda|Study Director|+1 877-825-3327|TrialDisclosures@takeda.com|
20227207|NCT02317991|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20227208|NCT04754646|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
20227209|NCT01460303|UMass Medical School|Dr. Michael K. Flynn||Michael.Flynn@umassmemorial.org|
20227210|NCT02962427|University of Colorado|Cristina Wood, MD|7208483323|cristina.wood@ucdenver.edu|
20227211|NCT02692586|Inari Medical|Ashleigh Willson|877-923-4747|ashleigh.willson@inarimedical.com|
20227212|NCT02880254|Baystate Medical Center|Rushika Conroy MD|413 794 5437|rushika.conroy@bhs.org|
20162996|NCT01564732|Duke University Medical Center|Dana Portenier, M.D.|919-470-7031|dana.portenier@duke.edu|
20209137|NCT05047601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209138|NCT04834375|Northwell Health|Dr. Stella Hahn|516-465-5400|sthahn@northwell.edu|
20227213|NCT04421040|Mayo Clinic|Dr. Grace Lin|507-255-1267|lin.grace@mayo.edu|
20227214|NCT02189668|Nationwide Children's Hospital|Peter Minneci|6147223066|peter.minneci@nationwidechildrens.org|
20227215|NCT03799614|Virginia Commonwealth University|Dr. Ingrid Pretzer-Aboff|804-828-3340|iaboff@vcu.edu|
20227216|NCT03316586|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-2335|Sara_Tolaney@dfci.harvard.edu|
20227217|NCT01053741|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)614-8762|ejfuchs@jhmi.edu|
20209139|NCT03026556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209140|NCT02924129|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
20209141|NCT03279731|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
20186045|NCT04783935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20186046|NCT01600222|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20186047|NCT02437318|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20186048|NCT05275842|Medical University of South Carolina|Cristina Lopez|843-792-2945|lopezcm@musc.edu|
20186049|NCT04419389|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20186050|NCT05493423|Hemotek Medical Inc|Chief Scientific Officer|7074942895|patrick@hemotekmedical.com|
20186051|NCT05086016|Renata Medical|Dali Alarian|8553184988|dali@renatamedical.com|6
20186052|NCT00920621|Brigham and Women's Hospital|Scott T. Weiss, MD, MS|617-525-2278|scott.weiss@channing.harvard.edu|
20209142|NCT02172820|The University of Vermont|Diann Gaalema, Ph.D., PI|802-656-9874|Diann.Gaalema@med.uvm.edu|
20209143|NCT01135368|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20209144|NCT01000311|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20209145|NCT00252499|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kristina.utzschneider@va.gov|
20209146|NCT01535638|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209147|NCT01365468|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20209148|NCT01482598|Abbott|Alessandra Denaro, Sr. Director Clinical Site Management||alessandra.denaro@abbott.com|
20209149|NCT00423267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20209150|NCT00827112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209151|NCT00515021|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
20209152|NCT03088345|Medical College of Wisconsin/Children's Hospital of Wisconsin|Dr. Amee Bigelow|5136364200|amee.bigelow@cchmc.org|
20209153|NCT01521494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20209154|NCT00689728|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209155|NCT01861587|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
20227218|NCT03407313|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
20227219|NCT01396083|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20227220|NCT00619827|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20227221|NCT00735709|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20227222|NCT02537951|Erasmus MC|Joost L.M. Jongen|+31107041415|j.jongen@erasmusmc.nl|
20227223|NCT03150082|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227224|NCT02119299|Scientific Intake|Richard P. Schneider|917-676-6251|rschneider@scientificintake.com|
20227225|NCT04110314|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20227226|NCT02326272|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20227227|NCT02196857|The University of Texas MD Anderson Cancer Center|Ravandi-Kashani,Farhad MD./Professor|713-745-0394|fravandi@mdanderson.org|
20227228|NCT05270980|NYU Langone Health|Dr. Joshua Chodosh|212-263-6768|Joshua.Chodosh@nyulangone.org|
20227229|NCT00735943|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227230|NCT02147613|Arizona State University - Downtown Phoenix Campus|Siddhartha S. Angadi, PhD., FACSM|6028272254|sangadi@asu.edu|
20227231|NCT00974311|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227232|NCT03131167|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20227233|NCT01164202|FFCD|Mrs Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20227234|NCT00643201|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20227235|NCT03760224|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
20227236|NCT01139996|Memorial University Medical Center|Imran Siddiqui, MD|912-350-8707|research2@memorialhealth.com|
20227237|NCT02276963|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
20227238|NCT02130999|Vince and Associates Clinical Research|Melodie Armstrong, MD, MPH|913-696-1601||
20227239|NCT03933449|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227240|NCT01158261|Ethicon, Inc|Director of Clinical Development|908-218-2492|jbatill2@its.jnj.com|
20227241|NCT02899065|UC Davis Medical Center|Larissa May, MD, MSHS, MSPH, Director of Emergency Medicine Innovation and External Partnerships|916-734-1593|lsmay@ucdavis.edu|
20209156|NCT00689299|Greer Laboratories, Inc. for Antigen Laboratories, Inc.|Mark Hites|828-759-7548|mhites@greerlabs.com|
20209157|NCT00758394|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20209158|NCT01197495|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20227242|NCT00971867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials.@bms.com|
20209159|NCT01002573|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
20227243|NCT00367003|Emory University|Dr. Patricio Riva Posse||privapo@emory.edu|
20227244|NCT02983045|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20192747|NCT03599622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20227245|NCT02533934|University of California San Francisco|Rodney Rogers|+14155951226|Rodney.Rogers@ucsf.edu|
20209160|NCT00617994|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
20209161|NCT00690612|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20209162|NCT02926833|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
20186053|NCT06074523|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
20209163|NCT01945866|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
20186054|NCT01426425|Medtronic|Jo Krueger, Senior Clinical Research Specialist|7635261551|jo.krueger@medtronic.com|
20186055|NCT03281291|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209164|NCT05040295|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186056|NCT04956861|University of Colorado|Christopher DeSouza Ph.D.|303-492-2988|desouzac@colorado.edu|
20186057|NCT04638309|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20209165|NCT01559649|Michael E. DeBakey VA Medical Center|Stephanie Daniels|713-743-2570|skdaniels@uh.edu|
20209166|NCT00346775|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209167|NCT02946515|University of Minnesota - Division of Epidemiology and Community Health|Dr. Nancy E. Sherwood, Associate Professor|612-625-4567|sherw005@umn.edu|
20209168|NCT02818582|National Institute of Allergy and Infectious Diseases|Higgs, Elizabeth|+1 301 768 3947|ehiggs@niaid.nih.gov|
20209169|NCT02196025|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
20209170|NCT00564876|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
20209171|NCT03039686|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20209172|NCT05981443|University of Kentucky|Dr. Cody Blanchard|859-323-5867|cody.blanchard@uky.edu|
20209173|NCT02087085|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20209174|NCT00635804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209175|NCT02680158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20209176|NCT03734601|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
20209177|NCT01512758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20209178|NCT01270139|Ural Institute of Cardiology|Dr. Alexander Kharlamov|0031627849118|drskharlamov@gmail.com|
20209179|NCT02452320|Weill Cornell Medicine|Farrell Cooke, Senior Research Assistant|212-746-2774|fac2010@med.cornell.edu|
20209180|NCT03382639|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20186058|NCT04237298|NUMalaysia|Dr Asma Ashari, Orthodontist and Senior Lecturer, Principal Investigator|+60192228440|asmaashari@ukm.edu.my|
20209181|NCT01072175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20209182|NCT02477215|Medical College of Wisconsin|Parameswaran Hari|414-805-4600|phari@mcw.edu|
20209183|NCT00285857|Stanford University|James M. Ford|(650) 498-6689|jmf@stanford.edu|
20209184|NCT00438815|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20209185|NCT02547064|Keimyung university|Hyun-Chang Kim|+821028862876|onidori1979@gmail.com|
20209186|NCT01811004|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20209187|NCT06104423|A.MENARINI I.F.R SrL|Simone Baldini Global Clinical Operations Manager|055 56801|sbaldini@menarini.it|
20209188|NCT05602818|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20209189|NCT00727246|University of Pittsburgh|Patricia M Arenth PhD|412-648-6666|arenpm@upmc.edu|
20209190|NCT03814499|Fondazione Telethon|Head of Clinical Development and Operations|+3902202217224|szancan@telethon.it|
20209191|NCT00334893|Memorial Sloan-Kettering Cancer Center|Dr. Martee L. Hensley|646-888-4222|hensleym@mskcc.org|
20209192|NCT01552408|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
20209193|NCT03223649|National Institutes of Health|Jack A. Yanovski, MD, PhD|3014960858|jy15i@nih.gov|
20209194|NCT02347345|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
20209195|NCT00596622|Indiana University School of Medicine|Amit Anand|3172747422|aanand@iupui.edu|
20209196|NCT01348828|Endologix|Sripad Bellary, Director Clinical Affairs|9257011628|sbellary@endologix.com|
20209197|NCT00545974|UCSF Memory and Aging Center|Dr. Adam L. Boxer|4154760668|aboxer@memory.ucsf.edu|
20227246|NCT00905424|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20227247|NCT00379899|Amgen Inc.|Study Director|866-572-6436||
20227248|NCT01922258|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
20227249|NCT05225389|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
20227250|NCT01585246|Michigan State University|Dr. Gwen Wyatt|517-884-4630|gwyatt@msu.edu|
20227251|NCT04552132|Saint Louis University|Dr. David Bingham|208-851-0618|davidbingham1623@gmail.com|
20227252|NCT01657162|Radius Health, Inc.|Radius Head of Clinical Operations|(617) 551-4700||
20186059|NCT02530671|University Kiel|Dr. Sonja Sälzer|00494315972810|saelzer@konspar.uni-kiel.de|
20227253|NCT01261390|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|sredline1@rics.bwh.harvard.edu|
20227254|NCT03421379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20227255|NCT01005576|Washington University School of Medicine|Dr. Shalini Shenoy|314-454-6018|shalinishenoy@wustl.edu|
20227256|NCT01497067|Alcon Research|Sr. Clinical Trial Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20186060|NCT02038569|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20209198|NCT02442284|AbbVie|Global Medical Services|800-633-9110||
20209199|NCT02815670|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209200|NCT03137173|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
20209201|NCT00842829|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20209202|NCT02127931|CogCubed|Monika Roots, MD|6122509737|monika.d.heller@gmail.com|
20209203|NCT01377194|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20209204|NCT00387621|Mayo Clinic|Dr Horng Chen|507-284-4343|chen.horng@mayo.edu|
20209205|NCT01190839|Janssen Pharmaceuticals|Strategic Lead Gastroenterology||ClinicalTrialDisclosure@its.jnj.com|
20209206|NCT02980211|University of Iowa College of Dentistry|Dr. Gustavo Avila-Ortiz, Professor and Chair, Department of Periodontics|3193357241|gustavo-avila@uiowa.edu|
20209207|NCT02993731|Sumitomo Dainippon Pharma Oncology|Cindy Oh|617-674-8628|coh@bostonbiomedical.com|
20209208|NCT00323479|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20209209|NCT01362062|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20209210|NCT04927858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0217|clinicaltriage.rdg@boehringer-ingelheim.com|
20209211|NCT02545504|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20209212|NCT00967343|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@Kiadis.com|
20209213|NCT00950755|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209214|NCT02549040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209215|NCT00508820|Amgen Inc.|Study Director|866-572-6436||
20209216|NCT02195349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209217|NCT04398030|Capillary BioMedical, Inc.|Alayne Lehman Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
20209218|NCT03503565|KYUNG HEE UNIVERSITY HOSPITAL AT GANGDONG|Dr Hyungseok Seo|+821029306885|seohyungseok@gmail.com|
20209219|NCT02713490|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20209220|NCT01054209|Brighton and Sussex University Hospitals Trust|Dr Mark Harper|01273696955|mark.harper@bsuh.nhs.uk|4307
20209221|NCT03044691|Unversity of Florida|Assistant Professor|(352) 294-4997|rsalloum@ufl.edu|
20209222|NCT00548340|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
20209223|NCT01096017|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20209224|NCT02600559|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20209225|NCT03410693|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20209226|NCT01789476|Cara Therapeutics, Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|(203) 567-1502|fmenzaghi@caratherapeutics.com|
20209227|NCT00953576|Beth Israel Deaconess Medical Center|Glenn Bubley, MD||gbubley@bidmc.harvard.edu|
20209228|NCT00501969|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20209229|NCT02965027|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
20209230|NCT00665366|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20209231|NCT02582216|Hôpital Erasme|Dominique Mouraux|+32/2.555.38.48|dmouraux@ulb.ac.be|
20209232|NCT03778021|University of Washington, Department of Epidemiology|Shirley A.A. Beresford, Principal Investigator|206 543 9512|beresfrd@uw.edu|
20209233|NCT01545375|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209234|NCT02687815|University of Pittsburgh|Dr. Juan Celedón|(412) 692-8429|juan.celedon@chp.edu|
20209235|NCT04177862|University of Minnesota|Dr. Jonah Pearson|218-280-8348|pears731@umn.edu|1
20186061|NCT03126019|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20209236|NCT02558634|Vancouver Coastal Health Research Association|Amanda Chisholm, Manager, Internal Awards|6048754111|amanda.chisholm@vch.ca|21696
20209237|NCT03814824|Northwell Health|Dr. Arvind Trindade|516-387-3990|atrindade@northwell.edu|
20209238|NCT05637515|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5302
20209239|NCT00151775|Daiichi Sankyo|Howard Kessler, Senior Director Regulatory Operations|732-590-5032|hmkessler@dsi.com|
20209240|NCT04516291|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209241|NCT02158949|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
20209242|NCT02145949|University of Oregon|Dr. Hans Dreyer|541-346-3902|hcdreyer@uoregon.edu|
20209243|NCT04250558|Dartmouth Hitchcock Medical Center|Dr. Ida Leah Gitajn|(603) 650-5133|ida.leah.gitajn@hitchcock.org|
20209244|NCT04812678|FasciaFrance|Dr Bertrand|+33682308609|isa.bertrand.cerap@gmail.com|
20209245|NCT01793610|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20209246|NCT01513538|Medtronic|Céline This|33 6 89 71 90 67|celine.this@medtronic.com|
20209247|NCT02702115|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
20209248|NCT03927209|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209249|NCT01161173|Hoffman-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20209250|NCT00792467|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
20209251|NCT00351611|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186062|NCT02891096|Swiss Paraplegic Research|Dr Gabi Mueller|+41419395563|gabi.mueller@paraplegie.ch|
20186063|NCT00170573|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
20186064|NCT04556656|Prilenia|Prilenia|+972 775558|info@prilenia.com|
20186065|NCT04541706|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186066|NCT05722704|Gulf Medical University|Dr. Rania Zaarour|+971 6 7431333|dr.rania@gmu.ac.ae|4184
20186067|NCT03498651|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
20209252|NCT02046993|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
20209253|NCT00598442|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20209254|NCT05375942|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186068|NCT05563246|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20186069|NCT01566695|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20186070|NCT03763708|Medtronic Neuromodulation|SCS Research Study Team|800-633-8766|rs.scsresearch@medtronic.com|
20186071|NCT05134636|University of Pennsylvania|Ronac Mamtani|215-662-7606|ronac.mamtani@pennmedicine.upenn.edu|
20186072|NCT03662607|Spectrum Health|Dr. Ryan Madder|6163916660|stephen.orey@corewellhealth.org|
20186073|NCT04294225|Mayo Clinic|Tufia C Haddad MD|507/284-2511|Haddad.Tufia@mayo.edu|
20186074|NCT01525966|City of Hope Medical Center|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
20186075|NCT04453592|FIFA|Dr Andreas Serner|+41796253899|andreas.serner@fifa.org|
20186076|NCT01331005|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
20209255|NCT04620356|kimberlyClark|Clinical Science Manager|+55 11 45034500|debora.rodrigues@kcc.com|
20186077|NCT03016169|Abbott|Karine Miquel, Associate Director of Project Management|+32 479 600 107|karine.miquel@abbott.com|
20209256|NCT00822185|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20186078|NCT01212029|National Institute of Child Health and Human Development|Dr. Amir Gandjbakhche|2402742949|gandjbaa@mail.nih.gov|
20209257|NCT00457951|Chimerix|Zahra Masoud|763-300-0559|zmasoud@chimerix.com|
20186079|NCT03131648|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
20209258|NCT03781167|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20209259|NCT00462501|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
20186080|NCT03973320|Hospital for Special Surgery, Anesthesiology|Dr. Jiabin Liu|2126061036|liuji@hss.edu|
20227257|NCT03771963|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20186081|NCT02496780|University of Minnesota|Antoinette Moran|612-624-5409|moran001@umn.edu|
20209260|NCT03740152|Massachusetts General Hospital|Dr. Paolo Cassano, M.D.|617-643-9622|pcassano@mgh.harvard.edu|
20227258|NCT03066830|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
20227259|NCT00691652|OHSU Knight Cancer Institute|Dr. Craig Okada|503-494-1080|Okadac@ohsu.edu|
20227260|NCT04888494|Northwestern University|A. Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
20227261|NCT03430856|Biocon Research limited|Dr. Subramanian L|080-28082808|subramanian.l101@biocon.com|1323
20227262|NCT01900847|University of Arizona|Jaiva Larsen|5039396612|jlarsen@aemrc.arizona.edu|
20227263|NCT02002871|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
20227264|NCT00565604|Lake Washington Vascular Surgery|Daniel Pepper, MD|(425) 453-1772||
20227265|NCT00395993|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20227266|NCT01051921|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|(858) 457- 7227|MHuyghe@conatuspharma.com|
20227267|NCT01001429|Rutgers New Jersey Medical School|Anuradha Patel, MD|973 972-1886|patelan@njms.rutgers.edu|
20227268|NCT01491022|University of Miami|Dr Corneliu Luca|3052432235|cluca@med.miami.edu|
20227269|NCT03934216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20227270|NCT01063855|Janssen Research & Development, LLC|CDTL, Cardiovascular and Metabolism|1 908 704-4648||
20227271|NCT01165307|Mayo Clinic|Dr. Abimbola O. Famuyide|507-284-7035|Famuyide.Abimbola@mayo.edu|
20227272|NCT01126099|VA Puget Sound|Lucy Wang|206-277-5089|wanglucy@u.washington.edu|
20227273|NCT02472730|Baylor College of Medicine|Dr. Kalpesh K. Patel|7137980947|kalpeshp@bcm.edu|
20227274|NCT03627832|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
20227275|NCT01950299|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
20227276|NCT02787499|Massachusetts General Hospital/Harvard Medical School|Mark Siedner|6177264686|msiedner@mgh.harvard.edu|
20227277|NCT00048035|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20227278|NCT05137717|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20227279|NCT02619617|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20227280|NCT04685993|Lipocine Inc|Senior Director of Clinical Development|801.994.7383|admin@lipocine.com|
20227281|NCT00509899|Incyte Corporation|Study Director|1-855-463-3463||
20186082|NCT03400059|Chordate Medical AB|Dr Jan Hermansson|+46 8 400 115 86|jan.hermansson@chordate.com|
20227282|NCT04658797|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
20227283|NCT02946892|UTSW|Ryan Butts|2144565822|ryan.butts@utsouthwestern.edu|
20227284|NCT01711983|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
20227285|NCT00737100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20227286|NCT00500578|UT MD Anderson Cancer Center|Roy F Chemaly, MD/MPH, MBA /Associate Professor|713-745-1116|rfchemaly@mdanderson.org|
20227287|NCT03713684|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20227288|NCT00528424|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20227289|NCT02595502|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S., F.A.A.O - Senrior Principal Research Optometrist|904-443-1290|BPALL@its.jnj.com|
20186083|NCT04150718|University of Pennsylvania|Dr. Jennifer Goldschmied|215-573-2774|jrgolds2@pennmedicine.upenn.edu|
20186084|NCT05285618|University of California, Santa Barbara|Michael Beyeler|(805) 893-4321|mbeyeler@ucsb.edu|
20186085|NCT06069713|Wake Forest University Health Sciences|Olivia Horton MSW, MPH|000.000.0000|ohorton@wakehealth.edu|
20186086|NCT03094663|Hospital for Special Surgery, Anesthesiology|Dr. David Kim|2126061036|kimd@hss.edu|
20209261|NCT00679354|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20227290|NCT03286218|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
20227291|NCT00458003|Northwestern University|Paul Fitzgerald|312-6951064|p-fitzgerald2@northwestern.edu|
20209262|NCT00408408|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20186087|NCT02167867|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20209263|NCT01636102|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20209264|NCT03724552|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
20209265|NCT05600101|Dana-Farber Cancer Institute|Dr. Gregory Abel|(877) 442-3324|Gregory_Abel@dfci.harvard.edu|
20209266|NCT03947333|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
20209267|NCT00267202|Novartis Pharmaceuticals|Clinical Director|862-778-1768|maria.figliomeni@novartis.com|
20209268|NCT00399542|Sucampo Pharmaceuticals, Inc.|Raymond Panas, PhD|301-961-3400|info@sucampo.com|
20209269|NCT00612456|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209270|NCT00808665|Vanderbilt University Medical Center|James Blair DO|615-343-6082|james.l.blair@vanderbilt.edu|
20209271|NCT01757821|University of Minnesota|James Carey|612-626-2746|carey007@umn.edu|
20209272|NCT03831282|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20209273|NCT01258803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20209274|NCT00920582|Provention Bio, Inc.|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
20209275|NCT05227404|University of Minnesota|Eileen Denning|612-626-8049|edenning@umn.edu|
20209276|NCT03360695|Massachusetts General Hospital|Kelly Irwin, MD, MPH|617-643-4453|kirwin1@partners.org|
20209277|NCT00556140|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
20209278|NCT05146999|Galderma Research & Development, LLC|Felipe Weinberg, MD, MPH|817-961-5000|aestheticclinicaltrials@galderma.com|
20209279|NCT03319160|Zoll|Mike Osz|412-968-3333|mosz@zoll.com|
20209280|NCT03604159|NYU Langone|Dr. Joshua Lee|646-501-3552|Joshua.Lee@nyulangone.org|
20209281|NCT00851721|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20209282|NCT00665002|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey E. Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
20209283|NCT04533204|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
20209284|NCT00383292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209285|NCT00697255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209286|NCT01005355|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209287|NCT03570658|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20209288|NCT01333501|Novartis Pharmaceuticals|Study Director|862-778-8300||
20209289|NCT04246996|Dell Medical School at The University of Texas at Austin|Mary Rieger, MD, MAS|512-324-7036|mary.rieger@austin.utexas.edu|
20227292|NCT06331507|University of Michigan|Prachi Agarwal|734-232-5132|prachia@med.umich.edu|
20227293|NCT01687114|Tufts University|Oliver Chen|617-5563128|oliver.chen@tufts.edu|
20227294|NCT01278342|Novartis Pharmaceuticals|Study Director|862-778-8300||
20227295|NCT03871153|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20227296|NCT01039467|Fuwai Hospital|Dr. Shu Zhang|861088398833|zsfuwai@vip.163.com|
20227297|NCT04742673|Vanderbilt University Medical Center|Christopher Hughes|615-322-5000|christopher.hughes@vumc.org|
20227298|NCT06290089|Scandinavian Biopharma Holding AB / Etvax|Head of Clinical Development|004684705600|info@scandinavianbiopharma.se|
20227299|NCT04073303|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
20227300|NCT01368263|Washington University School of Medicine|Timothy Pluard, M.D.|314-362-5645|tpluard@saint-lukes.org|
20227301|NCT03107208|"University of Colorado Denver | Anschutz"|Rebecca Ohman, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20227302|NCT00426764|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20227303|NCT04786691|University of Arkansas for Medical Sciences|Jessica Yeh|(501) 686-6114|jyeh@uams.edu|
20227304|NCT01871077|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|drricardollamas@gmail.com|1259
20186088|NCT04882449|Bodyport Inc.|Dorothy Kwok, Head of Clinical Operations|669-240-3077|dorothy@bodyport.com|
20227305|NCT00096538|Memorial Sloan Kettering Cancer Center|Dr. Ariela Noy|212-639-7423|noya@mskcc.org|
20227306|NCT01211756|UCSD|David Feifel||dfeifel@kadimanp.com|
20227307|NCT02686164|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20227308|NCT01691378|Rocky Mountain MIRECC|Lisa Brenner|720-723-6488|lisa.brenner@va.gov|
20227309|NCT02465164|Central Clinical Trials Office|Central Clinical Trials Office|3139537454|smarl1@hfhs.org|
20227310|NCT02324361|Partners Healthcare|Study Project Manager|4259856430|szan@mail.harvard.edu|
20227311|NCT01377636|New York University Langone Medical Center, Anesthesiology|Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services|212-263-5072|Patrick.Linton@nyumc.org|
20227312|NCT03030625|Hospital Universitario de La Princesa|Dr. Almudena Zapatero Laborda|+34 915 20 22 00|almudena.zapatero@salud.madrid.org|
20227313|NCT02223351|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20227314|NCT00003471|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20227315|NCT00715403|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20227316|NCT02371876|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20227317|NCT01815502|MUSC|Dr. Andrew M Atz|843-876-1698|atzam@musc.edu|
20227318|NCT04235504|Medtronic Diabetes|Javier Castaneda|+31 433566566|javier.castaneda@medtronic.com|
20227319|NCT00870467|Abbott|Global Medical Services|800-633-9110||
20209290|NCT04047342|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
20186089|NCT01416831|Earle A. Chiles Research Institute, Providence Cancer Institute|Brendan Curti, M.D.|503-215-6588|brendan.curti@providence.org|
20209291|NCT00280059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209292|NCT01212627|Brown University Oncology Research Group (BrUOG)|Angela Taber, MD|4018633000|kayla_rosati@brown.edu|
20209293|NCT00765726|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209294|NCT01674010|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20209295|NCT03159455|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209296|NCT05056311|Indiana University|Elaine Cuevas|317-278-7495|elinder@iu.edu|
20209297|NCT02641691|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
20209298|NCT03799198|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20209299|NCT00960869|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
20209300|NCT01714726|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20209301|NCT02501642|James A. Haley VA|Tracy Kretzmer, Ph.D.|813-972-2000|tracy.kretzmer@va.gov|5729
20209302|NCT01358266|Santen Inc.|Clinical Operations|+1-415-268-9100|clinicaltrials@santen.com|
20209303|NCT01710007|Orient Europharma Co., Ltd.|Vivian Lu|+886-2-2755-4881|Vivian.Lu@oppharma.com|2958
20209304|NCT01153971|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20209305|NCT03628781|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|15136368296|jeff.epstein@cchmc.org|
20209306|NCT00994123|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20209307|NCT00679042|CellTrans Inc.|Jennifer Cook|312-413-7727|jenny@celltransinc.com|
20209308|NCT00379639|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20209309|NCT03053102|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20209310|NCT01798056|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209311|NCT00835861|Maternal-Fetal Medicine and Obstetrics at UT Southwestern|M. Ashley Hickman Zink|469-303-3591|m.ashley.hickman@gmail.com|
20209312|NCT01238861|MedImmune, LLC|Rene van der Merwe, MBChB, MFPM, Medical Officer|301-398-0000|vandermerwer@medimmune.com|
20209313|NCT01269346|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20209314|NCT00247416|University of Kentucky Markey Cancer Center|Suzane Arnold, MD|859 323 8043|smarno0@uky.edu|
20209315|NCT01778296|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
20227320|NCT00101868|University of Illinois|James F. Graumlich, MD, Professor of Medicine|309-655-7734|jfg@uic.edu|
20227321|NCT03839394|Duke University|Nwora Lance Okeke, MD, MPH|919-684-2579|lance.okeke@duke.edu|
20162997|NCT01036321|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
20162998|NCT00381693|Mayo Clinic|Dr. Ruben A. Mesa|507-284-3533|mesa.ruben@mayo.edu|4-3533
20227322|NCT04001803|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227323|NCT01733745|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20227324|NCT01931397|Oregon Health & Science University|Dr. Amira Al-Uzri , Professor of Pediatrics|503-494-6956|aluzria@ohsu.edu|
20227325|NCT02472262|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manarymj@wustl.edu|
20227326|NCT02329327|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20227327|NCT02493517|Ipsen|Medical Director, Oncology||clinical.trials@ipsen.com|
20227328|NCT01367249|Bausch & Lomb Incorporated|James Gow|949-788-6000|james.gow@bausch.com|
20227329|NCT03718429|University of Florida|Dominick Angiolillo, MD,PhD|904-244-3378|dominick.angiolillo@jax.ufl.edu|
20227330|NCT05404711|University of Pittsburgh School of Medicine|Mary Ellen Vajravelu, MD,MSHP|412-692-6533|vajravelume@upmc.edu|
20227331|NCT02346877|Amgen Inc.|Study Director|866-572-6436||
20227332|NCT01817075|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20227333|NCT00816777|Generic Devices Consulting, Inc|John Greenbaum|772-353-5301|genericd@bellsouth.net|
20227334|NCT06236113|North Memorial Health Robbinsdale Hospital|Michaela A West, MD, PhD|763-581-3704|Michaela.West@NorthMemorial.com|
20227335|NCT00962078|Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany|Dr. Rainer Gloeckl|+49 8652 931630|rgloeckl@schoen-klinik.de|
20227336|NCT01395810|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20227337|NCT04940156|Oxford University Hospitals NHS Trust|Dr Richard Varini|01865220256|richard.varini@ouh.nhs.uk|
20227338|NCT03877224|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
20227339|NCT03143257|Medtronic Xomed|Sr Manager, Clinical Affairs|904-296-9600|rs.entgm@medtronic.com|
20227340|NCT01095497|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20227341|NCT02492802|University Medical Center Groningen|Jan-Willem Alffenaar, PhD|+31503614035|j.w.c.alffenaar@umcg.nl|
20227342|NCT03234036|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227343|NCT02163395|Clinical Research|Intsitut Straumann AG|0041619651111|research@straumann.com|
20162999|NCT02553395|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
20163000|NCT02003534|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20163001|NCT02546492|University of MAryland sSchool of Medicine|A Haririan|410-328-5720|ahariria@som.umaryland.edu|
20186090|NCT02897531|Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital|Sung-Bum Kang, MD, PhD|+82-031-787-7093|kangsb@snubh.org|
20186091|NCT04784559|PharmaMar|Clinical Development Virology Business Unit|+34 918466000|virologytrials@pharmamar.com|
20186092|NCT05974046|Clinical Development|Global Director|(804) 594-4488|trialdisclosure@indivior.com|
20186093|NCT03138512|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20209316|NCT04963231|Rhythm Clinical Trials|Rhythm Pharmaceuticals, Inc.|857-264-4280|clinicaltrials@rhythmtx.com|
20209317|NCT01059175|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
20209318|NCT02957149|Mayo Clinic|Matthew Gettman, MD|507-284-3249|Gettman.Matthew@mayo.edu|
20209319|NCT04550234|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20209320|NCT01097057|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20209321|NCT01827462|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20209322|NCT03198559|University of Melbourne|Professor Sharon Lewin|+61 (0)3 8344 3309|sharon.lewin@unimelb.edu.au|
20209323|NCT03737812|AbbVie|Global Medical Services|800-699-9110|abbvieclinicaltrials@abbvie.com|
20209324|NCT02624713|Tel-Hai College|Prof. Moria Golan|972547240330|moria.golan@mail.huji.ac.il|
20209325|NCT06304064|Capricor Inc.|Study Director|858-727-1755|mawadalla@capricor.com|
20209326|NCT04140942|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
20209327|NCT01911546|Former: Cedars-Sinai Medical Center, Comprehensive Transplant Center|Dr. Joseph Kahwaji, MD, MPH|310-423-2641|joseph.m.kahwaji@kp.org|
20209328|NCT03693846|University of Pennsylvania|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
20209329|NCT01407068|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20209330|NCT01100931|National Cancer Institute, National Institutes of Health|Dr. Giuseppe Giaccone|301-496-4916|giacconeg@mail.nih.gov|
20209331|NCT01474291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20209332|NCT03471507|Duke University Medical Center|Lance Roy, M.D.|919-684-8111|lance.roy@duke.edu|
20209333|NCT02213666|Beth Israel Deaconess Medical Center|Elad Anter, MD|617-632-9209|eanter@bidmc.harvard.edu|
20209334|NCT01399619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209335|NCT00750061|China Spinal Cord Injury Network|Dr. Wendy Cheng|+852 28660829|wendycheng@chinasci.net|
20209336|NCT03661346|University of Texas Medical Branch - Galveston|Dr. Mohamad Chaaban|281-338-0829|mrchaaba@UTMB.EDU|
20209337|NCT01388946|Aretaieo Hospital University of Athens|Argyro Fassoulaki|+30 6936701333|fassoula@aretaieio.uoa.gr|
20227344|NCT01099358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227345|NCT00165503|Brigham and Women's Hospital|Dr. David Sugarbaker|617-732-5004|dsugarbaker@partners.org|
20227346|NCT02346708|University of Colorado Denver - Anschutz Medical Campus|Isabelle Buard, PhD|(303)724-5973|Isabelle.Buard@cuanschutz.edu|
20227347|NCT02976519|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20227348|NCT03416270|University Health Network|Dr. David Cherney|416.340.4151|david.cherney@uhn.ca|
20227349|NCT00928434|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20227350|NCT05439421|Wake Forest University Health Sciences|Erin L. Sutfin, PhD|336.713.5282|esutfin@wakehealth.edu|
20227351|NCT01477762|Emory University|Dr. Tanja Jovanovic|(404) 778-1485|tjovano@emory.edu|
20227352|NCT02154139|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20227353|NCT00473655|AstraZeneca|Gerard Lynch|09645895|aztrial_results_posting@astrazeneca.com|44 15
20227354|NCT00848016|Mayo Clinic Cancer Center|Michael E. Menefee, M.D.||menefee.michael@mayo.edu|
20227355|NCT02087774|Marshall University|Rebecca Hayes, M.D.|3046173570|hayes79@live.marshall.edu|
20227356|NCT02076100|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227357|NCT00243919|Duke University|Pamela W. Duncan, PT, PhD, FAHA, FAPTA|919-681-2060|pamela.duncan@duke.edu|
20227358|NCT00496340|H. Lee Moffitt Cancer Center and Research Institute|Marcie Riches, MD|813-745-6284|marcie.riches@moffitt.org|
20227359|NCT04176939|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227360|NCT03250689|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227361|NCT02157519|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
20227362|NCT01656395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227363|NCT02318849|University of Hawaii|Cheryl Albright, PhD, Prinicipal Investigator|808-956-9716|cherylal@hawaii.edu|
20227364|NCT04919317|Temple University Hospital|George Taylor, MD, MS; surgical resident|2678150512|George.Taylor@tuhs.temple.edu|
20227365|NCT00230048|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
20227366|NCT02389959|Stanford University|Peter H. Hwang, MD|(650) 723-5281|hwangph@stanford.edu|
20227367|NCT00676403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20227368|NCT00297648|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20227369|NCT03225170|NHGRI|Dr. Lori Erby|301-443-2635|lori.erby@nih.gov|
20209338|NCT00538434|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
20209339|NCT04337827|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223-8100|TaussigResearch@ccf.org|
20209340|NCT04491955|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20227370|NCT02048722|Northwestern University|Mary Mulcahy, MD|312 695 4440|m-mulcahy@northwestern.edu|
20227371|NCT01575080|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20227372|NCT05209880|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|6175257771|kouchi@bwh.harvard.edu|
20192748|NCT01818427|University of Pittsburgh|Dr. Jason Sperry|412 6922850|sperryjl@upmc.edu|
20227373|NCT03437694|University of North Texas Health Science Center|Crystal Hodge|8177350131|crystal.hodge@unthsc.edu|
20227374|NCT01982695|Nationwide Children's Hopsital|Dr. Jerry R. Mendell|(614) 722-5615|Jerry.Mendell@NationwideChildrens.org|
20227375|NCT05635045|Columbia University Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
20227376|NCT05044429|GWUniversity|Principal Investigator|202-823-4259|eheinz@mfa.gwu.edu|
20192749|NCT01278615|University of Chicago|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
20227377|NCT03675360|Tulane University School of Public Health and Tropical Medicine|Dr. Kirsten Dorans, Assistant Professor, Department of Epidemiology|15049880883|kdorans@tulane.edu|
20227378|NCT03143101|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
20227379|NCT05227118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227380|NCT01435759|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20227381|NCT02541864|Kaohsiung Veterans General Hospital|Dr. Feng-Woei Tsay|+886-7-3422121|fwchaie@vghks.gov.tw|8233
20227382|NCT03727841|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
20227383|NCT03126786|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20227384|NCT01601496|Getinge Group|Elizabeth Bulger|603 880 1433 ext 5368|Elizabeth.Bulger@getinge.com|
20227385|NCT03243305|Evofem, Inc.|Chief Medical Officer|858 550 1900|kculwell@evofem.com|
20227386|NCT02689804|Columbia University|Carolyn L. Westhoff, MD|212-305-4805|clw3@columbia.edu|
20227387|NCT00227539|University of Washington|Renato G. Martins|206-288-6680|rgmart@uw.edu|
20227388|NCT01655719|University of Michigan|Tim Muth|734-615-8914|tmuth@med.umich.edu|
20227389|NCT00673257|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20227390|NCT01569126|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227391|NCT01166750|University of Kansas Medical Center|Michael A. Rapoff, PhD., Principal Investigator|913-588-6323|mrapoff@kumc.edu|
20227392|NCT04396626|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227393|NCT00289094|DePuy Orthopaedics, Inc.|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
20227394|NCT02417753|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@nih.gov|
20227395|NCT03113968|Department of Psychiatry, Mass General Brigham, and Harvard Medical School|Dr. Amit Anand|6177266421|aanand7@bwh.harvard.edu|
20209341|NCT00892710|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20227396|NCT04805671|INVIVYD, Inc.|Study Inquiry|+1 781-819-0080|ClinicalTrials@invivyd.com|
20227397|NCT01387178|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209342|NCT00638820|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20209343|NCT02951143|University of Kentucky|Mikhail Koffarnus|8593236402|koffarnus@uky.edu|
20209344|NCT01590628|Gamida Cell|Kelly Myers, CRA|026595631|kelly@gamida-cell.com|
20209345|NCT00229931|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6307|sonny-icks@dmei.org|
20209346|NCT00475657|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20209347|NCT02992743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209348|NCT00398476|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209349|NCT00998166|Columbia University|Mark Stoopler, MD|212-305-8230|mbs5@cumc.columbia.edu|
20209350|NCT01353976|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
20209351|NCT02354599|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20209352|NCT04806334|Cedars-Sinai Medical Center|Charles J Rosser, MD|310-423-3723|Charles.rosser@cshs.org|
20209353|NCT00660829|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20209354|NCT03590613|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209355|NCT04369742|NYU Langone Health|Mark Mulligan, MD|(212) 263-5182|Mark.mulligan@nyulangone.org|
20209356|NCT02984228|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
20209357|NCT00495794|VA Center for Clinical Management Research; University of Michigan|Dr. Michele Heisler|734-845-3504|mheisler@umich.edu|
20209358|NCT01130831|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20209359|NCT00951912|the First Affiliated Hospital of Sun Yat-sen University|Dr. Yan-bin Ye|8620-87755766|yanbinye72@163.com|8179
20209360|NCT02173158|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
20209361|NCT01728454|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20209362|NCT01832753|The Children's Hospital of Philadelphia|Andrea Kelly, MD MSCE|215-590-3174|kellya@email.chop.edu|43174
20209363|NCT03077646|Children's Hospital at Montefiore|Alyssa Silver, MD|718-741-2304|alysilve@montefiore.org|
20227398|NCT02111174|Johns Hopkins SKCCC|Thomas Smith, M.D.|410-955-2091|tsmit136@jhmi.edu|
20209364|NCT02058966|Veterans Affairs Portland Healthcare System|Dr. William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
20209365|NCT01265511|Scynexis|Katyna Borroto-Esoda|9192374431|katyna.borroto-esoda@scynexis.com|
20209366|NCT03014700|Stanford university School of Medicine|Glyn David Williams|650-723-5728|jumbo@stanford.edu|
20163002|NCT03920254|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20209367|NCT01272245|UT MD Anderson Cancer Center|Kantarjian,Hagop M|713-792-7026|CR_Study_Registration@mdanderson.org|
20209368|NCT03461705|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
20192750|NCT00905359|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20192751|NCT02138253|Conatus Pharmaceuticals, Inc.|Steven Mento, Ph.D., CEO|858-376-2622|smento@conatuspharma.com|
20209369|NCT03044730|Northwestern University, Feinberg School of Medicine|William John Gradishar, MD, FACP, FASCO|(312) 695-4541|w-gradishar@northwestern.edu|
20227399|NCT00901342|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
20186094|NCT05200247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209370|NCT01716221|University of Colorado|Dr. Olga Klepitskaya|303-724-8984|olga.klepitskaya@ucdenver.edu|
20209371|NCT01018680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209372|NCT02930889|University of Minnesota|Jafar Golzarian, MD|612-626-5566|jafar@umn.edu|
20209373|NCT01206296|MedStar Health Research Institute|Director of Clinical Trials|301-560-7300|Research@MedStar.Net|
20209374|NCT01520038|University of Pennsylvania|John Christodouleas, MD|215-662-6568|christojo@uphs.upenn.edu|
20209375|NCT03427931|University of Virginia|Sue Brown, MD|4349820602|sab2f@virginia.edu|
20209376|NCT01846442|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20209377|NCT01685320|Campus Bio-medico University|Prof. Massimiliano Carassiti|+39-06-225411952|m.carassiti@unicampus.it|
20209378|NCT02477319|Seattle Children's Hospital|Umer Khan (Principal Biostatistician)|206-884-7516|umer.khan@seattlechildrens.org|
20209379|NCT01008059|Washington University|Evan D. Kharasch, MD PhD|314-362-8796|kharasch@wustl.edu|
20209380|NCT00474994|Memorial Sloan Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|KeohanM@mskcc.org|
20209381|NCT02660489|Imperial College London|Professor Sebastian Johnston|+44 (0)20 7594 3764|s.johnston@imperial.ac.uk|
20209382|NCT00278473|Icahn School of Medicine at Mount Sinai|Dr. Mary V. Solanto|212-241-5420|Mary.Solanto@mssm.edu|
20227400|NCT02849587|University of California, San Diego; Center for Medicinal Cannabis Research|Thomas D. Marcotte, Phd|619-543-5044|tmarcotte@ucsd.edu|
20227401|NCT00687908|Galderma|Clinical Project Manager|+33 492 95 29 21|jean-charles.dhuin@galderma.com|
20227402|NCT03380377|Cedars Sinai Medical Center|Stan Jordan, MD|3104232641|stan.jordan@cshs.org|
20227403|NCT02716779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20227404|NCT00910845|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20227405|NCT02600923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227406|NCT00792909|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227407|NCT04865029|Tulane University|Franck Mauvais-Jarvis|504-259-1139|fmauvais@tulane.edu|
20227408|NCT01431339|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatx.com|
20227409|NCT01481558|University of Sao Paulo|Claudia Kimie Suemoto|551130618249|cksuemoto@usp.br|
20227410|NCT00689338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227411|NCT00808067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20227412|NCT03571724|22nd Century Group, Inc.|Karen E. Delaney|716-270-1523|kdelaney@xxiicentury.com|
20227413|NCT00735007|Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany|Elisabetta Verdun di Cantogno|+41 22 414 4887|elisabetta.verdun@merckserono.net|
20227414|NCT02104895|Radiation-Oncology Unit, AOU Careggi, Florence University, Florence, Italy|Dr. Icro Meattini|+39055794|icro.meattini@unifi.it|7719
20227415|NCT02249104|Galderma Laboratories L.P.|Dr. Jay Mashburn|817 961 5027|jay.mashburn@galderma.com|
20227416|NCT01683604|HoffmannLaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20227417|NCT02481050|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20227418|NCT01228591|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
20227419|NCT01095835|Hoffmann-La Roche|Medical Communications|800-821-8590||
20227420|NCT03110354|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20227421|NCT01298700|Allergan, Inc|Michael Robinson, MD|714-246-4500|clinicaltrials@allergan.com|
20227422|NCT04006145|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
20227423|NCT01053156|MIND Institute, University of California Davis Medical Center|Randi J. Hagerman MD, Medical Director of the MIND Institute|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
20227424|NCT00010257|ECOG Statistical Office|Study Statistician|617-632-3012||
20227425|NCT02063672|Lutonix|Heidi Ronhovde|7634632900|heidi.ronhovde@crbard.com|
20227426|NCT00313729|UCSF Neuro-Oncology|Susan Chang MD|415-353-2966|Susan.Chang@ucsf.edu|
20227427|NCT01965327|Children's Hospital of Philadelphia|David Lynch, MD, PhD|215-590-1719|lynch@email.chop.edu|
20227428|NCT02498678|Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo|Dr. Ricardo Vieira Carlos|55-11-99911-6677|ricardovieirac@gmail.com|
20227429|NCT01145482|The University of Texas at Austin|Dr. Andreana Haley|512-232-0863|haley@psy.utexas.edu|
20227430|NCT02067858|University of Pittsburgh|Karen Holeva|412-623-1275|holevakd@upmc.edu|
20227431|NCT01959113|University of California, San Diego|Director of Clinical Trials Unit|858-657-8390|dermstudies@ucsd.edu|
20186095|NCT05323084|Pennington Biomedical Research Institute|Prachi Singh|15072068331|prachi.singh@pbrc.edu|
20186096|NCT04382404|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
20186097|NCT03420833|Mayo Clinic|Dr. Yong-Mei Cha|507-255-0774|ycha@mayo.edu|
20186098|NCT05102409|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20186099|NCT04951492|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
20186100|NCT01809691|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
20186101|NCT01580488|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20186102|NCT05470517|Johns Hopkins All Children's Hospital|Nicole M. Chandler, MD|727-767-4170|nicole.chandler@jhmi.edu|
20186103|NCT02682342|Medical College of Wisconsin|Michael E. Widlansky, MD|414-955-6708|mwidlans@mcw.edu|
20192752|NCT01918371|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20192753|NCT01006889|University of Florida|Dr. Kenneth Cusi|352-273-8661|kcusi@ufl.edu|
20186104|NCT05868772|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
20209383|NCT00721513|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
20227432|NCT02452047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227433|NCT01868646|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20227434|NCT02735980|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20227435|NCT01854697|AbbVie|Global Medical Information|800-633-9110||
20227436|NCT02539992|Stryker European Operations BV|Dr. Eric Garling, Director Medical & Scientific Affairs Europe|+31 20 219 2660|eric.garling@stryker.com|
20227437|NCT04033146|Georgia Insitute of Technology|Dr. Gregory S. Sawicki; Professor Mechanical Engineering|919 448 5099|gregory.sawicki@me.gatech.edu|
20227438|NCT01607593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227439|NCT04428385|Duke University|Wendy Prudhomme - O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
20227440|NCT02515630|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227441|NCT00483652|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|(914) 347-4300|ablight@acorda.com|102
20227442|NCT00891813|Abbott|Global Medical Services|1-800-633-9110||
20227443|NCT04474483|University at Buffalo, SUNY|Sanjay Sethi MD|7168884864|ssethi@buffalo.edu|
20227444|NCT02513550|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227445|NCT00685516|UCLA|Susanne Henning, Ph.D., Principal Investigator|310-825-9345|shenning@mednet.ucla.edu|
20227446|NCT00597818|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20227447|NCT02869789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20227448|NCT03506048|Emory University|Dr. Taofeek Owonikoko|412-647-9975|owonikokotk2@upmc.edu|
20227449|NCT01529606|UTHSC|Professor|901-448-2369|lhong2@uthsc.edu|
20209384|NCT01700907|Sapporo Medical University School of Medicine|Michiaki Yamakage|+81116112111|yamakage@sapmed.ac.jp|3568
20209385|NCT00761761|Univeristy Of Pittsburgh Medical Center|K.N. Roy Chengappa, MD|412-246-5006|chengappakn@upmc.edu|
20209386|NCT00460421|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
20209387|NCT04602078|Spanish Oncology GenitoUrinary Group (SOGUG)|A responsible person designated by the Sponsor|0034934344412|investigacion@mfar.net|
20209388|NCT03757585|Massachusetts General Hospital|Janet Wozniak|6176436617|jwozniak@partners.org|
20209389|NCT03472586|Thomas Jefferson University|Marlana Orloff, MD|215-955-9974|marlana.orloff@jefferson.edu|
20209390|NCT02706327|Eastern Mediterranean University|Yasin YURT|+905338724271|fzt.yasinyurt@gmail.com|
20209391|NCT04542304|Stanford University|Tammy Lisa Sirich, MD|650-849-1907|tsirich@stanford.edu|
20209392|NCT02928900|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
20209393|NCT03868410|Cleveland Clinic|Dr. Ela Plow|216-445-6728|plowe2@ccf.org|
20209394|NCT06045026|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20209395|NCT04511533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209396|NCT01224171|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20209397|NCT01928758|Penn State College of Medicine|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
20209398|NCT02718131|University of Alabama at Birmingham|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
20209399|NCT02103608|Tennesse clinical research center|Dr. Michael Gold|615-383-2400|drgold@goldskincare.com|
20209400|NCT03417245|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20209401|NCT02708524|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D. PRINCIPAL RESEARCH OPTOMETRIST|904-443-1474|KCANAVA2@its.jnj.com|
20209402|NCT04435431|Integrative Research Laboratories Sweden AB|Joakim Tedroff, Chief Medical Officer|+46707601691|joakim.tedroff@irlab.se|
20209403|NCT00761735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209404|NCT00381680|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20209405|NCT03290131|RVL Pharmaceuticals, Inc.|Vice President, Regulatory Affairs and Quality|908-809-1300|Regulatory@RVLpharma.com|
20209406|NCT00731640|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20209407|NCT00361504|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20209408|NCT04899362|the First Hospital of Jilin University|Dr Yi Yang|0431|doctoryangyi@163.com|88782378
20209409|NCT03045926|Ipsen Pharma SAS|Medical Director|+33 (0)158335000|clinical.trials@ipsen.com|
20209410|NCT04548349|Beth Israel Deaconess Medical Center|Jean S. McGee, MD, PhD|(617) 667-5834|jmcgee2@bidmc.harvard.edu|
20209411|NCT03554798|FIDEC Corporation|Ricardo Rüttimann, PhD|+5491161188536|rruttimann@fidec-online.org|
20209412|NCT01374516|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20209413|NCT01982539|Depomed|Clinical Operations||clinicaltrials@depomed.com|
20209414|NCT00401414|Brigham and Women's Hospital|Mark A. Creager|617-732-5267|mcreager@partners.org|
20209415|NCT00450814|Mayo Clinic|Angela Dispenzieri, M.D., Morie A. Gertz, M.D.|(507) 284-2511|Dispenzieri.Angela@mayo.edu, Gertz.Morie@mayo.edu|
20209416|NCT04145531|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20227450|NCT01746862|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20227451|NCT02233530|University of Ibadan, Ibadan, Nigeria|Dr Adesola Ogunniyi|+2348038094173|aogunniyi892@gmail.com|
20227452|NCT04074265|University of California, Los Angeles|Rachel Thompson|8472200324|rathompson@mednet.ucla.edu|
20227453|NCT02577640|Ohio State University|Casey McClurkin|614-293-6255|casey.mclurkin@osumc.edu|
20227454|NCT04585919|Harvard TH Chan School of Public Health|James Daly|617-384-8915|jdaly@hsph.harvard.edu|
20227455|NCT04907214|Vanderbilt University Medical Center|Dr. Mona Mashayekhi|615-936-1760|mona.mashayekhi@vumc.org|
20209417|NCT04988035|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20186105|NCT04106583|Penumbra, Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
20209418|NCT03602976|University of Pennsylvania|Dr. Ethan Weinberg|215-349-8222|ethan.weinberg@pennmedicine.upenn.edu|
20209419|NCT03732534|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20209420|NCT02190604|Novartis|Study Director|862-778-8300||
20209421|NCT02797951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20209422|NCT03735849|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20209423|NCT05113277|Florida State University|Danielle M. Morabito|850) 645-1766|morabito@psy.fsu.edu|
20209424|NCT04585906|Johns Hopkins Center for Indigenous Health|Emily E. Haroz, PhD, Co-Director of Research|410-960-9503|eharoz1@jhu.edu|
20209425|NCT04626947|University of Pittsburgh|David G. Binion|412-647-4194|binion@pitt.edu|
20209426|NCT01766466|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888.779.MDCO|jayne.prats@themedco.com|1510
20209427|NCT01533974|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.|206-667-5074|jbricker@fredhutch.org|
20209428|NCT03907072|WAVE Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20209429|NCT00591305|Boston Medical Center|Zhi Wang, MD|617-414-1590|zwang@bu.edu|
20209430|NCT02463097|Medtronic Minimed|Thomas Thoub|8185763142|thomas.troub@medtronic.com|
20209431|NCT03326323|Inova Heart and Vascular Institute|Eric L. Sarin MD|703-776-4138|eric.sarin@inova.org|
20209432|NCT02078557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209433|NCT01830621|The Ottawa Hospital Regional Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
20209434|NCT03556202|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20209435|NCT03301272|University of North Carolina at Chapel Hill|Daniel Roque, MD|919-966-8178|droque@neurology.unc.edu|
20209436|NCT02243306|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209437|NCT02221882|Eli Lilly and Company|Chief Medical Officer|800+545-5979|ClinicalTrials.gov@lilly.com|
20186106|NCT02651428|CorMedix Inc.|Head of Clinical Operations|908-517-9500|lmasson@cormedix.com|
20209438|NCT00796367|Vivus, Inc|Wesley W Day, PhD|650.934.5200|day@vivus.com|
20209439|NCT01815099|Hartford Hospital|Gretchen Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
20209440|NCT01475214|Jean Mayer Human Nutrition Research Center on Aging at Tufts University|Dr. Bess Dawson-Hughes|617-556-3066|bess.dawson-hughes@tufts.edu|
20209441|NCT00643851|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20186107|NCT05102591|University of Calgary/Alberta Health Services|Dr. Serena Orr|403-955-7728|serena.orr@albertahealthservices.ca|
20186108|NCT04588298|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20227456|NCT00385918|University of Maryland Rehabiitation and Orthopaedic Institute|Peter H. Gorman, MD Chief Division of Rehabilitation Medicine|410-448-6261|pgorman@umm.edu|
20186109|NCT06064955|Ohio State University|Karen O. Moss|(614) 688-3100|Moss.391@osu.edu|
20186110|NCT04768569|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
20186111|NCT02281955|University of North Carolina at Chapel Hill|Dr. Colette Shen|984-974-0400|cjshen@email.unc.edu|
20209442|NCT03289676|UNIVERSITY OF MASSACHUSETTS BOSTON|Dr. Sun Kim|6172875372|sun.kim@umb.edu|6172875372
20186112|NCT04621266|The University of Hong Kong|Dr Kris Lok|39176690|krislok@hku.hk|
20186113|NCT05481216|Research Organization (KC) Ltd|HIV COCO Project Manager|+44 (0) 7494 795 982|hivcoco@rokcservices.com|
20186114|NCT02085421|University of Minnesota|Caroline Demro|(612) 625-3330|schi0599@umn.edu|
20209443|NCT00465894|University of Alabama at Birmingham|Dr. Holly E. Richter|205-934-1704|hrichter@uabmc.edu|
20186115|NCT02783300|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20186116|NCT03535272|Centers for Disease Control and Prevention|Kristina Angelo|404-718-4876|kangelo@cdc.gov|
20186117|NCT04302493|Johns Hopkins School of Medicine|Elisabeth B. Marsh, MD|410-550-8703|ebmarsh@jhmi.edu|
20209444|NCT01636076|Novartis Pharmaceuticals|Study Director|862-778-8300||
20209445|NCT01159665|ThromboGenics|Dr. Petra Kozma-Wiebe|+32 16751310|Petra.kozma@thrombogenics.com|
20209446|NCT00957827|University of Pennsylvania|Eric Granquist|215 880-7568|eric.granquist@uphs.upenn.edu|
20209447|NCT00934661|Anesthesiology|Dr. Pamela Nagle Assistant Professor|336-716-7180||
20209448|NCT03724305|Henry Ford Health|Chaewon Sagong|2483442409|csagong1@hfhs.org|
20209449|NCT05959564|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
20209450|NCT05064436|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20209451|NCT01711736|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209452|NCT01342445|University of Rhode Island|Dr. Lisa Weyandt|(401)874-2087|lisaweyandt@uri.edu|
20209453|NCT02652793|Hospital Clinic of Barcelona|Dr. José Luis Blanco|+34 932275400|jlblanco@clinic.cat|
20209454|NCT00070070|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20209455|NCT05450198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
20209456|NCT01319422|Yale University|Madhav Dhodapkar, M.D.|203-785-4144|madhav.dhodapkar@yale.edu|
20209457|NCT00933543|Photocure|Project director Per Fuglerud|+47 22 06 16 54|pf@photocure.no|
20227457|NCT00128661|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227458|NCT03758157|Wello, Inc.|Alan C. Heller|469-522-5200|allen.heller@welloinc.com|
20186118|NCT03892616|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209458|NCT03866811|Columbia University|Dr. Lauren Chernick|2123056628|lc2243@columbia.edu|
20209459|NCT04837807|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20209460|NCT00308555|UCSF/San Francisco General Hospital|Dr. Donald I. Abrams|415-476-4082|dabrams@hemeonc.ucsf.edu|444
20209461|NCT00814502|Massachusetts General Hospital|Kaloyan Tanev, M.D.|617-726-7511|ktanev@partners.org|
20209462|NCT00370994|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti|270-554-8373|drlm@thepainmd.com|101
20209463|NCT03260699|Department of Orthopaedic Surgery, Cleveland Clinic|Alison Klika, Research Manager|216 444-4954|klikaa@ccf.org|
20209464|NCT04278846|Cleveland Clinic|Raymond Isakov, MD|216 445-3765|ISAKOVR@ccf.org|
20209465|NCT01012765|Novartis Pharmaceuticals|Study Director|862-778-8300||
20209466|NCT01326312|Oncternal|Mary Breitmeyer|858-434-1113|mbreitmeyer@oncternal.com|
20209467|NCT00635362|University of Chicago|Amy Whitaker, MD|773-834-4129|awhitaker@babies.bsd.uchicago.edu|
20209468|NCT02071823|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20209469|NCT02787655|Atl VA|Joe Nocera|404 321 6111|joe.nocera2@va.gov|206354
20209470|NCT02223520|Johns Hopkins Medical Institutions|Aaron M. Milstone, M.D., M.H.S.|410-614-3917|amilsto1@jhmi.edu|
20209471|NCT02185131|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
20209472|NCT00499694|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
20209473|NCT02394457|Naval Medical Center San Diego|Steven Hanling, MD|619-532-8954|steven.r.hanling@mail.mil|
20209474|NCT01598831|Asahi Kasei Pharma America Corp.|Director of Clinical Operations|(781) 419-1919|pallton@akpamerica.com|
20209475|NCT02384096|Boston Scientific Neuromodulation|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
20209476|NCT02903121|Oregon Health and Science University|Alison Edelman, MD, MPH|5034943666|edelmana@ohsu.edu|
20209477|NCT02370173|University of Arizona|"Dr. William D. Scott Killgore"|(520) 621-0605|killgore@arizona.edu|
20209478|NCT04034225|Sensei Bio|Alice Drumheller|2404548027|adrumheller@senseibio.com|
20209479|NCT01591044|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20209480|NCT02249377|New York Langone Health|Eric Strauss, MD|646 501 7223|Eric.Strauss@nyumc.org|
20209481|NCT00307736|Massachusetts General Hospital|Lawrence Blaszkowsky|6177244637|lblaszkowsky@partners.org|
20209482|NCT01230021|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20209483|NCT01365182|Case Western Reserve University|Amy Zhang PhD|2163680968|amy.zhang@case.edu|
20209484|NCT00736840|Exalenz Bioscience|Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|513
20209485|NCT01411917|University of Wisconsin School of Medicine, Department of Anesthesiology|Kristopher Schroeder|608-232-1542|kmschro1@wisc.edu|
20209486|NCT02791906|University of Pennsylvania|Associate Professor|2152007779|julio.chirinos@uphs.upenn.edu|
20209487|NCT04553497|Ege University Faculty of Medicine, Physical Medicine and Rehabilitation|Dr. Emine Duran|+905372103145|docemineduran@gmail.com|
20209488|NCT01728194|Well Cornell Medicine|Faith M. Gunning, PhD, Vice Chair for Research, Dept of Psychiatry|212-746-5832|fgd2002@med.cornell.edu|
20209489|NCT03241485|University of Chicago Medicine|Richa Dhawan|773-702-1000|rdhawan@dacc.uchicago.edu|
20209490|NCT02309372|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
20209491|NCT00242658|Penn State Milton S. Hershey Medical Center|Chris Sciamanna, MD, MPH|717-531-8161|cns10@psu.edu|
20209492|NCT02054572|Amgen Inc.|Study Director|866-572-6436||
20209493|NCT00928642|Madigan Army Medical Center|COL David E. McCune, MD, MC|253-968-1155|david.e.mccune.mil@mail.mil|
20209494|NCT04604015|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
20209495|NCT02205177|Mayo Clinic|Stephen P Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
20209496|NCT02576652|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20209497|NCT01756209|Pugliese Hospital of Catanzaro|Dr Francesco Peltrone, Responsible of clinical trial|+.39 0961 7123222|gallelli@unicz.it|
20209498|NCT02811640|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@toh.ca|81620
20209499|NCT02229513|Baylor University Medical Center|Dr. Janice Mitchell, PI|713-705-6240|janicemitchellmd@gmail.com|
20209500|NCT01633398|National University Health System, Singapore|Carolyn Lam|(65)67048965|carolyn.lam@duke-nus.edu.sg|
20209501|NCT04557189|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20209502|NCT00954356|Xenon Pharmaceuticals Inc.|Vice President Clinical|6044843300|pgoldberg@xenon-pharma.com|
20209503|NCT01811693|Keck School of Medicine of USC|Nerses Sanossian, MD|323-442-7793|nsanossi@usc.edu|
20209504|NCT02939326|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
20209505|NCT01668017|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20209506|NCT01087944|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20209507|NCT00553319|Columbia University|Frances R. Levin, M.D.|646-774-6137|frl2@columbia.edu|
20209508|NCT01979003|University of Arkansas for Medical Sciences|Alexander Burnett|5016868274|aburnett@uams.edu|
20209509|NCT00976521|Atrium Medical Corporation|Leah Hollins, Director of Clinical Affairs|603-880-1433|lhollins@atriummed.com|5365
20209510|NCT01731600|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20209511|NCT03575975|Georgia Institute of Technology|Dr. Young-Hui Chang|404-894-9993|yh.chang@ap.gatech.edu|
20209512|NCT01526343|Washington University School of Medicine|Jennifer Bell, Manager of Clinical Trials|314-747-6969|jennifer.bell@wustl.edu|
20209513|NCT00129220|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20186119|NCT02243709|Brown University|Prof. Carolina Haass-Koffler|4155191385|carolina_haass-koffler@brown.edu|
20227459|NCT00614172|Loma Linda University Health|David Bush, MD, Vice Chair Clinical Affairs Radiation Medicine|909 558 1000|DBush@llu.edu|
20209514|NCT00544674|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
20186120|NCT05845398|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
20186121|NCT01787383|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leopharma.com|
20209515|NCT00540228|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209516|NCT01883362|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20186122|NCT04347161|University of Pennsylvania|Katharine A Rendle, PhD,MSW,MPH|215-349-5442|Katharine.Rendle@pennmedicine.upenn.edu|
20186123|NCT04533347|Fast-Track Drugs and Biologics, LLC|Bernadette Tock|240-401-8634|btock@fasttrackresearch.com|
20186124|NCT05520190|University of Rochester|Aileen Aldalur|(585) 371-6125|aileen_aldalur@urmc.rochester.edu|
20186125|NCT01748448|UZLeuven|Prof. Dr. M. Garmyn|0032 16 33 79 50|marjan.garmyn@uzleuven.be|
20186126|NCT04922502|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
20209517|NCT03740724|Castle Creek Biosciences|Castle Creek Biosciences Clinical Trial Director|484-713-6000|clinicalresearch@castlecreekbio.com|
20209518|NCT01230489|University of Missouri-Columbia|Harold Moore|5738824433|mooreh@health.missouri.edu|
20186127|NCT05147155|University of Thessaly|Research Committee - Special Account for Research Grants University of Thessaly|+306971894688|raniakotsiou@gmail.com|
20209519|NCT02451137|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20186128|NCT03562377|LEO Pharma A/S|Disclosure|+45|disclosure@leo-pharma.com|44945888
20227460|NCT02782741|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20186129|NCT03699709|University of Washington School of Public Health Department of Epidemiology|Dr. Amanda Fretts|2065431065|amfretts@uw.edu|
20209520|NCT03747497|MicuRx Pharmaceuticals, Inc.|Study Director|510-782-2022|info@micrux.com|
20209521|NCT01977573|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209522|NCT01441882|Oregon Health & Science University|Stephen Spurgeon|503-494-4606|spurgeos@ohsu.edu|
20209523|NCT02010359|Children's Hospital of Philadelphia|Dr. Rachana Shah|215-590-3390|shahr@email.chop.edu|
20209524|NCT00847002|Tactile Systems Technology, Inc|Sunday Hoy, Director of Clinical Research|612.355.5100||
20227461|NCT04157088|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20227462|NCT02421419|Penn State Milton S. Hershey Medical Center|Kenneth Taylor, M.D.|(717) 531-5638|ktaylor2@pennstatehealth.psu.edu|
20227463|NCT00726180|Universtiy of Michigan|Anne F. Schott, MD|734-936-6000|aschott@umich.edu|
20227464|NCT01676701|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227465|NCT02115607|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
20227466|NCT03377270|Northwestern University|Dr. Bonnie Martin-Harris|847-467-0407|bonnie.martinharris@northwestern.edu|
20227467|NCT05918406|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|marian.macsai@viatris.com|
20227468|NCT00196105|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
20227469|NCT04863872|Kaiser Permanente Washington Health Research Institute|James Ralston, MD, MPH|206-287-2076|James.D.Ralston@kp.org|
20227470|NCT05117112|UAMS|David Church|5015265769|dchurch@uams.edu|
20227471|NCT04058028|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20227472|NCT02227784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227473|NCT04010461|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
20227474|NCT00102596|NINDS/NIH|Mark Hallett, M.D.|301-496-9526|hallettm@ninds.nih.gov|
20227475|NCT01275144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227476|NCT00909064|UC Davis|Gavin Pereira|916-534-0919|gcpereira@ucdavis.edu|
20227477|NCT05607576|Cincinnati Children's Hospital Medical Center|Deborah Elder; Associate Professor|5136364744|Deborah.Elder@cchmc.org|
20227478|NCT01827592|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20227479|NCT02284386|Pacira|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
20227480|NCT05254340|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
20227481|NCT00418028|GEICAM (Grupo Español de Investigación en Cancer de Mama)|The Oncologist 2015;20:1-2 http://www.theoncologist.com/ Scientific Director and CEO|+34916592870|geicam@geicam.org|
20227482|NCT02532283|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20227483|NCT01945944|Rainbow Babies and Children's Hospital|Steven Shein, MD|216-844-3310|drstevenshein@gmail.com|
20227484|NCT04376515|University of California, Irvine|Dr. Dominic Ugarte|949-508-0135|dugarte@hs.uci.edu|
20227485|NCT03811821|Mayo Clinic|Adil Bharucha, M.B.B.S., M.D.|507-266-6931|bharucha.adil@mayo.edu|
20227486|NCT03574974|Yale University|Ilan Harpaz-Rotem Professor|203-937-4760|ilan.harpaz-rotem@yale.edu|
20227487|NCT05027815|University of California, San Francisco|Jonathan Esensten MD, PhD|415-502-3785|Jonathan.Esensten@ucsf.edu|
20227488|NCT03574038|Study's principal investigator|Dr. Mersedeh Bahr-Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
20227489|NCT00674206|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emoryhealthcare.org|
20227490|NCT00447902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20227491|NCT01386606|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20186130|NCT02907099|The University of Texas MD Anderson Cancer Center|Brandon Smaglo, MD|(713) 745-8763|bgsmaglo@mdanderson.org|
20209525|NCT00198107|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
20209526|NCT02513732|Abbott|Hajime Kusano, Senior Adviser Clinical|+1 4088451626|hajime.kusano@abbott.com|
20227492|NCT04159714|Mayo Clinic|Dr. Robert Hyde|507-255-4137|Hyde.Robert1@mayo.edu|
20227493|NCT02357459|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20163003|NCT03040674|Lung Health Institute|Melissa Rubio, PhD, APRN|2145042117|pidallas@thelunghealthinstitute.com|
20192754|NCT00243022|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Glen Stevens||steveng@ccf.org|
20192755|NCT02085473|MedImmune, LLC|Meena Jain|+44 (0) 1223 895966|jainm@medimmune.com|
20163004|NCT05173012|Sage Therapeutics|Carrie Vaudreuil|(857) 259-4766|carrie.vaudreuil@sagerx.com|
20163005|NCT00517361|The University of Chicago|Dr. Rita Nanda|773-834-2756|rnanda@medicine.bsd.uchicago.edu|
20163006|NCT01854034|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|lvsequist@partners.org|
20163007|NCT05234957|Benha University|Dr. Mohamed Farid|00201003354636|mohamed.farid@fmed.bu.edu.eg|
20163008|NCT03517228|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
20163009|NCT01340053|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
20163010|NCT03781414|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20163011|NCT00156390|University of Pittsburgh|Dr. Samir Saba|412-802-3372|sabas@upmc.edu|
20163012|NCT04752358|Adaptimmune|Clinical Trials Management|+1 (215) 825-9260|clinicaltrials@adaptimmune.com|
20163013|NCT00719355|University of Illinois at Chicago|Eileen G. Collins PhD, RN|312-413-5621|ecollins@uic.edu|
20163014|NCT01824355|Ascensia Healthcare|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20192756|NCT01390441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163015|NCT02465372|Wake Forest University Health Sciences|Dr. Justin Moore|336-716-3702|jusmoore@wakehealth.edu|
20209527|NCT02279082|Dr. Reddy's Laboratories|Clinical Operations Director|609-282-1476|kgulbronson@promiuspharma.com|
20163016|NCT01938833|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maysa Abu-Khalaf|215 503-4685|maysa.abu-khalaf@jefferson.edu|
20163017|NCT00836186|Johns Hopkins University|Jean Wright, MD PI|410-614-3950|jwrigh71@jhmi.edu|
20163018|NCT02186665|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
20163019|NCT01151371|Vistakon|Kathy Lorenz-Osborn, OD|+1 904 443-1032|kosborn@its.jnj.com|
20163020|NCT05232864|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20163021|NCT02023996|Memorial Sloan Kettering Cancer Center|Dr. Neeta Pandit-Taskar, MD|212-639-3046|pandit-n@MSKCC.ORG|
20209528|NCT00990782|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
20209529|NCT02848781|College of Medicine - Phoenix|Rodrick Tung, MD|602-521-3090|rodricktung@arizona.edu|
20209530|NCT03996694|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
20209531|NCT01171794|Stanford University School of Medicine|Grant S Lipman ( PI)|4152909286|lipmangrant@gmail.com|
20209532|NCT02748096|University of Oxford|Professor Anrew Price|+44 1865 223421|andrew.price@ndorms.ox.ac.uk|
20209533|NCT00656669|IndianaU|Dr. Kathy Miller|317-944-0920||
20209534|NCT03377803|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20209535|NCT02777554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20209536|NCT02147132|UC COM Psychiatry Dept. -- Addiction Sciences Division|Jeff Theobald|5135858281|theobajy@ucmail.uc.edu|
20209537|NCT01013207|ResMed Ltd|Alison Wimms|+61 8884 2583|alison.wimms@resmed.com.au|
20209538|NCT00808769|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
20209539|NCT04070157|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
20209540|NCT01541644|University of Maryland Baltimore Greenebaum Cancer Center|Emily Parks|410-328-7340|eparks@umm.edu|
20209541|NCT01966458|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
20209542|NCT01458535|AbbVie|Global Medical Services|800-633-9110||
20209543|NCT02842736|Channel Medsystems|Clinical and Regulatory Affairs|510-338-9301|clinreg@channelmedsystems.com|
20209544|NCT00453336|University of Miami Sylvester Comprehensive Cancer Center|Francisco Civantos MD|305-243-5276|fcivanto@med.miami.edu|
20209545|NCT00940446|OrthoIndy|Dr David A Fisher|(317) 802-2000|dafisher@orthoindy.com|
20209546|NCT02064231|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
20209547|NCT01711424|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20209548|NCT04854421|Pennington Biomedical Research Center|Dr. Steven Heymsfield|(225) 763-2541|steven.heymsfield@pbrc.edu|
20209549|NCT02322866|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20209550|NCT00718809|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
20209551|NCT00463385|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20209552|NCT00798161|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209553|NCT00344968|Alimera Sciences, Inc.|Kathleen Billman, Senior Director of Scientific Affairs|678-572-1302|kathleen.billman@alimerasciences.com|
20209554|NCT03735680|OncoNano Medicine, Inc.|Vice President, Clinical Operations|682-285-1411|clinicaltrials@onconanomed.com|
20209555|NCT01905631|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
20209556|NCT03930524|University of Michigan|Dr. Megan Patrick|734-763-5043|meganpat@umich.edu|
20209557|NCT03078504|Saint Louis University|Dr.Zafar Jamkhana|314-577-8856|zafar.jamkhana@health.slu.edu|
20209558|NCT01141569|BC Cancer Agency Vancouver Cancer Centre|Dr. Christian Kollmannsberger|604-877-6000|ckollmannsberger@bccancer.bc.ca|
20209559|NCT04001790|Virginia Commonwealth University|Carol Schall|8048286979|cmschall@vcu.edu|
20192757|NCT00621192|Eunice Kennedy Shriver National Institute of Child Health and Human Development|David Siegel, MD|301-595-8670|siegelda@mail.nih.gov|
20163022|NCT02652468|University of Madison Carbone Cancer Center|Vaishalee Kenkre|(608) 263-1699|vpkenkre@medicine.wisc.edu|
20209560|NCT03342911|Thomas Jefferson University|Jennifer Johnson|215-955-8874|jxj021@jefferson.edu|
20209561|NCT05028816|UT Southwestern Department of Plastic Surgery Research|Jennifer Barillas, Research Coordinator|214-645-8907|jennifer.bqarillas@utsouthwestern.edu|
20209562|NCT04552769|Stanford University|Saad A. Khan, MD|650-498-6000|saad.a.khan@stanford.edu|
20209563|NCT04576702|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20209564|NCT00683852|Massachusetts General Hospital, CTNI|Martina Flynn, Director, Clinical Trial Operations|617-643-6028|mflynn2@partners.org|
20209565|NCT02985996|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20209566|NCT00401726|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20209567|NCT02067728|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-655-3613|alc@uicomp.uic.edu|
20209568|NCT01015170|Centre for Addiction and Mental Health|Dr. Peter Selby; Dr. Laurie Zawertailo Principal Investigator|416-535-8501|laurie.zawertailo@camh.ca|77422
20209569|NCT00694070|Ascensia Diabetes Care|Clinical Research Scientist|574-257-3063||
20209570|NCT03532048|Baylor College of Medicine|Teresia O'Connor|7137986782|teresiao@bcm.edu|
20209571|NCT04629534|Medical University of South Carolina|Carol Wagner|843-792-5179|wagnercl@musc.edu|
20209572|NCT01901393|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
20209573|NCT03709342|CalciMedica|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
20209574|NCT02694393|University of Pittsburgh|Dr. Joseph Pilewski|(412) 692-2210‬|pilewskijm@upmc.edu|
20209575|NCT01225029|Icahn School of Medicine at Mount Sinai|Dr. Annemarie Stroustrup|212-241-6186|annemarie.stroustrup@mssm.edu|
20209576|NCT04113746|Icahn School of Medicine at Mount Sinai|Juan P. Wisnivesky, MD, DrPH|212-824-7567|juan.wisnivesky@mountsinai.org|
20209577|NCT03125382|IMP|Drª. Milene Fernandes|00351965751328|milenefernandes@hotmail.com|
20209578|NCT00830310|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
20209579|NCT06016556|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209580|NCT00629343|Columbia University|Robert Taub, MD, PhD|(212) 305-4076|rnt1@columbia.edu|
20209581|NCT04246593|State University of New York at Buffalo|Dr. Lucia Leone|(716) 829-6040|lucialeo@buffalo.edu|
20209582|NCT00265109|Weill Cornell Medicine|Katharine A. Phillips MD|646-962-2820|kap9161@med.cornell.edu|
20209583|NCT02967393|Vanderbilt University Medical Center|Kathryn M. Edwards MD|615-322-8792|kathryn.edwards@vanderbilt.edu|
20209584|NCT01049360|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
20209585|NCT00429026|U.T. M.D. Anderson Cancer Center|Naoto Ueno, MD, PhD / Associate Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
20209586|NCT00620191|Columbia University Medical Center|Jose Luchsinger|212-3054730|jal94@cumc.columbia.edu|
20209587|NCT00903357|Department of Pediatrics, Soonchunhyang University Hospital|Bok Yang Pyun, M.D.|+82-2-709-9339|bypyun@hanmail.net|
20209588|NCT04930562|BioNova Pharmaceutical Limited Company|Medical Director|+86(21)50901280|yu.wang@bionovapharma.com|
20209589|NCT00889928|Ethicon Endo Surgery, Inc|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
20209590|NCT00678652|Clinical Trials Center, WRAIR|Paul B. Keiser, M.D.||noinformation@available.com|
20209591|NCT00674440|Children's Hospital of Philadelphia/Perelman School of Medicine, University of Pennsylvania|Lisa J. States, MD|267-425-7146|states@chop.edu|
20209592|NCT01315158|Washington University School of Medicine|Faris Murad, M.D.||fmurad@northshore.org|
20209593|NCT01990339|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20209594|NCT02129192|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209595|NCT01231620|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209596|NCT01143818|Abbott|Global Medical Services|800-633-9110||
20209597|NCT03216499|Adult Brain Tumor Consortium (ABTC)|Roy Strowd, MD|410-955-8837|jfisher@jhmi.edu|
20209598|NCT02441517|Astellas Pharma Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
20209599|NCT01393444|University of Pittsburgh|Jennifer Collinger|412-383-1274|collingr@pitt.edu|
20209600|NCT03039699|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20209601|NCT01766024|BIOCAD|Director of Clinical Trials|7 (812) 380 49 33|biryulin@biocad.ru|925
20209602|NCT01302366|Perlmutter Cancer Center at NYU Langone|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
20209603|NCT00467051|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20227494|NCT03246347|Wake Forest|Danielle Boselli|2017903385|danielle.boselli@atriumhealth.edu|
20227495|NCT01548599|University of California, San Francisco|Sheri Weiser|(415) 314-0665|Sheri.Weiser@ucsf.edu|
20209604|NCT01756586|University of Chicago|TARIQ MALIK|773-834 3643|tmalik@dacc.uchicago.edu|
20227496|NCT02188160|Kala Pharmaceuticals, Inc.|VP, Clinical Development|781-996-5252|results002@kalarx.com|
20227497|NCT04113694|Medtronic Diabetes|Emma Pham, MSHS (Clinical Study Manager)|818 576 4878|emma.pham@medtronic.com|
20227498|NCT00464685|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20227499|NCT00916578|UT MD Anderson Cancer Center|Woodward,Wendy,M.D., PH.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
20227500|NCT00754741|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|chphsr@hfhs.org|
20227501|NCT01334086|Princess Margaret Cancer Centre|Dr. Karen Yee, Hematology and Medical Oncology Site Group Lead|416-946-4501|Karen.Yee@uhn.ca|4495
20227502|NCT04152200|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20227503|NCT04969289|Columbia University|Lauren Chernick, MD, MSc|212-305-9825|lc2243@columbia.edu|
20227504|NCT00593814|W.L. Gore and Associates|Tab Bonny|928 864 4275|tbonny@wlgore.com|
20227505|NCT02699996|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
20227506|NCT01921517|University of Pennsylvania Perelman School of Medicine|Felix W. Wehrli, Principal Investigator|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
20227507|NCT03593200|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20227508|NCT01307787|UMCG|G.Breedland||g.breedland@cvr.umcg.nl|
20209605|NCT00066573|NCIC Clinical Trials Group|Dr. Wendy Parulekar|1-613-533-6430|wparulekar@ctg.queensu.ca|
20209606|NCT00503035|UT MD Anderson Cancer Center|Dr. Imad Shureiqi, MD|713-745-4929|ishureiqi@mdanderson.org|
20209607|NCT04579666|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20209608|NCT00465101|American Medical Systems|Mara M. LaRock, Senior Manager, Clinical Franchise Lead|952-930-6000|mara.larock@bsci.com|
20209609|NCT03099096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209610|NCT03648073|University of Alabama at Birmingham|Samuel Galgano, Principal Investigator|2059341449|samuelgalgano@uabmc.edu|
20209611|NCT01050998|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
20209612|NCT00895817|Walter Reed Army Medical Center|Dr. Fouad J Moawad|(301) 295-4600|fouad.moawad@us.army.mil|
20209613|NCT00234533|Ipsen|Medical Director, Pediatric Endocrinology||clinical.trials@ipsen.com|
20209614|NCT02967055|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
20209615|NCT00976989|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20209616|NCT01539512|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20186131|NCT03272373|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
20209617|NCT04717466|University of Miami|Dr. Hideki Mochizuki|305-234-4472|hxm414@med.miami.edu|
20209618|NCT05705544|Vanderbilt University Medical Center|Dr. Fabian Maldonado|(615) 322-5000|fabien.maldonado@vumc.org|
20209619|NCT04668157|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20209620|NCT03958045|University of Kentucky|Dr. Zhonglin Hao|859-218-6704|zhonglin.hao@uky.edu|
20209621|NCT03158532|ISCS|Roberto Léo da Silva|55 48 999099790|robertoleo@hotmail.com|
20209622|NCT03457701|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209623|NCT03329404|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
20209624|NCT00740129|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20209625|NCT04081727|ZSX Medical, LLC|Director of Clinical Affairs|617-631-8865|info@zsxmedical.com|
20209626|NCT05664672|Altria|Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20209627|NCT00617942|Brown University Oncology Research Group (BrUOG)|William Sikov, MD|4018633000|BrUOG@brown.edu|
20209628|NCT04095039|Duke University School of Medicine|Hrishikesh Chakraborty, DrPH|919-668-1238|hrishikesh.chakraborty@duke.edu|
20209629|NCT04768881|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20209630|NCT04236986|Yale University|Dr. Kelly Cosgrove Principal Investigator|2037376969|kelly.cosgrove@yale.edu|
20209631|NCT01326481|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
20209632|NCT01475513|Virginia Commonwealth University|Kai Cheang|8049863269|kicheang@vcu.edu|
20209633|NCT03164629|University of Miami|Shivank Bhatia, MD|305-585-7500|SBhatia1@miami.edu|
20209634|NCT00735839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209635|NCT01038609|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20209636|NCT01314261|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20209637|NCT01466972|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
20209638|NCT04524507|University of North Carolina at Chapel Hill|Luther Bartelt, MD|919-966-2537|barteltl@ad.unc.edu|
20209639|NCT01594424|Cedars-Sinai Medical Center, Comprehensive Transplant Center|Jua Choi, PharmD|310-248-8186|jua.choi@cshs.org|
20209640|NCT01066624|South Texas Veterans Health Care System|Juan J Toro|210-617-5300|juan.toro2@va.gov|16777
20209641|NCT02486263|Nationwide Children's Hospital|Dr. Sudarshan Jadcherla|614-355-6643|sudarshan.jadcherla@nationwidechildrens.org|
20209642|NCT00508118|Duke University Medical Center|Andrew Shaw MD|919 286 6938|andrew.shaw@duke.edu|
20209643|NCT01078974|Dana-Farber Cancer Institute|Steven P. Treon|617-632-2681|steven_treon@dfci.harvard.edu|
20186132|NCT03818711|Vanderbilt University Medical Center|Senior ClinicalTrials.gov Administrator|615-322-3581|natalie.dilts@vumc.org|
20186133|NCT02913872|University of Leicester|Dr Erol Gaillard|+44116 252 3261|eag15@le.ac.uk|
20186134|NCT04739956|Imperial College Healthcare NHS Trust|Dr Margaret Pikovsky|+447870276373|m.pikovsky@nhs.net|
20186135|NCT03519581|University of California, Davis Eye Center|Clinical Research Supervisor|916 734-6303|dcmacias@ucdavis.edu|
20186136|NCT03110315|EvergreenHealth Research|Theodore Brown|4258995385|trbrown@evergreenhealthcare.org|
20186137|NCT01781468|Mayo Clinic Arizona|Alyx B. Porter Umphrey, M.D.|480-301-4062|Porter.alyx@mayo.edu|
20186138|NCT02736409|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20186139|NCT04390048|University of Miami|Brian Arwari|305-284-5418|b.arwari@umiami.edu|
20186140|NCT01415154|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
20186141|NCT03972813|University of Michigan|Abram Wagner|7347632330|awag@umich.edu|
20186142|NCT06283173|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
20186143|NCT05687916|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20186144|NCT03332017|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20186145|NCT01261312|Astex Pharmaceuticals, Inc.|Dr. Harold Keer|925-560-2913|harold.keer@astx.com|
20186146|NCT04682106|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20186147|NCT02790502|Department of Agriculture, Environmental and Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
20186148|NCT05165108|IndianaU|Thomas Nowak, MD|3179484272|tvnowak@iu.edu|
20186149|NCT03336333|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20209644|NCT02569996|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
20186150|NCT04927065|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20209645|NCT01383317|Wake Forest University Health Sciences|Dr. Scott Miller|3367167437|scmiller@wakehealth.edu|
20209646|NCT01349816|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20209647|NCT02730234|Midwest Cardiovascular Research Foundation|Nicolas W Shammas|5633242828|shammasg@mcrfmd.com|102
20209648|NCT01397409|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20209649|NCT02911285|Medical University of South Carolina|Stacey Sellers, Program Manager|843-792-5807|sellersst@musc.edu|
20209650|NCT01207427|Cubist Pharmaceuticals|Vice President Clinical Research|(781) 860-8660||
20209651|NCT00422227|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20209652|NCT03418727|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
20209653|NCT01941472|Peking Union Medical College Hospital|Bin Du|8610-69155036|dubin98@gmail.com|
20209654|NCT00686894|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20209655|NCT01791543|Vanderbilt University Medical Center|William G Stevenson, MD|1-615-322-2318|william.g.stevenson@vumc.org|
20209656|NCT00963040|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
20209657|NCT01790633|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
20209658|NCT01740297|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20209659|NCT00761462|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20209660|NCT02047929|Carolinas HealthCare System|Dr. Thomas Ludden|704-608-2390|tom.ludden@carolinashealthcare.org|
20209661|NCT02985541|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20209662|NCT02383966|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20209663|NCT02163759|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20209664|NCT02883400|Atrium Health|Dr. Mark Russo,|704-355-6649|mark.russo@atriumhealth.org|
20209665|NCT00333437|University of California San Francisco|Jeffrey A. Golden, MD|415-353-2935|Jeff.Golden@ucsf.edu|
20209666|NCT02032433|NYU School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyumc.org|
20209667|NCT02696980|University of Vermont|Anne Dixon, MD|802 847 2700|anne.dixon@uvm.edu|
20209668|NCT03022526|University of Pittsburgh|Dr. Grace Lim|412-641-2179|limkg2@upmc.edu|
20209669|NCT01479777|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Dr. Cristina Sadowsky|443-923-9210|sadowsky@kennedykrieger.org|
20209670|NCT00887562|Columbia University|Michio Hirano, MD|12123051048|mh29@cumc.columbia.edu|
20209671|NCT00451191|George Washington University Biostatistics Center|Kathryn Hirst, PhD, Research Professor, PI of coordinating center|301-881-9260|khirst@bsc.gwu.edu|8025
20186151|NCT03406871|NationalCCHE,JAPAN|Dr.Kohei Shitara|+81-4-7133-1111|regonivo_core@east.ncc.go.jp|
20186152|NCT05473234|UCSF FI Proctor|Dr. Catherine E. Oldenburg|415-502-8843|catherine.oldenburg@ucsf.edu|
20186153|NCT04021602|University of Kansas Medical Center|Lisette T. Jacobson, Ph.D., MPA, M.A., Associate Professor, Obstetrics and Gynecology|316-293-3484|ljacobson@kumc.edu|
20186154|NCT03151616|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20186155|NCT05391893|SpectrumLakeland|Rachelle Pichot; Clinical Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
20186156|NCT04750473|Emory University/Winship Cancer Institute|Dr. David Schuster|404-712-4859|dschust@emory.edu|
20209672|NCT01972282|St. Antonius Ziekenhuis, Nieuwegein, Netherlands|Dr. Lucas V.A. Boersma||l.boersma@antoniusziekenhuis.nl|
20209673|NCT00846573|UMass Medical School|Dr. Mitchell Albert|(617) 875-2141|albertmi@tbh.net|
20209674|NCT05732610|Medical Group Care|Tomaz Lovse|239 631 1907|tomaz.lovse@mgc.us|
20209675|NCT04717323|Altec Inc.|Dr. Paola Contessa|5085458236|pcontessa@altecresearch.com|
20209676|NCT01553708|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Associate Prof. Pornanong Aramwit, Pharm.D., Ph.D.|+66-02-218-8409|paramwit@gmail.com|
20209677|NCT03575806|Tsinghua University|Statistician of Clinical Trials||majunfan2@sina.com|
20209678|NCT00219349|New York State Psychiatric Institute|Franklin Schneier MD|2125435368|fschneier@nyspi.columbia.edu|
20209679|NCT05461742|Brown University|Dr. Tayla von Ash|401-863-6192|tayla_ash@brown.edu|
20209680|NCT00270205|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20209681|NCT03446846|Minerva Neurosciences, Inc.|Head of Research & Development|617.600.7375|jsaoud@minervaneurosciences.com|
20209682|NCT00869362|Massachusetts General Hospital Diabetes Center|Deborah J. Wexler MD|617-726-8722|dwexler@partners.org|
20209683|NCT01002118|University of Iowa|Jennifer Robinson|319-384-1563|jennifer-g-robinson@uiowa.edu|
20209684|NCT02646566|Acacia Pharma|Dr Gabriel Fox|01223875919764|GabrielFox@acaciapharma.com|
20209685|NCT02806700|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
20209686|NCT02191033|Yale University|Deepa Camenga, MD|203-737-8310|deepa.camenga@yale.edu|
20209687|NCT02815540|Gillette Children's Specialty Healthcare|Director of Research|651-229-1745|Research@gillettechildrens.com|
20209688|NCT02222246|Duke University|Dr. Paula Tanabe|919-613-6038|paula.tanabe@duke.edu|
20209689|NCT01255865|3M|Terri White|651-733-0228|twhite3@mmm.com|
20209690|NCT04887922|Washington University School of Medicine|Chet Hammill, M.D., MCR|314-273-1809|hamillc@wustl.edu|
20227509|NCT01294423|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20227510|NCT04773223|University Clinical Centre of Serbia|Petar Zlatanovic|+381644961020|petar91goldy@gmail.com|
20186157|NCT04169373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20209691|NCT00953017|Fort Belvoir Community Hospital|Dr. Michael Hjelkrem|531-231-2015|mhjelkrem@yahoo.com|
20186158|NCT04610892|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20209692|NCT01300741|Alcon Research|Director of Clinical Trials|1-800-241-7629||
20186159|NCT05081583|Washington State University|Dr. Mary Paine|5093587759|mary.paine@wsu.edu|
20209693|NCT01055184|University of Rochester|Dr. John J. Treanor|585-275-5871|john_treanor@urmc.rochester.edu|
20192758|NCT04706793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192759|NCT04438382|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20192760|NCT00823836|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192761|NCT01099579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20192762|NCT02725528|McMaster University|Dr. Achilles Thoma|905-523-0019|athoma@mcmaster.ca|
20192763|NCT02446613|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192764|NCT03432390|Anesthesiology Unit, Teaching Hospital of the Federal University of Pernambuco, Recife, Pernambuco, Brazil|Dr. Jayme Marques dos Santos Neto|5581996212977|jaymemed@yahoo.com.br|
20192765|NCT01214421|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20192766|NCT03545412|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20209694|NCT02544607|Massachusetts General Hospital|Dr. Cristina Cusin|617-726-6421|ccusin@mgh.harvard.edu|
20209695|NCT00238108|Brigham and Women's Hospital|Dr. Frank Scheer|617-732-7014|fscheer@rics.bwh.harvard.edu|
20209696|NCT01548573|University of Iowa|Guido Tricot, MD, PhD|319-356-3425|guido-tricot@uiowa.edu|
20209697|NCT01249625|University of Texas Southwestern|Dr. Trish Perl|214-648-9022|Trish.Perl@UTSouthwestern.edu|
20209698|NCT03541356|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
20209699|NCT00290511|UT MD Anderson Cancer Center|Dr. Felipe Samaniego, MD-Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
20209700|NCT00558831|Northwestern University|Amy Paller, MD|312-695-6829|apaller@nmff.org|
20209701|NCT00447265|DAIT/NIAID|Associate Director for Clinical Research|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20209702|NCT02204449|UHN Toronto|Dr. Sherry Grace|416.736.2100|sgrace@yorku.ca|22364
20209703|NCT04645342|UCSF|Dr. Thomas Dewland|415-476-5706|thomas.dewland@ucsf.edu|
20209704|NCT04311411|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20209705|NCT03533829|Duke Vaccine and Trials Unit|Kristen Gunnell|9196848891|kristen.gunnell@duke.edu|
20209706|NCT01976663|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20209707|NCT05888740|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
20209708|NCT01982942|Medicinova Inc|Director, Medical Writing|8582468680|makhay@medicinova.com|
20209709|NCT04384120|Henry Ford Health|Dr. Joseph Tramer|2165362904|jtramer1@hfhs.org|
20209710|NCT01151085|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163023|NCT03521479|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
20209711|NCT04969653|Momentum Data Ltd|Dr Andrew McGovern|07531221970|andy.mcgovern@momentumdata.co.uk|
20209712|NCT00489411|University of Michigan School of Nursing|Ellen Lavoie Smith, PhD, APRN, AOCN, FAAN|734-936-1267|Ellenls@med.umich.edu|
20209713|NCT04389294|Hospital for Special Surgery|Dr. Ellen M. Soffin|(212) 606-1206|SoffinE@HSS.edu|
20209714|NCT01748162|University of Michigan|Dr. David J. Brown||davidjb@med.umich.edu|
20209715|NCT03219372|Cedars Sinai Medical Center|Shehnaz K. Hussain, PhD, ScM|310-429-9859|Shehnaz.Hussain@cshs.org|
20209716|NCT03841331|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
20209717|NCT00779857|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
20209718|NCT04640168|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
20209719|NCT05059366|University of Miami|Alecia Sabartinelli Stein, MD|305 585 8380|asabartinelli@med.miami.edu|
20209720|NCT02866721|University Hospitals, Rainbow Babies and Children's Hospital|Erica Roesch, MD|(216) 844-3267|Erica.Roesch@UHHospitals.org|
20209721|NCT00442572|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20209722|NCT03557775|Medical University of South Carolina|Dr. Heather Shaw Bonilha|843-792-2527|bonilhah@musc.edu|
20209723|NCT03948646|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20209724|NCT02626910|University of Pennsylvania|Dr. Hillary R. Bogner|215-746-4181|Hillary.Bogner@uphs.upenn.edu|
20209725|NCT00276458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209726|NCT01428882|Hospital San Pedro de Alcantara, Caceres|Dr. Javier Molina-Infante|0034927621543|xavi_molina@hotmail.com|
20209727|NCT02304484|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20209728|NCT04338685|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20209729|NCT00570492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209730|NCT00908375|Northwestern University|K Malik|3129262280|kmalikmd@yahoo.com|
20209731|NCT04419558|FibroGen, Inc.|Clinical Trial Information Desk|(415) 978-1427|zephyrus@fibrogen.com|
20209732|NCT00752206|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20209733|NCT01484691|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
20209734|NCT03550989|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20209735|NCT02283411|Abbott Diabetes Care|Shridhara A Karinka, PhD|510-749-6393|shridhara.alva@abbott.com|
20209736|NCT05437211|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20209737|NCT03282123|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20209738|NCT01211405|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20209739|NCT01463631|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209740|NCT00104858|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
20209741|NCT06288607|The First Affiliated Hospital with Nanjing Medical University|Dr. Yang Xu|+8613851856794|yangxu@njmu.edu.cn|
20209742|NCT05966129|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20209743|NCT01298323|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20209744|NCT01241591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227511|NCT01405560|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227512|NCT01699750|Alcon Research, Ltd.|Jessie Lemp, DrPH|1-888-451-3937|alcon.medinfo@alcon.com|
20227513|NCT01484951|Alcon Global Medical Affairs|Abayomi Ogundele, Pharm.D|1-888-451-3937||
20227514|NCT00710931|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20227515|NCT01831427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20227516|NCT02169505|UT MD Anderson Cancer Center|Ahmed,Sairah,MD / Stem Cell Transplantation|713-792-7734|sahmed3@mdanderson.org|
20227517|NCT02035553|ACADIA Pharmaceuticals Inc.|James Youakim, Vice President, Clinical Development|609-250-6900|jyouakim@acadia-pharm.com|
20227518|NCT00917124|University Hospital Center Zagreb|Zeljko Colak|00385915624189|zcolak2000@yahoo.com|
20227519|NCT00565461|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
20227520|NCT00723827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20227521|NCT03191799|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20227522|NCT02654639|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
20227523|NCT00126594|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20227524|NCT00468585|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
20227525|NCT03769649|InMode|Maria Shusterman|855.411.2639|marias@inmodemd.com|
20186160|NCT00277394|Leo Pharma|Torsten Skov, Senior Medical Advisor|+45 72263990|tosdk@leo-pharma.com|
20186161|NCT01458782|University Hospital North Norway|Dr.Ann Kristin Hansen|+4777669763|ann.kristin.hansen@unn.no|
20186162|NCT02226276|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20186163|NCT03924986|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20186164|NCT02689284|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
20186165|NCT02386722|Cantonal Hospital Baselland|Dr. Claudia Gregoriano|+41619253765|claudia.gregoriano@ksbl.ch|
20186166|NCT05516147|Hopeful Aging|Michael Skrajner|440-477-7881|mike@hopefulaging.com|
20186167|NCT03992339|Antengene Corporation|Yumei Tang|18301318100|yumei.tang@antengene.com|
20186168|NCT03396926|University of California, San Francisco|Dr.Chloe Atreya, MD, PhD|(415) 353-9888|chloe.atreya@ucsf.edu|
20186169|NCT02035787|University of North Carolina Lineberger Comprehensive Cancer Center|Lauren Higgins|919- 966-4432|lqhiggin@ad.unc.edu|
20186170|NCT06414213|Appalachian State University|Dr. Jared Skinner|828-262-2512|skinnerjw@appstate.edu|
20186171|NCT05694286|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
20186172|NCT01728857|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20186173|NCT00450658|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
20186174|NCT01083758|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20186175|NCT03555448|Washington University|R. Delos Santos|3143628351|delossantos@wustl.edu|
20186176|NCT04640298|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20186177|NCT05311384|University of Alabama at Birmingham|Sarah dos Anjos|205.934.7323|smanjos@uab.edu|
20186178|NCT04322643|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|866-223-8100|TaussigResearch@ccf.org|
20186179|NCT05079789|University Hospital Tuebingen|Dr. Anja Schork|+49 707129 83172|Anja.Schork@med.uni-tuebingen.de|
20186180|NCT03302494|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186181|NCT05134233|Fralin Biomedical Research Institute at VTC|Jessica Florig|540-526-2261|jnw@vtc.vt.edu|
20186182|NCT01573442|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-4565|cloprinzi@mayo.edu|
20186183|NCT03649659|University of Michigan|Dr. Margherita Fontana|734-763-3988|mfontan@umich.edu|
20186184|NCT05710107|Medical University of South Carolina|Ellen Johnson|843-792-2322|hayell@musc.edu|
20186185|NCT04418466|Delpor, Inc.|Eesha Gupta|415-289-1770|eesha.gupta@delpor.com|
20186186|NCT05590312|Düzce University Faculty of Medicine|Assistant Professor Özlem Ersoy Karka|+905337293978|drozlemersoy@gmail.com|
20186187|NCT04952909|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
20186188|NCT03158714|Auburn University|Francesca Adler-Baeder|334-844-4151|adlerfr@auburn.edu|
20186189|NCT02515773|University of Cincinnati|Casey Moore|513-558-6307|casey.moore@uc.edu|
20186190|NCT05434078|Baylor College of Medicine|Dr. Bijan Najafi|+1 (424) 467-7127|bijan.najafi@bcm.edu|
20186191|NCT04918823|BostonSight|Dr. Daniel Brocks|7817267337|dbrocks@bostonsight.org|
20186192|NCT04072380|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
20186193|NCT03652688|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
20186194|NCT04406441|Geisinger Health System|Dr. Lisa Bailey-Davis|570-214-9625|ldbaileydavis@geisinger.edu|
20186195|NCT03468218|Emory University|Dr. Nabil Saba|404-778-1900|nfsaba@emory.edu|
20186196|NCT03033576|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
20186197|NCT03557697|NYU Langone Health|Lu Hu|646 501 3438|lu.hu@nyulangone.org|
20186198|NCT05026320|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20186199|NCT01214616|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186200|NCT05565092|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20186201|NCT04986501|Sunbio|Min-Jung Ahn|+82-31-423-5467|mjahn@sunbio.com|
20186202|NCT03047928|CCIT-DK|Prof. MD, Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|+45
20186203|NCT02380885|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
20186204|NCT04005716|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20209745|NCT01945034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209746|NCT00478218|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20209747|NCT02389621|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20186205|NCT04511286|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
20209748|NCT04158466|Bausch Health|Study Director|(585) 338-6399|robert.steffen@bausch.com|
20209749|NCT03323034|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20209750|NCT00661037|Ospedali del Tigullio, Lavagna, Italy|Dr Michele Brignole|0185 329567329|aritmo@asl4.liguria.it|0039
20209751|NCT02526017|Five Prime Therapeutics|Helen Collins, Chief Medical Officer|650-745-9633|helen.collins@fiveprime.com|
20209752|NCT00921934|Department for Complementary and Alternative Medicine|Dr. med. Martin Schencking|+0049-2602-684-614||
20209753|NCT00536991|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20209754|NCT00054639|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
20209755|NCT01600755|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20209756|NCT03464110|Duke University|Dr. Kathryn Pollak|919-681-4757|kathryn.pollak@duke.edu|
20209757|NCT01366846|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20209758|NCT03724422|University of Louisville|Salwa Rashid|5028526964|salwa.rashid@louisville.edu|
20209759|NCT05299359|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20209760|NCT04961645|Emory University|Daniel Dilks, PhD|404-727-2980|dilks@emory.edu|
20209761|NCT03988049|University of Utah Dermatology|Dr. David Smart, Assistant Professor, Dermatology|8015816465|david.smart@hsc.utah.edu|
20209762|NCT04780776|Boston University School of Medicine|Dr. Michael F. Holick|(617) 358-6139|mfholick@bu.edu|
20209763|NCT03113760|AB2 Bio Ltd.|Eduardo Schiffrin|+41 21 694 00 40|eduardo.schiffrin@ab2bio.com|
20209764|NCT03413618|Pirogov Russian National Research Medical University|Dr. Kirill Lobastov|+7-985-211-63-31|lobastov_kv@hotmail.com|
20209765|NCT04446182|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
20209766|NCT00003526|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20209767|NCT02059265|NRG Oncology|Christopher Purdy on behalf of Austin Miller|(716)845-1300|purdyc@nrgoncology.org|2296
20209768|NCT04196023|Vanderbilt University Medical Center|Dr. Qi Dai|(615)936-0707|qi.dai@vanderbilt.edu|
20209769|NCT01499498|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
20209770|NCT03303144|Rockwell Medical|Dr Ray Pratt|248 960-9009|rpratt@rockwellmed.com|405
20209771|NCT04804579|Boston University School of Public Health|Theresa W. Kim MD|(617) 414-6932|therkim@bu.edu|
20209772|NCT04366258|NYU Langone Health|Dan Iosifescu, MD|646-754-5156|Dan.Iosifescu@nyulangone.org|
20209773|NCT03546270|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20209774|NCT02940392|Boston Scientific|Director, Clinical Operations|9529306000|teresa.takle-flach@bsci.com|
20209775|NCT03205046|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
20209776|NCT01023815|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20209777|NCT01383759|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
20209778|NCT02556112|711 Human Performance Wing, U.S. Air Force|Col Nicole Armitage|937-255-3784|nicole.armitage@us.af.mil|
20209779|NCT01678586|Massachusetts General Hospital|Dr. Lucy Chen|617-724-6102|mghpainresearch@partners.org|
20209780|NCT03455556|Mayo Clinic|Alex A Adjei, MD, PhD|(507) 284-2511|Adjei.Alex@mayo.edu|
20209781|NCT00634933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209782|NCT02058849|University of Kentucky|Dr. Travis Thomas, Associate Professor|859-218-0863|dth225@uky.edu|
20209783|NCT01694849|GENFIT|Carol Addy, MD MMSc|+01 6179536469||
20209784|NCT02219477|AbbVie|Global Medical Services|800-633-9110||
20209785|NCT03449342|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20209786|NCT01683565|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
20209787|NCT04479358|University of Chicago|Pankti Reid, MD|7737021220|pankti.reid@bsd.uchicago.edu|
20209788|NCT06241768|Wake Forest University School of Medicine|Dr. Anna Snavely|336-716-2011|asnavely@wakehealth.edu|
20209789|NCT04957979|HealthPartners Institute|Steven P. Dehmer, PhD|952-967-5216|steven.p.dehmer@healthpartners.com|
20209790|NCT02566304|Thomas Jefferson University|Usama Gergis, MD|215-955-8874|usama.gergis@jefferson.edu|
20209791|NCT04410991|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20209792|NCT00764465|GSIDA|David Condoluci|856-566-3190|dcondoluci@gsida.org|
20209793|NCT01195662|ClinicalTrialTransparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
20209794|NCT00863265|Washington University School of Medicine|Richard E. Ostlund MD|314-362-3516|rostlund@wustl.edu|
20209795|NCT00938457|Mayo Clinic|Dr. Robert C. Miller|507-284-2669|miller.robert@mayo.edu|
20209796|NCT03679117|Lifespan Hospital|Margaret Bublitz|401-323-3356|mbublitz@lifespan.org|
20186206|NCT05178316|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20186207|NCT03683719|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20186208|NCT03907397|Icahn School of Medicine at Mount Sinai|Dr. Scott Sicherer|212-241-5548|scott.sicherer@mssm.edu|
20186209|NCT05369403|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20186210|NCT05337943|University of Pennsylvania|Dr. Lea Ann Matura|2157468819|matura@nursing.upenn.edu|
20192767|NCT03783689|SPR Therapeutics, Inc|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
20192768|NCT04996940|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
20192769|NCT01351337|Huashan Hospital|Dr Jinsong Wu|862152888771|wjsongc@126.com|
20192770|NCT02392104|William S. Middleton Memorial Veterans Hospital|Andrea Porter, PharmD|608-890-0742|andrea.porter@wisc.edu|
20192771|NCT01963169|University of Maryland, Baltimore|Eun-Shim Nahm|410-706-4913|enahm@son.umaryland.edu|
20192772|NCT03912532|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
20192773|NCT04913948|Ottawa Hospital Research Institute|Dr. Darine El-Chaar|(613) 737-8899|delchaar@toh.ca|78797
20192774|NCT03947918|University of California, San Francisco|Suzanna Martinez|415-476-2300|suzanna.martinez@ucsf.edu|
20192775|NCT03783871|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20192776|NCT05990387|Indiana University|Dr. Blair Johnson|8128558699|bj33@iu.edu|
20192777|NCT00815919|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|John_Koreth@dfci.harvard.edu|
20192778|NCT03522389|Mahidol University|Sunee Bovonsunthonchai|66855926144|sunee.bov@mahidol.ac.th|
20209797|NCT01738672|University of Pittsburgh|Ya'aqov Abrams, MD||abramsym@upmc.edu|
20209798|NCT00945815|SWOG Statistical Center|SWOG Leukemia Statistician|206-667-4408||
20209799|NCT02023515|UKentucky|Kelly Webber, PhD, RD, LD|859-257-4351|kelly.webber@uky.edu|859
20209800|NCT01590810|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209801|NCT02400281|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20209802|NCT00412360|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20209803|NCT03655951|innovation Research & Training|Dr. Tracy Scull|919-493--7700|tscull@irtinc.us|118
20209804|NCT00113321|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, M.D., Professor|713/792-7026|eharriso@mdanderson.org|
20209805|NCT00509223|Baker IDI Heart and Diabetes Institute|Jonathan Shaw, MD, FRACP, FRCP|+61 (0) 3 8532 1821|jonathan.shaw@bakeridi.edu.au|
20209806|NCT03965754|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20209807|NCT02335229|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
20209808|NCT00437294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209809|NCT00470301|Montefiore Medical Center|NYCC Coordinating Center|718-405-8404|jsparano@montefiore.org|
20186211|NCT03056040|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20186212|NCT04650087|Duke University Medical Center|Dr. Thomas Ortel|919-684-5350|thomas.ortel@duke.edu|3
20186213|NCT03445988|Stanford University|Beth Darnall, PhD|N/A|bdarnall@stanford.edu|
20186214|NCT03232138|University of Pittsburgh Cancer Institute|Jian-Min Yuan M.D., Ph.D.|412-864-7889|yuanj@upmc.edu|
20186215|NCT03001414|Northern Therapeutics, Inc.|Duncan Stewart, Clinical Trial Medical Consultant|613-737-8899|djstewart@toh.ca|76686
20186216|NCT03920111|University of Liverpool|Dr Lance Turtle|01517957554|lance.turtle@liverpool.ac.uk|
20186217|NCT05268393|Children's National Hospital|Dr. Eleanor Mackey|202-476-5307|emackey@childrensnational.org|
20186218|NCT04727554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20186219|NCT05763823|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20186220|NCT03778112|Rush University Medical Center|Dian Wang, MD|(708) 660-3476|Dian_Wang@rush.edu|
20186221|NCT01997840|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20186222|NCT05009004|Environment and Health Group|Patricia Weitzman|6174555976|pat.weitzman@ehgcambridge.com|
20186223|NCT05256706|Emory University|Dr. Arshed Quyyumi|404-712-2741|aquyyum@emory.edu|
20186224|NCT03898986|Stanford University|Philip Grant, MD|6507239001|pmgrant@stanford.edu|
20186225|NCT03850678|University of Nebraska-Lincoln|Marc Brennan|4024723132|marc.brennan@unl.edu|
20186226|NCT03720795|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
20186227|NCT05523154|Mayo Clinic|Dr. Marina Walther-Antonio|(507) - 284-2282|waltherantonio.marina@mayo.edu|
20186228|NCT04166773|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20186229|NCT04763265|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
20186230|NCT04510974|James J Peters VA Medical Center|Dr. Caitlyn Peters|9733243588|cpeters@kesslerfoundation.org|
20186231|NCT04115540|Stanford University|Michael Eisenberg MD|650-723-3391|meisenb@stanford.edu|
20186232|NCT03269136|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186233|NCT05071807|Penn State University|DCH Lab|8148638056|dchlab@psu.edu|
20186234|NCT03729999|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
20186235|NCT05308004|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
20186236|NCT04267172|Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford.|Professor Jonathan Rees|01865737540|jonathan.rees@ndorms.ox.ac.uk|
20186237|NCT04552223|University of Miami|Jose Lutzky MD|+1 (305) 6896500|jose.lutzky@med.miami.edu|
20186238|NCT04856163|RAND|Dr. Lori Uscher-Pines|703-413-1100|luscherp@rand.org|
20186239|NCT03762915|University of Minnesota|Michelle Arnette|6126243457|marnett@umn.edu|
20192779|NCT04680637|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20192780|NCT03167151|Oxford University Hospitals NHS Foundation Trust|Dr Andrew S Protheroe|01865 253275|andrew.protheroe@oncology.ox.ac.uk|
20209810|NCT02464176|Wake Forest Baptist Medical Center|Dr. James D. Turner|3367164998|jturner@wakehealth.edu|
20209811|NCT02277665|Dartmouth-Hitchcock|Dr. Alan J. Budney|603-646-7088|alan.j.budney@dartmouth.edu|
20209812|NCT05292248|Case Western Reserve University|Kylie Meyer, Principal Investigator|216-368-1928|knm77@case.edu|
20209813|NCT01473602|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20186240|NCT05369533|University of California, Los Angeles|Steven Cramer|424-522-7874|SCCramer@mednet.ucla.edu|
20186241|NCT04799704|UZ Leuven|Heleen Delbeke, MD|003216342229|heleen.delbeke@uzleuven.be|
20192781|NCT01458522|Duke University|Aatif M. Husain, M.D.|919-668-8700|aatif.husain@duke.edu|
20192782|NCT00516139|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192783|NCT00416598|The Ohio State University|William Blum, M.D.||William.Blum@osumc.edu|
20192784|NCT01226732|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20192785|NCT02166476|The Medicines Company|Global Health Science Center|888-977-6326|medical.information@themedco.com|
20192786|NCT05155566|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192787|NCT03752177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20227526|NCT03519009|Johns Hopkins University|Professor|4436176051|ksilverm@jhmi.edu|
20192788|NCT04367480|University of Rochester NCORP Research Base|Jennifer Gewandter, PhD|585-275-2141|Jennifer_Gewandter@urmc.rochester.edu|
20192789|NCT03382561|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20192790|NCT01131104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20192791|NCT01076244|Center for Pain Relief|Timothy Deer|(304) 347-6144|Diana.tolentino@stfh.net|
20192792|NCT04836559|Janssen Research & Development, LLC|Executive Medical Director Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20192793|NCT00730015|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
20192794|NCT01432626|University of Pittsburgh|Dr. Prem Soman|412 647 3435|somanp@upmc.edu|
20192795|NCT05382039|Loma Linda University|Eric Johnson|9095584632|ejohnson@llu.edu|47471
20192796|NCT01642147|Huashan Hospital Fudan University|Xiao-Yu Yang|086-021-52889999|xiaoyuyangfudan@gmail.com|7693
20192797|NCT03210519|Department of Nutrition, Chung Shan Medical University|Dr. Nae-Cherng Yang|886-0936810214|naeman@csmu.edu.tw|
20192798|NCT02270671|University College Dublin|Dr Amanda Fitzgerald|+35317168541|amanda.fitzgerald@ucd.ie|
20192799|NCT04486313|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
20192800|NCT00126659|UT MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor||caperez@mdanderson.org|
20192801|NCT00174447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20192802|NCT02643225|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20192803|NCT00940875|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192804|NCT03064152|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
20192805|NCT01951768|Geneva University Hospitals, Balgrist University Hospital|Dr. med. Ilker Uçkay|+41 44 386 11 11|ilker.uckay@balgrist.ch|
20192806|NCT03603639|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20192807|NCT01181492|Huazhong University of Science&Technology|Zhang Xianwei|027 83662853|ourpain@163.com|
20192808|NCT00720369|McLean Hospital|Cara McCabe, BA|617-855-2410|cfmccabe@partners.org|
20192809|NCT02402322|Universitat Autonoma de Barcelona|Dr. Pablo Oromendia|+34 665175467|p.oromendia@gmail.com|
20192810|NCT02818998|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20192811|NCT03414047|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20192812|NCT04919070|University of Rochester|Dr. Sally Norton|5852759814|sally_norton@urmc.rochester.edu|
20192813|NCT01704547|UMGCCC|Elizabeth M. Nichols, MD|410-328-2324|enichols1@umm.edu|
20192814|NCT03101033|Xijing Hospital, the Fourth Military Medical University|Dr yan lu|029-84775337|yanlu001@fmmu.edu.cn|029-847753
20192815|NCT02413593|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20192816|NCT01101061|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20192817|NCT00857233|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20192818|NCT00409409|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
20192819|NCT02569957|Sidney Kimmel Cancer Center at Thomas Jefferson University|Russell Schilder|215-503-3057|russell.schilder@jefferson.edu|
20192820|NCT02635386|Woman's Hospital|Dr Karen Elkind-Hirsch|2252315278|karen.elkind-hirsch@womans.org|
20192821|NCT03042299|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20192822|NCT02706847|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20192823|NCT02058836|Wake Forest University Health Sciences|Dr. Ryan Terlecki|336-716-2011|rterlecki@wakehealth.edu|
20192824|NCT00835185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20192825|NCT05702541|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20192826|NCT00798304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20192827|NCT04211389|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20192828|NCT00980590|Cleveland Clinic|Dr. Daniel Sessler|216-445-6500|sessled@ccf.org|
20192829|NCT03850275|Clarkson University|Ali Boolani|3152681663|aboolani@clarkson.edu|
20192830|NCT02168478|Medimetriks|Noah L. Rosenberg, MD, Chief Medical Officer|2019194083|Noahrosie@yahoo.com|
20227527|NCT00731822|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227528|NCT02127658|Indiana University|Dr. Paul Musey|(317) 880-3900|pmusey@iu.edu|
20227529|NCT03834493|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227530|NCT05796791|Medical University of South Carolina|Emily Amador|916-279-6481|emmcamador@gmail.com|
20192831|NCT01530087|Hollister Incorporated|Director, Global Clinical Affairs|847.918.3467|Stacy.Haddad@hollister.com|
20192832|NCT01324700|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD, Professor of Psychiatry|214-645-6950|sherwood.brown@utsouthwestern.edu|
20192833|NCT05479747|Faculty of Dentistry, Ain Shams University|Dr|+11112228724|AlaaMahmoud@dent.asu.edu.eg|
20227531|NCT04144322|University of Michigan|Dr. Tae-Ju Oh|7346473320|taejuoh@umich.edu|
20192834|NCT01087814|University of Minnesota|Ann Seguin|612-625-7472|segu0017@umn.edu|
20227532|NCT02277028|now at Northwestern University, Department of PM&R|Mary Ellen Stoykov|312-503-3106|mstoykov@sralab.org|
20209814|NCT00449761|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20186242|NCT04359108|Johns Hopkins Applied Physics Laboratory|Seth Billings|240-228-7462|seth.billings@jhuapl.edu|
20186243|NCT06393088|IR Technology LLC|Consulting Director of Clinical Trials|404 915-5938|andyn@invisaredtech.com|
20186244|NCT04176965|BVI medical|Rebecca McQuaid|+353871212615|RMcQuaid@bvimedical.com|
20186245|NCT04721912|University of New Mexico|Katrina Nardini, CNM, WHNP-BC, MPH|505-205-4118|hsc-familyplanningresearch@salud.unm.edu|
20186246|NCT04924660|Vanderbilt University Medical Center|Sean P. Collins, MD|615-343-8010|vcc@vumc.org|
20186247|NCT05894577|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
20186248|NCT05093478|The University of Texas Health Science Center at Houston|Kunal R Shetty, MD|713-486-5000|Kunal.R.Shetty@uth.tmc.edu|
20209815|NCT00560573|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209816|NCT01339273|Oxford University Hospitals NHS Trust|Dr Nicholas Crabtree|01865 221590|nicholas.crabtree@ouh.nhs.uk|
20209817|NCT00726882|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20209818|NCT00594568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209819|NCT01198327|Wilmer Eye Institute|Peter Campocahiro|410-955-5106|pcampo@jhmi.edu|
20209820|NCT01422876|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209821|NCT02856282|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20186249|NCT05891353|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
20186250|NCT04541147|Duke University|Eileen M. Raynor, MD|919-613-4573|eileen.raynor@duke.edu|
20209822|NCT02406937|Sprim (Shanghai) Consulting Co., Ltd.|Dr. Charlie Zhang|+86 (21) 51097272|charlie.zhang@sprim.cn|
20209823|NCT01363999|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20209824|NCT02506101|Johns Hopkins Medicine|Dr. Ginette Okoye|410-502-7546|CTReP@jhmi.edu|
20186251|NCT02949362|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20209825|NCT01308476|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209826|NCT02696382|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
20209827|NCT03986216|Northwestern University|Dr. Jun Yao|3129089060|j-yao4@northwestern.edu|
20227533|NCT02718911|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20227534|NCT04817332|University of Dundee, UK|Professor James D Chalmers|01382660111|jchalmers@dundee.ac.uk|
20227535|NCT01867008|Cochlear Americas|Clinical Project Manager|303-264-2340|knix@cochlear.com|
20227536|NCT00983372|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20227537|NCT01898403|Stanford University Medical Center|Dana T Lin, MD; Clinical Assistant Professor|650-498-6000|danalin@stanford.edu|
20227538|NCT03077893|Regenesis Biomedical|Heather M Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
20227539|NCT00359203|Medtronic Italia SpA|Silvia Giuli|003932814224|silvia.giuli@medtronic.com|
20227540|NCT01218542|Emory University|Dr. Hui-Kuo Shu|404-778-2161|hgshu@emory.edu|
20227541|NCT02131064|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20227542|NCT01062893|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-8278|ppan@wakehealth.edu|
20227543|NCT02554760|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20227544|NCT00394888|Medical College of Wisconsin|Dr. Beth Drolet|414-266-1569|bdrolet@mcw.edu|
20227545|NCT02078193|East Carolina University, Division of Nephrology|Austin Rice|252-744-1904|riceau15@ecu.edu|
20227546|NCT00936455|University of California San Diego|Dr Brett Meyer|619-543-7760|bcmeyer@ucsd.edu|
20227547|NCT00570401|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
20227548|NCT00871234|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iupui.edu|
20227549|NCT01710020|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227550|NCT01764841|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20227551|NCT00549549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227552|NCT02155699|Northwestern University|Dr. Vijay A Mittal|847-467-3880|vijay.mittal@northwestern.edu|
20227553|NCT02108977|Health Services Research & Development, Durham VAMC|Dr. Santanu Datta, Health Sciences Research Specialist, HSR&D|(919) 286-0411|Santanu.Datta@va.gov|7580
20227554|NCT02688933|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20227555|NCT00810199|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20227556|NCT01121939|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20227557|NCT00992017|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
20227558|NCT02864407|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20227559|NCT02992119|MORU|Lorenz von Seidlein|662036663|Lorenz@tropmedres.ac|
20227560|NCT01720316|McLean Hospital|Dr. Deborah L. Levy|617-855-2854|dlevy@mclean.harvard.edu|
20227561|NCT02287038|Ralph H. Johnson VA Medical Center|Dr. Zhewu Wang|8437897949|zhewu.wang@va.gov|
20227562|NCT02731300|Department of Physiology; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.|Paradee Auvichayapat|66896222624|aparad@kku.ac.th|
20227563|NCT02713178|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20227564|NCT01298167|Yale University|David Leffell, MD|203 785 7999|david.leffell@yale.edu|
20227565|NCT05502302|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
20227566|NCT01105312|Mayo Clinic|Winston Tan MD|507-284-1159|tan.winston@mayo.edu|
20227567|NCT02155985|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20227568|NCT03110133|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
20227569|NCT02998151|Cincinnati Children's Hospital Medical Center|Dr. Craig Erickson|513-636-0523|craig.erickson@cchmc.org|
20227570|NCT00952315|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
20227571|NCT04000438|Dilafor AB|Gunvor Ekman-Ordeberg|+467060833111|gunvor.ekman-ordeberg@dilafor.com|
20227572|NCT04414787|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
20227573|NCT04369833|Pusan national university hospital|Dr. Sang Soo Kim|+82-51-240-7837|drsskim7@gmail.com|
20227574|NCT00934375|Eisai Inc.|Anita Murthy, Study Director|201-692-1100||
20227575|NCT02674503|Birmingham VA - GRECC Director; Professor at UAB|Dr. Alayne Markland|205-558-7067|alayne.markland@va.gov|
20227576|NCT01022203|Southeast Louisiana Veterans Health Care System (SLVHCS)|Frederic Sautter, Ph.D.|504-988-3026|Fsautter@tulane.edu|
20192835|NCT01427738|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20227577|NCT04350593|Saint Luke's Hospital of Kansas City|DARE-19 Global Project Manager|816-932-9858|DARE-19@saint-lukes.org|
20227578|NCT03163446|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
20227579|NCT03638128|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20186252|NCT03476460|Hospital Universitario Ramón y Cajal, IRYCIS|Coordinator of Research Support Unit, Internal Medicine Dept.|0034913369082|martin.fabregate@salud.madrid.org|
20186253|NCT03703492|UW School of Medicine and Public Health|Amy Fowler, MD, PhD|608-262-2122|afowler@uwhealth.org|
20186254|NCT04550468|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
20186255|NCT04015167|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20186256|NCT03640312|Washington University in St. Louis|Guhan Iyer|3147479487|guhaniyer@wustl.edu|
20186257|NCT05733975|Duke Univerisity Medical Center|Dr. Monica Lemmon|919-668-0477|monica.lemmon@duke.edu|
20186258|NCT05455086|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20186259|NCT02761057|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
20186260|NCT06037369|Chang Gung University, Taiwan|Yen-Fan Chin|032118800|yenfan@mail.cgu.edu.tw|5189
20186261|NCT05492318|Italfarmaco SpA|Dr. Paolo Bettica, MD|+39 02 64431 (centralino)|p.bettica@italfarmacogroup.com|
20186262|NCT05008835|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20227580|NCT00611806|Massachusetts General Hospital|Joshua L. Roffman, MD|617-724-1920|jroffman@partners.org|
20186263|NCT03993509|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
20186264|NCT04876118|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20186265|NCT05089734|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20186266|NCT05179395|James A Haley Veterans' Hospital and Clinics|Dr. Jeffrey Heckman|813.972.2000|jeffrey.t.heckman@va.gov|7506
20186267|NCT00812461|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20192836|NCT05314374|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
20192837|NCT02658175|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20192838|NCT00762645|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20192839|NCT02918292|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20192840|NCT01966978|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20227581|NCT00587067|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-3624|jarnagiw@mskcc.org|
20227582|NCT00329108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20227583|NCT02371616|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227584|NCT02576899|VISN 1 MIRECC|Megan M. Kelly, Ph.D.|781-687-3317|Megan.Kelly1@va.gov|
20227585|NCT00500448|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
20227586|NCT04069715|KGK Science Inc.|Malkanthi Evans (Ph.D.), Chief Scientific officer|5194389374|mevans@kgkscience.com|239
20227587|NCT03205150|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20202963|NCT03136705|Northwestern University Feinberg School of Medicine|Doctor|312-503-6921|tamara.isakova@northwestern.edu|
20227588|NCT02723188|Tel Aviv University|Yair Bar-Haim|97236406393|yair1@post.tau.ac.il|
20163024|NCT01436266|Boston Medical Center|Sarita Sonalkar, MD|617 414 7304|sarita.sonalka@bmc.org|
20209828|NCT03246152|Cairo University|Dr. Ayman Elnahry|00201224927604|ayman_elnahri@hotmail.com|
20163025|NCT01496846|University of Michigan|Dr Tatiana Botero, Director of Postgraduate Program in Endodontics|734-936-2526|tbotero@umich.edu|
20163026|NCT01772576|Boston Scientific|Ursula Appl|003224167213|ursula.appl@bsci.com|
20209829|NCT00423137|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163027|NCT00923845|National Cancer Institute|Dr. Daniel Fowler|301-435-8641|fowlerda@mail.nih.gov|
20163028|NCT00639626|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
20163029|NCT00379912|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20209830|NCT01243762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20186268|NCT05297864|University of Oklahoma Health Sciences Center|James Battiste, MD|405-271-8777|James-Battiste@ouhsc.edu|
20186269|NCT04889755|Boston University|Associate Professor|(617) 358-4296|kalong@bu.edu|
20186270|NCT01969539|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186271|NCT03992274|Columbia University|Kathrine Meyers, DrPH, MPP, MSc|2123046110|kam2157@cumc.columbia.edu|
20209831|NCT04359758|Georgetown Lombardi Comprehensive Cancer center|Marc D. Schwartz, PhD|2026870185|schwartm@georgetown.edu|
20209832|NCT03358407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209833|NCT00483574|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20209834|NCT03605758|Albert Einstein College of Medicine|Dr. Christina Coyle|718-430-3525|christina.coyle@einsteinmed.edu|
20209835|NCT00750373|Asan Medical Center|Dr. Duk-Hyun Kang|82-2-3010-3149|dhkang@amc.seoul.kr|
20209836|NCT01042288|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20209837|NCT02276274|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20209838|NCT02279888|Vanderbilt University Medical Center|Dr. Lynne Stevenson|6159368187|lynne.w.stevenson@vanderbilt.edu|
20209839|NCT05240313|Boston College|Christopher Salas-Wright|617-552-1295|christopher.salas-wright@bc.edu|
20186272|NCT03366649|Emory University|Dr. Robert Guyton|404 686-4499|rguyton@emory.edu|
20186273|NCT03673111|Imperial College London|Professor Tricia Tan|020 8383 8038|t.tan@imperial.ac.uk|
20186274|NCT03792555|Crinetics Pharmaceuticals Inc.|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
20186275|NCT05593510|UT Southwestern Medical Center|Kelseanna Hollis-Hansen|214-645-7676|kelseanna.hollis-hansen@utsouthwestern.edu|
20186276|NCT04485039|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
20186277|NCT01747863|Research Institute of the McGill University Health Center|Dr. Guilherme Sant'Anna|(514) 412-4400|guilherme.santanna@mcgill.ca|23489
20209840|NCT00147290|Medtronic|Elisabetta Santi|003906328141|elisabetta.santi@medtronic.com|
20209841|NCT00262119|Medtronic|Senior Clinical Research Manager|0039-0632814225|andrea.grammatico@medtronic.com|
20209842|NCT00071006|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186278|NCT00378105|Dana-Farber Cancer Institute|Dr. Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
20186279|NCT02120456|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20192841|NCT02650466|Alfred E. Mann Insitute at the University of Southern California|Cesar E. Blanco,PhD; Sr Director R&D|2138211619|cblanco@usc.edu|2138211619
20192842|NCT00604188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20209843|NCT03142919|LIBR|Jonathan Savitz|9185025104|jsavitz@laureateinstitute.org|
20209844|NCT05261126|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209845|NCT03901274|University of South Carolina|Dr. Mark Weist|803-777-8438|weist@mailbox.sc.edu|
20209846|NCT05570604|Ohio State University|Dr. Diane Von Ah|614-688-0722|vonah.1@osu.edu|
20209847|NCT03810417|University of Maryland|Stephen Gottlieb, MD|410-328-7877|sgottlie@som.umaryland.edu|
20209848|NCT00953173|Apollo Endosurgery Inc|Director of Clinical Affairs|512-279-5157|jose.naveira@apolloendo.com|
20209849|NCT04828993|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209850|NCT01250418|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20209851|NCT01761565|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20209852|NCT05182840|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209853|NCT02161380|Bascom Palmer Eye Institute.|Dr. Byron Lam.|305 326 6021|blam@med.miami.edu|
20209854|NCT05510297|University of Southern California|Dr. Stacey Schepens Niemiec|323-442-2069|schepens@usc.edu|
20209855|NCT02478281|American Regent Inc.|Hal Rathfon, RPh|631-772-3555|HRathfon@americanregent.com|
20209856|NCT04409262|Hoffmann - La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20209857|NCT03205605|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20209858|NCT02396849|Indiana University|Christina Tiller|317-044-4522|ctiller@iu.edu|
20209859|NCT03328325|University of Rochester|Angela Branche, MD, Site Principal Investigator|585-275-5871|angela_branche@urmc.rochester.edu|
20209860|NCT03677440|Kessler Foundation|Brian Sandroff, PhD|973-965-6649|bsandroff@kesslerfoundation.org|
20209861|NCT00948896|University of California, San Francisco|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
20209862|NCT01869959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209863|NCT01965600|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209864|NCT04678557|Vertex|Medical Information|617-341-6777|medicalinfo@vrtx.com|
20209865|NCT00157157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20209866|NCT01678794|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
20209867|NCT00121251|Weill Cornell Medical College|Cooperative Group Program Manager|646-962-9377|has7003@med.cornell.edu|
20209868|NCT02260804|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
20209869|NCT06212310|UT Southwestern Medical Center|Sayoni Lahiri|214-645-2563|sayoni.lahiri@utsouthwestern.edu|
20227589|NCT00991081|Stanford University|Sean P. David, MD, SM, DPhil|650-498-4687|spdavid@stanford.edu|
20227590|NCT00871624|Tufts Medical Center|Russel Roberts, PharmD|617-636-4576|rroberts@tuftsmedicalcenter.org|
20227591|NCT02486692|Ralph H. Johnson VAMC|Anouk Grubaugh|843-532-6672|grubaugh@musc.edu|
20227592|NCT01204736|Rehabilitation Institute of Chicago|Dr. Wendy Murray|3122386965|w-murray@northwestern.edu|
20227593|NCT00001322|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
20227594|NCT00116688|Amgen Inc.|Study Director|866-572-6436||
20227595|NCT01640548|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20227596|NCT02864069|UCSD|Dr. Amy Jak|8586423742|ajak@ucsd.edu|
20227597|NCT01775670|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
20227598|NCT02169440|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20227599|NCT00643760|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20227600|NCT00857506|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20227601|NCT01547715|Novartis Vaccines and Diagnostics SRL|Posting Director||RegistryContactVaccinesUS@novartis.com|
20227602|NCT03353792|Associate Professor of Medicine|Raimund Herzog, MD, MHS|(877) 925-3637|raimund.herzog@yale.edu|
20227603|NCT00789321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20227604|NCT00104052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20227605|NCT03477162|Dartmouth Hitchcock Medical Center|Joseph Phillips, MD|603-650-5000|Joseph.D.Phillips@hitchcock.org|
20227606|NCT04735705|Perfect Care Distribution|Mihnea Mihalache, Chief Executive Officer|+40 786 749 087|contact@perfectcare.ro|
20227607|NCT03652818|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
20227608|NCT03964207|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20227609|NCT00830219|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20227610|NCT04789304|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20227611|NCT01241279|Valeant Pharmaceuticals/Bausch & Lomb|Johnson Varughese|908-927-1162|Johnson.Varughese@valeant.com|
20227612|NCT03041441|Duke University Dept of Radiology|Research Coordiantor|(919) 684-7732|christopher.vallanat@duke.edu|
20227613|NCT05252858|UPMC|Amy Monroe|412-623-6382|monroeal@upmc.edu|
20227614|NCT00239720|University of Chicago|Marcus Clark, MD|773-702-0202|mclark@medicine.bsd.uchicago.edu|
20227615|NCT01811732|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
20227616|NCT01783743|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
20186280|NCT05192200|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209870|NCT05981508|Morehouse School of Medicine|Candice L. Alick, PhD|404-752-1009|calick@msm.edu|
20186281|NCT03623321|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20186282|NCT03378570|University of Iowa Hospitals & Clinics|Dr. Nicholas Trapp|(319) 467-8188|nicholas-trapp@uiowa.edu|
20186283|NCT04241068|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20209871|NCT02263118|Ecole Polytechnique|Dr. Jose Tomas Prieto|+50252800643|jose-tomas.prieto@polytechnique.edu|
20186284|NCT03843151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209872|NCT04074109|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
20186285|NCT03443323|Children's Hospital of Philadelphia|Dr. Thomas J. Power|215-590-7447|power@chop.edu|
20209873|NCT02983305|University of Michigan|Sara|734-936-7567|weisssar@umich.edu|
20209874|NCT00822237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209875|NCT01519635|Service of Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne|Prof Michel Burnier|+41 21 314 11 54|michel.burnier@chuv.ch|
20209876|NCT01969201|IBSA Insitut Biochimique|Project Leader|+41 58 360 10 00|rd@ibsa.ch|
20209877|NCT00518531|Amgen Inc.|Study Director|866-572-6436||
20209878|NCT02192307|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20209879|NCT04621227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209880|NCT01728376|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20209881|NCT00626574|University of South Florida|Enrico M Camporesi MD|813-844-7170|ecampore@health.usf.edu|
20209882|NCT03891602|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
20209883|NCT02303977|Abramson Cancer Center, Penn Presbyterian Medical Center|Dr. Christine Ciunci|215-662-9801|christine.ciunci@pennmedicine.upenn.edu|
20209884|NCT00057330|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209885|NCT03681769|Medical University of South Carolina|Dr. Jeff Borckardt|843-792-3295|borckard@musc.edu|
20209886|NCT04888377|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
20209887|NCT00812968|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20209888|NCT00494234|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20209889|NCT03478982|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
20209890|NCT01005810|Medical University of South Carolina|Dr. Kevin M. Gray, Associate Professor|843-792-6330|graykm@musc.edu|
20227617|NCT02771275|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20227618|NCT05556148|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20227619|NCT04821063|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 6443 2575|m.caserini@italfarmacogroup.com|
20227620|NCT01421498|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20227621|NCT03059914|Loma Linda University Health|Sarat Ummethala|909 558 4983|saratdoc@yahoo.com|
20227622|NCT01290718|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20227623|NCT00915590|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
20227624|NCT02456727|Albert Einstein College of Medicine|Diane McKee|718-430-2952|Diane.Mckee@einstein.yu.edu|
20218133|NCT01481740|Department of Women's & Obstetric Anesthesia, IWK Health Centre|Dr. Ronald B George|902-470-6627|rbgeorge@dal.ca|
20163030|NCT02578186|Procter & Gamble|Andrew L. Carr, PhD|513-622-0928|carr.an@pg.com|
20218134|NCT01020799|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20218135|NCT04209335|University of Salford|ISOMETRIC CORE MUSCLE ENDURANCE IN HEALTHY ACTIVE AND NON-ACTIVE WORKING AGE POPULATIONS|07488550768|H.Holmberg@edu.salford.ac.uk|
20218136|NCT01510652|Institute of Cardiology, Univ. of Bologna, Bologna, Italy|Prof. Giuseppe Boriani||giuseppe.boriani@unibo.it|
20218137|NCT04079127|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
20218138|NCT00578071|Duke University Medical Center Radiation Oncology|Dr Brian Czito|668-7336|brian.czito@duke.edu|
20218139|NCT01560507|Duke University Medical Center|Dr. Jed Rose|919-668-5055|jed.rose@duke.edu|
20218140|NCT00560937|Durham Veterans Affairs Medical Center|Christine E. Marx, MD, MA|919 286-0411|marx0001@mc.duke.edu|7426
20218141|NCT01138111|Piramal Imaging|Juergen Hirschfeld, Senior Director Regulatory Affairs|+49 30 461 1246 15|juergen.hirschfeld@piramal.com|
20218142|NCT01118117|Terumo Medical Corporation|Adam Thompson, Clinical Program Manager|201-398-3283|adam.thompson@terumomedical.com|
20218143|NCT01660022|Medicines for Malaria Venture|Fiona Macintyre|0041 22 555 0319|macintyref@mmv.org|
20218144|NCT00306163|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20218145|NCT03179163|Penn State|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
20218146|NCT00195013|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
20218147|NCT02149121|Celltrion, Inc.|SungYoung Lee|+82 32 850 6532|SungYoung.Lee@celltrion.com|
20218148|NCT03166124|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20218149|NCT01398839|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
20218150|NCT00788593|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20218151|NCT00515034|Johnson and Johnson Pharmaceutical Research and Development L.L.C.|Senior Director of Clinical Development|510 248-2310||
20218152|NCT02858726|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20192843|NCT00589836|Cleveland Clinic|Zoran Popovic MD|216 444-9242|popoviz@ccf.org|
20186286|NCT04492007|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan PhD|919-966-8450|xianming@email.unc.edu|
20186287|NCT03463824|Virginia Commonwealth University|Dr. James Thomas|740-591-1563|jthomas32@vcu.edu|
20209891|NCT01797458|Preventive and Paediatric Dentistry Department of Greifswald University, Germany|Prof. Dr. Christian Splieth|+ 49 3834 867101|splieth@uni-greifswald.de|
20186288|NCT04177823|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20186289|NCT04229992|Vanderbilt University Medical Center|Dr. Martha Shrubsole, Dr. Qi Dai|(615)936-0707|Martha.shrubsole@vanderbilt.edu, qi.dai@vanderbilt.edu|
20192844|NCT04599907|Candesant Biomedical|Erin Tims, VP of Clinical Affairs|19255776863|etims@candesant.com|
20186290|NCT03770273|National Institute of Allergy and Infectious Diseases|Hirsh Komarow|+1 301 594 2197|komarowh@niaid.nih.gov|
20186291|NCT00418886|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20186292|NCT04060654|Indivior Inc|Sunita Shinde|804 379-1090|sunita.shinde@indivior.com|
20192845|NCT03780010|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
20192846|NCT03500835|Children's Hospital Los Angeles|Alaina Vidmar|323-361-4606|avidmar@chla.usc.edu|
20192847|NCT00443599|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
20192848|NCT00966264|Helsinki University|Ritva Hurskainen|+23845872267|ritva.hurskainen@hus.fi|
20192849|NCT00487825|Novartis Pharmaceuticals|Study Director|862-778-8300||
20192850|NCT01473745|ChangGungMH|Dr. Yi Hsuan Chen|+886227135211|acantehr@gmail.com|3533
20192851|NCT01986114|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20192852|NCT01190644|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192853|NCT02366143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20192854|NCT02172911|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20192855|NCT01589926|Children's Hospital at Montefiore|Kerry Morrone, MD, Asst Prof of Pediatrics|718-741-2342|kmorrone@montefiore.org|
20192856|NCT00575042|University of Miami|Dr. Cynthia Levy|305-243-2330|clevy@med.miami.edu|
20192857|NCT00566813|University of Illinois at Chicago|Jose Oberholzer, MD|312-996-6771|jober@uic.edu|
20192858|NCT04795336|NYU Langone Health|Joshua C Rozell, MD|212-598-6000|Joshua.rozell@nyulangone.org|
20192859|NCT01638390|Carl Zeiss Meditec, Inc.|Todd Otani, Senior Clinical Research Scientist|925-557-4513|todd.otani@zeiss.com|
20192860|NCT00158197|Friends Research Institute|Joy Chudzynski|323-333-8122|joychud@ucla.edu|
20192861|NCT04012619|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
20192862|NCT01536587|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192863|NCT02666664|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20192864|NCT04596995|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20209892|NCT04753606|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20209893|NCT04436497|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20209894|NCT01012609|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
20209895|NCT00761969|Department of Vascular Diseases, University of Ljubljana Med Ctr|Ales Blinc, MD, DSc|+386 1 522 80 32|ales.blinc@kclj.si|
20209896|NCT01725217|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20209897|NCT03253809|Cleveland Clinic|Dr. Mark Neibauer|216-444-3160|niebaum@ccf.org|
20209898|NCT03176953|National Center for PTSD|Sonya Norman, PhD|858-518-8266|sonya.norman@va.gov|
20209899|NCT03992456|Duke Cancer Institute|John Strickler, MD|(507) 284-2511|john.strickler@duke.edu|
20209900|NCT01068418|Brigham and Women's Hospital, Harvard Medical School|Jonathan S. Williams|6177325666|jwilliams5@partners.org|
20209901|NCT00910000|Dana-Farber Cancer Institute|Ursula Matulonis, MD|617-632-2334|umatulonis@partners.org|
20209902|NCT04637815|RAND|David P. Kennedy|3104673904|davidk@rand.org|6133
20209903|NCT01977625|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
20186293|NCT03707951|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20186294|NCT04887129|University of Rochester|John Foxe, Phd|585 - 275 - 2591|John_foxe@urmc.rochester.edu|
20186295|NCT04294290|Duke University|Joanne Kurtzberg, MD|919-668-1119|joanne.kurtzberg@duke.edu|
20186296|NCT01999075|CHEO Research Institute|Dr. Sherri Katz (Principal Investigator)|613-737-7600|skatz@cheo.on.ca|2956
20192865|NCT00129935|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20192866|NCT03445793|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|taylorcousarj@njhealth.org|
20192867|NCT02783573|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
20209904|NCT02594384|OrphAI Therapeutics|Esther Nkrumah|267 512-1750|enkrumah@orphai-therapeutics.com|
20192868|NCT03020069|NYU Langone Health|Jeniece Ilkowitz RN, MA, CDE|212-263-9910|Jeniece.ilkowitz@nyulangone.org|
20186297|NCT05521308|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
20192869|NCT00589303|Mayo Clinic|Dr. Win K. Shen|480-342-0348|wshen@mayo.edu|
20209905|NCT02427568|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20209906|NCT01717521|UWMC|Dr. Laurent Bollag|2063277328|bollag@uw.edu|
20209907|NCT03919669|University of WI Alzheimer's Disease Research Center|Dr. Sterling Johnson|608-262-9549|scj@medicine.wisc.edu|
20209908|NCT01265875|Dartmouth-Hitchcock Medical Center|Timothy Gardner, MD|603-650-6472|timothy.b.gardner@hitchcock.org|
20209909|NCT00483119|NYU School of Medicine|Elise Kelman, Associate Director of Research Administration|2122639073|elise.kelman@nyumc.org|
20209910|NCT04409509|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20209911|NCT04668066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209912|NCT02331680|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
20209913|NCT05147311|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭(617) 525-7472‬|hermioni_amonoo@dfci.harvard.edu|
20209914|NCT02504099|AbbVie|Global Medical Services|800-633-9110||
20209915|NCT04505592|Icahn School of Medicine at Mount Sinai|Dr. Hooman Poor|(212) 241-5656|hooman.poor@mountsinai.org|
20209916|NCT02648646|University of North Carolina|Yvonne Golightly PT, PhD, Assistant Professor of Epidemiology|919-966-0566|golight@email.unc.edu|
20209917|NCT03522506|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20209918|NCT03480243|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20209919|NCT00761085|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20209920|NCT01522755|Medtronic|Foudali Latifa|+33 631992144|latifa.foudali@medtronic.com|
20209921|NCT03414658|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|Adrienne_Waks@dfci.harvard.edu|
20209922|NCT02388906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20209923|NCT05934591|University of Illinois Urbana Champaign|Dr. Liliane Windsor|2173001782|lwindsor@illinois.edu|
20209924|NCT05770401|University of Montana|Jane Reynolds Salois|406-243-2138|jane.salois@umontana.edu|
20209925|NCT00402298|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20209926|NCT04784455|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
20209927|NCT04298229|Vanderbilt University Medical Center|Zachary Cox|615-966-7107|zachary.l.cox@vumc.org|
20209928|NCT00859313|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
20209929|NCT03671746|Massachusetts General Hospital|Dr. Arun Aneja, MD, PhD|617-726-6546|aaneja@mgh.harvard.edu|
20209930|NCT05643573|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20209931|NCT02500732|University of Calgary|Dr. Satish R Raj|403-210-6152|satish.raj@ucalgary.ca|
20209932|NCT03572153|Baylor University|Gary Elkins, PhD|254-296-0824|gary_elkins@baylor.edu|
20209933|NCT04794491|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@jazzpharma.com|
20209934|NCT00931515|Pioneer Surgical Technology|Director of Regulatory and Clinical Affairs|906-225-5602|emilydowns@pioneersurgical.com|
20209935|NCT01375491|University of California, San Diego|Dr. Karen Louise Herbst|858-552-8585|kaherbst@gmail.com|7384
20209936|NCT03145207|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20209937|NCT05436067|CFD Research Corporation|Dr. Paulien Roos|256 715 6817|paulien.roos@cfd-research.com|
20209938|NCT01396434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209939|NCT05689554|University of Washington|Dr. Elizabeth Phelan|(206) 744-9112|phelane@uw.edu|
20209940|NCT02899884|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20209941|NCT00347776|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
20209942|NCT00938392|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209943|NCT01683331|University of Michigan|Akinlolu Ojo|734 936-4890|aojo@umich.edu|
20209944|NCT06390085|University of Virginia, Systems and Information Engineering|Gregory Gerling|4349240533|gg7h@virginia.edu|
20209945|NCT05644756|Brown University|Dr. Ruben Martinez|4014441915|ruben_martinez@brown.edu|
20209946|NCT03985982|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20209947|NCT00302068|DukeUMC|Dr. James Blumenthal|919-684-3969|blume003@mc.duke.edu|
20209948|NCT01298362|Hellenic Society of Breast Surgeons|Christos J Markopoulos, MD, MPhil Professor of Surgery-Athens University Medical School|+30 210 6862527|cmarkop@hol.gr|
20209949|NCT02980666|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20209950|NCT00556907|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
20227625|NCT02059239|Weill Cornell Medicine|Dr. Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
20227626|NCT00193453|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|askSarah@scresearch.net|
20227627|NCT01268267|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20227628|NCT01222104|St Jude Medical|Andrew Campbell|651-756-5538|acampbell2@sjm.com|
20192870|NCT02056626|University of Rochester|John Bisognano|585-341-7800|john_bisognano @ urmc.rochester.edu|
20192871|NCT03415243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20192872|NCT04978350|UNC Lineberger Comprehensive Cancer Center|Angelo Navas|919-445-1128|angelo_navas@med.unc.edu|
20192873|NCT00013611|University of Minnesota|Gary Collins, M.S.|612-626-9006|gary-c@ccbr.umn.edu|
20209951|NCT01335620|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
20227629|NCT01418339|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20209952|NCT02951182|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20192874|NCT02577003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Dvelopment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192875|NCT02786004|GE Healthcare|Beth Heckel|262-312-7269|beth.heckel@med.ge.com|
20192876|NCT01234883|Baxter Healthcare|Drew Jones, M.D.|224-270-2659|Drew_Jones@baxter.com|
20209953|NCT00505765|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
20209954|NCT02743117|MedImmune, LLC|Raburn Mallory, MD|301-398-000|information.center@astrazeneca.com|
20209955|NCT03864406|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@niaid.nih.gov|
20209956|NCT01207219|The Department of Psychiatry,HKU|Dr.Lin Jingxia|+85222553064|jingxia.lin@gmail.com|
20209957|NCT01453296|GlaxoSmithKline|GSK Response Center|866-435-7343||
20209958|NCT00620776|University of Pennsylvania|Dr. Paul Crits-Christoph|(215) 662-7993|crits@mail.med.upenn.edu|
20209959|NCT00766727|Neodyne|VP, R&D/OPS|5104564128|jzepeda@neodynebio.com|128
20209960|NCT01828164|SmileSonica Inc.|John Simon, Regulatory Affairs Manager|780-975-0095|john@johnsimon.ca|
20209961|NCT00615927|Duke University Medical Center|Annick Desjardins, MD, FRCPC|919-668-|annick.desjardins@dm.duke.edu|
20209962|NCT00183170|Boston University School of Public Health|Dr. Jonathan Howland, Professor||jhowl@bu.edu|
20209963|NCT00924820|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Professor, Neuro-Oncology|(713) 745-3072|jdegroot@mdanderson.org|
20209964|NCT04983589|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20209965|NCT00585468|University of Utah|Fuad Shihab, MD|801-585-3823|fuad.shihab@hsc.utah.edu|
20209966|NCT04259905|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
20209967|NCT01279265|University of Texas Health Science Center at Houston|Dr. J. Marc Rhoads, Director, Pediatric Gastroenterology|713-500-7642|j.marc.rhoads@uth.tmc.edu|
20209968|NCT00978120|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20209969|NCT00762073|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20209970|NCT03668379|University of California, San Francisco|John Sauceda, PhD, Associate Professor|415-502-1000|john.sauceda@ucsf.edu|17172
20209971|NCT03155269|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20209972|NCT02319642|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20209973|NCT01958593|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20209974|NCT02369874|AstraZeneca|Nassim Morsli|+44 7384 520046|nassim.morsli@astrazeneca.com|
20209975|NCT00596466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209976|NCT00145795|The University of Chicago Department of Health Studies, Section of Infectious Diseases and Global Health|Dr. David Pitrak|(773) 702-2710|dpitrak@medicine.bsd.uchicago.edu|
20209977|NCT01891669|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20209978|NCT01015118|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20209979|NCT04365387|Galderma Research & Development, LLC|Sponsor|817 961 5000|aestheticclinicaltrials@galderma.com|
20209980|NCT00480077|Medtronic Bakken Research Center|Director CRDM|31-43-3566813||
20209981|NCT05939388|Wake Forest University Health Sciences|Michelle Olshan-Perlmutter|704-358-2800|michell.olshanperlmutter@atriumhealth.org|
20209982|NCT05074303|University of Florida|Dr. Wendy Dahl|3522943707|wdahl@ufl.edu|
20209983|NCT04527380|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20209984|NCT00938366|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20209985|NCT01085331|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20209986|NCT01215968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20209987|NCT00056472|Weill Cornell Medical College|Barnett S. Meyers, MD|914-997-5721|bmeyers@med.cornell.edu|
20209988|NCT01958619|Medicines for Malaria Venture (MMV)|Dr Thomas Rueckle PhD|+41 22 799 4567|ruecklet@mmv.org|
20209989|NCT01710839|Retina Consultants of Houston|Charles C Wykoff, PhD, MD|713-524-3434|ccwmd@houstonretina.com|
20209990|NCT03759340|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
20209991|NCT03795233|Boston Medical Center|Tamar Barlam, MD MSC|617 414 5190|tamar.barlam@bmc.org|
20209992|NCT01054443|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20209993|NCT00409565|University of Pittsburgh Cancer Institute|Michael Gibson, MD|412-692-2600|gibsonmk@upmc.edu|
20227630|NCT00685815|Luitpold Pharmaceuticals, Inc.|Angie Butcher|610-650-4200|abutcher@lpicrd.com|
20227631|NCT02204917|Children's Hospital of Philadelphia|Dr. Kassa Darge, MD, PhD, Radiologist-in-Chief|267-425-7110|DARGE@email.chop.edu|
20227632|NCT00909844|Ipsen Pharma|Medical Director, Endocrinology||clinical.trials@ipsen.com|
20227633|NCT02219685|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20227634|NCT00698815|Massachusetts General Hospital|Rebecca S. Heist, MD||rheist@partners.org|
20227635|NCT00706004|University of Arkansas for Medical Sciences|Catherine O'Brien|501-364-1828|obriencatherinee@uams.edu|
20227636|NCT02634073|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227637|NCT00485069|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227638|NCT00828113|University of Wisconsin School of Medicine and Public Health|Douglas E. Jorenby, Ph.D.|6082627527|dej@ctri.medicine.wisc.edu|
20227639|NCT01365130|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20227640|NCT05547386|Mayo Clinic|Geoffrey Johnson, M.D., Ph.D.|507-284-4104|johnson.geoffrey@mayo.edu|
20227641|NCT04622969|University of South Carolina|Director, Office of Research Compliance|8037777095|lisaj@mailbox.sc.edu|
20227642|NCT05616013|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20209994|NCT00985114|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
20209995|NCT02950831|St. Jude Medical|Filippo Agnesi|14694184987|filippo.agnesi@abbott.com|
20209996|NCT01119118|University of Wisconsin Carbone Cancer Center|Dr. Glenn Liu|608-265-8689|gxl@medicine.wisc.edu|
20227643|NCT05116202|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20209997|NCT04487886|Emory University|Edmund Waller, MD, PhD|404-727-4995|ewaller@emory.edu|
20227644|NCT05067972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186298|NCT03792256|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20186299|NCT04760678|Insitute of Tropical Medicine|Carolien Hoof|0470102562|choof@itg.be|
20186300|NCT04562649|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
20186301|NCT05368103|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20186302|NCT04864691|Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.|Feng Gao|13581936066|gaofengletter@sina.com|
20186303|NCT03675282|Weill Cornell Medicine|Carly Skudin; Research Program Manager|212-746-2003|cas4010@med.cornell.edu|
20186304|NCT05817708|Senhwa Biosciences, Inc.|Gina Huang|+886-2-89119856|ginahuang@senhwabio.com|111
20186305|NCT05784662|University at Buffalo, School of Social Work|Patricia Logan-Greene|7166451533|pblogang@buffalo.edu|
20186306|NCT04274764|University of Michigan|Paula Anne Newman-Casey|734 763-6967|panewman@med.umich.edu|
20186307|NCT01926496|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
20186308|NCT03210272|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186309|NCT03611621|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
20186310|NCT05424549|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
20186311|NCT03662698|University of Colorado Hospital|Jamie Studts|303-724-2284|jamie.studts@cuanschutz.edu|
20186312|NCT05177848|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|(540)526-2106|rflemos@vtc.vt.edu|
20186313|NCT03853746|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
20186314|NCT01084876|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20186315|NCT04487145|University of Califronia San Francisco|Liusheng Huang(Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
20186316|NCT05329493|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
20186317|NCT05386758|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20227645|NCT04391842|Medical Pain Consultants|Dr. Ralph Ortiz|(607) 844-9979|drortizmpc@gmail.com|
20186318|NCT05486078|Guna S.p.a|Dr. Vincenzo Miranda, Clinical Research & Scientific Service Manager|02 280.18.(358)|v.miranda@guna.it|
20186319|NCT02724631|Children's Hospital of Philadelphia|Sharon Y Irving|215 590-1000|irvings@chop.edu|
20186320|NCT05076708|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
20186321|NCT02908477|Mayo Clinic|Katharine Price M.D.|507-284-6139|Price.Katharine@mayo.edu|
20186322|NCT05305235|University of North Carolina at Chapel Hill|Nicole Short, PhD|702-895-3305|nicole.short@unlv.edu|
20186323|NCT04971395|Xentria, Inc.|Tom Matthews, Director of Clinical Research|224.443.4615|tmatthews@xentria.com|
20186324|NCT02487056|Cardiovascular Academy Society|Dr. Mehdi Zoghi|3904001|mehdi_zoghi@hotmail.com|
20186325|NCT02924272|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20186326|NCT05326776|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
20186327|NCT06213194|Ibn Haldun University|Dr. Dilruba Sönmez|905365646640|dilrubasonmez@gmail.com|
20186328|NCT03150810|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20186329|NCT03903146|University of Kentucky|Dr. Ana Maria Linares, PI|8593234726|am.linares@uky.edu|
20186330|NCT02919683|Dana-Farber Cancer Institute|Jonathan Schoenfeld, M.D. M.P.H.|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
20186331|NCT01552473|The University of Texas at Dallas, Center for BrainHealth|Dr. Daniel Krawczyk, Primary Investigator|214-905-3007|dck061000@utdallas.edu|
20186332|NCT05551637|National Institute of Nutrient|Dr. Nguyen Song Tu|0912322602|nguyensongtu@gmail.com|
20186333|NCT06491433|Department of Cardiology at Gangnam Severance hospital|Byoung Kwon Lee|+82-10-2721-8813|CARDIOBK@yuhs.ac|
20186334|NCT05796583|University of California San Diego|Professor of Anesthesiology|(858) 220-5714|bilfeld@health.ucsd.edu|
20186335|NCT05582746|University of Kansas Medical Center|Dr. Jason E Glenn|9135880076|jglenn4@kumc.edu|
20186336|NCT03197662|Montefiore Medical Center|Dr. Eric Hollander|718-839-7516|eholland@montefiore.org|
20227646|NCT00441285|Universidad Peruana Cayetano Heredia|Hector H. Garcia, MD, PhD|+511 3287360|hgarcia@jhsph.edu|
20227647|NCT00791219|Mayne Pharma|Stuart Mudge, VP Scientific Affairs|+613 8614 7704|stuart.mudge@maynepharma.com|
20227648|NCT02573259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227649|NCT00751140|H. Lee Moffitt Cancer Center and Research Institute|Philippe E. Spiess, M.D.|813-745-8343|philippe.spies@moffitt.org|
20227650|NCT02667301|StratejikYG|Murat Haluk Ozkul|0905327777842|kbbhaluk@gmail.com|
20227651|NCT00078286|Duke University|Dr. Ranga Krishnan|919-668-3647|krish001@mc.duke.edu|
20227652|NCT05770713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227653|NCT01883895|UW Madison|Nalini Sehgal|608-263-8639|sehgal@rehab.wisc.edu|
20227654|NCT02895295|Stanford University|Dr. M. Kate Bundorf|6507250067|bundorf@stanford.edu|
20227655|NCT00490919|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20227656|NCT00728494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20227657|NCT00853762|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20227658|NCT00956085|Stanford University|Carolyn Rodriguez, MD, PhD, Assistant Professor|6507236158|cr2163@stanford.edu|
20227659|NCT01607658|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
20163031|NCT02873338|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20227660|NCT02000921|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
20227661|NCT02914834|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
20186337|NCT03721952|University of Washington|Dr. Ruth Engelberg|206-744-9523|rengel@uw.edu|
20227662|NCT03108482|Esteve Pharmaceuticals, S.A.|Dr. Neus Gascon|+34934446000|ngascon@esteve.com|
20227663|NCT02631941|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
20227664|NCT00501631|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
20227665|NCT04456686|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20227666|NCT03836586|University of Florida|Dr. Ellen Terry|352-273-6441|elterry@ufl.edu|
20227667|NCT00578903|Baylor College of Medicine|Kathryn Leung|832-824-4269|kleung@bcm.edu|
20227668|NCT02532036|University of Oxford|Professor Helen McShane|+44 (0)1865 617606|helen.mcshane@ndm.ox.ac.uk|
20227669|NCT02858401|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20227670|NCT03722576|Mayo Clinic|Elizabeth J. Carey, M.D.|480-342-1094|Carey.Elizabeth@mayo.edu|
20227671|NCT00748241|Astra Tech AB|Head of Clinical Research Area Dental|+46317763000||
20227672|NCT01240382|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20227673|NCT01408706|Wheaton Franciscan Healthcare - All Saints|Dr. James Taylor|262-687-5000|james.taylor@wfhc.org|
20227674|NCT00888654|Barbara Ann Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8715|heathe@karmanos.org|
20227675|NCT03885908|Memorial Sloan Kettering Cancer Center|Dr. Armin Shahrokni, MD, MPH|646-888-3651|shahroka@mskcc.org|
20227676|NCT03669549|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
20227677|NCT04023578|Ossur Iceland ehf|Kristleifur Kristleifsson|6641112|kkristjansson@ossur.com|+354
20227678|NCT02974868|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227679|NCT02674516|Nanyang Technological University|Dr. Olivia Choy|(65) 65921522|oliviachoy@ntu.edu.sg|
20227680|NCT01064479|UT MD Anderson Cancer Center|Dr. Xiuning Le, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6980|xle1@mdanderson.org|
20227681|NCT03817606|Riverside Medical Center|Cynthia Koehn, Clinical Research Nurse|815-933-1671|ckoehn@rhc.net|
20227682|NCT01639352|University of Miami|Lynn Feun, M.D.|305-243-4909|lfeun@med.miami.edu|
20227683|NCT01663402|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
20227684|NCT00678418|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
20209998|NCT03225313|Theodor Bilharz Research Institute|Dr Muhammed Hussein|00201001434459|muhamed.hussein@gmail.com|
20227685|NCT03575702|R-Pharm|Georgiy Sharvadze, Medical Advisor|0074959567937|sharvadze@rpharm.ru|1175
20186338|NCT01463423|Stanford University|Maximilian Diehn, MD, PhD|650-725-4783|diehn@stanford.edu|
20186339|NCT04495894|Emory University|Viraj Master, MD, PhD|404-778-4898|vmaster@emory.edu|
20186340|NCT01000961|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
20186341|NCT04471038|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sab.bio|
20186342|NCT04836195|Pacylex Pharmaceuticals|VP Operations|1 (888) 580-4483|ryan.heit@pacylex.com|
20186343|NCT05609760|Universidad de concepción|Rosa Figueroa I, Associate Professor|+56412204247|rosa.figueroa@biomedica.udec.cl|
20186344|NCT03396588|University of Kentucky|Dr. Henrietta Bada|8593231019|henrietta.bada@uky.edu|
20186345|NCT05351554|Kinevant|Study Director|Please email|kinevant.resolve-heart@kinevant.com|
20186346|NCT04353661|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20186347|NCT00667251|Novartis Pharmaceuticals|Clinical Disclosure Office|1-862-778-8300|Novartis.email@novartis.com|
20186348|NCT04927637|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
20186349|NCT02727699|Actinogen Medical Limited|Director of Drug Development & Strategy|+61289647401|info@actinogen.com.au|
20186350|NCT02754882|Samsung Bioepis Co., Ltd|Director of Clinical Trials|031-8061-1096|sbregistry@samsung.com|
20186351|NCT04648033|University of Oxford|Professor Geoff Higgins|01865 617311|geoffrey.higgins@oncology.ox.ac.uk|
20186352|NCT03270956|ProKidney|to be determined|n/a|info@prokidney.com|
20186353|NCT03509116|Guy's & St Thomas' NHS Foundation Trust|Dr Alastair Duncan|02071882010|alastair.duncan@gstt.nhs.uk|
20186354|NCT02671903|Imperial College London|Dr Zachary I Whinnett|+44 (0)20 7594 5735|z.whinnett@imperial.ac.uk|
20186355|NCT03376321|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186356|NCT02992925|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp, clinicaldevelopment@mail.biken.or.jp|
20186357|NCT02995434|University of British Columbia|Dr. Bernie Garrett|604 822 7443|bernie.garrett@ubc.ca|
20186358|NCT05273749|Tonix Pharmaceuticals|Gregory Sullivan, MD|8629040355|greg.sullivan@tonixpharma.com|
20186359|NCT05097430|Centre for Addiction and Mental Health (CAMH)|Dr. Paul Shuper|416-535-8501|paul.shuper@camh.ca|34097
20186360|NCT02543281|Cleveland Clinic, Lerner Research Institute|Larisa Tereshchenko|2164442445|tereshl@ccf.org|
20186361|NCT05247489|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20186362|NCT04179500|TB Alliance|Antonio Lombardi|917-601-0024|Antonio.Lombardi-Consultant@tballiance.org|
20186363|NCT04606069|University of Maryland Medical Center|Dr. Christine Lau, MD, MBA, Department of Surgery, Surgeon-in-Chief|410-328-8407|CLLau@som.umaryland.edu|
20227686|NCT03903172|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
20227687|NCT01545388|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227688|NCT01900444|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20227689|NCT00072384|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20186364|NCT04059770|Universidade Federal de Ciências da Saúde de Porto Alegre|Professor Alessandro C. Pasqualotto|5551999951614|pasqualotto@ufcspa.edu.br|
20227690|NCT01825200|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20227691|NCT01255163|National Institute on Aging (NIA/NIH)|Dimitrios Kapogiannis, Clinical Investigator|410-350-3953|kapogiannisd@mail.nih.gov|
20227692|NCT00490035|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20227693|NCT06058390|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227694|NCT02495389|Loyola University Chicago|Alan Wolfe, Ph.D.|708-216-5814|awolfe@luc.edu|
20227695|NCT01297283|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
20227696|NCT02265965|University of California, San Francisco|Jennifer Lucero, MD|415-476-5535|jennifer.lucero@ucsf.edu|
20227697|NCT01802385|University of Minnesota|Joshua Rhein|612-624-1966|joshua.rhein@gmail.com|
20227698|NCT05559905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227699|NCT04003103|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227700|NCT02756910|Peking Union Medical College Hospital|Lijian Pei|＋86 10 69152020|hazelbeijing@vip.163.com|
20227701|NCT03041636|The University of Texas MD Anderson Cancer Center|Zeev Extrov MD./Professor|713-794-1675|zestrov@mdanderson.org|
20227702|NCT04195594|TRCGEN+ (managed by Trans Russian Co)|Nikolaos Tzenios|+447583902071|Nicolas@trccolleges.com|
20227703|NCT05518539|Newsom Eye|T Hunter Newsom|813-908-2020|hunter@newsomeye.net|
20227704|NCT03569397|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
20227705|NCT03589807|Emory Children's Center|Evan J. Anderson, MD|404-727-5642|evanderson@emory.edu|
20227706|NCT00338741|EMD Serono|Liz Gedney/Clinical Trial Leader|+781 681-2179||
20227707|NCT01534273|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227708|NCT01619865|University of Iowa Holden Comprehensive Cancer Center|Sue O'Dorisio, MD, PhD|319-356-7873|sue-odorisio@uiowa.edu|
20227709|NCT03586050|ETHICON|Jaclyn Calia Stanziola|908-808-6380|jcalia@its.jnj.com|
20227710|NCT01494818|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
20227711|NCT00593918|University of Wisconsin-Madison|Theresa Guilbert, MD|608-263-9608|tguilbert@wisc.edu|
20227712|NCT02638974|University of Manchester|Dr Kerry Gutridge, Trial Manager|0161-306-7931|kerry.gutridge@manchester.ac.uk|
20227713|NCT04663685|UBC/Arthritis Research Canada|Ellen Wang|2266980999|ewang@arthritisresearch.ca|
20227714|NCT01211145|AstraZeneca|Jamie Mullen, Medical Science Director|781-472-5032|jamie.mullen@astrazeneca.com|
20227715|NCT00791999|Medical Advisor of the Clinical Trial|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
20227716|NCT04458675|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
20227717|NCT01579513|Medical University of South Carolina|Eric Graham, MD|843-792-9570|grahamem@musc.edu|
20227718|NCT00617357|LifeCell|Dr Michael Franz|908 947 1100|mfranz@lifecell.com|
20227719|NCT00427908|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227720|NCT03976752|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20227721|NCT00866905|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20227722|NCT04202497|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20227723|NCT04344301|Dartmouth College|Dr. Paul Barr|+1-603-653-0863|paul.j.barr@dartmouth.edu|
20227724|NCT01747499|Washington University School of Medicine|Mark A. Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
20227725|NCT00072410|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20227726|NCT02903446|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Angelo Gaffo, MD; Associate Professor|205-996-6086|agaffo@uab.edu|
20227727|NCT00248651|Mayo Clinic|Dr. Yuri A. Saito Loftus|507-266-9094|saito.yuri@mayo.edu|
20209999|NCT02711306|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
20227728|NCT03834506|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20227729|NCT03160716|Q-Med AB|Reception|+46184749000|reception.seupp@galderma.com|
20227730|NCT01628848|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
20227731|NCT01939314|Indiana University School of Medicine|Jason Schaffer, MD|317-962-8026|jtschaff@iupui.edu|
20227732|NCT02951312|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20227733|NCT01107925|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227734|NCT04877990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20227735|NCT01949142|Otonomy, Inc|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20227736|NCT00903201|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227737|NCT01094288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20227738|NCT00563290|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
20227739|NCT02611882|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|2264
20227740|NCT01389232|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20227741|NCT01317940|Children's Hospital Los Angeles|Dr. Etan Orgel|3233612672|eorgel@chla.usc.edu|
20227742|NCT04678284|Hennepin Healthcare|Dr. Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
20227743|NCT00945243|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20227744|NCT03256578|Leiden University Medical Center|Dr. Arjan te Pas|+31 71 5265839|a.b.te_pas@lumc.nl|
20210000|NCT01255449|IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy|Dr. Giovanni Barisione|+39010555|giovanni.barisione@hsanmartino.it|3367
20210001|NCT01979029|First Hospital of Jilin University|Jian Suo|0431-88785605|suojian42@hotmail.com|
20227745|NCT01198002|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227746|NCT00129441|University of Pittsburgh|David A. Lewis, MD|(412) 246-6010|lewisda@upmc.edu|
20227747|NCT01996371|OhioU|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20192877|NCT04351269|Aziyo Biologics, Inc.|Associate Director of Clinical Operations|470-514-4085|clinical@aziyo.com|
20192878|NCT00476242|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
20192879|NCT01013961|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20192880|NCT00882115|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
20192881|NCT01271504|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20192882|NCT03865953|Lateral Pharma Pty Ltd|Mr David Kenley|+61 (0)400 151 490|dk@lateral-pharma.com|
20192883|NCT01667406|Imperial College London|Professor Waljit Dhillo|442083833242|w.dhillo@imperial.ac.uk|
20192884|NCT02768597|Mayo Clinic|Dr. Mark E. Morrey|507-284-2511|morrey.mark@mayo.edu|
20192885|NCT02229578|University of Florida|Brenda Fahy, MD|859-402-4360|bfahy@anest.ufl.edu|
20192886|NCT00943787|University of Virginia|Mary Oliveri|434-982-0602|mc7m@virginia.edu|
20192887|NCT00490945|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marelene.dressman@vandapharma.com|
20192888|NCT00567840|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
20192889|NCT03017937|Cincinnati Chidren's Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
20192890|NCT03721172|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20192891|NCT04883060|University of Iowa|Matthew Howard III|(319) 356-8468|matthew-howard@uiowa.edu|
20210002|NCT04075656|Emory University|Chia-shi Wang, MD, MS|404-727-5728|chia-shi.wang@emory.edu|
20210003|NCT00563706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210004|NCT01140815|AORI|Knee Research Director|7036194423|nancylparks@gmail.com|
20210005|NCT03280628|Vanderbilt University Medical Center|Dr. Holly Hanson|615-936-7317|holly.r.hanson@vumc.org|
20210006|NCT03315780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20210007|NCT01361308|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
20210008|NCT01001195|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20210009|NCT03839693|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
20210010|NCT04524351|Annovis Bio|Maria Maccecchini, PhD, CEO|(610) 727-3710|maccecchini@annovisbio.com|
20210011|NCT00700115|Emory University School of Medicine|Dr. Igho Ofotokun|404-616-0659|iofotok@emory.edu|
20210012|NCT00706901|Charleston VAMC|Elizabeth Santa Ana, Ph.D.|(843) 789-7168|elizabeth.santaana2@va.gov|
20210013|NCT00461591|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20210014|NCT00457249|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20210015|NCT02916056|vTv Therapeutics|Ann Gooch PhD, VP Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
20210016|NCT00124709|Novartis Pharmaceuticals|Study Director|862-778-8300||
20210017|NCT00122954|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20227748|NCT05310877|The Miriam Hospital|Emily Gathright, PhD|401-793-8271|Emily.Gathright@lifespan.org|
20227749|NCT00536510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227750|NCT01249417|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20227751|NCT03102762|Cairo University|Dr. Hussein Ghanem, Directer of this clinical trial|01001176111|hmhghanem@gmail.com|
20227752|NCT02779491|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
20227753|NCT03074695|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
20227754|NCT01774981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227755|NCT03362944|Frohlich Lab - University of North Carolina at Chapel HIll|Trevor McPherson|919-966-4755|trevor_mcpherson@med.unc.edu|
20227756|NCT03843372|Sleep Center, Chang Gung Memorial Hospital, Keelung, Taiwan|Dr. Chung-Chieh Yu|886+22432-9292|terminatorchieh@yahoo.com.tw|2658
20227757|NCT00902577|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
20227758|NCT02337062|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|GabrielFox@acaciapharma.com|
20227759|NCT01232790|Yale University School of Medicine, Department of Psychiatry|Cenk Tek MD, Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7484|cenk.tek@yale.edu|
20227760|NCT03322293|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
20227761|NCT00083915|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20227762|NCT01239797|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20227763|NCT00719901|Mayo Clinic|A. Keith Stewart|480-301-4411|stewart.keith@mayo.edu|
20227764|NCT02643693|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
20227765|NCT00492297|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20227766|NCT01307956|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
20227767|NCT00379145|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
20227768|NCT03918811|Hospitalsantojanni|Professor Mauro Andreu|+541168788298|mfandreu@gmail.com|
20227769|NCT03585270|Idorsia Pharmaceutical Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
20227770|NCT04683640|University of Florida|Yenisel Cruz-Almeida|(352) 294-5845|cryeni@ufl.edu|
20227771|NCT05002972|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
20210018|NCT03491800|University of North Carolina at Chapel Hill|Crystal Wiley Cené, MD, MPH, FAHA|919-445-6783|crystal_cene@med.unc.edu|
20210019|NCT04341727|Washington University School of Medicine|Jane O'Halloran|314 454 0058|janeohalloran@wustl.edu|
20210020|NCT05604521|Sanaria Inc.|Chief Medical Officer|301-770-3222|sanaria@sanaria.com|
20210021|NCT01491737|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20210022|NCT02354352|Ohio State University|Dr. Subha Raman|614-293-8963|raman.1@osu.edu|
20210023|NCT03587116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20210024|NCT05993299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20210025|NCT03110107|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20210026|NCT03093480|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
20210027|NCT03526549|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
20210028|NCT02989623|Thomas Jefferson University|Mathew Thakur|215-503-7874|Mathew.Thakur@Jefferson.edu|
20210029|NCT05471921|Columbia University|Jeremy Kane|212-305-2862|jk4397@cumc.columbia.edu|
20210030|NCT03927989|Medical University of South Carolina|Dr. Alana Rojewski (PI)|843-876-1593|rojewski@musc.edu|
20210031|NCT02593175|MD Anderson Cancer Center|Clinton Yam|832-589-8343|cyam@mdanderson.org|
20210032|NCT04199312|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20210033|NCT00478933|Medtronic BRC|Margriet Kruijshoop, Clinical Research Manager|+31623910708|margriet.kruijshoop@medtronic.com|
20210034|NCT05984784|Inmagene LLC|Clinical Trials Lead|(858) 345-6927|ClinicalTrials@imagenebio.com|
20210035|NCT00643006|Gothenburg University|Dr. K Mannerkorpi|046-31-24220|kaisa.mannerkorpi@rheuma.gu.se|
20210036|NCT03772574|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
20210037|NCT00617175|MEDTRONIC Clinical Research Institute|Laura Manotta|+39022413.1|laura.manotta@medtronic.com|
20210038|NCT02203305|University of North Carolina at Chapel Hill|Dr. Margaret Dillon|9199665251|mdillon@med.unc.edu|
20210039|NCT03586427|Gate Neurosciences, Inc|Chief Medical Officer|2032473895|ron.burch@gateneuro.com|
20210040|NCT02384200|UCSD Medical Center|Paul Zupkas, Ph.D.|6195432628|pzupkas@ucsd.edu|
20210041|NCT05125224|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20210042|NCT00593385|Getinge|Elizabeth Bulger, Director of Clinical Affairs|1-603-864-5368|elizabeth.bulger@getinge.com|
20210043|NCT01471197|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20210044|NCT02352831|Washington University School of Medicine|Andrea Wang-Gillam, M.D., Ph.D.|314-362-5740|awang-gillam@wustl.edu|
20210045|NCT00924313|National Cancer Institute, National Institutes of Health|Dr. Peter L. Choyke|301-402-8409|pchoyke@mail.nih.gov|
20210046|NCT01283009|Memphis VA Medical Center|Dr. Gianfranco U. Meduri|(901) 577-7520|Gianfranco.Meduri@va.gov|
20210047|NCT00595946|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20210048|NCT03056456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20210049|NCT04369885|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
20210050|NCT00455923|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210051|NCT02234427|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
20210052|NCT02686749|Cleveland Clinic|Oussama Wazni, MD|216-444-2131|waznio@ccf.org|
20210053|NCT04762771|baptist health south florida|Raul Herrera, MD (Director Miami Cardiac & Vascular Institute)|786-596-7609|RaulH@BaptistHealth.net|
20210054|NCT03107442|FIBAO|Dr José Antonio Vargas-Hitos|625943933|joseantoniovh@hotmail.com|+34
20210055|NCT00145119|Medtronic Bakken Research Center|Director CRDM|+31 43 3566||566
20210056|NCT01652040|Hunter Holmes McGuire VA Medical Center|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.gov|3386
20210057|NCT05267652|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
20210058|NCT01676818|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
20210059|NCT06768658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20210060|NCT03548454|Stanford University|Dr. Vafi Salmasi|650-725-0246|vsalmasi@stanford.edu|
20210061|NCT01600677|UPittsburgh|Steven M. Handler, MD, PhD|412-864-1878|handler@pitt.edu|
20210062|NCT02503215|Nephrology Division, University of São Paulo|Dr Bruno Caldin da Silva|5511997620521|brunocaldin@hotmail.com|
20210063|NCT03433482|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20210064|NCT01646268|UCB Clinical Trial Call Center|Study Director|+1 844-599-2279||
20210065|NCT00906776|Rotschild hospital|Prof Philippe Bouchard|+33614656947|phbouch@noos.fr|
20210066|NCT04478994|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
20210067|NCT01100073|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20210068|NCT00299546|Centocor Research & Development, Inc.|Associate Director Clinical Research|1-800-457-6399||
20210069|NCT03099265|Yale School of Medicine|Kimberly L. Johung, MD, PhD Associate Professor of Therapeutic Radiology|(203) 200-2008|kimberly.johung@yale.edu|
20210070|NCT01605539|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212-824-9314|yasmin.hurd@mssm.edu|
20210071|NCT00968539|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210072|NCT00326118|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227772|NCT01664091|Dana-Farber Cancer Institute|Julia Wong, MD|617-632-3591|JWONG@LROC.HARVARD.EDU|
20227773|NCT01172873|New York State Psychiatric Institute/Columbia University|Moira A. Rynn, M.D.|646-774-5805|RynnM@nyspi.columbia.edu|
20210073|NCT01741259|OB Anesthesia Associates|Christy Morgan, MD|314-469-6800|christylmorganmd@gmail.com|
20210074|NCT01256086|University of Florida, Department of Pharmacotherapy and Tanslational Research, 100486 Gainesville, FL 32610|Prof. Dr. Leslie Hendeles|+1 352 279|hendeles@cop.ufl.edu|6027
20227774|NCT02053493|Duke Clinical Research Insitute|Dr. Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
20186365|NCT04896476|Sonavex|Katy Feeny, Director of Clinical Affairs|443-862-2024|KFEENY@SONAVEX.COM|
20210075|NCT02074982|Novartis Pharmaceuticals|Study Director|862-778-8300||
20210076|NCT03305159|Northwestern University Feinberg School of Medicine|Supriya Rastogi|supriya.rastogi@northwestern.e|supriya.rastogi@northwestern.edu|
20210077|NCT02094573|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20210078|NCT01817764|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210079|NCT00514709|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20210080|NCT02411110|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20210081|NCT00526162|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
20210082|NCT05279807|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
20210083|NCT01169259|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
20210084|NCT04242446|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20210085|NCT04293341|Department of Veterans Affairs|Daniel Gros, PhD|843-789-7311|daniel.gros@va.gov|
20210086|NCT04058990|Boston Scientific Japan K.K.|Sachiyo Sato/Clinical Project Manager|+81-3-6853-7500|Sachiyo.Sato@bsci.com|
20210087|NCT05981365|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210088|NCT00005803|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
20210089|NCT03193996|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
20210090|NCT01353586|Biosense Webster, Inc|Kendra McInnis, Manager, Clinical Operations|909-839-7284|kmcinnis@its.jnj.com|
20210091|NCT05027958|Division of Intramural Research, NHLBI|Kevin P. Fennelly, M.D., MPH, ATSF|301-385-0807|kevin.fennelly@nih.gov|
20210092|NCT01293682|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
20210093|NCT00491322|Massachusetts General Hospital|Dr. Sherri-Ann M. Burnett-Bowie|6177245594|sburnett-bowie@mgh.harvard.edu|
20210094|NCT02277548|University of Pennsylvania|Dr. Erin McMenamin|251-662-2428|Erin.McMenamin@pennmedicine.upenn.edu|
20210095|NCT00807040|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
20227775|NCT01076543|University of Chicago|Dr. Sonali Smith, Professor of Medicine|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
20227776|NCT01791985|Imperial College London|Michael Seckl|+44 (0)20 3311 1421|m.seckl@imperial.ac.uk|
20227777|NCT04195061|Massachusetts General Hospital|Melanie S. Haines, MD|617-726-3870|mshaines@mgh.harvard.edu|
20227778|NCT04406714|University of North Carolina Lineberger Comprehensive Cancer Center|Alexis Moore|+1 919-962-5409|alexis.moore@unc.edu|
20227779|NCT02201342|Mezzion Pharmaceuticals|Won Geun Kim|3128980292|wg.kim@mezzion.com|
20227780|NCT00086190|University of Rochester Medical Center|Irene H. Richard, MD|585-341-7500|irene_richard@urmc.rochester.edu|
20227781|NCT03217591|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
20227782|NCT01787006|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
20227783|NCT03902613|Columbia University Irving Medical Center|Dr. Martin Lan|646 774 7610|martin.lan@nyspi.columbia.edu|
20227784|NCT00004547|National Cancer Institute, National Institutes of Health|Marybeth S. Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
20227785|NCT04467515|Precirix|Jonathan Delara, Clinical Trial Manager|+1 (512) 589-2114|jonathan.delara@precirix.com|
20227786|NCT04252625|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20227787|NCT03014206|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227788|NCT01091246|MedImmune, LLC|Judy Falloon, MD/ Sr Director Clinical Development|301-398-0000|falloonj@medimmune.com|
20227789|NCT04577794|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20227790|NCT03724357|University of Maryland, Baltimore|Marcelo Sztein, MD|410-706-5328|msztein@som.umaryland.edu|
20227791|NCT01676012|Radboudumc|Dr. Erik van der Heijden|0031243614579|Erik.vanderHeijden@radboudumc.nl|
20227792|NCT01217827|VA Palo Alto HCS|Paul Heidenreich|650-849-1205|paul.heidenreich@va.gov|
20227793|NCT00953290|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
20227794|NCT00596271|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 206 20|info@valneva.com|0
20227795|NCT01819727|BioMarin Pharmaceutical Inc.|Principal Scientist I, Clinical Sciences|415-506-6348|dlounsbury@bmrn.com|
20227796|NCT04460326|Boston Medical Center|Sara M Alexanian, MD|617-638-8545|sara.alexanian@bmc.org|
20210096|NCT00544713|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20186366|NCT05948670|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
20227797|NCT04794751|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
20227798|NCT00969228|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227799|NCT02530437|University of Texas MD Anderson Cancer Center|Dr. Jaffer Ajani|(713) 792-2828|jajani@mdanderson.org|
20227800|NCT04344028|University of Wisconsin - Madison|Dr. C. Shawn Green|(608) 263-4868|csgreen2@wisc.edu|
20227801|NCT02007720|Novartis Pharma AG|Study Director|+41613241111|novartis.email@novartis.com|
20227802|NCT05630196|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20227803|NCT03438266|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20227804|NCT00641563|University Hospital Bern, Switzerland|Dr. M. Hänggi|0316323029|matthias.haenggi@insel.ch|
20227805|NCT01655901|CHEO Research Institute|Dr. Jean-Philippe Chaput|613-737-7600|jpchaput@cheo.on.ca|3683
20227806|NCT00352118|Masonic Cancer Center, University of Minnesota|Frank Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
20227807|NCT00870727|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
20227808|NCT01712516|Novartis Pharmaceuticals|Study Director|862-778-8300||
20227809|NCT03268343|Achieve Life Sciences|Daniel Cain, Senior Director Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20227810|NCT01251952|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|(313) 576-8022|alkadhiz@karmanos.org|
20227811|NCT00496769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20227812|NCT03028142|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
20227813|NCT00869414|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20227814|NCT02810418|National Cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
20227815|NCT02224625|Bioscience Labs|C Beausoleil|406-587-5735|cbeausoleil@bioscience.com|
20227816|NCT01573000|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227817|NCT01125098|Department of Oncology Haematology and Respiratory Diseases|Leonardo Fabbri|+39 059422|leonardo.fabbri@unimore.it|4227
20227818|NCT00729521|Medical College of Wisconsin|Peter Layde, MD, MSc|414-955-8113|playde@mcw.edu|
20227819|NCT01100853|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
20227820|NCT01384877|BC Cancer|Dr. Philippa Hawley|604-877-6000|phawley@bccancer.bc.ca|67-2752
20227821|NCT04161391|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20227822|NCT01507181|Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai|Dr. J. W. Murrough|212-241-7574|james.murrough@mssm.edu|
20227823|NCT01162343|Vanderbilt University Medical Center|Dr. Jin Han, MD|615-936-0253|jin.h.han@vanderbilt.edu|
20163032|NCT02038075|University of Utah|Dr. Craig Bryan|8015877978|craig.bryan@utah.edu|
20163033|NCT04000581|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
20186367|NCT00390793|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./ Professor|713-745-0394|fravandi@mdanderson.org|
20186368|NCT05065658|Medical University of Graz|Dr. Juergen Prattes|004331638530046|juergen.prattes@medunigraz.at|
20186369|NCT00583349|Columiba University Medical Center|Dr. James McKiernan, John K. Lattimer Professor and Chair of Department of Urology|212-342-3976|jmm23@cumc.columbia.edu|
20186370|NCT03427580|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
20186371|NCT02677298|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20186372|NCT00845481|LEO Pharma|Torsten Skov, Senior Medical Advisor|+45 20 73 62 94|torsten.skov@leo-pharma.com|
20186373|NCT05441579|Nationwide Children's Hospital|Dr. Vanessa Olbrecht|614-722-4200|vanessa.olbrecht@nationwidechildrens.org|
20186374|NCT03064217|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
20186375|NCT04526704|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20186376|NCT00881621|Georgetown University|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
20186377|NCT05116787|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20186378|NCT02737436|University of Iowa|Dr Lane Strathearn|2193849464|lane-strathearn@uiowa.edu|
20186379|NCT03983018|Örebro University|Prof Susanne Bejerot|+46701655102|susanne.bejerot@oru.se|
20186380|NCT05179837|Washington University School of Medicine|Vladimir Kushnir, M.D.|314-362-3685|vkushnir@wustl.edu|
20186381|NCT03158129|MD Anderson Cancer Center|Tina Cascone, MD|713-792-6363|tcascone@mdanderson.org|
20186382|NCT03719443|Parexel International|Principal Investigator|(781) 487-9900|info@parexel.com|
20186383|NCT05051124|NYU Langone Health|Jessica Gjonaj|646-501-3663|Jessica.gjonaj@nyulangone.org|
20186384|NCT04782973|Massachusetts General Hospital|Kaavya Paruchuri, MD|617-726-1843|kparuchuri@mgh.harvard.edu|
20186385|NCT00554788|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20186386|NCT04572399|Cedars-Sinai|Melissa Hampton|3104230617|Melissa.Hampton@cshs.org|
20186387|NCT02577835|Italian Institute of Telemedicine|Stefano Omboni|00390331984176|stefano.omboni@iitelemed.org|
20186388|NCT04749615|Hospital for Special Surgery|Justas Lauzadis, PhD|212-774-2946|lauzadisj@hss.edu|
20186389|NCT02235909|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
20186390|NCT03547869|UTDallas|Sven Vanneste|n/a|sven.vanneste@utdallas.edu|
20186391|NCT05292365|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
20186392|NCT03364647|University of Kentucky|Brian Noehren|859-323-1100|b.noehren@uky.edu|
20227824|NCT01130272|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20186393|NCT05184894|Mayo Clinic|Erin Barreto, PharmD, MS|507-284-2511|barreto.erin@mayo.edu|
20227825|NCT01548404|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20186394|NCT06165146|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20227826|NCT00641056|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20227827|NCT01962675|Shepherd Center|Edelle Field-Fote|404-603-4274|edelle_field-fote@shepherd.org|
20227828|NCT00896493|Stanford University Medical Center|Wen-Kai Weng, Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20227829|NCT01657617|University of Kentucky|Ronald McGarry|859 323 6486|rcmcga2@email.uky.edu|
20227830|NCT03657069|Stanford University|Dung Nguyen, MD, PharmD, FACS|(650) 498-6004|nguyendh@stanford.edu|
20227831|NCT02026141|University of Saskatchewan-Department of Anesthesia|Dr. Ian Chan|306-717-8028|iac549@mail.usask.ca|
20227832|NCT00896064|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227833|NCT00960193|Mutual Pharmaceutical Company, Inc.|Medical Drector|215-697-1743|clinicaltrials@urlmutual.com|
20227834|NCT01324102|VA Boston Healthcare System|Jennifer Moye|774-826-3721|jennifer.moye@va.gov|
20227835|NCT03238417|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|818-891-7711|elizabeth.yano@va.gov|36031
20227836|NCT01249131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20163034|NCT03477838|Virginia Commonwealth University|Evan Sisson, PharmD|804-828-8076|emsisson@vcu.edu|
20163035|NCT01931163|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
20163036|NCT02519595|Children's Hospital of Michigan|Nirupama Kannikeswaran|313-745-5260|nkannike@dmc.org|
20227837|NCT00192114|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227838|NCT00113607|Janssen R&D US|Director Clinical Research Medical Leader|908 704 5779||
20227839|NCT01535118|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227840|NCT00749398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20227841|NCT03924323|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20227842|NCT01447888|Allina Health|John Mrachek, MD|612-871-7639|John.Mrachek@allina.com|
20227843|NCT02240667|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20227844|NCT02783898|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
20227845|NCT02849080|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20227846|NCT00965237|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20227847|NCT01533116|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20227848|NCT01831895|Vascular Dynamics|VP Clinical Affairs|949-942-1640|clinical@vasculardynamics.com|
20227849|NCT02864732|University of Pittsburgh|Research Assistant|412 4822283|mza7@pitt.edu|
20227850|NCT02283658|Mayo Clinic|Gerardo Colon-Otero, M.D.|(904) 953-2000|gcolonotero@mayo.edu|
20227851|NCT02421354|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD. Professor|713-745-3429|sverstov@mdanderson.org|
20227852|NCT03528551|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20227853|NCT03459625|Loma Linda University|Cameron Leigh Neece|909 558 4000|cneece@llu.edu|
20227854|NCT01789047|Rush University Medical Center|Director of Clinical Research|312 942 8002|Teresa_Chmura@rush.edu|
20227855|NCT03644017|Merit Medical Systems, Inc.|Casey Holland, Senior Director Clinical Operations|+1 (617) 842-0251|casey.holland@merit.com|
20227856|NCT02700048|University of Minnesota|Amir Moheet|6126249990|mohee002@umn.edu|
20227857|NCT02175225|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-632-8913|mselim@bidmc.harvard.edu|
20210097|NCT00890409|Children's Hospital, Fudan University|Prof. Xiaomei Shao|86-21-64931913|zhou_wenhao@yahoo.com.cn|
20227858|NCT02340000|Albany Medical College|Paul Sorum, MD|5182627500|sorump@mail.amc.edu|
20227859|NCT02668640|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20227860|NCT03311945|Hospital Clinic of Barcelona|Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
20227861|NCT01619878|Novartis Pharmaceuticals|Study Director|862-778-8300||
20227862|NCT01062308|Christian Medical College and Hospital, Ludhiana, Punjab, India|Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
20227863|NCT01305564|Bard Peripheral Vascular|Ryan Melloy|480-350-6074|ryan.melloy@crbard.com|
20227864|NCT02121860|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20227865|NCT00073918|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
20227866|NCT01409239|The Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
20210098|NCT03099655|Medtronic|Erika Pouliot|+17635261270|erika.pouliot@medtronic.com|
20227867|NCT01190813|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20227868|NCT00060606|George Washington University Biostatistics Center|Dr. Elizabeth A Thom|301-881-9260|e_thom@bsc.gwu.edu|8035
20227869|NCT04821830|University of Michigan|Dr. Roger Albin|734-936-9115|ralbin@med.umich.edu|
20227870|NCT00919633|Medtronic, Inc.|Study Trial Manager|763-505-4594|sarah.mische@medtronic.com|
20227871|NCT00960804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227872|NCT01702909|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20227873|NCT00922636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20227874|NCT00557466|Novartis Pharmaceuticals|Study Director|862-778-8300||
20227875|NCT02308046|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
20227876|NCT00607243|Seoul National University Hospital|Myoung-don Oh, M.D.|+82-2-2072-2945|mdohmd@snu.ac.kr|
20186395|NCT05332366|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20227877|NCT01181167|Daiichi Sankyo Co., Ltd.|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
20227878|NCT03342001|University of Maryland School of Medicine|Dr. Kashif Munir|443-682-6873|kmunir@som.umaryland.edu|
20227879|NCT01433159|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
20227880|NCT01968421|Peking Union Medical College Hospital|Dr. Jinming Gao, Director of Clinical Trials|8610691550549|gjinming@yahoo.com|
20227881|NCT00301834|University of California San Francisco|Dr. Morton Cowan|4154762188|mcowan@peds.ucsf.edu|
20227882|NCT02870868|Vanderbilt University Medical Center|Alfredo Gamboa|(615) 322-5000|alfredo.gamboa@vumc.org|
20227883|NCT04040439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227884|NCT00526474|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20227885|NCT03845894|Wake Forest School of Medicine|Jonathan Doug Jaffe DO|336-716-4498|jjaffe@wakehealth.edu|
20227886|NCT01248455|National Cancer Institute|Dr. Dickran Kazandijian|301-480-0532|kazandjiandg@mail.nih.gov|
20227887|NCT01117870|McMaster University/ St. Joseph's Healthcare Hamilton|Dr. Harsha Shanthanna|905-522-1155|harshamd@gmail.com|
20227888|NCT01309386|Neuroscience department, Clinical science department, R&D in Janssen, Chiyodaku, Tokyo 101-0065, Japan|Manager|+81-3-4411-5509||
20227889|NCT00723229|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
20227890|NCT01674725|AbbVie|Global Medical Information|800-633-9110||
20227891|NCT02089347|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20227892|NCT00001566|National Cancer Institute (NCI), National Institutes of Health (NIH)|Crystal Mackall, M.D.|301-402-5940|mackallc@mail.nih.gov|
20227893|NCT02461693|University of Alabama at Birmingham|Dr. David Allison, PI|205-975-9169|dallison@uab.edu|
20227894|NCT03060473|University of Texas Medical Branch|Dr. Nkechinyere Emezienna|4097476651|nkemezie@utmb.edu|
20227895|NCT03439137|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20227896|NCT04896216|University of Minnesota|Kumi Smith|612.301.3051|smi00831@umn.edu|
20227897|NCT04753034|Aditum Bio|VP, Clinical Operations|(510) 227-2102|Chris.resburg@aditumbio.com|
20227898|NCT01225549|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20227899|NCT01329198|University of Florida Center for Movement Disorders & Neurorestoration|Assistant Director of Clinical Trials|352-294-5000|stacy.merritt@neurology.ufl.edu|
20227900|NCT00473083|BC Cancer Agency|Dr. Barbara Melosky, Principal Investigator|604-877-6000|BMelosky@bccancer.bc.ca|
20227901|NCT02915835|University of Michigan|Dr. Cathie Spino|7346155469|spino@umich.edu|
20227902|NCT01184872|Novartis Pharmaceutical|Study Director|862 778 8300||
20227903|NCT03426345|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20227904|NCT00433836|Novartis Pharmaceuticals|Study Director|862-778-8300||
20227905|NCT01474486|Phoenix VA Health Care System|Diane J. Parrington|602-277-5551|diane.parrington@va.gov|7532
20227906|NCT04613518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20227907|NCT05057221|University of Michigan|Lena M. Napolitano MD|734-615-4775|lenan@med.umich.edu|
20227908|NCT01077323|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20227909|NCT02984982|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20227910|NCT00549393|Johns Hopkins University|Dr. Aaron Milstone|4106143917|amilsto1@jhmi.edu|
20227911|NCT02153918|National Cancer Institute|Dr. Peter Pinto|301-496-6353|pintop@nih.gov|
20227912|NCT02144701|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20227913|NCT02616783|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20227914|NCT01103323|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20227915|NCT00372424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227916|NCT01342354|The University of Chicago|Dr. Stanley Liauw|(773) 702-0817|Stanley.Liauw@uchospitals.edu|
20227917|NCT02956382|Seattle Cancer Care Alliance|Chaitra Ujjani, MD|(206) 606-1955|ujjani@uw.edu|
20227918|NCT04536701|Ohio State University|Dr. Karen Rose|614-292-4844|rose.1482@osu.edu|
20227919|NCT05214118|Virginia Commonwealth University|Dr. Caitlin E. Martin|(804) 628-7023|caitlin.martin@vcuhealth.org|
20227920|NCT03797898|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
20227921|NCT02314728|Montefiore Medical Center|Kafui A. Demasio, MD, MPH, Maternal Fetal Medicine, Dept of Obstetrics/Gynecology and Women's Health|718-920-2767|kdemasio@montefiore.org|
20227922|NCT01614470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20227923|NCT00249834|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20227924|NCT02848664|James Madison University|Dr. Erin Kamarunas|540-568-8846|kamaruee@jmu.edu|
20227925|NCT01405898|Queen Mary University London|Professor Amrita Ahluwalia|02078825720|a.ahluwalia@qmul.ac.uk|
20227926|NCT01835912|BrockU|Panagiota Klentrou|19056885550|nklentrou@brocku.ca|4538
20227927|NCT01687218|Division of Infectious Diseases - UPMC|Ross D. Cranston, MD, FRCP|412-383-2054|rdc27@pitt.edu|
20227928|NCT02322749|AstraZeneca|Information Centre||Information.centre@astrazeneca.com|
20227929|NCT02033759|Mercy Integrative Medicine|Sarah Stolker, MSPT, CLT-LANA|13145402858|sarah@stolker.com|
20163037|NCT00387036|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
20163038|NCT00850538|New England Baptist Hospital|Carl Talmo|617-724-5474|ctalmo@nebh.org|
20227930|NCT04347408|Queen's University Belfast|Dr Thomas Waterfield|028 9024 5133|t.waterfield@qub.ac.uk|
20227931|NCT01190085|Brown University|Dr. Lorenzo Leggio|401-863-1000|Lorenzo_Leggio@Brown.edu|
20227932|NCT00807365|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|4105506484|registerclinicaltrials@jhmi.edu|
20227933|NCT04853043|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20227934|NCT01526785|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20227935|NCT05163392|UCSF|Sylvie Baudart|415-203-4027|sylvie.baudart@ucsf.edu|
20227936|NCT01121263|Icahn School of Medicine at Mount Sinai|Deborah Ascheim, MD|212-659-9567|deborah.ascheim@mssm.edu|
20210099|NCT03715335|Cincinnati Children's Hospital Medical Center|Dr. Jennifer Reed|(513) 636-7966|jennifer.reed@cchmc.org|
20210100|NCT02242942|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20210101|NCT04882085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210102|NCT05014672|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
20210103|NCT04336189|UCSF|Grant Dorsey|415-310-0525|grant.dorsey@ucsf.edu|
20210104|NCT04881149|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20210105|NCT05681715|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20210106|NCT02951130|UC Davis School of Medicine|Satyan Lakshminrusimha|916 734 5178|slakshmi@health.ucdavis.edu|
20210107|NCT02756182|Laborie|Clinical Research Manager|9056121170|sgallone@laborie.com|1755
20210108|NCT01003691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210109|NCT03832907|Emory University|Dr. Umpierrez|404-778-1665|geumpie@emory.edu|
20210110|NCT00308230|Emory University|Wendy Book|404-778-5545|wbook@emory.edu|
20210111|NCT00828009|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20210112|NCT07002632|University of Health Sciences, Gaziosmanpasa Training and Research Hospital|Ethem ilhan, MD|+90 505 591 86 50|ethem.ilhan@sbu.edu.tr|
20210113|NCT04814654|Montefiore Medical Center|Dr. Viraj Patel|718-920-5256|vpatel@montefiore.org|
20210114|NCT05405218|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
20210115|NCT02207413|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210116|NCT05102162|University of Florida College of Pharmacy|Nicole Maranchick|352-273-6803|n.maranchick@cop.ufl.edu|
20210117|NCT01354015|Tulane University|Dr Vivian Fonseca|5049884026|vfonseca@tulane.edu|
20210118|NCT02871921|MGH|Dr. Hiroko Dodge, Director of Research Analytics|724-494-3605|hdodge@mgh.harvard.edu|
20210119|NCT00320801|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
20210120|NCT02511587|Medical University of Vienna|Univ.-Prof. Dr. Ursula Wiedermann|0043 1 40160 38291|ursula.wiedermann@meduniwien.ac.at|
20210121|NCT02353572|University of Colorado|Choon-kee Lee, MD|7208489252||
20210122|NCT01870921|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20210123|NCT02060188|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20210124|NCT02335411|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210125|NCT00510497|University of Pittsburgh|Sharon A. Riddler, MD, MPH|412-383-1675|riddler@pitt.edu|
20210126|NCT03075826|Weill Cornell Medical College|Dr.Pinkal Desai|646-962-2700|pid4006@med.cornell.edu|
20210127|NCT00650806|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
20210128|NCT04190056|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|pamela.munster@ucsf.edu|
20210129|NCT01465048|University of Oxford|Dr Susanne Sheehy||susanne.sheehy@balliol.ox.ac.uk|
20210130|NCT03707145|Aberystwyth University|Dr Marco Arkesteijn|+44(0)1970628559|maa36@aber.ac.uk|
20210131|NCT04221477|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20210132|NCT04455620|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20210133|NCT02316002|University of Pennsylvania (Abramson Cancer Center)|Dr. Joshua Bauml|215-662-4000|melissa.volpe@pennmedicine.upenn.edu|
20227937|NCT03810456|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
20227938|NCT00738426|Cosmetic Surgery|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
20186396|NCT05746455|Columbia University|Dr. Alice Saperstein|646-774-8464|ams2334@cumc.columbia.edu|
20186397|NCT06190340|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
20186398|NCT03896789|University of Washington|Dr. Monica S. Vavilala|206-744-7235|vavilala@uw.edu|
20186399|NCT04026555|Icahn School of Medicine at Mount Sinai|Dr. Matthew Levin|212-241-8382|matthew.levin@mssm.edu|
20186400|NCT01120223|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20186401|NCT04150900|University of Maryland, Baltimore|Dr. Ranee Mehra|410-328-4059|umgccregulatory@umm.edu|
20186402|NCT03447470|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
20186403|NCT05851573|University of Central Florida|Dr. Deena Schwen Blackett|407-823-0909|deena.blackett@ucf.edu|
20186404|NCT05184192|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo|314-362-8641|piccirj@wustl.edu|
20186405|NCT05538754|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
20186406|NCT06429319|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
20186407|NCT04295798|Hebrew SeniorLife|Junhong Zhou|617-971-5346|JunhongZhou@hsl.harvard.edu|
20186408|NCT04624633|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|617-632-4894|Jennifer_Brown@dfci.harvard.edu|
20186409|NCT01902173|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
20186410|NCT02649842|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|1+ 714-247-8429|djanaki1@its.jnj.com|
20186411|NCT04625283|Vanderbilt University Medical Center|Dr. Britany Martin|+1 (615)322-8476|britany.l.raymond@vumc.org|
20186412|NCT03382652|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
20186413|NCT05603143|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20186414|NCT05783102|Case Western Reserve University|Kylie Meyer|216-368-1928|knm77@case.edu|
20186415|NCT04505904|University of Arizona|Brian Arizmendi|9168473623|arizmendi@email.arizona.edu|
20186416|NCT03629990|Medical University of South Carolina|Brian Sherman, Ph.D.|843-792-8174|shermanb@musc.edu|
20186417|NCT04277442|The Ohio State University|Dr. Alice Mims|(614) 293-3196|Alice.Mims@osumc.edu|
20186418|NCT05084508|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227939|NCT01461733|The Ottawa Hospital Research Institute|Salmaan Kanji|613-737-8899|skanji@toh.on.ca|78159
20227940|NCT02100124|Penn State College of Medicine|Dr. Cynthia Chuang|7175318161|CChuang@psu.edu|
20227941|NCT00545623|Boston University|Bei-Hung Chang|508-856-8959|bhchang@bu.edu|
20227942|NCT04350827|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
20227943|NCT04265261|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20227944|NCT02997163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20227945|NCT02990000|University of Massachusetts Amherst|Dr. Michael J. Constantino|4135451388|mconstantino@psych.umass.edu|
20227946|NCT02812186|Stony Brook University|Dr. Ruchir Gupta|917-443-1263|gupta2005@yahoo.com|
20227947|NCT00161213|UMDNJ|Dr. Susan Goodin (Deputy Director, Associate Director for Clinical Science)|732-235-6783|goodin@umdnj.edu|
20227948|NCT03103503|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
20227949|NCT00194129|UHCMC Mood Disorders Program|David Kemp, MD|216-844-2865|David.Kemp@UHhospitals.org|
20227950|NCT05088772|University of Toronto|Dr. Connor Brenna|416 340 3598|connor.brenna@mail.utoronto.ca|
20227951|NCT00452374|The University of Texas M. D. Anderson Cancer Center|William Wierda, M.D./Associate Professor|713-745-0428|eharriso@mdanderson.org|
20227952|NCT01929889|Northwestern University|Dr. John Csernansky|312-503-9096|jcsernan@nmff.org|
20227953|NCT01003106|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Peter A. Campochiaro, MD|(410) 955-5106|pcampo@jhmi.edu|
20227954|NCT01669434|University of Nebraska Medical Center|Dr. Jason Shiffermiller|402-559-7299|jshiffermiller@unmc.edu|
20227955|NCT00183430|VA Puget Sound HCS|Murray A. Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
20227956|NCT02659501|Loma Linda University, Department of Plastic Surgery|Saba Motakef, Resident Physican|714-925-8932|smotakef@llu.edu|
20227957|NCT01878799|National Institute of Allergy and Infectious Diseases|Dr. Shyam Kottilil|+1 301 435 0936|skottilil@niaid.nih.gov|
20227958|NCT00883181|Amgen Inc.|Study Director|866-572-6436||
20186419|NCT01388777|UT MD Anderson Cancer Center|Hwang, Rosa, M.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
20227959|NCT01218308|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227960|NCT00426270|Octapharma USA|Michael Eppolito|201 604-1155|michael.eppolito@octapharma.com|
20227961|NCT02709746|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20227962|NCT00752089|GlaxoSmithKline|GSK Response Center|866-435-7343||
20227963|NCT01997125|The Ohio State University|Marcia Bockbrader MD PhD|6142937604|bockbrader.13@osu.edu|
20227964|NCT02446691|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
20227965|NCT04210986|Vice President of Operations|Suzanne Liv Page|970-401-8770|spage@sprivail.org|
20227966|NCT02378662|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20227967|NCT00289211|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20227968|NCT00000575|Johns Hopkins Bloomberg School of Public Health, Dept of Epidemiology|Alice Sternberg|410-955-3752|asternbe@jhsph.edu|
20227969|NCT02443623|Emergent Biosolutions Inc.|Clinical Development Representative|(204) 275-4196|ctgov@ebsi.com|
20227970|NCT02425306|University of Virginia|Craig Slingluff, MD, Professor of Surgery|434-924-9311|cls8h@virginia.edu|
20227971|NCT00898937|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
20227972|NCT02295644|University at Buffalo, School of Dental Medicine, Oral Diagnostic Sciences|Dr. Willard D McCall|(716)829-3559|wdmccall@buffalo.edu|
20227973|NCT01380366|Northwestern University|Dr. Jonathan Fryer, MD|312-695-2125|jfryer@nmh.org|
20227974|NCT04219189|Virginia Commonwealth University|Dr. Caroline Cobb|(804) 827-3562|cobbco@vcu.edu|
20227975|NCT03863353|University of Michigan|Dr. Terri Voepel-Lewis|734-6466803|terriv@umich.edu|
20227976|NCT04079790|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20227977|NCT00324155|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20227978|NCT01253161|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-6585|Jonathan.Strosberg@moffitt.org|
20227979|NCT05817669|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
20227980|NCT02184208|Boston Children's Hospital|Brian Kendall Walsh|617-919-3692|brian.walsh@childrens.harvard.edu|
20227981|NCT03810183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20227982|NCT00323063|Rutgers Cancer Institute of|Deborah Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
20227983|NCT04275336|Children's Hospital of Fudan University|Ms.Yu Zhuowen|18017591126|yzw100@126.com|
20227984|NCT03055936|Orion Corporation, Orion Pharma|Clinical Study Director|+358104264184|clinicaltrials@orionpharma.com|
20227985|NCT03167242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20227986|NCT02115984|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences|Dr. Sergey S. Bogachev|+7-963-946-57-69|labmolbiol@mail.ru|
20227987|NCT01578772|UCLA|Dr. Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
20227988|NCT05222880|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen|(904)254-0152|TKarkkai@its.jnj.com|
20227989|NCT00904007|Veterans Affairs Boston Healthcare System|Dr. B. Price Kerfoot|7742869230|price.kerfoot@gmail.com|
20227990|NCT02886923|Johnson & Johnson Vision|Ross Franklin - PRINCIPAL RESEARCH OPTOMETRIST|904 4431768|RFrankl1@its.jnj.com|
20186420|NCT05093829|University of Maryland School of Medicine|Wilbur H. Chen, M.D., M.S., FACP, FIDSA|410-706-5328|wchen@som.umaryland.edu|
20186421|NCT06132867|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20186422|NCT05302596|State University of NY at Buffalo|Husam Ghanim|7168818924|ghanim@buffalo.edu|
20227991|NCT03327324|NYU Langone Health|Joshua Chodosh, MD, MSHS|(212) 263-6768|Joshua.Chodosh@nyulangone.org|
20227992|NCT04232839|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186423|NCT05194514|Cedars-Sinai|Fardad Esmailian|310-248-7132|fardad.esmailian@cshs.org|
20186424|NCT05228730|Murdoch Children's Research Institute|Ms Kathryn Bright|+61 3 99366656|kathrynbright@mcri.edu.au|
20186425|NCT04363515|Hennepin Healthcare Research Institute|Dr. Allyson Hart|612-873-6998|allyson.hart@hcmed.org|
20210134|NCT05012943|Vinmec Healthcare System|Nguyen Xuan Hung|+84-865438388|v.hungnx1@vinmec.com|
20210135|NCT04228107|University of Colorado|Heather De Keyser MD MSCS|720-777-4108|heather.dekeyser@childrenscolorado.org|
20210136|NCT03792633|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20210137|NCT05382637|Children's National Hospital|Andrew Dauber, MD|202-476-2121|adauber@childrensnational.org|
20210138|NCT05455684|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20210139|NCT05116241|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
20210140|NCT02265874|The Ohio State University Wexner Medical Center|Dr. Elliott Crouser|16142934925|elliott.crouser@osumc.edu|
20210141|NCT02268214|AstraZenenca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20210142|NCT00457795|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20210143|NCT04563039|Avvio Medical, Inc.|VP of RA / QA / CA|4158872037|clinicalaffairs@avviomed.com|
20210144|NCT04584294|VA Puget Sound Health Care System|Lisa Callegari (Principal Investigator)|206-277-3129|Lisa.Callegari@va.gov|
20210145|NCT03447015|Mutah University|Dr Reham Khresheh|0791425992|rehamkh@mutah.edu.jo|
20210146|NCT04242498|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20210147|NCT04813484|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
20210148|NCT05153629|Stanford University|Simon Conti, MD|650-723-3391|sconti@stanford.edu|
20210149|NCT05125237|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20210150|NCT04089566|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20210151|NCT01083121|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20210152|NCT02665273|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
20210153|NCT03743571|University of Nevada Reno|Cynthia Lancaster|(775) 682-8144|cynthialancaster@unr.edu|
20210154|NCT04115488|Polpharma Biologics S.A.|Director Clinical Research and Development|+48 607 697 896|clinicaltrials@polpharmabiologics.com|
20210155|NCT00885677|Medtronic EMEA RCC|Valentina Amori|3425417863|valentina.amori@medtronic.com|
20210156|NCT03884556|Trishula Therapeutics|Trishula Info|(650) 509-5732|info@trishulatx.com|
20210157|NCT00352794|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD., Professor|713-745-3429|sverstov@mdanderson.org|
20210158|NCT02008396|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20210159|NCT01233284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20210160|NCT05403502|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|+18583666900|clinicalaffairs@tandemdiabetes.com|
20210161|NCT02630992|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
20210162|NCT01058707|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
20210163|NCT00516217|University of Chicago|Sonali Smith, M.D.||smsmith@medicine.bsd.uchicago.edu|
20210164|NCT00167414|University of Rochester|Hong Zhang|585-341-6750|hong_zhang@urmc.rochester.edu|
20210165|NCT03722459|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20210166|NCT03826771|Medical University of South Carolina|Chris Gregory|843-792-1078|gregoryc@musc.edu|
20210167|NCT01875731|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43632100|torresfernandoadrian@gmail.com|1014
20210168|NCT03417102|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20210169|NCT03188991|US Biotest, Inc.|Gere S. diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
20210170|NCT02996266|Becton, Dickinson and Company|Director, Global Clinical Affairs - Urology and Critical Care|9733077325|kirsten.hammitt@bd.com|
20210171|NCT04938687|Spaulding Rehabilitation Hospital|Qing Mei Wang, MD, PhD|(617) 952-5299|wang.qingmei@mgh.harvard.edu|
20210172|NCT03309072|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
20210173|NCT02284880|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20210174|NCT00887965|Amgen Inc.|Study Director|866-572-6436||
20210175|NCT01656850|Taipei Medical University|Liu, Jen-Fang|+886-3-2118999|liujenfa@mail.cgust.edu.tw|5487
20227993|NCT05324306|Medical University of South Carolina|Dr. Konrad Rajab|843-792-1414|tkrajab@uams.edu|
20227994|NCT00535652|University of Ulm|Prof. Dr. Henne-Bruns, PI|++4973150053500|doris.henne-bruns@uniklinik-ulm.de|
20227995|NCT00069264|Eisai Inc.|Dr. Peter Tarassoff|888-422--4743||
20227996|NCT03177148|University of Michigan|Mx. Emerson Delacroix|734-764-2014|emmed@med.umich.edu|
20227997|NCT02408198|King's College London|Dr Amy Hardy|0207 848 0033|amy.hardy@kcl.ac.uk|
20227998|NCT00732069|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
20227999|NCT00577317|NRG Oncology|Linda Gedeon for Helen Huang, MS.|716-845-1169|Linda.gedeon@roswellpark.org|
20228000|NCT00767572|UCSF|Dr. Doreen DeFaria Yeh|617-643-7024|ddefariayeh@partners.org|
20228001|NCT02360488|UCLA|Steve Cramer|424-522-7273|sccramer@mednet.ucla.edu|
20210176|NCT00396318|Genentech, Inc.|Medical Communications|800-821-8590||
20210177|NCT00795210|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
20228002|NCT03301636|Lumos Pharma Inc. (Formerly NewLink Genetics)|Lumos Pharma|515-598-2921|clinical.trials@lumos-pharma.com|
20228003|NCT01645059|Hospital San Pedro Alcántara|Dr. Santiago González Santiago||santidatvs@hotmail.com|
20228004|NCT00974363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228005|NCT00846586|Novartis Pharmaceuticals|Study Director|862 778-8300||
20228006|NCT00875810|MedtronicSpineECA|Cristina Faria|+41 21 802 70 00|cristina.faria@medtronic.com|
20228007|NCT00780975|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
20228008|NCT01061606|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20228009|NCT01204671|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228010|NCT02743364|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
20228011|NCT03106077|UT MD Anderson Cancer Center|Stacy Moulder, Professor, Breast Medical Oncology|(713) 792-2817|smoulder@mdanderson.org|
20186426|NCT04806594|Relife Srl|Clinical Trial Coordinator|055 56809345|sdipalma@relifecompany.it|
20186427|NCT04318548|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20186428|NCT04323137|Geisinger Health|Amir Goren, PhD|570-214-4395|agoren@geisinger.edu|
20210178|NCT03255226|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20210179|NCT00602927|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
20210180|NCT00296192|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20210181|NCT03504839|The Ohio State University Medical Center|Clinical Research Coordinator - Adrianne Miller|614-688-8252|adrianne.miller3@osumc.edu|
20210182|NCT00685763|University of Florida Proton Therapy Institute|Charles Nichols, M.D.|904-588-1800|rnichols@floridaproton.org|
20210183|NCT02525627|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Doug McGurty|+44 (0) 1635 500690|doug.mcgurty@stryker.com|
20210184|NCT02875340|ValiSeek Limited|Suzanne Dilly|+442030084416|suzanne.dilly@valirx.com|
20210185|NCT01160770|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
20210186|NCT01064830|University of North carolina-Chapel Hill|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
20210187|NCT04930536|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20210188|NCT01432600|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
20210189|NCT00848965|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210190|NCT01510704|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
20210191|NCT01605370|Mayo Clinic|Marek Belohlavek, M.D., Ph.D.|408-301-6694|belohlavek.marek@mayo.edu|
20210192|NCT01976104|Eisai Call Center|Eisai Inc.|888-422-4743|esi_medinfo@eisai.com|
20210193|NCT01509638|Cleveland Clinic Florida|Marylise Boutrous, MD|954-659-5000|canedoj@ccf.org|
20210194|NCT03862469|University of Illinois at Chicago|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
20210195|NCT02181673|Janssen Research & Development, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20210196|NCT00337727|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20210197|NCT00326625|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20210198|NCT06067191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210199|NCT00323362|Rutgers Cancer Institute of New Jersey|Dr. Joseph Aisner, MD|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20210200|NCT04764669|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20210201|NCT00625846|Mayo Clinic|Keith C. Bible, M.D., Ph.D.|507-284-2511|bible.keith@mayo.edu|
20210202|NCT03426995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20210203|NCT02181075|Oncology Clinical Trials Group|Sarah Pearson, Trial Management Director|01865 227160|sarah.pearson@oncology.ox.ac.uk|
20210204|NCT04150107|Oramed, Ltd.|Miriam Kidron, PhD|+972-2-566-0001|miriam@oramed.com|
20210205|NCT03091478|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Rachel Levy, MS, CCRP|410-502-8738|rlevy16@jhmi.edu|
20210206|NCT04456998|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB002, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
20210207|NCT00400985|Medtronic BRC, The Netherlands, Maastricht|Director CRDM|+31 43 3566||566
20210208|NCT00965562|Donaghue Medical Research Foundation|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
20210209|NCT05048875|Johns Hopkins School of Public Health Center for Immunization Research|Dr Anna Durbin|410-955-1622|adurbin1@jhu.edu|
20210210|NCT05445466|BIDMC|Dr. Paulo Lizano|201-776-6708|lizanopl@gmail.com|
20210211|NCT01714921|Medtronic GmbH|ProSA clinical research contact|004921598149|rs.dusclinicalcooperation@medtronic.com|0
20210212|NCT05204563|Evopoint Biosciences USA, Inc.|Evopoint Biosciences|646-750-2661|info@evopointbio.com|
20210213|NCT04411641|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20210214|NCT04755283|Anthos Therapeutics, a Novartis company|Study Director|+1-888-669-6682|Novartis.email@Novartis.com|
20210215|NCT03222570|University of Minnesota|Meredith Gunlicks-Stoessel|612-624-9249|mgunlick@umn.edu|
20210216|NCT04678440|University of California Davis|Simon Cherry|(530) 754-9419|srcherry@ucdavis.edu|
20210217|NCT05487625|Fralin Biomedical Research Institute at VTC|Roberta Freitas Lemos|540 526 2106|rflemos@vtc.vt.edu|
20210218|NCT04342390|Arkansas Children's Research Insitute|Emir Tas|4126928688|tase2@upmc.edu|
20210219|NCT01795534|Bangor University|Dr Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
20210220|NCT03741335|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
20210221|NCT02970877|University Health Network|Scientific Associate|416-340-5159|kschweng@uhnresearch.ca|
20210222|NCT04410978|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20210223|NCT02684162|The University of Texas MD Anderson Cancer Center|Betul Oran, MD / Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
20210224|NCT04560088|University of Rochester Medical Center|Autumn Gallegos, PhD|5852752824|autumn_gallegos@urmc.rochester.edu|
20210225|NCT03378921|Department of Gastrointestinal surgery, Helsinki University Hospital|Dr. Essi Karjalainen|+358504621853|essi.karjalainen@hus.fi|
20210226|NCT00594009|University of Texas Medical Branch|Victor Cardenas, MD|(409) 772-2436|vcardena@utmb.edu|
20210227|NCT00673712|Halyard Health|Sr. Director Clinical Research|5132538033|alan.dine@hyh.com|
20210228|NCT01489865|Lombardi Comprehensive Cancer Center|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
20210229|NCT01593761|CrystalGenomics, Inc.|Seonggu Ro, Ph.D, Chief Technology Officer|82 31 628 2783|sgro@cgxinc.com|
20210230|NCT00795886|Primary Children's Medical Center|Michael Pulsipher, MD|801-662-4732|Michael.Pulsipher@hsc.utah.edu|
20163039|NCT03139344|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
20228012|NCT01274533|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20228013|NCT03669588|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20228014|NCT02008526|Friends Research Institute|Dr. Cathy Reback|3234631601|reback@friendsresearch.org|
20228015|NCT00492726|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20228016|NCT04541355|University of California, San Francisco|Dr. Hyunseok Kang, MD|(888) 689-8273|hyunseok.kang@ucsf.edu|
20228017|NCT01100502|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20228018|NCT04386902|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
20228019|NCT01414244|Tulane University|QiQi Zhou|988-7800|qiqi06@gmail.com|
20228020|NCT00721799|The University of Iowa Department of Radiology|Yusuf Menda, MD|319-356-3214|yusuf-menda@uiowa.edu|
20228021|NCT05158140|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20228022|NCT04059250|University of California San Francisco|Dr. Peter Rechmann|4155143225|Peter.Rechmann@ucsf.edu|
20228023|NCT02337764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20228024|NCT03653741|Weill Cornell Medical College|David Chuang, MD|212-746-5519|dtc9002@med.cornell.edu|
20228025|NCT01949545|Amgen, Inc.|Study Director|866-572-6436||
20228026|NCT03631641|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.Hays@osumc.edu|
20228027|NCT01050153|Denver Health Medical Center|Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
20228028|NCT02860988|University of Kentucky|Dr. Joseph Calvert|(859) 323-5771|joe.calvert@uky.edu|
20228029|NCT02579629|Emory University|Katherine Egan|404-727-8463|kfegan@emory.edu|
20228030|NCT01930539|University of Nebraska Medical Center|Lynn Mack|402-559-6276|lmack@unmc.edu|
20228031|NCT01190891|Madigan Army Medical Center|Troy Patience, Research Operations Service|(253) 968-1160|usarmy.jblm.medcom-mamc.mbx.dci@mail.mil|
20228032|NCT01926028|NovaDigm Therapeutics, Inc.|Chief Scientific Officer|2676405189|john_hennessey@novadigm.net|
20228033|NCT00737048|JANSSEN PHARMACEUTICAL. K.K. , Neuroscience Department, Clinical Science Division|Medical Director|+81-3-4411-5509||
20228034|NCT04635839|University of California, Los Angeles|Dr. Thalia Mok|310-794-7274|tmok@mednet.ucla.edu|
20228035|NCT02737358|Medical University of South Carolina|Erin A. McClure, Ph.D.|843-792-7192|mccluree@musc.edu|
20228036|NCT01115452|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228037|NCT00744939|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20228038|NCT01739335|Bronx VA Medical Center|Dr. Julia Golier; Chief of Psychiatry|718-584-9000|julia.golier@va.gov|6587
20228039|NCT00288912|Durham VA HSR&D|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
20228040|NCT02105324|Massachusetts General Hospital|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
20228041|NCT00612235|Beth Israel Deaconess Medical Center|Andrew G. Herzog M.D., M.Sc.|781-431-0277|aherzog@bidmc.harvard.edu|
20228042|NCT00843349|University of Miami|Dr. Myles Wolf, Associate Professor of Medicine, Chief-Division of Nephrology and Hypertension|305-243-7745|mwolf@med.miami.edu|
20228043|NCT02124824|VAMC SLC|Scott Capps|8015821565|Scott.Capps@hsc.utah.edu|
20228044|NCT00879190|Stanford University, Department of Obstetrics & Gynecology|Anna Girsen, Manager of Maternal-Fetal Medicine Research Operations|(650) 725-0499|agirsen@stanford.edu|
20228045|NCT01587885|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20228046|NCT02209064|EpiEP|Pam Bunes CEO & Founder|+1 864 423 2526|pbunes@epiep.com|
20228047|NCT02062437|Tornier SAS|Nathalie Trétout|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
20228048|NCT02900352|Virginia Commonwealth University|Dr. Albert Arias|8048285793|albert.arias@vcuhealth.org|
20228049|NCT01235065|R Adams Cowley Shock Trauma Center|Dale Yeatts, Principal Investigator|443-909-0648|djyeatts@gmail.com|
20228050|NCT00386334|Sepracor Inc.|Lunesta Medical Director|1-866-503-6351||
20228051|NCT02280252|NYU Langone Health|Dr. Nelly Huppert|(212) 731-5003|Nelly.Huppert@nyulangone.org|
20228052|NCT00458237|Beth Israel Deaconess Medical Center|Gerburg Wulf|(617) 667-1910|gwulf@bidmc.harvard.edu|
20228053|NCT00975416|National Institute on Drug Abuse|Mary R. Lee, M.D.|301-825-0545|leemary@mail.nih.gov|
20228054|NCT00106002|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20228055|NCT01245101|University of Miami|Rafael E. Campo|305-689-7030|rcampo@med.miami.edu|
20228056|NCT01122173|Auris Health, Inc.|Emir Deljkich/Sr. Director, Clinical Affairs|650-397-2677|emir.deljkich@aurisrobotics.com|
20228057|NCT02730962|University of Minnesota|Dr. Alexander Khoruts|612-624-2101|khoru001@umn.edu|
20228058|NCT02133508|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20228059|NCT02431598|Duke University Medical Center|Dr. Mustafa Bashir|919-684-8111|mustafa.bashir@duke.edu|
20228060|NCT01026493|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20228061|NCT00466817|University of Alabama in Birmingham|David Kimberlin, MD|205-934-2424|dkimberlin@peds.uab.edu|
20228062|NCT03194334|University Ghent|Prof. Wim Derave|+32/9/2646326|wim.derave@ugent.be|
20228063|NCT03093181|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20228064|NCT00514618|MemorialCare Health Services LBMC|Lorna Camfield, Research Compliance Analyst|714-377-3227|lcamfield@memorialcare.org|
20228065|NCT03154086|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163040|NCT03188510|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20163041|NCT04182672|The University of Texas Health Science Center at Houston|Pritish Bawa, MD|713-500-7702|Pritish.Bawa@uth.tmc.edu|
20163042|NCT01088399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163043|NCT03637517|Medicines for Malaria Venture|Stephan Chalon, MD|+41 22 555 0369|chalons@mmv.org|
20228066|NCT04076917|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|800-547-0394|crystal.miller@biotronik.com|
20228067|NCT03148262|UT Southwestern Medical Center|Dr. Christina Riccio|214-590-7284|Christina.Riccio@UTSouthwestern.edu|
20228068|NCT01774591|University of Chicago|George L. Bakris, MD|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
20228069|NCT04710004|Emory University|Dr. Robert Gross|404-727-2354|rgross@emory.edu|
20228070|NCT01701245|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
20228071|NCT01159574|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
20228072|NCT01183923|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
20228073|NCT03555149|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20228074|NCT00286182|Columbia University|Mathew Maurer, MD, Professor of Medicine at the Columbia University Medical Center|212-305-9808|msm10@cumc.columbia.edu|
20228075|NCT02666222|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
20228076|NCT00630916|Sorin Group USA|Director of Clinical and Medical Affairs|512-435-3602|barbara.mathews@sorin.com|
20228077|NCT02147626|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|6175258264|jr33@partners.org|
20228078|NCT03504917|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WN39434|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
20228079|NCT01299584|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228080|NCT00572832|University of Pittsburgh|Richard Zimmerman|412-383-2354|zimmer@pitt.edu|
20210231|NCT05554471|Cordis|Jenny Jimenez|+1 646 483-6846|jenny.jimenez@cordis.com|
20210232|NCT04479241|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
20210233|NCT02576951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20210234|NCT03285581|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20210235|NCT02218619|Columbia University Irving Medical Center|Robin Goland, MD|212-851-5494|rsg2@cumc.columbia.edu|
20210236|NCT00710840|University of Colorado Denver, Anschutz Medical Center|Dr. Jennifer Stevens-Lapsley|303-724-9170|Jennifer.Stevens-Lapsley@ucdenver.edu|
20210237|NCT00157820|Hospital General Universitario de Valencia, Spain|Dr.A.Quesada||aquesadad@secardiologia.es|
20210238|NCT01419028|Alexion International Sarl|Alexion Pharmaceuticals||clinicaltrials@alxn.com|
20210239|NCT01568255|Cedars Sinai|Margo Minissian, PhD|310-423-5195|Margo.Minissian@cshs.org|
20210240|NCT02850159|Samsung Medical Center|Dr. Won Hyuk Chang|82234102818|wh.chang@samsung.com|
20210241|NCT02060526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20210242|NCT03572049|University of Alabama at Birmingham|Dr. Peter G. Pappas|2059347292|ppappas@uabmc.edu|
20210243|NCT03065517|Evidence-Based Practice Institute, Inc.|Angela Kelley Brimer|253-279-8659|research@jasprhealth.com|
20210244|NCT01441401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210245|NCT03457727|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20210246|NCT00242567|Novartis Pharmaceuticals|Study Director|862-778-8300||
20210247|NCT00464308|Janssen-Cilag Pty Ltd|Executive Director, Medical & Scientific Affairs|+61 2 9815 3219|mhandel@its.jnj.com|
20210248|NCT01721200|Yale University|Liana Fraenkel, MD, MPH, Department of Medicine||liana.fraenkel@yale.edu|
20210249|NCT00630994|Mayo Clinic|Dr. Ruben A. Mesa|507-284-2511|mesa.ruben@mayo.edu|
20210250|NCT01107834|Washington University|William T. Cade|314-286-1432|tcade@wustl.edu|
20210251|NCT03722849|The University of Melbourne|Dr Stuart Mazzone|+61383446457|stuart.mazzone@unimelb.edu.au|
20210252|NCT03533608|Center for Clinical Managment Research|Dr. Rebecca Sripada|734-222-7432|rebecca.sripada@va.gov|
20210253|NCT03286426|Duke Eye Center|Dr. Grace Prakalapakorn|+1 919 684 7679|grace.prakalapakorn@duke.edu|
20210254|NCT03514121|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20210255|NCT05553600|Kimberly-Clark Corporation|Jin Zhang|770-587-8000|jin.zhang@kcc.com|
20210256|NCT04292171|University of Nevada Las Vegas School of Medicine|Adam V. Levy MD|702-671-2300|adam.levy@unlv.edu|
20210257|NCT01900392|UPENN|Catherine Reale|2157464009|catherine.reale@uphs.upenn.edu|
20210258|NCT03079869|Kaiser Permanente|KPSC PRS Administrator|626-720-7463|RE-CTCAT@kp.org|
20163044|NCT01748825|National Cancer Institute|Dr. Naoko Takebe|240-781-3320|takeben@nih.gov|
20163045|NCT02921087|SUNY College of Optometry Clinical Vision Research Center|Danielle Iacono, OD|212-938-5936|diacono@sunyopt.edu|
20163046|NCT00852241|Loyola Medicine|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedicine.org|
20163047|NCT02524418|University of Florida|Dr. Peter V. Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
20163048|NCT00619307|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20163049|NCT00928694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163050|NCT00118430|Indiana University|Kurt Kroenke|3172749046|kkroenke@regenstrief.org|
20163051|NCT02147288|Yale University|Dr. Marc Walker||marc.walker@yale.edu|
20163052|NCT00669383|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
20163053|NCT02069392|University of Maryland School of Medicine|Britta Hahn, Ph.D.|4104026112|bhahn@som.umaryland.edu|
20163054|NCT00269633|Thomas Jefferson University|Roseann Talarico|215 503 4743|roseann.talarico@jefferson.edu|
20163055|NCT04412707|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20163056|NCT02927938|Levine Cancer Institute|Dr. James Symanowski; Chair, Department of Cancer Biostatistics|9804422371|james.symanowski@atriumhealth.org|
20163057|NCT01504412|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
20163058|NCT04784143|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20163059|NCT02551822|University of New Mexico Health Sciences Center, Department of Obstetrics & Gynecology, Division of Urogynecology|Dr. Yuko Komesu, MD|505-272-6382|YKomesu@salud.unm.edu|
20163060|NCT00526591|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
20163061|NCT00783614|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
20210259|NCT04633434|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
20210260|NCT03354143|IEEM|Dr. Rong Zhang|214-345-4245|rongzhang@texashealth.org|
20210261|NCT02530320|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
20210262|NCT00556972|Coloplast A/S|Thais Benjamin N. Christensen, Senior Clinical Project Manager|+4549112668|dkthc@coloplast.com|
20210263|NCT00348348|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
20210264|NCT00659945|University of Pittsburgh|Manuel C. Vallejo, MD|412-641-4260|vallejomc@anes.upmc.edu|
20210265|NCT02525575|Department of Veteran Affairs|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
20210266|NCT01301625|Abbott Vascular|Jeffrey T. Ellis|(408) 845-8184|jeffrey.ellis@av.abbott.com|
20210267|NCT01993238|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
20210268|NCT02684370|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20210269|NCT00944528|Assistant Research Practice Manager|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
20210270|NCT01165424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20210271|NCT00433771|Boston Scientific Corporation|Jeremy Bolt|508-683-4006|boltj@bsci.com|
20210272|NCT00943826|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20210273|NCT00517868|Vaneltix Pharma, Inc.|CEO|732-354-3217|info@vaneltix.com|
20210274|NCT00258310|Barbara Ann Karmanos Institute|George Yoo, M.D.|(313) 576-9782|yoog@karmanos.org|
20210275|NCT03992261|Mayne Pharma|Lee Ann McDowell, PharmD - Director of Medical Affairs|4124776681|leeann.mcdowell@maynepharma.com|
20210276|NCT03733418|Vanderbilt University Medical Center|Dr. Jin Han|16159360253|jin.h.han@vumc.org|
20210277|NCT00661960|UCaliforniaDavis|David Asmuth/Principal Investigator|9167348695|david.asmuth@ucdmc.ucdavis.edu|
20210278|NCT01833897|New York State Psychiatric Institute|Joshua Kantrowitz|646-774-6738|jkantrowitz@nki.rfmh.org|
20210279|NCT00669110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210280|NCT01244516|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
20210281|NCT00941681|Cytokinetics, Inc.|Project Manager|650-624-2918||
20210282|NCT04035694|innovation Research & Training|Dr. Tracy Scull|(919) 493-7700|tscull@irtinc.us|
20210283|NCT00077766|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20210284|NCT01883141|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
20210285|NCT04049474|NYU Langone Health|Lira Gutierrez|212-263-6181|Lira.Gutierrez@nyulangone.org|
20210286|NCT04103645|Weill Cornell Medicine|Joseph Scandura, MD|(212) 746-2072|jms2003@med.cornell.edu|
20210287|NCT00318357|The University of Hull; Department of Cardiology; United Kingdom|John Cleland, Professor|Telephone: 0044 1482 624084||
20210288|NCT00972309|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20210289|NCT02159872|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdaderson.org|
20210290|NCT02062385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210291|NCT06212544|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
20210292|NCT00223990|Kenya Medical Research Institute|Bernhards R. Ogutu, PhD|254-57-22942|bogutu@kisian.mimcom.net|
20210293|NCT04020822|Medtronic Diabetes|Kusal Ahangama, Clinical Study Manager|+18185765023|kusal.c.ahangama@medtronic.com|
20210294|NCT01319994|Queen Mary University of London|Prof M Korbonits|+442078826197|m.korbonits@qmul.ac.uk|
20210295|NCT01340794|Mayo Clinic Cancer Center|Keith Bible, M.D., Ph.D.||bible.keith@mayo.edu|
20210296|NCT00741026|American Medical Association|Vance L. Albaugh, Principle Investigator|(800) 243-1455|vance.l.albaugh@vanderbilt.edu|
20210297|NCT02674568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20210298|NCT01939834|University of Virginia|Sue Brown|434-924-1825|sab2f@virginia.edu|
20210299|NCT01808508|Children's Hospital of Philadelphia|Carole L. Marcus, MBBCh|267-426-5842|marcus@email.chop.edu|
20210300|NCT01118949|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20210301|NCT01035229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20210302|NCT01628159|BD|Director of Clinical Affairs|763-445-2385|anna.lovas@bd.com|
20210303|NCT02712359|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20210304|NCT03387423|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210305|NCT04476654|Virginia Commonwealth University|Dr. Vanessa Sheppard|804-828-8892|vlbsheppard@vcu.edu|
20210306|NCT01473589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210307|NCT00929201|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210308|NCT01299272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210309|NCT01387672|Womens' College Hospital|Dr. Sophie Jamal|416-351-3732|sophie.jamal@wchospital.ca|2873
20210310|NCT00665704|VA Center for Clinical Management Research Health Services Research & Development, VA Ann Arbor Healthcare System, Ann Arbor, MI.|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
20210311|NCT00540007|Washington University School of Medicine|Todd Fehniger, M.D., Ph.D.|314-747-1385|tfehnige@wustl.edu|
20210312|NCT00297882|University of Yaounde 1, Cameroon|Professor Wilfred Mbacham|+237 677579180|wfmbacham@yahoo.com|
20210313|NCT04242264|Cincinnati Children's Hospital Medical Center|Robert W Frenck, Jr, M.D.|513-636-4463|Robert.Frenck@cchmc.org|
20210314|NCT03710824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20163062|NCT01159015|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20210315|NCT01353209|University of Cincinnati|Susan McMahan, Clinical Research Manager|513-558-4831|Susan.mcmahan@uc.edu|
20163063|NCT04808141|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
20163064|NCT01401517|TheraVasc Inc.|Tony Giordano|318-349-3851|tgiordano@theravasc.com|
20210316|NCT03112720|RWJMS/Rutgers Health|william grubb md|732 235 7827|grubbwr@rwjms.rutgers.edu|
20228081|NCT00966433|Wake Forest University Health Sciences|Dr. Thomas Templeton, MD|336-716-4285|ttemplet@wakehealth.edu|
20228082|NCT00390689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228083|NCT03871556|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20163065|NCT02598297|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20228084|NCT03101020|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Lucas Villalta Santos|+5515998197899|lucasvillalta.s@gmail.com|
20228085|NCT01924533|AstraZeneca|Gershon Locker Global Clinical Lead (GCL)||gershon.locker@astrazeneca.com|
20228086|NCT04233879|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20228087|NCT03292016|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20228088|NCT00072449|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
20210317|NCT02686437|Sport and Spine Rehab Clinical Research Foundation|Jena Etnoyer-Slaski|301-251-2777|jslaski@ssrehab.com|838
20210318|NCT03237325|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
20210319|NCT00561600|DePuy Orthopaedics|Dave Whalen Clinical Portfolio Leader|574-372-7028|dwhalen@its.jnj.com|
20210320|NCT04139642|The Ohio State University|Dr. Ajit Chaudhari|+1-614-292-0558|chaudhari.2@osu.edu|
20210321|NCT01040624|University of Florida Health Proton Therapy Institute|Nancy P. Mendenhall, MD|904-588-1000|rtoton@floridaproton.org|
20210322|NCT03733301|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20210323|NCT02050373|UFGoias|Daniella Salvador|556235583272|danirnsalvador@gmail.com|
20210324|NCT04342130|University of Rochester|Paul Geha|203-752-8256|paul_geha@urmc.rochester.edu|
20210325|NCT03046966|University of Arkansas for Medical Sciences|Jennifer Rumpel, MD|501-364-2980|Jarumpel@uams.edu|
20210326|NCT01783860|Rasoule-Akram Hospital|Dr. Mohsen Bahmani-Kashkouli|00982166558811|bahmanik@eyeplasticsurgeries.com|
20210327|NCT00256217|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20210328|NCT00557830|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20210329|NCT00759668|Alcon Italia SpA|Marcello Fornoni|39.02.81.303.226|marcello.fornoni@alconlabs.com|
20210330|NCT00552812|Johns Hopkins School of Medicine|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
20210331|NCT01803464|University of Delaware|Dr. Christopher Modlesky|302-831-4185|modlesky@udel.edu|
20210332|NCT02424851|Oxford University Hospitals NHS Foundation Trust|Richard Brouwer|441865226950|richard.brouwer@ouh.nhs.uk|
20210333|NCT02860039|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
20210334|NCT02024386|Duke University School of Medicine|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
20210335|NCT01856257|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20210336|NCT03664024|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210337|NCT01157065|Alcon Research, Ltd.|Mehdi Hosseini, Clinical Trial Manager|1-888-451-3937|alcon.medinfo@alcon.com|
20210338|NCT00318409|San Francisco Department of Public Health|Moupali Das, MD, MPH|415-437-6204|moupali.das@sfdph.org|
20210339|NCT05275673|Faeth Therapeutics, Inc|Medical Monitor|7084069282|clinicaltrials@Faeththerapeutics.com|
20210340|NCT02325739|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20210341|NCT00227591|ECOG Statistical Office|Study Statistician|617-632-3012||
20210342|NCT01886105|Johns Hopkins University|Dr. Brian H. Ladle|443-287-3534|bladle@jhmi.edu|
20210343|NCT00357734|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20210344|NCT00389168|Karolinska Institutet, Stockholm, Sweden|Thomas Kahan, MD|+46 8 123 568 61|thomas.kahan@ds.se|
20210345|NCT02057549|The University of Texas Houston Health Science Center|Dr. Carlos J. Roldan MD|713-792 6070|croldan@mdanderson.org|
20210346|NCT03843775|Memorial Sloan Kettering Cancer Center|Dr. Rona Yaeger MD|646-888-5109|yaegerr@mskcc.org|
20210347|NCT00003726|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
20210348|NCT02212834|Group Health Research Institute|Karen J. Wernli, PhD|206-287-2934|wernli.k@ghc.org|
20210349|NCT00530621|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210350|NCT01281475|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
20210351|NCT04611152|Kodiak Sciences Inc|Pablo Velazquez-Martin|6502810850|clinops@kodiak.com|
20210352|NCT02080273|Colgate Palmolive Company|Maria Ryan|732-878-7766|maria_ryan@colpal.com|
20210353|NCT05444114|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
20210354|NCT00605839|Indiana University School of Medicine|Aaron E. Carroll|3172780552|aaecarro@iupui.edu|
20210355|NCT03917654|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
20210356|NCT02255422|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20228089|NCT04664205|University of North Carolina at Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
20228090|NCT01909804|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20228091|NCT01038687|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
20163066|NCT05651867|Quantum Surgical|Marion Chassouant|0033781425198|m.chassouant@quantumsurgical.com|
20186429|NCT05215314|University of Wisconsin-Madison|Daniel Grupe|608-263-7572|grupe@wisc.edu|
20186430|NCT01744782|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
20210357|NCT00602667|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|amar.gajjar@stjude.org|
20210358|NCT02339246|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
20210359|NCT03628872|Columbia University College of Dental Medicine|Dr. Philip Y Kang|212-342-5244|pyk2104@cumc.columbia.edu|
20210360|NCT03179462|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
20210361|NCT04636437|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20210362|NCT00790270|Stony Brook U|Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
20210363|NCT00816166|Codman Neuro|Jonathan Megerian, MD PhD|508-880-8274|jmegeri1@its.jnj.com|
20228092|NCT05401565|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20228093|NCT02439164|Beijing Tiantan Hospital|Dr. Nan Lin|861067096658|linnan127@163.com|
20228094|NCT02343224|Emory University|Dolly Aguilera MD|404-785-3515|Dolly.Aguilera@choa.org|
20228095|NCT03118934|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
20228096|NCT03080935|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20228097|NCT01251042|Wellspect HealthCare|Emma Tällberg, Clinical Research Manager|+46313764000||
20228098|NCT04249427|Duke University|David Jang, MD|919-613-6407|david.jang@duke.edu|
20228099|NCT03886272|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228100|NCT03974282|Virginia Commonwealth University|David Chester|8048287624|dschester@vcu.edu|
20228101|NCT02895347|GWU Medical Faculty Associates|Dr. Gaby Moawad|202-741-2500|jebert@mfa.gwu.edu|
20228102|NCT02589145|UT MD Anderson Cancer Center|Dr. Yago Nieto/Professor, Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
20228103|NCT01673178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228104|NCT02557399|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228105|NCT02456194|NSHA|Ross Leighton|1-902-473-4035|Ross.Leighton@nshealth.ca|
20228106|NCT00931632|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20228107|NCT01439035|Massachusetts General Hospital|Dr. Gary Tearney PI|617-724-2979|gtearney@partners.org|
20228108|NCT01419314|Texas Woman's University|Roberto Sandoval PT|713-859-9351|rsandoval@mail.twu.edu|
20228109|NCT02569892|Stanford University School of Medicine|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
20228110|NCT00402727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20228111|NCT03372798|Oxford University Hospitals NHS Foundation Trust|Dr Tim Betts|0044 01865 220256|ep.doctors@ouh.nhs.uk|
20228112|NCT03608826|Medtronic|Nicole Wood|8006338766|nicole.wood@medtronic.com|
20228113|NCT02084511|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228114|NCT01328964|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228115|NCT01733277|ArthroLab Inc.|Dr Jean-Pierre Pelletier|15148908000|dr@jppelletier.ca|26666
20228116|NCT00461734|Princess Alexandra Hospital|Dr. Gerald Kaye|07 3176 2111|gerald.kaye@health.qld.gov.au|
20228117|NCT03139552|University of Colorado Anschutz Health and Wellness Center|John C. Peters, PhD|303-724-9160|john.c.peters@ucdenver.edu|
20228118|NCT02236000|NSABP Foundation, Inc.|Judy Langer, Director of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
20228119|NCT01754519|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20210364|NCT02851069|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20210365|NCT00352664|UT MD Anderson Cancer Center|Eduardo Bruera, MD / Professor|713-792-6084||
20210366|NCT02146365|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20210367|NCT03222856|MedSIR|Scientific Director|+34 611261467|alicia.garcia@medsir.org|
20210368|NCT00698009|UT MD Anderson Cancer Center|Eugenie S Kleinerman,MD/Professor, Pediatrics - Research|(713) 497-6226|ekleiner@mdanderson.org|
20210369|NCT03862807|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20210370|NCT02513095|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201 326 5300|medinfo@eagleus.com|
20210371|NCT00798707|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210372|NCT00566969|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20210373|NCT02384239|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
20210374|NCT01513759|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
20210375|NCT03606109|NYU Langone Health|Michael J. Alaia, MD|646-501-7223|Michael.Alaia@nyulangone.org|
20210376|NCT02305329|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20210377|NCT03669640|F. Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20210378|NCT00366678|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20210379|NCT01150409|The Cleveland Clinic Foundation|Jorge Guzman MD|216-445-5765|guzmanj@ccf.org|
20210380|NCT00826176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20210381|NCT01687400|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
20210382|NCT00388674|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20210383|NCT03576131|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
20210384|NCT01339858|Indiana University Psychotic Disorders Program|Alan Breier|317-880-8495|abreier@iupui.edu|
20210385|NCT01456000|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
20210386|NCT00996632|University of Trieste|Prof. Nicolò de Manzini|+390403994152|nicolo.demanzini@aots.sanita.fvg.it|
20228120|NCT01257347|Columbia University Medical Center|Ian Kronish, MD, MPH|2123421335|ik2293@columbia.edu|
20228121|NCT03204643|Atrium Health|Dr. Jason Roberge|704-355-0268|Jason.Roberge@AtriumHealth.org|
20210387|NCT04305184|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20228122|NCT01768325|Indiana University School of Medicine|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
20228123|NCT01085643|Cedars-Sinai Medical Center|Edy Soffer, MD|(310) 423-6143|edy.soffer@cshs.org|
20228124|NCT00944710|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20228125|NCT00887484|GlaxoSmithKline|GSK Response Center|888-435-7343||
20228126|NCT00381628|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
20228127|NCT04054544|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20228128|NCT03044314|Duke University Medical Center|Richard Krasuski|919-681-6195|richard.krasuski@duke.edu|
20228129|NCT03122171|Rutgers-New Jersey Medical School|Alice Chu, MD|(973) 972-2076|chual@njms.rutgers.edu|
20228130|NCT01316224|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20228131|NCT00264147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20228132|NCT03234465|Oragenics, Inc.|Dr. Alan Jolyn|+ 1 813-286-7900|info@oragenics.com|
20228133|NCT00449163|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-4909|bardalan@med.miami.edu|
20228134|NCT00465530|University of Kansas Medical Center|Dr. Julie Wei|(913) 588-6664|jwei@kumc.edu|
20228135|NCT00541242|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20228136|NCT00606307|Italfarmaco S.p.A.|Tiziano Oldoni, MD|+39 02 6443|t.oldoni@italfarmaco.com|2540
20228137|NCT02563899|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228138|NCT03368807|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228139|NCT00628407|Children's Hospital of Philadelphia|Vinay Nadkarni, MD|215-590-7430|nadkarni@email.chop.edu|
20228140|NCT00597272|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
20228141|NCT03781726|University of Pennsylvania|Peter Reese|215-573-8070|Peter.Reese@pennmedicine.upenn.edu|
20228142|NCT01035749|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228143|NCT00948090|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20228144|NCT02139397|Beat Childhood Cancer|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
20228145|NCT00349336|Hoffmann-La Roche|Medical Communications|800-821-8590||
20228146|NCT02643875|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
20228147|NCT01721447|University of Utah Division of Cardiovascular Medicine|Dr. Brent Wilson|801-585-2341|brent.wilson@hsc.utah.edu|
20228148|NCT01339416|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228149|NCT02949947|UT MD Anderson Cancer Center|Saroj Vadhan,Clinical Professor, Cytokine & Supportive Oncology|(713) 792-7966|svadhanr@mdanderson.org|
20228150|NCT01677741|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20228151|NCT00720499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228152|NCT01973218|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20228153|NCT02247466|Department of Anaesthesiology, Herlev Hospital, University of Copenhagen|Roar Borregaard Medici, MD, Research Assistant|+4526390068|roar.borregaard.medici.01@regionh.dk|
20228154|NCT01004939|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228155|NCT01621009|University of Wisconsin Center for Tobacco Research and Intervention|Timothy Baker, PhD, Director of Research|(608) 262-7568|tbb@ctri.wisc.edu|
20228156|NCT01589315|Medical University of South Carolina|Mark S. George, MD|1843876 5142|georgem@musc.edu|
20163067|NCT00345865|Masonic Cancer Center, University of Minnesota|Dr.Veronika Bachanova|612-625-5469|bach0173@umn.edu|
20210388|NCT03731325|Washington University in St. Louis|Tina Day|314-286-0079|dayt@wustl.edu|
20210389|NCT04484805|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
20210390|NCT02118896|Astellas Pharma Europe Limited|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
20210391|NCT00544778|City of Hope National Medical Center|Paul Frankel, Ph. D.|(626)359-8111|pfrankel@coh.org|65265
20210392|NCT02116309|Johns Hopkins University|Dr. Vikesh Singh|4106146708|vakshin1@jhmi.edu|
20210393|NCT03292731|University of Pittsburgh|steve caritis|412 641 5256|scaritis@mail.magee.edu|
20210394|NCT00471237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210395|NCT02329834|scPharmaceuticals|Sr. Vice President of Clinical Development and Medical Affairs||jmohr@scpharma.com|
20210396|NCT00578448|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20210397|NCT01317199|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Channing Paller|410-955-8239|cpaller1@jhmi.edu|
20210398|NCT02920866|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
20210399|NCT01312948|ResMed Ltd|Alison Wimms|+6188842583|alison.wimms@resmed.com.au|
20210400|NCT04221373|Icahn School of Medicine at Mount Sinai|Dr. Chung-Ying Tsai|(212) 241-7073|chung-ying.tsai@mountsinai.org|
20210401|NCT00212446|New York Downtown Hospital (hospital bankrupt/closed)|Dr. Jeffrey Karsdon||JK_MD@yahoo.com|
20210402|NCT02203604|Dana Farber Cancer Institute|Ann Silk, MD|617-632-6571|Ann_Silk@dfci.harvard.edu|
20210403|NCT00552422|Columbia University|David Lederer|212-342-4167|tjb2134@cumc.columbia.edu|
20210404|NCT00627094|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
20210405|NCT00186875|St. Jude Children's Research Hospital|Sima Jeha, MD|866-278-5833|info@stjude.org|
20210406|NCT02912507|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20210407|NCT00029107|NIAID/NIH|Michael C Sneller, MD|301-496-0491|msneller@niaid.nih.gov|
20210408|NCT00138658|OncoGenex Pharmaceuticals|Dr. Patricia Stewart, Vice President Medical Affairs|425-686-1500|psstewartmd@oncogenex.com|
20210409|NCT00380861|DePuy Orthopaedics|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
20228157|NCT03400449|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20210410|NCT01965431|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228158|NCT02230891|Michael E DeBakey Veterans Affairs Hospital|Vijay Nambi|713-794-7300|vijay.nambi@va.gov|
20228159|NCT04356937|Massachusetts General Hospital|DRAI Director of Clinical Trials|617-726-7938|JHSTONE@mgh.harvard.edu|
20228160|NCT04158219|Hennepin Healthcare|Dr. Andrew Busch|6128736681|andrew.busch@hcmed.org|
20192892|NCT01162135|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
20192893|NCT00485953|University of Pittsburgh|Dr. Susan Greenspan|412-692-2476|greenspn@pitt.edu|
20192894|NCT01216072|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20210411|NCT00577031|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20210412|NCT04635631|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210413|NCT04776135|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20210414|NCT01067339|Mayo Clinic|Amir Lerman, MD|507-284-6429|lerman.amir@mayo.edu|
20210415|NCT00769132|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210416|NCT02586909|Axovant Gene Therapies|Yi Mo, PhD|1-929-227-3828|yi.mo@axovant.com|
20210417|NCT00877799|Cara Therapeutics Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
20210418|NCT00127192|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20210419|NCT00203892|University of Chicago|Dr. Hedy Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
20210420|NCT01139801|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
20210421|NCT00806416|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20210422|NCT01596088|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
20210423|NCT02989922|Jiangsu HengRui Pharmaceuticals Co., Ltd|Linna Wang|+862161053363|linna.wang@hengrui.com|
20210424|NCT01102972|ViiV Healthcare|GSK Response Center|866-435-7343||
20210425|NCT04935931|Children's Mercy Kansas City|Dr. Stephani Stancil|816-234-3000|slstancil@cmh.edu|
20210426|NCT01360021|Astrazeneca|Goran Eckerwall, MD||aztrial_results_posting@astrazeneca.com|
20210427|NCT02222168|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20210428|NCT02596009|Novartis Pharmaceuticals|Study Director|862-778-8300||
20210429|NCT01071278|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210430|NCT03539952|Orphalan SA|Frank Verheggen - Head Clinical Operations|+31625241264|frank.verheggen@orphalan.com|
20210431|NCT02184988|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
20210432|NCT01821391|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
20210433|NCT01843660|Janssen China, Beijing|Therapeutic Area Physician|+86-10-58218709||
20210434|NCT02500147|Columbia University|Aviva B Sopher, MD, MS|212-305-9362|ahs32@cumc.columbia.edu|
20210435|NCT01608321|VA Palo Alto Health Care System|Director, WRIISC|650-493-5000|wes.ashford@va.gov|
20210436|NCT03505606|Anglia Ruskin University|Mrs Louisa Haine - Lecturer in Vision Sciences|01223695445|louisa.haine@aru.ac.uk|
20210437|NCT00540982|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20210438|NCT02087865|Cleveland Clinic|Dr. Stephen M. Rao|216 312-4168|raos2@ccf.org|
20210439|NCT03781817|University of Alabama at Birmingham, Department of Pediatrics|James Statler, MD|(205) 638-6048|jstatler@uabmc.edu|
20210440|NCT01392469|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20210441|NCT01736527|Bausch & Lomb Incorporated|Raphaële Siou-Mermet, MD, MS|+33160871491|raphaele.siou-mermet@bausch.com|
20210442|NCT01017731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210443|NCT00511329|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
20210444|NCT00648739|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20210445|NCT02238639|Hospital Ramon y Cajal|David Jimenez|+34913368133|djimenez.hrc@gmail.com|
20210446|NCT00564486|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20210447|NCT02195921|Tianjin University of Traditional Chinese Medicine|Acupuncture for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial|+86 13920921016|guoyi_168@163.com|
20210448|NCT04362761|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20210449|NCT01819467|NHRMC|Dr. Henry Easley|910. 667-9238|sandy.easley@seahec.net|
20210450|NCT00896038|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|3014516960|melanies@mail.nih.gov|
20210451|NCT03926728|Statens Serum Institut|Per Skallerup|+4532688554|PRSK@SSI.dk|
20228161|NCT02374320|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
20228162|NCT01814007|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20228163|NCT01324947|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20228164|NCT01778413|Hospital Clínic de Barcelona|Dr. Esteban Martinez|932275400|estebanm@clinic.cat|
20228165|NCT04194814|University of Sheffield|Dr Simon Danby|0114 2268515|s.danby@sheffield.ac.uk|
20228166|NCT00434252|Genentech, Inc.|Medical Communications|800-821-8590||
20228167|NCT01446705|Center for Health Information and Communication, Roudebush VA Medical Center|Dr. David A. Haggstrom|317-988-2067|dahaggst@iu.edu|
20228168|NCT02349438|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST|904-443-3449|CColesb@ITS.JNJ.com|
20228169|NCT01831219|Think Surgical|Senior Manager of Clinical Applications|510-249-2339|nnetravali@thinksurgical.com|
20228170|NCT04745351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20228171|NCT01863771|Janssen Pharmaceutical K.K.|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20228172|NCT03499795|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20228173|NCT03636256|US Biotest, Inc.|Dr. Gere diZerega|805.595.1300|gere.dizerega@usbiotest.com|
20192895|NCT04070768|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20210452|NCT03993288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20210453|NCT02729545|Beijing Hospital of Integrated Traditional Chinese and Western Medicine|Dr. Yu Cao|086|howgreenbreeze@126.com|88223667
20210454|NCT00915473|Mayo Clinic|Dr. David Dodick|480-301-5797|dodick.david@mayo.edu|
20210455|NCT01389024|The Johns Hopkins University School of Medicine|Dr. James Casella|410-955-6132|jcasella@jhmi.edu|
20210456|NCT00704717|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20210457|NCT01245595|Stanford University Medical Center|Dr. David M. Axelrod|650-723-7913|daxelrod@stanford.edu|
20210458|NCT00529802|The University of Chicago|Walter Stadler, MD|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
20210459|NCT00367679|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210460|NCT00197184|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210461|NCT03286400|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
20210462|NCT00315328|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
20210463|NCT00740480|ENTrigue Surgical, Inc.|Gabriele Niederauer, PhD|210-298-6398|gabi.niederauer@entriguesurgical.com|6336
20210464|NCT00448630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20210465|NCT04662086|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
20210466|NCT01325701|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
20210467|NCT04253756|University of Texas Southwestern Medical Center|Sonja Stutzman, Research Programs Manager|214-648-6719|sonja.stutzman@utsouthwestern.edu|
20210468|NCT00568776|Transition Therapeutics Ireland Limited|Aleksandra pastrak, MD, PhD, Vice President, Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20210469|NCT01005680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210470|NCT01372254|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
20210471|NCT04928794|Anesthesiology Department, University of New Mexico|Anesthesiology Research Director|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
20210472|NCT03506646|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20210473|NCT03910439|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
20210474|NCT03952377|SpineThera|Jeff Missling, CEO|+1(612)-508-4795|jmissling@spinethera.com|
20210475|NCT00131573|Boston Scientific|Director of Clinical Operations|866-360-4747|valerie.lucero-cimmarusti@bsci.com|
20210476|NCT00539006|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210477|NCT01179191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210478|NCT00572910|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210479|NCT02230332|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
20210480|NCT01260194|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20210481|NCT04054011|UCSD Dermatology|Joyce Yuan, MD|(858) 657-8322|joyce.yuan2@ucsf.edu|
20210482|NCT00592007|UC San Diego, Moores Cancer Center|Lyudmila Bazhenova, MD|858 822 6189|lbazhenova@ucsd.edu|
20210483|NCT00595127|Memorial Sloan Kettering Cancer Center|Farid Boulad, MD, Attending|+1212-639-2429|bouladf@mskcc.org|
20210484|NCT00538473|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210485|NCT01569074|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20210486|NCT01410565|Spectrum Pharmaceutical Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
20210487|NCT02466776|Kaiser Permanente|Dr. Mary Zaki|503-332-2390|mary.nasry@gmail.com|
20210488|NCT01036594|University of California, San Francisco|Dr. Terence Friedlander, MD|(415) 514-6380|Terence.Friedlander@ucsf.edu|
20210489|NCT03387267|Nestlé Health Science|Kemuel Reyes|(908) 333-9379|Kemuel.Reyes@us.nestle.com|
20210490|NCT00244881|Dana-Farber Cancer Institute|Dr Harold Burstein|617-632-3800|hburstein@partners.org|
20210491|NCT03345485|Mundipharma Research Limited|Mónica Araujo - Senior Programmer, Data Management|+447922223436|monica.araujo@mundipharma-rd.eu|
20210492|NCT01610284|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20210493|NCT00442338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20192896|NCT02947100|Nemours/AI duPont Hospital|Dr Robin Miller|302-651-5500|rmiller@nemours.org|
20192897|NCT00822770|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PhD / Associate Professor|713-794-1628|mkonople@mdanderson.org|
20192898|NCT00926380|Massachusetts General Hospital|Natalie David||ndavid2@mgh.harvard.edu|
20192899|NCT02472145|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20192900|NCT01080326|Mayo Clinic|Juliane Bingener-Casey, M.D.|507-538-9007|BingenerCasey.Juliane@mayo.edu|
20192901|NCT01296555|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20192902|NCT03563313|University of Virginia|Sue Brown, MD|434-962-0602|sab2f@virginia.edu|
20192903|NCT01628692|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20192904|NCT01182181|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20192905|NCT01587118|Tuscaloosa Research and Education Advancement Corp|Sandra Creel|205-554-2000|sandra.creel@va.gov|1-2840
20192906|NCT00267098|Medtronic CRDM Clinical|BLOCK HF Clinical Trial Leader|763-526-2729|medtroniccrmtrials@medtronic.com|
20192907|NCT00547534|University of Rochester Medical Center|Dr. Jonathan Friedberg|585-275-4911|Jonathan_Friedberg@urmc.rochester.edu|
20192908|NCT00672451|Wake Forest University Health Sciences|Dr. John Burkart|33671662958|jburkart@wakehealth.edu|
20210494|NCT01125358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210495|NCT01060007|Washington University School of Medicine|Parag Parikh, M.D.|314-362-9703|pparikh@radonc.wustl.edu|
20210496|NCT05168657|University of Colorado|Dr. Sean Oser|3037245828|sean.oser@cuanschutz.edu|
20192909|NCT02688530|Hospital for Special Surgery|Meghan Kirksey, MD, PhD|212-606-1206|Kirkseym@hss.edu|
20192910|NCT01658020|Asan Midical Center|Principal Investigator|+82-2-3010-3136|ymoh55@amc.seoul.kr|
20192911|NCT04206085|Viveve|Vice President, Clinical & Medical Affairs|720-696-8100|clinicalaffairs@viveve.com|
20192912|NCT00763451|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20192913|NCT01473992|University of South Florida|M. Jason Highsmith|8139743806|mhighsmi@health.usf.edu|
20210497|NCT00358670|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20210498|NCT05794126|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
20210499|NCT00903409|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210500|NCT01497860|Children's National Medical Center|Associate Professor|2024765046|ehwang@childrensnational.org|
20210501|NCT01977482|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210502|NCT00209560|Eisai Inc|Eisai Medical Services|1-888-422-4743||
20210503|NCT05460832|Modern Biosciences|Chief Scientific Officer|+44 (0) 207 444 0066|IST-06@istesso.co.uk|
20210504|NCT01525407|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|2066672827|mmielcar@fredhutch.org|
20210505|NCT01721369|Hospital Vall hebron|Dr. Angel Moya||amoyamitjans@gmail.com|
20210506|NCT01771627|MUSC|Dr. Ben Toll|843-792-9162|toll@musc.edu|
20210507|NCT03486327|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
20210508|NCT03126682|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
20210509|NCT02682069|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
20210510|NCT02786810|University of Tennessee Health Science Center|Dr. David Hains|9012874876|dhains@uthsc.edu|
20210511|NCT03256526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210512|NCT01607398|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210513|NCT00534209|UM/Sylvester Comprehensive Cancer Center|Luis Raez MD|305-243-4909|lraez@med.miami.edu|
20210514|NCT02056431|Kaiser Permanente Division of Research|Dr. Alyce S. Adams|510-891-5921|Alyce.S.Adams@kp.org|
20210515|NCT03443973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20210516|NCT00467038|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|marianne.goodman@va.gov|5188
20210517|NCT00398632|Stanford University Medical Center, Department of Psychiatry|Lorrin Koran, M.D., Professor of Psychiatry, Emeritus|650 498 5035|lkoran@stanford.edu|
20210518|NCT00267020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210519|NCT00640614|Allerderm|Kim Sullivan|602-225-0595||
20210520|NCT01476345|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210521|NCT02209454|Menarini Ricerche S.p.A.|Corporate Director of Clinical Research|0555680|acapriati@menarini-ricerche.it|9990
20210522|NCT02545868|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20210523|NCT01777191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210524|NCT01932801|University of Washington / Washington State University|Dr. Susan Collins|12068327885|susan.collins@wsu.edu|
20210525|NCT04465916|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
20210526|NCT01856686|Spanish Foundation for Neurometrics Development|Dr. Moises Aguilar Domingo|+441615312645|moises@bigdata4brain.co.uk|
20210527|NCT00602979|Weill Cornell Medicine|Michele Steinkamp|212-746-2953|mls9004@med.cornell.edu|
20210528|NCT00468312|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20210529|NCT01426828|University of Pennsylvania|CCI @ University of Pennsylvania|(215)662-4000||
20210530|NCT01247974|CorMatrix Cardiovascular|Director, Clinical Development|240-247-1170|clinical@aziyo.com|
20210531|NCT01598740|Sorbent Therapeutics, Inc.|Howard Dittrich, MD|858-405-1429|hdittrich@sorbent.com|
20210532|NCT00916617|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210533|NCT02249065|Galderma Laboratories L.P.|Dr. Jean Philippe York|817-961-5468|jp.york@galderma.com|
20228174|NCT02426684|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
20210534|NCT00566631|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
20228175|NCT01040819|Baylor College of Medicine|Dr. Yochai Birnbaum|713-798-0273|ybirnbau@bcm.edu|
20228176|NCT04748718|Northern Vermont University|Dr. Eleanor Beltz|802-635-1329|Eleanor.Beltz@NorthernVermont.edu|
20228177|NCT01450813|Fletcher Allen Health Care at The University of Vermont|Donald Mathews, M.D.|(802) 847-2415|Donald.Mathews@vtmednet.org|
20192914|NCT00725543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20192915|NCT02357264|Maimonides Medical Center|Eitan Dickman, MD|718-283-6057|edickman@maimonidesmed.org|
20192916|NCT05594589|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-2-3451-5533|s-kwon@eisaikorea.com|
20192917|NCT03200444|Coloplast A/S|Director of Pre-Clinical Research|49111111|dklfn@coloplast.com|+45
20192918|NCT03623373|Washington University School of Medicine|Brad S. Kahl, M.D.|314-273-3591|bkahl@wustl.edu|
20192919|NCT01062971|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20192920|NCT02760485|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20192921|NCT01182207|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20192922|NCT02526186|MOMH|Amanda Crawford|7025633583|amanda.j.crawford.ctr@health.mil|
20192923|NCT03180008|University of Illinois at Chicago|Andrew DeMott, MPH|312-355-3174|ademot1@uic.edu|
20192924|NCT02581059|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20192925|NCT06638840|Oticon medical|Director of Clinical Affairs|+46 31 748 61 00|studyinfor@oticonmedical.com|
20210535|NCT02723786|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20210536|NCT01143610|School of Dentistry at Bauru - USP|Adriana Campos Passanezi Sant'Ana|00 55 14 3235-8278|acpsantana@usp.br|
20210537|NCT03170271|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20210538|NCT00535873|The University of Texas M D Anderson Cancer Center|Alessandra Ferrajoli, MD/Associate Professor|713-792-2063|eharriso@mdanderson.org|
20210539|NCT02709759|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
20210540|NCT03466060|Johnson & Johnson Vision Care Inc.|Meredith Bishop, OD, MS, FAAO- Senior Principal Research Optometrist|904-443-1396|MBishop4@its.jnj.com|
20210541|NCT03003793|Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen|Lise Gether, MD||lise.gether.01@regionh.dk|
20210542|NCT03159611|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20210543|NCT01984229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20210544|NCT02072174|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20210545|NCT02379442|NHLBI, NIH|Sawa Ito, MD|301-326-5233|itos3@upmc.edu|
20210546|NCT00937859|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20210547|NCT01771172|Medtronic, Inc.|Medtronic CRDM Clinical Trial Manager|763-505-6000|medtronicCRMtrials@medtronic.com|
20210548|NCT01418365|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20210549|NCT03226366|Intermountain Healthcare|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
20210550|NCT03319368|University of Maryland School of Medicine|Alison Lydecker, MPH|410-706-0065|alydecke@som.umaryland.edu|
20210551|NCT01267227|University of Mississippi|Dr. Daniel Riche|601-984-2640|driche@umc.edu|
20210552|NCT00824993|UT MD Anderson Cancer Center|Lu,Huifang,M.D. PH.D. / General Internal Medicine|713-563-4462|HLU@MDANDERSON.ORG|
20210553|NCT03409328|Rosalind Franklin University|Dr. Brian Feinstein|847-578-8736|brian.feinstein@rosalindfranklin.edu|
20210554|NCT00518011|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20210555|NCT02998645|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20210556|NCT03701516|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Director|1-904-629-2289|BPALL@its.jnj.com|
20210557|NCT02139969|Boston Scientific Corporation|Laura Olson, Clinical Project Manager|9529306428|laura.olson2@bsci.com|
20210558|NCT03930615|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210559|NCT01153685|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210560|NCT03644927|Veterans Administration Boston Healthcare System and BU School of Medicine|Erica R Scioli, PhD|857 364 6293|ericarose.scioli@va.gov|
20210561|NCT00956813|Mayo Clinic|Debra L. Barton, RN, PhD, AOCN||barton.debra@mayo.edu|
20210562|NCT02864953|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20210563|NCT00981019|Max Planck Institute for Human Development, Harding Center for Risk Literacy|Dr. Odette Wegwarth|+49-30-82406|wegwarth@mpib-berlin.mpg.de|695
20210564|NCT05083559|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
20210565|NCT03752866|Abbott|Vinny Podichetty, Sr. Director, Global Clinical Affairs|+1 408-845-1639|vinny.podichetty@abbott.com|
20210566|NCT00905437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210567|NCT03252015|Eli Lilly and Company|Cheif Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20210568|NCT03128931|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20210569|NCT04993339|University of Miami|Dr. Francesco Travascio|3052842371|f.travascio@miami.edu|
20210570|NCT01852669|Monash University|Dr Shaun Lee|55145890|shaun.lee@monash.edu|
20210571|NCT03075215|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
20210572|NCT01121224|VA North Texas Health Care System|Dr. Subhash Banerjee|(214) 857-1608|Subhash.Banerjee@va.gov|
20210573|NCT03712462|Drexel University|Dr. Adrienne Juarascio|215-553-7154|adrienne.s.juarascio@drexel.edu|
20210574|NCT01956123|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20210575|NCT01461369|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
20210576|NCT00997672|University Federico II, Naples, Italy|Dr. Francesco Saccà|3470734774|francesco.sacca@unina.it|+39
20210577|NCT00869141|Stein Eye Institute|Dr. Simon K. Law|(310)794-1477|law@jsei.ucla.edu|
20210578|NCT00254488|Weill Cornell Medical College|Robert C. Young, MD, Professor of Psychiatry|914-997-5886|ryoung@med.cornell.edu|
20210579|NCT01053078|University of Minnesota|Elizabeth Seaquist|612 624 9176|seaqu001@umn.edu|
20210580|NCT02886494|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
20210581|NCT01092676|LHSC Lawson HRI|Rodrick Lim|5198525496|rod.lim@lhsc.on.ca|
20210582|NCT03029104|CXL Ophthalmics, LLC|Chief Clinical Development Officer|339-234-6020|info@cxlophthalmics.com|
20210583|NCT01177735|University of Arkansas for Medical Sciences|Saad Usmani, MD|501-526-6876||
20210584|NCT00623441|Medtronic Bakken Research Center|Sofia Pateraki, MSc - Sr. Clinical Research Specialist|+31 43 3566785|sofia.pateraki@medtronic.com|
20210585|NCT00499252|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20228178|NCT02090881|Imperial College Healthcare NHS Trust|Dr Mohammed Aslam|02083831000|m.aslam@imperial.ac.uk|1541
20228179|NCT01118299|Abbott|Sripad Bellary|408845814|sripad.bellary@abbott.com|
20228180|NCT01935089|The Wistar Institute|Luis J. Montaner|+1 (215) 898-9143|montaner@wistar.org|
20228181|NCT02932943|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20228182|NCT02337491|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
20228183|NCT01483118|Columbia University, Department of OBGYN|Roger A. Lobo M.D.|212-3056337|ral35@columbia.edu|
20228184|NCT00785356|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20210586|NCT01341067|Rocky Mountain Diabetes and Osteoporosis Center|Mark Sulik, PharmD CCRP|208-528-9642|mark@idahomed.com|
20210587|NCT02822612|Moorfields Eye Hospital NHS Foundation Trust|Pearse Keane|02072533411|pearse.keane@moorfields.nhs.uk|
20210588|NCT00124579|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
20210589|NCT00703261|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20210590|NCT02701049|Brigham and Women's Hospital|Dr. Adil H. Haider|617-525-9280|ahhaider@bwh.harvard.edu|
20210591|NCT00722007|Corin USA Limited|Lucinda Gerber|(772) 321 2478|lucinda.gerber@coringroup.com|
20210592|NCT01700335|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
20210593|NCT01612780|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20210594|NCT00556166|Columbia University|Dennis Fowler|212-305-9914|dlf91@columbia.edu|
20186431|NCT01785719|Cornell University|Marla Lujan, PhD|(607) 255-3153|mel245@cornell.edu|
20186432|NCT03457142|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
20186433|NCT01413100|Fred Hutchinson Cancer Center|Dr. Leona Holmberg|206-667-6447|lholmb@fredhutch.org|
20186434|NCT04750525|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
20186435|NCT02203552|The Ohio State University Comprehensive Cancer Center|Dr. Bhuvaneswari Ramaswamy|614-293-7484|Bhuvaneswari.Ramaswamy@osumc.edu|
20186436|NCT05570175|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
20186437|NCT03476187|ZOLL|Nicole Bianco|4129683333|NBianco@zoll.com|14410
20186438|NCT04406857|University of Kentucky|Dr. Charles Kunos|859-323-6486|Charles.Kunos@uky.edu|
20186439|NCT06020534|Erasmus Medical Center|Drs. Yitian Fang|+31 645680154|y.fang.1@erasmusmc.nl|
20186440|NCT05875142|We The Village, Inc.|Jane Macky, PI/CEO|91768344267|jane@wethevillage.co|
20186441|NCT03436290|Vanderbilt University Medical Center|Myrick Shinall, principal investigator|615-343-5613|ricky.shinall@vumc.org|
20186442|NCT03988608|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20186443|NCT04142788|University of Glasgow|Prof John Cleland|0141 330 7774|john.cleland@glasgow.ac.uk|
20186444|NCT05260684|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186445|NCT05392192|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20186446|NCT05229146|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
20186447|NCT04671446|Queen Mary University of London|Dr Myles Lewis, Dr Paul Pfeffer|+4420 7882 5555|myles.lewis@qmul.ac.uk; p.pfeffer@qmul.ac.uk|
20186448|NCT04256941|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran|713-792-2817|sdamodaran@mdanderson.org|
20186449|NCT04145466|Department of Health and Sport Sciences, TUM School of Medicine and Health, Technical University of Munich|Christoph Hoechsmann|+49 (89) 289 - 24492|christoph.hoechsmann@tum.de|
20186450|NCT03300648|Michigan State University|Terrie E. Taylor|5178988467|ttmalawi@msu.edu|
20186451|NCT04622943|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
20186452|NCT05717907|Mahidol university|Pattamon Leelachaikul|+66863019830|pattamonl@hotmail.com|
20186453|NCT05908344|The Pennsylvania State University|Dr. Anne-Marie Chang|814-863-5226|amchang@psu.edu|
20186454|NCT01106209|University of Utah - Pediatrics|Christian Con Yost, MD|801-518-7052|christian.yost@u2m2.utah.edu|
20186455|NCT03766009|University of Wisconsin School of Medicine and Public Health|Heather B. Neuman, MD, MS|608-265-5852|neuman@surgery.wisc.edu|
20186456|NCT05087693|UNiversity of BRitish COlumbia|Michael Koehle|8229331|michael.koehle@ubc.ca|
20186457|NCT03936322|UNIVERSITY OF MIAMI|Rodrigo Ruano MD PhD|(305) 585-5610|rodrigoruano@hotmail.com|
20186458|NCT02734290|Providence Portland Medical Center|Dr. David B. Page|5032156588|david.page2@providence.org|
20186459|NCT01814501|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-3873|John.Hays@osumc.edu|
20186460|NCT03829410|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
20186461|NCT06205407|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186462|NCT03736720|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
20186463|NCT02962895|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20186464|NCT02936752|Yale School of Medicine|Amer Zeidan, MBBS|(203) 200-4363|amer.zeidan@yale.edu|
20186465|NCT03659734|Stanford University|Dr. Jennifer Hah|650-723-4000|map_pain_study@stanford.edu|
20186466|NCT03241459|Surmodics|Kimberly Hawkinson|952-500-7563|khawkinson@surmodics.com|
20186467|NCT05805865|Loma Linda University Health|Professor, Director of Student Research|909 558 5118|sorankwon@llu.edu|
20186468|NCT03793972|UAntwerpen|Stefan Morreel|003232658721|stefan.morreel@uantwerpen.be|
20186469|NCT03274310|Columbia University Vagelos College of Physicians and Surgeons|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
20186470|NCT04461405|Oregon Health & Science University|Dr. Deborah Cohen|503-781-8795|cohendj@ohsu.edu|
20192926|NCT03569891|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20192927|NCT04750577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192928|NCT04980378|Globus Medical|Jessica Fulwider, Lead Clinical Project Manager|703-772-1455|jfulwider@globusmedical.com|
20192929|NCT00796627|Johns Hopkins University|Dr. John Harmon|410-550-0405|jharmon@jhmi.edu|
20192930|NCT02647645|Nova Southeastern University|Raymond L Ownby, MD, PhD|9542621481|ro71@nova.edu|
20192931|NCT02037256|Barbara Ann Karmanos Cancer Institute|Dr. Divaya Bhutani|501-680-9229|db3203@cumc.columbia.edu|
20186471|NCT05282173|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
20186472|NCT06398886|Istanbul Nisantasi Universitesi|Metin Çınaroğlu|009053247320|metincinaroglu@gmail.com|
20186473|NCT04660201|University of Maryland School of Medicine|James Campbell, MD|410-706-5328|Jcampbel@som.umaryland.edu|
20186474|NCT02222155|ChemoCentryx|Study Director|650-210-2900||
20186475|NCT04719390|Partnership to End Addiction|Dr. Sarah Dauber|212-841-5270|sdauber@toendaddiction.org|
20186476|NCT03307343|West Virginia University|Bethany Barone Gibbs|304-581-1779|bethany.gibbs@hsc.wvu.edu|
20186477|NCT03477968|Diagnostica STAGO S.A.S|Nathalie THUILLIER|+33 146 882 167|nathalie.thuillier@stago.com|
20186478|NCT02305277|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20186479|NCT01798498|Croma Pharma|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
20228185|NCT01079780|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20186480|NCT05136417|Mayo Clinic|Dr. Mohamad Alkhouli|507-255-2502|Alkhouli.Mohamad@mayo.edu|
20186481|NCT01606215|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
20186482|NCT04592549|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
20186483|NCT01959425|Biosense Webster Inc.|Stephanie Lyke|(949) 285-7966|SLyke@its.jnj.com|
20186484|NCT05480124|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
20228186|NCT01206465|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
20228187|NCT01178294|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20228188|NCT02783066|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
20228189|NCT00551369|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20228190|NCT02051296|VA HCS Palo Alto|Dr Catherine Curtin|650-493-5000|ccurtin@stanford.edu|
20228191|NCT05379920|University at Buffalo|Haley Chizuk|7162043200|haleychi@buffalo.edu|2188
20228192|NCT01267279|Spokane Joint Replacement Center|Principal Investigator|509-466-6393|dfscott@mac.com|
20228193|NCT03176771|Mitsubishi Tanabe Pharma Corporation|Mitsubishi Tanabe Pharma Corporation Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20228194|NCT02251275|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20228195|NCT00667511|NxStage Medical, Inc.|Kristen Sheppard|978-687-4700||
20228196|NCT02265510|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20228197|NCT01004614|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228198|NCT02530385|Massachusetts General Hospital Endocrine Unit|Dr. Elaine Yu|617-726-6723|ewyu@mgh.harvard.edu|
20228199|NCT03044418|University of Pecs|Dr. Timea Bocskai|+36 72 507374|timokeri@gmail.com|
20228200|NCT01569022|VA Western New York|Ali El Solh|716-862-6525|ali.el-solh@va.gov|
20228201|NCT03613493|University of Miami|Dr. Susan Morgan|7654094919|semorgan@miami.edu|
20228202|NCT02111083|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20228203|NCT00116142|Dana Farber Cancer Institute|Anthony D'Amico|617.732.6310|ADAMICO@LROC.HARVARD.EDU|
20228204|NCT00644059|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20228205|NCT02152007|TransDerm, Inc.|Roger Kaspar, PhD|831-420-1684|roger.kaspar@transderminc.com|
20228206|NCT00447083|Wake Forest University Health Sciences|Steve feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
20228207|NCT01302899|Novartis Pharmaceuticals|Study Director|862-778-8300||
20228208|NCT02497469|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20228209|NCT03558516|Department of Anesthesiology, Faculty of medicine, Siriaj hospital, Mahidol University|Assoc. Prof. Manee Raksakietisak|+66814880620|manee95@hotmail.com|
20228210|NCT00472420|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20228211|NCT01658839|Alcon Research, Ltd.|Theresa Landry, Project Head, Clinical Trial Management|1-888-451-3937|alcon.medinfo@alcon.com|
20228212|NCT03144232|Stanford University|Gregory Sahlem|650-724-0444|gsahlem@stanford.edu|
20228213|NCT04081688|Cancer Institute of New Jersey Rutgers|Dr. Jabbour|732-757-9840|jabbousk@cinj.rutgers.edu|
20228214|NCT01462942|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
20228215|NCT02449434|King's College London|Prof David Bartlett|02071887462|david.bartlett@kcl.ac.uk|
20228216|NCT02737722|Lakewood Amedex|Chief Medical Officer|941 928 7774|poconnor@lakewoodamedex.com|
20228217|NCT02662569|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20228218|NCT00305162|The Medicines Company|Meredith Todd|+19732906088|meredith.todd@themedco.com|
20228219|NCT01690663|the University of Pennsylvania|Jiabin Liu, MD, PhD|215-573-8208|jiabin.liu@uphs.upenn.edu|
20228220|NCT02965924|Mayo Clinic|Arthur J. Sit, MD|507-284-2787|Sit.Arthur@mayo.edu|
20228221|NCT02785939|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20228222|NCT02668003|University of Aberdeen|Professor Gary Macfarlane|01224 437 143|g.j.macfarlane@abdn.ac.uk|
20228223|NCT01787552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20228224|NCT00243243|US Army Institute of Surgical Research|David G. Baer, PhD, Director Research|210-539-4327|david.g.baer@us.army.mil|
20228225|NCT03786380|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20228226|NCT02414698|Montefiore Medical Center|Sayed E Wahezi, MD|7189207246|swahezi@montefiore.org|
20186485|NCT01824394|Biosense Webster, Inc.|Megan Holden|(949) 923-4700|mholden8@its.jnj.com|
20228227|NCT02709317|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
20228228|NCT00423046|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228229|NCT01791595|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20228230|NCT02175121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186486|NCT02619838|Duke University|Mark Easley, M.D.|919-660-5066|mark.e.easley@duke.edu|
20186487|NCT05020249|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20186488|NCT05364671|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20186489|NCT05505292|SUNY College of Optometry|Danielle Iacono|2129385936|diacono@sunyopt.edu|
20186490|NCT03536754|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
20210595|NCT05005130|University of North Carolina at Chapel Hill|Michael Herce, MD, MPH, MSc|919-966-2537|michael_herce@med.unc.edu|
20210596|NCT02985515|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-393-2455|pawina@wustl.edu|
20210597|NCT03359473|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20210598|NCT05302414|National Yang Ming Chiao Tung University, Department of Nursing|Hui-Wen Chen Phd candidate|+886939947807|m513102001@gmail.com|
20210599|NCT02964910|Shandong Center for Disease Control and Prevention, Jinan, China|Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention|0531-82679606|aqxuepi@163.com|
20210600|NCT02628418|Fondazione Salvatore Maugeri|Dr. Palmira Bernocchi|00390308253|palmira.bernocchi@fsm.it|260
20210601|NCT00424632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20210602|NCT04007406|DAMIAN Pharma AG|Teresa Gerlock/Chief Operations Officer|+41 79 230 8591|teresa.gerlock@damianpharma.com|
20210603|NCT01071083|Biogen Idec Inc|Biogen Idec Medical Director|1-617-679-2000|neurologyclinicaltrials@biogenidec.com|
20210604|NCT01523301|UCB|Study Director|+1877 822 9493||
20210605|NCT01339000|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
20210606|NCT00728988|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210607|NCT00116207|University of Michigan|Eva L. Feldman, Professor of Internal Medicine|7347637274|efeldman@med.umich.edu|
20210608|NCT05674721|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20210609|NCT00091507|Tufts Medical Center|Co-Principal Investigator|617-636-8788|jbeshansky@tuftsmedicalcenter.org|
20210610|NCT00633009|Nielsen BioSciences, Inc.|Stewart Nielsen|858.571.2726|stewart@nielsenbio.com|
20210611|NCT05013749|Fundación Valle del Lili|Albaro José Nieto Calvache|(+57) 6023319090|albaro.nieto@fvl.org.co|3056 - 305
20210612|NCT00246441|MUSC|Dr. Sarah Book|8437925200|booksw@musc.edu|
20210613|NCT02017535|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
20210614|NCT03506425|Duke University|Richard Bedlack, M.D., Ph.D.|919-668-2839|richard.bedlack@duke.edu|
20210615|NCT03506724|Icahn School of Medicine at Mount Sinai|Dr. Dyese Taylor|973-926-5508|Dyesetaylor@gmail.com|
20210616|NCT04797637|Vanderbilt University Medical Center|Lisa C. Zukerwise, MD|9144203838|lisa.zuckerwise@vumc.org|
20210617|NCT02380248|Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA-GDD|1-888-451-3937|alcon.medinfo@alcon.com|
20210618|NCT04736316|University of Washington|Dr. Kelli O'Laughlin|206-744-2559|kolaugh@uw.edu|
20210619|NCT02262507|Cincinnati Childrens Hospital Sports Medicine|Dr. Gregory Myer|513-636-0249|greg.myer@cchmc.org|
20210620|NCT05376293|The Miriam Hospital|Dr. Jessica Unick|401-793-7966|junick@brownhealth.org|
20210621|NCT01205568|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@childrens.harvard.edu|
20210622|NCT00379821|Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine|Christopher Plowe, MD, MPH|410-706-2491|cplowe@medicine.umaryland.edu|
20210623|NCT00690573|Abbott|Global Medical Services|800-633-9110||
20210624|NCT00939367|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
20210625|NCT01126359|Department of Orthopaedics|Dr. Erik Kubiak|801-587-5404|Erik.Kubiak@hsc.utah.edu|
20210626|NCT01298661|Universidade Federal de São Carlos|Juliano Ferreira Arcuri|+55 (16) 33518343|julianoarcuri@gmail.com|
20210627|NCT00526227|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
20210628|NCT05378269|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
20210629|NCT00684645|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228231|NCT03329885|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|clinical.trials@bms.com|
20228232|NCT02037893|Pernix Therapeutics|Senior Director, Medical and Scientific Affairs|8007932145|egould@pernixtx.com|
20228233|NCT02027025|Sun Pharma Advanced Research Company Limited|Mudgal Kothekar|912266455645|mudgal.kothekar@sparcmail.com|
20228234|NCT01036802|University of North Carolina, Chapel Hill|Kenneth I. Ataga, MD|919-843-7708|kataga@med.unc.edu|
20228235|NCT01118052|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
20228236|NCT02845674|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
20228237|NCT00843492|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228238|NCT00369343|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20228239|NCT00794664|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20228240|NCT00457730|MS Center at Evergreenhealth Care|Theodore R. Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
20228241|NCT00193375|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20228242|NCT00828711|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20228243|NCT03883386|University of Michigan Medical School|Professor Kelly Walkovich|734-647-2893|kwalkovi@med.umich.edu|
20228244|NCT01618968|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
20228245|NCT01326871|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20228246|NCT02873689|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20228247|NCT00350545|Stanford University|David B. Miklos|650 725-4959|dmiklos@stanford.edu|650
20210630|NCT01186744|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228248|NCT01794702|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD./Associate Professor|713-745-6080|njain@mdanderson.org|
20228249|NCT02097732|University of Michigan Comprehensive Cancer Center|Dr. Christopher Lao, MD, MPH|(734) 936-4498|clao@med.umich.edu|
20228250|NCT04166214|NYU Langone Health - Hansjörg Wyss Department of Plastic Surgery|Mary E. Northridge, PhD, MPH, Director of Dental Research|347-377-4342|Mary.Northridge@nyulangone.org|
20228251|NCT01477567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20228252|NCT02470741|University of California, San Francisco|Lisa Abinanti, Project Director|415-353-9978|lisa.abinanti@ucsf.edu|
20228253|NCT03813108|Radboud university medical center|Matthew McCall, MD, PhD|+3124 3615363|Matthew.mccall@Radboudumc.nl|
20228254|NCT00720278|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20228255|NCT01677286|Boston Medical Center|John Berk, MD|617-638-4494|jberk@bu.edu|
20228256|NCT00623181|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20228257|NCT03630393|OhioHealth|Dr. Ryan Hedgepeth|614-788-2870|ryan.hedgepeth@ohiohealth.com|
20228258|NCT00408499|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
20228259|NCT01042795|University of Michigan|Cheryl T. Lee|614-685-6666|cheryl.lee@osumc.edu|
20228260|NCT01586195|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20228261|NCT00997334|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468|David_Jackman@dfci.harvard.edu|
20228262|NCT00702780|Seoul National University Hospital|Young Min Choe|82-2-2072-1730|howlow44@daum.net|
20228263|NCT01855958|Hospital de Clínicas de Porto Alegre|Wolnei Caumo, MD,PhD.|+555133598430|caumo@cpovo.net|
20228264|NCT01507350|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20228265|NCT02863666|University of Buffalo|Brooke Lerner PHD,|716.390.3509|lerner@buffalo.edu|
20228266|NCT02420639|Department of Anesthesiology & Intensive Care Medicine, Dnipropetrovsk Medical Academy|Alexander Tsarev|+38 057 701 52 00|tsarev03@rambler.ru|
20228267|NCT03946059|University of California San Diego|Dr. Jyoti Mishra|8582322855|jymishra@ucsd.edu|
20228268|NCT00266708|Montefiore Medical Center|Maria Coco, MD|718-920-4136|mcoco@montefiore.org|
20228269|NCT02791269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20228270|NCT02351934|Mayo Clinic|Ilya Danelich, Pharm.D., R.Ph.|507-255-5732|Danelich.Ilya@mayo.edu|
20228271|NCT02683109|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228272|NCT00368251|UCB|UCB Cares|+1877 822||9493
20228273|NCT03159143|University of Pittsburgh|Leonard Appleman, MD|412-648-6538|applemanlj@upmc.edu|
20228274|NCT00499122|UM/Sylvester Comprehensive Cancer Center|Alberto Montero MD|305-243-3771|amontero2@med.miami.edu|
20228275|NCT03312738|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20228276|NCT01130844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20228277|NCT03895801|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
20228278|NCT04539275|Palo Alto Cooperative Studies Program Coordinating Center|Lisa Zehm, Project Manager|(650)493-5000|lisa.zehm@va.gov|28805
20228279|NCT02466399|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
20228280|NCT00607893|Case Western Reserve University|Reena Mehra|216-445-1698|mehrar@ccf.org|
20228281|NCT01373164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228282|NCT01799941|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
20228283|NCT02669849|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20228284|NCT01605903|Massachusetts Eye and Ear Infirmar|Gillian Diercks, MD, MPH|617-573-3190|gillian_diercks@meei.harvard.edu|
20228285|NCT03408899|Johns Hopkins University|Craig Hendrix, MD|4109559707|chendrix@jhmi.edu|
20228286|NCT00606008|H. Lee Moffitt Cancer Center and Research Institute|Dr. Edward Pan|813-745-3871|edward.pan@moffitt.org|
20228287|NCT04596319|Armata Pharmaceuticals, Inc.|Mina Pastagia, MD|(310) 665-2928|mpastagia@armatapharma.com|
20228288|NCT01248416|Nemours Children's Clinic|Dr. Nelly Mauras|904-697-3674|nmauras@nemours.org|
20228289|NCT00547339|University of Texas Southwestern Medical Center Dallas|Dr. Robert Timmerman|214-645-8525|Robert.Timmerman@UTSouthwestern.edu|
20228290|NCT01603602|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@Allergan.com|
20228291|NCT04236284|The University of Texas Health Science Center at Houston|Melba Hernandez Tejada, PhD, DHA|7134862729|Melba.A.HernandezTejada@uth.tmc.edu|
20228292|NCT03785028|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
20228293|NCT03712280|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20228294|NCT01663623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20228295|NCT03638323|Groupe Hospitalier de la Rochelle Ré Aunis|Marie-Laure Vignaud, neuropsychologist|+33 (0)5 46 45 63 70|marie-laure.vignaud@ght-atlantique17.fr|
20228296|NCT00251758|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20228297|NCT02147301|University of California, San Francisco|Curt Johanson|415-353-2310|curt.johanson@ucsf.edu|
20228298|NCT01712711|Tehran University of Medical Sciences|Professor Raika Jamali|00982163120000|jamalira@tums.ac.ir|411
20228299|NCT01387269|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
20228300|NCT01471626|CHU St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@tpierre-bru.be|
20186491|NCT04891224|Advocate Health Care|Ramona Donovan, Research Project Manager|847-723-5792|ramona.donovan@aah.org|
20186492|NCT04709783|University of Florida|Chiung-ju (CJ) Liu|352-273-6496|c.liu1@phhp.ufl.edu|
20228301|NCT01200329|UT MD Anderson Cancer Center|Yago Nieto/Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
20228302|NCT00677898|VA VISN 5 Mental Illness Research, Education and Clinical Center|Julie Kreyenbuhl, Pharm.D., Ph.D.|410-637-1864|Julie.Kreyenbuhl@va.gov|
20228303|NCT02404545|Baptist Health South Florida - Miami Cancer Institute|Murugesan Manoharan MD, FRCS (Eng), FRACS (Urol)|305-595-2141|mmanoharan@baptisthealth.net|
20228304|NCT03641508|University of Iowa|Dr. Ericka Lawler|3193563943|ericka-lawler@uiowa.edu|
20192932|NCT01688310|Catholic University of Mozambique Medical School|Dr. Peter Millard|2078663503|pmillard@mac.com|
20192933|NCT00311246|UIC|Nadera J Sweiss|312-996-5723|nsweiss@uic.edu|
20210631|NCT02547779|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
20210632|NCT02325401|University of Cincinnati|Trisha Wise-Draper M.D., Ph.D., Associate Professor of Medicine, Medical Director of the UC Cancer C|(513) 558-2826|wiseth@ucmail.uc.edu|
20210633|NCT00734617|Duke Center for Nicotine & Smoking Cessation Research|Jed E. Rose, Ph.D.|919 668-5093|rose0003@mc.duke.edu|
20210634|NCT01211873|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
20210635|NCT00537056|David Geffen School of Medicine at UCLA|Andrew Quon, M.D. Professor Division of Nuclear Medicine|310-983-1419|aquon@mednet.ucla.edu|
20210636|NCT01257737|Horizon Therapeutics, LLC|Colleen Canavan, Director|1-224-383-3000|clinicaltrials@horizonpharma.com|
20210637|NCT01940276|Duke University|Daniel George, MD|919-668-4615|daniel.george@duke.edu|
20210638|NCT03020966|Hospital for Special Surgery|Dr. Jacques Yadeau|(212) 774-2224|Yadeauj@hss.edu|
20210639|NCT02115373|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20210640|NCT00157573|MGH DF/HCC|Richard T Penson MD MCCP|617-726-8566|rpenson@partners.org|
20210641|NCT00962013|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
20210642|NCT01638416|Australian and New Zealand Intensive Care Research Centre|Dr. Cooper|+61 3 9903 0071|anzicrc@monash.edu|30071
20210643|NCT00686231|UCSF|Andrew Boyle|415-514-0827|aboyle@medicine.ucsf.edu|
20210644|NCT00445458|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20210645|NCT01527942|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Ioannis Raftopoulos, MD||IRaftopo@stfranciscare.org|
20210646|NCT03972709|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20210647|NCT04732728|Boston Scientific|Thomas Stoltz, Clinical Trial Manager|1-800-CARDIAC|thomas.stoltz@bsci.com|
20210648|NCT01895088|AcuFocus, Inc.|Eugenia Thomas, Director Clinical Trials|9495859511|nthomas@acufocus.com|
20210649|NCT02067585|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
20210650|NCT04466956|Barts Health NHS Trust|Dr Anna McDougall|02078827272|anna.mcdougall@nhs.net|
20210651|NCT00203931|University of Chicago|Kristen Wroblewski|773-702-7173|kwroblewski@health.bsd.uchicago.edu|
20210652|NCT01393626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210653|NCT02426125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20210654|NCT02858076|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20210655|NCT01141049|NYSPI|john mariani md|646-774-6140|john.mariani@nyspi.columbia.edu|
20210656|NCT03265483|Vanderbilt University Medical Center|Martha J. Shrubsole|(615)936-0812|martha.shrubsole@Vanderbilt.Edu|
20210657|NCT00938015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210658|NCT02341482|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20210659|NCT03186794|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@cc.nih.gov|
20210660|NCT01166126|H. Lee Moffitt Cancer Center and Research Institute|Ragini Kudchadkar, M.D.|813-745-8581|ragini.kudchadkar@moffitt.org|
20210661|NCT00118209|Washington University School of Medicine|Nancy Bartlett, M.D.|314-362-5654|nbartlet@wustl.edu|
20210662|NCT00664066|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20210663|NCT03597620|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
20210664|NCT03509766|Johns Hopkins School of Medicine|Jody Tversky|410-550-5949|jodytversky@jhmi.edu|
20210665|NCT02180659|Titan Pharmaceuticals|Kate Beebe DeVarney|650-244-4990|kdevarney@titanpharm.com|
20210666|NCT03000075|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20210667|NCT00111007|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20210668|NCT01495793|UCB Pharma|UCB Clinical Trial Call Center|+1877-822||9493
20210669|NCT00440193|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20210670|NCT00834366|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20210671|NCT03014570|University of Maryland School of Nursing|Barbara Resnick PhD, CRNP Professor and PI among MPIs of the trial|410 706 5178|resnick@umaryland.edu|
20210672|NCT01154673|University of Toronto|Mario Ostrowski, Principal Investigator, Professor of Medicine|416-946-5805|mario.ostrowski@gmail.com|
20210673|NCT00090259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20210674|NCT04828551|Massachusetts General Hospital|Anthony Samir|6178523241|asamir@mgh.harvard.edu|
20210675|NCT00345969|Washington University School of Medicine|Ellen F. Binder, MD|314-286-2707|ebinder@wustl.edu|
20210676|NCT03083639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20210677|NCT01275170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210678|NCT00960687|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20210679|NCT02362646|Icahn School of Medicine at Mount Sinai|Annetine Gelijns, PhD|212-659-9567|annetine.gelijns@mssm.edu|
20210680|NCT00865306|Massachusetts General Hospital|Dina R. Hirshfeld-Becker, PhD|617-503-1408|dhirshfeld@partners.org|
20210681|NCT04141670|ARMGO Pharma, Inc|Eugene Marcantonio MD PhD|2014633634|gmarcantonio@armgo.com|
20210682|NCT02656875|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20210683|NCT02704130|Atrium Health|Blair Stephenson, Research Business Manager|704-446-4845|blair.stephenson@atriumhealth.org|
20210684|NCT03907540|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
20192934|NCT01466790|Janssen Research & Development, LLC|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
20192935|NCT00826228|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
20210685|NCT02184169|Boston Childrens Hospital|John Kheir|6173556000|john.kheir@childrens.harvard.edu|
20228305|NCT00525837|Butler Hospital|Noah S. Philip MD|401-455-6258|noah_philip@brown.edu|
20228306|NCT03087058|Vifor Pharma, Inc.|EMERALD Clinical Study Team|+41 588 518 000|EMERALD.study@viforpharma.com|
20228307|NCT01141608|UT Southwestern Medical Center|Dr. Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
20228308|NCT02577029|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20228309|NCT02078817|University of Minnesota|Katherine Cullen|612-273-9732|rega0026@umn.edu|
20228310|NCT02753881|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
20186493|NCT04810650|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
20228311|NCT00506675|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-975-8690|pedig@jaeb.org|
20228312|NCT01441973|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20228313|NCT01149655|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20228314|NCT01265498|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
20228315|NCT01502085|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20186494|NCT05794243|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20210686|NCT01216319|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
20210687|NCT02357173|Medical University of South Carolina|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
20228316|NCT03684408|University of Missouri|Megha Garg MD|573-882-1026|gargmeg@health.missouri.edu|
20228317|NCT00545025|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228318|NCT00617279|W. L. Gore & Associates, Inc.|Chad Badorek, Clinical Study Manager|928.864.3486|cbadorek@wlgore.com|
20228319|NCT00921024|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
20228320|NCT00733278|LA BioMed|Dr. Anita Nelson||anitanelsonwhc@earthlink.net|
20228321|NCT05994963|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228322|NCT02764801|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|John.Eisenbrey@jefferson.edu|
20228323|NCT01244477|Michael E DeBakey VAMC|Wright Williams, PhD, ABPP|713-794-7629|wright.williams@va.gov|
20228324|NCT02014272|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228325|NCT01516216|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
20228326|NCT03736967|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20228327|NCT02369653|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20228328|NCT03587636|University of Minnesota|James Flaherty|612-625-7675|jflahert@umn.edu|
20228329|NCT01458587|DUSA Pharmaceuticals, Inc.|Anna Houlihan|9147608796|houlihana@dusapharma.com|
20228330|NCT01006629|Abbott|Global Medical Services|800-633-9110||
20228331|NCT00316004|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
20228332|NCT00250484|Beth Israel Deaconess|Steven D. Freedman, MD Phd|631-667-2132|sfreedma@bidmc.harvard.edu|
20228333|NCT02665117|UT Southwestern Medical Center|Dr. Wanpen Vongpatanasin|214-648-9078|wanpen.vongpatanasin@utsouthwestern.edu|
20228334|NCT02271451|Cincinnati Children's Hospital|Dr. Gregory Myer|513-636-4366|gregory.myer@cchmc.org|
20228335|NCT00977197|Mayo Clinic|Yuri A. Saito Loftus, M.D.|507-284-2687|saito.yuri@mayo.edu|
20228336|NCT00958074|University of Washington|Dr. Andrei Shustov|206-288-6744|ashustov@uw.edu|
20228337|NCT01432951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228338|NCT02025075|Massachusetts General Hospital|Marcos Vidal Melo, MD, PhD|617-726-8980|VidalMelo.Marcos@mgh.harvard.edu|
20228339|NCT00095979|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20228340|NCT01829347|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
20228341|NCT03248297|University of Alabama at Birmingham|Alan Tita, MD|205-934-5612|atita@uab.edu|
20228342|NCT03530293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20228343|NCT00686972|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20228344|NCT02219256|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20228345|NCT04465422|Taipei City Hospital|Shu Chun Lee|+886 2 27263141|A1057@tpech.gov.tw|1004
20228346|NCT02667639|Monitor CRO|Murat Özdemir|902122341260|murato@monitorcro.com|
20228347|NCT02182804|Division of Gastroenterology. Department of Medicine. Faculty of Medicine. Chulalongkorn University.|Dr. Piyapan Prueksapanich|6622564000|mpkus1@gmail.com|81001
20228348|NCT02679976|Johnson & Johnson Vision Care Inc.|Tom Karkkainen SR. PRINCIPAL RESEARCH OPTOMETRIST|904-443-3500|TKarkkai@its.jnj.com|3402
20228349|NCT05412134|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
20228350|NCT03072186|Ohio State University Wexner Medical Center|Dr. Daniel Prevedello, MD|(614) 293-7190|Daniel.Prevedello@osumc.edu|
20228351|NCT03307174|University of California San Francisco|Paul Su|415-885-7246|paul.su@Ucsf.edu|
20228352|NCT01192815|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
20228353|NCT03444584|MedImmune, LLC|Armando Flor|+1-301-398-1955|information.center@astrazeneca.com|
20228354|NCT00863707|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20228355|NCT01142336|University of Washington|Ge Li, MD, PhD|(206) 764-2485|gli@uw.edu|
20228356|NCT01704261|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20228357|NCT02722967|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
20228358|NCT00808340|Vistakon|Tom Karkkainen, OD|904-443-3402||
20228359|NCT02783911|LomaLindaU|Dr. Jung-Wei Chen, Program director|9095584690|jwchen@llu.edu|85909
20228360|NCT01048424|University of California, San Francisco|Alison Huang, MD|415-353-9751|ahuang@medicine.ucsf.edu|
20228361|NCT00467519|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20228362|NCT01307813|University Hospitals Cleveland Medical Center|Jeffrey Marks, MD - General Surgeon|216-983-4930|Jeffrey.Marks@uhhospitals.org|
20228363|NCT00747214|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
20228364|NCT01218802|Case Western Reserve University|Grace McComsey, MD|2168442739|gam9@case.edu|
20228365|NCT02368132|Corporal Michael J Crescenz VA Medical Center|Dr. Shahrzad Mavandadi|215.823.5211|shahrzad.mavandadi@va.gov|
20228366|NCT01776554|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20228367|NCT01041859|Janssen Research&Development|Director, Clinical Leader|609-730-6777||
20228368|NCT02475369|BIDMC|Caitlin Barrett|617-667-8266|cbarret5@bidmc.harvard.edu|
20228369|NCT00595361|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
20228370|NCT02075125|Department of Cardiology, College of Medicine, Dong-A University.|Dr. Moo Hyun Kim; Director of Global Clinical Trial Center Dong-A University Hospital.|+82 (51) 240-2976|kimmh@dau.ac.kr|
20228371|NCT01991795|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20228372|NCT06119854|CityUNYSPH|Denis Nash|3473316554|denis.nash@sph.cuny.edu|
20228373|NCT00885118|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228374|NCT00094445|University of Texas (UT) MD Anderson Cancer Center|Vivek Subbiah, MD / Assistant Professor, Investigational Cancer Therapeutics|713-563-0393|CR_Study_Registration@mdanderson.org|
20228375|NCT00855218|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
20228376|NCT00942786|Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Austria|Elisabeth Mahla, MD|++43316385|elisabeth.mahla@medunigraz.at|13027
20228377|NCT02941640|University Clinical Center Tuzla|Samir Delibegovic|+387 61 149 131|delibegovic.samir@gmail.com|
20228378|NCT00769561|Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany|Dr. Meike Shedden Mora|+49-6421-282|m.shedden@staff.uni-marburg.de|3657
20228379|NCT02858908|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
20228380|NCT03824561|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20228381|NCT03191552|Department of Physical medicine and Rehabilitation, Marmara University School of Medicine, Istanbul,Turkey|Esra Giray|+90216624545|girayesra@hotmail.com|6515
20228382|NCT04865588|Icahn School of Medicine at Mount Sinai|Director of The Zena and Michael A. Wiener Cardiovascular Institute|(212) 241-4021|samin.sharma@mountsinai.org|
20228383|NCT02370511|Mayo Clinic|Dr. Mayra Guerrero|507-255-1267|Guerrero.Mayra@mayo.edu|
20228384|NCT01162733|Christiana Care Health System|Deb Marco|302 733-4130|dmarco@christianacare.org|
20228385|NCT03141359|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20228386|NCT02003144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20228387|NCT00929838|Medical College of Wisconsin|Jennifer Campbell|414-955-8829|jacampbell@mcw.edu|
20228388|NCT01296412|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20228389|NCT02160626|Aclaris Therapeutics Inc.|Judith Schnyder|+1-484-329-2144|jschnyder@aclaristx.com|
20228390|NCT05471505|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228391|NCT03415152|Abbott Laboratories|Irina Solnyshkina|+7 (495) 258-42 80|irina.solnyshkina@abbott.com|
20228392|NCT00737178|Columbia University|Anne Davis, MD|2123054951|ard4@columbia.edu|
20228393|NCT00485836|Genentech, Inc.|Medical Communications|800-821-8590||
20228394|NCT00750269|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20228395|NCT00542308|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20228396|NCT01898078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20186495|NCT00686335|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
20228397|NCT01075048|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20228398|NCT04596293|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|031-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
20163068|NCT02159976|Department of Internal Medicine, Seoul National University Bundang Hospital|Nayoung Kim, M.D., Ph.D.|+ 82-31-787-7008|nayoungkim49@empas.com|
20228399|NCT01258374|Hospital Clinic|Dr. Josep Mallolas Masferrer|00 44 93 227 54 00|mallolas@clinic.cat|3312
20228400|NCT02305316|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20228401|NCT00761319|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20228402|NCT02741284|Washington University in St Louis|Dr Nandini Raghuraman|314 362 7300|nraghuraman@wustl.edu|
20228403|NCT00183339|University of North Carolina|Linmarie Sikich, MD|919 966 8653|Lsikich@med.unc.edu|
20228404|NCT01715831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20228405|NCT00900562|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20228406|NCT03563222|Fresenius Kabi Germany|Jean-Marc Lohse, PhD|+49 6172|jean-marc.lohse@fresenius-kabi.com|4911
20228407|NCT03098979|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20228408|NCT02419807|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Stephen Grobmyer|1-866-223-8100|TaussigResearch@ccf.org|
20228409|NCT01065818|Columbia University|K.S. Clifford Chao, MD|212-305-9987|ksc2119@cumc.columbia.edu|
20228410|NCT02202252|Diskapi Training and Research Hospital|Melih Akinci, MD, Associate Prof|90 312 5962080|melihakinci@yahoo.com|
20186496|NCT03637660|University of Alabama at Birmingham|Edward W. Hook, III|205-932-4204|ehooks@uabmc.edu|
20210688|NCT03611751|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20210689|NCT00929864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20210690|NCT02666768|The Lundquist Institute at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1961|lpolgreen@lundquist.org|
20210691|NCT01023022|Institute of Cardiology|Prof. Hanna Szwed|48 22 343 46 00|hszwed@ikard.pl|
20210692|NCT03728257|University of Pittsburgh|Annette DeVito Dabbs|4126245314|ajdst42@pitt.edu|
20210693|NCT04686500|University of Texas Southwestern Medical Center|Dr. David Parsons|214/645-8525|david.parsons@utsouthwestern.edu|
20210694|NCT04176354|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210695|NCT01306968|Uniformed Services University of Health Sciences|Dr. R. Scott Miller, M.D.|301-816-8424|robert.s.miller@us.army.mil|
20210696|NCT01381068|UCSD|Neil Finer||nfiner@ucsd.edu|
20210697|NCT00797316|Novartis Pharmaceuticals|Study Director|862-778-8300||
20210698|NCT01516684|Wake Forest University Health Sciences|Thomas McLean|336-716-5440|tmclean@wakehealth.edu|
20210699|NCT03239340|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20210700|NCT04933708|Hospital of the University of Pennsylvania|Fei Cai|215-313-0656|feicai90@gmail.com|
20210701|NCT02392377|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr Jennifer Eads|(216) 844-6031|jennifer.eads@uhhospitals.org|
20210702|NCT00902486|Incyte Corporation|Study Director|855 463-3463||
20210703|NCT02332655|Kennedy Krieger Institute|Dr. Anne Comi|4439239172|comi@kennedykrieger.org|3-9172
20210704|NCT03284424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210705|NCT01838863|Denver Health Medical Center|Dr. Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
20210706|NCT01563029|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210707|NCT01569594|Aziyo Biolgics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
20210708|NCT03069365|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20210709|NCT02861534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210710|NCT02780115|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20210711|NCT00194116|Univeristy Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|Keming.Gao@uhhospitals.org|
20210712|NCT01327989|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949-837-3700|manish.gupta@medtronic.com|
20210713|NCT02086968|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
20210714|NCT03387735|UW Madison|CHESS Statistician|6084772614|ocody@wisc.edu|
20210715|NCT06251154|CooperVision, Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
20210716|NCT00742859|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20210717|NCT00792142|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20210718|NCT00943384|DePuy Synthes Clinical Affairs|Allyson Morris, PhD, CCRP, Staff Clinical Research Scientist|610-719-5298|morris.allyson@synthes.com|
20210719|NCT04193033|Michael E DeBakey VAMC|Dr. Natalie Hundt|713-440-4450|Natalie.Hundt@va.gov|
20210720|NCT02575807|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
20210721|NCT02587117|B.P. Koirala Institute of Health Sciences|Dr. Ramayan Prasad Kushwaha|977-9842207716|visitramayan007@yahoo.com|
20210722|NCT01955473|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20210723|NCT00478673|Boston Scientific Corporation|Jim Taufen, Regulatory Affairs Manager|763-255-0683|taufenj@bsci.com|
20210724|NCT01923961|eXcorLab GmbH|'Dr. Horst-Dieter Lemke|+49-6022-812647|horstdieter.lemke@excorlab.de|
20210725|NCT03791619|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@its.jnj.com|
20210726|NCT03940742|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20210727|NCT03428217|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20210728|NCT03889197|Department of Biostatistics and Health Data Science, Indiana University School of Medicine|Kelly Mosesso, MA; Biostatistician II|317-278-5439|kmosesso@iu.edu|
20210729|NCT00621309|University of Washington|Dr. David L. Eaton|206-543-7468|deaton@uw.edu|
20210730|NCT05246111|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20210731|NCT01187511|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
20210732|NCT01329562|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-890-7888|jtarrasch@clinvest.com|
20210733|NCT03151226|Wake Forest School of Medicine|Dr. Peter H. Pan|336-718-8278|ppan@wakehealth.edu|
20210734|NCT00061568|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|John Tisdale, M.D.|301.402.6497|johntis@nhlbi.nih.gov|
20210735|NCT00402779|UT MD Anderson Cancer Center|Dr. John V. Heymach, PHD/Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
20210736|NCT02925650|Alzheimer's Disease Cooperative Study|Howard Feldman MDCM, FRCP(C)|858-246-1347|hhfeldman@health.ucsd.edu|
20210737|NCT02424357|University of Miami|Hilda Capo|305-326-6555|hcapo@med.miami.edu|
20210738|NCT04616768|University of Pennsylvania|Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
20210739|NCT05004181|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20210740|NCT01526629|Medtronic|Latifa Foudali|0155381700|latifa.foudali@medtronic.com|
20210741|NCT03868059|Lipocine|Shadi Mehraban|801-994-7383|sm@lipocine.com|2191
20210742|NCT02061293|NYU Langone Health|Samantha Podrebarac, MSc|212-263-0912|Samantha.Podrebarac@nyulangone.org|
20210743|NCT04066894|M D Anderson Cancer Center|Dr. Craig Messick|(713) 745-1544|cmessick@mdanderson.org|
20210744|NCT04278872|Sojournix, Inc.|Head of Regulatory Affairs|6174758469|clinicaltrials@sojournixpharma.com|
20228411|NCT04459338|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
20210745|NCT02689973|SWPS University of Social Sciences and Humanities|Dr Aleksandra Luszczynska, Principal Investigator|+4877507260|aluszczynska@swps.edu.pl|
20228412|NCT03157089|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163069|NCT04846322|Yale University|Ula Hwang, MD|+1 (203) 7371774|ula.hwang@yale.edu|
20163070|NCT01934010|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
20163071|NCT01393821|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-7202|Jatoi.Aminah@mayo.edu|
20163072|NCT05419232|Nationwide Children's Hospital|Jason Newland|6147223416|jason.newland@nationwidechildrens.org|
20210746|NCT00777920|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20210747|NCT00483717|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|601-650-4200|dbregman@lpicrd.com|828
20210748|NCT03878108|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
20210749|NCT04800510|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20210750|NCT00604175|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)-628-3313|ACTGCT.Gov@s-3.com|
20210751|NCT02044094|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20210752|NCT03353415|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6713092635|MaryElizabeth.Patti@Joslin.Harvard.edu|
20210753|NCT03205163|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
20210754|NCT04502862|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20210755|NCT00359073|University of Wisconsin Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
20210756|NCT01371006|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20210757|NCT00891527|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@cardio.chboston.org|
20210758|NCT03291847|Johns Hopkins University School of Medicine|Lauren Jansson|4105504114|ljansson@jhmi.edu|
20210759|NCT03515837|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20210760|NCT01964898|The Miriam Hospital|Andrew Busch PhD|4017938189|andrew_busch@brown.edu|
20210761|NCT03151967|University of Washington|Ann Stapleton, MD|2066609981|stapl@uw.edu|
20210762|NCT02957682|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20210763|NCT03612713|Yale University School of Medicine|Data Manager|203-737-5430|Theresa.Babuscio@yale.edu|
20210764|NCT00830388|University of Alabama at Birmingham|Wendy Cantrell|205-502-9960|wcantrell@uabmc.edu|
20210765|NCT00149669|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20210766|NCT02458365|Pro-Change Behavior Systems, Inc.|Deborah Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
20210767|NCT02953262|Center for Healthcare Organization and Implementation Research (CHOIR) United States Department of Veterans Affairs VA Bedford Healthcare System|Stephanie Shimada, PhD|781-687-2208|Stephanie.Shimada@va.gov|
20210768|NCT00934622|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20210769|NCT03349437|Philips|Biostatistician|412-542-3651|jeff.jasko@philips.com|
20210770|NCT02406742|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20210771|NCT00765999|Allergan, Inc.|Vice President, Clinical Development, Gastrointestinal|1-862-261-7000|IR-CTRegistration@allergan.com|
20210772|NCT02367729|Medical College of Wisconsin|Dr. Katja Kovacic|4142663915|kkovacic@mcw.edu|
20210773|NCT00438932|University of Miami Miller School of Medicine|Tamara Isakova, MD, MMSc|305-243-4374|tisakova@med.miami.edu|
20210774|NCT00759174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210775|NCT01890109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20210776|NCT01643928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210777|NCT03336645|Shire|Study Physician|1 866-842-5335|ClinicalTransparency@takeda.com|
20210778|NCT03692078|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20210779|NCT05041803|Sun Pharmaceutical Industries Limited|Head, Regulatory Affairs|9122 66455645|Clinical.Trial@sunpharma.com|
20210780|NCT05723835|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20210781|NCT05226286|Medtronic|Mylene Champs|7635261627|mylene.champs@medtronic.com|
20210782|NCT03395197|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210783|NCT02148835|Preventive Cardiology, University of Munich|Prof. Dr. C. von Schacky|+49 89 44005 2165|clemens.vonschacky@med.uni-muenchen.de|
20210784|NCT01988337|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
20157584|NCT01816048|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-262-4961|jybruce@medicine.wisc.edu|
20157585|NCT04290624|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20157586|NCT01847443|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157587|NCT03571971|The Ohio State University|Stephanie Di Stasi, Principal Investigator|614-293-4220|stephanie.distasi@osumc.edu|
20157588|NCT04067492|R-Pharm|D.V. Bukhanova, Medical Adviser|0074959567|bukhanova@rpharm.ru|3838
20157589|NCT06158867|Taipei Medical University Hospital|Dr. Leon Tsung-Ju Lee|+886-2-27372181|TJ.LEE.SKIN@GMAIL.COM|8281
20157590|NCT00956384|University Health Network|Dr. Toni Zhong|4163404800|kbutler@uhnresearch.ca|2343
20157591|NCT00656370|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20157592|NCT05437419|Teijin America, Inc.|President|+1 (415) 887-9742|clinical-trials-contact@teijinpo.com|
20157593|NCT03402841|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20157594|NCT04133415|Washington University School of Medicine|Matthew Spraker, M.D., Ph.D.|314-362-8567|mspraker@wustl.edu|
20157595|NCT03366454|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
20157596|NCT03984188|University of Miami|Trishul Siddharthan|305-243-6388|tsiddhar@miami.edu|
20157597|NCT03384875|Cytosorbents|Darlene Lambert-Christie/ Director, Clinical Operations|732.822.3332|DLambert-Christie@cytosorbents.com|
20210785|NCT02742818|Hospital Israelita Albert Einstein|Dr. Nelson Wolosker|+55 11 2151-5423|nwolosker@yahoo.com.br|
20210786|NCT04701658|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20210787|NCT00457418|Merck Sharp & Dohme Corp.|Senior Vice President,Global CLinical Development||ClinicalTrialsDisclosure@merck.com|
20210788|NCT01785472|Novartis|Study Director|862-778-8300||
20210789|NCT01294709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210790|NCT03099161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210791|NCT00110084|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
20210792|NCT02446496|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210793|NCT04854707|IVFarma LLC|General Manager|+74996455342|info@ivfarma.ru|
20210794|NCT01793285|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210795|NCT02953418|Medtronic MITG-RGI|Director of Clinical Affairs|303-882-6759|Tumordirectedtherapiesclinical@Medtronic.com|
20210796|NCT00956709|CHU de Nantes|Dr Pham Dang|33 2 53 48 24 15|charles.phamdang@chu-nantes.fr|
20210797|NCT01346501|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20210798|NCT04101721|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20210799|NCT00486642|Bristish Columbia Cancer Agency|Dr. Kim N. Chi|604-877-6000|kchi@bccancer.bc.ca|2746
20210800|NCT02564952|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20210801|NCT00756652|Mentor Worldwide, LLC|Sponsor|949-453-6408|mgpas@its.jnj.com|
20210802|NCT03491228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210803|NCT03706209|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|
20210804|NCT01215955|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20210805|NCT00038467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210806|NCT04088734|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20210807|NCT00096200|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Steven Waggoner, MD|216-844-5011|steven.waggoner@uhhospitals.org|
20210808|NCT00835068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210809|NCT03974516|i Cure Biotech Co., Ltd.|David Liu|+886-955-104-105|white06041983a@gmail.com|
20210810|NCT05264506|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20210811|NCT05990075|James A. Haley Veterans' Hospital|Vanessa Panaite, PhD|813-768-2193|vanessa.panaite2@va.gov|
20210812|NCT02032823|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20210813|NCT04824560|University of New Mexico College of Pharmacy|Alexandra Herman|505-272-7630|asible@salud.unm.edu|
20210814|NCT02949219|Mayo Clinic|Robert R. McWilliams, M.D.|507-266-9161|mcwilliams.robert@mayo.edu|
20210815|NCT01283282|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
20210816|NCT00096031|SWOG Statistical Center|Study Statistician|206-667-4623||
20210817|NCT00083226|ECOG Statistical Office|Study Statistician|617-632-3012||
20210818|NCT00909857|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20210819|NCT01682681|Janssen Korea, Location: 25F, LS , Yongsan Tower, 191, Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Associate, Medical affairs|82-2-2094-4837||
20210820|NCT00975000|Amgen Inc.|Study Director|866-572-6436||
20210821|NCT00584831|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
20210822|NCT01393717|City of Hope National Medical Center|Dr. Robert Chen|626-256-4673|RChen@coh.org|82405
20210823|NCT01652573|Yale School of Medicine|Dr. Karl Insogna|203-737-2871|karl.insogna@yale.edu|
20210824|NCT01453101|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20210825|NCT02706041|The University of Texas Health Science Center at Houston|John A. Harvin, MD, FACS, Associate Professor|(713) 500-7244|John.Harvin@uth.tmc.edu|
20210826|NCT01052038|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20210827|NCT03976076|Bio-Pharm Solutions Co., Ltd.|Bio-Pharm Solutions Medical Information|NA|conference.clinical@b-psol.com|
20210828|NCT01316523|University of California, Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
20210829|NCT00602641|ECOG Statistical Office|Study Statistician|617-632-3012||
20210830|NCT06134128|VA Portland Healthcare System|Kate Shirley, PhD|503-220-8262|kate.shirley@va.gov|52470
20210831|NCT03901352|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20210832|NCT05150340|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20210833|NCT01615822|Medicines for Malaria Venture|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
20210834|NCT03981614|University of Texas; MD Anderson Cancer Center|Scott Kopetz, M.D.|(507) 266-0800|SKopetz@mdanderson.org|
20210835|NCT03901339|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20210836|NCT01787188|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
20210837|NCT05511428|Thomas Jefferson University|Adam Binder, MD|215-955-8874|Adam.binder@jefferson.edu|
20210838|NCT02643394|UT Southwestern Medical Center|David McDonagh, MD|214-648-8083|david.mcdonagh@utsouthwestern.edu|
20210839|NCT03354169|University of Pennsylvania|Kelly C. Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
20210840|NCT04971226|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20163073|NCT02608463|University of Arkansas for Medical Sciences|Dr. Shona Ray-Griffith|501-526-8428|slray@uams.edu|
20192936|NCT01090011|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20210841|NCT04439149|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20228413|NCT00784875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20228414|NCT00853385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228415|NCT01951950|Northwestern University|John F. Bebawy, MD, Principal Investigator|312-695-0061|j-bebawy@northwestern.edu|
20228416|NCT00470548|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20228417|NCT00941928|University of Texas MD Anderson Cancer Center|Anna Franklin, MD, Assistant Professor|713-792-3497|rnjackso@mdanderson.org|
20228418|NCT03073486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228419|NCT02300610|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jingsong Zhang|813-745-3973|jingsong.zhang@moffitt.org|
20228420|NCT04018066|Rutgers, The State University of New Jersey|Dr. Diana Roopchand, Study Investigator|8489320248|roopchand@sebs.rutgers.edu|
20228421|NCT05052580|Duke Clinical Research Institute|Tara Mann, PhD, RN|(919) 668-5111|schoolSETstudy@duke.edu|
20228422|NCT03181308|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
20228423|NCT02515227|University of Virginia|Craig Slingluff, MD|434 924-9311|cls8h@uvahealth.org|
20186497|NCT04652700|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20228424|NCT05998967|VA San Diego HCS|Ariel J Lang, PhD, MPH|(858) 552-8585|ariel.lang@va.gov|
20228425|NCT03451071|University of Alabama at Birmingham|Haller Smith|205-934-4986|hjsmith@uabmc.edu|
20228426|NCT03363906|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228427|NCT03261999|Foresee Pharmaceuticals Co., Ltd|John Mao|+886 2-7750-0188|john.mao@foreseepharma.com|
20228428|NCT00929669|University of Pennsylvania|Peter J. Snyder, MD|215-898-0208|pjs@mail.med.upenn.edu|
20228429|NCT02714153|Yale School of Medicine|Jude Clancy, MD Associate Professor Term; Director, Lead Management Program|(203) 785-4126|jude.clancy@yale.edu|
20228430|NCT01901185|Amgen Inc.|Study Director|866-572-6436||
20228431|NCT00250588|CCHMC|Michael Seid|5138030083|michael.seid@cchmc.org|
20228432|NCT02330341|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20228433|NCT03502798|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
20228434|NCT00485303|Janssen Research & Development, 10990 Wilshire Blvd, Suite 1200, Los Angeles, California 90024|Senior Director, Clinical Research|(310) 943-8040||2917
20228435|NCT00296335|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20228436|NCT04182958|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20228437|NCT04002791|Apex Heart Institute|Chairman|011 91 9824030576|theheartworld@gmail.com|
20228438|NCT01286129|IUCPQ|Louis-Philippe Boulet, principal investigator|418-656-4747|lpboulet@med.ulaval.ca|
20228439|NCT04142242|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20228440|NCT00846053|Washington University|Thomas Ferkol, MD|314 454 6000||
20228441|NCT00111761|Amgen Inc.|Study Director|866-572-6436||
20228442|NCT04264208|Stanford University|Andrei Iagaru, MD|(650) 725-4711|aiagaru@stanford.edu|
20228443|NCT01123655|Memphis VAMC|Arnold E. Postlethwaite,MD Principal Investigator|901 448 5774|apostlet@uthsc.edu|
20228444|NCT00062166|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
20228445|NCT01894906|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
20228446|NCT03642990|University of Iowa|Donna L. Hammond, Ph.D Professor|319-335-9595|donna-hammond@uiowa.edu|
20228447|NCT02717195|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20228448|NCT03092752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228449|NCT03882918|Ovid Therapeutics Inc|Julia Tsai, PhD|(203) 623-1996|jtsai@ovidrx.com|
20228450|NCT06996301|Doc Lab Inc|Roel Chavez|971 570-4008|roel@doclabinc.com|
20228451|NCT04030598|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20228452|NCT03658980|Hiroshima University|Zara Khair|+8801715342168|zara.oikee@gmail.com|
20228453|NCT01419535|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
20228454|NCT00747916|Titus Regional Medical Center|Dr. Gordon Downie|903-572-9050|downieg@trhta.net|
20228455|NCT02344316|UCSF Pediatric Headache Program|Amy Gelfand, MD|415-885-7832|Amy.Gelfand@ucsf.edu|
20228456|NCT05965752|Duke University|Daniel Laskowitz, MD|919-684-0056|daniel.laskowitz@duke.edu|
20228457|NCT01274351|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20228458|NCT00535613|University of Wisconsin|Cari Meyer|(608) 265-5980|cmeyer@wisc.edu|
20228459|NCT05399680|Cordis|Rajesh Nathan|(908) 528-3931|rajesh.nathan@cordis.com|
20228460|NCT03370172|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20228461|NCT02936999|Inova Health Services|Regulatory Research Coordinator|(571) 472-0239|elizabeth.gebregeorgis@inova.org|
20228462|NCT01113749|University of North Carolina Chapel Hill|Laura C. Hanson, MD, MPH|9199665945|lhanson@med.unc.edu|
20228463|NCT03427892|UTexasSouthwestern|Dr. E. Sherwood Brown|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
20228464|NCT03255187|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
20228465|NCT02034006|Novartis Pharmaceuticals|Study Director|862-778-8300||
20186498|NCT04187833|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|James Isaacs, MD|1-866-223-8100|TaussigResearch@ccf.org|
20186499|NCT01898754|University of Washington|Professor Lisa Frenkel|+1 206 987-5140|lfrenkel@uw.edu|
20228466|NCT02934178|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20228467|NCT04323592|University of Trieste|Prof. Marco Confalonieri|+393356895168|mconfalonieri@units.it|4667
20228468|NCT02340676|Dana-Farber Cancer Institute|Dr. John Koreth, MBBS, DPhil|(617) 632-2949|John_Koreth@dfci.harvard.edu|
20186500|NCT04209465|Black Diamond Therapeutics, Inc.|Medical Monitor|617-401-8444|ClinicalTrials@bdtx.com|
20186501|NCT03097549|Umeå University|Towe Wadensten|0046907865000|towe.wadensten@umu.se|
20228469|NCT00296244|Thomas Jefferson University|Carlo Gerardo B Ramirez, MD|215-955-5909|carlo.ramirez@jefferson.edu|
20228470|NCT00703534|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20163074|NCT00377858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163075|NCT03534141|University of California, San Francisco|Dr. Michael P. Bokoch, Principal Investigator|415-476-8389|Michael.Bokoch@ucsf.edu|
20163076|NCT04303572|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
20163077|NCT06312592|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsaystark@wustl.edu|
20163078|NCT04428619|UCLA|Lin Chang|310-206-0192|linchang@mednet.ucla.edu|
20186502|NCT03994653|Imperial College London|Dr James Flanagan|44 2075942127|j.flanagan@imperial.ac.uk|
20186503|NCT05417009|Queen Mary University of London|Professor Gareth Ackland|02035940348|g.ackland@qmul.ac.uk|
20186504|NCT02921230|Boston Scientific|Andrew Campbell|763-494-2722|Andrew.Campbell@bsci.com|
20186505|NCT04977947|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
20186506|NCT03338933|VA Portland Health Care System|Dr. William Hoffman|503-220-8262|hoffmaw@ohsu.edu|56214
20186507|NCT01396278|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186508|NCT04515576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20186509|NCT00999804|Baylor College of Medicine|Dr. Mothaffar Rimawi|7137981311|rimawi@bcm.edu|
20186510|NCT05653427|Janssen Research & Development, LLC|Global Medical Head Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186511|NCT01264406|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
20186512|NCT03891667|Lyme Research Center New York State Psychiatric Institute, New York, New York, United States, 10032|Dr. Brian A. Fallon|646-774-8052|baf1@cumc.columbia.edu|
20186513|NCT02933970|University at Buffalo|Andrew Talal|7168884737|AHTALAL@BUFFALO.EDU|
20186514|NCT05590403|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20228471|NCT01125930|University of Michigan|Dr. Lisa Maier|734-936-4192|maierl@med.umich.edu|
20228472|NCT03617588|Theragnostics Ltd|Director of Clinical Operations|+44 330 606 7437|archie.hale@theragnostics.com|
20228473|NCT03261401|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20228474|NCT01715298|Novartis Pharmaceuticals|Study Director|862-778-8300||
20228475|NCT03860753|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
20228476|NCT03424304|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20228477|NCT03248037|Cornea Research Foundation of America|Marianne Price|3178142990|mprice@cornea.org|
20228478|NCT03720119|Sofar|Dr Laura Patrucco|+39 02909362|laura.patrucco@sofarfarm.it|1
20228479|NCT01944423|Univeristy of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
20228480|NCT02765035|Otto Bock Healthcare GmbH|Director of Clinical Research and Services Vienna|+4315233786733|Milana.Mileusnic@Ottobock.com|
20228481|NCT01604772|Memorial Sloan Kettering Cancer Center|Alan Ho, M.D.||hoa@mskcc.org|
20228482|NCT01381120|Barrie Urology Associates|Dr. Joseph Zadra||joezadra@rogers.com|
20228483|NCT03703895|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
20228484|NCT02732639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20228485|NCT01668797|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20228486|NCT02834975|University of Miami|Abdulrahman Sinno, MD|+1 (305) 2432233|ak.sinno@med.miami.edu|
20228487|NCT01856933|Brown University Oncology Research Group (BrUOG)|Heinrich Elinzano, MD|4018633000|kayla_rosati@brown.edu|
20228488|NCT01391611|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
20228489|NCT02423408|Tonix Pharmaceuticals|Judith Gendreau, Senior Medical Director|858-433-5574|judy.gendreau@tonixpharma.com|
20228490|NCT04232137|Vanderbilt University Medical Center|Dr. Tobias Limperg|(615) 343-6710|tobias.limperg@vumc.org|
20228491|NCT01027845|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228492|NCT01670292|Palmer Center for Chiropractic Research|Dr. Ting Xia|563-884-5161|ting.xia@palmer.edu|
20228493|NCT03306199|Cardiovascular Institute of the South|Research Team Leader|(985) 873-5613|Deanna.Benoit@cardio.com|
20228494|NCT01308619|Galderma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
20228495|NCT01603277|KaloBios Pharmaceuticals Inc.|Nestor Molfino, MD|650-243-3100|nmolfino@kalobios.com|
20228496|NCT00087178|NRG Oncololgy|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20228497|NCT04494646|NYU Langone Health|Sripal Bangalore, MD, MHA|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
20228498|NCT01692119|ABDA, Department of Medicine|Dr. Martin Schulz|+49 30 40004-514|arzneimittel@abda.de|
20228499|NCT02465450|Corbus Pharmaceuticals|Ajay Aggarwal, MD|781-250-9176|aaggarwal@corbuspharma.com|
20228500|NCT00112957|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20228501|NCT01151436|Galderma|Ma May|+33 4 92 38 67 33|may.ma@galderma.com|
20228502|NCT01641042|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228503|NCT00477685|Grewal Eye Institute|S.P.S Grewal, MD|+91-172-5056969|drgrewal@gmail.com|
20228504|NCT03451045|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
20228505|NCT02391337|University of Birmingham|Prof. Dipak Kotecha|+44 (0) 7974 115676|d.kotecha@bham.ac.uk|
20228506|NCT03704064|University of Florida|Dr. Rebecca Pearl, Assistant Professor|352-294-5405|rebecca.pearl@ufl.edu|
20228507|NCT00830128|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228508|NCT02111200|Baylor|Mahshid Azamian|832-822-1529|azamian@bcm.edu|
20228509|NCT00773357|Yale School of Medicine|Sherry McKee|2037373529|sherry.mckee@yale.edu|
20228510|NCT01092767|Medtronic, Inc., Aortic and Peripheral Vascular|Laura Regan, MPH - Study Lead|707-591-2743|laura.e.regan@medtronic.com|
20228511|NCT00982345|Indiana University|Dr. Amit Anand|317-274-7422|aanand@iupui.edu|
20228512|NCT04798027|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20163079|NCT03785405|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20228513|NCT04609514|Duke University|Roger Vilardaga Viera, PhD|919-684-3441|roger.vilardaga@duke.edu|
20228514|NCT00943436|Healthy Eating and Activity Laboratory- University of Tenneessee|Emily Jokisch|865-974-0754|ejokisch@utk.edu|
20228515|NCT02816723|VA Northern California Health Care System|Juliana Baldo|925-372-4649|Juliana.Baldo@VA.gov|
20228516|NCT01981616|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20228517|NCT01773928|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
20228518|NCT03225287|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20228519|NCT03036267|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
20163080|NCT01948063|BIDMC|Michael W Donnino|617-754-2341|mdonnino@bidmc.harvard.edu|
20228520|NCT05117060|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
20228521|NCT05619471|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
20228522|NCT02074514|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20228523|NCT00032591|Palo Alto CSPCC|Bob Edson|(650) 493-5000|Bob.Edson@va.gov|22250
20228524|NCT04239924|BerbeeWalsh Department of Emergency Medicine|Dr. Manish Shah|608-263-9174|mnshah@medicine.wisc.edu|
20228525|NCT00666237|University of Miami|Steven Gedde, MD|305-326-6435|sgedde@med.miami.edu|
20228526|NCT02543840|VA Boston Healthcare System- Center for Healthcare Organization and Implementation Research|Dr. Mark S. Bauer, MD|857-364-6380|mark.bauer@va.gov|
20228527|NCT02659865|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228528|NCT00753519|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
20228529|NCT00959751|NeurAxon, Inc.|Thomas Lategan, PhD|417-673-6697|tlategan@neuraxon.com|
20228530|NCT01750502|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou,China|Dr. JiFei Tang|15968766021|jiftang@126.com|
20228531|NCT01171534|University of Missouri, Department of Orthopaedic Surgery|Gregory J. Della Rocca, MD, PhD, FACS|573-882-6562|dellaroccag@health.missouri.edu|
20228532|NCT03861039|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20163081|NCT01028846|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
20192937|NCT00307047|Abbott Vascular|Ellen Travis|408-845-1512|ellen.travis@av.abbott.com|
20192938|NCT00379769|GlaxoSmithKline|GSK Response Center|866-435-7343||
20192939|NCT03778294|Mayo Clinic|Dr Sujay Vora|480-342-1262|Vora.Sujay@mayo.edu|
20192940|NCT01641653|Rutgers-New Jersey Medical School|Vasanti Tilak, MD|973 972-7477|tilakva@njms.rutgers.edu|
20192941|NCT02825251|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20192942|NCT01197612|University of Michigan|Garrett Griffin, MD||ggriffin@mw-fp.com|
20192943|NCT00349466|Can-Fite Biopharma|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
20192944|NCT02852356|Ovation Fertility|Director|5126107474|tex@ovationfertility.com|
20192945|NCT01689363|Amphastar Pharmaceuticals, Inc.|Gisela Sharp|(909) 980-9484|GiselaS@amphastar.com|2016
20192946|NCT02104505|Center for Environmental Medicine, Asthma and Lung Biology; University of North Carolina, Chapel Hill|Allison Burbank, MD|919-843-2714|allison_burbank@med.unc.edu|
20192947|NCT01845805|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
20202964|NCT02564120|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
20228533|NCT02100631|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research||dcassie@ebsi.com|
20163082|NCT00245037|Oregon Health and Science University|Richard T. Maziarz, MD|503-494-6345|maziarzr@ohsu.edu|
20210842|NCT02494544|restor3d|Tara Mann - Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
20210843|NCT05919823|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20228534|NCT03944616|University of California, Irvine|Dr. Andrew Odegaard|949-824-8544|aodegaar@hs.uci.edu|
20228535|NCT01287936|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
20228536|NCT00427934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20228537|NCT04319224|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
20228538|NCT02058095|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
20228539|NCT01499511|Imperial College London|Professor Peter Sever|02075941100|p.sever@imperial.ac.uk|
20210844|NCT04521608|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
20228540|NCT00998946|Spectrum Pharmaceuticals, Inc|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20228541|NCT01653418|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20228542|NCT00148798|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20228543|NCT00915525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20228544|NCT02842866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20228545|NCT01432327|Katholieke Universiteit Leuven|Karen Van Hoye|0032498617141|Karen.Vanhoye@faber.kuleuven.be|
20228546|NCT00577408|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|edward.nunes@nyspi.columbia.edu|
20210845|NCT05256992|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20210846|NCT00285012|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20210847|NCT02843529|Altoida Inc.|Ioannis Tarnanas|+18325975076|Ioannis@altoida.com|
20210848|NCT05298345|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20228547|NCT02897349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228548|NCT01289522|Centre Antoine Lacassagne|Pr. Joël GUIGAY|+33492031000|joel.guigay@nice.unicancer.fr|
20228549|NCT03113955|Zhongda Hospital Southeast University|Dr. Gaojun Teng|13805171500|gjteng@vip.sina.com|+86
20228550|NCT03435055|University of Michigan|Richard Harris|734-998-6996|reharris@umich.edu|
20228551|NCT01708603|Bausch Health|Study Director|510-259-5284||
20228552|NCT01951066|Wilmer Eye Institute, Johns Hopkins University School of Medicine|[Peter A. Campochiaro|(410) 955-5106|pcampo@jhmi.edu|
20228553|NCT03817528|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-5340|marlene.carlson@nyspi.columbia.edu|
20228554|NCT00906243|University of Florida|Dr. Johannes Vieweg|352 273-6815|j.vieweg@urology.ufl.edu|
20228555|NCT03177395|Pharmacology, Therapeutics and Toxicology Unit, Centre for Cardiovascular Science, University of Edinburgh, UK|Dr James Dear|+44(0)131 242 9214|james.dear@ed.ac.uk|
20228556|NCT01027949|United Therapeutics|Louis Holdstock, PhD|919-425-8866|lholdstock@unither.com|
20228557|NCT03315949|College of Medicine, The Catholic University of Korea|Dr. Tae-Geun Gweon|82 32 340 2228|gweontae@naver.com|
20228558|NCT02052635|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20228559|NCT01712178|AbbVie|Global Medical Services|800-633-9110||
20228560|NCT00856180|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
20228561|NCT00671749|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
20228562|NCT00827567|Penn State|Allan Lipton, MD|717-531-5960|alipton@psu.edu|
20228563|NCT04418947|University of Pennsylvania|Dr. Anne Cappola|2155735359|acappola@pennmedicine.upenn.edu|
20228564|NCT01259245|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
20228565|NCT03316105|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
20228566|NCT00513799|Washington University|Stephanie Fritz|314-454-6050|fritz_s@kids.wustl.edu|
20228567|NCT03482024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228568|NCT00204737|University of Wisconsin - Madison|Catherine Johnson|608-280-7084|catherine.johnson2@va.gov|
20228569|NCT00217490|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD|503 335 6751|victor.j.stevens@kpchr.org|
20228570|NCT00676143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228571|NCT03937778|National Center for Complementary and Integrative Health|Chesler, Alexander|+1 301 594 1049|alexander.chesler@nih.gov|
20228572|NCT02318264|SUNY Upstate Medical|Michelle Dolphin, Associate Professor|315 464 6917|dolphinm@upstate.edu|
20186515|NCT05659537|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20186516|NCT04259632|University of Minnesota|Niki Oldenberg|612-625-8781|olden019@umn.edu|
20186517|NCT04717492|UAB Lung Health Center|Mark Dransfield|205-934-5425|mdransfield@uabmc.edu|
20186518|NCT04456517|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
20186519|NCT03575897|University of Alabama at Birmingham|Dr. Ariel Salas|205-934-4680|asalas@peds.uab.edu|
20186520|NCT05275231|Emory University|Dr. Megha K. Shah|404-778-6944|mkshah@emory.edu|
20186521|NCT01160211|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20186522|NCT06181006|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20186523|NCT03611491|CROMA - PHARMA|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
20186524|NCT04676022|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20228573|NCT02065557|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20210849|NCT04050293|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
20228574|NCT01200355|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
20210850|NCT05711524|Weill Cornell Medicine|Dr. Melissa Cushing|212-746-3527|mec2013@med.cornell.edu|
20192948|NCT02859064|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20192949|NCT00321685|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20192950|NCT00624910|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20192951|NCT00127842|Amgen Inc.|Study Director|866-572-6436||
20228575|NCT00706797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20228576|NCT02879032|Bangabandhu Sheikh Mujib Medical University|Dr. Md. Mashiul Alam|+8801724490475|mashiull@gmail.com|
20228577|NCT05169905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20228578|NCT00368550|University of Pennsylvania|Henry R. Kranzler, M.D.|215-222-3200|kranzler_h@mail.trc.upenn.edu|137
20228579|NCT03072550|DeviceFarm|Jeffrey N Roe|925-895-1584|jeffnroe1@devicefarmtech.com|
20228580|NCT01258049|Xidea Solutions Limited|Dr Daryl Bendel||daryl@xideasolutions.com|
20228581|NCT02309359|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
20228582|NCT01032928|Ralph H Johnson VA Medical Center|Dr. Bonnie Martin Harris|843-792-0879|Bonnie.Martin-Harris@va.gov|
20228583|NCT01604785|Oregon Health & Science University|David Sheridan|503 494-8311|sheridda@ohsu.edu|
20228584|NCT03040726|The University of Texas MD Anderson Cancer Center|Dr. David Hui|(713) 792-6258|dhui@mdanderson.org|
20228585|NCT02908347|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
20228586|NCT03104374|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20228587|NCT02121210|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20228588|NCT00909870|Shire Regenerative Medicine|Mollie Carter, MD, Medical Director|(858) 754-5678|mcarter@shire.com|
20228589|NCT01232283|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20228590|NCT02873975|Dana-Farber Cancer Institute|Geoffrey Shapiro M.D., PhDDana-Farber Cancer Institute|617-632-6594|Geoffrey_Shapiro@dfci.harvard.edu|
20228591|NCT03054428|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20228592|NCT01652690|Amgen Inc.|Study Director|866-572-6436||
20228593|NCT01499810|Research Institute of Cradiology, Siberian Branch of Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
20228594|NCT05079321|Centre for Ocular Research and Education|Lyndon Jones|(519) 888-4567|lwjones@uwaterloo.ca|35030
20228595|NCT01884597|Retina Consultants of Hawaii, Inc.|Gregg Kokame, MD|(808) 487-8928|retinahi@aol.com|
20228596|NCT02097823|Prevea Health/St Vincent Hospital|Dr. Catherine Long|9204338670|cathy.long@prevea.com|
20228597|NCT01081626|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20228598|NCT03759379|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20228599|NCT04021043|MD Anderson Cancer Center|Joe Chang, MD|(713) 563-2337|jychang@mdanderson.org|
20228600|NCT02325414|Northwestern University|Dr. Thomas Schnitzer|312-503-4043|tjs@northwestern.edu|
20192952|NCT01730950|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20228601|NCT05722522|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20192953|NCT03023722|Yale University|Stacey Stein, MD|203 737-1600|stacey.stein@yale.edu|
20192954|NCT00667459|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20192955|NCT03616964|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20192956|NCT02866669|University of Alabama at Birmingham|Dr. Andrea Cherrington|205-996-2885|acherrington@uabmc.edu|
20192957|NCT03792347|Ruijin Hospital, Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
20192958|NCT04071301|Essity Hygiene and Health|Fredrik Agholme, Clinical Trials Manager, Clinical Affairs|+46 73 0323634|Fredrik.AGHOLME@essity.com|
20192959|NCT01850589|Staten Island University Hospital|Dr. Jonathan Deitch, PI, Director of Vascular Surgery|718-226-9000|jonathan_deitch@siuh.edu|1278
20192960|NCT04560374|Marmara University Faculty of Health Sciences Department of Pediatric Nursing|Dr. Çağrı Çövener Özçelik|009-0216-777-57-00|ccovener@gmail.com|5773
20192961|NCT03721705|Renew Research|Billy Tally, CEO|949-545-8466|bill2@stage2innovations.com|
20192962|NCT01843777|National Center for Rehabilitative Auditory Research|M. Samantha Lewis, PhD|503-220-8262|Michele.Lewis3@va.gov|51996
20192963|NCT01821105|The Ohio State University|Edward Martin, MD|614-293-8843|Edward.Martin@osumc.edu|
20192964|NCT00632021|Vanderbilt University Medical Center|Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
20192965|NCT02049515|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20192966|NCT01200498|The University of Texas MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Assistant Professor|713-745-4009|eharriso@mdanderson.org|
20192967|NCT01640171|Retina Vitreous Associates of Florida|Steven Cohen|7274459110|scohen@health.usf.edu|
20192968|NCT01586975|Northwestern University|Northwestern University|312.503.4394|r-bernstein@northwestern.edu|
20192969|NCT01653210|Univerisity of Virginia|Sue Brown, MD||sab2f@virginia.edu|
20192970|NCT00224029|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20192971|NCT02872012|University of Michigan Kellogg Eye Center|Dr. Anjali Shah|734-763-8122|arshah@med.umich.edu|
20192972|NCT01728623|Eisai Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20192973|NCT03000348|NovaBiotics Ltd|Dr Deborah O'Neil, CEO|01224 711 377|deborah@novabiotics.co.uk|
20192974|NCT00020722|Barbara Ann Karmanos Cancer Institute|Lawrence G. Lum, M.D., D.Sc|(313) 576-8326|luml@karmanos.org|
20228602|NCT04441905|Pharmaceutical Product Development (PPD), part of Thermo Fisher Scientific|Kristie Miller, MD|512-747-1504|kristie.miller@ppd.com|
20228603|NCT04817189|Helsinn|Alessandro Alonzi, Medical Advisor|+41793262091|Alessandro.Alonzi@helsinn.com|
20192975|NCT01807182|Fred Hutchinson Cancer Center|Dr. Sylvia Lee|206-606-2274|smlee@fredhutch.org|
20210851|NCT05631093|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
20210852|NCT00417859|University Hospital of Lausanne|Prof Brigitte Jolles|0213149629|brigitte.jolles@chuv.ch|
20210853|NCT06232408|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
20228604|NCT03834961|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
20228605|NCT02555254|CHU Nantes|Jean-Baptiste Lascarrou|+33251446572|jeanbaptiste.lascarrou@chu-nantes.fr|
20228606|NCT04736199|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20228607|NCT03526679|National Taiwan University Hospital|Dr. Tom Wei-Wu Chen|+886-2-23123456|tomwchen@ntuh.gov.tw|66002
20228608|NCT04770753|Agios Pharmaceuticals, Inc .|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
20228609|NCT02775851|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
20228610|NCT04780659|Karolinska University Hospital|Soo Aleman Sponsor representative|+46 72595 7225|soo.aleman@regionstockholm.se|
20228611|NCT04369053|Freenome|Director of Clinical Development|(650)446-6630|medicalaffairs@freenome.com|
20186525|NCT05746494|University of Texas at Dallas|Dr. Linlin Fan|+(853) 8822 4226|linlin.fan@utdallas.edu; linlinfan@um.edu.mo|
20186526|NCT05409183|Tufts Medical Center|James Udelson, MD|(617) 636-8066|James.Udelson@tuftsmedicine.org|
20186527|NCT02274662|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
20186528|NCT03194217|BenevolentAI|Administrator|+44 20 3781 9360|LondonAdmin@benevolent.ai|
20186529|NCT04806451|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20186530|NCT05835336|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
20186531|NCT05191472|University of California, San Francisco|Dr. Alfred Chung, MD|(415) 476-1000|Alfred.Chung@ucsf.edu|
20186532|NCT02132936|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20186533|NCT03676764|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
20186534|NCT02561585|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20186535|NCT03134196|NYU Langone Health|Elisabeth Cohen, MD|9294552412|Elisabeth.Cohen@nyulangone.org|
20186536|NCT00875277|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20186537|NCT03016754|ZOLL|Nicole Bianco|4129683333|nbianco@zoll.com|14410
20186538|NCT06469138|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
20186539|NCT04683744|Indiana University|Dr. Peter H. Schwartz|317-278-4037|phschwar@iu.edu|
20186540|NCT02432404|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
20186541|NCT04185298|Saint John's Cancer Institute|Dr. Jennifer Bramen|310-525-0865|jennifer.bramen@providence.org|
20186542|NCT04114877|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
20186543|NCT04927364|VA Palo Alto Healthcare System|Claudia Padula|650-849-1211|padula@stanford.edu|
20186544|NCT03916510|University of Oxford|CEDAR Trial Manager, Oncology Clinical Trials Office (OCTO)|01865 617085|octo-CEDAR@oncology.ox.ac.uk|
20186545|NCT03483610|University of Rochester|Research Administrator|585-274-1509|peter_macdowell@urmc.rochester.edu|
20186546|NCT04316871|Assiut University|Dr Muhammad Shawqi|01100671067|m.shawqi@med.au.edu.eg|+20
20186547|NCT04650269|University of Miami Miller School of Medicine|Hansel Tookes|3056897030|hetookes@miami.edu|
20186548|NCT05087992|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186549|NCT04091750|Georgetown University|Geoffrey T. Gibney, MD|202-444-2223|Geoffrey.T.Gibney@gunet.georgetown.edu|
20186550|NCT02919306|Janssen Vaccines and Prevention BV|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186551|NCT04473222|University of Oregon|Ariel Williamson|971-352-4004|arielaw@uoregon.edu|
20186552|NCT04293055|The Miriam Hospital|Dr. Jacqueline Hayes|401-793-8917|jhayes3@lifespan.org|
20186553|NCT03560609|NYU Langone Health|Jamika Singleton-Garvin|(212) 263-2573|jamika.singleton-garvin@nyulangone.org|
20186554|NCT02839161|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
20186555|NCT06321809|Hacettepe University|Assoc.Prof. Duygu Ayhan Baser|+90-505-664-5210|dr.duyguayhan@gmail.com|
20186556|NCT03123848|Janssen Pharmaceutical K.K.|Director, IDV Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186557|NCT01369355|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186558|NCT02436096|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20186559|NCT02319759|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186560|NCT06424236|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
20186561|NCT04213872|ASU/PVHMC|Dr. Francisco Munoz|909-753-8391|fmunoz007@verizon.net|
20186562|NCT02262728|Janssen Research & Development, a division of Janssen Pharmaceutica NV|Medical Leader Hepatitis C, GCO ED&CP||ClinicalTrialDisclosure@its.jnj.com|
20186563|NCT00227344|Biosense Webster, Inc.|Pat Ticknor, Clinical Operations|909-839-8500|PTicknor@its.jnj.com|
20186564|NCT01987895|Actelion Pharmaceuticals Ltd|Clinical Trial disclosure Desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
20186565|NCT01422434|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
20186566|NCT05006872|Health Research Institute of the Balearic Islands|Dra. Rocío Zamanillo Campos|+34 971175883|rocio.zamanillo@ssib.es|
20186567|NCT01753414|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20186568|NCT04971681|Indiana University|Dr. Martin H. Plawecki, MD, PhD|3179486550|mplaweck@iu.edu|
20210854|NCT03494816|University of Cambridge|Prof Grant Stewart|01223 256211|gds35@cam.ac.uk|
20228612|NCT05507437|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20186570|NCT05647304|REGEnLIFE|Guillaume Blivet|+33434481535|gblivet@regenlife.com|
20210855|NCT05573113|Children's Mercy Kansas City|Sherwin Chan|816-234-3273|sschan@cmh.edu|
20210856|NCT05734014|Montana State University|Vanessa Simonds|4069947396|vanessa.simonds@montana.edu|
20210857|NCT04024254|Rush University Medical Center|Dr Lydia Usha|312-942-5904|Lydia_Usha@rush.edu|
20210858|NCT03515681|Columbia University|Steven J. Shea, MD|212-305-6355|ss35@cumc.columbia.edu|
20210859|NCT00005879|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
20210860|NCT01238172|Moores Cancer Center|J. Kellogg Parsons, M.D., MHS|858-822-7874|jkparsons@ucsd.edu|
20210861|NCT05022121|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
20210862|NCT01209234|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
20210863|NCT07046403|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
20210864|NCT03229941|New York Veterans Affairs Healthcare System, Brooklyn|Panagiotis Kougias|718-836-6600|panagiotis.kougias@va.gov|
20218153|NCT00754468|University of Miami|Dr. Alfonso Ribeiro|305-243-4000|Aribeiro@med.miami.edu|
20218154|NCT00787020|Duke University Medical Center|DaiWai M Olson|9196683751|Olson006@mc.duke.edu|
20218155|NCT01972035|University of Minnesota|Henry Balfour, MD|612-625-3998|balfo001@umn.edu|
20218156|NCT00233987|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
20218157|NCT02508259|University of California, San Diego School of Medicine|Dr. Robert K. Naviaux, MD, PhD|619-543-2904|naviaux@ucsd.edu|
20218158|NCT01699763|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20218159|NCT01481324|Shriners Hospital for Children|Dr. Todd Milbrandt|859-266-2101|tmilbrandt@shrinenet.org|
20218160|NCT01036490|Hines VA Hospiral|David J. Leehey, M.D.|(708)2022589|david.leehey@va.gov|
20218161|NCT02332980|Mayo Clinic|Wei Ding|5072845096|Ding.Wei@mayo.edu|
20218162|NCT00952276|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20218163|NCT02427984|Medical technology laboratory, Rizzoli Orthopaedic Institute|Susanna Stea|00390516366861|stea@tecno.ior.it|
20218164|NCT03714555|HonorHealth|Gayle Jameson, MSN, ACNP-BC, AOCN|480-323-1364|clinicaltrials@honorhealth.com|
20218165|NCT03821272|University of Arkansas for Medical Sciences|Mayumi Nakagawa, M.D., Ph.D.|(501) 686-8635|MNakagawa@uams.edu|
20218166|NCT05904769|Mayo Clinic|Guru Kowlgi M.B.B.S., M.S.|507-422-0549|Kowlgi.NarayanGurukripa@mayo.edu|
20218167|NCT03943537|McLean Hospital|Virginie-Anne Chouinard|617-855-3034|vchouinard@mclean.harvard.edu|
20218168|NCT05599269|Ivoclar Vivadent AG|Dr. med. dent. Ronny Watzke|+423 235 3401|Ronny.Watzke@ivoclar.com|
20218169|NCT01010126|Mayo Clinic|Henry Pitot, M.D.|(507) 284-2511|pitot.henry@mayo.edu|
20218170|NCT00635830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20218171|NCT00493246|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20218172|NCT03028948|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne|7322356759|mannesl@cinj.rutgers.edu|
20218173|NCT01207440|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20163083|NCT01511068|Cincinnati Children's Hospital Medical Center|Dr. Bruce Trapnell|513636-6361|Bruce.Trapnell@cchmc.org|
20218174|NCT03341000|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
20218175|NCT01592721|UTexas_SanAntonio|Anand B. Karnad, MD|2104501365|regulatoryaffairs@uthscsa.edu|
20218176|NCT02277704|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
20218177|NCT00380692|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20218178|NCT00522171|Ethicon Endo-Surgery|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
20218179|NCT02698865|DePuy Synthes|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20218180|NCT03861481|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20218181|NCT00773734|Celgene Corporation|Anne McClain|888-243-1360|clinicaltrialdisclosure@celgene.com|
20218182|NCT03715998|Quantum Genomics|Dr Bruno Besse|+33 1 85 34 77 73|bruno.besse@quantum-genomics.com|
20218183|NCT01660191|University of Kansas Medical Center|Julie-Ann Dutton|913-588-4064|JDUTTON@kumc.edu|
20218184|NCT01220297|Stanford Univesity|Laura Johnston, MD|650-723-0822|laura.johnston@stanford.edu|
20218185|NCT03111914|Duke University|Dr. Daniele Marin|919-684-7366|daniele.marin@duke.edu|
20163084|NCT00203424|Translational Oncology Research International|Dr. Fairooz F. Kabbinavar, Chief Medical Officer|310-824-1934|FKabbina@mednet.ucla.edu|
20218186|NCT02119286|GlaxoSmithKline|GSK Response Center|866-435-7343||
20218187|NCT04109313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20218188|NCT01272921|Northwestern University|Mark Kendall, M.D.|312-695-2528|m-kendall@northwestern.edu|
20218189|NCT01132664|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
20218190|NCT00882206|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612.672.7422||
20218191|NCT01996332|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20218192|NCT02113189|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|2146481559|karen.mccain@utsouthwestern.edu|
20218193|NCT05016622|Montefiore Medical Center|Dr. Balazs Halmos|718-405-8404|bahalmos@montefiore.org|
20218194|NCT01304693|Alcon Research, Ltd.|Georges Weissgerber, Executive Director, Novartis Pharma AG|1-888-451-3937|alcon.medinfo@alcon.com|
20218195|NCT02954159|Medical College Of Wisconsin|Andres Yarur, MD; Principal Investigator|414-955-6858|ayarur@mcw.edu|
20218196|NCT01237353|University of California San Francisco|Dr. Leslie Benet|415-476-3853|leslie.benet@ucsf.edu|
20218197|NCT02581163|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20218198|NCT03438396|Genmab A/S|Ibrahima Soumaoro|+1 609 430 2481|clinicaltrials@genmab.com|
20218199|NCT03394755|Cellphire Therapeutics, Inc.|Mike Fitzpatrick, PhD|240-268-2470|mfitzpatrick@cellphire.com|
20218200|NCT03578237|University of California San Diego|Program Manager|(858) 220-5714|baabdullah@health.ucsd.edu|
20218201|NCT02488330|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20210865|NCT00391092|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20210866|NCT03610646|Viatris|Dr. Prasanna Ganapathi, Head of Global Clinical Strategy and Innovation|+91 80 6672800|prasanna.ganapathi@viatris.com|
20210867|NCT00424515|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20210868|NCT04071366|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20210869|NCT02239692|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20210870|NCT00858234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210871|NCT01678924|Allergan plc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20210872|NCT01629134|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
20210873|NCT03232749|University of Florida|MaryBeth Horodyski, Ed.D., ATC, LAT, FNATA|352-273-7074|horodmb@ortho.ufl.edu|
20210874|NCT03569020|Beth Israel Deaconess Medical Center|Dr. Stephen Juraschek|617-754-1416|sjurasch@bidmc.harvard.edu|
20210875|NCT02428231|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20210876|NCT03978117|Masonic Cancer Center|Dorothy Hatsukami, PhD|(612) 626-2121|hatsu001@umn.edu|
20186571|NCT04171999|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
20210877|NCT00791154|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20210878|NCT02307188|Columbia University Medical Center|Abgelo Biviano|212-305-7646|ab542@columbia.edu|
20210879|NCT00817778|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20210880|NCT03343054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210881|NCT04256759|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
20210882|NCT04661540|CalciMedica|Sudarshan Hebbar, MD (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
20210883|NCT04075292|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20163085|NCT00555672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210884|NCT01826201|Moleculin, LLC|Chief Medical Officer|713-953-7676|Carena@moleculin.com|232
20210885|NCT05292053|Baylor Scott & White Research Institute|Clinical Research Manager|214-820-1771|Felicia.Padilla@BSWHealth.org|
20210886|NCT03829462|Institut régional du Cancer de Montpellier|Dr Emmanuelle Samalin|467613136|emmanuelle.samalin@icm.unicancer.fr|+33
20210887|NCT02843308|Stanford University School of Medicine|Carolyn Rodriguez, MD, PhD|650-723-4095|ocdresearch@stanford.edu|
20210888|NCT00481871|Allos Therapeutics, Inc.|Michael Saunders, MD|303-426-6262|msaunders@allos.com|
20210889|NCT06065176|University of Utah|Sarang Yoon, PI|801-203-0320|sarang.yoon@hsc.utah.edu|
20210890|NCT02588651|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Study Principal Investigator|1-866-223-8100|TaussigResearch@ccf.org|
20210891|NCT03801369|Oregon Health & Science University - Knight Cancer Institute|Gordon Mills, MD, PhD|503-346-4660|millsg@ohsu.edu|
20210892|NCT04083378|The University of Texas MD Anderson Cancer Center|Dr. Bruno Odisio|(713) 563-1066|bcodisio@mdanderson.org|
20210893|NCT04803214|Mainstay Medical|Jennifer Tinsley, Director of Clinical Affairs|(877) 702-8488|info@mainstaymedical.com|
20210894|NCT00644228|SWOG Statistical Center|Study Statistician|206-667-4623||
20210895|NCT06078124|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsay.stark@wustl.edu|
20210896|NCT05824273|Hackensack Meridian Health - Center for Discovery and Innovation|Ana Vielma|2018803100|ana.vielma@hmh-cdi.org|
20210897|NCT02736695|Mayo Clinic|Keith Josephs, M.D.|507-266-4106|josephs.keith@mayo.edu|
20210898|NCT04223193|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20210899|NCT00597883|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
20210900|NCT03193190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20210901|NCT03532295|Washington University School of Medicine|Dr. Milan Chheda|314-747-7222|mchheda@wustl.edu|
20210902|NCT06474715|Columbia University Irving Medical Center|Lauren Houghton, PhD Msc|212-342-0246|lh2746@cumc.columbia.edu|
20210903|NCT03732677|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20210904|NCT04644237|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20210905|NCT03131817|University of California, San Francisco|Dr. Simon Little|4152995650|simon.little@ucsf.edu|
20210906|NCT05838755|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20210907|NCT04439110|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20210908|NCT05073692|Kaiser Permanente Division of Research|Romain Neugebauer|510-891-3234|Romain.S.Neugebauer@kp.org|
20210909|NCT06873867|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
20210910|NCT04647253|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
20210911|NCT02706353|M.D. Anderson Cancer Center|Adi Diab, MD|713-792-2921|MDADiab@mdanderson.org|
20163086|NCT01053988|GlaxoSmithKline|GSK Response Center|866-435-7343||
20186572|NCT02301910|SuperGene LLC|Markin Sergey|(495) 287-98-07|info@supergene.ru|+7
20186573|NCT06181760|Island Pharmaceuticals|David Foster, CEO|510-393-6523|dfoster@islandpharmaceuticals.com|
20186574|NCT03524612|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20186575|NCT04623671|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
20186576|NCT00613106|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
20186577|NCT03854214|Kennedy Krieger Institute|Ann S. Choe, Ph.D.|443-923-9500|choea@kennedykrieger.org|
20186578|NCT02396134|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
20186579|NCT01424150|Alfred Health|Professor Paul Myles|61 3 9076 3176|p.myles@alfred.org.au|
20210912|NCT03560466|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20210913|NCT05257109|Yale University|Dr. Danielle Davis|2039747607|danielle.davis@yale.edu|
20210914|NCT02038959|University of Rochester|Ray Dorsey, MD|585-276-6824|ray.dorsey@chet.rochester.edu|
20210915|NCT03233737|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
20210916|NCT00819091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20210917|NCT01320826|University of Alberta|Dr. Michael Kolber|(780) 616-8411|mkolber@ualberta.ca|
20210918|NCT03911960|Hennepin Healthcare|Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
20210919|NCT04318535|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20210920|NCT01733186|MEDIPOST Co., Ltd.|Director of Product Development Department|+82-2-3465-6740|meehyunj@medi-post.co.kr|
20210921|NCT02675426|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20210922|NCT02277639|Children's Hospital of Philadelphia|Nancy Bunin, MD|215-590-2255|buninn@email.chop.edu|
20210923|NCT02156466|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20210924|NCT02237118|Clinique Mutualiste du Medoc|Dr Anne Solanilla|+33 5 56 73 11 43|annasolanilla@yahoo.fr|
20210925|NCT00080288|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20210926|NCT02253654|Amgen Inc.|Study Director|866-572-6436||
20210927|NCT00069160|National Cancer Institute, National Institutes of Health|Susan E. Bates, M.D.|301-402-1357|BatesS@mail.nih.gov|
20210928|NCT03044431|Lung Institute|Melissa Rubio, PhD, APRN|214-504-2117|pidallas@lunginstitute.com|
20210929|NCT03456726|Eisai Co., Ltd|Eisai Inquiry Service|None|eisai-chiken_hotline@hhc.eisai.co.jp|
20210930|NCT04470622|Heron Therapeutics, Inc.|Sophie Visonneau|858-251-7232|svisonneau@herontx.com|
20210931|NCT00399490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210932|NCT02328547|Montefiore Medical Center|Dr. Olga C. Aroniadis, PI|718-920-4846|oaroniad@montefiore.org|
20210933|NCT02576054|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210934|NCT00044005|Sunovion|Josephine Cucchiaro, PhD|201-592-2050|josepine.cucchiaro@sunovion.com|
20210935|NCT00176501|Rutgers Cancer Institute of New Jersey|Dr. Roger Strair, MD, PhD|732-235-8675|strairrk@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20210936|NCT01586624|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20210937|NCT00953927|Aeras|Bernard Landry|301-547-2919|blandry@aeras.org|
20210938|NCT01396161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210939|NCT04604496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210940|NCT02962739|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
20210941|NCT00414011|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
20210942|NCT03638102|University of Illinois Chicago|Sirimon Reutrakul|3124135357|sreutrak@uic.edu|
20210943|NCT00822679|University of Arizona|Sairam Parthasarathy|5206266109|sparthasarathy@deptofmed.arizona.edu|
20210944|NCT04221087|University of PIttsburgh|Dr. Allison Williams|4126925135|williamsae2@upmc.edu|
20210945|NCT02360397|Brigham and Women's Cardiovascular Associates at Kent Hospital|Chester M. Hedgepeth, MD, PhD|(401) 737-7010|chedgepeth@kentri.org|32880
20210946|NCT01537549|Weill Cornell Medicine|Dr. Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
20210947|NCT01208922|Dr. Falk Pharma GmbH|Department of Clinical Research|0049 7611514|zentrale@drfalkpharma.de|0
20210948|NCT02360059|The University of Texas (UT) MD Anderson Cancer Center|Dr. David L. Ramirez, Assistant Professor, Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20210949|NCT03403712|Helsinn SA|Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
20210950|NCT05349188|Northwell Health|Dr. Mark Butler, PhD|908-414-0238|markbutler@northwell.edu|
20210951|NCT00131937|ECOG Statistical Office|Study Statistician|617-632-3012||
20210952|NCT03703297|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20210953|NCT01211613|University of Pittsburgh, Department of Physical Therapy'|Michael J Schneider, DC, PhD|412-383-6640|mjs5@pitt.edu|
20210954|NCT01020773|Beijing Shijitan Hospital|Department of Respiratory Medicine|86-010-63926385|mayingmin@hotmail.com|
20210955|NCT03853213|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
20210956|NCT03302299|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
20210957|NCT01458132|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210958|NCT01788163|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|Haiyi.Jiang@astrazeneca.com|
20210959|NCT00545441|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
20210960|NCT00265239|Kumamoto University|Dr. Kenichi Tsujita|+81-96-373-5175|tsujita@kumamoto-u.ac.jp|
20210961|NCT02803138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20186580|NCT05296525|Gamida Cell|Associate director, Clinical Operations|+972556660324|aurelie@gamida-cell.com|
20210962|NCT00021229|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
20218202|NCT00584844|USAMRIID|Mark Goldberg, MD|301-619-4562|mark.goldberg@amedd.mil|
20210963|NCT02007369|School of Public Health, The University of Hong Kong|Dr. Cheung, Yee Tak Derek|+852 39176652|derekcheung@hku.hk|
20210964|NCT01858558|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Philip Imus, MD|410-955-8873|pimus1@jhmi.edu|
20210965|NCT01784419|University of California, San Francisco|Dennis W. Nielson, MD, PhD||Dennis.Nielson@ucsf.edu|
20210966|NCT00306852|University of Miami|Dr. Steven Gedde|305-326-6435|sgedde@med.miami.edu|
20210967|NCT03578276|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|hps@cepmd.com|
20210968|NCT00883740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20210969|NCT01818414|University of Minnesota|Christy Boraas, MD, MPH|612-273-7111|bora0021@umn.edu|
20210970|NCT01286207|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20210971|NCT00981409|GlaxoSmithKline|GSK Response Center|866-435-7343||
20210972|NCT00450177|Weill Cornell Medical College|Philip S. Barie, MD|646-962-2580|pbarie@med.cornell.edu|
20210973|NCT02923115|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20210974|NCT00774202|Weill Cornell Medical College|James B. Bussel, M.D. Professor of Pediatrics|212-746-3474|jbussel@med.cornell.edu|
20210975|NCT03869684|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
20210976|NCT04056299|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20210977|NCT03895307|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
20210978|NCT00720473|McLean Hospital|Dr. Brent Forester|(617) 855-3622|bforester@partners.org|
20210979|NCT01296152|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20210980|NCT04840901|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20210981|NCT01268683|Biogen|Medical Director|866-633-4636|clinicaltrials@biogen.com|
20210982|NCT00857493|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20210983|NCT00103259|Eastern Cooperative Oncology Group (ECOG) Statistical Office|ECOG Statistician|617-632-3012||
20210984|NCT01572428|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
20210985|NCT03224234|Emory University|Dr. Umpierrez|404-251-8957|geumpie@emory.edu|
20210986|NCT02610842|Unicamp - University of Campinas|Dr. Eduardo de Paiva Magalhaes|+55 (19) 35217113|dreduardomagalhaes@gmail.com|
20210987|NCT01988493|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20210988|NCT02494583|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20210989|NCT00639158|Abbott|Global Medical Services|800-633-9110||
20210990|NCT02192541|National Cancer Institute|Alice P. Chen, M.D.|(240) 781-3320|chenali@mail.nih.gov|
20210991|NCT02756078|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan - PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
20210992|NCT02268045|mAbxience|Susana Millan|+34917711500|Susana.Millan@mabxience.com|9284
20210993|NCT01158976|University of Chicago|Kathry Keenan|773-702-4449|kekeenan@uchicago.edu|
20210994|NCT03332212|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20210995|NCT00609115|AMES Technology, Inc.|Dr. Paul Cordo|503 970 6129|pcordo@amesdevices.com|
20210996|NCT02125734|Novartis Pharmaceuticals|Study Director|862-778-8300||
20210997|NCT01308762|Immodulon Therapeutics, The London Clinic Cancer Centre, London W1G 6JA,|Clinical Trials Co-ordinator|+44 (0)203 219 3568/3572|Ilda@immodulon.com|
20210998|NCT02617446|Windtree Therapeutics, Inc.|Phillip D. Simmons, Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
20210999|NCT03030638|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211000|NCT01556490|Boston Scientific|Clinical Research Manager|16138011844|chantal.laframboise@bsci.com|
20211001|NCT02058368|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211002|NCT01652872|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20211003|NCT03690375|Siperstein Dermatology Group|founder/physician|5613647774|info@sipderm.com|
20211004|NCT03985293|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211005|NCT03107715|University Hospitals Rainbow Babies and Children's Hospital|Lydia Furman MD, PI|216-844=8260|lydia.furman@uhhospitals.org|
20211006|NCT01907516|John A Burns School of Medicine / University of Hawaii Dept of Obstetrics and Gynecology|Marguerite Lisa Bartholomew MD|808-983-6761|mbarthol@hawaii.edu|
20211007|NCT02181127|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
20211008|NCT00350337|United States Army Medical Materiel Development Activity|Division of Regulated Activities and Compliance Director|301-619-0317|USAMRMCREGULATORYAFFAIRS@amedd.army.mil|
20211009|NCT01901146|Amgen Inc.|Study Director|866-572-6436||
20211010|NCT00297492|University of Vermont|Dr. John Hughes|802-656-9610|John.Hughes@uvm.edu|
20211011|NCT03724968|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
20211012|NCT02316678|University of Pennsylvania|James Lewis|215-573-5137|lewisjd@upenn.edu|
20211013|NCT00569231|University of Arkansas for Medical Sciences|Mayumi Nakagawa, MD, PhD|(501) 686-8635|mnakagawa@uams.edu|
20211014|NCT01614925|Straumann|Michel Mallaun||michel.mallaun@straumann.com|
20211015|NCT04313023|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
20211016|NCT00786019|University of Colorado|Judith Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
20211017|NCT02437890|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
20211018|NCT01190098|Cleveland Clinic|Nancy Foldvary-Schaefer, DO, MS|216-445-2990|foldvan@ccf.org|
20211019|NCT00344305|MedImmune, LLC|Raburn Mallory MD/ Sr Dir Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
20211020|NCT01999231|Shanghai Public Health Clinical Center|Shuihua Lu|(+86)18930811818|tubercle@gmail.com|
20211021|NCT00545181|Indiana University School of Medicine|David Haas, MD MS|3176307837|dahaas@iupui.edu|
20211022|NCT03870737|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20211023|NCT00390949|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
20186581|NCT01420237|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|Kevin.Barga@stryker.com|
20211024|NCT02556931|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Amy Dezern|410-502-7208|adezern1@jhmi.edu|
20211025|NCT03361917|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
20211026|NCT01227954|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20211027|NCT01307631|Dana-Farber Cancer Institute|Jennifer Curtis, MS|617-582-7183|jennifer_curtis@dfci.harvard.edu|
20211028|NCT01093482|VENTILA group|Andres Esteban|34916834982|aesteban@ucigetafe.com|
20211029|NCT02846740|University of Maryland Baltimore|Nithin krishna|4103286661|nkrishna@som.umaryland.edu|
20211030|NCT00078312|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20211031|NCT02039817|Conatus Pharmaceuticals|Jean L. Chan, MD|858 376 2632|jchan@conatuspharma.com|
20211032|NCT01117090|Medtronic Restorative Therapies Group - Targeted Drug Delivery|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
20211033|NCT01875991|Amgen Inc.|Study Director|866-572-6436||
20211034|NCT02216214|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20211035|NCT05354206|Washington University in St. Louis|Dr. Ismael Seáñez|3149357665|ismaelseanez@wustl.edu|
20211036|NCT01414062|Columbia University Irving Medical Center|Dawn Hershman, MD, MS|212-342-4580|dlh23@cumc.columbia.edu|
20211037|NCT04285983|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20211038|NCT04936334|Indiana University, Department of Urology|Jennifer Lehman, RN, Senior Research Leader|317-948-9575|jgeck@iu.edu|
20211039|NCT03583931|Denver Health and Hospital Authority|Dr Fredric Pieracci|303-602-1863|Fredric.Pieracci@dhha.org|
20211040|NCT00902265|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20211041|NCT00663039|MPRC|Elliot Hong|410-402-6828|ehong@mprc.umaryland.edu|
20211042|NCT02866695|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
20211043|NCT05016765|Washington University School of Medicine|Kevin J. Black, M.D.|1-314-362-5041|kevin@wustl.edu|
20211044|NCT03747939|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20211045|NCT00535301|SCPMG/Kaiser Permanente|John N. Nguyen, MD|562-657-2642|john.n.nguyen@kp.org|
20211046|NCT01447628|Imperial College London|Professor Martin Wilkins|0203 313 8078|jacob.bonner@nhs.net|38078
20211047|NCT00185731|Stanford University School of Medicine|Alice Fan, MD|650-725-6454|afan@stanford.edu|
20211048|NCT03087773|Medical University of Graz|Univ.-Prof. PD Harald Sourij, MD, MBA|+43 316 385 81310|ha.sourij@medunigraz.at|
20211049|NCT00396981|University of California, UCSF Medical Center|S. Claiboren Johnston, MD, PhD|415-502-7487|Clay.Johnston@ucsfmedctr.org|
20211050|NCT05144477|Columbia University Irving Medical Center|Dr. Talea Cornelius|(212) 342-5503|tmc2184@cumc.columbia.edu|
20211051|NCT02703779|University of Kansas Cancer Center|Dr. Sid Ganguly|913-588-6030|sganguly@kumc.edu|
20211052|NCT00627458|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211053|NCT03891875|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20211054|NCT02181842|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20211055|NCT04529096|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20211056|NCT00758706|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20211057|NCT03474640|TopAlliance BioSciences|Dr. Kevin Li|301-640-5166|kevin_li@topalliancebio.com|
20211058|NCT03454672|Novoxel Ltd|Ifat Klein|+972-52-6009860|ifat@novoxel.com|
20211059|NCT04166851|Rutgers School of Public Health|Cui Yang|1-732-235-9754|cui.yang@rutgers.edu|
20211060|NCT00367601|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20211061|NCT01488071|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20211062|NCT02139306|PTC Therapeutics, Inc|Joseph McIntosh|908 912-9138|jmcintosh@ptcbio.com|
20211063|NCT04449354|HidraMed Solutions Ltd|Suzanne Moloney|+353873220509|suzanne@hidramedsolutions.com|
20211064|NCT05899218|University of Pennsylvania|Dr. Jennifer Tran|2158983616|jtgtran@nursing.upenn.edu|
20211065|NCT02587325|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
20211066|NCT00390572|VA HSRD|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
20211067|NCT04236635|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20228613|NCT05064488|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20228614|NCT05918055|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20228615|NCT04986566|City of Hope Medical Center|Dr, Laleh Melstrom|626-359-8111|lmelstrom@coh.org|
20228616|NCT06583096|University of Michigan|Adam Horwitz|(734) 764-0231|ahor@med.umich.edu|
20186582|NCT04492722|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20186583|NCT02876588|Columbia University|Dr. Jason Adelman|646-317-4803|adelman.jason@columbia.edu|
20186584|NCT04873401|New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
20186585|NCT01333969|Hospital for Special Surgery|Dr. Stavros Memtsoudis|646-797-8522|MemtsoudisS@hss.edu|8522
20186586|NCT04029688|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20211068|NCT02913261|Novartis Pharmaceuticals|Study Directr|862-778-8300|novartis.email@novartis.com|
20163087|NCT01922271|Novartis Pharmaceuticals|Study Director|862-778-8300||
20211069|NCT02304302|Case Western Reserve University|Melissa Stasko, JD, MA|216-844-7281|Melissa.Stasko@case.edu|
20211070|NCT00391118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20211071|NCT01892020|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20192976|NCT03513068|ResMed|Maureen Crocker, Sr. Manager Market Access|+65 9815 2195|maureen.crocker@resmed.com|
20192977|NCT00745498|Seoul National University Bundang Hospital Department of Ophthalmology|Dr. Se Joon Woo|+82-31-787-7377|sejoon1@hanmail.net|
20192978|NCT03174782|University of California, San Francisco- Fresno|Kamell Eckroth-Bernard|559-431-6226|kamell.eckroth-bernard@ucsf.edu|
20192979|NCT00778921|Novartis Pharmaceuticals|Study Director|862-778-8300||
20211072|NCT02251431|Baylor Scott & White Research Institute|Biostatistician|8033190755|gelareh.rahimighazikalayeh@bswhealth.org|
20211073|NCT01445873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211074|NCT02493088|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Jérôme SAINT-MARTIN, study director|+33 5 46 45 66 03|jerome.saint-martin@ch-larochelle.fr|
20211075|NCT03078192|Duke University Medical Center|Bastiaan Driehuys|919-684-7786|bastiaan.driehuys@duke.edu|
20211076|NCT00094900|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Raphaela Goldbach-Mansky, MD|13014356243|goldbacr@mail.nih.gov|
20211077|NCT03739684|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
20211078|NCT03252756|NYU Langone Health|Michael Bogenschutz, PhD|646-501-4026|Michael.Bogenschutz@nyulangone.org|
20211079|NCT03594175|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20211080|NCT01915498|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20211081|NCT01336608|GlaxoSmithKline|GSK Response Center|866-435-7343||
20228617|NCT02562235|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20228618|NCT03945773|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20228619|NCT04090528|University of Wisconsin - Madison|Douglas G. McNeel, MD PhD|(608) 263-4198|dm3@medicine.wisc.edu|
20228620|NCT03595124|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
20228621|NCT04075903|University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology|Lesley Jackson, MD, MSPH|205-934-1779|lejackson@uabmc.edu|
20228622|NCT04771754|Chelsea and Westminster Hospital NHS Foundation Trust|Dr Ruth Byrne|02033152560|ruthbyrne@nhs.net|
20228623|NCT05610605|University of Cadiz|Cristina Casals|956016216|cristina.casals@uca.es|
20228624|NCT03607422|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20228625|NCT00042289|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20228626|NCT04588259|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20228627|NCT03973996|Ohio State University|Dr. Richard Bruno|8603358494|bruno.27@osu.edu|
20228628|NCT04916002|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20228629|NCT04832971|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
20228630|NCT04460885|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20228631|NCT02688803|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
20228632|NCT04082429|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20228633|NCT01920932|St. Jude Children's Research Hospital|Matt Ehrhardt, MD|(901) 595-5913|matt.ehrhardt@stjude.org|
20228634|NCT04953338|Pfizer Ltd|John Nesnas|01304 616161|john.nesnas@pfizer.com|
20228635|NCT05923112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228636|NCT04452045|University of California, San Francisco|Lauren Asarnow|(415) 353-2273|lauren.asarnow@ucsf.edu|
20228637|NCT03584152|Stanford University|Sam P. Most, MD, MBA|(650) 724-8019|smost@stanford.edu|
20228638|NCT04024462|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20228639|NCT02443077|University of California|Dr. Charalambos Andreadis|415-353-8363|candreadis@medicine.ucsf.edu|
20228640|NCT03055013|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20228641|NCT03118050|University of Texas Medical Branch|Elena Volpi, MD, PhD|210-562-6139|volpi@uthscsa.edu|
20228642|NCT04991766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228643|NCT05781750|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
20228644|NCT03466346|University of California San Francisco|Susan Meffert MD, MPH; Professor of Psychiatry; MPI|4158765455|susan.meffert@ucsf.edu|
20228645|NCT05621252|Pliant Therapeutics|Pliant Therapeutics Medical Monitor|650-481-6770|clintrials@pliantrx.com|
20228646|NCT02567422|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20228647|NCT01351805|Brigham and Women's Hospital/ Harvard Medical School|Karen Costenbader|16177326088|kcostenbader@bwh.harvard.edu|
20228648|NCT00433511|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20228649|NCT05274750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20228650|NCT03809000|American College of Radiology|Wendy Seiferheld|2155743208|wseiferheld@acr.org|
20228651|NCT05282823|Boston Scientific|Clinical Trial Manager|+6564188833|jamie.kwek@bsci.com|
20228652|NCT05569174|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
20228653|NCT05352815|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20228654|NCT05499130|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20228655|NCT06193967|University of Tennessee, Knoxville|Dr. Hollie Raynor|865-974-9126|hraynor@utk.edu|1
20228656|NCT04328623|Centre Hospitalier Départemental Vendée|Adeline TROJET-BOSSARD|251446572|adeline.trojet-bossard@ght85.fr|+33
20228657|NCT04456920|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20228658|NCT02312557|Oregon Health & Science University|Rachel Slottke|503-494-6117|slottker@ohsu.edu|
20228659|NCT03895086|Maison de la Recherche en Santé|Mr Thomas RULLEAU|6 35 55 03 35|thomas.rulleau@chu-nantes.fr|+33
20211082|NCT00821041|University of Manitoba|Study Coordinator|204-787-5098|NVincent@exchange.hsc.mb.ca|
20211083|NCT04723173|Sonova AG|Bernhard Buschle|+41 58 928 44 21|bernhard.buschle@sonova.com|
20211084|NCT02996448|NIAID, NIH|Alexandra Freeman|301-594-9045|freemaal@mail.nih.gov|
20211085|NCT01284244|Mount Sinai Hospital|Dr. Danny Lovatsis|416-586-4566|danny.lovatsis@sinaihealthsystem.ca|
20211086|NCT00303316|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20211087|NCT01375569|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@mail.nih.gov|
20228660|NCT04464421|University of Tennessee Health Science Center|Karen Derefinko, PhD|9014482526|kderefin@uthsc.edu|
20228661|NCT05687032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228662|NCT05452239|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20228663|NCT06290180|Cambridge Health Alliance|Heather Gray|(617) 575-5612|hgray@cha.harvard.edu|
20228664|NCT02134717|University of Pittsburgh|Kevin Gibson MD|412-624-7095|gibsonkf@upmc.edu|
20228665|NCT06129149|The Ohio State University|Christine Kimpel|614-247-1195|kimpel.28@osu.edu|
20228666|NCT04982588|Medtronic, Inc.|Fairy Liu|+86-02120325765|rs.evolutprochinaclinicalstudy@medtronic.com|
20228667|NCT03745794|UT MD Anderson Cancer Center|Dr. Ching-Wei D. Tzeng, MD/Associate Professor, Surgical Oncology|(713) 792-0386|cdtzeng@mdanderson.org|
20228668|NCT04649359|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228669|NCT03912662|Medtronic|Marion Blanc|+33 4 74 08 90 00|marion.blanc@medtronic.com|
20228670|NCT02309346|Hospital de Clínicas de Porto Alegre|Ricardo Francalacci Savaris|+55 51 33596042|rsavaris@hcpa.edu.br|
20228671|NCT04656652|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
20228672|NCT01449149|Department of Radiation Oncology, PENN MEDICINE|Michelle Alonso-Basanta, MD PhD|215 615 3782|michelleab@uphs.upenn.edu|
20228673|NCT06533527|Cleveland Clinic Florida (Weston Hospital)|Dr. Tilak Shah|954-659-5646|shaht3@ccf.org|
20228674|NCT02224469|University Medical Center Utrecht|Dr E.J. Aarnoutse|+31887555123|e.j.aarnoutse@umcutrecht.nl|
20228675|NCT06831786|prince of songkla university|Sarunyou Chusri|+66897340446|sarunyouchusri@hotmail.com|
20228676|NCT01385176|Institut Lorrain du Coeur et des Vaisseaux, CHU de Nancy, France|Principal Investigator of the Study, Prof. Faiez Zannad|+33 3 83 15 73 22|f.zannad@chu-nancy.fr|
20228677|NCT05911841|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20228678|NCT03880019|Columbia University Medical Center|Matthew Ingham, MD|646-317-7141|mi2337@cumc.columbia.edu|
20228679|NCT04889118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20228680|NCT03934099|LG Chem|Younghwan Jang|02-6987-4154|younghj@lgchem.com|
20228681|NCT05595369|Duke University|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
20228682|NCT05628285|Oticon Medical AB|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
20228683|NCT02339506|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
20228684|NCT00534469|City of Hope Medical Center|Dr. Anthony Stein|626-5375748|AStein@coh.org|
20228685|NCT05147350|Repare Therapeutics INC|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
20228686|NCT02869867|Centre Hospitalier Départemental Vendée|Dr Yves-Marie PLUCHON|251446248|yves-marie.pluchon@chd-vendee.fr|+33
20228687|NCT05218499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20228688|NCT03431584|Centre Hospitalier Departemental Vendée|Dr. Grégoire CORMIER|251446197|gregoire.cormier@ght85.fr|+33
20228689|NCT06476834|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20228690|NCT04530552|University of Arizona|Betsy Wertheim|5207771666|betsy@arizona.edu|
20228691|NCT06576674|University of North Carolina at Chapel Hill|Michael Bremmer, PhD|301-827-0566|mbremmer@unc.edu|
20228692|NCT05555615|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
20228693|NCT06136897|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20228694|NCT03377361|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20228695|NCT02025855|Frederick Health|Thomas Smoot|2405663250|tlsmoot@frederick.health|
20228696|NCT06469372|Columbia University Irving Medical Center|Timothy J. Poterucha, MD|(212) 932-4537|tp2558@cumc.columbia.edu|
20228697|NCT01225055|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20228698|NCT04287816|Ohio State University|Dr. Richard Bruno|6142925522|bruno.27@osu.edu|
20228699|NCT06733103|University of East Anglia|Sophie Livsey|07947272186|sophie.livsey1@nhs.net|
20228700|NCT03698994|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20228701|NCT02437071|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
20228702|NCT05082025|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
20228703|NCT04620369|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
20228704|NCT03802617|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
20228705|NCT02326064|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|0251446161|guillaume.ducarme@ght85.fr|
20228706|NCT04788511|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20228707|NCT04458922|National Cancer Institute|Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
20228708|NCT03025035|Cedars-Sinai Medical Center|Yuan Yuan, MD, PhD|3108888680|yuan.yuan@cshs.org|
20228709|NCT02921256|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5261|langerj@nrgoncology.org|
20192980|NCT01791413|Mahidol University|Dr. Weena Krutsawad|66812070264|vna_fe2@hotmail.com|
20211088|NCT01557452|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
20211089|NCT01543607|Mass. General Hospital|William R. Brugge|617-724-0578|wbrugge@partners.org|
20211090|NCT01160198|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211091|NCT01318733|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20211092|NCT01796860|University of Texas Southwestern Medical Center|Karen J McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
20211093|NCT02016755|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
20211094|NCT02533505|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20211095|NCT01289431|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20211096|NCT00563524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211097|NCT01230502|University of Wisconsin|Professor William Burlingham, PhD|(608) 263-0119|BURLINGHAM@SURGERY.WISC.EDU|
20228710|NCT05892341|ConvaTec Inc.|Cristin Taylor, Senior Director, Medical Affairs, Advanced Wound Care|1-800-422-8811|cristin.taylor@convatec.com|
20228711|NCT02282917|Mass General Brigham|Matthew E Stenerson, MSc, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
20228712|NCT04848480|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20228713|NCT02615938|LMU/ Haunersches Kinderspital|Prof. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
20228714|NCT04373031|Providence Portland Medical Center|Dr. David Page|503-215-1979|canrsrchstudies@providence.org|
20186587|NCT04130438|Stanford University|Jennifer A. Tremmel, MD, MS|(650) 723-0180|nocad_study@stanford.edu|
20228715|NCT06173687|Cochlear Limited|PRS Specialist|+612 9428 6555|cltd-prs-admin@cochlear.com|
20228716|NCT04590404|Vanderbilt University Medical Center|Dr. Hilary Tindle|(615) 875-9726|hilary.tindle@vumc.org|
20228717|NCT05597865|Washington University in St. Louis|Rachel Brathwaite|3147282869|rachel.brathwaite@yahoo.com|
20228718|NCT05063448|Colorado State University|Dr. Stephanie Rayburn|970-988-6306|Stephanie.Rayburn@colostate.edu|
20228719|NCT05903183|Icosavax Inc.|Icosavax Clinical Operations|206-737-0085|clinops@icosavax.com|
20228720|NCT05469438|University Hospitals Cleveland Medical Center (Case Western Reserve University)|Kylie Phillips (Clinical Research Regulatory Specialist III)|(440)328-7964|kylie.phillips@uhhospitals.org|
20228721|NCT03698019|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
20228722|NCT00569127|SWOG|SWOG Statistician|206-667-4408||
20228723|NCT04428151|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20228724|NCT04777331|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20228725|NCT02642042|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
20228726|NCT05147272|Repare Therapeutics|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
20228727|NCT03375320|Dana-Farber Cancer Institute|Jennifer A. Chan, MD, MPH|617-632-6315|jang@partners.org|
20228728|NCT04108468|Leeds Teaching Hospital Trust|Professor Helena Marzo-Ortega|+44 (0) 113 392 4848|H.Marzo-Ortega@leeds.ac.uk|
20228729|NCT03348631|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20228730|NCT03260023|Transgene|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
20228731|NCT03388632|National Cancer Institute|Dr. Jiran Ahmed|240-781-4042|jibran.ahmed@nih.gov|
20228732|NCT05035407|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scoot.norberg@nih.gov|
20186588|NCT03499821|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|
20228733|NCT04220021|University of Florida|Laura P.W. Ranum, PhD|(352) 294-5209|ranum@ufl.edu|
20228734|NCT03149029|Massachusetts General Hospital Cancer Center|Ryan J. Sullivan, MD|617-643-3614|RSULLIVAN7@mgh.harvard.edu|
20228735|NCT03892746|Cleveland Clinic|Ela Plow, Associate Professor|216-445-4589|plowe2@ccf.org|
20228736|NCT03172975|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
20228737|NCT02783690|Mayo Clinic|Robert Mutter, M.D.|507-284-2511|mutter.robert@mayo.edu|
20228738|NCT02421939|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20228739|NCT05238103|Johns Hopkins University|Lena Mathews, MD MHS|410-502-0469|lmathew6@jhmi.edu|
20228740|NCT04556305|University of Illinois Chicago|Dr. Shannon Halloway|(312) 996-7800|sthallow@uic.edu|
20228741|NCT05739994|Indiana University Bloomington|Dr. Hannah Block|8128555390|hjblock@iu.edu|
20186589|NCT02143726|Memorial Sloan-Kettering Cancer Center|Eric J. Sherman, M.D.|646-888-4234|shermane@mskcc.org|
20186590|NCT04764448|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20186591|NCT03812679|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20186592|NCT03953508|University of Oklahoma Health Sciences Center|Amy Cohn, PhD|4052711903|amy-cohn@ouhsc.edu|
20186593|NCT04574024|Rutgers, The State University of New Jersey|Suhayl Dhib-Jalbut|732-235-7335|jalbutsu@rwjms.rutgers.edu|
20186594|NCT02702102|Columbia University|William Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
20186595|NCT05119023|MGH-Institute of Health Professions|Sofia Vallila Rohter, Project Principle Investigator|617-724-3824|svallilarohter@mghihp.edu|
20186596|NCT03153410|SKCCC Johns Hopkins Medical Institution|Ana De Jesus-Acosta, MD|443-287-0411|adejesu1@jhmi.edu|
20186597|NCT03408340|Emory University|Justin B. Long, MD, Associate Professor|404-785-6670|justin.bradley.long@emory.edu|
20211098|NCT00323635|Brigham and Women's Hospital|Quentin Regestein|617-732-4497|qregestein@partners.org|
20228742|NCT05816070|IVIEW Therapeutics Inc.|Bo Liang, PhD|609 773 8580|info@iviewinc.com|
20228743|NCT04004000|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20211099|NCT03543046|Orlando Health|Corporate Director of Compliance and Regulations|3218413687|Tara.Roberts@orlandohealth.com|
20211100|NCT03061279|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
20211101|NCT02320838|Universidad de Castilla-La Mancha|Dr. Juan Avendaño Coy|+34 925268800|juan.avendano@uclm.es|5014
20211102|NCT03964220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211103|NCT00520494|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20211104|NCT04247594|Global Blood Therapeutics, Inc.|Eleanor Lisbon|+1 913 449 4319|elisbon@gbt.com|
20211105|NCT02748616|NYU Langone Health|Norman Javitt, MD|212-263-6588|Norman.Javitt@nyulangone.org|
20211106|NCT00713830|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20211107|NCT00422058|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20211108|NCT02209272|Mayo Clinic|Dr. Jacob L. Sellon|507-284-2608|sellon.jacob@mayo.edu|
20211109|NCT02787785|Boston Scientific|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
20211110|NCT02030834|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20211111|NCT03111407|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
20228744|NCT06121609|Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Scien|aijun xu|+8618627784217|ajxu@tjh.tjmu.edu.cn|
20211112|NCT03778190|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
20228745|NCT03299959|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
20211113|NCT00854607|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20228746|NCT06494761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20228747|NCT03735121|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20228748|NCT05190770|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
20228749|NCT05432232|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
20228750|NCT04865289|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20228751|NCT03836066|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
20228752|NCT04770779|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
20228753|NCT02176863|Instituto Grifols, S.A.|Sandra Camprubi, PhD/Senior Director, Clinical Operations|+34 67 0923160|sandra.camprubi@grifols.com|
20228754|NCT02799602|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20228755|NCT03692052|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
20228756|NCT06077773|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20228757|NCT03342196|University Hospitals, Case Comprehensive Cancer Center|Principle Investigator|216-844-0139|Leland.Metheny@uhhospitals.org|
20228758|NCT06006208|Thomas Jefferson University|Associate Professor|3059784358|moritayoshihisa2016@gmail.com|
20228759|NCT02473042|The University of Texas MD Anderson Cancer Center|Alicia Kowalski, MD|(713) 563-5614|amkowalsk@mdanderson.org|
20228760|NCT05430204|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
20228761|NCT03007732|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|David.Oh@ucsf.edu|
20228762|NCT04345913|Washington University in St. Louis School of Medicine|Nusayba Bagegni|3142733022|nbagegni@wustl.edu|
20228763|NCT03725605|Lytix Biopharma AS|Director Scientific Research Baldur Sweinbjornsson|+47 413 44 682|Baldur.Sveinbjornsson@lytixbiopharma.com|
20228764|NCT04596540|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
20228765|NCT03668223|Dana Farber Cancer Institute|Dr. Abby Rosenberg|617-632-5286|abbyr_rosenberg@dfci.harvard.edu|
20228766|NCT01503086|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
20228767|NCT05723263|University of North Carolina at Chapel Hill|Joseph Tucker, MD, PhD|919-966-2536|jdtucker@med.unc.edu|
20228768|NCT03210714|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20228769|NCT02950259|Earle A. Chiles Research Institute, Providence Cancer Institute|Dr. David B. Page|503-215-6588|david.page2@providence.org|
20228770|NCT02867592|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20228771|NCT00803179|UMass Medical School|Michael Stalvey, MD, Principal Investigator|508-856-4280|mstalvey@peds.uab.edu|
20228772|NCT03358472|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20228773|NCT05881733|Erasmus MC|Dr. Sing-Chien Yap|+31650031551|s.c.yap@erasmusmc.nl|
20228774|NCT03974022|Dizal Pharmaceuticals|Li Zheng|862161097899|clinicaltrials@dizalpharma.com|
20228775|NCT05516758|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20228776|NCT04158648|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20228777|NCT05502783|National Heart, Lung, and Blood Institute (NHLBI) at National Institutes of Health (NIH)|Dr. Georg Aue|301.547.9490|aueg@nhlbi.nih.gov|
20228778|NCT06017050|Center for Innovative Public Health Research|Michele Ybarra|8773026858|michele@innovativepublichealth.org|801
20228779|NCT02251821|Fred Hutchinson Cancer Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
20228780|NCT04589650|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20228781|NCT03811002|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20228782|NCT03818854|University of California San Francisco|Dr. Michael Matthay|415-476-1079|michael.matthay@ucsf.edu|
20228783|NCT04870957|University of Michigan|Afton Hassett, PsyD|734-763-5226|afton@med.umich.edu|
20186598|NCT04489771|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20192981|NCT03178045|Memorial Sloan Kettering Cancer Center|Robert Allen Jr., MD|646-608-8041|allenr1@mskcc.org|
20192982|NCT00521976|Stavanger University Hospital|Dennis W.T. Nilsen MD PhD FESC FAHA|+4705151|nide@sus.no|9455
20192983|NCT03636373|Rutgers, The State University of New Jersey|Naomi Schlesinger, MD|732 235 6117|Naomi.Schlesinger@hsc.utah.edu|
20211114|NCT02009982|Emory University|Dr. David De Lurgio|404-251-1481|ddelurg@emory.edu|
20211115|NCT00597727|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20211116|NCT00965263|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|6467746153|meg.haney@nyspi.columbia.edu|
20211117|NCT01766310|Queen Sirikit National Institute of Child Health|Dr. Orawan Iamopas|66-2-354-8415|orawaneamopas@yahoo.com|3327
20211118|NCT03151707|McLean Hospital|Dost Ongur|6178553922|dongur@partners.org|
20211119|NCT00514501|Progenics Pharmaceuticals, Inc.|Senior Director of Clinical Communications|914 784-1825|vdipippo@progenics.com|
20211120|NCT00646282|Emory University|Dr. Antonio Guasch|404-727-2522|aguasch@emory.edu|
20211121|NCT00530088|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20211122|NCT00902278|University of Massachusetts Medical School|Mary Co|5088562927|mary.co@umassmed.edu|
20211123|NCT02328404|Hayat Pharmaceutical industries|DR. ALA' ABU RUQA'A|00962 6 4162607|tbd@hayatpharma.com|225
20211124|NCT00397904|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
20211125|NCT02618772|MUHC|Dr. Jennifer Turnbull|514-412-4400|jennifer.turnbull@mcgill.ca|23039
20211126|NCT04348292|Emory University|Jennifer Carlisle, MD|404-778-2304|jennifer.w.carlisle@emory.edu|
20211127|NCT01236053|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211128|NCT00919932|University of Pittsburgh|Dr Han Liang|412-624-4141|liangh2@upmc.edu|
20211129|NCT02719639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211130|NCT02873195|Duke University Medical Center|Niharika Bansal Mettu, M.D.|919-681-2954|niharika.mettu@duke.edu|
20211131|NCT02508649|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20211132|NCT02360124|University of Hong Kong|Prof. E.C.M. Lo|852-2859 0292|edward-lo@hku.hk|
20211133|NCT02149199|AstraZeneca AB|Stefan Ivanov|000000000000|information.center@astrazeneca.com|
20211134|NCT01806259|UoA|Prof Patrice Forget|497 12 28 36|forgetpatrice@yahoo.fr|
20211135|NCT01500434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20211136|NCT00633217|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211137|NCT04881448|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211138|NCT01966107|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20211139|NCT02175472|PhotoPharmics, Inc.|Dan Adams|801-770-6960|dan.adams@photopharmics.com|
20211140|NCT00689273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211141|NCT02953873|Medical University of South Carolina|Caitlin Schaffner|843-792-7558|schaffne@musc.edu|
20211142|NCT05406596|Seigla Medical|John Schultz|7632133026|jschultz223@gmail.com|
20211143|NCT00700310|Eisai Call Center|Eisai Inc.|888-422-4743||
20211144|NCT01422720|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
20211145|NCT00606801|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20211146|NCT02082262|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20211147|NCT01143272|Johns Hopkins Bloomberg School of Public Health|Stephan Ehrhardt|410-502-3872|sehrhard@jhsph.edu|
20211148|NCT01726335|Janssen-Cilag Ltd.|Medical Group Manager|+55 11 30302738||
20211149|NCT01614613|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
20211150|NCT01074307|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20211151|NCT02625207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211152|NCT01528878|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20186599|NCT04711447|University of Manitoba|Dr. Trisha Scribbans|(204) 272-1699|trisha.scribbans@umanitoba.ca|
20211153|NCT02162511|Stanford University|Erica Goodwin|253-508-3556|egood55@stanford.edu|
20211154|NCT00448682|University of Miami Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-6608|bardalan@med.miami.edu|
20211155|NCT03565666|Mass. General Hospital|Dr. Steven J. Russell|617-726-8722|sjrussell@mgh.harvard.edu|
20186600|NCT04509674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186601|NCT00817219|LEO Pharma A/S|Malin Järnkrants|+45 7226 2990|malin.jaernkrants@leo-pharma.com|
20186602|NCT03800108|Cleveland Clinic|Dr. Darlene Floden|216-444-1298|flodend@ccf.org|
20186603|NCT03443388|University of Pennsylvania|Michael Gelfand, MD, PhD|215 662 3606|epilepsytrials@pennmedicine.upenn.edu|
20186604|NCT05916664|RSV Opco 5, Inc. (dba Kinto)|Joseph T Chung|(857) 600-2273|joe@kinto.care|
20192984|NCT00133575|Brigham and Women's Hospital|Lindsey R. Baden, M.D.|617-732-6801|LBaden@partners.org|
20163088|NCT02123823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20192985|NCT01280604|Mercer University/ Kaiser Permanente|Kendra Manigault, PharmD, BCPS, BCACP, CDE|678-547-6216|manigault_kr@mercer.edu|
20211156|NCT02703454|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
20211157|NCT02284373|New York University Langone Medical Center|Todd Berland, MD|212 263 5060|todd.berland@nyumc.org|
20211158|NCT02413879|Prescient Surgical|Director of Clinical|6504895025|lclaude@prescientsurgical.com|
20211159|NCT03067506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20211160|NCT02499406|VACHS|Investigator|203 932 5711|suzanne.decker@va.gov|
20186605|NCT05682937|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
20186606|NCT04064164|University of Kansas School of Nursing|Kristine Williams|7859797879|kwilliams1@kumc.edu|
20186607|NCT05373862|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186608|NCT04059484|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20186609|NCT04292223|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20186610|NCT06190691|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20211161|NCT01485588|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
20211162|NCT00552617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211163|NCT04651218|University of Kentucky|Dr. Kyle Flack|5182574351|kyle.flack@uky.edu|
20211164|NCT03940326|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
20211165|NCT01399125|Novartis Pharmaceuticals|Study Director|8627788300||
20211166|NCT03005379|VA Cooperative Studies Program|Yuan Huang, Ph.D., Biostatistician|2039325711|yuanhuang1@va.gov|
20211167|NCT02869295|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
20211168|NCT02580318|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
20211169|NCT00948025|AxoGen, Inc|Vice President, Clinical and Translational Sciences|3864626829|edevinney@axogeninc.com|
20211170|NCT00939705|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
20211171|NCT00716586|University of Illinois at Chicago|Emeritus Professor of Ophthalmology|312 997-3646|gerafish@uic.edu|
20211172|NCT05149989|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|+44(0)1517064553|tristan.payne@liverpoolft.nhs.uk|
20211173|NCT01591499|CooperVision|Caroline Bonneville and Sandrine Cheneau, Study Managers|+33609202762|caroline.bonneville@coopervision-fr.com|
20211174|NCT01289990|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdf@boehringer-ingelheim.com|
20211175|NCT00683904|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20211176|NCT01220128|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211177|NCT01115699|Mayo Clinic|Michelle Skime, Supervisor - Senior Clinical Research Coordinator|507-255-0501|skime.michelle@mayo.edu|
20211178|NCT01407107|University of Texas Southwestern Medical Center|Dr. Jonathan Dowell|214-648-7097|jonathan.dowell@utsouthwestern.edu|
20211179|NCT00752895|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20211180|NCT00314262|Emory University School of Medicine|Dong Shin, MD|404-778-2980|dmshin@emory.edu|
20211181|NCT00532779|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20211182|NCT02662556|AcelRx Pharmaceuticals, Inc.|Pamela P. Palmer, MD, PhD, Chief Medical Officer|650-216-3504|ppalmer@acelrx.com|
20211183|NCT00788008|Duke University Medical Center|Deborah Attix, PhD|919-668-2846|deborah.koltai@dm.duke.edu|
20211184|NCT02424799|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211185|NCT00828516|Lynda Jackson Macmillan Centre|Dr Beverley de Valois|+44(0)1923-844456|beverley.devalois@nhs.net|
20211186|NCT01556165|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
20211187|NCT03980561|MUSC|Amanda Wagner|8437920484|wagne@musc.edu|
20211188|NCT02531698|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20228784|NCT05970640|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20228785|NCT03512652|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Erich Hohenauer|+41 81 300 01 75|erich.hohenauer@supsi.ch|
20228786|NCT04935879|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20228787|NCT04340843|Washington University in St. Louis School of Medicine|Dr. Mia Weiss|3147473096|m.c.weiss@wustl.edu|
20186611|NCT05130762|Becton, Dickinson and Company|Stephan Hofmann|+49 160 105 3421|Stephan.Hofmann@bd.com|
20186612|NCT02023866|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
20186613|NCT03839940|Mayo Clinic|Dr. Kathryn J. Ruddy|507-293-1732|ruddy.kathryn@mayo.edu|
20186614|NCT05467345|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
20186615|NCT03524118|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20186616|NCT01437709|Memorial Sloan Kettering Cancer Center|Dr. Paul Hamlin, MD|646-608-1667|hamlinp@mskcc.org|
20186617|NCT01842542|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
20186618|NCT01715285|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186619|NCT05780437|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20186620|NCT03959696|Massachusetts General Hospital|Karen Sepucha|617-724-3350|ksepucha@mgh.harvard.edu|
20186621|NCT03452579|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
20186622|NCT03885518|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20186623|NCT05328362|Dartmouth College|Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
20228788|NCT05032066|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20228789|NCT05564637|Mayo Clinic|Yogesh Reddy, M.B.B.S.|507-284-2904|reddy.yogesh@mayo.edu|
20228790|NCT06178991|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
20211189|NCT02049931|Seoul National University|Professor Jin S. Yeom|82-31-787-7195|highcervical@gmail.com|
20211190|NCT01456494|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
20211191|NCT02395536|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
20228791|NCT04739800|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20192986|NCT00572533|University of Louisville|Adam E Gaweda|502-852-0766|adam.gaweda@louisville.edu|
20192987|NCT01078922|Oncology Specialists, SC|Research Manager|847-410-0658|ktolzien@oncmed.net|
20192988|NCT02353468|University of Colorado|Choon-kee Lee, MD|7208489252||
20192989|NCT00884897|Maryland Psychiatric Research Center|Deanna L. Kelly Pharm.D., BCPP|410-402-96860|dkelly@mprc.umaryland.edu|
20192990|NCT00003477|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20192991|NCT01236352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20192992|NCT01575873|Amgen Inc.|Study Director|866-572-6436||
20192993|NCT02031536|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20192994|NCT01850030|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
20192995|NCT04069585|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
20192996|NCT01031498|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
20192997|NCT03053453|NYU Langone Health|Dr. Arthur Hertling|2125986085|Arthur.Hertling@nyulangone.org|
20192998|NCT00763490|University of Michigan Comprehensive Cancer Center|Dr. Daniel Couriel, M.D.|734-936-8785|dcouriel@umich.edu|
20192999|NCT03845023|Apnimed, Inc|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
20193000|NCT02353871|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20193001|NCT00115336|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
20211192|NCT00701558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20211193|NCT01640964|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20211194|NCT02787746|Department of Neurology, Xuan Wu Hospital of Capital Medical University; Freindship Hospital of Capital Medical University|Jianping Jia|+86 10 83188730|jjp@ccmu.edu.cn|
20211195|NCT04633187|Enanta Pharmaceuticals|Study Director|617-607-0800|enquiries@enanta.com|
20211196|NCT04822701|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211197|NCT02771340|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
20211198|NCT04148508|University of Exeter|Professor Ed Watkins|01392 724692|e.r.watkins@exeter.ac.uk|
20211199|NCT00834288|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20211200|NCT00572468|Portland VA Health Care System|Wesley Stoller|503-220-8262|wesley.stoller@va.gov|54931
20211201|NCT04876482|Department of Physical Therapy, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan|Yi-Ju, Lai|+886963123117|jasmine19900728@gmail.com|
20211202|NCT03877484|Smith and Nephew|Clinical Study Manager|1482673917|rebecca.mcdonald@smith-nephew.com|+44
20211203|NCT01408576|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20228792|NCT05227677|Nagase Diagnostics Co.,Ltd.|Takuji Kohzuma|09080045463|takuji.kohzuma@nagase.co.jp|
20228793|NCT05462821|Jaeb Center for Health Research - Pediatric Eye Disease Investigator Group|Victoria Woodard, Publications Manager|813-975-8690|pedigpublications@jaeb.org|
20228794|NCT04526665|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20228795|NCT06070610|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20228796|NCT05752474|Hebrew Rehabilitation Center, Hebrew SeniorLife|Dae Hyun Kim|6179715362|daehyunkim@hsl.harvard.edu|
20228797|NCT06862154|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
20228798|NCT07000981|Inonu University|Asst. Prof. Gürkan ÖZDEN|+90 505 715 62 65|gurkan.ozden@inonu.edu.tr|
20228799|NCT03459846|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20228800|NCT00001481|National Institute of Mental Health (NIMH)|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
20228801|NCT04880850|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20211204|NCT00802529|Imperial College London|Professor Adolfo Bronstein (Clinical professor and Head of neuro-otology group)|(0)20 3313 5525|a.bronstein@imperial.ac.uk|+44
20193002|NCT03371823|University of Delaware|Dr. Megan Wenner|302-831-7343|mwenner@udel.edu|
20193003|NCT00356811|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193004|NCT02386839|Shire (Note: This product was divested to Oak Hill Bio in 2022)|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20193005|NCT01939301|Indiana University|Jeffrey A. Kline, MD|317-880-3900|jefkline@iu.edu|
20193006|NCT02242643|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193007|NCT02634814|University of North Carolina at Chapel Hill|Brian Pietrosimone, PhD|919-962-3617|brian@unc.edu|
20193008|NCT02101983|University of Rochester|Deborah Mulford|585-275-5823|deborah_mulford@urmc.rochester.edu|
20193009|NCT04243512|University of Maryland Baltimore|Amber Kleckner|410-706-5961|amber.kleckner@umaryland.edu|
20193010|NCT01103232|Vakif Gureba Training and Research Hospital|ILHAN KARACAN|+ 90 212 4531700|ilhankaracan@hotmail.com|
20193011|NCT05093504|CytoSorbents|Weihong Fan|1 732-329-888|wfan@cytosorbents.com|
20193012|NCT02272244|Thomas Jefferson Universiy|Ronald Myers(Priniciple Investigator)|215-5034085|ronald.myers@jefferson.edu|
20193013|NCT00212992|Ottawa Hospital Research Institute|Dr. Ian G. Stiell, Senior Scientist|613-798-5555|istiell@ohri.ca|18683
20193014|NCT05347485|Janssen Scientific Affairs, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20211205|NCT02476851|Haemonetics Corporation|Jan Hartmann, MD|(781) 348 7396|Jan.Hartmann@haemonetics.com|
20211206|NCT00337129|SWOG Statistical Center|Head and Neck Committtee Statistician|(206)-667-4623||
20211207|NCT00647426|Abramson Cancer Center|Tracey Evans MD|215 614 0861|Christine.Bonney@UPHS.upenn.edu|
20211208|NCT00804349|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
20193015|NCT04886518|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and Regulatory Writing|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
20211209|NCT03608696|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
20211210|NCT01467570|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Piescik-Lech|+48-22-45-23-309|hania@ipgate.pl|
20211211|NCT03712137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20211212|NCT02626182|National Jewish Health|Jennifer Taylor-Cousar, MD, MSCS, ATSF|3032702764|Taylor-CousarJ@NJHealth.org|
20211213|NCT02267850|Biolux Research Ltd|Clinical Studies Manager|1-604-669-0674|d.skrenes@bioluxresearch.com|
20211214|NCT01084603|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20211215|NCT02483481|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
20211216|NCT03836729|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
20211217|NCT03379246|TriHealth Inc.|Dr. Catrina Crisp|513-463-4300|Catrina_Crisp@trihealth.com|
20211218|NCT01331083|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
20228802|NCT02911805|Atlanta VA|Jeffrey H. Boatright, PhD|404-321-6111|jeffrey.boatright@va.gov|
20193016|NCT03733899|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
20228803|NCT03987295|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
20228804|NCT02485860|Centre Hospitalier Departemental Vendée|Dr. Emeric ABET|02 51 44 61 48|emeric.abet@ght85.fr|+33
20228805|NCT05706610|Cincinnati Children's Hospital Medical Center|Dr. Meghan McGrady|513-803-8044|meghan.mcgrady@cchmc.org|
20228806|NCT04091451|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20228807|NCT03540771|Albert Einstein Healthcare Network|Manisha Verma, MD, MPH. Director, Research|2154561026|Manisha.Verma@jefferson.edu|
20193017|NCT02035696|Seqirus|Clinical Trial Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20193018|NCT01882413|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20193019|NCT01246999|University of Rochester|John Treanor MD, Professor of Medicine|585-275-5871|John_Treanor@urmc.rochester.edu|
20193020|NCT01867047|Duke University Medical Center|Michael Bolognesi, MD||michael.bolognesi@duke.edu|
20193021|NCT04650698|NYU Langone|Arthur Hertling, MD|212-598-6085|Arthur.Hertling@nyulangone.org|
20193022|NCT02568397|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
20193023|NCT01385748|Onxeo|Berangere Vasseur, MD|+33 (0)1 45 58 76 00|b.vasseur@onxeo.com|
20193024|NCT02354651|University of Florida|Dr. Barbara Smith|3522945315|bksmith@ufl.edu|
20193025|NCT00581893|University of Iowa|Erik St. Louis|507-266-7456|StLouis.Erik@mayo.edu|
20193026|NCT00590564|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng|646-888-0841|dengg@mskcc.org|
20193027|NCT00656201|Brigham and Women's Hospital|Elena Yanushpolsky, MD|617-732-4648|lgreenberg@partners.org|
20193028|NCT01377389|UT MD Anderson Cancer Center|Aparicio,Ana,M.D. / Genitourinary Medical Oncology|713-792-7734|AAPARICIO@MDANDERSON.ORG|
20193029|NCT00159263|Imperial College London|Peter Barnes|+44 (0)20 7594 7959|p.j.barnes@imperial.ac.uk|
20193030|NCT01434680|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20193031|NCT01012245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20193032|NCT00725712|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193033|NCT01515943|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20193034|NCT02684123|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman-Yassky|(212) 241-9728|Emma.Guttman@mountsinai.org|
20193035|NCT05224843|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
20193036|NCT02120001|Massachusetts General Hospital|Robert Kacmarek, Director Respiratory Care|(617) 726-2000|rkacmarek@mgh.harvard.edu|
20193037|NCT03305887|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
20193038|NCT01245140|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193039|NCT02037477|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20193040|NCT02635360|University of Virginia|Dr. Linda R. Duska|434-944-9135|LRD5D@uvahealth.org|
20193041|NCT00983749|Department of Emergency Medicine, University of California San Diego Health System|Kama Guluma, M.D.|619-543-6463|kguluma@ucsd.edu|
20193042|NCT05765435|Cionic|Rebecca Webster|888-481-3724|rebecca@cionic.com|
20193043|NCT01952847|UT MD Anderson Cancer Center|Aung Naing, MD-Professor, Invest. Cancer Therapeutics|(713) 563-3885|anaing@mdanderson.org|
20193044|NCT00535938|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20193045|NCT01585441|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
20193046|NCT03182998|Mayo Clinic|Dr. Jon C. Tilburt, MD, MPH|480-301-3401|tilburt.jon@mayo.edu|
20193047|NCT02367352|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20193048|NCT01437423|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20193049|NCT05878873|Colorado State University|Dr. Brett Fling|(970) 491-3451|brett.fling@colostate.edu|
20193050|NCT02980523|Laboratorios Sophia|Clinical pharmacologist|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20211219|NCT02239601|CancerCare Manitoba|Marshall Pitz|2044751431|Mpitz@cc.umanitoba.ca|
20228808|NCT03907488|SWOG|Hongli Li|206-667-6077|hongli@fredhutch.org|
20211220|NCT01508325|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20211221|NCT01392170|University of Texas (UT) MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Professor, Leukemia|713-745-4009|CR_Study_Registration@mdanderson.org|
20211222|NCT02613416|Stony Brook University|Caterina Vacchi-Suzzi|631-444-8074|caterina.vacchi-suzzi@stonybrookmedicine.edu|
20211223|NCT00566618|UT MD Anderson Cancer Center|Debu Tripathy, Chair, Breast Medical Oncology|(713) 792-2817|dtripathy@mdanderson.org|
20211224|NCT01542684|The University of Texas MD Anderson Cancer Center|Zeev Estrov, MD/Professor|713-794-1675|eharriso@mdanderson.org|
20211225|NCT02535247|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
20211226|NCT01398982|UHN|Kate Butler|416-340-4800|kbutler@uhnresearch.ca|2343
20211227|NCT03174925|Stanford University Medical Center|Aya Kamaya, Professor of Radiology|650-725-1812|kamaya@stanford.edu|
20211228|NCT01791127|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
20211229|NCT00690924|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20211230|NCT02353299|Sleep Disorders and Research Center Henry Ford Hospital|Christopher L Drake|248-344-6672|cdrake1@hfhs.org|
20211231|NCT00589693|Janssen R&D US|Sr Director Clinical Development|1 510 248-2310||
20211232|NCT03231709|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20211233|NCT02609178|Stomatological Hospital of FMMU|Pingting Lin, PhD|+86 15249049902|biu79@hotmail.com|
20211234|NCT01128153|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20228809|NCT02394769|Massachusetts General Hospital|Andrew T. Chan, MD, MPH|(617) 726-3212|achan@partners.org|
20186624|NCT03913702|University of Texas Medical Branch Galveston|Dr. Jeremy Somerson|409-747-5701|jesomers@utmb.edu|
20186625|NCT02573493|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
20186626|NCT03798093|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
20186627|NCT02433613|Medtronic GmbH|Dr. Ralf Meyer|01755810431|ralf.meyer@medtronic.com|
20186628|NCT02677805|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20186629|NCT02291302|Boston Children's Hospital|Wanda Phipatanakul, MD. MS.|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
20186630|NCT04350463|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20186631|NCT04111536|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
20186632|NCT03544281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20186633|NCT02547987|Baylor College of Medicine|Mothaffar Rimawi, M.D.|713-798-1311|rimawi@bcm.edu|
20186634|NCT04282148|Abbott|Ikuko Kishimoto, Principal Research Scientist|480-482-8279|ikuko.kishimoto@abbott.com|
20186635|NCT01414400|Stanford University School of Medicine|Subhas Banerjee|650-723-2623|sbanerje@stanford.edu|
20186636|NCT04938492|University of Rochester|Dr. Lisham Ashrafioun|585-430-2026|lisham_ashrafioun@urmc.rochester.edu|
20186637|NCT01648023|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
20186638|NCT01986712|St. Luke's University Health Network|Neil Belman|484-503-4673|neil.belman@sluhn.org|
20186639|NCT04137289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186640|NCT04307355|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|najafi.bijan@gmail.com|
20186641|NCT04531280|Brigham and Women's Hospital|Dr. David Levine|6177328925|dmlevine@bwh.harvard.edu|
20186642|NCT03374787|Oticon Medical|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
20186643|NCT03752203|Children's Hospital Colorado|Dr. Todd Hankinson|7207776100|todd.hankinson@childrenscolorado.org|
20186644|NCT02547363|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20186645|NCT05028634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20186646|NCT02140554|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20186647|NCT03771417|Louisiana State University|Brian A. Irving, PhD|12255787179|brianairving@lsu.edu|
20186648|NCT02100813|LEO Pharma A/S|Clinical Trial Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20186649|NCT01963793|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20186650|NCT04682587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186651|NCT02884011|Rush University Medical Center|Joshua DeMott|312-947-0226|joshua_demott@rush.edu|
20186652|NCT00506519|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
20186653|NCT02975882|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20186654|NCT02105766|National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)|Matthew Hsieh M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
20186655|NCT02985957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
20186656|NCT04342494|University of Michigan|Amy Bohnert|(734) 936-4280|amybohne@med.umich.edu|
20186657|NCT05456360|The University of Texas MD Anderson Cancer Center|Dr. Vijaya Gottumukkala|(713) 794-1398|vgottumukkala@mdanderson.org|
20186658|NCT03059030|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
20186659|NCT00753545|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20186660|NCT02485938|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
20186661|NCT04633122|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
20186662|NCT03241745|Memorial Sloan Kettering Cancer Center|Dr. Claire Friedman, MD|646-888-4247|friedmac@mskcc.org|
20186663|NCT04799899|Massachusetts General Hopsital|Dr. Christina Luberto|617-643-9453|CLUBERTO@mgh.harvard.edu|
20211235|NCT01954082|University of Rochester|Dale Phelps|(585) 275-2972|dale_phelps@urmc.rochester.edu|
20186664|NCT04019873|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211236|NCT02419469|UT MD Anderson Cancer Center|Rytting,Michael E.,M.D. / PEDIATRICS|713-792-7734|CR_Study_Registration@mdanderson.org|
20211237|NCT01682512|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211238|NCT01377233|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
20211239|NCT01785875|Amgen Inc.|Study Director|866-572-6436||
20186665|NCT04636528|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
20211240|NCT03112993|University of Missouri|Dr. Boris Mraovic, MD, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
20186666|NCT04908722|Janssen Vaccines & Prevention B.V.|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186667|NCT03339713|Janssen Research & Development, LLC|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186668|NCT04858321|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
20186669|NCT04547920|Avation Medical|Clinical Operations Project Manager|(614) 591-4201|customercare@avation.com|
20186670|NCT03092518|National Cancer Institute|Dr. Jeremy Davis|2408583731|jeremy.davis@nih.gov|
20186671|NCT01814813|Mayo Clinic|Ian Parney, MD, PhD|507-284-8167|Parney.Ian@mayo.edu|
20186672|NCT05170009|Weill Cornell Medicine|Dr. Mirella Salvatore|(646) 318-8506|mis2053@med.cornell.edu|
20186673|NCT04925986|Yale School of Medicine|Sarah Goldberg, MD, MPH: Associate Professor of Internal Medicine (Medical Oncology)|(203) 200-5864|sarah.goldberg@yale.edu|
20186674|NCT05838313|University of South Florida Morsani College of Medicine, Department of Obstetrics and Gynecology|Anjali Kaimal, MD, MAS|(813) 259-8680|akaimal@usf.edu|
20186675|NCT04629716|Florida State University|Nicole Ennis, PhD|850-644-2334|nicole.ennis@med.fsu.edu|
20186676|NCT04770532|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20186677|NCT05457647|Studio Italiano di Oftalmologia|Dr. Marco Lombardo, Study Director|+393313438300|studiolombardo@visioeng.it|
20186678|NCT02852330|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
20186679|NCT03448107|NYU Dentistry|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
20186680|NCT04025554|National Institutes of Health|Dr. Daniel S. Reich|301-496-1801|reichds@ninds.nih.gov|
20186681|NCT03115476|LEO Pharma|Clinical Trial Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20186682|NCT04980248|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20186683|NCT05257486|Xoft, Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
20186684|NCT02310646|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20186685|NCT03021096|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
20186686|NCT04700163|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
20186687|NCT00670358|Mayo Clinic|Dr. Grzegorz Nowakowski|507-284-5096|Nowakowski.Grzegorz@mayo.edu|
20186688|NCT03865498|Columbia University|Sunmoo Yoon|+1 212 300 7081|sy2102@cumc.columbia.edu|
20186689|NCT04473430|University of Miami|Dr. Rodolfo Galindo|305-284-3781|rodolfo.galindo@miami.edu|
20186690|NCT04137367|University of Oslo|Nils Inge Landrø|+4795038479|n.i.landro@psykologi.uio.no|
20186691|NCT04158804|Massachusetts General Hospital|Michael K. Mansour, MD, Ph.D.|617-726-6726|mkmansour@mgb.org|
20186692|NCT02918890|Columbia University|Dr. Andrew M. Gordon|212.678.3332|ag275@columbia.edu|
20186693|NCT04065841|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20186694|NCT03298477|Endologix LLC|Tammy Stiver, Manager, Clinical Affairs|+15136731452|tstiver@endologix.com|
20186695|NCT04338061|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20186696|NCT04074759|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20186697|NCT03631784|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20186698|NCT05329220|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
20186699|NCT04204265|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20186700|NCT02465268|University of Florida|Duane Mitchell, MD, PhD|352-273-9000|duane.mitchell@neurosurgery.ufl.edu|
20211241|NCT00417027|Northwestern University Feinberg School of Medicine|Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
20211242|NCT03137082|Stony Brook University|Dr Helen C Fox|631 632 0057|helen.fox@stonybrookmedicine.edu|
20211243|NCT00707174|University of Utah|Glen Bowen, MD|801-581-0255|glen.bown@hci.utah.edu|
20211244|NCT00544557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186701|NCT00324805|ECOG-ACRIN Statistical Center|Study Statistician|617-632-3012||
20186702|NCT04364048|Hoosier Cancer Research Network|Andrew Benson|317-921-2050|abenson@hoosiercancer.org|
20186703|NCT03931174|Northwestern University|Sara Becker|312-503-4203|sara.becker@northwestern.edu|
20186704|NCT03322267|National Taiwan University Hospital|Dr Chih-Hung Hsu|+886-23123456|chihhunghsu@ntu.edu.tw|
20186705|NCT05792085|University of Pennsylvania|Lauren Eberly|2676244449|Lauren.Eberly@pennmedicine.upenn.edu|
20186706|NCT03046251|Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, USA.|Dr. Bianca Weinstock-Guttman|716-829-4415|bw8@buffalo.edu|
20186707|NCT05386030|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
20211245|NCT04057118|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
20211246|NCT01676311|Spaulding Rehabilitation Hospital|Ross Zafonte, DO|617-952-5227|rzafonte@mgh.harvard.edu|
20211247|NCT01029769|Technische Universitaet Muenchen, Germany|Prof. Dr. Dr. Stefan Leucht|+498941404200|stefan.leucht@tum.de|
20186708|NCT05228457|University of Pennsylvania|Walid Makhoul|215-573-2409|walid.makhoul@pennmedicine.upenn.edu|
20186709|NCT04382664|Ultimovacs ASA|Øivind Foss, Head of Clinical Operation|97008357|oivind.foss@ultimovacs.com|
20211248|NCT04333199|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20186710|NCT04528173|The Children's Hospital of Philadelphia|Tori Nicole Sutherland MD MPH|443-631-5032|sutherlant@chop.edu|
20186711|NCT03213691|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20186712|NCT02862210|Brown University|Edward Huey, MD|401-455-6403|edward_huey@brown.edu|
20211249|NCT03959137|MSD Belgium|Stephanie Coulon|0032 485 461 467|stephanie.coulon@merck.com|
20186713|NCT03161028|VA Portland Medical Center|Dr. Rebecca Spain|503-346-0768|rebecca.spain@va.gov|
20211250|NCT03304210|Ghent University|Prof|+32(0)93326251|wim.ceelen@ugent.be|
20193051|NCT00633945|University of Pennsylvania|Dr. Victoria Werth|215-898-0168|werth@mail.med.upenn.edu|
20193052|NCT02552147|Vanderbilt University Medical Center|Alan Lewis, MD, PhD|(615) 936-4997|alan.s.lewis@vumc.org|
20211251|NCT00810615|San Antonio Military Medical Center, Wilford Hall Ambulatory Surgical Center|Dr. George Wolf, Associate Investigator|210-292-3483|earl.wolf.ctr@us.af.mil|
20211252|NCT02567266|University of Miami|Dr. Amanda Jensen-Doss|+1 (305)284-8332|ajensendoss@miami.edu|
20211253|NCT00837031|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20211254|NCT02020785|Geisinger|Alex Chang, MD|570-271-8026|achang@geisinger.edu|
20211255|NCT00995488|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain|734-647-8903|mahahuss@umich.edu|
20211256|NCT02702271|Boston Scientific|Director of Clinical Trials|1-800-CARDIAC|peter.maurer@bsci.com|
20211257|NCT03091400|Icahn School of Medicine at Mount Sinai|James F Sumowski, PhD|212-241-6854|james.sumowski@mssm.edu|
20211258|NCT05789420|Philip Morris Products S.A.|Xavier Jaumont, Global Head of Clinical Development and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
20211259|NCT05473247|Berry College|Kameron Suire|3373968980|ksuire@berry.edu|
20211260|NCT02392559|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20211261|NCT02820324|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20228810|NCT04704219|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20228811|NCT05366725|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 06151725200|service@emdgroup.com|
20228812|NCT02839707|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20228813|NCT03570892|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
20228814|NCT03914612|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20228815|NCT04320888|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
20228816|NCT03586479|University of Kansas|Rebecca Swinburne Romine|7857668612|swin0024@ku.edu|
20228817|NCT00310180|ECOG-ACRIN Cancer Research Group|ECOG-ACRIN statistician|617-632-3000|eatrials@jimmy.harvard.edu|
20228818|NCT05938920|InSilico Medicine Hong Kong Limited|Yujin Tian|+86-21-50831718|Insilico-Clinicaltrial@insilico.ai|
20228819|NCT02634710|Froedtert and the Medical college of Wisconsin|Ciani Ellison, MD|414-805-4400|cellison@mcw.edu|
20228820|NCT00217737|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20186714|NCT03492216|University of California, San Francisco (UCSF)|Dr. Gabriel Chamie|415-476-4082|gabriel.chamie@ucsf.edu|445
20193053|NCT01790295|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
20193054|NCT05400837|Johns Hopkins University|Nino Isakadze|443-997-0270|nisakad1@jh.edu|
20193055|NCT03218566|Penumbra, Inc.|Erin Archard, Sr. Clinical Study Manager|+1 510 995 9801|earchard@penumbrainc.com|
20193056|NCT00443209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193057|NCT01318876|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
20193058|NCT00820664|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20193059|NCT00513747|The Arthur James Comprehensive Cancer Center|John Byrd, MD|614-293-9869|john.byrd@osumc.edu|
20193060|NCT00825305|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20193061|NCT04016272|Florida State University|Dr. Hyochol Ahn|850-644-2647|hahn@fsu.edu|
20193062|NCT03617289|Henry Ford Health System|Dr. Jason Muir|517-861-6451|jmuir1@hfhs.org|
20193063|NCT00153985|Dana-Farber Cancer Institute|Catherine Wu, MD|617-632-5943|cwu@partners.org|
20193064|NCT01715883|University of Pittsburgh|Matthew Morrell, MD|412-647-8477|morrellmr@upmc.edu|
20193065|NCT00246090|Eisai Call Center|Eisai Inc.|888-422-4743||
20193066|NCT01827046|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
20193067|NCT02554383|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
20193068|NCT02482610|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
20193069|NCT01536197|University of Illinois at Urbana Champaign|M. Yanina Pepino|217-300-2374|ypepino@illinois.edu|
20193070|NCT00715117|Pennsylvania State University|Jill P Smith, MD Professor Emeritus of medicine|717-531-3694|jsmith2@psu.edu|
20193071|NCT01545557|Galderma|Clinical project manager|817-961-5655|aestheticclinicaltrials@galderma.com|
20193072|NCT01999777|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
20193073|NCT01191008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193074|NCT00978562|OHSU KCI|Edward Neuwelt, MD|503-494-5626|huddlesa@ohsu.edu|
20193075|NCT03786744|Samara Medical Center Dinasty|Volchkov Stanislav|+78469564455|quality@cordbank.ru|
20211262|NCT02340078|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20228821|NCT03213704|Children's Oncology Group|Results Reporting Coordinator|(626) 241-1500|resultsreportingcoordinator@childrensoncologygroup.org|
20228822|NCT02259621|Johns Hopkins SKCCC Clinical Research Office Coordinating Center|Jasmine Brooks|6673068335|jbrook54@jhmi.edu|
20228823|NCT04284774|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20228824|NCT07169032|First Affiliated Hospital of Jinan University|LI ZHEN ZHONG|+8613711706774|nicolezlz@foxmail.com|
20228825|NCT03660826|NRG Oncology|Helen Huang on behalf of Danielle Enserro, PhD.|(716) 845-1300|huangh@nrgoncology.org|2318
20228826|NCT04978129|University of Texas at Arlington|Melissa Lewis|817-272-9833|Melissa.Lewis@uta.edu|
20228827|NCT04680533|University of Rochester|Jennifer Gewandter|(585) 276-5661|jennifer_gewandter@urmc.rochester.edu|
20186715|NCT00736723|University|Prof. Dr. Manfred Weiss|#49 731 500 60226|manfred.weiss@uni-ulm.de|
20186716|NCT02587403|RTI Surgical|Jennifer Johnson, Senior Clinical Manager|386-418-8888|jljohnson@rtix.com|
20186717|NCT04797897|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
20186718|NCT05966870|Indiana University|Nana Gletsu Miller|812-8557643|ngletsum@indiana.edu|
20186719|NCT01799265|Bluebird Consulting|Melinda Swanson|6123084500|melinda@bluebirddevice.com|
20186720|NCT03134092|University of Pennsylvania Perelman School of Medicine|Dr. Zachary Meisel|215-746-5618|zfm@pennmedicine.upenn.edu|
20186721|NCT04049643|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
20186722|NCT03774082|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
20186723|NCT05030233|The Ohio State University College of Nursing|Marliese D. Nist|614-247-5781|nist.10@osu.edu|
20186724|NCT05044793|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
20186725|NCT01461655|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20186726|NCT04728347|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
20186727|NCT02289209|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20186728|NCT01186367|Memorial Sloan Kettering Cancer Center|Dr. Jessica Scott, PhD|646-888-8093|scottj1@mskcc.org|
20186729|NCT03867500|Mayo Clinic|Michael D. Jensen, M.D.|507-255-6515|jensen@mayo.edu|
20193076|NCT02394665|University of Miami|Fazilat Ishkanian MD, PhD|305-243-4200|f.ishkanian@med.miami.edu|
20193077|NCT01527162|Seattle Children's Research Institute|Kristie Bjornson, PhD, PT|206 884-2066|kristie.bjornson@seattlechildrens.org|
20193078|NCT01310699|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
20193079|NCT00926575|Soligenix, Inc.|Dhara Patel, Clinical Coordinator|609-538-8200|dpatel@soligenix.com|
20193080|NCT00490698|The University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD / Professor||CR_Study_Registration@mdanderson.org|
20193081|NCT01907269|University of Alabama at Birmingham|Dr. Elizabeth J. Rahn|2059966552|rahneli@uab.edu|
20193082|NCT00668785|West Coast Retina Medical Group, Inc.|J. Michael Jumper, MD|415-972-4600|jmjumper@westcoastretina.com|
20193083|NCT03766373|Novus Therapeutics|Clinical Director|949-679-1110|study004@novustherapeutics.com|
20193084|NCT00738283|Baylor College of Medicine|Steven A. Abrams, MD|713-798-7164|sabrams@bcm.edu|
20193085|NCT02282059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193086|NCT00334542|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
20193087|NCT01673022|Indiana University School of Medicine|Research Coordinator|317-944-2654|jmvinter@iupui.edu|
20193088|NCT02078726|University of California, San Francisco|John Cello, MD|628-206-4767|John.Cello@ucsf.edu|
20211263|NCT01831596|KCI|VP, Global Clinical Development|210-255-5595|jkhart@mmm.com|
20211264|NCT01311505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211265|NCT00446134|Valeant Pharmaceuticals International, Inc.|Senior Director Clinical Development|908-927-1782|ralph.doyle@valeant.com|
20211266|NCT02737072|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20211267|NCT00567996|Novartis Pharmaceuticals|Study Director|862-778-8300||
20211268|NCT02956005|MedStar Georgetown Transplant Institute|Alexander Gilbert|202-444-0621|Alexander.J.Gilbert@gunet.georgetown.edu|
20211269|NCT02762877|Genomic Health, Inc.|Director of Clinical Trials|1.650.569.2042|kgran@genomichealth.com|
20211270|NCT02524665|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211271|NCT04179474|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20211272|NCT02602080|Hospital for Special Surgery|George Birch|212-774-7377|birchg@hss.edu|
20211273|NCT03934437|Johns Hopkins University|Larry Chang|4109551725|lchang8@jh.edu|
20211274|NCT01066039|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20211275|NCT00057785|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20211276|NCT01083901|University of Colorado Denver|Catherine M. Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
20211277|NCT02574260|Amgen, Inc.|Study Director|866-572-6436||
20211278|NCT01197456|UC San Diego|Irene Su, MD MSCE|858-822-5986|hisu@ucsd.edu|
20211279|NCT03022799|Kainos Medicine, Inc|Dr. JaeMoon Lee|+1 408 202 4017|jlee@kainosmedicine.com|
20211280|NCT02642991|CooperVision, Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
20211281|NCT00883129|David Geffen School of Medicine at UCLA|Donald P. Tashkin, M.D.|310-825-5316|dtashkin@mednet.ucla.edu|
20211282|NCT00683046|University of Chicago Medicine|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
20211283|NCT03273257|Papworth Hospital NHS Foundation Trust|David Jenkins, MD; Principal Investigator and ICA Board member|+44 1223 638000|david.jenkins1@nhs.net|
20211284|NCT00407966|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
20211285|NCT01185639|Wake Forest University Health Sciences|Dr. William Blackstock|336-713-6501|ablackst@wakehealth.edu|
20211286|NCT02200614|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20211287|NCT01898884|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20211288|NCT00434148|Novartis Pharmaceuticals|Study Director|862-778-8300||
20211289|NCT03958071|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211290|NCT01142466|Merck Serono GmbH, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
20211291|NCT04084028|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
20211292|NCT02414854|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20211293|NCT01355523|Herlev Hospital, Department of Surgery|MD Melissa Voigt Hansen|+45 20661119|melissa.voigt.hansen@regionh.dk|
20211294|NCT04575038|Clear Creek Bio, Inc.|Barbara Powers, Vice President Clinical Operations|16177652252|clinical@clearcreekbio.com|
20211295|NCT00634582|Comprehensive Cancer Center of Wake Forest Univeresity|Gary Schwartz, PhD|336-716-7446|gschwart@wakehealth.edu|
20211296|NCT00823459|University of California, San Francisco|Susan Chang, MD|(415) 353-2966|jessica.carlson@ucsf.edu|
20211297|NCT02766088|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
20211298|NCT01222715|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20211299|NCT05105477|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
20211300|NCT01207401|University of California, San Diego|Dr. Sheila Krishnan Mody|(619)543-6777|smody@ucsd.edu|
20211301|NCT01498419|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
20211302|NCT03555890|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211303|NCT03372369|University of North Carolina at Chapel Hill|Seri Link Anderson, PhD|919-619-0433|seri.link.a@gmail.com|
20211304|NCT04682639|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211305|NCT01383954|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
20211306|NCT00763269|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
20211307|NCT03471182|Yale University School of Medicine|Patrick Worhunsky|203-737-2668|patrick.worhunsky@yale.edu|
20211308|NCT01305265|Dept. of Anesthesia & Perioperative Care, UCSF San Francisco|Kolodzie, Kerstin M.D, PhD, Principal Investigator|4158853647|kolodziek@anesthesia.ucsf.edu|
20211309|NCT04440163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211310|NCT02229487|Ramathibodii Hospital, Mahidol University|Sirimon Reutrakul|66922011647|sreutrakul@yahoo.com|708
20211311|NCT00068406|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
20211312|NCT02018042|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
20211313|NCT03250507|Henry Ford Hospital|Christina Fidkowski, MD|313-916-7648|cfidkow1@hfhs.org|
20211314|NCT01850108|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20211315|NCT03127943|UNC Department of Oral and Maxillofacial Surgery|Raymond P. White Jr DDS, PhD|919-537-3944|ray_white@unc.edu|
20211316|NCT04671329|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs|(508) 826-7183|ClinicalResearch@Hologic.com|
20211317|NCT03273712|University of Iowa|M. Sue O'Dorisio, MD, PhD|(319) 335-7234|sue-odorisio@uiowa.edu|
20211318|NCT01468974|Abbott Vascular|Nadia bouhdi||nadia.bouhdi@av.abbott.com|
20211319|NCT00666718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20211320|NCT00963599|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20211321|NCT04000373|Cleveland Clinic Neurological Institute Mellen Center|Research Nurse Coordinator|216-445-5877|stoughd@ccf.org|
20211322|NCT00998582|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
20211323|NCT01032330|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20211324|NCT00190684|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20211325|NCT03496207|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211326|NCT00068445|Mayo Clinic|Charles L. Loprinzi, M.D.|507-284-3731|cloprinzi@mayo.edu|
20211327|NCT01155284|Sanford Research|Kurt J. Griffin, PhD, MD, Director of Clinical Trials|6053126000|kurt.griffin@sanfordhealth.org|
20211328|NCT01896700|Portland VA Health Care System|Andrea Hildebrand|503-220-8262|hildeand@ohsu.edu|52016
20211329|NCT00123487|Bristol-Myers Squibb|: Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20211330|NCT00423488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20211331|NCT00886782|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20211332|NCT01255722|Section Head Interventional and Cardiac Radiology - Kantonsspital Lucerne, Spitalstrasse, 6006 Lucerne, Switzerland|Prof. Dr. med. Martin HOFFMANN|+41 41 205 4660|martin.hoffmann@luks.ch|
20211333|NCT02245360|Abbott|Dmitri Kazei MD, PhD|+31 294477008|dmitri.kazei@abbott.com|
20211334|NCT03835975|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211335|NCT00947518|Department of Pediatrics, All India Institute of Medical Sciences, New Delhi|Mari Jeeva Sankar|+91-11-26594372|jeevasankar@gmail.com|
20211336|NCT00717873|Barnes Jewish Hospital|Darnetta Clinkscale|(314) 362-1276|MDB3455@bjc.org|
20211337|NCT00370396|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211338|NCT02282111|The Johns Hopkins Hospital|Dr. Mouen A. Khashab|410-502-0064|mkhasha1@jhmi.edu|
20211339|NCT04529499|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
20211340|NCT04628221|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
20211341|NCT02441179|Teleton Institute|Dr. Angela Navarrete-Opazo|+56 0226772075|angelaandrean@gmail.com|
20211342|NCT01494649|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211343|NCT03467971|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20211344|NCT01656967|The University of Texas Health Science Center at Houston|Dr. Carin A. Hagberg|(713) 500-6240|Carin.A.Hagberg@uth.tmc.edu|
20211345|NCT00479765|Boston Scientific Corporation|Jessie Stockwell|16126181136|jessie.stockwell@bsci.com|
20211346|NCT05166512|Johns Hopkins Bloomberg School of Public Health|Dr. Julia Wolfson|410-614-4907|jwolfso7@jhu.edu|
20211347|NCT00420849|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20211348|NCT00725725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Develpment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211349|NCT01619085|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211350|NCT01345058|Brigham and Women's Hospital|Jong Woo Lee, MD, PhD||JLEE38@BWH.HARVARD.EDU|
20211351|NCT00000135|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
20211352|NCT03162354|Penn State College of Medicine, Penn State Health Children's Hospital|Kent P. Hymel, MD; Professor of Pediatrics; Study PI|7036748989|kphymel@gmail.com|
20211353|NCT03125629|Stanford University|Andrei Iagaru|650-725-4711|aiagaru@stanford.edu|
20211354|NCT00743119|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|zc2160@cumc.columbia.edu|
20211355|NCT04816877|Beth Israel Deaconess Medical Center|Dr. Sunil Sheth|6176675576|ssheth@bidmc.harvard.edu|
20211356|NCT00759759|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20211357|NCT01861717|JOHN WAYNE CANCER INSTITUTE|Dr. Daniel Kelly|310-582-7450|Daniel.Kelly2@providence.org|
20211358|NCT04499391|Penn State College of Medicine|Dr. Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
20211359|NCT00833976|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
20211360|NCT02450760|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.edu|
20211361|NCT03724916|Takeda|Contact|+1-877-825-3327|medinfoUS@takeda.com|
20211362|NCT00683332|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211363|NCT00176852|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
20211364|NCT02464059|University of North Carolina at Chapel Hill|Michael Bradley Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
20211365|NCT01272193|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20211366|NCT02685956|Global BioClinical|Jennifer Maas|206-240-8632|jen.maas@globalbioclinical.com|
20211367|NCT02661282|UT MD Anderson Cancer Center|Shiao-Pei Weathers, MD, Associate Professor, Neuro-Oncology|(713) 792-3906|sweathers@mdanderson.org|
20211368|NCT00350519|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Vice President Medical Affairs COBS|215-325-4464||
20211369|NCT04388527|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
20211370|NCT02577900|Queen Elizabeth Hospital|Dr. Tsang Ka-Kit|+852-35062610|kktsang3@netvigator.com|
20211371|NCT00289731|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211372|NCT02660385|University of Connecticut/formerly Yale University|Meghan O'Connell, Program Manager|860-634-4152|meghan.oconnell@uconn.edu|
20211373|NCT01830920|Thrasos Therapeutics, Inc.|Jerome Rossert, MD, PhD, Chief Scientific Officer||Jerome.Rossert@thrasos.com|
20211374|NCT01313728|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
20211375|NCT00736333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development||ClinicalTrialsDisclosure@merck.com|
20211376|NCT01080209|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20211377|NCT00572156|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20211378|NCT02261974|Viveve, Inc.|Debbie Wilkerson, PhD, Vice President, Clinical and Medical Affairs|610-209-9980|dwilkerson@viveve.com|
20211379|NCT01440595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211380|NCT01347879|Virginia Clinical Research, Inc.|Dr David Pariser|757-625-0151|dpariser@pariserderm.com|
20211381|NCT00068770|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
20211382|NCT04736576|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163089|NCT02211456|Oxford University Hospitals NHS FT|Dr James Gamble|00441865221012|james.gamble@ouh.nhs.uk|
20211383|NCT02572427|University of Arkansas for Medical Sciences|Dr Richard Whit Hall|501-680-7894|HallRichardW@uams.edu|
20211384|NCT00720304|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Min Yao, MD|1-800-641-2422|CTUReferral@UHhospitals.org|
20211385|NCT01087801|ChiRhoClin, Inc.|Edward Purich, Ph.D.|301-476-8388|mdoerr@chirhoclin.com|
20211386|NCT04330482|Rhode Island Hospital|Geoffrey Tremont|401-444-4500|gtremont@lifespan.org|
20211387|NCT00996918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211388|NCT01754480|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
20211389|NCT01333475|National Cancer Institute|Dr. Shivaani Kummar|301-435-0517|kummars@mail.nih.gov|
20211390|NCT04440007|Sorrento Therapeutics, Inc.|Mike Royal, MD|858-203-4100|mroyal@sorrentotherapeutics.com|4146
20163090|NCT03605914|The University of Texas Health Science Center at Houston|Martin J. Citardi, MD, Professor and Chair, Department of Otorhinolaryngology|(713) 500-5410|Martin.J.Citardi@uth.tmc.edu|
20211391|NCT01466673|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
20211392|NCT02725671|Johns Hopkins University|Dr. Armin Zadeh|4105020549|arminzadeh@jhu.edu|
20211393|NCT02981602|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211394|NCT02492295|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|215-456-2313|MOHIUDDK@EISNTEIN.EDU|
20211395|NCT02525562|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
20211396|NCT02983227|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20211397|NCT01706770|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|(978) 658-6888||151
20211398|NCT02164539|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211399|NCT02643966|University of Pittsburgh|Dr. Wendie A. Berg|412-641-1635|bergwa@upmc.edu|
20211400|NCT01362959|Department of Intensive care, Deventer Hospital|Dr. Huub van den Oever|+31 570 535346|h.vandenoever@dz.nl|
20211401|NCT03070431|Department of Radiation Oncology, University of Lübeck, Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|rades.dirk@gmx.net|45400
20163091|NCT02910102|Axovant Sciences, Inc.|Director, Clinical Development|1-833-296-8268|clinicaltrials@axovant.com|
20211402|NCT00701935|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20211403|NCT01542736|University of Colorado Denver|Jennifer Raybin, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20211404|NCT01783483|Zimmer Biomet|Brian M Hatcher, PhD|904-741-4400|brian.hatcher@zimmerbiomet.com|
20211405|NCT02065791|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20211406|NCT00051636|Novartis|Study Director|862-778-8300||
20211407|NCT00975884|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211408|NCT01174368|The Rogosin Institute|Angelica Nazarian|212-746-1551||
20211409|NCT02580201|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
20211410|NCT00294632|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Wang, Professor, Lymphoma/Myeloma|713-792-2860|miwang@mdanderson.org|
20163092|NCT00328861|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20163093|NCT02275156|Amgen Inc.|Study Director|866-572-6436||
20186730|NCT01098812|Abbott Medical Optics|Kristen Featherstone|714-247-8621|kristen.featherstone@amo.abbott.com|
20186731|NCT03131154|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20186732|NCT05403827|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20186733|NCT05597085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20186734|NCT04098263|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
20186735|NCT02100891|Fred Hutchinson Cancer Center|Monica Thakar, MD - Professor of Pediatrics|206-667-5000|isioc@fredhutch.org|
20186736|NCT03309306|Department of Agricultural, Environmental & Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
20186737|NCT03916042|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20186738|NCT03474679|Janssen Pharmaceutical K.K.|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186739|NCT05490459|Element Science, Inc.|Chief Medical Officer|4158726500|zubin@elementsci.com|
20186740|NCT05604508|RAND|William Shadel|4126832300|shadel@rand.org|4489
20186741|NCT05337306|GogyUp|Ned Zimmerman-Bence, Co-Founder|6124605358|ned.zb@gogyup.com|
20186742|NCT01539083|Janssen R&D|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20211411|NCT00363129|Mayo Clinic|Lisa Kottschade, RN, MSN, CNP|507-284-2511|kottschade.lisa@mayo.edu|
20186743|NCT05533359|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
20211412|NCT03707522|University of Nevada, Reno|Martha Zimmermann|7756368067|mzimmermann@nevada.unr.edu|
20211413|NCT00383019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211414|NCT02278952|University of California, San Francisco|Dr. John Greenland|415-476-0789|john.greenland@ucsf.edu|
20211415|NCT00659581|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211416|NCT01337609|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|mfava@partners.org|
20211417|NCT00944125|Aurora Health Care|Imran K. Niazi, MD|414-645-6070|imran.niazi@aurora.org|
20211418|NCT02989610|Abbott|Tucker Tomlinson, Scientist, Clinical Research|+19725269646|Tucker.Tomlinson@Abbott.com|
20211419|NCT01532349|Johns Hopkins University|Dr. Meredith Atkinson|410-955-2467|matkins3@jhmi.edu|
20211420|NCT04508621|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|Greg.Sullivan@TonixPharma.com|
20211421|NCT02432456|Medical College of Wisconsin|Thomas Carver|414-955-1733|tcarver@mcw.edu|
20211422|NCT00864084|The University of Manitoba|Ms Elizabeth Harvey|204-977-5656|harveye@cc.umanitoba.ca|
20211423|NCT00918229|BioProtect|Shaul Shohat|+972545423774|Shaul@bioprotect.com|
20211424|NCT03053622|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20211425|NCT02598622|Indiana University|Dr. Chie Schin-Shih|317-944-8784|shih2@iu.edu|
20211426|NCT00581386|UTHSC- Houston Medical School|Dr. Carin A. Hagberg|713.500.6222|maddukuri.vineela@uth.tmc.edu|
20211427|NCT00681824|Baxter Healthcare Corporation|Guenter Zuelow, Associate Medical Director||guenter_zuelow@baxter.com|
20211428|NCT00201734|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
20211429|NCT03591107|RAND|Lisa Meredith, Senior Behavioral Scientist|310.393.0411|seidel@rand.org|7365
20211430|NCT01902134|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
20211431|NCT00305110|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
20211432|NCT03141931|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
20211433|NCT01363401|Hanyang University Seoul Hospital|Seung-Hyun Kim, M.D., Ph.D.|+82-2-2290-8114|kimsh1@hanyang.ac.kr|
20211434|NCT00736099|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211435|NCT01637961|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20211436|NCT03101293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20211437|NCT02833857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20211438|NCT02542150|"University of Colorado Denver | Anschutz"|Jody Tanabe, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20211439|NCT00670267|Baylor College of Medicine|N.A. Hanania, M.D.||hanania@bcm.edu|
20211440|NCT03512067|Brigham and Women's Hospital|Dr. Gyorgy Frendl|617-732-5910|gfrendl@bwh.harvard.edu|
20211441|NCT00406107|Palmetto Retina Center|John A. Wells, III, M.D.|803-931-0077|jackwells@palmettoretina.com|
20186744|NCT05499377|Virginia Commonwealth University|Augustus Whiet|(804) 828-8892|whiteam25@vcu.edu|
20186745|NCT04149704|Dana-Farber Cancer Institute|Jennifer Snaman|617632-5548|jennifer_snaman@dfci.harvard.edu|
20186746|NCT03629678|The Ohio State University|Dr Robert Cronin|6146889220|robert.cronin@osumc.edu|
20193089|NCT02833805|Johns Hopkins University|Dr. Amy DeZern|410-502-7208|adezerb1@jhmi.edu|
20193090|NCT01454739|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
20193091|NCT01375751|Amgen Inc.|Study Director|866-572-6436||
20193092|NCT01383447|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Patrick Brown|410-614-4915|pbrown2@jhmi.edu|
20193093|NCT02375347|University of Florida|Volker Mai, PhD, MPH|3522739398|vmai@epi.ufl.edu|
20193094|NCT00193479|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
20193095|NCT04312256|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
20193096|NCT00559377|UWMC Dept of Radiology|Joseph G Rajendran|206-221-4421|rajan@u.washington.edu|
20193097|NCT02743897|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
20193098|NCT00590226|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
20193099|NCT00777634|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
20193100|NCT02229227|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20193101|NCT00872001|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20193102|NCT01580904|Universidade Estadual da Paraíba|Impacto da Atenção Farmacêutica em pacientes diabéticos (IPCD)|558387010977|patriciatrindad@yahoo.com.br|
20193103|NCT01453023|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193104|NCT03178344|Department of Psychiatry, UNC Chapel Hill|Jhana Parikh|919-966-9929|jhana_parikh@med.unc.edu|
20186747|NCT00528268|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
20186748|NCT06215430|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20186749|NCT04632992|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20186750|NCT05714761|Icahn School of Medicine at Mount Sinai|Dr. Grenye O'Malley|212-241-7173|omallg01@mssm.edu|
20186751|NCT05235750|University of Arkansas for Medical Sciences|Dr. Mei Bai|501-603-1900|MBai@uams.edu|
20186752|NCT02146378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186753|NCT01743807|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20186754|NCT03603600|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bausch.com|
20193105|NCT04468230|Virginia Commonwealth University|Renato Martins, MD|804-828-1965|MasseyCPC@vcu.edu|
20193106|NCT03714659|New Jersey Regenerative Institute|Dr. Gerard Malanga|9739988301|gmalangamd@hotmail.com|
20211442|NCT03851107|McGill University|Dr. Dana Anaby|15143984400|dana.anaby@mcgill.ca|00394
20211443|NCT03451331|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20211444|NCT02773446|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
20211445|NCT04023994|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20211446|NCT01613131|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
20211447|NCT01020305|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20211448|NCT00467818|UMDNJ|Sherie Novotny MD|(732) 235-4119|novotnsl@rutgers.edu|
20186755|NCT04973254|Boston Medical Center|Laura Fletcher, LCSW MSW MPH|857-225-5183|laura.fletcher@bmc.org|
20186756|NCT05089019|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
20186757|NCT04997148|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20186758|NCT02683447|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
20186759|NCT04543357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186760|NCT01943409|Toronto General Hospital|Scientific Associate|4163405159|kschweng@uhnresearch.ca|
20186761|NCT04542317|University of California, Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
20186762|NCT03509402|"University of Campania Luigi Vanvitelli"|Prof. Marco Annunziata|0815665515|marco.annunziata@unicampania.it|0039
20186763|NCT05590962|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
20186764|NCT05543629|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@BMS.com|
20186765|NCT03313076|University of North Carolina at Chapel Hill|Matt Mauck, MD, PhD|919-966-5136|matt_mauck@med.unc.edu|
20186766|NCT05869383|Sriwijaya University|Nur Riviati|+6281377671384|eviqodir@yahoo.com|
20186767|NCT02535338|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20186768|NCT04573517|University of Texas Medical Branch|Dr. Marissa Berry|402-772-4099|majberry@utmb.edu|
20186769|NCT03270501|Department of Rheumatology, Gent University Hospital|Professor Dirk Elewaut|+32 9 332 22 30|reumatologie@uzgent.be|
20186770|NCT01623167|National Heart Lung and Blood Institute (NHLBI)|Neal S. Young, M.D, NIH Principal Investigator|301-496-5093|youngns@nhlbi.nih.gov|
20186771|NCT06264986|Blanquerna Institute - Universitat Ramon Llull|Olivia Coope|+447882461097|oliviacharlottec@blanquerna.url.edu|
20186772|NCT04478643|ASST SPEDALI CIVILI - UNIVERSITY OF BRESCIA|Dr. Magda Mensi|+390303995784|magda.mensi@unibs.it|
20186773|NCT05022329|University Health Network|Kevin Yau|416 480 4592|Kevin.Yau@uhn.ca|
20186774|NCT05246280|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
20211449|NCT01017029|Pharmaceuticals|Novartis|+1(862)778-8300||
20211450|NCT06118359|University of Wisconsin|Angela Ingraham|513-833-5205|aingraham.md.ms@gmail.com|
20211451|NCT02770716|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
20211452|NCT00446264|University of Lille|Violeta Raverdy|00 33 3 20 62 34 30|vraverdi@univ-lille2.fr|
20211453|NCT02753400|Kubota Vision Inc.|Clinical Trials Helpdesk|2068058310|clinicaltrials@kubotavision.com|
20211454|NCT03989115|Revolution Medicines|Vice-President Clinical Operations|650-779-2300|RMC-4630-02@revmed.com|
20211455|NCT00123110|University of Pennsylvania, School of Medicine|Anne R. Cappola, M.D., ScM|(215) 573-5359|ACappola@mail.med.upenn.edu|
20211456|NCT01382901|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|601-650-4200|mfalone@luitpold.com|
20211457|NCT02135094|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
20211458|NCT00657917|Uniformed Services University of the Heralth Sciences|COL Naomi Aronson MC|301-295-3621|naronson@usuhs.mil|
20211459|NCT02354976|AstraZeneca|Torbjörn Lundström|46 317064100|Torbjorn.lundstrom@astrazeneca.com|
20211460|NCT03118765|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20211461|NCT01612702|Joint Reconstruction Center, Seoul National University Bundang Hospital|Dr. TK Kim|82-31-787-7196|osktk@snubh.org|7200
20211462|NCT03674827|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211463|NCT00527397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20211464|NCT03398928|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
20211465|NCT05552430|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ryan Mace|617-724-7030|rmace@mgh.harvard.edu|
20211466|NCT00061945|University of Chicago Medical Center|Wendy Stock, M.D.||wstock@medicin.bsd.uchicago.edu|
20211467|NCT01039584|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20211468|NCT02740660|Pennington Biomedical Research Center|Dr. Daniel Hsia|225-763-3000|clinicaltrials@pbrc.edu|
20211469|NCT03672396|University of North Carolina at Chapel Hill|Erik Hanson, PhD|19199620816|edhanson@email.unc.edu|
20211470|NCT01890694|NYU Langone Medical Center|Office of Clinical Trials|646-754-7431|clinicaltrials@nyumc.org|
20211471|NCT04380701|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20211472|NCT03001011|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20211473|NCT00204932|U Wisconsin-Madison|Dale Schoeller Principal Investigator|608-262-1082|dschoell@nutrisci.wisc.edu|
20211474|NCT03593772|James A. Haley Veteran Hospital Research Service|Dr. Jolie Haun|904-377-6796|Jolie.Haun@va.gov|
20211475|NCT03125915|Hunter College, CUNY|Tyrel Starks, Associate Professor|212-206-7919|tstarks@hunter.cuny.edu|934
20211476|NCT02731833|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211477|NCT04542330|University of Southern Denmark|Professor Christine Stabell Benn|+45 25883964|cbenn@health.sdu.dk|
20211478|NCT02176642|Duke University|Nazema Siddiqui MD||nazema.siddiqui@duke.edu|
20211479|NCT00727298|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
20211480|NCT01309828|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20211481|NCT00295620|ABCSG|Trial Office Director|+43 1 4089230|info@abcsg.at|
20211482|NCT00217971|Columbia University|Frances R. Levin, M.D.|(212) 543-5896|frl2@columbia.edu|
20211483|NCT01397656|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
20211484|NCT06610279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20211485|NCT00084617|National Cancer Institute|Joanna Brell MD|240-276-7050|brelljm@mail.nih.gov|
20211486|NCT01625286|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20211487|NCT00928135|University of Iowa|Lakshmi Durairaj|3193537968|lakshmi-durairaj@uiowa.edu|
20211488|NCT04355767|Stanford University|Kevin Schulman, MD|(650) 724-0543|kevin.schulman@stanford.edu|
20211489|NCT01999322|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20211490|NCT02033382|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
20211491|NCT03338673|University of Michigan|Dr. Cynthia Burton|7347639259|czburton@umich.edu|
20211492|NCT01005407|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
20211493|NCT00301873|Duke Comprehensive Cancer Center|Mary Lou Affronti, RN, MSN, ANP, MHSc Senior Investigator|919-684-6239|mary.affronti@duke.edu|
20211494|NCT02936479|NYU Langone Health- Transplant Institute|Cecilia Deterville, MS, CCRC|212.263.3620|Cecilia.Deterville@nyulangone.org|
20211495|NCT04071392|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
20211496|NCT00678379|Charlotte Eye Ear Nose and Throat|Jonathan Moss MD|704-295-3000|jmoss@ceenta.com|
20211497|NCT01222871|SEMC|Dr. Peter catalano|1-617-789-5004|peter.catalano@steward.org|
20211498|NCT01440647|Women & Infants Hospital of Rhode Island|Abbot R. Laptook, MD, Professor of Pediatrics The Warren Alpert Medical School of Brown University M|401-274-1122|ALaptook@WIHRI.org|7404
20211499|NCT04036227|Gesynta Pharma AB|Charlotte Edenius|+46733864246|ctg@gesynta.se|
20211500|NCT04335110|Oregon Health & Science University|Dr. Allison Lindauer|15034946976|lindauer@ohsu.edu|
20211501|NCT01735877|Christian Medical College & Hospital|Dr Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
20211502|NCT04006847|Penn State Health|Seema Naik, MD|7175318678|snaik@pennstatehealth.psu.edu|
20211503|NCT02292433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211504|NCT03182920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20211505|NCT05319977|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
20211506|NCT02177773|Unviersity of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|22648
20211507|NCT03333382|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
20211508|NCT02314520|Penn State Health Milton S. Hershey Medical Center Dept of Neurosurgery|Dr. J. Christopher Zacko|717-531-1279|jzacko@pennstatehealth.psu.edu|
20211509|NCT02454972|Pharma Mar S.A.|Clinical Development, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
20211510|NCT00787566|Aviana Consulting, LLC|Vanaja V. Ragavan, M.D.|610-795-7403|vvragavan@comcast.net|
20211511|NCT00780715|University of Dundee|Professor Ewan Pearson|+44 (0) 1382 383387|e.z.pearson@dundee.ac.uk|
20211512|NCT01402115|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Dal-Sik Kim, MD|82-63-276-8284|dskim@chonbuk.ac.kr|
20211513|NCT03202628|Mayo Clinic|Dr. Prashant Kapoor|507-284-2511|Kapoor.Prashant@mayo.edu|
20186775|NCT04599062|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
20186776|NCT00986856|LEO Pharma|Anders Rhod Larsen, Scientific advisor|+45 72262990|anders.larsen@leo-pharma.com|
20186777|NCT01175356|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20186778|NCT04436276|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186779|NCT03852472|Chemocentryx|Study Director|650-210-2900|medinfo@amgen.com|
20186780|NCT05977530|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
20186781|NCT05692960|The University of Tennessee, Knoxville|Noël Arring, DNP, PhD, RN|865-974-1988|narring@utk.edu|
20186782|NCT04719832|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20186783|NCT03058289|Intensity Therapeutics|Lewis Bender|2032217377|LBender@intensityTherapeutics.com|
20186784|NCT03084536|Washington University School of Medicine|Ryan C. Guffey, M.D.|314-286-2883|rguffey@wustl.edu|
20186785|NCT04285515|Intra-Cellular Therapies, Inc.|Susan Kozauer, MD|646 440-9333|ITCIClinicalTrials@itci-inc.com|
20186786|NCT02618577|Universitätsklinikum Hamburg-Eppendorf|Prof. Dr. Paulus Kirchhof|+49 (0)40 7410-52438|p.kirchhof@uke.de|
20186787|NCT05192109|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
20186788|NCT04515849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20186789|NCT04078191|Navidea|Michael Blue, MD|6145714313|mblue@navidea.com|
20186790|NCT05002608|Massachusetts General Hospital|Elyse R. Park|6177246836|epark@mgh.harvard.edu|
20186791|NCT04164888|CiVi Biopharma, Inc.|Chief, Clinical Development|484-674-5456|chuck.shear@civibiopharma.com|
20186792|NCT04437615|Olympus Corporation|Jeremy Bolt, Global GI Lead|5085798495|jeremy.bolt@olympus.com|
20186793|NCT03491969|Zhongshan hospital, Fudan University|Dr. Hanchuan Chen|18459111985|chenhanchuan66@126.com|
20186794|NCT02696707|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
20186795|NCT00636077|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20186796|NCT05546749|Albert Einstein College of Medicine|Hector Perez|7189205756|heperez@montefiore.org|
20186797|NCT03869866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20211514|NCT01070966|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211515|NCT00618774|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211516|NCT03903640|Washington University School of Medicine|Dr. George Ansstas|314-508-4426|gansstas@wustl.edu|
20211517|NCT01725113|NYU Langone Health|Candace Grant|5166632171|Candace.Grant@nyulangone.org|
20211518|NCT02135874|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Proffessor|713-792-4764|eajabbour@mdanderson.org|
20211519|NCT01415921|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
20211520|NCT03007537|Nanjing First Hospital, Nanjing Medical University|Dr. Xiaobin Ji|13705174622|xbji007@126.com|
20211521|NCT04822467|Cleveland Clinic Foundation|Dr. Donald Kirby, MD|216-444-0446|kirbyd@ccf.org|
20211522|NCT01878500|Johns Hopkins University|Dr. John P Gearhart|410-955-5358|jgearha2@jhmi.edu|
20211523|NCT02117479|Incyte Corporation|Study Director|855 463-3463||
20211524|NCT01453374|Alkermes|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
20211525|NCT00459381|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
20211526|NCT02629133|Womene and Infants Hospital|Caron Zlotnick|401-474-3332|czlotnick@butler.org|
20211527|NCT03216954|University of Kentucky|William W. Stoops, PhD|859-257-5388|william.stoops@uky.edu|
20211528|NCT00323271|VA Connecticut Healthcare System|Robert Kerns, PhD|203-932-5711|robert.kerns@va.gov|3841
20211529|NCT01238822|Cincinnati Children's Hospital Medical Center|Jeff Epstein||jeff.epstein@cchmc.org|
20211530|NCT05180630|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20211531|NCT02011516|University of Pennsylvania|Teresa R. Franklin, Ph.D., Research Associate Professor of Neuroscience in Psychiatry|215-222-3200|teresafr@mail.med.upenn.edu|119
20211532|NCT00709735|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
20211533|NCT01632683|Oregon Health & Science University|Michael Aziz, MD|503-494-5581|azizm@ohsu.edu|
20211534|NCT00849524|University of California, San Diego|Januario Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
20211535|NCT00802633|Vanderbilt University|Sam Chang|615-322-2101|sam.chang@Vanderbilt.Edu|
20211536|NCT01027884|University Hospital Leuven-Children Hospital|Dr Gunnar Buyse|+32 016343845|gunnar.buyse@uzleuven.be|
20211537|NCT03636542|University of Minnesota|Jason Habeck|612-625-7675|habe0073@umn.edu|
20211538|NCT02059187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211539|NCT04130919|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20211540|NCT02624518|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
20211541|NCT02729194|University of Michigan Rogel Cancer Center|Dr. Ajjai Alva, M.D.|734-936-0091|ajjai@umich.edu|
20211542|NCT00845026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20211543|NCT03012815|Mayo Clinic|Ruth Bates|507-255-8716|Bates.Ruth@mayo.edu|
20211544|NCT01462695|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20211545|NCT02400905|Veryan Medical|Nick Yeo|+44 1403 258984|nick.yeo@veryanmed.com|
20211546|NCT00879970|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211547|NCT01431755|Q-Med AB|Head of Medical Affairs|+46 (0) 18 474 90 00|reception.SEUPP@galderma.com|
20211548|NCT00558519|University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
20211549|NCT01777425|UZ Leuven|Prof. Dr. P. Hellings|+3216332340|peter.hellings@uzleuven.be|
20211550|NCT01021137|James H. Quillen VA Medical Center|Director of Vestibular Laboratory|423-926-1171|faith.akin@va.gov|7376
20211551|NCT02122471|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
20211552|NCT02556632|University of Rochester|Julie Ryan Wolf, PhD, MPH; Associate Professor of Dermatology and Radiation Oncology|585-276-3862|julie_ryan@urmc.rochester.edu|
20211553|NCT00808015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211554|NCT03574818|Montefiore Medical Center|Balazs Halmos|7184058404|bahalmos@montefiore.org|
20211555|NCT00393978|University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience|Melissa P. DelBello, MD|513-558-2989|Melissa.DelBello@uc.edu|
20211556|NCT04583592|Sagent Pharmaceuticals, Inc.|Cynthia Tinkoff, Pharm.D. Manager, Medical Affairs|847-908-6913|ctinkoff@sagentpharma.com|
20211557|NCT04523831|Dhaka Medical College|Dr. Reaz Mahmud, Principal investigator|01912270803|reazdmc22@yahoo.com|+88
20211558|NCT04556838|VivaVision Biotech, Inc.|Joanne Li, M.D.|86-02158598290|joanne.li@vivavisionbio.com|
20211559|NCT00995930|Novartis Pharmaceuticals|Study Director|862-778-8300||
20211560|NCT01458119|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20211561|NCT03033069|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20211562|NCT01189071|University of Missouri-Columbia|Dr. Mark Wakefield|573-882-0496|wakefieldmr@health.nissouri.edu|
20211563|NCT02517099|Imperial College London|Professor Sejal Saglani|02075943167|s.saglani@imperial.ac.uk|
20211564|NCT01031134|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
20211565|NCT01246973|University of Rochester|Julie Ryan|585-276-3862|julie_ryan@urmc.rochester.edu|
20211566|NCT01416142|Bausch & Lomb Incorporated|Dr. William Reindel|(585) 338-8129|william.reindel@bausch.com|
20211567|NCT03254719|Palmer Center for Chiropractic Research|Dr. Anna Walden-Cobb|563-949-0676|anna.waldencobb@palmer.edu|
20211568|NCT01326702|Memorial Sloan Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
20211569|NCT02082912|Emory University|Dr. Andrew John Butler|404-413-1415|ajbutle@emory.edu|
20211570|NCT02580188|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
20211571|NCT02412956|The George Washington University|Dr. Lorien Abroms||lorien@gwu.edu|
20211572|NCT01835132|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
20211573|NCT00265083|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
20211574|NCT03208933|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20211575|NCT00361257|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20211576|NCT00782275|Beth Israel Deaconess Medical Center|David F. McDermott MD PhD|617-632-9262|dmcdermo@bidmc.harvard.edu|
20211577|NCT04378010|Enanta Pharmaceuticals, Inc|Alaa Ahmad|1-617-607-0800|aahmad@enanta.com|
20211578|NCT02019979|Icahn School of Medicine at Mount Sinai|Dr. Anish Parikh|(212) 241-4705|anish.parikh@mountsinai.org|
20211579|NCT02513459|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20211580|NCT03237611|Albert Einstein College of Medicine|Dr. Richard Gralla|718-918-6235|richard.gralla@nbhn.net|
20211581|NCT00747747|Galsor s.r.l.|Dr. Sandro Soriano/Director of Clinical Trials|0039 0827 601723|sandro.soriano@galsor.it|
20211582|NCT00923195|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20211583|NCT00525031|UT MD Anderson Cancer Center|Wen-Jen Hwu, MD/Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20211584|NCT01430182|Baylor College of Medicine|Neil Bailard|713-798-7356|bailard@bcm.edu|
20211585|NCT00830063|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211586|NCT02873481|Virginia Commonwealth University School of Nursing|Dr. Patricia Kinser, Assistant Professor|804-828-9140|kinserpa@vcu.edu|
20211587|NCT02140164|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20211588|NCT01814761|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20211589|NCT00272337|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
20211590|NCT00661674|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
20211591|NCT02184494|Florida State University|Michael J. Ormsbee|6103313126|mormsbee@fsu.edu|
20211592|NCT01872689|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20211593|NCT01551550|TissueTech|Medical Affairs|(888) 296-8858|info@tissuetech.com|
20211594|NCT00660790|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
20211595|NCT03094806|New York Methodist Hospital|Jeremy A Weingarten, MD|718-780-5835|jaw9031@nyp.org|
20211596|NCT04214951|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
20211597|NCT00686374|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20211598|NCT02143947|Quinnipiac University|Juan C Garbalosa, PT, PhD, Director Motion Analysis Laboratory|203 582 8552|juan.garbalosa@quinnipiac.edu|
20211599|NCT04980521|University of North Dakota|Dr. Gary Schwartz|701-777-6598|gary.schwartz@und.edu|
20211600|NCT01244815|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211601|NCT01173159|Cincinnati Children's Hospital Medical Center|Crystal Slaughter, BA, CCRC|513-636-0137|crystal.slaughter@cchmc.org|
20211602|NCT01808209|Opthalmic Research Group, Aston University, Birmingham, UK|Jonathan Walker||JWalker@coopervision.co.uk|
20211603|NCT00697112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211604|NCT02786498|University of Maryland Baltimore, School of Medicine, Department of Orthopaedics|Dr Gerard Slobogean|410-28-6280|gslobogean@som.umaryland.edu|
20211605|NCT01427920|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20211606|NCT04228302|EicOsis|Dr. William Schmidt|650-438-3018|wkschmidt@eicosis.com|
20211607|NCT05795062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211608|NCT03066440|UBMD Pediatrics|Dr. Amanda B. Hassinger, Medical Director of the UBMD Pediatrics Sleep Center|716-323-0158|albrooks@buffalo.edu|
20211609|NCT04991311|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
20211610|NCT02348619|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20211611|NCT01223196|UT Health Science Center San Antonio|Franco Folli, MD PhD/Professor|210-567-4826|FOLLI@uthscsa.edu|
20211612|NCT02598193|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20211613|NCT02487979|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20211614|NCT00447694|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20211615|NCT01169987|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20211616|NCT00829439|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
20211617|NCT00386100|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211618|NCT02523274|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
20211619|NCT01032759|Duke University Medical Center|Dr. Ashraf Habib|9196686266|habib001@dm.duke.edu|
20211620|NCT02328807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Julio M. Pow-Sang|813-745-2226|julio.powsang@moffitt.org|
20211621|NCT00117585|Portland VA Medical Center|Dr. David Hickam|(503) 721-7817|david.hickam@va.gov|
20211622|NCT00919802|UAB|Timothy Ness|205-975-9643|tness@uabmc.edu|
20211623|NCT01493531|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
20211624|NCT01946282|University of Texas Southwestern Medical Center, Moncrief Cancer Institute|Dr. Keith Argenbright, Director, Moncrief Cancer Institute|817-288-0070|keith.argenbright@utsouthwestern.edu|
20211625|NCT03031431|Boston Children's Hospital|Dr. Anne Hansen|(617)-355-6027|Anne.Hansen@childrens.harvard.edu|
20211626|NCT02128867|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
20211627|NCT01147016|Barbara Ann Karmanos Cancer Institute|Dr. Amy Weise|248-344-6688|aweise3@hfhs.org|
20211628|NCT03670537|Auerbach Hematology and Oncology|Michael Auerbach|4107804050|mauerbachmd@abhemonc.com|
20211629|NCT04133519|metaMe Health|Dr. David Recker, Chief Medical Officer|1-888-463-8262|info@metamehealth.com|
20211630|NCT02217345|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
20211631|NCT01203774|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20211632|NCT02565485|University Hospitals Cleveland Medical Center|Justin R. Lappen MD|216-844-3787|Justin.Lappen@UHhospitals.org|
20211633|NCT00789828|Novartis Pharmaceuticals|Study Director|862-778-8300||
20211634|NCT02623426|Johns Hopkins Bloomberg School of Public Health|Douglas A Jabs, MD, MBA|410 -955-1254|djabs1@jhmi.edu|
20211635|NCT02094937|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211636|NCT01133392|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20211637|NCT03185949|Endobar Solutions LLC|Director, Clinical Affairs|8456800424|nodar@endobarsolutions.com|
20211638|NCT02926053|National Center of Cancer Immune Therapy, Department of Oncology|Troels Holz Borch, MD, PhD, principal investigator|004524460492|troels.holz.borch@regionh.dk|
20211639|NCT00500656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20211640|NCT05788237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211641|NCT03751124|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20211642|NCT04777591|University of Virginia|John T Stranix, MD|434-924-5078|jts3v@uvahealth.org|
20211643|NCT01998035|Columbia University Irving Medical Center|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
20211644|NCT00555399|University of Texas M D Anderson Cancer Center|Dr. Vinay K. Puduvalli|(713) 745-2343|vpuduval@mdanderson.org|
20211645|NCT05458895|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20211646|NCT04639310|Xenon Pharmaceuticals Inc|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
20211647|NCT02322242|Sunnybrook Health Sciences Centre|Dr. Stephen Choi|4164804864|stephen.choi@sunnybrook.ca|
20211648|NCT01407575|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
20211649|NCT01835470|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20211650|NCT01011907|UCSF: EGCRC|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
20211651|NCT00304954|NEI|Dr. Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
20211652|NCT00524576|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211653|NCT00894465|Washington University School of Medicine|Dr. Paul Austin|(314) 454-6034|austinp@wustl.edu|
20211654|NCT01406873|University of Rochester|Charles Thornton, MD|585-275-2542|Charles_Thornton@urmc.rochester.edu|
20211655|NCT00207714|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
20211656|NCT03627195|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20211657|NCT00328042|VA San Diego|Dr. Erik Groessl|858-552-8585|erik.groessl@va.gov|
20211658|NCT02290028|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|1-800-547-0394|crystal.miller@biotronik.com|
20211659|NCT03862625|Istanbul University|Dr. Merve Damla Korkmaz|+905556297264|mervedml@gmail.com|
20211660|NCT03615079|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.Edu|
20211661|NCT00856778|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
20211662|NCT01681771|Linköping University, Department of social and welfare studies. Linköping University|Prof. RN Peter Johansson|+4613313685|peter.b.johansson@liu.se|
20211663|NCT03154333|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
20211664|NCT04242186|Hebrew SeniorLife|Sarah Berry, MD, MPH|617-971-5355|sarahberry@hsl.harvard.edu|
20211665|NCT00550420|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211666|NCT00331773|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20211667|NCT01792284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20211668|NCT00353938|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
20211669|NCT02732587|Yale University Dept of Psychiatry|Dr Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
20211670|NCT00379587|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH|617-632-5946|corey_cutler@dfci.harvard.edu|
20163094|NCT03929640|Milton S. Hershey Medical Center|Serdar Ural|717-531-6209|sural@pennstatehealth.psu.edu|
20211671|NCT03723590|Medline Industries|Julie Miller|630-418-6891|jamiller@medline.com|
20211672|NCT01990898|Cleveland Clinic|Dr. Daniel Shoskes||dshoskes@gmail.com|
20211673|NCT00054275|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Paula Silverman, MD|216-844-3951|paula.silverman@uhhospitals.org|
20211674|NCT00755937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20211675|NCT01106352|Bayer|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
20211676|NCT03876873|University of Missouri-Columbia|Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
20211677|NCT03547531|Prince of Songkla University|istiyanti Hapsari|+66980493996|istiyantihapsari@gmail.com|
20211678|NCT03944707|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20211679|NCT02649608|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20211680|NCT03402126|Medtronic Inc|Joy Aso, Clinical Research Specialist|4015454454|joy.a.aso@medtronic.com|
20211681|NCT02444182|Kuwait University - Faculty of Dentistry|Dr. Abrar Alanzi|24636812|aalanzi@hsc.edu.kw|
20211682|NCT01412710|Florida International University|Fatma G. Huffman|305-348-3877|huffmanf@fiu.edu|
20211683|NCT01959230|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
20211684|NCT01965535|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20211685|NCT01825876|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20211686|NCT05149287|University of Kentucky|Austin Stone|(859) 323-5533|austin.stone@uky.edu|
20211687|NCT03751020|Yale University School of Public Health (Social and Behavioral Sciences)|Dr. John Pachankis|(203) 785-3710|john.pachankis@yale.edu|
20211688|NCT01889862|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
20211689|NCT00528879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20211690|NCT00971204|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
20211691|NCT01256398|University of California San Diego Moores Cancer Center|Matthew Wieduwilt, MD, PhD|858-822-6848|mwieduwilt@ucsd.edu|
20211692|NCT01364298|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20211693|NCT01166997|EKOS Corporation|Lynn Allen|4254153100|Lynn.Allen@ekoscorp.com|
20211694|NCT04974645|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
20211695|NCT03550794|Montefiore Medical Center|Dr. Ari Moskowitz|7189202956|amoskowitz@montefiore.org|
20211696|NCT01864525|Syracuse University|Dr. Soren Lowell|315-443-9648|slowell@syr.edu|
20211697|NCT01890785|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20211698|NCT03296553|Instituto Nacional de Cancerología|Dr. Patricia Volkow|01 55 5628 0400|pvolkowf@gmail.com|12120
20211699|NCT00065065|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
20211700|NCT01050673|Northwestern Medical Faculty Foundation|Dr Robert D Galiano, Assistant Professor of Surgery|312-695-6022|rgaliano@nmh.org|
20211701|NCT04363736|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20211702|NCT01254045|Stanford University School of Medicine|Scott S. Hall, PhD|650-498-4799|hallss@stanford.edu|
20211703|NCT00520351|Centre for Contact Lens Research|Craig A Woods, Research Manager|519-888-4567|cawoods@sciborg.uwaterloo.ca|36547
20211704|NCT06079853|Columbia University School of Nursing|Allison A. Norful|2123057157|aan2139@cumc.columbia.edu|
20211705|NCT03797222|Children's Hospital of Philadelphia|Lauren Mitteer|215-590-3174|mitteerl@chop.edu|
20211706|NCT03567239|Madonna Rehabilitation Hospital|Chase Pfeifer, Ph.D.|402-413-4504|cpfeifer@madonna.org|
20211707|NCT00614458|UNC Chapel Hill|Professor of Medicine, Director Translational Research IGHID|919 966 6388|dmargo@med.unc.edu|
20211708|NCT03536819|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
20211709|NCT02769000|Virginia Commonwealth University|Timothy Harris, MD|804-828-7232|timothy.harris@vcuhealth.org|
20211710|NCT04288115|Central Arkansas Veterans Healthcare System|Spyridoula Maraka, MD, MS|(501) 257-5848|Spyridoula.Maraka@va.gov|
20211711|NCT00729365|Northwestern University Feinberg School of Medicine|Mark E. Molitch|312 503-4130|molitch@northwestern.edu|
20211712|NCT02720224|Estetra SPRL|Marie Mawet||mmawet@mithra.com|
20211713|NCT00751972|HeartWare Inc|Director Clinical Project Management|508 739-0867|sbell@heartwareinc.com|
20211714|NCT00869089|University Hospitals Case Medical Center|Neil J. Korman, MD Principal Investigator|216-844-7164|neil.korman@UHHospitals.org|
20211715|NCT02766400|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
20211716|NCT01374906|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20211717|NCT02795780|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20211718|NCT01880541|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
20211719|NCT00430638|Daiichi Sankyo|Global Clinical Leader|1-908-992-6400||
20211720|NCT02367781|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20211721|NCT01529749|Hospital Clínic|FELIPE GARCIA ALCAIDE|34619175783|FGARCIA@clinic.cat|
20211722|NCT00378482|AstraZeneca Clinical Study Information Center|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
20211723|NCT05166421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
20211724|NCT01335399|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20211725|NCT01883999|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20211726|NCT03202511|Division of Clinical Pharmacology, School of Medicine, Indiana University|Dr. Zeruesenay Desta|317-274-2823|zdesta@iu.edu|
20211727|NCT00096382|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20211728|NCT01270841|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20211729|NCT01375010|Columbia University|Elizabeth Shane, MD|212-305-6289|es54@cumc.columbia.edu|
20211730|NCT02614703|Dostor's Hospital at Renaissance|Dr Ingrid M Chacon|(956) 362-3636|I.chacon@dhr-rgv.com|
20211731|NCT02402933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20193107|NCT02239744|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
20193108|NCT00420784|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20193109|NCT00148668|Dana-Farber Cancer Institute|Dr Eric Winer|617-632-2335|eric_winer@dfci.harvard.edu|
20211732|NCT01110499|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20211733|NCT00854620|Stanford University, Stanford Cancer Center|Sandy Srinivas, MD|650-725-2078|sandysri@stanford.edu|
20211734|NCT02096029|Medical University of South Carolina|Amy Boatright, Program Coordinator|843-876-2440|boatrigh@musc.edu|
20211735|NCT06156969|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|PBONATO@mgh.harvard.edu|
20211736|NCT02962882|Molnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
20211737|NCT01725984|Ludwig Maximilian Universität|Dr. Ricarda Bauer|+49 89 7095|Ricarda.Bauer@med.uni-muenchen.de|
20211738|NCT03763331|Purdue University|Dr. Bruno Roseguini|7654906284|brosegui@purdue.edu|
20211739|NCT01155063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211740|NCT00936884|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
20211741|NCT01314703|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
20211742|NCT00597584|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20211743|NCT02797964|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211744|NCT02791659|Gastroenterology endoscopy center|Phonthep Angsuwatcharakon, MD|6622564265|borndeb@yahoo.com|
20211745|NCT00881959|Zimmer Dental|Hai Bo Wen|760 929 4312|haibo.wen@zimmer.com|
20211746|NCT01456052|Lexicon Pharmaceuticals, Inc.|Manager of Regulatory Affairs|281-863-3260|plogan@lexpharma.com|
20211747|NCT00623623|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211748|NCT02186808|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
20211749|NCT02265952|Regeneron Pharmaceuticals, Inc.|Clinical Trial Information|844-734-6643|clinicaltrials@regeneron.com|
20211750|NCT01042977|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20193110|NCT02417441|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20193111|NCT03080142|UC Davis Medical Center, Department of Anesthesiology|Jon Zhou MD|9167035028|jonzhou@ucdavis.edu|
20193112|NCT00983853|Vertex Pharmaceuticals Incorporated|Medical Monitor|1-617-444-6777|medicalinfo@vrtx.com|
20193113|NCT00325598|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
20193114|NCT00607672|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
20193115|NCT05034939|VentureMed Group, Inc.|Vice President, Clinical, Regulatory & Quality|763-296-2021|jschweiger@venturemedgroup.com|
20193116|NCT05288829|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20193117|NCT02599688|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
20193118|NCT03016598|Portland VA|Delaney.McKechnie@va.gov|360-696-4061|Delaney.McKechnie@va.gov|32017
20193119|NCT00996502|Columbia University|CU PRS Administrator|212-342-1643|ClinicalTrialsGov@cumc.columbia.edu|
20193120|NCT01667549|Monell Chemical Senses Center|Julia A. Mennella, PhD; Study Principal Investigator|267-519-4880|mennella@monell.org|
20193121|NCT01407276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193122|NCT04947514|Montefiore Medical Center|Dr. Amy Yao|7189204800|amyao@montefiore.org|123
20193123|NCT00813982|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20193124|NCT00478205|Eisai Call Center|Eisai Inc.|888-422-4743||
20193125|NCT04092452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193126|NCT00696488|Wake Forest University Health Sciences|Steve Feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
20193127|NCT01367444|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20193128|NCT01012947|Ajou University|Dr. Kang Soo Lee|821087812077|kpsimon@hanmail.net, antiaging@ajou.ac.kr|
20193129|NCT02127125|San Antonio Geriatric Research, Education, and Clinical Center|Dr. Nicolas Musi|(210) 562-6140|musi@uthscsa.edu|
20193130|NCT00855413|The University of North Carolina|Dr. Cynthia Gay|9198432726|cynthia_gay@med.unc.edu|
20193131|NCT03382769|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
20193132|NCT02493946|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
20211751|NCT02499354|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
20211752|NCT04303845|Mayo Clinic|Rashmi B. Halker Singh, M.D.|480-301-8100|Halker.Rashmi@mayo.edu|
20211753|NCT04356573|UAMS|Robert Wolfe|501-526-5708|rrwolfe2@uams.edu|
20211754|NCT02424565|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211755|NCT01677910|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
20211756|NCT03650400|Novartis Pharmaceuticals|Study Director|882 778 8300|Novartis.email@Novartis.com|
20211757|NCT00374543|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
20211758|NCT00183469|University of Texas Health Science Center San Antonio|Charles L. Bowden, M.D. Clinical Professor|210 567 5405|bowdenc@uthscsa.edu|
20211759|NCT02577042|Fundació Lluita contra la SIDA|Director of Clinical Trials|+34 93 497 84 14|enegredo@flsida.org|
20211760|NCT00751998|Boston Scientific Corporation|Joyce Peetermans, PhD, Director Endoscopy Clinical|508-683-4211|peetermj@bsci.com|
20211761|NCT04126733|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20211762|NCT02410837|Medtronic|Jennifer Wolvers|763-258-9405|Jennifer.Wolvers@Medtronic.com|
20211763|NCT01602198|Cleveland Clinic|Stephen Rao|216-444-1025|raos2@ccf.org|
20211764|NCT00711867|Mayo Clinic|Terrence L Trentman MD|480-301-8000|trentman.terrence@mayo.edu|
20211765|NCT00078819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20211766|NCT02555618|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20211767|NCT02372682|Saint Louis University|Anna Hardy, Research Nurse Coordinator|314-268-5785|anna.hardy@health.slu.edu|
20211768|NCT01325532|Massachusetts General Hospital, Dept of Psychiatry|Dr David Mischoulon|617-724-5198|dmischoulon@partners.org|
20211769|NCT02964897|Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System|Keith McInnes, Principal Investigator|617-504-1630|donald.mcinnes@va.gov|
20211770|NCT03196791|Korea university Anam Hospital|Dr. Shin Hoo Park|+82-10-6735-1824|bulsajo333@hanmail.net|
20211771|NCT03411642|University Medical Center Hamburg-Eppendorf|Prof. Dr. Götz Thomalla|+4940501377410|thomalla@uke.de|
20211772|NCT02238977|University of Arkansas for Medical Sciences|Pedro Delgado, M.D.|501-526-8100|pldelgado@uams.edu|
20211773|NCT01428024|Q-Med AB|Head of Medical Affairs|+ 46 (0) 18 4749000|reception.SEUPP@galderma.com|
20211774|NCT01280981|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20211775|NCT00524394|University of Texas Health Science Center|James Murphy, PhD|713-500-5714|james.r.murphy@uth.tmc.edu|
20211776|NCT01749033|Northwerstern University|Ling Hu M.D.|312-695-3428|l-hu2@northwestern.edu|
20211777|NCT00827073|Robert Cizik Eye Clinic|Joseph Selem, MD|713-559-5263|laurabaker@cizikeye.org|
20211778|NCT00904189|University of Rochester Medical Center|Steven Swarts|5852755623|christine_huggins@urmc.rochester.edu|
20211779|NCT03056001|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20211780|NCT01721967|Duke University Health System|Andrew Wang, MD|919-681-6197|a.wang@duke.edu|
20211781|NCT02295280|Saint Louis University|Dorothea Mostello, MD, Maternal Fetal Medicine Faculty|314-977-2090|mostello@slu.edu|
20211782|NCT02875067|NYU Langone Health|Catherine Diefenbach, MD|212-731-5670|Catherine.Diefenbach@nyulangone.org|
20211783|NCT01241565|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
20211784|NCT02713243|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20211785|NCT03056352|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
20211786|NCT02971605|Johns Hopkins University School of Medicine|Frederick Barrett, Ph.D., Principal Investigator|4105509777|fbarret2@jhmi.edu|
20211787|NCT00597207|ZOLL Medical Corporation|Sr. Director of Clinical Research|978-421-9655|uherken@zoll.com|
20211788|NCT02522949|Enzymatica AB|Enzymatica AB|+46 46 286 31 00|info@enzymatica.com|
20211789|NCT03439293|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20211790|NCT00493181|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
20211791|NCT00660049|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
20211792|NCT03077828|Northwestern University|Dr. Jane N. Winter, M.D.|3126954538|j-winter@northwestern.edu|
20211793|NCT00676026|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20211794|NCT05037409|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211795|NCT03499249|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
20211796|NCT04499235|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20211797|NCT01963676|UNC Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
20211798|NCT01447329|Mike O'Callaghan Military Medical Center, Clinical Investigation Program|Amanda Crawford|(702) 653-3583|amanda.j.crawford.ctr@health.mil|
20211799|NCT01120600|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20186798|NCT06516705|National Tainan Junior College of Nursing|Mei-Chuan Huang|886-0956646992|mayhuang@ntin.edu.tw|
20186799|NCT05579899|Evommune|Eugene Bauer, M.D., Chief Medical Officer|310-721-3364|eugene.bauer@evommune.com|
20186800|NCT05453773|Ohio State University Comprehensive Cancer Center|Marielle Brinkman|614-688-3226|brinkman.224@osu.edu|
20186801|NCT00391365|Center For Limb Loss Prevention and Prosthetic Engineering, VA Puget Sound Health Care System|Alan Wesley, Program Manager|206 277 1079|alan.wesley@va.gov|
20186802|NCT03023410|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
20186803|NCT05263037|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
20186804|NCT05210608|University of Colorado-Boulder|Anahi Collado, Assistant Research Professor|3037354140|anco7407@colorado.edu|
20211800|NCT00686790|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
20211801|NCT00382291|University of Florida|Dr. Regina Bussing|(352) 273-7550|rbussing@ufl.edu|
20211802|NCT02266706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211803|NCT01977352|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat||alishariatmd@gmail.com|
20211804|NCT00409188|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20211805|NCT02879747|Queen Silvia Children´s Hospital and University of Gothenburg|Dr Jovanna Dahlgren, PI and director of Department of Pediatrics|+46702750233|jovanna.dahlgren@gu.se|
20211806|NCT01265966|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
20211807|NCT01577966|UAB|Burt Nabors, MD|205-934-2424|bnabors@uabmc.edu|
20211808|NCT02609737|Memorial Sloan Kettering Cancer Center|Dr. Lisa Bodie, MD, PhD|212-639-6650|bodeil@mskcc.org|
20211809|NCT04636398|University of California San Francisco|Alison El Ayadi|415-659-8367|alison.elayadi@ucsf.edu|
20211810|NCT01169649|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes|646-888-4185|reidyd@mskcc.org|
20211811|NCT00534092|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20211812|NCT02919475|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
20211813|NCT01928446|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
20211814|NCT00628394|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
20211815|NCT02323295|Massachusetts General Hospital|Dr. Joseph Schwab|617-643-0547|JHSCHWAB@PARTNERS.ORG|
20211816|NCT02370784|University of Pittsburgh School of Medicine|Robyn T. Domsic, MD MPH|412-383-8000|rtd4@pitt.edu|
20211817|NCT00478361|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Nizar M Tannir, MDChair Ad Interim, Genitourinary Medical Oncology|713-563-7265|ntannir@mdanderson.org|
20211818|NCT00775983|UCSF|Abby Sokoloff|4155140440|sokoloffa@obgyn.ucsf.edu|
20211819|NCT01059071|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
20211820|NCT00325403|United Therapeutics Corporation|Kevin Laliberte; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
20211821|NCT04741503|Washington University School of Medicine|Ashley J. Housten, OTD, MSCI|314-454-7958|ahousten@wustl.edu|
20211822|NCT01663714|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211823|NCT00674219|UCLA Department of Psychiatry|Alexander Bystritsky MD PhD|(310) 206-5133|abystritsky@mednet.ucla.edu|
20211824|NCT02280421|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20193133|NCT00675584|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20193134|NCT03332784|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20193135|NCT03306420|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20193136|NCT01055704|Mayo Clinic|Dr Michael Camilleri|5072662305|camilleri.michael@mayo.edu|
20193137|NCT03272711|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
20193138|NCT02037776|Osaka Medical College|Kazunari Tominaga, M.D., Ph. D.|+81-72-683-1221|in2139@osaka-med.ac.jp|8096
20211825|NCT00515073|University of Texas MD Anderson Cancer Center|Anuja Jhingran, MD / Professor, Radiation Oncology Department|713-563-6900|CR_Study_Registration@mdanderson.org|
20211826|NCT02764489|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20211827|NCT03840811|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|(919) 843-6893|mmhobbs@med.unc.edu|
20211828|NCT01904383|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211829|NCT01625845|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
20211830|NCT02853929|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211831|NCT01294592|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211832|NCT00693784|Spinal Restoration, Inc.|Jeff F. Doerzbacher|512 225-0405|jeffdoerzbacher@spinalrestoration.com|
20211833|NCT02062606|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
20211834|NCT01072032|Baltimore Veterans Affairs|Dr. Ron Goodman|410-605-7000|ronald.goodman@va.gov|
20211835|NCT00326885|Fresenius Biotech|Manager, Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
20211836|NCT01577537|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
20211837|NCT01460927|El.En. Electronic Engineering S.p.A.|Alessandro Bizzarri|+39 055 8826807|a.bizzarri@elen.it|
20211838|NCT01703741|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20211839|NCT01717456|University of North Carolina at Chapel Hill|William E. Whitehead, PhD, Professor of Medicine|(919) 843-6961|William_Whitehead@med.unc.edu|
20211840|NCT00837577|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211841|NCT00986154|Daiichi Sankyo, Inc.|Lee Schwocho, Sr. Director|732-590-5000|lschwocho@dsi.com|
20211842|NCT02400073|ResMed|Senior Manager, Medical Affairs|+61 8884 1123|alison.wimms@resmed.com|
20211843|NCT00033631|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20211844|NCT03803085|Brandeis University|Yujun Liu|781-736-3300|lyujun@brandeis.edu|
20211845|NCT00272961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211846|NCT03216200|DeviceFarm|VP Operations|510-295-5293|timgrammer@devicefarmtech.com|
20211847|NCT01507831|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20211848|NCT01252238|Brigham and Women's Hospital|Dr. Jonathan Williams|617-278-0882|jwilliams5@partners.org|
20211849|NCT00068237|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20211850|NCT01190202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211851|NCT03029000|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20211852|NCT03276962|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211853|NCT01238211|The Ohio State University|Guido Marcucci, M.D.||Guido.Marcucci@osumc.edu|
20211854|NCT01358708|Aptalis Pharma US, Inc.|Robert Winkler MD, VP, Clinical Development and Operations|(908) 429-4479|rwinkler@aptalispharma.com|4175
20211855|NCT04080882|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20211856|NCT01364259|Stanford University Cancer Center|Dr. Scott G. Soltys, Assistant Professor|650.724.1569|sgsoltys@stanford.edu|
20211857|NCT02475980|University of New Mexico Health Sciences Center|Nancy Sokkary, MD|email|HSC-FamilyPlanningResearch@salud.unm.edu|
20211858|NCT00990093|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
20211859|NCT00281827|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20211860|NCT00435825|Hoffman-LaRoche|Medical Communications|800-821-8590||
20211861|NCT01246986|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20211862|NCT02496221|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211863|NCT03990389|The University of Chicago|Dr. David Beiser|773-702-0307|dbeiser@medicine.bsd.uchicago.edu|
20211864|NCT03770000|Rhizen Pharmaceuticals AG|Dr. Ajit Nair|+41 32 580 0113|an@rhizen.com|
20211865|NCT02464878|Massachusetts General Hospital|James Markmann|617-643-4533|jmarkmann@mgh.harvard.edu|
20211866|NCT02595528|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20211867|NCT00833547|Massachusetts General Hospital|Dr. Dara Manoach|617-726-6148|dara@nmr.mgh.harvard.edu|
20211868|NCT00142454|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20211869|NCT00566098|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
20211870|NCT02460874|UAB|Dr. Hunter Boggs|205-934-5670|dboggs@uabmc.edu|
20211871|NCT01690520|Deverra Therapeutics|Chief Scientific Officer|206-519-5304|cdelaney@deverratx.com|
20211872|NCT00275028|Dana-Farber Cancer Institute|Kimberley MacNeill|617-632-2621|kmacneill@partners.org|
20211873|NCT04364165|Desmond Tutu Health Foundation (DTHF)|Philip Smith|+27 21 650 1895|philip.smith@hiv-research.org.za|
20211874|NCT01847313|University College Dublin|Prof Carel le Roux|+353 1 716 6831|carel.leroux@ucd.ie|
20211875|NCT01014390|Hôpital Erasme|Jacques Devière, MD, PhD|(32) 0-2-555-4697.|Jacques.Deviere@erasme.ulb.ac.be|
20211876|NCT00598559|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20211877|NCT02762565|University of Pennsylvnia|Robyn Broach|215-662-7300|robyn.broach@uphs.upenn.edu|
20211878|NCT01113710|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20211879|NCT03103581|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
20211880|NCT01078623|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20211881|NCT00463866|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20211882|NCT00950183|OrthoCarolina|Dr. Robert B. Anderonson|704-323-2000|robert.anderson@orthocarolina.com|
20211883|NCT02883673|Alydia Health|Kathryn Wine, VP Clinical Operations|415-990-4104|kathryn@alydiahealth.com|
20211884|NCT03568500|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20211885|NCT02144259|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|courtney.schreiber@uphs.upenn.edu|
20211886|NCT00943800|University of Chicago|Hongtao Liu|773-834-8980|hliu2@medicine.bsd.uchicago.edu|
20211887|NCT01768000|Centre for Addiction and Mental Health|Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
20211888|NCT00950833|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211889|NCT02655354|University of Washington School of Medicine|Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
20211890|NCT03522584|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
20211891|NCT01170364|NYPInstitute|Dr. Laurel Mayer|646-774-8067|lsm16@columbia.edu|
20211892|NCT01368276|Amgen, Inc.|Study Director|866-572-6436||
20211893|NCT02041494|University of California, San Francisco|Dr. Hobart W. Harris, Chief of General Surgery|(415) 514-3891|hobart.harris@ucsf.edu|
20211894|NCT03341273|Duke University|Ephraim L. Tsalik, MD, MHS, PhD|919-684-3114|e.t@duke.edu|
20211895|NCT00685919|Vanderbilt University Medical Center|Alfredo Gamboa, MD|615-875-1003|alfredo.gamboa@vumc.org|
20211896|NCT02622074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211897|NCT02114931|Amgen Inc.|Study Director|866-572-6436||
20211898|NCT03726437|GEORGIA STATE UNIVERSITY|Dr. Laura Salazar|4044131396|lsalazar1@gsu.edu|
20211899|NCT00267007|Centocor Ortho Biotech Services, LLC (COBS)|Vice President|215 325 4464||
20211900|NCT00580333|Massachusetts General Hospital|Dr. Steven Isakoff|617 726 6500|sisakoff@partners.org|
20211901|NCT01917188|Intermountain Heart Institute|Patti Spencer|8015074700|patti.spencer@imail.org|
20211902|NCT03818919|Henry Ford Health System|Dr. Toufic Jildeh|(517)2308511|touficjildeh@gmail.com|
20211903|NCT01205529|Vanderbilt University Medical Center|Dan Roden|6153220067|dan.roden@Vanderbilt.Edu|
20211904|NCT03840135|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
20211905|NCT00667719|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20211906|NCT01159769|Alcon Research, Ltd.|Director of Medical Affairs|800-862-5266|medinfo@alconlabs.com|
20211907|NCT01827371|Group Health Research Institute|Lisa Jackson, M.D., M.P.H.|206-442-5216|Jackson.L@ghc.org|
20211908|NCT01361607|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
20211909|NCT00373685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211910|NCT02570165|GlaxoSmithKline|GSK Response Center|866-435-7343||
20211911|NCT01455545|SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA|Dr. Carlos Almonacid|+34 655 53 44 75|caralmsan@gmail.com|
20211912|NCT00411762|Yale University|Howard Hochster||Howard.Hochster@yale.edu|
20211913|NCT04428502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211914|NCT02995694|Alvogen Pine Brook|Meena Venugopal|973-532-7824|meena.venugopal@alvogen.com|
20211915|NCT03712228|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20211916|NCT01430104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20211917|NCT05288673|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|8557522356|clinicaltrials@alexion.com|
20211918|NCT04553484|Semler Scientific|Gena Parker|669-230-2729|gparker@semlerscientific.com|
20211919|NCT01565382|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20211920|NCT01164137|Westview Physician Collaborative|Allan Bailey, M.D.; Study Principal Investigator|(780)-975-1131|baileymd@telusplanet.net|
20211921|NCT01203319|Jiangsu Provincial Center for Disease Control and Prevention|Fengcai Zhu|#86-25-83759418|jszfc@vip.sina.com|
20211922|NCT04147611|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
20211923|NCT05003167|Purdue University|Jessica Huber, Professor and PI|765-494-3796|jhuber@purdue.edu|
20211924|NCT01010230|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-278-5833|kiri.ness@stjude.org|
20211925|NCT01585831|University of Colorado Denver|Nicole Tartaglia, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20211926|NCT01123980|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20211927|NCT01225991|University of California, Los Angeles|Dr. Helen Lavretsky,|310-794-4619|hlavretsky@mednet.ucla.edu|
20211928|NCT04444752|Head of Clinical Operations US|Malinda Longphre|+15105203361|Mlongphre@connectpharm.com|
20211929|NCT00579254|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20211930|NCT02557672|Mayo Clinic|Gregory A. Nuttall, M.D.|(507) 255-3298|gnuttall@mayo.edu|
20211931|NCT00343642|Rush University Medical Center|Ece A Mutlu, Principal Investigator|312 942 5861|Ece_Mutlu@rush.edu|
20211932|NCT02462382|Orlando Orthopaedic Center|Randy Schwartzberg, MD|407-254-2500|orlandosportsdoc@yahoo.com|
20163095|NCT01130896|Johns Hopkins University|Henry Halperin, MD|410-955-2412|nsaju1@jhmi.edu|
20186805|NCT04963270|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20211933|NCT00766506|Janssen-Cilag Ltd. 50-100 Holmers Farm Way, High Wycombe , BUCKS, UK, HP12 4EG|Study Responsible Physician|+44 (0) 1494 567 444||
20211934|NCT02006407|University of Michigan Comprehensive Cancer Center|Dr. Carl Johannes Koschmann, M.D.|734-647-2893|ckoschma@umich.edu|
20211935|NCT03262233|UW-Madison|John Curtin|608-262-0387|jjcurtin@wisc.edu|
20186806|NCT04802967|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20211936|NCT03877237|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
20211937|NCT03372083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20211938|NCT02236754|Columbia University|Dr. Paul Harris|212-305-7363|peh1@cumc.columbia.edu|
20211939|NCT02544633|Mirati Therapeutics, Inc.|Vanessa Tassell, Vice President, Clinical Science|858-332-3438|tassellv@mirati.com|
20211940|NCT02092961|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20211941|NCT02270983|Forest Research Institute, Inc., an affiliate of Allergan|Therapeutic Area Head|862-261-7000|IR-CTRegistration@allergan.com|
20211942|NCT00124176|Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
20211943|NCT01623830|Emory University|Barbara Rothbaum|404-712-8866|brothba@emory.edu|
20211944|NCT00928252|The Queen's Medical Center|Sandi Kwee, MD, PhD|8086915466|skwee@queens.org|
20211945|NCT01605461|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20211946|NCT02024698|CooperVision, Inc.|Manager Global Medical/Scientific Affairs|925-621-3761|javega@coopervision.com|
20211947|NCT03549130|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20211948|NCT04313283|University of Maryland Baltimore|Sarah Dababnah|14107068076|sdababnah@ssw.umaryland.edu|
20211949|NCT04895618|Regulatory Insight, Inc.|Elvira Cawthon|Results Point of Contact Name|elvira@reginsight.com|
20211950|NCT04132232|UAB|Christina Blanchard|205-934-7982|ctblanchard@uabmc.edu|
20211951|NCT00892697|University at Buffalo|Andrew Talal, MD|716-888-4737|ahtalal@buffalo.edu|
20211952|NCT00368537|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20186807|NCT01857245|Prisma Health|Dr. Claire Stam - Director, Addiction Medicine Center|(864) 979-6749|claire.stam@prismahealth.org|
20186808|NCT03122847|Aarhus University Hospital|Dr. Torben Harsløf|+4578455470|torbhars@rm.dk|
20186809|NCT01389856|Actelion Pharmaceuticals Ltd|Pegah Nowbakht/Senior Clinical Trial Scientist|+41 61 565 68 41|pegah.nowbakht@actelion.com|
20186810|NCT04863378|Oregon Heatlh & Science University|Raina Croff, PhD Study investigator/ KL2 trainee|503-494-2367|croff@ohsu.edu|
20186811|NCT04332926|Virginia Commonwealth University|Caroline Cobb, PhD, PI|804-828-8687|cobbco@vcu.edu|
20186812|NCT05832996|University of Iowa|Douglas Jin, MD|319-356-3185|Douglas-Jin@uiowa.edu|
20186813|NCT04376502|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
20186814|NCT02268253|Stemline Therapeutics, Inc.|Ira Gupta, MD|1-877-332-7967|clinicaltrials@menarinistemline.com|
20186815|NCT02547233|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20186816|NCT06019559|Kallyope Inc|Clinical Director|917-336-3279|contactus@kallyope.com|
20186817|NCT05949788|ShenzhenBMCHH|Dr. Jun Luo|015818671195|luojun-78@163.com|
20186818|NCT05213390|Newcastle University|Prof Edward Meinert|191 208 6000|edward.meinert@newcastle.ac.uk|
20186819|NCT01824537|McGill University|Eduardo L Franco|514-398-6032|eduardo.franco@mcgill.ca|
20186820|NCT05362487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186821|NCT05986682|Duke University School of Medicine|Dr. Thomas W. LeBlanc|919-668-2115|thomas.leblanc@duke.edu|
20186822|NCT06215521|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20186823|NCT04096040|ZOLL Medical|Director of Scientific Affairs|4129683333|nbianco@zoll.com|14410
20186824|NCT03333590|Abigail Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-355-2947|kevin.flanigan@nationwidechildrens.org|
20186825|NCT04044768|Adaptimmune|Clinical Trials Management|+1 (215) 825 9260|clinicaltrials@adaptimmune.com|
20186826|NCT03344094|University of Chicago|anthony t reder|773-702-6204|areder@neurology.bsd.uchicago.edu|
20186827|NCT03808818|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20186828|NCT05415722|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
20186829|NCT01363388|ChemoCentryx|Study Director|650-210-2900||
20186830|NCT06238609|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20186831|NCT04537715|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
20186832|NCT02191618|Sequent Medical, Inc|Director, Clinical Operations|714-247-8000|anne.hurley@microvention.com|
20186833|NCT03031470|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20186834|NCT03435614|MUHC-RIMUHC|Marc Perreault|514-343-6111|marc.perreault@umontreal.ca|3788
20186835|NCT04215146|Oncolytics Biotech Inc.|Chief Medical Officer|(403) 670-7377|info@oncolyticsbiotech.com|
20186836|NCT02489903|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
20186837|NCT03848065|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20186838|NCT03496168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20186839|NCT05530603|University of South Dakota|Soonhee Roh|6053571593|Soonhee.Roh@usd.edu|
20186840|NCT02619994|Seoul National University|Dr. Prof. JJ Yim|82-02-1588-5700|yimjj@snu.ac.kr|
20186841|NCT04568603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20186842|NCT04564742|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20186843|NCT04131686|Boryung|Ji-Yeon Kim|82-2-708-8128|jiyeonkim@boryung.co.kr|
20211953|NCT04248855|Kanyos Bio (A wholly owned subsidiary of Anokion SA)|Medical Director|+1 857-320-6607|clinicaltrials@anokion.com|
20211954|NCT05483920|Black Hills State University|Dr. Ashley Pfeiffer|(605) 381-5370|ashley.pfeiffer@bhsu.edu|
20211955|NCT02784925|WanFangH|Ming-Shun Wu|88629307930|mswu@tmu.edu.tw|7923
20186844|NCT05194540|Leo Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
20186845|NCT05126433|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20186846|NCT05144009|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20186847|NCT00764751|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20186848|NCT04710498|Stanford University|Dr. Vasu Divi|650-725-5968|vdivi@stanford.edu|
20186849|NCT04406623|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
20186850|NCT05827094|University of Washington School of Nursing|Associate Professor|2068493301|ozasl@uw.edu|
20186851|NCT02809443|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
20186852|NCT02690558|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20186853|NCT04948697|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20186854|NCT05201079|Mikrobiomik Healthcare Company S.L.|Olaia Aurtenetxe Saez|+34 944 540 166|ensayosclinicos@mikrobiomik.net|
20186855|NCT04145440|HI-Bio, A Biogen Company|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20186856|NCT03697096|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
20186857|NCT05281562|Prisma Health|J. Benjamin Jackson|803-296-9610|benjamin.jackson@prismahealth.org|
20186858|NCT01767636|Mayo Clinic|Brian Costello MD|507/284-2511|Costello.Brian@mayo.edu|
20186859|NCT04898673|Cochlear Limited|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20186860|NCT05123118|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
20186861|NCT03365882|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
20186862|NCT06181227|Aviceda Therapeutics|David Callanan|817-312-9258|dcallanan@avicedarx.com|
20186863|NCT05292872|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20186864|NCT00470704|Dana-Farber Cancer Institute|Nancy Lin|6176322335|Nancy_Lin@dfci.harvard.edu|
20186865|NCT02561247|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20186866|NCT05540665|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20186867|NCT04502888|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
20186868|NCT03462030|Johns Hopkins University|Dr. Robert Wood|410-955-5883|rwood@jhmi.edu|
20186869|NCT02675751|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan Ph.D.|+1 408-273-4081|skasthur@its.jnj.com|
20186870|NCT03371381|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186871|NCT02979327|Mayo Clinic|Anna Svatikova, M.D., Ph.D.|507-284-3685|Svatikova.Anna@mayo.edu|
20186872|NCT01073566|Calibra Medical|Vice President Clinical Affairs|650-298-4750|ddreon@calibra.com|
20186873|NCT05368402|Dompé Farmaceutici SpA|Clinical Development & Operations|+30 902 583831|clinicaltrials@dompe.com|
20186874|NCT05260112|University of Pennsylvania|Lily Arya, MD|267-785-8024|larya@pennmedicine.upenn.edu|
20186875|NCT05672069|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
20186876|NCT03001713|Kaiser Permanente Center for Health Research|Rachel Gold, PhD MPH|503-335-2400|rachel.gold@kpchr.org|
20186877|NCT03858634|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20186878|NCT03150173|Montefiore Medical Center|Dr. Aaron D. Fox, Professor, General Internal Medicine|718-920-7173|adfox@montefiore.org|
20186879|NCT04518917|Washington University in St. LOuis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
20186880|NCT03461276|Araclon Biotech, S.L.|Maria Pascual Lucas|+34976796562|mpascual@araclon.com|
20186881|NCT02724449|North Shore University Hospital|Mary Brennan, Assist Director WOCN|516-562-8252|mbrennan@northwell.edu|
20186882|NCT01802788|Abbott|Vinny Podichetty, Clinical Program Director|779-209-9425|vinny.podichetty@abbott.com|
20186883|NCT02043678|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20186884|NCT03216057|Hospital Infantil de Mexico Federico Gomez|Blanca Estela Del Rio Navarro|+525552289917|leijamjj@gmail.com|2444
20186885|NCT04625686|Cincinnati Children's Hospital Medical Center|Rosalie Hemphill LSW|5044940883|rosalie.hemphill@cchmc.org|
20186886|NCT03904147|Abbott|Natalie Richardson, Senior Clinical Project Manager|651-756-3842|natalie.richardson@abbott.com|
20186887|NCT05269667|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20186888|NCT05448105|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
20186889|NCT04349371|Columbia University|Anca Askanase, MD|212-305-0856|ada20@cumc.columbia.edu|
20186890|NCT05270408|UT Southwestern Medical Center|Dr Christian LoBue|2146485265|Christian.LoBue@utsouthwestern.edu|
20186891|NCT03768505|MEI Pharma|Richard Ghalie, MD CMO|858 898 0956|rghalie@meipharma.com|
20186892|NCT05331053|Penn State University|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
20186893|NCT06180954|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20186894|NCT04032704|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186895|NCT05038878|Icahn School of Medicine at Mount Sinai|Dr. Alice C. Levine|(212) 241-3422|alice.levine@mountsinai.org|
20186896|NCT03468868|Shepherd Center, Atlanta, GA|Deborah Backus, PT, PhD|404-352-2020|deborah.backus@shepherd.org|
20186897|NCT04992520|PATH|Patricia Njuguna/Senior Medical Officer|+254 20 3877177|pnjuguna@path.org|
20193139|NCT01018732|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20193140|NCT01536171|University of Florida|Dr. Heather K. Vincent, PhD|352-273-7410|vincehk@ortho.ufl.edu|
20163096|NCT02106403|GlaxoSmithKline|GSK Response Center|866-435-7343||
20186898|NCT05825755|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|val-hic@humanitcare.com|
20193141|NCT03928392|Loma Linda University|Dr. Dragana Krpalek|9095584328|dkrpalek@llu.edu|41340
20211956|NCT01674478|Wake Forest University Health Sciences|Dr. Qing Yang||qyang@wakehealth.edu|
20186899|NCT04103580|Washington University|Kyle Pitzer: Study Statistical Data Analyst|314-747-5361|kyleapitzer@wustl.edu|
20186900|NCT02749006|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|l.yatham@ubc.ca|
20186901|NCT05757453|NXTech|Principal Investigator for Study 31380|7814721140|external+studyinvestigator@nxtech.co|
20211957|NCT02281409|Memorial Sloan Kettering Cancer Center|Dr. Jedd Wolchok, MD, PhD|646-888-2315|wolchokj@mskcc.org|
20211958|NCT05784571|Pennington Biomedical Research Center, Baton Rouge, LA|Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
20211959|NCT02732561|Wake Forest Health Sciences|James Kimball, MD|1 (336) 716-9702|jkimball@wakehealth.edu|
20211960|NCT01886300|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20211961|NCT01156571|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
20211962|NCT01797120|PrECOG, LLC|Carolyn Andrews|267-207-4070|candrews@precogllc.org|
20211963|NCT00295854|Medicinova Inc|Richard E. Gammans PhD Chief Developing Officer|848-373-1500|gammans@medicinova.com|
20211964|NCT00672620|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20211965|NCT01095757|Winship Cancer Institute Emory University|Dr. Edmund Waller|404-727-4995|ewaller@emory.edu|
20211966|NCT01578707|Pharmacyclics, LLC|Anita Szoke|(669) 215-7235|aszoke@pcyc.com|
20186902|NCT05746299|University of Pennsylvania|Anna Schapiro|215-898-0482|aschapir@sas.upenn.edu|
20186903|NCT01919554|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 20 00|mroux@stallergenes.com|
20186904|NCT06457802|Vanderbilt University School of Nursing|Dr. Shelagh Mulvaney, PhD|6153221198|shelagh.mulvaney@vanderbilt.edu|
20186905|NCT01652196|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.hay@osumc.edu|
20186906|NCT04880863|NeoTX Therapeutics Ltd.|Dr. Ilana Lorber, VP of Clinical Operations|+972-3-912-5853|ilanal@neotx.com|213
20186907|NCT01152450|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186908|NCT05239455|Terumo BCT, Inc|Erin Goodhue, DO, MPH, Director, Clinical Affairs|614-400-4638|Erin.Goodhue@TerumoBCT.com|
20186909|NCT03459729|Froedtert and the Medical college of Wisconsin|Stuart Wong, MD|414-805-4600|swong@mcw.edu|
20186910|NCT05844137|Duke University|Anastasia Alexopoulos|1 919 684 4005|anastasia.alexopoulos@duke.edu|
20211967|NCT02736227|Northwestern University|Josh Levitsky|312-695-4413|j-levitsky@northwestern.edu|
20211968|NCT04120194|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20211969|NCT01202994|University of Utah|Dr. Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|801
20186911|NCT05704543|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
20186912|NCT05493072|Imperial College NHS Healthcare Trust|Calandra Feather|07977185577|calandra.feather@nhs.net|
20186913|NCT00597909|Horizon Pharma plc|Bruce Scharschmidt, MD||bscharschmidt@horizonpharma.com|
20186914|NCT05576155|University of Iowa|Kelsey Schwartz|319-467-3096|kelsey-schwartz@uiowa.edu|
20186915|NCT04081103|Amber Ophthalmics|Director of Clinical Trials|858-539-3418|clinical@Amberophthalmics.com|
20193142|NCT02781311|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20211970|NCT02528318|Windtree Therapeutics, Inc.|Robert Segal, MD, FACP|215-488-9300|rsegal@windtreetx.com|9450
20193143|NCT02165826|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20193144|NCT04115189|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193145|NCT00250432|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193146|NCT01255761|UCB Clinical Trial Call Center|(UCB) Study Director|+1 887 822 9493||
20193147|NCT00873327|Duke University Medical Center|Brian Smith, MD. MPH|919-668-8951|brian.smith@duke.edu|
20193148|NCT04147858|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20193149|NCT02336425|Novartis Pharmaceuticals|Study Director|862-778-8300||
20193150|NCT00794170|University of Pennsylvania|Karen Glanz|215-898-0613|kglanz@upenn.edu|
20193151|NCT00658606|Astellas Pharma Canada, Inc.|Director, Scientific Affairs||ClinicalTrials@us.astellas.com|
20193152|NCT03981939|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20211971|NCT03870997|Evidation Health|Executive Director, Digital Health Outcomes|650-389-9550|results@evidation.com|
20211972|NCT00219557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211973|NCT03063632|Cancer Immunotherapy Trials Network|Anna Wright|206-667-2541|akwright@fredhutch.org|
20211974|NCT00106028|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20211975|NCT02296606|The University of Texas Southwestern Medical Center|DaiWai Olson|214-648-8946|Daiwai.Olson@UTSouthwestern.edu|
20193153|NCT01056263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193154|NCT04101565|Johns Hopkins Dept of Pediatrics / Division of Adolescent/Young Adult Medicine|Dr. Arik Marcell|4432878946|amarcell@jhu.edu|
20193155|NCT04461158|Medical University of South Carolina|Dr. Jim C. Oates, MD, Rheumatology Division Director|843-792-1991|oatesjc@musc.edu|
20193156|NCT01068210|Memorial Sloan Kettering Cancer Center|Dr. Lee Jones, PhD|646-888-8103|jonesl3@mskcc.org|
20193157|NCT00699842|Thomas Jefferson University|Emmanuel Besa, MD|215-955-8874|Emmanuel.Besa@jefferson.edu|
20193158|NCT06314438|University of Washington|Principal Investigator|206-221-3595|stonew@uw.edu|
20193159|NCT01806389|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
20193160|NCT02201901|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20193161|NCT00869947|Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
20193162|NCT02559310|Nabriva Therapeutics US, Inc.|Jennifer Schranz, MD, Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
20193163|NCT02633397|Dean, University of Maryland School of Medicine, Vice President for Medical Affairs, University of Maryland, Baltimore|Mark Gladwin|410-706-7410|mgladwin@som.umaryland.edu|
20193164|NCT03595878|University of North Carolina Lineberger Comprehensive Cancer Center|Colette Shen|+1 984-974-0400|cjshen@email.unc.edu|
20193165|NCT00469859|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20193166|NCT03494985|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20193167|NCT04124471|Children's Hospital of Philadelphia|Ignacio Tapia, MD|(267) 426-5842|tapia@chop.edu|
20193168|NCT03036124|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
20193169|NCT02394925|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
20193170|NCT03670277|Johnson & Johnson Vision Care|Xu Cheng, MD, PhD, FAAO - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
20193171|NCT02660112|Mayo Clinic|Ralitza H. Gavrilova, M.D.|507-293-1283|Gavrilova.Ralitza@mayo.edu|
20193172|NCT02774668|University of Missouri|Elizabeth Parks, Professor of Nutrition and Exercise Physiology|573-882-5864|parksej@missouri.edu|
20193173|NCT04581343|PanCAN|Samantha Pedersen, Sr. Director Clinical Operations|310.706.3726|spedersen@pancan.org|
20193174|NCT04403542|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20193175|NCT02737826|Medical University of South Carolina|Dr. Kelly Barth|843-792-0686|stephen@musc.edu|
20193176|NCT00078377|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20193177|NCT04546217|University of Alabama at Birmingham|Dr. Sarah dos Anjos|2059347323|smanjos@uab.edu|
20193178|NCT00863512|Duke University Medical Center|David Harpole, M.D.||david.harpole@duke.edu|
20193179|NCT03121820|GEROPHARM|GEROPHARM Clinical Leader|+7(812) 703-79-75|inform@geropharm.ru|
20193180|NCT00580489|Metrohealth Medical Center|Charles Emerman|2167783577|cemerman@metrohealth.org|
20193181|NCT04292470|University of California Davis|Dr. Michelle Dossett|916-734-5367|mdossett@ucdavis.edu|
20193182|NCT00867100|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
20193183|NCT02906020|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20193184|NCT04698915|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
20193185|NCT01124097|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
20193186|NCT03023553|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20193187|NCT00399841|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20211976|NCT00947011|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20211977|NCT00814658|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
20211978|NCT05266456|Vaxcyte|Vice President of Clinical Development|(650) 585-0029|clinicaltrialsgov@vaxcyte.com|
20211979|NCT05267574|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
20211980|NCT01610167|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|(260) 755-1099||
20186916|NCT04581564|Assistant Professor. Speech, Language and Hearing|Dr. Yune Lee|972-883-5639|yune.lee@utdallas.edu|
20186917|NCT04828005|Opiant Pharmaceuticals|Clinical Director|+1 804 379 1090|PatientSafetyNA@Indivior.com|
20193188|NCT04829747|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20211981|NCT04726514|Berendo Scientific, LLC|Eric Kezirian|4152358706|eric.kezirian@gmail.com|
20211982|NCT06371079|Basrah Medical College|Loay Abdulmutalib Almusawi|009647705559205|loay.almusawi@uobasrah.edu.iq|
20211983|NCT02746705|NYU Langone Health|Leigh Charvet|929 455 5125|leigh.charvet@nyulangone.org|
20211984|NCT01964105|WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, SAINT LOUIS|TERENCE MICHAEL MYCKATYN, PI, PROFESSOR, PLASTIC SURGERY|314-362-4263|myckatyn@wustl.edu|
20211985|NCT00575328|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
20211986|NCT04322968|VA Ann Arbor Healthcare System|Dr. Alisher Dadabayev, Pain POC|734-222-7639|Alisher.Dadabayev@VA.GOV|
20211987|NCT00124449|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20211988|NCT03940586|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20211989|NCT02006147|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
20211990|NCT04643782|Northwestern University|Phyllis Zee, MD|312-503-5944|SleepSensors@northwestern.edu|
20211991|NCT01989195|Stanford University|Phillip C. Yang, MD|650-498-8008|phillip@stanford.edu|
20211992|NCT03360656|CoolTech|Director of Clinical Operations|2036856352|channan@cooltechcorp.com|
20211993|NCT00811070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20211994|NCT03821324|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20211995|NCT00585039|Phoenix Children's Hospital|Dr Blake Bulloch|602-546-1950|bbulloch@phoenixchildrens.com|
20211996|NCT00951899|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
20211997|NCT04929522|AinShams University|Director of Clinical Trials in Endodontics|+2022639083|endohashem@gmail.com|
20211998|NCT00860574|Fred Hutch/University of Washington Cancer Consortium|Joachim Deeg|206.667.5985|jdeeg@fredhutch.org|
20211999|NCT01893983|San Francisco VA Healthcare System|Dr. Karen Seal|415-2214810|karen.seal@va.gov|24852
20212000|NCT01165242|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212001|NCT01725815|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
20212002|NCT04126057|SightGlass Vision, Inc.|Joe Rappon, OD, MS, FAAC|678-642-9117|joe@sightglassvision.com|
20212003|NCT01859390|University of Colorado School of Medicine|Dr. Scott Sagel, Professor of Pediatrics|720-777-2522|scott.sagel@ucdenver.edu|
20212004|NCT01567371|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
20212005|NCT01706198|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212006|NCT01084005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212007|NCT02415166|LaurateInstitute|Jonathan Savitz|918 502 5104|jsavitz@laureateinstitute.org|
20212008|NCT03377556|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20212009|NCT00472446|Cantonal Hospital St. Gallen|Thomas Steffen, MD|0041 71 494 1111|thomas.steffen@kssg.ch|
20212010|NCT00621686|Mayo Clinic|Evanthia Galanis, M.D.|507/284-3559|Galanis.evanthia@mayo.edu|
20212011|NCT02008721|Department of Neurology, Ludwig-Maximilians-University Munich, Munich, Germany|Prof. Dr. Johannes Levin||johannes.levin@med.uni-munechen.de|
20212012|NCT01630200|Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology|Dr. Matthias Urban|+43(0)6508125980|matthias.urban1@gmx.net|
20212013|NCT04634110|University of Colorado Hospital|Dr. Chad Rusthoven|720-516-0150|chad.rusthoven@cuanschutz.edu|
20186918|NCT03450980|Schepens Eye Research Institute of Mass Eye & Ear, Harvard Medical School, Boston, MA, USA|Gang Luo|(617) 573-4177|gang_luo@MEEI.HARVARD.EDU|
20186919|NCT06212804|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
20186920|NCT03287817|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
20186921|NCT05543915|NYU Langone Health|Guiseppina Pilloni|646-501-9274|giuseppina.pilloni@nyulangone.org|
20186922|NCT04321395|Washington University in St. Louis|Assistant Professor|314-362-8708|ssfarabi@wustl.edu|
20186923|NCT01824875|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20186924|NCT02014649|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
20186925|NCT04195698|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20186926|NCT05459688|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20186927|NCT01129102|Nobelpharma|Department director of clinical development department 1|+81-5651-1177|murakami@nobelpharma.co.jp|
20186928|NCT04475679|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20186929|NCT03379675|Janssen Research and Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186930|NCT02817776|Biosense Webster Inc|Kendra McInnis|+1 949 322-8010|kmcinnis@its.jnj.com|
20186931|NCT05349500|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20186932|NCT03381196|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186933|NCT02359890|Biosense Webster|Robert Stagg|(800) 729-9010|RStagg@its.jnj.com|
20186934|NCT03628924|Janssen Research & Development, LLC|Product development portfolio leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186935|NCT04341896|New York University|Rhiannon Reed|205-999-3360|rjd1125@uab.edu|
20186936|NCT03032107|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
20186937|NCT04499924|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20186938|NCT04563546|Duke University|Julian T. Hertz, MD|919-681-0196|julian.hertz@duke.edu|
20186939|NCT03011333|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20186940|NCT04413708|Duke University|Sara LeGrand|919-438-0448|sara.legrand@duke.edu|
20186941|NCT06044090|University of Pittsburgh|Gabriella Alvarez, PhD|412-624-4500|gabyalvarez@pitt.edu|
20186942|NCT02861300|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. David Bajor|(216) 286-4414|david.bajor@uhhospitals.org|
20193189|NCT02330094|Mayo Clinic|Dr. William D. Freeman|904-953-7103|freeman.william1@mayo.edu|
20193190|NCT00708851|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel, MD|609-443-4501|dreamacres1@aol.com|
20193191|NCT01535001|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
20193192|NCT00079339|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
20212014|NCT00671671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212015|NCT00772577|Novartis Pharmaceuticals|Study Director|862-778-8300||
20163097|NCT02024724|Northwestern University, Feinberg School of Medicine|Antoun Nader, M.D.|312-695-4814|a-nader2@northwestern.edu|
20212016|NCT03211156|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|schwebke@uab.edu|
20212017|NCT00208949|Emory University|Dr. Sagar Lonial|404-778-1900|SLONI01@emory.edu|
20212018|NCT02145403|University of Michigan Rogel Cancer Center|Attaphol Pawarode, M.D.|734-936-8785|pawarode@med.umich.edu|
20212019|NCT03947788|NorthShore University HealthSystem|Emily White VanGompel|224-364-7300|ewhitevangompel@northshore.org|
20212020|NCT02199652|Medical College of Georgia; Augusta University|William Vaughn McCall|7067216719|WMCCALL@augusta.edu|
20212021|NCT00553540|Cleveland Clinic Florida|Dr. David Westerdahl|954-659-5422|westerd@ccf.org|5422
20212022|NCT02951884|Loyola University Medical Center|William Lack, M.D.|708-216-1175|wlack@luc.edu|
20212023|NCT01859325|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
20212024|NCT03565211|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20212025|NCT02662608|The University of Texas (UT) MD Anderson Cancer Center|Dr. Renata Ferrarotto, Asst Professor/Thoracic/Head & Neck Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20212026|NCT00950599|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20212027|NCT01684722|University of Washington|Ian de Boer, MD, MS|2066165403|deboer@u.washington.edu|
20212028|NCT01042496|Mayo Clinic|Dr. Mark A. Frye|507-284-6213|MFrye@mayo.edu|
20212029|NCT02273206|Clinical Directors Network|Andrea Cassells, MPH|212-382-0699|acass@cdnetwork.org|227
20212030|NCT03082391|Cleveland Clinic Foundation|Dr. Michael Rosen|2164453441|rosenm@ccf.org|
20212031|NCT00927888|Stanford University|David Drover, MD|6507250364|ddrover@stanford.edu|
20212032|NCT02741271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212033|NCT03652961|NYU Langone Health|Gregg J. Silverman, MD MACR|212 263 9440|Gregg.Silverman@nyulangone.org|
20212034|NCT00410410|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20212035|NCT01783496|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
20212036|NCT01023269|Medtronic International Trading Sarl|Alexandra Delacour, Clinical Research Manager|0041218027622|alexandra.delacour@medtronic.com|
20212037|NCT01953783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20212038|NCT01789281|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20212039|NCT00686920|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20212040|NCT00833781|Mass General Hospital|Dr. Rajesh Gandhi|617-724-9690|rgandhi@partners.org|
20212041|NCT00449930|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20212042|NCT01785186|Tropical Institute of the Ludwig-Maximilians University in Munich, Germany|Dr. Norbert Heinrich|0049 89 2180 17605|heinrich@lrz.uni-muenchen.de|
20212043|NCT03124381|Johnson & Johnson Consumer Inc.|Ali Fassih, Ph.D.|908-904-3259|Afassih@its.jnj.com|
20212044|NCT01365845|University of Florida Proton Therapy Institute|Dr. Julie Bradley|904-588-1800|jbradley@floridaproton.org|
20212045|NCT01190306|Topcon Medical Systems|Robert Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
20212046|NCT05017493|Hiwa Hospital - KRG|Dr. Dara Omer|+9647701586707|mailto:danaomar1979@gmail.com|
20212047|NCT02473510|MedImmune, LLC|Ashwin Swami, MD|+1 301 398 5000|information.center@astrazeneca.com|
20212048|NCT01392859|Children's Mercy Hospital|Dr. Bridgette Jones|816-302-3811|bljones@cmh.edu|
20212049|NCT00990561|UCSF|John Koo, Principle Investigator|415-476-4701|john.koo@ucsfmedctr.org|
20212050|NCT00345683|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212051|NCT00492089|The University of Texas MD Anderson Cancer Center|Monica Loghin, MD / Assistant Professor|K Hunter, RN 713-745-5769|CR_Study_Registration@mdanderson.org|
20212052|NCT03182686|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20212053|NCT00863369|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20212054|NCT01154127|Novartis Pharmaceuticals|Study Director|862-778-8300||
20212055|NCT01697449|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212056|NCT01169844|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
20212057|NCT01337050|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212058|NCT00003102|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20212059|NCT01559818|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
20212060|NCT04071626|University Hospitals Cleveland Medical Center|Dr. Trevor Jenkins|(216)844-1229|Trevor.Jenkins@UHhospitals.org|
20212061|NCT00931385|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212062|NCT05113901|Rush University Medical Center|Methylprednisolone Taper to Treat Delayed Post-Operative Recovery After Total Knee Arthroplasty: a D|3124322468|anne.debenedetti@rushortho.com|
20163098|NCT00961714|Alphatec Spine, Inc.|Glen Seidner, Clinical Affairs|760-494-6789|gseidner@alphatecspine.com|
20163099|NCT00177255|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
20212063|NCT04582409|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20212064|NCT00665626|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20212065|NCT01799213|Veterans Health Administration, West Haven, CT|Lisa G. Suter, MD|2039325711|lisa.suter@va.gov; lisa.suter@yale.edu|
20212066|NCT01629693|Alcon Research, Ltd.|Jessie Lemp, GMA Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20212067|NCT04385199|Henry Ford Health System|Dr Geneva Tatem|313-916-2431|gtatem1@hfhs.org|
20212068|NCT03927781|University of Missouri|Dr Katie Murray|573-884-8768|murraykat@health.missouri.edu|
20212069|NCT04079842|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
20212070|NCT01025193|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
20212071|NCT02904200|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
20186943|NCT04910152|The Ohio State University Comprehensive Cancer Center|Dr. Hannah Choe|614-293-3196|Hannah.choe@osumc.edu|
20186944|NCT05459857|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
20163100|NCT01128946|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212072|NCT01901211|Holland Bloorview Kids Rehabilitation Hospital|Darcy Fehlings, MD, MSc, FRCP(C)|416-425-6220|dfehlings@hollandbloorview.ca|3586
20212073|NCT02133352|Boston University|Kimberly Finch|617-638-4475|kimtobin@bu.edu|
20212074|NCT03705169|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20212075|NCT00185211|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20212076|NCT01759537|NYU College of Dentistry|Ismael Khouly|212-998-9800|iek3@nyu.edu|
20212077|NCT00606684|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212078|NCT01809054|Sinai Center for Thrombosis Research|Kevin Bliden|4106014795|kbliden@lifebridgehealth.org|
20212079|NCT01759381|Duke|Carlos A. Bagley|919-943-1564|carlos.bagley@gmail.com|
20212080|NCT00698022|Corcept_Therapeutics|Robert Roe, MD|650-688-8812|rroe@corcept.com|
20212081|NCT01275313|University of Pittsburgh|David Brienza, Professor|412-624-6383|DBRIENZA@pitt.edu|
20212082|NCT00631670|University of Florida, Dept. of Radiation Oncology|Bridget Fitzgerald, Clinical trials coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
20212083|NCT01907737|HCFMUSP/FFM|Adriana Conforto|551126617955|adriana.conforto@gmail.com|
20212084|NCT03135379|Brooke Army Medical Center|Benjamin M. Krainin|210-916-0808|Benjamin.M.Krainin.mil@mail.mil|
20212085|NCT00330421|Dana-Farber Cancer Institute|Jeffrey A. Morgan, M.D.|617-632-5204|jamorgan@partners.org|
20212086|NCT00909727|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
20212087|NCT01684566|Camurus AB|Håkan Olsson DDS, PhD|+46 46 2863852|Hakan.Olsson@camurus.com|
20212088|NCT00815490|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
20212089|NCT00829413|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
20212090|NCT02203565|Stanford University School of Medicine|Dr. Kathleen Horst|6507256009|kateh@stanford.edu|
20212091|NCT04272775|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20212092|NCT01967888|Dompé|Mauro P. Ferrari, Pharm D|+3902583831|info@dompe.com|
20212093|NCT00891774|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20212094|NCT00004143|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
20212095|NCT03175120|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20212096|NCT02578732|Brown University Oncology Research Group|Howard Safran, MD|401-863-300|BrUOG@BROWN.EDU|
20212097|NCT01614509|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
20212098|NCT01894984|XIAN-JANSSEN PHARMACEUTICAL|Medical affairs director|86-10-58218307||
20212099|NCT00827359|Beth Israel Deaconess Medical Center|Rupal Bhatt|6177352060|rbhatt@bidmc.harvard.edu|
20212100|NCT00323609|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
20212101|NCT03124797|Masimo|Tala Harake||studies@masimo.com|
20193193|NCT02563548|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
20193194|NCT01547598|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20193195|NCT00371176|Boston VA Healthcare System|Dr. Brett Litz|857 364 4131|brett.litz@va.gov|
20193196|NCT01573949|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
20193197|NCT00203047|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20193198|NCT00340704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193199|NCT00121667|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20193200|NCT02879383|Fractyl Laboratories, Inc.|Sarah Hackett, Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
20193201|NCT05186311|Becton, Dickinson and Company|Clinical Program Manager|9292850651|Pierre.Asselin@bd.com|
20193202|NCT02125279|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20193203|NCT02018653|University of Texas (UT) MD Anderson Cancer Center|Sai-Ching J. Yeung, MD||CR_Study_Registration@mdanderson.org|
20193204|NCT02677870|UHCMC|Dr. Lori-Anne Schillaci|216-844-3936|lori-anne.schillaci@uhhospitals.org|
20193205|NCT01607879|Froedtert and the Medical college of Wisconsin|Kathryn Bylow, MD|414-805-4600|kbylow@mcw.edu|
20193206|NCT01392703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20193207|NCT03845140|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20193208|NCT05020145|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193209|NCT03724253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20193210|NCT01592045|United Therapeutics Corporation|Allison Lim|919-425-8799|alim@unither.com|
20193211|NCT03343093|University of Minnesota|Gudrun Kilian|612-626-9568|kilian@umn.edu|
20193212|NCT01908751|McMaster University|Dr. Mohit Bhandari|9055274322|bhandam@mcmaster.ca|
20193213|NCT00742326|NIAID|Colleen Hadigan MD MPH|301-594-5754|hadiganc@niaid.nih.gov|
20193214|NCT04937920|DermBiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
20193215|NCT00894504|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20193216|NCT03635086|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193217|NCT00723125|BrUOG|William Sikov, MD|4018633000|Roxanne_Wood@brown.edu|
20193218|NCT02196077|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
20193219|NCT03316807|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
20212102|NCT00267293|Penn State Children's Hospital|Ian M Paul, MD, MSc|717-531-5656|ipaul@hmc.psu.edu|
20212103|NCT00676585|Beth Israel Deaconess Medical Center|Dr. Michael Donnino||mdonnino@bidmc.harvard.edu|
20212104|NCT01612156|University of Southern California|Begum Ozel, MD|323-441-9589|ozel@usc.edu|
20212105|NCT01141283|Purdue Pharma LP|Clinical Leader, Medical Director|800-733-1333||
20212106|NCT00198081|Indiana University|Christian M. Schmidt, MD|317-278-8349|maxschmi@iupui.edu|
20212107|NCT02124746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212108|NCT00397839|Hoffmann-La Roche|Medical Communications|800-821-8590||
20212109|NCT02868281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212110|NCT01722266|University at Buffalo|Nitesh D Kuhadiya,MD,MPH ;Co-Investigator;Assistant Professor of Medicine, Section of Endocrinology|716-626-7998|niteshku@buffalo.edu|
20212111|NCT03811249|Refocus Group, Inc.|Linda Stewart, Director of Regulatory and Quality|214-368-0200|lstewart@refocus-group.com|431
20212112|NCT01712230|University of Colorado Anschutz Medical Campus|Wendy Kohrt, PhD|303-724-1913|Wendy.Kohrt@CUAnschutz.edu|
20212113|NCT01504867|Mayo Clinic|Dr. Daryl J. Kor|507-284-7678|Kor.Daryl@mayo.edu|
20212114|NCT00571922|NYU Langone Medical Center|The Office of Clinical Trials|212.263.4210|clinicaltrials@nyumc.org|
20212115|NCT04525157|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
20212116|NCT01741480|WashingtonU|Dr. Marin Kollef|314-454-8764|mkollef@dom.wustl.edu|
20212117|NCT00362401|Aarhus University Hospital, Skejby|Dr. Thais A. Pedersen, primary investigator|+45 8949 5484|thais.a.pedersen@ki.au.dk|
20212118|NCT01783730|AbbVie|Global Medical Services|800-633-9110||
20212119|NCT02533999|Nemours Children's Specialty Care|Kathryn Blake, PharmD|904-697-3806|kathryn.blake@nemours.org|
20212120|NCT03210259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212121|NCT02163811|VA Puget Sound Health Care System|Dr. Aaron Turner|(206) 277-6134|Aaron.Turner@va.gov|
20212122|NCT01154153|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
20212123|NCT00389649|Universitry of Maryland|Stephen Gottlieb, MD|4103288788|sgottlie@medicine.umaryland.edu|
20212124|NCT00964223|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212125|NCT04304950|Rush University Medical Center|Dr. Garth R. Swanson|312-563-3871|Garth_Swanson@rush.edu|33871
20212126|NCT00408876|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20163101|NCT04698993|Draegerwerk AG & Co. KGaA|Dr Rainer Polzius|+498824514429|rainer.polzius@draeger.com|
20212127|NCT01488019|Mylan UK|Dik Ng, PhD, Director Clinical Science|+44 1304626895|dik.ng@mylan.co.uk|
20212128|NCT03404206|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20212129|NCT05478603|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212130|NCT03634488|Vanderbilt UniversityVanderbilt-Meharry Center of Excellence in Sickle Cell Disease|Leshana Saint Jean|6158751992|leshana.saint.jean@vumc.org|
20212131|NCT03654209|Indiana University|Clinical Research Coordinator|317-948-0724|rlahr@iu.edu|
20212132|NCT00096486|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
20212133|NCT01512979|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212134|NCT00529568|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212135|NCT04049552|UT Health San Antonio|Dean L Kellogg Jr.|210-617-5311|kelloggd@uthscsa.edu|
20212136|NCT01201356|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20212137|NCT02033876|Mayo Clinic|Dr. Michael Camilleri|507-284-2687|camilleri.michael@mayo.edu|
20212138|NCT00738920|University at Buffalo, SUNY|Dr. Jeffrey Lackner|716-898-5671|lackner@buffalo.edu|
20212139|NCT00530439|Odense University Hospital|Dr. Christina Vinter|+45 21782118|c.vinter@dadlnet.dk|
20212140|NCT00420290|Vanderbilt University|Adriana Hung, MD||adriana.hung@vanderbilt.edu|
20212141|NCT00677924|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20212142|NCT02257632|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20212143|NCT02468557|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20212144|NCT04967313|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
20212145|NCT03167099|West Virginia University|Dr. David Hubbard|304-293-3900|dhubbard@hsc.wvu.edu|
20212146|NCT03322462|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20212147|NCT01393990|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20212148|NCT00740727|Massachusetts General Hospital|Stephen H. Thomas MD MPH|6177267622|stephen-thomas@ouhsc.edu|
20212149|NCT05321810|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212150|NCT02720952|Diurnal Limited|Dr John Porter||info@diurnal.co.uk|
20212151|NCT00720798|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20212152|NCT00433381|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20212153|NCT00434161|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|clinical@sobi.com|
20212154|NCT02057952|Regenstried Institute|Daniel O. Clark, PhD|317-274-9292|daniclar@iu.edu|
20212155|NCT00549198|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212156|NCT01473758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20212157|NCT02480010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212158|NCT04229303|Zambon SpA|Arnd Mueller, MD|+39 02 665241|clinicaltrials@zambongroup.com|
20212159|NCT01764854|Ardelyx, Inc.|Chief Development Officer|617 513-4929|drosenbaum@ardelyx.com|
20212160|NCT03263195|Department of Pediatrics Ribeirão Preto Medical School|Dr. Marisa Mussi-Pinhata|55-16-3602-2807|mmmpinha@fmrp.usp.br|
20212161|NCT00910858|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20212162|NCT00827827|Baltimore VAMC|Frederick M. Ivey|410-375-8419|fivey@grecc.umaryland.edu|
20212163|NCT04169282|Duke University|Loretta Que, MD|919-681-8551|loretta.que@duke.edu|
20212164|NCT00447603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193220|NCT04042077|Menarini Ricerche S.p.A.|Corporate Director of Clinical Sciences|0555680|acapriati@menarini-ricerche.it|9990
20193221|NCT02046512|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
20193222|NCT03482752|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20193223|NCT01080300|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
20193224|NCT02844777|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
20193225|NCT01776008|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@dom.wustl.edu|
20193226|NCT00150618|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20193227|NCT04458818|Combined Military Hospital Kharian, Punjab Pakistan|Dr Muhammad Noman Karim|+923313358884|f9noman@gmail.com|
20193228|NCT01162486|Johns Hopkins University School of Medicine|Dr. Kelly E. Dooley|410-955-3100|kdooley1@jhmi.edu|
20193229|NCT00953615|Mayo Clinic|Keith D. Lindor, M.D.|507-284-2969|lindor.keith@mayo.edu|
20193230|NCT03434028|Massachusetts General Hospital|PETAL Clinical Coordinating Center PI|617-872-2882|tthompson1@mgh.harvard.edu|
20193231|NCT02498236|University of California, Los Angeles|Dr. Stephen R. Marder|3104783711|SMarder@mednet.ucla.edu|83647
20193232|NCT02296892|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
20193233|NCT00585078|Beth Israel Deaconess Medical Center Beth Israel Deaconess|Rebecca Miksad MD MPH|617.667.2100|rmiksad@bidmc.harvard.edu|
20163102|NCT00621140|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212165|NCT03818737|Emory University|Kenneth Mautner, MD|404-778-7142|kmautne@emory.edu|
20212166|NCT00322309|BUPA CSU, Boston University School of Medicine|Maryam Afshar, MD|617-414-1990|maryam.afshar@bmc.org|
20212167|NCT01165684|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20212168|NCT04549259|Center for AIDS Intervention Research, Medical College of Wisconsin|Dr. Jennifer Walsh and Dr. Andrew Petroll|414-955-7710|jwalsh@mcw.edu|
20212169|NCT00901628|Joint Reconstruction Center, Seoul National University Bundang Hospital|Tae Kyun Kim|82-31-787-7196|osktk@snubh.org|
20212170|NCT02203747|Abbott Medical Optics|Carrie Garufis|714-566-3728|carrie.garufis@abbott.com|
20212171|NCT00608205|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
20212172|NCT01003886|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212173|NCT02462421|University of Maryland School of Medicine|Dr. Simeon Taylor (Professor of Medicine)|410-706-6439|staylor2@som.umaryland.edu|
20212174|NCT00992264|Group Health Research Institute|Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
20212175|NCT01136226|Chesapeake Urology Research Associates|Heather Thomas, Administrator|443.471.5742|hthomas@cua.md|
20212176|NCT01339910|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20212177|NCT00287287|University of Kentucky|Kenneth Ain|8593236652|kenneth.ain@uky.edu|
20212178|NCT02965820|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
20212179|NCT01567306|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
20212180|NCT00738673|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20212181|NCT03882047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212182|NCT00723554|Actelion Pharmaceuticals, US, Inc.|Wade Benton, PharmD/ Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
20212183|NCT03596918|AMC Statistical and Data Analysis Center|Dr. Jeannette Y. Lee|(501) 526-6712|jylee@uams.edu|
20212184|NCT02436135|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20212185|NCT00475852|Johnson & Johnson Pharmaceutical Research & Development, LLC|Vice President, Franchise Development|610-651-6628||
20212186|NCT02063698|Mayo Clinic|Aminah Jatoi, MD|(507) 284-7202|Jatoi.Aminah@mayo.edu|
20212187|NCT00297479|UT MD Anderson Cancer Center|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
20212188|NCT01664494|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20212189|NCT03263819|Vanderbilt University Medical Center|Dr.Cyndya A. Shibao|6159364584|cyndya.shibao@vumc.org|
20212190|NCT00125931|McLean Hospital|Beth Murphy, MD PhD|617-855-2297|BMurphy5@partners.org|
20212191|NCT01427803|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
20212192|NCT00863057|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20212193|NCT02345486|Vanderbilt University Medical Center|Dr. Matthew Semler|615-322-3412|matthew.w.semler@vumc.org|
20212194|NCT03412019|Tufts Medical Center|Dan Drzymalski, MD|617 636 4526|ddrzymalski@tuftsmedicalcenter.org|
20212195|NCT03979677|Vanderbilt University Medical Center|Richard A. Roberts, Ph.D.|6153227384|richard.a.roberts@vanderbilt.edu|
20212196|NCT01215123|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212197|NCT02752256|University of Iowa Hospitals and Clinics|Brett Faine|319-384-6800|brett-faine@uiowa.edu|
20212198|NCT01172353|Hospital Sao Lucas|Vitor Osório Gomes, MD, PhD|55 51 33203494|pesquisa@cardiarte.com.br|
20212199|NCT05085613|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|301-712-8357|cweiger2@jhmi.edu|
20212200|NCT02974114|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212201|NCT03654898|Baylor College of Medicine Childrens Foundation Malawi|Maria Kim|+26599869090|mkim@tingathe.org|
20212202|NCT01138150|The Johns Hopkins University School of Medicine|Dr. Lee Peterlin|410-550-5452|lpeterlin@jhmi.edu|
20212203|NCT00545233|Hoffman-LaRoche|Medical Communications|800-821-8590||
20212204|NCT00973856|Cleveland Clinic Akron General|Eliot Mostow, MD||emostow@akronderm.com|
20212205|NCT01068873|Lewis Katz School of Medicine at Temple University|Lisa Landsberg|12157077303|lisa.landsberg@temple.edu|
20163103|NCT00145574|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20163104|NCT00527904|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
20186945|NCT03133546|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
20186946|NCT03532282|Stanford University|Rachel Manber, PhD|(650) 498-9111|rmanber@stanford.edu|
20186947|NCT04520191|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
20186948|NCT01501955|Zimmer Biomet|Linda Meijer|+31786292929|linda.meijer@zimmerbiomet.com|
20186949|NCT05034328|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
20186950|NCT02993159|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
20186951|NCT03482557|Beth Israel Deaconess MEdical Center|Marc Mccall|617-418-9216|mmccall1@bidmc.harvard.edu|
20186952|NCT05399459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186953|NCT05135650|Fred Hutch/University of Washington Cancer Consortium|Dr. Alpana Waghmare (Study Principal Investigator)|206-667-7329|awaghmar@fredhutch.org|
20186954|NCT03625167|Charité - Universitätsmedizin Berlin|Monira El Genedy-Kalyoncu|+49 30 450 529 434|monira.el-genedy@charite.de|
20186955|NCT02231164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186956|NCT05245682|Emory University|Nicole Schmitt|404-778-0278|nicole.cherie.schmitt@emory.edu|
20212206|NCT00479401|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212207|NCT02777931|Aevi Genomic Medicine|Garry A Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20212208|NCT01208402|Duke University Medical Center - Department of Anesthesiology|William White / Statistician|919-684-4081|white013@mc.duke.edu|
20212209|NCT01571635|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20212210|NCT02005354|Plymouth Hospitals NHS Trust|Dr David Tucker|01752 432595|david.tucker1@nhs.net|
20212211|NCT02151461|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
20212212|NCT00706706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212213|NCT02191579|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20212214|NCT02046369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20212215|NCT01191255|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
20212216|NCT02196506|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20212217|NCT01606137|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20212218|NCT00066807|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
20212219|NCT05028751|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
20212220|NCT04578548|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
20212221|NCT02248285|BioFire Diagnostics|Director of Clinical Affairs|8017366354|kevin.bourzac@biofiredx.com|
20212222|NCT00331630|Northwestern University|Virginia Kaklamani|312-695-1301||
20212223|NCT00803959|New England Research Institutes|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
20212224|NCT03342898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20212225|NCT01387282|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
20212226|NCT03997448|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
20212227|NCT02661126|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212228|NCT01312779|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20212229|NCT01621490|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20212230|NCT00506753|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
20212231|NCT00125359|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
20212232|NCT02451670|HealthPartnersInstitute|Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
20212233|NCT00461500|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212234|NCT01151813|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
20163105|NCT03323801|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
20212235|NCT00521456|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20212236|NCT01513551|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212237|NCT02763579|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212238|NCT02967133|Duke University Medical Center|Neal Ready MD PhD|(919) 681-6932|neal.ready@duke.edu|
20212239|NCT02117193|Federal University of Rio Grande do Sul|Dr Marco Aurélio Vaz|555133085860|marcovaz@esef.ufrgs.br|
20212240|NCT04467697|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
20212241|NCT05751629|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212242|NCT01909466|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20212243|NCT03051256|Relmada Therapeutics|Chief Medical Officer|646-876-3459|info@relmada.com|
20212244|NCT00673361|Duke University Medical Center|Michael A Morse, M.D.|919-681-3480|morse004@mc.duke.edu|
20212245|NCT01127581|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20212246|NCT00730522|Catalyst Pharmaceuticals|Chief Scientific Officer|305-420-3200|gingenito@catalystpharma.com|
20212247|NCT03038113|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212248|NCT00514137|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
20212249|NCT03421652|Karmanos Cancer Institute|Nitin Vaishampayan, MD|313-576-9624|nvaisham@med.wayne.edu|
20212250|NCT02619799|Rangaraya medical college|Dr.Paleti Sophia|9948599758 ,08842343023|dr.sophia29@gmail.com|
20212251|NCT01142297|University of Texas Health Science Center at San Antonio|Thomas W. Oates|210-567-3590|oates@uthscsa.edu|
20212252|NCT03563027|Crescenz Veterans Affairs Medical Center|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
20212253|NCT01698320|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
20212254|NCT00386724|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20212255|NCT02539563|Wake Forest School of Medicine|Lynnette Harris, BSN|336-716-6049|lcharris@wakehealth.edu|
20212256|NCT02040766|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20212257|NCT01271933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212258|NCT01620983|Virginia Commonwealth University|Dr. Daniel L. Riddle|804-828-0234|dlriddle@vcu.edu|
20212259|NCT01724359|Jan-Cil Mexico|GERENTE MEDICO REGIONAL|52 55 5237 3410||
20212260|NCT01335464|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193234|NCT04198571|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193235|NCT01814072|Northwestern University Feinberg School of Medicine|Bonnie Spring, PhD, ABPP|312-908-2293|bspring@northwestern.edu|
20212261|NCT00871169|University of New Mexico Comprehensive Cancer Center|Fa-chyi Lee, MD|505-925-0405|flee@salud.unm.edu|
20212262|NCT00252187|Mayo Clinic|Dr. Horng H. Chen|507-778-2354|chen.horng@mayo.edu|
20212263|NCT01665053|Boston Scientific|Patricia O'Mara, Clinical Trial Manager|518-792-5673|patricia.o'mara@bsci.com|
20212264|NCT01033383|Yale University|Dr. Manisha Juthani-Mehta|(203)785-7571|manisha.juthani@yale.edu|
20212265|NCT00769015|Thomas Jefferson University|Robin Casten|215-503-1250|Robin.Casten@jefferson.edu|
20212266|NCT02611206|University of Minnesota|Kathryn Cullen|612-625-3403|rega0026@umn.edu|
20212267|NCT02280356|Memorial Sloan Kettering Cancer Center|Dr. Marisa Kollmeier, MD|212-639-3952|KollmeiM@mskcc.org|
20212268|NCT03493698|Spring Bank Pharmaceuticals, Inc.|Don Mitchell, Vice President, Operations & Corporate Development|(508) 689-9737|dmitchell@springbankpharm.com|
20212269|NCT03361956|Janssen Sciences Ireland UC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20212270|NCT03198988|ART MEDICAL|Mrs Shirly Steinlauf|972-54-5804242|shirly@artmedical.com|
20212271|NCT00291330|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212272|NCT01829295|F.I. Proctor Foundation, UCSF|Dr. Nisha Acharya|4154768131|Nisha.Acharya@ucsf.edu|
20212273|NCT00757666|Boston Scientific|Director of Clinical Affairs|651-582-2277|cshd@bsci.com|
20212274|NCT02629965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212275|NCT03443869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212276|NCT02390219|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20212277|NCT00299728|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20212278|NCT02230085|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
20212279|NCT00580983|University of Michigan Comprehensive Cancer Center|Dr. Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
20212280|NCT01360632|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20212281|NCT01298596|University of Washington|Dr. Michael H. Chung|‭(206) 302-8361‬|mhchung@uw.edu|
20212282|NCT04128696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212283|NCT02173301|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
20212284|NCT03740100|MD Anderson Cancer Center|Dr. Faye Johnson|7137922121|fmjohns@mdanderson.org|
20212285|NCT03120520|Bausch Health Americas, Inc|Clinical Operations Director|908-927-0873|lindsey.mathew@bauschhealth.com|
20212286|NCT02340156|SynerGene Therapeutics, Inc.|Senior Consultant|301-706-1509|clinicaltrial@synergeneus.com|
20212287|NCT01710306|Department of Veteran's Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
20212288|NCT02123459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20212289|NCT03387059|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20212290|NCT00395083|VA Boston Healthcare System - MAVERIC|Dr. Sarah Leatherman|857-364-4220|sarah.leatherman@va.gov|
20212291|NCT00972153|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
20212292|NCT01077713|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20212293|NCT04136626|Massachusetts General Hospital|Dr. Sabine Wilhelm, Chief of Psychology|617-724-6146|swilhelm@mgh.harvard.edu|
20212294|NCT00628745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212295|NCT02060461|Cleveland Clinic|William J Dupps, Jr, MD, PhD|216-444-8396||
20212296|NCT01976390|Division of Transplant Surgery OSUMC|Director of Research Operations|614-293-8021|brenda.cuson@osumc.edu|
20212297|NCT02806232|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20212298|NCT01133821|University of Pittsburgh School of Medicine|Holly A. Swartz M.D.|412-246-5588|swartzha@upmc.edu|
20212299|NCT02917447|VA Puget Sound Health Care System|Keren Lehavot, PhD|206-277-1511|keren.lehavot@va.gov|
20212300|NCT03081767|Stanford University|Andrei Iagaru|6507254711|aiagaru@stanford.edu|
20212301|NCT05569148|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212302|NCT01267266|University of Chicago|Walter M. Stadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
20212303|NCT02149303|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20212304|NCT01335477|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212305|NCT02275923|Medtronic|Jennifer Seamans, Principal Clinical Research Specialist|7635262835|jennifer.l.seamans@medtronic.com|
20212306|NCT02038634|Medical College of Wisconsin|Karen Gonzalez|414-955-3221|kgonzalez@mcw.edu|
20212307|NCT03220230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212308|NCT01034137|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20212309|NCT03572933|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20212310|NCT01828255|The New York Eye and Ear Infirmary|Dr Gustavo De Moraes|+1 212 477 7540|demoraesmd@gmail.com|
20212311|NCT00439608|BrUOG|Howard Safran, MD|401-863-3000|Hsafran@lifespan.org|
20212312|NCT01464359|University of Minnesota, Pediatrics Blood and Marrow Transplant|Michael R Verneris|612-626-2961|verneris@umn.edu|
20212313|NCT02049359|Campbell University|Jennifer Smith|2522439800|jsmith@cfhcnc.org|224
20212314|NCT01405950|Acorda Therapeutics, Inc.|Herbert Henney, PharmD|914-347-4300|hhenney@acorda.com|5138
20212315|NCT01381900|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20212316|NCT01772368|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
20212317|NCT02449291|Acacia Pharma Ltd|Gabriel Fox|01-223919764|gabrielfox@acaciapharma.com|
20212318|NCT02363010|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
20212319|NCT03347695|Fujian Medical University Union Hospital|Dr. Liangwan Chen|861335825333|chenliangwan@tom.com|
20212320|NCT00996866|Winthrop-University Hospital|John Aloia, MD|516-663-2442|jaloia@winthrop.org|
20212321|NCT00671879|Meda Pharma US|David Ginsberg, DO Sr Dir Medical Scientific Affairs|732 564 2347|david.ginsberg@meda.us|
20212322|NCT04633837|American Health Network|Brian Badman|317-208-3866|bbadman@gmail.com|
20212323|NCT02668783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212324|NCT02884206|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20212325|NCT00112489|NRG Oncology - Buffalo Office|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
20212326|NCT02231710|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
20212327|NCT02491788|Stanford University|Dr. Jamie Zeitzer|16504935000|jzeitzer@stanford.edu|
20212328|NCT00124020|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20212329|NCT00268346|Cleveland Clinic Taussig Cancer Institute|David Adelstein MD|216-444-9310|adelstd@ccf.org|
20212330|NCT01799590|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
20212331|NCT00981253|Duke Health|Dr. James A. Blumenthal|919-684-3828|james.blumenthal@duke.edu|
20212332|NCT00294723|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20212333|NCT00752791|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20212334|NCT03341507|Iuliu Hatieganu University of Medicine and Pharmacy- Cluj Napoca Romania|Dr Ioan Florin Marchis|+40757065205|marchis.ioan@umfcluj.ro|0757065205
20212335|NCT02927847|Duke University|Maggie M Sweitzer, PhD|919-668-0094|maggie.sweitzer@duke.edu|
20212336|NCT02004704|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20212337|NCT01755858|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20212338|NCT03255031|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Gene-Jack Wang|301-496-5012|gene-jack.wang@nih.gov|
20212339|NCT01809314|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212340|NCT01092702|Mayo Clinic|J Taylor Hays. MD|507-266-1944|nicotineresearch@mayo.edu|
20212341|NCT03567057|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20212342|NCT00490061|Stanford University|Quynh Le|650-498-5032|qle@stanford.edu|6506370734
20212343|NCT01580020|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20212344|NCT02077192|Rigel Pharmaceuticals, Inc.|Director of Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
20212345|NCT00591253|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20212346|NCT01841359|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173092635|MaryElizabeth.Patti@joslin.harvard.edu|
20212347|NCT03764059|Peking University Hospital of Stomatology|Xiaoyan Wang|010-82195525|wangxiaoyanpx@163.com|
20212348|NCT01102777|VA Ann Arbor Center for Clinical Management Research|Fatima Makki|+1 (734) 845-3623|Fatima.Makki@va.gov|
20212349|NCT01875445|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
20212350|NCT01943461|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20212351|NCT01752920|Basilea Pharmaceutica International Ltd.|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
20212352|NCT01738581|University of Minnesota|Dr. Teresa Kimberley|612-626-4096|tjk@umn.edu|
20212353|NCT00210626|Centocor Ortho Biotech Services, LLC (COBS)|Vice President Medical Affairs|215-325-4464||
20212354|NCT00771901|Washington University School of Medicine in Saint Louis, Missouri|Samuel Klein, M.D.|314-362-8708|sklein@wustl.edu|
20212355|NCT02862535|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20212356|NCT04147715|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20212357|NCT00235833|Abbott|Medical Information Specialist|800-633-9110||
20212358|NCT02418910|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
20212359|NCT01288833|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
20212360|NCT02472977|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Clinical.Trials@bms.com|Clinical.Trials@bms.com|
20212361|NCT00140556|Duke University Medical Center, Dept Radiation Oncology|David Brizel, MD|919 668-5637|david.brizel@duke.edu|
20163106|NCT02669121|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20193236|NCT00383123|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212362|NCT00254397|University of Texas MD Anderson Cancer Center|Patrick Hwu, MD / Professor, Melanoma Medical Oncology|713-792-2921|phwu@mdanderson.org|
20212363|NCT03092089|University of Alberta Hospital|Dr Kevin Bainey|780-407-2176|Kevin.Bainey@albertahealthservices.ca|
20212364|NCT02482805|University of Texas at Austin|Michelle Davis|214-470-1371|michelledavis@utexas.edu|
20212365|NCT01806597|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20212366|NCT01144663|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212367|NCT04160078|Emory University|Dayna Johnson, PhD, MPH, MSW, MS|404-727-8708|dayna.johnson@emory.edu|
20212368|NCT03974152|Eastern Virginia Medical School|Dr. Paul Harrell|757-446-6047|harrelpt@evms.edu|
20212369|NCT00936377|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
20212370|NCT01467063|Nemours Children's Health System|Dominique Darmaun|904-697-3674|Ddarmaun@nemours.org|
20212371|NCT03877055|Memorial Sloan Kettering Cancer Center|Dr. Gilles Salles, MD, PhD|646-608-4153|SallesG@mskcc.org|
20212372|NCT00387712|Baltimore VAMC|Charlene Hafer-Macko|410-605-7000|charlene.hafer-macko@va.gov|5451
20212373|NCT02040428|Ethicon, Inc.|Richard Kocharian, MD, PhD|1 (908) 218-2013|rkochar1@ITS.JNJ.com|
20212374|NCT02030574|Brown Oncology Research Groupl|Kristen M. Mitchell|4018633000|kristen_mitchell@brown.edu|
20212375|NCT01411267|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20212376|NCT01927757|Amgen Inc.|Study Director|866-572-6436||
20212377|NCT01399723|KEMRI-Wellcome Trust Research Prorgamme|Dr. Ambrose Agweyu|254202715160|aagweyu@kemri-wellcome.org|
20212378|NCT01464827|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20212379|NCT00810732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212380|NCT03534986|International Biophysics Corporation|VP of Engineering and Quality|512-814-0046|quailty@biophysicscorp.com|
20212381|NCT04604184|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212382|NCT01769378|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20186957|NCT06103188|Jordan University Hospital|Dr Omar Ismail|+962791301329|omar.moh.isml@gmail.com|
20212383|NCT01090765|National Cancer Institute|Dr. William Dahut|301-496-4251|dahutw@mail.nih.gov|
20212384|NCT01977092|Public Health Institute|Elizabeth Mahoney|(818)310-2684|lmahoney@bhrsca.org|
20212385|NCT00678392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212386|NCT01958281|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20212387|NCT05117099|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
20212388|NCT02784106|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20212389|NCT00417274|Clevland BioLabs|Michael Kurman, MD|716-849-6810|mkurman@cbiolabs.com|
20212390|NCT00928083|Medicines for Malaria Venture|Dr. Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
20212391|NCT01665170|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiß|0641-7960|klinischeforschung@pascoe.de|
20212392|NCT01418352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20212393|NCT01224210|Tufts Medical Center|Ioana Preston MD|617-636-7609|ipreston@tuftsmedicalcenter.org|
20212394|NCT01401478|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20212395|NCT01814137|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20186958|NCT01541553|LEO Pharma A/S|Clinical trial disclosure|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
20212396|NCT01952574|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20186959|NCT05445427|Mayo Clinic|Dr. Ryan T. Hurt, MD, PhD|507-284-4461|hurt.ryan@mayo.edu|
20186960|NCT02969707|Stanford University|Dr. David Spiegel|650-723-6421|dspiegel@stanford.edu|
20212397|NCT01189240|Adult Brain Tumor Consortium (ABTC)|Dr. Edward Pan||Edward.Pan@UTSouthwestern.edu|
20212398|NCT00770991|Cleveland Clinic|Dr. Carol Burke|216 444-6864|burkec1@ccf.org|
20212399|NCT02159859|Beaumont Health|Lama Hsaiky, Pharm.D. (Primary investigator)|313-593-7264|lama.hsaiky@beaumont.org|
20212400|NCT02444533|Mayo Clinic|Dr. Daniel Price|507-293-4395|Price.Daniel@mayo.edu|
20212401|NCT00621179|Colorado Center for Reproductive Medicine|Eric Surrey|303-788-8300|esurrey@colocrm.com|
20212402|NCT00886483|The Ohio State University|L. Eugene Arnold, M.D. M.Ed.|614-685-6708|L.Arnold@osumc.edu|
20212403|NCT03944486|Imperial College London|Research Integrity Officer|+44 (0)20 7594 1872|e.magnusson@imperial.ac.uk|
20212404|NCT02168270|University of Nebraska Medical Center|Dr. Nicole Shonka|402-559-5166|nshonka@unmc.edu|
20212405|NCT00593333|Department of Surgery/Division of Orthopaedics|Taylor Vlack, Research Nurse Coordinator|205-996-6781|tmwebb@uabmc.edu|
20212406|NCT02175966|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20212407|NCT01878656|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
20212408|NCT00947765|Dr. Chetan Muralidhara Rao Dojode. Resident in Orthopaedics and Traumatology.|Dr. Chetan Muralidhara Rao Dojode, MBBS,MS(Ortho)|91 9844592532|docchetanmd@yahoo.co.in|
20212409|NCT01086215|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
20212410|NCT01965652|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
20212411|NCT02524106|University of California San Francisco|Priscilla Hsue, PI|415-206-8257|priscilla.hsue@ucsf.edu|
20212412|NCT01121900|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20212413|NCT03469271|Mayo Clinic|Aminah Jatoi, M.D.|507-266-0984|huyber.christine@mayo.edu|
20212414|NCT03929224|Michigan Ear Institute|Seilish Babu, MD|(248) 865-4444|sbabu04@gmail.com|
20186961|NCT06074172|Colorado State University Pueblo|Dr. Moussa Diawara|719-549-2813|Moussa.Diawara@csupueblo.edu|
20212415|NCT01328054|GlaxoSmithKline|GSK Response Center|866-435-7343||
20186962|NCT05583578|University of Florida|Dr. Clayton Swanson|3522735919|clayton.swanson@ufl.edu|
20186963|NCT00967447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20186964|NCT04314713|Pharmaron|Paolo DePetrillo|240-673-0500|paolo.depetrillo@pharmaron.com|1731
20212416|NCT03760510|Vanderbilt University Medical Center|Janna Landsperger|6153223412|janna.landsperger@vumc.org|
20186965|NCT00248287|Baylor Sammons Cancer Center|Dr. Joyce O'Shaughnessy|(214) 370 -1796|Joyce.OShaughnessy@usoncology.com|
20186966|NCT04700176|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20186967|NCT04248725|University of Washington|Dawn Ehde, PhD|206-591-3780|ehde@uw.edu|
20212417|NCT00871728|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
20212418|NCT02400710|Center for Integrated Healthcare, Syracuse Veterans Affairs Medical Center|Kyle Possemato, Ph.D.|315-425-4400|kyle.possmato@va.gov|53551
20186968|NCT05562401|UColima|Fabian Rojas Larios|3121206804|frojas@ucol.mx|
20186969|NCT05322044|Imperial College London|Dr Louise Fleming|02073528121|l.fleming@imperial.ac.uk|2938
20186970|NCT05312008|Indiana University|Dr. Ann E.K. Kosobud|3172740087|akosobud@iu.edu|
20186971|NCT04524442|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20186972|NCT02675777|Kaiser Permanente Washington Health Research Institute|Katharine Bradley, MD, MPH|206-948-1933|katharine.a.bradley@kp.org|
20186973|NCT04324359|Surface Ophthalmics Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
20186974|NCT05778695|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
20212419|NCT00686803|Palatin Technologies, Inc.|Robert Jordan, Executive Director of Clinical Operations|609.495.2200|rjordan@palatin.com|
20212420|NCT03867383|Stanford University|Dr. Jessica Ansari|760-845-0328|jansari@stanford.edu|
20212421|NCT00566709|"University Hospital Virgen del Rocío"|Santiago R Leal-Noval, MD, PhD|0034954012528|srlealnoval@gmail.com|
20212422|NCT03331965|Duke University Medical Center|Dr. James Ronald|919.684.7299|james.ronald@duke.edu|
20212423|NCT03775681|UT MD Anderson Cancer Center|Katherine Hagan, Associate Professor, Anesthesiology & PeriOper Med|(713) 794-5945|khagan@mdanderson.org|
20186975|NCT01544114|Horizon Pharma, Inc.|Julie Ball, Executive Director of Clinical Development & Operations||clinicaltrials@horizonpharma.com|
20212424|NCT00616928|GlaxoSmithKline|GSK Response Center|866-435-7343||
20186976|NCT04649476|Hospital of Stomatology, Wuhan university|Gang Chen, MD|+86 02787686215|geraldchan@whu.edu.cn|
20186977|NCT04223505|University of Ottawa Heart Institute|Dr. Benjamin Chow|6136966786|bchow@ottawaheart.ca|
20212425|NCT00895583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20186978|NCT02601313|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
20186979|NCT03800654|VA San Diego Healthcare System|Dr. Matthew Herbert|858-642-1411|Matthew.Herbert2@va.gov|
20186980|NCT06182033|Crane Center for Early Childhood Research and Policy at The Ohio State University|Dr. Laura Justice|614-247-7488|justice.57@osu.edu|
20186981|NCT04082143|Virginia Commonwealth University|Lyndon Cooper, Dean|(804) 828-7235|cooperlf@vcu.edu|
20186982|NCT03576885|AdventHealth|Hussnain Mirza MD|9736263952|Hussnain.Mirza.MD@adventhealth.com|
20186983|NCT02272998|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.roychowdhury@osumc.edu|
20186984|NCT02938377|University of Alabama at Birmingham|Karen Cropsey, Psy.D|(205) 975-4204|kcropsey@uab.edu|
20186985|NCT05476328|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20212426|NCT03529955|Tulane University|Carole Bitar, MD, FAAD|202-642-8122|cbitar@tulane.edu|
20186986|NCT04830800|PATH|Dr. Thang Tran Cong, Medical office|84-913301883|thangtran@path.org|
20186987|NCT02151981|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20186988|NCT03847311|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
20186989|NCT02975375|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20186990|NCT03272217|Hoosier Cancer Research Network|Fauzia Sharmin|317-634-5842|fsharmin@hoosiercancer.org|75
20186991|NCT05095779|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
20186992|NCT05251909|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20186993|NCT04987320|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20212427|NCT01986790|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
20212428|NCT01491490|GW Research Ltd.|Mr Colin Stott|+44 (0)1980 557000|cgs@gwpharm.com|
20186994|NCT00085735|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
20186995|NCT00433329|Actelion Pharmaceuticals, US, Inc.|Rajiv Patni/Medical Officer|(650) 624-6900||
20212429|NCT03016078|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
20212430|NCT02457728|St John of God Hospital Vienna|Bernhard Dauser, MD, PhD|+4321121|b.dauser@hotmail.com|5098
20186996|NCT02598388|Janssen Vaccines & Prevention B.V.|MEDICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20186997|NCT04002830|Shaare Zedek Medical Center|Majdolen Istaiti|972526659995|joleenist@szmc.org.il|
20186998|NCT05256017|Drugs for Neglected Disease initiative (DNDi)|Dr Junior Matanglia|+243 970 756 890|jmatangila@dndi.org|
20186999|NCT06132282|Texas Christian University|Danica Knight|817-257-4391|d.knight@tcu.edu|
20187000|NCT04881903|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
20187001|NCT05477095|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
20187002|NCT04663737|Senhwa Biosciences, Inc.|Kacy Huang, Director of Clinical Department|+886-2-8911-9856|kacyhuang@senhwabio.com|214
20187003|NCT03907878|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20187004|NCT01037881|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20187005|NCT02841579|Catalan Institute of Oncology, Institut d'Investigació en Ciències, de la Salut Germans Trias i Pujol|Dr. Rafael Rosell|+34 935 543 050|rrosell@iconcologia.net|
20187006|NCT02998268|Weill Cornell Medicine|Dr. Manish Shah|646-962-6200|mas9313@med.cornell.edu|
20187007|NCT02815566|University Health Network|Dr. Sharon Walmsley|416-340-3871|sharon.walmsley@uhn.ca|
20212431|NCT02378506|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187008|NCT03020199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20212432|NCT00528437|NYU Langone|Dr. Sharon Gardner|212-263-9913|Sharon.Gardner@nyulangone.org|
20187009|NCT04313972|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
20212433|NCT01070394|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
20187010|NCT05877976|NYU Langone Health|Lita Anglin|212-263-2519|Lita.anglin@nyulangone.org|
20187011|NCT03316573|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617-632-6633|edjacobsen@partners.org|
20187012|NCT03569631|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20187013|NCT04568486|University of Kentucky|Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
20187014|NCT01210807|University Eye Clinic, Tubingen, Germany|PD Dr. med. Peter Szurman|49-7071-29-84915|peter.szurman@med.uni-tuebingen.de|
20212434|NCT00634283|Laboratory of Brain, Behavior, and Pharmacology at UCLA|Director of the Laboratory of Brain|310-825-0207|info@brain.ucla.edu|
20212435|NCT03501550|Cocrystal Pharma Inc|Luz Pascual|9083611678|lpascual@cocrystalpharma.com|
20212436|NCT01386879|University of Missouri Columbia|Boris Mraovic|573-882-2568|mraovicb@health.missouri.edu|
20187015|NCT03029884|University of California, San Francisco|Prasad Shirvalkar MD, PhD - Principal Investigator|415-885-7246|Prasad.Shirvalkar@ucsf.edu|
20187016|NCT01710488|Fadoi Foundation|Antonella Valerio|0248005140|antonella.valerio@fadoi.org|
20187017|NCT05477186|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212437|NCT01743677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212438|NCT01715415|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20187018|NCT05698875|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
20212439|NCT01015612|Medtronic|Dr Deama Amr (PhD)|+61 2 9857 9157|deama.amr@medtronic.com|
20187019|NCT03728790|Columbia University|Dr. Leslie Moroz|646-532-8208|lm3000@cumc.columbia.edu|
20187020|NCT05496231|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20187021|NCT03896867|University of Minnesota|Benjamin Kloesel|612-301-1245|bkleosel@umn.edu|
20212440|NCT01956279|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
20212441|NCT02497391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20212442|NCT01664052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20187022|NCT05526430|Icahn School of Medicine at Mount Sinai|Jessica L Ables|(212) 241-2774|jessica.ables@mssm.edu|
20187023|NCT05482698|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2theraprutics.com|
20212443|NCT03740698|Imperial College London|Prof Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
20212444|NCT03015142|Philips|Rami Nachabe|+1-513-926-1486|rami.nachabe@philips.com|
20212445|NCT02625766|University of Maryland Medical Center|Research Administrator|4103289579|NO'Hara@som.umaryland.edu|
20212446|NCT01466686|Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins Medicine|Kristin Redmond, MD|4109556980|kjanson3@jhmi.edu|
20187024|NCT03879863|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20187025|NCT01674140|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|jmiao@fredhutch.org|
20187026|NCT02305888|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20212447|NCT02802514|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212448|NCT00633152|Cerexa, Inc.|Vice President, Clinical Sciences|510-285-9200|clinicaltrials@cerexa.com|
20187027|NCT05533918|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
20212449|NCT01045499|Columbia University|Jeffrey Zitsman, MD|212-305-8862|jlz2@cumc.columbia.edu|
20212450|NCT05216978|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭617-525-7472‬|hermioni_amonoo@dfci.harvard.edu|
20187028|NCT05940194|PATH|Dr. Thang Tran Cong, Medical office|+84913301883|thangtran@path.org|
20187029|NCT04914676|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20187030|NCT03085810|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20187031|NCT03024437|University at Buffalo|Dr. Roberto Pili|(716) 881-8918|rpili@buffalo.edu|
20212451|NCT02429869|University of California, San Francisco|Rodney Rogers|415-514-6454|Rodney.Rogers@ucsf.edu|
20212452|NCT00658320|Novartis Pharmaceuticals|Study Director|862-778-8300||
20187032|NCT03621371|Karolinska Institutet|Dr Benjamin Bohman|701713443|benjamin.bohman@ki.se|+46
20187033|NCT04625465|Georgia State University|Dr. Dominic Parrott, Distinguished University Professor of Psychology|+1 (404) 413-6287|parrott@gsu.edu|
20187034|NCT04947397|University of California San Francisco|Daniel Abelson|510 428 3000|daniel.abelson@ucsf.edu|
20212453|NCT03467412|Follicum AB|CEO Jan Alenfall|+46 (0)70 931 51 15|jan.alenfall@follicum.com|
20212454|NCT00789802|Washington University|Dr. Tessa Madden|3147471331|maddent@wustl.edu|
20187035|NCT03128021|University of Pittsburgh|Rachel Berta|4128607406|goodra@upmc.edu|
20212455|NCT01975090|Novate Medical|Gordon Crowley|+353 91 750 030|gordon.crowley@novate.ie|
20187036|NCT03584633|Cleveland Clinic|Dr. Wei F. Chen|319-333-6166|chenw6@ccf.org|
20212456|NCT02410252|Partners Connected Health Innovations|Amanda Centi|6177242158|acenti@partners.org|
20212457|NCT00746668|Jesse Brown VAMC|Dr. Janet P. Szlyk, PhD|312-997-3644|Janet.Szlyk@va.gov|
20212458|NCT03043274|University of Kentucky|Dr. Khaled M. Ziada|8593236036|khaled.ziada@uky.edu|
20212459|NCT01007916|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20187037|NCT05566639|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20187038|NCT05166577|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
20187039|NCT04054193|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212460|NCT00958581|NYU hospital for Joint Diseases|Dr. Thomas Errico (Chief of Spine), Dr. Kushagra Verma (Co-investigator)|212-598-6076|thomas.errico@nyumc.org; vermak01@gmail.com|
20187040|NCT04053075|Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Healthcare Institute|Dr. Meghan Baker, MD, ScD|617-867-4946|MBAKER1@BWH.HARVARD.EDU|
20212461|NCT02961920|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82324603624|jjchoi2@gilhospital.com|
20212462|NCT01492582|University of Alabama at Birmingham|Dr. Wendy Landier, Deputy Director, Institute for Cancer Outcomes and Survivorship|(205) 638-2120|wlandier@peds.uab.edu|
20187041|NCT05436262|Johns Hopkins University|Cherie Marvel|410-387-8510|cmarvel1@jhmi.edu|
20212463|NCT03907280|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212464|NCT03843957|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
20187042|NCT03710603|Stichting European Myeloma Network (EMN)|Sarah Lonergan|+31 10 268 70 65|sarah.lonergan@emn.life|
20187043|NCT02626533|Hospital for Special Surgery, Anesthesiology|Dr. Meghan Kirksey|2126061036|KirkseyM@hss.edu|
20212465|NCT04480463|SamChunDang Pharm. Co. Ltd.|Byung Jhip Ha, Director of Bio Research Center|+82-31-869-7327|scd411clinical@scd.co.kr|
20187044|NCT04753697|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20187045|NCT01658930|Canadian Cancer Trials Group|Lois E. Shepherd|6135336430|LShepherd@ctg.queensu.ca|
20212466|NCT00444795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
20187046|NCT03701763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20212467|NCT02322879|BIDMC|Michael Ganetsky, MD|617-754-2323|mganetsk@bidmc.harvard.edu|
20212468|NCT04081337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20212469|NCT00130520|Arizona Cancer Center, University of Arizona|Setsuko K. Chambers, M.D.|520-626-0950|schambers@azcc.arizona.edu|
20187047|NCT04200456|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20187048|NCT05658224|USouthDakota|Dr. Kory Zimney|6056586373|kory.zimney@usd.edu|
20187049|NCT03785964|SpringWorks Therapeutics|Head of Clinical Operations|877-279-4870|clinical@springworkstx.com|
20212470|NCT03487796|Rhode Island Hospital|Larry K. Brown, MD|(401) 793-8808|lkbrown@lifespan.org|
20187050|NCT05070728|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
20212471|NCT01633827|Brigham and Women's Hospital|David Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
20187051|NCT05446168|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
20187052|NCT04339101|City of Hope Medical Center|Dr. Ali Haris|626-359-8111|aharis@coh.org|
20187053|NCT02733159|Cancer Research UK Clincial Trials Unit, University of Birmingham|PePS2 Trial Coordinator|0121 414 8040|peps2@trials.bham.ac.uk|
20212472|NCT00613574|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187054|NCT02657005|Oncternal Therapeutics|Mary Breitmeyer|858-434-1113|clinical@oncternal.com|
20187055|NCT04168580|AdventHealth Translational Research Institute|Paul M. coen, PhD., Associate Investigator|765-426-9743|paul.coen@adventhealth.com|
20187056|NCT03257410|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20187057|NCT03069924|Medical University of South Carolina|Dr. Benjamin Toll|843-876-1132|toll@musc.edu|
20187058|NCT04500613|Hospital for Special Surgery|Marko Popovic|646-797-8948|popovicm@hss.edu|
20187059|NCT03854227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
20187060|NCT03668236|Rigshospitalet, University of Copenhagen|Prof. Anders Perner|+45 35458333|anders.perner@regionh.dk|
20187061|NCT03748953|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20187062|NCT02276885|NYU Langone Health|Naamit Gerber, MD|2127316338|Naamit.Gerber@nyulangone.org|
20187063|NCT01574274|Dana-Farber Cancer Institute|Dr. Lewis Silverman|16176326191|lewis_silverman@dfci.harvard.edu|
20187064|NCT04676763|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20187065|NCT03626766|Columbia University|Dr. Anthony Lin|(917) 628-6522|akl17@cumc.columbia.edu|
20187066|NCT01593917|Abbott Medical Devices, Structural Heart Divison|Clinical Scientist, Tissue Heart Valves|+1 651-756-2320|Roland.MaudeGriffin@Abbott.com|
20187067|NCT04016662|Jaeb Center for Health Research|Robert Henderson|(813) 975-8690|Rhenderson@jaeb.org|
20187068|NCT04225273|QMedAB|Clinical Project Manager|18179615000|aestheticclinicaltrials@galderma.com|
20193237|NCT04253119|MSD Pharmaceuticals LLC|Vladimir Achikyan, Medical Affairs Manager|79161981264|vladimir.achikyan@merck.com|
20193238|NCT03566979|Johnson & Johnson Worldwide|Steven Sacavage, Associate Director Clinical Research|215-273-8568|SSacavag@its.jnj.com|
20193239|NCT02562898|University of California, San Francisco|Dr. Margaret Tempero|415-353-7528|Margaret.Tempero@ucsf.edu|
20193240|NCT01936467|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
20193241|NCT01774045|Taipei Veterans General Hospital|Dr. Cheng-Ta Li|886-2-2871-2121|on5083@msn.com|7027
20193242|NCT04547023|Stanford University|Yair Blumenfeld, MD|650-498-4069|yairb@stanford.edu|
20212473|NCT00176904|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20212474|NCT05487456|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20212475|NCT02711956|Zenith Epigenetics Ltd|Zenith Study Team|(415) 470-5600|ZEN003694-002@zenithepigenetics.com|
20212476|NCT01924871|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
20212477|NCT01625377|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20212478|NCT02043366|Tianjin Medical University General Hospital|Dr. Guolin Wang|+8615822855556|wangguolinghad@hotmail.com|
20212479|NCT01412541|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
20212480|NCT01489956|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20212481|NCT04535609|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
20212482|NCT00718159|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20212483|NCT00782509|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212484|NCT00175019|Takeda Global Research & Development Center, Inc.|Senior Vice President, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20212485|NCT01405820|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20212486|NCT03222141|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
20212487|NCT00441584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20212488|NCT00619619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212489|NCT03151499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212490|NCT01798485|Synta Pharmaceuticals|President, Chief Executive Officer|781-541-7261||
20212491|NCT02087046|Abbott|Clinical Research Scientist|972-309-8000|mike.frassica@abbott.com|
20212492|NCT01107535|Abbott|Global Medical Services|1-800-633-9110||
20212493|NCT01155583|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Jason Valent|+1 216-445-7238|VALENTJ3@ccf.org|
20212494|NCT00585351|University of Iowa|Enrique Leira, MD, MS|319-356-8755|enrique-leira@uiowa.edu|
20212495|NCT01001169|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212496|NCT01945138|University of Minnesota|Dr. Melena Bellin|612-624-5409|bell0130@umn.edu|
20212497|NCT01608295|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
20212498|NCT02536378|Silk Road Medical, Inc.|Ric Ruedy, Executive VP, Clinical, Regulatory and Quality Affairs|408-585-2112|ric@silkroadmed.com|
20212499|NCT00602030|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
20212500|NCT00798889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212501|NCT05085964|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
20212502|NCT01534975|Los Angeles Biomedical Research Institute|Matthew Budoff|3102224107|mbudoff@labiomed.org|310
20212503|NCT03156270|Dept. of Otolaryngology-Head and Neck Surgery, The Ohio State University|Kai Zhao, PhD.|614-293-3857|zhao.1949@osu.edu|
20212504|NCT00446654|Progen Pharmacauticals Ltd|Director of Clinical Trials|+61 7 32739133||
20212505|NCT00707915|Minami-hanno Hospital|Director of clinical trials|81.42.972.7111|haloperidol1mg@hotmail.com|
20212506|NCT02087059|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20212507|NCT00947856|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20212508|NCT01261325|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20212509|NCT01033864|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212510|NCT03187080|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
20212511|NCT02330081|Terumo BCT|Beth Crump|+1 303 231-4606|beth.crump@terumobct.com|
20212512|NCT00722111|VAHSRD|Dr. JoAnne Robbins|608-256-1901|bert.landreth@va.gov|11697
20187069|NCT03652389|NYU Langone Health|Antoinette M. Schoenthaler|646-501-3434|Antoinette.Schoenthaler@nyulangone.org|
20187070|NCT05651308|Weill Cornell Medicine|Lisa M. Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
20187071|NCT02268461|University of Minnesota|Kate Frost|612-626-4913|jahnke.k.131@gmail.com|
20187072|NCT05283304|UT Southwestern Medical Center|Madhukar Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
20187073|NCT04447469|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20187074|NCT02714257|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
20187075|NCT05495555|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
20187076|NCT00704262|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20187077|NCT03656510|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187078|NCT00167674|University of Washington|Grace John-Stewart|206 948 9357|gjohn@uw.edu|
20187079|NCT03974178|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41229069239/+41795431713|ovalverde@dndi.org|
20193243|NCT01011868|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193244|NCT01262092|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20193245|NCT03784820|University of North Carolina at Chapel Hill|Hunna Watson, PhD|984-974-5217|hunna_watson@med.unc.edu|
20193246|NCT04905849|UC San Francisco|Dr. Joaquin A. Anguera, Associate Professor|415 502 7322|joaquin.anguera@ucsf.edu|
20193247|NCT04121897|University of North Carolina at Chapel Hill|Dana McCarty, PT, DPT|919-843-8792|dana_mccarty@med.unc.edu|
20193248|NCT05010850|SafeHeal|Heather Cronin, VP Clinical Affairs|5184289593|hcronin@safeheal.com|
20193249|NCT02037620|University of Louisville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
20193250|NCT02810873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Mathew Thakur|215-503-7874|mathew.thakur@jefferson.edu|
20193251|NCT00838929|Thomas Jefferson University|Wenyin Shi, MD, PhD|215-955-4111|Wenyin.Shi.@jefferson.edu|
20193252|NCT04683510|University of Tennessee Health Science Center|Principle investigator|(901)448-2383|mmart126@uthsc.edu|
20193253|NCT03771638|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628.217.7479|susan.buchbinder@sfdph.org|
20193254|NCT02325830|Cardiac Dimensions|Vice President of Clinica Affairs|425-605-5922|aswenson@cardiacdimensions.com|
20193255|NCT02923193|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
20212513|NCT02707432|University of North Carolina at Chapel Hill|Stephanie Hoover, PhD|919-966-1649|stephanie_hoover@med.unc.edu|
20212514|NCT01957657|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212515|NCT02668302|Collin County ENT|Keith E Matheny, MD (Principal Investigator)|(972) 596-4005|kmatheny618@gmail.com|
20212516|NCT03558997|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20212517|NCT01149616|Beth Israel Deaconess Medical Center|Dr Lauren Fisher|6176671853|lauren_fisher@dmgaz.org|
20212518|NCT03586830|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20212519|NCT04192799|The Dartmouth Institute for Health Policy & Clinical Practice|Stephanie Acquilano, Research Project Director|603-646-5937|stephanie.acquilano@dartmouth.edu|
20212520|NCT01016652|Johnson & Johnson Vision Care|Thomas R. Karkkainen OD, MS, FAAO Senior Principal Research Optometrist|(904)443-3402|TKarkkai@its.jnj.com|
20212521|NCT02034799|Ethicon, Inc|Senior Director of Ethicon Clinical R&D|(908) 218-2492|jbatill2@its.jnj.com|
20212522|NCT02265848|Center for Clinical Research / Carolinas Pain Institute|Dr. James North MD|3367656181|jhong@ccrpain.com|
20212523|NCT01717898|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
20212524|NCT00401882|Beaumont|David Haines, MD|248-898-4198|david.haines@beaumont.edu|
20212525|NCT00557882|MedStar Washington Hospital Center|Andrew Sokol, MD|2028776526|andrew.i.sokol@medstar.net|
20212526|NCT03433001|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20212527|NCT02058628|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212528|NCT01452529|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20212529|NCT01038557|Oregon Health & Science University|Dr. Martin A. Schreiber|503-494-8324|schreibm@ohsu.edu|
20212530|NCT04527471|Verona Pharma|Margot MacDonald-berko|833-417-0262|margot.macdonald-berko@veronapharma.com|
20212531|NCT02891200|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
20212532|NCT01172600|Cleveland Clinic|Alparslan Turan, MD|216-445-9857|turana@ccf.org|
20212533|NCT00988169|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
20212534|NCT02637076|CAMH|Dr. Stephen Kish|416-535-8501|stephen.kish@utoronto.ca|36256
20212535|NCT02642627|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
20212536|NCT02295774|Humanitas Research Hospital & Humanitas University|Alessandro Repici MD|00390282247493|alessandro.repici@hunimed.eu|
20212537|NCT03083483|Duke University|Hannah Palmer|919-613-7665|hlp14@duke.edu|
20212538|NCT01751412|Massachusetts General Hospital|Thomas F. DeLaney, MD|617-726-6876|TDELANEY@mgh.harvard.edu|
20212539|NCT00582036|University of Oklahoma Health Sciences Center|George Selby, MD|405-271-4022|george-selby@ouhsc.edu|
20212540|NCT03513497|University of North Carolina at Chapel Hill|Julie Marchesan, DDS, PhD|919-537-3853|julie_marchesan@unc.edu|
20212541|NCT03294538|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20212542|NCT03295643|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
20212543|NCT00422656|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
20212544|NCT02623959|UT MD Anderson Cancer Center|Ost,David,M.D. / DOST@MDANDERSON.ORG|713-745-8775|DOst@mdanderson.org|
20212545|NCT01462565|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212546|NCT01584609|Penumbra, Inc.|Michaella Corso|(510) 748-3200|mcorso@penumbrainc.com|
20212547|NCT00415532|Amgen Inc.|Study Director|866-572-6436||
20212548|NCT03687125|Mundipharma Research Limited|Terry Nichols|(0044)1223424444|terry.nichols@mundipharma-rd.eu|
20212549|NCT01992107|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20212550|NCT02022007|Woman''s Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
20212551|NCT01214603|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20193256|NCT02145169|Albert Einstein Medical Center|Kamran Mohiuddin. Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EISNTEIN.EDU|
20193257|NCT02358668|The Chinese University of Hong Kong|Dr Andrea Luk|852-26324276|andrealuk@cuhk.edu.hk|
20193258|NCT02419417|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20193259|NCT01240551|National Cancer Institute|Dr. Karen Kurdziel|301-443-0622|kurdziek@mail.nih.gov|
20193260|NCT03325790|Sound Pharmaceuticals, Inc.|Dr. Jonathan Kil|206-634-2559|info@soundpharma.com|
20193261|NCT01317875|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
20212552|NCT01507896|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20212553|NCT01413399|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
20212554|NCT01982383|Medical Faculty Associates|Nicole Swanson|202-741-2437|nswanson@mfa.gwu.edu|
20212555|NCT02746263|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20212556|NCT01523964|DART Therapeutics|Chief Operating Officer|415-341-5783|egoldstein@dartrx.com|
20212557|NCT01821625|UT Southwestern Medical Center at Dallas|William M Lee, MD|214 645 6111|william.lee@utsouthwestern.edu|
20212558|NCT02950753|UMCSouthernNevada|Dr. Tony Zitek|702-383-7885|zitek10@gmail.com|3
20212559|NCT03503474|University of Leeds|Professor Mark Wilcox|+441133926818|mark.wilcox@nhs.net|
20212560|NCT01847196|BiO2 Medical|Margaret Tumas, VP of Clinical Affairs|720-635-3232|mtumas@bio2medical.com|
20212561|NCT05425966|University of California San Francisco|Lauren Haack, PhD|415-502-8060|lauren.haack@ucsf.edu|
20212562|NCT00321711|Amgen Inc.|Study Director|866-572-6436||
20212563|NCT01186978|Duke University Health System|Assistant Research Practice Manager (ARPM) for Clinical Trials|919-668-5211|Jennifer.Mewshaw@duke.edu|
20212564|NCT01227668|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20212565|NCT02922959|University of Cincinnati Addiction Sciences Division|Theresa Winhusen|5135858292|winhust@ucmail.uc.edu|
20212566|NCT01360450|Johns Hopkins Medical Institution|Estelle B Gauda|4106140151|egauda1@jhmi.edu|
20212567|NCT02115256|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
20212568|NCT01505465|HSS|Dr. Memtsoudis|(212) 606-1000|MemtsoudisS@hss.edu|
20212569|NCT01626859|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20212570|NCT02826603|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20212571|NCT00905489|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212572|NCT00583596|St. Jude Medical Formally AGA Medical Corporation|Jeffrey Mifek|6517565586|jmifek@sjm.com|
20212573|NCT01855126|Rensselaer Polytechnic Institute|Mariana Figueiro|(518)687-7142|figuem@rpi.edu|
20212574|NCT01166971|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20212575|NCT04326842|The First Affiliated Hospital of Harbin Medical University|Dr. Hong Zhang|+86 0451-85553952|2315186458@qq.com|
20212576|NCT01357356|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20212577|NCT03944785|Supernus Pharmacueticals|Gianpiera Ceresoli-Borroni|301-838-2521|gceresoliborroni@supernus.com|
20212578|NCT04535583|Geisel School of Medicine at Dartmouth|Dr. Lisa A. Marsch|603-646-7092|lisa.a.marsch@dartmouth.edu|
20212579|NCT01078090|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20212580|NCT00924066|National Cancer Institute|Antonio Fojo, M.D.|301-496-2631|fojot@mail.nih.gov|
20212581|NCT01748890|Massachusetts General Hospital|Anthony E. Samir|6178523241|asamir@partners.org|
20212582|NCT00526890|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20212583|NCT01688037|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20212584|NCT03035227|Kansas City Heart Rhythm Institute|Dr. Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
20212585|NCT02100956|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
20212586|NCT02220907|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20193262|NCT01381575|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20193263|NCT01200342|UT MD Anderson Cancer Center|Sapna P. Patel, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20193264|NCT02748889|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
20193265|NCT02550938|Align Technology, Inc.|Allison Mossing, Sr. Clinical Research Associate|4084701046|amossing@aligntech.com|
20193266|NCT01367847|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-3995|djjones@email.unc.edu|
20193267|NCT01439867|Amgen Inc.|Study Director|866-572-6436||
20193268|NCT03941600|Washington University School of Medicine|Dr. Kerri Morgan|314-286-1659|morgank@wustl.edu|
20193269|NCT00283283|Walter Reed National Vaccine Healthcare Center Network|COL Renata J. M. Engler, MD|202-782-9461|renata.engler@na.amedd.army.mil|8819
20193270|NCT02701062|AtriCure|Nfii Ndikintum, VP Clinical Affairs and Biometrics|(513) 644-8192|nndikintum@atricure.com|
20193271|NCT01597843|Clement J Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
20193272|NCT01375673|WJB Dorn VAMC (VHA)|Andrea M. Boyd, PhD, Asscoaite Nurse Executive, Research/Education|803.776.4000|andrea.boyd@va.gov|5654
20193273|NCT00979953|Cubist Pharmaceuticals|VP of Clinical Research|(781) 860-8660||
20193274|NCT00577135|Duke University|Jeff Sharp|919.668.7086|jeff.sharp@dm.duke.edu|
20193275|NCT00425607|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
20193276|NCT00980642|Cleveland Clinic|Dr. Andrea Kurz|216 445-9924|KURZA@ccf.org|
20212587|NCT01983020|Beth Israel Medical Center|Ronald Kaplan, MD||rkaplan@chpnet.org|
20212588|NCT03280537|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212589|NCT02995837|University of Miami|Ignacio Tapia, MD|3052439885|itapia@miami.edu|
20212590|NCT01859702|Alcon Research, Ltd.|Abayomi Ogundele, Global Medical Affairs Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20212591|NCT03369756|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
20212592|NCT05286528|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212593|NCT02322528|University of Rochester|Dr. James V. Aquavella|585-276-7439|rick_barrett@urmc.rochester.edu|
20212594|NCT00458302|Jan-Cilag Germany|EMEA Medical Affairs Director Virology|+49 7624 907580||
20212595|NCT02224456|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212596|NCT01241461|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20212597|NCT00202449|VA PSHCS|Murray Raskind, MD|206-764-2702|Murray.Raskind@va.gov|
20212598|NCT01379781|Columbia University Medical Center|Catherine Monk, Ph.D., Assoc Professor|(646) 774-8941|cem31@columbia.edu|
20212599|NCT04942379|UMass Chan Medical School|Dr. Michelle Trivedi|7744418086|Michelle.Trivedi3@umassmed.edu|
20212600|NCT03287050|University of Michigan|Zachery Reichert|764-3066|zreiche@med.umich.edu|
20212601|NCT03273387|Department of Cardiology and Vascular Medicine, Universitas Indonesia|dr. Bambang WIdyantoro, FIHA, PhD|+628128164299|bambang_ui@yahoo.com|
20212602|NCT01717014|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
20212603|NCT00820235|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20212604|NCT00006170|University of Pittsburgh|Dr. Michele Levine|412-647-0703|levinem@upmc.edu|
20212605|NCT01162499|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
20212606|NCT00832078|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
20212607|NCT03551730|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20212608|NCT00955032|Center for Neurological Restoration Cleveland Clinic|Dr. Hubert Fernandez|(216) 445-1108|fernandez@neurology.ufl.edu|
20212609|NCT03158298|Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany|Dr. Benjamin Schleenvoigt|+49 3641 9 32 46|benjamin.schleenvoigt@med.uni-jena.de|70
20212610|NCT01628120|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212611|NCT01165996|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|216-444-8170|saunthy@ccf.org|
20212612|NCT00096265|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20212613|NCT00017563|OHSU Knight Cancer Institute|Tomasz Beer, M.D.|503-494-1080|beert@ohsu.edu|
20212614|NCT04690413|NOWDiagnostics|Beth Cobb|479-966-4531|beth.cobb@nowdx.com|
20212615|NCT00704418|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20212616|NCT01579474|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212617|NCT01075763|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20212618|NCT00586521|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20212619|NCT00747552|University of Utah|Donald Null M.D.|801.588-3865|donald.null@imail.org|
20212620|NCT01626820|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212621|NCT03734237|USUHS|Timothy Burgess, MD, MPH|(301) 295-9792|timothy.burgess@usuhs.edu|
20212622|NCT00118053|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20212623|NCT03119064|Brown University Oncology Research Group|Heinrich Elinzano, MD|401-863-3000|BrUOG@BROWN.EDU|
20212624|NCT00818623|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20212625|NCT00617461|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20212626|NCT00358826|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
20212627|NCT01110681|Q-Med AB|Head of Medical Affairs|+ 46 (0)18 4749000|reception.SEUPP@galderma.com|
20212628|NCT03559010|HRA Pharma|Christine VENARD|33 1 84 13 92 44|c.venard@hra-pharma.com|
20212629|NCT00457665|UTSouthwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
20212630|NCT00565370|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20212631|NCT02535000|Serviço de Anestesiologia de Joinville|Antonio Bedin|+554734331666|abjoimailbox-ct@yahoo.com|
20212632|NCT00168337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20212633|NCT01620489|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20212634|NCT03267030|NOPHO|Dr Birgitte Klug Albertsen|+45 20224643|biralber@rm.dk|
20212635|NCT01851590|Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital, Finland|Janne Jokinen, MD, PhD, Consultant Cardiothoracic Surgeon|50 554 8103|janne.jokinen@helsinki.fi|+358
20212636|NCT00696709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212637|NCT00310856|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20212638|NCT00443352|Thomas Jefferson University|William B Young, MD|215-955-2243|william.b.young@jefferson.edu|
20212639|NCT02462070|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20212640|NCT03979209|Rush UMC|Bobby Tajudeen, MD|312-942-6100|Bobby_Tajudeen@rush.edu|
20212641|NCT01306253|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20212642|NCT00543439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212643|NCT04749524|Intelligent Hearing Systems Corp|Dr. Rafael E. Delgado|305-668-6102|redelgado@ihsys.com|
20212644|NCT01709383|Georgetown University|Elizabeth H. Lacey, PhD, Study Coordinator|202-877-1124|ehl4@georgetown.edu|202
20212645|NCT03264066|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20212646|NCT01484028|Vistakon, Johnson and Johnson Vision Care|Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist|1 904 443 3252|mmayers@its.jnj.com|
20212647|NCT01193517|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-792-2828|moverman@mdanderson.org|
20212648|NCT00146770|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20212649|NCT03621085|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
20212650|NCT01626885|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20212651|NCT01533428|Astellas Pharma Global Development|Medical Science Director, Global Medical Science|+31(0)715454002|Astellas.resultsdisclosure@astellas.com|
20212652|NCT00961051|Abbott Medical Optics|Eugenia Thomas, O.D.|714-247-8723|eugenia.thomas@amo.abbott.com|
20212653|NCT02669264|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20212654|NCT02473991|ain shams university maternity hospital|prof Dr khaled ebrahim abdalla|00201023220701|drkhaled_abdallah@med.asu.edu.eg|
20212655|NCT00859469|Columbia University|Joshua Leinwand|212-305-4076|jcl2125@columbia.edu|
20212656|NCT04345471|Mochida Pharmaceutical Company, Ltd.|Director of Clinical Research Department|+81332256331|clinical.trials.contact@mochida.co.jp|
20212657|NCT01879800|Baylor College of Medicine|Dr. Lilian Dindo|713-791-1414|lilian.dindo@bcm.edu|10296
20212658|NCT01098240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212659|NCT01588106|GWT-TUD GmbH|Dr. Carsta Köhler|+49 (0) 351 25933 100|contact@gwtonline.de|
20212660|NCT00974142|University of Pittsburgh Medical Center|Michael Donahoe MD|412-648-9636|donahoem@upmc.edu|
20212661|NCT00982410|Ann Arbor Veteran Affairs|Dr. Mark Ilgen|(734) 845-3646|Mark.Ilgen@va.gov|
20212662|NCT04014959|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
20212663|NCT02004847|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
20212664|NCT03827213|Montefiore Medical Center|Elilary Medilla Medrano|(718) 920-4316|emontill@montefiore.org|
20212665|NCT01557595|UAB|Dr. Rachel Fargason|205-934-5151|rfargason@uab.edu|
20212666|NCT00759148|Alcon Research, Ltd.|Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20212667|NCT03381248|Avanos Medical|David Curd|470-448-5178|david.curd@avanos.com|
20212668|NCT05188521|Mayo Clinic|Dr. Aaron R. Mangold, Principal Investigator|480-301-9196|mangold.aaron@mayo.edu|
20212669|NCT04582266|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20212670|NCT01341639|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212671|NCT02247479|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
20212672|NCT01132118|Brigham and Women's Hospital|Dr. Daniel H. Solomon|617-525-8127|dsolomon@partners.org|
20212673|NCT03889756|Yale University|Dr. Michael Bloch|203 7374809|michael.bloch@yale.edu|
20212674|NCT01299038|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
20212675|NCT00322556|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20212676|NCT01590433|Beth Israel Deaconess Medical Center|Jody Dushay|617-667-9344|jdushay@bidmc.harvard.edu|
20212677|NCT00555009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20212678|NCT05432271|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
20212679|NCT01259427|VISN 5 MIRECC|Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
20212680|NCT03020472|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20212681|NCT01506323|VA San Diego Healthcare System|Dr. Jill E. Bormann|858-552-8585|jill.bormann@va.gov|x2378
20212682|NCT02232074|Boston Medical Center|Tracy Battaglia|617.638.8036|tracy.battaglia@bmc.org|
20212683|NCT00580853|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
20212684|NCT03581474|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
20212685|NCT04579926|Klein Buendel, Inc.|Julia Berteletti|3035654321|jberteletti@kleinbuendel.com|
20212686|NCT02588573|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
20212687|NCT01711021|Noven Pharmaceuticals, Inc.|Study Director|(305) 253-5099|ClinicalTrials@noven.com|
20212688|NCT01844583|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20212689|NCT02833415|University of Texas Southwestern Medical Center|Ian J. Neeland MD|214-645-1267|ian.neeland@utsouthwestern.edu|
20212690|NCT00449072|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
20212691|NCT01787825|CapsoVision, Inc.|Director of Clinical Affairs|408-624-1488|andra.thomas@capsovision.com|117
20212692|NCT03352427|University of Michigan|Carl Koschmann, MD|734-615-2736|ckoschma@umich.edu|
20212693|NCT04394754|Yale University|Francis Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
20212694|NCT00989261|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20212695|NCT01238848|Hospital General de Niños Pedro de Elizalde|Maria I. Espelt, MD|541146136968|cespelt@fibertel.com.ar|
20212696|NCT00576901|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212697|NCT02398188|Neothetics, Inc.|Neothetics Clinical|858-550-1900||
20212698|NCT01259869|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
20212699|NCT06076681|TenNor Therapeutics (Suzhou) Limited.|TenNor Medical Information|0512-86861979|info@tennorx.com|
20212700|NCT03209570|Insight Therapeutics, LLC|H. Edward Davidson, PharmD, MPH|7576246040|EDavidson@inther.com|
20212701|NCT00220701|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
20212702|NCT01176448|University of Virginia Dept of Otolaryngology Head and Neck Surgery|J. Jared Christophel MD|434-243-9391|jjchristop@gmail.com|
20212703|NCT00755326|University of Maryland Center for Integrative Medicine|Brian M. Berman|410706-6181|bberman@som.umaryland.edu|
20212704|NCT02140957|St. Michael's Hospital|Dr. Jonathon Maguire|(416) 919-3462|jonathon.maguire@utoronto.ca|
20212705|NCT02971956|Dana-Farber Cancer Institute|Peter C. Enzinger MD|(877) 442-3324|Peter_Enzinger@dfci.harvard.edu|
20212706|NCT03256968|Universtiy of Alabama at Birmingham|Steven Rowe|205-975-9776|srowe@uabmc.edi|
20212707|NCT01617577|University of South Florida|Professor Juan Sanchez-Ramos|813-974-5841|jsramos@health.usf.edu|
20212708|NCT00368966|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20212709|NCT01689974|New York University School of Medicine|Sylvia Formenti, MD|646.962.4073|formenti@med.cornell.edu|
20212710|NCT01333033|Alliance for Clinical Trials in Oncology|Karyn Goodman, M.D.|(212) 639-3983|goodmank@mskcc.org|
20212711|NCT00804609|Stanford University|Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
20212712|NCT01388647|Vector Oncology|Vice President of Scientific Affairs|901-435-5550|mwalker@vectoroncology.com|1759
20212713|NCT01544166|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20212714|NCT01336894|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
20212715|NCT00868309|Instituto Bioclon S.A. de C.V.|Walter Garcia|+52 (55)54883700|wgarcia@silanes.com.mx|3785
20212716|NCT00455663|UTHSCSA|Dawn I. Velligan|210-567-5508|velligand@uthscsa.edu|
20212717|NCT01684410|Grifols Therapeutics Inc.|Henry Li, PhD|919-316-6042|henry.li@grifols.com|
20212718|NCT00903383|Lexicon Pharmaceuticals, Inc.|Joel Freiman, MD, MPH|281-863-3070||
20212719|NCT01076166|Abbott|Global Medical Services|1-800-633-9110||
20212720|NCT02755545|Galderma|Director, Medical Affairs and Clinical Development|8179615325|matthew.meckfessel@galderma.com|
20212721|NCT00638157|Cubist Pharmaceuticals|Ed Campanaro / Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
20212722|NCT02110706|Yale School of Medicine|Dr. Richard Nowak, MD,MS|203-785-4085|richard.nowak@yale.edu|
20212723|NCT04992052|Northwell Health System|Nancy Dengler, Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
20212724|NCT02970669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20212725|NCT02531022|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
20212726|NCT04177810|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
20212727|NCT04756141|Mayo Clinic|Adrian G. Dumitrascu, M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
20212728|NCT00876733|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212729|NCT01714505|University of Virginia|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
20212730|NCT02611752|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
20212731|NCT02843074|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20212732|NCT03521999|Ralph H. Johnson VA Medical Center|Research Coordinator|843-301-9917|sarah.szafranski@va.gov|
20212733|NCT01564758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212734|NCT03872700|Montefiore Medical Center|Dr. Benjamin W Friedman|718-920-6626|befriedm@montefiore.org|
20212735|NCT00492206|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|412-648-6507|tarhiniaa@upmc.edu|
20212736|NCT01185288|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20212737|NCT02427607|Eisai Co., Ltd.|Hidetaka Hiramatsu|+81-3-3817-5245|esi_medinfo@eisai.com|
20212738|NCT02277769|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20212739|NCT00656019|StanfordU|Dr. Melinda Telli|650-724-9533|steinhau@stanford.edu|
20212740|NCT02407756|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20212741|NCT03083132|University of Arkansas for Medical Sciences|Dr. Tuhin Virmani|501-686-7235|tvirmani@uams.edu|
20212742|NCT03118739|AstraZeneca R&D|Fredrik Erlandsson, Global Clinical Lead|+46317762365|Fredrik.Erlandsson@astrazeneca.com|
20212743|NCT00669955|Axcan Pharma Inc.|Monique Giguere, PhD, Programs Director,|1-800-565-3255||2078
20212744|NCT00717977|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|rbeck@jaeb.org|
20212745|NCT01326026|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20212746|NCT00824460|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
20212747|NCT01170260|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
20212748|NCT04317053|NYU Langone Health|Kelly Doran, MD, MHS|212-263-5850|Kelly.Doran@nyulangone.org|
20212749|NCT04274192|University of Arkansas for Medical Sciences|Dr. Sherry Courtney|501-364-1028|SECourtney@uams.edu|
20212750|NCT00289458|University of Saskatchewan|Dr. Cathy M. Arnold|306 966 6588|cathy.arnold@usask.ca|
20212751|NCT03507439|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20212752|NCT00874757|University of Nebraska Medical Center|Timothy R McGuire|402-651-2496|trmcguir@unmc.edu|
20212753|NCT01073020|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 1966|mary.elizabeth.patti@joslin.harvard.edu|
20212754|NCT01644890|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
20212755|NCT04642950|Nobel Pharma Co. Ltd.|Information Desk|+81-3-6670-3800|taniguchi.masaki@nobelpharma.co.jp|
20212756|NCT02452060|NYU Langone Medical Center|Jing Wang|212-460-0176|jing.wang@nyulangone.org|
20212757|NCT03031899|The Oxford Dental college|Dr. Anisha Yaji|9480718531|dr.anishayaji@gmail.com|
20212758|NCT01060670|Integra LifeSciences, Inc.|Katie Bush, PhD- Manager, Global Medical Affairs- Tissue Technology|617-268-1616|katie.bush@integralife.com|267
20212759|NCT00094302|New England Research Institutes|Brian Harty|617-972-3224|bharty@neriscience.com|
20212760|NCT04089982|Duke University|James M. Davis, MD|919-668-5055|james.m.davis@duke.edu|
20212761|NCT01535326|Dalin Tzu Chi Hospital|Dr. Yu-Hsi Hsieh|88652648000|hsieh.yuhsi@msa.hinet.net|5241
20212762|NCT03705351|Providence Health & Services|Chiayi Chen / Director of PBSI and WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20212763|NCT00494975|Dermatology|Ko Mei-Ju|886-223123456|kmjmay@gmail.com|2141
20212764|NCT00929500|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
20212765|NCT02180061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212766|NCT02557945|New York State Psychiatric Institute|Scott Small, MD|212-305-1269|sas68@cumc.columbia.edu|
20212767|NCT00056160|Celgene Corporation|Robert Knight, M.D.|908-673-9749|rknight@celgene.com|
20212768|NCT01551095|Johns Hopkins University|Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
20212769|NCT01469364|Duke University|Dr. Scott Palmer|919-684-0245|palme002@mc.duke.edu|
20212770|NCT02742090|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20193277|NCT01236378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193278|NCT01163474|Houston VA HSR&D|Donna Smith/Project Coordinator|(713)440-4423|Donna.Smithd19d7@va.gov|
20193279|NCT04530604|University of Michigan|Principal Investigator, Dr. Greg Yanik|734 232-9335|gyanik@med.umich.edu|
20193280|NCT00762476|University of Virginia|Dr. Ronald Turner|(434) 243-9864|RBT2N@hscmail.mcc.virginia.edu|
20193281|NCT00965497|University of South Carolina School of Medicine|Meera Narasimhan, MD|803-434-1100|shardeman@uscmed.sc.edu|
20193282|NCT02878603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20193283|NCT02689453|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
20193284|NCT02838134|Radboud University Medical Center|Dr M.C. Warlé|+31-24362415333|Michiel.Warlé@radboudumc.nl|
20193285|NCT00794924|Kaplan-Harzfeld Geriatric Medical Center|Hilla Zaharoni|97288595350|hilla_z@clalit.org.il|
20193286|NCT03274895|SIFI SpA|Dr. Jelle Kleijn|+31615643708|jelle.kleijn@sifigroup.com|
20193287|NCT01294436|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20212771|NCT01767597|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
20212772|NCT03355742|Clinical Affairs, Abbott Vascular|Siok Hwee Tan, PhD, Principal Clinical Research Scientist|+1 408-845-3581|siokhwee.tan@abbott.com|
20212773|NCT02243020|MicroTransponder Inc.|VP Clinical Affairs|5123714160|brent@microtransponder.com|
20212774|NCT00836927|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212775|NCT04064229|ivWatch, LLC|Jason Naramore|1-855-489-2824|jason.naramore@ivwatch.com|7019
20212776|NCT02518230|Children's Mercy Hospital|Winston Manimtim|816-234-3000|wmmanimtim@cmh.edu|
20212777|NCT00614055|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20212778|NCT02710071|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
20212779|NCT02637557|Ironwood Pharmaceuticals, Inc.|IW-3718-202 Study Chair|1 (617) 621-7722|Info@ironwoodpharma.com|
20212780|NCT01673009|Indiana University|Kent Robertson MD PhD|317-944-8784|krobert@iu.edu|
20212781|NCT01236170|VA Pittsburgh Healthcare System|Dr. Larissa Myaskovsky|4123602241|Larissa.Myaskovsky@va.gov|
20212782|NCT03291509|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
20212783|NCT00952484|Alexion Pharma GmbH|Alexion Pharma GmbH|(617) 494-1393|ClinicalTrials@alxn.com|
20212784|NCT02750306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212785|NCT02659202|Mayo Clinic|Dr. Bruce Johnson|507-284-4375|johnson.bruce@mayo.edu|
20212786|NCT01829477|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20212787|NCT03361423|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
20212788|NCT00299156|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD /Professor|713-792-7026|eharrison@mdanderson.org|
20212789|NCT01725451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20212790|NCT01195922|University of California San Diego|D. J. Silvio Gutkind|(858) 534 5980|sgutkind@ucsd.edu|
20212791|NCT01934296|University of California San Francisco|Dr. Sarah Wang, Director of Clinical Research|416-353-7885|Sarah.Wang@ucsf.edu|
20212792|NCT00482547|C. R. Bard|Vanessa Dell Clinical Research Scientist|908-277-8094|vanessa.dell@crbard.com|
20212793|NCT02015793|AbbVie|Global Medical Services|800-633-9110||
20212794|NCT00320593|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
20212795|NCT00283686|Emory University|Dr. Arlene Chapman|(404) 712-1993|abchapm@emory.edu|
20212796|NCT00481247|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20212797|NCT01716754|Novartis Pharmaceuticals|Study Director|862-778-8300||
20212798|NCT04317781|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-794-4422|qbashir@mdanderson.org|
20212799|NCT04371419|Massachusetts Institute of Technology|Pierre-Luc Vautrey|(617) 258-7013|vautrey@mit.edu|
20212800|NCT02931565|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
20212801|NCT01211769|UNIFESP|José Carlos Fernandes Galduróz|55 11 21490168|galduroz@psicobio.epm.br|
20212802|NCT01214330|Mike O'Callaghan Military Medical Center|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
20212803|NCT00947427|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
20212804|NCT03402893|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20212805|NCT01569828|Novartis Pharmaceuticals|Study Director|862-778-8300||
20212806|NCT04738279|NorthShore University HealthSystem|Nirav Shah, MD, MPH|(847) 570-1236|nshah2@northshore.org|
20212807|NCT00686036|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20212808|NCT01411995|Washington University School of Medicine|Dr Colleen McNicholas|314-747-1331|mcnicholasc@wudosis.wustl.edu|
20212809|NCT00891878|Mayo Clinic|Aminah Jatoi, M.D|(507) 284-5352|jatoi.aminah@mayo.edu|
20212810|NCT01636297|Cleveland Clinic|Dr. Jay Alberts|216-445-3222|albertj@ccf.org|
20212811|NCT01297257|Clinical Research Director|Frank van Leeuwen, M.D.|+31433566622|frank.van.leeuwen@medtronic.com|
20212812|NCT00494806|MD Anderson Cancer Center|Robert L. Massey, PhD, RN|713-792-3704|rlmassey@mdanderson.org|
20212813|NCT01754259|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6291|mdicarli@partners.org|
20212814|NCT02387814|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20212815|NCT01364870|University of Iowa College of Nursing|Barbara Rakel, PhD, RN, FAAN|319-335-7036|barbara-rakel@uiowa.edu|
20212816|NCT01841606|UBC Department of Anesthesia - BC Women's Hospital|Mr. James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
20212817|NCT02102490|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20212818|NCT03065283|Department of Physical Therapy|Prof. Dr. Pedro Lima|558533668091|pedrolima@ufc.br|
20212819|NCT00095199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20193288|NCT02389764|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
20193289|NCT03037203|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2159707145|ClinicalTrialDisclosure@JazzPharma.com|
20193290|NCT01267240|Princess Margaret Cancer Centre|Dr.Eric Chen, Principal Investigator|416-946-4501|eric.chen@uhn.ca|2263
20193291|NCT04674189|CureVac SE|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
20193292|NCT01637077|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-1623|loprinzi.charles@mayo.edu|
20212820|NCT02525029|University of Minnesota, Masonic Cancer Center|Dr. Shernan Holtan, MD|(612) 626-5654|sgholtan@umn.edu|
20212821|NCT03896490|Queen's University Belfast|Dr Oliver Perra|+44289097|o.perra@qub.ac.uk|2313
20212822|NCT02938494|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20193293|NCT02266342|W.L. Gore & Associates|Charee Robe, Biostatistician|928-864-4048|crobe@wlgore.com|
20193294|NCT02638103|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20212823|NCT01736553|The Ohio State Unviersity Wexner Medical Center|Dr. Stephen Kolb|614-366-9050|stephen.kolb@osumc.edu|
20212824|NCT01896297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212825|NCT00003782|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20212826|NCT01890707|Northwestern University|Shireen Ahmad MD|312-472-3585|sahmad@northwestern.edu|
20212827|NCT02743442|Fondation Ophtalmologique A. de Rothschild|Dr Amélie Yavchitz (deputy head of the clinical research unit)|+33148036454|ayavchitz@for.paris|
20212828|NCT00385541|Columbia University|Dr. Pamela Flood|201-370-3933|pflood@stanford.edu|
20212829|NCT00929708|AstraZeneca|Carin Jorup, MSD||clinicaltrialtransparency@astrazeneca.com|
20212830|NCT01893138|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20212831|NCT02154529|Kadmon Corporation|Associate Vice President, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
20212832|NCT02761980|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212833|NCT01907087|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
20212834|NCT02192905|University of Massachusetts Medical School|Sherry Pagoto, Professor|508-856-5159|study@umassmed.edu|
20212835|NCT04820842|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20212836|NCT01296932|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212837|NCT00093964|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20212838|NCT01095003|Institut de Recherche Pierre Fabre|Karim Keddad|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
20212839|NCT04161144|Medical University of South Carolina|Dr. Michael Saladin|8437925306|saladinm@musc.edu|
20212840|NCT03617692|University of Colorado Boulder|Angela Bryan, PhD|3034929549|Angela.Bryan@Colorado.EDU|
20212841|NCT02363907|Dexcom|Eileen Casal, RN, MSN|8588759774|ecasal@dexcom.com|
20212842|NCT00634907|University of Utah|Dr. Gwen McMillin/Principal Investigator|801-583-2787|gwen.mcmillin@aruplab.com|2671
20212843|NCT04041570|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20212844|NCT01338636|Brigham and Women's Hospital Heart and Vascular Center|Aaron B. Waxman|617-525-9733|abwaxman@partners.org|
20212845|NCT02385526|Cyberonics, Inc.|Peter Sears, Clinical Project Manager|(281) 228-7597|peter.sears@cyberonics.com|
20212846|NCT02498522|AinShamsU|Dr. Ahmed kotb|1008681999|ahmedmkotp@hotmail.com|+20
20212847|NCT03532009|Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20212848|NCT01602614|University of Alabama at Birmingham|David Kimberlin, MD|205 934-2424|Dkimberlin@peds.uab.edu|
20212849|NCT02866175|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20212850|NCT01694485|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20212851|NCT02907203|W. L. Gore and Associates|Rizwan Afzal|6236404888|rafzal@wlgore.com|
20212852|NCT03463525|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
20212853|NCT00681863|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212854|NCT03588390|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212855|NCT00384033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212856|NCT01006707|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
20212857|NCT02422290|New York State Psychiatric Institute|Pablo H. Goldberg, MD|646-774-6318|Pablo.Goldberg@nyspi.columbia.edu|
20212858|NCT00760383|Human Physiology, University of Oregon|Hans C. Dreyer, PT, PhD|541-346-5775|hcdreyer@uoregon.edu|
20212859|NCT00192296|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
20212860|NCT01842958|Straumann USA, LLC|Kelly Jork|978-747-2533|kelly.jork@straumann.com|
20212861|NCT00897897|Philips Healthcare|Director, Clinical and Regulatory Affairs|425-487-7665|sarah.baxter@philips.com|
20212862|NCT03465891|Memorial Sloan Kettering Cancer Center|Dr. Lia Palomba|646-608-3711|palombam@mskcc.org|
20212863|NCT00710203|UC Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
20212864|NCT02737306|CytoDyn|Joseph Meidling Executive Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
20212865|NCT05034731|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
20212866|NCT00622908|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
20212867|NCT03937466|Wake Forest University School of Medicine|Nancy Avis, PhD|336-716-6974|navis@wakehealth.edu|
20212868|NCT03305055|Johns Hopkins University|James A. Fauerbach|410-550-0890|jfauerb1@jhmi.edu|
20212869|NCT03213210|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
20212870|NCT02540356|Baxalta, now part of Shire|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
20212871|NCT00963157|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
20212872|NCT01166568|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
20212873|NCT03335371|vTv Therapeutics LLC|Study Director|336-841-0300|clinicaltrials@vtvtherapeutics.com|
20212874|NCT00684671|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212875|NCT04571242|SGX Medical|VP of Clinical Affairs|818-527-2710|clinical@sgxmedical.com|
20212876|NCT02649231|University of Exeter|Professor Celia Morgan|01392 724649|Celia.Morgan@exeter.ac.uk|
20212877|NCT00437281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212878|NCT01832090|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
20212879|NCT00249821|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20212880|NCT02354378|Boston Children's Hospital|Keira Mason, MD|6173552339|keira.mason@childrens.harvard.edu|
20212881|NCT05105711|University of North Carolina at Chapel Hill|Melissa Gilkey, PhD|919-966-8650|gilkey@email.unc.edu|
20212882|NCT01348542|Penn State University College of Medicine|Alexandros Vgontzas|717 531-7278|vgontzas@pennstatehealth.psu.edu|
20212883|NCT00467584|Mayo Clinic|Dr. Dean M. Wingerchuk|480-301-6328|wingerchuk.dean@mayo.edu|
20212884|NCT00926289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20212885|NCT00319956|University of Kentucky Medical Center|Dr. Hubert O. Ballard|859-323-1496|hoball2@uky.edu|
20212886|NCT01202747|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
20212887|NCT01446913|Yale University School of medicine|Henry Klar Yaggi, MD (PI)|203-785-4163|henry.yaggi@yale.edu|
20212888|NCT04000009|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20212889|NCT02292238|Weill Cornell Med/ Burke Neurological Institute|Gary E Gibson, Professor of Neuroscience|9145972291|ggibson@med.cornell.edu|
20212890|NCT01103505|Notal Vision|Grace Chang, MD, PhD|571-719-6416|Grace.Chang@NotalVision.com|
20212891|NCT02041702|Abbott (formerly St. Jude Medical)|Clinical Project Leader Asia|0085229967605|lyim@sjm.com|
20212892|NCT00203307|Thomas Jefferson University/ Jefferson Headache Center|Stephen D. Silberstein, M.D.- Principal Investigator|215-955-2243|stephen.silberstein@jefferson.edu|
20212893|NCT01618305|Westat|Lauren Laimon, Project Manager|240-453-2987|laurenlaimon@westat.com|
20212894|NCT01960816|Aerin Medical, Inc.|Scott Wolf, M.D., President and Chief Medical Officer|650-434-3247|scott@aerinmedical.com|
20212895|NCT02099266|University of Kansas Cancer Center|Dr. Omar Aljitawi|(913) 588-6030|SWILLIAM@kumc.edu|
20212896|NCT02286518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20212897|NCT01309919|Baystate Medical Center|Dr. Katharine White|413-794-5256|katharine.white@bhs.org|
20212898|NCT02780661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20212899|NCT01104207|VA Portland Medical Center|Robert L. Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
20212900|NCT01806688|Agriculture and Agri-Food Canada|Dr. Heather Blewett|204 237-2954|hblewett@sbrc.ca|
20212901|NCT02708290|ImagiRation LLC|Dr. Andrey Vyshedskiy, Founder|6174338577|vysha@bu.edu|
20212902|NCT02958956|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20212903|NCT04583579|Lexitas Pharma Services|Dr. Andrew Pucker|9205792900|andrewpucker@hotmail.com|
20212904|NCT01691508|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212905|NCT00974493|Oxford University Hospitals NHS Trust|Matthew Scarborough|07872436461|matthew.scarborough@ouh.nhs.uk|
20212906|NCT03731182|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212907|NCT02006706|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20212908|NCT02442856|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
20212909|NCT02207621|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20212910|NCT01769209|Stanford University Medical Center|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
20212911|NCT00958256|University of Texas (UT) MD Anderson Cancer Center|Jorge Romaguera, MD/Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
20212912|NCT00049036|AIDS Malignancy Consortium|Jeannette Lee|501-526-6712|jylee@uams.edu|
20212913|NCT03036579|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
20212914|NCT02848599|University Hospital Osijek, Croatia|Dr. Gordana Kristek|+385915115746|gordanaldrmed@yahoo.com|
20212915|NCT05431153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212916|NCT04828161|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20212917|NCT02352337|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20212918|NCT02458638|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20212919|NCT01908127|Tehran University of Medical Sciences|Dr. Mehrsa Paryab|00989121091675|drmparyab@yahoo.com|
20212920|NCT03495648|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
20163107|NCT02687581|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
20163108|NCT00835341|Peking University School of Oncology|Department of Etiology|+8610-88196752|dengdajun@bjmu.edu.cn|
20212921|NCT02324972|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 604-629-9223|clinical@aqxpharma.com|
20212922|NCT02236338|Virginia Commonwealth University|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
20212923|NCT01082952|King Saud University|Dr. Rabih Halwani|00966551307134|rhalwani@ksu.edu.sa|
20212924|NCT00135707|Dept of Obstetrics and Gynecology, University of Pittsburgh|Dr. James Roberts|412-641-1427|RSIJMR@mwri.magee.edu|
20212925|NCT02337933|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20212926|NCT03093454|Duke Health|Scott Hollenbeck, MD|919-681-5079|scott.hollenbeck@duke.edu|
20212927|NCT04540497|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20212928|NCT02850068|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20212929|NCT00421174|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
20212930|NCT01681030|Ethicon, Inc|Richard Kocharian, MD, PhD|+1-908-218-2013|rkochar1@its.jnj.com|
20212931|NCT01829464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20212932|NCT02743702|University of Seville|Dr. Jose J. Jimenez-Rejano|+34667309369|jjjimenez@us.es|
20212933|NCT00992407|R&D Clinical Research, Seoul KOREA|Clinical Research Director|+82 2 2094 -4518||
20212934|NCT02207309|Ludwigs-Maximilians-Universtity of Munich|Lars Lindner|0049894400|Lars.Lindner@med.uni-muenchen.de|74768
20212935|NCT00761592|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
20212936|NCT04700449|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
20212937|NCT03738332|University of Pennsylvania|Dr. Jie Deng|215-573-2393|jiedeng@nursing.upenn.edu|
20212938|NCT02336737|Endomag|Clinical Develoment Director|+44 7851 247439|mwomack@endomag.com|
20212939|NCT02396381|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20212940|NCT03197064|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
20212941|NCT00356200|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
20212942|NCT00635778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212943|NCT02909140|Wilmer Eye Institute|Dr. Fasika Woreta|(410) 955-5650|fworeta1@jhmi.edu|
20212944|NCT02059993|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Zhihong Liu|+86-01088398196|zhihongliufuwai@163.com|
20212945|NCT01000337|Aretaieio Hospital, University of Athens|Argyro Fassoulaki|+30210 7286334|fassoula@aretaieio.uoa.gr|
20212946|NCT02227862|Mylan Inc.|David Gillogly, Head of Global Clinical Operations|+1 (724) 4856581|david.gillogly@mylan.com|
20212947|NCT00795665|University of California Davis|Analyst|916-734-8053|nlogihara@ucdavis.eduu|
20212948|NCT01612000|Protein Sciences Corproation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20212949|NCT02173704|GlaxoSmithKline|GSK Response Center|866-435-7343||
20212950|NCT00419926|Novartis Pharmaceuticals|Study Director|862-778-8300||
20212951|NCT03106870|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20212952|NCT02627742|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20212953|NCT01645306|advanceCOR GmbH|Prof. Dr. Götz Münch, CRP & CEO|+4989200020410|muench@advancecor.com|
20212954|NCT02584140|UCSD Medical Center, Antiviral Research Center|Jill Blumenthal, MD|(619) 471-3913|jblumenthal@health.ucsd.edu|
20212955|NCT03445195|Entasis Therapeutics|Chief Medical Officer|781-810-8940|Enquiries@entasistx.com|
20212956|NCT01180244|Department of Mechanical Engineering, Kettering University|Dr. Jeffrey B. Hargrove||jhargrov@kettering.edu|
20212957|NCT00906425|Institut Straumann|Michael Hotze, PhD|+4161965|michael.hotze@straumann.com|1235
20212958|NCT00620763|United States Department of Agriculture Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
20212959|NCT01595009|Novartis Pharmaceuticals|Study Director|862-778-1873||
20212960|NCT04956666|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
20212961|NCT00506909|UCSD|David Feifel||dfeifel@kadimanp.com|
20212962|NCT00783796|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20212963|NCT02300025|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
20212964|NCT00626925|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
20187080|NCT04283149|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
20187081|NCT03982459|University of California, San Francisco|Dr. Sue Yom, MD|415-353-7175|sue.yom@ucsf.edu|
20187082|NCT03899259|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20187083|NCT05670587|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187084|NCT03738852|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
20187085|NCT01205828|Georgetown University Medical Center|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
20187086|NCT01733316|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
20187087|NCT04508309|PATH|Niranjan Bhat, MD|206 302 4843|nbhat@path.org|
20187088|NCT05139810|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20187089|NCT03240016|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20187090|NCT05200403|Boston University School of Medicine|Kevin Thomas, PhD, MBA|617-358-9787|kipthoma@bu.edu|
20187091|NCT05299723|Columbia University Irving Medical Center|Ari Shechter|212-342-1335|as4874@cumc.columbia.edu|
20187092|NCT05546411|Dana Farber Cancer Institute|Kimberly Perez, MD|617-632-5370|KIMBERLY_PEREZ@DFCI.HARVARD.EDU|
20212965|NCT01215942|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20212966|NCT00753714|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20212967|NCT03520283|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
20212968|NCT00313703|Montefiore Medical Center|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20212969|NCT05780541|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20193295|NCT01358331|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure||ClinicalTrialsDisclosure@merck.com|
20212970|NCT03329027|Vibrantgastro|Clinical trials manager|046663322|service@vibrantgastro.com|
20212971|NCT04849988|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
20212972|NCT03185065|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
20212973|NCT02146430|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|+1 (908) 992-6400|CTRinfo@DSI.com|
20212974|NCT03312530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20212975|NCT03229252|Spyryx Biosciences|Dr. Rob Tarran|919-966-7052|rtarran@spyryxbio.com|
20212976|NCT02261428|"Attikon General University Hospital of Athens"|Mr. Konstantinos Grigoriadis ICU Physical Therapist|00302105832489|grigoriakost@gmail.com|
20212977|NCT04488575|Evelo Biosciences Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
20212978|NCT02401542|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
20212979|NCT00100165|University of Colorado, Denver|Dr. Robert Freedman|303 724-4940|robert.freedman@ucdenver.edu|
20212980|NCT02524379|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20212981|NCT03996603|University of Alabama at Birmingham|Kyle Norris, MD Principal Investigator|(205) 934-1704|kyleparkernorris@gmail.com|
20212982|NCT00812253|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
20212983|NCT01884025|Central Arkansas Veterans Healthcare System|Dr. Kristen Viverito|501-257-1699|KRISTEN.VIVERITO@VA.GOV|
20212984|NCT02655237|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20212985|NCT03679741|Johnson & Johnson Vision Care|John Buch, O.D., M.S. Sr. Prinicpal Research Optometrist|904 443-1707|JBUCH@its.jnj.com|
20212986|NCT05380635|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
20212987|NCT02456532|Henry Ford Health System|Timothy Roehrs|13138026681|troehrs1@hfhs.org|
20212988|NCT02750761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20212989|NCT00729859|University of Washington|Stephanie T. Page, MD, PhD|206-616-0483|page@u.washington.edu|
20212990|NCT03172780|Mylan Pharmaceuticals Pvt Ltd.|Dr. Prasanna C Ganapathi, Associate Vice President, Global Clinical Sciences|08066728952|PrasannaC.Ganapathi@mylan.in|28952
20212991|NCT01111110|University of Florida|Dr.Sreekala Prabhakaran. Clinical Assistant Professor Pediatrics|352-273-8381|sprabhakaran@peds.ufl.edu|
20212992|NCT03758365|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
20212993|NCT02623829|Icahn School of Medicine at Mount Sinai|Dr. Daniel Bernstein|212-731-3311|daniel.bernstein@mountsinai.org|
20212994|NCT00662025|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20212995|NCT01700621|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20212996|NCT02869646|Tibor Rubin VA Medical Center|Michael Hollifield, M.D.|562 826-8000|michael.hollifield@va.gov|4324
20212997|NCT02035137|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
20212998|NCT01288859|University of Naples|Prof. Vincenzo Fogliano|+39 0812539356|fogliano@unina.it|
20212999|NCT03349333|Mundipharma(China) Co.,Ltd|clinical study manager|8610-65636856|guodong.lu@mundipharma.com.cn|
20213000|NCT00290745|Duke University and Duke Cancer Institute|Dr. E. Shelly Hwang, MD, MPH|(919) 684-6849|shelley.hwang@duke.edu|
20213001|NCT02985151|Dermatology SLUCare Physician Group|Research Manager/Coordinator|314 977-1794|rhonda.lebbing@health.slu.edu|
20213002|NCT00780026|University of Michigan|Subramanian Sathishkumar||ssatish@med.umich.edu|
20213003|NCT02959775|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
20213004|NCT00113490|MedImmune|M. Pamela Griffin, MD/ Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
20213005|NCT00819247|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20213006|NCT02162758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20213007|NCT04471935|Flint Rehabilitation Devices|Ian Russell|3392232676|irussell@flintrehab.com|
20213008|NCT05343156|Oculis SA|Bastian Dehmel, Chief Development Officer|0041 21 711 39 70|bastian.dehmel@culis.com|
20213009|NCT01766921|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20213010|NCT01060592|Crospon|John O'Dea PhD|+353-91-519880|jodea@crospon.com|
20213011|NCT00708422|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
20213012|NCT03309449|SUNY Upstate Medical University|William Eggleston|315-464-8906|egglestw@upstate.edu|
20213013|NCT05476679|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|972-8-9126941|racheli@raziel-therapy.com|
20193296|NCT04946942|Weill Medical College of Cornell University|Catherine Riffin, PhD|(203) 303-4904|acr2213@med.cornell.edu|
20193297|NCT04907357|Medical University of South Carolina|Kathleen Brady, MD, PhD|843-792-5205|bradyk@musc.edu|
20193298|NCT00365547|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20213014|NCT00601354|Stanford University|Dr. Debra L Safer|650-723-7928|dlsafer@stanford.edu|
20213015|NCT04616417|University of Illinois at Chiago|Principal Investigor|312-355-3245|Sana.Salih@bsd.uchicago.edu|
20213016|NCT00278512|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
20163109|NCT01340573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20213017|NCT01620177|National Advanced Driving Simulator|Dr. Timothy L. Brown, Co-PI|319-335-4785|timothy-l-brown@uiowa.edu|
20193299|NCT03170518|Janssen Research & Development, LLC|Director Clinical Leader Internal Medicine|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20193300|NCT00546078|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193301|NCT02257918|Louisiana State University Health Sciences Center|Stephanie N. Taylor, MD|(504) 658-2622|staylo2@lsuhsc.edu|
20193302|NCT03023423|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20193303|NCT03512197|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20193304|NCT03842436|Brigham and Women's Hospital|Peter R. Chai, MD, MMS|617-732-5640|pchai@bwh.harvard.edu|
20213018|NCT04041609|Lyra Therapeutics|Lyra Clinical|617-393-4600|lyraclinical@lyratx.com|
20213019|NCT01789320|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20213020|NCT00310427|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
20213021|NCT00756964|University of Florida|A. Ahsan Ejaz, M.D.|3522735328|ejazaa@medicine.ufl.edu|
20213022|NCT00619385|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
20213023|NCT03730103|The Cleveland Clinic|Lynn Borzi, Research Administrator|216-445-3158|borzil@ccf.org|
20213024|NCT02626949|Icahn School of Medicine at Mount Sinai|Jeffrey Weiss, PhD, MS|212-824-7575|Jeffrey.Weiss@mountsinai.org|
20213025|NCT02789111|University of Virginia Department of Aneshtesiology|Bhiken Naik MD|434-924-2283|BIN4N@hscmail.mcc.virginia.edu|
20213026|NCT01488578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213027|NCT02308111|Intercept Pharmaceuticals, Inc.|Medical Information|+1 884-782-4278|medinfo@interceptpharma.com|
20213028|NCT01965561|USAISR|John Kragh, MD|210.539.2210|john.f.kragh.civ@mail.mil|
20213029|NCT03271528|Boston Medical Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
20213030|NCT00673790|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20213031|NCT00306384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20213032|NCT00717756|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20213033|NCT01483872|UCSD|Saima Aslam|858 657 7463|saslam@ucsd.edu|
20213034|NCT00929357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213035|NCT01873859|Cardiovascular research center, Shahid Beheshti University of Medical Sciences|Dr. Saeed Alipour Parsa, director of clinical trial|+9821 2208 3106|s_alipour@sbmu.ac.ir|
20213036|NCT03387033|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
20213037|NCT00601484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213038|NCT03977584|Hoffmann-La Roche|BN40199|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
20213039|NCT01042366|University of Pittsburgh|John Kirkwood, MD|(412) 623-7707|KirkwoodJM@upmc.edu|
20213040|NCT03504852|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20213041|NCT00745251|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
20193305|NCT02121912|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|
20213042|NCT02928848|University of Pennsylvania|Dr. H. Branch Coslett|2156623606|hbc@pennmedicine.upenn.edu|
20193306|NCT03995225|Yale School of Medicine|Kathleen A Garrison|415-260-8618|kathleen.garrison@yale.edu|
20193307|NCT01263054|Halyard Health, Inc.|Mark Lavigne|508-837-1427|mark.lavigne@hyh.com|
20213043|NCT03850509|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20213044|NCT00969332|UCLA|Dr. Kara L. Calkins|310-825-9330|KCalkins@mednet.ucla.edu|
20213045|NCT02666430|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
20213046|NCT03828461|Stanford University|Carolyn Rodriguez, MD, PhD|650-723-4095|cr2163@stanford.edu|
20213047|NCT00576199|Hoffmann-La Roche|Medical Communications|800 821-8590||
20213048|NCT04523142|Novaliq GmbH|Sonja Krösser|+49 6221 50259|info@novaliq.com|0
20213049|NCT05328375|Columbia University Irving Medical Center|Dr. Andrea T. Duran, Assistant Professor of Medical Sciences|212.342.4491|atd2127@cumc.columbia.edu|
20213050|NCT04849845|MannKind Corporation|Johanna Ulloa|818-661-5000|contact@mannkindcorp.com|
20213051|NCT02178709|IndianaU|Dr. Amikar Sehdev|(317) 274-0339|asehdev@iupui.edu|
20213052|NCT02946385|GlaxoSmithKline|GSK Response Center|866-435-7343|anand.n.harpalani@gsk.com|
20213053|NCT01526538|Johns Hopkins University|Matthew Johnson Ph.D.|4105500056|mwj@jhu.edu|
20213054|NCT02929979|VA Palo Alto Healthcare System|Adrienne Heinz|9196306847|adrienneheinz@gmail.com|
20213055|NCT00101582|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20213056|NCT01919190|Pacira Pharmaceuticals, Inc.|Paci|1-855-793-9727|MedInfo@pacira.com|
20213057|NCT01893905|Complejo Hospitalario de La Coruña (CHUAC)|Dr Francisco Blanco, study coordinator|981 17 80 00|fblagar@sergas.es|
20213058|NCT01768858|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20213059|NCT01581970|Masonic Cancer Center, University of Minnesota|Dr. Gautam Jha|612-624-5373|jhaxx014@umn.edu|
20213060|NCT03093324|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20213061|NCT01797471|University of Miami|Jean L. Wright MD|305-243-5965|jwright3@med.miami.edu|
20213062|NCT01693484|LSU Health Science Center Shreveport|Dr Todd Jaeblon|318 675 6180|tjaebl@lsuhsc.edu|419
20213063|NCT01691859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20213064|NCT00976664|National University of Health Sciences|Dr. Jerrilyn Cambron|630-889-6536|jcambron@nuhs.edu|
20213065|NCT00132002|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20213066|NCT01568008|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20213067|NCT02688400|Arthrolab inc.|Dr.Jean-Pierre Pelletier|+1 (514) 992-4939|dr@jppelletier.ca|
20213068|NCT02767388|University of Nebraska Medical Center|David Anderson|402-559-6870|david.anderson@unmc.edu|
20213069|NCT03467477|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20213070|NCT03493126|The Ohio State University|Dr. Andrew Hundley|614-293-4647|andrew.hundley@osumc.edu|
20213071|NCT03519256|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20213072|NCT00275002|Pediatric Brain Tumor Consortium|Dana Wallace|901-595-2617|dana.wallace@stjude.org|
20213073|NCT05456529|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20213074|NCT02374918|University of Arizona|"Dr. William Scott Killgore"|(520) 621-0605|killgore@psychiatry.arizona.edu|
20213075|NCT01506947|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20213076|NCT02511236|University of Miami Miller School of Medicine|David J. Lee|305-243-9680|dlee@med.miami.edu|
20213077|NCT02752776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20213078|NCT01816477|Mayo Clinic|Dr. Dawn E. Jaroszewski|480-301-7865|Jaroszewski.Dawn@mayo.edu|
20213079|NCT00108732|ECOG Statistical Office|Study Statistician|617-632-3012||
20213080|NCT00670956|University of California San Francisco|Hanmin Lee, MD|415-476-4086|hanmin.lee@ucsf.edu|
20213081|NCT02116803|Novartis Pharmaceuticals|Study Director|862-778-8300||
20213082|NCT01946165|UT MD Anderson Cancer Center|Christopher J. Logothetis M.D. / Genitourinary Medical Oncology|713-792-2830|clogothe@mdanderson.org|
20213083|NCT01901055|University of Pittsburgh|Eileen R. Chasens, PhD, Professor of Nursing|412-624-9380|chasense@pitt.edu|
20213084|NCT01807871|University of Vermont|Dr. John Hughes|802-656-1640|John.Hughes@med.uvm.edu|
20213085|NCT03019965|CISMexico|Dr. Yazmín Fuentes|55276900|yazmin_fuentes@hotmail.com|22462
20213086|NCT01659567|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213087|NCT01650324|Taipei Medical University - Wanfang Hospital|Dr. Yi-Jen Chen|886-2-2930-7930|yjchen@tmu.edu.tw|2543
20213088|NCT04582396|Columbia University|Dr. Sachin Agarwal|2123421335|sa2512@cumc.columbia.edu|
20213089|NCT01915732|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213090|NCT01325207|Northwestern University|Jeffrey Raizer, MD||Jeffrey.Raizer@nm.org|
20213091|NCT01654107|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|7322354341|marc.steinberg@rutgers.edu|
20213092|NCT00638365|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
20213093|NCT01569451|University of Colorado|Stefan Sillau|303-724-8657|stefan.sillau@ucdenver.edu|
20213094|NCT01974895|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213095|NCT01399736|Maasstad Hospital|Dr.Pieter Smits|+31102913322|SmitsP@maasstadziekenhuis.nl|
20193308|NCT00936598|University of Pittsburgh|Professor|412-623-5965|bovbjergdh@upmc.edu|
20213096|NCT02296775|Dr. Reddy's Laboratories Ltd, Biologics Survey No. 47, Bachupally Village, Bachupally Mandal, Medchal Malkajgiri District Telangana, India - 500 090|Dr. Ankit Ranpura, MD (Associate Director- Clinical Development)|040 4464 4000|ankitr@drreddys.com|
20213097|NCT04652453|Department of Internal Medicine: Yale School of Medicine|Lauren Ferrante, MD, MHS|(203) 785-3207|lauren.ferrante@yale.edu|
20213098|NCT04543136|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
20213099|NCT02192099|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20193309|NCT01654068|University of Kentucky|Ronal McGarry|859-323-6486|rcmcga2@email.uky.edu|
20213100|NCT00386009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213101|NCT00711464|University of California, Los Angeles|Michael Minzenberg, MD|(310) 825-7642|MMinzenberg@mednet.ucla.edu|
20213102|NCT00585780|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
20213103|NCT02026453|Cedars-Sinai Medical Center|Dr. Joshua M. Pevnick|310-423-6976|Joshua.Pevnick@cshs.org|
20213104|NCT02597543|UCSD|Paul Kim, MD|3104907217|pjk017@ucsd.edu|
20213105|NCT01862328|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20213106|NCT00936975|ECOG-ACRIN Cancer Research Group|Results Reporting Statistician|401-863-9188|bherman@stat.brown.edu|
20213107|NCT02482571|University of Minnesota|Silvia Mangia, PhD|6126254920|mangia@umn.edu|
20213108|NCT03922477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213109|NCT01498484|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
20213110|NCT02486796|Midwestern Regional Medical Center, Inc.|Director of ClinicalResearch|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
20213111|NCT03387098|Immunitybio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20213112|NCT02974153|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20213113|NCT00423800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20213114|NCT01576588|Vilnius University Hospital Santaros Klinikos|Regina Pileckyte, investigator|+370 5 2501384|regina.pileckyte@santa.lt|
20213115|NCT00679783|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20213116|NCT00814320|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20213117|NCT00491504|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20213118|NCT02114307|Imperial College London|Dr Tristan Lane|02033117317|tristan.lane@imperial.ac.uk|
20213119|NCT03111147|William Beaumont Hospitals|Pamela Sloan, Clinical Research Manager|248-551-6059|pamela.sloan@corewellhealth.org|
20213120|NCT01463683|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213121|NCT01565083|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213122|NCT01118728|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20213123|NCT01323998|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213124|NCT00231868|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8082|DYKUO@montefiore.org|
20213125|NCT03104205|Dartmouth-Hitchcock|John A. Batsis|6036505000|john.a.batsis@hitchcock.org|
20213126|NCT02226796|University of Minnesota Duluth|Sharyl Samargia-Grivette|218-726-8347|samargia@d.umn.edu|
20213127|NCT00266409|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20213128|NCT00712010|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont|+41217858054|maurice.beaumont@rdls.nestle.com|
20213129|NCT01179919|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
20213130|NCT01586741|Karolinska University Hospital|D. Peter Emanuelsson|+46851770000|peter.emanuelsson@sll.se|
20213131|NCT00698685|University of Arizona, Arizona Cancer Center|Andrew M. Yeager, MD|520-626-0662|ayeager@azcc.arizona.edu|
20213132|NCT01254409|Promedior, Inc.|Dr. Bernt van den Blink|781-538-4203|bvandenblink@promedior.com|
20213133|NCT01491620|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20213134|NCT00635154|Mayo Clinic|Dr. John Lust||lust.john@mayo.edu|
20213135|NCT01513148|Shenandoah University|Dr. Todd Telemeco|540-545-7398|ttelemec@su.edu|
20213136|NCT03500484|Yale University / Yale School of Medicine|Ania Jastreboff, MD, PhD|203 737 1932|ania.jastreboff@yale.edu|
20213137|NCT02795104|The Ohio State University Comprehensive Cancer Center|Ryan Baltic|614-293-4121|ryan.baltic@osumc.edu|
20213138|NCT01654380|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213139|NCT01575522|Dana-Farber Cancer Institute|Sara M. Tolaney, MD, MPH|617.632.5743|Sara_Tolaney@dfci.harvard.edu|
20213140|NCT02582970|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213141|NCT04128007|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20213142|NCT02901899|Northwestern University|Daniela Matei, MD|312.472.4684|daniela.matei@northwestern.edu|
20213143|NCT00546390|University of Alb erta|Dr B Finegan|7809701302|bfinegan@ualberta.ca|780
20213144|NCT00855842|Boston University|Lynn Borgatta, MD|617-414-3440|lynn.borgatta@bmc.org|
20213145|NCT02566135|Medical College, Baroda.|Dr Aditi Amrutlal Dhimar|09825334605|dhimaraditi@yahoo.in|
20213146|NCT00429923|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
20213147|NCT01265784|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
20213148|NCT01937364|Essentia Health|Jeffrey E. Lyon, M.D.|218-786-2802|jeffrey.lyon@essentiahealth.org|
20213149|NCT04799158|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT|medicalinformation@phathompharma.com|7426
20213150|NCT00440596|Kent State University|Joel Hughes|330-672-7721|jhughes1@kent.edu|
20213151|NCT01592799|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213152|NCT04104646|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20213153|NCT01199601|Columbia University|Dr. Catherine Todd|212-305-4805|cst2121@columbia.edu|
20193310|NCT03358238|University of Wisconsin-Madison|Amy Cochran|608-262-0772|cochran4@wisc.edu|
20213154|NCT02607800|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20213155|NCT01656889|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20193311|NCT01227616|AMAG Pharmaceuticals|Medical Information||CTInterest@covispharma.com|
20213156|NCT02521948|Essential Medical, Inc|Director of Operations|610-557-1009|todd@essmedclosure.com|
20213157|NCT02255513|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
20213158|NCT02568384|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20213159|NCT01055223|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213160|NCT01485536|The University of Texas (UT) MD Anderson Cancer Center|Yasuhiro Oki, Associate Professor, Lymphoma/Myeloma|713-792-7734|CR_Study_Registration@mdanderson.org|
20213161|NCT00329602|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193312|NCT04277507|Aerin Medical|Director of Clinical Operations|650-518-9624|alaborde@aerinmedical.com|
20213162|NCT00510510|Novartis Pharmaceuticals|Study Director|862-778-8300||
20213163|NCT01066052|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20213164|NCT01200394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213165|NCT00630565|University of Minnesota, Masonic Cancer Center|Dr. Daniel Weisdorf, MD|+1 612-624-3101|weisd001@umn.edu|
20213166|NCT04107493|ResMed|maureen crocker|+1 8588366653|maureen.crocker@resmed.com|
20213167|NCT02729896|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20213168|NCT01835145|Alliance for Clinical Trials in Oncology|Jason J. Luke, M.D.||jluke@medicine.bsd.uchicago.edu|
20213169|NCT00582309|UNM|Gary Iwamoto|505-272-4751|giwamoto@salud.unm.edu|
20213170|NCT03123822|UAB|Katherine Weise|2059752020|kweise@uab.edu|
20213171|NCT04094870|University of North Carolina at Chapel Hill|Elizabeth Stringer, MD, MSc|919-966-1601|elizabeth_stringer@med.unc.edu|
20213172|NCT00918671|NTNU|Professor Knut Hagen|+4772575080|knut.hagen@ntnu.no|
20213173|NCT02708277|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
20213174|NCT01058421|University of Colorado|Dr. Marc Moss|303-724-6079|marc.moss@ucdenver.edu|
20213175|NCT01924390|UTHSCSA Periodontics|Brian L. Mealey|210-567-3589|mealey@uthscsa.edu|
20213176|NCT02984683|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|option 6
20213177|NCT02785172|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20213178|NCT02415959|Abbott|Suntje Sander-Struckmeier|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
20213179|NCT01396044|Northwestern University|Dr. Curtis Weiss|(312) 695-6439|curtisweiss@northwestern.edu|
20213180|NCT01048333|Astra Zeneca|Gerard Lynch|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com|
20213181|NCT02739542|UT Southwestern Medical Center|Darin T. Okuda, M.D.|214-645-8800|darin.okuda@utsouthwestern.edu|
20213182|NCT03008460|Ipsen|Ipsen Medical Director|use email|clinical.trials@ipsen.com|
20213183|NCT04555525|Skin Sciences, PLLC|Senen Pena|502-451-9000|spdermresearch@yahoo.com|
20213184|NCT00955747|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
20213185|NCT03131999|Medical University of South Carolina|Charlton Strange, MD|843-792-3174|strangec@musc.edu|
20213186|NCT02260492|Oriel Therapeutics, a Novartis Company|Malinda Longphre PhD, Director Clinical Reserach|9193131290|mlongphre@orieltherapeutics.com|114
20213187|NCT03495869|Virginia Commonwealth University|Lori Keyser-Marcus, PhD|(804) 828-4164|lori.keysermarcus@vcuhealth.org|
20213188|NCT03482713|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-80-672-6372|ClinicalTrialsDisclosure@merck.com|
20213189|NCT04634409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20213190|NCT01497938|Medtronic|Thomas Troub|(818) 576-3142|thomas.troub@medtronic.com|
20213191|NCT00365352|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20213192|NCT00097695|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20213193|NCT00905125|Medicine and Molecular Virology & Microbiology, Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
20213194|NCT02448771|Dana-Farber Cancer Institute|Rinath Jeselsohn|617.632.6887|rinath_jeselsohn@dfci.harvard.edu|
20213195|NCT03457909|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
20213196|NCT02683187|Duke University Medical Center|Dr. David D'Alessio|919-684-5778|david.d'alessio@duke.edu|
20213197|NCT06611410|CooperVision|Lee Hall|+19256604365|LHall@coopervision.com|
20213198|NCT05856123|Mayo Clinic|Deanna Covelli|480-342-5284|covelli.deanna@mayo.edu|
20213199|NCT05514119|Mayo Clinic|Channa Jayasekera, M.D.|480-342-1095|jayasekera.channa@mayo.edu|
20213200|NCT00278200|Johns Hopkins University|Richard Ambinder, MD, PhD|4109558839|rambind1@jhmi.edu|
20213201|NCT01290263|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
20213202|NCT01521559|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
20213203|NCT02228382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213204|NCT02337465|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ping Xia|1-866-223-8100|TaussigResearch@ccf.org|
20213205|NCT02918162|Columbia University|Gulam Manji, MD, PhD|212-305-7115|gam2140@cumc.columbia.edu|
20213206|NCT00395226|Essentia Institute of Rural Health|Brian Johnson|218-786-8856|bjohnson3@eirh.org|
20213207|NCT00576381|The Children's Hospital of Philadelphia|Dr Athena Zuppa|267-426-5753|zuppa@email.chop.edu|
20213208|NCT01747850|CAMH|Dr. Jose Trigo|416.535.8501|jose.trigo@camh.ca|30021
20193313|NCT01431950|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193314|NCT00583947|Sepracor Inc|Respiratory Medical Director|866-503-6351||
20193315|NCT02314689|University of Mississippi Medical Center|Suvankar Majumdar MD|6019845220|smajumdar@umc.edu|
20193316|NCT00486252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20213209|NCT01031537|Division of Occupational Health and Safety, NIH|Dr. James M. Schmitt|301-496-4411|james_schmitt@nih.gov|
20213210|NCT03238677|Syracuse University|Jonathan Preston|3154433143|jopresto@syr.edu|
20213211|NCT03256799|UAB|Steven M. Rowe|205-975-9776|smrowe@uab.edu|
20213212|NCT02492958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213213|NCT03522948|Boston University|Tibor Palfai|617-353-9345|palfai@bu.edu|
20213214|NCT01948505|Pacific Neuroscience Institute|Dr. Walavan Sivakumar|424-212-5361|walavan.sivakumar@gmail.com|
20213215|NCT02187042|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213216|NCT02983448|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|405-271-4742|stavros-stavrakis@ouhsc.edu|37507
20213217|NCT02356471|Wake Forest University Health Sciences|Dr. Clancy Clark|336-716-7207|cjclark@wakehealth.edu|
20213218|NCT00337571|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20213219|NCT00948675|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20213220|NCT03552757|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20213221|NCT00449150|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
20213222|NCT06331156|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20213223|NCT02978326|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20213224|NCT02024087|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213225|NCT02129348|New York State Psychiatric Institute|Davangere Devanand, MD|646.774.8656|dpd3@cumc.columbia.edu|
20213226|NCT01598701|University of Texas Health Science Center at Houston|Carlos Artime, MD|713-500-6200|Carlos.Artime@uth.tmc.edu|
20213227|NCT01709032|Children's Hospital of Philadelphia|Janet Kwiatkowski, MD|215-590-3437|kwiatkowski@email.chop.edu|
20213228|NCT00865709|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20213229|NCT00662129|Mayo Clinic|Donald W. Northfelt, MD, FACP|507/284-1159|northfelt.donald@mayo.edu|
20213230|NCT03276975|Duke University Medical Center|Timothy J. Amrhein, MD|9196841909|timothy.amrhein@duke.edu|
20213231|NCT03978403|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
20213232|NCT02153736|Virginia Commonwealth University|Stacey Dusing, PT, PhD, PCS, Director Motor Development Lab|804-628-3632|scdusing@vcu.edu|
20213233|NCT00767507|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
20213234|NCT00966953|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20213235|NCT00796510|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213236|NCT01734772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213237|NCT05030753|Univeristy of Virginia|Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
20213238|NCT03580343|Washington University in St. Louis|Lynn Hassman, Assistant Professor and Study PI|3142730341|lhassman@wustl.edu|
20213239|NCT02099461|Amgen Inc.|Study Director|866-572-6436||
20213240|NCT03277183|NFSGVA|Dr. Mark Segal|3523761611|mark.segal@va.gov|104496
20213241|NCT00809809|Integrative Medicine Institute|David Riley, MD|505 690-0688|dsriley@integrativemed.org|
20213242|NCT00720122|Massachusetts General Hospital|Madhusmita Misra, M.D., Associate Professor in Pediatrics, Assistant Pediatrician|617-724-5602|mmisra@partners.org|
20213243|NCT03072459|Smith & Nephew, Inc.|Salima Reddy|817-916-2233|salima.reddy@smith-nephew.com|
20213244|NCT02275364|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213245|NCT03177603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20213246|NCT03595657|CStone Pharmaceuticals|Zhang Wenyun|+86 021-60333416|CstoneRA@cstonepharma.com|
20213247|NCT00663871|University of Pittsburgh, Heart and Vascular Institute|Matthew F. Muldoon, MD, MPH|412-624-8798|mfm10@pitt.edu|
20213248|NCT00669578|Mayo Clinic|Ayalew Tefferi, M.D.||tefferi.ayalew@mayo.edu|
20213249|NCT03384745|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20213250|NCT01592370|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20213251|NCT01050231|University of California Irvine|Dr David Reinkensmeyer|(949) 824-5218|dreinken@uci.edu|
20213252|NCT00319449|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20213253|NCT00455533|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20213254|NCT02739984|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20213255|NCT02042911|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
20213256|NCT00767325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20213257|NCT03538756|RxFunction, Inc.|Lars Oddsson, PhD|612-358-2140|loddsson@rxfunction.com|
20213258|NCT00752856|UCSD|Sheldon Morris|8583364088|shmorris@ucsd.edu|
20213259|NCT00996736|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
20213260|NCT02688608|Stanford Medicine at Stanford University|Saad A Khan, MD|650-507-5624|Saad.A.Khan@stanford.edu|
20213261|NCT01693783|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
20213262|NCT02346201|Johns Hopkins School of Public Health|Jennifer Jones, Research Coordinator|44377086812|jejones@jhu.edu|
20213263|NCT00764309|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20213264|NCT03708211|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20213265|NCT00462982|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
20213266|NCT03363581|Imperial College London|Prof Carel le Roux|07970719453|carel.leroux@nhs.net|
20213267|NCT05200858|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20213268|NCT02109133|Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine,Severance Hospital, Yonsei University Health System|Dr. Sun-Jun, Bae|+82-02-2228-4438|SJBAI1@yuhs.ac|
20213269|NCT00409578|Novartis Pharmaceuticals|Study Director|862 778-8300||
20213270|NCT00770315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20213271|NCT04256421|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20213272|NCT01052116|ALA - ACRC|Robert A. Wise|(410) 550-0545|rwise@jhmi.edu|
20193317|NCT01261247|Mayo Clinic Cancer Center|Patrick Johnston, MD, PhD|507-284-2511|johnston.patrick@mayo.edu|
20213273|NCT01739790|Minneapolis VA Healthcare System|Dennis E. Niewoehner, MD|612-467-4412|niewo001@umn.edu|
20213274|NCT00590395|Cedars Sinai Medical Center|Alan Waxman, M.D.|310-423-8000|Alan.Waxman@cshs.org|
20213275|NCT05568225|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20213276|NCT02675543|University of Brescia|Francesco Semeraro|+30 030 3995308|francesco.semeraro@unibs.it|
20213277|NCT02309099|University of North Carolina at Chapel Hill|Dr. Meredith Rooth|919-966-5251|meredith_rooth@med.unc.edu|
20213278|NCT03012477|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
20213279|NCT02819362|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20213280|NCT05301751|Allgenesis Biotherapeutics Inc.|Tan Nguyen, Vice President of R&D|+886-2-87871232|tan.nguyen@allgenesis.com|105
20213281|NCT02624843|South Florida Family Health & Research|Elisabeth Rivera|3053870051|elisabeth@sffhrc.com|
20213282|NCT02324465|Vanderbilt University Medical Center|Doug Hester|6153439419|doug.hester@vanderbilt.edu|
20213283|NCT02132247|IBSA Pharma Inc.|Christopher Jones, Ph.D.|(202) 753-6475|chris.jones@ibsapharma.com|7005
20213284|NCT00928954|Case Western Reserve University|R. John Leigh, M.D.|216-844-3190|rjl4@case.edu|
20213285|NCT00724568|University of Michigan Comprehensive Cancer Center|Dr. Moshe Talpaz|734-764-8195|mtalpaz@umich.edu|
20213286|NCT02433665|Duke University Medical Center|Dr. Daniele Marin|919.684.7709|daniele.marin@duke.edu|
20213287|NCT00520741|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20213288|NCT03702621|Indiana University|Dr. Yar Luan Yeap|317-274-0275|yyeap@iupui.edu|
20213289|NCT01385033|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213290|NCT01860976|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20213291|NCT02892500|Sanford Health|Christie Ellison|605-312-6030|christie.ellison@sanfordhealth.org|
20213292|NCT02354586|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20213293|NCT01134081|University of Michigan|Dr. William Giannobile|734 763 2105|wgiannob@umich.edu|
20213294|NCT02402166|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20213295|NCT02204371|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213296|NCT01141725|FHCRC/UWMC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@uw.edu|
20213297|NCT01024738|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20213298|NCT02362594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213299|NCT03803943|Northwestern University|Megan Roberts|(847) 491-3066|megan.y.roberts@northwestern.edu|
20213300|NCT01574248|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
20213301|NCT02922868|Wake Forest|Dr Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
20213302|NCT01781286|University of Missouri|Dr. Heather Leidy|(573) 882-4288|leidyh@health.missouri.edu|
20213303|NCT00995410|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
20213304|NCT03594123|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20213305|NCT03365375|Indiana University|Paul Musey|317-880-3900|pmusey@iu.edu|
20213306|NCT02483975|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213307|NCT02166697|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20213308|NCT00939653|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20213309|NCT01556009|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
20213310|NCT01505530|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213311|NCT03879239|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
20213312|NCT03622658|Kinevant Sciences Inc. on behalf of Kinevant Science GmbH|Dr. Simon Lowry, Chief Medical Officer|646-495-5368|simon.lowry@roivant.com|
20213313|NCT02720510|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20213314|NCT04763876|William Beaumont Army Medical Center Department of Emergency Medicine|Nathaniel James Turner|915-742-6228|nathaniel.j.turner3.mil@mail.mil|
20213315|NCT03179345|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
20213316|NCT02585700|Clinical Center of Serbia-Clinic for Infectious and Tropical Diseases|Dr. Goran Stevanovic|+381 64 1703059|goran_ste@yahoo.com|
20213317|NCT01618266|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20213318|NCT01966042|Federal University of Sao Paulo (UNIFESP)|Dr. Nelson Americo Hossne Junior|+55 11 5571-2719|nelson.hossne@gmail.com|
20213319|NCT00625807|Massachusetts General Hospital|Sara Lazar|617-724-2256|slazar@mgh.harvard.edu|
20213320|NCT03267264|Becton Dickinson|Michael Gibney|201-847-6170|michael_gibney@bd.com|
20193318|NCT01210651|UCSF|Sudha Prathikanti, MD|415-516-3867|sudha.prathikanti@gmail.com|
20193319|NCT01740154|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20163110|NCT04405076|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20193320|NCT04013971|Emory University|Trisha Kesar, PT, PhD|404-712-5803|tkesar@emory.edu|
20213321|NCT02224391|UT MD Anderson Cancer Center|Dr. Jason Robinson, PHD- Associate Professor, Behavioral Science|(713) 792-0919|jdrobinson@mdanderson.org|
20213322|NCT00084084|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20213323|NCT01802879|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20213324|NCT00454636|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20213325|NCT01400113|St. Joseph's Hospital Health Center|Michael Pratts, MD|315-726-8610|michael.pratts@sjhsyr.org|
20213326|NCT00282256|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
20213327|NCT01095510|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20213328|NCT01890915|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
20213329|NCT02114697|Emory University|John Oshinski PhD|404-727-5894|jnoshin@emory.edu|
20213330|NCT01984242|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213331|NCT00571428|Sunovion|Brovana Medical Director|1-866-503-6351||
20213332|NCT02246478|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20213333|NCT00998023|University of Florida|J Mocco, M.D.|352-273-9000|jmocco@neurosurgery.ufl.edu|
20213334|NCT02334059|Penn State Health Anesthesiology and Perioperative Medicine|Sanjib D Adhikary|717-531-6597|sadhikary1@pennstatehealth.psu.edu|
20213335|NCT02327195|The Ohio State University Wexner Medical Center|Nicoleta Stoicea|614-293-3559|nicoleta.stoicea@osumc.edu|
20213336|NCT02019940|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
20213337|NCT01457053|University of Cincinnati Medical Center|Dr. Myron C. Gerson/Professor of Medicine|5135583074|myron.gerson@uc.edu|
20213338|NCT00984295|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213339|NCT00979628|EUSOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
20213340|NCT00911859|Janssen R&D BE|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20213341|NCT02785913|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20213342|NCT02841709|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
20213343|NCT01929109|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213344|NCT01402908|Medigen Biotechnology Corp.|Clinical Research Manager|886-2-77361234|Doyce.Chen@medigen.com.tw|
20213345|NCT02581345|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
20213346|NCT02122796|Allina Health|Director of Integrative Health Reseach Center|612-262-2354|jeffery.dusek@allina.com|
20213347|NCT00234078|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20213348|NCT03471078|Dova|VP of Global Drug Development|9193387864|clinical@dova.com|
20213349|NCT01544361|MedImmune, LLC.|Joseph M. Parker, Director, Clinical Development|301-398-0000|parkerj@medimmune.com|
20213350|NCT00862979|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20213351|NCT02405325|UCSD|Loki Natarajan|8588224763|lnatarajan@ucsd.edu|
20213352|NCT01027143|Duke University Medical Center|Jason Lang, MD|919-684-9590|jason.lang@duke.edu|
20213353|NCT03068273|Scripps Health|Athena Philis-Tsimikas|858-678-7077|philis-tsimikas.athena@scrippshealth.org|
20213354|NCT03901573|NeoImmuneTech,INC|Alex Oh|301-337-2283|aho@neoimmunetech.com|
20213355|NCT00797108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213356|NCT02518113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20213357|NCT00287118|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20213358|NCT01631864|Novartis Pharmaceuticals|Study Director|862-778-8300||
20213359|NCT02134756|University of South Florida|Marcus Kilpatrick|(813) 362-6696|mkilpatrick@usf.edu|
20213360|NCT00583700|West Virginia University|Geraldine Jacobson, MD, MBA, MPH, FACR|(304) 293-7227|GMJACOBSON@hsc.wvu.edu|
20213361|NCT04471207|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
20213362|NCT06046482|The University of Texas MD Anderson Cancer Center|Renata Ferrarotto, MD|(713) 745-6774|rferrarotto@mdanderson.org|
20213363|NCT00561730|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20213364|NCT02841774|Northwestern University|Dr. Matthew Feinstein|3126643278|matthewjfeinstein@northwestern.edu|
20213365|NCT04908748|Teikoku Seiyaku Co.,Ltd.|Hirofumi Fujiwara|+81362649123|hirofumi-fujiwara@teiyaku.co.jp|
20213366|NCT00757601|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213367|NCT04373434|Emory University|Michelle C. Kegler, MPH, DrPH|404-712-9957|mkegler@emory.edu|
20213368|NCT00527423|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
20213369|NCT00650936|Abbott|Maren Wagner, Clinical Program Director|7517565585|maren.wagner@abbott.com|
20213370|NCT00067236|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20213371|NCT03194464|VA Northern California Health Care System|Dr. Carolynn Patten (Principal Investigator)|916.724.5029|carolynn.patten@va.gov|
20213372|NCT02153398|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
20213373|NCT01400425|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20213374|NCT00818883|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20213375|NCT00973700|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20213376|NCT03718455|Mayo Clinic|Genevieve A. Woodard, M.D., Ph.D.|507-538-3945|Woodard.Genevieve@mayo.edu|
20213377|NCT01105650|Masonic Cancer Center, University of Minnesota|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
20193321|NCT05853900|Click Therapeutics|Clinical Development|347-460-8607|click_ct_contact@clicktherapeutics.com|
20193322|NCT01340014|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20193323|NCT04577573|James J. Peters VA Medical Center|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
20193324|NCT04297618|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
20193325|NCT03931746|Northwell Health Department of Dermatology|Sr. Clinical Data Analyst|516-321-8508|astrunk1@northwell.edu|
20193326|NCT00551746|Intermountain Healthcare|Benjamin D Horne, PhD, MPH|801-507-4708|Benjamin.Horne@imail.org|
20193327|NCT05454813|Medline Industries, L:P|Julie Miller|630-418-6891|jamiller@medline.com|
20193328|NCT04949802|ViaLase Inc.|Melvin Sarayba, MD|9494662856|melvin.sarayba@vialase.com|
20193329|NCT00554996|Barbara Trautner, MD, PhD|Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
20193330|NCT02560753|T3DTherapeutics|John Didsbury, PhD|9199490517|didsj919@t3dtherapeutics.com|
20193331|NCT03267810|University of Miami|Elizabeth Felix|305-243-4497|efelix@med.miami.edu|
20213378|NCT01047345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213379|NCT00806156|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
20213380|NCT02106065|VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
20213381|NCT00424489|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
20213382|NCT03312257|Ohio State University|Jeffrey Walline|614-247-6840|walline.1@osu.edu|
20213383|NCT00982553|Imperial College|Dr Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
20213384|NCT00770510|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
20213385|NCT00235456|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20213386|NCT00536575|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20213387|NCT01089647|University of Cincinnati|Dr. Ann Romaker|513-475-7500|romakean@ucmail.uc.edu|
20213388|NCT00927810|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20213389|NCT00198029|Hospital for Special Surgery|Dr. Lisa Mandl|212-774-2555|MandlL@hss.edu|
20213390|NCT02465567|Pearl Therapeutics Inc|Pearl Therapeutics Inc|1-877-240-9479|information.center@astrazeneca.com|
20213391|NCT02001558|University of Alabama at Birmingham|Yuying Chen, MD, PhD|205-934-3329|yuyingchen@uabmc.edu|
20213392|NCT04117607|ICON CRU|Dr. Dennis Ruff, Senior Medical Director|210-283-4572|Dennis.Ruff@iconplc.com|
20213393|NCT01085344|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
20213394|NCT04894994|RAPT Therapeutics|William Ho|650-489-9037|bill.ho@RAPT.com|
20213395|NCT02780687|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213396|NCT02430870|Takeda|Medical Director Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20213397|NCT03982433|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
20213398|NCT01041781|Fox Chase Cancer Center|Martin J. Edelman, M.D.|(215) 728-4790|martin.edelman@fccc.edu|
20213399|NCT04257929|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and RegulatoryWriting|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
20213400|NCT05049460|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
20213401|NCT02532010|Weill Cornell Medicine|Dr. Sangmin Lee|646-962-2700|sal9053@med.cornell.edu|
20213402|NCT03644095|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20213403|NCT04333095|Baylor Scott & White Research Institute|Sarah Hale, Project Manager|469-814-4845|Sarah.Hale@BSWHealth.org|
20213404|NCT03740165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20213405|NCT03049618|University of Southern California|Victoria Soto|323-865-3441|victoria.soto@med.usc.edu|
20213406|NCT04582539|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20213407|NCT06052566|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20213408|NCT01004770|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|rubin.sheng@ge.com|
20213409|NCT00788957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20213410|NCT03845933|Evergreen General Hospital|Dr Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
20213411|NCT02579096|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
20213412|NCT02097121|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20213413|NCT03066999|PUR Clinic|Dr Sijo Parekattil|3525368761|sijo@orlandohealth.com|
20213414|NCT00661999|Mayo Clinic Rochester|Dr. Charles L. Loprinzi|507-284-8666|cloprinzi@mayo.edu|
20213415|NCT01790568|University of Michigan Comprehensive Cancer Center|Dr. Pavan Reddy, M.D.|734-936-8785|reddypr@umich.edu|
20213416|NCT01361126|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20213417|NCT02994056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20213418|NCT02742181|University Hospitals Cleveland Medical Center|Sharon Stein|(216)844-2873|Sharon.Stein@UHhospitals.org|
20213419|NCT01346410|Mercy|Dr Kathy Baglan|3144345886|kathy.baglan@mercy.net|
20213420|NCT02576990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213421|NCT01179490|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
20213422|NCT01508936|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20213423|NCT00679367|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
20213424|NCT03365947|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400|info@arrowheadpharma.com|
20213425|NCT02518685|BAROnova, Inc|Lian Cunningham, MD, PhD|650.638.9796|lcunningham@baronova.com|22
20213426|NCT05665595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20213427|NCT05771428|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20213428|NCT04025229|UNC Lineberger Comprehensive Cancer Center|Luz Andrea Cuaboy|1-919-843-1177|luz_cuaboy@med.unc.edu|
20213429|NCT03815942|University of Oxford|Dr Mark Tuthil|01865 227042|mark.tuthill@oncology.ox.ac.uk|
20213430|NCT01298570|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20213431|NCT00076102|National Cancer Institute (NCI), National Institutes of Health (NIH)|Brigitte C. Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
20213432|NCT01076972|Abbott|Global Medical Services|800-633-9110||
20213433|NCT02207231|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20213434|NCT02258256|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
20213435|NCT04637997|University Hospital Erlangen, Vascular Surgery|Dr. med. Antje Mükke|+4991318532968|antje.muekke@uk-erlangen.de|
20213436|NCT00502775|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213437|NCT01315145|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
20213438|NCT03392974|BioMarin Pharmaceutical Inc.|Medical Manager, Clinical Science|415-996-2917|divya.reddy@bmrn.com|
20213439|NCT00655642|Vanderbilt University|Dr. Tyler Barrett|6159360253|tyler.barrett@vanderbilt.edu|
20213440|NCT02016300|Stanford University|Jason Dragoo, MD|650-721-3430|jdragoo@stanford.edu|
20213441|NCT04815863|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
20213442|NCT06165744|Alcon Research, LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20213443|NCT01545076|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20213444|NCT01546987|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20213445|NCT02270736|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20213446|NCT02710123|SUNY Buffalo|John Leddy MD|7162043200|leddy@buffalo.edu|
20213447|NCT05381948|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
20213448|NCT06132919|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2therapeutics.com|
20213449|NCT02446132|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|clinicaltransparency@otsuka-us.com|
20213450|NCT05526248|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20213451|NCT03444038|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20213452|NCT02606500|University medical centre Ljubljana|Professor Eda Vrtacnik Bokal|+38615226060|eda.bokal@guest.arnes.si|
20213453|NCT01957488|Coloplast|Medical Director|+45 4911 1395|dkbir@coloplast.com|
20213454|NCT00721409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213455|NCT03104322|patientMpower|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
20213456|NCT00810368|Georgetown University Medical Center|Dr. James N Baraniuk|202-687-8231|baraniuklab@gmail.com|
20213457|NCT00623103|Novartis Pharmaceuticals|Study Director|862-778-8300||
20213458|NCT03239522|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20213459|NCT03272139|Department of Anesthesiology, Critical Care & Pain Management|Dr. David Kim|212-606-1206|kimd@hss.edu|
20213460|NCT00442936|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213461|NCT01449266|Guerbet|Dr. Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20213462|NCT00524459|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20213463|NCT02428699|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20213464|NCT02433678|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
20213465|NCT04424407|Stanford University|Andrea Goldstein-Piekarski, PhD|650-721-4780|agoldpie@stanford.edu|
20213466|NCT03209882|University of Texas at Arlington|Fenghua Tian|8178075271|fenghua.tian@gmail.com|
20213467|NCT01424722|Abbott Medical Devices|Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
20213468|NCT02684578|University of California, San Francisco|Dr. Jay Stewart|628-206-3123|jay.stewart@ucsf.edu|
20213469|NCT01153984|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213470|NCT02460159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213471|NCT03499964|Urotronic, Inc|Vice President of Clinical Affairs|763-285-7489|info@urotronic.com|
20213472|NCT01193608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213473|NCT01933295|Henry Ford Health|Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
20213474|NCT01025037|Tornier, Inc.|Manager of Clinical Operations|952-426-7674|serickson@tornier.com|
20213475|NCT01346852|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213476|NCT02674334|West Virginia University Department of Orthopaedics|Dr. George K Bal|304-293-1310|gbal@hsc.wvu.edu|
20213477|NCT00600925|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20213478|NCT04558554|Fred Hutchinson Cancer Center|Katrina Ortblad|206.667.7267|kortblad@fredhutch.org|
20213479|NCT02660242|Jaeb Center for Health Research|Stephanie DuBose|813.975.8690|sdubose@jaeb.org|
20213480|NCT04087395|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
20213481|NCT02796664|Asan Medical Center|Dr. Dae Chul Suh|+82-2-3010-4366|dcsuh@amc.seoul.kr|
20213482|NCT00995553|Minneapolis VA Health Care System|Dr. Tasha Nienow|612-467-1004|Tasha.Nienow@va.gov|
20213483|NCT01531205|H. Lee Moffitt Cancer Center and Research Institute|Julio Pow-Sang, M.D.|813-745-2226|julio.powsang@moffitt.org|
20213484|NCT00006156|National Institute of Child Health and Human Development|Nelson, Lawrence Merle|+1 301 402 6608|nelsonl@mail.nih.gov|
20213485|NCT01626079|Abbott|Sripad Bellary|4088458114|sripad.bellary@abbott.com|
20213486|NCT00814463|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
20213487|NCT02665143|Yale School of Medicine|Thomas Prebet, MD, PhD|(203) 200-4363|thomas.prebet@yale.edu|
20213488|NCT04803357|university of Washington Diabetes Institute|Dr, Nicole Ehrhardt|2404479566|nehrhard@uw.edu|
20213489|NCT00483496|Orfagen|Clinical project manager|0033534506462|caroline.miklaszewski@orfagen.com|
20213490|NCT05905783|Acelyrin Inc.|Clinical Trials Information Desk|(650) 231 6625|info@alumis.com|
20213491|NCT03968224|UIM Enfermedades Endocrinas. Hospital de Especialidades Centro Médico Nacional Siglo XXI|Aldo Ferreira Hermosillo|+(52)15556276900|aferreira@endocrinologia.org.mx|21913
20213492|NCT03717064|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20213493|NCT00262600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213494|NCT03103100|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
20193332|NCT00233480|Ahmanson-UCLA Cardiomyopathy Center|Tamara B Horwich, MD|310-825-8676|thorwich@mednet.ucla.edu|
20193333|NCT01443403|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20213495|NCT05227820|The Regenesis Project|Chief Research Coordinator|(989) 245-9205|jharoon@theneuroassociates.com|
20213496|NCT00977106|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213497|NCT00436007|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213498|NCT02419313|Yale-Department of Neurology|Bahman Jabbari M.D , Professor Emeritus- Neurology|914-482-8542|bahman.jabbari@yale.edu|
20213499|NCT00376948|Barbara Ann Karmanos Cancer Institute|Almhanna Khaldoun, M.D.|313-576-8746|almhanna@karmanos.org|
20213500|NCT00688064|Galderma|Jean-Charles Dhuin, Clinical Project Manager|+33 4 92 95 29 21|jean-charles.dhuin@galderma.com|
20213501|NCT02348385|Yale|Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
20213502|NCT01189123|Vanderbilt University Medical Center|Dr. Keipp Talbot|6153222035|keipp.talbot@vanderbilt.edu|
20213503|NCT02115646|MGH Wellman Center|Kachiu Lee, MD|4018303128|klee52@partners.org|
20213504|NCT01807637|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|15015267773|msmennemeier@uams.edu|
20213505|NCT00950807|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213506|NCT00337077|ECOG Statistical Office|Study Statistician|617-632-3012||
20213507|NCT04026126|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
20213508|NCT01434121|Virginia Commonweath University|Alpha A. Fowler, III, MD|804-628-5710|afowler@mcvh-vcu.edu|
20213509|NCT01492400|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20213510|NCT00659607|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213511|NCT02349893|Olympus Europa SE & Co. KG|Dr Samuel Faran|0049 1607168798|samuel.faran@olympus.com|
20213512|NCT02899338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213513|NCT06179108|LB Pharmaceuticals Inc|Leslie Callahan, Head, Clinical Operations|9086556884|leslie@lbpharma.us|
20213514|NCT01370408|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20213515|NCT05723822|RxFunction|Clinical Research Specialist|612-358-2141|Yvonne.Rumsey@rxfunction.com|
20213516|NCT05014412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213517|NCT02353169|British Columbia Children's Hospital Research Institute|Simon D. Whyte|604-875-2711|swhyte@cw.bc.ca|
20213518|NCT03356821|UMC Utrecht, The Netherlands|Prof. M.J.N.L. Benders, MD, PhD, neonatologist|+31 88 755 5555|m.benders@umcutrecht.nl|
20213519|NCT01334827|The Miriam Hospital|Dr Kate Guthrie, Co-Investigator, Project MIST Lead Investigator|401-793-8180|kate.guthrie@lifespan.org|
20213520|NCT00486837|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20213521|NCT02468778|Abbott Vascular|Sandeep Pingle, Principal Clinical Scientist|408-845-2111|Sandeep.pingle1@abbott.com|
20213522|NCT00414765|Novartis Pharmaceuticals|Study Director|18627788300|Novartis.email@novartis.com|
20213523|NCT05295953|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
20213524|NCT04559854|Oregon State University|Jessica Gorman|541-737-2323|Jessica.Gorman@oregonstate.edu|
20213525|NCT05694013|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20213526|NCT04817891|University of Michigan|Dr. Benjamin Hampstead|734-936-6185|bhampste@med.umich.edu|
20213527|NCT04534283|IndianaU|Dr. Anita Turk|(317) 274-0335|aaturk@iu.edu|
20213528|NCT05065502|VA Ann Arbor Health Care System|Jeremy Sussman, MD, MS, Corresponding Principal Investigator|N/A|Jeremy.Sussman@va.gov|
20213529|NCT03257462|Spruce Biosciences, Inc.|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
20213530|NCT00368277|Novaris Phamaceuticals|Study Director|862-778-8300||
20213531|NCT04347239|CytoDyn Inc.|Bernie Cunningham, PhD, MRPharmS; VP Operations|5164060197|bcunningham@cytodyn.com|
20213532|NCT00918567|SUNY Buffalo|James Waxmonsky M.D.|305 348 3258|jwaxmons@fiu.edu|
20213533|NCT00143819|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
20213534|NCT02698800|Columbia University Medical Center|Dr. Ari Shechter, Principal Investigator|212-342-4487|as4874@cumc.columbia.edu|
20213535|NCT03587207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163111|NCT04310566|Johnson & Johnson Vision Care|Thomas Karkkainen - Sr.Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20193334|NCT00474526|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20193335|NCT02763215|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20213536|NCT03283709|University of Kentucky|Hiroko Nagaoka|859-257-2101|h.nagaoka@uky.edu|
20213537|NCT05275998|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
20163112|NCT03301298|Promentis Pharmaceuticals|Dean Brostowin|617-300-6172|dbrostowin@promentispharma.com|
20213538|NCT03641742|Columbia University Irving Medical Center|Dr. Christine Kim Garcia|2123058203|ckg2116@cumc.columbia.edu|
20213539|NCT01600495|University of São Paulo.|Prof. Alessandra Cristina Marcolin|Tel.: (16) 36022587|dralemar@uol.com.br|55 +
20213540|NCT01867242|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
20213541|NCT04068142|UAMS|Dr Michael Wilson|501-686-7000|MPWilson@uams.edu|
20163113|NCT03747640|Florida State University|Hyochol Ahn, PhD, MSN, MS-ECE, MS-CTS, APRN, ANP-BC, FAAN|850-644-2647|hahn@fsu.edu|
20163114|NCT00384332|University of Alabama at Birmingham|Candace Cromer|2059753442|clreed@uab.edu|
20163115|NCT02560012|The University of Texas Health Science Center, Houston|Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
20163116|NCT00714311|Medical University of Vienna|Stephan Doering|+43140400|stephan.doering@meduniwien.ac.at|25190
20213542|NCT00264810|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
20213543|NCT02969499|University of British Columbia|Dr. Simon Woo|604-520-4662|simon.woo@fraserhealth.ca|
20213544|NCT02879643|Therapeutic Advances in Childhood Leukemia and Lymphoma|Ellynore Florendo, CCRP|323-361-3022|eflorendo@chla.usc.edu|
20213545|NCT00182091|Massachusetts General Hospital|Dr. Anne Klibanski|617-726-3870||
20213546|NCT02199509|National Institutes of Health|Dr. Mark Hallett||hallettm@ninds.nih.gov|
20213547|NCT02625545|NeoTract/Teleflex|Emily Hergenreter, Sr. Director of Clinical Affairs|650-793-5570|Emily.Hergenreter@Teleflex.com|
20213548|NCT02093689|Omeros Corporation|Medical Monitor|206-676-5000|info@omeros.com|
20213549|NCT01880099|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20213550|NCT00634179|Emory University|Christopher R. Flowers, MD, MS|404-778-3935|crflowe@emory.edu|
20213551|NCT00539539|Resusciatation Outcomes Consortium, University of Washington|Susanne May, Ph.D.|206-685-1302|sjmay@uw.edu|
20213552|NCT04947579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20213553|NCT04272801|University of Virginia|Dr. Shayna Showalter|434-956-8032|snl2t@uvahealth.org|
20213554|NCT00475020|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-745-3055|UPOPAT@MDANDERSON.ORG|
20213555|NCT02456909|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
20213556|NCT03481309|University of North Carolina at Chapel Hill|Dr. Sangtae Ahn|9195233127|sangtae_ahn@med.unc.edu|
20213557|NCT01575054|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20213558|NCT01566409|Pediatric Department, Hospital Lillebaelt, Kolding|Dr. Line Modin|0045 61386349|line.modin@rsyd.dk|
20213559|NCT02768298|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@@novartis.com|
20213560|NCT04603937|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
20213561|NCT01611090|Janssen Research & Development, LLC|Medical Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20213562|NCT05109234|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20213563|NCT04533646|University of Pittsburgh Medical Center|Associate Professor of Medicine|4125869700|ullalj@upmc.edu|
20213564|NCT00336024|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
20213565|NCT02585258|Amsterdam UMC, Vrije Universiteit|Prof Maarten Boers|+3120-4444474|eb@amsterdamumc.nl|
20213566|NCT05125952|Duke University School of Medicine|Elias Pratt|919-684-8111|elias.pratt@duke.edu|
20213567|NCT03946449|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
20213568|NCT03533946|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
20213569|NCT01210001|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213570|NCT00788125|City of Hope National Medical Center|Dr. Judith Sato|626-218-5430|jsato@coh.org|
20213571|NCT03724149|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
20213572|NCT01669538|University of Pennsylvania|Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
20213573|NCT03581448|Florida Atlantic University|Dr. Erik Engeberg|5612970530|eengeberg@fau.edu|
20213574|NCT02180711|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20213575|NCT03900624|Johns Hopkins All Children's Hospital|Dr. Anthony Sochet|7277672912|Anthony.Sochet@jhmi.edu|
20213576|NCT03165058|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
20213577|NCT03252964|Savvysherpa, Inc.|Jared Jones, PhD|7635493540|JaredJones@savvysherpa.com|8116
20213578|NCT00872079|University of Louisville|Michael Brier|502-852-0246|mbrier@louisville.edu|
20213579|NCT00458848|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20213580|NCT02684344|University of Rochester|Edward Messing|585 - 275 - 0998|edward_messing@urmc.rochester.edu|
20213581|NCT02303548|Asan Medical Center|Director of Clinical Trials|8230103350|wonpia73@naver.com|
20213582|NCT00863746|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20213583|NCT00153803|Dartmouth-Hitchcock Medical Center|Clinical Research Office||Cancer.Research.Nurse@Dartmouth.edu|
20213584|NCT03292653|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20213585|NCT04720664|Georgetown University|Nadia Ashai, MD|202-444-2223|nadia.ashai@medstar.net|
20213586|NCT05037097|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
20213587|NCT02322047|Veterans Affairs Puget Sound Health Care System|Tracy Simpson, PhD|206-277-3337|tracy.simpson@va.gov|
20213588|NCT01059500|indiana university school of medicine|jeffrey kline|317 880 3869|jefkline@iu.edu|
20213589|NCT05343715|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
20213590|NCT00376220|Johns Hopkins University School of Medicine|Jennifer L. Payne M.D.|410-502-0050|jpayne5@jhmi.edu|
20213591|NCT03311646|Medical University of South Carolina|Dr. Tracy Smith|843-792-5164|smithtra@musc.edu|
20213592|NCT00531206|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213593|NCT02906709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213594|NCT02773836|European Network for Smoking and Tobacco Prevention|Dr Constantine Vardavas|+306937281680|vardavas@tobcontrol.eu|
20213595|NCT01439165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20213596|NCT03331042|Sequential Medicine Ltd|Thomas Dahl|617-818-2735|tadahl@outlook.com|
20213597|NCT00683020|University of California, San Francisco|Dean Schillinger, MD/Study Principal Investigator|415-206-8940|dschillinger@medsfgh.ucsf.edu|
20213598|NCT00825227|Cephalon, Inc.|Vice President, Clinical Research|1-800-896-5855||
20213599|NCT03204526|UC Davis Health|Kiarash Shahlaie, MD, PhD, FAANS, Bronte Professor of Neurological Surgery|916-734-6342|krshahlaie@ucdavis.edu|
20213600|NCT00322491|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
20213601|NCT00048048|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20213602|NCT03992196|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20213603|NCT00733330|DePuy International|Kimberly Dwyer||kdwyer2@its.jnj.com|
20213604|NCT02388763|Alcon, A Novartis Division|GMA Franchise Head - Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20213605|NCT05518487|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20213606|NCT02003053|University of Kentucky|Dr. Peter Morris|8593235045|peter.morris@uky.edu|
20213607|NCT02194998|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20213608|NCT01362998|University Hospitals of Cleveland|Evan Goodman, principal investigator|2168445300|evan.goodman@uhhospitals.org|
20213609|NCT01458405|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
20213610|NCT02497781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213611|NCT02236130|University of Mississippi Medical Center|Madhankumar Sathyamoorthy|6018157066|msathyamoorthy@umc.edu|
20213612|NCT00525590|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20213613|NCT01632709|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
20213614|NCT01307098|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20213615|NCT03977051|Imperial College London|Dawn Goodall|+44 (0) 203 313 4268|dawn.goodall1@nhs.net|
20213616|NCT01345019|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20213617|NCT03830164|UT MD Anderson Cancer Center|Dr. Chad Tang, Associate Professor, Radiation Oncology Department|(713) 745-7179|ctang1@mdanderson.org|
20213618|NCT00320112|VA HSRD|Fatima Makki|734 845 3623|Fatima.Makki@va.gov|
20213619|NCT04354012|Wake Forest|Research Administrative Coordinator|336-716-2903|irichard@wakehealth.edu|
20213620|NCT01199861|Novartis Pharmaceuticals|Study Director|862-778-8300||
20213621|NCT04981912|UCSD|Michael Choi|8585341765|mychoi@ucsd.edu|
20213622|NCT00661505|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20213623|NCT05630547|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
20213624|NCT00977470|Mass General Hospital Cancer Center|Maria Kempner|508-533-4132|mkempner@partners.org|
20213625|NCT00796822|Indiana University School of Medicine|Dr. Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
20213626|NCT02364557|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20213627|NCT03978624|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
20213628|NCT03076255|Thomas Jefferson University|Voichita Bar-Ad, MD|215-955-6702|Voichita.BarAd@jefferson.edu|
20213629|NCT05097989|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
20213630|NCT04552704|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20213631|NCT01822548|Azienda ospedaliero-universitaria di Parma|Prof.ssa Ivana Zavaroni|+390521033306|ivana.zavaroni@unipr.it|
20213632|NCT00696449|Wake Forest University Health Sciences|Steven Feldman|3367167740|sfeldman@wakehealth.edu|
20193336|NCT03258723|Yale School of Medicine|Marcella Nunez-Smith, MD, MHS|(203) 785-6454|marcella.nunez-smith@yale.edu|
20193337|NCT01107899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213633|NCT00117949|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20213634|NCT00205049|University of Wisconsin|Research Program Manager - Kelly Richie|608-262-5404|kr2@medicine.wisc.edu|
20213635|NCT01658943|SWOG Statistical Center|SWOG Statistician|206-667-4408||
20213636|NCT03309956|Columbia University|Leonardo Liberman, MD|212-305-8509|ll202@cumc.columbia.edu|
20213637|NCT02130466|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213638|NCT04529109|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
20213639|NCT01922349|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213640|NCT00922779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213641|NCT00993616|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20213642|NCT05067504|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20213643|NCT02051309|Yale School of Medicine|Sherry McKee PhD|2037373529|sherry.mckee@yale.edu|
20213644|NCT03805438|Duke University|Riley Landreth, DO|919-684-8111|riley.landreth@duke.edu|
20213645|NCT01374919|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
20213646|NCT00366899|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20213647|NCT01619800|Icahn School of Medicine at Mount Sinai|Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20213648|NCT02848326|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20213649|NCT00414466|Medtronic Neuromodulation|Robert Spencer, Clinical Research Manager|(763) 514-0253|robert.j.spencer@medtronic.com|
20213650|NCT01483352|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20213651|NCT03480425|University of Saskatchewan|Dr. William P. McKay|306 250 5344|bill.mckay@usask.ca|
20213652|NCT01451762|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20213653|NCT03469297|MicroOptx|VP of Clinical|888-591-2784|info@microoptx.com|
20213654|NCT01771965|MUSC|Tracy Stecker, PhD|843.792.7287|stecker@musc.edu|
20213655|NCT00630305|Johnson & Johnson Vision Care, Inc.|Kurt Moody, OD|1-904-443-3088|kmoody1@its.jnj.com|
20213656|NCT01085045|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20213657|NCT02086188|EvergreenHealth|Theodore Brown, MD|4258995350|TRBrown@evergreenhealthcare.org|
20213658|NCT02248597|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-4761|krike@wakehealth.edu|
20213659|NCT02395822|University of Minnesota Masonic Cancer Center|Yumna Akhtar - Ct.gov Manager|612-624-6313|akhta012@umn.edu|
20213660|NCT02127281|Cleveland Clinic|Alison K. Klika, MS, Research Manager, Department of Orthopaedic Surgery|(216) 444-4954|klikaa@ccf.org|
20213661|NCT04510857|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
20213662|NCT04347291|Vanderbilt University Medical Center|Dr. Lindsay Mayberry|615-875-5821|lindsay.mayberry@vumc.org|
20213663|NCT02564263|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213664|NCT00920140|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213665|NCT01124149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20213666|NCT01644500|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213667|NCT01347788|Massachusetts General Hospital|Matthew R Smith, MDPhD|617-763-3748|smith.matthew@mgh.harvard.edu|
20213668|NCT02774798|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
20213669|NCT00720096|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, M.D., via Moffitt Cancer Center|813-745-4933|robert.wenham@moffitt.org|
20213670|NCT04557124|VA Connecticut Healthcare System|Joanna Fiszdon, Principal Investigator|203-932-5711|Joanna.fiszdon@va.gov|
20213671|NCT00001849|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
20213672|NCT01626664|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
20193338|NCT00953771|Mount Sinai Beth Israel|Dr. Ilan Shapira|212-844-8948|Ilan.Shapira@mountsinai.org|
20213673|NCT03127137|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20193339|NCT00974259|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
20193340|NCT03991741|University of California, San Diego|Gregory Daniels, MD, PhD|(858) 822-5354|CancerCTO@health.ucsd.edu|
20213674|NCT01346085|Ospedale San Raffaele|Dr Lorenzo Piemonti|+390226432706|piemonti.lorenzo@hsr.it|
20213675|NCT02747615|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
20193341|NCT00592293|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
20193342|NCT01606319|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
20193343|NCT05330988|Department of Veterans Affairs|Dr. John H. Kindred|8437924328|john.kindred1@va.gov|
20213676|NCT02319148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193344|NCT01784523|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
20193345|NCT01007110|University of Kansas Medical Center|Kathleen Gustafson, Ph.D.|(913) 588-0065|kgustafson@kumc.edu|
20213677|NCT00264797|Univ of Colorado Denver; Univ of Cincinnati|Dr. Paula Riggs; Dr. Theresa Winhusen|303-724-2235; 513-487-7800|paula.riggs@ucdenver.edu; winhusen@carc.uc.edu|
20193346|NCT02179177|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
20213678|NCT01249664|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20213679|NCT01767064|USCalifornia|Jason Doctor|213.821.8142|jdoctor@usc.edu|
20213680|NCT00762086|A. Stein Regulatory Affairs Consulting|Shmulik Adler|972-9-767-0002|shmulik@asteinrac.com|
20213681|NCT00860405|Fresenius Kabi Aktiengesellschaft, Else-Kröner-Str. 1, 61352 Bad Homburg, Germany|Professor Dr. Martin Westphal, Chief Medical Officer|+49 6172 686 7280|martin.westphal@fresenius-kabi.com|
20213682|NCT04457310|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
20213683|NCT00497796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20213684|NCT01074554|Vanderbilt University School of Medicine|Dr. Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
20213685|NCT04276883|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20213686|NCT05233163|Columbia University Irving Medical Center|Ani Nalbandian, MD|646-906-2255|an2558@cumc.columbia.edu|
20213687|NCT02120443|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
20213688|NCT02073643|Rush University Medical Center|Brad Appelhans, PhD|312-942-3477|brad_appelhans@rush.edu|
20213689|NCT00979732|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
20213690|NCT03696225|VA Portland Health Care System|Dr. Maya E. O'Neil, Principal Investigator|503-220-8262|Maya.Oneil@va.gov|54522
20213691|NCT02649387|Mayo Clinic|Asher Alban Chanan Khan|904-953-0450|Chanan-Khan.Asher@mayo.edu|
20213692|NCT01139164|Medical University of South Carolina|Dr. Robert K Stuart|843-792-4271|stuartrk@musc.edu|
20213693|NCT00406848|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213694|NCT01355081|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20213695|NCT02719522|Medtronic Neurovascular|Claudia Campo|0039 0224137325|claudia.campo@medtronic.com|
20213696|NCT03184441|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
20213697|NCT05932654|Biosion, Inc.|Kathy Zhang|+86 18801904945|kathy.zhang@biosion.com|
20213698|NCT04183231|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-2516831|drmilgrom@silverarrest.com|
20213699|NCT00860028|Yale School of Medicine|Dr. Stephanie O'Malley|203-974-7590|stephanie.omalley@yale.edu|
20213700|NCT00936390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20213701|NCT03218592|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|9199969998|akashuba@unc.edu|
20213702|NCT02514174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213703|NCT00444145|Vanderbilt University|Dr. Michael Vaezi|615-322-3739|tina.higginbotham@vanderbilt.edu|
20213704|NCT00419770|Los Angeles Biomedical Research Institute|Brad Spellberg|310-781-3680|bspellberg@dhs.lacounty.gov|
20213705|NCT00927992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213706|NCT01781637|Boston Children's Hospital|Lynda Schneider|617-355-6180|lynda.schneider@childrens.harvard.edu|
20213707|NCT02637232|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
20213708|NCT02999178|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213709|NCT00090857|Dana-Farber Cancer Institute|Judy E. Garber, MD, MPH|617.632.2282|Judy_Garber@dfci.harvard.edu|
20213710|NCT05097326|Stanford University|Principal Investigator|(650) 497-5175|gynresearch@stanford.edu|
20213711|NCT01244126|Baylor College of Medicine, Department of Anesthesiology|Dr. Helena Karlberg Hippard|832-824-5800|hxkarlbe@texaschildrens.org; karlberg@bcm.edu|
20213712|NCT05920161|Yale School of Medicine|Elizabeth Goldfarb, PhD|203-737-6365|elizabeth.goldfarb@yale.edu|
20213713|NCT02696070|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
20213714|NCT02424188|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20213715|NCT01701024|Exec Dir Clinical Dir|Johnson Varughese|908-927-1162|johnson.varughese@valeant.com|
20213716|NCT02753842|Emory University|Aaron Siegler|404-712-9733|asiegle@emory.edu|
20213717|NCT01494506|Merrimack Pharmaceuticals, Inc.|Dr. Eliel Bayever|6174411000|EBayever@merrimack.com|7676
20213718|NCT05216081|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
20213719|NCT02735174|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
20213720|NCT01880073|Center for Reproductive Medicine|Dr. Steven Spandorfer|646-962-3638|sdspando@med.cornell.edu|
20213721|NCT00755196|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213722|NCT01604850|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20213723|NCT01703832|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
20213724|NCT00243932|Columbia University|Hiroshi Mitsumoto, MD|2123052940|hm264@cumc.columbia.edu|
20213725|NCT00543309|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, M.D., M.P.H.|312 227 1551|jmcostello@luriechildrens.org|
20213726|NCT03831451|University of Michigan|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
20213727|NCT04084483|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20213728|NCT01931033|Massachusetts General Hospital|Gagan Joshi, MD|617-726-1541|gjoshi@mgh.harvard.edu|
20213729|NCT00708019|University of California, San Francisco|Christine Miaskowski|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
20213730|NCT00369590|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
20213731|NCT04538170|Department of Anaesthesiology and Intensive Care Medicine, Eberhard-Karls-University,Tuebingen, Germany|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
20213732|NCT01076452|Hines Veterans Affairs Hospital Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D|708-202-8387|frances.weaver@va.gov|25866
20213733|NCT01652001|University of Granada|Dr. Gómez-Moreno|+34000000000|ggomez@ugr.es|
20213734|NCT01682083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20213735|NCT00864097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213736|NCT05194839|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
20213737|NCT01661114|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
20213738|NCT01050647|Stanford University|Dr. Anna Girsen|6507255720|agirsen@stanford.edu|
20213739|NCT02724800|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD|412-360-2806|Adam.Bramoweth@va.gov|
20213740|NCT02412228|Brown University Oncology Research Group|John Reagan, MD|401-863-3000|BrUOG@Brown.edu|
20213741|NCT00365261|University of California, San Diego|Joel Dimsdale, M.D., Principal Investigator|619 543-5592|jdimsdale@ucsd.edu|
20213742|NCT05956665|Vanderbilt University School of Nursing|Jennifer Kim, DNP, GNP-BC|615-936-0739|jennifer.kim@vanderbilt.edu|
20213743|NCT01939197|AbbVie|Global Medical Services|800-633-9110||
20213744|NCT02545998|Oxshott Medical Practice|Dr Sarah Glynne|01372 844000|sarah.glynne@nhs.net|
20213745|NCT02942966|Philips Image Guided Therapy|Nicolas Aguirre|(612) 297-6655|nicolas.aguirre@philips.com|
20213746|NCT03118466|Massachusetts General Hospital|Andrew Brunner MD|6177241124|abrunner@mgh.harvard.edu|
20213747|NCT02933866|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20213748|NCT01430741|Bedford VA|Dr. David Smelson, Professor|781-570-1903|david.smelson@va.gov|
20213749|NCT02603952|MedImmune, LLC|Raburn Mallory|301-398-4095|information.center@astrazeneca.com|
20213750|NCT05215951|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20213751|NCT02789033|Universidad de Guadalajara|PhD. Leonel García Benavides|+52 (33) 20 00 23 00|drleonelgb@hotmail.com|64096
20213752|NCT00301756|Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
20213753|NCT04567342|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20213754|NCT02070237|Memorial Care|Dr. Jennifer McNulty|562-933-2730|jjmcnulty@sbcglobal.net|
20213755|NCT00958243|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20213756|NCT04646109|Afyonkarahisar Health Sciences University|Prof. Dr. Nurullah Okumuş|+90 532 4372406|drnuri@hotmail.com|
20213757|NCT06176768|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20213758|NCT01226797|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213759|NCT03571048|University of Colorado School of Medicine|Elizabeth Thomas, MD|303-724-9083|elizabeth.thomas@cuanschutz.edu|
20213760|NCT00577460|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213761|NCT03006978|Sight Sciences|Jaime Dickerson|(877) 266-1144|jdickerson@sightsciences.com|
20213762|NCT01318499|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
20213763|NCT01988922|Washington University in St. Louis School of Medicine|Dr. Lesley K Rao|3143690683|raol@wustl.edu|
20213764|NCT01641445|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
20213765|NCT01974141|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20213766|NCT01607645|FHCRC|Derek L. Stirewalt|2066675386|dstirewa@fhcrc.org|
20213767|NCT04028843|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
20213768|NCT04977336|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20213769|NCT03298451|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1 8772409479|information.center@astrazeneca.com|
20213770|NCT01347710|Lantheus Medical Imaging|CMO|978-671-8544|c.orlandi@lantheus.com|
20213771|NCT03339349|University of Utah|Daniel Jones|801-581-2121|daniel.jones2@gmail.com|
20213772|NCT04591626|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20213773|NCT01968382|Virginia Commonwealth University|Stephanie Taylor MSN, RN|804-828-9311|stephanie.taylor@vcuhealth.org|
20213774|NCT01004172|Dana-Farber Cancer Institure|Nancy Lin, MD|617.632.2335|nlin@partners.org|
20213775|NCT00615784|abramsoncc, University of Pennsylvania|Harjeet Sembhi, research program director|215-220-9688|harjeet.sembhi@pennmedicine.upenn.edu|
20213776|NCT03676803|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD|310-206-1987|zli@medent.ucla.edu|
20213777|NCT00878995|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
20213778|NCT01661270|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20213779|NCT02480764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20213780|NCT02457832|Associate Professor of Medicine Emory University School of Medicine, Department of Medicine, Division of Geriatrics and Gerontology; Research Health Scientist Atlanta VA Health Care System, Center for Visual and Neurocognitive Rehabilitation|Madeleine E. Hackney, Ph.D.|404-315-4100|mehackn@emory.edu, madeleine.hackney@va.gov|373141
20213781|NCT01333527|Research Associate|Anelise Silveira|780-492-2398|anelise.silveira@ahs.ca|
20213782|NCT01868009|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213783|NCT02467621|Copenhagen University Hospital Rigshospitalet, Dept. of Intensive Care 4131|Dr. Morten Hylander Møller|22555343|mortenhylander@gmail.com|+45
20213784|NCT01691248|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213785|NCT02445456|Oxford University Hospitals NHS Foundation Trust|Miss Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
20213786|NCT02352298|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303-724-6761|satish.garg@ucdenver.edu|
20213787|NCT02446626|National Institute of Allergy and Infectious Diseases|Marques, Adriana|+1 301 435 7668|amarques@niaid.nih.gov|
20213788|NCT04526210|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20213789|NCT02924038|University of California, San Francisco|Dr. Nicholas Butowski, MD|415-353-7500|Nicholas.Butowski@ucsf.edu|
20213790|NCT01269801|AboutSkin|Joel L. Cohen, MD|303-756-7546|research@aboutskinderm.com|
20213791|NCT02473640|Synthetic Biologics Inc.|Michael Kaleko, M.D.|(240) 238-3862|mkaleko@syntheticbiologics.com|
20213792|NCT02472522|Tata Main Hospital, Jamshedpur, India|Specialist, Anaesthesia & Critical Care|91-9431166582|debsanjay@gmail.com|
20213793|NCT02777528|WL Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
20213794|NCT00890981|Amgen Inc.|Study Director|866-572-6436||
20213795|NCT00453362|Hoffman-LaRoche|Medical Communications|800-821-8590||
20213796|NCT04885296|Johnson & Johnson Vision Care, Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-608-7238|jbuch@its.jnj.com|
20213797|NCT03718234|University of Minnesota|Kyriakie Sarafoglou|6126245965|saraf010@umn.edu|
20213798|NCT00433147|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@Alexion.com|
20213799|NCT01882647|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|585-571-1800|clinicalreseach@therapeuticsinc.com|
20213800|NCT02937701|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20213801|NCT02683083|Camel-IDS|Tony Lahoutte|0032 24799360|tony.lahoutte@camel-ids.com|
20213802|NCT00416520|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20187093|NCT02606422|Johns Hopkins University School of Medicine|Kyrana Tsapkini|410-614-2646|tsapkini@jhmi.edu|
20187094|NCT02966873|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
20187095|NCT03235544|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20187096|NCT00950742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213803|NCT00038675|University of Texas (UT) MD Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
20187097|NCT06176963|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
20187098|NCT01456949|Medtronic|Kirsten Rasmussen|763-526-2833|kirsten.l.rasmussen@medtronic.com|
20213804|NCT03601637|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20187099|NCT05002088|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
20187100|NCT05495971|Visioneering Technologies, Inc.|Dr. Douglas P. Benoit|6035459507|dbenoit@vtivision.com|
20187101|NCT04068181|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20187102|NCT02723591|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20187103|NCT03599661|Wake Forest Baptist Comprehensive Cancer Center|Stephanie Bunch|336-716-5180|sbunch@wakeforest.edu|
20187104|NCT03691935|Milton S. Hershey Medical Center|Urology Research Operations Manager|717-531-0003|UrologyResearch@pennstatehealth.psu.edu|287502
20213805|NCT03348423|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
20213806|NCT01108094|Stanford University Medical Center|Jean Tang MD PhD, Associate Professor of Dermatology|650-723-6316|tangy@stanford.edu|
20213807|NCT00633399|Massachusetts General Hospital CNTI|George I Papakostas, M.D. - Scientific Director|6177266697|gpapakostas@partners.org|
20187106|NCT05124704|Zhejiang Cancer Hospital|Jiangling Wang|15168373331|wangjl@zjcc.org.cn|
20187107|NCT05875467|dfusion Inc|Chief Executive Officer|8312225103|tamara.kuhn@dfusioninc.com|
20213808|NCT01759277|University of California San Diego|Brian Ilfeld|858-822-2171|bilfeld@ucsd.edu|
20187108|NCT04642820|University of Chicago|Harriet de Wit, Principal Investigator|773-702-1234|hdew@uchicago.edu|
20187109|NCT03905798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213809|NCT01137539|Michigan Institute of Women's Health|Salil Khandwala/Medical Director|313-982-0200||
20213810|NCT03290326|BIDMC|Principal Investigator - Emiliano Santarnecchi|617-667-0326|esantarn@bidmc.harvard.edu|
20187110|NCT06473662|Diabetology Ltd|Roger New|07818068012|rn@diabetology.co.uk|
20187111|NCT03138603|University of Chicago Medicine|Peter Nagele, MD, MSc|773-795-3544|pnagele@uchicagomedicine.org|
20187112|NCT03463044|INOTREM SA|Executive VP Research and Medical Sciences, INOTREM SA|30 62 86 51|jjg@inotrem.com|+33 (0)6
20187113|NCT04079218|Albert Einstein College of Medicine|Dr. Kerry Murphy|718-839-7885|kerry.murphy@einsteinmed.edu|
20187114|NCT03743532|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
20187115|NCT03617679|University of Colorado Denver|Bradley Robert Corr, MD|303-724-2066|bradley.corr@cuanschutz.edu|
20187116|NCT05907174|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
20187117|NCT04498390|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20187118|NCT05082116|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20187119|NCT04858451|Thirty Respiratory Ltd|Inva Hoti, PhD|+44 (0) 1235 431200|Inva.Hoti@30.technology|
20187120|NCT03314454|Northeastern University|Dr. Robert Leeman|6173736501|r.leeman@northeastern.edu|
20187121|NCT04119843|Ascelia Pharma AB|Andreas Norlin|+46 735179119|an@ascelia.com|
20187122|NCT04418232|University of Kansas Medical Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
20187123|NCT04233216|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20187124|NCT04231149|Coloplast A/S|Medical Affairs Vice President|+45 4911 1111|clinical-studies@coloplast.com|
20187125|NCT03252847|MeiraGTx|Program Manager|+44 (0)20 3866 4320|ocularinfo@meiragtx.com|
20187126|NCT05216315|University of Valencia|Dr Juan C Melendez|+34 963983844|melendez@uv.es|
20187127|NCT05808257|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|mantu.gupta@mountsinai.org|
20187128|NCT03986931|University of Iowa|Dr. Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
20187129|NCT04752709|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
20187130|NCT04111874|University of Pennsylvania|Dr. Andrew Guzick|215-573-3708|andrew.guzick@pennmedicine.upenn.edu|
20187131|NCT00576979|Department of Hematology and Hematopoietic Cell Transplantation, City of Hope|Anthony Stein, MD, corresponding author|626-256-4673|astein@coh.org|62405
20187132|NCT04893239|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
20187133|NCT05534789|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187134|NCT03819153|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20187135|NCT00691002|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20213811|NCT05086835|McLean Hospital|Dr. Roger Weiss|617-855-2242|rweiss@mclean.harvard.edu|
20187136|NCT04731818|Eastern Virginia Medical School|Andrea Thurman MD, Principal Investigator|7574465808|thurmaar@evms.edu|
20187137|NCT02322203|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301.402.0521|mamar@nhlbi.nih.gov|
20187138|NCT05446129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20213812|NCT00248638|Emory University|Thomas R. Ziegler M.D.|4047277354|Tzieg01@emory.edu|
20187139|NCT05374798|Medical University of South Carolina|Stacey sellers|843-792-5807|sellersst@musc.edu|
20187140|NCT04471246|Ottawa Hospital Research Institute|Krishan Yadav|613-798-5555|kyadav@toh.ca|19489
20187141|NCT05764525|Vivozon, Inc.|Chief Medical Officer|609 269 9140|adminus@vivozon.com|
20187142|NCT03334630|Medtronic|Katie Flor, Principal Clinical Research Specialist|+1 763 526 9651|katie.j.flor@medtronic.com|
20187143|NCT03404115|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20187144|NCT04019977|University of Maryland School of Social Work|Dr. Lisa Berlin|410 706 6392|lberlin@ssw.umaryland.edu|
20187145|NCT04533737|LEO Pharma A/S|Clinical Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
20187146|NCT05093842|West Virginia University|Bethany Barone Gibbs|304-581-1779|behany.gibbs@hsc.wvu.edu|
20187147|NCT05705518|University of California Berkeley Clinical Research Center|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
20187148|NCT03910478|Fred Hutchinson Cancer Research Center|Michael Boeckh, MD|206-667-6706|mboeckh@fredhutch.org|
20187149|NCT03953417|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
20213813|NCT05818137|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20213814|NCT01699607|Yale|Dr. Kelly Cosgrove, Ph.D.|203-737-6969|kelly.cosgrove@yale.edu|
20187150|NCT04089137|Georgia State University|Dr. Amanda Gilmore|(404) 413-2000|agilmore12@gsu.edu|
20187151|NCT04383496|Minneapolis VA Health Care System|Wei Duan-Porter|6124675845|wei.duanporter@va.gov|
20187152|NCT04032041|University of Iowa|Jason M Wilken, PT, PhD|319-335-9791|jason-wilken@uiowa.edu|
20187153|NCT01275677|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20193347|NCT00022659|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20193348|NCT04340947|University of Oklahoma Health Sciences|Professor of Pediatrics|405-271-1903|heal-lab@ouhsc.edu|
20193349|NCT02349152|University of Pittsburgh|Dr. Kathirvel Subramaniam, MD, MPH|412-647-5635|subramaniamk@upmc.edu|
20193350|NCT01907906|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832||
20193351|NCT00884650|Children's Hospital Colorado|Dr. Frank Chang|720-777-6900|Chang.Frank@tchden.org|
20193352|NCT00880022|vanderbilt university|sheila h ridner|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
20193353|NCT01634269|Medttronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
20193354|NCT02154906|UT Health Science Center San Antonio|Brian L. Mealey|210-567-3567|mealey@uthscsa.edu|
20193355|NCT04646369|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
20193356|NCT04052425|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20193357|NCT04334278|University of Kentucky|Caitlin Conley|8592571939|caitlin.conley2@uky.edu|
20193358|NCT01821937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187154|NCT03987022|Metrohealth System|Dr. Robert Pollard|2167781446|rpollard@metrohealth.org|
20187155|NCT05012683|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
20213815|NCT05346055|Weill Cornell Medical College|Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
20187156|NCT00207636|DFCI, Harvard|Jennifer Allen|617-632-2269||
20187157|NCT03478956|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20193359|NCT01677299|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20193360|NCT02153905|National Cancer Institute|Dr. Steven Rosenberg|240-858-3080|sr78a@nih.gov|
20193361|NCT00520845|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn|615-322-4967|leora.horn@vanderbilt.edu|
20193362|NCT01189110|VAMC St. Louis MO|Deborah Fritz FNP PhD|314-652-4100|deborah.fritz@va.gov|53692
20193363|NCT00351377|Novartis Pharmaceuticals|Study Director|862-778-8300||
20193364|NCT01516749|University of California, San Francisco|Kieron S. Leslie, MD|415-206-4777|lesliek@derm.ucsf.edu|
20193365|NCT01732549|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20193366|NCT02030002|University of Minnesota|Thorsten Gruenheid|612-625-3903|tgruenhe@umn.edu|
20187158|NCT04800211|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20193367|NCT00566540|The Ohio State University Comprehensive Cancer Center|Enzer Ozer, MD|614-293-8074|enver.ozer@osumc.edu|
20193368|NCT03994731|Horizon Therapeutics USA, Inc.|Medical Monitor|866-479-6742|clinicaltrials@horizontherapeutics.com|
20193369|NCT01150461|Massachusetts General Hospital|Michael A. Fifer, MD|617 726-1832|mfifer@partners.org|
20193370|NCT01681992|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193371|NCT01100606|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20193372|NCT01415934|University of Colorado|Carrie Brill|303 808 9708|CARRIE.BRILL@UCDENVER.EDU|
20193373|NCT02406248|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
20193374|NCT04148989|Intermountain Health|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
20193375|NCT00732992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193376|NCT01969851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20193377|NCT05226130|VA San Diego Healthcare System, San Diego, CA|Ruth Klaming, PhD|858-552-8585|rklaming@health.ucsd.edu|
20193378|NCT02520310|Abbott Structural Heart|Sripad Bellary|650-353-1726|sripad.bellary@abbott.com|
20193379|NCT02884492|Columbia University Medical Center (Taub Institute)|William C. Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
20193380|NCT05101993|AtriCure|Randall Lee, VP Medical Affairs, Clinical Affairs|650-347-0419|RLee@atricure.com|
20193381|NCT01124838|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20193382|NCT02065882|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
20193383|NCT03816761|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20193384|NCT04991753|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20193385|NCT05609604|UBuffalo|Paresh Dandona|17168818924|ghanim@buffalo.edu|
20187159|NCT04567238|Duke University School of Medicine|Angela Kirby|9198247729|angela.kirby@duke.edu|
20187160|NCT03643744|Wright State University|Dr. Jeffrey Travers|(937)-245-7500|Jeffrey.Travers@Wright.edu|
20187161|NCT05590728|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
20187162|NCT03734679|Surmodics|Thu Huyen Ha|952.500.7261|tha@surmodics.com|
20187163|NCT06201559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20213816|NCT00728949|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20187164|NCT00915759|Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir|Principal Investigator|571-231-1600|dha.belvoir.fbch.mbx.wresp-research@health.mil|
20213817|NCT01996033|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
20213818|NCT02252562|Dartmouth-Hitchcock Medical Center|Matthew D. Koff, MD Staff Physician, Anesthesiology|(603) 650-5922|Matthew.D.Koff@hitchcock.org|
20193386|NCT02797522|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20193387|NCT01475305|Medimmune, LLC|Hasan Jafri, Medical Director|301-398-4431|jafrih@medimmune.com|
20193388|NCT00132678|Johnson & Johnson Pharmaceutical Research and Development|Director of Clinical Research|609 730-4576||
20187165|NCT05546385|Rehaler A/S|Troels Johansen|004540977313|tj@rehaler.com|
20193389|NCT03222505|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
20187166|NCT00291525|Artivion|Clinical Project Manager (Yael Goode)|8454800137|Yael.Goode@Artivion.com|
20213819|NCT04818242|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
20193390|NCT00953147|Sunovion|Respiratory Medical Director|1-866-503-6351||
20193391|NCT02224404|Universitair Ziekenhuis Gent|Dr. Hilde Beele|09/332 22 87|Hilde.Beele@uzgent.be|
20193392|NCT01484431|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20193393|NCT01251770|Hospital General de Niños Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
20193394|NCT02514239|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193395|NCT01888874|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
20193396|NCT00475644|Eli Lilly and Company|Cheif Medical Officer|800-545-5979||
20193397|NCT01411241|Sanofi Pasteur|Director||Contact-US@sanofi.com|
20193398|NCT01976273|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20193399|NCT02980042|University of Colorado Anschutz, Neurology Department|Dr. Timothy Vollmer|3037242187|timothy.vollmer@ucdenver.edu|
20193400|NCT00769600|MSKCCC|Charles Rudin, MD|646-888-4336|rudinc@mskcc.edu|
20193401|NCT03211234|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
20193402|NCT02277054|Filatov Institite of Eye Diseases and Tissue Therapy of the NAMS of Ukraine|Dr. Oleksiy Buznyk|+380487181548|a_buznik@bk.ru|
20193403|NCT03104075|The Jackson Laboratory|Dr. Jacques Banchereau|860-837-2443|jacques.banchereau@jax.org|
20193404|NCT00944229|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20193405|NCT01810939|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20193406|NCT02963090|Duke Cancer Institute|Thomas Stinchcombe, MD|(919) 668-6688|thomas.stinchcombe@duke.edu|
20193407|NCT00709228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20193408|NCT02977286|Tufts Medical Center|Erik Garpestad, M.D.|617-636-5388|egarpestad@tuftsmedicalcenter.org|
20193409|NCT03329300|University of Alabama at Birmingham Department of Pediatrics|Marissa Gowey, PhD|2056386618|marissa.gowey.phd@gmail.com|
20193410|NCT00786643|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20193411|NCT04805073|University of Florida Health Gainesville|Adam Wendling, MD, Division Chief Obstetric Anesthesiology|3528707461|Awendling@anest.ufl.edu|
20193412|NCT00405938|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20193413|NCT02526498|Cancer Institute of New Jersey|Bruce Haffty|732-235-5203|hafftybg@cinj.rutgers.edu|
20193414|NCT05000047|Sonova USCS|Principal Investigator, Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20193415|NCT03937141|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
20193416|NCT03017742|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
20193417|NCT02975102|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
20193418|NCT02614690|Connecticut Children's Medical Center|Dr, Mark Lee|860-837-7421|Mlee01@connecticutchildrens.org|
20193419|NCT01825577|Saint Louis University|Dr. Ahsan Khan|314-977-4826|khanay@slu.edu|
20193420|NCT01093469|Wake Forest|Dr Alan Fleischer|336-716-3775|adclark@wakehalth.edu|
20193421|NCT01584518|Creighton University|Dr Anjan Talukdar|402-280-3586|talukdar.anjan@gmail.com|
20193422|NCT02332902|The University of Texas Health Science Center at Houston|Dr. Mary Kay Koenig||Mary.K.Koenig@uth.tmc.edu|
20193423|NCT01245374|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20187167|NCT05987813|Virginia Commonwealth University|Gisela Chelimsky|804-628-5882|gisela.chelimsky@vcuhealth.org|
20187168|NCT03088878|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
20187169|NCT02724969|University of Pittsburgh|Jill R. Demirci, PhD, RN, IBCLC|412-648-9236|jvr5@pitt.edu|
20193424|NCT04529005|University of Illinois Chicago College of Pharmacy|Scott Benken|3123554107|benken@uic.edu|
20193425|NCT01782690|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20193426|NCT02353312|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|16237
20193427|NCT04199052|University of California San Diego|Dr. Jamila K. Stockman, Professor|(858) 822-4652|jstockman@health.ucsd.edu|
20193428|NCT01948076|Brigham and Women's Hospital|Maria Yialamas|617-732-5500|myialamas@partners.org|
20193429|NCT01151423|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
20193430|NCT00681668|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20193431|NCT00920647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20193432|NCT00569192|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20193433|NCT00691600|Baylor College of Medicine|Andrea T. Cruz, MD, MPH|832-824-5582|acruz@bcm.edu|
20193434|NCT02706249|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
20193435|NCT06719986|Purdue Pharma|Clinical Leader|1-888-726-7535|Purduemedinfo@pharma.com|
20193436|NCT02600897|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20193437|NCT05304117|Western Carolina University|Dr. R Turner Goins|828.227.3515|rtgoins@wcu.edu|
20193438|NCT02614183|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20193439|NCT05992922|Iacta Pharmaceuticals|Chief Operating Officer|714-330-8532|sj@iactapharma.com|
20187170|NCT01346540|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187171|NCT03362476|New York University|Ralph J DiClemente|+1 (212) 992-3709|rjd438@nyu.edu|
20187172|NCT04690582|The Ohio State University College of Medicine|Dr. Craig Bryan, PsyD, ABPP|614-814-8612|craig.bryan@osumc.edu|
20163117|NCT02218008|Alkermes, Inc.|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
20187173|NCT05679908|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
20193440|NCT02473965|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20213820|NCT01087970|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20193441|NCT01183390|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20193442|NCT04057573|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20187174|NCT01236781|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
20187175|NCT04577963|HUTCHMED International, Inc.|William Schelman, MD, PhD, Senior Vice President, Clinical Development, US/Europe|+1 9733064490|williams@hutch-med.com|
20187176|NCT02709161|University of Pittsburgh|Kymberly Young|4126486179|youngk@pitt.edu|
20187177|NCT05121441|Aardvark Therapeutics, Inc.|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
20187178|NCT05167864|University of Pennsylvania|Dr. Ivona Percec, PhD, MD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
20187179|NCT04028284|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
20187180|NCT04059185|Boston College School of Social Work|Catherine Taylor, PhD, LCSW, MPH|(617) 552-4033|catherine.taylor.2@bc.edu|
20187181|NCT05229822|NJSC KARAGANDA MEDICAL UNIVERSITY|Dr. Yermek Turguov|+77016119655|Turgunov@qmu.kz|
20187182|NCT04707326|ErasmusMC|Dr. Casper Rokx|+310107040704|c.rokx@erasmusmc.nl|
20193443|NCT02113124|The Transitional Learning Center at Galveston|Dr. Brent Masel|409-762-6661|bmasel@tlcgalveston.org|411
20193444|NCT03299049|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20193445|NCT01901419|Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan|Dr. Tso-Chou Lin|+886-2-87927128|tclin@mail.ndmctsgh.edu.tw|
20193446|NCT05302440|University of Hong Kong|Dr. Derek Yee Tak CHEUNG|3917 6652|derekcheung@hku.hk|
20193447|NCT04486625|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193448|NCT00725270|Stanford University|Alan Schatzberg|650-723-8331|afschatz@stanford.edu|
20193449|NCT02301377|University of Michigan|Dr. Aarti Shakkottai|734-764-4123|aartik@med.umich.edu|
20193450|NCT03466047|Imperial College London|Carel le Roux|7970719453|c.leroux@imperial.ac.uk|
20193451|NCT01020877|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20193452|NCT00790400|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
20193453|NCT01006980|Hoffman-LaRoche|Medical Communications|800-821-8590||
20193454|NCT00078338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20193455|NCT01483144|Cancer Prevention Pharmaceuticals|Michelle Boytim|520-908-7774|mboytim@canprevent.com|
20193456|NCT02460575|Tulane University|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
20193457|NCT04307940|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20193458|NCT02521363|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina, MD|646-888-4558|trainat@MSKCC.ORG|
20193459|NCT05543174|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20193460|NCT06024278|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
20193461|NCT04896008|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
20193462|NCT03430583|Mezzion Pharmaceuticals|Dr. Scott Oglesby|919-260-5782|Oglesby@granzer.biz|
20193463|NCT04201288|Brown University|Ethan Moitra, Associate Professor of Psychiatry and Human Behavior|401-444-1949|ethan_moitra@brown.edu|
20193464|NCT01933243|Nationwide Children's Hospital|Andrea Bonny|614-722-2458|andrea.bonny@nationwidechildrens.org|
20193465|NCT01270828|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193466|NCT06456385|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
20193467|NCT00015847|OHSU Knight Cancer Institute|Dr. Brian Druker|503-494-7999|trials@ohsu.edu|
20193468|NCT04400487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20193469|NCT05890027|Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida|Dr. Sara T. Wester|(305)-243-2020|swester2@med.miami.edu|
20193470|NCT01594827|Johns Hopkins Unviversity School of Medicine|Dr. Mark Jennings|410-502-7044|mjenni15@jhmi.edu|
20193471|NCT02484664|Brigham and Women's Hospital|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
20187183|NCT04587453|Leo Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
20187184|NCT03125070|Fred Hutchinson Cancer Center|Dr. K. Scott Baker|206-667-5594|ksbaker@fredhutch.org|
20187185|NCT04884308|Johns Hopkins University|Noah Lechtzin|410-502-7044|nlechtz@jhmi.edu|4102994561
20187186|NCT00957047|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
20187187|NCT03936959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20187188|NCT04171141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187189|NCT03526887|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20187190|NCT02895464|Karolinska Institutet|Dr Elisabeth Rydwik|+46852488818|elisabeth.rydwik@ki.se|
20213821|NCT00290147|Naval Medical Research Center, Viral Diseases Department|Charmagne Beckett, LCDR, MC, USNR|301-295-6400|charmagne.beckett@med.navy.mil|
20213822|NCT02143102|Elucid Bioimaging|Andrew J. Buckler|978-468-0508|andrew.buckler@elucidbio.com|
20187191|NCT04298983|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|2059345670|ammcdonald@uabmc.edu|
20187192|NCT04042233|Houston Methodist Hospital|Thomas Sullivan|2817254460|tsullivan@houstonmethodist.org|
20187193|NCT04907851|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
20213823|NCT03027661|University of Tennessee Health and Science Center|Elaine Todd, Director of Sponsored Programs - Contracts and research agreements|9014483303|ElaineTodd@uthsc.edu|
20187194|NCT03766685|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20187195|NCT02116530|Indiana University School of Medicine South Bend|Rudolph M. Navari, MD, PhD, FACP|574-252-7225|rmnavari@gmail.com|
20187196|NCT04676165|McGill University|Bettina Habib, Research Project Manager|514-396-1156|bettina.habib@mcgill.ca|
20213824|NCT02636907|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187197|NCT02927236|National Institute on Drug Abuse (NIDA)|Yihong Yang, PhD|443-740-2648|yihong.yang@nih.gov|
20213825|NCT04099888|PCI Biotech AS|Chief Executive Officer|(+47) 67 11 54 00|post@pcibiotech.no|
20213826|NCT00023309|National Institute of Diabetes and Digestive and Kidney Diseases, NIH|Marc G. Ghany, M.D|3014961721|marcg@mail.nih.gov|
20187198|NCT03162783|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20187199|NCT04117347|University of Michigan|Dr. Helen Burgess|734-615-8303|bhelen@med.umich.edu|
20187200|NCT03512327|Scripps Clinic|Dr. Gauree Konijeti|8585548880|konijeti.gauree@scrippshealth.org|
20213827|NCT03629925|Innovent Biologics (Suzhou) Co., Ltd|YiBo|+86 13382419112|jessica.yi@innoventbio.com|
20187201|NCT03511664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20213828|NCT01225146|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
20187202|NCT01946789|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20187203|NCT01922050|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
20187204|NCT04971031|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20187205|NCT04421989|Cincinnati Children's Hospital Medical Center|Dr. Claire Aarnio-Peterson|5138037459|claire.aarnio-peterson@cchmc.org|
20213829|NCT01014728|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
20187206|NCT04707625|Wake Forest University Health Sciences|Mark Nelson, MD|336.713.1680|mhnelson@wakehealth.edu|
20187207|NCT02398656|University of Calgary|Dr. Shelagh Coutts|4039444286|scoutts@ucalgary.ca|
20187208|NCT05485779|AQILION AB|Anneli Tinnerholm|+46 730 88 14 15|anneli.tinnerholm@aqilion.com|
20213830|NCT03661528|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20187209|NCT04252573|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
20187210|NCT03030261|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
20187211|NCT05205460|Tri-service general hospital|Chia-Ying Lai|87923311|pokerface165@gmail.com|13606
20187212|NCT05293171|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
20187213|NCT02052882|Memorial Sloan Kettering Cancer Center|Dr. Cy Wilkins, MD|646-608-3720|wilkinsc@mskcc.org|
20187214|NCT02641639|Mateon Therapeutics Inc|CEO|(650) 635-7000|ir@oncotelic.com|
20213831|NCT02732210|Amgen Inc.|Study Director|866-572-6436||
20187215|NCT05170841|A Menarini Industrie Farmaceutiche Riunite SrL|Corporate Medical Affair and Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
20187216|NCT03806790|LEO Pharma A/S|Clinical disclosure|+4544945888|disclosure@leo-pharma.com|
20213832|NCT01876706|NeoTract|Monica Ransom Director of Clinical Operations|4159648770|Monica.Ransom@Teleflex.com|
20187217|NCT02240238|NANO MRNA Co.,Ltd.|NANO MRNA Clinical Info Admin|+81 (0)3-6432-4792|clinical.info@nanomrna.co.jp|
20187218|NCT04901078|Kinoxis Therapeutics Pty Ltd|Director of Clinical Operations|+61434360596|tiina.ahveninen@kinoxistherapeutics.com|
20187219|NCT04506866|Medtronic|Mylène Champs|612-433-0600|mylene.champs@medtronic.com|
20187220|NCT03617445|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
20213833|NCT00604500|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsresultsdisclosure@merck.com|
20187221|NCT05216406|Nova Southeastern University|Dr. Jose Antonio|(954) 262-8140|Jose.Antonio@nova.edu|
20187222|NCT05487404|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20187223|NCT04911296|Rani Therapeutics|Sr. Director of Clinical Operations|+1 (408) 457-3700|joshua.myers@ranitherapeutics.com|
20187224|NCT04270942|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20187225|NCT06357169|University of Minnesota|Ronda Farah|(612) 625-8625|rfarah@umn.edu|
20187226|NCT06081309|Wave Neuroscience, Inc.|Bill Phillips|714-883-7890|bill@waveneuro.com|
20213834|NCT02191891|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187227|NCT04386057|Dana-Farber Cancer Institute|Dr. Kimberly Perez, MD|617-632-5370|Kimberly_Perez@DFCI.HARVARD.EDU|
20187228|NCT03672916|Zimmer Biomet|Martina Hersberger, Clinical Project Lead|+41 79 535 90 29|martina.hersberger@zimmerbiomet.com|
20187229|NCT04797195|Massachusetts General Hospital Center for Global Health|Katharine Morley, MD|617-726-2000|kemorley@mgh.harvard.edu|
20187230|NCT03221309|Institute of Human Virology, University of Maryland School of Medicine|Dr. Elana Rosenthal / Associate Professor|2403674157|erosenthal@ihv.umaryland.edu|
20187231|NCT05623228|Private practice|Dr. Stavroula Rakitzi|6989766935|srakitzi@gmail.com|
20187232|NCT02397954|Ophthotech Corp|Keith Westby||Keith.Westby@ophthotech.com|
20187233|NCT04737330|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20187234|NCT02823145|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20187235|NCT04741776|Dartmouth-Hitchcock Clinic|Fallon Cluxton-Keller, Ph.D.|603-650-4724|Fallon.P.Cluxton-Keller@dartmouth.edu|
20213835|NCT00765648|Cleveland Clinic|Frank Peacock MD|(216) 445-4557|peacocw@ccf.org|
20213836|NCT03124966|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20187236|NCT02852655|Dana-Farber Cancer Institute|Jose R. McFaline Figueroa, MD, PhD|617-632-2166|jose_mcfalinefigueroa@dfci.harvard.edu|
20187237|NCT03825588|University of Texas Southwestern Medical Center, University of Pittsburgh|Dr. Beth Dohoney Kennard; Dr. David Brent|214.456.4244|beth.kennard@utsouthwestern.edu|
20213837|NCT02921737|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20213838|NCT03883906|Cincinnati Children's Hospital Medical Center|Michael Grimley, MD|513-803-3218|Michael.Grimley@cchmc.org|
20187238|NCT05309291|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20213839|NCT00874237|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
20187239|NCT05209152|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20187240|NCT02568566|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
20187241|NCT04857723|CooperVision Inc.|Paul Chamberlain|+19257306754|pchamberlain@coopervision.com|
20213840|NCT00147030|National Perinatal Epidemiology Unit, University of Oxford|Director of NPEU Clinical Trials Unit|01865 289700|ctu@npeu.ox.ac.uk|89728
20187242|NCT03221426|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20187243|NCT00462696|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20187244|NCT03663569|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213841|NCT01929642|Boling Center for Developmental Disabilities|Dr. Tanjala Gipson|901-448-6512|sbarden@uthsc.edu|
20213842|NCT02458469|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
20187245|NCT04979442|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
20187246|NCT04506307|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20187247|NCT04005794|Vanderbilt University|Dr. Sohee Park, Professor of Psychology and the principal investigator|615 322 3435|sohee.park@vanderbilt.edu|
20187248|NCT03287336|GW University|Homa K. Ahmadzia|2027412500|homa.khorrami@gmail.com|
20187249|NCT00104676|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
20187250|NCT05622812|Q-Med AB|Head of Development|1-817-961-5000|reception.seupp@galderma.com|
20213843|NCT02370407|Johns Hopkins University|Dr. Lauren Thomaier|410-955-6710|lthomai1@jhmi.edu|
20187251|NCT05297565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20187252|NCT03711734|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|1206
20213844|NCT03561883|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
20213845|NCT02096718|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187253|NCT05029622|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20187254|NCT04084288|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|
20187255|NCT01959607|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|clinicaltrials.pmi@pmi.com|
20187256|NCT03913442|NYU Langone Health|Michael H Pillinger, MD, FACP|646-501-2722|Michael.Pillinger@nyulangone.org|
20187257|NCT02433379|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
20187258|NCT03952338|University of Calgary|Dr. Dana Lee Olstad|403-210-8673|dana.olstad@ucalgary.ca|
20187259|NCT04850898|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sabbio.com|
20187260|NCT00592852|Massachusetts General Hospital|Gagan Joshi, MD|617-503-1084|joshi.gagan@mgh.harvard.edu|
20187261|NCT00248807|James J Peters VAMC|Dr. Jill M. Wecht; Principal Investigator|718 584-9000|JM.Wecht@va.gov|3122
20187262|NCT03744182|Hanmi Pharmaceutical Co., Ltd.|GAEUN PARK|+824108746|gaeun.park@hanmi.co.kr|8746
20187263|NCT03374241|HanmiPharma|khseo@hanmi.co.kr|+82 2 410 9042|khseo@hanmi.co.kr|
20187264|NCT04770402|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20187265|NCT04942613|University of Colorado Denver, Anschutz Medical Campus|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
20187266|NCT05274074|University of Rochester|Dr. Benzi M. Kluger|5852754259|benzi_kluger@urmc.rochester.edu|
20187267|NCT03687086|University of California, Los Angeles and VA Greater Los Angeles Healthcare System|Dr. Constance Fung|818 891-7711|Constance.Fung@va.gov|39311
20187268|NCT05194956|University Hospitals of Derby and Burton NHS Trust|Mrs Trishna Patel|01332340131|trishnaanil.patel@nhs.net|83556
20213846|NCT03441581|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20187269|NCT02505984|Massachusetts General Hospital|Dr. Sharon Dekel|617-726-1352|sdekel@mgh.harvard.edu|
20187270|NCT03709121|Aldeyra Therapeutics, Inc.|VP, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20187271|NCT04176601|University of Rochester|Dr. Kim Van Orden|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
20187272|NCT02317887|VegaVect, Inc.|Dr. Rob Lin|412-560-9760|r.lin@avistatx.com|
20187273|NCT02593773|Horizon Pharma Ireland, Ltd, Dublin Ireland|Julie Ball, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
20187274|NCT06258174|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20187275|NCT01828099|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
20187276|NCT04162665|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
20187277|NCT03859635|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|3172740275|yyeap@iu.edu|
20187278|NCT05934942|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187279|NCT05645757|DynPort Vaccine Company, a GDIT Company|George Saviolakis|301-835-4101|George.Saviolakis@gdit.com|
20213847|NCT02385097|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
20187280|NCT03924635|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20213848|NCT02809183|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
20187282|NCT00539591|St. Jude Children's Research Hospital|Alberto Pappo, MD|901-595-2322|info@stjude.org|
20187283|NCT04362254|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20187284|NCT04568434|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20187285|NCT05469464|UNION therapeutics A/S|UNION therapeutics A/S|+45 61 77 7435|clinicaltrials@uniontherapeutics.com|
20213849|NCT01471522|NYU Langone Health|Anna Naumova|212.263.6927|Anna.Naumova@nyulangone.org|
20187286|NCT01928394|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20187287|NCT02038777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187288|NCT04299464|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20187289|NCT04826471|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
20213850|NCT02863575|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20213851|NCT05628675|King's College London/South London and Maudsley NHS|Dr Rebecca Cockburn|02032288800|rebecca.cockburn@kcl.ac.uk|
20213852|NCT00726739|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20213853|NCT02918877|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|617-549-2974|bpogara@bidmc.harvard.edu|
20213854|NCT01367275|University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
20213855|NCT01648166|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
20213856|NCT00883090|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20213857|NCT02532764|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
20213858|NCT01717976|Durham VA HSR&D|Susan N. Hastings|919-286-0411|susan.hastings@va.gov|4033
20213859|NCT02148302|SerenaGroup|Thomas E. Serena, MD|617-945-5225|serena@serenagroups.com|
20213860|NCT00262223|The City College of New York|Denise A. Hien, Ph.D.|(212) 650-5666|dhien@ccny.cuny.edu|
20213861|NCT00437658|AbbVie|Global Medical Services|800-633-9110||
20213862|NCT03952143|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20213863|NCT01866319|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213864|NCT01351506|Chiang Mai University|Dr.Kaweesak Chittawatanarat|+66815951259|kchittaw@gmail.com|
20213865|NCT00623779|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
20213866|NCT00832377|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213867|NCT01273181|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20213868|NCT00944697|Mundipharma Research GmbH|Director of Medical Operations|44 01223424900|info@contact-clinical-trials.com|
20213869|NCT03249584|MedtronicNeuro|Eric Grovender|763-514-4000|eric.a.grovender@medtronic.com|
20213870|NCT02597998|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213871|NCT02339233|University of Lousiville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
20213872|NCT01062256|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20213873|NCT03049488|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
20213874|NCT00208026|The Children's Hospital of Philadelphia|Albert C. Yan, M.D.|(215) 590-2158|Yana@email.chop.edu|
20213875|NCT00891293|GlaxoSmithKline|GSK Response Center|866-435-7343||
20213876|NCT01448057|Novartis consumer Health a GSK Consumer Healtcare company|Director Clinical research Respiratory|(1) 5512065988|anna.x.grinienko@gsk.com|
20213877|NCT03472365|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Medical Director: Linna Wang|+86-13581990612|linna.wang@hengrui.com|
20213878|NCT00924326|National Cancer Institute|Steven Rosenberg, M.D., Ph.D.|240-858.3080|sar@nih.gov|
20213879|NCT00262964|Washington University School of Medicine|Elisa Fabbrini, MD|314-362-8156|efabbrini@dom.wustl.edu|
20213880|NCT03912337|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20213881|NCT00537030|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20213882|NCT02828917|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20213883|NCT01496183|The State University of New York at Buffalo|Dr. Elsa Daurignac, Research Assistant Professor|716-898-4540|ecd3@buffalo.edu|
20213884|NCT03130699|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
20213885|NCT03325426|UCSF|Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
20213886|NCT00669864|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20213887|NCT03682900|Oregon Research Behavioral Intervention Strategies, Inc.|Judy A. Andrews, Senior Scientist|541-484-2123|Judy.Andrews@Influentsin.com|
20213888|NCT06354270|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20213889|NCT00680121|University of Kansas Medical Center|Ann Manzardo, PhD|(913) 588-6473|amanzardo@kumc.edu|
20213890|NCT00162123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20213891|NCT02016170|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20213892|NCT00534703|Imperial College London|Dr Alexander Lyon|+442075943409|a.lyon@imperial.ac.uk|
20213893|NCT00582400|University of Texas Medical Branch at Galveston|Dr. Avi B. Markowitz|4097721164|abmarkow@utmb.edu|
20213894|NCT01936948|White River Junction VA Medical Center|Heiko Pohl|802-295-9363|heiko.pohl@va.gov|5591
20213895|NCT02365207|University of Texas Health San Antonio|Robert Svatek|210-567-5676|svatek@uthscsa.edu|
20213896|NCT01395030|The Queen's Medical Center|Program Director for PET Research|808-691-5466|skwee@queens.org|
20213897|NCT04538040|Gilead Sciences|Lisa Sterman, MD, MPH|415-407-8434|Lisa.Sterman@Gilead.com|
20213898|NCT02494713|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
20213899|NCT01606306|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
20213900|NCT01434342|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20213901|NCT00950872|Covidien|Noreen Fahey, Director, Clinical Program Management|203-821-4716|noreen.fahey@covidien.com|
20213902|NCT00159965|Rhode Island Hospital|W. Curt LaFrance, Jr., MD, MPH|401-444-3534|William_LaFrance_Jr@Brown.edu|
20213903|NCT00408902|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
20213904|NCT00970281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213905|NCT01759290|Abbott Vascular|Kunal Sampat|408-845-0746|kunal.sampat@av.abbott.com|
20213906|NCT00841100|University of Miami|Judy Schaechter|305-243-3993|JSchaech@med.miami.edu|
20213907|NCT03338972|Fred Hutchinson Cancer Center|Dr. Damian Green|2066675398|dgreen@fredhutch.org|
20213908|NCT03629249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20213909|NCT00352690|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovinda@dom.wustl.edu|
20187290|NCT04777721|University of Oxford|Professor Helen McShane|01865 617606|helen.mcshane@ndm.ox.ac.uk|
20187291|NCT03916276|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
20187292|NCT04971109|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
20187293|NCT03209973|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20187294|NCT03528928|Womens Health|Teresa Brousseau|866-432-4400|tbrousseau@isapin.com|
20187295|NCT05123586|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20187296|NCT04036253|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
20187297|NCT02432261|Health Decisions|Kimberly Myer|9842381297|Kimberly.Myer@premier-research.com|
20187298|NCT04200911|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
20187299|NCT05841004|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
20213910|NCT02589171|The University of Texas Health Science Center at Houston|Associate Professor|(713) 500-7277|Shinil.K.Shah@uth.tmc.edu|
20213911|NCT00448175|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
20213912|NCT03633721|Albert Einstein College of Medicine|Dr. Anjali Sharma|7185152593|anjali.sharma@einsteinmed.edu|
20213913|NCT03054103|Wake Forest University Health Sciences|Dr. Timothy Harwood|3367164498|tharwood@wakehealth.edu|
20213914|NCT01475474|Renew Medical, Inc.|Victoria Mackinnon, Vice President, Regulatory, Clinical & Quality|1-888-987-2929|victoria@renew-medical.com|
20213915|NCT05277389|Arizona State University|Claire Honeycutt, Associate Professor|4809658453|claire.honeycutt@asu.edu|
20213916|NCT03069937|Medical University of South Carolina|Principal Investigator|843-792-4271|gourdith@musc.edu|
20213917|NCT06096168|SERF|Sponsor|0472056010|clinical@serf.fr|
20213918|NCT01046253|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20213919|NCT02914795|Medical University of Grazt|Assoc. Prof. Dr. Dirk von Lewinski|+43 316 385|dirk.von-lewinski@medunigraz.at|80684
20213920|NCT02339909|Imperial College London|Colin Bicknell|02078866666|colin.bicknell@imperial.ac.uk|6072
20213921|NCT03086356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20213922|NCT01264952|Institute of Oncology Ljubljana|Gregor Sersa, PhD|+386 1 5879 434|gsersa@onko-i.si|
20213923|NCT01766778|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20213924|NCT01411332|University of Miami|Alan Pollack MD, PhD|305-243-4916|apollack@med.miami.edu|
20213925|NCT02079532|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20193472|NCT03334253|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
20193473|NCT00703339|Lung Rx|Rosa Negro-Vilar|240-821-1881|rnegrovilar@lungrx.com|
20193474|NCT00945672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193475|NCT00584077|University of Texas-Galveston|Alexander Duarte, MD|409-772-2436|aduarte@utmb.edu|
20193476|NCT03054337|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
20193477|NCT02838979|University of Washington|Ernest Ayers|206-685-1423|ayerse@uw.edu|
20193478|NCT00447590|Apollo Endosurgery|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
20193479|NCT01028677|UNC_ChapelHill|Dr. Cort Pedersen|919 966-4447|cort_pedersen@med.unc.edu|
20193480|NCT00775411|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20193481|NCT00609947|Medtronic CardioVascular|Lynda Chaplin - Study Manager|(707) 543-5459|lynda.chaplin@medtronic.com|
20193482|NCT05569421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20193483|NCT00504075|Bio Products Laboratory Limited|Tim Aldwinckle, MD|+44 2089572565|Tim.Aldwinckle@bpl.co.uk|
20193484|NCT04079634|Northwestern University|Nishant Verma, MD|3129262148|nishant.verma@nm.org|
20193485|NCT03812029|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
20193486|NCT00581477|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
20193487|NCT03106753|Icahn School of Medicine at Mount Sinai|Dr. Natalie Porat|973-919-6166|poratnat@gmail.com|
20193488|NCT01643044|Wayne State University|Steven Ondersma, PhD|313-444-9797|sondersm@med.wayne.edu|
20193489|NCT03149042|University at Buffalo|Dr. Ciprian Ionita|7164004283|cnionita@buffalo.edu|
20193490|NCT00790205|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193491|NCT02643628|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
20193492|NCT03933462|Philips|Sara Garbin|724-787-8550|sara.garbin@philips.com|
20193493|NCT04148651|Candela Corporation|Medical Director|+1 949.599.7657|konikap@candelamedical.com|
20193494|NCT00594022|R.P. Chiacchierini & Associates|R.P. Chiacchierini & Associates|(240) 683-3738|rpc@rpcaconsulting.com|
20193495|NCT02597712|Trio Medicines Ltd|Dr Malcolm Boyce|+44 20 8961 4130|mboyce@triomedicines.com|
20193496|NCT01441635|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20193497|NCT02637323|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20193498|NCT00358644|Eisai Inc.|Eisai Call Center|888-422-4743||
20213926|NCT01432171|Dana-Farber Cancer Institute|Dr. Andrew Norden, M.D., M.P.H. - Lead Principal Investigator|617-632-2166|anorden@partners.org|
20213927|NCT03422653|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20193499|NCT00513708|SUNY Buffalo|Schieder, Jeffrey|716-645-2977|jss10@buffalo.edu|
20193500|NCT00368875|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
20193501|NCT03327831|UC Irvine|Christopher Zachary|949-824-5515|czachary@uci.edu|
20193502|NCT01564277|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20193503|NCT02595372|IndianaU|Dr. Kathy Miller|(317) 948-3855|kathmill@iu.edu|
20193504|NCT02588872|Rush University Medical Center|Mukesh Ahuja|312-432-2380|cole.research@rushortho.com|
20193505|NCT00401258|McLean Hospital|Brian Brennan, M.D.|617-855-2911|bbrennan@partners.org|
20193506|NCT02694445|Department of Neurology, Xuan Wu Hospital,Beijing,China|Jianping Jia|010-63150669|jiajp@vip.126.com|
20193507|NCT01305239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193508|NCT03518567|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
20213928|NCT01519661|Novartis Pharmaceuticals|Study Director|862-778-8300||
20193509|NCT02506933|City of Hope Medical Center|Dr. Ryotaro Nakamura, MD|6263598111|RNakamura@coh.org|
20193510|NCT02726945|GID Bio|Director of Clinical Operations|3039524901|s.samudre@gidbio.com|105
20193511|NCT03085836|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20193512|NCT00699153|Bausch & Lomb, Inc.|Laura Trusso, MS.|(585) 338-5561|laura.trusso@bausch.com|
20193513|NCT03054051|Emory University|Kate Winskell Enger PhD|404-727-5286|swinske@emory.edu|
20193514|NCT01997905|Methodist Hospital Houston|Basel Ramlawi, MD|713-441-5200|basel.ramlawi@gmail.com|
20193515|NCT02356705|Bassett Healthcare|Dr. David Ullman|585-750-7510|doccfi@hotmail.com|
20193516|NCT06476548|Moffitt Cancer Center|Dr. Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
20213929|NCT01139047|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20213930|NCT00420303|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20213931|NCT00745420|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20213932|NCT01941095|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20213933|NCT04486066|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|tracy.simpson@va.gov|
20213934|NCT01532141|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20213935|NCT00594685|New England Research Institutes|Susan Assmann|617-923-7747|sassmann@neriscience.com|548
20213936|NCT00088829|Georgetown University Medical Center|Claudine Isaacs, MD|202-444-3677|isaacsc@georgetown.edu|
20213937|NCT03344510|Perelman School of Medicine at the University of Pennsylvania|Dr. Joseph Sobanko|215.360.0909|joseph.sobanko@uphs.upenn.edu|
20213938|NCT02215161|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
20163118|NCT01278797|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163119|NCT02110264|UCLA|David Farabee|3109630009|dfarabee@mednet.ucla.edu|
20163120|NCT00620113|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163121|NCT02973516|Guerbet|Jing Hao, MD, Head of Global Medical Affairs and Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20163122|NCT02268994|Keryx Biopharmaceuticals, Inc.|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
20163123|NCT03850535|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20163124|NCT01979133|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
20163125|NCT00486824|Stanford University|Dr. Deirdre Lyell|6507255720|dlyell@stanford.edu|
20163126|NCT02748070|Stanford University|Michael Chang|(650) 725-6500|michael.t.chang@stanford.edu|
20163127|NCT00240500|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163128|NCT01704404|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20163129|NCT02476006|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20193517|NCT04595682|University of Kentucky|Dr. Mark Fillmore|8592574728|fillmore@uky.edu|
20193518|NCT01877148|Universidade Federal de Pernambuco|Kátia Monte-Silva|+ 55 (81) 2126-7579|monte.silvakk@gmail.com|
20193519|NCT02870972|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20193520|NCT04497389|University of Utah|Joseph Tonna, MD|801-587-6271|joseph.tonna@hsc.utah.edu|
20193521|NCT00789360|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20193522|NCT03559062|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20193523|NCT05646719|Opus Genetics|Sarah Callahan|984-884-6030|Scallahan@opusgtx.com|
20193524|NCT03445533|Idera Pharmaceuticals, Inc.|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
20193525|NCT02615509|Philips AB|Daniel Stenströmer|+46 708 303 767|daniel.stenstromer@philips.com|
20193526|NCT03274453|New York University School of Medicine|Kirsten Boenigk|212 598 6085|Kirsten.Boenigk@nyumc.org|
20193527|NCT00968526|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193528|NCT02106962|California Insitute of Renal Research, Inc.|Mark M. Boiskin, M.D.|858-637-4600|mboiskin@bnmg.org|
20193529|NCT03926195|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20193530|NCT01762904|Universidad de Guanajuato|Alejandro E. Macías|+52 477 7 14 58 59|aaeemmhh@yahoo.com|4644
20193531|NCT01967069|Promius Pharma|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
20213939|NCT01475838|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20213940|NCT03765502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20213941|NCT00048568|Bristol Myers-Squibb|BMS Study Director||clinical.trials@bms.com|
20213942|NCT03831048|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
20213943|NCT01365650|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20163130|NCT00571974|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
20193532|NCT01186705|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
20193533|NCT01689857|Seoul National University Bundang Hospital|Dr. Chanyeong Heo|82317877222|lionheo@snu.ac.kr|
20193534|NCT00874731|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213944|NCT01595503|University of Michigan|stephan taylor|7349364955|sftaylor@umich.edu|
20213945|NCT01027780|University of Rochester|Dr. Jan Moynihan|585-275-4648|jan_moynihan@urmc.rochester.edu|
20213946|NCT01315249|Novartis|Study Director|41 61 324 1111||
20193535|NCT01528319|Johnson & Johnson K.K. Medical Company|Department Chief, Clinical Development & PMS|+81-3-4411-6789|yikeda5@its.jnj.com|
20213947|NCT03227445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20213948|NCT03538587|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
20213949|NCT00365300|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20213950|NCT01991470|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20193536|NCT02132832|The University of Texas Health Science Center at Houston|Scott D. Lane, PhD|(713) 486-2535|Scott.D.Lane@uth.tmc.edu|
20193537|NCT01736540|Novartis|Study Director|862-778-8300||
20193538|NCT00479882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20213951|NCT00771537|Indiana University|Gregory D Zimet|317-274-8812|gzimet@iupui.edu|
20193539|NCT03470740|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
20193540|NCT02874014|Mayo Clinic|Dr. C. Richard Choo|507-284-3261|Choo.C@mayo.edu|
20193541|NCT06381986|Sunhawk Vision Biotech|President|+886-72222660|hjuo@shvbiotech.com|
20193542|NCT02451176|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
20193543|NCT01434745|Washington State University|Dr. jean-Baptiste Roullet|5093587666|j.roullet@wsu.edu|
20193544|NCT04646291|Mosie Baby (Consultant)|Karina Loyo, Ph.D., MBA, CCDM|512-563-1393|karina@drkarina.com|
20193545|NCT01512797|Columbia University Medical Center|Dr. Blandine Laferrere|212-851-5562|bbl14@columbia.edu|
20193546|NCT02103114|Duke University|Dr. Edmund Jooste|919-681-4877|edmund.jooste@duke.edu|
20193547|NCT03004404|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193548|NCT01937975|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193549|NCT02522728|Stryker Orthopaedics|Eric Garling, PhD Snr. Director Medical & Scientific Affairs Europe|+31 6 467 135 18|Eric.Garling@stryker.com|
20193550|NCT02028325|Indiana University|Aaron Cohen-Gadol, MD, MSc|317-362-8760|acohen@goodmancampbell.com|
20193551|NCT00980746|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20193552|NCT01266161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193553|NCT02990468|BioMimetix JV LLC|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
20193554|NCT02335905|Baylor College of Medicine|Sheldon L. Kaplan|832-824-4330|skaplan@bcm.edu|
20193555|NCT01436305|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20193556|NCT03563066|McMaster University|Gail Gauvreau|9055259140|gauvreau@mcmaster.ca|22791
20193557|NCT01160237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193558|NCT00780455|Bayer Healthcare AG|Medical Affiars Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20193559|NCT03690427|University of California, Los Angeles|Mary Rezk-Hanna, PhD|3102068654|mrhanna@mednet.ucla.edu|
20193560|NCT02251236|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
20193561|NCT03519204|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20193562|NCT02609672|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
20193563|NCT03392168|Arcutis|Study Inquiry|650-847-4115|studyinquiry@arcutis.com|5
20193564|NCT04591171|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
20193565|NCT01721954|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
20193566|NCT00727740|Yale University School of Medicine|Priya Jamidar, MD|203-785-6228|priya.jamidar@yale.edu|
20193567|NCT02956837|GlaxoSmithKline|GSK Response Center|866-435-7343|shm60684@gsk.com|
20193568|NCT01824589|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
20193569|NCT01727505|University of Miami School of Medicine, Dept. of Pediatrics - Div. of Neonatology|Nelson Claure, MSc, PhD, Director Neonatal Pulmonary Research Lab|305 585 6408|nclaure@miami.edu|
20193570|NCT01594970|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20193571|NCT01427725|Medical affairs|Medical affairs manager|+81-3-5656-0516||
20193572|NCT01299480|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193573|NCT01661764|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
20193574|NCT01430468|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-445-5151|iannotj@ccf.org|
20193575|NCT01281839|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20193576|NCT04176731|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20193577|NCT00617929|Masonic Cancer Center, University of Minnesota|Jakub Tolar, MD|612-624-7180|tolar003@umn.edu|
20193578|NCT03229486|Pusan National University Yangsan Hospital|Professor|0553602756|anesktk@pusan.ac.kr|
20193579|NCT05672771|University of Illinois|Dr. Elizabeth A L Stine-Morrow|217-244-2167|eals@illinois.edu|
20193580|NCT01976572|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20193581|NCT04855734|Children's National Hospital|Dr. Maureen E. Lyon, Clinical Health Psychologist, Professor of Pediatrics|703-346-2873|mlyon@childrensnational.org|
20193582|NCT04535544|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20213952|NCT02896361|Abbott Neuromodulation|Filippo Agnesi, PhD|972-526-4860|filippo.agnesi@abbott.com|
20213953|NCT02831569|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193583|NCT00344032|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193584|NCT01754987|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
20193585|NCT03746509|University of Minnesota|Juergen Konczak|612-624-4370|jkonczak@umn.edu|
20193586|NCT05131477|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|contact-us@saonofi.com|6
20193587|NCT02194829|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20193588|NCT06915285|VisionQuest Biomedical Inc|Vinayak Joshi|3054845674|vjoshi@visionquest-bio.com|
20193589|NCT06840769|Helsinn Healthcare SA|Tulla Spinelli|+41.91.985.21.21|Tulla.Spinelli@helsinn.com|
20193590|NCT02412735|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
20193591|NCT01228318|Emory University|Igho Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
20193592|NCT03011567|NYU Langone Health|Christina Penfield, MD, MPH|646-754-2700|christina.penfield@gmail.com|
20193593|NCT00603525|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193594|NCT00770029|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
20193595|NCT02124811|Emory University|Robert Cotes, MD|(404) 616-4752|robert.o.cotes@emory.edu|
20193596|NCT04043143|"University of Colorado Denver | Anschutz"|Karsten Bartels, MD, PhD, MBA|303-724-1111|karsten.bartels@cuanschutz.edu|
20193597|NCT03480932|Johns Hopkins Bloomberg School of Public Health|Dr. Shruti Mehta|4432873837|smehta@jhu.edu|
20193598|NCT02734498|Wake Forest School of Medicine|James Kimball, MD|336-716-9702|jkimball@wakehealth.edu|
20193599|NCT04624243|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193600|NCT04996004|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193601|NCT03412916|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
20193602|NCT03374488|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20193603|NCT06490302|CooperVision, Inc.|Jose A. Vega,OD,MSc, PhD|9256213761|javega@coopervision.com|
20193604|NCT03065075|University of Massachusetts|Dr. Tania Sierra|508-334-9840|tania.sierra@umassmemorial.org|
20193605|NCT03322540|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20193606|NCT00583466|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20213954|NCT03164772|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20213955|NCT01029353|Vanderbilt University Medical Center|Martin L Blakely, MD|615-936-7211|martin.blakely@vumc.org|
20213956|NCT00954915|MacroGenics, Inc.|Teplizumab Program Manager||info@macrogenics.com|
20213957|NCT03002597|Children's Hospital of Pittsburgh UPMC|Dr. Kanwal Nischal|4126928940|nischalkk@upmc.edu|
20213958|NCT02932878|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20213959|NCT00849901|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20213960|NCT03828734|University of North Carolina at Chapel Hill|Justin Riddle, PhD|919-966-4755|justin_riddle@med.unc.edu|
20213961|NCT02152566|Fisher & Paykel Healthcare|Dr Rachel Vicars|09 574 0123|rachel.vicars@fphcare.co.nz|7759
20213962|NCT02731157|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
20213963|NCT01856309|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Associate Director, Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20213964|NCT00220337|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20213965|NCT02327130|Isomark, LLC|Dr. Daniel Butz, Chief Scientific Officer|(608) 561-1895|daniel.butz@isomark.com|
20213966|NCT00493831|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
20213967|NCT05214560|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
20213968|NCT02672553|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
20213969|NCT02003183|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Gary Small|3108250291|gsmall@mednet.ucla.edu|
20213970|NCT03104738|The Ohio State University|Ana Mavarez-Martinez, PostDoctoral Reseacher|614-293-3559|ana.mavarezmartinez@osumc.edu|
20213971|NCT02343120|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20213972|NCT01993875|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20213973|NCT02534493|Pressure Profile Systems|Jae Son|3106418100|jaeson@pressureprofile.com|
20213974|NCT00981305|SeoulNUH|Myung Jae Jeon|82-2-2072-1916|jeonmj@snu.ac.kr|
20213975|NCT02519322|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
20213976|NCT01054599|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
20213977|NCT01104662|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
20213978|NCT00743197|Northwestern University|Dr. Martha Gulati, Principal Investigator|312-695-4965|mgulati@nmh.org|
20213979|NCT01478620|"Kiev regional City Hospital"|Ivanov, Dmitry|+38 (039) 247 12 36|ivanovdd@i.kiev.ua|
20213980|NCT00672854|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20213981|NCT02380183|Montefiore Medical Center|Dr. Amaresh Vydynathan|718-920-4316|avydynathan@montefiore.org|
20213982|NCT02170688|Duke University Medical Center|Lisa Ho, MD|919-684-7890|lisa.ho@duke.edu|
20213983|NCT01894178|Baylor College of Medicine|Dr. Lee Chang|713-873-4321|lcchang@bcm.edu|
20213984|NCT01402947|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20213985|NCT02419690|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
20213986|NCT02405195|Västra Götalandsregionen|Lukas Lannemyr|46313428860|lukas.lannemyr@vgregion.se|
20213987|NCT01706926|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
20193607|NCT00168389|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20213988|NCT00479258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20213989|NCT00373217|University of Virginia|Craig Slingluff MD, Professor of Surgery|4349249311|cls8h@virginia.edu|
20213990|NCT00934934|CERU Queens University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
20213991|NCT04349917|University of North Carolina at Chapel Hill|Jessica R. Cohen, PhD|(919) 843-3753|jrcohen@unc.edu|
20213992|NCT02087514|Columbia University Medical Center|Dr. Eldad Hod|(212) 342-5648|eh2217@cumc.columbia.edu|
20213993|NCT04188106|Rose Research Center|Perry Willette, MD|919.908.0945|perry.willette@roseresearchcenter.com|
20213994|NCT00441467|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
20213995|NCT02289963|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20213996|NCT03514420|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20213997|NCT01042522|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20213998|NCT00318812|Ottawa Hospital Research Institute|Dr Deborah Zimmerman, principal investigator|613-738-8400|dzimmerman@toh.on.ca|82534
20213999|NCT01746017|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214000|NCT01507051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20214001|NCT01675622|Mundipharma (China) phamaceutical CO. LTD|Director of R&D|0086-10-65636800||
20214002|NCT01101022|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20214003|NCT02311361|National Cancer Institute|Dr. Tim Greten|240-760-6114|tim.greten@nih.gov|
20214004|NCT01978743|Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
20214005|NCT04455633|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
20214006|NCT03527745|Swiss Tropical and Public Health Institute|Jennifer Keiser, PhD|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
20214007|NCT04083859|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
20214008|NCT03433430|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20214009|NCT02942264|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
20214010|NCT01328093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214011|NCT04421508|Bellerophon Therapeutics|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
20214012|NCT03980483|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20214013|NCT00784849|LSU Dept of Surgery|Dr. Eugene Woltering|504 464-8500|ewolte@lsuhsc.edu|
20214014|NCT04622709|University of North Carolina, Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
20214015|NCT00760266|Novartis Pharmaceuticals|Study Director|862-778-8300||
20214016|NCT01239121|James J. Peters VA Medical Center|Kenneth Boockvar|718-584-9000|kenneth.boockvar@va.gov|3807
20214017|NCT03657160|Takeda|Study Director|+1-877-825-3327|medinfoUS@takeda.com|
20214018|NCT00488865|Rex Medical|James Bressler|610-940-0665|ebressler@rexmedical.com|
20214019|NCT00686959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214020|NCT01449630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214021|NCT03138330|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
20214022|NCT01735630|Transition Therapeutics Ireland Limited|Aleksandra Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
20214023|NCT01572948|University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine|J. Michael Wells, M.D.|205-934-6047|jmwells@uab.edu|
20214024|NCT01973348|Indiana University|Dr. Daniel Neely, PI|3172741214|deneely@iupui.edu|
20214025|NCT01270919|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
20214026|NCT01126736|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20214027|NCT00784823|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
20214028|NCT01720264|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
20214029|NCT02870920|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
20214030|NCT04448678|University of Utah|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
20214031|NCT01353495|Wright Medical Technology, Inc.|Jonette Hodge, MSN, RN, CCRP, Director, Medical Affairs|8002387188|jonette.hodge@wmt.com|4747
20214032|NCT01313416|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
20214033|NCT03117569|Viral Hepatitis Clinical Research Program Kirby Institute|Clinical Trials Manager|+61 9385 0900|pmarks@kirby.unsw.edu.au|
20214034|NCT01853553|University of Colorado|Dr. Michel Chonchol|303-724-7796|Michel.Chonchol@ucdenver.edu|
20214035|NCT03018249|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|linda.gedeon@roswellpark.org|
20214036|NCT02134522|Yale University|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
20214037|NCT01030965|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214038|NCT02097290|Boston Scientific|Gregory Voss|6515813068|Gregory.Voss@bsci.com|
20193608|NCT04703192|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20214039|NCT00824265|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20214040|NCT02888171|University of Alabama at Birmingham|Orlando M. Gutierrez, MD|205-996-2736|ogutierrez@uabmc.edu|
20214041|NCT02920996|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
20214042|NCT00591630|University of Texas MD Anderson Cancer Center|Issa F. Khouri, MD / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
20214043|NCT02218164|H. Lee Moffitt Cancer Center and Research Institute|Dr. Christine Chung|813-745-5061|christine.chung@moffitt.org|
20163131|NCT02813889|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
20163132|NCT00555880|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20214044|NCT00993187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372||
20214045|NCT00485472|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20214046|NCT01492361|Amarin Pharma, Inc.|Dr. Alexander Giaquinto, Executive Director, Regulatory Affairs|908-326-1324|alex.giaquinto@amarincorp.com|
20214047|NCT04015232|Lambda Therapeutic Research Ltd.|Dr. Adarsh Kumar Garg, M.B.B.S. Principal Investigator|+91-79-40202020|adarshgarg@lambda-cro.com|
20214048|NCT01453075|VA ORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|1251
20214049|NCT02576249|Mayo Clinic|Dr. Jacob Sellon|507-255-1141|sellon.jacob@mayo.edu|
20214050|NCT05150964|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20214051|NCT00643578|University of Florida Asthma Research Lab|Dr. Leslie Hendeles|352-273-6027|hendeles@cop.ufl.edu|
20214052|NCT01434693|Coronado Biosciences|Vice President Clinical Operations|781.652.4516|nsilver@coronadobio.com|
20214053|NCT04006171|Near East University|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
20214054|NCT00912288|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214055|NCT02506309|Brno University Hospital|dr. Martin Huser|+420532233843|huser.martin@fnbrno.cz|
20214056|NCT02016612|Bengtson Center|Dr Bradley Bengtson|616 588 8880|drb@bengtsoncenter.com|
20214057|NCT02087904|AbbVie|Global Medical Services|AbbVie|abbvieclinicaltrials@abbvie.com|
20214058|NCT01196052|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20214059|NCT02178722|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20214060|NCT03340727|RTI International|Abhik Das|301-770-8214|adas@rti.org|
20214061|NCT00440557|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sr Director of Clinical Research|908-927-2116||
20214062|NCT00669942|Novartis|Study Director|862-778-8300||
20214063|NCT02107092|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20214064|NCT04005859|Atrium Health|Dr. Kevin Kasten|704-355-1813|kevin.kasten@atriumhealth.org|
20163133|NCT00941915|Assistant Research Practice Manager|Joan Cahill, BSN RN OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
20193609|NCT02493062|St. Louis Fetal Care Institute|Dr. Laura Vricella|3146784488|fetalcare@ssmhealth.com|
20193610|NCT01327612|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20193611|NCT00387244|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20193612|NCT05105087|Thomas Jefferson University|Ji-Bin Liu, MD|215-955-4862|jxl120@jefferson.edu|
20193613|NCT01016262|Forest Laboratories|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20193614|NCT01730378|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193615|NCT03199469|Astellas Pharma Global Development, Inc. (APGD)|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20193616|NCT03836859|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 513831|clinical.trials@dompe.com|
20193617|NCT02470780|University of Cincinnati/UC Health|Hilary Perez PhD|5135582577|perezhe@ucmail.uc.edu|
20193618|NCT01023958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193619|NCT01031628|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
20193620|NCT03080493|University of California, Davis|Mitchell Creinin, MD|916-734-6670|mdcreinin@ucdavis.edu|
20193621|NCT00759642|University of Kansas Cancer Center|Priyanka Sharma, MD|913-945-5059|PSHARMA2@kumc.edu|
20193622|NCT00755417|Depomed|Head of Research & Development|650-462-5900|msweeney@depomed.com|108
20193623|NCT02676843|Columbia University|William Kreisl, MD|212-342-2380|wck2107@cumc.columbia.edu|
20193624|NCT02362503|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20193625|NCT02803593|Emory University|Dr. Eun Ok Im|404-712-9805|eun.ok.im@emory.edu|
20193626|NCT05143138|WL Gore|Cinzia Santin, Clinical Study Mgt, Gore Medical Products|+393463645539|csantin@wlgore.com|
20193627|NCT01993849|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20193628|NCT03632083|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20193629|NCT04245345|Medtronic|Rachel Vasseur, Sr. Clinical Research Specialist|6123550360|rachel.s.vasseur@medtronic.com|
20193630|NCT01834586|EvergreenHealth Multiple Sclerosis Center|Theodore Brown|425-8995350|trbrown@evergreenhealth.com|
20193631|NCT03443414|Verona Pharma|Brian Maurer, Senior Clinical Operations Director|(914) 767-5037|brian.maurer@veronapharma.com|
20193632|NCT03325777|The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
20193633|NCT01895036|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
20193634|NCT04210843|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20193635|NCT01099917|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
20193636|NCT04692467|Weill Cornell Medicine|Dr. Margaret McNairy|646-962-8140|mam9365@med.cornell.edu|
20193637|NCT01485120|GE Healthcare|Jeff Conner|414-721-2423||
20193638|NCT00422734|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20214065|NCT00581971|UAB Hospital|Dr. Sharon Spencer Professor of Radiation Oncology|205-934-2762|sspencer@uabmc.edu|
20214066|NCT01789905|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214067|NCT04213326|Exact Sciences|Adriann Kern|4843563027|akern@exactsciences.com|
20214068|NCT02549092|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20214069|NCT01954264|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214070|NCT01390233|University of Arizona (Investigator has changed institutions - study completed at University of South Carolina)|Meg Hill, MBBS|520 626 6174|meghanhill@obgyn.arizona.edu|
20214071|NCT03959683|INDIANA UNI SCHOOL OF MEDICINE|Erica Sahm|317-274-3560|esahm@iuhealth.org|
20214072|NCT03002077|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20214073|NCT02495467|Richmond Pharmacology Limited|Dr Jorg Taubel|020 8664 5200|j.taubel@richmondpharmacology.com|
20214074|NCT03287310|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
20214075|NCT03611608|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214076|NCT04625114|University Hospital Ghent|Dr Marie-Angélique De Scheerder|+32 9 33 21349|marie-angelique.descheerder@uzgent.be|
20214077|NCT01629381|University of Padua|Dr. Giuseppe Camporese|049 8212882|giuseppe.camporese@aopd.veneto.it|+39
20214078|NCT02158494|University of Wisconsin - Madison|Mitchell Tyler|608-262-5112|metyler1@wisc.edu|
20214079|NCT00906347|University of Texas Southwestern Medical Center|Dr. April Bleich|214-648-2316|april.bleich@gmail.com|
20214080|NCT00802100|Columbia University|Scott Stroup|(212) 543-5676|stroups@nyspi.columbia.edu|
20214081|NCT04448886|DFCI|Se Eun Kim|9196228080|seeunk@ds.dfci.harvard.edu|
20214082|NCT02688556|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|clinical.trials@sparcmail.com|
20214083|NCT02849652|University of Pennsylvania|Dr. Robert Schnoll|2157467143|schnoll@pennmedicine.upenn.edu|
20214084|NCT00472290|Amgen Inc.|Study Director|866-572-6436||
20214085|NCT00777829|UCSD|Dr. Sara C. Mednick|8586423192|mednicks@uci.edu|
20214086|NCT03205553|University of Arkansas for Medical Sciences|Dr. Patrick Bonasso|(501) 364-2943|PCBonasso@uams.edu|
20214087|NCT04826809|Mayo Clinic|Dr. Janielle R. Nordell|507-594-4700|Nordell.Janielle@mayo.edu|
20214088|NCT02359305|Nationwide Children's Hospital - Dept. of Anesthesiology & Pain Medicine|Dr. Arlyne Thung|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
20214089|NCT02461771|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20214090|NCT00854308|Hoffman-LaRoche|Medical Communications|800-821-8590||
20214091|NCT01390844|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193639|NCT02344342|University of Michgan Health Systems|Todd Koelling, MD|734-936-5265|tkoellin@med.umich.edu|
20193640|NCT00848484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193641|NCT03151746|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20193642|NCT01059305|The University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD/Professor, Thoracic/Head & Neck Med Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20193643|NCT03355209|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20193644|NCT01081886|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20193645|NCT02567708|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193646|NCT00706654|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
20193647|NCT02097303|Carolina Research Professionals, LLC|Dr. Neal D. Shore, MD, FACS, CPI|843-449-1010|nshore@carolinaresearchprofessionals.com|243
20214092|NCT00745095|JJPVAMC National Center of Excellence for the Medical Consequeunces of Spinal Cord Injury|Dr. Mark A. Korsten, Chief of Gastroenterology|718-584-9000|mark.korsten@va.gov|6753
20214093|NCT01479439|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
20193648|NCT05262751|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193649|NCT02627118|UConn Health|Andre Kaplan, MD||kaplan@uchc.edu|
20193650|NCT01154140|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193651|NCT02079025|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
20193652|NCT04276051|Emory University|Alexandra Migdal, MD|404-778-3280|alexandra.love.migdal@emory.edu|
20193653|NCT01912404|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20193654|NCT01754753|The University of Sheffield|Daniel Hind - Assistant Director Sheffield Clinical Trials Research Unit|441142220707|d.hind@sheffield.ac.uk|
20193655|NCT04379011|University of Minnesota|Dr. Ricardo Battaglino|612-625-2661|rbattagal@umn.edu|
20193656|NCT02078492|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
20193657|NCT02080546|Duke University Medical Center|Dr Paula S Lee|919-684-3765|paula.s.lee@duke.edu|
20193658|NCT00760747|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20193659|NCT00844597|Sarepta Therapeutics|Edward M. Kaye, MD, Interim CEO, SVP & Chief Medical Officer|617-274-4003|EKaye@Sarepta.com|
20193660|NCT01262547|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
20193661|NCT00723749|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
20193662|NCT00455741|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
20193663|NCT01292304|University of Florida|Giuseppe (Joseph) Morelli, MD|352-273-9508|giuseppe.morelli@medicine.ufl.edu|
20193664|NCT00243074|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fredhutch.org|
20193665|NCT00475228|University o Pittsburgh|Heather Hohmann, MD|412-641-1441|hhohmann@mail.magee.edu|
20214094|NCT02079766|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20214095|NCT00113425|University of Michigan Dept of Dermatology|Dr. Jeffrey Orringer|734-936-4075|jorringe@umich.edu|
20214096|NCT01106326|University of Rochester|Maria Fagnano|5852758220|maria_fagnano@urmc.rochester.edu|
20214097|NCT00304083|SARC|Research Project Manager|734-930-7600|sarc@sarctrials.org|
20214098|NCT01044732|Avantis Medical Systems|Jack Higgins, MD - Chief Medical Officer|6508239216|jhiggins@avantismedical.com|
20214099|NCT01765530|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-724-4490|rkacmarek@partners.org|
20214100|NCT03991494|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20214101|NCT00098371|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-9869|John.Byrd@osumc.edu|
20214102|NCT03883607|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
20214103|NCT01023074|Portland VA Medical Center|Robert Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
20214104|NCT03144687|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20214105|NCT01523899|University of California-Davis|Larissa May, MD|9167345000|lsmay@ucdavis.edu|
20214106|NCT00683293|Kantonsspital Aarau|Dimtri SARLOS|00418384141|la.kots@ksa.ch|
20214107|NCT02126306|HMO|Dr Gadi Lalazar|97226777337|lalazar@hadassah.org.il|
20214108|NCT02098993|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
20214109|NCT02507375|Hoffmann-La Roche|Medical Communications|800-821-8590||
20214110|NCT02158936|Novartis Pharma AG|Study Director|862-778-8300||
20214111|NCT00522457|Fresenius Biotech North America|Manager of Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
20214112|NCT00633256|Yale University|James Poling, Ph.D.|203-937-4830|james.poling@yale.edu|
20214113|NCT01387737|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20214114|NCT00911898|South Texas Accelerated Research Therapeutics|Dr. Muralibhar Beeram|210-593-5921|murali.beeram@stoh.com|
20214115|NCT01248247|UT MD Anderson Cancer Center|Dr. Marcelo Vailati Negrao, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 614-4938|mvnegrao@mdanderson.org|
20214116|NCT00705536|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
20214117|NCT00549718|Sunovion Pharmaceuticals Inc.|Josephine Cucchiaro|201-592-2050|josephine.cucchiaro@sunovion.com|
20214118|NCT04032977|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|clinicaltrials@prolleniumus.com|
20214119|NCT02158572|Agile Therapeutics|Michelle Previtera, Associate Director of Clinical Development|609-683-1880|mprevitera@agiletherapeutics.com|
20214120|NCT03075761|The University of Texas Southwestern Medical Center|Ayesha Zia, MD|214-456-7000|Ayesha.Zia@UTSouthwestern.edu|
20214121|NCT02880761|Continuous Quality Improvement Experts Congress of Changping District|Director of Continuous Quality Improvement Experts Congress of Changping District|+861069006549|zhangdongliang@pkuih.edu.cn|1069006789
20214122|NCT03597256|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20214123|NCT02106156|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20214124|NCT01907334|University of Florida|Leslie Hendeles, PharmD|352-273-6027|hendeles@cop.ufl.edu|
20214125|NCT00722124|Mayo Clinic|Amit Sood, MD|507-266-1944|nicotineresearch@mayo.edu|
20214126|NCT00581139|University of California, Irvine|Dr. Zeev Kain|714-480-0039|zkain@uci.edu|
20214127|NCT00560235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214128|NCT02091882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20214129|NCT03247556|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
20214130|NCT00637299|Fondazione Salvatore Maugeri|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
20214131|NCT02031978|USDA Food and Nutrition Service|Courtney Paolicelli|7036054370|Courtney.Paolicelli2@usda.gov|
20214132|NCT00051025|Eisai Call Center|Eisai Inc|888-422-4743||
20214133|NCT00274937|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20214134|NCT02189941|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
20214135|NCT00445003|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|aglassman@jaeb.org|
20193666|NCT02209181|McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.|Joseph Aquilina, MD, Senior Director, Clinical Research|(215) 273-8025|JAquilin@its.jnj.com|
20187300|NCT04231331|Asan Medical Center|Professor Duk-Hyun Kang|821030103166|dhkang@amc.seoul.kr|
20193667|NCT02579772|Queen's University|Dr. J. Alberto Neder|613-548-2255|nederalb@gmail.com|
20193668|NCT02281500|Instituto Grifols S.A.|Jordi Navarro Puerto|+34 935712200|jordi.navarro@grifols.com|
20187301|NCT01651403|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20187302|NCT04752657|Framingham Heart Study, Boston University|Joanne M Murabito, MD ScM|508-935-3461|murabito@bu.edu|
20187303|NCT05090683|University of the Fraser Valley|Dr. Cynthia Thomson|6045047441|cynthia.thomson@ufv.ca|2518
20187304|NCT04032847|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
20187305|NCT03325985|NYU Langone Health|Keith Goldfeld|(212) 263-5550|Keith.Goldfeld@nyulangone.org|
20193669|NCT00862836|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20193670|NCT00388804|UT MD Anderson Cancer|Andrew Lee, MD / Professor||lhamblin@mdanderson.org|
20193671|NCT04463680|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
20193672|NCT02592707|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
20193673|NCT03790306|Genesee Orthopedic & Hand Surgery Associates, P.C.|Andrew Wickline, MD|315-735-4496|awickline23@gmail.com|
20193674|NCT01769430|University of Maryland, College Park|Professor & Director PHAB Lab|424-246-8358|phablab@umd.edu|
20193675|NCT03429166|VA HSR&D|Amanda Borsky, PhD|2024435739|amanda.borsky@va.gov|
20193676|NCT01294397|Amgen Inc.|Study Director|866-572-6436||
20193677|NCT01661205|AtriCure, Inc.|Vice President, Clinical Operations|513-755-4562|SZink@AtriCure.com|
20193678|NCT00426127|University of Iowa|Daniel Berg, MD|319-353-7800|daniel-j-berg@uiowa.edu|
20193679|NCT00346905|Boston Scientific|Director, Endoscopy Clinical Affairs|1-508-333-1015||
20193680|NCT04191421|Emory University|Dr. Olatunji Alese, MD|404-778-6639|olatunji.alese@emory.edu|
20193681|NCT03111095|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|(206) 371-4014|khoppe2@wisc.edu|
20193682|NCT00955708|Boston Scientific|Director of Clinical Trial Management - cRM franchise|1-800-227-3422|elaine.larson@bsci.com|
20193683|NCT03738475|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20193684|NCT00737477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20193685|NCT01132820|NRG Oncology /GOG|Linda Gedeon for Michael Sill, PhD|716 845-1169|lgedeon@gogstats.org|
20193686|NCT01370655|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193687|NCT01048697|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
20193688|NCT05138289|HeartFlow|Saba Mirza|650-241-1221|smirza@heartflow.com|
20193689|NCT01735175|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
20193690|NCT00659880|RTI Surgical|Robin Waite, RN|386-418-8888|rwaite@rtix.com|
20193691|NCT01853475|Medicines for Malaria Ventire (MMV)|Dr Thomas Rueckle|+41 22 799 4567|ruecklet@mmv.org|
20193692|NCT02159040|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20163134|NCT04014062|Lambda Therapeutic Research Ltd.|Dr. Anshul Attrey, M.D. Principal Investigator|+91-79-40202020|anshulattrey@lambda-cro.com|
20193693|NCT01304498|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193694|NCT01151215|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
20193695|NCT02378038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20193696|NCT03697122|Duke University|Negmeldeen Mamoun, M.D.|919-681-3551|negmeldeen.mamoun@duke.edu|
20193697|NCT01374568|UAB|Dr. Amy Warriner|2059964004|awarriner@uabmc.edu|
20193698|NCT02269423|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193699|NCT00856245|University of Kansas Cancer Center|Siddhartha Ganguly, MD|(913) 588-6030|sganguly@kumc.edu|
20193700|NCT01443923|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
20193701|NCT01426230|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
20193702|NCT04160988|Acer Healthcare Inc.|Regulator Manager|886-6-26963131|Johnny.Lu@acer.com|5789
20193703|NCT01250509|University of California, San Francisco|Jennifer Daubenmier, PhD|415-514-8601|jennifer.daubenmier@ucsf.edu|
20193704|NCT02670122|Ramon y Cajal University Hospital. Vascular and Interventional Radiology Service|Jose Urbano Garcia, MD, PhD, EBIR, FCIRSE|+ 34 606 31 84 30|jurbano34@gmail.com ; jurbano@salud.madrid.org|
20193705|NCT03321253|Necip Fazil City Hospital|Dr. Bunyamin Kutluksaman|903442282800|bkutluksaman@gmail.com|
20193706|NCT02781649|Johns Hopkins University|Christine Durand, MD|410-955-5684|cdurand2@jhmi.edu|
20193707|NCT02762903|Columbia University|William N. Levine, MD|212-305-0998|wnl1@cumc.columbia.edu|
20193708|NCT01889069|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20193709|NCT00108745|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20193710|NCT01228175|University of Colorado Boulder|Dr. Kent Hutchison|303-492-8163|kent.hutchison@colorado.edu|
20193711|NCT03168542|Johnson & Johnson Vision Care, Inc.|Tom Karkkainen, OD MS, FAAO - Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
20193712|NCT01426347|Johns Hopkins University|Uzma Jalal Haque|410-550-0578|uhaque@jhmi.edu|
20193713|NCT00664534|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20193714|NCT01715207|SamsungMC|Prof Duk-Kyung Kim|01099333413|dukkyung.kim@samsung.com|
20193715|NCT03041792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193716|NCT04978090|University of Kentucky|Dr. Andrew Bernard|859-257-3253|andrew.bernard@uky.edu|
20193717|NCT03745898|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
20193718|NCT02227992|Ethicon, Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20193719|NCT00561145|Wageningen University|Dr Lisette de Groot|+31-317482220|lisette.degroot@wur.nl|
20193720|NCT00935532|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20193721|NCT04263987|Vanderbilt University Medical Center|Nicholas kavoussi|615-322-7401|nicholas.l.kavoussi@vumc.org|
20193722|NCT01691950|Imperial College London|Mr Richard M Kwasnicki PhD MRCS|+44 (0) 20 759 48904|rmk107@ic.ac.uk|
20193723|NCT01371708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
20193724|NCT00402051|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20193725|NCT02142153|F2G|Dr Anthony Kennedy|0044 161 785 1273|TKennedy@f2g.com|
20193726|NCT01791972|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|1-215-591-3000|ustevatrials@tevapharm.com|
20193727|NCT00632502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193728|NCT04954326|Institut de Recherches Internationales Servier|Therapeutic Area in Oncology|+33155724366|clinicaltrials@servier.com|
20193729|NCT00277095|Uromedica|Sabitha R Shriram|763-694-9880|sshriram@uromedica-inc.com|216
20193730|NCT04363957|University of California, San Diego|Dr. Jyoti Mayadev|(858) 822-5354|CancerCTO@health.ucsd.edu|
20193731|NCT00921947|VaxInnate|Dr. David N.Taylor|609-860-2260|david.taylor@vaxinnate.com|
20193732|NCT00281320|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20193733|NCT00338988|University Texas MD Anderson Cancer Center|Melanie Thomas, MD/Assistant Professor|713-794-4869|mjlim@mdanderson.org|
20193734|NCT00975676|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director Dr. Heidi Roschitzki-Voser Organization|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
20193735|NCT02548078|GlaxoSmithKline|GSK Response Center|866-435-7343|aal77632@gsk.com|
20193736|NCT03128671|University of Miami|Cindy Munro|305-284-2107|cmunro@miami.edu|
20193737|NCT04072445|Mayo Clinic|Dr. Amit Mahipal|507-293-0487|Mahipal.Amit@mayo.edu|
20193738|NCT04641962|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20193739|NCT02171247|Duke University Medical Center|Daniel T Boll, MD|919-684-2711|daniel.boll@duke.edu|
20193740|NCT05472740|Duke University|Amelia Scott, Research Program Leader|(919) 613-4584|amelia.lorenzo@duke.edu|
20193741|NCT03832595|University of Pittsburgh|Dr. Manisha Jhamb|4126477062|jhambm@upmc.edu|
20193742|NCT03277352|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20193743|NCT04147195|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20193744|NCT06926673|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20193745|NCT01424813|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20214136|NCT00528606|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20214137|NCT03656783|Brigham and Women's Hospital|Marcelo Di Carli, MD|6177326290|mdicarli@bwh.harvard.edu|
20214138|NCT01918397|Boston University School of Public Health|Charles R Horsburgh, MD|617-414-1282|rhorsbu@bu.edu|
20214139|NCT00880568|Merck Sharp & Dohme|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20214140|NCT00620022|Novartis Pharmaceuticals|Study Director|862 778-8300||
20214141|NCT01423760|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20193746|NCT03939689|Lantheus|June Li, Vice President, Biometrics and Data Sciences|978-671-8107|lij@lantheus.com|
20193747|NCT04427280|The Royal Marsden NHS Foundation Trust|Senior Trial Manager (for the CARDS study)|020 8642 6011|gi.trials@rmh.nhs.uk|3807
20214142|NCT00959660|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
20214143|NCT00496964|Virginia Commonwealth University|Dr. Sheryl Finucane|804-628-3639|sfinucan@vcu.edu|
20214144|NCT00705003|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
20214145|NCT02017964|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20214146|NCT02005536|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20214147|NCT00193037|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
20214148|NCT00150462|Amgen, Inc.|Study Director|866-572-6436||
20214149|NCT00569374|University of Arkansas for Medical Sciences Center for Addiction Research|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20193748|NCT05310201|Medical University of South Carolina|Angela Moreland, PhD|8437928209|moreland@musc.edu|
20193749|NCT04944290|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
20193750|NCT03388268|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
20214150|NCT01212874|Loma Linda University Anesthesiology|Patricia Moore|1-909-558-4475|pamoore@llu.edu|
20214151|NCT04638153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214152|NCT02829268|Washington University School of Medicine, Department of Medicine, Division of Endocrinology|Fumihiko Urano, MD, PhD|314-362-8683|urano@wustl.edu|
20214153|NCT01440283|St. Jude Children's Research Hospital|Chia-ho Hua, PhD|901-595-3610|chia-ho.hua@stjude.org|
20214154|NCT03021538|Cleveland Clinic|Michael Tong, M. D.|216-445-0807|tongz@ccf.org|
20214155|NCT01327963|EndoGastric Solutions|Adrian Lobontiu, Chief Medical Officer|1 650-474-9259|alobontiu@endogastricsolutions.com|
20214156|NCT03099538|Mayo Clinic|Aaron R. Mangold, MD|480-301-4256|mangold.aaron@mayo.edu|
20214157|NCT02015390|Texas Medical Branch, University of, Galveston|Study PI|409-747-5760|zgugala@utmb.edu|
20214158|NCT01878825|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214159|NCT01361048|UAB|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
20214160|NCT01661686|Erasmus University Medical Center|Dr. V.M.C.W. Spaander|0031 10 703 5643|v.spaander@erasmusmc.nl|
20214161|NCT04753710|Sintetica SA|Roberta Bianchi|0041 91 640 42 50|rbianchi@sintetica.com|
20214162|NCT00877032|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214163|NCT03752528|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
20214164|NCT04056182|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frances.levin@nyspi.columbia.edu|
20214165|NCT00259012|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20214166|NCT00076050|University of Miami|Silvina Levis MD|305-575-3388|slevis@med.miami.edu|
20214167|NCT02781727|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
20214168|NCT00487669|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
20214169|NCT01378975|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20193751|NCT02296502|University of Pittsburgh|Benjamin L Handen, PhD|412-235-5445|handenbl@upmc.edu|
20214170|NCT02304432|McLean Hospital|Dr. Deborah Levy|617-855-2854|dlevy@mclean.harvard.edu|
20214171|NCT00694551|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-4398|mayer.fishman@moffitt.org|
20214172|NCT01312922|ANeuroTech|Dr. E. Buntinx, MD|+32 (0) 473 861 079|erik.buntinx@aneurotech.com|
20214173|NCT01937390|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214174|NCT00515203|Amgen Inc.|Study Director|866-572-6436||
20214175|NCT00860314|University Hospital Hamburg-Eppendorf, Heart Center|Tim Risius, MD|+49-40-42803|risius@uke.uni-hamburg.de|4142
20214176|NCT03154658|University of Texas Southwestern|Anthony Machi M.D.|2146486400|anthony.machi@utsouthwestern.edu|
20214177|NCT02817841|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
20193752|NCT01667926|Massachusetts General Hospital|Dr. Cristina Cusin|6177263855|ccusin@mgh.harvard.edu|
20193753|NCT04227145|Children's Mercy Kansas City|Emily Hurley|(816) 731-7093|eahurley@cmh.edu|
20193754|NCT02271984|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20193755|NCT01088984|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20193756|NCT03312023|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel V. Chua|1-410-706-5704|jchua@ihv.umaryland.edu|
20193757|NCT04079868|Durham VA Geriatric Research Education and Clinical Center|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colon-emeric@va.gov|6932
20214178|NCT04742283|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20214179|NCT00397488|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20214180|NCT02424097|UCSF - School of Dentistry|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
20214181|NCT01458561|CryoLife, Inc.|Scott B. Capps, Vice President, Clinical Research|770-419-3355|capps.scott@cryolife.com|
20214182|NCT01215981|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
20214183|NCT02943447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20214184|NCT02606708|New York University School of Medicine|Carmen Perez, MD|212 731 5003|carmen.perez@nyumc.org|
20214185|NCT00840632|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214186|NCT01794039|Mayo Clinic|Shaji K. Kumar, M.D.|(507) 284-2017|kumar.shaji@mayo.edu|
20214187|NCT01136382|AstraZeneca|Geoff Gilmartin||ClinicalTrialTransparency@astrazeneca.com|
20214188|NCT02562378|Medica Scientia Innovation Research (MEDSIR)|Scientific director|+34 93 221 41 35|trialsregister.medsir@medsir.org|
20214189|NCT04503603|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20214190|NCT01725529|Janssen R&D US|ASSOCIATE DIRECTOR, MEDICAL DEPARTMENT||ClinicalTrialDisclosure@its.jnj.com|
20214191|NCT01104025|Cincinnati Children's Hospital Medical Center|Michael Jordan, MD|513-803-9063|Michael.Jordan@cchmc.org|
20214192|NCT04927013|Emory University|Yue Guan, PhD|404-712-1671|yue.guan@emory.edu|
20214193|NCT02653664|University of Washington|Dr. Mark Jensen|206-543-3185|mjensen@uw.edu|
20214194|NCT04657770|UCLA|Steve Cramer|424-522-7273|SCCramer@mednet.ucla.edu|
20214195|NCT00746798|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20214196|NCT00878878|GE Healthcare|Ruben Sheng, M.D.|1-609-514-6899|Rubin.Sheng@ge.com|
20214197|NCT00633594|Sarah Cannon Research Institute|Ian Flinn, MD|1-877-691-7274|asksarah@scresearch.net|
20214198|NCT00556049|MGH Cancer Center|Dr. M. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
20214199|NCT00727571|Amgen Inc.|Study Director|866-572-6436||
20214200|NCT01287013|National Institutes of Health|Bradford Wood, MD|(301) 496-7739|bwood@nih.gov|
20214201|NCT01900730|UT MD Anderson Cancer Center|Dr. Wendy Woodward, PHD/ Professor, Radiation Oncology Department|713-563-8481|wwoodward@mdanderson.org|
20214202|NCT01179048|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20214203|NCT02109042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214204|NCT01163760|Vistakon|Kurt Moody OD, FAAO|904-443-3088||
20214205|NCT03203447|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20214206|NCT00324168|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
20214207|NCT01203878|Tennessee Clinical Research Center|Medical Director|615-383-2400|jbiron@tnclinicalresearch.com|
20214208|NCT01471093|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20214209|NCT02475954|Rutgers - Robert Wood Johnson Medical School|Roseanne D. Dobkin|732-235-4051|dobkinro@rutgers.edu|
20214210|NCT00874887|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20214211|NCT03503578|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
20214212|NCT00358449|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214213|NCT01804270|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
20214214|NCT00978822|Albany Medical Center|Panayiotis Varelas|2488739855|varelap@amc.edu|
20214215|NCT01469767|Wake Forest University Health Sciences|Steve Feldman MD|336-716=3775|sfeldman@wakehealth.edu|
20214216|NCT02006160|UBMD Neurology|Dr. Ralph Benedict|7163230556|benedict@buffalo.edu|
20214217|NCT04407806|William Beaumont Hospital|Dr. Graham Krasan, Pediatric Infectious Disease Specialist|248-551-0046|graham.krasan@beaumont.org|
20214218|NCT01541891|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medical Director|+52 (33)30014200|leopoldo.baiza@sophia.com.mx|
20214219|NCT03478397|CEDES|Dr. Silvina Arrossi|541148651007|silviarrossi2020@gmail.com|
20214220|NCT05327491|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20214221|NCT04869787|Cincinnati Children's Hospital Medical Center|Dr. Stuart L.Goldstein|513-636-4837|stuart.goldstein@cchmc.org|
20214222|NCT00813293|Beth Israel Deasoness Medical Center|Andrea Bullock MD, MPH||abullock@bidmc.harvard.edu|
20214223|NCT00533273|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20214224|NCT02794974|HELIOS Medical Center Schwerin, Germany|Ronald Seidel|+49 385 5204251|ronald.seidel@helios-kliniken.de|
20214225|NCT05194722|Washington University School of Medicine|Abby Cheng, MD, PI|314-747-2823|chengal@wustl.edu|
20214226|NCT01873586|SeaSpine|Director Clinical Affairs||tish.mikoczi@seaspine.com|
20214227|NCT02202850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20214228|NCT00615069|W.L. Gore and Associates|Jennifer Gorman|928 864 3381|jgorman@wlgore.com|
20214229|NCT00454909|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214230|NCT02996682|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20214231|NCT01981720|Protalix Ltd.|Sari Alon MSc|+972-4-9028100|sari@protalix.com|215
20214232|NCT00282048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214233|NCT02703948|Galderma R&D, LLC|US A&C Clinical Operations|8179615111|courtney.maguire@galderma.com|
20214234|NCT02980978|Minneapolis Heart Institute Foundation|Population Health Program Manager|612-863-4222|gbenson@mhif.org|
20214235|NCT03048500|Northwestern University|Young Chae, MD|312-695-1301|young.chae@northwestern.edu|
20214236|NCT01941030|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
20214237|NCT04166032|Cleveland Clinic|Kimberly Jenkins, Research Administrator|216-445-4791|jenkink@ccf.org|
20214238|NCT01884740|Weill Cornell Medicine|Jeffery Greenfield, MD PhD|212-746-2363|jpgreenf@med.cornell.edu|
20214239|NCT00870870|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214240|NCT03005522|Banner University Medical Center|Dr Noah Tolby|520-694-8888|ntolby@aemrc.arizona.edu|
20214241|NCT01918800|Portland VA Medical Center|Cinda Hugos|503-220-8262|hugosc@ohsu.edu|52338
20214242|NCT03639311|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20214243|NCT00822926|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20214244|NCT04881968|The Dartmouth Institute|Dr. Amber Barnato|603-646-5237|amber.barnato@dartmouth.edu|
20214245|NCT03125200|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20214246|NCT01874951|Depression Clinical and Research Program, Massachusetts General Hospital|David Mischoulon, MD, PhD, Director of Research|617-724-5198|dmischoulon@partners.org|
20214247|NCT03544138|Preceptis Medical|Steve Anderson|612-327-4795|steve@preceptismedical.com|
20214248|NCT04190693|Imcyse SA|Jean Van Rampelbergh|+3243251100|j.vanrampelbergh@imcyse.com|
20214249|NCT05017480|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
20214250|NCT00963482|Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel|M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)|+41 61 325 53 33|sandra.mueller@upkbs.ch|
20214251|NCT02028715|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
20214252|NCT01710657|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20214253|NCT03334825|New York City Department of Health and Mental Hygiene|Dr. Ellen Wiewel|347-396-7653|ewiewel@health.nyc.gov|
20214254|NCT02188303|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214255|NCT02589808|Imperial College|Petros Nihoyannopoulos|020 3311 3311|p.nihoyannopoulos@imperial.ac.uk|
20193758|NCT01757197|Weill Cornell Medicine|Usama Gergis, MD|(212) 746-2119|usg2001@med.cornell.edu|
20214256|NCT04206332|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20214257|NCT02334722|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
20214258|NCT01644058|Université de Montréal|Elham Emami, DDS, MSc, PhD|514-343-6111|elham.emami@umontreal.ca|6053
20214259|NCT05612724|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
20214260|NCT01969747|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214261|NCT03112863|UC Davis Dermatology|Iryna Rybak|916-551-2636|irybak@ucdavis.edu|
20214262|NCT04000815|Dr.Ali Cenk Ozay|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
20214263|NCT00239577|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214264|NCT02631772|Medical University of South Carolina|Dr. Derek Dubay|843-792-3368|dubay@musc.edu|
20214265|NCT02422264|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20214266|NCT03021018|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20214267|NCT00840099|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214268|NCT00856388|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20214269|NCT02163837|Chu St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@stpierre-bru.be|
20214270|NCT01617668|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20214271|NCT00925769|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20214272|NCT01171690|Mayo Clinic|Marius Stan, MD|507-284-2463|stan.marius@mayo.edu|
20214273|NCT01038856|University of Oklahoma|Research Regulatory Specialist III|405-271-8777|sharon-ross@ouhsc.edu|48394
20214274|NCT02300103|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20214275|NCT04091971|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
20214276|NCT01666730|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. David Bajor|1-800-641-2422|CTUReferral@UHhospitals.org|
20214277|NCT03553823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20214278|NCT03603314|Sensorion|Director of Regulatory Affairs|+33467207720|contact@sensorion-pharma.com|
20214279|NCT01389102|KV Pharmaceutical Company|Jim Joffrion|314-645-6600|jjoffrion@kvph.com|3410
20193759|NCT05332912|University of Alabama, Tuscaloosa|Professor Emeritus|2052002183|emerrill@ua.edu|
20193760|NCT01174446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20214280|NCT03450070|Johnson & Johnson Consumer Inc.|Heather Smith|908-874-1235|HSmith21@its.jnj.com|
20214281|NCT00050778|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20214282|NCT00999037|University of California at Los Angeles|Katherine Wesseling-Perry|310-206-6987|kwesseling@mednet.ucla.edu|
20214283|NCT02910037|The University of California, San Francisco|Dr. Charles Chiu|(415) 514-8219|charles.chiu@ucsf.edu|
20214284|NCT00436553|Novartis Pharmaceuticals|Study Director|862 778-8300||
20214285|NCT01035060|University of Florida|Dr. Thomas Buford|352-273-5918|tbuford@ufl.edu|
20214286|NCT02770625|ISU ABXIS Co., Ltd.|Taekseung Kim|+82.31.696.4715|kimts@isu.co.kr|
20214287|NCT00064753|University of North Carolina at Chapel Hill|Dr. Myra Carpenter|9199429408|myra_carpenter@unc.edu|
20214288|NCT01346397|Boris Petrovsky research cener od surgery|Dr Michael Kaabak|+74992481344|kaabak@hotmail.com|
20214289|NCT02193880|University of Alabama at Birmingham|Tiffany D Hill|205-996-8023|tiffanydhill@uabmc.edu|
20214290|NCT03522675|NeXtGen Biologics, Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
20214291|NCT00707161|Huntsman Cancer Institute|Dennis Shrieve, MD|801-581-8793|dennis.shrieve@hci.utah.edu|
20214292|NCT02674477|Johns Hopkins University|Dr. Alexis Hammond|410-550-0045|ahammon9@jhmi.edu|
20214293|NCT00296647|UW-Center for Tobacco Research and Intervention|Stevens Smith, PhD|608-262-7563|sss@ctri.medicine.wisc.edu|
20214294|NCT00565448|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20214295|NCT01863745|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20214296|NCT00193609|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20214297|NCT01157091|City of Hope|Dr. Sumanta Pal|626-359-8111|SPal@coh.org|
20214298|NCT00735904|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214299|NCT03865654|Dana-Farber Cancer Institute|Rachel Freedman, M.D., M.P.H.|617-632-3800|rafreedman@partners.org|
20214300|NCT02543554|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wustl.edu|
20214301|NCT03361228|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20214302|NCT03660839|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20214303|NCT00720330|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20214304|NCT03693430|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20214305|NCT00585689|University of Michigan Comprehensive Cancer Center|Dr. David Smith, M.D.|734-936-6884|dcsmith@umich.edu|
20214306|NCT02930005|The University of Texas Health Science Center at Houston|Dr. Olaoluwa O. Okusaga|(713) 741-3952|Olaoluwa.O.Okusaga@uth.tmc.edu|
20214307|NCT02373098|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email.@novartis.com|
20214308|NCT01658228|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
20214309|NCT03252353|Chiasma|Asi Haviv, VP Clinical development|972-8-939-3888|Asi@chiasmapharma.com|
20214310|NCT01709474|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20214311|NCT00855738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214312|NCT03097783|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20214313|NCT03151057|Northwell Health Cancer Institute|Dr. Douglas Gladstone|(516) 734-8900|msteve35@jhmi.edu|
20214314|NCT00699491|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@im.wustl.edu|
20214315|NCT02287675|Kettering Health Network|Dr. Arash Kardan|937-395-8611|arash.kardan@ketteringhealth.org|
20214316|NCT00319735|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20214317|NCT01320696|Resilience Inc.|Wael El-Amin, M.D.|(240)885-1221|Wael.el-amin@resilience.com|
20214318|NCT00119379|University Hospitals Case Medical Center|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
20214319|NCT00154102|Merck Serono|Monika Foerster/Clinical Trial Leader|+496151729517|monika.foerster@merck.de|
20214320|NCT01811953|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214321|NCT02110277|UConn Health|Dr.Molly Brewer|860-679-2100||
20214322|NCT01721681|Bio Products Laboratory Ltd|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
20214323|NCT02055963|UT MD Anderson Cancer Center|Dr. Juan P. Cata, MD-Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
20214324|NCT02533258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214325|NCT03655106|William Beaumont Hospitals|Amit Bahl, MD|2488982245|amit.bahl@beaumont.edu|
20214326|NCT03921294|Indiana Hemophilia & Thrombosis Center|Kat Molitor|3178710011|kmolitor@ihtc.org|
20214327|NCT01049334|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
20214328|NCT01297348|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20214329|NCT01367457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|001
20214330|NCT03447262|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20214331|NCT02058498|Mayo Clinic Jacksonville|Jennifer Serotta, DNP, ARNP|904-956-3200|serotta.jennifer@mayo.edu|
20214332|NCT03988803|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214333|NCT00603187|University of Washington|Dr. John K. Amory|206.616.1727|jamory@u.washington.edu|
20214334|NCT01173211|Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
20214335|NCT01032083|Imperial College London|Professor Thomas Barnes||t.r.barnes@imperial.ac.uk|
20214336|NCT05038293|University of Washington Department of Periodontics|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
20214337|NCT01171989|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214338|NCT02822235|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20214339|NCT00627016|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20214340|NCT00829530|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214341|NCT05439252|University of Bath|Dr Oliver Perkin|01225384356|o.j.perkin@bath.ac.uk|
20214342|NCT04466111|SGX Medical|VP of Clinical|818-527-2710|clinical@sgxmedical.com|
20214343|NCT02379247|University of Kansas Medical Center|Dr. Priyanka Sharma|9135886079|psharma2@kumc.edu|
20214344|NCT01382719|Palatin Technologies, Inc.|Jeffrey Edelson, MD, FRCPC|(609) 495-2200|jedelson@palatin.com|
20214345|NCT02511782|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
20214346|NCT00112463|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
20214347|NCT01171963|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214348|NCT05093205|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214349|NCT00360360|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-MY-1-SCRI|asksarah@scresearch.net|
20214350|NCT00401778|Emory University|Suresh S. Ramalingam, MD|404-778-5378|ssramal@emory.edu|
20214351|NCT02979353|Vanderbilt University Medical Center|Sandra F Simmons, PhD, Principle Investigator|615-343-6729|sandra.simmons@vumc.org|
20214352|NCT02597101|Allegheny Health Network|Dr. Nick Giannoukakis|412-359-6394|nick.giannoukakis@ahn.org|
20214353|NCT01722877|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633200263|shammas@mchsi.com|
20214354|NCT00985257|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20214355|NCT02265783|Medtronic|Michael Luna-Victoria|3033052463|michael.luna-victoria@medtronic.com|
20214356|NCT05067647|Ethicon Endo-Surgery, Inc.|MEDICAL DIRECTOR LCM Compliance|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20214357|NCT03897088|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
20214358|NCT01874756|Indiana University|Dr. Alan Breier|3178808495|abreier@iupui.edu|
20214359|NCT04320849|Duke University Medical Center|Dr. Jonathan Piccini|919-668-8049|jonathan.piccini@duke.edu|
20214360|NCT00323193|VA VISN 5 Mental Illness Research, Education and Clinical Center|Richard W. Goldberg, Ph.D.|410-637-1851|richard.goldberg@va.gov|
20214361|NCT03929393|University of Minnesota|Brent Leininger|(612) 626-6477|lein0122@umn.edu|
20214362|NCT01314742|Vanderbilt University Sch of Medicine|Dr. Beatrice Stefanescu|6159365933|beatrice.stefanescu@Vanderbilt.edu|
20214363|NCT02268500|University of Minnesota|Orly Vardeny, Associate Professor of Medicine|612.467.4586|ovardeny@umn.edu|
20214364|NCT02227121|Medtronic Cardiac Rhythm and Heart Failure|Griet Wouters|800-328-2518|MedtronicCRMtrials@medtronic.com|
20214365|NCT03929367|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
20214366|NCT01569152|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
20214367|NCT01706536|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20214368|NCT03262012|AstraZeneca|Paul M. Dorinsky, MD|1-877-240-9479|information.center@astrazeneca.com|
20214369|NCT03187002|Stanford University|Research Manager|6507211567|fpresearch@stanford.edu|
20214370|NCT01469546|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
20214371|NCT01096290|University of South Alabama|Jack DiPalma, MD|251-660-5555|jdipalma@health.southalabama.edu|
20214372|NCT00385684|Tuscaloosa VA Medical Center|Andrea L. Snow|205-554-2000|lynn.snow@va.gov|2260
20214373|NCT02801877|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
20214374|NCT00463606|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20214375|NCT01223365|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20214376|NCT02682602|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
20214377|NCT02140060|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20214378|NCT03325114|University of Rochester|Carrie Dykes|15852750736|carrie_dykes@urmc.rochester.edu|
20214379|NCT00520130|National Cancer Institute|Dr. Steven Z. Pavletic|301- 402-4899|sp326h@nih.gov|
20214380|NCT04915755|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20214381|NCT01191320|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20214382|NCT01993030|The Second Xiangya Hospital of Central South University|Dr. Li Qian|+86-13958104032|649418291@qq.com|
20214383|NCT02736721|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20214384|NCT01838941|McGill University Health Centre|Dr. Nancy Braverman, Associate Professor, Human Genetics and Pediatrics|(514) 934-1934|nancy.braverman@mcgill.ca|23404
20214385|NCT01034358|Mayo Clinic|Jeanne Tung, MD|507-266-0114|tung.jeanne@mayo.edu|
20214386|NCT02968992|Johns Hopkins University|Jeremy D. Waltson, MD|410-550-1003|jwalston@jhmi.edu|
20214387|NCT01534663|University Hospital Jena|Christian Schulze, MD, PhD|03641-9 32 41 04|christian.schulze@med.uni-jena.de|
20214388|NCT02535611|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
20214389|NCT04088760|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD|(513) 803-1139|Rebecca.Marsh@cchmc.org|
20214390|NCT00377260|Children's Hospital of Pittsburgh of UPMC|Efficacy of Antimicrobials in Young children with Acute Otitis Media|412-692-5249|Hoberman@chp.edu|
20214391|NCT01391793|UPMC Children's Hospital of Pittsburgh|Nader Shaikh, MD, MPH|412-692-8111|nader.shaikh@chp.edu|
20214392|NCT01015625|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
20214393|NCT05600322|Photocure ASA|Clinical Director|+4722062210|research@photocure.com|
20214394|NCT03136380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20214395|NCT00830232|Dallas VA Medical Center|Dr. Carlos H Timaran|2148570336|carlos.timaran@va.gov|
20214396|NCT03834870|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
20163135|NCT03038126|University of Maryland Baltimore|Jeffrey C. Fink, MD MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
20214397|NCT02419937|United States Air Force|Dr. Matthew B. Carroll|228-376-3829|mcar100210@yahoo.com|
20214398|NCT02457520|SPIL|Clinical Trials|912266455645|Clinical.Trials@sparcmail.com|
20214399|NCT00286754|Department of Veterans Affairs|Sundar Natarajan, MD, Staff Physician|212-686-7500|Sundar.Natarajan@va.gov|3287
20214400|NCT02661295|NYU Langone Health|Candace Grant, MD|516-663-0333|candace.grant@nyulangone.org|9054
20214401|NCT00910663|TEVA Pharmaceuticals USA|Associate DIrector, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214402|NCT02726581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20214403|NCT02865850|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
20214404|NCT02024646|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
20214405|NCT01844375|Faculty of Medicine siriraj Hospital|Dr.Mingkwan Wongyingsinn|6624197995|mingkwan.won@mahidol.ac.th|
20214406|NCT00176306|University of Kentucky|Aaron Cook|8593239258|amcook0@email.uky.edu|
20214407|NCT01772537|The Johns Hopkins University|Dr. Charles Brown|410-955-0994|cbrown@jhmi.edu|
20214408|NCT03627091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20214409|NCT00450190|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20214410|NCT01536574|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214411|NCT01376167|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214412|NCT00834756|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214413|NCT00656305|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20214414|NCT02193165|Colgate Palmolive|William Devizio|732-878-7901|william_devizio@colpal.com|
20214415|NCT04239872|University of Michigan School of Dentistry|Dr. Livia Tenuta|734-763-3703|litenuta@umich.edu|
20214416|NCT03541941|Cleveland Clinic Foundation|Dr. Michael Rosen|216-445-3441|rosenm@ccf.org|
20214417|NCT01498120|UCB BIOSCIENCES GmbH|Clinical Trial Registries and Results Disclosure|40789+49 2173 48|clinicaltrials@ucb.com|15 15
20214418|NCT01173692|UT MD Anderson Cancer Center|Brandon Gunn, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2562|gbgunn@mdanderson.org|
20214419|NCT01472341|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20214420|NCT00579670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214421|NCT04365153|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
20214422|NCT03115177|Rush University Medical Center|Dr. Allison Rao|608-445-0545|allison.rao@gmail.com|
20214423|NCT01118312|Johns Hopkins University|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
20214424|NCT00678639|Wake Forest University Baptist Medical Center|Chadwick Miller, MD|336-716-1740|cmiller@wfubmc.edu|
20214425|NCT02642835|Medway NHS Foundation Trust|Professor Jonaathan Duckett -Consultant Urogynaecologist|01634|jraduckett@hotmail.com|835154
20214426|NCT03506386|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20214427|NCT01546545|Pennington Biomedical Research Center|Jeffrey Gimble, MD, PhD|225-763-3000|doctors@pbrc.edu|
20214428|NCT04060147|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20214429|NCT00986245|Seoul National University Hospital|BS Jeon|82-2-2072-2876|brain@snu.ac.kr|
20214430|NCT01214850|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20214431|NCT00610363|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20214432|NCT03204539|UC Davis|Dr. Jonathan Ducore|916-734-3461|jmducore@ucdavis.edu|
20214433|NCT03221374|Carnegie Mellon University|Dr. Bin He|412-268-9857|bhe1@andrew.cmu.edu|
20214434|NCT00818337|Creighton University|Kathleen Packard, PharmD|402-280-2668|kpackard@creighton.edu|
20214435|NCT02519491|University of Ottawa Heart Institute|Dr. Benjamin Hibbert, Cardiologist|613-696-7000|bhibbert@ottawaheart.ca|
20214436|NCT02567968|University of Chicago|Aaron Fox, PhD|7737020021|aaronfox@uchicago.edu|
20214437|NCT00302952|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20214438|NCT00336479|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20214439|NCT00550537|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn, Principal Investigator||leora.horn@vanderbilt.edu|
20214440|NCT02008565|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
20214441|NCT00268905|Eisai|Prash Krishna, Study Director|888-422-4743||
20214442|NCT00617305|Gilead Sciences|Ellen Shen, PhD, Senior Manager, Regulatory Affairs|+1 (650) 522-5278|Ellen.Shen@gilead.com|
20214443|NCT02193178|CooperVision, Inc.|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
20214444|NCT03435081|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214445|NCT00420238|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20214446|NCT00048581|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20214447|NCT01406795|Stanford University|Rusty Hofmann|6507366096|lhofmann@stanfordhealthcare.org|
20214448|NCT03966365|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20214449|NCT02228174|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
20214450|NCT03567174|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
20214451|NCT06090461|Currax Pharmaceuticals LLC|SVP, Chief Medical Officer|708.834.8254|mkyle@curraxpharma.com|
20214452|NCT06358820|Gaozhou People's Hospital|Shanshan Deng|13927596600|276531255@qq.com|
20214453|NCT04298918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20214454|NCT05376319|Mayo Clinic|Ulrich Specks, M.D.|507-284-2494|specks.ulrich@mayo.edu|
20214455|NCT01124175|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214456|NCT00942968|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193761|NCT02413645|Hospital Clinic-HIVACAT|Dr. Felipe Garcia|932275400|fgarcia@clinic.cat|2844
20193762|NCT05000216|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20193763|NCT03119233|Endologix|Tammy Stiver, Manager, Clinical Affairs|5136731452|tstiver@endologix.com|
20193764|NCT02057575|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
20193765|NCT00332462|Novartis Pharmaceuticals|Study Director|862-778-8300||
20193766|NCT02922023|University of Florida Colleges of Pharmacy and Medicine|Katherine Vogel Anderson, Pharm.D., BCACP, FCCP|352-273-6240|kvanderson@cop.ufl.edu|
20193767|NCT00863681|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20193768|NCT03842228|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
20193769|NCT01263509|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20193770|NCT05071053|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20193771|NCT02593123|Virginia Commonwealth University Massey Cancer Center|Dr. Amir Toor, Principal Investigator|804 828 5116|amir.toor@vcuhealth.org|
20193772|NCT03993210|DFCI|Clare Tempany|617-732-7858|ctempany@bwh.harvard.edu|
20193773|NCT01193010|Massachusetts General Hospital|Rachel Gottlieb, Clinical Research Coordinator|617.724.4985|rgottlieb3@mgh.harvard.edu|
20193774|NCT01445327|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
20193775|NCT01602510|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193776|NCT00895895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193777|NCT01001390|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-966-5934|info@stjude.org|
20193778|NCT01261000|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
20193779|NCT03019640|Yago Nieto, PhD / Stem Cell Transplantation Department|UT MD Anderson Cancer Center|713-792-8750|ynieto@mdanderson.org|
20193780|NCT01016847|Duke Asthma Allergy and Airway Center|Monica Kraft, M.D.|9194790719|denise.beaver@dm.duke.edu|
20193781|NCT01621776|University of Florida|Janet Silverstein, MD|352-334-1390|silvejh@peds.ufl.edu|
20193782|NCT01495572|National Cancer Institute|Udai Kammula M.D.|301-435-8606|kammulau@mail.nih.gov|
20193783|NCT04916730|University of California, San Diego|Michael J. Wilkinson, MD|(858)246-2510|mjwilkinson@health.ucsd.edu|
20193784|NCT02138097|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193785|NCT02514551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20193786|NCT00996606|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20193787|NCT00167206|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
20193788|NCT00305344|University of Florida|Dr Michael Haller|352.273.9264|hallemj@peds.ufl.edu|
20193789|NCT01213524|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
20214457|NCT04408586|Mayo Clinic|Andres J. Acosta, M.D., Ph.D.|507-266-6931|Acosta.Andres@mayo.edu|
20214458|NCT00428298|Johns Hopkins UNiversity School of Medicine|Jennifer L. Payne MD|410-502-0050|jpayne5@jhmi.edu|
20214459|NCT01340495|Massachusetts General Hospital|Shannon MacDonald, MD|617-643-7250|SMACDONALD@mgh.harvard.edu|
20214460|NCT00070291|ECOG Statistical Office|Study Statistician|617-632-3012||
20214461|NCT02262377|Boston Medical Center|Paula Gardiner|414-6267|Paula.GardinerMD@gmail.com|617
20214462|NCT01045096|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20193790|NCT00630734|University of Colorado Denver|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
20214463|NCT00156247|UMDNJ-Robert Wood Johnson Medical School|Melissa Magliocco, MD|(732) 235-5735|maglioma@umdnj.edu|
20214464|NCT01511939|Arthritis Treatment Center|Manager, Clinical Research Department|301-624-1168|tgillis@arthritistreatmentcenter.com|
20214465|NCT03649841|University of Washington|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
20214466|NCT03497897|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@novartis.com|
20214467|NCT03618147|Kuwait Society of Allergy & Clinical Immunology|Kuwait Society of Allergy & Clinical Immunology|0096524636478|walherz@hsc.edu.kw|
20214468|NCT01529060|Baylor|Alyssa Tran, BS|832-822-4264|alyssat@bcm.edu|
20214469|NCT00723528|Janssen Research & Development, LLC|Senior Director, Clinical Development|793-7633||215
20214470|NCT02962934|University of Queensland Center for Clinical Research|Professor Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
20214471|NCT02627924|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20214472|NCT01033565|University of Nebraska|Howard Needelman MD|402-559-4097|hneedelm@unmc.edu|
20214473|NCT01591785|Icahn School of Medicine at Mount Sinai|Gary Goldenberg, MD|212-241-6500|garygoldenbergmd@gmail.com|
20214474|NCT00667862|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20214475|NCT05087524|University of Wisconsin - Madison|Dr. Ellen Wald|(608) 263-8558|erwald@pediatrics.wisc.edu|
20214476|NCT03979079|Institut Bergonié|Dr Carine Bellera|33 0 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
20214477|NCT00546897|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20214478|NCT01819597|Cedars-Sinai Medical Center|Nestor Gonzalez, MD. Professor of Neurosurgery|310 423 0783|nestor.gonzalez@cshs.org|
20214479|NCT00987948|Hawaii Center for AIDS, University of Hawaii|Dr. Cecilia M Shikuma|8086921328|shikuma@hawaii.edu|
20214480|NCT02495857|Teva Pharmaceuticals Inc. USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
20214481|NCT02440308|Stanford Healthcare|Dr. Andrei Iagaru, Chief of the Division of Nuclear Medicine and Molecular Imaging|650-725-4711|aiagaru@stanford.edu|
20214482|NCT02883452|Celltrion, Inc.|SungHyun Kim|+82 32 850 5778|sunghyun.kim@celltrion.com|
20214483|NCT04257474|Moffitt Cancer Center|Susan T. Vadaparampil, PhD, MPH|813-745-1997|Susan.Vadaparampil@moffitt.org|
20214484|NCT00517530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20214485|NCT00667095|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|peterou.steven@mayo.edu|
20214486|NCT01520909|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214487|NCT00374335|Children's Mercy Hospitals and Clinics|Dr. Kimberly Horii|816-234-3924|kahorii@cmh.edu|
20214488|NCT01882257|University of Michigan Health System|Robert G. Sitrin, M.D.|(734) 936-5201|rsitrin@umich.edu|
20214489|NCT00830206|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214490|NCT01375660|Jesse Brown VA Medical Center|Dr. Barengolts, Attending Endocrinologist, Chief, Section of Endocrinology|312-569-7651|Elena.Barengolts@va.gov|
20214491|NCT01832259|Huntsman Cancer Institute / University of Utah|Josiah Lyn Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
20214492|NCT00654030|University of Kentucky|Dr. Edward Hirschowitz|859-323-5045|eahirs2@uky.edu|
20214493|NCT00487565|DePuy Orthopaedics, Inc.|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
20214494|NCT00905346|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214495|NCT01435265|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-7740|sfeldman@wakehealth.edu|
20214496|NCT02059070|Wayne State University, School of Medicine|Pranav Patel|313-745-7233|gmckelve@dmc.org|
20214497|NCT00909610|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214498|NCT01026623|Memorial Sloan Kettering Cancer Center|Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
20214499|NCT04123548|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20214500|NCT00645762|Entellus Medical|Entellus Medical|763-463-1599||
20214501|NCT04166630|Emory University|Randi Smith|404-251-8914|randi.smith@emory.edu|
20214502|NCT03107091|BioVie|Penelope Markham|17035989972|pmarkham@biovieinc.com|
20214503|NCT02332863|University of Colorado - Anschutz Medical Campus|Dr. Sachin Wani|720-848-2786|sachin.wani@cuanschutz.edu|
20214504|NCT03049215|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
20214505|NCT00105196|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20214506|NCT00893464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20214507|NCT01544127|Canandaigu VA Medical Center|Dr. Peter Britton|585-393-7926|peter.britton@va.gov|
20214508|NCT01256684|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20214509|NCT02914600|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
20214510|NCT01185548|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214511|NCT02605395|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214512|NCT00184600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20214513|NCT02763865|Medical University of South Carolina|Gonzalo REvuelta|843-792-7262|revuelta@musc.edu|
20214514|NCT00624065|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214515|NCT00696020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214516|NCT03257722|Augusta University|Asha Nayak, MD|706-721-2505|anayak@augusta.edu|
20214517|NCT01387022|CAPRISA|Head of Statistics and Data Management|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
20214518|NCT02076022|University of Pittsburgh Plastic Surgery|Patsy Simon|412-648-9207|simopa@upmc.edu|
20214519|NCT01972204|Mirai Iryo Research Center|Tomoko Machida (Director)|81-3-3263-4801|machida@mirai-iryo.com|
20214520|NCT00312663|WRAIR|James Cummings, MD|301-319-9312|james.cummings@us.army.mil|
20214521|NCT00524264|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20214522|NCT00819507|Oregon Health & Science University|Eric Simpson|503-494-2121|simpsone@ohsu.edu|
20214523|NCT02336165|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20214524|NCT01054586|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214525|NCT01010542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214526|NCT00857623|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20214527|NCT04185909|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
20214528|NCT02082392|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
20214529|NCT04510285|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
20214530|NCT00626548|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20214531|NCT05665426|Zhejiang Chhinese Medicial University|Siyi Zheng|+86159 9008 8547|zsy980714@gmail.com|
20214532|NCT01066143|McLean|Igor Elman, PI|(800) 333-0338|ielman@partners.org|
20214533|NCT01294787|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
20214534|NCT03785548|TriHealth Inc.|Tiffanie Tam, Md|513-463-4300|Tiffanie_Tam@trihealth.com|
20214535|NCT00396279|Amgen Inc.|Study Director|866-572-6436||
20214536|NCT01199848|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
20214537|NCT03351335|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20214538|NCT04605094|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20214539|NCT02724462|Fred Hutchinson Cancer Research Center|Dr. Jonathan Bricker|206-667-5077|jbricker@fredhutch.org|
20214540|NCT01900691|Cook Research Incorporated|Alan Saunders, MDR, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
20214541|NCT00469417|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20214542|NCT00979303|Children's Hospital Boston|Christina Miyake|832-826-5650|cymiyake@bcm.edu|
20214543|NCT01954394|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20214544|NCT03585790|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
20214545|NCT02337218|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20214546|NCT04089735|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
20214547|NCT02071108|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
20193791|NCT06411613|VA Puget Sound Health Care System|Dawn Bates|206-277-3012|dawn.bates@va.gov|
20193792|NCT02519348|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20193793|NCT01956097|Ewha Brain Institute, Ewha W. University|Soonhyun Ban, RN, MS|+82-2-3277-6550|soonhyun.s.ban@gmail.com|6554
20193794|NCT05415748|UCSF|Dr. Scott Bauer|650-515-2879|scott.bauer@ucsf.edu|
20193795|NCT03075527|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
20193796|NCT05985538|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
20193797|NCT06534671|Vanderbilt University Medical Center|Prince J. Kannankeril, MD, MSCI|(615) 322-7447|prince.kannankeril@vumc.org|
20193798|NCT01447576|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20193799|NCT05239598|Penn Dental Medicine|Dr. Pat Corby|215-898-1162|patcorby@upenn.edu|
20193800|NCT02222870|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20214548|NCT02128997|UPENN|Valerie Riis|2154989099|valerie.armendariz@uphs.upenn.edu|215
20214549|NCT02393417|Nielsen BioSciences Inc.|David Burney, PhD, MBA|858-571-2726|david@nielsenbio.com|
20214550|NCT03342157|Advocate Aurora Health|Dr. Bradley Gose|414-385-2590|bradley.gose@aah.org|
20214551|NCT00418184|Enzymotec Ltd|Yael Richter Ph.D|+972 74 7177 177|Yaelr@enzymotec.com|144
20214552|NCT02339558|Prince of Wales Hospital|Brigette B.Y. Ma|(852) 26321042|brigette@clo.cuhk.edu.hk|
20214553|NCT01247701|Baylor College of Medicine/Texas Children's Hospital|Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
20214554|NCT00096447|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20214555|NCT02473718|University of Texas Southwestern Medical Center|Catherine Chen|214-648-9095|catherine.chen@utsouthwestern.edu|
20214556|NCT02246166|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214557|NCT00834743|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214558|NCT01643707|Medtronic|Sr Clinical Research Program Manager|+1 (651) 308 3608|jennifer.tinsley@medtronic.com|
20214559|NCT04112823|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20214560|NCT01036009|Benioff Children's Hospital at UCSF|Biljana Horn|415 476 2188|hornb@peds.ucsf.edu|
20214561|NCT03025880|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20214562|NCT01275586|Indiana University|Dr. Melissa Markel|317-944-4969|memarkel@iu.edu|
20214563|NCT00625443|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20193801|NCT02998476|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20193802|NCT05855967|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20193803|NCT07025837|Citruslabs|Patrick Renner|4242450285|hello@citruslabs.com|
20193804|NCT01435772|BioMarin Pharmaceutical Inc.|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
20193805|NCT03238963|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193806|NCT01920477|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
20193807|NCT01681277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193808|NCT03838731|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20193809|NCT04707664|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
20193810|NCT01182441|Boston Scientific|WATCHMAN Trial Manager|1-800-227-3422||
20193811|NCT05620108|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
20193812|NCT02038842|Service d'immunologie clinique - Hôpital Henri Mondor|Pr. Jean-Daniel Lelièvre|+33 1 49 81 24 55|jean-daniel.lelievre@hmn.aphp.fr|
20193813|NCT05504954|Department of Medicine, Center for Dissemination and Implementation Science, University of Illinois Chicago|Dr. Geri Donenberg|312-996-8602|gerid@uic.edu|
20193814|NCT04440839|UNIVERSITY OF CALIFORNIA DAVIS|Misty Humphries|9167342028|mdhumphries@health.ucdavis.edu|
20193815|NCT02088957|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20193816|NCT01923662|VAORD|Ronald J Triolo|216-791-3800|Ronald.Triolo@va.gov|64138
20193817|NCT01128270|University of Florida|Peter W. Stacpoole,MD|(352) 273-9023|pws@ufl.edu|
20193818|NCT03296800|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
20193819|NCT00677534|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-3867|jstubbs@kumc.edu|
20193820|NCT00667394|National Cancer Institute, National Institutes of Health|Dr. Katherine Warren|301-435-4683|warrenk@box-w.nih.gov|
20193821|NCT05214378|Cleveland Department of Veterans Affairs|Dennis Bourbeau|216-791-3800|dennis.bourbeau@va.gov|
20193822|NCT04638660|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
20193823|NCT04028921|Children's Mercy Kansas City|Dr. Robin Shook, PhD|(816) 234-9443|rpshook@cmh.edu|
20193824|NCT04481373|Baylor College of Medicine|Thomas Giordano|7137988918|tpg@bcm.edu|
20193825|NCT04076943|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-092Study@fibrogen.com|
20193826|NCT00509249|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20193827|NCT02224703|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
20193828|NCT01476449|Retina Vitreous Associates of Florida|David Eichenbaum, MD|727-323-0077|deichenbaum@retinavitreous.com|
20193829|NCT00558844|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
20193830|NCT02579135|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
20193831|NCT01146600|Emory University School of Medicine|Lynn Marie Trotti, MD, MSc|404-728-4752|lbecke2@emory.edu|
20214564|NCT02728102|The Emmes Company|Adam Mendizabal, PhD|301-284-1798|amendizabal@emmes.com|
20193832|NCT04076787|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193833|NCT01886287|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
20193834|NCT03596762|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20193835|NCT02195479|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20193836|NCT00504777|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20193837|NCT03514277|Reconstructive Orthopedics|Robert Greenleaf|609-267-9400|bob.greenleaf1@gmail.com|
20193838|NCT01195623|Uppsala UH|Lena Blomgren MD PhD|+46851774173|lena.blomgren@karolinska.se|
20193839|NCT02278484|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|952
20193840|NCT01572740|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20193841|NCT00478192|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20193842|NCT00214019|UW Madison|Gina Crisafi|6082654554|gmc@medicine.wisc.edu|
20193843|NCT00477490|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20193844|NCT01346072|University of North Carolina Chapel Hill|Kirkwood F. Adams, Jr., MD|919-966-2877|kfa@med.unc.edu|
20193845|NCT01465763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193846|NCT01646177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20193847|NCT02920970|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
20193848|NCT02204657|University Malaya Medical Centre|Dr Sharmila SP|60379492299|sharmsp13@gmail.com|
20193849|NCT01711853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193850|NCT04230122|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20193851|NCT04910139|Sound Health Systems|Paramesh Gopi|408-316-3631|pgopi@soundhealth.life|
20193852|NCT03285555|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
20193853|NCT01277887|Yale University School of Medicine|Lisa Fucito, PhD|203 974-5759|lisa.fucito@yale.edu|
20193854|NCT03651700|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
20193855|NCT03874754|Johns Hopkins School of Nursing|Nada Lukkahatai|2407509867|nada.lukkahatai@jhu.edu|
20193856|NCT05479734|University of Oklahoma Health Sciences|David Bard, Director of EmBRACER Center|4052718001|David-Bard@ouhsc.edu|
20193857|NCT00600613|Memorial Sloan Kettering Cancer Center|Dr. Yoshiya Yamada|212-639-2950|yamadaj@mskcc.org|
20193858|NCT02623998|McMaster University|Dr. Natalia McInnes|19055212100|natalia.mcinnes@mcmaster.ca|73794
20193859|NCT01509547|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20193860|NCT01399918|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-888-4740|Feldmand@MSKCC.ORG|
20193861|NCT00570908|Baylor Coolege of Medicine|Dr. Mothaffar Rimawi|7137981811|rimawi@bcm.edu|
20193862|NCT00669877|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, Assistant Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20193863|NCT01110408|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
20193864|NCT03635099|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20193865|NCT04103892|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
20214565|NCT00672178|Duke University Medical Center|John Kirkpatrick, MD, PhD|919 668-7342|kirkp001@mc.duke.edu|
20214566|NCT02924883|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20214567|NCT00553280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214568|NCT01182415|Massachusetts General Hospital|Dr. Yi-Bin Chen|617-726-0187|YCHEN6@PARTNERS.ORG|
20214569|NCT01437501|Johns Hopkins Bloomberg School of Public Health|Thomas W. Kensler, PhD|410-955-1292|tkensler@jhsph.edu|
20214570|NCT04121364|RevBio|Dr. Alan Pollack|9145226972|apollack@revbio.com|
20214571|NCT05452798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20214572|NCT02587962|Medivir AB|Chief Medical Officer|+46854683100|info@medivir.com|
20214573|NCT00425672|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
20214574|NCT00234286|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
20214575|NCT01422538|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20214576|NCT01536405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20214577|NCT00267644|Maimonides Medical Center|Dr. Eitan Dickman, MD; Principal Investigator|718-283-6057|edickman@maimonidesmed.org|
20214578|NCT01263704|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20214579|NCT01061866|National Institute of Neurology and Neurosurgery of Mexico|Julio Sotelo|5255-5652-8285|jsotelo@unam.mx|
20214580|NCT02255097|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20214581|NCT02514122|University of Saskatchewan|Dr. William P. McKay|1 306 655 1202|bill.mckay@usask.ca|
20214582|NCT01675765|Aduro Biotech, Inc.|Corporate Communications|510-848-4400|press@aduro.com|
20214583|NCT03965091|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20214584|NCT02512393|The University of Texas Health Science Center at Houston|Hyochol Ahn, PhD, ARNP|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
20214585|NCT01534520|UPittsburgh|Dionne Best|412-641-5496|dbest@upmc.edu|
20193866|NCT03008005|Wayne State University|Dr. Christine Rabinak, Principal Investigator|(313) 577-9875|rabinak@wayne.edu|
20193867|NCT01555489|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
20193868|NCT07149155|Dell Medical School, The University of Texas at Austin|Project Coordinator|NA|SFA@austin.utexas.edu|
20214586|NCT01417078|Acorda Therapeutics, Inc.|Executive Medical Director - Clinical Development & Medical Affairs|914-347-4300|dsquillacote@acorda.com|5367
20214587|NCT00580138|University of Arkansas for Medical Sciences Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
20163136|NCT02451917|Endocrinology Division, University of São Paulo Medical School,|Marcia Silva Queiroz, MD, PhD|+ 5511 26616293|marcia.queiroz@hc.fm.usp.br|
20214588|NCT01059903|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20214589|NCT03555305|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214590|NCT00925054|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
20214591|NCT03135834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163137|NCT01724866|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20214592|NCT02100228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214593|NCT00214422|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphausen@nih.gov|
20214594|NCT03458871|The University of Texas Health Science Center at Houston|Dr. Argyrios Stampas|713-797-5938|argyrios.stampas@uth.tmc.edu|
20214595|NCT02612337|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20214596|NCT01073657|Veterans Health Adminstration|Marsha Langer Ellison, Ph.D.|781 687 3401|Marsha.Ellison@va.gov|
20214597|NCT02421952|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
20214598|NCT00854100|Allergan, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
20214599|NCT02744352|University of Pennsylvania|Anmol Madaan, Clinical Research Coordinator|2156623778|Anmol.Madaan@Pennmedicine.Upenn.edu|
20163138|NCT01340586|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20214600|NCT03486990|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20214601|NCT02216071|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
20214602|NCT04753437|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20214603|NCT02865122|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098600|Miki@elganpharma.com|
20163139|NCT00411671|University of Texas (UT) MD Anderson Cancer Center|George Blumenschein, MD / Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
20214604|NCT00486863|Warren Alpert Medical School of Brown University, Lifespan Center for International Health Research|Jennifer Friedman, M.D., Ph.D|(401) 444-7449|jennifer_friedman@brown.edu|
20163140|NCT01424501|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163141|NCT01980095|RedHill Biopharma|Dr. Ira Kalfus|1-917-817-7517|ira@redhillbio.com|
20163142|NCT03671213|Moximed, Inc.|Rose Weinstein, Director of Clinical Affairs|415-312-0255|rsweinstein@moximed.com|
20163143|NCT00889512|University Reproductive Associates|Dr. Peter G. McGovern|201-288-6330|mcgovepg@uranj.com|
20163144|NCT00546000|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20163145|NCT03223337|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163146|NCT01362608|Novartis|Clinical Disclosure Office|862-778-8300||
20163147|NCT00726414|Mutual Phrmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20163148|NCT00721188|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20163149|NCT00889824|WashingtonU|Joel Goebel, MD|(314) 362-7344|goebelj@ent.wustl.edu|
20163150|NCT01336140|Rush University Medical center|Rami Doukky|312-942-4655|rami_doukky@rush.edu|
20193869|NCT03345576|Richmond VAMC|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.ogv|3386
20193870|NCT04854850|University of Pittsburgh|Robyn T. Domsic|412-383-8000|rtd4@pitt.edu|
20193871|NCT04942366|Ziauddin University|Mubarra Rao|03343088915|mubarrar@gmail.com|
20193872|NCT06149104|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20193873|NCT05817383|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
20193874|NCT02354820|Indiana University School of Medicine|William E. Bennett, Jr. Principal Investigator|3172786928|webjr@iu.edu|
20193875|NCT02706405|Fred Hutchinson Cancer Center|Dr. Jordan Gauthier|2066672713|jgauthier@fredhutch.org|
20193876|NCT02304705|University of Kentucky|Dr. Maya Guglin|859-323-4738|maya.guglin@uky.edu|
20193877|NCT01195948|National Institutes of Health|Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
20193878|NCT03140280|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
20193879|NCT02981108|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
20193880|NCT00954187|Loma Linda University|Julio Narvaez, MD|9095589408|thamilton@llu.edu|
20193881|NCT05577715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20163151|NCT01048658|Oregon Health & Science University|Dr. Rosenne Botha|503-494-3666|whru@ohsu.edu|
20193882|NCT03412773|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20193883|NCT03317990|University College London|Professor Greg Shaw|+44 (0)20 7679 2000|ncita.neurosafe@ucl.ac.uk|
20163152|NCT00939536|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
20163153|NCT04809285|Medtronic|Binh Ngo (Clinical Research Director)|9492027218|binh.ngo@medtronic.com|
20163154|NCT00566462|Eisai Call Center|Eisai Inc.|888-422-4743||
20187306|NCT03213665|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20163155|NCT02837029|Northwestern University, Feinberg School of Medicine|Aparna Kalyan, MBBS, FRACP|312 926 4291|Aparna.kalyan@northwestern.edu|
20187307|NCT03056573|Abbott|Angelic Roach, Clinical Program Director|+16517563379|angelic.roach@abbott.com|
20187308|NCT00323856|Grifols|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20187309|NCT04086121|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163156|NCT03370042|Kamineni Institute of dental sciences|Dr. Raga Bindu|09849441800|ragha.j16@gmail.com|
20163157|NCT02034877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163158|NCT01013194|ISMETT-UPMC|Dr Giada Pietrosi|+390912192111|gpietrosi@ismett.edu|
20163159|NCT02461927|VA CT Healthcare System, Yale University|Dr. Gihyun Yoon|(203) 932-5711|gihyun.yoon@yale.edu|7421
20214605|NCT01948258|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
20214606|NCT00355797|BIOTRONIK, Inc.|CLEAR Study CSE|503-451-8051||
20214607|NCT01466166|Horizon Pharma Rheumatology LLC|Jeffery Nieves, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
20214608|NCT00834535|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214609|NCT03547622|Yale University|Theresa Babuscio Data Manager|203 737 5430|theresa.babuscio@yale.edu|
20214610|NCT00210223|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20214611|NCT02196766|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
20214612|NCT00851877|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
20214613|NCT00620074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20214614|NCT00829673|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214615|NCT03214952|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20214616|NCT00829790|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214617|NCT03769896|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
20214618|NCT00840866|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214619|NCT02377947|Abbott|Dr. Shubhangi Desai|+91 22 7175 7408|shubhangi.desai@abbott.com|
20214620|NCT00086996|SWOG Statistical Center|Study Statistician|206-667-4623||
20214621|NCT00004562|New York University School of Medicine|Judith S. Hochman, M.D.|212-263-6927|judith.hochman@nyumc.org|
20214622|NCT02770820|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
20214623|NCT00301366|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20214624|NCT01371786|Sunovion|Respiratory Medical Director|1-866-503-6351||
20214625|NCT00552669|Centro de Estudios en Cardiologia Intervencionista|Alfredo Rodriguez, MD, PHD|541149648721|rodrigueza@sanatorio-otamendi.com.ar|
20214626|NCT03195491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20214627|NCT01270503|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20214628|NCT02459951|Albert Einstein Healthcare Network|Nathaniel Mayer MD|215 663 6681|nmayer@einstein.edu|
20214629|NCT00724477|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20214630|NCT00252720|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
20214631|NCT00102440|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20214632|NCT00772941|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214633|NCT01314417|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
20214634|NCT04786184|Columbia University|Annamaria Norweg, PhD|212-305-1651|amn2212@cumc.columbia.edu|
20214635|NCT01745120|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20214636|NCT02834663|Wonkwang University Hospital|Dr. Seung Joon Lee|010-5004-8165|eunilsa@hanmail.net|
20214637|NCT02420210|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20214638|NCT01185821|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20214639|NCT01837654|Assaf Harofhe MC|Dr. Kobi Stav|972-8-9779409|stavkobi@yahoo.com.au|
20187310|NCT03100760|University of New Mexico Health Sciences Center|Justin Baca|505-272-5062|jtbaca@salud.unm.edu|
20214640|NCT02729714|EvergreenHealth Medical Center|Dr. Daniel Burdick|4258993108|djburdick@evergreenhealthcare.org|
20214641|NCT04107675|Zambon SpA|Ferdinando Ceravolo, MD|02 665241|ferdinando.ceravolo@zambongroup.com|
20214642|NCT01234103|University of California, San Francisco|Cherrie B. Boyer, PhD|4154762184|Cherrie.Boyer@ucsf.edu|
20214643|NCT02563808|University of Pennsylvania Hospital|Lee Fleisher|2156623738|lee.fleisher@uphs.upenn.edu|
20214644|NCT02392000|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley|781-687-2273|karen.quigley@va.gov|
20214645|NCT00385593|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20214646|NCT04384978|DreamFace Technologies, LLC|President and CEO|7202015694|mmahoor@dreamfacetech.com|
20214647|NCT01985308|Wave Neuroscience, Inc.|Mazaya Soundra, Clinical Trials Manager|9492292869|mazaya@waveneuro.com|
20214648|NCT03286465|The University of Texas Health Science Center at Houston|Javier Barreda Garcia, MD|713-500-6838|Javier.BarredaGarcia@uth.tmc.edu|
20214649|NCT03586726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20214650|NCT00965185|Massachusetts General Hospital|Dr. Steven K Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
20163160|NCT00394706|University of Washington|Siobhan Brown, PhD-Biostatistician|206-685-1302|spes@uw.edu|
20187311|NCT05292391|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|(206)-442-5216|Lisa.A.Jackson@kp.org|
20187312|NCT00636389|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20187313|NCT06130410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187314|NCT05809453|University of Texas at Southwestern|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
20187315|NCT01002235|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20193884|NCT01656252|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
20193885|NCT00929253|Virginia Tech|Dr. Warren K. Bickel|540-526-2015|wkbickel@vt.edu|
20193886|NCT03057847|University of Pittsburgh|Dr. Elizabeth Krans|412-641-3532|kransee@upmc.edu|
20193887|NCT00448201|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
20193888|NCT02769442|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi Md|4103288025|smoayedi@em.umaryland.edu|
20193889|NCT01706705|UT MD Anderson Cancer Center|Dr. Ann Klopp / Associate Professor, Radiation Oncology|713-563-6930|aklopp@mdanderson.org|
20193890|NCT03510455|National Institute of Dental and Craniofacial Research|Rachel I. Gafni|301-594-9924|gafnir@mail.nih.gov|
20214651|NCT03197883|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20214652|NCT04916548|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
20214653|NCT00322465|University of Alabama at Birmingham|Jane R. Schwebke, MD|(205) 975-5665|schwebke@uab.edu|
20193891|NCT00384189|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20193892|NCT04958642|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
20214654|NCT00183794|USC/Norris Cancer Comprehensive Cancer Center|Agustin Garcia, MD|323-865-3900|aagarcia@usc.edu|
20214655|NCT00389064|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20214656|NCT00762307|Zeltiq Aesthetics|Kerrie Jiang, Director of Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20214657|NCT02779543|Weill Cornell Medical College|Dr. Ana Krieger|6469629316|ack2003@med.cornell.edu|
20214658|NCT02372630|State University of NY at Buffalo|Paresh Dandona, B.Sc., M.B. B.S., D.Phil., F.R.C.P|71653518520|dandona@buffalo.edu|
20214659|NCT05275205|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
20214660|NCT02629094|National Institute of Allergy and Infectious Diseases|Hadigan, Colleen|+1 301 594 5754|hadiganc@mail.nih.gov|
20214661|NCT03962348|Columbia University Irving Medical Center|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
20214662|NCT02963259|Abbott|Erika Ross|+19725268207|Erika.ross@abbott.com|
20214663|NCT00091260|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
20214664|NCT03243630|Yale University|Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20214665|NCT00939003|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20214666|NCT02131129|IndianaU|Dr. Michael Francis|317-880-8495|mmfranci@iupui.edu|
20214667|NCT03707912|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20214668|NCT02934347|Glan Clwyd Hospital, Betsi Cadwaladr University Health Board|Dr Raj Reddy|01745 583910|Rajashekhar.Reddy@wales.nhs.uk|
20214669|NCT01313780|Seoul Asan Hospital|Taewon Kim|82-2-3010-3910|twkimmd@amc.seoul.kr|
20218203|NCT01206816|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20218204|NCT01939496|Janssen Scientific Affairs, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20218205|NCT01642914|Forest Research Institute|Steven Shiff, Executive Director, Clinical Development|201-427-8000|Steven.Shiff@actavis.com|8077
20218206|NCT01705236|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20218207|NCT03028740|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20218208|NCT00171301|Novartis Pharmaceuticals|Study Director|862-778-8300||
20218209|NCT04323098|BioMarin Pharmaceutical Inc.|Tara M Robinson, MD, PhD, Senior Medical Director, Late-Stage Clinical Development|415-455-7931|tara.robinson@bmrn.com|
20218210|NCT02589522|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20218211|NCT02025010|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
20218212|NCT01300052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218213|NCT01661881|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
20218214|NCT01231373|BTG International Inc.|David Wright MBBS|610-278-1660|david.wright@btgplc.com|
20218215|NCT01359748|Aguiflai Iberica, SL|Angel Pons Ferré|+34 93 7540370|calidad@keito.com|
20218216|NCT00102687|Celgene Corporation|CL Beach||CLBeach@celgene.com|
20218217|NCT01258101|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20218218|NCT00063882|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20218219|NCT00279955|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20218220|NCT01343095|Wake Forest Baptist Health|Matthew C. Miles|336-716-7765|mmiles@wakehealth.edu|
20218221|NCT00654654|CBR International Corp.|Kevin Hennegan|(720)746-1190|khennegan@cbrintl.com|
20218222|NCT05012865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20218223|NCT01949116|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20218224|NCT03399318|University of Rochester|Professor Gretchen L. Birbeck|+ 1(517) 505-0283|gretchen_birbeck@urmc.rochester.edu|
20218225|NCT02556307|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20218226|NCT03438227|Brown University|Dr. Methodius Tuuli|401-430-1575|MTuuli@wihri.org|
20218227|NCT02537873|Virginia Commonwealth University|F. Gerard Moeller, M.D.|804-628-7788|lmbobb@vcu.edu|
20218228|NCT00293202|University of California, Davis|George Kaysen MD PhD|916-734-3774|gakaysen@ucdavis.edu|
20218229|NCT05307887|Imperial College NHS Foundation Trust|Dr Thomas Sewell|02033122152|thomas.sewell2@nhs.net|
20218230|NCT00706992|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20218231|NCT01277718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20193893|NCT02942004|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
20193894|NCT05627258|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
20193895|NCT04517669|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20193896|NCT02138786|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20193897|NCT01541384|University of Pennsylvania|Dr. Peter Reese|215-898-6086|peter.reese@uphs.upenn.edu|
20214670|NCT03857919|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|18186873310|trodriguez@sightsciences.com|
20214671|NCT05369208|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
20214672|NCT04934722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20214673|NCT00371839|Portland VAMC|Dr. Marjorie R. Leek|(909)825-7084|Marjorie.Leek@va.gov|7293
20214674|NCT01149473|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20193898|NCT01199068|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20214675|NCT00773422|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
20214676|NCT00834249|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214677|NCT03450057|General Hospital of Athens 'Alexandra', Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine|Prof. Evangelos Terpos|+302102162540|eterpos@med.uoa.gr|
20214678|NCT05755282|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
20214679|NCT00573066|Children's Hospital of Philadelphia|Athena Zuppa|267-426-7359|zuppa@email.chop.edu|
20214680|NCT01015703|BTG International Inc.|SVP Clinical Development|610-278-1660|angela.ogden@btgplc.com|
20214681|NCT01693523|UT MD Anderson Cancer Center|Dr. David Fogelman/ Associate Professor, GI Medical Oncology|832-710-7754|dfogelman@mdanderson.org|
20214682|NCT00834418|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214683|NCT00085293|University of Texas MD Anderson Cancer Center|Steven I. Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
20214684|NCT02331394|Jewish General Hospita;|Goulnar Kasymjanova|514-340-8222|gkasymja@jgh.mcgill.ca|24312
20214685|NCT02841033|Boston Medical Center|Vaishali Sanchorawala, MD|617-638-8213|vaishali.sanchorawala@bmc.org|
20214686|NCT04459585|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20214687|NCT02098876|Northeast Georgia Health System|Habib Samady|770-297-3549|Habib.Samady@nghs.com|
20214688|NCT00783367|University of Pennsylvania, Clinical Research Unit, Lymphoma Group|Ellen Napier, CRNP|215.279.1972|Ellen.Napier@pennmedicine.upenn.edu|
20214689|NCT01602419|Octapharma AG|Sigurd Knaub/SVP CR&D Haematology|+41 55 4512141|Sigurd.Knaub@octapharma.com|
20214690|NCT01792635|Pfizer, Inc.|Pfizer ClnicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214691|NCT02294253|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
20214692|NCT04920929|Access Vascular Inc.|Brian Hanley|1-781-538-6594|bhanley@accessvascularinc.com|101
20214693|NCT02714062|VIVUS|Sr. Director, Clinical Research|650-934-5200||
20214694|NCT03956862|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB001, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
20214695|NCT00850174|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214696|NCT02413320|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
20214697|NCT02251886|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
20214698|NCT02819323|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20214699|NCT02682784|Medical University of South Carolina|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
20214700|NCT01702987|Beth Israel Deaconess Medical Center|Jim Wu|617-754-2390|jswu@bidmc.harvard.edu|
20214701|NCT02017223|University of Southern California|Donna Spruijt-Metz, MFA PhD|310-577-6248|dmetz@usc.edu|
20214702|NCT01401647|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
20214703|NCT00752973|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 345 9001|natalie.yantovskiy@taro.com|
20214704|NCT05428020|Rush University Medical Center|Anne DeBenedetti, Director of Research, Adult Reconstruction|3124322468|anne.debenedetti@rushortho.com|
20214705|NCT03502148|Privo Technologies|Dr. Manijeh Goldberg|9785872322|mgoldberg@privotechnologies.com|
20214706|NCT00365846|Emory University|Stuart Knechtle, MD|404-727-8465|stuart.knechtle@emoryhealthcare.org|
20214707|NCT01010932|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20214708|NCT00578552|Mayo Clinic|Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
20214709|NCT02057458|Augusta University|Ryan Harris, PhD|7067215998|ryharris@augusta.edu|
20214710|NCT04263649|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
20214711|NCT01783561|Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
20214712|NCT04503174|Tandem Diabetes Care|Clinical Affairs|877-801-6901|clinicalaffairs@tandemdiabetes.com|
20214713|NCT04400890|formerly of Mount Carmel Health Systems|Marvin McCreary, MD|614-526-8492|Marvin.McCreary+RCT@gmail.com|
20214714|NCT00221299|Unversity of California Davis|Nancy E. Lane MD, Director, Center for Musculoskeletal Health|916 734-0753|nancy.lane@ucdmc.ucdavis.edu|
20214715|NCT00846495|Clinvest|Rebecca Browning|417-841-3664|rbrowning@clinvest.com|
20214716|NCT01265056|The University of Iowa|Jennifer Lassner|319-335-2123|jennifer-lassner@uiowa.edu|
20214717|NCT01416584|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20214718|NCT01624363|Indiana Universtiy Schol of Medicine|John DeWitt, MD, Director, Endoscopic Ultrasound|317-944-1113|jodewitt@iu.edu|
20214719|NCT01650350|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-3000|Kayla_rosati@brown.edu|
20214720|NCT00537979|Abbott|Global Medical Services|800-633-9110||
20214721|NCT02601560|MedImmune, LLC|Richard George, MD, Director, Clinical Development|+1-301-398-5681|information.center@astrazeneca.com|
20214722|NCT03459807|University of California, San Francisco|Dr. Chi-yuan Hsu|415-476-2172|chi-yuan.hsu@ucsf.edu|
20214723|NCT02431494|Nova Southeastern University|Sue Breno|9542621447|sb1382@nova.edu|
20214724|NCT00576056|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
20214725|NCT00858845|University of California, Los Angeles (UCLA)|Dr. Holly R. Middlekauff|310-206-6672|hmiddlekauff@mednet.ucla.edu|
20214726|NCT04841317|Stanford University|Paul J. Wang, MD|(650) 723-7111|Paul.J.Wang@stanford.edu|
20214727|NCT01964092|University of Oslo|Silje Endresen Reme|22845236|s.e.reme@psykologi.uio.no|+47
20214728|NCT00998374|Lenox Hill Hospital|Dr. Mitchell Roslin|212-434-3285|MRoslin@NSHS.edu|
20214729|NCT03420300|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-223123456|jacque_liu@mail2000.com.tw|63572
20214730|NCT01790581|UNC Charlotte|Erik Wikstrom|704-778-5784|ewikstrom@uncc.edu|
20214731|NCT00584922|University of Oklahoma Health Science Center|Sunny Po, MD, PhD|405-271-9696|Sunny-Po@ouhsc.edu|
20214732|NCT03500692|Abbott|Sripad Bellary|6503531726|sripad.bellary@abbott.com|
20214733|NCT04149964|William Beaumont Hospitals|Mitchell Shecter, DO|2487629363|mitchell.shecter@corewellhealth.org|
20214734|NCT01379664|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
20214735|NCT03041025|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20214736|NCT02648880|University of Colorado|Ryan Marker|3037240819|ryan.marker@cuanschutz.edu|
20214737|NCT03880266|Dermira, Inc|Jordan Adajar|650-421-2919|jordan.adajar@dermira.com|
20214738|NCT02350647|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
20214739|NCT00831428|University of Dundee|Dr Karine Clearie|01382 496440|k.clearie@dundee.ac.uk|
20214740|NCT01577381|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214741|NCT02186821|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
20214742|NCT00467896|Actelion Pharmaceuticals, US, Inc.|Wade Benton, Pharm D / Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
20214743|NCT03772522|MAP Centre for Urban Health Solutions, Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|ThulienN@mcmaster.ca|
20193899|NCT01250925|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-3313|cornea_research@meei.harvard.edu|
20193900|NCT00678301|GlaxoSmithKline|GSK Response Center|866-435-7343||
20193901|NCT03338296|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20193902|NCT01939353|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20193903|NCT00458952|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
20193904|NCT03573947|Duke Cancer Institute|Dr. Jeffrey Clarke|9196819509|jeffrey.clarke@duke.edu|
20193905|NCT03237377|Johns Hopkins SKCCC CRO Coordinating Center|Jasmine Brooks, Senior Research Program Coordinator|667-306-8335|jbrook54@jhmi.edu|
20193906|NCT04421950|University of Arkansas for Medical Sciences and Arkansas Children's Nutrition Ce|Eva C. Diaz, Principal Investigator|5013643056|ecdiazfuentes@uams.edu|
20193907|NCT05048238|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20193908|NCT00186017|Stanford University School of Medicine|Dr. Terence A. Ketter, MD.|6507232507|tketter@stanford.edu|
20193909|NCT03289351|Phoenix Children's|Dr. Justin Lee|6029330016|jlee8@phoenixchildrens.com|
20193910|NCT00335140|Johns Hopkins Cancer Center|Lode Swinnen, MD|(410) 955-8603|lswinne1@jhmi.edu|
20193911|NCT04546425|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193912|NCT02687035|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
20193913|NCT01102764|Medical University of South Carolina|Ron Acierno, PhD|843-792-2949|acierno@musc.edu|
20193914|NCT03165747|Emory University|Roberto Pacifici, MD|404-712-8420|roberto.pacifici@emory.edu|
20193915|NCT02160730|Cedars-Sinai Medical Center|Dr. Ning-Ai Liu|310-423-7382|ning-ai.liu@cshs.org|
20193916|NCT02766777|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20193917|NCT00534495|Children's Hospital at Montefiore|Dr.Norman T.Ilowite|718-696-2602|NILOWITE@montefiore.org|
20193918|NCT00137969|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20193919|NCT00668265|Beth Israel Medical Center|Igor Galynker, MD|212 420 4535|igalynke@chpnet.org|
20193920|NCT02807272|Kura Oncology Inc.|Clinical Operations|+1 617 588-3755|KO-TIP-004@kuraoncology.com|
20193921|NCT04191616|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20214744|NCT03797872|University of Oxford|Professor Laura Coates|+447870257823|laura.coates@ndorms.ox.ac.uk|
20214745|NCT03818581|Massachusetts General Hospital|Dr. John Winkelman|617-643-9101|jwwinkelman@mgh.harvard.edu|
20214746|NCT01686451|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou, 325000, China|Dr. JiFei Tang|+8615968766021|jiftang@126.com|
20214747|NCT02096211|Johnson & Johnson MedTech|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
20214748|NCT01281501|Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital.|Khrongwong Musikatavorn, MD|+662-256-4000|kmusikatavorn@yahoo.com|4553-5
20214749|NCT02996591|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
20214750|NCT01439880|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20214751|NCT00328926|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20193922|NCT00604708|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
20193923|NCT02180243|War Related Illness and Injury Study Center|Matthew Reinhard, PsyD|202-745-8000|matthew.reinhard@va.gov|55785
20214752|NCT02269657|Children's Hospital of Philadelphia|Saba Pasha, PhD|215-590-1815|pashas@email.chop.edu|
20214753|NCT02956460|CooperVision|Jose Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
20214754|NCT03612960|Pennsylvania State University|Dr. Andrea Hobkirk|7175310003|ahobkirk@pennstatehealth.psu.edu|286415
20214755|NCT02440711|University of Washington|Dr. Brian Hafner|206-685-0214|bhafner@uw.edu|
20214756|NCT01980771|State University of New York, Downstate Medical Center|Tracey Wilson, Principal Investigator|718 270 2105|Tracey.Wilson@downstate.edu|
20214757|NCT04129346|Northwestern University Feinberg School of Medicine|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
20214758|NCT02646124|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
20214759|NCT03154047|Prothena Biosciences|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
20214760|NCT00857454|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214761|NCT00365365|Sanofi|Trial Transparency Team||Contact_Us@sanofi.com|
20214762|NCT02322593|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
20214763|NCT01083693|Abbott|Global Medical Services|1-800-633-9110||
20214764|NCT00200785|Silliker, Inc./Plant Bioactives Research Institute, Inc.|Larry D. Lawson|801-226-3041|larry.lawson@silliker.com|
20214765|NCT04567186|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO, Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20214766|NCT04274686|University of New Mexico|Dr. Neal Gerstein|505-272-2610|ngerstein@salud.unm.edu|
20214767|NCT00376623|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214768|NCT04247282|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20214769|NCT01313273|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20214770|NCT03687736|Q-Med AB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20214771|NCT02566239|Oregon Health & Science University|Dr. Jeffrey Kaye|503 494 6695|kaye@ohsu.edu|
20214772|NCT03496623|United Therapeutics|United Therapeutics Global Medical Information|240-821-1881|304perfectstudy@lungbiotechnology.com|
20214773|NCT02543203|The Ohio State University Nisonger Center|Dr. Jill Ann Hollway|614-688-3848|Jill.Hollway@osumc.edu|
20193924|NCT02202785|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20193925|NCT01137578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20193926|NCT03697551|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20214774|NCT03020615|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
20214775|NCT00089661|Amgen Inc.|Study Director|866-572-6436||
20214776|NCT00904345|University of Michigan Rogel Cancer Center|Shruti Jolly, M.D.|734-936-4302|shrutij@med.umich.edu|
20214777|NCT02062580|University of Cape Town and University of Washington|Heather Jaspan|+2721 4066823|hbjaspan@gmail.com|
20214778|NCT02077465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20214779|NCT05704426|Hackensack Meridian Health|Sameer Jamal, MD|15519962997|Sameer.Jamal@hmhn.org|
20214780|NCT02481830|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
20214781|NCT04627038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214782|NCT02325531|Kaiser Permanente Center for Health Research|Rachel Gold|5033352400|rachel.gold@kpchr.org|
20214783|NCT00794963|North Shore Long Island Jewish Health System, Zucker Hillside Hospita, Glen Oaks, NY|Peter Manu, MD|718 470-8290 pmanu@nshs.edu||
20214784|NCT03375463|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214785|NCT01827163|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
20214786|NCT01037114|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214787|NCT03075553|Mayo Clinic|Stephen M Ansell MD PhD|507/284-2511|ansell.stephen@mayo.edu|
20214788|NCT01808794|Tufts University|Associate Vice Provost for Research Administration & Development|617-627-7000|tss@tufts.edu|
20214789|NCT04314362|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
20214790|NCT02129426|University of Louisville|John W. Berkenbosch|502-852-3720|john.berkenbosch@louisville.edu|
20214791|NCT02294604|Shuang Ho Hospital, Taipei Medical University|Dr. Ka-Wai Tam|886-2-22490088|kelvintam@h.tmu.edu.tw|8860
20214792|NCT01780870|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
20214793|NCT01513174|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
20214794|NCT01363765|InCo-TB project, Gama Filho University|Anete Trajman|5521-82189194|atrajman@gmail.com|
20214795|NCT01900626|University of Wisconsin School of Medicine and Public Health|Benjamin J. Walker, MD|608/262-8858|bjwalker2@wisc.edu|
20214796|NCT04533594|JOHNS HOPKINS HOSPITAL|Dulce M. Cruz-Oliver, MD|4109558305|dcruzoli@jhmi.edu|
20214797|NCT02757105|RedHill Biopharma Ltd.|Dr. Terry F. Plasse|972-(0)3-541-3131|terry@redhillbio.com|
20214798|NCT00717405|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20214799|NCT01975948|Dalhousie University, Department of Psychiatry|Dr. Bianca Lauria-Horner|902-473-5633|bianca.horner@dal.ca|
20214800|NCT00982397|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
20214801|NCT05169710|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
20214802|NCT03999684|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
20214803|NCT00836056|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214804|NCT02158663|James A. Haley VA Hospital|F. Andrew Kozel|(813) 972-2000|FRANK.KOZEL@VA.GOV|
20214805|NCT02711852|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20214806|NCT00408070|UCHC|Paige Dunion|860-679-6571|pdunion@uchc.edu|
20214807|NCT03616106|University of Colorado College of Nursing|Samantha Stonbraker, Assistant Professor|720-880-8194|Samantha.Stonbraker@Cuanschutz.edu|
20214808|NCT01880593|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
20214809|NCT02272777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20214810|NCT04732195|Emory University|Dr. Lokesh Guglani|404-712-2324|lokesh.guglani@emory.edu|
20214811|NCT02298322|Zeltiq Aesthetics, Inc. an Allergan Affiliate|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20214812|NCT00440297|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20214813|NCT03206177|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
20214814|NCT02024932|Novartis Pharmaceuticals|Study Director|862-778-1873||
20214815|NCT02445339|NYU Langone Health|Ryan P. McCormack, MD|212-562-6561|Ryan.McCormack@nyulangone.org|
20214816|NCT03020641|Ramon y Cajal University Hospital|Characterization of changes in peritoneal cells gene expression after standard versus low pressure l|610 312962|aserranor@salud.madrid.org|+34
20214817|NCT04611789|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214818|NCT05472038|BioNTech clinical trials patient information|BioNTech SE|6131 90840|patients@biontech.de|
20214819|NCT00539071|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
20214820|NCT03235739|Cleveland Clinic|Alparslan Turan, MD|216-4459857|turana@ccf.org|
20214821|NCT02847650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214822|NCT00218257|University of Minnesota|Dr. Sheila Specker|612-273-9806|speck001@umn.edu|
20214823|NCT02517294|Nemours|Dr Katrin Post-Martens|904-330-9942|Katrin.Post-Martens@nemours.org|
20214824|NCT02175095|Asan Medical Center|Yong Sang Hong, M.D., Ph.D.|+82-2-3010-3227|yshong@amc.seoul.kr|
20214825|NCT00462345|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20214826|NCT03255733|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
20214827|NCT00561834|Rocky Mountain Lions Eye Institute, Dept. of Ophthalmology|Dr. Naresh Mandava, M.D.|720-848-2500|Naresh.mandava@ucdenver.edu|
20214828|NCT01530880|Columbia University|Michael Schmidt|212-305-8745|mjs2134@columbia.edu|
20214829|NCT02713425|Mayo Clinic|Stephen P. Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
20214830|NCT00738049|University of Texas Medical School at Houston|K. Lance Gould, MD|713-500-6611|K.Lance.Gould@uth.tmc.edu|
20214831|NCT03874715|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20214832|NCT00461786|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20214833|NCT00875550|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20214834|NCT00835991|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214835|NCT02378935|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20214836|NCT00272779|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
20214837|NCT01631331|Stanford University|Dr. Gina Kwon|650-724-3859|gkwon@stanford.edu|
20214838|NCT03199872|RhoVac ApS|Steven Glazer, MD|+4525674434|sgl@rhovac.com|
20214839|NCT02146105|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
20214840|NCT01163461|VAMC Puget Sound|Dr. Diane Kendall (PI)|206-762-1010|diane.kendall@va.gov|
20214841|NCT04089917|Department of Interventional Neuroradiology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Mariano Espinosa de Rueda|+34 968 36 96 42|mm.espinosa@gmail.com|
20214842|NCT03935880|University of Wisconsin - Madison|Andrew Brooks|248-953-9777|abrooks2@uwhealth.org|
20214843|NCT02476994|Baxter Healthcare|Clinical Trials Disclosure Group||joe_archer@baxter.com|
20214844|NCT02563561|Spectrum Pharmaceuticals, Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20214845|NCT04347018|University at Buffalo|Mohammed Al-Zainal|7168292845|malzaina@buffalo.edu|
20214846|NCT02718326|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20214847|NCT03122535|University of Utah|Elizabeth Nuttall|8012133461|elizabeth.nuttall@hsc.utah.edu|
20214848|NCT05025345|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
20214849|NCT03040362|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214850|NCT00984022|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
20214851|NCT00573443|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
20214852|NCT01153503|University of Texas Southwestern Medical Center|Irina Gasanova, MD, PhD|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
20214853|NCT03591458|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
20214854|NCT00418561|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20214855|NCT01796171|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
20214856|NCT01705574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20214857|NCT00777023|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
20214858|NCT02659150|Massachusetts General Hospital|Ahmed Tawakol, MD|617-724-3699|atawakol@mgh.harvard.edu|
20214859|NCT01215279|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
20214860|NCT02472366|Hopital Lariboisiere|Professor Pascale Massin|0149 95 24 74|pascale.massin@lrb.aphp.FR|
20214861|NCT01707420|University of Colorado|Thomas Notides|720-777-6005|thomas.notides@childrenscolorado.org|
20214862|NCT03699020|University of California San Diego|Maile Young Karris|1-619-543-5039|m1young@health.ucsd.edu|
20214863|NCT00280904|Codman & Shurtleff|J. Thomas Megerian|1-508-828-8274|jmegeri1@its.jnj.com|
20214864|NCT04860804|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
20214865|NCT03620747|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20214866|NCT01860521|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Dr. Umberto Leone Roberti Maggiore|00393289461340|ulrm@libero.it|
20214867|NCT00904423|Stanford Cancer Institute, Stanford University|Mark D Pegram, MD|650-723-5801|mpegram@stanford.edu|
20214868|NCT03861845|Florida International University|Dr. Jaclyn Schwartz|305-348-3106|jschwart@fiu.edu|
20214869|NCT03025945|Arizona Eye Consultants|Sean McCafferty, MD|520-327-3487|sjmccafferty66@hotmail.com|
20214870|NCT00635492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20214871|NCT03617523|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
20214872|NCT00467363|NICHD|Dr Enrique Schisterman|(301) 435-6893|schistee@mail.nih.gov|
20214873|NCT00473330|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20214874|NCT05615935|National Taiwan University|Dr. Piao-Yi Chiou|02-2312-3456|piaoyi@ntu.edu.tw|288427
20214875|NCT03925532|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
20214876|NCT01079988|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20214877|NCT01001208|Amgen Inc.|Study Director|866-572-6436||
20214878|NCT00833937|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214879|NCT00095212|Massachusetts General Hospital|Steven Grinspoon, MD|617 724 9109|sgrinspoon@partners.org|
20214880|NCT04234997|The University of Texas Health Science Center at Houston|Robert Suchting, MD|713-486-2521|Robert.Suchting@uth.tmc.edu|
20214881|NCT05844553|Imperial College London, National Heart & Lung Institute and RBH|Prof. Omar Usmani|02073518053|o.usmani@imperial.ac.uk|
20214882|NCT02032888|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20214883|NCT01697696|Novartis Pharmaceuticals|Study Director|862-778-8300||
20214884|NCT01424644|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20214885|NCT02066922|Alcon Research, Ltd.|Clinical Lead, Vision Care Development|1-888-451-3937|alcon.medinfo@alcon.com|
20214886|NCT02851992|Zimmer Biomet|Lisette Smid, Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
20214887|NCT00727961|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20214888|NCT03161405|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20214889|NCT00837486|Medtronic Neuromodulation|Eric Williamson, Clinical Evidence Specialist|763-526-7982|medtronicneurotrials@medtronic.com|
20214890|NCT02655679|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20214891|NCT01421277|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
20214892|NCT02039908|Florida International University|William E. Pelham, Jr., Ph.D.|305-348-0477|wpelham@fiu.edu|
20214893|NCT00829309|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214894|NCT00274781|The Cleveland Clinic|Mikkael Sekeres, MD, MS|216-445-9353|sekerem@ccf.org|
20214895|NCT02246920|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20214896|NCT02678286|Recro Pharma|Randall Mack|484-35-2470|rmack@recropharma.com|2406
20214897|NCT00448019|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Cancer Center Leukemia Department|713-792-7734|CR_Study_Registration@mdanderson.org|
20214898|NCT05342597|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20214899|NCT01273805|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942|Brian_Wolpin@dfci.harvard.edu|
20214900|NCT02647944|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20214901|NCT01246076|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20214902|NCT02760368|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
20214903|NCT01565902|Novartis Pharmaceuticals|Study Director|862-778-8300||
20214904|NCT03645785|Albany Medical Center|Vikas Bhatt|5182623341|bhattv@amc.edu|
20214905|NCT02214615|VAMC and Yale University|Stephen Waxman|203-937-3802|stephen.waxman@yale.edu|
20214906|NCT02902211|University of Nebraskat at Omaha|Sara Myers|402-554-3246|samyers@unomaha.edu|
20214907|NCT01200810|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|(732) 235-8675|steinmn@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
20214908|NCT02477202|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@MSKCC.ORG|
20214909|NCT00904215|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214910|NCT00838630|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20214911|NCT00640562|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20214912|NCT00448591|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20214913|NCT02937870|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20214914|NCT03749252|Guerbet|Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20214915|NCT00609674|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214916|NCT03098394|University of Maryland School of Medicine|Richard Gentry Wilkerson|4103285555|gwilkerson@som.umaryland.edu|
20214917|NCT00204373|The University of Alabama at Birmingham|Dr. C. Mel Wilcox|205-934-6060|melw@uab.edu|
20214918|NCT01885117|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20214919|NCT00244764|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214920|NCT02701556|Valeant Pharmaceuticals|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
20214921|NCT03702608|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20214922|NCT01312844|Massachusetts General Hospital|Dr. John Matthews|617-643-9095|jmatthews@partners.org|
20214923|NCT02648438|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20214924|NCT03138967|UT MD Anderson Cancer Center|Dr. Farzin Goravanchi / Anesthesiology & Perioperative Medicine|713-291-1163|fgoravan@mdanderson.org|
20214925|NCT04604275|University of Miami|Amanda Fifi|305-243-3166|amandacfifi@gmail.com|
20214926|NCT02689505|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214927|NCT00424619|McMaster University|Dr. Alexandra Papaioannou|905-521-2100|papaioannou@hhsc.ca|77715
20214928|NCT00723710|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20214929|NCT04405570|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
20214930|NCT04499963|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
20214931|NCT03546842|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20214932|NCT01884519|GlaxoSmithKline|GSK Response Center|866-435-7343||
20214933|NCT01723397|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
20214934|NCT01870856|Alcon Research, Ltd.|Anne Brobst, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20214935|NCT02352259|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
20214936|NCT04544787|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
20214937|NCT03031847|UPMC Presbyterian Hospital|Eric Pasquantonio|4126478210|pasquantonioej@upmc.edu|
20214938|NCT01353664|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20214939|NCT03273153|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20214940|NCT02512900|MedImmune, LLC|Rene van der Merwe, Senior Director, Clinical Development, Respiratory, and Inflammation|301-398-0000||
20214941|NCT01237054|National Cancer Institute|Dr. Peter Choyke|301-402-8409|pchoyke@mail.cc.nih.gov|
20214942|NCT00838539|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20214943|NCT01908205|Holland Bloorview Kids Rehabilitation Hospital|Lisa Genore|416-425-6220|lgenore@hollandbloorview.ca|6443
20214944|NCT05323396|University of North Carolina at Chapel Hill|Melisa Reimer-McAtee, MD|265 175 5056|melissa_reimer-mcatee@med.unc.edu|
20214945|NCT03134222|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20214946|NCT00520234|Mycoses Study Group|Luis Ostrosky-Zeichner, MD|(713) 500-6733|Luis.Ostrosky-Zeichner@uth.tmc.edu|
20214947|NCT00913627|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20214948|NCT02124122|Tulane SPHTM|Richard Oberhelman|5049882511|oberhel@tulane.edu|
20214949|NCT02089997|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20214950|NCT02444715|Luxembourg Institute of Science and Technology|Dr. Lübomira Spassova|+352 275 888 1|lubomira.spassova@list.lu|
20214951|NCT01944930|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
20214952|NCT02242201|Mayo Clinic|Dr. Rebecca L. Johnson|507-266-2049|Johnson.Rebecca1@mayo.edu|
20214953|NCT02335658|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
20214954|NCT05593965|University of North Carolina at Chapel Hill|Justin Riddle, PhD|(919) 966-4584|justin_riddle@med.unc.edu|
20214955|NCT04494867|Attune Medical|Erik Kulstad, MD|+1-708-651-0736|ekulstad@gmail.com|
20214956|NCT03238781|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20214957|NCT01597245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20214958|NCT00731783|Washington University|Stephanie A. Fritz, M.D., M.S.C.I.|314-454-6050|fritz_s@kids.wustl.edu|
20214959|NCT03909607|Maimonides Medical Center|Sergey Motov MD|718-283-8693|smotov@maimonidesmed.org|
20214960|NCT02267187|University of Pittsburgh|Patsy Simon|412-648-9207|simonpa@upmc.edu|
20214961|NCT02222818|Medtronic Cardiac Rhythm and Heart Failure|CRTee Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
20214962|NCT00934050|Transition Therapeutics Ireland Limited and Transition Therapeutics USA Inc.|Susan Abushakra, MD, Chief Medical Officer|+1 650 425 6370|susan.abushakra@tthi.us|
20214963|NCT03161158|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49 6172 609 93488|Jennifer.Braun@fmc-ag.com|
20214964|NCT02149420|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20214965|NCT03181594|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20214966|NCT02355886|University of Washington|George Schade|2065986190|grschade@uw.edu|
20214967|NCT00960297|Study Chair|David R. Spigel, M.D.|1-877-MY-1-SCRI|David.Spigel@scresearch.net|
20214968|NCT05763147|BD China|MA manager of Clinical Trial|0086 21 2325 4853|justina.zhu@bd.com|
20214969|NCT01299454|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3974||
20214970|NCT01891994|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
20214971|NCT01727180|Far Eastern Memorial Hospital|Hon-Yen Wu, MD, PHD|+886-2-8966-7000|honyenwu@gmail.com|1164
20214972|NCT00202722|Sorlandet Hospital HF|Tor Tveit|+4738073608|tor.tveit@sshf.no|
20214973|NCT03247972|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
20214974|NCT03500341|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20214975|NCT01010555|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20214976|NCT02576938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20214977|NCT00968812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20214978|NCT01593852|Catharina Hospital Eindhoven|Lukas Dekker, MD, PhD|+31 40 239 7000|lukas.dekker@catharina_ziekenhuis.nl|
20214979|NCT00571064|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20214980|NCT02600403|Wills Eye Hospital|Michael Waisbourd|2159283000|MWaisbourd@willseye.org|
20214981|NCT02169115|Charité- Dpt. of Dermatology and Allergy|Professor Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
20214982|NCT00003659|Memorial-Sloan Kettering Cancer Center|Dr. David Scheinberg|646-888-2190|scheinbd@mskcc.org|
20214983|NCT04022954|Abbott|Principal Scientist Clinical Research|1 202 253 5981|eric.horvath@abbott.com|
20214984|NCT03017885|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214985|NCT04267276|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20214986|NCT02258074|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|216-444-9938|gassmaj@ccf.org|
20214987|NCT05446870|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20214988|NCT05244421|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20214989|NCT04108858|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran, MD. PhD.|(832) 829-4307|sdamodaran@mdanderson.org|
20214990|NCT01005745|H. Lee Moffitt Cancer Center and Research Institute|Amod Sarnaik, M.D.|813-745-8581|amod.sarnaik@moffitt.org|
20214991|NCT03444090|Evergreen General Hospital, Taoyuan, Taiwan|Dr. Chi-Liang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
20214992|NCT00693628|Department of Orthopedic Surgery & Rehabilitation, Orthotics and Prosthetics Division|Jonathan Day||jonathan-day@ouhsc.edu|
20214993|NCT02399917|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
20214994|NCT01208337|University of Pittsburgh|Dr. Rakesh Sindhi|412-692-6110|rakesh.sindhi@chp.edu|
20214995|NCT03663179|University of Pennsylvania|Leah Bernardo|2157467162|lleah@pennmedicine.upenn.edu|
20193927|NCT03945825|University of Iowa Carver College of Medicine|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
20193928|NCT01461005|MCRA|Justin Eggleton, Senior Director, Spine Regulatory Affairs|2025525804|jeggleston@mcra.com|
20193929|NCT03197766|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
20193930|NCT01436253|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20193931|NCT05380362|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
20193932|NCT04844879|Medacta International SA|Medical Affairs Department|+41 91 696 60 60|myclinicaldata@medacta.ch|
20193933|NCT04520659|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(443) 813-0697|swoods12@jhu.edu|
20193934|NCT04430439|University of California, Irvine|Karen Lindsay|949-824-0148|kllindsa@hs.uci.edu|
20193935|NCT04485611|Durham VA Health Care System|Dr. Atilio Barbeito, Chief, Anesthesiology Service|(919) 286-6938|atilio.barbeito@va.gov|177150
20193936|NCT04879849|Takeda|Medical Director|+1-877-825-3327|Trialdisclosures@takeda.com|
20193937|NCT03603002|Johns Hopkins University, Department of Radiation Oncology|Dr. K. Ranh Voong|410-550-6597|kvoong1@jhmi.edu|
20214996|NCT03226522|Axsome Therapeutics|Study Director|212-332-5061|cstreicher@axsome.com|
20214997|NCT01615198|Novartis|Study Director|862-778-8300||
20214998|NCT01686438|Crescenz VA Medical Center|Dr. Samuel T. Kuna|215-823-4400|Samuel.Kuna@va.gov|
20214999|NCT00984126|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20215000|NCT01938066|The Ohio State University|Gayle Gordillo|6142938566|gayle.gordillo@osumc.edu|
20215001|NCT00501345|UT MD Anderson Cancer Center|Jean-Bernard Durand, MD / Professor||CR_Study_Registration@mdanderson.org|
20215002|NCT01029340|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
20193938|NCT04201262|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20193939|NCT02902770|Maimonides Medical Center|Antonios Likourezos|7182836896|alikourezos@maimonidesmed.org|
20215003|NCT01864174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20215004|NCT03335761|Medtronic|Mylène Champs (Sr Clinical Research Specialist)|+17635261627|mylene.champs@medtronic.com|
20215005|NCT02648347|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
20215006|NCT01639222|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20215007|NCT00214097|University of Wisconsin|Diana Trask|608-263-9528|trask@humonc.wisc.edu|
20215008|NCT02739997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215009|NCT00468286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20215010|NCT02196675|Ethicon|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20215011|NCT00359281|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
20215012|NCT01474551|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
20215013|NCT04395222|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
20215014|NCT02155465|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
20215015|NCT03686033|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20215016|NCT01854047|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20215017|NCT01045161|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20215018|NCT01114893|Alcon Research, Lt.d|Alcon Clinical|888.451.3937|medinfo@alconlabs.com|817.568.67
20215019|NCT04659603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20215020|NCT00017953|Wake Forest School of Medicine|Dr. Mark Espeland, Principal Investigator|336-922-2072|mespelan@wakehealth.edu|
20215021|NCT02374853|University of Alberta|Dr. John Mullen|780-902-6327|jmullen@ualberta.ca|
20215022|NCT02281084|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20215023|NCT03681470|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
20215024|NCT02305758|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20215025|NCT01077596|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215026|NCT03110003|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
20215027|NCT00811655|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
20215028|NCT02820350|SeaStar Medical|Eric Schlorff, CEO|844-427-8100|eric@seastarmed.com|
20215029|NCT01754597|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20215030|NCT01802320|The University of Texas MD Anderson Cancer Center, Clinical Research Operations|Dr. Scott Kopetz/Associate Professor, GI Medical Oncology|713-792-2828|SKopetz@mdanderson.org|
20215031|NCT02674152|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215032|NCT05265624|University of Utah Moran Eye Center|Paul Bernstein, Principal Investigator|801-585-7231|Paul.Bernstein@hsc.utah.edu|
20215033|NCT00001703|National Cancer Institute, National Institutes of Health|Samir N. Khleif, M.D.|301-496-0901|khleifs@mail.nih.gov|
20215034|NCT03071575|Centers for Disease Control and Prevention|Dr. Takudzwa SAYI|404-718-3797|prp2@cdc.gov|
20215035|NCT03666026|UCLA|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
20215036|NCT00834795|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215037|NCT00579345|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20215038|NCT01921894|University of Pittsburgh|Dr. Juan C. Celedon, Niels K. Jerne Professor of Pediatrics|412-692-8429|juan.celedon@chp.edu|
20215039|NCT03447353|National Advanced Driving Simulator, University of Iowa|Timothy Brown|3193354785|timothy-l-brown@uiowa.edu|
20215040|NCT02057835|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215041|NCT04299087|University of Florida|Dr. David Vaillancourt|(352) 294 - 1770|vcourt@ufl.edu|
20215042|NCT03025087|Duke University|Joseph Mathew, MD|919-681-6646|joseph.mathew@duke.edu|
20215043|NCT00508651|MedImmune, LLC|Judith Falloon, MD|301 398 0000|falloonj@medimmune.com|
20215044|NCT03155425|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Clinical Operation Director: Chenglei Qiao|+86-18036618600|chenglei.qiao@hengrui.com|
20215045|NCT01376037|Center for Clinical and Cosmetic Research|Mark S. Nestor, M.D., Ph.D|305-933-6716|nestormd@ADMCORP.com|
20215046|NCT01111461|Eisai, Inc.|Eisai Medical Services|18884224743|esi_medinfo@eisai.com|
20215047|NCT02598089|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
20215048|NCT00834067|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215049|NCT00440518|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
20215050|NCT01415232|UPittsburgh'|Dr. Manuel Vallejo|4126414260|vallejomc@anes.upmc.edu|
20215051|NCT00561015|Janssen Research & Development, LLC|Clinical Leader|609-730-3174||
20215052|NCT03570749|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20215053|NCT03616535|NYU Grossman School of Medicine and Langone Health|Dr. Mara McAdams DeMarco|1-646-987-1358|mara.mcadamsdemarco@nyulangone.org|
20215054|NCT02545283|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WO29519|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
20215055|NCT00804856|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215056|NCT00455312|Masonic Cancer Center, University of Minnesota|Dr. Jakub Tolar, MD||tolar003@umn.edu|
20215057|NCT03343535|TransMedics, Inc.|VP, Clinical Affairs|978-552-0900|ldamme@transmedics.com|
20215058|NCT03868891|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
20215059|NCT01518972|VA Puget Sound Health Care System|Tracy L. Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
20215060|NCT03410862|Cleveland Clinic|Jeff Negrey Study Coordinator|2166365504|negreyj2@ccf.org|
20215061|NCT02363803|Washington University in St. Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
20215062|NCT02159950|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20215063|NCT02107300|Medical University of South Carolina|Chitra Lal|(843) 792-7776|lalch@musc.edu|
20215064|NCT00741858|university of illinois at chicago|k.v. slavin|312-996-4842|kslavin@uic.edu|
20215065|NCT02308475|Medical University of South Carolina|Brian Jacobs - Program Assistant|843-876-4922|jacobsbr@musc.edu|
20215066|NCT02009163|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20215067|NCT03117296|Henry Ford Hospital|Adele Myszenski, PT, DPT|313-916-1334|amyszen1@hfhs.org|
20215068|NCT02453386|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
20215069|NCT02601625|AstraZeneca AB|Anifrolumab Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20215070|NCT01935934|University Health Network - Princess Margaret Cancer Centre|Dr. Neesha Dhani|416-946-4501|neesha.dhani@uhn.ca|2361
20215071|NCT00833586|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215072|NCT00838279|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215073|NCT01415986|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
20215074|NCT03359356|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
20215075|NCT03792477|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215076|NCT01681745|Pacira Cryotech, Inc.|Kent Jones/ Sr. Director Quality and Medical Affairs|(510)933-1513|kent.jones@pacira.com|
20215077|NCT00840411|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20163161|NCT03369249|New York State Psychiatric Institute|Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
20163162|NCT00887549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163163|NCT04112303|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20163164|NCT00100789|SWOG Statistical Center|Study Statistician|206-667-4623||
20163165|NCT03472950|University of Kansas Medical Center|Jeffrey Statland, MD|913-945-9933|Jstatland@kumc.edu|
20163166|NCT01318408|Drexel University College of Medicine|Carol Lippa, MD|215-762-7090|clippa@drexelmed.edu|
20163167|NCT02506192|Minneapolis VA Health Care System|Ronald R Bach, PhD, Principal Investigator|(612)467-6315|ronald.bach@va.gov|
20163168|NCT01685697|Univeristy of Alberta|Georg Schmolzer|7807354660|georg.schmoelzer@me.com|
20163169|NCT02703324|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215078|NCT04419311|Aksaray University Training and Research Hospital|Dr. Erdem Aras Sezgin|+905057777697|sezginmd@hotmail.com|
20163171|NCT01858766|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20163172|NCT00887510|University of Florida|Rhonda M Cooper-DeHoff|352 273-6184|dehoff@cop.ufl.edu|
20163173|NCT00795236|Oregon Health & Science University|Alfred Lewy|(503) 494-7746|lewy@ohsu.edu|
20163174|NCT01439594|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
20163175|NCT01821859|Oregon Health and Science University|Tanja Pejovic|503-494-5125|pejovict@ohsu.edu|
20163176|NCT00475709|St Jude Medical|Kelly Erickson|16517566580|kaerickson@sjm.com|
20163177|NCT04759157|University of Utah|Dr. Kelly Baron|801-585-7588|kelly.baron@utah.edu|
20163178|NCT04210622|Medtronic, Inc|Clinical Research Specialist|800-328-2518|medtroniccastrials@medtronic.com|
20163179|NCT04427072|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20163180|NCT03400176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20163181|NCT01561053|Grifols|AMBAR clinical manager|+34 935712200|AMBARclinical@grifols.com|
20163182|NCT02104947|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163183|NCT01090063|Tufts Medical Center|Dr. Alice Gottlieb|617-636-7462|Agottlieb@tuftsmedicalcenter.org|
20163184|NCT02326233|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
20163185|NCT02484222|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|18017591058@163.com|
20163186|NCT03202134|AZSintJanAV|Jan Mulier|003250452490|jan.mulier@azsintjan.be|
20163187|NCT00966550|Illinois Institute of Technology|Dr. Britt Burton-Freeman|312-567-5307|bburton@iit.edu|
20163188|NCT00206440|Baylor College of Medicine|Mothaffar Rimawi|713 798 1999|rimawi@bcm.tmc.edu|
20163189|NCT01371734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163190|NCT00958165|CardioFocus, Inc|Burke T. Barrett|508 658-7200|bbarrett@cardiofocus.com|
20163191|NCT01298765|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
20163192|NCT02467842|SK bioscience|Hayoung Lee|+82-2-2008-2552|haylee@sk.com|
20163193|NCT03565237|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20163194|NCT02021955|VA Puget Sound Health Care Sysem|Margaret Collins|206.764.2085|margaret.collins@va.gov|
20163195|NCT01140061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163196|NCT00952393|University of Colorado|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
20163197|NCT00428389|Novartis Pharmaceuticals|Study Director|862-778-8300||
20163198|NCT00766051|University of Utah at the time of the study|Lynne La Corte, PhD, OTR/L, OTD|970 4330981|lflacorte@independence.net|
20163199|NCT03216746|UFParaná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
20163200|NCT04384523|Wuhan Healthgen Biotechnology Corp.|Daichang Yang|18602708398|dyang@oryzogen.com|
20163201|NCT00635882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20163202|NCT02305238|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20163203|NCT01711645|Vanderbilt Medical Center|Kathryn M. Edwards, MD|615-322-3078|Kathryn.edwards@vanderbilt.edu|
20163204|NCT00408434|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20163205|NCT00588354|Mayo Clinic|Dr. Marc A. Huntoon|(507) 284-2511|huntoon.marc@mayo.edu|
20163206|NCT04230213|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163207|NCT00524472|Cleveland Clinic|Andra Duncan, MD|216 445-2372|DUNCANA@ccf.org|
20163208|NCT03058692|Baylor College of Medicine|Robert L. Atmar, M.D.|713-798-6849|ratmar@bcm.edu|
20215079|NCT00465270|Abbott|Dr. Laura O'Brien||laura.obrien@abbott.com|
20215080|NCT03373162|University of California, Irvine|Dr. Craig Stark, Professor|949-824-4201|cestark@uci.edu|
20215081|NCT03122457|Icahn School of Medicine at Mount Sinai|Dr. Anjali Vekaria|212-241-3288|anjali.shroff@mssm.edu|
20215082|NCT02388191|Planned Parenthood League of Massachusetts|Principal Investigator|6176298603|jfortin@pplm.org|
20215083|NCT01921062|University Medical Center Groningen|Dieuwke Broekstra, PhD; postdoctoral researcher|0031503613531|d.c.broekstra@umcg.nl|
20215084|NCT01911676|Yale University|Christina Luddy|203-932-5711|christina.luddy@yale.edu|4549
20215085|NCT00925119|University of Maryland|Dr. Amber Beitelshees|410-706-0118|abeitels@medicine.umaryland.edu|
20163209|NCT00806988|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
20163210|NCT02232022|Northwell Health|Jeffrey M. Katz|516-562-3062|jkatz2@northwell.edu|
20215086|NCT03670017|Washington University School of Medicine|Grant Bochicchio, Harry Edison Professor of Surgery, Chief of Acute and Critical Care Surgery|314-362-9347|gbochicchio@wustl.edu|
20163211|NCT04775953|Duke University|Thomas L. Holland, MD|919-613-4268|thomas.holland@duke.edu|
20163212|NCT01698814|Alcon Research, Ltd.|Terri Pasquine, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20163213|NCT00855959|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20193940|NCT02397447|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
20193941|NCT02994069|University of Kentucky|Dr. Susanne Arnold|859-323-6522|susanne.arnold@uky.edu|
20193942|NCT05823012|Xeris Pharmaceuticals, Inc.|Valentina Conoscenti, MD|1-877-XERIS-37|Clinicaltrials@xerispharma.com|
20193943|NCT05899413|University of California, San Francisco|Dr. Yoobin Park|6289461325|yoobin.park@ucsf.edu|
20193944|NCT04092530|University of Illinois at Chicago|Kristin Rankin|708-710-8411|krankin@uic.edu|
20193945|NCT04683627|Noven Pharmaceutical|Robert Kirshoff|5512332668|clinicaltrials@noven.com|
20193946|NCT03829501|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20193947|NCT00282672|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
20215087|NCT00657553|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-569-6990|pettynathanm@uams.edu|2461
20215088|NCT03173547|Therapeutics, Inc.|Clinical Project Manager|858-571-1800|ClinicalResearch@therapeuticsinc.com|
20215089|NCT01169558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20215090|NCT05528588|UT Southwestern Medical Center|Ambarish Pandey, Principal Investigator|2146200286|Ambarish.pandey@utsouthwestern.edu|
20215091|NCT03482882|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20215092|NCT03254420|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20215093|NCT01110005|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
20215094|NCT01136174|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215095|NCT04322500|University of Molise|Prof. Ciro Costagliola|+39 0874 404861/ 0874 404896|ciro.costagliola@unimol.it|
20215096|NCT00819741|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20215097|NCT00119015|University of Chicago|Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
20215098|NCT05302908|Wake Forest School of Medicine|Scott Rhodes, Ph.D|336-713-5080|srhodes@wakehealth.edu|
20215099|NCT03429712|Duke University Medical Center|Daniele Marin|919-684-2711|daniele.marin@duke.edu|
20215100|NCT05604170|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20215101|NCT03697109|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20215102|NCT03032172|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20215103|NCT06284525|Northern Arizona University|Principal investigator|928-523-1787|Zachary.Lerner@nau.edu|
20215104|NCT00101647|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20215105|NCT02436005|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
20215106|NCT00583453|University of Iowa|Douglas Van Daele|319-353-8162|douglas-van-daele@uiowa.edu|
20215107|NCT00905606|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215108|NCT03635320|Johnson & Johnson Medical (Shanghai) Ltd.|Jie, Zhou|+86 18600551010|JZHOU138@its.jnj.com|
20215109|NCT04523168|Mayo Clinic|Dr. Amir Lerman|507-255-2446|lerman.amir@mayo.edu|
20215110|NCT04512781|Vapotherm|Amy Bergeski|570-351-6966|Abergeski@vtherm.com|
20215111|NCT01558635|Medtronic, Bakken Research Center, Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen, Sr Clinical Research Manager|+31653227763|ber.kleijnen@medtronic.com|
20215112|NCT04994535|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20215113|NCT01158118|Washington University School of Medicine|Mark Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
20215114|NCT04111965|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
20215115|NCT00905840|Johannes-Gutenberg-University Mainz|Prof. Dr. Dr Bilal Al-Nawas, Principal Investigator|0049 6131 17|al-nawas@mkg.klinik.uni-mainz.de|3083
20215116|NCT02362997|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|philippe_armand@dfci.harvard.edu|
20215117|NCT03140631|Michigan Medicine|Dr. Hakan Oral|734-936-8214|oralh@med.umich.edu|
20215118|NCT01667679|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
20215119|NCT00575159|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215120|NCT01499147|University of Illinois Cancer Center|Damiano Rondelli, MD|312-996-6179|drond@uic.edu|
20215121|NCT03872128|Yale University|Nia Fogelman|(917)861-9865|nia.fogelman@yale.edu|
20215122|NCT02926677|Stanford University|Hilit Kletter|650-723-5511|hkletter@stanford.edu|
20215123|NCT00958334|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20215124|NCT02448862|Gangnam Severance hospital, Seoul, Korea|Dr. Jae Chul Koh, MD|82-01087023931|aneskoh@yuhs.ac|
20215125|NCT03419403|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20215126|NCT02738086|University of Colorado Denver|Cory L. Christiansen|303-724-9101|cory.christiansen@cuanschutz.edu|
20215127|NCT03552393|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20215128|NCT01910688|Columbia University Medical Center|Dr. Julian Abrams|(212) 235-1496|ja660@cumc.columbia.edu|
20215129|NCT01289262|DrLutfiKirdarTRH|DR CEM TURAN|00905323513423|cemturan@gmail.com|
20215130|NCT04887415|University of Florida|Emily K. Plowman, Ph.D. CCC-SLP|(352)273-8632|eplowman@ufl.edu|
20215131|NCT04608188|University of South Carolina|Robert Weaver|8037775605|weaverrg@mailbox.sc.edu|
20215132|NCT00838136|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215133|NCT03380845|MGH|Dr. Sandeep Saluja|6466621084|sandeep.s.saluja@gmail.com|
20215134|NCT01250912|University of Maryland, Baltimore|Dr. Timm-Michael Dickfeld|410-328-7801|tdickfel@som.umaryland.edu|
20215135|NCT00304187|New York State Psychiatric Institute|Dr. Michael Devlin|212-543-5748|mjd5@columbia.edu|
20215136|NCT05646251|Geisinger|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|
20215137|NCT01218867|National Cancer Institute|Dr. Steven Rosenberg|301- 496-4164|sar@mail.nih.gov|
20215138|NCT01424293|Maimonides Medical Center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20215139|NCT01304641|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215140|NCT03233724|National Cancer Institute|Dr. David S. Schrump|240-760-6239|david_schrump@nih.gov|
20215141|NCT02252133|Alcon Research, Ltd.|Senior Manager, Clinical Development, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
20215142|NCT00651820|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|817-900-4000|bert.slade@healthpoint.com|
20215143|NCT00773253|University of California San Francisco|Graham A. Glass, MD|415-353-2311|Graham.Glass@ucsf.edu|
20215144|NCT01566721|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20215145|NCT00446563|Novartis Pharmaceuticals|Study Director|862-778-8300||
20215146|NCT02911701|University of New Mexico, Division of Maternal-Fetal Medicine|Dr. Nathan Blue|505-272-6309|nblue1297@gmail.com|
20215147|NCT01302548|University of Florida|Richard F Petrik, MD|352-265-5911|rpetrik@ufl.edu|
20215148|NCT00852696|Cleveland Clinic Florida|Cecilia Calvo|954-659-5637|calvoc@ccf.org|
20215149|NCT02409355|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20215150|NCT02605928|Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital and University of Helsinki, Finland|PhD MD Ritva Peltomaa||ritva.peltomaa@hus.fi|
20215151|NCT00906165|UCL Eastman Dental lnstitute University College London|Professor N Donos|+4420 3456 1075|n.donos@eastman.ucl.ac.uk|
20215152|NCT02530905|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
20215153|NCT00322439|Amgen Inc.|Study Director|866-572-6436||
20215154|NCT01231906|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20215155|NCT04646213|Virginia Commonwealth University|Dr. Ashlee Loughan|804-828-4178|ashlee.loughan@vcuhealth.org|
20215156|NCT01085825|Planned Parenthood of NYC|Research Director|212-274-7255|cti@ppnyc.org|
20215157|NCT02441309|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
20215158|NCT00415363|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20215159|NCT01594047|Fondazione IRCCS Istituto nazionale dei Tumori|Tognoli Emiliano MD|+39 0223902282|Emiliano.Tognoli@istitutotumori.mi.it|
20215160|NCT02658084|University of Miami|Dr. Reshma Mahtani|954-698-3639|rmahtani@miami.edu|
20215161|NCT01051570|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath M.D.|313-576-8717|vaishamu@karmanos.org|
20215162|NCT03290781|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20215163|NCT02957942|University of Minnesota|Mo Chen|612-624-5220|mchen@umn.edu|
20215164|NCT01462279|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
20215165|NCT02538523|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20215166|NCT01258933|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|wwierda@mdanderson.org|
20215167|NCT04189848|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20215168|NCT01588236|Jiangsu Kanion Pharmaceutical Co. Ltd|Weiyi Liu, MD|3016533500|liuweiyi65@hotmail.com|
20215169|NCT04115293|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20215170|NCT02571907|Cook Research Incorporated|Alan Saunders, MS, Senior Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
20215171|NCT02286739|Stryker|Kevin Barga|201 831 5073|kevin.barga@stryker.com|
20215172|NCT01414153|Lpath, Inc.|Susan E. Hazel|858-926-3205|shazel@lpath.com|
20215173|NCT02635750|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215174|NCT00089011|Fred Hutch|David G Maloney, MD PhD|(206) 667-5616|dmaloney@fredhutch.org|
20215175|NCT04196907|Masimo Corporation|Vikram Ramakanth|949-297-7000|clinicalresearchdept@masimo.com|
20215176|NCT02642653|University of California Davis|Dr. Randi Hagerman|9167030247|rjhagerman@ucdavis.edu|
20215177|NCT02875392|Taipei Municipal Wanfang Hospital|Ming-Shun Wu|+886229307930|vw1017@gmail.com|
20215178|NCT02392286|Yale|Dr. Loren Laine|203-785-7312|loren.laine@yale.edu|
20215179|NCT04974684|IKEM Prague|Dr. Zuzana Tucanova|+420 776292211|zuzana.tucanova@ikem.cz|
20215180|NCT00834717|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215181|NCT01701674|H. Lee Moffitt Cancer Center and Research Institute|Dr. Amod Sarnaik|813-745-8581|amod.sarnaik@moffitt.org|
20215182|NCT05244447|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
20215183|NCT05292963|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20215184|NCT00834522|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215185|NCT04516967|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
20215186|NCT03165994|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
20215187|NCT00519194|St. Jude Medical|Sue Walgren, Manager Sr., Clinical Project|6517563210|swalgren@sjm.com|
20215188|NCT00665470|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20215189|NCT03270462|"University of Colorado Denver | Anschutz"|Larry Chan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20215190|NCT00462228|Department of Physical Medicine and Rehabilitation, University of Missouri|Dr. S. Jon Rupright|573-882-3101|RuprightJ@health.missouri.edu|
20215191|NCT00567320|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20215192|NCT01175018|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@mcvh-vcu.edu|
20215193|NCT03285594|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20215194|NCT02558491|University of Virginia Center for Diabetes Technology|Daniel R. Chernavvsky, MD|434-982-0602|mc7m@virginia.edu|
20215195|NCT00834431|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20163214|NCT05589610|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
20193948|NCT02525718|Northwestern Memorial Hospital|Dr. Mohammed Alghoul||malghoul@nm.org|
20163215|NCT02607618|Motif BioSciences|Stephanie Noviello|908-432-7802|stephanie.noviello@motifbio.com|
20193949|NCT03301155|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20193950|NCT03882177|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
20193951|NCT01685229|Acclarent Inc.|Clinical Manager|949-453-6408|PChen126@ITS.JNJ.com|
20163216|NCT00368641|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
20163217|NCT04737278|BDL Biochemistry, consultant for Mitosynergy|Dr Barbara Leinweber, PhD|(520)334-5444|barb@bdlbiochem.com|
20215196|NCT00746395|University of South Alabama|Jack A. DiPalma, M.D.|251-660-5555|jdipalma@usouthal.edu|
20215197|NCT03733444|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20215198|NCT03637764|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20215199|NCT00835263|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215200|NCT01020474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215201|NCT03987191|University of Colorado Anschutz Medical Campus|Dr. Viral Shah, Principal Investigator|303-724-8186|viral.shah@cuanschutz.edu|
20187316|NCT03916185|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20187317|NCT05593900|University of California Davis|Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
20187318|NCT06214559|Eurofins Dermscan Pharmascan|Project Manager|+33 (0)4 72 82 36 56|manon.laune@cpt.eurofinseu.com|
20187319|NCT02844465|MedtronicNeuro|Clinical Study Manager|(877) 590-7835|rs.slatestudy@medtronic.com|
20215202|NCT03169062|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20215203|NCT03450850|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
20215204|NCT02838420|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20215205|NCT00796653|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215206|NCT01341730|The Catholic University of Korea|Dr. Eun Ho Choo|82-10-8500-4569|cmcchu@catholic.ac.kr|
20215207|NCT01940341|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20215208|NCT02414152|Northwell Health|Dr. Andrea Vambutas|718-470-7550|avambuta@northwell.edu|
20215209|NCT00539110|Shriners Hospitals for Children|Michele Gottschlich PhD|513-872-6298|mgottschlich@shrinenet.org|
20215210|NCT05239754|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20215211|NCT01576042|Duke Clinical Research Institute|Sana M. Al-Khatib, MD, MHS|919-668-8649|sana.alkhatib@dm.duke.edu|
20215212|NCT05178927|UF Health Proton Therapy Institute|Dr. Perry Johnson|904-588-1253|PBJohnson@floridaproton.org|
20215213|NCT01141374|University of São Paulo|Leonice Fumiko Sato Kurebayashi|55-11-91126023|fumie_ibez@yahoo.com.br|
20163218|NCT02363621|Sierra Eye Associates|Dr. Arshad Khanani|775-329-0286|Arshad.Khanani@gmail.com|
20215214|NCT03769025|Perelman School of Medicine|Kyle M Kampman MD Principal Investigator|215 746 2764|kampman@pennmedicine.upenn.edu|
20215215|NCT03374176|Centro Universitario de Tonalá, Universidad de Guadalajara|Dr. Arieh Roldán Mercado Sesma|+52 (33) 20 00 23 00|arieh.mercado@academicos.udg.mx|6400
20215216|NCT00398983|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD / Associate Professor|713-745-0394|eharrison@mdanderson.org|
20215217|NCT00803686|Tarsa Therapeutics, Inc|Nicholas LaBella, Jr. Vice-President Global RA/QA|267-273-7944|nlabella@tarsatherapeutics.com|
20215218|NCT01641380|Johns Hopkins University School of Medicine|Maria Trent, MD, MPH, Principal Investigator|443-287-8945|mtrent2@jhmi.edu|
20215219|NCT03123471|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20215220|NCT05341622|University of Pennsylvania|Shivan Mehta|215-898-9807|shivan.mehta@pennmedicine.upenn.edu|
20215221|NCT01581658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215222|NCT04044521|University of Wisconsin-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
20215223|NCT03682653|UCSF FI Proctor|Dr. Thomas Lietman|(414) 476-1442|tom.lietman@ucsf.edu|
20215224|NCT03801707|The Ohio State University|Brenda Cuson|614-293-6883|Brenda.Cuson@osumc.edu|
20215225|NCT00787254|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20215226|NCT02608177|Kidney Research Institute, University of Washington|Dr. Ian de Boer, Associate Director|2067444029|IDeBoer@Nephrology.washington.edu|
20215227|NCT03761173|Inari Medical, Now Part of Stryker|Ashleigh Willson|925-330-3446|Ashleigh.Willson@Stryker.com|
20215228|NCT00316186|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215229|NCT06907719|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20215230|NCT02740413|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215231|NCT04037969|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20215232|NCT01343004|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
20215233|NCT00526188|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20215234|NCT00594035|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20215235|NCT02798458|Massachusetts General Hospital|Dr. Braden Kuo and Dr. Claire-Zar-Kessler|617-724-6038|bkuo@mgh.harvard.edu, czarkessler@mgh.harvard.edu|
20215236|NCT00795821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215237|NCT01285713|New York University, Langone Medical Center|Dr. Kari Posner|212-263-7300|kariposner@gmail.com|
20215238|NCT04210557|Yale University|Dr. Philip Corlett|203 974 7866|belieflab@yale.edu|
20215239|NCT03821675|Baylor College of Medicine|Prof. Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
20215240|NCT00712959|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20215241|NCT02255149|University of Michigan|Dr. Hsun-Liang Chan|734-763-3325|hlchan@umich.edu|
20215242|NCT00238615|Stanford University|Dr. Heather Wakelee|650-736-7221|hwakelee@stanford.edu|
20215243|NCT05700383|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
20215244|NCT04726345|Columbia University|Ezra J. Margolin, MD|212-305-0114|ejm2182@cumc.columbia.edu|
20215245|NCT02925884|Pacific University|Yu-Chi Tai|503-352-2289|ytai@pacificu.edu|
20215246|NCT04516434|Duke University Medical Center|Cindy Amundsen, MD|919-401-1000|cindy.amundsen@duke.edu|
20215247|NCT02301975|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215248|NCT01379222|Medtronic|Thushari Alahapperuma|763.526.8119|thushari.r.alahapperuma@medtronic.com|
20215249|NCT04278560|Hebrew SeniorLife|On-Yee Lo|6179715331|AmyLo@hsl.harvrd.edu|
20215250|NCT00163657|Baylor University Medical Center|Goran Klintmalm, MD Director|214-820-2050|michelle.acker@baylorhealth.edu|
20215251|NCT01319383|UNC Chapel Hill School of Medicine|Dr. David Margolis|919-966-6388|dmargo@med.unc.edu|
20215252|NCT02303405|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20215253|NCT01867164|Global Clinical Operations Mexico|Clinical Research Director|+52 55 5484 3184||
20215254|NCT01531894|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20215255|NCT03086460|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20215256|NCT04757298|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
20215257|NCT03600805|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20215258|NCT06195579|University of Lincoln|Dr Nima Moghaddam|01522882000|nmoghaddam@lincoln.ac.uk|
20215259|NCT02651272|Bosotn Medical Center|Elizabeth Klings, MD|617-638-7480|elizabeth.klings@bmc.org|
20215260|NCT03123094|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215261|NCT01735994|Pennington Biomedical Research Center|Dr. Tiffany Stewart, Director, Behavior Technology Laboratory|2257632554|tiffany.stewart@pbrc.edu|
20215262|NCT00604162|Given Imaging|Hila Debby|+972 4 9097774|Hila.Debby@givenimaging.com|
20215263|NCT04808362|Peptomyc|Dr Niewel|+34932543450|mniewel@peptomyc.com|8684
20215264|NCT00736190|Gilead Sciences, Inc.|Eduardo Bruno Martins, MD, DPhil, Sr. Director, Medical Affairs - Hepatitis|650-522-5792|eduardo.martins@gilead.com|
20215265|NCT01450189|University of North Carolina at Chapel Hill|William C Miller|9199669407|bill_miller@unc.edu|
20215266|NCT03128723|JnJ Worldwide|Gboyega Adenaike|908-874-1214|aadenaike@its.jnj.com|
20215267|NCT01688609|St. Luke's International Hospital|Dr. Teruo Yamauchi|+81-3-3541-5151|tryhi@luke.ac.jp|
20215268|NCT02909907|Cleveland Clinic Foundation|Hubert H Fernandez|2164451108|FERNANH@ccf.org|
20215269|NCT02115347|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215270|NCT00395694|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215271|NCT05956925|University of Nevada, Las Vegas|Dieu-My Tran (PI)|17028953371|dieu-my.tran@unlv.edu|
20215272|NCT02699866|Institut Straumann AG|Dr. Michael McCaskey, Team Leader Clinical Research|+41619651741|michael.mccaskey@straumann.com|
20215273|NCT02849457|University of Alabama at Birmingham|E. Martina Bebin M.D., M.P.A.|205-975-2890|ebebin@uabmc.edu|
20215274|NCT02599558|Mayo Clinic|Jeffrey A. Alexander, M.D.|507+284-0474|Alexander.Jeffrey14@mayo.edu|
20193952|NCT01012362|Masonic Cancer Center, University of Minnesota|Dr. Arkadiusz Dudek|651-254-3321|Arkadiusz.Z.Dudek@HealthPartners.com|
20215275|NCT00252967|Brown University|Samuel Dudley, MD, PhD|4014443024|samuel_dudley@brown.edu|
20215276|NCT04238754|Johns Hopkins Univeristy|Cecilia Bergeria|410-550-1979|cberge21@jhmi.edu|
20215277|NCT03302780|University of Texas McGovern Medical School - Houston|Sheng Li, MD, PhD|7137977125|sheng.li@uth.tmc.edu|713
20193953|NCT02964325|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
20215278|NCT01294917|Centre for Contact Lens Research|Clinical Scientist|519-888-4567|marc.schulze@uwaterloo.ca|36590
20215279|NCT00374231|University of Cincinnati|E. Steve Woodle, MD|(513) 558-6001|woodlees@uc.edu|
20215280|NCT03406156|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20215281|NCT05454956|Tarsus Pharmaceuticals, Inc.|Kavita Dhamdhere, Vice President of Clinical Development|650-223-4062|kdhamdhere@tarsusrx.com|
20215282|NCT00835536|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215283|NCT01686477|ImperialC|Luke Mills|+447989748017|l.mills@imperial.ac.uk|
20215284|NCT01863030|University of Kentucky Medical Center|Scott Roth M.D.|859-323-6346|sroth@uky.edu|240
20215285|NCT01471041|Vital Access|Mark Crawford|8014339390|mcrawford@vital-access.com|
20215286|NCT02233985|Instituto Mexicano del Seguro Social|Dr. Gloria Patricia Sosa-Bustamante|01 52 4777174800|patriciasosab@hotmail.com|31828
20215287|NCT01249651|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20215288|NCT00813592|Huntsman Cancer institute|Randy Jensen, MD, PhD|801-585-0255|randy.jensen@hci.utah.edu|
20215289|NCT01391273|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20215290|NCT03873272|Columbia University Irving Medical Center|Melissa Accordino, MD|646-317-4692|mkg2134@cumc.columbia.edu|
20215291|NCT04544410|Spruce Biosciences|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
20215292|NCT02430480|National Cancer Institute|Dr. Fatima Karzai|301-480-7174|karzaifh@mail.nih.gov|
20215293|NCT04493684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20215294|NCT01963728|Inova Health Care System|Anne Whitney Brown, MD Principal Investigator|703.776.3067|anne.brown@inova.org|
20215295|NCT04870606|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+86- 512 6263 9938|PR@kintor.com.cn|
20215296|NCT05152576|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
20215297|NCT00859430|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215298|NCT01660243|Toray Industries, Inc|Clinical Trials Information Desk||clinical-trials.toray.mb@mail.toray|
20215299|NCT03423654|VA|April Maa|4043216111|april.maa2@va.gov|206817
20215300|NCT04310345|Vanderbilt School of Nursing|Dr. Mary Jo Gilmer|6153430938|maryjo.gilmer@vanderbilt.edu|
20215301|NCT00828295|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
20215302|NCT01402050|Phoenix Perinatal Associates - Mednax|Ana Braescu|602-614-0488|ana_braescu@mednax.com|
20215303|NCT03220958|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20215304|NCT03098485|Washington University in St. Louis School of Medicine|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
20215305|NCT04200833|Medical University of Graz|PD MD Andrea Skrabl-Baumgartner|+43 316 385|andrea.skrabl-baumgartner@medunigraz.at|111
20215306|NCT01361633|Anxiety Disorders Center, Institute of Living/Hartford Hospital|Gretchen Diefenbach, Ph.D.|860-545-7685|gdiefen@harthosp.org|5-7396
20215307|NCT02328040|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
20215308|NCT03049748|Johns Hopkins University (Former Faculty at University of Michigan)|Dr. Jesus Casida|3132047665|jcasida1@jhu.edu|
20193954|NCT03085225|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20215309|NCT00835484|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215310|NCT04162899|ReistoneBiopharma|Roger Liu, Medical Director|8613917512446|roger.liu@reistonebio.com|
20215311|NCT01011413|University of New South Wales|Sean Emery|02 9385 0900|semery@kirby.unsw.edu.au|
20215312|NCT01909713|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
20215313|NCT02682238|Botanix Pharmaceuticals|Anthony Robinson, MS, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20215314|NCT01370317|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215315|NCT00075478|Fred Hutchinson Cancer Research Center/|Dr. Brenda Sandmaier|206-667-4961|bsandmai@fhcrc.org|
20215316|NCT04665375|University Health Network|Sharon Walmsley|416-340-5077|sharon.walmsley@uhn.ca|
20215317|NCT00002601|City of Hope|Paul Frankel, Ph.D.|(626)256-4673|pfrankel@och.org|65265
20193955|NCT01371825|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20215318|NCT02075463|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215319|NCT00673660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215320|NCT01527006|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20215321|NCT01776190|University of Texas Southwestern Medical Center|Benjamin Chong, MD|214-645-2400|ben.chong@utsouthwestern.edu|
20215322|NCT00834340|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215323|NCT00392665|Massachusetts General Hospital|Lori J. Wirth, MD|617-724-4000|LWIRTH@mgh.harvard.edu|
20215324|NCT02197481|The Second Affiliated Hospital of Anhui Medical University|Dr.Jiang-ming Chen|15855518651|chenjm10@126.com|86
20215325|NCT03673670|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
20215326|NCT00187720|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
20215327|NCT03437265|Norgine|Lucy Clayton|+441895826669|LClayton@norgine.com|
20215328|NCT02294786|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20215329|NCT01778010|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
20215330|NCT04859517|INVIVYD, Inc.|Study Inquiry|17818190080|ClinicalTrials@invivyd.com|
20215331|NCT02157623|Cleveland Clinic|Edward Maytin, MD, PhD|216-445-6676|maytine@ccf.org|
20215332|NCT01068821|Mayo Clinic, Florida|Dr. Mary Ellen Wechter|904 412 7351|wechter.mary@mayo.edu|
20215333|NCT02159183|ZMK University of Bern, Clinic of Periodontology|Prof. Dr. med. dent., Dr. h.c., M.S. Anton Sculean|004131 632 25 72|anton.sculean@zmk.unibe.ch|77
20215334|NCT02154672|Yale University School of Medicine|Dr. Preston Sprenkle|2037852815|preston.sprenkle@yale.edu|
20215335|NCT01124305|AORI|Knee Project Director|7036194423|nparks@aori.org|
20215336|NCT01244620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215337|NCT00620711|Vanderbilt university|William F Walsh|615-322-0545|bill.walsh@vanderbilt.edu|
20215338|NCT00840073|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215339|NCT01663233|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
20215340|NCT02321098|Galderma|Farzaneh Sidou Clinical Project Manager|04 93 95 70 51|farzaneh.sidou@galderma.com|33
20215341|NCT00840476|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215342|NCT01788423|Indiana University, Department of Speech and Hearing Sci|Larry E. Humes|812-855-3507|humes@indiana.edu|
20215343|NCT03249454|The University of Texas Health Science Center at Houston|Radha Korupolu, MD, MS|713-797-6976|Radha.Korupolu@uth.tmc.edu|
20215344|NCT01913405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20215345|NCT04813354|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20215346|NCT00705666|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20215347|NCT02105272|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
20215348|NCT03259139|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
20215349|NCT00064038|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
20215350|NCT03359863|University of California at San Francisco|Aida Venado, MD, MAS|4153532577|aida.venado@ucsf.edu|
20215351|NCT02964039|Ralph H. Johnson VAMC / MUSC|Jesse Dean|8437929566|deaje@musc.edu|
20215352|NCT05479058|Galapagos N.V.|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20215353|NCT05630885|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20215354|NCT01103713|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215355|NCT03435835|Purdue University/Indiana University|Dr. Bruno Roseguini|7654962612|brosegui@purdue.edu|
20215356|NCT01929863|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215357|NCT00251979|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20215358|NCT00284518|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20193956|NCT04868539|Brigham and Women's Hospital|Dr. Charles Czeisler, Ph.D., M.D.|617-732-4013|cacadmin@partners.org|
20193957|NCT01038427|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20193958|NCT01162863|University of Michigan|Dr. Richard J Saad|734-936-4780|rsaad@umich.edu|
20193959|NCT00588692|Mayo Clinic|Dr. Barry A. Borlaug|507-284-4442|borlaug.barry@mayo.edu|
20193960|NCT00820170|Memorial Sloan Kettering Cancer Center|Dr. Monica Fornier|646-888-4563|fornierm@mskcc.org|
20215359|NCT06185088|University of Michigan|Meghan Arnold|734-936-8978|meghanar@med.umich.edu|
20193961|NCT02221557|Sunstar Americas, Inc.|Akane Takemura, R&D Senior Manager|847-794-4276|akane.takemura@us.sunstar.com|
20215360|NCT01878292|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20215361|NCT03077451|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
20163219|NCT01128244|University of Florida|Dr. Jesse F. Gregory|(352) 392-1991|jfgy@ufl.edu|225
20163220|NCT05690555|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
20163221|NCT04506502|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20163222|NCT01449006|St Vincent's Hospital, Sydney, Australia|Prof. Bruce Brew|61 2 8382 1111|bruce.brew@svha.org.au|4100
20163223|NCT03526146|San Francisco Veterans Affairs Health Care System, San Francisco, CA|Linda L. Chao|415-221-4810|linda.chao@ucsf.edu|24386
20163224|NCT02588261|Astellas Pharma Global Development, Inc.|Senior Medical Director|1800 888-7704|astellas.resultsdisclosure@astellas.com|
20163225|NCT01898429|Dartmouth Hitchcock Medical Center|Paul E. Holtzheimer, MD|603-650-4914|Paul.E.Holtzheimer@hitchcock.org|
20163226|NCT01137032|Fougera Pharmaceuticals Inc.|Angela C. Kaplan, Associate Director Clinical Development|631-659-2256|angela.kaplan@sandoz.com|
20163227|NCT01746368|Tuscaloosa VA Medical Center (Retired)|Ann Mahaney-Price, DNP|205-409-8301|amparnp@yahoo.com|
20163228|NCT05636852|GE HealthCare|Paul Sherwin, MD, PhD|+1 (609) 510-3686|PaulSherwin@gehealthcare.com|
20163229|NCT00972725|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163230|NCT02096549|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
20163231|NCT03705559|University of Kentucky|Shanna Babalonis, Ph. D.|859-257-1881|babalonis@uky.edu|
20163232|NCT00195091|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina MD|646-888-4558|trainat@MSKCC.ORG|
20163233|NCT01543074|Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston TX|Rod Dashwood|7136777806|rdashwood@ibt.tamhsc.edu|
20163234|NCT00945256|University of Texas Medical Branch|Dr Melinda Sheffield-Moore, Professor of Medicine|409-772-8707|melmoore@utmb.edu|
20163235|NCT01979952|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163236|NCT04491539|Florida State University|Henna Budhwani|(850) 644-3296|hbudhwani@fsu.edu|
20163237|NCT04477759|Medical College of Wisconsin|Musaddiq Awan, MD|414-805-4497|mawan@mcw.edu|
20163238|NCT03364738|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20163239|NCT03245398|Swiss Tropical and Public Health Institute|Dr Jennifer Keiser|+41 61 284 8218|jennifer.keiser@swisstph.ch|
20163240|NCT04079816|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
20163241|NCT04531241|Johnson & Johnson Vision Care, Inc.|Meredith Bishop, OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
20163242|NCT02576795|BioMarin (UK) Ltd|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44 207-4203351|KonstantiaMaria.Chavele@bmrn.com|
20163243|NCT01702246|UCSF Benioff Children's Hospital Oakland|Dr. Carolyn Hoppe|(510)428-3193|choppe@mail.cho.org|
20163244|NCT03724890|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20163245|NCT01870505|Memorial Sloan Kettering Cancer Center|Dr. Sarat Chandarlapaty, MD, PhD|646-888-4311|ChandarS@MSKCC.ORG|
20163246|NCT02687139|Johns Hopkins University|Mohamad Allaf, MD|410-502-7710|mallaf@jhmi.edu|
20163247|NCT01635855|Merz Pharmaceuticals North America|Merz Pharmaceuticals North America|800-334-0514|clinicaltrials@merzusa.com|
20163248|NCT03190460|University of Washington School of Nursing|Dr. Hilaire Thompson|2066165641|hilairet@uw.edu|
20163249|NCT01350245|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
20163250|NCT02708355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163251|NCT01320202|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
20163252|NCT04090242|Becton Dickinson|Edward Mahoney|978-901-7248|Edward.Mahoney@bd.com|
20163253|NCT02513472|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20163254|NCT01019369|Baylor College of Medicine|Anitra Beasley, MD, MPH|832-826-7318|anitra.beasley@bcm.edu|
20163255|NCT00604695|Brigham & Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
20163256|NCT03214406|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20163257|NCT01898013|Durham VA Medical Center|Jennifer C. Naylor, PhD|9192860411|jennifer.naylor2@va.gov|
20163258|NCT01957410|Janssen Research & Development, LLC|Director||ClinicalTrialDisclosure@its.jnj.com|
20163259|NCT04560075|University of Pittsburgh|Dr. Tina Goldstein|(412) 246-5604|goldtr@upmc.edu|
20163260|NCT01098305|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
20163261|NCT04551950|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20187320|NCT05671653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215362|NCT01983969|UT MD Anderson Cancer Center|Nieto, Yago / Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
20215363|NCT00268203|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215364|NCT00950989|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20215365|NCT00730691|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20215366|NCT03331289|UTexas_SanAntonio|Ralph A DeFronzo|2105676691|defronzo@uthscsa.edu|
20215367|NCT05776901|University of California, Irvine|Dr. Melissa Pinto, Associate Professor, Sue & Bill Gross School of Nursing|949-824-9272|mdpinto@uci.edu|
20215368|NCT02324660|Azienda Ospedaliera Universitaria di Ferrara|Gianluca Campo, PI of the study|0532237079|cmpglc@unife.it|+39
20215369|NCT00682461|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215370|NCT00835705|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215371|NCT00665925|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20215372|NCT04035187|University of Maryland Baltimore|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
20215373|NCT02028221|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
20215374|NCT03581097|Ospedale Regionale di Bellinzona e Valli (ORBV)|Dr. med. Andrea Saporito, Vice-Chair Department of Anesthesia|091/811.91.11|andrea.saporito@eoc.ch|
20215375|NCT01881763|Northwell Health|Georgios Petrides, MD, PI|718-470-8569|gpetride@northwell.edu|
20215376|NCT00128219|University of Pittsburgh School of Medicine|Sharon Hillier, Ph.D.|412-641-6435|hillsl@mwri.magee.edu|
20215377|NCT01987765|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
20215378|NCT02557035|Helsinn Healthcare SA|Daniel Voisin|+41 91 985 2121|daniel.voisin@helsinn.com|
20215379|NCT03502811|Abbott|Nadia Bouhdi|32-479-94-10-37|nadia.bouhdi@abbott.com|
20215380|NCT01492439|Centre for Addiction and Mental Health|Dr. Sean A. Kidd|416-535-8501|sean.kidd@camh.ca|6295
20215381|NCT05014828|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20215382|NCT03382925|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
20215383|NCT00824291|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215384|NCT00933686|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
20215385|NCT00123734|AGEN Biomedical Ltd|Dr Michael Gerometta|+61 408 885 416|mgerometta@agenix.com|
20215386|NCT00113386|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
20215387|NCT01648582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215388|NCT04408794|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20215389|NCT03517085|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20215390|NCT01444378|Abbott Vascular|Robert McGreevy|408-845-3932|Robert.mcgreevy@abbott.com|
20215391|NCT00556322|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20215392|NCT03856320|William S. Middleton VA Hospital|Dr. Luke Funk|608-256-1901|Luke.Funk@va.gov|17899
20215393|NCT03261167|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20215394|NCT00835146|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215395|NCT03256695|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20215396|NCT00318461|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20215397|NCT03393208|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20215398|NCT04405765|University of Texas Southwestern Medical Center|Tara Kristof - research coordinator|214-648-9007|tara.kristof@utsouthwestern.edu|
20215399|NCT00868374|University Hospitals Cleveland Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
20215400|NCT01848938|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@umu.se|
20215401|NCT01757392|Nielsen Biosciences, Inc|David Burney|858-571-2726|david@nielsenbio.com|
20215402|NCT01218672|Boston Scientific Corporation|Teresa Takle-Flach, Director, Clinical Operations|(952)930-6000|teresa.takle-flach@bsci.com|
20215403|NCT03703791|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20215404|NCT00207090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20215405|NCT01552317|University of Oxford|Principal Investigator|+441865287794|chris.ocallaghan@ndm.ox.ac.uk|
20215406|NCT00841698|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215407|NCT00545506|Dep. Anesthesia And Intensive Care|Helmut Hager|+43 1 40400 4102|helmut.hager@meduniwien.ac.at|
20215408|NCT00099047|Cleveland Clinic|Matt Kalaycio, MD|216-444-3705|kalaycm@ccf.org|
20215409|NCT01348789|Northwestern Memorial Hospital|Dr. Jerome M. Garden|312-280-0891|j-garden@northwestern.edu|
20215410|NCT00323882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20215411|NCT05168735|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
20215412|NCT01668602|Emory University|Trisha Kesar, PT, PhD|404-712-5803|trisha.m.kesar@emory.edu|
20215413|NCT01636661|University of Minnesota|Dr. Bernadette Gillick|612.626.6415|brown029@umn.edu|
20215414|NCT00429416|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
20215415|NCT00830024|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215416|NCT02619682|Fred Hutchinson Cancer Care Center|Dr Leona A Holmberg|206-667-6447|lholmber@fredhutch.org|
20215417|NCT03600376|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
20215418|NCT02358538|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20215419|NCT06999265|University of Michigan at Ann Arbor|Tim Bruns|(734) 647-8727|bruns@umich.edu|
20215420|NCT02178787|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
20215421|NCT02554890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20215422|NCT01521780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215423|NCT00834275|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215424|NCT03649477|Levo Therapeutics|Vice President of Clinical Development|1-847-901-9260|contactus@levotx.com|
20215425|NCT01030133|Medical University of South Carolina|Dr. Jeffery J Borckardt|843.792.3127|borckardt@musc.edu|
20215426|NCT04377087|UPMC|Barbara Stadterman, MPH, CCRP|7245532539|stadtermanbm@upmc.edu|
20215427|NCT01750294|Indiana University & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
20215428|NCT01116739|University of Colorado Denver|Patricia A. Braun|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20215429|NCT01624233|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20215430|NCT05090839|University of Miami|Dr. Roger McIntosh|3052435166|r.mcintosh@miami.edu|
20215431|NCT05710718|Becton, Dickinson and Company|Director Clinical Affairs and Medical Affairs Strategy|551-225-1164|Kirsten.Hammitt@bd.com|
20215432|NCT03119025|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD Study Principal Investigator|383-236-03-29|ct_lab@mail.ru; ostanin62@mail.ru|+7
20215433|NCT01528696|University of Michigan|Mark Chames|734 764-1406|mchames@med.umich.edu|
20215434|NCT01056484|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
20215435|NCT02776774|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
20215436|NCT00835575|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215437|NCT02826694|The University of North Carolina at Chapel Hill|Dr. Cynthia M. Powell|9199667646|powellcm@med.unc.edu|
20215438|NCT01988376|Far Eastern Memorial Hospital|Hsiao, Sheng-Mou|(02)89667000|smhsiao2@gmail.com|1424
20215439|NCT03606174|Mirati Therapeutics|Director, Clinical Operations|858-381-5289|LatvenL@Mirati.com|
20215440|NCT00761813|University of Minnesota|Principal Investigator|612.273.8000|swion001@umn.edu|
20215441|NCT02241551|University of Pittsburgh Cancer Institute|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
20215442|NCT03246503|BiliCam, LLC|James Taylor|2064194923|uncjat@google.com|
20215443|NCT01556906|Aegerion Pharmaceutical|Chief Medical Officer|617-500-7867||
20215444|NCT02331108|Albert Einstein Healthcare Network|Jonathan Roth, M.D.|2154567979|rothj@einstein.edu|
20215445|NCT01896934|Vanderbilt University Medical Center|Dr. Warren D Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
20215446|NCT02197416|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215447|NCT00716625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215448|NCT04590027|University of Tuebingen, Department of Anaesthesiology and Intensive Care Medicine|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
20215449|NCT01383486|Bayer HealthCare LLC, Consumer Care|Head Clinical and Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
20215450|NCT01370369|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20215451|NCT03276754|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215452|NCT02777580|KU Leuven|Prof Frans Van de Werf|003216342111|frans.vandewerf@kuleuven.be|
20215453|NCT00927069|Innovaderm Research, Inc.|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
20215454|NCT02911792|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD - Chief Diabetes Division - Medicine|210 567 6706|defronzo@uthscsa.edu|
20215455|NCT00908128|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215456|NCT00796328|IWK Health Centre|Dr. Ron George|470-6627|rbgeorge@dal.ca|
20215457|NCT00529464|UT MD Anderson Cancer Center|Helen E. Rhodes, MD / Assistant Professor|713-792-2933|CR_Study_Registration@mdanderson.org|
20215458|NCT03199963|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
20215459|NCT00466167|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215460|NCT01144494|University of Nebraska Medical Center|Carol Toris|402-559-1852|ctoris@unmc.edu|
20215461|NCT00107991|UPenn|Jennifer Goldfarb|215-662-2540|jennifer.goldfarb@uphs.upenn.edu|
20215462|NCT01535222|The Medicines Company|Andreas van de Locht|+4989244180862|andreas.locht@themedco.com|
20187321|NCT03812549|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
20187322|NCT01197378|Horizon Pharma USA, Inc.|Evelyn Olson|224-383-3000|clinicaltrials@horizonpharma.com|
20187323|NCT03828799|Institut régional du Cancer de Montpellier|Representative of sponsor|467612446|aurore.moussion@icm.unicancer.fr|+33
20187324|NCT05196919|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
20187325|NCT06232590|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
20187326|NCT02589795|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
20187327|NCT04909801|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20187328|NCT04811040|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20187329|NCT05050149|Palvella Therapeutics, Inc.|Christine Kampf, Vice President of Regulatory Affairs|484-844-0865|christine.kampf@palvellatx.com|
20187330|NCT00321048|Indiana University|Richard Zellars|3179444505|rzellars@iu.edu|
20187331|NCT05299242|University of Oxford|Prof. Sally Hopewell|+441865223458|sally.hopewell@csm.ox.ac.uk|
20187332|NCT05370040|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20187333|NCT04432506|The University of Texas MD Anderson Cancer Center|Paolo Strati, MD|(713) 745-1776|pstrati@mdanderson.org|
20215463|NCT03669861|Massachusetts General Hospital|DRAI Director of Clinical Trials|6176920668|JHSTONE@mgh.harvard.edu|
20215464|NCT02760927|Hollister Incorporated|Stacy Haddad, Director Global Clinical Affairs|+1.847.680.2837|stacy.haddad@hollister.com|
20215465|NCT03930732|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20215466|NCT04708028|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
20215467|NCT02825680|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|Laura.Damschroder@va.gov|
20215468|NCT03279250|UT MD Anderson Cancer Center|Dr. Christopher Logothetis, MD-Professor, Genitourinary Medical Oncology|(713) 563-7210|clogothe@mdanderson.org|
20215469|NCT02913924|New York State Psychiatric Institute|John Mariani MD|646-774-8181|john.mariani@nyspi.columbia.edu|
20215470|NCT02645409|Indiana University|Courtney Dhondt, Clinical Research Nurse|317-274-1791|cgerler@iu.edu|
20215471|NCT03466866|Thomas Jefferson University|Barry Rovner,MD|215-503-1243|Barry.Rovner@Jefferson.edu|
20215472|NCT02089685|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215473|NCT02068820|Florida Hospital Gynecologic Oncology|Robert W. Holloway|407-303-2400|robhollowaymd@gmail.com|
20215474|NCT01172145|Brown University|Laura L. Frakey|401-729-3163|lfrakey@gmail.com|
20215475|NCT04134091|Lipocine Inc|Senior Director of Clinical Development|801-994-7383|admin@lipocine.com|
20215476|NCT03084471|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20215477|NCT00505622|Eisai Call Center|Eisai Inc.|888-422-4743||
20215478|NCT02354339|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uice@prodigy.net.mx|34212
20215479|NCT00835692|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215480|NCT01149733|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|866-384-5525|clinicaltrialqueries@tevausa.com|
20215481|NCT04078022|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Dr. Wilbur Chen|410-706-5328|wchen@som.umaryland.edu|
20215482|NCT00191815|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20215483|NCT03808376|Senseonics|Vice President, Clinical Sciences|301-515-7260|katherine.tweden@senseonics.com|
20215484|NCT03644550|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
20215485|NCT03804983|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20215486|NCT02152163|Delray Medical Center|Russell Weisz, MD|561-213-9371|rdweisz@gmail.com|
20215487|NCT02067611|Techfields|Dr. Chongxi Yu|571 276 5371|chongxiyu@hotmail.com|
20215488|NCT01097577|US Air Force|Julie Meek, Clinical Pharmacist|210-808-2200|julie.m.meek.mil@mail.mil|
20215489|NCT03190005|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
20193962|NCT03995316|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
20215490|NCT02433977|University of Pittsburgh|Stacy Gelhaus Wendell|412-648-1351|gstacy@pitt.edu|
20215491|NCT00748072|University of Bari|Dr. Carlo Manno|390805478878|c.manno@nephro.uniba.it|
20215492|NCT03114891|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
20215493|NCT01718301|Infetious disesases|Dr Josep Mallolas Masferrer|932275400|jmallolas@clinic.ub.es|3312
20215494|NCT05511935|KDH Research & Communication Inc.|President|4043958711|kholtz@kdhrc.com|
20215495|NCT00373256|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215496|NCT00334815|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fhcrc.org|
20215497|NCT03121586|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
20215498|NCT06381102|University of Miami|Marlon Wong, Associate Professor of Clinical|3052842670|mwong2@miami.edu|
20215499|NCT00836004|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215500|NCT00033917|Yale University School of Medicine|Dr. Laura Ment|203-785-5708|laura.ment@yale.edu|
20215501|NCT00446966|Carient Heart and Vascular|Dr Chirag Sandesara|7033358750|csandesara@carient.org|
20215502|NCT01440803|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
20215503|NCT00443651|Genentech, Inc.|Medical Communications|800-821-8590||
20193963|NCT01361594|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20215504|NCT01564394|Huntsman Cancer Institute, University of Utah|Anita Y. Kinney, PhD|801-585-1151|anita.kinney@hci.utah.edu|
20215505|NCT00859521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215506|NCT01609257|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20215507|NCT02125461|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20215508|NCT02305732|Cerus|Carol Moore, Senior VP Regulatory Affairs & Quality|925-288-6361|cmoore@cerus.com|
20215509|NCT02888756|Erasmus MC|Dr R.A. Gruters|+31 10 7032100|r.gruters@erasmusmc.nl|
20215510|NCT00834132|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20193964|NCT00415051|US Army Medical Research Institute of infectious Diseases (USAMRIID)|COL Phillip R. Pittman, MD, MPH|301-619-4994|phillip.pitman@amedd.army.mil|
20193965|NCT01460225|Dartmouth-Hitchcock Medical Center|Dr. Brian Lacy|603-650-5215|brian.e.lacy@hitchcock.org|
20193966|NCT03083665|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20193967|NCT06285240|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20193968|NCT05140915|University of Massachusetts Chan Medical School|Dr. Rajani Sadasivam|(508) 856-8923|rajani.sadasivam@umassmed.edu|
20193969|NCT03361865|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20215511|NCT01515891|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20215512|NCT05058430|Saliwell Ltd.|Dr. Andy Wolff|+972508801852|awolff@saliwell.com|
20193970|NCT05619575|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20193971|NCT02819024|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|3135768735|shieldsa@karmanos.org|
20193972|NCT05576662|Stanford University|Linda N. Geng, MD, PhD|650-723-4000|geng@stanford.edu|
20193973|NCT01647945|Stanford University|Dr. Edda Spiekerkoetter|650-724-1493|eddas@stanford.edu|
20193974|NCT05217641|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20193975|NCT05292586|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20193976|NCT02755129|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
20193977|NCT01744704|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20193978|NCT02645123|University of Ioannina School of Medicine|Dr. Georgios Krekoukias|00306934609400|gkrekos@gmail.com|
20193979|NCT03633799|Sebela Women's Health|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|Elizabeth.gray@sebelapharma.com|
20193980|NCT00777764|Genentech, Inc.|Medical Communications|800-821-8590||
20193981|NCT02367040|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20193982|NCT02477618|Sage Therapeutics|Helen Colquhoun, MD - Vice President, Medical Science|(617) 229-5234|Helen@sagerx.com|
20193983|NCT02446821|Sebela Women's Health Inc.|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|elizabeth.gray@sebelapharma.com|
20193984|NCT03007420|Boston Children's Hospital|Pradeep Dinakar, MD|857-218-3556|Pradeep.Dinakar@childrens.harvard.edu|
20193985|NCT01655251|Connecticut Children's Medical Center|Dr. Sharon R. Smith|860-545-9000|srsmith@connecticutchildrens.org|
20193986|NCT02638883|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
20193987|NCT02284009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20193988|NCT06532357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20193989|NCT00747227|Abbott medical Optics, Inc.|Nicholas Taranatino, O.D., Head, Global Clinical Research & Devlopment|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
20193990|NCT03554629|Clinical Research Program Manager|Kathleen H. Niebel RN BSN BSME|978-549-9325|kathleen.h.niebel@gmail.com|
20193991|NCT00685139|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20193992|NCT00225017|Northwestern University|Robert Murphy|312-503-9000|r-murphy@northwestern.edu|
20193993|NCT00663702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20193994|NCT03056300|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20193995|NCT02441985|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
20193996|NCT05241314|University of Minnesota|Sarah Hoffman|612-625-0606|hoff0742@umn.edu|
20193997|NCT04020185|ImmuneSensor Therapeutics Inc.|Vice President of Clinical Operations and Project Management|210-380-5164|tmooneyham@immunesensor.com|
20193998|NCT04087811|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
20193999|NCT02643303|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
20194000|NCT00974818|Memorial Slaon Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|Dalbagng@mskcc.org|
20194001|NCT00626197|F. Hoffmann-La Roche Ltd/Genentech Inc.|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20194002|NCT04833127|NYS Psychiatric Institute and Columbia University|Dr. Susie Hoffman|718 744 7686|sh51@cumc.columbia.edu|
20194003|NCT04339959|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
20194004|NCT04335591|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20194005|NCT05282121|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20194006|NCT05530577|University of Southern California|Christian Hendershot, PhD|323-442-1082|christian.hendershot@usc.edu|
20194007|NCT00561431|University of Alabama at Birmingham|Ashita Tolwani, M.D.|2059752021|atolwani@uab.edu|
20215513|NCT02768701|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
20215514|NCT02718963|Seoul National University Bundang Hospital, Seoul National University College of Medicine|Ju Seok Ryu|82-31-787-7739|jseok337@snu.ac.kr|
20215515|NCT01547286|Massachusetts General Hospital|Dr. Robert Scott Harris, MD|617-726-9429|rsharris@mgh.harvard.edu|
20215516|NCT00540995|City of Hope Medical Center|Dr. Anthony Stein|626-359-8111||
20215517|NCT01246258|Imperial Health|Joanne Rimmer|0061402931120|rimmer.joanne@gmail.com|
20215518|NCT03415308|Duke Center for Research to Advance Healthcare Equity|Alesha Majors|919-660-7545|alesha.majors@duke.edu|
20215519|NCT01471353|University of Florida|Dr. Thomas J. George, Jr.|352-273-8008|thom.george@medicine.ufl.edu|
20215520|NCT00836472|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215521|NCT01695239|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215522|NCT02007863|University of Miami|Martin Andreansky MD|305-243-0850|mandreansky@med.miami.edu|
20215523|NCT04383587|Mayo Clinic|Mark A. Parkulo, MD|9049532000|parkulo.mark@mayo.edu|
20194008|NCT00461981|MedImmune, LLC|Christopher Ambrose, MD|301-398-0000|ambrosec@medimmune.com|
20215524|NCT03913377|Johnson & Johnson Vision Care|Elizabeth Dow, PRINCIPAL RESEARCH OPTOMETRIST|+1800-843-2020|edow1@its.jnj.com|
20215525|NCT05239195|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
20215526|NCT03170219|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-668-5590|rachel.e.olson@duke.edu|
20215527|NCT03552484|Rush University Medical Center|Jori Fleisher, MD MSCE|3125632900|jori_fleisher@rush.edu|
20215528|NCT03499353|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215529|NCT02741687|Emory University|Maya Fayfman, MD|404-778-1664|maya.fayfman@emory.edu|
20194009|NCT05467293|Yuyu Pharma, Inc.|Robert Wonsang Yu|+82 2 6972 9062|wsyu@yuyu.co.kr|
20194010|NCT06264128|SleepRes|Bernie Hete|+1 615-921-2406|bhete@sleepres.com|
20194011|NCT01077128|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20194012|NCT00847626|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20194013|NCT02190903|University of Pennsylvania School of Medicine|Mark D Neuman|2157467468|neumanm@mail.med.upenn.edu|
20194014|NCT03031496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20194015|NCT01254552|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
20194016|NCT02979249|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-659-8512|hetanshi.naik@mssm.edu|
20215530|NCT01015287|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215531|NCT01592240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215532|NCT01117623|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20215533|NCT03264092|Texas Tech University Health Sciences Center|Dr. Antonio Mendoza Ladd|9152154678|antonio.mendoza-ladd@ttuhsc.edu|
20215534|NCT00862563|Department of Psychiatry, Boston Univ School of Medicine|Dr. Domenic A Ciraulo, Professor|617-414-1990|dciraulo@bu.edu|
20215535|NCT00469898|Vanderbilt-Ingram Cancer Center|Leora Horn, M.D.|615-322-4967|leora.horn@vanderbilt.edu|
20215536|NCT01426360|Sun Yat-sen University|Dr. Liu Hongchun|86-0-13826189071|hongchun751@sina.com|
20215537|NCT00529191|Children's Hospital of Philadelphia|Steven Willi, MD|215-590-3174|willi@chop.email.edu|
20215538|NCT01205035|Eye Center of Northern Colorado, PC|Dr. Arthur Korotkin, MD|970-221-2222|retina@eyecenternoco.com|
20215539|NCT02751424|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20215540|NCT01204294|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215541|NCT00245063|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20215542|NCT01839279|Acorda Therapeutics, Inc.|Executive Medical Director|914-437-4300|paupperle@acorda.com|5263
20215543|NCT01907607|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
20215544|NCT01505933|Penn State Health Milton S. Hershey Medical Center|Dr. Uma R Parekh, MBBS, DNB, FRCA, FFARCSI|717531-4264|uparekh@pennstatehealth.psu.edu|
20215545|NCT00840216|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215546|NCT01058668|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
20215547|NCT00316277|McLean Hospital/Harvard Medical School|Roger D. Weiss, M.D.|617-855-2242|rweiss@mclean.harvard.edu|
20215548|NCT05373173|Vanderbilt University Medical Center|Zachary Warren, Ph.D.|615-875-3085|zachary.e.warren@vumc.org|
20215549|NCT00848536|Alcon Research, Ltd.|Director Alcon Clinical|888.451.3937 or 817.568.6725||
20215550|NCT01370733|University of California Los Angeles|Dr. Andrew Leuchter, MD|(310) 825-0207|afl@ucla.edu|
20215551|NCT06539676|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+4631 3763191|freja.freedman@dentsplysirona.com|
20194017|NCT01125046|Northwestern University|Priya Kumthekar, MD||Priya.Kumthekar@nm.org|
20163262|NCT04565951|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|503-220-8262|alan.teo@va.gov|52461
20163263|NCT02748928|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
20163264|NCT00429169|Columbia University/NYSPI|Michael F. Grunebaum, MD|212-543-5842|mfg14@columbia.edu|
20163265|NCT01041521|Tufts University|Christine Wanke, Principal Investigator||christine.wanke@tufts.edu|
20163266|NCT03691662|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20163267|NCT01746173|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
20163268|NCT00147316|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20163269|NCT03771274|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
20163270|NCT02815644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163271|NCT04371666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-093DMDStudy@fibrogen.com|
20163272|NCT03621657|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
20163273|NCT02222610|Retina Consultants of Texas|Dr. Amy C. Schefler|(713) 524-3434|acsmd@retinaconsultantstexas.com|
20163274|NCT00615017|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
20163275|NCT03777059|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20163276|NCT02477124|Duke University|Jennifer Gallagher|9199701551|jennifer.gallagher@duke.edu|
20163277|NCT03974945|Rocky Mountain Regional Department of Veterans Affairs|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
20163278|NCT03350815|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20163279|NCT03571555|Royal Holloway University of London|Dr. Michael Evangeli|00447801543681|michael.evangeli@rhul.ac.uk|
20215552|NCT03214588|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20163280|NCT02214290|Texas Tech University|Dr. Arturo Figueroa|8068345587|arturo.figueroa@ttu.edu|
20163281|NCT02517541|Scientific and Regulatory affairs|Zenia M Størling|+45 49111869|dkzenst@coloplast.com|
20163282|NCT00699608|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163283|NCT01136408|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163284|NCT02828436|University of Minnesota|Manda Keller-Ross|612-625-3175|kell0529@umn.edu|
20163285|NCT04220554|University of Southern Denmark|Consultant, MD, PhD Mathias Tiedemann Svendsen|0045 61265827|mtsvendsen@health.sdu.dk|
20163286|NCT03078556|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163287|NCT03782701|Bascom Palmer Eye Institute|Dr. Wendy Lee|(305) 243-2020|wlee@med.miami.edu|
20163288|NCT04421482|NYU Langone Health|Nazeeh Hanna, MD|516-663-3853|Nazeeh.hanna@nyulangone.org|
20163289|NCT03010319|Integra LifeSciences|Andrew Tummon Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
20163290|NCT02128724|University of Oxford|Stasya Ng|+441865 617083|octo-BKM120@oncology.ox.ac.uk|
20163291|NCT01442714|Stanford University|Dr. Bruno Medeiros|650-723-5007|brunom@stanford.edu|
20163292|NCT04306510|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20194018|NCT03868787|Northwestern University Feinberg School of Medicine|Ashley Turner, MD Assistant Professor of Obstetrics and Gynecology|2316200549|ashley.turner1@nm.org|
20163293|NCT06068426|Cincinnati Children's|Dr. David Vitale|(513) 517-7040|David.Vitale@cchmc.org|
20163294|NCT04720417|Thomas Jefferson University|Rino Seedor, MD|215-955-8874|Rino.Seedor@Jefferson.edu|
20163295|NCT03329092|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163296|NCT03314987|University of Louisville|Dr. Timothy O'Toole Associate Professor|15024190808|tim.otoole@louisville.edu|
20163297|NCT03574779|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163298|NCT02751580|Sidney Kimmel Cancer Center at Thomas Jefferson University|Nicole Simone, MD|215-955-6702|nicole.simone@jefferson.edu|
20194019|NCT01399697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20194020|NCT02510040|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813-975-8690|rkraker@jaeb.org|
20194021|NCT03079284|Maine Medical Center|Dr. Alexa Craig|207-396-7337|craiga@mmc.org|
20215553|NCT00702377|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20215554|NCT00700739|DePuy Synthes Spine|Mark Lotito|(508) 880-8045|Mlotito@its.jnj.com|
20163299|NCT01664182|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA 96161|Thomas J Semrad, MD, MAS|+1 530 582 6450|tsemrad@tfhd.com|
20215555|NCT02314403|Massachusetts General Hospital|Tatsuo Kawai, MD PhD|617-726-0289|tkawai@mgh.harvard.edu|
20163300|NCT01076036|Corindus, Inc|Michail M. Pankratov, MD, PhD, Vice President of Clinical & Regulatory Affairs|508-653-3335|Michail.Pankratov@Corindus.com|206
20215556|NCT00185458|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20215557|NCT03503318|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20215558|NCT02687126|Shahid Gangalal National Heart Centre|Santosh Sharma Parajuli|+9779806532132|santoshparajuli77@hotmail.com|
20215559|NCT01767103|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
20215560|NCT00424047|Celgene Corporation|Anne McClain, Senior Manager|1-866-260-1599|ClinicalTrialDisclosure@celgene.com|
20215561|NCT02664961|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
20215562|NCT01010503|Hoffmann- LaRoche.|Medical Communications|800-821-8590|genentech@druginfo.com|
20215563|NCT01154231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215564|NCT01952691|Hacettepe University|Gul Oznur Karabicak|+90 505 3569409|guloznur@gmail.com|
20215565|NCT00199901|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20215566|NCT01279109|Wake Forest School of Medicine|Dr. Sabina B. Gesell|336-713-8738|sgesell@wakehealth.edu|
20215567|NCT00917735|University of Minnesota|Dr. Mindy Kurzer|612-624-9789|mkurzer@umn.edu|
20215568|NCT04517604|Edward Hines Jr., VA Hospital|Dr. Amy Herrold|708-202-5867|amy.herrold@va.gov|
20215569|NCT04336332|Cancer Institute of New Jersey|Dr. Sabiha Hussain|+1 732-718-3253|hussaisa@rwjms.rutgers.edu|
20215570|NCT02225106|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732-|Ramon.Diaz-Arrastia@uphs.upenn.edu|
20215571|NCT01958294|Silk Road Medical, Inc.|Ric Ruedy, Exec VP, Clinical Affairs|408-585-2112|ric@silkroadmed.com|
20215572|NCT02566850|Ekso Bionics|Katherine Strausser PhD|(510) 529-2529|kstrausser@eksobionics.com|
20215573|NCT03599193|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20215574|NCT00798603|Roswell Park Cancer Institute|Grace K. Dy, M.D.|507-284-9265|grace.dy@roswellpark.org|
20215575|NCT03256227|Minneapolis VA Health Care System|Laura Meis, PhD|612-467-4516|laura.meis@va.gov|
20215576|NCT04372238|Brown University School of Public Health|Brandon DL Marshall, PhD|4018636427|brandon_marshall@brown.edu|
20215577|NCT04241458|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215578|NCT06144424|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20187334|NCT03664700|Oxford University Hospitals|Dr Vassilis Athanassoglou|01865|vassilis.athanassoglou@ouh.nhs.uk|221590
20215579|NCT02832063|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20215580|NCT03733730|Alcon Research, LLC|Sr. Clinical Project Lead, CRD Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20215581|NCT00772603|Supernus Pharmaceuticals, Inc|Stefan Schwabe, M.D., Ph.D., Chief Medical Officer|301-838-2500|sschwabe@supernus.com|2527
20215582|NCT02342535|Northwestern University|Dr. Namratha Kandula|312-503-6470|nkandula@nm.org|
20215583|NCT00081653|Hoffmann-La Roche|Clinical Trials Study Director|+1 973 235 5000||
20215584|NCT02663349|Minneapolis VA Health Care System|Tasha Nienow, PhD|612-467-1004|tasha.nienow@va.gov|
20215585|NCT04145635|Procyrion, Inc.|Rubi Reyes-Fuentez, Clinical Research Associate II|-|rubi@procyrion.com|
20215586|NCT00928057|BD Medical, Medical Affairs|Kenneth Kassler-Taub, MD|201 847 6729|kenneth_kassler-taub@bd.com|
20215587|NCT02451696|NYU Langone|Dr. Orrin Devinsky|646-558-0800|od4@nyu.edu|
20215588|NCT01557751|University of Pittsburgh Medical Center (UPMC)|Dr. Jacques Chelly, MD, PHD MBA|412-623-6382|chelje@anes.upmc.edu|
20215589|NCT00721162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215590|NCT03674892|Tufts Medical Center|Pedram Hamrah, MD|617-636-5720|pedram.hamrah@tuftsmedicine.org|
20215591|NCT05099380|Johnson & Johnson Vision Care, Inc.|John R. Buch-Sr. Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
20215592|NCT02842853|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20215593|NCT04089553|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20215594|NCT01798264|Intarcia|Michelle Braon|510-782-7800||
20215595|NCT03682601|GTO Pharma|Clinical Trial Coordinator|9175436934|akhmea01@gmail.com|
20215596|NCT01175135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215597|NCT01572662|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
20215598|NCT03364192|VA Center for Integrated Healthcare|Emily M. Johnson, Ph.D., PI|315-425-4400|Emily.Johnson1@va.gov|53487
20215599|NCT03317444|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
20215600|NCT04547192|KWAME NKRUMAH UNIVERSITY/SCIENCE/TECH|Dr Adam Gyedu|+233248228838|drgyedu@gmail.com|
20215601|NCT02479763|Montreal General Hospital|Dr. De QH Tran|514-934-1934|de_tran@hotmail.com|43261
20215602|NCT00935012|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215603|NCT01442155|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20215604|NCT04626414|Shield Therapeutics|Jackie Mitchell|+44 (0) 191 511 8500|jackie.mitchell@shieldtx.com|
20215605|NCT02284867|Ain Shams university (AinShamsU)|Ahmed Mohammed Abass , Ass.lecturer in faculty of medicine|002-01066903903|ahmedmams@hotmail.com|
20215606|NCT01590563|Synexus Hungary|Dr. Beata Szoczei, MD|+36 1 436 7330||
20215607|NCT02927639|Children's Hospital of Philadelphia|Tara Kaushal, MD|6177322603|tara.kaushal@joslin.harvard.edu|
20215608|NCT04342663|Washington University School of Medicine|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
20215609|NCT02699463|ResMed Ltd|Dr Alison Wimms|+61 8884 1123|alison.wimms@resmed.com|
20215610|NCT02294981|UCSF Psoriasis and Skin Treatment Center|Tina Bhutani|4159147618|psoriasis@ucsf.edu|
20215611|NCT00911274|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215612|NCT00909038|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215613|NCT01640197|Northumbria University|Emma Wightman|(+44) 0191 2437253|emma.l.wightman@northumbria.ac.uk|
20215614|NCT00909753|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215615|NCT01895335|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20215616|NCT01647828|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
20215617|NCT01169753|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante, MD / Chair, General Internal Medicine||CR_Study_Registration@mdanderson.org|
20215618|NCT00205777|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215619|NCT03734861|Connecticut Children's Medical Center, Asthma Center|Dr. Jessica Hollenbach, PhD|860-837-5333|jhollenbach@connecticutchildrens.org|
20215620|NCT01794845|University of Miami|Matthew C. Abramowitz MD|305-243-4319|MAbramowitz@med.miami.edu|
20215621|NCT02139826|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
20215622|NCT01125163|UTexas_Houston|Dr. Kathleen A. Kennedy|713-500-6708|Kathleen.A.Kennedy@uth.tmc.edu|
20215623|NCT00436163|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20215624|NCT03719040|Abbott|Dr. Kwangdeok Lee|9725269673|kwangdeok.lee@abbott.com|
20215625|NCT06647173|Emory University|Dr. Aaron Siegler|404-712-9733|asiegle@emory.edu|
20215626|NCT01841554|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20215627|NCT00815087|Wang tyng|Dr.Wang TG|+886-2-23123456|patty.jt@gmail.com|67587
20215628|NCT01473953|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20215629|NCT00312897|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
20215630|NCT01278953|Abbott|Lori Rusch, Ph.D.|651-756-2668|lori.rusch@abbott.com|
20215631|NCT03100344|Galderma|Kenny Frazier|817-961-5120|Kenny.frazier@galderma.com|
20215632|NCT04633564|Mylan GmbH|Keri Vaughan, Senior Director|+215.280.2846|keri.vaughan@viatris.com|
20215633|NCT02011945|Bristol-Myers squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
20215634|NCT00902538|Daiichi Sankyo Europe GmbH|Bettina Ammentorp|0049 89 7808 0|bettina.ammentorp@daiichi-sankyo.eu|585
20215635|NCT03527485|Yale School of Medicine|Gustavo A. Angarita, MD, MHS|(203) 974-7536|gustavo.angarita@yale.edu|
20215636|NCT00926887|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
20215637|NCT02324335|Innovation Pharmaceuticals Inc.|Arthur P. Bertolino MD, PhD, MBA|978.921.4125|abertolino@IPharmInc.com|
20215638|NCT00830258|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215639|NCT01002287|Integra LifeSciences|Stefani Battaglia|44 7880 732691|stefani.battaglia@integralife.com|
20215640|NCT03206749|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20194022|NCT00967005|Yale University|Dr. Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
20215641|NCT02752074|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20163301|NCT02221674|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
20215642|NCT00488774|Janssen Research & Development|Senior Director|215-793-7540||
20215643|NCT05523895|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2289|medicalinformation@acadia-pharm.com|
20215644|NCT00041392|Duke University|Dr. Mark F. Newman|919-681-6646|newma005@mc.duke.edu|
20215645|NCT01959672|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
20215646|NCT05041361|University of California, San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
20215647|NCT01919112|Beth Israel Deaconess Medical Center|Sandeep Kumar, MD|617-632-8917|skumar@bidmc.harvard.edu|
20215648|NCT02944617|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20215649|NCT04692155|UAB|Amitkumar Mehta|2059968400|amitkumarmehta@uabmc.edu|
20215650|NCT02554877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215651|NCT00274651|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20215652|NCT03446768|University of California, San Diego, La Jolla, CA|Carl Stepnowsky, PhD|858-642-1240|cstepnowsky@health.ucsd.edu|
20215653|NCT01108445|Duke University Medical Center|Dr. Andrew J Armstrong|919-668-4615|andrew.armstrong@duke.edu|
20215654|NCT02488239|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
20215655|NCT05283148|University of California Davis Comprehensive Cancer Center|Oyebimpe Adesina, MD, MS|9167035166|adesina@ucdavis.edu|
20215656|NCT00095784|University of Chicago|Olatoyosi Odenike, MD|773-702-3354|todenike@medicine.bsd.uchicago.edu|
20215657|NCT02960295|Kaiser Permanente Southern California|Steven Jacobsen MD, PhD. Director, Department of Research and Evaluation|626-564-3470|Steven.J.Jacobsen@nsmtp.kp.org|
20215658|NCT04345653|JFK University Medical Center - Hackensack Meridian Health|Dr. Jawad Kirmani|7327745805|jawad.kirmani@hmhn.org|
20215659|NCT01370811|Quest Research Institute|Aaron L. Ellenbogen, OD, MPH|+1 248 644 7770|aellenbogen@comcast.net|
20215660|NCT03480763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215661|NCT00418938|Amgen Inc.|Study Director|866-572-6436||
20218232|NCT04400760|The University of the West Indies, St. Augustine|Dr. Naveen Seecheran|18687537686|nseecheran@gmail.com|
20215662|NCT01718873|National Cancer Institute, IRCCS, G. Pascale Foundation|Antonio Avallone, Dierctor of Experimental Abdominal Medcial Oncology|+390815903629|a.avallone@istitutotumori.na.it|
20215663|NCT00115063|PenningtonBRC|Tiffany Prather, RN, CDE|225-763-2979|tiffany.prather@pbrc.edu|
20215664|NCT01316055|Vice President - Clinical Development & Medical Affairs (CDMA)|Herbert Henney, PharmD|(914) 347-4300|hhenney@acorda.com|5138
20215665|NCT00003470|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20215666|NCT02992067|Zhejiang Cancer Hospital|Yu Xingfei|057188122001|yuxf1177@zjcc.org.cn|+86
20215667|NCT04667338|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20215668|NCT00748566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215669|NCT01124786|Clovis Oncology, Inc.|VP Clinical Development|415-409-5440|clinicaltrialinfo@clovisoncology.com|
20215670|NCT01442376|Helsinn Healthcare SA|Spinelli Tulla|+4191985 21 21|tulla.spinelli@helsinn.com|
20215671|NCT00863330|Aurora Health Care|IIR regulatory specialist|414-219-7886|jackie.blundon@aurora.org|
20215672|NCT04404725|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
20215673|NCT01075516|Department of Cardiology, San Filippo Neri Hospital - Rome|Dr. Renato P. Ricci||renatopietroricci@tin.it|
20215674|NCT02252016|Merck Sharp & Dohme Corp.|Senior Vice President, Glocal Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215675|NCT02319824|Fred Hutchinson Cancer Research Center|Seth Pollack|206-667-6629|spollack@fhcrc.org|
20215676|NCT01825798|Holland Bloorview Kids Rehabilition Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
20215677|NCT04171115|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
20215678|NCT00834873|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215679|NCT02811003|Smith+Nephew, Inc.|Samantha Andrews|978.971.8990|samantha.andrews@smith-nephew.com|
20215680|NCT02055547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215681|NCT02911025|Brigham and Women's Hospital|Dr. Milena Pavlova|6174772129|mpavlova@bwh.harvard.edu|
20215682|NCT02709018|University of California San Diego|Murray B. Stein MD, MPH|858-534-6451|mstein@health.ucsd.edu|
20215683|NCT01910831|Center for Clinical and Cosmetic Research|Andrew Frisina, Clinical Research Coordinator|305 933 6716|A.Frisina@admcorp.com|
20215684|NCT02923349|Incyte Corporation Call Centre|Incyte Biosciences International Sàrl|8554633463|RA@incyte.com|
20215685|NCT00363077|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215686|NCT01120028|University of Oxford|Prof Peter Friend|01865223872|ccc@ctsu.ox.ac.uk|
20215687|NCT03250117|Titan Pharmaceuticals, Inc.|Kate Beebe DeVarney, PhD|650-244-4990|medinfo@titanpharm.com|
20215688|NCT04063878|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+46 31 376 44 11|marie.ahlson@dentsplysirona.com|
20215689|NCT02751827|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20215690|NCT01248728|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-425-6220|eanagnostou@hollandbloorview.ca|6005
20163302|NCT05292131|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20163303|NCT03829449|Akari Therapeutics Plc|Dr Wynne Weston-Davies|0208 004 6106|wynne.weston-davies@akaritx.com|
20163304|NCT04390880|VA Greater Los Angeles Healthcare System|Gholam Berenji, M.D.|310-268-3547|Gholam.Berenji@va.gov|
20163305|NCT02557542|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
20163306|NCT00465452|The University of Toledo|Julia Spears|419-383-6728|julia.spears@utoledo.edu|
20163307|NCT03254940|Duke University|Dr. Gary G. Bennett (PI/Dean of Trinity College of Arts & Sciences)|(919) 808-7821|gary.bennett@duke.edu|
20163308|NCT00172042|Novartis Pharmaceuticals|Study Director|862-778-8300||
20163309|NCT01771250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163310|NCT01180296|Fetal Medicine Foundation?USA|David McKenna|937-208-4005|dsmckenna@mvh.org|
20163311|NCT00483938|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20163312|NCT01718444|UIC|Albert Asante, MD MPH|3123552634|akdasante@yahoo.com|
20163313|NCT03364309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20163314|NCT01371552|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
20163315|NCT00615992|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163316|NCT02328027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20163317|NCT03319212|Johnson & Johnson Vision Care, Inc.|Elizabeth Dow, OD, FAAO - Principal Research Optometrist|904-443-1061|edow1@its.jnj.com|
20163318|NCT00349778|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
20163319|NCT01811186|Asan Medical Center|Hoseong Lee|82-2-3010-3521|hosng@amc.seoul.kr|
20163320|NCT02465203|Novartis|Study Director|+41613241111||
20163321|NCT02387554|Bundang Seoul National University Hospital|Principal Investigator||mekka@snu.ac.kr|
20163322|NCT04072887|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20163323|NCT00856297|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20163324|NCT02022436|University of Pittsburgh Medical Center|Rabih Chaer|4128023025|chaerra@upmc.edu|
20163325|NCT02248636|Puget Sound VA|William Banks, Associate Chief of Staff for Research|206 764-2701|william.banks4@va.gov|
20163326|NCT03294850|AdventHealth Translational Research Institute|Dr. Karen Corbin|(407) 303-7100|Karen.Corbin@AdventHealth.com|
20163327|NCT02508428|Anderson Orthopaedic Research Institute|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
20163328|NCT02859441|National Institutes of Health|Henry E Wiley, M.D., Principal Investigator, NEI|301-496-6583|wileyhe@nei.nih.gov|
20163329|NCT00801398|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
20163330|NCT00534976|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20163331|NCT00861471|New York University Cancer Institute|Anna Ferrari, MD|212-731-5389|anna.ferrari@nyumc.org|
20163332|NCT02092025|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20163333|NCT00264537|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
20163334|NCT02123576|The Pennsylvania State University Division of Gastroenterology and Hepatology Milton S. Herhsey Medical Center|Dr. Jonathan G. Stine|717-531-0003|jstine@pennstatehealth.psu.edu|28-9478
20163335|NCT00934128|The University of Texas (UT) MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC||HMoreno@mdanderson.org|
20163336|NCT03228212|Johnson & Johnson Vision Care Inc.|John Buch -SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
20163337|NCT02834247|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20163338|NCT01807299|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
20163339|NCT04829916|Guard Therapeutics|Head of Clinical Operations|+46733319438|trials@guardtherapeutics.com|
20194023|NCT04606901|Temple University Hospital|Dr. Ellen Hauck|2674438719|ellen.hauck@tuhs.temple.edu|
20194024|NCT00441259|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20215691|NCT01838681|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@lundbeck.com|
20215692|NCT00796562|Johns Hopkins University|Heather Symons, MD|4105029961|hsymons2@jhmi.edu|
20215693|NCT05350137|Tongji Hospital affiliated Tongji Medical College of Huazhong University of Science and Technology|Dr. Wei Ping|+8613437101581|247046170@qq.com|
20215694|NCT02584608|Indiana Univerity School of Medicine|Micheal Econs|317-274-1339|mecons@iu.edu|
20215695|NCT04198363|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20215696|NCT05344118|Nationwide Children's Hospital|Dr. Joseph D Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
20215697|NCT03067987|University of Miami|Ranjith Ramasamy|3052434873|ramasamy@miami.edu|
20215698|NCT04827394|University of Oklahoma Health Sciences Center|Birju Shah, MD|405-271-5215|birju-shah@ouhsc.edu|42167
20215699|NCT01404988|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
20215700|NCT00829764|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215701|NCT04594252|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20215702|NCT00477594|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20215703|NCT00640341|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
20163340|NCT01761019|Department of Dermatology, University of Pittsburgh School of Medicine|Laura K. Ferris, MD, PhD|412-647-2013|ferrlk@upmc.edu|
20194025|NCT01401153|Research Institute of Child Nutrition|Prof. Dr. Mathilde Kersting|+49-231-792210-18|kersting@fke-do.de|
20194026|NCT05486728|Sunhawk Vision Biotech|President|+886-7-2222660|hjuo@shvbiotech.com|
20215704|NCT03578809|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20194027|NCT01818531|Wake Forest University Health Sciences|Dr. Daryl Henshaw|3367166344|dhenshaw@wakehealth.edu|
20163341|NCT02287467|NIAID|Dr. Richard Davey|301-496-8029|rdavey@niaid.nih.gov|
20215705|NCT02488109|University of California, San Francisco, Department of Pediatrics|Andrea Garber, PhD, RD|415-514-2180|andrea.garber@ucsf.edu|
20215706|NCT02302716|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215707|NCT02906813|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20215708|NCT00557245|University of Washington|Dr. Connie Celum|206-520-3824|ccelum@uw.edu|
20215709|NCT00521586|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215710|NCT02645253|AstraZeneca AB|AZD7594 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20215711|NCT02722239|Biocard Research LLC|Nadiya Rizvanova|+74993088278|n.rizvanova@biocard.com|
20215712|NCT01384591|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8126|melmoore@utmb.edu|
20215713|NCT02392195|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
20215714|NCT00907907|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215715|NCT00545792|Dana-Farber Cancer Institute|Akila N. Viswanathan, MD, MPH|617-732-6331|aviswanathan@lroc.harvard.edu|
20215716|NCT01642277|Loyola University Chicago, Microbiology and Immunology|Dr. Alan J. Wolfe|224-392-4002|awolfe@luc.edu|
20215717|NCT03679598|University of Alabama at Birmingham|Dr. James Wells|2059345555|LungHealth@uabmc.edu|
20215718|NCT03605342|VA Connecticut Healthcare System|Dr Ismene Petrakis|203-932-5711|Ismene.Petrakis@va.gov|1-2244
20215719|NCT00629122|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-8720|mea9008@med.cornell.edu|
20215720|NCT01403194|Mayo Clinic|Dr. Seema Kumar|507-538-2724|kumar.seema@mayo.edu|
20215721|NCT01447017|Centre for Clinical Studies in Malmö|Dr. Pekka Koskinen|+46 (0)40 97 12 60|pekka@clsm.se|
20215722|NCT03428750|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
20215723|NCT04474405|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20215724|NCT00918645|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
20215725|NCT05133180|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20215726|NCT01604941|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20215727|NCT03366792|NYU Langone Health - Perlmutter Cancer Center|Samir S. Taneja, MD|(212) 263-6301|Samir.Taneja@nyulangone.org|
20215728|NCT03283982|Cleveland Clinic Foundation|Dr. Ajita Prabhu|2164444790|prabhua@ccf.org|
20215729|NCT00158925|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
20215730|NCT03325881|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20215731|NCT02121067|University of North Carolina|Matthew Zerden, MD, MPH|6179352394|mzerden@gmail.com|
20215732|NCT03676634|California Department of Public Health|Stephen S. Arnon, M.D., M.P.H., Chief, Infant Botulism Treatment and Prevention Program|510-231-7600|Stephen.Arnon@cdph.ca.gov|
20215733|NCT03556618|University of California, Los Angeles|Dr. Elizabeth Barnert, Principal Investigator, Associate Professor|(310) 206-1483|ebarnert@mednet.ucla.edu|
20215734|NCT02213263|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215735|NCT01188681|Emergent BioSolutions|Scott C. Stromatt|206-859-6675|sstromatt@ebsi.com|
20215736|NCT02277093|Washington University School of Medicine|Benjamin R. Tan|314-362-9915|btan@wustl.edu|
20215737|NCT00493805|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20215738|NCT00216736|Joseph Epstein Centre for Emergency Medicine Research|Prof Anne-Maree Kelly|+61383456666|anne-maree.kelly@wh.org.au|
20215739|NCT02890992|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20215740|NCT02622386|University of Michigan|Johann Gudjonsson|(734) 615-4508|johanng@med.umich.edu|
20215741|NCT03236311|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20215742|NCT01528150|St. Jude Medical|Director Clinical Studies|+1 818 493 3648|aoza@sjm.com|
20215743|NCT00918684|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
20215744|NCT01051349|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20215745|NCT00402103|Novartis Pharmaceuticals|Study Director|862-778-8300||
20215746|NCT00484679|University of Minnesota|Maria Hordinsky, MD|612-624-5721|hordi001@umn.edu|
20215747|NCT00841542|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215748|NCT00418145|Icahn School of Medicine at Mount Sinai|Dr. Fred Lublin|212-241-6854|fred.lublin@mssm.edu|
20215749|NCT02462837|Southern Illinois University School of Medicine|Dr. Danuta Dynda|217-545-7443|ddynda@siumed.edu|
20215750|NCT04428307|Duke University|Wendy Prudhomme-O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
20215751|NCT01075282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215752|NCT02679729|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
20215753|NCT01026402|AstraZeneca|Bryony Harrop|01625 582828|ClinicalTrialTransparency@astrazeneca.com|
20215754|NCT00906399|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20215755|NCT00624286|Novartis Pharmaceuticals|Study Director|862 778-8300||
20215756|NCT00075608|Boston Medical Center|Principal Investigator|617-638-8261|sfenness@bu.edu|
20215757|NCT02177617|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
20215758|NCT03488108|Mayo Clinic|Alison J. Bruce, M.B., Ch.B|904-953-6412|Bruce.Alison@mayo.edu|
20215759|NCT00883233|Galderma|Jean-Charles Dhuin|+33492952921|jean-charles.dhuin@galderma.com|
20215760|NCT00794547|University of Michigan Comprehensive Cancer Center|Dr. Nithya Ramnath|734-647-1417|nithyar@umich.edu|
20215761|NCT00674128|Mayo Clinic|Gregory Altemose MD|480-301-8000|altemose.gregory@mayo.edu|
20215762|NCT00685477|Temple University|Alan Maurer, MD|215-707-8269|amaurer@temple.edu|
20215763|NCT04631562|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
20215764|NCT02615249|Allerderm (dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smartpractice.com|7208
20215765|NCT01457196|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20215766|NCT02096692|Biotronik, Inc.|Clinical Studies Engineer|503-451-8049|justin.michalski@biotronik.com|
20215767|NCT00351039|Fox Chase Cancer Center (formerly at H. Lee Moffitt Cancer Center & Research Institute)|George Simon, M.D.|215-728-2509|george.simon@fccc.edu|
20215768|NCT03703258|University of Washington School of Medicine|Dr. Emily R. Dworkin|206-221-6932|edworkin@uw.edu|
20215769|NCT00849797|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215770|NCT00679081|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinicaltrials@organo.com|
20215771|NCT00725322|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20215772|NCT01279486|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
20215773|NCT03442322|University of Pittsburgh|Natalie Leland|(412) 383-3405|NEL24@pitt.edu|
20215774|NCT01885949|MGH Cancer Center|Dr. Dror Michaelson|6177244000|dmichaelson1@mgh.harvard.edu|
20215775|NCT03500094|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20215776|NCT01662960|Albert Einstein Healthcare Network|Dr. Steven Jax|215-870-0196|stevenandrewjax@gmail.com|
20215777|NCT00433745|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
20215778|NCT02727192|Oslo University Hospital|Professor Lars Gullestad|+4797644772|lars.gullestad@medisin.uio.no|
20215779|NCT02891863|Boston Scientific CRM|Greg Voss|651-581-3068|gregory.voss@bsco.com|
20215780|NCT01380782|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|6176322166|pwen@partners.org|
20215781|NCT01701063|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20215782|NCT02043132|Beaumont Health|Dr. J. Michael Wiater|248-551-3140|J.Michael.Wiater@beaumont.edu|
20215783|NCT04194801|CStone Pharmaceuticals|Hua Hu|+86 021-60333416|CstoneRA@cstonepharma.com|
20215784|NCT00506831|Stanford University|Lorinda Chung|650-493-5000|shauwei@stanford.edu|62042
20215785|NCT02464657|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, MD/Professor|(713)745-0394|fravandi@mdanderson.org|
20215786|NCT01410227|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20215787|NCT01808651|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215788|NCT01165047|Aurora Health Care|Katernie Slotke|414-649-2615|katherine.Slotke@aurora.org|
20215789|NCT00585286|University of California, Irvine|Christopher Zachary, FRCP, MBBS/Prinicipal Investigator|(949) 824-7103|czachary@uci.edu|
20215790|NCT04188392|Baylor College of Medicine|Melissa B Jones, MD|713-791-1414|melissa.jones2@bcm.edu|24747
20215791|NCT01161420|Inspire Medical Systems|Quan Ni|763-205-7968|quanni@inspiresleep.com|
20215792|NCT00608322|Cooper University Hospital|Stephen Trzeciak, MD, MPH|856-342-3342|trzeciak-stephen@cooperhealth.edu|
20215793|NCT03497130|Department of Dermatology at Johns Hopkins University|Dr. Anna Chien|410-502-7546|achien3@jhmi.edu|
20215794|NCT04002648|IRCCSSRaffaele|Prof. Michele De Bonis|+390226437102|debonis.michele@hsr.it|
20215795|NCT04313751|University of North Carolina at Chapel Hill|Yamnia Cortes, PhD, MPH, RN|319-335-1131|yamnia-cortes@uiowa.edu|
20215796|NCT03060486|AOU Careggi|Riccardo Pace, DMD|00390557945608|riccardo.pace@unifi.it|
20215797|NCT00835614|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20187335|NCT05089877|AtriCure|Nfii Ndikintum, VP of Clinical Affairs and Biometerics|5136448192|NNdikintum@atricure.com|
20187336|NCT04024020|University of Pennsylvania|Philip Gehrman|2157463578|philip.gehrman@pennmedicine.upenn.edu|
20187337|NCT05193409|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
20187338|NCT04726371|The Mongan Institute at Massachusetts General Hospital|Dr. Stephen Bartels|617-726-5213|sjbartels@mgh.harvard.edu|
20187339|NCT05061069|Ghent University|Prof. Dr. Leen Maes|093324066|leen.maes@ugent.be|+32
20187340|NCT04083170|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206.667.5925|fmilano@fredhutch.org|
20187341|NCT00746096|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
20187342|NCT02296684|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
20187343|NCT03571581|The Miriam Hospital|Elena Salmoirago-Blotcher|401-793-8325|Elena_Salmoirago_Blotcher@brown.edu|
20187344|NCT01188928|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20187345|NCT03295721|Heron Therapeutics, Inc.|Vice President, Clinical Operations|855-251-7232|svisonneau@herontx.com|
20187346|NCT02795858|Dana-Farber Cancer Institute|Dr. Jennifer Chan, MD|617-632-6315|jennifer_chan@dfci.harvard.edu|
20187347|NCT02393885|AtriCure, Inc.|Nfii Ndikintum|1-513-755-4100|nndikintum@atricure.com|
20187348|NCT00429364|New England Research Institutes, Inc.|Paul Stark, PhD|617-972-3362|pstark@neriscience.com|
20187349|NCT04871529|SWOG|Melissa Plets|206 667 2707|mplets@fredhutch.org|
20187350|NCT05184452|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20187351|NCT05586490|University of Michigan|Chatkaew Pongmala, PhD|734-936-1168|pchatkae@umich.edu|
20187352|NCT03034356|VA Eastern Colorado Health Care System|Jason Tregellas, PhD|303-724-6232|jason.tregellas@va.gov|
20187353|NCT02684227|MD Anderson Cancer Center|Shannon Westin, MD|713-794-4314|swestin@mdanderson.org|
20187354|NCT04047602|Indiana University Health|Kevin Shiue, MD|317 944 2524|kshiue@iuhealth.org|
20187355|NCT04689256|UMass Chan Medical School/UMass Memorial Health|Dr. Brian Silver|508-334-5989|Brian.Silver@umassmemorial.org|
20187356|NCT04867278|Emory University|Dr. Adam Boissonneault|(404) 616-1000|adam.boissonneault@emory.edu|
20187357|NCT05267470|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20187358|NCT05828017|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
20187359|NCT04428203|University of Kentucky|Dr. Zin Myint|8593233964|zin.myint@uky.edu|
20194028|NCT01677767|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20215798|NCT00606281|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20194029|NCT01068665|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20215799|NCT00829712|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20194030|NCT01373580|ReVision Optics|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
20194031|NCT00858689|FRAXA Research Foundation|Michael R. Tranfaglia MD|978-462-1990|info@fraxa.org|
20215800|NCT00617396|UNC Chapel Hill|Dr. Douglas Drossman|919-966-0141|douglas_drossman@med.unc.edu|
20215801|NCT03131895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20194032|NCT02992691|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20194033|NCT05071586|University of Wisconsin - Madison|Bernadette Gillick|608-381-2699|bgillick@wisc.edu|
20215802|NCT01339247|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194034|NCT00392925|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20194035|NCT03552523|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
20194036|NCT03538938|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy|6082655949|demccarthy@ctri.wisc.edu|
20194037|NCT00755105|USDA Grand Forks Human Nutrition Research Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
20194038|NCT02985840|OhioHealth Research Institutute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
20215803|NCT05752721|NYU Langone Health|Pasquale Rummo|646-501-3371|Pasquale.Rummo@nyulangone.org|
20215804|NCT02280863|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
20194039|NCT03398902|Rory Meyers College of Nursing, New York University|Dr. Susan Malone|212-992-7047|sm7760@nyu.edu|
20194040|NCT01518153|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-8750|CR_Study_Registration@mdanderson.org|
20215805|NCT02903407|Duke University|Angela Lowenstern|919-684-0111|angela.sandelin@duke.edu|
20215806|NCT05143047|Vanderbilt University Medical Center|Alison Carroll, MD, MPH|615-875-5025|alison.carroll@vumc.org|
20194041|NCT00847522|Huntsman Cancer Institute|Mark Wade|8012135746|mark.wade@hci.utah.edu|
20194042|NCT01840410|Novartis|Study Director|862-778-8300||
20215807|NCT02287480|Geneva University Hospitals|Prof. Claire-Anne Siegrist|0041 22 379 5778|claire-anne.siegrist@unige.ch|
20215808|NCT03158727|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20215809|NCT00669162|University of Kansas Cancer Center|Xinglei Shen, MD|913-588-3600|ctnursenav@kumc.edu|
20215810|NCT00807495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20215811|NCT00985439|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
20215812|NCT01174186|Silkeborg Regional Hospital|René Oestgaard|0045 78 41 50 00|ostgard@immunology.au.dk|
20215813|NCT01631552|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20215814|NCT00463684|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20215815|NCT01906372|University of Pittsburgh, Division of Rheumatology|Rohit Aggarwal, MD|412-647-2840|aggarwalr@upmc.edu|
20215816|NCT05143801|University of New Mexico|Dr. Christine Mermier|5052772664|cmermier@unm.edu|
20215817|NCT03629054|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20215818|NCT00924638|Medtronic, Inc.|Medtronic CRDM clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
20215819|NCT00367133|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
20215820|NCT01447511|University of Minnesota|Dr. Richard Brundage|612-624-3115|brund001@umn.edu|
20215821|NCT00847535|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
20194043|NCT00839956|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20194044|NCT04041037|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
20194045|NCT01289210|VentiRx Pharmaceuticals Inc.|Kristi Manjarrez, Vice President, Clinical Affairs|206-689-2259|kmanjarrez@ventirx.com|
20194046|NCT01647542|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20194047|NCT01040169|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20194048|NCT00350727|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194049|NCT03564353|UT Dallas|Clinical Trial Manager|972-883-7277|Sarah.McLeod@utdallas.edu|
20194050|NCT03551691|Children's Hospital of Philadelphia|Dr. Virginia Stallings|267-425-1633|stallingsv@chop.edu|
20194051|NCT04193826|Conformal Medical, Inc|Aly Dechert / Manager of Clinical Operations|(603) 718-8742|adechert@conformalmedical.com|
20194052|NCT01876082|Department of Medical Oncology, Institut bergonié|Pr Antoine Italiano, coordinating investigator|05.47.30.60.88|a.italiano@bordeaux.unicancer.fr|
20194053|NCT02964013|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194054|NCT01123070|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8270|USMedInfo@tevapharm.com|
20215822|NCT01252953|Nuffield Department of Population Health, University of Oxford|Prof Martin Landray|+44 (0)1865 743743|martin.landray@ndph.ox.ac.uk|
20215823|NCT02336074|Imperial College London|Professor Sarah Fidler|004420331|s.fidler@imperial.ac.uk|26790
20215824|NCT00836758|University of Florida|Richard B. Berry, MD|352-262-1575|sleep_doc@msn.com|
20215825|NCT01665508|Massachusetts General Hospital|Nandita S. Scott|6177241739|nsscott@partners.org|
20215826|NCT02054715|University of Rochester Medical Center|Gary R. Morrow, PhD, MS; Deans Professor of Oncology|585-275-9961|Gary_Morrow@urmc.rochester.edu|
20194055|NCT03284229|Spectranetics Corporation|Spectranetics Corporation|719-447-2211|Ami.Sood@philips.com|
20215827|NCT00858780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194056|NCT03789175|NHLBI, NIH|Dr. Paul Hwang|3014353068|hwangp@mail.nih.gov|
20194057|NCT01977677|Stanford University School of Medicine|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
20194058|NCT01498887|Novartis Pharmaceuticals|Study Director|862-778-8300||
20194059|NCT01151852|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20194060|NCT03079297|University of Texas Southwestern|Maria Monastirsky|214-648-0174|Maria.Monastirsky@utsouthwestern.edu|
20194061|NCT00667225|University of North Carolina, Chapel Hill|Dean Morrell|919-843-5539|morrell@med.unc.edu|
20215828|NCT01001403|Seoul National University Hospital|CW Jung|82-2-2072-2467|spss@snuh.org|9
20215829|NCT03867838|Stanford University|Cole Simpson|4049077708|cole.simpson@stanford.edu|
20215830|NCT05098743|Vanderbilt University|Dr. Christa Hartch, PI|203-979-2044|christahartch@me.com|
20194062|NCT03733990|Faron Pharmaceuticals Ltd|Chief Medical Officer|+35824695151|info@faron.com|
20194063|NCT02993406|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20194064|NCT03563157|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20194065|NCT02248818|AstraZeneca LP|Joel Posner MD||ClinicalTrialTransparency@astrazeneca.com|
20194066|NCT05262517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194067|NCT02942277|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
20194068|NCT05602727|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194069|NCT02187159|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
20215831|NCT01456221|Coordinacion de Investigacion en Salud, Mexico|Dr. Mardia Guadalupe Lopez Alarcon||marsau2@prodigy.net.mx|
20215832|NCT04025021|MetroHealth Medical Center|Stephanie Merlino Barr|216-778-3269|SMERLINO@METROHEALTH.ORG|
20215833|NCT03498560|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
20187360|NCT04571619|University of Pennsylvania|Natalie Kuzla|2155732935|nkuzla@pennmedicine.upenn.edu|
20187361|NCT02361216|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
20187362|NCT04622774|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20187363|NCT04228042|M D Anderson Cancer Center|Mehrad Adibi, MD|713-563-7458|mllozano@mdanderson.org|
20187364|NCT02460458|Hematology and Transfusion Medicine, L. Sacco University Hospital, University of Milan, Via G. B. Grassi, 74 20157 Milan, Italy|Prof. Augusto B. Federici|+39-0250319895|augusto.federici@unimi.it|
20187365|NCT04197310|Dana Farber Cancer Institute|Dr. Kimberly Perez|617-632-5960|Kimberly_Perez@DFCI.HARVARD.EDU|
20187366|NCT03725384|Sunnybrook Health Sciences Centre|Dr. Yulia Lin|4164804042|yulia.lin@sunnybrook.ca|
20187367|NCT04550221|University of Washington|Susan M. Graham|206-351-0414|grahamsm@uw.edu|
20187368|NCT04447040|Johnson & Johnson Consumer, Inc.|Assoc Dir Med Sci Leader US Self Care Pain|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20215834|NCT00838162|Jan-Cil UK|VP Head of Discovery & Early Development|44 1494 553458|ksimmen1@its.jnj.com|
20187370|NCT01208662|Dana-Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
20187371|NCT04076618|Wake Forest University School of Medicine|Kristen Beavers, PhD, MPH, RD|336-758-5855|kbeavers@wakehealth.edu|
20194070|NCT04325282|Stanford University|Fiona Baumer, MD, MS|(650) 723-0993|fbaumer@stanford.edu|
20163342|NCT03781778|Fred Hutchinson Cancer Research Center|Marian L. Neuhouser, PhD|2066674797|mneuhous@fredhutch.org|
20163343|NCT03106636|University of Oregon|Dr. Philip Fisher|541-346-4968|philf@uoregon.edu|
20194071|NCT00465998|Stavanger University Hospital|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
20163344|NCT00225498|Feinstein Institute for Medical Research, Zucker Hillside Hospital|Anil K. Malhotra, MD|718-470-8012|malhotra@lij.edu|
20215835|NCT00867360|Stanford University|Dr. Alan Schatzberg|650-723-6811|afschatz@stanford.edu|
20215836|NCT01004510|Rochester General Hospital|Todd Sheppard, MD|585-922-4409|todd.sheppard@rochestergeneral.org|
20215837|NCT03275623|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
20215838|NCT00112437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215839|NCT00659828|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
20215840|NCT01824576|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5606|nburkhart@zoll.com|
20215841|NCT03218787|Abbott|Lijuan Jenn Wang, Advisor, Clinical Affairs|01-408-8453133|Lijuan.wang1@abbott.com|
20215842|NCT00147498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215843|NCT01229150|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20215844|NCT03531827|National Cancer Institute|Dr. Ravi Madan|301.480-7168|madanr@mail.nih.gov|
20215845|NCT01935674|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
20215846|NCT01494532|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215847|NCT03506633|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20215848|NCT03944057|Antengene Corporation|Shimin Sun|+8613701803117|jasmine.sun@antengene.com|
20215849|NCT02973269|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20215850|NCT00258856|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20187372|NCT04778397|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20215851|NCT03247686|Resolve Therapeutics LLC|James Posada|208 727 7010|jp@resolvebio.com|
20215852|NCT00159419|Indiana University School of Medicine|Dr. Linda DiMeglio|317-944-3889||
20215853|NCT01109849|Penn State College of Medicine|James Waxmonsky MD|7175318646|jwaxmonsky@pennstatehealth.psu.edu|
20215854|NCT03930849|Department of Veterans Affairs|Carolyn Turvey, Ph.D.|319 338 0581|Carolyn.Turvey@va.gov|637714
20215855|NCT05259852|Case Western Reserve University|Jin Kim-Mozeleski|216-368-6793|jin.kim-mozeleski@case.edu|
20215856|NCT01251393|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
20215857|NCT01541215|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20215858|NCT02633241|Boston Children's Hospital|Joseph P. Cravero|617-355-4292|Joseph.Cravero@childrens.harvard.edu|
20215859|NCT03232736|University of Colorado Anschutz Medical Campus|William Cornwell|16142961686|william.cornwell@ucdenver.edu|
20215860|NCT03102879|Universidad de los Andes|Claudia Brizuela|56 2 26181166|clau@cibrizuela.com|
20215861|NCT00851409|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
20215862|NCT01127087|Mayo Clinic|Dr. John C. Lieske|507-266-7960|lieske.john@mayo.edu|
20215863|NCT02316223|Icahn School of Medicine at Mount Sinai|Dr. Alex Federman|212-824-7565|alex.federman@mountsinai.org|
20215864|NCT01275664|NRG Oncology|Linda Gedeon for Helen Huang, MS|716-845-1169|lgedeon@gogstats.org|
20215865|NCT00529763|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20215866|NCT03669250|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
20215867|NCT00828321|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215868|NCT02997176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215869|NCT04039022|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20215870|NCT00365053|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20215871|NCT02985749|Massachusetts General Hospital|Gagan Joshi, MD|617-724-1541|gjoshi@mgh.harvard.edu|
20215872|NCT01630616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215873|NCT03390257|SF Otolaryngology|Dr. Jacob Johnson|4153625443|jjohnson@sfotomed.com|
20215874|NCT00691704|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
20215875|NCT04406194|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
20215876|NCT02244554|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20215877|NCT04102345|HealthPartners Neuroscience Research|Bhavani Kashyap, MBBS, PhD|651-495-6358|bhavani.x.kashyap@healthpartners.com|
20215878|NCT00834964|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215879|NCT00491738|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20215880|NCT00385736|Abbott|Global Medical Services|800-633-9110||
20215881|NCT05497557|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20215882|NCT03827395|Emory University|Evan J. Anderson, MD|404-727-1746|evanderson@emory.edu|
20215883|NCT01923740|Abbott Vascular|Siok Hwee Tan|+1 408-845-3581|siokhwee.tan@abbott.com|
20215884|NCT01537887|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215885|NCT04723693|Oxford university Hospitals NHS Foundation Trust|Simon Fletcher|01865 225316|simon.fletcher@ouh.nhs.uk|
20215886|NCT00294047|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215887|NCT02157974|University of Colorado Anschutz Medical Campus|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
20215888|NCT00538031|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20215889|NCT00540423|GlaxoSmithKline|GSK Response Center|866-435-7343||
20215890|NCT04077645|University of Illinois Urbana Champaign|Dr. Sean P Mullen|217-244-4502|spmullen@illinois.edu|
20215891|NCT00263588|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20194072|NCT05520775|University of North Carolina at Chapel Hill|Christian Hendershot|(213) 821-0769|christian.hendershot@usc.edu|
20215892|NCT02412852|TheraVasc Inc.|Tony Giordano|3183493851|tgiordano@theravasc.com|
20215893|NCT05274763|Emory University|Dr. Jennifer Mascaro|404-727-4301|jmascar@emory.edu|
20194073|NCT01283152|Baylor University Medical Center|Robert S. Rahimi, M.D., M.S.C.R. Assistant Professor, Department of Medicine|214-820-8500|Robert.Rahimi@Baylorhealth.edu|
20215894|NCT02121184|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
20194074|NCT04414202|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20194075|NCT02783027|University of Pittsburgh|Dr. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
20215895|NCT03393754|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
20194076|NCT01736189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20194077|NCT01499303|AstraZeneca|Bernadette Weidman|800-456-3669|ClinicalTrialTransparency@astrazeneca.com|
20194078|NCT03809039|Mitsubishi Tanabe Pharma Europe Ltd|Clinical Trials, Information Desk|Please e-mail|regulatory@mt-pharma-eu.com|
20215896|NCT03349567|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel-livorsi@uiowa.edu|
20194079|NCT02658877|NYU Langone Health|Joan Reibman|212 263 6479|Joan.Reibman@nyulangone.org|
20194080|NCT00608868|Medical, Astrazeneca Korea|Hui Jung Sin||huijung.sin@astrazeneca.com|
20215897|NCT00101439|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194081|NCT00626626|Penn State Hershey Medical Center|Dr David Claxton|717-531-8401|dclaxton@hmc.psu.edu|
20215898|NCT01867658|C.R. Bard Inc.|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
20194082|NCT02863289|NHS Tayside|Mr Benedict Clift|01382 660111|ben.clift@nhs.net|35160
20194083|NCT03853551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|8772409479
20215899|NCT02845336|Johns Hopkins University|Timothy J McCulley, MD|4105503000|tmccull5@jhmi.edu|
20215900|NCT01496118|Sarah Cannon Development Innovations, LLC|Dr. Jesus Berdeja|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20215901|NCT00932477|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20194084|NCT02476175|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
20194085|NCT01238536|University of Washington|Janna Friedly M.D.|206-744-3664|friedlyj@uw.edu|
20215902|NCT03031795|OhioHealth|John O. Elliott PhD, MPH Research Specialist Medical Education|614-566-3643|john.elliott@ohiohealth.com|
20194086|NCT00758342|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20215903|NCT01151618|Philips Respironics|Bob Romano, Biomedical Engineer|724-387-7781|bob.romano@philips.com|
20194087|NCT00879775|Department of Family Medicine, Dongguk University Ilsan Hospital, Republic of Korea|Sang-Yeon Suh, M.D.,Ph.D|0082-031-961-7490|fmmodel@gmail.com|
20194088|NCT02440425|Moffitt Cancer Center|Robert M. Wenham, MD, MS, FACOG, FACS|813-745-5739|Robert.Wenham@moffitt.org|
20194089|NCT00842244|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194090|NCT04145700|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20194091|NCT00780559|University of Maryland School of Medicine|Clinical Research Coordinator|(410) 328-6583|inmed@som.umaryland.edu|
20194092|NCT00818779|Texas Tech University Health Sciences Center School of Medicine|Gary Meyerrose|806-743-3150|gary.meyerrose@ttuhsc.edu|
20194093|NCT01229878|VA Providence Healthcare System|Kel Morin|347-346-0380|kel.morin@va.gov|
20194094|NCT02775071|Temple University|David Sarwer|215-707-8632|dsarwer@temple.edu|
20194095|NCT01327846|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20194096|NCT01766713|UCSD|Rohit Loomba|858-534-2624|roloomba@ucsd.edu|
20194097|NCT00245960|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20215904|NCT00562718|UT Southwestern Medical Center|ann spangler|(214) 648-3111|ResearchRegistry@utsouthwestern.edu|
20194098|NCT00672737|Stanford University|Anthony Doufas, MD, PhD|(650) 498-7699|agdoufas@stanford.edu|
20194099|NCT01077518|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20194100|NCT01495598|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
20194101|NCT03852719|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20194102|NCT03086655|University of California San Francisco|Dr. Maria Ekstrand|+1 (415) 502-1000|Maria.Ekstrand@ucsf.edu|17142
20194103|NCT05371665|Montana State University|Brandon Scott|(406) 994-5218|brandon.scott2@montana.edu|
20194104|NCT03841526|Xeris Pharmaceuticals|Dawn Harper, VP Clinical Devlopment|1-877-XERIS-37|clinicaltrials@xerispharma.com|
20194105|NCT04897841|University of Wisconsin - Madison|Sharon Blohowiak|608-417-6957|sblohowiak@wisc.edu|
20215905|NCT02227238|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20194106|NCT02603328|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|773-702-8996|astadnik@bsd.uchicago.edu|
20194107|NCT03524092|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20194108|NCT04303780|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20215906|NCT01507662|University of Iowa|Dr. Fredric Wolinsky|(319) 384-3821|fredric-wolinsky@uiowa.edu|
20163345|NCT01915173|Massachusetts General Hospital|Michelle L. Dossett, MD, PhD, MPH|617-643-6034|mdossett@mgh.harvard.edu|
20215907|NCT05604209|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
20215908|NCT02896296|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
20163346|NCT04343755|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20163347|NCT03755882|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO- Director of clinical Sciences|904 443-1290|BPALL@its.jnj.com|
20215909|NCT03124758|Masimo|Tala Harake||studies@masimo.com|
20194109|NCT04893460|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
20194110|NCT05718466|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
20215910|NCT02264977|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
20194111|NCT00387426|UT MD Anderson Cancer Center|Srdan Verstovsek, MD / Associate Professor||eharriso@mdanderson.org|
20194112|NCT01253135|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20194113|NCT01901432|ITALFARMACO S.p.A.|Medical Expert|+39 026443 258|p.bettica@italfarmaco.com|
20194114|NCT00379288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20194115|NCT00918879|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20215911|NCT00243347|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20215912|NCT03329209|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20215913|NCT04364191|University of Pennsylvania|Miranda McPhillips|215-898-8281|mvarr@nursing.upenn.edu|
20215914|NCT03961204|Merck Healthcare KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
20215915|NCT01189747|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20215916|NCT02452463|Roswell Park|CTRP/CT.gov Registry Coordnator|716-845-1073|KIM.BROSIUS@ROSWELLPARK.ORG|
20215917|NCT02153645|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|908-809-1357|gwagner@osmotica.ccom|
20215918|NCT03969641|Duke University|Dr. Geeta Swamy|919.681.5220|geeta.swamy@duke.edu|
20215919|NCT05157048|University of Pennsylvania|Victoria Constantine|215-746-4069|vmcl@pennmedicine.upenn.edu|
20215920|NCT01006967|Geisel School of Medicine at Dartmouth|Jon D. Lurie, MD, MS|603 653-3575|jon.d.lurie@dartmouth.edu|
20215921|NCT01023776|University of Rochester|John Treanor< M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
20215922|NCT00754052|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20215923|NCT02466087|University of Vermont|Emily Tarleton, MS, RD|802-847-4730|emily.tarleton@uvm.edu|
20215924|NCT01086228|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20215925|NCT02658019|University of Miami|Lynn G. Feun, MD|305-243-6606|lfeun@med.miami.edu|
20215926|NCT03234907|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20215927|NCT02986139|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20215928|NCT00414726|Massachusetts General Hospital|Aneesh B. Singhal, MD|617 726 8459|asinghal@partners.org|
20215929|NCT02107196|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
20215930|NCT01993186|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20215931|NCT04158687|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20215932|NCT04523480|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|3052434562|ramasamy@miami.edu|
20215933|NCT00640393|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20215934|NCT02109458|Johns Hopkins University School of Medicine|Dr. Lonny Yarmus|4105025224|lyarmus@jhmi.edu|
20215935|NCT00845130|Univeristy of Kansas Medical Center|In-Young Choi, Ph.D.|913-588-0174|ichoi@kumc.edu|
20215936|NCT02920476|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20215937|NCT03540160|Menlo Therapeutics, Inc.|Iain Stuart, PhD|1-800-775-7936|Iain.Stuart@foamix.com|
20215938|NCT00198133|IndianaU|Patrick J. Loehrer, Sr., M.D.|(317)944-0920|ploehrer@iu.edu|
20215939|NCT02518945|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
20215940|NCT00835666|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215941|NCT00635648|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20215942|NCT02511535|Med Uni Wien, Institut für Spezifische Prophylaxe und Tropenmedizin|Erika Garner-Spitzer, PhD|0043 1 40160|erika.garner-spitzer@meduniwien.ac.at|38255
20215943|NCT02450539|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20215944|NCT05780463|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20215945|NCT01484912|Sinphar Pharmaceutical Co., Ltd. Taiwan|Justine Tang||justine@sinphar.com.tw|
20215946|NCT02351700|Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center|Andrew S. Little, MD|602-406-3181|neuropub@dignityhealth.org|
20215947|NCT00472212|The Ohio State University College of Optometry|Marjean Kulp|614-688-3336|kulp.6@osu.edu|
20215948|NCT04029545|Prollenium Medical Technologies|Director Clinical Affairs|19055081469|clinicaltrials@prolleniumus.com|
20215949|NCT05485662|UT Health San Antonio|Bennett Amaechi, BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
20215950|NCT01439620|Massachusetts General Hospital|Gary Tearney, MD|Optical Frequency Domain Imagi|gtearney@partners.org|
20215951|NCT01007994|Northwell|Christine Sethna|7184703423|csethna@northwell.edu|
20215952|NCT00958724|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20215953|NCT05604014|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
20215954|NCT00840203|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20215955|NCT03616379|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
20215956|NCT02484807|Centre for pulmonary hypertension of the Thoraxclinic at the University Hospital Heidelberg|Professor Dr. med. Ekkehard Grünig|+4962213968053|ekkehard.gruenig@med.uni-heidelberg.de|
20215957|NCT02674711|Brooke Army Medical Center|Dr Dan Rhon|210-916-3303|daniel.i.rhon.ctr@mail.mil|
20215958|NCT00989950|CoxHealth|Arie Ashkenasi, MD|011 972 50 3007477|ashkenasi1@gmail.com|
20194116|NCT03149809|Atlanta VA Health Care System|E. Camille Vaughan, MD, MS|404 315 4100|elizabeth.vaughan2@va.gov|373100
20194117|NCT00357110|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20215959|NCT01851772|Xoft, Inc.|Crystal Leonard, CCRP|9375038588|cleonard@icadmed.com|
20194118|NCT01174576|Harokopio University|Dr. Mary Yannakoulia|00302109549175|myianna@hua.gr|
20194119|NCT03425097|Stanford University|Thomas A Zikos, MD|(408) 426-5599|zikosta@stanford.edu|
20194120|NCT01255631|CUMC Plastic Surgery|Christine Rohde|212-342-3707|chr2111@cumc.columbia.edu|
20194121|NCT03339245|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
20215960|NCT03101358|US Biotest, Inc.|Gere diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
20215961|NCT04739735|Faculty of dentistry, Alexandria University, Egypt|Dr. Rodaina Helmy|00201100001193|rodaina.helmy@alexu.edu.eg|
20215962|NCT02426918|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
20194122|NCT00515671|IUPUI|Michelle Salyers|317-274-2904|mpsalyer@iupui.edu|
20194123|NCT00384774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20215963|NCT03272685|University of Minnesota|Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
20194124|NCT00814177|McMaster University|Sam Schulman, MD|1-905-5270271|schulms@mcmaster.ca|44479
20215964|NCT00495222|Ethicon Endo-Surgery|Susan Knippenberg|513 337-3452|sknippen@its.jnj.com|
20215965|NCT00834405|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20194125|NCT02420951|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177329501|wfitz@partners.org|
20215966|NCT01190865|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20194126|NCT00288639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20194127|NCT02952534|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20194128|NCT00527787|POZEN Inc|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
20215967|NCT00829452|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20194129|NCT04210427|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
20194130|NCT03512964|Johns Hopkins University School of Medicine, Division of Infectious Diseases|Joyce Jones, MD|443-287-8530|jjone154@jhmi.edu|
20194131|NCT01252355|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20194132|NCT01876901|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20194133|NCT02242097|Northwestern University, Feinberg School of Medicine|Dr. Reem Karmali|(312) 695-0990|reem.karmali@northwestern.edu|
20194134|NCT01562041|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20194135|NCT02339545|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
20194136|NCT03435692|Seattle Children's Hospital|David E. Liston, MD, MPH|206-987-3996|david.liston@seattlechildrens.org|
20194137|NCT04313608|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20194138|NCT01145898|Indiana University|Alon Harris|317-278-00177|alharris@indiana.edu|
20194139|NCT01712061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194140|NCT01701102|Hospital for Special Surgery|Jennifer Cheng|212-774-7377|chengj@hss.edu|
20194141|NCT02205034|CHU Toulouse|Pr Maithe Tauber|+33534558551|tauber.mt@chu-toulouse.fr|
20194142|NCT00203268|Thomas Jefferson University|Stephen D. Silberstein, MD|215-955-2243|Stephen.Silberstein@Jefferson.edu|
20215968|NCT01296841|VA Palo Alto|Roy Soetikno|650-493-5000|soetikno@earthlink.net|64800
20215969|NCT00574847|Duke University Medical Center|Wei Jiang, MD|919-668-0762|jiang001@mc.duke.edu|
20194143|NCT04343976|Massachusetts General Hospital|Sponsor-Investigator|617-724-3836|chung.raymond@mgh.harvard.edu|
20163348|NCT02292446|Novaratis Pharmaceuticals|Study Director|888-669-6682|novartis.email@novartis.com|
20163349|NCT00412243|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
20215970|NCT00178178|University of Rochester|Dr. Robert Bronstein|585-275-1024|robert_bronstein@urmc.rochester.edu|
20215971|NCT02471807|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
20215972|NCT05032807|King's College London|Dr Edward Chesney|+44 (0)20 7848 0728|edward.chesney@kcl.ac.uk|
20215973|NCT01559363|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20215974|NCT00746421|Emory University|Jeffrey Rakofsky, MD|404-712-5083|jrakofs@emory.edu|
20215975|NCT00957021|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
20215976|NCT05327777|Thomas Jefferson University Hospital|Research Resident|516-547-7676|ryan.lamm@jefferson.edu|
20215977|NCT01822119|The HEARing CRC & Hearworks, Audiology Hearing and Speech Science, Melbourne, Australia|Professor Robert Cowan|+61 3 9035 5346|r.cowan@unimelb.edu.au|
20215978|NCT00487435|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20215979|NCT01807026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20215980|NCT01608906|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20215981|NCT00868998|Columbia University|Robert Fine|212-305-1168|rlf20@columbia.edu|
20215982|NCT02047305|Medtronic MITG-RGI|Senior Director of Clinical Affairs|303-581-7064|Tumordirectedtherapiesclinical@Medtronic.com|
20215983|NCT01483820|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
20215984|NCT03985657|Johns Hopkins University|Mudiaga Sowho|4105506264|msowho1@jhmi.edu|
20215985|NCT01395017|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20215986|NCT01780350|University of Texas Health Science Center San Antonio|David Wampler, PhD|210.567.7598|wamplerd@uthscsa.edu|
20215987|NCT00858403|H. Lee Moffitt Cancer Center and Research Institute|Eric Haura, M.D., via Moffitt Cancer Center|813-745-6827|eric.haura@moffitt.org|
20215988|NCT00860938|University Hospital Basel, Switzerland|Jörg D. Leuppi, MD PhD, principle investigator|+41-61-2654294|jleuppi@uhbs.ch|
20215989|NCT00412464|Children's Hospital Los Angeles|Guy Young|323-361-5507|gyoung@chla.usc.edu|
20215990|NCT01730846|Yale School of Medicine|Sherry McKee, PhD|203-737-3529|sherry.mckee@yale.edu|
20215991|NCT01018862|Meda Pharmaceuticals Inc|Sr.Director Medical Scientific Affairs|732 564 2200|David.ginsberg@meda.us|
20215992|NCT01222234|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-9252|jstubbs@kumc.edu|
20215993|NCT01968031|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20215994|NCT00874276|University of Florida|Dr. Peter Stacpoole/Principal Investigator|1-352-273-9023|pws@ufl.edu|
20215995|NCT00697801|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20215996|NCT02485158|University of Chicago|Dr. Harriet de Wit|773-702-1537|hdew@uchicago.edu|
20215997|NCT01098851|Covidien|Fran Haury|303 305-2314|fran.haury@covidien.com|
20215998|NCT03087786|Niconovum USA|Dr. Abraham Varghese|336-741-2315|varghea@rjrt.com|
20215999|NCT01472432|Second University Naples|Dr Raffaele Marfella|++390815665110|raffaele.marfella@unina2.it|
20163350|NCT01073449|Dept. of Arrhythmology - Cliniche Humanitas Gavazzeni|Dr. Giosue Mascioli|+39 035 4204159|giosuemascioli@mac.com|
20163351|NCT01822457|Imperial Vascular Unit|Mr Pasha Normahani|+44 (0) 20 759 48904|pnormahani@gmail.com|
20187373|NCT01627574|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-2830|lmurphy@uri.edu|
20187374|NCT05233800|MedStar Health Research Institute|Hannah Arem, Scientific Director, Implementation Science|2028932430|hannah.arem@medstar.net|
20187375|NCT04487860|Aché Laboratórios Farmacêuticos S.A|Dr. Fabio Ikedo|55 11 26086933|fabio.ikedo@ache.com.br|
20187376|NCT03249090|University of North Carolina at Chapel Hill|Principal Investigator|9194456223|symptom_study@unc.edu|
20216000|NCT02155257|Wake Forest University Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
20216001|NCT00516295|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20216002|NCT00834444|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216003|NCT02052895|Mochida Pharmaceutical|Hironori Sato|+81-3-3225-6331|hnsato@mochida.co.jp|
20216004|NCT00731939|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
20216005|NCT02704091|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
20216006|NCT01634139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216007|NCT00425308|Novartis Pharmaceuticals|Study Director|862-778-8300||
20216008|NCT04411680|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
20216009|NCT00841659|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216010|NCT02420353|Hopsital For Special Surgery and University of Michigan|Dr. Christopher Mendias|212-249-2373|mendiasc@hss.edu|
20216011|NCT02463981|UESTC|Prof. Keith Kendrick|+86028-61830811|k.kendrick.uestc@gmail.com|
20216012|NCT03810703|University of Chicago|Dave Arndt|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20216013|NCT00073307|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20216014|NCT01438060|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20216015|NCT01149057|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20216016|NCT01964950|Takeda Pharmaceutical Company Limited|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20216017|NCT04608448|UT Health San Antonio|Ellen Kraig, PhD|210-567-3818|kraig@uthscsa.edu|
20216018|NCT03499873|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20216019|NCT03602339|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20216020|NCT01297504|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20216021|NCT00654186|Oncology Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
20216022|NCT00690495|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
20216023|NCT00840281|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216024|NCT01024855|Abbott Medical Optics, Inc.|Nick Tarantino, Head, Clinical Research and Development|714-247-8613|nicholas.tarantino@amo.abbott.com|
20216025|NCT01003938|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
20216026|NCT03306277|AveXis, Inc|US Medical Information|833-828-3947|medinfo@avexis.com|
20216027|NCT00326872|Mayo Clinic|Dr. Dusica Babovic-Vuksanovic||dbabovic@mayo.edu|
20216028|NCT01968551|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20216029|NCT04060251|Brigham Health|Dr. Wolfgang Fitz|617-732-9501|wfitz@bwh.harvard.edu|
20216030|NCT01155531|Theracos, Inc|Monica Tettamanti, MSc|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
20216031|NCT01087502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216032|NCT01653704|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
20216033|NCT02705716|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216034|NCT01986647|University of Pittsburgh|Jennifer S. Brach, PhD, PT|412-383-6533|jbrach@pitt.edu|
20216035|NCT04541173|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20163352|NCT01290757|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163353|NCT00570310|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216036|NCT01663896|St. Jude Medical|Sr. Manager, Global Clinical Affairs|651-756-5585|mwagner2@sjm.com|
20216037|NCT00999687|Chang Gung Memorial Hospital|Lin Yin-Ku MD.Ph.D.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
20216038|NCT01790685|Johns Hopkins|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
20216039|NCT03541252|Bispebjerg Hospital|Dr. Emily Wenande, MD, PhD|+4540505590|emily.cathrine.wenande@regionh.dk|
20216040|NCT03349632|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20216041|NCT01960296|Icahn School of Medicine at Mount Sinai|Dr. Celia M. Divino|212-241-5499|celia.divino@mountsinai.org|
20216042|NCT02003391|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20216043|NCT02272803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20216044|NCT02611323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20216045|NCT02597049|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20216046|NCT02463487|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20216047|NCT03573544|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
20216048|NCT01899053|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20216049|NCT03105297|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216050|NCT01345539|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
20216051|NCT00227370|Duke Clinical Research Institute|Scott M. Palmer, MD, MHS|919 684 0254|scott.palmer@duke.edu|
20216052|NCT03846193|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20216053|NCT04693429|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
20216054|NCT00755235|Group Health Research Institute|Gregory Simon, Principal Investigator|206-287-2979|simon.g@ghc.org|
20216055|NCT01401062|NYU Langone Medical Center|Nelly Huppert|212-731-5003|Nelly.Huppert@nyumc.org|
20216056|NCT01131260|The George Washington University Biostatistics Center|Rebecca Clifton, Ph.D.|301-881-9260|rclifton@bsc.gwu.edu|
20216057|NCT01165450|University of Maryland School of Medicine|Bennie H. Jeng, MD, MS|667-214-1111|bjeng@som.umaryland.edu|
20216058|NCT03544216|Marshall B. Ketchum University (The Ohio State University during study data collection)|Erin Rueff, OD, PhD|7654145644|em.rueff@gmail.com|
20216059|NCT03684928|CooperVision,Inc.|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
20218233|NCT02746627|Vanderbilt University Medical Center|Sarah Jaser, PhD|615-343-6775|sarah.jaser@vanderbilt.edu|
20163354|NCT00352001|CCCC|Dr. Mikkael Sekeres|216-445-9353|sekerem@ccf.org|
20218234|NCT04464993|Arizona State University|Matthew P Buman, PhD, Director & Professor|602-496-8617|mbuman@asu.edu|
20216060|NCT01891357|on behalf of Westdeutsche Studiengruppe GmbH|Anja Braschoss, Consultant Clinical Research and Medical Writing|0049-176-82119153|anja.braschoss@wsg-online.com|
20216061|NCT00840879|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216062|NCT03733145|Atrium Health Wake Forest Baptist|Rohesh J. Fernando, MD|336.716.2712|rfernan@wakehealth.edu|
20216063|NCT00527098|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
20216064|NCT02259348|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
20216065|NCT01622660|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
20216066|NCT02583048|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20216067|NCT01851876|Karadeniz Technical University, School of Medicine, Dept Obs and Gyn.|Dr. Suleyman Guven, Director of clinical trial|+904623775869|drsuleymanguven@yahoo.com|
20216068|NCT02034513|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20216069|NCT00960154|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20216070|NCT04661202|National Cheng Kung University|Dr. Kuan-Yin Lin|06-2353535|10802003@gs.ncku.edu.tw|6737
20216071|NCT02578641|Tessa Therapeutics|Khong-Bee Kang, Senior Manager Clinical Development|+65 6978 6594|kangkhongbee@tessacell.com|
20216072|NCT02132910|DVCIPM|Chester Buckenmaier|301-816-4710|cbuckenmaier@dvcipm.org|
20216073|NCT02313558|Guanghua School of Stomatology, Sun Yat-sen University,|Dr. Hongchun Liu|0086-0-13826189071|hongchun751@sina.com|
20216074|NCT02015832|European Cardiovascular Research Institute|Dr. Ernest Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
20216075|NCT01876992|Johns Hopkins University|Sally Radovick|7322359524|sradovick@jhmi.edu|7733073353
20216076|NCT05293106|Weill Cornell Medicine|Marianne Nellis, MD|2127463056|man9026@med.cornell.edu|
20216077|NCT02694536|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216078|NCT01911429|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20216079|NCT06078501|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20216080|NCT03707587|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scott.norberg@nih.gov|
20216081|NCT00114504|Kurume University|Hisashi Kai|+81-942-31-7562|naikai@med.kurume-u.ac.jp|
20216082|NCT01694563|Atricure Inc.|Nfii K. Ndikintum, PhD, MBA / VP, Clinical Affairs and Biometrics|513-644-8192|NNdikintum@atricure.com|
20216083|NCT01266902|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20216084|NCT00979147|Minneapolis VAMC|Terence Gioe M.D.|612-467-1780|tjgioe@gmail.com|
20216085|NCT05562011|Wake Forest University School of Medicine|Timothy Harwood, M.D.|336.716.8830|tharwood@wakehealth.edu|
20216086|NCT04567329|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20216087|NCT04540094|University of Edinburgh|Prof Alasdair Gray|0131 242 1340|alasdair.gray@ed.ac.uk|
20216088|NCT02045108|The Mind Research Network|Dr. Eric Claus|505-272-5028|eclaus@mrn.org|
20216089|NCT02974907|ReGenTree, LLC|Shinwook Kang|609-649-5505|swkang@regentreellc.com|
20194144|NCT02807883|University of Texas MD Anderson Cancer Center|Partow Kebriaei, MD / Stem Cell Transplantation Department|713-745-0663|pkebriae@mdanderson.org|
20194145|NCT00594880|the Wistar Institute|Luis Montaner|215 898 3934|montaner@mail.wistar.org|
20194146|NCT00694109|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20194147|NCT02523690|Johns Hopkins University|Dr. Dale Needham|410-287-3343|dale.needham@jhmi.edu|
20216090|NCT01545193|NorthShore University HealthSystem|Glenn S. Murphy,MD|847-570-2760|dgmurphy2@yahoo.com|
20216091|NCT00076622|University of Pennsylvania|Joel Streim||Joel.Streim@uphs.upenn.edu|
20216092|NCT03209505|University of Houston College of Optometry|Eric Ritchey, OD, PhD|713-743-1933|erritche@central.uh.edu|
20216093|NCT04306952|Northwestern University|Jennifer Mundt PhD|312-503-2846|jennifer.mundt@nm.org|
20216094|NCT03082586|Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr tingfeng Chen|86-021-37798364|tingfeng138138@163.com|
20216095|NCT00881751|Medical University of South Carolina|Kate Anderton, MPH, CCRP|anderton@musc.edu|anderton@musc.edu|
20216096|NCT04431518|Indiana University School of Medicine|Samir K. Gupta|3172747926|sgupta1@iu.edu|
20216097|NCT02436200|Imperial College London|Professor Alun Davies, Professor of Vascular Surgery|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
20216098|NCT00672984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20216099|NCT00009945|NSABP Foundation, Inc.|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20216100|NCT03053245|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
20216101|NCT00819169|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20194148|NCT01254747|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
20216102|NCT00406393|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20194149|NCT00846807|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20194150|NCT00737698|Imperial College London|Dr Samantha Amanda Sathyapala|+442073518029|s.sathyapala@imperial.ac.uk|
20216103|NCT01632306|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216104|NCT01156987|University of MN|Curt Corum|(612) 625-5000|corum003@umn.edu|
20216105|NCT03966911|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
20216106|NCT00985751|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216107|NCT00380588|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216108|NCT02905435|PolyNovo Biomaterials Pty Ltd|Tim Barker, PhD|+61386814054|tim.b@polynovo.com|
20216109|NCT00595153|University of California, San Francisco|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
20194151|NCT01067846|Brain Imaging Research Center|Clint Kilts, PhD|526-8163|CDKilts@uams.edu|
20194152|NCT02817906|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20194153|NCT01675453|Academician EN Meshalkin State Budget Research Institute of Circulation Pathology|Dr. Evgeny Fominskiy|+79139538754|evfominskiy@gmail.com|
20194154|NCT00201877|The Ohio State University Comprehensive Cancer Center|Kristie Blum, MD|614-293-4519|Kristie.Blum@osumc.edu|
20216110|NCT00804973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194155|NCT02193490|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
20216111|NCT02701101|Bruin Biometrics|Vignesh Iyer|3102689494|viyer@bruinbiometrics.com|
20216112|NCT01046084|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20194156|NCT02299414|University of Alabama at Birmingham|Dr. Alan Tita|(205) 934-9616|atita@uabmc.edu|
20216113|NCT00474188|Celgene Corporation|Robert Kinght, M.D.|908-673-9749|rknight@celgene.com|
20216114|NCT03614728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216115|NCT02818894|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
20216116|NCT01533038|NeoTract|Director of Clinical Affairs|925-401-0641|ehergenreter@neotract.com|
20194157|NCT03686423|NYU Langone Health|Ryan Brown, PhD|2122633396|Ryan.Brown@nyulangone.org|
20194158|NCT02833077|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20194159|NCT04608773|University of Pittsburgh|Anne Fisher|4126479665|amf91@pitt.edu|
20194160|NCT01868425|University of Wisconsin - Madison|John Shepler|608-263-8100|jashepler@wisc.edu|
20216117|NCT00842309|Massachusetts General Hospital|Dr. Hilary Weingarden|617-643-6206|hilary_weingarden@mgh.harvard.edu|
20216118|NCT01962298|Antwerp University Hospital|Dr Tom Schepens|003238213265|tom.schepens@uza.be|
20216119|NCT04476277|National Heart, Lung, and Blood Institute (NHLBI)|Mathew Hsieh, M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
20216120|NCT01576705|Institut Jérôme Lejeune|Dr Clotilde Mircher|00 33 1 56 58 63 00|clotilde.mircher@institutlejeune.org|
20216121|NCT03727139|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20216122|NCT00566722|Abbott|Global Medical Services|800-633-9110||
20216123|NCT01390948|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20216124|NCT05203146|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
20216125|NCT02218216|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
20216126|NCT03111381|Yale Urology|Jamil Syed|2037852815|Jamil.syed@yale.edu|
20216127|NCT00787124|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
20216128|NCT05740098|University of Vermont|Stephen T. Higgins, PhD., P.I.|802-656-9615|stephen.higgins@uvm.edu|
20216129|NCT03867760|University of Washington Bothell|Dr. Linda Eaton|4253523645|lineaton@uw.edu|
20187377|NCT06085547|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
20216130|NCT01073631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187378|NCT04359654|University College London|Ms Donna Basire|+44-2031087748|d.basire@ucl.ac.uk|
20187379|NCT06122194|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187380|NCT04314778|University of Pennsylvania|S. Ryan Greysen, MD (Principal Investigator)|215-614-0095|Ryan.Greysen@pennmedicine.upenn.edu|
20187381|NCT05218096|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20187382|NCT04134208|The University of Texas M D Anderson Cancer Center|Dr. Gregory Ravizzini|(713) 518-9866|gravizzini@mdanderson.org|
20187383|NCT05863156|Uskudar Univercity|Tugba YILMAZ ESENCAN|05057084946|tugba.yilmazesencan@uskudar.edu.tr|
20187384|NCT04249362|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20187385|NCT03655028|Edward Hines Jr., VA Hospital|Eileen Collins|312-3550118|ecollins@uic.edu|
20187386|NCT03513302|Indiana University Indianapolis|Dr. Andrew Coggan|3172740656|acoggan@iu.edu|
20187387|NCT05256654|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20187388|NCT02112526|Acerta Pharma LLC|Study Director|1-888-292-9613|acertamc@dlss.com|
20187389|NCT00866684|Charité Universitätsmedizin Berlin Augustenburger Platz 1 13353 Berlin|Prof. Dr. Petra Reinke|+49 30 450 653 490|petra.reinke@charite.de|
20187390|NCT03268382|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20187391|NCT04862416|Radboud university medical center|Dr. Matthew McCall|+31 24 361 43 56|Matthew.McCall@radboudumc.nl|
20187392|NCT03852550|McMaster University|Research Coordinator|9055259140|galuppi@mcmaster.ca|27852
20187393|NCT02807545|Scottish Rite for Children|Karina Zapata|214-559-7790|karina.zapata@tsrh.org|
20187394|NCT04295512|San Diego State University|Kelsey Dickson|(619) 594-5380|kdickson@sdsu.edu|q
20187395|NCT04089059|UCSF School of Medicine|Liviu Klein|415-476-2143|liviu.klein@ucsf.edu|
20187396|NCT00179400|Albert Einstein College of Medicine|Prof. Meredith A. Hawkins|718 430 3186|meredith.hawkins@einsteinmed.edu|
20187397|NCT02329262|The Ohio State University Martha S. Pitzer Center for Women, Children and Youth|Principal Investigator|16142924578|smith.5764@osu.edu|
20187398|NCT04243070|BIOTRONIK SE & Co. KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20187399|NCT01009788|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-835-2285|SISAKOFF@mgh.harvard.edu|
20187400|NCT02800356|San Raffaele Hospital|Prof. Giuseppe Querques|00390226434004|querques.giuseppe@hsr.it|
20187401|NCT01309672|University of Colorado, School of Medicine|Dr. Thomas W. Flaig, MD||Thomas.Flaig@ucdenver.edu|
20187402|NCT03895996|Avotres Inc.|Tuochuan Dong, Director, Business & Operations|7169093370|tuochuan.dong@avotres.com|
20187403|NCT01254864|The University of Texas MD Anderson Cancer Center|Paul Corn, MD|(713) 563-7208|pcorn@mdanderson.org|
20187404|NCT03283722|Medtronic|Jenell Lorenz, Sr. Clinical Research Specialist|651-269-4768|jenell.m.lorenz@medtronic.com|
20187405|NCT04141891|University of Colorado|Dr. Marian Betz|303-550-5669|marian.betz@cuanschutz.edu|
20187406|NCT03626220|An Nan Hospital, China Medical University, Tainan, Taiwan|Dr. Chien-Chen Huang|886-6-3553111|chenchinh2013@gmail.com|2231
20187407|NCT04625725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20187408|NCT04618315|Northwestern University|Sumitrajit Dhar|847 491 8542|s-dhar@northwestern.edu|
20187409|NCT03911141|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
20187410|NCT05565820|Alliance Pharmaceuticals|R&D Director|01249 466966|medaffairs@allianceph.com|+44
20187411|NCT03746106|University of California, San Francisco|Dr. Kathleen Giacomini|4155144363|kathy.giacomini@ucsf.edu|
20187412|NCT03556293|Dartmouth College|Dr. Jeremiah Brown|(603) 646-5409|jeremiah.r.brown@dartmouth.edu|
20187413|NCT05104463|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
20187414|NCT04484428|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20187415|NCT04070573|Weill Cornell Medicine|Dr Line Malha|6469622606|lim9120@med.cornell.edu|
20187416|NCT04132518|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20187417|NCT03092453|University of Pennsylvania|Regulatory Lead|215-573-7101|psom-ind-ide@pobox.upenn.edu|
20187418|NCT05425420|Duke University|Kanecia Zimmerman|919-668-8651|kanecia.zimmerman@duke.edu|
20187419|NCT04056611|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187420|NCT02946736|Oregon Health & Science University|Dr. Leslie Hammer, PI|503-494-9313|hammerl@ohsu.edu|
20187421|NCT02631746|Duke University - Duke Cancer Institute LAO|Christy Arrowood|919-613-6130|christy.arrowood@duke.edu|
20187422|NCT05395871|Imperial College London|Amish Acharya|0203312 6666|aa2107@ic.ac.uk|
20187423|NCT05098158|Washington State University|Marian Wilson|509-324-7443|marian.wilson@wsu.edu|
20187424|NCT04183283|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20187425|NCT03397654|Imperial College London|Dr David Pinato|+44 20 7594 2799|david.pinato@imperial.ac.uk|
20187426|NCT03220035|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20187427|NCT00696111|University of Chicago|Karla Temple, Clinical Research Manager|773-702-3334|katemple@uchicago.edu|
20187428|NCT05299073|mAbxience Research S.L.U.|Susan Millan PhD|+34 917711500|susana.millan@mabxience.com|
20187429|NCT05452460|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
20187430|NCT04433208|Prolacta Bioscience|Dr David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
20187431|NCT03208049|VA Palo Alto Health Care System, Palo Alto, CA|Dr. Andrea Goldstein-Piekarski|(650) 493-5000|Andrea.Goldstein2@va.gov|60584
20187432|NCT02010242|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|+46 556659-9766|richard.philipson@calliditas.com|
20216131|NCT02589067|The Lundquist Institute at Harbor-UCLA|Dr. Loren G. Miller|310-222-3775|lmiller@lundquist.org|
20216132|NCT00438750|Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital|David Ring, MD, PhD|617-724-3953|dring@partners.org|
20216133|NCT00919113|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
20216134|NCT05984290|Bausch & Lomb Incorporated|Director, Medical Affairs, Vision Care R&D|585-413-6397|marjorie.rah@bausch.com|
20216135|NCT04573309|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20216136|NCT00605150|Carolinas Healthcare System|David Iannitti, MD|704-446-4838|jessica.drummond@carolinashealthcare.org|
20216137|NCT01487499|University of Florida|Michael A. Jantz, MD|352-273-8737|michael.jantz@medicine.ufl.edu|
20216138|NCT01691430|Yale University|Dr. Manisha Juthani-Mehta|(203)785-4140|manisha.juthani@yale.edu|
20216139|NCT01894230|Duke University|Dr. Deepak Voora|919-668-1755|Deepak.vorra@duke.edu|
20216140|NCT02756949|World Bank|Ms Marelize Gorgens|0012024730547|mgorgens@worldbank.org|
20216141|NCT02219009|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20216142|NCT00660387|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20216143|NCT02966340|UW Madison|John J. Curtin|608-262-0387|jjcurtin@wisc.edu|
20216144|NCT04211766|Fred Hutchinson Cancer Center|Dr. Johanna Lampe|(206) 667-6580|JLampe@fredhutch.org|
20216145|NCT00202839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20216146|NCT00642993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163355|NCT00759161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216147|NCT03119662|GE Healthcare|Francois Tranquart, M.D., Ph.D.|00-44-1494-543037|francois.tranquart@ge.com|
20216148|NCT00757705|Janssen Research & Development|Medical Director|886 2 23762155||
20216149|NCT02817828|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
20216150|NCT04956289|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
20216151|NCT03123874|Cornell University|Sarah Reyes|208-921-4967|smr296@cornell.edu|
20216152|NCT03544242|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
20216153|NCT00659815|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
20216154|NCT02651987|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
20216155|NCT04408924|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20216156|NCT01981044|Allergan Medical|Marcio Torre, M.D., M.A., Medical Monitor|805-683-6761|torre_marcio@allergan.com|
20216157|NCT02998541|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20216158|NCT01134549|Amgen, Inc|Study Director|866-572-6436||
20216159|NCT01513239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216160|NCT00396162|University of Michigan|Jeffrey E. Terrell|734 936 7633|terrelj@umich.edu|
20216161|NCT01741545|Bristol Myers Squibb|Bristol Myers Squibb Study Director|Please email|clinical.trials@bms.com|
20216162|NCT01456962|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Peter Anderson, Pharm D|303-724-6128|peter.anderson@ucdenver.edu|
20216163|NCT02856594|Massachusetts General Hospital|Dr, Oluwaseun Johson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
20216164|NCT03358147|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
20216165|NCT02933060|Cooper University Health System|Dr. Christopher Jones|856-342-2627|jones-christopher@cooperhealth.edu|
20216166|NCT01945580|Boston Scientific|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
20216167|NCT03068780|Amryt Research Limited|Janet Boylan|+3531518|Janet.boylan@amrytpharma.com|0200
20216168|NCT05034874|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|intervexion@gmail.com|
20216169|NCT00474058|UCB|UCB Clinical Trial Call Center|+1877 822 9493||
20216170|NCT02640235|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20216171|NCT01322633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216172|NCT00503867|Sirtex Medical|Medical Director|011 61 2 9964 8470|dcade@sirtex.com|
20216173|NCT05616728|Enanta Pharmaceuticals, Inc.|Justin Aubin|857-760-0591|jaubin@enanta.com|
20216174|NCT00577655|Teval Global Respiratory Research LLC|Teva Study Physician|215-293-6482||
20216175|NCT04224753|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20216176|NCT00875524|Sanofi Pasteur SA|Medical Director||Contact-US@sanofi.com|
20216177|NCT02016235|Mayo Clinic|John C. Lieske, M.D.|507-266-7960|Lieske.John@mayo.edu|
20187433|NCT03676192|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
20187434|NCT04731129|Centre hospitalier universitaire de liège|Dr Olivier Bonhomme|003243239580|obonhomme@chuliege.be|
20187435|NCT03386578|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20187436|NCT02424617|BerGenBio ASA|BerGenBio Clinical Team|+ 47 55961159|registry.postings@bergenbio.com|
20187437|NCT02694822|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
20187438|NCT01868997|Horizon Pharma USA, Inc.|Julie Ball, Executive Director||clinicaltrials@horizonpharma.com|
20187439|NCT01960452|University of Wisconsin|Meredith Rumble, PhD|608-232-3171|rumble@wisc.edu|
20187440|NCT05133739|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
20187442|NCT04066205|University of Washington|Teresa Ward, Professor, Department of Pediatrics|206-884-1439|teresa.ward@seattlechildrens.org|
20187443|NCT06415292|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20187444|NCT04294641|National Cancer Institute|Dr. Steven Z. Pavletic|240-760-6174|sp326h@nih.gov|
20187445|NCT04870307|University of Oklahoma Tulsa|Dr. Juell Homco|918-660-3038|juell-homco@ouhsc.edu|
20216178|NCT01370863|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20216179|NCT04090658|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216180|NCT02096705|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20216181|NCT02377349|GlaxoSmithKline|GSK Response Center|866-435-7343|en736091@gsk.com|
20216182|NCT03486938|agenebio|Richard Mohs|317-997-3241|richard.mohs@agenebio.com|
20216183|NCT03277248|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20216184|NCT03515044|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20216185|NCT02235870|Obalon Therapeutics, Inc.|Amy VandenBerg, Vice-President, Clinical Affairs and Regulatory Affairs|760.795.6551|avandenberg@obalon.com|
20216186|NCT05412121|University of Michigan|Anne Murphy|734-936-5566|aemurph@med.umich.edu|
20216187|NCT01971645|Nationwide Children's Hospital|Giorgio Veneziano, MD|6147224200|Giorgio.Veneziano@nationwidechildrens.org|
20216188|NCT02119936|UNC Chapel Hill|Holly Krohn|919-445-0218|holly_krohn@med.unc.edu|
20216189|NCT04116957|University of Missouri|Jung Hyup Kim|5738840354|kijung@missouri.edu|
20216190|NCT01566435|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-7402|dadkins@wustl.edu|
20216191|NCT04236596|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
20216192|NCT02957331|UCHealth|Thomas J. Schroeppel, MD, MS|719 365 2422|thomas.schroeppel@uchealth.org|
20216193|NCT02588339|Moffitt Cancer Center|Lia E. Perez, MD|813-745-3665|Lia.Perez@moffitt.org|
20216194|NCT03922490|Hospital for Special Surgery|Jessica Rios|212-774-7321|riosj@hss.edu|
20216195|NCT01120899|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20216196|NCT02664415|MHRP|Biostatistician|3015003715|spinyakorns@hivresearch.org|
20216197|NCT01151280|Boston Scientific Corporation|Alexis James, Clinical Project Manager|508-683-4074|jamesa@bsci.com|
20216198|NCT00660660|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
20216199|NCT02308241|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
20216200|NCT00486434|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+4522901317|bjr@nordicbioscience.com|
20216201|NCT02218541|University of North Carolina at Chapel Hill|Gidgetta Jenkins|919-537-3968|gidget_jenkins@unc.edu|
20216202|NCT00856349|Medtronic Cardiac Rhythm Disease Management|Daniel Lexcen, Clinical Research Specialist|763-526-9702|daniel.lexcen@medtronic.com|
20216203|NCT02725515|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|
20216204|NCT02889393|University of Miami|Dr. D. Dante Yeh|3055851178|dxy154@med.miami.edu|
20216205|NCT04707846|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
20216206|NCT02297230|New York University School of Medicine|Sylvia Formenti|646.962.4073|lao2003@med.cornell.edu|
20216207|NCT01759251|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20216208|NCT00183196|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
20216209|NCT03387462|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628-217-7479|susan.buchbinder@sfdph.org|
20163356|NCT03329846|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20216210|NCT01460628|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
20216211|NCT04179396|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
20216212|NCT03820258|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20216213|NCT01664039|Alcon Research, Ltd|Global Brand Lead, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20216214|NCT02837913|Cedars-Sinai Medical Center|Dr. Mark Zakowski|310-423-5841|mark.zakowski@cshs.org|
20216215|NCT01853176|Emory University|Albert Losken MD|404-686-8143|alosken@emory.edu|
20216216|NCT01944722|Becton, Dickinson and Company|Clinical Study Manager|410-316-4000|BDClinicalTrials@bd.com|
20216217|NCT01310855|UCL and CTC Cancer Trials Centre|Mark Phillips|0207 679 9139|ctc.doric@ucl.ac.uk|
20216218|NCT01085539|Covidien|Fran Haury, RRT Research Coordinator|303 305-2314|fran.haury@covidien.com|
20216219|NCT02906917|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20216220|NCT01095887|Mayo Clinic|Dr. Mark D. Stegall|507-266-2812|stegall.mark@mayo.edu|
20216221|NCT00687739|University of Colorado Anschutz Medical Campus|Wendy M Kohrt, PhD|3037241913|wendy.kohrt@ucdenver.edu|
20216222|NCT02542462|Cincinnati Childrens Hospital Medical Center|Nancy Back RN MPH|513-636-2479|Nancy.Back@cchmc.org|
20216223|NCT05387408|Washington University|Dr. Ann Marie Dale, Principal Investigator|3144548470|amdale@wustl.edu|
20216224|NCT00496860|Altor Bioscience|Hing C. Wong, Chief Clinical Officer|9544438600|hingwong@altorbioscience.com|
20216225|NCT03599362|NYU Langone Health|Fraustina Hsu|6467547124|Fraustina.Hsu@nyulangone.org|
20216226|NCT02312154|Konkuk University|Yang Won Lee|8220305172|20130112@kuh.ac.kr|
20216227|NCT01370083|Toronto Rehabilitation Institute - University Health Network|Prof. Catriona Steele|4165973422|catriona.steele@uhn.ca|7603
20216228|NCT01167829|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
20216229|NCT02072096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216230|NCT01044537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216231|NCT00726830|University of Texas MD Anderson Cancer Center|Michael J. Fisch, MPH/Clinical Professor, General Oncology|(713) 563-9905|mfisch@mdanderson.org|
20216232|NCT01168856|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216233|NCT04442503|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20163357|NCT00108862|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20216234|NCT00387153|Myriad Therapeutics, Inc.|Richard Wenstrup, MD, VP Chief Medical Officer|801-584-3009|rwenstru@myriad.com|
20194161|NCT00972322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194162|NCT04958200|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
20194163|NCT02387970|Columbia University|Panos N. Papapanou, DDS, PhD|(212) 342-3008|pp192@cumc.columbia.edu|
20194164|NCT00671177|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
20194165|NCT01310231|Mount Sinai Hospital|Pamela Goodwin/PI|416 586-8211|Pamela.goodwin@sinaihealth.ca|
20194166|NCT04662060|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
20194167|NCT00316017|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
20194168|NCT03599687|Yorkshire Ambulance Service NHS Trust|Richard Pilbery|+447463734823|r.pilbery@nhs.net|
20194169|NCT01800890|Coloplast A/S|Marian Sinvani|+45 4911 2356|dkmards@coloplast.com|
20194170|NCT05511038|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20194171|NCT03746392|University of Washington|Program Coordinator (Elizabeth Nielsen)|206-744-9516|eniels9@uw.edu|
20194172|NCT05543187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20194173|NCT04777864|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
20194174|NCT01198067|M.D. Anderson Cancer Center|Sheeba K. Thomas, MD|713-792-2860|sthomas@mdanderson.org|
20216235|NCT03334734|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
20216236|NCT00301964|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
20216237|NCT02385708|Vanderbilt University Medical Center|Steven Klintworth|615-936-3298|steven.klintworth@vumc.org|
20216238|NCT01852799|Shanghai Changzheng Hospital|Jian Hou, PhD|86021-63610109-73221|houjian@medmail.com.cn|
20216239|NCT03504085|UC San Diego|Erik Groessl, PhD|858-642-6347|egroessl@ucsd.edu|
20216240|NCT02761915|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20216241|NCT01143337|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20216242|NCT00834561|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216243|NCT05533411|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
20216244|NCT03276559|Weill Cornell Medicine|Hillary Winoker|646-962-7143|hiw4002@med.cornell.edu|
20216245|NCT01926119|Stanford University|Kevin Johnson, PhD RN|(650) 721-1988|johnsk@stanford.edu|
20216246|NCT02442687|Duke University|Dr. Manal F. Abdelmalek|919-684-8356|manal.abdelmalek@duke.edu|
20216247|NCT02654145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216248|NCT00354835|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20216249|NCT00645853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20216250|NCT00431041|Astellas Pharma Global Development|Astellas Medical Monitor||ClinicalTrials@us.astellas.com|
20216251|NCT02637141|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20216252|NCT01597791|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.eud|
20216253|NCT01728116|GI Dynamics, Inc|Brian Callahan|781.357.3302|bcallahan@gidynamics.com|
20216254|NCT01868243|Hospital Ana Nery|Andre Rodrigues Duraes|+557191888399|andreduraes@gmail.com|
20216255|NCT00467597|Portland VA Health Care System (PORVAHCS)|Kathryn Chung, MD|503.220.8262|CHUNGKA@OHSU.EDU|51091
20216256|NCT03366428|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20216257|NCT02166606|Boston Scientific|Dipl.-Ing. (FH) Jens Goetzke|+49171|jens.goetzke@bsci.com|5426813
20216258|NCT02083809|University of Hawaii|Dr.|8082036500|whrc@ucera.org|
20216259|NCT00379353|University of Texas M.D. Anderson Cancer Center|Dr. Eduardo Bruera, Professor|713-563-4157|ammarin@mdanderson.org|
20216260|NCT01958476|Tufts Medical Center Floating Hospital for Children|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
20216261|NCT02248714|6thShanghaiJiaotongU|Dr. Yuqian Bao|(021)64369181|byq522@163.com|
20163358|NCT02021643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20216262|NCT02670551|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20216263|NCT00714051|Edward Hines Jr., VA Hospital|Eileen Collins PhD, RN|708-202-3525|eileen.collins@va.gov|
20216264|NCT05315713|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20216265|NCT02535923|Department of Veterans Affairs|Elizabeth A Klingaman PhD|410-259-7810|elizabeth.klingaman@va.gov|
20216266|NCT02233751|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
20216267|NCT05471349|University of Wisconsin - Madison|Mark Zehner|608-262-7568|mark.zehner@wisc.edu|
20216268|NCT00685334|New York State Psychiatric Institute|Evelyn Attia, MD|212-253-5923|ea12@columbia.edu|
20216269|NCT03694197|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20216270|NCT01800838|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Elma Baron|216-368-4971|elma.baron@uhhospitals.org|
20216271|NCT02300987|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
20216272|NCT03086135|Radboud University Medical center, Nijmegen|Professor Emmanuel Mylanus|+31 24 361 49 34|Emmanuel.Mylanus@radboudumc.nl|
20216273|NCT01023061|University of Washington|Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20216274|NCT00929981|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216275|NCT04590781|Xencor, Inc|Benjamin Thompson, MD, PhD|858-480-3133|bthompson@xencor.com|433
20163359|NCT00900666|Mary Free Bed Rehabilitation Hospital|Krisanne B. Chapin, PhD|616-493-9831|krisanne.chapin@maryfreebed.com|
20194175|NCT03446001|TauRx Therapeutics Management Ltd.|Sotereos Gates, PhD|+44 (0) 7771 570707|s.gates@taurx.com|
20194176|NCT04746846|Virginia Commonwealth University|Ingrid Pretzer-Aboff, Ph.D., RN , FGSA, FAAN|804-828-3340|iaboff@vcu.edu|
20194177|NCT02815579|University of California, San Francisco|Dr. Sheri Weiser|(628) 206-2427|Sheri.Weiser@ucsf.edu|
20194178|NCT02385240|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20194179|NCT02311673|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20194180|NCT01014208|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216276|NCT04313296|Pen Bay Medical Center|Caroline Knight|207-301-8959|caroline.knight@mainehealth.org|
20216277|NCT02400463|University of Michigan Rogel Cancer Center|Ryan Wilcox|734-615-1482|rywilcox@umich.edu|
20216278|NCT00820599|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
20216279|NCT03686215|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
20216280|NCT00522041|Allergan plc|Susan Fox, PhD|201-427-8225|susan.fox@allergan.com|
20216281|NCT00874549|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20216282|NCT01710358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216283|NCT00084864|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20216284|NCT00831987|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20216285|NCT01327976|EnteroMedics|Director of Clinical Research|651-634-3209|mbroich@enteromedics.com|
20216286|NCT01721772|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20216287|NCT04542694|A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation|Academician Dmitry Pushkar|+7495-609-67-00|dmitry.pushkar@gmail.com|
20216288|NCT00969124|Avantis Medical Systems , Inc.|Jack Higgins, MD - Chief Medical Officer|4086367226|jhiggins@avantismedical.com|
20216289|NCT04462198|Pipeline Therapeutics, Inc.|Stephen Huhn, MD|858-333-5280|SHuhn@pipeline-tx.com|
20216290|NCT01202253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163360|NCT01345188|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633242828|shammas@mchsi.com|
20194181|NCT02683772|ResMed|Maureen Crocker, Manager Medical Affairs|8588366653|maureen.crocker@resmed.com|
20216291|NCT00000136|The Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
20216292|NCT00874822|University of Nebraska Medical Center|Jason Shiffermiller, MD, MPH|402-559-7299|jshiffermiller@unmc.edu|
20216293|NCT02854800|West Virginia University|Dr. Melissa Blank|304-293-8341|Melissa.Blank@mail.wvu.edu|
20216294|NCT03056144|The Hong Kong Polytechnic University|Dr Tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
20216295|NCT05278858|University Hospitals Cleveland Medical Center|Dr. Sonal Shah, Director of Pediatric Dermatology|216-286-7285|Sonal.Shah@UHhospitals.org|
20216296|NCT00840658|University of California, San Diego|Steffanie Strathdee, PhD|(858) 822-1952|sstrathdee@ucsd.edu|
20216297|NCT01632423|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20187446|NCT04730739|Zimmer Biomet|Octavia Gladden, Clinical Research Speaclist|704.493.0178|octavia.gladden@zimmerbiomet.com|
20187447|NCT03308877|University of Rochester Medical Center|Marc T. Swogger, Associate Professor, Psychiatry and Medicine|585-301-7738|marc_swogger@urmc.rochester.edu|
20187448|NCT03397706|Viracta Therapeutics|Medical Director|858-400-8470|ClinicalTrials@Viracta.com|
20187449|NCT05646355|NYU Langone Health|Aasma Shaukat|6465012906|Aasma.Shaukat@nyulangone.org|
20187450|NCT04738591|Health Research Institute of the Balearic Islands (IdISBa)|Dr. Rocío Zamanillo Campos|971175897|rocio.zamanillo@ssib.es|
20187451|NCT03523572|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20187452|NCT00957684|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20187453|NCT04685135|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20194182|NCT00414908|Abbott Products|Sven Voet - Global Communication|+41 61 487 08 56|sven.voet@abbott.com|
20194183|NCT01076153|Abbott|Global Medical Services|1-800-633-9110||
20187454|NCT02315703|Janssen Vaccines & Prevention B.V.|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187455|NCT05974501|University of Miami|Dr. Victor H. Hernandez|305-243-4000|vhh1@med.miami.edu|
20187456|NCT03625115|Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
20187457|NCT04197336|Johns Hopkins University|Clifford Weiss, MD|410-614-1046|cweiss@jhmi.edu|
20187458|NCT04304144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20187459|NCT05868382|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20187460|NCT04585815|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187461|NCT04362085|St. Michael's Hospital|Dr. Michelle Sholzberg|4168606060|michelle.sholzberg@unityhealth.to|
20187462|NCT02497950|Rigshospitalet Copenhagen, Denmark|Prof. Finn Gustafsson|+4535459743|finn.gustafsson@regionh.dk|
20187463|NCT04660539|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20187464|NCT03808961|VAORD|Chandramohan Wakade|7067211106|cwakade@augusta.edu|
20187465|NCT03756662|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20187466|NCT05207982|University at Buffalo, Department of Psychiatry|Daniel Antonius|7168582792|danielan@buffalo.edu|
20194184|NCT00567567|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
20194185|NCT03433677|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20194186|NCT03330405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194187|NCT00702962|MSHERSHEY MC|Dr. C. Belani|717-531-1078|cbelani@psu.edu|
20194188|NCT03417544|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-3800|Nancy_Lin@dfci.harvard.edu|
20194189|NCT02175641|Washington Universtiy in St. Louis|Leopoldo J. Cabassa, Associate Professor|314-935-2829|ljcabassa@wustl.edu|
20194190|NCT02931253|The Donald Guthrie Foundation for Education and Research|Pramod Deshmukh, MD|570 887 2284|Pramod.Deshmukh@guthrie.org|
20194191|NCT05435482|University of California, San Francisco|Ji Won Choi|415.340.1434|jiwon.choi@ucsf.edu|
20194192|NCT01923467|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
20194193|NCT03750786|Isofol|Karin Gedda|+46 (0) 729 9453 37|karin.gedda@isofolmedical.com|
20194194|NCT04462289|Minneapolis VA Health Care System|Dr. Anne Melzer|6124674413|anne.melzer2@va.gov|
20194195|NCT02206061|University of Rochester|Jill Halterman, MD|5852755798|jill_halterman@urmc.rochester.edu|
20194196|NCT04187326|UMass Chan School of Medicine|Dr. Elliot Edmiston, Associate Professor of Psychiatry & Behavioral Sciences|5088566480|kale.edmiston@umassmed.edu|
20194197|NCT01949389|VA Connecticut Healthcare system|Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
20194198|NCT01807000|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20194199|NCT02870049|UC San Diego|Samir Gupta, MD|07/09/2018|s1gupta@health.ucsd.edu|
20194200|NCT05686122|Duke University School of Medicine|Sarah Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
20194201|NCT05235269|Attralus|Scott Stephens, Senior Director Clinical Operations|321-228-7400|sstephens@attralus.com|
20194202|NCT03810235|School of Medicine and Public Health University of Wisconsin-Madison|Kathleen M. Antony, M.D, M.S.C.I|608-417-6099|kantony@wisc.edu|
20216298|NCT01859598|The George Institute for Global Health at Peking University Health Science Center|Pro. Linong Ji|82800577|jiln@bjmu.edu.cn|
20216299|NCT00573313|University of California Davis|Dr. Charles H. Halsted|530-752-4054|chhalsted@ucdavis.edu|
20194203|NCT00798434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216300|NCT00835588|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216301|NCT00295490|University of Southampton|Dr Sarah Brien|07870642667|sbb@southampton.ac.uk|
20216302|NCT03885934|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216303|NCT03255980|Helsinn Healthcare SA|Dr. Fabio Macchi|0041919852121|fabio.macchi@helsinn.com|
20216304|NCT04473326|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
20194204|NCT04522921|Department of Clinical Medicine, Aarhus University / Steno Diabetes Center Aarhus, Aarhus University Hospital|Dorthe Dalstrup Pauls|+45 28256406|dorthedalstrup@clin.au.dk|
20194205|NCT00871286|Northwestern|Rakesh Chandra|312-695-8182|rchandra@nmff.org|
20194206|NCT03682185|University of Pennsylvania|Dr. Nancy A. Hodgson|215-573-7387|hodgsonn@nursing.upenn.edu|
20194207|NCT04908631|Duke University|Howard W. Francis, MD|919-681-8069|howard.francis@duke.edu|
20194208|NCT00558792|Bracco Diagnostics Inc|Usha Halemane, Executive Director of Medical Biometrics and Medical Writing|609-514-2578|usha.halemane@diag.bracco.com|
20194209|NCT02336451|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20194210|NCT00462605|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
20194211|NCT03520712|BioMarin Pharmaceutical (UK) Ltd.|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44207|KonstantiaMaria.Chavele@bmrn.com|4203351
20194212|NCT03468478|Hospital do Rim - Fundação Oswaldo Ramos|Dr. Helio Tedesco Silva Junior|55 11 50878113|heliotedesco@medfarm.com.br|
20194213|NCT06988800|Muvik|Dr. Chelsea Gordon|9063990332|chelsea@muviklabs.io|
20194214|NCT02344290|REPRIEVE Clinical Coordinating Center|REPRIEVE Project Manager|617-724-9109|mghreprievetrial@mgb.org|
20194215|NCT04998812|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20194216|NCT03898778|Minnesota Medical Technologies Corporation|VP of Regulatory Affairs|507-533-0366|rmanglin@mnmedicaltechnologies.com|
20194217|NCT05430815|Emory University|Anne Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
20194218|NCT04047862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20194219|NCT06122870|Johns Hopkins University|Dr. Kawsar Talaat|410-336-9164|ktalaat@jhu.edu|
20194220|NCT05014568|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20194221|NCT06748729|Össur Iceland ehf.|Laurine Roussillon|+3548221812|lroussillon@ossur.com|
20194222|NCT03578887|University of Washington|Ellen Schur, MD, MS|206-543-8433|ellschur@uw.edu|
20194223|NCT06118957|University of Utah Obgyn|Elizabeth Turner, MPH, Senior Regulatory Coordinator|8012018929|elizabeth.e.turner@hsc.utah.edu|
20216305|NCT03504020|Medtronic CRM Clincial Research|CRM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20216306|NCT01451541|Sunovion|Respiratory Medical Director|1-866-503-6351||
20216307|NCT03660787|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|1150
20216308|NCT04164758|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
20216309|NCT05248399|The University of Texas Health Science Center at Houston|Maria E Fernandez Esquer, PhD|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
20216310|NCT04736537|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
20216311|NCT00537095|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20216312|NCT00533507|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216313|NCT02943096|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
20216314|NCT05065619|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20216315|NCT03790137|Massachusetts General Hospital|Dr. Elizabeth Thiele|6177266540|ethiele@mgh.harvard.edu|
20216316|NCT00758758|Zimmer, Inc|Laura Herdrich, Sr. CRA|952-830-6224|laura.herdrich@zimmer.com|
20216317|NCT00570128|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20216318|NCT03868631|Point Loma Nazarene University|Dr. Heidi Lynch|619-806-3306|hlynch@pointloma.edu|
20216319|NCT01929681|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
20216320|NCT01426854|Alcon (China) Ophthalmic Product Co., Ltd.|Terence Li, Clinical Research Manager, Development & Medical Affairs, China|+86 10 5829 1452|Terence.li@alcon.com|
20216321|NCT01971554|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216322|NCT02161705|Johns Hopkins University School of Medicine|Dr. Pathik Aravind|4437879385|paravin1@jhmi.edu|
20216323|NCT03555695|Rush University Medical Center|Dr. Jori Fleisher|312-563-2900|jori_fleisher@rush.edu|
20216324|NCT03505151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216325|NCT01942135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216326|NCT01717040|Univeristy Hospitals Cleveland Medical Center|Carla Conroy, MPH|216-844-2871|carla.conroy@UHhospitals.org|
20216327|NCT03196284|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20216328|NCT01139762|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216329|NCT01675596|Edwards Lifesciences|Tenley Koepnick||tenley.koepnick@edwards.com|
20216330|NCT03018925|Institut d'Investigació Biomèdica de Girona - Hosp Univ Dr Josep Trueta|MD PhD X Aldeguer|34972940200|xaldeguer.girona.ics@gencat.cat; abahi@idibgi.org|2401
20216331|NCT00087529|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216332|NCT02282722|Dana-Farber Cancer Institute|Dr. Deb Schrag|617-582-8301|deb_schrag@dfci.harvard.edu|
20216333|NCT00377572|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20216334|NCT02937506|Mount Carmel Health System|Anantha Padmanabhan, MD|614-234-1079|apadmanabhan@mchs.com|
20216335|NCT01273857|Okayama University Hospital|Prof. Hidemasa Oh|+81-086-235-6506|hidemasa@md.okayama-u.ac.jp|
20216336|NCT00769314|BioAlliance Pharma|Dr Pierre ATTALI|+33145587600|pierre.attali@bioalliancepharma.com|
20216337|NCT01662024|Brigham and Women's Hospital|Christopher C. Thompson, MD, MSc|617-525-8266|ccthompson@bwh.harvard.edu|
20216338|NCT00927251|Medtronic, Bakken Research Center|Model 4296 Left Ventricular (LV) Lead Study Sr. CRS|+31-43-3566602|margriet.kruijshoop@medtronic.com|
20194224|NCT01015560|SWOG Statistical Center|Study Statistician|206-667-4623||
20194225|NCT01692951|Cleveland Clinic Foundation|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
20194226|NCT00264303|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20194227|NCT02389452|Sanofi|Trial Transparency Team||Contact --US@Sanofi.com|
20194228|NCT01006252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194229|NCT02566044|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
20194230|NCT00769652|Rutgers Cancer Institute of New Jersey|Dr. Elizabeth Poplin, MD (sub-investigator)|732-235-8675|poplinea@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20194231|NCT04165031|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20194232|NCT00818168|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20194233|NCT01332630|UT MD Anderson Cancer Center|Ibrahim,Nuhad K.,M.D. / Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20216339|NCT01813435|Jessa Ziekenhuis, Hasselt, Belgium|Dr. Pascal Vranckx|+32 11 30 9589|pascal.vranckx@jessazh.be|
20216340|NCT01490190|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20187467|NCT03728608|University of Florida|Leslie Parker|352 273 6384|parkela@ufl.edu|
20216341|NCT01390415|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216342|NCT02435433|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@Lilly.com|
20216343|NCT01243151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216344|NCT00072514|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
20216345|NCT03237156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20216346|NCT00397254|Clinvest|M.E. Beach|417-841-3618|mbeach@clinvest.com|
20216347|NCT00210639|Janssen R&D US|Director, Clinical Research|1 609 730-3158||
20216348|NCT02786953|Vanderbilt University Medical Center|Sarah S Jaser|6153436775|sarah.jaser@vumc.org|
20216349|NCT01897077|Johns Hopkins School of Medicine|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
20216350|NCT05014438|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20216351|NCT02627963|AVEO Pharmaceuticals, Inc.|AVEO Clinical Trial Office|857-400-0101|Clinical@aveooncology.com|
20216352|NCT05053360|Inova Health System|Jaimee Robinson, Labor and delivery Clinical Nurse Educator|7038586028|jaimee.robinson@inova.org|
20216353|NCT04697173|Virginia Commonwealth University|Nikki Miller Ferguson MD|804-828-4080|nikki.millerferguson@vcuhealth.org|
20216354|NCT05004649|University of Pennsylvania|Dr. David Brainard|215-573-7579|brainard@psych.upenn.edu|
20216355|NCT01859637|Sandoz Biopharmaceutical, Hexal AG|Roumen Nakov|+49 8024 4764704|roumen.nakov@sandoz.com|
20216356|NCT04133311|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20216357|NCT02911909|University of Missouri|Ennio Rizzo|573-882-7615|eardvb@health.missouri.edu|
20216358|NCT00728754|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20216359|NCT00270634|Isotechnika Pharma Inc.|Robert Huizinga|780 487 1600|robert.huizinga@isotechnika.com|223
20216360|NCT00354159|Medtronic CRDM|REDUCEhf Clinical Research Specialist|1-800-328-2518|medtronicCRMtrials@medtronic.com|62736
20163361|NCT00684775|"Johns Hopkins School of Medicine: Department of Psychiatry"|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20216361|NCT03405363|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216362|NCT00630253|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
20216363|NCT01532908|MassBiologics|Director of Clinical Affairs|617-474-3000|Mblclinicaldirector@Umassmed.edu|
20216364|NCT01993940|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
20216365|NCT01824498|USDA, GFHNRC|Susan Raatz, PhD, RD|701-795-8294|susan.raatz@ars.usda.gov|
20216366|NCT01567527|Otsuka Pharmaceutical Development & Commercialization, Inc.|Joan Amatniek, Senior Director, Global Clinical Development|(609) 512-4464|joan.amatniek@otsuka-us.com|
20216367|NCT00325780|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
20216368|NCT02311894|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20216369|NCT01377441|NYU School of Medicine|Lisa Doan, MD|212.263.5072|lisa.doan@nyumc.org|
20216370|NCT01050764|Stanford University Medical Center|Everett H Meyer, MD, PhD; Assistant Professor of Medicine|650-725-5816|evmeyer@stanford.edu|
20216371|NCT03786770|Revance Therapeutics, Inc.|Domenico Vitarella, Sr. Director, Clinical Development|510-742-3400|dvitarella@revance.com|
20216372|NCT00924053|Theracos, Inc|Yuan-Di Halvorsen|617 726-4236|yhalvorsen@ccib.mgh.harvard.edu|
20216373|NCT02243579|Fred Hutchinson Cancer Research Center|Asa Davis|206-667-5300|akdavis@fredhutch.org|
20216374|NCT00556673|Novartis Pharmaceuticals|Study Director|862-778-8300||
20216375|NCT01528735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216376|NCT00757172|Washington University School of Medicine|Dr. A. Craig Lockhart|314-454-8306|alockhar@dom.wustl.edu|
20216377|NCT00494013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216378|NCT04194151|Hospital Central de la Defensa Gomez Ulla|Dr. Paula Agostina VULLO|+34681054151|agosvullo@hotmail.com|
20216379|NCT01499043|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20216380|NCT04203823|Medtronic|Clinical Study Manager|8185765849|carrie.corrigan@medtronic.com|
20216381|NCT03193021|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
20216382|NCT02286466|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
20216383|NCT00835081|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216384|NCT00421304|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20216385|NCT04750239|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
20187468|NCT05207956|University of Pennsylvania|Dr. David Mandell|(215) 573 7494|david.mandell@pennmedicine.upenn.edu|
20187469|NCT06180980|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20187470|NCT01828112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
20187471|NCT02945176|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20187472|NCT05244187|MEDIcept Inc|Adelina Paunescu, VP Clinical Affairs|781-526-8152|apaunescu@medicept.com|
20187473|NCT04410328|Rutgers New Jersey Medical School|Dr. Amit Singla|319-512-3558|as3321@njms.rutgers.edu|
20216386|NCT01912807|University of Saskatchewan|Andrea Vasquez Camargo|306 7660444|a.vasquez@usask.ca|
20216387|NCT00919711|Amgen Inc.|Study Director|866-572-6436||
20216388|NCT02614196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20187474|NCT04308681|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20194234|NCT01008553|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20194235|NCT01663922|St Stephens AIDS Trust|Dr Akil Jackson|0203 315 6503|akil.jackson@chelwest.nhs.uk|
20194236|NCT01534143|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kahdimi, M.D.|(313) 576-8022|zalkadh@emory.edu|
20194237|NCT01008410|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20194238|NCT02988050|Menoufia University|Professor Ezzeldin Ibrahim, Professor of Anaesthesia|00201006303178|ezzeldin7@yahoo.com|
20194239|NCT04143945|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20194240|NCT04045964|The University of Texas Health Science Center at Houston|Angela Stotts, PhD|(713) 500-7590|Angela.L.Stotts@uth.tmc.edu|
20194241|NCT02787044|Brigham and Women's Hospital|Dr. Scott Solomon|857-307-1960|ssolomon@bwh.harvard.edu|
20194242|NCT02324608|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger|
20194243|NCT03889704|University of Pittsburgh|Dr. Edward Burton|4126924670|eab25@pitt.edu|
20194244|NCT03482466|Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Menninger Clinic|Ramiro Salas|7137983502|rsalas@bcm.edu|
20194245|NCT04552899|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20194246|NCT00673959|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20194247|NCT00731133|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20194248|NCT02383940|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20194249|NCT02308787|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|(303) 231-4357|Ray.Goodrich@terumobct.com|
20194250|NCT02672852|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20194251|NCT01725126|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194252|NCT01734239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194253|NCT01240915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216389|NCT00903877|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
20216390|NCT01562613|Abbott|Taco Baardman||taco.baardman@abbott.com|
20216391|NCT04388787|Virginia Commonwealth University|Olivier Rolin, MD, PhD|(804) 828-4230|olivier.rolin@vcuhealth.org|
20216392|NCT00663234|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20216393|NCT00840840|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216394|NCT01253564|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20216395|NCT01723202|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-366-5068|Bhvana.konda@osumc.edu|
20216396|NCT01751087|Planned Parenthood League of Massachusetts, Inc.|Principal Investigator|617.616.1600||
20216397|NCT02061358|Emergent BioSolutions|Clinical Development Representative||ctgov@ebsi.com|
20216398|NCT03388008|Washington University in St. Louis|Ramsey Hachem, MD|(314) 454-7953|Rhachem@wustl.edu|
20216399|NCT05194202|Children's Mercy Hospital|Dr. Kimberly Randell|816-302-3503|karandell@cmh.edu|
20216400|NCT01520987|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20216401|NCT02005562|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216402|NCT04729101|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
20216403|NCT00274625|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
20194254|NCT04297631|Washington University|Venessa Riegler|3143621721|rieglerv@wustl.edu|
20216404|NCT02940522|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20216405|NCT01639664|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Guido Bertolini|035 4535 313|guido.bertolini@marionegri.it|
20216406|NCT00762411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216407|NCT02959840|Rutgers-Robert Wood Johnson Medical School|Dr. Shaul Cohen, M.D., Professor of Clinical Anesthesiology, Director of Obstetric Anesthesia|732-937-8841|cohensh@rwjms.rutgers.edu|
20216408|NCT02710214|University of California, San Francisco|Dr. Riley Bove|415-595-2795|riley.bove@ucsf.edu|
20216409|NCT02832167|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20216410|NCT01754376|MGH Cancer Center|Ryan Sullivan|617-724-4000|rsullivan7@mgh.harvard.edu|
20216411|NCT04556734|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216412|NCT02497235|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
20216413|NCT04264819|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20216414|NCT01680016|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20216415|NCT03480685|Avinger, Inc.|Thomas Lawson, PhD|650-241-7030|tlawson@avinger.com|
20216416|NCT00704496|milton s hershey medical center|timothy craig,|717-531-6525|tcraig@psu.edu|1
20216417|NCT01134198|new york state psychiatric institute|wilfrid raby, md|212-923-3031|wilfrid.raby@nyspi.columbia.edu|
20216418|NCT02846883|Roudebush VA Medical Center|Michael P. Murphy, MD|317-988-4049|mipmurph@iupui.edu|
20216419|NCT01550367|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20216420|NCT04768296|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20216421|NCT05353036|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
20216422|NCT04489303|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
20216423|NCT00452348|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216424|NCT02413034|Hospital del Mar|Daniel Pérez-Prieto|0034932483196|dperezprieto@hospitaldelmar.cat|
20216425|NCT03538795|University of Alabama of Birmingham|Gitendra Uswatte|205-975-5089|guswatte@uab.edu|
20216426|NCT02655224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20216427|NCT01119625|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216428|NCT00217724|OHSU Knight Cancer Institute|Joseph Bublao|503-494-1054|bubaloj@ohsu.edu|
20216429|NCT03073798|Johns Hopkins University|Nadia N Hansel, MD MPH|410-550-2935|nhansel@jhmi.edu|
20216430|NCT01250730|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216431|NCT00897676|The Children's Hospital of Philadelphia|Diva DeLeon, MD|267-426-5529|deleon@email.chop.edu|
20216432|NCT02372006|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216433|NCT04848688|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20216434|NCT00582205|University of Oklahoma|Dr. Joan Walker|405-271-8707|joan-walker@ouhsc.edu|
20216435|NCT01991548|Medtronic Diabetes|Clinical Research Manager|818-576-5000||
20216436|NCT02611362|Rhode Island Hospital|Dr. Larry K. Brown|(401) 793-8808|lkbrown@lifespan.org|
20216437|NCT00458822|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|LandauH@mskcc.org|
20216438|NCT02229084|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
20216439|NCT05128058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216440|NCT01328782|Children's Hospital Colorado|Gaia Georgopoulos, MD|720-777-2588|Gaia.Georgopoulos@childrenscolorado.org|
20216441|NCT02533466|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216442|NCT00400634|Ceregene, Inc.|Raymond T. Bartus, Executive Vice President and Cheif Scientific Officer|858-458-8823|rtbartus@ceregene.com|
20216443|NCT01559116|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216444|NCT04610580|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20194255|NCT01598662|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
20216445|NCT02179190|Medtronic Plc|Senior Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
20216446|NCT01170715|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
20216447|NCT02571634|Womack Army Medical Center|Michael Bartoszek, MD|910-907-6000|michael.w.bartoszek.mil@mail.mil|
20216448|NCT00881569|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20216449|NCT03480022|Woman's Hospital|Director of Research|12252315278|karen.elkind-hirsch@womans.org|
20216450|NCT02948426|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
20216451|NCT01670097|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20216452|NCT03259165|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
20216453|NCT01949532|Amgen, Inc.|Study Director|866-572-6436||
20216454|NCT05665387|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20216455|NCT00884390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216456|NCT01152112|Hologic, Inc.|Christina Mastandrea / Clinical Research manager|5082638772|christina.mastandrea@hologic.com|
20216457|NCT02805517|Loma Linda University Health|Dr. Duane Baldwin|909-588-4000|dbaldwin@llu.edu|44196
20216458|NCT03980522|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20216459|NCT01091363|University of Massachusetts Medical School|Dr. Sun S Kim|201-388-2656|sun.kim@umb.edu|
20216460|NCT01874535|Kaohsiung Chang Gung Memorial Hospital, Taiwan|Dr. Seng-Kee Chuah and Dr. Wei-Chen Tai|886-975056007|chuahsk@seed.net.tw|
20216461|NCT01215721|UC Irvine|Thomas Ahlering, MD|714-456-6068|tahlerin@uci.edu|
20216462|NCT00045162|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
20216463|NCT01044433|Abramson Cancer Center|Dr. Corey Langer|215-615-5121|Corey.Langer@uphs.upenn.edu|
20216464|NCT02616380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20216465|NCT02413008|ITF Research Pharma SLU|Concepción Nieto Magro|0034916572323|concepcion@itfsp.com|
20216466|NCT04387617|Mayo Clinic|Karen L. Stern, M.D.|480-342-3868|Stern.Karen@mayo.edu|
20216467|NCT00939523|Cedars-Sinai Medical Center|Odelia Cooper|310-423-4774|coopero@cshs.org|
20216468|NCT00024258|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner|212-639-6793|kushnerb@mskcc.org|
20216469|NCT03711396|University of Colorado School of Medicine|Dr. Hillary D. Lum|303-724-1911|hillary.lum@cuanschutz.edu|
20216470|NCT04492397|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
20216471|NCT00442351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20216472|NCT01863186|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
20216473|NCT00603564|IRCCS Fondazione Po.Ma.Re, Milan, Italy|Roberto Cosentini, MD|00390255033602|roberto.cosentini@policlinico.mi.it|
20216474|NCT00108628|Philadelphia VA Medical Center|Dr. Richard Ross|(215) 823-4046|Richard.Ross2@va.gov|
20216475|NCT01453153|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
20216476|NCT03547635|Integra LifeSciences|Jessica Knowlton, Sr Mgr, Clinical Research & PMCF Strategy|609-325-0111|jessica.knowlton@integralife.com|
20216477|NCT03239496|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
20216478|NCT02415387|Center for Biostatistics, The Ohio State University|Juan Peng|614-293-5869|juan.peng@osumc.edu|
20216479|NCT03035890|WVCTSI|Tara Riddle|304-581-1829|tlr0011@hsc.wvu.edu|
20216480|NCT03243396|Duke University|Kathryn Whetten, PhD, MPH|919-613-5313|k.whetten@duke.edu|
20216481|NCT04578132|An organization designated by the Sponsor|A person designated by the Sponsor|+34934344412|investigacion@mfar.net|
20216482|NCT05113563|NYSPI|Diana Martinez|646-771-7774|dm437@cumc.columbia.edu|
20216483|NCT02560051|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
20216484|NCT00544167|Sarah Cannon Research Institute|John Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20216485|NCT02898740|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
20216486|NCT03343639|Chief Scientific Officer|Paul Kwon|650-486-1416|pkwon@menlotx.com|
20216487|NCT00076245|Department of Psychology, University of Vermont|Kelly J. Rohan, Ph.D.|802-656-0798|kelly.rohan@uvm.edu|
20216488|NCT00859040|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
20216489|NCT00735696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216490|NCT02153723|Montefiore Medical Center|Aleksandra Djukic|718 920 4378|adjukic@montefiore.org|
20216491|NCT02274558|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20194256|NCT02574845|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216492|NCT02460835|University of Michigan Rogel Cancer Center|Dr. Theodore Lawrence|734-647-9955|tsl@umich.edu|
20216493|NCT01151449|Princess Margaret Cancer Centre|Dr. Srikala Sridhar|416-946-2662|srikala.sridhar@uhn.ca|
20216494|NCT01876953|City of Hope Medical Center|Ahmed Aribi|626-359-8111|aaribi@coh.org|
20216495|NCT00964353|University of Chicago|Dr David Meltzer|773-702-0836|dmeltzer@medicine.bsd.uchicago.edu|
20216496|NCT02318550|Lancaster General Health|Project Manager|7175447395|Tawnya.Vernon@pennmedicine.upenn.edu|
20216497|NCT02733627|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216498|NCT00059332|UCLA, David Geffen School of Medicine|Dr. Jeffrey Saver|310-794-6379|jsaver@mednet.ucla.edu|
20216499|NCT02483416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216500|NCT02587143|Servicio de Urgencias, Hospital de Basurto, Bilbao, España|Dr. Ballesteros-Peña|(+34)946012804|sendoa.ballesteros@ehu.eus|
20216501|NCT02754492|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
20216502|NCT00487695|Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology|Dr. Marcia Canto.|410-614-5388|mcanto@jhmi.edu|
20216503|NCT03490916|UMass Medical School|Principal Investigator|4136279111|vincent.kan08@gmail.com|
20216504|NCT01207752|Southern California College of Optometry at MBKU|Jerry Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
20216505|NCT01186458|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20216506|NCT04281472|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
20216507|NCT00152451|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20216508|NCT05109104|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20216509|NCT00323258|Duke University Medical Center|Sara Calvert, PharmD|919-668-7540|sara.calvert@duke.edu|
20216510|NCT01055834|Eisai Co., Ltd.|Kenya Nakai, Study Director|+81-3-3817-3865|k3-nakai@hhc.eisai.co.jp|
20216511|NCT01717313|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216512|NCT00994604|Johns Hokpins Medical Institutions|Dr. Robert Brown|410-614-5451|rbrown2@jhmi.edu|
20216513|NCT00743145|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
20216514|NCT01745094|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512 Ext:|motoko.ida@astellas.com|
20216515|NCT01097694|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
20216516|NCT03922750|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20216517|NCT00668395|Indiana University School of Medicine|Zeruesenay Desta, PhD|317-274-2823|zdesta@iu.edu|
20216518|NCT00697827|Synthes|Ann Marie Simon|610-719-5418|simon.annmarie@synthes.com|
20216519|NCT03174158|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@partners.org|
20216520|NCT03732833|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20216521|NCT05068661|Duke University School of Medicine|Dr. Ashraf Habib|9196682024|habib001@mc.duke.edu|
20216522|NCT01691612|Brigham & Women's Hospital|Elliot Israel, M.D.|617-732-8110|eisrael@partners.org|
20216523|NCT02623218|AOMA Graduate School of Integrative Medicine|Dr. John Finnell|512-492-3057|jfinnell@aoma.edu|
20216524|NCT01726803|University of Utah|Julie Fritz|801-581-6861|julie.fritz@hsc.utah.edu|
20216525|NCT00759707|Brigham and Women's Hospital|Dr. Joshua Beckman|6175257053|jbeckman@partners.org|
20216526|NCT01211262|Immunocore, LLC|Chris Holland, Executive Director Head of Biostatistics|1-267-589-9204|chris.holland2@immunocore.com|
20216527|NCT02005276|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
20216528|NCT01970592|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
20216529|NCT00499473|The Ohio State University Comprehensive Cancer Center|Robert Cavaliere, MD|614-293-4968|Robert.Cavaliere@osumc.edu|
20216530|NCT00021541|National Institutes of Health, National Cancer Institute|Brigitte Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
20216531|NCT01689155|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
20216532|NCT00936351|Roudebush VA Medical Center|Louanne W. Davis PsyD|317-988-4523|louanne.davis@va.gov|
20216533|NCT01341405|CrystalGenomics, Inc|Sang-Yoon Lee, M.D.|82-31-628-2871|sang-yoon.lee@cgxinc.com|
20216534|NCT05263505|Washington University School of Medicine|Dr. Michael Paley, Director of the Ocular Rheumatology Clinic|314-273-7556|paleym@wustl.edu|
20216535|NCT00826241|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|gilbertmr@nih.gov|
20216536|NCT03407729|Case Western Reserve University|Dr. Michael J. Decker|2163682467|mjd6@case.edu|
20216537|NCT01898598|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216538|NCT03833427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20216539|NCT00176891|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|(612) 626-2313|orcha001@umn.edu|
20216540|NCT02707276|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
20216541|NCT03428945|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@yale.edu|
20216542|NCT00950300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216543|NCT01596127|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Associate Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
20216544|NCT00438633|Massachusetts General Hospital|Dr. Neal Chen|6177264700|nchen1@partners.org|
20216545|NCT01539239|Ivantis|Richard Hope|949-333-1310|rhope@ivantisinc.com|
20216546|NCT02179788|University of Cincinnati|Dr. Laurie Nommsen-Rivers|513-558-0461|laurie.rivers@uc.edu|
20216547|NCT05135273|Laboratory of Malaria Immunology and Vaccinology, NIAID/NIH|Dr. David Cook|240.627.3066|david.cook@nih.gov|
20216548|NCT03023709|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20216549|NCT04284553|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20216550|NCT00122447|Emory University School of Medicine|Mary Rhee, M.D.|404-778-1660|mrhee@emory.edu|
20216551|NCT04225260|Galderma Research & Development|Galderma Research & Development|817-961-5000|clinical.studies@galderma.com|
20216552|NCT00578968|Mayo Clinic|Bruce D. Johnson, PhD|507-284-4441|johnson.bruce@mayo.edu|
20216553|NCT00945334|Cedars-Sinai Medical Center|Mark Pimentel|3104233792|chuak@cshs.org|
20216554|NCT01196117|Medical College of Wisconsin|B. Tucker Woodson|414-805-7667|bwoodson@mcw.edu|
20163362|NCT06041919|Thirty Respiratory Ltd|Inva Hoti|+44 (0) 1235 431200|Inva.Hoti@30.technology|
20163363|NCT04526145|Ohio State University|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
20163364|NCT01588444|UT Health Sci Ctr San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
20216555|NCT01350934|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216556|NCT01011335|Uniformed Services University of the Health Sciences|David Tribble, MD, DrPH|301-816-8404|dtribble@idcrp.org|
20216557|NCT03028896|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|31
20216558|NCT00275275|University of Kansas Medical Center|Kelly E. Lyons, PhD|913-588-7159|klyons@kumc.edu|
20216559|NCT00117806|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli@va.gov|
20216560|NCT01765751|Palmer College of Chiropractic|Maruti R. Gudavalli, PhD|563-884-5260|gudavalli_r@palmer.edu|
20216561|NCT04632641|Aurora Health Care|Dr. Mahmoud Ali|(262) 948-6630|mahmoud.ali@aah.org|
20216562|NCT02383706|Duke University Medical Center|Dr Jennifer Dominguez|(919) 668-2024|jennifer.dominguez@dm.duke.edu|
20216563|NCT01257581|Massachusetts General Hospital|Nazem Atassi, MD|617-643-1807|natassi@partners.org|
20216564|NCT02212106|bioCSL PTY LTD|Clinical Program Director||bioCSL.ClinicalTrials@biocsl.com.au|
20216565|NCT02509260|Cleveland Clinic Foundation|Dr. David Liska|1-216-444-9219|liskad@ccf.org|
20216566|NCT01853371|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
20216567|NCT00517192|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216568|NCT02951195|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20216569|NCT03167606|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
20216570|NCT04808908|University of Minnesota|Kevin Escandón|612-626-9344|escan012@umn.edu|
20216571|NCT01286805|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
20216572|NCT02104817|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
20216573|NCT04633642|Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain|Dr. Francisco Javier Álvaro Afonso|913-941-502|alvaro@ucm.es|+34
20216574|NCT00611884|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20216575|NCT00981799|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
20216576|NCT02167594|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20216577|NCT03433703|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20216578|NCT02181140|Interdisciplinary Endoscopy Department and Clinic University Hospital Hamburg-Eppendorf|Professor Dr. Thomas Rösch|+4940 7410|t.roesch@uke.de|50098
20216579|NCT02518139|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20216580|NCT01586039|Brigham and Women's Hospital|Dr. Steven W. Lockley|617-732-4977|slockley@hms.harvard.edu|
20216581|NCT04436198|Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20216582|NCT02429583|The Rockefeller University|Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
20216583|NCT01943435|University of Pittsburgh|Michael Schneider, PhD, DC - Associate Professor and Principal Investigator|412-383-6640|mjs5@pitt.edu|
20216584|NCT01412281|Crucell Switzerland|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20216585|NCT01728636|Northwestern University|Luanne Carabini MD|312-695-0061|l-carabini@northwestern.edu|
20216586|NCT01617096|International Partnership for Microbicides|Dr John Steytler|+27218602300|jsteytler@ipmglobal.org|
20216587|NCT01753362|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
20216588|NCT01936662|IndianaU|Nicole Horn, MD|3179449981|ndhorn@hotmail.com|
20216589|NCT02046122|Duke University|Anthony Sung, MD|919-668-1002|anthony.sung@duke.edu|
20216590|NCT00106106|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
20216591|NCT04535986|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
20216592|NCT01196390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20216593|NCT01632215|Federal University of São Paulo|Dr. Rioko K. Sakata|055 11 5084 7463|riokoks.dcir@epm.br|
20216594|NCT01885897|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
20216595|NCT03141151|Vanderbilt University Medical Center|William Heerman, MD MPH|615-322-7080|bill.heerman@vumc.org|
20216596|NCT04561115|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
20216597|NCT02985398|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20216598|NCT01653405|Rand Corporation|Dr. Adam Rose|617-338-2059|arose@rand.org|8672
20216599|NCT00283842|Wyeth|U.S. Contact Center||clintrialresults@wyeth.com|
20216600|NCT02004691|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20216601|NCT02472639|Cedars Sinai Medical Center|Karen Zaghiyan, MD|310-289-9224|kzaghiyan@yahoo.com|
20216602|NCT00751023|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
20216603|NCT03617419|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
20216604|NCT02099318|University Hospitals Cleveland Medical Center|Valerie Cwiklinski Clinical Research Nurse|216-983-5144|valerie.cwiklinski1@uhhospitals.org|
20216605|NCT04207333|University of North Carolina at Chapel Hill|Lee Stoner, PhD, MPH|919-962-0534|stonerl@unc.edu|
20163365|NCT04211441|Medtronic, Inc|Director of Clinical Research|800-328-2518|medttroniccastrials@medtronic.com|
20216606|NCT01277510|Amgen Inc.|Study Director|866-572-6436||
20216607|NCT01685008|MorphoSys AG|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
20216608|NCT04049097|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20216609|NCT01320722|Brigham and Women's Hospital|John P Forman, MD||jforman@partners.org|
20216610|NCT00784095|VA Health Services Research and Development|Dr. Karen Steinhauser|9196682148|karen.steinhauser@va.gov|
20216611|NCT01540045|Instituto Nacional de Cancerología de México|Dr. Oscar Arrieta|5628-0400|ogarrieta@gmail.com|832
20216612|NCT03828539|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20216613|NCT01849458|Tornier Inc.|Marcela Bravo|9526837481|marcela.bravo@tornier.com|
20216614|NCT03950674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216615|NCT00982228|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20216616|NCT03231345|University Medical Center of Southern Nevada|Dr. Zitek|702-383-7885|zitek10@gmail.com|
20216617|NCT04841967|University of Illinois Chicago|Patricia Hershberger|3129961305|phersh@uic.edu|
20216618|NCT00360490|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20216619|NCT00538863|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602-910-2617|ldillaha@insysrx.com|
20216620|NCT00633022|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216621|NCT00987480|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
20216622|NCT01994980|Denver Health|Dr Fredric Pieracci|303-436-4029|Fredric.Pieracci@dhha.org|
20216623|NCT02569541|Arrevus, Inc.|Carl Kraus, MD (CEO)|9193665503|ckraus@arrevus.com|
20216624|NCT01109576|VHAPORHCS|Mitchel Turbin, PhD|503-220-8262|Bonnie.Becker@va.gov|
20216625|NCT01958060|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216626|NCT01705717|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216627|NCT02293460|LFB Biotechnologies|Clinical trial information desk|0033169827010|supportqcm@lfb.fr|
20216628|NCT01427881|Fred Hutchinson Cancer Research Center|Marco Mielcarek, MD|206-667-2827|mmielcar@fredhutch.org|
20216629|NCT00500318|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20216630|NCT00706719|Repros Therapeutics, Inc|Ronald Wiehle, PhD|281.719.3406|rwiehle@reprosrx.com|
20216631|NCT00799708|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20216632|NCT00880334|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard/edu|
20216633|NCT02473393|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20216634|NCT01149434|Huntsman Cancer Institute Unversity of Utah|Sunil Sharma, MD|801-585-0255|sunil.sharma@hci.utah.edu|
20216635|NCT03033134|Boston Scientific Japan|Yutaka Gomi|+81.3.6853.7500|Yutaka.Gomi@bsci.com|
20216636|NCT01157234|University of Florida|Alfonso H. Santos Jr, M,D,|352-273-6374|Alfonso.santos@medicine.ufl.edu|
20216637|NCT01775722|University of California, Irvine. Beckamn Laser Institute|J Stuart Nelson|9498247997|jsnelson@uci.edu|
20216638|NCT00963430|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
20216639|NCT00063258|University of Texas M.D. Anderson Cancer Center|Mellanie Price, B.S.|713-792-4392|mejprice@mdanderson.org|
20216640|NCT02246764|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20216641|NCT05393271|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216642|NCT03408730|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
20216643|NCT00413049|Novartis Pharmaceuticals|Study Director|862 778-8300||
20216644|NCT01884844|Department of Psychiatry, Universtity of Massachusetts|Director of the Bipolar Disorders Specialty Clinic|508-334-5052|wendy.marsh@umassmemorial.org|
20216645|NCT03314857|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
20216646|NCT00555893|Marshfield Clinic Research Foundation|Edward Belongia, MD|715-389-3783|belongia.edward@mcrf.mfldclin.edu|
20216647|NCT01408888|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216648|NCT00287053|Pennington Biomedical Reseach Center|Corby Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
20216649|NCT00695110|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
20216650|NCT00264381|University of Oklahoma Health Sciences Center|Suman Rathbun MD,MS|405271-4742|suman-rathbun@ouhsc.edu|44773
20216651|NCT03211039|Rady Children's Institute for Genomic Medicine|Dr. Stephen F. Kingsmore|816 854 0882|skingsmore@rchsd.org|
20216652|NCT02575339|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20216653|NCT00550147|Indiana University School of Medicine|David W. Dunn, MD|317-944-8162|ddunn@iupui.edu|
20216654|NCT04768114|Washington University School of Medicine|Alex T. Ramsey, Ph.D.|314-362-5370|aramsey@wustl.edu|
20216655|NCT02013050|Soligenix, Inc.|Dr. Richard Straube||rstraube@soligenix.com|
20216656|NCT01963260|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216657|NCT04994431|UMass Memorial Health Care|Feiran Lou|5083348996|feiran.lou@umassmemorial.org|
20216658|NCT00160524|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20216659|NCT04892147|Duke University|Guy G. Potter, PhD|919-668-1269|guy.potter@duke.edu|
20216660|NCT01837537|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
20216661|NCT02667951|School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan|Dr. Yea-Ing L. Shyu|+886-3-211 8800|yeaing@mail.cgu.edu.tw|5275
20163366|NCT01625000|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20163367|NCT00566852|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20163368|NCT01147055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216662|NCT00057941|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20194257|NCT01720277|Brown University and Providence VA Medical Center|Dr. Stefan Gravenstein|401-863-3172|Stefan_gravenstein@brown.edu|
20194258|NCT04246021|King Hussein Cancer Center|Dr. Hikmat Abdel-Razeq|0096265300460|habdelrazeq@khcc.jo|1403
20194259|NCT02781090|Montefiore Medical Center|Dr. Jonathan Shuter|718-920-7845|jshuter@montefiore.org|
20194260|NCT01867333|National Cancer Institute|Ravi A. Madan|301-480-7168|rm480i@nih.gov|
20194261|NCT02551653|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20194262|NCT02683785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20194263|NCT00795275|University of Colorado Anschutz Medical Campus|Leigh Perreault, MD|303-249-7732|leigh.perreault@ucdenver.edu|
20194264|NCT01696045|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20194265|NCT00368927|National Jewish Health|James R. Jett, M.D.|303-270-2601|JettJ@NJHealth.org|
20216663|NCT02760433|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
20216664|NCT00766493|W. L. Gore & Associates|Bryan Randall|(800) 437-8181|BRandall@WLGore.com|
20216665|NCT04721145|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
20216666|NCT03439085|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, Chief Patient Experience Ofc, Ofc of Chief Operating Officer|(713) 792-9599|mfrumovitz@mdanderson.org|
20194266|NCT03525392|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
20216667|NCT01863433|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20194267|NCT03284203|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
20194268|NCT03262662|University at Buffalo|Larry Hawk, PhD|716-829-2323|lhawk@buffalo.edu|
20194269|NCT03309813|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs|214-630-9900|NadirA@Insightec.com|
20194270|NCT04978493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20194271|NCT01128114|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
20194272|NCT02654652|Universidade Federal de Minas Gerais|Dr. Maria Isabel Correia|+55 31 34098033|isabel_correia@uol.com.br|
20194273|NCT02738853|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
20194274|NCT01390870|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194275|NCT04157400|MUSC|Nathan Rowland|843-792-6590|rowlandn@musc.edu|
20194276|NCT01809834|School of Optometry, University of Waterloo|Lyndon Jones, PhD, FCO|519-888-4742|ljones@uwaterloo.ca|
20216668|NCT02224053|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20216669|NCT03448692|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216670|NCT02289820|MedImmune LLC|Judith Falloon, MD, FACP, FIDSA, Senior Director, Clinical Development|+1-301-398-4010|information.center@astrazeneca.com|
20216671|NCT02054754|e-Therapeutics Plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
20216672|NCT02786927|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216673|NCT01801917|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20216674|NCT01924364|University of Pittsburgh Plastic Surgery|Danielle Minteer|412-383-4804|minteerdm@upmc.edu|
20216675|NCT00265785|SWOG Statistical Center|Study Statistician|206-667-4623||
20216676|NCT04979858|Georgia Institute of Technology|Dr. Sundaresan Jayaraman|404.894.2461|sundaresan.jayaraman@gatech.edu|
20216677|NCT04253236|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
20216678|NCT03919695|San Diego State University|Assist. Vice President Research Support Services|619-594-5938|rgulizia@sdsu.edu|
20216679|NCT01706263|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216680|NCT02416934|West Virginia University Department of Orthopaedics|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
20216681|NCT00591760|Federico II University|Prof. Antonio Cittadini|0039(0)817464375|antonio.cittadini@unina.it|
20216682|NCT03490227|Pennington Biomedical Research Center|Dr. Leanne Redman|225-763-0947|leanne.redman@pbrc.edu|
20216683|NCT00804999|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
20216684|NCT00789776|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
20216685|NCT02627001|San Antonio Military Medical Center|Dr. Michael D. April|(210) 916-0808|Michael.D.April@post.harvard.edu|
20216686|NCT01337596|Eli Lilly Company|Chief Medical Officer|1-800-545-5979||
20216687|NCT02946255|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
20216688|NCT03201003|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20216689|NCT00834613|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216690|NCT03646162|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
20216691|NCT00697619|Sun Yat-sen University Cancer Centre|Dr. Li Zhang|86-20-87343458(O)|zhangli6@mail.sysu.edu.cn|
20216692|NCT03093025|Taisho Pharmaceutical R&D Inc.|Taisho Pharmaceutical R&D Inc. Study Director|800-602-0203|ClinicalTrials@taisho-rd.com|
20216693|NCT00968019|Johnson and Johnson Medical Iberia|Mayda Lopez-Belmonte, PhD|+34 91 7228481|tlopezbe@its.jnj.com|
20216694|NCT03460990|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20216695|NCT01188226|UCLA|Neal Garrett, MD||ngarrett@ucla.edu|
20216696|NCT04980456|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20216697|NCT00224484|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216698|NCT00673764|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20216699|NCT01074008|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20216700|NCT02805309|Hebrew SeniorLife Marcus Institute for Aging Research|Dr. Dae Hyun Kim, Associate Scientist|617-632-5362|daehyunkim@hsl.harvard.edu|
20216701|NCT01636934|UT MD Anderson Cancer Center|Zhongxing Liao, MD/ Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
20216702|NCT01435824|The Hospital for Sick Children|Dr. Shinya Ito|416-813-5776|shinya.ito@sickkids.ca|205776
20216703|NCT02339415|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
20216704|NCT03687242|Spruce BioSciences Inc.|Spruce CMO, MD|415-655-4169|clinicaltrials@sprucebio.com|
20216705|NCT01528293|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research, MGUH Center for Wound Healing and HBOT|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
20216706|NCT00377156|Mayo Clinic|Paul Brown, M.D.|507-538-0948|Brown.Paul@mayo.edu|
20216707|NCT00288704|Regeneron Pharmaceuticals|Doug Nadler, MS Statistics|914 345 7905|clinicaltrials@regeneron.com|
20216708|NCT01579006|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216709|NCT00324896|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
20216710|NCT01802216|University of California, San Francisco|Dr. Vanessa Grubbs|415-206-5649|Vanessa.Grubbs@ucsf.edu|
20216711|NCT04675775|University of Michigan|Elliot Tapper|734-647-9252|etapper@med.umich.edu|
20216712|NCT05431777|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20216713|NCT02340780|Canadian Cancer Trials Group|Bingshu Chen|613-533-2430|bchen@ctg.queensu.ca|
20194277|NCT01803282|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20194278|NCT02671500|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20194279|NCT01217437|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20216714|NCT01957150|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216715|NCT03223909|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20216716|NCT03971578|Intelligent Hearing Systems|Dr. Rafael E. Delgado, Director of Research & Development|305-668-6102|redelgado@ihsys.com|
20216717|NCT01856192|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20216718|NCT01698554|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20216719|NCT00252564|US Oncology|Allen L. Cohn|303- 388-4876|Allen.Cohn@USOncology.com|
20216720|NCT01583530|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216721|NCT02416180|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216722|NCT00640926|Melinta Therapeutics, Inc.|Sue Cammarata, MD|(203) 624-5606|scammarata@melinta.com|
20216723|NCT01841073|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20216724|NCT02564016|Medical University of South Carolina|Laura L Roberts MD, Assistant Professor|843 792 2322|roberll@musc.edu|
20216725|NCT04404907|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
20216726|NCT02858037|International Partnership for Microbicides|Dr John Steytler|+27 21 860 2300|jsteytler@ipmglobal.org|
20216727|NCT04320745|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20216728|NCT00046839|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20216729|NCT01282086|Abbott (Ukraine)|Global Medical Services|1-800-633-9110||
20216730|NCT01181596|University of California - San Diego|Jae Kim, MD|619-543-3759|neojae@ucsd.edu|
20216731|NCT02050321|University of Arizona Cancer Center|Dr. Lee Cranmer|520 626-0501|lcranmer@uacc.arizona.edu|
20216732|NCT01321177|Northwell Health|Patricia Marcy|347-439-8035|pmarcy@northwell.edu|
20216733|NCT03720704|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
20216734|NCT01285076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20216735|NCT00715676|Deltanoid Pharmaceuticals|Hector F. DeLuca, President and Chief Executive Officer|608-238-7710|info@deltanoid.com|
20216736|NCT01816230|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
20216737|NCT01067521|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|001-215-591-3000|info.era-clinical@teva.de|
20216738|NCT01547728|Mayo Clinic Rochester|Dr. William Oliver|507-255-4240|oliver.william@mayo.edu|
20216739|NCT02151149|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20216740|NCT05653362|Indiana University School of Medicine|Claire Edelman|3176509107|ceedelma@iu.edu|
20216741|NCT03419962|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216742|NCT04142658|Artivion|Melissa Thalin, Director, New Indications|770-419-3355|melissa.thalin@artivion.com|
20216743|NCT01781234|University of Illinois College of Pharmacy|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
20216744|NCT00193492|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
20216745|NCT00830167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216746|NCT02585245|ThedaCare|Lori Hartz MS, RDN Manager of Nutrition and Diabetes Education|920 831-5077|lori.hartz@thedacare.org|
20216747|NCT04720547|Wayne State University|Dr. Abdulghani Sankari|313-576-3548|atarbich@med.wayne.edu|
20216748|NCT01499160|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20216749|NCT01438476|UT MD Anderson Cancer Center|Dr. Jean-Nicolas Vauthey,MD/Professor, Surgical Oncology|713- 792-2022|jvauthey@mdanderson.org|
20216750|NCT00603512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216751|NCT01688882|Novartis Pharmaceuticals|Study Director|862-778-8300||
20216752|NCT02095340|University of Houston|Andres G Viana, Ph.D., Associate Professor|832-842-0234|agviana@uh.edu|
20216753|NCT00860262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216754|NCT00124618|Mayo Clinic|Aminah Jatoi, M.D.|507/538-0268|jatoi.aminah@mayo.edu|
20216755|NCT00608634|Arizona Cancer Center|Steven P. Stratton, PhD|520-626-9295|sstratton@azcc.arizona.edu|
20216756|NCT04315272|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
20216757|NCT04640194|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216758|NCT01709903|Novartis Pharmaceuticals|Study Director|862-778-8300||
20216759|NCT02061280|Nemours Children's Specialty Care|Kathryn Blake, Pharm.D.|9046865047|kathryn.blake@nemours.org|904
20216760|NCT00096460|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
20216761|NCT05590039|Cynosure|Jamie Trimper|(201) 479-9612|jamie.trimper@cynosure.com|
20216762|NCT05186415|Nemours Children's Hospital, Delaware|Shannon Nees, MD|302-651-6600|shannon.nees@nemours.org|
20216763|NCT03403439|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216764|NCT04662710|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20216765|NCT04390750|New York University|Bei Wu|12129925951|bw75@nyu.edu|
20216766|NCT01841736|UCSF Helen Diller Family Comprehensive Cancer Center|Emily Bergsland, M.D.|415-353-9888|emily.bergsland@ucsf.edu|
20216767|NCT05480800|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216768|NCT03978598|UNM Obstetrics & Gynecology|Family Planning Research Team|505-205-4118|HSC-FamilyPlanningResearch@salud.unm.edu|
20216769|NCT05693805|BUCA School of Medicine, Psychiatry; Boston Veterans Administration|Barbara L Niles, PhD|857-364-4128|barbara.niles@va.gov|
20216770|NCT05707403|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216771|NCT03807661|LimFlow SA|Kristi McCaffrey|+1 559 970-1012|kristi.mccaffrey@stryker.com|
20194280|NCT05570630|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
20194281|NCT04531982|Acadia Pharmaceuticals Inc.|Senior Director, Medical Information|8444222342|medicalinformation@acadia-pharm.com|
20194282|NCT06655558|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20194283|NCT04839185|UW School of Medicine and Public Health|Dinesh Shah, MD|608-417-6099|dmshah@wisc.edu|
20194284|NCT01736943|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20194285|NCT00890695|KEMRI/Wellcome Trust Research Programme|Dr James Berkley|+254 41 522535|jberkley@kilifi.kemri-wellcome.org|
20194286|NCT01802151|Department of Food Science and Human Nutrition, University of Florida|Dr. Wendy Dahl|352-392-1991|wdahl@ufl.edu|224
20194287|NCT00129480|Portland VA Medical Center|Steven K. Dobscha MD|503-220-8262|steven.dobscha@va.gov|52207
20194288|NCT00926497|Children's Hospital of Lucerne|Martin Stocker, MD|0041412051288|martin.stocker@ksl.ch|
20194289|NCT00833261|UT Southwestern Medical Center|Dr. Lucien Nedzi|214-645-7653|lucien.nedzi@utsouthwestern.edu|
20194290|NCT03439254|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20194291|NCT00568178|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194292|NCT01531673|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20194293|NCT00837694|University at Buffalo|Jennifer L. Temple|716-829-5593|jltemple@buffalo.edu|
20194294|NCT03268603|Mayo Clinic|Nathan Staff, M.D., Ph.D.|507-293-1283|Staff.Nathan@mayo.edu|
20194295|NCT02591953|Rush|Dr. Jeremy Alland|3124322434|jeremy.alland@rushortho.com|
20194296|NCT02060370|University of Texas MD Anderson Cancer Center|Dr. Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-2830|ejonasch@mdanderson.org|
20194297|NCT04939701|Astellas Pharma Global Development Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20194298|NCT03098563|Johns Hopkins University|Claudia Campbell|4105507989|ccampb41@jhmi.edu|
20194299|NCT01517295|International Clinical Research Institute|Srinivas Nalamachu|913.317.5300|nalamachu@yahoo.com|
20194300|NCT03248882|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194301|NCT04308590|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20194302|NCT00356408|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20194303|NCT02734576|North Shore University Hospital Northwell Health|Dr. Athos Patsalides|516-562-2244|apatsalides@northwell.edu|
20194304|NCT01156376|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20194305|NCT05487586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194306|NCT01493427|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20194307|NCT00565773|Duke University|Allan D. Kirk, MD, PhD|919-681-1400|allan.kirk@duke.edu|
20194308|NCT05775991|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
20194309|NCT01075958|Northumbria University|Dr Philippa Jackson|+44 191 204 8818|philippa.jackson@northumbria.ac.uk|
20194310|NCT01072630|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20194311|NCT00643617|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
20194312|NCT02075073|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
20194313|NCT02530970|Aziyo Biologics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
20194314|NCT00827099|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
20216772|NCT04254198|University of New Mexico Health Sciences|Janet Page-Reeves|505-272-1694|JPage-Reeves@salud.unm.edu|
20216773|NCT02152982|Mayo Clinic|Jann N. Sarkaria, MD|507-284-8227|Sarkaria.jann@mayo.edu|
20216774|NCT05661344|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216775|NCT00527475|Texas Retina Associates|David Callanan, MD|817-261-9625|dcallanan@texasretina.com|
20216776|NCT03230487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216777|NCT05212948|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20216778|NCT05347693|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20216779|NCT02048813|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20194315|NCT02233803|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194316|NCT03846453|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
20216780|NCT01708954|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20194317|NCT00468143|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
20194318|NCT01606670|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20194319|NCT01681121|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20194320|NCT03878277|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
20194321|NCT01249027|Abbott Vascular|Leong Roy|8133 7475|roy.leong@abbott.com|+65
20194322|NCT00968071|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur M.D./Associate Proffesor|713-563-1586|eharriso@mdanderson.org|
20194323|NCT01559129|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20194324|NCT01152814|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20194325|NCT00831129|University of Chicago|Dr. George Bakris|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
20194326|NCT01877239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194327|NCT01333813|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194328|NCT02917603|UMissouri|Debra Parker Oliver; PI|573-356-6719|oliverdr@missouri.edu|
20194329|NCT01204710|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194330|NCT00743431|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20194331|NCT03291288|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20194332|NCT04276415|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20194333|NCT00208325|DePuy International|Kimberly Dwyer, Ph.D, CCRA||kdwyer2@its.jnj.com|
20194334|NCT02145468|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194335|NCT00586612|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194336|NCT00623805|Hoffmann-La Roche|Medical Communications|800 821-8590||
20194337|NCT00422812|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20194338|NCT00635128|GlaxoSmithKline|GSK Response Center|866-435-7343||
20203023|NCT00474630|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20203024|NCT03088605|Topivert Pharma Ltd|Director of Clinical Trials|+44 203 763 9469|info@topivert.com|
20203025|NCT00352781|Centre for Addiction and Mental Health|Co-Investigator|416-535-8501|laurie_zawertailo@camh.net|7422
20203026|NCT02225223|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
20203027|NCT03567291|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20203028|NCT03666143|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20203029|NCT01103349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203030|NCT01148056|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
20203031|NCT00958568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216781|NCT05996198|NYU Langone Health|Heidi Schambra, MD|212-598-6000|Heidi.Schambra@nyulangone.org|
20216782|NCT01192776|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
20216783|NCT03542344|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216784|NCT05552261|Dompé Farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinicaltrials@dompe.com|
20216785|NCT03760003|ABIVAX|Fabio Cataldi|+33 (0) 1 53 83 08 41|clinicaltrials@abivax.com|
20216786|NCT04941768|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20216787|NCT01737619|M.D. Anderson Cancer Center|Pamela Soliman, MD|713-745-2352|psoliman@mdanderson.org|
20216788|NCT03302078|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216789|NCT01886872|Ohio State University|Jennifer Woyach, MD|614-685-5667|jennifer.woyach@osumc.edu|
20216790|NCT00098475|ECOG Statistical Office|Study Statistician|617-632-3012||
20216791|NCT03422068|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216792|NCT04116658|Enterome|Jan Fagerberg|+33175772785|info@enterome.com|
20216793|NCT05633862|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20216794|NCT05584553|Zimmer Biomet|Dr Nesma Bayrich|+41793001484|nesma.bayrich@zimmerbiomet.com|
20216795|NCT06128525|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
20216796|NCT03538262|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
20216797|NCT03294317|Medtronic CRM Clinical|Nonye Harcourt|6122421785|nonye.o.harcourt@medtronic.com|
20216798|NCT03566238|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
20216799|NCT06107036|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20216800|NCT04490057|Yale University|E. Jennifer Edelman, MD, MHS|203-727-7115|ejennifer.edelman@yale.edu|
20216801|NCT04771286|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216802|NCT06891729|Next Life Sciences|Darlene Walley|415-407-5229|darlene.walley@nextlifesciences.org|
20216803|NCT04584983|The University of Texas Health Science Center at Houston|Lindsay F Holzapfel, MD, MS|713-500-6422|Lindsay.N.Fleig@uth.tmc.edu|
20216804|NCT05377489|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|
20216805|NCT05718648|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216806|NCT00851006|University of Utah|Douglas Kondo, M.D.|801-587-1549|doug.kondo@hsc.utah.edu|
20216807|NCT02722616|Johns Hopkins, East Baltimore|Dr. Amol Narang|410-913-3395|anarang2@jhmi.edu|
20216808|NCT02031237|University of Michigan Comprehensive Cancer Center|Dr. Yue Cao|(734) 936-8695|yuecao@umich.edu|
20216809|NCT01474915|The Ohio State University Department of Anesthesiology|Andrew Otey|6142933559|Andrew.otey@osumc.edu|
20216810|NCT00676650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216811|NCT00292591|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
20216812|NCT02297841|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20216813|NCT05061992|University of Michigan|Dr. Elliot Tapper|734-647-9252|etapper@med.umich.edu|
20216814|NCT01891812|Columbia University Irving Medical Center|Dr. Daniel Tsze, Professor of Pediatrics|212 305 9825|dst2141@cumc.columbia.edu|
20216815|NCT01833754|Amgen Inc.|Study Director|866-572-6436||
20216816|NCT01507233|University of Miama/Jackson Memorial Hospital|Keith Candiotti, MD|305-585-5332|info@jhsmiami.org|
20216817|NCT01402128|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Soo-Wan Chae, MD|82-63-276-8284|soowan@jbnu.ac.kr|
20216818|NCT01358877|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20216819|NCT01312181|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
20216820|NCT02003222|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20216821|NCT05148299|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|medical.info@sobi.com|
20216822|NCT05383170|Cytovation ASA|CEO|+4747718809|contact@cytovation.com|
20216823|NCT04269993|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
20216824|NCT03807440|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216825|NCT02451358|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
20216826|NCT00960414|UCSF Osher Center for Integrative Medicine|Rick Hecht, MD|4153739743|rick.hecht@ucsf.edu|
20216827|NCT04010227|Indiana University|Dr. Catherine Mosher|3172746769|cemosher@iupui.edu|
20216828|NCT01176981|Hospital for Sick Children|Dr. Abha Gupta|14168137744|abha.gupta@sickkids.ca|
20216829|NCT02033317|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20216830|NCT04307849|NYU Langone Health|Marie Brault, PhD|210-276-9012|Marie.Brault@nyulangone.org|
20216831|NCT01294449|University of Rochester Heart Research Follow-up Program|Dr. Arthur Moss|585-275-5291|Arthur.Moss@heart.rochester.edu|
20216832|NCT02911935|Washington University School of Medicine.|Dr. Avraham Beigelman|314-454-2694|beigelmana@wustl.edu|
20216833|NCT05317195|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20216834|NCT05467540|AORN Cardarelli|Dr. Prof. Mario Muto|+39800019774|mutomar2@gmail.com|
20216835|NCT03061903|Columbia University|Roshan P. Shah, MD|212-305-8193|rs3464@cumc.columbia.edu|
20216836|NCT03370510|Yale Child Study Center|Dr. Pamela Ventola|(203) 737-4378|ventolalab@yale.edu|
20216837|NCT03382041|The University of Alabama at Birmingham (UAB)|Dr. Clay Spitler|205-934-6413|caspitler@uabmc.edu|
20216838|NCT01374451|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20216839|NCT01977456|University of Cincinnati|Dr. Opeolu Adeoye|513-558-3117|opeolu.adeoye@uc.edu|
20194339|NCT01012297|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Administration and Operations|(716) 845-5702|kurasa@nrgoncology.org|
20194340|NCT03548220|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
20194341|NCT02906007|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20194342|NCT04372121|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20194343|NCT00542542|University of Texas MD Anderson Cancer Center|Dr. Farzin Goravanchi, Professor, Anesthesiology & Perioperative Medicine|713-563-5613|CR_Study_Registration@mdanderson.org|
20163369|NCT00577824|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20194344|NCT02745353|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
20194345|NCT04015869|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|Elizabeth.Ralevski@yale.edu|1-4282
20194346|NCT03820947|Medtronic|Wendy Moeyersons, Clinical Research Specialist|+32486313172|wendy.moeyersons@medtronic.com|
20194347|NCT04500769|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
20216840|NCT01756885|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
20216841|NCT02459418|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
20216842|NCT00653159|The University of Chicago Department of Health Studies, Biostatistics Laboratory|Dr. Sydeaka Watson, PhD|773-834-2378|swatson@health.bsd.uchicago.edu|
20216843|NCT01872715|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
20216844|NCT00683592|PGxHealth, LLC|Director of Medical Affairs|203-786-3400||
20216845|NCT02814708|Biomedizinische Forschung & Bio-Produkte AG|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
20216846|NCT02697617|Indiana University School of Medicine|Dr. Sharon Moe|317 278 2868|smoe@iu.edu|
20216847|NCT03303417|University of Nottingham|Robin Spiller|0115 823 1090|robin.spiller@nottingham.ac.uk|
20216848|NCT01578317|NIH|John Tsang|301-496-0304|tsangjs@mail.nih.gov|
20216849|NCT00381849|Mayo Clinic|Beverly Tietje, Study Coordinator|507-255-0401|tietje.beverly@mayo.edu|
20216850|NCT02824640|Prisma Health|Megan Groome|864-382-1023|megan.groome@primsahealth.org|
20216851|NCT01504711|Barbara Ann Karmanos Cancer Institute|Dr. Philip A. Philip, M.D., Ph.D., F.R.C.P|(313)576-8624|philipp@karmanos.org|
20216852|NCT01765270|Duke Clinical Research Institute|L. Kristin Newby, MD, MHS|919-668-8805|kristin.newby@duke.edu|
20216853|NCT00329160|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20216854|NCT02419573|Unviersity of Texas Health Science Center at Houston|Henry E. Wang, MD, MS|713-500-7878|henry.e.wang@uth.tmc.edu|
20216855|NCT00493792|Mayo Clinic, Rochester, MN|Emilee Andersen, M.A., Clinical Research Coordinator|507-266-9807|andersen.emilee@mayo.edu|
20216856|NCT02315261|Faculty of Medicine Siriraj Hospital|Dr.Mingkwan Wongyingsinn|66824197995|minkcheerful@hotmail.com|81
20216857|NCT00623636|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20216858|NCT02426541|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20216859|NCT00745134|M D Anderson Cancer Center|Dr. Jillian Gunther|832-710-7864|JGunther@mdanderson.org|
20216860|NCT04167618|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
20216861|NCT02877017|Boston Children's Hospital|Alisa Khan, MD, MPH|6173552565|alisa.khan@childrens.harvard.edu|
20216862|NCT02943993|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20216863|NCT04178096|VA Pittsburgh Healthcare System|Dr. Shari Rogal|412 360 6177|shari.rogal@va.gov|
20216864|NCT00876265|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
20216865|NCT04443569|Massachusetts General Hospital|Christopher Arkfeld|4029803860|carkfeld@mgh.harvard.edu|
20216866|NCT00996437|Diabetic Retinopathy Clinical Research Network|Adam R. Glassman|813-975-8761|drcrstat4@jaeb.org|
20216867|NCT01755975|Memorial Sloan Kettering Cancer Center|Dr. Steven Horwitz, MD|646-608-2680|horwitzs@mskcc.org|
20216868|NCT03653026|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20216869|NCT05560555|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216870|NCT00852917|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20216871|NCT02510261|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20216872|NCT02161549|MotusGI|Ravit Peled -Director of Clinical Trial|+972 (0)4 6214447|ravit@motusgi.com|203
20216873|NCT00979212|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20216874|NCT02046317|The University of Texas Health Science Center at Houston|Carlos J Roldan, MD|713-745-7246|Carlos.J.Roldan@uth.tmc.edu|
20216875|NCT04886063|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
20216876|NCT03287687|University of Iowa|Dr. Warren Bishop, Professor of Pediatrics|319 356 2977|warren-bishop@uiowa.edu|
20216877|NCT02988882|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20216878|NCT01405469|University Hospital Hamburg-Eppendorf|Prof. Dr. Thomas Rösch, Principal Investigator|+49 40 7410 50098|t.roesch@uke.de|
20216879|NCT00965757|Eisai Co., Ltd.|Kota Nagai|+81-3-3817-5238||
20216880|NCT01398787|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20216881|NCT03414034|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
20216882|NCT02725645|Universidade Fernando Pessoa|Sandra Beatriz Pereira Rodrigues||sandrar@ufp.edu.pt|
20216883|NCT02351167|Washington University School of Medicine|Li-Shiun Chen, M.D.|314-362-3932|li-shiun@wustl.edu|
20216884|NCT01332968|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20216885|NCT00702507|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194348|NCT01967147|Alcon Research, Ltd.|Global Brand Med Affairs Lead, GCRA, GMA Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20194349|NCT03843554|University of Pittsburgh|Associate Vice Chancelor, Clinical Trials Operations|412-383-2561|pat.corby@pitt.edu|
20194350|NCT01099215|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20194351|NCT02896075|University of Texas at Austin|Stephanie Lapierre|512-471-8594|stephlap1116@gmail.com|
20194352|NCT04420949|University of Wisconsin - Madison|Dr. Kreg Gruben|608 262 2711|kreg.gruben@wisc.edu|
20216886|NCT02308696|Univ. WI Madison|Amy Amessoudji|608-263-2621|amessoudji@surgery.wisc.edu|
20216887|NCT01194908|Emory University School of Medicine|Ruth O'Regan, MD|404-778-4824|roregan@emory.edu|
20216888|NCT01742208|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20194353|NCT04396366|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20216889|NCT01055886|VA Medical Center|Angela Kirby|919-286-0411|angela.kirby@va.gov|5526
20163370|NCT01518374|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20187475|NCT05873556|University of Washington|Dr. Anne Fairlie|2062215896|afairlie@uw.edu|
20187476|NCT03606408|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
20163371|NCT03035331|Mayo Clinic|Yi Lin|507-293-5189|Lin.Yi@mayo.edu|
20187477|NCT02584647|Columbia University|Gulam A. Manji|212 305 0592|gam2140@cumc.columbia.edu|
20187478|NCT04862234|Emory University|Georgia Davis, MD|404-251-8957|georgia.marie.davis@emory.edu|
20194354|NCT00166712|Comprehensive Transplant Center, Northwestern University|Joseph Leventhal, MD, PhD, Associate Professor|(312) 695-1703|jleventh@nmh.org|
20194355|NCT04684394|Gemini Therapeutics, Inc.|Gemini Therapeutics, Inc.|617-401-4401|clinicaltrials@geminitherapeutics.com|
20194356|NCT03986944|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20187479|NCT03292484|Aimmune Therapeutics, a Nestlé Health Science Company|Jay Patel|(800) 422-2752|jay.patel@uk.nestle.com|
20187480|NCT06193070|Fred Hutchinson Cancer Center|Dr. Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
20187481|NCT05069896|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20187482|NCT04068831|Memorial Sloan Kettering Cancer Center|Dr. Ritesh Kotecha, MD|646-422-4791|kotechar@mskcc.org|
20187483|NCT04538378|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20187484|NCT02839265|Montefiore Medical Center|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
20187485|NCT04560595|Johns Hopkins University|Dr. Dustin C. Lee|410-550-4035|dlee214@jhmi.edu|
20216890|NCT04194008|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|0542220121|daganh@theranica.com|
20216891|NCT02361736|Tianjin Medical University General Hospital|Dr. Yuanyuan Zhang|13821685913|doctorkelly@126.com|
20216892|NCT02287636|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
20216893|NCT02522780|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20216894|NCT02260635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216895|NCT01992874|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20216896|NCT00926367|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216897|NCT01517867|Johns Hopkins University|Deborah Gross|410-614-5311|debgross@jhu.edu|
20216898|NCT01685216|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20216899|NCT00645827|Emory University|G. Randy Smith Jr.|404.686.6730|grsmith@emory.edu|
20216900|NCT00756717|Loyola University Medical Center|Dr. Kathy Albain|708-327-3102|KALBAIN@lumc.edu|
20216901|NCT02846233|University of California San Francisco, Fresno Medical Education Program|SOE NAING|5593239236|snaing@fresno.ucsf.edu|
20216902|NCT02466386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20216903|NCT00889252|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
20216904|NCT02710591|EspeRare Fondation|Florence Porte-Thomé|22 794 4004|porte.florence@esperare.org|+41
20216905|NCT04235660|Indiana University School of Medicine|Paul Haste|317-944-5005|phaste@iu.edu|
20216906|NCT02387762|Acerta Pharma|Ahmed Hamdy, MD, VP of Early Development|650-591-2800|a.hamdy@acerta-pharma.com|145
20216907|NCT00593827|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20216908|NCT01160640|University of Pittsburgh|Dr. Harold Wiesenfeld|412-641-1403|wieshc@mail.magee.edu|
20216909|NCT02169336|Recro Pharma, Inc|Randall Mack|484-395-2400|rmack@recropharma.com|
20216910|NCT01598896|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
20216911|NCT00268762|University of Texas Health Science Center at Houston|Andrew D. Barreto, MD|713-500-7002|andrew.d.barreto@uth.tmc.edu|
20216912|NCT00239005|Novartis Pharmaceuticals|Study Director|862-778-8300||
20216913|NCT02614898|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
20216914|NCT00688844|Emory University|Rani H. Singh|404-448-8519|rsingh@emory.edu|
20216915|NCT03297541|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
20216916|NCT03493919|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216917|NCT00724958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialDisclosure@merck.com|
20216918|NCT00965731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216919|NCT04773600|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20216920|NCT02129062|UT MD Anderson Cancer Center|Jan Burger, MD/ UT MD Anderson Associate Professor, Leukemia|713-794-4329|CR_Study_Registration@mdanderson.org|
20216921|NCT02710240|University of Pennsylvania|Marie Kerr, Project Manager|215-829-6720|marie.kerr@pennmedicine.upenn.edu|
20216922|NCT04814459|Oakland University|Dr. Sara Arena|2483648682|arena@oakland.edu|
20216923|NCT01841060|Institut Bergonie|Pr Simone Mathoulin-Pélissier|33556333333|s.mathoulin@bordeaux.unicancer.fr|
20216924|NCT01848210|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20216925|NCT04592419|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
20216926|NCT04501094|National Cancer Institute|Dr. Andrea B. Apolo|301-480-0536|andrea.apolo@nih.gov|
20216927|NCT05838456|The University of Texas Health Science Center at Houston|Sunil A. Sheth, MD|713-500-7897|Sunil.A.Sheth@uth.tmc.edu|
20216928|NCT00685035|University of Minnesota School of Medicine|Dr. Robert Kempainen|612-873-6413|kempa001@umn.edu|
20216929|NCT00784979|Tampa General Hospital|Dr. John Leone|813-844-5666|jpleone@tgh.org|
20216930|NCT00894933|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
20216931|NCT02812771|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
20216932|NCT01503333|Michigan State University College of Nursing|Dr. Lorraine Robbins|517-353-3011|Lorraine.Robbins@hc.msu.edu|
20216933|NCT00468208|Vasculitis Clinical Research Consortium|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
20216934|NCT00631007|InteKrin Therapeutics|Chief Executive Officer|650-941-5501|Info@intekrin.com|
20216935|NCT00683787|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20216936|NCT02674633|Akili Interactive Labs|Kathryn Jenkins|8572543399|kjenkins@akiliinteractive.com|
20216937|NCT00460109|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.|507/284-4642|ansell.stephen@mayo.edu|
20216938|NCT01235715|Hospital for Special Surgery|Dr. Mark P. Figgie|212-606-1932|figgiem@hss.edu|
20216939|NCT03619876|Columbia University|Laura Geraldino-Pardilla, MD|212-305-4308|lbg2124@cumc.columbia.edu|
20216940|NCT02344745|Keck School of Medicine|Begum Ozel, M.D.|323-226-3416|ozel@usc.edu|
20187486|NCT04167553|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|+8224100377|jiyeon.kang@hanmi.co.kr|
20216941|NCT02788513|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216942|NCT04982445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20216943|NCT00646763|Emory University Winship Cancer Institute|Edmund Waller, MD, PhD|1-888-946-7447|ewaller@emory.edu|
20216944|NCT04968925|Johnson & Johnson Vision Care, Inc. (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
20216945|NCT02046863|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
20216946|NCT00835796|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20216947|NCT02327325|Health Services Research & Development, Durham VA Healthcare System|Kelli Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
20216948|NCT02457819|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20216949|NCT01933919|AbbVie|Global Medical Services|800-633-9110||
20216950|NCT00763555|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20216951|NCT00784030|New York University School of Medicine|Dr. Irina Barash|212.263.5851|irina.barash@nyumc.org|
20216952|NCT00177164|UPMC|K.N. Roy Chengappa|412-246-5006|chengappakn@upmc.edu|
20216953|NCT01214980|University South Florida|Dr. Lisa Gould|(410) 736-4646|lgould44@hotmail.com|
20216954|NCT00974350|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20216955|NCT01344018|EORTC (European Organisation for Research and Treatment of Cancer)|EORTC HEADQUARTERS|+32 2 774 16 11|eortc@eortc.be|
20216956|NCT05070754|Medical University of South Carolina|Dr. Lara Wine Lee|(843) 792-3021|winelee@musc.edu|
20216957|NCT00194792|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20216958|NCT02339038|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
20216959|NCT02340962|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7020|lwchang@taigenbiotech.com|1227
20216960|NCT00434837|Rhode Island Hospital|Dr. Braden C. Fleming|401-316-4737|braden_fleming@brown.edu|
20216961|NCT00726895|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20216962|NCT01812473|Universitaire Ziekenhuizen Leuven|Kim Vanstraelen, PharmD|0032 16 342339|kim_vanstraelen@hotmail.com|
20216963|NCT01266603|U T MD Anderson Cancer Center|Dr. Michael A Davies, BA,MD,PHD/Melanoma Medical Oncology|713-792-3454|MDavies@mdanderson.org|
20216964|NCT02725411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20216965|NCT03847974|LIB Therapeutics|Evan A Stein MD PhD FACC|18596533141|estein@libtherapeutics.com|
20216966|NCT02654015|Icahn School of Medicine at Mount Sinai|Samantha St. Elin|(212) 241-1497|samantha.stelin@mountsinai.org|
20187487|NCT03812289|OHSU Knight Cancer Institute|Nima Nabavizadeh, MD|503-418-3685|nabaviza@ohsu.edu|
20187488|NCT05660434|West Virginia University|Dr. Marian Reven, PhD, RN, AHN-BC, CNE, RA|304-293-3399|marian.reven@hsc.wvu.edu|
20187489|NCT03298945|Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center|Yu-Xiao Yang, MD, MSCE|215-823-5800|yuxiao.yang@va.gov|
20216967|NCT02418754|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20163372|NCT02314221|VA RR&D National Center for the Medical Consequences of Spinal Cord Injury|Ann M. Spungen, EdD|718-584-9000|ann.spungen@va.gov|5814
20163373|NCT05725746|Washington University in St. Louis|Cindy Schwarz|314-935-3063|cschwarz@wustl.edu|
20163374|NCT04607837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20163375|NCT02362464|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|maengh@mail.nih.gov|
20163376|NCT03375489|Massachusetts General Hospital|Jennifer Temel, MD|617-724-4000|jtemel@mgh.harvard.edu|
20163377|NCT04209205|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20163378|NCT05870865|TrialSpark|TrialSpark|Please Email|soothe.info@trialspark.com|
20163379|NCT03427749|University of Ottawa Heart Institute|Dr. Terrence Ruddy|613-696-7267|truddy@ottawaheart.ca|
20163380|NCT05747027|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
20163381|NCT03828019|JHSPH Center for Clinical Trials|Elizabeth E. Sugar|410-614-7837|esugar2@jhu.edu|
20163382|NCT05715242|Stanford University School of Medicine|Michele L. Patel, PhD|650-549-7047|michele.patel@stanford.edu|
20163383|NCT03071393|University of Florida|Emily Fox, Principal Investigator|904-742-2500|ejfox@phhp.ufl.edu|
20163384|NCT00048347|NIAID|Peter Mannon, MD|205-934-4726|pmannon@uab.edu|
20163385|NCT00195663|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20163386|NCT01100775|University of Maryland Baltimore|Ms. Dawn Detamore|410 402 6820|DDetamore@som.umaryland.edu|
20163387|NCT03182907|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163388|NCT02109809|Wake Forest University Health Sciences|Dr. Gordon Phillips|336-716-0659|gophilli@wakehealth.edu|
20194357|NCT02548845|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
20194358|NCT03002220|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
20163389|NCT00166439|Mayo Clinic|Patrick B. Johnston, M.D., Ph.D.|507/284-5362|johnston.patrick@mayo.edu|
20163390|NCT01511081|UT MD Anderson Cancer Center|Joe Chang, MD/Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
20194359|NCT00482690|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
20194360|NCT01183260|Cleveland Clinic|Alison Klika, Research Program Manager|216-444-4954|klikaa@ccf.org|
20194361|NCT03795753|Emory University|Dr. Nancy Collop|404-712-7533|nancy.collop@emory.edu|
20194362|NCT02225132|National Heart Lung and Blood Institute|Fitzhugh, Courtney|+1 301 402 6496|courtney.fitzhugh@nih.gov|
20163391|NCT00106353|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163392|NCT03193736|iSTAR Medical|Zubair Hussain, VP Clinical and Regulatory Affairs|+3210771658|zubair@istarmed.com|
20163393|NCT03369236|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|1 855-752-2356|clinicaltrials@alexion.com|
20163394|NCT00423449|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163395|NCT01153724|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163396|NCT03334812|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20163397|NCT02697435|VAPHS|Debra Kaye Weiner, M.D.|412-360-2920|Debra.Weiner@va.gov|
20163398|NCT00367835|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20163399|NCT00870545|Memphis VAMC|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
20163400|NCT02178696|University of Michigan|Jon-Kar Zubieta||JONKAR.ZUBIETA@hsc.utah.edu|
20163401|NCT04338971|Neurolutions|Director of Clinical Affairs|831-316-5466|lsouders@neurolutions.com|
20194363|NCT01202903|Novartis Pharmaceuticals|Study Director|862-778-8300||
20194364|NCT01302080|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163402|NCT00445770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163403|NCT02395614|Vanderbilt university medical center|Dr. Kent K. Higdon|615-936-0160|kent.hidgon@vumc.org|
20194365|NCT01318018|Dept. of Anesthesiology and Intensive Care Medicine|Prof. Dr.Martin Soehle|++49-228-287-|martin.soehle@ukb.uni-bonn.de|11378
20194366|NCT02124603|Casa di Cura Di Stefano|Dr.Marcello Santocono|+393356070002|santocono.m@alice.it|
20194367|NCT01507987|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
20194368|NCT00297427|University of Pittsburgh|Dr. Sandra Engberg|412-624-6616|sje1@pitt.edu|
20194369|NCT04512703|ZOLL Medical Corporation|Mike Osz|4129683333|mosz@zoll.com|14104
20194370|NCT04786964|Checkpoint Therapeutics|James Oliviero|212-574-2830|jfo@checkpointtx.com|
20194371|NCT01896557|Heart Institute of University of Sao Paulo Medical School|Remo Holanda de Mendonca Furtado|+5511 26615058|remo_holanda@hotmail.com|
20194372|NCT02182947|Children's Mercy Hospital|Nadia Hijaz|3139204958|nmhijaz@cmh.edu|
20194373|NCT00919191|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
20194374|NCT01021618|Hartford Hospital|Gary V Heller, MD, PhD|860-545-5527|aahlber@harthosp.org|
20194375|NCT02757872|NYU Langone|Dr. Michal Melamed|212-263-0705|michal.melamed@nyulangone.org|
20163404|NCT00811174|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
20163405|NCT01938040|Rutgers/State University of New Jersey (NJMS)|Alex Bekker, MD, PhD|973 972-5007|bekkeray@njms.rutgers.edu|
20194376|NCT03151993|Federal Center for Brain and Neurotechnology|Dr. Eugene I. Gusev, President of the Federal Center for Brain and Neurotechnology|495-280-01-74|egusev2339@gmail.com|+7
20194377|NCT03894618|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
20194378|NCT04481568|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
20194379|NCT00416195|Eisai Call Center|Eisai Inc.|888-422-4743||
20194380|NCT01882764|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
20194381|NCT00414167|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
20194382|NCT01305408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20194383|NCT03101462|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
20194384|NCT02119442|UCLA|Soraya Sadeghi|3108255950|smsadeghi@mednet.ucla.edu|
20194385|NCT02770612|Brigham and Women's Hospital|Brian T Bateman|617-278-0930|bbateman@partners.org|
20194386|NCT02636725|University of Miami|Jonathan Trent MD|305-243-2581|JTrent@med.miami.edu|
20194387|NCT05254080|Medical University of South Carolina|Dr. Christopher W. Austelle|843-792-2872|austelle@musc.edu|
20194388|NCT03653208|ImmuneMed Inc.|Byoungok Ahn|+82-2-527-8391|ahnbo@immunemed.co.kr|
20194389|NCT03478904|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
20194390|NCT00886795|Johns Hopkins University|Clifton O. Bingham III, M.D.|410-550-0578|cbingha2@jhmi.edu|
20194391|NCT02297100|Wake Forest University Health Sciences|Dr. Robert Evans|336-713-0320|revans@wakehealth.edu|
20194392|NCT04368364|The University of Texas Health Science Center at Houston|Sudipta Sen, MD, Assistant Professor|713-500-6200|Sudipta.Sen@uth.tmc.edu|
20194393|NCT01669577|University of São Paulo|Luiz Guilherme Villares da Costa, MD|5511985584737|lgvc76@yahoo.com.br|
20194394|NCT01283516|Novartis Pharmaceuticals|Study Director|862-778-8300||
20194395|NCT01098318|University of Pennsylvania|Dr. Jun Mao, Associate Professor|215-746-2481|jun.mao@uphs.upenn.edu|
20194396|NCT00860847|Los Angeles Biomedical Research Inst.|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
20194397|NCT00444275|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20194398|NCT00132873|Jazz Pharmaceuticals, Inc.|Mortimer Mamelak, MD|650 496 3777|roman.skowronski@jazzpharma.com|
20194399|NCT03030859|University of Pennsylvania School of Nursing|Jie Deng, PhD, PI|215-573-2393|jiedeng@nursing.upenn.edu|
20194400|NCT01896726|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194401|NCT04561778|Geisinger Health System|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|5444
20194402|NCT04662931|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20194403|NCT02406677|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD, VP, CVMD TA|302-886-5526|Naeem.Khan@astrazeneca.com|
20194404|NCT01114880|Abbott|Global Medical Services|1-800-633-9110||
20194405|NCT02539459|Fox Chase Cancer Center|Robert Uzzo, M.D.|215-728-3096|robert.uzzo@fccc.edu|
20163406|NCT00999544|University of Kentucky|Dr. Sharon Walsh|859-257-6485|sharon.walsh@uky.edu|
20163407|NCT01392547|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20163408|NCT04683835|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
20163409|NCT02936635|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20163410|NCT02407223|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20163411|NCT00447226|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163412|NCT02309944|Masonic Cancer Center, University of Minnesota|Deanna GK Teoh|612-626-3111|dkteoh@umn.edu|
20163413|NCT03049917|University of Washington|Dr.|206-422-5564|jsyker@uw.edu|
20163414|NCT00584012|Holden Comprehensive Cancer Center|Cena Jones-Bitterman|319-353-4596|cena-jones@uiowa.edu|
20194406|NCT01533753|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-263-7107|jybruce@medicine.wisc.edu|
20194407|NCT04531904|CERENOVUS|Cerenovus Clinical Research Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20163415|NCT04404556|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|513-636-4864|avani.modi@cchmc.org|
20163416|NCT02029911|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
20163417|NCT00763386|Zimmer|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
20163418|NCT00502671|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20163419|NCT01402817|Indiana University School of Medicine - Pediatrics|Chie-Schin Shih, MD|317-948-8568|shih2@iu.edu|
20163420|NCT00681629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20163421|NCT03796637|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20163422|NCT01173601|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163423|NCT02274792|Amgen Inc.|Study Director|866-572-6436||
20163424|NCT01510158|Ardea Biosciences, MD|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
20163425|NCT05258149|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
20163426|NCT00476827|Duke University|Kimberly Blackwell, MD|919-668-1748|kimberly.blackwell@duke.edu|
20163427|NCT00832416|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20163428|NCT02114606|University of North Carolina at Chapel Hill|Evan Dellon, MD|919-966-2511|evan_dellon@med.unc.edu|
20163429|NCT01999400|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
20163430|NCT01466127|Massachusetts General Hospital|Elizabeth Hoge, M.D.|617-724-0859|ehoge@mgh.harvard.edu|
20163431|NCT01023711|University of Rochester|John Treanor, M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
20163432|NCT05786508|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
20163433|NCT04426318|Center for Healthy Minds|Matthew Hirshberg|608-262-0035|hirshberg@wisc.edu|
20163434|NCT04587050|Imperial College london|Dr Tamara Elliott|02075946230|te04@ic.ac.uk|
20163435|NCT02152761|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20163436|NCT01957202|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163437|NCT01456169|Takeda GlobalResearch and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20163438|NCT02652156|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
20163439|NCT00496080|Ethicon|Piet Hinoul MD|908-218-2585|phinoul@its.jnj.com|
20216968|NCT01896505|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20216969|NCT00462839|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|(312)926-9015|r-mccarthy@northwestern.edu|
20216970|NCT03259789|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20216971|NCT02063217|Washington University School of Medicine|Dr. Brendan Lucey|314-362-4342|luceyb@wustl.edu|
20216972|NCT04203667|Interscope, Inc.|Alexis James, Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
20216973|NCT03718039|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20216974|NCT01833169|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20216975|NCT01183884|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
20216976|NCT02922582|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20216977|NCT04718129|Vanderbilt University|Principal Investigator|615-330-5605|jgarber.vanderbilt@gmail.com|
20216978|NCT02212457|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216979|NCT00681473|Massachusetts General Hospital|Helen A. Shih, MD|617-724-9627|HSHIH@Partners.org|
20216980|NCT00420095|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20216981|NCT00393705|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20216982|NCT03346902|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|9493796569
20216983|NCT01120691|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20216984|NCT00642811|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20216985|NCT00938782|Stanford University|Dr. David R Drover|650-725-0364|ddrover@stanford.edu|
20216986|NCT04553406|SperoTherapeutics|Dr. Jon Bruss|(+1) 269-352-3766|jbruss@sperotherapeutics.com|
20163440|NCT03101254|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
20163441|NCT00479336|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20216987|NCT00772148|Veloxis Pharmaceuticals|Christina Sylvest|+45 20553877|csy@veloxis.com|
20194408|NCT04531098|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
20216988|NCT00749658|University of Minnesota|Marc Mooney PhD||moon0078@umn.edu|
20163442|NCT03066193|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
20163443|NCT02859246|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-4331|Reza_Dana@meei.harvard.edu|
20216989|NCT03573336|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20216990|NCT01525628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216991|NCT03108820|University of Wisconsin School of Medicine and Public Health|Dr. Ben Zarzaur|(608) 265-9574|zarzaur@surgery.wisc.edu|
20163444|NCT05280717|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20163445|NCT00080301|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20163446|NCT01397461|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
20216992|NCT00787605|Novartis Pharmaceuticals|Study Director|862-778-8300||
20216993|NCT03298880|University of Exeter, Royal Devon and Exeter Hospital|Dr Andrew Appelboam, Isabel FitzGerald|07515688294|andy.appelboam@nhs.net ; if223@exeter.ac.uk|
20216994|NCT02299869|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20216995|NCT00178711|University of Texas Health Science Center|Guy L Clifton|2024224824|guy@guyclifton.com|
20216996|NCT00089973|GlaxoSmithKline|GSK Response Center|866-435-7343||
20216997|NCT01223027|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
20194409|NCT02628028|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20194410|NCT00283244|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20194411|NCT02839889|Four Seasons Compassion for Life|Janet Bull, MD|8286926178|jbull@fourseasonscfl.org|302
20194412|NCT03361605|University of Michigan|Amy McKinney|734-647-8129|adrongo@med.umich.edu|
20194413|NCT03826030|Duke University|Wayne Feng, MD|919-681-1700|wayne.feng@duke.edu|
20194414|NCT03333876|Philips Respironics|Noah Papas|4122776436|Noah.Papas@philips.com|
20194415|NCT00979550|University of Kentucky Healthcare|Henry C. Vasconez, MD|8593236328|betsy.fink@uky.edu|
20194416|NCT05020327|University Hospitals Cleveland Medical Center|Dr. Ankita Desai|216-844-3645|Ankita.Desai@UHhospitals.org|
20194417|NCT00921687|Louis Stokes Cleveland VA Medical Center|Paul Drawz, MD, MHS, MS|6126255423|draw0003@umn.edu|
20216998|NCT01214239|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20216999|NCT01321697|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
20217000|NCT00243152|Boston Children's Hospital|Dr. David Borsook|617-281-7135|david.borsook@childrens.harvard.edu|
20217001|NCT00857818|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20217002|NCT01049581|ChangGungMH|Dr Chia- Ling Chen|886-3-3281200|clingchen@gmail.com|3846
20217003|NCT00559637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20217004|NCT04231409|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
20217005|NCT00003404|Dartmouth Hitchcock Medical Center|Richard J. Barth Jr., MD|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
20217006|NCT02786719|Baylor College of Medicine|Sarah Whittle, MD MS|8328241471|whittle@bcm.edu|
20217007|NCT04129944|Unity Biotechnology, Inc.|Chief Medical Officer|650-416-1192|Clinicaltrials@unitybiotechnology.com|
20217008|NCT02252445|Keimyung university|Assistant professor|+821028862876|onidori1979@gmail.com|
20203032|NCT04978376|University of Illinois Chicago|Kelsey Gabel|312-413-8911|kdipma2@uic.edu|
20217009|NCT01114997|Cedars Sinai Medical Center|Dr. Roya Yumul|310-423-1682|Roya.Yumul@cshs.org|
20217010|NCT00396630|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217011|NCT00651183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217012|NCT00357955|Providence VA Medical Center|Wen-Chih Wu, MD; Principal Investigator|4012737100|wen-chih.wu@va.gov|6237
20217013|NCT02919111|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|22648
20217014|NCT00951093|Clinica Gastrobese|Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery|+55(54)3045-4070|madalosso@gastrobese.com.br|
20217015|NCT01118026|Alliance for Clinical Trials in Oncology|Ann S. LaCasce, MD|617-632-5959|alacasce@partners.org|
20217016|NCT06217796|Eyenovia|Greg M. Bennett, VP, Clinical Program Strategy and Development|833-393-6684|gbennett@eyenovia.com|5
20217017|NCT03330236|Yale University|Lingzhong Meng, MD|(203) 785-2198|lingzhong.meng@yale.edu|
20217018|NCT01191476|Abbott|Global Medical Services|800-633-9110||
20217019|NCT00493064|PaloAltoMF|Renee Kaneshiro, study coordinator|650-853-4744|kaneshr@pamf.org|
20217020|NCT03449199|Teijin America, Inc.|President|1-415-887-9742|clinical-trials-contact@teijinpo.com|
20217021|NCT03307564|SKCCC @ Johns Hopkins|Amol Narang. MD|410-955-7390|anarang2@jhmi.edu|
20217022|NCT01470196|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
20217023|NCT01190930|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20217024|NCT05932810|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20217025|NCT00113919|University of Arkansas for Medical Sciences|Nathan Petty|501-837-3894|pettynathanm@uams.edu|
20217026|NCT00722436|The Childrens Hospital of Pittsburgh of UPMC|Franklyn Cladis|412-692-5260|cladfp@upmc.edu|
20217027|NCT02914457|Medtronic Bakken Research Center|Richard Cornelussen|+31433566651|richard.cornelussen@medtronic.com|
20217028|NCT01769222|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
20217029|NCT02092857|University of Alberta|Dr. Tom Clandinin|7804925188|tclandin@ualberta.ca|
20217030|NCT01292837|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
20217031|NCT02174276|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20217032|NCT00216060|Hoosier Oncology Group|Christopher Sweeney, M.B., B.S.|(617) 632 4524|christopher_sweeney@dfci.harvard.edu|
20203033|NCT00283712|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20203034|NCT03321617|New York State Psychiatric Institute|Ragy Girgis, MD|646-774-5553|ragy.girgis@nyspi.columbia.edu|
20203035|NCT00915967|Oregon Health & Science University|Director of Clinical Trials|503-494-4314|nsgclinicalresearch@ohsu.edu|
20203036|NCT03735095|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20203037|NCT01958606|University of Cincinnati|Pierce Boyne|513-558-7499|Pierce.Boyne@uc.edu|
20203038|NCT01215318|University Hospital of Zurich|Irene A Burger|+41 44 255 11 11|irene.burger@usz.ch|
20203039|NCT04655586|Arca biopharma Inc.|Dr. Michael Bristow|720-940-2100|Michael.Bristow@arcabio.com|
20203040|NCT02345369|Bassett Medical Center|clinical research nurse supervisor|6075476965|jennifer.victory@bassett.org|
20203041|NCT03897712|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
20203042|NCT00553059|University of Texas (UT) MD Anderson Cancer Center|Michael J. Fisch, MD/Department of General Oncology|713-563-9905|mfisch@mdanderson.org|
20203043|NCT01966731|Cincinnati Children's Hospital Medical Center|Russell Ware, MD, PhD|(513) 803-1108|russell.ware@cchmc.org|
20203044|NCT01380093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203045|NCT04734873|Corvus Pharmaceuticals|Study Director|650-900-4520|clinicaltrials@corvuspharma.com|
20203046|NCT00592683|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
20203047|NCT00201201|University of Connecticut|Patricia J. Neafsey, PhD|860-486-0779|pjneafsey@actualmeds.com|
20203048|NCT00621933|Allergan, Inc|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20203049|NCT04901897|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20203050|NCT00545818|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20203051|NCT00609609|The University of Texas (UT) MD Anderson Cancer Center|Dr. Amin Majid Alousi, Associate Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
20203052|NCT02240628|The University of Texas Health Science Center at Houston|Dr. Samia Khalil|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
20217033|NCT01206439|University of Cincinnati|Jack Rubinstein|513-558-3062|rubinsjk@ucmail.uc.edu|
20217034|NCT05889039|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
20217035|NCT02661022|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|877-332-7967|clinicaltrials@menarinistemline.com|
20217036|NCT03417739|Dana Farber Cancer Institute|Elizabeth Buchbinder, MD|617-632-5055|Elizabeth_buchbinder@dfci.harvard.edu|
20217037|NCT00781079|Pittsburgh VA|Matthew Chinman|412 360-2438|matthew.chinman@va.gov|
20217038|NCT00609154|Albert Einstein College of Medicine|Dr. Daniel Stein|718-430-2237|daniel.stein@einsteinmed.edu|
20217039|NCT04531527|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20217040|NCT00569660|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
20217041|NCT02180230|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
20217042|NCT03937791|National Cancer Institute|Scott Norberg, D.O.|301-275-9668|scott.norberg@mail.nih.gov|
20217043|NCT04155840|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
20217044|NCT01819064|Women and Children's Hospital of Buffalo, State University of New York at Buffalo|Dr. Jerrold Lerman|7168787701|jlerman@buffalo.edu|
20217045|NCT03702816|Cleveland Clinic|Aaron Ritter, MD|17024836000|rittera@ccf.org|
20217046|NCT04079452|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
20217047|NCT01785615|University of Florida College of Medicine Jacksonville|Dr. Gladys Velarde|(904)244-2060|Gladys.Velarde@jax.ufl.edu|
20217048|NCT00345033|Massachusetts General Hospital|David C. Henderson|(617) 912-7800|dchenderson@partners.org|
20217049|NCT01881737|Stanford University School of Medicine|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
20217050|NCT02102932|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20217051|NCT01450800|Duke University Medical Center|Dr. Alexis Dieter|919-401-1006|alexis.dieter@duke.edu|
20217052|NCT01562132|Yale University|Dr. Ana-Claire Meyer|203-737-8372|ana-claire.meyer@yale.edu|
20217053|NCT03496298|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20217054|NCT01658995|Mayo Clinic|Petra M. Casey, M.D.|507-266-9873|Casey.Petra@mayo.edu|
20217055|NCT03316976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20217056|NCT01186562|University of Minnesota|Melena D. Bellin|612-624-5409|bell0130@umn.edu|
20217057|NCT02608476|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20217058|NCT02058160|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20217059|NCT04106817|WCCT Global|Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
20217060|NCT03310619|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20217061|NCT00152516|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20217062|NCT04291508|Massachsetts General Hospital|PETAL Network Coordinatine Center PI, B. Taylor Thompson, MD|617 872-2882|tthompson1@mgh.harvard.edu|
20217063|NCT00398073|Memorial Sloan Kettering Cancer Center|Jedd Wolchok, MD, Chief Attending|+1646-888-2315|wolchokj@MSKCC.ORG|
20217064|NCT01263561|Department of Ophthalmology and Vision Sciences, University of Toronto|Dr Yvonne Buys|416-603-5682|y.buys@utoronto.ca|
20217065|NCT04084990|Washington University in St. Louis|Alexander Hincker, Associate Professor of Anesthesiology|3143231312|hinckera@wustl.edu|
20217066|NCT03185741|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
20217067|NCT01488448|Children's Hospital at Montefiore/Albert Einstein College of Medicine|Dr. Alyssa Silver|718-741-2304|alysilve@montefiore.org|
20217068|NCT00654641|West Viginia University|Michael L. Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
20217069|NCT01992094|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20217070|NCT01475487|Department of Anesthesia and Pain Management, Mount Sinai Hospital Toronto, Canada|Dr Naveed Siddiqui|4165864800|naveed.siddiqui@uhn.ca|5270
20217071|NCT02528409|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
20217072|NCT01834027|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
20217073|NCT04428645|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
20217074|NCT03168906|Tufts Medical Center|Jaime Chisholm|617-636-5409|jchisholm1@tuftsmedicalcenter.org|
20217075|NCT00810602|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-764-8630|sungchoi@med.umich.edu|
20217076|NCT01745952|UZ Leuven|Prof W Van Paesschen & Dr L Seynaeve|+3216349062|laura.seynaeve@uzleuven.be|
20217077|NCT03840382|Rhode Island Hospital|Dr. Larry Brown|+1 (401) 793-8808|lkbrown@lifespan.org|
20217078|NCT02625974|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20217079|NCT01142661|Eisai Inc.|Prash Gopalakrishna|888-422-4743||
20217080|NCT01195116|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
20217081|NCT02367872|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20217082|NCT02625298|Faculty of Dentistry, University of Belgrade|Dr. Dejan Markovic, professor at Clinic for Pediatric and Preventive Dentistry|+381600203041|dejan.markovic@stomf.bg.ac.rs|
20217083|NCT01923311|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20217084|NCT03429049|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
20217085|NCT04703855|Abbott|Carlo Gazzola|+3227746811|carlo.gazzola@abbott.com|
20217086|NCT04241133|Montana State University|Dr. Carmen Byker Shanks|406-994-1952|cbykershanks@montana.edu|
20217087|NCT02994394|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20217088|NCT02576717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20217089|NCT01363011|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20217090|NCT00399893|Duke University Medical Center|Michael Freemark, MD|919-684-5091|andrea.haqq@albertahealthservices.ca|
20217091|NCT04412057|Avalo Therapeutics, Inc.|Scott White, MD|484-763-3080|swhite@avalotx.com|
20194418|NCT01127893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194419|NCT01262677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194420|NCT03283254|Columbia University|Elizabeth Werner, Ph.D.|646-774-8945|ew150@cumc.columbia.edu|
20194421|NCT02055781|CTI BioPharma Corp.|Beth Ziemba||bziemba@ctibiopharma.com|
20194422|NCT05816330|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter D Crompton|301-761-5042|pcrompton@niaid.nih.gov|
20194423|NCT03829475|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
20194424|NCT02060539|CooperVision|Cheryl McKinnon|925-251-2034|cmckinnon@coopervision.com|
20194425|NCT02796300|UCLA Medical Center|Principal Investigator|310-267-8771|EdwardLee@mednet.ucla.edu|
20194426|NCT05141500|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
20194427|NCT01470001|University at Buffalo|Dr Tova Ablove|716-878-7138|tablove@buffalo.edu|
20194428|NCT01066520|Biologische Heilmittel Heel GmbH|Dr. Istvan Zatik|+4972215013192|istvan.zatik@heel.com|
20194429|NCT03896152|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20194430|NCT04514510|National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)|Arun Shet, MD, PhD|301.827.6808|arun.shet@nih.gov|
20194431|NCT04091061|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194432|NCT00821587|University of Florida|Roberto J. Firpi-Morell, MD|352-273-9500|firpirj@medicine.ufl.edu|9466
20194433|NCT01693900|Beaumont Health|Randy Fayne, DO|248-898-1905|rfyane@beaumont.org|
20194434|NCT04488770|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20194435|NCT01208103|UT MD Anderson Cancer Center|Dr. Michael Overman/Gastrointestinal Medical Oncology|713-745-4317|MOverman@mdanderson.org|
20194436|NCT02045875|Asthma Management Systems|Andrew G Weinstein MD|302 893 5455|agwmd@aol.com|
20194437|NCT01276379|GEMCAD|Joan Maurel Santasusana|+ 34 93 434 44 12|JMAUREL@clinic.cat|
20194438|NCT00864253|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
20194439|NCT01111240|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20194440|NCT01989169|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20194441|NCT01585155|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20194442|NCT01743989|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
20194443|NCT00515723|Washington University School of Medicine and Florida Atlantic University|John Newcomer, M.D.|561-297-0252|jnewcomer@fau.edu|
20194444|NCT02235311|University of Missouri - Columbia|Ashley McCormick, PharmD, BCPS|573-771-7798|ausmusash@health.missouri.edu|
20194445|NCT04655027|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94 79|information.center@astrazeneca.com|
20194446|NCT00658788|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
20194447|NCT00653523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20194448|NCT02245022|University of Liverpool|Catriona Waitt|0778288217|cwaitt@liverpool.ac.uk|
20194449|NCT03519997|University Texas Southwestern Medical Center|David Hsieh|214/648-4180|David.Hsieh@UTSouthwestern.edu|
20194450|NCT05543707|Pardes Biosciences|Vice President, Quality|4042815163|jenna.tagliaferri@pardesbio.com|
20194451|NCT00186888|St. Jude Children's Research Hospital|Ibrahim Qaddoumi MD|1-866-278-5833|info@stjude.org|
20194452|NCT02108964|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20194453|NCT03006848|St Jude Children's Research Hospital|Dr. Michael Bishop|866-278-5833|referralinfo@stjude.org|
20194454|NCT05384938|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20194455|NCT03898167|The University of Texas MD Anderson Cancer Center|Dr. Jane Montealegre|713-792-0919|jrmontealegre@mdanderson.org|
20194456|NCT01937026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194457|NCT01187381|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20194458|NCT00384397|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20194459|NCT01525238|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20194460|NCT01214642|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194461|NCT00994175|National Heart Lung and Blood Institute|Levine, Stewart|+1 301 402 1448|levines@nhlbi.nih.gov|
20194462|NCT04696653|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20194463|NCT01946529|St. Jude Children's Research Hospital|Sara Federico, MD|901-595-2220|sara.federico@stjude.org|
20187490|NCT03702270|VANDERBILT UNIVERSITY MEDICAL CENTER|Dr. Cosby A Stone, Jr.|6153223412|Cosby.a.stone@vumc.org|
20194464|NCT02954198|Medical University of South Carolina|Dr. David Taber|843-792-4003|taberd@musc.edu|
20194465|NCT05820295|Weill Cornell Medicine|Lisa Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
20194466|NCT04348435|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20194467|NCT00848588|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20194468|NCT02218606|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin, MD, PhD|646-422-4472|slovins@MSKCC.ORG|
20217092|NCT00368316|PDMI, NICHD, NIH|Dr. Rachel Schneerson, Co-Director|301-469-0850|schneerr@mail.nih.gov|
20217093|NCT00928226|Stanford University|Scott Soltys, Associate Professor of Radiation Oncology|65072441569|sgsoltys@stanford.edu|
20217094|NCT03710590|Virginia Commonwealth University|Dr. Alison Breland|804 628 2300|abbrelan@vcu.edu|
20217095|NCT00407745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20217096|NCT00108082|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217097|NCT02419924|Mayo Clinic|Dr. Amy Foxx-Orenstein|480-301-6990|foxx-orenstein.amy@mayo.edu|
20217098|NCT00955552|Eurofarma Laboratórios|Eurofarma Laboratórios|08007043876||
20217099|NCT02940730|University of Colorado|Dr. Tyree Kiser|3037242883|ty.kiser@ucdenver.edu|
20217100|NCT01522950|University of Minnesota|Jay N. Cohn, M.D., Professor of Medicine|612.625.5646|cohnx001@umn.edu|
20217101|NCT01795079|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mhg.harvard.edu|
20217102|NCT01701037|Vanderbilt-Ingram Cancer Center|Mark C. Kelley|615-936-7423|mark.kelley@vanderbilt.edu|
20217103|NCT00298740|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20217104|NCT01064531|Smith & Nephew, Inc|Tracey Brengola, MS|978-749-1491|Tracey.brengola@smith-nephew.com|
20217105|NCT01091103|Medivation, Inc.|Mohammad Hirmand, MD, VP, Clinical Development|415-829-4126|mohammad.hirmand@medivation.com|
20217106|NCT01270620|Stanford University School of Medicine|Dr. Pedro Tanaka|6507244066|ptanaka@stanford.edu|
20217107|NCT00684567|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217108|NCT03136406|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20217109|NCT00906373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20217110|NCT01597479|Hospital de la Santa Creu i Sant Pau|Dra. Mireia Rodriguez Prieto|677896054|mrodriguezpr@santpau.cat|
20217111|NCT01045707|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20217112|NCT00348816|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1103|swansong@uthscsa.edu|
20217113|NCT00848042|Nanospectra Biosciences, Inc.|Robin Dickson|7138422720|rdickson@nanospectra.com|216
20217114|NCT01628549|Allergan|Thearpeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20217115|NCT00115869|Fred Hutchinson Cancer Research Center|Arthur V. Peterson, Jr. PhD|206-667-5131|avpeters@fhcrc.org|
20217116|NCT01999894|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
20217117|NCT02958319|Servicio de Reumatología del Hospital Universitario|David Vega-Morales MD|52 81 80485210|drdavidvega@yahoo.com.mx|
20217118|NCT02448563|Boston Medical Center|Ashley McCarthy, Clinical Research Manager|617-638-5906|ashley.mccarthy@bmc.org|
20187491|NCT04479761|New York University|Prof. Anat Lubetzky|2129989195|anat@nyu.edu|
20187492|NCT05493852|Boston Scientific|Dr Xiuyue Jia|+86 15104673346|xiuyue.jia@bsci.com|
20187493|NCT03717753|Hospital for Special Surgery|Dr. Jacques YaDeau, MD PhD|212- 606-1206|yadeauj@hss.edu|
20187494|NCT03106740|Massachusetts General Hospital|Marco Loggia|(617) 643-7267|marco.loggia@mgh.harvard.edu|
20187495|NCT04565990|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187496|NCT04797858|University of Pennsylvania|Robert Gross|2158982437|grossr@pennmedicine.upenn.edu|
20187497|NCT03963518|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Carine Bellera|+33556333333|c.bellera@bordeaux.unicancer.fr|
20187498|NCT05361031|Helixmith, Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
20187499|NCT03841773|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
20187500|NCT04491617|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
20187501|NCT05163496|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
20187502|NCT05269966|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20187503|NCT05575219|The University of Texas Health Science Center at Houston|Andrea Leigh Heifner, MD|407-729-2972|andrea.heifner@stjude.org|
20187504|NCT04267120|Washington University School of Medicine|Joel Picus, M.D.|314-362-9115|jpicus@wustl.edu|
20187505|NCT05427253|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc, Global Medical Director|+46 317880560|info@vicorepharma.com|
20187506|NCT03476343|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
20187507|NCT03711474|West Virginia University|Scott Daffner, MD|304-293-1172|sdaffner@hsc.wvu.edu|
20187508|NCT05147116|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
20187509|NCT04101357|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20187510|NCT05618587|University at Buffalo|Thomas Guttuso, Jr., MD|716-932-6080|tguttuso@buffalo.edu|
20187511|NCT06007781|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
20187512|NCT05204654|University at Buffalo|No Dr. Alexandria Newton|716-829-2845|amnewton@buffalo.edu|
20187513|NCT01221948|Bostons Scientific Neuromodulation|Nic Van Dyck, Director International Clinical Operations|+31 43 3568328|vandyckn@bsci.com|
20194469|NCT03203473|Dana Farber Cancer Institute|Toni K Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
20217119|NCT00721955|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|:jcassella@alexza.com|
20217120|NCT01272076|TLC Eyecare and Laser Centers|Carmelina Gordon, MD|(517) 7821213|shellie.fuentes@tlcmi.com|
20163447|NCT05729568|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20163448|NCT04181762|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20163449|NCT02440685|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
20194470|NCT01882543|Department of Urology, Queens University, Ontario|J. Curtis Nickel|613-548-2497|jcn@queensu.ca|
20194471|NCT01325311|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
20217121|NCT01362192|Main Line Center for Laser Surgery|Eric F. Bernstein, M.D., M.S.E.|610-645-5551|dermguy@dermguy.com|
20217122|NCT01077258|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20217123|NCT00515216|Washington University School of Medicine|A. Craig Lockhart, M.D.|314-362-5740|alockhar@dom.wustl.edu|
20217124|NCT00142116|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
20217125|NCT05862844|School of Medicine, Virginia Commonwealth University|Asmaa Namoos|804-628-4754|Asmaa.Namoos@vcuhealth.org|
20217126|NCT01115933|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
20217127|NCT01160445|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20217128|NCT02767947|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
20217129|NCT03224520|University of Massachusetts Medical School|Rajani Sadasivam|508-856-8923|rajani.sadasivam@umassmed.edu|
20217130|NCT01086969|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20217131|NCT01514513|Tec Laboratories, Inc.|Wendy Langley|5419264577|wendy@teclabsinc.com|338
20217132|NCT01466036|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
20217133|NCT03401918|Stanford University|Ruth Bunker Lathi|(650) 498-7911|clinicaltrials-gov@stanford.edu|
20217134|NCT03222037|Johnson & Johnson Vision Care, INC.|Chantal Coles-Brennan -PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
20217135|NCT00250705|The University of Iowa|An Open Label Trial of Aripiprazole in the Treatment of Conduct Disorder in Adolescents.|319-356-1482|Samuel-Kuperman@uiowa.edu|
20217136|NCT00176930|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
20217137|NCT00129116|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217138|NCT00879684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217139|NCT00708682|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20217140|NCT02132650|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
20217141|NCT01148225|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20217142|NCT03689894|Dartmouth Hitchcock Medical Center|Director of Clinical Research|2167129120|sean.hobson@hitchcock.org|
20217143|NCT02304406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217144|NCT02839798|Butler Hospital|Dr. Linda Carpenter|401-455-6349|Linda_Carpenter_MD@brown.edu|
20217145|NCT00571194|Arkansas Children's Hospital|Dr. Eileen Ellis|501-364-1847|elliseileenn@uams.edu|
20217146|NCT05258630|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
20217147|NCT03431337|Albany Medical College|Dr. Paul Sorum|518-262-7500|sorump@amc.edu|
20217148|NCT00401245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217149|NCT02076776|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
20217150|NCT01560819|Helen DeVos Children's Hospital of Spectrum Health Hospitals|Dr. Sachin Kunde|616-267-2100|sachin.kunde@helendevoschildrens.org|
20217151|NCT02014441|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20217152|NCT00114231|Memorial Sloan Kettering Cancer Center|Julio Garcia-Aguilar, MD|212-639-5506|garciaaj@mskcc.org|
20217153|NCT02156154|Cleveland Clinic|Alparslan Turan, MD|216-445-0998|turana@ccf.org|
20217154|NCT02051595|University of Florida|Dr. Ettore Crimi|617-697-2861|ettorecrimi@gmail.com|
20217155|NCT01625507|University of Alberta|Dr. Catherine Chan|780-492-9939|cbchan@ualberta.ca|
20217156|NCT01961882|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20194472|NCT02314780|Medical University of Vienna|Dr. Martin Andreas|+ 43 1 40400|martin.andreas@meduniwien.ac.at|69660
20203053|NCT02677701|Seattle Children's Hospital|Arthur Baines|2068841431|arthur.baines@seattlechildrens.org|
20203054|NCT04530825|Washington University School of Medicine|Maura Kepper, Ph.D.|314-935-0142|kepperm@wustl.edu|
20203055|NCT03870022|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
20203056|NCT04101422|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
20203057|NCT00552305|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20203058|NCT01241513|USARIEM|Charles S Fulco, PI|508 233-4893|charles.fulco@us.army.mil|
20203059|NCT04983901|The University of M.D. Anderson Cancer Center|Dr. Issam I Raad|713-792-6237|iraad@mdanderson.org|
20203060|NCT01174784|Avinger Inc.|Thomas Lawson, PhD|650.241.7900|tlawson@avinger.com|
20203061|NCT01671488|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20203062|NCT00943878|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
20203063|NCT01457339|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20203064|NCT01832961|Imperial College|Ada Clarice Gastaldi|55 020 7351 8051|ada@fmrp.usp.br|
20203065|NCT01164501|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20203066|NCT03489291|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
20203067|NCT01096667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203068|NCT00408681|Fred Hutchinson Cancer Research Center|Paul J. Martin, M.D.|206-667-4798|pmartin@fredhutch.org|
20217157|NCT01901848|Durham Veterans Health Care System|Eric Dedert, Ph.D.|919-384-8582|eric.dedert@va.gov|4055
20217158|NCT01729026|South Texas Veterans Health Care System; University of Texas Health Science Center at San Antonio|Dr. Stephen Stern|210-887-3754|stephen.stern@va.gov; sterns@uthscsa.edu|
20217159|NCT02488824|VAORD|Dr John Handrakis|(718) 584-9000|John.Handrakis@va.gov|5439
20217160|NCT03765996|Dr. İsmail Atabek Physiotherapy and Rehabilitation Center|Ertan Şahinoğlu|+90 532 647 86 53|ertan.sahinoglu@hotmail.com|
20217161|NCT02970552|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joni@email.unc.edu|
20217162|NCT02668822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217163|NCT03036839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20217164|NCT00412737|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20217165|NCT03519282|CooperVision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|MNguyen@coopervision.com|
20217166|NCT02740920|Canadian Cancer Trials Group|Janet Dancey|613-533-2430|jdancey@ctg.queensu.ca|
20217167|NCT00513617|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
20217168|NCT01201759|UNIVERSITY OF MIAMI- The Miami Project to Cure Paralysis|Dr. Mark S. Nash|(305) 243-3628|MNash@med.miami.edu|
20217169|NCT02744755|Hexal AG/Sandoz Inc.|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
20217170|NCT04317599|Pierre Fabre|Project leader|+33(0)1 49 10 81 84|farida.beghdad@pierre-fabre.com|
20217171|NCT00809965|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Development Head Cardiovascular/Urology|1 215 628-5257||
20217172|NCT02780167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217173|NCT02916693|Johns Hopkins University|Dr. Arthur L. Burnett|410-614-3986|aburnet1@jhmi.edu|
20217174|NCT03346850|The University of Texas Health Science Center at Houston|Raymond Parlar-Chun, MD|713-500-5666|Raymond.L.Chun@uth.tmc.edu|
20217175|NCT04205162|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
20217176|NCT05181800|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20217177|NCT01519947|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20217178|NCT00693225|Mayo Clinic|Dr. Yvonne Romero|507-266-9156|romero.yvonne@mayo.edu|
20217179|NCT01077817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217180|NCT00372996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217181|NCT01186016|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
20217182|NCT00890916|Louis Stokes Cleveland VAMC|Dr. Kevin Kilgore|216-9573657|klk4@case.edu|
20217183|NCT00452543|Massachusetts General Hospital|Dr. Janet Witte|617-726-5104|jwitte@partners.org|
20217184|NCT02525263|CTI|Dr William S Aronstein|5135989290|baronstein@ctifacts.com|
20217185|NCT02250651|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20217186|NCT02907073|Mayo Clinic|Dr. Timothy R. DeGrado|507-293-3793|DeGrado.Timothy@mayo.edu|
20217187|NCT02795676|Protalix Ltd.|Sari Alon, MSc|+972-4-9028100|sari@protalix.com|215
20217188|NCT00676494|Pathway Medical Technologies, Inc.|Kevin Peters/Director of Clinical Affairs|425-636-4053|petersk@pathwaymedical.com|
20217189|NCT00732160|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|James.Luther@Vanderbilt.edu|
20217190|NCT01203917|AstraZeneca|Haiyi Jiang|+86 21 60302408|aztrial_results_posting@astrazeneca.com|
20217191|NCT01264835|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20217192|NCT01201486|StavangerUH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
20217193|NCT00218335|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
20217194|NCT00108550|VA San Diego Healthcare System|J. H. Atkinson MD|858-642-3775|joseph.atkinson@va.gov|
20217195|NCT02427399|Fenway Health|Dr. Jennifer Potter|617-416-0986|jpotter@bidmc.harvard.edu|
20217196|NCT04660032|University of Michigan|Dr. Jourdan Triebwasser|734-764-1406|jtriebwa@med.umich.edu|
20217197|NCT00090753|Hoffmann-La Roche|Medical Communications|800-821-8590||
20217198|NCT01041209|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43070140|slaip@intramed.net|
20217199|NCT01609582|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20217200|NCT00819767|Novartis Pharmaceuticals|Study Director|862 778-8300||
20217201|NCT02690935|ECSOR|Dr. Stephane Heijmans|3267444093|Jacques.Bruhwyler@ecsor.com|
20217202|NCT04784637|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
20217203|NCT01104090|The University of Texas Health Science Center at Houston|Davide Cattano, MD, PhD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
20217204|NCT02030535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217205|NCT04547036|Dept. Ophthalmology at Paracelsus Medical University Salzburg|PD Dr. Markus Lenzhofer PhD FEBO|+43 57255|m.lenzhofer@salk.at|24201
20217206|NCT01169038|Vanderbilt University|Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
20217207|NCT03257254|Boston Scientific|Timothy Keo|425-599-3814|Timothy.Keo@bsci.com|
20217208|NCT02329431|UNC Chapel Hill|Kathleen Thomas|919-966-3387|kathleen_thomas@unc.edu|
20217209|NCT01557582|VentriPoint, Inc.|Jim bodtke, Vice President Clinical Affairs and Development|206-283-0221|jbodtke@ventripoint.com|
20217210|NCT03203642|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20217211|NCT02413294|University of Michigan|Dr. Amanda Leggett|734-232-0538|leggetta@med.umich.edu|
20217212|NCT00434590|Novartis Pharmaceuticals|Study Director|862-778-8300||
20217213|NCT00548431|Rigshospitalet, Juliane Marie Centret|Thomas Frandsen|+45 35458364|thomas.leth.frandsen@rh.regionh.dk|
20217214|NCT04057248|Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)|Dr. Alan Schorr|2157501691|abs@sugardoc.com|
20187514|NCT03314688|Yale School of Medicine|Tara Sanft, MD|(203) 200-2328|tara.sanft@yale.edu|
20194473|NCT02083107|AinShams University|Dr. Mohamed S. Sweed, Dr.Mourad M.El-Said, Dr.Amgad E. Abou-Gamrah, Dr.Mohamed M. Abd-El-Hamid|01001222047|drmsweed@gmail.com|+2
20194474|NCT01077271|Abbott|Global Medical Services|1-800-633-9110||
20194475|NCT00215137|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
20194476|NCT00336700|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
20194477|NCT00095498|Amgen Inc.|Study Director|866-572-6436||
20194478|NCT00550589|Statistical Center of AIDS Malignancy Consortium|Jeannette Lee|(501) 526-6712|jylee@uams.edu|
20194479|NCT00640133|Butler Hospital|Dr. Benjamin Greenberg|(401) 455-6602|be3ngreenb@gmail.com|26602
20194480|NCT00128102|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194481|NCT03232580|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20194482|NCT04370548|Dare Bioscience, Inc.|VP, Clinical Operations|858-926-7655|nzack@darebioscience.com|109
20194483|NCT02654691|Aarhus University|Nanna Finnerup|0045 78463382|finnerup@clin.au.dk|
20194484|NCT00306670|Georgetown University|Craig M Kessler, MD|202-444-8676|kesslerc@georgetown.edu|
20194485|NCT00503139|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194486|NCT01827475|Emergency Medicine, Stony Brook U|Dr. Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
20194487|NCT00833833|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20194488|NCT02040259|Stryker Neurovascular|Minyi Ji, Biostatistician, Clinical Evidence|+1 (510) 980-5689|minyi.ji@stryker.com|
20194489|NCT04476251|National Cancer Institute|Scott M. Norberg D.O.|301-275-9668|scott.norberg@nih.gov|
20194490|NCT02334982|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20217215|NCT00271739|Columbia University|Walter Palmas, M.D.|212-305-3163|wp56@columbia.edu|
20217216|NCT00317642|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20217217|NCT02315066|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217218|NCT03180801|SEEK|Dr Olga Pleguezuelos|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
20217219|NCT02667821|Canadian Memorial Chiropractic College|Dr. Nicholas Moser|416-482-2340|nmoser@cmcc.ca|319
20217220|NCT01142908|Veterans Administration HSRD, Durham COIN|Hayden B. Bosworth, PhD, Assoc Dir, Durham HSR&D COIN|919-286-0411|hayden.bosworth@va.gov|6936
20217221|NCT01601691|Oulu University Hospital|Dr. Markku Vaarala|+3588315|markku.h.vaarala@ppshp.fi|2840
20217222|NCT00035555|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20217223|NCT00337428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217224|NCT02618382|Dignity Health Research Institute|Lisa Arnold, Clinical Research Operations Manager|602-406-9593|lisa.arnold@arrowneuro.org|
20217225|NCT04090879|Brown University|Jennifer W. Tidey|4018636418|jennifer_tidey@brown.edu|
20217226|NCT00529217|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
20217227|NCT00779402|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
20217228|NCT03068949|University of Rochester|Dr. Angela Branche|5852750526|angela_branche@urmc.rochester.edu|
20217229|NCT01315028|University of Glasgow|Professor Andrew Gumley|0044 141 211 3927|andrew.gumley@glasgow.ac.uk|
20217230|NCT01992016|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
20217231|NCT01303068|University of New Mexico|Hengameh Raissy|5052725484|hraissy@salud.unm.edu|
20217232|NCT02274948|Faculty of Medicine, University of Colombo|Prof V Pujitha Wickramasinghe|+94112688748|pujithaw@yahoo.com|170
20217233|NCT03636386|Universidad Andrés Bello|Professor Hernán Andrés de la Barra Ortiz|+56984706322|quiropraxiayequilibrio@gmail.com|
20217234|NCT03843125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20217235|NCT01098539|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217236|NCT01386125|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20217237|NCT03173560|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20217238|NCT03460899|Medical University of Graz|Assoc.-Prof. Harald Sourij, MD|0043 316 385|ha.sourij@medunigraz.at|81310
20217239|NCT04254809|Southeast Louisiana Veterans Health Care System|Joseph Boffa, PhD|504-507-2000|joseph.boffa@va.gov|67372
20217240|NCT02972515|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
20217241|NCT01928615|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20217242|NCT01889797|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3627|jmanola@jimmy.harvard.edu|
20217243|NCT01589601|Duke University Medical Center|Joseph G. Rogers, MD|919-681-1370|joseph.rogers@duke.edu|
20217244|NCT03023137|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|5521999737500|sclapauch@gmail.com|
20217245|NCT00680524|VA Puget Sound Health Care System|Bradford Felker, MD|(206)277-1191|Bradford.Felker@VA.GOV|
20217246|NCT01808248|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20217247|NCT00685750|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217248|NCT04974580|Ohio State University College of Public Health|Dr. Elizabeth G. Klein|614-292-5424|klein.232@osu.edu|
20217249|NCT00587431|Memorial Sloan-Kettering Cancer Center|Dr. Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
20217250|NCT05467982|Dartmouth-Hitchcock|Sarah Pratt, PhD-Contact PI|603-496-2665|sarah.i.pratt@dartmouth.edu|
20217251|NCT00496262|CSL Behring|Program Director, Clinical R&D|Use email contact.|clinicaltrials@cslbehring.com|
20217252|NCT00260689|NHLBI, NIH|Danielle Townsley MD|301-402-3477|townsleydm@nhlbi.nih.gov|
20194491|NCT00597246|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
20194492|NCT03446781|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20163450|NCT01514201|St. Jude Children's Research Hospital|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
20163451|NCT02352844|Washington University School of Medicine|Saiama Waqar, M.D.|314-362-5737|saiamawaqar@wustl.edu|
20163452|NCT05888181|UZ Leuven|Patrick Verschueren|003216342541|patrick.verschueren@uzleuven.be|
20163453|NCT03124836|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20163454|NCT00637416|University of Kansas Medical Center|Director, ENT Clinical Research|(913) 588-7154|ksykes@kumc.edu|
20163455|NCT01070173|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
20163456|NCT03318016|University of Colorado Hospital|Daniel Pollyea, MD Associate Professor|720-848-8084|daniel.pollyea@cuanschutz.edu|
20163457|NCT01717001|University of Tennessee|Rebecca Robertson|865-974-2093|rrober28@utk.edu|
20163458|NCT02534909|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20163459|NCT00132808|Novartis Pharmaceuticals|Study Director|862-778-8300||
20163460|NCT03165916|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
20163461|NCT04137731|Joint Replacement Center of Montefiore Medical Center|Clinical Research Director|9292466352|sereffer@montefiore.org|
20163462|NCT00362648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163463|NCT02204072|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20163464|NCT03983304|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
20163465|NCT00799435|Baylor|David Aguilar, MD|713-798-0280|daguilar@bcm.edu|
20163466|NCT03319134|UT Dallas|Clinical Trial Manager|9723337277|Sarah.McLeod@utdallas.edu|
20163467|NCT01587040|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20163468|NCT00432341|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20163469|NCT04300309|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20163470|NCT03453489|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|313-576-8735|shieldsa@karmanos.org|
20163471|NCT04346654|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20163472|NCT04030520|University of California San Francisco|Dr Rachel King|+256785304516|rachel.king@ucsf.edu|
20163473|NCT02343406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20163474|NCT00858637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20163475|NCT01380834|Children's Hospital of UPMC|Dr. Mihaela Visoiu|412-692-5260|visoium@upmc.edu|
20163476|NCT04677504|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20163477|NCT00112125|Impulse Dynamics (USA) Inc|Angela Stagg, Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
20163478|NCT02058563|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163479|NCT04039217|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20163480|NCT00167310|UPittsburgh|Dr. Jeffrey K. Yao, Research Professor|412-360-6781|jkyao@pitt.edu|
20163481|NCT03304873|NYU Grossman School of Medicine|Jennifer Lighter, MD|212-263-5454|Jennifer.Lighter@nyulangone.org|
20163482|NCT01895959|University of California, San Francisco|Xiaojuan Li, PhD|415-353-4909|Xiaojuan.li@ucsf.edu|
20163483|NCT01868477|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20163484|NCT00042991|Operations and Biostatistics Center for Pediatric Brain Tumor Consortium (PBTC)|Mehmet Kocak|9015952947|mehmet.kocak@stjude.org|
20163485|NCT01574651|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20163486|NCT03274856|GLWL Research Inc|Caroline Fortier|1.514.708.4417|caroline.fortier@glwlresearch.com|
20163487|NCT01101035|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20163488|NCT02871635|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163489|NCT01764711|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
20194493|NCT02093949|Saint joseph hospital|Dr Julien Seitz|+330491807044|jseitz@hopital-saint-joseph.fr|
20194494|NCT03568318|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20194495|NCT04410523|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20194496|NCT00794144|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20194497|NCT01638429|Cedars-Sinai Medical Center|Dr Ruchi Mathur|310-423-4774|Ruchi.Mathur@cshs.org|
20194498|NCT02885324|Indiana University|Dr. Scott Coven|317-944-8784|scoven@iu.edu|
20194499|NCT02040584|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20217253|NCT02997722|University of Mississippi Medical Center|Allen Richert, MD|(601) 984-4820|arichert@umc.edu|
20217254|NCT01493596|Catalyst Pharmaceutical Partners, Inc.|Douglas Winship, Vice President of Regulatory Operations|305 529-2522|dwinship@catalystpharma.com|12
20217255|NCT04381481|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-962-5907|mghall@unc.edu|
20217256|NCT00761176|Regenesis Biomedical, Inc.|VP of Clinical Research and Regulatory|602-309-2118|mark.davis@regenesisbio.com|
20217257|NCT02762994|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
20217258|NCT01139294|Vanderbilt University Medical Center|Thomas Abramo, MD||tjabramo@uams.edu|
20217259|NCT05103657|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217260|NCT02020967|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
20217261|NCT03507686|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20194500|NCT00996476|Janssen Pharmaceutical K.K., Japan|DIrector|81 3 44115639||
20217262|NCT00585312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163490|NCT00412893|Astellas Pharma Global Development, Inc.|Medical Head Immunology, Transplant and Infectious Disease Therapeutic Area||resultsdisclosure@astellas.com|
20163491|NCT00853151|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163492|NCT01751984|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20194501|NCT01802567|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
20194502|NCT01940939|Dr.LIU|ShanghaiMHC|862134773775|erliu110@126.com|
20194503|NCT01895101|Amphia Hospital|Dr. Thierry V Scohy|0031765955570|tscohy@amphia.nl|
20194504|NCT00436852|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20194505|NCT00370682|Phramongkutklao Hospital, Bangkok, Thailand|Verrachai Watanaveeradej, MD|662-644-8971|veerachaiw@yahoo.com|
20194506|NCT03167359|Emory University|Dr. Mylin Torres|404-778-3473|matorre@emory.edu|
20194507|NCT03339583|I.M. Sechenov First Moscow State Medical University|Polina Pchelina|+79036701725|polbox@mail.ru|
20194508|NCT00943852|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20194509|NCT00734591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194510|NCT01656200|University of Liverpool|Dr Lance Turtle|+44 151 795 9626|lance.turtle@liverpool.ac.uk|
20194511|NCT02236988|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20194512|NCT00730275|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194513|NCT01652495|Istituto Ortopedico Rizzoli|Milva Battaglia, Director of Clinical Trials|0516366026|milva.battaglia@ior.it|0039
20163493|NCT00935311|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20163494|NCT01797263|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; matthew.bair@va.gov|
20194514|NCT06612255|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
20194515|NCT00821951|Yale University|Dr. Roy H Decker, MD PhD|203 737-2758|roy.decker@yale.edu|
20194516|NCT03921723|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20194517|NCT01461811|Alcon Research, Ltd.|Mary Fahmy, OD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20194518|NCT03015129|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
20194519|NCT05187364|Medical University of South Carolina|Dr. Amber Jarnecke|843-876-3115|jarnecka@musc.edu|
20194520|NCT00338962|Yale University|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
20194521|NCT03733314|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
20194522|NCT03046121|Penn State University|Marie Boltz PhD|215-962-9712|mpb40@psu.edu|
20194523|NCT03214640|Wake Forest Health Science|Peter Pan, MD|336-716-1228|ppan@wakehealth.edu|
20194524|NCT04155047|Sunovion Respiratory Development Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20194525|NCT00403767|Johnson & Johnson Pharmaceutical Research & Development L.L.C.|Head of Development, CV & UROL|1 908-927-7767||
20194526|NCT00799981|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
20217263|NCT04234464|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20217264|NCT00983528|UC San Diego|MCC Clinical Trials Office|(858) 534-5417|tkipps@ucsd.edu|
20217265|NCT03604432|Corewell Health|Dr. Charles Willekes|616-459-7258|Charles.Willekes@corewellhealth.org|
20217266|NCT02578745|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
20217267|NCT00330460|Amgen Inc.|Study Director|866-572-6436||
20217268|NCT03712124|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20217269|NCT01332721|TRACON Pharmaceuticals|Dr Charles Theuer|8585500780|ctheuer@traconpharma.com|233
20217270|NCT02941523|Noxopharm Limited|Clinical Manager|+61 499005049|marinella.messina@noxopharm.com|
20217271|NCT02539368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217272|NCT02203578|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
20217273|NCT00105157|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20217274|NCT00127166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217275|NCT01237080|Department of Anaesthesiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark|Mogens Ydemann|+4531155995|clinicaltrials@ydemann.dk|
20217276|NCT01396421|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20217277|NCT04728620|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
20217278|NCT00569777|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
20217279|NCT00709306|Fox Chase Cancer Center|Carolyn Heckman, PhD|215-214-3962|carolyn.heckman@fccc.edu|
20217280|NCT02843659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20217281|NCT03169816|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@columbia.edu|
20217282|NCT04974736|Massachusetts General Hospital|Jonathan P. WInickoff|(617) 726-2728|jwinickoff@mgh.harvard.edu|
20217283|NCT01621906|Memorial Sloan Kettering Cancer Center|Dr. Andrew Seidman, MD|646-888-4559|seidmana@MSKCC.ORG|
20217284|NCT03180528|Stanford University|Kavita Yang Sarin|(650) 723-6316|ksarin@stanford.edu|
20217285|NCT02447887|Fox Chase Cancer Center|Dr. Daniel M. Geynisman|215-728-3889|daniel.geynisman@fccc.edu|
20217286|NCT00109837|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
20217287|NCT01185028|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
20217288|NCT01563237|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
20217289|NCT00988208|Celgene Corporation|Senior Manager , Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20217290|NCT01602471|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
20217291|NCT04364737|NYU Langone Health|Mila B. Ortigoza, MD, PhD|646-634-7803|Mila.Ortigoza@nyulangone.org|
20217292|NCT01220609|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20217293|NCT04735068|University of Pennsylvania|Melissa Volpe|215-220-9703|melissa.volpe@Pennmedicine.upenn.edu|
20217294|NCT03173170|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20217295|NCT00868296|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20217296|NCT00112294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20217297|NCT02418455|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20217298|NCT02445287|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
20217299|NCT03235479|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20217300|NCT00367016|University of California-Davis, Department of Dermatology|Fu-Tong Liu, M.D., Ph.D.|916-734-6556|fliu@ucdavis.edu|
20217301|NCT02001051|National Cancer Institute|Dr. Dhaval Patel|301-827-4989|pateldt@nih.gov|
20217302|NCT02407171|Yale School of Medicine|Allison Campbell, MD/PhD: Assistant Professor of Clinical Therapeutic Radiology|(203) 863-3700|allison.campbell@yale.edu|
20217303|NCT03750695|Duke University|Dr. William Todd Cade|919-660-9825|todd.cade@duke.edu|
20194527|NCT02229851|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20217304|NCT04480307|GeNeuro SA|David Leppert, Study director|225524800|dl@geneuro.com|+41
20217305|NCT03604549|Penn State Health Milton S. Hershey Medical Center|Richard S. Legro, M.D., Principal Investigator|717-531-6210|rsl1@psu.edu|
20187515|NCT02446236|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20187516|NCT05086796|Cedars-Sinai Medical Center|Itai Danovitch, MD|310-423-2600|itai.danovitch@cshs.org|
20187517|NCT02573779|Baylor College of Medicine/Texas Children's Hospital|Dr. Amy B. Hair|832-826-1398|abhair@bcm.tmc.edu|
20187518|NCT05290493|Nobias Therapeutics, Inc.|Patrick Dougherty|(215) 821-4698|dougherty@nobiastx.com|
20187519|NCT05419830|University of Pittsburgh|Shachi Tyagi, MD, MS|4126471274|sht55@pitt.edu|
20187520|NCT05012163|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
20187521|NCT03804788|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
20187522|NCT04003246|University of Texas Southwestern Medical Center|Dr. Yuanyuan Zhang|2146458525|yuanyuan.zhang@utsouthwestern.edu|
20187523|NCT03914742|Johns Hopkins University|Program Manager Adult Brain Tumor Consortium (ABTC) and Brain Cancer Program|410-955-8837|jfisher@jhmi.edu|
20187524|NCT02567409|City of Hope|Paul Frankel. Ph.D.|626-218-5265|pfrankel@coh.org|
20187525|NCT03673501|Deciphera Pharmaceuticals, LLC|INTRIGUE Clinical Team|781-209-6400|clinicaltrials@deciphera.com|
20187526|NCT04599634|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20187527|NCT03714815|Actelion Pharmaceuticals Ltd|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187528|NCT05987072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187529|NCT03733925|Johnson & Johnson Private Limited|Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187530|NCT03213873|Karolinska Institutet|Erika Franzén|08-52488878|erika.franzen@ki.se|
20187531|NCT01385189|George Washington University|Dr. David J. Diemert, Associate Professor|202.994.2909|ddiemert@gwu.edu|
20187532|NCT05776875|Yale University|Wei Cheng|203-737-7005|w.cheng@yale.edu|
20187533|NCT04709419|The University of Texas Health Science Center at San Antonio|Lawrence Lavery, DPM|214-399-5381|lavery@uthscsa.edu|
20187534|NCT05683340|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20187535|NCT05046639|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20187536|NCT03824366|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
20187537|NCT04587024|Johns Hopkins University|Dr. Cozumel S. Pruette|410-955-2467|csouthe1@jhmi.edu|
20194528|NCT03541200|Mitsubishi Tanabe Pharma Development America|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
20217306|NCT00605176|Graceway Pharmaceuticals LLC|Sharon F. Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
20194529|NCT03466073|BioAegis Therapeutics Inc.|Mark DiNubile MD|609-706-5866|mdinubile@bioaegistx.com|
20217307|NCT01256060|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
20217308|NCT00220727|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20217309|NCT02221817|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20217310|NCT02508116|University of Pennsylvania School of Medicine|Sony Tuteja, PharmD, MS|215-573-7834|sonyt@pennmedicine.upenn.edu|
20217311|NCT00109850|SWOG Statistical Center|Study Statistician|206-667-4623||
20217312|NCT00476593|Department of Ophthalmology, St. Olavs Hospital, Trondheim Norway|Dr Alexandra Wexler|99716763|a.wexler@online.no|0074
20217313|NCT03635983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20217314|NCT03430011|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20217315|NCT04763278|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
20217316|NCT04126343|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20217317|NCT00136760|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
20217318|NCT04458467|UC San Diego|John Finneran|(619) 543-2202|jfinneran@health.ucsd.edu|
20217319|NCT01290237|Boston Children's Hospital|Dr. Alicia Demirjian||alicia.demirjian@post.harvard.edu|
20217320|NCT00388037|Cancer Centre of Southeastern Ontario at Kingston|Dr. James Biagi|(613) 544-2630|jim.biagi@krcc.on.ca|
20217321|NCT00602537|University of Pennsylvania|Dr. Jay Amsterdam|(215) 662-3462|jamsterd@mail.med.upenn.edu|
20217322|NCT04330157|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
20217323|NCT00337987|Yale University School of Medicine|Francine Foss, MD|203-737-5312|francine.foss@yale.edu|
20217324|NCT04314843|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20217325|NCT01899326|Albert Einstein College of Medicine|Dr. Amit Verma|718-430-4091|amit.verma@einsteinmed.edu|
20217326|NCT01020526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217327|NCT03558139|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20217328|NCT00373425|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Oncology||clinicaltrial.disclosure@us.astellas.com|
20217329|NCT03073811|Durham VA Health Care System|Kathryn Starr, PhD, RD; Research Health Scientist|919-660-7571|kathryn.starr2@va.gov|
20217330|NCT00551616|HRA Pharma|Henri Mathé|+33140331130|medical2914@hra-pharma.com|
20217331|NCT02808819|AstraZeneca|AstraZeneca Information Center|+1 8002369933|information.center@astrazeneca.com|
20217332|NCT02752802|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|952-955-8236|mshepard@ospreymed.com|
20217333|NCT00251316|NIDDK, NIH|Dr. Monica Skarulis|301-496-6087|monicas@intra.niddk.nih.gov|
20217334|NCT03139240|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
20217335|NCT05022563|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217336|NCT01610063|Mayo Clinic|Dr. Daniel K. Hall-Flavin|507-255-4151|flavin.daniel@mayo.edu|
20217337|NCT03314662|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20217338|NCT02919826|Queen's University|Dr. Muhammad Ayub|613-549-7944|ma84@queensu.ca|
20217339|NCT01867606|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-4918|jatoi.aminah@mayo.edu|
20217340|NCT01378962|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20217341|NCT04511208|CCF|Daniel Sessler, MD|216-444-4900|sseslerd@ccf.org|
20217342|NCT02248662|Dana-Farber Cancer Institute|Rinaa Punglia, MD|617-582-8759|rinaa_punglia@dfci.harvard.edu|
20217343|NCT01835548|Neos Tx|Carolyn Sikes, PhD|972-408-1300|csikes@neostx.com|1255
20217344|NCT01634854|Vanderbilt University Medical Center|Angela Wilson-Liverman CNM||angela.wilson-liverman@vanderbilt.edu|
20217345|NCT02490800|Basilea Pharmaceutica International Ltd, Allschwil|Thomas Kaindl, MD|+41 61 567 15 24|thomas.kaindl@basilea.com|
20217346|NCT00537017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217347|NCT00948792|University of Oklahoma Health Sciences Center|Doug Dannaway|4052715215|douglas-dannaway@ouhsc.edu|42048
20217348|NCT03365791|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20217349|NCT00739973|Novartis Pharmaceuticals|Study Director|862 778-8300||
20217350|NCT00987831|Oklahoma Medical Research Foundation|Joan T Merrill, M.D|405-271-7805|JTMmail@aol.com|
20217351|NCT02219308|University of California, San Diego|Dr. Sheila Mody|858-249-1205|smody@ucsd.edu|
20217352|NCT04149535|Boston Scientific|Sarah Zanon - Director Clinical Trials, Interventional Cardiology|+41798407006|sarah.zanon@bsci.com|
20217353|NCT02175368|Ivoclar Vivadent AG|Dr. Erik Braziulis||erik.braziulis@ivoclarvivadent.com|
20217354|NCT02875028|Medical University of Vienna|Bernd Jilma|+4314040029910|bernd.jilma@meduniwien.ac.at|
20217355|NCT05068284|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20217356|NCT01989676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217357|NCT03941834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217358|NCT02717078|University of Minnesota|Anne Bantle|612-625-8673|endofixer@umn.edu|
20217359|NCT02688387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20217360|NCT03388502|Rush University Medical Center|Dr Philip Louie|2539069256|louie.philip@gmail.com|
20194530|NCT05745701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163495|NCT02342223|VA Northern California Health Care System|Jared Jagdeo, MD, MS|917-837-9796|jrjagdeo@gmail.com|
20194531|NCT03568643|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
20194532|NCT02425904|Dana-Farber Cancer Institute/Boston Children's Hospital|Barbara Degar, MD|617-632-5186|Barbara_Degar@dfci.harvard.edu|
20194533|NCT01732822|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
20194534|NCT00591370|Memorial Sloan-Kettering Cancer Center|Dr. Paul Chapman|212-639-7357|chapmanp@mskcc.org|
20194535|NCT04019990|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
20194536|NCT02735577|New York State Psychiatric Institute|Nasir Naqvi, MD|6467748181|nasir.naqvi@nyspi.columbia.edu|
20217361|NCT00802178|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217362|NCT01606228|Janssen China|Medical Affairs Director, CNS, Asia Pacific|8610 5821 8766||
20217363|NCT04100096|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800 562-3974|clinicaltransparency@otsuka-us.com|
20217364|NCT02137382|Abbott|Suntje Sander - Struckmeier|+49 (0) 511 6750 3254|suntje.sander-struckmeier@abbott.com|
20217365|NCT00991510|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20217366|NCT01976728|Ferring Pharmaceuticals|Clinical Development Support|+1 833-548-1402|DK0-Disclosure@ferring.com|
20217367|NCT02356211|TVHS GRECC, Nashville TN|James S. Powers MD, Clinical Associate Director, GRECC|615-873-8032|james.powers2@va.gov|
20217368|NCT02211014|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
20194537|NCT00316602|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20194538|NCT01142232|IndianaU|Dr. Attaya Suvannasankha|(317) 278-9306|asuvanna@iu.edu|
20194539|NCT00626990|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
20194540|NCT04138576|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
20194541|NCT01994837|AbbVie|Global Medical Services|800-633-9110||
20194542|NCT01951352|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
20194543|NCT00574873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194544|NCT00581555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194545|NCT00201643|Obstetrix Medical Group, Inc.|Kimberly A. Maurel, MSN, CNS|714-593-9171|kimberly_maurel@pediatrix.com|
20194546|NCT04142359|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20194547|NCT02898077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20194548|NCT03207451|Inova Health System|Director of Clinical Trials|443-244-1497|kevin.bliden@inova.org|
20194549|NCT00772330|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
20194550|NCT01519089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194551|NCT00127205|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
20194552|NCT03199118|Cairo University|Sarah Elbanna, assistant lecturer at the Oral Medicine and Periodontology department|+201000760002|srhelbanna@gmail.com|
20194553|NCT01353859|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20194554|NCT01659853|Galerma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
20194555|NCT05032872|Brandeis University|Xin Yao Lin|6462583562|xylin@brandeis.edu|
20194556|NCT00910039|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
20194557|NCT01911390|Department of Environmental and Radiological Health Sciences|Dr Elizabeth Ryan|970-491-1536|E.P.Ryan@colostate.du|
20194558|NCT00406692|Boston University|Clifford Knapp, PhD|617-414-1990|cknapp@bu.edu|
20194559|NCT00400725|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20194560|NCT03547739|University of Alabama at Birmingham|Janet M. Turan, PhD, MPH|2059757770|jmturan@uab.edu|
20194561|NCT05731999|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
20194562|NCT04928287|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20194563|NCT01744392|Health Services Research & Development, Durham VAMC|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
20194564|NCT04678505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194565|NCT00635661|New York University,. Rusk Institute|Dr. Irene Ward|212-263-6073|Irene.ward@nyumc.org|
20194566|NCT00472849|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
20194567|NCT02369068|Beaumont Hospital, Royal Oak|Deborah Hasenau RN, Director, Urology Research|248-551-0804|Deborah.Hasenau@Beaumont.org|
20194568|NCT04664075|Imperial College London|Senior Clinical Research Nurse|02083833231|flu-rsv-study@imperial.ac.uk|
20194569|NCT01353118|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20194570|NCT03192475|University of Pittsburgh|Elizabeth Mary Venditti PhD, Associate Professor of Psychiatry and Epidemiology|(412) 647-1027|vendittiem@upmc.edu|
20194571|NCT01641159|University of Cincinnati College of Medicine; Department of Psychiatry|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
20194572|NCT00798590|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20194573|NCT01404429|PGIMER, India|Varun Dhir, Assistant Professor, Internal Medicine|+91-8872229998|varundhir@gmail.com|
20194574|NCT05330676|University of Pennsylvania|John C. Greenwood, MD, MS|856-816-7172|john.greenwood@pennmedicine.upenn.edu|
20194575|NCT02741323|University of California, San Francisco|Clinical Research Manager|415-595-1226|Rodney.Rogers@ucsf.edu|
20194576|NCT03417570|Washington University School of Medicine|Vladimir M. Kushnir, M.D.|314-454-5960|vkushnir@wustl.edu|
20194577|NCT00573859|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
20194578|NCT00744757|Medical Affairs, Janssen Taiwan|Medical Director|+886-2-23761255||
20194579|NCT03682302|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20194580|NCT00532493|VA Puget Sound Health Care System|Dr. Murray Rasknd|(206) 764-2702|Murray.Raskind@va.gov|
20194581|NCT05833100|i-SENS, Inc.|Moon Hwan Kim|+82 (0)2 910 0521|mhkim@i-sens.com|
20194582|NCT00707759|FONDECYT|Maria Angela Delucchi|56-2-25755972|madelucchi@gmail.com|
20194583|NCT00888927|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20194584|NCT02153073|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20194585|NCT01607476|Mayo Clinic|Dr. Val Lowe|507-255-3616|vlowe@mayo.edu|
20194586|NCT04445987|Arcutis Biotherapeutics|Arcutis Medical Information|+1 844 692-6729|medinfo@arcutis.com|
20163496|NCT02223338|Loma Linda University|Dr. David Sierpina|9095582154|dsierpina@llu.edu|
20163497|NCT04098809|Benaroya Research Institute at Virginia Mason|Dr. Andrew Stamm|206-223-6772|Andrew.Stamm@virginiamason.org|
20194587|NCT00749957|Applied Genetic Technologies Corporation|Chief Medical Officer|386-462-2204|jchulay@agtc.com|7205
20194588|NCT00293059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20194589|NCT01170390|Oregon Health & Science University|Dr. Alison Edelman|503.418.2585|edelmana@ohsu.edu|
20194590|NCT02001064|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
20194591|NCT01609062|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
20194592|NCT00680992|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20194593|NCT03772587|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20194594|NCT05148962|Gritstone bio, Inc.|Elizabeth Martin, Vice President, Clinical Development Infectious Disease|+1 (877) 520-2233|clinicalstudies@gritstone.com|
20194595|NCT04362189|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20194596|NCT02111681|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum, MD|914-367-7273|gelblumd@mskcc.org|
20194597|NCT05116540|Hope Biosciences Research Foundation|Maureen Gerwin|(346) 900-0340|maureen@hopebio.org|
20194598|NCT00095056|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20194599|NCT03918499|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20194600|NCT00682851|Magee-Womens Research Institute|Lorna Rabe|412-641-6042|lrabe@mwri.magee.edu|
20194601|NCT02731690|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20194602|NCT03828747|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20194603|NCT00490490|Stanford University Medical Center|Susan J. Knox, MD, Associate Professor of Radiation Oncology|(650) 725-2720|sknox@stanford.edu|
20194604|NCT02141620|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
20194605|NCT04343287|BRIM Biotechnology, Inc.|Erin Chang, Vice President of Portfolio Management Department|0226598779|erin.chang@brimbiotech.com|119
20194606|NCT03582943|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
20194607|NCT03527550|McLean Hospital|Dr. Andrew Peckham|617-855-2946|adpeckham@mclean.harvard.edu|
20217369|NCT00966381|UNC Greensboro|Cheryl Lovelady|336 256-0310|cheryl_lovelady@uncg.edu|
20187538|NCT05210569|Image Plus Laser Eye Centre|Dr James Wiens|1-204-943-6287|jamesjwiens@gmail.com|
20187539|NCT00544414|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20187540|NCT02988661|Emory University|Cristina Drenkard, MD, PhD|404-251-8901|cdrenka@emory.edu|
20187541|NCT04750941|Columbia University|Jennifer E. Amengual, MD|212-326-5720|jea2149@cumc.columbia.edu|
20187542|NCT02323880|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20187543|NCT02484430|Mayo Clinic|Aref Al-Kali, M.D.|(507) 284-2511|alkali.aref@mayo.edu|
20187544|NCT04750538|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
20187545|NCT03624465|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20187546|NCT04951076|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
20187547|NCT04766892|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20187548|NCT03085719|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-582-8731|Jonathan_Schoenfeld@dfci.harvard.edu|
20187549|NCT05716763|Unither-Pharmaceuticals|Non-clinical & clinical Project Manager|33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
20187550|NCT03381586|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20187551|NCT03703908|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
20187552|NCT01130519|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
20187553|NCT05280574|Outcomes Research Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio|Daniel I. Sessler MD, Professor and Michael Cudahy Chair|216-870-2620|DS@OR.org|
20187554|NCT04197869|UCLA Health|Dr. Alexandra Goodwin|917-969-1654|zangoodwin@gmail.com|
20187555|NCT04180462|Washington University School of Medicine|Allison King, M.D., Ph.D., MPH|314-454-4291|king_a@wustl.edu|
20187556|NCT05237284|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20187557|NCT00670241|LEO Pharma|Anders Rhod Larsen, Scientific Advisor|+4572262990|anders.larsen@leo-pharma.com|
20187558|NCT02224144|Columbia University|Thomas Nickolas MD, MS|2123053273|tln2001@cumc.columbia.edu|
20187559|NCT03505008|Keio University School of Medicine|Prof. Y Kaneko|+81-3-5363-3786|ykaneko@z6.keio.jp|
20187560|NCT03276676|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
20187561|NCT04753788|LSHTM|Professor Michael Marks|+44020 7636 8636|michael.marks@lshtm.ac.uk|
20187562|NCT02962076|Mercy Research|Michelle Bryant, MPH|314-251-8827|michelle.bryant@mercy.net|
20187563|NCT02780700|Boehringer Ingelheim|Boehringer IIngelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187564|NCT03926130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20187565|NCT03583333|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20187566|NCT05723575|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
20187567|NCT06397443|IRCCS Istituto Ortopedico Rizzoli|Dr. Manila Boarini|+39 051 63666062|manila.boarini@ior.it|
20187568|NCT03367754|Clinical Center|Kovacs, Joseph|+1 301 496 9907|jkovacs@mail.nih.gov|
20187569|NCT01569659|Northwestern University|Herbert Meltzer, MD|312-503-9096|h-meltzer@northwestern.edu|
20187570|NCT03149822|University of Colorado Hospital|Dr. Elaine Lam|7208480723|elaine.lam@cuanschutz.edu|
20194608|NCT01085968|VA Overton Brooks|Elizabeth Disbrow|318-6757184|edisbr@lsuhsc.edu|
20194609|NCT03053518|NYU Langone Health|Mary Sevick, MD|646-501-2621|Mary.Sevick@nyulangone.org|
20194610|NCT02683876|MEBO Research|Maria De la Torre|7862286880|maria.delatorre@meboresearch.org|
20194611|NCT02071290|St. Michael's Hospital|Dr. Ori Rotstein|416-864-6060|rotsteino@smh.ca|5304
20194612|NCT00939822|University of Wisconsin School of Medicine and Public Health|Dr. Cynthia M. Carlsson|608-256-1901|cmc@medicine.wisc.edu|11691
20194613|NCT01232738|UKansasMCRI|Yunxia Wang|913-588-6970|ywang@kumc.edu|
20194614|NCT02147899|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
20194615|NCT01143870|University of Pennsylvania|Anjali Gopalan|575-640-3893|agopalan@upenn.edu|
20194616|NCT04073446|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
20194617|NCT01365481|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20194618|NCT00047697|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
20194619|NCT02946853|University of Rochester|Dr. Jonathan Steinberg|9734364155|jsteinberg@summithealth.com|
20194620|NCT00958841|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20194621|NCT00632489|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20194622|NCT00436605|Yale University School of Medicine|Harriet Kluger|203-737-2572|Harriet.Kluger@yale.edu|
20194623|NCT03014011|Bispebjerg Hospital|MD Malin Nilsson|50595861|mnil0028@regionh.dk|0045
20194624|NCT02755818|University of California, Davis|George Kaysen MD - Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
20194625|NCT05319912|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20194626|NCT00359983|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194627|NCT01143181|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20194628|NCT01280357|Monica Healthcare Ltd|Ian How|+44 (0)115912|ianhow@monicahealthcare.com|4540
20194629|NCT01259089|Northwestern University|Clinical Trials Office|312-695-1301||
20194630|NCT02818244|Cleveland Clinic|Marc Gillinov MD|216 445-8841|GILLINOM@ccf.org|
20194631|NCT02310100|Abbott|Lori Rusch, Ph.D.|1-651-756-2668|lori.rusch@abbott.com|
20194632|NCT00688870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194633|NCT00477659|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20194634|NCT01140295|The Children's Hospital of Philadelphia|Petar Mamula|215-590-9146|mamula@email.chop.edu|
20194635|NCT00992225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194636|NCT01253018|VA Maryland Health Care System|Dr. Christopher T. Bever, Jr. MD, MBA|(410) 605-7000|christopher.bever@va.gov|7130
20194637|NCT03449901|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-3096|bvantine@wustl.edu|
20194638|NCT01769326|University of California Irvine|Steven Cramer, M.D.|(949) 824-8748|scramer@uci.edu|
20194639|NCT03459443|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
20194640|NCT03702231|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
20194641|NCT03592745|Feinstein Institutes for Medical Research at Northwell Health|Senior Research Coordinator|5165623646|jchang14@northwell.edu|
20194642|NCT00421954|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
20194643|NCT02729831|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
20194644|NCT01821352|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20194645|NCT05260021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20194646|NCT03842358|Washington University School of Medicine|Debbie Bennett, M.D.|314-454-7696|debbie.bennett@wustl.edu|
20194647|NCT02626455|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
20194648|NCT06665919|Tbilisi State Medical University|Konstantine Liluashvili , MD., PH.D.|+995599908899|k.liluashvili@tsmu.edu|
20194649|NCT01200290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194650|NCT01144377|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194651|NCT00607724|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20194652|NCT00151281|Weill Cornell Medical College|Dr. Jia Ruan|646-962-2068|jruan@med.cornell.edu|
20194653|NCT01717742|Hospital for Sick Children|Dr. Eyal cohen|416-813-7654|eyal.cohen@sickkids.ca|
20194654|NCT01133418|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
20194655|NCT04150068|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20163498|NCT01200368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163499|NCT02741596|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20163500|NCT02947646|Actuated Medical|Director Quality Assurance & Regulatory Affairs|814-355-0003|medical.affairs@actuatedmedical.com|
20163501|NCT04854551|University of Colorado Anschutz Medical Campus|Joshua Gowin|3037243769|joshua.gowin@cuanschutz.edu|
20163502|NCT00181766|Massachusetts General Hospital|Joseph Biederman, MD|617-726-1743|jbiederman@partners.org|
20163503|NCT00687804|Novartis Pharmaceuticals|Study Director|862 778-8300||
20163504|NCT00413218|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
20163505|NCT00206336|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
20163506|NCT04034004|UC San Diego|Dr. Fadel Zeidan|858-246-8342|zeidanlaboratory@ucsd.edu|
20163507|NCT04317040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163508|NCT03672292|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
20163509|NCT02518971|Michigan Medicine|Andrew Urquhart|734-936-6636|andrewu@med.umich.edu|
20194656|NCT05316701|Orca Biosystems, Inc.|Chief Medical Officer|530-414-9743|info@orcabio.com|
20194657|NCT04679935|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20163510|NCT03088917|Radboudumc|Prof. dr. J.P.H. Drenth|0031243613999|joost.drenth@radboudumc.nl|
20194658|NCT03960047|University Of Guelph|Professor Barbara A. Morrongiello|5195461637|bmorrong@uoguelph.ca|
20163511|NCT00757237|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
20194659|NCT00905515|East Carolina University|Director of Clinical Trials|252-744-0671|bryantw@ecu.edu|
20194660|NCT00775463|United Therapeutics Corporation|Oral Treprostinil Program Head|919-485-8350|klaliberte@unither.com|
20194661|NCT00969709|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
20194662|NCT02980731|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20194663|NCT02075476|Hospital Gregorio Marañón|Dr. Carlos Álvarez|0034915868000|calvargon@gmail.com|
20194664|NCT00091169|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20194665|NCT00660543|Oregon Health and Science University|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
20194666|NCT00661479|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20194667|NCT02699086|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
20194668|NCT03786042|Dartmouth college|Research Scientist|603-646-5408|john.brand@dartmouth.edu|
20194669|NCT05263388|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
20194670|NCT00836745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194671|NCT02366468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20194672|NCT05540717|Allergy Therapeutics (UK) Ltd.|Pieter-Jan De Kam, Clinical Director|+44 (0) 1903 844 700|pieter-jan.dekam@allergytherapeutics.com|
20194673|NCT03651622|University of North Carolina at Chapel Hill|Elizabeth Mayer-Davis, PhD|919-966-7218|mayerdav@email.unc.edu|
20194674|NCT00307684|Janssen-Cilag G.m.b.H.|European Medical Affairs Director Neurology|+49 2137 955258|bschaeu2@its.jnj.com|
20194675|NCT03784001|University of California, Los Angeles|Tanera van Diggelen|4086231219|tvandiggelen@gmail.com|
20194676|NCT02580305|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
20194677|NCT00224887|Stanford University|Dr. Donna Matheson|650-723-5895|donna.matheson@stanford.edu|
20194678|NCT04032613|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|919-445-2656|jflythe@med.unc.edu|
20194679|NCT03535506|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
20194680|NCT05126563|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20217370|NCT01124695|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20217371|NCT01119807|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
20217372|NCT01922219|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jm2233@cumc.columbia.edu|
20217373|NCT01796964|Alcon Research, Ltd.|Clinical Project Group Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20217374|NCT04025684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20217375|NCT03008837|VAORD|Dr. Anna Woodbury|404-321-6111|anna.woodbury@va.gov|
20217376|NCT04894084|Coloplast A/S|Medical Affairs Project Manager|+4549111341|dkteaa@coloplast.com|
20217377|NCT01573533|Mayo Clinic|Fernando C. Fervenza, M.D., Ph.D.|507-266-1045|Fervenza.Fernando@mayo.edu|
20217378|NCT03122587|University of North Carolina at Chapel Hill|Stacey Daughters, PhD|9199629924|daughter@unc.edu|
20217379|NCT01613378|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20217380|NCT03170388|Bausch Health Americas, Inc|Study Director|5102595284|aloncaric@bauschhealth.com|
20217381|NCT02000531|HoffmannLa Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20217382|NCT02285634|Mayo Clinic|Dr. Tobias Kummer|507 255 4732|vanmeter.derek@mayo.edu|
20217383|NCT00794417|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20217384|NCT02956616|Montefiore Medical Center|Peter S. Bernstein, MD, MPH|718-904-2767|pbernste@montefiore.org|
20217385|NCT03764735|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
20217386|NCT01345318|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217387|NCT00556491|St Louis University|Tarek El-Achkar|317 278 6822|telachka@iu.edu|
20217388|NCT01239472|Hospital e Maternidade Marieta Konder Bornhausen|Dr Andre Barreto Pereira|+55 47 984482826|andrebarper@yahoo.com.br|
20217389|NCT02695719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20217390|NCT01163084|UT MD Anderson Cancer Center|Logothetis, Christopher, M.D. / Genitourinary Medical Oncology|7137922830|clogothe@mdanderson.org|
20217391|NCT01534078|Massachusetts General Hospital|Jeremy Abramson, MD|617-724-4000|JABRAMSON@mgh.harvard.edu|
20217392|NCT01049412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20217393|NCT03440424|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20217394|NCT05966090|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20217395|NCT00804141|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20217396|NCT00309985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20217397|NCT00232479|UMiami|Judith Hurley|305-243-6698|jhurley@miami.edu|
20217398|NCT01148524|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20217399|NCT01734694|Augusta University|Jose Vazquez|(706) 723-0105|JVAZQUEZ@augusta.edu|
20217400|NCT03110380|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20217401|NCT01546519|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20217402|NCT01714739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
20217403|NCT01028911|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217404|NCT00707434|UT MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20217405|NCT03585959|Medtronic|Katie Bayliss|(763) 647-5547|katie.j.bayliss@medtronic.com|
20217406|NCT02531594|Cincinnati Children's Hospital Medical Center|Dr. Melinda Mahabee-Gittens|513-636-7966|melinda.mahabee-gittens@cchmc.org|
20217407|NCT00614822|Christiana Care Health System|Dr. Michael Guarino|302 366 1200|mguarino@cbg.org|
20217408|NCT00448227|Novartis Pharmaceuticals|Study Director|862-778-8300||
20194681|NCT01244529|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|kosborn@its.jnj.com|
20217409|NCT02359864|William Beaumont Hospital|Dr. James Fontanesi, Professor of Neurosurgery, Director of Radiation Oncology|947-521-8121|james.fontanesi@beaumont.org|
20194682|NCT00859222|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|Patrick_Wen@dfci.harvard.edu|
20194683|NCT00488475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194684|NCT00941070|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
20194685|NCT00942305|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20194686|NCT03174431|The Ohio State University|Silpa Nekkanti|614-293-4643|silpa.nekkanti@osumc.edu|
20194687|NCT02111187|Associate professor of oncology and urology|Emmanuel Antonarakis|443-287-0553|eantona1@jhmi.edu|
20194688|NCT04075994|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
20163512|NCT00947271|The Miriam Hospital|Dr. Michael Carey|401-793-8218|michael_carey@brown.edu|
20194689|NCT01141647|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli-slone@va.gov|
20194690|NCT04850794|University of North Carolina at Chapel Hill|Kelsey Thompson, MS|919-966-1007|kelsey_thompson@med.unc.edu|
20194691|NCT00267085|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
20194692|NCT01227382|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20194693|NCT01941719|TUSPM|Dr. Jinsup Song|2157775872|jsong@temple.edu|
20194694|NCT00252577|VA San Diego Healthcare System|John Kelsoe|858-552-8585|john.kelsoe@va.gov|5704
20194695|NCT01480219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203069|NCT03004846|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163513|NCT00490269|Uniformed Services University for the Health Sciences|Dr. Lou Cantelina|301-295-3240|louis.cantelina@usuhs.edu|
20194696|NCT02797080|Horizon Pharma Ireland, Ltd, Dublin, Ireland|Julie Ball, MS, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
20194697|NCT02638597|University of Texas Southwestern Medical Center|Principal Investigator|2146480188|madhukar.trivedi@UTSouthwestern.edu|
20194698|NCT00951015|ViiV Healthcare|GSK Response Center|866-435-7343||
20194699|NCT01167452|Texas Tech University Health Sciences Center|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
20194700|NCT03819634|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
20194701|NCT00299494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194702|NCT00757627|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20194703|NCT02402153|UNEEG medical A/S|Clinical Manager|+45 41414244|lybl@UNEEG.com|
20194704|NCT02033083|Planned Parenthood of New York City|Director of Clinical Training and Research|212-274-7340|ctri@ppnyc.org|
20194705|NCT01696955|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20194706|NCT02416453|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20194707|NCT00841555|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
20194708|NCT01036438|Molnlycke Health Care AB|Ann Larkö|+46 722 3338|ann.larko@molnlycke.com|
20194709|NCT01413503|University of California, San Francisco|Paul A. Fitzgerald, MD|415-665-1136|Paul.Fitzgerald2@ucsf.edu|
20194710|NCT02091206|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20194711|NCT03970538|LimFlow|Director, Clinical Affairs|559-970-1012|kmccaffrey@limflow.com|
20194712|NCT03367429|Weill Cornell Medicine|Michael O'Dell, M.D.|19175495179|mio2005@med.cornell.edu|
20194713|NCT05907707|University of North Carolina at Chapel Hill|Andrea Seiler, MD|+41 316322111|andrea.seiler@insel.ch|
20194714|NCT05051462|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
20194715|NCT05452278|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
20194716|NCT03663257|Philips Medical Systems Nederland B.V.|Joris de Groot|+31621949619|joris.ah.de.groot@philips.com|
20194717|NCT05597787|University of Delaware|Valerie Earnshaw|(302) 831-6500|earnshaw@udel.edu|
20194718|NCT01241604|Philips Respironics|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
20194719|NCT03621787|co-PI|Kathleen Sienko|734647249|sienko@umich.edu|
20163514|NCT05150990|University of California Santa Barbara|Dr. Nancy Collins|805-568-0042|ncollins@ucsb.edu|
20194720|NCT04349631|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
20187571|NCT03687762|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
20187572|NCT01866163|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20187573|NCT04723147|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
20187574|NCT03640286|Neurovalens|Head of Clinical and Regulatory|02890991835|sinead.watson@neurovalens.com|
20187575|NCT03181516|Georgetown University Medical Center|Dr. Daniel Merenstein|2026872745|djm23@georgetown.edu|
20187576|NCT04580914|Boston Scientific|Claire Dietzsch, Senior Clinical Trials Specialist|9529306745|Claire.Dietzsch@bsci.com|
20194721|NCT03037931|American Regent, Inc.|Elizabeth Ernst, Global Executive Director of Regulatory Affairs|631-605-5753|eernst@americanregent.com|3551
20194722|NCT00872989|SWOG Statisticial Center|Lung Committee Statistician|206-667-4623||
20194723|NCT02407990|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20194724|NCT00923260|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Miguel F Herrera|(+52) 55 54870208|miguelfherrera@gmail.com|
20194725|NCT03809429|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20194726|NCT00692276|Vertiflex|Steve Reitzler|442-325-5934|sreitzler@vertiflex.com|
20194727|NCT01033422|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
20194728|NCT03377699|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20194729|NCT02440659|Arbor Research Collaborative for Health|Francesca Tentori|734-665-4108|christina.pustulka@arborresearch.org|
20194730|NCT00774930|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20194731|NCT01153321|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
20194732|NCT01177800|Beijing, China R&D|Senior Therapeutic Area Physician|+86 010 58218358||
20194733|NCT00424385|Oncology Specialists, SC|Sigrun Hallmeyer, MD Director of Research; Chadi Nabhan, MD FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
20217410|NCT00725764|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217411|NCT02255487|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
20217412|NCT01216410|Duke University Medical Center|Ashraf Habib|919 668 6266|habib001@dm.duke.edu|
20217413|NCT01857206|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20217414|NCT02681406|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
20217415|NCT01679054|The Chinese University of Hong Kong|Vivian Lee|+85239438012|vivianlee@cuhk.edu.hk|
20217416|NCT00575380|Inspire|Mike Schiewe|919-941-9777|mschiewe@inspirepharm.com|
20217417|NCT01334957|Cumberland Pharmaceuticals Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
20217418|NCT00559364|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20217419|NCT01235442|Amgen Inc.|Study Director|866-572-6436||
20217420|NCT00084799|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20194734|NCT05560243|University of Alabama at Birmingham|Isabel Scarinci, Principal Investigator|2059757177|scarinci@uab.edu|
20194735|NCT05870228|University of Strathclyde|Stephanie McCrory|07538376660|stephanie.mccrory@strath.ac.uk|
20217421|NCT01857973|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20217422|NCT02663882|Yeshiva University|Dr. Andrea Weinberger|(646) 592-4474|andrea.weinberger@yu.edu|
20194736|NCT02503852|Kerastem|Eric Daniels, M.D., Chief Medical Officer|858.348.8050|edaniels@puregraft.com|
20194737|NCT03231800|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20194738|NCT01247285|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20194739|NCT04035499|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
20194740|NCT01538966|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
20194741|NCT01417104|The Ohio State University|Sanjay Rajagopalan, MD|614-247-7760|sanjay.rajagopalan@osumc.edu|
20194742|NCT01416389|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194743|NCT01125514|Novartis Pharmaceuticals|Study Director|862-778-8300||
20194744|NCT00858364|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20194745|NCT03980808|Georgia Institute of Technology|Salimah LaForce, M.S.|404-385-4614|salimah@cacp.gatech.edu|
20194746|NCT01655693|ONXEO|Olivier De Beaumont; Chief Medical Officer|+33 (0) 1 45 58 95 33|o.debeaumont@onxeo.com|
20194747|NCT00357331|Weill Medical College|Assistant Professor of Medicine|212-746-1670|sinhana@med.cornell.edu|
20194748|NCT00929110|Novartis Pharmaceuticals|Study Director|862 778-8300||
20194749|NCT03794700|University of Colorado Anschutz Medical Campus|Channing Tate, PHD Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
20194750|NCT02120287|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
20194751|NCT01163292|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20194752|NCT02535091|SK Life Science, Inc.|Medical Director|402-835-5977|smisra@sklsi.com|
20194753|NCT03223662|National Cancer Institute|Caryn Steakley|240-858-3749|steaklec@nih.gov|
20194754|NCT02643472|Children's National Health System|Dr. Karen Fratantoni|202-476-4793|kfratant@childrensnational.org|
20194755|NCT01258595|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20194756|NCT01012414|Thomas Jefferson University|David Whellan MD|215 955 5050|david.whellan@jefferson.edu|
20194757|NCT01215188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20194758|NCT02601300|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20194759|NCT01127763|Mt Sinai School of Medicine|Amy Tiersten, MD|212-249-3300|amy.tiersten@mssm.edu|
20194760|NCT00528931|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20194761|NCT02571153|Pontificia UCSP|Eduardo Toshiyuki Moro||eduardo_moro@terra.com.br|
20194762|NCT03835351|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
20194763|NCT02285153|Medical University of Vienna|Bernd Jilma|+434040029180|bernd.jilma@meduniwien.ac.at|
20194764|NCT00924118|Johns Hopkins Hospital|Steven P. Schulman, MD|4109557378|sschulma@jhmi.edu|410
20194765|NCT01390077|University of California, San Diego|William Leo Nyhan, M.D., Ph.D.|(619)543-5337|wnyhan@ucsd.edu|
20194766|NCT01489891|Hospital Universitario Infanta Cristina|Dr. Felipe de la Morena|0034659716030|felipe_de_la_morena@hotmail.com|
20194767|NCT02327351|National Research Center for Pediatric Hematology , Moscow, Russian Federation|Balashov Dmitriy, head of HSCT department|84956647078|Dmitriy.Balashov@fccho-moscow.ru|6534
20194768|NCT00844532|Abbott Vascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
20194769|NCT02576587|Cleveland Clinic|Dr. Reena Mehra|216-444-4946|mehrar@ccf.org|
20194770|NCT00948766|Novartis Pharmaceuticals|Study Director|862 778-8300||
20194771|NCT00777088|Medtronic|Darren LaCour|949-680-1274|darren.j.lacour@medtronic.com|
20194772|NCT01278173|Lundbeck|H||LundbeckClinicalTrials@Lundbeck.com|
20194773|NCT02546921|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20194774|NCT03381339|Marquette Univeristy|Associate Dean|4142885944|andrew.dentino@marquette.edu|
20217423|NCT01701973|Vanderbilt University Medical Center|Dr. Jessica Devin|6159361665|jessica.devin@vanderbilt.edu|
20194775|NCT01593787|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
20217424|NCT00908882|Eastern Colorado Health Care System|Catherine Battaglia PhD RN|720-857-5099|catherine.battaglia@va.gov|
20194776|NCT00452023|The University of Texas MD Anderson Cancer Center|Lucia Masarova MD/Assistant Professor|832-750-4211|LMasarova@mdanderson.org|
20194777|NCT01022112|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20194778|NCT02081443|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20194779|NCT00591721|University of Illinois at Chicago|Marcia Finlayson, PhD|312-996-4603|marciaf@uic.edu|
20194780|NCT00901186|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
20194781|NCT01597141|Maine Medical Center Research Institute|William R. McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
20194782|NCT02383056|University of Miami|Dr. Keyvan Nouri|305-243-3380|Knouri@med.miami.edu|
20194783|NCT03900416|Lawrence University|Dr. Lori Hilt|920-832-7050|lori.m.hilt@lawrence.edu|
20194784|NCT03507777|Abbott Vascular|Jana Buccola, Director Clinical Programs|+1-408-845-1049|jana.buccola@abbott.com|
20194785|NCT02245737|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
20194786|NCT03866798|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
20194787|NCT00359216|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20194788|NCT01181323|Cincinnati Children's Hospital Medical Center|Mark Steinhoff, MD|513-636-2791|Mark.steinhoff@cchmc.org|
20194789|NCT01680640|University of Southampton|Christopher D Byrne|44 (0)23 8120 8818|cdtb@soton.ac.uk|
20194790|NCT03122223|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20194791|NCT02935660|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20194792|NCT00291642|UCB S.A.|UCB|+1844 599|UCBCares@ucb.com|2273
20194793|NCT00735475|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20194794|NCT01712659|National Cancer Institute|Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
20194795|NCT00684723|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20194796|NCT00548262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194797|NCT04535310|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
20194798|NCT00939159|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
20194799|NCT02338973|National Institutes of Health|Wadih Zein, MD, Principal Investigator, NEI|301-496-8118|zeinw@nei.nih.gov|
20194800|NCT01472549|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
20194801|NCT03189745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194802|NCT05086276|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
20194803|NCT03590366|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20194804|NCT00738894|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
20194805|NCT05017103|M D Anderson Cancer Center|Neeta Somaiah, MD|713-792-3626|nsomaiah@mdanderson.org|
20194806|NCT03699826|University of Iowa|Aaron Boes|319-353-8587|aaron-boes@uiowa.edu|
20187577|NCT04544007|University of Alabama at Birmingham|Coretta Thomas, Scientist & Data Manager for NF Consortium|205-975-8629|coretta@uab.edu|
20187578|NCT03331835|LEO Pharma AS|Clinical Disclosure|(+1) 877-557-1168|disclosure@leo-pharma.com|
20187579|NCT04667468|University of Pittsburgh|Dr. Jason Sperry|412-215-7025|sperryjl@upmc.edu|
20194807|NCT01630694|University of Rochester|Jacek Wojtczak|585-273-2972|jacek_wojtczak@urmc.rochester.edu|
20194808|NCT03796962|Xenon Pharmaceuticals Inc.|Medical Affairs|+1-604-484-3300|medicalaffairs@xenon-pharma.com|
20194809|NCT00719329|Johns Hopkins Bloomberg School of Public Health|Dr. Luke Mullany|410-502-2626|lmullany@jhsph.edu|
20194810|NCT03211117|Mayo Clinic|Ashish V. Chintakuntlawar, MBBS, Ph.D.|(855) 776-0015|Chintakuntlawar.Ashish@mayo.edu|
20194811|NCT01118013|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD||abashey@bmtga.com|
20194812|NCT01747551|Dana-Farber Cancer Institute|Peter Enzinger|617-632-3029||
20194813|NCT03916458|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194814|NCT01373151|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20194815|NCT02186600|University of Nebraska Medical Center|Laura Bilek|402-559-6923|lbilek@unmc.edu|
20194816|NCT01504477|Georgetown University|Michael Pishvaian|202-444-2223|pishvaim@georgetown.edu|
20194817|NCT03026075|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
20194818|NCT01546675|Department of Veterans Affairs|Linda Resnik, PT, PhD|401-273-7100|linda.resnik@va.gov|2368
20194819|NCT02387268|M.C.Carmel|Dr.Kobie Dickstein|048250055|kobiedi@clalit.org.il|
20194820|NCT04927247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194821|NCT01253070|Washington University School of Medicine|Geoffrey Uy, MD||guy@dom.wustl.edu|
20194822|NCT04828837|NTUNHS|Wang Szu-Yi|886-97140315|jachiex@gmail.com|
20194823|NCT01397422|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20194824|NCT00545753|ParaPRO LLC|Director of Quality and Regulatory|317-810-6205|kerrym@parapro.com|
20194825|NCT00636805|Duke University Medical Center|Mary Lou Affronti|919-6846239|mary.affronti@dm.duke.edu|
20194826|NCT00710905|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20194827|NCT03776539|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
20194828|NCT03691909|Hope Biosciences Stem Cell Research Foundation|Linette Rehkopf RPh|346-900-0340|linette@hopebio.org|102
20194829|NCT05061472|University of Colorado Anschutz Medical Campus|Adnin Zaman, MD|5852761001|adnin.zaman@cuanschutz.edu|
20194830|NCT02489968|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20194831|NCT01728337|CBED|Dr Doris Hexsel|30262633|cbed@cbed.com.br|
20194832|NCT04577001|Mayo Clinic|Dr. Hilary DuBrock|(507) 284-2957|DuBrock.Hilary@mayo.edu|
20194833|NCT05618912|Indiana University School of Medicine|Dr. Syril Keena T. Que|317-944-7744|ques@iu.edu|
20194834|NCT03973931|University of Colorado|Dr. Michael Ho|303-590-5969|michael.ho@cuanschutz.edu; p.michael.x-ho@kp.org|
20194835|NCT01982448|Dana-Farber Cancer Institute|Clinical Trials Office|617-632-5313|ctopm@dfci.harvard.edu|
20217425|NCT05070390|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217426|NCT00597428|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
20217427|NCT02412722|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20217428|NCT04449341|Carl R Darnall Army Medical Center|Matthew Perdue|(254) 553-4653|matthewperdue94@gmail.com|
20217429|NCT04499482|Pennington Biomedical Research Center|Dr. Candida Rebello|2252882411|Candida.Rebello@pbrc.edu|
20217430|NCT00869440|PAION UK Ltd|Trial Information||reg_paion@paion.com|
20217431|NCT00931996|Ullinois|Dr. Jeffrey Bishop|312-413-3495|jbishop@uic.edu|
20217432|NCT03546647|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@central.uh.edu|
20217433|NCT00124462|Boston Univeristy|ClinicalTrials.gov Administrator|617 638 8862|damusk@bu.edu|617
20217434|NCT02400476|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
20217435|NCT02487082|Stony Brook Medicine Dept. of Neurology|Ruth A. Reinsel Ph.D., Clinical Research Associate II|(631) 638-2087|ruth.reinsel@stonybrookmedicine.edu|
20217436|NCT03922139|UW School of Medicine and Public Health|Michael Suer, MD|608-265-3207|suer@rehab.wisc.edu|
20217437|NCT01588548|AstraZeneca|Karen Keating|+1 781 839 4182|karen.keating@astrazeneca.com|
20217438|NCT00760526|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|direcnet@jaeb.org|
20217439|NCT02190279|National Cancer Institute|Dr. Maria Liza Lindenberg|240-760-6109|liza.lindenberg@nih.gov|
20217440|NCT02938442|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
20217441|NCT01115855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217442|NCT00831233|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20217443|NCT00480324|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217444|NCT00784134|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
20217445|NCT03785145|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
20217446|NCT00097786|Novartis Pharmaceuticals|Study Director|862 778-8300||
20217447|NCT02960438|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20217448|NCT03686150|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
20217449|NCT02265341|Mayo Clinic|Mitesh J. Borad, MD|480/301-8335|Borad.Mitesh@mayo.edu|
20217450|NCT02443324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20217451|NCT01647711|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217452|NCT03244475|VA San Diego Health System|Dr. Mingxiong Huang|858-534-1254|mingxiong.huang@va.gov|
20217453|NCT03404401|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20217454|NCT02948257|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|408-470-7119|Terry_Alverson@cardivamedical.com|
20217455|NCT01844531|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217456|NCT02070757|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217457|NCT01546922|University Medical Center Groningen|A. P. van Beek, MD PhD|00315036110388|a.p.van.beek@umcg.nl|
20203070|NCT03896425|University of Minnesota|Rebecca Kazinka|612-626-6772|kazin003@umn.edu|
20203071|NCT00447421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203072|NCT01787591|The Ohio State University|Richard S. Bruno, PhD, RD|614-292-1698|bruno.27@osu.edu|
20203073|NCT01435512|BVARI|Dr. Casey Taft|857-364-6261|casey.taft@va.gov|
20203074|NCT02725177|Cleveland Clinic Foundation|Daniel Culver, DO|216-444-6508|culverd@ccf.org|
20203075|NCT00377299|UT Southwestern Medical Center at Dallas|Dr. E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
20203076|NCT00638846|Vistakon|Kurt Moody OD|904-443-3088||
20203077|NCT02989727|Univeristy of Saskatchewan|Dr. Evyn Peters|13062904493|evyn.peters@usask.ca|
20203078|NCT01507246|Atlanta Colon and Rectal Surgery|Stephen Cohen, MD|770-997-1975|klong@atlantacolon.com|
20203079|NCT04902950|Reading Hospital|Amir Behnam, MD|610-988-9127|amir.behnam@towerhealth.org|
20203080|NCT02975349|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20203081|NCT03551522|CymaBay Therapeutics, Inc.|Barry Crittenden, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
20163515|NCT00779025|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
20163516|NCT01022138|Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
20163517|NCT05139927|NYU|Marya Gwadz, PhD|917-863-2125|mg2890@nyu.edu|
20163518|NCT00590863|Univeristy of Texas Southwestern Medical Center, Dallas|Madhukar H. Trivedi, M.D.|214-648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
20163519|NCT03054649|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20163520|NCT02735343|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20163521|NCT01804881|North York Family Health Team|Principal Investigator|4164943003|dsouthgate@nyfht.com|130
20163522|NCT02403999|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163523|NCT03830359|Laboratoires Thea|ESTRADE|0635156453|marielle.estrade@theapharma.com|
20163524|NCT00310817|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20163525|NCT02915978|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20163526|NCT03657849|Regions Hospital|Meghan O'Brien / Study Coordinator|612-437-1141|meghan.e.obrien@healthpartners.com|
20163527|NCT03402035|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
20163528|NCT00548145|Osaka University Hospital|Hiroaki Kazui,Ph.D.|81-6-6879-3051|kazui@psy.med.osaka-u.ac.jp|
20163529|NCT00874848|Biothera|Jamie Lowe, Vice President, Clinical Development|651-256-4653|jlowe@biothera.com|
20163530|NCT03089541|Yale School of Medicine|Dr. Deepa Camenga, Principal Investigator|12037378310|deepa.camenga@yale.edu|
20163531|NCT02324816|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20163532|NCT05169424|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20163533|NCT04522141|Lucerne University of Applied Sciences and Arts|Dr. Mirjam Stieger|0041798852810|mirjam.stieger@hslu.ch|
20163534|NCT03052049|Northwestern Medical Group|Jennifer Karp RN|312-926-5289|jkarp@nm.org|
20163535|NCT03508609|Caladrius Biosciences, Inc.|William Sietsema|9495352391|bsietsema@caladrius.com|
20194836|NCT01789567|Medtronic Bakken Research Center|Kitty Schapira|+31433566802|kitty.schapira@medtronic.com|
20163536|NCT00122369|Beth Israel Deaconess Medical Center (at time of study); now Hypnalgesics, LLC|Elvira V. Lang, MD|978 404 9724|elang@bidmc.harvard.edu|
20163537|NCT00999518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194837|NCT02914275|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20163538|NCT00250276|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163539|NCT01546688|Eisai Call Center|Eisai Inc.|888-422-4743||
20194838|NCT01238900|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
20194839|NCT05130047|Mayo Clinic|Michael Camilleri, M.D., D.Sc.|507-284-2687|camilleri.michael@mayo.edu|
20217458|NCT00450983|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
20217459|NCT00792623|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217460|NCT00743509|University of Michigan|Scott Schuetze|734-647-8925|scotschu@umich.edu|
20217461|NCT00418522|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20217462|NCT01652729|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
20217463|NCT00483548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20217464|NCT04523324|Centers for Disease Control and Prevention|Dr. Ashley Fowlkes|4046394830|afowlkes@cdc.gov|
20217465|NCT01280617|Lahey Hospital & Medical Ctr|Mary Ann Simpson, Ph.D|781-744-2500|Mary.a.Simpson@Lahey.org|
20217466|NCT00573170|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217467|NCT00263887|Talecris Biotherapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
20217468|NCT04364763|Renibus Therapeutics|Stacey Ruiz|682-285-1711|sruiz@renibus.com|
20194840|NCT00834626|Kirloskar Hospital|Dr. Neeraj Gupta|+91-40-23296241|drugale@kirloskarhospital.com|
20217469|NCT03904550|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
20194841|NCT02738203|Stanford University, Department of OB/GYN|Research Manager|6507211562|familyplanningresearch@stanford.edu|
20194842|NCT03241927|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20194843|NCT01198756|GlaxoSmithKline|GSK Response Center|866-435-7343||
20194844|NCT04004936|Atlanta VAHCS|Dr. Elizabeth Camille Vaughan/ Atlanta Site Section Chief Birmingham/Atlanta GRECC|404 315 4100|elizabeth.vaughan2@va.gov|373118
20194845|NCT02915302|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
20194846|NCT03725085|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20194847|NCT02704754|Howard University|Thomas A Mellman|12022575961|TMellman@Howard.edu|
20194848|NCT00423943|University of California, Los Angeles|Michael Minzenberg|310-825-7642|MMinzenberg@mednet.ucla.edu|
20194849|NCT02134977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20194850|NCT04464954|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026532067|amanda.j.crawford.ctr@health.mil|
20194851|NCT00538915|DallasAllergyImmunology|Richard L. Wasserman, M.D., Ph.D.|(972) 566-7788|drrichwasserman@gmail.com|
20194852|NCT02716818|Diurnal Limited|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
20194853|NCT04187989|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
20194854|NCT03646656|Department of Veterans Administration|Dr. Karen Goldstein|919.826.0411|karen.goldstein@va.gov|1707764
20194855|NCT02551718|University Of Washington|Dr. Percival|206-606-1320|mperciva@seattlecca.org|
20194856|NCT00697697|MAP Pharmaceuticals, Inc. a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20194857|NCT04988867|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20194858|NCT01327495|University of Washington|Stephanie Page, MD, PhD|206-616-0483|page@uw.edu|
20194859|NCT03909529|CMP Pharma|Paul Sudhakar|816-507-8249|pauls@ptspharma.com|
20194860|NCT03020576|Columbia University Medical Center/ Dept. of Rehabilitation & Regenerative Medicine|Lauri Bishop, PT, DPT Research Physical Therapist|212-305-6095|LB2413@cumc.columbia.edu|
20194861|NCT03385343|Mayo Clinic|Kevin Buller Clinical Research Coordinator|507-255-4803|Buller.Kevin@mayo.edu|
20194862|NCT01841931|Maimonides Medical Center|Director of Research, Department of Psychiatry|718-283-7162|tjacob@maimonidesmed.org|
20194863|NCT00700427|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194864|NCT00355199|Ospedale Papa Giovanni XXIII, Bergamo|Alessandro Rambaldi|0352673684|arambaldi@asst-pg23.it|+39
20194865|NCT03307005|Johns Hopkins University|Rashmi Nisha Aurora, MD, MHS|443-513-6535|rnaurora@jhmi.edu|
20194866|NCT00294515|Hoffmann-La Roche|Medical Communications|800-821-8590||
20194867|NCT00560066|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20194868|NCT00506441|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20194869|NCT00673400|Cantonal Hospital St. Gallen, Department of Surgery|Ulrich Beutner PhD|+41 71 494 1111|ulrich.beutner@kssg.ch|
20194870|NCT01151410|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20194871|NCT01820585|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
20194872|NCT02544451|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20194873|NCT03358251|Prudentix Ltd.|Head of QA/RA|+972-72-394-22-24|tsipi@prudentix.com|
20194874|NCT02656329|GE Healthcare|Francois Tranquart, M.D., Ph.D.|0-44-1494-543037|francois.tranquart@ge.com|
20194875|NCT01081665|Abbott|Global Medical Services|1-800-633-9110||
20194876|NCT03230877|Fisher & Paykel Healthcare Ltd.|Sarah Gunson|+64 9 574 0123|sarah.gunson@fphcare.co.nz|7675
20194877|NCT03117998|REMD Biotherapeutics, Inc|"Dung Zung Thai, MD, PhD"|415-225-9338|zungthai@remdbio.com|
20194878|NCT01468181|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194879|NCT04664400|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
20194880|NCT03491891|First Hospital of Jilin University|Xiang Wang|+86-13504321434|jdwxiang123@126.com|
20194881|NCT01011153|MELA Sciences, Inc.|Joanna Adrian, Director of Clinical Operatons and Medical Affairs|914-591-3783|adrian@melasciences.com|732
20194882|NCT02688218|Oregon Health and Science University|Joseph El Youssef|503-418-5128|elyoussj@ohsu.edu|
20194883|NCT01081132|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20194884|NCT02297139|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20194885|NCT02577822|Northwestern University|David Manning, MD|312-695-6800|david.manning@nm.org|
20194886|NCT02101385|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20194887|NCT04512430|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20194888|NCT03670004|Jesse Brown VA Medical Center|Dr. Matthew Major|312-503-5731|matthew.major2@va.gov|
20194889|NCT00383110|Ralph H. Johnson VAMC|Leonard Egede, MD, MS|843-789-6670|leonard.egede@va.gov|
20194890|NCT03738423|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20194891|NCT02299089|Camurus AB|Clinical Trial Manager|+46 46 2876 530|Info@Camurus.com|
20194892|NCT00588900|UNC Lineberger Comprehensive Cancer Center|Bert O'Neil, M.D.||bert_oneil@med.unc.edu|
20194893|NCT04949243|Duke University|Saira Siddiqui, MPH|919-688-8464|saira.siddiqui@duke.edu|
20194894|NCT01865747|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20194895|NCT00925353|St. Luke's Mountain States Tumor and Medical Research Institute|Colleen K. Lambertz, MBA, MSN, FNP|208 463 6018|lambertc@slhs.org|
20194896|NCT02199743|UT Southwestern Medical Center|Debra Bushong, MS, LPC|214-648-4653|debra.bushong@utsouthwestern.edu|
20194897|NCT02158052|Massachusetts General Hospital|Thomas Spitzer, MD|6177241124|tspitzer@mgh.harvard.edu|
20194898|NCT02516332|Duke University|Patrick Smith, Ph.D.|919-681-3006|patrick.j.smith@duke.edu|
20194899|NCT03695237|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20194900|NCT00055601|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20194901|NCT00452426|Ethicon Endo-Surgery|James Martin, PhD|513 337-7000||
20194902|NCT03541174|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58844 1977|idorsiaclinicaltrials@idorsia.com|
20194903|NCT00605215|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20194904|NCT04461483|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20194905|NCT00275262|Abbott|Global Medical Services|800-633-9110||
20194906|NCT02002650|Xijing hospital of digestive diseases|Hui Luo|862984771536|fmmulh@163.com|
20194907|NCT02217332|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20194908|NCT01342341|Ernest Gallo Clinic and Research Center|Dr. Jennifer Mitchell, Clinical Project Director|510-985-3921|jmitchell@gallo.ucsf.edu|
20194909|NCT01546636|NorthShore University HealthSystem|Glenn Murphy, MD, Director of Clinical Research|847-570-2760|gmurphy@northshore.org|
20194910|NCT01302067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194911|NCT00266227|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20194912|NCT03573583|University of Florida|Todd Manini|(352) 273-5914|tmanini@ufl.edu|
20194913|NCT00670631|University of Iowa|Guido Tricot, MD, PhD||guido-tricot@uiowa.edu|
20194914|NCT02062593|Imperial College London|Rasha Al-Lamee|+447976276923|r.al-lamee13@imperial.ac.uk|
20194915|NCT04343872|University of Alabama at Birmingham|Dr. Andrea L. Cherrington|205-996-2885|acherrington@uabmc.edu|
20194916|NCT01850446|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20194917|NCT01290315|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@luitpold.com|811
20194918|NCT02295553|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
20194919|NCT01658150|Icahn School of Medicine at Mount Sinia|Dr. Katherine Burdick|212-659-8841|katherine.burdick@mssm.edu|
20194920|NCT03602066|University of Arizona Cancer Center|Jared Robbins, MD|520-626-6724|jrobbins@arizona.edu|
20194921|NCT00621777|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|a_eden_evins@hms.harvard.edu|
20194922|NCT00446043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20194923|NCT01239043|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20194924|NCT01008319|University of Oklahoma|LaTasha Craig, MD|405-271-8787|latasha-craig@ouhsc.edu|
20194925|NCT02929329|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20194926|NCT02121301|Ciurem Pharma Inc|Gosse B. Bruinsma|613-866-9609|gbb@CIUREM.COM|
20194927|NCT04513652|American Genomics, LLC|Martin Uram, MD|848-444-0665|martin@amgenomics.net|
20194928|NCT02663518|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194929|NCT00353522|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20194930|NCT01144052|Ospedale Civico|Claudio Globbi, Dr. med.|+41 91 811 6921|claudio.gobbi@eoc.ch|
20194931|NCT00105001|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20194932|NCT03836716|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20194933|NCT01879722|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20194934|NCT01983254|Duke University|Christopher Cox, PI|9196817232|christopher.cox@duke.edu|
20194935|NCT01954966|University of Pennsylvania|Claudia Iannelli|6104424426|Claudia.iannelli@pennmedicine.upenn.edu|
20194936|NCT00434213|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
20194937|NCT00037830|Thomas Jefferson University|Dr. Jay Schneider|215-503-0370|jay.schneider@jefferson.edu|
20194938|NCT01253304|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20194939|NCT01699503|Indiana University|Dr. Nicole Fowler|317-274-9021|fowlern@iupui.edu|
20194940|NCT00831753|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20194941|NCT01639560|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
20194942|NCT03178643|DCRI|Dr. Steve Taylor|9198245232|steve.taylor@duke.edu|
20194943|NCT02015455|University of Washington|Dr. Sandra K Johnston, PhD, RN Executive Administrative Director- CLEAR Center|206-221-7444|stonesk@uw.edu|
20194944|NCT01467882|Debiopharm International, S.A.|Eija Lundström|:+41 21 3210111|eija.lundstrom@debiopharm.com|
20163540|NCT00667849|Bioventus LLC|Peter Heeckt, MD (CMO)|1-800-396-4325|peter.heeckt@bioventusglobal.com|
20194945|NCT01090479|Northwestern University|Michael Murray, MD|312-926-4444|m.murray8278@gmail.com|
20194946|NCT01631227|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20163541|NCT00782483|University of Arkansas for Medical Sciences/Arkansas Children's Hospital|Dr. Gal Shafirstein|501-364-7546|jboswell@uams.edu|
20163542|NCT03543137|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163543|NCT01135095|Department of Medicine, Cardiology Division, Columbia University Medical Center and New York Presbyterian Hospital, New York|Dr. Andrew J. Einstein|+1 212 305-4275|Andrew.einstein@columbia.edu|
20163544|NCT01052077|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20217470|NCT01903564|University of Wisconsin-Madison|Ronald Wakai, Ph.D.|6082654988|rtwakai@wisc.edu|
20194947|NCT00766363|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
20194948|NCT03292432|University of North Carolina at Chapel Hill|Rachel Goolsby - Research Manager|9198430685|rwgoolsby@unc.edu|
20194949|NCT03398213|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
20194950|NCT01767701|Queen Mary University of London|Professor Gavin Giovannoni||g.giovannoni@qmul.ac.uk|
20194951|NCT04245228|Mayo Clinic|Dr. Cassie Kennedy, PI|1-507-284-2511|kennedy.cassie@mayo.edu|
20194952|NCT00964886|VA San Diego Healthcare System|Joseph H. Atkinson MD|858 552 8585|joseph.atkinson@va.gov|2568
20194953|NCT02758847|University of Pittsburgh|Dr Rabih Chaer|4128023333|chaerra@upmc.edu|
20194954|NCT04587752|Yale University|Dr. Janet Lydecker|2037374299|janet.lydecker@yale.edu|
20194955|NCT02006251|Cleveland Clinic|Wael Barsoum|2164444954|barsouw@ccf.org|
20194956|NCT03500159|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|604-629-9223|clinical@aqxpharma.com|
20194957|NCT03535597|Memorial Healthcare Systerm|Dr. Jianli Niu|954-265-6653|jniu@mhs.net|
20194958|NCT03412747|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20194959|NCT03484273|University of Calgary|Dr. Satish R. Raj|403-210-6152|satish.raj@ucalgary.ca|
20194960|NCT01426867|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20194961|NCT00468104|Midwest Pulmonary and critical care|George Thommi|402 206 7372|tommi4@cox.et|
20194962|NCT00461513|Veterans Health Administration|Dr. Meg Plomondon|303-370-75770|Meg.Plomondon@va.gov|
20194963|NCT02706899|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20194964|NCT00324675|"University Hospital Carl Gustav Carus, Dresden"|Dr. Frank Pistrosch|0049 351 4400580|frank.pistrosch@uniklinikum-dresden.de|
20194965|NCT00381615|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20194966|NCT01670760|3M|Terri White|651-733-0228|twhite3@mmm.com|
20194967|NCT02335710|University of Tennessee|Richard D. Komistek, Ph. D.|8659742093|rkomiste@utk.edu|
20194968|NCT03992131|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
20194969|NCT02432196|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20194970|NCT01905150|Hirschfeld Oncology|Dr. Azriel Hirschfeld|718-732-4050|ah@honcology.com|
20194971|NCT02592876|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20194972|NCT01464775|MercyMC|Dr. Fermin Barrueto|410-321-8452|fbarrueto@mdmercy.com|
20194973|NCT00611975|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
20194974|NCT03465904|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|ClinicalTrial@cefaly.com|
20194975|NCT04625413|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
20194976|NCT01305200|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
20194977|NCT03981861|ChildrensMHC|Tania Burgert|203 676 4545|tsburgert@cmh.edu|
20194978|NCT00432666|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
20163545|NCT01445080|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20163546|NCT03887221|Zambon S.p.A.|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
20194979|NCT00978627|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20194980|NCT00565851|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20163547|NCT00947115|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163548|NCT02487030|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20163549|NCT03857542|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20163550|NCT01985425|Population Health Research Institute|Dr. Philip Devereaux|905-527-4322|philipj@mcmaster.ca|40654
20163551|NCT04649177|BostonSight|Daniel Brocks, MD|(781)726-7337|ecrowley@bostonsight.org|
20163552|NCT01594931|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
20163553|NCT00597402|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
20163554|NCT04864639|Duke University|Leonor Corsino, MD, MHS|919-684-4005|leonor.corsinonunez@duke.edu|
20163555|NCT01860287|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20163556|NCT02848222|University of Alabama at Birmingham|Dr Jason Nichols|205-975-3497|jjn@uab.edu|
20163557|NCT01478971|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20163558|NCT01525615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163559|NCT04050618|CooperVision, Inc.|Jose A. Vega, O.D., MSc, FAAO|925-621-3761|javega@coopervision.com|
20163560|NCT05561582|University of Central Florida|Abigail Wilson|407-823-1026|Abigail.Wilson@ucf.edu|
20163561|NCT01026012|University of Maryland Cardiology|Dr. Scott Jerome|410-876-0086|sjerome@medicine.umaryland.edu|
20194981|NCT03730480|Ascensia Diabetes Care|Pragathi Shelat|1 (862) 229-6679|pragathi.shelat@ascensia.com|
20194982|NCT01587027|Medical Center of the Rockies|Gary Luckasen, M.D.|(970)624-1686|gary.luckasen@uchealth.org|
20194983|NCT01164644|University of Wisconsin School of Medicine and Public Health|Dr. Scott R. Chaiet|(608) 263-1092|scottchaiet@yahoo.com|
20194984|NCT00704379|Baylor College of Medicine|Dr. Ricardo Jorge|713-794-7010|Ricardo.Jorge@bcm.edu|
20194985|NCT01534689|Regulatory Insight, Inc.|Clinical Consultant|6157129743|elvira@reginsight.com|
20194986|NCT00006011|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20194987|NCT00911937|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20194988|NCT02796625|University of Maryland Baltimore|Dr. David Seminowicz|14107063476|dseminowicz@umaryland.edu|
20194989|NCT02057523|Loyola University Medical Center|Sanjeev Akkina|7082166389|sanjeev.akkina@lumc.edu|
20194990|NCT01263665|W.L. Gore & Associates|Keli Sapp|9288643964|kesapp@wlgore.com|
20194991|NCT01435616|Eli Lilly and Company|Chief Medical Officer|800 545 5979||
20194992|NCT04771611|Mayo Clinic|James L. Kirkland, M.D., Ph.D.|507-538-3817|Kirkland.James@mayo.edu|
20194993|NCT00396019|AstraZeneca|Dr. Regina Jakacki||regina.jakacki@astrazeneca.com|
20194994|NCT04811131|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
20194995|NCT04718779|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20194996|NCT00003453|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20194997|NCT00620282|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20194998|NCT02217475|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20194999|NCT02615002|Neurim Pharmaceuticals|Tali Nir, DVM, VP Clinical and Regulatory Affairs|+972-3-7684902|talin@neurim.com|
20195000|NCT04738292|Froedtert / Medical College of Wisconsin|Sailaja Kamaraju, MD, MS|414-805-4600|skamaraju@mcw.edu|
20195001|NCT00371683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20195002|NCT02601976|Getz Pharma|Mr. Jaffer Bin Baqar|111111511|jaffer.baqar@getzpharma.com|2710
20195003|NCT03181789|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20195004|NCT01131182|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195005|NCT03001076|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20195006|NCT04602221|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20195007|NCT01080716|Vaccine Trial Treatment Center, Mahidol University|Punnee Pitisutithum, MBBS, DTM&H, FRCPT|66-2-643-5599|tmppt@mahidol.ac.th|
20195008|NCT01056718|Mercy Hospital East Communities|Denise Janosik, MD|314-251-3920|Denise.Janosik@mercy.net|
20195009|NCT02270515|University of Illinois, Chicago|Dr. Denise M. Hynes, Professor, College of Medicine|312-355-0083|dhynes@uic.edu|
20195010|NCT01139580|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163562|NCT00948753|University of Pennsylvania Abramson Cancer Center|David Porter|215-662-2862|david.porter@pennmedicine.upenn.edu|
20195011|NCT00633880|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20195012|NCT00700778|Fox Chase Cancer Center|Dr. Jose Russo|215-728-4782|Jose.Russo@fccc.edu|
20195013|NCT00350103|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20195014|NCT02842151|Alcon, A Novartis Division|Senior Global Brand Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20195015|NCT02559895|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20195016|NCT00878826|Stanford University|Dr. Deirdre Lyell|650-736-1191|dlyell@stanford.edu|
20195017|NCT04540887|Wake Forest Institute for Regenerative Medicine|Dr. Stephen Walker|33-713-7272|swalker@wakehealth.edu|
20195018|NCT00760474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20195019|NCT00513305|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
20195020|NCT01262027|The University of Texas (UT) MD Anderson Cancer Center|Vicente Valero, MD/Professor, Breast Medical Oncology|713-792-7734|vvalero@mdanderson.org|
20195021|NCT03014479|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20195022|NCT03419832|Wake Forest School of Medicine|Joseph E. Andrews, Jr., PhD, CIP, CCRP|336-716-7658|jandrews@wakehealth.edu|
20195023|NCT02217501|UT Southwestern Medical Center|Subhash Banerjee, MD|214-857-1608|Subhash.Banerjee@utsouthwestern.edu|
20195024|NCT01394978|Davol, Inc.|Dawn Heimer, PhD|+1-401-825-8681|Dawn.Heimer@CRBard.com|
20195025|NCT02019667|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
20195026|NCT01942785|Email contact via H. Lundbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
20195027|NCT05121246|mAbxience Research S.L.U.|Dr. Susana Millán|+34 682821346|susana.millan@mabxience.com|
20195028|NCT05453201|James J. Peters Veterans Affairs Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
20195029|NCT01934790|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20195030|NCT04688320|"LLC SuperGene"|Dr. Sergey Markin|(495) 287-98-07|info@supergene.ru|+7
20195031|NCT03798691|UW School of Medicine and Public Health|Freddy Caldera, DO|608-628-8201|fcaldera@medicine.wisc.edu|
20195032|NCT00552929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195033|NCT04155203|Padagis|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
20195034|NCT02368457|Oral and Maxillofacial Surgeon|Dr. Miriam Martos|+34932746179|miryam.martos@gmail.com|
20195035|NCT01147536|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
20195036|NCT03762200|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
20195037|NCT03387137|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(410) 614-1880|swoods12@jhu.edu|
20195038|NCT05559476|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20195039|NCT05110690|Washington University School of Medicine|Michael Avidan, MBBCh, FCASA|314-273-4136|avidanm@wustl.edu|
20195040|NCT04058366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20195041|NCT02594163|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20195042|NCT04497142|Brigham and Women's Hospital|Steven Tobochnik, MD|617-732-7432|stobochnik@bwh.harvard.edu|
20195043|NCT02233543|Novartis Pharmaceuticals|Study Director|862-778-8300||
20195044|NCT00603304|University of Alabama at Birmingham|Dr. Alan Cantor|(205) 934-6887|acantor@uab.edu|
20195045|NCT01076192|AbbVie|Global Medical Information|800-633-9110||
20195046|NCT01034176|Brigham and Women's Hospital|Dr. Anil Chandraker|617-525-8203|achandraker@partners.org|
20195047|NCT00715962|Birmingham VAMC|Cynthia J. Brown, MD, MSPH|205-933-8101|cynthia.brownd44b2@va.gov|7300
20195048|NCT05087979|Virginia Commonwealth University|Vishal Yajnik, MD, MS|804-663-3519|vishal.yajnik@vcuhealth.org|
20195049|NCT00616902|Abbott|Global Medical Services|800-633-9110||
20195050|NCT01135537|Sickkids|Dr Tal Schechter-Finkelstein|4168136906|tal.schechter-finkelstein@sickkids.ca|
20195051|NCT02680002|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
20195052|NCT00705679|University of Washington|Jeanne Marrazzo, MD, MPH, FACP, FIDSA|206-744-3679|jmm2@uw.edu|
20195053|NCT00759915|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
20195054|NCT03245151|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20195055|NCT04772898|Creighton University|Anastasia Kyvelidou|4022805749|aky61380@creighton.edu|
20195056|NCT02470910|DFCI/BWH|Anthony D'Amico|8572151489|adamico@bwh.harvard.edu|
20195057|NCT00560560|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195058|NCT01854138|ProMedica|Karl J. Beer, MD|419-578-4260|karl.beer@promedica.org|
20195059|NCT01004848|Icahn School of Medicine at Mount Sinai|Carol R. Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
20195060|NCT00768079|MedImmune, LLC|Joseph M. Parker, Director, Clinical Development|+1 301-398-4095|information.center@astrazeneca.com|
20195061|NCT01498679|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195062|NCT02483000|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
20195063|NCT03212989|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
20163563|NCT00655538|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
20163564|NCT02451943|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20195064|NCT00795366|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-585-1178|kproctor@med.miami.edu|
20195065|NCT00158860|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195066|NCT03047395|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20195067|NCT01145209|National Heart Lung and Blood Institute|Wiestner, Adrian MD, PhD|+1.301.594.6855|wiestnea@nhlbi.nih.gov|
20195068|NCT04560010|NYU Langone|Arthur Hertling, MD|212-263-5072|Arthur.hertling@nyulangone.org|
20195069|NCT01871805|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20195070|NCT00564889|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20195071|NCT00635427|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20195072|NCT03097484|University of Kentucky|John Bauer, MD|859-218-2927|john.bauer@uky.edu|
20195073|NCT04860297|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20195074|NCT00741390|Becton Dickinson|Kenneth Kassler-Taub, VP Medical Affairs|201-847-7009|kenneth_kassler_taub@bd.com|
20217471|NCT00981227|Bial-Portela & Cª, S.A.|Head of Clinical Research Section|+351 22 986 6100|clinical.trials@bial.com|
20217472|NCT00985231|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.t.reindel@bausch.com|
20195075|NCT02703259|Christiana Care Health Systems|Dr. Terri Huynh|302-623-4410|terri.huynh@christianacare.org|
20163565|NCT03633344|Omnifarma Kyiv LLC|Oleg Kurchenko|+380503319653|Kurchenko@omnifarma.kiev.ua|
20163566|NCT00217425|ECOG Statistical Office|Study Statistician|617-632-3012||
20163567|NCT03951077|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20163568|NCT00681889|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|Cornea_Research@meei.harvard.edu|
20163569|NCT01473732|Montefiore Medical Center|Dr. Enver Akalin, Medical Director Kidney Transplant|718-920-4815|eakalin@montefiore.org|
20163570|NCT01395901|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
20163571|NCT01798966|Hamilton Glaucoma center|Anjali Parekh|+1858 822-1553|anjalism@gmail.com|
20163572|NCT01165983|Beth Israel Deaconess Medical Center|Aristidis Veves, Research Director|617-632-7075|aveves@bidmc.harvard.edu|
20163573|NCT01217944|Novartis Pharmaceuticals|Study Director|862-778-8300||
20163574|NCT03579940|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20163575|NCT00671034|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20163576|NCT00713544|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20163577|NCT00797277|National Taiwan University Hospital|Dr. Tzung-Jeng Hwang|+886-2-23123456|tjhwang@ntu.edu.tw|66792
20163578|NCT02471014|University of Florida|Mathew Sebastian, PhD|8644901978|mathewsebastian@ufl.edu|
20163579|NCT02380287|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20163580|NCT04473963|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
20163581|NCT01641601|UCSF|Kirsten Salmeen|628-213-5314|kesalmeen@gmail.com|
20163582|NCT00587158|Mayo Clinic|Hatem Amer, MD, FASN; Assistant Professor of Medicine; Division of Nephrology and Hypertension|507-256-1963|amer.hatem@mayo.edu|
20163583|NCT01284517|Sunovion|Medical Director, CNS|1-866-503-6351||
20163584|NCT01165541|Geisel School of Medicine At Dartmouth|Mary Brunette, MD|603-271-7642|mary.brunette@dartmouth.edu|
20163585|NCT04390243|Cedar Sinai Medical Center|Andrew Hendifar, M.D.|310-423-2217|Andrew.Hendifar@cshs.org|
20163586|NCT01314001|University of Pennsylvania|Paul M. Sanborn, M.S.|215-746-7150|sanborn@mail.med.upenn.edu|
20163587|NCT01196026|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163588|NCT02486016|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchomb (PI)|410-706-2646|astinchc@rx.umaryland.edu|
20163589|NCT00799903|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163590|NCT00632619|Florida International University|James G Waxmonsky|305 348 3258|jwaxmons@fiu.edu|
20163591|NCT01221350|Centro Universitario de Ciencias de la Salud, Mexico|Fernando R Siller Lopez, Ph.D.|523310585200|fsiller@cucs.udg.mx|33723
20163592|NCT05919888|SSMHealth SLUCare Physician Group|Dr. Randall Otto|314-614-2970|randall.otto@slucare.ssmhealth.com|
20163593|NCT02715609|Washington University School of Medicine|Dr. Jiayi Huang|314-362-8516|jiayi.huang@wustl.edu|
20163594|NCT03838978|Moximed, Inc.|Alexandra Kraenzlin, Director of Clinical Affairs|+41 44 515 62 06|akraenzlin@moximed.com|
20163595|NCT05236257|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20163596|NCT04752332|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20163597|NCT01895946|AstraZeneca UK Limited|Dr Justin P. O. Lindemann, MBChB MBA, Medical Science Director, AZD5363|(0)7920 250301|Justin.Lindemann@astrazeneca.com|+44
20163598|NCT00924443|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20163599|NCT03559933|Stimdia Medical, Inc.|Tim Miller|612.940.3454|tmiller@stimdia.com|
20163600|NCT02451124|Case Comprehensive Cancer Center|Amitabh Chak|2168443217|axc22@cwru.edu|
20163601|NCT03301350|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
20163602|NCT01248949|MedImmune, LLC|Mohammed Dar, MD|301-398-0000|information.center@astrazeneca.com|
20163603|NCT00286429|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20163604|NCT01973413|Univeristy of VIrginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20163605|NCT01746225|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
20163606|NCT00942825|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
20163607|NCT03245775|University of Virginia|Dr. Jamie Zoellner, Professor of Public Health Sciences|4349624488|jz9q@virginia.edu|
20163608|NCT03401671|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20163609|NCT02713828|ECOG Stats Center|Dr Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
20163610|NCT02451514|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163611|NCT03302247|Fox Chase Cancer Center|Martin Edelman|215-728-5682|Martin.Edelman@fccc.edu|
20163612|NCT03197376|PATH|Dr. Steve Lamola|+ 1 206.302.6067|slamola@path.org|
20163613|NCT01092910|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
20163614|NCT01773187|CTI BioPharma Corp.|Beth Ziemba|206-272-4347|bziemba@ctibiopharma.com|
20163615|NCT02978833|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
20163616|NCT01123395|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20163617|NCT03691571|The Hospital of the University of Pennsylvania|Dr. Cory M. Tschabrunn|215-614-0482|coryt@pennmedicine.upenn.edu|
20163618|NCT01606709|UConnHealth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
20195076|NCT02971761|Department of Medical Oncology, City of Hope|Yuan Yuan, MD, PhD.|626-256-4673|yuyuan@coh.org|89200
20163619|NCT03937713|VA ORD|Associate Chief of Staff for Research|716-862-6528|ali.el-solh@va.gov|
20163620|NCT03652181|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|(773) 702-8996|astadnik@bsd.uchicago.edu|
20163621|NCT00988013|University of Illinois at Chicago|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
20163622|NCT00922623|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
20163623|NCT02420379|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
20163624|NCT00086047|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|Susmita.Kashikar-Zuck@cchmc.org|
20163625|NCT03923790|The University of Texas Health Science Center at Houston|Anjail Sharrief, MD, MPH, Associate Professor|713-500-6538|anjail.z.sharrief@uth.tmc.edu|
20163626|NCT02279667|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20163627|NCT00269919|Janssen Korea Ltd., Korea|Medical CRA|+82-2-2094-4804||
20163628|NCT00786799|University of California, San Francisco|Robert L. Hendren, D.O.|415-476-7198|robert.hendren@ucsf.edu|
20163629|NCT02123849|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
20163630|NCT00950846|Baylor College of Medicine/Texas Children's Hospital|Dr. Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
20195077|NCT00662818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163631|NCT01717872|Women and Children's Hospital of buffalo|Dr. Jerrold Lerman|716 878 7701|jerrold.lerman@gmail.com|
20163632|NCT01799226|UMichigan|Janet Kinney|734-615-5452|kinneyj@umich.edu|
20163633|NCT02178995|Stanford University|Jesse Adams, MD|2069144771|jadamsuw@stanford.edu|
20163634|NCT00981461|Lexington International, LLC|David Michaels|5614170200|dm@hairmax.com|
20163635|NCT03187119|West Virginia University|Dr. Christina Duncan|304-293-1289|Christina.Duncan@mail.wvu.edu|
20163636|NCT03361293|University of Minnesota|Jeffrey Wozniak, PhD, LP|612-273-9741|jwozniak@umn.edu|
20163637|NCT00483405|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20163638|NCT00571038|Clement J. Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
20163639|NCT01426958|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163640|NCT02631551|Glenmark Pharmaceuticals Ltd.|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20163641|NCT02968368|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20163642|NCT00040443|RespireRx Pharmaceuticals|Richard Purcell|732-492-1797|rpurcell@respirerx.com|
20163643|NCT02073682|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
20163644|NCT01965704|Stanford University|David Drover|650-725-0364|ddrover@stanford.edu|
20195078|NCT02442336|Fox Chase Cancer Center|Carolyn Fang|215-728-4062|carolyn.fang@fccc.edu|
20195079|NCT00998790|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
20195080|NCT01302860|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20195081|NCT01237587|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20195082|NCT01942590|Duke University Health System|Dwight Koeberl, M.D., Ph.D.|919-684-2036|dwight.koeberl@duke.edu|
20195083|NCT01011387|Mölnlycke Health Care AB|Jenny Thorell|0046 31 7223000|jenny.thorell@molnlycke.com|
20195084|NCT01142115|Clinical Regulatory Development, Global R&D|Trine Møller Kruse|+4549112174|dktrm@coloplast.com|
20195085|NCT03208036|Minneapolis VA Health Care System|Tasha Nienow|612-467-1004|tasha.nienow@va.gov|
20195086|NCT03406078|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
20195087|NCT00453193|The University of Texas M D Anderson Cancer Center|Farhad Ravandi-Kashani MD/Associate Professor|713-745-0394|eharriso@mdanderson.org|
20195088|NCT03661762|Norfolk and Norwich University Hospitals NHS Foundation Trust|Mr John Phillips|: +44 1603 593054|john.phillips@mac.com|
20195089|NCT01879553|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20195090|NCT00591851|Memorial Sloan-Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
20195091|NCT00438672|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
20195092|NCT00320528|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20195093|NCT01099475|Maastricht University Medical Centre|Dr. MAJ van den Broek, MD|31 43 3884502|m.vandenbroek@maastrichtuniversity.nl|
20195094|NCT01030406|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
20195095|NCT00610740|Masonic Cancer Center, University of Minnesota|Levi Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
20195096|NCT01781078|Boston Scientific|Kelly Aspinwall|651-582-4560|Kelly.Aspinwall@bsci.com|
20195097|NCT00531453|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
20195098|NCT03748992|Medical University of South Carolina|Patrick Flume, MD|843-792-3167|flumepa@musc.edu|
20195099|NCT03924765|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
20195100|NCT05038163|NBER|Sarah Holmes Berk|617-588-1445|sholmes@nber.org|
20195101|NCT03562975|University Of South Florida|Clinical Research Manager|18139749423|amjackson@usf.edu|
20195102|NCT00728910|University of Pennsylvania|Richard Dunbar MD|215-662-9024|richard.dunbar@uphs.upenn.edu|
20195103|NCT00669279|University of Florida|Dr. Benjamin J Epstein|3523590945|epstein@cop.ufl.edu|
20195104|NCT00835900|Roswell Park Cancer Institute|Dr. Martin Mahoney|7168452300|martin.mahoney@roswellpark.org|
20195105|NCT01758900|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
20195106|NCT03122691|Johns Hopkins University School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20195107|NCT00935818|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
20195108|NCT01846494|Duke Clinical Research Institute|Allison DeLong|919-668-6855|allison.delong@duke.edu|
20163645|NCT00061893|Children's Oncology Group|Results Reporting Coordinator||resultsreportingcoordinator@childrensoncologygroup.org|
20163646|NCT01526213|UNC-Chapel Hill|Mary F. Paine, RPh, PhD|919-966-9984|mpaine@unc.edu|
20195109|NCT00117845|National Cancer Institute, National Institutes of Health|Thomas Waldmann, M.D.|301-496-6656|tawald@mail.nih.gov|
20195110|NCT03527173|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20195111|NCT02856828|Duke University Health Systems|Dr. Rachel Reilly|919-668-0291|rachel.reilly@duke.edu|
20195112|NCT01248780|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
20195113|NCT04097301|AGC Biologics|Anna Stornaiuolo|0221277440|astornaiuolo@agcbio.com|
20195114|NCT01227577|Novartis|Study Director|862-778-8300||
20195115|NCT02480153|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195116|NCT00107120|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Daniel Ventura, PhD|201-427-8252|daniel.ventura@frx.com|
20195117|NCT03241225|Weill Cornell Medicine|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
20195118|NCT00852540|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195119|NCT01639495|Biosense Webster, Inc.|Robert Stagg, PhD, Manager, Clinical Franchise|(949) 450-7779|rstagg@its.jnj.com|
20195120|NCT01119105|Nabriva Therapeutics|Jennifer Schranz, M.D., Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
20195121|NCT03296033|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-6344|dhenshaw@wakehealth.edu|
20195122|NCT04214600|Cairo University|Dr. Nadine Mansour|(+2)01001482455- 01001465719|lotfynadine@gmail.com|
20195123|NCT02935452|University of Southampton|Ms Lindsay Welch|07881205106|lw13e14@soton.ac.uk|
20195124|NCT00435591|Astellas Pharma Global Development|Senior Medial Director, Medical Affairs||clinicaltrials@us.astellas.com|
20195125|NCT02618915|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
20195126|NCT00210470|University of Michigan Hospital|Gregory T. Wolf||gregwolf@umich.edu|
20217473|NCT00838981|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20163647|NCT04498143|University of Denver|Dr. Kathryn Fox|3015202715|Kathryn.Fox@du.edu|
20195127|NCT01635920|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
20163648|NCT06260670|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
20163649|NCT00195039|Weill Cornell Medicine|Scott Tagawa, MD||guonc@med.cornell.edu|
20195128|NCT01664598|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20195129|NCT00686725|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20195130|NCT00092495|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20195131|NCT02778932|University Hospital Schleswig-Holstein, Campus Kiel|Priv.-Doz. Dr. med. Axel Fudickar|0049500|axel.fudickar@uksh.de|20801
20195132|NCT03182725|University of California - San Diego Health|Dr. Pam Taub|858-246-2342|ptaub@health.ucsd.edu|
20195133|NCT03103763|Penobscot Bay Medical Center|Caroline Knight, RN, Clinical Research Manager|207-301-8959|cknight@pbmc.org|
20195134|NCT00938470|Mayo Clinic|Steven R Alberts MD MPH|507-284-4918|alberts.steven@mayo.edu|
20195135|NCT00936741|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20195136|NCT03356626|Seoul National University Hospital, Seoul National University College of Medicine|Seong-Ho Kong|+82-2-2072-4199|seongho.kong@snu.ac.kr|
20195137|NCT01346475|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
20195138|NCT01552603|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
20195139|NCT00618618|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20195140|NCT01183234|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20195141|NCT03250234|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
20195142|NCT00309959|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
20195143|NCT02947087|MUSouthCarolina|Hongjun Wang, PhD|8437921800|wangho@musc.edu|
20195144|NCT01160289|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20195145|NCT02876159|Emory University|Dr. Mark J. Mulligan, M.D., F.I.D.S.A|404-712-1370|mmulli2@emory.edu|
20195146|NCT01844687|Columbia University Medical Center|Margaret Haney, PhD., Professor|(646) 774-6153|mh235@columbia.edu|
20195147|NCT02235831|Alcon Research, Ltd.|Sr. Global Brand Lead, GCRA, Vision Care|1-888-451-3937||
20195148|NCT02029872|Johns Hopkins University School of Nursing|Dr. Jason Farley|4105027563|jfarley1@jhu.edu|
20195149|NCT01963923|Complejo Hospitalario Universitario A Coruña|Esther Gimenez Moolhuyzen|679336288|raquel.sebio@udc.es|
20195150|NCT02065687|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
20195151|NCT00938860|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20195152|NCT01605019|Houston Methodist Research Institute|Raquel R Bunge|713-441-3912|rrbunge2@houstonmethodist.org|
20195153|NCT01464840|University of Alabama at Birmingham|Amelia Sutton, M.D., Ph.D.|205-934-5612|alsutton@uab.edu|
20195154|NCT00324116|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20195155|NCT02624791|UVa Center for Behavioral Medicine Research|Project Coordinator|434-924-8656|tab2v@hscmail.mcc.virginia.edu|
20195156|NCT01642251|ECOG-ACRIN Cancer Research Group|Study Statistician||eatrials@jimmy.harvard.edu|
20195157|NCT01993927|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20195158|NCT00895154|Washington University|Dr. Allison King|314-454-4291|king_a@wustl.edu|
20195159|NCT00287690|Imperial College London|Dr Carolyn Webb|+44 3301288121|c.webb@imperial.ac.uk|
20195160|NCT01146782|ApniCure, Inc.|Andrea Brown, Director, Clinical Affairs|650-361-9000|abrown@apnicure.com|122
20195161|NCT00470366|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, MD|646-422-4491|feldmand@mskcc.org|
20195162|NCT02414932|Trinity College Dublin|Dr Martha Finnegan|0035312493385|mfinneg@tcd.ie|
20195163|NCT00540046|Basic Health International|Miriam Cremer MD MPH|(646) 593-8694|miriam.cremer@gmail.com|
20195164|NCT02478710|Premier Health|Director of Clinical Research|19374747850|jllader@premierhealth.com|
20195165|NCT01021215|University of Texas (UT) MD Anderson Cancer|Dr. Powel H. Brown, MD Anderson Phase I/II Prevention Consortium|(713) 745-3672|CR_Study_Registration@mdanderson.org|
20195166|NCT04887064|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20163650|NCT01843023|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
20163651|NCT00466921|Northwestern University|Clinical Trials Office|312-695-1301||
20217474|NCT02994290|Yale University|Dr. Sangini Sheth|203-785-5545|Sangini.Sheth@yale.edu|
20195167|NCT03417895|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yuanchao Wang; SPM|86-18036618707|yuanchao.wang@hengrui.com|
20195168|NCT04548544|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|Olga.Tymofiyeva@ucsf.edu|
20195169|NCT00867308|Johns Hopkins University|Amy DeZern, MD|4105027208|adezern1@jhmi.edu|
20195170|NCT00604825|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195171|NCT05593445|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20195172|NCT03647488|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20195173|NCT00812331|Janssen Research & Development United States|Global Clinical DVLP Manager||ClinicalTrialDisclosure@its.jnj.com|
20195174|NCT01506453|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
20195175|NCT03694275|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20195176|NCT02502799|Florida International University|Dr. William E. Pelham Jr.|305-348-3002|wpelham@fiu.edu|
20195177|NCT01783847|Iran university of Medical Sciences|Mohsen Bahmani Kashkouli|00989121777003|mkashkouli2@gmail.com|
20195178|NCT03706313|Duke University|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
20195179|NCT00153062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195180|NCT00690040|Hemek Medical center|Dr. Raed Salim|97246494031|salim_ra@clalit.org.il|
20195181|NCT01304238|GlaxoSmithKline|GSK Response Cente|866-435-7343||
20195182|NCT02340767|National Dental PBRN|Dr. Sonia Makhija|2059965298|smakhija@uab.edu|
20195183|NCT01589237|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20195184|NCT01621737|UCSD|David Feifel|(858) 412-4130|dfeifel@kadimanp.com|
20195185|NCT01022268|Imperial College London|Dr Jethro Herberg|+44 - 0207 594 3990|j.herberg@imperial.ac.uk|
20195186|NCT00734097|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20195187|NCT00910689|Ohio University|Kenneth Holroyd|(740) 593-1085|holroyd@ohio.edu|
20195188|NCT01764685|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
20195189|NCT03207009|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
20195190|NCT00645801|retired|Director of Gastrointestinal Research||anngimd@icloud.com|
20195191|NCT04259645|UPMC Department of Anesthesiology and Perioperative Medicine|Anna Uskova, MD|412-623-2167|uskoaa@upmc.edu|
20195192|NCT01403610|UT Health San Antonio|Andrew Brenner|210-450-1000|regulatoryaffairs@uthscsa.edu|
20195193|NCT00203476|TuscaloosaREAC|Raela Williford, PharmD|(205) 554-2000|Raela.Williford@va.gov|2433
20195194|NCT01190514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20195195|NCT02080312|UCSD|Julie Bykowski|619-543-6766|jbykowski@ucsd.edu|
20195196|NCT02550470|Rutgers - New Jersey Medical School|Dr. Eloy, PI|973 972 5007|eloyje@njms.rutgers.edu|
20195197|NCT01775475|AIDS Malignancy Consortium Statistical and Data Analysis Center|Study Statistician|(212) 659-9558|amcpm@emmes.com|
20195198|NCT03076333|Joint UNC/NC State Department of Biomedical Engineering|David S Lalush|919-513-7671|dslalush@ncsu.edu|
20195199|NCT00896051|Tibotec|Senior Director|+32 (0) 14 641 265||
20195200|NCT01813929|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20195201|NCT00007345|National Cancer Institute|Dr. Kieron Dunleavy|301-435-1007|DunleavK@mail.nih.gov|
20195202|NCT04433585|Nektar Therapeutics|Study Director|8554828676|StudyInquiry@nektar.com|
20195203|NCT02074553|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20195204|NCT00194987|Weill MC|Dr James Bussel|917-291-5091|jbussel@med.cornell.edu|
20195205|NCT02342743|CEFALY Technology|Clinical Trials Department director|+3243676722|info@cefaly.com|
20163652|NCT00587678|University of Virginia|Dr Christopher Kramer|434-243-0736||
20195206|NCT04875676|Vaxart|Vice President Regulatory|(650) 747-6028|mdrayton@vaxart.com|
20195207|NCT02454179|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
20195208|NCT01970345|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
20195209|NCT01488877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195210|NCT00955253|Imperial College London|Dr Paresh Malhotra|0208 846 1234|p.malhotra@imperial.ac.uk|
20195211|NCT04797650|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20195212|NCT00703937|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20195213|NCT03840915|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20195214|NCT00822172|CPC Clinical Research|William Hiatt, MD, President|3038609900|william.hiatt@cpcmed.org|
20195215|NCT00700258|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195216|NCT00473265|Columbia University Medical Center|John P. Bilezikian MD|212-305-2663|jpb2@columbia.edu|
20195217|NCT01156792|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195218|NCT01097707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20195219|NCT01236534|University of Rochester|Andrew Goodman, MD|585-275-7854|andrew_goodman@urmc.rochester.edu|
20195220|NCT03139669|University of Virginia|Dr. Emma Mitchell Associate Professor|4342433962|emm6z@virginia.edu|
20195221|NCT03775434|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
20195222|NCT01621568|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@mail.nih.gov|
20195223|NCT01859988|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20195224|NCT01226095|Abbott|Global Medical Services|800-633-9110||
20217475|NCT02913131|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
20163653|NCT05282927|Durham VA Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Dr. Kelli Allen|919-286-0411|Kelli.Allen@va.gov|177090
20195225|NCT01688830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195226|NCT04822597|University of Wisconsin School of Medicine and Public Health|Heather B Neuman, MD, MS, FACS|(608) 263-7064|neuman@surgery.wisc.edu|
20195227|NCT01285609|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20195228|NCT03283072|University of Florida|Mark Bishop|3522736112|bish@ufl.edu|
20195229|NCT02552368|Washington University School of Medicine - Department of Neurology|Dr. Thy Huskey|314-362-4503|huskeyt@wustl.edu|
20195230|NCT00911768|Kyung Hee East-West Neo Medical Center|Jae-Woo Park, KMD, PhD|+082-02-440-6219|pjw2907@khu.ac.kr|
20195231|NCT02734953|Allegheny Health Network|Dr Raymond Benza|412-359-3131|raymond.benza@ahn.org|
20195232|NCT00515853|University of Southampton|Sophie A. Pilkington|+44 (0)23 8059 5058|rgioinfo@soton.ac.uk|
20195233|NCT04041453|Universidad Nacional de Salta|Alejandro J Krolewiecki|+54 911 3183-8673|alekrol@hotmail.com|
20195234|NCT02819557|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20195235|NCT02631577|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20195236|NCT00979134|AstraZeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
20195237|NCT02924428|Venus Concept Ltd.|Director, Clinical Affairs|416-222-6144|mgronski@venusconcept.com|517
20195238|NCT00932113|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
20195239|NCT00512317|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20195240|NCT04390022|Barcelona Institute for Global Health|Carlos Chaccour|0034666293112|carlos.chaccour@isglobal.org|
20195241|NCT03064035|Methodist Hospital|Zachary Stoecker, PharmD|952-977-5520|Zachary.Stoecker@parknicollet.com|
20195242|NCT01143038|Amgen Inc.|Study Director|866-572-6436||
20195243|NCT00618982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20195244|NCT03346161|Washington University School of Medicine|Mary C. Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
20195245|NCT04289051|Sunstar Americas, Inc.|Akane Takemura|18477944276|akane.takemura@us.sunstar.com|
20195246|NCT00717067|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20195247|NCT00657020|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163654|NCT02741635|Fisher & Paykel Healthcare Ltd.|Christine Lambert|+64 9 574 0123|christine.lambert@fphcare.co.nz|7172
20217476|NCT00983476|VA Greater Los Angeles Healthcare System, Los Angeles, CA|Dr. Alexander S. Young|310-794-7219|alexander.young@va.gov|
20217477|NCT01175473|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20217478|NCT01083680|AbbVie|Global Medical Information|800-633-9110||
20217479|NCT01352182|Cincinnati Children's Hospital Medical Center|Jennifer Kaplan|513-636-4259|jennifer.kaplan@cchmc.org|
20217480|NCT00003531|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20217481|NCT00588731|Yale University|Mohini Ranganathan, M.D.|203-932-5711|mohini.ranganathan@yale.edu|2546
20217482|NCT00346164|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
20217483|NCT03297294|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20217484|NCT01198873|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
20217485|NCT04569786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217486|NCT02692482|Istituto Ortopedico Rizzoli|Cristiana Forni|0516366694|cristiana.forni@ior.it|0039
20217487|NCT01841216|Sport & Spine Rehab Clinical Research Foundation|Jena Etnoyer, Clinical Research Coordinator|240-766-0300|jetnoyer@ssrehab.com|838
20217488|NCT00133679|University of California, San Francisco|Roberta Keller, MD|(415) 476-1888|roberta.keller@ucsf.edu|
20217489|NCT01955044|NorthShore University HealthSystem|Brandy L Frost|847-570-2033|bfrost@northshore.org|
20217490|NCT02376257|Boston UCRC|Michael Otto, PhD|617-353-9610|mwotto@bu.edu|
20217491|NCT02260258|BIDMC|Mike Donnino|6177542882|mdonnino@bidmc.harvard.edu|
20217492|NCT00690482|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
20217493|NCT00724373|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20217494|NCT01393457|The University of Texas Health Science Center at Houston|Charles Green, PhD|713-500-6402|charles.green@uth.tmc.edu|
20217495|NCT00925301|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20217496|NCT03043560|Icahn School of Medicine at Mount Sinai|Dr, James Murrough|212-585-4640|james.murrough@mssm.edu|
20217497|NCT00438659|Mayo Clinic|Robert C. Miller, M.D.||miller.robert@mayo.edu|
20217498|NCT05766787|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20195248|NCT02190045|CAVHS/ UAMS|Kalpana Padala, MD|501-257-1000|kppadala@uams.edu|
20195249|NCT00370331|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195250|NCT02937454|Vifor (International) AG.|FER-CARS-06 Clinical Study Team|+41 588 518 000|FER-CARS-06.study@viforpharma.com|
20195251|NCT02192879|Duke University Medical Center|Elizabeth Malinzak, MD|919-681-9660|elizabeth.malinzak@duke.edu|
20195252|NCT00993668|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
20195253|NCT01833845|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|104
20195254|NCT04955444|The Methodist Hospital Research Institute|Elsie Rizk|7134412557|erizk@houstonmethodist.org|
20195255|NCT03606668|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
20195256|NCT01014143|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20195257|NCT03699085|University of Washington|Lauren Whiteside, Primary Investigator|206-744-8464|laurenkw@uw.edu|
20217499|NCT02056652|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
20217500|NCT00292227|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20217501|NCT01114581|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
20217502|NCT03253094|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
20195258|NCT03215810|Moffitt Cancer Center|Ben Creelan, MD|813-745-4541|ben.creelan@moffitt.org|
20217503|NCT00576303|F. Hoffmann-La Roche AG|Name/Official Title:Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20217504|NCT00824369|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217505|NCT00442546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20217506|NCT00392782|Masonic Cancer Center, University of Minnesota|Daniel Weisdorf, M.D.|612-624-0123|weisd001@umn.edu|
20217507|NCT00101413|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20217508|NCT00858013|Ajou University|Kwan Woo Lee|82-31-219-4526|lkw65@ajou.ac.kr|
20217509|NCT05427045|UArkansas|Dr. Santos-Horta|507-250-5880|ESantoshorta@uams.edu|
20217510|NCT02521181|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|(216) 444-9938|gassmaj@ccf.org|
20217511|NCT01598545|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
20217512|NCT03581188|The University of Sydney, Australia|Associate Professor Katy Bell|+61 415 764 321|katy.bell@sydney.edu.au|
20217513|NCT01619579|VA Medical Center & UCSD Center for Pain Medicine|Tobias Moeller-Bertram, MD|858-552-8585|tmoellerbertram@ucsd.edu|3123
20217514|NCT03907241|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
20217515|NCT02012452|VA Boston healthcare system|Sandra Japuntich|6082398018|sjjapuntich@gmail.com|
20217516|NCT04403399|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
20217517|NCT04815850|University of Leicester|Dr Matthew Graham-Brown|01162588043|mgb23@le.ac.uk|
20217518|NCT01316419|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163655|NCT02727907|BIOCAD|Linkova Yuliya|+7(495)9926628|linkova@biocad.ru|930
20195259|NCT03098420|University of Alabama at Birmingham|Dr. Joel Feinstein|205-934-4696|jfeinstein@uabmc.edu|
20195260|NCT01029652|Novartis Pharmaceuticals|Study Director|862 778-8300||
20195261|NCT02318992|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
20195262|NCT02313233|Kaohsiung Municipal TA- TUNG Hospital|Dr. Ching- Chia Li|886-7-291-1101||
20195263|NCT02095951|Wayne State University School of Medicine - Children's Hosp. of Michigan|Eric McGrath, MD|313-745-5862|emcgrath@med.wayne.edu|
20195264|NCT03618823|UPMC Children's Hospital of Pittsbugh|Senior Research Associate|1412-692-9879|nelsonjl2@upmc.edu|
20195265|NCT04638920|University Hospital Zurich|Prof. Malcolm Kohler, Sponsor-Investigator|+41442551111|malcolm.kohler@usz.ch|
20195266|NCT05383508|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20195267|NCT02081417|Department of Psychiatry and Behavioral Sciences, University of New Mexico|Annette Crisanti, PhD|505-850-7430|acrisanti@salud.unm.edu|
20195268|NCT00580645|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
20195269|NCT01157676|University of Miami|Dipen Parekh, MD|305 243 6591|parekhd@miami.med.edu|
20195270|NCT00682890|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
20195271|NCT01721460|University od Wisconsin - Madison|Dr. Aeyal Raz|608-263-8100|raz@wisc.edu|
20195272|NCT03028220|Imperial College London|Prof Nick Oliver|02075942460|nick.oliver@imperial.ac.uk|
20195273|NCT00141219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20195274|NCT01506609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20195275|NCT01710891|MinneapolisMRF|Brian Driver|6128739528|Brian.Driver@hcmed.org|
20195276|NCT01096823|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|(310) 825-0731|LZeltzer@mednet.ucla.edu|
20195277|NCT00577473|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20195278|NCT01580423|Dartmouth-Hitchcock Medical Center|Donald A. Mahler|603 650-5533|Donald.a.mahler@hitchcock.org|
20195279|NCT02595073|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20195280|NCT02261597|Beth Israel Deaconess Medical Center, Harvard Medical School|Dr. Monika Haack|617-667-5234|mhaack@bidmc.harvard.edu|
20195281|NCT01990560|Ichan School of Medicine at Mount Sinai|Dr. Alice C. Levine|212-241-1500|alice.levine@mountsinai.org|
20195282|NCT02884908|University of Maryland School of Medicine|Dr. Melanie Bennett|4107060892|mbennett@som.umaryland.edu|
20195283|NCT01324440|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195284|NCT00732225|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20195285|NCT01801735|Iroko Pharmaceuticals, LLC|Alexis Gomez, Director of Clinical Operations|267-546-1426|agomez@iroko.com|
20195286|NCT02084056|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195287|NCT04080908|NYU Langone Health|Stuart Katz|2122633946|Stuart.Katz@nyulangone.org|
20195288|NCT01293487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195289|NCT01975974|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
20195290|NCT00468559|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20195291|NCT01153958|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20195292|NCT01856868|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
20195293|NCT01034163|Novartis|Study Director|862-778-8300||
20195294|NCT03988920|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20195295|NCT01605916|Biometrics Department, Science Affairs Division, R&D, Astrazeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
20195296|NCT01465347|Diffusion Pharmaceuticals Inc|Chief Executive Officer|(434) 220-0718|DKalergis@diffusionpharma.com|
20195297|NCT02996474|National Heart Lung and Blood Institute|Christopher Hourigan|+1 301 451 0257|christopher.hourigan@nih.gov|
20195298|NCT04493502|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20195299|NCT02891837|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
20195300|NCT01588431|UT Health San Antonio|Anand Karnad, MD|210-450-1267|karnad@uthscsa.edu|
20195301|NCT03954392|Vanderbilt University|Judy Garber, Ph.D., Professor of Psychology and Human Development|16153305605|judy.garber@vanderbilt.edu; jgarber.vanderbilt@gmail.com|
20195302|NCT01103362|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20195303|NCT02533531|LifeWatch Services, Inc.|Paul Hanneman|1 847 720 2231|Phanneman@gobio.com|
20195304|NCT02047903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195305|NCT00312923|Rush University Medical Center|Barbara Swanson|312-942-8977|barbara_a_swanson@rush.edu|
20195306|NCT00467350|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343000|mmiller@cmh.edu|
20195307|NCT03538301|Nitto Denko Corporation|Nitto Denko Corporation Study Director|858-255-3010|clinicaltrialinfo005@nitto.com|
20195308|NCT03616977|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20195309|NCT05917470|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
20195310|NCT00715754|University of Utah|Laurie Moyer-Mileur|801/587-7488|Laurie.Moyer-Mileur@hsc.utah.edu|
20195311|NCT03029351|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
20195312|NCT01290029|Amgen Inc.|Study Director|866-572-6436||
20195313|NCT01877837|Hackensack Meridian Health|Elana Smilow|5519965673|Elana.Smilow@hmhn.org|
20195314|NCT00504660|UT MD Anderson Cancer Center|Charles A. Conrad, MD / Professor|713-745-1896|skang@mdanderson.org|
20195315|NCT01773291|Kaohsiung Chang Gung Memorial Hospital|Wen-Long Hu, Deputy Director, Department of Chinese Medicine|+886-7-7317123|oolonghu@gmail.com|2334
20195316|NCT01491672|Novartis|Study Director|862-778-8300||
20195317|NCT02336178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195318|NCT03310268|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20195319|NCT01197833|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
20195320|NCT00706433|Dusa Pharmaceuticals, Inc.|Anna Houlihan||houlihana@dusapharma.com|
20195321|NCT01035073|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
20195322|NCT01236365|Nemours Children's Clinic|Nelly Mauras, MD|904-697-3674|nmauras@nemours.org|
20195323|NCT00832637|University of New Mexico|Yehuda Patt, MD|5059250405|yzpatt@salud.unm.edu|
20195324|NCT01874431|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20195325|NCT00545051|Hoffmannb-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20195326|NCT01375114|UT MD Anderson Cancer Center|Dr. Sriram Yennu, MD-Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20195327|NCT01879059|University of Kansas Medical Center|John P. Thyfault, PhD|913-588-1790|jthyfault@kumc.edu|
20195328|NCT01888900|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Marc Ghany|301-402-5515|marcg@mail.nih.gov|
20195329|NCT03271021|Foamix Pharmaceuticals|Senior Director, Clinical Operations|9089630117|kendra.gulbronson@foamix.com|
20195330|NCT01474434|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20195331|NCT02207569|Medtronic|Kristin Smith|763-526-3095|kristin.m.smith@medtronic.com|
20195332|NCT00952120|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
20195333|NCT03568331|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
20195334|NCT00495586|CAMFIC|Carl Llor|+34 3011777|carles.llor@urv.cat|
20195335|NCT03038438|Medtronic|Stephanie Cihlar|763.258.9524|stephanie.a.cihlar@medtronic.com|
20195336|NCT00992433|Baylor College of Medicine|Hana El Sahly, MD|713-798-2058|hanae@bcm.edu|
20195337|NCT02038543|Mayo Clinic|Dr. John C. Lieske|507-284-2064|Lieske.John@mayo.edu|
20195338|NCT02647866|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
20195339|NCT03406260|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20195340|NCT00944073|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
20195341|NCT02399254|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD|860-714-4055|RZuWalla@TrinityHealthOfNE.org|
20195342|NCT02334423|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
20195343|NCT02930226|University of Cincinnati|Jose A. Cancelas, M.D., Ph.D.|513-558-1324|Jose.Cancelas@cchmc.org|
20195344|NCT00652327|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20195345|NCT01076647|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20195346|NCT02765802|Eiger BioPharmaceuticals, Inc|SVP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20195347|NCT00920075|Medical University of South Carolina|Deborah A Bowlby, Asst.Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
20195348|NCT02926898|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20195349|NCT04595318|Montefiore Health System|Dr. Shadi Nahvi|718 920 5379|snahvi@montefiore.org|
20195350|NCT03814031|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
20195351|NCT02292927|Imperial Colege London|Colin Bicknell|02033126072|alison.deslandes@imperial.nhs.uk|
20195352|NCT00568802|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
20195353|NCT01039792|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
20195354|NCT01656733|University of Connecticut School of Medicine|Cheryl Oncken, MD, MPH|860-679-3425|oncken@uchc.edu|
20195355|NCT01065844|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
20195356|NCT00297596|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
20195357|NCT02054741|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_GAP70@urmc.rochester.edu|
20195358|NCT02684851|CarolinasHS|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
20217519|NCT00455962|Massachusetts General Hospital|Janet E. Hall, MD|617-877-1112|jehall@partners.org|
20217520|NCT01344616|PHCC LP|James G. Christian|7195468633|jim@phcclp.com|
20217521|NCT02760264|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
20217522|NCT00983918|Baylor College of Medicine|Jaime Ortiz, MD|713-873-2860|jaimeo@bcm.edu|
20217523|NCT05918822|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20217524|NCT02451150|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20217525|NCT03346070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217526|NCT03325972|NYU Langone Health|Lisa Doan, MD|212.201.1004|Lisa.Doan@nyulangone.org|
20217527|NCT04086641|University of Washington|Conrad Slater|5409318478|conslate13@gmail.com|
20217528|NCT00255151|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
20217529|NCT01685073|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
20217530|NCT00934596|Cardiothoracic Surgery, Skåne University Hospital Lund|Dr. Bansi Koul MD, PhD, Principal Investigator|+46 46 171649|bansi.koul@skane.se|
20217531|NCT00572039|Thomas Jefferson University|Barry W. Rovner, MD|2155031254|Barry.Rovner@jefferson.edu|
20217532|NCT03756883|Teva Pharmaceuticals, USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
20217533|NCT05045469|CGMH|Dr. HuanHsuan Hsu|0978839349|10356017a@cgmh.org.tw|
20217534|NCT03460158|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
20217535|NCT02136238|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
20217536|NCT01011556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20217537|NCT01845116|Atrium Health Levine Children's Hospital|Ricardo A. Caicedo, MD|704-381-8840|ricardo.caicedo@atriumhealth.org|
20217538|NCT02147587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217539|NCT01355302|Eisai Inc.|Eisai Medical Services|888-422-4743||
20217540|NCT03649412|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20217541|NCT00865514|University of Florida|Dr. Peter W. Stacpoole|(352) 273-9023|pws@ufl.edu|
20217542|NCT02865395|George Washington University|Dr. Patrick Mufarrij|2027154000|pmufarrij@gmail.com|
20217543|NCT00530348|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20217544|NCT02684396|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20217545|NCT01557920|Massachusetts General Hospital|Dr. Matthias Eikermann|6176434408|meikermann@partners.org|
20217546|NCT01839838|Hospital of the University of Pennsylvania|Gary Freedman, MD|215-615-6767|Gary.freedman@pennmedicine.upenn.edu|
20217547|NCT04220775|M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
20217548|NCT00089076|Mayo Clinic|Dr. Stephen Ansell|507-284-0923|ansell.stephen@mayo.edu|
20217549|NCT00808509|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20217550|NCT00931463|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
20217551|NCT00436917|Mayo Clinic Jacksonville|Stephanie L. Hines, M.D.|507-266-0800|hines.stephanie@mayo.edu|
20217552|NCT05633082|CooperVision Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
20217553|NCT02169791|Northside Hospital|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
20217554|NCT03170869|University of Colorado|Dr. Thor Johnson|720-848-1765|thor.johnson@ucdenver.edu|
20217555|NCT04936594|University of Kentucky|Dr. Gopalkumar Rakesh|859-562-2348|gopalkumar.rakesh@uky.edu|
20217556|NCT03420768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20217557|NCT02969876|Massachusetts General Hospital|Dr. Andrew Nierenberg|6175122641|anierenberg@mgh.harvard.edu|
20217558|NCT02630316|United Therapeutics|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20217559|NCT01997723|UIllinois|Bharati Prasad|3129968433|bpradsad@uic.edu|
20217560|NCT01040793|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217561|NCT00807209|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20217562|NCT00703976|University of Pittsburgh|Julie Bauman, MD|412-623-7833|baumanje@upmc.edu|
20217563|NCT00843830|University of Michigan Comprehensive Cancer Center|Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
20163656|NCT01427933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20217564|NCT03942211|Janssen Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20217565|NCT04798482|Boston Children's Hospital|Keira Mason MD|617-355-5775|keira.mason@childrens.harvard.edu|
20217566|NCT01886937|New York State Psychiatric Institute|Dr. Laurel Mayer|646-774-8067|lsm16@cumc.columbia.edu|646
20217567|NCT03496987|Yale University School of Medicine|Jonathan Puchalski, MD|2037375699|jonathan.puchalski@yale.edu|
20217568|NCT01930175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20217569|NCT00605917|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217570|NCT00789113|University of Minnesota College of Pharmacy|Dr. Rory P. Remmel|6126240472|remme001@umn.edu|
20217571|NCT00890552|Stanford University School of Medicine|Brenda Hann, RN, MBA, CCRC|650-723-0966|bhann@stanford.edu|
20163657|NCT01643382|University of California, San Francisco|Justin Parekh, MD, MAS|415-595-3707|justin.parekh@ucsfmedctr.org|
20217572|NCT01506908|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217573|NCT01818518|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
20217574|NCT01117766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217575|NCT04405739|Ridgeback Biotherapeutics|Wendy Painter, MD, MPH|786-687-2495|EIDD2801@ridgebackbio.com|
20217576|NCT01436643|Novartis Pharmaceuticals|Study Director|862-778-8300||
20217577|NCT01917968|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
20163658|NCT01633541|University of Michigan Rogel Cancer Center|Dr. Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
20163659|NCT03472326|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20163660|NCT05447663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20163661|NCT01128426|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163662|NCT01592071|University of Miami|Dr. John Lewis|(305) 243-6227|jelewis@miami.edu|
20163663|NCT01100320|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
20163664|NCT04669301|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
20163665|NCT05049850|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
20163666|NCT02863328|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20163667|NCT01870726|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20163668|NCT00595478|Dartmouth College|Catherine Stanger, Ph.D.|603-646-7023|catherine.stanger@dartmouth.edu|
20163669|NCT00746694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20163670|NCT00186901|St. Jude Children's Research Hospital|Sue Kaste, DO|866-278-5833|referralinfo@stjude.org|
20163671|NCT00555217|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Linda Fried, MD, MPH|412-360-3930|Linda.Fried@va.gov|
20163672|NCT02921490|Mayo Clinic|Vance Lehman|1-507-284-2511|lehman.vance@mayo.edu|
20163673|NCT02155920|University of Texas Southwestern Medical School|Daniel C. Bowers, MD|214-648-3896|Daniel.Bowers@utsouthwestern.edu|
20163674|NCT01802710|Hospital Galdakao-Usansolo|Dra Miren Orive|0034 944007105|miren.orivecalzada@osakidetza.net|
20163675|NCT02528786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20163676|NCT02363959|Duke University|Scott Shofer MD, PhD|919-668-2402|scott.shofer@duke.edu|
20163677|NCT00950248|National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Bibiana Bielekova|(240) 669-2724|bibi.bielekova@nih.gov|
20163678|NCT02663622|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163679|NCT00662545|UCSF SFGH|Anne Luetkemeyer|415 476 4082|aluetkemeyer@php.ucsf.edu|130
20163680|NCT00930930|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
20163681|NCT04618744|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
20195359|NCT03430531|Penn State Hershey Medical Center|Dr. Verghese Cherian|7175318521|vcherian@pennstatehealth.psu.edu|
20195360|NCT02325557|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
20195361|NCT01502631|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20195362|NCT01488487|Div. of Hematology and Oncology, Univ. of North Carolina at Chapel Hill|Dr. Hanna Sanoff|919-966-4431|hanna_sanoff@med.unc.edu|
20195363|NCT00395460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20195364|NCT02489123|University of Washington|Ajay K. Gopal, MD|206-606-2037|agopal@uw.edu|
20195365|NCT04299438|University of Pennsylvania|Dr. Jennifer McCoy|215 662 4000|jennifer.mccoy@pennmedicine.upenn.edu|
20195366|NCT04223830|Boston Scientific|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
20195367|NCT00862719|IndianaU|Dr. Sherif Farag|317-944-0920|ssfarag@iu.edu|
20195368|NCT01806623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195369|NCT01737827|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20195370|NCT00528645|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
20195371|NCT01445301|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195372|NCT00752557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195373|NCT00190749|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20195374|NCT02665338|Medical University of South Carolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
20195375|NCT05652647|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195376|NCT05326815|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
20195377|NCT04617275|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195378|NCT04927884|CSSIFM|Chaitali Nangia, MD Oncologist|855-797-9277|Chaitali.nangia@cssifm.org|
20195379|NCT01007643|University of Manitoba|Dr Erika Persson|780-492-4752|epersson@ualberta.ca|
20195380|NCT01710332|Mid Atlantic Retina|Allen C. Ho, MD|215-459-0477|mformoso@midatlanticretina.com|
20195381|NCT02359877|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20195382|NCT02110147|Wellstat Therapeutics Corporation|Wellstat Medical Information|800.914.0071|medinfo@wellstat.com|
20195383|NCT00189488|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20195384|NCT02349425|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195385|NCT02186223|Bio2 Medical, Inc.|Chief Medical Officer|720-833-5675|langel@bio2medical.com|
20195386|NCT00252733|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
20195387|NCT02090959|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20195388|NCT03480217|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Ian Kronish|212-342-1335|ik2293@columbia.edu|
20195389|NCT02808143|Northwestern University Feinberg School of Medicine|Joshua Meeks, MD, PhD|312-363-8959|Joshua.meeks@northwestern.edu|
20195390|NCT00522873|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20195391|NCT02029846|Johns Hopkins University|Dr. Hsin-Chieh Yeh|410-614-4316|hyeh1@jhmi.edu|
20195392|NCT02966301|MEDSENIC|RIEGER François - CEO - Scientific Director|+33671733159|fr@medsenic.org|
20195393|NCT02561754|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-3880|jdonnelly@ku.edu|
20195394|NCT02349646|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
20195395|NCT02367820|Nektar Therapeutics|Medical Affairs|855-482-8676|StudyInquiry@nektar.com|
20195396|NCT01336803|Stanford University|Heike Daldrup-Link|650-723-8996|heiked@stanford.edu|
20195397|NCT00523640|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20163682|NCT00900029|Smith & Nephew, Inc.|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20195398|NCT02224690|GW Research Ltd.|Medical Enquires||medinfo.USA@gwpharm.com, medinfo@greenwichbiosciences.com|
20195399|NCT01577745|MedImmune, LLC|Mohammed Dar|301-398-1008|information.center@astrazeneca.com|
20217578|NCT01435928|Sunovion|Medical Director, CNS|1-866-503-6351||
20195400|NCT00122460|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
20163683|NCT02709330|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
20195401|NCT00825916|Capstone Therapeutics|Denise Lamon, Director of Regulatory Affairs|800-937-5520|dlamon@capstonethx.com|5206
20195402|NCT02962960|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
20195403|NCT02450799|Alcon, A Novartis Division|Phase IV, Clinical and Regulatory Affairs, Alcon Japan|1-888-451-3937|alcon.medinfo@alcon.com|
20195404|NCT04196101|Enanta Pharmaceuticals, Inc|Guy De La Rosa, MD Senior Director, Infectious Diseases|(617) 607-0800|gdelarosa@enanta.com|
20195405|NCT02344004|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
20195406|NCT02319525|UAB|Dr. Jasvinder Singh, Principal Investigator|2059343235|jasvinder.md@gmail.com|
20195407|NCT01451827|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20195408|NCT01964924|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
20195409|NCT01528345|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20195410|NCT02424734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195411|NCT02141451|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
20195412|NCT02150343|Circassia Ltd|VP Clinical Operations|+44 1865 405560|kirsten.evans@circassia.com|
20195413|NCT02729753|C2 Therapeutics|Marcia Wachna, Director of Clinical Research||marcia@c2therapeutics.com|
20195414|NCT01090427|Janssen Research & Development, LLC|VICE PRESIDENT IMMUNOLOGY||ClinicalTrialDisclosure@its.jnj.com|
20195415|NCT01154010|Massachusetts Eye and Ear Infirmary|Director of the Ocular Immunology and Uveitis Service|617-573-5549|George_Papaliodis@meei.harvard.edu|
20195416|NCT00439231|NHLBI/NIH|Georg Aue|301.451.7141|AueG@nhlbi.nih.gov|
20195417|NCT03294148|Weill Cornell Medicine|Dr. Yoni Ashar|(646) 962-2820|joa9188@med.cornell.edu|
20195418|NCT02073747|University Medical Center of Southern Nevada|Emergency Department Research Coordinator|702-224-7124|wesley.forred@umcsn.com|
20195419|NCT02413333|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20195420|NCT00709852|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20195421|NCT02632526|AstraZeneca AB|A study to assess the safety, tolerability, pharmacokinetics & dynamics of AZD5718 in healthy male||ClinicalTrialTransparency@astrazeneca.com|
20195422|NCT01048671|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195423|NCT03814187|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20195424|NCT00296400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20163684|NCT03152591|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20163685|NCT02587819|Biosceptre UK|Dr Shaun McNulty|01223496092|shaun.mcnulty@biosceptre.com|
20163686|NCT00511238|Onyx Pharmaceuticals|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
20163687|NCT03868254|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20163688|NCT03449758|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20163689|NCT03795116|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|347-466-9263|jared.jagdeo@downstate.edu|
20163690|NCT00859547|ZymoGenetics|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
20163691|NCT00977171|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20163692|NCT01410890|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20163693|NCT03271424|University of North Carolina Chapel Hill|Dr. Audrey Pettifor|919-966-7439|apettif@email.unc.edu|
20163694|NCT00997035|University of California, San Francisco|Kathryn Ray|415-514-3227|kathryn.ray@ucsf.edu|
20163695|NCT03110471|swansea university|sue jordan|+44 (0) 1792 518541|s.e.jordan@swansea.ac.uk|
20163696|NCT03726489|University of Pennsylvania|Brooke Bishop|215-615-0523|brooke.bishop@pennmedicine.upenn.edu|
20195425|NCT03901482|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
20195426|NCT01014533|University of Michigan|Kirk Brower||kbrower@med.umich.edu|
20195427|NCT00669682|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
20195428|NCT00412061|Novartis Pharmaceuticals|Study Director|862-778-8300||
20195429|NCT00060424|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
20195430|NCT02689518|University of California San Diego|Professor Michael Goldbaum|858 534 3516|mgoldbaum@ucsd.edu|
20195431|NCT01853774|Arizona State University|Professor, College of Nursing and Health Innovation|6024960740|linda.larkey@asu.edu|
20195432|NCT05332145|HealthPartners Institute|Stephanie Hooker, PhD, MPH|952-967-5056|stephanie.a.hooker@healthpartners.com|
20195433|NCT04555031|Bausch & Lomb|Study Director|5853386399|robert.steffen@bausch.com|
20195434|NCT02433340|AbbVie|Global Medical Services|800-633-9110||
20195435|NCT01178385|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
20195436|NCT00857272|Braintree Laboratories, Inc.|John McGowan, Associate Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
20195437|NCT03797677|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20195438|NCT02679508|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20195439|NCT03143166|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195440|NCT03103490|Professor of Radiology (Nuclear Medicine)|Andrei Iagaru|(650) 725-4711|aiagaru@stanford.edu|
20195441|NCT03683823|The University of Texas at Austin|Dr. Michael Telch|512-560-4100|telch@austin.utexas.edu|
20195442|NCT03965351|Cincinnati Children's Hospital Medical Center|Mary Banks|513-636-2147|mary.banks@cchmc.org|
20195443|NCT03456427|GE Healthcare|Beth Heckel|1-262-312-7269|beth.heckel@med.ge.com|
20195444|NCT00994682|University of Florida|Dr. Kenneth Cusi|352-273-8662|kcusi@ufl.edu|
20195445|NCT01323972|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195446|NCT00928018|Dana Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
20195447|NCT02677428|VA Connecticut Healthcare System|Marc Rosen|203-932-5711|marc.rosen@va.go|2112
20195448|NCT00943111|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20195449|NCT02859324|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20195450|NCT03539887|The University of Texas Health Science Center at Houston|Rodrigo Machado-Vieira, MD, PhD, MSc|(713) 741-5000|Rodrigo.MachadoVieira@uth.tmc.edu|
20195451|NCT00589121|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20195452|NCT00998335|University of Florida|Dr. Kenneth Cusi|352-273-7236|KCusi@ufl.edu|
20195453|NCT00847808|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20195454|NCT00925132|University of Iowa|Mohammed Milhem|319-356-2324||
20195455|NCT02545933|University of Florida|Dr. Dominick Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
20195456|NCT03149549|CytomX Therapeutics|Monika Vainorius|(650) 515-3185|clinicaltrials@cytomx.com|
20195457|NCT03136445|NHS Blood and Transplant|A/Prof Lise Estcourt|44 1865 387789|Lise.Estcourt@nhsbt.nhs.uk|
20195458|NCT01892540|University Hospitals|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
20195459|NCT01370590|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195460|NCT05172050|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20195461|NCT02909764|Monell Chemical Senses Center|Julie A. Mennella|2675194880|mennella@monell.org|
20195462|NCT03141905|University of Maryland, Baltimore|Jeffrey C. Fink MD, MS (Principal Investigator)|410-328-4822|jfink@som.umaryland.edu|
20195463|NCT05180500|University of Pittsburgh|Dr. Sharon Hillier, PhD|412-641-6435|hillsl@mwri.magee.edu|
20195464|NCT03422198|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20195465|NCT02437253|Los Angeles Biomedical Research Institute at Harbor-UCLA|Dr. Lynda Polgreen (PI)|310-222-1961|lpolgreen@labiomed.org|
20195466|NCT01533597|Soonchunhyang Bucheon Hospital|Dr. Kwang-Woo Lee|+82 32 621 5465|urolkw@schmc.ac.kr|
20195467|NCT00727311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclsoure@merck.com|
20195468|NCT03992846|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20195469|NCT00876928|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
20195470|NCT01111474|Federal University of São Paulo|Dr. Olga Dumont Flecha - PHD student|38 35326082|olgaflecha@gmail.com|
20163697|NCT00972335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20163698|NCT02544503|Emory University|Cathrin Buetefisch, MD, PhD|404-712-5507|cathrin.buetefisch@emory.edu|
20195471|NCT02564354|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
20195472|NCT04101318|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
20195473|NCT00558259|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195474|NCT02874924|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
20195475|NCT04609306|University of Orthopaedics|Jonathan Wright, MD|(352) 273-7001|wrightjo@ortho.ufl.edu|
20195476|NCT01415531|Forest Research Institute|Tatjana Lukic, MD, MSc|(201) 427-8649|tanya.lukic@frx.com|
20195477|NCT05753670|Endeavor Health|Dr. Ghazaleh Rostami Nia|847-570-4729|GRostamiNia@northshore.org|
20217579|NCT00862537|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
20195478|NCT02483585|Amgen Inc.|Study Director|866-572-6436||
20195479|NCT01935180|VA Medical Center|Dr. Heiko Pohl|8022959362|heiko.pohl@dartmouth.edu|5595
20195480|NCT02534038|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|sdube@avanir.com|
20195481|NCT02943226|The University of Texas Health Science Center at Houston|Joseph P. Hasapes, M.D.|(713) 566-5440|Joseph.P.Hasapes@uth.tmc.edu|
20195482|NCT00250926|Dana Farber Cancer Institute|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
20195483|NCT02354443|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
20195484|NCT01808326|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195485|NCT00116753|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20195486|NCT01200589|Novartis Pharmaceuticals|Study Director|862-778-8300||
20195487|NCT01590082|The University of Texas (UT) MD Anderson Cancer Center|Sapna P. Patel, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|sppatel@mdanderson.org|
20195488|NCT01853644|Northwestern University|Daniela Matei|312.472.4684|daniela.matei@northwestern.edu|
20195489|NCT02891408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20195490|NCT00185965|School of Medicine, Stanford University|Ronald Levy, MD / Robert K and Helen K Summy Professor of Medicine|650-725-6452|levy@stanford.edu|
20195491|NCT00578461|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
20195492|NCT02009761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195493|NCT00825825|Steward St. Elizabeth's Medical Center|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
20195494|NCT00950950|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20195495|NCT01047293|Huntsman Cancer Institute|Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
20195496|NCT00491829|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
20195497|NCT01809002|Axogen|Stacy Arnold, VP of Clinical Research|770-833-2570|sarnold@axogeninc.com|
20195498|NCT01920854|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
20195499|NCT00757783|Johnson & Johnson Pharmaceutical Research & Development|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
20195500|NCT03032393|Youngstown State University|Associate Professor|330941-2702|wge@ysu.edu|
20195501|NCT01043393|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
20195502|NCT02372136|Gerber Foundation, UT Southwestern Med Ctr, Children's Medical Center|National Grant Gerber Foundation) (LPB); George L. MacGregor Professorship (CRR); National Children'|214-648-3903|luc.brion@utsouthwestern.edu|
20195503|NCT00985946|University of Wisconsin Carbone Cancer Center|Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
20195504|NCT03002753|Christoph-Dornier-Stiftung Münster|Christian Rupp, M. Sc.|00492514183440|rupp@cds-muenster.de|
20195505|NCT03265938|Icahn School of Medicine at Mount Sinai|Dr. Samuel DeMaria|(212) 241-1518|samuel.demaria@mountsinai.org|
20195506|NCT02673515|Medical University of Graz|Assoc.-Prof.Dr. Harald Sourij|+43 316 385|norbert.tripolt@medunigraz.at|78038
20195507|NCT02008877|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20195508|NCT01049217|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195509|NCT01946438|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20195510|NCT02412371|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20195511|NCT01116102|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
20195512|NCT05000931|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20195513|NCT01134952|LondonHSC|Dr Vivian McAlister|5196632920|vmcalist@uwo.ca|
20195514|NCT06298669|Rutgers|Maya Guglin|9085968459|maya.guglin@rutgers.edu|
20195515|NCT04227704|Washington University School of Medicine|Dr. David Monks|314-323-1845|dmonks@wustl.edu|
20195516|NCT00133809|Emory University|Nicole Turgeon MD|404-727-3257|nturgeo@emory.edu|
20195517|NCT01775124|Novartis|Study Director|862-778-8300||
20195518|NCT02317432|Disparities Research Unit, MGH|Margarita Alegria, PI|617-724-1237|malegria@mgh.harvard.edu|
20195519|NCT04807582|Imperial College London|Professor Eric Aboagye|0203 313 3720|eric.aboagye@imperial.ac.uk|
20195520|NCT00031551|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
20195521|NCT00850603|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
20195522|NCT00484289|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20195523|NCT02831387|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
20195524|NCT00192647|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20195525|NCT00156819|Johns Hopkins Center for Clinical Trials|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
20195526|NCT01689337|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20195527|NCT03834051|Vancouver Island Health Authority|Dr. Christine Lee|250 519 1898|christine.lee@viha.ca|
20195528|NCT00642772|Center for Health Services Research in Primary Care, Durham VA Medical Center|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
20195529|NCT03718533|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20195530|NCT05877508|University of California San Francisco|Michael Peluso|(415) 502-2449|michael.peluso@ucsf.edu|
20195531|NCT01147601|Oregon Health & Science University|Dr. Alfons Krol|503-494-9993|krola@ohsu.edu|
20195532|NCT04800432|University of South Florida|Tatyana Harris|(813) 974-7454|trharris1@usf.edu|
20195533|NCT00888628|Massachusetts General Hospital|James F. Markmann, M.D. Ph.D - Chief, Division of Transplant Surgery|617-643-4087|kcrisalli@mgh.harvard.edu|
20195534|NCT05398237|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
20195535|NCT02370810|Anglia Ruskin Univeristy|Eldre Beukes|1223698847|eldre.beukes@anglia.ac.uk|2847
20195536|NCT01529203|Galderma|Clinical Project Manager|(33) 4 92 38 67 33|may.ma@galderma.com|
20195537|NCT04601870|University of Wisconsin-Madison School of Medicine and Public Health Center for Tobacco Research and Intervention|Mark Zehner|16082627568|mark.zehner@ctri.wisc.edu|
20217580|NCT02105701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195538|NCT01312857|Memorial Sloan Kettering Cancer Center|Dr. Nancy Kemeny, MD|646-888-4180|kemenyn@MSKCC.ORG|
20217581|NCT03234608|Portland State University|Dr. Christina Nicolaidis|503-725-9603|nicol22@pdx.edu|
20195539|NCT04193436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195540|NCT01248065|Penn State University Dept. of Public Health Sciences|Tonya S. King, PhD|717-531-7178|tking@psu.edu|
20195541|NCT02234687|New York University School of Medicine|Charles Marmar, MD|646 754 4855|Charles.Marmar@nyumc.org|
20195542|NCT00893984|Minneapolis Heart Institute Foundation|Chief Medical Officer|612-863-3900|scott.sharkey@allina.com|
20217582|NCT03693950|BIOCAD|Yulia Linkova Medical Director|+7 (495) 992 66 28 ext. 930|linkova@biocad.ru|
20195543|NCT01762501|Sogo Rinsho Medefi Co., Ltd|Naoyuki Takano|+81-3-6901-6079|takano.naoyuki@sogo-medefi.jp|
20195544|NCT02781844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20195545|NCT02725801|University of Kentucky Division of Plastic Surgery|Lesley Wong|859-323-7505|lesley.wong@uky.edu|
20195546|NCT02518490|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20195547|NCT04256629|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20195548|NCT00321373|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195549|NCT01383499|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195550|NCT01774487|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
20195551|NCT00346632|Kyowa Kirin Pharmaceutical Development, Inc.|Project Leader|6099191100|clinical.info@kyowakirin.com|
20195552|NCT00477334|Novartis Pharmaceuticals|Study Director|862-778-8300||
20195553|NCT04275089|Reia, LLC|Kaitlin Maier|2032742886|kaitlin@reiahealth.com|
20195554|NCT02418676|State University of Maringá - Paraná - Brazil|Dra. Graciette Matioli|55 44 3011-3868|gmatioli@uem.br|
20195555|NCT02354508|Novartis Pharmaceuticals|Study Director|826-778-8300|novartis.email@novartis.com|
20195556|NCT01028937|NTK Enterprises, Inc.|Nancy Lockerman|831-869-1384|nlockerman@opti-k.com|
20195557|NCT03587974|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
20195558|NCT02585232|Tuscaloosa VA Medical Center|Dr. Michelle Hilgeman|205-554-2000|Michelle.Hilgeman@va.gov|3278
20195559|NCT01847469|Yale University School of Medicine, VA Connecticut Healthcare System|Dr. Ismene Petrakis|(203) 932-5711|ismene.petrakis@yale.edu|
20195560|NCT00461032|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195561|NCT00760006|Chilsren's Hospital of Pittsburgh of UPMC|Dr. Joseph E. Losee|412-692-6203|joseph.losee@chp.edu|
20195562|NCT04447846|Kenndey Krieger Institute|Dr. Anne Comi|443-923-9127|comi@kennedykrieger.org|
20195563|NCT00180323|Rigshospitalet, Copenhagen Unviversity Hospital, Denmark|Dr. Jesper Hastrup Svendsen||jesper.hastrup.svendsen@rh.regionh.dk|
20195564|NCT00297232|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20195565|NCT02257567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20195566|NCT02350777|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|212-639-5987|tamarir@mskcc.org|
20195567|NCT03625895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20195568|NCT01288521|University of Iowa|Sony Tuteja, Pharmd|215-573-7834|sony.tuteja@gmail.com|
20195569|NCT00552240|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195570|NCT02679573|Melinta Therapeutics, Inc.|Sue Cammarata|312-724-9401|scammarata@melinta.com|
20195571|NCT03545503|New Hanover Regional Medical Center|William F. Powers, IV, MD, FACS|910-667-9232|william.powers@nhrmc.org|
20195572|NCT00912301|Mayo Clinic|Michael L. Camilleri, MD|507-266-2306|camilleri.michael@mayo.edu|
20195573|NCT01236339|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.234.5263|artscott@wlgore.com|
20195574|NCT01098097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20195575|NCT00394082|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20195576|NCT01945060|University of Virginia|Marc D Breton|14349826484|mb6nt@virginia.edu|
20195577|NCT01708213|TauTona Group|Ann Thomas|650-331-2461|athomas@tautonagroup.com|
20195578|NCT00577577|Insmed|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
20195579|NCT00232544|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20195580|NCT00906945|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
20195581|NCT02434497|AstraZeneca Plc|Robin Mukherjee|+46317761000|robin.mukherjee@astrazeneca.com|
20195582|NCT01210664|University of California San Francisco Diabetes Center|Jeffrey Bluestone, PhD|415-502-5677|jeff.bluestone@ucsf.edu|
20195583|NCT01054170|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20195584|NCT02951767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20195585|NCT02751320|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195586|NCT02549196|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20195587|NCT01442779|Texas Tech University Health Sciences Center|Lorenz Lutherer, MD, PhD|806-743-2532|Lorenz.Lutherer@ttuhsc.edu|
20195588|NCT05249829|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20195589|NCT00513604|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20195590|NCT00196976|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195591|NCT01535560|Alcon Research, Ltd.|Sally Schieb, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20195592|NCT02740374|The Ohio State University Wexner Medical Center - Department of Anesthesiology|Alberto Uribe|6142933559|alberto.uribe@osumc.edu|
20195593|NCT02697292|Mayo Clinic|Sean J. Pittock, M.D.|507-2084-4741|Pittock.Sean@mayo.edu|
20195594|NCT00609765|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
20195595|NCT03801915|National Cancer Institute|Dr. Jonathan Hernandez|240-760-6072|jonathan.hernandez@nih.gov|
20202965|NCT03952650|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Dave Cook|240.627.3066|david.cook@nih.gov|
20202966|NCT00631319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20202967|NCT00891657|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
20202968|NCT04084392|Vanderbilt University Medical Center|Dr. Dave Marcovitz|615-936-3555|david.marcovitz@vumc.org|
20202969|NCT03988751|Wake Forest University School of Medicine|Dr. Clancy Clark|335-480-8064|cjclark@wakehealth.edu|
20217583|NCT01362296|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217584|NCT00248170|Novartis|Study Director|862-778-8300||
20217585|NCT03123783|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
20217586|NCT00749411|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195596|NCT00729378|University of Arizona|Dr. Scott Going, Ph.D.|520-626-3432|going@u.arizona.edu|
20195597|NCT01586910|Medtronic, Inc.|Peggy Yunker|763-514-4000|surtavi@medtronic.com|
20195598|NCT03224351|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20195599|NCT01328717|Ascensia Diabetes Care|Dr. Daniel Brown|574-256-7754|daniel.brown@ascensia.com|
20195600|NCT00346268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195601|NCT02164383|University of Wisconsin Center for Tobacco Research and Intervention|Tanya Schlam, PhD|608-262-4149|trschlam@ctri.wisc.edu|
20195602|NCT00743275|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20195603|NCT01672723|University of California, Los Angeles|Dr. Naomi Eisenberger|310-267-5196|neisenbe@ucla.edu|
20195604|NCT01966380|Sahlgrenska university hospital|Prof. Jan Faergemann|031-3421000|jan.faergemann@derm.gu.se|
20195605|NCT00575029|University of Arkansas|Dr. Donald Bodenner|501-526-5710|bodennerdonald@uams.edu|
20195606|NCT04487834|Calisia University, Kalisz, Poland|Jacek Piatek|+48883389788|drpiatek@interia.eu|
20195607|NCT01828073|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20195608|NCT01592500|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20195609|NCT00690443|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
20195610|NCT03057977|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195611|NCT00953407|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20195612|NCT02502097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195613|NCT01350336|Boston Scientific Corp.|G Mark Grubb|(412) 716-0717|grubbm@bsci.com|
20195614|NCT00118755|Hoffmann-La Roche|Medical Communications|800-821-8590||
20195615|NCT02204176|Wayne State University and Michigan State University|Dr. Phuong Vo|616-634-0566|votrucph@msu.edu|
20195616|NCT00292162|NHS|Michael MacDonald|01412112000|michael.macdonald@nhs.net|
20195617|NCT01016977|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195618|NCT02394951|Washington University in Saint Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
20195619|NCT05081388|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20195620|NCT01776541|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20195621|NCT04279392|University of Nebraska Medical Center|Laura Bilek|402-690-3524|lbilek@unmc.edu|
20195622|NCT01171807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
20195623|NCT01901341|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20195624|NCT01981473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195625|NCT00738582|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20195626|NCT00757588|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20195627|NCT00549783|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20195628|NCT00624923|Joslin Diabetes Center|Dr. Allison Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
20195629|NCT00799513|San Raffaele Hospital IRCCS|Principal Investigator|0226437649|ferreri.andres@hsr.it|
20195630|NCT05062759|AstraZeneca Clinical Study Information Center|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
20195631|NCT00903006|University of Texas MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD / Associate Professor, Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
20195632|NCT01749904|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
20195633|NCT02572882|University of Pennsylvania|Natalie Kuzla|215-573-2935|nkuzla@pennmedicine.upenn.edu|
20195634|NCT02469389|VISN 5 MIRECC|Dr. Melanie Bennett|(410) 637-1850|Melanie.Bennett@va.gov|
20195635|NCT01079663|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
20195636|NCT03486457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195637|NCT03536143|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
20195638|NCT01878214|Washington University School of Medicine in St. Louis|Jaime Strickland, MA|314-454-7337|jstrickl@dom.wustl.edu|
20195639|NCT00946101|MedImmune, LLC an affiliate of AstraZeneca AB|Elissa Malkin, D.O.|301-398-0000|malkine@medimmune.com|
20195640|NCT01174160|Cardiome Pharma|Jonathan Mather, Director, Head of Regulatory Affairs|+44 (0)7581148916|jmather@cardiome.com|
20195641|NCT01590017|AMC Statistical Center|Jeannette Lee, PhD.|501-526-6712|jylee@uams.edu|
20195642|NCT00093808|Mayo Clinic|Winston Tan, MD|904-953-7290|Tan.Winston@mayo.edu|
20195643|NCT00871780|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20195644|NCT02527343|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20195645|NCT00701220|The Ohio State University|Philip F. Binkley, MD, MPH|(614) 293-3956|binkley.2@osu.edu|
20195646|NCT05767021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20195647|NCT03575754|London Health Sciences Centre|Dr. Derek Cool|519-685-8500|derek.cool@lhsc.on.ca|54965
20195648|NCT06377488|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|RFrankl1@its.jnj.com|
20195649|NCT00116337|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
20195650|NCT01485055|Nationwide Childrens Hospital|Rajinder Bajwa|6147222000|rajinder.bajwa@nationwidechildrens.org|
20195651|NCT01831856|Institut de Recherche Pierre Fabre|Karim KEDDAD, MD, PhD Head of Medical Unit|+33 5 34 50 61 69|Karim.keddad@pierre-fabre.com|
20195652|NCT05208866|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
20195653|NCT00986973|The Children's Hospital of Philadelphia|Dr. Can Ficicioglu|2155905876|ficicioglu@email.chop.edu|
20195654|NCT00598273|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20195655|NCT02842827|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195656|NCT01815138|UConn Helth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
20195657|NCT00577356|Virginia Mason Medical Center|Jacqueline Vuky, MD|(206) 223-6193|Jacqueline.Vuky@vmmc.org|32246
20195658|NCT00882687|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20195659|NCT02649946|BD/Bard|Heather Lam, Associate Project Manager, Clinical Affairs|(763) 390-8616|heather.lam@bd.com|
20195660|NCT02054520|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
20195661|NCT01272804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195662|NCT01588496|Amgen Inc.|Study Director|866-572-6436||
20195663|NCT01551212|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20195664|NCT05924945|Masimo Corporation|Chelsea Frank|9492977000|clinicalresearchdept@masimo.com|
20195665|NCT02471833|Emory University|Whitney Wharton, PhD|404-712-7359|w.wharton@emory.edu|
20195666|NCT01413087|Anchiano Therapeutics Israel Ltd.|Dr. David Kerstein|857-259-4626|david.kerstein@anchiano.com|
20195667|NCT02232243|University of Kentucky|Peng Wang|(859) 257-4488|p.wang@uky.edu|
20195668|NCT00490724|Clinical Science Initiative Dept. Janssen Pharmaceutical K.K./ Tokyo Japan|Manager|+81.3.4411.5653||
20195669|NCT05026710|University of Michigan|Khurshid Ghani, MD|734-763-2797|kghani@med.umich.edu|
20195670|NCT00126503|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
20217587|NCT00880087|University of Utah|Dr. Rich Holubkov, Professor of Pediatrics|807-587-3326|richard.holubkov@hsc.utah.edu|
20195671|NCT00974376|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20195672|NCT02760277|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
20195673|NCT01201317|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
20195674|NCT02079610|University of Pittsburgh School of Medicine|Kymberly Young, PhD|412-648-6179|youngk@pitt.edu|
20195675|NCT04964388|UNIVERSITY OF MISSISSIPPI MEDICAL CENTER|Amy Wigglesworth|6018153164|ajwigglesworth@umc.edu|
20195676|NCT01093521|University of Washington|Christopher H. Goss, MD MSc|206-543-3166|goss@u.washington.edu|
20195677|NCT01052103|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20195678|NCT04874415|University of Pittsburgh|Dr. Mary Ellen Vajravelu|412-692-6533|MaryEllen.Vajravelu@pitt.edu|
20195679|NCT03405792|University of Florida|Ashley Ghiaseddin, MD|352-273-9000|ashley.ghiaseddin@neurosurgery.ufl.edu|
20195680|NCT00372229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20195681|NCT01347762|Beth Israel Deaconess Medical Center|Kevin P. Hill, M.D., M.H.S., Principal Investigator|617 667 1597|khill1@bidmc.harvard.edu|
20195682|NCT03235284|Federal University of Bahia - FUBA|Dr.Pietro Araújo|71992520519|pietro.araujo@ufba.br|
20217588|NCT03662308|SPINAL CORD DAMAGE RESEARCH CENTER|Dr. John Handrakis|718.584.9000|john.handrakis@va.gov|3129
20195683|NCT00310037|University of California, San Francisco|Lawrence D. Kaplan, MD||lkaplan@medicine.ucsf.edu|
20195684|NCT02700945|Medtronic|Carola Alfaro Vives|763-526-1539|carola.alfaro.vives@medtronic.com|
20195685|NCT01382706|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
20195686|NCT05559099|National Institute of Allergy and Infectious Diseases|Lori Dodd|2406695247|doddl@niaid.nih.gov|
20195687|NCT04018092|University of Florida - Norman Fixel Brain Institute|Dr. Dawn Bowers|3522220100|dawnbowers@phhp.ufl.edu|
20195688|NCT03476707|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20195689|NCT04055090|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20195690|NCT04745026|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20195691|NCT05478499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20195692|NCT04426851|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195693|NCT01944371|University of California, San Francisco|Steven G. Deeks|4156064082|Steven.Deeks@ucsf.edu|404
20195694|NCT03256851|Wayne State University|Dr. Nora Fritz|(313) 577-1096|nora.fritz@wayne.edu|
20195695|NCT00801931|Columbia University|Prakash Satwani, MD|212-305-0223|ps2087@cumc.columbia.edu|
20195696|NCT02476279|Division of Gastroenterology & Hepatology, Medical University of South Carolina|Dr. B. Joseph Elmunzer|8437926982|elmunzer@musc.edu|
20202970|NCT02623361|UCSF|Matthias Behrends, PI|415 476 3761|matthias.behrends@ucsf.edu|
20195697|NCT00319839|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
20195698|NCT02128542|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20195699|NCT01778023|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20195700|NCT00903630|University of Minnesota, Dept. of OBGYN|Dr. Levi Downs, Jr|612-626-3111|downs008@umn.edu|
20195701|NCT03086213|Shenzhen Third People,s Hospital|Thoracic surgical department|13823135410|daoren_000113@126.com|
20195702|NCT02939170|Alcon, A Novartis Division|Clinical Project Lead, Clinical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20195703|NCT00138671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20195704|NCT00402597|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|VP FRANCHISE MED LDR|1 908 927 7767||
20195705|NCT00298090|UTHSCSA|Jane Youngers|210-567-2340|youngers@uthscsa.edu|
20195706|NCT02996565|HealthPartners Institute|Karen Margolis, MD MPH|952-967-7301|Karen.L.Margolis@HealthPartners.com|
20195707|NCT00509587|Princess Margaret Cancer Centre|Dr. Natasha Leighl|416-946-2399|natasha.leighl@uhn.ca|
20195708|NCT03572387|Icahn School of Medicine at Mount Sinai|Vaibhav Patel, MD|212-659-5511|vaibhav.patel@mountsinai.org|
20195709|NCT04129216|Johns Hopkins University|Dr. Mehran Habibi|4105505522|mhabibi2@jhmi.edu|
20195710|NCT00968227|Washington University|Michael Diringer PI|314-362-2999|diringerm@wustl.edu|
20195711|NCT02581631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20195712|NCT03426605|OrphAI Therapeutics|Esther Nkrumah|2675121750|enkrumah@orphai-therapeutics.com|
20195713|NCT03386110|Hunter College|Tyrel J. Starks|212-206-7919|tstarks@hunter.cuny.edu|
20195714|NCT01981772|The Ohio State University College of Dentistry|Sara Fowler|6142923596|fowler.276@osu.edu|
20195715|NCT01211288|University of Alabama at Birmingham|Dr. Toni Tien Neumeier|205-934-5459|neumeier@uab.edu|
20195716|NCT04217590|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astazeneca.com|
20195717|NCT01013285|UCLA Neuro-Oncology Program|Albert Lai|310-825-5321|albertlai@mednet.ucla.edu|
20195718|NCT01986075|New York State Psychiatric Institute|Kenneth Carpenter, PhD|646-774-8181|kenneth.carpenter@nyspi.columbia.edu|
20195719|NCT03102645|Department of Clinical Pharmacology, University Hospital Bispebjerg and Frederiksberg|Jonatan Kornholt|+4538635604|jonatan.kornholt@regionh.dk|
20195720|NCT01395888|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195721|NCT03218397|Duke University|Vance Fowler, MD, MHS|919-613-5678|vance.fowler@duke.edu|
20195722|NCT01796548|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
20195723|NCT02457559|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20195724|NCT02374671|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
20195725|NCT00903682|Janssen-Cilag EMEA|EMEA Medical Affairs Director Virology|+31 6 542 454 37||
20195726|NCT00462332|GIMEMA Foundation Data Center|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20195727|NCT03866473|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
20195728|NCT02495792|Brooke Army Medical Center|MAJ Jamie Morris|210-221-3700|jamie.b.morris.mil@mail.mil|
20195729|NCT02523599|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20195730|NCT05590884|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 680249334|frantz.hebert@guerbet.com|
20195731|NCT02112838|Rigel Pharmaceuticals|Sandra Tong|1-650-624-1207|stong@rigel.com|
20195732|NCT04308395|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
20195733|NCT04443153|UVA Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
20195734|NCT05182125|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20195735|NCT03519971|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20195736|NCT06729606|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
20195737|NCT04849507|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
20195738|NCT05929339|Wake Forest University School of Medicine|James C. Eisenach, MD|336716-4182|jimeisenach@gmail.com|
20195739|NCT05195489|NYU Langone Health|Kimberly Hoagwood, PhD|240-401-4289|Kimberly.Hoagwood@nyulangone.org|
20195740|NCT03440320|Colorado State University|Dr Arlene Schmid|970-491-7562|arlene.schmid@colostate.edu|
20195741|NCT00409773|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195742|NCT01201343|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20195743|NCT01919814|Pennington Biomedical Research Center|Frank Greenway, MD|2257632578|frank.greenway@pbrc.edu|
20195744|NCT01980654|Pharmacyclics|Dr. Jutta Neuenburg|408-215-3735|jneuenburg@pcyc.com|
20195745|NCT01177722|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20195746|NCT02049151|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Centre|496151725200|service@merckgroup.com|
20195747|NCT02563522|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20195748|NCT00918580|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195749|NCT02136420|Massachusetts Eye and Ear Infirmary|Faisal Karmali|617-573-5593|faisal_karmali@meei.harvard.edu|
20195750|NCT01984671|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
20195751|NCT02208999|CEMKA|Stéphane Bouée, Medical director|331.41.87.95.25|stephane.bouee@cemka.fr|
20195752|NCT04494256|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20195753|NCT00262951|University of Minnesota, Masonic Cancer Center|Edward Greeno, M.D.|612-626-6418|green049@umn.edu|
20195754|NCT04025580|National Institutes of Health|Rachel Sparks|240-292-4642|rachel.sparks@nih.gov|
20195755|NCT01768117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195756|NCT01616056|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
20195757|NCT01249274|Yale University|Kimberly A. Yonkers, M.D.|203-764-6621|kimberly.yonkers@yale.edu|
20195758|NCT01000636|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|
20195759|NCT03658668|NYU Langone Health|Mathew Lustberg, MA|929 445 5090|Matthew.Lustberg@nyulangone.org|
20195760|NCT04634825|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20195761|NCT02777385|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20195762|NCT01100034|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195763|NCT04756960|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20195764|NCT04578574|University of Miami|Eva Widerstrom-Noga, PhD; Roberta Vastano, PhD|305243-7125; 305243-8847|ewiderstrom-noga@med.miami.edu; Rxv331@med.miami.edu|
20195765|NCT00828841|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
20195766|NCT00836095|Penn State Milton S. Hershey Medical Center|Sonia Vaida MD, Professor of Anesthesiology|7175318433|svaida@hmc.psu.edu|
20195767|NCT01602562|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195768|NCT03609853|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20195769|NCT04964414|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
20195770|NCT00819390|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20195771|NCT01191268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20195772|NCT00336895|UPittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
20195773|NCT02308020|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
20195774|NCT01270971|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
20195775|NCT02411357|University of Vermont|Sarah H. Heil, PhD|802-656-8712|sarah.heil@uvm.edu|
20195776|NCT00001984|NIDDK, NIH|Dr. Alan Kirk||allank@intra.niddk.nih.gov|
20195777|NCT03333837|Wake Forest University School of Medicine|Christina Hugenschmidt, PhD|336-713-8116|chugensc@wakehealth.edu|
20195778|NCT00705523|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@mail.med.upenn.edu|152
20195779|NCT02464033|Linkoeping University|Johnny Ludvigsson, MD, PhD, Prof Linkoeping University|+46 13 28 68 54|Johnny.Ludvigsson@liu.se|
20195780|NCT04619251|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195781|NCT02003573|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195782|NCT03324451|College of Nursing,Kaohsiung Medical University|Ruey-Hsia Wang|886-3-3121101|wrhsia@kmu.edu.tw|2641
20195783|NCT00803751|UT Medical School, Houston|Maria Matuszczak|713-498-2768|maria.matuszczak@uth.tmc.edu|
20195784|NCT02112708|Institut Català de la Salut|Principal Investigator: Carme Rovira Aler|+34686838979|crovira.bcn.ics@gencat.cat|
20195785|NCT00704405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195786|NCT03169101|University of Pennsylvania|Rebecca Ashare, PhD|7168296273|rlashare@pennmedicine.upenn.edu|
20195787|NCT00600886|Novartis Pharmaceuticals|Study Director|862-778-8300||
20195788|NCT02053792|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20195789|NCT01321151|UT Southwestern Medical Center|Megan Marks, Ph.D.|214-648-0882|megan.marks@utsouthwestern.edu|
20195790|NCT03801473|Sultan Abdulhamid Han Training and Research Hospital|Tugba Ozsoy|+902165422020|tugbaozsoyy@gmail.com|3876
20195791|NCT04546789|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20195792|NCT00790751|Vivus, Inc|Wesley W Day PhD|650-934-5200||
20195793|NCT04976621|Corporal Michael J. Crescenz VA Medical Center|Helene Moriarty, PhD, RN|610-519-5735|helene.moriarty@va.gov|
20195794|NCT04118374|Vanderbilt University Medical Center|Justin M Gregory, MD, MSCI|(615) 322- 7427|metabolism@vumc.org|
20195795|NCT02549014|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195796|NCT01078454|ECOG Statistical Office|Study Statistician|617-632-3012||
20195797|NCT05227703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20195798|NCT04763421|Ethicon Endo-Surgery|Senior Director of Clinical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20195799|NCT04134845|Vanderbilt University Medical Center|Dr. William Stevenson|615-322-2318|William.g.stevenson@vumc.org|
20195800|NCT03110224|Zimmer Biomet|Annette Tieu|971-482-9622|annette.tieu@zimmerbiomet.com|
20195801|NCT05328167|Thomas Jefferson University|Dr. John Eisenbrey, Associate Professor|215-503-5188|john.eisenbrey@jefferson.edu|
20195802|NCT00112047|Gilead Sciences|Dara Wambach MA, Associate Director, Regulatory Affairs|650-522-5163|dara.wambach@gilead.com|
20195803|NCT01307579|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20195804|NCT03727438|Department of Veteran Affairs ADAPT|Jennifer Zervakis|919 286-0411|jennifer.zervakis@va.gov|17 6174
20195805|NCT03170349|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20195806|NCT02491632|UT MD Anderson Cancer Center|Sriram Yennu,MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20163699|NCT03315572|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163700|NCT00991939|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
20163701|NCT00714415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195807|NCT05406752|Unither-Pharmaceuticals|Non-Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
20195808|NCT00185679|Stanford Cancer Institute|Ginna G Laport, MD|650-723-8222|ginna.laport@stanford.edu|13911
20195809|NCT01440374|Novartis Pharmaceuticals|Study Director|862-778-8300||
20195810|NCT01036763|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195811|NCT00619762|LifeCell|Director of Clinical Operations|908.809.7856|djacobs@lifecell.com|
20195812|NCT04812548|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20195813|NCT01845220|Johns Hopkins University|Jed W. Fahey, Sc.D.|4106142607|jfahey@jhmi.edu|
20195814|NCT02673151|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|(650) 725-4711|aiagaru@stanford.edu|
20195815|NCT02141984|AbbVie|Global Medical Services|800-633-9110||
20195816|NCT05220254|Stanford University|Judith Prochaska|(650) 724-3608|jpro@stanford.edu|
20195817|NCT00861263|University of FLorida|Dr. Peter Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
20195818|NCT03184870|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20195819|NCT02978144|Columbia University|Gebhard Wagener, MD|(212) 305-6494|gw72@cumc.columbia.edu|
20195820|NCT03786783|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20195821|NCT04363801|Leap Therapeutics, Inc.|Douglas Onsi / President and CEO|617-218-1116|donsi@leaptx.com|
20195822|NCT01285843|Medacta International|Ing. Elisa Bonacina, Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
20195823|NCT00250679|Sepracor Inc.|Respiratory Medical Director|1-866-503-6351||
20195824|NCT00448279|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20217589|NCT01005329|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
20217590|NCT02504723|Kaohsiung Veterans General Hospital|Dr. Wen-Chi Chen|886-7-3422121|wcchen@vghks.gov.tw|2139
20217591|NCT00126126|Miami VAHS & University of Miami, Department of PT|Robert Gailey, PhD, PT|305-284-4535|rgailey@miami.edu|
20217592|NCT04975321|University of Washington|Mariella Garcia|2065431740|mgarciaf@uw.edu|
20217593|NCT00986570|Biolab Sanus Farmacêutica Ltda.|Priscilla Padilha, MD|55(11)35736335|ppadilha@biolabfarma.com.br|
20217594|NCT02225665|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
20217595|NCT03852524|Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
20217596|NCT01470417|University of Florida|Thomas J. George, Jr., MD|(352) 273-8008|thom.george@medicine.ufl.edu|
20195825|NCT03907410|Children's Hospital of Philadelphia|Chen Kenyon|2674266339|kenyonc@chop.edu|
20217597|NCT03488030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20195826|NCT04776148|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20195827|NCT02440451|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
20195828|NCT01749605|University of Iowa|Brett Faine, PI|319-310-8067|brett-faine@uiowa.edu|
20195829|NCT00666679|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195830|NCT00691327|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
20195831|NCT04882995|UMass Chan Medical School|Dr. Deepali Maheshwari|4137948764|deepali.mahesh@gmail.com|
20195832|NCT04371198|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|Joan.Cahill@duke.edu|
20195833|NCT04754477|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20195834|NCT02579174|Northwestern University|Melissa Shauver, MPH|312-472-6024|melissa.shauver1@nm.org|
20195835|NCT00655486|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
20195836|NCT00440999|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
20195837|NCT04572841|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20195838|NCT05041101|The University of Texas MD Anderson Cancer Center|Sadia Saleem, MD|(281) 566-1900|ssaleem@mdanderson.org|
20195839|NCT01205152|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
20195840|NCT00249002|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20195841|NCT00069108|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20195842|NCT02783768|CUIMC|Elizabeth C. Oelsner, MD, MPH|212-305-9056|eco7@cumc.columbia.edu|
20195843|NCT01323647|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195844|NCT01853137|Osama AlAli|Dr.|00963992262582|osama-alali@hotmail.com|
20163702|NCT03315039|Moleculin Biotech Inc|Chief Scientific Officer|862-273-1432|DPicker@moleculin.com|
20195845|NCT03401229|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
20195846|NCT00690820|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
20195847|NCT05333224|Istanbul Medeniyet University|Ayca Evkaya Acar|+905544263263|ayca.evkaya@gmail.com|
20195848|NCT00585377|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
20195849|NCT01411215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195850|NCT00848926|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20195851|NCT02203695|Johns Hopkins University, School of Medicine|Dr. Daniel Song|410-502-5875|dsong2@jh.edu|
20195852|NCT02832154|Wake Forest University Health Sciences|Study coordinator|336-713-5061|drlittle@wakehealth.edu|
20195853|NCT00966277|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20195854|NCT03339570|Hospital Gregorio Maranon|Dr. Mikel Aburto|34915868000|mikelaburto@hotmail.com|7007
20195855|NCT03451162|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20163703|NCT01461707|University of California, San Francisco|JiWon Choi|415-514-2534|jiwon.choi@ucsf.edu|
20163704|NCT01450761|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20195856|NCT03305731|University of Illinois at Chicago|Dr. Emily Kringle|312-996-9665|kringle@uic.edu|
20195857|NCT01952054|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
20195858|NCT01127139|Abbott|Global Medical Services|1-800-633-9110||
20195859|NCT01136772|Columbia University|T. Scott Stroup|646-774-8435|stroups@nyspi.columbia.edu|
20195860|NCT01498653|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195861|NCT04409886|Maimonides Medical Center|Gene Sobol|718-283-6000|gsobol@maimonidesmed.org|
20195862|NCT01718353|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20195863|NCT01477333|United Therapeutics Corp.|Kevin LaLiberte, PharmD|919-425-8176|KLaliberte@unither.com|
20195864|NCT00455325|Washington University School of Medicine|Janet McGill, MD|(314) 362-8688|jmcgill@wustl.edu|
20195865|NCT00286078|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
20195866|NCT04948333|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20195867|NCT03804502|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
20195868|NCT04016558|University of California, San Francisco|Danielle Hessler|415-476-6196|danielle.hessler@ucsf.edu|
20195869|NCT05849103|Vanderbilt University Medical Center|Sarah Osmundson, MD, MS|6158752231|sarah.osmundson@vumc.org|
20195870|NCT03464097|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20195871|NCT03035201|Wake Forest University School of Medicine|Mark Espeland, PhD; Multiple Principal Investigator|336-716-2826|mespelan@wakehealth.edu|
20195872|NCT02390050|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20195873|NCT01522469|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20195874|NCT05572021|Atrium Health|Greg Scarola, MS, MBA|704-355-5766|Gregory.Scarola@advocatehealth.org|
20195875|NCT04576455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20195876|NCT03432260|DURECT Corporation|Director of Regulatory Affairs|408-777-1418|jill.burns@durect.com|
20195877|NCT02186847|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20195878|NCT02871258|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20195879|NCT05370521|Spruce Biosciences|Chief Medical Officer|415-655-4169|clinicaltrials@sprucebio.com|
20195880|NCT04873232|Helixmith, Co., LTD|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
20195881|NCT00235547|University of Washington|Dr. Sarah Prager|415-206-8715|pragers@uw.edu|
20195882|NCT01912456|CSL Behring GmbH|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20195883|NCT01422226|University of Colorado Denver|Christina Gavito|303-724-5559|christina.gavito@ucdenver.edu|
20195884|NCT00709696|University of Minnesota|Dr. Marc Mooney|612-991-6875|moon0078@umn.edu|
20195885|NCT00171704|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
20195886|NCT00231153|Cadence Pharmaceuticals, Inc.|Catherine Hardalo, MD Vice President Anti-Infectives, Clinical Development|858-436-1439|chardalo@cadencepharm.com|
20195887|NCT03938545|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
20195888|NCT01060540|Durham VA Medical Center|Corrine Voils, PhD|919-286-0411|corrine.voils@va.gov|5196
20195889|NCT04262947|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
20195890|NCT01222507|Washington University|Dr. Jay Piccirillo|314-362-7508|piccirilloj@ent.wustl.edu|
20195891|NCT02647320|Daiichi Sankyo|Daiichi Sankyo Contact for Clinical Trial Information|+81-3-6225-1111(M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
20195892|NCT03572478|University of Chicago|Walter STadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
20195893|NCT00596427|Kinemed, Inc|Carine Beysen, PhD|5106556525|cbeysen@kinemed.com|123
20195894|NCT00320541|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20195895|NCT03836989|Oregon Health and Science University|Dr. Myriam Loyo|503-494-8510|loyo@ohsu.edu|
20195896|NCT02401867|Fenway Community Health|Sari Reisner, ScD|617-927-6017|sari.reisner@childrens.harvard.edu|
20195897|NCT01650246|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6721|mfung@ardeabio.com|
20195898|NCT00081770|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20195899|NCT02268474|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20195900|NCT03435497|RAND Corporation|Laura Bogart, PhD|3103930411|lbogart@rand.org|7281
20195901|NCT04234425|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
20195902|NCT02315352|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20195903|NCT02795429|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20195904|NCT03719170|VA Ann Arbor Healthcare System|Dr. Sameer Saini|734-845-3504|sameer.saini@va.gov|
20195905|NCT01640054|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20195906|NCT00029172|Roudebush VAMC Center of Excellence|Dr. Linda Williams|317-988-3337|linda.williams6@va.gov|
20195907|NCT03794908|University of Michigan|Helen Burgess|734-615-8303|bhelen@umich.edu|
20195908|NCT02080221|Brown University Oncology Research Group|Howard Safran, MD|4018633000|BrUOG@BROWN.EDU|
20195909|NCT04005053|University of Minnesota|Kathryn Cullen|612-273-9732|rega0026@umn.edu|
20195910|NCT04218084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195911|NCT06469242|Alcon Research, LLC|Sr. Principal, Clinical Project Management, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20195912|NCT03421431|Enanta Pharmaceuticals|Kristin Sanderson|617-607-0775|ksanderson@enanta.com|
20195913|NCT03881553|University of Pittsburgh School of Medicnie|Elisabeth Salisbury, PhD|412-246-5378|salisburye2@upmc.edu|
20195914|NCT01959516|Novartis Pharmaceuticals|Study Director|862-778-8300||
20195915|NCT04620811|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20195916|NCT01078675|AstraZeneca, R&D, B&I|Niklas Berglind, GPS|+46317766310|niklas.berglind@astrazeneca.com|
20195917|NCT02501538|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20195918|NCT01366495|Friends Research Institute|Dr. Michael S. Gordon, Senior Research Scientist|410-837-3977|mgordon@friendsresearch.org|251
20195919|NCT02316366|Nationwide Children's Hospital|Dr. Renee Quarrie, fellow|2037136871|reneepetagae@gmail.com|
20195920|NCT01765465|DongGuk University Ilsan Hospital|Dr. In Woong Han||cardioman76@gmail.com|
20195921|NCT00928746|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20195922|NCT01804062|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
20195923|NCT02745392|Zosano Pharma Corporation|Dr. Donald Kellerman|(510) 745-4004|dkellerman@zosanopharma.com|
20195924|NCT02955147|Mass General Hospital|Dr. Sebastian Unizony|(617) 726-7938|sunizony@mgh.harvard.edu|
20195925|NCT02004353|Cochlear|Jasmin Kaur|+41612058238|jakaur@cochlear.com|
20195926|NCT01691768|CAPRISA|Nonhlanhla Yende-Zuma|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
20195927|NCT04023110|University of Pennsylvania|Bonnie Ky, MD, MSCE|215-573-6606|bonnie.ky@pennmedicine.upenn.edu|
20195928|NCT01651442|National Jewish Health|Bryan Simmons|303-398-1850|simmonsb@njhealth.org|
20195929|NCT01759368|VTT Technical Research Centre of Finland|Anna-Leena Orsama|+358408485966|anna-leena.orsama@vtt.fi|
20195930|NCT01959334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20195931|NCT01313689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20195932|NCT03362879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20195933|NCT01768637|University of Arkansas for Medical Sciences|Nishank Jain, MD|5016865295|njain2@uams.edu|
20195934|NCT02481947|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
20195935|NCT01007448|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
20195936|NCT00887432|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
20195937|NCT00899548|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Antonio C. Wolff, M.D.|410-614-4192|awolff@jhmi.edu|
20195938|NCT01337115|Centro Hospitalar do Porto|Dr Raul Carvalho|+351226176114|raul@meo.pt|
20195939|NCT02666846|Futura Medical Developments Limited|Director of Clinical Development|01483685683|tim.holland@futuramedical.com|
20195940|NCT02684253|Memorial Sloan Kettering Cancer Center|Dr. Sean McBride, MD, MPH|646-608-2450|mcbrides@mskcc.org|
20195941|NCT02094755|University of Southern California|Dr. Leonardo Clavijo|3234426130|lclavijo@usc.edu|
20195942|NCT01001559|Red Oak Psychiatry Associates|Dr. Lawrence Ginsberg|281-893-4111|larrydg@earthlink.net|151
20195943|NCT01209780|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20195944|NCT00419666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20195945|NCT03110185|Washington University School of Medicine Department of Anesthesiology|Dr. Ben Palanca|314-273-9076|palancab@wustl.edu|
20195946|NCT02641496|Veterans Affairs Palo Alto Health Care System|Lisa Kinoshita, Ph.D. (Principal Investigator)|650-493-5000|Lisa.Kinoshita@va.gov|65633
20195947|NCT02250092|University of Minnesota|Bernadette Gillick|612-626-6415|gillick@umn.edu|
20195948|NCT03075410|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20195949|NCT01427751|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
20195950|NCT01028027|Bausch & Lomb Incorporated|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
20195951|NCT02775695|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-805-9720|stsai@mcw.edu|
20195952|NCT05330312|Vicore Pharma|Director Clinical Operations|+46317880560|info@vicorepharma.com|
20195953|NCT02572843|Swiss Cancer Institute|Regulatory Affairs|+41 31 389 91 91|regulatory@swisscancerinstitute.ch|
20195954|NCT00001962|NIH National Heart, Lung and Blood Institute|Neal Young MD|301-496-5093|youngns@nhlbi.nih.gov|
20195955|NCT01605292|Long Beach VA Medical Center|Arnold Seto, MD, MPA|(562) 826-8000|arnold.seto@va.gov|5486
20195956|NCT04281004|University of Utah|Mark Mifflin, MD|801-583-4152|mark.mifflin@hsc.utah.edu|
20195957|NCT00701779|Deaconess Clinic, Inc.|Paul F. Siami, MD CPI|812-426-9576|research.paul.siami@deaconess.com|
20195958|NCT03442985|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20195959|NCT01620255|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20195960|NCT03077360|"University of Colorado Denver | Anschutz"|Bryan Bergman|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20195961|NCT01716117|Stryker Neurovascular|Scott Courts, Clinical Program Manager|5104132170|scott.courts@stryker.com|
20195962|NCT01557283|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20195963|NCT03645057|University of Rochester|Julie Ryan|(585) 276-3862|Julie_Ryan@URMC.Rochester.edu|
20195964|NCT01873495|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
20195965|NCT01206777|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-688-7942|Jeffrey.Jones@osumc.edu|
20195966|NCT03607539|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20195967|NCT04187053|University of Texas Health Science Center at Houston|Srinivas Ayilavarapu, BDS, DSc, MDS|713-486-4390|srinivas.ayilavarapu@uth.tmc.edu|
20195968|NCT00120406|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
20195969|NCT01155375|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
20195970|NCT00762970|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
20195971|NCT00975507|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20195972|NCT01295034|Icahn School of Medicine at Mount Sinai|Andrea D. Branch PhD|212 659 8371|andrea.branch@mssm.edu|
20195973|NCT03818204|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
20195974|NCT00887250|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20195975|NCT05754333|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20195976|NCT03864146|Minneapolis VAHCS|Eric Dieperink, MD|612-467-4010|eric.dieperink@va.gov|
20195977|NCT00824161|The University of Texas M.D. Anderson Cancer Center|Scott Kopetz, MD|713-792-2828||
20195978|NCT00879762|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
20195979|NCT04981366|University of São Paulo|Prof. Hamilton Roschel|+55 11 30618789|hars@usp.br|
20195980|NCT01112306|Actelion Pharmaceuticals Ltd|Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20195981|NCT00881608|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
20195982|NCT03214094|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20195983|NCT01115660|Wake Forest School of Medicine|Dr. Cheryl Bushnell|(336) 716-2357|cbushnel@wakehealth.edu|
20195984|NCT01313637|GlaxoSmithKline|GSK Response Center|866-435-7343||
20195985|NCT01274585|Massachusetts General Hospital|Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients|617-643-0541|lsavitt@partners.org|
20195986|NCT00676065|Center for Epidemiology and Health Research Germany|Juergen Dinger, MD, PhD|+49 30 945 101 20|dinger@zeg-berlin.de|
20195987|NCT00795951|Rady Children's Hospital, San Diego, CA|SE Jacob, MD and L Eichenfield, MD|858-576-1700|leichenfield@rchsd.org|4825
20195988|NCT00427336|UT MD Anderson Cancer Center|Paolo Anderlini, MD / Professor||mvpacheco@mdanderson.org|
20195989|NCT00816348|NSLIJ Health System|Cindy Haller MD|516-472-3650|challer@lij.edu|
20195990|NCT05093699|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
20195991|NCT00211185|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20195992|NCT00986674|ECOG Statistical Office|Study Statistician|617-632-3012||
20195993|NCT01468831|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
20195994|NCT00842985|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
20195995|NCT01037244|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20195996|NCT04507126|MGH|Research Operations Director|617-724-1992|jgerber2@mgh.harvard.edu|
20195997|NCT04316182|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
20195998|NCT02875977|Loyola University Medical Center|Cynthia Brincat, M.D., Ph.D.|708-216-2180|cbrincat@lumc.edu|
20195999|NCT02959450|INCMNSZ|Dr. Aurora Serralde|+52-55-54870900|aurora.serraldez@incmnsz.mx|2193
20196000|NCT02070588|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
20196001|NCT02388646|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
20196002|NCT00141726|University of Michgan Comprehensive Cancer Center|Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
20196003|NCT02216357|Cumberland Pharmaceuticals Inc.|Senior Manger, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|250
20196004|NCT04147650|Aurinia Pharmaceuticals|Clinical Trial Support|(250) 744-2487|clinicaltrials@auriniapharma.com|
20196005|NCT00235326|McMaster University|John Marshall|9055212100|marshllj@mcmaster.ca|76782
20196006|NCT01178671|Research Foundation for Mental Hygiene|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
20196007|NCT02435966|Physios & Universidad Europea de Madrid|Gracia M. Gallego, M.Sc.|+34 609036607|gracia.maria.gallego@gmail.com|
20196008|NCT03311334|Sumitomo Pharma America|Mimi M. Lee, MSW, CCRP|617-674-6800|mimi.lee@oncology.sumitomo-pharma.com|
20196009|NCT02513303|Vascular Therapies, Inc.|Rakesh Raghubanshi|9176204369|rakesh@vasculartx.com|
20196010|NCT00700973|VA Palo Alto Health Care System|Christine Timko|650-617-2746|Christine.Timko@va.gov|
20196011|NCT02145247|UCSDMED|R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
20196012|NCT02294227|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
20196013|NCT00610467|University of California Irvine|Professor|949-824-6001|msu@uci.edu|
20196014|NCT03426267|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20196015|NCT00551460|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
20196016|NCT04781387|Crestone, Inc.|Vice President, Clinical Development|(609) 900-5733|lboccumini@crestonepharma.com|
20196017|NCT01636960|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196018|NCT00527592|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
20196019|NCT01580969|Huntsman Cancer Institute|Josiah Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
20196020|NCT01745848|University of Pittsburgh|Dr. Jessica Bon Field|412-648-6494|bonjm@upmc.edu|
20196021|NCT00448123|William Beaumont Hospital|Robert Swor, DO|248-89-81970|raswor@beaumont.edu|
20196022|NCT02027623|Washington University|Linda van Dillen, PT, PhD, FAPTA; Research Division Director|314-286-1427|vandillenl@wustl.edu|
20196023|NCT05007808|Buzzz Pharmaceuticals Limited|Deirdre O'Keefe, PhD, Head of IP and Portfolio Management|+447733104786|deirdre@hotmail.co.uk|
20196024|NCT01886378|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20196025|NCT02318797|University of Pittsburgh Department of Psychiatry|Charles Reynolds, MD|412-246-6414|reynoldscf@upmc.edu|
20196026|NCT01736865|Tufts Medical Center|Dr. Anastassios Pittas|617-636-5694|apittas@tuftsmedicalcenter.org|
20196027|NCT00645047|University of California San Diego|Zia Agha|858-552-8585|zagha@ucsd.edu|
20196028|NCT02656160|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
20196029|NCT01105754|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
20196030|NCT00815685|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D., via Moffitt Cancer Center|813-745-6885|nagi.kumar@moffitt.org|
20196031|NCT01079741|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
20196032|NCT02709096|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
20196033|NCT00406653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20196034|NCT01275131|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|(858)794-8889||
20196035|NCT01340196|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20196036|NCT03660553|The Lundquist Research Institute|Rajesh Garg|310-222-1968|rajesh.garg@lundquist.org|
20196037|NCT01709747|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
20196038|NCT04109196|Rush University Medical Center|Dr. Philip Held|312-942-1423|philip_held@rush.edu|
20196039|NCT00604279|Xian-Janssen Pharmaceutical Ltd|Local Trial Manager|86-10-5821 8213||
20196040|NCT00816400|MedImmune|A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575|1-877-240-9479|information.center@astrazeneca.com|
20196041|NCT00601419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196042|NCT01786174|Massachusetts General Hospital|James D. Berry, MD, MPH|617-726-5097|jdberry@mgh.harvard.edu|
20196043|NCT01614197|Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)|Roy Leong|323-361-5132|rleong@chla.usc.edu|
20196044|NCT01824160|Johns Hopkins University|RICHARD RINGEL|410-714-6745|rringel@jhmi.edu|
20196045|NCT03628898|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20196046|NCT00362453|Tufts Medical Center|Chenchen Wang, MD, MSc, Associate Professor|617-636-3251|cwang2@tuftsmedicalcenter.org|
20196047|NCT01217957|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20196048|NCT00971932|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20196049|NCT02482870|Recep Tayyip Erdogan University School of Medicine|Dr. Başar Erdivanlı|+904642130491|berdivanli@gmail.com|2128
20196050|NCT04344600|Johns Hopkins School of Medicine|Mark Sulkowski|410-955-7538|msulkowski@jhmi.edu|
20196051|NCT00876694|Novartis Pharmaceuticals|Study Director|862-778-8300||
20196052|NCT00288509|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
20196053|NCT02382016|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
20196054|NCT00084266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196055|NCT01535014|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20196056|NCT02047643|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
20196057|NCT04256603|MetroHealth|c. kim|216 778 7800|ckim3@metrohealth.com|
20196058|NCT01386788|EKoch|Ernst Koch|++49 6257 1788|Ernst.MW.Koch@t-online.de|
20196059|NCT05580588|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
20196060|NCT00679627|Johnson & Johnson Pharmaceutical Research & Development|Director, Clinical Research|1 609-730-7674||
20196061|NCT03463161|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
20196062|NCT00511472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196063|NCT00446992|University of Nevada School of Medicine|Dr. Brian Kirkpatrick|775-682-8459|bkirkpatrick@medicine.nevada.edu|
20196064|NCT00818649|Masonic Cancer Center, University of Minnesota|Erica Warlick, M.D.|612-625-5467|ewarlick@umn.edu|
20196065|NCT00505284|Eisai Call Center|Eisai Inc.|888-422-4743||
20196066|NCT03513588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196067|NCT00940108|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20196068|NCT02292654|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20196069|NCT01740323|Emory University|Andrew Miller, MD|404-727-8260|amill02@emory.edu|
20196070|NCT02858349|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
20163705|NCT00535002|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
20163706|NCT01582139|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
20163707|NCT01327677|Johns Hopkins University School of Medicine|Athir Morad, M.D.|4109552611|morada@jhmi.edu|
20196071|NCT06172881|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
20196072|NCT01911065|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20217598|NCT02973321|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|
20217599|NCT01098110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196073|NCT02594826|Fox Chase Cancer Center|Dr. Carolyn Fang|1-888-369-2427|carolyn.fang@fccc.edu|
20196074|NCT00953745|Washington University School of Medicine|Dr. Charles R. Conway, MD|314-362-7566|conwayc@psychiatry.wustl.edu|
20196075|NCT03527238|University of Florida|Ali Zarrinpar|352-265-0606|ali.zarrinpar@surgery.ufl.edu|
20196076|NCT03063125|University of Kansas Medical Center|Katie Glavin|913-588-8721|kglavin@kumc.edu|
20196077|NCT01427595|University of Virginia Center for Research in Reproduction|Dr. Christine Burt Solorzano|4342436911|pcos@virginia.edu|
20196078|NCT04262817|Yale School of Medicine|Asti Jackson, Ph.D.|475-241-4904|asti.jackson@yale.edu|
20196079|NCT02427464|Helixmith Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
20196080|NCT00557947|Ethicon Inc|John Lombard|908-218-2877|Jlombar8@its.jnj.com|
20196081|NCT04737187|Taiho Oncology, Inc.|Taiho|+1-844-878-2446|medicalinformation@taihooncology.com|
20196082|NCT03756129|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20196083|NCT03567434|Baylor University|Dr. Jason Carter|254-710-4499|jason_carter1@baylor.edu|
20196084|NCT01439360|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196085|NCT00345293|Rockefeller University|Mayu Frank, MS, ANP, Clinical Research Nurse Practitioner|212-327-7443|frankm@rockefeller.edu|
20196086|NCT03319849|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20196087|NCT03045068|The University of Texas Health Science Center at Houston|Nischal K Gautam, MD|713-500-6200|Nischal.K.Gautam@uth.tmc.edu|
20196088|NCT01122160|USDA|Beverly Clevidence|301-504-8367|beverly.clevidence@ars.usda.gov|
20196089|NCT01765192|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20196090|NCT01322048|Vanderbilt University Medical Center|Mayur B. Patel|6153225000|mayur.b.patel@vanderbilt.edu|
20196091|NCT00730171|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
20196092|NCT01729156|Department of Nuclear Medicine & PET Centre, Aarhus University Hospital|Lars C. Gormsen, Consultant|004578456260|lars.christian.gormsen@clin.au.dk|
20196093|NCT01215422|UNIVERSITY OF ALBERTA|DR. JOAN ROBINSON|780-248-5540|jr3@ualberta.ca|
20196094|NCT04335812|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
20196095|NCT02113241|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20196096|NCT00388453|Vanderbilt University|Michael Vaezi, MD, PhD|615.322.3739|michael.vaezi@vanderbilt.edu|
20196097|NCT02901041|Boston University|Dr. Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
20196098|NCT01480674|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20196099|NCT01996813|Loyola University Medical Center|Douglas Evans, M.D.|708-216-2523|devans@lumc.edu|
20196100|NCT00605644|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20196101|NCT00655863|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20196102|NCT05103228|Dunamenti REK IVF Center (former Kaali Institute)|Dr Peter Kovacs|+3612022802|peterkovacs1970@hotmail.com|
20196103|NCT00712673|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20196104|NCT03603028|UAB|David A. Brown|205-975-2788|dbrownpt@uab.edu|
20196105|NCT02963610|Fox Chase Cancer Center|Hossein Borghaei, DO, MS|215-214-4297|Hossein.Borghaei@fccc.edu|
20163708|NCT01220739|University of California, San Diego|Dr. Thomas Hemmen|858-657-7190|themmen@ucsd.edu|
20163709|NCT02794766|Universidade de Passo Fundo|Prof. Fernando Fornari|+555433168395|fernandofornari@gmail.com|
20163710|NCT00123123|University at Buffalo|Frank A. Scannapieco|716-829-3373|fas1@buffalo.edu|
20163711|NCT03071887|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
20163712|NCT03801174|University of Wisconsin - Madison|Corrine Voils, PhD|608-262-9636|voils@surgery.wisc.edu|
20163713|NCT00855816|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
20163714|NCT03393494|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20163715|NCT00337207|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
20163716|NCT01521507|TearScience, Inc.|Study Director|919-467-4007|cstevens@tearscience.com|
20163717|NCT03573323|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20163718|NCT03188432|Wake Forest Baptist Comprehensive Cancer Center|Principal investigator|3367135440|Michael.G.Kelly@advocatehealth.org|
20163719|NCT03869008|UTMC|Bashar Kahaleh, MD|4193834271|bashar.kahaleh@utoledo.edu|
20163720|NCT01687296|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163721|NCT04912583|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.korupolu@uth.tmc.edu|
20163722|NCT02336230|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
20163723|NCT02524171|Center for Innovation to Implementation, VA Palo Alto|Daniel M. Blonigen, PhD|650-493-5000|daniel.blonigen@va.gov|27828
20163724|NCT01695135|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20163725|NCT02507388|Alcon, A Novartis Division|Global Program Clinical Head, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
20163726|NCT00216671|Janssen Cilag Spain|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
20163727|NCT02714569|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20196106|NCT00063154|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20163728|NCT01684202|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20196107|NCT01122862|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163729|NCT03305770|Alcon, A Novartis Division|Sr Director Project Leadership|1-888-451-3937|alcon.medinfo@alcon.com|
20196108|NCT01222273|Children's Hospital of Pittsburgh of UPMC|Joseph M. Pilewski, MD|(412) 692-2164|pilewskijm@upmc.edu|
20196109|NCT00846391|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196110|NCT02924064|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
20196111|NCT02699983|Rutgers Robert Wood Johnson Medical School|Jeanne Ferrante|848-932-5252|jeanne.ferrante@rutgers.edu|
20196112|NCT03575143|University of California San Diego|Robert L. Owens, MD|8586575258|rowens@health.ucsd.edu|
20196113|NCT02566265|Yale University School of Medicine|Andrew Branagan, MD|617-459-5234|andrew.branagan@yale.edu|
20163730|NCT03539601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163731|NCT00226811|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20163732|NCT01010971|Sunovion|Respiratory Medical Director|1-866-503-6351||
20163733|NCT03386721|Hoffmann-La Roche|Medical Communications|08008218590|genentech@druginfo.com|
20163734|NCT03676972|Peking University Third Hospital|Dr. Lulin Ma|13701010872|malulin@medmail.com.cn|+86
20163735|NCT00700713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20163736|NCT00550953|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163737|NCT03797586|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Dr.Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
20163738|NCT04980612|University of California San Francisco|Wolf Mehling, MD|415|wolf.mehling@ucsf.edu|9021331
20163739|NCT00666406|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20163740|NCT01502228|IndianaU|Dr. Theodore Logan|(317) 948-7449|tlogan@iu.edu|
20163741|NCT05730387|Institute for Global Health at BC Children's Hospital and BC Women's Hospital + Health Centre|Matthew O. Wiens|6048292562|matthew.wiens@bcchr.ca|
20163742|NCT02728089|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163743|NCT01219985|Centre Hospital-Universitaire d'Amiens|Pr. Marc-Etienne Meyer|+33 3 22 45 59 64|meyer.marc-etienne@chu-amiens.fr|
20163744|NCT00596752|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20163745|NCT04797780|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
20163746|NCT02940496|MD Anderson Cancer Center|Ahmed Kaseb, MD|(713) 792-2828|akaseb@mdanderson.org|
20163747|NCT02586727|Murray Ocular Oncology & Retina|Dr. Timothy Murray|3054877470|tmurray@murraymd.com|
20163748|NCT04289311|Medical University of South Carolina|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
20163749|NCT04089761|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical and Regulatory Affairs|+972723909755|daganh@theranica.com|
20163750|NCT02119663|Incyte Corporation|Study Director|855 463-3463||
20163751|NCT00699660|Veterans Affairs at TVHS|Theodore Speroff PhD|615-636-9476|ted.speroff@va.gov|
20163752|NCT03137225|Virginia Commonwealth University|Henry J. Rozycki, MD|8048289602|henry.rozycki@vcuhealth.org|
20163753|NCT02601833|University of Michigan School of Dentistry|Emily Yanca Project and Data Manager|734-763-3988|emthorpe@umich.edu|
20163754|NCT00103740|Novartis Pharmaceuticals|Study Director|862-778-8300||
20163755|NCT02771197|The Blood and Marrow Transplant Group of Georgia/Northside Hospital|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20163756|NCT03310723|BC Women's Hospital, Department of Anesthesia|Research Assistant|604-875-2424|james.taylor1@phsa.ca|6076
20163757|NCT02098746|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20163758|NCT00330759|Amgen Inc.|Study Director|866-572-6436||
20163759|NCT04070989|JnJ MedTech|Mary Panozzo|+15744049398|MPanozzo@its.jnj.com|
20163760|NCT01072188|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20163761|NCT06083987|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
20163762|NCT04685798|Washington University School of Medicine|Gloria J. Guzman Pérez-Carrillo, M.D.|314-362-5950|guzman.gloria@wustl.edu|
20163763|NCT04640311|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163764|NCT01908530|Imperial College London|Prof Nick Oliver|07957163617|nick.oliver@imperial.ac.uk|
20163765|NCT01388907|Sofradim Production COVIDIEN|Patrice BECKER, Global Director, Clinical Affairs|+33 4 74 08 92 38|patrice.becker@covidien.com|
20196114|NCT04040400|University of Louisville Brown Cancer Center|Shiao Woo, MD Principal Investigator|502-562-4360|shiao.woo@louisville.edu|
20196115|NCT00972205|National Cancer Institute (NCI), National Institutes of Health (NIH)|Susan S. Bates, M.D.|301-402-0984|Batess@mail.nih.gov|
20196116|NCT01849822|California Institute of Technology|Dr. Richard Andersen|16263958336|andersen@vis.caltech.edu|
20196117|NCT01790126|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196118|NCT02269332|Mike O'Callaghan Military Medical Center|Senior Research Associate/Research Manager|7026533583|amanda.j.crawford.ctr@health.mil|
20196119|NCT03143816|Barbara Davis Center for Diabetes, University of Colorado|Satish Garg MD|3037246713|satish.garg@ucdenver.edu|
20196120|NCT02169453|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20196121|NCT02434939|Makerere University ,College of Health Sciences, Department of Anesthesia and Critical care|Dr.Lubega Felix Anthony|+256777756571|falubega@chs.mak.ac.ug|
20196122|NCT06338462|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
20196123|NCT00390182|University of Maryland Baltimore|Nancy Kennedy|410-328-2513|nkennedy@umm.edu|
20196124|NCT00069238|National Cancer Institute|Dr. Wyndham WIlson|301-435-2415|wilsonw@mail.nih.gov|
20196125|NCT02791945|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
20196126|NCT01001832|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20196127|NCT02453360|University of Wisconsin School of Medicine|Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
20196128|NCT03318809|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20196129|NCT01134016|Golden Biotechnology Corp.|Dr. Howard Cheng, Director of clinical trials|886-2808-6006|howard@goldenbiotech.com.tw|
20196130|NCT00051363|Stanford University|Deborah A. Nichols|208-908-7364|dnichols@cableone.net|
20196131|NCT04819776|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20196132|NCT01668667|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20196133|NCT00979810|Memorial Sloan Kettering Cancer Center|Michelle Bradbury, MD, PhD|646-888-3373|bradburm@mskcc.org|
20196134|NCT00511901|University of Medicine and Dentistry of New Jersey|Jeffrey L Carson, MD|732-235-7122|carson@umdnj.edu|
20196135|NCT03525431|University of California, San Francisco|Mary Norton|(415) 476 4080|mary.norton@ucsf.edu|
20196136|NCT01564628|Acarix A/S|Claus Christensen|+45 29724411|dkcbc@acarix.com|
20196137|NCT04640077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20196138|NCT01257425|Ipsen|Director, Uro-oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20196139|NCT01822301|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
20196140|NCT03430206|Stanford University|Thomas Caruso, MD, MEd|(626) 275-0341|tjcaruso@stanford.edu|
20196141|NCT00368992|SWOG|Lung Committee Statistician|206-667-4623||
20196142|NCT04877730|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
20196143|NCT01013597|University of Wisconsin Carbone Cancer Center|Abigail Mapes, Thoracic Oncology Research Program Manager|608-262-8158|acmapes@medicine.wisc.edu|
20196144|NCT00427895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196145|NCT02953860|University of Colorado|Professor Anthony Elias|720-848-0347|anthony.elias@cuanschutz.edu|
20196146|NCT00585195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196147|NCT00603720|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20196148|NCT02796560|University of Sherbrooke|Dr Marjorie Carbonneau|819-346-1110|Marjorie.Carbonneau@USherbrooke.ca|22180
20196149|NCT03534284|University of Washington|Dr. Raj Mehrotra|206-221-7138|rmehrotr@uw.edu|
20196150|NCT03316300|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20196151|NCT05437510|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20196152|NCT03573401|Biofrontera Bioscience GmbH|Research and Development|+49 214 876 32|regulatory@biofrontera.com|66
20196153|NCT00355056|St. Jude Medical|Director, Global Clinical Affairs|818-493-3648|aoza@sjm.com|
20196154|NCT02884427|Universidad Andrés Bello|Professor Hernán Andrés de la Barra O., DC,PT,Mg|56226618402|quiropraxiayequilibrio@gmail.com|
20196155|NCT01072877|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
20196156|NCT00995020|Affiliation: Oswaldo Cruz Foundation|Investigator: MJCamargo [Camargo Maria José] Official Title: PHD|00552199777009|mariaj.camargo@hotmail.com|
20196157|NCT02245672|Mylan Pharma UK Ltd|Dik Ng, PhD|+44-7467-941703|dik.ng@mylan.co.uk|
20196158|NCT05779397|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
20196159|NCT02730988|Wake Forest University|Kristen Beavers|3367585855|beaverkm@wfu.edu|
20196160|NCT01256658|Novartis|Study Director|41 61 324 1111||
20196161|NCT03330457|Portola Pharmaceuticals|Head of Clinical Development|650-246-7000|ClinicalTrials@Portola.com|
20196162|NCT00719563|University of Michigan School of Nursing|Debra L. Barton, RN, PhD, AOCN, FAAN|734-763-3868|debbartn@umich.edu|
20196163|NCT00294554|Johns Hopkins University School of Medicine|Laura Marsh, MD|713-794-8907|laura.marsh2@va.gov|
20196164|NCT00462865|BrUOG|Bachir Sakr, MD|4018633000|kayla_rosati@brown.edu|
20196165|NCT02986334|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
20196166|NCT04142450|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20196167|NCT06336603|Regulatory Affairs|Head|9122 66455645|Clinical.Trial@sunpharma.com|
20196168|NCT05398016|University of Nevada Las Vegas|Dr. Brenna Renn, PI|7028950569|brenna.renn@unlv.edu|
20196169|NCT01146054|Stanford University Comprehensive Cancer Center|Albert C. Koong, M.D., Ph.D., Sue and Bob McCollum Professor, Associate Chair of Radiation Onocology|650-498-7703|akoong@stanford.edu|
20196170|NCT03890419|Duke University|Padma Gulur|919-681-4660|padma.gulur@duke.edu|
20196171|NCT03249714|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20196172|NCT01990209|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20196173|NCT03021954|Dr Cipto Mangunkusumo Hospital|dr. Fernandi Moegni|+62-82298111778|fernandi71@ui.ac.id|
20196174|NCT01242800|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
20196175|NCT04176848|Canadian Cancer Trials Group|Dr. Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
20196176|NCT02640157|AbbVie|Global Medical Services|800-633-9110||
20196177|NCT00710021|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20196178|NCT01679405|University Medical Center Mainz|Prof. Dr. Markus Moehler|0049613117|Markus.Moehler@unimedizin-mainz.de|7275
20196179|NCT04677179|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20196180|NCT01536015|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20196181|NCT04508023|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196182|NCT04845633|Damascus University|Dr. Line Droubi|00963966896989|droubiline@gmail.com|
20196183|NCT02341859|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
20196184|NCT03598088|Dare Bioscience, Inc.|Jessica Hatheway VP, Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
20196185|NCT03581825|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
20196186|NCT02447172|Innocoll|Charlene A. Tucker MS, Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20196187|NCT06020118|Duke University|Dr. Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
20196188|NCT03261700|National Center for PTSD, located at the VA Boston Healthcare System|Dr. Katherine Iverson, PI|857-364-2066|katherine.iverson@va.gov|
20196189|NCT01204398|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20196190|NCT03562247|Vanderbilt University Medical Center|Lisa Lancaster, MD|615-322-2386|lisa.lancaster@vumc.org|
20196191|NCT00983931|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20196192|NCT01723254|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196193|NCT02668185|Imperial College London|Professor Wajit Dhillo|+44 (0)20 7594 2489|w.dhillo@imperial.ac.uk|
20196194|NCT00770341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com|
20196195|NCT02533570|Seattle Genetics, Inc|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20196196|NCT03995667|Oregon Health & Science University|Dr. Timur Mitin, MD, PhD|503-494-8756|mitin@ohsu.edu|
20196197|NCT00529958|University of Calgary Sport Medicine Centre|ACL RCT Research Coordinator|403-220-8944|aclstudy@ucalgary.ca|
20196198|NCT03816332|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20196199|NCT04947527|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
20196200|NCT03164564|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
20196201|NCT03373201|Vanda Pharmaceuticals|Medical Director|202-734-3400|clinicaltrials@vandapharma.com|
20196202|NCT02656823|DENTSPLY IH AB,|Ulrika Bonander|31 376 30 68|ulrika.bonander@dentsplysirona.com|+46
20196203|NCT01910181|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20196204|NCT00822523|Loma Linda University|Gordon Perterson, MD|909-558-4000|gpeterson@llu.edu|
20196205|NCT01340651|Incyte Corporation|Study Director|855 463-3463||
20196206|NCT01315353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20196207|NCT01009580|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20196208|NCT01000285|Washington University School of Medicine|Lee Ratner, M.D., Ph.D.|314-362-8836|lratner@dom.wustl.edu|
20196209|NCT02880540|Children's National Hospital|Janelle Vaughns MD|202-476-2025|jvaughns@childrensnational.org|4165
20196210|NCT04469270|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20196211|NCT01607112|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196212|NCT05269355|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20196213|NCT03705832|Columbia University|Emily DiMango, MD|212-305-0631|ead3@columbia.edu|
20196214|NCT01050790|Virginia Commonwealth University/Massey Cancer Center|Amir A. Toor, MD, Associate Professor of Medicine|804-828-4360|atoor@mcvh-vcu.edu|
20196215|NCT01880528|Mayo Clinic|Terence T Sio, MD, MS|480/301-7050|Sio.Terence@mayo.edu|
20196216|NCT00081497|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20196217|NCT02254278|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@gmail.com|
20196218|NCT05203068|"Federal State Budgetary Institution National Medical Research Center of Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation"|Dr. Kazakov Aleksey Vladimirovich, principal investigator|+79254666638|alexeykazakov1982@yandex.ru|
20196219|NCT06609135|UMASS Chan Medical School|Dr. Lawrence Rhein, Chair of Pediatrics at UMASS Chan Medical School|5083346581|lawrence.rhein@umassmemorial.org|
20196220|NCT06729593|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
20196221|NCT01138007|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196222|NCT03548987|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20196223|NCT04661878|Duke University School of Nursing|Dr. Marta Mulawa|(919) 684-9555|marta.mulawa@duke.edu|
20196224|NCT03867175|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367130031|mfarris@wakehealth.edu|
20196225|NCT02768870|Edwards Lifesciences, LLC|Sabrina Hundt, Director, Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
20196226|NCT01774110|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
20217600|NCT03920280|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20217601|NCT02423317|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|8937963828|bikramjit.anesth@gmail.com|
20196227|NCT00640016|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20196228|NCT01287065|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196229|NCT01259726|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20196230|NCT00490009|Stanford University Medical Center|Susan J Knox, MD, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
20196231|NCT00887679|Duke University Medical Center|Dr. Ashwin A Patkar Associate Professor|919-668-3626|ashwin.patkar@duke.edu|
20196232|NCT02683941|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20196233|NCT00261846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196234|NCT03136328|Montefiore Medical Center|Charito Love, MD|718-406-8462|clove@montefiore.org|
20196235|NCT00959166|Imperial College London|Prof Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
20196236|NCT00325039|New England Research Institutes, Inc.|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
20196237|NCT02287376|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
20196238|NCT01009203|University of Pittsburgh Medical Center|Julie E. Bauman, MD|4126486507|baumanje@upmc.edu|
20196239|NCT01776424|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20196240|NCT00426153|Mayo Clinic|Marie Hogan, MD, PhD, Assistant Prof of Medicine, College of Medicine|507-266-9364|hogan.marie@mayo.edu|
20196241|NCT00615836|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20196242|NCT01630434|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
20196243|NCT00687973|Novartis Pharmaceuticals|Study Director|862 778-8300||
20196244|NCT03554954|National University of Singapore|Dr. Kim Jung Eun|65161136|fstkje@nus.edu.sg|+65
20196245|NCT02121834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196246|NCT02578862|Ochsner Medical Center|Edward D McCoul, MD, MPH|504-842-4080|edward.mccoul@ochsner.org|
20196247|NCT01110876|University of Texas (UT) MD Anderson Cancer Center|John de Groot, MD/Associate Professor, NEURO-ONCOLOGY|(713) 745-3072|jdegroot@mdanderson.org|
20196248|NCT04465760|OREGON HEALTH & SCIENCE UNIVERSITY|Joseph Shatzel MD MCR|5034948311|shatzel@ohsu.edu|
20196249|NCT03128008|Duke University Health System|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
20196250|NCT01768520|Hanlim Pharm|Clinical Trial Unit|82234896297|yrsong@hanlim.com|2234896297
20196251|NCT02075541|GlaxoSmithKline|GSK Response Center|866-435-7343|lp542096@gsk.com|
20196252|NCT00343252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196253|NCT02076178|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196254|NCT00731120|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20196255|NCT01142596|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196256|NCT02019927|Will Eye Hopsital|Ann Murchison MD|267-733-9617|Visionresearch@willseye.org|
20196257|NCT02618031|Cleveland Clinic Akron General|John Elias|330-344-6176|eliasj@ccf.org|
20196258|NCT00394953|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20196259|NCT01426763|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20196260|NCT03181451|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20196261|NCT00604812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196262|NCT00928447|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
20196263|NCT01610011|McLean Hospital|Marc J. Kaufman, Ph.D., Principal Investigator|617-855-3469|kaufman@mclean.harvard.edu|
20196264|NCT01259284|UT MD Anderson Cancer Center|Ara Vaporciyan, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
20196265|NCT00927160|Icahn School of Medicine at Mount Sinai|Dr. William Hung|718-584-9000|william.hung@mssm.edu|
20196266|NCT00710996|Alcon Research, Ltd.|Rick Potvin|817-551-4815|Rick.Potvin@alconlabs.com|
20196267|NCT02335125|University of Washington Harborview Medical Center|Douglas Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
20196268|NCT02917278|Purdue University|Kathleen Hill Gallant|765-494-0101|hillgallant@purdue.edu|
20196269|NCT02196714|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20196270|NCT00690833|Wake Forest University Health Sciences|Dr Steve feldman|336-716-3775|sfeldman@wakehealth.edu|
20196271|NCT01592864|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196272|NCT02271425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196273|NCT01326533|University of Pittsburgh|Frederico Toledo|412-692-2848|.toledofs@upmc.edu|
20196274|NCT01519466|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
20196275|NCT00307125|DAIT/NIAID|Director, Clinical Research Operations Program (CROP)|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20196276|NCT00807235|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
20196277|NCT00926211|Restoration Robotics|Miguel Canales, M.D.|650-965-3612|miguel@restorationrobotics.com|206
20196278|NCT01210079|School of Nursing, University of California, Los Angeles|Margaret (Peggy) Compton, RN PhD|(310) 206-2825|pcompton@sonnet.ucla.edu|
20196279|NCT01032382|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
20196280|NCT01012713|University of California San Francisco|Dr. John Koo|4154764701|john.koo@ucsfmedctr.org|
20196281|NCT00982995|University of Michgan Comprehensive Cancer Center|Susan Urba|734-615-4762|surba@umich.edu|
20196282|NCT01596621|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20196283|NCT02988622|Univeristy of Iowa, Hospitals and Clinics|Dr. Marta VanBeek|(319) 384-6012|marta-vanbeek@uiowa.edu|
20196284|NCT02390245|Wills Eye Hospital|Dr. L. Jay Katz|215-825-4713|jmolineaux@willseye.org|
20196285|NCT03454828|Yale University School of Medicine: Pediatrics Endocrinology|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
20196286|NCT03722407|Moffitt Cancer Center|Eric Padron, MD|813-745-2864|eric.padron@moffitt.org|
20196287|NCT04878731|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163766|NCT01910402|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196288|NCT02864381|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20196289|NCT03290196|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
20187580|NCT05205486|B. Braun Medical Inc.|Director, Scientific Affairs Operations|610-596-2512|kevin.minnich@bbraunusa.com|
20187581|NCT05791435|Nemours Children Health System|Tariq Rahman|302 651 6831|trahman@nemours.org|
20187582|NCT02998528|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20187583|NCT06029452|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187584|NCT03485729|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
20187585|NCT05035654|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
20163767|NCT00824473|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20163768|NCT01359904|MUHC|Sameena Iqbal|5149341934|sameena.iqbal@mcgill.ca|44034
20163769|NCT02660853|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20196290|NCT02120625|Nimbus Concepts, LLC|J. Scott Bainbridge, MD (PI)|303-522-5219|jscottbainbridge@gmail.com|
20196291|NCT01707225|Virginia Commonwealth University|Rajiv Malhotra, DO|804-828-9071|rajiv.malhotra@vcuhealth.org|
20196292|NCT03008707|University of Pusa|Dario Tartaglia|+393334491229|dario261184@gmail.com|
20196293|NCT03278106|Mayo Clinic|Amit Mahipal MBBS|+1 (507) 293-0487|Mahipal.amit@mayo.edu|
20196294|NCT01942720|Medtronic|Clinical Trials Manager|+972-4-9097952|michal.kedar-datel@medtronic.com|
20196295|NCT01607554|University of New Mexico Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
20196296|NCT03952806|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
20196297|NCT01137955|Celiac Disease Center at Columbia University|Dr. Peter Green|(212) 305-5590|mtm2111@columbia.edu|
20196298|NCT01211197|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20196299|NCT02796001|University of Virginia School of Medicine|Ronald Turner, MD|4349819964|rbt2n@virginia.edu|
20196300|NCT00892723|Capstone Therapeutics|Denise Lamon|800-937-5520|dlamon@capstonethx.com|5206
20196301|NCT04388774|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
20196302|NCT01026454|University of Washington|Connie Celum, MD, MPH|206-520-3800|ccelum@uw.edu|
20196303|NCT03975595|University of Virginia|Dr. Patrick Finan|(720) 244-1702|tpx4xe@virginia.edu|
20196304|NCT01054846|Parkview Health|Thein Zhu|260-266-1279|thein.zhu@parkview.com|
20196305|NCT02120716|University of Michigan|Golfo Tzilos, PhD|7349987120|gtzilos@med.umich.edu|
20196306|NCT04079803|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD, Chief Medical Officer|512-501-1900|nfriedmann@cassavasciences.com|
20196307|NCT03353350|Hanmi Pharmaceutical Co., Ltd.|Sujin Jung|+82-2-410-0473|sujin.jung@hanmi.co.kr|
20196308|NCT03037619|University of South Carolina|Christine Pellegrini|803-777-0911|cpellegrini@sc.edu|
20196309|NCT04318951|Medical School Berlin|Prof. Dr. Benjamin Stahl|+49 30 7668 375 708|benjamin.stahl@medicalschool-berlin.de|
20196310|NCT00759330|Teikoku Pharma USA, Inc.|Director of Clinical Trials|408-501-1821||
20196311|NCT01881750|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
20196312|NCT01201265|Hoffmann-La Roche|Medical Communications|800-821-8590||
20196313|NCT01575028|Nationwide Children's Hospital|Tarun Bhalla|(614) 722-4200|Tarun.Bhalla@NationwideChildrens.org|
20196314|NCT02409368|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20196315|NCT01296347|ImperialNHSTrust|Dr Gillian Chumbley|+44 203 311 1000|gillian.chumbley@imperial.nhs.uk|Bleep 5865
20196316|NCT02240693|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20196317|NCT03343301|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
20196318|NCT01585987|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20196319|NCT02041520|Instituto Mexicano del Seguro Social, UMAE HE No. 1 Bajio|Dr. Norma Amador|+524777174800|norma.amador@imss.gob.mx|31315
20196320|NCT00413972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20196321|NCT04633551|University of South Carolina|Abbi Lane-Cordova|8037777568|lanecord@mailbox.sc.edu|
20196322|NCT01992393|Case Western Reserve University|Joy Yala, Data & Regulatory Coordinator II|216-368-0783|jxy790@case.edu|
20196323|NCT01898923|Oneness Biotech Co., Ltd.|Henry Chang, Associate Director of Clinical Research|+886 2 2703 1098|henry.chang@onenessbio.com.tw|366
20196324|NCT03087019|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
20196325|NCT02678247|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
20196326|NCT01907360|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
20196327|NCT02279394|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
20196328|NCT00723021|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196329|NCT00282282|Dana-Farber Cancer Institute|Vincent T. Ho, MD Associate Professor of Medicine, Harvard Medical School|(617) 632-5938|vincent_ho@dfci.harvard.edu|
20196330|NCT02265367|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20196331|NCT02739360|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20196332|NCT00637923|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
20196333|NCT01163916|Abbott|Global Medical Services|800-633-9110||
20196334|NCT00026208|Stanford Univeristy Medical Center|Jessica C Lam, BS|650-723-0437|jclam11@stanford.edu|
20196335|NCT04002401|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20196336|NCT00423930|Memorial Sloan Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
20196337|NCT02337751|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20196338|NCT02618642|Rzeszow University|Jolanta Zwolińska PhD|48 505095199|jolantazwolinska@op.pl|
20196339|NCT02881957|University of Utah|Dr. Michael Karsy|801-581-6908|michael.karsy@hsc.utah.edu|
20196340|NCT04485858|CorNeat Vision|Clinical Research Associate|0586753739|talia@corneat.com|
20196341|NCT03413735|The Ohio State University|Dr. Richard Bruno|614-292-5522|bruno.27@osu.edu|
20196342|NCT01078220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196343|NCT00959647|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20196344|NCT03824639|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
20196345|NCT05959629|University of Pennsylvania School of Dental Medicine|Dr. Bekir Karabucak|215-898-4927|bekirk@upenn.edu|
20196346|NCT02788903|Penn State College of Medicine|Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
20196347|NCT05677893|Oneness Biotech Co., Ltd.|Director of Clinical Research|+886-2-2703-1098|Jessica.Ho@onenessbio.com.tw|
20196348|NCT01097785|University of Missouri|Paul Fadel|1-573-884-5220|fadelp@health.missouri.edu|
20196349|NCT01708122|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Urology|Richard Reznichek|3102222724|RReznichek@dhs.lacounty.gov|
20196350|NCT00420017|Purdue University|James E Tisdale PharmD|317-613-2315|hwroblew@iupui.edu|306
20196351|NCT01717989|Amgen Inc.|Study Director|866-572-6436||
20196352|NCT03224325|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|+1
20196353|NCT02525861|Baxalta|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20196354|NCT05195814|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196355|NCT04823221|Boao Yiling Life Care Center|Dr. Ming Liu|139 1103 6970|liuming9876@yeah.net|+86
20196356|NCT02027701|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20196357|NCT00756470|University of Texas (UT) MD Anderson Cancer Center|Ricardo Alvarez, MD/Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
20196358|NCT00820027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196359|NCT02982187|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196360|NCT01978262|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
20163770|NCT03594773|University of Pittsburgh School of Medicine|Holly Swartz, MD|4122465588|SwartzHA@upmc.edu|
20163771|NCT01550757|US Department of Veterans Affairs|Thomas O'Toole, MD|(401) 273-7100|thomas.otoole@va.gov|6359
20163772|NCT03191630|The Ohio State University|Dr. Tara O'Brien|6142928045|obrien.782@osu.edu|
20163773|NCT02707146|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|510-891-5993|Richard.W.Grant@kp.org|
20163774|NCT00193206|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20163775|NCT01433016|Exalenz Bioscience|Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
20163776|NCT02148523|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
20163777|NCT01631994|NYU Winthrop Hospital, Dep't of Gastroenterology|David Friedel, MD|(516) 663-2528|DFriedel@nyuwinthrop.org|
20163778|NCT00740584|Starpharma Pty Ltd|Clinical Development Manger|+61 3 9532 2700|clare.price@starpharma.com|
20163779|NCT01588561|McLean Hospital|Scott Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
20196361|NCT02604433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20196362|NCT03285178|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
20196363|NCT01128894|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196364|NCT03437278|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20196365|NCT01128738|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196366|NCT00973362|Hologic, Inc.|Vice President Clinical Affairs|858-410-8000|rainer.ziermann@hologic.com|
20196367|NCT01917513|Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany|Prof. Ralf Kiesslich||ralf.kiesslich@hsk-wiesbaden.de|
20196368|NCT02673203|Yale University School of Medicine|Renata Belfort De Aguiar, MD, PhD; Assistant Professor of Medicine (Endocrinology)|(877) 925-3637|renata.aguiar@yale.edu|
20196369|NCT05116046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20196370|NCT02168842|University of Rochester Medical Center, Department of Biostatistics and Computational Biology|David Oakes, PhD|5852752405|david_oakes@urmc.rochester.edu|
20196371|NCT02147353|Icahn School of Medicine at Mount Sinai|Dr. Shelbi C. Jim On|212-241-6500|shelbi.jimon@mountsinai.org|
20196372|NCT02974088|Medical Entomology Centre|Ian Burgess|+44 1223 810070|ian@insectresearch.com|
20196373|NCT00150969|University Health Network|Dr. Angela M Cheung|416-340-4841|jscher@uhnresearch.ca|
20196374|NCT00146757|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20196375|NCT02019888|NCRAR|M. Patrick Feeney|503-273-5306|Patrick.Feeney@va.gov|
20196376|NCT00550368|Stanford University|Dr. Julie Parsonnet|(650) 725-4561|parsonnt@stanford.edu|
20196377|NCT02893930|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20196378|NCT02349360|University of Florida|Wendy Dahl Associate Professor|3522943707|wdahl@ufl.edu|
20196379|NCT04250987|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
20196380|NCT01971203|Icahn School of Medicine at Mount Sinai|Cindy J. Aaronson, MSW, PhD|212-241-3169|cindy.aaronson@mssm.edu|
20196381|NCT01294683|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196382|NCT01794923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196383|NCT01862133|Regenstrief Institute|William M. Tierney, MD|(317) 274-9094|wtierney@regenstrief.org|
20196384|NCT00985153|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20196385|NCT02571049|Dr. Reddy's|Director of Clinical Development|609-375-9900|cfritz@drreddys.com|
20217602|NCT02438540|Nanjing university of TCM|Dr. Amir Firouzjaei|+989125397047|amirfi@yahoo.com|
20163780|NCT03461146|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20163781|NCT01337336|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196386|NCT03552822|University of Alabama at Birmingham|Dr. Mark Powell|2059346007|mfpowell@uabmc.edu|
20196387|NCT01055262|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
20196388|NCT03370471|Atlanta VA Health Care System|Amy D Rodriguez, PhD|404-321-6111|amy.rodridguez@va.gov|204201
20196389|NCT00865969|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20196390|NCT00561951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20196391|NCT01765179|Clarus Therapeutics|Sr. VP Clinical and Medical Affairs|847-562-4300|tdanoff@clarustherapeutics.com|
20196392|NCT01581541|Stanford University School of Medicine|Dr. Shivaani Kummar|650-724-9084|skummar@stanford.edu|
20196393|NCT04329832|Intermountain Healthcare|Naresh Kumar|8013827483|naresh.kumar@imail.org|
20196394|NCT00392327|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20196395|NCT00986440|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20196396|NCT00178126|University of PIttsburgh|David Brienza|(412) 624-6383|DBrienza@pitt.edu|
20196397|NCT04009850|Yale School of Medicine|Dr. Krysten Bold|203-974-7603|krysten.bold@yale.edu|
20196398|NCT01281969|NIMH|Dr. David I. Driver|301.496.1683|david.driver@nih.gov|
20196399|NCT01323634|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196400|NCT05056987|Alcon Research, LLC|Senior Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20196401|NCT01182194|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20196402|NCT02520284|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20196403|NCT05462886|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20196404|NCT02181387|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
20196405|NCT02903368|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
20196406|NCT06515483|Loops, LLC|Steven Kayser, President|360-366-3009|stevenkayser@flossloops.com|
20196407|NCT00147823|SUNY Upstate Medical University|Timothy A. Damron, MD|315-464-8604|damront@upstate.edu|
20196408|NCT03217266|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20196409|NCT02101034|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
20196410|NCT01390181|Grand Traverse Heart Associates|Anna Booher|231 935-5800|annabooher3@gmail.com|
20217603|NCT02010996|changhai hospital|Bi-Hongda|86-13918233009|bihongda0411@yahoo.com.cn|
20196411|NCT03081052|Duke University|Kamrouz Ghadimi, M.D., M.H.Sc.|919-681-6532|kamrouz.ghadimi@duke.edu|
20217604|NCT01009515|University of New Mexico|Montaser Shaheen, MD, PhD|505-925-0404|MoShaheen@salud.unm.edu|
20217605|NCT01321437|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
20217606|NCT01966809|Medical College of Wisconsin|Dr. Harry T. Whelan|414-266-7516|hwhelan@mcw.edu|
20217607|NCT01501110|Hospital de Clínicas de Porto Alegre|Josi Vidart|+55 51 98472520|josividart@gmail.com|
20217608|NCT03573817|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
20217609|NCT03554317|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Mark Markowski|410-614-0567|mmarko12@jhmi.edu|
20217610|NCT00444821|Medtronic|Kristel Wittebols|707-591-3275|kristel.wittebols@medtronic.com|
20217611|NCT01832402|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
20217612|NCT00612677|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D., via Moffitt Cancer Center|813-745-3050|alberto.chiappori@moffitt.org|
20217613|NCT01491633|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-3000|phammerman@partners.org|
20196412|NCT00955487|University of Colorado School of Medicine/Children's Hospital Colorado|Dr. John Kinsella|(303) 724-2853|john.kinsella@ucdenver.edu|
20196413|NCT01101477|Chang Gung Memorial Hospital|Dr. Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
20196414|NCT00720941|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
20196415|NCT02544217|Khondrion B.V.|Edwin Spaans, PharmD.|+31654997700|spaans@khondrion.com|
20196416|NCT00819260|Dartmouth-Hitchcock|Carolyn L. Kerrigan MD|603-650-5148|carolyn.kerrigan@hitchcock.org|
20196417|NCT00667355|Abbott|Global Medical Services|1-800-633-9110||
20196418|NCT00937833|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
20196419|NCT02175004|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20196420|NCT00162032|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|Cesare.Orlandi@lantheus.com|
20196421|NCT00818389|Massachusetts General Hospital|Elizabeth Simpson|617-726-3430|esimpson1@partners.org|
20196422|NCT04263909|BWH Anesthesia|Linda S. Aglio, MD MS|6177328480|laglio@bwh.harvard.edu|33328
20196423|NCT05193500|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
20196424|NCT03840486|Emory University|Steven Lindsey, MD|913-706-0232|steven.m.lindsey@emory.edu|
20196425|NCT01806129|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20196426|NCT04442737|Janssen Scientific Affairs, LLC|Vice President Medical Affairs Infectious Disease and Vaccines (IDV)|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196427|NCT01720173|NRG Oncology|Angela Kuras on behalf of Wei Deng, PhD|716-845-5702|kurasa@nrgoncology.org|
20163782|NCT02501590|Head of The Pediatric Neurology and Developmental Unit|Aviva Mimouni-Bloch|97297709048|abloch@clalit.org.il|
20196428|NCT03673865|Emory University|Dina Amin|404-251-8895|dina.amin@emory.edu|
20196429|NCT03588728|University of Pittsburgh|Cynthia Conklin, Ph.D.|4125869840|conkca@upmc.edu|
20196430|NCT01388790|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20196431|NCT00195507|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20196432|NCT02202551|Adamas Pharmaceuticals, Inc.|Reed Johnson|510-450-3500|rjohnson@adamaspharma.com|
20196433|NCT02311998|The University of Texas MD Anderson Cancer Center|Nitin Jain MD/Associate Professor|713-745-6080|njain@mdanderson.org|
20196434|NCT00186069|Stanford University|Anna Girsen, Manager of Research Operations|(650) 725-5720|agirsen@stanford.edu|
20196435|NCT00759291|UT Southwestern|Dr. Joshua Beckman|214-648-3100|joshua.beckman@utsouthwestern.edu|
20196436|NCT01176773|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
20196437|NCT03586687|Penn State Hershey Medical Center|Cayce Onks, DO|7175317127|conks@pennstatehealth.psu.edu|
20196438|NCT01614743|DeNova Research|Steven H Dayan, MD|312-335-2070|sdayan@drdayan.com|
20196439|NCT02919657|Medfit Rx|David Michael|9196109893|dmichael@medfitrx.net|
20196440|NCT02446886|Weill Cornell Medicine|Research Coordinator|6469625736|liz4005@med.cornell.edu|
20196441|NCT04384848|Northwestern University|David Cella|312-503-1725|d-cella@northwestern.edu|
20196442|NCT00256451|University of Pennsylvania|David Oslin, MD|2158235894|oslin@upenn.edu|
20196443|NCT03478163|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
20196444|NCT01762722|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
20196445|NCT01285050|Johns Hopkins University|David Thomas|410-502-6043|dthomas@jhmi.edu|
20196446|NCT01498289|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
20196447|NCT01423253|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20196448|NCT02804178|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
20196449|NCT01290601|WRAIR|Shirley Lee-Lecher|301-251-5000|usarmy.detrick.medcom-wrair.mbx.ocid@mail.mil|
20196450|NCT04071795|NYU Langone Health|Erin Rogers|6465012544|Erin.Rogers@nyulangone.org|
20196451|NCT03057808|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
20196452|NCT00421707|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196453|NCT01401907|MGH|Jennifer Temel MD|617-724-4000|jtemel@partners.org|
20196454|NCT01948908|Columbia University College of Physicians and Surgeons|Daniel S. Tsze|212-305-9825|dst2141@columbia.edu|
20196455|NCT02197767|Mayo Clinic|Dr. Stephen B. Erickson|507-284-4083|Erickson.Stephen@mayo.edu|
20196456|NCT01280110|Departamento de Oftalmologia - Universidade Estadual de Campinas - Campinas - Brazil|Vital Paulino Costa|55-19-35217396|vp.costa@uol.com.br|
20196457|NCT01759407|Nationwide Children's Hospital|Nicole Elsey, MD|614-722-4200|Nicole.Elsey@nationwidechildrens.org|
20196458|NCT03737474|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20196459|NCT03349892|University of California, Los Angeles|Robert K. Chin, MD, PhD , Assistant Clinical Professor|(310) 825-9771|rkchin@mednet.ucla.edu|
20196460|NCT02370043|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
20196461|NCT01231516|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196462|NCT02225353|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
20196463|NCT02910739|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196464|NCT02513719|Abbott Vascular|Kusano Hajime|408-645-1626|hajime.kusano@av.abbott.com|
20196465|NCT05312151|Compass Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
20196466|NCT04223856|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20196467|NCT03226275|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20196468|NCT03442114|Cincinnati Children's Medical Center|Dr. Lori Crosby|5136365380|Lori.Crosby@cchmc.org|
20196469|NCT04968197|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|(480) 301-5351|Pradhan.Gaurav@mayo.edu|
20196470|NCT03511053|Dallas VA Medical Center|Dr. Thiru M. Annaswamy, Staff Physician, PM&R Service|2148570273|thiru.annaswamy@va.gov|
20196471|NCT02425644|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196472|NCT00733993|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
20196473|NCT02720536|Novartis Pharmaceuticals|Study Director|888-778-8300|Novartis.email@novartis.com|
20196474|NCT01028222|Study Director|Novartis|862-778-8300||
20196475|NCT00146328|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217614|NCT00860743|Wayne State University and John D. Dingell VA Medical Center|Jason H. Mateika|313-576-4481|jmateika@med.wayne.edu|
20163783|NCT02915263|Beth Israel Deaconess Medical Center|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
20163784|NCT02478463|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163785|NCT01290614|University of Minnesota|Paul Drawz, MD|6126255423|draw0003@umn.edu|
20196476|NCT00300781|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20196477|NCT00792805|Novartis Pharmaceuticals|Study Director|862 778-8300||
20196478|NCT02598557|UT MD Anderson Cancer Center|Parijatham S. Thomas, MD., Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
20196479|NCT01213589|Medtronic|Richard Jonkers, PhD|800-217-1617|richard.jonkers@medtronic.com|3727
20196480|NCT02072434|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@dsi.com|
20196481|NCT00619190|UNC Chapel Hill|Linmarie Sikich, MD|919-972-7499|lsikich@med.unc.edu|
20196482|NCT03599557|University of California, Los Angeles|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
20196483|NCT02952001|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20196484|NCT00389857|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
20196485|NCT00888433|Baker IDI Heart and Diabetes Institute|Murray Esler, Principal Investigator||murray.esler@bakeridi.edu.au|
20196486|NCT01810692|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20196487|NCT02276872|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
20163786|NCT00452868|Wake Forest Baptist Health|Dr. Janet Tooze|336-716-0286|jtooze@wakehealth.edu|
20163787|NCT01479868|Janssen Research & Development|Director & Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
20196488|NCT03312348|Sheffield Children's NHS Trust|Dr Shammi Ramlakhan - Chief Investigator|+44 1142262331|shammi.ramlakhan@sch.nhs.uk|
20196489|NCT04356183|Duke University|Kim Huffman, MD, PhD|919-613-7797|kim.huffman@duke.edu|
20196490|NCT00402363|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196491|NCT02090374|Imperial College London|Professor Trevor Hansel|+44 (0)20 3312 5733|t.hansel@imperial.ac.uk|
20196492|NCT00744523|Medtronic Aortic and Peripheral Vascular|Arslan Malik, Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20196493|NCT01139021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20196494|NCT02349451|AbbVie|Global Medical Services|800-633-9110||
20196495|NCT00078754|The University of Chicago|Dr. Emil F. Coccaro, MD|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
20196496|NCT04668586|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
20196497|NCT00412971|Fredriksberg hospital|Gregers G. Hermann|(+45) 38163536|gregershermann@hotmail.com|
20196498|NCT01106404|Neuromodulation Emerging Therapy Clinical Research, Medtronic, Inc|Mark Sun, Senior Clinical Research Manager|763-526-8098|mark.sun@medtronic.com|
20196499|NCT00775450|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20196500|NCT01749540|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196501|NCT00752622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196502|NCT00576836|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
20196503|NCT00894686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196504|NCT00287339|UNC_ChapelHill|Dr Nicholas Shaheen|919 9667047|nshaheen@med.unc.edu|
20196505|NCT00564018|UT Southwestern Medical Center|Soumya Adhikari, MD|214 456 5959|soumya.adhikari@utsouthwestern.edu|
20196506|NCT03267940|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
20196507|NCT01869075|Sunnybrook HSC|Artemis Diamantouros|416-480-6100|artemis.diamantouros@sunnybrook.ca|3654
20196508|NCT00388154|University of Texas (UT) MD Anderson Cancer Center|Jubilee Brown, MD/Associate Professor, Gynecology Oncology & Reproductive Medicine|713-745-8837|CR_Study_Registration@mdanderson.org|
20196509|NCT01074216|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
20196510|NCT00803270|New England Resesarch Institutes|Anne M. Stoddard|617-972-3331|astoddard@neriscience.com|
20196511|NCT02737917|Lincoln Medical Center|Dr. Nicholas Caputo|718-579-6010|ncaputo.md@gmail.com|
20196512|NCT00960531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196513|NCT00593957|Kennedy Krieger Institute|Dr Sakkubai Naidu Professor of Neurology and Pediatrics|443-923-2778|naidu@kennedykrieger.org|
20196514|NCT02411578|Jaeb Center for Health Research|Stephanie DuBose|813-975-8690|t1dstats2@jaeb.org|
20196515|NCT01030198|Cynosure, Inc.|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20196516|NCT00332189|BioMarin Pharmaceutical, Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
20196517|NCT05266586|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20196518|NCT03707925|UT MD Anderson Cancer Center|Roberto Casal, MD/ Associate Professor, Pulmonary Medicine|713-745-2645|rfcasal@mdanderson.org|
20196519|NCT01193920|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20196520|NCT03099005|UCSD|Brook Henry|(619) 543-4737|blhenry@ucsd.edu|
20196521|NCT04195958|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20196522|NCT02876835|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196523|NCT01117857|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
20196524|NCT04683731|Trustees of Indiana University|Dr. Peter H. Schwartz, MD, PhD|317-278-4037|phschwar@iu.edu|
20196525|NCT02791737|The Ohio State University Comprehensive Cancer Center|Dr. Ashley Rosko|614-293-3196|Ashley.Rosko@osumc.edu|
20196526|NCT00883051|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20196527|NCT01411839|University of California, San Francisco|Dr. John A. Sauceda|415-460-6045|john.sauceda@ucsf.edu|
20163788|NCT01618669|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Medical Affairs||Astellas.resultsdisclosure@astellas.com|
20163789|NCT01177007|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20163790|NCT03259087|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163791|NCT04950465|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20163792|NCT04308941|BostonSight|Dr. Daniel Brocks|(781) 726-7506|ecrowley@bostonsight.org|
20163793|NCT01155336|University of Rochester|Dr. Robert Block|585 275-3356|robert_block@urmc.rochester.edu|
20163794|NCT02230566|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
20163795|NCT02526277|The Ohio State University|Ariane Park, MD|614.293.4969|Ariane.Park@osumc.edu|
20163796|NCT01379183|Mayo Clinic|Dr. Jeff L. Fidler|507-284-5010|fidler.jeff@mayo.edu|
20163797|NCT02753946|Nabriva Therapeutics plc|Chief Medical Officer|(610) 816-6640|officeUS@nabriva.com|
20163798|NCT01369784|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (GELTAMO)|Dr. Carlos Panizo|+ 34 948 25 54 00|cpanizo@unav.es|
20163799|NCT02680665|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163800|NCT02905266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20163801|NCT04871425|University of Washington|Complex Family Planning Division|206.221.9074|uwfp@uw.edu|
20163802|NCT03149172|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
20163803|NCT02292719|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20163804|NCT05973006|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20163805|NCT02481297|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain/Associate Professor|713-745-6080|njain@mdanderson.org|
20163806|NCT05431478|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20163807|NCT02326597|Emory University|Lakshmanan Krishnamurti, MD|4047270710|lkrishn@emory.edu|
20163808|NCT02286921|SKCCC at JHU|Dr. Samual Denmeade|410-955-8875|denmesa@jhmi.edu|
20163809|NCT00770601|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
20163810|NCT00428948|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
20163811|NCT02506634|FirstSunYetSen|Dr. Niandi Tan|+86 15989117039|tanniandi@126.com|
20163812|NCT03884790|GreenBone Ortho SpA|Senior Clinical Affairs Manager|+393479747691|sonia.granados@greenbone.it|
20163813|NCT05907395|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163814|NCT04544956|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163815|NCT01099397|University of Florida|Mariellen Moore|352-273-6381|marielm@ufl.edu|
20163816|NCT02696759|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
20163817|NCT00003199|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
20163818|NCT00940498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163819|NCT00650845|Guerbet|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs.|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20163820|NCT03761810|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
20163821|NCT02267538|Peking University First Hospital|Dr. Dong-Xin Wang,PHD,the director of department of Anesthesiology and Critical Care Medicine|+8613910731903|wangdongxin@hotmail.com|
20163822|NCT03932760|University of Utah|Gwen Latendresse|801-587-9636|Gwen.Latendresse@nurs.utah.edu|
20163823|NCT04178720|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20163824|NCT00869518|University of California, San Francisco|Brian S. Schwartz, MD|415-476-5767|brian.schwartz@ucsf.edu|
20163825|NCT02774148|Spectrum Health|Andrea Mantel|616-486-2051|andrea.mantel@spectrumhealth.org|
20163826|NCT03922620|Geisinger Medical Center|Dr. Gerard Cush|5702716700|MSKIresearch@geisinger.edu|
20163827|NCT00983385|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
20163828|NCT02137096|University of Florida|John Fort, MD|352-273-9120|john.fort@ufl.edu|
20163829|NCT01223183|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
20187586|NCT04204083|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20187587|NCT05814211|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
20187588|NCT05856435|Cincinnati Children's Hospital Medical Center|Katie Nause|513-803-1506|Katie.Fox@cchmc.org|
20196528|NCT03282240|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20196529|NCT01675479|Abbott Medical Optics|Head of Clinical Science|714-247-8613|khileman@its.jnj.com|
20196530|NCT03620890|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD, Assistant Professor|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
20196531|NCT04596384|City of Hope|Virginia Sun, Professor|+16269888652|VSun@coh.org|
20196532|NCT04751656|University of Florida|Megan McVay|352-294-1638|megan.mcvay@ufl.edu|
20196533|NCT03253926|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
20196534|NCT01485354|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
20196535|NCT03566810|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20196536|NCT01103245|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|james.luther@vanderbilt.edu|
20196537|NCT00826111|Steward St. Elizabeth's Medical Center of Boston, Inc.|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
20196538|NCT02805725|Institut Bergonie|Pr Antoine Italiano|+ 33 5 47 30 60 88|a.italiano@bordeaux.unicancer.fr|
20196539|NCT02445196|Stanford University|Dr. C. Barr Taylor|415-987-1810|btaylor@stanford.edu|
20196540|NCT01195545|University of Washington|Brant Oelschlager, MD|206-543-3518|brant@uw.edu|
20196541|NCT01837069|NYU Langone Health|Jeffrey Berger|212 263 4004|Jeffrey.Berger@nyulangone.org|
20196542|NCT00567268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196543|NCT03236246|Keryx|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
20196544|NCT01794520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20196545|NCT04175808|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20196546|NCT00281021|James Graham Brown Cancer Center, University of Louisville|Dr. Goetz Kloecker|502-562-4358|ghkloe01@exchange.louisville.edu|
20196547|NCT02021292|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
20196548|NCT01386658|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20196549|NCT00592761|UAMS Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
20163830|NCT00163020|Obstetrix Medical Group, Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@pediatrix.com|
20196550|NCT02064855|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
20196551|NCT02465463|Emory|Dr. Tanvi Dhere|404-686-1000|tdhere@emory.edu|
20196552|NCT01087931|Vanderbilt University|Kevin O'Neill|615-936-5677||
20196553|NCT01067326|Mayo Clinic|Dr. Amir Lerman|507-255-4152|lerman.amir@mayo.edu|
20196554|NCT00696761|the Department of Urology, Asan Medical Center, University of Ulsan College|Kanghyon Song, Myung-Soo Choo, Kyu-Sung Lee, Ji-Yeon Han, Young-Suk Lee,|82-2-3010-3735|mschoo@amc.seoul.kr|
20196555|NCT00769860|University of Kansas Medical Center|Dr. Richard Barohn|(913) 588-6094|RBAROHN@kumc.edu|
20196556|NCT00934141|University of Wisconsin - Madison|Dr. David H Gustafson|608-890-1436|dhgustaf@wisc.edu|
20217615|NCT00823199|Bronx Psychiatric Center|Nigel Bark MD|7188625429|Nigel.Bark@omh.ny.gov|
20196557|NCT01629784|Northwestern University|Hae Bae, CRCC|312-695-6829|j-bae@northwestern.edu|
20196558|NCT03681886|Alcon, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20196559|NCT03291587|Wake Forest NCORP Research Base|Lead Biostatistician|3367160891|NCORP@wakehealth.edu|
20196560|NCT00796120|PharmaMar SA Av de los Reyes 1, Poligono Industrial La Mina 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
20217616|NCT02776553|University of Arkansas for Medical Sciences|Arny A. Ferrando, Ph.D.|501-526-5711|aferrando@uams.edu|
20217617|NCT02898103|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
20217618|NCT05197829|University of Massachusetts Chan Medical School|Mark O'Connor|508-334-1000|mark.oconnor2@umassmed.edu|
20217619|NCT01640184|Peking University International Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
20196561|NCT03482583|University of Florida|Dr. Ramzi Salloum, Assistant Professor|352-294-4997|rsalloum@ufl.edu|3522944994
20196562|NCT01477320|University of Louisville|Dr. Mohamed Saad|5028525841|mohamed.saad@louisville.edu|
20196563|NCT02513745|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
20196564|NCT01209143|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20217620|NCT01684878|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20163831|NCT03772665|Acucela, dba Kubota Vision|Dr. Jeff Gregory|2068058310|clinicaltrials@acucela.com|
20163832|NCT03678311|Cleveland Clinic|Dr. Reena Mehra|216-444-2165|mehrar@ccf.org|
20196565|NCT00267631|Maimonides Medical Center|Dr. Estevan Garcia, MD; Principal Investigator|718-283-6352|EsGarcia@maimonidesmed.org|
20196566|NCT00381303|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
20196567|NCT01211522|Vanderbilt University Medical Center|E Wesley Ely|‭(615) 936-3395‬|wes.ely@vumc.org|
20196568|NCT02441062|University of Iowa, Holden Comprehensive Cancer Center|M.Sue O'Dorisio|(319) 335-7234|sue-odorisio@uiowa.edu|
20196569|NCT01145755|AstraZeneca|Gerard Lynch|645895|aztrial_results_posting@astrazeneca.com|+44 1509
20196570|NCT02740972|NS Pharma, Inc.|Medical Affairs|(201) 986-3860|trialinfo@nspharma.com|
20196571|NCT01116882|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
20196572|NCT00547365|University of Tennessee Graduate School of Medicine|Alan Solomon, MD|865-305-9167|asolomon@utmck.edu|
20196573|NCT01139658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20196574|NCT03933774|St. Vincent's Hospital|Dr. Jung Min Bae|82-31-881-8982|jminbae@gmail.com|
20196575|NCT01777269|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196576|NCT00504881|UCB Clinical Trial Call Center|UCB (Study Director)|+1 877 822 9493||
20196577|NCT00352911|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
20196578|NCT01783041|Children's Hospital at Montefiore, Albert Einstein College of Medicine|Mamta Fuloria|718-904-4105|mfuloria@montefiore.org|
20196579|NCT03717129|Johns Hopkins University|Dr. Craig Hendrix|4109559707|chendrix@jhmi.edu|
20196580|NCT03796260|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20196581|NCT00753272|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196582|NCT00971243|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20196583|NCT01966471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20196584|NCT00742053|C.R. Bard|Christopher DiMatteo/Clinical Scineces Manager|801-522-5487|chris.dimatteo@crbard.com|
20196585|NCT02092220|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
20196586|NCT03481023|Riverside Medical Center|Dr. Brad Suprenant|(815) 939-9400|blsuprenant@comcast.net|
20196587|NCT00494481|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20196588|NCT05245097|ActiveProtective|Dr Rebecca J Tarbert|267-242-6125|Rebecca@activeprotective.com|
20196589|NCT04770493|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
20196590|NCT04931836|University of Minnesota|Mark Pereira, PhD|612-624-4173|map@umn.edu|
20196591|NCT00692978|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
20196592|NCT03254485|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
20196593|NCT03019796|University of Castilla-La Mancha|Proffessor|925268800|ricardo.mora@uclm.es|
20196594|NCT00475033|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20196595|NCT01377753|National Cancer Institute|Dr. Peter Pinto|240-760-6249|pintop@mail.nih.gov|
20196596|NCT03231943|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196597|NCT01572922|St. Jude Children's Research Hospital|Jane Hankins, MD|866-278-5833|Jane.Hankins@stjude.org|
20196598|NCT02818920|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
20196599|NCT01335009|Eisai Inc.|Eisai Medical Information|18882742378|esi_medinfo@eisai.com|
20196600|NCT00445068|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20196601|NCT04824521|University of Montana|Dr. Sarah Reese|7313940288|Sarah.reese@mso.umt.edu|
20196602|NCT04821869|Pulmonary Research Institute of Southeast MIchigan|Gary T Ferguson, MD, Director|248-478-6908|garytferguson@msn.com|
20196603|NCT03444324|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
20196604|NCT03769181|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20196605|NCT03971422|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20196606|NCT05640466|Sohag University|Hussien Sedik Mohamed, Orthopedic Surgery Resident, Sohag University|+20-1065840049|hussien_sediek_post@med.sohag.edu.eg|
20196607|NCT01444651|Massachusetts General Hospital|Dr. Jennifer Ho|617-726-6411|jho1@partners.org|
20196608|NCT03338192|Washington University Pain Center in St. Louis|Burel Goodin|3142736403|burel@wustl.edu|
20196609|NCT01929980|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-9063|Pooja.Khandelwal@cchmc.org|
20196610|NCT06078579|Cairo university|Dr. Bahaa Mahmoud Fawzy|+201033559646|bahaamust66@gmail.com|
20196611|NCT01570036|Cancer Insight|Program Director, Karen Arrington, RN, BSN|210-243-5711|karrington@cancerinsight.com|
20196612|NCT00969878|Baylor|Thomas Kosten|7137947032|kosten@bcm.edu|
20196613|NCT00568321|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196614|NCT01859078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196615|NCT00823901|MGH CURTIS|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
20196616|NCT01369511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196617|NCT05057923|DreamTec Research Limited|Keith Kwong|+85237052355|keithkwong@dreamtec.hk|
20196618|NCT01180998|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
20196619|NCT01376349|Alliance for Clinical Trials in Oncology|Debra Barton, R.N., Ph.D.||debbartn@med.umich.edu|
20163833|NCT02744092|Dana-Farber Cancer Institute|Dr. Jean Connors|(617) 632-3000|jconnors@bwh.harvard.edu|
20163834|NCT01633788|Allergan plc|Ronald Bradford|1-714-846-5486|Bradford_Ron@allergan.com|
20163835|NCT01929226|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
20163836|NCT03553758|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
20163837|NCT01227980|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|301-451-6960|melanies@mail.nih.gov|
20163838|NCT00287222|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
20163839|NCT00592904|Eisai Call Center|Eisai Inc.|888-422-4743||
20163840|NCT02640547|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20163841|NCT02525588|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
20163842|NCT03018691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20163843|NCT03618420|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
20163844|NCT03369418|UCLA|Kirsten Tillisch|1 310 208-5400|ktillisch@mednet.ucla.edu|
20163845|NCT01485094|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20163846|NCT01172535|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20163847|NCT05413668|Quotient Sciences|Jeffrey Levy|+44 (0)115 974 9000|jeffrey.levy@quotientsciences.com|
20163848|NCT02698826|Cooper University Health Care|Brian Roberts, MD/ REOX Study Director|856-342-2352|roberts-brian-w@cooperhealth.edu|
20163849|NCT02545608|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
20163850|NCT00945282|ViiV Healthcare|GSK Response Center|866-435-7343||
20163851|NCT01879683|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20163852|NCT01825187|New Hanover Regional medical Center|Dr. William Hope|(910)667-9233|william.hope@nhrmc.org|667
20163853|NCT01508169|Hospital de Clinicas da Universidade Estadual de Campinas (Unicamp)|Cecilia de Morais Barbosa|+55-19-35217113|cecimbarbosa@gmail.com|
20163854|NCT01698502|University of Copenhagen|Michael Lund|+45 3532 7519|michaeltl@sund.ku.dk|
20163855|NCT00004092|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626) 256-4673|pfrankel@coh.org|65265
20163856|NCT01961271|Mundipharma Pte Ltd|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
20163857|NCT03600740|Mayo Clinic|Erik H. Middlebrooks, M.D.|904-953-6696|Middlebrooks.Erik@mayo.edu|
20163858|NCT01702558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20163859|NCT01680666|Stanford University|Matias Bruzoni, MD|650-723-6439|mbruzoni@stanford.edu|
20163860|NCT02396212|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20196620|NCT01176968|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196621|NCT00718640|Janssen Inc., Canada|Director, Medical Affairs Oncology|416-382-5078||
20196622|NCT00819286|Biomet Microfixation|Brian Hatcher|904-741-4400|brian.hatcher@biomet.com|
20196623|NCT00068588|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20196624|NCT04098068|Sidney Kimmel Comprehensive Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20196625|NCT05664763|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
20163861|NCT01623115|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20163862|NCT06309953|Bausch & Lomb|Jason Vittitow, PhD|908-541-3060|jason.vittitow@bausch.com|
20196626|NCT03871829|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196627|NCT02993523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20196628|NCT03694418|Montana State University|Dr. Elizabeth Rink|4066000297|elizabeth.rink@montana.edu|
20196629|NCT04288778|Janssen Research & Development, LLC|Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196630|NCT04485104|Jazz Pharmaceuticals, Inc.|Director Clinical Trial Disclosure & Transparency|+1 215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20196631|NCT04092101|University of Vermont|Stacey C. Sigmon, PhD|802-656-9987|stacey.sigmon@uvm.edu|
20196632|NCT05057247|Dana-Farber Cancer Institute|Glenn J. Hanna, M.D.|617-632-309|glenn_hanna@dfci.harvard.edu|
20196633|NCT00784693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196634|NCT05458479|Massachusetts General Hospital Lurie Center for Autism|Dr. Robyn Thom|7818601700|rthom@mgh.harvard.edu|
20196635|NCT00528866|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20196636|NCT02888665|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
20196637|NCT00993915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163863|NCT00940901|Johns Hopkins University, School of Medicine|Dr. Arthur L. Burnett, Director of Sexual Medicine Fellowship Program|410-614-3986|aburnett@jhmi.edu|
20202971|NCT01938170|UNC Chapel HIll|Ravi Jhaveri MD|919-962-5136|ravi.jhaveri@unc.edu|
20163864|NCT01338818|Novartis Pharmaceuticals|Study Director|8627788300||
20196638|NCT01368809|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Paul F White|214-7703775|paul.white@cshs.org|
20196639|NCT02430051|University of Southern California|Dr. Leah Stein Duker|(323)442-0371|lstein@chan.usc.edu|
20196640|NCT02198430|Real Fundación Victoria Eugenia|Dr. Rubén Cuesta-Barriuso|+34913146508|ruben.cuestab@gmail.com|
20196641|NCT03272763|Fisher & Paykel Healthcare Ltd.|Rebecca Thomson|+64 9 574 0123|Rebecca.Thomson@fphcare.co.nz|7675
20196642|NCT01050907|Fast-Track Drugs and Biologics, LLC|Jonathan D. Berman|301-922-2097|jberman@fasttrackresearch.com|
20196643|NCT02030405|Stanford University Medical Center|Bruno Carneiro de Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
20196644|NCT00132496|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
20196645|NCT04526197|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20196646|NCT01136811|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
20196647|NCT00372385|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
20196648|NCT05062083|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
20196649|NCT01119001|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
20196650|NCT04343248|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
20196651|NCT03604523|UMass Medical School|Dr. David Cave|508-856-8399|david.cave@umassmemorial.org|
20196652|NCT06389838|Kranus Health GmbH|Director of Clinical Trials|+491756939818|medical@kranushealth.com|
20196653|NCT01162317|Atlanta VAMC|Wei Huang (PI)|404-321-6111|wei.huang@va.gov|6517
20196654|NCT01005459|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
20196655|NCT00810394|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20196656|NCT00467285|Samuel Stratton VAMC|Dr. Subhashini Yaturu|518-626-5642|Subhashini.Yaturu@va.gov|
20196657|NCT03891524|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196658|NCT01598311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163865|NCT01620086|University of Arkansas for Medical Sciences|Erik Messias, MD|501-526-8142|emessias@uams.edu|
20196659|NCT00658684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196660|NCT00688103|School of Medicine, Toho University|Dr. Hideto Kameda|+81-3-3468-1251|hideto.kameda@med.toho-u.ac.jp|2326
20196661|NCT06605391|Emory University|Fayron Epps, PhD, RN|678-723-8188|fepps@emory.edu|
20196662|NCT03144804|Massachusetts General Hospital|Aparna Parikh, MD|617-339-8452|aparna.parikh@mgh.harvard.edu|
20196663|NCT04417127|Brown University School of Public Health|Omar Galarraga, PhD (Study Contact PI)|+1 (401) 863-2331|omar_galarraga@brown.edu|
20196664|NCT06060717|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
20196665|NCT06018844|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
20196666|NCT02087748|Lotus Clinical Research, LLC|Anne Arriaga, VP of Clinical Operations|626-397-3412|anne@lotuscr.com|
20196667|NCT00509665|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20196668|NCT01672788|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20196669|NCT03874325|Moffit Cancer Center|Hung Khong, MD|813-745-3828|hung.khong@moffitt.org|
20196670|NCT03329196|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
20196671|NCT01128361|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
20196672|NCT04796896|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20196673|NCT05972733|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
20196674|NCT04533451|Mayo Clinic|Dr. Aminah Jatoi|507-266-9160|Jatoi.Aminah@mayo.edu|
20196675|NCT01177787|Gachon University of Medicine and Science|Dr. Kyu Rae LeeMD.PhD.|8232-770-1215|baria07@daum.net|
20196676|NCT02158520|Mayo Clinic|Svetomir N. Markovic MD, PhD|507/266-0800|markovic.svetomir@mayo.edu|
20196677|NCT01637623|University of Wisconsin School of Pharmacy|John M. Dopp|608-265-9352|john.dopp@wisc.edu|
20196678|NCT02824263|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
20196679|NCT01676909|Department of Veterans Affairs, VAMHCS MIRECC|Mary Brighid Walsh|410-637-1860|marybrighid.walsh@va.gov|
20196680|NCT02076113|Lahey Hospital & Medical Center|Zoher Ghogawala, MD|781-744-8984|zoher.ghogawala@lahey.org|
20196681|NCT03260595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163866|NCT00740207|Bracco Diagnostics Inc.|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
20163867|NCT05065905|Saint-Petersburg State Medical Academy n.a. I.I.Mechnikov of Ministry of Health, Saint-Petersburg, Russia, 195067|Dr. med. Sc., Prof. Tamara Sologub|+78125439609|mechnik@mail.ru|
20163868|NCT05202418|Emory University|Dr. Bonney Reed|404-727-8312|ebreed@emory.edu|
20163869|NCT02562716|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|smcdonou@fredhutch.org|
20163870|NCT00684996|SWOG Statistical Center|Study Statistician|206-667-4623||
20163871|NCT01775371|Albert Einstein College of Medicine|Dr. Polly Bijur|718-430-4217|polly.bijur@einsteinmed.edu|
20163872|NCT02519439|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20163873|NCT04400058|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
20163874|NCT01078441|ECOG Statistical Office|Study Statistician|617-632-3012||
20163875|NCT02868554|University of North Carolina at Chapel Hill|Ching-Chang Ko, DDS, PhD|919-537-3763|ching-chang_ko@unc.edu|
20163876|NCT04915729|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20163877|NCT04961541|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
20163878|NCT00191308|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163879|NCT00851279|Stereotaxis Inc.|Dr Qun Sha, MD, Director of Clinical Trials|314 678 6143|qun.sha@stereotaxis.com|
20163880|NCT03710642|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
20163881|NCT01970306|Memorial Sloan Kettering Cancer Center|Dr. Vivian Strong, MD|212-639-5056|strongv@mskcc.org|
20163882|NCT03066596|Montefiore Medical Center|Marina Reznik, MD, MS|718-741-2494|mreznik@montefiore.org|
20163883|NCT02864901|Office of Regulated Activities|Emily Badraslioglu, Senior Regulatory Advisor & FDA Sponsor Representative|(301) 619-6828|emily.d.badraslioglu.civ@health.mil|
20163884|NCT00782717|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937 and 817.568.6725|medinfo@alconlabs.com|
20163885|NCT02446717|AbbVie|Global Medical Services|800-633-9110||
20163886|NCT02538042|Duke University|Dr. F. Joseph McClernon|9196682963|joseph.mcclernon@duke.edu|
20163887|NCT05167825|Janssen Pharmaceutical K.K.|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20163888|NCT03967054|Colorado State University|Brian D. Foy, PhD.|970-491-3470|Brian.Foy@colostate.edu|
20163889|NCT04739436|Duke University Medical Center|Sherri L. Smith, PhD, AuD, CCC-A|(919) 684-2426|sherri.smith@duke.edu|
20163890|NCT00676013|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu|
20163891|NCT03201419|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20196682|NCT04231539|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20196683|NCT01222260|Columbia University Medical Center|Suzanne Lentzsch, M.D., PhD.|212-304-5485|sl3440@cumc.columbia.edu|
20196684|NCT03170154|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20196685|NCT02279862|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20196686|NCT02460666|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
20196687|NCT03431857|Zimmer Biomet|Emilie Rohmer, Clinical Ops manager|+41588548210|emilie.rohmer@zimmerbiomet.com|
20196688|NCT01323621|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196689|NCT00651157|Mayo Clinic Cancer Center|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
20196690|NCT01721603|University of California, San Francisco|Alain Algazi, MD|(415) 353-7552|Alain.Algazi@ucsf.edu|
20196691|NCT02088788|Geisinger|Melissa Troup|570-214-5433|matroup@geisinger.edu|
20196692|NCT03510988|Weill Cornell Medicine|Katerina Dodelzon, MD|646 962 9650|kad9090@med.cornell.edu|
20196693|NCT01163721|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20196694|NCT00688181|Boston Scientific Corporation|Director, Clinical Operations|(952) 930-6300|Teresa.Takle-Flach@bsci.com|
20196695|NCT01050205|University of Pittsburgh|Dr. Andrea Kriska|412-383-1286|aky@pitt.edu|
20196696|NCT00324701|Ralph H. Johnson VAMC|Leonard E. Egede, MD, MS|843-789-6670|Leonard.Egede@va.gov|
20196697|NCT01295281|Wellspect HealthCare|Dikran Shamoun|+46313764275|dikran.shamoun@wellspect.com|
20196698|NCT00292461|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
20196699|NCT00954421|University of Florida|Dr. Kelly Foote|352-273-5550|foote@neurosurgery.ufl.edu|
20196700|NCT01891721|VA Greater Los Angeles Healthcare System|Dr. Carol Jahchan|310-478-3711|carol.jahchan@va.gov|42953
20196701|NCT00633061|Univesity of Oklahoma College of Medicine|Janna Journeycake, MD||janna-journeycake@ouhsc.edu|
20196702|NCT02979925|VA San Diego Healthcare System|Albert Leung, MD|858-552-8585|albert.leung@va.gov|3866
20196703|NCT02708095|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20196704|NCT05629962|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
20196705|NCT05640648|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
20196706|NCT00458341|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20196707|NCT05461794|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20196708|NCT02083705|University of Alberta|Georg Schmölzer|7807354647|georg.schmoelzer@me.com|
20196709|NCT02730598|University of Kansas Medical Center|Neil Segal|(913) 945-8985|segal-research@kumc.edu|
20196710|NCT02271477|Ente Ospedaliero Cantonale|Dr. med. Andrea Saporito, Vice-Director of Anaesthesiology|091/811.89.78|andrea.saporito@eoc.ch|
20196711|NCT01104116|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
20196712|NCT01210118|Hellenic Anticancer Society|Professor Panagiotis Behrakis|00302106470056|pbehraki@hsph.harvard.edu|
20196713|NCT02958267|OhioHealth|Joseph J Ruane, DO|614-566-3810|joseph.ruane@ohiohealth.com|
20196714|NCT00777946|Novartis Pharmaceuticals|Study Director|862-778-8300||
20196715|NCT03221192|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196716|NCT05066724|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20196717|NCT01491893|Istari Oncology|Garrett Nichols, MD|(919) 245.7662|gnichols@istarioncology.com|
20196718|NCT00763867|Duke University|Jenny Ibarra|919.236.3291|jenny.ibarra@duke.edu|
20196719|NCT01389765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196720|NCT02069353|University of Pittsburgh|Jonathan Elmer|412-647-9489|elmerjp@upmc.edu|
20196721|NCT03645954|Lithuanian Univrsity of Health Sciences|Principal Investigator Inna Jaremko|+37064857386|inna.jaremko@kaunoklinikos.lt|
20196722|NCT03877432|Taipei Medical University|Dr. Chih-Wei Peng|886-2-27361661|cwpeng@tmu.edu.tw|3070
20196723|NCT01696942|Milton S. Hershey Medical Center|Dr. David Stewart|717-531-0003|dstewart@pennstatehealth.psu.edu|
20196724|NCT01422850|CytoVac A/S|Christer Lundell-Ek, Project Manager - Clinical Development||cle@cytovac.dk|
20196725|NCT04484831|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
20196726|NCT00508352|Ottawa Hospital Research Institute|Dr. Jean-Michel Caudrelier|613-737-8899|jcaudrelier@toh.ca|70216
20196727|NCT02244996|Hong Kong Polytechnic University|Dr. Henry Chan|85227667937|henryhl.chan@polyu.edu.hk|
20196728|NCT00174265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20196729|NCT01473160|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
20196730|NCT00047320|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
20196731|NCT03471871|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20196732|NCT02577601|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|503-494-0757|mccrimmo@ohsu.edu|
20196733|NCT03040622|Inova Heart and Vascular Institute|Kevin Bliden|443-244-1497|kevin.bliden@inova.org|
20196734|NCT05591274|University of Miami, Miller School of Medicine|Russell Saltzman|3052431152|R.Saltzman@med.miami.edu|
20196735|NCT03219320|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
20196736|NCT03078907|Actelion Pharmaceuticals Ltd|Clinical Registry group|844-434-4210|clinical-trials-disclosure@its.jnj.com|
20196737|NCT01955122|UMC Utrecht|Prof. Peter Siersema|+31 88 7559338|P.D.Siersema@umcutrecht.nl|
20196738|NCT00985166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196739|NCT02464228|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-002@kuraoncology.com|
20196740|NCT00530868|UAB|Lisle Nabell|205 934-3061|Lnabell@uabmc.edu|
20196741|NCT01117454|Vanderbilt University Medical Center|Dr. Prince J. Kannankeril, MD, MSCI|615 322-7447|prince.kannankeril@vanderbilt.edu|
20196742|NCT01774851|Merrimack Pharmaceuticals|MM-111 Medical Director|617-441-1000||
20196743|NCT00148954|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
20196744|NCT01681628|Thought field Therapy Foundation UK Ltd.|Dr R H Robson|+44 (0)1952550688|r.robson2@btinternet.com|
20196745|NCT00257686|Kowa Research Institute|Bill Arana|9194331600|barana@kowaus.com|
20196746|NCT00846651|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
20163892|NCT02701283|Medtronic Structural Heart & Aortic Clinical Research & Medical Science|Kristin Smith, Clinical Research Manager|763-526-3095|kristin.m.smith@medtronic.com|
20163893|NCT00892775|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163894|NCT00398320|Stanford University School of Medicine|Pamela L Kunz, MD|650-725-8738|pkunz@stanford.edu|
20163895|NCT00064792|NICHD, NIH|Dr. Forbes Porter, Clinical Director, NICHD|301-435-4432|fdporter@mail.nih.gov|
20163896|NCT03160898|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20163897|NCT03405818|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163898|NCT00121186|SWOG Statistical Center|Study Statistician|206-667-4623||
20163899|NCT02682992|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20163900|NCT00291486|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20163901|NCT03274063|University of Edinburgh|Dr Philip Riches|07944625313|priches@staffmail.ed.ac.uk|
20163902|NCT01045694|University of Missouri-Columbia|Stephen Colbert|573-882-2275|colberts@health.missouri.edu|
20163903|NCT00992459|Hyperion Therapeutics|Bruce Scharschmidt, MD, SVP, Chief MedicaL & Development Officer|650-745-7851|bruce.scharschmidt@hyperiontx.com|
20163904|NCT01408459|University of Illinois at Chicago|Dr. Phyllis E. Bowen|708-524-0586|pbowen@uic.edu|
20163905|NCT03421106|University of Connecticut|Caitlin Caspi|(860) 486-2834|caitlin.caspi@uconn.edu|
20163906|NCT01023724|Bucci Laser Visiosn|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
20163907|NCT01511016|Baylor College of Medicine|Leanne Scott, PhD, Director of Sponsored Programs|713-798-6978|lbscott@bcm.edu|
20163908|NCT01025830|University of California Berkeley|Jayne Byakika Tusiime|1 510 219 7567|tusiimej@berkeley.edu|
20163909|NCT02578199|YALE|Dr. Rachel Barnes|203-785-6395|rachel.barnes@yale.edu|
20163910|NCT01657292|Birken AG|Head of pharmaceutical development|+49 7233 97490|t.zahn@birken.eu|
20163911|NCT02424175|Brigham and Women's Hospital|Dr. Jessica Allegretti|6177325500|jallegretti@bwh.harvard.edu|
20163912|NCT04725500|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20163913|NCT02986711|Penn State University College of Medicine|Jessica Yingst|7175310003|jmy5048@psu.edu|289511
20163914|NCT01467505|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20163915|NCT02807623|Defense Health Agency Immunization Healthcare Division South Atlantic Region Vaccine Safety hub|Laurie Housel|910-432-4015|laurie.a.housel.civ@mail.mil|
20163916|NCT03811340|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
20163917|NCT05104450|Veterans Health Administration|Dr. Lucas Donovan|206-277-6783|Lucas.Donovan@va.gov|
20163918|NCT01380769|Cerulean Pharma Inc.|Adrian Senderowicz|617 551 9600|asenderowicz@ceruleanrx.com|
20163919|NCT04057807|Yale School of Medicine|Adam Mecca|203.764.8100|adam.mecca@yale.edu|
20163920|NCT01080807|Cephalon, Inc.|Vice President, Medical Affairs|610-727-6353||
20163921|NCT02271698|Duke University Health System|Dr. Stuart Alan Grant|919-681-6437|stuart.grant@duke.edu|
20163922|NCT04472611|Yale University School of Medicine|Dr. Alexandra Lansky|203 737 2142|alexandra.lansky@yale.edu|
20163923|NCT00984308|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
20196747|NCT01566682|ProLung|Michael Garff, Chief Operating Officer|8012049625|mag@prolunginc.com|
20196748|NCT04229472|Oxford University Hospitals NHS Foundation Trust|Timothy R Betts|+44 (0)1865 220256|timothy.betts@cardiov.ox.ac.uk|
20163924|NCT00790192|Sunovion|Josephine Cucchiaro, PhD, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
20163925|NCT03456076|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20196749|NCT03422172|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196750|NCT05787782|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20196751|NCT05736211|Wake Forest University School of Medicine|Dr. Parissa Ballard|704-355-2000|parissa.ballard@advocatehealth.org|
20196752|NCT00980681|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20196753|NCT00992511|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163926|NCT02045095|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20196754|NCT04615247|Principal Investigator|Alison Huang, MD|415-353-7900|alison.huang@ucsf.edu|
20196755|NCT00247377|UCI|Ninh Nguyen|714-456-8598|ninhn@uci.edu|
20196756|NCT02743377|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
20196757|NCT04658186|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20196758|NCT03952585|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20196759|NCT00954174|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
20196760|NCT02234323|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
20196761|NCT00867113|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20196762|NCT01886313|Winston Pharmaceuticals|Dr. Scott B. Phillips|8473628200|scott@winstonlabs.com|
20196763|NCT04614662|The Hospital for Sick Children|Lillian Sung|4168135287|lillian.sung@sickkids.ca|
20196764|NCT01207726|SKCCC|Charlie Rudin, MD|646.888.4527|rudinc@mskcc.org|
20196765|NCT01633814|University of Missouri|Principal Investigator|573-884-5220|fadelp@health.missouri.edu|
20196766|NCT01774084|Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden;|Thomas Nyström MD, PhD|+4686163211|thomas.nystrom@ki.se|
20196767|NCT02973048|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
20196768|NCT02097641|University of California San Francisco|Michael A. Matthay, MD|415-502-7434|michael.matthay@ucsf.edu|
20196769|NCT02340091|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20196770|NCT01906346|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
20196771|NCT01786239|Northwell Health|Delbert Robinson MD|7184708195|drobinso@northwell.edu|
20196772|NCT00364156|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
20196773|NCT02511678|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
20163927|NCT02459119|Dana Farber Cancer Institute|Dr. Guru Sonpavde, MD|617-632-2429|gsonpavde@gmail.com|
20217621|NCT00810888|Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center|Dr Jane Khoury, Professor of Pediatrics|513-636-2690|jane.khoury@cchmc.org|
20217622|NCT01435031|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
20217623|NCT02927834|Loma Linda University|Dr. Kristin Seiberling|9095582002|kseiberling@llu.edu|
20217624|NCT03746002|University of Maryland School of Pharmacy|Brent Reed|410-706-1452|breed@rx.umaryland.edu|
20217625|NCT04925713|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
20217626|NCT00613730|Amgen Inc.|Study Director|866-572-6436||
20217627|NCT00479388|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20217628|NCT00777855|UCSF|Leslie Benet|(415) 476-3853|leslie.benet@ucsf.edu|
20217629|NCT01876368|Novartis Pharmaceuticals|Study Director|862-778-8300||
20217630|NCT00611325|Duke University Medical Center|Dr. Katherine B. Peters|(919) 684-6173|katherine.peters@duke.edu|
20217631|NCT02563769|Temple University Episcopal Hospital|Yaminah Carter Research Coordinator|2678097602|yaminah.carter@tuhs.temple.edu|
20217632|NCT01644149|PharmaJet, Inc.|Marilyn Dysart, Clinical Affairs Manager|720-214-9399|marilyn.dysart@pharmajet.com|
20217633|NCT00104247|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
20163928|NCT01837277|Federal University of Bahia|Professor Carlos Brites|+5555992329552|crbrites@hotmail.com|
20196774|NCT00680823|Children's Hospital of Pittsburgh|Dr. Robert Hickey|412 692 7692|robert.hickey@chp.edu|
20196775|NCT02208297|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20196776|NCT05125679|Janssen-Cilag Limited|Senior EMEA Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196777|NCT04908189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20217634|NCT00925756|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
20217635|NCT01411488|Cleveland Clinic|Nancy Albert|216-444-7028|albertn@ccf.org|
20196778|NCT05101707|Medical University of South Carolina|Dr Dorothea Jenkins|(843)792-2112|jenkd@musc.edu|
20163929|NCT01020786|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196779|NCT00607022|University of Iowa|Clark Stanford|319-335-7381|CStanford@uiowa.edu|
20196780|NCT04540133|UCSF|Dr. Alessandro Villa|415-476-2045|Alessandro.Villa@ucsf.edu|
20196781|NCT05090995|Yale University School of Medicine|Lisa Fucito, PhD|203-200-1470|Lisa.fucito@yale.edu|
20196782|NCT04893577|University of Utah MidValley Dermatology|Christopher Hull, MD|801-213-0375|adrianne.evans@hsc.utah.edu|
20163930|NCT01818596|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20163931|NCT01740414|New York State Psychiatric Institute|Dr. Sandra Comer|646-774-6146|comersd@nyspi.columbia.edu|
20163932|NCT03081156|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|William Stringer, MD|424-571-7626|stringer@ucla.edu|
20163933|NCT03767257|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz, MD, PhD|646-608-3714|hultcram@mskcc.org|
20163934|NCT04435366|Astellas Pharma Global Development, Inc|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20163935|NCT04502290|University of Pittsburgh|Amit Sethi|4123836619|asethi@pitt.edu|
20163936|NCT00837213|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163937|NCT02293798|Mark Mofid, M.D.|Dr. Mark Mofid|8589099000|drmofid@drmofid.com|
20163938|NCT01556451|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20163939|NCT04497116|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
20163940|NCT04152772|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|Mascha_vant_Wout@brown.edu|
20163941|NCT01358825|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163942|NCT03782233|The First Affiliated Hospital of Nanjing Medical University|Dr. He Huang|13852476684|hh19871117@126.com|
20163943|NCT03742973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20163944|NCT04524858|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
20163945|NCT02109640|University of Edinburgh|Hugh M Paterson|44 131 537 1000|hugh.paterson@ed.ac.uk|
20163946|NCT03740659|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
20163947|NCT02366195|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20163948|NCT00113841|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-9660|xzhou@mdanderson.org|
20163949|NCT03507036|UT Southwestern|Jennifer Barillas|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20163950|NCT01788566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163951|NCT00580723|University of California, Irvine|Brian Swasdibutra, Clinical Research Coordinator|9498247103|bswasdib@uci.edu|
20163952|NCT00556998|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163953|NCT00895284|Mayo Clinic|Dr. Rosanne Kho|408-301-5811|kho.rosanne@mayo.edu|
20163954|NCT03030417|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
20163955|NCT01539759|University of North Carolina|Erika Levi, MD and Gretchen Stuart, MD|(919) 843-5633|Erika.Levi@gmail.com|
20163956|NCT01076959|Abbott|Global Medical Services|800-633-9110||
20163957|NCT01425801|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20163958|NCT02175017|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
20163959|NCT02491983|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
20163960|NCT02330055|Beth Israel Deaconess Medical Center|Dr. Matthias Eikermann|6176673364|meikerma@bidmc.harvard.edu|
20163961|NCT02959437|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20163962|NCT01951651|Baylor|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
20196783|NCT02673619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20217636|NCT02820740|Monteris Medical|Clinical Program Manager|763-401-1727|medicalaffairs@monteris.com|
20217637|NCT04965389|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20217638|NCT03903159|University of Minnesota|Amy Krentzman|612-625-2312|akrentzm@umn.edu|
20217639|NCT03060759|Massachusetts General Hospital|Farrah J. Mateen, MD, PhD, Associate Professor of Neurology|617-724-8653|fmateen@mgh.harvard.edu|
20217640|NCT03770078|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
20217641|NCT03718117|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196784|NCT03834038|Vancouver Island Health Authority|Dr. Christine Lee|250-519-1898|christine.lee@islandhealth.ca|
20217642|NCT01382251|Department of Anesthesiology, The Ottawa Hospital|Dr. Gregory L Bryson|613.761.4169|glbryson@ottawahospital.on.ca|
20217643|NCT01839695|Medtronic Vascular|Taryn Dellaripa, Principal Clinical Research Specialist|541-301-3181|taryn.dellaripa@medtronic.com|
20217644|NCT01117987|Novartis Pharmaceuticals|Study Director|862-778-8300|Trialandresults.registries@novartis.com|
20217645|NCT01246713|BIDMC|Michael Ganetsky, MD|6177542323|mganetsk@bidmc.harvard.edu|
20217646|NCT00206102|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20217647|NCT03623035|Wake Forest Baptist Health|Christopher Edwards|3367168222|chedward@wakehealth.edu|
20217648|NCT00834236|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
20217649|NCT04232540|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
20217650|NCT02774850|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
20217651|NCT04230876|Amptify|Chris Cardinal|3143999940|Chris@amptify.com|
20217652|NCT02093923|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20217653|NCT03200535|Kaiser Permanente Colorado|Dr. Emily Schroeder|303-636-2478|emily.b.schroeder@kp.org|
20217654|NCT01662362|Abbott|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
20217655|NCT01451996|University of Chicago|Anup Malani, J.D., Ph.D|773-702-9602|amalani@uchicago.edu|
20217656|NCT04350008|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20196785|NCT01313117|Northwestern University|Jeffrey Allen M.D.|312-695-8636|jallen1@nmff.org|
20196786|NCT01786187|Michigan State University|Amy Hoffman, RN, PhD|517 355 8348|amy.hoffman@ht.msu.edu|
20196787|NCT01350453|University of Southampton|Jane Burridge|+44(0)2380 598 885|jhb1@soton.ac.uk|
20196788|NCT03602261|OPKO Health|Akhtar Ashfaq|305-575-423|AAshfaq@opko.com|
20196789|NCT02960113|Rutgers Robert Wood Johnson Medical School|Shaul Cohen, MD|732-235-8717|chohensh@rwjms.rutgers.edu|
20196790|NCT03157232|Masimo|Tala Harake||studies@masimo.com|
20196791|NCT04697264|University of Surrey|Miss Irene Ray|07490749704|i.ray@surrey.ac.uk|
20196792|NCT00909792|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20196793|NCT03434353|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20196794|NCT01990534|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20196795|NCT00234494|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20196796|NCT01831544|Medtronic|Methee Schreuder|+31611597388|methee.schreuder@medtronic.com|
20196797|NCT01521897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196798|NCT02194062|Yale School of Medicine|Paul Neubauer|2037855430|paul.neubauer@yale.edu|
20196799|NCT00293722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196800|NCT00538304|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20196801|NCT05344092|Department of Veterans Affairs|Dr. Erin Reilly|781-687-2000|Erin.Reilly@va.gov|4191
20196802|NCT03865940|Vanderbilt University Medical Center|Shelby Meier, PhD - Senior Scientific Project Manager|6159369228|shelby.meier@vumc.org|
20196803|NCT02634346|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20196804|NCT04498169|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs.|+1 908-947-3551|msenchyna@aeriepharma.com|
20196805|NCT01662115|Cleveland Clinic Florida|Chief Academic Office|9546595278|weisse@ccf.org|
20196806|NCT02691260|University of Wisconsin-Madison|Corrine Voils|608-262-9636|voils@surgery.wisc.edu|
20196807|NCT03118674|Wake Forest School of Medicine|Herbert L. Bonkovsky, MD|3367137341|hbonkovs@wakehealth.edu|
20196808|NCT01324323|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20196809|NCT00908232|Janssen-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492||
20196810|NCT03153137|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196811|NCT01821378|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20196812|NCT02260882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196813|NCT01601847|Case Western Reserve University|Dr. Anna Maria Hibbs|216-844-3387|annamaria.hibbs@cwru.edu|
20196814|NCT02267356|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@viamet.com|
20196815|NCT01063829|AiCuris Anti-infective Cures GmbH|Chief Medical Officer|004920231763|info@aicuris.com|0
20196816|NCT05073679|Penn State College of Medicine|Dr. Rosemary Claire Roden|717-531-1383|rroden@pennstatehealth.psu.edu|
20196817|NCT01284062|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196818|NCT00533468|Children's Hospital of Philadelphia|Dr James Reingold|6027516093|reingoldj@email.chop.edu|
20196819|NCT00559585|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20196820|NCT04209621|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Sun, Clare, M.D. Principal Investigator, NIH, NHLBI|301.402.1806|clare.sun@nih.gov|
20196821|NCT02249767|Spear Pharmaceuticals|Dr. Spear|239-560-2411|spear@spearpharm.com|
20196822|NCT01372410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196823|NCT02644941|Humacyte Global Inc|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
20196824|NCT04585646|CooperVision, Inc|Lee Hall, PhD|(925) 251 6684|lhall@coopervision.com|
20163963|NCT03622814|Medical University of South Carolina|Teresa Kelechi|843-810-3157|kelechtj@musc.edu|
20196825|NCT01145495|Weill Cornell Medical College|Peter Martin, M.D.||pem9019@med.cornell.edu|
20196826|NCT04044183|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
20196827|NCT00706550|Michael E. DeBakey Veterans Affairs Medical Center|Dr. Maria C. Rodriguez-Barradas|713-794-7384|Maria.Rodriguez-Barradas2@va.gov|
20196828|NCT01230788|Emory University|Dr. Todd Cooper|404-785-3000|tmcoope@emory.edu|
20196829|NCT04226833|Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
20196830|NCT01472380|Mutual Pharmaceutical Company, Inc.|VP, Clinical Development and Medical Affairs|215-697-1743|clinicaltrials@urlmutual.com|
20196831|NCT03829319|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20196832|NCT02846532|Janssen Research & Development, LLC|SR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196833|NCT04484259|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904-244-5515|francesco.franchi@jax.ufl.edu|
20196834|NCT03951220|University of Oxford|Gaurav Agarwal|07826636655|gaurav.agarwal@medsci.ox.ac.uk|
20196835|NCT05359003|Wake Forest University School of Medicine|Halley Alexander, MD, MS, FACNS|336-716-6898|halley.alexander@advocatehealth.org|
20196836|NCT03140423|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Susan S. Huang, MD, MPH|(714) 456-5047|sshuang@hs.uci.edu|
20196837|NCT06268288|Mayo Clinic|Lytitia Shea, M.D.|507-422-9847|shea.lytitia@mayo.edu|
20196838|NCT03049735|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20196839|NCT02146326|Indiana University|Michelle Salyers, PhD / Professor, Department of Psychology|317-274-2904|mpsalyer@iupui.edu|
20196840|NCT03153111|Actelion|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196841|NCT04225221|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-235-0858|jhbaker@med.unc.edu|
20196842|NCT01079130|Novartis Pharmaceuticals|Study Director|862-778-8300||
20196843|NCT01853982|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
20196844|NCT00390910|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196845|NCT01839487|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
20196846|NCT03622619|Eye Research Group, SOVS, UNSW Sydney|Dr Jacqueline Tan|02 9385 6551|jacqueline.tan@unsw.edu.au|
20163964|NCT03269994|Memorial Sloan Kettering Cancer Center|Dr. Michael D'Angelica, MD|212-639-3226|dangelim@mskcc.org|
20196847|NCT03714425|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
20196848|NCT04585776|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20196849|NCT01658826|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
20196850|NCT00724308|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
20163965|NCT04417361|UCSF|Jeffrey D. Sharon|4153532757|jeffrey.sharon@ucsf.edu|
20163966|NCT01862536|VA Boston Healthcare System|Dr. Ronald Goldstein|857-203-6578|Ronald.Goldstein@va.gov|
20196851|NCT06071754|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20196852|NCT01306890|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
20196853|NCT02217436|Rady Children's Hospital San Diego|Dr. Amy Williams Bryl|8589668036|abryl@rchsd.org|
20196854|NCT03739762|Kaiser Permanente|Dori Rosenberg, Principal Investigator|206-287-2532|dori.e.rosenberg@kp.org|
20196855|NCT00607880|Mayo Clinic|Albert G. Hakaim, M.D.||Hakaim.Albert@mayo.edu|
20196856|NCT02170389|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20196857|NCT01008696|Medical Affairs, Seoul, Korea|Clinical Research Associate|82-2-2094-4835||
20196858|NCT02366728|Duke University|Mustafa Khasraw, M.D.|919-668-6688|mustafa.khasraw@duke.edu|
20196859|NCT02960854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
20196860|NCT00221195|Tulane University|Cindy Leissinger|504-988-5433|cleissi@tulane.edu|
20196861|NCT01247571|NRG Oncology|Linda Gedeon for William Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
20196862|NCT01383161|University of California, Los Angeles|Gary Small, MD|310-825-0291|gsmall@mednet.ucla.edu|
20196863|NCT00833911|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20196864|NCT02431650|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
20196865|NCT01736085|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
20196866|NCT03942406|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
20196867|NCT01207596|International Clinical Research Institute|Srinivas Nalamachu|913-317-5300|nalamachu@yahoo.com|
20196868|NCT00216203|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20196869|NCT01621230|UTexasSouthwestern|Margaret Craig, MD|2142638919|maggieanes@gmail.com|
20196870|NCT02596620|Chang Gung Memorial Hospital, Taiwan|Dr. Wei-Chen Tai|886-975056026|luketai1019@gmail.com|
20196871|NCT01054144|Moffitt Cancer Center|Rachid Baz, MD|813-745-3163|Rachid.Baz@moffitt.org|
20196872|NCT02748018|Medtronic Diabetes|Colleen Haberman, Sr. Clinical Research Manager|6127503275|colleen.p.haberman@medtronic.com|
20196873|NCT06069778|BioNTech SE|BioNTech clinical trials patient information|+49 61319084|patients@biontech.de|0
20196874|NCT02856893|EORTC|Yassin Pretzenbacher|+32 2 774 1365|yassin.pretzenbacher@eortc.org|
20196875|NCT03801902|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20196876|NCT02310672|Actelion Pharmaceuticals Ltd|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196877|NCT03258554|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20196878|NCT04704336|NYU Langone Health|Olugbenga Ogedegbe, MD|646-501-3435|Olugbenga.Ogedegbe@nyulangone.org|
20196879|NCT00537485|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
20196880|NCT02119325|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196881|NCT05361668|Crinetics Pharmaceuticals, Inc.|Study Director|(858) 450-6464|medinfo@crinetics.com|
20196882|NCT00642382|Cartiva, Inc|Director Clinical Operations|770-754-3805|rtownsend@cartiva.net|
20196883|NCT04325308|University of Alabama at Birmingham|Ariel Salas|2059344680|asalas@uab.edu|
20196884|NCT00323297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196885|NCT01236105|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196886|NCT01603082|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9393|ClinicalTrialTransparency@astrazeneca.com|
20196887|NCT04086433|Regulatory Mark|Alison Sathe|5133047971|alison@regulatorymark.com|
20196888|NCT00852592|UPittsburgh|Assistant Professor of Psychiatry|412-246-5248|sitdk@upmc.edu|
20196889|NCT00634010|The University of Texas (UT) MD Anderson Cancer Center|Eduardo Bruera, MD, Chair, Palliative Care Medicine||CR_Study_Registration@mdanderson.org|
20196890|NCT01026142|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20196891|NCT05467774|MetroHealth Hospital/Case Western Reserve University|Dr. James Sulzer|5125419036|jss280@case.edu|
20196892|NCT01452854|UCSF|Dr. Mitchell Rosen|415-353-7394|thomas.remble@ucsfmedctr.org|
20196893|NCT00846885|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20196894|NCT01862640|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|DT-inquiry@otsuka.jp|
20196895|NCT04884763|Indiana University School of Dentistry|Dr. Domenick Zero|3179877507|dzero@iu.edu|
20196896|NCT01019317|University of Texas (UT) MD Anderson Cancer Center|Elias Joseph Jabbour MD/Assistant Professor|713-792-4764|eharriso@mdanderson.org|
20196897|NCT02178553|Mayo Clinic Rochester|Dr. James D. Hannon|507-284-7289|hannon.james@mayo.edu|
20196898|NCT05085665|Washington University in St. Louis|Dr. Philip Budge|314-747-5532|pbudge@wustl.edu|
20196899|NCT00695253|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Rodney A. White, M. D.|310 963-5230|rawhite@ucla.edu|
20196900|NCT01641809|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196901|NCT03294109|university of Californiia|Siamak Rahman, MD|310 2678839|sirahman@mednet.ucla.edu|
20196902|NCT03030235|Saint Luke's Hospital of Kansas City|PRESERVED-HF Study Manager|816-932-9858|PRESERVED-HF@saint-lukes.org|
20217657|NCT02339090|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
20163967|NCT04707469|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20163968|NCT04854694|FaceView Mask, LLC|Jeanne Hahne, MSN, RN|4155188574|jeannehahne@gmail.com|
20163969|NCT02784171|Canadian Cancer Trials Group|Dr. Lesley Seymour|613533600|lseymour@ctg.queensu.ca|75544
20163970|NCT04661150|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20163971|NCT04965688|Inova Health System|Adam Cohen, MD|7035767279|adam.cohen@inova.org|
20163972|NCT03868943|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7548|rstrowd@wakehealth.edu|
20163973|NCT02777827|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20163974|NCT04551066|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20163975|NCT00369577|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20163976|NCT03915470|Destiny Pharma|Clinical Project Manager|+44 (0)1273-704440|info@destinypharma.com|
20163977|NCT04441255|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20163978|NCT02679170|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20163979|NCT00549445|University of Alabama at Birmingham|J. Edwin Blalock, PhD|205-934-6439|blalock@uab.edu|
20163980|NCT01900652|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163981|NCT03566082|Smith + Nephew|Fleur Derdeyn, Principal Clinical Study Manager|0032 497 60 20 32|fleur.derdeyn@smith-nephew.com|
20163982|NCT00857857|GlaxoSmithKline|GSK Response Center|866-435-7343||
20163983|NCT04437485|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
20163984|NCT01454791|MS Center at Evergreenhealth Care|Theodore R, Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
20163985|NCT01412164|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
20163986|NCT01848158|Seattle Children's Hospital|Jane Di Gennaro, MD MS|206-987-6988|jane.digennaro@seattlechildrens.org|
20163987|NCT01389882|Seoul National University Hospital|Dr. Juyoung Lee|lamb4122@snu.ac.kr|lamb4122@snu.ac.kr|
20163988|NCT01045967|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20163989|NCT03057496|Schepens Eye Research Institute of Massachusetts Eye and Ear|Alex Bowers|617 912 2512|alex_bowers@meei.harvard.edu|
20163990|NCT02040623|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20163991|NCT00280917|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20163992|NCT03529110|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20163993|NCT01584232|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20163994|NCT03689582|University of Michigan Rogel Cancer Center|Morand Piert, MD|734-936-5388|mpiert@med.umich.edu|
20163995|NCT02723773|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20163996|NCT00769886|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20163997|NCT04367831|Columbia University|Sahil A. Parikh, MD|212-305-3617|sap2196@cumc.columbia.edu|
20163998|NCT05904470|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
20163999|NCT04662359|University of Pennsylvania|Dr. Michael George|215-662-2454|michael.george@pennmedicine.upenn.edu|
20164000|NCT00381004|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
20164001|NCT03273673|Virginia Tech|Dr. Robin Queen|(540) 231-3134|rmqueen@vt.edu|
20164002|NCT00178477|University of Rochester Medical Center|Walter O'Dell, Ph.D.|585-275-9996|walter_odell@urmc.rochester.edu|
20164003|NCT03654690|Brown University|Dr. Tyler Wray|4018636659|tyler_wray@brown.edu|
20164004|NCT00742183|Mölnlycke Health Care|Viktoria Ahlenius Körner|+46-31-722 32 46|viktoria.ahleniuskorner@molnlycke.com|
20164005|NCT02430090|Ankara Numune Training and Research Hospital|Dr. Müge Çakırca|+905054433177|mugeturkoglu81@hotmail.com|
20164006|NCT03922581|Emory University|Abigail Lott, PhD|404-712-0159|abigail.lott@emoryhealthcare.org|
20164007|NCT00764699|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
20164008|NCT01508312|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz|212-639-4839|moskowia@mskcc.org|
20164009|NCT02223715|Otsuka Pharmaceutical Co., LTD.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
20164010|NCT00494585|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
20164011|NCT01507688|VA HSRD PRIS-M QUERI and CHIC HSRD Centers|Teresa Damush Ph.D.|317-988-4277|Teresa.Damush@va.gov|
20164012|NCT02107703|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20164013|NCT03906071|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20164014|NCT00466440|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20164015|NCT03187132|CedarsSinaiMC|R. Brennan Spiegel|310-423-6784|Brennan.Spiegel@cshs.org|
20164016|NCT00965081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20164017|NCT02541812|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
20164018|NCT01367834|UNC Chapel Hill|Rebecca Knickmeyer Santelli|9199662216|rebecca_knickmeyer@med.unc.edu|
20164019|NCT00988598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164020|NCT01303939|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
20164021|NCT02485561|Washington University in St. Louis|Amy McQueen|3142862016|amcqueen@wustl.edu|
20164022|NCT01141712|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20164023|NCT05350163|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
20164024|NCT03609177|Dana Farber Cancer Institute|James Tulsky, MD, Chair of Suppportive Oncology Department|617-582-9201|JamesA_Tulsky@dfci.harvard.edu|
20196903|NCT03690141|Effector Therapeutics|Mark Densel, Vice President Development Operations|8589258215|mdensel@effector.com|
20196904|NCT04744285|Roswell Park Comprehensive Cancer Center|Kris Attwood|877-275-7724|askroswell@roswellpark.org|
20196905|NCT01717768|TesoRx Pharma LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
20196906|NCT00448435|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196907|NCT00809523|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
20196908|NCT04195581|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
20196909|NCT00821431|ConvaTec|Kim Peters, Director of Clinical Affairs|07889841338|kim.peters@convatec.com|
20196910|NCT01387230|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196911|NCT03712189|Children's Hospital Los Angeles|Dr Todd P Chang|13233612109|tochang@chla.usc.edu|
20196912|NCT03026127|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
20196913|NCT04561765|Yale University|Ondrej Blaha|203.737.4468|ondrej.blaha@yale.edu|
20196914|NCT01182766|University of Virginia School of Medicine|Dr. Nassima Ait-Daoud Tiouririne|(434) 243-0570|NAT7B@uvahealth.org|
20196915|NCT03027557|Aalborg University Hospital|Professor Peter Vestergaard|+45 97 66 36 00|p.vestergaard@rn.dk|
20196916|NCT03270332|University of Miami|Dr. Adam Wanner|3053010563|awanner@miami.edu|
20196917|NCT02510560|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098626|Miki@elganpharma.com|
20196918|NCT01699789|RAND Corporation|Kenneth B. Wells|310-794-3728|kwells@mednet.ucla.edu|
20196919|NCT02554903|Actelion Pharmaceuticals US, Inc|Medical Affairs Associate Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196920|NCT00822588|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
20196921|NCT04427501|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20196922|NCT04974515|University of Miami, Miller School of Medicine|Naresh M. Punjabi, MD, PhD|305-243-6388|npunjabi@miami.edu|
20196923|NCT00639223|U. of Pennsylvania Health System|Steven Halbert MD, MSCE|215 510 2221|shalbert@mail.med.upenn.edu|
20196924|NCT04936841|University of Wisconsin School of Medicine and Public Health|Zachary Morris, MD, PhD|(608) 263-2603|zmorris@humonc.wisc.edu|
20196925|NCT01244451|GIMEMA|Alfonso Piciocchi|+39 06 70390528|a.piciocchi@gimema.it|
20196926|NCT01444209|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
20196927|NCT02540538|MaastrichtUMC|Astrid ML Oude Lashof, MD, PHD|0031433876644|a.oudelashof@mumc.nl|
20196928|NCT00408603|Sunesis Pharmaceuticals, Inc.|Dr. Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
20196929|NCT01557348|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20196930|NCT00403754|Novartis Pharmaceuticals|Study Director|862 778-8300||
20196931|NCT02000427|Amgen Inc.|Study Director|866-572-6436||
20196932|NCT04498832|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20196933|NCT02684357|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20196934|NCT04567615|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20196935|NCT05028517|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
20196936|NCT05772156|NewYork-Presbyterian Hospital, Columbia University Irving Medical Center|Intramuscular Methylergonovine to Decrease Blood Loss During Cesarean Delivery for Twins: A Triple-B|877-843-2229|hbg2115@cumc.columbia.edu|
20196937|NCT01426516|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
20196938|NCT05104476|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20196939|NCT04964960|University of Kentucky|Dr. John Villano|859-323-0405|jlvillano@uky.edu|
20196940|NCT01423812|The Ruth M. Rothstein CORE Center|Gregory Huhn, MD|312-572-4575|ghuhn@cookcountyhhs.org|
20196941|NCT03155373|Imperial College Healthcare NHS Trust|Jonathan Afoke|02033132026|j.afoke@nhs.net|
20196942|NCT02616614|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20196943|NCT02075411|Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|215-590-1858|gurnaney@email.chop.edu|
20196944|NCT05103280|University of Nebraska at Omaha|Sara A. Myers, PhD - Professor|(402) 554-3246|samyers@nebraska.edu; ffallahtafti@unomaha.edu|
20196945|NCT05649657|New Taipei Municipal Tucheng Hospital, Chang Gung Memorial Hospital|Dr. Shu-Chun Huang|0952818169|h0711@ms13.hinet.net|
20196946|NCT04598477|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
20196947|NCT05183360|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20196948|NCT05579990|University of Alabama at Birmingham|Dr. Camille Worthington|205-975-7274|cschneid@uab.edu|
20196949|NCT05118204|Albert Einstein College of Medicine|Aaron Fox|718-920-7173|adfox@montefiore.org|
20196950|NCT06263582|UNC Lineberger Comprehensive Cancer Center|Sorgi Kate|919-966-5280|kasorgi@email.unc.edu|
20196951|NCT01313650|GlaxoSmithKline|GSK Response Center|866-435-7343||
20196952|NCT03454308|Medical University of South Carolina|Dr. Jessica Chandler|843-792-1928|chandlje@musc.edu|
20196953|NCT05393037|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20196954|NCT01012739|Novartis Pharmaceuticals|Study Director|862 778-8300||
20196955|NCT04029480|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20217658|NCT02737592|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20196956|NCT04786119|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
20196957|NCT06132763|Virginia Commonwealth University|Sarah Farthing|804-527-4756|sarah.malone@vcuhealth.org|
20196958|NCT02593786|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20196959|NCT03857321|Atrium Health Wake Forest|Suzanne Craft, PhD|336-713-8846|suzcraft@wakehealth.edu|
20196960|NCT00012298|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
20196961|NCT03901053|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20196962|NCT02408861|Icahn School of Medicine at Mount Sinai|Dr Himanshu Joshi MBBS MPH PhD|2126599635|Himanshu.Joshi@mountsinai.org|
20196963|NCT03998176|University of Nebraska Medical Center|Josh Havens|402-559-2674|jhavens@unmc.edu|
20196964|NCT02656420|JHSPH|Dr. Thomas W. Kensler|410-955-1292|tkensle1@jhu.edu|
20196965|NCT01088464|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20196966|NCT01611948|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20196967|NCT01940354|Hospital of the University of Pennsylvania|Scott Trerotola, MD|215-662-6983|scott.trerotola@uphs.upenn.edu|
20196968|NCT01890148|AstraZeneca|Larsson, Bengt|+46 (0) 317064277|ClinicalTrialTransparency@astrazeneca.com|
20196969|NCT01215175|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20196970|NCT03872453|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20196971|NCT01678209|Icahn School of Medicine at Mount Sinai|Beth Krone, PhD|212-241-8014|beth.krone@mssm.edu|
20196972|NCT03756350|Venus Concept|Dr. Matthew Gronski|(888) 907-0115|mgronski@venusconcept.com|
20196973|NCT04283981|The University of Texas Health Science Center at Houston|Simon Young|(713) 486-2568|simon.young@uth.tmc.edu|
20196974|NCT01096342|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
20196975|NCT00929656|Malcom Randall VAMC|Dr. Dorian Rose, Research Health Scientist|352-376-1611|Dorian.Rose@va.gov|5238
20196976|NCT03308942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20196977|NCT01131351|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20196978|NCT01281007|EMS|Manager of Clinical Trials|+5501938874176|pesquisa.clinica@ems.com.br|
20196979|NCT04147234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
20196980|NCT00140231|BIDMC|Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
20196981|NCT04344860|University Of Pittsburgh|Nicoletta Machin|(412) 209-7280|machinnc2@upmc.edu|
20196982|NCT01233869|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20196983|NCT00729781|Medtronic Xomed, Inc.|David Hodge, Project Manager|(+1-904) 281-2774|david.l.hodge@medtronic.com|
20196984|NCT02378220|Harding University College of Pharmacy / Unity Health - White County Medical Center, Searcy, Arkansas, USA|Lindsay Elliott|5012794800|lselliott@harding.edu|
20196985|NCT00866723|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos|(617) 632-5269|panagiotisa_konstantinopoulos@dfci.harvard.edu|
20196986|NCT02616523|University Clinical Center Ljubljana|dr. Lea Andjelković|0038615223810|lea.andjelkovic@gmail.com|
20196987|NCT01975428|Scripps Translational Science Institute|Eric J. Topol, M.D.|858-554-5708|etopol@scripps.edu|
20196988|NCT00628251|AstraZeneca|Paula del Rosario|+44 7884 735492|ClinicalTrialTransparency@astrazeneca.com|
20196989|NCT01822522|AMC Operations and Data Management Cener|Kim Mosby-Griffin|301-251-1161|kmosby@emmes.com|10158
20196990|NCT01807923|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20196991|NCT02403622|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|mosman@openbiome.org|
20196992|NCT02558231|Actelion Pharmaceuticals Ltd.|Principal Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20196993|NCT00995007|National Cancer Institute|Dr. Katherine E. Warren|301-435-4683|warrenk@box-w.nih.gov|
20196994|NCT03933397|Duke Clinical Research Institute - Duke University Medical Center|Huiman Barnhardt, PhD|919-668-7313|huiman.barnhart@duke.edu|
20196995|NCT03367715|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
20196996|NCT01078207|Covidien|Fran Haury, RRT Research Coordinator, Clinical Affairs|303 305-2314|fran.haury@covidien.com|
20196997|NCT02066051|Mayo Clinic|Dr. Joanne F. Shen|480-301-8377|shen.joanne@mayo.edu|
20196998|NCT02257957|Universidad Nacional de Colombia|Dr Marcel Y Avila|+5713165000|myavilac@unal.edu.co|15119
20196999|NCT04721821|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197000|NCT01237340|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20197001|NCT01610687|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20197002|NCT03836807|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20197003|NCT00685685|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20197004|NCT04029116|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
20197005|NCT01272947|Novartis Consumer Health S.A.|Clinical Project Leader|+41 22 3635528||
20197006|NCT03531788|University of Pittsburgh|Roxanna M. Bendixen, Principal Investigator|4123836603|bendixen@pitt.edu|
20197007|NCT02469896|Barrow Neurological Institute|Shafeeq Ladha, MD|602-406-8989|Shafeeq.Ladha@Barrowneuro.org|
20217659|NCT04243096|Boston University|Deepak Kumar, PT, PhD|617-358-3037|kumard@bu.edu|
20217660|NCT02664987|Mundipharma Pte Ltd|Valerie Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
20217661|NCT01631682|Massachusetts General Hospital|Scott P. Orr, Ph.D.|617-643-7269|scott_orr@hms.harvard.edu|
20197008|NCT02019420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217662|NCT03183141|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
20217663|NCT04052698|Octapharma|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20164025|NCT04112810|Medical College of Wisconsin|William R Drobyski, MD, FACP, FASTCT|414-456-4941|wdrobysk@mcw.edu|
20164026|NCT05963022|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20164027|NCT01012258|Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
20164028|NCT03575403|University of Kentucky|Dr. Craig R. Rush, Ph.D.|8592575388|crush2@uky.edu|
20164029|NCT00773513|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
20164030|NCT02946034|Massachusetts General Hospital|Dr. Raymond Chung|617-726-5925|Chung.Raymond@mgh.harvard.edu|
20164031|NCT04544358|University of Illinois at Chicago|Dr. David X Marquez|312.996.1209|marquezd@uic.edu|
20164032|NCT03359174|Yale Univeristy|Clinical Research Coordinator|203 737 6839|laura.cusack@yale.edu|
20164033|NCT00239733|Weill Cornell|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
20164034|NCT03715803|Universidad de Buenos Aires|Dr. Agustín Sampietro|+5491158336327|asampietro@live.com.ar|
20164035|NCT01332994|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20164036|NCT04170543|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20164037|NCT04303559|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
20164038|NCT00592488|Vanderbilt University|Todd Rice, MD|615 322-3412|todd.rice@vanderbilt.edu|
20164039|NCT04378270|University of Pittsburgh|Jeffrey Gusenoff, MD|(412) 641-3960|gusenoffja@upmc.edu|
20164040|NCT01327599|Alcon Research, Ltd.|Doug Hubatsch, Therapeutic Unit Head, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20164041|NCT01156714|VAORD|Fred Ivey|410-605-7000|Frederick.Ivey@va.gov|6582
20164042|NCT01132313|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164043|NCT02052752|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164044|NCT04266795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20164045|NCT03043872|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20164046|NCT00434109|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
20164047|NCT02937558|Xeris Pharmaceuticals, Inc.|Khaled Junaidi|312-517-1461|xerisclintrials@xerispharma.com|
20164048|NCT04186871|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20197009|NCT02401412|Hollister Incorporated|Stacy Haddad, Global Clinical Affairs Director|847-680-2837|stacy.haddad@hollister.com|
20164049|NCT03790917|National Medical Research Center for Preventive Medicine|professor Sergey Yu. Martsevich|89161643690|sergeymartsevich@mail.ru|
20197010|NCT02374398|Eastern Maine Medical Center|Dr. Alexandru Seviciu|207-973-5918|aseviciu@emhs.org|
20197011|NCT00882310|Columbia University|Paul Oberstein, MD|212-305-0592|po2178@cumc.columbia.edu|
20197012|NCT01093625|Vistakon|Katherine E. Osborn||clinicalstudies@its.jnj.com|
20197013|NCT04722250|Medtronic Cardiovascular|Myra Fan Director|763 514 4000|rs.smarttrial@medtronic.com|
20197014|NCT01464229|MGH|Esther Howe|617-726-8895|ehowe3@partners.org|
20197015|NCT02756351|CytaCoat AB|Dr Jacob Odeberg|+46 (0) 70 2087571|jacob.odeberg@scilifelab.se|
20197016|NCT04233164|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Franco, Luis|+1 240 220 4366|luis.franco@nih.gov|
20197017|NCT00717054|Drexel University College of Medicine|Michael Green, DO|215-762-7798|michael.green@drexelmed.edu|
20197018|NCT04556396|Loyola University Medical Center|Kristin Baldea|708-216-9000|kbaldea@lumc.edu|
20197019|NCT01843218|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20197020|NCT01431534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197021|NCT01009554|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20197022|NCT01605253|Rush University Medical Center|Mark Pollack, MD|3129425372|mark_pollack@rush.edu|
20197023|NCT01405937|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197024|NCT04145544|Nurami Medical Ltd|Dr. Amir Bahar (COO & Clinical Director)|+972-747408888|Amir@nurami-medical.com|
20197025|NCT04201821|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20197026|NCT01868139|University of Maryland School of Medicine|Dr. Bruce Greenwald|4103288731|bgreenwa@medicine.umaryland.edu|
20197027|NCT00835120|University Hospitals Case Medical Center|Carla Conroy|216-844-2871|carla.conroy@Uhhospitals.org|
20197028|NCT02564926|Astrazeneca, Korea|EunYoung Kim / Local Study Specialist|82 2 2188 0946|EunYoung.Kim@astrazeneca.com|0946
20197029|NCT00617188|Masonic Cancer Center, University of Minnesota|Peter Argenta, M.D.|612-626-6037|argenta@umn.edu|
20197030|NCT01019980|Novartis Pharmaceuticals|Study Director|862-778-8300||
20197031|NCT01554488|William S. Middleton Memorial VA Hospital|Mihaela Teodorescu, MD-Principle Investigator|(608)2561901|mt3@medicine.wisc.edu|11080
20197032|NCT01474863|Vanderbilt University Medical Center|Todd Rice, MD|6153223412|todd.rice@vanderbilt.edu|
20197033|NCT00708175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20197034|NCT02038920|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
20197035|NCT03196232|Stanford University|George A Fisher, Colleen Haas Chair in the School of Medicine|650) 725-9057|georgeaf@stanford.edu|
20197036|NCT02383589|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20197037|NCT00866697|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20197038|NCT03747419|Dana-Farber Cancer Institute|Kent Mouw|6176325734|kent_mouw@dfci.harvard.edu|
20197039|NCT01829399|Anesthesiology Department, University of NC at Chapel Hill|Randall F. Coombs, M.D.|919-966-5136|rcoombs@aims.unc.edu|
20197040|NCT02906787|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
20197041|NCT04275297|Osher Center for Integrative Health|A. Gracie Kelly, MS, Research Assistant|6153431554|gracie.kelly@vumc.org|
20197042|NCT05564299|Massachusetts General Hospital|Ingrid V Bassett|617-724-3341|ibassett@mgh.harvard.edu|
20197043|NCT00447382|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20197044|NCT01703663|University of Michigan|Devin L. Brown, MD, MS|734-936-9075|devinb@umich.edu|
20197045|NCT03823768|Medical University of South Carolina|Professor|8437922724|taberd@musc.edu|
20197046|NCT04600336|Mayo Clinic|Bradley J. Stish, MD|507-538-6120|stish.bradley@mayo.edu|
20197047|NCT04225806|InterVene, Inc|Clinical Affairs|6509957137|ClinSupport@intervene-med.com|
20197048|NCT00805038|Case Western Reserve University|Ash Sehgal|216-778-7728|axs81@cwru.edu|
20197049|NCT04890054|Oregon Rural Practice Research Network|Robert Durr, M.P.H.|503-418-3592|durrr@ohsu.edu|
20197050|NCT03706417|MaineHealth|Principal Investigator|207-396-6920|alexa.craig@mainehealth.org|
20197051|NCT03746951|Nationwide Children's Hospital|Dr. Senthil Krishna|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
20197052|NCT02113579|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20197053|NCT01436071|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197054|NCT01194453|Sun Yat-sen University Cancer Center|Dr. Li Zhang|87342288|zhangli6@mail.sysu.edu.cn|
20197055|NCT00726622|Mayo Clinic|Tonia M. Young-Fadok, M.D.||youngfadok.tonia@mayo.edu|
20197056|NCT03808688|Aerie Pharmaceuticals|VP, Medical Affairs|949-246-8731|jmwilliams@aeriepharma.com|
20197057|NCT04612036|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
20197058|NCT01974089|Centre for Clinical Research, North Denmark Regional Hospital, Hjoerring, Denmark|Dorte Melgaard|+4526281086|dmk@rn.dk|
20197059|NCT03018587|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
20197060|NCT00749879|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20197061|NCT04650282|University of Michigan|Michael Popovich|(734) 936-1808|mipopovi@med.umich.edu|
20197062|NCT01016964|Lexington International, LLC|David Michaels|5614170200|las@hairmax.com|
20197063|NCT03873493|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20197064|NCT00702845|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197065|NCT00440700|University of Minnesota|Dr. Linda Chlan|612-624-6658|chlan001@umn.edu|
20197066|NCT00928564|UC Irvine|Dr. Felicia Lane|17144566155|kbacca@uci.edu|
20197067|NCT01244243|University of California, Irvine|Steve Cramer|7144566876|scramer@uci.edu|
20197068|NCT04906616|University of California, San Francisco|Dr. Amy Conroy|415-476-6021|Amy.Conroy@ucsf.edu|
20197069|NCT00390611|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20197070|NCT00385203|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20197071|NCT02496897|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|SHolland@Altimmune.com|40
20197072|NCT01524133|Atlanta VAMC|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|3122
20197073|NCT04606771|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20197074|NCT01346488|AbbVie|Global Medical Information|800-633-9110||
20197075|NCT00786825|University of Minnesota|Elizabeth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
20197076|NCT04682977|University of Illinois Chicago|Dr. Mansha Mirza|312-355-5427|mmirza2@uic.edu|
20197077|NCT03083847|National Institute of Allergy and Infectious Diseases|Patrick Duffy|(301) 761-5089|Patrick.Duffy@nih.gov|
20197078|NCT01187550|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20197079|NCT00733304|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197080|NCT00129623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20197081|NCT01627002|ProtAffin Biotechnologie AG|ProtAffin Biotechnologie AG||office@protaffin.com|
20197082|NCT02445755|Stanford University School of Medicine|Vinod K. Bhutani, MD|(650) 723-5711|bhutani@stanford.edu|
20197083|NCT05352048|University of Kentucky|Dr. Francis Farhadi|859-323-5661|francis.farhadi@uky.edu|
20197084|NCT01214187|Brigham and Women's Hospital|Ivan Rosas, MD|617-278-0434|irosas@rics.bwh.harvard.edu|
20197085|NCT02967354|Uppsala University Hospital|Dr Per-Ola Carlsson|+46184714425|per-ola.carlsson@mcb.uu.se|
20197086|NCT01158651|UAB|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
20197087|NCT01191541|Department of pediatrics, Institute of Hematology and Blood Diseases Hospital.|xiaofan Zhu|+86 22 23909001|xfzhu@ihcams.ac.cn|
20197088|NCT00631189|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20197089|NCT04464265|University of Michigan Medical School|Zirui Huang, PhD|734-615-2875|huangzu@med.umich.edu|
20197090|NCT00974090|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20197091|NCT03189862|University of Michigan|Leah E. Robinson|(734) 647-7645|lerobin@umich.edu|
20197092|NCT00056862|National Institute of Diabetes and Digestive and Kidney Diseases|Jay H. Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
20197093|NCT05341700|Virginia Tech|Dr. Enette Larson-Meyer|5402311025|enette@vt.edu|
20197094|NCT01438151|Mount Sinai|Dr. Shradha Agarwal|212-659-9261|shradha.agarwal@mssm.edu|
20197095|NCT01836042|Glaukos|Jeff Wells, PharmD, MBA, RAC|949-367-9600|jwells@glaukos.com|227
20197096|NCT02459769|University of Rochester|Charles Kamen, PhD|585-275-9958|charles_Kamen@urmc.rochester.edu|
20197097|NCT00312221|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20197098|NCT02060721|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20197099|NCT05105789|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
20197100|NCT01271803|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20197101|NCT04178967|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20197102|NCT02545322|Department of Therapeutic Radiology and Oncology, Medical University of Graz|Peter Winkler, PhD (Head of Medical Physics)|+43 316 385|peter.winkler@medunigraz.at|83193
20197103|NCT01463384|Huntington Medical Research Institutes|Principal Investigator|6263975840|mrs@hmri.org|
20197104|NCT01251120|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20197105|NCT04409353|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
20197106|NCT02767128|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
20197107|NCT01544023|University of Rostock, Klinikum Südstadt der Hansestadt Rostock, Frauenklinik|Dr. Max Dieterich|+4938144016145|max.dieterich@uni-rostock.de|
20197108|NCT02499770|G1 Therapeutics|Chandra Lovejoy|001 9192991250|clovejoy@g1therapeutics.com|
20197109|NCT01351753|University of Iowa|Gary Pierce, PhD|13193359487|gary-pierce@uiowa.edu|
20197110|NCT00671554|Greenville Hospital System|Joe Stephenson, MD|864-455-3600|joe.stephenson@usoncology.com|
20197111|NCT07052682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20197112|NCT04667247|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
20197113|NCT04124614|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20197114|NCT05938998|University of Kansas Medical Center|Dr. Amy Bodde|913-588-7983|abodde@kumc.edu|
20197115|NCT04313153|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
20164050|NCT01971385|Massachusetts General Hospital|Dr. Maria Alora-Palli|6177265066|mpalli@mgh.harvard.edu|
20197116|NCT05586269|Boston Children's Hospital|Dr. Allison Wu|6173556058|allison.wu@childrens.harvard.edu|
20197117|NCT04752475|Associate Professor of Prenatal Pediatrics at CUIMC|Russell Miller, MD|212-305-3151|rsm20@cumc.columbia.edu|
20197118|NCT04532372|City of Hope Medical Center|Dr. Sanjeet Dadwal|626-359-8111|sdadjeet@coh.org|
20197119|NCT03435003|Stony Brook University|Dr. Konstantinos Spaniolas|631-444-8330|konstantinos.spaniolas@stonybrookmedicine.edu|
20197120|NCT00523718|Yale University|Christopher Pittenger|(203) 974-7675|christopher.pittenger@yale.edu|
20197121|NCT04641299|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20197122|NCT03662139|Department of PM&R, Marmara University School of Medicine|Naime Evrim Karadag-Saygi, Prof. Dr.|00902166570606|evrimkaradag4@hotmail.com|1628
20197123|NCT02348775|Baylor College of Medicine|R. V. Sekhar M.D.|713-798-3908|rsekhar@bcm.edu|
20164051|NCT04408040|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
20197124|NCT03335163|University of Colorado Anschutz Medical Campus|Dr. Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
20197125|NCT02137512|Jaeb Center for Health Research|John Lum, Artificial Pancreas Project Director|8139758690|jlum@jaeb.org|
20197126|NCT02020863|University of California, Irvine Health|Maxime Cannesson, PhD|714- 456-5059|mcanness@uci.edu|
20164052|NCT02919072|Sintetica SA|Anna Guaita|+41 (0)91640 42 50|aguaita@sintetica.com|
20197127|NCT00352885|Emory University|Bobbi Woolwine|404-712-9620|bwoolwi@emory.edu|
20197128|NCT01920594|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197129|NCT00863109|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197130|NCT04085341|Graybug Vision|Director, Global Clinical Development Operations|5622098872|bpatel@graybug.vision|
20197131|NCT00682565|Cytokinetics, Inc.|Medical Director|650-624-3053||
20197132|NCT02973425|UMass Chan Medical School|Rajani Sadasivam|15088568923|Rajani.Sadasivam@umassmed.edu|
20197133|NCT02393677|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|(05946)-228393|bikramjit_81@rediff.com|
20197134|NCT00813319|Emory University Rollins School of Public Health|Dr. Ralph DiClemente, Principal Investigator|404-727-0237|rdiclem@emory.edu|
20197135|NCT01448213|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
20197136|NCT03503513|University of Michigan|Dr. Denise Tate|(734) 647-5195|dgtate@umich.edu|
20197137|NCT00454532|Bionovo|Mary Tagliaferri, MD|5106012000|clinicaltrials@bionovo.com|
20197138|NCT03632109|University of Washington|Dr. Lindley Barbee, Principal Investigator|206.744.2595|lbarbee@u.washington.edu|
20197139|NCT00059839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20197140|NCT03842163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197141|NCT03829241|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20197142|NCT00698451|Janssen Services, LLC|Senior Director|1 215 325-5329|tmcgowan@its.jnj.com|
20197143|NCT01292447|Women and Infants Hospital|Rebecca Allen|4012741122|rhallen@wihri.org|
20197144|NCT02224599|Kiromic|CMO and Head of Clinical Operations|(832) 968-4888|sdahlbeck@kiromic.com|
20197145|NCT05178134|Scandinavian Biopharma Holding AB|Head of Clinical Development|+4684705600|info@scandinavianbiopharma.se|
20197146|NCT01330914|San Francisco Veterans Affairs Medical Center|Dr. Anne Schafer|(415) 221-4810|anne.schafer@va.gov|24895
20197147|NCT04504357|Boston University School of Public Health, Departments of Global Health and Epidemiology|Jacob Bor, ScD SM|(617) 358-2176|jbor@bu.edu|
20197148|NCT01660607|Stanford University|Dr. Everett Meyer|650-725-5816|evmeyer@stanford.edu|
20197149|NCT02308007|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
20197150|NCT00528567|Hoffman-LaRoche|Medical Communications|800-821-8590||
20197151|NCT00467389|Substance Abuse Research Laboratory, Kansas City VA Medical Center|Kenneth Grasing|(816) 922-2756|kenneth.grasing@va.gov|
20197152|NCT03085758|Adrenomed AG|Jens Zimmermann|+49 (0) 3302 20 77 810|jzimmermann@adrenomed.com|
20197153|NCT01122576|Bausch & Lomb Incorporated|Quintus Ngumah, OD, PhD|(973) 360-6450|Quintus.Ngumah@bausch.com|
20197154|NCT05696236|University of Michigan|Charles Schuler|734-232-2154|schulerc@med.umich.edu|
20197155|NCT01829360|University of Kansas|Holly Storkel|7858640099|hstorkel@ku.edu|
20197156|NCT03574441|Augusta University|Efrain Riveros Perez|7067217361|eriverosperez@augusta.edu|
20197157|NCT03326895|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
20197158|NCT03974334|University of Massachusetts Medical School|Dr. Paula Gardiner|7744416716|paula.gardiner@umassmed.edu|
20197159|NCT00931944|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20197160|NCT01109173|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
20197161|NCT01132612|Novartis Pharmaceuticals|Study Director|862-778-8300||
20197162|NCT03610399|Acre Health State Secretariat|Suiane Negreiros|55 68 9983 1266|omsvalle@hotmail.com|
20197163|NCT02252536|NIAAA|Megan Ryan|3014434225|mryan1@mail.nih.gov|
20197164|NCT02340728|Memorial Sloan Kettering Cancer Center|Mark Schattner, MD|212-639-3148|schattnm@mskcc.org|
20197165|NCT00859950|Weill Cornell Medical College|Dr. Ana Krieger|646-962-7378|ack2003@med.cornell.edu|
20197166|NCT02822950|Michigan State University|Gary Stein|517-353-5126|steing@msu.edu|
20197167|NCT00006392|SWOG Statistical Center|Study Statistician|2066674623||
20197168|NCT00578786|Gilead Sciences, Inc.|Hunter Gillies, MD, DSEM|650-522-1214|hunter.gillies@gilead.com|
20197169|NCT00038727|George Washington University|Marinella Temprosa, PI of Coordinating Center|3018819260|ella@bsc.gwu.edu|
20197170|NCT00728481|Mayo Clinic|Dr. Amy Foxx-Orenstein, D.O., Associate Prof. of Medicine, College of Medicine|480-301-8806|foxx-orenstein.amy@mayo.edu|
20197171|NCT00041067|SWOG|Study statistician|206-667-4623||
20197172|NCT00778622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20197173|NCT01968070|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197174|NCT03078595|Johann Wolfgang Goethe-University Frankfurt|Prof. Dr. med. dent. Peter Eickholz|+4915112433230|eickholz@med.uni-frankfurt.de|
20197175|NCT00890929|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
20197176|NCT00108069|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@box-w.nih.gov|
20197177|NCT02014740|University of Miami|Prof Gianluca Iacobellis|3052433636|giacobellis@med.miami.edu|
20197178|NCT02608879|NYU Langone Medical Center|Patricia Corby, Principal Investigator|646-501-2615|patricia.corby@nyumc.org|
20197179|NCT03684642|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20197180|NCT02742766|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20197181|NCT00223678|Vanderbilt Medical Center|Dr. Anthony Langone|615-936-1179|anthony.langone@vanderbilt.edu|
20197182|NCT01840605|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20197183|NCT03739437|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
20197184|NCT01959048|Hadassah-Hebrew University|Jacob Strahilevitz|972508946353|jstrahilevitz@hadassah.org.il|
20197185|NCT01351623|Memorial Sloan Kettering|Nikoletta Lendvai, MD|(212) 639-3368|lendvain@mskcc.org|
20197186|NCT01130974|Bausch & Lomb Inc.|Robert Steffen|(585) 338-6399|robert.steffens@bausch.com|
20197187|NCT01395316|University of Chicago|Dr. Adil Javed||ajaved@neurology.bsd.uchicago.edu|
20197188|NCT03359590|Profil Institut für Stoffwechselforschung GmbH|Dr. Christoph Kapitza|+49 2131 4018|christoph.kapitza@profil.com|157
20197189|NCT06132425|University of California, Los Angeles|Nora Barnes-Horowitz|(310) 825-2961|nbarneshorowitz@ucla.edu|
20197190|NCT06308666|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
20197191|NCT04376060|Saint Joseph University|Dr Sarah Khalil|0096170322739|sarahfkhalil2@gmail.com|
20197192|NCT00977574|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
20197193|NCT05460273|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20197194|NCT05749952|University of Pittsburgh|Sashwati Roy|412 624 0422|sasr453@pitt.edu|
20197195|NCT06950879|Ghent University|Ruth Van der Looven|003293324237|ruth.Vanderlooven@uzgent.be|
20197196|NCT01310803|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20197197|NCT00332839|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
20197198|NCT00789867|Imperial College|Samia Soussi|0207 594 7980|s.soussi@imperial.ac.uk|
20197199|NCT03047551|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
20197200|NCT01999569|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
20197201|NCT00594516|Johnson & Johnson Pharmaceutical Research & Development|Mila Etropolski, MD Clinical Leader|609-730-4537|metropol@its.jnj.com|
20197202|NCT02462928|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20197203|NCT01493557|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197204|NCT00982865|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20197205|NCT03876171|University of Miami|Louis Herns Marcelin, Ph.D.|3052848493|lmarcel2@miami.edu|
20197206|NCT02012296|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20197207|NCT04321980|Orpheris, Inc.|Jeffrey L Cleland, PhD, Executive Chair|650-505-5048|cleland@orpheris.com|
20197208|NCT01170039|Emory University|Jennifer Christie|404-778-4594|jchris6@emory.edu|
20197209|NCT00908583|University of Cincinnati|E. Steve Woodle|513-558-6001|woodlees@ucmail.uc.edu|
20197210|NCT00993954|University of Alberta|Dr Andrew Dixon|780-492-3553|andrew.dixon@albertahealthservices.ca|
20197211|NCT00860951|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
20197212|NCT00727649|Birmingham VA Medical Center|Dr. Alayne Markland, PI of this clinical trial|205-933-8101|alayne.markland@va.gov|6365
20197213|NCT01826851|URochester|Peter A. Knight, MD|(585) 275-6340|Peter_Knight@URMC.Rochester.edu|
20197214|NCT02953639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20197215|NCT01830855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197216|NCT00699803|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20197217|NCT00295633|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20197218|NCT02294682|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197219|NCT01516970|Janssen-Cilag GmbH|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
20197220|NCT02024165|Winnie Palmer Hospital for Women and Babies|John Busowski, MD|407-435-1485|john.busowski@orlandohealth.com|
20197221|NCT01186796|Mayo Clinic|Johannes. D. Veldhuis, M.D.|507-255-0902|Veldhuis.Johannes@mayo.edu|
20197222|NCT03838198|University of Michigan|Ewa Czyz|734-764-9466|ewac@umich.edu|
20197223|NCT03606980|Children's Hospital of the King's Daughters|Dana Reesman, PT, DPT|757-668-4894|dana.reesman@chkd.org|
20197224|NCT02218190|Washington University School of Medicine|Michael P. Kelly, MD, MSc|314-747-2511|kellymi@wustl.edu|
20197225|NCT01294150|NeoTract|Emily Hergenreter Director of Clinical Affairs|650-739-5570|ehergenreter@neotract.com|
20197226|NCT03675776|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20197227|NCT04513665|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
20197228|NCT01643525|Johns Hopkins University|Dr. Paul Nyquist||pnyquis1@jhmi.edu|
20197229|NCT06154213|University of Connecticut|Sherry Pagoto, PhD|(860) 486-5917|sherry.pagoto@uconn.edu|
20197230|NCT00999713|Penn State College of Medicine|Neal J. Thomas, M.D.|717-531-5337|nthomas@psu.edu|
20197231|NCT00690235|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
20197232|NCT02939989|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20197233|NCT01416987|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20197234|NCT03427125|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20197235|NCT02876302|Dana-Farber Cancer Institute|Dr. Filipa Lynce, MD, Principal Investigator|617-632-3800|Filipa_Lynce@dfci.harvard.edu|
20197236|NCT05390580|Washington University School of Medicine - Neurology Department|Dr. Osvaldo J. Laurido-Soto, PI|314-362-7382|ojlaurido-soto@wustl.edu|
20197237|NCT04014361|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20197238|NCT05225103|Duke University|David Goldston|919-681-1100|david.goldston@duke.edu|
20197239|NCT01130051|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20164053|NCT00543387|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197240|NCT05315947|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20197241|NCT04252287|Janssen Scientific Affairs, LLC|Director CVM Health Equity|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20197242|NCT01080677|Stanford University School of Medicine|Professor of Neurology|650-723-5184|chos@stanford.edu|
20164054|NCT02373774|Columbia University Medical Center|Raquel Schrager|(212) 305-4687|rs3823@cumc.columbia.edu|
20197243|NCT01298518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197244|NCT03610165|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
20197245|NCT02129205|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197246|NCT01578967|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20197247|NCT02204566|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
20197248|NCT04115878|University of Arizona|Daniel Combs, MD|520-626-7780|combs89@arizona.edu|
20197249|NCT04435782|Actelion Pharmaceuticals Ltd|Study Responsible Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20197250|NCT03672461|University of California, San Francisco|Alison Huang, MD|415-353-7900|Alison.Huang@ucsf.edu|
20197251|NCT00315939|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
20197252|NCT04223791|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197253|NCT03022318|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
20197254|NCT00395863|Bracco Diagnostics Inc.|Gianpaolo Pirovano, MD, Executive Director, Head Corporate Medical Development|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
20197255|NCT02592551|Baylor College of Medicine|Bryan Burt, MD|713-798-6376|burt@bcm.edu|
20197256|NCT00521924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20197257|NCT01876251|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197258|NCT01355484|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
20197259|NCT01667081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197260|NCT03034460|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20197261|NCT01798992|University of Colorado, Denver|Dr. Michael Bristow, MD PhD|303-724-5453|Michael.Bristow@ucdenver.edu|
20197262|NCT00434421|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20197263|NCT01205438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197264|NCT03823404|Quince Therapeutics, Inc.|Dr. Karen Smith|650 722 9813|ksmith@quincetx.com|
20197265|NCT02334787|Otsuka Pharmaceutical Co., LTD.|Study Director, Department of Clinical Management|+81-3-6361-7366||
20197266|NCT00931242|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
20197267|NCT03631667|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
20197268|NCT00892177|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-7733|galanis.evanthia@mayo.edu|
20197269|NCT02645760|Khonkaen University|Rungthip Chalermsan|+66 835603675|chalermsanrungthip@gmail.com|
20197270|NCT02267603|Cancer Immunotherapy Trials Network|Administrative Director|206-667-6609|citn.core.reg@hvtn.org|
20197271|NCT04621734|University of Texas Health Science Center at San Antonio|Dr. Veronica Armijo-Garcia|210-274-8969|mirelesv@uthscsa.edu|
20197272|NCT00404066|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
20197273|NCT01754857|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|800-622-9822|clinicaltrials@cancer.wisc.edu|
20197274|NCT01399190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20197275|NCT00966823|Rhode Island Hospital|Francois I. Luks, MD, PhD|401-228-0556|Francois_Luks@brown.edu|
20197276|NCT01636414|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2265|susan.odum@orthocarolina.com|
20197277|NCT00596934|University of Michigan|Dr. Elif A. Oral|734-615-7271|eliforal@med.umich.edu|
20197278|NCT02315898|University of Michigan|Dr. Kathleen Stringer|734-647-4775|stringek@med.umich.edu|
20164055|NCT00513435|Memorial Sloan-Kettering Cancer Center|Matthew Fury, MD|646-888-4233|furym@mskcc.org|
20197279|NCT03239483|"Fundacio Lluita Contra la Sida, Hospital Universitari Germans Trias | Pujol"|Dr. Ross D. Cranston|34-934-657-897|rdcranston@outlook.com|
20197280|NCT00998426|Johns Hopkins Medicine|Kirti Shetty, MD|202 660 5555|kshetty1@jhmi.edu|
20197281|NCT01296035|Women & Infants Hospital|Director of Clinical Trials|401-274-1122|jmari@wihri.org|
20197282|NCT03352011|VA Center for Integrated Heathcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
20197283|NCT01674712|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20197284|NCT00201838|The Ohio State Unversity Comprehensive Cancer Center|Miguel Villalona-Calero, MD|614-293-5484|Miguel.Villalona@osumc.edu|
20164056|NCT01792115|NIDDK|Dr. Yaron Rotman|301-451-6553|rotmanyaron@mail.nih.gov|
20164057|NCT03790111|TerSera Therapeutics Inc.|Janine North, Executive Director-Clinical Development|888 600 8116|jnorth@tersera.com|
20164058|NCT03074409|University of Electronic Science and Technology of China|Dr. Shuxia Yao|+8618111297596|yaoshuxia@uestc.edu.cn|
20164059|NCT02467179|University of California San Diego|Dr. Gregory Feld|(858) 246-2972|gfeld@ucsd.edu|
20164060|NCT02796677|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20164061|NCT03798717|University of Portsmouth|Dr. Ant Shepherd|02392845289|ant.shepherd@port.ac.uk|
20164062|NCT00942903|The Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
20164063|NCT04002960|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
20164064|NCT00961181|University Medical Center, Freiburg i.Br., Germany|Prof. Dr. Christoph Hehrlein|+49 761 270|christoph.hehrlein@uniklinik-freiburg.de|6095
20164065|NCT03212326|Weill Cornell Medical College|Dr. Christopher Liu|212-746-2655|chl7001@med.cornell.edu|
20164066|NCT02918617|University of Texas Health San Antonio|Bennett Amaechi, DDS|210-567-3185|amaechi@uthscsa.edu|
20197285|NCT05395104|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
20197286|NCT00381563|New England Baptist Hospital|Director of Clinical Trials|(617)754-6602|pmccree@caregroup.harvard.edu|
20197287|NCT01049243|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-1877|sfeldman@wfubmc.edu|
20197288|NCT01287364|Sunovion|Respiratory Medical Director|1-866-503-6351||
20197289|NCT01936909|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
20197290|NCT00744211|University of South Carolina SOM|Francis G. Spinale|803-777-3964|cvctrc@uscmed.sc.edu|
20197291|NCT00000125|Washington University School of Medicine|Michael Kass MD|314-362-5713|kass@vision.wustl.edu|
20197292|NCT05372653|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20164067|NCT01790594|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20197293|NCT02797067|Changhai Hospital|Yangyang Qian|13818040017|919835863@qq.com|
20197294|NCT01003990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20197295|NCT01829425|University of New Mexico|Dr. Yuko Komesu|5052490726|ykomesu@salud.unm.edu|
20197296|NCT05211739|Alcon Research, LLC|Clinical Project Lead, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20197297|NCT01505010|University of Leuven|Dr. Jan A. Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
20197298|NCT03837379|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20197299|NCT02354781|Nationwide Children's Hospital|Dr. Jerry Mendell|1-614-722-4877|Jerry.Mendell@nationwidechildrens.org|
20197300|NCT00626210|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
20197301|NCT04553068|Evofem|Catherine Maher|8585501900|cmaher@evofem.com|
20197302|NCT02080455|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-242-5142|alison.long@aegerion.com|
20197303|NCT01006265|Actelion Pharmaceuticals Ltd.|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20197304|NCT00698932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20197305|NCT00757003|Stanford University|Dr. Daniel Sze, Principal Investigator|650-723-0728|dansze@stanford.edu|
20197306|NCT02966223|Indiana University|Mark Tann, MD|317- 948-8782|matann@iupui.edu|
20197307|NCT01326728|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
20197308|NCT01184053|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20197309|NCT03785678|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20197310|NCT00375219|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20197311|NCT01667107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197312|NCT01791803|North Shore Medical Center|Dr. Faysal M. Hasan|978-741-1200|fhasan@partners.org|4901
20197313|NCT04572854|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20197314|NCT00972777|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20197315|NCT01093326|Actelion Pharmaceuticals Ltd|Director Clinical Leader Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20197316|NCT05868811|Children's Mercy Hospital|Dr. Kai Ling Kong|5157712880|kkong@cmh.edu|
20197317|NCT02039726|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20197318|NCT02460497|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20197319|NCT01650285|BrUOG|Dr. Anthony Mega|4018633000|kayla_rosati@brown.edu|
20197320|NCT01681810|University of Pittsburgh|Dr. Kara Hughan|4126925173|kara.hughan@chp.edu|
20197321|NCT02053909|Boca Raton Regional Hospital|Dr. Alexander Kulik|561-955-6300|alex_kulik@yahoo.com|
20197322|NCT00283049|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
20197323|NCT00884325|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20197324|NCT04439071|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20197325|NCT01446016|Houston Methodist|Dr. Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
20197326|NCT02525055|hVIVO Services Limeted|Dr Nicolas Noulin|+442077561365|n.noulin@hvivo.com|
20197327|NCT01087957|Innovative Neurotronics|Helen Rogers PT, PhD|512-721-1922|hrogers@ininc.us|
20197328|NCT01002456|Dept. of Veterans Affairs|Dr. Madeline McCarren|708 786 7987|madeline.mccarren@va.gov|
20164068|NCT01560286|BioMarin Pharmaceutical Inc|Sr. Medical Director, Clinical Science|415-475-5854|Ari.Gershman@bmrn.com|
20164069|NCT00404651|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20164070|NCT02785185|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
20164071|NCT01364584|University of Colorado School of Medicine|Judith G Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
20164072|NCT00666666|Rutgers Cancer Institute of New Jersey|Robert DiPaola, MD|732-235-8675|zelinsta@cinj.rutgers.edu, dipaolrs@cinj.rutgers.edu, rizzoji@cinj.rutgers.edu|
20164073|NCT00181363|Maastro Radiation Oncology|J. Buijsen,|+31 (0)88-44-55-666|jeroen.buijsen@maastro.nl|
20164074|NCT02372877|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
20164075|NCT02362321|CHU de Québec|Principal Investigator|418-649-0252|michel.prudhomme.chuq@gmail.com|
20164076|NCT01121146|AORI|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
20164077|NCT01982123|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
20164078|NCT01822197|Nationwide Childrens Hospital|Dr Ben Kopp|6147224766|benjamin.kopp@nationwidechildrens.org|
20164079|NCT03999515|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
20164080|NCT00763412|Washington University in St Louis|Ana Maria Arbelaez|314-286-1138|arbelaez_a@kids.wustl.edu|
20164081|NCT05030350|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
20164082|NCT02711137|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20164083|NCT00203229|Thomas Jefferson University|M. Alan Stiles|215-955-6215|Alan.Stiles@Jefferson.edu|
20164084|NCT03477396|City of Hope|Dr. MIna Sedrak|626-359-8111|msedrak@coh.org|
20197329|NCT04216251|Massachusetts General Hspital|Andrew T. Chan, MD, MPH|617-726-3212|achan@partners.org|
20197330|NCT01835015|Alcon Research, Ltd.|Director, Translational Medicine Expert, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
20197331|NCT01178333|New England Research Institutes|Dr. Susan Assmann, Principal Research Scientist|617-972-3048|sassmann@neriscience.com|
20197332|NCT03678103|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20197333|NCT04214301|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20197334|NCT01241552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197335|NCT02606461|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20197336|NCT02092350|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20197337|NCT00024167|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD/Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
20197338|NCT02764164|Cincinnati Childrens Hospital Medical Center|Dr. Ernest Pedapati|5137361901|ernest.pedapati@cchmc.org|
20197339|NCT00956657|NHS Greater Glasgow & Clyde|Gavin H. Taylor, Clinical Psychologist|0141 211 2134|gavin.taylor@ggc.scot.nhs.uk|
20197340|NCT00806676|Johns Hopkins University School of Medicine|Dr. Jeffrey Fadrowski|410-955-2467|jfadrow1@jhmi.edu|
20197341|NCT02137122|University of Florida|Adam Woods|352-294-5842|ajwoods@phhp.ufl.edu|
20197342|NCT00072358|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|1-833-MSK KIDS|kushnerb@MSKCC.ORG|
20197343|NCT00789750|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400||
20197344|NCT00113230|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Associate Professor|713-792-2933||
20197345|NCT03568045|Yale School of Medicine|Dr. Melissa Knauert|203-785-4162|melissa.knauert@yale.edu|
20197346|NCT00770770|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
20197347|NCT01761279|Portsmouth Hospitals NHS Trust|Dr Pete Basford, Endoscopy Research Fellow|+447890990445|petebasford@hotmail.com|
20197348|NCT00117507|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20197349|NCT00800436|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20197350|NCT04808622|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
20197351|NCT00711529|Stanford Hospital|Shannon MacLaughlan, MD|650-724-0456|smaclaug@stanford.edu|
20197352|NCT01673568|Hvidovre Hospital University of Copenhagen|Mette W. Christoffersen|38625826|mette.willaume@gmail.com|
20197353|NCT03740997|GE HealthCare|David Thompson, MD, PhD|+44 7775 543206|david.thompson1@gehealthcare.com|
20197354|NCT00928174|The Queen's Medical Center|Sandi Kwee, Principal Investigator|808-691-5466|skwee@queens.org|
20197355|NCT01343485|Planned Parenthood Federation of America|Zoe Unger, Research Program Coordinator|212-261-4702|zoe.unger@ppfa.org|
20197356|NCT03681951|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20197357|NCT02187809|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20197358|NCT01020448|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20197359|NCT00601705|Cleveland Clinic|Dr. David Adelstein|216 444-9310|ADELSTD@ccf.org|
20164085|NCT00068341|Jonsson Comprehensive Cancer Center|Helena Chang, M.D., Ph.D., Revlon/UCLA Breast Center|310-794-5640|hchang@mednet.ucla.edu|
20164086|NCT05098028|Bausch Health Americas, Inc|Varsha Bhatt|7072301712|varsha.bhatt@bauschhealth.com|
20164087|NCT01745367|Aveo Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20164088|NCT00354679|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
20164089|NCT01814527|East Carolina University|Joseph Armen DO|252-744-3212|armenj@ecu.edu|
20164090|NCT03571204|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|msneller@niaid.nih.gov|
20164091|NCT00488488|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164092|NCT00857285|Daiichi Sankyo, Inc.|Senior Director, Regulatory Operations|732-590-5000|hmkessler@dsus.com|
20164093|NCT01126723|Institute for Aging Research, Hebrew SeniorLife|Dr. Lewis Lipsitz|617-971-5318|lipsitz@hsl.harvard.edu|
20164094|NCT03435185|University of Health Sciences Dr. Lütfi Kırdar Kartal Training and Research Hospital|Dr. Cem Bölük|+902164413900|cem.boluk@sbu.edu.tr|
20164095|NCT03901144|Perrigo/ACO Hud Nordic|Dr Tina Holm|+46732744113|tina.holm@perrigo.com|
20164096|NCT03081884|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
20164097|NCT03948334|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20164098|NCT05114473|University of Valencia|Dr. Borja Perez-Dominguez|697464680|f.borja.perez@uv.es|34
20164099|NCT04936061|CoolTech|Clinical Trial Manager|570-228-8140|jholland@cooltechcorp.com|
20164100|NCT04445662|Massachusetts General Hospital|Travis P Baggett MD MPH|617-643-9314|tbaggett@mgh.harvard.edu|
20164101|NCT00279916|Mayo Clinic|Dr. Laura Orvidas|507-284-3410|orvidas.laura@mayo.edu|
20164102|NCT01807598|Stanford University|Jason R. Gotlib|650-736-1253|jason.gotlib@stanford.edu|
20164103|NCT01451385|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20164104|NCT00731679|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
20164105|NCT01598922|McLean Hospital|Dr.Isabelle Rosso|6178552607|irosso@partners.org|
20164106|NCT02488005|Icahn School of Medicine at Mount Sinai|Becky Phan|212-824-7785|becky.phan@mssm.edu|
20164107|NCT03384940|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20164108|NCT04184297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164109|NCT02412098|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20164110|NCT03089580|University of Michigan / Kellogg Eye Center|Sarah Wood|734-615-2479|skwood@med.umich.edu|
20164111|NCT03087513|Toronto Western Hospital/University Health Network|Study Coordinator|416-603-5800|emad.alazazi@uhnresearch.ca|6237
20164112|NCT04628780|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164113|NCT05315479|Baudax Bio|Development|484-395-2440|info@baudaxbio.com|
20164114|NCT01987102|Isofol Medical AB|Chief Medical Officer|+46 (0)702433750|karin.ganlov@isofolmedical.com|
20164115|NCT01288989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197360|NCT01653964|Mayo Clinic|Dr. Carrie Hruska|5072663991|hruska.carrie@mayo.edu|
20164116|NCT01236521|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; Matthew.Bair@va.gov|
20164117|NCT03890588|HealthPartners Institute|JoAnn Sperl-Hillen, MD, Senior Clinical Investigator|952-967-5009|joann.m.sperlhillen@healthpartners.com|
20164118|NCT00165672|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
20164119|NCT03946748|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20164120|NCT05864586|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20164121|NCT03635424|Medtronic Coronary and Structural Heart Clinical|Hatice Bilgic Lim, PhD; Principal Clinical Research Specialist|763-526-1018|hatice.bilgic.lim@medtronic.com|
20164122|NCT05081219|Atrium Health Wake Forest Baptist|Suzanne Craft, PhD|336.713.8846|Suzanne.Craft@advocatehealth.org|
20164123|NCT06019728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20164124|NCT05017701|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20164125|NCT02452424|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20164126|NCT01463306|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164127|NCT01059318|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20164128|NCT04266925|University of Alabama at Birmingham|Dr David Schwebel,|205-934-4068|schwebel@uab.edu|
20164129|NCT02302365|Terumo BCT|Isobelle Galeon, MD, MPH, MSCS, Medical Monitor Clinical Safety|+1 303 542-5166|Isobelle.Galeon@Terumobct.com|
20164130|NCT02719171|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20164131|NCT02614729|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
20164132|NCT00227721|Barbara Ann Karmanos Cancer Institute|Robert Morris, M.D.|313-576-9436|rmorris@med.wayne.edu|
20164133|NCT01083849|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20164134|NCT04456634|Medicines for Malaria Venture (MMV)|Jacques Herve|+41 79 370 40 63|hervej@mmv.org|
20164135|NCT05298202|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
20164136|NCT01875159|Uniformed Services University|Carl E. Hunt, M.D.|240-694-2676|carl.hunt@usuhs.edu|
20164137|NCT01253642|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
20164138|NCT02539797|University of California, Los Angeles|Dr. Yuri Rassovsky|3104783711|yurir@ucla.edu|
20164139|NCT01432405|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
20164140|NCT01139814|Catheter Robotics, Inc.|Vice President, Clinical and Regulatory Affairs|973-426-0300|research@catheterrobotics.com|
20164141|NCT02752880|Chang Gung Memorial Hospital|Dr. YH Huang|+886975360240|igighuang@gmail.com|
20164142|NCT01609348|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
20164143|NCT01777308|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164144|NCT03430791|Miami Cancer Institute at Baptist Health, Inc.|Yazmin Odia|786-596-2000|YazminO@baptisthealth.net|
20164145|NCT00383786|Baylor College of Medicine|Sanjay Mathew, MD/PI|7137985439|sjmathew@bcm.edu|
20164146|NCT00985673|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164147|NCT05736874|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20164148|NCT00531284|Amgen, Inc.|Study Director|866-572-6436||
20164149|NCT00291135|University of Kansas Medical Center Research Institute|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
20164150|NCT02219464|Vanderbilt University Medical Center|Cindy Pastern, RN BSN CCRP|615-343-0259|cindy.pastern@vanderbilt.edu|
20164151|NCT00984256|US Army Medical Materiel Development Activity (USAMMDA)|Michelle Mathers|301-619-8061|Michelle.mathers@us.army.mil|
20164152|NCT02981368|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
20164153|NCT03493945|National Cancer Institute|Dr. James L. Gulley|301-480-7164|gulleyj@mail.nih.gov|
20164154|NCT01517750|HELIOS-Klinik Ambrock|Dr Georg Nilius|+492331-9742005|klinik-ambrock.pneumo@t-online.de|
20164155|NCT01307319|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20164156|NCT02735239|Ludwig Institute for Cancer Research|Jonathan Skipper|212-450-1539|jskipper@lcr.org|
20164157|NCT02719535|The Hong Kong Polytechnic University|Dr. Andrew Lam|85227666109|andrew.kc.lam@polyu.edu.hk|
20164158|NCT02152631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20164159|NCT00527735|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20164160|NCT01855412|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
20164161|NCT01293825|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|(216) 844-2808|martha.sajatovic@uhhospitals.org|
20164162|NCT00346216|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164163|NCT01132807|Alliance for Clinical Trials in Oncology|David J. Straus, MD|212-639-8365|strausd@mskcc.org|
20164164|NCT02222558|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
20164165|NCT00896298|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
20164166|NCT02322281|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
20164167|NCT02163824|Kala Pharmaceuticals, Inc|VP, Clinical Development||Results001@kalarx.com|
20164168|NCT00936702|Mayo Clinic|Matthew P. Goetz, M.D.|507 284-2511|goetz.matthew@mayo.edu|
20164169|NCT01844388|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20164170|NCT02420093|University of Michigan Health System|Patricia Connors, PT, DScPT, OMPT|734-763-6464|pattyconnors219@gmail.com|
20164171|NCT01495286|University of Arkansas|Anita Mitchell PhD, coinvestigator|501-686-7021|AMitchell@uams.edu|
20164172|NCT03001557|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20164173|NCT01794000|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20164174|NCT00964496|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
20164175|NCT00255190|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20164176|NCT02513121|University of California, San Diego|Dr. Jeffrey Schwimmer|858-966-8907|jschwimmer@ucsd.edu|
20217664|NCT02756637|Abramson Cancer Center of the University of Pennsylvania|John Christodouleus|215-662-2428|John.Christodouleas@uphs.upenn.edu|
20217665|NCT06442410|Medtronic|Thanh Tran|7278082652|thanh.tran2@medtronic.com|
20217666|NCT01507090|Children's Mercy Hospital|Principal Investigator|816-234-3059|srahman@cmh.edu|
20217667|NCT04947150|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
20217668|NCT02449473|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20217669|NCT04678817|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
20217670|NCT05368012|Hospital for Special Surgery|MIDCAB (Mid-Calf Block) for foot surgery: A pilot study|646-797-8948|popovicm@hss.edu|
20217671|NCT03535857|University of Pittsburgh|Dr, Gnankang Sarah Napoe|412-641-7850|napoegs@upmc.edu|
20217672|NCT02121041|UNC Chapel Hill|Dr. Anthony Viera|984-974-4636|viera@med.unc.edu|
20217673|NCT02124902|Washington University School of Medicine|Foluso Ademuyiwa, M.D., MPH|314-362-7201|bisiademuyiwa@wustl.edu|
20217674|NCT03632135|Cordgenics|Pier Paolo Claudio, MD, Chief Scientific Officer|6064657226|claudio@cordgenics.com|
20217675|NCT02928536|Istituto di Ricerche Farmacologiche Mario Negri|Silvano Gallus, head of the Laboratory of Lifestyle Epidemiology|0039023901|silvano.gallus@marionegri.it|4657
20217676|NCT00546910|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20217677|NCT01467479|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20217678|NCT03815240|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
20217679|NCT02284347|Medtronic Xomed|Director of Clinical Trials|904-296-9600|dl.nuventstudy@medtronic.com|
20217680|NCT03185182|Lund University|Professor Håkan Axelson|+46 046 2226434|hakan.axelson@med.lu.se|
20217681|NCT03407612|Jameson Crane Sports Medicine Institute|Maria Munsch|614-293-3600|maria.munsch@osumc.edu|
20217682|NCT01684215|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164177|NCT02609308|Universidad Autónoma de Nuevo León|Carlos Acosta-Olivo, PhD|+52 81 8347-3056|dr.carlosacosta@gmail.com|
20164178|NCT03392935|University of Utah Dermatology|Dr. Karen Stolman, Assistant Professor, Dermatology|8015816465|ks@checkmateproductions.com|
20164179|NCT01156480|NorthShore University HealthSystem|Dr. Brandy Frost|847-570-2033|bfrost@northshore.org|
20164180|NCT04537793|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20164181|NCT00429949|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20164182|NCT02878317|University of Nottingham|Professor Maarten Taal|01332 224618|m.taal@nottingham.ac.uk|
20164183|NCT02462148|Wake Forest Baptist Health|Dr. Jimmy Turner|3368064498|jturner@wakehealth.edu|
20164184|NCT01308736|Rutgers Robert Wood Johnson Medical School|Dr. Marc Steinberg|7322354341|marc.steinberg@rutgers.edu|
20164185|NCT01946139|Emmes Company, LLC|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
20164186|NCT01191723|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20164187|NCT03101566|University of Michigan Rogel Cancer Center|Vaibhav Sahai, MBBS, MS|734-936-4991|vsahai@med.umich.edu|
20164188|NCT01363700|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20164189|NCT02721875|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164190|NCT00837200|Milton S Hershey Medical Center|Joseph J Drabick, MD|717-531-5911|jdrabick@hmc.psu.edu|
20164191|NCT00675909|Seattle Children's Hospital|Eileen Klein, MD, MPH|206-987-2599|eileen.klein@seattlechildrens.org|
20164192|NCT01329978|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20164193|NCT02021669|Washington University School of Medicine|Robert M. Carney, Ph.D|314-286-1305|carneyr@wustl.edu|
20164194|NCT04896593|Anxiety Disorders Center|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
20164195|NCT00452790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164196|NCT05551611|Kocaeli University|Dr. Suzi ÖZDEMİR|05548488674|suzi.ozdemir@gmail.com|
20164197|NCT00543777|UT MD Anderson Cancer Center|Haesun Choi, MD/Professor, Abdominal Imaging Department|(713) 745-4693|hchoi@mdanderson.org|
20164198|NCT02110095|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20164199|NCT00386243|Center on Implementing Evidence Based Practice|Matthew J. Bair, MD MS|317-988-2058|mbair@iupui.edu|
20164200|NCT02781610|Seattle Children's|Michelle Skalland (Biostatistician)|206-884-7519|michelle.skalland@seattlechildrens.org|
20164201|NCT00176462|Rutgers Cancer Institute of New Jersey|Richard Drachtman, MD|732-235-8675|drachtri@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
20164202|NCT01840345|Virginia Commonwealth University|Dr. Dace Svikis|(804) 827-1184|dssvikis@vcu.edu|
20164203|NCT01150097|Novartis Pharmaceuticals|Study Director|862-778-8300||
20164204|NCT01604291|Hoffmann-La Roche|Medical Communications|800-821-8590|Genentech@druginfo.com|
20164205|NCT01301833|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20164206|NCT01279681|Mayo Clinic|Joleen M. Hubbard, M.D.|507 284-3121|hubbard.joleen@mayo.edu|
20164207|NCT03410628|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20164208|NCT02252146|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20164209|NCT03270943|University of North Carolina at Chapel Hill|Christine Lathren, MD, MPH|919-966-8586|lathren@email.unc.edu|
20164210|NCT00246519|University of Florida|Julie A. Johnson|352-273-6007|johnson@cop.ufl.edu|
20164211|NCT02544321|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20164212|NCT04388111|Houston Methodist Hospital|Research Coordinator|346 238 1603|tsullivan@houstonmethodist.org|
20164213|NCT03776747|University of Iowa|Dr. Eric Hoffman|(319) 356-1381|eric-hoffman@uiowa.edu|
20164214|NCT02038153|Montefiore|Dr. Ira Braunschweig|718 920-4826|ibraunsc@montefiore.org|
20164215|NCT02647281|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164216|NCT01050634|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164217|NCT01302483|Department of Periodontics & Endodontics, School of Dental Medicine, University of Buffalo, SUNY|Dr. Sebastian Ciancio|(716) 829-3848|ciancio@buffalo.edu|
20164218|NCT03347123|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20164219|NCT02960516|Vanderbilt university medical center|Dr. Wesley Thayer|+1 (615)936-3759|wesley.thayer@vumc.org|
20164220|NCT00669214|Genentech, Inc.|Medical Communications|800-821-8590||
20164221|NCT00754377|Louis Stokes VA Medical Center|Dr. David Aron|(216) 791-2300|david.aron@va.gov|5836
20164222|NCT03431441|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|904-443-1396|mbishop4@its.jnj.com|
20164223|NCT01276639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197361|NCT02232282|Loyola University Chicago|Larissa Bresler, MD|7086433827|lbresler@lumc.edu|
20164224|NCT04363879|AtriumHealth|Dr. Brad Hurst, Director of Assisted Reproduction Program|7043553153|Brad.Hurst@atriumhealth.org|
20164225|NCT03985761|Rutgers The State University of NJ|Dr. Gerard G Fluet DPT, PhD|(973) 972-8529|fluetge@shp.rutgers.edu|
20164226|NCT03956550|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20164227|NCT03400852|Mallinckrodt|Medical Information Call Center|1-800-844-2830|MedInfo@mnk.com|
20164228|NCT01285401|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20164229|NCT02366312|NYU College of Dentistry|Dr. Brian Schmidt|212-998-8900|brianl.schmidt@nyu.edu|
20164230|NCT02532465|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
20164231|NCT05200143|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
20164232|NCT03719131|Emory University|Kavita Dhodapkar, MD|404-785-1112|kavita.dhodapkar@emory.edu|
20164233|NCT01544920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164234|NCT02493036|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
20164235|NCT03170661|LUMC|Drs. Maarten Honing|0715264038|g.h.m.honing@lumc.nl|
20164236|NCT03244917|Hebrew SeniorLife|Susan Mitchell MD, MPH|6172813669|smitchell@hsl.harvard.edu|
20164237|NCT01272232|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20164238|NCT02159066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-102|ClinicalTrials.gov_Inquiries@pfizer.com|
20164239|NCT01135134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20164240|NCT05470387|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
20164241|NCT03831477|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20164242|NCT01176058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164243|NCT02254473|TRIA Orthopaedic Center|Megan Reams|952-806-5329|megan.reams@tria.com|
20164244|NCT00256724|Advanced Circulatory|Nathan Burkhart|651.403.5600|nburkhart@advancedcirculatory.com|
20164245|NCT01217463|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
20164246|NCT02197702|StJustineH|Dr Francine Ducharme|5143454931|Francine.m.ducharme@umontreal.ca|4398
20164247|NCT01858363|Spectranetics|Nicolas Aguirre|+1-312-297-6655|nicolas.aguirre@philips.com|
20164248|NCT00706446|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
20164249|NCT01569841|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20164250|NCT00057863|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20164251|NCT00764361|Nanotherapeutics, Inc.|John Abernethy, MD - Medical Director|386-462-9663|jabernethy@nanotherapeutics.com|326
20164252|NCT02090426|Massachusetts Institute of Technology|Amy Finkelstein, PhD|6173246995|jgubb@mit.edu|
20164253|NCT02079038|Vertiflex|Steve Reitzler|442-325-5934|Stephen.reitzler2@bsci.com|
20164254|NCT03480152|National Cancer Institute|Dr. Steven Rosenberg|240-858.3080|steven-rosenberg@nih.gov|
20164255|NCT03634085|Venn Life Sciences|Simone van Broekhoven / Clinical Trial Manager|+310765480625|simone.vanbroekhoven@vennlife.com|
20164256|NCT04276233|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20164257|NCT03246789|Weill Cornell Institute of Geriatric Psychiatry|Dr. Patricia Marino|(914) 997-8691|pam2029@med.cornell.edu|
20164258|NCT00148759|Emory University|Ighovwerha Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
20164259|NCT01454596|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
20164260|NCT02451995|Imperial College Healthcare|Dr Vishal Luther|07828913612|v.luther14@imperial.ac.uk|
20164261|NCT01887132|National Institute of Mental Health (NIMH)|Ashura W Buckley|(301) 496-5190|shu.buckley@nih.gov|
20164262|NCT05006261|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
20164263|NCT02354534|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|CervixDoctor@jhmi.edu|
20164264|NCT02800863|Abbott Vascular|Nicole Harbert|(972) 526-4841|Nicole.harbert@abbott.com|
20164265|NCT03957551|University of Iowa|John Rieth, MD|(319) 356-1616|john-rieth@uiowa.edu|
20164266|NCT04532034|Temple University|Elizabeth THomas|215-204-1699|tug66715@temple.edu|
20164267|NCT01550809|Departamento de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, Universitat de València, Valencia, Spain|Francisco Javier Ampudia Blasco|+34 96 3862665|Francisco.J.Ampudia@uv.es|
20164268|NCT04106609|Maple Tree Cancer Alliance|Dr. Karen Wonders|937-477-8213|karen.wonders@mapletreecanceralliance.org|
20164269|NCT03775486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20164270|NCT01572480|National Cancer Institute|Dr. Elizabeth Hill|240-760-6183|Elizabeth.Hill@nih.gov|
20164271|NCT04194944|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20164272|NCT00801216|IRCCS Ospedale San Raffaele|Dr. Andrés José Maria Ferreri|022643 7649|ferreri.clinicaltrials@hsr.it|
20164273|NCT05214768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20164274|NCT05481359|Cortex, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
20164275|NCT06235905|Navitorpharma|Senior Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
20164276|NCT00319254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164277|NCT03145259|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20164278|NCT04177212|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20164279|NCT02525653|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
20164280|NCT01147666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
20164281|NCT00796666|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164282|NCT02531217|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20164283|NCT00474955|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20164284|NCT02576639|Novartis Pharmaceuticals|Study Director|862-778-8300||
20164285|NCT00631358|Alcon Labs|Alcon Clinical|1-888-451-3937; 1-817-568-6725|medinfo@alconlabs.com|
20164286|NCT04140396|Stanford University|Chi-Ho Ban Tsui|(650) 200-9107|bantsui@stanford.edu|
20164287|NCT01255423|Novartis Consumer Health|Clinical Project Leader|0041223635528||
20164288|NCT03367858|University of Rhode Island|Dr. Sarah Feldstein Ewing|401-874-4251|feldsteinewing@uri.edu|
20164289|NCT01859923|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20164290|NCT03148613|Carrot Inc.|Director Clinical Affairs|650-906-4255|craig@carrot.co|
20164291|NCT03174366|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
20164292|NCT00876200|Hospices Civils de Lyon|Dr Behrouz KASSAI-KOUPAI|472116911|behrouz.kassai-koupai@chu-lyon.fr|+33
20164293|NCT00101686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20164294|NCT00296816|Sanofi|Trial Trans[parency Team||Contact_us@sanofi.com|
20164295|NCT00985465|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164296|NCT01054456|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20164297|NCT00687401|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20164298|NCT02643459|Herlev Hospital, Department of Cardiology|Dr. Martin Schultz|004538683868|martin.schultz@regionh.dk|
20164299|NCT01721161|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20164300|NCT00230126|The Ohio State University|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
20164301|NCT00434226|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20164302|NCT02052544|DSM Nutritional Products Ltd Branch Pentapharm|Anne Brisset|41 61 706 4837|Anne.Brisset@pentapharm.com|
20164303|NCT03483896|University of Southern California|Prof. Kyle Konis, Ph.D|(213) 740-2723|kkonis@usc.edu|
20164304|NCT02888106|Hepatera LLC|Yana Deloveri|+7 495 762 52 53|deloveri@hepatera.ru|42-14
20164305|NCT02314936|KGK Synergize Inc.|Dr. Tetyana Pelipyagina|5194389374|drtetyana@kgksynergize.com|
20164306|NCT00430716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164307|NCT03865446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164308|NCT02952365|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
20164309|NCT03324802|Mayo Clinic|Carlos E. Vargas, M.D.|4803421262|Vargas.Carlos@mayo.edu|
20197362|NCT02146599|Abbott Medical Optics|Anne Buteyn; Manager, Clinical Research|949-505-2029|anne.buteyn@abbott.com|
20197363|NCT02743351|Fate Therapeutics|Executive Director, Clinical Operations|858.875.1800|info@fatetherapeutics.com|
20164310|NCT01433172|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jhanelle Gray|813-745-3050|jhanelle.gray@moffitt.org|
20164311|NCT00104650|Amgen Inc.|Study Director|866-572-6436||
20197364|NCT02101021|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20197365|NCT00387764|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164312|NCT02294058|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|AMcClain@celgene.com|
20197366|NCT04399122|Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center|Dr. Jose E. Capo-Aponte|(210) 292-2554|Jose.E.CapoAponte.ctr@mail.mil|
20197367|NCT01083628|University of California, Berkeley|Dr. Adrian Aguilera|510-642-8564|aguila@berkeley.edu|
20197368|NCT03620019|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
20197369|NCT05426759|AtriAN Medical Ltd|Barry O'Brien PhD|+353872934292|barry.obrien@atrianmedical.com|
20197370|NCT02536755|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20197371|NCT01174238|University of California, San Francisco|Adil Daud, MD|415-353-7392|adaud@medicine.ucsf.edu|
20197372|NCT02301936|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20197373|NCT02499081|University of Arkansas for Medical Sciences|Maurizio Zangari, MD|501-686-8274|MZangari@uams.edu|
20197374|NCT02322229|Alcon, A Novartis Division|Worldwide Medical Affairs Director, GMA Retina Lucentis|1-888-451-3937|alcon.medinfo@alcon.com|
20197375|NCT00705432|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20197376|NCT01102803|Southern Methodist University|Dr. Jasper Smits|214-768-4125|jsmits@smu.edu|
20197377|NCT00521053|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|1-865-769-4011|wachter@pvct.com|23
20197378|NCT00824824|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
20197379|NCT02281357|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
20197380|NCT02684279|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20197381|NCT01162239|University of California, San Francisco|Dr. Gary Humfleet, PhD|(415) 476-7674|Gary.Humfleet@ucsf.edu|
20197382|NCT05180279|Medical University of South Carolina|Dr Garth Swanson|843-876-2152|swansong@musc.edu|
20197383|NCT04448756|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20197384|NCT02733185|Mount Sinai Medical Center of Florida|Dr. Gervasio Lamas|305-674-2162|Gervasio.Lamas@msmc.com|
20197385|NCT02877927|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
20197386|NCT00601250|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197387|NCT01810016|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20197388|NCT00591825|Laureate Institute for Brain Research (LIBR)|Robin Aupperle, PhD|(913) 588-9078|raupperle@laureateinstitute.org|
20197389|NCT05162027|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
20197390|NCT02553265|NYU Langone Health|Horacio C Kaufmann, MD|212-263-7225|Horacio.Kaufmann@nyulangone.org|
20197391|NCT04415658|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@wustl.edu|
20197392|NCT01025492|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
20197393|NCT00659529|National Jewish Health|Jennifer L. Taylor-Cousar, MD|(303) 270-2764|Taylor-CousarJ@NJHealth.org|
20197394|NCT00916539|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
20197395|NCT01086410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197396|NCT04196803|Vanderbilt University Medical Center|Dr. Qi Dai|615)936-0707|qi.dai@vanderbilt.edu|
20197397|NCT01022996|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
20197398|NCT01667536|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
20197399|NCT01950247|American Regent, Inc.|Mark Falone, MD.|631.772.3544|mfalone@americanregent.com|
20197400|NCT00763971|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20197401|NCT00710879|Bausch & Lomb Incorporated|Joseph Barr, OD, MS|(585) 338-6439|joseph.t.barr@bausch.com|
20197402|NCT03498131|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20197403|NCT03383289|Columbia University in the City of New York|Jeanne Teresi, EdD, PhD|212-305-9379|jat61@cumc.columbia.edu|
20197404|NCT00832117|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20197405|NCT01186939|Celgene Corporation|CL Beach||CLBeach@celgene.com|
20197406|NCT01817855|AstraZeneca|Naimish Patel|+1 781 839 4061|Naimish.Patel@astrazeneca.com|
20197407|NCT03945591|NYU Langone Health|Ahmad Al-Homsi|6465017621|Samer.Al-Homsi@nyulangone.org|
20197408|NCT00698204|University of Connecticut Health Center|Dr. Rajesh V. Lalla|860-679-8007|lalla@uchc.edu|
20197409|NCT01179672|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197410|NCT00314249|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
20197411|NCT01949155|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20197412|NCT04667377|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197413|NCT00210184|Institut Bergonie|Pr Marianne Fonck|+33556333333||
20197414|NCT02316340|UT Health San Antonio|Dr. Sukeshi Arora|2104502872|ARORAS@UTHSCSA.EDU|
20197415|NCT03923556|University of Colorado School of Medicine|Dr. Ana Fernandez-Bustamante|720-848-6744|ana.fernandez-bustamante@cuanschutz.edu|
20197416|NCT01690897|University of British Columbia|Dr. Lori Brotto|604 875 4111|Lori.Brotto@vch.ca|68901
20197417|NCT01118325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20197418|NCT03334409|Mayo Clinic, Rochester|Lance Pagliaro, M.D.|(507)293-0566|Pagliaro.lance@mayo.edu|
20197419|NCT00975715|Novartis|Study Director|41 61 324 1111||
20197420|NCT00418951|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
20197421|NCT02563093|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20197422|NCT04004429|SynAct Pharma|Thomas Jonassen, Chief Scientific Officer|+45 4015 6669|tj@SynActpharma.com|
20197423|NCT00588536|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
20197424|NCT03496324|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20197425|NCT00646906|University of Pennsylvania|Tilo Grosser, MD|215-573-7600|tilo@pennmedicine.upenn.edu|
20197426|NCT00729482|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20197427|NCT02448225|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20197428|NCT00851682|Washington University|Robert Grubb, III|314 454-7185|grubbr@wudosis.wustl.edu|
20197429|NCT01033552|University of Minnesota, Masonic Cancer Center|Dr. Jakub Tolar|(612) 626-5654|tolar003@umn.edu|
20197430|NCT04422990|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20197431|NCT00713479|University of California, Los Angeles|Dr Edythe London|(310) 825-0606|elondon@mednet.ucla.edu|
20197432|NCT02224313|Eastern Virginia Medical School|Dr.David Archer|7574467444|archerdf@evms.edu|
20197433|NCT02486653|University of Wisconsin - Madison|Dr. Evie Carchman, MD|608-263-2521|carchman@surgery.wisc.edu|
20197434|NCT05417607|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
20197435|NCT01750931|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197436|NCT02518997|Stanford University|Melissa Scala|650-723-5711|mscala@stanford.edu|
20197437|NCT01230554|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
20197438|NCT00307333|University of Virginia|Joseph R. Moorman, MD|434-982-3367|rm3h@virginia.edu|
20197439|NCT01245387|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197440|NCT04246801|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
20197441|NCT01368042|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20197442|NCT01621542|Sunovion Pharmaceuticals Inc.|WT2725 Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20197443|NCT03694613|Fundacion Santa Fe, Bogotá, Colombia|Dr. Sergio Lerma|+57 3017752726|serlerma@gmail.com|
20197444|NCT02221349|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20197445|NCT02632721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197446|NCT04207801|Aurigene Discovery Technologies Limited|Divyesh Mandavia|9427181182|divyesh_m@aurigene.com|
20164313|NCT01894607|University of Texas (UT) MD Anderson Cancer Center|Ott Le, MD/Associate Professor, Diagnostic Radiation Body Imaging||CR_Study_Registration@mdanderson.org|
20164314|NCT00431626|Northwestern U|Borko D. Jovanovic, MS, PhD|312 503 2008|borko@northwestern.edu|
20197447|NCT00544648|Vanderbilt-Ingram Cancer Center|Vicki Keedy, MD|615-936-3524|vicki.keedy@vanderbilt.edu|
20197448|NCT02663271|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
20197449|NCT01572675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197450|NCT04166383|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
20197451|NCT00460551|Genmab A/S|Eva Järlid Westerberg PhD|+45 7020 2728|E.Westerberg@genmab.com|
20197452|NCT03346057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197453|NCT03044886|Department of Stomatology, Beijing Chao-yang Hospital, Capital Medical University|Dr. Wang Zuomin|+86-010-85231492|wzuomin@sina.cn|
20197454|NCT02921269|Johns Hopkins University|ETCTN Grants Administrative Manager|443-927-3568|jmurra33@jhmi.edu|
20197455|NCT00703053|Saint Louis University|Robert Belshe, MD|314-977-9030|belsherb@slu.edu|
20197456|NCT03065023|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197457|NCT00228566|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20197458|NCT05975840|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20197459|NCT02715466|B. Braun Melsungen AG|Study Manager|00495661/71|studies@bbraun.com|0
20197460|NCT01624259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197461|NCT00782288|Johns Hopkins University|Pamela L. Zeitlin, M.D., Ph.D., Professor and Director of SOM Pediatric Pulmonary|443-287-8981|pzeitlin@jhmi.edu|
20197462|NCT00823303|Washington University School of Medicine|Dr. Daniel W. Coyne|3143627211|dcoyne@dom.wustl.edu|
20197463|NCT01330134|University of Chicago|John P. Kress, MD|773-702-1000|jkress@medicine.bsd.uchicago.edu|
20197464|NCT02246582|Medtronic Diabtes|Smita Barua, Clinical Trial Manager|818.576.5534|smita.barua@medtronic.com|
20197465|NCT02229539|Mayo Clinic|Robert C. Miller, MD, MS|904-953-1003|miller.robert@mayo.edu|
20197466|NCT02899078|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20197467|NCT02060383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20197468|NCT03441334|Texas Woman's University|Hui-Ting Goh, Assistant Professor|2146897723|HGoh1@twu.edu|
20197469|NCT04946825|University of Vermont|Elias Klemperer, PhD|802-656-1641|elias.klemperer@med.uvm.edu|
20197470|NCT01932242|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
20197471|NCT03426787|Washington University in St. Louis School of Medicine|Dr. Mary C Politi|3147471967|mpoliti@wustl.edu|
20197472|NCT00316355|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
20197473|NCT01653288|Children's Hospital of Philadelphia|Dr. Nancy Kassam-Adams|2155903118|adamsn@email.chop.edu|
20197474|NCT00713817|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20197475|NCT03627767|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197476|NCT00907257|Valeant Pharmaceuticals International, Inc|David Lineberry|949-973-1153|David.Lineberry@valeant.com|
20197477|NCT04163900|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
20197478|NCT01873417|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20197479|NCT00785044|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
20164315|NCT03084796|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20197480|NCT01628107|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197481|NCT02767323|Duke University|Dr. Lysianne Beynel|9193386273|lysianne.beynel@gmail.com|
20197482|NCT00930722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197483|NCT03523728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20164316|NCT01708317|Washington University School of Medicine|Dr. Fahd A Ahmad|314-286-0298|ahmad_f@kids.wustl.edu|
20197484|NCT02230254|Second Affiliated Hospital of Zhejiang University|Dr. Wang Jian'an|010-85216440|Yuwei.Zhang@bsci.com|
20197485|NCT00621751|Atrium Health; Currently at Indiana University School of Medicine|Flora Hammond, MD|317-292-6781|flora.hammond@rhin.com|
20197486|NCT02023242|Ivantis, Inc.|Richard Hope|949-333-1310|rhope@ivantisinc.com|
20197487|NCT02528370|Hospital Galdakao-Usansolo|Dr Cristobal Esteban|0034 94 400 7000|cristobal.estebangonzalez@osakidetza.eus|7002
20197488|NCT00419120|Tengion, Inc.|Sunita Sheth, MD - Chief Medical Officer|267-960-4805|sunita.sheth@tengion.com|
20197489|NCT01831921|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolin@wakehealth.edu|
20197490|NCT01069120|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20197491|NCT02251379|Johns Hopkins University|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
20197492|NCT01655329|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
20197493|NCT01809132|UTexas Southwestern Medical Center|Dr. Mack C. Mitchell|2146485036|mack.mitchell@utsouthwestern.edu|
20197494|NCT04854434|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20197495|NCT03349775|Beth Israel Deaconness Medical Center|Dr. Jennifer Ho|617-735-4102|jho@bidmc.harvard.edu|
20197496|NCT02667275|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
20197497|NCT02022085|Radboud University Medical Centre, Nijmegen, The Netherlands|Professor Emmanuel Mylanus|+31 24 361 1111|Emmanuel.Mylanus@radboudumc.nl|
20197498|NCT03583450|University of California, San Francisco|Dr. Jina Sinskey|857-998-0137|jina.sinskey@ucsf.edu|
20197499|NCT03938038|The University of Texas Health Science Center at Houston|Gabrielle Hatton, MD|713-500-7211|gabrielle.e.hatton@uth.tmc.edu|
20197500|NCT00791258|Daiichi Sankyo, Inc|John Raia|(973) 944-2683|jraia@dsi.com|
20197501|NCT02150499|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclousre@sunovion.com|
20164317|NCT02401347|Stanford Medicine at Stanford University|Melinda L Telli, MD|(650) 724-9533|mtelli@stanford.edu|
20164318|NCT01685567|Silk Road Medical, Inc.|Linda Ruedy. Sr. Director, Clinical and Regulatory Affairs|(408) 585-2113|lruedy@silkroadmed.com|
20164319|NCT00607087|sanofi-aventis|Medical Affairs Study Director||publicregistryGMA@sanofi-aventis.com|
20164320|NCT02717494|Westat|Lauren Laimon, Senior Study Director|240-453-2987|LaurenLaimon@westat.com|
20164321|NCT01887184|The University of Hong Kong|Professor Chi Wai Cheung|22553303|cheucw@hku.hk|
20164322|NCT01168726|University of Missouri|Dr. Matthew P. Martens, Professor; Division Executive Director|573-882-3382|martensmp@missouri.edu|
20164323|NCT03370718|M.D. Anderson Cancer Center|Mouhammed A. Habra, MD|713-792-2841|mahabra@mdanderson.org|
20164324|NCT00214539|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412-716-0717|Mark.Grubb@bsci.com|
20164325|NCT03095248|Cincinnati Children's Hospital Medical Center|Senior Regulatory Specialist|15135350640|andrea.bidwell@cchmc.org|
20164326|NCT05477485|Virginia Commonwealth University|Dr. April D. Kimmel|(804) 628-6273|adkimmel@vcu.edu|
20164327|NCT06172348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164328|NCT03116685|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
20164329|NCT05274958|Carilion Clinic|Director Psychiatry Clinical Research|540-527-4900|askablinger@carilionclinic.org|
20164330|NCT03066063|Barron Associates, Inc.|Richard Adams|434-973-1215|adams@bainet.com|
20164331|NCT05579977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164332|NCT01406990|Creighton University|Dr. Katie Packard, PharmD|402-280-4566|kathleenpackard@creighton.edu|
20164333|NCT01611194|Intermountain Healthcare|Lindell Weaver, MD, FACP, UHM|801-408-3623|lindell.weaver@imail.org|
20164334|NCT00348673|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164335|NCT02756572|University of Washington/Seattle Cancer Care Alliance|Mary-Elizabeth Percival, MD, MS|206-606-1320|mperciva@seattlecca.org|
20164336|NCT01712204|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
20164337|NCT02679287|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
20164338|NCT01114828|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20164339|NCT00794950|University of Michigan|Alon Z. Weizer, MD, MS|734-615-6662|aweizer@umich.edu|
20164340|NCT02485704|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
20164341|NCT01777776|Array BioPharma, Inc.|Study Director|303-381-6604|info@arraybiopharma.com|
20164342|NCT01137370|Department of Medicine and Lung Institute, Seoul National University College of Medicine|Jae-Joon Yim|+82-2-2072-2059|yimjj@snu.ac.kr|
20164343|NCT01943591|Centre hospitalier de l'Université de Montréal Research Centre|Dr. Jean Raymond|514-890-8000|jraymond.nri@gmail.com|27235
20197502|NCT05215262|Mount Sinai Adolescent Health Center|Sarah Wood, MD, MSHP|(332) 227-4355|Sarah.Wood@mountsinai.org|
20197503|NCT00239226|Medtronic BRC - Medtronic Italia SpA|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
20164344|NCT04104256|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
20197504|NCT01892306|Massachusetts General Hospital|Kristen Ellard, PhD|617-726-6422|kellard@partners.org|
20197505|NCT04060563|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20197506|NCT01534013|Imperial College London|Prof Nick Oliver|02075942433|nick.oliver@imperial.ac.uk|
20197507|NCT03633526|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
20197508|NCT01958788|Concordia University|Elizabeth Hebert|1-514-848-2424|el_heber@live.concordia.ca|2199
20197509|NCT01379573|NYU Langone Health|Jill Buyon|+1 212 263 0746|Jill.Buyon@nyulangone.org|
20197510|NCT00962390|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
20197511|NCT02613884|Kate Farms|Vanessa Millovich|3522634409|vannanole@gmail.com|
20197512|NCT02844920|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
20197513|NCT00131469|OHSU|Eric Orwoll|15034940225|orwoll@ohsu.edu|
20197514|NCT02871778|Parion Sciences|Karl Donn|919 313 1185|kdonn@parion.com|
20197515|NCT00232141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20197516|NCT02273726|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|064study@fibrogen.com|
20197517|NCT01479829|Loyola University Medical Center|Dr. Angelos Halaris|708-216-3272|ahalaris@luc.edu|
20197518|NCT00846547|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
20197519|NCT04263896|University of Chicago|Dr. Sandra Laveaux|773-702-6118|slaveaux@bsd.uchicago.edu|
20197520|NCT00088907|ECOG Statistical Office|Study Statistician|617-632-3012||
20197521|NCT04050670|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20197522|NCT00483561|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
20197523|NCT00880555|Department of Veterans Affairs|Dr. David Glenn Clark|843-792-7446|clarkda@musc.edu|
20197524|NCT01651104|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20164345|NCT01131507|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20197525|NCT01756040|University of Maryland Baltimore|Rose Marie Viscardi, M.D.|410-328-6003|rviscard@som.umaryland.edu|
20197526|NCT01274715|Michael DeBakey VAMC|Aanand Naik, MD|713-794-8541|anaik@bcm.edu|
20197527|NCT04479436|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
20197528|NCT02713542|Arthrex|Clinical Affairs Manager|2395984302|INC_ClinicalResearch@arthrex.com|
20197529|NCT02357134|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20197530|NCT05097716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197531|NCT01303965|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
20197532|NCT04234672|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20197533|NCT00433914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20197534|NCT04534491|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20197535|NCT00240981|Brigham & Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
20197536|NCT00766090|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197537|NCT03331861|Columbia University Irving Medical Center|Barry Fine, MD|212-305-5755|bmf2002@cumc.columbia.edu|
20197538|NCT00528580|University of Chicago|Millie Maleckar|773-702-1472|mmalecka@bsd.uchicago.edu|
20197539|NCT03024970|CooperVision, Inc.|Myhanh Nguyen, OD, FAAO|925-730-6716|mnguyen@coopervision.com|
20197540|NCT02945150|Massachusetts General Hospital|Dr. Raymond Chung|617-724-7562|Chung.Raymond@mgh.harvard.edu|
20197541|NCT02653300|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
20197542|NCT03530917|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20197543|NCT01910116|Seoul National University Hospital|Prof. Eun Bong Lee|822-2072-3944|leb7616@snu.ac.kr|
20197544|NCT02289352|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20197545|NCT01390272|Durham VA Medical Center, Durham, NC|Dr. George Lee Jackson, PhD MHA|919-286-0411|George.Jackson3@va.gov|7091
20197546|NCT01177384|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197547|NCT01849497|Amgen Inc.|Study Director|866-572-6436||
20197548|NCT04458103|Massachusetts General Hospital|David D'Alessandro|617-726-8841|DADALESSANDRO@mgh.harvard.edu|
20197549|NCT01983839|Aarhus University Hospital, Department of infectious diseases|Dr Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
20197550|NCT01772004|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20197551|NCT00911625|Rush University Medical Center|David Baldwin, MD|312-942-2813|david_baldwin@rush.edu|
20164346|NCT01147042|NIH CC|Dr. John Gallin|301-827-5428|jgallin@cc.nih.gov|
20197552|NCT01289821|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20197553|NCT03591354|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
20197554|NCT00590044|Emory University SOM|Guillermo Umpierrez|4047781663|geumpie@emory.edu|
20197555|NCT03945357|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
20197556|NCT04666350|PATH|Chris F Ockenhouse, MD, PhD|+1 (202) 716-5849|cockenhouse@path.org|
20197557|NCT02729740|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
20197558|NCT00531882|University Hospitals Case Medical Center|Michael W Konstan, MD|2168445267|michael.konstan@uhhospitals.org|
20197559|NCT05144113|Spaulding Rehabilitation Hospital|Dr. J.Andrew Taylor|616-758-5503|jandrew_taylor@hms.harvard.edu|
20197560|NCT03422679|Cellestia Biotech AG|Maria Bobadilla, Chief Development Officer|+41616332957|maria.bobadilla@cellestia.com|
20197561|NCT00175877|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20197562|NCT03061175|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne, Associate Director, Population Science|732-235-6759|mannesl@cinj.rutgers.edu|
20197563|NCT00995475|University of Dundee|Professor Brian J Lipworth|+44 1382 383188|b.j.lipworth@dundee.ac.uk|
20197564|NCT03044249|Mediti Pharma Inc.|Chief Executive Officer|1-514-993-7207|ivan.shaw@meditipharma.com|
20197565|NCT00955279|Johnson & Johnson Pharmaceutical Research & Development|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20197566|NCT00760669|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
20197567|NCT01235793|Cedars-Sinai Medical Center|Yuliya Linhares, MD|310-423-4646|Yuliya.Linhares@cshs.org|
20197568|NCT01692691|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20197569|NCT01159912|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197570|NCT01883986|VA Puget Sound Health Care System|Lynn F. Reinke, PhD, ARNP|206-277-4186|lynn.reinke1@va.gov|
20197571|NCT02456662|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5367|sarah_betstadt@urmc.rochester.edu|
20197572|NCT00822354|Northwestern University|Clinical Trials Coordinator|312-695-6829|j-bae@northwestern.edu|
20197573|NCT02374021|Brigham and Women's Hospital|Dr. Daniel Solomon|617-732-5356|dsolomon@bwh.harvard.edu|
20197574|NCT00982007|Luitpold Pharmaceuticals, Inc.|Mark A. Falone|610-650-4200|mfalone@luitpold.com|
20197575|NCT00504153|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
20197576|NCT04411953|Cycle Pharmaceuticals|Head of Global Regulatory Affairs and Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
20197577|NCT00732251|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
20197578|NCT00805025|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20197579|NCT04029961|Medical College of Wisconsin|John LaDisa|414-288-6739|jladisa@mcw.edu|
20197580|NCT02347488|UCLA Department of Anesthesiology|Nir Nahum Hoftman, MD|310-267-8679|nhoftman@mednet.ucla.edu|
20217683|NCT01301482|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20217684|NCT01682642|Fertility Center AZ Jan Palfijn|dr. Wim Decleer, PI|0032 9 325 92 20|wim.decleer@janpalfijngent.be|09/2248851
20217685|NCT02234752|George Washington University, Washington, DC|Maju Koola|678-200-8613|majumkoola@gmail.com|
20197581|NCT05314712|Center for American Indian and Rural Health Equity|Vernon Grant|406-531-9310|vernon.grant@montana.edu|
20197582|NCT03007979|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
20197583|NCT00683163|UNIVERSITY OF CALIFORNIA, SAN FRANCISCO|Dr. Dennis Black|415-514-8159|dblack@psg.ucsf.edu|
20197584|NCT00682448|Rush University Medical Center|Stephanie Cavanaugh, MD||Stephanie_Cavanaugh@rush.edu|
20197585|NCT00829049|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20197586|NCT00761306|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20197587|NCT00268437|Mayo Clinic|Aminah Jatoi, M.D.|507/284-4918|jatoi.aminah@mayo.edu|
20197588|NCT00525044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197589|NCT01817907|Brigham and women's Hospital|D. Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
20197590|NCT02982239|Sleep and Health Research Program - University of Arizona|Dr. Michael Grandner|5206260105|grandner@psychiatry.arizona.edu|
20197591|NCT04296877|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
20197592|NCT00760019|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-6186|jbeckman@partners.org|
20197593|NCT04311697|Applied Pharma Rersearch|Paola Prina|4847169881|paola.prina@apr.ch|
20197594|NCT01540825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197595|NCT01383096|Nucleus Network|Peter Hodsman|+ 613 9076 8900|businessdevelopment@nucleusnetwork.com.au|
20197596|NCT01172197|NHS Tayside|Dr G McLeod|+44 1382 7974440848|g.a.mcleod@dundee.ac.uk|
20197597|NCT00616434|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20197598|NCT04872348|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
20197599|NCT00467779|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20197600|NCT01509079|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
20197601|NCT05111041|Duke University|Devon Noonan, Ph.D.|919-684-3786|devon.noonan@duke.edu|
20197602|NCT00041080|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20197603|NCT00436618|Mayo Clinic|Thomas E. Witzig M.D.|(507) 284-0527|witzig.thomas@mayo.edu|
20197604|NCT01994382|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20197605|NCT01011439|CLIOSS S.r.l.|Dr. Cristina Davite|+39 0031 58|regulatory@clioss.com|1482
20197606|NCT02428855|Massachusetts General Hospital|Dr. Bruce Giantonio|617-724-4000|BGIANTONIO@mgh.harvard.edu|
20197607|NCT00359021|Tibotec|SENIOR DIRECTOR R&D|1 609 730-7548||
20197608|NCT02066311|The Feinstein Institute for Medical Research|Dr. Meggan Mackay|516-562-3838|mmackay@northwell.edu|
20197609|NCT00006151|University of Pennsylvania|Peter Gariti||gar1iti@mail.med.upenn.edu|
20197610|NCT04353596|Medizinische Universität Innsbruck/ Medical University Innsbruck|Prof. Dr. Axel Bauer|0043 512 504 25621|Axel.Bauer@i-med.ac.at|
20197611|NCT05418673|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20197612|NCT01986920|Aclaris Therapeutics|Christopher Powala, Chief Operating Officer|484-324-7933|cpowala@aclaristx.com|
20197613|NCT03781323|University of Rochester|Richard Dunne|585-275-5823|Richard_Dunne@urmc.rochester.edu|
20197614|NCT01338415|Actelion Pharmaceuticals Ltd|Principal Clinical Scientist||ClinicalTrialDisclosure@its.jnj.com|
20197615|NCT03000088|Ajou University School of Medicine|Dr. Jiyoung Lee|82-31-219-5689|leejiyoung0616@gmail.com|667
20197616|NCT00233363|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20197617|NCT01495858|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20197618|NCT01526551|University of Kentucky College of Public Health|Dr. Robin Vanderpool|859-218-2102|robin@kcr.uky.edu|
20197619|NCT00874770|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
20197620|NCT00866749|The University of Texas MD Anderson Cancer Center|Michael Andreeff MD./Professor|713-792-7261|mandreeff@mdanderson.org|
20197621|NCT04880447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197622|NCT00718549|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20197623|NCT01353508|Novartis|Study Director|862-778-1873||
20197624|NCT01576172|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
20197625|NCT01196533|Morristowm Memorial Hospital|Dr. Frank Smart|973-214-2601|frank.smart@atlantichealth.org|
20197626|NCT01688856|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
20197627|NCT01514136|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1990|dkbir@coloplast.com|
20197628|NCT01010633|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
20197629|NCT01561495|AbramsonCC Radiation Oncolocy|Susan Prendergast, RN|215-662-4267|susan.prendergast@pennmedicine.upenn.edu|
20197630|NCT00888381|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20197631|NCT04267770|Imperial College London|Nick Oliver|+44 20 7594 1796|nick.oliver@imperial.ac.uk|
20197632|NCT02431897|University of Texas Southwestern Medical Center Dallas|Dr. David D. Rahn|12146486430|david.rahn@utsouthwestern.edu|
20197633|NCT01995578|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari MD|646-608-3738|tamarir@mskcc.org|
20197634|NCT01560923|Masonic Cancer Center, University of Minnesota|Dr.Gautam Jha|612-624-5373|jhaxx014@umn.edu|
20197635|NCT03142438|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
20197636|NCT04411628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20197637|NCT03828292|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20197638|NCT01444456|Amgen Inc.|Study Director|866-572-6436||
20197639|NCT01744353|Brown Oncology Research Group|Helena Lau|4018633000|helena_lau@brown.edu|
20197640|NCT04376827|Janssen Research & Development, LLC|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20197641|NCT06291831|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197642|NCT00311376|Allergan, Inc.|Therapeutic area Head|714-246-4500|clinicaltrials@allergan.com|
20197643|NCT00257166|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197644|NCT02142738|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197645|NCT03688880|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
20197646|NCT01704287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197647|NCT02615470|Auburn University|Salisa Westrick|3348448314|westrsc@auburn.edu|
20197648|NCT03713034|Yale University|Tyra Pendergrass Boomer|(203) 737-6101|tyra.pendergrass@yale.edu|
20197649|NCT03042780|H Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
20197650|NCT02000596|University of Maryland Greenebaum Comprehensive Cancer Center|Kate Tkaczuk|410-328-7394|ktkaczuk@umm.edu|
20197651|NCT04024228|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20197652|NCT00886704|Ludwig Maximilians-University Munich|Clemens von Schacky, Head, Preventive Cardiology, University of Munich|+498951600|clemens.vonschacky@med.uni-muenchen.de|2165
20197653|NCT02982590|HOSPITAL UNIVERSITI SAINS MALAYSIA|DR W YUS HANIFF W ISA|09-767 3000|wyhaniff@usm.my|
20197654|NCT04968041|Florida State University|Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
20197655|NCT01168973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197656|NCT00415506|Oregon Health & Science University|Dr. Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
20197657|NCT01847430|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197658|NCT00618436|University of Pittsburgh|Dr. Lori Shutter|1-412-647-8410|shutterla@upmc.edu|
20197659|NCT02163187|Memorial Sloan Kettering Cancer Center|Dr. Martin Weister, MD|212-639-6698|weiser1@mskcc.org|
20197660|NCT02709694|Hospital for Special Surgery|Dr. Lisa Mandl|(212) 774-2960|mandll@hss.edu|
20197661|NCT03281668|University of North Carolina at Chapel Hill/Thurston Arthritis Research Center|Yvonne Golightly, PhD|919-966-0566|golight@email.unc.edu|
20197662|NCT01901575|NYU Langone Medical Center|Avrimin M. Kogan, MD|(212) 263-5072|Avrimin.Kogan@nyumc.org|
20217686|NCT01915940|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20217687|NCT00614926|Columbia University|Judith Rabkin, PhD|212 543 5762|jgr1@columbia.edu|
20197663|NCT04774250|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
20197664|NCT01673919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20197665|NCT00986544|"Department of Surgery, Hospital P. Colombo, Via Orti Ginnetti 7, 00049 Velletri (Rome), Italy"|Marcello Picchio|+39696102228|marcellopicchio@libero.it|
20197666|NCT01871220|University of Iowa College of Dentistry|Dr. Christopher Barwacz|3193843002|chris-barwacz@uiowa.edu|
20164347|NCT00599872|Greer Laboratories|Bob Esch, VP Research & Development|828.759.7845|esch@greerlabs.com|
20164348|NCT03052101|University of Cincinnati|Elizabeth Kopras|513-558-4831|koprasej@uc.edu|
20164349|NCT05473026|University of Florida|Lakeshia Cousin, PhD, APRN, AGPCNP-BC|352-273-6318|lakeshiacousin@ufl.edu|
20164350|NCT02193776|TB Alliance|Almari Conradie, Director, Clinical Operations|+27 12 991 6328|almari.conradie@tballiance.org|
20164351|NCT01702844|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20164352|NCT00914186|Taisho Pharmaceutical R&D Inc.|Fred Henry MS, MPH,|973-898-6200|F-Henry@taihso-rd.com|
20164353|NCT03788057|The Regional Public Hospital in Lesko, Poland|Dr. Janusz Ciółkowski|+48 134698071|ciolkowski.janusz@gmail.com|
20164354|NCT00248495|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20164355|NCT03812380|UT Southwestern Medical Center|Khashayar Sakhaee, MD|214-648-0324|Khashayar.Sakhaee@UTSouthwestern.edu|
20164356|NCT00981149|ECU SODM|Sharon Gordon, DDS|2527377125|gordons@ecu.edu|
20164357|NCT02341235|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
20164358|NCT03518294|The Penn State College of Medicine|Dr. Jonathan Stine|7175311017|jstine@pennstatehealth.psu.edu|
20164359|NCT04115384|HealthPartners Institute|Manager Research Operations|651-495-6363|ClinicalTrials@HealthPartners.com|
20164360|NCT04244253|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20164361|NCT00619515|Case Comprehensive Cancer Center|Dr. Lee Ponsky|216-844-4831|lee.ponsky@uhhospitals.org|
20164362|NCT01839058|Western University|Keith McIntosh|519-646-6100|keith.mcintosh@sjhc.london.on.ca|61312
20164363|NCT03294590|Boston University Henry M. Goldman School of Dental Medicine|Belinda Borrelli, PhD|617-358-3358|belindab@bu.edu|
20164364|NCT00411749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164365|NCT01441843|Erasmus University Medical Centre|Dr. M. Klimek|+31107033713|m.klimek@erasmusmc.nl|
20164366|NCT00628030|Virginia Commonwealth University|Suzanne E Mazzeo, Professor of Psychology|804-827-9211|semazzeo@vcu.edu|
20164367|NCT04177706|Medical University of South Carolina|Prinicipal Investigator|8438761199|JONJEN@musc.edu|
20164368|NCT04154943|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20164369|NCT01292187|Tarsa Therapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
20164370|NCT03880058|Scarless Labs Inc.|Dr. Elisabeth Leeflang|213-788-2128|Clin_Info@scarlesslabs.com|
20197667|NCT04746833|VA Connecticut Healthcare System|Dr. Brent A. Moore|2034352243|brent.moore@yale.edu|
20197668|NCT02247765|Medtronic|Michael Luna-Victoria|3034068955|michael.luna-victoria@medtronic.com|
20197669|NCT01641237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197670|NCT00709111|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20197671|NCT02716675|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20197672|NCT00623974|UT MD Anderson Cancer Center|Mimi Hu, MD / Professor||CR_Study_Registration@mdanderson.org|
20197673|NCT01301456|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197674|NCT02015442|Imperial College London|Prof Gary Frost|020 7594 0959|g.frost@imperial.ac.uk|
20164371|NCT03827655|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20164372|NCT03649217|Moterum Technologies, Inc.|Brianne Darcy|(864) 659-3180|brie@moterumtechnologies.com|
20197675|NCT00290290|Baylor College of Medicine|Rabih Darouiche, M.D.|713-794-8858|rabihd@bcm.edu|
20197676|NCT00915772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197677|NCT03374995|Wake Forest University Health Sciences|Principal investigator|336-716-5440|kwinkfie@wakehealth.edu|
20197678|NCT00393796|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|1-800-865-1125|mahahuss@umich.edu|
20197679|NCT04013789|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20197680|NCT04747834|Regulatory Pathways Group, Inc.|Gretchen Neumann|19494667124|gneumann@regulatorypathways.com|
20197681|NCT03319407|Mayo Clinic|Robert L. McClain, M.D.|904-956-1728|Mcclain.Robert@mayo.edu|
20197682|NCT01488279|Frist Clinic Endocrinology|Dr. Annis Marney|615-403-8398|annis.marney@hcahealthcare.com|
20197683|NCT00119041|Louis Stokes VA Medical Center|David C. Aron, MD, MS|(216) 791-2300|david.aron@va.gov|5702
20197684|NCT02783443|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
20197685|NCT03023059|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
20197686|NCT01364623|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
20217688|NCT03694808|University Hospitals Cleveland Medical Center|Dr. David Canaday|216-368-5537|dxc44@case.edu|
20217689|NCT00521989|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
20187589|NCT04934072|Fresenius Kabi SwissBioSim GmbH|Clinical Development|+41 793075735|medinfo_biosim@fresenius-kabi.com|
20187590|NCT03631290|Duke University Medical Center|Rasheeda Hall, M.D.|919-660-6861|rasheeda.hall@duke.edu|
20187591|NCT02828358|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20187592|NCT02413489|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187593|NCT05285137|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
20187595|NCT04601480|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
20187596|NCT03717935|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
20187597|NCT01820611|Zimmer Biomet|Linda Meijer|+31 6 57933741|linda.meijer@zimmerbiomet.com|
20197687|NCT01614821|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
20197688|NCT02902081|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20197689|NCT00619970|CHLA|Brynie Slome Collins MD|323 361 2181|bcollins@chla.usc.edu|
20164373|NCT01092728|The University of Texas (UT) MD Anderson Cancer Center|Kevin Kim, MD/Melanoma Medical Oncology|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
20164374|NCT02520726|University of Utah|Brent Kious, MD|801-585-1418|brent.kious@hsc.utah.edu|
20164375|NCT02336607|Astrazeneca|BP of Astrazeneca|+86 21 60302288|aztrial_results_posting@astrazeneca.com|
20164376|NCT02119871|Department of Cardiothoracic Surgery, Lund University|Maya Landenhed Smith|+4646173639|maya.landenhed_smith@med.lu.se|
20164377|NCT02552966|Northwestern University|Dr. John Pandolfino, Principal Investigator|3126950182|j-pandolfino@northwestern.edu|
20164378|NCT00961311|Medtronic Cardiovascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20164379|NCT00721396|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20164380|NCT00271375|Atlanta VAMC|Patricia Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
20164381|NCT02365649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20197690|NCT04792567|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20164382|NCT03476135|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20164383|NCT04142034|University of Arkansas for Medical Sciences|Jeannette Lee|5015266712|jylee@uams.edu|
20164384|NCT04875806|NextCure, Inc|Senior VP, Clinical and Translational Development|240-399-4900|NCClin@nextcure.com|
20164385|NCT02021565|Atlanta VA Medical Center|Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
20164386|NCT01188772|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20164387|NCT00287716|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
20164388|NCT04388254|Cassava Sciences|Sr. Associate Director|5125013180|bmurray@cassavasciences.com|
20164389|NCT02927392|University of Colorado Anschutz Medical Campus|Edward L. Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
20164390|NCT00512876|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
20164391|NCT03259555|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20197691|NCT01314963|Stanford Univeristy Medical Center|Craig Levin, PhD; Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine)|650-736-0449|cslevin@stanford.edu|
20164392|NCT00700440|Cancer Center, Sun Yat-sen University|Dr. Lu Tai-xiang|86-20-87343372|lutx@mail.sysu.edu.cn|
20164393|NCT00154297|Novartis Pharmaceuticals|Study Director|862-778-8300||
20164394|NCT00650767|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
20164395|NCT01774799|Hebrew SeniorLife|Dr. Susan Mitchell|617-971-5326|smitchell@hsl.harvard.edu|
20164396|NCT02910466|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20164397|NCT01125800|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20197692|NCT00889226|CMC|Dr. Hoyoung Sohn|82-2-222-2222|abc@snu.ac.kr|3333
20197693|NCT01106027|Mayo Clinic|Dr. Mark Stegall|507-284-6275|Stegall.Mark@mayo.edu|
20197694|NCT02170779|VA Research and Development|Cinda Hugos, Physical Therapist|503-220-8262|hugosc@ohsu.edu|52338
20197695|NCT00369785|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20197696|NCT00800683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197697|NCT00356889|University of Wisconsin Cancer Center|William Schelman, M.D.||wrs@medicine.wisc.edu|
20197698|NCT02678416|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20197699|NCT01848353|University of Oklahoma Health Sciences Center|Kevin Short, PhD, Associate Professor|(405) 271-8001|kevin-short@ouhsc.edu|43094
20197700|NCT00935272|Medicis Global Services|Heather M Corey|480-291-5981|hcorey@medicis.com|
20197701|NCT00953719|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|shimden@its.jnj.com|
20197702|NCT01170546|Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital|Shih-Wei Chou, MD, PhD|88633281200|h0711@ms13.hinet.net|3846
20197703|NCT02017379|Texas Tech University Health Sciences Center at El Paso|Research Compliance Officer|915-215-4814|jackie.roberts@ttuhsc.edu|
20197704|NCT03492554|Apple|Health Technology Clinical Operations|1-866-905-5303|htclinicalquestions@apple.com|
20197705|NCT01727765|University of Portsmouth|Dr Mitch Lomax|02392845297|mitch.lomax@port.ac.uk|
20197706|NCT00736034|Sourazky Tel-Aviv Medical Center|Dr. V. Vakhapova|972-3-6973698|vedanicek@gmail.com|
20197707|NCT01478360|Novartis Pharmaceuticals|Study Director|862-778-8300||
20197708|NCT01353079|GREER Laboratories, Inc.|Terrance Coyne, M.D., Executive Vice President of Research & Development; Chief Medical Officer|(828) 759-7495|tcoynemd@greerlabs.com|
20197709|NCT02336763|UCLA|Mitchell Kamrava, MD|310-825-9775|mkamrava@mednet.ucla.edu|
20164398|NCT03061201|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164399|NCT04037891|Akari|Wynne H Weston-Davies|+44(0)7801 281283|wynne.weston-davies@akaritx.com|
20164400|NCT02511379|Alcon, A Novartis Division|Study Director Med Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
20197710|NCT02232126|University of Southern California|Dr. Susan Enguidanos|213-740-9822|enguidan@usc.edu|
20164401|NCT03446313|University of California, San Francisco|Linda Park, Principle Investigator|415-502-6616|linda.park@ucsf.edu|
20197711|NCT03086265|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
20197712|NCT05293743|The Hospital for Sick Children|Dr. Maryse Bouchard|4168137654|maryse.bouchard@sickkids.ca|224522
20197713|NCT02064920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197714|NCT03598647|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
20197715|NCT04310085|Medicines for Malaria Venture|Dr Stephan Chalon|+41 22 555 0379|chalons@mmv.org|
20197716|NCT05834348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20197717|NCT03734016|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20197718|NCT01979835|principal investigator|Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
20197719|NCT00314353|NSABP Foundation, Inc.|Diana Gosik|412-330-4692|diana.gosik@nsabp.org|
20197720|NCT01428661|Vanda Pharmaceuticals Inc.|Curt Wolfgang, Ph.D.|202-734-3400|curt.wolfgang@vandapharma.com|
20197721|NCT05907213|University of Pittsburgh, UPMC Department of Anesthesiology & Perioperative Medicine|Dr. Katherine Grace Lim, Chief of the Division of OB & Women's Anesthesiology|412-641-1778|limkg2@upmc.edu|
20197722|NCT01944293|Columbia University Medical Center - NY State Psychiatric Institute|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
20197723|NCT00388505|Novartis Pharmaceuticals|Study Director|862-778-8300||
20197724|NCT01490684|King Abdulaziz Medical City|Dr Hasan Al-Dorzi|966535888632|aldorzih@yahoo.com|
20197725|NCT01180478|CROES|J. de la Rosette, chairman CROES|+31 20 5666030|info@croesoffice.org|
20197726|NCT03785925|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20197727|NCT01575106|Massachusetts General Hospital|Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
20197728|NCT01206062|Wake Forest University Health Sciences|David Reboussin|336-716-6844|drebouss@wakehealth.edu|
20197729|NCT00957528|The University of Texas Medical Branch at Galveston|Randall Urban, M.D., Professor of Medicine|409- 772-1176|rurban@utmb.edu|
20197730|NCT00762892|UT Health Science Center Houston|Tanvir Bell, MD|713-500-6759|Tanvir.K.Bell@uth.tmc.edu|
20197731|NCT00338039|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Professor||CR_Study_Registration@mdanderson.org|
20197732|NCT03947983|The University of Texas Austin|Kavita Radhakrishnan|5124717936|kradhakrishnan@mail.nur.utexas.edu|
20197733|NCT02091778|Podiatry and Foot health, Stott Lane Salford ,UK|Paul Chadwick|0161 206 4710|paul.chadwick@salford.nhs.uk|
20197734|NCT01841749|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20197735|NCT00677820|MedImmune LLC, an affiliate of AstraZeneca|Raburn Mallory, MD/ Sr Dir Clinical Development|301-398-0000|malloryr@medimmune.com|
20197736|NCT01211535|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
20197737|NCT00549939|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20197738|NCT03593850|Universidad del Rosario|Dr. Juan Sebastian Martin Saavedra|2672200532|juans.martin@urosario.edu.co|
20197739|NCT00003895|Providence Cancer Center, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center|Walter J. Urba, MD, PhD; Physician Director of Research|503-215-5696|Walter.Urba@providence.org|
20197740|NCT01735279|Department of Psychobiology, Universidade Federal de São Paulo (UNIFESP), Rua Napoleão de Barros, São Paulo , Brazil|Md PhD José Carlos F. Galduróz|+55 11 2149 0000|galduroz@unifesp.br|
20197741|NCT02490475|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20197742|NCT04130633|Johns Hopkins University School of Medicine|C. Austin Zamarripa, PhD|410-550-6969|czamarr2@jh.edu|
20197743|NCT04748653|University of California San Francisco|Alison El Ayadi, Associate Professor|415-476-5877|alison.elayadi@ucsf.edu|
20197744|NCT01701999|California Department of Public Health|Dr. Jessica Khouri|510-231-7600|Jessica.Khouri@cdph.ca.gov|
20197745|NCT01195090|Department of Internal Medicine, Mackay Memorial Hospital|Dr. Sung-Chen Liu|886-2-2543-3535|pine3.tw@yahoo.com.tw|2174
20197746|NCT04912245|Wake Forest University Health Sciences|Tele Voice|336.716.8028|jgabbard@wakehealth.edu|
20197747|NCT01205230|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197748|NCT00058552|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20197749|NCT03861936|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20197750|NCT02319668|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197751|NCT00702364|Craig Hospital|Cynthia Harrison-Felix, PhD|303-789-8565|charrison-felix@craighospital.org|
20197752|NCT01312038|Middle Ear Physiology Laboratory|Ellen Mandel, MD|412-692-6214|mandele@pitt.edu|
20197753|NCT01372150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197754|NCT03198520|Solvay® Dental 360|Tim Shary Compliance and Product Specialist|770-772-8665|Tim.shary@solvay.com|
20197755|NCT01670539|West Virginia University|Georgia L Narsavage|304-293-6729|gnarsavage@hsc.wvu.edu|
20197756|NCT01236573|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20197757|NCT02665052|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Susan S. Conroy|(410) 637-3213|susan.conroy@va.gov|
20197758|NCT00823823|Children's Hospital Boston|Dr. Donald Bae|617-355-6808|donald.bae@childrens.harvard.edu|
20197759|NCT02234284|University of California San Francisco|Dr. David Thom|415-206-2278|David.Thom@UCSF.edu|
20197760|NCT00536809|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197761|NCT04569032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197762|NCT00873366|Mayo Clinic|Dr. Matthew P. Goetz|507-284-2511|goetz.matthew@mayo.edu|
20197763|NCT00324753|Center for Health Equity Research and Promotion (VAPHS)|Maria K. Mor|(412) 360-2240|maria.mor@va.gov|
20197764|NCT00303979|Medtronic Cardiac Rhythm Disease Management|IMPROVE HF, Clinical Research Specialist||medtronicCRMtrials@medtronic.com|
20197765|NCT04366050|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
20197766|NCT01127659|University of Buffalo|Paresh Dandona|716) 961-9900|pdandona@kaleidahealth.org|
20197767|NCT00496730|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20197768|NCT03769246|Columbia University Medical Center|Dr. Anna-Christina Bevelaqua|(212) 342-0085|ab3302@cumc.columbia.edu|
20197769|NCT00113074|University of Iowa|Mark Vander Weg|319-338-0581|mark-vanderweg@uiowa.edu|7717
20197770|NCT01365585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197771|NCT03123250|PROCEPT BioRobotics Corporation|Angela Lee|650-232-7215|a.lee@procept-biorobotics.com|
20197772|NCT04340557|Sharp HealthCare|Matthew Geriak, PharmD|858-939-3717|matthew.geriak@sharp.com|
20197773|NCT00773136|University of Miami|Dr. Sara Wester|305-326-6132|swester2@med.miami.edu|
20197774|NCT02032550|University of Pennsylvania|Ravishankar Jayadevappa|215-898-3798|jravi@pennmedicine.upenn.edu|
20197775|NCT02463071|AstraZeneca|Torbjorn Lundstrom, MD, PhD|+46 31 706 4100|torbjorn.lundstrom@astrazeneca.com|
20197776|NCT02941926|Novartis Pharmaceuticals|Study director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20197777|NCT00097773|Seattle Childrens Hospital|Bonnie Ramsey, MD|206-987-5725|bonnie.ramsey@seattlechildrens.org|
20197778|NCT01009034|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
20197779|NCT04305275|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
20197780|NCT02705807|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197781|NCT00199836|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20197782|NCT02243865|Chordate|Dr Jan-Åke Åkesson|+46 8 40015586|info@chordate.com|
20197783|NCT00053703|UNC Chapel Hill|Linmarie Sikich, MD|919-972-9744|lsikich@med.unc.edu|
20197784|NCT01500525|Capital Institute of Pediatrics|Ling Cao，MD,Pulmonologist, Professor|86-13910610319|caoling9919@163.com|
20197785|NCT02003014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20197786|NCT01660451|Bayer|Therapeutic Area Head|+1-888-8422937|clinical-trials-contact@bayer.com|
20197787|NCT05093322|HUTCHMED Limited|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
20197788|NCT00407654|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
20197789|NCT00074581|Fred Hutchinson Cancer Research Center|Dr. Deborah Donnell|2066675661|deborah@scharp.org|
20197790|NCT03613662|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|6503866709|cambrose@scilexpharma.com|
20197791|NCT00617604|Astellas Pharma Europe B.V|Senior Director Medical Science||Astellas.resultsdisclosure@astellas.com|
20197792|NCT03250832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20197793|NCT00916279|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
20197794|NCT00310804|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20197795|NCT00688155|Wake Forest School of Medicine|Mark Espeland, PhD|336-761-2826|mespelan@wakehealth.edu|336
20197796|NCT04631796|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20197797|NCT00121836|Hoffmann-LaRoche|Medical Communications|800-821-8590||
20197798|NCT00382720|sanofi-aventis|International Clinical Development Clinical Study Director||contact-us@sanofi-aventis.com|
20197799|NCT02414399|University of Washington|Dr. Patricia Pavlinac|206 616-8326|ppav@uw.edu|
20197800|NCT02737852|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annhita.ghassemi@churchdwight.com|
20197801|NCT01183143|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20197802|NCT05745675|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20197803|NCT04042740|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20197804|NCT01717287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197805|NCT04490395|Duke University|Jennifer Plumb Vilardaga, PhD|919-668-6123|jennifer.plumb.vilardaga@duke.edu|
20197806|NCT01861028|Conformis|Director of Clinical and Technical Research|781-345-9103|sumesh.zingde@conformis.com|
20197807|NCT02650999|University of Pennsylvania, Clinical Research Unit|Ellen Napier, Nurse Pracitioner|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
20197808|NCT05092919|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
20197809|NCT01942148|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
20197810|NCT02248259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197811|NCT00625989|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
20197812|NCT02807480|Laureate Institute for Brain Research|Robin Aupperle|918-502-5744|raupperle@laureateinstitute.org|
20197813|NCT02369848|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
20197814|NCT01979159|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@va.gov|1363
20197815|NCT02114164|OhioHealth|Dr. Oscar Martinez|(614) 544-8104|oscar.martinez@ohiohealth.com|
20197816|NCT00096785|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20197817|NCT02573870|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197818|NCT02081534|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20197819|NCT02234479|University of Maryland|Elizabeth Nichols, MD|410-328-2324|enichols1@umm.edu|
20197820|NCT02285920|University of Pennsylvania|Laura M. Dember, MD|215-573-5264|ldember@pennmedicine.upenn.edu|
20197821|NCT01825057|Yale School of Medicine|Steve Martino|203-932-5711|steve.martino@yale.edu|7418
20197822|NCT01688596|Penn State Milton S. Hershey Medical Center|Dr. Matthew F. Davies, M.D.|7175310003|mdavies@hmc.psu.edu|283519
20197823|NCT01480284|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197824|NCT00066742|SWOG Statistical Center|Lung Committee Statistician|206-652-2267||
20197825|NCT02809131|Vanderbilt University Medical Center|Christopher R. Ellis, MD, FACC, FHRS|(615)-936-2523|Christopher.ellis@vumc.org|
20197826|NCT05368961|Cleveland Clinic|Michelle Levay, Nurse Research Manager|216-445-4749|levaym@ccf.org|54749
20197827|NCT00415857|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/792-7305|eharrison@mdanderson.org|
20197828|NCT01380730|Amgen Inc.|Study Director|866-572-6436||
20197829|NCT05686928|Galderma|Thu Q. Nguyen, PhD|8179615495|thu.nguyen@galderma.com|
20197830|NCT00922480|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
20197831|NCT04784897|Innovation Pharmaceuticals Inc.|Senior Vice President, Clinical Sciences|978-921-4125|info@ipharminc.com|
20197832|NCT00550654|National Cancer Institute, National Institutes of Health|Deborah Citrin, M.D.|301-496-5457|citrind@mail.nih.gov|
20197833|NCT04754802|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
20197834|NCT01970488|Amgen Inc.|Study Director|866-572-6436||
20197835|NCT02201420|Navidea Biopharmaceuticals, Inc.|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
20197836|NCT01490814|Medtronic|Ralf Meyer|+49215981490|ralf.meyer@medtronic.com|
20197837|NCT01537198|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20197838|NCT00574288|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20197839|NCT02367066|AstraZeneca|Dr. Stanko Skrtic, MD, PhD||ClinicalTrialTransparency@astrazeneca.com|
20197840|NCT02247960|University of Rochester|Jean Joseph|585-341-7795|jean_joseph@urmc.rochester.edu|
20197841|NCT01898689|UC San Diego|Dr. Brian Ilfeld|(858) 444-5949|bilfeld@ucsd.edu|
20197842|NCT01591317|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197843|NCT03716050|Wake Forest Baptist Health|Ivo Pestana|336-716-4171|ipestana@wakehealth.edu|
20197844|NCT02361944|Vanderbilt University|Frederic T. BIllings IV|6159368487|frederic.t.billings@vumc.org|
20197845|NCT01221727|Amgen Inc.|Study Director|866-572-6436||
20197846|NCT00529451|Novartis Pharmaceuticals|Study Director|862-778-8300||
20197847|NCT01210170|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
20197848|NCT03086057|Brown University|Dr. Katie Biello|401-863-3082|katie_biello@brown.edu|
20197849|NCT01494350|Institut Pasteur of Tunis|Afif Ben Salah, MD, PhD|011-216-71-792-429|afif.bensalah@pasteur.rns.tn|
20197850|NCT02179671|AstraZeneca|Phillip Dennis|1 + 301-398-5549|Phillip.Dennis@astrazeneca.com|
20197851|NCT03098836|Duke University Medical Center|Daniel George, MD|(919) 668-8108|daniel.george@duke.edu|
20197852|NCT03986866|University of Arkansas for Medical Sciences|Johnathan Goree, MD|(501) 686-8818|JHGoree@uams.edu|
20197853|NCT00898443|UAB|Marsha Wakefield, M.D.|205-934-4696|mwakefield@uab.edu|
20197854|NCT02303704|Ch. Pervaiz Elahi Institute of Cardiology, Multan, Pakistan.|Dr. Muhammad Sher-i-Murtaza|0333-6107570|sherm.cpeic@gmail.com|
20197855|NCT01380639|Schön Klinik Berchtesgadener Land|Dr. Klaus Kenn|+49 8652 931541|kkenn@schoen-kliniken.de|
20197856|NCT01034540|Biofortis Clinical Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
20197857|NCT00932425|University of California San Francisco|Wade Smith, MD, PhD|415-353-8897|smithw@neurology.ucsf.edu|
20197858|NCT02774616|Biotronik SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20197859|NCT01721876|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197860|NCT00493220|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
20197861|NCT02109562|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20197862|NCT00068575|UT MD Anderson Cancer Center|Peter Pisters, MD / Professor||asanmigu@mdanderson.org|
20197863|NCT01590550|Loma Linda University|Rita Sheth, MD|909-558-8242|rsheth@llu.edu|
20197864|NCT01889238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197865|NCT04136184|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20197866|NCT04887155|UCLA Semel Institute|Marc Weintraub|3108251300|mjweintraub@mednet.ucla.edu|
20197867|NCT03318978|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
20197868|NCT02844816|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
20217690|NCT00706095|Eisai Call Center|Eisai Inc.|888-422-4743||
20217691|NCT01332578|GlaxoSmithKline|GSK Response Center|866-435-7343||
20197869|NCT01292798|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
20197870|NCT01499953|University Hospital Dresden, Centre for Vascular Medicine|PD Dr. med. Jan Beyer-Westendorf|+49-351-4582899|Jan.Beyer@uniklinikum-dresden.de|
20197871|NCT02717754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20197872|NCT01200238|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20197873|NCT00482703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20197874|NCT03548285|University of Texas Southwestern Medical Center|David Sher, MD|214-645-8525|david.sher@utsouthwestern.edu|
20197875|NCT00667823|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20197876|NCT00891319|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|216
20197877|NCT04890314|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-6363|jch9011@med.cornell.edu|
20197878|NCT03697720|NorthShore University HealthSystem|Kevin Hellman, Research Associate Professor|847-570-2622|khellman@northshore.org|
20197879|NCT04096274|Boise State University|Dr. Nathaniel Williams|2084263145|natewilliams@boisestate.edu|
20197880|NCT00257725|New York State Psychiatric Institute|Laurence Greenhill, MD|212-543-5340|GREENHIL@nyspi.columbia.edu|
20197881|NCT01858532|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20197882|NCT00514514|Novartis|Study Director|862-778-8300||
20197883|NCT02829307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20197884|NCT01408992|Khon Kaen University|Dr. Kwanchanok Yimtae|66-43348396|kwayim@kku.ac.th|
20197885|NCT01021956|STEBA Biotech|Bertrand Gaillac International Project Leader|+33 9 74 19 79 05|b.gaillac@stebabiotech.com|
20197886|NCT05506956|Johns Hopkins University|Kristen Murray, Program Manager|410-614-6707|kmeckel2@jhmi.edu|
20197887|NCT01848288|Alcon Research, Ltd.|Doug Fanney, Director, Global Medical Affairs, Cataract Instrumentation|1-888-451-3937|alcon.medinfo@alcon.com|
20197888|NCT03677596|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197889|NCT03794583|United Therapeutics|United Therapeutics Global Medical Information|1-240-821-1881|305PerfectOLEStudy@lungbiotechnology.com|
20197890|NCT03634397|Penn State College of Medicine|Dr Candice Maenza|7175310003|cmaenza@pennstatehealth.psu.edu|283146
20197891|NCT02752035|Astellas Pharma Global Development, Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20197892|NCT01519934|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20197893|NCT01161043|Medtronic Diabetes|Suiying Huang|8185763319|suiying.huang@medtronic.com|
20217692|NCT02429375|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz, MD|\646-608-3726|moskowia@mskcc.org|
20217693|NCT01311557|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20217694|NCT05212883|Duke University|Saira Siddiqui, M.P.H.|919-688-8464|saira.siddiqui@duke.edu|
20217695|NCT02075606|Ipsen|Medical Director|00441753627777|clinical.trials@ipsen.com|
20217696|NCT01265667|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
20217697|NCT01439724|Instituto Nacional de Cancer|Dr. Heliton Spindola Antunes|55 21 32076597|hspindola@inca.gov.br|
20217698|NCT04019054|UCLA Psychiatry|Dr. Michael K. Leuchter|3108906943|mkleuchter@mednet.ucla.edu|
20217699|NCT01118845|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
20217700|NCT00574067|Friends Research Institute|Dr. Michael Gordon|410-837-3977|mgordon@friendsresearch.org|251
20217701|NCT01261624|Italfarmaco S.p.A.|Clinical R&D Director|026443|p.bettica@italfarmaco.com|2584
20217702|NCT00271024|University of Chicago|Dr. Andrea King|7737026181|aking@bsdad.uchicago.edu|
20197894|NCT01846728|University of Colorado Anschutz Medical Campus|Edward Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
20197895|NCT02161575|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20197896|NCT02446314|The University of Reading|Prof Claire Williams|0118 378 7540|claire.williams@reading.ac.uk|
20217703|NCT01913795|Boston Children's Hospital|Dr. Wanda Phipatanakul|617-355-6117|Wanda.Phipatanakul@childrens.harvard.edu|
20197897|NCT01621633|Novartis Pharmaceuticals|Study Director|862-778-8300||
20197898|NCT00701090|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197899|NCT00702754|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
20197900|NCT01085786|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
20197901|NCT01299376|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197902|NCT03680911|University of Miami|Roy R. Casiano, MD|305-243-5290|rcasiano@med.miami.edu|
20197903|NCT01786603|University of Kansas Medical Center|Dr. Richard Barohn|913-945-9944|rbarohn@kumc.edu|
20164402|NCT03400475|University of Iowa|Dr. Ahmed Mahrous|3193336517|ahmedmohamed-mahrous@uiowa.edu|
20197904|NCT03700320|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20197905|NCT01978535|Mayo Clinic|Dr. Amie Jones|507-284-6063|Jones.Amie@mayo.edu|
20197906|NCT01937598|Div. Diabetology, Med. Dep. I, St. Josef-Hospital (Ruhr-Univeristy Bochum), change of address 01.01.20015|Prof. Dr. M. A. Nauck, Principle Investigator|+49-234-509|michael.nauck@rub.de|6332
20197907|NCT00749476|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20197908|NCT01022242|Uppsala University Hospital|Monica Wiig||monica.wiig@akademiska.se|
20197909|NCT02054325|UPECLIN|Dr. Matheus Bertanha|+55 14 38116305|matheus.fameca@ig.com.br|
20197910|NCT03880032|Johns Hopkins Bloomberg School of Public Health|Pamela Surkan|4105027396|psurkan@jhu.edu|
20197911|NCT01770912|University of Florida|Charles G. Widmer, Associate Professor|352-273-5696|widmer@dental.ufl.edu|
20197912|NCT01708291|University of Rochester|Sandra Jee|585-273-4657|sandra_jee@urmc.rochester.edu|
20197913|NCT03407651|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
20197914|NCT01536951|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197915|NCT00351416|Massachusetts General Hospital|Janet Hall|617-877-1112|jehall@partners.org|
20197916|NCT00615472|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
20197917|NCT03982342|Nationwide Children's Hospital|Carl Backes, MD|1-614-355-6729|Carl.Backes@nationwidechildrens.org|
20197918|NCT00430482|Boston University Charles River Campus|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
20197919|NCT00555477|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@umich.edu|
20197920|NCT00545402|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20197921|NCT01817751|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center CTO Operations Managers|877-4627739|ctoclinops@vcu.edu|
20197922|NCT00397033|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
20197923|NCT03519867|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20197924|NCT00382018|SWOG|Breast Committee Statistician|2066675712|jmiao@fredhutch.org|
20197925|NCT01252810|GE Healthcare|Ruben Sheng, M.D.|609-514-6899|Rubin.Sheng@ge.com|
20197926|NCT01721057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197927|NCT01020591|CDHA|Wendy Jardine|902 429 6218|wendymjardine@gmail.com|
20197928|NCT01202279|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
20197929|NCT03805750|University of California San Diego|F.B. Nahab MD|858-822-6683|fnahab@health.ucsd.edu|
20197930|NCT01984164|Emory University|Dr. Hajjar|404-712-2036|ihabhajjar@emory.edu|
20197931|NCT02811549|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
20197932|NCT03472924|Oregon State University|Marc Norcross, PhD, ATC|541-737-6788|marc.norcross@oregonstate.edu|
20197933|NCT01908972|Seoul National University College of Medicine|Prof. Tae Hyun Choi|82-10-5595-5829|psthchoi@snu.ac.kr|
20197934|NCT03057613|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Shlomo Koyfman|1-866-223-8100|TaussigResearch@ccf.org|
20197935|NCT02546765|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|6176320706
20197936|NCT00475722|University of Michigan|Dr. Zora Djuric|734-615-6210|zoralong@umich.edu|
20197937|NCT00698997|University California Davis|Dr. Sally Rogers|916-703-0264|sjrogers@ucdavis.edu|
20197938|NCT04633174|Dartmouth-Hitchcock Medical Center|Dr. Nicholas Daniel, Staff Physician, Emergency Services|(603) 650-7254|Nicholas.Daniel@hitchcock.org|
20197939|NCT02592018|UCSF Department of Dermatology|Dr. Wilson Liao|415-476-4701|wilson.liao@ucsf.edu|
20197940|NCT06156215|University of California San Francisco|Dr Melanie Molina|512.294.4366|melanie.molina@ucsf.edu|
20197941|NCT04456764|University of Pittsburgh|P. Daniel Patterson|412-647-3078|pdp3@pitt.edu|
20197942|NCT05050318|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20164403|NCT03741088|HistoSonics, Inc.|Clinical Affairs Manager|651.398.7586|christine.sullivan@histosonics.com|
20217704|NCT01143649|Laboratory of Neuromodulation and Center of Clinical Research Training. Spaulding Rehabilitation Hospital.|Dr. Felipe Fregni|617.952.6153|info@neuromodulationlab.org|
20197943|NCT03116997|Memorial Sloan Kettering Cancer Center|Dr. German Echeverry, MD|212-639-8865|echeverg@mskcc.org|
20197944|NCT05338515|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20197945|NCT00574145|Vanderbilt-Ingram Cancer Center|Nancy Wells, DNSc., R.N|615-322-6184|nancy.wells@vanderbilt.edu|
20197946|NCT03227471|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20197947|NCT02322125|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
20197948|NCT01463670|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun MD|646-608-3718|hassounh@mskcc.org|
20197949|NCT03029715|Menoufia Univeristy|Dr Ezzeldin Ibrahim|0021006303178|ezzeldin7@yahoo.com|
20197950|NCT03427047|Medacta USA|Rena Mandino, Director, Clinical Research|352-359-3581|rmandino@medacta.us.com|
20197951|NCT00766038|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
20197952|NCT04183790|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20197953|NCT01524198|King Saud University|Dr. Abdullah Alangari|966506287276|alangari100@gmail.com|
20197954|NCT01973777|University of British Columbia|Dr Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
20197955|NCT01462435|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
20197956|NCT03887533|National Institute of Child Health and Human Development (NICHD)|Dr. Forbes Porter|301-435-4432|fdporter@mail.nih.gov|
20197957|NCT01543152|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
20197958|NCT04639973|Baylor College of Medicine|Cara Buskmiller, MD|832-824-1000|cara.buskmiller@bcm.edu|
20197959|NCT02053168|BD Interventional - Surgery|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
20197960|NCT00857532|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20197961|NCT02687542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197962|NCT00636675|University of North Carolina Chapel HIll|Ruth A. Anderson|919-966-8785|rutha@email.unc.edu|
20197963|NCT01838616|Grünenthal GmbH|Study Director|+49 241 569|Clinical-Trials@grunenthal.com|3223
20197964|NCT01007032|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197965|NCT01101438|Canadian Cancer Trials Group|Professor Bingshu Chen|+16135336000|bechen@ctg.queensu.ca|77703
20197966|NCT00791336|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
20197967|NCT05714982|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
20197968|NCT00806195|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20197969|NCT00112671|Princess Margaret Phase II Consortium|Dr. Srikala Sridhar|416-946-4501|srikala.sridhar@uhn.ca|2662
20197970|NCT01231659|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20197971|NCT03962738|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20197972|NCT01286454|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197973|NCT00702325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20197974|NCT00814671|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
20197975|NCT04556136|Madigan Army Medical Center|Dr. Mary McCarthy|253-968-3695|mary.s.mccarthy1.civ@health.mil|
20197976|NCT01507779|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20197977|NCT01022502|Chang Gung Memorial Hospital|Yin-Ku Lin, MD. PhD.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
20197978|NCT02566577|Emory University|Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
20197979|NCT00861913|Karmanos Cancer Institute, Wayne State University|Amy M. Weise, D. O.|313-576-8952||
20197980|NCT02101515|George Washington University School of Medicine and Health Sciences|Alexis Gimovsky, MD|2027412603|agimovsk@mfa.gwu.edu|
20197981|NCT02901574|Johns Hopkins University School of Medicine|Rajani Sebastian, PhD|410-502-5012|rsebast3@jhmi.edu|
20197982|NCT01751399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20197983|NCT00073528|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20197984|NCT02937194|The University of Hong Kong|Prof Wong, May Chun Mei|852-28590422|mcmwong@hku.hk|
20197985|NCT00003702|NRG Oncology|Angela M. Kuras on behalf of Virginia Filiaci|7168455702|kurasa@nrgoncology.org|
20197986|NCT02887404|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
20197987|NCT02790138|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20197988|NCT03199040|Washington University School of Medicine|Williams Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
20197989|NCT01226459|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
20197990|NCT00474708|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20197991|NCT03770091|UPMC|John Fowler|412-605-3245|fowlerjr@upmc.edu|
20197992|NCT02132884|Fox Chase Cancer Center|Dr. Hossein Borghaei|215-2141515|Hossein.Borghaei@fccc.edu|
20197993|NCT01092143|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20197994|NCT03654976|ALK-Abelló A/S|Senior Director Global Clinical Development|0045 45747576|clinicaltrials@alk.net|
20197995|NCT00117598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20197996|NCT00545064|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20197997|NCT01775735|Boston Scientific|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
20197998|NCT04688775|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
20197999|NCT01843972|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198000|NCT01854645|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20198001|NCT04261504|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
20198002|NCT02219321|University of Texas Southwestern Medical Center|Enas Kandil|214-648|Enas.Kandil@UTSouthwestern.edu|9374
20198003|NCT00427349|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20198004|NCT05082376|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
20198005|NCT00445224|University of Kentucky|Dr. Tim L. Uhl Principal Investigator|859-323-1100|tluhl2@uky.edu|80858
20198006|NCT01771055|University of Louisville|Dr. Jason Smith|502-852-5675|josmit19@louisville.edu|
20198007|NCT03372928|US Army Research Institute of Environmental Medicine|Jess Gwin|508-206-2300|jessica.a.gwin.ctr@mail.mil|
20198008|NCT01054742|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20198009|NCT04360551|University of Hawaii at Manoa John A Burns School of Medicine|Cecilia M. Shikuma MD|808 692-1328|shikuma@hawaii.edu|
20198010|NCT03496012|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20217705|NCT01719562|Wake Forest University|Project Manager|+1(336) 758-3728|jvolpini@wakehealth.edu|
20153238|NCT00754923|OSU|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
20153240|NCT01401322|Stanford University|Bruno C. Medeiros|650-498-6000||
20153241|NCT00486044|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-280-7000|cmc@medicine.wisc.edu|
20153242|NCT00997893|University of Illinois at Chicago|Dr. Pauline Maki|312 996-6941|pmaki1@uic.edu|
20153243|NCT00226655|Celtic Pharma Development Services America Inc|Director Medical Sciences|(212) 616 4016|henk-andre.kroon@dev.celticpharma.com|
20153244|NCT00701363|Ipsen|Medical Director, Clinical Endocrinology and Metabolism|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20153245|NCT04759131|Bioverativ Therapeutics Inc. (a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20153246|NCT05144945|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20153247|NCT05853120|Emory University|Colleen Kelley|404-712-1823|scolleen.kelley@emory.edu|
20153248|NCT03207399|Duke University Medical Center|Dr. Omar Mohamedaly|919-684-4589|omar.mohamedaly@duke.edu|
20153249|NCT02592824|Linköping University Hospital|Dr Jonas Holm|+46101034498|jonas.holm@regionostergotland.se|
20153250|NCT00465517|Marinus Pharmaceuticals, Inc.|Marinus|(484) 801-4670|clinicaltrials@marinuspharma.com|
20153251|NCT01090180|Veterans Affairs North Texas Health Care System|Alina Suris|817-715-0625|alina.suris@va.gov|
20153252|NCT00289276|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
20153253|NCT00869960|UAB|Jennifer King|205-934-2696|jenking@uab.edu|
20153254|NCT00726609|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20153255|NCT03084237|Shanghai Henlius Biotech|Head of Clinical Development|+86 021-33395800|contact@henlius.com|
20153256|NCT01067586|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
20153257|NCT00706563|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153258|NCT00746551|Mahidol University, Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Faculty of Medicine, Siriraj Hospital|Pharuhas Chanprapaph|+66819920053|pharuhasc@gmail.com|
20153259|NCT02029417|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20198011|NCT00520884|University of Pennsylvania, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism|Anne Cappola, M.D., Sc.M.|215-573-5359|ACappola@mail.med.upen.edu|
20198012|NCT04701138|University of North Carolina at Chapel Hill|Saame Shaikh, PhD|919-843-4348|shaikhsa@email.unc.edu|
20198013|NCT00449670|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198014|NCT01251653|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198015|NCT03138538|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20198016|NCT01798589|Dermatology Specialists|Joseph Fowler, MD|502-583-7546|fowlerjoe@msn.com|
20198017|NCT03650842|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-5817|Joseph.Tobias@nationwidechildrens.org|
20198018|NCT02232802|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
20198019|NCT00634634|Cancer Institute of New Jersey|Dr. Deborah Toppmeyer|732-235-5203|toppmede@cinj.rutgers.edu|
20198020|NCT00885703|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20198021|NCT05745662|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20198022|NCT05030454|Washington University School of Medicine|Pamela Samson, M.D., MPHS|314-747-1786|psamson@wustl.edu|
20198023|NCT01490450|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20198024|NCT03197493|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
20198025|NCT00938717|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
20198026|NCT00998049|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20198027|NCT03600142|University of Utah|Dr. Melissa Watt|8015817201|melissa.watt@hsc.utah.edu|
20198028|NCT02329964|Korea University Anam Hospital|Seolju Park|+82-10-6314-6013|gursla2@naver.com|
20198029|NCT00139776|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20198030|NCT02210065|U.T. MD Anderson Cancer Center|Dr. Betul Oran / Associate Professor, Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
20198031|NCT00674583|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153260|NCT00843466|Unilever|Jamie Regan|203-381-4448|Jamie.Regan@unilever.com|
20198032|NCT04223843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198033|NCT03901105|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20198034|NCT00914927|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20198035|NCT00357214|Tufts University|Bess Dawson-Hughes|617 556 3066|bess.dawson-hughes@tufts.edu|6175100519
20198036|NCT01687179|Brigham and Women's Hospital|Elizabeth P. Henske, MD|857-307-0782|ehenske@bwh.harvard.edu|
20198037|NCT03442036|University of California San Diego|John J. Finneran IV, MD|4083073004|jfinneran@ucsd.edu|
20198038|NCT00330876|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
20198039|NCT02164929|Duke University Medical Center|Timothy Miller, MD||timothy.miller2@duke.edu|
20198040|NCT03496220|Angulus|Dr. Perry Dubin|‪(917) 426-5911‬|perry@angulus.us|
20198041|NCT00971178|Department of Anaesthesiology, the University of Hong Kong|Clinical Assistant Professor|852-22553303|cheucw@hku.hk|
20198042|NCT00365456|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
20198043|NCT02475070|Lund University|Dr Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
20198044|NCT00714285|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198045|NCT01131676|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20198046|NCT04109222|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20198047|NCT02138617|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
20198048|NCT04630171|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20198049|NCT01961349|CO RI&A TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
20198050|NCT05525689|Northwestern University|Dr. David Mohr|312-503-1403|d-mohr@northwestern.edu|
20198051|NCT01353196|VA Medical Center VA Maryland Health Care System, Baltimore, MD|Brajesh K. Lal, MD|410-605-7000|blal@som.umaryland.edu|
20198052|NCT02343159|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20198053|NCT03959332|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20198054|NCT00509067|Department of Psychiatry Georgetown University Medical School|Dr. Stephen I. Deutsch|757.446.5888|DeutscSI@EVMS.EDU|
20198055|NCT01846624|Stanford University Medical Center|David Joseph Iberri, MD; Clinical Assistant Professor (Hematology)|650-498-6000|diberri@stanford.edu|
20198056|NCT04702737|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20198057|NCT01177683|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20198058|NCT00580372|University of Arkansas for Medical Science|Dr. Bart Barlogie|501-526-2873||
20198059|NCT00617539|University of California San Francisco|Michelle Melisko, MD|415-353-7070|Michelle.Melisko@ucsf.edu|
20153261|NCT00465179|The University of Texas (UT) MD Anderson Cancer Center|Nizar M Tannir, MD, Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
20153262|NCT00976339|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
20153263|NCT04062227|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|Bhavani.X.Kashyap@HealthPartners.com|
20153264|NCT05219162|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20198060|NCT04743921|University of Alabama at Birmingham Department of Orthopaedic Surgery|Dr. Amit Momaya|205-975-2663|amomaya@uabmc.edu|
20217706|NCT00508027|Children's Hospital & Research Center Oakland|Dr. Carolyn Hoppe, Principal Investigator|(510)428-3193|choppe@mail.cho.org|
20153265|NCT03506061|Emory University|Eric Sorscher, MD|205-612-1327|esorscher@emory.edu|
20198061|NCT01977820|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
20198062|NCT01660321|ParaPro|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
20198063|NCT03491007|Durham VA Healthcare Center|Susan O'Loughlin|919-286-0411|susan.o'loughlin@va.gov|
20198064|NCT02568475|Florida Atlantic University|Ruth M. Tappen, Principal Investigator|561-297-2613|rtappen@health.fau.edu|
20198065|NCT02625233|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
20198066|NCT02426476|Columbia VA Health Care System, Virginia Commonwealth University, University of South Carolina|James Burch, MS, PhD, Professor|803-404-1552|burch@mailbox.sc.edu|
20198067|NCT02504554|Arizona State University|James Adams|480 965 3316|jim.adams@asu.edu|
20198068|NCT03023930|Yale University|Dr. Gail D'Onofrio|(203) 785-7059|gail.donofrio@yale.edu|
20198069|NCT04425720|Montefiore Medical Center|Dr. Jonathan Leff|7189204316|jleff@montefiore.org|
20198070|NCT00290186|Dayton Children's Hospital|Daniel J. Lacey, MD, PhD|937-641-3080|LaceyD@childrensdayton.org|
20198071|NCT04391036|University of Pittsburgh Medical School|Dr. Leslie Meyn|412-641-4233|meynla@mwri.magee.edu|
20198072|NCT03184077|Virginia Commonwealth University|Lindsay Morrell, MD|410-823-1120|lmorrellmcv@gmail.com|
20153266|NCT00171249|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20153267|NCT00471497|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20153268|NCT00392223|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20153269|NCT04386785|Venclose|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
20153270|NCT01420536|Araraquara Dental School -Universidade Estadual Paulista (Sao Paulo State University)|Prof. Marco Antonio Compagnoni|+55-16-3331-6411|compagno@foar.unesp.br|
20153271|NCT00764790|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153272|NCT03533751|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
20153273|NCT01899911|University of California, San Francisco (UCSF)|Philip E. Bickler, MD, PhD, Professor of Anesthesia|415-476-1411|Philip.Bickler@UCSF.edu|
20153274|NCT01749956|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
20153275|NCT03082729|University of Pennsylvania|Joel Gelfand, MD, MSCE|215-662-2737|joel.gelfand@pennmedicine.upenn.edu|
20153276|NCT04176224|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20153277|NCT01533259|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20153278|NCT01950663|Dean McGee Eye Institute / University of Oklahoma Health Sciences Center|Dr. Stephen R. Fransen|405-271-1092|stephen-fransen@dmei.org|
20153279|NCT00863122|Johns Hopkins School of Medicine|Jaishri Blakeley|410-955-6827|jblakel3@jhmi.edu|
20153280|NCT03150043|UTMB|Katherine Jelliffe|2146635394|katherine.emilie@gmail.com|
20153281|NCT00548327|Clinical Brain Disoders Branch-National Institute of Mental Health (NIMH)-National Institute of Health (NIH)|Jose A. Apud MD, PhD|301 5946561|apudj@mail.nih.gov|
20153282|NCT01673386|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20153283|NCT00109343|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20153284|NCT01721798|FHI 360|Catherine Todd|+1-919-544-7040|ctodd@fhi360.org|
20153285|NCT01649765|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20153286|NCT02194465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20153287|NCT00961064|National Heart Lung and Blood Institute|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
20153288|NCT01408641|FDA|Bernard Fischer, M.D.|240-402-4511|Bernard.Fischer@fda.hhs.gov|
20198073|NCT01675635|Mundipharma (China) pharmaceutical Co, LTD.|Ms. Dan Zhu, Clinical operation and quality lead of the study|0086-10-65636800|medical.mcpc@mundipharma.com.cn|
20153289|NCT01648764|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20153290|NCT00715208|Millennium Pharmaceuticals|Carol Ann Satler, MD, PhD|617- 551-3729|carol.satler@mpi.com|
20153291|NCT00076570|NIDDK, National Institutes of Health|Dr. Monique Cho|3014355058|moniquec@intra.niddk.nih.gov|
20153292|NCT01294046|Cleveland Clinic|Kathryn O'Connor||oconnok@ccf.org|
20153293|NCT00420745|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153294|NCT01588509|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20153295|NCT01454284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20153296|NCT00393367|The Children's Hospital of Philadelphia|Cynthia J. Mollen|215-590-4410|mollenc@email.chop.edu|
20153297|NCT00795340|Division of Medical Oncology, the Ottawa Hospital, Ottawa, Ontario, Canada|Dr. Scott Laurie|1-613-737-7700|slaurie@toh.on.ca|
20153298|NCT00397579|University of Texas Southwestern Medical Center at Dallas|Clinical Research Office|214-648-7097|studyfinder@utsouthwestern.edu|
20153299|NCT02524119|UT Southwestern Medical Center|Dr. Muhammad Beg|2146484180|Muhammad.Beg@UTSouthwestern.edu|
20153300|NCT02054156|Seattle Children's Hospital|Margaret Kloster|2068847862|margaret.kloster@seattlechildrens.org|
20153301|NCT04810962|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
20153302|NCT02412657|MaisonneuveRH|Dr Veronique Brulotte|(514)252-3400|veronique.brulotte@umontreal.ca|
20153303|NCT01281306|Novartis|Study Director|862-778-8300||
20153304|NCT02410629|University of California Irvine|Dr An Do|(714) 456-2332|and@uci.edu|
20153305|NCT01206764|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20198074|NCT00262522|Abbott|Global Medical Services|800-633-9110||
20153306|NCT02456896|AIIMS, Bhubaneswar, India|Dr. Rituparna Maiti|9438884191|rituparnamaiti@gmail.com|
20153307|NCT02366871|University of Colorado, Anschutz Medical Campus|Dr. Saketh Guntupalli|303-724-2033|saketh.guntupalli@cuanschutz.edu|
20153308|NCT00961415|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20153309|NCT02841046|Guangzhou Panyu central Hospital|Dr. Yang Lin|+8615915721012|salinyangyl@163.com|
20153310|NCT01311661|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20153311|NCT00284856|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198075|NCT02454140|University of California, San Diego|Dr. James D. Murphy|(858) 822-6040|j2murphy@health.ucsd.edu|
20153312|NCT03692949|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20198076|NCT05359679|Kaiser Permanente Washington|Lorella Palazzo PhD|206-287-2900|lorella.g.palazzo@kp.org|
20198077|NCT04714073|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198078|NCT02710136|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20198079|NCT00450242|University of North Carolina, Dept. of Obstetrics and Gynecology|Denniz Zolnoun, MD, MPH|919-966-7764|denniz_zolnoun@med.unc.edu|
20153313|NCT06309394|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20198080|NCT02072928|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20153314|NCT04431206|Wake Forest University School of Medicine|Dr. James Eisenach|3367164182|james.eisenach@advocatehealth.org|
20153315|NCT03350919|University of Rochester|Steven E. Feldon, MD|585-273-1050|Steven_Feldon@urmc.rochester.edu|
20153316|NCT01434511|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20153317|NCT00833755|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
20153318|NCT00262925|ECOG Statistical Office|Study Statistician|617-632-3012||
20153319|NCT04682301|Fred Hutchinson Cancer Center|Madison Snidarich, Clinical Research Coordinator|2066674589|msnidari@fredhutch.org|
20153320|NCT00560404|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20153321|NCT06015490|Virginia Polytechnic Institute and State University|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
20153322|NCT02187783|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
20153323|NCT03344757|University of Miami|Dr. Frank Penedo|305-284-4290|fpenedo@miami.edu|
20153324|NCT00269152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20153325|NCT04622345|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20153326|NCT00671788|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
20153327|NCT03043053|Massachusetts General Hospital|Elizabeth A. Lawson, MD, MMSc|617-726-3870|ealawson@mgh.harvard.edu|
20153328|NCT02792504|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153329|NCT01535924|The Ohio State University|Dr. Beth Christian|614-293-7807|Beth.Christian@osumc.edu|
20153330|NCT01035138|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20153331|NCT00848497|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
20153332|NCT01832766|University of Colorado Denver|Lynn Johnson, Pharm.D.|303 724 6221|lynn.johnson@ucdenver.edu|
20153333|NCT02139540|Washington University|Principal Investigator|7737022544||
20153334|NCT01114724|Medtronic Inc., Aortic and Peripheral Vascular|Celeste Claudy - Study Lead|763-514-0130|celeste.m.claudy@medtronic.com|
20153335|NCT02966834|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20153336|NCT03699748|Stanford University|Dr. Manali Patel|6504859462|manalip@stanford.edu|
20153337|NCT02814526|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
20153338|NCT01222299|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20153339|NCT01132508|Synthes GmbH|Clinical Research Scientist|+41619656592|clinicalaffairs.emea@synthes.com|
20198081|NCT02269787|Department of Veterans Affairs|Dr. Christine Timko, Research Career Scientist|6504935000|Christine.Timko@va.gov|23336
20198082|NCT00798135|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
20198083|NCT00687440|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20198084|NCT02722863|Korea Otsuka Pharmaceutical Co.,Ltd.|Huiyeong,Shim/Associate CTM for LPS & ISS|02-3287-9220|hyshim@otsuka.co.kr|
20198085|NCT00586261|Mayo Clinic|Dr. Patricia Best|507-284-4441|best.patricia@mayo.edu|
20198086|NCT00404820|Novartis Pharmaceuticals|Study Director|862 778-8300||
20198087|NCT00366275|Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia|Luca Arcaini MD|+390382501308|luca.arcaini@unipv.it|
20198088|NCT00176605|Rutgers Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20217707|NCT02013531|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20153340|NCT02866643|Stanford University|Clinical Research Manager|6507247826|gynresearch@stanford.edu|
20153341|NCT04711005|Duke University School of Medicine|Michelle Mack|919 613 1107|michelle.mack@duke.edu|
20153342|NCT03114150|The University of Iowa|Dr. Michelle Voss, Study Principal Investigator|319-335-2057|michelle-voss@uiowa.edu|
20153343|NCT04530630|Weill Cornell Medicine|Catherine Small, MD|212-746-9803|cbs9003@med.cornell.edu|
20153344|NCT00850642|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153345|NCT03675308|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20153346|NCT05335161|Purdue University|Bruno Tesini Roseguini|7654962612|brosegui@purdue.edu|
20153347|NCT05032183|The Univeristy of Texas MD Anderson Cancer Center|Ghayas Issa MD./Associate Professor|713-745-6798|GCIssa@mdanderson.org|
20153348|NCT05539131|Yongin Severance Hospital|Woo Jung Kim|01092827943|woojungkim@yuhs.ac|
20153349|NCT04006457|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153350|NCT03729362|Amicus Therapeutics, Inc.|Patient advocacy|001 6096622000|clinicaltrials@amicusrx.com|
20153351|NCT02807259|Karnataka Health Promotion Trust|Prakash Javalkar|+91 80 4040 0200|prakashj@khpt.org|
20153352|NCT00849056|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153353|NCT00274456|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20153354|NCT02314546|Bassett Healthcare Network|David A. Ullman, MD, Senior Attending Anesthesiologist|607-547-3153|david.ullman@bassett.org|
20153355|NCT00375752|Novartis Pharmaceuticals|Study Director|862-778-8300||
20153356|NCT03042546|Harboview|research coordinator|206.744.4406|bagel@uw.edu|
20153357|NCT03588624|Sight Sciences|VP Medical and Clinical Affairs|(877) 266-1144|info@sightsciences.com|
20198089|NCT01321710|University of California, San Francisco|Kathryn Lee, RN, PhD|415-476-4442|kathryn.lee@nursing.ucsf.edu|
20198090|NCT03370536|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|(212) 241-7114|vivek.reddy@mountsinai.org|
20198091|NCT01566773|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
20198092|NCT00833053|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
20198093|NCT02187471|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
20198094|NCT02236520|Vanderbilt University Medical Center|Alp Ikizler|(615) 343-7592|alp.ikizler@vumc.org|
20198095|NCT01785160|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198096|NCT02318667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198097|NCT01033734|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20198098|NCT05335356|Biocon Biologics Limited|Dr Sarika D|080 2808|Sarika.Deodhar@biocon.com|5302
20198099|NCT02865018|Icahn School of Medicine at Mount Sinai, Corrine Goldsmith Dickinson Center for MS|Ilana Katz Sand|212-241-6854|ilana.katzsand@mssm.edu|
20198100|NCT00111800|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198101|NCT00326209|Bausch Health Americas, Inc.|Director of Clinical Operations||lindsey.mathew@bauschhealth.com|
20198102|NCT02577406|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20198103|NCT05143489|Maimonides Medical Center|Director of Research Administraton|7182836896|alikourezos@maimo.org|
20198104|NCT01111851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20198105|NCT05500274|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
20198106|NCT04252859|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
20198107|NCT05807464|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20198108|NCT00125762|BIDMC|Nezam Afdhal|6176321118|nafdhal@bidmc.harvard.edu|
20153358|NCT00890162|National Institute of Allergy and Infectious Diseases|Carter, Melody|+1 301 496 8772|mc396j@nih.gov|
20153359|NCT01140906|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20153360|NCT00336544|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
20153361|NCT01316614|Washington University School of Medicine|Daniel K. Mullady, M.D.|314-362-8546|dmullady@dom.wustl.edu|
20153362|NCT03427411|National Cancer Institute|Dr. Julius Strauss|240-858-3999|julius.strauss@nih.gov|
20153363|NCT00089648|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20153364|NCT00423605|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Director Clinical Development & Medical Monitor|650-496-3777||
20153365|NCT03183908|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
20153366|NCT02156258|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20153367|NCT03738696|University of Alabama at Birmingham, Department of Orthopaedics|Dr. Amit Momaya|205-930-8339|amomaya@uabmc.edu|
20153368|NCT00409825|University of Pittsburgh|Steve N. Caritis, MD|412-641-4874|scaritis@mail.magee.edu|
20153369|NCT02019069|Stanford University|Rondeep Singh Brar|(650) 498-6000|rbrar@stanford.edu|
20153370|NCT01983930|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
20153371|NCT00091819|Theravance, Inc.|Steven Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20153372|NCT05001620|University of Maryland School of Nursing|Dr. Joan G. Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
20153373|NCT00819039|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164404|NCT05524220|The University of Texas Health Science Center at Houston|Erikka Washington, MD|713-500-6202|Erikka.L.Washington@uth.tmc.edu|
20164405|NCT04491136|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20164406|NCT02918357|University of California, San Francisco|Dr. Thomas Hope|(415) 221-4810|thomas.hope@ucsf.edu|2264
20164407|NCT01505374|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD|212-606-1206|memtsoudiss@hss.edu|
20164408|NCT02360228|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
20164409|NCT02315534|Sumitomo Dainippon Pharma Oncology|Connor Marshall|843-364-8039|cmarshall@bostonbiomedical.com|
20164410|NCT02464410|Veterans Health Administration|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
20164411|NCT00851786|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20164412|NCT02831764|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20164413|NCT00865345|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
20164414|NCT03737123|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20164415|NCT01519323|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20164416|NCT04290039|BARDA|Brenda Wolling, Regulatory SME|(202) 692-4763|Brenda.Wolling@hhs.gov|
20164417|NCT03439280|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20164418|NCT01459588|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20164419|NCT03858049|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20164420|NCT02079740|Massachusetts General Hospital|Ryan Corcoran, MD PhD|617-724-4000|rbcorcoran@mgb.org|
20164421|NCT04617782|Corium, Inc.|Ronald Tashjian, Sr. Director of Clinical Operations|6172337474|rtashjian@coriumintl.com|
20164422|NCT00915954|Cedars-Sinai Medical Center|Dr. Odelia Cooper|310-423-2830|coopero@cshs.org|
20164423|NCT01474317|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20164424|NCT01914003|QOL Medical, LLC|Heather Smith, Director of One Patient Services|919-832-4949|hsmith@onepatientservices.com|
20198109|NCT01555151|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
20198110|NCT03596866|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20198111|NCT01816061|DCVAMC|Dr.Joel Scholten|2027458000|joel.scholten@va.gov|55099
20198112|NCT00731055|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|amb107@columbia.edu|
20198113|NCT01671111|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20198114|NCT00829179|Duke University Medical Center|John S. Sundy M.D. PhD|(919) 668-2169|john.sundy@duke.edu|
20198115|NCT00596947|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark, Clinical Transplant Research Pharmacist|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
20198116|NCT03000179|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20198117|NCT00635479|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20198118|NCT02114268|MedImmune, LLC|M. Pamela Griffin, MD, Senior Director|301-398-0000|information.center@astrazeneca.com|
20198119|NCT00258011|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20198120|NCT01921751|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20198121|NCT03269435|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
20198122|NCT01075412|The University of Iowa|Sarah McGuire, PhD|214-645-7613|Sarah.McGuire@utsouthwestern.edu|
20198123|NCT02512809|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|joseph.tobias@nationwidechildrens.org|
20198124|NCT00865904|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20198125|NCT02228720|Intersect ENT|James Stambaugh|6506412103|jstambaugh@intersectent.com|
20198126|NCT00282295|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198127|NCT00290199|UAB|Dr. Alan Tita|205-934-9616|atita@uab.edu|
20198128|NCT03337542|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20198129|NCT01401842|University of South Florida|John M. Mayer, DC, PhD / Study Director|813-974-3818|jmayer2@health.usf.edu|
20198130|NCT02786134|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6290|mdicarli@bwh.harvard.edu|
20198131|NCT05470465|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
20198132|NCT00232583|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20198133|NCT04702451|Volta Medical|Paola Milpied|+33768025499|paola.milpied@volta-medical.com|
20198134|NCT03996980|Universidad de Sevilla|Dr. Manuel Pabón-Carrasco|954 350 997|mpabon2@us.es|+34
20198135|NCT00583024|University of Iowa/Holden Comprehensive Cancer Center|David Lubaroff, PhD|(319) 335-8423|david-lubaroff@uiowa.edu|
20198136|NCT04347226|Columbia University|Mark N. Stein, MD|917-658-2771|mns2146@cumc.columbia.edu|
20198137|NCT03977974|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20198138|NCT03366298|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20198139|NCT02481921|Providence VA Medical Center|Dr. Wen-Chih Wu|401-273-7100|wen-chih.wu@va.gov|16237
20198140|NCT00736255|DukeUMC|Scott Kollins, PhD|9196810014|kolli001@mc.duke.edu|
20198141|NCT00095875|Dana Farber Cancer Institute|Robert I Haddad, MD|617-632-3090|rihaddad@partners.org|
20198142|NCT02833974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20198143|NCT01439282|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20198144|NCT04419610|Imperial College|Dr David Owen|07575089144|d.owen@imperial.ac.uk|
20198145|NCT00751777|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
20198146|NCT00675922|University of Texas Medical Branch|Tina Mack-Moshay, ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
20198147|NCT01502709|University of North Carolina|Dr Asma Khan|919 537 3389|asma_khan@dentistry.unc.edu|
20198148|NCT00307151|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20153374|NCT04796415|Indiana University School of Nursing|Yvonne Lu, PhD, RN, FGSA, FAAN, Professor, Science of Nursing Care Department|3172782042|yuelu@iu.edu|
20153375|NCT00154466|National Taiwan University Hospital|Dr. Bai-Chin Lee|0223123456|lebai@ntu.edu.tw|63352
20153376|NCT03185208|University of Pittsburgh|Ariel Gildengers, M.D.|412-246-6002|ariel.gildengers@pitt.edu|
20153377|NCT03834350|University of Chicago|Dr. Valerie Press|773-702-5170|vpress@bsd.uchicago.edu|
20153378|NCT02701634|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20153379|NCT03620162|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20153380|NCT05824026|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
20153381|NCT04009837|University of Delaware|Dr. Gregory Hicks, PT, PhD, FAPTA, FGSA|(302) 831-2690|ghicks@udel.edu|
20153382|NCT03134768|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
20153383|NCT03426878|Kaiser Permanente Center for Health Research|Joanna Bulkley, PhD|5033352400|joanna.e.bulkley@kpchr.org|
20153384|NCT02855268|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20153385|NCT05033041|Northwestern University|Paul C. Fitzgerald,RN,BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20153386|NCT00914069|Bard Access Systems, Inc.|Gina Gilbert|407-489-0835|Gina.Gilbert@crbard.com|
20153387|NCT00071981|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20153388|NCT01451372|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20164425|NCT00387881|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164426|NCT00453154|Duke University Medical Center|Dr. Neal Ready||ready001@mc.duke.edu|
20198149|NCT00346073|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198150|NCT02204150|Mass General Hospital|Gary Tearney|617-724-2979|gtearney@partners.org|
20198151|NCT01535573|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD, Professor and Director of Center For Neurobehavioral Research On Addictions||Joy.M.Schmitz@uth.tmc.edu|
20198152|NCT04179734|Imperial College London|Professor Waljit S. Dhillo, Principal Investigator|00442075943487|w.dhillo@imperial.ac.uk|
20198153|NCT00937937|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
20198154|NCT02966509|Stanford University and VA Palo Alto Health Care System|Dr. Manali Patel|650-723-4000|manalip@stanford.edu|
20198155|NCT00984490|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
20217708|NCT03877926|Emergent BioSolutions Inc.|Bojan Drobic, Director, Clinical Research|204 275 4196|bdrobic@ebsi.com|
20153389|NCT01933594|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20153390|NCT01316575|University of Saskatchewan|Dr. William McKay|306-655-1202|william.mckay@saskatoonhealthregion.ca|
20153391|NCT00402831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20153392|NCT04773028|Kartal Kosuyolu Hihg Speciality Training and Research Hospital|Dr.Ahmet Zengin|+905365022173|dr.zenginahmet@gmail.com|
20153393|NCT04585893|UNC Lineberger Comprehensive Cancer Center|Matthew S Painschab|919-966-4431|matthew_painschab@med.unc.edu|
20153394|NCT02431299|Indiana University Purdue University Indianapolis|Dr. Alan B. McGuire|3179882725|abmcguir@iupui.edu|
20153395|NCT03880474|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
20153396|NCT01526408|House Institute Foundation|Mahta Marefat|(213) 770-1808|mmarefat@hifla.org|
20153397|NCT03415178|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20153398|NCT01366092|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|JKoreth@partners.org|
20153399|NCT01093846|Novartis Pharmaceuticals|Study Director|862-778-8300||
20153400|NCT00763360|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20153401|NCT04066374|Cleveland Clinic|Yuki Kuramochi, BSN, RN|216-445-4063|kuramoy@ccf.org|
20153402|NCT02781324|Children's Hospital Colorado|Eun Kim, Spine Research Assistant|720-777-8026|eun.kim@childrenscolorado.org|
20153403|NCT00834041|Novartis Pharmaceuticals|Study Director|862 778-8300||
20153404|NCT03074500|Marmara University School of Medicine|Gulseren Derya Akyuz|+90 216 657 06 06|girayesra@hotmail.com|1628
20153405|NCT03321721|St. Louis University School of Medicine|Dr. Trevor L. Tredway|314-577-5630|trevor.tredway@health.slu.edu|
20153406|NCT02634177|Genomind|Chief Medical Officer|267-989-3461|dkrause@genomind.com|
20153407|NCT01416571|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153408|NCT03608163|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-430-2903|meredith.hawkins@einsteinmed.edu|
20153409|NCT03353220|Columbia University|Sharon Wardlaw, MD|212-305-3725|sw22@cumc.columbia.edu|
20153410|NCT00315341|University of California, Los Angeles|Walter Ling, M.D.|(310) 933-8111|lwalter@ucla.edu|
20153411|NCT00661388|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20153412|NCT04240314|Nationwide Children's Hospital|Megan Waldrop, Sponsor-Investigator|614-722-2231|megan.waldrop@nationwidechildrens.org|
20153413|NCT01191749|University of Texas (UT) MD Anderson Cancer Center|Tapan Kadia, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20153414|NCT03454555|RTI International|Dr. Lauren McCormack|919-541-6277|lmac@rti.org|
20153415|NCT06128954|Orphalan SA|Carla Bennett|07918380893|carla.bennett@orphalan.com|
20153416|NCT05019430|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
20153417|NCT01288430|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20153418|NCT06125964|University of Southern California|Genevieve Dunton (Principal Investigator)|323-442-8224|dunton@usc.edu|
20153419|NCT03405870|University of Florida College of Medicine|Dr. Faheem Guirgis, MD|352-733-1469|fguirgis@ufl.edu|
20153420|NCT05172609|University of Pennsylvania|Dr. Emily Becker-Haimes|215-573-5614|emily.haimes@pennmedicine.upenn.edu|
20153421|NCT03737994|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20153422|NCT02987868|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
20153423|NCT00498550|Dartmouth Medical School|Christopher OKeefe|603-271-5287|chris.okeefe@hitchcock.org|
20153424|NCT03643848|Florida International University|Dana L. McMakin, PhD, ABPP|305-348-0042|dmcmakin@fiu.edu|
20153425|NCT01566370|Yale/VA Connecticut Healthcare system|Albert Arias|2039325711|albert.arias@va.gov|8155
20153426|NCT00576758|Hoffman-LaRoche|Medical Communications|800-821-8590||
20153427|NCT00903968|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
20153428|NCT03979313|Astrazeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
20153429|NCT04889040|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20153430|NCT02631057|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20153431|NCT03837847|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
20153432|NCT00726453|Medtronic Vascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20153433|NCT02690727|Algorithme Pharma Inc.|Dr. Eric Sicard|(514) 858-6077|esicard@algopharm.com|
20153434|NCT00656617|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
20153435|NCT02030600|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20153436|NCT02736617|Oregon Health and Sciences University, Knight Cancer Institute|Dr. Stephen E. Spurgeon, Associate Professor of Medicine|503-494-8950|spurgeos@ohsu.edu|
20153437|NCT01718691|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1125||
20153438|NCT00481676|Novartis Pharmaceuticals|Study Director|862 778-8300||
20153439|NCT02911116|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
20153440|NCT01240694|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20153441|NCT01513590|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20198156|NCT00054704|NIMH, DIRP, Experimental Therapeutics and Pathophysiology Branch|Dr. Carlos Zarate|3014510861|zaratec@mail.nih.gov|
20198157|NCT02877693|Abbott|Grant Kim, Director Clinical Programs|818-493-3147|grant.kim1@abbott.com|
20198158|NCT00003535|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20198159|NCT04814342|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20198160|NCT05102344|University of California, Irvine|Sabrina E.B. Schuck, Ph.D.|9495335465|sabrina@uci.edu|
20198161|NCT01489670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20198162|NCT02289742|Alcon Research, Ltd.|Global Medical Affairs, Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20198163|NCT01365039|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|(585) 338-6399|robert.steffen@bausch.com|
20198164|NCT00867789|Children's Mercy Hospital|Dr. Joan Giovanni|8162343430|gegiovanni@cmh.edu|
20198165|NCT03807349|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
20198166|NCT00294060|Medtronic CRDM|P3 Study Team|800-328-2518|medtroniccrmtrials@medtronic.com|
20198167|NCT01360554|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198168|NCT00187096|St. Jude Children's Research Hospital|Jeffrey Rubnitz, MD|1-866-278-5833|info@stjude.org|
20198169|NCT01911442|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20198170|NCT00309465|Beaumont Health System|Tamra Dukatz, CRNA, MSN|248 992-4741 (pager)|tdukatz@beaumont.edu|
20198171|NCT03329911|Bio-Thera Solutions Ltd.|Yufeng Zhang|+86 2038251386|yfzhang@bio-thera.com|
20198172|NCT03668600|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20198173|NCT01925573|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
20198174|NCT00424749|Mayo Clinic|Dr. Fernando C. Fervenza||fervenza.fernando@mayo.edu|
20198175|NCT01263483|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20198176|NCT04451161|University of Washington|Dr. Aaron Lyon|(206) 221-8604|lyona@uw.edu|
20198177|NCT00454857|Amgen Inc.|Study Director|866-572-6436||
20198178|NCT01431274|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198179|NCT01378858|Albert Einstein College of Medicine|Shadi Nahvi, MD, MS|718 920 5379|snahvi@montefiore.org|
20198180|NCT02664272|Smith & Nephew, Inc.|Vice President of Medical Affairs|+41 41 7662222|luca.orlandini@smith-nephew.com|
20198181|NCT03073980|Massachusetts General Hospital|John C. Petrozza, M.D.|617-726-8868|jpetrozza@mgh.harvard.edu|
20198182|NCT01358760|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20198183|NCT01506960|Massachusetts General Hospital|Iris McNulty|617 726 2612|imcnulty@partners.org|
20198184|NCT01806857|Center for Neurological Study|Richard Smith, MD|858-455-5463|cnsonline@ymail.com|
20198185|NCT02047253|University of Alabama at Birmingham|Pam Dixon, RN, BSN, OCN|205-975-9875|pamdixon@uab.edu|
20198186|NCT03574753|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20198187|NCT01034592|Stanford University Medical Center|Jason R Gotlib, MD, Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
20198188|NCT00832520|UNM Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
20198189|NCT00789880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20198190|NCT01379469|Washington University School of Medicine|David Rudnick MD, PhD- Associate Professor|314-286-2832|rudnick_d@wustl.edu|
20198191|NCT00912002|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198192|NCT00609986|Medical University of South Carolina|Dr. Kathie Hermayer|843-792-2529|hermayer@musc.edu|
20198193|NCT03159091|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20198194|NCT04814823|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20198195|NCT02044133|Centre hospitalier départemental Vendée|Dr Yves BLEHER|0251446572|yves.bleher@ght85.fr|
20198196|NCT04085523|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
20198197|NCT04272892|University of Oxford|Dr Melanie Fleming|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
20198198|NCT06557122|Encoll Corp|Dr. Subramanian Gunasekaran, PhD|+1 (510) 396-8581|guna@encoll.com|
20198199|NCT05318937|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
20198200|NCT04722042|University of North Carolina at Chapel Hill|Margaret Dillon, AuD, PhD|919-966-5251|mdillon@med.unc.edu|
20198201|NCT01877915|Janssen Research & Development, LLC|SENIOR DIRECTOR, CLINICAL LEADER CV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20198202|NCT02247245|University of Leeds|Dr Haqeel Jamil|0113 343 3241|haqeel.jamil@nhs.net|
20198203|NCT05678257|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
20198204|NCT02046096|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20153442|NCT01056276|Sarah Cannon Development Innovations|Charles Davis, RAC||charles.davis2@scri-innovations.com|
20153443|NCT01881425|InnFocus, Inc. (a Santen Company)|Sharon Herbert, Director of Global Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
20164427|NCT03629886|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20198205|NCT03520959|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198206|NCT01449461|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20198207|NCT00487396|Given Imaging|Director, Clinical Affairs|+972-4-9097777|Hila.Debby@givenimaging.com|
20198208|NCT05314517|Kinevant|Study Director|(+1) 646-494-6491|kinevant.resolve-lung@kinevant.com|
20198209|NCT04969276|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20198210|NCT04551677|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20198211|NCT04490018|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20198212|NCT01777412|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
20198213|NCT00943579|Children's Health Council|Glen R. Elliott, Ph.D., MD|650.688.3649|gelliott@chconline.org|
20198214|NCT00418665|Amgen Inc.|Study Director|866-572-6436||
20198215|NCT01133379|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20198216|NCT00841204|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
20198217|NCT00591214|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20198218|NCT04857996|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
20198219|NCT01129921|Napa Pain Institute|Eric Grigsby, MD|707-252-9660|egrig@aol.com|
20198220|NCT03743311|AO Servier|Olga Linnik|+7 495 9370700|olga.linnik@servier.com|
20153444|NCT04154956|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20153445|NCT04424901|UConnHealth|Ellen Ciesielski|860-679-6004|eciesielski@uchc.edu|
20153446|NCT00147238|UT MD Anderson Cancer Center|Haesun Choi, MD / Professor|713-745-4693||
20153447|NCT01348269|University Hospital Wuerzburg - Department of Orthopaedics (Clinical Study Unit)|Dr. Lothar Seefried|+499318033590|l-seefried.klh@uni-wuerzburg.de|
20153448|NCT00805532|VA Portland Health Care System|Amy W. Wagner, Ph.D.|(503) 220-8262|amy.wagner@va.gov|33365
20153449|NCT01859741|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
20153450|NCT03823131|University of California, San Francisco|Dr Chase Heaton, MD|(415) 502-1889|Chase.Heaton@ucsf.edu|
20153451|NCT02606253|Lipscomb University College of Pharmacy|Dr. Zachary Cox, Associate Professor|6159667163|zac.cox@lipscomb.edu|
20153452|NCT00890721|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20153453|NCT02765165|Proximagen, LLC|Chief Medical Officer|952-658-7440|tcmeng@proximagen.com|
20164428|NCT03291067|Mitsubishi Tanabe Pharma Development America, Inc.|Clinical Trials, Information Desk|Please e-mail|information@mt-pharma-us.com|
20153454|NCT02567188|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20153455|NCT02511717|Lawson Health Institute|Dr Blayne Welk|5196466000|lawson@lawsonsresearch.com|
20153456|NCT02026297|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
20153457|NCT01189266|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20153458|NCT00537277|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20153459|NCT02767531|UT Southwestern Medical Center|Abhimanyu Garg, MD|2146482895|abhimanyu.garg@utsouthwestern.edu|
20153460|NCT00410163|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153461|NCT04513366|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
20153462|NCT01426581|University of Chicago|Valerie G. Press, MD, MPH|73-702-5170|vpress@medicine.bsd.uchicago.edu|
20153463|NCT01498549|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
20153464|NCT00655889|Biologics Consulting Group|Dr. Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
20153465|NCT03573297|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20153466|NCT04084015|Massachusetts General Hospital|Dr. David D'Alessandro|617-726-8841|DADALESSANDRO@MGH.HARVARD.EDU|
20153467|NCT03456245|Harvard TH Chan School of Public Health|Dr. David Bloom|6174320650|dbloom@hsph.harvard.edu|
20153468|NCT02273167|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
20153469|NCT06649409|Santhera Pharmaceuticals LTD|Shabir Hasham MD, Chief Medical Officer|+41 79 520 95 18|shabir.hasham@santhera.com|
20153470|NCT03857256|Montreal Heart Institute|Dr Jean-Claude Tardif|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
20164429|NCT03683173|Washington University School of Medicine|Diana Parra Perez, Ph.D.|314-286-1426|parrad@wustl.edu|
20164430|NCT03016312|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20164431|NCT00496015|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164432|NCT01116401|Brigham & Women's Hospital|Hadine Joffe|617-732-4906|hjoffe@partners.org|
20164433|NCT01535807|Inova Heart and Vascular Institute|Lisa Fornaresio, PhD|703-776-7071|lisa.fornaresio@inova.org|
20164434|NCT01590979|Staten Island University Hospital, Northwell Health|Soad Bekheit, MD|718-226-6629|msills@northwell.edu|
20164435|NCT02730728|University of Pennsylvania|Dr Nabil Elkassabany|2156628000|nabil.elkassabany@uphs.upenn.edu|
20164436|NCT01521026|UCSD|Elizabeth Twamley, PhD|6195436684|etwamley@ucsd.edu|
20164437|NCT00934635|Janssen Cilag|Medical Development Manager; Medical and Scientific Affairs|0049-2137-955-1240||
20164438|NCT02123134|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
20164439|NCT00904813|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
20164440|NCT01731912|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20164441|NCT02043938|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20164442|NCT03010527|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20164443|NCT01458639|Cyclomedica Australia Pty Ltd|Gary Somerville, Quality and Regulatory Manager|+61 (0)2 9541 0411|gsomerville@cyclomedica.com.au|
20164444|NCT02656017|University of Pittsburgh|Dr. Kyongtae Bae|412-647-3500|baek@upmc.edu|
20164445|NCT01755234|Northwestern University|Gildasio De Oliveira|312-695-4858|g-jr@northwestern.edu|
20164446|NCT00622505|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20164447|NCT03004365|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
20164448|NCT01619839|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
20164449|NCT03822897|Canadian Cancer Trials Group|Dr. Wendy Ranjana Parulekar|613 533 6430|wparulekar@ctg.queensu.ca|
20164450|NCT01216202|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
20198221|NCT00847145|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20198222|NCT02701868|Pennington Biomedical Research Center|Abby Altazan|2257632801|Abby.Altazan@pbrc.edu|
20198223|NCT00980200|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198224|NCT03703882|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
20198225|NCT01617460|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20198226|NCT01140360|Indiana University|Dr. Kent Robertson|317-944-4969|krobert@iu.edu|
20198227|NCT02013180|Catalca Ilyas Cokay State Hospital|Dr. Mustafa Zafer Temiz|+90 212 787 19 12|dr_mustafazafertemiz@hotmail.com|1178
20198228|NCT00457015|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20198229|NCT03670953|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
20198230|NCT00290615|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
20198231|NCT00362414|University of California Irvine|Dr. Steven Cramer|(714) 456-6876|scramer@uci.edu|
20198232|NCT02603120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20198233|NCT04467424|University Hospital of Split|Dr. Ana Nevescanin Biliskov, pediatric anesthesiologist|00385912508001|anevescanin@gmail.com|
20198234|NCT01227187|George Washington University|Lakhmir Chawla|202-715-4752|lchawla@mfa.gwu.edu|
20198235|NCT00840086|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20153471|NCT01509105|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198236|NCT03332498|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@moffitt.org|
20198237|NCT02554019|Biotest AG|Dr. Peter Röttgen|+496103801|peter.roettgen@biotest.com|803
20198238|NCT02181816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20198239|NCT02113436|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198240|NCT02159729|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
20198241|NCT01148537|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
20198242|NCT00754832|Oregon Health & Science University|Dr. Michelle Cameron|503-418-1971|cameromi@ohsu.edu|
20198243|NCT00827606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198244|NCT03437564|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20198245|NCT00243386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20198246|NCT04037748|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20198247|NCT00133991|Johns Hopkins University|Yvette Kasamon, MD||ykasamon@jhmi.edu|
20153472|NCT05352763|Cassava Sciences|Project Manager|5125013180|closedstudyinfo@cassavasciences.com|
20153473|NCT05493111|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
20153474|NCT03836053|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20153475|NCT00788671|UT MD Anderson Cancer Center|Dr. Shannon N. Westin, MD, Associate Professor, Gyn Onc & Reproductive Med|(713) 794-4314|swestin@mdanderson.org|
20153476|NCT04486716|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20153477|NCT03846479|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
20153478|NCT02332707|Merck Sharp & Dohme Corp.|Senior VIce President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20153479|NCT01473134|Clinical Affairs Associate Director|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
20153480|NCT04761822|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20153481|NCT00362232|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20153482|NCT02700841|University of Nebraska Medical Center|IIT Office|402-559-4596|IITOffice@unmc.edu|
20153483|NCT06023563|Indiana University|Dr. Georgia Frey, Faculty, Department of Kinesiology|(812) 855-1262|gfrey@iu.edu|
20153484|NCT05423743|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
20153485|NCT05020015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20153486|NCT02233413|Massachusetts General Hospital|Dr. Rajiv Gupta|617-726-0369|rgupta1@mgh.harvard.edu|
20198248|NCT01953575|Mayo Clinic|David A. Katzka|507-284-4824|Katzka.David@mayo.edu|
20153487|NCT00090103|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153488|NCT02515253|University of Portsmouth|Dr Emma Sharland||emma.sharland@port.ac.uk|
20153489|NCT01799889|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20153490|NCT03265964|VA Salt Lake City Health Care System, VISN 19 Rocky Mountain MIRECC for Veteran Suicide Prevention|Dr. Douglas Kondo|801-587-1549|douglas.kondo@va.gov|
20153491|NCT04476043|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20153492|NCT06217380|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20153493|NCT06633965|Center for Diabetes Technology|Dr. Marc Breton|434-982-6484|mb6nt@virginia.edu|
20153494|NCT00320086|University of New Mexico|Aaron Jacobs, MD|(505)272-5551|Ajacobs@salud.unm.edu|
20153495|NCT04213261|Castle Creek Biosciences|Associate VP of Clinical Trials|16506901024|rblumenthal@castlecreekbio.com|
20153496|NCT02469233|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
20164451|NCT02851303|Brown Family Medicine|Dr. Mary Beth Sutter|401-921-7981|marybeth_sutter@brown.edu|
20198249|NCT04995055|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
20198250|NCT04695392|UPENN|Martha A.Q. Curley, RN, PhD|2155739449|curley@nursing.upenn.edu|
20198251|NCT00807742|Brown University|Damaris Rohsenow, Ph.D.|401-863-6648|damaris_rohsenow@brown.edu|
20198252|NCT03834519|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|Clinicaltrialsdisclosure@msd.com|
20198253|NCT05248295|MGH IHP|Lauryn Zipse|6176433245|lzipse@mghihp.edu|
20198254|NCT04655144|University of Miami|Prasoon Mohan, MD|7736563386|prasoonpm@gmail.com|
20198255|NCT05097144|CooperVision Inc.|José A. Vega OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
20198256|NCT01484977|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20198257|NCT00853749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198258|NCT01392677|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20198259|NCT01181076|Oslo University Hospital|Kristin Skaarud|4723070000|kskaarud@ous-hf.no|
20198260|NCT00121108|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20198261|NCT02726971|Department of Hysteroscopic Center, Fuxing Hospital, Capital Medical University, Beijing, China|Dr. YH Liu|8618301474064|emmagj@126.com|
20198262|NCT01380379|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
20198263|NCT02324075|Stanford University|Prof. Stephen P. Luby, MD|+1-650-723-4129|sluby@stanford.edu|
20198264|NCT01538628|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
20198265|NCT01357577|VA National Center for PTSD|Jessica L. Hamblen, PhD|8022965132|jessica.hamblen@va.gov|
20198266|NCT03080883|Mayo Clinic|Dr. Robert McBane|(507)266-3964|mcbane.robert@mayo.edu|
20198267|NCT01469182|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20198268|NCT01114503|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198269|NCT01761292|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
20198270|NCT02463409|Vanderbilt University Medical Center|Dr. Ashley Shoemaker|615-343-8816|ashley.h.shoemaker@vanderbilt.edu|615
20198271|NCT00916357|Halozyme|Vice President, Endocrinology Clinical Development|858-794-8889||
20198272|NCT03577730|University of Michigan|Phillip Vlisides|734-936-4280|pvliside@umich.edu|
20198273|NCT02538016|Boston Children's Hospital|Alyssia Venna|617-919-6352|Alyssia.Venna@childrens.harvard.edu|
20198274|NCT02634151|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
20198275|NCT02347098|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
20198276|NCT01444742|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|CR_Study_Registration@mdanderson.org|
20198277|NCT02187172|University of Pennsylvania|Dr. Joel Gelfand|215-662-3514|joel.gelfand@pennmedicine.upenn.edu|
20198278|NCT02830880|Emory University|David Schuster, MD|(404) 712-4859|dschust@emory.edu|
20198279|NCT05400213|University of Texas Health Science Center at San Antonio|Brian Mealeey, DDS, MS|210-450-8736|mealey@uthscsa.edu|
20198280|NCT02349048|Janssen R&D BE|Associate Director, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
20198281|NCT02219282|DorkuzEU|Semih Kucukguclu|902324125707|semih.kucukguclu@gmail.com|
20198282|NCT00094770|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20198283|NCT00253643|Oregon Health & Science University|Dr. Jackilen Shannon|503-220-8262|shannoja@ohsu.edu|54868
20198284|NCT01368536|Novartis Pharmaceuticals|Study Director|862-778-8300||
20198285|NCT00383084|Johns Hopkins University|Kevin Fontaine, PhD|443-449-4314|kfontai1@jhmi.edu|
20198286|NCT01648790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198287|NCT01486927|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20198288|NCT04075721|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20198289|NCT02636582|UT MD Anderson Cancer Center|Dr. Isabelle Bedrosian, MD, Professor, Breast Surgical Oncology|(713) 563-1872|ibedrosian@mdanderson.org|
20198290|NCT00573430|AstraZeneca|Gerard Lynch|+44 7780 956181|aztrial_results_posting@astrazeneca.com|5895
20198291|NCT01278745|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20198292|NCT00896779|Stanford University|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
20198293|NCT01843842|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
20153497|NCT00947544|Hyperion Therapeutics|Craig James-Associate Director, Clinical Operations|650-745-7840|craig.james@hyperiontx.com|
20153498|NCT00300053|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
20153499|NCT02385318|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20153500|NCT00396292|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com|
20153501|NCT02566005|Mount Sinai Health Systems|Dr. Zainab Al-Ibraheemi||Zainab.Al-ibraheemi@mountsinai.org|
20153502|NCT01963611|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20198294|NCT02953340|Spectrum Pharmaceuticals Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
20198295|NCT01376778|The George Washington University Biostatistics Center|Dr. Rebecca Clifton, MFMU Principal Investigator|301-881-9260|rclifton@bsc.gwu.edu|
20198296|NCT00632099|New York State Psychiatric Institute|Dr. Suzette Evans|646-774-6136|se18@columbia.edu|
20198297|NCT04712110|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20198298|NCT04490863|Masimo Corporation|Vikram Ramakanth|949-297-7000|ClinicalResearchDept@masimo.com|
20198299|NCT00761007|Menarini Group- Clinical Research|Angela Capriati MD PhD, Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
20198300|NCT00271596|University of Iowa; Elks Rehab Hospital|Leigh Beglinger, PhD|319-353-4489|leigh-beglinger@elksrehab.org|
20198301|NCT04707157|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20198302|NCT01063075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198303|NCT01329679|DavidGrant|Sachin Shah|707-423-3277|sshah@pacific.edu|
20153503|NCT03801252|University of Oklahoma Health Sciences Center|Dr. Stephanie Pierce|(405) 271-8787|stephanie-pierce@ouhsc.edu|
20153504|NCT02471183|Actelion Pharmaceuticals Ltd|Global Post approval studies Director||lperchen@its.jnj.com|
20198304|NCT01409213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198305|NCT03625687|Massachusetts General Hospital|Raymond Chung, MD|6177247562|Chung.Raymond@mgh.harvard.edu|
20198306|NCT04206605|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20198307|NCT01396226|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20198308|NCT01651351|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20198309|NCT05879107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20198310|NCT00589420|Abramson Cancer Center|Ravi Amaravadi|2156622222|ravi.amaravadi@pennmedicine.upenn.edu|
20198311|NCT02662036|Washington University School of Medicine|Terence Myckatyn, M.D.|314-996-8800|myckatyn@wustl.edu|
20198312|NCT01017003|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20198313|NCT01412554|Oslo University Hospital Ullevål, Norway|MD PhD Tonje Amb Aksnes|+22119101|tonjeaksnes@hotmail.com|47
20198314|NCT00450723|UM/Sylvester Comprehensive Cancer Center|Eli Avisar MD|305-243-4902|eavisar@med.miami.edu|
20198315|NCT01987960|A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
20198316|NCT01279850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198317|NCT01131520|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|
20198318|NCT04118270|University of Massachusetts Medical School|Alok Kapoor|917-856-4538|alok.kapoor@umassmed.edu|
20164452|NCT01775774|University of California San Francisco|Michael A. Matthay, MD|415-353-1206|michael.matthay@ucsf.edu|
20164453|NCT00614380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164454|NCT01506271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164455|NCT01391663|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20164456|NCT02303093|Octapharma Pharmazeutika Produktionsgesm.b.H.,|Dr. Bernhard Rohrbacher|+431610324182|bernhard.rohrbacher@octapharma.com|
20164457|NCT00152503|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20164458|NCT04393493|hospital civil de guadalajara|Dr Jonathan Chavez Iñiguez|3313299609|jonarchi_10@hotmail.com|
20198319|NCT01436084|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
20198320|NCT05419128|CHESS - University of Wisconsin--Madison|Kasey Thompson|608-590-7821|kfwagner@wisc.edu|
20198321|NCT04506086|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20198322|NCT05599672|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
20198323|NCT01839396|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
20198324|NCT02321930|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
20198325|NCT01293968|Qazvin University of Medical Sciences|Dr.Katayun Borhanmojabi|09127841440|ka.mojabi@yahoo.com|
20198326|NCT00255970|RTI Biologics|Clinical Projects, Director|386-418-8888|rparkhurst@rtix.com|
20198327|NCT03996876|University of California, San Francisco|Aoife O'Donovan, Associate Professor of Psychiatry|4152214810|aoife.odonovan@ucsf.edu|x24959
20198328|NCT02971631|University of Cambridge|Mr Geoffrey Roberts|01223767176|geoffroberts@cantab.net|
20202972|NCT02441803|University of Texas MD Anderson Cancer Center|Dr. Richard Champlin, MD/Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
20202973|NCT03065530|The First Affiliated Hospital of Nanjing Medical University|Dr. Shijiang Liu, Dr. Mei Gao|+862568303569|liushijiang1983@hotmail.com|
20153505|NCT02478671|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
20153506|NCT03726476|University of New Mexico Health Sciences Center|Cassandra Darley|505-967-8428|cjdarley@salud.unm.edu|
20153507|NCT02328105|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20153508|NCT00614393|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20153509|NCT00855582|Eli Lilly and Company|Chief Medical Office|800-545-5979||
20153510|NCT02612857|Idera|Senior Development Operations Director|877-888-6550|clinicaltrials@iderapharma.com|2
20153511|NCT03345004|Diamyd Medical AB|Director of Clinical Development|+46 (0) 8 661 00 26|clinicaltrials@diamyd.com|
20153512|NCT06094647|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|919-962-1401|kelsey_ludwig@med.unc.edu|
20153513|NCT01104285|Maimonides Medical Center|Yizhak Kupfer MD|718-283-8380|ykupfer@maimonidesmed.org|
20153514|NCT01013753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20153515|NCT03556683|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
20153516|NCT03286504|Weill Cornell Medicine|Dr. Daniel Fitzgerald|646-962-8140|dwf2001@med.cornell.edu|
20153517|NCT02805998|UCSF|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
20153518|NCT01107015|University of Maryland, Baltimore|Cindy Geppi|4107062406||
20153519|NCT00851591|Texas Tech University Health Sciences Center|Thomas Hale, PhD.|806-354-5528|thomas.hale@ttuhsc.edu|
20153520|NCT00634504|BTG International Inc.|SVP, Clinical Development|610-278-1660|angela.ogden@btgplc.com|
20153521|NCT02110693|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|276
20153522|NCT01928849|Duke University Department of Anesthesiology|Thomas Buchheit, MD Division Chief, Pain Medicine|9196811924|Thomas.Buchheit@duke.edu|
20153523|NCT01186770|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20153524|NCT01394276|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20153525|NCT02696798|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20164459|NCT00965250|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20164460|NCT00055692|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20198329|NCT04090580|"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Vasco de Quiroga 15, Belisario Domínguez Secc 16, Tlalpan, 14080, CDMX, Mexico. Department of endocrinology and lipid metabolism"|Miguel Ángel Gómez Sámano|+52 1 55 59939816|miguel.gomezs@incmnsz.mx|
20198330|NCT00597753|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
20198331|NCT00388973|AstraZeneca|Medical Science Director, Seroquel||AZTrial_Results_Posting@astrazeneca.com|
20198332|NCT02562924|University of Vermont Medical Center|Dr. Daniel Gerges|8028474535|daniel.gerges@uvmhealth.org|
20198333|NCT01258504|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
20198334|NCT00075023|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
20198335|NCT03382665|Zimmer Biomet|Fabrizio Lucchini, Clinical Jr.Project Lead|0041798575924|Fabrizio.Lucchini@zimmerbiomet.com|
20198336|NCT02982954|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20198337|NCT04002037|UMissourri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20198338|NCT00747643|H. Lee Moffitt Cancer Center and Research Institute|Thomas H. Brandon, Ph.D.|813-745-1750|thomas.brandon@moffitt.org|
20198339|NCT00516048|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20198340|NCT02263079|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20198341|NCT03557281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20198342|NCT01999465|University of Michigan|Dr. Lynda Yang|7349365017|bpclinic@umich.edu|
20198343|NCT02933034|Stanford University|Phillip C. Yang|(650) 498-8008|phillip@stanford.edu|
20198344|NCT00871845|Allegheny Singer Research Institute|Hossam Kandil||Hossam.KANDIL@ahn.org|
20198345|NCT01549275|Kaohsiung Medical University Hospital|Dr. Zu-Yau LIn|886-7-323-4553|linzuyau@yahoo.com.tw|
20198346|NCT01040351|Cairo university|Usama M.Fouda, M.D, PhD|+20123595106|umfrfouda@yahoo.com|
20198347|NCT00825500|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
20198348|NCT03448068|Mayo Clinic|Dr. Andrew W. Gorlin|480-342-2446|Gorlin.Andrew@mayo.edu|
20198349|NCT04773106|Implandata Ophthalmic Products GmbH|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20198350|NCT00291447|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20198351|NCT00122681|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198352|NCT01422356|Melbourne Sexual Health Centre, Alfred Health|Associate Professor Marcus Chen|+61 3 9341 6260|mchen@mshc.org.au|
20198353|NCT06243198|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20198354|NCT02819635|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20198355|NCT04172714|Emory University|Nima Kokabi, MD|(404) 778-4747|nima.kokabi@emory.edu|
20198356|NCT01035099|Weill Cornell Medicine|Rodriq Stubbs|646-962-3276|res2011@med.cornell.edu|
20198357|NCT03179891|Aquestive Therapeutics|Director of Clinical Operations|908-941-1900|clinicaltrials@aquestive.com|
20198358|NCT02833922|Institute for Reproductive Health|Dr. Victoria Jennings|2026871392|Victoria.Jennings@georgetown.edu|
20198359|NCT02969187|Cleveland Clinic|Dr. Philip R. Schauer|216-444-4794|schauep@ccf.org|
20198360|NCT01761084|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
20198361|NCT03719690|Kura Oncology, Inc.|Clinical Operations|617-588-3755|KO-TIP-007@kuraoncology.com|
20198362|NCT01471015|University of Utah|Dr. Mariana Baserga|801-581-7052|mariana.baserga@hsc.utah.edu|
20198363|NCT00988143|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20153526|NCT01277861|University of Texas Southwestern Medical Center at Dallas|Girish P. Joshi, MD|214-590-7259|girish.joshi@utsouthwestern.edu|
20153527|NCT03308669|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20153528|NCT01157845|Virginia Commonwealth University|R. Todd Stravitz|804-828-8514|rstravit@vcu.edu|
20153529|NCT03311555|Duke University|Andrew Armstrong, MD|919-668-8797|andrew.armstrong@duke.edu|
20153530|NCT00505635|UT MD Anderson Cancer Center|Nicholas E. Papadopoulos, MD / Professor|713-792-2921|CR_Study_Registration@mdanderson.org|
20153531|NCT02394275|St. Joseph's Healthcare Hamilton, ON|Dr. Marek Smieja|905 521 6021|smiejam@mcmaster.ca|
20153532|NCT00782067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20153533|NCT04757636|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
20153534|NCT02730130|Memorial Sloan Kettering Cancer Center|Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
20153535|NCT00141921|Amgen Inc.|Study Director|866-572-6436||
20153536|NCT00621530|Wake Forest School of Medicine|Dr. James C. Eisenach|336-716-4498|jimeisenach@gmail.com|
20153537|NCT03813654|Brigham and Women's Hospital|Jeanne F. Duffy, Principal Investigator|617-732-7995|jduffy@bwh.harvard.edu|
20153538|NCT01732692|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
20153539|NCT01155323|Johnson and Johnson K.K.|Wakana Katabami|81-34411-8040|wkatabam@its.jnj.com|22025
20153540|NCT02081807|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20153541|NCT03104413|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20153542|NCT01208051|University of Chicago|Chih-Yi Liao, MD|(773) 702-6241|andyliao@medicine.bsd.uchicago.edu|
20153543|NCT02721069|Neurelis, Inc.|Cyndi Guerra|9736156258|cguerra@neurelis.com|
20153544|NCT02349386|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
20153545|NCT00973973|AbbVie|Global Medical Services|800-633-9110||
20164461|NCT02093793|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
20164462|NCT01808196|Cincinnati Children's Hospital Medical Center|Pablo Abonia, MD|513-636-|pablo.abonia@cchmc.org|
20164463|NCT00271102|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
20198364|NCT03672370|Zimmer Biomet|Clinical Project Lead, Sandra Rosser|+41 (0)58 854 84 09|sandra.rosser@zimmerbiomet.com|
20198365|NCT00928889|Novartis Pharmaceuticals|Study Director|862 778-8300||
20198366|NCT02006342|The University of Texas Health Science Center at Houston|Dr. Pratik B. Doshi|713-608-6537|Pratik.B.Doshi@uth.tmc.edu|
20198367|NCT01118273|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20198368|NCT02375724|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20198369|NCT02684604|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
20198370|NCT01197521|AstraZeneca|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20198371|NCT01517893|University of Massachusetts Medical School|John E. Harris, MD, PhD|508-856-1982|john.harris@umassmed.edu|
20198372|NCT03462576|Exalenz Bioscience|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737513|avrahamh@exalenz.com|
20198373|NCT01496131|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20198374|NCT05032612|The University of Texas Health Science Center at Houston|Timothy Kirkpatrick, DDS|713-486-4227|timothy.c.kirkpatrick@uth.tmc.edu|
20198375|NCT01543828|Novartis Pharmaceuticals|Study Director|862-778-8300||
20198376|NCT00941668|Colgate Palmolive|Willliam DeVizio-DMD|732-878-7901|William_DeVizio@colpal.com|
20198377|NCT01069172|AMO Development, LLC|Luis Atiles, Manager, Clinical Research|214 537-6784|luis.atiles@amo.abbott.com|
20198378|NCT02225080|Integra LifeSciences Corporation|Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
20198379|NCT00711425|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
20198380|NCT00585611|UW-Madison at time of study|Nancy Sweitzer||nancysweitzer@shc.arizona.edu|
20198381|NCT03901079|BSC|Chenchen FAN|+861085216427|chenchen.fan@bsci.com|
20198382|NCT03113656|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20198383|NCT04311216|University of Liverpool|Dr Fraser Philp|01517942000|f.philp@liverpool.ac.uk|
20198384|NCT03710486|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20198385|NCT00445705|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20198386|NCT01555567|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
20198387|NCT01252745|Acerus Pharmaceuticals Corporation|Vice President|(416) 679-0776|nbryson@aceruspharma.com|
20198388|NCT01439672|University of Virginia|Sue Brown, MD||sab2f@virginia.edu|
20198389|NCT03497585|Pennine Acute NHS Trust|Dr Deborah Antcliff|0161 7242168|Deborah.Antcliff@pat.nhs.uk|
20198390|NCT01744665|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20198391|NCT02904915|The University of Texas Health Science Center at Houston|Pamela D. Berens, MD|713-500-6471|Pamela.D.Berens@uth.tmc.edu|
20198392|NCT03067571|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD/Professor|713-563-1586|gborthak@mdanderson.org|
20198393|NCT02090413|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20198394|NCT01045798|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198395|NCT02530528|MicroBioTest|Dr. MH Bashir|7039250100|muhammad.bashir@microbac.com|
20198396|NCT01652885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198397|NCT00075400|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20198398|NCT01183559|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|215 728-3135|Igor.Astsaturov@fccc.edu|
20198399|NCT03723707|NYU Langone Health|Mauricio Arcila-Mesa|646-501-4660|Mauricio.arcila-mesa@nyulangone.org|
20198400|NCT04342871|UNC Lineberger|Eliza Park|919-966-3494|leeza_park@med.unc.edu|
20198401|NCT00666458|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20198402|NCT02222207|BAYER|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
20198403|NCT02611154|Sports Medicine Research & Testing Laboratory|Dr. Geoffry Miller|801-994-9519|gmiller@smrtl.org|
20198404|NCT04682405|Washington University School of Medicine|Keith Stockerl-Goldstein, M.D.|314-747-7859|ksgoldstein@wustl.edu|
20198405|NCT01429584|University of Utah Department of Anesthesiology|Dr. Elizabeth Thackeray|(801) 581-6393|elizabeth.thackeray@hsc.utah.edu|
20198406|NCT00750698|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
20198407|NCT05030012|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
20198408|NCT02628236|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|8452681943|Anna.Houlihan@sunpharma.com|
20198409|NCT01584479|University of Michigan|William Giannobile, Principal Investigator|734-764-1562|wgiannob@umich.edu|
20153546|NCT02471339|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
20153547|NCT00984867|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20153548|NCT06057064|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20153549|NCT01541748|Coloplast|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
20153550|NCT03340883|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
20153551|NCT01675778|Jacobi Medical Center|Dr. Shujun Xia|718-918-5800|shujun.xia@nbhn.net|
20153552|NCT00626639|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
20153553|NCT01461551|Ruijin Hospital|Dr. Lijie Jia|13916667704|litery0301@163.com|
20153554|NCT01155141|Stanford University|Dr. Richard Lafayette|650-498-6063|czar@stanford.edu|
20153555|NCT02240329|University of Florida|Erin Pearson Ph.D CCC/SLP|352-339-4100|epearson@ufl.edu|
20153556|NCT03473197|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
20153557|NCT00785629|Denver Nephrologists, P.C.|Geoffrey A. Block, MD|303-364-4775|gablock@denverneph.net|
20153558|NCT00267670|Northwestern University|Mary E. Rinella, MD|312-503-4592|m-rinella@northwestern.edu|
20153559|NCT01114555|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak, MD|212-639-7623|modaks@mskcc.org|
20153560|NCT02326883|Kaiser Permanente Washington Health Research Institute|Gregory Simon, Investigator|206-287-2979|gregory.e.simon@kp.org|
20217709|NCT04155073|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20153561|NCT04773795|Nitinotes Ltd.|Ravit Peled- Director of clinical operations|0526145354|ravit@nitinotesurgical.com|
20153562|NCT01038765|Radboud University Medical Centre|Anne E.M. Speckens|0031243610449|a.speckens@psy.umcn.nl|
20153563|NCT02107898|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20198410|NCT01423162|Food and Nutrition Research Institute|Trinidad P. Trinidad|6328372071|trinidadtp@yahoo.com.ph|2281
20198411|NCT00390546|University of British Columbia|Dr. Shubhayan Sanatani|604-875-2345|ssanatani@cw.bc.ca|7955
20198412|NCT01308008|VA GRECC|Neil Alexander MD|734-845-3048|nalexand@umich.edu|
20153564|NCT03329989|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
20153565|NCT01283386|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20153566|NCT02469857|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
20153567|NCT00937950|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20153568|NCT02210195|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20153569|NCT03483103|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
20153570|NCT02378181|Public Health Management Corporation|Adam C. Brooks, Ph.D.|215-399-0636|abrooks@tri.phmc.org|
20153571|NCT00297167|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 2634||
20153572|NCT03988647|Stanford University|Susan J Knox, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
20153573|NCT01898130|Northwestern University|Priya Kumthekar, MD|312-503-1818|p-kumthekar@northwestern.edu|
20153574|NCT00920816|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153575|NCT01953237|University of Maryland, Baltimore|Julie Kreyenbuhl|410-637-1864|jkreyenb@som.umaryland.edu|
20153576|NCT04167462|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20153577|NCT03331562|Translational Genomics Research Institute (TGen) An Affiliate of City of Hope|Derek Cridebring, PhD. Director, Molecular Medicine Division|6023438629|dcridebring@tgen.org|
20153578|NCT00505921|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Associate Professor|713-792-8848|pmcadams@mdanderson.org|
20153579|NCT01033136|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
20153580|NCT00142415|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20153581|NCT02674659|Harapan Kita National Cardiovascular Center|Bambang Dwiputra, MD, FIHA|0215684093|bambangdwiputra@gmail.com|
20153582|NCT01572792|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20153583|NCT01807455|Q-Med AB|Chief Medical Officer|+ 46 (0) 18 474 90 00|Reception.SEUPP@galderma.com|
20153584|NCT03530696|George Washington Cancer Center|Dr. Pavani Chalasani|(202) 741-2277|pavani.chalasani@email.gwu.edu|
20153585|NCT02472353|Avera|Stacy Kehoe|605.322.3082|Stacy.Kehoe@avera.org|
20153586|NCT00797563|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20153587|NCT03416179|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153588|NCT00475332|University of Florida|Bridget Fitzgerald, Clinical trials coordinator|(352) 265-0680|fitzgb@shands.ufl.edu|87829
20153589|NCT00688597|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
20153590|NCT06438601|CooperVision, Inc.|Jose A. Vega, OD, MSc, PhD|925-621-3761|javega@coopervision.com|
20153591|NCT03136198|Indiana University|Peter S. Pang|317-880-3900|ppang@iu.edu|
20153592|NCT05233761|Defined Research Institute|Paul Muchowski|415-413-8666|paul.muchowski@definedresearch.org|
20153593|NCT01052948|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153594|NCT04058717|Penn State College of Medicine|Nicolle Krebs|7175315673|nkrebs@pennstatehealth.psu.edu|
20153595|NCT00846365|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20153596|NCT01925417|Rebiotix|Sarah Mische PhD, Associate Director of Clinical Research|6512122839|smische@rebiotix.com|
20153597|NCT05203185|NYU Langone Health|Safiya Richardson, MD, MPH|212-263-8313|Safiya.Richardson@nyulangone.org|
20153598|NCT01047319|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20153599|NCT02072200|Mundipharma Korea Ltd|Kim Bu Yeon|+82 2 568 5689|BuYeon.Kim@mundipharma.co.kr|
20153600|NCT03095287|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20153601|NCT02594111|VA NY Harbor Healthcare System|Dr. Binita Shah|212-686-7500|binita.shah@va.gov|
20153602|NCT01294514|Covidien|Ulf Borg, Director of Clinical Affairs|303 305 2400|ulf.borg@covidien.com|
20153603|NCT02018107|Brigham & Women's Hospital INC|Paul Shyn, MD|6177326304|PSHYN@BWH.HARVARD.EDU|
20153604|NCT04398966|University of North Carolina at Chapel Hill|Markeela Lipscomb|919-843-3670|markeela_lipscomb@med.unc.edu|
20153605|NCT00671060|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
20153606|NCT00303186|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153607|NCT02020941|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
20153608|NCT02832037|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187598|NCT05736458|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
20187599|NCT00971087|Hologic|Jennifer Bartoshevich, Sr Manager of Clinical Affairs|781-999-7764|jennifer.bartoshevich@hologic.com|
20187600|NCT04011644|Dept of Family Medicine and Community Health, UW-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
20187601|NCT01199133|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 29 70|mroux@stallergenes.com|
20187602|NCT05100628|Noxopharm|Lorena Figueroa, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
20187603|NCT04588415|University of Ottawa|Dr. James Downar|613 562 6262|jdownar@toh.ca|1502
20187604|NCT02575950|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20198413|NCT03357731|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20198414|NCT01417195|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20198415|NCT01733472|Region Skane|Andreas Harsten|46708870567|andreas.harsten@skane.se|
20198416|NCT02257372|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217710|NCT02240186|Mayo Clinic|Dr. Kenton Kaufman, Principal Investigator|507-284-2262|kaufman.kenton@mayo.edu|
20217711|NCT00939627|Vanderbilt Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
20217712|NCT03396874|University of Michigan|Morand Piert|734-936-5385|mpiert@med.umich.edu|
20217713|NCT00537199|UT MD Anderson Cancer Center|Mark Chambers, MS, DMD / Professor|713-792-6510||
20217714|NCT02127073|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
20217715|NCT02039063|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
20217716|NCT02621463|University of Utah|Dr. Kai Kuck, PhD|8012051010|kai.kuck@hsc.utah.edu|
20217717|NCT02740179|Massachusetts General Hospital|Dr. Steven K. Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
20217718|NCT00467831|NHGRI/NIH|Dr. Thomas Markello|301-451-1305|markellot@mail.nih.gov|
20217719|NCT02326363|Medical University of South Carolina|Nathaniel L Baker|843-792-5028|bakern@musc.edu|
20217720|NCT01998243|Hospital severo ochoa|Dr Luis Ramon Rabago Torre|34914818000|lrabagot@gmail.com|8326
20217721|NCT02492841|UNIVERSIDAD DE LOS ANDES|Dra. CLAUDIA BRIZUELA CORDERO|562226181166|clau@cibrizuela.com|
20217722|NCT04117945|Mayo Clinic|Daniel H. Ahn, D.O.|(480) 342-4800|Ahn.Daniel@mayo.edu|
20217723|NCT02568007|Medical College of Wisconsin|Praveen Goday|4142663690|pgoday@mcw.edu|
20217724|NCT03391115|University of Colorado, College of Nursing|Heather Coats, PhD, APRN-BC, PI|303-724-3740|heather.coats@cuanschutz.edu|
20217725|NCT00562120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217726|NCT02148445|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
20217727|NCT03450629|Sun Pharma Advanced Research Company Limited|Head, Clinical Developmnt|912266455645|clinical.trials@sparcmail.com|
20217728|NCT03438006|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20217729|NCT01447225|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20217730|NCT01181531|Amgen Inc.|Study Director|866-572-6436||
20217731|NCT01168687|Ernest Gallo Clinic and Research Center, UCSF|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
20217732|NCT00955721|University of Miami|Peter J. Hosein MD|3052433462|phosein@miami.edu|
20217733|NCT03512002|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
20217734|NCT00503113|Hoffman-LaRoche|Medical Communications|800-821-8590||
20217735|NCT01253317|Boston Children's Hospital|Walter E. Kaufmann, MD|617-355-5230|rettresearch@childrens.harvard.edu|
20217736|NCT02280226|University of Bonn|Dr. Jonas Doerner|017632817006|jonas.doerner@ukb.uni-bonn.de|
20217737|NCT00096122|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
20217738|NCT04034355|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46 732344698|kristina.sjoblom@egetis.com|
20217739|NCT01552369|University of Pittsburgh - Medicine - Infectious Diseases|Nina Singh, MD|412-360-1688|nis5@pitt.edu|
20217740|NCT02322788|AstraZeneca R&D Gothenburg, SE-431 83 Mölndal, Sweden|Göran Eckerwall, MD, PhD|+46 708467664|goran.eckerwall@astrazeneca.com|
20217741|NCT03326986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217742|NCT02999984|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
20217743|NCT02631837|Imelda ziekenhuis Bonheiden|Dr Jan Baekelandt|+ 32 15 505208|jan.baekelandt@imelda.be|
20217744|NCT00754013|Eisai inc.|Eisai Medical Services|1-888-422-4743||
20217745|NCT04039919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20217746|NCT02310789|Stanford University|Jeff Wine, PhD|650-725-2462|wine@stanford.edu|
20217747|NCT01197417|Medical College of Wisconsin|David Brousseau MD, MS|414-266-2625|dbrousse@mcw.edu|
20217748|NCT03250299|Basilea Pharmaceutica International Ltd (Basilea)|Thomas Kaindl, MD, Global Medical Director|+41615671505|thomas.kaindl@basilea.com|
20217749|NCT01202071|Eisai Co., Ltd.|Masaharu Yokoyama, Director|+81-3-3817-3908|m-yokoyama@hhc.eisai.co.jp|
20217750|NCT02548312|BMJ|Dr Sara Schroter|02073836744|sschroter@bmj.com|
20217751|NCT02551679|Hemostemix|Dr. Fraser Henderson|2022978858|fhenderson@hemostemix.com|
20217752|NCT01546142|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20153609|NCT01401166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20153610|NCT04383132|Şehit Prof. Dr. İlhan Varank Eğitim Ve Araştırma Hastanesi|Dr. Beslen Göksoy|05349530112|beslengoksoy@gmail.com|
20153611|NCT01531153|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
20153612|NCT00435942|Bolton Medical, Inc.|Annie Weiller|954-838-9699|AWeiller@boltonmedical.com|
20153613|NCT01180777|Johnson & Johnson Vision Care|Michael S. Mayers, O.D., FAAO|1-904-443-3252|MMayers@its.jnj.com|
20153614|NCT04491994|Pak Emirates Military Hospital (PEMH) Rawalpindi|Sultan Mehmood Kamran|+923008501100|sultanmajoka79@hotmail.com|
20217753|NCT01213836|Astra Zeneca|Gerard Lynch||ClinicalTrailTransparency@astrazeneca.com|
20217754|NCT01679197|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
20217755|NCT04213209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20153615|NCT02234180|Memorial Sloan-Kettering Cancer Center|Yelena Y. Janjigian MD|646-888-4186|janjigiy@mskcc.org|
20153616|NCT02475213|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20217756|NCT00385788|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
20217757|NCT03050697|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20198417|NCT04325542|Medical Mission Institute|Dr Christa Kasang||christa.kasang@medmissio.de|
20198418|NCT01849874|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198419|NCT02104583|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20198420|NCT04203745|Candela Medical|Dr. Konika Patel Schallen|508-358-0357|konikap@candelamedical.com|
20198421|NCT04640272|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
20198422|NCT01523496|University Hospitals Cleveland Medical Center|Dr Grace McComsey|216-844-2739|Grace.McComsey@UHhospitals.org|
20198423|NCT02535715|University of Texas Health San Antonio|Curtis Triplitt, PharmD|210-358-7228|triplitt@uthscsa.edu|
20198424|NCT00909181|Antares Pharma|Kaushik Dave|609 359 3020|kdave@antarespharma.com|
20198425|NCT04353284|Yale School of Medicine|Geoffrey Chupp, MD Professor of Medicine (Pulmonary); Director, Yale Center for Asthma and Airways D|(203) 785-3627|geoffrey.chupp@yale.edu|
20198426|NCT01875783|Joslin Diabetes Center|Dr. Jennifer Sun|617-209-2554|jennifer.sun@joslin.harvard.edu|
20198427|NCT03045861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20198428|NCT00530894|Edwards Lifesciences|Tenley Koepnick|949-250-6504|tenley_koepnick@edwards.com|
20198429|NCT01349465|Janssen Research & Development, LLC|Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
20198430|NCT02605187|Stanford University School of Medicine|Dr. Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
20198431|NCT05433571|Johnson & Johnson Vision Care (JJVC)|Ross Franklin|1-800-843-2020|RFRANKL1@its.jnj.com|
20198432|NCT04329702|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
20198433|NCT01438489|MedImmune, LLC|Gabor Illei, MD, Senior Director|301-398-0000|illeig@Medimmune.com|
20198434|NCT00766532|University of Wisconsin|Dr. Karen Hansen|608-263-0517|keh@medicine.wisc.edu|
20198435|NCT03451786|Carl Zeiss|Michael Bonilla|+1 925-557-4100|michael.bonilla@zeiss.com|
20198436|NCT00940589|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
20198437|NCT00676676|Massachusetts General Hospita|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
20198438|NCT00429403|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
20198439|NCT01372384|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20198440|NCT00842231|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20198441|NCT01977599|UCL|Dr Robert Kerrison, Senior Research Fellow|02076798268|Robert.kerrison.13@ucl.ac.uk|
20198442|NCT01923285|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
20198443|NCT03374189|St. Vincent's Hospital|Dr. Hee Youn Kim|82-31-249-7473|khyoun10589@gmail.com|
20198444|NCT03962101|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20198445|NCT03699007|Stanford University Medical School|Dr. Laura Simons|(650) 736-0838|lesimons@stanford.edu|
20198446|NCT00843518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198447|NCT01748942|Oregon Health and Science University|Daniel Clayburgh, MD PhD|503-494-8510|clayburg@ohsu.edu|
20198448|NCT00804570|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198449|NCT00290342|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198450|NCT03341975|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343430|mmiller@cmh.edu|
20153617|NCT02441283|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20153618|NCT00630292|University of North Carolina|William Irvin, Jr. MD / Co-Principal Investigator|919-966-6735|william_irvin@med.unc.edu|
20153619|NCT02382939|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20153620|NCT04342169|University of Utah School of Medicine Division of Infectious Diseases|Dr. Adam Spivak|8015871964|adam.spivak@hsc.utah.edu|
20153621|NCT01553851|Washington University School of Medicine|Dr. Douglas Atkins|314-747-8475|datkins@dom.wustl.edu|
20153622|NCT02101294|Finger Relief|Molly Choate Summers|703-517-8951|summers.molly@gmail.com|
20153623|NCT01129128|University of Washington|James A Taylor, MD|206-616-1206|uncjat@uw.edu|
20153624|NCT00844519|University of California San Francisco|Dr. Priscilla Hsue|415-206-8257|phsue@medsfgh.ucsf.edu|
20153625|NCT02709369|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
20153626|NCT01900314|University of Michigan|Stephan Taylor|734-936-4955|sftaylor@umich.edu|
20153627|NCT02013414|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
20153628|NCT03282097|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
20153629|NCT02226159|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
20153630|NCT01056536|Travel Clinic, Department of Ambulatory Care and Community Medicine, University Hospital of Lausanne|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
20153631|NCT04497883|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20153632|NCT01551173|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20153633|NCT04530344|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20153634|NCT03869268|The University of Sheffield|Dr William Parker|01142266159|w.parker@sheffield.ac.uk|
20153635|NCT05352399|Yale School of Medicine|Cameron Gettel|717-228-7759|cameron.gettel@yale.edu|
20153636|NCT01654276|University of Texas Southwestern Medical Center|Naim Maalouf. MD|214-648-2954|naim.maalouf@utsouthwestern.edu|
20153637|NCT02657551|Dana-Farber Cancer Institute|Kartik Seghal|000-000-0000|Kartik_Sehgal@dfci.harvard.edu|
20153638|NCT04478266|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20153639|NCT01579214|Massachusetts General Hospital|Dr. Mark Siedner|617-726-4686|msiedner@mgh.harvard.edu|917
20198451|NCT01056510|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20198452|NCT02997735|Children's Hospital of Philadelphia|Brian Jenssen, MD MSHP|215-554-4390|JenssenB@email.chop.edu|
20198453|NCT00912028|University of Campinas, Brazil|Carlos E Leite Arieta MD, PhD||ra-visus-clnclstds@its.jnj.com|
20198454|NCT02242578|The University of Texas at Austin|Robert J Buchanan, MD|512-324-7991|robertbuchanan@utexas.edu|
20153640|NCT01977846|Foundation Fighting Blindness|Chief Scientific Officer|410-423-0600|info@FightBlindness.org|
20153641|NCT00296517|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153642|NCT03513952|Fred Hutchinson Cancer Center|Cancer Immunotherapy Trials Network Trial Manager|514-718-2858|citn@fredhutch.org|
20153643|NCT01093417|University Hospitals Case Medical Center|Grace McComsey, MD|2168443607|gam9@case.edu|
20153644|NCT02630030|Emory University|Dr. Jeffrey Olson|404-778-5770|jolson@emory.edu|
20153645|NCT00596635|Yale University School of Medicine|Manisha Juthani-Mehta, MD|(203)785-4140|manisha.juthanimehta@yale.edu|
20153646|NCT01484340|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|443-287-2969|jgolub@jhmi.edu|
20153647|NCT01143324|MedtronicSpineECA|Christel Van Dam|+31433566523|christel.van.dam@medtronic.com|
20153648|NCT01010763|Zimmer Biomet G.K.|Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
20153649|NCT01101178|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20153650|NCT01850641|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20153651|NCT00127803|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20153652|NCT01643213|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
20153653|NCT00944554|Johns Hopkins University|Maxine Stitzer, PhD|410-550-0042|mstitze1@jhmi.edu|
20198455|NCT03418129|Duke University|Eric Elbogen, Ph.D.|919-684-9983|eric.elbogen@duke.edu|
20198456|NCT02087956|University of Rochester|Dr. Ellen Poleshuck|585-275-3138|ellen_poleshuck@urmc.rochester.edu|
20198457|NCT00974246|Valley Medical Research|Meenakshi Patel, MD|937-208-8298|mpatelmd@ymail.com|
20198458|NCT01617070|USC/Keck School of Medicine|Shoji Yano|323-226-3816|syano@usc.edu|
20198459|NCT00942175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20198460|NCT01066585|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
20198461|NCT01940471|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20153654|NCT01020123|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20153655|NCT03133676|Calibr, a Division of Scripps Research|Study Director|(858) 242 1000|KA34ph1@scripps.edu|
20153656|NCT04901624|University of Southern California|Dr. Jason Doctor|213.821.8142|jdoctor@usc.edu|
20153657|NCT02587936|UT Southwestern Medical Center|Miguel A Vazquez|214-648-8884|Miguel.Vazquez@UTSouthwestern.edu|
20153658|NCT03654417|Duke University|Dr. Laura Havrilesky|(919) 684-0188|laura.havrilesky@duke.edu|
20153659|NCT03479905|UTexasSouthwestern|Christina Riccio|214-590-7284|Christina.Riccio@utsouthwestern.edu|
20153660|NCT00862992|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20153661|NCT00720759|VAHSRD|Stephen E. Nadeau|352-374-6082|stephen.nadeau@va.gov|
20153662|NCT02318940|Universidad de Chile|Dr. Pietro Pietroboni Fuster|+56982261539|pietroboni@gmail.com|
20153663|NCT03100747|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
20153664|NCT04376567|University of Arizona|Tze-Woei Tan|3234426835|tze-woei.tan@med.usc.edu; ttan@arizona.edu|
20153665|NCT00658619|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20153666|NCT03261193|UPMC|Nicholas Schott, MD|412-692-4503|schottnj@upmc.edu|
20153667|NCT05032196|Wave Life Sciences USA, Inc|Medical Director, MD|+1 617-949-2900|info@wavelifesci.com|
20153668|NCT00857389|UT MD Anderson Cancer Center|Kris M Mahadeo, Associate Professor, Pediatrics - Patient Care|(713) 792-2873|kmmahadeo@mdanderson.org|
20153669|NCT05260008|Allay Therapeutics, Inc|Study Director|669-679-5081|clinicaltrialsinfo@allaytx.com|
20153670|NCT00001305|National Institute of Child Health and Human Development|Marini, Joan|+1 301 594 3418|marinij@mail.nih.gov|
20153671|NCT04584788|Masimo Corporation|Cristina Johnson|(949) 297-7576|clinicalresearchdept@masimo.com|
20153672|NCT05350423|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|Mantu.Gupta@mountsinai.org|
20153673|NCT01890577|Amgen Inc.|Study Director|866-572-6436||
20153674|NCT02097277|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
20153675|NCT00835926|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20153676|NCT01091259|Perlmutter Cancer Center at NYU Lagone|Franco Muggia, MD|212-263-6485|Franco.Muggia@nyumc.org|
20153677|NCT03320369|Northwestern University|Nirmala Gonsalves|312-695-4054|n-gonzalves@northwestern.edu|
20153678|NCT03901300|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
20153679|NCT04727749|University of Saskatchewan|Dr. Colleen Dell|306-966-5912|Colleen.Dell@usask.ca|
20153680|NCT02320396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20153681|NCT03718000|University of Georgia|Dr. Jamie Cooper, Associate Professor|706-542-4903|jamie.cooper@uga.edu|
20153682|NCT05383209|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
20153683|NCT02411643|Northwestern University|Stephanie Rangel|3125035942|stephanie.rangel@northwestern.edu|
20153684|NCT00321763|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153685|NCT00717886|Memorial Sloan Kettering Cancer Center|Dr. Leslie Montgomery|(212) 639-5386|Montgoml@mskcc.org|
20153686|NCT00716417|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20153687|NCT00149643|University of Pittsburgh|Jack R. Cornelius, M.D.|412-246-6906|corneliusjr@upmc.edu|
20198462|NCT00884273|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20217758|NCT01002794|Oslo University Hospital|Professor May Arna Risberg|+4741312776|marisb@ous-hf.no|
20153688|NCT03822416|University of Minnesota|Harry Lando, PhD|612-624-1877|lando001@umn.edu|
20153689|NCT01303419|GE Healthcare|Jean-Paul Antonini|+33 130709703|Jean-Paul.antonini@ge.com|
20198463|NCT00258674|Baylor Research Institute|Baylor Research Institute|214-820-9991|Elizabeth.Cothran@baylorhealth.edu|
20198464|NCT03715153|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr. Pierre-François PENELAUD|+ 33 1 55 72 68 58|pierre-francois.penelaud@servier.com|
20198465|NCT00353834|Joslin Diabetes Center|Edward S. Horton, MD|6173091995|edward.horton@joslin.harvard.edu|
20198466|NCT02973087|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20198467|NCT01147744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198468|NCT01342484|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198469|NCT01840579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198470|NCT01058070|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
20198471|NCT03302975|Univeristy of British Columbia|Chris Napier|604-721-1310|chris.napier@ubc.ca|
20198472|NCT04018794|University of California, San Francisco|Dr. Melissa Dvorsky|4154767167|melissa.dvorsky@ucsf.edu|
20198473|NCT00432042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198474|NCT00492752|BAYER|Therapeutic Area Head|<not disclosed>|clinical-trials-contact@bayerhealthcare.com|
20198475|NCT01357655|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20198476|NCT05003622|Pierre Fabre Medicament|Jean Claude Vedovato|+33 609828746|jean.claude.vedovato@pierre-fabre.com|
20198477|NCT03803059|Crown Laboratories, Inc|Thomas Hitchcock, PhD.|8883723982|THitchcock@crownlaboratories.com|
20198478|NCT03497806|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
20198479|NCT04066491|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20198480|NCT00402649|University of Maryland Center for Vaccine Development|Ina Stephens, MD|410-706-1123|istephen@medicine.umaryland.edu|
20198481|NCT01199042|Bethesda North Hospital|Dr. Shahrokh Javaheri|513-793-7378|shahrokhjavaheri@icloud.com|
20198482|NCT01773109|University of Pennsylvania (Abramson Cancer Center)|Dr. Charu Aggarwal|2156624000|charu.aggarwal@pennmedicine.upenn.edu|
20198483|NCT01239342|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|EJonasch@mdanderson.org|
20198484|NCT03118232|University of California, Irvine|Dr. Susan Huang|714-456-5047|sshuang@hs.uci.edu|
20198485|NCT02325219|Janssen Pharmaceutical K.K., Japan|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20198486|NCT04036708|Michigan State University|Michael J Boivin|1-517-884-0281|boivin@msu.edu|
20198487|NCT02918864|Rush University Medical Center|Dr. Latha Valluripalli Soorya|(312) 942-6238|latha_soorya@rush.edu|
20198488|NCT04766021|Indiana University|Dr. Blair Johnson|8128558699|bj33@indiana.edu|
20198489|NCT03303950|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
20198490|NCT03289650|Northwestern University|Lorenzo Gallon|312 695 4457|l-gallon@northwestern.edu|
20198491|NCT01656031|Comprehensive Cancer Center of Wake Forest University|Dr. Bayard Powell|336-716-7970|bpowell@wakehealth.edu|
20198492|NCT04673292|Johns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University School of Nursing|Jacky Jennings,PhD, MPH; Shruti Mehta, PhD, MPH; Jason Farley, PhD, MPH, ANP-BC, FAAN|410-550-4132|jennings@jhmi.edu; smehta@jhu.edu; jfarley1@jhu.edu|
20198493|NCT00880399|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198494|NCT01476475|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20198495|NCT00751400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20198496|NCT03129321|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
20198497|NCT02576444|Yale School of Medicine: Medical Oncology|Joseph Paul Eder, MD|(203) 737-6980|joseph.eder@yale.edu|
20198498|NCT03503877|University of California, San Francisco|Mitchell Rosen|415-353-7475|Mitchell.Rosen@ucsf.edu|
20198499|NCT03370120|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
20198500|NCT04206020|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
20198501|NCT02700412|University of Alabama at Birmingham|Dr. Jerzy Szaflarski, MD, PhD|205-934-3866|jszaflarski@uabmc.edu|
20198502|NCT02310776|Northwestern Medicine|Ellen B. Mendelson, MD, FACR, Lee F. Rogers Professor of Medical Education in Radiology, Profess|3124720436|emendels@nm.org|
20198503|NCT04962022|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198504|NCT02888093|University of Iowa Hospitals and Clinics|Dr. Joseph Kowalski|3193561616|joseph-kowalski@uiowa.edu|
20198505|NCT04416555|Cleveland Clinic|Dr. Sabry Ayad|216.476.7052|Saayad@ccf.org|
20198506|NCT00530270|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
20198507|NCT03078075|UT Southwestern Medical Center|Dr. Madhukar Trivedi|214/648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
20198508|NCT03782402|CUIMC|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
20198509|NCT01517529|University of Cincinnati|Dr. Mohamed Tarek M Shata|(513) 558-6110|mohamed.shata@uc.edu|
20198510|NCT00330382|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
20198511|NCT01356407|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20198512|NCT04512040|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
20153690|NCT03769493|Brown University|Ethan Moitra, Ph.D.|4014441949|ethan_moitra@brown.edu|
20153691|NCT01104766|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
20153692|NCT01136915|Bracco Diagnostics, Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
20153693|NCT00743093|Denver Heatlh Rocky Mountain Poison and Drug Center|Jody Green, PhD|303-389-1246|jody.green@rmpdc.org|
20153694|NCT01732211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153695|NCT02755090|University of New Mexico|Sharla Biefeld Research Coordinator|505-272-9703|hsc-familyplanningresearch@salud.unm.edu|
20198513|NCT01309659|Duke University Medical Center|Harvey J Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
20198514|NCT02018822|University of Rochester|Hans Malmstrom|585-275-5087|hans_malmstrom@urmc.rochester.edu|
20198515|NCT02285777|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198516|NCT03201458|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20198517|NCT01785459|Carolinas Medical Center|Dr. Sean Fox|704-355-3181|Sean.Fox@atriumhealth.org|
20198518|NCT00715026|Zimmer|Director, Clinical Affairs|574-371-8019|erin.osborn@zimmer.com|
20198519|NCT00552175|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198520|NCT00750737|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|CR_Study_Registration@mdanderson.org|
20198521|NCT02614859|Fox Chase Cancer Center|Dr. Daniel Geynisman|215-728-3889|Daniel.Geynisman@fccc.edu|
20198522|NCT05112536|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20198523|NCT03972969|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
20198524|NCT00445484|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
20198525|NCT04607148|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20198526|NCT04251910|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
20198527|NCT00916149|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
20198528|NCT00841568|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20198529|NCT03002155|University of Washington (affiliation)|Sara Morgan, PhD|651-229-1719|sjmorgan@uw.edu|
20198530|NCT00978029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20198531|NCT02830776|Formerly - Tulane University Department of Dermatology. Currently - Suzanne Bruce and Associates, PA|Megan Couvillion, MD, FAAD|504-473-2915|megan.couvillion@gmail.com|
20198532|NCT01793142|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198533|NCT01820364|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
20198534|NCT03451084|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
20198535|NCT01087775|San Francisco VA Medical Center|Dr. Karen Seal|4152214810|Karen.Seal@va.gov|24852
20198536|NCT03029143|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20198537|NCT03300674|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
20198538|NCT05289570|Duke University|Ian Welsby, MD|919-681-6752|ian.welsby@duke.edu|
20198539|NCT03096730|Tianjin Medical University General Hospita|Dr. Guolin Wang|13002211205|1464322162@qq.com|
20198540|NCT00573989|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
20153696|NCT04940221|Christiana Care Health System|Heather Bittner Fagan, MD MPH|302 320 4110|hbittner-fagan@christianacare.org|
20153697|NCT05473039|SEID|Ana Gavilán|+34 630928812|agavilan@lab-seid.com|
20153698|NCT01564407|University of Pittsburgh|Amy Steele, RN, MSN, CCRC|412-641-3728|steeleam@upmc.edu|
20153699|NCT02373865|GWT-TUD GmbH, Study center Prof. Hanefeld|Prof. Dr. Markolf Hanefeld|+49 351 44005|Markolf.Hanefeld@gwtonline.de|82
20153700|NCT00879658|Novartis Pharmaceuticals|Study Director||Novartis.email@novartis.com|
20153701|NCT00639509|Memorial Sloan-Kettering Cancer Center|Ghassan K. Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
20153702|NCT00294658|University of Alabama at Birmingham|Dr. Gary Cutter, Professor|205-975-5048|cutter@uab.edu|
20153703|NCT01402700|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20153704|NCT03507790|Cogntion Therapeutics Inc|Dr. Anthony Caggiano|914-221-6730|acaggiano@cogrx.com|
20153705|NCT03279952|Penn State College of Medicine|Raman Baweja, MD|7175318521|rbaweja@pennstatehealth.psu.edu|
20153706|NCT00157755|Medtronic Neuromodulation|Clinical Program Manager|763-526-8172|medtronicneurotrials@medtronic.com|
20153707|NCT02141555|University of California, San Diego|Dr. Sheila Mody||smody@ucsd.edu|
20153708|NCT01719653|Gastroenterology Services, Ltd|David Gerard, MD|630 969 1167|davidpgerard@comcast.net|
20153709|NCT05049122|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20153710|NCT03314935|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20153711|NCT00168298|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20153712|NCT03636477|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20153713|NCT05168800|Dartmouth College|Glyn Elwyn|(603) 646-5623|glynelwyn@gmail.com|
20153714|NCT04958707|University of Medicine and Pharmacy at Ho Chi Minh City|Dr. Nguyen Tran To Tran|+84 979635889|nguyentrantotran@ump.edu.vn|
20153715|NCT02489539|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
20153716|NCT05457855|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20153717|NCT03331341|University of Washington|Dr. Ryan Lynch, Associate Professor|206-606-1739|rclynch@uw.edu|
20153718|NCT05722015|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20153719|NCT05523297|Toronto General Hospital|Dr Keyvan Karkouti|(416) 340-8597|keyvan.karkouti@uhn.ca|
20198541|NCT04544475|NYU Langone Health|Lila Nachtigall|2122636361|Lila.Nachtigall@nyulangone.org|
20198542|NCT00808236|BeneChill, Inc.|Becky Inderbitzen, Vice President of Clincial Affairs|858-695-8118|binderbitzen@benechill.com|
20198543|NCT05376215|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20198544|NCT02031770|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@ucdenver.edu|
20198545|NCT01301950|DePuy Synthes|Sam Himden, Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
20198546|NCT04041284|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20198547|NCT00964743|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
20198548|NCT01549002|ColumbiaU|Dr. Daniel Fenster|212-305-9825|dbf2114@columbia.edu|
20198549|NCT01671423|Einstein Medical Center|Scott Goldstein|2154561836|goldstes@einstein.edu|
20198550|NCT04093843|West Virginia University|Amelia Adcock, MD|304-598-6127|akadcock@hsc.wvu.edu|
20198551|NCT03709654|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
20198552|NCT01902966|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD, Professor, Gynecologic Oncology & Reproductive Medicine|713-745-0307|lramonde@mdanderson.org|
20198553|NCT01230307|University of Michigan|Barry Bleske|734-763-3232|bbleske@umich.edu|
20198554|NCT02387359|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
20198555|NCT01230242|MaineHealth|Clinicaltrials.gov Administrator|207.396.8228|llemire@mmc.org|
20198556|NCT02256540|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau|303-724-1914|kerrie.moreau@cuanschutz.edu|
20198557|NCT03923426|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrialsgov_Inquiries@Pfizer.com|
20198558|NCT01918007|National and Kapodistrian University of Athens School of Medicine and Aghia Sophia Children's Hospital, Athens, Greece|Dr. Athanasios Kaditis, Head, Division of Pediatric Pulmonology, First Department of Pediatrics|+302132013000|akaditis@med.uoa.gr|
20198559|NCT01261507|Georgetown University Medical Center|Matthew T. Freedman, MD|4105429680|freedmmt@georgetown.edu|
20198560|NCT01140451|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20198561|NCT00441974|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198562|NCT02152085|University of Colorado Boulder|Roger Enoka|3034927232|enoka@colorado.edu|
20198563|NCT00067028|The University of Texas M. D. Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
20198564|NCT00661531|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
20198565|NCT03134599|CooperVision|Jose Vega, O.D., MSc., FAAO|9252516213761|javega@coopervision.com|
20198566|NCT01265615|Ural Institute of Cardiology, Ural State Medical Academy|Dr. Alexander Kharlamov|+79638547663|drskharlamov@gmail.com|
20198567|NCT03070470|U.S. Food and Drug Administration|Jose Vicente, PhD|301-796-8442|Jose.VicenteRuiz@fda.hhs.gov|
20198568|NCT04784182|Auburn University|Drew Frugé|3348448433|adf0003@auburn.edu|
20198569|NCT01628588|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20198570|NCT01399788|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198571|NCT02919436|Maine Medical Center|Dr. Anand Rughani|207-885-0011|arughani@mmc.org|
20198572|NCT01441037|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
20198573|NCT00283595|Massachusetts General Hospital|Anne Klibanski, MD|617-726-3870|aklibanski@partners.org|
20198574|NCT01389752|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198575|NCT03259074|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20198576|NCT01594515|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198577|NCT00053417|Acorda Therapeutics|Andrew Blight, PhD|914-347-4300|ablight@acorda.com|102
20153720|NCT02512419|Brown University|Dr. Bess Marcus|401-863-9858|bess_marcus@brown.edu|
20198578|NCT01713621|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 03 00|moehrlej@mmv.org|
20198579|NCT00705783|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
20198580|NCT02327052|Hospital São Rafael|Dr. Milena Botelho Pereira Soares|+557132816455|milenabpsoares@gmail.com|
20198581|NCT01722604|Bausch & Lomb|Daniel Donatello|(585) 338-5306|Daniel.Donatello@bausch.com|
20198582|NCT02184195|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|information.center@astrazeneca.com|
20153721|NCT02340949|MFAR Clinical Research|Pau Doñate Macian|0034934344412|investigacion@mfar.net|
20153722|NCT01192178|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153723|NCT02460289|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20153724|NCT01155570|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20153725|NCT02164916|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408|smcdonou@fredhutch.org|
20153726|NCT03229499|Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine|Dr. Steven M Kawut, MD, MS|646-352-1654|kawut@upenn.edu|
20153727|NCT00964782|Milton S. Hershey Medical Center|Compliance Specialist|7175310003|clinicaltrials.gov@pennstatehealth.psu.edu|287544
20153728|NCT00141817|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153729|NCT02546570|National Center for PTSD|Dr. Lauren Sippel|802-295-9363|lauren.m.sippel@dartmouth.edu|6082
20153730|NCT01740206|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
20153731|NCT02472405|University of Miami|Keyvan Nouri MD|305-243-3380|KNouri@med.miami.edu|
20153732|NCT01134042|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153733|NCT01733953|University of Minnesota|Cameron Naughton|612-625-3623|naug0009@umn.edu|
20153734|NCT00674297|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
20198583|NCT02285998|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20153735|NCT01137786|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
20153736|NCT00770367|Medical University of South Carolina|Dana King MD|843-792-8112|kingde@musc.edu|
20198584|NCT00545298|Nitric BioTherapeutics Inc|Frank J. McCaney, CEO Sponsor|215-788-6200|fmccaney@nbtherapeutics.com|
20198585|NCT00685880|Mayo Clinic|Dr. Jeffrey S. Brault|507-284-1643|brault.jeffrey@mayo.edu|
20198586|NCT03339206|University of North Carolina at Chapel Hill|Adam O. Goldstein|984-974-0210|adam_goldstein@med.unc.edu|
20198587|NCT02668874|University of Iowa College of Dentistry|Director of Clinical Research|319-467-1398|dentistry-research@uiowa.edu|
20198588|NCT00974675|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20198589|NCT01394627|Brigham and Women's Hospital|Gail Adler|617-732-5661|gadler@partners.org|
20198590|NCT04744207|Gesynta Pharma AB|Study Director|+46 73 386 4246|ctg@gesynta.se|
20198591|NCT02588976|Triemli City Hospital|Director Clinical Trial|+41 44 416 25 52|christoph.hofer@triemli.stzh.ch|
20198592|NCT03223428|TerSera Therapeutics LLC|Noran Osman, PharmD, MHS, Associate Director, External Research and Medical|+1-224-754-4605|nosman@tersera.com|
20198593|NCT02777268|Simbec Research Limited|Dr Girish Sharma|+44 1443 690977||
20198594|NCT00777101|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20198595|NCT02230384|University of Pittsburgh|K.N. Roy Chengappa, MD / Principal Investigator|412-246-5006|chengappakn@upmc.edu|412
20198596|NCT00961220|Case Comprehensive Cancer Center|Dr. Kevin Cooper|216-844-3111|kevin.cooper@uhhospitals.org|
20198597|NCT02153528|Institute of Tropical Medicine Antwerp|Clinical Trials Unit ITM|0032 32470778|jbuyze@itg.be|
20198598|NCT01947816|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20198599|NCT00282334|Dept. of Medical Research, Holstebro Hospital|Line Bille Madsen|+45 99125421|linemads@rm.dk|
20198600|NCT00471705|Universidad de Antioquia - Colombia|Iván Darío Vélez Bernal|574 + 219 6501 - 02|idvelez@pecet-colombia.org|
20198601|NCT02651584|Braeburn Pharmaceuticals|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
20198602|NCT01024010|Mayo Clinic|Tait D. Shanafelt, M.D.||shanafelt.tait@mayo.edu|
20198603|NCT00841789|Seattle Childrens hospital|Michael A Portman|2069871014|michael.portman@seattlechildrens.org|
20198604|NCT01071538|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
20198605|NCT00825162|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20198606|NCT01784770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198607|NCT03455491|PHARMENTERPRISES LLC|CEO Vladimir Nebolsin|+7 (985) 728-75-72|ph@pharmenterprises.ru|
20198608|NCT01391286|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20198609|NCT02086786|Rovi S.A. Laboratorios Farmacéuticos|Jordi Llaudó Garín ( Clinical Development Manager)|+34913756230|jllaudo@rovi.es|
20198610|NCT03317795|Mayo Clinic|Dr. Shannon K. Laughlin-Tommaso|507-538-5783|LaughlinTommaso.Shannon@mayo.edu|
20198611|NCT00939783|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198612|NCT02189161|Laser Surgery Care|Dr. Stephen E. Goldstone, MD|212-242-6500|segmd@prodigy.net|
20198613|NCT00455689|Brigham & Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
20198614|NCT00501007|Rutgers, The State University of New Jersey|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
20198615|NCT03917823|University of California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@health.ucsd.edu|
20198616|NCT00135668|Duke University Medical Center|Scott Schulman, MD|919-681-4877|schul003@mc.duke.edu|
20198617|NCT01732809|Brazilian Center for Studies in Dermatology|Scientific Coordinator|+55 51 30262633|cientifico@cbed.org.br|
20198618|NCT02424253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20198619|NCT00781911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198620|NCT00891982|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198621|NCT02012621|University of Colorado-AMC|Dr. Jose Castillo-Mancilla|303-724-4934|jose.castillo-mancilla@cuanschutz.edu|
20198622|NCT05885737|CSL Behring|Clinical Study Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20198623|NCT02037295|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Jonathan Krakoff, M.D.|(602) 200-5217|jkrakoff@mail.nih.gov|
20198624|NCT02841397|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
20198625|NCT01757678|HeartFlow|VP Clinical, Quality & Regulatory Affairs|650-241-1221|clinicalresearch@heartflow.com|
20198626|NCT02004262|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
20198627|NCT01146873|Columbia University|Louise Kuhn, PhD|212-305-2398|lk24@cumc.columbia.edu|
20198628|NCT04331795|University of Chicago, Department of Medicine Section of Rheumatology|Dr. Pankti Reid|773-702-6119|pankti.reid@uchospitals.edu|
20198629|NCT03200366|Indiana University|Susan M. Rawl, PhD, RN, FAAHB, FAAN|317-278-2217|srawl@iu.edu|
20198630|NCT04677959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20198631|NCT00732303|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20198632|NCT00264875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20198633|NCT01074190|Northwerstern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20198634|NCT00397813|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
20153737|NCT01989975|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
20153738|NCT01545336|University of Pennsylvania|Dr. Steven M. Kawut|215-573-0258|kawut@upenn.edu|
20153739|NCT03881371|Zambon S.p.A|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
20153740|NCT01101100|Valeant Pharmaceuticals International|Lindsey Mathew|908|lindsey.mathew@valeant.com|
20153741|NCT02508389|Galera Therapeutics, Inc.|Kara Terry|610-725-1500|kterry@galeratx.com|
20198635|NCT01500278|Cares|UCB|+1877 822||9493
20198636|NCT02459795|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20153742|NCT01869374|New York State Psychiatric Institute|Stefan Rowny, MD|(646) 774-5417|stefan.rowny@nyspi.columbia.edu|
20198637|NCT04718974|Infectious Diseases Institute, College of Health Sciences, Makerere University|Dr. Agnes Bwanika Naggirinya|+256752521570|anaggirinya@idi.co.ug|
20198638|NCT01709435|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20153743|NCT01138046|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198639|NCT02409290|MRC CTU at UCL, University College London, London UK|Dr Ruth Goodall|+44 2076704728|r.goodall@ucl.ac.uk|
20198640|NCT02121262|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20198641|NCT01553188|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
20198642|NCT02445625|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
20164464|NCT00479713|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198643|NCT03998046|Northwestern University|Ronald Ackermann, MD, MPH|(312)-503-3232|r.ackermann@northwestern.edu|
20198644|NCT00075088|University of California, San Francisco|Barbara J Drew, PhD|415-476-4302|barbara.drew@nursing.ucsf.edu|
20198645|NCT01378104|the Catholic University of Korea|Dr. Kwon|+82322805886|doctorkwon@catholic.ac.kr|
20198646|NCT00455013|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20198647|NCT01445951|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20198648|NCT04901481|TheraNova, LLC|Director of Clinical|4159268616|clinicalstudy@theranova.com|
20198649|NCT01519765|Stanford University|Dr. Linh Tran|925-642-2241|lltran20@gmail.com|
20198650|NCT00078325|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20198651|NCT03054922|Nationwide Children's Hospital|David P. Martin, MD|614-722-4200|david.martin@nationwidechildrens.org|
20198652|NCT04126083|Mayo Clinic|W. Michael Hooten, M.D.|507-266-9672|Hooten.William@mayo.edu|
20198653|NCT02354222|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20198654|NCT02739620|University of Vermont|Michael J. Toth|802-656-7989|michael.toth@med.uvm.edu|
20198655|NCT00578136|The Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|267-426-5850|gurnaney@email.chop.edu|
20198656|NCT00730964|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|Rubin.Sheng@ge.com|
20198657|NCT00754793|University of Washington|Dr. Greg E. Davis, MD MPH|206-543-5230|gedavis@uw.edu|
20198658|NCT02218242|University of Kentucky|Angela Mahan|859 257 4488|angela.mahan@uky.edu|
20198659|NCT00932360|University of Iowa|Dana Dailey|319-335-7149|dana-dailey@uiowa.edu|
20198660|NCT02536313|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20198661|NCT02941705|Cedar Sinai|Russell Haber|(310) 967-8322|Russell.Haber@CSHS.org|
20217759|NCT03614494|The University of Hong Kong|Dr Raymond Li|+852 22554517|raymondli@hku.hk|
20217760|NCT02997657|Brown University School of Public Health|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
20217761|NCT01322971|Stanford University|Ruth Lathi||rlathi@stanford.edu|
20217762|NCT00892281|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20217763|NCT02129647|NYU Langone|Theodore Nicolaides|212-263-9959|Theodore.Nicolaides@nyualangone.org|
20217764|NCT00608517|Vanderbilt-Ingram Cancer Center|Brian Engelhardt, M.D.|615-936-1803||
20217765|NCT01833533|AbbVie|Global Medical Information|800-633-9110||
20217766|NCT03478865|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
20217767|NCT02502734|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217768|NCT03476317|Children's Hospital of Philadelphia|Lindsey Albenberg, DO|267-426-0139|albenbergl@chop.edu|
20217769|NCT01740791|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20217770|NCT01463982|HanmiPharma|Director of clinical research team|8224109038|jajung@hanmi.co.kr|
20217771|NCT04625062|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
20217772|NCT03417830|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20217773|NCT00467987|State University of NY at Buffalo|Paresh Dandona|17165351852|dandona@buffalo.edu|
20217774|NCT01396382|Vanderbilt-Ingram Cancer Center|Dr. Ronald Walker|615-343-8516|ronald.walker@vanderbilt.edu|
20217775|NCT00941720|CCCC|Dr. Ronald Sobecks|216-444-6833|sobeckr@ccf.org|
20153744|NCT02178956|Sumitomo Dainippon Pharma Oncology|Marilyn Fontaine|617-674-8556|mfontaine@bostonbiomedical.com|
20153745|NCT03323502|Indiana University School of Nursing|Dr. Susan Hickman|317-274-0032|hickman@iu.edu|
20153746|NCT02327078|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20153747|NCT01138735|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20153748|NCT04797169|Icahn School of Medicine at Mount Sinai|Thomas B Hildebrandt, Psy.D.|(212) 659-8673|tom.hildebrandt@mssm.edu|
20153749|NCT02337829|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
20153750|NCT02236364|University of Toledo|Basil Akpunonu, MD|419-383-4909|Basil.Akpunonu@utoledo.edu|
20153751|NCT03839641|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
20164465|NCT01670721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20164466|NCT00141102|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164467|NCT02647723|University of Chicago|Dr. Kate Keenan|773-702-4449|kekeenan@uchicago.edu|
20164468|NCT04894669|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
20198662|NCT03471975|Ajou University School of Medicine|Jihoon Hwang|+821093103304|kironojh@gmail.com|
20153752|NCT04291131|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
20198663|NCT04402970|University of Missouri|Dr. Zach Holliday|5738829072|hollidayz@health.missouri.edu|
20217776|NCT01748955|New York State Psychiatric Institute|Michael F. Grunebaum, MD|6467747573|mgruneb@nyspi.columbia.edu|646
20217777|NCT03827018|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
20217778|NCT01566526|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20198664|NCT03499509|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
20198665|NCT01475175|Medtronic CRDM|AdOpt CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62736
20198666|NCT02437864|University of New Mexico Health Sciences Center (HSC)|Dr. Codruta Soneru|5052722610|csoneru@salud.unm.edu|
20198667|NCT01892163|Moorfields Eye Hospital NHS Foundation Trust|Professor Sobha Sivaprasad|02072533411|sobha.sivaprasad@moorfields.nhs.uk|
20198668|NCT01924182|Medtronic Neuromodulation|Mary Markert Sr Prin Clinical Research Specialist|763-526-8162|mary.a.markert@medtronic.com|
20198669|NCT01080248|Washington University School of Medicine|Joel Picus, M.D.|314-362-5740|jpicus@dom.wustl.edu|
20198670|NCT02822885|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
20198671|NCT00645593|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|(734) 647-8903|mahahuss@umich.edu|
20198672|NCT01585272|Novartis Pharmaceutical|Study Director|862-778-8300||
20198673|NCT03704142|University of Massachusetts Amherst Dept. of Communication Disorders|Dr. Karen Helfer|413-545-4014|khelfer@comdis.umass.edu|
20198674|NCT00993265|Yale University, Child Study Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
20198675|NCT02577146|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
20198676|NCT00219284|Novartis Pharmaceuticals|Study Director|862-778-8300||
20198677|NCT03924752|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
20198678|NCT00361270|Michael E DeBakey VAMC|Wright Williams, Ph.D., ABPP|713-794-7629|wright.williams@va.gov|
20198679|NCT00533442|University of Miami|Dr. George W. Burke, III|305-355-5111|gburke@med.miami.edu|
20198680|NCT02258451|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20198681|NCT01031550|UMDNJ|Yuriy Gubenko, MD|973 972-5007|yuriygubenko@yahoo.com|
20198682|NCT04048616|Tufts University and Tufts Medical Center|Lisa Ceglia, MD MS|(617) 636-8171|lisa.ceglia@tuftsmedicine.org|
20198683|NCT04473690|KBio Inc|Katrina Whelan|2706893345|katrinaw@KBio.com|
20198684|NCT00517751|Medtronic Spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20198685|NCT03021499|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20198686|NCT01210690|UCB|UCB Cares|+1 877 822 9493||
20198687|NCT00495820|Central Arkansas Veterans Healthcare System|Prasad Padala, MD, MS, Associate Director for Clinical Programs, GRECC|5012572537|prasad.padala@va.gov|
20198688|NCT00470054|Wake Forest University|Antonius Miller||aamiller@wfubmc.edu|
20198689|NCT00820950|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
20198690|NCT01878526|Khon Kaen University|Dr.Chingching Foocharoen|6643363746|fching@kku.ac.th|
20198691|NCT00528021|Boston Scientific Corporation|Jessie Stockwell|612-618-1136|jessie.stockwell@bsci.com|
20198692|NCT02122198|University of Colorado Denver|Kerry Hildreth, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20198693|NCT02581202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20198694|NCT04050982|Stanford University|Linda Ottoboni|(650) 498-5914|LOttoboni@stanfordhealthcare.org|
20198695|NCT01246583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198696|NCT05264740|McMaster University|Dr. Laura Anderson|N/a|ln.anderson@mcmaster.ca|
20198697|NCT00609791|City of Hope|Dr. Mina Sedrak|6263598111|msedrak@coh.org|
20153753|NCT04221490|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20153754|NCT03765073|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153755|NCT05850494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20153756|NCT05653843|Boston Scientific|Andrea Burbage, Principal Clinical Trial Manager|7812544679|andrea.burbage@bsci.com|
20153757|NCT04325386|University of Maryland, Baltimore|Dr Deanna L. Kelly, PharmD, BCPP|410-402-6861|dlkelly@som.umaryland.edu|
20153758|NCT00722020|Winthrop University|Jon Roberts, MD|516-663-4600|jroberts@winthrop.org|
20153759|NCT03188822|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
20153760|NCT04537299|Mayo Clinic|Brandon Verdoorn, M.D.|507-266-6201|Verdoorn.Brandon@mayo.edu|
20153761|NCT00957359|NYU Langone Health|Stephen Ross, MD|212-263-7264|Stephen.Ross@nyulangone.org|
20153762|NCT00392041|Princeton University|Lesley Allen, Ph.D.|609-924-9213|lesleyaallen@gmail.com|
20153763|NCT03034967|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20153764|NCT03806296|University of Pittsburgh School of Medicine|Brant Hasler, PhD|412-246-6413|haslerbp@upmc.edu|
20153765|NCT04297917|Vaccitech Plc|Tom Evan, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
20153766|NCT04279483|University of Pennsylvania|Emily Falk|215-573-9901|emilybfalk@falklab.org|
20153767|NCT01998360|University of New England|Peter S. Millard, MD, PhD|2078663503|pmillard@mac.com|
20153768|NCT04613453|Yale University|Brooke Rivera|203-974-2241|Brooke.rivera@yale.edu|
20153769|NCT04800627|UT MD Anderson Cancer Center|Dr. Michael Overman,MD- Assoc VP, CN Research, SVP, Cancer NW Clin & Acad Dev|(713) 792-2828|moverman@mdanderson.org|
20153770|NCT04926233|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20153771|NCT02084797|Oakland University|Tamara Hew-Butler|248-364-8686|hew@oakland.edu|
20153772|NCT02550795|Gil hospital|Dr. Youn Yi Jo|82324603636|endless37@gilhospital.com|
20153773|NCT02802228|Cumberland Pharmaceuticals|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
20153774|NCT05984030|UNC Institute for Global Health and Infectious Diseases|Sarah Rutstein, MD, PhD|919-966-2537|sarah_rutstein@med.unc.edu|
20198698|NCT04218201|NYU Langone Health|Rebecca Stone|646-754-5322|Rebecca.Stone@nyulangone.org|
20153775|NCT00695019|Amarillo Biosciences, Inc.|Martin J. Cummins, Director of Clinical & Regulatory Affairs|806-376-1741|mcummins@amarbio.com|14
20198699|NCT00619255|University of Washington|Doug Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
20153776|NCT02763566|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20153777|NCT04896385|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20198700|NCT02716987|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20198701|NCT02829138|University of Guelph|Dr. David M Mutch|+1-519-824-4120|dmutch@uoguelph.ca|53322
20198702|NCT01765920|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20198703|NCT01081249|University of California, San Diego Medical Center, Department of Psychiatry|Dr. Kai MacDonald|619-203-7393||
20198704|NCT02025907|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
20153778|NCT00562328|Mayo Clinic|Timothy G. Call, M.D.|507-266-4671|Call.Timothy@mayo.edu|
20153779|NCT01925794|CeloNova BioSciences Inc.|Mark Barakat, MD|(210) 489-4004|mbarakat@celonova.com|
20153780|NCT01901562|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
20153781|NCT00790036|Novartis Pharmaceuticals|Study Director|862-778-8300||
20153782|NCT02612155|Duke University|Dr. Kim Fisher, Ph.D., FNP-BC|919-681-4913|kimberley.fisher@duke.edu|
20153783|NCT03197129|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972-2-6776135|fuxavia@gmail.com|
20153784|NCT06026813|UT Southwestern Medical Center|Dr. Peter Crisologo|214/648-7284|Peter.Crisologo@UTSouthwestern.edu|
20153785|NCT05007925|Shockwave Medical|Denise Winn|410-991-9311|dwinn@its.jnj.com|
20153786|NCT02442349|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+441625231825||
20153787|NCT03126110|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20153788|NCT01285518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153789|NCT00580840|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20153790|NCT00208975|Emory University|Dr. Christopher Flowers|404-778-3942|crflowe@emory.edu|
20153791|NCT01910441|Novartis|Study Director|862-778-8200||
20153792|NCT05845619|University of California San Francisco|Pamela Murnane|4155021000|pamela.murnane@ucsf.edu|
20153793|NCT04279522|Neurolief Ltd.|Yaron Gruper, Director of Clinical affairs|+972-544330712|Yaron.Gruper@neurolief.com|
20153794|NCT02629159|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20153795|NCT04383223|Emory University|Dr. Sophia Hussen|404-727-2446|sophia.ahmed.hussen@emory.edu|
20153796|NCT05277207|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
20153797|NCT02401230|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
20153798|NCT00830765|UMississippi|Dr John Morrison|601-984-5300|jmorrison@umc.edu|
20153799|NCT01299909|University of Wisconsin|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
20153800|NCT02774889|University of Wisconsin-Madison|Associate Research Specialist|6082631105|wpalmer3@wisc.edu|
20153801|NCT02525523|Atlantic Pharmaceuticals|Dr Chris Dunk, Director of Clinical Development|+44 1799 513391|chris.dunk@atlantichc.com|
20153802|NCT01349595|Mayo Clinic|Dr. Mark Stegall|507-266-2812|Stegall.Mark@mayo.edu|
20153803|NCT04356833|Royal Free London NHS Foundation Trust|Professor Pratima Chowdary|0207 794 0500|p.chowdary@nhs.net|35921
20153804|NCT04817410|Rutgers New Jersey Medical School|Ethan Cowan|917-447-4964|ethan.cowan@rutgers.edu|
20153805|NCT03166709|Center for Suicide Prevention and Recovery, University of Washington|Dr. Katherine Anne Comtois|206-744-1752|uwcspar@uw.edu|
20153806|NCT00549055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153807|NCT01431976|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153808|NCT00055237|National Cancer Institute, National Institutes of Health|Robert Yarchoan, M.D.|301-496-0328|Robert.Yarchoan@nih.gov|
20153809|NCT00867932|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.||ClinicalTrials@Alexion.com|
20153810|NCT00460798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153811|NCT03589703|Johns Hopkins University|Nada Lukkahatai, PhD, MSN, RN, CNE, FAAN|410-614-5297|nada.lukkahatai@jhu.edu|
20153812|NCT02321527|The University of Texas (UT) MD Anderson Cancer Center|Dr. Basak Dogan/Diagnostic Radiology|713-792-7734|CR_Study_Registration@mdanderson.org|
20153813|NCT02196831|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@mgh.harvard.edu|
20153814|NCT02313155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20153815|NCT01654887|Icahn School of Medicine at Mount Sinai|Dr. James Tsung|212-241-6272|james.tsung@mountsinai.org|
20153816|NCT04666298|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20153817|NCT01532089|Duke University|Thomas E. Stinchcombe, M.D.|507/284-4565|thomas.stinchcombe@duke.edu|
20153818|NCT01995201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20153819|NCT03329001|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20153820|NCT00622518|University of Washington|James A. Taylor, MD|206-616-1206|uncjat@u.washington.edu|
20153821|NCT03149770|University of Minnesota|Anjali Kumar|612-301-7040|studydiabetes@umn.edu|
20153822|NCT00963235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153823|NCT00585182|University of Utah|Dr Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
20153824|NCT01756235|AbbVie|Global Medical Information|800-633-9110||
20153825|NCT05376358|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
20153826|NCT04225832|RAND|Laura Bogart, PhD|3103830411|lbogart@rand.org|7281
20153827|NCT01234116|Henry Ford Health Sytem|Indira Brar, MD|313-916-2565|ibrar1@hfhs.org|
20198705|NCT02017327|Laboratoires Thea|Director of medical operation|+473985089|J.auger@laboratoires-thea.fr|
20153828|NCT03965923|Fred Hutchinson Cancer Center|Daniel Szydlo|2066677451|dszydlo@fredhutch.org|
20153829|NCT02452190|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20153830|NCT04635345|Barts Health NHS Trust|Jessica Gaddie|020 7480 4737|j.gaddie1@nhs.net|
20153831|NCT06001021|University of Gujrat|Dr. Sameera Shafiq (Lecturer, M. Phil, QAU; Ph.D., UOG)|923345116648|sameera.shafiq@uog.edu.pk|
20164469|NCT00866814|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
20164470|NCT00848783|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
20164471|NCT03628976|Georgia Institute of Technology|Dr. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
20164472|NCT01232868|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20164473|NCT04481243|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
20164474|NCT04564846|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
20164475|NCT01342913|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164476|NCT02777021|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
20164477|NCT05482308|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164478|NCT04319198|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20164479|NCT05801991|Southern California College of Optometry|Erin Rueff, OD, PhD (Principal Investigator)|714-463-7586|erueff@ketchum.edu|
20164480|NCT01378988|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20164481|NCT03489863|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
20164482|NCT01893801|Cancer Research and Biostatistics|Adam Rosenthal|(206) 839-1797|adamr@crab.org|
20164483|NCT02995980|University of Alabama at Birmingahm|Rachael Lancaster, MD|205-934-4080|mvetrano@uabmc.edu|
20164484|NCT03714178|Farapulse|Kit Schneider|617-686-7661|kschnieder@farapulse.com|
20164485|NCT01169103|Massachusetts General Hospital|Madhusmita Misra|617-724-5602|mmisra@partners.org|
20164486|NCT02634333|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
20164487|NCT02611479|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
20164488|NCT03936608|The University of Kansas|Amit Noheria|9135889757|amit.noheria@gmail.com|
20164489|NCT01332123|university of pittsburgh|Goeran Fiedler|4126246475|gfiedler@pitt.edu|
20164490|NCT03275740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164491|NCT00890825|AstraZeneca|Tracy Cunningham|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
20164492|NCT04701333|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20164493|NCT02920892|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
20164494|NCT02519023|University of Minnesota|Dr. Jacob Hutchins|6122505535|hutc0079@umn.edu|
20164495|NCT00646646|University of Alabama at Birmingham|Dr. Michael Froelich|205-934-4711|froelich@uab.edu|
20164496|NCT00377520|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20164497|NCT00660192|Yale School of Medicine|Baman,Jabbari M.D. Porfessor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
20164498|NCT04908397|Vanderbilt University Medical Center|Anna R. Hemnes|615-343-8227|anna.r.hemnes@vumc.org|
20164499|NCT00462306|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20164500|NCT03515824|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164501|NCT00920855|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20164502|NCT00539994|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164503|NCT02021942|Klinik und Poliklinik für Neurologie der Universitaet Regensburg|Prof. Dr. Berthold Schalke|+49 941 941|berthold.schalke@medbo.de|3010
20164504|NCT02673918|University of British Columbia|Bolette Rafn|604-827-1914|bolette.rafn@ubc.ca|
20164505|NCT00510835|UPittsburgh|Derek C. Angus, MD, MPH, FRCP|(412) 647-6965|angusdc@ccm.upmc.edu|
20164506|NCT05470985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20164507|NCT01917747|UK Dept. of Otolaryngology Head and Neck Surgery|Dr. Matthew L. Bush|859-218-2168|matthew.bush@uky.edu|
20164508|NCT06451965|University of East Anglia|Ercan Hassan (Trainee Clinical Psychologist)|07496337806|nue22cyu@uea.ac.uk|
20164509|NCT02741245|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164510|NCT02997501|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20164511|NCT01787461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164512|NCT03253679|M D Anderson Cancer Center|Dr. Siqing Fu|713-792-4318|siqingfu@mdanderson.org|
20164513|NCT06098937|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
20164514|NCT04816214|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20164515|NCT02586623|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20164516|NCT04487106|The University of Texas MD Anderson Cancer Center|Nichols Short MD/Associate Professor|713-563-4485|NShort@mdanderson.org|
20164517|NCT04037865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164518|NCT05051579|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20164519|NCT02221869|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20164520|NCT00066677|Fox Chase Cancer Center|Steven J. Cohen|215-728-2450|s_cohen@fccc.edu|
20198706|NCT02411539|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20198707|NCT00713427|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
20198708|NCT01298752|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20198709|NCT01923129|Cedars Sinai Medical Center|Dr. Phillip Fleshner|(310) 289-9224|Phillip.Fleshner@cshs.org|
20164521|NCT04332107|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
20153832|NCT00390013|University of Iowa|Colleen Kennedy Stockdale, MD, MS|319-384-6849|colleen-stockdale@uiowa.edu|
20153833|NCT02225587|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20153834|NCT00924898|The University of North Carolina|Dr. Cynthia Gay|919-843-2726|cynthia_gay@med.unc.edu|
20153835|NCT03116230|Stanford University|Thomas Andriacchi|650-|tandriac@stanford.edu|
20153836|NCT05258721|Arcadia Consumer Healthcare, Inc.|Jai Shewale|504-913-4344|jshewale@arcadiach.com|
20153837|NCT04512924|Medical University of South Carolina|Dr. Brantlee Broome|843-792-3370|broomeb@musc.edu|
20153838|NCT05291689|Morphic Therapeutic Inc.|Head of Clinical Development|781-996-0955|clinicaltrials@morphictx.com|
20153839|NCT01931098|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@nih.gov|
20153840|NCT00230737|University of Pennsylvania|Dr. Nalaka Gooneratne|2674083789|ngoonera@upenn.edu|
20153841|NCT02278354|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20153842|NCT03073759|Johns Hopkins University|Mohammad Khoshnoodi|410-955-5460|mkhoshn1@jhmi.edu|
20153843|NCT01601977|GSTT|Gill Arbane, Clinical trials coordinator|02071888070|gill.arbane@gstt.nhs.uk|
20153844|NCT00314145|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20153845|NCT05495997|Yale School of Medicine|Sule Tinaz|203-737-6158|sule.tinaz@yale.edu|
20153846|NCT02572167|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20153847|NCT00976027|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20153848|NCT04612400|The University of Arkansas for Medical Sciences|Katie Rose Hisrch, Ph.D.|5015265708|krhirsch@uams.edu|
20153849|NCT04435626|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20153850|NCT01160614|Purdue Pharma L.P.|Medical Services|888-726-7535, option 1||
20153851|NCT03805841|Rain Oncology Inc.|Chief Medical Officer|(510) 953-5559|info@rainoncology.com|
20153852|NCT04357795|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
20153853|NCT02382380|Loyola University Medical Center|Ari Goldberg, M.D.|708-216-2229|argoldberg@lumc.edu|
20153854|NCT01295944|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
20153855|NCT01802281|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
20153856|NCT00831844|Children's Oncology Group|Results Reporting Coordinator|626-241-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
20153857|NCT00315445|Purdue Pharma L.P.|Medical Director|800-733-1333||
20153858|NCT02530541|BSL|C. Beausoleil|406-587-5735|cbeausoleil@biosciencelabs.com|
20153859|NCT02353780|University of Pittsburgh|Larry Moreland, MD|412-648-4098|lwm5@pitt.edu|
20153860|NCT00858988|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454-2178|manary@kids.wustl.edu|
20153861|NCT01706328|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153862|NCT04409002|Massachusetts General Hospital|Theodore Hong, MD|617-726-6050|TSHONG1@mgh.harvard.edu|
20153863|NCT02924376|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20153864|NCT06481579|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20153865|NCT03595748|Albert Einstein College of Medicine|Dr. Ladan Golestaneh|718-920-5442|lgolesta@montefiore.org|
20153866|NCT04809974|Massachusetts General Hospital|Edmarie Guzmán-Vélez|6176436107|eguzman-velez@mgh.harvard.edu|
20153867|NCT01120197|Faculty of Health Sciences, Oslo University College, Oslo, Norway|Professor, Ph. D, Researcher. Astrid Bergland.|+4722452507|astrid.bergland@hf.hio.no|
20153868|NCT04070703|Oregon Research Institute|Fuzhong Li|5414842123|fuzhongl@ori.org|
20153869|NCT03481049|Washington State University|Michael G. McDonell|509-368-6967|mmcdonell@wsu.edu|
20153870|NCT00770809|University of North Carolina - Lineberger Comprehensive Cancer Center|Lisa Carey, M.D.||lisa_carey@med.unc.edu|
20153871|NCT01080261|Boston Scientific Corporation|Ruth Starzyk, Ph.D.|508-683-6577|ruth.starzyk@bsci.com|
20153872|NCT01787838|Carilion Clinic|Rebecca Culver Clark|540-588-8184|rcclark@carilionclinic.org|
20153873|NCT01240746|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20153874|NCT04601506|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
20153875|NCT01126424|Astellas Pharma Europe Ltd.|Associate Medical Director Urology||clinicaltrials@us.astellas.com|
20153876|NCT02127671|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20153877|NCT00248560|Barbara Ann Karmanos Cancer Institute|Ammar Sukari, M.D.|313-576-8751|sukaria@karmanos.org|
20153878|NCT03834168|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|2059754720|parora@uabmc.edu|
20153879|NCT00764517|Knight Cancer Institute, Oregon Health & Science University|Dr. Stephen E. Spurgeon MD|503-494-4606|spurgeos@ohsu.edu|
20153880|NCT00520468|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
20153881|NCT01433913|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
20153882|NCT04706221|Zynex Monitoring Solutions|Donald Gregg|(800) 495-6670|dgregg@zynex.com|3802
20153883|NCT02239328|Washington University|Dr. Benjamin Kozower|314-362-8089|kozower@wustl.edu|
20153884|NCT00350220|University of Rochester Medical Center|Jill M. Cholette MD|585-275-0189|Jill_Cholette@urmc.rochester.edu|
20153885|NCT04115059|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
20153886|NCT03755076|Albert Einstein Healthcare Network|Dr. Shailesh Kantak|562-385-7111|skantak@ranchoresearch.org|
20153887|NCT01088789|SKCCC Johns Hopkins Medical Institution|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
20153888|NCT03517137|EORTC|Catherine Fortpied|+32 2 774 1681|catherine.fortpied@eortc.org|
20153889|NCT03575364|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
20153890|NCT01866592|University of Pennsylvania|Suzette Baez VanderBeek, MPH|2156623514|suzette.baezvanderbeek@uphs.upenn.edu|
20198710|NCT01664559|BWH|Dr. Lynn Ngo, Lead Study Coordinator/investigator|(617)732-8798|llngo@partners.org|
20153891|NCT05522751|University of California San Francisco|Khaled Moussawi|415-502-6343|khaled.moussawi@ucsf.edu|
20153892|NCT06420232|University of Texas Medical Branch, Galveston|Heather Celkis, OTR, PPOTD|409-|hdcelkis@UTMB.EDU|
20153893|NCT01325441|Sumitomo Pharma Oncology|Tegan Nguyen|6176748745|tegan.nguyen@oncology.sumitomo-pharma.com|
20153894|NCT01582451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20153895|NCT01369433|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20153896|NCT01838876|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20153897|NCT00689936|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20153898|NCT01682031|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20153899|NCT01932606|Mayo Clinic|Dr. Barry A. Borlaug|507-284-6704|Borlaug.Barry@mayo.edu|
20153900|NCT06525727|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
20153901|NCT00933933|Abbott Diagnostic Division|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
20153902|NCT01341470|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20153903|NCT04057235|Integrity Implants Inc|Lauren Kamer, Senior Director of Regulatory and Clinical Affairs|+1.561.529.3861|lkamer@integrityimplants.com|
20153904|NCT03225482|VA San Diego Healthcare System|Elizabeth Twamley, PhD|858-642-3848|Elizabeth.Twamley@va.gov|
20153905|NCT00311168|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
20153906|NCT05658887|University of Iowa Hospitals and Clinics|Dr. Colin Johnson|3193561616|colin-johnson@uiowa.edu|
20153907|NCT06001866|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
20153908|NCT04341636|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
20153909|NCT03112603|Call Center|Incyte Corporation|1.855.463.3463|medinfo@incyte.com|
20153910|NCT00207740|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
20153911|NCT03916926|Case Western Reserve University|Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
20153912|NCT04725188|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20153913|NCT02879695|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20153914|NCT04235374|University of Maryland|Barbara Resnick|410 706 5178|resnick@umaryland.edu|
20153915|NCT04426656|University of North Carolina at Chapel Hill|Chunyan Li, MSc|919-966-6695|chunyli@live.unc.edu|
20153916|NCT03837704|Philip Morris Products S.A.|Global Head Clinical Development & Operations|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20153917|NCT06181799|I.M. Sechenov First Moscow State Medical University (Sechenov University)|Basheer Abdullah Marzoog|+7(996) 960 28 20|marzug@mail.ru|
20153918|NCT01771107|Emmes Company|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
20153919|NCT00619528|Northwestern University|Joseph Leventhal MD, PhD|312-695-0427|jleventh@nm.org|
20153920|NCT02296125|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
20153921|NCT05248386|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|000
20153922|NCT02864992|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20153923|NCT03621592|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
20153924|NCT05807477|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
20153925|NCT04967222|Icahn School of Medicine at Mount Sinai|Dr. Harold W Koenigsberg|(718) 584-9000|harold.koenigsberg@mssm.edu|
20153926|NCT01149083|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20153927|NCT03785366|Sebela Women's Health|Elizabeth Gray|760.593.8383|Elizabeth.Gray@sebelapharma.com|
20153928|NCT02783274|Johnson & Johnson MedTech|Kirstin Cosgrove|+1 574 4049398|kcosgro1@its.jnj.com|
20153929|NCT02213003|Diabetes Research Institute/University of Miami|Rodolfo Alejandro, MD|305-243-3389|Ralejand@med.miami.edu|
20153930|NCT06354257|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20153931|NCT02685735|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
20153932|NCT04132050|Kissei Pharmaceutical Co., Ltd.|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
20153933|NCT04812015|Wayne State University|Danielle Taylor, PhD|6166486793|dtaylo@med.wayne.edu|
20153934|NCT04133909|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20153935|NCT01063114|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
20153936|NCT04635423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20153937|NCT04431960|University of Connecticut|Ock K. Chun|18604866275|ock.chun@uconn.edu|
20153938|NCT01811238|Samsung Medical Center|Dr.Sungsoo Chung|82-3410-1226|ssc0385@skku.edu|
20153939|NCT02517658|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
20153940|NCT02916927|Alameda Health Systemt - Highland Hospital|Dr. Andrew Herring|(510) 437-4564|aherring@alamedahealthsystem.org|
20153941|NCT05759338|Wake Forest University Health Sciences|Amy McMichael|704-355-2000|Amy.Mcmichael@Advocatehealth.org|
20153942|NCT01471639|Cleveland Clinic Healthcare System|Sharon Mace MD|216-445-4598|maces@ccf.org|
20153943|NCT04835441|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20153944|NCT05253807|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20153945|NCT02293499|University of Rochester School of Nursing|Hyekyun Rhee PhD, RN, FAAN|585-276-3775|Hyekyun_Rhee@urmc.rochester.edu|
20153946|NCT00690898|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20153947|NCT05977868|West Virginia University|Dr. Joy J. Juskowich|304-293-3306|jjuskowi@hsc.wvu.edu|3
20153948|NCT04385888|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
20153949|NCT00255177|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
20153950|NCT00620542|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20153951|NCT01970371|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
20198711|NCT06290206|University of Utah|Kaila Christini, MsPH, MS|801-587-4565|Kaila.Christini@hci.utah.edu|
20198712|NCT03631732|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20198713|NCT00886600|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20198714|NCT01251367|Ipsen|Medical Director, Neurology,||clinical.trials@ipsen.com|
20198715|NCT02255409|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
20198716|NCT00047060|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
20198717|NCT02189213|RFMH|Amir Levine|646 481 2566|amir.levine@nyspi.columbia.edu|
20198718|NCT03775421|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20198719|NCT02016820|Columbia University|Daniel E. Freedberg, MD, MS||def2004@cumc.columbia.edu|
20198720|NCT00473343|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20198721|NCT02008682|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20198722|NCT02290873|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
20198723|NCT02370615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20198724|NCT02431572|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
20198725|NCT02287623|University of Minnesota|Dr. Jacob Hutchins|612-624-9990|hutc0079@umn.edu|
20198726|NCT02700997|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
20198727|NCT02512224|The University of Tokyo Hospital|Dr. Sumito Ogawa|+81-3-5800-8830|suogawa-tky@umin.ac.jp|
20198728|NCT01441570|Brigham and Women's Hospital|Dr. Steven Gabardi|617-732-7658|sgabardi@partners.org|
20198729|NCT00506883|AR Scientific, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20198730|NCT02870309|Grifols Therapeutics LLC|Susan Sorrells|919-316-6582|susan.sorrells@grifols.com|
20198731|NCT01473563|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198732|NCT03610724|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20198733|NCT00786565|Bausch & Lomb|Jon Hayashida|(585) 338-6370|jon.hayashida@bausch.com|
20198734|NCT01699542|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
20198735|NCT02943564|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20198736|NCT04143009|University of North Carolina at Chapel Hill|Brian Wells Pence, PhD|+1 919-966-7446|bpence@unc.edu|
20198737|NCT03765138|Columbia University Medical Center/New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|Yuval.Neria@nyspi.columbia.edu|
20198738|NCT01445821|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20198739|NCT02351505|The Ohio State University Comprehensive Cancer Center|Erin Bertino, MD|614-293-8054|Erin.Bertino@osumc.edu|
20198740|NCT04013529|Corporal Michael J. Crescenz VA Medical Center|Manik Chhabra|(215) 823-5800|manik.chhabra@va.gov|
20198741|NCT03116698|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759910|srinivassidgiddi@drreddys.com|
20198742|NCT00788372|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20198743|NCT05815719|Instituto Bernabeu|Juan Carlos Castillo|+34965154000|jcastillo@institutobernabeu.com|
20198744|NCT02116777|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20198745|NCT01733628|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20198746|NCT05472012|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
20198747|NCT01423851|NS Pharma, Inc.|Medical Affairs|201-986-3860|trialinfo@nspharma.com|+1
20198748|NCT02901925|Dartmouth-Hitchcock|Dr. David Roberts|603-650-|David.W.Roberts@dartmouth.edu|
20153952|NCT01481779|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20153953|NCT02145676|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20153954|NCT06540170|National Healthcare Group Polyclinics|Senior Wound Nurse Clinician|64966611|julia_zhu@nhgp.com.sg|
20153955|NCT03318341|MUSC|Na Jin Seo, PhD|8437920084|seon@musc.edu|
20153956|NCT00487188|Hoffman-LaRoche|Medical Communications|800-821-8590||
20153957|NCT04882800|Sonova US|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
20153958|NCT05696847|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20153959|NCT00820534|Novartis Consumer Health|Head of Clinical Research|+4122363311||
20153960|NCT03330197|Alaunos Therapeutics|Jaymes Holland|650 273-2627|jholland@alaunos.com|
20153961|NCT01014091|GlaxoSmithKline|GSK Response Center|866-435-7343||
20153962|NCT01139879|Wolcott and Associates|Randy Wolcott|806-793-8869|lisa@randallwolcott.com|
20198749|NCT00733954|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20153963|NCT03240874|Northwestern University|Lynn Yee, MD, MPH|312-472-4685|lynn.yee@northwestern.edu|
20153964|NCT05252702|Abbott Medical Devices, Cardiac Rhythm Management|Nicole Harbert, Director of Clinical Research|972-526-4841|nicole.harbert@abbott.com|
20153965|NCT04153864|Sinai Health System (Canada)|Dr. Daisy R Singla|416-535-8501|daisy.singla@utoronto.ca|39423
20153966|NCT03834688|Dana-Farber Cancer Institute|Opeyemi Jegede, Statistician|(617) 582-7613|ojegede@ds.dfci.harvard.edu|
20198750|NCT02663453|Thammasat University|Dr.Wilaiporn Techasatid|66890339442|wilaiporn66@gmail.com|
20153967|NCT03036254|Icahn School of Medicine at Mount Sinai|Dr. Mary Sano|(212) 659-8838|mary.sano@mssm.edu|
20198751|NCT03416153|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20153968|NCT00278408|Saarland University Medical School|Dr. Viola Poeschel|+4968411615014|dshnhl@uks.eu|
20198752|NCT04138017|University of Virginia|Eric McVey, Clinical Research Coordinator|434.243.5382|eric.mcvey@uvahealth.org|
20198753|NCT01292642|McLean Hospital|Kevin P Hill, MD, MHS|617-855-4501|khill@mclean.harvard.edu|
20198754|NCT04649255|Sirtex Medical|Janet Bell|+ 888-474-7839|jbell@sirtex.com|
20198755|NCT02484911|First Affiliated Hospital of Harbin Medical University|Dr.Zhang|85555068|daxinmay@126.com|
20198756|NCT04129528|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20198757|NCT00218491|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
20198758|NCT00605423|Johns Hopkins University|Peter Campochiaro, M.D.||pcampo@jhmi.edu|
20198759|NCT01682135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198760|NCT00490568|GlaxoSmithKline|GSK Response Center|866-435-7343||
20198761|NCT01395394|Emory University|Kathryn Coakley|404-778-1286|kcoakle@emory.edu|
20198762|NCT01066364|UCSD|Rohit Loomba, MD|858-246-2201|roloomba@ucsd.edu|
20198763|NCT05121480|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
20198764|NCT00105443|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20153969|NCT03033355|houston methodist Hospital|Dr. Rose Khavari|713-363-9154|rkhavari@houstonmethodist.org|
20198765|NCT01157078|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20198766|NCT00772954|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20198767|NCT01093027|Mayo Clinic|Virgilio Evidente MD|480-301-8000|evidente.virgilio@mayo.edu|
20198768|NCT00665457|University of Nebraska Medical Center|Elizabeth Reed, M.D.|402-559-5388|ereed@unmc.edu|
20198769|NCT03402607|Duke University Health System|Linda Kaltenbach|919-681-6804|Linda.Kaltenbach@duke.edu|
20198770|NCT00789529|Manhattan Vision Associates / Institute for Vision Research|Dr. George Zikos|2126884277|gzikos@mvaivr.com|
20198771|NCT01135498|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20198772|NCT00129766|MedImmune|M. Pamela Griffin, Sr. Director, Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
20198773|NCT02181829|Memorial Sloan Kettering Cancer Center|Suzanne Wolden, MD|212-639-5148|woldens@MSKCC.ORG|
20198774|NCT01081912|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
20198775|NCT00556452|University of Michigan Cancer Center|Dr. John Magenau|734/936-8785|johnmage@umich.edu|
20198776|NCT03077347|University of CA Davis Health|Tiffany T . Norris|916-703-9193|ttnorris@ucdavis.edu|
20153970|NCT05965427|Research Organization (KC) Ltd|MASH1 Clinical Project Manager|+44 (0) 7494 795 982|mash1@rokcservices.com|
20153971|NCT03133156|Joslin Diabetes Center|Laura Simpson|617-735-3924|laura.simpson@joslin.harvard.edu|
20153972|NCT05748626|Northwestern University|Paul C. Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
20153973|NCT05020743|Vigil Neuro|VP, Clinical & Medical Sciences|+18572280538|jchavez@vigilneuro.com|
20153974|NCT03488524|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
20153975|NCT02390284|University of Miami|Dr. Vittorio Porciatti|3053266050|vporciatti@med.miami.edu|
20153976|NCT03980223|University of California, San Francisco|Anne Luetkemeyer|415-502-5753|annie.luetkemeyer@ucsf.edu|
20153977|NCT00434434|Genentech, Inc.|Medical Communications|800-821-8590||
20153978|NCT01922934|Denver Health|Dr. Daniel H. Bessesen|303-602-5021|daniel.bessesen@ucdenver.edu|
20153979|NCT02290184|University of California San Francisco|Melinda Sarmiento Bender, PhD, RN|415 502 5668|melinda.bender@ucsf.edu|
20153980|NCT02354118|TriHealth|Rachel Baker, Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20153981|NCT01069939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20153982|NCT00724945|Vistakon|Thomas Karkkainen OD|904-443-3402|tkarkkai@its.jnj.com|
20153983|NCT05166876|Clear Creek Bio, Inc.|Vikram Sheel Kumar|(617) 765-2252|kumar@clearcreekbio.com|
20153984|NCT00658528|Eisai Call Center|Eisai Inc.|888-422-4743||
20153985|NCT02402062|MFAR Clinical Research|Federico Nepote|0034934344412|investigacion@mfar.net|102
20153986|NCT01147458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20153987|NCT01034553|Mayo Clinic|Alexander Keith Stewart, M.B.CH.B|(480)301-4411|stewart.keith@mayo.edu|
20153988|NCT01017250|Duke University Radiation Oncology|John Kirkpatrick, MD, PhD|919 668-7342|robert.clough@dm.duke.edu|
20153989|NCT00832975|Hospital Clínico Universitario Puerta de Hierro|Dr Ignacio Fernández Lozano|913445000|iflozano@secardiologia.es|
20153990|NCT04685811|Weill Cornell Medical College|Dr. Juana Martinez Zuloaga|212-746-6000|jum4005@med.cornell.edu|
20153991|NCT01270659|University of Oklahoma Health Sciences Center Tulsa|Dr. Nasir Mushtaw|918/660-3680|Nasir-Mushtaq@ouhsc.edu|
20153992|NCT03160170|University of Miami Miller School of Medicine|Ian Cote|305-256-4492|Icote@med.miami.edu|
20153993|NCT02811159|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20153994|NCT01859091|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
20153995|NCT04603066|Washington University in St Louis|Simon Haroutounian|3132861715|sharout@wustl.edu|
20153996|NCT06717399|Saint Joseph's University|Nabila Enam|2155967348|nenam@sju.edu|
20153997|NCT01092923|Austin Health|Dr Phil Peyton|9496 5000|phil.peyton@austinhealth.org.au|5704
20153998|NCT01089595|Fox Chase Cancer Center|Margaret von Mehren, Principal Investigator|215-728-4300|margaret.vonmehren@fccc.edu|
20153999|NCT01692015|Imperial College London|professor Claire Shovlin|+44 (0)20 7589 5111|c.shovlin@imperial.ac.uk|
20154000|NCT00177671|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
20154001|NCT05370326|Yale School of Medicine|Melissa B. Weimer, DO, MCR, DFASAM|(203) 859-2962|melissa.weimer@yale.edu|
20198777|NCT02770547|Purdue University|Bruno Roseguini, Assistant Professor|(765) 496-2612|brosegui@purdue.edu|
20154002|NCT02880176|Fox Chase Cancer Center|Dr. Marshall Strother|555-555-5555|m12912988@gmail.com|
20154003|NCT01991314|Barts Health NHS Trust|Prof David Rampton|+442035943500|d.rampton@qmul.ac.uk|7885
20198778|NCT05396742|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20198779|NCT01324232|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
20198780|NCT05440539|Houston Methodist Hospital|Dr. Emily Rutledge|713-441-5800|erut@me.com|
20154004|NCT01136954|Eisai Call Center|Eisai Inc.|888-422-4743||
20154005|NCT03317496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154006|NCT01035788|Department of Veterans Affairs|Dr. Louanne Davis|317-988-4523|louanne.davis@va.gov|
20154007|NCT00410488|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
20154008|NCT03841513|TMC|Dr Tsung Mou|6176365890|tmou@tuftsmedicalcenter.org|
20154009|NCT03071744|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
20154010|NCT01988415|Abbott Medical Optics|Janice Tarrant|408-273-4163|janice.tarrant@abbott.com|
20154011|NCT00704353|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
20154012|NCT02034591|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20154013|NCT00817063|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154014|NCT01496456|UMichigan|Dr. Mathilde C Peters||mcpete@umich.edu|
20154015|NCT02199496|NIAID - LCIM|Fuss, Ivan|+1 301 496 9663|ifuss@niaid.nih.gov|
20154016|NCT01697579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154017|NCT03093844|University of Colorado|Dr. Jonathan Gutman|303-724-9562|JONATHAN.GUTMAN@CUANSCHUTZ.EDU|
20154018|NCT04092777|Massachusetts General Hospital|Dr. Margarita Alegria|617-724-1237|malegria@mgh.harvard.edu|
20154019|NCT05219552|University of California School of Nursing|Dr. Emily Tuthill|2078411983|emily.g.tuthill@gmail.com|
20154020|NCT00876343|Otsuka Pharmaceutical Co., Ld.|Director of Clinical Research and Development|+81-3-6361-7366||
20154021|NCT00848185|IVI Madrid|Dra Cerrillo|911802900|maria.cerrillo@ivi.es|
20154022|NCT00088153|Massachusetts General Hospital|Anne Klibanski|617-726-3870|aklibanski@partners.org|
20154023|NCT00261040|The Ottawa Hospital - Ottawa Hospital Research Institute|Dr Paul Kim|613-737-8920|pkim@toh.ca|
20154024|NCT02595892|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos, MD, PhD|617-632-5269|panagiotis_konstantinopoulos@dfci.harvard.edu|
20154025|NCT06442800|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-445-1310|mghall@unc.edu|
20154026|NCT00373672|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
20154027|NCT04717557|Duke University|Dr. Richard Moon|919-684-8762|richard.moon@duke.edu|9199065651
20154028|NCT05484778|IstanbulU|Aysen Elif YILMAZ|+905059466301|aysen.elif4@gmail.com|
20154029|NCT03168672|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
20154030|NCT02246777|Alcon, A Novartis Division|Associate, Medical Group 1, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
20154031|NCT01470170|Department of Thoracic Medicine|Dr. Yu-Lun, Lo|+886-3-3281200|loyulun@hotmail.com|5108
20154032|NCT00927472|Taro Pharmaceuticals U.S.A.,|Director, Clinical Research|914-345-9001|Natalie.Yantovskiy@Taro.com|
20154033|NCT00433537|ECOG Statistical Office|Study Statistician|617-632-3012||
20154034|NCT05436613|University of East Lonson|Professor Cynthia Fu|020 8223 4119|c.fu@uel.ac.uk|
20154035|NCT03771716|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
20154036|NCT05317546|Medical University of South Carolina|Dr. Lindsay Squeglia|843-792-5454|squegli@musc.edu|
20154037|NCT03331250|Massachusetts General Hospital|Gregory Cote, MD, PhD|617-726-8748|GCOTE@mgh.harvard.edu|
20154038|NCT04590963|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20154039|NCT05350202|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154040|NCT04115098|The University of Texas Health Science Center at Houston|Mark C. Hwang, MD|(713) 500-6597|Mark.C.Hwang@uth.tmc.edu|
20154041|NCT05556057|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.Korupolu@uth.tmc.edu|
20154042|NCT01525589|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
20154043|NCT04611126|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
20154045|NCT03421561|Philips|Nicolas Aguirre|612-297-6655|nicolas.aguirre@philips.com|
20154046|NCT00639093|GRAP, Clinique de Psychologie au Travail|Benoît Girard|418-542-2030|g.r.a.p@videotron.ca|
20154047|NCT00143507|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
20154048|NCT00876395|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20154049|NCT04919161|Gaylord Hospital Inc.|Dr. Henry C. Hrdlicka, Research Coordinator|203-284-2864|hhrdlicka@gaylord.org|
20154050|NCT02489773|Asahi Kasei Pharma Corporation|Takuji Kohzuma PhD|+81-3-3296-3617|kouzuma.tb@om.asahi-kasei.co.jp|
20154051|NCT00712920|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
20154052|NCT00584285|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
20154053|NCT02362451|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
20154054|NCT02887586|Clinical Cancer Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences|Hebin|13520253895|hebinbj68@163.com|
20154055|NCT02696616|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154056|NCT00884065|Catalan Institut of Health - Servei de Rhb Sant Ildefons|Martín Eusebio Barra López||martinbarra@gmail.com|
20154057|NCT01732783|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20154058|NCT01500083|Lundbeck Canada Inc.|Lundbeck Canada Inc.|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
20154059|NCT01555931|University of North Carolina School of Medicine|Dr. Gretchen Stuart|919-962-4880|gstuart@med.unc.edu|
20154060|NCT01063907|Kyowa Hakko Kirin Pharma, Inc.|Senior VP Drug Development|609-919-1100|clinical.info@kyowa-kirin-pharma.com|
20198781|NCT00393887|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
20154061|NCT03600428|Vanderbilt University Medical Center|C. Buddy Creech, MD, MPH|6153430332|buddy.creech@vumc.org|
20198782|NCT01732796|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198783|NCT00354770|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
20198784|NCT02324920|BIOTRONIK Italiy|Daniele Giacopelli|+39 3491712305|daniele.giacopelli@biotronik.com|
20198785|NCT01967628|University of Iowa|Dr. Alicia Gerke|319-356-1869|alicia-gerke@uiowa.edu|
20198786|NCT00838331|Emory University|John Roback, MD PhD|404-712-1774|jroback@emory.edu|
20198787|NCT01379274|Rush University Medical Center|Dr. Jamile Shammo|312-CANCER-1|jamile_shammo@rush.edu|
20198788|NCT01224626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198789|NCT02055820|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20198790|NCT05074251|UCLA|Dr. Dvora Joseph Davey|310-701-1526|dvoradavey@ucla.edu|
20198791|NCT00930761|Instituto de Puericultura e Pediatria Martagão Gesteira - UFRJ|Dr. Arnaldo Prata Barbosa|+55 21 25904891|arnaldoprata@globo.com|
20198792|NCT00631020|UCLA Center for Health Promotion and Disease Prevention|Dr. Steven Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|225
20198793|NCT01468584|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20198794|NCT03571646|Medtronic|Geraldine Kelly|+353 879840223|geraldine.kelly@medtronic.com|
20198795|NCT03548935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20198796|NCT01970995|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20198797|NCT00734799|Durham VAMC|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
20198798|NCT00845728|Novartis Pharmaceuticals|Study Director|862-778-8300||
20198799|NCT01157364|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20198800|NCT01780662|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20198801|NCT01263639|Vanderbilt Medical Center|Dr. Brent J. Morris Orthopaedic Resident|615-835-0699|brent.j.morris@vanderbilt.edu|
20198802|NCT01576549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198803|NCT02370875|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
20198804|NCT04081363|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20198805|NCT00586495|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20198806|NCT01707043|Wake Forest|Steve Feldman, MD|336-716-3775|sfeldman@wakehalth.edu|
20198807|NCT03099187|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20198808|NCT02958007|VA Maryland Healthcare System|Anjana Muralidharan|443-421-6275|anjana.muralidharan2@va.gov|
20198809|NCT02899689|UTMB|Antonio F Saad|4097720982|afsaad@utmb.edu|
20198810|NCT00359138|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20198811|NCT03187769|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
20154062|NCT03802110|Boston Scientific Cardiac Rhythm Management|Stephen J. Hahn, PhD|1-800-227-3422|stephen.hahn@bsci.com|
20198812|NCT01611974|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20198813|NCT00001379|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
20198814|NCT05525533|University of California, San Francisco|Jenny Liu|6503800762|jenny.liu2@ucsf.edu|
20198815|NCT05626270|Erchonia Corporation|Travis Sammons|864-531-0064|tsammons@erchonia.com|
20198816|NCT03703102|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
20198817|NCT00876187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198818|NCT00405067|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
20198819|NCT03287219|Cosmo Technologies Ltd|R&D Manager||rjones@cosmopharma.com|
20154063|NCT04803279|Oticon Medical|Nicole Amichetti, PhD, MS, Manager of Clinical Affairs|6093660424|nitc@oticonmedical.com|
20154064|NCT01044498|Hoffmann-La Roche|Medical Communications|800 821-8590||
20154065|NCT05513950|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20154066|NCT02903914|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
20154067|NCT04443452|University of Nottingham|Professor Ana Valdes|0115823114|ana.valdes@nottingham.ac.uk|
20154068|NCT01963234|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
20154069|NCT04225039|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20154070|NCT02320175|Boston Children's Hospital|Isabella Liss, Patient and Family Centered I-PASS SCORE Study Coordinator|857-218-3229|isabella.liss@childrens.harvard.edu|
20154071|NCT02242630|Keesler Medical Center|Matthew B. Carroll|228-376-3629|matthew.carroll.1@us.af.mil|
20154072|NCT00975923|Vanderbilt University School of Medicine|Dr. Theodore Speroff|615-636-9476|ted.speroff@vanderbilt.edu|
20154073|NCT01670006|Cochlear|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
20154074|NCT00005047|University of Southern California|Dr. Susan Groshen|323-865-0375|Susan.Groshen@med.usc.edu|
20198820|NCT00957008|University of South Carolina|Project director|8037773881|msui@mailbox.sc.edu|
20198821|NCT00811135|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20198822|NCT01118351|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
20198823|NCT02797808|University of Minnesota|Dr. Gail Bernstein|612-625-1632|berns001@umn.edu|
20198824|NCT00822757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198825|NCT00708500|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20198826|NCT00595556|UCHC|Albert J. Arias, M.D.|8606794423|alarias@uchc.edu|4423
20198827|NCT03975920|The Restful Jaw Company, LLC|Dr. Eric Schiffman|(651)338-3344|schif001@umn.edu|
20198828|NCT00371293|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
20217779|NCT00268892|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20198829|NCT02798536|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
20198830|NCT02182687|Lahey Hospital & Medical Center|Julia Roache|781-744-3055|julia.roache@lahey.org|
20198831|NCT02788097|Antalya IVF|Kevin Coetzee|090 242 345 4700|kevincoetzee61@yahoo.co.nz|
20198832|NCT02631525|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
20198833|NCT00794677|Children's Hospital Oakland Research Institute|Ronald M Krauss|510.450.7912|rkrauss@chori.org|
20198834|NCT03882970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20198835|NCT03831971|Clinical Center|Masur, Henry|+1 301 496 9320|hmasur@cc.nih.gov|
20198836|NCT05284760|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20198837|NCT02863809|Massachusetts Eye and Ear|Odeta Dyrmishi & Joseph Ciolino|7742745014|Odeta_Dyrmishi@meei.harvard.edu; Joseph_Ciolino@meei.harvard.edu|
20198838|NCT00607386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20198839|NCT01991990|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20198840|NCT03292809|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
20198841|NCT01439204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20198842|NCT00336973|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20198843|NCT02445807|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
20198844|NCT01227044|Yale School of Medicine|Dr. Lynn Fiellin|203-737-3347|lynn.fiellin@yale.edu|
20198845|NCT04247061|Boston University|Director of Center for Behavioral Science Research|6173583358|belindab@bu.edu|
20198846|NCT00768521|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20198847|NCT01997411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198848|NCT00205855|Boston Scientific Corporation|Natalie Bloom Lyons|763-228-9040|lyonsn@bsci.com|
20198849|NCT05513625|AiCuris Anti-infective Cures AG|Information Desk|+4920231763|info@aicuris.com|0
20198850|NCT00063570|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20198851|NCT02461550|Memorial Sloan Kettering Cancer Center|Dr. Stephen Solomon|212-639-5012|solomons@mskcc.org|
20198852|NCT01073267|University of Texas (UT) MD Anderson Cancer Center|Bouthaina Dabaja, MD/Associate Professor, Radiation Oncology Department||CR_Study_Registration@mdanderson.org|
20198853|NCT04341441|Henry Ford Health System|John McKinnon, MD, MSc|313-916-8828|jmckinn3@hfhs.org|
20198854|NCT00917150|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20198855|NCT02039375|Johns Hopkins University School of Medicine|Victor C. Urrutia, MD|4109552228|vurruti1@jhmi.edu|
20198856|NCT03891264|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@partners.org|
20198857|NCT01505634|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198858|NCT01916928|Medstar Washington Hospital Center|Cecily A. Clark-Ganheart|202-877-3067|ganheartmd@gmail.com|
20198859|NCT03817775|• Department of Anaesthesia and Intensive Care, American Hospital of Paris|Dr Gilles BOCCARA|+33 1 46 41 25 25|gilles.boccara@ahparis.org|
20198860|NCT01624662|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
20198861|NCT01027819|Seoul National University Hospital|Dr. Dongwook Kim|821067395311|daljookim@gmail.com|
20198862|NCT01714687|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
20198863|NCT02572752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198864|NCT03921021|Weill Cornell Medicine|Manish Shah, MD|(646) 962-6200|mas9313@med.cornell.edu|
20198865|NCT01439555|UMass Medical School|Elizabeth DeGrush, DO|508-334-1000|elizabeth.degrush@umassmemorial.org|
20198866|NCT03310450|Universitas Negeri Semarang|Mahalul Azam|+628122853982|mahalul.azam@mail.unnes.ac.id|
20198867|NCT04869345|Cornell University|Dr. Anthony Ong|6072559993|anthony.ong@cornell.edu|
20198868|NCT00868348|Aarhus University Hospital|Karen V Andersen|51263173|karenand@rm.dk|0045
20198869|NCT01500759|ResMed Germany Inc|Medical Affairs CRS|089990100|ClinicalResearch&Strategy@ResMed.com|
20198870|NCT00396201|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20198871|NCT00616122|University of California, San Francisco|Hope S. Rugo|877-827-3222|clinicaltrials@ucsf.edu|
20198872|NCT04867473|Stanford University|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
20198873|NCT01143727|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
20198874|NCT01076049|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
20198875|NCT05054114|SPP Pharmaclon Ltd.|Julia Isakova|81079055353311|isakova@pharmaclon.ru|
20198876|NCT01806779|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
20154075|NCT03884374|University of Florida|Eric Weber|352-273-7802|ebweber@ufl.edu|
20154076|NCT05423756|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
20154077|NCT05708924|Masonic Cancer Center|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
20154078|NCT06455111|Boston University School of Medicine Endocrinology, Diabetes, Nutrition & Weight Management|Nicole L Spartano, PhD|315-415-2040|spartano@bu.edu|
20154079|NCT02141113|Rochester Center for Behavioral Medicine|Joel L. Young, MD|2486088800|jyoung@rcbm.net|
20154080|NCT00357565|Masonic Cancer Center|Christen Ebens, MD, MPH|(612) 626-2961|ebens012@umn.edu|
20154081|NCT07021443|UZ Brussel|Prof. dr. Hendrik Reynaert|+32 2 477 68 11|hendrik.reynaert@uzbrussel.be|
20154082|NCT04262219|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20154083|NCT03069989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20198877|NCT02595450|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20198878|NCT00199914|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|Manee Rattanachaiyanont|+66-2419-4657|manee.rat@mahidol.ac.th|
20198879|NCT01934556|Palmetto Retina Center, LLC|John F. Payne, MD|(803) 931-0077|jpayne@palmettoretina.com|
20154084|NCT02145390|University of Miami|Adrian Ishkanian MD|305-243-4200|aishkanian@miami.edu|
20198880|NCT02813551|The University of Texas Health Science Center at Houston|Oscar Andres Viteri Molina, MD|(713) 500-6412|Oscar.A.ViteriMolina@uth.tmc.edu|
20198881|NCT00102960|Perinatal HIV Research Unit, Johannesburg and Children's Infectious Diseases Clinical Research Unit, Cape Town all in South Africa|Dr Avy Violari and Prof Mark Cotton|27 11 989 9702/27 21 938 4219|violari@mweb.co.za|9702/4219
20198882|NCT03471065|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
20198883|NCT03770260|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
20198884|NCT02366611|University of Michigan, School of Dentistry|Alexandre DaSilva|7346153807|adasilva@umich.edu|
20198885|NCT00938314|Stem Cell Therapeutics Corp.|Chief Scientific Officer|403.245.5495|adavidoff@stemcellthera.com|226
20198886|NCT01908101|Seattle Cancer Care Alliance|Stefanie Parker|206-889-0917|parkers@seattlecca.org|
20198887|NCT03379662|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
20198888|NCT00166205|Worldwide Clinical Operations|Sheryl Helsinger, Director|513-337-3079|shelsing@its.jnj.com|
20198889|NCT02356562|AbbVie|Global Medical Services|800-633-9110||
20154085|NCT06231511|Shirley Ryan Abilitylab|Sara Prokup PT, DPT|312-238-1355|sprokup@sralab.org|
20198890|NCT00150592|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20198891|NCT00412750|Novartis Pharmaceuticals|Study Director|862-778-8300||
20198892|NCT03787472|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
20198893|NCT00919035|Oncolgy Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
20154086|NCT00000142|Johns Hopkins Bloomberg School of Public Health|Dr. Curtis Meinert|410-955-8175|cmeinert@jhsph.edu|
20154087|NCT02606305|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20154088|NCT00879359|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
20154089|NCT00970944|Spaulding Rehabilitation Hospital|Joseph T Giacino, PhD|617-573-2757|jgiacino@partners.org|
20154090|NCT02008370|Maimonides Medical Center|Dr G Trunfio|718-283-6000|gtrunfio@maimonidesmed.org|
20154091|NCT00662259|University of California San Diego|Gregory G. Brown|858-246-0607|gbrown@ucsd.edu|
20154092|NCT00972738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20154093|NCT00601627|Alliance for Clinical Trials in Oncology|George P. Kim, M.D.|507-284-4918||
20154094|NCT03915067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20154095|NCT02693418|Evofem Biosciences|Kelly Culwell, MD, MPH, FACOG|858-550-1900|kculwell@evofem.com|225
20154096|NCT01199614|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
20154097|NCT01750346|National Institutes of Health|Dr. Codrin Lungu|301-402-0976|lunguci@ninds.nih.gov|
20154098|NCT01001104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154099|NCT00597675|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20154100|NCT00599313|Texas Oncology Cancer Center|Dr. Guru Sonpavde|2813327505|Guru.Sonpavde@USOncology.com|
20154101|NCT01793935|University of Pittsburgh|Dr. K.N. Roy Chengappa - PI|412-246-5006|chengappakn@upmc.edu|
20154102|NCT01121926|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20154103|NCT02782468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20154104|NCT00458835|Covis Pharma|Clinical Trials Interest|1-877-374 -4177|CTInterest@covispharma.com|
20154105|NCT00356590|Amgen Inc.|Study Director|866-572-6436||
20154106|NCT01149785|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154107|NCT01201863|Craig Hospital|Don Gerber, PsyD|303-789-8478|dgerber@craighospital.org|
20154108|NCT00448357|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
20154109|NCT03439514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154110|NCT02175758|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20154111|NCT02299167|Dammam University|Roshdi R. Al-Metwalli|+966 50 289 3485|rmetwalli@iau.edu.sa|
20154112|NCT04398134|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
20154113|NCT05142774|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20154114|NCT03954535|Columbia University School of Social Work|Dr. Traci Schwinn|212-851-2280|tms40@columbia.edu|
20154115|NCT04871074|UW School of Medicine and Public Health|Barbara Bendlin, PhD, MA|(608) 265-2483|bbb@medicine.wisc.edu|
20154116|NCT06011798|Unity Biotechnology, Inc.|Anirvan Ghosh|-|anirvan.ghosh@unitybiotechnology.com|
20154117|NCT03506477|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
20154118|NCT03462680|Charlie Norwood VAMC|Dr. Chandramohan Wakade|706-733-0188|chandramohan.wakade@va.gov|2379
20154119|NCT01757847|VA San Diego Healthcare System|Niloofar Afari, PhD|858-642-3387|niloofar.afari@va.gov|
20154120|NCT04556097|McLean Hospital|Dr. Brent Forester|617-855-3622|bforester@mclean.harvard.edu|
20154121|NCT02516241|AstraZeneca|Medical Science Director|1-877-240-9479|information.center@astrazeneca.com|
20154122|NCT04057365|Massachusetts General Hospital|Joseph Franses, MD, PhD|617-724-4000|JFRANSES@MGH.HARVARD.EDU|
20154123|NCT04738487|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20154124|NCT03409367|Oregon Health & Science University|Director of Clinical Trials|503-764-8544|michaell@ohsu.edu|
20154125|NCT04164979|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
20154126|NCT06480032|Rehman Medical Institute|Dr.Iftikhar qayum|+92 91 5838 333|iftikhar.qayum@rmi.edu.pk|4708
20154127|NCT04046471|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-1687|jdonnelly2@kumc.edu|
20198894|NCT02227693|Eisai Inc.|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
20154128|NCT03824158|University of Pittsburgh|Yael Schenker, MD, MAS, FAAHPM|415-254-9958|yas28@pitt.edu|
20198895|NCT00874120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20198896|NCT01823679|Stanford University Medical Center|Alexander Dimitrios Colevas, MD|650-724-9707|colevas@stanford.edu|
20198897|NCT03615183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198898|NCT01977781|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana, MD, MPH|617-573-4331|reza_dana@meei.harvard.edu|
20198899|NCT02135692|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20198900|NCT01097746|UT MD Anderson Cancer Center|Dr. Anil K. Sood, MD/Professor, Gyn Onc & Reproductive Med|(713) 745-5266|asood@mdanderson.org|
20198901|NCT00522431|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20198902|NCT02495844|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20198903|NCT03927105|Hoosier Cancer Research Network|Adelai Neal|317-921-2053|aneal@hoosiercancer.org|
20198904|NCT02289222|University of Maryland Greenebaum Comprehensive Cancer Center|Ashraf Badros M.B.Ch.B|410-328-1230|Abadros@umm.edu|
20198905|NCT01667471|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800-821-8590|genentech@druginfo.com|
20198906|NCT02145741|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198907|NCT05634577|M D Anderson Cancer Center|Mouhammed Habra, MD|713-792-2841|mahabra@mdanderson.org|
20198908|NCT01192022|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20198909|NCT01351389|Brown University, Center for Alcohol and Addiction Studies|Dr. Peter Monti|(401) 863-6661|peter_monti@brown.edu|
20198910|NCT04839978|Emory University|Kelli Komro, PhD|404-727-8742|kkomro@emory.edu|
20198911|NCT03239574|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20198912|NCT00623480|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20198913|NCT03551509|Cleveland Clinic|Dr. Gregory Gilot|786 566-9176|gilotg@ccf.org|
20198914|NCT01594853|Kennedy Krieger Institute|Kathleen Zackowski|443-923-2716|zackowski@kennedykrieger.org|
20198915|NCT01515787|Memorial Sloan Kettering Cancer Center|Dr.Deborah Schrag|617-416-5194|schragd@mskcc.org|
20198916|NCT02631200|Queen's University Belfast|Dr Peter O'Halloran|02890972490|p.ohalloran@qub.ac.uk|
20198917|NCT01877187|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
20198918|NCT02340585|Stryker|Stacy Phung|678 469 2428|stacy.phung@stryker.com|
20198919|NCT00769002|Hackensack University Medical Center|Dr. David Schwartz|551-996-2000|DSchwartz@hackensackumc.org|
20198920|NCT02868242|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20198921|NCT02699892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20154129|NCT02337686|UT MD Anderson Cancer Center|Dr. Vinaykumar Puduvalli, MD-Chair, Neuro-Oncology|(713) 745-2343|vpuduval@mdanderson.org|
20198922|NCT01981590|Medtronic Bakken Research Center|Lilian Kornet, Prin.Scientist|+31433566710|lilian.kornet@medtronic.com|
20198923|NCT04677712|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
20198924|NCT00711100|University_of_Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20198925|NCT00847912|Providence VA mendical Center|Martin Weinstock MD, PhD|401-457-3333|Martin.Weinstock@va.gov; Martin_Weinstock_MD@brown.edu|
20198926|NCT00783094|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20198927|NCT02513329|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
20198928|NCT01294670|Memorial Sloan Kettering Cancer Center|Tanya Trippett, MD|1-833-MSK-KIDS|trippet@mskcc.org|
20198929|NCT00517595|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20198930|NCT00060346|ECOG Statistical Office|Study Statistician|617-632-3012||
20198931|NCT02083380|Medical University of Vienna, Division of Infectious Diseases and Tropical Medicine|Associate Professor Dr Michael Ramharter|+43140400-44400|michael.ramharter@meduniwien.ac.at|
20198932|NCT04091087|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198933|NCT03808077|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Rieth, MD|212-639-5737|riethe@mskcc.org|
20198934|NCT04152161|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
20198935|NCT02412787|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20198936|NCT03246958|Dana Farber Cancer Institute (DFCI)|Dr. Kartik Sehgal|617-632-3090|kartik_sehgal@dfci.harvard.edu|
20198937|NCT02311153|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD||justin.h.turner@vanderbilt.edu|
20198938|NCT04086823|Raziel Therapeutics|Racheli Gueta , Director of Clinical trials|97289124670|racheli@raziel-therapy.com|
20198939|NCT01650636|University of Miami|Dr. Michael Antoni|305-284-5466|mantoni@miami.edu|
20198940|NCT01560780|VA North Texas Healthcare System|Shuaib Abdullah|214-857-1458|shuaib.abdullah@va.gov|
20198941|NCT01577186|Janssen Research & Development|Medical Director|886 2 23762155||
20198942|NCT00518154|Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán|Dr. Carlos Aguilar Salinas, Director of Ethics in Human Research Committee|5554870900|carlos.aguilars@incmnsz.mx|4524
20198943|NCT01685463|Medical University of south Carolina|Dr. Xingbao Li|8437925729|lixi@musc.edu|
20198944|NCT03345108|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20154130|NCT02266576|Stanford University|Jan J. Vasquez|408-858-4457|jan.vasquez@stanford.edu|
20154131|NCT04336943|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
20154132|NCT05184842|Montefiore Medical Center|Mendel Goldfinger, MD|718-920-4826|mgoldfin@montefiore.org|
20198945|NCT02192827|Johns Hopkins all childrens hospital|Meghan Martin|9417373107|mmart163@jhmi.edu|
20154133|NCT00325416|H. Lee Moffitt Cancer Center and Research Institute|Daniel M. Sullivan, M.D.|813-745-3878|dan.sullivan@moffitt.org|
20154134|NCT06239610|Parkview Health System|Jan Powers PhD, RN, CCNS, CCRN, CNRN, NE-BC, FCCM|260-266-7761|jan.powers@parkview.com|
20198946|NCT01437852|Stratatech Corporation, a Mallinckrodt Company|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
20198947|NCT00414453|University of Rochester|Robert H Dworkin|275-8214|robert_dworkin@urmc.rochester.edu|
20198948|NCT02041377|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
20198949|NCT01717209|Stanford University|Charles Hill|(650) 725-1930|chill1@stanford.edu|
20198950|NCT03362970|University of Calgary|Stephen Freedman|403-955-7740|stephen.freedman@ahs.ca|
20198951|NCT01265797|University of Toledo|Gretchen Tietjen, MD|419-383-3544|gretchen.tietjen@utoledo.edu|
20198952|NCT01422915|BrighamHospital|Dr. Peter V. Tishler|617-525-2123|repvt@channing.harvard.edu|
20198953|NCT02980224|Brace Consulting Group Inc.|Jeremy Brace, President|7274582823|jbrace@braceconsultinggroup.com|
20198954|NCT01979536|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20198955|NCT03077685|NanOlogy, LLC|Mark Mitchell|8179004074|Mark.Mitchell@dfb.com|
20198956|NCT02408471|Smith+Nephew, Inc.|Belinda Larson, Director, Global Clinical Strategy (Trauma)||belinda.larson@smith-nephew.com|
20198957|NCT04194528|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
20198958|NCT03921424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198959|NCT00867321|Mayo Clinic|Steven R. Alberts, MD MPH|507/284-4918|Alberts.steven@mayo.edu|
20198960|NCT01779024|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
20198961|NCT02330978|University São Paulo|Jayter Silva de Paula, MD, PhD|55 16 3602-2499|jspaula@fmrp.usp.br|
20198962|NCT04294901|VA Boston Healthcare System|Amy Linsky, MD, MSc|857-364-2760|amy.linsky@va.gov|
20198963|NCT02589496|Samsung Medical Center|Jeeyun Lee|82234101779|jyunlee@skku.edu|
20198964|NCT05038020|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
20198965|NCT02909985|University of New Mexico|L. Olivia Hopkins|(505) 925-7769|LHopkins@salud.unm.edu|
20198966|NCT01394939|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
20198967|NCT02831673|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20198968|NCT00477165|Stanford University|Uri Ladabaum, MD, MS||ladabau@stanford.edu|
20198969|NCT03955133|Swansea University|Professor Sue Jordan|+44 (0) 1792518541|s.e.jordan@swansea.ac.uk|
20198970|NCT00141765|University of Michigan Cancer Center|Dr. John E. Levine, MD|734-936-8456|jelevine@umich.edu|
20198971|NCT03657368|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
20198972|NCT01623271|Massachusetts General Hospital|Jianren Mao, MD, PhD|617-724-6102|jmao@mgh.harvard.edu|
20198973|NCT02586675|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
20198974|NCT03186677|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
20198975|NCT00631371|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20198976|NCT03378076|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
20198977|NCT01659320|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
20198978|NCT00590590|KV Pharmaceutical|Jim Joffrion, Sr. Director, Clinical Affairs|314-645-6600|jjoffrion@kvph.com|
20198979|NCT01870401|Becton Dickinson|Lisa Erickson|763-463-2897|Lisa.Erickson@bd.com|
20198980|NCT00713700|Abbott|Ashish Oza|1-818-493-3648|aoza@sjm.com|
20198981|NCT00781456|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20198982|NCT03174132|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
20198983|NCT03124823|Masimo|Tala Harake||studies@masimo.com|
20198984|NCT03776175|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217780|NCT04099641|OncXerna Therapeutics, Inc.|CDO, OncXerna Therapeutics, Inc.|(781) 907-7810|medical@oncxerna.com|
20217781|NCT00895037|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154135|NCT01683526|Beth Israel Medical center|Michael Silverberg|2124202377|msilverberg2@chpnet.org|
20154136|NCT02324153|Johns Hopkins University School of Medicine|Karin Neufeld MD MPH: PI of Trial|410-550-0197|kneufel2@jhmi.edu|
20154137|NCT03279458|University of Mississippi Medical Center|Dr. Madhankumar Sathyamoorthy, Principal Investigator|6018157066|msathyamoorthy@umc.edu|
20154138|NCT01937299|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20154139|NCT01913353|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20154140|NCT00385840|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154141|NCT04017962|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou, MD|212-639-6483|papanicg@mskcc.org|
20154142|NCT01428245|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
20154143|NCT01260948|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20154144|NCT00462462|Orfagen|Clinical Project Manager|+33 5 34 50 64 62|info@orfagen.com|
20154145|NCT02555878|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20154146|NCT00765076|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154147|NCT01163617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20154148|NCT02875080|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20154149|NCT02394756|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan- PRINCIPAL RESEARCH OPTOMETRIST|1 904 443 3449|CColesb@ITS.JNJ.com|
20217782|NCT01043926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217783|NCT01523587|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20198985|NCT00960661|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20198986|NCT03405259|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20154150|NCT00768053|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154151|NCT01164475|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20154152|NCT02335944|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20154153|NCT03018938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20154154|NCT01202591|Astrazeneca|Richard Mather|+44 1763 263593|ClinicalTrialTransparency@astrazeneca.com|
20154155|NCT01769586|VA Connecticut Healthcare System|Dr. Loren Laine|203-932-5711|loren.laine@yale.edu|
20154156|NCT00191100|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20154157|NCT02406612|Essential Medical|Sam Nardone|6105571009|sam@essmedclosure.com|
20154158|NCT01744821|Northwestern University|Assistant Professor|312-472-4684|dcarson@nm.org|
20154159|NCT02830087|Wake Forest University Health Sciences|Maxwell Langfit, MD||mlangfit@wakehealth.edu|
20154160|NCT02916771|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@DFCI.Harvard.edu|
20154161|NCT03424148|Cutera|Margout Doucette|415-656-9612|mdoucette@cutera.com|
20154162|NCT01235377|Veterans Health Administration Pharmacy Benefits Management|Madeline McCarren, PhD|7087867987|madeline.mccarren@va.gov|
20154163|NCT03496129|University of Louisville|Dr. Martha Bickford|502-852-3527|martha.bickford@louisville.edu|
20154164|NCT01680172|Mayo Clinic|Robert Bright, MD|480-301-4853|bright.robert@mayo.edu|
20154165|NCT00529035|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
20154166|NCT01879852|University of Florida|Dr. Terese Chmielewski|(352)273-6104|tchm@ufl.edu|
20154167|NCT02115386|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20198987|NCT03363321|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154168|NCT02493855|AbbVie|Global Medical Services|800-633-9110||
20154169|NCT02453048|ILIAD Biotechnologies|Ken Solovay|9543360777|ken@iliadbio.com|
20154170|NCT02111980|UC San Diego School of Medicine|Dr. Ulrika Birgersdotter-Green|858-657-5310|ubgreen@ucsd.edu|
20154171|NCT00741611|CR Bard|Anne Marie Harcarik|908-277-8051|annemarie.harcarik@crbard.com|
20154172|NCT01385644|The Prince Chalres Hospital|Assoc Professor Daniel Chambers|+61 7 3139 4000|daniel.chambers@health.qld.gov.au|
20154173|NCT03562507|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Cancer Center Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20154174|NCT04339972|Medical University of South Carolina|Dr. Mark George or Dr. Bashar Badran|843-792-6076|georgem@musc.edu|
20154175|NCT02403271|Pharmacyclics LLC, An AbbVie Company|Thorsten Graef|(408) 215-3127|tgraef@pcyc.com|
20154176|NCT04837521|Duke University|Dr. Andrada Neacsiu|+1 919 684 6714|andrada.neacsiu@duke.edu|
20154177|NCT03487445|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
20154178|NCT00221104|Translational Research Informatics Center, Kobe, Hyogo|Director of Medical Statistics Division|+81-78-303-9108|kagimura@tri-kobe.org|
20154179|NCT02989389|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20154180|NCT01666652|WRAIR|Robin Nielsen, RN|301-319-9063|trials.clinical@amedd.army.mil|
20154181|NCT04470427|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20154182|NCT01018979|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
20154183|NCT01695746|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20154184|NCT01163656|The Children's Hospital of Philadelphia|John Fiadjoe, MD|215-590-3916|fiadjoej@email.chop.edu|
20154185|NCT03976375|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20154186|NCT04818112|University of Arizona|Dr. Aleeca Bell|5206260575|aleecab@arizona.edu|
20154187|NCT01563081|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154188|NCT00700635|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20154189|NCT06170827|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@GSK.com|
20154190|NCT04882709|Sonova Canada Inc.|Dr. Jinyu Qian|6472624826|jinyu.qian@sonova.com|
20154191|NCT05635370|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20154192|NCT05666245|Center for Vaccine Development and Global Health (CVD)|Wilbur Chen, MD, MS|410-706-5328|wilbur.chen@som.umaryland.edu|
20154193|NCT00632359|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20154194|NCT04253626|Stanford University|Deirdre J. Lyell, MD|(650) 498-4069|dlyell@stanford.edu|
20154195|NCT06904404|Wolfe Eye Clinic|Edward Hu|(319) 362-8032|ehu@wolfe.com|
20154196|NCT03043573|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
20154197|NCT05291975|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
20154198|NCT05578872|Anaveon AG|Medical Director, MD|+41615218383|anaveonclinicaltrials@anaveon.com|
20154199|NCT01440920|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20154200|NCT02626611|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
20154201|NCT03641924|Corporal Michael J. Crescenz VAMC|Dr. James Cobb Scott|2158235800|James.Scott2de50a@va.gov|207138
20154202|NCT04333498|New York State Psychiatric Institute/ HIV Center|Research Program Manager|646-774-6904|christopher.ferraris@nyspi.columbia.edu|
20154203|NCT00479232|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20198988|NCT01032915|Novartis|Study Director|862-778-8300||
20198989|NCT02915523|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
20154204|NCT05399771|Atrium Health Wake Forest Baptist|Nicole Levi|336-716-4171|nlevi@wakehealth.edu|
20154205|NCT05463055|Varian Medical Systems|Sophia Shao|+86-21-23156400|sophia.shao@varian.com|
20154206|NCT00484159|Johns Hopkins|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
20154207|NCT04766333|Rutgers University|Shawna V. Hudson|848-932-0215|hudsonsh@rutgers.edu|
20198990|NCT01780831|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20198991|NCT00183274|UPENN|Karl Rickels, M.D.|215-746-6417|krickels@mail.med.upenn.edu|
20198992|NCT00879645|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20198993|NCT01783080|NY State Psychiatric Institute|David J Hellerstein MD, Professor of Clinical Psychiatry, Columbia|646-774-8000|hellers@nypsi.columbia.edu|
20154208|NCT00104234|BioMarin Pharmaceutical Inc.|Medical Information Services|8009834587|medinfo@bmrn.com|
20154209|NCT01239680|Truman Medical Center|Charles W. Van Way, III, M.D.|816.235.2553|vanwayc@umkc.edu|
20154210|NCT03033901|James A. Haley Veterans' Hospital|Risa Richardson, PhD|813-972-2000|Risa.Richardson@va.gov|5309
20154211|NCT01797185|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
20154212|NCT00729586|NRG Oncology|Angela Kuras on behalf of Virginia Filiaci|716-845-5702|kurasa@nrgoncology.org|
20154213|NCT02734667|Stanford University|Dr. Korey Hood|6504976899|kkhood@stanford.edu|
20154214|NCT05177094|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
20154215|NCT01858948|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
20154216|NCT01033942|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20154217|NCT02737618|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
20154218|NCT02513199|Icahn School of Medicine at Mount Sinai|Michael Buckstein|212-241-7502|michael.buckstein@mountsinai.org|
20154219|NCT01115231|Ralph H. Johnson VA Medical Center, Division of Research, Charleston, SC, USA|Baerbel Rohrer, PhD; VA Research Scientist|843-792-5086|rohrer@musc.edu|
20154220|NCT03014362|Walter Reed National Military Medical Center|Christopher E Hines, MD|301-319-8122|christopher.e.hines.civ@mail.mil|
20154221|NCT01143792|The Ohio State University|Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
20154222|NCT02260986|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20154223|NCT03235414|Cincinnati Children's Hospital Medical Center; Department of Radiology|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
20154224|NCT02397837|Brigham and Women's Hospital|Dr. Katherine Burdick|617-732-5789|kburdick1@bwh.harvard.edu|
20154225|NCT04764604|University College London Hospitals NHS Foundation Trust|Brian Saccente-Kennedy, Speech and Language Therapist|+44 20 3456 5180|brian.saccente-kennedy@nhs.net|
20154226|NCT01111370|Dexcom, Inc|Andy Balo/Sr. VP|8582000203|abalo@dexcom.com|
20154227|NCT00313170|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20154228|NCT01733888|DMG Dental Material Gesellschaft|Manager Clinical Research|+494084006|clinicalresearch@mtcompanies.com|0
20154229|NCT02199574|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20154230|NCT00407511|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20154231|NCT02409901|University of Illinois Chicago|Shyreen Kamal, Director of Clinical Research|2068830173|shyreen@uic.edu|
20154232|NCT01482221|AstraZeneca|Sanjeev Pathak||ClinicalTrialTransparency@astrazeneca.com|
20154233|NCT03086343|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20154234|NCT01716195|University of California Davis|Dr. Megan Daly|916-734-5428|medaly@ucdavis.edu|
20154235|NCT01047501|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
20154236|NCT04602000|Celltrion, Inc|Yun Ju Bae / Head of Clinical Planning 1 Department|+82 32 850 4160|YunJu.Bae@celltrion.com|
20154237|NCT05607043|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
20154238|NCT01846871|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
20154239|NCT00478036|University of Colorado, Dept. of Ophthalmology|Malik Kahook, MD|720-848-2501|Malik.kahook@ucdenver.edu|
20154240|NCT00731198|Changhai Hospital, Second Military Medical University, Shanghai, China|Zhaoshen Li M.D.|86-21-81873271|zhaoshenlismmu@gmail.com|
20154241|NCT00429299|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154242|NCT01510756|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
20154243|NCT02447029|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
20154244|NCT00924482|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|wallacea@anesthesia.ucsf.edu|3732
20154245|NCT01566162|Sunovion|Medical Director CNS Clinical Trials|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20154246|NCT02202616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20154247|NCT04502524|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
20154248|NCT00776997|Torax Medical|Amy Derosier, VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
20154249|NCT05221866|University of Nebraska Medical Center|Karsten Bartels|402-559-4081|anesthesiology.research@unmc.edu|
20154250|NCT02717611|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20154251|NCT04598828|Atrium Health Wake Forest Baptist|Project Manager|336-713-8793|richarlette.hightower@advocatehealth.org|
20154252|NCT02676973|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
20154253|NCT02580604|University of Colorado Anschutz Medical Campus|Dr. Sarah Wherry|303-724-1927|sarah.wherry@cuanschutz.edu|
20154254|NCT01078662|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
20154255|NCT03122106|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
20154256|NCT03244189|Duke University|Charles D. Scales Jr, MD MSHS FACS|919-684-1999|chuck.scales@duke.edu|
20154257|NCT03611946|Johns Hopkins CIR|Dr Anna Durbin|410-955-7283|adurbin1@jhu.edu|
20154258|NCT04950686|innovation Research and Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
20198994|NCT02076997|Baylor College of Medicine|Dr. Jennifer Foster|832-824-4646|jhfoster@texaschildrens.org|
20198995|NCT02533063|University of Wisconsin|Diane Krueger|6082656410|dckruege@wisc.edu|
20154259|NCT02872714|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20154260|NCT05061888|Pennington Biomedical Research Center|Corby Martin|225-763-2585|corby.martin@pbrc.edu|
20154261|NCT05800145|Wake Forest University Health Sciences|Deepak Palakshappa, MD|3367161795|dpalaksh@wakehealth.edu|
20154262|NCT02850406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154263|NCT01565694|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|310715455050|astellas.resultsdisclosure@astellas.com|
20154264|NCT01373229|Duke University Medical Center|Danielle Brander, MD|919-286-6897|danielle.brander@duke.edu|
20154265|NCT02906618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154266|NCT03234881|VA Connecticut Healthcare System|Robin Masheb, PhD|203-932-5711|Robin.Masheb@va.gov|3954
20154267|NCT03807843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154268|NCT01312129|The Mind Research Network|Kent Hutchison, Ph.D.|720-663-0745|khutchison@mrn.org|
20154269|NCT03720847|University of North Carolina at Chapel Hill|Tory Eisenlohr-Moul|859-317-0503|moul@med.unc.edu|
20154270|NCT00990288|Hospital for Special Surgery|Mark P. Figgie MD|212-606-1932|figgiem@hss.edu|
20154271|NCT02636283|University of Minnesota|Otto Sanchez|615-833-9867'|sanc0050@umn.edu|
20154272|NCT03418675|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
20154273|NCT01178411|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154274|NCT00753142|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20154275|NCT02383173|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
20154276|NCT04900272|Northwestern University Feinberg School of Medicine|Katherine O'Brien|314-747-5361|obrien.k@wustl.edu|
20154277|NCT01625182|Novartis Pharmaceuticals|Study Director|862-778-8300||
20154278|NCT00263562|Baylor College of Medicine|Andrea T. Cruz, MD, MPh|832-824-5582|acruz@bcm.edu|
20154279|NCT05059080|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20154280|NCT01922011|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154281|NCT04871113|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20154282|NCT01239745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154283|NCT01565551|University of California, San Francisco|Geoffrey Manley, MD, PhD|415-206-8300|manleyg@neurosurg.ucsf.edu|
20198996|NCT00542269|Novartis Pharmaceuticals|Study Director|862 778-8300||
20154284|NCT00315822|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
20154285|NCT01257542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154286|NCT00081458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20154287|NCT02132468|Mateon Therapeutics|Clinical Operations|6506357000|ca@mateon.com|
20154288|NCT00243061|Juravinski Cancer Centre|Dr. Elaine McWhirter|905-387-9495|elaine.mcwhirter@hrcc.on.ca|67559
20154289|NCT00693303|Shenandoah University|Deborah Marr ScD, OTR/L|540-678-4312|dmarr@su.edu|
20154290|NCT00549328|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154291|NCT00770484|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
20154292|NCT02162433|Massachusetts Eye and Ear|Dr. Makara Cayer|617-573-3380|makara_cayer@meei.harvard.edu|
20154293|NCT03097315|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
20154294|NCT01946802|Seoul National University Hospital|Pf. Gil Joon Suh|82-2-2072-2196|suhgil@snu.ac.kr|
20154295|NCT00153920|Dana-Farber Cancer Institute|Paul G. Richardson|617.632.2104|Paul_Richardson@dfci.harvard.edu|
20154296|NCT00195429|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20154297|NCT02143778|Exalenz Bisocience|Clinical Trial Manager|97289737500|avrahamh@exalenz.com|
20154298|NCT00063622|Virginia Commonwealth University|Arun J. Sanyal||asanyal@mcvh-vcu.edu|
20154299|NCT03384966|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
20154300|NCT00367458|National Cancer Institute|Frank Maldarelli|301-435-8019|fmalli@mail.nih.gov|
20198997|NCT03873714|Medtronic Neurovascular|Director, Global Clinical Research|949.837.3700|rs.advance@medtronic.com|
20198998|NCT04514523|Yale School of Medicine|Dr. Kasia Lipska|203-737-4853|kasia.lipska@yale.edu|
20154301|NCT02556788|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
20154302|NCT01334515|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20154303|NCT04327271|University of Washington|Caryl Feldacker|+1-314-600-6743|cfeld@uw.edu|
20154304|NCT03599713|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20154305|NCT06400914|CooperVision, Inc.|Jose A. Vega, OD, MSc, FAAO|925-621-3761|javega@coopervision.com|
20154306|NCT06937346|Karaganda Medical University|Amirbekova Mariyam Sayatovna|+77472224951|Amirbekova31081998@gmail.com|
20154307|NCT03580928|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
20154308|NCT02798952|GlaxoSmithKline|GSK Response Center|866-435-7343|eg763112@gsk.com|
20154309|NCT00587457|MedImmune, LLC.|Mark C Lanasa|301-398-0000|clinicaltrialenquiries@medimmune.com|
20154310|NCT00541229|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20154311|NCT00924651|University of Rochester Medical Center|Karen M. Mustian, PhD, MPH, Associate Professor|585-273-1796|Karen_Mustian@urmc.rochester.edu|
20154312|NCT02506036|Johns Hopkins University School of Medicine|Dr. Argye Hillis|410-614-2381|argye@jhmi.edu|
20154313|NCT00607594|Cross Cancer Institute|Dr. Heather-Jane Au|780-432-8500|heathera@cancerboard.ab.ca|
20154314|NCT05276804|Atrium Health|Gregory T. Scarola|704 355-5379|gregory.scarola@advocatehealth.org|
20198999|NCT00708123|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154315|NCT02827708|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20199000|NCT01811875|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 20 8957 2200|medinfo@bpl.co.uk|
20199001|NCT01632995|Bridge HIV, San Francisco Department of Public Health|Dr. Albert Liu, Clinical Research Director|415-437-7408|albert.liu@sfdph.org|
20199002|NCT00401375|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20199003|NCT02821715|Theranexus|Chief medical officer|+33680026779|werner.rein@theranexus.fr|
20199004|NCT00677014|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
20199005|NCT00640328|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199006|NCT03115567|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
20199007|NCT02374099|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20154316|NCT00898807|Johns Hopkins|Anne Casper|410-955-8183|ashankl1@jhu.edu|
20154317|NCT03928327|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20154318|NCT01521364|University of Groningen, University Medical Center Groningen|Dr. J.W.C. Alffenaar|+31-50-3614070|j.w.c.alffenaar@umcg.nl|40378
20154319|NCT03637374|Johns Hopkins University|Dr. James H. Black, III|(410) 955-5165|jhblack@jhmi.edu|
20154320|NCT03759184|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
20154321|NCT00363168|Johns Hopkins University|Neil M. Bressler|410-955-8342|nbressler@jhmi.edu|
20199008|NCT01033825|Sunovion|Respiratory Medical Director|1-866-503-6351||
20199009|NCT04294719|Centre for Addiction and Mental Health|Courtney Brennan|4165358501|courtney.brennan@camh.ca|
20199010|NCT00350142|Stanford Cancer Center|Dr. Albert Koong|650-498-7703|akoong@stanford.edu|
20199011|NCT00081159|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20154322|NCT01365611|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20154323|NCT01479530|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20154324|NCT04795323|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20154325|NCT02120079|Tufts Medical Center|Dr. Pedram Hamrah|617-636-5321|phamrah@tuftsmedicalcenter.org|
20154326|NCT00303628|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20154327|NCT00376506|James Madison University|Christy L. Ludlow, PhD|540-568-3876|ludlowcx@jmu.edu|
20154328|NCT04925934|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20154329|NCT03158688|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20154330|NCT03683901|MetroHealth Rehabilitation Institute|Dr. Victoria Whitehair|216-778-4414|vwhitehair@metrohealth.org|
20154331|NCT03780387|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
20154332|NCT00565864|Oregon Health & Science University|Dr. Mary Samuels|5034945242|samuelsm@ohsu.edu|
20154333|NCT06069609|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
20154334|NCT02948400|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
20154335|NCT01716156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154336|NCT05561140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154337|NCT05955378|Shirley Ryan AbilityLab|Arun Jayaraman|312-238-6875|ajayaraman@sralab.org|
20154338|NCT01188447|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
20154339|NCT03301714|Kornber School of Dentistry|Dr. Marisol Tellez Merchan|2177071773|marisol@temple.edu|
20154340|NCT02522845|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
20154341|NCT02112552|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
20154342|NCT04285411|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
20154343|NCT04055519|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20154344|NCT02317549|Leading BioSciences|Tom Hallam, PhD, MBA|631-739-3088|tom.hallam@leadingbiosciences.com|
20154345|NCT03349515|Medical University of South Carolina|Dr. Michelle Rovner|843-792-2322|rovner@musc.edu|
20154346|NCT01132755|Memorial Sloan Kettering Cancer Center|Dr. Peter Kingham MD|212-639-5260|kinghamt@mskcc.org|
20154347|NCT02393755|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20154348|NCT00781950|St. Boniface Hospital Research Centre|Dr. Grant Pierce|(204) 235-3414|GPierce@sbrc.ca|
20154349|NCT02949934|University of Colorado School of Medicine|Joseph P. Schacht, Ph.D.|(303) 724-3773|joseph.schacht@cuanschutz.edu|
20154350|NCT01684592|Battelle|Dr. Victoria Coleman-Cowger|4103722748|colemancowger@battelle.org|
20154351|NCT00657605|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
20154352|NCT04069520|Emory University|Dr. Kim Barber Foss|404-544-1306|kim.barberfoss@emory.edu|
20154353|NCT00849472|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154354|NCT00825175|University of Michigan|Julia Looper|253 534 8499|jlooper@umich.edu|
20154355|NCT04822194|Rice University|Bryan Denny|713-348-8257|bryan.denny@rice.edu|
20154356|NCT04615507|Johnson & Johns Vision Care Inc.|Thomas Karkkainen- Sr. Research Principal Optometrist|1-800-843-2020|tkarkkai@its.jnj.com|
20154357|NCT00248547|Oregon Health & Science University, Knight Cancer Institute|Joseph Bubalo, PharmD|503-494-1054|bubaloj@ohsu.edu|
20199012|NCT03693625|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20154358|NCT00118287|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
20154359|NCT05494632|Washington University School of Medicine|Jill B Firszt, PhD|314-362-4760|firsztj@wustl.edu|
20154360|NCT03091439|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20199013|NCT00684255|New York Medical College|Dr. Mitchell S. Cairo|914-594-3650|mitchell_cairo@nymc.edu|
20199014|NCT01883635|University of Rochester|Dr. Charles Kamen|585-275-9958|charles_kamen@urmc.rochester.edu|
20154361|NCT05172570|Indiana Univeristy School of Medicine|Randomized prospective study comparing variable Gabapentin dosages for postoperative analgesia follo|317-274-0275|yyeap@iupui.edu|
20154362|NCT04507321|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20154363|NCT03550209|Nationwide Children's Hospital|Dr. Sarah Keim|1-800-792-8401|sarah.keim@nationwidechildrens.org|52849
20154364|NCT01590875|Medical College of Wisconsin|Marcie Berger, MD|414-955-6806|mgberger@mcw.edu|
20154365|NCT02347787|University of Pennsylvania School of Medicine|Lindsey Norton|215-573-9961|lindsey.turr@uphs.upenn.edu|
20154366|NCT02013427|Northwestern University|Apkar Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
20154367|NCT05643794|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20154368|NCT02813447|Duke University Medical Center|Neil MacIntyre|919 681 2720|macin001@mc.duke.edu|
20154369|NCT04167670|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|Please email|medicalinformation@phathompharma.com|
20154370|NCT01127061|University of Michigan School of Medicine|Dr. Sara Saberi, MD, MS|734-764-4500|saberis@med.umich.edu|
20154371|NCT01192698|Carolinas Medical Center|Dr. Mark W. Russo|704-355-6649|mark.russo@carolinashealthcare.org|
20154372|NCT04827446|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20154373|NCT00962598|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
20154374|NCT03921541|Immedica Pharma AB|Vice President, Head of Global Integrated Evidence / Global Head of Genetic and Metabolic Diseases|+46 8 533 39 500|Clinical@immedica.com|
20154375|NCT05399485|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154376|NCT02955394|University of Colorado Hospital|Anthony Elias|720-848-0300|anthony.elias@cuasnchutz.edi|
20154377|NCT01363076|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|
20154378|NCT04706403|UMass Chan Medical School|Dr. Kimberly Fisher|(508)8561975|Kimberly.Fisher@umassmemorial.org|
20154379|NCT00182637|UC Irvine|Dr. Lauren Pinter-Brown|(714) 456-5153|lpinterb@uci.edu|
20154380|NCT02642679|Brigham and Women's Hospital|Indranil Sinha, MD|617-732-5282|isinha@bwh.harvard.edu|
20154381|NCT01112267|Janssen Korea/ Seoul|Therapeutic area Scientist|+82-2-2094-4802||
20154382|NCT00003456|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20154383|NCT03690544|Mayo Clinic|Alison J. Bruce, M.B., Ch.B.|904-953-6402|Bruce.Alison@mayo.edu|
20154384|NCT05416203|Department of Veteran Affairs|Dr. Nicholas Allan|8502740567|nicholas.allan@va.gov|
20154385|NCT06059066|Houston Methodist Hospital|Julu Benoy|(713) 441-6455|jbenoy@houstonmethodist.org|
20154386|NCT02787291|Abbott CAHF CRM|Dr. Adam Cline- Clinical Scientist|818-493-2025|adam.cline@abbott.com|
20154387|NCT03128086|HOSPITAL UNIVERSITARIO GENERAL DE CASTELLÓN, SPAIN. CONSELLERIA SANITAT|DR. ALBERTO BELENGUER-MUNCHARAZ|964 72 50 00|belengueralberto8@gmail.com|
20154388|NCT00134719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154389|NCT01807520|Novartis Pharmaceuticals|Study Director|862-778-8300||
20154390|NCT01500096|Johns Hokpins University|Adriana Andrade|410-955-7287|aandrade@jhmi.edu|
20154391|NCT00639379|Vistakon|Kurt Moody, OD|904-443-3088||
20154392|NCT03096353|National Center for Complementary and Integrative Health|Catherine Bushnell|+1 301 496 2222|mary.bushnell@nih.gov|
20154393|NCT03298061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20154394|NCT00580398|Massachusetts General Hospital|Elyse Park, Ph.D., MPH|617-724-6836|epark@partners.org|
20154395|NCT04772547|University of Florida|Dr. Carolina B. Maciel|(352) 273-5550|carolina.maciel@ufl.edu|
20154396|NCT00992836|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
20199015|NCT01187953|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
20154397|NCT04119336|Massachusetts General Hospital|Andrew Yee, MD|617-724-4000|AYEE1@mgh.harvard.edu|
20154398|NCT01410604|Hospital Regional de Alta Especialidad del Bajio|M.D. Maria L. Evia-Viscarra|+52 (477) 267-2000|evialola@hotmail.com|1405
20154399|NCT05427916|Icahn School of Medicine at Mount Sinai|John C Lantis II|(212) 523-4797|John.Lantis@mountsinai.org|
20154400|NCT00800540|Alcon Research, Ltd.|Director, Global Medical Affairs|1-888-451-3937||
20154401|NCT04757584|Weill Cornell Medicine|Maryam Hyder|646-962-5904|mah4022@med.cornell.edu|
20154402|NCT00357162|Washington University|Amanda Cashen, M.D.||acashen@im.wustl.edu|
20154403|NCT03927157|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20154404|NCT00726557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20154405|NCT05630755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20154406|NCT04868682|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 891-7711|cathy.alessi@va.gov|39311
20154407|NCT02541903|UAB|Dr. Lisle Nabell, MD, Professor|(205) 934-3061|lnabell@uabmc.edu|
20154408|NCT03880565|University of Minnesota|Demetri Yannopoulos, MD|612-626-2935|yanno001@umn.edu|
20154409|NCT00585650|Wake Forest Baptist Health, Department of Dermatology|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
20154410|NCT03144635|Kyushu University Hospital|Dr. Eiichi Ogawa / Assistant Professor|81926425909|eogawa@gim.med.kyushu-u.ac.jp|
20154411|NCT01403584|Universitätsklinik, Essen|Prof. Helmut Teschler|0201 433 4001|teschlerh@t-online.de|
20154412|NCT02635035|NYU Langone Health|Terry Leon|1 646 754 4841|Terry.Leon@nyulangone.org|
20154413|NCT05073315|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20154414|NCT00303953|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|mleblanc@fhcrc.org|
20154415|NCT03290768|Savvysherpa, LLC|Jared Jones|763-549-3540|JaredJones@savvysherpa.com|8116
20199016|NCT01464307|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20199017|NCT02911922|Weill Cornell Medicine - New York Presbyterian Hospital|Josephine Kang, M.D. Ph.D.|212-746-3607|jok9106@med.cornell.edu|
20199018|NCT00761514|Abbott|Medical Information Specialist|1-800-633-9110||
20199019|NCT03449095|University of Illinois at Urbana-Champaign|Dr. Catharine Fairbairn|215-300-5850|cfairbai@illinois.edu|
20199020|NCT02457637|Renji Hospital, Shanghai Jiao Tong University School of Medical|Professor Hai Li , Director of Clinical Trials|+86-13818525494|haili＿17@126.cpm|
20199021|NCT00159861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199022|NCT01848184|Medtronic|Michelle DiSalvo|774 284 6089|michelle.v.disalvo@medtronic.com|
20199023|NCT01553136|Yale University|Stephanie Samples O'Malley, PhD, Professor of Psychiatry|(203) 974-7590|stephanie.omalley@yale.edu|
20199024|NCT03885089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199025|NCT06080451|University of Michigan|Dr. David Flood|734-647-2892|dcflood@umich.edu|
20199026|NCT03349099|Cleveland Clinic|Manoj Monga MD|216-445-8678|mongam@ccf.org|
20199027|NCT00278993|Eisai Call Center|Eisai Inc.|888-422-4743||
20199028|NCT02701387|UCLA School of Dentistry|Perry R. Klokkevold, DDS, MS, FACD|310-825-1927|pklokkevold@dentistry.ucla.edu|
20199029|NCT01290874|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
20199030|NCT01040052|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20199031|NCT03451773|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|rudloffu@mail.nih.gov|
20199032|NCT01964352|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199033|NCT03468855|Aclaris Therapeutics, Inc.|David Gordon|484-540-6296|Clintrials@aclaristx.com|
20199034|NCT00879229|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20199035|NCT03962439|University of Texas at Dallas|Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
20154416|NCT02239289|Université du Québec à Trois-Rivières|Martin Descarreaux|1-819-376-5011|martin.descarreaux@uqtr.ca|3791
20154417|NCT03010501|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
20154418|NCT00942851|Office of the Clinical Director, NINDS, NIH|Codrin Lungu, MD|301-496-5295|lunguci@ninds.nih.gov|
20154419|NCT00640289|Children's Hospital of Orange County|Clinical Trial Coordinator||KBirschbach@choc.org|
20154420|NCT00306488|National Eye Institute|Wai Wong, MD, PhD|301-496-7566|wongw@mail.nih.gov|
20154421|NCT04298853|Indiana University School of Medicine|Anna Thomas, MD|317-944-9392|aeschwar@iu.edu|
20154422|NCT01059851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154423|NCT02207608|University of Rome Tor Vergata|Prof. Enrico Finazzi Agro|+393296152920|efinazzi@tin.it|
20154424|NCT04941898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20154425|NCT01653262|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20154426|NCT00371631|Michael E. DeBakey Veterans Affairs|Dr. Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
20154427|NCT00420407|University of Texas Health Science Center at San Antonio|Stephen Cohn, M.D.|210-567-5724|mccarthyj@uthscsa.edu|
20154428|NCT04928339|University of Wisconsin - Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
20154429|NCT04633447|Janssen Research & Development, LLC|Manager Clinical Science Translational|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20154430|NCT05417113|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-4743|christina.jeng@Mountsinai.org|
20154431|NCT01022580|University of California, San Francisco|Roberta A Ballard, MD|415-476-4193|roberta.ballard@ucsf.edu|
20154432|NCT03439839|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20154433|NCT04529980|Children's Health Children's Medical Center|Dr. Mayra Garcia, DNP, APRN, PCNS-BC, EBP-C|12144567990|Mayra.Garcia@childrens.com|
20154434|NCT05124184|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
20154435|NCT00723944|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20154436|NCT02582632|AbbVie|Global Medical Services|800-633-9110||
20154437|NCT01956942|Ophthalmology Department The George Washington University|Dr. David Belyea|2027412800|dbelyea@mfa.gwu.edu|
20154438|NCT01771913|Faculdade de Medicina - Universidade de Sao Paulo|Dr. Luiz Alexandre Lorico Tissiani|55-11-981798707|latissiani@gmail.com|
20154439|NCT04307394|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|brandon_gaudiano@brown.edu|
20154440|NCT01724190|Nationwide Childrens Hospital|Kathryn Obrynba|6147224425|kathryn.obrynba@nationwidechidrens.org|
20154441|NCT00138294|Baylor College of Medicine|Pedro A Piedra, MD|713-798-5240|ppiedra@bcm.edu|
20154442|NCT00818272|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20154443|NCT01617967|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|1-877-256-9526|medinfo@alnylam.com|
20154444|NCT02536794|Northwestern University|Ami Shah, MD|312 503 5488|amishah@northwestern.edu|
20154445|NCT00416949|SKCCC|George Sgouros|4106140116|gsgouros@jhmi.edu|
20154446|NCT03228914|The University of Texas Health Science Center at Houston|William C. Yao, MD|713-500-5410|william.c.yao@uth.tmc.edu|
20154447|NCT02985710|Massachusetts General Hospital|PI|6177260580|akaraa@mgh.harvard.edu|
20154448|NCT01471574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20154449|NCT01177410|Salix Pharmaceuticals, Inc.|Vice President of Clinical Operations|919-862-1000|enoch.bortey@salix.com|
20154450|NCT02249793|Upenn|Dr. Carsten Skarke|215-573-0673|cskarke@pennmedicine.upenn.edu|
20154451|NCT02836769|Sunnybrook Research Institute|Dr. Sara McEwen|416-226-6780|sara.mcewen@sunnybrook.ca|7957
20154452|NCT02503865|Republican Scientific Center for Emergency care at Nazarbayev University|Dr. Kuat Oshakbayev|+77013999141|okp.kuat@mail.ru|
20154453|NCT01529268|Johns Hopkins Data Coordinating Center|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
20154454|NCT00021255|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20199036|NCT00513409|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199037|NCT01049035|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20217784|NCT02732691|JenaValve Technologies Inc.|Vinny Podichetty, Vice President: Clinical & Med Affairs|949-767-2110|podichetty@jenavalve.com|1050
20154455|NCT02232698|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
20154456|NCT00728923|New York State Psychiatric Institute|Dr. Carolyn Rodriguez|212-543-5637|cr2163@columbia.edu|
20154457|NCT05324371|Boston Scientific|Nilou Zilinek|508-683-6127|nilou.zilinek@bsci.com|
20154458|NCT01131585|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
20154459|NCT01786109|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
20154460|NCT02641834|Department of Experimental and Clinical Medicine, University of Florence, Italy|Prof. Francesco Sofi|+390557949429|francescosofi@gmail.com|
20154461|NCT03491917|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20154462|NCT01068912|MediVector, Inc., managing member MDVI, LLC|Dr. Carol Epstein, Chief Medical Officer|617-439-4500|cepstein@medivector.com|
20154463|NCT02762604|Albert Einstein College of Medicine|Dr. Helena Blumen|7184303810|helena.blumen@einsteinmed.edu|
20154464|NCT05893823|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini|0516366418|francescocastagnini@hotmail.it|+39
20154465|NCT04057768|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
20154466|NCT01257438|Bard Peripheral Vascular|Josh Smale, Associate Director Clinical Affairs|(480) 603-8140|Josh.Smale@crbard.com|
20154467|NCT01648959|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
20154468|NCT00627978|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
20154469|NCT03442569|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
20154470|NCT02943213|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
20154471|NCT04050605|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20154472|NCT01917773|Riley Hospital for Children, Indiana University|Joseph Croffie|317-944-3774|jcroffie@iupui.edu|
20154473|NCT02260622|Ottawa Hospital Research Institute|Penny Phillips|613-737-8899|pphillips@ohri.ca|
20154474|NCT00544882|Teva Branded Pharmaceutical Products R&D|Director of Clinical Research|610-786-7047|clinicaltrialsdisclosure@tevapharm.com|
20154475|NCT00308685|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20154476|NCT03770455|Tulane University School of Medicine|Jodi L. Layton, MD|504-988-6121|jlayton@tulane.edu|
20154477|NCT04937387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20154478|NCT02583269|Wake Forest University Health Sciences|Study Nurse|336-713-7748|saverill@wakehealth.edu|
20154479|NCT00223821|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
20154480|NCT01039675|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154481|NCT00153842|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|Cancer.Research.Nurse@Dartmouth.edu|
20154482|NCT03579771|Robert H. Lurie Comprehensive Cancer Center of Northwestern University Clinical Cancer Center|Shishir Maithel, MD|312-908-5250|shishir.maithel@nm.org|
20154483|NCT06048068|Columbia University Irving Medical Center|Dr. Sachin Agarwal, MD MPH|212-305-7236|sa2512@cumc.columbia.edu|
20154484|NCT01847209|Brigham and Women's Hospital|Dr. Raphael Bueno|617-732-8148|rbueno@partners.org|
20154485|NCT01870596|Sidney Kimmel Comprehensive Cancer Center|B. Douglas Smith|(410) 287-2935|bdsmith@JHMI.edu|
20154486|NCT03600350|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD, PhD|(608) 263-4198|dm3@medicine.wisc.edu|
20154487|NCT04575324|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
20154488|NCT03712852|Università degli studi G. D'ANNUNZIO|Prof. Michele Paolantonio|3395204073|mpaolantonio@unich.it|
20154489|NCT04764539|iTherapy, LLC|Lois Brady, CEO|9258120037|lois@itherapyllc.com|
20154490|NCT01952678|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
20154491|NCT01137812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20154492|NCT00845182|UTexas_SanAntonio|Devjit Tripathy|2105676691|tripathy@uthscsa.edu|
20154493|NCT04621760|University of California, San-Francisco|Dr. Dominika Seidman|(415) 353-2119|Dominika.Seidman@ucsf.edu|
20154494|NCT03380572|Imperial College London|Mr R Aggarwal|02033126840|r.aggarwal@ic.ac.uk|
20154495|NCT00447278|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154496|NCT03677401|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
20154497|NCT02421211|Janssen Research & Development|Trial Physician, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
20154498|NCT00471354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154499|NCT05950906|Calibr-Skaggs|Director of Clinical Operations|(858) 242-1000|abrooks@scripps.edu|
20154500|NCT01119222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187605|NCT04271046|Kaiser Permanente Washington Health Research Institute|Robert Penfold|206-287-2232|robert.b.penfold@kp.org|
20154501|NCT01186406|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
20154502|NCT03142750|Children's Hospital Colorado|Pediatric Surgery Research Fellow|720-777-5371|youngmeeyoungmee@gmail.com|
20154503|NCT02942407|Duke Universitey|Christopher Granger, MD|919-668-8900|christopher.granger@duke.edu|
20154504|NCT00933166|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20154505|NCT04618471|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
20154506|NCT03914703|Zimmer Biomet|Jarrod Hunnicutt, Clinical Affairs Manager|574-453-7834|jarrod.hunnicutt@zimmerbiomet.com|
20154507|NCT05774977|University of Pennsylvania Perelman School of Medicine|Dr. Mathias Basner, MD, PhD, MScEpi|215-573-5866|basner@pennmedicine.upenn.edu|
20154508|NCT00374868|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154509|NCT03325439|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20187606|NCT04230681|Washington University|Dr. Greg Miller|314-454-6000|g.c.miller@wustl.edu|
20187607|NCT06149338|Saint Andrew's General Hospital of Patras|Dr. Vasileios Boviatsis|+306982925945|billboviatsis@gmail.com|
20199038|NCT01500109|Loma Linda University|Chelan Nour, MD|909-558-8493|cnour@llu.edu|
20199039|NCT01526902|Indiana University|Pete Kollbaum, OD, PhD, FAAO, FBCLA, Principal Investigator|812-856-0108|kollbaum@indiana.edu|
20199040|NCT00812214|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|617-744-1310|Spierings@MedVadis.com|
20199041|NCT01514682|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
20199042|NCT00132132|SEMC|Dr. Shirley Gonzalez|617-926-0114|shirley.gonzalez@steward.org|
20199043|NCT03470493|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
20199044|NCT03605680|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20199045|NCT03189446|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
20199046|NCT00647556|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20199047|NCT05594173|University Health Network|Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
20199048|NCT01692964|Rapid Pathogen Screening, Inc.|Robert Sambursky, MD|941-556-1853|rob.sambursky@lumosdiagnostics.com|
20154510|NCT03188185|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
20199049|NCT03865706|Columbia University|Daniel E. Freedberg, MD, MS|857-998-9370|def2004@cumc.columbia.edu|
20199050|NCT02095535|UBC Department of Anesthesia - BC Women's Hospital|Tashya De Silva|604-875-2158|tashya.desilva@cw.bc.ca|
20199051|NCT02646982|University of Texas Southwestern|Ihab Hajjar, MD|214-645-9533|ihabhajjar@emory.edu|
20199052|NCT03273166|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20199053|NCT04852848|University of Oregon|Anne Marie Mauricio, Research Associate Professor|602-920-7459|amariem@uoregon.edu|
20199054|NCT01897285|Arrowe Park Hospital|Mrs Gwenneth Lawrence|0151 678 5111|gwen.lawrence@nhs.net|8362
20154511|NCT00774748|UNC Chapel Hill School of Medicine Dept. Hematology|Clinical Research Coordinator|919-966-2359|catherine_soriano@med.unc.edu|
20154512|NCT04913636|Procter & Gamble|Clinical Trial Manager|513-622-4601|conde.e.1@pg.com|
20154513|NCT03412890|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
20199055|NCT00915681|Meda Pharma GmbH & Co KG (A Viatris company)|Baerbel Fingerhut|+49 6172 888|baerbel.fingerhut@viatris.com|1419
20217785|NCT02244424|Michigan State University, College of Nursing|Dr. Mildred A. Horodynski|(517) 355-6744|millie@msu.edu; silkk@msu.edu|
20154514|NCT02315625|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@nih.gov|
20154515|NCT02337946|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20154516|NCT00927082|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20154517|NCT02369458|Washington University School of Medicine|Peter Oppelt, M.D.|636-916-9922|poppelt@wustl.edu|
20154518|NCT03853798|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
20154519|NCT02743494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20154520|NCT02068794|Mayo Clinic|Evanthia Galanis MD|(507) 284-2511|galanis.evanthia@mayo.edu|
20154521|NCT04439175|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20199056|NCT03221751|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
20217786|NCT03366194|Esthetic Education LLC|Study Coordinator|(480) 656-2251|Support@skinstylus.com|
20217787|NCT03078478|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20217788|NCT00545688|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20217789|NCT02792218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20217790|NCT02408445|University of Colorado|Dr. Shanlee Davis|720-777-6073|shanlee.davis@childrenscolorado.org|
20217791|NCT00932282|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20217792|NCT03182751|Mayo Clinic|Dr. Brandon Yuan|507-255-6112|Yuan.Brandon@mayo.edu|
20217793|NCT00441350|Menarini Group|Angela Capriati, MD PhD - Global Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
20217794|NCT02597582|Taichung Veterans General Hospital|Shih-An Liu|+886-4-23592525|saliu@vghtc.gov.tw|5409
20217795|NCT00423683|North Shore LIJ Health System|Valerie Blake|516-562-0100|vblake@nshs.edu|
20217796|NCT02065713|Instituto Medicina Molecular|Elsa Vieira-Sousa|00351 217999544|elsa-sousa@hotmail.com|47221
20217797|NCT01680783|University of Chicago|John P. Kress|7737026790|jkress@medicine.bsd.uchicago.edu|
20217798|NCT04862156|OrganOx|Katerina de Metz|19713442167|katerina.demetz@organox.com|
20217799|NCT03738020|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20217800|NCT00256776|EBMT|Clinical Study Unit|+31(0)715265005|ebmtcsu@lumc.nl|
20217801|NCT01048502|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
20217802|NCT00685802|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20217803|NCT01333072|MUSouthCarolina|C. Lindsay DeVane, Pharm.D.|8432701818|devaneL@musc.edu|
20217804|NCT00619359|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20217805|NCT03093272|Dana-Farber Cancer Institute|Lauren Harshman, MD|617-632-2429|laurenc_harshman@dfci.harvard.edu|
20217806|NCT00103038|Oregon Health and Science University|Gerda Teglassy, MD|5034945626|tothg@ohsu.edu|
20217807|NCT01430819|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20217808|NCT01483625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20217809|NCT01731886|Columbia University|Suzanne Lentzsch, MD, PhD, Professor of Medicine|646-317-4840|sl3440@cumc.columbia.edu|
20217810|NCT02280187|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20217811|NCT02094261|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
20217812|NCT04668274|Marshall A. Hayward, Ph.D., Jupiter Orphan Therapeutics Inc.|David Wyatt|305-547-5857|david.wyatt@syneoshealth.com|
20199057|NCT04338815|University of Nebraska-Omaha|Philippe Malcolm|617-487-1148|pmalcolm@unomaha.edu|
20199058|NCT01598779|University of Buenos Aires|Dr. Laura Fleider|541159508000|laurafleider@hotmail.com|8582
20199059|NCT00919503|Fred Hutchinson Cancer Research Center|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
20199060|NCT00535132|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
20199061|NCT01242267|Hackensack Meridan Health|Joshua Zenreich|5519964248|Joshua.Zenreich@hmhn.org|
20199062|NCT00618410|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
20199063|NCT03824808|University of Missouri|Dr Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
20199064|NCT03958552|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
20199065|NCT03948178|Orion Corporation|Head of Compliance and UK Study Management, Clinical Operations|+441159487100|clinicaltrials@orionpharma.com|
20199066|NCT01297270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199067|NCT00401752|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20199068|NCT00382993|Glaxo Smith Kline|GSK Response Center|1-866-435-7343||
20199069|NCT00714792|University of Rochester|Michael K. Flynn, MD|585-273-3232|michael_flynn@urmc.rochester.edu|
20199070|NCT03196076|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20199071|NCT02461992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199072|NCT03015259|KINDEVA DRUG DELIVERY|Lester Harrison, PhD|6122714814|lester.harrison@kindevadd.com|
20199073|NCT01965262|Coopervision|Paul Chamberlain, BSc Honors, Sr. Manager Clinical Research|(925) 730-6754|pchamberlain@coopervision.com|
20199074|NCT01029366|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
20199075|NCT01479543|Hero Institute for Infant Nutrition|Esther Matencio Hilla|+0034 968 89 89 00|esther.matencio@hero.es|
20199076|NCT00906087|University of Michigan|Sayoko E. Moroi|734-763-3732|smoroi@med.umich.edu|
20199077|NCT03341962|Immunic AG|Andreas Muehler, MD|004989|Andreas.Muehler@imux.com|20804770
20199078|NCT04474795|Washington University In St. Louis School of Medicine|Cynthia Herrick, MD, MPHS|3147470278|herrickc@wustl.edu|
20199079|NCT00814775|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20199080|NCT02941627|Oticon Medical|Clinical Research Director|+33 4 93 95 18 18|mhoe@oticonmedical.com|
20199081|NCT00606320|Otsuka Pharmaceutical Co, Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20199082|NCT00563186|University of Calgary|Dr. John Conly|403-944-8090|John.Conly@albertahealthservices.ca|
20199083|NCT01152021|Department of Anesthesia, Perioperative and Pain Medicine|Rachel Dabek|857-218-5413|rachel.dabek@childrens.harvard.edu|
20199084|NCT02595723|UT Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
20199085|NCT04839380|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20199086|NCT01087905|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.medicine.wisc.edu|
20199087|NCT00513500|Boston University|Kojo Yeboah-Antwi|617-414-1275|kyantwi@bu.edu|
20199088|NCT04288154|Mayo Clinic|Amir Lerman, M.D.|507-255-2398|lerman.amir@mayo.edu|
20199089|NCT00749996|Medtronic Spinal & Biologics|Irène Ayer, Clinical research specialist|+41 21 803 84 27|irene.ayer@medtronic.com|
20199090|NCT00996944|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199091|NCT00769184|NeoStrata Co., Inc.|Barbara Green, RPH, MS|(609) 520-0715|bgreen@neostrata.com|
20199092|NCT00586209|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
20199093|NCT03042715|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
20199094|NCT00385255|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199095|NCT00583362|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199096|NCT00345176|The EMMES Corporation|Traci Clemons, PhD|301-251-1161|tclemons@emmes.com|212
20199097|NCT01136655|AstraZeneca|Göran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
20199098|NCT04377711|Covis Pharma|Clinical Trial Interest|1-877-374 -4177|CTInterest@covispharma.com|
20199099|NCT02873936|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20199100|NCT01015768|Southern California College of Optometry|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@scco.edu|
20199101|NCT01225731|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199102|NCT00577642|Massachusetts General Hospital|Dr Noopur Raje|6177260711|nraje@partners.org|
20199103|NCT04770389|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20199104|NCT02613936|University of New Mexico|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
20199105|NCT01556425|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20199106|NCT02185404|University of South Florida|Kyle B. Reed|813-974-2385|kylereed@usf.edu|
20154522|NCT01631188|Rutgers University|Enrique Pantin, MD|7328900640|pantinej@rwmjs.rutgers.edu|
20154523|NCT00886236|Medical University of South Carolina|Larry Field|843-876-5744|field@musc.edu|
20154524|NCT02810327|Medical University of South Carolina|Kimberly Brown Foil|843-792-6474|foilk@musc.edu|
20154525|NCT06262607|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
20154526|NCT02639559|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
20154527|NCT01692756|Univerisity of Kentucky|Cale Jacobs, ATC, PhD|8592183065|Kycartilagedoc@gmail.com|
20199107|NCT00794157|Novartis Pharmaceuticals|Study Director|862 778-8300||
20199108|NCT01970501|Arca biopharma Inc.|Dr. Michael Bristow|7209412100|Michael.Bristow@arcabio.com|
20199109|NCT01692275|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|LONG_C@palmer.edu|
20154528|NCT02969018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199110|NCT00845650|Emergent Product Development Gaithersburg, Inc.|Study Director||clinicalstudies@ebsi.com|
20199111|NCT00814892|Mayo Clinic|Dr. Manish Kohli|507-284-2511|kohli.manish@mayo.edu|
20199112|NCT04486950|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20199113|NCT00950664|Seoul National University Hospital|BS Jeon|+82220722876|brain@snu.ac.kr|
20199114|NCT01326546|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
20199115|NCT03152019|Hospices Civils de Lyon|Dr Dupuis Girod|427856522|sophie.dupuis-girod@chu-lyon.fr|+33
20199116|NCT00755274|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20199117|NCT01548339|University Hospital Lausanne|Prof. N. Demartines||demartines@chuv.ch|
20199118|NCT00923130|National Cancer Institute|Dr. Ravi Madan|301-496-3493|madanr@mail.nih.gov|
20199119|NCT04311502|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20199120|NCT03040999|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20199121|NCT01979523|Memorial Sloan Kettering Cancer Center|Dr. Alexander Shoushtari|646-888-4161|shoushta@mskcc.org|
20199122|NCT01339559|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20199123|NCT00971945|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20199124|NCT03354663|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
20199125|NCT01661140|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20199126|NCT01137773|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
20199127|NCT03548051|Hope Clinic of the Emory Vaccine Center|Nadine Rouphael|404-377-3719|nroupha@emory.edu|10
20199128|NCT03874377|Children's National Medical Center|Dr. Sarah Hornack|202-895-3860|shornack@childrensnational.org|
20199129|NCT00817531|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
20199130|NCT02239939|WFSM|Dr. Barbara Nicklas|3367138569|bnicklas@wakehealth.edu|
20199131|NCT03678402|The Ohio State University Wexner Medical Center|Dr. Tammy Moore|6142937847|tammy.moore@osumc.edu|
20199132|NCT03325673|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20199133|NCT00919100|MMJ Labs|Dr. Amy Baxter|877-805-2899|abaxter@mmjlabs.com|106
20199134|NCT02590588|Boston Medical Center|Mark Sloan MD|617-638-2367|mark.sloan@bmc.org|
20199135|NCT00763815|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20199136|NCT01751308|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20199137|NCT02918773|Emory University|Andi L Shane MD/MPH/MSc|404-727-9880|ashane@emory.edu|
20199138|NCT02559687|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199139|NCT03524339|Cleveland Clinic|Graham Chapman|440-312-2229|gchapman5@gmail.com|
20199140|NCT04442230|Altimmune, Inc.|Sarah K. Browne, MD/Senior Director, Clinical Development|240-654-1450|sbrowne@altimmune.com|
20199141|NCT03504410|Cornerstone Pharmaceuticals Inc|Sanejev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
20199142|NCT02706873|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20199143|NCT00440947|ViiV Healthcare|GSK Response Center|866-435-7343||
20199144|NCT01827670|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199145|NCT01142401|Icahn School of Medicine at Mount Sinai|Joseph Sparano, MD|212-241-3300|joseph.sparano@mssm.edu|
20199146|NCT00689572|University of Virginia|Nassima Ait-Daoud Tiouririne, M.D.|(434)243-0570|nat7b@virginia.edu|
20199147|NCT00283075|The Rogosin Institute|Dr. Barry H. Smith, CEO|212-746-1551|bas2005@nyp.org|
20199148|NCT00524342|University of Pittsburgh|Dr. Margaret Ragni|412-209-7288|ragni@dom.pitt.edu|
20199149|NCT00549172|University of Helsinki|Dr. Teppo Järvinen, Head of study chair||teppo.jarvinen@helsinki.fi|
20199150|NCT02813694|Nabriva Therapeutics US, Inc|Jennifer Schranz, M.D., Chief Medical Officer|610 981 2842|jennifer.schranz@nabriva.com|
20199151|NCT01236300|University of Chicago Medical Center|Dr. Vani J.A. Konda|773-702-1460|vkonda@medicine.bsd.uchicago.edu|
20154529|NCT04999020|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20154530|NCT05706701|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
20154531|NCT02691663|Campbell University|Snezana Petrovic, MD, PhD, FASN|(910) 893-1751|spetrovic@campbell.edu|
20154532|NCT04268979|Moffitt Cancer Center|Margaret Byrne, Ph.D.|813-745-5569|Margaret.Byrne@moffitt.org|
20199152|NCT01797575|The University of Texas Health Science Center at Houston|Jair C Soares, MD|713-486-2627|jair.c.soares@uth.tmc.edu|
20154533|NCT04425018|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
20154534|NCT01944774|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
20154535|NCT01835756|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20154536|NCT00866320|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20199153|NCT03761615|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
20154537|NCT00387127|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199154|NCT02671136|Loma Linda University Health|Ahmed Khocht|909 558 4000|akhocht@llu.edu|
20199155|NCT01347554|Yonsei University Wonju College of Medicine|Dr. Seung-Hwan Lee|+82-33-741-0920|carshlee@yonsei.ac.kr|
20154538|NCT05101317|Peking University|Dr. Ruiping Xiao|86-010-62757243|xiaor@pku.edu.cn|
20154539|NCT01327703|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20154540|NCT00812097|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20154541|NCT00729807|University of Maryland Greenebaum Cancer Center|Edward A. Sausville, M.D., Ph.D.|410-328-7394|esausville@umm.edu|
20199156|NCT02248727|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
20199157|NCT04639583|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
20217813|NCT03767062|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
20199158|NCT02223260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199159|NCT00004259|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20199160|NCT03711500|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|6467746738|Joshua.Kantrowitz@nyspi.columbia.edu|
20199161|NCT01902290|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20199162|NCT00517829|Texas Oncology, Tyler Cancer Center|Dr. Donald Richards|903-579-9800|donald.richards@usoncology.com|
20199163|NCT02443883|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20199164|NCT02199080|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Antoine Milhem|+33546455050|antoine.milhem@ch-larochelle.fr|
20199165|NCT02250274|Marshfield Clinic Research Foundation|Director of the Center for Clinical Epidemiology & Population Health|715-389-3444|belongia.edward@mcrf.mfldclin.edu|
20199166|NCT02018627|Massachusetts General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
20199167|NCT00446511|Novartis Pharmaceuticals|Study Director|862-778-8300||
20199168|NCT01179009|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
20199169|NCT00835237|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199170|NCT03339921|MOMH|Amanda Crawford|7026533583|amanda.j.rawford.ctr@health.mil|
20199171|NCT01265550|Dallas VA Medical Center|Stuart Spechler||sjspechler@aol.com|
20199172|NCT02079987|University of Florida|Donna L. Carden, MD, MPH|352-265-5911|dcarden@ufl.edu|
20199173|NCT01627860|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
20199174|NCT02970292|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261-2897|medicalinformation@acadia-pharm.com|
20199175|NCT00894556|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199176|NCT00254462|University of Nebraska Medical Center|Christopher J. Kratochvil|402-552-6005|ckratoch@unmc.ed|
20154542|NCT02723331|University of Colorado Hospital|Wells Messersmith, MD|303-724-0747|wells.messersmith@cuanschutz.edu|
20199177|NCT01014689|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
20199178|NCT02159703|University of Pennsylvania|Alexander Lin, MD|(215) 662-3198|alexander.lin@uphs.upenn.edu|
20199179|NCT02549209|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
20199180|NCT00333359|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
20199181|NCT00939900|SeoulNUBH|Professor|82317877194|khkoo@snu.ac.kr|
20199182|NCT00805480|Novartis Pharmaceuticals|Study Director|862-778-8300||
20199183|NCT06706245|Brown University Health|Joshua Kemp, Assistant Professor|4014321466|joshua_kemp@brown.edu|
20199184|NCT05159648|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
20199185|NCT04099251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20199186|NCT05032157|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20199187|NCT02068547|Washington University St. Louis|Wilson Z. Ray, MD|314-362-9959|rayz@wustl.edu|
20154543|NCT02513563|Moffitt Cancer Center|Jhanelle E. Gray, MD|813-745-2677|Jhanelle.Gray@moffitt.org|
20199188|NCT03657043|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20199189|NCT03047980|Kennedy Krieger Institute|Research Assistant|443-923-9569|vedmurthyp@kennedykrieger.org|3-9569
20199190|NCT01197326|Philips Healthcare|Duane A Young-Kershaw RN, BSN, Clinical Researcher|508-817-7001|duane.young-kershaw@philips.com|
20154544|NCT03573700|St. Jude Children's Research Hospital|Aimee Talleur, MD|8662785833|referralinfo@stjude.org|
20154545|NCT03674411|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|(612) 626-5654|macmi002@umn.edu|
20154546|NCT06428591|Tandem Diabetes Care|Manager, Clinical Affairs|8583666900|clinicalaffairs@tandemdiabetes.com|
20154547|NCT06086340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154548|NCT06038643|McGill University|Maiya R. Geddes|514-398-8751|maiya.geddes@mcgill.ca|
20154549|NCT02227199|University of Washington|Dr. Ajay Gopal|26-606-2037|agopal@uw.edu|
20154550|NCT01767415|Weill Cornell Medicine|Anita Ou|646-962-8188|ano2014@med.cornell.edu|
20199191|NCT02627495|Spaulding Rehabilitation Hospital|Prof. Felipe Fregni|+1 (617) 935-2743|Fregni.Felipe@mgh.harvard.edu|
20199192|NCT00880893|Sanofi Pasteur|Director||Contact-US@sanofi.com|
20199193|NCT01982292|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20199194|NCT04762537|New York Psychiatric Institute|Kenzie Potter|2535920386|kenzie.potter@nyspi.columbia.edu|
20199195|NCT02730884|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD/Professor|713-794-5783|jcortes@mdanderson.org|
20199196|NCT01695473|University of California, San Francisco|Dr. Won Kim, MD|877-827-3222|Won.Kim@ucsf.edu|
20199197|NCT01496885|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20154551|NCT03998462|North Florida/South Georgia VA Healthcare System|Dr. Dawn Schiehser, Ph.D.|352-376-1611|Dawn.Schiehser@va.gov|107538
20154552|NCT05710224|Instituto Butantan|Fernanda Castro Boulos - Diretoria Médica, Centro de Ensaios Clínicos e Farmacovigilância|+55 11 3723-6797|fernanda.boulos@fundacaobutantan.org.br|
20154553|NCT03369223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20154554|NCT03573882|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154555|NCT02965833|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
20154556|NCT02085551|Penumbra, Inc.|Michaella Corso|+1 510-995-2079|mcorso@penumbrainc.com|
20154557|NCT01769365|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@isca.vghks.gov.tw|8233
20154558|NCT03370302|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20199198|NCT00539695|Texas Children's Hospital|Dr. Rayne Rouce|832-824-4716|rouce@bcm.edu|
20199199|NCT02669017|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
20199200|NCT01289015|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
20154559|NCT03407482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20154560|NCT06061952|University Hospitals Cleveland Medical Center|Martha Sajatovic, MD|216-844-2808|martha.sajatovic@UHHospitals.org|
20154561|NCT03659916|Albireo, An Ipsen Company|Medical Director|see email|clinical.trials@ipsen.com|
20154562|NCT04185246|Trust Biosonics, Inc.|Charly Kang|+886-3-668-4965|charlykang@trust-biosonics.com|211
20154563|NCT00504231|University of Washington|Ru-Chien Chi B.S., M.D., M.S.|206 768-5217|rchi@u.washington.edu|
20154564|NCT00835978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154565|NCT01002105|Shaar Menashe Mental Health Center|Prof. Alexander Grinshpoon|+972-4-6278719|alexander.grinshpoon@sm.health.gov.il|
20154566|NCT05027282|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
20154567|NCT03695094|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
20154568|NCT00266812|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20154569|NCT00977184|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
20154570|NCT02313597|Services Institute of Medical Sciences|Dr, Shabbar Hussain Changazi|923059700111|shabbarchangazi246@gmail.com|
20154571|NCT01263379|Abeona Therapeutics|Chief Medical Officer|(216) 282-8150|clinicalresults@abeonatherapeutics.com|
20154572|NCT00552058|UCB|Study Director|+1 877 822 9493||
20154573|NCT03520569|University of Virginia|Eugene Barrett|434-924-1263|EJB8X@VIRGINIA.EDU|
20154574|NCT00743262|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5252550|f.hilgers@nki.nl|
20154575|NCT02965716|SWOG Data Management Center|Melanoma Committee Statistician|206-667-4623|jmoon@fredhutch.org|
20154576|NCT05558410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20154577|NCT04368910|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
20154578|NCT02265744|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20154579|NCT00574951|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
20154580|NCT00923702|International Agency for Research on Cancer|Dr Partha Basu|+3347273|basup@iarc.fr|8167
20154581|NCT05161936|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20154582|NCT01086475|Christian Sarkine Autism Treatment Center|Dr. Minshawi|317-944-8162|nminshaw@iupui.edu|
20154583|NCT01158404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20154584|NCT05278065|Brown University|Alexander Sokolovsky|401-863-6629|alexander_sokolovsky@brown.edu|
20154585|NCT02029443|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20154586|NCT00875329|Tampa VAMC|Rodney Vanderploeg, Ph.D|(813) 972-2000|Rodney.Vanderploeg@va.gov|6728
20154587|NCT03270241|Johns Hopkins Medicine Dermatology Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
20154588|NCT01017497|Duke University Medical Center|John Kirkpatrick MD|919 6687342|john.kirkpatrick@dm.duke.edu|
20154589|NCT00827242|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154590|NCT04790201|University of North Carolina at Chapel Hill|Bradley Gaynes, MD, MPH|(919) 445-0214|bradley_gaynes@med.unc.edu|
20154591|NCT02609633|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20154592|NCT02320292|Mayo Clinic|Dr. Thomas E Witzig|507-266-4994|witzig.thomas@mayo.edu|
20154593|NCT05762679|Johns Hopkins school of medicine|Dr. Preeti Raghavan|9174889626|praghavan@jhmi.edu|
20154594|NCT03670628|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-4562|ramasamy@miami.edu|
20154595|NCT01431846|Eastern Colorado Health Care System|Dr. Michael Ho|720-857-5115|michael.ho@va.gov|
20154596|NCT00997126|MinneapolisMRF|James Miner|6128732493|miner015@umn.edu|
20154597|NCT01197898|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
20154598|NCT00471107|NIH/NINDS|Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
20154599|NCT03925220|Tufts University|Dr. Margie Skeer|8579191262|margie.skeer@tufts.edu|
20154600|NCT04828486|Mayo Clinic|Nguyen H Tran MD MPH|507-284-2511|Tran.Nguyen@mayo.edu|
20154601|NCT02063724|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Czerniecki|813-745-7575|brian.czerniecki@moffitt.org|
20154602|NCT00896233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20154603|NCT02965456|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
20154604|NCT04465955|NGM Biopharmaceuticals|VP, Clinical Operations|(650)243-5555|ngm282@ngmbio.com|
20154605|NCT05399355|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
20154606|NCT04056468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20154607|NCT00317369|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20154608|NCT02475837|Stanford University|Ken Mahaffey MD|650.723.3096|kmahaf@stanford.edu|
20154609|NCT00371449|Mountain Home VA Medical Center|Sherri L. Smith|423.926.1171|sherri.smith@va.gov|7569
20154610|NCT00250718|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
20154611|NCT05942040|Rutgers University|Dr. Elizabeth Luth, Principal Investigator|6465120670|eluth@rwjms.rutgers.edu|
20154612|NCT03159195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199201|NCT03799458|University of New Mexico Health Sciences Center|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
20154613|NCT01750073|University of Nebraska Medical Center|Amulya C Yellala|402-559-5388|amulya.yellala@unmc.edu|
20154614|NCT05259033|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20154615|NCT01068249|UT MD Anderson Cancer Center|Dr. Pamela Soliman,Professor, Gyn Onc & Reproductive Med|(713) 745-2352|psoliman@mdanderson.org|
20154616|NCT04234568|University of Kentucky|Dr. Susanne Arnold|859-323-8043|susanne.arnold@uky.edu|
20199202|NCT01485627|UNIVERSITY OF ROCHESTER DEPARTMENT OF FAMILY MEDICINE|Ronald Epstein MD|5855069484|ronald_epstein@urmc.rochester.edu|
20199203|NCT03621280|Cortendo AB|Valentina Conoscenti, MD|1-877-937-4737|OPTICS@cortendo.com|
20199204|NCT01709149|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
20199205|NCT03509350|Emory University|Jon Sevransky MD, MHS|404-778-5734|jonathan.sevransky@emoryhealthcare.org|
20199206|NCT01425203|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199207|NCT02246062|Faculdade de ciências médicas da Santa Casa de São Paulo|Dr Débora de Oliveira Cumino|+55 11 33617333|comissaocientifica@fcmsantacasasp.edu.br|
20199208|NCT04951037|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
20199209|NCT01968135|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
20199210|NCT05630937|Nerviano Medical Sciences S.r.l.|Alberto Ocana|39 0331 58 1111|DL-Clinicaltrials@nervianoms.com|
20199211|NCT04749459|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20199212|NCT00267748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199213|NCT03245450|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20199214|NCT05051904|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199215|NCT03759665|IntraBio Ltd.|Taylor Fields, Chief Product Development Officer|+44 8081|tfields@intrabio.com|641283
20199216|NCT05098041|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20199217|NCT00464334|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199218|NCT02424526|Sacramento State|Katrin Mattern-Baxter, PT, DPT|19162785766|kbaxter@csus.edu|
20199219|NCT02898259|Clevleland|Dr. Brian Hill|1-866-223-8100|TaussigResearch@ccf.org|
20199220|NCT02681172|Piramal Imaging|Dr. Juergen Hirschfeld, Head of GRA & PV|+49 30461124615|Juergen.Hirschfeld@piramal.com|
20199221|NCT01850485|Medical Center Leeuwarden|Matty Koopmans, MSc|0031582866738|matty.koopmans@znb.nl|
20199222|NCT01046877|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20199223|NCT00967551|Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brasil|Hugo Costa-Ribeiro||hugocrj@ufba.br|
20199224|NCT03350217|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
20199225|NCT03016325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20199226|NCT03681119|NYU Langone Health|Abraham Brody, PhD, RN, FAAN|212-992-7341|Abraham.Brody@nyulangone.org|
20199227|NCT03389854|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
20199228|NCT00109707|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20199229|NCT00907101|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
20199230|NCT01618214|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20199231|NCT01297335|The Center for Clinical Research|Medical Director|3367656181|rrauck@ccrpain.com|
20199232|NCT03436862|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20199233|NCT02937818|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20199234|NCT04352439|Duke University|Dr. Brittany Davidson|+1 919 684 0188|brittany.davidson@duke.edu|
20199235|NCT01929408|Fred Hutchinson Cancer Research Center|Mohamed Sorror, MD, MSc|(206) 667-6298|msorror@fredhutch.org|
20199236|NCT02692495|MEBO Research|Irene Gabashvili, Scientific Director|(408) 341-9355|irene.gabashvili@meboresearch.org|
20199237|NCT00391222|Janssen Cilag Spain|EMEA Medical Affairs Director|+34 91 7228043||
20199238|NCT02249143|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
20199239|NCT00763750|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
20199240|NCT00689871|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
20199241|NCT02054897|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20199242|NCT00960843|Ethicon Endo-Surgery Inc.|Michael Schwiers Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20199243|NCT00652366|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199244|NCT00889265|Zimmer Dental|Dr Hai Bo Wen, Director of Research|760-929-4312|haibo.wen@zimmer.com|
20199245|NCT02069899|Sobi AG|Radmila Kanceva/Senior Medical Director Immunology|+ 41 22 551 91 63|Radmila.Kanceva@sobi.com|
20199246|NCT02511730|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20199247|NCT00531752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199248|NCT04703075|Johns Hopkins University School of Medicine|Maria Beatriz Kohler, Senior Research Nurse|4104048921|bkohler@jhmi.edu|
20199249|NCT00550680|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199250|NCT01119248|Rutgers/New Jersey Medical School|Anuradha Patel, MD Director of Pediatric Anesthesiology|973 972-1886|patelan@njms.rutgers.edu|
20199251|NCT01967550|Novartis Consumer Health|Clinical Project Leader pain category|+41223633111||
20199252|NCT01100437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199253|NCT00802204|Vanderbilt University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
20199254|NCT02587650|University of California, San Francisco|Dr. Adil Daud|(415) 353-7392|Adil.Daud@ucsf.edu|
20199255|NCT01534533|Peking University|Dr. Zhiyong Zou|+8610-13581525193|harveyzou2002@bjmu.edu.cn|
20154617|NCT05866367|HealthPartners Institute Neuroscience Research|Clinical Research Coordinator|651-495-6363|ClinicalTrials@HealthPartners.com|
20154618|NCT05877586|Duke University|Cristina C. Hendrix, DNS, GNP, FAAN|919-684-9358|cristina.hendrix@duke.edu|
20199256|NCT04874194|The university of Texas MD Anderson Cancer Center|Courtney DiNardo MD, Professor|713-794-1141|cdinardo@mdanderson.org|
20154619|NCT04337021|Cprl. Michael J. Crescenz VA Medical Center|Dr. Amy Helstrom|215-823-4164|amy.helstrom@va.gov|
20199257|NCT03368170|Integrative Research Laboratories AB|Joakim Tedroff/Chief Medical Officer|+ 46 707 601691|joakim.tedroff@irlab.se|
20199258|NCT04365465|UPMC Magee-Womens Hospital|Dr. Grace Lim, MD, MSc|412-641-2179|limkg2@upmc.edu|
20199259|NCT02164981|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
20199260|NCT01736579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20199261|NCT00479154|NINDS/NIH|Fatta Nahab|301-496-9526|nahabf@ninds.nih.gov|
20199262|NCT03036293|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20199263|NCT01995071|AbbVie|Global Medical Services|800-633-9110||
20199264|NCT01783678|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20199265|NCT02404103|University Louisville|Nemr Eid, MD|502-852-3772|n.eid@louisville.edu|
20199266|NCT02543528|Johnson & Johnson Vision|Elizabeth Dow -PRINCIPAL RESEARCH OPTOMETRIST|904-443-1061|edow1@its.jnj.com|
20199267|NCT01408147|Cal Poly|Suzanne Phelan|805 756 2087|sphelan@calpoly.edu|
20199268|NCT01761266|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20199269|NCT00112905|ECOG Statistical Office|Study Statistician|617-632-3012||
20199270|NCT01042600|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@mail.amc.edu|
20199271|NCT02600507|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20199272|NCT01975922|Vanderbilt University|Ann Kaiser|615-322-8163|ann.kaiser@vanderbilt.edu|
20199273|NCT02643004|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20199274|NCT04541004|ALK-Abelló A/S|David Hal Mollerup, Senior Director|+45 45747576|ClinicalTrials@alk.net|
20199275|NCT00605085|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
20199276|NCT00621504|Cerexa, Inc|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
20199277|NCT00600015|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20199278|NCT00731874|Weill Cornell Medical College/Division of Transplant Surgery|Dr. Meredith J Aull|(212) 746-0727|mea9008@med.cornell.edu|
20199279|NCT03257267|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20199280|NCT03445000|ETOP IBCSG Partners Foundation|Heidi Roschitzki-Voser|+41 31 511 94 00|ALERT-lung@etop.ibcsg.org|
20199281|NCT03311711|Emory University|Mi-Kyung Song, PhD|404-727-3134|mi-kyung.song@emory.edu|
20199282|NCT02229552|SUNY Buffalo|Leonard H Epstein|716-826-3400|ckk@buffalo.edu|
20199283|NCT00706134|Novartis Pharmaceuticals|Study Director|862-778-8300||
20199284|NCT03354754|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20199285|NCT00746252|University of Marylland, Baltimore|Gloria M. Reeves, M.D.|410-706-3522|greeves@psych.umaryland.edu|
20199286|NCT01391000|Istituto Ortopedico Rizzoli|Dr Roberta Monesi|0516366694|cristiana.forni@ior.it|0039
20199287|NCT00082888|Mayo Clinic|Thomas E. Witzig, M.D.|507-266-2040|witzig@mayo.edu|
20199288|NCT01069562|Post Graduate Institute of Medical Education and Research|Puri GD|91-9914209509|gdpuri007@hotmail.com|
20199289|NCT02684981|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199290|NCT00820898|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
20199291|NCT01000662|NYU Langone Medical Center|Dr. Silvia Formenti, Chairman, Department of Radiation Oncology|(212) 731-5039|silvia.formenti@nyumc.org|
20199292|NCT00452699|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154620|NCT03677206|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
20154621|NCT01181479|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
20154622|NCT01685437|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20154623|NCT03969420|Sumitomo Pharma Oncology, Inc|Reyna Bishop|512-363-8755|reyna.bishop@oncology.Sumitomo-Pharma.com|
20154624|NCT00500890|UT MD Anderson Cancer Center|Dr. Richard Gorlick, MD/Division Head, Pediatrics Administration|713- 563-2516|rgorlick@mdanderson.org|
20154625|NCT03837938|Dompé Farmaceutici SpA|Mauro P Ferrari, Pharm D|+39 02 583831|clinical.trials@dompe.com|
20154626|NCT01789775|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
20154627|NCT01121575|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154628|NCT03656133|Moffitt Cancer Center|Jimmy Caudell, MD, PhD|813-745-8226|jimmy.caudell@moffitt.org|
20154629|NCT06818708|University of California San Diego|Baharin Abdullah|+1 858-220-5714|baabdullah@health.ucsd.edu|
20154630|NCT03393013|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
20154631|NCT03860584|Ohio State University|Richard Bruno|8603358494|bruno.27@osu.edu|
20154632|NCT06923033|Moffitt Cancer Center|Dr. Christine Vinci, Ph.D.|813-745-5421|Christine.Vinci@Moffitt.org|
20154633|NCT03083379|University of Virginia Health System|Daniel D. Rowley, MSc, RRT-ACCS, FAARC|434-465-7235|ddr8a@virginia.edu|
20154634|NCT02400736|Tuscaloosa VA Medical Center|Lori L. Davis, M.D.|205-554-2000|Lori.Davis@va.gov|1-3819
20154635|NCT01105130|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20154636|NCT00943904|University of California, Riverside|Dr. Karen Noblett|(951) 827-7581|karen.noblett@ucr.edu|
20199293|NCT03031301|Vibrantgastro|clinical trial manager|046663322|service@vibrantgastro.com|
20199294|NCT00003460|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20199295|NCT02429414|UT MD Anderson Cancer Center|Jagtar S Heir, Professor, Anesthesiology & PeriOper Med|(713) 745-3793|jsheir@mdanderson.org|
20154637|NCT02927145|University of Oxford|Dr Angela Minassian|0044 01865611425|angela.minassian@ndm.ox.ac.uk|
20154638|NCT00327171|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20154639|NCT01363440|Regeneron|Clinical Trial Management|914 847 7000|clinicaltrials@regeneron.com|
20199296|NCT02214238|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
20199297|NCT00983983|Massachusetts General Hospital|Dr. Anne-Marie Wills|855-644-6387|awills@partners.org|
20199298|NCT01784861|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@wustl.edu|
20199299|NCT01604265|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20199300|NCT02599961|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
20199301|NCT02432235|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
20199302|NCT01895322|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
20199303|NCT00143312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20199304|NCT01834274|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20199305|NCT00606086|GlobeImmune, Inc.|Clinical Operations Manager|3036252700|Alicia.Mattson@globeimmune.com|
20199306|NCT02500628|Woodinville Psychiatric Associates|Jon Berner MD PhD|425-481-0429|jonbernermd@gmail.com|
20199307|NCT01471457|University of New Mexico|Kate Meriwether|5052495967|meriwet2@salud.unm.edu|
20199308|NCT01890642|Medical College of Wisconsin|Maren Lunoe|414-266-2625|mlunoe@mcw.edu|
20199309|NCT03028870|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
20199310|NCT00490451|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20199311|NCT01181011|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257|clintriage.rdg@boehringer-ingelheim.com|Option 4
20199312|NCT00610987|University of Missouri, Department of Orthopaedics|Dr. Brett Crist|573-882-6562|cristb@health.missouri.edu|
20199313|NCT00254501|University of Florida|Dale Kraemer||Dale.Kraemer@jax.ufl.edu|
20199314|NCT01223703|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr Savina Nodari|00390303996|nodari@med.unibs.it|587
20199315|NCT04249687|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
20199316|NCT00250835|University of New Mexico|Fa-Chyi Lee, MD|5059250405|flee@salud.unm.edu|
20199317|NCT01550562|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
20199318|NCT04011280|Pacific Treatment and Research Center|Dr. Benjamin McKenna|858-534-8817|bmckenna@health.ucsd.edu|
20199319|NCT01035905|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20199320|NCT04942925|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20199321|NCT01452152|University of Maryland School of Medicine|Dr. Alan R. Shuldiner|410-706-1623|ashuldin@medicine.umaryland.edu|
20199322|NCT01332357|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199323|NCT02380716|W. L. Gore & Associates|Greg Miller|623-234-5910|gmiller@wlgore.com|
20199324|NCT02867995|Boston Medical Center|Dr. Manishi Desai|671-414-8806|Manishi.Desai@bmc.org|
20199325|NCT03315871|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
20199326|NCT05048719|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20199327|NCT03936387|BOSTON CHILDREN'S HOSPITAL|ROLAND BRUSSEAU MD|6173557737|roland.brusseau@childrens.harvard.edu|
20199328|NCT00616109|University of Michigan|Gregory Kalemkerian, M.D.|(734) 936-4991|kalemker@umich.edu|
20154640|NCT03017261|Think Surgical|Valentina Campanelli|510-249-2314|vcampanelli@thinksurgical.com|
20199329|NCT03300466|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20199330|NCT02921971|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20199331|NCT01602692|University of Wisconsin - Madison|Dr. Venkat Rao|(608) 263-1223|rao@surgery.wisc.edu|
20199332|NCT00648375|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
20199333|NCT00679952|Seoul National University College of Medicine|Clinical instructor|82-2-2072-2817|meejookang@gmail.com|
20199334|NCT01022190|Radboud University Nijmegen Medical Centre|Study director|+31 24 36 13918||
20199335|NCT01903837|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
20199336|NCT01857713|Somna Therapeutics, L.L.C.|James Miller|262-345-5553|jmiller@somnatherapeutics.com|102
20199337|NCT02615743|Children's Hospital of Philadelphia|Dr. Chen Kenyon, Faculty PolicyLab and Assistant Professor University of Pennsylvania|267-426-6339|kenyonc@email.chop.edu|
20199338|NCT01857869|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199339|NCT02465073|Southwest Regional Wound Care Center|Randall Wolcott|806-793-8869|randy@randallwolcott.com|
20199340|NCT04400474|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
20199341|NCT03303794|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
20199342|NCT03603496|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-3548|nrigotti@partners.org|
20199343|NCT03594227|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
20199344|NCT00790907|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199345|NCT01888640|University of Iowa|Dr. Kathleen A. Sluka|319-335-9791|kathleen-sluka@uiowa.edu|
20199346|NCT00774345|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@BMS.com|
20199347|NCT01277549|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
20199348|NCT00075504|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
20199349|NCT02228590|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|clinicaltrialdisclosure@sunovion.com|
20199350|NCT02109484|Chris Hani Baragwanath Academic Hospital|Michelle J. Groome, MD, PhD|+27 11 983 4283|groomem@rmpru.co.za|
20199351|NCT02111993|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
20154641|NCT02323334|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20199352|NCT01097863|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20199353|NCT00796315|Procter & Gamble|Guhan Balan|513.622.2657|balan.g@pg.com|
20199354|NCT00440505|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
20199355|NCT04074928|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20199356|NCT05182554|MIT|LISA HO|5106505455|lisaho@mit.edu|
20199357|NCT01400451|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20199358|NCT03496428|Implantology Institute|Prof. Dr. Duarte Marques|+351217 210 980|d.marques@institutoimplantologia.com|
20199359|NCT01618942|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
20199360|NCT00558870|University of Texas (UT) MD Anderson Cancer Center|Sriram Yennurajalingam, Palliative Care & Rehabilitation Medicine||CR_Study_Registration@mdanderson.org|
20199361|NCT04417894|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20199362|NCT02864368|Duke University Medical Center|Principal Investigator|(919) 684-5301|dukebrain1@duke.edu|
20199363|NCT04036968|Johns Hopkins University School of Medicine|Kelly Dunn, Professor|410-550-2254|kdunn9@jhmi.edu|
20199364|NCT02997904|Piedmont Pharmaceuticals|Dr. Kathy Palma|336 544 0320|kpalma@piedmontpharma.com|202
20199365|NCT00106171|Johns Hopkins University|Dr. Joseph Margolick|410-955-1436|jmargoli@jhsph.edu|
20199366|NCT01836783|University of Alabama at Birmingham|Maninder Kaur, BDS, MPH, MS, Principal Investigator|205-9344506|maninder@uab.edu|
20199367|NCT00853671|Massachusetts General Hospital|Dr. Brian B. Ghoshhajra|617-726-3745|bghoshhajra@partners.org|
20199368|NCT01273883|Mayo Clinic|Dr. Michael J. Cevette|480-301-7020|mcevette@mayo.edu|
20199369|NCT03649061|UZLeuven|Prof. Dr. Patrick Verschueren|+3216342541|patrick.verschueren@uzleuven.be|
20199370|NCT02124564|Cares|UCB|+1844599|UCBCares@ucb.comTokyo|2273
20199371|NCT04489888|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199372|NCT01003275|University of Washington|Ian H. de Boer, MD, MS, Associate Professor of Medicine|2066165403|deboer@u.washington.edu|
20199373|NCT02043548|University of Pittsburgh|Chester Oddis, MD|412-383-8861|cvo5@pitt.edu|
20154642|NCT00530075|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
20154643|NCT01166945|University of Wisconsin School of Medicine and Public Health|Ellen Wald, MD|608-263-8558|erwald@pediatrics.wisc.edu|
20154644|NCT00442689|Northwestern University|Dr. Laura Torchen|312-227-6492|ltorchen@luriechildrens.org|
20154645|NCT03202550|Johns Hopkins University|Katrina Thaler|410-550-8506|kstouff3@jhmi.edu|
20154646|NCT00784927|Mayo Clinic Arizona|Craig B. Reeder, MD||Reeder.Craig@mayo.edu|
20154647|NCT01779362|George Washington University Biostatistics Center|Sharon Edelstein, Lead Research Scientist|301-881-9260|sharone@bsc.gwu.edu|
20154648|NCT00714272|eXcorLab GmbH|Dr. Horst-Dieter Lemke|+49-6022-812648|horstdieter.lemke@excorlab.de|
20154649|NCT00422461|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164522|NCT00717249|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S. Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
20164523|NCT00871871|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20164524|NCT03863509|University of Wisconsin-Madison|Dr James H. Stein|608-262-2075|jhs@medicine.wisc.edu|
20164525|NCT03799341|VA Pittsburgh Healthcare System|Sarah Forster, PhD|412-209-9208|sarah.forster2@va.gov|
20164526|NCT00990106|VA Puget Sound Health Care System|Murray Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
20164527|NCT03100149|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20164528|NCT01857297|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20164529|NCT03492125|MingSight Pharmaceuticals|Kai Zhang|8582055958|kzhang@mingsight.com|
20164530|NCT03213834|University of Florida|Erin Silverman, Research Coordinator|352-273-5870|erin.silverman@medicine.ufl.edu|
20164531|NCT00791908|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
20164532|NCT01855360|Brigham and WQomen's Hospital|Rodney H Falk|6175257053|rfalk@bwh.harvard.edu|
20164533|NCT00932321|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20164534|NCT00445549|National Cancer Institute, National Institutes of Health|Elise C. Kohn, M.D.|301-496-4916|kohne@mail.nih.gov|
20164535|NCT02849418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20164536|NCT01405768|Washington University School of Medicine|L. Stewart Massad, M.D.|314-362-3181|massadl@wudosis.wustl.edu|
20164537|NCT03692208|The University of Chicago|Dr. Elbert Huang|(773) 834-9143|ehuang@medicine.bsd.uchicago.edu|
20164538|NCT04755816|University of Michigan College of Pharmacy|Dr. MICHAEL DORSCH|734/647-1452|mdorsch@umich.edu|
20164539|NCT02792231|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20154650|NCT02357485|UCLA Medical Center|Peter Fodor, MD|3102039818|pbfodor@centurysurgery.com|
20154651|NCT01795937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154652|NCT01028053|GE Healthcare|Paul Sherwin M.D.|16095146820|Paul.Sherwin@ge.com|
20154653|NCT02346916|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
20154654|NCT01004393|Seirei Hamamatsu General Hospital|Masanori Mori, MD|81-53-474-2222|Masanori.Mori@sis.seirei.or.jp|
20154655|NCT03281538|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20154656|NCT02313272|Moffitt Cancer Center|Peter Forsyth, MD|813-745-3063|peter.forsyth@moffitt.org|
20154657|NCT01336972|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20154658|NCT00593645|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20154659|NCT02441114|Seoul National University Hospital|Clinical Pharmacology and Therapeutics|82-2-2072-4081|rheesjin@gmail.com|
20164540|NCT05196828|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
20164541|NCT04073186|Johnson & Johnson Vision Care|Thomas Karkkainen- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20154660|NCT03446573|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20199374|NCT00507559|Medtronic Endovascular|Kristin Schwartz|(763) 514-4000|kristin.schwartz@medtronic.com|
20199375|NCT00631748|VA Puget Sound Health Care System|Andre Tapp, MD|253-589-4176|andre.tapp@va.gov|
20199376|NCT00400881|Texas Tech University|Juan Figueroa-Casas|915 5456626|juan.figueroa@ttuhsc.edu|235
20199377|NCT00456989|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|ctobcc@louisville.edu|
20199378|NCT01430455|Depression Evaluation Service (New York State Psychiatric Institute)|Jonathan W. Stewart|646-774-8070|jws6@nyspi.columbia.edu|
20154661|NCT01793909|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
20154662|NCT01279187|University of Michigan|Jill Bashutski||jillbashutski@gmail.com|
20154663|NCT01769443|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20154664|NCT00634972|University of South Alabama|Fabien Eyal, MD|251-415-1055|feyal@health.southalabama.edu|
20154665|NCT00837447|Ewha Womans University School of Medicine|Young-Hoo Kim, MD|822-26505900|younghookim@ewha.ac.kr|
20154666|NCT02122952|AveXis, Inc.|Doug Feltner, MD|833-828-3947|medinfo@avexis.com|
20154667|NCT02508207|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20154668|NCT02991521|Medical City Arlington, 3301 Matlock Rd, Arlington, TX 76015|Danielle A Pigneri, MD, FACS|(502) 387-3117|dpigneri@gmail.com|
20154669|NCT06042855|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
20154670|NCT05901467|Massachusetts General Hospital|Stephanie Seminara|617-726-1309|MGHKisspeptinResearch@partners.org|
20154671|NCT01428128|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Chul S. Ha, MD, Professor and Chair|210-450-1109|hac@uthscsa.edu|
20154672|NCT04136366|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20154673|NCT04439123|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20154674|NCT01405911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154675|NCT06375655|University Hospitals Cleveland Medical Center|Dr. Furman|216-844-3971|Lydia.Furman@UHhospitals.org|
20154676|NCT04124965|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20154677|NCT00002874|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20154678|NCT04249778|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
20154679|NCT03828383|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20154680|NCT02643199|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
20154681|NCT00504309|Penn State University|Ann Skulas-Ray|814-863-0856|aus164@psu.edu|
20154682|NCT03345095|EORTC|Dr. Thierry Gorlia|+32 2 7741652|thierry.gorlia@eortc.org|
20154683|NCT03158311|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20154684|NCT02665455|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|+44 1993 863094|joe.bugler@abbott.com|
20154685|NCT03812328|Tetherex Pharmaceuticals|Jonathan Stocker, Ph.D.|855-222-0722|jstocker@tetherex.com|
20154686|NCT03011372|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20154687|NCT07085845|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
20154688|NCT06922760|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
20154689|NCT03554473|National Cancer Institute|Dr. Anish Thomas|2407607343|anish.thomas@nih.gov|
20154690|NCT01501513|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
20154691|NCT04971837|Colorado State University|Dr. Christopher Bell, Director, Laboratory of Integrative Physiology|(970) 491-7522|Christopher.Bell@colostate.edu|
20154692|NCT03735498|Massachusetts General Hospital|Dr. Deborah Forst|617-724-8770|dforst@partners.org|
20154693|NCT00160615|Cares|UCB|+1844 599||2273
20154694|NCT03166631|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154695|NCT02740582|University of California, San Franciso|Jennifer Mitchell, PhD|510-985-3522|jennifer.mitchell@ucsf.edu|
20154696|NCT05675020|Florida State University|Rachel Sharp|850-865-4443|rls14c@fsu.edu|
20154697|NCT03787212|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, OD - Principal Research Optometrist|904 443 3449|CColesb@its.jnj.com|
20154698|NCT02014103|University of Cincinnati|Rita Alloway|513.558.1568|rita.alloway@uc.edu|
20154699|NCT05638737|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20154700|NCT00567580|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20154701|NCT02169401|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
20154702|NCT03022630|Vanderbilt University Medical Center|Dr. Cheryl Gatto|6153432252|cheryl.l.gatto.1@vumc.org|
20154703|NCT00884949|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
20154704|NCT00382070|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20154705|NCT03422718|University of Michigan|Principal Investigator|734-615-2766|mdome@umich.edu|
20199379|NCT02866279|Montefiore Medical Center|Erika Levi|7184058200|elevi@montefiore.org|
20199380|NCT03829657|Theravance Biopharma Ireland Limited|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
20199381|NCT00858858|VA|Stuart Spechler|214-857-1603|Stuart.Spechler@va.gov|
20199382|NCT04418076|Associate Director Domestic Projects|Natalie Kil|203.737.2883|natalie.kil@yale.edu|
20199383|NCT02553512|Proteus Digital Health|Lorenzo DiCarlo MD, Vice-President of Clinical and Medical Affairs|+1 650 637 6199|ldicarlo@proteus.com|
20199384|NCT01425008|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20199385|NCT00264238|Stanford University School of Medicine, Dept of Psychiatry|Dr John Barry, Professor|(650) 725-5588|jbarry@stanford.edu|
20199386|NCT01295216|Institute of Nutrition of Central America and Panama|Manuel Ramirez-Zea|+502 24719913|mramirez@incap.int|
20199387|NCT00562588|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154706|NCT03309605|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
20199388|NCT04527185|Yale School of Medicine|Terril Verplaetse|203-737-6496|terril.verplaetse@yale.edu|
20199389|NCT02240654|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199390|NCT02532231|The University of Texas MD Anderson Cancer Center|Tapan Mahendra Kadia, MD/Professor|713-563-3534|tkadia@mdanderson.org|
20199391|NCT00264004|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20199392|NCT03691974|Regeneron Pharmaceuticals, Inc|Study Director|844-734-6643|clinicaltrials@regeneron.com|
20199393|NCT00691483|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199394|NCT00439946|United Therapeutics|Remodulin Program Leader|(919) 485-8350|ClinicalRecordsManagement@unither.com|
20199395|NCT03860961|NRG Oncology|Wendy Seiferheld|(215) 574-3208|seiferheldw@nrgoncology.org|
20199396|NCT02105454|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199397|NCT00493870|US Oncology Research|Taqi Mohammad|281-863-6439|taqi.mohammad@mckesson.com|
20199398|NCT00272038|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD, FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
20199399|NCT02721355|Immunology Research Institute in Gifu|Dr. Van Sa Nguyen|+819068053288|nguyen@ew-nutrition.co.jp|
20199400|NCT00356278|Emory University|Barbara O. Rothbaum, PhD, ABPP|404-712-8866|brothba@emory.edu|
20154707|NCT01129284|Columbia University Medical Center|Dr. Andrew S. Bomback, MD, MPH|212-305-0320|asb68@columbia.edu|
20199401|NCT01166230|The University of Texas|H. Barton Grossman, MD|713-563-7456|hbgrossman@mdanderson.org|
20154708|NCT01629862|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
20154709|NCT03050489|First State Pavlov Medical University|Nikolay Bunenkov|+7-950-028-17-40|bunenkov2006@gmail.com|
20154710|NCT00245570|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154711|NCT04565288|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
20154712|NCT01913470|Emory University|Miriam Vos, MD, MSPH|404-727-9930|mvos@emory.edu|
20154713|NCT00727337|Department of Veterans Affairs|Rachel McArdle|727-398-6661|Rachel.mcardle@va.gov|17479
20154714|NCT00412451|ThromboGenics NV|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
20154715|NCT03300336|HSRD ADAPT|S. Nicole Hastings|919-286-6936|susan.hastings@va.gov|
20154716|NCT01901588|NYU School of Medicine|Assistant Professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine|212.263.5072|wanda.chin@nyumc.org|
20154717|NCT01030575|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
20154718|NCT00489268|Mayo Clinic, Arizona|David E. Fleischer, M.D.|(480) 301-4461|fleischer.david@mayo.edu|
20154719|NCT00505362|Stanford University|Anna Girsen, Manager of Research Operations|6507250499|agirsen@stanford.edu|
20154720|NCT01579305|Allergan, Inc.|Medical Monitor|805 961 5000|devicetrials@allergan.com|
20154721|NCT02384460|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
20154722|NCT02400580|University of Pittsburgh Medical Center|Dr. Noah Rindos|(412) 641-8769|rindosnb@upmc.edu|
20154723|NCT00965094|Novartis Pharmaceuticals|Study Director|862-778-8300||
20154724|NCT01060111|Medical Affairs / Janssen-Cil Korea|Clinical Research Associate|82-2-2094-4837||
20154725|NCT00625378|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20154726|NCT04270760|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20154727|NCT02070991|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
20154728|NCT04018001|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154729|NCT02448043|Department of Ophthalmology, Northwestern University Feinberg School of Medicine|Dr. David J. Palmer|3126958150|dpalmermd@comcast.net|
20154730|NCT04022694|University of Pennsylvania|Deputy Director of PEACH Lab|2158987093|thepeachlab@gmail.com|
20154731|NCT03296345|Valley Children's Hospital|Jonathan Bryan Cooper-Sood, MD|559-353-3000|coopersoodj@usacs.com|
20154732|NCT02487485|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
20154733|NCT04149353|North Carolina State University|David Lalush|919-513-7671|dslalush@ncsu.edu|
20154734|NCT02068599|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20154735|NCT01871727|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20154736|NCT01263028|Kaiser Permanente|John J. Sim, MD||john.j.sim@kp.org|
20154737|NCT03838874|Mayo Clinic|Dr. Matthew Abdel|507-538-1296|Abdel.Matthew@mayo.edu|
20154738|NCT02958527|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154739|NCT02691572|Department of Anesthesia and Surgical Intensive Care, Mansoura University Hospitals, Mansoura, Egypt.|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
20164542|NCT00473434|Jan-Cil Australia|Regional Medical Affairs Therapeutic Lead Immunol|61 2 88753219||
20164543|NCT00558246|Ethicon|Phyllis Britnell|1 908 218-3060|pbritnel@its.jnj.com|
20164544|NCT05552027|Children's Hospital of Philadelphia|Morgan O'Donald|267-499-4114|ODONALDM@chop.edu|
20164545|NCT00423657|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
20199402|NCT00883337|sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20164546|NCT02748863|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20164547|NCT02422498|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
20164548|NCT03206216|Stanford University Medical Center|Seema Nagpal, MD|650-725-8630|snagpal@stanford.edu|
20164549|NCT00657046|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
20154740|NCT01947933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154741|NCT00294398|CHOP|Esther Sampayo MD MPH|215-590-1944|sampayo@email.chop.edu|
20154742|NCT00985790|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164550|NCT06237049|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
20199403|NCT01652287|Georgetown University Medical Center, Department of Family Medicine|Director of Research Programs|202-687-1600|FamilyMedResearch@georgetown.edu|
20199404|NCT01578980|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
20199405|NCT00527605|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199406|NCT01480297|The University of Michigan|Rodica Pop-Busui, MD, PhD|734-763-3056|rpbusui@umich.edu|
20199407|NCT01535365|Stony Brook U|Adam Singer|631-444-7856|adam.singer@stonybrook.edu|
20199408|NCT03126760|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
20199409|NCT00763139|Vanderbilt|Dr. Charles Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
20199410|NCT01592760|Universtiy of Wisconsin School of Medicine and Public Health|Richard E. Galgon, MD, MS|608-263-8100|galgon@wisc.edu|
20199411|NCT04312009|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
20199412|NCT01008280|VISN 22 Network Office|Peter Hauser, MD, VISN 22 Mental Health Services Lead|562 826 8000|peter.hauser2@va.gov|2629
20199413|NCT01363986|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199414|NCT01637142|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20199415|NCT03468309|VA Puget Sound Health Care System|Dr. Amanda E. Wood; Clinical Research Psychologist, VA PSHCS|253-583-1652|amanda.wood@va.gov|71652
20199416|NCT02396732|University of Miami|Kenneth Proctor|305-585-1178|kproctor@med.miami.edu|
20199417|NCT00179309|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D., Ph.D.|301-435-2956|gulleyj@mail.nih.gov|
20199418|NCT00488982|University of California, San Francisco|Dr. Rahul Aggarwal|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
20199419|NCT03340610|Southeast Retina Center|Dr. Dennis Marcus|706650061|dmarcus@southeastretina.com|
20199420|NCT02698735|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
20199421|NCT01777152|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20199422|NCT03548558|University of Southern California|Dr. Jill Luoto|+1-213-764-1581|jluoto@usc.edu|
20199423|NCT03716869|MS Hershey MC|Deepa Sekhar, Associate Professor of Pediatrics, Executive Director Penn State PRO Wellness|7175310003|dsekhar@pennstatehealth.psu.edu|281334
20199424|NCT01789814|Tufts Medical Center|Carey Kimmelstiel, MD Director of the Adult Cardiac Catheterization Laboratory|617-636-4504|Ckimmelstiel@tuftsmedicalcenter.org|
20199425|NCT05726318|University of Pittsburgh|Megan Bradley, MD|412-641-3189|bradleym4@upmc.edu|
20199426|NCT04589988|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
20199427|NCT05980299|Miami University|Dr. Katherine Abbott|513-529-0869|abbottkm@miamioh.edu|
20199428|NCT06117319|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20199429|NCT00290433|The University of Texas (UT) MD Anderson Cancer Center|Christopher Flowers/Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
20199430|NCT03001674|Tufts Medical Center|Dr. Navin Kapur|617 636 0720|nkapur@tuftsmedicalcenter.org|
20199431|NCT00793650|Emory University|Dr. Sagar Lonial|404-727-5572|sloni01@emory.edu|
20199432|NCT02264990|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20199433|NCT02128230|University of Arkansas for Medical Sciences|Frits Van Rhee, MD|501-526-2873|vanrheefrits@uams.edu|
20199434|NCT00876993|Johns Hopkins All Children's Hospital|Stacie Stapleton|727-767-4176|stacie.stapleton@jhmi.edu|
20199435|NCT01849172|Guang'an Men Hospital, China Academy of Chinese Medical Sciences|Dr.Zhishun Liu|+86 01088002331|liuzhishun@aliyun.com|
20199436|NCT01098071|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20199437|NCT01515657|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
20199438|NCT00797732|Dana-Farber Cancer Institute|Weidong Lu, PhD, MB, Lic.Ac.|617.632.4350|weidong_lu@dfci.harvard.edu|
20199439|NCT02164422|Yale School of Medicine|Dr. Sherry McKee|2037373529|sherry.mckee@yale.edu|
20199440|NCT02112370|Seoul National University Hospital Department of Surgery|Dr. Kyu Eun Lee|+82)-2-2072-2817|kyueunlee@snu.ac.kr|
20199441|NCT01558661|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
20199442|NCT02154386|UT Health Science Center San Antonio (School of Dentistry)|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
20199443|NCT05515250|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
20199444|NCT04607733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20199445|NCT01665807|Mount Sinai Hospital, IDERU|Brenda L. Coleman, PhD,|416-586-4800|bcoleman@mtsinai.on.ca|4538
20199446|NCT03504397|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20199447|NCT00758745|Alcon Research, Ltd.|Director of Clinical Research|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20199448|NCT03215771|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
20199449|NCT02685709|Amryt|Asi Haviv, VP Clinical development|972 8 9393888|Asi@amrytpharma.com|
20199450|NCT00574275|Sanofi|International Clinical Development Study Director||Contact-Us@sanofi.com|
20199451|NCT02703311|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
20199452|NCT00619073|Children's Hospital Boston|Alan D. Michelson, M.D.|617-919-2116|alan.michelson@childrens.harvard.edu|
20199453|NCT01967537|Principal Investigator|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
20199454|NCT00137111|St. Jude Children's Research Hospital|Ching-Hon Pui|1-866-278-5833|info@stjude.org|
20199455|NCT02788747|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
20199456|NCT00562354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154743|NCT00762177|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
20199457|NCT00317109|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199458|NCT01026831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199459|NCT03124771|Masimo|Tala Harake||studies@masimo.com|
20199460|NCT01079182|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20154744|NCT03753542|Institute of Nursing Dow University of Health Sciences, Karachi/Sindh Nurses Examination Board, Karachi|Nomi Waqas Gul, Student MSN DUHS ION and Asst. Controller Sindh Nurses Examination Board, Karachi|0345-2506790|nomiwg@gmail.com|
20154745|NCT06100250|University of Michigan|Dr. Akshay Sharma|734-647-0151|akshaydr@umich.edu|
20154746|NCT04180696|Medtronic, Bakken Research Center B.V.|Lidwien Vainer|+31610419653|lidwien.vainer@medtronic.com|
20154747|NCT05537571|Silence Therapeutics plc|Global Regulatory|+442034576900|global-regulatory@silence-therapeutics.com|
20199461|NCT01508702|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
20154748|NCT04210375|Salubris Biotherapeutics, Inc|SVP, Clinical Development|16176459160|amanda.mcewen@salubrisbio.com|
20154749|NCT00424008|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20154750|NCT02593864|Stanford University|Constance Chu, MD|650-723-5643|chucr@stanford.edu|
20154751|NCT02184156|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20154752|NCT01276652|University of Iowa|Brian Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
20154753|NCT02213575|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
20154754|NCT03233217|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
20154755|NCT02114684|CAPRISA|Mrs Nonhlanhla Yende-Zuma|0027312604392|Nonhlanhla.Yende@caprisa.org|
20154756|NCT02530242|UCSF Benioff's Children's Hospital Oakland|Ashutosh Lal, MD||Ashutosh.Lal@ucsf.edu|
20154757|NCT00283959|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20199462|NCT00879697|University of São Paulo|Raphael Dias|55 81 9728 6878|raphaelritti@gmail.com|
20199463|NCT02500121|Hoosier Cancer Research Network|Clinical Trials Results Coordinator|317-634-5842|aneal@hoosiercancer.org|21
20199464|NCT03730116|Sevier|Mrdical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|1389
20199465|NCT01437397|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20199466|NCT00903175|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20199467|NCT03074474|TELA Bio|Neal Overbeck|484-802-9570|noverbeck@telabio.com|
20199468|NCT03441178|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
20199469|NCT00970853|Children's Hospital of Philadelphia|Dr. Jerilynn Radcliffe|215-590-7446|radcliffe@email.chop.edu|
20199470|NCT03221738|Massachusetts General Hospital|Anna Schwartzberg|617-724-7161|aschwartzberg@mgh.harvard.edu|
20199471|NCT00328627|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20199472|NCT02049944|Memorial Care|Dr. Morgan Swank|5624808460|morganswankmd@gmail.com|
20199473|NCT01662440|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20199474|NCT01765673|James Madison University|Christy Ludlow|540-937-3007|ludlowcx@jmu.edu|
20199475|NCT01284114|Division of Nephrology, Department of Internal Medicine, Jichi Medical University|Dr. Yoshiyuki Morishita|81-285-58-7346|ymori@jichi.ac.jp|
20199476|NCT03409744|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20199477|NCT04872101|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20199478|NCT02475681|Acerta Clinical Trials|Study Director|18882929613|acertamc@dlss.com|
20199479|NCT02896595|Virginia Commonwealth University Health Department of Anesthesiology|Praveen Prasanna|804-828-2207|praveen.prasanna@vcuhealth.org|
20199480|NCT02323698|Spaulding Rehabilitation Hospital|Dr. Randy D Trumbower, PI|(617) 952-6953|randy.trumbower@mgh.harvard.edu|
20199481|NCT02025426|Duke University, School of Medicine, Department of Anesthesiology|Dr. Ashraf Habib|(919) 681-4544|ashraf.habib@duke.edu|
20154758|NCT01214720|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20154759|NCT05591755|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20154760|NCT01397747|Exact Sciences|Director of Clinical Operations|608-284-5700|tvaughn@exactsciences.com|
20154761|NCT05865886|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154762|NCT01671059|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20154763|NCT00314106|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20154764|NCT01033071|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20154765|NCT02564978|National Institutes of Health|Tiarnan Keenan, MD, PhD, Principal Investigator, NEI|301-451-6330|tiarnan.keenan@nih.gov|
20154766|NCT01729091|The University of Texas MD Anderson Cancer Center|Samer Srour, MD / Stem Cell Transplantation|713-794-4354|SSrour@mdanderson.org|
20154767|NCT05206604|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154768|NCT00142597|University of Michigan|Richard E. Harris|734-998-6996|reharris@med.umich.edu|
20154769|NCT00456612|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
20154770|NCT01834261|Stony Brook University|Lilianne Mujica Parodi, PhD / Study Principal Investigator|631-632-1008|lilianne.strey@stonybrook.edu|
20154771|NCT02316613|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20154772|NCT01108796|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154773|NCT00758043|Vertex Pharmaceuticals Incorporated|Robert Kauffman, MD, PhD|617-444-6158|Robert_Kauffman@vrtx.com|
20154774|NCT03989570|Minia university|Dr. Hassan Elshorbagy|1204427271|Hassan.Hetta@mu.edu.eg|0020
20154775|NCT00358579|Singapore General Hospital|A/Prof Marcus Ong Eng Hock|+6563213590|marcus.ong.e.h@sgh.com.sg|
20154776|NCT05788328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154777|NCT00771602|UT MD Anderson Cancer Center|Stefan Faderl, MD / Professor|713-745-4613||
20154778|NCT00145327|Novartis Pharmaceuticals|Study Director|862-778-8300||
20154779|NCT04027946|National Cancer Institute|Dr. Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
20199482|NCT01745146|Moss Rehabilitation Research Institute|Dr. Tessa Hart, PhD|215-663-6153|thart@einstein.edu|
20199483|NCT04623242|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
20199484|NCT03598166|VA|Anika Zaman|6464190648|anika.zaman@nyulangone.org|
20199485|NCT00326898|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20199486|NCT03847987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199487|NCT01869647|Yale Emergency Medicine|Dr. Chris L. Moore|(203)737-3313|chris.moore@yale.edu|
20199488|NCT02605642|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199489|NCT02165384|Preceptis Medical|CEO|6123274795|steve@preceptismedical.com|
20199490|NCT02762513|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
20199491|NCT01390909|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199492|NCT02111564|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20199493|NCT00687362|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20199494|NCT02354703|University of Maryland School of Medicine|Dr. David Gorelick|410-408-6806|dgorelick@som.umaryland.edu|
20199495|NCT03438045|NYU Grossman School of Medicine|Mary E. Northridge, PhD, MPH, Director of Dental Research|(347) 377-4342|Mary.Northridge@nyulangone.org|
20154780|NCT03593629|Jomo Kenyatta University of Agriculture and Technology and University of Washington|Kenneth Ngure|+254722362219|kngure@uw.edu|
20154781|NCT03315689|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
20154782|NCT00864513|Georgetown University|Dr. Jimmy Hwang|202-444-2198|jh96@gunet.georgetown.edu|
20154783|NCT03073109|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154784|NCT01297244|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
20154785|NCT01348698|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
20154786|NCT01875237|UT MD Anderson Cancer Center|Champlin,Richard,M.D. / Stem Cell Transplantation|713-792-8750|rchampli@mdanderson.org|
20154787|NCT03558672|Tactile Medical|Director of Clinical Research|612.540.5267|astone@tactilemedical.com|
20154788|NCT00666978|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
20154789|NCT00983957|Bristol-Myers Squibb International Corporation|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20154790|NCT03055195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20154791|NCT00986232|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154792|NCT00790933|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20154793|NCT00875667|Celgene Corporationi|Anne McClain, Senior Manager, Clinical Trial Disclosure|8882601599|ClinicalTrialDisclosure@Celgene.com|
20154794|NCT03395990|Duke University Medical Center|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
20154795|NCT00894647|Graceway Pharmaceuticals|Vice President Medical Affairs|267-948-0400|Sharon.levy@gracewaypharma.com|
20154796|NCT01967277|Capillus LLC|Patricia Schnoor|7868881874|pschnoor@capillus.com|
20154797|NCT02573467|Novartis Pharmaceuticals|Study Director|862-778-8300||
20154798|NCT01829165|Stanford University|Amit Etkin, MD, PhD|(650) 725-5736|aetkin@stanford.edu|
20154799|NCT04285684|Ketamine Research Foundation|Philip E Wolfson, MD|415-550-1700|ketamine.research@gmail.com|
20154800|NCT01404260|Shanghai Chest Hospital|Shun LU|86-2162821990|shun_lu11@163.com|
20154801|NCT00710970|Baylor College of Medicine|Seth P. Lerner, M.D., F. A. C. S.|713-798-6841|slerner@bcm.edu|
20154802|NCT01028560|Jacobi Medical Center / Albert Einstein College of Medicine|Gabriele de Vos, M.D.|7184152809|gabriele.de-vos@einstein.yu.edu|
20154803|NCT02153827|University of St. Augustine|Eric Chaconas|904-826-0084|echaconas@usa.edu|1275
20154804|NCT01033227|Children's Hospital Los Angeles|Dr. Thomas Coates|323 361 3841|TCoates@chla.usc.edu|
20154805|NCT01960842|AbbVie|Global Medical Information|1-800-633-9110||
20154806|NCT00397930|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20154807|NCT02391584|Entellus Medical|Clinical Affairs Manager|7634631595|rschacherer@entellusmedical.com|
20154808|NCT03676725|AlkaliDx|Lynn Feldman|16178791670|lynn@alkalidx.com|
20154809|NCT05696158|Mahana Therapeutics|Kathryn Jenkins|17742666693|kathryn@mahanatherapeutics.com|
20154810|NCT03034928|Alcon, A Novartis Division|Sr CDMA Project Lead, GCRA - Vision Care|1-888-451-3937|Alcon.medinfo@alcon.com|
20154811|NCT03019588|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154812|NCT00887588|Novartis Pharmaceuticals|Study Director|862-778-8300||
20154813|NCT00366535|Symptoms Biology Unit, DIR, NINR, NIH|Leorey Saligan, Chief|301-451-1685|saliganl@mail.nih.gov|
20154814|NCT00106535|Hoffmann-La Roche|Medical Communications|800-821-8590||
20154815|NCT00699751|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20154816|NCT04514458|Yale University|Tariq Ahmad|203-843-1667|tariq.ahmad@yale.edu|
20154817|NCT05089357|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20154818|NCT05752487|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20164551|NCT02525471|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
20164552|NCT00844376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20199496|NCT01968460|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
20199497|NCT01268293|Eisai Co., Ltd.|Tatsuya Sasaki|81-3-3817-5252||5252
20199498|NCT00699348|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20154819|NCT01860989|Novartis Pharmaceuticals|Study Director|862-778-8300||
20154820|NCT00759096|Alcon Research, Ltd.|Benny Li, PhD|+86 21 6375 8762|Benny.Li@Alconlabs.com|
20199499|NCT01099202|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
20199500|NCT02597855|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
20199501|NCT05362526|University of Florida|Ashleigh Wehy, MD|9042449440|amweyh@gmail.com|
20199502|NCT03522324|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|lcb@colorado.edu|
20199503|NCT03704194|Washington university in St.louis|Brittany Minor|314-273-4118|bminor@wustl.edu|
20199504|NCT00925015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199505|NCT03491384|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|CUChange@Colorado.edu|
20199506|NCT04681170|Amryt Pharmaceuticals DAC|Head of Clinical Operations|+35315180200|janet.boylan@amrytpharma.com|
20199507|NCT04986202|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20199508|NCT02118792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199509|NCT05131204|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20199510|NCT01484626|Loyola University Medical Center|Scott Smith, M.D., Ph.D.|708-327-3142|ssmith8@lumc.edu|
20199511|NCT02363686|University of Colorado|Carrie Higgins|7205603037|carrie.higgins@cuanschutz.edu|
20199512|NCT03756038|University of Pittsburgh|Dr. Maria Pacella|412-647-3183|pacellam@upmc.edu|
20199513|NCT02952222|Boston Children's Hospital|Dr. Keira Mason|(617) 355-7737|keira.mason@childrens.harvard.edu|
20199514|NCT05526833|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
20199515|NCT02469090|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
20199516|NCT00586573|Massachusetts General Hospital|Craig Surman, MD|617-503-1424|csurman@partners.org|
20199517|NCT04852120|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20199518|NCT00522795|BrUOG|Kayla Rosati|401-863-3000|Kayla_Rosati@brown.edu|
20199519|NCT03823391|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20199520|NCT01833130|Allergan, Inc|Medical Director,||clinicaltrials@allergan.com|
20199521|NCT05215600|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
20199522|NCT04283123|Washington University School of Medicine in St. Louis|Susan Stark, PhD, OTR/L, FAOTA|(314)273-4114|sstark@wustl.edu|
20199523|NCT05882318|Valencia Technologies|Dylan Beyer|+1 (661) 775-1414|dbeyer@valenciatechnologies.com|
20199524|NCT03461445|UC Davis Health|Associate Professor of Medicine|916-734-5141|lxchen@ucdavis.edu|
20199525|NCT05030311|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20199526|NCT03042468|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
20199527|NCT04175626|Biotronik, Inc|Crystal Miller|1 800-547-0394|crystal.miller@biotronik.com|
20199528|NCT03494881|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
20199529|NCT03557359|Columbia University|Fabio Iwamoto|212-342-0571|fi2146@cumc.columbia.edu|
20199530|NCT03092726|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20199531|NCT00428974|Can-Fite BioPharma Ltd|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
20199532|NCT01662895|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-63208913|mselim@bidmc.harvard.edu|
20199533|NCT00705939|Protalix Ltd.|Vice President Product Development|+(972) 4-9889488|einata@protalix.com|137
20154821|NCT00990769|Duke University Medical Center|Dr. Heather Frederick|919-812-6204|heather.frederick@duke.edu|
20154822|NCT01346683|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20154823|NCT03694652|University of New Mexico|Dr. Tracie Collins|505-272-4979|tccollins@salud.unm.edu|
20154824|NCT01018953|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20154825|NCT03927716|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
20154826|NCT01186419|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20154827|NCT02507284|Azevan Pharmaceuticals, Inc.|Neal Simon, PhD|(610) 419-1057|ngsimon@azevan.com|
20154828|NCT00853047|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
20154829|NCT01695772|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20154830|NCT00727064|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20154831|NCT00004859|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20154832|NCT04073407|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
20154833|NCT02860000|Mayo Clinic|Dr Tufia C Haddad|507-284-2511|Haddad.Tufia@mayo.edu|
20154834|NCT03651609|Institute of Clinical Neurophysiology, Division of Neurology, University Medical Centre Ljubljana, Slovenia|Gregor|+38631226546|gregor.omejec@kclj.si|
20154835|NCT01258855|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20154836|NCT04289298|Weill Cornell Medical College|Dr. Patricia Marino, PhD|914-997-8691|pam2029@med.cornell.edu|
20154837|NCT01734928|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20199534|NCT05048342|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20154838|NCT01552889|Washington University School of Medicine|Dr. Robert Carney|314-286-1313|carneyr@wustl.edu|
20154839|NCT00620035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20154840|NCT01292265|UCB, Inc.|Study Director|+1 887 822 9493||
20154841|NCT01778985|University of Texas Southwestern Medical Center|David D. Rahn, M.D.|214-648-6430|david.rahn@utsouthwestern.edu|
20154842|NCT01629563|PregLem|Dr Pablo Arriagada|0041228840355|info@preglem.com|
20154843|NCT04290676|EyePoint Pharmaceuticals|Dario Paggiarino, MD|(617) 610-3411|dpaggiarino@eyepointpharma.com|
20199535|NCT01441063|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
20154844|NCT00088881|ECOG Statistical Office|Study Statistician|617-632-3012||
20199536|NCT02275338|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20154845|NCT04229381|The Ohio State University Comprehensive Cancer Center|Dr. Carolyn Presley|614-293-9424|Carolyn.Presley@osumc.edu|
20154846|NCT03761914|Sellas Life Sciences|Dr Dragan Cicic, Chief Development Officer|646-200-5278|info@sellaslife.com|
20154847|NCT01309880|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
20154848|NCT02370394|Butler Hospital/Women and Infants Hospital|Caron Zlotnick, Ph.D.|(401) 455-6529|CZlotnick@Butler.org|
20154849|NCT03684057|Brown University|Dr. Judson Brewer|401-863-2826|judson.brewer@brown.edu|
20154850|NCT00960856|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
20154851|NCT00908388|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20154852|NCT05938010|Scripps Optometric Group|Dr Jay Mashouf|1-858-530-2800|jaymashouf@gmail.com|
20154853|NCT02083263|Karolinska University Hospital|Maria Cecilia Rodriguez Hortal|0046709558699|cecilia.rodriguez-hortal@karolinska.se|
20154854|NCT02707744|Imperial College|Yura Mareev|+79166364410|mareev84@gmail.com|
20154855|NCT02331407|Columbia University|Dr. Tomoko Kitago|212-305-8389|tk2229@columbia.edu|
20154856|NCT01562444|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154857|NCT04017910|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
20154858|NCT02002208|Atopix Therapeutics Limited|Chief Medical Officer|+44 1235 841 522|atopix@atopixtherapeutics.co.uk|
20154859|NCT02296801|NSABP Foundation Inc|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
20154860|NCT04233580|University of Texas Southwestern Medical Center|Tara Kristof|214-648-8602|tara.kristof@utsouthwestern.edu|
20154861|NCT01371565|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20154862|NCT00668564|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20154863|NCT02061592|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
20154864|NCT04996264|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
20154865|NCT04433975|University of Michigan Medical School|Dr. Mark Ilgen|734-845-3646|marki@med.umich.edu|
20154866|NCT00685698|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
20154867|NCT04392635|Stanford University|Study Team|650-723-6189|smeyer27@stanford.edu|
20154868|NCT02213107|University of Rochester|Chunkit Fung, MD|585 - 275 - 5823|chunkit_fung@urmc.rochester.edu|
20154869|NCT02030418|Abbott Cardiac Rhythm Management|Nicole Harbert, Director Clinical Research|972-526-4841|nicole.harbert@abbott.com|
20154870|NCT01179516|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20154871|NCT02697422|VA Puget Sound Health Care System|Dr. Karin Nelson|(206)277-4507|karin.nelson@va.gov|
20154872|NCT01659541|MetroHealth Medical Center|Anthony F. DiMarco, MD|216-778-3906|afd3@case.edu|
20154873|NCT03501277|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20154874|NCT03983109|Flat Medical Co., Ltd|LI YU LIN|+886 25672959|liyulin@flatmedical.com|16
20154875|NCT02939781|Great Ormond Street Hospital NHS Trust|Dr Samiran Ray|4420274059200|samiran.ray@gosh.nhs.uk|8213
20154876|NCT01740427|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154877|NCT00963508|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 -345-9001|natalie.yantovskiy@taro.com|
20154878|NCT02759458|Rush University Medical Center|Nikhil Verma, MD|(312) 563-2214|nikhil.verma@rushortho.com|
20154879|NCT03585543|Medical University of South Carolina College of Nursing|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
20154880|NCT04739709|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
20154881|NCT01980888|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20154882|NCT02193152|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5737|danielmorgensztern@wustl.edu|
20154883|NCT04625972|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20154884|NCT00433290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154885|NCT01483651|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
20154886|NCT01799278|Weill Cornell Medical College|Dr. Himisha Beltran|(646) 962-2072|GUONC@med.cornell.edu|
20154887|NCT00724503|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
20154888|NCT04115228|Nine Continents Medical, Inc.|Peter Jacobson|6128105810|PETERJACOBSON777@YAHOO.COM|
20154889|NCT01928771|AstraZeneca|Mitchell Goldman , Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
20154890|NCT01937117|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Jenna Canzoniero, MD|410-955-8983|jcanzon1@jhmi.edu|
20154891|NCT01455519|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
20154892|NCT01407367|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-382-4822|jfink@som.umaryland.edu|
20154893|NCT01271855|Northwestern University|Kimberly Kenton MD, MS|312-472-3874|kkenton@nm.org|
20154894|NCT02269488|MedImmune, LLC, a wholly-owned subsidiary of AstraZeneca PLC|Raburn Mallory|+1 301-398-5799|malloryr@medimmune.com|
20154895|NCT01245062|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154896|NCT01452347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154897|NCT05762744|University of Maryland School of Medicine|Simeon Taylor, MD, PhD (Professor of Medicine0|4107066439|staylor2@som.umaryland.edu|
20154898|NCT03630354|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
20154899|NCT01560416|Dana-Farber Cancer Institute|Nancy Lin|617-632-2335|Nancy_Lin@dfci.harvard.edu|
20154900|NCT03018730|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
20154901|NCT00254072|UC Irvine Medical Center|Ninh T. Nguyen, M.D.|714-456-8580|ninhn@uci.edu|
20154902|NCT05136430|Brown University|Cara M. Murphy, Ph.D.|4018636519|murphybrownlab@brown.edu|
20154903|NCT02724644|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
20154904|NCT05890586|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20164553|NCT00988884|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164554|NCT04621448|University of California, San Francisco|Dr. Deborah Barnes|415-502-2943|deborah.barnes@ucsf.edu|
20164555|NCT03022396|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20164556|NCT00468299|University of Rochester|Dr. Sarah Betstadt|585-276-5368|sarah_betstadt@urmc.rochester.edu|
20164557|NCT03546621|Hepatera LLC|Dr.Alexander Alexandrov|+7 (495) 726-52-53|alexandrov@myr-pharma.com|42-03
20164558|NCT00226590|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., Ph.D., c/o Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
20164559|NCT02111447|GLA|Research Coordinator|7163236570|tgensler@greatlakesanes.com|
20164560|NCT00973752|Massachusetts General Hospital|Dr. Amir Fathi|617-724-1124|afathi@partners.org|
20164561|NCT03318549|University of Miami|Vice Chair of Research|305-326-6373|fmedeiros@med.miami.edu|
20164562|NCT02870283|Universidade Federal do Rio Grande do Sul|Dra. Ana Flávia Silva Lima|+5551999185180|afbslima@gmail.com|
20164563|NCT03649074|Akili Interactive|Clinical Operations and Research Manager|8572543399|dfarlow@akiliinteractive.com|
20164564|NCT02537717|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20164565|NCT05675046|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
20164566|NCT02348593|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
20164567|NCT03861273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164568|NCT01673828|Department of Neurology, School of Medicine, University of California, Davis|Dr. Michael Rogawski|916-734-6285|rogawski@ucdavis.edu|
20164569|NCT00191334|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20164570|NCT01116648|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
20164571|NCT04539938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164572|NCT03064490|Duke University Health System (DUHS)|Linda Kaltenbach/Regulatory Coordinator|(919) 668-3726|linda.kaltenbach@duke.edu|
20164573|NCT06319898|Atrium Health Wake Forest Baptist|Dr. Erin Franks|7043041160|erin.franks@atriumhealth.org|
20164574|NCT02926638|SWOG|Lung Committee Statistician|2066677733|kmini@fredhutch.org|
20164575|NCT01663012|Stanford University School of Medicine650-|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
20164576|NCT01871519|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20164577|NCT00320515|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20164578|NCT01063153|Massachusetts General Hospital|Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD|(617)-724-0006|jbiederman@partners.org|
20164579|NCT00350844|Ann and Robert H. Lurie Children's Hospital of Chicago|Dr. Robert I. Liem|312-227-4842|Rliem@luriechildrens.org|
20164580|NCT01420926|Weill Medical College of Cornell University|Gail Roboz, M.D||gar2001@med.cornell.edu|
20164581|NCT01782898|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
20164582|NCT01572207|Case Western Reserve University|Matthew Plow|216-368-8969|map208@case.edu|
20164583|NCT01650298|ABBOTT|Grant Kim|818-493-3147|gkim@sjm.com|
20164584|NCT00882440|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20164585|NCT05295849|University of Connecticut|Sherry Pagoto, PhD|860-486-5917|sherry.pagoto@uconn.edu|
20164586|NCT01381016|University of Colorado Denver|Associate Professor|(303) 724-2037|alex.polotsky@ucdenver.edu|
20164587|NCT00905450|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20164588|NCT00467077|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20164589|NCT01451723|Louisiana Health Sciences Center-New Orleans|Jesus Lovera MD|50-903 9302|jlover@lsuhsc.edu|
20164590|NCT01329263|University of Pennsylvania|Dr. Andrew Strasser|2157465788|strasse3@mail.med.upenn.edu|
20164591|NCT01366872|Orthopaedic Associates of Michigan, PC|Dr. John G. Anderson|616-459-7101|John.Anderson@oamichigan.com|797
20164592|NCT01631435|Given Imaging- Covidien|Ravit Peled , Clinical trials manager|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
20164593|NCT00833040|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
20164594|NCT04233008|Brigham and Women's Hospital|Sarah Little|617-732-5452|selittle@bwh.harvard.edu|
20164595|NCT00416624|Mayo Clinic|Charles L. Loprinzi, M.D.|507-266-6247|loprinzi.charles@mayo.edu|
20164596|NCT01005251|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20164597|NCT02754570|University of Colorado|Rachel Gerle|720-848-5096|rachel.gerle@ucdenver.edu|
20164598|NCT00962208|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
20199537|NCT01232829|University of Colorado Cancer Center|Dr. Wells Messersmith|303-724-3808|wells.messersmith@ucdenver.edu|
20199538|NCT03099486|Fox Chase Cancer Center|Dr. Namrata Vijayvergia|215-214-4283|Namrata.Vijayvergia@fccc.edu|
20199539|NCT00784654|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20199540|NCT03461757|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20199541|NCT02425826|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-800-260-1599|ClinicalTrialDisclosure@celgene.com|
20199542|NCT03861559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199543|NCT02987621|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
20199544|NCT01344876|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
20199545|NCT05107765|The University of Texas Health Science Center of Houston|Jin H Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
20164599|NCT00657540|Rocky Mountain Poison and Drug Center|Victoria Anderson - Research Projects Manager|303-389-1236|victoria.anderson@rmpdc.org|
20164600|NCT04375150|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20154905|NCT02545127|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
20154906|NCT03197935|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20154907|NCT02197104|Rush University Medical Center|Dr. Deborah A Hall|312-563-2900|Movementdisorder@rush.edu|
20154908|NCT00985192|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Dr. Zev Wainberg|310 794-6500|zwainberg@mednet.ucla.edu|
20154909|NCT00669331|Pharmaxis Ltd|Dr Brett Charlton, Medical Director|+61 2 94547210|brett.charlton@pharmaxis.com.au|
20154910|NCT02595749|USC Dept. of Preventive Medicine|Matthew Kirkpatrick|3234428221|mgkirkpa@usc.edu|
20154911|NCT01454063|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
20154912|NCT00069329|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Goldbach-Mansky, Raphaela|+1 301 435 6243|goldbacr@mail.nih.gov|
20154913|NCT01286324|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
20154914|NCT00546273|UTE. Fund. Inst. Germans Trias i Pujol|Cristina Vilaplana, MD|+34 93 497 86 81|cvilaplana@gmail.com|
20154915|NCT03387046|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20154916|NCT00509600|UT MD Anderson Cancer Center|Robert J. Wells, MD / Professor|713-792-6620||
20154917|NCT01908842|University of Virginia|Dr. Erik Gunderson, MD, FASAM|(434) 202-8612|EWG2N@hscmail.mcc.virginia.edu|
20154918|NCT02568423|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20154919|NCT00038610|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, MD/Leukemia||CR_Study_Registration@mdanderson.org|
20154920|NCT02550210|Dartmouth Hitchcock Medical Center|Dr. Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
20154921|NCT03794544|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20154922|NCT01027416|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20154923|NCT00421733|Abbott|Global Medical Services|800-633-9110||
20154924|NCT00120250|Massachusetts General Hospital|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
20154925|NCT00720083|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
20154926|NCT01676350|WellSpan York Hospital|Brent Becker|717-851-2223|bbecker2@wellspan.org|
20154927|NCT00103506|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
20154928|NCT00585585|University of Cincinnati|Erik Nelson, MD|513-558-5115|erik.nelson@uc.edu|
20154929|NCT02056288|Baylor College of Medicine|Chris D. Glover, MD, MBA, Principal Investigator|832-824-5800|cdglover@texaschildrens.org|
20154930|NCT01433978|Eisai Call Center|Eisai Inc.|888-422-4743||
20154931|NCT01441414|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154932|NCT01773889|The Cancer and Therapy Center at The University of Texas Health Science Center San Antonio|Tyler Curiel, MD|210-562-5287|CURIELT@UTHSCSA.EDU|
20154933|NCT03954938|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
20154934|NCT00617903|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20154935|NCT02565186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20154936|NCT00976391|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154937|NCT04676646|AstraZeneca|Global Clinical Lead|18772409479|information.center@astrazeneca.com|
20154938|NCT02217982|Rocky Mountain MS Research Group|Tammy Hoyt|8014085711|thoyt@rmmsc.com|
20154939|NCT05156125|Oppilan Pharma Ltd|Clinical Trial Contact|+1(888)-411-5176|clinicaltrials@ventyxbio.com|108
20154940|NCT03123588|Incyte Corporation|Call Center|1.855.463.3463|medinfo@incyte.com|
20154941|NCT02822287|GlaxoSmithKline|GSK Response Center|866-435-7343||
20154942|NCT01623752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20154943|NCT01814332|San Francisco VA Medical Center|Jennifer Hlavin|415-221-4810|jennifer.hlavin@va.gov|26624
20154944|NCT02933476|Stanford School of Medicine|Raumin Neuville|6507236709|raumin@stanford.edu|
20154945|NCT05987540|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
20154946|NCT02734147|Christiana Care Health Services|Jamie Rosini, Pharm D|302-733-6364|jrosini@christianacare.org|
20154947|NCT03896217|UCL Institute of Neurology|Prof. Richard Nicholas|0208 383 0675|richard.nicholas3@nhs.net|
20154948|NCT01810952|Baylor College of Medicine|Professor of Medicine|713-660-9902|glennc@bcm.edu|
20199546|NCT01407926|McMaster University|Maureen Markle-Reid, Associate Professor and Canada Research Chair, School of Nursing|905-525-9140|mreid@mcmaster.ca|22306
20199547|NCT02814565|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20199548|NCT02468648|NIDDK|Marc Ghany, MD, MHSc|301-402-5115|marcg@intra.niddk.nih.gov|
20199549|NCT04232696|Neuspera Clinical Research|Mark Vollmer|612-281-4875|mark.vollmer@neuspera.com|
20199550|NCT02787863|Samara State Medical University, Institute of Sera and Vaccines RAS|Professor Andrei Dmitrievich Protasov, Professor Mikhail Petrovich Kostinov|+79277444126|crosss82@mail.ru|
20199551|NCT01368835|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20199552|NCT01678144|Medtentia International Ltd Oy|Olli Keränen / CEO|+358 50 3567090|ok@medtentia.com|
20199553|NCT03118297|WashingtonU|Intervention To End Recurrent Unscheduled bleeding Trial (INTERRUPT): A randomized-controlled trial|3143228697|rachelezig@gmail.com|
20199554|NCT02754726|HonorHealth Research Institute|Erkut Borazanci, MD MS|4803231350|clinicaltrials@honorhealth.com|
20199555|NCT01885000|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20154949|NCT01290731|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
20154950|NCT04246476|Washington University in St. LOuis|Gammon Earhart|3142861407|earhartg@wustl.edu|
20164601|NCT04245111|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
20154951|NCT01399099|Neodyne Biosciences|Sr. Director of R&D|510-456-4128|jjackson@neodynebio.com|128
20154952|NCT02216851|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
20199556|NCT01676714|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20154953|NCT01149538|University of Minnesota|Jeffrey R. Wozniak, Ph.D.|612-273-9741|jwozniak@umn.edu|
20154954|NCT00888849|Ethicon Endo Surgery, Inc|Sheryl Helsinger/Clinical Affairs Director|513-337-3079|shelsing@its.jnj.com|
20154955|NCT02636322|University of Texas M D Anderson Cancer Center|Dr. Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
20154956|NCT02336503|Botanix Pharmaceuticals|Vice President, Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
20154957|NCT01254877|JohnHopkinsU|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
20154958|NCT02583477|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20154959|NCT02904356|Baylor College of Medicine|Sameer Sheth, MD, PhD|713-798-4696|sasheth@bcm.edu|
20154960|NCT01118091|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20154961|NCT00464464|Rutgers- Robert Wood Johnson Medical School|Dr. Roseanne Dobkin|732-235-4051|dobkinro@rutgers.edu|
20154962|NCT05610267|Integra LifeSciences|Dr. Dennis Adam Young|443 766 2569|dennis.young@integralife.com|
20154963|NCT01873833|USC Norris Comprehensive Cancer Center|Victoria Soto, Regulatory Administrator|323-865-0432|Victoria.Soto@med.usc.edu|
20154964|NCT03055507|University of Washington, Department of Otolaryngology - Head & Neck Surgery|Dr. Greg Davis, Director of Rhinology and Skull Base|(206) 598-4022|GEDavis@uw.edu|B
20154965|NCT06025695|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20154966|NCT01301092|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20154967|NCT01350973|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20154968|NCT03738215|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20154969|NCT02638493|University of North Carolina at Chapel Hill|Julie B. Dumond, PharmD, MS, BCPS, AAHIVP|919-966-5017|jdumond@unc.edu|
20154970|NCT05894564|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
20154971|NCT03882801|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20154972|NCT03150797|UCSF|Dr. Amy Gelfand|415-502-1914|amy.gelfand@ucsf.edu|
20154973|NCT00944645|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154974|NCT05715346|Levation Pharma|Houman Hemmati, M.D., Ph.D.|424 274 2642|info@levationpharma.com|
20154975|NCT03928704|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20154976|NCT03404167|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
20154977|NCT01148420|Harbor - UCLA Medical Center|Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
20154978|NCT03403517|Rigshospitalet|Kristin steinthorsdottir|004531666112|kjs@dadlnet.dk|
20154979|NCT04132466|Kestra Medical Technologies, Inc.|Laura Gustavson|14255264759|laura.gustavson@kestramedical.com|
20154980|NCT01245751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20154981|NCT02082483|Kidney Transplant Research|Dr. John Gill|6046822344|jgill@providencehealth.bc.ca|64706
20154982|NCT02181621|Smith & Nephew, Inc.|Matthew Christensen|+1-303-249-5812|Matthew.Christensen@smith-nephew.com|
20154983|NCT00762788|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|1 904 443-1032|kosborn@its.jnj.com|
20154984|NCT01783015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199557|NCT02162732|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
20154985|NCT02320825|Memorial Sloan Kettering Cancer Center|Dr. Ilya Laufer, MD|212-639-2368|lauferi@mskcc.org|
20154986|NCT01045265|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
20154987|NCT00289978|Novartis Pharmaceuticals|Study Director|862 778-8300||
20154988|NCT01524705|University of Washington|Jeffrey L Probstfield, MD|206-616-0292|jeffprob@uw.edu|
20154989|NCT01243424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20154990|NCT02011464|Maimonides Medical Center|Dr. Piyush M Gupta|7182837189|pgupta@maimonidesmed.org|
20154991|NCT01567020|VA Portland Health Care System|Dr. Frederick Gallun|5032208262|Frederick.Gallun@va.gov|57472
20154992|NCT01215240|University of Alberta|Dr. Lindsay Ryerson|780 407 3396|ryerson@ualberta.ca|780
20154993|NCT01160744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20154994|NCT04366583|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Dr. Huay-Min Wang|+886-7-3422121|hmwang@vghks.gov.tw|2075
20154995|NCT00500110|MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
20154996|NCT03646188|Medicus Pharma|Dr. Huma Qamar, MD., Chief Scientific Officer|610- 540-7515|hqamar@medicuspharma.com|106
20154997|NCT04863807|Imperial College Healthcare NHS Trust|Dr Alex Wickham|+4420233121248|alex.wickham@nhs.net|
20154998|NCT02421510|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20199558|NCT04373369|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5817|danielmorgensztern@wustl.edu|
20199559|NCT02163434|University at Buffalo|Dr. Thomas Guttuso, Jr.|7169326080|tguttuso@gmail.com|
20199560|NCT03446885|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
20199561|NCT01390259|University of Virginia|Marc Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
20199562|NCT04302727|University of North Carolina at Chapel Hill|Thomas Keyserling, MD|984-974-4462|thomas_keyserling@med.unc.edu|
20199563|NCT04735653|University of Michigan Medical School|Dr. Paula Anne Newman-Casey|734-763-6967|panewman@med.umich.edu|
20199564|NCT03142321|Washington University School of Medicine GI Division|Dr. Parakkal Deepak|3143623201|nixd@wustl.edu|
20199565|NCT02507011|University of Minnesota|Thenappan Thenappan, MD|612-625-2191|cvheart@umn.edu|
20154999|NCT02852434|Stanford University Division of Family Planning Services and Research|Stanford University, Department of OB/GYN|6507211562|familyplanningresearch@stanford.edu|
20199566|NCT00252057|Boston Medical Center|Brian Jack PI|617-414-44675|brian.jack@bmc.org|
20199567|NCT01084265|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20155000|NCT05075772|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155001|NCT03203512|University of Reading|Professor Parveen Yaqoob|+443787113|p.yaqoob@reading.ac.uk|
20155002|NCT00393380|The EMMES Corporation|Adam Mendizabal, Statistician|301-251-1161|amendizabal@emmes.com|221
20155003|NCT02993302|Dr. Cipto Mangunkusumo Hospital|Dyah Purnamasari|62213907703|dyah_p_irawan@yahoo.com|
20155004|NCT01717859|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
20155005|NCT01755637|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155006|NCT04389671|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
20155007|NCT00899847|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20155008|NCT02287025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20155009|NCT04053452|Duke University|Natalia Gonzalez, MD|919-684-5422|natalia.gonzalez@duke.edu|
20155010|NCT01421134|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
20155011|NCT02959892|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20155012|NCT03338023|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20155013|NCT03528577|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
20155014|NCT04882215|University of Glasgow|Professor Jonathan Evans|0141 330 3299|Jonathan.Evans@glasgow.ac.uk|
20155015|NCT03911687|Columbia University|Sarah Collins Rossetti, PhD|2123056605|sac2125@cumc.columbia.edu|
20155016|NCT04098302|UConn Health|Jonathan Covault Study PI|860-679-7560|jocovault@uchc.edu|
20155017|NCT04402957|Arch Biopartners Inc.|Richard Muruve|647-428-7031|rm@archbiopartners.com|
20155018|NCT05061706|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
20155019|NCT00724893|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20155020|NCT03362957|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20155021|NCT01279200|University of Michigan|Senait Fisseha, MD, JD|734-763-4323|sfisseha@med.umich.edu|
20155022|NCT04308694|Duke University|William John, Ph.D.|919-681-7291|william.john@duke.edu|
20155023|NCT05064800|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155024|NCT00629239|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20155025|NCT01181128|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20155026|NCT02371252|Mahidol University|Dr. Aasis Unnanuntana|+66836871159|uaasis@gmail.com|
20155027|NCT01851369|National Cancer Institute|Dr. Alice P.Chen|2407813320|chenali@mail.nih.gov|
20155028|NCT00183391|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey H Newcorn|212-659-8705|jeffrey.newcorn@mssm.edu|
20155029|NCT00395512|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20155030|NCT03712618|National Institutes of Health, Clinical Center (NIH CC)|Dr. Willy Flegel|+1 301 594 7401|bill.flegel@nih.gov|
20155031|NCT01478087|Mayo Clinic|Jeffrey Lawrence Winters, MD|507-538-1707|winters.jeffrey@mayo.edu|
20155032|NCT02618187|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|617-945-9626|mtrucksis@serestherapeutics.com|
20155033|NCT05507450|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20155034|NCT05436288|Kiora Pharmaceuticals, Inc.|Eric Daniels|858-353-0469|edaniels@kiorapharma.com|
20155035|NCT03948386|Thomas Jefferson University|Eric S Schwenk, MD|215-955-6161|eric.schwenk@jefferson.edu|
20155036|NCT03767894|Columbia University|Dr. Joel Stein|(212) 305-4818|js1165@columbia.edu|
20155037|NCT01860404|Children's Hospital of Philadelphia|Dr. Daniel Corwin|215-327-2306|corwind@chop.edu|
20155038|NCT00632970|Medical Faculty Associates|Gary Simon|202 741-2234|Gsimon@mfa.gwu.edu|
20155039|NCT00356421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20155040|NCT04203056|University of California, Los Angeles|Kenneth Subotnik, PhD|3108250334|ksubotnik@mednet.ucla.edu|
20155041|NCT00421993|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
20155042|NCT02547935|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20155043|NCT01767285|Duke University|Dr. Beverly Gray|919-684-8111|beverly.gray@dm.duke.edu|
20155044|NCT03888274|Tivic Health Systems|Blake Gurfein|5615737652|blake.gurfein@tivichealth.com|
20155045|NCT00003474|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20155046|NCT03334175|UCSF|Meghana Gadgil|4153537922|meghana.gadgil@ucsf.edu|
20155047|NCT04193176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20155048|NCT01058005|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20155049|NCT01145222|PAION UK Ltd|Trial Information||reg_paion@paion.com|
20155050|NCT01698008|University of Nebraska Medical Center|Whitney Goldner|402-559-3579|wgoldner@unmc.edu|
20155051|NCT02053584|Wolfson Medical Center|Dr. Julio Weinstein|972-3-5028371|vainstein@wolfson.health.gov.il|
20155052|NCT00508300|lausanne university hospital|martin hübner|+41795561506|martin.hubner@chuv.ch|
20155053|NCT02203786|Centre for Addiction and Mental Health|Dr. Daniela Lobo, Qualified Investigator for Study, Clinician-Scientist|416-535-8501|Daniela.Lobo@camh.ca|36568
20155054|NCT00122187|VAHSRD|Linda Humphrey|503-220-8262|linda.humphrey@va.gov|57176
20155055|NCT00580294|Icahn School of Medicine at Mount Sinai|Marco Pappagallo, MD|212-241-7749|dionne.bobb@mountsinai.org|
20199568|NCT01294800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199569|NCT03326843|Dova Pharmaceuticals|Associate Director, Clinical Operations|919-338-7864|clinical@dova.com|
20155056|NCT03099863|MetroHealth Medical Center|Dr. Jeffrey Mangel|2167784444|jmangel@metrohealth.org|
20155057|NCT04865978|Inova Schar Heart and Vascular|Dr. Palak Shah|703-776-2213|palak.shah@inova.org|
20199570|NCT00493038|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20164602|NCT02039115|Center for Interventional Endoscopy|Robin (Barron-Nelson) Kangas|407.303.5503|Robin.Barron@flhosp.org|
20199571|NCT04418765|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20164603|NCT06039579|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20199572|NCT03345472|Medtronic Restorative Therapies Group, Spinal Cord Stimulation|Stacie Hallaway/Senior Clinical Research Specialist|763-526-3844|RS.VectorsPM@medtronic.com|
20164604|NCT02469623|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|442232608-|steven.mcquillan@acutus.com|
20164605|NCT03309878|Johns Hopkins University|Grants Administrative Manager|443-927-3568|JHCCCRO@jhmi.edu|
20164606|NCT01096316|Dept Psychiatry & Behavioral Sciences University of Washington|Jurgen Unutzer MD MPH MA, Professor and Chair|206-543-3752|unutzer@uw.edu|
20164607|NCT01884077|Washington University School of Medicine - Dept of Orthopaedic Surgery|Dr. Aaron Chamberlain|314-362-9283|chamberlaina@wudosis.wustl.edu|
20164608|NCT02836652|Abbott|Poornima Sood|7818528334|poornima.sood@abbott.com|
20164609|NCT02349633|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164610|NCT03679975|Aquestive Therapeutics|Gary Slatko, Chief Medical Officer|908-941-7050|clinicaltrials@aquestive.com|
20164611|NCT00303823|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
20164612|NCT00667628|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
20164613|NCT04663321|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20164614|NCT03360682|Hospital Clínic/IDIBAPS, University of Barcelona|Jose M. Miro Meda (PI), MD, PhD, Consultant, Infectious Diseases Service|93 227 54 30|JMMIRO@clinic.cat|
20199573|NCT01926782|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20164615|NCT03232346|NYS Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|adam.bisaga@nyspi.columbia.edu|
20164616|NCT01962441|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20164617|NCT04862065|Abbott Laboratories|Tuan Bui (Manager Clinical Research)|224-668-4702|tuan.l.bui@abbott.com|
20164618|NCT01453140|Hackensack University Medical Center|Dr. Michele Donato, MD|551-996-2000|MDonato@hackensackumc.org|3524
20164619|NCT00743249|Alcon Research, Ltd.|Theresa A. Landry, Ph.D.|1-888-451-3937|alcon.medinfo@alcon.com|
20164620|NCT00718510|Department of Psychiatry, University of Alberta|Dr. Serdar Dursun|(780) 492-7319|dursun@ualberta.ca|
20164621|NCT02201524|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20164622|NCT02795117|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20164623|NCT02653326|Universidad de Valparaiso|Carla Taramasco|2508306|carla.taramasco@uv.cl|+56 32
20164624|NCT02855203|Peter MacCallum Cancer Centre|Office of Cancer Research|+61 3 85597364|OCR@petermac.org|
20164625|NCT01752426|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
20164626|NCT03650088|University of North Carolina at Chapel Hill|Deborah F. Tate, PhD|919-966-5851|dtate@unc.edu|
20164627|NCT00231777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164628|NCT00702468|GW Pharma Ltd|Richard Potts Clinical Operations Director|+44 1353 616600|rp@gwpharm.com|
20164629|NCT04864249|University of Pittsburgh Medical Center, Magee-Womens Hospital|Dr. Alisse Hauspurg|412-641-1381|janickia@upmc.edu|
20164630|NCT01239381|Massachusetts General Hospital|Theodore S Hong, MD, physician radiation oncology|617-726-6050|TSHONG1@mgh.harvard.edu|
20164631|NCT04678115|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
20164632|NCT02972931|AIDS Research Institute IrsiCaixa|Dr. Judith Dalmau|934656374|jdalmau@irsicaixa.es|161
20164633|NCT03550378|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
20164634|NCT04486235|Corporal Michael J. Crescenz VA Medical Center|Jocelyn Remmert, PhD|215-823-5800|jocelyn.remmert@va.gov|
20164635|NCT04590014|Vapotherm Inc|Katherine Gerich|5854696753|kgerich@vtherm.com|
20164636|NCT03935126|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164637|NCT01091675|Unidad de Reumatología, Hospital Parc Tauli de Sabadell. Institut Universitari UAB|Dr. Jordi Gratacós Masmitjá|937.23.10.10|jgratacosmas@gmail.com|
20164638|NCT03040141|Visterra Inc.|Head of Regulatory Affairs|+1 617-498-1070|info@visterrainc.com|
20164639|NCT02426580|The Nephrology Department, the Chengdu Second Affiliated Hospital of Chongqing Medical University, the Third Peoples's Hospital of Chengdu|Dr. Gong Rong, Dr. Han Tianzhao, Dr. Leonard Stern|+86 028-61318708|gongr2006@sina.com|
20164640|NCT00383552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20164641|NCT00966654|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20164642|NCT00575185|University of Minnesota|Hank Balfour MD|(612) 626-5670|balfo001@umn.edu|
20164643|NCT01600326|University of Michigan|Jon Jacobson|734 936-4365|jjacobsn@umich.edu|
20164644|NCT04456504|University of Wisconsin School of Pharmacy|Mary Hayney, PharmD, MPH, FCCP, BCPS|608-265-4666|mary.hayney@wisc.edu|
20164645|NCT01393158|Oregon Health & Science University|Dr. Eric Simpson,|503-494-2121|simpsone@ohsu.edu|
20164646|NCT02413918|University of Texas HEalth Science Center San Antonio|Charles Bowden, MD|210-567-5405|BowdenC@uthscsa.edu|
20164647|NCT02173769|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164648|NCT02869633|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
20164649|NCT04024891|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
20199574|NCT03988335|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
20217814|NCT02363439|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20217815|NCT00707447|FIDAM|Norbert Hermanns|0049 7931 594|hermanns@diabetes-zentrum.de|553
20199575|NCT02482675|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
20164650|NCT01693029|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|004980244760|biopharma.clinicaltrials@sandoz.com|
20164651|NCT00308139|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
20164652|NCT02152826|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20164653|NCT02313766|CaenUH|Pr Jean-Luc Hanouz|33 2 31 06 47 36|hanouz-jl@chu-caen.fr|
20164654|NCT02542046|UCaliforniaSF|Dr. Benjamin Yeh|4155149318|ben.yeh@ucsf.edu|
20164655|NCT00791388|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20164656|NCT02690181|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164657|NCT01173016|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
20164658|NCT00141453|Daiichi Sankyo, Inc|Howard Kessler|732-590-5032|hmkessler@dsi.com|
20164659|NCT00443040|Tioga Pharmaceuticals|Dr. Allen Mangel, Chief Medical Officer|919-485-5668|mangel@tiogapharma.com|
20164660|NCT02843165|University of California, San Diego|Andrew Sharabi|(858) 822-5354|CancerCTO@health.ucsd.edu|
20164661|NCT02763644|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20164662|NCT02648204|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20164663|NCT00659802|Hutchison Medipharma|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
20164664|NCT05757648|University Hospitals Cleveland Medical Center|Dr. Ying An|(216)368-3277|Ying.An@UHhospitals.org|
20164665|NCT01220167|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
20164666|NCT01008943|Cook Medical|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
20164667|NCT02356159|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20164668|NCT06418152|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
20164669|NCT05789745|Nucleus Network|Trisha Shamp, Ph.D|651-641-2925|t.shamp@nucleusnetwork.com|
20164670|NCT05108246|SUNY at Buffalo|Nikhil Satchidanand|7168162884|ns1@buffalo.edu|
20164671|NCT05256901|Emory University|Viola Vaccarino, MD, PhD, Principal Investigator|404-727-8710|lvaccar@emory.edu|
20164672|NCT02055898|Imperial College London|Keith Boland||k.boland@imperial.ac.uk|
20164673|NCT01500772|Debiopharm International S.A.|Vice President, Clinical Research and Development|4121 321 01 11|info-international@debiopharm.com|
20164674|NCT02314052|Dicerna Pharmaceuticals|Ralf Rosskamp|617-621-8097|rrosskamp@dicerna.com|
20164675|NCT02646826|Wellesley Pharmaceuticals, LLC|David Dill|2154930168|ddill@wellesleypharma.com|
20164676|NCT01960140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20164677|NCT00472108|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
20164678|NCT00005906|TMB/NHLBI|Joel Moss|301-496-1597|mossj@nhlbi.nih.gov|
20164679|NCT04551989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20164680|NCT03192826|Patras Medical School|OPHTHALMOLOGY PATRAS|6975801961|cgeorg@upatras.gr|
20199576|NCT02501265|Duke University School of Medicine|Dr. James Davis|919-668-5055|james.m.davis@duke.edu|
20199577|NCT02728830|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
20199578|NCT02365714|Medstar Georgetown University Hospital|Sonali Rudra, M.D.|202-444-3320|sonali.rudra@gunet.georgetown.edu|
20199579|NCT00070941|NYU Parkinson and Movement Disorders Center|Dr. Alessandro Di Rocco|212-263-4838|Alessandro.Dirocco@nyumc.org|
20199580|NCT00684788|Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
20199581|NCT00623428|Hoffman-LaRoche|Medical Communications|800-821-8590||
20199582|NCT01212302|Cardiology Dep, Ruhr-University Bochum|Dr Horst Neubauer|+49-234-509-2326|Horst.Neubauer@rub.de|
20199583|NCT02342015|University of Padova|Marcello Rattazzi|+300498211867|marcello.rattazzi@unipd.it|
20199584|NCT01692301|Novartis Pharmaceuticals|Study Directors|862-778-8300|trialandresults.registries@novartis.com|
20199585|NCT01142726|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20199586|NCT01568593|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
20199587|NCT03987854|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
20155058|NCT05574764|Duke University|Emily M. D'Agostino, DPH, MS, MEd, MA|646-853-1223|emily.m.dagostino@duke.edu|
20155059|NCT04263532|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20155060|NCT04072432|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
20155061|NCT01584388|MGH Rheumatology|John H Stone|617-726-7938|jhstone@partners.org|
20155062|NCT02043847|University of Illinois at Chicago|Dr. Rondelli|312-996-6179|drond@uic.edu|
20155063|NCT02181738|Bristol Myers Squibb|Bristol Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
20155064|NCT01668537|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20155065|NCT01968317|Obstetrics and Gynecology Hospital of Fudan University|Xiaojun Chen|33189900|xiaojunchen2013@sina.com|
20155066|NCT04219774|Duke University|David Hasan, MD, MSc|919-684-7777|david.hasan@duke.edu|
20155067|NCT04477486|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20164681|NCT00686777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20164682|NCT00883779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199588|NCT02780648|IndianaU|Dr. Robert Miller|317-944-1317|millro@iu.edu|
20199589|NCT00265538|Iowa City VA Health Care System|Dr. Peter Kaboli|319-338-0581|Peter.kaboli@va.gov|
20155068|NCT02502071|University of Colorado School of Medicine|Dr. Petter Bjornstad, Assistant Professor|7207774659|petter.bjornstad@childrenscolorado.org|
20164683|NCT00499681|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD, Principal Investigator|615-936-2033|ingrid.mayer@vanderbilt.edu|
20164684|NCT00983346|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
20164685|NCT00099372|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
20199590|NCT03557892|University of Florence Medical School and AOU Careggi|Dr Ilaria Dicembrini|+393387861041|Ilaria.dicembrini@unifi.it|
20199591|NCT00293579|Ohio State University Comprehensive Cancer Center|Anterpreet Neki|614-257-2900|Anterpreet.Neki@osumc.edu|
20199592|NCT00419380|University of Colorado School of Medicine - Department of Pediatric Otolaryngology|Kenny H. Chan, MD|7207774776|kenny.chan@childrenscolorado.org|
20199593|NCT03099707|Brigham and Women's Hospital|Ingrid T. Katz|617-525-8194|ikatz2@bwh.harvard.edu|
20199594|NCT03167073|Washington University of St Louis (where research was conducted). Now at Brown University|Dr. Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|47447
20199595|NCT01276236|University of California, San Francisco|Dr. Toby Maurer, MD|(628) 206-8680|Toby.Maurer@ucsf.edu|
20199596|NCT01097304|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
20199597|NCT03127384|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20199598|NCT02340338|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
20199599|NCT00343889|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20199600|NCT01951820|University of Michigan School of Dentistry|Dr. Carlos Gonzalez|734-763-3391|carlosgc@umich.edu|
20199601|NCT01294579|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20199602|NCT04472429|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20199603|NCT01180660|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20199604|NCT00262873|University of Rochester|Jane Liesveld, M.D.|585-275-4099|Jane_Liesveld@urmc.rochester.edu|
20199605|NCT00088374|National Cancer Institute, National Institutes of Health|William M. Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
20199606|NCT01785134|Karolinska Institutet|Dr Erik Näslund|+46812355017|Erik.Naslund@ki.se|
20199607|NCT02189850|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
20199608|NCT05073458|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20199609|NCT01632566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20199610|NCT04428424|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199611|NCT01262365|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20199612|NCT06414512|University of Minnesota|David Boulware|612-624-9996|idim@umn.edu|
20199613|NCT01394081|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|Lori.Davis@va.gov|3819
20199614|NCT01272999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199615|NCT02792842|Asahi Kasei Pharma Corporation|Contact for Clinical Trial Information|+81-3-6699-3600|ct-info@om.asahi-kasei.co.jp|
20199616|NCT02064387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20199617|NCT00703664|Massey Cancer Center, Virginia Commonwealth University|Dr. Beata Holkova|804-628-2581|bholkova@mcvh-vcu.edu|
20199618|NCT03728309|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20199619|NCT02436876|Microbion Corporation|Brett Baker, President and Chief Innovation Officer|4065991190|bbaker@microbioncorp.com|
20199620|NCT03950973|University of Michigan School of Public Health, Department of Health Behavior & Health Education|Minal R. Patel, Ph.D, M.P.H|(734) 763-0087|minalrp@umch.edu|
20199621|NCT00999908|Novartis Pharmaceuticals|Study Director|862 778-8300||
20199622|NCT01290692|Saint Lukes Hospital KC, Missouri and Washington University School of Medicine, St.Louis Missouri|Michael E. Salacz,MD and David Tran,MD, PH.D|9134922221|gwood@tvaxbiomedical.com|
20199623|NCT01849770|University of Washington|Michael D. Weiss, MD|206-598-7688|mdweiss@uw.edu|
20199624|NCT03403205|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20199625|NCT00706030|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20199626|NCT02682901|Eastern Virginia Medical School|Henri Parson|7574467976|parsonhk@evms.edu|
20199627|NCT00844753|University of Pittsburgh|Ben Handen|412-235-5452|HandenBL@upmc.edu|
20199628|NCT05130463|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20199629|NCT00470600|Cumberland Pharmaceuticals|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
20199630|NCT03440814|Soleno Therapeutics, Inc.|C601 Project Manager|650-353-2051|C601ProjectManager@soleno.life|
20199631|NCT02751502|NYU Langone Health|Renat Sukhov, MD|347-377-5138|Renat.Sukhov@nyulangone.org|
20199632|NCT00852995|Smith & Nephew|Jamie E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20199633|NCT03595553|Summit Therapeutics|Katie Tran|408 677 6503|Katie.Tran@Summitplc.com|
20199634|NCT02573155|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20199635|NCT04397094|Faculty of Dentistry Ain Shams University|Dr. Mariem Wassel|+2 0064871416|mariem.wassel@dent.asu.edu.eg|
20199636|NCT00371865|VA San Diego Healthcare System|Dr. Julie Wetherell, PI|858-552-8585|Julie.Wetherell@va.gov|2752
20199637|NCT00713583|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
20199638|NCT01031914|Philips|Dr. David P. White|724 387 4554|Dr.DavidWhite@philips.com|
20199639|NCT01545700|NorthShore University HealthSystem|Glenn S. Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
20199640|NCT01227551|Viralytics|Mark Grose|1 647 821 7673|Mark.Grose@Viralytics.com|
20199641|NCT02158091|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
20199642|NCT05913232|D. Western Therapeutics Institute, Inc.|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
20199643|NCT01318109|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20199644|NCT01328951|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199645|NCT06485479|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
20199646|NCT04230304|Mayo Clinic|Sikander Ailawadhi|904-953-2000|Ailawadhi.Sikander@mayo.edu|
20199647|NCT01627899|LifeScan Scotland|Mike Grady|+44 01463 721000|MGRADY@its.jnj.com|
20199648|NCT05103332|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20199649|NCT04428476|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
20199650|NCT03627403|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20199651|NCT04982250|Fred Hutchinson Cancer Center|Katrina F Ortblad, ScD, MPH|2066677267|kortblad@fredhutch.org|
20199652|NCT03485820|Washington University in St. Louis|Susy Stark|3142734114|sstark@wustl.edu|
20199653|NCT04289116|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
20199654|NCT04685876|University of Texas, Houston|Dr. Alparslan Turan|713-500-6279|Mehmet.A.Turan@uth.tmc.edu|
20199655|NCT04205409|University of Washington|Dr. Andrew Cowan|2066067348|ajcowan@fredhutch.org|
20199656|NCT01358864|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199657|NCT02656485|AOBIOME|Masha Gaber|617-475-1605|mgaber@aobiome.com|
20199658|NCT03194373|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
20199659|NCT04042103|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20199660|NCT03430921|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20199661|NCT05853380|Mindset Medical|Jeremy Markovich|8583055323|jeremy@mindsetmedical.com|
20199662|NCT04209855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20199663|NCT02289950|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
20199664|NCT04518462|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9729|MedInfo@Pacira.com|
20199665|NCT01003210|University of Washington|Dr. James Taylor|206-6165-1206|uncjat@uw.edu|
20199666|NCT00271817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199667|NCT03963011|Children's Mercy Hospital|Erin Opfer, DO|816-324-3273|ekopfer@cmh.edu|
20199668|NCT00931359|Miramar Labs|Kathy O'Shaughnessy, PhD|408-940-8700|kathyo@miramarlabs.com|
20199669|NCT04153188|Candela Corporation|Medical Director|+1 904 6549629|konikap@candelamedical.com|
20199670|NCT01471782|Amgen, Inc|Study Director|866-572-6436||
20155069|NCT01543503|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20155070|NCT02460380|Maimonides Medical Center|Mohamad Irani|3472862167|mohamad.irani@hotmail.com|
20155071|NCT02957123|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD|+7 (383) 236-03-29|ostanin62@mail.ru|
20155072|NCT04576949|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20155073|NCT00052715|North American Brain Tumor Consortium|Michael Prados, MD|410-955-8837|jfisher@jhmi.edu|
20155074|NCT01936974|CTCA|Jessica Coats, RN|6232073899|jessica.coats@ctca-hope.com|
20155075|NCT04584554|Duke University School of Nursing|Tolu Oyesanya, PI of study|919-684-5292|tolu.oyesanya@duke.edu|
20155076|NCT01853085|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20155077|NCT01708525|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20155078|NCT04097223|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155079|NCT02280499|Smith & Nephew|Evita Leiber, Clinical Study Manager|+41 41 766 2205|evita.leiber@smith-nephew.com|
20155080|NCT01222351|Columbia University|Yaakov Stern|212-342-1350|ys11@columbia.edu|
20155081|NCT01436500|Cumberland Pharmaceuticals Inc|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
20155082|NCT00977561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155083|NCT02826551|Cedars-Sinai|Josh Page|3104233198|josh.page@cshs.org|
20155084|NCT01482286|Pennington Biomedical Research Center|Dr. Joshua R. Sparks|2257632928|joshua.sparks@pbrc.edu|
20155085|NCT01109381|Synergy Pharmaceuticals Pte Ltd|Medical Director|+64 9 522 4278|damian@pethica.net|
20155086|NCT02018809|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
20155087|NCT05254210|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20155088|NCT01270867|Concentric Medical / Stryker Neurovascular Inc|Paula Schmidt, Clinical Project Manager|510-413-2271|paula.schmidt@stryker.com|
20155089|NCT03511066|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
20155090|NCT00625729|Masonic Cancer Center, University of Minnesota|Veronika Bachanova, M.D.|612-625-5469|bach0173@umn.edu|
20155091|NCT04560309|Nationcal Cardiovascular Center Harapan Kita|I Made Adi Parmana, M.D.|+62 812-4601-212|adiparmana13@gmail.com|
20155092|NCT05085405|University of Michigan|Dr. Jacob E Kurlander, MD, MS|734-647-9252|jkurland@umich.edu|
20155093|NCT04146909|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
20155094|NCT05001165|VA Greater Los Angeles|Boback Ziaeian|310-478-3711|boback.ziaeian@va.gov|
20155095|NCT03808909|University of New Mexico, Health Sciences Center|Pilar Sanjuan|505/272-7055|psanjuan@salud.unm.edu|
20155096|NCT00676689|Edwards Lifesciences|Sharanjeet Dhanjal|949-250-2083|sharanjeet_dhanjal@edwards.com|
20155097|NCT01827943|Institut Bergonie|Dr Nadine Houede, oncologist|05.56.33.33.33|nadine.HOUEDE@chu-nimes.fr|
20155098|NCT01106950|Masonic Cancer Center, University of Minnesota|Jeffrey S. Miller, M.D.|612-625-7409|mille011@umn.edu|
20155099|NCT00309244|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
20155100|NCT00501085|Apollo Endosurgery, Inc.|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
20155101|NCT01487161|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20155102|NCT00663351|Smith & Nephew, Inc.|Rachael Winter, Director, Global Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
20164686|NCT00003468|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20199671|NCT00936208|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199672|NCT00861744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155103|NCT00567112|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155104|NCT03113136|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20155105|NCT03677180|Henry Ford Hospital|Dr. Mir Babar Basir|313-916-2896|mbasir1@hfhs.org|
20155106|NCT04786600|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20155107|NCT04689009|EMOLED SRL|Dr. Rossi Degl'Innocenti Duccio, Clinical Affairs Manager|+390550751960|d.rossi@emoled.com|
20155108|NCT02362412|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
20155109|NCT02187055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155110|NCT03336866|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
20155111|NCT02512445|UCSD|Dr. Sonya Norman|858-518-8266|snorman@ucsd.edu|
20155112|NCT03462563|Ethicon SARL|Richard Kocharian|+1 609 6423787|rkochar1@its.jnj.com|
20155113|NCT05737745|Virginia Tech Carilion Clinic|Shannon Armbruster MD, MPH|540-581-0160|sdarmbruster@carilionclinic.org|
20155114|NCT02021318|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
20155115|NCT00689052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199673|NCT01411085|Geisel School of Medicine at Dartmouth|Alan I Green, MD|603-650-7549|alan.i.green@dartmouth.edu|
20199674|NCT04818593|NYU Langone Health|Rani Fritz, DO, PhD, FACOG|718-935-9766|rani.fritz@nyulangone.org|
20199675|NCT01564862|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20199676|NCT03809611|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20199677|NCT00313209|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20199678|NCT02193074|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20199679|NCT03784079|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20199680|NCT02600494|Intra-Cellular Therapies, Inc.|Vice President, Clinical Development|646-440-9333|ITCIClinicalTrials@itci-inc.com|
20199681|NCT03124563|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
20199682|NCT02452528|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20164687|NCT00739401|Endologix|Elisa Hebb, VP Clinical Affairs|949-598-4628|ehebb@endologix.com|
20199683|NCT03473145|UC San Diego|Sheri Hartman|(858) 534-9235|sjhartman@health.ucsd.edu|
20199684|NCT04179175|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20199685|NCT05593016|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
20199686|NCT04705051|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20199687|NCT00598975|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
20199688|NCT01178138|University of Arkansas for Medical Sciences|W. Brooks Gentry, MD|501 686 6119|gentrywilliamb@uams.edu|
20199689|NCT01241708|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
20199690|NCT05159557|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20199691|NCT02040298|UCSF|Tracy Tran, BA|415-353-2707|tracy.tran@ucsf.edu|
20199692|NCT01790503|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20199693|NCT00049673|Canadian Cancer Trials Group|Director of Clinical Trials|613-533-6340|jdancey@ctg.queensu.ca|
20199694|NCT01535729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199695|NCT00748579|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
20199696|NCT00494091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199697|NCT04161131|Stanford University|Molly Tanenbaum|650-725-3955|mollyt@stanford.edu|
20199698|NCT01265459|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
20199699|NCT00984204|St. Jude Medical|Nabil Kanaan|949-769-5000|nkanaan@sjm.com|
20199700|NCT02848079|Yale University|Dr. Jeremy Kortmansky|1 (203) 407-8002|jeremy.kortmansky@yale.edu|
20199701|NCT01707472|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20199702|NCT03790683|Sidney Kimmel Medical College, Thomas Jefferson University and Hospitals|Marc C. Torjman, Ph.D.|(215) 955-5275|Marc.Torjman@Jefferson.edu|
20199703|NCT01411345|University of Miami|Matthew Abramowitz MD|305-243-4200|mabramowitz@med.miami.edu|
20199704|NCT02479802|Grifols Bioscience Industrial Group|Miquel Barcelo, PhD|+34 935.712.368|Miquel.Barcelo@Grifols.com|
20199705|NCT03757988|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
20199706|NCT03806127|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20199707|NCT01100944|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
20199708|NCT00577993|UT MD Anderson Cancer Center|Nathan Fowler,MD, Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
20199709|NCT04668352|Adicet Bio|Nick Harvey|857-315-5528|nharvey@adicetbio.com|
20199710|NCT02217566|Janssen Research & Development, LLC|Regional Medical Affairs Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20199711|NCT02296242|BioMed Valley Discoveries|Dean Welsch, PhD|8163898831|dwelsch@biomed-valley.com|
20199712|NCT01639833|Covidien|Michael Rohan|781-839-1757|Michael.Rohan@Covidien.com|
20199713|NCT00883246|Medtronic|Clinical Program Manager|763-398-7000|michael.p.swierzewski@medtronic.com|
20199714|NCT02679469|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20164688|NCT04575155|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
20199715|NCT02499029|MUSC|Sudie Back, PhD|843-792-9383|backs@musc.edu|
20199716|NCT01999582|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20199717|NCT01081795|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
20199718|NCT02462473|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
20155116|NCT02569242|Ono Pharmaceutical Co. Ltd|Medical Information Center|ー|clinical_trial@ono.co.jp|
20155117|NCT04906421|Sagimet Biosciences, Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
20155118|NCT04796207|University of Arizona|Floyd H. Chilton|520-621-5327|fchilton@arizona.edu|
20155119|NCT03003468|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20155120|NCT02405962|The Hong Kong Polytechnic University|Dr. Yim Wah Mak|(852) 2766-6421|yw.mak@polyu.edu.hk|
20155121|NCT00165698|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
20155122|NCT01107457|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20155123|NCT03020888|Endomag|Dr Matthew Womack|+44 7851 247439|mwomack@endomag.com|
20155124|NCT01348490|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20155125|NCT00300495|Houston Methodist Hospital|Min Kim|7134415177|mpkim@houstonmethodist.org|
20155126|NCT03461861|Medical College of Wisconsin|Dr. Yang Wang|4149555473|yangwang@mcw.edu|
20155127|NCT02186171|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20155128|NCT00574353|Memorial Sloan Kettering Cancer Center|Dr. John Humm, PhD|212-639-7367|hummj@MSKCC.ORG|
20155129|NCT02015104|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
20155130|NCT01030900|National Cancer Institute|Dr. Wyndham Wilson|(240) 760-6092|wilsonw@mail.nih.gov|
20155131|NCT03277274|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20155132|NCT00126737|Edward Hines, Jr. VA Hospital|Elly Budiman-Mak, MS MPH MD|708-202-2414|elly.mak@va.gov|
20155133|NCT03055221|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20155134|NCT01034527|Mayo Clinic|Dr. Timothy Hewett|513-636-5971|hewett.timothy@mayo.edu|
20155135|NCT00299221|Newark Beth Israel Medical Center|David Baran MD|973-926-7205|dbaran@barnabashealth.org|
20155136|NCT01964560|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20155137|NCT03926598|Research Scientist|Jiten Chhabra|4048942000|jiten@imtc.gatech.edu|
20155138|NCT01093885|University of Pennsylvania Health System|Dr. Chris Derk|215-662-2792|chris.derk@uphs.upenn.edu|
20155139|NCT01301001|University of Tennessee Health Science Center|Dr. Candace Brown|9014124341|CSBROWN@TENNESSEE.EDU|
20155140|NCT01560988|Brigham and Women's Hospital|Dr. Joshua Boyce|617-525-1261|jboyce@partners.org|
20155141|NCT03737032|University of Pittsburgh Medical Center, Department of Psychiatry|Dr. Erika Forbes|412-383-5438|forbese@upmc.edu|
20155142|NCT02301429|Medtronic Regional Clinical Center|Clinical Study manager|0039(0)22 241371|laura.manotta@medtronic.com|
20155143|NCT01502072|UT MD Anderson Cancer Center|Roy F. Chemaly, MD,MPH- Professor, Infectious Diseases|(713) 745-1116|rfchemaly@mdanderson.org|
20155144|NCT04250363|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20155145|NCT01975285|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
20155146|NCT04535362|Yale School of Medicine|Mehmet Sofuoglu, MD, PhD: Professor of Psychiatry; Director of VA New England Mental Illness Researc|(203) 937-4809|mehmet.sofuoglu@yale.edu|
20155147|NCT03791060|Beth Israel Deaconess Medical Center|Co-Director Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS)|6176675834|mporter3@bidmc.harvard.edu|
20155148|NCT03611062|University of Massachusetts Lowell|Dr. Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
20155149|NCT02018887|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20155150|NCT00927186|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20155151|NCT01011283|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
20155152|NCT02619812|Mayo Clinic|Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20155153|NCT00799864|Janssen R&D BE|Director 1 Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20155154|NCT02614768|Medical University of Graz|Mader, Julia, Assoz. Dr.med.univ.|0043316385|julia.mader@medunigraz.at|12383
20155155|NCT01210443|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155156|NCT00986583|Cleveland Clinic|Alparslan Turan, M.D.|216-444-4000|turana@ccf.org|9857
20155157|NCT02807181|Sirtex|Director, Clinical Research Operations|+1-888-474-7839|info-us@sirtex.com|
20155158|NCT00063999|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-545-8321|lgedeon@gogstats.org|
20155159|NCT01078545|Abbott|Global Medical Services|1-800-633-9110||
20155160|NCT02497755|University of Washington|Dr. Amy Bauer|206.221.8385|abauer1@uw.edu|
20155161|NCT01774370|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155162|NCT00514917|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20155163|NCT03193307|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155164|NCT02829957|Indiana University|Dr. Jeffrey Kline|317-880-3869|jefkline@iu.edu|
20155165|NCT01663987|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155166|NCT01783236|Weill Cornell Medicine|Hugh Hemmings, MD, PhD|212-746-2953|hchemmi@med.cornell.edu|
20155167|NCT04193527|GE Healthcare Ltd.|Yongqing Tang, MD, PhD|21 38774044|Yongqing.Tang@ge.com|+86
20155168|NCT02945046|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20155169|NCT01266083|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
20155170|NCT01509807|University of South Florida|Jorge Marcet, MD|813-844-4545|jmarcet@health.usf.edu|
20155171|NCT06171399|Wake Forest University School of Medicine|Dr. Beth Reboussin|336-713-5213|brebouss@wakehealth.edu|
20155172|NCT04159480|University of Colorado, Anschutz Medical Campus|Lisa Brenner|7208481980|lisa.2.brenner@cuanschutz.edu|
20155173|NCT00541775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155174|NCT01666314|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20155175|NCT00032487|Hines CSPCC|Project Manager|708-202-5785|tamara.paine@va.gov|
20199719|NCT00661271|Johns Hopkins School of Medicine|Erica Sibinga|410-550-4134|esibinga@jhmi.edu|
20199720|NCT03138876|Mayo Clinic|Dr. William O. Tatum|904-953-2498|tatum.william@mayo.edu|
20199721|NCT01707693|University of Arkansas for Medical Sciences|Leanne L. Lefler, PhD, APN, RN Principal Investigator|5012961939|LeflerLeanne@uams.edu|
20199722|NCT00927095|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
20199723|NCT04336995|VUMC|Ken Monahan|6153222318|ken.monahan@vanderbilt.edu|
20199724|NCT01662583|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
20199725|NCT03115151|UT Southwestern Medical Center|Dr. Enas Kandil|214/648-9374|Enas.Kandil@UTSouthwestern.edu|
20199726|NCT05779072|Coopervision|Paul Chamberlain|9257306754|pchamberlain@coopervision.com|
20199727|NCT03713944|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20199728|NCT03847610|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
20199729|NCT03298022|AltruBio|Vice President of Clinical Operations|17142150224|simona.reed@altrubio.com|
20199730|NCT00044512|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20199731|NCT04817111|Children's Hospital of Philadelphia|Dr. Shana McCormack|215-590-3174|mccormacks1@email.chop.edu|
20199732|NCT02508194|MedImmune, LLC|Judith Falloon, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
20199733|NCT00393874|University of Pittsburgh|Dr. Anne Germain|412-383-2150|GERMAX@upmc.edu|
20199734|NCT00511355|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20155176|NCT04267328|HealthPartners Institute - Neuroscience|Clinical Research Coodinator|651-495-6360|clincialtrials@HealthPartners.com|
20155177|NCT04913675|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20155178|NCT02975700|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20155179|NCT04501445|Rush University Medical Center|Jared A Greenberg|312-942-6744|jared_greenberg@rush.edu|
20155180|NCT02082288|al-azhar university|wael mohamed hamed|002-01001556162|wael79hamed@yahoo.com|
20155181|NCT03378336|University of Pennsylvania|Dr. Alexis Ogdie-Beatty|215-614-2454|alexis.ogdie@pennmedicine.upenn.edu|
20155182|NCT01125748|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20155183|NCT01751685|University of California, San Francisco|Wendy Katzman, PT|415-353-7598|Wendy.Katzman@ucsf.edu|
20155184|NCT01028391|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372||
20155185|NCT00694161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155186|NCT03601052|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
20155187|NCT00837330|Southeast Retina Center, P.C.|Dr. Dennis M Marcus Principal Investigator|706-650-0061|dmarcus@southeastretina.com|
20155188|NCT02641353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20155189|NCT01398475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20155190|NCT00694122|Massachusetts General Hospital|David M. Nathan, MD|617-726-1848|dnathan@partners.org|
20155191|NCT00086307|NIMH|Dr. Carlos A. Zarate|301-451-0861|zaratec@mail.nih.gov|
20155192|NCT00105508|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
20155193|NCT00683384|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155194|NCT00120874|NYU Langone Medical Center|Barry Reisberg|121-263-8550|barry.reisberg@nyumc.org|
20155195|NCT01727154|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
20155196|NCT00845000|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155197|NCT01184118|UW Madison|Mihaela Teodorescu, MD|608-256-1901|mt3@medicine.wisc.edu|
20155198|NCT00908687|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
20155199|NCT05067270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20155200|NCT01198548|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20155201|NCT03834883|Purdue University|James E. Tisdale, PharmD|317-880-5418|jtisdale@purdue.edu|
20155202|NCT01179399|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20155203|NCT00441896|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
20155204|NCT03572218|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Pearl|215-746-5129|rpearl@pennmedicine.upenn.edu|
20155205|NCT06765889|A*STAR|Alessandro Sparacio|80728247|Alessandro_Sparacio@sics.a-star.edu.sg|
20155206|NCT01793129|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
20155207|NCT04128215|University of Florida|Dr. Demetra Christou|3522941715|ddchristou@ufl.edu|
20155208|NCT01567085|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc. (Sponsor)||clinicaltrials@alexion.com|
20155209|NCT03076164|Memorial Sloan Kettering Cancer Center|Dr. Helene Yu, MD|646-608-3912|YuH@mskcc.org|
20155210|NCT00324857|VA|Said A. Ibrahim, MD, MPH|215 823 5800|Said.Ibrahim2@va.gov|7163
20155211|NCT03312114|University of Texas Southwestern Medical Center|Phase II trial of Concurrent Anti-PD-L1 and SAbR for Patients with Persistent or Recurrent Epithelia|(214) 645-7296|kevin.albuquerque@utsouthwestern.edu|
20155212|NCT03537729|Grand Valley State University|Dr. Rebecca Davis|616.331.3079|davirebe@gvsu.edu|
20155213|NCT00284934|Novartis Pharmaceuticals|Study Director|862-778-8300||
20155214|NCT00454142|National Cancer Centre Singapore|Dr. Wan Teck LIM|65-64368174|dmolwt@nccs.com.sg|
20155215|NCT04634903|Stony Brook University|Dr. Jessica Schleider|917-439-1872|jessica.schleider@stonybrook.edu|
20155216|NCT01389284|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
20155217|NCT00476788|Greenville Hospital System|Elaine Moreland MD|8644545661|emoreland@ghs.org|
20199735|NCT00454805|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20199736|NCT00217087|Mayo Clinic|Kenneth Wang MD|507-255-7495|wang.kenneth@mayo.edu|
20155218|NCT01748552|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20199737|NCT00802685|University of Miami|Ilene R. S. Sosenko, M.D.|305-585-6408|isosenko@miami.edu|
20199738|NCT03208231|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20199739|NCT03321097|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
20199740|NCT03861143|NImmune Biopharma, Inc.|Clinical Development|(540) 218-2262|info@nimmunebio.com|
20199741|NCT04947800|Dartmouth-Hitchcock|james stahl|6036502000|james.e.stahl@hitchcock.org|
20199742|NCT03977467|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
20199743|NCT05721482|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
20199744|NCT06232317|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
20199745|NCT03711578|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
20199746|NCT01314716|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20199747|NCT00700271|Novartis Pharmaceuticals|Study Director|862-778-8300||
20199748|NCT04440592|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
20199749|NCT03845582|Alkeus Pharmaceuticals, Inc.|Meena Venugopal|877-255-7476|mvenugopal@alkeus.com|
20199750|NCT02028455|Seattle Children's Therapeutics|Dr. Colleen Annesley|206-987-7122|ICC-PLAT@seattlechildrens.org|
20199751|NCT05429073|Regulus Therapeutics|Kristen Gillotti, Senior Director Clinical Operations|203-313-8185|kgillotti@regulusrx.com|
20199752|NCT02396589|Washington University in St. Louis School of Medicine|Dr. Susan Stark|3142734114|sstark@wustl.edu|
20199753|NCT03087955|Drugs for Neglected Diseases|Sandra Rembry, PharmD|+41229077734|srembry@dndi.org|
20199754|NCT02392429|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20199755|NCT06523491|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
20199756|NCT02968810|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
20155219|NCT00504556|Daiichi Sankyo Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
20199757|NCT04183335|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20155220|NCT01260324|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155221|NCT03607695|University of Washington|Valerie E. Kelly, PT, PhD|206-598-5350|vekelly@uw.edu|
20155222|NCT02741193|NYU Langone Health|Anli Liu|9294552340|Anli.Liu@nyulangone.org|
20155223|NCT02502383|University of New Mexico Health Sciences|Alberta Kong|505-272-5551|AKong@salud.unm.edu|
20155224|NCT00676052|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199758|NCT02787850|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director of Clinical, Regulatory and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
20155225|NCT01428713|Baylor College of Medicine/TCH|Dr. Lakshmi Srivaths|832-822-1514|lvsrivat@txch.org|
20155226|NCT02930941|University of California, Davis Medical Center|Aimee Moulin, MD|916-703-6110|akmoulin@ucdavis.edu|
20155227|NCT02979054|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
20155228|NCT00903344|University of Kansas Medical Center|Dr. Leigh Eck|913-588-6022|leck2@kumc.edu|
20155229|NCT00382928|Atlanta Research and Education Foundation|Dr. A. Maziar Zafari|404-321-6111|azafari@emory.edu|4019
20155230|NCT00585169|Yale Unviersity|Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
20155231|NCT03794323|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155232|NCT00710554|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20155233|NCT01368185|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155234|NCT03992482|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
20155235|NCT01507103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20155236|NCT03774810|University of Pennsylvania|Michael L. Perlis, PHD|215-746-3577|mperlis@upenn.edu|
20155237|NCT00604383|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
20155238|NCT00943202|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
20155239|NCT00290758|NorthwesternU|Seema Khan, MD|312-695-0288|skhan@nmh.org|
20155240|NCT01556100|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
20155241|NCT03994120|National Institutes of Health/NINDS|Dr. Eric Wasserman|301-495-0151|wassermanne@ninds.nih.gov|
20155242|NCT01111292|Northwestern University|Dr. Seema Khan|(312) 503-4236|SKhan@nm.org|
20155243|NCT01096186|Impax Laboratories, Inc.|Daven Mody, PharmD, MBA, Director, Regulatory Affairs|510-240-6073|dmody@impaxlabs.com|
20155244|NCT02728726|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
20155245|NCT00793611|University of New Mexico Health Sciences Center and CTSC|Yuko Komesu MD|505-925-4395|ykomesu@salud.unm.edu|
20155246|NCT00673114|Duke University Medical Center|Dr. Joanne Kurtzberg|919-668-1100|kurtz001@mc.duke.edu|
20155247|NCT05587998|AstraZeneca|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20155248|NCT03892915|RAND Corporation|Glenn Wagner|310-393-0411|gwagner@rand.org|7695
20164689|NCT05748275|Multack Eye Care|Dr Sam Multack|815-889-3333|smultack@mecvision.com|
20199759|NCT02326805|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
20199760|NCT02322710|Mylan Medical SAS|Rafik NAMANE MD.|0033146258607|rafik.namane@mylan.com|
20199761|NCT03733392|Abbott|Emily Jesser, Ph.D.|763-954-1350|emily.jesser@abbott.com|
20155249|NCT00191152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20155250|NCT00114777|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20164690|NCT03915717|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
20155251|NCT03335267|Weill Cornell Medical College|Dr. Ellen K. Ritchie|646-962-2700|ritchie@med.cornell.edu|
20155252|NCT02864914|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20155253|NCT04243837|PureTech Health, Inc|Director of Clinical Trials|6034982261|ckorth@puretechhealth.com|
20155254|NCT02555098|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20155255|NCT01457430|MGH Allergy Associates|Dr. Aleena Banerji|617-726-3850|abanerji@mgh.harvard.edu|
20155256|NCT00400205|Emory University Winship Cancer Institute|Nabil Saba, MD|1-888-946-7447|nfsaba@emory.edu|
20155257|NCT00137280|Greater Los Angeles Veterans Healthcare Center|Dr. Alexander S. Young|310-268-3416|alexander.young@va.gov|
20155258|NCT01829503|University of Pittsburgh Cancer Institute|Dr. Annie P. Im|412-623-2393|imap@upmc.edu|
20155259|NCT02675452|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20155260|NCT00545948|Duke University Medical Center|Neal Ready, PhD, MD|919-681-6932|neal.ready@duke.edu|
20155261|NCT03467945|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20155262|NCT02821793|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20199762|NCT00130832|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199763|NCT03905863|Serena Group Inc|Dr Thomas Serena|671-945-5225|serena@serenagroups.com|
20199764|NCT00532480|Indiana University|Dr. Amit Anand|317-944-7422|aanand@iupui.edu|
20199765|NCT02168686|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
20199766|NCT04415073|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD|+1-781-419-1400|kmadigan@syndax.com|
20199767|NCT00618748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20199768|NCT04401267|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
20199769|NCT02392013|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
20199770|NCT03881007|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
20199771|NCT00559507|Memorial Sloan-Kettering Cancer Center|Clifford Hudis, MD|646-888-4551|hudisc@mskcc.org|
20199772|NCT02770326|Memorial Sloan Kettering Cancer Center|Dr. Robin Mendelsohn, MD|212-639-8286|mendelsr@mskcc.org|
20199773|NCT01629797|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
20199774|NCT01191697|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|(877) 442-3342|peter_enzinger@dfci.harvard.edu|
20199775|NCT04227899|Abbott|Karine Ruster|(408) 845-0764|karine.piard-ruster@abbott.com|
20199776|NCT02421887|NICHD|Esther Eisenberg, NICHD Project Scientist|301-496-6516|esther.eisenberg@nih.gov|
20199777|NCT01882907|Pusan National University Hospital|In Joo Kim|+82-51-240-7224|injkim@pusan.ac.kr|
20199778|NCT03124784|Masimo Corporation|Tala Harake|949-297-7000|studies@masimo.com|
20199779|NCT05702515|Duke University|Deborah Hutch Allen|919-681-4719|hutch.allen@duke.edu|
20199780|NCT01784965|Stanford Universtiy|Gerald Reaven, Professor Emeritus|650-724-3416|greaven@stanford.edu|
20199781|NCT04580290|Xiros Ltd|Tracey Oxley|07810337555|Tracey.Oxley@xiros.co.uk|
20199782|NCT01467492|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20155263|NCT01541254|MicroVention, Inc.|Mary Schmitz|714-247-8025|mary.schmitz@microvention.com|
20155264|NCT05660538|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20155265|NCT04518410|ACTG Network Coordinating Center, DLH|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20155266|NCT01227395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155267|NCT01940146|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
20155268|NCT03259308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20155269|NCT01807104|VOA Research Foundation|Dr. William P. Barrett, MD|425-656-5060|wpbarrett@comcast.net|3063
20155270|NCT03632720|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20155271|NCT03389750|New York State Psychiatric Institute|Jermaine Jones|646 774-6113|jermaine.jones@nyspi.columbia.edu|
20155272|NCT01117350|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20155273|NCT04902144|University of Washington|Dr. Marianne Dubard-Gault|206-606-6990|mdg2019@uw.edu|
20155274|NCT01049828|Washington University in St. Louis|Dr. Andre Wineland|314-362-5296|winelanda@ent.wustl.edu|
20155275|NCT00290238|RS Medical|Clinical Research Manager|360-891-7299||
20155276|NCT03361072|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
20155277|NCT01537367|Division of HIV/AIDS (Epidemiology Branch), National Center for HIV/Hepatitis/STD/Tuberculosis Prevention, Centers for Disease Control and Prevention|Lytt I. Gardner, Ph.D., CDC Project Officer|(404) 639-6163|lig0@cdc.gov|
20155278|NCT02487199|AbbVie|Global Medical Services|800-633-9110||
20155279|NCT03885206|Landsforeningen for hjerte- og lungesyke|Senior Consultant|0047 95706313|irene.steinsvik@lhl.no|
20155280|NCT01213251|Medtronic plc|PRomPT Clinical Team|+1 800-328-2518|MedtronicCRMtrials@medtronic.com|
20155281|NCT00594308|Indiana University School of Medicine|Robert Nelson, MD|317-278-6871|ronelson@iupui.edu|
20164691|NCT03808090|University of Alabama at Birmingham|Dr Kyle Wood|205-996-2295|kylewood@uabmc.edu|
20199783|NCT02450487|Bauru School of Dentistry University of Sao Paulo|Dr. Adriana Calvo|+551432358200|birinjela@yahoo.com.br|
20199784|NCT04269395|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
20217816|NCT04061577|UCLA|Dr. Mersedeh Bahr Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
20155282|NCT00295503|UT Southwestern|Jonathan Dowell|214-648-4180|jonathan.dowell@utsouthwestern.edu|
20155283|NCT03453515|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
20155284|NCT00520572|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20155285|NCT03532490|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
20155286|NCT02802865|University of Iowa|Dr. Rachel Mejia|319-356-3143|rachel-mejia@uiowa.edu|
20155287|NCT02504775|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199785|NCT01491178|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199786|NCT03132636|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20199787|NCT01415752|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20199788|NCT01445028|MidAtlantic Retina|Richard Kaiser, MD|215-928-3092|research@midatlanticretina.com|
20199789|NCT01562548|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199790|NCT01285908|National Institute of Neurological Disorders & Stroke|Dr. David S. Goldstein||david.goldstein1@nih.gov|
20199791|NCT01239160|Tactile Medical|Director of Clinical Research|612-540-5267|astone@tactilemedical.com|
20199792|NCT01415427|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|pslasor@bmrn.com|
20155288|NCT01723839|John Theurer Cancer Center at Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
20155289|NCT01803737|University of Arizona|David O. Garcia, PhD|520-626-4641|davidogarcia@email.arizona.edu|
20155290|NCT01529112|Eisai Call Center|Eisai Inc.|888-422-4743||
20155291|NCT01161121|St. Louis University|Dr. Michael Lim|314-268-7992|limmj@slu.edu|
20155292|NCT01530256|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20155293|NCT01084759|SKCCC at Johns Hopkins|Dr. Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
20155294|NCT00527748|University of Missouri|Dr. Saul G Trevino|573/884-8840|trevinos@health.missouri.edu|
20155295|NCT02164721|University of Rochester|Valentina Kutyifa MD, PhD|585-275-2676|valentina.kutyifa@heart.rochester.edu|
20155296|NCT02016885|Dermira Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20155297|NCT02004275|Levine Cancer Institute|Peter Voorhees|980-442-5219|peter.voorhees@carolinashealthcare.org|
20155298|NCT04621786|University of New Mexico|Dr. Chris Abbott|5052720406|cabbott@salud.unm.edu|
20155299|NCT00292370|Ralph H. Johnson VA Medical Center|Mark Hamner, MD|843-789-7799|Mark.Hamner@va.gov|
20155300|NCT01346709|European Society of anaesthesiology|Brigitte Leva, Research Team Leader|+3222109414|research@esahq.org|
20155301|NCT01990352|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
20155302|NCT00949078|Johns Hopkins University School of Medicine|Professor Robert Wood, M.D.|rwood@jhmi.edu|rwood@jhmi.edu|
20155303|NCT02194088|Brigham and Women's Hospital|Edwards Robert|617-732-9486|rredwards@partners.org|
20155304|NCT01282138|Alcon Research|Head, Global Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
20155305|NCT00548691|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
20155306|NCT04821245|Benaroya Research Institute|Joseph M. Neal, MD|206-223-6980|Joseph.Neal@virginiamason.org|
20155307|NCT00605657|NIAID|V. Koneti Rao, MD|301-496-6502|korao@niaid.nih.gov|
20155308|NCT02284854|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20155309|NCT02773537|Medical University of South Carolina|Dr. Eric Bolin|843-792-2322|bolin@musc.edu|
20155310|NCT01840163|University of Michigan|Dr. Sarah Hawley|734-936-8816|sarahawl@med.umich.edu|
20155311|NCT00662038|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20155312|NCT00397046|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20155313|NCT00383565|MD Anderson Cancer Center|Dr. Luis E. Fayad / Associate Professor|713-792-2860|jmdennison@mdanderson.org|
20155314|NCT01749293|University of Illinois|Dr. Pritesh Patel|312-996-5762|prpatel8@uic.edu|
20155315|NCT03939494|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
20155316|NCT01291160|Ogenix|S.Sarangapani|7817026732|ssarangapani@ogenix.com|
20155317|NCT00493285|MedImmune, LLC|Elissa Malkin, DO, MPH|301-398-0000|malkine@medimmune.com|
20155318|NCT03021005|Johns Hopkins University|Dr. Yu-Hsiang Hsieh|410-735-6413|yhsieh1@jhmi.edu|
20155319|NCT00337194|The Ohio State University|Dr. Kristie Blum||kristie.blum@osumc.edu|
20155320|NCT03188705|University of Maryland School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
20155321|NCT03074643|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
20155322|NCT02212977|Duke University Medical Center|Dr. Charles Kim|9196847424|charles.kim@duke.edu|
20155323|NCT01174459|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155324|NCT03615534|Al-Kindy College of Medicine, ////university of Baghdad|Lewai Sharki Abdulaziz|750 659 0024|lewaisharki@kmc.uobaghdad.edu.iq|+964
20155325|NCT05688657|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|jvega2@coopervision.com|
20155326|NCT04914000|Moffitt Cancer Center|Dr. Ursula Martinez|813-745-1754|Ursula.Martinez@moffitt.org|
20155327|NCT00981175|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20155328|NCT01834651|Cedars-Sinai Medical Center|Dr. Edwin Posadas|310-423-7600|Edwin.Posadas@cshs.org|
20155329|NCT01750281|AstraZeneca|Dr Gabriella Mariani|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
20155330|NCT04189588|TerSera Therapeutics Inc.|Executive Director Clinical Development|888 600 8116|jnorth@tersera.com|
20155331|NCT03302936|Icahn School of Medicine at Mount Sinai|Annacecilia Peacher-Holderied|2104887216|apeacher4@gmail.com|
20164692|NCT03748823|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20199793|NCT04781816|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20199794|NCT01121393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199795|NCT02123485|Department of Affective Disorder, Aarhus University Hospital, Denmark|Dr Poul Erik Buchholtz|21474299|Buchholtz.Hansen@ps.rm.dk|
20155332|NCT01122680|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155333|NCT03760640|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20155334|NCT02046200|UCLA Department of Psychology|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
20199796|NCT04372927|University of Washington School of Medicine|Dr. Jing Zeng|206-598-4115|jzeng13@uw.edu|
20199797|NCT01077973|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199798|NCT00119158|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
20199799|NCT00608985|Actelion Pharmaceuticals Ltd|Ouali Berkani/Clinical Trial Leader|+41 61 565 5342||
20199800|NCT03033745|CSL Behring|Trial Registration Coordinator|610 878-4000|clinicaltrials@cslbehring.com|
20199801|NCT01568606|Ahmanson-UCLA Cardiomyopathy Center|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
20199802|NCT02706730|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
20199803|NCT01014741|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20199804|NCT01243320|University of Utah|Mark A. Munger, Pharm.D.|8015816165|mmunger@hsc.utah.edu|
20199805|NCT00953758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199806|NCT01536860|RSSL|Rungano Munyuki|+44 118 918 4166|rungano.munyuki@rssl.com|
20199807|NCT01164722|AIDS Malignancy Consortium|Group Statistician|1-501-526-6712|jylee@uams.edu|
20199808|NCT02902120|Institute of Human Virology, University of Maryland School of Medicine|Lydia Tang|410-706-6567|LydiaTang@ihv.umaryland.edu|
20199809|NCT01445769|Incyte Corporation|Study Director|855 463-3463||
20199810|NCT03694925|Cleveland Clinic Arthroplasty Research Group|Alison Klika|4123017914|klikaa@ccf.org|
20199811|NCT03104725|National Institutes of Health/NINDS|Dr. David Goldstein|301-496-2103|goldsteind@ninds.nih.gov|
20199812|NCT01639872|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5054|mary.f.brunette@hitchcock.org|
20199813|NCT02799069|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
20199814|NCT04906980|Janssen Research & Development, LLC|GLOBAL MEDICAL LEADER RESPIRATORY INFEC|+12153252489|ClinicalTrialDisclosure@its.jnj.com|
20199815|NCT03652662|MUSC|Sarah Miller, PhD, RN|8427921692|millesar@musc.edu|
20199816|NCT00487539|Janssen Research & Development|Senior Director|215-793-7540||
20217817|NCT02087176|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
20217818|NCT03812991|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20217819|NCT00304707|University of Massachusetts Medical School|David Kalman, PhD|9785782371|kalmand@comcast.net|
20217820|NCT02938013|Johns Hopkins University School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
20217821|NCT00712244|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20217822|NCT02063087|Mayo Clinic|Dr. Erik Hess|507-255-6501|hess.erik@mayo.edu|
20155335|NCT00682838|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
20155336|NCT00185900|Stanford University|Dr. Anna Girsen|(650) 725-5720|agirsen@stanford.edu|
20155337|NCT01986751|University of Alabama Birmingham|Dr. Promil Kukreja|205-996-7025|pkukreja@uabmc.edu|
20155338|NCT03566550|University of Nottingham|Professor Alan Smyth|01158230612|alan.smyth@nottingham.ac.uk|
20155339|NCT03095976|Indiana University School of Dentistry|Dr. Yusuke Hamada|317-274-5121|yuhamada@iupui.edu|
20155340|NCT01968785|Medstar Health Research Institute|Megan Rowland|2028772959|megan.e.rowland@medstar.net|
20155341|NCT00098293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155342|NCT00754559|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20155343|NCT00455455|CCLR|Dr Craig A Woods|519 888 4567|cawoods@uwaterloo.ca|36547
20155344|NCT01370538|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
20217823|NCT01931527|Washington University School of Medicine|Elisa Fabbrini, MD, PhD|314-362-8156|efabbrini@dom.wustl.edu|
20217824|NCT02470091|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20217825|NCT04072315|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
20217826|NCT02598895|University of Washington/Fred Hutchinson Cancer Center|Dr. Heather Cheng|206-606-7416|hhcheng@uw.edu|
20217827|NCT02210052|Mayo Clinic|Dr. Tim J. Lamer, M.D.|507 778-8760|lamer.tim@mayo.edu|
20217828|NCT02389101|Turku Univesrity Hospital, Turku, Finland|Heikki Minn, MD|+35823130000|heikki.minn@utu.fi|30149
20217829|NCT01192399|Alexion Pharmaceuticals, Inc|Alexion Pharmaceuticals, Inc||clinicaltrials@alexion.com|
20217830|NCT00303667|Masonic Cancer Center|Sarah Cooley, M.D.|612-626-4024|cool0023@umn.edu|
20217831|NCT01029392|William Beaumont Hospital|Dr. Peter Gerrits|248-551-0487|peter.gerrits@beaumont.org|
20217832|NCT01103479|Northwestern University|Kenzie A. Cameron|312-503-3910|k-cameron@northwestern.edu|
20217833|NCT01298778|Wake Forest School of Medicine|Dr. Jessica Booth|336-718-8278|jbooth@wakehealth.edu|
20217834|NCT00536484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20217835|NCT02083926|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
20217836|NCT00384176|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20217837|NCT02139124|Purdue Pharma|Dr Lance Payne|1-800-384-5349|Lance.Payne@purdue.ca|
20217838|NCT02691741|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20217839|NCT01425528|University of utah|Kathryn Swoboda MD|801-585-9717|Swoboda@genetics.utah.edu|
20217840|NCT00307931|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20155345|NCT03335566|GE Healthcare|Francois Tranquart, M.D, PhD|011-44-1494-543037|francois.tranquart@ge.com|
20199817|NCT02695628|Stanford University|Rajesh Shah|650-723-0728|rajshah@stanford.edu|
20217841|NCT03069417|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
20155346|NCT01084135|Duke University Medical Center|Jane Ann Baker,MS, CGC|919-668-4576|janeann.mckillop@duke.edu|
20217842|NCT00402025|Amgen, Inc.|Study Director|866-572-6436||
20217843|NCT02767934|University of Washington|Dr. Ryan Cassaday|206-606-1202|cassaday@seattlecca.org|
20199818|NCT02678390|Research Centre on Aging|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
20199819|NCT03499028|Cleveland Clinic|Anabelle Visperas|216-444-2416|vispera@ccf.org|
20199820|NCT00720109|Children's Oncology Group|Results Reporting Coordinator|626-241-1546|resultsreportingcoordinator@childrensoncologygroup.org|
20199821|NCT01110200|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199822|NCT03467958|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20199823|NCT02692209|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
20199824|NCT02925156|Loyola University Chicago|Amy Luke, Ph.D.|(464) 220-9243|aluke@luc.edu|
20199825|NCT00866307|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20199826|NCT01687712|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
20155347|NCT03587857|UCSF|Dr. Parya Saberi|415-502-1000 ext. 17171|parya.saberi@ucsf.edu|
20155348|NCT04595370|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20155349|NCT02218268|University of Florida|Michael Haller|352-265-0111|hallemj@peds.ufl.edu|
20155350|NCT03651336|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
20155351|NCT01341990|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20155352|NCT00809146|University of Michigan|Robert Silbergleit MD, Principal Investigator|734-232-2142|robie@umich.edu|
20155353|NCT04826731|Ankara Sanatoryum Training and Research Hospital|Dr. Kerem Ensarioğlu|905426142727|kerem.ensarioglu@gmail.com|
20155354|NCT03181009|The Sean N. Parker Center for Allergy and Asthma Research at Stanford University|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|650 - 521 - 7237|andresap@stanford.edu|
20155355|NCT01557244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155356|NCT01313676|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155357|NCT01862029|National Institute of Health, NHLBI, Laboratory of Obesity and Aging Research|Jay H. Chung, Ph.D, MD|301-496-3075|chungj@nhlbi.nih.gov|
20155358|NCT03254147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155359|NCT03931785|Ironwood Pharmaceuticals, Inc.|Wilmin Bartolini, Ph.D.|617.621.8314|wbartolini@ironwoodpharma.com|
20155360|NCT03548415|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
20155361|NCT04605588|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
20155362|NCT01230814|University of Arkansas for Medical Sciences|Shelly Lensing, MS|501-686-8203|sylensing@uams.edu|
20155363|NCT02527265|MannKind Corporation|Clinical Development|844.323.7399|mapp@mannkindcorp.com|
20155364|NCT04630626|NuVasive, Inc.|Nicole Czaplewski, Manager Clinical Affairs|308-660-2021|nczaplewski@nuvasive.com|
20155365|NCT02533674|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
20155366|NCT02799290|Tampere University Hospital|Ilkka Kaartinen|505687096|ilkka.kaartinen@pshp.fi|
20155367|NCT02365064|Sleep and Human Health Institute|Dr. Barry Krakow|(505) 9987204|bkrakow@sleeptreatment.com|
20155368|NCT02123511|Mayo Clinic|Michele Halyard, M.D.; Robert Foote, M.D.|480-301-4567|mhalyard@mayo.edu; foote.robert@mayo.edu|
20155369|NCT00458705|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|landauh@mskcc.org|
20155370|NCT01531803|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
20155371|NCT00378560|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20155372|NCT03636269|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20155373|NCT03008213|UCSD|Eric Roeland, MD|858- 534-7079|eroeland@ucsd.edu|
20155374|NCT00948935|Abramson Cancer Center|Bruce Giantonio|(215) 615-5858|bruce.giantonio@uphs.upenn.edu|
20155375|NCT01433081|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20155376|NCT00271570|University of California, San Diego|Jane Burns, MD, Professor|858-246-0155|jcburns@ucsd.edu|
20155377|NCT00201773|The Ohio State University Comprehensive Cancer Center|Steven Provoski, MD|614-293-8700|Stephen.Povoski@osumc.edu|
20155378|NCT01658735|University of Utah School of Medicine|Matthew A Hughes, MD, MPH|8015814800|matthew.hughes@hsc.utah.edu|
20155379|NCT03757715|UAB|Dr. Jessica W. Grayson|205-801-7801|jgrayson@uabmc.edu|
20155380|NCT03156621|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844 734 6643|clinicaltrials@regeneron.com|
20155381|NCT01379937|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155382|NCT00079781|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
20155383|NCT00576407|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
20155384|NCT04641975|Astellas Pharma Global Development Inc|Clinical Trial Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20155385|NCT04299425|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
20155386|NCT01431573|NYSPI|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
20155387|NCT01259024|Washington University|Patricia Nieters, RN, BSN, Clinical Research Specialist|314-362-3371|nietersp@wustl.edu|
20155388|NCT01657500|Case Western Reserve Univ and University Hospitals Case Medical Center|Jonathan Lass MD|2168445893|jonathan.lass@uhhospitals.org|
20155389|NCT00063362|University Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
20155390|NCT00756444|Amgen Inc.|Study Director|866-572-6436||
20155391|NCT00564070|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|(305) 284-2818|ssafren@miami.edu|
20155392|NCT00087672|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes, M.D./ Professor|713-794-5783|eharriso@mdanderson.org|
20199827|NCT01681433|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20199828|NCT00730639|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20155393|NCT02264821|CHU Brugmann|Dr Madeleine Wilwerth|003224773996|madeleine.wilwerth@chu-brugmann.be|
20155394|NCT00552279|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155395|NCT00619242|The University of Chicago|Ezra Cohen, MD|773/702-4137|ecohen@medicine.bsd.uchicago.edu|
20155396|NCT03142334|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155397|NCT03835117|Autism Discovery & Treatment Foundation|Richard E Frye|844-ADTF-Research|DrFrye@AutismDiscovery.org|1
20155398|NCT06083493|University of Michigan|Zirui Huang|734-615-2875|huangzu@med.umich.edu|
20155399|NCT04034056|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20155400|NCT03225989|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
20155401|NCT03093870|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
20155402|NCT00601107|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20155403|NCT01362270|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|underwos@ohsu.edu|
20155404|NCT02318277|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20155405|NCT02453191|University of Iowa, Holden Comprehensive Cancer Cente|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
20155406|NCT03364686|University of Pittsburgh|Darrell J. Triulzi, MD|412-209-7304|triudj@upmc.edu|
20155407|NCT01520714|The Heart Hospital Baylor Plano|Research Manager|469-814-4712|natalie.settele@baylorhealth.edu|
20155408|NCT02201628|King's College Hospital NHS Foundation Trust|Dr Emily Haberman|07890549924|emilysaffer@gmail.com|
20155409|NCT01895647|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|886-975837711|jeff01@mmh.org.tw|
20155410|NCT00407030|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
20155411|NCT01489358|Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr Julie E Ledgerwood||ledgerwood@mail.nih.gov|
20155412|NCT03722030|University of Wisconsin - Madison|Dr. Lisa Cadmus-Bertram|608-262-1167|lisa.bertram@wisc.edu|
20155413|NCT00736476|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20155414|NCT03343886|Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, Spain.|José Luis Ayuso Mateos||joseluis.ayuso@uam.es|
20155415|NCT03518203|Cincinnati Children's Hospital Medical Center|Sonata Jodele, MD|(513) 636-5917|Sonata.Jodele@cchmc.org|
20155416|NCT00345592|S. Anna Hospital|Giovanni Luca Botto|0315851|gluca.botto@gmail.com|+39
20155417|NCT02523040|Dana-Farber Cancer Institute|Eric Jacobsen, MD|857-215-1405|eric_jacobsen@dfci.harvard.edu|
20155418|NCT04000724|Friends Research Institute, Inc.|Cathy Reback|3234631601|reback@friendsresearch.org|
20155419|NCT02366130|UT MD Anderson Cancer Center|Dr. Naoto T Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
20155420|NCT01065766|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-888-577-8839|ClinicalTrialsDisclosure@merck.com|
20155421|NCT04223687|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
20155422|NCT01608308|The University of Texas Health Science Center at Houston|Davide Cattano|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
20155423|NCT06173648|State Univeristy of Paulista Júlio de Mesquita Filho, School of Dentistry at Araraquara|Dr. Renato de Toledo Leonardo|+55-16-3301-6391|rleonard@foar.unesp.br|
20155424|NCT00286455|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20155425|NCT04032327|Walter Reed National Military Medical Center|Katherine L Dengler, MD|301-400-2468|katherine.l.dengler.mil@mail.mil|
20155426|NCT04985682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20155427|NCT01694186|Eyepoint Pharmacueticals|Clinical Affairs|6179726204|fleonin@eyepointpharma.com|
20155428|NCT00501943|UCSF|Dr Emmanuelle Waubant, MD|415- 514 2468|Emmanuelle.Waubant@ucsf.edu|
20155429|NCT03016403|Latino Research and Policy Center, University of Colorado Denver|Evelinn Borrayo, Associate Director|303-724-0884|Evelinn.Borrayo@cuanschutz.edu|
20155430|NCT05463705|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@mgb.org|
20155431|NCT00621322|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155432|NCT00225758|Dartmouth-Hitchcock Medical Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
20155433|NCT02350998|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
20155434|NCT01655069|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
20155435|NCT02346370|Halozyme, Inc.|Halozyme Study Information|1-844-855-4256|medinfo@halozyme.com|
20155436|NCT01217047|Kennedy Krieger Institute|Daniel Becker, M.D.|888-923-9222|dbecke13@jhu.edu|
20155437|NCT06399471|Georgia Institute of Technology|Kinsey Herrin, MSPO, C/LPO, FAAOP, Senior Research Scientist|470-578-7600|kinsey.herrin@gatech.edu|
20155438|NCT05529173|Rutgers - NJ Medical School|Dr. Dennis Grech|973 972-5007|grechde@njms.rutgers.edu|
20155439|NCT01530997|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20155440|NCT00428077|University of Utah Huntsman Cancer Institute|Michael Deininger, MD, PhD|801-585-3229|michael.deininger@hci.utah.edu|
20155441|NCT00609973|University of North Carolina|Hans Herfarth|9199666806|hherf@med.unc.edu|
20155442|NCT02298491|UMaryland|Horea Rus|410-706-3170|hrus@som.umaryland.edu|
20155443|NCT01691482|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155444|NCT01392495|Novartis Pharmaceuticals|Study Director|862-778-8300||
20155445|NCT00483509|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
20155446|NCT04957082|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
20155447|NCT02719366|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20155448|NCT05938816|Oregon Health and Science University|Josh Kaplan, PhD|503) 494-8311|kaplajos@ohsu.edu|
20155449|NCT02540434|Weill Cornell Medicine|Michele Steinkamp|2127462953|mls9004@med.cornell.edu|
20155450|NCT01796470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20199829|NCT00903929|University of Rochester|Jane L. Liesveld|585-275-5823|jane_liesveld@urmc.rochester.edu|
20199830|NCT01141595|Arkansas Children's Hospital Reseach Insitute|Richard Frye|501-364-5465|REFrye@uams.edu|
20199831|NCT00361595|Cleveland Clinic|Chad Deal|216-444-6575|dealc@ccf.org|
20199832|NCT01844895|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20199833|NCT06142643|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
20199834|NCT02177201|Adnan Menders University, Anesthesiology and Reanimation Department|Dr. Sinan Yılmaz|+905055954374|dr_snnylmz@hotmail.com|
20199835|NCT05061719|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
20199836|NCT04341948|SPR|Clinical Affairs|216-378-9106|support@SPRPainRelief.com|
20199837|NCT00482014|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20199838|NCT02257580|Hospital for Special Surgery|Colson Zucker, Research Coordinator|6467146029|zuckerc@hss.edu|
20199839|NCT03591380|University of Wisconsin - Madison|David Foley, MD|608-263-2527|foley@surgery.wisc.edu|
20199840|NCT01934140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199841|NCT00808444|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199842|NCT00122135|Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), MEDVAMC, Houston, TX|Dr. Ursula Braun|832 687 1645|ubraun@bcm.edu; ursula.braun@va.gov|
20199843|NCT03269344|Henry Ford Cancer Institute|Dr. Andrew Cook|3135568400|acook11@hfhs.org|
20199844|NCT01846455|RECKITT BENCKISER PHARMACEUTICALS, INC.|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090||
20199845|NCT01449708|Coastal Anesthesiology|Patrick Ziemann-Gimmel, MD|904-819-4478|pziemann@yahoo.com|
20199846|NCT05499559|Arthro Therapeutics/Joint Academy|Study Director|+46708971677|leif@jointacademy.com|
20199847|NCT05022641|University of Michigan|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
20199848|NCT02889796|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20199849|NCT04294459|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20199850|NCT04033367|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20199851|NCT02908880|Essential Medical, Inc.|Sam Nardone|6105571009|sam@essmedclosure.com|
20199852|NCT03521505|Chang-Gung Memorial Hospital|Dr Ting-Yu Lin|886 3281200|yuebaoyuebao@gmail.com|8467
20199853|NCT01604512|Memorial Sloan Kettering Cancer Center|Dr. Robert Young, MD|212-639-8196|youngr@mskcc.org|
20199854|NCT03286842|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20199855|NCT02261727|The George Institute for Global Health|Prof Christine Jenkins|+61280524300|christine.jenkins@sydney.edu.au|
20199856|NCT01391507|Janssen Research & Development, LLC|Associate Director Biostatistics||ClinicalTrialDisclosure@its.jnj.com|
20199857|NCT01453855|Alcon Research, Ltd.|Theresa A Landry, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20199858|NCT00857727|Mount Sinai St. Luke's|Dr. Jinu Kim|212-523-6121|JiKim@chpnet.org|
20199859|NCT01202656|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
20199860|NCT03066102|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
20199861|NCT01496066|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
20199862|NCT02926209|GI View Ltd.|CEO, Dr. Tal Simchony|+97235753199|tal@giview.com|
20199863|NCT01587079|Pearl Therapeutics, Inc|Colin Resiner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20199864|NCT03005054|Mallinckrodt|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
20199865|NCT01764633|Amgen Inc.|Study Director|866-572-6436||
20199866|NCT00825565|Northwestern University|Stephanie Rangel|312-503-5942|stephanie.rangel@northwestern.edu|
20199867|NCT04142983|GCAM / Biomat USA - Grifols|Center Medical Director|956-729-7677|laredomedical@gcamplasma.com|
20199868|NCT00328770|Liver Transplant Program, University of Alberta Hospitals|Dr. Norman Kneteman|780-407-6168|norm.kneteman@albertahealthservices.ca|
20199869|NCT02062658|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
20199870|NCT01789970|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20199871|NCT00643994|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
20199872|NCT03382847|NYU LANGONE TRANSPLANT INSTITUTE|Dr. Bonnie Lonze|2122638365|Bonnie.Lonze@nyumc.org|
20199873|NCT03545906|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
20199874|NCT03423342|University of Washington|Dr. Kevin O'Brien, Study PI|206-529-7802|cardiac@uw.edu|
20199875|NCT01347034|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
20199876|NCT01847885|SPR Therapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
20199877|NCT01895127|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
20155451|NCT00147537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155452|NCT01927861|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20155453|NCT03124602|Masimo|Tala Harake|9492977459|studies@masimo.com|
20155454|NCT00468546|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20199878|NCT02574637|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20199879|NCT04016311|The University of Texas at Austin, School of Nursing|Gayle M. Timmerman PhD, Professor|5124719087|gtimmerman@mail.utexas.edu|
20199880|NCT00584480|UCSF|Robert L. Hendren, D.O.|415-476-7198|Robert.Hendren@ucsf.edu|
20199881|NCT04311086|Medtronic|Sara Dinkins SPYRAL DYSTAL Global Study Manager|303-840-4034|rs.spyraldystal@medtronic.com|
20199882|NCT04029519|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|, clinicaltrials@prolleniumus.com|
20199883|NCT00355394|CHOP|Dr. Nicholas Abend|215-590-1719|abend@email.chop.edu|
20199884|NCT00794560|Pharmaceutical Care Research Group, University of Basle, Switzerland|Dr. Seraina Mengiardi|061 267 15 29|seraina.mengiardi@unibas.ch|0041
20199885|NCT00094055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199886|NCT04823949|The Medical University of South Carolina|Dr. Matthew Finneran|(843) 792-4500|finneram@musc.edu|
20199887|NCT01175902|Seoul St. Mary's Hospital|Chan Kee Park|82222586208|ckpark@catholic.ac.kr|
20199888|NCT02347176|MedImmune, LLC|Rene van der Merwe|301-398-4095|information.center@astrazeneca.com|
20199889|NCT02556255|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
20199890|NCT04673786|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
20155455|NCT00472641|Stanford University School of Medicine|Dr. Po W. Wang|650-723-2483|wangp0@stanford.edu|
20155456|NCT02006654|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20155457|NCT00684554|New York State Psychiatric Institute|Dr. Frances Levin|646-774-6137|frl2@columbia.edu|
20155458|NCT02991859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20155459|NCT00712075|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
20155460|NCT04217057|Washington University School of Medicine|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
20155461|NCT02468700|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
20155462|NCT03907579|Dartmouth-Hitchcock Norris Cotton Cancer Center|Director of Community Education and Prevention|603-653-9960|nccc.community.outreach@dartmouth.edu|
20155463|NCT01945242|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20155464|NCT01064284|"Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano"|Prof. Flora Peyvandi|0039 0255035414|flora.peyvandi@unimi.it|
20155465|NCT01016015|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20155466|NCT03163264|VA New York Harbor Manhattan|Dr. Melanie Jay|212-686-7500|melanie.jay@va.gov|5097
20155467|NCT02057666|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20155468|NCT05661734|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20155469|NCT02970812|Family Medicine Clinic, Pusan National University Yangsan Hospital|Sang Yeoup Lee|3601442|saylee@pnu.edu|55
20155470|NCT02489045|Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
20155471|NCT02402036|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
20155472|NCT01312675|B. Braun Medical Inc.|Dr. Diana Velencia, Associate Director of Clinical Affairs|610-596-2875|diana.valencia@bbraunusa.com|
20155473|NCT00930176|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
20155474|NCT01108055|Stanford University|Sandy Srinivas, MD|650 498 6000|sandysri@stanford.edu|
20155475|NCT00362609|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20155476|NCT04002557|Imperial College London|Ms Ann-Eneli Allas|07508775892|anastassija@hotmail.com|
20155477|NCT02278237|University of Chicago|Valerie G. Press, MD, MPH|773-702-5170|vpress@medicine.bsd.uchicago.edu|
20155478|NCT02687165|New York State Psychiatric Institute|Alla Landa PhD|6467746717|AL2898@cumc.columbia.edu|
20155479|NCT00236197|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
20155480|NCT00682435|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
20155481|NCT01800058|Hospital Universitario de La Princesa|Almudena Zapatero, MD PhD|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
20155482|NCT00800384|Population Health Research Institute, McMaster University|Dr. Jeff Healey|001 905 330 6760|jeff.healey@phri.ca|
20155483|NCT05486065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20155484|NCT01064622|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
20155485|NCT01245049|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155486|NCT02151604|Oxford University Hospitals NHS Foundation Trust|Avianna Laws, Clinical Research Operations Manager|01865 (2)26221|avianna.laws@ouh.nhs.uk|
20155487|NCT01395537|Case Comprehensive Cancer Center|David Adelstein MD|216-444-9310|adelstd@ccf.org|
20155488|NCT04495478|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20155489|NCT03178942|Encube Ethicals Pvt ltd|GM-Strategy & Commercial|+91-22-6228-8000|Pratik.K@EncubeEthicals.com|8003
20155490|NCT06097273|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
20155491|NCT03020082|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
20155492|NCT00684138|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20155493|NCT00800345|Vector Oncology|Vice President of Scientific Affairs|901.435.5570|mwalker@vectoroncology.com|1759
20155494|NCT04668599|The MetroHealth|Vidya Krishnan|2167784527|vkrishnan@metrohealth.org|
20155495|NCT02935036|Taro Pharmaceuticals U.S.A., Inc.|Manager, Clinical Research|9143459001|Businessdevelopment@taro.com|
20155496|NCT00326495|National Cancer Institute|Dr. Alice Chen|240-276-6565|chenali@mail.nih.gov|
20155497|NCT02933151|Dialysis Clinic, Inc. /Tufts Medical Center|Dr. Daniel Weiner|6176365070|dweiner@tuftsmedicalcenter.org|
20155498|NCT00394472|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20155499|NCT01013870|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
20155500|NCT01755156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155501|NCT01292473|Genentech, Inc|Medical Communications|800 821-8590||
20155502|NCT04432298|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1346|jcharpentier@fibrogen.com|
20155503|NCT00678574|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20155504|NCT02451007|Pharma Mar, S.A.|Clinical Development Department of PharmaMar's Oncology Business Unit|+34 91 846 60 00|clinicaltrials@pharmamar.com|
20199891|NCT04926779|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6462718593|jstega@optonline.net|
20199892|NCT01787916|CHU de Quebec|Weisnagel|4185254444|john.weisnagel@crchul.ulaval.ca|47035
20199893|NCT01422239|Yale University School of Medicine|Andrea Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
20199894|NCT02171611|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199895|NCT01539590|Yale University Medical Center|Dr. Joesph Brennan|(203) 483-8300|Brennan.Joesph@yale.edu|
20199896|NCT02065154|UAB|Omer Jamy|205-934-9294|omerjamy@uabmc.edu|
20199897|NCT06245551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20199898|NCT02772432|Mass General Hospital|Elyse Park|6177246836|epark@mgh.harvard.edu|
20199899|NCT04338009|University of Pennsylvania|Dr. Jordana Cohen|215-662-4000|jco@pennmedicine.upenn.edu|
20199900|NCT01250379|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199901|NCT01489527|H. Lee Moffitt Cancer Center and Research Institute|Anna R. Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
20199902|NCT01984268|Dartmouth-Hitchcock Medical Center|Director, Office of Research Operations|(603) 650-6340|Barbara.A.Moskalenko@hitchcock.org|
20199903|NCT04899232|University of Miami|Enrique Ginzburg, MD|305-585-1178|eginzbur@med.miami.edu|
20199904|NCT00898560|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20199905|NCT01327157|Master-Pos graduação em Otorrinolaringologia|Dra Rosana de Queiroz Costa|55___11___98579-8799|rosanaqueiroz@msn.com|
20199906|NCT02926950|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20199907|NCT05036083|M.D. Anderson Cancer Center|Olena Weaver|713-471-3613|ooweaver@mdanderson.org|
20199908|NCT04622046|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20155505|NCT04334681|Principal investigator|Dr. Alpaslan Şahin|0332310500|drasahin@gmail.com|50510
20199909|NCT03505021|Orion Corporation|Director, Clinical Operations|358104261|clinicaltrials@orionpharma.com|
20199910|NCT03686397|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
20199911|NCT00403260|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
20199912|NCT01664793|University of Pittsburgh|Richard K. Zimmerman|412-383-2355|zimmer@pitt.edu|
20199913|NCT04137887|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20199914|NCT00898222|Brigham and Women's Hospital|Dr. Shamsah Kazani|617-732-8201|skazani@partners.org|
20199915|NCT05064059|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20199916|NCT02740478|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
20199917|NCT00741156|The Hospital for Sick Children|Dr. Kyong-Jin Lee|416-813-7326|kyong-jin.lee@sickkids.ca|
20199918|NCT02615990|University of Kentucky|Lisa Fryman|859 323 2060|lisa.fryman@uky.edu|
20199919|NCT04316585|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20199920|NCT03195517|University of Perugia - Italy|Dr. Rita Lombardini|+39 075 578 4027|rita.lombardini@unipg.it|
20199921|NCT01072344|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao|646-888-0866|maoj@mskcc.org|
20199922|NCT03312517|Henry Ford Sleep Research Center|Christopher Drake, PhD|248-344-6672|cdrake1@hfhs.org|
20199923|NCT01294384|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20199924|NCT02944448|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
20199925|NCT02803164|Mayo Clinic|Dr. Mathew Thomas|904-953-2000|thomas.mathew@mayo.edu|
20199926|NCT00200850|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
20199927|NCT00805740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155506|NCT02327143|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20155507|NCT01585207|Icahn School of Medicine at Mount Sinai|Dr. Barbara J. Coffey|212-659-1663|Barbara.coffey@mssm.edu|
20155508|NCT03606213|University of California, San Francisco (UCSF)|Professor of Medicine|14154761000|Steven.Deeks@ucsf.edu|
20155509|NCT02105012|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
20199928|NCT02066792|Institute for Mental Health Research and Department of Psychology, The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
20199929|NCT03660878|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20199930|NCT01282073|Kyungpook National University Hospital|Sun-Hee Park|+82532005547|sh-park@knu.ac.kr|
20199931|NCT04288570|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20199932|NCT05227690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20199933|NCT00223496|UTHSCSA|Dr. Charles Bowden|210-567-5479|Bowdenc@uthscsa.edu|
20199934|NCT00847587|UUtah|Kirtly Parker Jones|801-581-3834|kirtly.jones@hsc.utah.edu|
20199935|NCT02723201|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
20199936|NCT04669678|University of Alabama at Birmingham|Rena C Patel|2059348145|renapatel@uabmc.edu|
20199937|NCT02634580|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20199938|NCT00540579|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20199939|NCT01978093|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155510|NCT04498273|University of Pittsburgh|Dr. Frank Sciurba|412-648-6494|sciurbafc@upmc.edu|
20155511|NCT00474968|CytoCore, Inc.|Richard Domanik, Ph.D.|312-222-9550|rdomanik@cytocoreinc.com|
20199940|NCT01396005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
20199941|NCT00491179|National Taiwan University Hospital|Chen-Hua Liu|886223123456|jacque_liu@mail2000.com.tw|63572
20199942|NCT00159432|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-226-6384|victoria.soto@med.usc.edu|
20155512|NCT00215553|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
20199943|NCT01262846|University of Pennsylvania|Pablo Tebas|215-6626932|pablo.tebas@uphs.upenn.edu|
20199944|NCT03529773|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199945|NCT00756938|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20199946|NCT01420146|Institut Jules Bordet|Dr Géraldine Gebhart|025413095|geraldine.gebhart@bordet.be|+32
20155513|NCT01429623|Bar Ilan University|Jonathan Rabinowitz, PhD|+972544643889|Jonathan.Rabinowitz@biu.ac.il|
20155514|NCT05345405|University of Washington|Principal Investigator|206-503-3287|edworkin@uw.edu|
20155515|NCT02193347|Duke University|Katy Peters, M.D., Ph.D.|919-684-6173|katherine.peters@duke.edu|
20155516|NCT01550965|AbbVie|Global Medical Information|800-633-9110||
20155517|NCT03071965|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
20155518|NCT00986102|Jan-Cil Singapore|VP MEDICAL AFFAIRS ASIA PACIFIC|+65 6827 6753||
20199947|NCT00699907|University of Arizona|Dr. Setsuko K. Chambers|520-626-0950|schamber@uacc.arizona.edu|
20199948|NCT00430508|Daiichi Sankyo|James McCarthy / Director Regulatory Operations|732-590-3430|jmccarthy@dsus.com|
20199949|NCT01675960|Children's of Minnesota|Scott Schwantes|(612)813-7888|sschwantes@gillettechildrens.com|
20199950|NCT03889639|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20199951|NCT01703858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199952|NCT04600895|Appili Therapeutics Inc|Prasann Bavaniya, MS-BioTech|902-442-4655|pbavaniya@appilitherapeutics.com|5
20199953|NCT03506295|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-3412|fabien.maldonado@vumc.org|
20199954|NCT01543087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199955|NCT01665118|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20199956|NCT04438174|University of Utah|Dr. Giavonni Lewis|801-581-3050|giavonni.lewis@hsc.utah.edu|
20199957|NCT00143455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20199958|NCT01325428|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199959|NCT01298492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20199960|NCT03870555|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20199961|NCT02340663|University of Michigan|Dr. Geoffrey Gerstner|734-763-7717|geger@umich.edu|
20199962|NCT02004873|Medtronic Cardiac Rhythm and Heart Failure|Micra Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
20199963|NCT01353703|GlaxoSmithKline|GSK Response Center|866-435-7343||
20199964|NCT01337076|Mayo Clinic, Rochester|Dr. Colin Driscoll|507 266 1965|driscoll.colin@mayo.edu|
20199965|NCT01459705|DCoE|Gregory A. Gahm, PhD|253-320-5772|gregory.a.gahm.civ@mail.mil|
20199966|NCT04116112|University of Cincinnati|Dr. Eva A. Mistry|513-558-1291|mistryea@ucmail.uc.edu|
20199967|NCT02665286|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
20199968|NCT00512798|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
20199969|NCT00425386|OHSU Knight Cancer Institute|Dr. Christopher Ryan|5034946197|ryanc@ohsu.edu|
20199970|NCT00281879|OHSU Knight Cancer Institute|Dr. Richard Maziarz|503-494-1551|maziarzr@ohsu.edu|
20199971|NCT03075085|University of Arkansas for Medical Sciences|Dr. Taren Swindle|870-236-0997|tswindle@uams.edu|
20199972|NCT05036681|The University of Texas MD Anderson Cancer Center|Dr. Siqing Fu|(713) 792-4318|siqingfu@mdanderson.org|
20155519|NCT04635280|Air Liquide|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
20155520|NCT04135352|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20155521|NCT00965991|University of New Mexico|Lisa Moore|5052727028|hkhawaja@salud.unm.edu|
20155522|NCT00449007|Perelman School of Medicine, University of Pennsylvania|Maria A. Oquendo, M.D., Ph.D.|215-662-2818|moquendo@pennmedicine.upenn.edu|
20155523|NCT00819832|UT MD Anderson Cancer Center|Dawid Schellingerhout, MD/Asst. Professor||CR_Study_Registration@mdanderson.org|
20155524|NCT01063881|Janssen Research & Development, LLC|Sr. Director CDTL, RA CVM Urology|1 908 704-4648||
20155525|NCT01309100|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
20155526|NCT03063164|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
20155527|NCT01452789|Thomas Jefferson University|Walter Kraft|215 955 9077|walter.kraft@jefferson.edu|
20155528|NCT01340170|Dentsply Sirona Implants|Manager of Global Clinical Reseach|+46313763500|clinicalresearchmolndal@dentsplysirona.com|
20155529|NCT02222181|Unesp|Fernanda Mariana de Oliveira|+551636640217|femoliveira12@gmail.com|
20155530|NCT01248468|Novartis Consumer Health|Clinical Project Leader|973-503-8000||
20155531|NCT05370209|Circius Pharma AB|Maria Carlsson|+46 (0) 31-81 84 00|RAQA@circiuspharma.com|
20155532|NCT01933425|Herlev Hospital, University of Copenhagen, Department of Anesthesiology|Dr. Matias Vested Madsen|+4538689058|matias.vested.madsen@regionh.dk|
20155533|NCT01905267|University of Illinois at Chicago|Rachel Jacobs|3124139178|rjacobs@psych.uic.edu|312
20155534|NCT03438656|University of Washington|Assistant Professor|414-331-4871|jennessj@uw.edu|
20155535|NCT05094102|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS|(608) 262-2025|neuman@surgery.wisc.edu|
20155536|NCT02882178|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
20155537|NCT04128228|Department of Psychiatry, Yale University School of Medicine|Dongju Seo|475-441-3457|dongju.seo@yale.edu|
20155538|NCT03520387|VA Puget Sound Health Care System Seattle Division, Seattle, WA|Pradeep Suri, MD|206-764-2673|Pradeep.Suri@va.gov|
20199973|NCT03718143|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
20217844|NCT02409329|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
20217845|NCT04290494|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20199974|NCT01461044|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20155539|NCT05652140|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
20199975|NCT00716976|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20199976|NCT02971202|Vanderbilt University Medical Center|Justin M. Gregory MD MSCI|615-875-9669|justin.m.gregory.1@vumc.org|
20199977|NCT01414257|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20199978|NCT01534676|Columbia University Medical Center|Eldad Hod, MD|212-342-5648|eh2217@cumc.columbia.edu|
20199979|NCT03193398|BlackThorn Therapeutics, Inc.|Jane Tiller, MD; Study Director|(415) 548-5313|jane.tiller@blackthornrx.com|
20199980|NCT02653768|Center to Accelerate Discovery and Practice Transformation, Durham VA|Kelli Allen, Associate Director|919-286-0411|kelli.allen@va.gov|177090
20199981|NCT00424827|Universiy of MA Medical School|Bilal Piperdi, MD|508-426-0442|UMMScommunications@umassmed.edu|
20199982|NCT02170662|Duke University Medical Center|Dr. Elise Olsen|919-668-5613|elise.olsen@dm.duke.edu|
20199983|NCT02009878|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20199984|NCT01583894|Boston Scientific Corporation|Nitzan Mekel-Bobrov, Director of Scientific Communications|6619494537|nitzan.mekel-bobrov@bsci.com|
20199985|NCT01790048|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454 2178|manarymj@wustl.edu|
20199986|NCT05159596|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
20199987|NCT05689047|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20199988|NCT03083886|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20199989|NCT03178487|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20199990|NCT04161495|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20155540|NCT03375164|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
20199991|NCT00253630|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20199992|NCT06219577|Scripps Optometric Group|Dr Jay Mashouf|18585302800|jaymashouf@gmail.com|
20199993|NCT00209339|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
20199994|NCT00429858|University of California, San Francisco|Dr. Andrew Ko, MD|(415) 353-7286|Andrew.Ko@ucsf.edu|
20199995|NCT02268058|McMaster Children's Hospital|Dr. Tina Petrelli|905-521-2100|petrelli@hhsc.ca|75162
20199996|NCT02475655|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20155541|NCT04648241|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155542|NCT04401293|System Director - Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital Affiliation: Northwell Health|Alex Spyropoulos, MD|(212) 434-6776|aspyropoul@northwell.edu|
20155543|NCT03679884|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
20155544|NCT01026038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155545|NCT02774278|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20199997|NCT00257010|Janssen-Ortho LLC|Vice President, Medical Affairs||ClinicalTrialDisclosure@its.jnj.com|
20155546|NCT05181657|University of California, San Diego|Dr. Steffanie Strathdee|858-822-1952|sstrathdee@health.ucsd.edu|
20155547|NCT03782103|Zurex Pharma|Andrew Morgan Exec. VP RA/QA Clinical|16082175239|amorgan1@charter.net|
20155548|NCT00066937|Johns Hopkins University|Jennifer Haythornthwaite|410-550-7985|jhaytho1@jhmi.edu|
20155549|NCT03315559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20155550|NCT00063232|National Institute of Diabetes and Digestive and Kidney Diseases|Jay Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
20155551|NCT03339453|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20155552|NCT02903381|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|irene_ghobrial@dfci.harvard.edu|
20155553|NCT01300065|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20155554|NCT03772340|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
20155555|NCT02946996|Medical University of South Carolina|Tricia Bentz CTO Administrative Director|8437921415|adraleta@musc.edu|
20155556|NCT06868667|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20155557|NCT04967417|Samsung Medical Center|Myung-Ju Ahn|+82-2-3410-3438|silkahn@skku.edu|
20155558|NCT05330429|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20155559|NCT00450749|University of Texas MD Anderson Phase I/II Prevention Consortium|Powel H Brown, MD, PhD/Professor of Medicine and Cancer Prevention|713-792-2830|PHBrown@mdanderson.org|
20155560|NCT00655746|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20155561|NCT02931539|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20155562|NCT04857281|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
20155563|NCT01569763|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|Eugenes@minervasurgical.com|
20155564|NCT01926509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155565|NCT02730169|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
20155566|NCT03004183|Houston Methodist Cancer Center|Jenny C Chang, MD|713-441-0629|ccresearch@houstonmethodist.org|
20155567|NCT03681093|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20155568|NCT02529488|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20199998|NCT02272686|UT MD Anderson Cancer Center|Issa F. Khouri, MD, Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
20199999|NCT00441545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20200000|NCT03326141|University of Minnesota|Siobhan McMahon|612-625-3225|skmcmaho@umn.edu|
20200001|NCT00411554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20200002|NCT00236977|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
20200003|NCT01891331|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
20200004|NCT00939692|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
20200005|NCT04317274|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
20200006|NCT03534427|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20200007|NCT02161211|University of Minnesota|Matt Kushner, Ph.D.|612-625-7546|kushn001@umn.edu|
20200008|NCT01307930|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
20200009|NCT04409873|University of California San Francisco|Dr. Stuart A. Gansky and Dr. Sepideh Banava|415-502-8094; 415-630-0094|stuart.gansky@ucsf.edu ; sepideh.banava@ucsf.edu|
20200010|NCT00797823|Legacy Health System|W Kenneth Ward MD|503-413-5171|wardk@ohsu.edu|
20200011|NCT00492973|Lexington Clinic|Cale Jacobs, PhD|859-258-8238|cjaco@lexclin.com|
20200012|NCT03439033|Weill Cornell Medical College|Dr. Kritika Subramanian|212-746-6000|krs9089@nyp.org|
20200013|NCT01158521|Cleveland Clinic|Dr. Brian Rini|(216) 444-9567|rinib2@ccf.org|
20200014|NCT04173429|Qilu Hospital of Shandong University|Professor Gao Yanjing|18560086087|gaoyanjing@sdu.edu.cn|
20200015|NCT00993031|University of California, San Francisco|Diane V Havlir, MD|01-415-476-4082|dhavlir@php.ucsf.edu|400
20200016|NCT00465595|Johns Hopkins University School of Medicine|Roland R. Griffiths, Ph.D., Principal Investigator|4105500034|rgriff@jhmi.edu|
20200017|NCT01834729|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
20200018|NCT00288080|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20200019|NCT03403192|Wake Forest Health Science|Benjamin Morris, MD|336.716.6533|bmorris@wakehealth.edu|
20200020|NCT01269710|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
20200021|NCT02387580|Medicines for Malaria Venture (MMV)|Fiona Macintyre PhD|+41 22 555 0319|Macintyref@mv.org|
20200022|NCT00087646|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20200023|NCT01331304|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-724-0837|anierenberg@mgh.harvard.edu|
20200024|NCT06488157|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
20200025|NCT03850912|Dana-Farber Cancer Institute|Michael Hassett|617-726-5200|michael_hassett@dfci.harvard.edu|
20200026|NCT03650192|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20200027|NCT04925752|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20200028|NCT00516737|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200029|NCT03920670|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
20200030|NCT03436615|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
20200031|NCT04820309|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
20200032|NCT05165654|BIDMC|Dr. Paulo Lizano|202-776-6708|lizanopl@gmail.com|
20200033|NCT01355705|Stanford University|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
20200034|NCT02192931|University of Utah|Danielle Boxer|801-587-1549|danielle.boxer@utah.edu|
20200035|NCT03266016|Children's Hospital Los Angeles|Dr. Robinder Khemani, MD. Medical Staff/USC Faculty|3233612376|rkhemani@chla.usc.edu|
20200036|NCT00939198|George Washington University|Dr. David Diemert|2029942909|ddiemert@gwu.edu|
20200037|NCT00836355|New York University Langone Medical Center|Saran Jonas|212 263 7591|Saran.Jonas@nyumc.org|
20200038|NCT01636466|Emory University|Dr. Ashtar Chami|404-712-7735|ashtar.chami@emory.edu|
20200039|NCT01966770|Clinical Research Center-UC berkely|Meng C. Lin O.D., PhD, FAAO|510-643-9252|mlin@berkeley.edu|
20200040|NCT03160560|Center for Dental Research, Loma Linda University|Yiming Li, DDS, MSD, PhD, Professor and Associate Dean for Research|909-558-8069||
20155569|NCT02698787|Cochlear|Naomi Croghan|+13032642131|ncroghan@cochlear.com|
20200041|NCT02594644|UC Davis Department of Dermatology|Tatyana Petukhova MD||tpetukhova@ucdavis.edu|
20200042|NCT02303431|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20200043|NCT01354028|University of Arkansas for Medical Sciences|Dr Richard W Hall MD, Professor of Neonatology|501-680-7894|HallRichardW@uams.edu|
20200044|NCT01777763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20200045|NCT02109159|London School of Hygiene and Tropical Medicine|Dr Junko Kiriya|+442076368636|junko.kiriya@lshtm.ac.uk|
20200046|NCT00975156|Mischer Neuroscience Institute, Memorial Hermann-TMC|Elizabeth Noser||elizabeth.noser@memorialhermann.org|
20200047|NCT05425563|Dartmouth College|Dr. Tor Wager, professor|603-646-2196|tor@dartmouth.edu|
20200048|NCT02298933|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
20200049|NCT00584233|University of California Davis|Dr. John Boone|(916) 849-3580|jmboone@ucdavis.edu|
20200050|NCT01970176|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
20200051|NCT04537208|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20200052|NCT03655756|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
20200053|NCT01340209|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200054|NCT03237065|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
20200055|NCT02263833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20155570|NCT05033561|FIDEC Corporation|Ricardo Rüttimann|+5491161188536|rruttimann@fidec-online.org|
20200056|NCT00704964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20200057|NCT02161562|Novartis Pharmaceuticals|Study Director|862-778-8300||
20200058|NCT01573273|MUSC|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
20200059|NCT01699087|Alcon, A Novartis Division|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20200060|NCT00094757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200061|NCT03433781|NYU Langone|Perla Arriola|347-630-0311|perla.arriola@nyulangone.org|
20200062|NCT03033875|Emory University|Dr. Kenneth Hepburn|404-712-9286|khepbur@emory.edu|
20200063|NCT03726164|University College London|Prof Derek Hausenloy|+6584053767|d.hausenloy@ucl.ac.uk|
20200064|NCT02286947|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
20200065|NCT03979274|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20200066|NCT04520113|Johns Hopkins Bloomberg School of Public Health|Dr. Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
20200067|NCT01614093|Morgan State University|Kimberly R. Warren, Ph.D.|443-885-3492|kimberly.warren@gmail.com|
20200068|NCT00848354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200069|NCT03790280|University of California, Los Angeles (UCLA)|Angela Martinez, Research Manager|310-206-7630|angelamartinez@mednet.ucla.edu|
20200070|NCT00915343|Shire|Study Physician|1866-842-5335|clinicaltransparency@shire.com|
20200071|NCT00626093|St. Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
20200072|NCT00911989|Ethicon-Endo Surgery|Director of Clinical Operations|1.513.337.3079|SHelsing@its.jnj.com|
20200073|NCT03064841|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200074|NCT03434977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20200075|NCT01145066|Wake Forest University Health Sciences|Dr. Michael Seeds|3367169811|mseeds@wakehealth.edu|
20200076|NCT00573794|AbbVie|Global Medical Services|800-633-9110||
20200077|NCT01407094|University of Texas Southwestern Medical Center|Dr. Madhukar H. Trivedi|214-648-0188|madhukar.trivedi@UTSouthwestern.edu|
20200078|NCT01724528|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
20200079|NCT00466310|DUMC|Rima Kaddurah-Douk, Associate Professor|919-684-2611|rima.kaddurah-daouk@duke.edu|
20200080|NCT05574062|MedtronicD|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
20200081|NCT00289107|DePuy Orthopaedics|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
20200082|NCT06033079|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
20200083|NCT03512418|Brigham and Women's Hospital|Peter Chai|617-732-5640|pchai@bwh.harvard.edu|
20200084|NCT04811716|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20200085|NCT04202679|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20200086|NCT05902364|Alcon Research, LLC|Clinical Project Lead, Dry Eye|1-888-451-3937|alcon.medinfo@alcon.com|
20200087|NCT02270242|Icahn School of Medicine at Mount Sinai|Dr. Roxana Mehran|212-659-9691|roxana.mehran@mountsinai.org|
20200088|NCT03864653|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D. [Research Scientist]|(323) 463-1601|jfletcher@friendsresearch.org|126
20200089|NCT03048422|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20200090|NCT02482129|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
20200091|NCT01928381|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicine Unit|Joel Posener, MD - Head Early Clinical Development||CinicalTrialTransparency@astrazeneca.net|
20200092|NCT01877083|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20200093|NCT00762515|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
20200094|NCT00429585|Boston Medical Center|Paul Tornetta, MD|617-414-6295|paul.tornetta@bmc.org|
20200095|NCT01582308|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200096|NCT02017574|Baltimore Veterans Affairs|Jeremy Rietschel, PhD|410-605-7000|jeremy.rietschel@va.gov|3233
20200097|NCT04663945|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|PT.studies@cuanschutz.edu|
20200098|NCT03376477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Syed Abbas Ali, MD- Assistant Professor- Division of Hematologic Malignancies|4432877104|sali35@jhmi.edu|
20200099|NCT00772668|UM/Sylvester Comprehensive Cancer|Denise Pereira MD|305-243-9127|dpereira2@med.miami.edu|
20200100|NCT03631706|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20200101|NCT01844986|AstraZeneca|Elizabeth Lowe|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20200102|NCT01841333|University of Colorado|Dr. Daniel Pollyea|720-848-8084|DANIEL.POLLYEA@cuanschutz.edu|
20155571|NCT01882829|Icahn School of Medicine at Mount Sinai|Dr. James W Murrough|212-241-7574|james.murrough@mssm.edu|
20200103|NCT03406897|University of Miami, Diabetes Research Institute|Dr. David Baidal|305-243-7740|dbaidal@med.miami.edu|
20200104|NCT01299766|Thomas Jefferson University|Robin Casten|215-503-1250|robin.casten@jefferson.edu|
20200105|NCT03179085|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
20200106|NCT01815229|Washington University School of Medicine|Dr. Carlos Puyo|314-747-1709|cpuyo@wustl.edu|
20200107|NCT00305578|Indiana University|Dr. Amit Anand||aanand@iupui.edu|
20200108|NCT03472560|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20200109|NCT01946178|Mirabilis Medica, Inc.|Director of Clinical Affairs|425-486-8230|patrick@mirabilismedica.com|
20155572|NCT06358144|Wake Forest University Health Sciences|Beth Reboussin, PhD|336-713-5213|brebouss@wakehealth.edu|
20155573|NCT02469961|Maimonides Medical Center|Piyush Gupta, Director of clinical affairs|718-283-7189|pgupta@maimonidesmed.org|
20155574|NCT03435107|Academic Research Office, Clinical Trial Center, Asan Medical Center|Project manager|82-2-3010-7187|jiyun.an@amc.seoul.kr|
20200110|NCT01087541|Jordi Gol i Gurina Foundation|Cecilia Borau|34 934824617|cborau@idiapjgol.org|
20200111|NCT02494596|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200112|NCT02222714|Cedars-Sinai Medical Center|Patrick Lyden, MD, FAAN, FAHA|(310) 423-5166|Patrick.Lyden@cshs.org|
20200113|NCT03470129|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20200114|NCT01537211|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
20200115|NCT00653861|Allergan Medical|Therapeutic Area Head|(805) 961-5500|devicetrials@allergan.com|
20200116|NCT01394705|Boston Children's Hospial|Tracy Curran|617355-5445|tracy.curran@cardio.chboston.org|
20200117|NCT01877564|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
20200118|NCT00353418|Hoffmann-La Roche|Medical Communications|800-821-8590||
20200119|NCT00343512|Vanderbilt-Ingram Cancer Center|Bapsi Chak, M.D.|615-322-2555||
20200120|NCT00323557|UT MD Anderson Cancer Center|Amar Safdar, MD/Professor||CR_Study_Registration@mdanderson.org|
20200121|NCT00197054|Kombewa Clinic, US Army Medical Research Unit, Kisumo Kenya|LTC Mark Polhemus MD, MC|877-379-3788|GSKClinicalSupportHD@gsk.com|
20200122|NCT00684515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200123|NCT02450578|Medicines for Malaria Venture|Jörg Möhrle|+41 22 555 0330|moehrlej@mmv.org|
20200124|NCT04428411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200125|NCT02918019|Hoffmann-La Roche|Medical Comunications|1-800-821-8590|genentech@druginfo.com|
20200126|NCT00662792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200127|NCT00090545|National Cancer Institute, National Institues of Health|William Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
20200128|NCT02474082|Novartis Pharmaceuticals|Study Director|862 -778- 8300||
20200129|NCT01463098|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20200130|NCT03452371|Boston Medical Center/ Boston University Schools of Medicine and Public Health|Karen Lasser|617-414-6688|karen.lasser@bmc.org|
20200131|NCT01528787|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20200132|NCT03285243|Baylor college of Medicine|Adam Adler|832-8245800|Adam.adler@bcm.edu|
20200133|NCT02971670|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
20200134|NCT02793232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200135|NCT04849780|Johnson & Johnson Vision Care, Inc.|John R. Buch, OD, MS, FAAO|1-800-846-2020|jbuch@its.jnj.com|
20200136|NCT01580397|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20200137|NCT03522441|Catawba|Zaidoon A. Al-Zubaidy|1-980-242-3977|Zaidoon@catawbaresearch.com|
20200138|NCT01405053|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20200139|NCT00868101|Universidade de Sao Paulo|Marcos Alves Pavione|55 79 9199 9576|mapavione@hotmail.com|
20200140|NCT04063371|The Ohio State University|Dr. Douglas Scharre|614-293-4969|Doug.Scharre@osumc.edu|
20200141|NCT03365778|Wills Eye Hospital|Clinical Research Coordinator|215-928-3213|jtran@willseye.org|
20200142|NCT02082678|UT Southwestern|E. Sherwood Brown. MD, PhD, MBA|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
20200143|NCT00357500|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
20200144|NCT02301403|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
20200145|NCT01128829|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
20200146|NCT01060059|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20200147|NCT02302963|University of Virginia Center for Diabetes Technology|Director|434-924-5592|bpk2u@virginia.edu|
20200148|NCT03528512|William Beaumont Hospitals|Dr. Margaret Menoch|2489897289|margaret.menoch@beaumont.edu|
20200149|NCT00535925|University of Campania|Prof. Ferdinando Carlo Sasso. MD, PhD|+39-081-5665010|ferdinandocarlo.sasso@unicampania.it|
20200150|NCT01816243|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
20200151|NCT02180893|NYU Langone Medical Center|Peter Neuberger|212 263 5821|Peter.Neuburger@nyumc.org|
20200152|NCT02838407|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200153|NCT02067039|CDC|Robin MacGowan|404-639-1920|rmacgowan@cdc.gov|
20200154|NCT01478854|Johns Hopkins University School of Medicine|Kristin Redmond, MD|410-955-6980|kjanson3@jhmi.edu|
20200155|NCT02319044|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
20200156|NCT02317562|LFB|Clinical Information Desk|0033169827010|supportqcm@lfb.fr|
20200157|NCT00603915|Univerisity Health Network|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.on.ca|
20200158|NCT03891901|Emory University|Dr. Cynthia Giver|404-778-5806|cgiver@emory.edu|
20200159|NCT03550066|Kaiser Permanente Northern California|Dr. Susan D. Brown|5108913544|susan.d.brown@kp.org|
20155575|NCT04566510|UCSF|Dr. Grant Dorsey|628-206-4680|grant.dorsey@ucsf.edu|
20155576|NCT03635996|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
20155577|NCT02821000|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155578|NCT04359680|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
20155579|NCT02596893|Celgene Corporation|Anne Mcclain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20155580|NCT03280615|Institute of Nutrition and Food Technology University of Chile|Dr. Francisco Perez Bravo, Director|+5629781411|fperez@inta.uchile.cl|
20155581|NCT03052257|Durham VA Medical Center, Durham, NC|Dr. Kelly Muir|919-286-0411|Kelly.Muir@va.gov|174035
20200160|NCT02105415|Mayo Clinic|Dr. Nathan Smischney|507-255-4305|smischney.nathan@mayo.edu|
20200161|NCT03687502|Children's Mercy Hospital|Dr. Tolulope Oyetunji|816-234-3575|taoyetunji@cmh.edu|
20155582|NCT02683954|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
20155583|NCT00004228|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20155584|NCT02255279|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20155585|NCT01386645|VA Puget Sound Hlthcare System|Kristina Utzschneider|206-277-3568|kutzschn@uw.edu|6-3568
20155586|NCT00432991|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
20155587|NCT01489826|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
20155588|NCT03048019|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
20155589|NCT00862277|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20155590|NCT00382863|Paracor Medical, Inc.|Michael Kolber, General Manager, VP of Regulatory Affairs|408-734-6000|info@paracor.com|
20155591|NCT02168439|Children's Hospital of Pittsburgh of UPMC|Desiree Neville|4126927692|desiree.neville@chp.edu|
20155592|NCT01889563|Federal university of Sao Carlos|Audrey Borghi e Silva|+55 163351-8952|audrey@ufscar.br|
20155593|NCT03912805|Clinical Research Management Group|Patrick Murphy|(866) 337-1868|p.murphy@crmg-usa.com|
20155594|NCT00348374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20155595|NCT02062008|University of California San Francisco|miguel hernandez pampaloni|4153531886|miguel.pampaloni@ucsf.edu|
20155596|NCT02685436|Manicure university children hospital|Dr.Ahmed Zaki|0201008335567|drahmedmd17@yahoo.com|
20155597|NCT01631929|HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE|Ferreira Juan Pablo MD|+5491136085959|ferreirajuanpablo@hotmail.com|
20155598|NCT00782379|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20155599|NCT02595437|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
20155600|NCT01423084|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20155601|NCT02695771|Corewell Health|Dr. Brian Lane|616-267-7333|brian.lane@corewellhealth.org|
20155602|NCT02925143|Herlev Hospital|Dr. Jakob Thomsen|004538683868|dr.j@demants.dk|
20155603|NCT02180672|The Children's Hospital of Philadelphia|Ignacio Tapia, MD, Principal Investigator, Associate Professor|(267) 426-5842|tapia@chop.edu|
20155604|NCT00661687|Bausch & Lomb Incorporated|Gerard Cairns|(585)338 - 5170|gerard.cairns@bausch.com|
20155605|NCT03777176|Zealand Pharma|Sune Birch|+45 5060 3864|SBirch@zealandpharma.com|
20155606|NCT03574389|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155607|NCT02551809|United Neuroscience|Responsible Medical Officer|+(353) 1 524 0397|info@unitedneuroscience.com|
20155608|NCT02070380|Bracco Diagnostics, Inc.|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
20155609|NCT02837952|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155610|NCT03023683|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20155611|NCT03850431|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|5032208262|alan.teo@va.gov|52461
20155612|NCT01362530|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155613|NCT01133977|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20155614|NCT01682603|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
20155615|NCT02462057|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
20155616|NCT04315961|Johns Hopkins University School of Medicine|Dustin Lee|410-550-4035|dlee214@jhmi.edu|
20200162|NCT01777581|Duke University Medical Center|David Marks, MD|919 668-2859|d.marks@duke.edu|
20155617|NCT03917901|University of Houston|Brooke Kauffman|(713) 743-8056|bkauffma@central.uh.edu|
20155618|NCT04046952|Long Beach VA Healthcare System|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|12876
20155619|NCT00281580|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155620|NCT03093246|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
20155621|NCT01696214|University of California San Diego|Dr. Joe Ramsdell|619-543-7241|jramsdell@ucsd.edu|
20155622|NCT02261532|Taiho Pharmaceutical co., ltd.|Clinical Trial Registration Contact|+81-3-3293-2113|toiawase@taiho.co.jp|
20155623|NCT00066170|Jazz Pharmaceuticals, Inc|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
20155624|NCT01089543|Eisai Inc.|Yoshiumi Okubo, Study Director|+81-3-3817-3908|y4-okubo@hhc.eisai.co.jp|
20155625|NCT03888482|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20155626|NCT01189227|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
20155627|NCT00563316|Amgen Inc.|Study Director|866-572-6436||
20155628|NCT00908908|Eisai Call Center|Eisai Inc.|888-422-4743||
20155629|NCT00425854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155630|NCT01378273|University of Washington|Sandra Juul MD, PhD|2062216814|sjuul@uw.edu|
20155631|NCT00567229|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
20155632|NCT01630811|Sutter Medical Group, Neurology|Michael Chez, MD|(916) 454-6667|ChezM@sutterhealth.org|
20155633|NCT00979615|Alcon Research, Ltd.|Maria J. Tort, PhD|(817) 302-5968|Maria.Tort@alconlabs.com|
20155634|NCT04274218|US Department of Veterans Affairs|Matthew Major|3125035731|matthew.major2@va.gov|
20155635|NCT00964444|Pinnacle Health|David B. Peisner MD|717-231-8472|dpeisner@pinnaclehealth.org|
20155636|NCT03760666|Clear Creek Bio, Inc.|Vice President, Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
20155637|NCT02129556|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
20200163|NCT05702736|Ege University|Dr. Merve UGURYOL UNAL|+902323115545|merve.uguryol.unal@ege.edu.tr|
20200164|NCT01172652|VA Palo Alto Health Care System|Dr. Trisha Suppes, MD PhD|(650) 493-5000|tsuppes@va.gov|67576
20200165|NCT02321436|Ipsen|Medical Affairs Director, Neurology||clinical.trials@ipsen.com|
20200166|NCT00644787|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20200167|NCT01680900|University of Pennsylvania|Dr. Ellen Freeman|215-662-3329|freemane@mail.med.upenn.edu|
20155638|NCT03721367|Baylor College of Medicine|Dr. Lindsay Burrage|832-822-4280|burrage@bcm.edu|
20155639|NCT02059642|Alcobra|Dr. Jonathan Rubin|610-940-1631|jrubin@alcobra-pharma.com|
20200168|NCT00502216|Yale University School of Medicine|Benjamin Toll, Ph.D.|203-974-5767|benjamin.toll@yale.edu|
20200169|NCT02549755|Indiana University School of Medicine|Justin Sims, M.D.|317 948-6340|simsjb@iupui.edu|
20200170|NCT00578305|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20200171|NCT01879345|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20200172|NCT00865020|Novartis Pharmaceuticals|Study Director|862-778-8300||
20217846|NCT02369354|Duke University School of Medicine|Dr. L. Ebony Boulware|919-613-2099|ebony.boulware@duke.edu|
20155640|NCT06896734|Eminence Clinical Research, Inc.|Nick Leppo|719-400-7464|nleppo@ecr-inc.com|
20155641|NCT03645681|W. L. Gore & Associates|Bre Lester|480-698-6670|blester@wlgore.com|
20155642|NCT03061214|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20155643|NCT01027754|Albert Einstein College of Medicine/Montefiore Medical Center|Dr. Shadi Nahvi|718 920 5379|SNAHVI@montefiore.org|
20155644|NCT02562040|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
20155645|NCT00368849|The University of Iowa|Leigh J. Beglinger, Ph.D.|319-335-8765|leigh-beglinger@uiowa.edu|
20155646|NCT02006836|Huazhong University of Science and Technology|Dr.Yu|862783662883|xfyu188@163.com|
20155647|NCT01902303|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
20155648|NCT01699685|Novartis Pharmaceuticals|Study Director|862-778-8300||
20155649|NCT05058456|Shockwave Medical|Kavita Arjungi|1-510-279-4262|karjungi@shockwavemedical.com|
20155650|NCT01654250|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155651|NCT01832038|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20155652|NCT03211858|Trial Transparency Team|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20155653|NCT01267136|Children's Hospitals and Clinics of Minnesota|Andrea Postier/Clinical Research Program Manager|612-813-6409|andrea.postier@childrensmn.org|
20155654|NCT01934231|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155655|NCT02457546|Ethicon, Inc.|Richard Kocharian, MD, PhD|1-908-218-2013|rkochar1@its.jnj.com|
20155656|NCT00363467|H. Lee Moffitt Cancer Center|Jeffrey Lancet MD|813-745-6841|Jeffrey.Lancet@moffitt.org|
20155657|NCT05069415|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
20155658|NCT00090402|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20155659|NCT01052428|University of Alabama at Birmingham|Louis J. Dell'Italia, M.D.|205-934-0850|loudell@uab.edu|
20155660|NCT03400787|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20155661|NCT01716559|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20155662|NCT01644331|Duke Clinical Research Institute|G. Michael Felker, MD|919-668-8919|Michael.Felker@duke.edu|
20155663|NCT01791205|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20155664|NCT01908699|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
20155665|NCT01697501|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20155666|NCT02242903|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20155667|NCT01896986|MCRI|Dr. Nigel Crawford|9345 4772|nigel.crawford@rch.org.au|
20155668|NCT02944461|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
20155669|NCT04045145|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20155670|NCT03374956|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
20155671|NCT00276380|Ipsen|Medical Director||clinical.trials@ipsen.com|
20155672|NCT01018056|Johns Hopkins University|Dr. Harvey S. Singer|410-955-7212|hsinger@jhmi.edu|
20155673|NCT00983801|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20155674|NCT01651208|University of Miami|Ana M. Palacio|3052439754|apalacio2@med.miami.edu|
20155675|NCT02067156|University of California, San Diego Moores Cancer Center|Dr. David Piccioni|858-657-7000|dpiccioni@ucsd.edu|
20155676|NCT03473301|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
20155677|NCT04829214|Otonomy, Inc.|Medical Information|+1 844-686-4636|medinfo@otonomy.com|
20155678|NCT02965976|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
20155679|NCT01370642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155680|NCT01928576|Johns Hopkins|Amber Michalik|667-306-8336|amichal2@jhmi.edu|
20155681|NCT00987935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200173|NCT03196180|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
20200174|NCT01227902|GlaxoSmithKline|GSK Response Center|866-435-7343||
20217847|NCT03291041|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
20155682|NCT00452530|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20155683|NCT03721107|4D pharma plc|Programme Development Director|+4401138950130|clinicaltrials@4dpharmaplc.com|
20155684|NCT02294019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200175|NCT05280756|University of Pittsburgh Medical Center|Dr. Alexandre Paim Diaz|(412) 624-1000|paimdiaza@upmc.edu|
20155685|NCT00846482|Montefiore Medical Center|Dr. Sanjay Goel|718-405-8404|sgoel@montefiore.org|
20155686|NCT01217411|University of Texas (UT) MD Anderson Cancer Center|Morris D. Groves, MD / Professor|713-792-2573|mgroves@mdanderson.org|
20155687|NCT04818086|Virginia Commonwealth University|Dr. Frederick Gerald Moeller|804-828-4134|fgmoeller@vcu.edu|
20155688|NCT03319654|Antwerp University Hospital, Belgium|Dr. Alessa Sugihara|00328213684|alessa.sugihara@uza.be|
20155689|NCT06048705|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20155690|NCT00968968|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20155691|NCT01185366|UT MD Anderson Cancer Center|Amado Zurita-Saavedra,Associate Professor, Genitourinary Medical Oncology|(713) 563-6966|azurita@mdanderson.org|
20155692|NCT01083472|LifeCell|Sandra VanGuldener|310612504695|svanguldener@lifecell.com|
20155693|NCT00127933|Hoffman-LaRoche|Medical Communications|800-821-8590||
20155694|NCT00308282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20155695|NCT01339013|Region Skane, Lund University Hospital, Lund, Sweden|Dr Louise Walther Sturesson|+46 46 171953|louise.waltersturesson@skane.se|
20155696|NCT01783938|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20155697|NCT03111732|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
20155698|NCT03072875|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|research@ebpi.org|83
20155699|NCT03406975|Mayo Clinic|Dr. Barham Abu Dayyeh|507-266-4347|AbuDayyeh.Barham@mayo.edu|
20155700|NCT00401830|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
20155701|NCT00452400|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155702|NCT01943825|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20155703|NCT00667589|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
20155704|NCT02792257|Johns Hopkins University|Dr. Paul Rosenberg|4105509883|prosenb9@jhmi.edu|
20155705|NCT00553475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20155706|NCT01623154|Otsuka America Pharmaceutical, Inc|Tao Wang, PhD|240-683-3213|Tao.Wang@otsuka-us.com|
20155707|NCT04921800|Northwestern University|Shuai Xu|312-695-3721|stevexu@northwestern.edu|
20155708|NCT04028960|HealthPartners Institute dba International Diabetes Center|Anders Carlson, MD|952-993-1927|Anders.L.Carlson@HealthPartners.Com|
20155709|NCT02318979|Denver Research Institute|Judith Jung, DRI Executive Director|303-501-0540|Judith.Jung@dri-va.org|
20155710|NCT00954538|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155711|NCT01905683|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
20155712|NCT01157429|Tulane University|Dr. Michael Scheeringa|5049882167|mscheer@tulane.edu|
20155713|NCT03404375|UTMB Galveston|Antonio Saad|4097721571|afsaad@utmb.edu|
20155714|NCT00537082|Novartis Pharmaceuticals|Study Director|862-778-8300||
20155715|NCT02568254|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan BSc, OD, FAAOPrincipal Research Optometrist|904 443 3449|CColesb@ITS.JNJ.com|
20155716|NCT01866150|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
20155717|NCT00600704|Larissa University Hospital Dept. of Anesthesiology|Dr Athina Kleitsaki|00306948481865|theoath1@gmail.com|
20155718|NCT03137407|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20155719|NCT00107614|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
20155720|NCT02722330|ENT Department, Royal Hallamshire Hospital, Sheffield|Professor Jaydip Ray|+44 (0)114 271 1900|jaydip.Ray@sth.nhs.uk|
20155721|NCT04392362|University of Pretoria|Dr. Amanda Makhubela|0722746091|neurosurgeon76@gmail.com|
20155722|NCT01897896|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20155723|NCT02918630|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|(713) 486-2796|Jin.Ho.Yoon@uth.tmc.edu|
20155724|NCT00101400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20155725|NCT03160573|University Health Resources Group|Sushma Nachnani, MS, PhD|(310) 645-8576|sushnach@yahoo.com|
20155726|NCT01620047|Gulf-to-Bay Anesthesiology Associates LLC|Director of Research|813-844-4413|rkarlnoski@fgtba.com|
20155727|NCT03142451|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20155728|NCT04250675|Purdue University|Bruno Roseguini|7654906284|brosegui@purdue.edu|
20155729|NCT02743312|San Francisco State University|Dr. Diane Allen|4153386837|ddallen@sfsu.edu|
20155730|NCT01730729|Northwestern University|Cesar Santa-Maria, MD|312-695-6180|cancertrials@northwestern.edu|
20155731|NCT00871000|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155732|NCT03408808|NHS Grampian|Miss Katharine Hamlin|0845 456 6000|katharine.hamlin@nhs.scot|56755
20155733|NCT02402907|Icahn School of Medicine at Mount Sinai|Dr. Joanne Stone|212-241-5681|joanne.stone@mssm.edu|
20155734|NCT00449787|Montefiore Medical Center|Benjamin Friedman|718-920-6626|bwfriedmanmd@gmail.com|
20155735|NCT02003898|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
20155736|NCT01537432|Novartis Pharmaceuticals|Study Director|862-778-8300||
20155737|NCT05166902|CooperVision|Jose A Vega, OD, MSc, FAAO|9256213761|javega2@coopervision.com|
20155738|NCT01998477|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20155739|NCT03436420|Emory University|Miriam Vos, MD|404-727-9930|mvos@emory.edu|
20155740|NCT01061710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155741|NCT00159874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155742|NCT01234714|University of Zurich|Dr Dimitri Aristotle Raptis, Principal Investigator|+41442553300|dimitri.raptis@usz.ch|
20155743|NCT02197065|Hospital for Special Surgery|Anne R. Bass, MD|212-774-7043|bassa@hss.edu|
20217848|NCT04184999|SR Cornea Consultants|Dr. Sanjay Rao|8476685498|sanjaynraomd@gmail.com|
20200176|NCT02363478|"Academic Department of Gastroenterology, LAIKON General Hospital"|Dr. George P. Karamanolis|+30.213.2061307|georgekaramanolis@yahoo.co.uk|
20200177|NCT00768898|Alcon Research, Ltd.|Alison Ramsey, O.D., Manager|817-551-6986|Alison.ramsey@alconlabs.com|
20200178|NCT02527707|Eiger BioPharmaceuticals, Inc.|SVP Clinical Development|1-650-272-6138|info@eigerbio.com|
20200179|NCT00542997|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
20200180|NCT00352534|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20200181|NCT02388568|The University of Pennsylvania's Center for Weight and Eating Disorders|Dr. Jena Shaw Tronieri|215-746-5045|jena.tronieri@pennmedicine.upenn.edu|
20200182|NCT00544869|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
20200183|NCT00619502|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20164693|NCT02903160|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|212-604-6010|bobby.liaw@mountsinai.org|
20200184|NCT03968419|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20200185|NCT00935883|University of Miami Miller School of Medicine|Philip J Rosenfeld|305-326-6148|prosenfeld@med.miami.edu|
20200186|NCT01641939|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200187|NCT02894840|Mahidol university|Prof.Punnee Pitisuttithum|662 6435599|punnee.pit@mahidol.ac.th|
20200188|NCT00804687|Janssen Research and Development|Senior Medical Director|858-784-3111||
20200189|NCT03037281|University of Leicester|Dr Christopher Hebbes|0116 252 2522|christopher.hebbes@le.ac.uk|
20200190|NCT01029730|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20200191|NCT02397473|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20155744|NCT02771145|Alcon, A Novartis Division|Sr. Clinical Project Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20200192|NCT00374803|University of Cincinnati|Rita Alloway, PharmD|5135581568|rita.alloway@uc.edu|
20200193|NCT01001702|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affair|800 562-3974||
20200194|NCT01757717|Memorial Sloan Kettering Cancer Center|Josh Yamada, MD|212-639-2950|yamadaj@mskcc.org|
20200195|NCT02624492|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200196|NCT00883675|Maestro|Michael Mann, MD|650-380-9579|michael.mann@ucsfmedctr.org|
20200197|NCT05325775|Acer Therapeutics Inc ( a wholly owned subsidiary of Zevra Therapeutics Inc|Chief Medical Officer|844-902-6100|aquartel@zevra.com|
20200198|NCT03244033|University of Illinois at Chicago|Dr. Saul Weiner|312-355-1700|sweiner@uic.edu|
20200199|NCT00634569|Grifols|Paul J. Pinciaro, PhD|410-814-7617|paul.pinciaro@grifols.com|
20200200|NCT01163786|Northwestern University|Clinical Trials at Northwestern University|312-695-6180|cancertrials@northwestern.edu|
20200201|NCT01212185|UNC_ChapelHill|Dr. Cort Pedersen|919-966-4447|cort_pedersen@med.unc.edu|
20200202|NCT02582957|University of Colorado|Dr. Richard Albert|303-602-5011|RICHARD.ALBERT@cuanschutz.edu|
20200203|NCT03021642|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20200204|NCT03419078|Imperial College Healthcare NHS Trust|Julie Beckerson|02033131922|julie.beckerson@nhs.net|
20200205|NCT02568046|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
20200206|NCT02809833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200207|NCT00523991|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200208|NCT01700192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Corporate Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217849|NCT02642237|Radboud university medical centre|Matthijs Kox|+31243653881|matthijs.kox@radboudumc.nl|
20164694|NCT01838317|University of Texas Southwestern Medical Center|Dr. Muhammad Shaalan Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
20164695|NCT01664910|The University of Texas MD Anderson Cancer Center|Dr. Issa Khouri, MD/Stem Cell Transplantation and Cellular Therapy Department|713-745-0049|ikhouri@mdanderson.org|
20164696|NCT02527681|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
20164697|NCT02374164|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20164698|NCT00867165|Merck Sharp & Dohme.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164699|NCT02738008|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
20164700|NCT00399516|Boston Scientific|Brad Hershey, MS|(661) 949-4828|Brad.Hershey@bsci.com|
20164701|NCT02734693|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20164702|NCT00982735|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164703|NCT02794207|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
20164704|NCT00756106|Massachusetts General Hospital|Dr. Elizabeth Gerstner||EGERSTNER@mgh.harvard.edu|
20164705|NCT00837902|Vanderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
20164706|NCT04879628|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20164707|NCT02775916|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20155745|NCT01391299|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20155746|NCT03596983|NYU Langone Health|Susan Malone, PhD, RN|212 992-7047|Susan.Malone@nyulangone.org|
20155747|NCT05287685|Florida International University|Shayl Griffith, PhD|305-348-9891|shagriff@fiu.edu|
20155748|NCT02134028|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20155749|NCT00806026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155750|NCT02777190|Penn State Milton S. Hershey Medical Center|Dr. Jaimey Pauli|717-531-8142|jpauli@pennstatehealth.psu.edu|5
20155751|NCT01903733|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200209|NCT00363038|Northwestern University Department of Dermatology|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
20200210|NCT00744874|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA- AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
20200211|NCT00566930|UQTR|Martin Descarreaux|819 376-5011|martin.descarreaux@uqtr.ca|3077
20200212|NCT01727895|Radboud UMC|Drs. Jenneke Leentjens|0031-243668420|Jenneke.Leentjens@radboudumc.nl|
20200213|NCT02486757|Massachusetts General Hospital|Dr. Natalie Shaw||natalie.shaw@nih.gov|
20200214|NCT00725075|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200215|NCT03984305|Global Kinetics Corporation|Director of Clinical Affairs|612.240.2437|karen.krygier@globalkineticscorp.com|
20200216|NCT00352105|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
20200217|NCT02979431|Ablynx NV|Medical Monitor|+32 (0)9262 00 00|clinicaltrials@ablynx.com|
20200218|NCT01235962|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20200219|NCT00693160|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
20200220|NCT01099969|The University of Texas Health Science Center at Houston|Dr. Davide Cattano|713.500.6235|davide.cattano@uth.tmc.edu|
20200221|NCT05787847|University of Vermont|Dr. Richard Rawson|‭+1 (310) 951-9091‬|richard.rawson@uvm.edu|
20200222|NCT06468059|Kennesaw State University|Mark Geil|(470) 578-4805|mgeil@kennesaw.edu|
20200223|NCT02199197|Huntsman Cancer Institute Research Compliance Office|Data Manager|801-585-0601|compliance@hci.utah.edu|
20200224|NCT02882633|University of Pennsylvania|Ignacio Badiola|215-893-7251|Ignacio.Badiola@uphs.upenn.edu|
20200225|NCT06098729|Yale University|Garrett Ash|2034443079|garrett.ash@yale.edu|
20200226|NCT02129660|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
20200227|NCT00630955|Yale University|Dr. Suchitra Krishnan-Sarin, Associate Professor of Psychiatry|203-974-7595|suchitra.krishnan-sarin@yale.edu|
20200228|NCT01665144|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20200229|NCT01920711|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20200230|NCT01972074|Massachusetts General Hospital|Gagan Joshi, MD|(617) 724-1541|joshi.gagan@mgh.harvard.edu|
20200231|NCT03551743|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20200232|NCT00742469|Valeant Pharmaceuticals|Valeant Pharmaceuticals|(866) 246-8245||
20200233|NCT01493180|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20200234|NCT01211600|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
20200235|NCT03110900|University of Arkansas for Medical Sciences|Michael Wilson, M.D.|(501) 686-5515|mpwilso1@outlook.com|
20200236|NCT03355300|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
20200237|NCT00546052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200238|NCT01031446|Vanderbilt-Ingram Cancer Center|Ingrid A. Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
20200239|NCT00500682|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20200240|NCT03344003|Octapharma AG|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20200241|NCT05442853|Malcom Randall VA Medical Center|Andrew J. Franck|3523761611|Andrew.Franck@va.gov|105771
20200242|NCT05027932|Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH|Luca Giurgea|301-538-5235|Luca.giurgea@nih.gov|
20200243|NCT00684957|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
20200244|NCT04484285|University of Florida|Eric Porges, Associate Profressor|(352) 294-5838|eporges@ufl.edu|
20200245|NCT00930059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200246|NCT04002310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20200247|NCT03064763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20200248|NCT00680836|George E. Wahlen V.A. Medical Center, Salt Lake City, UT|Ashok Tuteja, M.D.|801-582-1565|ashok.tuteja@va.gov|4019
20200249|NCT03786432|William Beaumont University Hospital|Grace San Agustin|248 551 6679|grace.sanagustin@beaumont.org|
20200250|NCT03038308|Columbia University|Gabrielle Page-Wilson, MD|212-305-3725|gp2287@cumc.columbia.edu|
20200251|NCT03695913|University of Michigan|Spring Stonebraker|734-649-0219|sprstone@med.umich.edu|
20200252|NCT01773421|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20200253|NCT01220414|University of Wisconsin-Madison|Kelli F. Koltyn|608 262-4234|kelli.koltyn@wisc.edu|
20200254|NCT00669617|Novartis Pharmaceuticals|Study Director|862-778-8300||
20200255|NCT00623831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20200256|NCT03720899|University of Alabama at Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uab.edu|
20200257|NCT01337973|VA Ann Arbor|Stephen Chermack, Ph.D.|734 845-5046|chermack@umich.edu|
20200258|NCT03256045|University of Washington|Dr. Andrew Cowan|206-606-7348|ajcowan@seattlecca.org|
20164708|NCT00948064|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
20164709|NCT02722564|St. Luke's University Health Network|Holly Stankewicz, D.O.|484-526-4000|holly.stankewicz@gmail.com|
20164710|NCT00644423|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
20164711|NCT03096834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20164712|NCT04046328|Pharmascience Inc.|Clinical Study Manager|514-340-9800|researchsupport@pharmascience.com|
20200259|NCT00997516|University of California, San Francisco|Jonathan T. Carter, MD, FACS|415-476-0974|jonathan.carter@ucsfmedctr.org|
20200260|NCT02876887|Northwestern University|Mary McDermott, MD, Jeremiah Stamler Professor|1 312 503 6419|mdm608@northwester.edu|6419
20200261|NCT00191451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20200262|NCT01192347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20200263|NCT02623335|University of Wisconsin, Madison|Gretchen Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
20200264|NCT03739528|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
20200265|NCT01262976|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200266|NCT02400255|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20200267|NCT00193063|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20200268|NCT03261531|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
20200269|NCT01127165|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
20200270|NCT00379795|Genentech|Genentech||ctg-post-d@gene.com|
20200271|NCT00763321|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20200272|NCT02435849|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20200273|NCT03175549|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
20200274|NCT01017952|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200275|NCT01064167|Cardiovascular Institute & Fuwai Hospital|Guyan Wang|86-10-88398377|guyanwang2006@163.com|
20200276|NCT02194439|IndianaU|Sophie Paczesny|317-278-5487|sophpacz@iu.edu|
20200277|NCT03076983|Drägerwerk AG & Co. KGaA|Mr. Robin Hüwel|+49 451 882 6830|ClinicalAffairs@draeger.com|
20200278|NCT01656434|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200279|NCT00993928|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
20200280|NCT01913483|Miami Cardiac & Vascular Institute, Baptist Health South Florida|Chief Medical Executive|800-273-2700|MCVI@BaptistHealth.net|
20200281|NCT02420873|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/ Associate Professor|713-794-4392|ndaver@mdanderson.org|
20200282|NCT00632853|Mayo Clinic|Dr. Steven Schild|480-301-9692|sschild@mayo.edu|
20155752|NCT01714063|Department of Pediatrics UAMS/COM|Ariel Perlinkski MT||berlinskiariel@uams.edu|
20155753|NCT03878602|Ospedale Buon Consiglio Fatebenefratelli|Dr.Giuseppe De Bernardo|3357441303|pinodebtin@gmail.com|+39
20200283|NCT03564626|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
20200284|NCT01658657|UNC Chapel Hil|Anthony Viera|919-966-0758|viera@med.unc.edu|
20155754|NCT03733483|University of Colorado, Anschutz Medical Campus|Christine Swanson, MD, MCR, Assistant Professor|(303)724-0073|christine.swanson@cuanschutz.edu|
20155755|NCT02191397|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155756|NCT00318136|Genentech, Inc.|Medical Communications|800-821-8590||
20155757|NCT02176525|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155758|NCT04135443|dfusion, Inc|Tamara Kuhn, Vice President and Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
20155759|NCT00478140|The University of Texas (UT) MD Anderson Cancer Center|Dr. Ahmed Kaseb / Associate Professor|713-792-2828|akaseb@mdanderson.org|
20155760|NCT00728182|NoNO Inc.|Roberta Anderson, Vice President of Clinical Development|613 833-1020|randerson@nonoinc.ca|
20155761|NCT02236767|Hartford Hospital|Gretchen Diefenbach|860-545-7396|gretchen.diefenbach@hhchealth.org|
20155762|NCT03000751|University of California San Francisco|Rebecca Smith-Bindman, MD|415-353-4946|rebecca.smith-bindman@ucsf.edu|
20155763|NCT02268305|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
20155764|NCT01725308|Astellas Pharma Inc.|Head of Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
20155765|NCT02364271|Chinese University of Hong Kong|Professor Timothy Rainer|00 852 2632 1034|thrainer@cuhk.edu.hk|
20155766|NCT02971137|VA Connecticut Healthcare System|Dr. Lori A. Bastian|203-932-5711|lori.bastian@va.gov|2655
20155767|NCT01217515|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
20155768|NCT02614066|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
20155769|NCT01331330|Abbott Medical Devices|Devyani Nanduri|+1 510-561-4328|devyani.nanduri@abbott.com|
20155770|NCT05226884|Clinical Research Coordinator|Diana Hill|713-526-1600|diana.hill@berkeleyeye.com|
20155771|NCT01691313|Laguna Pharmaceuticals, Inc.|Howard C. Dittrich|858-405-1429|HDittrich@lagunarx.com|
20155772|NCT00907088|The Hospital for Sick Children|Dr. Patricia Parkin|416-813-7654|patricia.parkin@sickkids.ca|301544
20155773|NCT04679818|Cleveland Clinic|Kurt Ruetzler|216 636-0561|ruetzlk@ccf.org|
20155774|NCT01539525|Yale University School of Medicine|Kimberly A Yonkers|203-764-6621|kimberly.yonkers@yale.edu|
20155775|NCT01098578|Ottawa Hospital Research Institute|Dr. Shaun Kilty|613-798-5555|skilty@ottawahospital.on.ca|18514
20155776|NCT02205359|CRM|Janelle van Wel|+3166 273 886 62|janelle.van.wel@medtronic.com|
20155777|NCT02427672|Nanyang Technological University|Dr. Olivia Choy|(65)65921522|oliviachoy@ntu.edu.sg|
20155778|NCT02496156|Nemours Children's Health System|Vicky Funanage, PhD, Operational Vice President for Research|302-651-6819|vfunanag@nemours.org|
20155779|NCT01412983|Bausch & Lomb|Dr. Robert Steffen|1 585 338 6399|robbert.steffen@bausch.com|
20155780|NCT00890097|Alcon Research, Ltd.|Dana Sager, Clinical Manager Group Leader|1-888-451-3937|alcon.medinfo@alcon.com|
20155781|NCT01703221|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155782|NCT03810495|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
20155783|NCT03810365|School of Nursing, University at Buffalo|Dr Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
20155784|NCT02389738|Johns Hopkins/NIH|Principal Investigator|4109558837|sjacks78@jhmi.edu|
20155785|NCT05333965|CooperVision|Jose A. Vega, OD, MSc, FAAO|9256213761|jvega2@coopervision.com|
20155786|NCT03701074|University of South Alabama|Ramachandra Bhat|2514151055|rbhat@health.southalabama.edu; rambhat79@gmail.com|
20155787|NCT01517178|Bispebjerg Hospital|Tonny Karlsmark||tkar0002@bbh.regionh.dk|
20155788|NCT01959919|Pfizer Clinical Trial.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrails.gov_Inquiries@Pfizer.com|
20200285|NCT00486278|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20200286|NCT05168267|University of Wisconsin Madison - Incarceration and Mental Health Lab|Michael Koenigs|(608) 263-1679|mrkoenigs@wisc.edu|
20200287|NCT00494143|VA Puget Sound Health Care System|Dr. Joseph Czerniecki|206 277 5188|joseph.czerniecki@va.gov|
20200288|NCT04247425|Oregon Health & Science University|Lara Davis, MD|5034948423|davisla@ohsu.edu|
20200289|NCT02247193|The University of Texas Health Science Center at Houston|Matthew R. Greives, MD|713-500-7275|Matthew.R.Greives@uth.tmc.edu|
20200290|NCT00692211|New Mexico VA Health Care System|Richard Hoffman, MD|505-265-1711|richard.hoffman2@va.gov|5318
20200291|NCT02531646|Carestream Health, Inc.|Susan Pate, RN, MS, RAC, Senior Clinical Manager|585-627-6557|susan.pate@carestream.com|
20200292|NCT02851173|University of Texas at Austin|Andreana Haley|512-232-0863|haley@austin.utexas.edu|
20200293|NCT04698629|University of Washington|Dr. Judith Tsui|206-744-1835|tsuij@uw.edu|
20200294|NCT02320487|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200295|NCT06228586|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20200296|NCT01182428|Abbott Vascular|Ellen Travis, Clinical Science|408-845-3000|Ellen.Travis@av.abbott.com|
20200297|NCT06272370|DARTNet Institute|Wilson Pace, MD|800-434-0278|Wilson.pace@dartnet.info|12
20200298|NCT03303911|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
20200299|NCT02949128|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20200300|NCT02324270|Teva Pharmaceuticals USA, Inc|Senior Director, Global Gx Clinical R&D- PD/CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20200301|NCT03521791|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20200302|NCT01475734|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200303|NCT00771472|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200304|NCT03054363|University of Colorado Hospital|Elena Shagisultanova, MD, PhD|7208480300|elena.shagisultanova@cuanschutz.edu|
20200305|NCT01390389|McLean Hospital|Cara McCabe|617-855-2410|cfmccabe@partners.org|
20200306|NCT03593915|Sumitomo Oncology|Holly Beever|210-365-9014|holly.beever@oncology.sumitomo-pharma.com|
20200307|NCT01583179|University of Wisconsin-Madison|Melanie Donnelly|720-848-0000|melanie.donnelly@ucdenver.edu|
20200308|NCT01246206|Barbara Ann Karmanos Cancer Institute|Dr. Zaid Al-Kadhimi|800-527-6266|zalkadh@emory.edu|
20200309|NCT02002975|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20200310|NCT04660643|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200311|NCT03988907|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20200312|NCT04391959|Azura Ophthalmics|Chief Medical Officer|17145598435|charles.bosworth@azuraophthalmics.com|
20217850|NCT02953678|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20164713|NCT01195701|TriHealth Hatton Research Institute|Academic Clinical Research Supervisor|513-862-2330|Angie_Fellner@trihealth.com|
20164714|NCT04233801|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164715|NCT00762359|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20164716|NCT01419795|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
20164717|NCT01391364|Bausch Health|Study Director||robert.steffen@bausch.com|
20164718|NCT01690052|Indiana University School of Dentistry|Juan F. Yepes DDS, MD, MPH, MS, DrPH, Associate Professor|317-944-9601|jfyepes@iupui.edu|
20164719|NCT02421172|Novartis Pharmaceuticals|Study Director|8627788300||
20164720|NCT00928486|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
20164721|NCT01841281|UC Davis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
20164722|NCT00683878|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20164723|NCT03112681|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20164724|NCT02041325|BVARI|Dr. Nikhil C. Munshi|857-203-6172|nikhil_munshi@va.gov|
20164725|NCT03397264|Opthea|Director of Clinical Research|+61 3 9826 0399|info@opthea.com|
20164726|NCT02682381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20164727|NCT01048879|University of Michigan|Bruce A. Mueller|7346154578|muellerb@umich.edu|
20164728|NCT00851357|UCSD|Principal Investigator|858-300-1056|szhu@ucsd.edu|
20164729|NCT02714400|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|62155
20164730|NCT02891174|University of Michigan|Dr. Elizabeth Langen|734-764-3406|elangen@med.umich.edu|
20164731|NCT04235140|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20164732|NCT01421017|NYU Langone Health|Sylvia Adams|212-731-5795|sylvia.adams@nyumc.org|
20164733|NCT02660788|BC Cancer|Dr. Alan Nichol|604-877-6046|anichol@bccancer.bc.ca|
20164734|NCT04673214|MEXICAN SOCIAL SECURITY INSTITUTE|Dr. GILBERTO CRUZ ARTEAGA|55 87 44 22|gilberto.cruz@imss.gob.mx|15320
20164735|NCT00866177|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
20164736|NCT00861705|Warren Alpert Medical School of Brown University, Department of Medicine|William M. Sikov, M.D.|401-793-7151|wsikov@lifespan.org|
20164737|NCT00088530|CTIBioPharma Corp.|Simran Bedi Singh|(206) 272-4000|ssingh@ctibiopharma.com|
20164738|NCT02694744|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
20164739|NCT01945021|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164740|NCT02163902|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
20164741|NCT02898454|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20164742|NCT00689390|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164743|NCT02343263|Indiana University|Bruce H. Matt, MD, MSc|3172781215|bmatt@iupui.edu|
20217851|NCT02966184|Norton Healthcare|Tristan Murray, PharmD|5026295571|tristan.murray@nortonhealthcare.org|
20200313|NCT01276171|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|48517
20200314|NCT03609619|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20200315|NCT00167245|University of Pennsylvania|Dr. Kyle Kampman|2152223200|kampman@mail.med.upenn.edu|109
20200316|NCT02307916|Massachusetts Eye and Ear|Dr. Brad Welling|617-573-4075|brad_welling@meei.harvard.edu|
20200317|NCT00568555|Stanford University School of Medicine|Jarred Younger, PhD|650-724-2795|jyounger@stanford.edu|
20200318|NCT01871090|St Jude Medical, Inc.|Todd Stirman, Clinical Manager|(972) 526-9625|Tstirman@sjm.com|
20200319|NCT01231555|ViiV Healthcare|GSK Response Center|866-435-7343||
20200320|NCT03562663|Moss Rehabilitation Research Institute|Dylan Edwards|(215) 663-6411|EdwardDy@einstein.edu|
20200321|NCT00688909|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20200322|NCT03502330|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
20200323|NCT01496157|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
20200324|NCT00445302|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
20200325|NCT00445887|NRG Oncology|Linda Gedeon for James Kauderer, MA|716-845-1169|lgedeon@gogstats.org|
20200326|NCT03065179|UT Southwestern Medical Center|Dr. Hans Hammers|214/645-7445|Hans.Hammers@UTSouthwestern.edu|
20200327|NCT02472847|University of Illinois at Chicago|Dr. K. Luan Phan|312-355-5954|klphan@psych.uic.edu|
20200328|NCT03793439|Oregon Health & Science University|Dr. Marcia Friedman|5034948637|friedmam@ohsu.edu|
20200329|NCT03657459|Cleveland Clinic|Nancy M. Albert PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
20200330|NCT01276821|Department of Child Health, Tribhuvan University Teaching Hospital, Institute of Medicine.|Dr. Aayush Khanal|977-1-4421532|aayush_khanal@yahoo.com|
20200331|NCT02707770|Imperial college healthcare NHS trust|vijay padmanaban|02033122349|vijay.padmanaban@nhs.net|
20200332|NCT01748071|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
20200333|NCT03068325|New York State Psychiatric Institute|Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
20200334|NCT00066690|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, Head Trial Activities/Deputy Director|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
20200335|NCT03856255|NYU Langone Health|Mark Pochapin, MD|212-263-9177|Mark.Pochapin@nyulangone.org|
20200336|NCT00929071|Susan H. Weinkle, MD|Susan H. Weinkle, MD|941-794-5432|sweinkle@aol.com|
20200337|NCT00272987|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20164744|NCT02570503|Virginia Commonwealth University|Teresa Potter|804-828-6749|teresa.potter@vcuhealth.org|
20164745|NCT04731636|LifeTechScientific|Clinical manager|15695219339|Xuwei@lifetechmed.com|
20164746|NCT04264442|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
20164747|NCT01623479|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20164748|NCT01384734|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20164749|NCT01290523|University of California San Francisco Department of Radiology|Dr Nicholas Fidelman|(415) 353-1300|Nicholas.Fidelman@ucsf.edu|
20164750|NCT03071263|Vifor Pharma Inc.|Clinical Support & Regulatory Intelligence, Regulatory Affairs Director|+1 250 708 4296|Clive.Burge@viforpharma.com|
20164751|NCT00662207|Hines VA Hospital, Research Service|James S. Walter, Ph.D.|708-202-5805|James.Walter@va.gov|
20164752|NCT00647296|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
20164753|NCT02922725|University of Utah|Brent M. Kious|801-585-1418|brent.kious@hsc.utah.edu|
20164754|NCT01300234|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164755|NCT00360412|Eisai Call Center|Eisai Inc.|888-422-4743||
20164756|NCT04612725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20164757|NCT02354235|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20164758|NCT03069352|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20164759|NCT02621424|VA Palo Alto|Jauhtai Cheng, MD, Staff Neurologist|650-493-5000|jauhtai.cheng2@va.gov|63617
20164760|NCT05626673|Pray.com|Breanne Laird|9095574002|breanne.laird@pray.com|
20164761|NCT05148234|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
20164762|NCT01650194|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20164763|NCT01928927|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20164764|NCT04158583|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20164765|NCT03043885|UCSF|Daniel Clark|415.476.1101|daniel.clark@ucsf.edu|
20164766|NCT02649556|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
20164767|NCT03349723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164768|NCT03409796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20164769|NCT00837252|National Eye Institute|Catherine M. Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
20164770|NCT01414634|Neuroimmunology and MS Research, Department of Neurology, University Hospital Zürich, 8091 Zürich, Switzerland|Roland Martin|044 255 11 25|roland.martin@usz.ch|
20164771|NCT00960622|St Luke's Roosevelt Hospital New York|Dr. Donald Phillip Kotler|212 523 3670|dkotler@chpnet.org|
20164772|NCT03270436|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
20164773|NCT01453049|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164774|NCT02985827|Ora|Senior Director of Research and Development|9786858900|klane@oraclinical.com|
20164775|NCT01977547|Washington University School of Medicine|Dr. Philip C. Spinella|3142860858|pspinella@wustl.edu|
20217852|NCT01961687|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
20164776|NCT03287791|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20200338|NCT00356031|Massachusetts General Hospital|Dr. Sam S. Yoon, Principal Investigator|617 643-9475|syoon@partners.org|
20200339|NCT01076348|Medtronic, Inc.|Stefanie Lorinser, Sr. Clinical Research Specialist|763-526-2742|stefanie.lorinser@medtronic.com|
20200340|NCT01872338|VA New Jersey Healthcare System|Alejandro Interian, PHD|908-647-0180|alejandro.interian@va.gov|4617
20200341|NCT03555266|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
20200342|NCT00510809|University of Kansas Medical Center|James Backes, PharmD|(913) 588-5324|JBACKES@kumc.edu|
20200343|NCT03370770|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200344|NCT02167945|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20200345|NCT00132730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200346|NCT01284504|Stanford University|Anthony Doufas, MD, PhD|1-650-498-7699|agdoufas@stanford.edu|
20200347|NCT03072160|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
20200348|NCT00395967|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20200349|NCT01109940|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20164777|NCT03441477|NIDEK Co., LTD.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
20164778|NCT03095651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164779|NCT02210000|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164780|NCT03585660|Department of Radiology, University of Chicago|Dr. Aytekin Oto, MD, MBA|1-773-702-8553|aoto@bsd.uchicago.edu|
20164781|NCT05635461|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
20164782|NCT03255902|William Beaumont Hospitals|Donna Marvicsin, Nurse Practitioner, Pediatric Endocrinology|248-568-6932|donna.marvicsin@beaumont.org|
20164783|NCT01620060|Sunovion|Medical Director, CNS|1-866-503-6351||
20164784|NCT02269124|Massachusetts Eye and Ear|Dr. Michael S. Cohen, MD|6175733190|Michael_Cohen@MEEI.HARVARD.EDU|
20164785|NCT03776864|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
20164786|NCT00614575|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164787|NCT03452540|Afimmune|Study Director|+353 1 2946380|regulatory.afimmune@afimmune.com|
20164788|NCT01582061|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20164789|NCT05075746|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
20164790|NCT01045460|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
20164791|NCT04664153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164792|NCT03388346|UIHC|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
20164793|NCT00189098|Wilhelmina Children's Hospital, University Medical Center Utrecht|Prof. A. Schilder|0031 302504580|A.Schilder@umcutrecht.nl|
20164794|NCT00524485|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20164795|NCT00474123|Heart Institute (InCor) Hospital of the Faculty of Medicine, University of São Paulo (HCFMUSP)|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Mode|55-11-30695058|eduardopesaro@hotmail.com|
20164796|NCT01600885|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
20164797|NCT00716963|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
20164798|NCT00642356|Novartis Pharmaceuticals|Study Director|862 778-8300||
20164799|NCT01009060|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164800|NCT04201431|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
20164801|NCT02726620|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
20164802|NCT00667888|UT MD Anderson Cancer Center|Karen Huffman, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2339|khoffman1@mdanderson.org|
20164803|NCT02140047|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml@ml.mt-pharma.co.jp|
20164804|NCT02174731|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20164805|NCT00079040|ECOG Statistical Office|Study Statistician|617-632-3012||
20164806|NCT03119259|Indiana University|Dr. Richard Holden|812-586-1965|rjholden@iu.edu|
20164807|NCT00325897|Denver Health Medical Center|Dr. Richard Albert|303-436-6900|ralbert@dhha.org|
20164808|NCT03535974|Fundatia Bio-Forum|Dr. Felician Stancioiu|+40727500402|felicians11@gmail.com|
20164809|NCT04059549|UW Madison|Olivia Vjorn|6084772614|ocody@wisc.edu|
20164810|NCT00549640|Mayo Clinic|Dr. Richard D. Hurt|507-266-1944|nicotineresearch@mayo.edu|
20164811|NCT00803283|Janssen Taiwan|Medical Advisor|886-2-23762158||
20164812|NCT00626275|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
20164813|NCT01362348|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164814|NCT02675907|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
20164815|NCT01611792|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|802 847-6733|Sharon.Henry@uvm.edu|
20164816|NCT03360903|University of Chicago|Aaron Fox|(773) 702-0021|aaronfox@uchicago.edu|
20164817|NCT04097431|Mount St Mary's University|Dr. Griffin Rooker|(301) 447-5143|g.w.rooker@msmary.edu|
20164818|NCT01991808|University of Pennsylvania|Lilie Lin, MD|215-622-6515|lin@uphs.upenn.edu|
20164819|NCT03289208|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml@ml.mt-pharma.co.jp|
20200350|NCT00179959|Children's Memorial Hospital|Amy Paller, MD|312-695-6829|apaller@nmff.org|
20200351|NCT00236080|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20164820|NCT00550407|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164821|NCT00584415|University of Oklahoma Health Sciences Center|Sunny Po, MD., Study Principal Investigator|405-271-9696|sunny-po@ouhsc.edu|
20164822|NCT00556894|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20164823|NCT03883581|NOVA Southeastern University|Lauren Tabor Gray|954-914-5447|Lauren.taborgray@nova.edu|
20164824|NCT03332459|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20200352|NCT01214044|Oregon Health & Science University and VA Portland Health Care System|Jonathan Emens, M.D.|503-220-8262|emensj@ohsu.edu|58490
20164825|NCT04750642|Cochlear|Aaron Parkinson|13039414951|aparkinson@cochlear.com|
20200353|NCT00408694|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20164826|NCT00410956|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-7601|jarnagiw@mskcc.org|
20200354|NCT01961544|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20200355|NCT01983787|Aarhus University Hospital, Department of infectious diseases|Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
20164827|NCT01697397|G-Tech Medical|Steve Axelrod, PhD, CEO|650-269-1479|steve.axelrod@gtechhealth.com|
20164828|NCT00399308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20164829|NCT00740220|Wake Forest University|Arjun Chatterjee, MD, MS, FCCP|336.716.4649|achatter@wfubmc.edu|
20200356|NCT03543410|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
20164830|NCT01962792|Pharmacyclics LLC|Thorsten Graef, Head of Clinical Development|+1 (408) 215-3127|tgraef@pcyc.com|
20164831|NCT01908426|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20200357|NCT02435914|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20200358|NCT02883244|Sunstar Americas, Inc.|Senior Manager of R&D|8477944276|akane.takemura@us.sunstar.com|
20164832|NCT03346434|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20164833|NCT03240601|Shepherd Center|Dr. Edelle Field-Fote|4046034274|edelle.field-fote@shepherd.org|
20200359|NCT01727258|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20200360|NCT02642094|University of Texas Health Science Center|LUZHE SUN, Ph.D.|210-567-5746|sunl@uthscsa.edu|
20200361|NCT01818726|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20164834|NCT01941485|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Refractive, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
20200362|NCT04871711|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
20200363|NCT01469000|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200364|NCT04033419|University of North Carolina at Chapel Hill, Department of Psychiatry|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
20200365|NCT03618056|Fred Hutchinson Cancer Research Center|Jessica Andriesen|206-667-5812|jandries@fredhutch.org|
20200366|NCT02026063|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD|281-863-3000|plapuerta@lexpharma.com|
20200367|NCT00723788|Children's National Health System|Pranav Vyas, MD|2024760186|PVyas@childrensnational.org|
20200368|NCT02154087|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
20200369|NCT00931489|University of California Davis, Department of Ophthalmology & Vision Science|Lawrence S. Morse, MD, PhD|916 734 6074|lsmorse@ucdavis.edu|
20200370|NCT02183519|University of Florida Communicative Disorders|Karen Hegland, PhD|352-273-3710|kwheeler@ufl.edu|
20200371|NCT04556617|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
20200372|NCT04949841|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20164835|NCT04416204|University of Alabama at Birmingham|Dr. Rita Basu|2059341200|rbasu@uabmc.edu|
20164836|NCT00812708|University of California Los Angeles|Kevin M. Miller, MD|(310) 206-9951|millerpatients@jsei.ucla.edu|
20164837|NCT01183689|Wake Forest University School of Medicine|Mark Espeland|336-716-2826|mespelan@wakehealth.edu|
20164838|NCT03965130|Yale|Dr. Kitt Falk Petersen|203 737 1942|kitt.petersen@yale.edu|
20164839|NCT01364896|University of Pittsburgh|Ross Cranston|412-383-1675|rdc27@pitt.edu|
20164840|NCT03224130|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
20164841|NCT00414635|Community Research Initiative of New England (CRINE)|Calvin Cohen, MD|617 502 1700|ccohen@crine.org|
20164842|NCT01314313|Edwards Lifesciences|Tenley Koepnick||Tenley_Koepnick@edwards.com|
20164843|NCT04124939|Urology Department, Wake Forest University|Sachin N. Vyas, Research Manager|336-713-4098|svyas@wakehealth.edu|
20164844|NCT03893396|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
20164845|NCT04346745|Columbia University|Associate Professor|2128512246|jl4658@columbia.edu|
20164846|NCT04607668|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
20164847|NCT02250326|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20164848|NCT02587520|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20164849|NCT04516746|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20164850|NCT01751061|Duke University|Dr. Christopher Cox|9196817232|Christopher.cox@duke.edu|
20164851|NCT00322777|Canadian Institute of Natural and Integrative Medicine|Dr. Badri Rickhi|403-220-0022|b.ricki@cinim.org|0
20164852|NCT00503750|Emory University|Dr. Ruth O'Regan|404-778-8808|roregan@emory.edu|
20164853|NCT00768989|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20164854|NCT05626738|ENDOSTART SRL|Alessandro Tozzi|0571843033|a.tozzi@endostart.com|0039
20164855|NCT04951115|Weill Cornell Medicine|Ashish Saxena|646-962-2066|ahs9018@med.cornell.edu|
20164856|NCT02681809|ThromboGenics|Global Clinical Development|+3216751310|info@oxurion.com|
20200373|NCT02937350|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
20164857|NCT00435409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164858|NCT05120713|University of Southern California|Dr. Andy Kim|213-740-5156|andyk@usc.edu|
20164859|NCT03316196|VA San Diego Healthcare System|Dr. Jessica Bomyea|8585528585|jessica.bomyea@va.gov|1416
20200374|NCT00695565|Arcion Therapeutics, Inc.|Dr. James Campbell|(410) 522-8701|jcampbell@arciontherapeutics.com|
20200375|NCT01462266|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200376|NCT01106846|Northwestern University|Shireen Ahmad, M.D.|321-472-3585|sah704@northwestern.edu|
20200377|NCT03502993|Imperial College London|Dr J Herberg|0207 594 3900|j.herberg@imperial.ac.uk|
20200378|NCT02288273|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|Sergey.Zhuplatov@astrazeneca.com|
20200379|NCT03382574|UT MD Anderson Cancer Center|Dr. Powel Brown, Chair, Clinical Cancer Prevention|(713) 745-3672|phbrown@mdanderson.org|
20200380|NCT02419508|Alcon, A Novartis Division|Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
20200381|NCT02490293|SeoulStmary's hospital|Tae-ho Hong|010-5206-5266|gshth@catholic.ac.kr|
20200382|NCT05556525|Mayo Clinic|Dr. Sebastian Fernandez-Bussy|904-953-6320|Fernandez-Bussy.Sebastian@mayo.edu|
20200383|NCT01602341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200384|NCT02554929|The Hospital for Sick Children|Dr. Suneeta Monga|416-813-8954|suneeta.monga@sickkids.ca|
20164860|NCT03661723|Dana-Farber Cancer Institute|David A. Reardon, MD (Clinical Director, Center for Neuro-Oncology)|617-632-2166|david_reardon@dfci.harvard.edu|
20164861|NCT03631940|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
20164862|NCT03562195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20164863|NCT02529852|M D Anderson Cancer Center|Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
20164864|NCT00117637|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20164865|NCT00097500|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20164866|NCT01889667|Oramed|Chief Scientific Officer|+972-2-566-0001|aviva@oramed.com|
20164867|NCT02767271|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
20164868|NCT04055675|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
20164869|NCT00300755|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20164870|NCT04571944|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164871|NCT00966186|Seoul National University Bundang Hospital|Jung-Won Hwang|82-31-787-7499|jungwon@snubh.org|
20164872|NCT04079296|Astellas Pharma Global Development Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20164873|NCT02639494|Mayo Clinic|Dr. Rajiv Gulati|507-538-6325|Gulati.Rajiv@mayo.edu|
20164874|NCT01919229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20164875|NCT01011673|Montefiore Medical Center, Albert Einstein College of Medicine|Benjamin Friedman, MD|718-920-6626|BEFRIEDM@montefiore.org|
20164876|NCT04368260|University of Virginia|Dr. Amy Mathers|434-924-9678|ajm5b@virginia.edu|
20164877|NCT03261336|Inova Schar Cancer Institute|Stephanie Van Bebber, Sr. Director Clinical Trials|5714720213|Stephanie.VanBebber@inova.org|
20164878|NCT03174353|University of Washington|Dr. Venu Pillarisetty|206-616-4924|vgp@uw.edu|
20164879|NCT00292942|Uniformed Services University of the Health Sciences|Louis Cantilena, Jr., MD, PhD|301-295-0016|lcantilina@usuhs.mil|
20164880|NCT00644358|Allergan, Inc.|Therapeutic Area Head|1-877-277-8566|IR-CTRegistration@allergan.com|
20164881|NCT03180385|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
20164882|NCT02732600|VISN 5 Mental Illness Research, Education, and Clinical Center|Richard Goldberg|410-637-1851|Richard.Goldberg@va.gov|
20164883|NCT03324776|MODEL Clinical Research LLC|Philip Levin, MD|4102413438|pal3420@yahoo.com|
20164884|NCT00651924|VA Connecticut Healthcare System|Robert Kerns, Ph.D.|203-932-5711|robert.kerns@va.gov|3841
20164885|NCT00758771|UCSF|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
20164886|NCT00960063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200385|NCT01916980|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200386|NCT00700180|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20164887|NCT01759420|Carl R Darnall Army Medical Center|Peter Moffett MD|254-288-8302|peter.m.moffett.mil@mail.mil|
20164888|NCT01129622|Mount Sinai Hospital|Robert F Casper|416-972-0777|casper@lunenfeld.ca|
20164889|NCT02051764|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20164890|NCT00591006|The University of Texas Southwestern Medical Center|E. Sherwood Brown|214 645 6950|sherwood.brown@utsouthwestern.edu|
20164891|NCT00732212|CURE Digestive Diseases Research Center|Dennis M. Jensen, M.D.|310-268-3569|djensen@mednet.ucla.edu|
20164892|NCT05190120|University of California San Francisco|Dr. Pedram Aleshi|(415) 271-1627|pedram.aleshi@ucsf.edu|
20164893|NCT02099864|Oregon Health & Science University|Dr. Alexandra Sokolova, M.D.|(503) 494-4396|sokolova@ohsu.edu|
20164894|NCT03062358|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164895|NCT05790460|Abramson Cancer Center at the University of Pennsylvania|Charu Aggarwal, MD, MPH|215-662-6318|charu.aggarwal@pennmedicine.upenn.edu|
20164896|NCT05550779|University of Colorado Colorado Springs|Dr. Lori James|7192554172|ljames@uccs.edu|
20164897|NCT01602224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20164898|NCT00633477|Takeda|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
20164899|NCT02539823|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212 824 9314|yasmin.hurd@mssm.edu|
20164900|NCT00770653|Takeda Pharma GmbH, Aachen (Germany)|Medical Director|+49 800 8253325|clinicaltrialregistry@tpna.com|
20164901|NCT00289653|Centre for Addiction and Mental Health|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|36859
20164902|NCT04906499|University of North Carolina at Chapel Hill|Caroline Lisee, PhD|919-962-2025|liseecar@email.unc.edu|
20164903|NCT00179621|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20200387|NCT01613326|Novartis Pharmaceuticals|Study Director|4 161 324 1111||
20200388|NCT02088385|Changi General Hospital|Dr Andrew Kwek Boon Eu|6788 8833|andrew_kwek@cgh.com.sg|
20200389|NCT03980938|EIP Pharma, Inc|Jennifer Conway|(617) 744-4400|jconway@eippharma.com|
20200390|NCT02939131|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20200391|NCT00605267|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20200392|NCT02408692|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
20155789|NCT02923167|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@mgh.harvard.edu|
20200393|NCT03569202|Finnsusp Ltd.|Dr. Jarmo Laihia, Manager of Clinical & Formulation Development|358 50 377 1212|jarmo.laihia@piiloset.fi|
20200394|NCT00420511|Leadership Sinai Centre for Diabetes, Mount Sinai Hospital|Dr. Ravi Retnakaran|416-586-4800|rretnakaran@mtsinai.on.ca|3941
20200395|NCT02415712|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20155790|NCT02094885|Ethicon, Inc|Jonathan Batiller, Senior Clinical Director|+1 908 218-2492|JBatill2@its.jnj.com|
20164904|NCT05622734|University of Washington School of Nursing|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
20164905|NCT01273766|Comprehensive Cancer Center of Wake Forest University|Dr. Mary Ann Knovich|336-716-7973|mknovich@wakehealth.edu|
20164906|NCT03525444|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20164907|NCT00262860|University of Rochester|Jonathan W. Friedberg|585-273-4150|jonathan_friedberg@urmc.rochester.edu|
20164908|NCT02741128|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20155791|NCT00779909|Boston University School of Dental Medicine|Raul I Garcia, DMD|617-638-6385|rig@bu.edu|
20155792|NCT01104870|United Therapeutics, Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
20155793|NCT02134808|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
20155794|NCT02317042|University of Western Australia|Prof Nigel McArdle & Prof Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
20155795|NCT02570425|Sydney Medical School, University of Sydney & Woolcock Institute of Medical Research|Assoc Prof Sinthia Bosnic-Anticevich|+61 2 9114 0040|sinthia.bosnic-anticevich@sydney.edu.au|
20155796|NCT02150863|Massachusetts General Hospital|Elizabeth Morehouse, Clinical Research Coordinator|617-724-2168|emorehouse@partners.org|
20155797|NCT05965323|University of Washington|Linda K Ko, PhD, Principal Investigator|2062568261|lindako@uw.edu|
20155798|NCT00835549|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20155799|NCT00835042|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20155800|NCT04008069|Stanford University, School of Medicine, Immunology & Rheumatology|Dr. Matthew C. Baker, Principal Investigator|650- 498-4528|mbake13@stanford.edu|
20155801|NCT00511199|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20155802|NCT04543786|University of Pittsburgh|Lee Fisher|412-383-1329|lef44@pitt.edu|
20155803|NCT04601493|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
20155804|NCT02314247|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20155805|NCT01953354|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20155806|NCT02571244|Federal University of Juiz de Fora/Brazil|Dr. Erica Cruvinel|55-32-99174-8855|ericacruvinel@gmail.com|
20155807|NCT01570192|University of Florida, Department of Medicine|Dr. George L. Drusano|407-313-7060|gdrusano@ufl.edu|
20155808|NCT00930787|LifeCell|Dr Michael Franz|908094701100|mfranz@lifecell.com|
20155809|NCT00489359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20155810|NCT03180138|Johns Hopkins University|Sanjay K Jain|4105028241|sjain5@jhmi.edu|
20155811|NCT04191733|DePuy Orthopaedics|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20155812|NCT01775410|Avinger, Inc.|Director of Clinical Trials|650 241 7030|tlawson@avinger.com|
20155813|NCT01260311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155814|NCT02633527|Supernus|Joseph Hull, PhD, Director Clinical Research|240-403-5324|jhull@supernus.com|
20155815|NCT01950039|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 2635|mary.elizabeth.patti@joslin.harvard.edu|
20155816|NCT03856177|University of New Mexico|Dr. James F. Cavanagh|4158670303|jcavanagh@unm.edu|
20155817|NCT01898091|Medical University of South Carolina|Susan G. Reed, DDS, MPH, DrPH|843 792-1577|reedsg@musc.edu|
20155818|NCT03211832|Prevention Research Center, Brown School, Washington University in St. Louis|Ross Brownson|3149350121|rbrownson@wustl.edu|
20155819|NCT03888287|Hackensack Meridian Health|Hooman Azmi, MD|201-342-2550|hooman.azmi@hmhn.org|
20155820|NCT02913326|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155821|NCT01514422|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
20155822|NCT03511209|VA Greater Los Angeles Healthcare System|Constance H. Fung, MD, MSHS|818-891-7711|Constance.Fung@va.gov|39311
20155823|NCT03189433|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
20155824|NCT04743206|University of Florida|Silvia Delgado Villalta|7185684198|silviadelgado@ufl.edu|
20155825|NCT02598973|Crescenz VA Medical Center|James Morley|215-823-5934|james.morley@va.gov|
20155826|NCT02844075|Yonsei University|Byoung Chul Cho|+82 2 2228 4190|cbc1971@yuhs.ac|
20155827|NCT02592655|Marcus Migura|Marcus Migura|(619) 436-7323|mwmigura@gmail.com|
20155828|NCT00911157|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155829|NCT00215657|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20155830|NCT03769467|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
20155831|NCT04565756|Exonate|Loic Lhuillier|+44 (0)1223 734716|loic.lhuillier@exonate.com|
20155832|NCT05259722|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
20155833|NCT03688139|Weill Medical College of Cornell University|Dr. Jennifer N. Bress|914-997-8683|jeb2061@med.cornell.edu|
20164909|NCT02973100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20164910|NCT01419769|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
20200396|NCT01668654|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200397|NCT04557384|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200398|NCT01175005|Phoenixchildrens|Amanda Kasem|6025461910|akasem@phoenixchildrens.com|
20200399|NCT00454779|Amgen Inc.|Study Director|866-572-6436||
20200400|NCT01418001|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20200401|NCT00168831|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200402|NCT01622569|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
20200403|NCT01505894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200404|NCT05210504|VUMC|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
20200405|NCT04173741|Hacettepe University|Dr. Asli Melek|+905376636789|aslimelek121@gmail.com|
20200406|NCT02522767|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20200407|NCT03222427|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20164911|NCT00878501|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20164912|NCT01959503|C.R. Bard|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
20164913|NCT01419236|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20164914|NCT00281463|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
20164915|NCT02764385|Oregon Health & Science University|Sue Flocke|5034946697|flocke@ohsu.edu|
20164916|NCT03598036|Aurinia Pharmaceuticals Inc.|Clinical Trial Support|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
20164917|NCT04494841|MMJ Labs|Dr. Amy Baxter|1 877 805 2899|abaxter@mmjlabs.com|
20164918|NCT01838694|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
20164919|NCT00945958|SPARC|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
20164920|NCT00672555|Department of surgery, Cantonal hospital of St. Gallen|Lukas Marti; principal investigator|0041794120153|lukas.marti@kssg.ch|
20164921|NCT02780401|University of Washington Medical Center|Jennifer S. Childs|2066162305|childj@u.washington.edu|
20164922|NCT00350025|Fox Chase Cancer Center|Dr. Yu-Ning Wong|215-728-3889|yu-ning.wong@fccc.edu|
20164923|NCT02153086|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20164924|NCT00446849|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20164925|NCT01194830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164926|NCT03115359|Pennsylvania State University|Aleksandra E. Zgierska, MD, PhD|717-531-8187|azgierska@pennstatehealth.psu.edu|
20164927|NCT04861597|Montefiore Medical Center|Ruby Greywoode M.D. M.S., Assistant Professor of Medicine|347-671-8205|rgreywoode@montefiore.org|
20164928|NCT01317472|Indiana University|Terese Stevens, Dept administrator|317-278-3187|tstevens@iupui.edu|
20164929|NCT01815918|Hospital for Special Surgery|Kethy Jules-Elysee, MD|212-606-1206|JulesElyseeK@HSS.EDU|
20164930|NCT04682197|Atrium Wake Forest Baptist Health|Dr. Charles H. Tegeler|336-716-9447|BBRP@wakehealth.edu|
20164931|NCT03284710|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20164932|NCT03285724|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20164933|NCT04992312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20164934|NCT02412306|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20164935|NCT04231669|Washington University in St. Louis|Dr. Ozge Sensoy Bahar|314-935-9403|ozge.sensoybahar@wustl.edu|
20164936|NCT03480048|Michigan State University|Jean Kerver, PhD, MSc, RD, Assistant Professor|231-392-8227|jkerver@epi.msu.edu|
20164937|NCT03804840|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20164938|NCT03793751|Tata Main Hospital, Tata Steel|Dr.Deb Sanjay Nag|+91-9431166582|debsanjay@gmail.com|
20164939|NCT03760029|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164940|NCT03532542|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
20164941|NCT00436332|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fhcrc.org|
20164942|NCT04698343|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
20164943|NCT00286442|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20164944|NCT02756338|BIOTRONIK, Inc.|Crystal Miller|800-547-0394|crystal.miller@biotronik.com|
20164945|NCT04309110|Firstkind Ltd|Dr Kieron Day|+44 (0) 1494 572040|kieron.day@firstkindmedical.com|
20164946|NCT01339689|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20164947|NCT01856270|University of Washington|Dr. Jeanne Hoffman|206-221-6511|jeanneh@uw.edu|
20164948|NCT00467740|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164949|NCT00730158|UPMC Hillman Cancer Center|Edward Chu, MD|(412) 648-6589|chue2@upmc.edu|
20200408|NCT00254566|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20200409|NCT00059202|Mayo Clinic|Dr. Keith Lindor|507-284-2511||
20200410|NCT03378479|UZ Leuven|Prof. Dr. Joost Wauters - Intensivist|016344275|joost.wauters@uzleuven.be|
20200411|NCT00548548|Hoffman-LaRoche|Medical Communications|800-821-8590||
20164950|NCT01632020|University of Arkansas for Medical Sciences|Daisy Wade|5016868274|dewade@uams.edu|
20164951|NCT04999839|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20200412|NCT01044966|Medical University of South Carolina|Dr. Bruce Frankel|8437922052|frankel@musc.edu|
20164952|NCT03740048|Wake Health|Dr Zhidong Lin|3367138720|zlin@wakehealth.edu|
20200413|NCT01705691|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
20200414|NCT02658448|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20200415|NCT03106779|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20200416|NCT04088409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200417|NCT04233229|Air Liquide Santé International|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
20200418|NCT02288247|Astellas Pharma Europe Ltd. (APEL)|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
20200419|NCT04652804|Johns Hopkins Bloomberg School of Public Health|Shruti H. Mehta|443-287-3837|smehta@jhu.edu|
20200420|NCT00584194|USAMRIID Medical Division|Janice Rusnak, MD|301-619-4156|janice.rusnak@amedd.army.mil|
20200421|NCT04093531|University of Rochester|Ummara Shah, MD|585-275-1643|ummara_shah@urmc.rochester.edu|
20200422|NCT00841763|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20200423|NCT03634800|Weill Cornell Medicine|Dr. Himanshu Nagar|212-746-3704|hnagar@med.cornell.edu|
20200424|NCT03118596|University Hospitals Coventry & Warwickshire NHS Trust|Dr Cyprian Mendonca|02476964000|cyprian.mendonca@hotmail.com|25871
20200425|NCT00927368|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
20200426|NCT00364689|University of Miami|Clinical Trial Disclosure Manager|305-243-0494|y.p.davis@med.miami.edu|
20200427|NCT03887299|University of Texas Medical Branch Galveston|Antonio F Saad|4097476646|afsaad@utmb.edu|
20200428|NCT03473561|Abbott Laboratories|Suntje Sander, PhD|0049 - 511 - 6750 3254|suntje.sander@abbott.com|
20200429|NCT00964431|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
20200430|NCT01114529|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|trialandresults.registries@novartis.com|
20200431|NCT00592475|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20200432|NCT00331409|Oregon Health and Science University|Christopher W. Ryan|503-494-1951|ryanc@ohsu.edu|
20200433|NCT01482910|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20200434|NCT00305942|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20200435|NCT03222349|Aquestive Therapeutics|Director of Clinical Operations|908-941-1887|denis.scheper@aquestive.com|
20200436|NCT02614079|University of Toledo Medical Center|Joseph Atallah, MD|419-383-6699|joseph.atallah@utoledo.edu|
20200437|NCT00820755|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20200438|NCT02063035|Massachusetts General Hospital, Boston, MA, USA|Dr. Kirkham B. Wood|617-726-2000|kbwood@stanford.edu|+1
20200439|NCT03604445|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20155834|NCT00420056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155835|NCT03274661|Miami Cancer Institute at Baptist Health, Inc.|Dr. John Diaz, Principal Investigator|(786) 527-8284|johnpd@baptisthealth.net|
20155836|NCT01390584|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20155837|NCT00498485|Rutgers|Dr Benjamin Natelson|973-2236370|bnatelson@chpnet.org|
20155838|NCT01292538|Regulatory Insight, Inc.|Elvira Walls|615-712-9743|elvira@reginsight.com|
20155839|NCT01712074|Pfizer|Pfizer|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155840|NCT02268851|Dana-Farber Cancer Institute|Matthew Davids, MD, MMSc|617-632-6331|matthew_davids@dfci.harvard.edu|
20155841|NCT03377127|Beaumont Health|Dr. Alexandra Halalau|2485513481|alexandra.halalau@beaumont.org|
20155842|NCT03378635|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
20155843|NCT02539394|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@hss.edu|
20155844|NCT02413346|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20155845|NCT01472835|Johns Hopkins|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
20155846|NCT02403778|Univesity Colorado Ansshutz Medical Campus|Martin McCarter|303-724-2728|martin.mccarter@ucdenver.edu|
20155847|NCT01044693|Vanderbilt University|Italo Biaggioni MD|615-936-3420|italo.biaggioni@vanderbilt.edu|
20155848|NCT03425188|Respicardia, Inc.|Tim Meyer, VP Clinical Affairs|952-540-4479|tmeyer@respicardia.com|
20155849|NCT01835431|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20155850|NCT02978508|Mayne Pharma LLC|Associate Director, Clinical Operations|919 573 7948|phoevos.hughes@maynepharma.com|
20155851|NCT02301793|Johns Hopkins Medical Institutions|Elliott R Haut M.D, PhD, Associate Professor of Surgery, Anesthesiology &Critical Care Medicine|410-502-3122|ehaut1@jhmi.edu|
20155852|NCT01316900|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155853|NCT00562861|Tufts Medical Center|Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
20155854|NCT01684033|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20155855|NCT00480025|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155856|NCT02189629|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
20155857|NCT03726879|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20155858|NCT02766478|Emory University|Dr. Jessica Alvarez|404-727-1390|jessica.alvarez@emory.edu|
20155859|NCT00761137|NeuroHealing Pharmaceuticals|Daniel Katzman|617-965-0872|info@neurohealing.com|
20155860|NCT01093573|Case Comprehensive Cancer Center|Brenda Cooper MD|(216) 844-3213|Brenda.cooper@uhhospitals.org|
20155861|NCT00089583|ViiV Healthcare|GSK Response Center|866-435-7343||
20155862|NCT04349098|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20155863|NCT03508440|University of Missouri|Rebecca Schneider, Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
20155864|NCT02113878|Dana Farber Cancer Institute|Glenn J. Hanna, MD|617.632.6799|GJHanna@partners.org|
20155865|NCT01251965|The University of Texas (UT) MD Anderson Cancer Center|Srdan Verstovsek, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
20155866|NCT00530257|The Children's Hospital of Philadelphia|Dr. Nathan Blum|215-590-6336|blum@email.chop.edu|
20155867|NCT00385515|Mucosal Therapeutics, LLC|Eward G. Fey, PhD|857-228-1100||
20155868|NCT05130281|Weill Cornell Medicine|Maddy Schier|(646) 289-5271|mas4019@med.cornell.edu|720
20200440|NCT00773279|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20200441|NCT03543085|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
20200442|NCT02251912|University of North Carolina at Chapel Hill|Dr. Cort Pedersen|919-923-3284|cort_pedersen@med.unc.edu|
20200443|NCT00480857|University of Michigan Comprehensive Cancer Center|Dr. Daniel Hamstra|(734) 936-4300|dhamm@umich.edu|
20200444|NCT02551159|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20200445|NCT00243659|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20200446|NCT00268242|The Cleveland Clinic|Anjali S. Advani, MD|216-445-5330|advania@ccf.org|
20200447|NCT02175680|CytoDyn Inc.|Joseph Meidling, Sr. Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
20200448|NCT03969888|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20200449|NCT00836433|Durham VA GRECC|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colonemeric@va.gov|6777
20200450|NCT00464178|Hackensack University Medical Center|Dr. David Siegel|551-996-2000|DSiegel@hackensackumc.org|
20200451|NCT02052557|Des Moines University|Grants and Contracts Manager|5152711657|mlyon@dmu.edu|
20200452|NCT01557166|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20200453|NCT04506294|Children's Hospital of Philadelphia|Nancy Kassam-Adams, PhD (Principal Investigator)|215-590-3118|adamsn@chop.edu|
20200454|NCT00946309|Fred Hutchinson Cancer Research Center|Dr. Daniel Lin|206-221-0797|dwlin@uw.edu|
20200455|NCT02986230|HealthPartners Institute|Dr. Tom Elliott|218-525-7268|elliottt793@gmail.com|
20200456|NCT03434379|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20200457|NCT00428597|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20200458|NCT03122431|Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo|Prof Eloisa Bonfa|551130617490|eloisa.bonfa@hc.fm.usp.br|
20200459|NCT02558374|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20200460|NCT00769119|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20200461|NCT00686647|AngioScore|Gary Gershony, MD/ Chief Medical Officer|510-933-7900|gary@angioscore.com|
20200462|NCT01116544|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
20200463|NCT00578643|Baylor College of Medicine|Robert Krance, MD|(832) 824-4661|rakrance@txch.org|
20200464|NCT01725750|Icahn School of Medicine at Mount Sinai|Jacob Greisman|212-241-4886|Jacob.greisman@mountsinai.org|
20164953|NCT01476722|alcon Blobal Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
20164954|NCT00526292|Memorial Sloan Kettering Cancer Center|Dr. Katherine Hsu|646-888-2667|hsuk@mskcc.org|
20164955|NCT00528957|Gilead Sciences|Clinical Trial Disclosures & Transparency||GileadClinicalTrials@gilead.com|
20164956|NCT03111875|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|sessled@ccf.org|
20164957|NCT00539981|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20164958|NCT01323582|University of Florida|Baharak Moshiree MD|305-243-2515|bmoshiree@med.miami.edu|
20164959|NCT01422161|New York University School of Medicine|Preeti Raghavan, MD|212 598 6206|raghap01@nyumc.org|
20164960|NCT00988832|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20164961|NCT03473236|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|R. Aranda M.D. / Senior Vice President of Clinical Development|(858) 684-1300|raranda@gossamerbio.com|
20164962|NCT00392392|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
20164963|NCT03155724|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
20164964|NCT00525512|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164965|NCT01239511|Sinphar Pharmaceutical Co., Ltd.|Melanie Huang|886-2-27603688|wthuang@sinphar.com.tw|2190
20164966|NCT05893862|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20164967|NCT02919761|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20164968|NCT04388683|Tufts Medical Center|Dr. Marvin Konstam|617-636-6293|mkonstam@tuftsmedicalcenter.org|
20164969|NCT00880698|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20164970|NCT04972162|WSAUDAS|Dr. Veronika Littmann|+4991313080|veronika.littmann@wsa.com|
20187608|NCT04414722|Dept. of Family Medicine, Georgetown University Medical Center|Dan Merenstein, Director of Research Programs|202-687-1600|djm23@georgetown.edu|
20187609|NCT05270876|Cochlear|PRS Specialist|+61294286555|cltd-prs-admin@cochlear.com|
20187610|NCT05906784|University of California, San Francisco|Maria Chao, DrPH, MPA, Principal Investigator|415-353-7749|Maria.Chao@ucsf.edu|
20187611|NCT02668692|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
20187612|NCT03442309|New York University|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
20217853|NCT01730040|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
20187614|NCT00661141|Horizon Pharma USA, Inc.|Beth Robinson, Executive Director||clinicaltrials@horizonpharma.com|
20187615|NCT05062330|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
20187616|NCT05524402|Massachusetts General Hospital|Dr. Jonathan Greenberg|617-643-9402|jgreenberg5@mgh.harvard.edu|
20187617|NCT05976334|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20187618|NCT05363163|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
20187619|NCT05735652|Boston Scientific|Taimin.Yue|18911590729|Taimin.yue@bsci.com|
20187620|NCT05838027|University of Pennsylvania|Eva Fabian|760-791-2633|eva.fabian@pennmedicine.upenn.edu|
20200465|NCT01831960|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
20200466|NCT03179436|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200467|NCT01119456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200468|NCT01332071|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200469|NCT01634555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20200470|NCT02542761|Mayo Clinic|Kenton Kaufman, Ph.D.|507-266-0136|Kaufman.Kenton@mayo.edu|
20200471|NCT01738971|University of Edinburgh|Dr Lucy Michie|0131 5361542|michieluc@yahoo.co.uk|
20200472|NCT05888103|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20200473|NCT05900115|innovation Research & Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
20200474|NCT02152345|Columbia University Irving Medical Center|Dr. Mark A. Hardy|(212) 305-5502|mah1@cumc.columbia.edu|
20200475|NCT01641120|Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital|Lindsay Tuttle, MPH|860-714-2149|LTuttle@stfranciscare.org|
20200476|NCT00546364|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20200477|NCT02090855|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6489|Paul.Sherwin@ge.com|
20200478|NCT04024501|AstraZeneca|AstraZeneca information Centre|1-877-240-9479|information.center@astrazeneca.com|
20200479|NCT00388947|Whitinsville Medical Center|Dr Samuel Zylstra|508-243-6260|samuelzylstra@milreg.org|
20200480|NCT04187092|University of Virginia|Joe M Hart|434.243.0256|jmh3zf@virginia.edu|
20200481|NCT00278876|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20200482|NCT01903265|Tonix Pharmaceuticals|Gregory M. Sullivan, MD, Chief Medical Officer|212 980 9155|Gregory.Sullivan@TonixPharma.com|117
20200483|NCT00845195|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20200484|NCT04793399|ZERO LMC|Valentín García|91 336 86 86|jvalentingg@gmail.com|
20200485|NCT00880750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20200486|NCT03242954|Indiana University School of Nursing|Amy Knopf|206-356-9430|asknopf@iu.edu|
20200487|NCT04690699|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
20200488|NCT00667576|Abbott Japan Co., Ltd.|Global Medical Services|800-633-9110||
20200489|NCT02265913|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20200490|NCT00483327|Perlmutter Cancer Center at NYU Langone|Stephanie Blank, MD|212-731-5705|stephanie.blank@nyumc.org|
20200491|NCT00618722|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20200492|NCT00200057|Medtronic Neuromodulation|Chad Giese|763-377-5955|chad.giese@medtronic.com|
20200493|NCT05512949|St. Louis University|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
20200494|NCT02810964|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
20200495|NCT03523351|Memorial Sloan Kettering Cancer Center|Dr. Divya Yerramilli, MD|646-449-1931|yerramid@mskcc.org|
20200496|NCT01430442|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20164971|NCT00904943|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20164972|NCT05546476|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20164973|NCT02498925|McLean Hospital|Christian Webb, PhD|6178554429|cwebb@mclean.harvard.edu|
20164974|NCT00910104|Boston Children's Hospital|Mark Puder MD PhD|617-355-1838|mark.puder@childrens.harvard.edu|
20164975|NCT03137654|UFlorida|Ben Lewis, Assistant Professor, UF Department of Psychiatry|3522948724|benlewis@ufl.edu|
20164976|NCT03583099|Weill Cornell Medicine|Fernando J. Martinez, MD, MS|646-962-2370|fjm2003@med.cornell.edu|
20164977|NCT04890652|Department of Psychiatry, Yale University School of Medicine|Dongju Seo, Associate Professor|475-441-3457|dongju.seo@yale.edu|
20164978|NCT04364386|InPress Technologies Inc|Jan Segnitz, MD|(408) 238-9279|jsegnitz@gmail.com|
20164979|NCT04709068|Current Health|Clinical Research Lead|617-208-4239|study.team@currenthealth.com|
20164980|NCT04019379|University of Minnesota|Kathleen M. Hill Gallant, PhD|612-625-5285|hillkm@umn.edu|
20164981|NCT04750824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20164982|NCT00807911|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
20164983|NCT04175730|University of Illinois at Chicago|Dr. Michael Abern|312-996-9330|mabern1@uic.edu|
20164984|NCT04349891|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
20164985|NCT05164120|MedStar Health Georgetown Transplant Institute|Alexander Kroemer, MD; Khalid Kahn, MD|202-444-3700|Alexander.Kroemer@gunet.georgetown.edu; Khalid.M.Khan@gunet.georgetown.edu|
20164986|NCT04851691|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
20164987|NCT00836589|BIOTRONIK, INC|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
20164988|NCT03324607|Duke University Medical Center|Yuh-Chin T. Huang, MD, MHS|9196843069|huang002@mc.duke.edu|
20164989|NCT02914639|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
20164990|NCT01814774|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20164991|NCT01018030|GlaxoSmithKline|GSK Response Center|866-435-7343||
20164992|NCT01924845|BioMarin Pharmaceuticals|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
20164993|NCT00062439|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
20164994|NCT04529083|VA North Texas Health Care System|Dr. James Le Page|214-857-1437|james.lepage@va.gov|
20200497|NCT03363633|Duke University Medical Center|Ellen D. Dillavou, MD, FACS||ellen.dillavou@duke.edu|
20200498|NCT00325078|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
20200499|NCT00772629|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20200500|NCT04866290|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
20200501|NCT04051957|The University of Texas Health Science Center at Houston|Jaya Kala, MD|713-500-6868|jaya.kala@uth.tmc.edu|
20200502|NCT01097629|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200503|NCT03760484|University of Alberta|Dr. Dina Kao|780-233-6025|dina.kao@ualberta.ca|
20200504|NCT05197803|Sonova AG|Study Manager|519 895 0100|carolina.rubiano@sonova.com|2135
20200505|NCT00132041|American College of Radiology Imaging Network|Donna Harfeil, Director of Protocol Management|215-717-2765|Donna Hartfeil <dhartfeil@acr.org>|
20200506|NCT05162066|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20200507|NCT01171820|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
20200508|NCT03969875|Icahn School of Medicine at Mount Sinai|Dr. Poonam Pai|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
20200509|NCT01307033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200510|NCT03856944|Gainesville Eye Associates|Clayton Blehm, MD|770-532-4444|claytonblehm@gmail.com|
20200511|NCT02327260|University of Missouri, Kansas City|Dr. Kym Bennett|816-235-6370|bennettkk@umkc.edu|
20200512|NCT01936389|NYGRI|Jessica Jasien, MEn|2124777540|jjasien.ganyresearch@gmail.com|371
20200513|NCT02804763|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20200514|NCT00860158|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20200515|NCT03588741|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20200516|NCT00006227|NRG Oncology|Christopher Purdy on behalf of Mark Brady PhD|(716)845-1300|purdyc@nrgoncology.org|2296
20200517|NCT00840827|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
20200518|NCT01445535|National Cancer Institute|Dr. Wyndham Wilson|240-760-6092|wyndham_wilson@nih.gov|
20200519|NCT03216382|Ryerson University|Dr. Naomi Koerner|416-979-5000|naomi.koerner@ryerson.ca|ext. 5521
20200520|NCT05130008|Massachusetts General Hospital|Dr. Jocelyn Carter|617 724 9000|jcarter0@mgh.harvard.edu|
20200521|NCT00358657|Fred Hutchinson Cancer Research Center|Dr. Kanwaldeep Mallhi|206-667-2014|kmallhi@fredhutch.org|
20200522|NCT01940484|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200523|NCT04137783|Children's Hospital of Chongqing Medical University|Dr. Jianhui Wang|13678428167|wangjh@cqmu.edu.cn|
20164995|NCT00060528|National Cancer Instititute (NCI), National Institutes of Health (NIH)|James L. Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
20164996|NCT04196686|Lucile Packard Children's Hospital Stanford|Samuel Rodriguez, MD|(650)723-6412|sr1@stanford.edu|
20164997|NCT05106959|University of New Mexico South West Clinical Trials Network|Cade Arnink|505-918-0341|clarnink@salud.unm.edu|
20164998|NCT01995708|Memorial Sloan Kettering Cancer Center|Dr. David Chung, MD, PhD|646-608-3770|ChungD1@MSKCC.ORG|
20164999|NCT00265564|Office of Mental Health Operation, Veterans Health Administration|Jodie Trafton, Director Program Evaluation and Resource Center|650-493-5000|Jodie.Trafton@va.gov|22474
20165000|NCT03043534|WakeForest|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
20165001|NCT00119847|Stony Brook University|Dr. Eric J. Rashba|631-444-3575|eric.rashba@stonybrookmedicine.edu|
20165002|NCT01553084|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
20165003|NCT00659061|Aga Khan University|Professor Zulfiqar Ahmed Bhutta|4930051|zulfiqar.bhutta@aku.edu|4782
20165004|NCT00590187|Cyclacel Pharmaceuticals|Julius, Huang, PhD.|760-877-2708|jhuang@cyclacel.com|
20165005|NCT00475670|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20165006|NCT04949191|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20165007|NCT01168349|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200524|NCT02769624|Cincinnati Children's Hospital Medical Center|Katy Fischesser|513-803-5191|katy.fischesser@cchmc.org|
20200525|NCT02769728|Medical University of Graz|Prof. Harald Sourij|0316 385 81310|ha.sourij@medunigraz.at|
20200526|NCT01552681|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20200527|NCT00448708|Angiotech Pharmaceuticals|Dr. Trudy Estridge|604-221-7676|testridge@angio.com|
20200528|NCT04698525|Medicine Faculty, Universidad Autónoma de San Luis Potosi|Ildefonso Rodriguez-Leyva MD, PhD|4442043016|ildefonso.rodriguez@uaslp.mx|
20200529|NCT00354601|Wake Forest University Health Sciences|Doug Case Biostatistician|336-716-1048|dcase@wfubmc.edu|
20200530|NCT01893567|Galderma Laboratories, L.P.|Senior Clinical Project Manager|817-961-5000|jay.mashburn@galderma.com|
20217854|NCT00544817|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20217855|NCT02813421|Children's Hospital Los Angeles|Dr. Jessica Ferris|323-361-4606|jeferris@chla.usc.edu|
20217856|NCT00977548|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, Principal Investigator|813-745-4692|rami.komrokji@moffitt.org|
20217857|NCT01042535|H. Lee Moffitt Cancer Center and Research Institute|Hatem Soliman, M.D.|813-745-4933|hatem.soliman@moffitt.org|
20217858|NCT00682617|Oregon Health & Science University|Dr. Nels Carlson|(503) 494-6420|carlsonn@ohsu.edu|
20217859|NCT00107042|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20217860|NCT03919448|Laboratorios Richmond|Regulatory Affairs Department|(+54 11) 5555 - 1600|info@richmondlab.com|
20217861|NCT03341546|NHS Tayside|Mark Worrall|01382632177|markworrall@nhs.net|
20217862|NCT01221090|Scott & White Hospital|Dr. Samuel N. Forjuoh|(254) 771-7695|SFORJUOH@sw.org|
20217863|NCT03438539|University of Kentucky|Craig Rush, Ph.D.|859-257-5388|crush2@uky.edu|
20217864|NCT04776746|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
20217865|NCT00440466|J&J PRD|Peter Bowers|908-927-2116||
20217866|NCT01891305|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
20165008|NCT02678351|Stanford Medicine at Stanford University|Andrea Otte|650-736-4183|anotte@stanford.edu|
20165009|NCT01636765|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20217867|NCT00655850|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
20217868|NCT02459665|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
20200531|NCT00130286|Weill Cornell Medical College|Dr. Marshall J. Glesby|212-746-4177|mag2005@med.cornell.edu|
20200532|NCT01360645|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20200533|NCT00956254|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
20200534|NCT01465659|Northwestern University|Sheetal Kircher, MD|312-695-0990|sheetal.kircher@nm.org|
20200535|NCT03828487|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20200536|NCT03042936|UTHSC|Joan Han|9012876408|jhan14@uthsc.edu|
20200537|NCT02022826|Medtronic|Michal Kedar-Datel|+972-4-9097952|michal.kedar-datel@medtronic.com|
20200538|NCT02887521|Mayo Clinic|Roberto Benzo, MD, MSc|(507) 284-0561|benzo.roberto@mayo.edu|
20200539|NCT02065453|Saint Louis University|M. Brigid Holloran-Schwartz, MD|314-781-8605|holloran@slu.edu|1
20200540|NCT05523973|University of Cincinnati|Dr. Brittany Krekeler, PI|5132272759|krekelby@ucmail.uc.edu|
20200541|NCT05499520|University of Pennsylvania|Andy Tan|2157466546|andy.tan@asc.upenn.edu|
20200542|NCT03580616|Dartmouth-Hitchcock Medical Center|Dr. Elijah Stommel|6036505104|elijah.w.stommel@hitchcock.org|
20200543|NCT00793793|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200544|NCT02487108|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20200545|NCT00883493|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20200546|NCT01110395|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
20165010|NCT02654782|Mayo Clinic|Dr. William C. Oliver, Jr.|507-255-4240|oliver.william@mayo.edu|
20200547|NCT01016873|Oraya Therapeutics Inc.|Denis O'Shaugnessy, Ph.D.|917-417-3974|doshaughnessy@orayainc.com|
20200548|NCT00506857|UT MD Anderson Cancer Center|Richard E. Champlin/Professor||ytdinh@mdanderson.org|
20200549|NCT05099640|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20200550|NCT04139122|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
20200551|NCT01987908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20200552|NCT03711604|Rhizen Pharmaceuticals AG|Dr.Prajak Barde|9820503970|pjb@rhizen.com|
20200553|NCT00923117|National Cancer Institute, National Institutes of Health|Dr. Teri Kreisl|301-402-3423|kreislt@mail.nih.gov|
20200554|NCT01500057|Brooklyn Urology Research Group|Ivan Grunberger, M.D. Medical Director|718-230-7788|ivg9002@nyp.org|
20200555|NCT00441792|Advocate Christ Medical Center|Erik Kulstad, MD, MS|7086843889|kulstad@uic.edu|
20200556|NCT01731678|University of Calgary|Frank MacMaster, PI of the project|403-955-2784|fmacmast@ucalgary.ca|
20200557|NCT02471716|FivePrime Theraputics|Medical|415-365-5600|nick.mahasuwan@fiveprime.com|
20200558|NCT01539980|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Professor Pornanong Aramwit, Pharm.D., Ph.D.|+66899217255|aramwit@gmail.com|
20200559|NCT01815645|Federal University of Sao Paulo|Andre Q. C. Miguel|005511 965884111|aqcmiguel@gmail.com|
20200560|NCT01014585|Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc.|Joel Trugman, MD|201-427-8681|joel.trugman@frx.com|
20200561|NCT02154425|Cares|UCB|+1877 822||9493
20200562|NCT02211261|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217869|NCT00099268|Novartis Pharmaceuticals|Study Director|862 778-8300||
20217870|NCT01360866|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|609 524 6788|clinicaltransparency@otsuka-us.com|
20165011|NCT02978417|Duke University|Michele Easter, Ph.D.|919-385-0862|michele.easter@duke.edu|
20165012|NCT03273426|Seoul National University Hospital|Dr. Wonshik Han|+82-2-2072-1958|hanw@snu.ac.kr|
20165013|NCT03485924|Johns Hopkins Medical Institute|Dr. Eun Ji Shin|4106140950|eshin3@jhmi.edu|
20165014|NCT05288816|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20165015|NCT03416868|Massachusetts General Hospital; Harvard Medical School|Jarrad Van Stan, PhD, CCC-SLP|617-643-8410|jvanstan@mgh.harvard.edu|
20165016|NCT02970799|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20165017|NCT00564681|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20165018|NCT03174184|Vanderbilt University Medical Center|Kelly Dooley, MD, PhD|6153228972|kelly.e.dooley@vumc.org|
20165019|NCT01969708|The Emmes Corporation|Principal Investigator of the SCORE2 Data Coordinating Center|301-251-1161|score2@emmes.com|
20165020|NCT03138369|Neurovalens Ltd|Paul McGeoch, MD|858-232-3312|paul.mcgeoch@neurovalens.com|+1
20165021|NCT00409539|Sunovion|Medical Director, Urology|1-866-503-6351||
20165022|NCT02588599|Arizona Institute of Footcare Physicians|Kerry Zang DPM|480-834-8804|kerryzang@aol.com|
20165023|NCT03353675|Transgene|Director of Medical Affairs|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
20165024|NCT03309020|National Institutes of Health|Teresa Magone, MD, Principal Investigator, NEI|301-435-4562|teresa.magonedequadroscosta@nih.gov|
20165025|NCT00402168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20165026|NCT01128049|University of Rochester Medical Center, Flaum Eye Institute|James Aquavella, MD|585-275-8944|James_Aquavella@URMC.Rochester.Edu|
20165027|NCT00601835|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20165028|NCT00582361|UAB|Research Nurse Coordinator|205-996-6781|Talyor.vlack@ortho.uab.edu|
20165029|NCT02370420|Universidad Autonoma de Nuevo Leon|Felix Vilchez Cavazos|811 049 80 70|vilchez.doctor@hotmail.com|
20165030|NCT00880620|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|908-307-2234|kaihong.jiang@amneal.com|
20165031|NCT01400698|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
20165032|NCT05086705|The Ohio State University Comprehensive Cancer Center|Dr. Sagar Sardesai|614-293-6401|sagar.sardesai@osumc.edu|
20200563|NCT02817087|Houston Methodist Neurological Institute|David Chiu, M.D.|713-441-5801|dmccane@houstonmethodist.org|
20200564|NCT00508391|BIOTRONIK, Inc.|Clay Cohorn|503-387-2614|clay.cohorn@biotronik.com|
20200565|NCT00880256|VA Puget Sound Health Care System|Dr. David Kearney|206-764-2285|david.kearney@va.gov|
20200566|NCT00802360|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20200567|NCT02041962|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
20200568|NCT01481896|Anderson Orthopaedic Research Institute|Robert H. Hopper, Jr., PhD|(703) 619-4411|research@aori.org|
20200569|NCT01649947|Rutgers Cancer Institute of New Jersey|Joseph Aisner, MD|732-235-7401|aisnerjo@cinj.rutgers.edu|
20200570|NCT01920802|New York State Psychiatric Institute|Jeffrey A. Lieberman, MD|646-774-8436|jlieberman@columbia.edu|
20165033|NCT05316597|University of Washington|Dr. Gregory Bratman|2065437591|bratman@uw.edu|
20165034|NCT03859024|University of Alabama at Birmingham|Dr. Adam Baumgarten|205-996-6769|abaumgarten@uabmc.edu|
20165035|NCT01706458|UWCCC|Mary Jane Staab - Program Manager|608-262-4304|mjs@medicine.wisc.edu|
20165036|NCT03547518|William Beaumont Hosptial|Jennifer Giordano, RN BSN Clinical Research Manager|248-551-3517|jennifer.giordano@corewellhealth.org|
20165037|NCT00907426|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20165038|NCT04854135|Washington University in St. Louis|Paulina Cruz Bravo, MD|314-922-8620|pcruz@wustl.edu|
20165039|NCT05875532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165040|NCT03192176|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20165041|NCT00072462|Queen Mary University of London|Professor Jack Cuzick|+442078823504|j.cuzick@qmul.ac.uk|
20165042|NCT02384551|VA ORD|Heidi J Silver|615-875-9355|heidi.j.silver@vumc.org|
20165043|NCT03679247|Brigham and Women's Hospital|Lipika Samal|6177327063|lsamal@bwh.harvard.edu|
20165044|NCT05796557|Yale|Oliver Karam|203-785-4651|oliver.karam@yale.edu|
20165045|NCT04247347|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
20165046|NCT03035032|Astellas Pharma Sinagpore Pte Ltd|Clinical Trial Disclosure|+65 6500 9330|astellas.resultsdisclosure@astellas.com|
20165047|NCT03789669|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
20165048|NCT00442169|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20200571|NCT01286493|Queen Saovabha Memorial Institute|Dr.Suda Sibunruang|+66 2 2520161|sudapunrin@gmail.com|125
20200572|NCT01162421|AbbVie|Global Medical Information|800-633-9110||
20202974|NCT00909090|University of Georgia|Dr. Billy Hammond, Principal Investigator|(706) 54204812|bhammond@uga.edu|
20202975|NCT02004990|University of Minnesota|Robert S. Jones DDS PhD|612-626-2900|rsjones@umn.edu|
20202976|NCT01749735|Spaulding Rehabilitation Hospital|Dr. Paolo Bonato|617-952-6319|pbonato@partners.org|
20202977|NCT02926573|Washington University School of Medicine|Melanie Townsend, M.D.|314-362-4470|townsendm@wustl.edu|
20202978|NCT03099369|University of North Carolina at Chapel Hill|David Lee, MD|347-882-8010|dave.lee0530@gmail.com|
20202979|NCT00611455|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202980|NCT01678846|London School of Hygiene and Tropical Medicine|Dr Karen Devries|0207958 8164|Karen.Devries@lshtm.ac.uk|8164
20202981|NCT04601272|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
20202982|NCT00414440|Novartis|Study Director|+1 (862) 778-8300||
20202983|NCT02732912|Oxford Brookes University|Dr Derick Wade|+447818452133|derick.wade@ntlworld.com|
20202984|NCT04382651|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20202985|NCT01507545|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20202986|NCT01873742|Modum Bad Research Institute|Dr. Terje Tilden|+4732749869|tilden@modum-bad.no|
20202987|NCT00790296|University of Connecticut Health Center|Andrew Winokur MD PhD|860-679-6775|awinokur@uchc.edu|
20202988|NCT02708212|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|
20202989|NCT02694029|UT Southwestern Medical Center|Asal Rahimi, MD|214/645-8556|Asal.Rahimi@UTSouthwestern.edu|
20202990|NCT01417286|Cancer Institute of New Jersey Rutgers|Dr. Haffty|732-235-8675|hafftybg@cinj.rutgers.edu|
20202991|NCT00853905|Wills Eye Hospital Glaucoma Research Center|Marlene Moster MD|215-825-4713|jmolineaux@willseye.org|
20202992|NCT05610969|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@pennmedicine.upenn.edu|
20202993|NCT01596595|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
20202994|NCT02262130|CHU de Reims|Pr Manuelle Viguier|00333 26 78 43 43|mviguier@chu-reims.fr|
20202995|NCT04441931|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20202996|NCT04799782|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
20202997|NCT02050048|NorthShore Univeristy HealthSystem|Dr. Russell Brown|847-657-1900|rbrown@northshore.org|
20202998|NCT02088216|Qilu Hospital of Shandong University|Yu Li|13791122770|qlliyu@163.com|
20202999|NCT03118843|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20203000|NCT01589094|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
20203001|NCT04224987|UCSF Proctor foundation|Dr Thomas Lietman|4154761442|tom.lietman@ucsf.edu|
20203002|NCT00969618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20203003|NCT05094154|Vanderbilt University Medical Center|Edward T Qian, MD|615-322-2386|edward.t.qian@vumc.org|
20203004|NCT00945750|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203005|NCT02100657|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
20203006|NCT02531035|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20203007|NCT03990766|Washington University School of Medicine|Dr. Jake Lee|3143937248|jakejlee@wustl.edu|
20203008|NCT01543490|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
20200573|NCT03336502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200574|NCT01054079|Comprehensive Cancer Center of Wake Forest University|Dr. K.C. Balaji|336-618-2272|kbalaji@wakehealth.edu|
20200575|NCT00611247|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
20200576|NCT01107444|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200577|NCT01750255|Universidad de Antioquia|Pedro Amariles Muñoz|57 4 2195456|pedro.amariles@udea.edu.co|
20200578|NCT01948830|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20200579|NCT01890421|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
20200580|NCT03310970|University of Iowa|Nicole Brogden, Associate Professor|319-335-8752|nicole-brogden@uiowa.ed|
20200581|NCT01133171|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
20200582|NCT02526550|Siriraj Hospital|Prof.Kulkanya Chokephaibulkit|662 4195695|kulkanya.cho@mahidol.ac.th|
20200583|NCT03875950|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
20200584|NCT01260454|University of Rochester|R. James White, MD, PhD|585-486-0869|jim_white@urmc.rochester.edu|
20200585|NCT00091832|Amgen Inc.|Study Director|866-572-6436||
20200586|NCT03357393|Region Östergötland|Lena Nilsson|+46 10 103 00 00|lena.nilsson@regionostergotland.se|1838
20200587|NCT01446419|Relievant Medsystems, Inc.|V.P. of Clinical & Regulatory Affairs|650-261-2259|lhook@relievant.com|
20200588|NCT00874250|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
20200589|NCT00282841|University of California San Diego|Thilo Hoelscher, MD|619-543-5251|thoelscher@ucsd.edu|
20200590|NCT00374244|Yale University School of Medicine, Dept of Psychiatry|Handan Gunduz-Bruce MD|(203) 932-5711|handan.gunduz-bruce@yale.edu|4130
20200591|NCT02445586|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200592|NCT01698528|Joslin Diabetes Center|Dr William Hsu|617-309-5803|william.hsu@joslin.harvard.edu|
20200593|NCT02385279|European Cardiovascular Research Institute|Dr. E. Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
20200594|NCT00604968|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200595|NCT02542072|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
20200596|NCT03961360|The University of Texas Health Science Center at Houston|Farah Amro, MD|713-500-6421|farah.h.amro@uth.tmc.edu|
20200597|NCT00654498|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200598|NCT01990261|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20200599|NCT01609842|VHA Eastern Colorado Health Care System|Marina McCreight|720-857-2785|marina.mccreight@va.gov|
20200600|NCT00954109|Harry S Truman Memorial VA Hospital and University of Missouri|John Thyfault, Associate Professor|573-814-6000|thyfaultj@health.missouri.edu|53742
20200601|NCT02474329|Radboudumc|Marjan Meinders|+00000000|Marjan.Meinders@radboudumc.nl|
20200602|NCT01583374|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20200603|NCT02447848|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20200604|NCT02307370|Spectranetics, LLC now a part of Philips Image Guided Therapy Devices|Nicolas Aguirre, Senior Manager, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
20200605|NCT01506882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20200606|NCT04320407|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20200607|NCT03219866|Wake Forest Health Science|Jill Ohar, MD|336-716-1210|johar@wakehealth.edu|
20200608|NCT01811147|Cleveland Clinic Foundation|Dr. Amit Anand|216-636-2840|ananda@ccf.org|
20200609|NCT01821300|The Children's Hopsital of Philadelphia|Dr. Andrea Kelly|215590-3174|kellya@email.chop.edu|
20200610|NCT03267004|University of Tennessee|Hollie Raynor|865-974-6259|hraynor@utk.edu|
20200611|NCT03694392|Kaiser Permanente Vaccine Study Center|Amber Hsiao Hyman, Senior Research Project Manger|510-267-7517|Amber.Hyman@kp.org|
20200612|NCT02863068|Albert Einstein College of Medicine|Dr. Caterina Minniti|240-498-8684|bloodconsultant@gmail.com|
20200613|NCT01400932|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200614|NCT04656990|University of South Carolina|Director, USC Office of Research Compliance|803 777-6670|lisaj@mailbox.sc.edu|
20200615|NCT03244059|University of Alabama at Birmingham|Mark Dransfield MD|205-934-5425|mdransfield@uabmc.edu|
20200616|NCT00806221|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-2121|simpsone@ohsu.edu|
20165049|NCT01809938|GuysThomasNHSTrust / Rockingham General Hospital|Dr. Sam Hillyard|+61424055820|sghillyard@yahoo.co.uk|
20200617|NCT00282243|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
20200618|NCT00686127|University of California, San Francisco|Dr. Christine Miaskowski, PI|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
20200619|NCT06441877|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
20200620|NCT06062264|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20200621|NCT05256888|University of Maryland School of Nursing|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
20200622|NCT01072409|University of Michigan|Teresa Zwolan, Ph.D.|(313) 618-9669|zwolan@umich.edu|
20200623|NCT03706365|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20200624|NCT05195528|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20165050|NCT02595983|Alnylam Pharmaceuticals Inc|Chief Medical Office|866.330.0326|Clinicaltrials@alnylam.com|
20165051|NCT01890343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20200625|NCT01552902|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20200626|NCT02720757|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165052|NCT02399215|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
20200627|NCT02631538|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165053|NCT00772538|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200628|NCT00400400|Novartis Pharmaceuticals|Study Director|862-778-8300||
20165054|NCT00189540|AnGes|Director of Clinical Operations|240-780-9031|information@anges-mg.com|
20165055|NCT01089504|University of Rochester|Ronnie Guillet|585-275-6209|ronnie_guillet@urmc.rochester.edu|
20165056|NCT00001832|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20165057|NCT00713609|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200629|NCT00648167|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
20200630|NCT01688050|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20165058|NCT01903356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200631|NCT01554579|Afferent Pharmaceuticals|Clinical Development|650-286-1276|info@afferentpharma.com|
20200632|NCT00234039|SWOG Statistical Center|Study Statistician|206-667-4623||
20200633|NCT00110019|ECOG Statistical Office|Study Statistician|617-632-3012||
20200634|NCT03897751|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
20200635|NCT01046695|Mayo Clinic|Deborah J. Engen, OT, CMT|507-255-5504|engen.deborah@mayo.edu|
20200636|NCT02239263|cochlear|Lori O'Neill Director of Research|8005235798|loneill@cochlear.com|
20200637|NCT04426695|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20200638|NCT04303000|University of Alabama at Birmingham|Melinda Clarke|205-975-7809|melindaclarke@uabmc.edu|
20200639|NCT00822107|Oregon Health & Science University|Dr. David H. Ellison|5034944465|ellisond@ohsu.edu|
20200640|NCT04276207|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200641|NCT05655377|Flint Rehabilitation Devices|Ian Russell|9496670140|irussell@flintrehab.com|
20200642|NCT01256177|AstraZeneca|Dhaval Desai (MSD, Seroquel)|+13028857643|aztrial_results_posting@astrazeneca.com|
20200643|NCT03118947|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20200644|NCT03653390|University of Washington|Dr. Ivan Molton, PhD|2065433602|imolton@uw.edu|
20200645|NCT01261819|Florida Hospital|Katherine Kratz, M.D.||katiegoodrich@gmail.com|
20200646|NCT04451330|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20165059|NCT01001221|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
20165060|NCT03448406|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165061|NCT01292486|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
20165062|NCT04369404|Massachusetts General Hospital|Karen Sepucha, PhD|617-724-3350|ksepucha@mgh.harvard.edu|
20165063|NCT03130738|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|407-323-1887|nini.ramirez@hillderm.com|
20165064|NCT03988400|Ralph H. Johnson VA|Jesse Dean|8437929566|deaje@musc.edu|
20165065|NCT05139680|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165066|NCT02542865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165067|NCT03582215|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.strauss@fda.hhs.gov|
20165068|NCT04913610|Drugs for Neglected Diseases initiative|Clinical Trial Data|41 22 906 9230|ctdata@dndi.org|
20165069|NCT01210716|Fenwal, Inc|Sr. Mgr. Clinical Affairs|847-550-5620|carrie.pineda@fenwalinc.com|
20165070|NCT03186209|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20165071|NCT03164668|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20165072|NCT01277744|UT MD Anderson Cancer Center|Andrea Hayes-Jordan M.D. / Surgical Oncology|713-794-4616|AHJORDAN@MDANDERSON.ORG|
20165073|NCT01791244|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20165074|NCT04657679|Georgetown University|Sandra Swain, MD,|(202) 687-8487|sandra.swain@georgetown.edu|
20165075|NCT03853473|Medical College of Wisconsin|Matthew J. Durand, Ph.D., Principal Investigator|414-955-5619|mdurand@mcw.edu|
20165076|NCT02240485|Université du Québec à Trois-Rivières|Dr. Joël Tremblay|4186592170|joel.tremblay@uqtr.ca|2820
20165077|NCT00953667|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
20165078|NCT04038359|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
20165079|NCT05121766|Hackensack Meridian Health|Arunima Sarkar, MD|5519961140|arunima.sarkar@hmhn.org|
20165080|NCT03259230|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
20165081|NCT05468814|Hospital Universitario Reina Sofía|Ms. Irene Calzado Álvarez de Lara|+34618093419|ircaalla@gmail.com|
20165082|NCT01983228|Minneapolis Veterans Affairs Health Care System|Dr. Diana Burgess, Principal Investigator|612-467-1591|diana.burgess@va.gov|
20165083|NCT02955589|Huya Japan G.K.|Huya Japan clinical development||japanclinical@huyabio.com|
20165084|NCT04716426|ELJ Consultancy|Ernesto Cesar Pinto Leal Junior|+55 11 975222856|ceo@eljconsultancy.com|
20165085|NCT02987231|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@unesp.br|
20165086|NCT01046565|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20165087|NCT01650558|University of Maryland School of Medicine|Miriam K. Laufer, M.D., M.P.H.|410-706-5333|mlaufer@som.umaryland.edu|
20200647|NCT00849667|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20165088|NCT02960217|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20165089|NCT01069484|Norwegian School of Sport Sciences, Department of Sports Medicine, Oslo, Norway|Dr. Gunvor Hilde|+47 41366045|gunvor.hilde@gmail.com|
20200648|NCT03501966|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
20200649|NCT00189462|West Penn Allegheny Health System|David Skoner, MD|4123594099|dskoner@wpahs.org|
20200650|NCT00553163|Barts Health NHS Trust|Prof D S Rampton|+442035943300|d.rampton@qmul.ac.uk|
20200651|NCT00553462|Yale Cancer Center|Rogerio Lilenbaum, M.D.||Rogerio.lilenbaum@yale.edu|
20200652|NCT01262625|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
20200653|NCT01869348|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
20200654|NCT02789657|BrUOG|Brown University Oncology Research Group|4018633000|BrUOG@Brown.edu|
20200655|NCT03075163|UC Davis Anesthesiology & Pain Medicine|Neal Fleming, MD, PhD|916 734-5046|nwfleming@ucdavis.edu|
20200656|NCT04398732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200657|NCT00486447|GE Healthcare|Angela N. Johnson, Senior Manager Clinical Affairs Operations|262-226-9495|angela.johnson@ge.com|
20200658|NCT02055404|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|1-888-451-3937|alcon.medinfo@alcon.com|
20200659|NCT03882424|Zhejiang Teruisi Pharmaceutical Inc.|Yilin Li, Medical Director|13601247168|yilin.li@teruisipharm.com|
20200660|NCT00947284|UCaliforniaSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
20200661|NCT00602355|Women and Infants Hospital|Caron Zlotnick|401-455-6529|czlotnick@butler.org|
20200662|NCT02772757|Mountain Home VA Medical Center|Sherri L. Smith, Au.D., Ph.D.|423.926.1171|sherri.smith@va.gov|7569
20200663|NCT02086331|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
20200664|NCT03329378|Icahn School of Medicine at Mount Sinai|Dr. Aarti Bhardwaj|(212) 824-8578|Aarti.Bhardwaj@mountsinai.org|
20200665|NCT00510276|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20200666|NCT03486392|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20200667|NCT01225341|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20200668|NCT03715426|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
20200669|NCT03665285|NextCure, Inc.|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
20200670|NCT00888355|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20200671|NCT00880360|University of Texas Health Science Center at San Antonio|Dr. Tyler Curiel|210-450-1000|curielt@uthscsa.edu|
20200672|NCT03603652|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20200673|NCT00666926|Verastem, Inc.|Mitchell Keegan|617-252-9300|mkeegan@verastem.com|
20200674|NCT01960855|AbbVie|Global Medical Services|800-633-9110||
20200675|NCT02058147|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20200676|NCT03640832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20200677|NCT01318122|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
20200678|NCT01486199|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
20200679|NCT00626743|INJE University Pusan Paik Hospital|Jae Gook Shin, MD,PhD|+82-51-890-8954|phshinjg@paik.ac.kr|
20200680|NCT02981069|University of Texas Health San Antonio|Professor|12103587200|cersosimo@uthscsa.edu|
20200681|NCT04178772|Johnson & Johnson VIsion Care, Inc.|Thomas Karkkanien - Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
20200682|NCT02808390|PPM Services|Salvatore Bellinvia|+41916961710|sbellinvia@ppmservices.ch|
20200683|NCT01558063|Columbia University|J. John Mann, MD|646-774-7553|jjm@columbia.edu|
20200684|NCT04897867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20165090|NCT00079326|Dana-Farber Cancer Institute|Craig Bunnell|617-632-3800|cbunnell@partners.org|
20165091|NCT05083351|Masimo|Director, Clinical Lab Operations|(949) 297-7000|studies@masimo.com|
20165092|NCT04326920|UZ Gent|Cedric Bosteels|+3293325909|cedric.bosteels@ugent.be|
20165093|NCT00960375|V Maryland Healthcare System|Dr. Melanie Bennett, Research Health Scientist|410-637-1859|Melanie.Bennett@va.gov|
20165094|NCT00083889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20165095|NCT03624881|Biosense Webster, Inc.|Senior Safety Officer CSS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20165096|NCT03019406|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20165097|NCT03668873|Cleveland Clinic Foundation|Cynthia R. Johnson, PhD|216 448-6440|johnsoc@ccf.org|
20165098|NCT04267380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165099|NCT00593346|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
20165100|NCT02228681|GOG Foundation|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
20165101|NCT00849940|Duke University Medical Center|David MacLeod, M.B.|919-681-3551|david.macleod@dm.duke.edu|
20165102|NCT04258423|Indiana University|Dr. Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
20165103|NCT01784991|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
20165104|NCT01601535|New Approaches to Neuroblastoma Therapy|NANT Medical Director|323-361-5687|nantops@chla.usc.edu|
20165105|NCT02856412|San Francisco Veterans Health Care System|Thomas Neylan, MD|415-750-6961|Thomas.Neylan@va.gov|
20165106|NCT04273737|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
20165107|NCT04199351|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20165108|NCT03623243|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20165109|NCT03007966|Wake Forest University Health Sciences|Christopher Edwards|336-716-4498|chedward@wakehealth.edu|
20165110|NCT03365102|Brown University|Richard Jones|401-444-1943|rich_jones@brown.edu|
20200685|NCT01916629|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
20200686|NCT00330187|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
20200687|NCT02908516|Yale School of Medicine, Department of Orthopaedics and Rehabilitation|Dr. Michael P. Leslie|(203) 737-6358|michael.leslie@yale.edu|
20200688|NCT01225562|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20155869|NCT04804709|Columbia University Irving Medical Center|Cheng-Chia Wu, MD, PhD|646-317-3033|cw2666@cumc.columbia.edu|
20155870|NCT02290574|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
20155871|NCT01509404|Medical University of South Carolina|James Fleming|843-792-0312|fleminj@musc.edu|
20155872|NCT02144337|University of Nottingham (UK)|Helen Quirk|01157484325|ntxhq1@nottingham.ac.uk|
20155873|NCT00203242|Thomas Jefferson University/Jefferson Headache Center|Stephen D. Silberstein-Principal Investigator|215-955-9477|Stephen.Silberstein@jefferson.edu|
20155874|NCT01500135|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20155875|NCT01661595|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
20155876|NCT00912509|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
20155877|NCT02715856|UT MD Anderson Cancer Center|Dr. Robert Satcher, Associate Professor, Orthopaedic Oncology|(713) 794-5242|rlsatcher@mdanderson.org|
20155878|NCT01050218|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20155879|NCT01772693|Insightec|Nadir Alikacem, Ph.D., VP Clinical Research|214-630-2000|nadira@insightec.com|
20155880|NCT01633112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20155881|NCT01879826|University of California San Francisco|Cynthia Kim|(415)353-1328|cynthia.kim@ucsf.edu|
20155882|NCT03439072|Xeris Pharmaceuticals, Inc.|Martin J. Cummins|312-736-1624|mcummins@xerispharma.com|
20155883|NCT05084885|Centre for Addiction and Mental Health|Dr. Nigel Turner|416-535-8501|nigel.turner@camh.ca|36063
20155884|NCT00128492|Gilead Sciences, Inc.|Mark Bresnik, Director of Clinical Research|650-522-5934|Mark.Bresnik@gilead.com|
20155885|NCT01079390|Mass General Hospital|Jian Kong|617-726-7893|kongj@nmr.mgh.harvard.edu|
20155886|NCT00692237|Sapienza University of Rome|Dr Andrea Isidori|+39 0649970540|andrea.isidori@uniroma1.it|
20155887|NCT01347086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20155888|NCT02624687|University of Pittsburgh|Bethany Barone Gibbs|4123834002|bbarone@pitt.edu|412
20155889|NCT00347269|University of Washington|Peter Roy-Byrne MD Professor of Psychiatry|206-313-8504|roybyrne@u.washington.edu|
20155890|NCT03654326|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20155891|NCT04893811|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155892|NCT02662582|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20155893|NCT01725282|Astellas Pharma Inc.|Vice President, Clinical Development Administration||clinicaltrials@us.astellas.com|
20187621|NCT04820322|INQUIS Clinical Research|Principal Scientist|4168619177|twolever@inquis.com|
20187622|NCT03156465|University of Iowa|Camille Dunn|319-353-8776|camille-dunn@uiowa.edu|
20187623|NCT04380337|Stanford University|Dr. Erqi Pollom|650-498-0484|erqiliu@stanford.edu|
20187624|NCT04444518|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
20187625|NCT05715528|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20187626|NCT03118518|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
20187627|NCT04880733|University California-Irvine|Jeffery Dusek|617-519-8082|jdusek@hs.uci.edu|
20187628|NCT05848947|Sirtex Medical|Janet Bell, Director, Clinical Research Operations|978-866-1798|jbell@sirtex.com|
20187629|NCT05533190|The Institute of Cancer Research|Prof Ceire Costelloe|20 3437 6777|ceire.costelloe@icr.ac.uk|
20187630|NCT03421340|Boston Scientific|Pooja Goswamy|15086834335|pooja.goswamy@bsci.com|
20187631|NCT06324344|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
20187632|NCT00780494|Stanford University|Pamela Kunz|650-725-8738|pkunz@stanford.edu|
20187633|NCT05664958|Duke Unversity School of Medicine|Ashraf Haib|919-668-2024|ashraf.habib@duke.edu|
20187634|NCT03213678|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20187635|NCT04218851|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20187636|NCT06435624|Nanjing Mingzhou Rehabilitation Hospital|Jingzhi Zhang|16677137704|170787717@qq.com|86
20187637|NCT04874948|Klinikum der Universität München (LMU)|Dr. med. vet. Julia Dreisbach|+49 89 4400|julia.dreisbach@med.uni-muenchen.de|59825
20187638|NCT03988621|University of Pennsylvania|Barbara Riegel, PhD, RN, Professor|2158989927|briegel@nursing.upenn.edu|
20187639|NCT05013385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187640|NCT04247802|Oxford University Hospitals NHS Foundation Trust|Mrs Martha Batting|01865|martha.batting@ouh.nhs.uk|737526
20187641|NCT05265065|Murdoch Children's Research Institute|Kim Mulholland|+61 3 99366656|kim.mulholland@mcri.edu.au|
20187642|NCT01447719|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20187643|NCT03235440|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20187644|NCT03252288|University of South Carolina|Jan Ostermann|+1803-777-8747|jano@mailbox.sc.edu|
20187645|NCT00758862|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20187646|NCT02641730|Janssen Pharmaceutical K.K.|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187647|NCT05460871|University of Iowa Hospitals and Clinics|Dr. Lee Kral|(319) 384-6593|lee-kral@uiowa.edu|
20187648|NCT00721149|Biosense Webster, Inc.|Diana Bordley, Director, Regulatory Affairs|800-729-9010|dbordley@its.jnj.com|8604
20187649|NCT05158504|IstanbulSBU|HKARTAL|05378870982|kartal_hilal@yahoo.com|
20187650|NCT03309644|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20187651|NCT03606512|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187652|NCT05513937|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|055 5680459|pfabrizzi@menarini.it|+39
20165111|NCT00474487|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
20165112|NCT01428258|University of Wisconsin-Madison|Dr. Denise M Ney|608-262-4386|ney@nutrisci.wisc.edu|
20165113|NCT00419393|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20165114|NCT00979901|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20165115|NCT00681044|Boston Medical Center|Dr. Vaishali Sanchorawala, Director of Stem Cell Transplant Program|617-637-7017|vaishali.sanchorawala@bmc.org|
20165116|NCT02994238|Northwestern University|Kathy Boon- Clinical Research Associate|312-503-4687|kathy.boon@northwestern.edu|
20165117|NCT05941702|University of Manchester|Krishna Panchmatia|07857543272|krishna.panchmatia@postgrad.manchester.ac.uk|
20165118|NCT02814916|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20165119|NCT04392739|SIGA Technologies|Emily Blum, Assoc. Director of Clinical Research|541-224-1305|eblum@siga.com|
20165120|NCT05543265|Massachusetts General Hospital|Mark Clapp, MD|617-724-2000|mark.clapp@mgh.harvard.edu|
20165121|NCT02766023|University of California San Francisco|Craig Cohen, MD, MPH|(415) 476-5874|Craig.Cohen@ucsf.edu|
20165122|NCT03359629|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
20165123|NCT00286468|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20165124|NCT02953652|Huya Japan G.K.|Huya Japan Clinical Development||japanclinical@huyabio.com|
20200689|NCT00165958|Emory University|Dr. Suephy Chen|4047783084|schen2@emory.edu|
20200690|NCT02601573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200691|NCT00928421|BTG International Inc|David Wright MB FRCS|610-943-3513|david.wright@btgplc.com|
20200692|NCT00670007|CSL Behring|Clinical Trial Disclosure Manager|Use Email contact|clinicaltrials@cslbehring.com|
20200693|NCT00925600|Amgen Inc.|Study Director|866-572-6436||
20200694|NCT00624221|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
20200695|NCT04785612|hVIVO|Alex Mann|+44(0)7738321671|a.mann@hvivo.com|
20155894|NCT04581629|Calcilytix Therapeutics, Inc., a BridgeBio company|Medical Information|650.600.3610|MedInfo@bridgebio.com|
20155895|NCT03255200|Mainstay Medical|Director, Clinical Affairs|877 702-8488|clinical@mainstaymedical.com|
20155896|NCT01687595|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
20155897|NCT03719300|Anchiano Therapeutics, Israel Ltd.1 Kendall Square, Building 1400, Suite 105 Cambridge, MA 02139|David Kerstein, M.D.,Chief Medical Officer|857-259-4626|David.Kerstein@anchiano.com|
20155898|NCT04130425|Mayo Clinic|Stephanie Kannas, OTR/L, OTD, CHT|507-284-8841|kannas.stephanie@mayo.edu|
20155899|NCT05451329|VivaVision Biotech, Inc.|Xiao-Yan (Joanne) Li, M.D.|(858) 692-9752|joanne.li@vivavisionbio.com|
20155900|NCT02349477|Medical University of South Carolina|Dr. Michaela Hoffman|8437927758|HoffmaMi@musc.edu|
20155901|NCT02100644|GlaxoSmithKline|GSK Response Center|866-435-7343||
20155902|NCT02852005|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20155903|NCT04629521|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20155904|NCT01618708|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20155905|NCT04792970|Duke University Medical Center|Scott Shofer|(919) 668-2402|scott.shofer@duke.edu|
20155906|NCT02369159|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20155907|NCT02554474|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
20155908|NCT02214628|Ophthotech Corp.|Keith Westby|732-824-7474|keith.westby@ophthotech.com|
20155909|NCT02770365|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
20155910|NCT00489476|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
20155911|NCT02628145|University of Rhode Island|Matthew Delmonico|4018745440|delmonico@uri.edu|
20155912|NCT03000166|University of Wisconsin-Milwaukee|Jeanne M. Erickson, PhD, RN|414-229-6920|ericksoj@uwm.edu|
20155913|NCT04409418|William Beaumont Hospitals|Dr. Amit Bahl|248 898-9111|amit.bahl@corewellhealth.org|
20155914|NCT01444924|University of Wisconsin Hospitals and Clinics|Dr. David Kushner|608-263-0796|dmkushner@facstaff.wisc.edu|
20155915|NCT02757963|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20155916|NCT01887600|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
20155917|NCT00962650|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20155918|NCT00231465|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
20155919|NCT03624036|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
20155920|NCT02470377|University of Minnesota|Yoon-Hee Cha|612-301-2738|ycha@umn.edu|
20155921|NCT00298155|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20155922|NCT00291226|Yale University School of Medicine|Scott W. Woods, MD|203-974-7038|scott.woods@yale.edu|
20155923|NCT03478787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20155924|NCT02474901|University of Colorado|Adriana Weinberg, MD|3037244480|adriana.weinberg@ucdenver.edu|
20155925|NCT00655356|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
20155926|NCT01044459|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20155927|NCT04105725|Medical University of South Carolina|Dr. Kathryn Gex|(843) 876-2084|soltisk@musc.edu|
20155928|NCT05346640|Cionic|Rebecca Webster, Clinical Operations Manager|9257886649|rebecca@cionic.com|
20155929|NCT04634331|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
20155930|NCT05626686|Coloplast|Zenia Størling, Senior Director of Clinical Strategies|+4549111869|dkzenst@coloplast.com|
20200696|NCT00127127|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200697|NCT03652909|Ascending Hearing Technologies, LLC|Christina Runge|2623523478|chrunge@mcw.edu|
20200698|NCT01059448|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20200699|NCT00778830|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20200700|NCT01891643|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20200701|NCT01542307|Massachusetts General Hospital|Aneesh Singhal, MD|6177268459|asinghal@partners.org|4
20200702|NCT02591615|NorthShore Medical Group|Thomas Hensing|847.570.2112|thensing@northshore.org|
20200703|NCT04188197|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
20200704|NCT01734655|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
20200705|NCT03932799|University of Washington|Andrea Elmore|206-685-7194|aelmore@uw.edu|
20200706|NCT01322022|Children's Hospital of Pittsburgh/University of Pittsburgh|Dr. Cynthia Johnson|412-692-8404|cynthia.rheney.johnson@gmail.com|
20200707|NCT01929057|UCSD Dermatology Clinical Trials|Dermatology Clinical Trial Manage|(858)657-8390|dermstudies@ucsd.edu|
20200708|NCT00956943|University of Pennsylvania|Robert A. Schnoll, Ph.D.|215-746-7143|schnoll@mail.med.upenn.edu|
20200709|NCT02613208|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20200710|NCT02663895|Stanford University|Dr. Lorinda Chung|(650) 723-6961|shauwei@stanford.edu|
20165125|NCT02927301|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
20200711|NCT03057366|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20200712|NCT02911688|Center for Environmental Medicine Asthma and Lung Biology|Carole Robinette Assistant Director of Clinical Research|919 966-5638|carole_robinette@med.unc.edu|
20200713|NCT00809328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200714|NCT04201717|FIrst Hospital of Jilin University|Dr. Quan Wang|+86 ‭15843073207‬|wquan@jlu.edu.cn|
20200715|NCT02274688|University of Washington|Douglas Zatzick|2067446701|dzatzick@uw.edu|
20200716|NCT00947531|EVERNeuro Pharma|Head of R&D|+43 7665 20555|stefan.winter@everpharma.com|0
20200717|NCT00851903|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
20200718|NCT00270894|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
20200719|NCT01070329|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20200720|NCT02863848|Universitat Rovira i virgili|Dr. Joaquin Escribano|+ 34 977 759364|joaquin.escribano@urv.cat|
20200721|NCT03220412|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
20200722|NCT03116113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20165126|NCT04742556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165127|NCT00524511|UMass Memorial Medical Center|Dawn Tasillo, MD|5083346255|tasillod@ummhc.org|
20165128|NCT03305666|Denver Health and Hospital Authority|Dr. Fredric Pieracci|(303) 436-4029|Fredric.Pieracci@dhha.org|
20165129|NCT01166139|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
20165130|NCT02546609|Nusirt Biopharma Inc.|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
20165131|NCT01048593|Eyepoint Pharmaceuticals, Inc.|Regulatory Affairs Specialist|6179726318|dbauer@eyepointpharma.com|
20165132|NCT02212015|Universität Heidelberg/Universitätsmedizin Mannheim|Prof. Dr. med. Peter Hohenberger|+49 0621 383 2609|peter.hohenberger@umm.de|
20165133|NCT03780452|UAB Department of Orthopaedic Surgery|Dr. Ashish Shah|(205) 930-8339|ashishshah@uabmc.edu|
20165134|NCT00914849|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8304|jdipersi@dom.wustl.edu|
20165135|NCT04701814|Pharos university in Alexandria|P.T Moataz Abdelaal|1060081213|moataz.abd.student@pua.edu.eg|+20
20165136|NCT02388269|electroCore LLC|Clinical Affairs Department electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
20165137|NCT00087152|SWOG|Lead Statistician - Breast Cancer Committee|(206) 839-1761|williamb@crab.org|
20165138|NCT04602390|Anokion US|Medical Director|+1 857.320.6607|clinicaltrials@anokion.com|
20165139|NCT03581279|MDC Associates, Inc.|Manager, Regulatory and Clinical Affairs|9787055012|t2@mdcassoc.com|
20165140|NCT03882021|Abbott|Laura Zitella Verbick|+1-612-961-7336|laura.zitellaverbick@abbott.com|
20165141|NCT01546857|Rutgers-New Jersey Medical School|Jean Daniel Eloy|9739721470|eloyje@njms.rutgers.edu|973
20165142|NCT00375999|Gangnam Severance Hospital, Yonsei University College of Medicine|Dr. Jae Yong Cho|82-2-2019-4363|chojy@yuhs.ac|
20165143|NCT05005260|Mayo Clinic|Johar Paul|5072556804|Paul.Johar@mayo.edu|
20165144|NCT02970981|NYU Langone Health - Perlmutter Cancer Center|Jeffrey S. Weber, MD, PhD|212 731 6262|Jeffrey.Weber@nyulangone.org|
20165145|NCT01033240|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20165146|NCT02913482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20165147|NCT00918385|Duke University|Dr. Daniel George|(919) 668 4615|daniel.george@duke.edu|
20165148|NCT03207126|Imperial College London|Diana Marcus|07525133957|diana.marcus@nhs.net|
20165149|NCT02296164|Helsinn Therapeutics (U.S.), Inc.|Bill Bailey|+1 732 603 2848|bill.bailey@helsinn.com|
20165150|NCT02005016|VA Pittsburgh Healthcare System|Dr. Michael Dickey|412-360-6467|michael.dickey@va.gov|
20165151|NCT00625131|VA Medical Center, Durham, NC|Angela Kirby, MS; Regulatory Coordinator|9192860411|angela.kirby@va.gov|5526
20165152|NCT01003301|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
20165153|NCT00168844|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165154|NCT01026844|Massachusetts General Hospital|Lecia Sequist, MD|617-724-4000|lvsequist@partners.org|
20165155|NCT01260649|MGH|Dr. Cristina Cusin|617 726 64221|ccusin@mgh.harvard.edu|
20200723|NCT02159807|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
20200724|NCT00950170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200725|NCT01254669|Boston Medical Center|Dr. Natalie Joseph|1-617-414-5202|napierre@bu.edu|
20200726|NCT02367521|Johns Hopkins University School of Medicine|Vani Rao, MD|4105502288|vrao@jhmi.edu|
20200727|NCT00600171|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165156|NCT03557970|Oregon Health and Science University|Elie Traer, MD PhD|5034943553|traere@ohsu.edu|
20200728|NCT02104414|Mount Sinai St. Luke's|Dr. Ali Shariat|914-409-5023|alishariatmd@gmail.com|
20200729|NCT00469612|The Ohio State University|Dr. Don Mutti|614-247-7057|mutti.2@osu.edu|
20200730|NCT00542191|Leo W. Jenkins Cancer Center|Dr. Paul Walker|252-744-1015|walkerp@ecu.edu|
20200731|NCT02932787|Sheffield Hallam University|Martin Lamb|01142552782|m.lamb@shu.ac.uk|
20200732|NCT00289913|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
20200733|NCT02620904|Montefiore Einstein|Jessica Maria Atrio|7184058260|jatrio@montefiore.org|
20200734|NCT02357420|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20200735|NCT01061008|UWalesBangor|Dr. Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
20165157|NCT00112736|Adult Brain Tumor Consortium (ABTC)|Dr. Patrick Y Wen||pwen@partners.org|
20165158|NCT02138890|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
20165159|NCT05435339|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
20165160|NCT00537394|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)628-3313|ACTGCT.Gov@s-3.com|
20165161|NCT04875013|DR. EYTAN A. DAVID, MD, Otolaryngologist|Dr. Eytan David|(604) 988-0598|dr.david@shaw.ca|
20165162|NCT04764162|Virginia Tech|Dr. Kevin Davy|(540)231-3487|kdavy@vt.edu|
20165163|NCT05556265|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20165164|NCT03980730|vTv Therapeutics LLC|VP Clinical Operations|3368410300|jfreeman@vtvtherapeutics.com|
20165165|NCT02392806|Saint Louis University|Noah Hillman|3145779292|noah.hillman@health.slu.edu|
20165166|NCT01319981|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
20165167|NCT02016781|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20165168|NCT02977403|Eunice Kennedy Shriver National Institute of Health, NIH|Dr. Jack Yanovski|301-496-0858|jy15i@nih.gov|
20165169|NCT02891447|University of M D Anderson Cancer Center|Dr. Brian Badgwell|713-745-7351|bbadgwell@mdanderson.org|
20165170|NCT03724942|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20165171|NCT02429830|Torax Medical, Inc|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20165172|NCT03960541|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165173|NCT01352117|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20165174|NCT01766050|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20165175|NCT03577275|NorthSea Therapeutics BV|Dr Patrick Round|+44(0)7979502770|patrick.round@northseatherapeutics.com|
20165176|NCT02081677|Johnson & Johnson Vision Care Inc.|Tawnya Wilson, Principal Research Optometrist|904-443-1834|TWilson@ITS.JNJ.com|
20165177|NCT00089297|ECOG Statistical Office|Study Statistician|617-632-3012||
20165178|NCT01097668|Apitope Technology (Bristol) Ltd|Chief Executive Officer|+44(0)117 3707720|keith.martin@apitope.com|
20165179|NCT00385671|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20165180|NCT01910298|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20165181|NCT00717574|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
20165182|NCT03037385|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20165183|NCT04515771|Richard L. Roudebush VA Medical Center|Dr. Johanne Eliacin|317-988-5000|Johanne.Eliacin@va.gov|
20165184|NCT00278343|Juarvinski Cancer Centre|Dr. Hal Hirte|905-387-9495|hirteh@hhsc.ca|
20165185|NCT01021020|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
20200736|NCT01492673|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett, MD|212-639-8267|trippet1@mskcc.org|
20200737|NCT02024971|Takeda Pharmaceuticals Company Limited|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20200738|NCT02908100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20200739|NCT04933123|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
20165186|NCT02535481|UCL|EPIGRAAFT Trial team|020 7679 2000|epigraaft@gmail.com|
20165187|NCT00948246|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
20165188|NCT00148317|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
20165189|NCT03924622|University of Washington|Becky Ostrem CIP Compliance Administrator, Regulatory Affairs|2066858138|bostrem@uw.edu|
20165190|NCT02887820|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
20165191|NCT02923726|Boston Scientific|Jacqueline Beaulieu, Sr. Clinical Trial Manager|1-800-227-3422|jacqueline.beaulieu@bsci.com|
20165192|NCT03550118|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
20165193|NCT01187017|NIHNHLBI|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
20165194|NCT03617172|Vanderbilt University Medical Center|Sr. Clinical Trials Operations Manager|6159360815|stephanie.anne.smith@vumc.org|
20165195|NCT02051452|Harvard Medical School|Dr. Ken Solt, MD, Associate Professor of Anaesthesia|6177264359|ksolt@mgh.harvard.edu|
20165196|NCT02587221|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20165197|NCT02689427|The University of Texas MD Anderson Cancer Center|Clinton Yam, MD|(832) 589-8343|cyam@mdanderson.org|
20165198|NCT01176032|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20200740|NCT05254418|Vanderbilt University Medical Center|Dr. Talat Alp Ikizler|6159366646|alp.ikizler@vumc.org|
20203009|NCT00403117|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
20200741|NCT00440726|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
20200742|NCT01808612|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20200743|NCT03683394|The University of California, San Francisco|Dr. Kristine Yaffe|(415) 476-7307|kristine.yaffe@ucsf.edu|
20200744|NCT02690194|Boston Children's Hospital|Greggory Kobelski|7812161093|Greggory.Kobelski@childrens.harvard.edu|
20200745|NCT01175798|Icahn School of Medicine at Mount Sinai|Anita Mehrotra MD|2122415153|anita.mehrotra@mssm.edu|
20200746|NCT00638937|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@ottawahospital.on.ca|70175
20200747|NCT03062657|Medtronic|Rhys Jones, PhD; Senior Clinical Research Specialist|+44 7826874430|rhys.j.jones@medtronic.com|
20200748|NCT01242644|University of South Alabama|Office of Research Compliance|251-460-7573|swhite@southalabama.edu|
20200749|NCT03157531|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
20200750|NCT00331006|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-972-3048|sassmann@neriscience.com|
20200751|NCT00579813|University of Arkansas for Medical Sciences|Robert E. McGehee Jr., Ph.D.|501-603-1998|rem@uams.edu|
20200752|NCT03450083|Johns Hopkins University School of Medicine|Jody Tversky, MD|410-550-8017|hoddin1@jhmi.edu|
20200753|NCT00109473|Cincinnati Children's Hospital Medical Center|Lee A. Denson|513-636-7575|lee.denson@cchmc.org|
20200754|NCT03213366|Albert Einstein College of Medicine|Dr. Viraj V Patel|718.920-7102|vpatel@montefiore.org|
20200755|NCT01290627|The University of Tennessee|Richard Komistek, Ph. D.|86598744159|rkomiste@utk.edu|
20200756|NCT02532855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200757|NCT00756548|Braintree Laboratories, Inc.|John McGowan, Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
20200758|NCT01879410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200759|NCT01012492|Emory University School of Medicine|Leslie S Kean|404-376-0187|Leslie.kean@emory.edu|
20200760|NCT00820573|University of Texas HSC at San Antonio|Eugenio Cersosimo, MD PhD|210 358 7200|Eugenio.cersosimo@uhs-sa.com|
20200761|NCT01154933|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
20200762|NCT03002974|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
20200763|NCT01737931|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20200764|NCT01573910|Alcon Research, Ltd.|Firoz Vohra, Project Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20200765|NCT00364182|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200766|NCT04244370|BD|Heather Vander Ploeg|602-751-3268|heather.vander.ploeg@bd.com|
20200767|NCT04062214|Yale University|Marc Rosen, MD|2039325711|marc.rosen@yale.edu|12112
20200768|NCT02604940|West Virginia University|Pavithra Ranganathan Ellison, MD|304-598-4929|pavithra.ellison@wvumedicine.org|
20200769|NCT02349178|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
20200770|NCT01356589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200771|NCT04343651|CytoDyn Inc.|Dr. Scott Kelly, Chief Medical Officer|(360) 980-8524|skelly@cytodyn.com|
20200772|NCT01542645|NorthShore University HealthSystem|Glenn Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
20200773|NCT04714372|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|612-624-5109|maaka001@umn.edu|
20200774|NCT04025632|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|Please email|clinicaltrials@ucb.com|
20200775|NCT00376961|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
20200776|NCT04047797|MD Anderson Cancer Center|Hun J Lee, MD|713-792-2860|hunlee@mdanderson.org|
20200777|NCT01793792|MicroVention, Inc|Anne Hurley|714-247-8000|anne.hurley@microvention.com|
20200778|NCT00709826|Tragara Pharmaceuticals|Tracy Parrott|760-208-6919|tparrott@tragarapharma.com|
20200779|NCT02064764|Medtronic, Inc.|Vanessa DeBruin|6123607687|vanessa.debruin@medtronic.com|
20200780|NCT03822884|Biosidus S.A.|Clinical Trial Manager - Dr. Roberto A. Diez|+5411 4909 8000|r.diez@biosidus.com.ar|
20200781|NCT01989221|TempleU|Dr. Henry Parkman|2157072498|henry.parkman@temple.edu|
20200782|NCT00542620|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20200783|NCT03617705|University of Florida|Dr. Yan Wang|3522945942|ywang48@ufl.edu|
20200784|NCT00214461|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20200785|NCT01058096|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
20200786|NCT00559273|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200787|NCT00536172|University of Nebraska|William Burke MD|4025526005|wjburke@Unmc.edu|
20200788|NCT02516670|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Channing Paller Associate Professor Urologic Oncology|4109558239|cpaller1@jhmi.edu|
20200789|NCT01925209|Novartis Pharmaceuticals|Study Director|862-778-8300||
20200790|NCT00675025|Eisai Inc|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20200791|NCT00110994|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20200792|NCT01299727|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20200793|NCT01589484|University of Sao Paulo Medical School|Dr. Fabio Torricelli|+55 11 94308951|fabio_torri@yahoo.com.br|
20200794|NCT02395991|Seoul National University Hospital|Professor Jeong Min Lee|82-2-2072-3154|jmsh@snu.ac.kr|
20200795|NCT01727089|City of Hope|Jeff Longmate, Ph.D.|626-218-2478|jlongmate@coh.org|
20200796|NCT00944034|Novartis Vaccines|Posting Director|+39 0577 245863|anh.phung@novartis.com|
20200797|NCT01596257|Memorial Sloan Kettering Cancer Center|Dr. Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
20200798|NCT01570244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200799|NCT00384241|Medical College of Georgia, Georgia Regents University|Haidong Zhu MD, PhD, Assistant Professor|706 721 5470|hzhu@gru.edu|
20200800|NCT00464204|Fresenius Kabi Aktiengesellschaft|Professor Dr. Martin Westphal|+49 6172 686|martin.westphal@fresenius-kabi.com|7280
20200801|NCT05384041|Climb Technologies, Inc.|Julia Lanoha|(925) 405-5458|julia@climb.care|
20200802|NCT02266108|UCSDMED|Elizabeth Reed, Associate Professor|5082121517|elizared7@gmail.com|
20200803|NCT03176316|Loyola University Medical Center|Russell Nockels, M.D.|847-618-9565|neurocare@nch.org|
20200804|NCT01349140|University California San Diego|Brian Ilfeld, MD, MS|1-858-444-5949|bilfeld@ucsd.edu|
20200805|NCT00531960|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200806|NCT02737163|Johns Hopkins All Children's Hospital|Gerald Tuite, MD|7277678181|gtuite1@jhmi.edu|
20200807|NCT01564706|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20200808|NCT00713219|Memorial Sloan Kettering Cancer Center|Dr. Matthew Fury|646-888-4233|furym@mskcc.org|
20200809|NCT01814787|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
20200810|NCT01958645|AstraZeneca|Anders Berggren, MD, PhD||clinicaltrialtransparency@astrazeneca.com|
20200811|NCT03183128|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
20200812|NCT03773302|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|PROOF301.ct@qedtx.com|
20200813|NCT01686568|Mayo Clinic|Dr. Ian R. Lanza|507-255-8147|lanza.ian@mayo.edu|
20200814|NCT02978222|Marker Therapeutics|Gerald Garrett|713.400.6400|ggarrett@markertherapeutics.com|
20200815|NCT03258814|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20200816|NCT01413958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200817|NCT01900002|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD, Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
20200818|NCT04591054|Penn State Hershey Medical Center|Seth Pantanelli MD|717-531-4696|spantanelli@pennstatehealth.psu.edu|
20200819|NCT01751971|Brigham and Women's Hospital|Scott Sands, PhD|6172780911|sasands@bwh.harvard.edu|
20200820|NCT03382509|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200821|NCT02921425|University of Miami|Dr. Joseph Sharit|305-284-6472|jsharit@miami.edu|
20200822|NCT01227967|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
20200823|NCT01145560|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
20200824|NCT00712348|Protalix Ltd.|VP Medical Affairs|+972-4-9028100|raul@protalix.com|
20200825|NCT01273064|Conatus Pharmaceuticals Inc.|MiRa Huyghe, Vice President, Clinical Development|(858) 457-7227|mhuyghe@conatuspharma.com|
20200826|NCT01228903|University of Colorado|Diana Jalal|3037244867|diana.jalal@ucdenver.edu|
20200827|NCT02602223|Oregon Health & Sciences University|Dr. Sivaraman Prakasam|503-346-4711|prakasam@ohsu.edu|
20200828|NCT01375764|Amgen Inc.|Study Director|866-572-6436||
20200829|NCT02867761|University of Michigan|Meilan K. Han|734 615-9772|mrking@med.umich.edu|
20200830|NCT03595280|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
20200831|NCT03158220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200832|NCT00622895|Fred Hutchinson Cancer Research Center|George E. Georges MD|206-667-6886|ggeorges@fredhutch.org|
20200833|NCT01144598|Abbott|Global Medical Services|1-800-633-9110||
20200834|NCT00848120|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20200835|NCT00560755|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200836|NCT02344225|SUNY Downstate Medical Center|Jacob V. Aranda, MD, PhD, FRCPC, Principal Investigator|718-270-1912|jaranda@downstate.edu|
20200837|NCT02525549|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20155931|NCT00289900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20200838|NCT01578031|University of Pennsylvania|Samuel T. Kuna, MD|215-823-4400|skuna@mail.med.upenn.edu|
20200839|NCT01961115|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
20200840|NCT03497845|BARDA|Silvija Tresnjak-Smith, Regulatory Operations Branch Chief, Regulatory and Quality Affairs Division|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
20200841|NCT01439945|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
20200842|NCT04082663|Washington University School of Medicine|Dr. Gammon Earhart|314-286-1407|earhartg@wustl.edu|
20200843|NCT00777179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20200844|NCT05501119|Medical University of South Carolina|Dr. Diana Layne|(843) 792-8515|layne@musc.edu|
20200845|NCT01752023|SKCCC at Johns Hopkins|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
20200846|NCT01445678|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
20200847|NCT01943565|Brigham and Women's Hospital|Dirk J Varelmann, MD|617-732-8280|dvarelmann@partners.org|
20155932|NCT01152385|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
20155933|NCT02656173|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
20155934|NCT03449147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
20155935|NCT00992394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20155936|NCT03338686|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059344506|rva@uab.edu|
20155937|NCT04681885|Sunstar Americas, Inc.|Toru Saito|1-847-794-4271|toru.saito@us.sunstar.com|
20155938|NCT01197300|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20155939|NCT04744831|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20155940|NCT02376010|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
20200848|NCT01265524|Sorbent Therapeutics|Howard Dittrich, MD FACC|858-405-1429|hdittrich@sorbent.com|
20200849|NCT00821678|VA HSR&D|John Fortney|206.764.2821|john.fortney@va.gov|
20200850|NCT02281591|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20200851|NCT01974817|Michigan State University|Dr Subhashis Mitra|517-353-3128|mitrasub@msu.edu|
20200852|NCT00937235|University of Pennsylvania|Dr. Edna Foa|2157463327|foa@mail.med.upenn.edu|
20200853|NCT02216695|Derby Teaching Hospital NHS Trust|Nitin V Kolhe|01332788266|nitin.kolhe@nhs.net|
20200854|NCT02923271|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
20200855|NCT01678976|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
20200856|NCT05742984|Cinclus Pharma|Cinclus Pharma Holding AB|+46 8 13 33 10|gosta.hiller@cincluspharma.com|
20200857|NCT02162862|University of Pittsburgh Medical Center|Dr. Eva Szigethy|412-802-6696|szigethye@upmc.edu|
20200858|NCT00254410|The University of Texas MD Anderson Cancer Center|Wierda,William G, MD./Professor|713-745-0428|wwierda@mdanderson.org|
20200859|NCT04226469|University of Illinois Chicago|Phimon Atsawasuwan|3124132651|patsawas@uic.edu|
20200860|NCT01409928|UTSW|Olga T. Gupta|(214) 648-8718|olga.gupta@utsouthwestern.edu|
20200861|NCT00988247|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20200862|NCT01703000|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
20200863|NCT02633371|University of Colorado|Dr. Anna Bruckner|720-777-0955|anna.bruckner@ucdenver.edu|
20200864|NCT03990870|Posit Science Corporation|Dr. Kyu Lee|415-528-7235|kyu.lee@positscience.com|
20200865|NCT01279057|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20200866|NCT01196442|Virginia Commonwealth University|Dr. Craig W. Swainey|804-828-9723|cswainey@mcvh-vcu.edu|
20217871|NCT03702049|University of California, Irvine, Sue & Bill Gross School of Nursing|Adeline M Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
20217872|NCT01057381|Baylor College of Medicine|Olutoyin A. Olutoye, M.D., M.Sc.|(832) 824-5800|oao@bcm.edu|
20217873|NCT02678442|Mayo Clinic|Dr. Michael B. Wallace|904-953-2222|wallace.michael@mayo.edu|
20165199|NCT01469221|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20165200|NCT00790803|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skk@retinacenterspc.com|
20165201|NCT01490151|Stanford University|Dr. Bruce Buckingham, MD|408-356-0911|buckingham@stanford.edu|
20165202|NCT01149096|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20165203|NCT04914364|Duke University|Ashley Poole|919-538-6272|ashley.poole@duke.edu|
20165204|NCT02358473|Kyowa Kirin Pharmaceutical Development, Inc.|Regional_Program Lead|1-609-919-1000|clinical.info@kyowa-kirin-pharma.com|
20165205|NCT06047210|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
20165206|NCT06133816|University of Pennslyvania|Katharine Rendle, PI|215-349-5442|katharine.rendle@pennmedicine.upenn.edu|
20165207|NCT04819945|GATT Technologies B.V.|Dr Stuart Head, MD, PhD, Chief Medical Officer|+31645306042|s.head@gatt-tech.com|
20165208|NCT00703014|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165209|NCT02004236|BrainMech Foundation|Moises Domingo president of Brainmech Foundation|+441615312645|moises@bigdata4brain.co.uk|
20165210|NCT04797585|Cleveland Clinic Foundation|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
20165211|NCT00214045|University of Wisconsin School of Medicine and Public Health|Dr. Stephen Nakada|(608)263-1359|nakada@urology.wisc.edu|
20165212|NCT00918281|GE Healthcare|Matthew Miller|011-44-1494-543981|matthew.miller@ge.com|
20165213|NCT01446159|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
20165214|NCT01283139|MedImmune, LLC|Gabor Illei, MD, Senior Director, Clinical Development|301-398-0000|IlleiG@Medimmune.com|
20165215|NCT00004563|University of Texas Health Science Center at Houston|Maureen Mayes, MD|+1 (713) 500-6900|Maureen.D.Mayes@uth.tmc.edu|
20165216|NCT00995761|Gyeongsang National University Hospital|Gyeong-Won Lee M.D.Ph.D.|82-55-750-8066|brightree@lycos.co.kr|
20165217|NCT00762164|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
20165218|NCT03896438|University of Minnesota|Melanie Stimac|612-301-2449|stima011@umn.edu|
20165219|NCT01336933|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
20165220|NCT00321789|Veterans Affairs Medical Center|Corrine I. Voils|919-286-0411|corrine.voils@va.gov|5196
20165221|NCT04576988|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20165222|NCT01938079|Columbia University|Amy L. Dzierba, Pharm.D., BCPS, BCCCP, FCCM|212-305-5852|ald9012@nyp.org|
20165223|NCT03371836|KennedyKrieger|Project Director|443-923-7600|Salpekar@kennedykrieger.org|
20165224|NCT04897711|Utah State University|Stephanie Borrie|435-797-1388|stephanie.borrie@usu.edu|
20165225|NCT02362724|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20165226|NCT02025179|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20165227|NCT00556075|Repros Therapeutics Inc.|Jennifer L. Wike|2817193402|jwike@reprosrx.com|
20165228|NCT01854359|National Institutes of Allergy and Infectious Diseases|Dr. Peter Kosa (Staff Scientist)|(301) 731-6444|peter.kosa@nih.gov|
20165229|NCT01927497|Academic medical center|prof. dr. P.J. Tanis|0031205669111|g.d.musters@amc.nl|
20165230|NCT00395746|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20165231|NCT04528641|Reithera|Medical Director|06 99775|roberto.camerini@reithera.com|352
20165232|NCT00517296|Vanderbilt University Medical Center|David A. Schwartz, MD|615-322-4643|david.a.schwartz@vanderbilt.edu|
20165233|NCT05358366|University of North Carolina at Chapel Hill|Natalia Villegas Rodriguez, PhD|919-966-4260|navilleg@email.unc.edu|
20165234|NCT03137992|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
20165235|NCT02103309|Alcon Japan, Ltd.|Director of Clinical Trials|1-888-451-3937|alcon.medinfo@alcon.com|
20165236|NCT03077542|National Heart, Lung, and Blood Institute at National Institutes of Health|Courtney Fitzhugh, M.D.|301.402.6496|fitzhughc@nhlbi.nih.gov|
20165237|NCT04359810|Columbia University Irving Medical Center|Max O'Donnell, MD|212-305-5794|mo2130@columbia.edu|
20200867|NCT01427309|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20200868|NCT00956930|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
20200869|NCT00849017|GlaxoSmithKline|GSK Response Center|866-435-7343||
20200870|NCT03502187|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
20200871|NCT02913313|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20200872|NCT01841619|UC Irvine Dermatology Research Center|Sergei A. Grando|949 824 7103|sgrando@uci.edu|
20200873|NCT04130646|Medical University of South Carolina|Associate Professor-Faculty|(843) 792-6076|badran@musc.edu|
20200874|NCT06118385|Benevolent|Judit Molnar, MD, PhD|+44 20 3781 9360|judit.molnar.md@benevolent.ai|
20200875|NCT02411448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200876|NCT01848145|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
20200877|NCT01577238|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
20200878|NCT03624946|Emergent BioSolutions Canada Inc.|Jason Richardson, Senior Scientist, Clinical Research|204-275-4266|jrichardson@ebsi.com|
20200879|NCT01728779|Johns Hopkins University|Dana Kaplin|410-614-3950|dkaplin1@jhmi.edu|
20200880|NCT00624520|Department of Veterans Affairs|Dr Douglas C Russell|608-256-1901|Dcrussel@facstaff.wisc.edu|
20200881|NCT02002702|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20200882|NCT00701714|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20200883|NCT01950819|Novartis Pharma|Study Director|8627788300|Novartis.email@novartis.com|
20200884|NCT00781365|HealthPartners Institute for Education and Research|Dr. Karen Margolis, MD MPH|952-967-7301|karen.l.margolis@healthpartners.com|
20200885|NCT02649634|University of Calgary|Dr. Kristin von Ranson|403.220.7085|kvonrans@ucalgary.ca|
20200886|NCT00238264|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20200887|NCT01662648|Janssen China|Regional Medical Franchis Director AP|+86 10 582 187 66||
20200888|NCT01261559|University of Washington|Dr. Claire Sandstrom|206-744-3561|cks13@uw.edu|
20200889|NCT02928952|VAPHS, Center for Heath Equity Research and Promotion|Monica DiNardo PhD, Primary Investigator|412 360-2262|monica.dinardo@va.gov|
20200890|NCT01850615|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20200891|NCT00974220|Queen's University, Kingston, ON, Canada|Dr. Denis O'Donnell|1-613-548-2339|odonnell@queensu.ca|
20200892|NCT00706628|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200893|NCT03403400|Advent Health|Amie Jasper|407-303-8626|amiemarie.jasper@adventhealth.com|42
20200894|NCT00989989|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
20200895|NCT02284165|Duke Clinical Resarch Institute|Janet Prvu Bettger, ScD|617-901-0277|janet.bettger@duke.edu|
20200896|NCT02266433|New York University School of Medicine - Division of Hand Surgery|Anthony Sapienza, MD / Assistant Professor|212 737 3301|Anthony.Sapienza@nyulangone.org|
20200897|NCT00565617|Medical University of South Carolina|Gregory Sahlem|843-792-5716|sahlem@musc.edu|
20200898|NCT02678429|VUMC|Fenna Phibbs|614-936-0060|fenna.phibbs@vumc.org|
20200899|NCT00125034|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
20200900|NCT01512264|Universtiy of Alabama at Birmingham|Dr. Jerzy P. Szaflarski|205.975.5587|jszaflarski@uabmc.edu|
20165238|NCT00795704|University of Mississippi Medical Center|Daniel Riche|601-984-2640|driche@umc.edu|
20200901|NCT01194440|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|HopkinsBreastTrials@jhmi.edu|
20200902|NCT00854828|Washington University|Keith H. Bridwell, MD|314-747-2655|bridwellk@wustl.edu|
20200903|NCT01931059|Northwell Health|Dr. Miklos Argyelan|718-470-8175|margyela@northwell.edu|
20200904|NCT02675075|James A. Haley VA Hospital|Dr. Sam Phillips|813 558 3995|samuel.phillips@va.gov|
20200905|NCT02292212|Asahi Kasei Medical Co., Ltd.|Masaharu Aritomi, Ph.D.||aritomi.mb@om.asahi-kasei.co.jp|
20200906|NCT02411747|Copenhagen Academy for Medical Education and Simulation, Rigshospitalet, Copenhagen University Hospital|Dr. Sarah Bube, director of the CYSTOSIM project|+4561339183|sarahbube@gmail.com|
20200907|NCT02149810|London Health Sciences Centre|Dr. Akshya Vasudev|519-685-8500|akshya.vasudev@lhsc.on.ca|75504
20200908|NCT01176916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200909|NCT00675597|Memorial Sloan Kettering Cancer Center|Dr. Mark G. Kris|646-888-4205|Krism@mskcc.org|
20200910|NCT01014403|UT Southwestern Medical Center|Dr. Herb Phelan|214-648-6841|herb.phelan@utsouthwestern.edu|
20200911|NCT00705263|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20200912|NCT02730260|Washington University School of Medicine|Dr. Walton Sumner|314-454-8164|wsumner@dom.wustl.edu|
20200913|NCT02440581|University of Kentucky|Division Administrator|859-218-4943|daniel.ormond@uky.edu|
20200914|NCT01285427|Life Technologies|Deanna Vella, Staff Regulatory Engineer|760-918-3000|deanna.vella@lifetech.com|
20200915|NCT05032950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200916|NCT02959814|Skejby University Hospital, Denmark|Niels Ramsing Holm, MD|004526849066|Niels.holm@clin.au.dk|
20200917|NCT01245673|University of Pennsylvania|Liz Veloso|215|eveloso@pennmedicine.upenn.edu|
20165239|NCT01300728|Sutter Neurology Medical Group|Shawn Kile, MD|(916) 454-6850|KileS@sutterhealth.org|
20165240|NCT01247324|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20165241|NCT01486966|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20165242|NCT03125226|University of Washington School of Medicine|Dr. Jing Zeng|2065985998|jzeng13@uw.edu|
20165243|NCT00301808|Barbara Ann Karmanos Cancer Institute|Shrish Gadgeel, M.D.|(313) 556-8820|sgadgee1@hfhs.org|
20165244|NCT01607957|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20165245|NCT04570930|University of Michigan|Dr. Noelle E Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
20165246|NCT04972786|University of New Mexico|Dr. Jeremy Hogeveen|773-941-2182|jhogeveen@unm.edu|
20200918|NCT03404648|Mayo Clinic|Dr. Ming Yang|480-342-0988|Yang.Ming@mayo.edu|
20200919|NCT01784796|Edward Hines VA Hospital|Karen Saban, PhD|708-202-5264|Karen.Saban@va.gov|
20200920|NCT05243628|Mannkind Corporation|Jennifer Pleitez, Director of Clinical Operations|818-661-5032|endocrineresearch@mannkindcorp.com|
20200921|NCT03120832|Senseibio|Ramzi Melhem MD Medical Director|9168336928|rmelhem@senseibio.com|
20200922|NCT01078805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20200923|NCT03641560|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20200924|NCT03219164|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20200925|NCT02689492|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200926|NCT02732951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20200927|NCT01750918|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20200928|NCT04585763|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
20200929|NCT02828267|Duke University Medical Center|Catherine Staton|9196845537|catherine.staton@duke.edu|
20200930|NCT00961532|Northwestern Medicine|Andrew M Naidech|312-503-3335|a-naidech@northwestern.edu|
20200931|NCT02010203|Clinical Development|Lori McDermott|9197948950|lmcdermott@heatbio.com|9197948950
20200932|NCT05047523|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
20200933|NCT00008385|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
20200934|NCT00582556|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
20200935|NCT01993888|Ethicon, Inc.|Senior Director of Ethicon Clinical R&D|908-218-2492|jbatill2@its.jnj.com|
20200936|NCT01341457|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20200937|NCT00999830|HOPITAL DE PURPAN Service Hematologie|Dr Michel ATTAL|+33 (0)5.61.77.77.84|attal.m@chu-toulouse.fr|
20200938|NCT04647110|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200939|NCT04486560|Johns Hopkins University|Dr. Lonny Yarmus|410-502-5224|lyarmus@jhmi.edu|
20200940|NCT01719757|Suyoun Yang|CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
20200941|NCT02626338|AROG Pharmaceuticals Inc.|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20200942|NCT01910792|Vitamin D, Skin, and Bone Research Laboratory|Dr. Michael F Holick|6176384546|mfholick@bu.edu|
20200943|NCT06415305|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
20200944|NCT00103012|National Institutes of Health, Clinical Center, Department of Pharmacy|Scott Penzak|301-496-2997|spenzak@cc.nih.gov|
20200945|NCT03051633|Colorado State University|Dr. Meghan Crabtree|2105875584|meghan.crabtree@colostate.edu|
20200946|NCT05211336|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20200947|NCT01790490|NYSPI|Elias Dakwar, MD|(646) 774-8728|dakware@nyspi.columbia.edu|
20200948|NCT00393718|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20200949|NCT04271761|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|3105
20200950|NCT01084551|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20200951|NCT03902080|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
20200952|NCT03575104|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
20200953|NCT04684420|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151 72 5200|service@emdgroup.com|
20200954|NCT00463476|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20200955|NCT01989130|University of California-Davis|Larissa May, MD|916-736-5010|lsmay@ucdavis.edu|
20200956|NCT00434967|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20200957|NCT00928070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200958|NCT00544830|City of Hope|Dr. Cy Stein|626-359-8111||
20200959|NCT01963481|NYU Langone Health|Sylvia Adams|212 731 5795|Sylvia.Adams@nyulangone.org|
20200960|NCT01551693|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
20200961|NCT04134494|BIDMC|Roger Lefevre|6176674070|rlefevre@bidmc.harvard.edu|
20200962|NCT02849639|University of Kentucky|Daniela C Moga MD PhD, Associate Professor|859-323-9682|daniela.moga@uky.edu|
20200963|NCT01756456|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20200964|NCT01838044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200965|NCT03709602|Duke University|Dr. Lisa Mansfield|919-681-9198|lisa.mansfield@duke.edu|
20200966|NCT02658812|UT MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD-Professor Breast Medical Oncology|713-792-8754|nueno@mdanderson.org|
20165247|NCT03905096|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165248|NCT01943344|Vivasure Medical|Dr Chris Martin|+353 9 395 440|chris.martin@vsuremed.com|
20165249|NCT05460754|Montana State University|Dr. Mary P Miles|406 994-6678|mmiles@montana.edu|
20165250|NCT02994108|Florida State University College of Medicine|Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
20165251|NCT00904969|American Medical System|Laura Olson, Clinical Project Manager|952-930-6000|laura.olson2@bsci.com|
20165252|NCT04396756|Pliant Therapeutics, Inc.|Gregory P. Cosgrove, MD, Vice President, Clinical Development|1-650-481-6770|GCosgrove@pliantrx.com|
20165253|NCT03406377|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20165254|NCT00574197|Cedars-Sinai Medical Center|Ernst Schwarz, MD, PhD|(310) 840-7089|Ernst.Schwarz@cshs.org|
20200967|NCT03400800|Novartis|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
20165255|NCT00558142|University of Edinburgh|Prof M Eddleston|01312426776|m.eddleston@ed.ac.uk|
20200968|NCT01859247|The University of New Mexico Health Sciences Center|Dr. Sarah Pirio Richardson, MD|505-272-3342|spiriorichardson@salud.unm.edu|
20200969|NCT01282229|Millenium Dental Technologies, Inc|Dr. David Harris|510-502-3345|dharris@LANAP.com|
20200970|NCT00896532|Amgen Inc.|Study Director|866-572-6436||
20200971|NCT01671280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20200972|NCT03686969|CRMG|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
20200973|NCT03219073|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
20200974|NCT02238847|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
20200975|NCT01988090|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
20200976|NCT01734317|Mölnlycke Health Care|Joan Wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
20200977|NCT04870671|Eastern Virginia Medical School|Dr. Terry Jacot|757-446-7056|jacotta@evms.edu|
20200978|NCT01083667|HSS/WCMC|Dale Lange|6467978917|langed@hss.edu|
20200979|NCT03887130|Pierre Fabre|Gustavo Villanova M.D|+33149108265|gustavo.villanova@pierre-fabre.com|
20200980|NCT01468987|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20200981|NCT03430986|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20200982|NCT03257189|MC10 Inc|Chief Medical Officer|8572145600|ACombs@mc10inc.com|
20200983|NCT00299988|Weill Cornell Medical College|Norman Relkin, MD, PhD|212-746-9882|nrelkin@med.cornell.edu|
20200984|NCT00961961|UPenn|Dr. Robert J. DeRubeis|215-573-5804|derubeis@psych.upenn.edu|
20200985|NCT02153099|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20200986|NCT04722991|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20217874|NCT03647046|University of Rochester|Study Coordinator|(585) 276-6922|keratoconusstudy@gmail.com|
20165256|NCT00755183|Andover Eye|Dr. Mark Abelson|9784750705||
20165257|NCT00809185|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|216-445-9354|advania@ccf.org|
20165258|NCT00804908|AbbVie|Global Medical Information|800-633-9110||
20165259|NCT02047032|Gunang'anmen Hospital|Zhishun Liu|86 88002331|liuzhishun@aliyun.com|
20165260|NCT02118584|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20165261|NCT04386291|NYS Psychiatric Institute|Dr. Brian A Fallon|646-774-8052|baf1@cumc.columbia.edu|
20165262|NCT00989911|Ahamanson/UCLA ACHDC|Dr. Jamil Aboulhosn|3108255950|jaboulhosn@mednet.ucla.edu|
20165263|NCT00671658|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD./ Chair|713-792-7026|eharriso@mdanderson.org|
20165264|NCT02918370|UT Southwestern|E. Sherwood Brown MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
20165265|NCT00322855|University of New Mexico|Christine M. Gan, Ph.D|5059250387|cgan@salud.unm.edu|
20165266|NCT01680341|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20165267|NCT00499486|The Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins|Dr. Hidalgo||mhidalgo@cnio.es|
20165268|NCT03098641|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Philippe Ferry|+33 5 46 45 50 50|philippe.ferry@ch-larochelle.fr|
20165269|NCT03796728|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20165270|NCT04205240|The Ohio State University Comprehensive Cancer Center|Dr. Srinivas Devarakonda|614-293-3196|Srinivas.Devarakonda@osumc.edu|
20165271|NCT02476617|AbbVie|Global Medical Services|800-633-9110||
20165272|NCT01383928|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20165273|NCT05467007|The George Washington University|Dr. Andrew C. Meltzer|202-741-2952|Ameltzer@mfa.gwu.edu|
20165274|NCT01263769|UT MD Anderson Cancer Center|Dr. Jose Karam, MD, Associate Professor, Urology|(713) 745-0374|jakaram@mdanderson.org|
20165275|NCT01346358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20165276|NCT05058365|The University of Hong Kong|Professor Lam Shui-fong|85239172388|lamsf@hku.hk|
20165277|NCT05444855|Children's Mercy Hospitals and Clinics|Melissa Miller MD|816234300|mmiller@cmh.edu|
20165278|NCT00702702|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
20165279|NCT00551759|ECOG Statistical Office|Study Statistician|617-632-3012||
20165280|NCT01667900|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20165281|NCT01283555|PATH|Jessica Cohen|206-285-3500|jcohen@path.org|
20165282|NCT02954536|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
20165283|NCT00568022|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20165284|NCT03025282|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20165285|NCT00685165|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20165286|NCT01377584|University of Pittsburgh|Faith Luyster, PhD|412-624-7910|fsl3@pitt.edu|
20165287|NCT01576341|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
20165288|NCT01844765|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20165289|NCT03218384|NYU Langone Health|Stuart Katz, MD|2122633946|Stuart.Katz@nyulangone.org|
20165290|NCT03914417|Icahn School of Medicine at Mount Sinai|Dr. Sharon Rose|212-241-3288|sharone.rose@gmail.com|
20165291|NCT01897025|National University Hospital|Dr Effie Chew|65-67726198|effie_chew@nuhs.edu.sg|
20165292|NCT03836625|Vanderbilt University|Kate Clouse|(615) 343-5351|kate.clouse@vanderbilt.edu|
20200987|NCT03186989|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
20165293|NCT00310765|retired|Dr. Ann Silverman||anngimd@icloud.com|
20165294|NCT03361137|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20165295|NCT00791934|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
20165296|NCT00829738|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20165297|NCT03413891|University Hospitals Leuven|Mrs. Barbara Debaveye|003216 341463|barbara.debaveye@uzleuven.be|
20200988|NCT03057795|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
20200989|NCT01370460|Henry Ford Health System|Andrew Georgiadis, MD|313-916-7520|ageorgi1@hfhs.org|
20200990|NCT02246621|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20200991|NCT04152824|Oregon Health & Science University|Dr. Leslie Hammer|503-494-9313|hammerl@ohsu.edu|
20200992|NCT01292057|Medical University of South Carolina|Joseph Schacht, Ph.D.|(843) 792-7497|schacht@musc.edu|
20200993|NCT01459614|Sidney Kimmel Comprehensive Cancer Center|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
20200994|NCT04451707|Groupe Hospitalier La Rochelle Ré Aunis|Dr Florence Hoefler|+330546455050|florence.hoefler@ch-troyes.fr|
20200995|NCT02587338|Universitätsklinikum Würzburg|Prof. Dr. Martin Herrmann|+4993120176650|Herrmann_m@ukw.de|
20200996|NCT00630331|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20200997|NCT01302808|UT Southwestern Medical Center|David Gerber, MD|2146484180|david.gerber@utsouthwestern.edu|
20200998|NCT06120530|Indiana University School of Medicine|Jose Lazaro|7274241947|jlazarow@iu.edu|
20200999|NCT02425098|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20201000|NCT02078219|Study Information Center AstraZeneca|Fredrik Erlandsson, MD|+1 877-240-9479|information.center@astrazeneca.com|
20201001|NCT03036527|University of Louisville|Charles Hubscher|502-852-3058|charles.hubscher@louisville.edu|
20201002|NCT02761967|University of Granada|Dr. Rodríguez-Blanque|+34644322567|rarobla@gmail.com|
20155941|NCT00590317|Emory University|Dr. Daniel Wu|(404) 251-8875|dtwu@emory.edu|
20155942|NCT01428635|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD./Professor|713-563-1586|GBorthak@mdanderson.org|
20155943|NCT05170061|SUNYBuffalo|Joseph Izzo MD|7168985625|jizzo@buffalo.edu|
20155944|NCT03443401|USouthDakota|Kory Zimney, PhD|6056586373|kory.zimney@usd.edu|
20155945|NCT02363283|UT MD Anderson Cancer Center|Dr. Sapna Pradyuman Patel,MD/ Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
20155946|NCT02257138|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani|713-745-0394|fravandi@mdanderson.org|
20155947|NCT03676270|Institut Bergonié|Pr Antoine Italiano|335 56333333|a.italiano@bordeaux.unicancer.fr|
20155948|NCT01394185|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
20155949|NCT05401409|Westmead Hospital and Westmead Institute for Medical Research|Prof Gopala Rangan|8627 3000|g.rangan@sydney.edu.au|
20155950|NCT02371889|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-746-1943|kranzler@pennmedicine.upenn.edu|
20155951|NCT05520333|RTI International|Nisha Gottfredson O'Shea|9192481826|nishaoshea@rti.org|
20155952|NCT02410200|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20155953|NCT00866775|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
20155954|NCT05538728|Galderma Research and Development, LLC|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
20155955|NCT01034657|Novartis|Study Director|862-778-8300||
20155956|NCT00781898|University Of Pennsylvania|Charle P. O'Brien|215-222-3200|obrien@mail.med.upenn.edu|
20155957|NCT03992872|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_NA@bavarian-nordic.com|
20155958|NCT03446690|University of Alabama at Birmingham|Chung How Kau|205-934-1289|ckau@uab.edu|
20155959|NCT00889005|New York Langone Medical Center Department of Psychiatry|Arieh Y. Shalev, M.D.|6467544782|arieh.shalev@nyumc.org|
20155960|NCT00612768|SmartPractice|Kathy Shannon|602-225-0595|kshannon@smarthealth.com|7208
20155961|NCT03704922|University of North Carolina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.Karafin@unchealth.unc.edu|
20155962|NCT01132690|Protalix Biotherapeutics|Senior VP Development|+972-4-902-8100|einat@protalix.com|
20155963|NCT00756314|IMIP - Instituto Materno Infantil Prof. Fernando Figueira|Ana Laura Carneiro Gomes Ferreira - MD|+558121224779|analaura@imip.org.br|
20155964|NCT04629157|Alder Hey Children's NHS Foundation Trust|Miss Rachel Harwood|0151 228 4811|rachel.harwood@alderhey.nhs.uk|
20155965|NCT02872142|Grifols Bioscience Industrial Group|Michael Woodward|+34 938008784|michael.woodward@grifols.com|
20155966|NCT02605967|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20155967|NCT03956082|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|DAVID.LEVINE@MERCY.NET|
20155968|NCT01903720|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20155969|NCT04019704|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20155970|NCT03627468|Botanix Pharmaceuticals|Anthony Robinson, MS, MBA, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20155971|NCT05122143|Altamira Medica Ltd.|Thomas Meyer|0041 61 201 13|ra@altamiramedica.com|50
20155972|NCT00309946|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
20155973|NCT02244957|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|
20155974|NCT02579057|Johns Hopkins Hospital|Stuart Russell MD|4109555708|srusse14@jhmi.edu|
20155975|NCT00395447|BIOTRONIK, Inc|Crystal Miller, Clinical Studies Engineer|503-451-8051|crystal.miller@biotronik.com|
20155976|NCT02090894|Indiana University School of Medicine|Dr. Ally-Khan Somani|317-944-7744|somania@iupui.edu|
20155977|NCT03111108|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20155978|NCT01853280|Massachusetts General Hospital|Dr. Craig Surman|617-726-8422|csurman@partners.org|
20155979|NCT00104884|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20155980|NCT03032484|University of Texas Health San Antonio|Andrew Brenner, MD|210-562-4090|brennera@uthscsa.edu|
20155981|NCT01689649|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
20155982|NCT03492385|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
20155983|NCT03760081|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20155984|NCT04064567|University of Arkansas for Medical Sciences|Director, Research Programs|501-686-6427|hkhorton@uams.edu|
20201003|NCT03283085|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20201004|NCT03136107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201005|NCT02292771|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201006|NCT01468311|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|gconlonkc@mail.nih.gov|
20201007|NCT00110305|Janssen-Virco BE|Director|32 14 641418||
20201008|NCT03338556|PrEP Biopharm Limited|Chief Medical Officer|8666207176|info@prepbiopharm.com|0
20201009|NCT01495819|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20201010|NCT00224016|Watson Laboratories, Inc|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20201011|NCT03021577|Columbia University Irving Medical Center|Ziad A. Ali, MD Assistant Professor of Medicine|212-305-7060|zaa2112@cumc.columbia.edu|
20201012|NCT01524991|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
20201013|NCT01805180|Terumo BCT|Raymond P. Goodrich, PhD / VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|303.205.2680|Ray.Goodrich@terumobct.com|
20201014|NCT01922921|University of Washington|Director of Clinical Operations|2066162305|childj@u.washington.edu|
20201015|NCT04574999|Italfarmaco|Dr. Concepción Nieto|+34 91 657 23 23|cnieto@itfsp.com|
20201016|NCT00391599|Edith Wolfson Medical Center|Investigator|+972-35028329|lurie@wolfson.health.gov.il|
20201017|NCT03631927|Tata Memorial Hospital|Dr. Jigeeshu Divatia|+919869077435|jdivatia@yahoo.com|
20201018|NCT00206726|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20201019|NCT04646148|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
20201020|NCT05148884|Neurolixis|Adrian Newman-Tancredi, PhD, DSc, CEO|(+33) 605 14 09 64|contact@neurolixis.com|
20201021|NCT00595231|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
20201022|NCT00365989|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20201023|NCT01676831|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|deborah.leahy@uphs.upenn.edu|
20201024|NCT00832819|Eisai Co., Ltd.|Wataru Yusa|+81 3-3817-5252||5252
20201025|NCT00317044|AstraZeneca|ClinicalTrialTransparency||ClinicalTrialTransparency@astrazeneca.com|
20201026|NCT02318095|Regulatory Coordinator|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
20201027|NCT01717638|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20201028|NCT01901224|Brigham and Women's Hospital|Mark A. Creager, MD|603-650-8283|mark.a.creager@hitchcock.org|
20201029|NCT02300129|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
20201030|NCT04801758|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20201031|NCT00522392|ECOG Statistical Office|Study Statistician|617-632-3012||
20201032|NCT00687453|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20201033|NCT00430755|Robert-Bosch-Hospital|Prof. Dr. Mark Dominik Alscher|+4971181013496|dominik.alscher@rbk.de|
20201034|NCT00970606|Vanderbilt University Medical Center|Gordon R. Bernard, MD, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@vanderbilt.edu|
20217875|NCT00918463|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
20217876|NCT01784666|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
20217877|NCT01014624|Daiichi Sankyo, Inc.|Brian Baker|973-944-2712|bbaker@dsi.com|
20217878|NCT02834806|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
20217879|NCT03465748|Illinois College of Optometry|Dr. Yi Pang|3129497287|YPang@ico.edu|
20217880|NCT02596321|Abbott|Therapeutic Area Clinical Director|+31294477008|dmitri.kazei@abbott.com|
20217881|NCT01231750|University of Cincinnati|Dr. Faisal Khan|513-558-4272|faisal.khan@uc.edu|
20217882|NCT01117337|Moulana Hospital|Mohamed Ismail, Chief Consultant, Moulana Hospital, Perianthalmanna|0091-9447128511|drgargpankaj@yahoo.com, mdismail13@gmail.com|
20217883|NCT01045993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20217884|NCT01659736|The Institute of Living|Gretchen J. Diefenbach, Ph.D|860-545-7685|Gretchen.Diefenbach@hhchealth.org|
20217885|NCT00391079|GW Pharmaceuticals|Richard Potts Clinical Operations Director|+44 1223 266800|rp@gwpharm.com|
20217886|NCT01004042|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
20217887|NCT00276549|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
20217888|NCT00474851|Boston Children's Hospital|Dr. Amy D. DiVasta|617-355-3792|Amy.DiVasta@childrens.harvard.edu|
20217889|NCT01746264|Mayo Clinic|Dr. Seema Kumar|507-538-2724|Kumar.Seema@mayo.edu|
20217890|NCT02791893|Mount Sinai Beth Israel, New York, NY|Dr. Benjamin Natelson|212-844-6768|Benjamin.Natelson@mountsinai.org|
20217891|NCT01570283|Center for Cell and Gene Therapy|Dr. Helen Heslop|832-824-4662|heheslop@txch.org|
20217892|NCT04051463|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
20155985|NCT03689179|University of Utah|Rebecca Utz|801 699 5685|rebecca.utz@utah.edu|
20155986|NCT05524948|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
20155987|NCT05155085|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20155988|NCT02758626|NYU Langone Health, Comprehensive Epilepsy Center|Orrin Devinsky, MD|6465580803|Orrin.Devinsky@nyulangone.org|
20155989|NCT02739828|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20155990|NCT01722734|Harvard School of Public Health|Dr Günther Fink|6174327389|gfink@hsph.harvard.edu|
20155991|NCT01837550|Sodra Alvsborg, Hearing Organisation|Milijana Malmberg, PhD student|0046 703 80 36 63|milijana.lundberg.malmberg@vgregion.se|
20155992|NCT01971593|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
20155993|NCT01682720|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20155994|NCT01307618|University of Chicago Comprehensive Cancer Center|Tomas Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
20201035|NCT02472457|The Children's Hospital of Philadelphia|Ronen Stein, MD|215-590-7801|ibdresearch@email.chop.edu|
20165298|NCT04905134|Duke University|Walter T. Lee, MD, MHS|919-613-6407|walter.lee@duke.edu|
20165299|NCT03009058|Immodulon Therapeutics Ltd|Chief Medical Odfficer|+44 (0)20 3137 6346|info@immodulon.com|
20165300|NCT03221556|Boston Medical Center|Caroline Kistin, MD MSc|(617) 414-3638|caroline_kistin@brown.edu|
20165301|NCT04760782|University of Vermont|Dr. David Lunardini|(802) 847-2663|david.lunardini@uvmhealth.org|
20165302|NCT02234843|Therapeutic Area Head|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20165303|NCT02787564|University of Hohenheim|Prof. Dr. Nanette Ströbele-Benschop|+49711 459 24260|N.Stroebele@uni-hohenheim.de|24260
20165304|NCT00506350|GlaxoSmithKline|GSK Response Center|866-435-7343||
20187653|NCT02846545|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187654|NCT06468982|Atatürk University|Dr. Ümit Arslan|05418209007|kvcumit@gmail.com|
20187655|NCT04181736|Stanford University|Laura Hack, MD, PhD|650-724-7478|lhack@stanford.edu|
20187656|NCT05080283|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
20187657|NCT03993392|Indivior, Inc|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
20187658|NCT03995979|University of Florida|Dr. Salvatore Scali|(352) 376-1611|salvatore.scali@surgery.ufl.edu|
20187659|NCT05654662|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20187660|NCT05962814|Bionics Institute|Prof Colette McKay|+61 408698202|cmckay@bionicsinstitute.org|
20187661|NCT03057054|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20187662|NCT00696124|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20187663|NCT06262477|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20187664|NCT01064440|Helixmith, Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20187665|NCT04108130|Columbia University Medical Center|Dr. Marcos F. Vidal Melo|2123424799|mv2869@cumc.columbia.edu|
20187666|NCT05507333|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
20187667|NCT03426891|Moffitt Cancer Center|Dr. Peter Forsyth|813-745-3063|Peter.Forsyth@moffitt.org|
20187668|NCT05365958|University of Houston|Dr. Chakema Carmack, Ph.D., Associate Professor|713-743-6231|ccarmack@central.uh.edu|
20187669|NCT05247034|Universidad Anáhuac México Norte|Dr. Carlos Alberto Cuéllar Ramos|5556270210|carlos.cuellarra@anahuac.mx|8736
20187670|NCT03489122|VA Bedford Healthcare System|Administrative Officer/R&D|781-687-2903|karen.smith9@va.gov|
20187671|NCT05176093|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20187672|NCT04136912|UNC Lineberger Comprehensive Cancer Center|Desma Jones|(919) 843-9463|desma_jones@med.unc.edu|
20187673|NCT04615273|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650-461-4835|ads@ascendispharma.com|
20187674|NCT03018366|Mayo Clinic|Dr. Chrisandra Shufelt|904-953-7224|shufelt.chrisandra@mayo.edu|
20187675|NCT03154190|Stanford University School of Medicine|Manali Patel|650-723-4000|manalip@stanford.edu|
20187676|NCT04999111|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187677|NCT03169972|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20187678|NCT03931408|University of Louisville|Dr. Harkema|502-582-7676|lori.clark2@louisville.edu|
20187679|NCT02437136|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
20187680|NCT01314105|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187681|NCT02056834|Synthes GmbH|Clinical Research Scientist Biomaterials|0041327204465|clinicalaffairs.emea@synthes.com|
20187682|NCT04117178|Department of Neurology, Zealand University Hospital|Michael Fischer|+4547322800|mihh@regionsjaelland.dk|
20187683|NCT04312841|The Ohio State University Comprehensive Cancer Center|Dr. John Reneau|614-293-3196|John.Reneau@osumc.edu|
20187684|NCT04526886|Dartmouth Hitchcock Medical Center|Gabriel Brooks|(603) 650-4344|gabriel.a.brooks@hitchcock.org|
20187685|NCT05482360|University of Washington|Anjuli Wagner, PI|978 460 2331|anjuliw@uw.edu|
20187686|NCT03980925|MFAR Clinical Research|Federico Nepote|+34 93 434 44 12|investigacion@mfar.net|
20187687|NCT05130814|Emoled srl|Duccio Rossi Degl'Innocenti|+390550751960|d.rossi@emoled.com|
20187688|NCT04227288|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
20187689|NCT03174275|University of North Carolina Lineberger Comprehensive Cancer Center|Dr. Jared Weiss|+1 919-843-7718|jared_weiss@med.unc.edu|
20187690|NCT03484819|Mayo Clinic|Nora Bennani, M.D.|(507) 284-2511|bennani.nora@mayo.edu|
20187691|NCT05970861|Asfendiyarov Kazakh National Medical University|Prof. Abdugani Musayev|+77772509406|musaev.dr56@gmail.com|
20187692|NCT04456296|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
20187693|NCT02990338|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20187694|NCT04186819|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
20187695|NCT05900154|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187696|NCT03655080|Washington University School of Medicine|Hiram A. Gay, M.D.|314-362-8516|hiramgay@wustl.edu|
20187697|NCT02905331|Janssen Research & Development, LLC|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187698|NCT05408663|Extend Biosciences|Laura Hales PhD|(732) 599-8581|lhales@extendbio.com|
20187699|NCT04102111|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187700|NCT02542631|Johnson & Johnson Diabetes Companies|Brian Levy, MD-Chief Medical Officer|484 328-6128|BLevy1@its.jnj.com|
20187701|NCT03334695|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187702|NCT02938923|Washington University in St. Louis School of Medicine|Dr. Ellen F. Binder, Professor of Medicine and Occupational Therapy|314-286-2707|ebinder@wustl.edu|
20187703|NCT01240122|Abbott Medical Optics|Senior Manager, Clinical Research|714.247.8723|eugenia.kao@amo.abbott.com|
20155995|NCT04204902|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20155996|NCT02202577|Virginia Commonwealth University Health System|Edward H Springel, MD|804-828-8468|edward.springel@vcuhealth.org|
20155997|NCT00214526|Boston Scientific Corporation|Mark G. Grubb|412-749-1423|Mark.Grubb@bsci.com|
20155998|NCT04754399|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20155999|NCT00025233|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20156000|NCT00507507|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20156001|NCT02916433|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
20156002|NCT03708770|Becton Dickinson (BPV)|Courtney Rothwell|480.350.6037|courtney.rothwell@bd.com|
20156003|NCT01694771|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20156004|NCT00974233|University of Wisconsin|Julie E. Chang, MD|608-262-3970|jc2@medicine.wisc.edu|
20156005|NCT04616196|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20156006|NCT06844812|mazhar osman mental and nervous diseases hospital|Dr. Enes Faruk ALTUNKILIÇ|+905077362191|enesfarukaltunkilic@gmail.com|
20156007|NCT04255381|Yale University|Dr. Stuart Weinzimer|203-785-5831|stuart.weinzimer@yale.edu|
20156008|NCT04565353|Behavior Change for Good initiative|Dr. Joseph Kay|2157466609|jskay@wharton.upenn.edu|
20156009|NCT06151418|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20156010|NCT02593630|University of New England|Peter S. Millard, MD, Phd|2072992131|pmillard@mac.com|207
20156011|NCT00003907|ECOG Statistical Office|Study Statistician|617-632-3012||
20156012|NCT02336555|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156013|NCT00993473|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
20156014|NCT01630109|Genesys Regional Medical Center Office of Research|Dr. Steven Brooks|8106067722|Steven.Brooks@genesys.org|
20156015|NCT02790736|NY State Psychiatric Institute|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
20156016|NCT01085903|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|501 526 7773|msmennemeier@uams.edu|
20156017|NCT03682367|UC Davis Health|Arnaud Bewley|9167342704|abewley@ucdavis.edu|
20156018|NCT04157738|Emory University|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
20156019|NCT00160563|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20156020|NCT02118831|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
20156021|NCT03232892|University of California, San Francisco|Dr. Collin Blakely, MD PhD.|(415) 502-6959|Collin.Blakely@ucsf.edu|
20156022|NCT03766906|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
20156023|NCT01514357|Mayo Clinic|Dr. John C. Burnett|507-284-7932|burnett.john@mayo.edu|
20156024|NCT00752219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156025|NCT02811419|University of California San Francisco|Trilokesh Kidambi|909-973-0629|tkgastromd@gmail.com|
20156026|NCT04691115|AnaMar AB|Chief Medical Officer|+46 (0)46-275 60 00|info@anamar.com|
20156027|NCT01514279|School of Medicine, Case Western Reserve University|Dr. Elaine Borawski, PhD|216)368-1024|exb11@case.edu|
20156028|NCT05898178|Maribor University Medical Centr|Borut Kovačič||Borut.KOVACIC@ukc-mb.si|0038631211
20156029|NCT01586897|Massachusetts General Hospital|Steven J. Atlas, Director of Massachusetts General Primary Care Practice Based Research Network|617-724-4736|satlas@partners.org|
20156030|NCT04717479|University of Michigan|Sarah Yon|734-763-0412|shlim@umich.edu|
20156031|NCT03813121|Wake Forest University School of Medicine|Dr. Merideth Addicott|336-716-7792|maddicot@wakehealth.edu|
20156032|NCT04525183|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-362-2334|alexi_wright@dfci.harvard.edu|
20156033|NCT02542280|Ain Shams Maternity Hospital|Ahmed Bahaa|+20 1111700556|abahaa0503@yahoo.com|
20156034|NCT03777020|University of Maryland School of Nursing|Dr. Erika Friedmann|410 706 0659|friedmann@umaryland.edu|
20156035|NCT04439903|University of Virginia Center for Diabetes Technology|Patricio Colmegna, PhD|434-924-5592|pc2jx@virginia.edu|
20156036|NCT02899754|Philadelphia VA Medical Center (CMCVAMC), Philadelphia, PA|Dr. Marilyn M Schapira, Senior Investigator, Center for Health Equity Research & Promotion (CHERP)|215 898 2022|mschap@pennmedicine.upenn.edu|
20156037|NCT04818229|Connect Biopharma|Dr. Chin Lee, MD Chief Medial Officer|+1 650 676 9617|clee@connectpharm.com|
20156038|NCT03769116|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
20156039|NCT02181413|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20156040|NCT01512251|University of California, San Francisco|Alain Algazi|(415) 353-7552|alain.algazi@ucsf.edu|
20156041|NCT04003142|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20156042|NCT00890656|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
20156043|NCT01924065|Akdeniz Sifa Konyaalti Medical Center|Mehmet Ozaydin|905533354243|mehmetozaydin@hotmail.com|
20156044|NCT03657407|University of Maryland Medical Center|Anna Reinert, MD|6029089960|anna.reinert@gmail.com|
20156045|NCT04755231|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20156046|NCT02069184|Montefiore Medical Center|Jeffrey Bernstein|718-920-4317|JBernste@montefiore.org|
20156047|NCT01720602|University of Washington|Hannah Linden, MD|206-288-6989|hmlinden@u.washington.edu|
20156048|NCT03109769|Riyadh Colleges of Dentistry and Pharmacy|Omar Alkadhi|966505154754|omar.alkadhi@riyadh.edu.sa|
20165305|NCT03474588|Yale University Department of Psychiatry|Dr. Brian Kiluk, Ph.D.|203-737-1544|brian.kiluk@yale.edu|
20165306|NCT03902418|University of CApe Town|Landon Myer|0829430578|landon.myer@uct.ac.za|
20165307|NCT01691794|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20165308|NCT00844844|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc.||clinicaltrials@alxn.com|
20165309|NCT01001975|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20165310|NCT00945009|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20165311|NCT04886154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165312|NCT05305443|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
20165313|NCT03919773|UT Southwestern Medical Center|Dr. Steven Vernino|214-648-8816|steven.vernino@utsouthwestern.edu|
20165314|NCT04659044|Perlmutter Cancer Center at NYU Langone Health|Catherine Diefenbach M.D.|(212) 731-5670|Catherine.diefenbach@nyulangone.org|
20165315|NCT04966013|EmitBio Inc|Chief Medical Officer|919.321.1734|info@emitbio.com|
20201036|NCT01834235|Precision Biologics Inc.|Dr. Philip Arlen President and CEO|3015008646|philip.arlen@precision-biologics.com|
20201037|NCT02661594|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
20201038|NCT01169779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20201039|NCT00191854|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201040|NCT02348099|Gerontology Research Lab|Mr Boris Feldman, Research Associate|16048755115|boris.feldman@vch.ca|
20201041|NCT00556426|C.R. Bard|John Reviere, Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|
20201042|NCT04340050|University of Chicago|Leila Yazdanbakhsh|773-834-5087|leila.yazdanbakhsh@bsd.uchicago.edu|
20165316|NCT01740713|Consorzio per Valutazioni Biologiche e Farmacologiche|Clinical Research Coordinator|0039 0382 25075|mariagraziafelisi@cvbf.net|
20165317|NCT02336282|St. Jude Children's Research Hospital|Kevin Krull, PhD|(901) 595-5891|kevin.krull@stjude.org|
20165318|NCT04084171|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
20165319|NCT03563209|İzmir Katip Çelebi University, Faculty of Medicine|ilker şengül|05337333698|ilkrsngl@gmail.com|
20165320|NCT01404039|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526156|felipe.fregni@ppcr.hms.harvard.edu|
20165321|NCT04875975|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20165322|NCT02177695|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
20165323|NCT03904017|University of Colorado|Layne Dylla|303-724-1716|layne.dylla@cuanschutz.edu|
20165324|NCT00248625|University of Pittsburgh|Robert H. Squires, Jr.|412-692-8648|squiresr@upmc.edu|
20165325|NCT02464540|Federal University of Pelotas|Dr Noéli Boscato|5553999530000|noeliboscato@gmail.com|
20165326|NCT00976183|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
20165327|NCT00834977|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20165328|NCT05719311|Entero Therapeutics|VP, Regulatory, QA & Compliance|9194491484|AChandler@Enterothera.com|
20165329|NCT05176314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20165330|NCT05753449|Allegheny Health Network|Megan Hendricks, regulatory Specialist|412-330-6206|megan.hendricks@ahn.org|
20165331|NCT04204447|University at Buffalo|Andrew Talal|7168884737|ahtalal@buffalo.edu|
20165332|NCT03103542|Swedish Orphan Biovitrum AB|Medical Information|+468 6972000|medical.info@sobi.com|
20165333|NCT03557294|Arizona State University|Scott Leischow, PhD|602-496-3300|scott.leischow@asu.edu|
20165334|NCT02939287|Rush University Medical Center|Danielle Murphy, PharmD, BCOP, BCPS|3129472401|danielle_murphy@rush.edu|
20165335|NCT03402217|Ci3 at the University of Chicago|Ellen McCammon|773-834-8462|emccammon@bsd.uchicago.edu|
20165336|NCT02005549|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20165337|NCT00333775|Hoffmann-La Roche|Medical Communications|800 821-8590||
20165338|NCT03926208|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
20165339|NCT02968134|The University of Queensland|Prof. Jason Roberts|+61 7 3646 4108|j.roberts2@uq.edu.au|
20165340|NCT02491684|AstraZeneca|Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20165341|NCT01350947|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
20165342|NCT04739982|Stanford University|Kaiti Dunlap, Clinical Research Coordinator|650-497-9214|kdunlap2@stanford.edu|
20165343|NCT03651765|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20165344|NCT01349543|Imperial College London|Prof Peter JM Openshaw|07973820801|p.openshaw@imperial.ac.uk|
20165345|NCT02839096|University of Missouri School of Medicine|Research Success Core|(573) 817-3386|obgynresearchsuccesscore@health.missouri.edu|
20165346|NCT01500733|National Heart Lung and Blood Institute|Ahn, Inhye|+1 301 827 1203|inhye.ahn@nih.gov|
20165347|NCT03521570|Emory University|Nabil F. Saba MD, FACP|404-778-0278|nfsaba@emory.edu|
20165348|NCT03279081|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20165349|NCT00322881|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
20165350|NCT03496844|University of Arizona|Phillip Kuo, MD PhD|5206268318|pkuo@arizona.edu|
20165351|NCT05379179|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
20165352|NCT00771914|University of Rochester Division of Epidemiology, Department of Community and Preventive Medicine|Robert Block, MD, MPH, FACP|585-275-3356|robert_block@urmc.rochester.edu|
20165353|NCT01259063|Memorial Sloan Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|dalbagng@mskcc.org|
20165354|NCT00468169|University of Chicago|Everett E Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
20165355|NCT04372017|Sanford Health|Dr. Susan Hoover|605-328-8120|Susan.Hoover@sanfordhealth.org|
20165356|NCT01521117|Oregon Health & Science University|Amie Hiller, MD|503 721 1091|peterami@ohsu.edu|
20201043|NCT00486603|Adult Brain Tumor Consortium|Director of ABTC|410-955-3657|jfisher@jhmi.edu|
20165357|NCT01056822|Pharmaceuticals|Novartis|+1 (862) 778-8300||
20165358|NCT00784563|Veterans Affairs Medical Center of Iowa City|Ergun Y. Uc, MD|319-356-8753|ergun-uc@uiowa.edu|
20165359|NCT02946580|Massachusetts General Hospital|Dr. Kyle Staller|617-724-7556|kstaller@mgh.harvard.edu|
20165360|NCT01668784|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20165361|NCT03638453|Dana Farber Cancer Institute/Boston Children's Hospital|Dr. Kira Bona, MD, MPH|617-632-4688|kira.bona@childrens.harvard.edu|
20165362|NCT05135871|Shanghai LianBio Development Co., Ltd|Brianna Sun|+862123081188|brianna.sun@lianbio.com|
20165363|NCT00464698|Massachusetts General Hospital|Darin D. Dougherty, MD|617-724-6300|ddougherty@partners.org|
20165364|NCT02855281|Hospital Bethanien Solingen, Clinic of Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Solingen, Germany|Dr. Lars Hagmeyer|0212636004|institut@klinik-bethanien.de|
20165365|NCT00534365|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
20165366|NCT00374140|University of Pittsburgh|Ahmad Tarhini, MD, PhD|(412) 648-6578|tarhiniaa@upmc.edu|
20165367|NCT00617734|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20165368|NCT02485691|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20165369|NCT00604565|Rockwell Medical|Ajay Gupta, MD|248-960-9009|rd@rockwellmed.com|
20165370|NCT04756427|Washington University|Darla Shores|314-454-6173|shores@wustl.edu|
20165371|NCT04292535|Michigan State University|Matthew B. Pontifex|517-432-5105|pontifex@msu.edu|
20165372|NCT02747186|University of North Carolina at Chapel Hill|Raymond P. White Jr., DDS, PhD|919-537-3944|ray_white@unc.edu|
20165373|NCT03542812|University of Utah|Candice Fike|801-587-7804|candice.fike@hsc.utah.edu|
20165374|NCT01420861|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
20165375|NCT04076540|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20165376|NCT05010707|Washington University in St. Louis, School of Medicine|Thomas Baranski, MD, PhD|314-747-3997|baranski@wustl.edu|
20165377|NCT05472090|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
20165378|NCT03414983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20187704|NCT04984590|OnPoint Vision Inc.|Head of Clinical|949-688-0660|larcher@onpoint-vision.com|
20187705|NCT04583280|Janssen Research & Development LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187706|NCT04614948|Janssen Vaccines & Prevention B.V.|VICE PRESIDENT Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187707|NCT04129554|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187708|NCT01570361|Johnson & Johnson Medical N.V., Biosense Webster|Liesbeth Vanderlinden|+32 (0) 2 746 3446|lvanderl@its.jnj.com|
20187709|NCT05215613|Zimmer Biomet|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
20187710|NCT04633538|Oxford University Hospital|Dr Elizabeth Orchard|01865223084|elizabeth.orchard@ouh.nhs.uk|
20187711|NCT02938520|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20187712|NCT03245840|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20187713|NCT01116895|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20187714|NCT02518048|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
20187715|NCT06834490|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
20187716|NCT02585323|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
20187717|NCT01130883|Abbott|Global Medical Services|1-800-633-9110||
20187718|NCT04998305|Columbia University|Hiroshi Mitsumoto, MD|212-305-1319|hm264@cumc.columbia.edu|
20187719|NCT01880515|Instituto Nacional de Cancerología de México|Oscar Gerardo Arrieta Rodriguez|+52 1 55 56 28 04 00|ogar@unam.mx|71101
20187720|NCT03972150|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187721|NCT03505710|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
20187722|NCT05879991|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187723|NCT03981926|University of California, Los Angeles|April W. Armstrong, MD, MPH; Professor and Chief of Dermatology|424-365-4129|skinstudy@mednet.ucla.edu|
20187724|NCT06262347|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
20187725|NCT03677141|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20187726|NCT05465239|Barron Associates, Inc.|Jason Burkholder|434-973-1215|burkholder@bainet.com|
20187727|NCT06038708|BIOTRONIK Italy|Paola Napoli, Clinical Project Manager|3357369277|paola.napoli@biotronik.com|0039
20187728|NCT05423730|Beth Israel Deaconess Medical Center|Kenneth J Mukamal|617-754-1401|kmukamal@hsph.harvard.edu|
20187729|NCT03550170|Case Western Reserve University|Dr. Matthew Plow|216-368-8969|map208@case.edu|
20187730|NCT04536012|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
20187731|NCT04276935|Memorial Sloan Kettering Cancer Center|Dr. Thomas M. Atkinson|646-888-0089|atkinsot@mskcc.org|
20187732|NCT06106022|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20187733|NCT05015751|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
20187734|NCT04089865|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD, MBA|(212) 606-1206|memtsoudiss@hss.edu|
20187735|NCT04417998|Mayo Clinic|Bradley J. Kemp, Ph.D.|507-284-4399|Kemp.Brad@mayo.edu|
20187736|NCT02827838|Wake Forest Baptist Comprehensive Cancer Center|Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
20187737|NCT05850052|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
20187738|NCT04209595|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20187739|NCT03580356|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
20187740|NCT02834390|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20165379|NCT02608684|Cedars-Sinai Medical Center|Bobbie J. Rimel, MD|310-423-1126|Bobbie.Rimel@cshs.org|
20165380|NCT00751296|University Health Network - Princess Margaret Cancer Centre|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
20165381|NCT02958917|National Jewish Health|Dr. Evans Fernández|303-388-4461|fernandezevans@njheallth.org|
20165382|NCT00181168|Johns Hopkins Univ|Paul W. Ladenson, MD, Professor and PI|4109553663|ladenson@jhmi.edu|
20165383|NCT01775501|Massachusetts General Hospital|Dr. Lipika Goyal|617-724-4000|LGOYAL@PARTNERS.ORG|
20165384|NCT02318706|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
20165385|NCT01702311|Emory University|Guillermo Umpierrez, MD|404-778-1663|geumpie@emory.edu|
20165386|NCT02166346|Johns Hopkins University|Michael Levy, Principal Investigator|443-287-4412|mlevy@jhmi.edu|
20165387|NCT02670811|Centro de Investigación en Alimentación y Desarrollo, A.C.|Dr. Belinda Vallejo Galland|526622892400|vallejo@ciad.mx|365
20165388|NCT03714672|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
20165389|NCT02364700|New York University|Grace Kim PhD, OTR/L|121-998-5846|gjk207@nyu.edu|
20165390|NCT01054885|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165391|NCT01280903|University of Pittsburgh|Elizabeth A. Schlenk|412-624-4103|els100@pitt.edu|
20165392|NCT03453164|Fukushima medical university of medicine|Prof. Koji Kono|+81245471259|kojikono@fmu.ac.jp|
20165393|NCT00874510|Center for Health Incentives and Behavioral Economics|Kevin Volpp, MD, PhD|215.573-0270|volpp70@exchange.upenn.edu|
20165394|NCT01074502|UNC Chapel Hill|Aida Lugo-Somolinos MD-PI|919-843-9447|alugosom@med.unc.edu|
20165395|NCT01691534|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
20165396|NCT02220920|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20165397|NCT04945733|Janssen Pharmaceutical K.K.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20165398|NCT00726063|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
20165399|NCT02007096|Division of General Surgery, Department of Surgery, The Mount Sinai Medical Center|Dr. Celia M Divino|212-241-5499|Celia.Divino@mountsinai.org|
20165400|NCT01231984|Becton Dickinson|Laurence Hirsch, MD|201-847-6513|Laurence_Hirsch@bd.com|
20165401|NCT01968447|LUMC|Albert Dahan|+31 71 52 62301|a.dahan@lumc.nl|
20165402|NCT02182895|Brigham and Women's Hospital|Dr. Rajesh Garg, MD|617-732-5584|rgarg@partners.org|
20165403|NCT01827137|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
20165404|NCT03566511|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
20165405|NCT04026113|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20165406|NCT04613362|Richard L. Roudebush VA Medical Center|Dr. Teresa Damush|317-988-4277|teresa.damush@va.gov|
20165407|NCT02218372|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20165408|NCT03406780|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
20165409|NCT04090203|Cleveland Clinic|Dr. Jaclyn Bjelac|216 445-1449|bjelacj2@ccf.org|
20165410|NCT01488045|St. Joseph Mercy Hospital|Robert K. Cleary, MD|734.712.8150|Robert.Cleary@trinity-health.org|
20165411|NCT05043363|Imperial College London|Mr James Kinross|02033121947|j.kinross@imperial.ac.uk|
20165412|NCT05365217|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20165413|NCT01527149|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20165414|NCT02230410|Mayo Clinic|Dr. Kenneth K. Wang|507-293-7911|wang.kenneth@mayo.edu|
20165415|NCT02135861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165416|NCT04558125|Cedars-Sinai Medical Center|Victor Tapson, MD|919-971-6441|Victor.Tapson@cshs.org|
20165417|NCT03199976|Helsinki University Central Hospital|Dr Anne Kotaniemi-Syrjänen|+35894711|anne.kotaniemi-syrjanen@hus.fi|
20165418|NCT01761877|Stony Brook University|Dr. Alison T Stopeck|5206476982|Alison.Stopeck@stonybrookmedicine.edu|
20165419|NCT04076696|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20165420|NCT02151487|UT Southwestern Medical Center|Dawood Nasir|214-590-5352|Dawood.Nasir@UTSouthwestern.edu|
20165421|NCT00561652|Minneapolis VA Medical Center|Dr. Howard Fink|612-467-3304|howard.fink@va.gov|
20165422|NCT04842747|Veru|Gary Barnette PhD CSO|800-606-9382|veruclinicaltrials@verupharma.com|
20165423|NCT01743469|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20165424|NCT00317473|USAMRU-K|Mark A. Withers, MD PhD|+254-722-449-357|aodika@wrp-ksm.org|
20165425|NCT02516696|Weill Cornell Medicine|Multiple Myeloma Program Manager|646.962.9376|hyk4001@med.cornell.edu|
20165426|NCT01502293|OncoSec Medical Incorporated|Kellie Malloy, Chief Clinical Development Officer|858-375-9989|kmalloy@oncosec.com|
20165427|NCT01468558|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20165428|NCT03710187|University of Tennessee Medical Center|Pharm D, Pharmacist Specialist, Critical Care|865-305-9134|swinters@utmck.edu|
20165429|NCT01126749|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
20165430|NCT00599014|Emory University|Dr. Javed Butler|404-778-5136|jbutle4@emory.edu|
20165431|NCT00976274|Department of Family Medicine, Yonsei University College of Medicine|Dr. Jae-Yong Shim|(+82) 2-2019-3480|hope@yuhs.ac|
20165432|NCT00627393|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
20165433|NCT02183675|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165434|NCT03337308|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
20165435|NCT05328102|Xencor, Inc|Michael Chiarella|858-945-2415|mchiarella@xencor.com|
20165436|NCT01569191|Aston University|Prof James Wolffsohn|+44(0)1212044140|j.s.w.wolffsohn@aston.ac.uk|
20201044|NCT00763009|UCHC|Michael Azrin|8606793343|azrin@uchc.edu|
20201045|NCT02547623|Icon Bioscience, Inc.|Vice President, Quality and Compliance|510-933-8381||
20156049|NCT01941628|Dept. of Anaesthesiology and Intensive Medicine, General University Hospital in Prague|Assoc. Prof. Jan Blaha, MD, PhD|+420 224962243|jan.blaha@lf1.cuni.cz|
20156050|NCT04132427|Arizona State University|James B. Adams|480 965-3316|jim.adams@asu.edu|
20156051|NCT05177328|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20156052|NCT03927846|Wake Forest Health Sciences|Dennis Ang, Primary Investigator|336-705-8701|dang@wakehealth.edu|
20156053|NCT03878069|Chiesi Canada Corp.|Anna Rozova, MD, Clinical Program Leader|1-800-854-3534|a.rozova@chiesi.com|7038
20156054|NCT00834587|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156055|NCT00176254|University of Kentucky|Dr. Emily Van Meter/Assistant Professor, Division of Cancer Biostatistics|859-323-3076|emily.vanmeter@uky.edu|
20156056|NCT03289741|Memorial Sloan Kettering Cancer Center|Dr. Nitya Raj, MD|646-888-4849|rajn@mskcc.org|
20156057|NCT00879619|University of California, Irvine|Nicole Macaranas, Clinical Research Specialist|714-456-6550|nicole.macaranas@uci.edu|
20156058|NCT02536339|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20156059|NCT02043860|UIC Cancer Center Clinical Trials Office|Annette Kinsella, RN, CCRC, QA Education Specialist|312-996-5931|annettek@uic.edu|
20156060|NCT02037984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156061|NCT00527878|NIAID, NIH|Alexandra Freeman MD, Staff Clinician, Lead Associate Investigator for Protocol|301-594-9045|freemaal@mail.nih.gov|
20156062|NCT01691092|Yale University - Psychiatry Department|Irina Esterlis, Ph.D.|(203)737-6820|irina.esterlis@yale.edu|
20156063|NCT00561821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156064|NCT01657942|Insightec|Nadir Alikacem|214-630-9900|nadira@insightec.com|
20156065|NCT04526925|Rush University|Jie Li|3125634643|jie_li@rush.edu|
20156066|NCT00088699|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
20156067|NCT00581100|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20156068|NCT04129398|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156069|NCT04280783|Emory University|Dr. Jacob Kariuki|4047272353|jacob.kariuki@emory.edu|
20156070|NCT02904265|Mayo Clinic|Dr. Katherine Nickels|5072660774|nickels.katherine@mayo.edu|
20156071|NCT00185614|Stanford University School of Medicine|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20156072|NCT02579759|Pharnext|Susanne Dorn|+33 (0)1 41 09 22 30|contact@pharnext.com|
20156073|NCT02735642|Yale University School of Nursing|Ann Kurth|N/A|ann.kurth@yale.edu|
20156074|NCT01254214|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
20156075|NCT03829514|Medical University of South Carolina|Misti Leyva|endo office|leyva@musc.edu|
20156076|NCT01339091|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatherapeutics.com|
20156077|NCT04556006|Kilis 7 Aralık University|Dr. Uğur Doğan|+903488139301|63ugurdogan@gmail.com|
20156078|NCT00770679|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|4105505717|hsilber@jhmi.edu|
20156079|NCT00129974|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
20156080|NCT00944021|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212 227 7540|Dan.Everitt@tballiance.org|
20156081|NCT01475825|Kastle Therapeutics, LLC|Medical Information|1-800-745-4447|medinfo@genzyme.com|
20156082|NCT00867334|George Mason University|Emanuel Petricoin|571-830-4166|epetrico@gmu.edu|
20156083|NCT01220687|OUHSC College of Medicine, Pediatrics, Neonatal-Perinatal Medicine|Krishnamurhty Sekar, MD, Professor of Pediatrics|405-271-5215|kris-sekar@ouhsc.edu|
20156084|NCT00601731|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20156085|NCT01047540|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
20156086|NCT04250207|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20156087|NCT01437189|ZhejiangU|Bo Wang|87784711|wangke1121@163.com|
20156088|NCT02772302|Massachusetts General Hospital|Brian Edlow|6177246352|bedlow@mgh.harvard.edu|
20156089|NCT04526158|Minneapolis VAMC|Dr. Diana Burgess|612-567-1591|diana.burgess@va.gov|
20156090|NCT00677040|Essentia Health|Ken Dornfeld|218 786-1311|kenneth.dornfeld@essentiahealth.org|
20156091|NCT05201495|Element Science, Inc.|Chief Medical Officer|(415) 872-6500|zubin@elementsci.com|
20156092|NCT05263791|MacKay Memorial Hospital|Chien-Chung Huang|02-25433535|titanh@gmail.com|3009
20156093|NCT04576481|Children's Hospital of Philadelphia|James Guevara, MD MPH|215-590-1130|guevara@chop.edu|
20156094|NCT03464461|University of Missouri|Dr. Matthew Robinson|573 884-4400|robinsonmt@health.missouri.edu|
20156095|NCT01397591|OHSU Knight Investigational Cancer Services|Jeff Donovan|503-494-7702|mastersj@ohsu.edu|
20156096|NCT05261490|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156097|NCT02732145|Ginekološka poliklinika Dr. Vesna Harni|Dr. Vesna Harni|0038512923648|vesnaharni@gmail.com|
20156098|NCT04103814|Rush University Medical cEnter|Dr E Bailey Terhune|8018249805|bailey.terhune@rushortho.com|
20156099|NCT01244412|University of Rochester|David Kleinman, MD||david_kleinman@urmc.rochester.edu|
20156100|NCT00456365|PKD Research Group, University of Colorado Anschutz Medical Campus|Melissa Cadnapaphornchai, MD|3037241690|pkd@ucdenver.edu|
20156101|NCT06091956|Mayo Clinic|Aaron Mangold, M.D.|480-301-6169|Mangold.Aaron@mayo.edu|
20156102|NCT00742157|University of Nebraska Medical Center|Fedja Rochling, MD|402-559-3652|frochling@unmc.edu|
20156103|NCT04710303|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20165437|NCT01614249|University of Nairobi|Mrs. Rose Okoyo Opiyo|+254 020 2726300|roseopiyo@uonbi.ac.ke|43481
20201046|NCT01355289|Eisai Call Center|Eisai Inc.|888-422-4743||
20165438|NCT02731469|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
20165439|NCT02761330|Washington Universtiy School of Medicine|Alyssa Labonte|314-273-7338|alabonte@wustl.edu|
20165440|NCT00888134|Massachusetts General Hospital|Donald P. Lawrence|617-643-3614|dplawrence@mgh.harvard.edu|
20165441|NCT03043313|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20165442|NCT02657889|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165443|NCT00795535|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-355-4960|kproctor@med.miami.edu|
20165444|NCT03341299|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20165445|NCT02702492|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20201047|NCT01221857|Gamida Cell|Kelly Myers|+972-2-659-5631|clinicaltrials@gamida-cell.com|
20165446|NCT03735875|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
20165447|NCT03593044|The Ohio State University College of Optometry|Dr. Jeffrey Walline|(614) 247-6840|walline.1@osu.edu|
20165448|NCT03863795|National Cancer Institute|Annette Kaufman|301-467-8521|kaufmana@mail.nih.gov|
20165449|NCT00781768|Loyola University Medical Center|Patrick Stiff, M.D.|708-327-3148|pstiff@lumc.edu|
20165450|NCT01395797|New York State Psychiatric Institute|Sandra Comer PhD|646 774-6146|sdc10@columbia.edu|
20165451|NCT04567628|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20165452|NCT02458313|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristian.legget@cuanschutz.edu|
20165453|NCT00199381|Kyowa Hakko Kirin Pharma, Inc.|Director of Clinical Trials|609-919-1100|mcantillon@kyowa-kirin-pharma.com|
20165454|NCT00603408|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wudosis.wustl.edu|
20165455|NCT02892344|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20201048|NCT00481845|Stanford Cancer Institute, Stanford University|Mark Daniel Pegram; Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
20201049|NCT02706938|Universidad Nacional de Colombia|Dr. Ivan Mauricio Villamil Morales|+573178755369|imvillamilm@unal.edu.co|
20201050|NCT01379625|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
20201051|NCT01647737|Georgia Regents University|Dr. Scot DeRossi, Chairman of the ORal Medicine & Diagnostic Sciences Department|706-721-2607|Sderossi@gru.edu|
20201052|NCT02507349|UPMC Center for High-Value Health Care|Kelly Williams, Program Administrator|412-454-1198|Williamsk17@upmc.edu|
20201053|NCT00813995|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201054|NCT00754156|University of Kentucky Medical Center|Phillip Chang, M.D. PI or Anna Rockich, Pharm.D. GSRP Director|859-323-6346|arockich@uky.edu|247
20201055|NCT01614964|Tulane University|Jeffrey G Shaffer|504-988-1142|jshaffer@tulane.edu|
20201056|NCT00860470|JHSPH|Keith P. West, Jr.|4109552061|kwest@jhsph.edu|
20201057|NCT00348140|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201058|NCT01032629|Janssen- Cilag International NV|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20201059|NCT02868892|WRMC|Jessica L. Coats|6233417220|jessica.coats@ctca-hope.com|
20201060|NCT00619957|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20201061|NCT00723957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20201062|NCT00868790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201063|NCT01763164|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201064|NCT03377634|Wake Forest University School of Medicine|Amber Brooks, MD|336-716-4498|akbrooks@wakehealth.edu|
20201065|NCT01264939|Genentech, Inc.|Medical Communications|800 821-8590||
20201066|NCT03384329|Institute of Physiology and Basic Medicine|Dr. Lyubomir Aftanas|+7-913-912-2228|liaftanas@gmail.com|
20201067|NCT01167608|Rutgers-Robert Wood Johnson Medical School|Dr. Roseanne Dobkin, Associate Professor of Psychiatry|732-235-4051|dobkinro@rutgers.edu|
20201068|NCT03251326|New York State Psychiatric Institute|Margaret Haney, Ph.D.|646-774-6129|meg.haney@nyspi.columbia.edu|
20201069|NCT01384292|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20201070|NCT03670030|Ochsner Medical Center|Robert Ramirez, DO|504-464-8500|awendt@ochsner.org|
20201071|NCT01171612|Corporacion Sanitaria y Universitaria Parc Tauli|Anna Rodriguez-Pont|0034937231010|anna.r.pont@gmail.com|21283
20201072|NCT00737529|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
20201073|NCT04666038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20201074|NCT01239355|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20201075|NCT04957290|Noxopharm|Lorena, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
20201076|NCT00996203|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201077|NCT01959165|Biometrics|Nii Masahiro|+81 6 7711 4571|Masahiro.Nii@astrazeneca.com|4571
20201078|NCT03094195|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
20201079|NCT00360399|Emory University|Helen Mayberg|404-727-6740|hmayber@emory.edu|
20201080|NCT00927563|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
20165456|NCT01295814|IC Study, LLC|Philip C. Bosch, MD|760-743-3135|pboschmd@gmail.com|
20165457|NCT02170376|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20165458|NCT04106557|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|802-752-5168|tbaumgartner@ovidrx.com|
20165459|NCT02326155|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
20165460|NCT05024032|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20165461|NCT01209689|Hoffmann-La Roche|Medical Communications|800 821-8590||
20165462|NCT03780244|QMedAB|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
20165463|NCT03175367|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
20165464|NCT03937570|Division of Cardiac Surgery, Department of Surgery - University of Verona|Marzia Lilliu, MD, PhD|+39 3281383539|marzialilliu@gmail.com|
20165465|NCT03629535|NYU Langone Health|Greta Piper, MD|212-263-4778|Greta.Piper@nyulangone.org|
20165466|NCT03649646|Boryung Pharm. CO., LTD|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
20165467|NCT03085095|Myovant Sciences GmbH|Clinical Trials at Myovant|650-278-8743|ClinicalTrials@Myovant.com|
20165468|NCT02770014|Dana-Farber Cancer Institute|Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
20165469|NCT03459079|University of Florida|Kenneth Cusi|352-505-9060|kcusi@ufl.edu|
20165470|NCT00674817|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165471|NCT02379728|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
20165472|NCT01112917|BRIGHT Research Partners|Andrea Fenton Abbs - Study Director|612-298-7460|andrea@brightresearchpartners.com|
20165473|NCT05101122|Apnimed|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
20165474|NCT03363841|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
20165475|NCT00821795|Lexington VAMC|Dennis G Karounos, MD Principal investigator|859 233-4511|dennis.karounos@va.gov|4430
20165476|NCT02156076|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
20165477|NCT06271993|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
20165478|NCT04196777|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel.livorsi@va.gov|
20165479|NCT00687596|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
20165480|NCT02753283|University of Pittsburgh|Dr. Susan Greenspan|+14126922477|greenspn@pitt.edu|
20165481|NCT03331315|University of Tennessee - West Cancer Center|Michael Ulm|404-281-9480|mulm@westclinic.com|
20165482|NCT04614363|Houston Methodist|Dr. Brian Miles|713-441-8113|bjmiles@houstonmethodist.org|
20165483|NCT02558894|AstraZeneca|Global Clinical Lead|+1 301-398-0000|ClinicalTrialTransparency@astrazeneca.com|
20165484|NCT02992288|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20165485|NCT00656513|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20165486|NCT03379818|University of Birmingham|Dr Andrea Krott|+44 (0)121 414 4903|a.krott@bham.ac.uk|
20165487|NCT03962491|Virginia Commonwealth University|Kathryn Polak, PhD|(804) 827-1184|polakkm@vcu.edu|
20165488|NCT03020667|Uwatoko Clinic|Kunihiko Uwatoko, MD|+81-52-991-4602|uwatoko.clinic@gmail.com|
20165489|NCT03697252|Karuna Therapeutics, Inc.|Stephen Brannan|857-449-2234|sbrannan@karunatx.com|
20165490|NCT03288103|Cincinnati Childrens Hospital Medical Center|Dr. Philippe Backeljauw, MD|15136368444|Philippe.backlejauw@cchmc.org|
20165491|NCT01867671|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20165492|NCT03165617|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
20165493|NCT05236270|University of Oklahoma Health Sciences|Dr. Amanda Janitz|405-271-2229|amanda-janitz@ouhsc.edu|48081
20165494|NCT04097678|Twin Cities Spine Center|Clinical Research Director|612-775-6222|jmdawson@tcspine.com|
20165495|NCT03694678|Massachusetts General Hospital|Ana-Maria Vranceanu|6178931664|avranceanu@mgh.harvard.edu|
20165496|NCT02435212|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
20165497|NCT04711850|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
20165498|NCT00135226|Nuffield Department of Population Health|Prof Jane Armitage|+44 (0)1865 743743|ascend@ndph.ox.ac.uk|
20165499|NCT00965354|Imperial College|Openshaw, Peter J M|07973 820 801|p.openshaw@imperial.ac.uk|
20165500|NCT02380573|University of Texas Health Science Center at San Antonio|Dr. Peter Fox|210-567-8150|fox@uthscsa.edu|
20165501|NCT04552301|Icahn School of Medicine at Mount Sinai|Dr. Juan Wisnivesky|(212) 241-2125|juan.wisnivesky@mountsinai.org|
20165502|NCT02893293|Stanford University|Heike Daldrup-Link, MD|(650) 725-2548|mairead@stanford.edu|
20165503|NCT04531176|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
20165504|NCT01260493|Vårdalinstitute, University of Gothenburg|Professor Synneve Dahlin-Ivanoff ( Research leader)|+46 31 7865733|synneve.dahlin-ivanoff@gu.se|
20165505|NCT02718898|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20165506|NCT01451606|University of Maryland, Baltimore|Dr. Joel Greenspan|4107067090|jgreenspan@umaryland.edu|
20165507|NCT01590264|Washington University in Saint Louis|Dr. Jay F. Piccirillo|314-362-8641|piccirilloj@ent.wustl.edu|
20165508|NCT02989493|University of Wisconsin|John Curtin|608-262-0387|jjcurtin@wisc.edu|
20165509|NCT02559622|Novartis Pharmaceuticals|Study Director|862--778--8300||
20165510|NCT02163538|University Louisville|Dr. Resad Pasic|502-561-7465|resad.pasic@louisville.edu|
20165511|NCT04643808|Medical Univesristy of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
20165512|NCT04484961|Houston Methodist Hospital|Bradley Lambert, PhD|8326872483|bslambert@houstonmethodist.org|
20165513|NCT00388349|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
20165514|NCT01063049|Gastroenterology Services|Dr. David Gerard|630 969 1167|davidpgerard@comcast.net|
20165515|NCT01345240|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165516|NCT04011540|University of Pennsylvania|Lauren Southwick|267-428-0125|lauren.southwick@pennmedicine.upenn.edu|
20165517|NCT01808755|Divisione Urologia IRCCS Policlinico San Matteo Pavia, Italy|D. Porru|39-0382-503868/503872|danieleporru@tin.it|
20165518|NCT02673372|Maimonides Medical Center|Sergey Motov, Director of Research|718-283-8693|smotov@maimonidesmed.org|
20165519|NCT01339832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20203010|NCT04192448|Eastern Michigan University|Elizabeth Neilson|734-487-4988|eneilso1@emich.edu|
20165520|NCT00231816|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165521|NCT00774046|University of Chicago|Dr. Lucy A. Godley|773-702-4140|lgodley@medicine.bsd.uchicago.edu|
20165522|NCT05498649|Scripps Optometric Group|Dr Keith Wan|858-530-2800|keithmwan@gmail.com|
20165523|NCT04609319|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165524|NCT03804528|University of Miami|Joyce Gomes-Osman|305-284-2632|j.gomes@miami.edu|
20165525|NCT04607005|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165526|NCT00668148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20165527|NCT02711891|Rush University Medical Center|Kathleen C. Heneghan, RN, PhD|3123395943|kheneghan@facs.org|
20165528|NCT05856422|Clinimark|Associate Researcher|833 373 0998|Carolyn.Cohen@element.com|1
20165529|NCT04944992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165530|NCT00303069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
20165531|NCT03531112|University of North Carolina at Chapel Hill|Rachel Goode, PhD|919-962-6429|rwgoode@email.unc.edu|
20165532|NCT01972217|AstraZeneca|Medical Director|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
20165533|NCT04295720|University of Arizona|Phillip H. Kuo, MD, PhD|520-626-1957|pkuo@arizona.edu|
20165534|NCT04328077|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
20165535|NCT01456039|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20165536|NCT04936945|Soahg University|Dr. Magdy Mohamed Amien|0934602963|portal@med.sohag.edu.eg|
20165537|NCT00335777|Jefferson Headache Center|Stephen D. Silberstein, MD|215-955-2243|stephen.silberstein@jefferson.edu|
20165538|NCT02798627|University of Pennsylvania Perelman School of Medicine|Kyle Kampman, MD|2157462764|kampman@pennemdicine.upenn.edu|
20165539|NCT03821402|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20165540|NCT00578539|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
20165541|NCT00939393|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
20165542|NCT02851615|Cincinnati Children's Hospital Medical Center|Dr. Lori Crosby|513-636-5380|Lori.Crosby@cchmc.org|
20165543|NCT00313014|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
20165544|NCT01843621|Dept of Pediatrics, Pharmongkutklao Hospital, Bankok, Thailand|Sriluck Simasathien, MD|66-2-644-8971|ssriluck@yahoo.com|
20165545|NCT00371150|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20165546|NCT02345070|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20165547|NCT03081117|Johns Hopkins University|Dr. Leah Rubin, Associate Professor of Neurology, Psychiatry, and Epidemiology|410-955-7311|lrubin@jhu.edu|
20165548|NCT00473564|University of Alabama at Birmingham|William Carroll, MD|205-934-9767|wcarroll@uabmc.edu|
20165549|NCT03131219|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20165550|NCT00616759|Loma Linda University|Ronald L. Warnell, M.D.|909-558-9551|rwarnell@llu.edu|
20165551|NCT02437344|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
20165552|NCT04723056|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
20165553|NCT05106894|Children's Hospital Los Angeles|Dr. Beth A. Smith|3233614670|bsmith@chla.usc.edu|
20165554|NCT04441138|Rush University Medical Center|Dr. Gaurav Marwaha|3129424399|Gaurav_Marwaha@Rush.edu|
20165555|NCT03431285|King Fahd University Hospital- Imam Abdulrahman Bin Faisal University|Dr. Muhammed Alshahrani|+966138966666|msshahrani@iau.edu.sa|2002
20165556|NCT04538989|Rezolute|Chief Medical Officer (Dr. Brian Roberts)|650-206-4507|brian@rezolutebio.com|
20165557|NCT00981656|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20165558|NCT02903771|Kazia Therapeutics Ltd|Jeremy Simpson|+61 400410974|Jeremy.simpson@kaziatherapeutics.com|
20165559|NCT03299556|Purdue Pharma L.P.|Thomas Alfieri, PhD - Director, Medical Affairs Strategic Research|(475) 299-6085|thomas.alfieri@pharma.com|
20165560|NCT01709721|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
20165561|NCT03137381|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20165562|NCT01684917|Imperial College London|Professor Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20165563|NCT03044106|University of North Carolina at Chapel Hill|Nicholas Wise, DC|(864) 494-1001|nicholas_wise@med.unc.edu|
20165564|NCT01748292|Retina Consultants of Houston|Charles C. Wykoff, MD, PhD|713-524-3434|ccwmd@houstonretina.com|
20165565|NCT03520998|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
20165566|NCT01435382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165567|NCT00771277|VA Medical Center Memphis|Dr. Linda O. Nichols|901 523-8990|linda.nichols@va.gov|5082
20165568|NCT00423579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20165569|NCT02392637|UT MD Anderson Cancer Center|Dr. Milind Javle, Professor, GI Medical Oncology|(713) 792-5434|mjavle@mdanderson.org|
20165570|NCT03542877|University of Colorado|Dr. Wells Messersmith|303-724-0747|wells.messersmith@cuanschutz.edu|
20165571|NCT03913455|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20165572|NCT01310777|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20165573|NCT03125395|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20165574|NCT00106704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165575|NCT01780506|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
20165576|NCT00643864|CarolinasHS|Dr. Mark Hirsch, Senior Scientist|704 355 7673|mark.hirsch@carolinashealthcare.org|
20165577|NCT02967991|University Hospitals Case Western Reserve|Shaffer Mok|4404065500|Shaffer.Mok@UHHospitals.org|
20165578|NCT03486912|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20165579|NCT00412984|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20201081|NCT02497001|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|1-877-240-9479|information.center@astrazeneca.com|
20165580|NCT01499940|West Virginia Universtiy|Gerald Higa, PharmD|(304) 293-1461|ghiga@hsc.wvu.edu|
20201082|NCT00909155|University of Wisconsin|Dr. Michael Peterson|608 265 8130|mpeterson2@wisc.edu|
20201083|NCT02899156|University of California Davis Medical Center|Kendra Schomer, PharmD|916-734-2243|kjschomer@ucdavis.edu|
20165581|NCT02199184|The University of Texas MD Andeerson Cancer Center|Elias Joseph Jabbour|713-792-4764|ejabbout@mdanderson.org|
20201084|NCT00787787|Cancer Consortium|Medical Director, Clinical Research Support|206-667-5767|lmendels@fredhutch.org|
20201085|NCT03135249|UT Southwestern Medical Center|Dr. Olaf Stuve, Principal Investigator|12146484559|olaf.stuve@utsouthwestern.edu|
20201086|NCT02116621|University of California, Davis|Richard Kravitz, MD, MSPH|916-734-1248|rlkravitz@ucdavis.edu|
20201087|NCT01889602|University of Minnesota|Dr. Susan Marino|612-624-2964|marin007@umn.edu|
20201088|NCT01412957|Amgen Inc.|Study Director|866-572-6436||
20201089|NCT00484315|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
20201090|NCT00943683|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20165582|NCT02383576|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20165583|NCT02285855|UT MD Anderson Cancer Center|Stephen Chun/Assistant Professor, Radiation Oncology|713- 563-9600|sgchun@mdanderson.org|
20165584|NCT00528112|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20165585|NCT03183869|Lawson Health Research Institute|Chantelle Graf, RN|519-685-8500|chantelle.graf@sjhc.london.on.ca|35352
20165586|NCT03050801|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
20165587|NCT00584948|University of California, Davis Medical Center|Randi J Hagerman, MD|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
20165588|NCT04825574|Blueprint Medicines|Blueprint Medicines Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
20165589|NCT03518086|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20165590|NCT01243190|The university of Texas MD Anderson Cancer Center|William Wierda MD./Professor|713-745-0428|wwierda@mdanderson.org|
20165591|NCT02677493|IL-YANG PHARM.|Clinical Research Manager|+82-70-7165-7316|hlpark@ilyang.co.kr|7316
20165592|NCT03204188|National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)|Adrian Wiestner, M.D., Ph.D., Principal Investigator|301-594-6855|wiestnea@nhlbi.nih.gov|
20165593|NCT00758667|Vanderbilt University|R. Bruce Shack, MD|615-936-0160|bruce.shack@vanderbilt.edu|
20165594|NCT00732030|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20165595|NCT02151058|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
20165596|NCT00124943|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20165597|NCT03829228|USANA Health Science|Dr. Junqiang Tian|8019547462|jeremy.tian@usanainc.com|
20165598|NCT03337477|AstraZeneca Clinical|Study Information Center|+1 877 240 9479|information.center@astrazeneca.com|
20165599|NCT02844569|University of North Carolina at Chapel Hill|Dr. Thiago Morelli|919-537-3727|thiago_morelli@unc.edu|
20165600|NCT02443688|Celtaxsys, Inc.|Director, Clincal Operations|4702060153|sbirnbaum@celtaxsys.com|123
20165601|NCT01698333|Therapeutics Inc.|Clinical Research|858-571-1800|clinicalresearch@therapeuticsinc.com|
20165602|NCT00408317|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
20165603|NCT02092610|Radboud University Hospital Nijmegen Medical Centre|Dr. Myrthe Hol|(024) 36 14934|Myrthe.Hol@radboudumc.nl|
20165604|NCT02135432|University of Alabama at Birmingham|Steven M. Rowe|205-975-6385|smrowe@uab.edu|
20165605|NCT00242502|University of Texas MD Anderson Cancer Center|Ahmed Kaseb, MD/ Professor||MJLim@mdanderson.org|
20165606|NCT04135417|Humacyte Inc.|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
20165607|NCT01635504|University of British Columbia|Dr. Shannon Humphrey|(604) 714-0222|shannon@carruthers-humphrey.com|
20165608|NCT02177123|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
20165609|NCT05660577|Bausch & Lomb|Study Director|5102595284|aloncaric@bausch.com|
20165610|NCT02878343|UPenn|Dr. Karen Glanz||kglanz@pennmedicine.upenn.edu|
20165611|NCT00481832|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20165612|NCT03416985|University of California Los Angeles|Joan Pi Anfruns, DMD|310-825-0834|jpianfruns@dentistry.ucla.edu|
20165613|NCT00581308|W. L. Gore & Associates|Jay Donosky|(800) 437-8181|jdonosky@wlgore.com|
20165614|NCT02006472|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20165615|NCT00886379|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-7929|jr33@partners.org|
20165616|NCT03219723|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20165617|NCT00459316|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20165618|NCT01980017|University of Ottawa Heart Institute|Dr. Robert Reid|6136967393|breid@ottawaheart.ca|
20165619|NCT03848325|University of Pittsburgh|Sanjay R. Patel MD, MS|412-383-0607|patelsr2@upmc.edu|
20201091|NCT03035760|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
20201092|NCT01552343|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20201093|NCT04492566|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
20201094|NCT02237235|Northwestern University|Herbert Y. meltzer|312-503-0309|h-meltzer@northwestern.edu|
20201095|NCT04533711|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20201096|NCT00460993|Atlanta VA Medical Center|Dr. Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
20165620|NCT01207414|Novartis Pharmaceuticals|Study Director|862-778-8300||
20165621|NCT02057250|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20201097|NCT02561897|Electrophysiology Research Foundation|Sanjeev Saksena|7323029990|eprf@aol.com|
20201098|NCT00659295|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20201099|NCT04840667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20201100|NCT00654927|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
20201101|NCT03658889|ChugaiPF|Isabelle Idier, Rheumatology Medical Leader|+33 (0) 1 56 37 44 89|idier@chugai-pharm.fr|
20201102|NCT04628936|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
20201103|NCT04317690|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
20201104|NCT01099111|KFMC|Dr. Ahmed Al Omair|+96612889999|aalomair@kfmc.med.sa|8771
20201105|NCT03312218|McGill University|Dr. Roland Grad|514-947-3718|roland.grad@mcgill.ca|
20201106|NCT02747927|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20201107|NCT01154101|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201108|NCT05019131|University of California, San Francisco|Dr. Patience Afulani|(415) 476-1000|Patience.Afulani@ucsf.edu|
20201109|NCT00432237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20201110|NCT01354132|Beth Israel Deaconess Medical Center|Larry Seidman, PhD|617 754-1238|lseidman@bidmc.harvard.edu|
20201111|NCT00582517|University of Alabama at Birmingham|Taylor Vlack, RN|205-996-6781|tmwebb@uabmc.edu|
20201112|NCT02360098|TORONTO WESTERN HOSPITAL/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
20201113|NCT04355013|University Hospital of Salamanca|Dr. José A. Sastre|+34923291100|jasastre@saludcastillayleon.es|55580
20201114|NCT01479348|National Cancer Institute|Dr. Karen Kurdziel|804-897-1207|kurdziek@nih.gov|
20201115|NCT00412529|Novartis Pharmaceuticals|Study Director|862-778-8300||
20201116|NCT03293654|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
20201117|NCT01919307|Denver Health and Hospital Authority|Edward Maa|303-602-5099|Edward.Maa@dhha.org|
20201118|NCT03742427|Marmara University|Sinan KARACABEY|+902166254545|karacabeysinan@gmail.com|
20201119|NCT02275533|University of Chicago|Theodore Karrison|708-925-6771|tkarrison@health.bsd.uchicago.edu|
20201120|NCT03289416|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
20201121|NCT05023252|Veterans Health Administration, Greater Los Angeles Veterans Healthcare Center|Alexander Young MD|310-478-3711|alexander.young@va.gov|
20201122|NCT02157883|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20201123|NCT01323478|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20201124|NCT01551979|Beth Israel Deaconess Medical Center|Mark Halko|6176670367|mhalko@bidmc.harvard.edu|
20201125|NCT04067518|Institut de Recherches Internationales Servier|Clinical Studies Department|+33 1 55 72 43 66|scientificinformation@servier.com|
20201126|NCT02771522|Calcivis Ltd|Director of Clinical Research|+44 131 658 5152|mwillins@calcivis.com|
20201127|NCT02673333|Memorial Sloan Kettering Cancer Center|Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
20201128|NCT02347631|UT Southwestern Medical Center|Danielle Robertson|214-648-3416|danielle.robertson@utsouthwestern.edu|
20201129|NCT01509625|Hospital Clínico San Cecilio Granada|Dr Isabel Blancas|+34 958023498|blancaslb@hotmail.com|
20201130|NCT02318784|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20201131|NCT00934102|University of Waterloo|Craig Woods, PhD, FAAO / Research Manager|1-519-888-4742|cclr2@uwaterloo.ca|
20201132|NCT02304926|FISABIO-University Hospital Dr Peset|Dr Antonio Hernández|961622492|hernandez_antmij@gva.es|
20201133|NCT04258579|Weill Cornell Medical College|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
20201134|NCT02388295|AstraZeneca Pharmaceuticals LP|Jamie Mullen MD||Clinicaltrialtransparency@astrazeneca.net|
20201135|NCT04007159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201136|NCT01510327|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
20201137|NCT02076165|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|36080
20201138|NCT03804684|Wills Eye Hospital|M. Reza Razeghinejad, MD|12159283197|reza@willseye.org|
20201139|NCT02429856|UAlberta|Director of NACTRC|780-407-8007|ron.welch@ahs.ca|
20201140|NCT00495157|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
20201141|NCT03838484|Vanderbilt University Medical Center|Alan S. Lewis, M.D., Ph.D.|615-875-4027|alan.s.lewis@vumc.org|
20201142|NCT03618030|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|Sailaja.Bhaskar@ImbriumThera.com|
20201143|NCT03689192|National Center for Cancer Immune Therapy|Cathrine Lund Lorentzen|004538683868|cathrine.lund.lorentzen@regionh.dk|
20201144|NCT00888238|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20201145|NCT02700984|Alcon Research|Sr Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20201146|NCT03705481|Corindus, Inc.|John Van Vleet, VP Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
20201147|NCT00516919|Yale University School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
20201148|NCT01007526|Samsung Medical Center|Won Seog Kim|82234106548|wskimsmc@skku.edu|
20201149|NCT00413959|Oncology Specialists SC|Sigrun Hallmeyer, MD Director of Research|847-268-8200|shallmeyer@oncmed.net|
20201150|NCT01870739|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20201151|NCT01986062|Arbor Pharmaceuticals|Dr. Steve Caras|(470) 235-2327|scaras@arborpharma.com|
20201152|NCT03538743|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201153|NCT00524537|AbbVie|Global Medical Information|800-633-9110||
20201154|NCT01565980|Michigan State University College of Nursing|Rebecca H. Lehto, PhD, Assistant Professor|517-353-4757|rebecca.lehto@hc.msu.edu|
20156104|NCT01681849|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
20156105|NCT00979407|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156106|NCT01166646|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20165622|NCT03367793|Ohio State University College of Optometry|Dr. Heather Anderson, Study PI|614-247-5825|anderson.3881@osu.edu|
20165623|NCT00260533|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
20165624|NCT00003475|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20165625|NCT01096875|Ankara University Medical Faculty, Department of Cardiovascular Surgery|Prof. A. Ruchan Akar MD., FRCS(CTh).|+90 533 646 06 84|akarruchan@gmail.com|
20165626|NCT01440959|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
20165627|NCT05179785|University of Pittsburgh|Mary Phillips|4123838206|fmristudies@upmc.edu|
20165628|NCT03292926|Hospital for Special Surgery, Anesthesiology|Dr. Jonathan Beathe|2126061036|beatheJ@hss.edu|
20165629|NCT02453737|Mayo Clinic|Dr. Robert W. Mutter|507-284-3191|Mutter.Robert@mayo.edu|
20165630|NCT04852302|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
20165631|NCT05249582|Palo Alto University|Erick Kim|(510) 457-1584|ekim@paloaltou.edu|
20165632|NCT03267277|National Institute of Environmental Health Sciences|Dr. Adam Schiffenbauer|+1 301 451 6270|adam.schiffenbauer@nih.gov|
20165633|NCT01436149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20165634|NCT04393935|Emory University|Natalie Crawford, PhD|404-712-9445|ndcrawford@emory.edu|
20165635|NCT04849364|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20165636|NCT03844997|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD|866-223-8100|TaussigResearch@ccf.org|
20165637|NCT04689139|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
20165638|NCT01184898|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
20165639|NCT00074165|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
20165640|NCT05261386|ADS Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
20165641|NCT02738801|Galapagos NV|Evelyn Fox|003215342900|evelyn.fox@glpg.com|3215342900
20165642|NCT01643668|Massachusetts General Hospital|Yi-Bin Chen, MD|617-726-0187|YCHEN6@PARTNERS.ORG|
20165643|NCT04771455|Northwestern University|Dr. Andrea Graham|312-503-5266|andrea.graham@northwestern.edu|
20165644|NCT03253796|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165645|NCT03656939|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165646|NCT01075243|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165647|NCT01318577|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
20165648|NCT03593902|Northwestern University|Kathleen Quigley|312-695-8192|kathleen.quigley@nm.org|
20165649|NCT00286728|VAHSRD|Christine Timko|650-617-2746|Christine.Timko@va.gov|
20165650|NCT03600909|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
20165651|NCT02651675|Regenxbio Inc.|Clinical Development Lead|240-552-8968|srastogi@regenxbio.com|
20165652|NCT02246530|University of Alabama at Birmingham|Dr. Breanna Willeford, DO|205-934-4131|breannawilleford@uabmc.edu|
20165653|NCT03816696|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165654|NCT01506596|Vector Oncology LLC|Dr. Mark Walker, VP of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
20165655|NCT05810740|Pierre Fabre Médicament|Ana Catarina Pinto, Responsible Medical Officer|5 3450 6059|ana.catarina.pinto@pierre-fabre.com|
20165656|NCT01488890|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
20165657|NCT05712460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165658|NCT05560425|University of North Carolina at Chapel Hill|Elena Vidrascu, PhD, MSc|919-843-9193|elena91@live.unc.edu|
20165659|NCT05135767|Brown University|Hayley Treloar Padovano, PhD|4018636623|hayley_treloar@brown.edu|
20165660|NCT02694185|Rocky Mountain Regional VA Medical Center|Elizabeth Cheng|720-857-5101|elizabeth.cheng@va.gov|
20165661|NCT05082857|Wake Forest University School of Medicine|Anna Miller-Fitzwater, MD, MPH|336-713-0630|amillerf@wakehealth.edu|
20165662|NCT03645122|VA Pittsburgh Healthcare System|Assistant Director for Clinical and Regulatory Affairs|412-822-3669|Nikitha.Deepak@va.gov|
20165663|NCT02260934|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20165664|NCT04366349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165665|NCT01235897|University of California, San Francisco|Jo Chien, MD|415-885-7577|crss@ucsf.edu|
20165666|NCT03755206|Johns Hopkins Center for Indigenous Health|Dr. Emily E. Haroz, Associate Professor|4109556931|eharoz1@jhu.edu|
20165667|NCT05737069|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20165668|NCT02532517|Cerenovus|Christopher Hendricks|415-656-6565|CHendric@its.jnj.com|
20165669|NCT00498940|Columbia University Medical Center|Santos Cabreriza/ Associate Scientist|212-305-9515|sc45@cumc.columbia.edu|
20165670|NCT05138653|Cerevel Therapeutics|Cerevel Central Contact|8572500977|info@cerevel.com|
20165671|NCT02331134|University of Colorado Hospital|Antonio Jimeno, MD, PhD|3037242478|antonio.jimeno@cuanschutz.edu|
20165672|NCT05967260|Oregon Health & Science University|Clara Mosquera-Lopez|503--418-4129|mosquera@ohsu.edu|
20165673|NCT02845297|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivana Gojo|410-502-8775|igojo1@jhmi.edu|
20165674|NCT01350999|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20165675|NCT00079417|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
20165676|NCT01615939|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
20165677|NCT04671017|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
20165678|NCT02121535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20187741|NCT04393207|Yale|Antonio Gonzalez|203.785.2802|antonio.gonzalez-fiol@yale.edu|
20187742|NCT06197360|Yangzhou University|Yueqi Zhao|13390676131|mz120221975@stu.yzu.edu.cn|
20165679|NCT00092417|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20165680|NCT01520506|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20165681|NCT00425269|University of Oslo|Victoria Telle Hjellset|0047 22 85 06 12|t.v.t.hjellset@medisin.uio.no|
20165682|NCT01084655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20165683|NCT00906204|Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA|Dr. R. Brian Stevens, MD, PhD, FACS|937-545-4817|rbstevens1@icloud.com|
20165684|NCT02231086|Amsterdam UMC|Prof. dr. P.J. Tanis|+31-20-4444444|p.j.tanis@amsterdamumc.nl|
20165685|NCT03181932|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20165686|NCT03304626|University of Cincinnati|Khurram Bari|513-558-2898|khurram.bari@uc.edu|
20165687|NCT00744497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20165688|NCT03027609|Aridis Pharmaceutical Inc|Lynne Deans|001-925200|deansl@aridispharma.com|3089
20165689|NCT03298035|The University of Texas Health Science Center at Houston|Catherine C. Beaullieu, MD|(713) 500-6044|Catherine.C.Beaullieu@uth.tmc.edu|
20165690|NCT03182374|Zimmer Biomet|Clinical Project Lead|+41791522905|miguelcorreatapia@zimmerbiomet.com|
20165691|NCT01462370|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165692|NCT03198715|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20165693|NCT03651479|Eastern Mediterranean University|Asst. Prof. Dr. Gozde Iyigun|+903926303011|gozde.iyigun@emu.edu.tr|
20165694|NCT00853307|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20165695|NCT00914316|William Beaumont Hospital|Barbara Higgins, RN|248 551-1535|Barbara.Higgins@beaumont.org|
20165696|NCT01528332|Philips Consumer Lifestyle|Dr. Elke Naujokat|+31 (0) 631974213|elke.naujokat@philips.com|
20165697|NCT02399163|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165698|NCT03163303|University of California, San Francisco|Dr. Derek Satre|(415) 476-7382|derek.satre@ucsf.edu|
20165699|NCT00600080|Johnson & Johnson Vision Care|Kurt Moody, OD|+1 904 443-3088|kmoody1@its.jnj.com|
20165700|NCT04163952|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger.edu|
20165701|NCT01391546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165702|NCT03961672|City of Hope Medical Center|Dr. Alexey Danilov, MD|626-359-8111|adanilov@coh.org|
20165703|NCT02988466|University of Minnesota, Masonic Cancer Center|Mark Juckett, MD|(612) 626-5654|juck0001@umn.edu|
20165704|NCT04225897|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165705|NCT05172128|Duke University Medical Center|Dr. P. Murali Doraiswamy|9196845933|murali.doraiswamy@duke.edu|
20165706|NCT00074711|Creighton University|Robert P Heaney, MD|402 280 4029|rpheaney@creighton.edu|
20165707|NCT03466658|Penn State Health|Dr. Hyunmin Kim|717-531-4826|hkim2@pennstatehealth.psu.edu|
20165708|NCT00837434|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20165709|NCT01921205|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20165710|NCT00360230|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165711|NCT00456846|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
20165712|NCT00910650|University of California at Los Angeles, Jonsson Comprehensive Cancer Center|Ignacio Baselga|310 206-2090|ibaselga@mednet.ucla.edu|
20165713|NCT04682366|Wake Forest|Majid Mirzazadeh|336-716-4131|mmirzaza@wakehealth.edu|
20165714|NCT01028820|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
20165715|NCT02224560|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20165716|NCT04543279|Washington University School of Medicine|Dr. Amy Zhou|314-362-8814|a.zhou@wustl.edu|
20165717|NCT00929695|Fred Hutchinson Cancer Research Center|Marco Mielcarek|206-667-2827|mmielcar@fhcrc.org|
20165718|NCT04030143|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20165719|NCT03216226|Zealand Pharma A/S|Kim Mark Knudsen|+45 50603780|KMKnudsen@zealandpharma.com|
20165720|NCT04218240|University of Pennsylvania|Kyle M. Kampman, MD|2157462764|kampman@pennmedicine.upenn.edu|
20165721|NCT05131308|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
20165722|NCT05966142|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
20165723|NCT00573508|Astellas Pharma Global Development|Astellas Medical Monitor||clinicaltrials@us.astellas.com|
20165724|NCT00894803|University of Cincinnati|Dr Arthur Pancioli|513-558-8087|arthur.pancioli@uc.edu|
20165725|NCT01069003|Medtronic|Sidney Cohen, Sr. Clinical Medical Advisor|707-591-7277|sidney.a.cohen@medtonic.com|
20165726|NCT00347022|GUERBET|Corinne DUBOURDIEU|+33.1.45.91.50.00|corinne.dubourdieu@guerbet-group.com|
20201155|NCT05391438|Children's Hospital Los Angeles|Alaina Vidmar|3236614606|avidmar@chla.usc.edu|
20201156|NCT01629615|SOLTI|Scientific Manager|(+34) 93 343 63 02|pamela.celiz@gruposolti.org|
20201157|NCT01929135|Universidad de los Andes|Dra. Catherine Andrade|056-972862308|catherine.perio@gmail.com|
20201158|NCT00895830|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
20201159|NCT00382031|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
20201160|NCT00288574|NYSPI|BT Walsh, MD|646-774-8066|edru@nyspi.columbia.edu|
20201161|NCT03639948|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
20201162|NCT01926626|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
20165727|NCT03094416|IBSA|Claudia Scarsi|+41583601000|claudia.scarsi@ibsa.ch|
20165728|NCT00979940|Indiana University School of Medicine|Dr. Rolf Kreutz|3179620500|rkreutz@iu.edu|
20165729|NCT02158442|Osprey Medical|Michele Shepard|952.955.8236|mshepard@ospreymed.com|
20165730|NCT01409707|University of Mississippi Medical Center|Dr. Scott Coffey|601-815-5588|scoffey@umc.edu|
20201163|NCT01817790|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201164|NCT01671345|Jesse Brown VA Medical Center|Howard S. Gordon, MD|312-569-7331|howard.gordon2@va.gov|
20201165|NCT05070338|RAND Corporation|Katherine E. Watkins|310-393-0411|kwatkins@rand.org|6509
20201166|NCT06001307|Illinois Institute of Technology|Arryn Guy|312-567-6467|aguy1@iit.edu|
20201167|NCT03532100|CLiMB|Glenn Klute, PhD|206.277.6724|Glenn.Klute@va.gov|
20201168|NCT04439279|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20201169|NCT02031679|Johns Hopkins University School of Medicine|Dr. Eric Oliver|410-550-2300|eolive15@jhmi.edu|
20201170|NCT04544566|Coloplast A/S|Head of Scientific Affairs|+45 4911 1111|clinicaltrialsgovSA@coloplast.com|
20201171|NCT02338843|La Jolla Pharmaceutical Company|George Tidmarsh, MD, PhD|858-207-4264|gtidmarsh@ljpc.com|
20201172|NCT00023322|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Theo Heller, M.D.|(301) 402-7147|Theoh@mail.nih.gov|
20201173|NCT04246554|UH Cleveland Medical Center|Dr. Michael Karns|216-844-7200|srmengers@gmail.com|
20201174|NCT01609933|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20201175|NCT01252966|University of Pennsylvania (Perelman School of Medicine)|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
20201176|NCT03340350|VA Nebraska-Western Iowa Health Care System|Sriram Ramaswamy, MD|402-995-4712|Sriram.Ramaswamy@va.gov|
20165731|NCT01217229|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20165732|NCT05386329|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
20165733|NCT01292135|Pharmacyclics|Thorsten Graef, MD|855.427.8846|medinfo@pcyc.com|
20165734|NCT00521079|EnteroMedics Inc|Senior Vice President of Clinical|651-634-3209|ktweden@enteromedics.com|
20165735|NCT04408989|mabxience Research SL|Susana Millan|+3491771500|susana.millan@mabxience.com|
20165736|NCT04363320|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|tdmolfenter@wisc.edu|
20165737|NCT03475004|University of Colorado|Dr. Christopher Lieu|303-724-6390|christopher.lieu@cuanschutz.edu|
20165738|NCT01436526|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20165739|NCT03605667|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
20165740|NCT05632211|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
20165741|NCT05421624|Boston University|Franchino Porciuncula, EdD, PT, DScPT|(617) 353-7525|fporciun@bu.edu|
20165742|NCT05194124|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20165743|NCT03642873|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20187743|NCT03536884|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20156107|NCT00967486|Vascular center of excellence (CAMC medical staff-with admitting privileges)|Ali Fawazi AbuRahma MD|304-388-9973||
20156108|NCT01335685|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20156109|NCT03460704|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clinicaltrials@zambongroup.com|
20156110|NCT01767857|Janssen Research & Development, LLC|Product Development Portfolio Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20156111|NCT01421459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20156112|NCT01422382|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
20156113|NCT04126174|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
20156114|NCT03138382|UCSD|Dr Paul McGeoch|858-232-3312|pdmcgeoch@ucsd.edu|
20156115|NCT05181085|NorthSea Therapeutics BV|Michelle Yokley|31 035760 65 05|info@northseatherapeutics.com|
20156116|NCT04379271|Immunic AG|Silke Kropp, Specialist Regulatory Operations & Systems|+49|Silke.Kropp@imux.com|1626774453
20156117|NCT01854762|Fundação Bahiana de Infectologia / Universidade Federal da Bahia|Dr. Carlos Brites|5571992329552|crbrites@gmail.com|
20156118|NCT03186378|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20156119|NCT03784300|Cassava Sciences|Michael R Marsman, PharmD|5125822173|mmarsman@cassavasciences.com|
20156120|NCT02514746|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
20187744|NCT01726257|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
20187745|NCT02874001|Institut Bergonié|S Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
20187746|NCT05860114|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 64431|m.caserini@italfarmacogroup.com|
20187747|NCT03314740|Istituto di Ricerche Farmacologiche Mario Negri|Elena Biagioli|+39 0239014650|elena.biagioli@marionegri.it|
20187748|NCT04075318|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
20187749|NCT05599334|Pierre Fabre Médicament|Medical Director (Jeanne Suissa)|+33149108269|jeanne.suissa@pierre-fabre.com|
20187750|NCT00844415|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187751|NCT02473445|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
20187752|NCT04778410|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20187753|NCT02944968|Johnson and Johnson Medical NV/SA|Nathalie Macours, Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
20187754|NCT00631475|Actelion Pharmaceuticals Ltd|Isabelle Leconte, PhD/Data Science Group Leader, Director|+ 41 61 565 64 18|isabelle.leconte@actelion.com|
20187755|NCT00303459|Actelion Pharmaceuticals Ltd|Jonathan Tolson|+41 61 565 56 04|jonathon.tolson@actelion.com|
20187756|NCT01146704|Department of Veterans Affairs, VAGLAHS|Dr. Joseph Pisegna|3104783711|Joseph.Pisegna@va.gov|41664
20187757|NCT03691298|Smith+Nephew|Laura Everson|+447718320892|laura.everson@smith-nephew.com|
20187758|NCT04072861|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
20187759|NCT02492711|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
20187760|NCT03663205|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
20165744|NCT03312231|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
20165745|NCT05178173|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
20165746|NCT00453895|University of Würzburg|Prof. Dr. Martin Fassnacht|+49-931-201-39201|fassnacht_m@medizin.uni-wuerzburg.de|
20165747|NCT03157830|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20165748|NCT03694353|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr. Director, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
20165749|NCT04309396|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
20165750|NCT05720897|Indiana University|Stuart Schrader|3172781409|sschrade@iu.edu|
20165751|NCT00400179|Taiho Pharma USA, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20201177|NCT05194345|University of South Florida|Heewon Gray|(813) 974-9881|hlgray@usf.edu|
20165752|NCT04780061|Patterson Institute for Integrative Oncology Research|Clinical Trial Coordinator|6137921222|mlegacy@thechi.ca|1
20165753|NCT00734149|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|gaspa001@mc.duke.edu|
20165754|NCT03205709|Columbia University Medical Center|D.P. Devanand, M.D.|774-8658|dpd3@cumc.columbia.edu|646
20165755|NCT00626106|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20165756|NCT03253393|University of New South Wales|Dr Jacqueline Tan|+612 9385 6551|jacqueline.tan@unsw.edu.au|
20201178|NCT03890679|Tufts Medical Center|Dr. Jonathan Davis|6176365322|jdavis@tuftsmedicalcenter.org|
20165757|NCT03641937|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20165758|NCT01586364|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20165759|NCT00091949|Yale School of Medicine|Walter N. Kernan|203-764-7000|walter.kernan@yale.edu|
20165760|NCT01256788|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Douglas Wyland|864-454-7422|dwyland@ghs.org|
20165761|NCT05366738|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
20201179|NCT04854499|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20165762|NCT05291520|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201180|NCT05415449|Children's Medical Center|Maria Leal|2144560276|Maria.leal@childrens.com|
20165763|NCT01347112|Mayo Clinic|Dr. Richard Hurt|507-284-7313|rhurt@mayo.edu|
20165764|NCT00696072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20201181|NCT05428332|Stanford University|Allen Seo|9254939732|allenseo@stanford.edu|
20201182|NCT03455673|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, manager of clinical trials|+33546455050|caroline.allix-beguec@ght-atlantique17.fr|
20201183|NCT02185521|Philips Healthcare|Dr. Szymon Bieganski|978-284-3271|szymon.bieganski@philips.com|
20201184|NCT00398112|Mayo Clinic|Tait Shanafelt||shanafelt.tait@mayo.edu|
20165765|NCT01597596|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
20165766|NCT01601236|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
20165767|NCT00992108|UCLA Neurology|Marisa Chang, MD|310-794-1870|marisachang@mednet.ucla.edu|
20165768|NCT04639245|Fred Hutchinson Cancer Center|Dr. Damian Green|(855) 557-0555|dgreen@fredhutch.org|
20165769|NCT02189317|Emory University|John W Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
20165770|NCT02419001|Synthetic Biologics Inc.|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
20165771|NCT00535496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20165772|NCT01074814|Translational Drug Development|Linda Vocila, Executive Director Clinical Strategy|6023588311|lvocila@td2inc.com|
20165773|NCT03591406|Vifor (International) Inc.|VIT-IRON-2011-004 Clinical Study Team|+41 58 851 80 00|VIT-IRON-2011-004.study@viforpharma.com|
20165774|NCT01083771|Brown University Oncology Research Group (BrUOG)|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu|
20165775|NCT02208310|University of Michigan|Peter Higgins|7346472964|phiggins@umich.edu|
20165776|NCT00321620|Amgen Inc.|Study Director|866-572-6436||
20165777|NCT01887327|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|ClinicalTrials@mnk.com|5
20165778|NCT01747876|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20165779|NCT02584686|Department of Andrlolgy, Sexology & STDs, Cairo University|Prof. Dr. Hussein Ghanem, Chairman of Andrology Department|00201001176111|hmhghanem@gmail.com|
20165780|NCT01122238|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
20165781|NCT01537666|Savara Inc.|Taneli Jouhikainen, MD, MBA; Chief Operating Officer|(888) 302-4876|info@savarapharma.com|
20165782|NCT02121158|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Michael T. Wininger, Ph.D., Study Biostatistician|203-932-5711|michael.wininger@va.gov|3262
20165783|NCT02703597|University of Florida|Assistant Professor|3526279467|gkhalil@ufl.edu|
20165784|NCT01614886|Novartis Pharmaceuticals|Study Director|862-778-8300||
20165785|NCT01834911|New York Medical College|Dr. Robert Fekete|9143451313|robert_fekete@nymc.edu|
20165786|NCT01523366|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
20165787|NCT02461758|University of Wisconsin School of Medicine and Public Health|FREDDY CALDERA, ASST PROFESSOR , GASTROENTEROLOGY|(608) 263-1995|fcaldera@medicine.wisc.edu|
20165788|NCT01710345|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20165789|NCT01766440|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
20165790|NCT00449696|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
20201185|NCT03802721|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
20165791|NCT01033019|Novartis|Study Director|862-778-8300||
20165792|NCT02105740|Universidade de Brasília|Gil Montenegro|556181487323|prof.gilmontenegro@gmail.com|
20201186|NCT01887912|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
20165793|NCT03431259|Massachusetts General Hospital|Marilyn Heng, Principal Investigator|6176430149|mheng@mgh.harvard.edu|
20165794|NCT03931941|Clinical Development|Clinical Development|651-705-8778|US8-Studyinfo@ferring.com|
20165795|NCT00551642|Mallinckrodt|Medical Information Call Center|800-556-3314|medinfo@mnk.com|
20165796|NCT03011099|UT health PM&R|Chang, Shuo-Hsiu, PT, PhD|713-799-7016|Shuo-Hsiu.Chang@uth.tmc.edu|
20165797|NCT02784548|VA San Diego Healthcare System|Dr. Thomas Rutledge|8585528585|thomas.rutledge@va.gov|7273
20165798|NCT03094325|NYU Langone Health|Daniel Swistel, MD|646-754-7217|Daniel.Swistel@nyulangone.org|
20165799|NCT01903460|Mirum|Study Physician|+1 650-667-4085|medinfo@mirumpharma.com|
20165800|NCT03104868|Northwestern University|Dr. Michael Wolf|312-503-5592|mswolf@northwestern.edu|
20165801|NCT01253291|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20165802|NCT02920632|Amsterdam UMC, Vrije Universiteit|Dr. Chris Vriend|+31625694912|c.vriend@amsterdamumc.nl|
20165803|NCT01838395|BioLineRx Ltd.|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
20165804|NCT00723736|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20165805|NCT01723384|San Francisco Department of Public Healt|Dr. Glenn-Milo Santos|415-437-6231|glenn-milo.santos@ucsf.edu|
20165806|NCT02086175|Dana-Farber Cancer Institute|Caron A. Jacobson, MD|617-632-6404|cajacobson@partners.org|
20165807|NCT00938704|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20165808|NCT02023086|Université de Montréal|Langis Michaud|5149166312|langis.michaud@umontreal.ca|
20165809|NCT04760613|NYU Langone health|Stephen Ross, MD|212-263-6289|Stephen.ross@nyulangone.org|
20165810|NCT03589859|VA Northeast Ohio Healthcare System|Dr. Mark Walker|216-791-3800|mark.walker5@va.gov|65229
20165811|NCT04671901|Memorial Sloan Kettering Cancer Center|Dr. Michael Ortiz MD|212-639-6057|ortizm2@mskcc.org|
20165812|NCT05565742|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20165813|NCT04163341|University of Alabama at Birmingham|Dr. Michael Mugavero|202-966-5822|mmugavero@uab.edu|
20165814|NCT05417438|UMass Chan Medical School|Reem Najjar|7742750890|Reem.najjar@umassmed.edu|
20165815|NCT04272242|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20165816|NCT04053036|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
20165817|NCT02681523|Imperial College London|Laura Kenny|+44 (0)20 7594 2806|l.kenny@imperial.ac.uk|
20165818|NCT04082819|SE Health|SE Research Centre|N/A|research@sehc.com|
20165819|NCT02505919|PROCEPT BioRobotics Corporation|Angela Lee|6502327215|a.lee@procept-biorobotics.com|
20165820|NCT04743778|University of Michigan, School of Social Work|Dr. Jaclynn Hawkins|(734) 615-2817|jachawk@umich.edu|
20165821|NCT01181349|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20165822|NCT01533207|NRG Oncology|Linda Gedeon on behalf of Danielle Enserro, PhD|716-845-1169|linda.gedeon@roswellpark.org|
20165823|NCT00874094|NY Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
20165824|NCT01047358|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165825|NCT00129402|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20165826|NCT03041038|Northwestern University|Dr. Amy Paller|3126953721|NUderm-research@northwestern.edu|
20165827|NCT02131259|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165828|NCT02796170|Tulane University|Dragana Lovre|(504)988-9928|dlovre@tulane.edu|
20165829|NCT02191111|University of Mississippi|Dr. Meagen Rosenthal|662-915-2475|mmrosent@olemiss.edu|
20165830|NCT01527370|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165831|NCT04843007|NanoAlvand|Dr. Hamidreza kafi|9129232594|Kafi.h@orchidpharmed.com|+98
20165832|NCT01352715|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20165833|NCT04596267|Boston Medical Center|Dr. Eric Devine|617-418-7888|eric.devine@bmc.org|
20165834|NCT00071058|National Cancer Institute, National Institutes of Health|Antonio Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
20201187|NCT02924896|Imperial College London|Prof Gary Frost|020 7589 5111|g.frost@imperial.ac.uk|
20201188|NCT04033926|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
20201189|NCT03932812|University of Iowa|Sato Ashida|319-384-1477|sato-ashida@uiowa.edu|
20201190|NCT03155997|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20201191|NCT01111305|NIAID/NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
20201192|NCT00862251|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201193|NCT02796755|Emory University|Andrew H Miller, MD|404-727-8260|amill02@emory.edu|
20201194|NCT02371850|University of Maryland School of Pharmacy|Audra Stinchcomb, PharmD|410-706-2646|astinchc@rx.umaryland.edu|
20201195|NCT05617521|Hospital Central Norte PEMEX|Dr. Antonio Marmolejo|+526142231826|dr.marmolejo.ch@gmail.com|
20201196|NCT00891995|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
20201197|NCT02054702|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20165835|NCT00765206|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20165836|NCT02416206|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
20165837|NCT02000440|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165838|NCT01690143|University of Alabama at Birmingham|Luciano J Costa, Principal Investigator|205-209-6038|ljcosta@uabmc.edu|
20165839|NCT02698215|University of California Los Angeles|Lara Ray, PhD|310-794-5383|lararay@psych.ucla.edu|
20165840|NCT04757766|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
20165841|NCT02226367|VA Puget Sound Health Care System|Murray Raskind, MD|(206) 277-3797|Murray.Raskind@va.gov|
20201198|NCT00848744|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
20201199|NCT04354428|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
20201200|NCT03700047|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
20201201|NCT00670709|UCLA|Jennifer Villalobos|310-825-3351|info@brain.ucla.edu|
20201202|NCT00863551|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20201203|NCT00680225|New England Retina Associates|Dr. Peter Liggett|203-288-2020|neretina@msn.com|
20201204|NCT01111604|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979||
20201205|NCT02494570|Aadi Bioscience|Medical Information|1-888-246-2234|MedInfo@aadibio.com|
20201206|NCT01295125|University Hosptials Cleveland Medical Center|Dr. Michael Rosen|216-396-9937|rosenm@ccf.org|
20201207|NCT01360996|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
20201208|NCT01454076|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20201209|NCT02965378|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
20201210|NCT04964258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20201211|NCT04525703|University of Wisconsin - Madison|Pajarita Charles, PhD|608-263-3834|paja.charles@wisc.edu|
20165842|NCT00870740|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20165843|NCT04006288|University of Florida|Dr. Dominick J Angiolillo. Professor of med University of Florida College of Medicine-Jacksonville|904-244-3378|dominick.angiolillo@jax.ufl.edu|
20165844|NCT00129246|Associate Professor of Psychiatry and Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven|Benjamin A. Toll, PhD|(203) 974 5767|benjamin.toll@yale.edu|
20165845|NCT02252666|University of Wisconsin - Madison|Dr. Mitchell Tyler|(608) 262-5112|metyler1@wisc.edu|
20165846|NCT00283296|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
20165847|NCT01353898|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165848|NCT02668653|Daiichi Sankyo Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20165849|NCT03558737|University of Utah|Bradley Yoder|801-581-7052|bradley.yoder@hsc.utah.edu|
20165850|NCT01294553|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165851|NCT03041181|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
20165852|NCT03224819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20165853|NCT03536572|VA San Diego Healthcare System|Carl J. Stepnowky, Deputy ACOS R&D|858-642-3269|carl.stepnowsky@va.gov|
20165854|NCT00005780|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
20165855|NCT04973449|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20165856|NCT01539824|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
20165857|NCT02735863|ABIVAX|Sharon Skare|+33153830961|sharon.skare@abivax.com|
20165858|NCT00829426|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20165859|NCT03955146|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|zephyrus@fibrogen.com|
20165860|NCT02628873|Wright State University|Steven Lindheim|858-740-1083|doclalalindheim@gmail.com|
20165861|NCT00537134|Centre Hospitalier de l'Université de Montréal (CHUM)|Ruby Klink|(514) 890-8000|ruby.klink.chum@ssss.gouv.qc.ca|27235
20165862|NCT02560038|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
20165863|NCT03597347|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
20165864|NCT04606134|University of Rochester Medical Center|Mara Weinstein MD|(585) 275-7546|Mara_Weinsteinvelez@URMC.Rochester.edu|
20165865|NCT00107653|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20165866|NCT02961894|Rex Medical|Colin Valentis|610-629-6051|cvalentis@rexmedical.com|
20165867|NCT01099267|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20165868|NCT04986904|University of Virginia|Dr. Kelly Shaffer|434-982-1022|kshaffer@virginia.edu|
20165869|NCT02867436|Motol University Hospital|Zdeněk Šumník, PI|+420702000087|zdenek.sumnik@lfmotol.cuni.cz|
20165870|NCT01551186|Washington University School of Medicine, St. Louis, Missouri|Dr. Erik Dubberke, MD, MSPH|314-454-8354|edubberk@wustl.edu|
20165871|NCT02018562|Johns Hopkins University|Vinciya Pandian PhD, MSN, RN, ACNP-BC, FAAN|4436553482|vpandia1@jhu.edu|
20165872|NCT04080505|Columbia University|Jennifer Kuo, MD|212-305-6969|jhk2029@cumc.columbia.edu|
20165873|NCT03175679|BeijingYouanH|Dr. LJUN|861366138148|lujun98@ccmu.edu.cn|
20165874|NCT05494385|Indiana University School of Medicine|Dr. Anna Guanzon|2197651884|amguanzon89@gmail.com|
20165875|NCT03108131|The University of Texas MD Anderson Cancer Center|Dr. Kanwal Raghav|(917) 733-0356|kpraghav@mdanderson.org|
20201212|NCT00291551|Paracor Medical, Inc.|Michael Kolber, General Manager, VP, Regulatory Affairs|408-734-6000|info@paracor.com|
20165876|NCT04050553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20165877|NCT05430854|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20165878|NCT04314284|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
20165879|NCT03353688|University of Alabama at Birmingham|Program Manger|(205) 934-0683|clg17@uab.edu|
20165880|NCT01652235|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
20201213|NCT02452762|Children's Hospital of Eastern Ontario|James Dayre McNally, Principal Investigator and Pediatric Intensivist|613-737-7600|dmcnally@cheo.on.ca|3553
20201214|NCT01957137|Pelvic Health and Gastric Therapies|Rachael McNamara / Clinical Research Specialist|763.526.8107|rachael.m.mcnamara@medtronic.com|
20201215|NCT01656772|Stereotaxis, Inc.|Qun Sha M.D. (Study Director)|314-678-6143|qun.sha@stereotaxis.com|
20165881|NCT03472885|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20165882|NCT02201953|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20165883|NCT04051996|Yale University|Dr. Amer Zeidan|(203) 200-4363|amer.zeidan@yale.edu|
20165884|NCT06904586|Duzce University|Assistant Professor|+905059313588|gizem123demir@hotmail.com|
20165885|NCT01710501|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165886|NCT02536976|Struthers Parkinson's Center|Dr. Sotirios Parashos|001-952-993-5495|sotirios.parashos@parknicolet.com|
20165887|NCT01198795|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|58124
20165888|NCT01271946|Arstasis|Debra Cogan, Director of Quality, Regulatory and Clinical|650-261-8073|dcogan@arstasis.com|
20165889|NCT01472289|TotipotentSC|Dr. Venkatesh Ponemone|+91-124-4976860|venkatesh.ponemone@totipotentsc.com|
20165890|NCT02435992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20165891|NCT04004988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20165892|NCT00912808|Oregon Health & Science University|Kathryn Chung, MD|503 220 8262|chungka@ohsu.edu|51091
20165893|NCT03873116|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20165894|NCT02989597|Montefiore Medical Center|Dr. Andrew J. Kobets|718-920-7400|akobets@montefiore.org|
20165895|NCT02531802|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20165896|NCT03611829|McGill University|Mallory Frayn, PhD (c)|514-398-1399|mallory.frayn@mail.mcgill.ca|
20165897|NCT03941288|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
20165898|NCT04454918|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20187761|NCT05932407|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20187762|NCT05890105|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187763|NCT04505410|University of Miami Miller School of Medicine|Associate Professor, Director of Translational Studies for the Crohn's and Colitis Center|3057733573|odamas@med.miami.edu|
20187764|NCT03419052|Indiana University|Daniel Clark, PhD|317-274-9292|daniclar@iu.edu|
20187765|NCT05123027|Medical University of South Carolina|Dr. Ralph Ward|843-876-6110|wardrc@musc.edu|
20187766|NCT06946888|Kaohsiung Veterans General Hospital|Li-Ying Lin|07-3422121|llylin@vghks.gov.tw|71571
20187767|NCT05505578|225.763.2500 Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20187768|NCT05311176|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
20187769|NCT05464069|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
20187770|NCT05320406|Emory University|Dr. Sagar Patel|404-778-1900|sagar.patel@emory.edu|
20187771|NCT01449513|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
20187772|NCT04200313|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|kruedy@jaeb.org|
20187773|NCT05524116|Boston University|Dr. Deepak Kumar|3026901455|kumard@bu.edu|
20187774|NCT01540994|Sharp Healthcare|Dr. Geoffrey Weinstein|858-939-5010|geoffrey.weinstein@sharp.com|
20187775|NCT03489434|Georgia State University|Amanda Gilmore|404-413-2000|agilmore12@gsu.edu|
20187776|NCT05552508|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20187777|NCT04605159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20187778|NCT02787031|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20187779|NCT05717400|M D Anderson Cancer Center|Harrys A. Torres, MD|(713) 792-6503|htorres@mdanderson.org|
20187780|NCT05424380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20187781|NCT03204825|University of Stirling|Dr Chris Seenan|+441413318151|christopher.seenan@stir.ac.uk|
20187782|NCT02909686|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
20187783|NCT05268276|Faculty of nursing /cairo university|Asmaa Abdallah Ahmed Hussein|01006961502|asmaaabdallah.cu@cu.edu.eg|
20187784|NCT03015532|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20187785|NCT03914469|UT Southwestern Medical Center|Dr. Makris|214 648 3133|una.makris@utsouthwestern.edu|
20187786|NCT03318159|Seoul National University Hospital|Dr. Koh|82220727217|go01@snu.ac.kr|
20187787|NCT04574583|National Cancer Institute|Dr. James Gulley|301-480-8870|james.gulley@nih.gov|
20187788|NCT00677365|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
20187789|NCT05422885|Marcus Institute|Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
20187790|NCT01121588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187791|NCT00942877|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@nih.gov|
20187792|NCT04502186|University of Michigan School of Social Work|Dr. Addie Weaver|734-615-2122|weaverad@umich.edu|
20187793|NCT01385202|Biosense Webster, Inc.|Robert Stagg, Manager, Clinical Operations|(800) 729-9010|RStagg@its.jnj.com|8611
20187794|NCT02874742|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187795|NCT04332211|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi MD|4103288025|Mak.Moayedi@som.umaryland.edu|
20187796|NCT04068792|Janssen Research & Development, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187797|NCT03969563|VA Northern California Health Care System|Dr. Jerry Nadler, Chief of Research|9168432776|Jerry.Nadler@va.gov|
20187798|NCT02561611|Pennington Biomedical Research Center|Corby Martin|225-763-2585|Corby.Martin@pbrc.edu|
20187799|NCT05571267|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
20187800|NCT04424316|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20187801|NCT05070741|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
20165899|NCT02871934|VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA|Dr. Jason Vassy|857-364-2561|jvassy@partners.org|
20165900|NCT00538902|Abbott|Global Medical Services|800-633-9110||
20165901|NCT00425802|Memorial Sloan Kettering Cancer Center|Hugo Castro-Malaspina, MD|212-639-8197|castro-h@mskcc.org|
20165902|NCT03131570|ROCKEFELLER UNIVERSITY|Dr. James G. Krueger|2123277409|KRUEGEJ@MAIL.ROCKEFELLER.EDU|
20165903|NCT00497081|San Francisco Department of Public Health|Glenn-Milo Santos, MPH|415.437.6231|glenn-milo.santos@sfdph.org|
20165904|NCT04109547|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20201216|NCT01651780|The Medicines Company|Global Health Science Center|800-388-1183||
20165905|NCT00871975|LABORIE|Clinical Research Administrator|905 612 1170|acampbell@laborie.com|2274
20201217|NCT03898063|University of Miami|Nick Carcioppolo|3052845633|n.carcioppolo@miami.edu|
20165906|NCT01210313|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
20165907|NCT03982355|IMperial COllege London|Dr SImon Dryden|+447828464949|simon.dryden@imperial.ac.uk|
20165908|NCT03773978|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20165909|NCT03592186|Brown University School of Public Health|Sara Becker, Ph.D, Principal Investigator|4018636604|sara_becker@brown.edu|
20165910|NCT03755934|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20165911|NCT00817843|UMC Utrecht|Professor F.L.J. Visseren, MD PhD|0031-88-7555555|f.l.j.visseren@umcutrecht.nl|
20165912|NCT01052493|Imperial College London|Dr Tricia Tan|020 83838038|t.tan@imperial.ac.uk|
20165913|NCT00307801|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20165914|NCT01498068|Janssen Belgium|Compound Development Team Leader|32 14 64 13 70||
20165915|NCT03944577|University of Nebraska Medical Center|Douglas Stoller|402-559-0815|douglas.stoller@unmc.edu|
20165916|NCT02596867|TTUHSC-EP|Zeina Nahleh|9152155195|zeina.nahleh@ttuhsc.edu|
20165917|NCT00391586|Dana Farber Cancer Institute|Dennie Jones, MD|617-632-6478|DennieV_Jones@DFCI.HARVARD.EDU|
20201218|NCT02949830|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20201219|NCT00054132|Memorial Sloan Kettering Cancer Center|Dr. Maura Dickler|646-888-4560|dicklerm@mskcc.org|
20201220|NCT01290887|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20201221|NCT01628926|Otsuka Pharmaceutical Co, Lts.|Director of Clinical Research and Development|+81-3-6361-7366||
20201222|NCT00323284|Glaukos|Jeff Wells, Sr. VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
20201223|NCT01272583|Academic Medical Center|Dr. Josefine E. Schopman|+31 20 5669111|j.e.schopman@amc.uva.nl|
20201224|NCT03437447|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20201225|NCT03952559|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20201226|NCT02875223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20201227|NCT01110252|Labcel|João Tadeu Ribeiro Paes|55 18 3302 5800|labcel.tronco@gmail.com|5856
20201228|NCT03636906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201229|NCT00891202|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20201230|NCT03431467|The Hospital of the University of Pennsylvania|Dr. Christian Bermudez|2153165151|christian.bermudez@pennmedicine.upenn.edu|
20201231|NCT04596891|New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
20201232|NCT03690869|Regeneron Pharmaceuticals Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20201233|NCT04981223|Stanford University|Dr. Geoffrey Sonn|(650) 498-6000|gsonn@stanford.edu|
20201234|NCT04280081|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20201235|NCT03896581|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20201236|NCT04063384|University of Texas at Austin|Dr. Elizabeth Lippard|512-495-5216|elizabeth.lippard@austin.utexas.edu|
20201237|NCT03263806|Beaumont Hospitals|Korana Stakich-Alpirez|248 898 0315|Korana.Stakich-Alpirez@beaumont.org|
20201238|NCT00142506|MEMORIAL SLOAN KETTERING CANCER CENTER|MICHAEL J ZELEFSKY|+1212-639-6802|zelefskm@MSKCC.ORG|
20201239|NCT03275870|Beth Israel Lahey Health|Dr. Elena Gonzalez Brant, PI|6173191221|emgbrant@gmail.com|
20201240|NCT01133639|Mount Auburn|Emily Cook|(617) 354-3131|ecook@mah.harvard.edu|
20201241|NCT00450580|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201242|NCT06331884|4TEEN4 Pharmaceuticals|Kathleen Richter|0049 1784027078|richter@4teen4.de|
20201243|NCT04091347|Johns Hopkins School of Nursing|Janiece Taylor|443-287-4503|jwalke90@jhu.edu|
20201244|NCT04572633|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
20201245|NCT00332709|Novartis Pharmaceuticals|Study Director|862-778-8300||
20201246|NCT06161012|Johnson & Johnson Vision Care, Inc. (JJVC)|David Murakami, OD, MPH, FAAO|1-800-843-2020|dmuraka2@its.jnj.com|
20201247|NCT01933932|AstraZeneca Research and Development|Dr Gabriella Mariani|+44 (0)1763 263801|ClinicalTrialTransparency@astrazeneca.com|
20201248|NCT00408005|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20201249|NCT05424276|ABLi Therapeutics|Milton Werner|9174940831|info@ablitherapeutics.com|
20201250|NCT04526730|Moffitt Cancer Center|Ahmad Tarhini, MD, PhD|813-745-8581|Ahmad.Tarhini@moffitt.org|
20201251|NCT01701258|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
20201252|NCT04454489|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336 -713-5440|mporosnicu@wakehealth.edu|
20165918|NCT00198822|Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health|Prof. Keith P West, Jr., Principal Investigator|410-955-2061|kwest@jhsph.edu|
20201253|NCT03049449|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
20201254|NCT00887458|Johns Hopkins University|Dr. Michael Carducci|410-614-3977|carducci@jhmi.edu|
20201255|NCT01262898|GlaxoSmithKline|GSK Response Center|866-435-7343||
20165919|NCT02968758|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
20165920|NCT00453206|Wake Forest University Health Sciences|David Hurd, MD|336-716-2843|dhurd@wakehealth.edu|
20165921|NCT00577889|Mayo Clinic Cancer Center|Robert McWilliams, M.D.||McWilliams.robert@mayo.edu|
20165922|NCT01467960|Villa Melitta|Sarah Dassati|+39 0471 471|sarahdassati@yahoo.it|471
20165923|NCT00888173|NRG Oncology|Linda Gedeon For Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
20165924|NCT03542487|Office of Evaluation Sciences, General Services Administration|Mattie Toma|859-621-0517|mattie.toma@gsa.gov|
20165925|NCT00737672|W.L. Gore and Associates, Inc.|Clinical Project Manager|928-864-3771|cavery@wlgore.com|
20165926|NCT03529669|Oxford University Hospitals NHS Trust|Dr Somnath Mukherjee|01865 617018|Somnath.Mukherjee@ouh.nhs.uk|
20165927|NCT04798183|Pusan National University Yangsan Hospital|Sungchul huh, M.D., Ph.D.||dr.huhsc@gmail.com|0553604250
20165928|NCT00311766|RegeneRx Biopharmaceuticals, Inc.|Study Director, David R. Crockford|617-285-5588|dcrockford@regenerx.com|
20165929|NCT02002598|Columbia University|Suzanne Lentzsch, MD|646-317-4840|sl3440@cumc.columbia.edu|
20165930|NCT04672239|Recovery Research Institute, Department of Psychiatry, Massachusetts General Hospital|Bettina B. Hoeppner, Ph.D., MS|617-643-1988|bhoeppner@mgh.harvard.edu|
20165931|NCT00541658|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20165932|NCT03373240|Yale University|Dr. Arielle Baskin-Sommers|203-432-9257|arielle.baskin-sommers@yale.edu|
20165933|NCT04123470|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
20165934|NCT04029883|Cedars-Sinai Medical Center|Dr. Joseph Ebinger|424-315-2284|cda-research@cshs.org|
20165935|NCT04876521|All India Institute of Medical Sciences|Dr. Biswa Ranjan Mishra|09438884220|psych_biswa@aiimsbhubaneswar.edu.in|
20165936|NCT05972993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20165937|NCT04792645|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
20165938|NCT03866577|Momenta Pharmaceuticals, Inc.|Senior Director Clinical Development Head Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20165939|NCT05530252|BeijingSHCMU|Dr.Nannan Han|15701545851|qhddenver@126.com|
20165940|NCT04370873|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20165941|NCT02344108|Mass General Brigham|Matthew E Stenerson, MS, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
20165942|NCT01535040|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20165943|NCT01074970|Hoosier Cancer Research Network|Director of Clinical Data Management|317-634-5842|jsmith@hoosiercancer.org|41
20165944|NCT01664975|Zhengzhou University|Mingzhi Zhang|0371-66295564|mingzhi_zhang@126.com|
20165945|NCT05523089|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
20165946|NCT02514083|National Heart Lung and Blood Institute (NHLBI)|Inhye Ahn, M.D.|301-827-1203|inhye.ahn@nih.gov|
20165947|NCT01899040|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
20165948|NCT02638220|Travere Therapeutics, Inc.|Cheryl Wong Po Foo/Director, Clinical Development|8889697879|cheryl.wongpofoo@travere.com|
20165949|NCT01350258|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
20165950|NCT02153632|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|9088091357|gwagner@osmotica.ccom|
20165951|NCT02393378|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20165952|NCT00071890|INSERM U897 Bordeaux FRANCE|Pr G. Chene|557571392|genevieve.chene@isped.u-bordeaux2.fr|+33
20165953|NCT02144610|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
20201256|NCT00792298|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201257|NCT00499109|H. Lee Moffitt Cancer Center and Research Institute|Charles C. Williams, M.D., Study Chair|813-745-7282|charles.williams@moffitt.org|
20201258|NCT01756274|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20156121|NCT01375140|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
20156122|NCT03382873|Indiana University|Dr. Carla Miller (current affiliation)|812-855-1608|ckm1@iu.edu|
20156123|NCT05021224|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
20156124|NCT03996395|Baylor College of Medicine|Nancy E. Moran, PhD|713-798-0520|nancy.moran@bcm.edu|
20156125|NCT05375929|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156126|NCT03973489|VA Portland Health Care System|William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
20156127|NCT03301415|The University of Alabama at Birmingham|David W. Kimberlin, MD|205-934-5316|dkimberlin@peds.uab.edu|
20156128|NCT03247673|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
20156129|NCT00622843|Infectious Disease Clinical Research Program, Uniformed Services University and HJF|Dr. Brian Agan, Deputy Science Director|240-694-2946|bagan@idcrp.org|
20156130|NCT02184442|Edwards Life Sciences|Tenley Koepnick|949-250-6504|Tenley_Koepnick@Edwards.com|
20156131|NCT00966446|Perelman School of Medicine, University of Pennsylvania|Ebbing Lautenbach, MD, MPH, MSCE|215-898-6977|ebbing@mail.med.upenn.edu|
20156132|NCT04110145|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20156133|NCT00980044|University of Kentucky College of Medicine|Michelle Lofwall, MD, Associate Professor|8593239321|michelle.lofwall@uky.edu|
20156134|NCT03026777|LSUHSC New Orleans|Dr. David Janz|504-913-5006|djanz@lsuhsc.edu|
20156135|NCT00963638|William Beaumont Hospitals|Catherine Coleman, RN, BSN|248-655-5865|cjcoleman@beaumont.edu|
20156136|NCT04622267|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
20156137|NCT00833703|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
20156138|NCT02553473|Sørlandet hospital HF|Anne Marit Solheim, MD|0047 38 07 39 10|anne.marit.solheim@sshf.no|
20156139|NCT01557569|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
20165954|NCT02169427|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20165955|NCT01432730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165956|NCT03881852|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
20165957|NCT05887388|University of North Carolina at Chapel Hill|Mark Toles, PhD|919-966-5684|mtoles@email.unc.edu|
20165958|NCT01550224|Stanford University Medical Center|Steven Edward Coutre, MD; Professor of Medicine (Hematology)|650-725-4040|coutre@stanford.edu|
20165959|NCT01424215|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
20165960|NCT02993107|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20165961|NCT03038100|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20165962|NCT01116986|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
20165963|NCT03250273|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
20165964|NCT04154904|Oregon Health and Science University|Jessica Castle|1503-494-7072|castleje@ohsu.edu|
20165965|NCT02392624|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20165966|NCT00936715|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20165967|NCT03841604|Zambon SpA|Elena Tiberio, BSc|+39 02665241|clinicaltrials@zambongroup.com|
20165968|NCT02492763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20165969|NCT01337960|VA Maryland Health Care System|Larry Forrester, PhD|410-637-3241|Larry.Forrester@va.gov|
20165970|NCT03877510|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
20165971|NCT00267059|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Associate Professor|713-792-2063|eharriso@mdanderson.org|
20165972|NCT02085161|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20165973|NCT04591353|University of Alabama at Birmingham|Promil Kukreja|205-934-4042|Pkukreja@uab.edu|
20165974|NCT03537404|R-Pharm|Emiliya Krasavina, Medical Adviser|0074959567937|krasavina@rpharm.ru|
20165975|NCT01936870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165976|NCT00842335|Jubilant Clinsys Inc.|Jane Fisher, Senior Manager, Regulatory Affairs|+1 (919) 518-8786|jfisher@clinsys.com|
20165977|NCT02930824|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
20165978|NCT00628108|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20165979|NCT03848832|GW Research Ltd|Medical Enquiries|1-833-424-6724|medinfo@gbio.com|
20165980|NCT02494323|Bet-Loewenstein|Dr.Yaron Sacher|97297709918|ysacher@clalit.org.il|
20165981|NCT00719472|Genentech, Inc.|Medical Communications|800-821-8590||
20165982|NCT02086500|University of Pittsburgh|Dr. Jason Sperry MD, MPH|4128028270|sperryjl@upmc.edu|
20165983|NCT00711191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20165984|NCT01744977|Durham Veterans Affairs Medical Center|Hayden Bosworth, PhD|919-286-6936|hayden.bosworth@va.gov|
20165985|NCT01213472|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
20165986|NCT00767364|Wayne State University School of Medicine, Children's Hospital of Michigan|Eric McGrath, MD|313-745-5863|emcgrath@med.wayne.edu|
20165987|NCT03345784|University Health Network, Princess Margaret Cancer Centre|Dr. Stephanie Lheureux, PI|416-946-2818|stephanie.lheureux@uhnresearch.ca|
20165988|NCT03415685|Lutronic|Alexander Denis, Global Manager of Clinical Research|9788959206|adenis@lutronic.com|
20165989|NCT02512783|Children's Hospitals and Clinics of Minnesota|Angela Doucette|6128137144|angela.doucette@childrensmn.org|
20165990|NCT00482053|Stanford University Medical Center|Wen-Kai Weng, Assistant Professor of Medicine|650-723-7689|wkweng@stanford.edu|
20165991|NCT00728689|Siga Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
20165992|NCT02415608|Stanford University Medical Center|Jason Robert Gotlib, MD; Professor of Medicine (Hematology)|650-498-6000|C.Langford@stanford.edu|
20165993|NCT01055197|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20165994|NCT00389610|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
20165995|NCT00887809|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
20165996|NCT01615484|University of North Carolina at Chapel Hill|Thomas Egan, MD, MSc, FACS|919-966-3381|thomas_egan@med.unc.edu|
20165997|NCT01550003|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20165998|NCT05567783|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20165999|NCT05005182|Mayo Clinic|Abhishek Mangaonkar|507-538-0173|Mangaonkar.Abhishek@mayo.edu|
20166000|NCT03675126|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
20166001|NCT00001959|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
20166002|NCT03113487|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20166003|NCT03777982|Dana Farber/Mass General Brigham Cancer Care|Anthony D'Amico|857-215-1489|adamico@bwh.harvard.edu|
20166004|NCT02958995|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20166005|NCT04189952|University of Miami|Craig Moskowitz, MD|305-243-9009|chm78@med.miami.edu|
20166006|NCT04475081|Louisiana State University Health - New Orleans|Associate Dean for Research|9858693445|pfidel@lsuhsc.edu|
20166007|NCT04298697|Emory University|Colleen Kelley, MD, MPH|404-712-1823|colleen.kelley@emory.edu|
20166008|NCT03995368|VA Greater Los Angeles Healthcare System|Dr. Jonathan K. Wynn|3104783711|Jonathan.Wynn@va.gov|44957
20166009|NCT04266717|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
20166010|NCT00361296|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
20166011|NCT00940771|Bill Holt Clinic, Phoenix Children's Hospital|Janice Piatt, MD, Medical Director|602-933-0955|jpiatt@phoenixchildrens.com|
20166012|NCT01032538|Martina Hansens Hospital|Tor Kjetil Nerhus|+47 93409934|kjnerhus@gmail.com|
20166013|NCT03058146|University of California, San Diego|Dr. Zvinka Zlatar|858-822-7737|zzlatar@health.ucsd.edu|
20166014|NCT00632229|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
20166015|NCT02323217|Imperial College London|Dr Robin J Tyacke|(0)20 7594 7096|r.tyacke@imperial.ac.uk|+44
20166016|NCT03146585|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
20166017|NCT00993967|Santhera Pharmaceuticals|Thomas Meier, PhD|+41 61 906 89 50|thomas.meier@santhera.com <Thomas.Meier@santhera.com>|
20166018|NCT03783078|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20166019|NCT05452486|University of Arkansas for Medical Sciences|Dr. Caitlin Price|(501) 686-8125|CEPrice@uams.edu|
20166020|NCT04825678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20166021|NCT00651742|Taiho Oncology, Inc|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20166022|NCT00911170|Amgen Inc.|Study Director|866-572-6436||
20166023|NCT02594124|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20166024|NCT01824836|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20166025|NCT00664443|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20166026|NCT00595088|Bnai Zion Medical Center|Dr. Sarel Halachmi|+97248359542|sarel.halachmi@b-zion.org.il|
20166027|NCT00735436|Duke University Medical Center|Annick Desjardins, MD, FRCPC||annick.desjardins@dm.duke.edu|
20166028|NCT04323124|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166029|NCT02083354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20166030|NCT01615120|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
20166031|NCT02937116|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20166032|NCT02066181|Memorial Sloan-Kettering Cancer Center|Mrinal Murugesan Gounder M.D.|646-888-4167|gounderm@mskcc.org|
20166033|NCT00354978|UT MD Anderson Cancer Center|Scott Kopetz, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
20166034|NCT05764785|University of Massachusetts Boston|Dr. Jean Rhodes|(617) 620-9147‬|jean.rhodes@umb.edu|
20166035|NCT02141295|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20166036|NCT01671319|University of Wisconsin Carbone Cancer Center|Dr. Amyé Tevaarwerk|608-262-2837|at4@medicine.wisc.edu|
20166037|NCT01389596|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166038|NCT00214201|UW Madison|Director of Clinical Trials|608-263-2565||
20166039|NCT01354899|Molnlycke Health Care AB|Tina Kjellen|+46317223098|tina.kjellen@molnlycke.com|
20166040|NCT00463567|Novartis Pharmaceuticals|Study Director|862-778-8300||
20166041|NCT00641667|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20166042|NCT01235741|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20156140|NCT03895476|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
20156141|NCT02254460|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156142|NCT02267447|Ottawa Hospital Research Institute|Dr. Doug Manuel|613-798-5555|dmanuel@ohri.ca|19108
20156143|NCT03257657|University of Colorado|Darcy Thompson, Associate Professor|303 724 7471|darcy.thompson@ucdenver.edu|
20156144|NCT00137449|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20156145|NCT02296099|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
20156146|NCT00690339|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
20156147|NCT02263547|University of South Florida, COM Neurology|Assistant Director of Research|8139746378|aaungst@health.usf.edu|
20156148|NCT00685295|Harvard/MGH|Stephen Thomas|6177267622|sthomasmd@gmail.com|
20156149|NCT03707821|Johnson & Johnson VIsion|John Buch OD, MS, FAAO Sr. Principal Research Optometrist|9044431707|JBUCH@its.jnj.com|
20156150|NCT00414609|Novartis Pharmaceuticals|Study Director|862-778-8300||
20156151|NCT00266032|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20156152|NCT00124657|St. Jude Children's Research Hospital|Alberto Broniscer, MD|866-966-5934|info@stjude.org|
20166043|NCT01421719|Stanford University|Rodney U. Anderson, MD|6504984240|rua@stanford.edu|
20166044|NCT01124006|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
20166045|NCT00565084|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20166046|NCT01712399|MedImmune, LLC.|Marius Albulescu, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
20166047|NCT01357850|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166048|NCT04610281|Ullo World|Dr. Brigitte Laurent|+33782096875|brigitte@ullo.fr|
20166049|NCT02648919|University of Hawaii Cancer Center|Stacy Mercado, IIT/ Education Manager|8084404561|smercado@cc.hawaii.edu|
20166050|NCT01803607|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166051|NCT03824769|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
20166052|NCT00632814|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20166053|NCT00706238|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166054|NCT03819114|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20166055|NCT01772316|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20156153|NCT03318393|UT Southwestern Medical Center|Lakshmi Raman|214-456-6222|lakshmi.raman@utsw.edu|
20166056|NCT01213316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166057|NCT04790916|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20156154|NCT03680521|Mirati Therapeutics|Sr. Clinical Operations Trial Manager|858-332-3540|hallinm@mirati.com|
20166058|NCT00832299|Beth Israel Medical Center|Peter Kozuch, MD||pkozuch@chpnet.org|
20166059|NCT04646044|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20166060|NCT04803396|Dompé farmaceutici SpA|dr. Mauro P. Ferrari|+39 02 583831|clinops@pec.dompe.it|
20166061|NCT03038880|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20166062|NCT02803580|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166063|NCT02633306|University of Minenesota|Stephen Haines, MD|612 624-6666|shaines@umn.edu|
20166064|NCT03910244|Cleveland Clinic|Keith McCrae, MD|216-445-7809|mccraek@ccf.org|
20166065|NCT01101867|The Ohio State University|Dr. Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
20166066|NCT03774576|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20166067|NCT01746901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166068|NCT02683577|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
20166069|NCT03594110|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166070|NCT03734692|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
20166071|NCT02085460|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20166072|NCT00089752|University of Pennsylvania School of Nursing|Terri E. Weaver, PhD, RN, FAAN|215-898-2992|tew@nursing.upenn.edu|
20166073|NCT00907335|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
20166074|NCT03879772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166075|NCT00930046|Boston Children's Hospital|Dr. Navil Sethna|781-216-1650|navil.sethna@childrens.harvard.edu|
20166076|NCT01598532|Spaulding Rehabilitation Hospital|Ross D. Zafonte, DO|617-952-5227|rzafonte@partners.org|
20166077|NCT00702221|BTG International Inc.|SVP, Clinical Development|610-278-1660|thomas.king@btgplc.com|
20166078|NCT03769519|Duke|Isaretta L. Riley, MD, MPH|919-286-0411|isaretta.riley@duke.edu|
20166079|NCT03429270|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
20166080|NCT04798196|UW-Madison|Gina Landucci|(608) 890-1440|gina.landucci@wisc.edu|
20166081|NCT01249261|Warner Chilcott|Grexan J. Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20166082|NCT03114683|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20166083|NCT01967940|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
20201259|NCT03371355|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20201260|NCT02633540|Fox Chase Cancer Center|Dr. Thomas Galloway|215-728-5536|Thomas.Galloway@fccc.edu|
20201261|NCT00661583|University of Colorado Denver|Dr.Malik Kahook|720-848-2020|malik.kahook@ucdenver.edu|
20201262|NCT01508455|Hospira|Dr. Marcelo Garcia da Rocha|224-212-4424|marcelo.rocha@hospira.com|
20201263|NCT01231412|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20201264|NCT03040024|Emory University|Dr. Amit Prabhakar|404-686-2747|amit.prabhakar@emory.edu|
20201265|NCT02278783|Huntsman Cancer Institute|Theresa Werner|801-587-3486|theresa.werner@hci.utah.edu|
20201266|NCT00096161|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20201267|NCT00584870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201268|NCT03682120|St Louis University School of Medicine|Sharon Frey, MD|314-997-5500|sharon.frey@health.slu.edu|
20201269|NCT01015833|Memorial Sloan-Kettering Cancer Center|Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
20201270|NCT02630953|Brown University|Dr. Bess Marcus, Principle Investigator|401-863-6950|bess_marcus@brown.edu|
20201271|NCT02844998|Ankara TRH|Dr. Muhammet Fatih Kilinc|+90 312 595 3700|mdfatihkilinc@yahoo.com|3724
20201272|NCT00650858|Johns Hopkins University|Daniel F. Hanley, MD|410-614-6996|dhanley@jhmi.edu|
20201273|NCT03633084|Ribomic USA|Yusuf Ali, Ph.D.|(707) 287-4313|yusuf.ali@ribomic.com|
20201274|NCT02914509|Ocular Therapeutix, Inc.|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
20201275|NCT03529409|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
20201276|NCT01497262|Novartis Pharmaceuticals|Study director|862-778-8300||
20201277|NCT03359902|University of Florida|John Williamson|352-548-6920|john.williamson@ufl.edu|
20201278|NCT01795547|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
20201279|NCT01551745|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
20201280|NCT00382148|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
20201281|NCT02764541|Dana-Farber Cancer Institute|Otto Metzger|6176323800|otto_metzger@dfci.harvard.edu|
20201282|NCT02040142|Montefiore Medical Center|Dr. John McAuliffe, Associate Professor Department of Surgery and Department of Pathology|718-379-6865|jomcauli@montefiore.org|
20201283|NCT04752384|Medical College of Wisconsin|Stuart J. Wong, MD|414-805-4600|swong@mcw.edu|
20201284|NCT04828330|VA Puget Sound Health Care System|Dr. Pradeep Suri|207-762-1010|pradeep.suri@va.gov|
20201285|NCT02330419|Department of Community Health Systems, University of California at San Francisco|Glenn-Milo Santos, Associate Professor|(628) 2177-6231|glenn-milo.santos@ucsf.edu|
20201286|NCT01997463|University of Arizona|Clara Ehrman|520-621-5439|csehrman@email.arizona.edu|
20201287|NCT00667615|Memorial Sloan Kettering Cancer Center|David Straus MD|212-639-8365|strausd@mskcc.org|
20201288|NCT01955707|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20201289|NCT01905956|InQpharm Europe Ltd|Pee-Win Chong|+603 6201 9690|pwchong@inqpharm.com|358
20201290|NCT04167345|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20201291|NCT01445171|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
20201292|NCT00951821|Brown University|Anthony Spirito|401-444-1929|anthony_spirito@brown.edu|
20201293|NCT03804671|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201294|NCT03480802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201295|NCT02557178|Mayo Clinic|Johanna Hoult|507-293-1989|hoult.johanna@mayo.edu|
20201296|NCT02542267|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
20156155|NCT00814983|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
20156156|NCT01935947|Johns Hopkins University|Gary Rosner|410-955-4884|grosner1@jhmi.edu|
20156157|NCT00836901|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156158|NCT00830336|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156159|NCT01148771|Center for Anti-Infective Research and Development, Hartford Hospital|Joseph L. Kuti, Pharm.D. / Associate Director, Clinical and Economic Studies|860-545-3612|jkuti@harthosp.org|
20156160|NCT01229111|Case Comprehensive Cancer Center|Dr. Smitha Krishnamurthi|216-844-5234|smitha.krishnamurhti@uhhospitals.org|
20156161|NCT04102514|University of Kansas Medical Center|Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
20156162|NCT03268499|The Chinese University of Hong Kong|Simon Chun Ho Yu|+852 35051035|simonyu@cuhk.edu.hk|
20156163|NCT04169009|University of Colorado Anschutz Medical Campus|Adriana Weinberg MD|303-724-4480|adriana.weinberg@cuanschutz.edu|
20156164|NCT02517918|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
20156165|NCT05702047|Florida State University|Director, Cardiovascular and Applied Physiology Laboratory|8506441828|jwatso@fsu.edu|
20156166|NCT05071027|Montefiore Medical Center|Dr. David Altschul, Department of Neurosurgery|718-920-7498|daltschu@montefiore.org|
20156167|NCT04463914|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20156168|NCT05463952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20156169|NCT00595075|Sentara Neurology Specialists|Daniel Cohen|757-388-6323|dacohen@sentara.com|
20156170|NCT03329131|University of Texas Health Science Center in San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
20156171|NCT02360085|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
20156172|NCT03876808|University of Missouri - Columbia|Dr. Boris Mraovic, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
20156173|NCT02096354|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|858-229-1062|boronsky@epicentrx.com|
20156174|NCT05273437|University of California San Diego|Dr. Eric Hekler|8584299370|ehekler@health.ucsd.edu|
20156175|NCT03566732|University of Bergen|Professor Dagny F. Haugen|+4747606633|dagny.haugen@uib.no|
20156176|NCT03579719|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20156177|NCT00069953|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20156178|NCT01646216|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
20156179|NCT02800785|University of Washington|Erin Fannon|206-685-9770|ecarney@uw.edu|
20156180|NCT00113373|NRG Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20156181|NCT02395627|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|Pamela.Munster@ucsf.edu|
20156182|NCT03253627|New York University Meyers College of Nursing|John Merriman, PhD, RN|212-998-5375|john.merriman@nyu.edu|
20156183|NCT03829683|Virginia Commonwealth University|Arun J Sanyal, MD|804-828-4060|arun.sanyal@vcuhealth.org|
20156184|NCT03163667|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
20156185|NCT02420314|University of Iowa|Dr. Muhammad Furqan|319-356-1616|muhammad-furqan@uiowa.edu|
20156186|NCT03760068|Sr. Director Global Clinical Operations, General Medicine|Keri L. Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
20156187|NCT05430919|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20156188|NCT00855166|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20156189|NCT00803049|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20156190|NCT04082364|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20156191|NCT04042311|Hull University Teaching Hospitals NHS Trust|Dr Sean Pymer|01482 674643|s.pymer@nhs.net|
20156192|NCT03249558|Massachusetts General Hospital|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
20156193|NCT01426555|VA Boston Healthcare System|Dr. Antonio Lazzari|857-364-6381|antonio.lazzari@va.gov|
20156194|NCT00908141|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Robert Dreicer MD|216-445-4623|dreicer@ccf.org|
20156195|NCT01258985|Tufts Medical Center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
20156196|NCT05670756|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
20156197|NCT02254291|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
20156198|NCT02078869|TCART|Robert F Casper, PI|416-972-0777|casper@lunenfeld.ca|
20156199|NCT05796245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156200|NCT00267488|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156201|NCT00353119|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20156202|NCT02943499|Brown University|Dr. Judson Brewer|401-863-2826|judson_brewer@brown.edu|
20156203|NCT01904279|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20156204|NCT00839930|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156205|NCT02500836|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
20156206|NCT03562156|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
20156207|NCT02801578|The University of Texas MD Anderson Cancer Center|Prithviraj Bose, MD./Associate Professor|713-792-7747|PBose@mdanderson.org|
20156208|NCT01356940|MS Center at Evergreenhealth|Theodore R. Brown, MD|425-899-5350|trbrown@evergreenhealth.com|
20166084|NCT04351334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166085|NCT00904982|University of Pennsylvania Perelman School of Medicine|Stephen E. Kimmel, MD, MSCE/Director, Clinical Epidemiology|(215) 898-1740|stevek@mail.med.upenn.edu|
20166086|NCT02593006|Hackensack University Medical Center|Yukiko Kimura MD|551-996-5306|yukiko.kimura@hackensackmeridian.org|
20166087|NCT00963859|The University of Texas (UT) MD Anderson Cancer Center|John W. Davis, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
20166088|NCT02072668|University of Tennessee Center for the Heath Sciences|Dr. Kenneth Ataga|901.448.3181|kataga@uthsc.edu|
20166089|NCT02054689|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20166090|NCT03678493|University of Minnesota, Masonic Cancer Center|Armin Rashidi, MD, PhD|(612) 273-8383|arashidi@umn.edu|
20166091|NCT01352793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166092|NCT00656448|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
20166093|NCT01929317|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166094|NCT02667119|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
20166095|NCT04504253|University of Utah|Brent Kious, MD|8015851418|brent.kious@hsc.utah.edu|
20166096|NCT03205423|New York State Psychiatric Institute|Jermaine Jones|7577533212|jermaine.jones@NYSPI.Columbia.edu|
20166097|NCT04467905|Milestone Pharmaceuticals Inc.|Leonid Kokovin-Sher|1 450-912-6783|lkokovin-sher@milestonepharma.com|
20166098|NCT03894124|Chelsea and Westminster NHS Foundation Trust|Research Operations Manager|+442033156825|chelwest.research@nhs.net|
20166099|NCT04684836|Vanderrbilt University|Jessica Ancker, MS, PhD|(615) 322-5000|jessica.s.ancker@vumc.org|
20166100|NCT01582477|St. Elizabeth's Medical Center|Andrew Sternlicht, MD|617-789-2777|andrew.sternlicht@steward.org|
20166101|NCT04145349|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20166102|NCT03312634|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20166103|NCT04828343|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20166104|NCT01148979|McLean Hospital|J. Alexander Bodkin, MD|617-855-3186|abodkin@mclean.harvard.edu|
20166105|NCT00777153|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20166106|NCT00554216|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
20166107|NCT01679314|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
20166108|NCT05462756|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20166109|NCT02079246|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20166110|NCT03666663|UCSF|Dr.Nina Riggins|7028064831|Nina.Riggins7@gmail.com|
20166111|NCT04040933|Johnson & Johnson Consumer Inc. (J&JCI)|Robin Mathew|908-904-5034|rmathew1@its.jnj.com|
20166112|NCT00775190|Beaumont Health System|Evie Russell, RN|248-898-5388|Evie.Russell@beaumont.org|
20166113|NCT01709084|Janssen R&D US|Director, R&D, Medical Departement||ClinicalTrialDisclosure@its.jnj.com|
20166114|NCT02409277|University of Utah|Flory Nkoy|801-662-3660|flory.nkoy@hsc.utah.edu|
20166115|NCT00420771|NYSPI|John J. Mariani, MD|212-543-5987|jm2330@columbia.edu|
20166116|NCT02696967|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20166117|NCT00753506|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
20166118|NCT04441892|Mayo Clinic|Dr. Michael J. Ackerman|507-284-8900|ackerman.michael@mayo.edu|
20166119|NCT04226742|University of California, Irvine|Stephen Schueller|949-824-3850|s.schueller@uci.edu|
20166120|NCT01193244|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166121|NCT01417377|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20166122|NCT02113982|Stemline Therapeutics, Inc.|Ira Gupta, MD|877-332-7967|clinicaltrials@menarinistemline.com|
20166123|NCT00384670|Department of Pediatrics, Pharamongkutklao Hospital|Sriluck Simasathien ; Infectious Disease Consultant|66-2-644-8971||
20166124|NCT03763877|Poxel|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
20166125|NCT03040336|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
20166126|NCT03906448|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
20166127|NCT01774721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166128|NCT02453321|University of Pittsburgh Medical Center|Kevin King, DO - Clinical Asst. Professor|412 748-5589|kingkk@upmc.edu|
20166129|NCT04827680|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20166130|NCT02054104|National Cancer Institute|Dr. David Schrump|240-858-7000|schrumpd@mail.nih.gov|
20166131|NCT00080535|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
20166132|NCT02004041|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
20166133|NCT00763035|Wake Forest University Health Sciences|Gregory Hundley|+1 (336) 716-0607|ghundley@wakehealth.edu|336
20166134|NCT01807624|Jean Brown Research Center|Dr. Derek Muse|(801) 261-2000|participate@jeanbrownresearch.com|
20166135|NCT04916587|University of Colorado, Denver|Dr. Monica Perez Jolles|303-724-0829|monica.jolles@cuanschutz.edu|
20166136|NCT04355169|Shionogi Inc.|Shionogi Clinical Trials Administrator Clinical Support Help Line|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20166137|NCT01658436|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|trialandresults.registries@novartis.com|
20166138|NCT00686712|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20166139|NCT01151189|Aeras|Product Director; Bernard Landry|301-547-2919|blandry@aeras.org|
20166140|NCT01318915|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20166141|NCT00926237|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
20166142|NCT04119414|University of Miami|Stephen Weiss|7862108684|sweiss2@med.miami.edu|
20201297|NCT00501228|U.T. M.D. Anderson Cancer Center|Martin Korbling, MD / Professor|713-745-3219||
20201298|NCT02673229|The University of Kansas Health System|Suzanne Mitchell, PhD, ARNP, FNP-BC, CWS|913-588-5000|smitchell3@kumc.edu|6562
20201299|NCT03304522|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20201300|NCT01474590|University of Western Ontario and Windsor Clinical Research Inc., 2224 Walker Rd. Suite 300, Windsor, ON, Canada|Dr. Jerry Tan||jerrytan@bellnet.ca|
20156209|NCT02971839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20156210|NCT00668642|Northshore University Healthsystem|Dr. Daniel Shevrin|847-570-2515|Dshevrin@northshore.org|
20166143|NCT02431637|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
20166144|NCT04322526|University of Pittsburgh|Dr. Marta Pecina|734-945-2473|pecinam@upmc.edu|
20166145|NCT01716234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166146|NCT01523756|Coloplast A7S|Marianne Raff|+45 4911 2562|dkmr@oloplast.com|
20166147|NCT03994081|University of North Carolina at Chapel Hill|Tobias Schwippel, MD|919-966-9929|tobias_schwippel@unc.edu|
20166148|NCT02758210|Emory University|Mikhael El Chami, MD|404-686-2504|melcham@emory.edu|
20166149|NCT02620774|Center for Anti-infective Research and Development|David Nicolau|860-972-3941|david.nicolau@hhchealth.org|
20166150|NCT00474812|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Charles Nock MD|216-844-3862|charles.nock@uhhospitals.org|
20166151|NCT02059278|Point Guard Partners LLC|Jeremy Brace|727-458-2823|jbrace@pointguardllc.com|
20166152|NCT02180100|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86755-83923333|fanshangrong@163.com|5502
20166153|NCT05408429|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166154|NCT03435211|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
20166155|NCT02195518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20166156|NCT03818256|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
20166157|NCT01342211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166158|NCT05378672|Zealand Pharma A/S|Clinical Operations|+45 88 77 36 00|clinicaltrials@zealandpharma.com|
20166159|NCT03111121|West Virginia University|Pavithra Ranganathan Ellison, MD|3045984122|pavithra.ellison@hsc.wvu.edu|
20166160|NCT01588522|BPGbio Inc.|Bing Nie|617-588-1002|bing.nie@bpgbio.com|
20166161|NCT03043794|Johns Hopkins University, Department of Radiation Oncology|Dana Baker Kaplin, MPH|410-614-3950|dkaplin1@jhmi.edu|
20166162|NCT04223479|The University of Jordan|Lana M. Agraib|+962|lanamg2007@yahoo.com|00000
20166163|NCT02749422|NYU Langone Health|Anli Liu|929-455-2340|Anli.Liu@nyulangone.org|
20166164|NCT02855125|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
20166165|NCT05370495|Seinda|Jing-Feng Huang, Ph.D.|1.858.254.9188|jfhuang@SeindaPharm.com|
20166166|NCT03712358|Istari Oncology|Lisa Franklin|919-245-7662|lfranklin@istarioncology.com|
20166167|NCT04586205|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
20166168|NCT02786394|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
20166169|NCT01833247|Stanford University Department of Neurology|Robert S. Fisher, MD, PhD|650-7215289|robert.fisher@stanford.edu|
20166170|NCT01646125|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20166171|NCT02230995|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166172|NCT03124342|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
20166173|NCT00959985|Massachusetts General Hospital|Dr. Alphonse G Taghian, MD PhD|617-726-6050|ataghian@partners.org|24369
20166174|NCT01942837|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
20166175|NCT01298648|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20166176|NCT02201394|Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon||Juan.Badimon@mssm.edu|
20166177|NCT03252431|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
20166178|NCT03077412|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20166179|NCT02812342|Yale Dermatology - Middlebury|Brett King, MD, PhD, BA, Associate Professor of Dermatology|(203) 737-4825|brett.king@yale.edu|
20166180|NCT02266888|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20166181|NCT02351856|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156211|NCT03412591|Penn State College of Medicine|Dr. Scott Bunce|2155108295|sbunce@pennstatehealth.psu.edu|
20156212|NCT02272985|University Medical Center Groningen|Dr. C.F.M. Franssen|+0031(0)50 3616161|c.f.m.franssen@umcg.nl|
20156213|NCT02489279|Think Now, Inc.|Dr. Gregory V. Simpson|4156016522|greg@think-now.com|
20156214|NCT00505687|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
20156215|NCT03283241|AddBio AB|Ulf Sewerin, CEO|+46708797988|ulf.sewerin@addbio.se|
20156216|NCT01382108|Centre for Contact Lens Research|Kathy Dumbleton|519-888-4567|kdumble@uwaterloo.ca|32694
20156217|NCT00666263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20156218|NCT02439957|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
20156219|NCT00586157|Massachusetts General Hospital|Timothy Wilens, MD|617-726-1731|twilens@partners.org|
20156220|NCT00062764|National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health|Jay H. Hoofnagle, MD|3014961333|hoofnaglej@extra.niddk.nih.gov|
20156221|NCT02014467|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156222|NCT01230060|Bausch & Lomb Incorporated|Jon Hayashida|(949) 521-7876|jon.hayashida@bausch.com|
20156223|NCT03802916|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
20166182|NCT04939714|Emory University|Carolyn Clevenger, DMP, APRN|404-712-2394|carolyn.clevenger@emory.edu|
20166183|NCT01458392|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166184|NCT03762993|Purdue University|Preeti Sivasankar|765-494-3788|preeti@purdue.edu|
20166185|NCT01281124|The Ohio State University Comprehensive Cancer Center|Greg Otterson|614-293-2887|Greg.Otterson@osumc.edu|
20166186|NCT00918255|Abbott|Global Medical Services|800-633-9110||
20166187|NCT02038933|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20166188|NCT01635439|NWAFH|Ahmed Abdelaziz|0096644411088|webmaster@nwafh.med.sa|
20166189|NCT01394003|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166190|NCT01647217|Tissuetech Inc|Hosam El Sheha, MD, PhD|305-274-1299|hsheha@tissuetechinc.com|
20166191|NCT00068692|ECOG-ACRIN statistical office|Statistician||eatrials@jimmy.harvard.edu|
20166192|NCT01222689|university of california san francisco|Dr. Andrew Ko, MD|415-353-7286|Andrew.Ko@ucsf.edu|
20166193|NCT01600716|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20166194|NCT00248040|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20166195|NCT00779155|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303-795-3222|abraswell@pico-tesla.com|
20166196|NCT03481595|Cleveland Clinic Florida|Carlos Higuera|9546595430|higuerc@ccf.org|
20166197|NCT03557034|Cleveland Clinic|Khaldoun Tarakji, MD, MPH|216-445-9225|TARAKJK@ccf.org|
20166198|NCT02540629|Seoul National University Hospital|Dr. Jeong Ho Park|+821035426282|timthe@gmail.com|
20166199|NCT01759446|Acura Pharma|Dr. Al Brzeczko|847-705-7709|abrzeczko@acurapharm.com|
20166200|NCT01760733|Telemark Hospital Trust|MD, PhD Kristian Heldal|+4790018417|hkri@ous-hf.no|
20166201|NCT00815659|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20166202|NCT03847896|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
20166203|NCT02395471|Medtronic MITG Gastrointestinal & Hepatology|Dr.Jaime Kean|303-882-6759|Jaime.M.Kean@medtronic.com|
20166204|NCT00118417|Massachusetts General Hospital|Naomi M. Simon, MD|617-726-7913|nsimon@partners.org|
20166205|NCT02978781|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20166206|NCT00785785|Novartis Pharmaceuticals|Study Director|862-778-8300||
20166207|NCT01244893|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Senior Research Optometrist|(904) 443-1290|BPALL@its.jnj.com|
20201301|NCT02036320|Johnson and Johnson Vision Care Inc.|Meredith Jansen,O.D.,M.S., FAAO|904-443-3500|mjanse12@ITS.JNJ.com|1396
20166208|NCT00357552|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20166209|NCT00976404|Northwestern University|Baiba Berzins, MPH|312-695-5012|baiba@northwestern.edu|
20166210|NCT03089281|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
20166211|NCT02301416|Wake Forest School of Medicine|Jamy Ard|336-716-9837|jard@wakehealth.edu|
20166212|NCT00882557|Cubist Pharmaceuticals, Inc.|Ed Campanaro/Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
20166213|NCT00842296|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
20166214|NCT02282605|Destiny Pharma|Director of Projects|+44 (0) 1273 704440|medinfo@destinypharma.com|
20166215|NCT01528969|Kuwait University, Faculty of Dentistry|Prof. Eino Honkala|+965 65638938|eino.honkala@hsc.edu.kw|
20166216|NCT04816552|Johns Hopkins School of Public Health|Dr. Christine Marie George|(202) 657-5798|cmgeorge@jhu.edu|
20166217|NCT01908062|Oregon Health & Science University|Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20166218|NCT03584789|HealthPartners Institute|D. Brad Rindal, DDS, Associate Dental Director Research|952-967-5026|donald.b.rindal@healthpartners.com|
20166219|NCT01357525|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
20166220|NCT02035267|Allergan, Inc|Beta Bowen|1-714-246-4446|Bowen_Beta@allergan.com|
20166221|NCT02404025|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
20166222|NCT00823615|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20166223|NCT00955916|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, M.D.|813-745-4291|rami.komrokji@moffitt.org|
20166224|NCT03134703|Johns Hopkins All Children's Hospital|Sandra Brooks, MD|727-767-4313|sbrook36@jhmi.edu|
20166225|NCT00084136|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20166226|NCT01524796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166227|NCT03543878|Georgia Institute of Technology|Annabelle C. Singer, PhD|510-501-9659|asinger@gatech.edu|
20166228|NCT01374438|Metabolic Solutions Development Company|Dr. Jerry Colca|269.343.8732|jcolca@msdrx.com|
20166229|NCT03938259|Baylor College of Medicine7|Dr. Adam Adler|832-824-5801|Adam.adler@bcm.edu|
20166230|NCT00836693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166231|NCT02612779|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20166232|NCT03856788|Icahn School of Medicine at Mount Sinai|Christina Jeng, MD, FASA|212) 241-6426|christina.jeng@mountsinai.org|
20166233|NCT02420821|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20166234|NCT03507569|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201302|NCT00004054|NRG Oncology|Wendy Seiferheld||wseiferheld@nrgoncology.org|
20201303|NCT03954626|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
20201304|NCT00473876|University of Dundee|Professor Chim C Lang|0044(0)1382 496375|c.c.lang@dundee.ac.uk|
20201305|NCT03952286|University of Arizona Asthma & Airway Disease Research Center|Dr. Ashley A. Lowe|5206268814|aaray@email.arizona.edu|
20201306|NCT00755079|VAHSRD|Joshua Hobson, MS|(718) 584-9000|joshua.hobson@va.gov|3129
20166235|NCT03815929|Principle Investigator|Dr. Ekta Kapoor|507 538-7103|kapoor.ekta@mayo.edu|
20166236|NCT03313037|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166237|NCT02760498|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20166238|NCT02205736|Levine Cancer Institute at Carolinas Healthcare System|Dr. James Symanowski|9804422371|james.symanowski@carolinashealthcare.org|
20166239|NCT04701762|Cleveland Clinic|Kurt Ruetzler|216 407-4108|ruetzlk@ccf.org|
20166240|NCT05786651|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
20166241|NCT00904033|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
20166242|NCT00865566|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20166243|NCT03403283|University of Alabama at Birmingham|maria grant|13528714314|mariagrant@uabmc.edu|
20166244|NCT03252925|The First Affiliated Hospital of Soochow University|Yue Han|13901551669|hanyue@suda.edu.cn|
20166245|NCT00521404|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20166246|NCT01383356|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166247|NCT00602472|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166248|NCT02885025|VA Greater Los Angeles Healthcare System|Joseph Yusin Chief division Allergy Immunology|3104783711|joseph.yusin2@va.gov|40230
20166249|NCT00194532|University Of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
20166250|NCT01908803|Alcon Research, Ltd.|Sr Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20166251|NCT00098813|Memorial Sloan-Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
20166252|NCT03926611|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
20166253|NCT02230670|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
20166254|NCT01002339|Hospital Universitario de Canarias. Universidad de La Laguna. Spain|Dr. Armando Torres Ramírez|+34630989515|atorres@ull.es|
20166255|NCT01907854|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20166256|NCT02215252|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166257|NCT00892099|Massachusetts General Hospital|Dr. Ishir Bhan|617-726-3934|ibhan@mgh.harvard.edu|
20166258|NCT01657019|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20166259|NCT00956007|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20166260|NCT01750229|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
20166261|NCT02346721|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20166262|NCT01285323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20166263|NCT00217399|Georgetown University|Dr. Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
20166264|NCT02158546|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
20166265|NCT02376998|University Magna Graecia of Catanzaro|Prof. Raffaele Serra|+3909613647380|rserra@unicz.it|
20166266|NCT02351817|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
20166267|NCT00803569|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20166268|NCT01194856|Cleveland Clinic|Marisa Tungsiripat|2164442037|tungsim@ccf.org|
20166269|NCT02488915|Neuravi Ltd|Mairsíl Claffey|0035391394123|mclaffey@neuravi.com|
20166270|NCT03216512|Duke University|Dr Scott Kollins|919-681-0014|scott.kollins@duke.edu|
20166271|NCT03408392|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20166272|NCT00885170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166273|NCT03771664|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20166274|NCT01011894|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|212-639-7053|brentjer@mskcc.org|
20166275|NCT03418714|Johns Hopkins University|Frederick Barrett|4105509777|fbarret2@jhmi.edu|
20166276|NCT04041414|University of Southern California|Jeremy Goldbach, PhD, LMSW|(213) 821-6460|goldbach@usc.edu|
20166277|NCT00665652|Dartmouth Hitchcock Medical Center|Elijah Stommel|603-650-5104|elijah.w.stommel@hitchcock.org|
20166278|NCT01526577|LG Life Sciences|Dong Yeop Shin|82 2 6924 3114|dongyeopshin@lgls.com|
20166279|NCT02900378|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20166280|NCT03818321|TriHealth|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
20166281|NCT01134055|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166282|NCT05038982|Johns Hopkins University|Shawn Kwatra|410-502-7546|skwatra1@jhmi.edu|
20166283|NCT04170608|FARAPULSE|Christopher Schneider|617-686-7661|kschneider@farapulse.com|
20166284|NCT01454102|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20166285|NCT03739203|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20166286|NCT01782378|VA Boston Healthcare System, Jamaica Plain Campus, Boston, MA|Margaret Naeser, PhD|857-364-4030|Margaret.Naeser@va.gov; mnaeser@bu.edu|
20166287|NCT02233517|VAORD|Elizabeth Van Voorhees|(919) 286-0411|elizabeth.vanvoorhees@va.gov|6435
20166288|NCT01663103|University of Colorado Anschutz Medical Campus|Dr. Kristen Nowak|303-724-4842|Kristen.Nowak@ucdenver.edu|
20166289|NCT01656408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166290|NCT04008745|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
20166291|NCT05465317|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20166292|NCT00999102|NY Presbyterian Hospital - Weill Cornell Medical Center|Dr. Samuel Mann, PI|212-746-2200|sjmann@med.cornell.edu|
20166293|NCT01808456|Inova Fairfax Hospital|Dr. Ravinder Wali|7037764001|ravinder.wali@inova.org|
20166294|NCT02708186|Axovant Sciences GMBH|Senior Director of Clinical Research|1-833-296-8268|clinicaltrials@axovant.com|
20201307|NCT03751111|Xiangya Hospital, Central South University|Dr. Minxue Shen|86-15973164022|shenmx1988@csu.edu.cn|
20166295|NCT00888940|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
20166296|NCT03326713|Rutgers Cancer Institute|Anita Y. Kinney, PhD|(732) 865-3375|anita.kinney@rutgers.edu|
20166297|NCT00771758|Ortho-McNeil Janssen Scientific Affair, LLC.|Senior Director of Clinical Development, Pain|(908)927-5465||
20166298|NCT03067077|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
20166299|NCT02529072|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
20166300|NCT00935584|VA san Diego Healthcare System|Dr. Zia Agha|8586421295|zia.agha@va.gov|
20166301|NCT02546388|University of Pennslyvania|Paco Bravo, MD|1-215-220-9494|Paco.Bravo@pennmedicine.upenn.edu|
20166302|NCT03801408|University of Arkansas for Medical Sciences|Sara Jones, Principal Investigator|501-526-7846|sljones@uams.edu|
20166303|NCT02530515|UT MD Anderson Cancer Center|Dr. Chitra Hosing / Stem Cell Transplantation|(713) 745-3219|cmhosing@mdanderson.org|
20166304|NCT00174187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166305|NCT05069948|The University of Edinburgh and NHS Lothian|Aimun Jamjoom|0131 536 1000|v1ajamjo@ed.ac.uk|
20166306|NCT01198977|Rehabilitation Care Services; MS Center of Excellence (MSCOE), VA Puget Sound Health Care System|Aaron Turner, PhD, Director, Rehabilitation Psychology; Asst Director Research, MSCOE|206-277-6134|Aaron.Turner@med.va.gov|
20166307|NCT01285557|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
20201308|NCT01285349|Social Intervention Group|Dr. Nabila El-Bassel|212-851-2391|ne5@columbia.edu|
20201309|NCT02909153|Rockwell Medical|clinical project manager|248-960-9009|sgrimberg@rockwellmed.com|
20166308|NCT04410367|Blue Earth Diagnostics, Ltd.|Chief Medical Officer|+44 (0)1865 784 186|contact@blueearthDx.com|
20166309|NCT06482125|Universitas Pelita Harapan|Dr. Corry Quando Yahya|2181383190900|corry.yahya@lecturer.uph.edu|
20166310|NCT05353777|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20166311|NCT05174416|Peking Union Medical College Hospital|Prof. Shuyang Zhang|+86 13911667211|shuyangzhang103@163.com|
20166312|NCT01648751|University of PIttsburgh|Pamela Moalli MD PHD|412-641-6052|moalpa@upmc.edu|
20166313|NCT02833233|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Comen|646-888-4525|comene@mskcc.org|
20166314|NCT04377659|Memorial Sloan Kettering Cancer Center|Dr. Boglarka Gyurkocza, MD|646-608-3768|gyurkocb@mskcc.org|
20166315|NCT05030129|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
20166316|NCT02484391|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7970|bpowell@wakehealth.edu|
20166317|NCT00905164|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20166318|NCT00790842|PrECOG|PrECOG Statistician|978-835-3516|jbmanola@gmail.com|
20166319|NCT02968004|OPKO Health, Inc.|OPKO Health, Inc.|3055754100|contact@opko.com|
20166320|NCT05029362|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD, MSc, DrPH|(713) 500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
20166321|NCT05571605|University of North Texas|Dr. Justin Sprick|940-565-2226|justin.sprick@unt.edu|
20166322|NCT00419952|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20166323|NCT03126591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20166324|NCT02606643|Saint Louis University|Gary Furhman|314-977-2090|jathompson@slu.edu|
20201310|NCT03056443|West Virginia University|Robert Stansbury, MD|304-293-4661|rstansbury@hsc.wvu.edu|
20166325|NCT00093041|Genmab A/S|VP Clinical Operations Eva Järlid Westerberg|+45 7020 2728|E.Westerberg@genmab.com|
20166326|NCT01208207|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166327|NCT03122509|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
20166328|NCT02161016|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
20166329|NCT01749215|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki|415-221-4810|steven.batki@ucsf.edu|23671
20166330|NCT02382705|University of British Columbia|Dr. Robert Enns|604 688 6332|cgalorport@gmail.com|
20166331|NCT04320316|University of Alabama at Birmingham|M.D|12056389107|hdabdullatif@uabmc.edu|
20166332|NCT00571493|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
20166333|NCT03060096|Wake Forest NCORP Research Base|Dr. Emily Dressler|336-716-0891|NCORP@wakehealth.edu|
20166334|NCT01441076|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Grayson, Peter|+1 301 827 9187|peter.grayson@nih.gov|
20166335|NCT00380367|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166336|NCT01605799|San Francisco VA Medical Center|Dr. Shira Maguen|415-221-4810|shira.maguen@va.gov|22511
20166337|NCT01559857|Stanford University|Dr. Natalie Rasgon|6507249694|natalie.rasgon@stanford.edu|
20166338|NCT00847210|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20166339|NCT00472576|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
20166340|NCT04355143|University of California Los Angeles|Reza Ardehali, MD, PhD|310-825-5280|rardehali@mednet.ucla.edu|
20166341|NCT02148874|The Ohio State University Wexner Medical Center|Lisa Christian, PhD|614-293-0936|lisa.christian@osumc.edu|
20166342|NCT00830440|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
20166343|NCT02592798|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20166344|NCT00942604|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20201311|NCT01526148|University Hospitals Cleveland Medical Center|Keming Gao, MD, PhD|216-844-2865|keming.gao@UHhospitals.org|
20201312|NCT01173653|Vanderbilt University Emergency Medicine Department|Benjamin Heavrin, MD|615-936-0253-|benjamin.heavrin@vanderbilt.edu|
20201313|NCT00631137|Johns Hopkins|Jaishri Blakeley|410-955-8837|jblakel3@jhmi.edu|
20166345|NCT01143246|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20166346|NCT00722072|OHSU Knight Cancer Institute|Dr. Stephen Chui|503-494-8534|chuis@ohsu.edu|
20166347|NCT03987503|University of California, San Francisco|Dr. Meghan D. Morris, Associate Professor|415-574-0651|meghan.morris@ucsf.edu|
20166348|NCT02911844|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
20166349|NCT03133793|Sponsored Programs Adminstration (SPA)|Dr. Mario Medina, Director of Sponsored Programs Administration|913-588-5724|mmedina3@kumc.edu|
20166350|NCT03486834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166351|NCT00702299|University of Arizona|Dr. Setsuko Chambers|520/626.0950|schambers@azcc.arizona.edu|
20166352|NCT02745119|Hoffmann-La Roche|Medical Communications|616878333|global.trial_information@roche.com|+41
20166353|NCT01624350|Medtronic|Medtronic (Sponsor)|508.452.4095|michelle.v.disalvo@medtronic.com|
20187802|NCT03582033|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
20156224|NCT02069847|Mayo Clinic|Michael B. Wallace|507-953-2221|wallace.michael@mayo.edu|
20156225|NCT00480532|University of Hawaii (UH)|Bliss Kaneshiro|808-203-6500|bkaneshiro@ucera.org|
20156226|NCT00831389|Medtronic Diabetes|Harry Clark|818-576-5653|bud.clark@medtronic.com|
20156227|NCT01377402|Stavanger University Hospital|Dennis WT Nilsen, MD, phd, professor|+4795777735|dnilsen1@getmail.no|
20156228|NCT00278161|Johns Hopkins University|Lode Swinnen, MD|4106146398|lswinne1@jhmi.edu|
20156229|NCT01817777|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156230|NCT00443456|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20156231|NCT03242434|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156232|NCT01592747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20156233|NCT03177798|Vanderbilt University Medical Center|Dr. Jorge L. Gamboa|615-343-4176|jorge.gamboa@vumc.org|
20156234|NCT00425555|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20156235|NCT00619918|Children's Hospital Los Angeles|Susan Wu|323-361-6177|suwu@chla.usc.edu|
20156236|NCT03533491|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
20156237|NCT04889950|Novoxel Ltd|Ifat Klein|972-6009860|ifat@novoxel.com|
20156238|NCT03168529|Wayne State University|Phillip Levy, MD|3135771214|plevy@med.wayne.edu|
20156239|NCT04661839|Emergent BioSolutions Canada Inc.|Clinical Development Representative|204-275-4074|ctgov@ebsi.com|
20156240|NCT00928720|University of Virginia School of Nursing|Ann Gill Taylor, Professor Nursing|434-924-0113|agt@virginia.edu|
20156241|NCT02951819|Janssen Scientific Affairs|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20156242|NCT03715829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156243|NCT01469156|Southeast Retina Center|Dr. Dennis Marcus|706-650-0061|dmarcus@southeastretina.com|
20156244|NCT01813227|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
20156245|NCT03773562|Mayo Clinic|Dr. Todd Schwedt|480-342-2695|schwedt.todd@mayo.edu|
20156246|NCT03131479|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20156247|NCT01272219|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20156248|NCT01491919|Duke Clinical Research Institute|Uptal Patel, MD|919-668-4601|uptal.patel@duke.edu|
20156249|NCT04003389|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
20156250|NCT00257933|The Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
20156251|NCT00392288|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20156252|NCT04091438|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20156253|NCT00912873|University California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20156254|NCT02370693|Northwestern University|Manu Jain, MD|312-503-4242|m-jain@northwestern.edu|
20156255|NCT02691494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20156256|NCT02657356|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20156257|NCT03379870|The Children's Cochlear Implant Center at UNC|Lisa Park, AuD|919-419-1449|lisa_park@med.unc.edu|
20156258|NCT02471144|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20156259|NCT00834574|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156260|NCT03058952|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
20156261|NCT00107575|Brown University|Christopher Kahler|(401) 863-6651|Christopher_Kahler@brown.edu|
20156262|NCT03768336|Massachusetts General Hospital/Harvard Medical Schoool|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
20156263|NCT05654181|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156264|NCT04101331|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
20156265|NCT01444781|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20156266|NCT06790303|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156267|NCT03413995|Johns Hopkins University|Mark Markowski, MD|410-614-0567|mmarko12@jhmi.edu|
20156268|NCT04378153|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
20156269|NCT00500331|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156270|NCT03345550|University of Michigan|Frederick Korley|734 647-0261|korley@med.umich.edu|
20156271|NCT04999267|Duke University - Duke Human Vaccine Institute|Chip Walter|919 620 5346|chip.walter@duke.edu|
20156272|NCT00889330|Johnson & Johnson Vision Care, Inc.|Arthur Shedden, MD|904-443-1557|ashedden@its.jnj.com|
20156273|NCT03033784|The University of Toledo|Elissar Andari, PhD|419-383-5227|elissar.andari@Utoledo.edu|
20156274|NCT01149460|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20166354|NCT01662765|Bahcesehir University, School of Medicine|Dr. Mehmet Kaplan|+905056268899|dr.kaplan27@gmail.com|
20166355|NCT00687193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166356|NCT02447003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166357|NCT01394016|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20166358|NCT03534804|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20166359|NCT04161157|University of Kentucky|Dr. Laurie McLouth|859-562-2526|laurie.mclouth@uky.edu|
20166360|NCT03752567|Farmacia La Regina|Dr. Raffaele La Regina|+393389066138|raffaele.laregina@gmail.com|
20166361|NCT01899521|Atlanta VA Medical Center|Dr. Ashish Mehta|404-321-6111|Ashish.Mehta@va.gov|207133
20166362|NCT02538510|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
20166363|NCT04922216|University of North Carolina at Chapel Hill|Brooke Nezami, PhD|919-966-5852|bnezami@unc.edu|
20166364|NCT04721977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166365|NCT03278249|University of Cincinnati Cancer Center|Rekha Chaudhary, MD, Adjunct-Associate Professor of Medicine|513-558-2119|Rekha.chaudhary@uc.edu|
20166366|NCT02017405|Entera Health, Inc.|Audrey L. Shaw, Ph.D.|919 971 8000|audrey.shaw@enterahealth.com|
20166367|NCT00811590|Huntsman Cancer Institute|Dr. Randall Burt|801-585-3281|randall.burt@hci.utah.edu|
20166368|NCT02864394|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20166369|NCT02374450|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20166370|NCT04730804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
20166371|NCT02202759|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166372|NCT02105662|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166373|NCT02118441|Department of Anesthesia, St. Paul's Hospital|S. K. W. Schwarz, MD, PhD|604-806-8337|stephan.schwarz@ubc.ca|
20166374|NCT02042274|University of Guelph|Dr. David Mutch, Associate Professor|519-824-4120|dmutch@uoguelph.ca|53322
20166375|NCT00990704|Abbott|Global Medical Services|800-633-9110||
20166376|NCT01732718|University of North Carolina at Chapel Hill|Kenneth Ataga, MD|901-448-2813|kataga@uthsc.edu|
20166377|NCT00847509|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
20166378|NCT02115048|Translational Research In Oncology (TRIO)|Director, Project Management|+33 1 58 10 09 09|TRIO020.contact@trioncology.org|
20166379|NCT03722238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166380|NCT00561925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20156275|NCT02310269|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
20156276|NCT01432444|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20156277|NCT02157610|Moffitt Cancer Center|Jennifer Vidrine, PhD, MS|813-745-8764|jennifer.vidrine@moffitt.org|
20156278|NCT01683812|Boston Children's Hospital|Michele DeGrazia PhD, RN, NNP-BC, FAAN|617-919-1222|Michele.DeGrazia@childrens.harvard.edu|
20156279|NCT00607477|University of Chicago|Michael Maitland, MD, PhD|773-702-4400|mmaitlan@medicine.bsd.uchicago.edu|
20156280|NCT01946880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20156281|NCT03647137|Department of Veteran Affairs|Dr. Nicolaas Bohnen|7347697100|nicolaas.bohnen@va.gov|
20156282|NCT01443026|University of Illinois at Chicago|Dr. Peter Gann|312-355-3723|pgann@uic.edu|
20156283|NCT02034565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20156284|NCT00581919|University of Wisconsin Hospital and Clinics|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
20156285|NCT02655601|BioMimetix JV, LLC|Sara Penchev|610-308-6640|sara.penchev@bmxpharma.com|
20156286|NCT00829868|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156287|NCT01969409|University of Alabama at Birmingham|Steven R. Duncan, MD|(205) 934-5017|duncsr19@uab.edu|
20156288|NCT01548885|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20156289|NCT02799043|Abbott|Anne Sarver, PhD|1-651-756-3813|anne.sarver@abbott.com|
20156290|NCT01603368|University of Linköping|Thomas Abrahamsson, MD PhD|+46.10.1030000|thomas.abrahamsson@liu.se|
20156291|NCT01554904|University of Florida|Richard B Berry, M.D. Principal Investigator|3522621575|Richard.Berry@medicine.ufl.edu|
20156292|NCT03285893|University of Minnesota|Joni Jensen|612-624-5178|jense010@umn.edu|
20156293|NCT04806373|Memorial Healthcare System|Mark Block, Chief, Division of Thoracic Surgery|9542651125|mblock@mhs.net|
20156294|NCT05810597|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20156295|NCT02214212|University of Washington|Jeanne Hoffman|2062216511|jeanneh@u.washington.edu|
20156296|NCT03630679|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
20156297|NCT02061085|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
20156298|NCT03213405|Pontificia Universidad Católica de Chile|Dr. Alexis Kalergis|+56223541924|akalergis@bio.puc.cl|
20156299|NCT03555994|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20156300|NCT03204812|UT MD Anderson Cancer Center|Dr. Sumit Subudhi, PhD-Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|sksubudhi@mdanderson.org|
20156301|NCT02412436|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20156302|NCT02544763|GW Research Ltd|Medical Enquiries|+1 833 424 6724|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
20156303|NCT05135754|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
20156304|NCT00787800|Mayo Clinic|Paul A. Friedman, MD, Professor of Medicine|507-284-7661|friedman.paul@mayo.edu|
20166381|NCT00417417|NHLBI/NIH|Richard O. Cannon III, MD|301-496-9895|cannonr@nih.gov|
20166382|NCT00684021|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
20166383|NCT00891904|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20166384|NCT02976038|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20166385|NCT01046396|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20166386|NCT00724698|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
20166387|NCT02177032|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20166388|NCT04592887|Varian, a Siemens Healthineers Company|Senior Manager, Clinical Trials|437-991-3496|ClinOps@varian.com|
20166389|NCT02556177|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
20166390|NCT00658359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166391|NCT00734539|Duke Univiersity Medical Center|Daniel K. Benjamin Jr|919-668-7081|danny.benjamin@dm.duke.edu|
20166392|NCT01187355|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20166393|NCT02504151|Yale|Dr. Mohini Ranganathan|(203)932-5711|mohini.ranganathan@yale.edu|2546
20201314|NCT03308188|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
20201315|NCT01791855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201316|NCT00481065|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20201317|NCT00772447|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20201318|NCT00454207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20201319|NCT01672957|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201320|NCT00151892|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20201321|NCT02549716|Milton S. Hershey Medical Center|Sprague W. Hazard III, M.D.|717-531-0003|shazard@pennstatehealth.psu.edu|311253
20201322|NCT00749190|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201323|NCT00784758|University of California, Los Angeles|Dr. Eric Kleerup|310-794-6593|ekleerup@mednet.ucla.edu|
20201324|NCT02797470|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
20201325|NCT05142826|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
20201326|NCT04439331|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20201327|NCT00888511|Odense University Hospital|Olfred Hansen|+45 2424 1588|olfred.hansen@rsyd.dk|
20201328|NCT03726268|Duke University|Evan Kharasch, MD, PhD|919-613-1154|evan.kharasch@duke.edu|
20201329|NCT04336397|Alaska Native Tribal Health Consortium|Dr. Diana Redwood|907-729-3959|dredwood@anthc.org|
20201330|NCT04370509|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|david.oh@ucsf.edu|
20201331|NCT04696861|Duke University School of Nursing|Brandon Knettel|1 919 660 1218|brandon.knettel@duke.edu|
20201332|NCT01827384|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
20201333|NCT02921386|Clarus Therapeutics Inc.|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
20156305|NCT00373360|United Therapeutics Corporation|Rex Mauthe; Senior Director, Regulatory Affairs|919-485-8350|rmauthe@unither.com|
20156306|NCT02481141|SBI Pharmaceuticals Co, Ltd.|Dr. Riyadh Rehani, President of MENA Region|+973 66394100|rrehani@sbigroup.co.jp|
20156307|NCT04309500|University of Michigan|Annalise M. Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
20156308|NCT01270555|Massachusetts General Hospital|Timothy Wilens, MD|617-503-1053|twilens@partners.org|
20156309|NCT00773461|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20156310|NCT00913835|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20156311|NCT01827306|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|7179915595|jslaski@ssrehab.com|
20156312|NCT00637156|Medtronic Spine and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20156313|NCT02374255|Icahn School of Medicine at Mount Sinai|Radhi Yagnik|212-659-5933|radhi.yagnik@mountsinai.org|
20156314|NCT02093520|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
20156315|NCT03014089|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20156316|NCT00851084|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20156317|NCT00734032|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156318|NCT03840967|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20156319|NCT00337168|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4623||
20156320|NCT01225952|Bausch & Lomb Incorporated|Omid Khodai, OD,RAC|(949) 521-7894|omid.khodai@bausch.com|
20156321|NCT01052779|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
20156322|NCT03663582|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20156323|NCT02367885|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20156324|NCT01602484|Brigham and Women's Hospital|Dr. Eric Bluman|6179837363|ebluman@partners.org|
20156325|NCT01378195|Photozig, Inc.|Bruno Kajiyama|650-694-7496|info@photozig.com|
20156326|NCT03427619|University of Iowa|Dr. Richard Smith|319-356-2177|richard-smith@uiowa.edu|
20156327|NCT00498628|NIAAA|Dr. Raye Litten|301-443-0636||
20156328|NCT03574363|KBP Biosciences USA, Inc.|Kimberly Miller|4847644862|kimberly.miller@kbpbiosciences.com|
20156329|NCT05763381|The Geneva Foundation|Elizabeth Metzger, Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
20156330|NCT02853136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166394|NCT00705016|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20166395|NCT01188343|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20166396|NCT00363480|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166397|NCT00385216|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
20166398|NCT04634253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20166399|NCT01499355|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20166400|NCT02048670|Mayo Clinic|Dr. Devin L. McCaslin|507-284-3410|mccaslin.devin@mayo.edu|
20166401|NCT01457703|University of Colorado Denver|Clinical Research Regulatory Manager|303-724-6501|Chanel.mansfield@ucdenver.edu|
20166402|NCT00454324|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20166403|NCT03000608|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@santalispharmaceuticals.com|101
20166404|NCT02535806|Children's Mercy Hospital|Dr. Keith August|816-302-6808|kjaugust@cmh.edu|
20166405|NCT00432172|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20166406|NCT02536963|Rebiscan|CEO|857-600-0982|jgshaka@rebiscan.com|
20166407|NCT03714880|University of Pittsburgh|Suji Uhm, MD, MPH|412-641-4590|uhms@upmc.edu|
20166408|NCT03352609|MUSC|Dr Friedrich|843-792-9888|friedric@musc.edu|
20166409|NCT00515619|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20166410|NCT02379091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166411|NCT02053376|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20166412|NCT02129699|European Thoracic Oncology Platform|European Thoracic Oncology Platform|+41 31389 93 91|SPLENDOUR@etop-eu.org|
20166413|NCT01607255|VA Northern California Healthcare Systems - Mather|Joseph W. Leung, MD, Chief of Gastroenterology|916-366-5339|Joseph.Leung2@va.gov|
20166414|NCT00658385|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-6684|bouladf@mskcc.org|
20166415|NCT00670748|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
20166416|NCT03529695|USC Center for Economic and Social Research|Kayla De La Haye, PhD, Research Scientist|323-442-8228|delahaye@usc.edu|
20166417|NCT03863080|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
20166418|NCT02582775|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
20166419|NCT04194437|TransMedics, Inc.|VP Cliinical Affairs|978-552-0900|ldamme@transmedics.com|
20166420|NCT02991768|University of Kansas Medical Center|Clinical Research Coordinator|913-588-3520|edelaney2@kumc.edu|
20166421|NCT03467750|Emory University|Dr. Laura Gilbertson|404-785-6670|laura.gilbertson@emory.edu|
20166422|NCT05673876|Genentech Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
20166423|NCT03529422|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
20166424|NCT03052829|Medical College of Wisconsin|Amberly Anger|414-955-6708|aanger@mcw.edu|
20166425|NCT02000115|Abbott Structural Heart|Daniella Corporan|779-220-7309|daniella.corporan@abbott.com|
20166426|NCT04815824|VA Eastern Colorado Health Care System|Dr. Sarah Wherry|303-704-8054|sarah.wherry@va.gov|
20166427|NCT05006573|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
20166428|NCT04949490|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20166429|NCT06714682|Ain Shams university|Dr. Mohamed Ibrahim , Lecturer of anesthesia|01115560811|T.majestic@hotmail.com|002
20166430|NCT04988477|Hennepin Healthcare Research Institute|Dr. Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
20166431|NCT01987453|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20166432|NCT01590888|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
20166433|NCT04953728|University of Michigan|Jiande Chen|734-764-3880|cjiande@med.umich.edu|
20166434|NCT02331277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166435|NCT04375085|Elixir Medical Corp|Candace Elek, EVP Clinical Research|4086362000|celek@elixirmedical.com|
20166436|NCT01399372|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20166437|NCT01376804|Hoffman-LaRoche|Medical Communications|800-821-8590||
20166438|NCT01071798|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20166439|NCT02653417|Radius Pharmaceuticals, Inc.|Clinical Operations|617-551-4000|clinopsinfo@radiuspharm.com|
20166440|NCT01705509|Cardiovascular Institute of the South|Agostino Ingraldi, MD, FACC|337-988-1585|Agostino.Ingraldi@cardio.com|
20166441|NCT02736890|Icahn School of Medicine at Mount Sinai|Dr. Thomas Bryce|212-241-6321|thomas.bryce@mountsinai.org|
20166442|NCT02904954|Weill Cornell Medicine|Cathy Spinelli, RN BSN|212-746-3328|caf2007@med.cornell.edu|
20166443|NCT05097963|Mayo Clinic|Vinay Chandrasekhara, M.D.|507-284-2687|Chandrasekhara.Vinay@mayo.edu|
20166444|NCT00214890|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
20166445|NCT03349034|Icahn School of Medicine at Mount Sinai|Dr. Brett Miles|(212) 241-9410|brett.miles@mountsinai.org|
20166446|NCT01039376|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20166447|NCT00123422|Edward Hines Jr. ,VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
20166448|NCT01554241|University of California, San Francisco|Janice B.Schwartz, M.D., Professor of Medicine|(415) 406-1573|janice.schwartz@ucsf.edu|
20166449|NCT02118961|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk / Clinical Development counter||cti-inq-ml@ml.mt-pharma.co.jp/clinicaldevelopment@mail.biken.or.jp|
20166450|NCT04287036|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
20166451|NCT03809104|Ci-Shan Hospital, Health and Welfare of Minister, Taiwan|Ms. Chia-Yu Wei|+886-7-6615523|ivywei@chis.mohw.gov.tw|1729
20166452|NCT01532986|VA Greater Los Angeles Healthcare System|Eric M Cheng|3102067671|echeng@mednet.ucla.edu|
20166453|NCT02120898|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20166454|NCT04313244|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20166455|NCT05021978|Praxis Precision Medicines|Charmaine Manilay|2243996121|cmanilay@praxismedicines.com|
20166456|NCT04069702|Duke University|Sarah Kelleher, PhD|9194163405|sarah.kelleher@duke.edu|
20166457|NCT03096288|University of Florida College of Medicine - Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
20166458|NCT02690948|Stanford University|Anne Lynn S. Chang, Associate Professor of Dermatology|650-721-7151|alschang@stanford.edu|
20166459|NCT02551887|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
20166460|NCT02004093|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20166461|NCT01411891|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
20166462|NCT04085289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20166463|NCT04639258|Medtronic Structural Heart & Aortic|Robert Waltonen|763-526-0424|robert.waltonen@medtronic.com|
20166464|NCT00414596|NEMA Research, Inc|Jospeph V Pergolizzi, MD|239-597-3564|nemaresearch@aol.com|
20166465|NCT01924949|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20166466|NCT04614974|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
20166467|NCT01635153|Dartmouth-Hitchcock|Dr C Fordham von Reyn|6036507167|fvr@dartmouth.edu|
20166468|NCT00831480|Baylor College of Medicine|Dr. Gilad E. Amiel|713-798-4079|lhiggins@bcm.edu|
20166469|NCT02558296|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20166470|NCT02754440|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
20166471|NCT02832115|Aultman Hospital|Dr. Prabhakaran Gopalakrishnan|3304548076|prab.gopalakrishnan@aultman.com|
20166472|NCT02919995|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|
20166473|NCT02560558|Emory University|Dr. Idelberto Badell|404-712-6562|ibadell@emory.edu|
20166474|NCT02245217|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
20166475|NCT01263197|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166476|NCT01967576|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
20166477|NCT03449667|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20166478|NCT02369796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166479|NCT01821118|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166480|NCT00345358|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166481|NCT01385293|Duke University|Andrew J. Armstrong, MD ScM FACP|919 668 4667|andrew.armstrong@duke.edu|
20166482|NCT02892448|The Ottawa Hospital Research Institute|Dr. Paul E Beaule|613-737-8899|pbeaule@toh.ca|73265
20166483|NCT00346697|Johns Hopkins University|Dr Todd Brown, Associate Professor of Medicine and Epidemiology|410-502-2327|tbrown27@jhmi.edu|
20166484|NCT00499083|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
20166485|NCT03066947|BriaCell Therapeutics Corporation|Dr. William Williams|1-888-485-6340|williams@briacell.com|
20166486|NCT04587661|University of Pittsburgh|Dr. Charles Jonassaint|+14125869850|cjonassaint@pitt.edu|
20166487|NCT00318643|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
20166488|NCT01812252|Fred Hutch Cancer Center|Bart Lee Scott M.D.|(206)909-0977|bscott@fredhutch.org|
20166489|NCT02557139|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
20166490|NCT01378871|Albert Einstein College of Medicine|Dr, Amit Verma||amit.verma@einsteinmed.edu|
20166491|NCT01146795|Columbia University|Jason Wright, MD|212-305-3410|jw2459@cumc.columbia.edu|
20166492|NCT05375760|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20166493|NCT03853109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20166494|NCT03102437|Impulse Dynamics|Angela Stagg|18453592389|astagg@impulsedynamics.com|
20166495|NCT01721044|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166496|NCT04032093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166497|NCT00960999|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
20166498|NCT02141204|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20166499|NCT02139007|UAB|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
20166500|NCT03123731|University of California, San Diego|Dr. Brook Henry|619-543-4737|blhenry@ucsd.edu|
20166501|NCT03397966|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|615-343-7592|alp.ikizler@vumc.org|
20166502|NCT00921895|Rapid Pathogen Screening, Inc.|Robert Sambusky, MD|941-556-1853|sambursky@rpsdetectors.com|
20166503|NCT01177397|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
20166504|NCT04555616|University of Kentucky|Elizabeth Rhodus|859-257-5567|elizabeth.rhodus@uky.edu|
20166505|NCT01943903|HeartFlow|VP, Clinical|408-314-2335|smullen@heartflow.com|
20166506|NCT05488535|Advanced Bionics|Emily Cardenas, Au.D.|16616785405|Emily.Cardenas@advancedbionics.com|
20166507|NCT01106690|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
20166508|NCT00998296|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187803|NCT06010836|Johns Hopkins|Associate Professor|4109552611|jsampso4@jhmi.edu|
20187804|NCT04923776|Columbia University|Brian Henick, MD|212-342-5162|bh2682@cumc.columbia.edu|
20187805|NCT04817176|Florida State University College of Medicine|Dr. Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
20187806|NCT04763772|UH Cleveland Medical Center|Ian Neeland|216-844-5965|ian.neeland@uhhospitals.org|
20166509|NCT04396639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166510|NCT01544335|Massachusetts General Hospital|Associate Director, Lymphedema Research Program|6177240127|cbrunelle@mgh.harvard.edu|
20166511|NCT00124514|cincinnatichildrens|Hermine Brunner|5136367982|hermine.brunner@cchmc.org|
20166512|NCT03977818|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
20166513|NCT03219528|University of Michigan|Allen Lee|734-936-4785|allenlee@med.umich.edu|
20166514|NCT00241839|University of Florida|Mark S. Segal, MD, PhD; Assistant Professor and Chief, Division of Nephrology|352-273-8821|Mark.Segal@medicine.ufl.edu|
20166515|NCT05050227|VA Greater Los Angeles Healthcare System, UCLA David Geffen School of Medicine|Lucinda B. Leung, MD, PhD, MPH|310-478-3711|lleung@mednet.ucla.edu|
20166516|NCT00927953|MacroGenics, Inc.|Medical Officer||info@macrogenics.com|
20166517|NCT04048356|University of New Mexico|Peter Jeppson, site contact for study|505-967-8428|pjeppson@salud.unm.edu|
20166518|NCT00196313|Duramed Research|Duramed Research Protocol Chair|215-293-7279|role_medical_affairs@tevapharm.com|
20166519|NCT00043979|National Cancer Institute, National Institutes of Health|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
20166520|NCT01059435|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20166521|NCT00297258|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166522|NCT01470326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166523|NCT03967444|Galderma Research & Development, Aesthetics|Director of Clinical Operations|817-961-5655|aestheticclinicaltrials@galderma.com|
20166524|NCT01942694|Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center|Dr. Anastassios Pittas|617-636-3232|apittas@tuftsmedicalcenter.org|
20166525|NCT02387502|Govt. Medical College, Haldwani.|Dr. Geeta Bhandari|8958267145|bhandari_geetantl@rediff.com|
20166526|NCT01519921|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20166527|NCT01227993|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
20166528|NCT01216189|Karolinska Institutet|Professor Anna Martling|+46851770000|anna.martling@ki.se|
20166529|NCT00541385|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
20166530|NCT01733680|SUNy Upstate Medical University|Gail P DePalma|3154643260|depalmag@upstate.edu|
20166531|NCT05126953|Bausch + Lomb Incorporated|Schafer, Jill|0000000|Jill.Schafer@bausch.com|
20166532|NCT04269889|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|David J. Young, MD, PhD|301.827.7823|david.young2@nih.gov|
20166533|NCT03155841|University of Pennsylvania|Jose Bauermeister|215-898-9993|bjose@upenn.edu|
20166534|NCT01526733|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|858-794-8889||
20166535|NCT04987333|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20166536|NCT03129568|Okayama University Hospital|Dr. Hidemasa Oh|086-235-6506|hidemasa@okayama-u.ac.jp|6506
20166537|NCT00949702|Hoffmann-La Roche|Medical Communications|800-821-8590||
20166538|NCT01654302|Northwestern University|Julia Marks, CRC|312-503-1215|julia.marks@northwestern.edu|
20166539|NCT01569607|Emory University|Dr. Cathrin Buetefisch|404-712-5507|cathrin.buetefisch@emory.edu|
20166540|NCT01356277|McGill University Health Centre|Dr. Bethany Foster|514-412-4461|bethany.foster@mcgill.ca|
20166541|NCT04539795|University of Alabama at Birmingham (UAB)|Dr. Wells (Study PI)|205-934-5555|LungHealth@uabmc.edu|
20166542|NCT02699749|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166543|NCT01167504|Institute of Food Research|Professor Peter Wilde|+441603255258|peter.wilde@ifr.ac.uk|
20166544|NCT02377817|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
20166545|NCT02839200|Idorsia Pharmaceuticals|Clinical Trial Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
20166546|NCT02952820|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20166547|NCT04139018|Washington University School of Medicine Department of Otolaryngology - Head and Neck Surgery|Jay Piccirillo, M.D., Vice Chair for Research|314-362-8641|piccirij@wustl.edu|
20166548|NCT02565108|GW Research Ltd.|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
20201334|NCT03866200|The University of Texas Health Science Center at Houston|Karen Posey, PhD|713-500-5786|karen.posey@uth.tmc.edu|
20166549|NCT02364570|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
20166550|NCT01310075|UT MD Anderson Cancer Center|Dr. Mark W Clemens, Associate Professor, Plastic Surgery|713-794-1247|mwclemens@mdanderson.org|
20166551|NCT03614156|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20166552|NCT00646048|Boston Scientific|Colleen Holthe, Clinical Project Manager|651-581-4632|Colleen.Holthe@bsci.com|
20166553|NCT01094119|Cleveland Clinc|Daniel Sessler|216-444-4900|DS@OR.org|
20166554|NCT01696188|Sidney Kimmel Medical College at Thomas Jefferson University|Dr. Eric Schwenk|215-955-6161|Eric.Schwenk@jefferson.edu|
20166555|NCT02668393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166556|NCT00606593|Actelion Pharmaceuticals Ltd|Pascal Charef/Clinical Trial Leader|+41 61 565 65 65||
20166557|NCT03181529|Johns Hopkins University|Dr. Roland Griffiths|410-550-0034|rgriff@jhmi.edu|
20166558|NCT00536744|SANUWAVE, Inc.|Dr. Daniel Jorgensen, MD|678-578-0116|daniel.jorgensen@sanuwave.com|
20166559|NCT02581410|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166560|NCT02876601|Medical University of Vienna|Univ.Prof. Dr. Bernd Jilma|+4314040029810|bernd.jilma@meduniwien.ac.at|
20166561|NCT04774094|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20201335|NCT04291560|University of North Carolina at Chapel Hill|Jamie Crandell, PhD|919-966-5803|jcrandell@unc.edu|
20201336|NCT03498521|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20201337|NCT05654714|Baxter|Jessica Gregory|N/A|jessica_gregory@baxter.com|
20201338|NCT03812172|Columbia University Irving Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
20201339|NCT04022343|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
20201340|NCT02029976|George Mason University, College of Health and Human Services|Dr. Martha Y Kubik, Professor and Director School of Nursing|703-993-1971|mkubik@gmu.edu|
20166562|NCT02433366|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20166563|NCT05232682|Brown University|Mollie Monnig, PhD|4018633491|mollie_monnig@brown.edu|
20166564|NCT04098237|Cedars-Sinai Medical Center|Dr. Andrew Hendifar, MD|310-423-2217|andrew.hendifar@cshs.org|
20166565|NCT03207763|Emory University|Evan Anderson, MD|404-727-1746|evanderson@emory.edu|
20166566|NCT03751657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1)866-867-7178|clinicaltrials@novonordisk.com|
20166567|NCT02248246|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20166568|NCT01189409|BC Cancer|Dr. Philippa Hawley|607-877-6000|PHawley@bccancer.bc.ca|67-2707
20166569|NCT01938716|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|713-792-2828|gvaradha@mdanderson.org|
20166570|NCT01358721|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20166571|NCT01765972|Johnson & Johnson Vision Care Inc.|Katherine Osborn Lorenz, OD, MS|614 459-9477|KOSBORN@its.jnj.com|
20166572|NCT02446899|AstraZeneca AB|Global Clinical Lead|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20166573|NCT01051518|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
20166574|NCT04730271|DePuy Synthes|Ian Leslie|N/A|ileslie1@its.jnj.com|
20166575|NCT02350296|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20166576|NCT02223858|Veterans Affairs Pittsburgh Healthcare System|Dr. Leslie R.M. Hausmann|412-360-2112|leslie.hausmann@va.gov|
20166577|NCT04211909|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20166578|NCT04455815|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20166579|NCT02106390|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166580|NCT00473382|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
20166581|NCT01189032|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
20166582|NCT01166282|AbbVie|Global Medical Information|800-633-9110||
20166583|NCT02577718|MD Anderson Cancer Center|Dr. A M Chaftari|7137923491|achaftar@mdanderson.org|
20166584|NCT03588884|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
20166585|NCT01995838|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20166586|NCT00275509|New York University Langone Transplant Institute|Robert Montgomery, MD|646-501-2418|Robert.Montgomery@nyumc.org|
20166587|NCT02819804|Northwestern University|Shira Dinner, MD|312-695-6180|shira.dinner@nm.org|
20166588|NCT03196349|Duke University|Dr. Thomas Ortel|919-684-5350 ext 3|thomas.ortel@duke.edu|
20166589|NCT01963078|MUSC|Dr. Megan Moran-Santa Maria|843-817-6233|moranm@musc.edu|
20166590|NCT03388164|Laureate Institute for Brain Research|Teresa Victor|918-502-5108|tvictor@laureateinstitute.org|
20166591|NCT02210039|Massachusetts General Hospital|Guillermo Tearney, PI|617-724-2979|gtearney@partners.org|
20166592|NCT00686686|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20166593|NCT01012440|University of Chicago|Dr. Kirti Kulkarni|(773) 702-2781|kkulkarni@radiology.bsd.uchicago.edu|
20166594|NCT01278212|Medical University of South Carolin|Harriet Eldredge-Hindy|8437926382|eldredge@musc.edu|
20166595|NCT00131248|UT Houston Medical School|Kathleen A. Kennedy, MD, MPH|713 500-6708|kathleen.a.kennedy@uth.tmc.edu|
20166596|NCT00272311|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
20166597|NCT01052701|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410) 614-8762|ejfuchs@jhmi.edu|
20166598|NCT00477386|IndianaU|Daniela Matai, MD|317-944-0920|dmatai@iupui.edu|
20166599|NCT01254422|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
20166600|NCT02207088|AbbVie|Global Medical Services|800-633-9110||
20166601|NCT00643162|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
20166602|NCT02691507|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
20166603|NCT03023397|University of North Carolina at Chapel Hill|Allison Burbank, MD|919-962-5136|allison_burbank@med.unc.edu|
20166604|NCT01587924|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166605|NCT03848728|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
20166606|NCT05720312|Stanford University|Gregory Sahlem, MD|(650) 434-7844|gsahlem@stanford.edu|
20166607|NCT00787644|University of Vermont|Dr. Anne Dixon|802 656 3525|anne.dixon@uvm.edu|
20166608|NCT02264249|Cleveland Clinic Florida|Dr. Alison Schneider|954-659-5646|schneia2@ccf.org|
20166609|NCT01642589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20166610|NCT01108185|Abbott|Global Medical Services|1-800-633-9110||
20166611|NCT00298558|New England Research Institutes|Sharon L. Tennstedt, PhD|617-972-3362|stennstedt@neriscience.com|
20166612|NCT01393392|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
20166613|NCT02908672|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20166614|NCT01424072|University of São Paulo|Leonice Fumiko Sato Kurebayashi|5511 991126023|fumie_ibez@yahoo.com.br|
20166615|NCT01185080|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20166616|NCT00759941|Alcon Research, Ltd.|Head, Global Medical Affairs|800-862-5266|medinfo@alconlabs.com|
20166617|NCT01322945|Barrow Neurological Institute|Andrew S. Little, MD|602-406-3181|heidi.jahnke@dignityhealth.org|
20166618|NCT01781728|Johns Hopkins University, Department of Radiation Oncology|Dr. Amol Narang|410-913-3559|anarang2@jhmi.edu|
20166619|NCT05615922|NYU Langone Health|Leigh Charvet, PhD|929-455-5141|Leigh.Charvet@nyulangone.org|
20166620|NCT06083506|WestVirginiaU|Arif Salman Abdul Shakore|304-293-5831|arifsalman.abdulshakore@hsc.wvu.edu|
20203011|NCT04168645|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
20166621|NCT04858035|Montclair State University|Elaine R. Hitchcock|9732293797|hitchcocke@montclair.edu|
20166622|NCT05307692|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20166623|NCT04500158|Virginia Commonwealth University|Dr. Caroline Carrico|(804) 828-8328|ckcarrico@vcu.edu|
20166624|NCT01967238|Stanford University|Taia Wang|5103873941|taiawang@stanford.edu|
20166625|NCT04364867|Orthopedic Institute, Norton Healthcare|Ryan Krupp MD|502-394-6341|Ryan.Krupp@nortonhealthcare.org|
20166626|NCT02110069|Boston Children's Hospital|Dr. Denise M. Adans|617-919-6407|adamsdm@chop.edu|
20166627|NCT04400643|Hamilton Medical AG|Jean Michel Arnal|+33 1 84 04 97 58|jarnal@hamilton-medical.com|
20166628|NCT05522153|Virtua Medical Group, PA|Sean McMillan|908-812-7542|smcmillan@virtua.org|
20166629|NCT03493464|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
20166630|NCT04983680|Massachusetts General Hospital/Harvard Medical School|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
20166631|NCT01442103|Molnlycke Health Care|Joan wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
20166632|NCT05358353|Reflow Medical|Carolyn Mascho|949-481-0399|cmascho@reflowmedical.com|
20166633|NCT02064582|UT Southwestern Medical Center|Kevin Courtney, MD|214-648-4180|Kevin.Courtney@utsouthwestern.edu|
20166634|NCT01136980|EndoGastric Solutions|Adrain Lobontiu|+16504749259|alobontiu@endogastricsolutions.com|
20166635|NCT02605122|Cempra Pharmeuticals, a wholly owned subsidary of Melinta Therapeutics, Inc.|Melissa Allaband|9199140822|mallaband@melinta.com|
20166636|NCT04603027|Evelo Biosciences, Inc.|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
20166637|NCT03894813|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86-0755-83923333|fanshangrong@163.com|
20166638|NCT02139592|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166639|NCT01014351|SCRI Development Innovations LLC|John D. Hainsworth, M.D.|615-329-7274|asksarah@scresearch.net|
20166640|NCT02223702|Kocaeli University|Chair and Associate Professor of Periodontology|+902623442222|esragd@yahoo.com|5102
20166641|NCT00372593|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20166642|NCT00433004|University of Pennsylvania|Arden McAllister|215-662-3532|arden.mcallister@uphs.upenn.edu|267
20166643|NCT00742235|Massachusetts General Hospital|Principal Investigator|617-726-3934|ibhan@partners.org|
20166644|NCT05661409|Emory University|Dr. Matthew K. Whalin|404-616-5014|mwhalin@emory.edu|
20166645|NCT04954833|Johnson & Johnson Vision Care, Inc. (JJVC)|Xu Cheng|1-800-843-2020|xcheng6@its.jnj.com|
20166646|NCT04288661|1st Propaedeutic Surgery Department,Hippocration Hospital,University of Athens, Greece|Dr Maria Malvina Eleftheriou|+30 6945176503|malvina_el@hotmail.com|
20166647|NCT00831181|Beth Israel Medical Center|Dr Peter Kozuch|212 844-8282|pkozuch@chpnet.org|
20166648|NCT02863419|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20166649|NCT02362282|North Florida/South Georgia Gainesville VA Medical Center|Janis J Daly, Ph.D., Director Brain Rehabilitation Research Center|352-548-6000|Janis.Daly@va.gov|6603
20166650|NCT01219881|The Ohio State University|Dr. Joseph Werner|614-293-8487|Joseph.Werner@osumc.edu|
20166651|NCT00533117|NYSPI|Barbara Stanley|6467747582|bhs2@columbia.edu|
20166652|NCT02284243|Recro Pharma|Randall Mack|484-395-2470|rmack@recropharma.com|2406
20166653|NCT01932437|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
20166654|NCT00074490|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
20166655|NCT06404021|University of Calabria|Antonio Curcio|+390984681889|antonio.curcio.cardio@unical.it|
20166656|NCT02981446|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
20166657|NCT04411667|Sharp HealthCare|Matthew Geriak, PharmD / Research Pharmacist|8589393717|matthew.geriak@sharp.com|
20166658|NCT02481219|Given Imaging (a Medtronic company)|Liron Bar Yaakov|+97249097946|liron.bar-yaakov@covidien.com|
20166659|NCT01599637|Novartis Pharmaceuticals|Study Director|862-778-8300||
20166660|NCT00760617|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166661|NCT00638014|Duke University|Elliott Bennett-Guerrero|9196819660|benne011@mc.duke.edu|
20166662|NCT04287517|Istanbul University Faculty of Medicine Sports Medicine Department|Dr. Sergen Devran, Residency in Istanbul University Sports Medicine Department|00905377782594|sergendevran@gmail.com|
20166663|NCT00734500|Duke University|Michael Cohen-Wolkowiez|9196688812|michael.cohenwolkowiez@duke.edu|
20166664|NCT03857867|Stanford|Peter Tass|650-304-8849|ptass@stanford.edu|
20166665|NCT01869764|Wake Forest University Health Sciences|Edward Levine, MD|336-716-5440|elevine@wakehealth.edu|
20201341|NCT02660580|Fresenius Kabi SwissBioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
20166666|NCT01626872|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20201342|NCT01028352|University of Michigan Comprehensive Cancer Center|Dr. Norah L. Henry|734-936-4991|norahh@umich.edu|
20166667|NCT01578486|UMass Medical School|Xiaoduo Fan, MD, MPH|508-856-3881|xiaoduo.fan@umassmed.edu|
20166668|NCT02425943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20166669|NCT03810105|Memorial Sloan Kettering Cancer Center|Dr. Karen Autio, MD|646-422-4632|autiok@mskcc.org|
20166670|NCT05503823|University of Manitoba|Dr. Zahra Moussavi|204 474-7023|zahra.moussavi@umanitoba.ca|
20166671|NCT01106248|Eisai|Dr. Peter Tarassoff|888-422-4743||
20166672|NCT00357903|Amgen Inc.|Study Director|866-572-6436||
20166673|NCT01600170|University of Pennsylvania School of Medicine|Ronald G Collman|215-898-0913|collmanr@pennmedicine.upenn.edu|
20166674|NCT02506244|Scripps Research Translational Institute|Steven R. Steinhul, MD, Prinicipal Investigator|858-554-5757|steinhub@scripps.edu|
20201343|NCT02612909|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
20201344|NCT05224258|Medtronic Diabetes|Thomas Troub, Sr Clinical Research Program Manager|8052089091|thomas.troub@medtronic.com|
20201345|NCT05067127|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20201346|NCT04462536|NoNO Inc.|Michael Tymianski|6472932232|mtymianski@nonoinc.ca|
20166675|NCT01319552|Columbia University|Dr. Steven Spitalnik|2123425648|eldad.hod@gmail.com|
20166676|NCT00314795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166677|NCT04717336|The National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|Georg Aue, MD|301.451.7141|aueg@nhlbi.nih.gov|
20166678|NCT02039843|Tennesse Valley HCS|Joan Richerson|615-574-8198|joan.richerson@va.gov|
20201347|NCT01499173|University of Michigan, Neurology|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
20166679|NCT03962062|Medicines Development for Global Health|Sally Kinrade, Vice President, Project Leader, Onchocerciasis & Lymphatic Filariasis|+61 3 9912 2400|sally.kinrade@medicinesdevelopment.com|
20166680|NCT01958164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166681|NCT04546672|Oregon Health & Science University|Dr. Brandon Togioka|503-494-4572|togioka@ohsu.edu|
20166682|NCT00525161|University of Kentucky|Dr. Suleiman Massarweh|8593238043|massarweh@uky.edu|
20166683|NCT01076361|Medtronic|4968 Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
20166684|NCT02807402|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20166685|NCT02819011|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
20166686|NCT01284335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166687|NCT02873702|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166688|NCT03249116|Tufts University|Dr. Megan K Mueller|508-887-4543|megan.mueller@tufts.edu|
20166689|NCT03762317|Hennepin County Medical Center|Dr. Kunal Gupta|6128732677|kunal.gupta@hcmed.org|
20166690|NCT00221117|Toronto RI Institute|Dr. Milos Popovic|416-597-3422|milos.popovic@utoronto.ca|6305
20166691|NCT03108469|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
20166692|NCT01255436|University of the Philippines Manila|Dr. Lia M. Palileo|6325679740|liapalileo@gmail.com|
20166693|NCT04816669|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
20166694|NCT01229267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166695|NCT00826462|University of Oslo|Professor Morten Lindbaek|+47-22850646|morten.lindbak@medisin.uio.no|
20166696|NCT00659737|Drexel university|Michael Green|215-762-1524|micheal.green@drexelmed.edu|
20166697|NCT00867815|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20166698|NCT04050202|University of California, San Francisco|Danielle Roubinov, PhD|919-843-5898|danielle.roubinov@ucsf.edu|
20166699|NCT00001213|National Institutes of Health|Rachel J. Bishop, MD, Principal Investigator, National Eye Institute|301-402-3771|bishopra@nei.nih.gov|
20166700|NCT01742117|Mayo Clinic|Dr. Naveen L. Pereira|507-284-4441|Pereira.Naveen@mayo.edu|
20166701|NCT01499277|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
20201348|NCT00893516|Emergent Biosolutions|Clinical Development Representative||ctgov@ebsi.com|
20201349|NCT02988856|Massachusetts Eye and Ear|Kevin Houston|617-573-4177|kevin_houston@meei.harvard.edu|
20201350|NCT01562028|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|belief@etop-eu.org|
20201351|NCT04439266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20203012|NCT02400346|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
20166702|NCT01614392|Jean Mayer USDA HNRCA, Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
20166703|NCT02974543|University of Michigan|Susan Shore, Professor of Otolaryngology|734 647-2116|sushore@umich.edu|
20166704|NCT03534180|City of Hope|Dr. Jasmine Zain, MD|6263598111|jazain@coh.org|
20166705|NCT00220636|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
20166706|NCT00539942|University of Alabama at Birmingham|Warner K. Huh, MD|205-996-4662|warner.huh@ccc.uab.edu|
20166707|NCT01237899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166708|NCT00790088|Medtronic Int. Trading SaRL|Dr Odile Carrette|+41218038119|odile.osullivan@medtronic.com|
20166709|NCT02636595|AbbVie|Global Medical Services|800-633-9110||
20166710|NCT00880919|University of Minnesota|Dr. S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
20166711|NCT01576809|Novartis Consumer Health|Clinical project Leader|41223633111||
20166712|NCT02015637|Melinta Therapeutics, Inc.|Susan K. Cammarata, M.D. (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
20166713|NCT01695304|Centers for Disease Control and Prevention|Ciara O'Reilly, PhD|404-639-1953|bwf1@cdc.gov|
20166714|NCT03198507|Redhill Biopharma Inc.|June Almenoff, Chief Scientific Officer|(984) 444 7010|jalmenoff@redhillus.com|
20166715|NCT02454517|Fred Hutchinson Cancer Center|Jeannette M. Schenk, PhD|206-667-6860|jschenk@fredhutch.org|
20166716|NCT02194985|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20166717|NCT03281200|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20166718|NCT00225732|Cumberland Pharmaceuticals Inc.|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
20166719|NCT01155518|suny buffalo|sandeep dhindsa||sandhindsa@yahoo.com|
20166720|NCT00594815|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212-639-7523|omuroa@mskcc.org|
20166721|NCT02304367|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
20166722|NCT03599089|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
20166723|NCT03214666|GT Biopharma, Inc.|Dr. Gregory Berk|925-719-3531|gb@gtbiopharma.com|
20166724|NCT03417154|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|(612) 626-5654|maaka001@umn.edu|
20166725|NCT03511937|University of North Carolina at Chapel Hill|Anna Grummon, PhD|(617) 495-2021|agrummon@hsph.harvard.edu|
20166726|NCT02921841|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
20166727|NCT04139798|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20166728|NCT03895840|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
20166729|NCT01931566|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20166730|NCT00411684|HRA Pharma|Paul Carter - Chief Scientific Officer|+33 1 40 33 11 30|p.carter@hra-pharma.com|
20166731|NCT04476797|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
20166732|NCT02395081|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-8264|jr33@partners.org|
20166733|NCT04625101|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
20166734|NCT02991040|Prollenium Medical Technologies Inc.|Mr. Ario Khoshbin|+1 (905) 508-1469|ario@prollenium.com|
20166735|NCT02721966|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
20166736|NCT03070964|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
20166737|NCT01286480|University of Alberta|Dr. Andrew Mackie|780-407-8361|andrew.mackie@ualberta.ca|
20166738|NCT00834093|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617.632.6799|GJHANNA@PARTNERS.ORG|
20166739|NCT01209325|University of California, San Francisco|Dr. Joel M. Palefsky|415-476-1574|jpalefsky@medicine.ucsf.edu|
20166740|NCT00607373|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20166741|NCT01918306|Vanderbilt-Ingram Cancer Center|Dr. Vandana Abramson|800-811-8480|vandana.abramson@vanderbilt.edu|
20166742|NCT02773576|Braeburn Inc|Christine Kampf|6104678728|ckampf@braeburnrx.com|
20166743|NCT01237197|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20166744|NCT01160822|Novartis Pharmaceuticals|Study Director|862-778-8300||
20166745|NCT04772560|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@uh.edu|
20166746|NCT02170077|BIAL - Portela & Cª, SA|Head of Clinical Research|+351 22 9866100|clinical.trials@bial.com|
20166747|NCT02015910|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
20166748|NCT01780974|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
20166749|NCT01724346|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20201352|NCT02354833|West Virginia University|Dr. Manuel C. Vallejo, Chair of Department of Anesthesiology|304-598-4929|mvallejo@wvumediciane.org|
20201353|NCT05052723|University of Kentucky|Dr. Joseph Kim|859-257-4490|joseph.kim@uky.edu|
20201354|NCT02601950|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
20201355|NCT05540652|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
20201356|NCT05113940|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20201357|NCT02073487|Houston Methodist|Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
20201358|NCT00442598|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
20156331|NCT00841815|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156332|NCT03729609|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20156333|NCT04805593|Alcon Research, LLC|Clinical Projects Director, Surgical|18884513937|alcon.medinfo@alcon.com|
20156334|NCT02997085|Baylor Scott & White Research Institute|Dr. Mark Powers|2148652409|Mark.Powers1@bswhealth.org|
20156335|NCT01661283|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20156336|NCT03787615|The Pennsylvania State University|Dr. David Conroy|814-863-3451|conroy@psu.edu|
20156337|NCT00492544|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156338|NCT01704157|Pacira Bioscience, Inc.|Pacira MedInfo|1-855-793-9729|MedInfo@Pacira.com|
20156339|NCT03412929|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
20156340|NCT04989218|The University of Alabama at Birmingham|Dr. Mehmet Akce, Associate Professor|2059342992|makce@uabmc.edu|
20156341|NCT05418426|Daré Bioscience, Inc.|Jessica Hatheway, VP of Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
20156342|NCT01674062|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20156343|NCT02951481|Fundación de investigación Hospital Universitario 12 de Octubre|MD, PhD José María Aguado García|913908000|jaguadog1@gmail.com|4632
20156344|NCT01051661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156345|NCT01916226|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156346|NCT02915601|University of Colorado Anschutz Medical Campus|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@cuanschutz.edu|
20156347|NCT00680914|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156348|NCT01848457|The Children's Hospital of Philadelphia|Frank Balis, MD|2674265414|balisf@email.chop.edu|
20156349|NCT00143845|University of Michigan Comprehensive Cancer Center|Dr. John Levine, M.D.|734-936-8456|jelevine@umich.edu|
20156350|NCT00521352|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
20156351|NCT01813357|Monash University and Alfred Health|Dr Janine Trevillyan|03 90762000|janine.trevillyan@monash.edu|
20156352|NCT02298946|National Cancer Institute|Dr. Tim F. Greten|301-451-4723|gretentf@mail.nih.gov|
20156353|NCT00050011|Novartis Pharmaceuticals|Study Director|862-778-8300||
20156354|NCT05535972|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156355|NCT02614248|Genesis Medical Center|Michelle Martin, RN|562-421-7743|MartinMi@genesishealth.com|
20156356|NCT04197583|Boston Scientific|Director, Clinical Operations|5133058628|teresa.takle-flach@bsci.com|
20156357|NCT04629196|NYU Langone Health|David Hudesman, MD|646-501-9327|David.Hudesman@nyulangone.org|
20156358|NCT03792737|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
20156359|NCT01450631|KCI USA, Inc.|Jill Twardowski, Director of Clinical Operations|210-515-4166|jill.twardowski@kci1.com|
20156360|NCT02170519|Duke University Medical Center|Neil MacIntyre, MD|919-681-2720|neil.macintyre@dm.duke.edu|
20156361|NCT04903093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166750|NCT03710577|Univerisity of Wisconsin-Madison|Dr. Kelli Koltyn|608-262-4234|koltyn@education.wisc.edu|
20166751|NCT01397968|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
20166752|NCT02970162|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
20166753|NCT00750438|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20156362|NCT01111552|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20156363|NCT01027351|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20156364|NCT04650893|University of Nebraska Medical Center|Peter Danielson|402-559-1703|peter.danielson@unmc.edu|
20156365|NCT00057577|Vanderbilt University|Dr. Steven D. Hollon|615-322-3369|steven.d.hollon@vanderbilt.edu|
20156366|NCT04090749|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
20156367|NCT02528305|University of Striling|Dr Niels Vollaard|+441786466488|n.vollaard@stir.ac.uk|
20156368|NCT00421408|Yale University|Dr. Karl Insogna|203-737-2871|Karl.insogna@yale.edu|
20156369|NCT04691492|University at Buffalo|Jennifer Read, PhD.|(716) 645-0193|jpread@buffalo.edu|
20156370|NCT00461812|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20156371|NCT01308788|Indiana University|Alon Harris|3170278-0177|alharris@indiana.edu|
20156372|NCT00322218|Spectrum Pharmaceuticals,Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
20156373|NCT04548219|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20156374|NCT03193437|Georgetown University|Chul Kim, MD|(202) 444-2223|Chul.Kim@gunet.georgetown.edu|
20156375|NCT04778709|NYU College of Dentistry|Aikaterini Georgantza|212-998-9986|ag4222@nyu.edu|
20156376|NCT02414841|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
20156377|NCT02842242|MyoKardia Inc.|Dr. Amy Sehnert|650-741-7798|asehnert@myokardia.com|
20156378|NCT05293314|Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University，Shanghai, China|Jin-Fu Xu|008621 65115006|jfxu@tongji.edu.cn|
20156379|NCT00934180|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156380|NCT03549507|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
20156381|NCT03941093|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1337|lapis@fibrogen.com|
20156382|NCT03918031|University of Houston|Brooke Kauffman|(713) 743-8056|byredmond@central.uh.edu|
20156383|NCT04732468|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
20156384|NCT05339659|Kaiser Permanente|Dr. Jennifer McClure|206-287-2737|jennifer.b.mcclure@kp.org|
20156385|NCT01415453|Columbia University Medical Center|Dr Ronald Silverman|2123055484|rs3072@columbia.edu|
20156386|NCT04191135|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156387|NCT00003645|UT MD Anderson Cancer Center|Dr. Curtis A. Pettaway, M.D.- Professor, Urology|713-792-7734|cpettawa@mdanderson.org|
20156388|NCT01198691|TriHealth|Donna Lambers, MD|513-862-2828|donna_lambers@trihealth.com|
20156389|NCT03332056|University of Washington|Jonathan Harper|2065988279|jdharper@uw.edu|
20156390|NCT00321932|Masonic Cancer Center, University of Minnesota|Linda Burns, M.D.|612-624-8144|burns023@umn.edu|
20156391|NCT01798225|Medical University of South Carolina|Renata Leite|843-792-3908|leiter@musc.edu|
20156392|NCT03360344|Loma Linda University|Donnamarie Krause|7347642243|donnamarie.krause@gmail.com|
20156393|NCT01145183|Baylor College of Medicine|Thomas Kosten, MD|713 798 8628|kosten@bcm.edu|
20156394|NCT00133705|University of Rochester|Dr. Kevin Fiscella|585-271-1206|kevin_fiscella@urmc.rochester.edu|205
20156395|NCT00959049|Seqirus|Clinical Program Director||Seqirus.ClinicalTrials@Seqirus.com|
20156396|NCT01765400|University of Nebraska Medical Center|Paul P Dobesh|402-559-3982|pdobesh@unmc.edu|
20156397|NCT04881058|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20156398|NCT01342666|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)|Favorable effect of tomato consumption on HDL-c serum levels|525555133891|shiverqks@hotmail.com|
20156399|NCT04033640|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
20156400|NCT01892189|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20156401|NCT01599286|Children's National Hospital|Robert McCarter|202-476-3140|RMcCarte@childrensnational.org|
20156402|NCT01992757|University of Pennsylvania Hospital|Rupa Chowdary|215-615-4105|rupa.chowdary@uphs.upenn.edu|
20156403|NCT03440411|Fondazione EMN Italy Onlus|Fondazione EMN Italy Onlus|+39 011 0243236|clinicaltrialoffice@emnitaly.org|
20156404|NCT00095576|Merck, Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20156405|NCT01344356|Mercy Research|Mercy Research Manager - Regulatory Operations|314-251-8827|michelle.bryant@mercy.net|
20156406|NCT02301897|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20156407|NCT01189760|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20156408|NCT01217892|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
20156409|NCT00605189|KCI, an Acelity Company|Senior Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
20156410|NCT02697448|Medical University of South Carolina|George Guldan|(843) 792-2322|guldan@musc.edu|
20156411|NCT04620668|University of New Brunswick|Luke MacNeill|506-648-5500|luke.macneill@unb.ca|
20156412|NCT03685149|University of Rochester|Dr. Wojciech Zareba|585-275-5391|wojciech_zareba@urmc.rochester.edu|
20156413|NCT06301815|University of Winchester|Amelia Shaw|01962 717478|a.shaw2.18@unimail.winchester.ac.uk|
20156414|NCT01922895|U.T. Southwestern Medical Center|Mack C. Mitchell, MD|2146485036|mack.mitchell@utsouthwestern.edu|
20156415|NCT05781685|UT Southwestern Medical Center|Chance Ryan Strenth|337-274-7647|chance.strenth@utsouthwestern.edu|
20156416|NCT01257750|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
20156417|NCT05360784|Bausch and Lomb|Johnson Varughese|908-927-1162|johnson.varughese@bausch.com|
20156418|NCT02796651|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
20156419|NCT04248153|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
20166754|NCT03959176|Wake Forest University School of Medicine|Keith Walter, MD|336-716-2144|kwalter@wakehealth.edu|
20166755|NCT00256997|Janssen Inc. Toronto, Ontario, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
20166756|NCT02736578|Stanford University|Eben Rosenthal|650-723-2967|elr@stanford.edu|
20166757|NCT00354432|Wake Forest University School of Medicine|Dr. Doug Case|(336) 716-5425|dcase@wakehealth.edu|
20166758|NCT00802945|Nektar|Alison Hannah, MD||AHannah@nektar.com|
20166759|NCT01104311|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
20166760|NCT02633059|Mayo Clinic|Dr. Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
20166761|NCT02102204|Amgen Inc.|Study Director|866-572-6436||
20166762|NCT01213199|GALDERMA|Fabien AUDIBERT, CPM|+ 33 4 92 95 29 21|fabien.audibert@galderma.com|
20166763|NCT00807001|Idenix Pharmaceuticals, Inc.|John Z. Sullivan-Bolyai, MD, MPH|877-433-6491||
20166764|NCT02656693|Brigham and Women's Hospital|Heather J. Baer, ScD|617-525-7503|hbaer@bwh.harvard.edu|
20166765|NCT00842751|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
20166766|NCT02269267|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
20166767|NCT03773796|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
20166768|NCT00590772|Penn State University|Timothy Craig|717-531-6525|tcraig@psu.edu|
20166769|NCT03805659|Medical College of Wisconsin|Peter Kraegel|414-955-0657|pkraegel@mcw.edu|
20166770|NCT01350401|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
20166771|NCT02273596|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20166772|NCT02604160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166773|NCT01069900|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20166774|NCT00145158|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20166775|NCT06131476|Johnson & Johnson Vision Care|Principal Research Optometrist, Clinical Sciences|1 800-843-2020|njoshi30@its.jnj.com|
20166776|NCT03085797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20166777|NCT00859456|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
20166778|NCT02297373|Ottawa Hospital|Dr Gregoire Le Gal|613-737-8899|glegal@toh.ca|
20166779|NCT05782179|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
20166780|NCT06170242|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
20166781|NCT04141839|University of Arizona|Mary Koss|5204818610|mpk@arizona.edu|
20166782|NCT00614432|University of Hawaii|Investigator|808-203-6500|whrc@hawaii.edu|
20166783|NCT00343460|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
20166784|NCT03682770|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20166785|NCT01491607|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
20166786|NCT01317277|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
20166787|NCT00774566|Stardtisches Klinikum Karlsruhe, Medizinische Klinik IV|Dr. Armin Luik|0049-721974|armin.luik@klinikum-karlsruhe.de|2901
20166788|NCT02688777|North Florida/South Georgia Veteran's Health System|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov|105238
20166789|NCT02549365|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20166790|NCT00912795|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1 - 801#
20166791|NCT04896073|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
20166792|NCT00176917|Masonic Cancer Center, University of Minnesota|Paul J. Orchard, M.D.|612-626-2313|orcha001@umn.edu|
20166793|NCT03565497|Boston University|Dr. Michael Otto|617-306-1836|mwotto@bu.edu|
20166794|NCT02999672|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20166795|NCT01075685|Inpes|Juliette Guillemont|+331 49 33 22 55|juliette.guillemont@inpes.sante.fr|
20166796|NCT00531661|CardioMEMS, Inc.|Jordan Bauman|4043458235|jbauman@cardiomems.com|
20166797|NCT02858362|Summit Therapeutics|Clinical Disclosure|Please Email|clinicaltrials@summitplc.com|
20166798|NCT00392769|UT MD Anderson Cancer Center|Judith Wolff, MD / Professor||CR_Study_Registration@mdanderson.org|
20166799|NCT02561832|AstraZeneca Pharmaceuticals LP|Carsten Goessl MD|+1 2404490654|Carsten.Goessl@astrazeneca.com|
20166800|NCT04103749|Boston Scientific Corporation|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
20166801|NCT00439517|Merck KGaA|Merck KGaA Communication Center|+49-6151-75-5200|service@merckgroup.com|
20166802|NCT02058303|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
20166803|NCT03527732|Swiss Tropical and Public Health Institute|Prof. Dr. Jennifer Keiser|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
20166804|NCT01262989|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166805|NCT00470275|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20166806|NCT02500797|Memorial Sloan-Kettering Cancer Center|Sandra P. D'Angelo, M.D.|646-888-4159|dangelos@mskcc.org|
20166807|NCT00060840|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20166808|NCT00357006|Monash Alfred Psychiatry Research Centre|Prof Jayashri Kulkarni|+61 390766924|j.kulkarni@alfred.org.au|66924
20166809|NCT00976560|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166810|NCT03710161|University of Nebraska Medical Center|Dr. Laura Graeff-Armas|402-559-6310|laura.armas@unmc.edu|
20166811|NCT02902237|Department of Medicine A, University Hospital Muenster, Germany|Prof. Dr. Wolfgang Berdel, Professor of Medicine|+49 251 835|berdel@uni-muenster.de|2672
20201359|NCT01147926|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20166812|NCT03239106|Washington University School of Medicine|Brian Kim, Associate Professor of Medicine|314-273-1376|briankim@wustl.edu|
20166813|NCT04150861|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
20166814|NCT03613519|Boston University School of Public Health|Lynn Rosenberg, ScD|617.734.6006|lrosenbe@bu.edu|
20166815|NCT02175030|University of Utah|David Turok, MD, PI|801-581-5160|david.turok@hsc.utah.edu|
20166816|NCT02533453|Astrazeneca, Korea|Hyun Jung Kang / Local Study Leader|82 2 2188 0846|hyunjung.kang@astrazeneca.com|0846
20166817|NCT04674761|Albireo AB|Albireo AB|medinfo@albireopharma.com|medinfo@albireopharma.com|
20166818|NCT01974635|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
20166819|NCT01594216|Abramson Cancer Center|Angela DeMichele, MD|215-615-5329|Angela.DeMichele@pennmedicine.upenn.edu|
20166820|NCT05340478|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|713 791-1414|Ellen.Teng@va.gov|
20166821|NCT00092443|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166822|NCT01493167|Helsinki University Hospital|Dr Nina Linfors|358 9 4711|nina.c.lindfors@hus.fi|
20166823|NCT02963506|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20166824|NCT02284035|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|ESTEBANM@clinic.cat|
20166825|NCT00630838|University of Michigan|Daniel Teitelabum|734-936-8464|dttlbm@umich.edu|
20166826|NCT00928408|Amgen Inc.|Study Director|866-572-6436||
20166827|NCT03843541|Zambon S.p.A.|Valentina Zanin|+39026652441|valentina.zanin@zambongroup.com|
20166828|NCT05978713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20166829|NCT04163016|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20166830|NCT04693767|Penumbra Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
20166831|NCT04301193|University of Maryland|Division Chief of Obstetric Anesthesiology|(410) 328-4229|bkodali@som.umaryland.edu|
20166832|NCT02930018|NoNO Inc.|Michael Tymianski, MD PhD|4165831687|mtymianski@nonoinc.ca|
20166833|NCT03284307|University of Sydney|Robert Sanders, MBBS, PhD, FRCA|02 9036 3136|robert.sanders@sydney.edu.au|
20166834|NCT01404936|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
20166835|NCT01596062|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20166836|NCT02255435|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20166837|NCT01745822|French National Research Institute for Sustainable Development (IRD)|Gonzague Jourdain|+66818830065|gonzague.jourdain@ird.fr|
20166838|NCT02741518|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
20166839|NCT00476008|Charles E. Schmidt College of Medicine, Florida Atlantic University|Peter Holland, MD|561-297-0164|holland@fau.edu|
20166840|NCT01788358|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20166841|NCT01168219|Washington University School of Medicine|Ravi Vij, MD||rvij@im.wustl.edu|
20166842|NCT01227018|Vanderbilt-Ingram Cancer Center|Dr. Dana Cardin|615-936-8580|dana.cardin@vanderbilt.edu|
20166843|NCT02948634|UT Southwestern|Jason Zafereo|14-648-1002|jason.zafereo@utsouthwestern.edu|2146481002
20166844|NCT03007225|Ain Shams University|Dr Iman Montasser, Assistant professor of Tropical Medicine member of HCC clinic and group , Ain Sha|0020201065065333|imanfawzy2@gmail.com|
20166845|NCT01413204|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20166846|NCT00753649|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166847|NCT00499616|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20166848|NCT00333762|VA Pittsburgh Healthcare System|Dana Sinciline|412-822-3683|dana.sinciline@va.gov|
20166849|NCT01837823|Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai|Dr. Annapoorna Kini|212-241-4181|annapoorna.kini@mountsinai.org|
20166850|NCT01864603|University of California, San Francisco|Tamara Clark|628-206-8790|Tamara.Clark@ucsf.edu|
20166851|NCT03848182|Montefiore Medical Center; 1695 Eastchester Road|Dr. Jennifer Chuy, Co-Investigator, Assistant Professor (Oncology)|718-405-8505|jchuy@montefiore.org|
20166852|NCT05801341|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
20166853|NCT00673738|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
20166854|NCT03830892|Virginia Commonwealth University|Dr. Andrew J. Barnes|804-827-4361|abarnes3@vcu.edu|
20166855|NCT00330967|Phoenix VA Health Care System|Charles Oh|602-277-5551|charles.oh@va.gov|1-5127
20166856|NCT04269265|University of Minnesota|Kevin Escandon, MD MS|612-626-9344|escan012@umn.edu|
20166857|NCT04439136|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20166858|NCT05814367|Johnson & Johnson Vision Care, Inc. (JJVC)|Nabin Joshi|1-800-843-2020|njoshi30@its.jnj.com|
20166859|NCT02578706|Icahn School of Medicine at Mount Sinai|Dr. Meagan O'Brien||Meagan.O'Brien@mssm.edu|
20166860|NCT00408200|University of Pennsylvania|Anthony Killian|215-615-5299|tony.killian@uphs.upenn.edu|
20166861|NCT04849559|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
20166862|NCT00921518|Wilkes University|Judith Kristeller|570-408-4272|judith.kristeller@wilkes.edu|
20166863|NCT02910986|Mayo Clinic|Celine M. Vachon, Ph.D.|507 293-3247|Vachon.Celine@mayo.edu|
20166864|NCT04902924|Rehabilitation and Exercise Science Laboratory (RESlab), University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Vanessa Wellauer|0041 81 300 01 78|vanessa.wellauer@supsi.ch|
20166865|NCT03217058|University of California San Francisco|Dr. Derek Satre, Principal Investigator|415-476-7382|Derek.Satre@ucsf.edu|
20201360|NCT01670994|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20166866|NCT01662102|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
20201361|NCT00758784|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20201362|NCT00891735|Genentech, Inc.|Medical Communications|800-821-8590||
20201363|NCT00885365|Chiesi Farmaceutici S.p.A.|Chiesi Clinical Trials||clinicaltrials_info@chiesi.com|
20201364|NCT01824979|Fisher and Paykel Healthcare|Clinical Research Scientist|+ 64 09 574 0100|CPAPtrial@fphcare.co.nz|
20201365|NCT01365156|UT MD Anderson Cancer Center|Michael Frumovitz,Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
20201366|NCT02198833|Baylor College of Medcine|Rabih Darouiche, MD|713-794-8858|rabihd@bcm.edu|
20166867|NCT02586207|Sanford Health|Steven F. Powell, MD|605-328-8000|Steven.Powell@sanfordhealth.org|
20166868|NCT03048578|NYU Langone Health - Weight Management Program|Holly F. Lofton, MD|(212) 263-3166|Holly.Lofton@nyulangone.org|
20166869|NCT00526071|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20166870|NCT03306173|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|540 526 2106|rflemos@vtc.vt.edu|
20166871|NCT00573144|Mayo Clinic|Dr. Horng H. Chen|507-284-1644|chen.horng@mayo.edu|
20166872|NCT02983552|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20166873|NCT03210337|Aclaris Therapeutics|Executive Director, Clinical Operations|4843292144|jschnyder@aclaristx.com|
20166874|NCT00125164|Ipsen|Medical Director, Pediatric Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20166875|NCT01339052|Dana-Farber Cancer Institute|Patrick Y. Wen, MD, Director, DFCI Center for Neuro-Oncology|617-632-2166|pwen@partners.org|
20166876|NCT02637037|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20166877|NCT03702283|VANDERBILT UNIVERSITY MEDICAL CENTER|Cosby A Stone, Jr. MD, MPH|6153223412|Cosby.a.stone@vumc.org|
20166878|NCT02023697|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20166879|NCT04853017|Elicio Therapeutics, Inc.|Study Director|(857) 209-0050|info@elicio.com|
20166880|NCT01469377|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20166881|NCT04939415|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
20166882|NCT04308291|Medtronic Diabetes|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
20166883|NCT00003469|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20166884|NCT03610269|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
20166885|NCT00523302|Medical University of South Carolina|Edward B. Short|8437923295|shortb@musc.edu|
20166886|NCT00714870|St. Elizabeth's Medical Center|Dr. Shirley Gonzalez|617-926-0114|shirleyg2008@gmail.com|
20166887|NCT03399552|Memorial Sloan Kettering Cancer Center|Dr. Andreas Rimner, MD|646-608-2449|Rimnera@MSKCC.ORG|
20166888|NCT02357368|Emory University|Lisa Haddad, MD|404-778-1385|lisa.haddad@emory.edu|
20166889|NCT00659789|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
20166890|NCT00611026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166891|NCT02109497|Prana Biotechnology|Dr Caroline Herd|+6133494906|info@pranabio.com|
20166892|NCT01147874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166893|NCT01436435|Boston Scientific|DeeAnn Tinjum, Clinical Trial Manager|763-494-1927|deeann.tinjum@bsci.com|
20166894|NCT04845568|Washington University|Ellen Fitzsimmons-Craft|3142862074|fitzsimmonse@wustl.edu|
20166895|NCT03217071|University of California, San Francisco|Dr. Sue Yom, MD, PhD|(415) 353-9893|Sue.Yom@ucsf.edu|
20166896|NCT03892967|Mayo Clinic|Andrea L. Cheville, MD|507-284-1402|Cheville.Andrea@mayo.edu|
20166897|NCT04434937|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20166898|NCT02587637|Abbott|Robyn Capobianco|+1 512 286 4274|robyn.capobianco@abbott.com|
20166899|NCT05603312|MeiraGTx, LLC|Program Manager|646-860-7982|patients@meiragtx.com|
20166900|NCT03387085|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20166901|NCT04193189|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20166902|NCT01077050|SciBase|Director of Clinical Operations|+46841062001|per.svedenhag@scibase.se|
20166903|NCT05475483|SOM Innovation Biotech SA|Chief Medical Officer|+41 79 552 15 78|medori@sombiotech.com|
20166904|NCT02042872|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
20166905|NCT01006291|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20166906|NCT00684060|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
20166907|NCT00702715|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20166908|NCT01865552|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
20166909|NCT03079102|Baylor College of Medicine|Cameron Dezfulian|832-826-6210|cameron.dezfulian@bcm.edu|
20166910|NCT02923921|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20166911|NCT00854113|Theracos|Yuan-Di Halvorsen|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
20166912|NCT04683887|Azienda Unità Sanitaria Locale di Piacenza|Massimo Guasconi|+39-0523-303853|m.guasconi2@ausl.pc.it|
20166913|NCT01250145|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166914|NCT02687191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166915|NCT03180840|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
20166916|NCT05780424|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20166917|NCT01934647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20166918|NCT01079299|Center for Curative and Palliative Wound Care Calvary Hospital|Oscar M. Alvarez / Principal Investigator|718-518-2577|oalvarez@calvaryhospital.org|
20166919|NCT02563067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20201367|NCT03456115|Johns Hopkins University Hospital|Christopher Razavi, MD|410-955-2307|crazavi1@jhmi.edu|
20201368|NCT01276288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201369|NCT03496701|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
20201370|NCT04552470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201371|NCT00620061|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
20203013|NCT00500149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20166920|NCT00774267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20166921|NCT01039519|Synta Pharmaceuticals|VP Clinical Research|781-541-7156|aoneill@syntapharma.com|
20166922|NCT05844007|Montana State University|Dr. Lauren Davis|828-773-6328|lauren.davis6@montana.edu|
20166923|NCT00808080|UC San Diego Moores Cancer Center|Dr. Thomas Lane, Stem Cell Lab Director|858-822-5364|jreiner@Ucsd.edu|
20166924|NCT00423917|Mayo Clinic|Winston Tan MD|507/284-1159|tan.winston@mayo.edu|
20166925|NCT00243269|University of Rochester|Joseph Roscoe PhD|585 275-9962|joseph_roscoe@urmc.rochester.edu|
20166926|NCT03052400|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20166927|NCT00555061|GlaxoSmithKline|GSK Response Center|866-435-7343||
20166928|NCT00337675|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20166929|NCT03021343|Khalidi Hospital & Medical Center|Dr. Ramzi Tabbalat|00962795535522|ramzi_md@yahoo.com|
20166930|NCT00441064|Novartis Pharmaceuticals|Study Director|862-778-8300||
20166931|NCT03962504|National Center for PTSD at VA Boston Healthcare System|Dr. Denise Sloan|857-364-6333|denise.sloan@va.gov|
20166932|NCT01470118|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20166933|NCT01497496|Moffitt Cancer Center|Celeste Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
20166934|NCT01243580|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
20166935|NCT03111628|JohnsHopkinsU|Sarbjit S. Saini|410550-2129|ssaini@jhmi.edu|
20166936|NCT03937999|Montefiore Medical Center|Paul Riska, MD|718-920-6494|priska@montefiore.org|
20166937|NCT00067002|UT MD Anderson Cancer Center|Simrit Parmar, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|SParmar@mdanderson.org|
20166938|NCT01354314|The Johns Hopkins University|Dr. Ned Sacktor|410-550-1045|sacktor@jhmi.edu|
20166939|NCT00478023|Grunenthal GmbH|Claudia Leinweber|49 241 569 2509|claudia.leinweber@grunenthal.com|
20166940|NCT02622178|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20166941|NCT05019521|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20166942|NCT02453711|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20166943|NCT01292629|Hoya Surgical Optics, Inc.|Kees den Besten, Vice President Global Quality, Regulatory Affairs, and Clinical Research|+65 6681 0025|kees.denbesten@HOYA.com|
20166944|NCT03695367|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
20166945|NCT00068419|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20166946|NCT03519711|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20166947|NCT02469870|Trifoia|Dr. Jordan Pennefather|1-877-874-3642|jordanp@trifoia.com|
20166948|NCT01627288|Duke University Health System|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
20166949|NCT00396253|Genentech, Inc.|Medical Communications|800-821-8590||
20166950|NCT01951963|Health Partners|Dr. Aaron Burnett|651-254-5304|Aaron.M.Burnett@HealthPartners.Com|
20166951|NCT03523988|University of Washington|Lead Investigator|4254668544|akeith@uw.edu|
20166952|NCT05307965|John Radcliffe Hospital|Giovanni Luigi De Maria|+441865228364|GiovanniLuigi.DeMaria@ouh.nhs.uk|
20166953|NCT02538354|Universy Medical Center Groningen|dr. J.Z.H. von Martels|0031503616161|j.z.h.von.martels@umcg.nl|
20166954|NCT04672655|Stanford University|Molly Tanenbaum, PhD|(650) 725-3955|mollyt@stanford.edu|
20166955|NCT02641561|Cooper University Hospital|Shaffer R. S. Mok, M.D., M.B.S.|6099804564|mok.shaffer@gmail.com|
20166956|NCT01027806|School of Medicine, University of Missouri Health|Leila Kheirandish-Gozal, M.D., M.Sc.|(573) 884-3229|gozall@health.missouri.edu|
20166957|NCT01677377|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
20166958|NCT00479687|Bioventus LLC|Regulatory and Clinical Affairs|18003964325|CT.gov@bioventusglobal.com|
20166959|NCT00295880|Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
20166960|NCT01474239|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20166961|NCT02082119|Humanitas Cancer Center|Dr. Marta Scorsetti|+390282248524|marta.scorsetti@hunimed.eu|
20166962|NCT00796419|Emory University|Greg Martin, MD, MSc|404-616-0148|greg.martin@emory.edu|
20166963|NCT02840799|University of Pennsylvania|Hannah Maynard|215-662-7580|hannah.maynard@pennmedicine.upenn.edu|
20166964|NCT02565784|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20166965|NCT02642315|University of Missouri Columbia|Pradeep Sahota MD|573-882-6402|sahotap@missouri.edu|
20166966|NCT01760785|Denver Research Institute|Dr. Thomas Beresford|303-399-8020|thomas.beresford@ucdenver.edu|3732
20166967|NCT01349049|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
20166968|NCT02933450|Emergency Department, Baylor College of Medicine|Dr Zubaid Rafiue|7138732626|zubaidrafique@gmail.com|
20166969|NCT00552188|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
20166970|NCT03887702|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
20166971|NCT04432727|Tactile Medical|Michelle Wetherby|612-230-4576|mwetherby@tactilemedical.com|
20166972|NCT01089517|Ophthotech|Jeffrey Nau|646-573-7045|jeff.nau@ophthotech.com|
20166973|NCT01193257|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20201372|NCT00629083|Contura International A/S|Ieva Ankorina-Stark, Ph D, Chief Scientific Officer|011 45 8110 0900|ieva.ankorina-stark@contura.com|
20201373|NCT01193686|VA Puget Sound Health Care System|Rhonda Williams, Ph.D.|206-277-6290|Rhonda.Williams1@va.gov|
20201374|NCT03401749|University of Alabama at Birmingham|Ashish Shah|205-930-6722|ashishshah@uabmc.edu|
20201375|NCT05003115|Vanderbilt University Medical Center|Dr. Ebele Umeukeje|615-322-3221|ebele.m.umeukeje@vumc.org|
20166974|NCT03059355|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305 243 5579|JHare@med.miami.edu|
20166975|NCT01675544|Creighton University School of Medicine|Dr. Venkata M. Alla|(402) 280-4292|venkataalla@creighton.edu|
20166976|NCT03544333|University Hospital of Psychiatry Zurich, Switzerland|Stephanie Homan, PhD|0041 44 384|stephanie.homan@bli.uzh.ch|28 02
20166977|NCT02810509|Ilsan Paik Hospital Inje University|Keun-Sik Hong, MD, PhD, Prof|82-31-910-7680|nrhks@paik.ac.kr|
20166978|NCT02950467|UCSF|Michelle Matvey|4152214810|michelle.matvey@ucsf.edu|24117
20166979|NCT03656562|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20166980|NCT02136069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20166981|NCT04693234|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
20166982|NCT00459186|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-632-3237|Mary_Taplin@dfci.harvard.edu|
20166983|NCT02920242|Novartis Pharmaceuticals|Study Director|862-778-1873|novartisemail@novartis.com|
20166984|NCT04995419|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
20166985|NCT01409811|City of Hope|Carolyn Behrendt, Ph.D.|626-218-1148|cbehrendt@coh.org|
20166986|NCT00634101|Johnson & Johnson Vision|DIR CLINICAL NEW PRODUCT DEVELOPMENT|1-800-843-2020|KMoody1@its.jnj.com|
20166987|NCT01543633|Neuroscience Statistics Research Laboratory, Massachusetts General Hospital|Dr. Emery N. Brown|(617) 726-8786|enb@neurostat.mit.edu|
20166988|NCT00838513|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
20166989|NCT01491984|IWK Health Centre|Dr. Ronald George|902-470-6627|rbgeorge@dal.ca|
20166990|NCT03051178|University of Florida|Dr. Aysegul Gunduz|3522736877|agunduz@bme.ufl.edu|
20166991|NCT00953056|Merck Sharp and Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20156420|NCT05142306|Emergent BioSolutions Canada Inc|Mila Mirceta, PhD, Senior Scientist, Clinical Research|204-275-4074|mircetam@ebsi.com|
20156421|NCT02251041|UZLeuven|Diethard Monbaliu|+32 16 348727|diethard.monbaliu@uzleuven.be|
20156422|NCT04079920|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156423|NCT04918771|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20156424|NCT01046669|Spectral Diagnostics Inc.|Debra Foster, VP Clinical Development|4166263233|dfoster@spectraldx.com|2001
20156425|NCT05014919|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
20156426|NCT02971163|Mount Sinai Medical Center|Dr. Marc A. Probst|212-824-8094|marc.probst@mssm.edu|
20156427|NCT02702999|The University of Texas Health Science Center at Houston|Olaide Azizat Ashimi Balogun, MD|(713) 500-6412|Olaide.A.Ashimi@uth.tmc.edu|
20156428|NCT04104477|University of Florida|Jennifer Nichols, Ph.D.|352-294-8803|jnichols@ufl.edu|
20156429|NCT04910165|Saint Luke's University Health Network|Dr. Chinenye Nwachuku|6096101054|chinenye.nwachuku@sluhn.org|
20156430|NCT01287208|Massachusetts General Hospital|Anne Thorndike, MD, MPH|617-724-4608|athorndike@partners.org|
20156431|NCT02940223|UT MD Anderson Cancer Center|Sriram Yennu,Professor, MD- Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20156432|NCT05305651|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156433|NCT00526799|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
20156434|NCT01441492|Baylor College of Medicine|Amy McElhany, Clinical Research Manager|7137981016|pancreas@bcm.edu|
20156435|NCT00522379|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20156436|NCT03135067|University of Pennsylvania|Dr. Harsha Thirumurthy|215-746-0410|hthirumu@upenn.edu|
20156437|NCT02100826|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20156438|NCT00967499|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20156439|NCT05070819|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
20156440|NCT03975660|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
20156441|NCT02365688|Duke University Medical Center, Department of Anesthesiology|Timothy Miller MB ChB, FRCA|(+1) 919 6819660|timothy.miller2@duke.edu|
20156442|NCT04134936|MorphoSys|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
20156443|NCT03518060|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156444|NCT05078112|Duke University|Sujay Kansagra, MD|919-668-0477|sujay.kansagra@duke.edu|
20156445|NCT00323622|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156446|NCT00835354|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156447|NCT03538808|University of Alabama at Birmingham|Samantha Schiavon|9515509388|sschiavon@uabmc.edu|
20156448|NCT02097225|Massachusetts General Hospital|Ryan Sullivan, MD|617-643-3614|RSULLIVAN7@PARTNERS.ORG|
20156449|NCT03926247|University of New Mexico|Dr. Jessica Goodkind|505-277-2501|jgoodkin@unm.edu|
20156450|NCT01852214|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
20156451|NCT02679274|University of Texas Medical Branch|Dr. Edgar L. Dillon|409 772 8701|eldillon@utmb.edu|
20156452|NCT04976855|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
20156453|NCT05487378|APR Applied Pharma Research s.a.|Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
20156454|NCT04603560|Brigham and Women's Hospital|Nancy Haff, MD, MPH|617-278-0930|nhaff@mgb.org|
20156455|NCT05472870|Shanghai Jiaotong University School of Medicine Xinhua Hospital|Fei Li|18930830950|feili@shsmu.edu.cn|
20156456|NCT01385995|Brigham and Women's Hospital|Dr. Susan Redline|857-307-0352|sredline1@rics.bwh.harvard.edu|
20156457|NCT00112385|Brigham and Women's Hospital|A Pilot Study of Etanercept in Dermatomyositis|617-732-8046|aamato@partners.org|
20166992|NCT02813577|Becton Dickinson|Anna Lovas|763-445-2385|anna.lovas@bd.com|
20166993|NCT01388335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20166994|NCT03339219|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20166995|NCT01004991|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
20166996|NCT00885534|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
20166997|NCT03008369|Mayo Clinic|Ashish Vitthalrao Chintakuntlawar, MBBS, Ph.D.|5072930504|Chintakuntlawar.Ashish@mayo.edu|
20166998|NCT01273519|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20166999|NCT04292899|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20167000|NCT01032889|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20167001|NCT01721837|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167002|NCT01500720|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20167003|NCT03830307|University of Pittsburgh|Dr. Grace Lim|412-641-4260|limkg2@upmc.edu|
20167004|NCT00740857|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20167005|NCT03433040|University of South Florida|Wendy Duncan, QA/QI Research Compliance Manager|8139747454|wduncan3@usf.edu|
20167006|NCT03532451|ECOG Stats Center|Xiangying Chu|3472770190|xchu@ds.dfci.harvard.edu|
20167007|NCT02527421|Prosoft Clinical|Robert Babilon President|484 320 2068|b.babilon@prosoftclinical.com|
20167008|NCT02541604|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20167009|NCT00828204|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
20167010|NCT01615029|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20167011|NCT05064358|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20167012|NCT01287741|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20167013|NCT04421027|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20167014|NCT05407064|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
20167015|NCT05186805|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20167016|NCT00487461|University of Illinois at Chicago|Ali Alaraj, MD|312-996-4842|alaraj@uic.edu|
20167017|NCT05767749|Weill Cornell Medicine|Dr. Kira Minkis|(646) 962-3376|kim9036@med.cornell.edu|
20167018|NCT03760718|Oregon Health & Science University|Brandon Togioka, MD|503-494-4572|togioka@ohsu.edu|
20167019|NCT03083873|Iovance|Sr. Medical Director, Rana Fiaz|661-645-3572|rana.fiaz@iovance.com|
20167020|NCT01264705|UT Southwestern Medical Center|Adam Yopp, MD|214-648-5870|adam.yopp@utsouthwestern.edu|
20167021|NCT02260180|Aclaris Therapeutics, Inc.|Judith Schnyder, Senior Director of Clinical Operations|1-484-329-2144|jschnyder@aclaristx.com|
20167022|NCT01812668|Barbara Ann Karmanos Cancer Institute|Dr. Elisabeth Heath|313-576-8734|heathe@karmanos.org|
20167023|NCT00689260|EMD Serono, Inc.|Sanja Dragnic, MD|781-681-2337|sanja.dragnic@emdserono.com|
20167024|NCT01170247|University of Iowa|Brett Faine|319-310-8067|brett-faine@uiowa.edu|
20167025|NCT00662298|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
20167026|NCT03126344|Shanghai ninth people's hospital|Sun Yu|13611895542|dr_sunyu@163.com|+86
20167027|NCT01027273|Icahn School of Medicine at Mount Sinai|Carol R Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
20167028|NCT04657094|City of Hope Medical Center|Dr. Alexey Danilov|6263598111|adanilov@coh.org|
20167029|NCT00839319|University of Washington|Mara Roth, MD|206-221-0519|mylang@u.washington.edu|
20167030|NCT01330108|University of Alabama at Birmingham|Robert C Bourge|205-934-3624|bbourge@uab.edu|
20167031|NCT00485134|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
20167032|NCT00970684|Case Comprehensive Cancer Center|Nathan Pennell MD|216-445-9285|penneln@ccf.org|
20167033|NCT04294680|Campbell Clinic|Principal Investigator|9017595522|tbrolin@campbellclinic.com|
20167034|NCT00475306|Montefiore Medical Center|Dr. BW Friedman|718-920-6626|befriedm@montefiore.org|
20167035|NCT03565328|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
20167036|NCT00905645|Sientra|Chief Technology Officer|(805) 562-3500|denise.dajles@sientra.com|
20167037|NCT04881942|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
20167038|NCT00578292|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
20167039|NCT01485172|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167040|NCT01587014|Medical Center of the Rockies|Dr. Julie Dunn|970-624-1680|julie.dunn@uchealth.org|
20167041|NCT02028208|Allerdern (dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|7208
20167042|NCT02948088|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20167043|NCT02416622|AGTC|Dr. Matt Feinsod|386-462-2204|mfeinsod@agtc.com|7202
20167044|NCT00139477|Nemours Children's Clinic|Dr. Nelly Mauras, Chief, Division of Endocrinology|904-697-3674|nmauras@nemours.org|
20167045|NCT00975780|Yale University School of Medicine|Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio|(203) 785-7571|vincent.quagliarello@yale.edu|
20167046|NCT01056016|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
20167047|NCT01077076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20167048|NCT02289157|UTSW Medical Center|Dr. Scott Roberts|214-648-3113|scott.roberts@utsouthwestern.edu|
20167049|NCT01976741|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20167050|NCT01415882|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
20167051|NCT00670306|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
20201376|NCT03757039|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20167052|NCT01301027|University of Utah|Srinivansan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
20167053|NCT00845897|Washington University School of Medicine|Mary Hastings PT, DPT, ATC|314 286 1433|hastingsmk@wustl.edu|
20167054|NCT02722499|Medical College of Wisconsin|Jennifer A. Campbell|414-955-8829|jacampbell@mcw.edu|
20201377|NCT03406962|Magenta Therapeutics|Medical Director|(857) 242-0170|clinicaltrials@magentatx.com|
20167055|NCT01009619|Katholieke Universiteit Leuven and University Hospital Leuven|Prof. Dr. GM Verleden|+32 16 34 68 08|geert.verleden@uzleuven.be|
20167056|NCT01620216|OHSU|Dr. Stephen Spurgeon|5034948950|spurgeos@ohsu.edu|
20167057|NCT03566485|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
20167058|NCT00369265|Philadelphia ENT Associates|Robert T. Sataloff, M.D., D.M.A., FACS|215-545-3322|rtsataloff@phillyent.com|
20167059|NCT01192191|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167060|NCT00467753|UMDNJ|Sherie Novotny, MD|(732) @35-4119|novotnsl@rutgers.edu|
20167061|NCT02037230|University of Michigan Rogel Cancer Center|Theodore Lawrence, M.D., Ph.D.|734-647-9955|tsl@umich.edu|
20167062|NCT01072643|The Children's Hospital of Philadelphia|Dr. Aruna T. Nathan|215-590-1858|aruna.nathan@gmail.com|
20167063|NCT02817464|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20167064|NCT04420325|UZ Leuven|Lennert Minten|+32496397568|lennert.minten@gmail.com|
20167065|NCT01369888|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20167066|NCT05220436|South London & Maudsley NHS Foundation Trust|Dr Emilie Bourke|07702686322|emilie.bourke@slam.nhs.uk|
20167067|NCT01704599|Dept. Dermatology Wayne StateUniversity|Peter J. Aronson, MD|(313)_745-7845|paronson@med.wayne.edu|
20167068|NCT02840461|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20167069|NCT06139887|White River Junction VA Medical Center|Dr. Natalie Riblet|1-802-295-9363|natalie.riblet@va.gov|5893
20167070|NCT01737502|Mayo Clinic in Florida|Yanyan Lou, MD|904-953-0315|lou.yanyan@mayo.edu|
20167071|NCT03801044|Sisli Hamidiye Etfal Training and Research Hospital|Mustafa Sevinc|00905309291239|musevinc@hotmail.com|
20167072|NCT02285439|Children's Hospital Los Angeles|Dr. Nathan Robison|323.361.2121|mek162@chla.usc.edu|
20167073|NCT02003924|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167074|NCT02219659|MemorialCare Long Beach|Division of Pulmonary and Critical Care|(562) 933-2000|mtanios@yahoo.com|
20167075|NCT00124306|University of Pennsylvania|J. Richard Landis, PhD|215-5734922|hultman@upenn.edu|
20167076|NCT00427765|UT MD Anderson Cancer Center|Partow Kebriaei, MD/Associate Professor||celsaenz@mdanderson.org|
20167077|NCT00560352|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20167078|NCT00114517|University of Southern California|Howard N. Hodis, M.D., Director, Atherosclerosis Research Unit|323-442-1478|athero@usc.edu|
20167079|NCT02685267|PCCTC|Jake Vinson|646-422-4383|vinsonj@mskcc.org|
20167080|NCT00611403|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20167081|NCT00539864|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
20167082|NCT00578734|Penn State Children's Hospital|Dr. Neal J. Thomas|717-531-5337|nthomas@hmc.psu.edu|
20167083|NCT04990804|Vanderbilt University Medical Center|Research Coordinator|615-936-7107|kennadie.long@vumc.org|
20167084|NCT04202419|Miami Dermatology and Laser Institute|Dr. Jill Waibel|(305) 615-2393|info@miamidermlaser.com|
20167085|NCT00943072|Regeneron Pharmaceuticals|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
20167086|NCT01170533|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
20167087|NCT00662675|Johnson & Johnson Pharmaceutical Research & Development, LLC|Director, Clinical Team Leader|609-730-3158||
20167088|NCT01717053|Duke University|Dr. Bridget Koontz|919-668-5213|bridget.koontz@duke.edu|
20167089|NCT03860818|Ralph H. Johnson VA Healthcare System|Dr. David J. Taber|843.789.6624|David.Taber2@va.gov|
20167090|NCT00792571|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
20167091|NCT02600819|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20167092|NCT01715857|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20167093|NCT00505778|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20167094|NCT01373671|Siemens Medical Solutions USA, Inc.|Director of Clinical Affairs|610-448-6468|lesley.ewing@siemens.com|
20167095|NCT04857320|LANGFORD RESEARCH INSTITUTE|Managing Director|5614296429|KKirby@Langfordresearch.org|150
20167096|NCT03790696|Washington University School of Medicine|Jennifer Harper / Clinical Research Coordinator|314-286-2697|jenniferharper@wustl.edu|
20167097|NCT03062540|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
20167098|NCT03291964|Oregon Health and Science university|David Sheridan Assistant Prof|5034941691|sheridda@ohsu.edu|
20167099|NCT02936648|Department of Veterans Affairs, CHOIR and BridgeQUERI|Vera Yakovchenko|781.687.3374|vera.yakovchenko@va.gov|
20167100|NCT02914301|George Washington University School of Medicine & Health Sciences- Department of Emergency Medicine|Dr. Andrew C. Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
20167101|NCT00481091|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20167102|NCT02881567|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20167103|NCT02405442|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20167104|NCT00373113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167105|NCT02078960|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20167106|NCT03275350|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
20167107|NCT02173509|University Aveiro|Teresa Herdeiro|+351234370200|teresaherdeiro@ua.pt|
20167108|NCT04661579|PATH|Christian F. Ockenhouse, MD, PhD|1 (206) 285-3500|cockenhouse@path.org|
20167109|NCT01396447|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20167110|NCT01743859|University of Colorado|Dr. Daniel Pollyea||daniel.pollyea@ucdenver.edu|
20167111|NCT01402102|Clinical trial center for Functional Food in Chonbuk Nat'l University Hospital|Dr. Dal-Sik Kim|82-63-250-1793|dskim@chonbuk.ac.kr|
20167112|NCT01386970|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
20167113|NCT01056302|Department of Veterans Affairs|Dr. Rebeka Silva|415-221-4810|rebeka.silva@va.gov|22784
20167114|NCT02423902|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20167115|NCT04329806|Vanderbilt University Medical Center|Dr. Alfredo Gamboa|615 875 1003|alfredo.gamboa@vumc.org|
20167116|NCT04838626|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20167117|NCT02867384|Dana-Farber Cancer Institute|Corey Cutler, MD|6176323470|corey_cutler@dfci.harvard.edu|
20167118|NCT03901469|Zenith Epigenetics|Zenith Study Team|587-390-7865|ZEN003694-004@zenithepigenetics.com|
20167119|NCT03710083|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
20167120|NCT01727024|Novartis Pharmaceuticals|Study Director|862-778-8300||
20167121|NCT01047553|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20167122|NCT00948441|University of Pittsburgh|Judith M. Martin, MD|412-692-7028|judy.martin@chp.edu|
20167123|NCT04473469|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
20167124|NCT00104520|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
20167125|NCT01026324|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617-632-5053|stephen_hodi@dfci.harvard.edu|
20167126|NCT02442804|Brown University|John Bellone, Ph.D.|4012737100|john_bellone@brown.edu|6168
20167127|NCT01640834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167128|NCT02624986|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20167129|NCT02116205|WRAIR Clinical Trials Center|Dr. Kristin Mills, Principal Investigator|301-319- 2039|Kristin.t.mills.ctr@mail.mil|
20167130|NCT02561338|Hua Medicine|Yi Zhang|+86-21-58869997|yzhang@huamedicine.com|3269
20167131|NCT04200352|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20167132|NCT00806819|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167133|NCT02373683|Case Western Reserve University|Katherine Slain|12168443310|katherine.slain@uhhospitals.org|
20167134|NCT03564678|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
20167135|NCT04016623|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
20167136|NCT00912197|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
20167137|NCT02267837|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
20167138|NCT00756613|VA|Tamara Paine|7082028387|tamara.paine@va.gov|25785
20167139|NCT04901715|University of North Carolina at Chapel Hill|Kelli Sullivan, MPH|919-962-9786|kelli_sullivan@med.unc.edu|
20167140|NCT01326104|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
20167141|NCT04022499|Denver Health and Hospital Authority|Rocio Pereira, Medical Director, Community Integrated Health Care|303-436-6000|rocio.pereira@dhha.org|
20167142|NCT00494676|Schepens Eye Research Institute|Alex Bowers|617-912-2512|alex_bowers@meei.harvard.edu|
20167143|NCT04073225|Johns Hopkins University|Michelle Carlson|(410) 790-8205|mcarlso2@jhu.edu|
20167144|NCT06019611|Mayo Clinic|Dr. Kristin Zhao, Director of the Assistive and Restorative Technologies Laboratory|507-284-8942|zhao.kristin@mayo.edu|
20167145|NCT04681352|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
20167146|NCT03010488|New York State Psychiatric Institute|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
20167147|NCT00975689|National Institute of Child Health and Human Development; NIH|Dr. Forbes D Porter, Senior Investigator|(301) 435-4432|fdporter@mail.nih.gov|
20167148|NCT04335136|APEIRON Biologics AG|Dr. Romana Gugenberger|+4366488506236|romana.gugenberger@apeiron-biologics.com|
20187807|NCT05953740|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20187808|NCT04206787|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187809|NCT04046094|University of Kansas Medical Center|Faith Rahman|913-588-2502|frahman2@kumc.edu|
20187810|NCT02865538|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20187811|NCT04451772|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20187812|NCT04311632|ITB-MED LLC|Jesse Scott, MPH|+46 8 410 02 887|KTX@itb-med.com|
20187813|NCT04632225|Helixmith Co, Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20187814|NCT02278211|University of Edinburgh|Professor Dave Newby|0131 242 6515|D.E.Newby@ed.ac.uk|
20187815|NCT03858517|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
20187816|NCT04804540|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20187817|NCT05172232|Linköping University|Professor Magnus Falk|+46708106176|magnus.falk@liu.se|
20187818|NCT04012931|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187819|NCT02997202|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
20187820|NCT03778801|Aksaray University training and Research Hospital|Principal Investigator|905555289493|mlk.aykut@gmail.com|
20187821|NCT03165786|University of Illinois Chicago|Pamela Martyn-Nemeth, Professor|(312) 996-7903|pmartyn@uic.edu|
20187822|NCT04629339|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20187823|NCT06356285|Imperial College London|Dr Kate Grailey|07912563290|k.grailey18@imperial.ac.uk|
20187824|NCT04158739|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20187825|NCT05308979|UC Irvine Medical Center|Dr. Carly Crowder|7144562911|crowderc@hs.uci.edu|
20187826|NCT04084574|Duke University|Crystal Tyson, MD, MHS|919-660-6671|crystal.simpson@duke.edu|
20187827|NCT02782676|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head of Clinical Sciences|714-247-8613|kendra.hileman@abbott.com|
20187828|NCT00964392|Biosense Webster, Inc.|Robert Stagg, Clinical Franchise|(800) 729-9010|RStagg@its.jnj.com|
20187829|NCT04055012|The University of Pittsburgh|Study Coordinator|412-692-2084|kesslerl@upmc.edu|
20167149|NCT01598506|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
20167150|NCT02367833|Penn State University|Dr. Mary Jane De Souza|8148630045|mjd34@psu.edu|
20167151|NCT02268175|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mary_taplin@dfci.harvard.edu|
20167152|NCT00775593|GIMEMA|Edoardo La Sala|+39 06 70390524|e.lasala@gimema.it|
20167153|NCT02067676|Enteric Disease Department, Naval Medical Research Center|Ramiro Gutierrez, MD|301-319-3193|ramiro.l.gutierrez.mil@mail.mil|
20167154|NCT00996333|Columbia University|Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
20167155|NCT01327482|Massachusetts General Hospital|Dr. Caroline Mitchell|617-724-2182|caroline.mitchell@mgh.harvard.edu|
20167156|NCT00476229|UT MD Anderson Cancer Center|Chitra M. Hosing, MD/Associate Professor||gmccormi@mdanderson.org|
20167157|NCT02164461|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|Sheeri@advaxis.com|
20167158|NCT01814241|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20167159|NCT02100696|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20167160|NCT02471326|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
20167161|NCT00078897|University of Arizona|Dr. Elizabeth Jacobs|(520) 626-0341|jacobse@email.arizona.edu|
20167162|NCT03865381|Verily Life Sciences|Head of Clinical Science|(650) 253-0000|info@verily.com|
20167163|NCT04999852|Indiana University|Clarissa Tokash|(812) 855-7686|catokash@iu.edu|
20167164|NCT05626322|Pfizer Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167165|NCT03776812|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20167166|NCT04950816|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
20167167|NCT04758637|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
20167168|NCT02879812|Emory University|Dr. Rachel Patzer|404-727-6047|rpatzer@emory.edu|
20167169|NCT05110872|Fralin Biomedical Research Institute at Virginia Tech Carilion|Dr. Freitas-Lemos|540-526-2106|rflemos@vtc.vt.edu|
20167170|NCT04059159|Spinal Singularity|Derek Herrera|949-436-7974|dherrera@urodevmedical.com|
20167171|NCT03350672|Philadelphia FIGHT Community Health Centers|Linden Lalley-Chareczko|2155258695|lchareczko@fight.org|
20167172|NCT01847027|University of North Texas Health Science Center|Meharvan Singh, PhD|8177355429|meharvan.singh@unthsc.edu|
20167173|NCT00048074|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20167174|NCT02873377|University of Miami|Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
20167175|NCT04518358|Guiding Technologies Corp.|John Nosek|609-605-9273|john.nosek@guidingtechnologies.com|
20167176|NCT01583296|Ferkauf Graduate School of Psychology, Yeshiva University|Jonathan M. Feldman|6465924508|jonathan.feldman@einstein.yu.edu|
20167177|NCT01063283|Inova|Michael Maitland, MD, PhD|571-472-4724|Michael.Maitland@inova.org|
20167178|NCT00356304|VA New Jersey Healthcare System|Alejandro Interian, Principal Investigator|908-647-0180|alejandro.interian@va.gov|4617
20167179|NCT02504216|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20167180|NCT02598583|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20167181|NCT03237286|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
20167182|NCT02792829|Eisai Inc.|Eisai Medical Research Inc.|1-888-422-4743|esi_medinfo@eisai.com|
20167183|NCT02797613|Memorial University|Peter Daley|7097250240|pkd336@mun.ca|
20167184|NCT01151904|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20167185|NCT02282514|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20167186|NCT03043105|Peking Union Medical College Hospital|Dr. Jian Li|86-010-69155027|lijian@pumch.cn|
20167187|NCT01668589|Amgen Inc.|Study Director|866-572-6436||
20167188|NCT00993148|Northwestern University|Dr. Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
20167189|NCT02302339|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
20167190|NCT02752165|University of Rochester|Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
20167191|NCT00826202|Nathan Kline Institute|Daniel Javitt MD, PhD|845-398-6534|javitt@nki.rfmh.org|
20167192|NCT05036733|University of Michigan|Yvonne J Huang MD|734-936-5047|yvjhuang@med.umich.edu|
20167193|NCT04917757|University Hospital Würzburg|Prof Dr. Martin Fassnacht|4993120139021|fassnacht_m@ukw.de|
20167194|NCT03568461|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20167195|NCT04695977|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20167196|NCT02175199|Alcon Research, Ltd.|Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20167197|NCT05480111|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
20167198|NCT03983317|TheraNova, LLC|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
20167199|NCT01761162|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
20167200|NCT01643772|Mundipharma (China) Pharmaceutical Co.Ltd|Ms. Dan Zhu, Clinical operation and quality lead of the study|+8610 6563 6891|dan.zhu@mundipharma.com.cn|
20167201|NCT01621802|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167202|NCT03436082|Yale School of Medicine|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
20167203|NCT01296672|UT Health|Jonathan Gelfond|210 567-0836|gelfondjal@uthscsa.edu|
20167204|NCT01716052|UTHSCSA @CTRC|Dr. Kenneth Kist|210-450-5600|KIST@UTHSCSA.EDU|
20201378|NCT03853694|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20201379|NCT03333577|Cochlear|George Cire|303 885 5440|gcire@msn.com|
20167205|NCT04027608|University at Buffalo|Jennifer Temple, Principle Investigator|7168295593|jltemple@buffalo.edu|
20167206|NCT00787618|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20167207|NCT01305577|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
20167208|NCT00796978|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Cynthia Owusu|+1 216-844-7670|cynthia.owusu@uhhospitals.org|
20167209|NCT01147627|The Third Affiliated Hospital of Sun Yat-sen University|Dr. Jianping Weng|86-20-85253162|wjianp@mail.sysu.edu.cn|
20167210|NCT01092546|GE Healthcare|Paul Sherwin, M.D.|609-514-6820|Paul.Sherwin@ge.com|
20167211|NCT02197078|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167212|NCT00622440|University of California, San Francisco|Naomi Jay, PhD|415-353-7443|Naomi.Jay@ucsf.edu|
20167213|NCT02223377|Department of Anesthesia, McMaster University, Canada|Dr. Thuvaraha Vanniyasingam|(905) 525-9140|tvanniya@stjosham.on.ca|21736
20167214|NCT00771953|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20167215|NCT03328208|Hypnalgesics, LLC|Elvira V. Lang, MD, CEO|6177349087|drevlang@comforttalk.com|
20167216|NCT00947193|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20167217|NCT04364984|Medical Practice Prof D.Ivanov|Prof Dmytro Ivanov|0504448788|drivanovdd@gmail.com|+38
20167218|NCT01349959|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Clinical Research Office|410-955-8866|jhcccro@jhmi.edu|
20167219|NCT02675634|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
20167220|NCT01652534|Northwestern University|Dr. Tanya Simuni|312-503-2970|tsimuni@nm.org|
20167221|NCT01941186|Child Health Institute of New Jersey|Manuel Jimenez, MD, MS|732-235-6230|jimenema@rwjms.rutgers.edu|
20167222|NCT03860259|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
20167223|NCT00811018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167224|NCT01976091|Sarepta Therapeutics, Inc|Medical Information|1-800-690-2003|SareptAlly@sarepta.com|
20167225|NCT02722304|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20167226|NCT00934362|University of North Carolina at Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
20167227|NCT02566369|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
20167228|NCT01092117|Endologix|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
20167229|NCT04380519|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
20167230|NCT03656380|University of North Carolina at Chapel Hill|Lindsay Cortright, MA|919-445-4911|lindsay_cortright@med.unc.edu|
20167231|NCT02283827|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20167232|NCT02147561|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20167233|NCT00393861|IndianaU|Lawrence H. Einhorn, M.D.|(317) 944-0920|leinhorn@iu.edu|
20167234|NCT05300763|Johnson & Johnson Vision Care, Inc.|John R. Buch, Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
20167235|NCT02283762|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
20167236|NCT00974480|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
20167237|NCT00528450|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
20167238|NCT04625517|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
20167239|NCT00889720|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167240|NCT00223080|Department of Disease Control, Ministry of Public Health|Dr. Supachai Rerks-Ngarm|66-2-590-3006|supachai@health.moph.go.th|
20167241|NCT03193593|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
20167242|NCT00947882|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20167243|NCT01262820|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20167244|NCT00452361|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20167245|NCT05188053|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|507-266-5895|schouten.gabriel@mayo.edu|
20167246|NCT00794313|Oregon Health & Science Universtiy|Kathyrn Chung MD|503 721 - 1091|chungka@ohsu.edu|
20187830|NCT03652272|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
20187831|NCT02326974|Dana-Farber Cancer Institute|Project Manager|617-632-3500|ctopm@dfci.harvard.edu|
20201380|NCT01818297|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
20156458|NCT04136288|Mayo Clinic|Chandler Chapman, DHSc, MPH, Senior Clinical Research Coordinator|9049538681|Chapman.Chandler@mayo.edu|
20156459|NCT03053362|Brain and Cognition Discovery Foundation|Dr. Roger McIntyre|(416) 943-6284|rogermcintyre28@gmail.com|
20156460|NCT06003829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156461|NCT05700422|Scheie Eye Institute|Ophthalmology Clinical Research|215-662-8038|ophth.clinicalresearch@pennmedicine.upenn.edu|
20156462|NCT02397720|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
20156463|NCT02613507|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20156464|NCT03514134|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
20156465|NCT02947984|Massachusetts General Hospital|Nina Sanford, MD||NSANFORD@PARTNERS.ORG|
20156466|NCT04073056|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat|212-523-2500|AliNima.Shariat@mountsinai.org|
20156467|NCT04717258|University of York|Sarah Cockaiyne|01904321736|sarah.cockayne@york.ac.uk|
20156468|NCT00363298|Stanford University Medical Center, Department of Psychiatry|Lorrin M. Koran, M.D.|650 498-5035|lkoran@stanford.edu|
20156469|NCT00688740|sanofi-aventis|International Clinical Development Study Director||Contact-us@sanofi-aventis.com|
20156470|NCT01943227|UC Davis Medical Center|Neal Fleming, MD, PhD|916-734-5046|nwfleming@ucdavis.edu|
20156471|NCT00856557|Jesse Brown VA Medical Center|Dr. Saul J. Weiner|3125192697|Saul.Weiner@va.gov|
20156472|NCT03673176|Stanford University|Joseph Shrager, MD|(650) 721-2086|shrager@stanford.edu|
20156473|NCT02378480|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
20167247|NCT01010867|Columbia University Medical Center|Monica Bhatia, MD|2123055808|mb2476@cumc.columbia.edu|
20167248|NCT00442364|BTG International Inc|David DI Wright MB BS|610-278-1660|david.wright@btgplc.com|
20167249|NCT00556504|TCM Biotech International|Dr. Ya-Chun Wang, EVP/CSO|886-2-26581677|yachunwang@tcmbio.com|733
20167250|NCT01120964|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
20167251|NCT02621151|NYU Langone Health|Minas Economides, MD|2127315413|minas.economides@nyulangone.org|
20167252|NCT04198714|MetroHealth Medical Center|Dr. Jeffrey Mangel|216-778-5595|jmangel@metrohealth.org|
20167253|NCT04238819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20167254|NCT02529553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20167255|NCT03704389|Northwestern University|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
20167256|NCT02355184|CytoDyn|Joseph Meidling|(360) 980-8524|jmeidling@cytodyn.com|
20167257|NCT04075812|The Ohio State University|Marcia Bockbrader MD PhD|6142933127|bockbrader.13@osu.edu|
20167258|NCT00147069|Imperial College London|Professor Louise Donnelly|+44 (0)20 7594 7895|l.donnelly@imperial.ac.uk|
20167259|NCT04458090|University of Colorado Anschutz Medical Campus|Dr. Channing Tate, Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
20167260|NCT00459732|Children's Hospital & Research Center, Oakland|Ellen Fung, PhD RD CCD|510-428-3885|efung@mail.cho.org|4939
20167261|NCT01124864|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20167262|NCT01243242|Alcobra|Dr Yaron Daniely CEO|972-072-2204662|yaron@alcobra-pharma.com|
20167263|NCT03093662|Brooke Army Medical Center|Dr. Derek Brown|2109160808|Derek.J.Brown1.mil@mail.mil|
20167264|NCT01322841|Indiana University School of Medicine|Aaron Carroll|3172789616|aaecarro@iu.edu|
20167265|NCT01077921|Duke University Medical Center|Laura De Castro, MD, MHSc|(412) 623-7026|laura.decastro@dm.duke.edu|
20167266|NCT01505764|Department of Veterans Affairs|Jose M Garcia MD, PhD, Clinician Investigator|206-7642984|jose.garcia@va.gov|
20167267|NCT02160899|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20167268|NCT01256294|Novartis Pharmaceuticals|Study Director|862-778-8300||
20167269|NCT04129151|Dana-Farber Cancer Institute|David S Shulman, MD|617-632-6670|david_shulman@dfci.harvard.edu|
20167270|NCT02603666|Karolinska University Hospital, Huddinge, 141 86 Stockholm|Ferenc Karpati M.D., Ph.D., Senior Consultant|+46858580000|ferenc.karpati@karolinska.se|81656
20167271|NCT00724711|Gilead Sciences|Dara Wambach, MA, Associate Director, Regulatory Affairs|650 522 5163|Dara.Wambach@gilead.com|
20167272|NCT02631590|Moffitt Cancer Center|Richard Kim, MD, Principal Investigator|813-745-1277|Richard.Kim@moffitt.org|
20167273|NCT01088048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20167274|NCT01149148|UmichiganHS|Dr. Wei C. Lau|734 9369479|weiclau@med.umich.edu|
20167275|NCT00950859|ViiV Healthcare|GSK Response Center|866-435-7343||
20167276|NCT04896086|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20167277|NCT02917642|University of São Paulo|Dr. Ericka T. Pinheiro|551126488293|erickapinheiro@usp.br|
20167278|NCT02249832|Feinstein Institutes for Medical Research|Bruce T. Volpe, MD|(516) 562-3384|bvolpe1@northwell.edu|
20167279|NCT04216264|Duke University|Dr. Charles Wood|919-620-4772|charles.wood@duke.edu|
20167280|NCT00724867|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167281|NCT00436345|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167282|NCT01175083|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167283|NCT00093379|The University of Texas (UT) MD Anderson Cancer Center|Cathy Eng, MD/ Professor||CR_Study_Registration@mdanderson.org|
20167284|NCT01737593|UCLA|Dr. Wendy Ren|310.267.8678|wren@mednet.ucla.edu|
20167285|NCT02105961|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20167286|NCT04154189|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20167287|NCT02280408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20167288|NCT02474069|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
20167289|NCT04173494|Sierra Oncology LLC - a GSK company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20167290|NCT01623050|SinuSys Corporation|Janie Mandrusov, Director of Pre-Clinical and Clinical Development|4084104411|emandrusov@sinusys.com|
20167291|NCT01191762|Kenneth R. Phelps, M.D.|Kenneth R. Phelps, M.D.|518-626-5641|kenneth.phelps@va.gov|
20167292|NCT03898557|University of Pennsylvania|Alison M. Buttenheim, PhD MBA|215.573.5314|abutt@nursing.upenn.edu|
20167293|NCT01519869|University of Kentucky|Rachel Miller|859-323-2169|raware00@uky.edu|
20167294|NCT03023813|Cleveland Clinic|Glen Taksler PhD|216-445-7499|taksleg@ccf.org|
20167295|NCT00202878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20167296|NCT01421355|Brigham and Women's Hospital|Joshua Beckman, MD|617-732-6320|jbeckman@partners.org|
20167297|NCT02123472|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167298|NCT00577798|University of Nebraska Medical Center|Thomas Porter, MD|+1 (402) 559-8150|trporter@unmc.edu|
20167299|NCT02433080|University College London|Dr Anne Lanceley|+442076796807|a.lanceley@ucl.ac.uk|
20167300|NCT03801031|University of Iowa|David Bender, MD|319-356-2015|david-bender@uiowa.edu|
20167301|NCT01209702|Hoffman-LaRoche|Medical Communications|800-821-8590||
20167302|NCT00126490|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-8311|mayer.fishman@moffitt.org|
20167303|NCT05854784|CLINUVEL UK LTD|Director, Global Clinical Affairs|+4401372860765|mail@clinuvel.com|
20167304|NCT05487196|UPMC Magee Women's Hospital|Dr. Grace Lim, MD, MSc|412-641-1778|limkg2@upmc.edu|
20167305|NCT01459497|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214-645-7603|puneeth.iyengar@utsouthwestern.edu|
20167306|NCT01120717|Novartis Pharmaceuticals|Study Director|862 778-8300||
20167307|NCT03117140|Univesity of Iowa Hospitals and Clinics|Melinda Seering|3193561616|melinda-seering@uiowa.edu|
20167308|NCT02379637|Novartis|Dr Marianna Armogida Director Clinical Research Innovation|+41223635182|marianna.armogida@novartis.com|
20167309|NCT01309282|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20167310|NCT02087423|AstraZeneca|Phillip Dennis, MD, PhD|+1 301 398-5549|ClinicalTrialTransparency@astrazeneca.com|
20167311|NCT03601117|Stanford University|Dr Nolan Williams|(650)800-6920|nolanw@stanford.edu|
20167312|NCT02762370|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20167313|NCT02445794|Retrotope, Inc|Frederic Heerinckx/VP Clinical Operations|650-437-0700|frederic@retrotope.com|109
20167314|NCT01136785|The University of Chicago|Dr. Eve Van Cauter/Dr. Babak Mokhlesi|773-702-0169 or 773-702-2181|evcauter@medicine.bsd.uchicago.edu; bmokhles@medicine.bsd.uchicago.edu|
20167315|NCT02654769|Teva Pharmaceuticals Inc., USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
20167316|NCT00233064|MedImmune, LLC|Hasan S. Jafri, MD|301-398-0000||
20167317|NCT04393454|Albert Einstein College of Medicine|Dr. Chaoyuan Kuang|718-430-3516|chaoyuan.kuang@einsteinmed.edu|
20167318|NCT01003769|Mayo Clinic|Asher Alban Chanan-Khan, M.D.|(716) 845-3221|chanan-khan.asher@mayo.edu|
20167319|NCT03304249|University of Kansas Medical Center|Megan Olalde|913-588-2042|molalde@kumc.edu|
20167320|NCT04976192|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20167321|NCT00924027|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
20167322|NCT04549545|Aerin Medical|Tien Dang Sr. Clinical Affairs Manager|669-256-6596|tdang@aerinmedical.com|
20167323|NCT03390114|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
20167324|NCT03036215|HealthPartners Institute|James Fricton, DDS, Senior Research Investigator|6126191678|james.r.fricton@healthpartners.com|
20167325|NCT01395524|AstraZeneca|Mark Sostek||aztrial_results_posting@astrazeneca.com|
20167326|NCT01657461|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949 297 5494|manish.s.gupta@medtronic.com|
20167327|NCT01868542|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20167328|NCT00130247|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D., Principal Investigator|(216) 368-1949|jlj@case.edu|
20167329|NCT01574183|MUSC|Aimee McRae-Clark, PharmD|843-792-5216|mcraeal@musc.edu|
20167330|NCT02609113|Wake Forest Baptist Health|Vanessa Baute, MD|336-716-8140|vbaute@wakehealth.edu|
20167331|NCT00843284|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20167332|NCT00122980|Baylor College of Medicine|Russell E. Ware, MD, PhD, Director, Texas Children's Hematology Center|(832) 824-1368|reware@bcm.edu|
20167333|NCT03844945|Aerie Pharmaceuticals Ireland Limited, Japan Branch|Clinical Research, Japan|+81-3-6860-8410|JapanCS208@aeriepharma.com|
20167334|NCT03159260|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
20167335|NCT01856218|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
20167336|NCT03718091|Massachusetts Genera Hospital|Gregory M Cote MD PhD|6177244000|gcote@partners.org|
20167337|NCT02490670|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167338|NCT01139008|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20167339|NCT02516969|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
20167340|NCT01588418|University of Texas Health Science Center at San Antonio|Dr. Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
20167341|NCT00857714|IndianaU|Sunil Badve, MD|317-491-6417|sbadve@iupui.edu|
20167342|NCT00545272|Novartis Pharmaceuticals|Study Director|862-778-8300||
20167343|NCT02934503|NYU Langone|Dr. Joshua Sabari|212-731-6363|Joshua.Sabari@nyulangone.org|
20167344|NCT04248491|Beaumont Health|Director Urology Research|2485511488|bernadette.zwaans@Corewellhealth.org|
20167345|NCT01068964|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20167346|NCT01311024|head of Clinical Research Unit, National Institute for Health and Welfare|Arto Palmu, MD, PhD Research manager,|+358295247910|arto.palmu@thl.fi|
20167347|NCT01652469|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
20167348|NCT02834793|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20167349|NCT02364336|NIDDK|Dr. Marc Ghany|301-402-5115|mg228m@nih.gov|
20167350|NCT01731938|Grifols Therapeutics, Inc.|Henry Li, PhD, RAC|1-919-316-6042|Henry.Li@Grifols.com|
20167351|NCT04931888|Yale University|Julia Rosenberg, MD MHS|2037777411|julia.rosenberg@yale.edu|
20167352|NCT01049009|Emory University School of Medicine|Dr. Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
20167353|NCT03179202|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
20167354|NCT00859638|McMaster University|Dr. Julie Richardson|(905) 525-9140|jrichard@mcmaster.ca|27811
20167355|NCT02910505|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20167356|NCT02969408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20167357|NCT04643158|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20167358|NCT01068600|Novartis Pharmaceuticals|Study Director|862-778-8300||
20167359|NCT01474018|Baylor Endocrine Center|Dr. Erin D. Roe|214-820-3466|edr@roemd.com|
20167360|NCT03563183|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20167361|NCT01594528|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
20167362|NCT00486291|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
20201381|NCT04439344|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20201382|NCT03770403|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
20167363|NCT04036292|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
20167364|NCT03462511|Columbia University School of Nursing|Arlene Smaldone, PhD, RN|212-342-3048|ams130@columbia.edu|
20167365|NCT02925416|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
20167366|NCT02625909|The Kirby Institute|Pip Marks, Clinical Trials Manager|+61 2 9385 0886|pmarks@kirby.unsw.edu.au|
20167367|NCT00200356|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20156474|NCT04642976|University of Pennsylvania|Timothy Markman|215-615-4332|timothy.markman@pennmedicine.upenn.edu|
20167368|NCT02577445|Livanova|Clinical Project Manager|0032498644704|renske.dezwaef@livanova.com|
20167369|NCT03001817|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
20167370|NCT03855059|University of Arizona/Deptartment of Anesthesiology|Peter Lichtenthal, MD|5206267221|plich@arizona.edu|
20167371|NCT00035932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20167372|NCT01297491|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20167373|NCT01805791|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
20167374|NCT04413617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167375|NCT00312195|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
20167376|NCT03152929|Spectrum Health|Marianne Melnik|616-486-6333|marianne.melnik@corewellhealth.org|
20167377|NCT02511106|AstraZeneca AB|Global Clinical Leader|+447920183730|ClinicalTrialTransparency@astrazeneca.com|
20167378|NCT01015638|GlaxoSmithKline|GSK Response Center|88-435-7343||
20167379|NCT01719744|Princess Margaret Cancer Centre|Dr. ALBIRUNI RAZAK|416-586-4800|Albiruni.Razak@uhn.ca|5371
20167380|NCT01703754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20167381|NCT03530124|Duke University|Dr. Rachel Greenberg|919 668 4725|rachel.greenberg@duke.edu|
20167382|NCT03179319|Brown University|Katie Biello|401-863-3082|katie_biello@brown.edu|
20167383|NCT03849118|Telix Pharmaceuticals (Innovations) Pty Ltd|Dr. Kavita Vadali, Sr. Clinical Project Manager|+1 919-924-8887|kavita.vadali@telixpharma.com|
20167384|NCT06057727|University of Pennsylvania|Dr. Shivan Mehta|2679726027|shivan.mehta@pennmedicine.upenn.edu|
20167385|NCT01561313|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20167386|NCT04535453|Janssen Vaccines & Prevention B.V.|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20167387|NCT01387542|Janssen-Cilag Ltd.: 106 Moo 4 Lad Krabang Industrial Estate, Chalongkrung Rd., Lamplatew, Lad Krabang, Bangkok 10520|Medical Affairs Director|+66 2 7397200||5888
20167388|NCT01233232|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20167389|NCT00268853|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
20167390|NCT02917122|National Cheng Kung University|Dr. Kao Chin Chen|+886-6-2353535|andchen@mail.ncku.edu.tw|5213
20167391|NCT03574181|Boston Medial Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
20167392|NCT02633020|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20167393|NCT00934440|University of Kansas Cancer Center|Dr. Peter Van Velduizen|(913) 945-5059|SWILLIAM@kumc.edu|
20167394|NCT02152956|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
20167395|NCT00530816|Onyx Pharmaceuticals, Inc.|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
20167396|NCT01014910|Children's Mercy Hospital Kansas City|Dr. Russell McCulloh|816-234-3061|rmcculloh@cmh.edu|
20167397|NCT01388985|Institute of Tropical Medicine Antwerp|Dr. Patrick Soentjens|+32 3 247 66 41|psoentjens@itg.be|
20167398|NCT03761368|Medical University of Łódź|Karolina Stokfisz|+48422014260|stokfisz.karolina@gmail.com|
20167399|NCT02954172|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
20167400|NCT01519167|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20167401|NCT01881828|Jaeb Center for Health Research|Kellee Miller|15310 Amberly Drive|t1dstats@jaeb.org|
20167402|NCT02635425|Ain Shams university|Dr. Ahmad Hussieny Salama|00201223114626|ahmdhsf@hotmail.com|
20167403|NCT01925131|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|amoseley@fredhutch.org|
20167404|NCT00745849|University of Texas Southwestern|Ganesh Shanmugam, MD|9797036112|ganesh01@yahoo.com|
20167405|NCT01754727|AbbVie|Global Medical Information|800-633-9110||
20167406|NCT02338882|University of Plymouth|Dr Phillip Buckhurst|01752 588884|phillip.buckhurst@plymouth.ac.uk|
20167407|NCT04838977|University of Utah|Heather Keenan|8015877567|heather.keenan@hsc.utah.edu|
20167408|NCT00265148|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167409|NCT01463007|BrUOG-Brown University Oncology Research Group|Dr. Jaroslaw Hepel|4018633000|kristen_mitchell@brown.edu|
20167410|NCT00942994|Novartis Pharmaceuticals|Study Director|862-778-8300||
20167411|NCT03583385|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20167412|NCT01320137|GlaxoSmithKline|GSK Response Center|866-435-7343||
20187832|NCT02577354|Mainstay Medical|Vice President Clinical Affairs|7637727637|diane.burnside@mainstay-medical.com|
20187833|NCT05985382|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
20187834|NCT05043064|Aalborg University Hospital|Dr Gennady V Atroshchenko|97 66 46 49|g.atroshchenko@rn.dk|45
20187835|NCT04214834|RTI International|Dr. Abhik Das|3017708214|adas@rti.org|
20156475|NCT03226691|National Heart Lung and Blood Institute|John Tisdale|+1 301 402 6497|johntis@nhlbi.nih.gov|
20156476|NCT01285102|Fox Chase Cancer Center|Dr. Efrat Dotan|215-214-4283|Efrat.Dotan@fccc.edu|
20156477|NCT04189484|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
20156478|NCT00557440|Novartis Pharmaceuticals|Study Director|862-778-8300||
20156479|NCT03524157|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
20167413|NCT00095940|Pediatric Brain Tumor Consortium|Assistant Director Operations and Biostatistics Center|901-595-2617|dana.wallace@stjude.org|
20167414|NCT00296296|Stanford University|Stephan Busque, MD|650-498-6189|sbsuque@stanford.edu|
20201383|NCT04373460|Johns Hopkins University Bloomberg School of Public Health|David J. Sullivan|410-502-2522|dsulliv7@jh.edu|
20201384|NCT00591734|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20201385|NCT05775289|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20201386|NCT01984515|Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
20167415|NCT02314637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20167416|NCT04126278|NYU Langone Health|Mehul Shah|616-501-7223|Mehul.Shah@nyulangone.org|
20167417|NCT03029988|Navidea Biopharmaceuticals|Bonnie Abbruzzese Senior Director|614.793.7500|babbruzzese@navidea.com|147
20167418|NCT01421472|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
20167419|NCT00856232|UMDNJ|Dr. Boris Veysman|732-235-8717|veysmabo@umdnj.edu|
20167420|NCT03241030|Baylor College of Medicine|Nidhi Singh, MD|832-824-2771|nidhi.singh@bcm.edu|
20167421|NCT00621348|AIIMS|Rakesh Lodha|91 11 26593621|rakesh_lodha@hotmail.com|
20167422|NCT02453347|Audie L. Murphy Veterans Administration Hospital|Dr. Carlos Jaramillo|210-617-5300|jaramilloc3@uthscsa.edu|15773
20167423|NCT02597478|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20167424|NCT05043142|Yuria-Pharm|Tetiana Sprynsian|+380665134849|Tetiana.Sprynsian.pm@pharmaxi.com.ua|
20167425|NCT01256190|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20167426|NCT02350478|Medical University of Graz|Assoz.-Prof. Dr. Harald Sourij|+43316385|ha.sourij@medunigraz.at|81310
20167427|NCT02779556|University of Arkansas for Medical Sciences|Kristie Hadden, PhD/Associate Professor|501-993-3178|KBHADDEN@uams.edu|
20167428|NCT03236662|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
20167429|NCT03110770|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20167430|NCT01667419|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20167431|NCT00856518|North Florida/South Georgia Veterans Health System|Dr. Janis Daly|352-376-1611|janis.daly@neurology.ufl.edu|5223
20167432|NCT03364270|Cedars-Sinai Medical Center|Balaji Tamarappoo, MD|3104232219|Balaji.Tamarappoo@cshs.org|
20167433|NCT02082340|American University of Armenia|Dr. Harutyunyan||aharutyunyan@aua.am|
20167434|NCT04915950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20167435|NCT02644109|Nutrition and Food Technology Institute, University of Chile|Dr. Sandra Hirsch|+56229781495|shirsch@inta.uchile.cl|
20167436|NCT00536913|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20167437|NCT04195893|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20167438|NCT06026124|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
20167439|NCT00918736|Veterans General Hospital, Kaohsiung, Taiwan|Shu-Fen Sun|886-73422121|sfsun.tw@yahoo.com.tw|4210
20167440|NCT01942733|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
20167441|NCT01980589|Amgen, Inc.|Study Director|866-572-6436||
20167442|NCT04080167|St. Jude Children's Research Hospital|Jane Hankins, MD|(901) 595-4974|jane.hankins@stjude.org|
20167443|NCT02167139|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|dh01.shin@samsung.com|
20167444|NCT00518089|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
20167445|NCT00984620|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20187836|NCT04947137|Navidea Biopharmaceuticals|Senior Medical Director|6149737555|mblue@navidea.com|
20187837|NCT04924400|Geisinger|Dr. Thomas Morland|703-593-0088|tmorland@geisinger.edu|
20187838|NCT04109066|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20187839|NCT03812614|University of Pittsburgh School of Medicine|Ann-Marie Rosland, MD, MS|412-648-5660|roslandam@pitt.edu|
20187840|NCT05205161|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20187841|NCT05652010|Coloplast A/S|Senior Scientific Manager|+4549113192|dkmbs@coloplast.com|
20187842|NCT05864040|Rob Surgical Systems|Jaume Amat, CEO|+34 93 013 08 83|jaume.amat@robsurgical.com|
20187843|NCT05741294|Almirall S.A|Valentina Cappello/Global Medical Operations Manager|+34932913000|valentina.cappello@almirall.com|
20187844|NCT05451693|HealthPartners Institute|Bhavani Kashyap, PhD, MBBS|651-495-6363|Bhavani.x.kashyap@healthpartners.com|
20187845|NCT04704869|The University of Texas Health Science Center at Houston|Bryan A Cotton, MD|713-500-7313|Bryan.A.Cotton@uth.tmc.edu|
20187846|NCT04325815|University College London|Professor Laurence B Lovat|020-7679-9060|l.lovat@ucl.ac.uk|
20187847|NCT03681912|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|850-644-2334|sylvie.naar@med.fsu.edu|
20187848|NCT04707768|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
20187849|NCT02510235|Dompé farmaceutici SpA|Clinical Development & operations|+39583831|clinical.trials@dompe.com|
20187850|NCT05008055|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20201387|NCT04743856|University of Pittsburgh|Bonny Rockette-Wagner|4126240188|bjr26@pitt.edu|
20201388|NCT04439188|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20201389|NCT01707992|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
20201390|NCT04108429|Northwestern University|Dr. Emily Lattie|312-503-5509|emily.lattie@northwestern.edu|
20201391|NCT00998738|Mayo Clinic|Dr. Charles Loprinzi|507-266-6247|cloprinzi@mayo.edu|
20201392|NCT04211337|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
20201393|NCT04977037|The University of Texas Health Sciences Center at Houston|Nuray Yozbatiran, PhD, PT|7137975282|Nuray.Yozbatiran@uth.tmc.edu|
20217893|NCT03233958|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
20167446|NCT04296448|Johns Hopkins University Department o Peidaitrics Division of Pediatric Emergency Medicne|Dr. Therese Canares|(410) 955-6146‬|therese.canares@jhmi.edu|
20167447|NCT00947167|Stanford University School of Medicine|Pamela L. Kunz, MD, Leader GI Oncology Research Group|650-725-8738|pkunz@stanford.edu|
20167448|NCT00324961|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167449|NCT00344487|University of Maryland Institute of Human Virology|Charles E. Davis, Jr. MD|410-706-1684|cdavis@ihv.umaryland.edu|
20167450|NCT01247272|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20167451|NCT01966718|Arthritis Treatment Center|Dr. Nathan Wei|301-694-5800|nwei@arthritistreatmentcenter.com|
20167452|NCT02791763|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|7343
20167453|NCT03686007|City of Hope Medical Center|Dr. Virginia Sun|626-359-8111|VSun@coh.org|
20167454|NCT01456897|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
20167455|NCT01400880|University of Florida|Dr. Tony Gregg|352-265-0111|greggar@ufl.edu|
20167456|NCT01396070|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
20167457|NCT04254913|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml@ml.mt-pharma.co.jp|
20167458|NCT01396057|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20167459|NCT01742286|Study Director|Study Director|862-778-8300|novartis.email@novartis.com|
20167460|NCT04530136|Pharming Technologies BV|Anurag Relan, MD|0031 (0)71 5247400|a.relan@pharming.com|
20167461|NCT05661851|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|(347) 903-5029|njoshi30@its.jnj.com|
20167462|NCT01057589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167463|NCT00870584|Novartis Pharmaceuticals|Study Director|862-778-8300||
20167464|NCT01497366|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20167465|NCT03911102|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20167466|NCT00419445|CoMentis (formerly Athenagen)|Carl Grove|650-869-7600|cgrove@comentis.com|
20167467|NCT03508908|Aurum Institute|Dr. Eduard Sanders|254723593762|ESanders@auruminstitute.org|
20167468|NCT00472030|University of Iowa|Janet Fairley, M.D.|319-384-8560|janet-fairley@uiowa.edu|
20167469|NCT00829504|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20167470|NCT04189224|Johnson & Johnson Vision Care, Inc.|Thomas R Karkkainen.|1-800-843-2020|tkarkkai@its.jnj.com|
20167471|NCT05283031|Imperial College Ophthalmology Research Group|Jamie Spofforth|020 3312 6666|Jamiespofforth@nhs.net|
20167472|NCT04236141|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20167473|NCT03278067|GlaxoSmithKline|GSK Response Center|866-435-7343|emily.p.lu@gsk.com|
20167474|NCT01217307|University Medical Center Groningen|Dr. I.C.C. van der Horst||i.c.c.van.der.horst@umcg.nl|
20167475|NCT01303224|Menarini Ricerche S.p.A.|Angela Capriati MD PhD, Corporate Director of Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9933
20167476|NCT01888432|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20167477|NCT03054129|Dr. İsmail Atabek Physical Therapy and Rehabilitation Center|Ertan Şahinoğlu, PT, PhD|+90 5326478653|ertan.sahinoglu@hotmail.com|
20167478|NCT01696929|Georgia Regents University|Dr. Brian Miller|706-721-4445|brmiller@gru.edu|
20167479|NCT01043939|Masonic Cancer Center, University of Minnesota|Cindy K. Blair, MPH|612-624-9668|blair016@umn.edu|
20167480|NCT04473235|Universidade Federal de Minas Gerais|Elisa de Paula França Resende|+55 31 3307 9417|elisa.resende@gbhi.org|
20167481|NCT02726542|Massachusetts General Hospital|Takara Stanley, MD|617-726-5312|tstanley@mgh.harvard.edu|
20167482|NCT00798759|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20167483|NCT02156271|Duke University Medical Center|Dr. Andrew Krystal|919-681-8742|andrew.krystal@duke.edu|
20167484|NCT00955305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20167485|NCT03387111|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20167486|NCT00407381|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
20167487|NCT01945710|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
20167488|NCT02730195|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
20167489|NCT00375609|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20167490|NCT01368562|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20167491|NCT02491944|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20167492|NCT02810444|Biotest AG|Dr. med. Andrea Wartenbrg-Demand|+49 6103 801|andrea.wartenberg-demand@biotest.com|0
20167493|NCT05111301|Tandem Diabetes Care|Supervisor, Clinical Operations|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
20167494|NCT02785770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167495|NCT03968939|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
20167496|NCT04540510|Nuvance Health (formerly Western Connecticut Health Network)|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
20167497|NCT01129583|Columbia University Medical Center|TTC research fellow|212-305-3912|ttc@gmail.com|
20167498|NCT01328405|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
20156480|NCT04507763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156481|NCT03322566|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
20156482|NCT00361712|Rabin Medical Center|Dr Leonid Edilman|972-9376850|leidelman@clalit.org.il|
20156483|NCT05473715|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
20156484|NCT06045273|Johns Hopkins Center for Indigenous Health|Dr. Victoria O'Keefe|410-955-6931|vokeefe3@jhu.edu|
20156485|NCT02592863|University of Missouri|Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
20167499|NCT01904773|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicines Unit|Joel Posener, MD - Head, Early Clinical Development||ClinicalTrialTransparency@astrazeneca.net|
20167500|NCT04518995|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20167501|NCT02506985|University of Kentucky|Susan Smyth|859-323-2274|susansmyth@uky.edu|
20167502|NCT00669409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167503|NCT00813943|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20167504|NCT05367492|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
20167505|NCT00353470|Albert Einstein College of Medicine|Barbara Milrod, M.D., PI|212-595-0806|bmilrod@montefiore.org|
20167506|NCT04978454|Duke University Medical Center|Christopher Woods|919-684-7916|chris.woods@duke.edu|
20167507|NCT01971086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167508|NCT02891070|Baxter Healtcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
20167509|NCT02704143|Changhai Hospital affiliated to Navy Medical University|Dr. Huojun Zhang|86-021-31162207|chyyzhj@163.com|
20167510|NCT01235598|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
20167511|NCT05525078|Medical University of South Carolina|Tracy Smith, PhD|843 792 5164|smithtra@musc.edu|
20167512|NCT04780919|Charles University, 2nd Faculty of Medicine|Jakub Katolicky|+420 739 081 676|jakub@katolicky.eu|
20167513|NCT04491604|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
20167514|NCT00641641|University of New South Wales|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
20167515|NCT02191865|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
20167516|NCT01523275|University of California, San Francisco|Jolie Chang|415-353-2203|jolie.chang@ucsf.edu|
20167517|NCT01206322|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
20167518|NCT00260962|Ottawa Hospital Research Institute|Dr. Hany Bissada|613-798-5555|hbissada@ottawahospital.on.ca|78042
20167519|NCT01179113|Cedars Sinai Medical Center|Dr. Roya Yumu', Anesthesiology Program Director|310-423-1682|Roya.Yumul@cshs.org|
20167520|NCT02888119|NYU Langone Health|Dr. Ravinder Regatte|(212) 263-4857|Ravinder.Regatte@nyulangone.org|
20167521|NCT01767142|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20167522|NCT04726969|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
20167523|NCT04975230|Case Western Reserve University|Stephanie Griggs|404-544-9915|stephanie.griggs2@emory.edu|
20167524|NCT00926029|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20167525|NCT03206788|Kansas University Medical Center|Dr. Matthias Salathe|913 588 6045|msalathe@kumc.edu|
20167526|NCT02471612|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
20167527|NCT05573386|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
20167528|NCT05246514|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20167529|NCT03646123|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167530|NCT02209532|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
20167531|NCT01802073|Stanford University|Dr. Kenneth Cox|(650) 723-5070|KCox@stanfordchildrens.org|
20167532|NCT00332722|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|101
20167533|NCT02657408|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167534|NCT05343624|University Hospitals Cleveland Medical Center|Dr. Tanureet Arora|(440)892-6424|Tanureet.Arora@UHhospitals.org|
20167535|NCT02093819|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167536|NCT02447302|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20167537|NCT01901250|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
20167538|NCT05334212|University Hospitals Cleveland Medical Center|Dr. Gabriel Smith|(440)827-5088|Gabriel.Smith@UHhospitals.org|
20167539|NCT00910299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167540|NCT02695420|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20167541|NCT04449263|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256402964|javega2@coopervision.com|
20167542|NCT00916929|St Jude Medical|Tamara Shipman|408 522-6410|tshipman@sjm.com|
20167543|NCT02929407|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20167544|NCT02428478|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
20167545|NCT02878798|Virginia Commonwealth University|Dr. A. Gordon Smith|801-828-9869|gordon.smith@vcuhealth.org|
20167546|NCT01761240|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20167547|NCT03500224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20167548|NCT01324401|Harvard Medical School / Massachusetts General Hospital|Wayne Shreffler|617-726-6147|wshreffler@mgh.harvard.edu|
20167549|NCT03632954|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
20167550|NCT01708902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167551|NCT01442844|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
20167552|NCT00499590|OPKO Health, Inc.|Jane Hsiao, PhD, MBA|305-575-6004|jhsiao@opko.com|
20167553|NCT01980485|Penn State University|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
20167554|NCT01430169|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20167555|NCT03098615|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
20167556|NCT02281383|Memorial Sloan Kettering Cancer Center|Dr. Harry Herr, MD|646-422-4411|herrh@MSKCC.ORG|
20167557|NCT01215097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167558|NCT02252939|Massachusetts General Hospital|Rachel Gottlieb, Research Coordinator|617-726-1569|rgottileb3@mgh.harvard.edu|
20167559|NCT00932828|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
20167560|NCT01516034|Dr David Friedman Laser & Skin Center|David J. Friedman, Principal Investigator|+972-2-5635673|drfriedmanlaser@gmail.com|
20167561|NCT01033448|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20167562|NCT00580671|Geisel School of Medicine at Dartmouth|Alan J. Budney, PhD|855-290-2822|alan.j.budney@dartmouth.edu|
20167563|NCT00746512|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20167564|NCT01282463|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167565|NCT01954927|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
20167566|NCT03320824|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20167567|NCT00109590|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20167568|NCT02123251|University of Hawaii, Center on Disability Studies|Dr. Chuan Chinn|8089565379|chuanc@hawaii.edu|
20167569|NCT01221285|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20167570|NCT00588159|Mayo Clinic|Dr. Michelle A. O. Kinney|507-266-9877|kinney.michelle@mayo.edu|
20167571|NCT00727441|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
20167572|NCT01239992|University Munich|Klaus G. Parhofer|+49-89-7095-3010|klaus.parhofer@med.uni-muenchen.de|
20167573|NCT00535288|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20167574|NCT04672954|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167575|NCT02248675|VA Center of Excellence for Suicide Prevention|Wilfred R. Pigeon, PhD|(585) 393-7945|wilfred.pigeon2@va.gov|
20167576|NCT04565327|University of California, San Francisco|Dr. Zhen Wang, MD|(415) 476-3767|Zheng.Wang@ucsf.edu|
20167577|NCT03390101|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
20167578|NCT01511055|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
20167579|NCT00830869|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20167580|NCT00480987|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
20167581|NCT00395057|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20167582|NCT00281658|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20167583|NCT04590248|AstraZeneca Clinical Study Information Centre|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
20167584|NCT01109056|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20167585|NCT02052414|The Center for Clinical Research|James M. North MD|3367656181|jnorth1@ccrpain.com|
20167586|NCT01816711|Aarhus University Hospital|Mette Abildgaard Pedersen|31411180|meabpe@rm.dk|
20167587|NCT01303003|Steward St. Elizabeth's Medical Center|Meghan Cashman, IRB Manager|617-789-2804|meghan.cashman@steward.org|2804
20167588|NCT05011279|Dana-Farber Cancer Institute|Catherine Marinac|617-632-4703|CatherineR_Marinac@dfci.harvard.edu|
20167589|NCT01343693|Zimmer Biomet Spine|Zimmer Biomet Spine Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
20167590|NCT02151773|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
20167591|NCT02551991|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
20167592|NCT00395343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20167593|NCT03101111|Themis Bioscience|Christiane Thomasser|01 236 7151|christiane.thomasser@themisbio.com|
20167594|NCT02507960|University of Maryland Medical Center|Elizabeth Nichols|4103287586|enichols1@umm.edu|
20167595|NCT00387790|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
20167596|NCT01874340|Novartis|Study Director|862-778-8300||
20167597|NCT03539549|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20167598|NCT01290913|Boston Children's Hospital|Clinical Coordinator|6173556127|sara.little@childrens.harvard.edu|
20167599|NCT02864862|The University of Texas Health Science Center at Houston|Chun-Teh Lee|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
20167600|NCT04605991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20167601|NCT03263702|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
20167602|NCT03598114|Washington University School of Medicine|Sarah Moreland-Russell, Ph.D., MPH|314-935-8382|smoreland-russell@wustl.edu|
20167603|NCT02527200|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20167604|NCT00689117|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167605|NCT00444678|NYU Langone Health|Deirdre Cohen, MD|212-731-5656|Deirdre.Cohen@nyulangone.org|
20167606|NCT01324518|Orion Global Clinical Operations|Clinical Study Director||jutta.hanninen@orionpharma.com|
20167607|NCT00329797|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20167608|NCT02645019|Nationwide Children's Hospital|Mineto Kamada|6147224200|mineto.kamata@gmail.com|
20167609|NCT02055118|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20167610|NCT01955629|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20167611|NCT01221311|Medical University of South Carolin|Gregory Cote|843-876-4261|cotea@musc.edu|
20201394|NCT05105243|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|Michelle.Charles@cerevance.com|
20201395|NCT00960076|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20201396|NCT02511522|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
20156486|NCT02743221|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr Patrick Therasse|+33 1 55 72 43 47|patrick.therasse@servier.com|
20156487|NCT04547556|UMC Utrecht|Dr Cristina Prat Aymerich|+31631118128|c.prataymerich-2@umcutrecht.nl|
20156488|NCT03528902|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
20156489|NCT03411044|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
20156490|NCT02947048|Yamo Pharmaceuticals|Tracy Fischer|8596855862|tfischer@yamopharma.com|
20156491|NCT03658304|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20156492|NCT02609503|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20156493|NCT05889468|Duke University Medical Center|Brenna L. Hughes, MD, MSc|919-684-8111|brenna.hughes@duke.edu|
20156494|NCT04481685|University of Kansas Medical Center|Gregory Gan, MD PhD|913 588 5881|ggan@kumc.edu|
20156495|NCT01881932|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
20156496|NCT00802503|Geneva University Hospitals, Division of Intensive Care,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14/Switzerland|Dr CP Heidegger|+41223827440|claudia-paula.heidegger@hcuge.ch|
20156497|NCT01833078|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
20156498|NCT02457065|Dartmouth-Hitchcock Medical Center|Michael S Chapman, MD|(603) 650-5000|Michael.Shane.Chapman@hitchcock.org|
20156499|NCT01840072|Tulane University|Dr. Jiang He|5049885165|jhe@tulane.edu|
20156500|NCT01251757|Kaiser Permanente Center for Health Research|William M Vollmer, PhD|503-335-2400|william.vollmer@kpchr.org|
20156501|NCT04642079|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156502|NCT05807945|ABC Medical Center|Angel Cruz Miranda|5516647121|cruz.angel@aol.com|
20156503|NCT02226653|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20156504|NCT02412982|UC Health - University of Cincinnati Medical Center|Molly Droege, PharmD|513-584-2126|molly.droege@uchealth.com|
20156505|NCT05007639|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20156506|NCT04011241|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20156507|NCT03863574|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20156508|NCT04554836|Evangelisches Krankenhaus Hamm Werler Str. 110, 59063 Hamm|Prof. Dr. Alexander Baraniskin|+49 (0) 2381 / 589 1863|Alexander.Baraniskin@ruhr-uni-bochum.de|
20156509|NCT02871219|The University of Texas MD Anderson Cancer Center|Jason Westin, MD|(713) 792-3750|jwestin@mdanderson.org|
20156510|NCT00723632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20156511|NCT05251805|UZ Brussel|Head of the anesthesiology department|024776001|anesthesiology.clinicaltrials@uzbrussel.be|+32
20156512|NCT05697380|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
20156513|NCT00835172|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156514|NCT03048682|Wake Forest Baptist Health|Dr. Catherine Matthews|336-716-4131|camatthe@wakehealth.edu|
20156515|NCT00821821|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20156516|NCT02605616|University of Virginia|Dr. Rita Basu|434-924-5183|rb4vd@virginia.edu|
20156517|NCT03648372|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20156518|NCT00791648|Vanderbilt University|Frederic Billings|615-343-6268|frederic.t.billings@vanderbilt.edu|
20156519|NCT00462826|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20156520|NCT00499447|Comprehensive Cancer Center of Wake Forest University|Dr. James Urbanic|336-713-3600|jurbanic@wakehealth.edu|
20156521|NCT01373281|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
20156522|NCT03502681|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20156523|NCT03436732|National Cancer Institute|Dr. Raffit Hassan|240-760-6322|rh276q@nih.gov|
20156524|NCT00939185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20156525|NCT03552029|Daiichi Sankyo|Contact for Clinical Trial Disclosure Information|908-992-6400|CTRinfo@dsi.com|
20156526|NCT02085980|The Christ Hospital - Cincinnati, OH|Dr. Mickey Karram|(513) 463-2500|mickey.karram@thechristhospital.com|
20156527|NCT03468998|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059341125|rva@uab.edu|
20156528|NCT00836706|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156529|NCT02989857|Servier Pharmaceuticals LLC|Medical Affairs|888-788-1735|clinical.trial.management@servier.com|
20156530|NCT01467557|Vistakon|Jurandir Araujo|+1 904 443-1379|jaraujo7@its.jnj.com|
20156531|NCT01905540|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20156532|NCT03847519|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
20156533|NCT02743962|University of Bradford|Hilary Pape|01274 236228|hpape@bradford.ac.uk|
20156534|NCT04023045|Orthocare Innovations, LLC|Sarah Chang|425-771-0797|schang@orthocareinnovations.com|1007
20156535|NCT00725985|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20156536|NCT01847014|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani|6508086586|scott.tsurutani@actelion.com|
20156537|NCT03931330|Medical College of Wisconsin|Gisela Chelimsky, MD|414-266-3690|gchelimsky@mcw.edu|
20156538|NCT04330859|University of Virginia Children's Hospital|Santina Zanelli|4349242697|sz5d@virginia.edu|
20156539|NCT04897568|University of Colorado|Dan Mattlock|(303)724-9941|daniel.matlock@cuanschutz.edu|
20156540|NCT01381679|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156541|NCT04023487|University of Southern California|Beth Pyatak|323-442-2615|beth.pyatak@chan.usc.edu|
20156542|NCT03900650|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
20167612|NCT02560025|Massachusetts General Hospital|Amir Fathi, MD|617-724-1124|AFATHI@mgh.harvard.edu|
20167613|NCT03800420|Clinical Trials_inquiries|Clinical Trials_inquiries|+82-31-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
20167614|NCT02703337|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167615|NCT00282308|Genentech, Inc.|Medical Communications|800 821-8590||
20167616|NCT00329524|UAMS Department of Otolaryngology|John Dornhoffer, MD|501-686-7000|dornhofferjohnl@uams.edu|
20167617|NCT01584440|Avanir Pharmaceuticals, Inc.|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
20167618|NCT04237116|Novartis Pharma GmbH|Study Director|(862) 778-8300|novartis.email@novartis.com|
20167619|NCT00899431|The University of Texas MD Anderson Cancer Center|Dr. Issa F. Khouri, MD/Professor, Stem Cell Transplantation|713- 745-0049|ikhouri@mdanderson.org|
20167620|NCT03212144|Columbia University|Dr. Richard Sloan|6467748947|rps7@columbia.edu|
20167621|NCT00661427|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
20167622|NCT00599339|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20167623|NCT05564052|Janssen Research & Development, LLC|Sr. Director Clinical Sciences Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20167624|NCT01821560|University of Pennsylvania|Dr. Teresa R. Franklin|215-746-1883|teresafr@pennmedicine.upenn.edu|
20167625|NCT00531427|Purdue Pharma|Clinical Leader, Executive Medical Director|800-733-1333||
20167626|NCT01338298|Maryland Psychiatric Research Center|AnnMarie Kearns, MS|4104066854|akearns@som.umaryland.edu|
20167627|NCT02872285|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
20167628|NCT00238355|OHSU Knight Cancer Institute|Dr. Lynne Strasfeld|503-494-1551|strasfel@ohsu.edu|
20167629|NCT02660983|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
20167630|NCT01224145|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20167631|NCT02902146|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
20167632|NCT01253577|Intersect ENT|James Stambaugh, Vice President Clinical Affairs|650-641-2103|jstambaugh@intersectent.com|
20167633|NCT00721968|Glaukos|Jeff Wells. Sr VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
20167634|NCT05601544|Johnson & Johnson Vision Care, Inc. (JJVC)|Senior Principal Research Optometrist|904-608-7238|jbuch@its.jnj.com|
20167635|NCT01064947|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20167636|NCT06457204|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20167637|NCT00773604|University of California, San Francisco|Jill Ostrem|415-353-7885|Jill.Ostrem@ucsf.edu|
20167638|NCT01601652|UC Davis|Arthur J de Lorimier, Director of Pediatric Gastroenterology|916-734-3112|adelorimier@ucdavis.edu|
20167639|NCT03524729|VA|Dr. Sangeorzan|206-516-3261|bruce.sangeorzan@va.gov|
20167640|NCT00488683|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20167641|NCT01548833|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20167642|NCT03818035|Janssen Research & Development LLC|GUIDE-Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20167643|NCT00982423|Mayo Clinic|Dr. Horng Chen|507-538-2354|chen.horng@mayo.edu|
20167644|NCT03374202|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
20167645|NCT02712047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20167646|NCT01794338|Carolinas HelathCare System|Research Director|704-355-3168|Amy.Lincourt@carolinashealthcare.org|
20167647|NCT01754402|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
20167648|NCT02165839|Stanford University|Oxana Palesh, Associate Professor of Psychiatry and Behavioral Sciences|(650) 725-7011|oxana.palesh@stanford.edu|
20167649|NCT02848729|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20167650|NCT02617485|Mabion S.A.|Adam Tuszyner|+48504441105|a.tuszyner@mabion.eu|
20167651|NCT03861988|Stanford University|Boris Heifets, MD, PhD|(650) 497-8057|bheifets@stanford.edu|
20167652|NCT00220779|Talecris Biotherapeutics|Ralph Kantor, PhD|1-800-520-2807|ralph.kantor@talecris.com|
20167653|NCT00791076|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
20167654|NCT01049945|Mayo Clinic|Shaji K. Kumar, M.D.||kumar.shaji@mayo.edu|
20167655|NCT00507728|UT MD Anderson Cancer Center|Paul M Cinciripini, MD, Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
20167656|NCT03619811|UCSD|Clinical Research Coordinator|858-246-5236|mgreytak@ucsd.edu|
20167657|NCT01734889|Swedish Orphan Biovitrum|Medical Director|+46 8 697 20 00|erik.brouwer@sobi.com|
20167658|NCT00966875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167659|NCT00802113|Columbia University|Prakash Satwani, MD|(212) 305-0223|ps2087@cumc.columbia.edu|
20167660|NCT01589653|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20167661|NCT01536067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20167662|NCT02747433|MGH Institute of Health Professions|Susan Fasoli, ScD OTR/L, Associate Professor|617-643-4777|sfasoli@mghihp.edu|
20167663|NCT00606905|University of Chicago|Mary D. Stephenson, M.D. MSc|773 834-1167|mstephen@babies.bsd.uchicago.edu|
20167664|NCT02386189|Iowa City VA Health Care System|Dr. Carolyn Turvey|319 358 9501|carolyn.turvey@va.gov|7714
20201397|NCT03783195|University of North Carolina at Chapel Hill|Saroja Voruganti, PhD|704-250-5009|saroja@unc.edu|
20201398|NCT02240134|University of Montana|Curtis Noonan, PhD|406-243-4957|curtis.noonan@umontana.edu|
20167665|NCT04657666|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20167666|NCT03120351|ClevelandCF|Bruce Vrooman|216-444-2200|vroomab@ccf.org|
20167667|NCT01651806|Rush University Medical Center|Brett Levine, MD|708.236.2664|levine.research@rushortho.com|
20167668|NCT01790243|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
20167669|NCT01558128|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
20167670|NCT04250077|We The Village|Jane Macky, CEO|9176844267|jane@wethevillage.co|
20167671|NCT01022398|Creighton University|Cardiology Research Manager|402-280-4566|tammyburns@creighton.edu|
20167672|NCT04693052|Northwestern University|Dr. Jeffrey Rado, MD,MPH,FAPA|312-695-5060|jeffrey.rado@nm.org|
20167673|NCT03319745|The University of Texas MD Anderson Cancer Center|Dr. Neema Navai|(713) 792-3250|nnavai@mdanderson.org|
20167674|NCT00870103|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20167675|NCT01317550|MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|713-563-2300|zliao@mdanderson.org|
20167676|NCT03255629|Joslin Diabetes Center|Mary Elizabeth Patti, MD|(617) 309-2635|MaryElizabeth.Patti@joslin.harvard.edu|
20167677|NCT04540198|Baylor Scott & White Health Research Institute|Dr. Alan Stevens|254-215-9885|alan.stevens@bswhealth.org|
20167678|NCT01086358|Cleveland Clinic Foundation|Jennifer Kriegler, MD|216-444-8265|krieglj@ccf.org|
20167679|NCT01996839|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20167680|NCT03330002|Essential Medical, a wholly owned subsidiary of Teleflex, Inc.|Darra Bigelow, Clinical Trials Manager|610-331-7299|darra.bigelow@teleflex.com|
20167681|NCT00833417|Genentech, Inc.|Medical Communications|800-821-8590||
20167682|NCT01625260|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20167683|NCT03899805|Dana Farber Cancer Institute|Suzanne George MD, PI|6176326826|suzanne_george@dfci.harvard.edu|
20167684|NCT01999517|Mount Sinai Medical Center|Gervasio Lamas, MD|305-674-2162|gervasiolamas@gmail.com|
20167685|NCT02291016|University of Tennessee Graduate School of Medicine|Clinical Trials Coordinator|865-305-7975|jferris@utmck.edu|
20167686|NCT01776307|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
20167687|NCT02902484|UT Southwestern Medical Center|Dr. Salwan Al Mutar|214-648-4008|salwan.almutar@utsouthwestern.edu|
20167688|NCT05051631|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615-875-5649|lucy.b.spalluto@vumc.org|
20167689|NCT03679754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
20167690|NCT00964171|Institut Bergonié|Dr Marianne Fonck|05.56.33.32.42|m.fonck@bordeaux.unicancer.fr|
20167691|NCT05871450|German University of Health and Sports|Wolfgang Ruf|+49 (030) 577 97 37 370|wolfgang.ruf@dhgs-hochschule.de|
20167692|NCT02872935|University of Iowa|Dr. Kokila Thenuwara|319-384-5876|kokila-thenuwara@uiowa.edu|
20167693|NCT02640508|UT Health San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
20167694|NCT00862082|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
20167695|NCT05405257|Baylor College of Medicine|Keren Machol|7137987359|machol@bcm.edu|
20167696|NCT01472718|Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana,|Marco De Carlo, MD, PHD|+39 050995326|marcodecarlo@gmail.com|
20167697|NCT01469715|University of Virginia|Stacey Anderson, MD||sg4c@virginia.edu|
20167698|NCT00862641|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20167699|NCT03179605|Prosoft Clinical|Robert Babilon President|4843202068|b.babilon@prosoftclinical.com|
20167700|NCT00635999|Penn State University|Michelle G. Newman|814-863-1148|mgn1@psu.edu|
20167701|NCT00711477|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20167702|NCT03037580|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
20167703|NCT02873429|University of Pittsburgh|Carol M. Greco, Associate Professor of Psychiatry|412-623-6873|grecocm@upmc.edu|
20167704|NCT01567839|The Ohio State University, Division of Endodontics|Dr. John Nusstein|614-292-9412|nusstein.1@osu.edu|
20167705|NCT00853567|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20167706|NCT00782834|Fox Chase Cancer Center|Margaret von Mehren, M.D., Director of Sarcoma Oncology|215-728-2814|margaret.vonMehren@fccc.edu|
20167707|NCT02259088|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20167708|NCT01818752|Amgen Inc.|Study Director|866-572-6436||
20167709|NCT04270370|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20167710|NCT01324141|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
20167711|NCT02745080|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20167712|NCT05073432|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
20167713|NCT01001325|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
20167714|NCT02758184|Duke University|Sergio Mendoza Lattes, M.D.|919-684-2023|sergio.mendoza@duke.edu|
20167715|NCT05286749|UW School of Medicine and Public Health|Tana Chongsuwat, MD, MPH|224-260-1666|tana.chongsuwat@fammed.wisc.edu|
20167716|NCT02051933|CarolinasHS|Christine Churchill|704-355-6947|christine.churchill@carolinashealthcare.org|
20167717|NCT00594945|Jazz Pharmaceuticals, Inc.|Executive Director, Clinical Development|650 496 3777||
20167718|NCT00588861|Biomet Manufacturing|Nick Higdon, Clinical Research Specialist|1-800-348-9500|nicholas.higdon@biomet.com|3047
20167719|NCT02438358|Lumicell|Jorge Ferrer, Ph.D.|617-571-0592|jmferrer@lumicell.com|
20167720|NCT00923949|National Cancer Institute|Giuseppe Giaccone M.D.|301-496-4916|giacconeg@mail.nih.gov|
20167721|NCT03254459|Insys Therapeutics, Inc.|Director, Clinical Development|4805003105|gdecastro@insysrx.com|
20167722|NCT04434846|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
20167723|NCT03745820|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20167724|NCT03317405|Northwestern University|Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
20167725|NCT04075734|Rutgers Cancer Institute of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
20201399|NCT01871506|Elyse Park|Associate Professor|617-724-6836|epark@mgh.harvard.edu|
20167726|NCT01137604|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20167727|NCT00591318|New York State Psychiatric Institute|Brian Fallon|646-774-8052|brian.fallon@nyspi.columbia.edu|
20167728|NCT01584544|Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College|Dr. Jing Jin|8601087788122|jingjin1025@163.com|
20167729|NCT01024309|OrthoCarolina Research Institute|Dr. Susan Odum|704.323.2265|Susan.Odum@OrthoCarolina.com|
20167730|NCT03236155|Rush University Medical Center|Anne DeBenedetti, CRC|3124322468|anne.debenedetti@rushortho.com|
20167731|NCT02745145|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20167732|NCT03083990|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
20167733|NCT01018810|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167734|NCT02424578|Iroko Pharmaceuticals|SVP Medical Affairs, Pharmacovigilance and Medical Information|2675463003|eoimagosie@iroko.com|3182
20167735|NCT00776919|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167736|NCT03116152|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
20167737|NCT01454258|University Hospital Frankfurt|Prof Dr Dr Kai Zacharowski, FRCA|004969630186668|kai.zacharowski@kgu.de|
20167738|NCT01798849|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
20167739|NCT02636361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20167740|NCT02448641|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
20167741|NCT02413151|University of Lisbon|Maria Helena Santa-Clara Pombo Rodrigues|00351917377277|santaclara@fmh.ulisboa.pt|
20167742|NCT02410343|Teva Branded Pharmaceutical Products|Director of Clinical Trials|215-591-3000|Public_CTD@tevapharm.com|
20167743|NCT02036853|Cook Children's Health Care System|Director of Research Operations|682-885-2103|CookChildrensResearch@cookchildrens.org|
20167744|NCT00228553|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
20167745|NCT02663934|Washington University in St. Louis|Brittany Nelson, Senior Clinical Research Coordinator|314-747-8425|bmnelson@wustl.edu|
20167746|NCT04556383|GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB004, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
20167747|NCT01146457|BIDMC|Philip Hess|617-667-3353|phess@bidmc.harvard.edu|
20167748|NCT02692391|Ohio State University|Georgios Papachristou, MD PhD|6142836255|georgios.papachristou@osumc.edu|
20167749|NCT00884741|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20167750|NCT00335764|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-3657|jfisher@jhmi.edu|
20167751|NCT00612807|Duke University Medical Center|Jill Compton, Ph.D.|919-416-2089|compton@duke.edu|
20167752|NCT00800254|University of Colorado Denver|Jennifer Stevens-Lapsley, PhD|303-724-9170|jennifer.stevens-lapsley@ucdenver.edu|
20167753|NCT00744042|Alexion Pharma GmbH|Alexion Pharma GmbH||ClinicalTrials@alxn.com|
20167754|NCT03435783|Brown University School of Public Health|Tyler Wray|401-863-6659|tyler_wray@brown.edu|
20167755|NCT04303195|Neurogastrx|Chief Scientific Officer|17817304040|info@neurogastrx.com|
20167756|NCT02970942|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20167757|NCT00508196|University of Dundee|DR Anna Maria Choy|01382 383482|a.choy@dundee.ac.uk|
20167758|NCT01065454|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20167759|NCT05688670|Duke University Medical Center|Lisa Einhorn, M.D.|(919) 668-4000|lisa.einhorn@duke.edu|
20167760|NCT00273793|UTexas_SanAntonio|Dr. RJ Lamb|210-567-5480|lamb@uthscsa.edu|
20167761|NCT02537015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20167762|NCT04469998|AxeroVision, Inc.|Dr. Houman Hemmati|+1 (310) 600-4123|houman@axerovision.com|
20201400|NCT03124459|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201401|NCT01903876|Georgia State University|Dr. Laura Salazar|404-413-1396|lsalazar1@gsu.edu|
20201402|NCT00278629|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
20201403|NCT02357992|UT MD Anderson Cancer Center|Dr. Jack Roth, MD- Professor, Thoracic & Cardio Surgery-Rsch|(713) 792-7664|jroth@mdanderson.org|
20201404|NCT00826748|Weill Cornell Medicine|Grace Mammen|646-962-2672|gwm2004@med.cornell.edu|
20217894|NCT00493454|The University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
20217895|NCT02593396|UNIVERSITY MALAYA|Dr. Anne Yee|+60379492068|annyee17@um.edu.my|
20156543|NCT00823797|University of Washington|Maciej Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
20156544|NCT02014376|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
20156545|NCT01531335|Pontificia Universidad Javeriana|Dr Saul Rugeles|5715946161|rujeles@javeriana.edu.co|2240
20156546|NCT00103844|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20156547|NCT00721110|Cleveland Clinic|Daniel Sessler, MD|216-444-4200|sesslerd@ccf.org|
20156548|NCT01202162|Northwestern University|Gildasio De Oliveira, M.D.|312-926-8371|g-jr@northwestern.edu|
20156549|NCT00635050|UAB|John Carpenter, M.D.|205-910-8886 or 205-934-2084|jtc4321@bellsouth.net|
20156550|NCT01648322|Generon (shanghai) corporation|Chief Medical Officer|8621-61760866|tangt@generonbiomed.com|
20156551|NCT00086515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156552|NCT02871440|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
20156553|NCT00209131|Emory University|Dr. Kenneth Ogan|404-778-4898|kogan@emory.edu|
20156554|NCT00811850|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20156555|NCT05081843|University of Pittsburgh School of Public Health|Dr. Jaime Sidani|412-383-0733|jes107@pitt.edu|
20156556|NCT03034044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156557|NCT02120261|The University of Texas Health Science Center at Houston|Carlos J. Roldan, MD||Carlos.J.Roldan@uth.tmc.edu|
20156558|NCT01950520|NIDDK|Kong Chen, PhD, MSCI|301-451-1636|chenkong@niddk.nih.gov|
20167763|NCT01097005|Mylan EPD Japan|Takao Miki, Medical Affairs||takao.miki@mylan.com|
20167764|NCT04627285|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20167765|NCT04507373|UT Southwestern Medical Center|Dr. Zahid Ahmad|214/648-2377|ZAHID.AHMAD@UTSouthwestern.edu|
20167766|NCT02793856|West China Hospital, Sichuan University|You Lu|+862885423571|283494287@qq.com|
20167767|NCT00617669|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20167768|NCT03680742|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
20167769|NCT02894502|University of Rome Tor vergata, Rome, Italy|Dr. Ercole Vellone|+393387491811|ercole.vellone@uniroma2.it|
20167770|NCT00615901|Memorial Sloan Kettering Cancer Center|Dr. Pamela Drullinksy|516-256-3955|drullinp@mskcc.org|
20167771|NCT03630770|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
20167772|NCT02420015|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
20167773|NCT00796445|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167774|NCT00388583|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20167775|NCT02737891|Saniona A/S|Kim Krogsgaard|20148384|kim.krogsgaard@saniona.com|0045
20167776|NCT05194579|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167777|NCT01988584|The University of Texas Health Science Center at Houston|Charles S. Cox, MD, Professor|713-500-7300|charles.s.cox@uth.tmc.edu|
20167778|NCT03595228|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422|medical.information_us@bavarian-nordic.com|8274
20167779|NCT03232333|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
20167780|NCT01087736|University of California, San Francisco|David L. Pennington, PhD (Research Psychologist II)|415-221-4810|david.pennington2@va.gov|4504
20167781|NCT01253811|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20167782|NCT03495856|University of North Carolina School of Medicine|Carrie Brintz|919-445-6109|carrie_brintz@med.unc.edu|
20167783|NCT00435045|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167784|NCT00567255|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
20167785|NCT05037578|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
20167786|NCT01743001|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
20167787|NCT03194737|Teleflex/NeoTract|Emily Friedland, Director, Global Clinical Operations|925.387.6014|emily.friedland@teleflex.com|
20167788|NCT03052426|West Virginia University|Dr. Brandy Brown|304-293-1955|bkenned2@hsc.wvu.edu|
20167789|NCT05387434|University of Kansas Medical Center|Dr. Anna Gorczyca|913-588-9077|agorczyca@kumc.edu|
20167790|NCT01565343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20167791|NCT01012674|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20167792|NCT04233918|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20167793|NCT01853839|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167794|NCT03672097|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20167795|NCT05099263|Aerin Medical|Anais Laborde, Sr. Director of Clinical Operations|6505189624|alaborde@aerinmedical.com|
20167796|NCT03087617|Imbio, Inc|Director of Engineering|612520360|laurenkeith@imbio.com|2142
20167797|NCT01896206|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
20167798|NCT04450381|Masimo Corporation|Vikram Ramakanth|949-297-7000|clincalresearchdept@masimo.com|
20167799|NCT03764293|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yongli Xie|18581831003|yongli.xie@hengrui.com|
20167800|NCT02059291|Novartic Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20167801|NCT00470834|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167802|NCT02673541|Dartmouth-Hitchcock Medical Center|Dr Jeffrey Adler|603-650-5261|Jeffrey.m.adler@hitchcock.org|
20167803|NCT01989208|Sulfagenix|President and CEO|1-318-349-3851|tgiordano@sulfagenix.com|
20167804|NCT02693132|University of Colorado Denver|Seth Creasy|720-848-6477|seth.creasy@ucdenver.edu|
20167805|NCT00080899|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|: 60094
20167806|NCT03048006|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
20167807|NCT04615832|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7882
20167808|NCT01276054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
20167809|NCT04343235|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
20167810|NCT00787267|Duke University Medical Center|Michael Kelley , MD|919-286-0411|kelleym@duke.edu|7326
20167811|NCT01763996|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20167812|NCT00865280|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20167813|NCT01419197|Hoffmann-La Roche|Medical Communications|800 821-8590||
20167814|NCT00743106|Cleveland Clinic Foundation|Jerome O'Hara, MD|216-444-8278|oharaj@ccf.org|
20167815|NCT00597597|Rush University Medical Center|Ruta Rao|312-942-3324|ruta_d_rao@rush.edu|
20167816|NCT00145977|The University of Chicago|Tamara Vokes, MD|773-702-1465|tvokes@medicine.bsd.uchicago.edu|
20167817|NCT03060551|Department of Plastic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea|Suk-Ho Moon|821090803527|nasuko@catholic.ac.kr|
20201405|NCT00603239|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20201406|NCT03367871|University of Miami|Abdulrahman Sinno MD|+1 (305) 243-2233|ak.sinno@med.miami.edu|
20201407|NCT03837184|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
20167818|NCT04629066|Duke Clinical Research Institute|Marjan Cobbaert|919-668-9740|mr157@duke.edu|
20167819|NCT03456882|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Elisabetta Pupillo|+390239014605|elisabetta.pupillo@marionegri.it|
20167820|NCT01254760|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
20167821|NCT00610480|UT Southwestern Medical Center|Peter Chen|214-648-3837|peter.chen@utsouthwestern.edu|
20167822|NCT04359901|VA Boston Healthcare System|Westyn Branch-Elliman, MD, MMSc|857-203-5116|westyn.branch-elliman@va.gov|
20167823|NCT04410133|Blue Earth Diagnostics|Head of Research and Development|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
20167824|NCT00893815|Henry Jackson Foundation|Infectious Diseases Clinical Research Program||contactus@idcrp.org|
20167825|NCT00167219|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan, MD|+1 612-626-2961|macmi002@umn.edu|
20167826|NCT04947085|Maimonides Medical Center|Sergey Motov|718-283-6000|smotov@maimo.org|
20167827|NCT01808092|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.wilson2@astrazeneca.com|
20167828|NCT01909011|Mount Sinai Beth Israel|Igor Galynker MD PhD|212-420-4535|igalynke@chpnet.org|
20167829|NCT03425253|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20167830|NCT04614324|Aerin Medical|Anais Laborde Sr. Director of Clinical Affairs|650-518-9624|alaborde@aerinmedical.com|
20167831|NCT01031836|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20167832|NCT00490529|Stanford University|Ronald Levy|650-725-6452|levy@stanford.edu|
20167833|NCT01248104|Loma Linda University Medical Center|Dr. Jason Gatling|909-558-4475|jgatling@llu.edu|44475
20167834|NCT01410357|Case Western Reserve University School of Medicine and Neurological Institute|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
20167835|NCT01710137|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
20167836|NCT04620213|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
20167837|NCT03467152|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20167838|NCT00945906|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20167839|NCT04583709|Geisinger Heart Institute|Pugazhendhi Vijayaraman|5708085444|pvijayaraman1@geisinger.edu|
20167840|NCT03700684|University of Massachusetts Amherst|Kelly Richardson|413-545-2007|krichardson@umass.edu|
20167841|NCT01120782|Johnson & Johnson Vision Care|Ross Franklin, OD|1-904-443-1379|RFrankl1@its.jnj.com|
20167842|NCT04140227|Bausch and Lomb|Johnson Varughese VP Clinical Services|908-927-1162|johnson.varughese@bausch.com|
20167843|NCT00635219|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20167844|NCT01639729|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
20167845|NCT00759564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167846|NCT04145219|ALK-Abelló A/S|Vice President, Clinical Operations Strategy|+45 4574 7576|clinicaltrials@alk.net|
20167847|NCT01640314|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20167848|NCT01290796|Bard Medical Division|Jaime Ritter, MPH, CCRP, CIC|770-784-6437|jaime.ritter@crbard.com|
20167849|NCT01632267|AssureRx|Joel Winner, MD|513-234-0510|jwinner@assurerxhealth.com|
20167850|NCT02709538|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20167851|NCT00835211|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20167852|NCT02343549|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
20167853|NCT01838980|Motus GI Medical Technologies Ltd.|Medical Consultant|+972-4-6214446|rose@motusgi.com|104
20167854|NCT02160041|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|novartis.email@novartis.com|
20167855|NCT01403948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167856|NCT01090323|Novartis Pharmaceuticals|Study Director|862-778-8300||
20167857|NCT05498701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167858|NCT01864005|Astrazeneca|Judith Hsia|1-301-398-0102|judithhsia@astrazeneca.com|
20167859|NCT01962961|Indiana University School of Medicine|Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
20167860|NCT03899467|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+8651262639938|PR@kintor.com.cn|
20201408|NCT02013544|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
20167861|NCT02184572|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167862|NCT00763698|St. Jude Medical|Director, Clinical Affairs|(408) 522-6410|tshipman@sjm.com|
20167863|NCT02495038|Yonsei University Wonju college of medicine|Dr. Wooyoung Park|563664250|wongulung28@gmail.com|971
20167864|NCT00638183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167865|NCT00006409|University of North Carolina - Chapel Hill|June Stevens|919-966-7218|june_stevens@unc.edu|
20167866|NCT01433289|Baylor|Supriya Parikh|832-824-2589|supriya.parikh@bcm.edu|
20167867|NCT00244140|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20167868|NCT05408637|Massachusetts General Hospital and Harvard Medical School|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
20167869|NCT04973436|Duke University School of Medicine|Tamara Somers, PhD|9194163408|tamara.somers@duke.edu|
20167870|NCT01168986|University of Florida|Joel Bialosky, PT, PhD|352-273-8636|jbialosky@phhp.ufl.edu|
20167871|NCT01788215|University of Rochester|Kathleen Hoeger MD MPH|585-275-7891|kathleen_hoeger@urmc.rochester.edu|
20167872|NCT02751385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167873|NCT02299791|KaiserPermanente Center for Health Research|Rachel Gold|503-528-3902|rachel.gold@kpchr.org|
20167874|NCT02365480|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
20167875|NCT03091348|Men|Abraham Morgentaler|617-277-5000|research@menshealthboston.com|
20167876|NCT00706342|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
20167877|NCT04534686|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
20167878|NCT01034670|Stanford University|Shai Friedland, MD|(650) 617-2732|shaif@stanford.edu|
20167879|NCT04762719|Mayo Clinic|Madhusudan (Madhu) Grover, M.B.B.S.|507-293-2698|Grover.Madhusudan@mayo.edu|
20167880|NCT01781299|University of Pittsburgh Plastic Surgery|Kenneth Shestak|412-641-1487|shestakkc@upmc.edu|
20167881|NCT01099449|Mayo Clinic|Charles Loprinzi, M.D.|(507) 284-3731|cloprinzi@mayo.edu|
20167882|NCT00146848|Clinical Affairs|Kira Stolen|1 800 CARDIAC|cshd@bsci.com|
20167883|NCT00850421|Park Nicollet Institute|Park Nicollet Institute|952-993-3123||
20167884|NCT00824733|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
20167885|NCT00119678|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20167886|NCT03704636|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
20167887|NCT02720042|Becton, Dickinson and Company|Sandra van Guldener|+31 6 46900840|sandra.vanguldener@bd.com|
20167888|NCT00791817|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
20167889|NCT02356900|Duke University Medical School|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
20167890|NCT01134705|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20167891|NCT00509145|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20167892|NCT00246740|Departments of Pediatrics and Pharmacology, University of Alberta|Dr Richard Schulz|780-492-6581|richard.schulz@ualberta.ca|
20167893|NCT00125528|Northwestern Universiyt|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
20167894|NCT00101452|Massachusetts General Hospital|Maurizio Fava|617-724-2513|mfava@partners.org|
20201409|NCT03514914|University of California San Diego|Dr. Anita Raj|(858) 246-0066|anitaraj@health.ucsd.edu|
20201410|NCT00826514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201411|NCT02639351|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
20201412|NCT00691665|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20201413|NCT02209506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20201414|NCT01834404|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20201415|NCT01147809|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201416|NCT01307423|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20201417|NCT01499290|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
20201418|NCT02209766|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
20201419|NCT00327444|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
20201420|NCT03896295|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20201421|NCT00552110|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20201422|NCT03029832|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20201423|NCT01412229|UNC Lineberger|Robin Johnson|(919) 966-1125|Robin_V_Johnson@med.unc.edu|
20201424|NCT02553135|University of Miami|Byron Lam , MD|305-326-6021|blam@med.miami.edu|
20201425|NCT01557790|University of Pennsylvania|Justin E. Bekelman, MD|(215)662-7292|bekelman@xrt.upenn.edu|
20201426|NCT00700804|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Reserch Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
20201427|NCT02901431|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201428|NCT04223609|Mayo Clinic|Gaurav N. Pradhan, PhD|480-301-5351|Pradhan.Gaurav@mayo.edu|
20201429|NCT03440944|Boston University School of Medicine|Joseph Pare, MD|6174144925|Joseph.pare@bmc.org|
20167895|NCT01994889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201430|NCT04672083|Navigen, Inc.|Alan L. Mueller, VP Research|801-243-9703|amueller@nvgn.com|
20201431|NCT02500537|Medtronic|Michelle DiSalvo|774.284.6089|michelle.v.disalvo@medtronic.com|
20201432|NCT01661790|China PLA General Hospital|Dr. Nan Du|86-13911599657|dunan05@aliyun.com|
20201433|NCT02536248|Laval university|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
20201434|NCT02048904|University of Missouri|Principal Investigator|573-882-2273 lastrag@healt|lastrag@health.missouri.edu|
20201435|NCT02413203|Univesrity of Pennsylvania|Garret A. FitzGerald|215-898-1185|garret@upenn.edu|
20201436|NCT03832387|HOSPITAL GENERAL UNIVERSITARIO DE CASTELLÓN|Dr. ALBERTO BELENGUER MUNCHARAZ|96472500|belengueralberto8@gmail.com|
20201437|NCT00355121|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20201438|NCT00490542|Tufts Medical Center|S. Nassir Ghaemi, MD, MPH|617-636-5735|nghaemi@tuftsmedicalcenter.org|
20201439|NCT01438008|Children's Hospital of Eastern Ontario|Dr. Denise Harrison|6137377600|dharrison@cheo.on.ca|6045
20201440|NCT01813890|Janssen Research & Development, L.L.C.|Mila Etropolski, Clinical Leader|609-730-4537|MEtropol@its.jnj.com|
20201441|NCT04482647|UT MD Anderson Cancer Center|Santhosshi Narayanan, MD-Assistant Professor, Integrative Medicine Program|(346) 228-6676|snarayanan2@mdanderson.org|
20201442|NCT00046228|Centocor Inc.|Executive Director Clinical Research|1-800-972-9063|EBarnath@ITS.JNJ.COM|6171
20201443|NCT00655928|Imperial College LOndon|Mark J Griffiths|+44 (0) 2073518523|m.griffiths@imperial.ac.uk|
20201444|NCT04980391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201445|NCT07145541|AION Biosystems|Samara Barend|9079024986|sam@aionbiosystems.com|
20201446|NCT00500266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167896|NCT02969655|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201447|NCT01431287|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201448|NCT00162773|Johns Hopkins University School of Medicine|Clinical Trials Program JHU ICTR|410-550-6484|registerclinicaltrials@jhmi.edu|
20167897|NCT02674204|Cedars-Sinai Medical Center|Marc Goodman, PhD|310-423-6188|Marc.Goodman@cshs.org|
20167898|NCT02646371|LimmaTech Biologics AG|Director of Clinical Trials|+41 44 733 8585|info@lmtbio.com|
20167899|NCT02466659|Indiana University|Daniel Neely|3172741214|deneely@iupui.edu|
20167900|NCT01536392|UT MD Anderson Cancer Center|Michael Frumovitz, Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
20167901|NCT03753789|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
20167902|NCT00601952|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
20167903|NCT01573052|VA Salt Lake City Medical Center|Dr. Christopher Stock|801-582-1565|christopher.stock@va.gov|1172
20167904|NCT01030666|JWGUniversity|Prof. Dr. Peter Eickholz|+496963015642|eickholz@med.uni-frankfurt.de|
20167905|NCT04002908|Ariadne Labs|Katherine Semrau|6177805311|ksemrau@ariadnelabs.org|
20167906|NCT05225805|Nabriva Therapeutics US, Inc.|Christine Guico-Pabia, MD, MBA, MPH|610-981-2874|christine.guico-pabia@nabriva.com|
20167907|NCT02369172|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20167908|NCT05477108|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-94 79|information.center@astrazeneca.com|
20167909|NCT00334113|VA Boston Healthcare System|Dr. DeAnna Mori|857-364-4121|deanna.mori@va.gov|
20167910|NCT02083861|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
20167911|NCT03376295|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201449|NCT02251743|Ohio State University|Dr. L Eugene Arnold|614-685-6701|L.Arnold@osumc.edu|
20201450|NCT00215150|Duke University Medical Center|Wei Zhang, MD|(919) 684 5645|wei.zhang@duke.edu|
20201451|NCT00496366|Rutgers Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-6789|toopmede@cinj.rutgers.edu|
20201452|NCT02718820|Medical University of Vienna|Thorsten Fuereder|+43140400|thorsten.fuereder@meduniwien.ac.at|44450
20201453|NCT03062917|Imperial College NHS trust|Study PI Simon Nadel|02033126202|s.nadel@imperial.ac.uk|
20201454|NCT00673855|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20201455|NCT03576144|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201456|NCT03323749|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
20201457|NCT01444716|The University of Texas MD Anderson Cancer Center|Allessandra Ferrajoli, MD./Professor|713-792-2063|aferrajo@mdanderson.org|
20201458|NCT04214080|Marmara University|Assoc. Prof Aysel Yıldız Ozer|5334674433|aysel.yildiz@marmara.edu.tr|+90
20201459|NCT02863263|Mundipharma Singapore Holding Pte. Limited|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
20201460|NCT00824564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201461|NCT03198221|Cleveland Clinic|Dr. Carol Burke|216-444-6864|BurkeC1@ccf.org|
20201462|NCT03895203|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20201463|NCT04125680|University of Michigan|Emily Feuerherm|810-766-6725|feuerher@umich.edu|
20201464|NCT04938648|Johns Hopkins University|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
20201465|NCT00364793|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20201466|NCT00391976|Novartis Pharmaceuticals|Study Director|862 778-8300||
20201467|NCT00049127|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072841370|jaecle.kurt@mayo.edu|
20201468|NCT00310310|VA San Diego Healthcare System|Carl J. Stepnowsky,PhD|858-642-1240|Carl.Stepnowsky@va.gov|
20201469|NCT02724033|Department of Otolaryngology, Indiana University School of Medicine|Dr. Charles Yates, Primary Investigator|317-278-1286|cwyates@iupui.edu|
20201470|NCT01287754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201471|NCT03193866|Karolinska Institutet|Professor Fredrik Piehl|+46-(0)8-517 798 40|fredrik.piehl@ki.se|
20201472|NCT02516657|Jacobs School of Medicine and Biomedical Sciences, Department of Pediatrics|Lucy D. Mastrandrea|716-323-0170|ldm@buffalo.edu|
20201473|NCT00001337|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
20201474|NCT03878147|Michigan State University|Michael J. Boivin|+15178840281|boivin@msu.edu|
20201475|NCT05817045|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
20201476|NCT00378326|Rockefeller University|Robert B. Darnell, MD, PhD|212-327-7474|darnelr@rockefeller.edu|
20201477|NCT03093402|DAIT/NIAID|Director, Clinical Research Operations Program|3015947669|DAITClinicalTrialsGov@niaid.nih.gov|
20201478|NCT00054847|Southern Arizona VA Health Care System|Steven Goldman, MD|(520) 792-1450|Steven.Goldman@va.gov|4624
20201479|NCT02731742|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201480|NCT01316042|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rlegro@hmc.psu.edu|
20201481|NCT00461175|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
20201482|NCT03093155|Yale School of Medicine/Yale Cancer Center|Alessandro Santin, MD|(203) 737-4450|alessandro.santin@yale.edu|
20201483|NCT02786901|Bausch Health|Study Manager|(908) 242-8287|sandra.narain@bauschhealth.com|
20201484|NCT00607048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201485|NCT04336163|University of California, Irvine|Kristen Kelly, MD|949-824-6550|kmkelly@uci.edu|
20201486|NCT01773473|Eli Lilly and Company|Medical Officer|800-545-5979||
20201487|NCT01085682|The Catholic University of Korea|Kun-Ho Yoon, professor|82-2-2258-8281|yoonk@catholic.ac.kr|
20201488|NCT01451645|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
20201489|NCT03926143|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20201490|NCT00967941|CAMC Health System|Patrick Stone, MD|304-388-8250|pstone0627@yahoo.com|9901
20201491|NCT04579549|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
20201492|NCT01053312|GE Healthcare|Paul Sherwin, MD|1-609-514-6820|paulsherwin@ge.com|
20201493|NCT02207907|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167912|NCT02509026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167913|NCT00243841|Indiana University|Amy Miller Research Manager|317 944 1242|amym@iu.edu|
20167914|NCT04219085|Yale University|Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
20167915|NCT01948193|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20167916|NCT04601454|Medtronic|DTM-LE Clinical Research Study Team|763-514-4000|rs.scsresearch@medtronic.com|
20167917|NCT01964755|University of Miami|Juan C. Ramos MD|305-243-1326|jramos2@med.miami.edu|
20167918|NCT00576680|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
20167919|NCT01331213|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
20167920|NCT03897439|University of Kanas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
20167921|NCT03124927|Masimo Corporation|Vikram Ramakanth||clinicalresearchdept@masimo.com|
20167922|NCT04586387|Virginia Commonwealth University|Carrie Peterson|804 827 5270|clpeterson@vcu.edu|
20167923|NCT02047344|Golden Biotechnology Corp.|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
20167924|NCT00361634|Amgen Inc.|Study Director|866-572-6436||
20167925|NCT05315908|University of California San Diego|Dr. Jesse Nodora|(858) 822-3686|jnodora@health.ucsd.edu|
20167926|NCT00294762|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
20167927|NCT02937584|AstraZeneca|Stephan Stenglein, MD|+46 (0)31 776 1000|stephan.stenglein@astrazeneca.com|
20167928|NCT00280384|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|81-3-3817-5235|h3-shimizu@hhc.eisai.co.jp|
20167929|NCT02238080|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20167930|NCT01738646|Duke Univeristy Medical Center|Katherine Peters|919 684-3914|katherine.peters.@dm.duke.edu|
20167931|NCT01598129|Oncos Therapeutics|Director, Clinical Operations||info@oncos.com|
20167932|NCT00505076|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
20167933|NCT02250703|University of Mississippi Medical Center|Madhankumar Sathyamoorthy. PI|6018157066|msathyamoorthy@umc.edu|
20167934|NCT04093024|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20167935|NCT03145818|Providence VA Medical Center|James Rudolph, MD, Principal Investigator|401-273-7100|James.Rudolph@va.gov|6406
20167936|NCT03180619|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20201494|NCT02589977|Vanderbilt University Medical Center|Marvin Kronenberg, MD|615-322-2318|marvin.w.kronenberg@vumc.org|
20167937|NCT00729469|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
20167938|NCT00514852|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
20167939|NCT00561977|UMass Medical School|Barbara Olendzki, RD MPH LDN|508-856-5195|barbara.olendzki@umassmed.edu|
20167940|NCT04975438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20167941|NCT00977080|Abbott|Global Medical Services|800-633-9110||
20167942|NCT00566696|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
20167943|NCT01534897|Massachusetts General Hospital Cancer Center|Dr. Lori J. Wirth|617 724 4000|lwirth@mgh.harvard.edu|
20167944|NCT01462253|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
20167945|NCT01518270|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20167946|NCT02246413|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
20167947|NCT02371941|The University of Tennessee Health Science Center|Dr. Jay Lieberman|901-287-7337|jlieber1@uthsc.edu|
20167948|NCT00275340|University of Toronto|Monica Parry, RN, PhD, CCN(C)||parrym@kgh.kari.net|
20167949|NCT03163017|The University of Texas Health Science Center at Houston|Joshua Gary, MD|713-486-6500|Joshua.L.Gary@uth.tmc.edu|
20167950|NCT00653939|OXiGENE, Inc.|Chief Executive Officer|650-635-7000|info@oxigene.com|
20167951|NCT02032238|OD-OS GmbH|Ulrike Weber|+49 332831282|ulrike.weber@od-os.com|100
20167952|NCT00612105|Valeant Pharmaceuticals International, Inc.|Associate Director Clinical Operations|919-294-3080|david.lineberry@valeant.com|
20167953|NCT00717236|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20167954|NCT01105767|USUHS|LTC Michael Ellis|301-295-2254|Michael.Ellis@usuhs.edu|
20167955|NCT00475982|VA Medical Center Greater Los Angeles Healthcare System|William Aronson, MD|3102683446|waronson@ucla.edu|
20167956|NCT02778113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20167957|NCT00817596|Medasys, Inc.|Clinical Trials Manager|973-426-9229|jarrambide@medasyspumps.com|
20167958|NCT00783198|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20167959|NCT01510769|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6671|mfung@ardeabio.com|
20167960|NCT00929643|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167961|NCT02874144|Northwestern|Anju Peters|3126950513|anju.peters@northwestern.edu|
20167962|NCT02975557|Ophthalmology and Visual Sciences, University of Illinois, Chicago, IL|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
20167963|NCT01578850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20167964|NCT01711216|Abbott|Senior Global Medical Director|+49 160 749 0615|Claire.Pexman-Fieth@abbott.com|
20201495|NCT01025635|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20167965|NCT02228980|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20167966|NCT02929498|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20167967|NCT03562988|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|609-806-1200|annahita.ghassemi@churchdwight.com|
20167968|NCT00750152|Merz Pharmaceuticals, LLC|Merz Pharmaceuticals, LLC|800-334-0514||
20167969|NCT01028300|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
20167970|NCT00715910|GlaxoSmithKline|GSK Response Center|866-435-7343||
20167971|NCT03698591|Duke University|Dr. Kevin LaBar, PhD.|(919)668-2424|klabar@duke.edu|
20167972|NCT01165216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20167973|NCT06221826|Pharmasoft|Meshcherskiy Y.E., Medical director|+7(495)626-47-55|meshcherskiy_y@pharmasoft.ru|140
20167974|NCT01379508|Novartis|Clinical Disclosure Office|862-778-8300||
20167975|NCT04180540|Emory University|Michael lloyd|404-712-4063|mlloyd@emory.edu|
20167976|NCT02626624|CarboFix Orthopedics Ltd.|Dvir Sherpsky, Director of Clinical Trials|+972-54-770-9920|dvir@carbo-fix.com|
20167977|NCT00695097|University of California, San Francisco|Flavio Vincenti|415-353-1322|flavio.vincenti@ucsfmedctr.org|
20167978|NCT03338959|University of Washington|Lee Cranmer, MD, PhD, Sarcoma Program Director|206-606-7439|ldcranme@fredhutch.org|
20167979|NCT03381742|Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China|Dr. Yue Li|86-451-85555673|ly99ly@vip.163.com|
20167980|NCT00409331|UT MD Anderson Cancer Center|Mark Chambers, DMD / Associate Professor|713-745-2672||
20167981|NCT02184455|DeCell Technolpogies Inc.|Dr. Paul F. Gratzer, CSO|902-223-2179|pfgratzer@decelltechnologies.com|
20167982|NCT02933671|Duke University|W. Michael Bullock, MD, PhD|919-668-2024|william.bullock@duke.edu|
20167983|NCT00730028|San Francisco General Hospital, UCSF|Henry F. Chambers, MD|(415) 206 - 5437|hchambers@medsfgh.ucsf.edu|
20167984|NCT02870933|National Cardiovascular Center Harapan Kita|Tri Wisesa Soetisna, M.D, MHA, PhD|+62215684093|tricts2000@yahoo.com|
20167985|NCT02204124|Washington University School of Medicine|William Hawkins, M.D.|314-286-0702|hawkinsw@wustl.edu|
20167986|NCT01250496|Rush University Medical Center|Dr. Rami Doukky; Director of Nuclear Cardiology|312-942-4655|rami_doukky@rush.edu|
20167987|NCT00003590|SWOG Statistical Center|Study Statistician|(206)667-4623||
20167988|NCT01491113|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
20167989|NCT01425463|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20167990|NCT01332799|University of Iowa|Dr. Roberto Kalil|319-355-6564|roberto-kalil@uiowa.edu|
20167991|NCT00668733|Graceway Pharmaceuticals|Sharon F. Levy, MD / Sr. VP, Clinical Product Development|267-948-0400|sharon.levy@gracewaypharma.com|
20167992|NCT02248688|Dayton Interventional Radiology-Research|Mubin Syed, MD|937-215-0878|mubinsyed@aol.com|
20167993|NCT00538785|MedImmune, LLC|Pamela Griffin, Senior Director, Clinical Development|301 398 0000|griffinp@medimmune.com|
20167994|NCT00647270|Abbott|Global Medical Services|800-633-9110||
20167995|NCT00945295|New Mexico VA Healthcare System|JoAnn Harnar, Research Nurse|505-256-5701|Joann.Harnar@va.gov|
20167996|NCT03615040|University of Leicester|Professor Chris Brightling|+44 116 250 2704|ceb17@le.ac.uk|
20167997|NCT01566084|University of Colorado Denver|Dr. Kristen Jablonski|303-724-4842|KRISTEN.NOWAK@UCDENVER.EDU|
20167998|NCT01541397|The University of Texas Health Science Center at Houston|Heather Saavedra|713-500-7098|Heather.Saavedra@uth.tmc.edu|
20167999|NCT02267317|University of Texas Health San Antonio|Hanyu Liang|210-617-5300|liangh0@uthscsa.edu|15197
20168000|NCT01128621|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168001|NCT00807560|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|Katharine.Loeb@mssm.edu|
20168002|NCT00583713|Braintree Laboratories, Inc.|Russell Pelham, PhD|781-843-2202|rpelham@braintreelabs.com|
20168003|NCT00233454|Stanford University Medical Center|Jason R Gotlib, MD, Associate Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
20168004|NCT04224688|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20168005|NCT04074161|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20168006|NCT02317744|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
20168007|NCT00329849|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20168008|NCT00322621|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20168009|NCT04987788|Icahn School of Medicine at Mount Sinai|Sarah Miller|(212) 824-7783|sarah.miller@mssm.edu|
20168010|NCT01038869|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
20168011|NCT02238067|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20168012|NCT00700141|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
20168013|NCT02010151|Seoul National University Hospital|Dr. Sun Young Lee|+82-10-9269-2376|sy2376@gmail.com|
20168014|NCT03726996|Yale University|Yong-Hui Jiang, MD, PhD|203-785-2660|yong-hui.jiang@yale.edu|
20168015|NCT01328444|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168016|NCT03531632|MacroGenics, Inc.|Stephen Eck, M.D., Chief Medical Officer|301 251-5172|ecks@macrogenics.com|
20168017|NCT02743611|Bellicum|Contact for Clinical Trials|(832) 384-1100|clinicaltrials@bellicum.com|
20168018|NCT00600119|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
20168019|NCT01616693|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20168020|NCT01950013|Indiana University, Dept of Speech & Hearing Sci|Larry Humes|812-855-3507|humes@indiana.edu|
20168021|NCT00993226|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
20168022|NCT00271505|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
20201496|NCT02393209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20201497|NCT00727402|Case Western Reserve University Dept Ophthalmology & Visual Sciences|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
20201498|NCT03545282|University of Washington|India Ornelas|206-685-8887|iornelas@uw.edu|
20201499|NCT02582671|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20168023|NCT00539188|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
20201500|NCT01755169|MUSC|Dr. Amy-Lee Bredlau|843-876-0444|bredlau@musc.edu|
20168024|NCT04784442|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
20168025|NCT00574236|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
20201501|NCT02537678|University of South Florida|Alison Salloum|8139741535|asalloum@usf.edu|
20168026|NCT01748240|academic group|Groupe Francophone des Myelodysplasies|+ 33 (0)1 71 20 70 59|fatiha.chermat@aphp.fr|
20168027|NCT00486811|Grünenthal GmbH|Claudia Leinweber|+49 241 569 2509|claudia.leinweber@grunenthal.com|
20168028|NCT01012089|University of Oklahoma College of Pharmacy|Teresa Lewis Pharm D|405-271-2859|Teresa-Lewis@ouhsc.edu|
20168029|NCT02037555|Grifols Therapeutics, LLC|Miquel Barceló, PhD|+34 935.712.368|Miquel.Barcelo@grifols.com|
20168030|NCT00852371|Makerere University Kampala|Nankabirwa Joaniter|+256772676429|jnankabirwa@yahoo.co.uk|
20168031|NCT02756806|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
20168032|NCT03158285|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20168033|NCT03753113|Tabriz University of Medical Sciences|Dr. Farid Masoud|+989036859062|faridmasoud@gmail.com|
20168034|NCT01008423|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20168035|NCT01809639|Spartanburg Regional Healthcare System|John Lucas|423-309-5646|jlucas@srhs.com|
20168036|NCT04166240|VAORD|Hardeep Singh|713 7948515|hardeep.singh@va.gov|
20168037|NCT00946153|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
20168038|NCT03512457|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
20168039|NCT00530504|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20168040|NCT00006289|National Institute of Nursing Research|Dr. Leorey Saligan (Principal Investigator, former PI: Dr. Raymond Dioone)|301-451-1685|saliganl@mail.nih.gov|
20168041|NCT02973438|University of Miami|Mark S. Nash, Ph.D.|3052433628|mnash@med.miami.edu|
20168042|NCT02043808|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168043|NCT02465099|Ethicon Inc|Jason Waggoner|(513) 337-8130|jwaggon1@its.jnj.com|
20168044|NCT00582075|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
20168045|NCT05141448|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|614-531-6781|anixon1@its.jnj.com|
20168046|NCT03865316|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
20168047|NCT04084561|Center for Asian Health, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
20168048|NCT02695160|Sangamo Therapeutics|Medical Monitor|+1 510 307 7266|clinicaltrials@sangamo.com|
20168049|NCT03137069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20168050|NCT00336856|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
20168051|NCT02720107|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20168052|NCT02522624|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
20168053|NCT01325337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20201502|NCT00805207|Washington University in St Louis|Gordon Smith, PhD|314-362-4375|gsmith@wustl.edu|
20168054|NCT03483922|HKG Epitherapeutics|David Cheishvili|5142601972|david.cheishvili@hkgepitherapeutics.com|
20168055|NCT04313647|Ruijin Hospital , Shanghai Jiao Tong University School of Medicine|Dr. Qu|(+86)2164370045|jmqu0906@163.com|
20168056|NCT00843778|UCB|UCB Clinical Trial Call Center|+1 877 822||9493
20168057|NCT00369629|Northwestern University|Barbara Pro||barbara.pro@nm.org|
20168058|NCT02600871|University of Texas Health San Antonio|Dr. Adriana Segura Olson|2152649796|adriana.s.olson@gmail.com|
20168059|NCT01604278|Novartis Pharmaceuticals|Study Director|862-778-8300||
20168060|NCT00762424|WellSpan Health|Barbara Stahlman MS, Clinical Research Associate|717-851-2450|bstahlman@wellspan.org|
20168061|NCT01347580|AstraZeneca|Dr Tomas Andersson MD|00 46 31 77 61966|tomas.lg.andersson@astrazeneca.com|
20168062|NCT00874939|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168063|NCT01909791|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
20168064|NCT02908490|University of Pittsburgh|Kimberly P. Liang, MD, MS|412-586-3550|liangkp@upmc.edu|
20168065|NCT01659554|Columbia University Medical Center|Reena M. Vattakalam, CCRP|212-342-6895|rmv2110@cumc.columbia.edu|
20168066|NCT01236547|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20168067|NCT04022733|Ajou University|Associate professor in Anesthesiology Department|82-31-2195689|beye98@aumc.ac.kr|
20168068|NCT04144127|Emory University|Dr. Felipe Lobelo|(770) 488-5737|felipelobelo@emory.edu|
20168069|NCT04941443|Boston Medical Center, Department of Anesthesiology|Rachel Achu, MD|(617) 414-2000|rachel.achu@bmc.org|
20168070|NCT01707238|Visioncare Research Ltd.|Graeme Young|01252 718719|g.young@visioncare.co.uk|207
20168071|NCT00947791|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
20168072|NCT02208063|Cumberland Pharmaceuticals Inc.|Senior Director of Clinical and Regulatory Affairs|615-255-0068|ahaeberle@cumberlandpharma.com|
20168073|NCT02279407|AstraZeneca|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
20168074|NCT02500056|Tartu University Hospital|Ceith Nikkolo|+37253319082|ceith.nikkolo@kliinikum.ee|
20168075|NCT00864916|Indiana University School of Medicine|Samir K. Gupta, MD|317-274-7926|sgupta1@iu.edu|
20168076|NCT03816709|North Dakota State University|Kara Gange, Associate Professor|701-231-5777|kara.gange@ndsu.edu|
20168077|NCT02331095|The Ohio State University|Dr. Tzu-Fei Wang|614-366-8366|tzufeiwang@gmail.com|
20168078|NCT01816945|Yale University|Megan Smith Associate Professor|203 764 8655|megan.smith@yale.edu|
20168079|NCT01155011|UCSD|Jacqueline Kerr|858-534-9305|jkerr@ucsd.edu|
20168080|NCT01323855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20203014|NCT00089843|Massachusetts General Hospital|Anne Klibanski, M.D.|617-726-3870|aklibanski@partners.org|
20168081|NCT02122783|MossRehab|Mukul Talaty|2156636682|mctalaty@einstein.edu|
20168082|NCT00618098|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
20168083|NCT00740376|Corin|Global Regulatory Affairs and Clinical Director|+44 (0)1285 659866||
20168084|NCT01214057|The University of Texas Health Science Center at Houston|Davide Cattano, MD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
20168085|NCT02213133|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20168086|NCT00568633|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation)|650-725-8950|rlowsky@stanford.edu|
20168087|NCT02744040|Fred Hutchinson Cancer Research Center|Ann C Duerr, MD, PhD, MPH, Member|206-667-7938|aduerr@fredhutch.org|
20168088|NCT01642615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20168089|NCT00096356|Wake Forest University Comprehensive Cancer Center|Dr. Glenn Lesser|(336) 713-5440|glesser@wakehealth.edu|
20168090|NCT02453672|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
20168091|NCT00402740|Abbott Vascular|Ellen Travis, MS, NFP|408 845-1512|Ellen.Travis@av.abbott.com|
20168092|NCT02140593|Herlev and Gentofte Hospital University of Copenhagen|Dr. Matias Vested Madsen|+4538683868|matias.vested.madsen@regionh.dk|
20168093|NCT01699867|Johns Hopkins Medicine|Lisa K. Jacobs, M.D.|410-502-0880|ljacob14@jhmi.edu|
20168094|NCT00183729|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
20168095|NCT00796926|Singapore National Eye Center|Dr Louis Tong|65 62277255|Louis.tong.h.t@snec.com.sg|
20168096|NCT04160975|Harvard University|Dr. Marcella Alsan|617-496-1770|marcella_alsan@hks.harvard.edu|
20168097|NCT03009396|Redhill Biopharma|Reza Fathi, Sn. VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
20168098|NCT01675167|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20168099|NCT03255083|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20168100|NCT00363545|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168101|NCT01457352|Sun Pharma Advanced Research Company Limited|SPARC|912266455645|Clinical.Trials@Sparcmail.com|
20168102|NCT03952039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20168103|NCT05009979|National Cancer Institute|Dr. Esther Mena Gonzalez|240-760-6111|esther.menagonzalez@nih.gov|
20168104|NCT04174365|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20168105|NCT03472547|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
20168106|NCT02957968|Virginia Commonwealth University Massey Cancer Center|Massey CTO Breast Team|804-628-6430|masseyctbrst@vcu.edu|
20168107|NCT03035487|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
20168108|NCT02168387|Duke University Medical Center|Ira M. Cheifetz, MD, FCCM, FAARC|919-681-4080|ira.cheifetz@dm.duke.edu|
20168109|NCT01561703|University of Missouri - Department of Otolaryngology - Head and Neck Surgery|Research Coordinator|5738822549|schneiderri@health.missouri.edu|
20168110|NCT00594425|Virginia Clinical Research, Inc|David Pariser MD|757-625-0151|dpariser@pariserderm.com|
20168111|NCT00640224|Children's Hospital of Pittsburgh of UPMC|Dr. Silva Arslanian|412-692-6935||
20168112|NCT00422513|Hoffman-LaRoche|Medical Communications|800-821-8590||
20168113|NCT03135119|Penn State College of Medicine|Dr. Brian Allen|7175314100|ballen1@pennstatehealth.psu.edu|
20168114|NCT01478048|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20168115|NCT00955201|Edward Hines Jr. VA Hospital|Evan Stubbs|708-202-3507|evan.stubbs@va.gov|
20168116|NCT01252667|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
20168117|NCT04644315|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20168118|NCT03032380|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20168119|NCT01836276|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
20168120|NCT01561898|Janssen Pharm KK Japan|Medical Director|03-4411-5067||
20168121|NCT01847131|Faculty of Medicine Siriraj Hospital, Mahidol University|Torpong Thongngarm, M.D.|66-2-419-8263|torpong.tho@mahidol.ac.th|
20168122|NCT00331552|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
20168123|NCT01445548|National Eye Institute|Wai T. Wong, MD, PhD|301-496-7566|wongw@nei.nih.gov|
20168124|NCT01883453|Umeå University|Dr Krister Tano|0046705569043|krister.tano@umu.se|
20168125|NCT02204761|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
20168126|NCT04497038|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20168127|NCT03642132|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168128|NCT00856414|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20168129|NCT02577887|Abbott (previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim@abbott.com|
20168130|NCT00913458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168131|NCT02366091|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
20168132|NCT03595618|Galapagos NV|Galapagos Medical Information|+32 15342900|medicalinfo@glpg.com|
20168133|NCT02338232|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
20168134|NCT03890666|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20168135|NCT01105065|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
20168136|NCT03996369|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20168137|NCT00653432|Anika Therapeutics, Inc.|Kara Mezger, Exec Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20168138|NCT05277337|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20168139|NCT00357760|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20168140|NCT02350764|Memorial Sloan Kettering Cancer Center|Dr. Adam Schoenfeld, MD|646-608-4042|schoenfa@mskcc.org|
20201503|NCT00064701|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
20168141|NCT02535572|Medical University of South Carolina|Morgan Dancy|843-876-5141|maddoxm@musc.edu|
20168142|NCT04620798|Indiana University Bloomington School of Public Health|Molly Rosenberg, MPH, PhD|(812) 856-2509|rosenmol@indiana.edu|
20168143|NCT01224782|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20168144|NCT01960907|RESTECH srl|Dr. Pasquale Pio Pompilio, R&D manager|+39 02 3659 3690|p.pompilio@restech.it|
20168145|NCT00324259|Washington University School of Medicine|Dr. Matthew Ellis|314-362-8866|mjellis@bcm.edu|
20168146|NCT00441116|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168147|NCT02925338|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168148|NCT02395172|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20168149|NCT00597896|Mount Sinai School of Medicine|Katherine E. Burdick, PhD||katherine.burdick@mssm.edu|
20168150|NCT02369744|Albert Einstein Medical Center|Kamran Mohiuddin; Director ED Clinical Research|2154562313|MOHIUDDK@EISNTEIN.EDU|
20168151|NCT02717832|University of Michigan|Dr. Jeffrey Horowitz|734-647-1076|jeffhoro@umich.edu|
20168152|NCT02057081|VISN 5 Mental Illness Research, Education, and Clinical Center|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
20168153|NCT02878057|Department of Breast Oncology, Peking University Cancer Hospital and Institute|Dr. Huiping Li|86-10-88196739|huipingli2012@hotmail.com|
20168154|NCT00978757|Francisco C. Bonofiglio|MD|541149590200|francisco.bonofiglio@hospitalitaliano.org.ar|4949
20168155|NCT03288142|Northwestern University Feinberg School of Medicine|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
20168156|NCT01094522|Stanford University School of Medicine|Dr. Gregory Hammer|6507367359|ham@stanford.edu|
20168157|NCT01214395|PathWest Laboratory Medicine WA|Dr Kerry Carson Trial Manager|+61 8 93464092|kerry.carson@uwa.edu.au|
20168158|NCT02034409|VA Salt Lake City Health Care System|Daniel Clegg, MD|801-582-1565|daniel.clegg@va.gov|
20168159|NCT00934843|Medical University of South Carolina|Dr. Eric Graham|843-792-8704|grahamem@musc.edu|
20168160|NCT00985829|skin research center|Zohreh Tehranchi-nia, assist. prof|+989121029415|zohreh_tehranchi@yahoo.com|
20168161|NCT03612856|Aronora, Inc.|Christina U. Lorentz|503-964-0250|christina.lorentz@aronorabio.com|
20168162|NCT01576159|Middle East Technical University|Ozgur Celik PhD.|+903122104016|ozgur@udel.edu|3663
20168163|NCT01011309|IDRI|Jill Ashman, MSc, Associate Director of Clinical Operations|206-858-6041|jill.ashman@idri.org|
20168164|NCT01085006|Tehran University of Medical Sciences|Dr. Laleh Eslamian|+982184902415|leslamian@tums.ac.ir|
20168165|NCT00831493|UT MD Anderson Cancer Center|Sunil Krishnan, MD / Associate Professor||mclemons@mdanderson.org|
20168166|NCT04784065|Baylor College of Medicine|Dr. Grace Lo, Associate Professor of Medicine|713-791-1414|ghlo@bcm.edu|227804
20168167|NCT00557856|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168168|NCT05092360|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
20168169|NCT01525225|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20168170|NCT01182844|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
20168171|NCT03048383|University of Utah|Dr. P. Daniel Ward|801-581-8471|PDanielWard@hsc.utah.edu|
20168172|NCT00910624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20168173|NCT01122264|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168174|NCT02558829|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
20168175|NCT00097981|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Director|1 215 325-5329||
20168176|NCT00412373|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|jhulihan@its.jnj.com|
20168177|NCT01009840|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
20168178|NCT04240678|UC Davis Medical Center|Eric Chak|916-734-3751|echak@ucdavis.edu|
20168179|NCT00541190|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
20168180|NCT00732901|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
20168181|NCT01486043|Children's Hospital Los Angeles|Dr. Jamie Wood|323-361-7388|jawood@chla.usc.edu|
20168182|NCT01002820|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20168183|NCT01673347|William Beaumont Hospital|Erin Baker, PhD|248-551-1816|erin.baker@beaumont.org|
20168184|NCT01031420|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
20168185|NCT02528721|Exalenz Bioscience|VP of Clinical Affairs|972-8-9737502|melinaa@exalenz.com|
20168186|NCT00813176|University of Iowa|Dr Javier H Campos|3193567208|javier-campos@uiowa.edu|
20168187|NCT00895011|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|medaffairs@vivus.com|
20168188|NCT02617901|Sheffield Children's NHS Foundation Trust|Dr Amaka C Offiah|0114 271 7557|a.offiah@sheffield.ac.uk|
20168189|NCT00177047|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
20168190|NCT00052442|Memorial Sloan-Kettering Cancer Center|Owen A. O'Connor, MD, PhD|212-639-8889|oo2130@columbia.edu|
20168191|NCT02661178|Drugs for Neglected Diseases initiative|Sophie Delhomme|+41229069230|sdelhomme@dndi.org|
20168192|NCT03859973|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168193|NCT02855541|University of Colorado Boulder|James Peterman, PhD|303-735-0358|james.peterman@colorado.edu|
20168194|NCT01839604|AstraZeneca Pharmaceuticals LP|Martin Scott, MD/PhD|Martin.Scott@astrazeneca.com|Martin.Scott@astrazeneca.com|
20168195|NCT04493892|Columbia University|Jasmine A. McDonald|12123053586|jam2319@cumc.columbia.edu|
20168196|NCT01689532|Janssen Pharmaceutical K.K.|Senior Manager||ClinicalTrialDisclosure@its.jnj.com|
20168197|NCT01363349|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
20168198|NCT01958489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168199|NCT00766753|University of Pittsburgh Cancer Institute|Frank Lieberman|(412) 648-6507|liebermanf@upmc.edu|
20201504|NCT02249052|Dr. Zachary E. Gerut|Dr. Zachary E. Gerut, Sponsor/Investigator|516 295-2100|zger@optonline.net|
20168200|NCT00422084|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
20168201|NCT03774823|Venus Concept Ltd.|Director, Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
20168202|NCT01568528|Emory University|Dr. Erica Duncan|404-321-6111|eduncan@emory.edu|
20168203|NCT01410344|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20168204|NCT00362128|Albert Einstein College of Medicine|Judith Wylie-Rosett|718-430-3345|Judith.Wylie-Rosett@einstein.yu.edu|
20168205|NCT01782469|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20168206|NCT02614469|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-764-9611|michaels@helix.mgh.harvard.edu|
20168207|NCT01844479|University of Michigan|James Wrobel, DPM, MS|734-647-4940|jswrobel@med.umich.edu|
20168208|NCT02012582|vasopharm GmbH|Dr. Reinhard Schinzel|+49 931 359099|schinzel@vasopharm.de|115
20168209|NCT03207438|University of Saskatchewan|Evyn Peters|13068441312|evyn.peters@usask.ca|
20168210|NCT03241368|Medtronic GIH|Amanda Wenisch, Clinical Resaerch Coordinator / Study Manager|1-206-225-4025|amanda.m.wenisch@medtronic.com|
20168211|NCT04821362|Ege University|Dr. Sercan Yalçınlı|+90 505 537 41 01|sercan.yalcinli@ege.edu.tr|
20168212|NCT00548184|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
20168213|NCT00280748|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20168214|NCT00029146|University of North Carolina at Chapel HIll|William J. Powers, MD||powersw@neurology.unc.edu|
20168215|NCT01765218|University of California, Davis|Kristin Hoffman, MD|916-205-2755|krhoffman@ucdavis.edu|
20168216|NCT00946985|Ortho-McNeil Janssen Scientific Affairs, LLC|Clinical Project Scientist|609-730-3229||
20168217|NCT00313781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168218|NCT02199717|Hospital for Sick Children|Vanessa Bouskill NP|4168135871|vanessa.bouskill@sickkids.ca|
20168219|NCT01546623|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
20168220|NCT03567343|The University of Arizona|Dr Michael Grandner|15206266346|grandner@email.arizona.edu|
20168221|NCT01590758|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
20168222|NCT04525885|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168223|NCT00684541|SDSU|Professor Nader Amir|6192293744|namir@mail.sdsu.edu|
20168224|NCT01185353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168225|NCT01294098|Washington University School of Medicine|Lauren Westlund|314-454-5345|davislauren@wustl.edu|
20168226|NCT02270944|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168227|NCT01144299|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168228|NCT03353233|Duke University Medical Center|W. Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
20168229|NCT02342418|University of Michigan|Manjunath Pai, Associate Professor|7346470006|amitpai@med.umich.edu|
20168230|NCT04255394|Zimmer Biomet|Linda Meijer|+31627933741|linda.meijer@zimmerbiomet.com|
20168231|NCT00428584|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|fernando.dangond@emdserono.com|
20168232|NCT00528541|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20168233|NCT03259620|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
20168234|NCT02390791|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
20168235|NCT01181986|Phoenix VA Health Care System|Dr. Juraj Koska|602-277-5551|juraj.koska@va.gov|7685
20168236|NCT01055067|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20168237|NCT00548652|VANebraska|Cyrus Desouza|4023468800|cyrus.desouza@va.gov|5506
20168238|NCT03602560|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
20168239|NCT00222131|Texas Tech|Jerzy Sarosiek, MD, PhD, AGAF, FACG|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
20168240|NCT01330017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20168241|NCT04096482|Emory University|Joshua M Levy|(404) 778-3381|joshua.levy2@emory.edu|
20168242|NCT00576420|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
20168243|NCT01221272|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20168244|NCT03225859|Minneapolis VA Medical Center|Shannon Kehle-Forbes, PhD|612-467-4772|Shannon.Kehle-Forbes@va.gov|
20168245|NCT03521102|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|bfriedm@montefiore.org|
20168246|NCT02043899|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
20168247|NCT03254108|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20168248|NCT01771809|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20168249|NCT00362180|Kastle Therapeutics, LLC|Christopher Bryant, Ph.D.|8152633913|cbryant@kastletx.com|
20168250|NCT01106092|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168251|NCT03930264|Nova Laboratories Limited|Dr Hussain Mulla|+44 (0)116 223 0100|hussain.mulla@novalabs.co.uk|
20168252|NCT01371032|Cedars Sinai Medical Center|Dr. Roya Yumul, MD, PhD|310-423-1682|Roya.Yumul@cshs.org|
20168253|NCT02434471|Duke University|Mustafa R. Bashir, M.D.|919-684-7366|mustafa.bashir@duke.edu|
20168254|NCT01473368|Beth Israel Deacones Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
20168255|NCT04839562|Massachusetts General Hospital|Dr. Craig Surman|6176808489|csurman@partners.org|
20168256|NCT00911443|R&D Department - Sigma-Tau SpA|Roberto Camerini|+390691393562|roberto.camerini@sigma-tau.it|
20168257|NCT01949337|Memorial Sloan-Kettering Cancer Center|Michael J. Morris, MD|646-422-4469|morrism@mskcc.org|
20168258|NCT00003472|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20168259|NCT01012219|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168260|NCT00522925|Ligand Pharmaceuticals, Inc.|Ram Kapil, PhD/ Sr. Director, Clinical Pharmacology|858-550-7603|rkapil@ligand.com|
20168261|NCT00918931|Organization: The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
20168262|NCT01350544|RAND Corporation|Laura M. Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
20168263|NCT02396160|University of Queensland|Dr Niikee Schoendorfer|0413122076|n.schoendorfer@uq.edu.au|
20168264|NCT01444092|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
20168265|NCT01328366|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20168266|NCT03005873|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
20168267|NCT04585009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20168268|NCT01713933|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20168269|NCT00918125|Duke University Medical Center|Dr. Kevin Thomas|919-668-7857|kevin.thomas@dm.duke.edu|
20168270|NCT02882152|University of São Paulo|Dr. Joaquim Edson Vieira|+55 11 3061 8716|joaquimev@usp.br|
20168271|NCT02871882|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
20168272|NCT00791973|University of Chicago|Dr. Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
20168273|NCT01104376|Indiana University|Zeruesenay Desta, PhD|317-630-8860|zdesta@iupui.edu|
20168274|NCT00797966|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20168275|NCT01514786|UMichigan|Dr. Masahito Jimbo|734-998-7120|mjimbo@med.umich.edu|
20168276|NCT01408329|Stanford University|Anne L Friedlander|650-725-7531|afriedlanderCW@gmail.com|
20168277|NCT01242813|Novartis Pharmaceuticals|Study Director|862-778-8300||
20168278|NCT01910311|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168279|NCT01369329|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
20168280|NCT00701662|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20168281|NCT03337490|Mayne Pharma LLC|Associate Director, Clinical Operations|9195737948|phoevos.hughes@maynepharma.com|
20168282|NCT03560518|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
20168283|NCT00159822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20187851|NCT05117008|Medical College of Wisconsin|Meera Mohan MD, MS|414-805-4600|memohan@mcw.edu|
20201505|NCT00582894|University of Oklahoma Health Sciences Center|George Selby, MD|405/271-4022|george-selby@ouhsc.edu|
20201506|NCT03185546|Wake Forest School of Medicine|Eric Donny, PhD|336-713-1520|edonny@wakehealth.edu|
20187852|NCT03003533|Spark Therapeutics|Spark Therapeutics|Please Email|clinicaltrials@sparktx.com|
20187853|NCT03011034|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20187854|NCT04564209|University of Colorado College of Nursing|Dr. Samantha Stonbraker, Study PI|720-880-8194|Samantha.Stonbraker@CUAnschutz.edu|
20187855|NCT02361658|Toronto Western Hospital, University Health Network|Emad Al Azazi|4166035800|emad.alazazi@uhnresearch.ca|2508
20187856|NCT03735979|Medical University of South Carolina|Jordan J. Elm, PhD|843-876-1605|elmj@musc.edu|
20187857|NCT05958927|Usak University Medical Faculty|Suzan Doğruya|05322270732|sdogruya@hotmail.com|
20187858|NCT01438853|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@Immunitybio.com|
20187859|NCT03165955|Athenex Inc.|Regional Project Manager|+886-978365735|lmeiying@athenex.com|
20187860|NCT03745716|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20187861|NCT04761198|Mereo BioPharma|Mereo BioPharma|Please Email|enquiries@mereobiopharma.com|
20187862|NCT02994927|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
20187863|NCT00626795|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
20187864|NCT03875339|University of Kentucky|Dr. Matthew L. Bush, Professor and Chair of Otolaryngology- Head and Neck Surgery|(859)218-2139|matthew.bush@uky.edu|
20187865|NCT03533257|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
20187866|NCT05525104|Erasmus Medical center|I.J. de Heer, MD|+31107040704|i.deheer@erasmusmc.nl|
20187867|NCT02039401|Helixmith, LLC|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
20187868|NCT03364127|University of Illinois Chicago|Judith M. Schlaeger, PhD, CNM, LAc, FAAN|(312) 413-4469|jschlaeg@uic.edu|
20187869|NCT04466098|University of Minnesota, Masonic Cancer Center|Dr. David Ingbar|612-624-9452|ingba001@umn.edu|
20187870|NCT04389957|San Francisco Veterans Affairs Medical Center|Dr. Tonya Kaltenbach|(415) 221-4810|tonya.kaltenbach@va.gov|24406
20187871|NCT04214860|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
20187872|NCT05405985|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
20187873|NCT01917084|New England Research Institutes|Felicia Trachtenberg|617-972-3120|FTrachtenberg@neriscience.com|
20187874|NCT03571386|Vanderbilt University|David Vago|236-516-6530|vago.dave@gmail.com|
20187875|NCT03938246|Sagimet Biosciences Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
20187876|NCT06037668|Sumitomo Pharma America|Director, Frontier Business Office|1-866-503-6351|gazeleh.vakili@us.sumitomo-pharma.com|
20187877|NCT05224544|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
20187878|NCT01828021|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
20187879|NCT04881461|ALK-Abelló A/S|Senior Director, Clinical Data Science, Global Clinical Development|+4545747576|clinicaltrials@alk.net|
20187880|NCT04938726|University of Alabama at Birmingham|Dr. Eric P. Plaisance|2057090980|plaisep@uab.edu|
20187881|NCT03866837|Columbia University|Gary M. Brittenham, M.D.|212 305 7005|gmb31@cumc.columbia.edu|
20187882|NCT03681262|Stanford University|Vafi Salmasi, MD. MS.|6507250246|vsalmasi@stanford.edu|
20187883|NCT04370834|National Cancer Institute|Dr. Richard Little, Principal Investigator|240-276-6093|littler@mail.nih.gov|
20201507|NCT02930174|University of Michigan Health System|Carl Haas|734-936-5234|chaas@med.umich.edu|
20201508|NCT01587989|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201509|NCT03128957|University of Michigan|Dr. Paul Picton|734 615 9864|ppicton@med.umich.edu|
20201510|NCT03313050|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201511|NCT01291017|University of Florida|Priya K Gopalan, MD|352-273-8699|gopalpk@ufl.edu|
20201512|NCT02963376|NuvOx Pharma|Evan Unger, MD|520-624-6688|eunger@nuvoxpharma.com|
20201513|NCT02848833|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201514|NCT02847598|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20201515|NCT04375761|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20201516|NCT03797001|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
20201517|NCT05404776|University of Texas Medical Branch|Meagan Benson, DO|409-772-0982|meaganbenson88@gmail.com|
20201518|NCT05630846|GlaxoSmithKline Biologicals SA|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20201519|NCT05556616|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20201520|NCT04840836|Columbia University|Samantha Garbers, PhD, Principal Investigator|212-305-0123|svg2108@cumc.columbia.edu|
20201521|NCT03697564|University of California, San Diego|Dr. Hitendra Patel|(858) 822-5354|CancerCTO@health.ucsd.edu|
20201522|NCT00075881|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20201523|NCT02224664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201524|NCT03019549|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
20201525|NCT00371267|San Francisco VA Medical Center|Timothy P. Carmody, Ph.D.|415-221-4810|Timothy.Carmody@va.gov|6344
20201526|NCT04030195|Precision BioSciences|Michael Karg, Senior Director, Clinical Operations|919-324-5512|michael.karg@precisionbiosciences.com|1574
20201527|NCT01412879|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
20201528|NCT03195894|KontigoCare AB|Markku Hämäläinen, Research Director|0769 47 31 32|markku.hamalainen@kontigocare.com|
20201529|NCT01575912|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
20201530|NCT00608465|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
20201531|NCT03263091|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|082MDSstudy@fibrogen.com|
20201532|NCT03026803|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|62478
20201533|NCT01821963|University of Texas (UT) MD Anderson Cancer Center|Harrys A. Torres, MD/Assistant Professor, Infectious Diseases|(713) 792-6503|htorres@mdanderson.org|
20201534|NCT00506389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201535|NCT04053387|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20201536|NCT03095703|Amsterdam UMC, location Academic Medical Center|Prof. dr. Evelien Dekker|+3120-5663534|e.dekker@amsterdamumc.nl|
20201537|NCT04092257|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu|919-962-0000|Melahat_Canter@med.unc.edu|
20201538|NCT00318292|Mayo Clinic|Michaele Menghini|480-301-6651|menghini.michaele@mayo.edu|
20201539|NCT02443402|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20201540|NCT02241486|Loyola University Medical Center|Dr. Joseph R. Holtman|7082168563|jholtman@luc.edu|
20201541|NCT01934504|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20201542|NCT02770521|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201543|NCT02665689|Charité University, Berlin|Prof. Dr. Antonia Joussen|+49 30 84452331|antonia.joussen@charite.de|
20201544|NCT00486902|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
20201545|NCT01217606|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20201546|NCT03615222|CTX VA|Suzannah Creech|254-654-7241|suzannah.creech@va.gov|
20201547|NCT01552057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201548|NCT00476086|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susanna_campos@dfci.harvard.edu|
20201549|NCT02900092|Massachusetts General Hospital|Karen K. Miller, MD|617-726-3870|KKMiller@mgh.harvard.edu|
20201550|NCT01389245|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
20201551|NCT02292849|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
20201552|NCT00097539|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20156559|NCT03709472|University of Miami|Victoria Mitrani|3052849139|vmitrani@miami.edu|
20156560|NCT03559556|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214-645-7637|robert.timmerman@utsouthwestern.edu|
20156561|NCT03506360|Mayo Clinic|Yi Lin|5072845096|Lin.Yi@mayo.edu|
20156562|NCT01969058|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20156563|NCT03207347|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
20156564|NCT02085720|Chinese University of Hong Kong|Dr Susanna Ng SS|85226322211|drsssng123@yahoo.com.hk|
20156565|NCT00689884|Dartmouth-Hitchcock Medical Center|John M. Hill, MD - Principal Investigator|603-650-4628|john.m.hill@hitchcock.org|
20156566|NCT02038036|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20156567|NCT05572567|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20156568|NCT05528445|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
20156569|NCT05964166|Nationwide Children's Hospital|Dr. Joseph Tobias|6147224200|Joseph.Tobias@nationwidechildrens.org|
20156570|NCT01397253|University of Pittsburgh|Kenneth J Smith, MD, MS|4126474794|smithkj2@upmc.edu|
20168284|NCT00917644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20168285|NCT02307253|Fondazione Policlino Universitario A Gemelli IRCCS|Dr Alberto Larghi|0630156580|alberto.larghi@yahoo.it|
20168286|NCT00915499|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
20168287|NCT00958438|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20168288|NCT02788279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20168289|NCT00924040|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitman@mail.nih.gov|
20168290|NCT01579812|UPMC Hillman Cancer Center|Dr. Ronald Buckanovich, MD, PhD|412-641-4721|buckanovichrj@mwri.magee.edu|
20168291|NCT05168501|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
20168292|NCT03271983|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20168293|NCT01185301|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20168294|NCT01213576|University of Liverpool|Professor Neil French|+441517959630|french@liv.ac.uk|
20168295|NCT04987944|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168296|NCT00606047|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8920|pbeaule@toh.ca|
20168297|NCT00345332|University of Rochester|Division of Urogynecology|585-273-3232|amy_keller@urmc.rochester.edu|
20168298|NCT04121078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20168299|NCT04136444|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20168300|NCT00253708|Beth Israel Deaconess Medical Center|Russell S. Phillips, MD|6174322222|Russell_phillips@hms.harvard.edu|
20168301|NCT01981057|Medical University of Vienna|Nadja Haiden M.D.|+4314040032320|nadja.haiden@meduniwien.ac.at|
20168302|NCT02095132|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20168303|NCT04905498|University of Kansas Medical Center|Amanda S. Bruce|4014990576|abruce2@kumc.edu|
20168304|NCT00409175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168305|NCT00430183|Memorial Sloan-Kettering Cancer Center|James A. Eastham, MD|646-422-4390|easthamj@mskcc.org|
20168306|NCT02599051|Cleveland Clinic Florida|G W Davila|9546595559|davilag@ccf.org|
20168307|NCT02946931|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168308|NCT03339297|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
20168309|NCT01054183|Akron Children's Hospital|Michael T. Bigham, MD|330-543-8639|MBigham@chmca.org|
20201553|NCT05127486|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20201554|NCT02582515|Johns Hopkins University School of Medicine|Assistant Professor|443-287-5143|jfmcguire@jhmi.edu|
20201555|NCT05027802|Ipsen Bioscience Inc.|Medical Director|see email|clinical.trials@ipsen.com|
20201556|NCT03464045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201557|NCT03826875|University of Washington|Professor of Neurological Surgery|2067449330|mlevitt@uw.edu|
20201558|NCT03905928|Pennsylvania State University College of Medicine|Andrea Hobkirk|717-531-7279|alh98@psu.edu|
20201559|NCT01725165|M D Anderson Cancer Center|Dr, Chad Tang|(713) 745-7179|ctang1@mdanderson.org|
20201560|NCT05590377|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20201561|NCT02688647|Kadmon Corporation|Karin Herrera, Vice President, Clinical Operations|1-724-778-6134|karin.herrera@kadmon.com|
20201562|NCT03619213|AstraZeneca AB|AstraZeneca Clinical Study Information Center|877-240-9479|Information.center@astrazeneca.com|+1
20201563|NCT00382967|GE Healthcare|Igor Grachev, MD|1-609-514-6857|igor.grachev@ge.com|
20201564|NCT02886702|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20201565|NCT01276184|University of Maryland School of Medicine|Dr. J. Kathleen Tracy, PhD|410-706-1205|ktracy@som.umaryland.edu|
20201566|NCT01808560|TearScience, Inc.|Manager of Clinical and Medical Affairs|919-459-4842|LJi4@its.jnj.com|
20168310|NCT00065429|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
20168311|NCT02080819|Virginia Commonwealth University|Dr. Liangsuo Ma|8048282871|liangsuo.ma@vcuhealth.org|
20187884|NCT01474122|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
20187885|NCT04801368|Mayo Clinic|Dr. Matthew Ziegelmann|507-266-3982|Ziegelmann.Matthew@mayo.edu|
20187886|NCT06097494|Pfizer Ltd|Ranjit Nagra|01304 616161|ranjit.nagra@pfizer.com|
20187887|NCT04265807|University of Washington|Graham Nichol|206 521 1784|nichol@uw.edu|
20187888|NCT06609486|Hanyang University Seoul Hospital|Jongshill Lee, Ph.D.|+82-10-6209-4260|netlee@hanyang.ac.kr|
20187889|NCT03372057|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
20187890|NCT00450216|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
20187891|NCT00640822|LeoPharma|Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
20187892|NCT05112900|Huntsman Cancer Institute at the University of Utah|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
20187893|NCT00319111|Actelion Pharmaceuticals Ltd|Loïc Perchenet PhD/Clinical Trial Leader|+41 61 565 6457||
20187894|NCT05386589|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20187895|NCT02919917|Icahn School of Medicine at Mount Sinai|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
20187896|NCT04807777|Columbia University|Alexander Wei, MD|212-305-7115|aw3056@cumc.columbia.edu|
20187897|NCT04743973|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@mayo.edu|
20187898|NCT04330040|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20187899|NCT06229119|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
20187900|NCT02461134|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
20168312|NCT00832624|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168313|NCT01332461|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168314|NCT00636363|Bausch & Lomb|Robert Steffen|(585) 338-6399|robert.steffen@bausch.com|
20168315|NCT05396599|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
20168316|NCT01433250|Novartis Pharmaceuticals|Study Director|862-778-8300||
20168317|NCT03148691|Aclaris Therapeutics|Executive Director, Clinical Operations|4843247933|jschnyder@aclaristx.com|
20168318|NCT02000154|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
20168319|NCT01340872|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
20168320|NCT01502332|USaoPaulo|Dr Alcino Costa Leme|55 11 989044014|costaleme@uol.com.br|
20168321|NCT02656680|University of Connecticut|Dr. Sherry Pagoto|8604868979|sherry.pagoto@uconn.edu|
20168322|NCT01215929|UAMS|Michael J Mancino MD|501-526-8440|mjmancino@uams.edu|
20168323|NCT01246466|AtriCure|Vice President, Clinical Affairs and Biometrics|1-513-644-8192|nndikintum@atricure.com|
20168324|NCT00877773|University of Texas (UT) MD Anderson Cancer Center|Daniel Karp, MD / Professor, Investigational Cancer Therapeutics||CR_Study_Registration@mdanderson.org|
20168325|NCT00603590|Tehran University of Medical Sciences|Mansoor Rastegarpanah|+989121255960|rastegar@sina.tums.ac.ir|
20168326|NCT01430754|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
20168327|NCT02766582|Medical College of Wisconsin|D. Denise Uyar|414-805-6606|duyar@mcw.edu|
20168328|NCT00275821|Novartis Pharmaceuticals|Study Director|862-778-8300||
20168329|NCT03708562|Becton Dickinson (BPV)|Courtney Rothwell|480-350-6037|courtney.rothwell@bd.com|
20168330|NCT01133990|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20201567|NCT01147497|Emory University|Eva Lathrop, MD, MPH|404-778-1379|elathro@emory.edu|
20201568|NCT02991599|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
20201569|NCT04026568|Penn State Hershey Medical Center|Kenneth Taylor, MD, Professor of Orthopaedics and Rehabilitation|717-531-2948|ktaylor3@pennstatehealth.psu.edu|
20201570|NCT00331760|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20201571|NCT02514044|University of Texas Health Science Center at Houston (UTHealth)|Dr. Gerard E. Francisco, Chairman and Professor, Physical Medicine and Rehabilitation|713.797.5246|gerard.e.francisco@uth.tmc.edu|
20201572|NCT03417440|University of Southern California Chan Division of OS-OT|Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
20201573|NCT01687790|University of Pittsburgh|Dr. Christiane Hakim|412-641-1965|chakim@magee.edu|
20201574|NCT00673595|Mayo Clinic|Dr. John H. Eisenach|507-266-8715|eisenach.john@mayo.edu|
20201575|NCT03663166|Moffitt Cancer Center|Bradford A. Perez, MD|813-745-4380|bradford.perez@moffitt.org|
20201576|NCT04485455|University of North Carolina at Chapel Hill|Shahzad Ali, MD|984-974-0033|shali@med.unc.edu|
20201577|NCT01110187|University of Alabama at Birmingham|Jerzy P. Szaflarski, MD|205-934-3866|szaflaj@uab.edu|
20201578|NCT00422279|Nobel Biocare|Isabelle Arrighi, Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
20201579|NCT02561156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20201580|NCT03862027|University of North Carolina at Chapel Hill|Amanda Kovacich, MD|919-966-2532|amanda.kovacich@unchealth.unc.edu|
20201581|NCT01071070|Abbott|Global Medical Services|800-633-9110||
20201582|NCT00158184|Substance Use Research Center|Dr. Sandra D. Comer|212-543-5981|sdc10@columbia.edu|
20201583|NCT01748799|Centre for Addiction and Mental Health (CAMH)|Bernard Le Foll|416.535.8501|bernard.lefoll@camh.ca|34772
20201584|NCT02620020|Regeneron Pharmaceuticals|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20201585|NCT03624816|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
20201586|NCT03168867|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
20201587|NCT04348851|North Florida/South Georgia Veterans Health System|Dr. Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
20201588|NCT00195650|Abbott|Global Medical Services|800-633-9110||
20201589|NCT01478958|University of Reading|Professor Julie Lovegrove|+44 (0)118 3786418|j.a.lovegrove@reading.ac.uk|
20201590|NCT00642642|Biologics Consulting Group|Dr/ Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
20201591|NCT04640766|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
20201592|NCT01106040|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
20201593|NCT01041248|Childrens Hospital of Eastern Ontario|Dr Johannes Roth|6137377600|jroth@cheo.on.ca|1015
20201594|NCT02654002|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20201595|NCT06119191|CooperVision, Inc.|Cameron Postnikoff|925-730-6734|postnikoff@coopervision.com|
20201596|NCT02109029|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201597|NCT01056107|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
20201598|NCT01225263|BIDMC|Catherine Buettner, MD MPH|617-754-9600|cbuettne@bidmc.harvard.edu|
20201599|NCT02364778|Icahn School Of Medicine at Mount Sinai|Dr. Annapoorna Kini||annapoorna.kini@mountsinai.org|
20201600|NCT02811744|Univerisity of Pennsylvania|Erin Schubert|215-573-6569|erin.schubert@pennmedicine.upenn.edu|
20201601|NCT00260208|Novartis Pharmaceuticals|Study coordinator|862-778-8300||
20168331|NCT02282345|UT MD Anderson Cancer Center|Dr. Jennifer Litton,VP, Clinical Research, VP Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
20168332|NCT02683746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201602|NCT02091440|Osaka University Hospital|Prof. Yoshiki Sawa|+81 668793160|sawa@surg1.med.osaka-u.ac.jp|
20201603|NCT00768222|J&J Medical, China Ltd.|Xiaowei SUN, MD PhD|86 10 5952 3103|xsun5@its.jnj.com|
20168333|NCT01280201|Group for Neuroendocrine Tumors (GETNE)|Dr. Enrique Grande (Hospital Universitario Ramón y Cajal)|931780742|getne@getne.org|201
20201604|NCT03539432|The Mind Research Network|Dr. Eric Claus|5055151556|eclaus@mrn.org|
20168334|NCT02596750|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
20168335|NCT02108262|CSLBehring|Trial Registration Coordinator|610-878-4000|clinicaltrials@cslbehring.com|
20168336|NCT03492840|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
20168337|NCT00869778|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
20168338|NCT02126748|Vrije Universiteit Brussel|Filip Van Ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
20168339|NCT01976988|Cedars Sinai Medical Center|Phillip Fleshner MD|310-289-9224|pfleshner@aol.com|
20168340|NCT03316911|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
20168341|NCT01119937|Novartis Pharmaceuticals|Study Director|862-778-8300||
20168342|NCT01270802|Indiana University School of Medicine|Dr. Samir K. Gupta, Principal Investigator|317-274-7926|sgupta1@iu.edu|
20168343|NCT01512667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168344|NCT01883856|University of Virginia|Peter A. Netland, MD, PhD|4349821086|pan9c@virginia.edu|
20168345|NCT04740905|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20168346|NCT01566214|Iowa City VA Health Care System|Mark Vander Weg|319-338-0581|mark.vanderweg@va.gov|7717
20168347|NCT03051620|Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark|Anne Sophie Sølling|+45 78 45 54 75|annesoel@rm.dk|
20168348|NCT00393510|Institute of Chinese Medicine, Chinese University of Hong Kong|Prof. Leung Ping Chung|(852)2252 8863|pingcleung@cuhk.edu.hk|
20168349|NCT04132804|Massachusetts General Hospital|Dr. Kyle Staller|617-726-5565|kstaller@mgh.harvard.edu|
20168350|NCT02700334|INSTITUTO DE TERAPUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
20168351|NCT03077087|Regions Hospital|Joshua S Rosenzweig / Study Coordinator|651-254-3351|joshua.s.rosenzweig@healthpartners.com|
20168352|NCT00770146|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20168353|NCT01023477|Inova Health Care|Kirsten Edmiston, MD|703-850-9555|Kirsten.edmiston@inova.org|
20168354|NCT02412488|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
20168355|NCT01989468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20168356|NCT01967784|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20168357|NCT00674154|Aarhus University Hospital|Lars Rolighed|004520677876|larsrolighed@gmail.com|
20168358|NCT03222492|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20168359|NCT00816023|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD, MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
20168360|NCT04449029|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20168361|NCT01476202|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168362|NCT01073462|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20168363|NCT03554486|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
20201605|NCT01381094|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
20201606|NCT04504318|Stanford University|Dr. Arash Momeni|650-723-6189|amomeni@stanford.edu|
20201607|NCT01217749|Pharmacyclics, Inc.|Dr. Jutta K. Neuenburg|877-877-3536|medinfo@pcyc.com|
20201608|NCT00810797|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20201609|NCT02935738|Barz IVF Center for Embryo Research and Infertility Treatment|Dr. Saeeda A. Muhsen-Alanssari|9798201303|barzivfcenter@gmail.com|
20201610|NCT00469508|UCLA Center for Behavioral and Addiction Medicine|Steven Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
20201611|NCT04178590|Department of Periodontology and Oral Medicine, School of Dental Medicine, University of Belgrade|Dr Mila Vuckovic|+381637060694|jovanovic.dr.mila@gmail.com|
20201612|NCT00775021|Vistakon|Kurt Moody, Director Design R&D|904-443-3088||
20201613|NCT00363415|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201614|NCT04802837|Summit Therapeutics|Katie Tran|4086776503|Katie.Tran@Summitplc.com|
20201615|NCT01506141|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20201616|NCT04889209|Baylor College of Medicine|Dr. Robert L. Atmar|713-798-6849|ratmar@bcm.edu|
20201617|NCT04607408|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|2066675812|hvtn.covpn.sdmc@hvtn.org|
20201618|NCT02148029|Veterans Administration of Baltimore Maryland|Dr. Brajesh K. Lal|410-328-5840|blal@som.umaryland.edu|
20201619|NCT04586504|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
20201620|NCT05039086|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
20201621|NCT02725788|3M|Laura Rutledge|651-733-5394|lfrutledge1@mmm.com|
20201622|NCT00474240|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
20201623|NCT00809133|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201624|NCT00833092|USDA Grand Forks Human Nutrition ResearchCenter|Forrest H Nielsen, PhD|701-790-8455|forrest.nielsen@ars.usda.gov|
20201625|NCT00619229|UCB|UCB Clinical Trial Call Center|+ 1 877 822 9493 (UCB)||
20201626|NCT01700829|NY State Psychiatric Institute-Columbia University Medical Center|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
20201627|NCT00316264|MedImmune|Pamela Griffin|301 398 0000|clinicaltrialenquiries@medimmune.com|
20201628|NCT04927312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168364|NCT02992197|The University of Vermont College of Medicine|Benjamin Lee|8026567748|blee7@uvm.edu|
20168365|NCT04114617|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
20201629|NCT03424161|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20168366|NCT02509117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
20201630|NCT04919564|National Cardiovascular Center Harapan Kita Jakarta|Prieta Adriane, MD|+62 852-2004-0006|prietaadriane@gmail.com|
20168367|NCT04345367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168368|NCT01876329|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
20168369|NCT01522937|University of Michigan Comprehensive Cancer Center|Dr. Kyle Cuneo, M.D.|734-936-4300|kcuneo@umich.edu|
20201631|NCT00929240|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20201632|NCT01287104|National Cancer Institute|Dr. Nirali N. Shah|301-451-0390|shahnn@nih.gov|
20201633|NCT00296322|Asan Medical Center, University of Ulsan College of Medicine|Dr. Yoon-Koo Kang|+82-2-3010-3230|ykkang@amc.seoul.kr|
20201634|NCT00098787|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20201635|NCT00684814|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20201636|NCT02203149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201637|NCT00278525|Northwestern University|Dr. Richard Burt|312-908-0059|rburt@northwestern.edu|
20201638|NCT00446030|sanofi-aventis|Trial Transparency Team||Contact-us@sanofi-aventis.com|
20201639|NCT00608140|Duke University|Mary Ann Sellers|919-668-8544|maryann.sellers@duke.edu|
20201640|NCT00858832|USF Health Department of Obstetrics and Gynecology|Patrick Teefey MD|813-259-8680|ObGynClinicalResearch@health.usf.edu|
20201641|NCT05292755|University of Florida|Dr. Yujia Zhou|3053429166|yzhou1996@ufl.edu|
20201642|NCT00432809|Cleveland Clinic|Dr. Philip Schauer|216-444-4794|schauep@ccf.org|
20201643|NCT04052139|Boston Medical Center|Dr. Jeffrey H. Samet|617-414-7288|jsamet@bu.edu|
20201644|NCT00707577|Massachusetts General Hospital|Dr. Anne Thorndike|617-724-4608|athorndike@mgh.harvard.edu|
20201645|NCT00519077|The University of Chicago|Tanguy Lim-Seiwert|773-702-2452|seiwert@uchicago.edu|
20201646|NCT01967225|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20201647|NCT01709331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201648|NCT02643095|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|Fogt.78@osu.edu|
20201649|NCT02305563|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20201650|NCT01207466|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|joseph.rappon@cibavision.com|
20201651|NCT04906707|Emory University|Dr. Nadine Matthie|404-712-8449|nadine.matthie@emory.edu|
20201652|NCT01976806|Beth Israel Deaconess Medical Center|Dr. Kenneth Mukamal|617-754-1401|kmukamal@bidmc.harvard.edu|
20201653|NCT04551014|Stanford University|Shai Friedland, MD|650-723-4000|shaif@stanford.edu|
20201654|NCT01946516|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|karnold@fredhutch.org|
20201655|NCT04429022|University at Buffalo|Dr Sarah Andres, PI|7163230631|seandres@buffalo.edu|
20201656|NCT01530243|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
20201657|NCT01769105|Department of ophthalmology, University of Duesseldorf|Dr. David Finis|+49 211 8117320|David.Finis@med.uni-duesseldorf.de|
20201658|NCT00963807|Washington University in St. Louis|John P Crandall|(314) 747 - 5561|jcrandall@wustl.edu|
20201659|NCT01587950|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201660|NCT00684177|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201661|NCT05818124|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20201662|NCT01380899|Facultad de Medicina, Universidad Autonoma de San Luis Potosi|Ildefonso Rodriguez-Leyva|+52 4442043016|ildefonso.rodriguez@uaslp.mx|
20201663|NCT00783289|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
20201664|NCT03739619|Emory University|Jonathon Cohen, MD|404-778-2214|jonathon.cohen@emory.edu|
20201665|NCT03370757|Duke University School of Nursing|Dr. Debra Brandon|919-681-3813|debra.brandon@duke.edu|
20201666|NCT01035151|University of South Caroina|Jeannette Andrews|803 777 3862|j.andrews@sc.edu|
20201667|NCT00996840|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201668|NCT01075178|Abbott|Global Medical Services|800-633-9110||
20201669|NCT02983604|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20201670|NCT00355264|BioMarin Pharmaceutical Inc.|Joshua Lilienstein|651-523-0310|MEDINFO@bmrn.com|
20201671|NCT00699192|Novartis Pharmaceuticals|Study Director|862 778-8300||
20201672|NCT00605826|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20201673|NCT04433117|University of Kentucky|Dr. Mohanad Al-Sabbagh|859-257-3003|malsa2@email.uky.edu|
20201674|NCT00190775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201675|NCT01794780|Novartis Pharmaceutical|Study Director|862-778-8300||
20201676|NCT04214652|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
20201677|NCT02107755|The Ohio State University Comprehensive Cancer Center|Dr. Jose Bazan|614-688-7040|Jose.Bazan2@osumc.edu|
20201678|NCT03303989|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|2059966086|pjfoster@uabmc.edu|
20201679|NCT01658514|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20201680|NCT01275222|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20201681|NCT01511445|Amedica Corporation|Sonny Bal, MD|(573) 808-4512|SBal@amedica.com|
20201682|NCT02823457|GV Sonny Montgomery VAMC|Mary Jane Burton|6013624471|mary.burton2@va.gov|
20168370|NCT03774719|Washington University in Saint Louis|Gonzalo Matzumura|3143627211|g.matzumuraumemoto@wustl.edu|
20201683|NCT01856114|UT MD Anderson Cancer Center|Dr. David Hui, MD, Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
20201684|NCT00144170|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201685|NCT00332202|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201686|NCT00957853|UT MD Anderson Cancer Center|Dr. Maura Gillison, PHD/Professor, Thoracic-Head & Neck Med Onc|713-792-6363|mgillison@mdanderson.org|
20168371|NCT02576145|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20168372|NCT01227824|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168373|NCT00781885|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
20168374|NCT01755026|west virginia university|michael stitely|304-293-5631|mstitely@hsc.wvu.edu|
20168375|NCT00875589|Daroff-Dell'Osso Ocular Motility Laboratory|Jonathan Jacobs, PhD|216-791-3800|jxj24@case.edu|2947
20168376|NCT02184624|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168377|NCT01700387|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-883-7889|rcady@banyangroupinc.com|
20168378|NCT03417713|Hamilton General Hospital|Dr. Theodore Rapanos|905-521-2100|rapanost@mcmaster.ca|44652
20168379|NCT01295879|Brigham and Women's Hospital|David E. Leaf, M.D., Renal Fellow|617-732-5951|DELEAF@partners.org|
20168380|NCT02730793|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
20168381|NCT02365233|University of Texas Medical Branch|Nicola Abate, MD - Professor and Director of Endocrinology Division|409 772 1922|niabate@utmb.edu|
20168382|NCT00995566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168383|NCT00545129|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168384|NCT03678870|Vanderbilt University Medical Center|Sarah Osmundson, Assistant Professor of Obstetrics and Gynecology|(615) 343-7869‬|sarah.osmundson@vumc.org|
20168385|NCT01454778|Sanford Health|Dr. Patrick Kelly|605-312-7300|Patrick.Kelly@SanfordHealth.org|
20168386|NCT00348881|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20168387|NCT00575146|Dr. Senckenberg Institute of Neurooncology|Dr. Johannes Rieger|+49 69 6301|johannes.rieger@med.uni-frankfurt.de|87711
20168388|NCT03207035|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
20168389|NCT00645450|Manchester VA Medical Center|Dr. Scott P. Orr|603-624-4366|scott.orr@va.gov|6565
20168390|NCT03708393|Seno Medical|Shaan Schaeffer VP of Clinical Operations|610-698-3259|sschaeffer@senomedical.com|
20168391|NCT01981551|National Cancer Institute|Dr. Geraldine H O'Sullivan Coyne|240-781-3371|osullivancoyngh@nci.nih.gov|
20168392|NCT02880956|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20168393|NCT00833664|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20168394|NCT03658876|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
20168395|NCT02616146|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168396|NCT03039621|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20168397|NCT00925938|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20168398|NCT05338671|University of Washington|Avina Paranjpe|206-543-5044|avina@uw.edu|
20168399|NCT01733212|New York Methodist Hospital|Sandip Darji|718/780-3779|darji_sandip2005@yahoo.com|
20168400|NCT03085914|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20168401|NCT01215916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168402|NCT02353143|Menarini Ricerche|Director of Clinical Sciences|003905556809990|acapriati@menarini-ricerche.it|
20168403|NCT01029405|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168404|NCT01534182|Novartis|Study Director|+1 (862) 778-8300||
20168405|NCT01640327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20168406|NCT02312882|Stanford University|Anthony E Oro, M.D., Ph.D.||oro@stanford.edu|
20168407|NCT00641316|University of Alabama at Birmingham|Nicolaas Geurs, DDS,MS|2059344506|ngeurs@uab.edu|
20168408|NCT02025556|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20168409|NCT02486627|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
20168410|NCT00968032|pfm medical ag|Christof Schmeer|+49 6873 9011|christof.schmeer@pfmmedical.com|41
20168411|NCT02189954|DorkuzEU|Anaesthesiology and Reanimation, Dr. Sule Ozbilgin|0905055252901|ozbilginsule@gmail.com|
20168412|NCT02775240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20168413|NCT00247611|Center for Health, Intervention & Prevention|Dr. Jeffrey Fisher, Principal Investigator|(860) 486-4940|jeffrey.fisher@uconn.edu|
20168414|NCT00568386|Alcon Research|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20168415|NCT01251536|UZ Leuven|Prof Dr Eric Van Cutsem|003216344218|eric.vancutsem@uzleuven.be|
20168416|NCT01764919|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
20168417|NCT00796991|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20168418|NCT00171834|Novartis Pharmaceuticals|Study Director|862-778-8300||
20168419|NCT02431260|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20168420|NCT03208985|HRA Pharma|Christine VENARD|+33184139244|c.venard@hra-pharma.com|
20168421|NCT00439738|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
20168422|NCT00392379|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
20168423|NCT01978938|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
20168424|NCT00200343|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20168425|NCT01806662|Rockefeller University|James Krueger|2123278333|gilleap@mail.rockefeller.edu|
20168426|NCT00043550|Adelphi University, The Derner Institute of Advanced Psychological Studies|Jacques P.Barber, PhD, Dean and Professor|516.877.4807|jbarber@adelphi.edu|
20168427|NCT01479426|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jong-Kwan Park, MD|82-63-276-8284|rain@chonbuk.ac.kr|
20201687|NCT00518349|NorwegianDohsa|Dr. Geir Hoff|+4791866762|hofg@online.no|
20201688|NCT05202808|RxSight, Inc.|Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|300
20168428|NCT01143701|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
20168429|NCT00368290|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
20168430|NCT00710762|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168431|NCT01375075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168432|NCT00821509|National Institute for Health and Welfare|Tapani Hovi, Project Leader|+358 400 517299|tapani.hovi@thl.fi|
20168433|NCT03127098|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20168434|NCT03104816|USCalifornia|Eugenia Ayrian|8186363161|eayrian@med.usc.edu|
20168435|NCT01894568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168436|NCT00807573|Memorial Sloan Kettering Cancer Center|Dr. Maria Pietanza, Assistant Attending|+1646-888-4203|PietanzM@mskcc.org|
20168437|NCT01426789|Novartis Pharmaceuticals|Study Director|862-778-8300||
20168438|NCT04054947|White River Junction VA Medical Center|Dr. Brian Shiner|802-295-9363|brian.shiner@va.gov|6070
20168439|NCT00311584|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20168440|NCT03720652|University of North Carolina at Chapel Hill|Philip D. Sloane, MD, MPH|+1 (919) 966-4439|philip_sloane@med.unc.edu|
20168441|NCT00620503|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20168442|NCT03073733|jCyte, Inc.|Robert Beathard|9492430687|rob.beathard@jcyte.com|
20168443|NCT00835731|Planned Parenthood League of Massachusetts|Principal Investigator|6176161600||
20168444|NCT01227629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168445|NCT01588470|UT Health Science, San Antonio|Dr. Muhammad Abdul-Ghani, MD|210-567-6691|abdulghani@uthscsa.edu|
20168446|NCT03976648|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
20168447|NCT00881868|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20168448|NCT01155167|UCSF|Andrew Boyle MD|4153533817|aboyle@medicne.ucsf.edu|
20168449|NCT00960570|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20168450|NCT01451437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168451|NCT01252732|Melinta Therapeutics, Inc.|Karen Fusaro|6098270956|kfusaro@melinta.com|
20168452|NCT02081859|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
20168453|NCT02055365|Icahn School of Medicine at Mount Sinai|Brad Rosenberg, MD, PhD||brad.rosenberg@mssm.edu|
20168454|NCT02248558|UNC Project-China|Weiming Tang|+86-15920567132|weimingtangscience@gmail.com|
20168455|NCT01258998|The University of Texas (UT) MD Anderson Cancer Center|Christopher R Flowers,Chair, Lymphoma-Myeloma|713- 745-6095|crflowers@mdanderson.org|
20168456|NCT01143389|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
20168457|NCT02930980|Medtronic EMEA RCC|Valentina Amori, Medical Writer|+39 06 32814236|valentina.amori@medtronic.com|
20168458|NCT00636701|Atlanta VA Medical Center|Dr. Andrew Butler|404-413-1415|andrewbutler@gsu.edu|
20168459|NCT00002931|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
20168460|NCT02276027|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20168461|NCT03224598|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
20168462|NCT02361476|Rigshospitalet|Mogens Ydemann, MD|+45 35455620|mogens@ydemann.dk|
20168463|NCT02446171|AstraZeneca AB|Ian Wogan|+1 301 398 0670|ClinicalTrialTransparency@astrazeneca.com|
20168464|NCT01142089|Cosmo Technologies Ltd.|Richard Jones|+35318170370|RJones@cosmopharma.com|
20168465|NCT01145638|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
20168466|NCT00789074|Queen Mary University of London|Professor Peter Hajek|+44 207 882 8231|p.hajek@qmul.ac.uk|
20168467|NCT02907892|University of Minnesota|Dr. Rachel Vogel|6513345982|isak0023@umn.edu|
20168468|NCT01974765|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
20168469|NCT01525901|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
20168470|NCT01229462|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20168471|NCT05027971|Boston Scientific|Winnie Chen|952-930-6000|FlexivaPulseRegistry@bsci.com|
20168472|NCT02112045|Washington University School of Medicine|Meagan Jacoby, M.D., Ph.D.|314-454-8304|mjacoby@wustl.edu|
20168473|NCT00627445|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20168474|NCT01238588|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-5500|kzandinejad@partners.org|34769
20168475|NCT00081861|U.T. M.D. Anderson Cancer Center|Barbara Pro, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
20168476|NCT01126671|Boston Children's Hospital|Dr. Sarah Pitts|617-355-3732|sarah.pitts@childrens.harvard.edu|
20168477|NCT01544088|VA Boston Healthcare System|Denise Sloan, Ph.D.|(857) 364-6333|denise.sloan@va.gov|
20168478|NCT05395091|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
20168479|NCT00445588|Adult Brain Tumor Consortium|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
20201689|NCT04091217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201690|NCT00100048|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201691|NCT03878485|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
20201692|NCT01822561|Tufts Medical Center|Andre Witkin|6176367950|awitkin@tuftsmedicalcenter.org|
20168480|NCT01509053|Otsuka Pharmaceutical Development & Commercialization, Inc.|Medical Affairs|800-562-3974||
20168481|NCT03192358|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
20201693|NCT02747004|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20168482|NCT01915303|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20168483|NCT00637780|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168484|NCT00834080|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
20168485|NCT03467685|UPMC Dermatology|Dr. Rashek Kazi|5167105208|kazir@upmc.edu|
20168486|NCT03396952|University of California, San Francisco|Dr. Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
20168487|NCT00796523|University of Toledo|Jonna M. McRury, M.D.|419-389-1118|jmcrury@aol.com|
20168488|NCT02252744|Western University of Health Sciences|Jasmine Wong Yumori OD FAAO|(909) 706-3886|jyumori@westernu.edu|
20168489|NCT00321646|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
20168490|NCT00400803|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
20168491|NCT01284491|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
20168492|NCT02694757|11 Health|Michael Seres|+16572660570|michael@11health.com|
20168493|NCT00095147|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20168494|NCT02395302|Tactile Medical|Clinical Research Manager|(612)355-5123|mbroich@tactilemedical.com|
20168495|NCT02650921|Galderma Research & Development, LLC|Assoc Director of Clinical Operations|817-961-5000|courtney.maguire@galderma.com|
20168496|NCT00783302|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
20168497|NCT00160667|Cares|UCB|+1844599|UCBCares@ucb.com|2273
20168498|NCT00300430|Abbott|Medical Information Specialist|800-633-9110||
20168499|NCT01917656|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20168500|NCT02285062|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20168501|NCT02015221|Tactile Medical|Director of Clinical Research|6123555121|shoy@tactilemedical.com|
20168502|NCT01306929|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
20168503|NCT01905423|Washington University in St Louis Medical School|Peter Fischer|+1 (314) 747-5198|pufischer@wustl.edu|
20168504|NCT03709576|Penn State Cancer Institute|Michelle Stojanovic|7175310003|mstojanovic1@pennstatehealth.psu.edu|287412
20168505|NCT00270842|James A. Haley VA|Dr. Patricia A. Quigley|8135583912|patricia.quigley@va.gov|
20168506|NCT03041129|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
20168507|NCT03608150|Luminopia, Inc.|VP of Clinical Development|9788067080|endri@luminopia.com|
20168508|NCT00890045|Houston Methodist Hospital|George M. Nassar M.D.|713-790-1963|georgemnassar@gmail.com|
20168509|NCT00510653|The University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD / Professor||CR_Study_Registration@mdanderson.org|
20168510|NCT04355728|University of Miami|Camillo Ricordi|305-243-6913|ricordi@miami.edu|
20168511|NCT00483756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168512|NCT01947855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168513|NCT00436501|UT MD Anderson Cancer Center, Office of Multicenter Clinical Research|Robert Coleman, MD / Professor||RColeman@mdanderson.org|
20168514|NCT00495040|UT MD Anderson Cancer Center|Chang,Joe Y.,M.D. / Radiation Oncology|713-563-2337|jychang@mdanderson.org|
20168515|NCT01872325|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
20168516|NCT01390064|University of Arkansas for Medical Sciences|Dr. Laura Hutchins|5016868274|hutchinslauraf@uams.edu|
20168517|NCT00621621|Medtronic- AF Solutions|Adam Cline, MD, MSc.- Sr. Clinical Research Specialist|763-526-9601|adam.cline@medtronic.com|
20168518|NCT04157673|University at Buffalo|Leonard H. Epstein, PhD|7168293400|lhenet@buffalo.edu|
20168519|NCT02452931|Tolmar, Inc.|Vice President of Clinical Development|970-212-4500|info@tolmar.com|
20168520|NCT03011892|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20168521|NCT02282293|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
20168522|NCT00562315|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
20168523|NCT01059929|University of Chicago|John Kress|773-702-6790|jkress@medicine.bsd.uchicago.edu|
20168524|NCT03381729|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
20168525|NCT01264601|University of Michigan|Matthew Greenhawt, MD, MBA|734/936-5634|mgreenha@umich.edu|
20168526|NCT02000908|University of Minnesota|Peter Argenta MD|612-626-3111|argenta@umn.edu|
20168527|NCT00384111|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
20168528|NCT00906971|Universidade Federal de Pernambuco|Carlos André Gomes Silva|+55 83 9913-4949|carlosandrejpa@hotmail.com|
20168529|NCT01551420|Providence VA Medical Center|Linda Resnik, Research Career Scientist|401-273-7100|Linda.Resnik@va.gov|2368
20168530|NCT00169442|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168531|NCT00223236|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
20168532|NCT04463069|Hong Kong Baptist University|Dr. Yang Gao|+852 3411 3082|gaoyang@hkbu.edu.hk|
20168533|NCT00678743|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
20168534|NCT00336583|Asan Medical Center|Cheolwon Suh|82 2 3010 3209|csuh@amc.seoul.kr|
20168535|NCT04966910|University of Washington|Michael Pullmann|206-685-0408|pullmann@uw.edu|
20168536|NCT01845103|CryoLife, Inc.|Scott Capps, MS/ Vice President, Clinical Research|800-438-8285|clinicaltrialregistration@cryolife.com|
20168537|NCT00830791|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|(800) 672-6372|ClinicalTrialsDisclosure@merck.com|
20168538|NCT00456807|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168539|NCT03328182|Hollister Incorporated|Director Global Clinical Affairs|8476802837|stacy.haddad@hollister.com|
20168540|NCT04531462|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168541|NCT00504582|UT MD Anderson Cancer Center|Dr. Paul F Mansfield, Professor, Surgical Oncology|(713) 794-5499|pmansfie@mdanderson.org|
20168542|NCT04175509|Aultman Hospital|Dr. Michaela Beynon|2488218826|michaelabeynon@gmail.com|
20168543|NCT00348933|University of California and Rady Children's Hospital, San Diego|Lynne M. Bird, MD|858-966-5840|Lbird@rchsd.org|
20168544|NCT01264081|National Cancer Institute|Dr. Udo Rudloff'|301-496-3098|rudloff@nih.gov|
20168545|NCT01489111|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20168546|NCT02716896|University of Texas Health San Antonio|Dharam Kaushik|210-567-5676|kaushik@uthscsa.edu|
20168547|NCT01727700|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20168548|NCT01546402|Post Graduate Institute of Medical Education and Research|Aniruddha Agarwal|+911722756111|aniruddha9@gmail.com|
20168549|NCT01631656|WakeForest University Health Sciences|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
20168550|NCT01757691|Novartis|Study Director|862-778-8300||
20168551|NCT02641483|VAORD|Dennis Bourbeau|2167913800|dennis.bourbeau@va.gov|
20168552|NCT02484859|Recep Tayyip Erdoğan Üniversitesi|Dr. Başar Erdivanlı|04642130491|berdivanli@gmail.com|2128
20168553|NCT02054481|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168554|NCT02320903|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|grants@ebpi.org|
20168555|NCT02564432|Department of Veterans Affairs|James Peter Beck|801-231-6309|james.beck@hsc.utah.edu|
20168556|NCT00883688|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Multicenter coordinating for Collaborative Ependymoma Research Network Study (CERN)||CR_Study_Registration@mdanderson.org|
20168557|NCT00464490|University of California San Francisco|Julin F. Tang, MD, MS|415-206-5274|tangj@anesthesia.ucsf.edu|
20168558|NCT03188042|NYU Langone Health|Joel Schuman, MD, FACS|929-455-5030|Joel.Schuman@nyu.edu|
20168559|NCT01634256|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
20168560|NCT01440543|Digestive Diseases Center, Vitkovice Hospital, Ostrava, Czech Republic|Premysl Falt MD|+420602689561|faltprem@centrum.cz|
20168561|NCT03860935|Eidos Therapeutics, Inc., a BridgeBio Company|VP, Clinical Operations|415-887-1471|info@bridgebio.com|
20168562|NCT03086967|Atrium Health|Dr. Susan Bliss|(704)562-4860|Susan.Bliss@atriumhealth.org|
20168563|NCT04461600|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
20168564|NCT01020006|Pharmacyclics|Dr. Laurence Elias|855-427-8846|pharmacyclics@medcomsol.com|
20168565|NCT04575597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168566|NCT01209832|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168567|NCT01268579|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
20168568|NCT02692651|University of Michigan|Krishna Rao|734 615-9730|krirao@med.umich.edu|
20168569|NCT02480712|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20168570|NCT01535976|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
20168571|NCT04964193|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
20168572|NCT01037192|Fraser Health Authority|Anna Yuen, BSc. Pharm|604-520-4005|anna.yuen@fraserhealth.ca|
20168573|NCT01087788|Cares|UCB|+1877 822||9493
20168574|NCT04604132|Basilea Pharmaceutica International Ltd, Allschwil|Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
20168575|NCT00952380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168576|NCT03235180|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
20168577|NCT01779219|Wroclaw University Hospital, Department of Neurosurgery|Dr. Marcin Czyz|+48 734-34-00|mt.czyz@gmail.com|
20168578|NCT00534313|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20168579|NCT00927940|Medtronic Japan Co.,Ltd|Hiroko Okubo|+81-3-6430-7017|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
20168580|NCT03007888|Impax Laboratories, LLC|Pamela Fitzpatrick, Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
20168581|NCT03471624|Stanford University|Mindie H Nguyen, Professor of Medicine, GI & Hepatology, Liver Transplant|650-498-6084|mindiehn@stanford.edu|
20168582|NCT00827931|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168583|NCT01870076|Shriners Hosptials for Children|Laura Fowler/Clinical Research Coordinator|513-872-6000|lfowler@shrinenet.org|6249
20168584|NCT00492063|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20168585|NCT01402427|State Health Center, Hungary|Istvan Hizoh, MD, PhD / Senior Consultant|+36 1 4651800|ihizoh@web.de|71773
20168586|NCT00608569|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20168587|NCT04456153|UT Southwestern Medical Center|Dr. Mamta K. Jain|2140648-9914|mamta.jain@utsouthwestern.edu|
20168588|NCT02312687|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
20168589|NCT00878436|NYU Langone Medical Center|Fraustina Hsu|646 754 712|fraustina.hsu@nyumc.org|
20168590|NCT04545944|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
20168591|NCT00123643|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20168592|NCT02103153|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20168593|NCT01634191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20168594|NCT03645434|AstraZeneca AB|AstraZeneca AB|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
20168595|NCT00167778|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
20168596|NCT02654717|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759900|srinivassidgiddi@drreddys.com|
20168597|NCT01556347|Tim Icenogle MD PLLC|Timothy B Icenogle MD|509-220-1900|timicenogle@comcast.net|
20187901|NCT05305560|MedinCell|Head of Clinical Development|6 40 38 93 83|caroline.denot@medincell.com|0033
20168598|NCT02531971|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
20168599|NCT02013141|Cumberland Pharmaceuticals Inc|Clinical Scientist|615-255-0068|bgibson@cumberlandpharma.com|229
20168600|NCT01475071|Galderma|Cyril Moulin|+33 4 92 38 30 14|cyril.moulin@galderma.com|
20168601|NCT02713256|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
20168602|NCT02230527|Cleveland Clinic|Joseph Campbell, MD|216-444-9836|campbej10@ccf.org|
20168603|NCT01752036|SKCCC|Terrence Caldwell|443-287-1889|caldwte@jhmi.edu|
20168604|NCT01011478|NSABP Foundation|Director, Department of Regulatory Affairs|412-339-5300||
20168605|NCT02278471|UT southwestern|Dr. Thomas J Wang|6159361717|thomas.wang@UTsouthwestern.edu|
20168606|NCT00640835|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
20168607|NCT01437995|Johns Hopkins University|Alexis Rea|4432878496|area5@jhu.edu|
20168608|NCT04618770|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
20168609|NCT04456673|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20168610|NCT04391049|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20168611|NCT03874429|Laboratoires Thea|Corentin Le Camus|0680382020|corentin.lecamus@theapharma.com|+33
20168612|NCT00775203|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20168613|NCT00704522|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20168614|NCT00636220|Chembio Diagnostic Systems, Inc.|Javan Esfandiari|(631) 924-1135|jesfandiari@chembio.com|112
20168615|NCT04896229|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
20168616|NCT04395001|Wake Forest School of Medicine|Dennis C. Ang|3367058701|dang@wakehealth.edu|
20168617|NCT04418661|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20168618|NCT01203644|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20168619|NCT03442868|Texas Woman's University|Hui-Ting Goh|2146897723|HGoh1@twu.edu|
20168620|NCT00329901|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20168621|NCT00992589|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
20168622|NCT00045942|Novartis|Study Director|862-778-8300||
20168623|NCT01101308|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
20168624|NCT02984943|David Grant Medical Center, Travis Air Force Base|Dr. Michelle Sit|707-423-3875|michelle.t.sit.mil@mail.mil|
20168625|NCT02280122|JWGUniversity|Prof. Dr. Peter Eickholz|+49696301|eickholz@med.uni-frankfurt.de|5642
20168626|NCT00880464|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
20168627|NCT00711516|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
20168628|NCT02921061|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
20168629|NCT01431209|University of Nebraska Medical Center|Dr. Julie M. Vose|402-559-3848|jmvose@unmc.edu|
20168630|NCT01895361|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20168631|NCT01887743|Children's Mercy Kansas City|Valentina Shakhnovich, MD|816-302-3068|vshakhnovich@cmh.edu|
20168632|NCT02324543|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
20168633|NCT05463198|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
20168634|NCT01860846|AbbVie|Global Medical Services|800-633-9110||
20168635|NCT01856764|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20201694|NCT05087030|Gedeon Richter Plc.|Medical Information Scientific Service|+36 1 505 70 32|medinfo@richter.hu|
20201695|NCT02722044|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
20201696|NCT03658954|Yale University School of Medicine|Lisa Fucito, PhD|(203) 200-1470|lisa.fucito@yale.edu|
20201697|NCT00818259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201698|NCT03372941|Washington University School of Medicine|Stephen Liang|3017470750|syliang@wustl.edu|
20201699|NCT00741819|United Therpaeutics Corporation|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagment@unither.com|
20201700|NCT02863198|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
20201701|NCT00609622|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201702|NCT00686543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20201703|NCT00825370|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|7189207464|achang@montefiore.org|
20201704|NCT01237951|UT MD Anderson Cancer Center|Dr. Nieto, Yago, M.D./Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
20201705|NCT00752986|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20168636|NCT02239120|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168637|NCT00466687|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
20168638|NCT00046891|Mayo Clinic|Debra L. Barton, R.N., Ph.D.|507-266-6247|barton.debra@mayo.edu|
20168639|NCT01367080|Dong Wha Pharm. Co. Ltd.|Cheol-Hee Lim. Clinical Research Manager (CRM)|+82-2-2021-9300|cheolhee.lim@dong-wha.co.kr|551
20168640|NCT00853996|University of Kansas Mecical Center|Bruce F. Kimler Ph.D|913-588-4523|bkimler@kumc.edu|
20168641|NCT02536404|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
20168642|NCT02158364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20168643|NCT01944839|Ophthotech|Denise Teuber||denise.teuber@ophthotech.com|
20168644|NCT00609362|University of Aarhus|Torben Harsløf, MD|+4589497681|torbhars@rm.dk|
20168645|NCT01911910|Queen Mary University London/ Barts Health NHS Trsut|Dr Mohammed Khanji|020 7363 8079|m.khanji@qmul.ac.uk|
20168646|NCT01239732|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201706|NCT00682630|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
20201707|NCT03481270|Stanford University|Marcella Alsan, Associate Professor of Medicine|(650) 721-1352|malsan@stanford.edu|
20201708|NCT02226965|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201709|NCT00924703|BioMarin Pharmaceutical Inc.|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
20201710|NCT00666562|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
20201711|NCT01523873|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
20201712|NCT02570672|UT Health San Antonio|Sara Espinoza|210 617 5197|Sara.Espinoza@cshs.org|
20201713|NCT00275561|Mayo Clinic|Jeffrey A. Alexander, MD, Assistant Professor of Medicine|507-538-2403|alexander.jeffrey14@mayo.edu|
20201714|NCT00407355|Wilmer Eye Institute|Peter Campocahiro|: 410-955-5106|pcampo@jhmi.edu|
20201715|NCT02093702|Barrie and Community Family Health Team|Dr. Andrew Wozniak|(705) 728-2618|andrew.wozniak@barriefht.ca|
20201716|NCT02108457|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
20201717|NCT03551028|University of Virginia|Emma Mitchell|4342433962|emm6z@virginia.edu|
20201718|NCT00377962|Novartis Pharmaceuticals|Study Director|862 778-8300||
20201719|NCT02677779|AOU Careggi|Dr. Matteo Monami, Director Diabetic Foot Unit|00390557946563|matteo.monami@unifi.it|
20201720|NCT02432807|Eyevance Pharmaceuticals|Mark Jasek|817-677-6127|mjasek@eyevance.com|
20201721|NCT02966314|University of Wisconsin - Madison|Ravi Viswanathan|(608) 263-1081|rviswanathan@medicine.wisc.edu|
20201722|NCT02081963|Department of Respiratory Medicine, Qilu Hospital of Shandong University|Dr.Yu Li|13791122770|qlliyu@163.com|
20201723|NCT00828464|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201724|NCT00502840|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201725|NCT02197377|DorkuzEU|Anaesthesiology and Reanimation|0905055252901|ozbilginsule@gmail.com|
20201726|NCT01974323|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20201727|NCT02351115|Engage Therapeutics, Inc|Chief Medical Officer||studydirector@engagetherapeutics.com|
20201728|NCT01241786|Hackensack University Medical Center|Dr. Anthony Mato|551-996-2000|AMato@hackensackumc.org|
20201729|NCT03431012|KCL|Dr D D'Antoni||donatella.d'antoni@kcl.ac.uk|
20201730|NCT05340504|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
20201731|NCT03068715|Stanford University|Dr. Nolan Williams|(650)800-6920|nolanw@stanford.edu|
20201732|NCT00503399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201733|NCT03075839|Yale University|Krysten Bold|203-974-7603|Krysten.bold@yale.edu|
20201734|NCT02469246|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20156571|NCT00775658|Vanderbilt Medical Center|John Fahrenholz, M.D.|615-936-2727|john.m.fahrenholz@vanderbilt.edu|
20156572|NCT00488293|Department of Veterans Affairs|John D. Whited, MD, MHS|919-286-6926|john.whited@va.gov|
20156573|NCT03134209|NYU Langone Health|Ran Schwarzkopf, MD|646-356-9405|Ran.Schwarzkopf@nyulangone.org|
20156574|NCT00633126|Cerexa, Inc.|David Friedland, MD|510-285-9200|clinicaltrials@cerexa.com|
20156575|NCT00793520|Forest Research Institute|Allan Spera|201-427-8399|allan.spera@frx.com|
20156576|NCT01882816|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
20156577|NCT02541591|ZOL Genk|Koen Ameloot|0485685969|koen.ameloot@zol.be|
20156578|NCT00567502|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20156579|NCT01638507|Medtronic, Coronary Clinical Affairs|Lisa Bousquette, Clinical Research Director|(707) 591-2967|lisa.r.bousquette@medtronic.com|
20156580|NCT06034340|Emory University|Dr. Eric Felner -Professor of Pediatrics|404-785-0935|efelner@emory.edu|
20156581|NCT00863304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156582|NCT02327169|Takeda|Takeda Study Registration Call Center|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
20156583|NCT04047355|New York State Institute for Basic Research|J. Helen Yoo, Ph.D.|718-494-5295|jhelen.yoo@opwdd.ny.gov|
20156584|NCT00023595|Duke University Health System|Dr. Eric Velazquez|919-668-8700|velaz002@mc.duke.edu|
20156585|NCT01309230|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
20156586|NCT05468918|Sonova USCS|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20156587|NCT00427700|Hospital de Clínicas de Porto Alege|Dr. Ricardo Francalacci Savaris|51 33598405|rsavaris@hcpa.edu.br|
20156588|NCT00356187|Denver Health and Hospital Authority|Elizabeth Kingsley, Senior Grants Analyst|3036027061|elizabeth.kingsley@dhha.org|
20156589|NCT01362790|National Cancer Institute|Dr. Raffit Hassan|301-451-8742|raffit_hassan@nih.gov|
20156590|NCT03038087|SENSE Diagnostics, Inc.|Joe Korfhagen|844-373-6730|jkorfhagen@senseneuro.com|
20156591|NCT01969214|Analyze & Realize|Felix Alt|+49 30 4000 8194|FAlt@a-r.com|
20156592|NCT00759395|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20156593|NCT01435356|EAU Research Foundation|Wim P.J. Witjes, MD, PhD Scientific and Clinical Research Director|+31 26 389 0677|w.witjes@uroweb.org|
20156594|NCT03485157|MIMEDX|Chief Medical Officer|(770) 651-9100|CTInquiries@mimedx.com|
20156595|NCT01849276|Northwestern University|Dr. Jessica Altman|312-503-1761|J-altman@northwestern.edu|
20156596|NCT00539500|University of Texas MD Anderson Cancer Center|Laura L. Worth, MD / Professor, Pediatrics|713-792-6620|CR_Study_Registration@mdanderson.org|
20156597|NCT02011542|University of Utah, Dept. of Gastroenterology|Dr. Ashok Tuteja|801-581-5679|ashok.tuteja@hsc.utah.edu|
20156598|NCT01299961|UCLA|Veena K. Ranganath, MD, MS Assistant Clinical Professor|310-825-3061|vranganath@mednet.ucla.edu|
20156599|NCT02904096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20201735|NCT00885079|Otsuka Pharmaceutical Co., Ltd.|Mr. Kyoji Imaoka|-81-6-6943-7722||
20201736|NCT04325503|Unversity of Michigan|Nicolaas Bohnen|734-998-8400|nbohnen@umich.edu|
20201737|NCT02337387|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168647|NCT01381562|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201738|NCT02853760|University of Innsbruck, Department of Sport Science|Martin Niedermeier||martin.niedermeier@uibk.ac.at|
20168648|NCT04876690|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20168649|NCT02971033|Edward Hines Jr. Veterans Administration Hospital|Susan L. Uprichard|(336) 402-1086|susan.uprichard@va.gov|
20168650|NCT00308581|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20168651|NCT03493932|Emory University|Edjah K. Nduom, MD, FAANS|404-778-5770|edjah.k.nduom@emory.edu|
20168652|NCT01892384|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168653|NCT01254942|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
20168654|NCT03985878|Sarepta Therapeutics, Inc.|Medical Director|1-888-SAREPTA (1-888-727-3782)|SareptAlly@sarepta.com|
20168655|NCT00599131|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
20168656|NCT01514370|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20168657|NCT01159431|UCLA|Dr. Christopher DeGiorgio|310-206-3753|cmd@mednet.ucla.edu|
20168658|NCT03068091|University of Missouri|Talissa Altes|573 882 1026|ALTEST@HEALTH.MISSOURI.EDU|
20168659|NCT01439815|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
20168660|NCT00129311|Yale Unviersity|Dr. Andrea Weinberger|203-974-7598|andrea.weinberger@yale.edu|
20168661|NCT00604214|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168662|NCT00534599|AstraZeneca|Gerard Lynch||AZtrial_results_posting@astrazeneca.com|
20168663|NCT01543581|Loma Linda University Health, Department of Dermatology|Dr. Abel Torres, PI|(909) 558-2055|atorres@llu.edu|
20168664|NCT00853970|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20168665|NCT03050775|Mayo Clinic|Jean M. Guyer, DNP|507-255-5716|guyer.jean@mayo.edu|
20168666|NCT03603509|Mayo Clinic|Richard Kennedy, PhD|507-284-0708|Kennedy.Rick@mayo.edu|
20168667|NCT02197455|Yale Univ School of Medicine|Brett King, MD|2037854092|brett.king@yale.edu|
20168668|NCT00773383|Hoffman-LaRoche|Medical Communications|800-821-8590||
20168669|NCT03384693|University of California, San Francisco|Dr. Christine Higham|415-476-2188|christine.higham@ucsf.edu|
20168670|NCT03386253|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20168671|NCT03493815|The Pennsylvania State Univ College of Medicine, The Milton S. Hershey Medical Center|Stephanie Estes, M.D.|717-531-8478|sestes@pennstatehealth.psu.edu|
20168672|NCT02415842|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20168673|NCT03811093|Vidantis Technologies, Inc|Thomas A. Namynanik - Consultant to invisa-RED Technologies|404 915-5938|andyn997@vidantis.com|
20168674|NCT00178503|University of Texas Medical School at Houston|Deborah A. Pearson, Ph.D.|713-486-2588|Deborah.A.Pearson@uth.tmc.edu|
20168675|NCT01095094|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
20168676|NCT00874614|Progenics Pharmaceuticals, Inc|Jessica D Jensen, MPH|646-975-2513|jjensen@progenics.com|
20168677|NCT03699475|Bellicum|Contact for Clinical Trial Information|(832) 384-1100|clinicaltrials@bellicum.com|
20168678|NCT00137839|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
20168679|NCT00528970|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
20168680|NCT00266851|Wisconsin Resaerch & Education Network|Dr. David Hahn|608-234-3212|dlhahn@wisc.edu|
20168681|NCT03616223|Frequency Therapeutics|Carl LeBel, PhD, CDO|781-315-4600|clinicaltrialsinformation@frequencytx.com|
20168682|NCT03739242|A. Menarini Industrie Farmaceutiche Riunite SrL|Dr Paolo Fabrizzi Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
20168683|NCT01122394|VA New York Harbor Healthcare System|Jennifer Friedberg, Ph.D.|212-951-3314|jennifer.friedberg@va.gov|
20168684|NCT00039871|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20168685|NCT02446743|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168686|NCT03361176|Maryland Laser Skin and Vein|Robert A. Weiss, MD|4106662839|cmyers@mdlsv.com|
20168687|NCT02478398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168688|NCT00923364|National Cancer Institute|Dr. Dennis Hickstein|301-594-1718|hicksted@mail.nih.gov|
20168689|NCT00357032|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20168690|NCT01661088|University of Michigan Rogel Cancer Center|Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
20168691|NCT03023046|University of Washington|Ryan Cassaday, MD|2066061202|cassaday@seattlecca.org|
20168692|NCT01205581|St. Jude Children's Research Hospital|Jon McCullers, MD|866-278-5833|info@stjude.org|
20168693|NCT00635024|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
20168694|NCT00713310|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
20168695|NCT05508074|InFlectis Bioscience|Beatrice Lejeune|+33 668919060|beatricelejeune@inflectisbioscience.com|
20168696|NCT02142387|Laboratory of Emergency Medical Services, Seoul National University Hospital Biomedical Research Institute|Dr. Gwan Jin Park|82-10-7477-3293|pkj83531@naver.com|
20168697|NCT03490981|VA Center for Integrated Healthcare|Dr. Gregory P. Beehler, Associate Director of Research|716-862-7934|gregory.beehler@va.gov|
20201739|NCT01642212|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20201740|NCT00981526|UMass Medical School|Dr. Xiaoduo Fan|508-856-3881|xiaoduo.fan@umassmed.edu|
20201741|NCT01243268|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201742|NCT01564784|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168698|NCT01982968|University of California, San Francisco|Harold Collard, MD|415 4761000|Harold.Collard@ucsf.edu|
20201743|NCT02272790|AstraZeneca|Pejvack Motlagh, MD|+44 (0) 7384 799 850|pejvack.motlagh@astrazeneca.com|
20201744|NCT03871491|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
20168699|NCT00420641|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168700|NCT03723603|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
20168701|NCT01653028|Memorial Sloan Kettering Cancer Center|Mark Andrew Dickson M.D.|6468884164|dicksonm@mskcc.org|
20168702|NCT03459690|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-634- 2721|bsubrama@bidmc.harvard.edu|
20168703|NCT02586506|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168704|NCT00654147|University of Miami School of Medicine|Director AIDS Clinical Research Unit|305-243-3838|mfischl@med.miami.edu|
20168705|NCT02538783|UPenn|Catherine Reale|215-746-4009|catherine.reale@uphs.upenn.edu|
20168706|NCT01607203|AZ JAN PALFIJN|dr.Decleer Wim|+32 9 325 92 20|wim.decleer@janpalfijngent.be|092248851
20168707|NCT04381988|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@MSKCC.ORG|
20168708|NCT05093790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20168709|NCT00924170|National Cancer Institute|Dr. Robert Kreitman|301-496-6947|Robert_Kreitman@nih.gov|
20168710|NCT04098224|ART MEDICAL|Mrs. Shirly Steinlauf|972-54-5804242|Shirly@artmedical.com|
20168711|NCT00787904|Emory University|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
20168712|NCT01878149|Baxano Surgical®|Sr. Director of Clinical Affairs|919.899.9760|teresa.schroeder@baxsurg.com|
20168713|NCT02548728|University of North Carolina at Chapel Hill|Cort Pedersen, MD|919-923-3284|cort_pedersen@med.unc.edu|
20168714|NCT04672252|NYU Langone Health|Michael J. Alaia, MD|(646) 501-7223|Michael.Alaia@nyulangone.org|
20168715|NCT06054269|CDC|Perrine Marcenac|6782830242|pmarcenac@cdc.gov|
20168716|NCT01587898|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168717|NCT00502203|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD / Professor||CR_Study_Registration@mdanderson.org|
20168718|NCT02055638|Azevan Pharmaceuticals, Inc.|Dr. Neal Simon, CEO|(610) 419-1057|ngsimon@azevan.com|
20168719|NCT01903252|Tillotts Pharma AG|Dr. Robert Hofmann, MD PhD|+4161 935 27 14|robert.hofmann@tillotts.com|
20168720|NCT03735238|Baylor College of Medicine|Jasvinder Singh, MD, MPH; Senior Faculty and Chief of Immunology, Allergy, and Rheumatology|713.798.1365|jasvinder.md@gmail.com|
20168721|NCT02660138|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
20168722|NCT00899353|Marshall University Joan C. Edwards School of Medicine|Dr. W. Elaine Hardman|304-696-3721|hardmanw@marshall.edu|
20168723|NCT01247298|University of Alabama at Birmingham (UAB)|Rojymon Jacob, MD|205-975-9704|rjacob@uabmc.edu|
20168724|NCT04475198|SiteOne Therapeutics|John Mulcahy|+1 (650) 392-0419|john.mulcahy@site1therapeutics.com|
20168725|NCT02489422|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
20168726|NCT03400956|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20168727|NCT02004288|Sestre milosrdnice University Hospital Center Vinogradska 29, Zagreb, Croatia|Orjena Žaja, MD MSc PhD primarius Ass Prof Pediatrics, Pediatric gastroenterologist|P:+38513787342 M:+3859937872|Orjena Žaja <orjenazf@yahoo.com>|
20168728|NCT03044574|Pirogov Russian National Researching Medical University|Dr. Kirill Lobastov, Associated professor at the Department of General Surgery and Radiology|+7-985-211-63-31|lobastov_kv@hotmail.com|
20168729|NCT00592774|Eisai Call Center|Eisai Inc.|888-422-4743||
20168730|NCT03445156|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
20168731|NCT01924429|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Newcorn|212-659-8775|Jeffrey.newcorn@mssm.edu|
20168732|NCT01453387|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20168733|NCT01606878|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20168734|NCT01484288|CVRx|Vice President, Global Clinical Research|763-416-2876|egalle@cvrx.com|
20168735|NCT05486416|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
20168736|NCT02076425|Early Emotional Development Program at Washington University School of Medicine|Dr. Joan Luby|3142862730|lubyj@wustl.edu|
20168737|NCT00156936|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
20168738|NCT02491359|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
20168739|NCT04085367|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
20168740|NCT04133064|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
20168741|NCT03274999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20168742|NCT00130442|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
20168743|NCT00814333|University of Kansas Medical Center|Kevin Sykes, PhD|913-588-7154|ksykes@kumc.edu|
20168744|NCT01527357|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20168745|NCT00910247|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
20168746|NCT02404532|Otsuka Pharmaceutical Development & Commercialization, Inc|Tim Peters-Strickland|800 562-3974||
20168747|NCT02519855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168748|NCT00003830|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20168749|NCT05347147|Executive Director Invex Australia|Tom Duthy|+61 (08) 6382 0137|tduthy@invextherapeutics.com|
20168750|NCT03565367|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
20168751|NCT02057042|VA Center for Clinical Managment Research|Paul Pfeiffer|7348453649|paul.pfeiffer@va.gov|
20201745|NCT04996797|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20201746|NCT02793544|National Marrow Donor Program/BeTheMatch|Steve Spellman|763-406-8334|sspellma@nmdp.org|
20201747|NCT04174599|Evivebiotech|Catrina Wang|021-61760866|catrina.wang@evivebiotech.com|
20168752|NCT01555957|University of Rochester|Sanjiv Amin|585-273-2696|sanjiv_amin@urmc.rochester.edu|
20203015|NCT01157169|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20168753|NCT01397825|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20168754|NCT01931670|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20168755|NCT03042702|Innovation Pharmaceuticals|Arthur P. Bertolino MD, PhD, MBA|9789214125|abertolino@IPharmInc.com|
20203016|NCT00663858|Aeterna Zentaris|Herbert Sindermann|+49 69 42602 3429|HSindermann@aezsinc.com|
20168756|NCT00976508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168757|NCT04352127|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
20168758|NCT01992159|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20168759|NCT01198158|Georgetown University Hospital|George Philips MBBS, MD, MPH, FACP|202-444-2198|George.K.Philips@gunet.georgetown.edu|
20168760|NCT01236118|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168761|NCT04535167|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168762|NCT00075270|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168763|NCT02160002|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
20168764|NCT03390842|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
20168765|NCT05028361|Duke Human Vaccine Institute|Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
20168766|NCT01993836|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
20168767|NCT00686634|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
20168768|NCT00779259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
20168769|NCT00799773|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
20168770|NCT03312751|Swedish Orphan Biovitrum AG|Radmila Kanceva, MD, Medicine Development Lead|+41 793048899|Radmila.Kanceva@sobi.com|
20168771|NCT01178827|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20168772|NCT01107379|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
20168773|NCT04559529|Vanderbilt University Medical Center|Stephan Heckers, MD; Principal Investigator|6153222665|stephan.heckers@vumc.org|
20168774|NCT00579436|University of Kentucky|Phillip Kern|859 323 4933|pake2222@uky.edu|
20168775|NCT01203852|University of Florida|Dr. Julie A. Johnson|(352) 273-6309|johnson@cop.ufl.edu|
20168776|NCT02582684|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20168777|NCT05478681|The University of Texas Health Science Center at Houston|Kendra M Anderson, PhD|713-486-0513|Kendra.M.Anderson@uth.tmc.edu|
20168778|NCT01431300|Duke University Medical Center|Charles Kim|919-684-7284|charles.kim@duke.edu|
20168779|NCT01738477|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168780|NCT01302834|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20168781|NCT00899392|Children's Hospital of Philadelphia/OHSU/Doernbecher Children's Hospital|Joel A Friedlander|503-494-1078|friedlan@ohsu.edu|
20168782|NCT02437110|National Institutes of Health|Dr. Avi Nath|301-496-1561|natha@mail.nih.gov|
20168783|NCT01431638|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20168784|NCT01261780|University of Wisconsin Carbone Cancer Center|Toby Campbell|608-263-3962|tcc@medicine.wisc.edu|
20168785|NCT03562767|Emory University|Dr. Ambar Kulshreshtha|(404) 686-2410|akulshr@emory.edu|
20168786|NCT02048241|New York State Psychiatric Institute|Stephen J. Donovan, MD|646-774-8078|sd45@columbia.edu|
20168787|NCT01138917|AVITA Medical|Director of Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
20168788|NCT02819908|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
20168789|NCT04658940|Acutus Medical|Karen Stephens, Director Clinical Affairs|442-232-6080|karen.stephens@acutus.com|
20168790|NCT02589600|University of Pittsburgh|Susan Greenspan|4126922477|greenspn@pitt.edu|
20168791|NCT01816451|University of Trás-os-Montes and Alto Douro|Ph.D. Laura Castro de Garay|+55 21 22275084|laura@virtualsoftware.com.br|
20168792|NCT01700439|Edwards Lifesciences, LLC|Jennifer Currin, Senior VP of Medical and Clinical Affairs, Surgical Structural Heart|949-250-2500|Jennifer_Currin@edwards.com|
20168793|NCT00714571|VA Ann Arbor Healthcare System|Dr. Benjamin M. Hampstead|734-763-9259|Benjamin.Hampstead@va.gov|
20168794|NCT01829243|Duke University Medical Center|Ashwin A. Patkar, MD|919-668-3626|ashwin.patkar@duke.edu|
20168795|NCT04850781|Johns Hopkins University|Kali Thomas|(410) 955-4766|kali.thomas@jhu.edu|
20168796|NCT03758755|Inova Health System|Dr. Edward Chang|571-472-0464|edward.chang@inova.org|
20168797|NCT00053898|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
20168798|NCT00266877|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20168799|NCT03848871|Skin Sciences, PLLC|Maureen McAllister|5024519000|mmdermresearch@yahoo.com|
20168800|NCT03705273|Vanderbilt University School of Medicine|Donald H. Arnold, MD, MPH|16155790516|don.arnold@vumc.org|
20168801|NCT00830076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20168802|NCT01077375|Forest Research Institute|Allan Spera, Director, Clinical Development|(201) 427-8399|Allan.Spera@frx.com|
20156600|NCT03988205|Froedtert and the Medical college of Wisconsin|Laura Michaelis, MD|414-805-6700|lmichaelis@mcw.edu|
20156601|NCT00663260|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
20156602|NCT01799135|Dana Farber Cancer Institute|Raymond H. Mak|617.632.3591|RMAK@PARTNERS.ORG|
20156603|NCT02678377|Northwestern University|Dr. Kimberly Kenton|3124723874|kkenton@nm.org|
20156604|NCT01979185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20156605|NCT00980798|Janssen-Cilag Ireland|EMEA Medical Affairs Director Analgesia|0035 878 339174||
20156606|NCT02402647|VA San Diego|Catherine Ayers|858-220-4041|catherine.ayers1@va.gov|
20156607|NCT03637348|Cornea Research Foundation of America|Marianne Price, PhD|3178142990|mprice@cornea.org|
20156608|NCT00553969|University of Minnesota Medical School|Jay N. Cohn, M.D.|612.625.5646|cohnx001@umn.edu|
20168803|NCT00729846|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
20168804|NCT02162576|Propeller Health|Dr. Meredith Barrett|415-409-9258|meredith.barrett@propellerhealth.com|
20168805|NCT01089361|Beth Israel Deaconess Medical Center|Dr. Daniel Talmor|617-754-2675|dtalmor@bidmc.harvard.edu|
20168806|NCT03353740|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|
20168807|NCT02232880|Vanderbilt University|David Harrison||david.g.harrison@Vanderbilt.Edu|
20187902|NCT04499521|University of Virginia|Kara Romano, MD|434-982-6278|ked7c@uvahealth.org|
20187903|NCT04678856|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20187904|NCT03734029|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20201748|NCT02901314|Cleveland Clinic|Nancy M. Albert, PhD, CCNS, CCHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
20201749|NCT02495948|Alcon, A Novartis Division|Global Medical Affairs Brand Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20201750|NCT01701622|University of Mississippi Medical Center|Debbie Minor|601-984-6888|DMinor@umc.edu|
20201751|NCT01444300|Oregon Health & Science University|Dr. Michelle Cameron|503-218-1971|cameromi@ohsu.edu|
20201752|NCT04826900|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
20201753|NCT04885257|Birmingham VA Medical Center|Research Compliance Officer|205-933-8101|latanya.higginbottom@va.gov|336885
20201754|NCT02597062|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
20201755|NCT01708057|AstraZeneca|Carin Jorup||aztrial_results_posting@astrazeneca.com|
20201756|NCT01697345|Creighton University|Dr. Melissa A Dahir|402-657-2847|melissadahir@creighton.edu|
20201757|NCT02970929|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1 866-503-6351|clinicaltrialdisclosure@sunovion.com|
20201758|NCT00291343|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201759|NCT02382133|Barnes-Jewish Hospital|Dr. Marilyn Schallom|314-286-0835|marilyn.schallom@bjc.org|
20201760|NCT04188730|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
20201761|NCT01245647|University of Florida|Dr. Bob Cook|352-273-5869|cookrl@ufl.edu|
20201762|NCT02370121|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
20201763|NCT00342355|National Institute of Allergy and Infectious Diseases, Dvision of Clinical Research|Michael A Polis, MD, MPH|301-496-8027|mpolis@niaid.nih.gov|
20201764|NCT03929250|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
20201765|NCT03971721|The Ohio State University|Dr. Ulysses Magalang|(614) 293-4925|Ulysses.Magalang@osumc.edu|
20201766|NCT05262764|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20201767|NCT01392183|UT MD Anderson Cancer Center|Amado J. .Zurita-Saavedra, MD/ Associate Professor, Genitourinary Medical Oncology|713- 563-6966|azurita@mdanderson.org|
20201768|NCT05198713|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
20201769|NCT00000479|Brigham and Women's Hospital|Julie E. Buring|617 732 4965|jburing@rics.bwh.harvard.edu|
20201770|NCT00045032|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
20201771|NCT02582658|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20201772|NCT01841632|University Hospital Regensburg|Prof. Dr. Marc-H. Dahlke, Ph. D.|+49941944|marc.dahlke@ukr.de|6809
20201773|NCT04068103|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
20201774|NCT03277196|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20201775|NCT01587963|Rutgers RWJMS|Vincente Gracias|732-235-7920|graciavh@rwjms.rutgers.edu|
20201776|NCT04101890|Children's Research Institute|Elena Gibson|(202) 476-6877|egibson@cnmc.org|
20201777|NCT00686205|Abbott Diagnostics Division|Peggy Moreno|847-937-2044|Peggy.Moreno@abbott.com|
20201778|NCT00265941|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20201779|NCT03976401|Akero Therapeutics, Inc.|Brittany de Temple, Senior Director Clinical Operations|(650) 868-7935|brittany@akerotx.com|
20201780|NCT00942409|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
20201781|NCT02015819|City of Hope Medical Center|Dr. Jana Portnow|6262189200|jportnow@coh.org|
20201782|NCT01464697|University of British Columbia|Dr. Jerilynn C. Prior, Professor|6048755927|jerilynn.prior@ubc.ca|
20201783|NCT01697215|Cleveland Clinic Foundation|Adriano Tonelli, MD|216-444-0812|tonella@ccf.org|
20201784|NCT01057277|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20201785|NCT00466505|Vanderbilt-Ingram Cancer center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
20201786|NCT02886715|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
20201787|NCT01676961|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
20201788|NCT03812510|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
20201789|NCT01172067|CRT, Global Clinical Affairs, Cardiac Arrhythmias and Heart Failure, Abbott Medical Devices|Clay Cohorn, Program Director|+1 972 309 8087|clay.cohorn@abbott.com|
20201790|NCT00768560|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20201791|NCT00117312|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20201792|NCT01128387|University of Wisconsin Carbone Cancer Center|Dr. Mark Ritter|608-263-8500|ritter@humonc.wisc.edu|
20201793|NCT02635204|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
20201794|NCT01535235|Medical College of Wisconsin|Dr. Leslie Cockerham|414-805-0738|lcockerham@mcw.edu|
20201795|NCT01021111|Stanford University|Professor Thomas P. Andriacchi|6507238024|tandriac@stanford.edu|
20201796|NCT03932240|Emory University|Laura Downey, MD|404-785-6670|laura.ansley.downey@emory.edu|
20201797|NCT02216136|Washington University School of Medicine|Terence M. Myckatyn, M.D.|314-996-3873|myckatyn@wustl.edu|
20168808|NCT01481129|Centre Léon Bérard (now CHLS)|Dr Hervé Ghesquieres|0426556824|herve.ghesquieres@chu-lyon.fr|
20168809|NCT01752712|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
20168810|NCT02233946|Boston Children's Hospital|Dr. Sion Kim Harris|8572184304|sion.harris@childrens.harvard.edu|
20168811|NCT01879579|New York University School of Medicine|Dr. Natalie Levy|2122638924|Natalie.Levy@nyumc.org|
20168812|NCT02927067|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20168813|NCT01695668|University of Michigan|Dr Shahzad Mian|734-647-8397|smian@med.umich.edu|
20168814|NCT02292784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20168815|NCT00134784|Institute for Neurodegenerative Disorders|Principal Investigator|203 401 4300|kmarek@indd.org|
20168816|NCT02919969|Dana Farber Cancer Institute|James Cleary|617-632-6073|james_cleary@dfci.harvard.edu|
20168817|NCT03621475|University of Vermont|Renee Stapleton, MD, PhD|(802) 656-7975|renee.stapleton@med.uvm.edu|
20168818|NCT01842633|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168819|NCT04179409|Abigail Wexner Research Institute, Nationwide Children's Hospital|Dr. Kevin Flanigan, Center for Gene Therapy Director|614-722-5615|kevin.flanigan@nationwidechildrens.org|
20168820|NCT01206387|Taro Pharmaceuticals U.S.A., Inc|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
20168821|NCT00706849|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
20168822|NCT02616601|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20168823|NCT03718299|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trials@sunpharma.com|5689
20168824|NCT04389970|University of Alabama at Birmingham|Brooks Wingo|2059345982|bcwingo@uab.edu|
20168825|NCT01343823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20168826|NCT02153476|Allegro Ophthalmics, LLC|Director of Clinical Research|949-444-5722|lkarageozian@allegroeye.com|
20168827|NCT03702244|Heartflow Inc|Director, Clinical Operations|877-478-3569|whuey@heartflow.com|
20168828|NCT04656899|Washington State University Elson S. Floyd College of Medicine, Analytics and PsychoPharmacology Laboratory (APPL)|Dr. Crystal Smith (backup: Dr. Sterling M. McPherson)|(509) 368-6876|crystal.lederhos@wsu.edu|
20168829|NCT01848782|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
20168830|NCT02409914|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
20168831|NCT03513848|University of California, Irvine|Alyson Zalta|949-824-3409|azalta@uci.edu|
20168832|NCT02195687|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20168833|NCT02047318|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20168834|NCT02296138|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168835|NCT01653132|Beth Israel Deaconess Medical center|Dr. Pushpa Narayanaswami|617-667-8130|pnarayan@bidmc.harvard.edu|
20168836|NCT02677324|DFCI|Jorge J. Castillo|617-632-2681|jorgej_Castillo@dfci.harvard.edu|
20168837|NCT00461331|Tulane University Health Sciences Center|Tina K. Thethi, MD, MPH|504-988-5044|tthethi@tulane.edu|
20168838|NCT00761150|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20168839|NCT00282464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20168840|NCT00475423|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20168841|NCT01214174|Icon Bioscience, Inc.|Wendy Murahashi, MD|650-369-4049|wendymurahashi@iconbioscience.com|
20168842|NCT02757950|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
20168843|NCT01499862|Department of Physical Therapy and Rehabilitation, University of California San Francisco|Dr. Nancy N. Byl|415-514-4816|byln@ptrehab.ucsf.edu|
20168844|NCT00868517|Department of Veterans Affairs|Michelle Kennedy Prisco|202-745-8000|michelle.prisco@va.gov|56235
20168845|NCT05072470|Sonova USCS|Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
20168846|NCT02496676|National Institute of Allergy and Infectious Diseases|Ravell Aumaitre, Juan|+1 301 761 6669|juan.ravell@nih.gov|
20168847|NCT02963831|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
20168848|NCT01966432|Duke University, Dept. of Psychiatry and Behavioral Sciences|Dr. Li-Tzy Wu, Professor in Psychiatry|(919) 889-9369|litzy.wu@duke.edu|
20168849|NCT00181623|Massachusetts General Hospital|Corrine Welt, MD|617-716-8437|cwelt@partners.org|
20168850|NCT00684047|Grifols Biologicals Inc.|Paul Pinciaro|443-375-8825|Paul.Pinciaro@grifols.com|
20168851|NCT02815280|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
20168852|NCT00603642|Amgen Inc.|Study Director|866-572-6436||
20168853|NCT01230177|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168854|NCT02514473|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20168855|NCT03915860|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20168856|NCT01009281|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20168857|NCT00548405|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20168858|NCT01624870|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|maarten.hollander@medtronic.com|
20168859|NCT03901456|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
20168860|NCT00625703|University of Texas Southwestern Medical Center|Lus Stella Muniz, MD|214-648-3111|irb@utsouthwestern.edu|
20168861|NCT03734705|Stanford University|Katie Fracalanza, PhD|408-769-0589|kfracalanza@stanford.edu|
20201798|NCT01159262|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
20168862|NCT02181517|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
20168863|NCT03836001|Stanford University|Albert Chiou|(650) 721-8418|achiou@stanford.edu|
20201799|NCT02696083|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
20201800|NCT02704104|Arch Therapeutics, Inc|Medical/Scientific Affairs|617 431-2313|jprats@archtherapeutics.com|
20168864|NCT01642732|University of Michigan Hospital|Dr. Daniel Hamstra, Associate Professor of Radiation Oncology|734-936-4300|dhamm@umich.edu|
20168865|NCT02438475|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
20168866|NCT02805504|Loma Linda University Health|Duane Baldwin, MD Director of Urologic Research|909 558 4196|dbaldwin@llu.edu|
20168867|NCT01230125|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20168868|NCT00402233|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168869|NCT00821327|US Oncology Research, McKesson Specialty Health|Dr. Matthew D. Galsky|212-659-5412|matthew.galsky@mssm.edu|
20168870|NCT02119676|Incyte Corporation|Study Director|855 463-3463||
20168871|NCT00056498|Maryland Psychiatric Research Center|Robert W. Buchanan, MD|410-402-7876|rwbuchanan@mprc.umaryland.edu|
20168872|NCT00278915|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
20168873|NCT01007253|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
20156609|NCT05216380|UMass Chan Medical School|Jamie Faro|7744553744|Jamie.faro@umassmed.edu|
20168874|NCT02486718|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20168875|NCT02093351|AstraZeneca Pharmaceuticals|Dr Carsten Goessl, Indication Lead||clinicaltrialtransparency@astrazeneca.com|
20168876|NCT01099709|Purdue Pharma LP|Stephen C. Harris, MD|203-588-7592|Stephen.Harris@pharma.com|
20168877|NCT01611454|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute|786-596-3505|raulh@baptisthealth.net|
20168878|NCT00920907|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20168879|NCT01275339|Washington University School of Medicine|Brian R. Lindman, MD|615-936-5949|brlindman@wustl.edu|
20168880|NCT00718081|AcelRx|Dr. Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
20168881|NCT00815516|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
20168882|NCT01689909|Medical College of Georgia; Augusta University|William Vaughn McCall|706-721-6719|WMCCALL@augusta.edu|
20168883|NCT00244842|Aurinia Pharmaceuticals Inc.|Robert Huizinga|250-708-4322|rhuizinga@auriniapharma.com|
20168884|NCT02415855|University of Alberta|Dr. Kenneth Butcher|780-407-4366|ken.butcher@ualberta.ca|
20201801|NCT00824421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201802|NCT02499952|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20201803|NCT05089708|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20201804|NCT02120417|Incyte Corporation|Study Director|855 463-3463||
20201805|NCT02286102|Hospital for Special Surgery|Oheneba Boachie-Adjei, MD|212 606-1723|rosst@hss.edu|
20201806|NCT00927485|University of Puerto Rico Medical Sciences Campus|Dr. Marcia Cruz-Correa|787-758-2525|marcia.cruz1@upr.edu|1722
20201807|NCT03830281|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20201808|NCT00594399|Durham VA Medical Center (GRECC/HSRD)|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
20201809|NCT01440101|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20156610|NCT04906512|Ruijin Hospital|Dr. Hongping Qu|021-64370045|rjhcrc@126.com|
20156611|NCT03211416|Roswell Park Comprehensive Cancer Center|Kris Attwood|8772757724|Kris.Attwood@roswellpark.org|
20156612|NCT01350479|VA Maryland Healthcare System|Mary-Claire Roghmann|410-706-0062|mroghman@epi.umaryland.edu|
20156613|NCT02927964|Stanford University|Dr. Ronald Levy|(650) 725-6452|levy@stanford.edu|
20156614|NCT02496000|Orange County Research Center|Joel M. Neutel, M. D.|714-541-5591|jmneutel@aol.com|
20156615|NCT02255656|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20156616|NCT01877278|University of Messina|Gianfilippo Bagnato|00390902212502|gianbagnato@gmail.com|
20156617|NCT04727151|Triumvira Immunologics|Maria Apostolopoulou, Clinical Scientist|518-892-8426|mapostolopoulou@triumvira.com|
20156618|NCT03510715|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20156619|NCT03546439|Saint Luke's Hospital of Kansas City|Sanjaya Gupta, MD|8169311883|sgupta@saint-lukes.org|
20156620|NCT04262479|NTNU|Ingrid K Hals|+47 73412207|ingrid.hals@ntnu.no|
20156621|NCT05318287|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
20156622|NCT04983979|Queen Mary University of London|Emily Kirkpatrick|02078825673|cvctu@qmul.ac.uk|
20156623|NCT04144517|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
20156624|NCT00391716|The Scripps Research Institute|Dr. Barbara J. Mason|858-784-7324|mason@scripps.edu|
20156625|NCT02757768|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20156626|NCT04093453|Imperial College London|Dr. Edward Chambers|+44 20 7594 0959|e.chambers@imperial.ac.uk|
20156627|NCT02495883|UCSD|Fatta Nahab, MD|858-822-5871|fnahab@health.ucsd.edu|
20156628|NCT03557502|University of Oregon|Dr. Christopher Minson|541-953-2231|minson@uoregon.edu|
20156629|NCT02620865|Karmanos Cancer Institute|Dr. Anthony Shields|313-576-8735|shieldsa@karmanos.org|
20156630|NCT04632030|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
20156631|NCT00964678|Virginia Commonwealth University Health System|Dan Grinnan, MD|804-828-9000|daniel.grinnan@vcuhealth.org|
20156632|NCT03359395|Wake Forest Health Science|T. Quinn McCutchen, MD|336.716.4498|tmccutch@wakehealth.edu|
20156633|NCT03164356|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
20156634|NCT00543127|Department of Medical Oncology, Hospital Universitario Gregorio Marañón|Dr. Miguel Martin||miguel.martin@salud.madrid.org|
20156635|NCT00131885|University of Utah|Patricia Murphy, DrPH|801-793-5729|patricia.murphy@nurs.utah.edu|
20156636|NCT02520154|University of Texas M D Anderson Cancer Center|Dr. Amir Jazaeri MD|(713) 745-1613|aajazaeri@mdanderson.org|
20156637|NCT02953457|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
20168885|NCT05478174|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
20168886|NCT01545843|University of Michigan|Dr. J. Todd Arnedt|734-764-1234|tarnedt@med.umich.edu|
20168887|NCT02311582|Washington University School of Medicine|Milan G. Chheda, M.D.|314-747-2712|mchheda@wustl.edu|
20168888|NCT05822531|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
20168889|NCT03404960|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20168890|NCT02642744|University of Pennsylvania|Laura Stein|215-662-6214|laura.stein@pennmedicine.upenn.edu|
20168891|NCT00246571|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168892|NCT03422627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20168893|NCT02455557|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
20168894|NCT04656275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168895|NCT00300742|UVA Center for Addiction Research and Education|Dr. Nassima Ait-Daoud|434-243-0541|uvacare@virginia.edu|
20168896|NCT05293392|Nemours Children's Health|Thao-Ly Phan, MD, MPH|302-331-7342|thaoly.phan@nemours.org|
20168897|NCT00934648|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20168898|NCT02288377|FFCD|Karine Le Malicot|+ 33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
20168899|NCT04369924|University of Miami|Amanda Jensen-Doss|3052848332|ajensendoss@miami.edu|
20168900|NCT03828370|Klein Buendel Inc.-|Dr. W. Gill Woodall, Ph. D.|5053829796|gwoodall@kleinbuendel.com|
20168901|NCT00290407|James Graham Brown Cancer Center|Roger H Herzig, MD|502/396-3119|rhherz01@louisville.edu|
20168902|NCT01076296|GE Healthcare|Anita Johnson|262-548-2825|Anita.Johnson@ge.com|
20168903|NCT01933789|University of Washington|Dr. J. Randall Curtis|206-744-3356|jrc@uw.edu|
20168904|NCT03398278|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
20168905|NCT01925989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20168906|NCT05442775|Cytokinetics|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
20168907|NCT04739865|COMPASS Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
20168908|NCT01361854|CHU St Pierre|Dr Marie Bruyneel|003225354219|Marie_BRUYNEEL@stpierre-bru.be|
20168909|NCT00040846|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
20168910|NCT01514162|St Jude Medical|Jennifer Johnson|6517566803|jjohnson101@sjm.com|
20168911|NCT01698710|Massachusetts General Hospital|Dr. William Brugge|6173083532|Brugge.William@mgh.harvard.edu|
20168912|NCT02830438|AlbertEHN|Mario Naranjo-Tovar|2157965542|mario.edu6@hotmail.com|
20168913|NCT03935399|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
20168914|NCT02106923|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168915|NCT03485495|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20168916|NCT01323920|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
20168917|NCT03103061|Medical University of South Carolina|Hunter Gray, Program Coordinator|843-876-3185|grayhu@musc.edu|
20201810|NCT00659438|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20168918|NCT03102190|Massachusetts Eye and Ear Infirmary|Project Manager, Clinical Trials|617-573-6981|elizabeth_grimm@meei.harvard.edu|
20168919|NCT02217527|Univ of Pittsburgh|Dr. Kenneth A. Perkins, Prof of Psychiatry|412-246-5395|perkinska@upmc.edu|
20168920|NCT00938886|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
20168921|NCT03579602|Blaze Bioscience|Dr. Kristi Harrington|206-535-8144|Clinical.trials@blazebioscience.com|
20168922|NCT01233518|Heartflow, Inc.|Whitney Huey|650.257.6697|whuey@heartflow.com|
20168923|NCT02518464|Columbia University Medical Center|Robert Sommer, MD|212-305-7060|rs2463@cumc.columbia.edu|
20168924|NCT00481507|GEORGETOWN UNIVERSITY|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
20168925|NCT01120067|VA Boston Healthcare System|John Otis|857-364-5740|john.otis@va.gov|
20168926|NCT00819793|Abbott|Poornima Sood||psood@sjm.com|
20168927|NCT03720392|Massachusetts General Hospital|Zachariah DeFilipp, MD|617-643-3944|ZDEFILIPP@MGH.HARVARD.EDU|
20168928|NCT03021564|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Maxime Leloup|+33 (0)5 46 45 66 09|maxime.leloup@ght-atlantique17.fr|
20168929|NCT02889562|Sanford Health|Todd Chapin PharmD|701-417-2351|todd.chapin@sanfordhealth.org|
20168930|NCT01943474|C. R. Bard|Gina Gilbert|407-489-0835|gina.gilbert@crbard.com|
20168931|NCT01470989|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20168932|NCT00969280|Korea Institute of Oriental Medicine|Tae-Hun Kim, Researcher|82-10-6532-5524|rockandmineral@gmail.com|
20168933|NCT00217464|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20168934|NCT00873873|National Jewish Health|Head, Pediatric Clinical Pharmacology|303-398-1193|szeflers@njhealth.org|
20201811|NCT00410891|Stanford|Professor|6504984791|cta@stanford.edu|
20168935|NCT00527488|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20168936|NCT02545543|Seqirus|Seqirus Clinical Trial Disclosure Lead|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
20168937|NCT04675151|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
20168938|NCT04035486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20201812|NCT00201851|International Breast Cancer Research Foundation|Richard R. Love|608-698-7881|richardibcrf@gmail.com|
20168939|NCT01730937|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
20201813|NCT00046566|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|5049885165|jhe@tulane.edu|504
20168940|NCT03947684|UT southwestern medical center|Dr. Yasin Dhaher|2146450064|yasin.dhaher@utsouthwestern.edu|
20168941|NCT03875235|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20168942|NCT00622739|Baylor College of Medicine|Kirti Saxena|832-822-4065|kxsaxen1@texaschildrens.org|
20168943|NCT02155946|VA Ann Arbor|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
20168944|NCT02873585|University of North Carolina at Chapel Hill|Angela Broome, DDS, MS|9195373160|abroome@unc.edu|
20168945|NCT01276197|CHOIR|Dr. Thomas K. Houston|781-687-2884|thomas.houston2@va.gov|
20168946|NCT03123185|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168947|NCT03468543|Lyndra|Andrew Bellinger, MD, PhD|857-302-7878|abellinger@lyndra.com|
20168948|NCT00470158|AHRQ|Stephanie Chang|301 427-1490|stephanie.chang@ahrq.hhs.gov|
20168949|NCT00880685|University of Chicago|Dr. Jon Grant|773-834-1326|jongrant@uchicago.edu|
20168950|NCT01249118|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20168951|NCT04179890|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20168952|NCT01063712|"Cardiology Medical Center Kardiozentrum"|Alexandra Heath MD Ph.D|005912 2785037|draheath@gmail.com|
20168953|NCT00978432|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
20168954|NCT02579928|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
20168955|NCT02352922|Center for Advanced Gynecology, PLLC|Dr. Kenneth I Barron|5088876896|kenneth.barron.md@gmail.com|
20168956|NCT04300751|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
20168957|NCT05033002|Duke University School of Nursing|Michael Relf, Ph.D.|919-684-9219|michael.relf@duke.edu|
20168958|NCT05204381|University of North Carollina at Chapel Hill|Zachary Stewart|919-966-9929|zachary_stewart@med.unc.edu|
20168959|NCT04972630|Medical University of South Carolina|Dr. Suparna Qanungo|(843) 876-1125|qanungo@musc.edu|
20168960|NCT04251156|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20168961|NCT00807027|GREEN CROSS CELL|CRA of Clinical Trial|82-2-2101-0665|a1pole@greencrosscell.com|665
20168962|NCT03997383|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20168963|NCT05954143|Bolt Biotherapeutics, Inc.|Director of Clinical Development Operations|1-650-434-8640|clinicaltrials@boltbio.com|
20168964|NCT01129024|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20168965|NCT02361580|Massachusetts Generla Hospital|Taylor Pong, Research Coordinator||tpong1@partners.org|
20168966|NCT00708201|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20168967|NCT00761748|Coloplast A/S|Director of Medical Outcome||dkbir@coloplast.com|
20168968|NCT01857310|NICHD|Dr. Enrique Schisterman|3014356893|schistee@mail.nih.gov|
20168969|NCT00812487|Ohio State University|Kathleen Dungan, MD, MPH|614-685-3333|kathleen.dungan@osumc.edu|
20168970|NCT00998764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20168971|NCT01995045|Emory University|Dr. Timothy Olsen|404-778-4996|tolsen@emory.edu|
20168972|NCT04761627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20168973|NCT06390839|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20168974|NCT02891603|Moffitt Cancer Center|Joseph Pidala, MD, PhD|813-745-2556|Joseph.Pidala@moffitt.org|
20168975|NCT01495676|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
20168976|NCT02720094|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
20168977|NCT02067975|Maryland Psychiatric Research Center|Sam Kane-Gerard|410-402-6120|SGerard@som.umaryland.edu|
20168978|NCT00732940|GlaxoSmithKline|GSK Response Center|866-435-7343||
20168979|NCT02581839|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
20168980|NCT04711837|Haisco USA Pharmaceutical Inc.|Yu-Ling Lai Senior Director Clinical Operations|1 732-26-4759|Yuling.lai@Haisco-usa.com|
20168981|NCT00459979|CCCC|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
20168982|NCT00989573|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20168983|NCT01629771|Northwestern University|Clinical Trials Unit Coordinator|312-695-6829|j-bae@northwestern.edu|
20168984|NCT05214573|Mayo Clinic|Rozalina McCoy, M.D., M.S.|507-538-7955|mccoy.rozalina@mayo.edu|
20168985|NCT00814801|Janssen Pharm KK Japan|Director|81-3-4411-5717||
20168986|NCT04148872|University of Wisconsin - Madison|Scott Chaiet, MD|608-263-0192|chaiet@surgery.wisc.edu|
20168987|NCT02520089|Universidad Autonoma de Nuevo Leon|Dr. Carlos Alberto Acosta-Olivo|+528183476698|dr.carlosacosta@gmail.com|
20168988|NCT03351101|Bausch Health|Study Director|+1 (585) 338-6399|Robert.Steffen@bausch.com|
20168989|NCT02216812|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
20168990|NCT01278927|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20168991|NCT00721253|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20168992|NCT02829944|Duke University Medical Center|Emily Barney|9709031869|ezb2@duke.edu|
20168993|NCT06447688|Medicalpark Hospital|Sefa SURAL|+90 532 565 0160|sesural@hotmail.com|
20168994|NCT02104739|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|(713) 500-6641|Absalon.D.Gutierrez@uth.tmc.edu|
20168995|NCT01395784|New York State Psychiatric Institute|Jermaine Jones, PhD|646 774-6113|jonesje@nyspi.columbia.edu|
20168996|NCT05772702|Pulvinar Neuro|Dr. Christopher Walker|8043173403|chris.walker@pulvinarneuro.com|
20168997|NCT04268823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20168998|NCT00884377|Walter Reed Army Medical Center|Dr. Naomi Aronson, Principal Investigator|202-782-8691|naronson@usuhs.mil|
20168999|NCT06312462|Jiangsu Institute of Parasitic Diseases|Dr. Huang Yuzheng|19941716698|huangyuzheng@jipd.com|
20169000|NCT05247398|University of Minnesota|Corey McGee|612-626-5645|mcge0062@umn.edu|
20169001|NCT04214288|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20169002|NCT04798781|Cedars-Sinai Medical Center|Andrew Hendifar, MD, MPH|3104232217|andrew.hendifar@cshs.org|
20169003|NCT00924781|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20169004|NCT02554279|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20169005|NCT01117792|Boston Scientific|Tom Stoltz, Clinical Trial Manager|1-800-227-3422|thomas.stoltz@bsci.com|
20169006|NCT05867342|Stanford University|Peter H. Hwang, MD|(650) 725-6500|hwangph@stanford.edu|
20169007|NCT00723203|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
20169008|NCT01410552|LivaNova|Scientific Communication manager|33146013082|Anne.rousseauplasse@sorin.com|
20169009|NCT01277081|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169010|NCT00274924|ECOG Statistical Office|Study Statistician|617-632-3012||
20169011|NCT01055496|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169012|NCT00584740|Novartis|Study Director|862-778-8300||
20169013|NCT01673282|UCB Cares|UCB (Study Director)|+1 887 822 9493||
20169014|NCT02915874|University of Iowa|Jess G Fiedorowicz, MD, PhD|319-384-9267|jess-fiedorowicz@uiowa.edu|
20169015|NCT01325792|W. L. Gore & Associates, Inc., Sponsor|Lori Norton, PhD|800-437-8181|lnorton@wlgore.com|
20169016|NCT05318183|The Ohio State University|Richard Bruno|614.292.5522|bruno.27@osu.edu|
20169017|NCT01046825|St. Jude Children's Research Hospital|Raul Ribeiro, MD|901-595-3694|raul.ribeiro@stjude.org|
20169018|NCT03681288|PROVIDENCE VAMC/ BROWN UNIVERSITY|Erica Eaton, Ph.D.|14012737100|erica_eaton@brown.edu|13428
20169019|NCT06400251|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20169020|NCT01150474|Mayo Clinic|Dr. Kristina A. Butler|480-301-5934|butler.kristina@mayo.edu|
20169021|NCT00219544|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20169022|NCT01163032|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
20169023|NCT02081248|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
20169024|NCT01037088|UCaliforniaDavis|Dr. Barth Wilsey, MD|916-843-9082|blwilsey@ucdavis.edu|
20169025|NCT01958827|AbbVie|Global Medical Information|800-633-9110||
20169026|NCT03036800|University of Leicester|Prof Melanie Davies|0116 258 6481|melanie.davies@uhl-tr.nhs.uk|
20169027|NCT01947907|Ascendis Pharma A/S|VP Clinical Development|+49 172 155 2596|mb@ascendispharma.com|
20169028|NCT01077154|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20201814|NCT03293680|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
20201815|NCT00922935|Straumann|Kristina Espemar Holst, Senior Clinical Trial Manager|+41 61 965 11 11|info@straumann.com|
20201816|NCT01491945|Endologix|Sripad Bellary, Director of Clinical Affairs|9257011628|sbellary@endologix.com|
20201817|NCT00636818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201818|NCT02201940|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20201819|NCT01119040|University Hospitals Case Medical Center|Jeffrey Marks, MD/Principal Investigator|216-983-4930|jeffrey.marks@UHhospitals.org|
20201820|NCT00074958|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20201821|NCT04898166|Jinnah postgraduate medical centre|Syeda Mahanum Ali|03033901112|mahanumsyed8@gmail.com|
20201822|NCT01894672|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman MD|646-888-4162|chapmanp@MSKCC.ORG|
20201823|NCT02690701|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|Novartis.email@novartis.com|
20201824|NCT02700451|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@HSS.EDU|
20201825|NCT01852084|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20201826|NCT01578902|Sunnybrook Research Institute|Dr Andrew Loblaw, Director GU Radiation Trials|4164804806|andrew.loblaw@sunnybrook.ca|
20201827|NCT02115308|Cardiovascular Imaging Technologies, LLC|Joseph Soltys, PhD|816-531-2842|jsoltys@cvit.com|103
20201828|NCT00404092|University of Cologne|Oliver A. Cornely|+49 221 478 6494|Oliver.Cornely@zks-koeln.de|
20201829|NCT00749203|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-241-1563|adriana.feder@mssm.edu|
20201830|NCT02658461|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201831|NCT02344576|University of Colorado School of Medicine|Dr. Larry Allen, Principal Investigator|303-724-4713|larry.allen@ucdenver.edu|
20201832|NCT01271686|University of California, San Diego|Dr. John Liu|858 534-7056|joliu@ucsd.edu|
20201833|NCT04233424|PolyPid|Clinical Development Manager|+972-74-7195700|olga.b@polypid.com|
20201834|NCT02698189|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201835|NCT02319369|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20201836|NCT00702143|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20201837|NCT00463437|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201838|NCT01624142|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20201839|NCT01053429|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201840|NCT00947349|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201841|NCT03972488|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
20201842|NCT02730546|Mayo Clinic|Harry H Yoon MD MHS|507-284-2511|yoon.harry@mayo.edu|
20201843|NCT02770807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
20201844|NCT04907045|Kaiser Permanente Washington Health Research Institute|Joseph E Glass, PhD|206-287-4266|joseph.e.glass@kp.org|
20169029|NCT02207946|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20169030|NCT05744258|UZ Brussel|prof. dr. Sebastien Kindt|+32 2 477 60 11|sebastien.kindt@uzbrussel.be|
20169031|NCT04155567|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
20201845|NCT00222105|University of Kansas Medical Center|Cancer Center Clinical Trials Office|(913) 945-5059|SWILLIAM@kumc.edu|
20169032|NCT03764033|San Francisco VA Health Care System|Shira Maguen, PhD|415-221-4810|Shira.Maguen@va.gov|22511
20169033|NCT06372782|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
20169034|NCT06432088|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
20169035|NCT01006603|AstraZeneca|Boaz Hirshberg , MSD||ClinicalTrialTransparency@astrazeneca.com|
20169036|NCT02964078|Moffitt Cancer Center|Jad Chahoud MD, MPH|813-745-6926|Jad.Chahoud@moffitt.org|
20169037|NCT01892722|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20169038|NCT05568888|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
20169039|NCT02003365|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20169040|NCT00625742|University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Med||CR_Study_Registration@mdanderson.org|
20169041|NCT02316548|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
20169042|NCT00371761|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20169043|NCT00334074|Baylor University Medical Center|Dr. Edward Agura|214-818-8472|Sandyli@baylorhealth.edu|
20169044|NCT02607514|Massachusetts General Hospital|Maren Nyer|6072796290|mnyer@partners.org|
20169045|NCT05171816|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20169046|NCT02937571|Memorial Sloan Kettering Cancer Center|Dr. Neha Korde, MD|646-608-3708|korden@mskcc.org|
20169047|NCT03675321|Medical College of Wisconsin|Clinical Research Manager|4142666131|ksiegel@mcw.edu|
20169048|NCT05040971|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20169049|NCT05622604|Pray.com|Breanne Laird, PhD|9095574002|breanne.laird@pray.com|
20169050|NCT01351896|The Ohio State University Comprehensive Cancer Center|Dr. Kerry Rogers|614-293-3873|Kerry.Rogers@osumc.edu|
20169051|NCT04391569|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
20169052|NCT02751931|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
20169053|NCT05856760|Travere Therapeutics, Inc.|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
20169054|NCT06661954|University of Alabama at Birmingham|Rachel Cowan, PhD|205-934-5034|recowan@uabmc.edu|
20169055|NCT03375788|Massachusetts General Hospital|Dr. Takara Stanley|617-724-9109|tstanley@mgh.harvard.edu|
20169056|NCT02477696|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20169057|NCT07123272|University of Michigan|Anna Kratz|734-647-5982|alkratz@med.umich.edu|
20169058|NCT04153149|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
20169059|NCT05618782|Levicept|Iwona Bombelka|0000000000|info@levicept.com|
20169060|NCT04641221|Butler Hospital|Lisa Uebelacker, PhD|401-455-6381|luebelacker@butler.org|
20169061|NCT00773838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169062|NCT02502006|University of Pennsylvania|Katherine N. Theken, PharmD, PhD|2158987470|ktheken@upenn.edu|
20169063|NCT01589770|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|michael.stein@vanderbilt.edu|
20169064|NCT00997113|Minneapolis Medical Reseach Foundation|James Miner|6128738791|miner015@umn.edu|
20169065|NCT02283177|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
20169066|NCT01101191|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
20169067|NCT06165627|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20169068|NCT01464723|University of California San Diego Shiley Eye Center|Dr. Stuart Brown|(858) 822-2585858-246-0814|sibrown@ucsd.edu|
20169069|NCT01683825|Brigham and Women's Hospital|Sharmila Dorbala, Director Nuclear Cardiology|617-732-6290|sdorbala@bwh.harvard.edu|
20169070|NCT03615508|Denver Health|Dr. Ifantides|303-602-0156|cristos.ifantides@dhha.org|
20169071|NCT03473548|Washington University|Dr. David Leonard|314-454-6162|dsleonard@wustl.edu|
20169072|NCT02233478|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|61987
20169073|NCT01986933|Chugai Pharmaceutical|Clinical trials information||clinical-trials@chugai-pharm.co.jp|
20169074|NCT03624517|Medical University of South Carolina|Dr. Don Rockey|(843) 792-6982|rockey@musc.edu|
20169075|NCT03370276|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
20169076|NCT04030026|Trevi Therapeutics, Inc.|Thomas Sciascia, MD, Chief Scientific Officer|203-304-2499|info@trevitherapeutics.com|
20169077|NCT00811642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20169078|NCT01602666|Children's Oncology Group|Results Reporting Coordinator|626 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20169079|NCT02361346|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
20201846|NCT02101437|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
20201847|NCT00745030|Northwestern University|Angelica Marconi|312-503-1999|a-marconi@northwestern.edu|
20201848|NCT01024244|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201849|NCT01232946|Indiana University|Kieren J. Mather MD|317-278-7826|kmather@iu.edu|
20201850|NCT00374556|Johns Hopkins University School of Medicine|Michael Smith, PhD, Associate Professor of Psychiatry, Director of Behavioral Medicine|410-550-7000|msmith62@jhmi.edu|
20201851|NCT00473694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201852|NCT03285529|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
20201853|NCT02468193|Novartis PharmaCeuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20201854|NCT00742781|Pennsylvania State University|Dr. Margherita Cantorna|814-863-2819|mxc69@psu.edu|
20201855|NCT01416181|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20169080|NCT01163318|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20169081|NCT03666676|University of Rochester|Dr. Laurel H. Carney|585-276-3948|Laurel_Carney@URMC.Rochester.edu|
20169082|NCT04445792|Duke Clinical Research Institute|Kady-Ann Steen-Burrell, Ph.D.|919-668-8300|kady.ann.steen.burrell@duke.edu|
20169083|NCT03587727|University of Colorado|Yesenia Garcia Reyes|720-777-6984|Yesenia.GarciaReyes@childrenscolorado.org|
20169084|NCT04102189|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20169085|NCT05797974|University of Florida|Dr. Jana Sacco|904-244-7418|Jana.Sacco@jax.ufl.edu|
20169086|NCT03576274|Johns Hopkins School of Nursing|Dr.Nada Lukkahatai,|410-614-5297|nada.lukkahatai@jhu.edu|
20169087|NCT00562627|Baerum Hospital|Ulrich Johannes Spreng|004798499184|ulispreng@hotmail.com|
20169088|NCT00997438|VA Portland Health Care System|Dr. Sonemany Salinthone|5032208262|salintho@ohsu.edu|54394
20169089|NCT04393298|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20169090|NCT04633460|Hospital of the University of Pennsylvania|Payman Zamani|(215) 662-4000|payman.zamani@pennmedicine.upenn.edu|
20169091|NCT03754972|Medical Metrics, Inc|Trevor Grieco|713-850-7500|tgrieco@medicalmetrics.com|247
20169092|NCT01155479|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169093|NCT02360605|LSUShreveport|Dr. Connie Arnold|318-675-4324|carnol@lsuhsc.edu|
20169094|NCT00689091|University of Michigan|Dr. George A Mashour|734-936-4280|gmashour@med.umich.edu|
20169095|NCT00926588|VA HSRD|Dr. Kurt Kroenke|317-988-3476|kkroenke@regenstrief.org|
20169096|NCT02497976|IC Study LLC|Philip C. Bosch, MD|760 743-3135|pboschmd@gmail.com|
20169097|NCT00058539|Hoffmann-LaRoche|Medical Communications|: 800-821-8590|genentech@druginfo.com|
20169098|NCT02524977|University of Cincinnati Health|VP Research UC Health|513-558-6937|christopher.lindsell@uc.edu|
20169099|NCT01903525|Scottish Rite for Children|Dr. Shane Miller|469-515-7222|shane.miller@tsrh.org|
20169100|NCT03977454|Yale School of Medicine: Anesthesiology|Jinlei Li, MD, PhD|(203) 785-2802|jinlei.li@yale.edu|
20169101|NCT00963677|The Second Xiangya Hospital of Central South University|Ru-Ping Dai, B.Sc(Med), PhD, Associate Professor|86-731-85295970|Ruping_dai@yahoo.com.cn|
20169102|NCT02483533|Neothetics|Director of Clinical Trials|8585501900||
20169103|NCT04365257|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Chetan Bettegowda|4109558620|cbetteg1@jhmi.edu|
20169104|NCT01112683|University of Colorado School of Medicine|Dr. Alberto Costa|303-724-6007|Alberto.Costa@ucdenver.edu|
20169105|NCT02129777|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20169106|NCT02301611|Lumabridge, LLC|Marsha Greene|(484) 319-1117|mgreene@lumabridge.com|
20169107|NCT01609478|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
20169108|NCT03116347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20169109|NCT00476047|Fred Hutchinson Cancer Research Ctr|Mazyar Shadman, MD|2066675467|mshadman@fredhutch.org|
20169110|NCT04966741|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20169111|NCT03835728|UT Southwestern, Dept of Neurology|Dr. Steven Vernino|214-645-8800|steven.vernino@utsouthwestern.edu|
20169112|NCT03964337|Duke University|Michael Harrison, M.D.|919-668-8108|michael.harrison@duke.edu|
20169113|NCT02241889|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
20169114|NCT00509262|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169115|NCT01853618|National Cancer Institute|Dr. Tim F. Greten|(301) 451-4723|tim.greten@nih.gov|
20169116|NCT01658813|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
20169117|NCT00558571|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169118|NCT02398227|University of Akron|Dawn M Johnson, Ph.d|3309722505|johnsod@uakron.edu|
20169119|NCT01715129|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
20169120|NCT02009384|University of Louisville|Jason Chesney|502-562-3429||
20169121|NCT01146860|ENT practice|Dr. Rainer Jund, Specialist in Otorhinolaryngology|+49 89 804880|RainerJund@gmx.de|
20169122|NCT00722371|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169123|NCT01092832|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169124|NCT02674854|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
20169125|NCT02128100|University of Louisville|Dr. Neal Dunlap|502-561-2700|neal.dunlap@louisville.edu|
20169126|NCT02635646|University of Guanajuato|Dr. Rodolfo Guardado-Mendoza||guardamen@gmail.com|
20169127|NCT00913692|National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases|Jeffrey I. Cohen, MD|(301) 496-5265|jcohen@niaid.nih.gov|
20169128|NCT03761797|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169129|NCT02995369|Montefiore Medical Center|Nuntiya Kakanantadilok|718-405-8057|nkakanan@montefiore.org|
20169130|NCT00879879|SunCoast CCOP Research Base|Dr. Jeffrey Krischer, Principal Investigator|813-396-9245|ccop@epi.usf.edu|
20169131|NCT02387476|FRESCA Medical|Robert Lahaderne|949-542-3535|rlahaderne@frescamed.com|
20169132|NCT03769376|"University of Colorado Denver | Anschutz"|Kerri Font, DDS, MS|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20169133|NCT00645788|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20169134|NCT03149848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20169135|NCT00495079|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
20169136|NCT01486810|New York Psychiatric Institute|Dr. John Mariani|646-774-8181|John.mariani@nyspi.columbia.edu|
20169137|NCT00971620|National Cancer Institute|Dr. Edward Cowen|301-496-4299|cowene@mail.nih.gov|
20169138|NCT00400153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 Option 4|clintriage.rdg@boehringer-ingelheim.com|
20201856|NCT03109951|International St. Mary's Hospital, Catholic Kwandong University|Myong Ki Baeg|82-10-6391-9010|baegmk@gmail.com|
20169139|NCT00330161|University of Michigan Comprehensive Cancer Center|Erin Sargent|(734) 936-3348|esargent@umich.edu|
20169140|NCT00002975|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20169141|NCT00327470|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169142|NCT04738318|Vanderbilt University Medical Center|Dr. Jed Maslow|615-936-7846|jed.i.maslow@vumc.org|
20169143|NCT01226121|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|3178759105|tdk@hand.md|
20169144|NCT04231981|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
20169145|NCT02581943|Wake Forest Baptist Comprehensive Cancer Center|Assistant Director of Clinical Research Operations|336-713-6913|mebrown@wakehealth.edu|
20169146|NCT00378079|Friends Research Institute|Dr. Timothy Kinlock|(410) 837-3977|tkinlock@friendsresearch.org|224
20169147|NCT01233687|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
20169148|NCT02290431|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20169149|NCT00432601|VA HSRD|Dr. Angela Fagerlin|801-587-1694|angie.fagerlin@hsc.utah.edu|
20169150|NCT00829985|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20169151|NCT02197234|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20169152|NCT03783702|Stanford University School of Medicine|Noel Ayoub|3109407055|nfa@stanford.edu|
20169153|NCT02274038|University of Pennsylvania Perelman School of Medicine|Dr. Sharyn Katz, Principal Investigator|215-662-4000|sharyn.katz@pennmedicine.upenn.edu|
20169154|NCT04473482|University of Michigan|Jessica Mellinger|734-232-0284|jmelling@umich.edu|
20169155|NCT03122301|Northwestern Medicine|David Walega, MD|13129271345|d-walega@northwestern.edu|
20169156|NCT00453388|Fred Hutchinson Cancer Research Center|Dr. Hans-Peter Kiem|206-667-4425|hkiem@fredhutch.org|
20169157|NCT00745615|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20169158|NCT00570232|University of Alabama at Birmingham|Eben Rosenthal,MD|2059349713|erosenthal@uabmc.edu|
20169159|NCT01076075|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169160|NCT01445886|Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Keelung, Taiwan|Yin-Ku Lin|886-2-2431-3131|lin1266@adm.cgmh.org.tw|2127
20169161|NCT02935543|Univ. of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20169162|NCT04078178|MGH|Kayla McEachern|617-643-5265|kmceachern2@mgh.harvard.edu|
20169163|NCT02038829|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
20169164|NCT05283928|The University of Texas Health Science Center at Houston|Popi Stylianou, DDS,MS|713-486-4048|Popi.Stylianou@uth.tmc.edu|
20169165|NCT05803603|University of Maryland School of Social Work|Jay Unick|410-706-3735|junick@ssw.umaryland.edu|
20169166|NCT03544775|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
20169167|NCT04911426|Texas Christian University Institute of Behavioral Research|Dr.Jennifer Pankow|8172577226|j.pankow@tcu.edu|6475
20169168|NCT05128929|Stanford University School of Medicine|Roham Zamanian, MD|650-725-5495|zamanian@stanford.edu|
20169169|NCT02651714|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
20169170|NCT01515540|Northwestern University|Javeria Ali Hashmi|3125037991|j-hashmi@northwestern.edu|
20169171|NCT02987660|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20169172|NCT03707184|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|8012136110|sam.mitchell@hci.utah.edu|
20169173|NCT04950608|Dana-Farber Cancer Institute|Dr. Yvan Beaussant|617-582-9318|patresearch@dfci.harvard.edu|
20169174|NCT05007717|University of Washington|Data Analyst|7347809402|wenwenj@uw.edu|
20169175|NCT03553836|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20169176|NCT04062123|University of Pittsburgh|Keith Vogt, MD, PhD|4126473147|vogtkm@upmc.edu|
20169177|NCT04111939|RTI International|Charles Knott|9195416294|cknott@rti.org|
20169178|NCT03469570|Edwards Lifesciences|Edwards Critical Care Clinical Affairs|(949) 250-7169|afmidestudy@edwards.com|
20169179|NCT04626310|University of Massachusetts Amherst|Katherine Dixon-Gordon, PhD|413-545-0226|katiedg@umass.edu|
20169180|NCT02278341|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
20169181|NCT04902326|University of Michigan Medical School|Jeffrey Kullgren|734-845-3613|jkullgre@med.umich.edu|
20169182|NCT02397564|University of Louisville|W. James Tidwell|5025831749|wjamestidwell@gmail.com|
20169183|NCT02604017|AbbVie|Global Medical Services|800-633-9110||
20169184|NCT01041495|SUNY Upstate MEdical Univ|thomas schwartz|3154643166|schwartt@upstate.edu|
20169185|NCT01487577|Children's Hospital of Pittsburgh of UPMC|Randy M. Windreich, MD|412-692-5225|randy.windreich@chp.edu|
20169186|NCT05048082|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
20201857|NCT00541307|W. L. Gore & Associates, Inc.|Chad Badorek|928/437-8181|cbadorek@wlgore.com|
20201858|NCT04723537|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
20201859|NCT02513940|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@iu.edu|
20201860|NCT04645797|Apros Therapeutics|Tom Wu, PhD|+1-858-284-8839|tom_wu@aprostx.com|
20201861|NCT00089128|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
20201862|NCT03424109|NYU Langone Health|Allison Cuthel|212-263-8631|Allison.Cuthel@nyulangone.org|
20201863|NCT01929083|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@purdue.edu|
20201864|NCT02599402|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20169187|NCT00634270|The Univ of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.5140|kcole@uab.edu|
20169188|NCT01479985|Washington University in St. Louis|Dr. Tessa Madden, MD, MPH|314-747-6495|maddent@wudosis.wustl.edu|
20169189|NCT01653782|Karolinska Institute|Dr. Irene Jensen|+46852483218|irene.jensen@ki.se|
20169190|NCT05765227|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20201865|NCT01591005|University Hospital Ostrava|Prof. David Skoloudik, MD, Ph.D.|+420597375613|skoloudik@hotmail.com|
20169191|NCT02777749|Columbia University Medical Center|Dr. Matthew Grosso|2123058193|mgrosso13@gmail.com|
20169192|NCT01850602|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
20169193|NCT00367770|Actelion Pharmaceuticals Ltd.|Loïc Perchenet, Head of Global Post-Approval Studies|+41 61 565 64 57|loic.perchenet@actelion.com|
20169194|NCT00057681|Washington University in St. Louis|Barbara Geller, M.D.|314-747-3657|gellerb@wustl.edu|
20169195|NCT01315236|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
20169196|NCT01634178|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20169197|NCT03115580|Icahn School of Medicine at Mount Sinai|Annapoorna S. Kini, MD|212-241-4181|annapoorna.kini@mountsinai.org|
20169198|NCT00287079|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20169199|NCT00470184|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20169200|NCT01721577|Rush University Medical Center|Crista Brawley|312-563-2312|crista_brawley@rush.edu|
20169201|NCT01778179|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|doris@hexsel.com.br|
20201866|NCT01075087|Northwestern University|Gildasio De Oliveira MD,MS|312-472-3573|g-jr@northwestern.edu|
20201867|NCT01486264|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
20156638|NCT05943990|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156639|NCT04494971|Pennington Biomedical Research Center|Dr. Hanim Ecem Diktas|(225) 763-2832|hanim.diktas@pbrc.edu|
20156640|NCT02185183|ENZO|Dr. Elazar Rabbani|2125830100|erabbani@enzo.com|
20156641|NCT03977155|Boston Pharmaceuticals, Inc.|Craig Basson|(617) 655-9681|clinicaltrials@bostonpharmaceuticals.com|
20156642|NCT00936936|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, PhD. / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
20156643|NCT02278003|Memorial Sloan Kettering Cancer Center|Dr. Eric Kelhoffer, MD|212-639-8781|kelhoffe@mskcc.org|
20156644|NCT02296476|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156645|NCT00313560|Sidney Kimmel Comprehensive Cancer Center|Dr. Amol Narang|410-502-3823|anarang2@jhmi.edu|
20156646|NCT03440385|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20156647|NCT02956473|Dana-Farber/Brigham Cancer Center|Dr. Tari King|617-582-8292|tking7@bwh.harvard.edu|
20156648|NCT00730327|Apollo Endosurgery|Laura Eaton, Study Director, RN, BSN, CCRN-R,|949-468-9301|laura.eaton@apolloendo.com|
20156649|NCT05012579|Cala Health|Alex Kent|267-973-4180|alex.kent@calahealth.com|
20156650|NCT02682056|Emory University|Eric Felner MD|404-727-7651|efelner@emory.edu|
20156651|NCT05157360|Department of Surgery, University of Kansas School of Medicine-Wichita|Dr. Thomas Resch|316-268-5990|tresch@wsspa.com|
20156652|NCT03835078|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
20156653|NCT02332928|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center Cancer Prevention & Control Team|877-462-7739|masseycpc@vcu.edu|
20156654|NCT02323048|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
20156655|NCT04484857|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-096Study@fibrogen.com|
20156656|NCT01425814|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
20201868|NCT00283387|Mayo Clinic|Dr. Dawn S. Milliner|507-284-7431|milliner.dawn@mayo.edu|
20201869|NCT00327392|Eisai Inc|Eisai Medical Services|1-888-422-4743||
20201870|NCT03723447|Cedars-Sinai|Dr Karen Zaghiyan|(310) 289-9224|kzaghiyan@yahoo.com|
20201871|NCT00500071|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20201872|NCT01122927|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20201873|NCT03182738|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
20201874|NCT03584009|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20201875|NCT00389207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201876|NCT03102411|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
20201877|NCT01588821|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-724-4000|rheist@partners.org|
20201878|NCT00509106|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
20201879|NCT01309737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201880|NCT03322358|University of Pennsylvania|Heather Schofield|617-233-4775|hschof@wharton.upenn.edu|
20201881|NCT02240706|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201882|NCT03119649|Galapagos NV|Evelyn Fox|0032 15 34 29 00|evelyn.fox@glpg.com|
20201883|NCT01126580|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20201884|NCT04109599|play2PREVENT Lab, Yale Center for Health and Learning Games, Department of Internal Medicine|Tyra Pendergrass Boomer, Deputy Director of Programs and Partnerships|+1 (203) 737-6101|tyra.pendergrass@yale.edu|
20201885|NCT01731002|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
20201886|NCT00803114|University of Toronto|Dr. Alison Macarthur|416 586 4800|alison.macarthur@uhn.on.ca|6632
20201887|NCT03430310|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
20201888|NCT01446809|University of Washington|Dr Darin Davidson|206-543-3690|djdavi@uw.edu|
20201889|NCT01331161|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20201890|NCT02581995|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
20201891|NCT03874234|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156657|NCT03243084|UNC Chapel Hill|Julianna Prim|919-962-5271|jhprim@email.unc.edu|
20156658|NCT00600340|CECOG|MD. Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
20156659|NCT00127439|University of Louisville|Andrea L. Behrman, PhD, PT|502-582-7451|andreabehrman@catholichealth.net|
20217896|NCT01218984|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
20217897|NCT03095118|Mayo Clinic|Dr. Fernando C. Fervenza|507-266-1045|Fervenza.Fernando@mayo.edu|
20217898|NCT03208673|Allergan|Medical Director|714-246-4500|CTRegistration@allergan.com|
20217899|NCT01682148|Ipsen|Medical Director, Neurology|clinicaltrials@ipsen.com|clinicaltrials@ipsen.com|
20217900|NCT00171340|Novartis Pharmaceuticals|Study Director|862- 778 8300||
20217901|NCT01056640|Mayo Clinic|Dr. Paul Takahashi|507-284-2511|takahashi.paul@mayo.edu|
20217902|NCT01803269|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
20217903|NCT00606138|Rush University Medical Center|Mathew MacCumber, MD, PhD|312-563-4032|denise_voskuil-marre@rush.edu|
20217904|NCT01351350|Takeda|Medical Director, Clinical Science|+1-866-835-2233|trialdisclosures@takeda.com|
20156660|NCT00376558|nyspi|Diana Martinez|212-543-6628|dm437@columbia.edu|
20217905|NCT02080507|Emory University|Dr. William McDonald|404-712-6945|wmcdona@emory.edu|
20217906|NCT00775528|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
20217907|NCT04647383|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20156661|NCT02095106|Orthopaedic Institute for Children|Dr. Mauricio Silva|213-742-1109|msilva@mednet.ucla.edu|
20217908|NCT01099631|Masonic Cancer Center, University of Minnesota|Daniel Saltzman|612 626 4214|saltz002@umn.edu|
20217909|NCT00285584|NYU School of Medicine|Michael Marmor, Ph.D.|212-263-6667|michael.marmor@nyumc.org|
20156662|NCT02546323|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20156663|NCT04476784|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20156664|NCT00478257|UCSD|Dr. Sonia Ancoli-Israel|858 642-7710|sancoliisrael@ucsd.edu|
20217910|NCT04776954|University of Minnesota|Michael Todd|6126264551|mmtodd@umn.edu|
20217911|NCT03851588|University of Cape Town|Prof Gary Maartens|214066008|gary.maartens@uct.ac.za|+27
20217912|NCT01884688|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
20217913|NCT01770431|Huazhong University of Science and Technology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong Wuhan, Hubei, China|Xiaoping Chen, Professor|+86 27 83663400|chenxp@medmail.com.cn|
20217914|NCT02549573|US WorldMeds|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
20217915|NCT00161382|The University of Texas Health Science Center at Houston (UTHealth) School of Public Health|Dr. Susan R. Tortolero|713-500-9634|Susan.Tortolero@uth.tmc.edu|
20217916|NCT02610816|Cincinnati Childrens Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|Marc.Rothenberg@cchmc.org|
20217917|NCT02919813|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
20156665|NCT00952692|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
20156666|NCT01055028|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
20217918|NCT00854373|University of California, San Francisco|Mitchell P. Rosen, MD|415-353-7475|rosenm@obgyn.ucsf.edu|
20217919|NCT02697773|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156667|NCT06582732|Glaukos Corporation|Study Director|714-478-2287|ldoan@glaukos.com|
20217920|NCT00613834|The Ohio State University|Dr. Michelle Isley|614-293-4203|Michelle.Isley@osumc.edu|
20217921|NCT00842530|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
20156668|NCT01182350|Dana-Farber Cancer Institute|Karen Wright|617.632.6740|KarenD_Wright@dfci.harvard.edu|
20156669|NCT05498870|Medical University of South Carolina|Carey Brewbaker|843-792-2322|brewbake@musc.edu|
20217922|NCT02939950|Bausch Health Americas, Inc.|Director of Clinical Operations|(585) 338-5306|Daniel.Donatello@bausch.com|
20217923|NCT02243293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20217924|NCT00440115|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
20217925|NCT02377063|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD - Principal Investigator|310-206-1987|zli@mednet.ucla.edu|
20156670|NCT02919618|Washington University|Dr. Phillip Cuculich|314-454-7698|pcuculic@wustl.edu|
20217926|NCT01524913|Emory University|Gary Bouloux, MD, DDS|404-778-4500|gfboulo@emory.edu|
20217927|NCT00702208|CUNY School of Public Health, Hunter College|Heidi Jones|212-396-7750|hjon@hunter.cuny.edu|
20217928|NCT00380757|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
20217929|NCT03064438|Accuitis, Inc.|Chief Science Officer|678-812-1492|info@accuitis.com|
20217930|NCT01937351|Avinger|Thomas Lawson|650.241.7030|tlawson@avinger.com|
20156671|NCT04503616|NYU Langone Health|Kelli Cole, NP|646-501-4848|Kelli.Cole@NYULangone.org|
20217931|NCT01223235|Memorial Sloan Kettering Cancer Center|Dr. Paul Sabbatini, MD|212-639-4016|sabbatip@mskcc.org|
20217932|NCT00156715|Dartmouth Medical School|Christopher OKeefe, M.A|603-271-5287|chris.okeefe@hitchcock.org|
20156672|NCT04770285|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20217933|NCT00865098|Merck Serono Co., Ltd, Tokyo, Japan|Masataka Ota|+81 0 3 6853 8611||
20156673|NCT03766399|AstraZeneca Clinical Study Information Center|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
20156674|NCT05030766|University of Miami|Dr. Taghrid Asfar|+1 (901) 371-7229|tasfar@miami.edu|
20156675|NCT00645658|VA Palo Alto Health Care System|Jonathan Myers|6504503440|drj993@aol.com|
20156676|NCT03605693|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Dr. Ian Kronish|212-342-1335|ik2293@columbia.edu|
20156677|NCT04258631|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
20217934|NCT03623620|Massachusetts General Hospital, Center for Women's Mental Health|Lee Cohen, MD|617-724-8020|lcohen2@mgh.harvard.edu|
20217935|NCT03265288|Laurent Pharmaceuticals Inc.|Dr Jean-Marie Houle, VP Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
20217936|NCT00811434|Riley Hospital|Girish Subbarao|317-944-3774|gsrao@iupui.edu|
20217937|NCT02790034|Newron Pharmaceuticals S.p.A.|Ravi Anand MD, Chief Medical Officer|+41 793741364|regulatoryaffairs@newron.com|
20217938|NCT00836017|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20156678|NCT03093415|Oregon Health and Sciences University|Andrew Seaman, MD|1 (971) 271 - 6102|seaman@ohsu.edu|
20156679|NCT03895372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156680|NCT03559530|Unversidade de Sao Paulo|Dr Priscila Rosalba Domingos de Oliveira|551126616900|priscila.rosalba@hc.fm.usp.br|
20156681|NCT00304161|University of Pennsylvania|Dr. Daniel Weintraub|215-349-8207|daniel.weintraub@uphs.upenn.edu|
20156682|NCT01646827|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
20217939|NCT02164734|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@amc.edu|
20217940|NCT01715896|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
20156683|NCT04486677|VA San Diego|Dr. Emily Treichler|6192288075|emily.treichler@va.gov|
20217941|NCT05506358|The University of British Columbia|Pranav Shrestha|6507893270|pranav.shrestha@alumni.ubc.ca|
20217942|NCT04943159|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
20217943|NCT03050203|Istituto Ortopedico Rizzoli|Cristiana Forni|0039516366|cristiana.forni@ior.it|694
20217944|NCT04578886|University of Alabama at Birmingham, Department of Anesthesiology and Perioperative Medicine|Dr. Andrew B. Barker, MD|205-934-6007|abbarker@uabmc.edu|
20156684|NCT04380142|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
20156685|NCT00437073|GlaxoSmithKline|GSK Response Center|866-435-7343||
20156686|NCT05205616|University of Califronia, San Francisco|Sepehr Hashemi, DMD|4133674736|sepehr.hashemi@ucsf.edu|
20217945|NCT03336242|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
20156687|NCT04875533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
20156688|NCT01275300|Upenn|Wenliang Song, MD|215-662-4652.|wenliangsong@gmail.com|
20156689|NCT03338920|Currax Pharmaceuticals LLC|Dr. Michael Kyle|708.834.8254|mkyle@curraxpharma.com|
20217946|NCT03053583|Anesthesiology|Jerrold Lerman MD|716-323-6570|jlerman@buffalo.edu|
20217947|NCT02457611|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20156690|NCT02657343|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
20217948|NCT00384293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20217949|NCT03005067|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20217950|NCT02560779|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|
20217951|NCT02296853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20156691|NCT02607722|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20156692|NCT04347538|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD|615-343-8848|justin.h.turner@vumc.org|
20156693|NCT02135133|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(877) 442-3324|Jennifer_Brown@dfci.harvard.edu|
20217952|NCT01790113|Arthrex|Clinical Affairs Manager|2392161894|melissa.hirschberg@arthrex.com|
20217953|NCT00845975|McDonald hearing Aid Centers|Louis A Looper, MA, CCC-A|916-218-4100|llooper@hearingmed.com|
20217954|NCT02674386|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20217955|NCT02462486|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
20217956|NCT00277524|Medtronic Cardiac Rhythm Disease Management|Melinda Hoey, Clinical Research Specialist|763-526-2831|Melinda.hoey@medtronic.com|
20217957|NCT04625673|University of Pennsylvania|Regulatory Lead|215.573.7101|psom-ind-ide@pobox.upenn.edu|
20217958|NCT02310763|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156694|NCT02259231|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20217959|NCT04744155|Children's Mercy Kansas City|Melissa K. Miller MD|8162343430|mmiller@cmh.edu|
20217960|NCT02010255|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20217961|NCT00351351|IU Health Methodist Hospital|James Lingeman, MD|317-962-0870|lrawlings@iuhealth.org|
20217962|NCT03176784|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
20217963|NCT02990806|Nichi-Iko Pharmaceutical Co., Ltd|Hiroshi Anekawa|+81-3-6262-1564|hiroshi-anekawa@nichiiko.co.jp|
20217964|NCT01010750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20217965|NCT02269631|Emory Unioversity|Hartman, Terry Professor, SPH Epidemiology|404-727-8713|terryl.johnson.hartman@emory.edu|
20217966|NCT01067716|Abbott Medical Optics|Amelia Saliba|408-273-4158|amelia.saliba@amo.abbott.com|
20156695|NCT03238196|Vanderbilt-Ingram Cancer Center|Brent Rexer, MD, PhD, Assistant Professor|615-322-4967|brent.rexer@vumc.org|
20217967|NCT02646917|Crown Laboratories, Inc.|Thomas Hitchcock, PhD|8883723982|THitchcock@crownlaboratories.com|
20217968|NCT01202877|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
20217969|NCT00396331|Genzyme|Medical Monitor||medinfo@genzyme.com|
20156696|NCT04562090|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
20156697|NCT00847730|KCI|VP, Global Clinical Affairs|2102555595|jane.hart@kci1.com|
20156698|NCT04341012|Mayo Clinic|Tushar Patel|9049532000|patel.tushar@mayo.edu|
20156699|NCT04938427|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20156700|NCT03408262|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
20156701|NCT03633058|Vanderbilt University Medical Center|Jeffrey L. Neul, MD, PhD, Principal Investigator|615-322-8242|jeffrey.l.neul@vumc.org|
20156702|NCT03607500|University of Michigan|Abhijit Naik|734-763-0990|abhinaik@med.umich.edu|
20156703|NCT03312543|Johnson & Johnson Consumer Inc.|Sidney Hornby|908-874-2756|SHornby@its.jnj.com|
20156704|NCT04507269|Brii Biosciences Limited|Clinical Research|86 10 6299 8808|clinicaltrials@briibio.com|
20156705|NCT05852340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156706|NCT00375713|UCB Pharma|UCB Clinical Trial Call Center|+ 1 877 822 9493||
20156707|NCT01722669|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617-667-9299|jzwicker@bidmc.harvard.edu|
20156708|NCT02457793|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20156709|NCT04316143|BIAL - Portela & Ca, SA|Responsible of Clinical Research & Operations|+351229866100|clinical.trials@bial.com|
20156710|NCT03814044|Smith + Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.Horner@smith-nephew.com|
20156711|NCT05218434|Simbec Orion|Dr Annelize Koch|01443694313|gabrielle.brill@simbecorion.com|
20156712|NCT00835367|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20156713|NCT05929326|Hung Vuong Hospital|Dr. Huan N Pham|+84906884435|huanpmd@gmail.com|
20156714|NCT04890509|BerGenBio ASA|BerGenBio Clinical Team|+ 47 559 61 159|cmo@bergenbio.com|
20156715|NCT02625428|Mayo Clinic|J. Scott Kriegshauser|480-342-5664|skriegshauser@mayo.edu|
20156716|NCT00710944|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
20156717|NCT03369158|Medacta International|Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
20156718|NCT00442702|Hoffman-LaRoche|Medical Communications|800-821-8590||
20156719|NCT03744637|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156720|NCT04123704|Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center|Dr. C. Kent Osborne|713-798-1640|kosborne@bcm.edu|
20156721|NCT03122184|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
20156722|NCT01212900|National Heart Lung and Blood Institute|Mehta, Nehal|+1 301 827 0483|mehtann@mail.nih.gov|
20156723|NCT02965781|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
20156724|NCT01497197|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20156725|NCT02390076|Minneapolis VA Health Care System|Seth Disner|3105605990|disne014@umn.edu|
20156726|NCT05093621|Yale School of Medicine|Jeffrey Testani, MD, MTR Associate Professor of Medicine|(203) 785-7191|jeffrey.testani@yale.edu|
20156727|NCT01206517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156728|NCT03493958|Clinical Center|Wallen, Gwenyth|+1 301 496 0596|gwallen@cc.nih.gov|
20156729|NCT01029535|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20156730|NCT00895921|Veterans Medical Research Foundation|Jonathan M. Meyer, MD|858-964-0777|jmmeyer@ucsd.edu|
20156731|NCT01358734|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20156732|NCT01822925|NeuroBo Pharmaceuticals, Inc.|Vice President Clinical Operations|617-313-7331|nikki.shannon@neurobopharma.com|
20156733|NCT01731782|Cleveland Clinic Florida Region|Dr. Conor Delaney|954-659-6001|DELANEC@ccf.org|
20156734|NCT01195597|University of Catania|Prof Riccardo Polosa|0957436413|polosa@unict.it, p.caponnetto@unict.it|0039
20156735|NCT03641287|University of Washington Medical Center|Kathryn Pennington, MD|206-598-8300|katypenn@uw.edu|
20156736|NCT05870345|University of CHicago|Alisa Brennan, Pediatric Emergency Medicine Fellow, Physician, Co-PI|9787585263|Brennanak@gmail.com|
20169202|NCT01282203|AbbVie (prior sponsor Abbott)|Global Medical Services|1-800-633-9110||
20169203|NCT04163822|CHCMU|no sponsor, PI: Yuan Shi|13508320283|shiyuan@hospital.cqmu.edu.cn|
20169204|NCT03282565|University of Michigan|Dr. Riann Palmieri-Smith|734-615-3154|riannp@umich.edu|
20169205|NCT00740051|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169206|NCT02011893|St. Jude Medical|Roni Diaz, Director Clinical Studies|972-309-8601|RDiaz@sjm.com|
20169207|NCT00930982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20169208|NCT00991952|Memorial Sloan-Kettering Cancer Center|Dr. Yelena Janjigian|646-888-4186|janjigiy@mskcc.org|
20169209|NCT00518973|UCSD Eating Disorders Treatment and Research Center|Walter H. Kaye|858-534-3951|wkaye@ucsd.edu|
20169210|NCT03452527|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
20169211|NCT00582816|University of Wisconsin Carbone Cancer Center|Dr. Ken DeSantes|608-263-8563|kbdesantes@pediatrics.wisc.edu|
20169212|NCT03239665|Rutgers University Center for Health Outcomes, Policy, & Economics|Laura T. Pizzi, PharmD, MPH|8484456825|laura.pizzi@rutgers.edu|
20169213|NCT01931709|University of Washington|Jennifer Specht, MD|206-288-6889|jspecht@uw.edu|
20169214|NCT01565499|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20169215|NCT00781508|MetroHealth Medical Center|Robert C. Bahler, MD|216 778-2431|rbahler@metrohealth.org|
20169216|NCT01255787|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20169217|NCT03170232|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20169218|NCT03160859|Veterans Administration Greater Los Angeles Healthcare System|Felix W. Leung, M.D, Staff Gastroenterologist|818-891-7711|felix.leung@va.gov|32520
20169219|NCT01423604|Incyte Corporation|Study Director|1-855-463-3463||
20169220|NCT03114059|Dietrich-Bonhoeffer-Klinikum|Ahmed Medra|+49 395 775 13483|a.medra@live.com|
20156737|NCT03373435|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
20156738|NCT00553254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169221|NCT04466228|University of California, San Francisco|Wan-Yu Hsu|+14153531140|wanyuhsu3@gmail.com|
20156739|NCT00189137|University of Michigan Comprehensive Cancer Center|Dr. Scott Schuetze, M.D., Ph.D.|1-800-865-1125|scotschu@umich.edu|
20169222|NCT05038904|Johns Hopkins University School of Medicine|Melanie C. Dispenza, MD, PhD|410-550-2301|mdispen1@jhmi.edu|
20169223|NCT00586664|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20169224|NCT04856865|Alladapt Immunotherapeutics|Chief Medical Officer|650-420-3900|info@alladapt.com|
20169225|NCT04721067|Indiana University|Dr. Samir K. Gupta|3172747926|sgupta1@iu.edu|
20169226|NCT01585584|University of Calgary|Dr. Samuel Lee|403-220-8457|samlee@ucalgary.ca|
20169227|NCT00686998|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20156740|NCT02314923|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156741|NCT05134649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20156742|NCT04618276|University Hospital Zurich|PD Dr. med. Yvonne Achermann|+41 44 396 74 18|yvonne.achermann@usz.ch|
20156743|NCT03896633|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
20156744|NCT01722643|Dartmouth-Hitchcock|Dr. Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
20156745|NCT01472185|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20156746|NCT05078437|University of Kentucky|Daniela Moga, Associate Professor|8593239682|daniela.moga@uky.edu|
20156747|NCT03232567|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|sholland@altimmune.com|40
20156748|NCT01153516|University of Texas Southwestern at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20156749|NCT05837481|Massachusetts General Hospital|Chien Yi Maximilian Png, MD|617-726-5308|cypng@mgh.harvard.edu|
20156750|NCT04581395|IU school of Medicine, Department of Anesthesiology|Dr. Leighan Bye, Assistant Professor of Clinical Anesthesia|317-274-0275|lbye@iu.edu|
20156751|NCT00815633|Icahn School of Medicine at Mount Sinai|Dr. Joshua Zeichner||joshzeichner@gmail.com|
20156752|NCT01605097|BC Cancer|Dr Juanita Crook|250 712 3958|jcrook@bccancer.bc.ca|
20156753|NCT02038647|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20156754|NCT03078868|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
20156755|NCT03038620|UT Southwestern Medical Center|Dr. Parag Joshi|2146458000|parag.joshi@utsouthwestern.edu|
20156756|NCT05036343|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
20156757|NCT02733757|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
20156758|NCT01483560|University of Glasgow|Prof John Petrie|+44 141 330|John.Petrie@glasgow.ac.uk|3325
20156759|NCT02878785|University of Maryland Greenebaum Cancer Center|Maria Baer, M.D.|410-328-8708|mbaer@umm.edu|
20156760|NCT01968980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156761|NCT00265122|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
20156762|NCT04716894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20156763|NCT00608062|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau. PI|303-724-1914|kerrie.moreau@cuanschutz.edu|
20156764|NCT04992065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20156765|NCT00330733|Phoenix VA Health Care System|Peter Reaven|602 277 5551|Peter.Reaven@va.gov|5817
20156766|NCT00982280|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 0|Clinical-Trials@grunenthal.com|
20156767|NCT01506726|Duke University Medical Center|Harvey J. Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
20156768|NCT02231580|Ipsen|Vice President Early Development & Clinical Pharmacology||clinical.trials@ipsen.com|
20156769|NCT04724837|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94|information.center@astrazeneca.com|79
20156770|NCT03620981|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|06-6943-7722|CL_OPCJ_RDA_Team@otsuka.jp|
20156771|NCT02420717|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain MD./Associate Professor|713-745-6080|njain@mdanderson.org|
20156772|NCT04116489|UMass Chan Medical School; Tan Chingfen Graduate School of Nursing|Donna Perry, PhD, RN|508-856-3621|DonnaJ.Perry@umassmed.edu|
20156773|NCT03781570|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
20156774|NCT01107496|Supernus Pharmaceuticals, Inc.|Jonathan Rubin, MD, Senior Vice President and Chief Medical Officer|240-403-5710|jrubin@supernus.com|
20156775|NCT01346592|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20156776|NCT02476448|Cleveland Clinic Florida|Dr. Eric Hurtado|954-659-5559|hurtade@ccf.org|
20156777|NCT00937105|University Hospitals Eye Institute|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
20156778|NCT05185453|University of Pittsburgh|Dr. Alison Culyba|412-692-6056|alison.culyba@chp.edu|
20156779|NCT02516813|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20156780|NCT02399228|University of Texas Health Science Center at San Antonio|Dr. Ying Li, M.D., Ph.D.|210-450-1719|liy8@uthscsa.edu|
20156781|NCT03664544|Mitsubishi Tanabe Pharma Europe Ltd|General Information|Please e-mail|regulatory@mt-pharma-eu.com|
20156782|NCT04976777|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20156783|NCT02552225|Boson Medical Center|Pieter Noordzij, MD|(617) 414-1756|pieter.noordzij@bmc.org|
20156784|NCT01168596|University of Florida Center for Movement Disorders and Neurorestoration|Irene A. Malaty, MD|352-273-5550|Irene.Malaty@neurology.ufl.edu|
20156785|NCT00189423|Advanced Circulatory Systems, Inc.|Director of Clinical Trials|651-403-5600|csetum@advancedcirculatory.com|
20156786|NCT01332981|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20156787|NCT03901430|University of New Mexico|Julia Hess|5052724462|jmhess@unm.edu|
20156788|NCT01999530|Centre for Addiction and Mental Health|Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|34772
20169228|NCT05985980|Istanbul Medeniyet University|Mehmet Agirbasli MD|+902166065200|agirbasli@gmail.com|
20169229|NCT02625389|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20169230|NCT04854642|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20169231|NCT01709578|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20169232|NCT01107418|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20169233|NCT00597701|Essentia Health|Charles E Gessert, MD, MPH|218-786-8176|cgessert@eirh.org|
20169234|NCT00988325|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20169235|NCT01155219|Laboratoires Thea|Dr Pascale Pouliquen|0473981436|p.pouliquen@laboratoires-thea.fr|
20169236|NCT02670343|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Christina Wang, MDAssociate Director UCLA Clinical and Translational Science Institute|1-310-222-1888|wang@labiomed.org|
20169237|NCT01314911|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D|301-451-9881|jbeigel@niaid.nih.gov|
20169238|NCT00306202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20169239|NCT01394718|Children's Hospital of Philadelphia|Athena Zuppa, MD, MSCE|267-426-7359|zuppa@email.chop.edu|
20169240|NCT03387150|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20169241|NCT04006119|Alaunos Therapeutics, Inc|Jaymes Holland, Clinical Consultant|6502732627|jholland@alaunos.com|
20169242|NCT04617795|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
20169243|NCT00472459|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20169244|NCT04850313|University of Arkansas for Medical Sciences|Dr. David Warner|501-686-5822|DBwarner@uams.edu|
20169245|NCT04999982|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Andrea Spencer|3122273402|aspencer@luriechildrens.org|
20169246|NCT03269552|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
20169247|NCT02186301|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
20169248|NCT01490723|U.T. MD Anderson Cancer Center|Issa F. Khouri, M.D., Stem Cell Transplantation|(713) 745-0049|ikhouri@mdanderson.org|
20169249|NCT03560739|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20169250|NCT01362595|Feinstein Institutes for Medical Research|Dr. Adrianna Vlachos|516-562-1504|avlachos@northwell.edu|
20201892|NCT00430040|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
20201893|NCT01896232|Amgen Inc.|Study Director|866-572-6436||
20201894|NCT02983058|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-8436|marlene.carlson@nyspi.columbia.edu|
20201895|NCT00852644|Boston Medical Center|Minh Tam Truong|617-638-7070|minh-tam.truong@bmc.org|
20201896|NCT01583647|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201897|NCT03816995|The Cleveland Clinic|Rita Brienza|216-399-9186|brienzr@ccf.org|
20201898|NCT01324830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20201899|NCT01485614|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201900|NCT00733902|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201901|NCT02210780|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20201902|NCT03537664|University of Sao Paulo|Dr. Ericka Pinheiro|551126488293|erickapinheiro@usp.br|
20201903|NCT02872103|Generon|Jianmin Chen|7327100262|jianmin_chen@generonbiomed.com|
20201904|NCT03617926|Oystershell Laboratories|Frank Eertmans|+3293772485|fe@oystershell.be|
20201905|NCT01503021|Rockwell Medical, Inc|Senior Director, Clinical Research|248-960-9009|rd@rockwellmed.com|
20201906|NCT03941548|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
20201907|NCT01242111|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
20201908|NCT00870688|Desitin|Lohmueller|0049(0)40-59101|lohmueller@desitin.de|373
20201909|NCT00987415|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
20201910|NCT02945657|Medimetriks Pharmaceuticals, Inc.|Director of Clinical Development|973-882-7512|clinicaltrials.gov_inquiries@medimetriks.com|524
20201911|NCT00087438|Radition Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
20201912|NCT02904226|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
20201913|NCT03348514|University of Kansas Medical Center|Dr. John A Taylor III|913-588-8170|Jtaylor27@kumc.edu|
20201914|NCT02371629|Novartis Pharmaceuticals|Study Director|862-778-8300||
20156789|NCT01385579|Northwestern University|Dr. Muriel Jean-Jacques, Assistant professor|312-503-9642|mjean@nmff.org|
20156790|NCT03359161|St. Elizabeth's Medical Center|Dr. Lana Tsao|617-789-3036|lana.tsao@steward.org|
20156791|NCT01681147|Joslin Diabetes Center|Dr. Florence Brown|617-309-2675|Florence.Brown@joslin.harvard.edu|
20156792|NCT00565747|Origio A/S|Chief Scientific Officer|+45 46790200|sbendz@origio.com|
20156793|NCT00183248|University of Miami|George W. Burke III, M.D.|(305) 355-5060|Gburke@med.miami.edu|
20156794|NCT01697709|NYSPI|john mariani. MD|212-923-3031|John.mariani@nyspi.columbia.edu|
20156795|NCT04734210|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
20156796|NCT02684461|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|gmelahat@med.unc.edu|
20156797|NCT04507204|Purdue Pharma L.P.|Jaromir Mikl, PhD MSPH|800-745-7445|jaromir.mikl@pharma.com|7277
20156798|NCT03580044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156799|NCT00687076|Baylor College of Medicine|Gerd Brunner, PhD|713-790-5800|gbrunner@bcm.edu|
20156800|NCT03594500|VA NY Harbor Healthcare System|Dr. Joshua Chodosh|212-686-7500|joshua.chodosh@va.gov|5043
20169251|NCT00959374|Covidien|Amy Pollack M.D. Vice President Medical Affairs, STI|203-821-4719|amy.pollack@covidien.com|
20169252|NCT02448680|LFB USA, Inc.|Kerry Biron, Director US Clinical Operations|508-370-5166|kerry.biron@lfb-usa.com|
20169253|NCT01285947|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20169254|NCT04243421|Medical University of Białystok|Małgorzata Pietruska|+48606461092|mpietruska@wp.pl|
20169255|NCT01741012|Wayne State University School of Medicine|Dr. J. Patricia Dhar, MD, Principal Investigator|313-577-6011|pdhar@med.wayne.edu|
20169256|NCT00095238|Britol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20169257|NCT03505671|Wake Forest Baptist Comprehensive Cancer Center|Nancy Avis, PhD|336-713-5440|navis@wakehealth.edu|
20169258|NCT00586729|Maricopa Integrated Health System|Karen Richey, RN|602-344-5125|karen.richey@mihs.org|
20169259|NCT00749580|USF Health|Charurut Somboonwit, MD|813 3078067|csomboon@health.usf.edu|
20169260|NCT03410823|University of Maryland School of Medicine|Denise Orwig|410-706-2406|dorwig@som.umaryland.edu|
20169261|NCT06460493|Verona Pharma|Clinical Development|844-341-9901|clinicaltrials@veronapharma.com|
20169262|NCT04704154|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20169263|NCT03220438|University of Maryland Baltimore|Dr Laura Rowland|410-402-6073|lrowland@som.umaryland.edu|
20169264|NCT04565236|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20169265|NCT02339376|Beth Israel Deaconess Medical Center|Bernard S. Chang, M.D.|617-632-8930|bchang@bidmc.harvard.edu|
20169266|NCT01117051|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20169267|NCT03584373|Montefiore Medical Center|Dr. Kara Watts, Associate Professor, Department of Urology|718-920-4531|kwatts@montefiore.org|
20169268|NCT03780400|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
20169269|NCT03127956|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20169270|NCT01001299|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20169271|NCT01923168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20169272|NCT03882008|University of Washington|Bobby Kwanghoon Han|206-685-9950|hank4@uw.edu|
20169273|NCT04831788|University of Novi Sad, Faculty of Medicine|Prof. Vladimir Petrovic|+381648028800|vladimir.petrovic@izjzv.org.rs|
20169274|NCT00768469|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20169275|NCT00957593|Lehigh Valley Health Netword|Joanne N. Quinones MD MSCE|6104021221|joanne_n.quinones@lvhn.org|
20169276|NCT01582854|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
20169277|NCT04068896|NGM Biopharmaceuticals|VP Clinical Operations|(650)243-5555|ngm120@ngmbio.com|
20169278|NCT02953509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20169279|NCT05780268|University of Minnesota|Birgit Grund|612- 626-8622|birgit@ccbr.umn.edu|
20169280|NCT00484185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169281|NCT00459056|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
20169282|NCT02522871|TransMedics|Laura Damme|978-552-0910|LDamme@TransMedics.com|
20169283|NCT00573287|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|6036507549|alan.i.green@dartmouth.edu|
20169284|NCT01222403|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20169285|NCT00725842|Merck Sharp & Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20169286|NCT00947505|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
20169287|NCT00618839|Stratatech Corporation|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
20169288|NCT02793622|University of California, San Francisco|Grant Dorsey, MD|628-206-4680|grant.dorsey@ucsf.edu|
20169289|NCT03442400|Cleveland Clinic|Samir Kapadia, MD|216-444-6735|kapadis@ccf.org|
20169290|NCT01075191|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20169291|NCT00133978|Clinical Evaluation Research Unit|Dr. Daren Heyland|613-549-6666|dkh2@queensu.ca|4847
20169292|NCT00718237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169293|NCT02068768|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
20169294|NCT00555425|Yale University|Dr. David Fiellin|203-688-2471|david.fiellin@yale.edu|
20169295|NCT01262352|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20169296|NCT01185834|Alcon Research, Ltd.|Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO|1-800-241-7629||
20169297|NCT01683019|NeoSync, Inc.|Dr. Bill Phillips|949-333-2906|bill@neosync.com|
20169298|NCT03070444|Folktandvården Gävleborg AB|Anke Krämer|+4625155680|anke.kramer@regiongavleborg.se|
20169299|NCT01373489|Medical College of Wisconsin|Jennifer Campbell|4149558829|jacampbell@mcw.edu|
20169300|NCT00543855|Eisai Co., Ltd.|Masaki Nakagawa, Study Director|+81-3-3817-5245||
20169301|NCT04285580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20169302|NCT02582255|FIDEC|Ricardo Rüttimann|+13058540075|rruttimann@fidec-online.org|
20169303|NCT00847171|Johns Hopkins University|Dr. Leisha Emens||emensle@jhmi.edu|
20169304|NCT04509739|University of Washington|Christina Zhao|206-221-6415|zhaotc@uw.edu|
20169305|NCT04050371|UCSF|Robert Grant|415-323-6658|robert.grant@ucsf.edu|
20169306|NCT01547780|National Institute of Mental Health|Robert Innis|+1 301 594 1368|innisr@mail.nih.gov|
20169307|NCT02195414|The General Hospital of Shenyang Military Region|Yaling Han, Study Chair of Clinical Trials|+86-024-28856123|hanyaling@263.net|
20169308|NCT01736657|Terumo BCT, Inc.|Ray Goodrich, Phd, VP Scientifc and Clinical Affairs|303-205-2680||
20169309|NCT04198818|Haihe Biopharma Co., Ltd|Medical Officer|86-(021)-20568888|fugen.li@haihepharma.com|8988
20169310|NCT04123665|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20169311|NCT01680549|Texas Tech University Health Sciences Center|Nancy Swinford|806-743-2569|nancy.swinford@ttuhsc.edu|
20169312|NCT02547714|Novartis Pharmaceuticals|Study Director|862-778-8300||
20169313|NCT04396496|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
20169314|NCT01711879|University of Colorado School of Medicine|Rachel Gerle|720-848-2020|rachel.gerle@ucdenver.edu|
20169315|NCT00958789|Stryker Orthopaedics|Ellen Axelson, Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
20169316|NCT02464917|Memorial Health Systems|Michael Nageotte, MD|562-933-2748|mnageotte@memorialcare.org|
20201915|NCT03502746|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
20201916|NCT00551707|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
20201917|NCT01073943|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20156801|NCT02134184|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20156802|NCT01137890|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
20156803|NCT04700800|Mayo Clinic|Lori Roust|(602) 543-4254|Roust.Lori@mayo.edu|
20156804|NCT02300233|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20156805|NCT02836249|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20156806|NCT04752566|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
20156807|NCT03331354|VA North Texas Health Care System|James LePage|214-857-0240|james.lepage@va.gov|
20156808|NCT00928668|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20156809|NCT02958865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156810|NCT01767987|Kettering Health Network|Suzanne Coleman, PhD|937-395-8390|suzanne.coleman@khnetwork.org|
20156811|NCT05112640|University of Texas Medical Branch|Brett Goldman|9542632359|brettryangoldman@gmail.com|
20156812|NCT00189475|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|4123594099|dskoner@wpahs.org|
20156813|NCT02474498|Piracicaba Dental School - University of Campinas|Prof.Dr. Enilson Antonio Sallum|+55 19 2106-5301|easallum@fop.unicamp.br|
20156814|NCT00244985|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20156815|NCT00654355|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3885|sfeldman@wfubmc.edu|
20156816|NCT05022719|Medtronic|Melanie Crystal|774-245-8756|melanie.crystal@medtronic.com|
20156817|NCT05006495|Seoul National University Hospital|Researcher of Clinical Trials|+821049051485|junhiya@snu.ac.kr|
20156818|NCT02284893|AstraZeneca|Katarina Fridman|+46(31)7762040|katarina.fridman@astrazeneca.com|62040
20156819|NCT02757430|Abbott|Clinical Research Scientist|6517562885|amber.miller@abbott.com|
20156820|NCT04116684|Cleveland Clinic|Venu Menon, M. D.|216-445-5390|menonv@ccf.org|
20156821|NCT02908178|Yale University|Shi-Yi Wang, MD, PhD|2037852886|shiyi.wang@yale.edu|
20156822|NCT02106832|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20156823|NCT03648892|NIH|Dr. Kevin Hall|301-402-8248|kevinh@niddk.nih.gov|
20156824|NCT02268656|Gil hospital|Dr. Hyun Jeong Kwak|82324603636|hyun615@gilhospital.com|
20156825|NCT04537650|KITE Research Institute - University Health Network|Catriona M. Steele, PhD|14165973422|catriona.steele@uhn.ca|7802
20156826|NCT01772654|Mayo Clinic|Cheolsu Shin, M.D.|507-284-4961|shin@mayo.edu|
20156827|NCT01890031|University of Rochester|Robert Block, MD, MPH; Clinical Trial Director|585-275-3356|robert_block@urmc.rochester.edu|
20156828|NCT00071032|Rutgers Robert Wood Johnsom Medical School|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@rutgers.edu|
20156829|NCT01903863|Duke University Hospital|Dr. Caroline Ozment|919-681-2554||
20156830|NCT04261985|UCLA DGSOM|Dr. Alma Guerrero|3102672789|aguerrero@mednet.ucla.edu|
20156831|NCT02096107|Medical University of South Carolina|David Taber|843-792-3368|taberd@musc.edu|
20156832|NCT03537508|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20156833|NCT01972659|Kocaeli University Medical Faculty|Assistant Professor Dr Z Ipek ARSLAN AYDIN|00905325011339|zehraipek48@gmail.com|
20156834|NCT04652765|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Cathy Handy Marshall|4109550231|chm@jhmi.edu|
20156835|NCT04308512|Baylor College of Medicine|Dr. Bijan Najafi|(424) 467-7127|najafi.bijan@gmail.com|
20156836|NCT03176173|Stanford University|Clinical Associate Professor, Radiation Oncology - Radiation Therapy|(650) 723-6171|mgens@stanford.edu|
20156837|NCT05715827|Medtronic|Yewon Lee|1031132023|yewon.lee@medtronic.com|
20156838|NCT04569084|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|908-607-1980|information@mt-pharma-us.com|
20156839|NCT02513641|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
20156840|NCT06022107|Yale University|Li Yan McCurdy, PhD|2037372912|liyan.mccurdy@yale.edu|
20156841|NCT02333799|Global Alliance for TB Drug Development|Eugene Sun, MD|212-227-7540|eugene.sun@tballiance.org|
20156842|NCT05484895|Emory University|Dr. Don Operario|404-727-0503|don.operario@emory.edu|
20156843|NCT02964377|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
20156844|NCT00876447|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20156845|NCT00123630|University of Utah|Dr. John Fang|801-581-7802|john.fang@hsc.utah.edu|
20156846|NCT02297516|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
20156847|NCT00710593|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20156848|NCT04490278|Washington University|Chris Palmer|314-215-7384|cmpalmer@wustl.edu|
20156849|NCT00525421|University of California San Francisco|Nita Chainani-Wu|415-476-2045|nita.wu@ucsf.edu|
20156850|NCT00366457|Massachusetts General Hospital|Lawrence S. Blaszkowsky, MD|6172191230|LBLASZKOWSKY@mgh.harvard.edu|
20156851|NCT02829996|Inotek Pharmaceuticals Corp.|Roni Cohen|781-676-2100|rcohen@inotekpharma.com|
20169317|NCT00478881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20201918|NCT02700529|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
20169318|NCT01466179|Amgen Inc.|Study Director|866-572-6436||
20169319|NCT03028350|Cumberland Pharmaceuticals|Senior Clinical Scientist|6154257644|bgibson@cumberlandpharma.com|
20169320|NCT01083173|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20169321|NCT02266914|The Ohio State University Wexner Medical Center|Tamara McMath, MPH|614-293-8082|tamara.mcmath@osumc.edu|
20169322|NCT00792077|UT MD Anderson Cancer Center|Sriram Yennu, MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
20169323|NCT03139604|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20169324|NCT00585559|Vanderbilt University Medical Center|Dr. Matthew Fusco|615-322-1054|matthew.r.fusco@vumc.org|
20169325|NCT00740246|Luitpold Pharmaceuticals, Inc.|Mark A Falone|610-650-4200|mfalone@americanregent.com|844
20169326|NCT02882074|Cleveland Clinic|Dr. Marta Kelava|2162133218|kelavam@ccf.org|
20169327|NCT03535571|KGK Science Inc.|Dr. Mal Evans|519-438-9374|mevans@kgkscience.com|
20169328|NCT00662532|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
20169329|NCT00366340|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169330|NCT00442468|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169331|NCT00589784|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|KaleyT@mskcc.org|
20169332|NCT03823378|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20169333|NCT01606254|Janssen Pharm KK Japan|Medical Director|81-3-4411||5509
20169334|NCT01056380|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
20169335|NCT03189381|Indiana University (IU)|Dr. Kevin Shiue|317 944 2524|kshiue@iupui.edu|
20169336|NCT01975831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20169337|NCT01401959|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20169338|NCT00251004|Novartis Pharmaceuticals|Study Director|862-778-8300||
20169339|NCT02051816|LSU School of Medicine New Orleans|David Janz, MD, MSc|504-568-3167|djanz@lsuhsc.edu|
20169340|NCT02694718|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20169341|NCT02925793|DS Biopharma|Study Director|+35312933590|regulatory.dsbiopharma@dsbiopharma.com|
20169342|NCT01244490|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20169343|NCT00393042|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
20169344|NCT00824070|Bausch & Lomb Inc|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
20169345|NCT03020446|University of Toledo|Munier Nazzal, MD|419-383-3576|Munier.Nazzal@utoledo.edu|
20169346|NCT01115582|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
20169347|NCT03324581|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20169348|NCT01120834|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
20169349|NCT00321893|University of Texas MD Anderson|Powel H. Brown, MD, PhD/Professor of Medicine and Cancer Prevention||CR_Study_Registration@mdanderson.org|
20169350|NCT03455764|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
20169351|NCT03523000|University Hospitals Cleveland Medical Center|Dr. Salim Hayek|216-844-2685|salim.hayek@uhhospitals.org|
20169352|NCT00495131|National Taiwan University Hospital|Chen-Hua Liu, MD|886223123456|jacque_liu@mail2000.com.tw|63572
20169353|NCT00727532|Northwestern University|Results Entry Administrator|312-695-1301|croqualityassurance@northwestern.edu|
20169354|NCT00829933|Daiichi Sankyo.,LTD|So Yoshino, Manager|81-90-8024-0742|yoshino.so.ej@daiichisankyo.co.jp|
20169355|NCT00523367|University of Florida|Juan Munoz, MD|904-633-0089|juan.munoz@jax.ufl.edu|
20169356|NCT01848041|RVL Pharmaceuticals|Sr. Director, Clinical Development|908-809-1423|mvelasco@osmotica.com|
20169357|NCT04461509|Cedars-Sinai Medical Center|Laura Sarmiento|310-423-4295|Laura.sarmiento@cshs.org|
20169358|NCT00076024|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169359|NCT02417844|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169360|NCT00902161|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169361|NCT01785095|IBSA Institut Biochimique SA|IBSA Clinical Research Manager|+41583601000|rd@ibsa.com|
20169362|NCT00301821|Mayo Clinic|Ivana N. M. Micallef, M.D.|507-284-4642|micallef.ivana@mayo.edu|
20169363|NCT02294773|Midwest Fertility Specialists or St. Vincent Women's Hospital|Dr. Matt Will or Dr. Lauren Messinger|317-415-7528|laurenmessinger@gmail.com|
20169364|NCT03052764|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20169365|NCT03150485|Johnson & Johnson Vision|Thomas Karkkainen - SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
20169366|NCT02097537|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group||clinical@santen.co.jp|
20169367|NCT05828095|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20169368|NCT01981759|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
20169369|NCT03206073|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
20169370|NCT00255801|Memorial Sloan Kettering Cancer Center|Dr. David Straus|212-639-8365|strausd@mskcc.org|
20169371|NCT03332771|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
20169372|NCT00403403|Genentech, Inc.|Medical Communications|800-821-8590||
20169373|NCT00096954|Hoffman-LaRoche|Medical Communications|800-821-8590||
20169374|NCT04176497|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-966-4432|Melahat_Canter@med.unc.edu|
20169375|NCT03442764|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20169376|NCT04478123|Memorial Sloan Kettering Cancer Center|Dr. Michael Scordo, MD|646-608-3771|scordom@mskcc.org|
20169378|NCT02395016|Biotech Pharmaceutical Co., Ltd.|Director of Clinical Trials|010-51571020|lucy_he@biotechplc.com|8753
20169379|NCT04444895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20169380|NCT00719264|Novartis Pharmaceuticals|Study Director|862-778-8300||
20169381|NCT00814879|Yale University School of Medicine: Internal Medicine: Infectious Diseases: AIDS Care Program / Viral Hepatitis Program|Dr. Michael J. Kozal|(203)737-4040|michael.kozal@yale.edu|
20169382|NCT01277042|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169383|NCT00588952|Yale University|Ismene Petrakis|203-932-5711|Ismene.petrakis@yale.edu|2244
20169384|NCT01461057|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20169385|NCT03034200|Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Peter Anderson|216-308-2706|andersp@ccf.org|
20169386|NCT01288976|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
20169387|NCT01966692|Unversity of Florida|Dr Yuanyuan Jiao|(407) 313-7014|yyjiao@cop.ufl.edu|
20169388|NCT01823510|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|212-241-8484|juan.badimon@mssm.edu|
20169389|NCT05523323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169390|NCT02469038|University of Chicago|Melanie Norstrom|773-702-1991|mnorstrom@medicine.bsd.uchicago.edu|
20169391|NCT03435640|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20169392|NCT00636987|St Jude Medical|Sr. Clinical Manager|6517566803|jjohnson101@sjm.com|
20169393|NCT01251146|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20169394|NCT01739400|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
20169395|NCT03350984|University of Guanajuato|Dra. Paulina Crespo Morfin|+52 4431300112|pb.crespomorfin@outlook.es|
20169396|NCT00642473|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20169397|NCT01347307|Mercy Research|Lead Regulatory Coordinator - Investigator Initiated Trials|314-251-8827|michelle.mcfarland@mercy.net|
20169398|NCT02876640|University of Wisconsin - Madison|Lisa Barroilhet, MD, MS|608-264-3204|barroilhet@wisc.edu|
20169399|NCT00920829|Medical University of South Carolina|Dr. Raymond Anton|843-792-1226|antonr@musc.edu|
20169400|NCT04533880|NYU Langone Health|Larry Chen|(646) 501-7200|Larry.Chen@nyulangone.org|
20169401|NCT05654441|University of North Carolina at Chapel Hill|Keely Muscatell, PhD|919-843-5467|kmuscatell@unc.edu|
20169402|NCT02284178|University of Central Florida|Mary Lou Sole|407-823-5496|mary.sole@ucf.edu|
20169403|NCT01955980|PARI Pharma|Friedrich Gruber|+4989742846|friedrich.gruber@pari.com|10
20169404|NCT01483690|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
20201919|NCT01051739|Iowa City Veterans Administration Medical Center|Michael Wall, M.D.|319-3380581|michael-wall@uiowa.edu|
20169405|NCT02260531|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
20169406|NCT04534465|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20169407|NCT02239224|aTyR Pharma|Gennyne Walker|858 731 8389|clinicaltrials@atyrpharma.com|
20169408|NCT00073073|Georgetown University|Dr. Claudine Isaacs|(202)444-3677|isaacsc@georgetown.edu|
20169409|NCT00737464|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20169410|NCT04218123|Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina|Habib Rizk, MD, MSc|8438760112|rizkh@musc.edu|
20156852|NCT02538614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20156853|NCT01098747|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156854|NCT03302767|Institut Bergonié|Véronique GERAT-MULLER|0556337839|v.gerat-muller@bordeaux.unicancer.fr|
20156855|NCT01383005|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20156856|NCT02458235|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
20156857|NCT00845702|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
20156858|NCT00030264|Children's Hospital of Philadelphia|Ratnakar Patti|267-426-5503||
20156859|NCT02300545|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
20156860|NCT01517984|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20156861|NCT04903288|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20156862|NCT00904371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20156863|NCT04252014|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
20156864|NCT04617860|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
20156865|NCT03898180|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20156866|NCT02507934|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20156867|NCT04392154|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20156868|NCT01559935|Weill Cornell Medicine|Ruben Niesvizky, MD|6469626500|run9001@med.cornell.edu|
20156869|NCT02661815|Dana-Farber Cancer Insitute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
20156870|NCT02527512|Boston Children's Hospital|Lauren Hutchinson, Clinical Research Manager|6179191632|lauren.hutchinson@childrens.harvard.edu|
20156871|NCT05805150|CooperVision|Jose Vega|925-621-3761|jvega2@coopervision.com|
20156872|NCT01983111|Mundipharma Korea Ltd.|PhD. Miyoung Song||miyoung.song@mundipharma.co.kr|
20156873|NCT03817580|Eurofins EVIC|Commercial Manager|40 213357090|luciachirita@eurofins.com|
20156874|NCT00105066|National Institute On Aging|Dr. James Strait|4105588084|straitj@mail.nih.gov|
20201920|NCT03527043|Weill Cornell Medicine|Jonathan Gal|646-962-4811|jog4018@med.cornell.edu|
20169411|NCT03190369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20169412|NCT04543409|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20169413|NCT01289782|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20169414|NCT02131532|University of Edinburgh|Dr Simiao Wu|0044-131-242-6371|simiao.wu@ed.ac.uk|26371
20169415|NCT02093026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20169416|NCT04499599|L-Nutra, Inc.|Dr. Min Wei|323.791.2426|mwei@l-nutra.com|
20169417|NCT03742440|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
20169418|NCT00055224|National Institute of Mental Health|Dr Maryland Pao|(301) 435 5770|paom@mail.nih.gov|
20169419|NCT03436810|Mahidol University|Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|
20169420|NCT00121173|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
20169421|NCT04081233|The University of Texas Health Science Center at Houston|David E. Meyer, MD, MS, FACS|713-500-7244|David.E.Meyer@uth.tmc.edu|
20201921|NCT04871815|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
20169422|NCT01677312|Center for Interventional Endoscopy, Florida Hospital|Dr. Shyam Varadarajulu, MD|407-303-2570|svaradarajulu@yahoo.com|
20169423|NCT02195011|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
20169424|NCT00977808|University of Virginia|Boris Kovatchev, Ph.D./Principal Investigator|434-982-6479|pcm9b@virginia.edu|
20169425|NCT04291001|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
20169426|NCT00174291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169427|NCT00450112|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
20169428|NCT01642407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169429|NCT02045303|Texas Health Resources Presbyterian Hospital of Dallas|Lisley Viana, Physical Therapist|214-345-4334|lisleyviana@texashealth.org|
20169430|NCT01856023|Clinigen|Head of Medical Affairs|8323263256|nancy.gregory@clinigengroup.com|
20169431|NCT00829283|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
20169432|NCT00424255|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169433|NCT00256282|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
20169434|NCT02431247|Janssen Sciences Ireland UC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20169435|NCT00667446|AbbVie, (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20169436|NCT02829983|Universidade Estadual Paulista Júlio de Mesquita Filho|Mauro Pedrine Santamaria|3947-9033|mauro.santamaria@ict.unesp.br|
20169437|NCT00322153|Forest Research Institute|Stephen M Graham, PhD|201-427-8156|Stephen.Graham@frx.com|
20169438|NCT03004248|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
20169439|NCT02414139|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
20169440|NCT00591578|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20169441|NCT04644783|University of Michigan|Mohamad El Zaatari|734-647-2954|mohamade@med.umich.edu|
20169442|NCT01723696|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
20169443|NCT01952470|Alfred Health|Benjamin James Tarrant|+61404455658|b.tarrant@alfred.org.au|
20169444|NCT02300727|Aurora Health Care - Bay Area Medical Center|Dhimant Patel, MD|920-288-4123|dhimant.patel@aurora.org|
20169445|NCT00356122|Sanofi-Aventis|Trial Transparency Team||Contact-Us@sanofi.com|
20169446|NCT00491556|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20169447|NCT00782795|University of Michigan|Matthew DiMagno||mdimagno@umich.edu|
20169448|NCT04480424|Scientific Innovation Office (SIO) Clinical Program Leader/Director Bioscience Clinical & Pharmacovigilance|Rhonda Griffin|+1 919 316 6693|Rhonda.griffin@grifols.com|
20169449|NCT01094561|Columbia University|Elizabeth Hecht, MD|(212)305-6510|eh2560@cumc.columbia.edu|
20169450|NCT01909453|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169451|NCT03437512|University of Michigan|Emily O. Garnett, PhD, CCC-SLP|734-232-3371|emilyog@med.umich.edu|
20169452|NCT01897714|Oncopeptides AB|Eva Nordström|+4686152040|trials@oncopeptides.com|
20169453|NCT01994590|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-2830|PCorn@mdanderson.org|
20169454|NCT01801072|University of Michigan|Dr. Aditya Pandey, Chair, Department of Neurosurgery|734-936-7010|adityap@umich.edu|
20169455|NCT03693170|Pierre Fabre Medicament|Isabelle Klauck, MD|+33149108018|isabelle.klauck@pierre-fabre.com|
20169456|NCT00053365|Gynecologic Oncology Group|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20169457|NCT03718871|Weill Cornell Medicine|Dr. Radhika Sundararajan|(646) 962-4654|ras9199@med.cornell.edu|
20169458|NCT03183778|NYU Langone Health|David Goldfarb, MD|212-263-0744|David.Goldfarb@nyulangone.org|
20169459|NCT01885871|Cutera, Inc|Clinical Research Department|1-888-428-8372|gweiss@cutera.com|
20201922|NCT02039947|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
20201923|NCT01772134|GlaxoSmithKline|GSK Response Center|866-435-7343||
20201924|NCT02500550|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
20201925|NCT03352245|Yale University|Dr. Brett Bade|203 785 6670|Brett.bade@yale.edu|
20201926|NCT00424398|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20201927|NCT01023789|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
20201928|NCT00095563|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
20169460|NCT00721123|Hoffmann-La Roche|Medical Communications|800 821-8590||
20169461|NCT00905827|Department of Veteran Affairs|Kathryn Magruder|843-789-7280|Kathryn.Magruder@va.gov|
20201929|NCT02335502|St. Jude Medical|Roni Diaz|+19723098601|RDiaz@sjm.com|
20169462|NCT00872027|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
20169463|NCT00509392|VNUS Medical Technologies / Covidien (sponsor)|Eppie Chang, MS; Director Clinical Research|408-360-7200|eppie.chang@covidien.com|
20169464|NCT05386823|HighField BioPharmaceuticals Corporation|Dr. Yuhong Xu|+86-571-86961869|yhxu@hf-biopharm.com|
20169465|NCT03007407|NSABP Foundation|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
20169466|NCT03228420|Nevro Corp.|Donald Middlebrook|(650) 433-2218|don.middlebrook@nevro.com|
20169467|NCT05959200|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20169468|NCT03954041|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20169469|NCT02090075|Los Angeles Biomedical Research Institute at Harbo|Dr Matthew Budoff|3102224107|mbudoff@labiomed.org|
20169470|NCT03868124|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
20169471|NCT04177355|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20169472|NCT03981822|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20169473|NCT02742246|Yale University School of Medicine|Dr. Brian Kiluk, Associate Professor of Psychiatry|203-737-1544|Brian.kiluk@yale.edu|
20169474|NCT03489551|University of Iowa|Michelle Weckmann|319-384-7538|michelle-weckmann@uiowa.edu|
20169475|NCT02519387|Mundipharma Pharmaceuticals Sdn Bhd|Elayne Chan|+60 122162170|Elayne.Chan@mundipharma.com.my|
20169476|NCT00054717|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169477|NCT01896479|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20169478|NCT00206076|Drexel University College of Medicine|David Reich, MD|215-762-7143|David.Reich@DrexelMed.edu|
20169479|NCT01060345|University of Chicago|Nora Jaskowiak, MD|773-702-2048|njaskowi@surgery.bsd.uchicago.edu|
20169480|NCT01754909|Baltimore VAMC|Dr Eric Cohen|410 605 7000|eric.cohen@va.gov|5/7182
20169481|NCT03418571|Ablynx NV|Medical Monitor|+32 9 262 00 00|clinicaltrials@ablynx.com|
20169482|NCT00586326|Hologic, Inc.|Nancy Chenette, Director, Clinical Affairs|508-263-8770|nancy.chenette@hologic.com|
20169483|NCT03595774|Indiana University Purdue University Indianapolis|Dr. Andrew R. Coggan|3172740656|acoggan@iu.edu|
20169484|NCT03519386|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
20169485|NCT02783469|University of Dundee|Professor Blair H. Smith|01382383795|b.h.smith@dundee.ac.uk|
20169486|NCT03101267|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
20169487|NCT00107952|Theravance Biopharma Antibiotics, Inc.|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
20169488|NCT03794882|University of Wisconsin-Madison|Dr Kristin Bevil|6082638100|kbevil@wisc.edu|
20169489|NCT01376557|Lexicon Pharmaceuticals, Inc.|Dr. Paul Strumph|(281) 863-3302|pstrumph@lexpharma.com|
20169490|NCT03063203|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
20169491|NCT02632838|School of Nursing, Rutgers, the State University of New Jersey|Dr. Peijia Zha|7327637412|peijiaz@sn.rutgers.edu|
20169492|NCT03945175|NYU Langone Health|Terry Leon|646 754 4837|terry.leon@nyulangone.org|
20169493|NCT02797054|University of Colorado|Julie A Maertens|303-724-7319|julie.maertens@ucdenver.edu|
20169494|NCT03221764|University of Louisville|Dr. Victor van Berkel|502-588-7600|victor.vanberkel@ulp.org|
20169495|NCT00769483|UT MD Anderson Cancer Center|Milind Javle, MD/Professor, GI Medical Oncology|713-792-2828|mjavle@mdanderson.org|
20169496|NCT01306877|Covidien|Tam LaFleur, Clinical Project Manager|203-821-4744|tam.lafleur@covidien.com|
20169497|NCT00006389|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20169498|NCT01958112|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
20169499|NCT00939952|Albany College of Pharmacy and Health Sciences|Katie Cardone|518-694-7875|katie.cardone@acphs.edu|
20169500|NCT04812080|University of California Davis|Dr. Moon Chen|916-734-1191|mschenjr@ucdavis.edu|
20169501|NCT00999921|Medical College and Hospital Kolkata|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
20169502|NCT02376283|The Royal Wolverhampton NHS Trust|Prof James Cotton|01902307999|jamescotton@nhs.net|
20169503|NCT05074173|Tulane University School of Medicine|Keith Ferdinand|504-988-5492|kferdina@tulane.edu|
20169504|NCT02495103|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
20169505|NCT00772070|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
20169506|NCT01309308|Baskent University|Ayse Parlakgumus|00903224586868|ayseparlakgumus@yahoo.de|2102
20169507|NCT02750215|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-726-8033|RHEIST@PARTNERS.ORG|
20169508|NCT01307020|Menarini Ricerche S.p.A.|Dr Angela Capriati, Corporate Clinical Research Director|+39 055 5680 9933|acapriati@menarini-ricerche.it|
20169509|NCT02380690|VA ORD|Robert O'Brien|2024435741|Robert.O'Brien2@va.gov|
20169510|NCT00266864|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
20169511|NCT02338336|Norwarta|Peggy Hagerty|267-240-4010|hagertymws@comcast.net|
20169512|NCT04647890|Certa Therapeutics Pty Ltd|Prof Darren Kelly, CEO|+61 3 9657 0700|dkelly@certatherapeutics.com|
20169513|NCT03687970|Washington University|Simon Haroutounian, PhD. Assistant Professor,|314-286-1715|simon.haroutounian@wustl.edu|
20169514|NCT03119701|Faron Pharmaceuticals Ltd|Chief Medical Officer|+3584005529411|medical@faron.com|
20169515|NCT02691962|Becton Dickinson and Company|Dawn Heimer|+1-401-825-8681|Dawn.Heimer@bd.com|
20169516|NCT00596362|Memorial Sloan Kettering Cancer Center|Dr. David Abramson|212-639-7232|abramsod@mskcc.org|
20169517|NCT02793128|UroGen Pharma Ltd.|Madlen Malinowski|6467689533|madlen.malinowski@urogen.com|
20169518|NCT00427960|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
20169519|NCT01142128|University of Florida|Phillip Toskes, M.D.|352-273-9493|phillip.toskes@medicine.ufl.edu|
20201930|NCT00246259|Janssen Inc., Toronto, ON, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
20169520|NCT03355664|Mahidol Oxford Tropical Medicine Research Unit (MORU)|Thomas Peto|(+66) 802 187 460|tom@tropmedres.ac|
20169521|NCT01337687|Montefiore Medical Center, Albert Einstein College of Medicine|Casara Jean Ferretti|3472499694|cferrett@montefiore.org|
20169522|NCT02145507|Haemonetics (trial sponsor)|Adrian Orr, Clinical Research Director|781.356.9647|aorr@haemonetics.com|
20169523|NCT01960387|University of Pittsburgh Cancer Institute|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
20169524|NCT00423670|Merck, Sharp and Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20169525|NCT04163718|Moffitt Cancer Center|Javier Pinilla, MD, PhD|813-745-8212|javier.pinilla@moffitt.org|
20169526|NCT01466595|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20169527|NCT02313454|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20169528|NCT02376829|Align Technology Inc|Sherri Wilson-Lopes|408-470-1032|swilson@aligntech.com|
20169529|NCT03631355|NYU Langone Health Orthopedic Hospital|Dr. Michael J. Alaia|6465017223|michael.alaia@nyulangone.org|
20169530|NCT02810340|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20169531|NCT01412918|Medical College of Wisconsion|Dr. David Friedland|414-805-|dfriedland@mcw.edu|
20169532|NCT00870233|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi ME|212-639-5016|chid@mskcc.org|
20169533|NCT01085500|Mayo Clinic|Benjamin Zendejas, MD|507-538-5413|zendejas.benjamin@mayo.edu|
20169534|NCT01781169|Shenzhen Center for Chronic Disease Control|Dr. Ji-Chang Zhou|86-755-25503842|jichangzhou@gmail.com|
20169535|NCT01057901|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
20169536|NCT01987401|Department of Veterans Affairs, Office of Research and Development|Dr. Nicholas L. Smith, Director of Seattle Cooperative Studies Program|2067642773|nicholas.smith@va.gov|
20169537|NCT01962922|Veloxis Pharmaceutical|Leslie Callahan|732-321-3221|lca@veloxis.com|
20169538|NCT00744471|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169539|NCT03224546|University of Kentucky|William W. Stoops|859-257-5383|william.stoops@uky.edu|
20169540|NCT04706416|Valley Baptist Medical Center|Dr. Ameer Hassan|973-303-8146|ameerehassan@gmail.com|
20169541|NCT00970736|University of Florida|Karen Hegland|352 359-1830|kwheeler@ufl.edu|
20169542|NCT01616082|Translational Research Institute for Metabolism and Diabetes|Dr. Steven R. Smith|407-303-7115|steven.r.smith.md@flhosp.org|
20169543|NCT04705363|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
20169544|NCT00976573|Mayo Clinic|Robert R. McWilliams, MD|507/284-8432|mcwilliams.robert@mayo.edu|
20169545|NCT02117427|Aevi Genomic Medicine|Garry A Neil|610-254-4208|garry.neil@aevigenomics.com|
20169546|NCT02730208|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20169547|NCT00995865|GE Healthcare- Life Sciences|Amanda Culliton|1-508-683-2232|Amanda.Culliton@ge.com|
20169548|NCT00439465|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603-650-6432|Kenneth.R.Meehan@hitchcock.org|
20169549|NCT00410202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20169550|NCT00144027|Central Arkansas Veterans Healthcare System|Jeff Pyne|501-257-1083|jeffrey.pyne@va.gov|
20169551|NCT05080660|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20169552|NCT01520454|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
20169553|NCT04221230|Neumora Therapeutics, Inc.|Study Contact|+1- (857) 760-0900|clinicaltrials@neumoratx.com|
20169554|NCT01827358|University of Maryland Medical Center|Karen Kotloff, MD|410-706-5328|kkotloff@medicine.umaryland.edu|
20169555|NCT00048893|National Cancer Institute (NCI), National Institutes of Health (NIH)|Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
20169556|NCT00817479|The University of Chicago, Department of Medicine|Dr. Gini Fleming, MD|(773) 702-6149|gfleming@medicine.bsd.uchicago.edu|
20169557|NCT02043379|UAB Pediatric Cardiac Critical Care Medicine|Jeffrey Alten, MD|(205) 975-3123|jalten@peds.uab.edu|
20169558|NCT02355977|Zhejiang University|Dr. Ying Wang|86-571-87217437|wyi1006@sina.com|
20169559|NCT02359851|Vanderbilt-Ingram Cancer Center|Principal Investigator|615-936-7423|douglas.b.johnson@vanderbilt.edu|
20169560|NCT00055471|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20169561|NCT01854944|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20169562|NCT05419999|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6700|straud@uthscsa.edu|
20169563|NCT00282347|Genentech, Inc.|Medical Communications|800-821-8590||
20169564|NCT02101112|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20169565|NCT02125604|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
20169566|NCT04340063|Edward Hines Jr. VA|Dr. Keith Gordon|(312) 503-3339|keith.gordon2@va.gov|
20169567|NCT01030783|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|617-588-1960|Clinical@aveooncology.com|
20169568|NCT02782923|NYU Langone Madison Avenue Orthopaedics|Yong H. Kim, MD|212-427-3986|Yong.Kim@nyulangone.org|
20169569|NCT02418156|Aziyo Biolgics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
20169570|NCT03368118|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
20169571|NCT01445626|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20169572|NCT00993044|Children's Hospital Los Angeles|Rajkumar Venkatramani|3233615504|rvenkatramani@chla.usc.edu|
20169573|NCT04894916|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
20169574|NCT00734747|Medigus Ltd|Aviel Roy-Shapira, MD|+972 8646 6880|avrish@gmail.com|
20169575|NCT05824741|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
20169576|NCT00911742|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20169577|NCT03642327|University of Maryland School of Medicine|Howard Dubowitz, MD, Professor of Pediatrics|4107066144|hdubowitz@som.umaryland.edu|
20169578|NCT05063318|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit|0034918466000|clinicaltrials@pharmamar.com|
20169579|NCT03287635|Toyos Clinic|Dr.|9137064408|mtoyos@toyosclinic.com|
20169580|NCT03670836|Columbia University Medical center|Rachana Gavara|914-356-2730|rg2460@cumc.columbia.edu|
20169581|NCT00396032|Genentech, Inc.|Medical Communications|800-821-8590||
20169582|NCT00323869|Stanford University Medical Center|Heather A Wakelee, MD, Associate Professor of Medicine (Oncology)|650-498-6000|hwakelee@stanford.edu|
20169583|NCT01654861|Eastern Regional Medical Center|Eiko Klimant, MD|215-537-7400|eiko.klimant@ctca-hope.com|
20169584|NCT01056328|St. Jude Medical|Nicole Glowacki, Clinical Project Manager|651-756-3432|NGlowacki@sjm.com|
20156875|NCT01467466|MAVERIC, VA Boston|Christopher Donnelly, Chief of Data Management|857-364-2332|christopher.donnelly2@va.gov|
20156876|NCT03261505|Massachusetts General Hospital|Prof. Jian Kong|16179620978|kongj@nmr.mgh.harvard.edu|
20156877|NCT01262105|Nimbic Systems|Sean Self|281-565-5700|self@nimbicsystems.com|
20156878|NCT01957384|Coloplast A/S|Marian Dyreborg Sinvani, Clinical Manager|+45 4911 2356|dkmards@coloplast.com|
20156879|NCT03199079|Advanced Tactile Imaging, Inc.|Egorov Vladimir, Principal Investigator|609 883-0100|egorov@tactile-imaging.com|
20156880|NCT03773484|University of Southern California|Dr. Jason Doctor|213-821-8142|jdoctor@usc.edu|
20156881|NCT04079738|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20156882|NCT05552859|Sanofi|Trial Transparency email recommended (Toll free for US & Canada)|800-633-1610|Contact-us@sanofi.com|Option 6
20156883|NCT04251533|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
20156884|NCT05634538|Corindus|Alison Lord|617-943-5472|alison.lord@siemens-healthineers.com|
20156885|NCT06378008|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
20156886|NCT01889251|Alcon Japan, Ltd.|Group Manager, Clinical Development|+81368995277||
20156887|NCT02784587|Maine Medical Center|Research coordinator|2076622862|richaj3@mmc.org|
20156888|NCT05852470|Alcon Research, LLC|Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20156889|NCT06071104|Alcon Research LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20156890|NCT00085839|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
20156891|NCT03636022|Minnesota HealthSolutions|Sara Seifert|6128036998|sara@minnhealth.com|
20156892|NCT03140969|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
20156893|NCT00642759|Massachusetts General Hospital|Dr. Rebecca Heist|6177244000|rheist@partners.org|
20156894|NCT03612570|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
20156895|NCT05212168|Vaxart|Maria Apkarian|+1 (650) 779-4560|mapkarian@vaxart.com|
20156896|NCT03274466|"KCI | 3M"|Director of Clinical Research|(210) 515-4060|actate@mmm.com|
20156897|NCT02371187|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
20156898|NCT06899100|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
20156899|NCT00618787|Tyco Healthcare Group|Tonya Eggleston, RN, MPH, Study Director|(508) 261-8420|Tonya.Eggleston@Covidien.com|
20156900|NCT01107886|AstraZeneca LP|Boaz Hirshberg MD, MBA|1 302 885 4997|ClinicalTrialTransparency@astrazeneca.com|
20156901|NCT01994876|Coloplast A/S|Director of Clinical Affairs|+45 4911 25 23|dkdac@coloplast.com|
20156902|NCT01346176|University of Pennsylvania School of Medicine|Scott D. Halpern|215.573.9461|elcooney@exchange.upenn.edu|
20156903|NCT05819398|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20156904|NCT04795531|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20156905|NCT04887831|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
20156906|NCT03396445|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20156907|NCT04622592|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
20156908|NCT01664624|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20156909|NCT02369536|IRCCS Neuromed|Dr. Chiara Cerletti, operative responsible of the trial and corresponding author of the data public|0865915246|chiara.cerletti@moli-sani.org|
20156910|NCT02243358|Henry Ford Cancer Institute|Dr. Gazala Khan, MD|313-598-2860|gkhan1@hfhs.org|
20156911|NCT00573768|Novartis Consumer Health|Sandy Hamelsky|+19735037258|sandy.hamelsky@novartis.com|
20156912|NCT05296824|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
20156913|NCT01838226|Durham VAHCS HSR&D|Dr. David Edelman|919-286-6936|david.edelman@va.gov|
20156914|NCT03057548|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
20156915|NCT04198012|DEKA Research|Regulatory Affairs Manager|603-669-6491|psmolenski@dekaresearch.com|
20156916|NCT03139721|Medtronic|Jessica Halverson, Clinical Research Director|763-514-9756|rs.CSHHAMMOCKPAS@medtronic.com|
20156917|NCT03502200|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
20156918|NCT00855335|Janssen Scientific Affairs, LLC|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
20156919|NCT01734525|Federal University of Rio de Janeiro|Marcio Nucci|5521-39382463|mnucci@hucff.ufrj.br|
20156920|NCT00731484|TearLab, Inc.|Dr. Benjamin Sullivan|855-832-7522|bdsulliv@TearLab.com|
20156921|NCT05126303|Guard Therapeutics|Sara Thuresson, Head of Clinical Operations|+46733319438|sara.thuresson@guardtherapeutics.com|
20156922|NCT00509288|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
20156923|NCT02526290|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20156924|NCT02082977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156925|NCT00049543|NCIC Clinical Trials Group|Dr. Keyue Ding|1-613-533-6000|king@ctg.queensu.ca|77705
20156926|NCT00737360|The University of Texas M.D, Anderson Cancer Center|Dr. Anne Tsao, Principal Investigator|713-792-6363||
20156927|NCT00538850|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
20169585|NCT01082380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169586|NCT01770652|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
20169587|NCT01052844|Faculdade de Medicina do ABC|Felipe Melo Cruz|+55+11+27595914|felipemcruz@yahoo.com.br|
20169588|NCT01241240|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20169589|NCT01439347|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
20169590|NCT00542451|Dana Farber Cancer Institute|SARA TOLANEY, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
20169591|NCT02788474|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169592|NCT00048061|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20169593|NCT04115644|UT Southwestern Medical Center|Dr. Michael Khazzam|214/645-8917|michael.khazzam@utsouthwestern.edu|
20169594|NCT02325791|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20169595|NCT01028378|Clinical Research Consultants, Inc.|Barbara S. Fant, Pharm.D.|513-961-8200|bsfant@crc-regulatory.com|
20169596|NCT01298193|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20169597|NCT01569464|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
20169598|NCT03475875|Johnson & Johnson Vision|John Buch - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
20169599|NCT01390220|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
20169600|NCT04025710|BIOTRONIK SE & Co.KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
20169601|NCT00755911|University of Michigan|Darnell Kaigler|734-998-1468|dkaigler@umich.edu|
20169602|NCT00245583|Icahn School of Medicine at Mount Sinai|Dr. Heather Berlin|212-241-4761|heather.berlin@mssm.edu|
20169603|NCT02273739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20169604|NCT04718103|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20169605|NCT01309893|Bausch & Lomb|Dr. Robert Steffen|585 338-6399|robert.steffen@bausch.com|
20169606|NCT01879540|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20169607|NCT01343901|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20169608|NCT01369485|Ethicon Surgical Care|John Lombard, Manager Clinical Research|908 218 2877|Jlombar8@its.jnj.com|
20169609|NCT02721979|University of Washington|Dr. Michael Schweizer|(206) 606-6252|schweize@uw.edu|
20169610|NCT03370289|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20169611|NCT00922701|University G. D'Annunzio|Mario Bonomini, M.D.|+39 0871 540120|m.bonomini@nephro.unich.it|
20169612|NCT00873860|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
20169613|NCT02764190|Seattle Children's Research Institute|Cari McCarty|206-884-8243|Carolyn.McCarty@seattlechildrens.org|
20169614|NCT00236951|Luitpold Pharmaceuticals|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
20169615|NCT01484938|Alcon Research, Ltd.|Jami Kern, Ph.D., Global Medical Affairs|800-862-5266||
20169616|NCT00708071|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
20169617|NCT02140775|New York State Psychiatric Institute|Dr. Martin McElhiney|646.774.8035|mcelhin@nyspi.columbia.edu|
20169618|NCT03696927|Abilitech Medical|Director of Clinical and Product Management|833.225.3123|info@abilitechmedical.com|
20169619|NCT02942576|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
20169620|NCT00945854|Federico II University|Riccardi Gabriele|+390817462117|riccardi@unina.it|
20169621|NCT00938964|Duke University Health System|Joseph Mathew, M.D|919-681-6646|joseph.mathew@duke.edu|
20169622|NCT02139800|Children's Hospital of Philadelphia (CHOP)|Dr. Haresh Kirpalani|215-590-2455|kirpalanih@email.chop.edu|
20169623|NCT01765803|University of New Mexico|Stuart Winter, MD|505-272-4461|SWinter@salud.unm.edu|
20169624|NCT04697381|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169625|NCT01227564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169626|NCT04811573|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20169627|NCT06309407|Oregon Health and Science University|Dr. Sandy Christiansen|2038092318|chrissan@ohsu.edu|
20169628|NCT02096575|U of New Mexico - Dept of OBGYN/Family Planning|Michel Paves, HS Research Specialist|505-272-9703|MDaliva@salud.unm.edu|
20169629|NCT00704808|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20169630|NCT00633867|NHS Grampian|W Brampton||william.brampton@nhs.net|
20169631|NCT01654796|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|MFAVA@mgh.harvard.edu|
20169632|NCT05308290|Stanford University|Charles Brown, MD PhD|6504983512|chbrown@stanford.edu|
20169633|NCT00473746|Janssen R&D US|Sr. Director, Clinical Research|(310)914-2917||
20169634|NCT00667420|MassGH|David P. Ryan|617-724-0245|dpryan@partners.org|
20169635|NCT01017575|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
20169636|NCT04867434|Raziel Therapeutics|Dr. Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
20169637|NCT01490788|Tonix Pharmaceuticals, Inc.|Greg Sullivan, MD||greg.sullivan@tonixpharma.com|
20169638|NCT03500679|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20169639|NCT00095628|London Regional Cancer Centre|Dr. Eric Winquist|519-685-8600|eric.winquist@lhsc.on.ca|53243
20201931|NCT03022461|Abbott|Poornima Sood|+17818528334|poornima.sood@abbott.com|
20201932|NCT01076179|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20169640|NCT01388920|Theratechnologies|Senior Medical Advisor|514-336-7800|jmamputu@theratech.com|
20169641|NCT01484054|Johnson & Johnson Vision Care|Michael Mayers, OD, FAAO|904-443-3252|mmayers@its.jnj.com|
20169642|NCT01539317|Oregon Health and Science University|Dr. Martha Goetsch|503-494-3666|whru@ohsu.edu|
20201933|NCT03459040|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
20169643|NCT04490239|University of Mississippi|Dr. Joshua Sharp|662-915-1758|jsharp@olemiss.edu|
20169644|NCT01674634|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20169645|NCT04533685|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
20169646|NCT05223335|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
20169647|NCT01232205|Dept Obstetrics Gynecology Indonesia University|Yuditiya Purwosunu|+44 753 870 6897|yudi@med.showa-u.ac.jp|
20169648|NCT02945787|Moffitt Cancer Center|Thomas H. Brandon PhD|813 745-1750|Thomas.Brandon@moffitt.org|
20169649|NCT02021656|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20169650|NCT00510952|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20169651|NCT01604109|ThammasatU|Thanya Sitthisettapong|6629869213|thanyasang@yahoo.com|7150
20169652|NCT03581786|Shanghai Junshi Bioscience Co., Ltd.|Xiaojun Wang|86-021-50796193|xiaojun_wang@junshipharma.com|
20169653|NCT00510874|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169654|NCT00775944|University of Nottingham|Graeme Docherty|01158321380|graeme.docherty@nottingham.ac.uk|
20169655|NCT01583543|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
20169656|NCT00397943|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169657|NCT06053463|The Ohio State University College of Optometry|Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
20169658|NCT03436563|M D Anderson Cancer Center|Dr. Van Morris|713-792-2828|vkmorris@mdanderson.org|
20169659|NCT02806973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20169660|NCT02840240|Cleveland Clinic|Fabio Rodriguez|216444-9950|rodrigf3@ccf.org|
20169661|NCT04209426|Medextens SARL|Frederic C Daoud, M.D., M.Sc., Epidemiologist-Biostatistician|+33964281703|fcdaoud@medextens.com|
20169662|NCT02285283|The University of Texas Health Science Center at Houston|Amber U. Luong, MD, PhD|713-486-5000|Amber.U.Luong@uth.tmc.edu|
20169664|NCT03682809|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
20169665|NCT02661711|Moorfields Eye Hospital|Tumelo Kaminskas|02072533411|moorfields.resadmin@nhs.net|2036
20169666|NCT01751802|Psyadon Pharmaceuticals|President/CEO|301-919-2020|info@psyadonrx.com|
20169667|NCT01617148|Cleveland Clinic Foundation|Dr. Rishi Singh|330-888-4000|singhr@ccf.org|
20169668|NCT00521001|Mayo Clinic|Svetomir Markovic, MD, PhD|507/284-1370|markovic.svetomir@mayo.edu|
20169669|NCT02821910|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169670|NCT00900601|Oslo University Hospital|Thomas Kibsgård|99030831|kibsgard@gmail.com|+47
20169671|NCT01082640|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20169672|NCT03727373|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
20169673|NCT00413478|University of Texas (UT) MD Anderson Cancer Center|Zeev Estrov, MD/Professor, Leukemia|713-794-1675|CR_Study_Registration@mdanderson.org|
20201934|NCT00986349|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
20169674|NCT03577171|Assembly Biosciences|Linda Baher, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
20169675|NCT01025154|The University of Texas MD Anderson Cancer Center|Stefan Faderl, MD / Associate Professor|713-745-4613|eharriso@mdanderson.org|
20201935|NCT02299934|University of Colorado, Denver|Dr. Samuel Chang|720-848-1875|SAMUEL.CHANG@UCDENVER.EDU|
20201936|NCT03815175|Abbott|Lijuan Jenn Wang|01-408-8453133|Lijuan.wang1@abbott.com|
20201937|NCT03577990|The University of North Carolina at Charlotte|Willie M. Abel, Associate Professor of Nursing|704-687-7949|wmabel@uncc.edu|
20201938|NCT05662332|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
20201939|NCT03248128|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201940|NCT01914679|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
20201941|NCT01696357|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
20201942|NCT01696461|National Marrow Donor Program/BeTheMatch|Dr. Steven Devine|7634068239|sdevine2@nmdp.org|
20201943|NCT00538681|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20201944|NCT03040154|Children's Hospital Los Angeles|Joyce R. Javier, MD, MPH, MS|(323)669-2113|jojavier@chla.usc.edu|
20201945|NCT05369806|University of Washington|Keshet Ronen|2065854363|keshet@uw.edu|
20201946|NCT00628355|Ribeirao Preto Medical School - University of Sao Paulo|Omero Benedicto Poli Neto|551636023183|polineto@fmrp.usp.br|
20201947|NCT00140855|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20201948|NCT01815957|UNewMexico|Bina Ahmed|505-272-7028|hkhawaja@salud.unm.edu|
20201949|NCT03072602|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|12059754720|parora@uabmc.edu|
20201950|NCT03912584|Optos|Michael Sinai, PhD|+1 800 854 3039|MSinai@optos.com|1495
20201951|NCT04984889|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20201952|NCT01075347|Natinal Taiwan University Hospital|We-Li Chen , MD|886-2-2356|chenweili@ntu.edu.tw|5206
20201953|NCT00817414|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20201954|NCT00886938|Washington University|Dr. Jay F Piccirillo|(314) 362-8641|piccirilloj@ent.wustl.edu|
20201955|NCT01552876|Johnson & Johnson Vision Care|Katherine Osborn OD, MS FAAO|1 904 443-1032|kosborn@its.jnj.com|
20201956|NCT01012661|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
20169676|NCT01810432|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20169677|NCT00057954|ECOG Statistical Office|Study Statistician|617-632-3012||
20169678|NCT00559754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20201957|NCT03806452|THERAVIA|Clinical Operation Manager|+330149709583|laura.thomas-bourgneuf@theravia.com|
20201958|NCT03872180|Emory University Hospital/Winship Cancer Institute|Dr. Jonathon Cohen|4047781900|jonathon.cohen@emory.edu|
20169679|NCT01264016|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
20169680|NCT02117414|Medtronic, Inc|Evera MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
20169681|NCT01629706|Alcon Research, Ltd.|Alan Landers, Project Head, Vision Care R&D|1-888-451-3937|alcon.medinfo@alcon.com|
20169682|NCT00701376|Cleveland Clinic|Brian Parker, MD|216-444-9950|parkerb1@ccf.org|
20169683|NCT02537574|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20169684|NCT02663687|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20169685|NCT01151098|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333 OR 800-745-7445||
20169686|NCT01593722|Laboratory of Parasitic Diseases, NIAID, NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
20169687|NCT03343067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20169688|NCT00116168|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
20169689|NCT05153473|CHU de Poitiers|Dr Louis Etienne GAYET|+33(0)5.49.44.44.92|Louis-Etienne.GAYET@chu-poitiers.fr|
20169690|NCT03555435|National Center for PTSD|Eve Carlson|6504935000|eve.carlson@va.gov|24058
20169691|NCT01828515|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
20169692|NCT00992927|Seoul National University Hospital|Sun Gun Chung/Professer|+82-2-2072-3954|suncg@snu.ac.kr|
20169693|NCT01058265|Mayo Clinic in Arizona|Larry Bergstrom, MD|480-301-7108|bergstrom.larry@mayo.edu|
20169694|NCT02869438|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
20169695|NCT01601431|Baylor College of Medicine|Mohamed Othman, M.D.|713 798 0947|mohamed.othman@bcm.edu|
20169696|NCT02343081|FLENI- mrc (FLENI Multi-specialty Research Center)|Dr. Alejandro Muggeri (Principal Investigator)|54-11-5777 3200|alemuggeri@hotmail.com.ar|2020
20169697|NCT02169284|University of Wisconsin Carbone Cancer Center|Dr. Tracy Downs|608-263-9534|downs@urology.wisc.edu|
20169698|NCT03583073|Brown U|Anthony Spirito|4013692435|anthony_spirito@brown.edu|
20169699|NCT01257802|University of Michigan|W Joseph McCune MD Professor of Rheuntic Diseases University of Michigan|734 936 5560|jmccune@med.umich.edu|
20169700|NCT02964507|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20169701|NCT02340715|Medical College of Wisconsin|Ergun Ahunbay|4148057898|eahunbay@mcw.edu|
20169702|NCT04341662|University of Birmingham|Dr Adam Devall|+447971823452|a.j.devall@bham.ac.uk|
20169703|NCT05323656|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
20169704|NCT03862040|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20169705|NCT00645710|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20169706|NCT00064298|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
20169707|NCT03614975|University of Pittsburgh, Department of Family Medicine|Richard Zimmerman, MD|412-383-2354|zimmrk@upmc.edu|
20169708|NCT00450385|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
20169709|NCT03533686|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
20169710|NCT01858636|St. Jude Medical|Andrew Campbell|+1.651.756.5538|acampbell2@sjm.com|
20169711|NCT01172275|Yale University|Dr. Michael H. Bloch|203-737-4809|michael.bloch@yale.edu|
20169712|NCT02862600|Heart Metabolics, Ltd.|Mark G. Midei, MD, Executive Director and Head of Cardiology|4103715357|markgmidei@gmail.com|410
20169713|NCT04650854|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20169714|NCT04859114|Medical College of Wisconsin|Mir A Basir|4142666820|mbasir@mcw.edu|
20169715|NCT02378025|Veterans Affairs Palo Alto Healthcare System|Dr. Peter Bayley|650 493-5000|peter.bayley@va.gov|
20169716|NCT00194675|VA Puget Sound Health Care System|Alvin M. Matsumoto, MD|(206) 764-2760|alvin.matsumoto@med.va.gov|
20169717|NCT01285960|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
20169718|NCT00586196|BIDMC|Edward R Marcantonio|617-754-1405|emarcant@bidmc.harvard.edu|
20169719|NCT04437368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20169720|NCT04271280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20169721|NCT02034422|Salt Lake City VAMC|Joel Trinity, PhD|801-582-1565|joel.trinity@va.gov|1794
20169722|NCT01280955|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|mitchel.horwitz@duke.edu|
20169723|NCT00364130|Children's Hospital of Philadelphia|Mary Leonard, MD, MSCE|215-590-0874|leonard@email.chop.edu|
20169724|NCT00901927|The University of Texas (UT) MD Anderson Cancer Center|Nathan Fowler/Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
20169725|NCT03737851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20169726|NCT01860573|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
20169727|NCT00937391|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20169728|NCT00245219|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|Scheier@cmu.edu|
20169729|NCT00723931|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20169730|NCT04808999|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
20169731|NCT01865084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20169732|NCT02247531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20169733|NCT00572897|Univeristy of Illinois Hospital & Health Sciences System|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
20169734|NCT00606944|Seoul National University Bundang Hospital|Sung-Bum Kang|+82-31-787-7093|kangsb@snubh.org|
20169735|NCT03875118|National Taipei University of Nursing Health and Sciences|Director of Nursing Department|886-2-28227101|tsaejyy@ntunhs.edu.tw|3118
20169736|NCT02237911|University of Pittsburgh|Dr. Sara Piva|(412) 383-6712|spiva@pitt.edu|
20169737|NCT02423109|CooperVision|Myhanh Nguyen, OD|9257306716|mnguyen@coopervision.com|
20169738|NCT02428608|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
20203017|NCT02435173|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20201959|NCT00644592|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
20201960|NCT01157117|Ichan School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
20201961|NCT01931865|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
20156928|NCT04138056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156929|NCT03815344|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
20156930|NCT02421094|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
20156931|NCT02706392|Fred Hutchinson Cancer Center|Dr. David Maloney|2066675616|dmaloney@fredhutch.org|
20156932|NCT03290027|Dr. Reddys Laboratories Inc.|Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
20156933|NCT06203717|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|mascha_vant_wout@brown.edu|
20156934|NCT01138514|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
20156935|NCT01474109|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
20156936|NCT01276106|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
20156937|NCT03078452|Emory University|Dr. Ajay Nooka|404-778-1900|anooka@emory.edu|
20156938|NCT01242514|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
20156939|NCT01082939|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
20156940|NCT00862940|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20156941|NCT00787150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156942|NCT00879398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156943|NCT02347410|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|6512568503|Rgriffith@spineology.com|
20156944|NCT01380080|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20156945|NCT05901636|Janssen Research & Development, LLC|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20156946|NCT02303821|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20156947|NCT00210132|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
20156948|NCT02711202|Institute for Clinical and Experimental Medicine|Prof. Ondřej Viklický, M.D., Ph.D.|+420 2 6136 4110|ondrej.viklicky@ikem.cz|
20156949|NCT00432965|Acelity|Sr Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
20156950|NCT04312022|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
20156951|NCT01344226|Discover Vision Centers|Melissa Morrison Toyos|8164781230|mtoyos@discovervision.com|
20156952|NCT05677347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20156953|NCT04118764|Columbia University|Elisa Konofagou, PhD, Robert and Margaret Hariri Professor in Biomedical Engineering and Radiology|212-342-0863|ek2191@columbia.edu|
20156954|NCT04716725|University of California, San Francisco|Dr. Ivan de Kouchkovsky, MD|(415) 221-4810|ivan.dekouchkovsky@ucsf.edu|2129
20156955|NCT03909971|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156956|NCT05177354|Medtronic Neuromodulation|Nancy McClelland|1-800-633-8766|nancy.l.mcclelland@medtronic.com|
20156957|NCT03734536|Smith+Nephew|Samantha Andrews|9789718990|samantha.andrews@smith-nephew.com|
20156958|NCT03229057|University of Pennsylvania|Dr Anuja Dokras|215-615-0085|adokras@pennmedicine.upenn.edu|
20156959|NCT06028464|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20156960|NCT03448393|National Cancer Institute|Dr. Nirali N. Shah|240-760-6970|shahnn@mail.nih.gov|
20156961|NCT01587196|University of Pennsylvania|Daniel Langleben, MD|215-760-7067|langlebe@pennmedicine.upenn.edu|
20156962|NCT03826472|California Health Sciences University College of Osteopathic Medicine|Emily Johnston|9737685888|eajohnst@gmail.com|
20156963|NCT04604431|Northwestern University Feinberg School of Medicine|Lucy Bilaver, Associate Professor of Pediatrics, iREACH Co-Investigator|312-503-5618|l-bilavere@northwestern.edu|
20156964|NCT00643279|Medtronic|Dana Wigert|763-526-2802|dana.wigert@medtronic.com|
20156965|NCT04846868|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20156966|NCT04116853|Advocate Aurora Research Institute|Kathryn Ross, PhD MPH|414-647-6312|Kathryn.Ross@aah.org|
20156967|NCT04522973|Virginia Commonwealth University|Michelle Peace, PhD|804-828-8240|mrpeace@vcu.edu|
20156968|NCT01649869|University of Alabama at Birmingham|David Kimberlin, MD|(205) 638-2530|DKimberlin@peds.uab.edu|
20156969|NCT02776735|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20156970|NCT01139515|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156971|NCT05847686|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
20156972|NCT03021486|UT MD Anderson Cancer Center|David Hui, MD- Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
20156973|NCT03226418|University of Nebraska Medical Center|Vijaya Bhatt|402-559-5520|IITOffice@unmc.edu|
20156974|NCT03309202|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20156975|NCT01209767|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
20156976|NCT01702298|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20156977|NCT00400686|Cleveland Clinic|Beth Faiman, MSN,CNP, AOCN|216-445-3738|faimanb@ccf.org|
20156978|NCT02008617|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale, M.D.|312-695-4814|rrahangd@nmff.org|
20156979|NCT00583219|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|petrou.steven@mayo.edu|
20156980|NCT02090764|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
20169739|NCT04521777|UT MD Anderson Cancer Center|An T Ngo-Huang, Assistant Professor, Rehabilitation Medicine|(713) 745-2327|ango2@mdanderson.org|
20169740|NCT02477423|Neonatology, Department of Pediatrics, University of Chicago|Dr. Christina S. Kim|773-702-6210|christinakim13@gmail.com|
20169741|NCT00842764|Department of Otolaryngology/UCI|Brian J Wong, MD, PhD|7144565753|bjwong@uci.edu|
20169742|NCT01278303|Johns Hopkins Hospital|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
20169743|NCT01869725|University of Iowa|M. Sue O'Dorisio, MD, PhD|319-335-7234|sue-odorisio@uiowa.edu|
20169744|NCT01143207|FHI 360|Vera Halpern, MD|919-54-7040|vhalpern@fhi360.org|11390
20169745|NCT04457973|University of Arizona|Dr. Hyochol Ahn|520-626-1769|hbrian@arizona.edu|
20169746|NCT02960997|Stanford University|Joyce Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
20169747|NCT04824365|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
20169748|NCT03416374|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20169749|NCT01813110|Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
20169750|NCT03463031|Glenmark Pharmaceuticals Ltd|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
20169751|NCT01068652|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20169752|NCT00417482|New York State Psychiatric Institute|Davangere P. Devanand, MD|212-543-5612|dpd3@columbia.edu|
20169753|NCT03739840|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
20169754|NCT01323946|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169755|NCT01243671|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20169756|NCT02962765|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
20169757|NCT06207435|University of Pennsylvania|Dr. Farouk Dako|2673091241|farouk.dako@pennmedicine.upenn.edu|
20169758|NCT00750880|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20169759|NCT05014490|"PrJSC Pharmaceutical Firm Darnytsia"|Andrii Doroshenko, PhD, MD|+38 044 207 73 53|a.doroshenko@darnytsia.ua|
20169760|NCT02495233|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20169761|NCT05078138|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@health.mil|
20169762|NCT03880461|Kaiser Permanente Northern California|Monique Hedderson, Ph.D.|925-520-0785|monique.m.hedderson@kp.org|
20169763|NCT00672204|University of Minnesota|Bernhard J. Hering, M.D.|612-626-5735|bhering@umn.edu|
20169764|NCT01115803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20169765|NCT00136604|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169766|NCT02017171|Joslin Diabetes Center|Dr. Alessandro Doria (Sponsor and PI of the study)|617-319-0970|alessandro.doria@joslin.harvard.edu|
20169767|NCT01562873|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|Nancy_Lin@dfci.harvard.edu|
20169768|NCT02536833|Samumed|Christopher Swearingen, PhD, VP of Clinical Outcomes and Analytics|858.926.2952|chris@samumed.com|
20169769|NCT02220998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20169770|NCT04186481|Smith+Nephew, Inc.|Alison Walker, Regional Operation Manager ANZ|+61 466 322 200|Alison.walker@smith-nephew.com|
20169771|NCT02280473|Allergan plc|Michael Robinson|1-714-246-6415|Robinson_Michael@Allergan.com|
20169772|NCT01525173|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20169773|NCT03014492|Cincinanti Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
20169774|NCT04223232|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
20169775|NCT04616027|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169776|NCT01158703|BROOKE ARMY MEDICAL CENTER|AHMAD M. SLIM, MD, LTC, MC|210-916-4717|AHMAD.SLIM@US.ARMY.MIL|
20169777|NCT05281601|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20169778|NCT01482351|George Mason University|Dr. Kathy C. Richards|(703) 946-3725|kricha11@gmu.edu|
20169779|NCT00191646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20169780|NCT02595996|Columbia University Irving Medical Center|June K. Wu, MD|212-342-3704|jw92@cumc.columbia.edu|
20169781|NCT03194490|Loma Linda University|Dr. Everett Lohman III|(909) 558-4632|elohman@llu.edu|83171
20169782|NCT01505647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169783|NCT01574079|University of Mississippi Medical Center|Principle investigator|601-984-6369|lbarnes@umc.edu|
20169784|NCT00406718|UT_SanAntonio UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
20169785|NCT03640559|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|189
20169786|NCT01436162|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20169787|NCT01888003|University of Alabama at Birmingham Department of Anesthesiology and Perioperative Medicine|Dr. Thomas Vetter|205.934.6501|tvetter@uab.edu|
20201962|NCT00215930|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
20201963|NCT03494647|Children's Hospital Colorado|Emily Sweeney, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20156981|NCT02037529|Mayo Clinic|Minetta Liu|5072930526|Liu.Minetta@mayo.edu|
20203018|NCT01277289|Erydel|Angelo Andriulli, MD|+39 882 410784|aandriulli@operapadrepio.it|
20156982|NCT02131766|UVA|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
20156983|NCT02384421|Stanford University|Dr. Helen Bronte-Stewart, MD, MSE|650-723-6709|bronte-stewart-lab@stanford.edu|
20156984|NCT00718315|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20156985|NCT01959685|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
20156986|NCT00806585|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDevelopment@merck.com|
20156987|NCT01394159|Center for Interventional Endoscopy, Florida Hospital|Dr Shyam Varadarajulu|407-303-2570|svaradarajulu@yahoo.com|
20156988|NCT02621892|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
20201964|NCT01531725|ZNA Middelheim Department Interventional Cardiology, Antwerpen, Belgium|Paul Vermeersch, MD, PhD|+32 3 280 3211|paul.vermeersch@zna.be|
20201965|NCT03215277|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20156989|NCT01864434|University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
20156990|NCT00673920|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20156991|NCT01650402|UConn Health|William White, MD|860-679-4556|wwhite@uchc.edu|
20156992|NCT00998010|University of California at Los Angeles|Mark Glover|(310) 794-8742|mglover@mednet.ucla.edu|
20156993|NCT00833690|The Parkinson Study Group|Michael A. Schwarzschild, MD, PhD|617-724-9611|mschwarzschild@partners.org|
20156994|NCT04773665|VBI Vaccines Inc|Francisco Diaz-Mitoma, MD, PhD|613-749-4200|fdiazmitoma@vbivaccines.com|
20156995|NCT03648385|Brown University Health, Center for Advanced Lung Care|Corey Ventetuolo, MD|401-444-2733|corey_ventetuolo@brown.edu|
20156996|NCT04562116|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
20156997|NCT03057704|Wake Forest University School of Medcine|Timothy N. Harwood MD|3367164498|tharwood@wakehealth.edu|
20156998|NCT04462471|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
20156999|NCT03097289|Terumo BCT, Inc.|Ned Cosgriff, MD|+1 303-239-2316|ned.cosgriff@TerumoBCT.com|
20157000|NCT00619866|AbbVie|Global Medical Services|800-633-9110||
20157001|NCT01098422|UC San Diego|Dr. Tony Reid|8583531942|treid@ucsd.edu|
20157002|NCT03949517|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
20157003|NCT00485173|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
20157004|NCT00829244|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20157005|NCT03112902|University of Colorado|Brice McConnell|303-724-3897|brice.mcconnell@cuanschutz.edu|
20157006|NCT05705375|University of Texas at Arlington|Ziyad Ben Taleb|817-272-8297|ziyad.bentaleb@uta.edu|
20157007|NCT02302222|Acelity|Sr Director, Global Clinical Development|2102555595|jane.hart@acelity.com|
20157008|NCT03193801|Edwards Lifesciences|Director of Research|949-250-2500|THV_ct.gov@edwards.com|
20157009|NCT03138564|Emory University|Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
20157010|NCT06517394|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Principal investigator|6177267913|apresciutti@mgh.harvard.edu|
20157011|NCT02876172|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
20157012|NCT03330847|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20157013|NCT03532256|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
20157014|NCT05211596|National Center for Deaf Health Research|Steven Barnett, PhD|585-506-9484|steven_barnett@urmc.rochester.edu|
20157015|NCT02769481|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20157016|NCT06272383|University of Manitoba|Dr Alex Aregbesola|2047893957|Alex.Aregbesola@umanitoba.ca|
20157017|NCT04398706|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20157018|NCT04630769|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
20157019|NCT02445911|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
20157020|NCT05395338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20157021|NCT03716830|Massachusetts General Hospital|Jian Kong, PI of the clinical trial|6177267893|kongj@nmr.mgh.harvard.edu|
20157022|NCT05489328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157023|NCT01083602|Novartis Pharmaceuticals|Study Director|862-778-8300||
20157024|NCT01657370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20157025|NCT01323192|Janssen Pharm KK Japan|Medical Director|+81-3-4411-5509||
20157026|NCT03326245|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Dardo Tomasi|+1 301 496 1589|tomasidg@mail.nih.gov|
20157027|NCT02180828|Peking University|Shangrong Fan|860755-83923333|fanshangrong@163.com|5502
20157028|NCT02276040|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
20157029|NCT02835690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157030|NCT03674281|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
20157031|NCT00582907|Shaare Zedek Medical Center/Cleveland Clinic|Philip Hashkes, MD, MSc|972-2-6555307|hashkesp@szmc.org.il|
20157032|NCT01441960|Mass General Hospital|Ala Nozari|978-318-3933|anozari@partners.org|
20157033|NCT02481414|University of Arkansas for Medical Sciences|Matthew Kovak, Director of Clinical Trials|501-686-8274|MRKovak@uams.edu|
20157034|NCT00415636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157035|NCT01263119|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157036|NCT02138825|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20157037|NCT03014635|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
20157038|NCT05201807|Johnson & Johnson Vision Care, Inc.|John R. Buch-Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
20157039|NCT01690273|Universidade Sao Paulo|Andrea Lopes Gallinaro; Researcher|55112601|algallinaro@gmail.com|8022
20157040|NCT01752049|St. Michael's Hospital|Dr. Marie Faughnan|416-864-6060|marie.faughnan@unityhealth.to|5412
20157041|NCT05077969|Leidos, Inc.|Tilly Lawrence|703-578-7034|tilly.lawrence@leidos.com|
20157042|NCT02367456|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157043|NCT02862574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20157044|NCT04573972|Carnegie Mellon University|Gretchen Chapman, PhD|4122687380|gchapman@andrew.cmu.edu|
20157045|NCT02610634|Newcastle University|Professor Lynn Rochester|0191 208 1291|lynn.rochester@ncl.ac.uk|
20157046|NCT03746015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20169788|NCT05032859|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
20169789|NCT01535664|Acorda Therapeutics, Inc.|Gustavo Suarez, MD|(914) 326-5394|gsuarez@acorda.com|
20169790|NCT01931202|New York State Psychiatric Institute|Bret R. Rutherford|6467748660|bret.rutherford@nyspi.columbia.edu|
20169791|NCT04597918|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20169792|NCT01069185|Pablo Tobon Uribe Hospital|Dr.Jorge Donado Research Unit Chief|+574459753|jdonado@hptu.org.co|
20169793|NCT05140382|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20169794|NCT03172910|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
20169795|NCT04233034|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
20169796|NCT04088656|University of Washingtion|Carmen Hazim|4042451459|chazim@uw.edu|
20169797|NCT00451451|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
20169798|NCT00122278|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
20169799|NCT01002482|CH Chartres|Dr. Pierre Kalfon|003323730303073|pkalfon@ch-chartres.fr|
20169800|NCT03861611|Montefiore Medical Center|Eddie Irizarry, MD|718-904-2104|eddiriza@montefiore.org|
20169801|NCT03468985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20169802|NCT04060862|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20169803|NCT01880047|Weill Cornell Medicine|Sujit Sheth|2126463400|shethsu@med.cornell.edu|
20169804|NCT01367119|Mayo Clinic|Dr. Keith G. Rassmussen|507-284-2933|rasmussen.keith@mayo.edu|
20169805|NCT05342532|Icahn School of Medicine at Mount Sinai|Gres Karim|212-241-2499|gres.karim@mountsinai.org|
20169806|NCT02675231|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20169807|NCT02652767|GenSight Biologics|Magali Taiel CMO|1 76 21 72 26|mtaiel@gensight-biologics.com|0033
20169808|NCT03953183|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
20169809|NCT03367247|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harard.edu|
20169810|NCT00887744|Medtronic Spinal & Biologics Europe and Central Asia|E. Wülfert, Medical Affairs & Clinical Operations Director||inca.studyregistration@medtronic.com|
20169811|NCT02398409|VHA|Dr. Virginia (Daggett) Wilder|307-675-3659|virginia.wilder@va.gov|
20169812|NCT02354482|University of Kentucky|Jessica Clouser|8593230284|jess.clouser@uky.edu|
20169813|NCT00089674|Amgen Inc.|Study Director|866-572-6436||
20169814|NCT01528215|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
20169815|NCT01610271|Baylor College of Medicine|Rabih Darouiche, MD|713.799.5088|sdself@gmail.com|
20169816|NCT04105543|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|(608) 262-4961|jybruce@medicine.wisc.edu|
20169817|NCT02961218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20169818|NCT01462227|Yale University|Robert Stanley Sherwin, MD|203 737 1932|robert.sherwin@yale.edu|
20169819|NCT00591266|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20169820|NCT01234207|UCaliforniaBerkeley|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
20169821|NCT00586846|Memorial Sloan Kettering Cancer Center|Dr. Paul Meyers|212-639-5952|meyersp@mskcc.org|
20169822|NCT02239627|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
20169823|NCT05298306|Lateral Pharma|Dr Stuart Mudge|+61424588904|sm@lateral-pharma.com|
20169824|NCT00413166|The University of Texas (UT) MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, Professor, Leukemia|7137927734|fravandi@mdanderson.org|
20169825|NCT01352468|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
20169826|NCT01178073|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169827|NCT03497676|Family Health International (FHI 360)|IMPAACT ClinicalTrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
20169828|NCT03496571|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20169829|NCT00484718|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169830|NCT01226043|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20169831|NCT02204007|Cleveland Clinic Foundation|Dr. Carlos A Higuera, MD|2166361136|higuerc@ccf.org|
20169832|NCT01702571|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20169833|NCT00910988|Washington University|Julie Schweiger/Michael Yingling|3143623153/5735791412|schweigj@psychiatry.wustl.edu/yinglinm@psychiatry.wustl.edu|
20169834|NCT04638673|Medical University of South Carolina|Dr. Mark S. George|843-876-5142|georgem@musc.edu|
20169835|NCT01977937|OHSU|Dr Elizabeth Pedigo|5039705211|pedigo@ohsu.edu|
20169836|NCT03004443|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
20169837|NCT00392821|Sarah Cannon Research Institute|John D Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20169838|NCT00828854|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
20169839|NCT00915356|AstraZeneca|Gerard Lynch||clinicalTrialTransparency@astrazeneca.com|
20169840|NCT01782833|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
20169841|NCT03425019|The University of Texas Health Science Center at Houston|Hyochol Ahn|(713) 500-2179|hahn@fsu.edu|
20201966|NCT01854177|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20201967|NCT00728416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20201968|NCT03596164|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20201969|NCT01120626|Stanford University|Allan Reiss, MD|650-498-4538|reiss@stanford.edu|
20169842|NCT00322101|Fred Hutchinson Cancer Research Center|Bart Lee Scott|206-667-1990|bscott@fhcrc.org|
20169843|NCT01753739|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20201970|NCT00488631|Janssen Research & Development|Senior Director|215-793-7540||
20201971|NCT05421754|Northwestern University|Shuai Xu|312-695-8106|stevexu@northwestern.edu|
20169844|NCT00972088|bikur holim hospital|samuel n adler md, director of clinical trial|972 2 6464206|nasnadler@gmail.com|
20169845|NCT03911843|Azienda Ospedaliero-Universitaria di Novara, Italy|Dr. Francesco Cadario, Head of the Pediatric Diabetology service|+39 347 226 6507|francesco.cadario@gmail.com|
20169846|NCT02819518|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20169847|NCT00880165|Philadelphia VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
20169848|NCT01907100|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169849|NCT01758289|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20169850|NCT02865343|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
20169851|NCT00667602|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20169852|NCT01594385|St. Luke's University Health Network|Stanislaw P. Stawicki, M.D.|484-526-4426|stanislaw.stawicki@sluhn.org|
20169853|NCT00285467|Indiana University School of Medicine|Sharon Moe, MD|317-278-2868|smoe@iupui.edu|
20169854|NCT03187756|Perlmutter Cancer Center, NYU Langone Health|David Kaminetzky, MD|212-731-5855|David.Kaminetzky@nyulangone.org|
20169855|NCT02153710|University of Washington|Diane Kendall|2066160537|dkendall@uw.edu|
20169856|NCT01876810|Centre for Addiction and Mental Health|Bernard LeFoll|416-535-8501|bernard.lefoll@camh.ca|34772
20169857|NCT00729924|Vanderbilt University|David W. Haas, MD|615-936-8594|david.w.haas@vanderbilt.edu|
20169858|NCT04070144|Injeq|Chief Scientific Officer|+358405805944‬|info@injeq.com|
20169859|NCT01659658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20169860|NCT01847001|Columbia University Medical Center|Dr. Kevin Kalinsky|212-305-1925|cancerclinicaltrials@cumc.columbia.edu|
20169861|NCT01927341|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169862|NCT01397201|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169863|NCT01948310|Duke Medical Center|Leslie Willis|9196606782|leslie.willis@duke.edu|
20169864|NCT01557894|Babes-Bolyai University|Bogdan Tudor Tulbure|+40745753061|btulbure@gmail.com|
20169865|NCT03402659|EIP Pharma|Jennifer Conway, Associate Director of Clinical Development|(617) 744-4400|jconway@eippharma.com|
20169866|NCT00695578|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
20169867|NCT01442038|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20169868|NCT00089284|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
20169869|NCT03092024|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
20169870|NCT03956056|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
20169871|NCT03347188|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20169872|NCT02128828|University of Hawaii|Dr. Cecilia Shikuma|808 692-1328|shikuma@hawaii.edu|
20169873|NCT00090051|Hoffmann-La Roche|Medical Communications||global.clinical_trial_registry@roche.com|
20169874|NCT01298531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169875|NCT01092507|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20169876|NCT03646643|University of Pennsylvania|Dr. Saman Nazarian|215-615-5220|Saman.Nazarian@pennmedicine.upenn.edu|
20169877|NCT04882501|InovaHCS|Principal Investigator Inova Fair Oaks Hospital|703 391-4892|Laura.McNicholl@inova.org|
20169878|NCT05314478|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|01517064553|tristan.payne@liverpoolft.nhs.uk|
20169879|NCT02007512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169880|NCT04629508|1-855-463-3463|Study Director|1-855-463-3463|medinfo@incyte.com|
20169881|NCT03288454|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
20169882|NCT04073368|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
20169883|NCT00145600|St. Jude Children's Research Hospital|Jamie Flerlage, MD|1-866-278-5833|info@stjude.org|
20169884|NCT01229397|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20169885|NCT00608543|UT Southwestern Medical Center|Dr.Prabha Sunderajan|214-648-0156|prabha.sunderajan@utsouthwestern.edu|
20169886|NCT03051646|Columbia University Medical Center|Victoria M. Leavitt|212 342 1351|vl2337@cumc.columbia.edu|
20169887|NCT01742936|Nationwide Children's Hospital|Vidya Raman, MD|614-722-4200|Vidya.Raman@nationwidechildrens.org|
20169888|NCT01251744|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169889|NCT00214500|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
20169890|NCT02147184|Baylor College of Medicine|Dr. Chadi Calarge|832-824-4764|chadi.calarge@bcm.edu|
20169891|NCT06400979|University of California, Davis Medical Center|Carolyn Mofidi, RN-BC, BSN, MS-L|(916) 734-3333|cmofidi@ucdavis.edu|
20169892|NCT01287078|National Heart Lung and Blood Institute|Dr Richard Childs|301-451-7128|childsr@nhlbi.nih.gov|
20169893|NCT00117286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20169894|NCT01272661|UHospitalsCleveland; Rainbow Babies and CHildren's Hospital|Lydia Furman MD, PI|216-844-8260|Lydia.Furman@uhhospitals.org|
20169895|NCT02314143|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20169896|NCT03963401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169897|NCT01982331|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20169898|NCT00237185|Novartis|Study Director|862-778-8300||
20169899|NCT04350606|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20169900|NCT05211284|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
20169901|NCT00252629|Northport, VAMC|Mohammad M. Amin, MD|6312614400|mohammad.amin2@va.gov|2469
20169902|NCT02325856|Department of Nephrology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan|Lim Paik-Seong|886-4-26581919|jamespslim@gmail.com|
20169903|NCT04192370|Brigham and Women's Hospital|Joji Suzuki, MD|617-455-7981|Jsuzuki2@bwh.harvard.edu|
20169904|NCT02750943|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169905|NCT00395538|Rho, Inc|Robert James|(919) 595-6468|robert_james@rhoworld.com|
20157047|NCT00455702|Massachusetts General Hopsital|Donald C Goff|617-912-7899|goff@psych.mgh.harvard.edu|
20169906|NCT01857583|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
20169907|NCT02211638|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20169908|NCT04382755|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
20169909|NCT00859027|University of Connecticut Health Center|Pamela Taxel MD|860-679-4743|taxel@nso.uchc.edu|
20169910|NCT01510457|Rehabilitation Institute of Chicago Center for Pain Studies|Dr. R. Norman Harden|312.238.5654|centerforpainstudies@ric.org|
20169911|NCT02775903|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20169912|NCT04041700|Cochlear|Johan Blechert|+46766498632|jblechert@cochlear.com|
20169913|NCT03173534|Cleveland Clinic|Samir Kapadia, MD Chairman Cardiovascular Medicine|216 444-6735|KAPADIS@ccf.org|
20169914|NCT00458536|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
20169915|NCT04468321|Yale University|Joseph Ross, MD, MHS|2037852987|joseph.ross@yale.edu|
20169916|NCT00285207|TigrisPharmaceuticals|Chief Medical Officer||info@tigrispharma.com|
20169917|NCT02658097|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223 8100|TaussigResearch@ccf.org|
20169918|NCT03552965|University of Arkansas for Medical Sciences|Rashad Perry|501-686-8274|Rperry3@uams.edu|
20169919|NCT03120624|Mayo Clinic|Jamie N Bakkum-Gamez MD|507-284-2511|bakkum.jamie@mayo.edu|
20169920|NCT04571515|MEDA Pharma GmbH & Co. KG (A Viatris Company)|Susanne Vogt|+49 (0) 172 19 20 321|susanne.vogt@viatris.com|
20169921|NCT01711372|CogCubed|Dr Monika Roots, Chief Medical Officer|6173082009|monika@cogcubed.com|
20169922|NCT00309738|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
20169923|NCT01104701|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTrasparency@astrazeneca.com|
20169924|NCT04382391|Allegheny Health Network (AHN)|Tariq Cheema, MD, Vice President and Medical Director AHN Research Institute|412-321-3344|tariq.cheema@ahn.org|
20169925|NCT02171065|Lund University|Principal Investigator: David Erlinge, MD, PhD|+46-733746165|david.erlinge@gmail.com|
20169926|NCT00084838|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
20169927|NCT00518687|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169928|NCT02598960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20169929|NCT01846104|Department of Clinical Research Division of Medicine USAMRIID|Matthew Chambers, MD|301-619-6731|matthew.s.chambers@mail.mil|
20169930|NCT00851630|Duke University Medical Center|Dr. Nathan Thielman|919-6687174|n.thielman@duke.edu|
20169931|NCT00398411|University of Cologne|Prof. Dr. Oliver A. Cornely|+49 221 478 88794|oliver.cornely@zks-koeln.de|
20169932|NCT01397162|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169933|NCT00931879|Eastern Virginia Medical School|Dr. Henri Parson|(757)446-7976|parsonhk@evms.edu|
20169934|NCT00401531|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20169935|NCT01614600|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
20169936|NCT02437513|Protip Medical|Linda Nicolini CEO|0033388103068|l.nicolini@protipmedical.com|
20169937|NCT03403374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20169938|NCT04879225|Wake Forest University School of Medicine|Emily Harwood|8284067599|eaharwoo@wakehealth.edu|
20169939|NCT03257696|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Camille Bonnin|+0546455050|camille.bonnin@ght-atlantique17.fr|
20169940|NCT00736957|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K. 5-2, Nishi-kanda 3-chome, Cyiyoda-ku, Tokyo 101-0065 JAPAN|Medical Director|+81-3-4411-5509||
20169941|NCT01409434|University of Florida|Dr. Rhonda Cooper-DeHoff|352-273-6184|dehoff@cop.ufl.edu|
20169942|NCT02213042|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20169943|NCT04622735|Unither Pharmaceuticals|Non Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
20169944|NCT04087213|DEKA Research|Clinical Research Manager|(603) 669-5139|clinical@dekaresearch.com|
20169945|NCT01134315|AbbVie|Global Medical Services|800-633-9110||
20169946|NCT03126370|University of Colorado Anschutz Medical Campus|Jennifer Kiser, PharmD, PhD|3037246131|jennifer.kiser@cuanschutz.edu|
20169947|NCT00920231|Baltimore VA MC|Dr Cha-Min Tang|410 706-2347|ctang@som.umaryland.edu|
20169948|NCT02545075|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20169949|NCT03090412|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-6269|Chong.Wang@roswellpark.org|
20169950|NCT01669096|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157048|NCT02329587|Butler Hospital|Sarah Garnaat|401-455-6659|sgarnaat@butler.og|
20157049|NCT03510273|PATH|Dr. Silvia de Sanjose|2062853500|sdesanjose@path.org|
20157050|NCT01606150|Georgetown University NICU|Judith Palafoutas, Research Director|202 444 8756|jxp11@gunet.georgetown.edu|
20157051|NCT02589938|Wake Forest NCORP Research Base|Lead Biostatistician (Dr. Emily Dressler)|336-716-0891|NCORP@wakehealth.edu|
20157052|NCT01121757|Duke University Health Center|Anne Beaven, MD, Associate Professor|9196848964|anne.beaven@duke.edu|
20157053|NCT04222673|Pittsburgh VA|Matthew Chinman|8184813909|chinman@rand.org|
20157054|NCT03861338|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
20157055|NCT02274571|Pennington Biomedical Research Center|Dr. Eric Ravussin|2252844345|eric.ravussin@pbrc.edu|
20157056|NCT03213509|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
20201972|NCT01697332|Brigham and Women's Hospital|Samuel Patz|6172780616|patz@bwh.harvard.edu|
20201973|NCT01740362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20201974|NCT03124069|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
20201975|NCT02604264|Fresenius Medical Care North America|Jeffrey L. Hymes, MD|615-567-4821|Jeffrey.HymesMD@fmc-na.com|
20201976|NCT03192904|Ruijin Hospital Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
20201977|NCT02533089|Li Ka Shing knowledge institute|Dr. L M Puchalski Ritchie|416 864 6060|lisa.puchalskiritchie@utoronto.ca|
20201978|NCT02034123|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20201979|NCT04454411|University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
20201980|NCT00477087|Stanford University Medical Center|Sandy Srinivas, MD; Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20201981|NCT01397851|independent|Richard Sedlmayr|6468412169|richard.sedlmayr@gmail.com|
20201982|NCT02333227|Baylor College of Medicine, Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine|Dr. Kjersti Aagaard|7137988467|aagaardt@bcm.edu|
20157057|NCT02297412|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
20157058|NCT05047627|Dartmouth College|Nicholas Jacobson|(603) 646-7037|Nicholas.C.Jacobson@dartmouth.edu|
20157059|NCT03374306|HK Polytechnic University|Prof. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
20157060|NCT05322408|Masonic Cancer Center|Melissa Geller, MD, MS|612-626-3111|gelle005@umn.edu|
20157061|NCT04583618|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
20157062|NCT03584490|Northwestern University|James W. Griffith, PhD|3125035345|j-griffith@northwestern.edu|
20157063|NCT05196776|Temple University Hospital|Ryan Gibbons|2157075522|ryan.gibbons@tuhs.temple.edu|
20157064|NCT00016354|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-4192|awolff@jhmi.edu|
20157065|NCT03110562|Karyopharm Therapeutics Inc.|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
20157066|NCT02274675|Universiti Teknologi Malaysia|Project Leader||cfyeong@utm.my|
20157067|NCT02160808|Dartmouth-Hitchcock Medical Center|Timothy B. Gardner MD MS|603-650-6472|timothy.b.gardner@hitchcock.org|
20157068|NCT03189719|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20157069|NCT03012880|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
20157070|NCT01355627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20157071|NCT00253422|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722|aude.espinasse@icr.ac.uk|4349
20157072|NCT05239221|Amolyt Pharma|Senior VP of Clinical Development and Regulatory Affairs|+33 428 01 21 54|contact@amolyt.com|
20157073|NCT02581930|University of North Carolina at Chapel Hill|Dr. Stergios Moschos|919-843-7713|stergios_moschos@med.unc.edu|
20157074|NCT01400412|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
20157075|NCT05395936|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Adam Katz|336-716-4171|akatz@wakehealth.edu|
20157076|NCT04043286|Loma Linda University, School of Dentistry|Dr. Sasiya Bhumpattarachai|6267565156|sbhumpattarachai@llu.edu|
20157077|NCT00805389|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157078|NCT03698279|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20157079|NCT02004158|Massachusetts General Hospital|Jeff Huffman|617-724-2910|jhuffman@partners.org|
20157080|NCT04388826|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
20157081|NCT04047446|Hospital for Special Surgery|Dr. David H. Kim|212-606-1036|kimd@hss.edu|
20157082|NCT00329420|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20157083|NCT03136055|University of California, San Francisco|Dr. Emily Bergsland|(415) 353-9888|Emily.Bergsland@ucsf.edu|
20157084|NCT00892008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20157085|NCT00284180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
20157086|NCT01161771|Allergan, Inc.|Vice President, Global Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20157087|NCT02410772|Centers for Disease Control and Prevention|Dr. Ekaterina Kurbatova, MD, PhD, MPH|4046392017|ies3@cdc.gov|
20157088|NCT00822094|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
20157089|NCT03564886|University of Missouri, Department of Orthopaedics|Lasun Oladeji, MD|573-884-7796|OladejiL@health.missouri.edu|
20157090|NCT05067335|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20157091|NCT02724839|Cincinnati Children's Hospital Medical Center|Dr.Kristen Copeland|5136361687|kristen.copeland@cchmc.org|
20157092|NCT01636284|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
20157093|NCT01645176|Stanford University School of Medicine|Mark C. Genovese|650-498-4528|genovese@stanford.edu|
20157094|NCT05878067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20157095|NCT04987372|UZ Ghent|dr. Harlinde Peperstraete|+3293325185|harlinde.peperstraete@uzgent.be|
20157096|NCT00949533|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157097|NCT02649920|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|02 51 44 61 61|guillaume.ducarme@ght85.fr|
20157098|NCT01198587|Boston Children's Hospital|Michelle Niescierenko MD MPH|617-919-4121|michelle.niescierenko@childrens.harvard.edu|
20157099|NCT01493089|Norgine Ltd|Dr. Richard Ng Kwet Shing|+441895453584|RNg@Norgine.com|
20157100|NCT02234362|MGH Center for Women's Mental Health|Dr. Marlene Freeman|617-723-6403|mfreeman@partners.org|
20157101|NCT01440764|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|(617)667-0572|rbanzett@bidmc.harvard.edu|
20157102|NCT00560417|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20169951|NCT05246397|University of Washington|Andrew Bowdle MD, PhD, FASE|206-979-0477|bowdle@u.washington.edu|
20169952|NCT00735254|Arizona Dermatology and Cosmetic|Edward Galiczynski, MD|(602) 277-1449|egaliczynski@arizonaderm.com|
20169953|NCT01952600|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
20169954|NCT00315146|Wake Forest Universtiy Baptist Medical Center|Stephen Kritchevsky|336-713-8548|skritche@wakehealth.edu|
20169955|NCT00147251|MedStar Research Institute|Barbara V Howard|301-560-7305|barbara.v.howard@medstar.net|
20169956|NCT00751621|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20169957|NCT05402020|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169958|NCT01272284|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
20169959|NCT04865640|"Medical Products Group | Analog Devices Inc."|Tony Akl|781-937-1665|tony.akl@analog.com|
20169960|NCT02694523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20169961|NCT01086423|GlaxoSmithKline|GSK Response Center|866-435-7343||
20169962|NCT01417936|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
20169963|NCT00984568|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20169964|NCT04505540|University of Vermont|Dr. Scott Mackey, PhD|8028478767|msmackey@uvm.edu|
20169965|NCT02808871|Baylor College of Medicine|Ivan O. Rosas, MD|617-510-9910|Ivan.Rosas@bcm.edu|
20169966|NCT02057393|Penn State Hershey Medical Center|Colette Pameijer, Associate Professor of Surgery|717-531-5272|cpameijer@pennstatehealth.psu.edu|
20169967|NCT03180684|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
20169968|NCT03091777|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
20169969|NCT01437878|Actelion Pharmaceutical Ltd|Maziar Assadi Gehr|+41 61 565 5525|maziar.assadi-gehr@actelion.com|
20169970|NCT01070043|Novartis Pharmaceuticals|Study Director|862 - 778- 8300||
20169971|NCT01194427|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
20169972|NCT00832390|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20169973|NCT01476644|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
20169974|NCT02393690|Academic and Community Cancer Research United (ACCRU)|Alan Ho, M.D.|212-639-7202|hoa@mskcc.org|
20169975|NCT03488927|University of Nebraska-Lincoln|Katie Edwards|402-472-2223|katie.edwards@unl.edu|
20169976|NCT00586066|Massachusetts General Hospital|Andrew Nierenberg, Principal Investigator|6177240837|anierenberg@partners.org|
20169977|NCT02676466|University of Florida|ENRGISE Coordinating Center Project Manager|352-294-5800|ENGISEACC@aging.ufl.edu|
20169978|NCT02059005|Treatment Research Institute|Adam Brooks, PhD|215-399-0980|abrooks@tresearch.org|128
20169979|NCT00760084|Eisai Inc.|Yufang Lu, MD, PhD|888-422-4743||
20169980|NCT02745210|Loma LInda University Medical Center|Brenda Bartnik Olson|1-909-558-4000|BBartnik@llu.edu|85216
20169981|NCT06120777|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
20169982|NCT02231918|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20169983|NCT03714620|Trinity Health, Loyola University Medical Center, Stritch School of Medicine|Shannon Lovett, MD, Associate Professor of Emergency Medicine|7082168705|slovett@lumc.edu|
20169984|NCT00547196|City of Hope|Dr. Anna Pawlowska, MD|626-359-8111|apawlowska@coh.org|
20169985|NCT00137631|Department of Human Development, State University of New York at Binghamton|Leo Wilton, PhD|607-777-9215|lwilton@binghamton.edu|
20169986|NCT02611960|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20169987|NCT00085709|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
20169988|NCT00293215|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20169989|NCT03026088|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20169990|NCT03611010|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Development|6155642188|imaciasperez@cumberlandpharma.com|
20169991|NCT00504985|UT MD Anderson Cancer Center|Xin Shelley Wang, MD, MPH / Associate Professor|713-745-3504||
20169992|NCT01288027|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
20169993|NCT01550471|Allegheny Health Network|Deborah Gentile, Principal Investigator|412-359-4099|dgentile@wpahs.org|
20169994|NCT00760214|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20169995|NCT00994318|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
20169996|NCT03960554|Columbia University Irving Medical Center|Thomas L. Nickolas MD|212-305-5020|tln2001@cumc.columbia.edu|
20169997|NCT00736879|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
20169998|NCT02360111|Memorial Sloan Kettering Cancer Center|Dr. Ann Jakubowski, Ph.D., MD|212-639-5013|jakubowa@mskcc.org|
20169999|NCT00718302|Boston Medical Center|Paul Tornetta, III, MD|617-414-6295|tornetta@bu.edu|
20170000|NCT01431131|University of Louisville|Dr. Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
20170001|NCT01933217|Children's Hospital Medical Center, Cincinnati|Brad Kurowski, MD, MS|513-803-3655|brad.kurowski@cchmc.org|
20170002|NCT02861131|Oregon Health & Science University|Brandon Togioka|5034944572|togioka@ohsu.edu|
20170003|NCT03923738|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20170004|NCT02751788|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
20170005|NCT01684020|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20170006|NCT03583164|F2G Ltd|Daniela Zinzi|43 664 3582281|dzinzi@f2g.com|
20170007|NCT01031381|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
20170008|NCT04489732|University of Wisconsin Carbone Cancer Center|Randy Kimple, MD, PhD, FASTRO|608-263-5361|rkimple@humonc.wisc.edu|
20170009|NCT00573248|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
20170010|NCT05619523|University of Maryland, College Park|Dr. Melanie Killen|(301) 405-3176|mkillen@umd.edu|
20170011|NCT02791594|Abramson Cancer Center|Dr. Michael Farwell|215-662-7750|michael.farwell@pennmedicine.upenn.edu|
20170012|NCT00805948|Medtronic, Inc|Michael McGuffey, Clinical Research Director|707-591-7126|michael.mcguffey@medtronic.com|
20170013|NCT04007198|Equillium|Clinical Operations|8582401200|clinicaltrials@equilliumbio.com|
20170014|NCT04950166|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
20170015|NCT05896748|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170016|NCT04847622|Research Organisation King's Cross (KC) Ltd.|Toni Sobande, Clinical Project Manager|447494 795 982|toni.sobande@rokcservices.com|
20170017|NCT03207555|The University of Texas MD Anderson|Jan Burger, MD/Professor|713-563-1487|jaburger@mdanderson.org|
20170018|NCT06138145|University of Pennsylvania|Dr. Kevin B. Johnson|215-573-5885|Kevin.Johnson1@Pennmedicine.upenn.edu|
20170019|NCT03660488|University of Southern California|Jeffrey D Klausner MD MPH, Clinical Professor of Population and Public Health Sciences|4158768901|jdklausner@med.usc.edu|
20170020|NCT00857415|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20170021|NCT04508140|Highlight Therapeutics S.L.|Marisol Quintero|+34 961 10 99 55|mquintero@highlighttherapeutics.com|
20170022|NCT01130103|Research Foundation for Mental Hygiene|Franklin Schneier MD|212-543-5368|frs1@columbia.edu|
20201983|NCT01982630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20201984|NCT00561353|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
20201985|NCT01273818|S.B.Ankara Diskapi Yildirim Beyazit Education and Teaching Hospital|Dr.Gaye Seker|+905323360618|gayeebru@superonline.com|
20201986|NCT03934684|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20201987|NCT05300087|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
20201988|NCT00761215|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
20201989|NCT00519532|UCB|UCB Clinical Trial Call Center|+18778229493||
20201990|NCT00667277|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|(212) 241-2297|ronald.hoffman@mssm.edu|
20201991|NCT01363050|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
20201992|NCT00256295|University of California, Irvine|Nicole Macaranas|714-456-6550|nicole.macaranas@uci.edu|
20201993|NCT01236391|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
20201994|NCT03542682|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
20201995|NCT04321343|POXEL|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
20201996|NCT00765765|Cancer Institute of New Jersey|Dr. Vassiliki Karantza|732-235-8675|karantva@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20201997|NCT02871479|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@satalispharma.com|101
20201998|NCT01097044|Clinuvel Pharmaceuticals Limited|Dr. Dennis Wright, Acting Chief Scientific Officer|646 527 7310|Dennis.Wright@clinuvel.com|
20201999|NCT01212445|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20202000|NCT01682044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20202001|NCT00843986|Astellas Pharma Global Development|Medical Director||clinicaltrials@us.astellas.com|
20202002|NCT01903148|Hospital de Bellvitge|Dr. Alberto Martínez Castelao|610 459 262|albertomcastelao@gmail.com|
20202003|NCT04865731|University of Texas Health Science Center at San Antonio|Dr. Shraddha Dalwadi|210-567-1203|dalwadi@uthscsa.edu|
20157103|NCT03807089|Massachusetts General Hospital|Dr. Norman Nishioka|617-726-4422|nnishioka@partners.org|
20157104|NCT01870869|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20157105|NCT00557193|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20157106|NCT00261833|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20157107|NCT00622726|University of Texas Health Science Center-Houston|Helen Mintz-Hittner, M.D.|713-559-5277|Helen.A.Mintz-Hittner@uth.tmc.edu|
20157108|NCT04358406|BioAegis Therapeutics Inc.|Mark J. DiNubile, MD|609-706-5866|mdinubile@bioaegistx.com|
20157109|NCT01948427|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
20157110|NCT00402987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20157111|NCT02434081|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|NICOLAS@etop-eu.org|
20157112|NCT00419744|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20157113|NCT05528770|Center for Diabetes Technology|Manager of Clinical Research|434-982-0602|mc7m@uvahealth.org|
20157114|NCT01190527|University of Michigan Comprehensive Cancer Center|Dr. Shruti Jolly, M.D.|734-936-4300|shrutij@umich.edu|
20157115|NCT01117779|Boston Scientific|Chantal Laframboise, Clinical Research Manager|613-882-0876|chantal.laframboise@bsci.com|
20157116|NCT02448381|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
20157117|NCT03130569|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Hay|646-888-0039|hayj@mskcc.org|
20157118|NCT01500317|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20157119|NCT00976456|Krankenhaus Martha-Maria Halle-Doelau gGmbH|Prof. Dr. Wolfgang Schuette|+49 345 5591440|wolfgang.schuette@martha-maria.de|
20157120|NCT01874392|Sansum Diabetes Research Institute|Director of Research and Innovation|8056827640|dkerr@sansum.org|
20157121|NCT04856527|University of Cincinnati|Sarah Schwab|5135587477|schwabsr@mail.uc.edu|
20157122|NCT02468583|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
20157123|NCT01463527|Yale University|Dr. Melissa Langhan|203-737-7413|melissa.langhan@yale.edu|
20170023|NCT03839082|University of California Los Angeles|Monica Tincopa|310 825-2631|mtincopa@mednet.ucla.edu|
20170024|NCT01822678|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20170025|NCT01200862|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
20170026|NCT01336296|UCincinnati|Research Associate Professor|5135852145|adele.rike@uc.edu|
20170027|NCT00249288|Schizophrenia Program, Massachusetts General Hospital|Michelle Hill|617-912-7846|michelehill1@gmail.com|
20170028|NCT03059446|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20170029|NCT04795622|Merz Aesthetics|Public Disclosure Manager|+49 69 1503|Aesthetic.Trials@merz.com|1
20170030|NCT03309046|MemphisVAMC|Dr. Linda Olivia Nichols|901 523-8990|linda.nichols@va.gov|5082
20170031|NCT01810588|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
20170032|NCT00337350|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
20170033|NCT01369615|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
20170034|NCT04263454|University of Alabama at Birmingham|Jarred Younger|205-975-5821|youngerlab@uab.edu|
20170035|NCT01016561|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
20170036|NCT00986479|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
20170037|NCT01721070|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20170038|NCT01302379|University of San Diego, California|Ruth Patterson|8585349235|repatterson@ucsd.edu|
20170039|NCT01090973|H. Lee Moffitt Cancer Center and Research Institute|Celeste Bello, M.D.|813-745-8623|celeste.bello@moffitt.org|
20170040|NCT00908011|St. Paul's Hospital/University of B.C.|Dr. Greg Bondy|604-806-8192|gbondy@providencehealth.bc.ca|
20170041|NCT02103218|UNC Greensboro|Lisa Goble Director Office of Research Integrity|336-256-1173|lagoble@uncg.edu|
20170042|NCT00739596|Novartis Pharmaceuticals|Study Director|862-778-8300||
20170043|NCT06352060|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-934-4300|dlakkireddy@gmail.com|
20170044|NCT02176343|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20170045|NCT02567552|IVI Barcelona|Evelin Lara Molina|+34 93 531 63 00|Evelin.Lara@ivi.es|27503
20170046|NCT02301988|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20170047|NCT02891161|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20170048|NCT00990938|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
20170049|NCT01074047|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
20170050|NCT04669535|UMass Chan Medical School|Dr. Terence Flotte|508-856-8992|terry.flotte@umassmed.edu|
20170051|NCT01298544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170052|NCT05169567|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
20170053|NCT02037607|Indiana University|Heather Cero, Research Nurse Manager|317-396-1298|hcero@iupui.edu|
20170054|NCT03237871|Johns Hopkins Bloomberg School of Public Health|Principal Investigator|410-955-3537|ljennin6@jhu.edu|
20170055|NCT05419908|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20170056|NCT02981940|Dana-Farber Cancer Institute|Eudocia Q Lee, MD MPH|617.632.2166|eudocia_lee@dfci.harvard.edu|
20170057|NCT05069259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170058|NCT00814788|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
20170059|NCT01828320|University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
20170060|NCT02160782|Mirum Pharmaceuticals|Mirum Clinical Trials|1 650-667-4085|medinfo@mirumpharma.com|
20170061|NCT00413400|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
20170062|NCT00891462|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20170063|NCT00970073|Cleveland Clinic|Bijan Eghtesad|2164029954|eghtesb@ccf.org|
20170064|NCT00423722|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD / Professor|713-792-6085|ebruera@mdanderson.org|
20170065|NCT00215683|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
20170066|NCT01083485|Mundipharma Research|Maggie Wilson|+ 4401223 424444||2303
20170067|NCT04493333|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|iwen@uams.edu|24024
20170068|NCT02791399|VA Portland Health Care System|Benjamin Morasco, PhD|5032208262|benjamin.morasco@va.gov|
20170069|NCT00674973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20170070|NCT00414271|Johns Hopkins Singapore|Prof Alex Chang|+65 68802220|alexchang@imc.jhmi.edu|
20170071|NCT00763048|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
20170072|NCT05108922|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20170073|NCT00683085|Research Hospital, The Institute of Medical Science, The University of Tokyo|Hitomi Nagayama, M.D., Ph.D. / Project Lecturer|+81-3-3443-8111|zephyrus@ims.u-tokyo.ac.jp|
20170074|NCT05036369|VibrantGastro|Clinical trials manager|+972 046663322|service@vibrantgastro.com|
20170075|NCT00704912|Penn State College of Medicine, Penn State Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rsl1@psu.edu|
20170076|NCT02260440|UPMC Hillman Cancer Center|Anuradha Krishnamurthy, MD|412-623-3283|krishnamurthya2@upmc.edu|
20170077|NCT02349061|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20170078|NCT01956435|University of Texas at Austin Medical School and Seton Family of Hospitals|Ammar Ahmed, MD|512-504-0855|amahmed@seton.org|
20170079|NCT02095223|University of Miami|Christopher Kuenze|5174325018|kuenzech@msu.edu|
20170080|NCT01507298|Imperial College London|Dr. Richard Mark Kwasnicki|07851759471|rmk107@ic.ac.uk|
20170081|NCT03906461|Abbott|Clinical Research Scientist|16517563101|laura.zitellaverbick@abbott.com|
20170082|NCT04925271|Thomas Jefferson University|Anand Kumar, Associate Professor of Medicine|215-955-8900|anand.kumar@jefferson.edu|
20170083|NCT00426231|Johns Hopkins University|Dhananjay Vaidya|410-6142307|dvaidya1@jhmi.edu|
20170084|NCT01795638|University of Cincinnati Medical Center|Barbara Isemann|513-584-5060|barbara.isemann@uchealth.com|
20170085|NCT03061097|Microbiome Health Research Institute|Majdi Osman, MD, MPH|617-575-2201|majdi@openbiome.org|
20170086|NCT01043146|Corimmun, GmbH|Gary Peters, MD, Managing Director|001-215 628-5257|gpeters7@its.jnj.com|
20170087|NCT00595465|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
20170088|NCT00107783|NHGRI|William Gahl, MD/Clinical Director|301-402-2739|gahlw@mail.nih.gov|
20170089|NCT00422097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20170090|NCT02572388|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|adrian.hill@ndm.ox.ac.uk|
20170091|NCT02360995|Loma Linda University School of Dentistry|Yiming Li, DDS|909-558-8069|yli@llu.edu|
20170092|NCT00810108|University of California San Diego|Dr. Brookie M. Best, Associate Professor|858-822-5550|brookie@ucsd.edu|
20170093|NCT01051466|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20170094|NCT00331864|Novartis Pharmaceuticals|Study Director|862-778-8300||
20170095|NCT02395666|Beat Childhood Cancer|Dr. Giselle Sholler|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
20170096|NCT00994929|The University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
20170097|NCT04839146|Radboudumc|Benjamin Mordmüller (Principal investigator)|+31 (0)24 3619499|benjamin.mordmueller@radboudumc.nl|
20170098|NCT00351000|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
20170099|NCT04131556|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20170100|NCT00841971|University of Pittsburgh|Dr Nina Singh|412 360-1688|nis5@pitt.edu|
20170101|NCT01229371|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20170102|NCT05015530|BG ClinicalS|Dr Bernard Gout|+33 (0)561 531 944|b.gout@bgclinicals.com|
20170103|NCT04735536|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
20170104|NCT00761579|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
20170105|NCT00950911|Amgen Inc.|Study Director|866-572-6436||
20170106|NCT02476422|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20170107|NCT01859143|MedImmune, LLC|Raburn Mallory, MD/Senior Director, Clinical Development|301-398-0000|malloryr@medimmune.com|
20170108|NCT00438451|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|C. Ruckes|+49 (0) 6131 17|ruckes@izks-mainz.de|9919
20170109|NCT02413372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20170110|NCT04157621|MUSC|Vanessa Hinson|843-876-0829|hinsonvk@musc.edu|
20170111|NCT04587271|University of Kentucky|Dr. Suzanna Attia|859-323-6211|suzanna.attia@uky.edu|
20170112|NCT02180165|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170113|NCT03875768|Duke University|Gary G. Bennett, PhD|919-684-4510|gary.bennett@duke.edu|
20170114|NCT01925274|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170115|NCT04327674|Department of Respiratory Diseases and Allergy. Aarhus University Hospital. Denmark.|Søren Helbo Skaarup|28911869|soeska@rm.dk|
20170116|NCT00723398|Milton S. Hershey Medical Center|Dr. Andrea Manni|717-531-8395|amanni@pennstatehealth.psu.edu|
20170117|NCT00470847|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-2335|nlin@partners.org|
20170118|NCT02035475|OhioHealth|Dr. Ronney Abaza|614-544-8104|ronney.abaza@ohiohealth.com|
20170119|NCT02047227|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20170120|NCT01721473|VA San Diego Healthcare System|Arthur Brody|8585528585|arthur.brody@va.gov|
20170121|NCT02766465|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
20170122|NCT02435069|Nemours Children's Clinic|Kimberly S. Jarczyk, PhD, C-PNP|9044611730|jarczykks@gmail.com|
20170123|NCT03112590|Moffitt Cancer Center|Hyo S. Han, MD|813-745-4933|Hyo.Han@moffitt.org|
20170124|NCT00590889|St.Jude Medical|Heidi Hinrichs, VP of Clinical Study Management, St. Jude Medical||hhinrichs@sjm.com|
20170125|NCT02520661|UW School of Medicine and Public Health|Manish N. Shah, MD, MPH|608-263-6690|mnshah@medicine.wisc.edu|
20170126|NCT00843726|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
20170127|NCT02443519|Yeshiva University & Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|elizabeth.seng@yu.edu|
20202004|NCT02656472|Advocate Children's Hospital|Andrew VanBergen|7086848758|andrew.vanbergen@advocatehealth.com|
20170128|NCT03309150|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20170129|NCT00171054|Novartis Pharmaceuticals|Study Director|862-778-8300||
20170130|NCT03861702|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20170131|NCT00598702|Mallinckrodt Pharmaceuticals|Lawrence Hill, VP Clinical Development|908-238-6370|lawrence.hill@mallinckrodt.com|
20170132|NCT02600351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20170133|NCT02521766|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20170134|NCT00567593|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
20202005|NCT01167712|NRG Oncology|Linda Gedeon for Mark Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
20202006|NCT04909463|CommonSpiritHealth|Trenton Bradbury|7193730213|trenton_b1@yahoo.com|
20170135|NCT02106910|University of North Carolina at Chapel Hill|Nicholas J. Shaheen, MD|919-966-7655|nicholas_shaheen@med.unc.edu|
20202007|NCT01672892|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20202008|NCT00468715|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
20170136|NCT00700570|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170137|NCT02563990|University of Miami|Andres Missair|3055857037|amissair@miami.edu|
20170138|NCT00093782|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
20170139|NCT03153956|NYU Langone Health|Dennis A. Cardone, DO|+1 646 501 7223|Dennis.Cardone@nyulangone.org|
20170140|NCT04396665|University of Oviedo|Vicerrectorado de investigación|+34985104190|viceinvestigacion@uniovi.es|
20170141|NCT00267189|Novartis Pharmaceuticals|Study Director|862-778-8300||
20170142|NCT00745940|Lakehead University|Dr. Michel Bédard|807-343-8630|mbedard@lakeheadu.ca|
20170143|NCT00559936|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|cornea_research@meei.harvard.edu|
20170144|NCT04137224|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
20170145|NCT01225887|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
20170146|NCT00566501|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20170147|NCT00925990|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|858-457-7227|mhuyghe@conatuspharma.com|
20170148|NCT00835159|NYU Langone Medical Center|ALEXANDER ZASLAVSKY|212-263-5569|michael.haile@nyumc.org|
20170149|NCT00749515|St. Jude Children's Research Hospital|Ellis Neufeld, MD, PhD|901-595-7509|ellis.neufeld@stjude.org|
20170150|NCT01368432|Johns Hopkins University & school of Medicine|Vani Rao|410-550-2288|vrao@jhmi.edu|
20170151|NCT01270542|Doheny Eye Institute/USC/University of Iowa|Dr. Elliott Sohn|319-356-3185|elliott-sohn@uiowa.edu|
20170152|NCT00437320|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20170153|NCT02148107|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170154|NCT02315989|Linkou Chang Gung Memorial Hospital|Hong, Ji-Hong M.D.|03-3281200|jihong@cgmh.org.tw|2600
20170155|NCT00762216|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20170156|NCT00277446|Northwestern University|Lewis J. Smith|312-503-0501|ljsmith@northwestern.edu|
20170157|NCT01680887|Perelman School of Medicine|Kyle Kampman|215 746 2764|kampman@pennmedicine.upenn.edu|
20202009|NCT01491958|The Ohio State University Comprehensive Cancer Center|Yvonne Efebera, M.D|614-293-3196|Yvonne.Efebera@osumc.edu|
20202010|NCT01419171|Peter Maurer, Director Clinical Trials|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
20202011|NCT01385696|Almirall S.A.|Clinical Project Leader and Trial Manager|+34 93 291 3200||
20202012|NCT01695369|University of Houston, College of Optometry, TERTC|Jan Bergmanson, OD,PhD|713-743-1950|jbergmanson@uh.edu|
20202013|NCT03528681|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20202014|NCT01195025|University Hospital Linköping|Dr. Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
20202015|NCT02017444|University of Birmingham|Professor Alex Sinclair|+44 121 415 9125|a.b.sinclair@bham.ac.uk|
20202016|NCT01614457|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20202017|NCT00918723|Fred Hutchinson Cancer Research Center|Dr. Mazyar Shadman|2066675467|mshadman@fredhutch.org|206
20202018|NCT02342171|Institute of Tropical Medicine|Prof. Dr. Johan van Griensven|+3232476426|jvangriensven@itg.be|
20202019|NCT02062177|Università Vita-Salute San Raffaele|Professor Testoni Pier Alberto|+390226432756|testoni.pieralberto@hsr.it|
20202020|NCT03518840|Loyola University Chicago|Colleen Fitzgerald, M.D., M.S.|708-216-3380|CFITZGERALD@lumc.edu|
20202021|NCT00920309|Yale University School of Medicine|Dr. Neera Dahl|203-785-4184|neera.dahl@yale.edu|
20202022|NCT00875420|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
20202023|NCT01612793|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
20202024|NCT00886821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202025|NCT00914628|AGC Biologics S.p.A|Anna Stornaiuolo|00390221277440|astornaiuolo@agcbio.com|
20202026|NCT03311126|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|(608) 263-9823|jc2@medicine.wisc.edu|
20202027|NCT00942162|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202028|NCT02799381|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20202029|NCT03368859|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20202030|NCT02698410|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
20202031|NCT01713348|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
20202032|NCT00621023|Duke University Medical Center|Dr. Carlos de Castro|919-684-8964|decas003@mc.duke.edu|
20202033|NCT01712360|Merz North America, Inc.|Ashlee Duncan|984-222-6040|Ashlee.Duncan@merz.com|
20202034|NCT04425850|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
20202035|NCT02907944|Yale School of Medicine|David Fiellin, MD|(203) 688-5555|david.fiellin@yale.edu|
20202036|NCT00698516|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202037|NCT00753636|Northwestern University|Dr. Tanya Simuni, MD|312-503-2970|tsimuni@nmff.org|
20202038|NCT04331899|Stanford University|Dr. Prasanna Jagannathan, MD|1-650-724-5343|prasj@stanford.edu|
20202039|NCT00101361|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|
20202040|NCT02424539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170158|NCT03686514|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
20170159|NCT01400815|22nd Century Group, Inc.|Karen Delaney|716-270-1523|kdelaney@xxiicentury.com|
20170160|NCT01123850|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
20170161|NCT02234986|CASI Pharmaceuticals, Inc.|Dr. Alexander Zukiwski|+1 240 864 2888|alexz@casipharmaceuticals.com|
20170162|NCT02310321|Astellas Pharma Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
20202041|NCT00719810|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
20202042|NCT00450463|National Cancer Institute|Dr. Ravi Madan|301-480-7168|ravi_madan@nih.gov|
20157124|NCT01493414|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20157125|NCT01072526|University of Missouri|Lenworth Johnson, MD|573-882-8473|JohnsonLN@health.missouri.edu|
20157126|NCT05448950|Phraxis, Inc.|Cindy Setum, PhD|16128016730|csetum@phraxis.com|
20157127|NCT01728246|Janssen Pharmaceutica|Medical Affairs Manager|+632-8247901||
20157128|NCT01143402|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646 888 4162|chapmanp@mskcc.org|
20157129|NCT02481557|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20157130|NCT02135484|UT MD Anderson Cancer Center|John C. Araujo, Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|johna@mdanderson.org|
20157131|NCT01959932|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
20157132|NCT00397540|Seoul National University Hospital Boramae Medical Center|Won Kim|82 2 870 2233|wonshiri@yahoo.com|
20157133|NCT01656161|Debiopharm International|Eija Lundstrom, Medical Director|+41 21 321 06 03|eija.lundstrom@debiopharm.com|
20157134|NCT00963872|University of Minnesota|Dr. Claudio Brunstein|612-625-3918|bruns072@umn.edu|
20157135|NCT00776230|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43120620|info@valneva.com|0
20157136|NCT01215851|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|dan.everitt@tballiance.org|
20157137|NCT04212442|University of Pennsylvania|Dr. Rebecca Brown|215-573-2021|rebecca.brown@pennmedicine.upenn.edu|
20157138|NCT01561469|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157139|NCT04532749|Janssen Research & Development, LLC|Executive Director CDTL Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20157140|NCT01230411|Thomas Jefferson University- Jefferson Headache Center|Dr. Hsiangkuo Yuan|2159552243|Hsiangkuo.Yuan@jefferson.edu|
20157141|NCT02106429|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
20157142|NCT04756531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157143|NCT05643495|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20157144|NCT04237584|MANA RBM|Penelope Manasco, CEO|9195566456|pmanasco@manarbm.com|
20157145|NCT00285779|Stanford University Department of Dermatology|David Fiorentino|650-723-6316|fiorentino@stanford.edu|
20157146|NCT04164277|Michigan State University|Jiying Ling|5173538591|lingjiyi@msu.edu|
20157147|NCT01334918|Astellas Scientific and Medical Affairs, Inc. / Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||ClinicalTrials.Disclosure@us.astellas.com|
20157148|NCT00529633|University of California, Davis|George Kaysen MD PhD, Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
20157149|NCT04096417|Mayo Clinic|Tanios Bekaii-Saab M.D.|480-342-2000|Bekaii-Saab.Tanios@mayo.edu|
20157150|NCT02777086|Texas Christian University|Wayne E.K. Lehman, Ph.D.|18172577226|w.lehman@tcu.edu|
20157151|NCT01133665|The University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
20157152|NCT01819272|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
20157153|NCT01784029|Children's Hospital at Montefiore|Hina Talib|718-920-6781|htalib@montefiore.org|
20157154|NCT01444911|University of Wisconsin Carbone Cancer Center|Dr. David Kushner|608-263-1210|dmkushner@facstaff.wisc.edu|
20157155|NCT00069641|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20157156|NCT03186638|University of Rochester Medical Center, Dept of Surgery, Supportive Care in Cancer|Michelle Janelsins, PhD, MPH|585-276-4656|michelle_janelsins@urmc.rochester.edu|
20157157|NCT02239926|Mayo Clinic|Dr. Yuri Saito Loftus|507-255-3680|saito.yuri@mayo.edu|
20157158|NCT02704208|San Diego State University|Keith J. Horvath|619-594-3346|khorvath@sdsu.edu|
20157159|NCT00560508|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157160|NCT00548886|Emory University|Dr. Peter Seth Fischbach|404-256-2593|pfischb@emory.edu|
20157161|NCT03983421|Department of Psychiatry and Behavioral Sciences, Health Sciences Center, University of New Mexico|Annette Crisanti, PhD|5052726238|acrisanti@salud.unm.edu|
20157162|NCT03386773|Colorado School of Public Health|Susan L. Moore, PhD, MSPH|303-724-8858|susan.l.moore@cuanschutz.edu|
20157163|NCT03639610|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
20157164|NCT01959529|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20157165|NCT02164864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157166|NCT00652834|UCLA Kidney Transplant Research Program|Dr. Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
20157167|NCT02569853|Dr. Reddy's|Director, Clinical Development|609-375-9900|ebrandschieber@drreddys.com|
20157168|NCT01668004|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157169|NCT02668666|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20157170|NCT03462745|American University of Beirut Medical Center|Dr. Roland Kaddoum|01350000|rk16@aub.edu.lb|6704
20157171|NCT00335829|Johns Hopkins, Interventional Radiology|Jeff Geschwind, MD|410-614-6597|jfg@jhmi.edu|
20157172|NCT00854360|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20157173|NCT00754572|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20157174|NCT00427037|Emory University School of Medicine|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
20157175|NCT02006927|William Beaumont Hospitals|Deborah Hasenau, RN|248 551-0804|deborah.hasenau@beaumont.org|
20157176|NCT03229538|Duke University|Kevin Hill, MD|919-681-6846|kevin.hill@duke.edu|
20157177|NCT02735200|Dammam University|Dr Dalal Bubshait|+966505848281|dbubshait@ud.edu.sa|
20157178|NCT02746809|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
20157179|NCT01416025|JohnHopkinsU|Dr. Darin Ostrander|(443) 287-6217|dostrander@jhu.edu|
20157180|NCT01164007|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170163|NCT01698905|Novartis|Study Director|862-778-8300|novartis.email@novartis.com|
20170164|NCT01729247|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
20170165|NCT00764504|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
20170166|NCT02456103|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20170167|NCT04010539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170168|NCT05708586|University of Michigan|Dr. Noelle Whyte|734 936-5780|whyteno@umich.edu|
20170169|NCT03194503|The Children's Hospital of Philadelphia|Dr. Akira Nishisaki|267-426-0665|NISHISAKI@email.chop.edu|
20170170|NCT00568685|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20170171|NCT00542971|The University of MD Anderson Cancer Center|Farhad Ravandi-Kashani, M.D./Associate Professor|713-745-0394|fravandi@mdanderson.org|
20170172|NCT01638819|Sutter Health|Michael Chez, MD|(916) 773-8711|ChezM@sutterhealth.org|
20170173|NCT00471146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170174|NCT01267656|Bausch Health|Study Director||susan.harris@bauschhealth.com|
20170175|NCT00467610|Rush university medical center|Jamile shammo|312-942-5157|jamile_shammo@rush.edu|
20170176|NCT01460368|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20170177|NCT02322021|Eisai Medical Information|Eisai Ltd.|+1-888-274-2378|esi_medinfo@eisai.com|
20170178|NCT04181320|Mölnlycke|Vice President Corporate Clinical & Medical Affairs CMO & RQA|+46317223045|jane.clark@molnlycke.com|
20170179|NCT02001181|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170180|NCT00445978|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
20170181|NCT01483807|VA SALT LAKE CITY HEALTHCARE SYSTEM|Dr. Julie Wambaugh|8015821565|julie.wambaugh@health.utah.eduj|1363
20170182|NCT03643159|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
20170183|NCT03438383|Department of Vascular Surgery, Korgialeneio-Benakeio Hellenic Red Cross Hospital, Athens, Greece|Dr. Konstantinos Roditis, Study Chair|+306976686951|roditis.k@gmail.com|
20170184|NCT01528033|Witten/Herdecke University|Dörthe Seidel|00492219895731|Doerthe.Seidel@uni-wh.de|
20170185|NCT01498601|Fraser Health|Trudy Robertson RN, MSN, CNN(c)|604-520-4715|Trudy.Robertson@fraserhealth.ca|
20170186|NCT03170856|Boston Children's Hospital|Dr. William Meehan|781-216-1328|william.meehan@childrens.harvard.edu|
20170187|NCT03374631|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
20170188|NCT02780609|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-1856|Taiga.Nishihori@moffitt.org|
20170189|NCT02898116|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20170190|NCT03635788|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20170191|NCT01015131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170192|NCT02900560|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|026@trioncology.org|
20170193|NCT04191187|Moffitt Cancer Center|Dr. Nelli Bejanyan|813-745-6008|Nelli.Bejanyan@moffitt.org|
20170194|NCT05521906|University of Nebraska-Lincoln, Department of Educational Psychology/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
20170195|NCT02339285|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
20170196|NCT01564914|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
20170197|NCT00282412|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
20170198|NCT02793921|University of Pittsburgh|Dr. Catherine Bender, Principal Investigator|412-624-3594|cbe100@pitt.edu|
20170199|NCT01920555|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
20170200|NCT03911713|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20170201|NCT00145704|Upstate Orthopedics|Timothy A. Damron|315-464-8602|damront@upstate.edu|
20170202|NCT01845818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20170203|NCT00195273|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20170204|NCT01680965|Moffitt Cancer Center|Joseph Pidala, M.D., PhD|813-745-2069|Joseph.Pidala@moffitt.org|
20170205|NCT02595970|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|Novartis.email@novartis.com|
20170206|NCT02570074|University of Illinois at Chicago|Keith A. Rodvold, PharmD, FCCP, FIDSA|312-996-3341|kar@uic.edu|
20170207|NCT02923427|DorkuzEU|Anaesthesiology and Intensive Care, Sule Ozbilgin|905055252901|ozbilginsule@gmail.com|
20170208|NCT01325623|Cyberonics Europe BVBA|Wim Van Grunderbeek, Clinical Operations Manager Cyberonics Europe|+32 2 720 95 93|wim.vangrunderbeek@cyberonics.com|312
20170209|NCT01420653|AFT Pharmaceuticals Ltd.|Jennifer Zhang|+ 64 9 488 0232|jenniferz@aftpharm.com|710
20170210|NCT01539642|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
20170211|NCT02063880|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
20170212|NCT02556203|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20170213|NCT01146275|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
20170214|NCT01924988|Georgetown University Medical Center|James B. Spies MD MPH|202-444-3450|spiesj@gunet.georgetown.edu|
20170215|NCT02943460|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20170216|NCT00122109|VA Pacific Islands Healthcare System|Leslie A. Morland, PsyD, Principal Investigator|(808) 566-1934|leslie.morland@va.gov|
20170217|NCT00100178|Barbara Davis Center for Childhood Diabetes, Health Sciences Center, University of Colorado|Peter Gottleib, MD|303-724-6714|Peter.Gottleib@uchsc.edu|
20170218|NCT00783965|ChildrensHRCOakland|Raj Prasad|510-450-7602|rprasad@chori.org|7602
20170219|NCT01480089|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
20170220|NCT02781779|Kansas City Heart Rhythm Institute|Donita Atkins|816-651-1969|donita.atkins@hcahealthcare.com|
20170221|NCT00631696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170222|NCT00365144|UCaliforniaSF|Andrew Ko, MD|415-353-9888|andrewko@medicine.ucsf.edu|
20170223|NCT01439568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20170224|NCT01578330|Novartis|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20170225|NCT01134731|UAB|Dr. Richard Shelton|205-934-2484|rshelton@uab.edu|
20170226|NCT01669928|Imperial College London|Professor Neil Poulter|+44 20 7594 3446|n.poulter@imperial.ac.uk|
20170227|NCT02439879|Universidad Popular Autonoma del Estado de Puebla|Dr. Hector Garcia Alcala|+522222299400|hector.garcia@upaep.mx|7466
20170228|NCT01631110|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
20170229|NCT01199731|ViiV Healthcare|GSK Response Center|866-435-7343||
20170230|NCT02448810|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20170231|NCT04231318|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
20170232|NCT00381381|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical team manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
20170233|NCT00846287|UMass Medical School|Dr. Mitchell Albert|(807) 684-7270|albertmi@tbh.net|
20170234|NCT01231230|University of Miami|Adam Wanner, MD|(305)243-2568|awanner@med.miami.edu|
20170235|NCT00979069|Atlanta VAMC|Dr. Joe Nocera|404 321 6111|joe.nocera2@va.gov|6354
20170236|NCT03538431|Massachusetts General Hospital|Dr. Joseph Biederman|6177261743|biederman@helix.mgh.harvard.edu|
20170237|NCT03530800|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
20202043|NCT04893265|University of California San Francisco|Janice Tsoh, PhD, Professor/ Principal Investigator|4155028438|janice.tsoh@ucsf.edu|
20202044|NCT02523586|Oregon Health and Science University|Jeffrey Kirsch|503-494-9000|kirschje@ohsu.edu|
20202045|NCT00573131|Boston Scientific Corporation|Jessie Stockwell|1-612-618-1136|jessie.stockwell@bsci.com|
20202046|NCT03090191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202047|NCT01251575|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
20202048|NCT01479725|Beaumont Hospital, Royal Oak|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.edu|
20202049|NCT03102736|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-1640|james.murrough@mssm.edu|
20202050|NCT01315574|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|
20202051|NCT02176486|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20202052|NCT00759577|New York University|Dr. Victor Nitti|646 825 6300|Victor.Nitti@NYUMC.org|
20202053|NCT04249882|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
20202054|NCT00651040|Rheumatology Institute Prague|Rheumatology Institute Prague|+420234075111|vencovsky@revma.cz|
20202055|NCT00472303|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
20202056|NCT01043640|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
20202057|NCT04112914|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
20202058|NCT02389881|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20202059|NCT01244737|Children's Hospital of Philadelphia|Dr. Frederick Grant|267-600-1542|grantf@chop.edu|
20202060|NCT01667848|LudwigBoltzmannIOL|Dr. Bettina Klugsberger|+43 732 7806 2133|Bettina.Klugsberger@akh.linz.at|
20202061|NCT02955329|University of California, San Francisco|Dr. Gideon St. Helen|628-206-2687|gideon.sthelen@ucsf.edu|
20202062|NCT00759603|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
20202063|NCT02835495|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolinn@wakehealth.edu|
20202064|NCT00356915|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202065|NCT01225354|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
20202066|NCT05614011|QuantuMDx|Alice Toomey-Smith|4408708031234|alice.toomey-smith@quantumdx.com|
20157181|NCT00894387|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20157182|NCT00744861|Bioventus LLC|Manager Clinical Affairs|1-800-396-4325||
20157183|NCT02493764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157184|NCT01561976|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157185|NCT03443635|Tulane University Goldring Center for Culinary Medicine|Principal Investigator|3373290724|dominique.monlezun@gmail.com|
20157186|NCT01977222|Boston Children's Hospital|Dr. Fred Wu|6173556508|fred.wu@cardio.chboston.org|
20157187|NCT04165824|Mitsubishi Tanabe Pharma Development America, Inc.|Clinical Trials, Information Desk|Please email|information@mt-pharma-us.com|
20157188|NCT04403919|NYU Langone Health|Ran Schwarzkopf, MD|646-501-7070|Ran.Schwarzkopf@nyulangone.org|
20157189|NCT04319809|Minnesota HealthSolutions|Sara Seifert, President|6128036998|sara@minnhealth.com|
20157190|NCT01605669|Naval Medical Center San Deigo|LCDR William Bennett MD FACC|619-532-7400|william.bennett5@med.navy.mil|
20157191|NCT04846231|Cleveland Clinic|Luke Laffin, MD|216-372-4315|Laffinl@ccf.org|
20157192|NCT02980107|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
20157193|NCT02303262|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
20157194|NCT00934921|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20157195|NCT03781479|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
20157196|NCT01014871|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
20170238|NCT01231347|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
20170239|NCT01212107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157197|NCT01038323|Wake Forest|dennis ang|336-716-4209|dang@wakehealth.edu|
20157198|NCT02257528|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
20157199|NCT00404248|Adult Brain Tumor Consortium Central Office - Johns Hopkins|Director of Adult Brain Tumor Consortum|410-955-3657|jfisher@jhmi.edu|
20157200|NCT00789555|Alcon Research|Terri Pasquine, Sr. Clinical Lead|817-551-4760|terri.pasquine@alconlabs.com|
20157201|NCT00698841|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157202|NCT04696146|Cedars-Sinai Medical Center|Noriko Ammerman|3102488186|noriko.ammerman@cshs.org|
20157203|NCT01270529|University of California, San Francisco|Dr. Kirsten Johansen|415-221-4810|kirsten.johansen@ucsf.edu|23598
20157204|NCT01576783|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
20157205|NCT01897493|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157206|NCT01658059|Hadassah Medical Organization|Moti Moskovitz||motim@ekmd.huji.ac.il|
20157207|NCT01227785|Guidant, a Boston Scientific Company|Paji Vitoff, Senior Clinical Manager|651-582-5415|paji.vitoff@bsci.com|
20157208|NCT01732536|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
20157209|NCT01409096|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
20157210|NCT05111145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
20157211|NCT02359006|Yale University|Dr. Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
20157212|NCT01276704|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
20157213|NCT01359956|NCI Naples|Paolo A Ascierto, M.D., Ph.D|+39 081 5903431|p.ascierto@istitutotumori.na.it|
20157214|NCT03728933|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20157215|NCT00370292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157216|NCT00276419|Mayo Clinic|Dr. Robin L. Smith|507-284-1210|smith.robin@mayo.edu|
20157217|NCT03801525|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
20157218|NCT01766102|Massachusetts General Hospital|Michelle Specht, MD|617-726-0340|MSPECHT@mgh.harvard.edu|
20157219|NCT03545672|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
20157220|NCT01628913|Novartis Pharmaceuticals|Study Director|862-778-8300||
20157221|NCT02673944|Laborie|Clinical Researcher|905-612-1170|sbitzos@laborie.com|1755
20157222|NCT01528592|Northwestern University|Darren Gitelman, MD|312-908-8266|d-gitelman@northwestern.edu|
20157223|NCT02271880|Florida International University|Dr. William Pelham|305-348-0477|wpelham@fiu.edu|
20157224|NCT00474903|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.||limburg.paul@mayo.edu|
20157225|NCT00399529|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Leisha Emens|412-623-3239|emensla@upmc.edu|
20157226|NCT01170663|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157227|NCT00742625|Massachusetts General Hospital Cancer Center|Eyal Attar, MD|617-724-1124|eattar@partners.org|
20157228|NCT01093014|University of Iowa / Iowa City VA Medical Center|Richard K. Shields PhD, PT|319-335-9791|richard-shields@uiowa.edu|
20157229|NCT02519842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157230|NCT02319486|Zhongshan Ophthalmic Center, Sun Yat-sen University|Huasheng Yang|+862087331539|yanghs64@126.com|
20157231|NCT01295710|Neovii|Anne Kuan|781 966 3832|anne.kuan@neovii.com|
20157232|NCT01612676|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20157233|NCT02976181|Medtronic|Carina Leone, Latam CVG Trial Leader|+5411 5789 8521|carina.leone@medtronic.com|
20157234|NCT01204788|University of Texas (UT) MD Anderson Cancer Center|Emil Freireich, MD, Professor, Department of Medical Education|713-745-2723|CR_Study_Registration@mdanderson.org|
20157235|NCT04064905|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
20157236|NCT01448616|University of Washington|Rachel Bender Ignacio, MD MPH|2065204340|rbi13@uw.edu|
20157237|NCT00431964|Seattle Children's Hospital|Nicole Hamblett|206-987-5725|tdncc@seattlechildrens.org|
20157238|NCT02170064|BIAL - Portela & Cª, SA|Head of Clinical Research|+351-22 9866100|clinical.trials@bial.com|
20157239|NCT04211363|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844)692-6729|medinfo@arcutis.com|
20157240|NCT03961308|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20157241|NCT01800786|Brigham and Women's Hospital|Ina Djonlagic|617 667 5129|idjonlag@bidmc.harvard.edu|
20157242|NCT00659425|MedImmune, LLC|Mark Lanasa, MD Associate Director, Clinical Development, Oncology|301-398-0000|information.center@AstraZeneca.com|
20157243|NCT03358030|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20157244|NCT03342560|Massachusetts General Hospital|Anthony E. Samir|6176432009|asamir@mgh.harvard.edu|
20157245|NCT02604511|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
20157246|NCT03770286|Children's Hospital Los Angeles|Alexander Alcaraz|323-361-2130|aalcaraz@chla.usc.edu|
20157247|NCT04951193|MUSC|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
20157248|NCT01729039|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
20157249|NCT04646005|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20157250|NCT05788991|Medinova|Dr. Anahí Hurtado|+41443061396|hurtado.anahi@medinova.ch|
20157251|NCT04464473|Florida State University|Dr. Derek Nee|8506441963|dnee@fsu.edu|
20157252|NCT03802396|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
20157253|NCT01005290|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
20157254|NCT02661672|Icahn School of Medicine at Mount Sinai|Sydney Edwards|212-241-2524|sydney.edwards@mountsinai.org|
20157255|NCT02114177|Janssen Infectious Diseases BVBA|Associate Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
20157256|NCT02986074|Abbott|Yagna Pathak|+1-469-243-0088|yagna.pathak@abbott.com|
20170240|NCT04398316|Hennepin County Medical Center, Department of Emergency Medicine|Elliott Chinn, DO|612-873-3508|elliott.chinn@hcmed.org|
20170241|NCT01842815|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20170242|NCT00292318|Greater Los Angeles VA Medical Center|Felix W. Leung, MD|818-891-7711|felix.leung@va.gov|9403
20170243|NCT02027376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20170244|NCT00706810|Huntsman Cancer Institute|Dr. Randy Jensen|801-581-6908|randy.jensen@hci.utah.edu|
20170245|NCT05466448|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
20170246|NCT01278160|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20170247|NCT01945112|Stanford Department of Emergency Medicine|Grant Lipman|415-290-9286|gslipman@stanford.edu|
20170248|NCT02030938|Sofregen|Clinical Project Manager|4029991564|fjawed@sofregen.com|
20170249|NCT03148275|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20170250|NCT05098938|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20170251|NCT03803683|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
20170252|NCT00492050|UT MD Anderson Cancer Center|Sheeba Thomas, MD-Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
20170253|NCT01262131|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
20170254|NCT00866788|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170255|NCT02053051|Imperial College London|Prof Nick Oliver|02075941862|nick.oliver@imerial.ac.uk|
20170256|NCT00537238|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170257|NCT01854658|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
20170258|NCT03538678|University of Pittsburgh|Kar-Hai Chu|412-692-2578|chuk@pitt.edu|
20170259|NCT01193660|CHA Bundang Medical Center, CHA University|Minyoung Kim, MD, PhD|82-31-780-1872|kmin@cha.ac.kr|
20170260|NCT01012167|Maryland Psychiatric Research Center|William Carpenter, Jr.|410-402-7101|wcarpent@mprc.umaryland.edu|
20170261|NCT02367131|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170262|NCT02841189|Indiana University|Nicole Horn MD|317-944-9981|nhorn@iupui.edu|
20170263|NCT03326726|Medline Industries|Sr. Regulatory Affairs Specialist|847-643-3515|aminarcik@medline.com|
20170264|NCT01973569|Contact for Clinical Trial Information|Daiichi Sanyko|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
20170265|NCT05061966|University of Pensylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
20170266|NCT01237821|Penn State Hershey Medical Center|Diane Thiboutot|717-531-1513|dthiboutot@pennstatehealth.psu.edu|
20170267|NCT03793556|Sofar Spa|Dr Francesca Baldan|0039 02 909362|francesca.baldan@sofarfarm.it|1
20170268|NCT04416633|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20202067|NCT01523821|Fred Hutchinson Cancer Research Center|H. Joachim Deeg, MD|206-667-5985|jdeeg@fredhutch.org|
20202068|NCT01442181|UF Healthcare|Dr. Thomas Beaver|352-273-5503|thomas.beaver@surgery.ufl.edu|
20202069|NCT00709202|Nathan Kline Institute for Psychiatric Research|Dr. Robert C Principal Investigator. Smith,|845-398-6531|robert.smith@nki.rfmh.org|
20202070|NCT03133767|University of Iowa|Nicholas Mohr|319-384-8285|nicholas-mohr@uiowa.edu|
20202071|NCT03664726|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
20202072|NCT03301857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20202073|NCT00855439|University of Michigan|Rodica Pop-Busui, MD, PhD|734 647-9809|rpbusui@med.umich.edu|
20202074|NCT05502289|Johnson & Johnson Vision Care, Inc. (JJVC) 7500 Centurion|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
20202075|NCT00613626|Hoosier Cancer Research Network|Georgia Gould|317-921-2050|ggould@hoosiercancer.org|
20202076|NCT00397150|Centre for International Health, University of Bergen, Norway|Prof Thorkild Tylleskar|+47 55588562|Thorkild.Tylleskar@cih.uib.no|
20202077|NCT04375878|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589 7020|info@firstwavebio.com|
20202078|NCT05480514|Johnson & Johnson Vision Care, Inc. (JJVC)|Brian Pall|1-800-843-2020|bpall@its.jnj.com|
20202079|NCT03232073|Actelion Pharmaceuticals Ltd|Associate Director Clinical Sciences Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20202080|NCT03395210|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
20202081|NCT00853632|Edwards Lifesciences|Director of Clinical Affairs|949-250-2500|Aya_Westbrook@edwards.com|
20202082|NCT04364854|Medical University of South Carolina|Principal Investigator|843-876-8311|bonilha@musc.edu|
20157257|NCT02415556|Beth Israel Deaconess Medical Center (BIDMC)|Dr. Vera Novak, Principal Investigator|6176328680|vnovak@bidmc.harvard.edu|
20157258|NCT01146613|NIAAA|Megan Ryan, M.B.A.|301-443-4225|mryan1@mail.nih.gov|
20157259|NCT00320606|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
20157260|NCT03984825|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20157261|NCT02196922|Northwell Health|Renee Pekmezaris, Ph.D., Vice President Community Health & Health Services Research|516 465-3161|rpekmeza@northwell.edu|
20157262|NCT02115321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157263|NCT02639390|Department of Veterans Affairs|Peter Lum|12023195181|lum@cua.edu|
20157264|NCT01908140|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20157265|NCT00427193|Duke University Medical Center|William E. Kraus, Director of Clinical Research, Duke Center for Living|919-681-6733|william.kraus@duke.edu|
20157266|NCT00698828|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20157267|NCT02013609|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20157268|NCT01816295|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20170269|NCT00785928|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20170270|NCT04644003|STALICLA SA|Eric Painbeni, PhD - Head of Clinical Operations|+41 (0)79 918 33 16|clinical@stalicla.com|
20170271|NCT03764007|University of California, San Francisco|Dr. Thomas A. Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
20170272|NCT04465162|UT MD Anderson Cancer Center|Dr. Bouthaina S Dabaja, MD-Professor, Radiation Oncology Department|(713) 563-2406|bdabaja@mdanderson.org|
20170273|NCT01675427|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170274|NCT00739999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20170275|NCT00611533|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
20170276|NCT01359007|University of Oklahoma|Ingrid Block - CTO Directo|405-271-8777|ingrid-block@ouhsc.edu|
20170277|NCT01892267|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
20170278|NCT05021081|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, O.D., M.S., F.A.A.O.|1-800-843-2020|jbuch@its.jnj.com|
20170279|NCT01967433|University of Oklahoma Health Sciences Center and VAMC, Oklahoma City|Salman Nusrat|4052715428|salman-nusrat@ouhsc.edu|
20170280|NCT00922233|FHI360|Dr. Vera Halpern|9195447040|vhalpern@fhi360.org|
20170281|NCT01072669|Cleveland Clinic|Dr. Soumya Chatterjee|216-444-9945|chattes@ccf.org|
20170282|NCT01461980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170283|NCT04171765|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20170284|NCT03584100|Stanford University|Jeffrey Yao|650-723-5643|jyao@stanford.edu|
20170285|NCT02540226|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|212-606-1206|JulesElyseeK@HSS.EDU|
20170286|NCT00809354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170287|NCT03028103|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
20170288|NCT01954342|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
20170289|NCT02409810|The Ohio State University|Judy Opalek Director, Research Administration|6147789696|judy.opalek@osumc.edu|
20170290|NCT01465191|Columbia University|Richard Smiley, MD|212-342-2742|rms7@cumc.columbia.edu|
20170291|NCT00457366|USC|Dr George Simpson|7604687106|gsimpson@usc.edu|
20170292|NCT01916967|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170293|NCT00620464|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20170294|NCT05394350|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170295|NCT01336569|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Medical Affairs Leader, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20170296|NCT03911154|University of Pennsylvania|Dr. David Dinges|215-898-9665|dinges@pennmedicine.upenn.edu|
20170297|NCT00406354|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20170298|NCT01385371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20170299|NCT01224665|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
20170300|NCT00304239|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20170301|NCT02979197|Kitov Pharma Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
20170302|NCT01631812|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20170303|NCT02436681|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
20170304|NCT01414608|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|gedeonl@nrgoncology.org|
20170305|NCT05156073|Johns Hopkins University School of Medicine|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
20170306|NCT00973349|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20170307|NCT03763318|Equillium|Clinical Operations|858-240-1200|clinicaltrials@equilliumbio.com|
20170308|NCT05597020|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
20170309|NCT05430022|University of Southern California|Dr. Jessica Schwartzman, Assistant Professor|3232075910|jstrendlab@gmail.com|
20170310|NCT03029702|University of Pittsburgh|Maisa Feghali|412 641 1000|feghalim@upmc.edu|
20170311|NCT02718300|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20170312|NCT02452697|Duke University|Cristina Gasparetto, MD|919-668-1000|cristina.gasparetto@duke.edu|
20170313|NCT05595382|Rutgers University Associate Professor|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
20202083|NCT04933812|Duke University|Dr. Sarahn Wheeler|919-668-5462|sarahn.wheeler@duke.edu|
20157269|NCT01119287|Alcon Research|Head, Alcon Clinical|1-888-451-3937||
20157270|NCT00680628|Indiana University School of Medicine|Jeffrey Kline|3172873004|jefkline@iupui.edu|
20157271|NCT01076010|AVEO Pharmaceuticals, Inc.|Cheif Medical officer|857-400-0101|Clinical@aveooncology.com|
20157272|NCT01156844|Novartis Pharmaceuticals|Study Director|862-778-8300||
20157273|NCT03892317|Imperial College Healthcare Trust|Goodall Dawn|+44 (0)20 7589 5111|dawn.goodall1@nhs.net|
20157274|NCT00945659|Nemours Foundation: Dept. of Biomedical Research|Tim Wysocki, PhD|904-697-3483|twysocki@nemours.org|
20157275|NCT04067011|Emergent Biosolutions|Clinical Development Representative|+1 (204) 275-4196|ctgov@ebsi.com|
20157276|NCT05209386|University of Pittsburgh|Taylor Abel|412-692-9631|abeltj@upmc.edu|
20157277|NCT03767881|Boston Scientific|Evelyne Ho, Clinical Project Manager|1-978-483-8856|Evelyne.ho@bsci.com|
20157278|NCT05200845|Virginia Tech|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
20157279|NCT02412670|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20157280|NCT02622191|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20157281|NCT00565409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170314|NCT00560885|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
20170315|NCT02887859|Humacyte Inc.|Dr. Shamik Parikh, MD, CMO|919-313-9633|sparikh@humacyte.com|
20202084|NCT04493619|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
20202085|NCT00934895|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
20202086|NCT04442581|University of Washington|Madeline Jacoby|2026068246|mjacoby@seattlecca.org|
20202087|NCT03716726|Boston Medical Center|Patricia Kavanagh, MD|617-414-3573|Patricia.Kavanagh@bmc.org|
20202088|NCT02833311|Case Western Reserve University|Matthew Plow, Ph.D.|216-368-8969|map208@case.edu|
20202089|NCT01006356|Medical department / Korea|Medical Director|+82-2-2094-4518||
20202090|NCT01670201|Harborview Medical Center / Seattle, Washington|Dr Nicole Gibran|206-744-3140|nicoleg@uw.edu|
20202091|NCT01756157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20202092|NCT01623466|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
20202093|NCT03952130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20202094|NCT04191668|Ectosense|Frederik Massie|+1 786 305 8547|frederik.massie@ectosense.com|
20202095|NCT02638012|St. Michael's Hospital|Dr. John Lee|416-864-5306|John.Lee@unityhealth.to|
20202096|NCT01498991|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
20202097|NCT02559505|University Of Rochester|Dr. Jennifer Nayak|5852767404|Jennifer_Nayak@URMC.Rochester.edu|
20202098|NCT03523585|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
20202099|NCT01473004|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
20202100|NCT05882890|Rahbek FYS|Cathrine Rahbek|0045 30645390|cathrinerahbek@outlook.dk|
20202101|NCT03815292|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
20202102|NCT01495988|The Emmes Corporation|Damon Collie|301-251-1161|dcollie@emmes.com|
20202103|NCT01062399|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20202104|NCT03453060|Aronora, Inc.|Norah G. Verbout, Senior Scientist and Project Manager|503-964-0250|norah.verbout@aronorabio.com|
20202105|NCT04106492|Shasqi Inc|Jose M. Mejia Oneto, MD, PhD|415-800-1376|clinicalstudies@shasqi.com|
20202106|NCT00893789|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20202107|NCT02024464|Alcon Research, LLC|Director, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20202108|NCT01845025|Novartis Pharmaceuticals|Study Director|862-778-8300||
20202109|NCT01973283|New York State Psychiatric Institute|Patrick J Brown|646-774-8666|patrick.brown@nyspi.columbia.edu|
20202110|NCT01126619|Abbott|Global Medical Services|800-633-9110||
20202111|NCT00947154|Stanford Medical Center, Department of Psychiatry|Matthew White, M.D., clinical assistant professor|650 725-5598|mpwhite@stanford.edu|
20202112|NCT00900796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202113|NCT02233842|National Cancer Institute (NCI)|Dr. Stephanie Land|240-276-6946|stephanie.land@nih.gov|
20202114|NCT03981029|Ottawa Hospital Research Institute|Alysha Harvey|613-737-8899|alyharvey@ohri.ca|73838
20202115|NCT01602731|VA Loma Linda Healthcare System|Dr. Helme Silvet, cardiologist|9095836097|helme.silvet@va.gov|
20202116|NCT01049776|Illinois CancerCare, P.C.|Sachdev Thomas, M.D.|309-243-3000|sthomas@illinoiscancercare.com|
20202117|NCT02586805|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20202118|NCT01859403|VA San Diego Health Sciences|Amir Zarrinpar, MD, PhD, Assistant Professor of Gastroenterology|858-246-1665|azarrinpar@health.ucsd.edu|
20202119|NCT00811252|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
20202120|NCT03014648|UPMC Hillman Cancer Center|Barbara M Stadterman, Regulatory Supervisor, Clinical Research Services|412-647-5554|stadtermanbm@upmc.edu|
20202121|NCT00813748|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20202122|NCT00749606|SUNY Upstate Medical University|Ruth S. Weinstock MD PhD|315-464-5740|weinstor@upstate.edu|
20202123|NCT01829048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202124|NCT01121406|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202125|NCT00504257|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, Principal Investigator|813-745-8478|robert.wenham@moffitt.org|
20202126|NCT00892437|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20202127|NCT01961531|BrUOG- Brown University Oncology Research Group|Jaroslaw Hepel, MD|401-863-3000|BrUOG@brown.edu|
20202128|NCT03185130|University Medical Center of Southern Nevada|Tony Zitek, MD|7023837885|zitek10@gmail.com|4
20202129|NCT00716443|Galderma Laboratories, L.P.|Ron W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
20202130|NCT02750410|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20202131|NCT02504541|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
20202132|NCT01860170|Spectrum Health|A. Samer A;-Homsi|616-486-5933|a.samer.al-homsi@spectrumhealth.org|
20202133|NCT02318602|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
20202134|NCT02580058|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202135|NCT00730236|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
20202136|NCT00462423|Northern California Medical Center|Lynn E. Spitler, MD|415-435-9861|lynn@drspitler.com|
20202137|NCT03486314|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20157282|NCT01484652|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
20157283|NCT00476645|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
20157284|NCT02284191|NHS Lothian|Prof Alasdair Gray Chief Investigator|0131 242 1284|alasdair.gray@ed.ac.uk|
20202138|NCT00465569|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
20157285|NCT04849897|University of Southern California|Steven Richeimer|323-442-6202|steven.richeimer@med.usc.edu|
20202139|NCT02362373|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
20170316|NCT06624449|University of Cincinnati|Fahad Alanezi|5138845844|alanezfz@mail.uc.edu|
20170317|NCT00257608|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20170318|NCT00697073|Santhera|Dr Thomas Meier|+41 61 906 8964|thomas.meier@santhera.com|
20170319|NCT00108433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170320|NCT02203071|University of Missouri|Research Project Analyst|573-882-7583|jonesvicki@health.missouri.edu|
20170321|NCT01886716|Miami University|Dr. Elise Clerkin|513-529-2483|clerkiem@miamioh.edu|
20170322|NCT00161473|VA Puget Sound Healthcare System|Lucy Y. Wang, M.D.|206-277-5089|wanglucy@u.washington.edu|
20170323|NCT01006369|Rutgers Cancer Institute of New Jersey|Elizabeth Poplin MD|732-235-7620|poplinea@cinj.rutgers.edu|
20170324|NCT00082342|NINDS, NIH|Mark Hallett, MD, Chief|301-496-9526|hallettm@ninds.nih.gov|
20170325|NCT04806503|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20170326|NCT03589469|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
20202140|NCT01985321|Benu BioPharma, Inc.|Dr. Eric M. Morrel|5082085634|emorrel@benubio.com|
20202141|NCT00482001|Sunnybrook Health Sciences Centre|Dr. Mark Rapoport|416-480-4085|Mark.Rapoport@sunnybrook.ca|
20202142|NCT03826914|University of Manitoba|Dr. Semone Myrie|(204) 474-7290|semone.myrie@umanitoba.ca|
20202143|NCT01015443|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20202144|NCT02379858|Medical College of Wisconsin|Matthew Goldblatt, MD|414-955-5751|mgoldbla@mcw.edu|
20202145|NCT03842137|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|aabrantes@carene.org|
20202146|NCT05139030|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20202147|NCT03655444|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
20202148|NCT01416129|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
20202149|NCT00816036|Department of Veterans Affairs|David Katz, MD, MSc|319-338-0581|david-katz@uiowa.edu|7598
20202150|NCT01299025|Region Örebro County|Dr Anette Forsberg|+46-19-6025788|anette.forsberg@regionorebrolan.se|
20202151|NCT00004980|Yale University School of Medicine|Ralph Hoffman|203-688-9734|ralph.hoffman@yale.edu|
20202152|NCT01624194|Stanford University|Antonio Y. Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
20202153|NCT03212261|Massachusetts General Hospital/Harvard Medical School|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
20202154|NCT00820040|Medtronic|Heather McManus|2038213323|heather.mcmanus@medtronic.com|
20202155|NCT02256358|Haeundae Paik Hospital, Inje University|Kihwa Lee|82-51-797-0426|tedy333@paik.ac.kr|
20202156|NCT03195140|Tandem Diabetes Care, Inc|Jordan Pinsker, MD|858-366-6900|clinicalaffairs@tandemdiabetes.com|
20202157|NCT01259466|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
20202158|NCT02296840|Emory University|Roy Rajan, MD|404-778-2400|royrajan@yahoo.com|
20202159|NCT00729430|Brigham and Women's Hospital|Dr. Raymond Y. Kwong, Director of Cardiac Magnetic Resonance Imaging|857-307-1960|rykwong@partners.org|
20202160|NCT03429075|Imperial College London|Dr Robin Carhart-Harris|02075947992|r.carhart-harris@imperial.ac.uk|
20202161|NCT00814710|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202162|NCT03885284|Georgetown University|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
20202163|NCT04333966|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
20202164|NCT00484354|Wake Forest School of Medicine|Michael Rocco, MD|3367164650|mrocco@wakehealth.edu|
20202165|NCT00002850|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
20202166|NCT02932267|Galderma|Rajeev Chavda|0033|rajeev.chavda@galderma.com|492382928
20202167|NCT03476239|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20202168|NCT05405166|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20202169|NCT01386385|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
20202170|NCT01084252|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20202171|NCT00597558|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director|919-843-9087|edwinkim@email.unc.edu|
20202172|NCT03063385|University of Pennsylvania School of Nursing|Dr. Antonia M. Villarruel|2158988283|amvillar@nursing.upenn.edu|
20202173|NCT01756976|Haemonetics|Clinical Project Manager|781-356-9595|michael.dioguardi@haemonetics.com|
20202174|NCT02579603|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202175|NCT00469079|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
20202176|NCT02981472|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20202177|NCT02189382|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20202178|NCT03440112|University of Michigan|Stiven Roytman|7349988424|stivenr@med.umich.edu|
20202179|NCT03199911|University of California, San Francisco|Davin Ashraf MD|415-353-2800|davin.ashraf@ucsf.edu|
20202180|NCT02123329|Qatar University College of Pharmacy|Dr. Maguy El Hajj|0097444035577|maguyh@qu.edu.qa|
20202181|NCT02939300|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
20202182|NCT05309668|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20170327|NCT02219438|UCSD|Dr Brian Ilfeld|(619) 543-5560|bilfeld@ucsd.edu|
20170328|NCT02202837|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170329|NCT02486302|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170330|NCT01871142|Colorado State University|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
20202183|NCT01584024|University of Michigan|Dr. Mathilde Peters (PI)|734-925-2750|mcpete@umich.edu|
20203019|NCT03454048|Radboud university medical center|Prof. dr. Teun Bousema|+3124 3614306|teun.bousema@radboudumc.nl|
20170331|NCT02006888|IconBioscience|Howard Franklin|2153961332|hfranklin@iconbioscience.com|215
20170332|NCT00734474|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20170333|NCT02754557|Emory University|Negar Fani, PhD|404-712-0354|nfani@emory.edu|
20170334|NCT00942448|IBSA Institut Biochimique|Barbara Gugliotta|+41 58 360 1000|barbara.gugliotta@ibsa.ch|
20170335|NCT03089320|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
20170336|NCT00231842|Montefiore Medical Center|Mark Einstein, MD, MS|718-405-8082|meinstei@montefiore.org|
20170337|NCT00639678|GlaxoSmithKline|GSK Response Center|866-435-7343||
20170338|NCT02436304|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20170339|NCT05027464|Veterans Affairs San Francisco HCS|Nicole McCamish|415-221-4810|nicole.mccamish@va.gov|24284
20170340|NCT02477839|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
20170341|NCT01784848|HCor|Dr Carlos Schiavon|1130536611|schiavon.ca@gmail.com|8201
20170342|NCT02607930|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20170343|NCT01050543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20170344|NCT00149734|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
20170345|NCT03053271|Millendo Therapeutics|Clinical Trial Information|+1 734 845-9000|millendo@millendo.com|
20170346|NCT00570765|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
20170347|NCT02517866|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20170348|NCT02657538|Department of Preventive, Restorative and Pediatric Dentistry, University of Bern|PD Dr. Klaus Neuhaus|+41 (0)31 632 49 74|klaus.neuhaus@zmk.unibe.ch|
20170349|NCT03114488|University of Minnesota|Elias Boroda|763-498-4176|borod002@umn.edu|
20170350|NCT01436006|Università di Palermo|Sergio Salerno|00390916552315|sergio.salerno@unipa.it|2315
20170351|NCT03711266|Michigan Medicine|Rebecca Sripada|734-222-7432|rekaufma@med.umich.edu|
20170352|NCT01646073|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20170353|NCT04558281|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
20170354|NCT05095454|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
20170355|NCT00057876|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
20170356|NCT00679055|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170357|NCT00853073|Wills Eye Hospital|Marlene R. Moster, MD|215-928-3123|marlenemoster@gmail.com|
20170358|NCT02758171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170359|NCT01999114|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stephen.harris@pharma.com|
20170360|NCT02437383|University of North Carolina at Chapel Hill|Dr. Inna E. Tchivileva|1 919 537 3291|inna_tchivileva@unc.edu|
20170361|NCT00943124|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170362|NCT02992132|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20170363|NCT01289457|The University of Texas M D Anderson Cancer Center|Jabbour,Elias Joseph, M.D./Associate Professor|713-792-4764|CR_Study_Registration@mdanderson.org|
20170364|NCT01687036|Medical University Innsbruck, Department of Internal Medicine III, Cardiology|Markus Stühlinger, MD|+43 512 504|markus.stuehlinger@uki.at|81 320
20170365|NCT00179127|Vanderbilt University Medical Center|Sheila McMorrow|615-343-8332||
20202184|NCT00613314|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202185|NCT01568944|Dental College of Georgia|chairman|706-7212442|chcutler@augusta.edu|
20202186|NCT04902885|Jiangsu Simcere Pharmaceutical Co., Ltd.|Study Director|86-025-85566666|simcere@simcere.com|
20202187|NCT02465034|Emory University|Dr. Michael Borich|404-712-0612|michael.borich@emory.edu|
20202188|NCT01142323|University of Miami|Dr. Cynthia Levy|305-243-2147|clevy@med.miami.edu|
20202189|NCT01959204|PPSI|Study Director|8139279302|mgoodhead@pharmaprojectsolutions.com|
20202190|NCT02401256|Indiana University School of Medicine|Dr. Zeruesenay Desta|3172742823|zdesta@iu.edu|
20202191|NCT04419506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202192|NCT04586712|University of Florida|Dr. Paul Borsa|352-294-1726|pborsa@ufl.edu|
20202193|NCT00427661|University of Pittsburgh-Department of Pediatrics|Nancy Harter-Administrative Director of Research|412-692-7487|harterne@upmc.edu|
20202194|NCT01021007|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20202195|NCT03047005|Yale University|Dr. Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
20202196|NCT03669133|Indiana University|Regina Weber|317-278-3584|reginaw@iu.edu|
20202197|NCT03293030|University of California San Francisco|Wilson Liao|415-476-8364|wilson.liao@ucsf.edu|
20202198|NCT04899271|Dompé Farmaceutici SpA|Clinical Development and Operations|+39 (0) 583831|clinical.trials@dompe.com|
20202199|NCT02388776|Weill Cornell Medicine|Christine Lennon, M.D.|212-746-2621|chl9083@med.cornell.edu|
20202200|NCT03652454|IzmirKCU|dr.dt.mücahid faik şahin|+902323254040|m.faiksahin@hotmail.com|
20202201|NCT00542828|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
20202202|NCT00095303|University of Miami Miller School of Medicine|Viviana E. Horigian, MD|305-243-4305|vhorigian@med.miami.edu|
20202203|NCT01773395|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-5938|Vincent_Ho@dfci.harvard.edu|
20202204|NCT01364467|Virginia Commonwealth University|Kelley M. Dodson, MD, FACS|804-828-3965|kelley.dodson@vcuhealth.org|
20202205|NCT03228186|Rogel Cancer Center|Gregory Kalemkerian, MD|734-647-8921|kalemker@med.umich.edu|
20202206|NCT01634243|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
20202207|NCT04312997|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
20170366|NCT02759354|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170367|NCT01104155|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
20170368|NCT00975637|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
20170369|NCT02787551|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20170370|NCT03799211|NYU Langone Health|Mia Minen, MD, MPH|212-263-7744|Mia.Minen@nyulangone.org|
20170371|NCT00764491|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|651-256-8503|Rgriffith@spineology.com|
20170372|NCT00923936|National Cancer Institute|Dr. Robert Yarchoan|301-496-0328|yarchoanr@pop.nci.nih.gov|
20170373|NCT00240227|VA Puget Sound Health Care System|Andrew J. Saxon, M.D.|206-764-2782|andrew.saxon@va.gov|
20170374|NCT02038452|Keele University|Dr Edward Roddy|01782 734715|e.roddy@keele.ac.uk|
20170375|NCT03139279|Department of Anesthesiology, SUNY Downstate Medical Center|Dennis Dimaculangan, MD|718-270-3765|dennis.dimaculangan@downstate.edu|
20170376|NCT02337738|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20170377|NCT01565642|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
20170378|NCT01934972|The Ohio State University|Nicholas Breitborde, PhD|614-685-6052|nicholas.breitborde@osumc.edu|
20170379|NCT03171051|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20170380|NCT01599832|University of Chicago Comprehensive Cancer Center|Walter Stadler|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
20170381|NCT03954132|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
20170382|NCT02856698|Hospital Universitario de Canarias|Alberto Dominguez Rodriguez. MD, PhD, FESC|+34 922678000|adrvdg@hotmail.com|
20170383|NCT00932737|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170384|NCT01881373|University of Hawaii|Rachel Novotny|808-956-3848|novotny@hawaii.edu|
20170385|NCT02401022|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20170386|NCT02906332|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
20170387|NCT02949700|Baylor College of Medicine|Dr. Vlad Sandulache|713-798-7218|Vlad.Sandulache@bcm.edu|
20170388|NCT02046902|Saint Luke's Mid America Heart Institute|Carole Decker|(816) 932-5440|c1decker@saint-lukes.org|
20170389|NCT02422940|Acorda Therapeutics|Holy Roberts, Executive Medical Director - Medical Affairs|914-326-5224|hroberts@acorda.com|
20170390|NCT03722173|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170391|NCT04128579|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
20170392|NCT01554397|UCSD Moores Cancer Center|Dr. Loren Mell|858-246-4071|lmell@health.ucsd.edu|
20170393|NCT02875132|The Chinese University of Hong Kong|Dr. Herbert Ho Fung LOONG|35052166|h_loong@clo.cuhk.edu.hk|
20170394|NCT01896050|University of Michigan Comprehensive Cancer Center|Norah Lynn Henry, MD|734-936-4991|norahh@med.umich.edu|
20170395|NCT03693300|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20170396|NCT02206048|UT MD Anderson Cancer Center|Dr. Kathleen M. Schmeler, MD|713-745-3518|kschmele@mdanderson.org|
20170397|NCT03265665|University of Illinois at Chicago|Dr. Sharmilee Nyenhuis|3124131655|snyenhui@uic.edu|
20170398|NCT01858376|The Ohio State University|Chandan K. Sen|6142477786|chandan.sen@osumc.edu|
20170399|NCT03150160|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
20170400|NCT00509041|University of Minnesota Masonic Cancer Center|Arkadiusz Dudek, MD, PhD||dudek002@umn.edu|
20170401|NCT02910362|Arizona Eye Consultants|Sean McCafferty, MD|(520) 791-7401|sjmccafferty66@hotmail.com|
20170402|NCT03894046|Entasis Therapeutics|Dr. David Altarac - Chief Medical Officer|+1 781 810 0120|david.altarac@entasistx.com|
20170403|NCT01348607|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Administrator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
20170404|NCT03572244|University of Iowa|Dr. Chris Barwacz|3193843002|chris-barwacz@uiowa.edu|
20170405|NCT04066647|Cedars Sinai Medical Center|Kacey Haptonstall|424-315-4489|kacey.haptonstall@cshs.org|
20170406|NCT04172623|Yale School of Medicine|Krysten Bold, PhD|2039747603|krysten.bold@yale.edu|
20170407|NCT00369122|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
20170408|NCT02651467|GlaxoSmithKline|GSK Response Center|866-435-7343||
20170409|NCT00408629|Abbott|Global Medical Services|800-633-9110||
20170410|NCT00191906|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20170411|NCT00573937|Mayo Clinic|Donald Northfelt, MD|480-301-8335|northfelt.donald@mayo.edu|
20170412|NCT00333801|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-3819|lori.davis@va.gov|
20170413|NCT03633617|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20170414|NCT01890746|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20170415|NCT02059902|Health Partners|Dr. William J Mohr|(651)454-5304|William.J.Mohr@healthpartners.com|
20170416|NCT00777205|Veterans Affairs Healthcare System|Marcia Valenstein, MD|734-845-3649|marcia.valenstein@va.gov|
20170417|NCT03257371|University of Missouri|Dr. James Cook|573-882-7189|cookjl@health.missouri.edu|
20170418|NCT02268955|Maricopa Integrated Health System|Dan Quan, DO|602-344-5058|dany_quan@dmgaz.org|
20170419|NCT04046055|University of Iowa|Dr. Craig D. Workman|319-467-0746|craig-workman@uiowa.edu|
20170420|NCT03198078|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20170421|NCT01676727|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|Maarten.Hollander@medtronic.com|
20202208|NCT03953118|University of California San Francisco CA|Julie Schallhorn, MD|415-514-1922|julie.schallhorn@ucsf.edu|
20170422|NCT00580970|Virginia Commonwealth University/Massey Cancer Center|Mitchell S. Anscher, M.D. Professor and chairman|804-828-7238|mitchell.anscher@vcuhealth.org|
20170423|NCT02654314|Yale Center for Analytical Sciences|Jesse S Reynolds|(203) 785-5445|jesse.reynolds@yale.edu|
20170424|NCT03161093|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20170425|NCT01031706|University of North Carolina at Chapel Hill|Dr. Scott H. Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
20170426|NCT02124161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170427|NCT01393301|Massachusetts General Hospital|Dr. Conall O'Cleirigh, PI|(617) 643-0385|cocleirigh@mgh.harvard.edu|
20170428|NCT03342963|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20170429|NCT01008150|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
20170430|NCT04040244|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
20170431|NCT01309165|Sunnybrook Research Institute|Dr. Sara McEwen|4162266780|sara.mcewen@sunnybrook.ca|7957
20170432|NCT01497275|Duke University Medical Center|Anne Beaven, MD|919-668-1211|anne.beaven@duke.edu|
20170433|NCT01649609|Columbia University Medical Center|Sumit Mohan, MD|2123053273|sm2206@cumc.columbia.edu|
20170434|NCT02617888|Ft. Belvoir Community Hospital|Michael K. Cheezum, MD|571-231-2159|Michael.k.cheezum.mil@mail.mil|
20170435|NCT00737438|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
20170436|NCT02410551|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
20170437|NCT01739309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20170438|NCT04137627|Universitas Indonesia|Dr. dr. Diani Kartini, Sp.B-K(Onk)|+628122684919|d.kartini@gmail.com|
20170439|NCT01649804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20170440|NCT03719586|NIAID/NIH|Dr. Richard T. Davey, Jr., M.D., U.S. study PI|301-496-8029|rdavey@niaid.nih.gov|
20170441|NCT03845543|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
20170442|NCT05012657|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
20170443|NCT04242173|Moffitt Cancer Center|Christine Chung|1-813-745-5061|Christine.Chung@moffitt.org|
20170444|NCT04429243|WL Gore|Charee Robe|9288644048|crobe@wlgore.com|
20202209|NCT04283461|Kaiser Permanente Washington|Lisa Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
20170445|NCT02028871|University of Illinois at Chicago|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
20170446|NCT02907268|ICLS|Shantel Demay|905-842-2262|s.demay@icls.ca|
20170447|NCT02633501|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
20170448|NCT02080637|Duke University|Kevin Hill, M.D.|919-668-8305|kevin.hill@duke.edu|
20170449|NCT01626495|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
20170450|NCT02955797|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
20170451|NCT03131453|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20170452|NCT04176705|Wake Forest University Health Sciences|John Bailey, MD|(336) 716-8002|jkbailey@wakehealth.edu|
20170453|NCT03772678|Arch Biopartners Inc.|Richard Muruve|(647) 428-7031|info@archbiopartners.com|
20170454|NCT03805646|University of California Los Angeles|Dr. Catherine Juillard|310-267-9609|cjuillard@mednet.ucla.edu|
20170455|NCT03950791|Stanford University School of Medicine|Maisa Ziadni, PhD|(650) 724-9143|mzaidni@stanford.edu|
20170456|NCT02925923|University of Alabama at Birmingham|Leah Pogwizd|(205) 996-4410|leahpogwizd@uabmc.edu|
20170457|NCT01863953|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20170458|NCT01854242|University of Florida|David A. Weinstein, MD, MMSc|3522650855|weinsda@peds.ufl.edu|
20170459|NCT01182610|Accelerated Community Oncology Research Network, Inc.|Vice Presidnet of Scientific Affairs||mwalker@acorncro.com|
20170460|NCT00809848|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20170461|NCT01824342|Amgen Inc.|Study Director|866-572-6436||
20170462|NCT02160990|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
20170463|NCT04195906|Sanifit Therapeutics S. A.|Peter Szecsödy|+41588529079|clinicaltrials@cslbehring.com|
20170464|NCT03485391|Ralph H. Johnson VA Health Care System|Stephanie Hart|843-577-5011|Stephanie.Hart4@va.gov|205103
20170465|NCT01601860|University of São Paulo|Dra. Alessandra Cristina Marcolin|+55(16)36022813|dralemar@uol.com.br|
20170466|NCT01137396|Yale University|Peter Morgan|203-974-7560|peter.morgan@yale.edu|
20170467|NCT00385762|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
20170468|NCT02104752|VA Greater Los Angeles Healthcare System/UCLA|Jonathan K. Wynn, Ph.D.|(310) 478-3711|jkwynn@ucla.edu|44957
20170469|NCT02899299|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20170470|NCT00313300|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20170471|NCT02336373|Baylor College of Medicine|Vivien Sheehan, MD, PhD|(832) 824-4459|vxsheeha@txch.org|
20170472|NCT00428792|Novartis Pharmaceuticals|Study Director|862 778-8300||
20170473|NCT00850343|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
20170474|NCT00371826|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20170475|NCT03423641|Kaiser Permanente|Elizabeth McGlynn, Ph.D.|6265643807|Elizabeth.A.Mcglynn@kp.org|
20170476|NCT02710396|Columbia University Herbert Irving Comprehensive Cancer Center|Catherine Shu|212 305 3997|cas2145@cumc.columbia.edu|
20170477|NCT04612790|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
20170478|NCT02497612|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20170479|NCT02239354|ViaCyte|Corporate Communications|858-207-0500|info@viacyte.com|
20170480|NCT03387683|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20170481|NCT00629772|Innovaderm Research|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
20202210|NCT05490771|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
20202211|NCT04246047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170482|NCT03840174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170483|NCT00722423|VA San Diego Healthcare System|Dr. Samuel B. Ho|8586423280|Samuel.Ho2@va.gov|
20170484|NCT01950169|Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden|Dr. Lena Flodin|Mobile: 0701910300|lena.flodin@sll.se|
20170485|NCT05143541|Kantonsspital St. Gallen|Dr. André E. Dutly|071 494 9944|andre.dutly@kssg.ch|
20170486|NCT01938573|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
20170487|NCT03420625|Karolinska University Hospital|Dr. Paul Ackermann|+46 8 517 700 00|paul.ackermann@sll.se|717 34
20170488|NCT01495975|MGH Diabetes Center|Nancy Wei, MD|617-724-7597|ncwei@mgh.partners.org|
20170489|NCT05085730|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20170490|NCT05447897|General Internal Medicine, University of Colorado School of|Dr. Gina Kruse, PI|303-724-4811|gina.kruse@cuanschutz.edu|
20170491|NCT04553679|University of Southern California|Marika Demers, PhD, OT, post-doctoral research fellow|13234421196|demers@pt.usc.edu|
20170492|NCT00178633|University of Texas Medical School at Houston|Heinrich Taegtmeyer, MD, DPhil, Principal Investigator|713 500-6569|heinrich.taegtmeyer@uth.tmc.edu|
20170493|NCT04926077|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
20170494|NCT03789214|The Johns Hopkins University School of Medicine|Andrew S. Huhn, Ph.D.|410-550-1971|ahuhn1@jhu.edu|
20170495|NCT03649867|NHS Tayside - Dundee Adult Psychological Therapies Service|Dr Lucie Bartoskova|00441382346556|lucie.bartoskova@nhs.net|
20170496|NCT01912963|Dana-Farber Cancer Institute|Rachel Freeman MD|617.632.3000|Rachel_Freedman@dfci.harvard.edu|
20170497|NCT03616171|Emory University|Ashley Coombe, PhD|404-712-9313|ashley.coombe@emory.edu|
20170498|NCT03139318|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
20170499|NCT04856891|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20170500|NCT00390234|Princess Margaret Hospital|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
20170501|NCT01833546|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20170502|NCT01147172|Anika Therapeutics|Adrian Orr, Director Clinical Affairs|781.457.9000|aorr@anikatherapeutics.com|
20170503|NCT01069627|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170504|NCT02396251|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
20170505|NCT02617784|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170506|NCT02963935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20170507|NCT00464269|UCB|Clinical Trial Call Center|+1 877 822 9493||
20170508|NCT00747461|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
20170509|NCT02149875|Shanghai Sixth People's Hospital|Dr. Hao Chen|02164369181|chenhao_316@aliyun.com|8405
20170510|NCT05055453|Sonova|Jean Anne Schnittker, Research Audiologist|+41 58 928 01 01|jeananne.schnittker@sonova.com|
20170511|NCT00299182|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7966|CR_Study_Registration@mdanderson.org|
20170512|NCT04102956|Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.|Xiaoyun Liu PhD|+8613191887318|audrey-l@163.com|
20170513|NCT01209923|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
20170514|NCT00725504|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
20170515|NCT00771316|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170516|NCT03648827|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
20170517|NCT02081183|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170518|NCT02024555|Vanderbilt University Medical Center|Wonder Drake, MD|(615) 322-2035|wonder.drake@vumc.org|
20170519|NCT03319173|Bristlecone Health, Inc.|Dr. Kelly J. Gibas|763-913-4600|kelly-gibas@bethel.edu|
20170520|NCT03673046|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
20170521|NCT03817879|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
20170522|NCT03428932|Nemours Children's Health|Nelly Mauras, MD|904-697-3674|Nelly.Mauras@nemours.org|
20170523|NCT02614092|VISN 21 MIRECC, VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
20170524|NCT00392015|United States Military Malaria Vaccine Program Naval Medical Research Center|Dr. Judith Epstein|301-252-9026|judith.epstein@med.navy.mil|
20170525|NCT00717093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170526|NCT00721500|Vistakon|Kurt Moody OD FAOO / Director|904-443-3088||
20170527|NCT01543698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170528|NCT02742441|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
20157286|NCT02257684|Jazz Pharmaceuticals|Head of Clinical Development|650-496-3777||
20157287|NCT01570387|Boston Medical Center|Vaishali Sanchorawala|617-638-7017|vaishali.sanchorawala@bmc.org|
20157288|NCT02943473|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|(212) 241-7873|ajai.chari@mountsinai.org|
20157289|NCT02347605|University of Minnesota|Michael Kotlyar|612-251-8780|kotly001@umn.edu|
20157290|NCT01567722|AMC Statistical Center|Madhu Mazumdar|(212) 659-9558|madhu.mazumdar@mountsinai.org|
20157291|NCT02814656|AstraZeneca|Ioannis Psallidas||ClinicalTrialTransparency@astrazeneca.com|
20157292|NCT00654732|UT MD Anderson Cancer Center|Dr. Hun Ju Lee, Associate Professor, Lymphoma/Myeloma|713 794-1829|hunlee@mdanderson.org|
20157293|NCT04442893|National Yang Ming University|Chiu-Yueh Yang, Professor|886-2-28267388|cyyang3@ym.edu.tw|8862282673
20157294|NCT01734902|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157295|NCT00758563|Colgate Palmolive|William DeVizio - DMD|732-878-7901|William_DeVizio@colpal.com|
20170529|NCT02495831|CROSS REsearch SA|Dr. Milko Radicioni|+41.91.63.00|clinic@croalliance.com|510
20170530|NCT03789396|University of Colorado|Adit Ginde, MD, MPH|720-848-6777|ADIT.GINDE@CUANSCHUTZ.EDU|
20170531|NCT02422303|University of Texas Health Science Center San Antonio|Bonnie Gillis|210-567-4500|gillis@uthscsa.edu|
20170532|NCT01126801|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
20202212|NCT02481505|Sintetica SA, via Penate 5 Mendrisio|Elisabetta Donati Clinical Project Leader|+41.91.640.42.50|edonati@sintetica.com|
20202213|NCT02814721|Henry Ford Hospital|Dr. Lalathaksha Kumbar|3136271761|lkumbar1@hfhs.org|
20202214|NCT02502864|H. Lee Moffitt Cancer Center and Research Institute|Christine M. Walko, Pharm.D., BCOP|813-745-1519|christine.walko@moffitt.org|
20202215|NCT01175369|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
20202216|NCT04378426|Palo Alto VA|Carolyn Rodriguez, MD, PhD|650-493-5000|carolyn.rodriguez@va.gov|60067
20202217|NCT00931164|University of Utah|Dr. Kathryn Swoboda|801-585-9717|taran@genetics.utah.edu|
20202218|NCT01472276|Queen's University, Belfast|Michelle McKinley, Professor|02890978936|m.mckinley@qub.ac.uk|
20202219|NCT01341912|Octapharma|VP of Clinical Research and Development|+41 554512141|sigurd.knaub@octapharma.com|
20202220|NCT03679494|Taipei MU|MS. Po-Yao Chiu|+886-2-27361661|m437106006@tmu.edu.tw|6311
20202221|NCT02527304|Montefiore Medical Center|Dr. Madhur Garg, Clinical Director, Department of Radiation Oncology|718-920-4361|mgarg@montefiore.org|
20202222|NCT01824602|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
20202223|NCT00104871|UT MD Anderson Cancer Center|Steven Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
20202224|NCT05036785|Royal Devon and Exeter NHS Trust|Dr Ellen Richards|01392 411611|ellen.richards6@nhs.net|
20202225|NCT03721328|Nor Consult, LLC|Nor Consult|206-607-6861|regulatory@nor-consult.com|
20202226|NCT00457639|UT Southwestern Medical Center|Zahid Ahmad, M.D.|214-648-2377|zahid.ahmad@utsouthwestern.edu|
20202227|NCT02117687|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20202228|NCT01586091|University of Charité Berlin; Dpt. of Dermatology and Allergy|Professor Marcus Maurer|+49 30 450 518 043|marcus.maurer@charite.de|
20202229|NCT00590161|Cleveland Clinic Lerner College of Medicine of Case Western Reserve University|Claudia O. Zein, MD, MSc|216-444-0421|zeinc@ccf.org|
20202230|NCT01687673|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|Katie.Kelley@ucsf.edu|
20202231|NCT02234622|Roudebush VA Medical Center|Louanne Davis Psy.D.|317-710-1338|louannedavis52@gmail.com|
20202232|NCT00618956|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|201-427-8218|robert.palmer@frx.com|
20202233|NCT01200433|Clevland Clinic Foundation|Ehab Farag, MD|216-444-9950|farage@ccf.org|
20202234|NCT01887210|Rhode Island Hospital|Dr. Larry Brown|401-793-8808|lkbrown@lifespan.org|
20202235|NCT02452359|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20170533|NCT03481907|George Washington University|Dr. Adam Friedman|214 235 7381|ajfriedman@mfa.gwu.edu|
20170534|NCT01364649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
20170535|NCT00902668|Virginia Commonwealth University|Laurie W. Cuttino, MD|804-828-7232|LCuttino@mcvh-vcu.edu|
20170536|NCT00004635|National Cancer Institute, National Institutes of Health|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
20170537|NCT01788046|Amgen Inc.|Study Director|866-572-6436||
20170538|NCT01453725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170539|NCT01076231|University of Pennsylvania|Dr. Jacob Shabason|215-662-3998|susan.mazzoni@uphs.upenn.edu|
20170540|NCT03605212|Menarini Group|Angela Capriati, MD PhD - Corporate Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
20170541|NCT01254292|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20170542|NCT03277690|Cortendo AB|Xeris Medical Director|+1 610-254-9200|LOGICS@cortendo.com|
20170543|NCT00747812|Boston Scientific|Lyn Pimentel, Clinical Project Manager|(661) 949-4174|Lyn.Pimentel@bsci.com|
20170544|NCT01484132|New England Research Institutes|Felicia Trachtenberg, Principal Research Scientist|617-972-3120|ftrachtenberg@neriscience.com|
20170545|NCT04048122|Washington University School of Medicine|Dr. Erin Foster|314-286-1638|erfoster@wustl.edu|
20170546|NCT02484287|University of Oklahoma Health Science Center|Blair Apple|4052714658|Blair-Apple@ouhsc.edu|1
20170547|NCT04209348|The University of Tennessee, Knoxville|Dr. Samantha Ehrlich|510 299 8747|sehrlic1@utk.edu|
20170548|NCT01697358|Medtronic Restorative Therapies Group - Pain Stim|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
20170549|NCT05055128|Cinclus Pharma Holding AB|Kajsa Larsson, MD, PhD|+46 70 675 01 28|kajsa.larsson@cincluspharma.com|
20170550|NCT00273910|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
20170551|NCT00936611|Dana-Farber Cancer Institute|Irene Ghobrial|6176324101|irene_ghobrial@dfci.harvard.edu|
20170552|NCT01783054|Medical University of South Carolina|Eric Kimchi, MD|842-792-4271|kimchi@musc.edu|
20170553|NCT02497300|University of Alabama at Birmingham|Eric Judd|205 934-9509|ejudd@uab.edu|
20170554|NCT01822496|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
20170555|NCT03467048|Cleveland Clinic|Dr. Kurt Ruetzler|216-445-8105|ruetzlk@ccf.org|
20170556|NCT03841448|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
20170557|NCT00543543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170558|NCT04308304|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170559|NCT00945555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170560|NCT00834678|The Ohio State University Comprehensive Cancer Center|Rachel Layman, MD|614-366-8541|Rachel.Layman@osumc.edu|
20202236|NCT00662155|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
20202237|NCT02515669|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20170561|NCT04502979|University of North Carolina at Chapel Hill|Eric A Hodges, PhD, FNC-BC, FAAN|919-966-0534|eahodges@email.unc.edu|
20170562|NCT03318900|M D Anderson Cancer Center|Amir A. Jazaeri, MD|713-792-2921|aajazaeri@mdanderson.org|
20170563|NCT00772304|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20170564|NCT00165984|Emory University|Paul Kirshbom|404-785-6330|pkirshb@emory.edu|
20170565|NCT03945266|Pennsylvania State University|Dr. Abigail Pauley|814-863-7354|amp34@psu.edu|
20170566|NCT01686828|University of Washington|Dr. Katya Rubinow|206-7543-3470|rubinow@uw.edu|
20170567|NCT03750461|Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH Geisel School of Medicine, Hanover, NH|Matthew Z. Wilson, MD MSc FACS FASCRS|(603) 650-8113|Matthew.Z.Wilson@hitchcock.org|
20170568|NCT01532973|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170569|NCT01736124|James J. Peters Veterans Affairs Medical Center|Dr. Jeremy Silverman|718-584-9000|jeremy.silverman@va.gov; jeremy.silverman@mssm.edu|1700
20170570|NCT02734433|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
20202238|NCT02985801|Mayo Clinic|Dr. Massimo Raimondo|904-953-6982|Raimondo.Massimo@mayo.edu|
20202239|NCT00630032|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
20202240|NCT04067661|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
20202241|NCT05768789|University of Pittsburgh, UPMC|Harikesh Subramanian, MBBS, MS, D.ABA, ABPM-CI|412-647-9085|subramanianh4@upmc.edu|
20202242|NCT03746080|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
20202243|NCT05738486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20202244|NCT03665155|Memorial Sloan Kettering Cancer Center|Jason Lewis, PhD|314-276-1830|lewisj2@mskcc.org|
20202245|NCT01826214|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
20202246|NCT00955110|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20202247|NCT02128490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20202248|NCT02243176|ASTRAZENECA INVESTMENT (CHINA) CO., LTD.|Xia, Zhang|+86 21 6030 2288|Xia.Zhang@astrazeneca.com|2035
20202249|NCT03113500|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
20202250|NCT06470087|Adichunchanagiri Institute of Medical Sciences, BG Nagara|Dr Naveen N|9980023372|drnaveenn@bgsaims.edu.in|+91
20202251|NCT02517515|AbbVie|Global Medical Services|800-633-9110||
20202252|NCT04745832|MEI Pharma|Richard Ghalie, MD CMO|858.898-0956|rghalie@meipharma.om|
20202253|NCT06400238|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20202254|NCT03638011|Maimonides Medical Center|Dr Dennis Feierman|718-283-6000|dfeierman@maimonidesmed.org|7703
20202255|NCT03187379|Cleveland Clinic Foundation|Dr. Matthew Kroh|12164457410|krohm@ccf.org|
20202256|NCT01009463|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202257|NCT04430348|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
20202258|NCT04260607|Naval Medical Center Camp Lejeune|Naval Medical Center Camp Lejeune|317-691-1718|nathan.butler@usmc.mil|
20202259|NCT00702624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20202260|NCT03033108|Kubota Vision Inc.|Clinical Trials Helpdesk|(206) 805-8310|clinicaltrials@kubotavision.com|
20202261|NCT03818815|Novus Therapeutics|Clinical Director|949-679-1110|study006@novustherapeutics.com|
20202262|NCT05408858|Massey University|Dr. Ilana Seager van Dyk|+64 4 979 3625|i.seagervandyk@massey.ac.nz|
20202263|NCT03618641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
20202264|NCT04329949|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
20202265|NCT03851744|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
20202266|NCT01475955|DUSA Pharmaceuticals, Inc|Manager of Clinical Studies||houlihana@dusapharma.com|
20202267|NCT01458340|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20202268|NCT03767738|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20202269|NCT03695276|UCSF|Rachel Willard-Grace|415-476-5248|Rachel.Willard@ucsf.edu|
20202270|NCT01702805|Emeritus Professor U Pennsylvania at CHOP and Emeritus Professor McMaster University, Dept Pediatrics|Haresh Kirpalani|267-844-3233|kirpalan@mcmaster.ca|
20202271|NCT04876391|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
20202272|NCT02286960|NYU Langone Health|Milan Amin|646-754-1206|Milan.Amin@nyulangone.org|
20202273|NCT01882725|Arizona Institute of Footcare Physicians|Kerry Zang, DPM|480-834-8804|kerryzang@aol.com|
20202274|NCT02317510|Lutfiye NBGH|Dr. Turgut Donmez|00905347400967|surgeont73@hotmail.com|
20202275|NCT03427073|Almac Discovery|Professor Richard Kennedy, Medical Director|+44 28 3833 2200|richard.kennedy@almacgroup.com|
20202276|NCT02095561|INSTITUTO NACIONAL DEL CÁNCER, ARGENTINA|Silvina Arrossi, Phd|541152390562|silviarrossi2020@gmail.com|
20202277|NCT01193335|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202278|NCT01733329|Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León|Dr. Flavio Hernández Castro|8112776459|flaviohernandezc@yahoo.com|
20202279|NCT01078753|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
20202280|NCT01576471|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
20202281|NCT04322708|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
20202282|NCT02493751|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202283|NCT00184054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
20202284|NCT02513446|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202285|NCT00843180|UCSF|Dr. Wolf Mehling, MD|415-353 9506|mehlingw@ocim.ucsf.edu|
20170571|NCT02628769|Imperial College London|Louise Donnelly|+44 02075947895|l.donnelly@imperial.ac.uk|
20170572|NCT03242824|Mayo Clinic|Nadia N. Laack, MD, MS|507/284-2511|Laack.Nadia@mayo.edu|
20170573|NCT03882788|Research Office|Clinical Trials Manager|650-724-1720|clinicaltrials-gov@stanford.edu|
20170574|NCT03698331|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
20170575|NCT06033521|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170576|NCT02130024|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20170577|NCT01467583|Harper University Hospital|Krista Wahby, Critical Care Pharmacist in the Medical ICU|313-745-2711|kwahby@dmc.org|
20170578|NCT03727425|Auris Health, Inc.|Scott Rehage|9256832590|scott.rehage@aurishealth.com|
20170579|NCT05274165|Sonova USCS|Senior Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
20170580|NCT02717273|University of Virginia|Robert Sawyer|4349821632|rws2k@virginia.edu|
20170581|NCT04432272|Beaumont Hospitals|Matthew Sims, MD|248-551-0027|matthew.sims@beaumont.org|
20170582|NCT02127723|Q-Med AB|Q-Med AB|+46 18 474 9000|medicalinfo.q-med@alderma.com|
20170583|NCT04916769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170584|NCT05736224|Yale University Department of Dermatology|Kacie Carlson, Physician Assistant|203 785 7432|Kacie.carlson@yale.edu|
20170585|NCT04526509|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170586|NCT03806491|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
20170587|NCT04294277|EAU Research Foundation|Dr. Wim Witjes|31263890677|w.witjes@uroweb.org|
20170588|NCT03448653|Centre Hospitalier Départemental Vendée|Dr. Vincent MACE|0251446572|vincent.mace@ght85.fr|+33
20170589|NCT02719327|Madison Veterans Affairs Geriatrics Research, Education & Clinical Center (GRECC)|Cynthia Carlsson, MD, MS; Professor of Medicine (Geriatrics)|608-280-7000|cynthia.carlsson@va.gov|
20170590|NCT04340193|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20170591|NCT03350620|Vyluma, Inc|VP of Clinical Development|9083677400|info@vyluma.com|
20170592|NCT01066000|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20170593|NCT03507400|Practice for Neurology and Ludwigs-Maximilians-Universitiy Munich|Dr. Monika Empl|+4989500598710|dr.empl@dr-empl-neurologie.de|
20170594|NCT02475031|Indiana University School of Medicine - Anesthesia Division|Dr. Yar Yeap|317-274-0275|yyeap@iupui.edu|
20170595|NCT06350474|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
20170596|NCT00217620|SWOG Statistical Center|Study Statistician|206-667-4623||
20170597|NCT00418015|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|3129269015|r-mccarthy@northwestern.edu|
20170598|NCT00089414|Behavioral Endocrinology Branch/National Institute of Mental Health/NIH|Pedro E. Martinez, M.D., Principal Investigator|301-402-0615|martinep@mail.nih.gov|
20170599|NCT01517074|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
20170600|NCT02008318|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20170601|NCT02281773|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170602|NCT00546104|Duke University Health System|Kimberly Blackwell, MD|919-668-1478|kimberly.blackwell@duke.edu|
20170603|NCT02022020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170604|NCT01797731|Hospital for Special Surgery|David Mayman|2127742024|maymand@hss.edu|
20170605|NCT03711318|NYS Psychiatric Institute|Dr. Adam Bisaga, study PI|646-774-6155|adam.bisaga@nyspi.columbia.edu|
20170606|NCT00091442|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Director Medical Leader|908 218 7361||
20170607|NCT00917501|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
20170608|NCT03656107|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
20170609|NCT01954160|Duke Clinical Research Institute|Kathy Moore|919-668-8065|kathy.moore@dm.duke.edu|
20170610|NCT00808483|University of Oslo|Professor Anne Marit Mengshoel|004790036933|a.m.mengshoel@medisin.uio.no|
20170611|NCT02038881|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20170612|NCT00333840|Novartis Pharmaceuticals|Study Director|862-778-8300||
20170613|NCT03945214|University of California San Francisco|Dr. Rachel Radin|845-641-9569|rachel.radin@ucsf.edu|
20170614|NCT02391701|Hospital Clínico Universitario de Santiago|Dr. María del Mar Calvo Malvar|34 981950395|mariadelmar.calvo.malvar@sergas.es|
20170615|NCT01955564|Newron Pharmaceuticals S.p.A.|Dr. Ravi Anand|+39 026103461|ravi@anand.ch|
20170616|NCT02480920|Department of Cardiology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey|Volkan Emren||vemren@hotmail.com|
20170617|NCT01436396|Sanofi Pasteur|Director||Contact-US@sanofi.com|
20170618|NCT00875979|Hoffmann-La Roche|Medical Communications|800 821-8590||
20170619|NCT00216476|Janssen Cilag European Medical Affairs|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
20170620|NCT00303901|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
20170621|NCT03417804|Centro Hospitalar do Porto|Dr. Simão Esteves|+351222077549|simao.esteves@me.com|
20170622|NCT00369707|Northwestern University|Leo Gordon, MD|312-695-4520|l-gordon@northwestern.edu|
20170623|NCT03594435|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
20170624|NCT02394548|Massachusetts General Hospital|Dr. Henning Willers|617-726-5184|hwillers@mgh.harvard.edu|
20170625|NCT04562792|Children's Mercy|Dr. Alan Gamis|816-302-6808|agamis@cmh.edu|
20170626|NCT02083081|Mayo Clinic|Christi Patten PhD|507-538-7370|patten.christi@mayo.edu|
20170627|NCT02263131|The Catholic University of Korea, Seoul St. Mary's Hospital|Dr. Kang Jin Han|+82-10-4251-8375|kjhan@catholic.ac.kr|
20170628|NCT01230710|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20170629|NCT02905149|Instituto de Investigación Sanitaria La Fe|Maria Cortell|961246611|investigacion_clinica@iislafe.es|
20170630|NCT01708161|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
20170631|NCT01349231|Yale University, Connecticut Mental Health Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
20170632|NCT00590460|BAYLOR|Malcolm Brenner, MD|832-824-4663|mbrenner@bcm.edu|
20170633|NCT01986140|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
20170634|NCT02927262|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20170635|NCT02853344|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
20170636|NCT02913612|Duke Clinical Research Institute|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
20170637|NCT04836312|University of Pennsylvania|Alexander Fanaroff, MD|215-615-7674|alexander.fanaroff@pennmedicine.upenn.edu|
20170638|NCT04141046|University of North Carolina at Chapel Hill|Saira Sheikh, MD|919-966-0545|szsheikh@email.unc.edu|
20170639|NCT02711345|Novartis Pharma AG|Study Director|862 778-8300|Novartis.email@novartis.com|
20170640|NCT00961649|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20170641|NCT04043728|Rush University Medical Center|Dr. Amanda Mathew|13125631273|amanda_mathew@rush.edu|
20170642|NCT00675259|The Ohio State University|Ewa Mrozek, MD|614-293-0066|Ewa.mrozek@osumc.edu|
20170643|NCT00072176|Princess Margaret Hospital, Toronto, Canada|Dr. Amit M. Oza|416 946 4501|amit.oza@uhn.ca|2818
20202286|NCT02485717|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
20170644|NCT02000180|St. Michael's|Dr. Samir C. Grover|4168645628|samir.grover@utoronto.ca|
20170645|NCT04128371|National Institute of Allergy and Infectious Diseases|Dr. Paneez Khoury|+1 301 402 3673|paneez.khoury@nih.gov|
20170646|NCT01739361|LSU Health Sciences Center New Orleans|Dr. David R Janz, MD, MSc, Assistant Professor of Medicine|504-568-3167|djanz@lsuhsc.edu|
20170647|NCT00968864|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
20170648|NCT01346969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170649|NCT00586625|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
20170650|NCT03353246|Duke University Medical Center|Michael Haglund, M.D., Ph.D.|919-684-6936|haglu001@mc.duke.edu|
20170651|NCT04032652|NorthShore University HealthSystem|Asst Director Research Compliance|2243647975|rpulido@northshore.org|
20170652|NCT02423772|Queen's University of Belfast|Kevin Vowles|+44 (0)28 9097 5445|k.vowles@qub.ac.uk|
20170653|NCT01470859|Department of Neurology, Huashan Hospital affiliated to Fudan University.|Dr. Jian Wang|+86-13321934789|wangjian336@hotmail.com|
20170654|NCT01386008|Clinical Research Center (CRC) UC Berkeley School of Optometry|Meng Lin, OD, PhD|(510) 642-9731||
20170655|NCT03001882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20202287|NCT02192359|City of Hope Medical Center|Dr. Jana Portnow|626-546-8293|JPortnow@coh.org|
20170656|NCT00566111|Yale University Department of Psychiatry|Dr. Gerard Sanacora|(203) 974-7535|gerard.sanacora@yale.edu|
20170657|NCT04449861|Jilin Cancer Hospital|Ying Cheng, MD|NA|jl.cheng@163.com|
20170658|NCT05268055|UMass Chan Medical School|Melissa L. Anderson, PhD|508-856-5820|melissa.anderson@umassmed.edu|
20170659|NCT01555983|UC Davis (currently at UC San Diego)|Barth Wilsey MD|916-402-2270|bwilsey@ucsd.edu|
20170660|NCT02353754|Pacira Pharmaceuticals Inc.|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
20170661|NCT00289718|GlaxoSmithKline|GSK Response Center|866-435-7343||
20170662|NCT00573183|Univerity of Washington Alcohol & Drug Abuse Institute|Dr. Dennis Donovan|206-543-0937|ddonovan@u.washington.edu|
20170663|NCT05439941|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
20170664|NCT00726375|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-615-5707|sungchoi@umich.edu|
20170665|NCT01926015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170666|NCT01914757|AstraZeneca|Mitchell Goldman, Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
20170667|NCT00615108|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170668|NCT02585843|Columbia University|A. Reshad Garan|(917) 374-3346|arg2024@cumc.columbia.edu|
20170669|NCT02765269|Xinhua Translational Institute for Cancer Pain, Shanghai|Gang Ding|021-69691540||
20170670|NCT01147640|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
20170671|NCT01856907|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5278|karen.elkind-hirsch@womans.org|
20170672|NCT02927327|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
20170673|NCT02175628|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|9199664997|rad_research@med.unc.edu|
20170674|NCT03534362|Saint Louis University|Joe D Brunworth, MD|314-577-8884|joe.brunworth@health.slu.edu|
20170675|NCT04517500|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
20170676|NCT00986830|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
20170677|NCT02191137|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20170678|NCT01332331|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170679|NCT01464996|University of North Carolina at Chapel Hill School of Dentistry|Dr. Andre Ritter, Professor and Chair|919-537-3987|andre_ritter@unc.edu|
20170680|NCT01904058|Mirum|Study Physician|1-650-667-4085|medinfo@mirumpharma.com|
20170681|NCT03096483|GE Healthcare|Beth Heckel|2623127269|beth.heckel@ge.com|
20170682|NCT04810481|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
20170683|NCT02664610|University of Michigan|Lesli Skolarus|734-936-9075|lerusche@umich.edu|
20202288|NCT01450540|Philips|Senior Data Scientist|+14125423651||
20202289|NCT01477450|University of Cincinnati|Richard Branson||bransord@uc.edu|
20202290|NCT04002167|Stanford University|Hadi Hosseini|6507235798|hosseiny@stanford.edu|
20170684|NCT01318642|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
20170685|NCT06448078|Ege University|Gizem Kececi Ozgur|+90 506 678 71 28|gizem.kececi.1991@gmail.com|
20170686|NCT02556736|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20170687|NCT00285818|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
20170688|NCT01191411|University of Texas Southwestern Medical Center|Keith E. Argenbright, MD|817-288-9898|keith.argenbright@utsouthwestern.edu|
20170689|NCT04041375|Michael E. DeBakey VAMC|Dr. Natalie E. Hundt|713-791-1414|natalie.hundt@va.gov|10315
20170690|NCT01967342|University of Alabama|Beverly E. Thorn, Ph.D.|(205) 348-8024|bthorn@ua.edu|
20170691|NCT01986946|Duke University Hospital|Dr. Erin Manning|919-681-3551|erin.manning@duke.edu|
20170692|NCT04674644|Suleyman Demirel University|Dr Esra Oz|05326788040|esrakaraagac@sdu.edu.tr|
20170693|NCT01268150|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
20170694|NCT00395733|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20170695|NCT03725852|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
20170696|NCT05835323|Johnson & Johnson MedTech Surgery|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
20170697|NCT02808650|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20170698|NCT03072732|ZOLL|Project Manager|14127216444|moszm@yahoo.com|
20170699|NCT01672736|University Health Network - Princess Margaret Cancer Centre|Dr. Suzanne Trudel|416-946-4501|Suzanne.Trudel@uhn.ca|4566
20170700|NCT02387710|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
20202291|NCT03598777|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20202292|NCT02006576|University of Nebraska Medical Center|Amy Nelson|402-559-5536|amyjnelson@unmc.edu|
20202293|NCT00785577|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20202294|NCT05175170|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Diane Chen|312-227-2939|DiChen@luriechildrens.org|
20202295|NCT01650805|ARIAD Pharmaceuticals, Inc.|Maureen Conlan, Senior Medical Director|1-617-621-2316|Maureen.Conlan@ariad.com|
20202296|NCT02332915|University of Utah|Julie Wambaugh|8015846164|julie.wambaugh@health.utah.edu|
20202297|NCT01909492|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
20202298|NCT01901328|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
20202299|NCT02928289|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
20202300|NCT05110300|Gaylord Specialty Healthcare|John Corbett|2032943224|jcorbett@gaylord.org|
20202301|NCT02396147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20202302|NCT01981187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202303|NCT01362322|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202304|NCT03451825|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20202305|NCT02874794|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20202306|NCT03549520|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
20202307|NCT03839524|TRANSGENE|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
20202308|NCT03715465|University of Michigan|Leslie Swanson|734-764-2242|lmswan@med.umich.edu|
20202309|NCT02494141|"University of Colorado Denver | Anschutz"|Kristen Nowak, Ph.D.|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
20202310|NCT00917384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20202311|NCT01521845|Shaheed Beheshti Medical University|Dr.Jamshid Salamzadeh|00982188662334|j.salamzadeh@yahoo.com|
20202312|NCT01451515|St. Jude Children's Research Hospital|Hiroto Inaba, MD, PhD|(901) 595-3144|hiroto.inaba@stjude.org|
20202313|NCT03717922|UCLA Psychiatry & Biobehavioral Sciences|Dr. Taylor P. Kuhn, PhD|‭(310) 829-5968‬|tkuhn@mednet.ucla.edu|
20202314|NCT01532453|Galderma Spirig|Dr. Francine Santoro|+41 62 387 87 87|Francine.santoro@galderma.com|87 20
20202315|NCT02417415|Vanderbilt University Medical Center|Italo Biaggioni|(615) 322-2318|italo.biaggioni@vumc.org|
20202316|NCT01575548|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20202317|NCT05980416|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
20202318|NCT01748227|Richard L. Roudebush VAMC HSR&D|Dr. Marianne Matthias|317-988-4514|marianne.matthias@va.gov|
20202319|NCT01660815|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
20202320|NCT01486238|Valley Retina Institute, PA|Victor Gonzalez, MD|956-631-8875|research@vritx.com|
20202321|NCT00736229|Saint Luke's Health System|Steven P. Marso, MD|816-932-5773|smarso@saint-lukes.org|
20202322|NCT01415960|Grand Strand Urology Carolina Urology Reseearch Centre|Dr. Neal Shore MD|+1 843 839 1679|nshore@grandstrandurology.com|
20202323|NCT00693706|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202324|NCT04207710|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
20202325|NCT04786210|NYU Langone Health|Nayoung Lee, MD|212-263-7019|nayoung.lee@nyulangone.org|
20202326|NCT04334148|Duke University|Dr. Susanna Naggie|919-684-2584|susanna.naggie@duke.edu|
20202327|NCT00498173|Lurie Center for Autism, Massachusetts General Hospital|Christopher John McDougle, M.D.|7818601721|cmcdougle@mgh.harvard.edu|
20202328|NCT06129487|University of Connecticut|Zexin Ma, Ph.D.|(860) 486-6871|zexin.ma@uconn.edu|
20170701|NCT02345226|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20170702|NCT01848704|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
20170703|NCT01710046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202329|NCT00258154|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20202330|NCT03772327|Weill Cornell Medicine|Dr. Grant Ellsworth|212-746-7204|gre9006@med.cornell.edu|
20170704|NCT02503410|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
20170705|NCT01021306|Palmer Center for Chiropractic Research, Palmer College of Chiropractic|Dr. James DeVocht|563.884.5150|james.devocht@palmer.edu|
20170706|NCT02282358|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
20170707|NCT01898208|Mayo Clinic|Ritu Banerjee, M.D., Ph.D.|507-284-6904|banerjee.ritu@mayo.edu|
20170708|NCT01498978|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
20170709|NCT01033851|Massachusetts General Hospital|Dr. Elizabeth Hoge|6177240859|ehoge@partners.org|
20170710|NCT02349542|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
20170711|NCT01011738|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20170712|NCT00200161|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
20170713|NCT03896165|Ohio State University College of Nursing|Assistant Professor|614-292-5684|thrane.2@osu.edu|
20170714|NCT01163266|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20170715|NCT02919696|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
20170716|NCT03181893|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170717|NCT02158975|University of Michigan Comprehensive Cancer Center|Dr. Ryan Wilcox, M.D.|734-615-1482|rywilcox@umich.edu|
20170718|NCT01706822|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
20170719|NCT03329508|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
20170720|NCT04815031|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170721|NCT01558739|Novartis Pharmaceuticals|Study Director|862-778-8300||
20170722|NCT04266769|LightForce Orthodontics|Kelsey Fafara|7329775646|kelsey@lightforceortho.com|
20170723|NCT01193842|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
20170724|NCT00894127|bioAffinity|Maria Zannes|505-400-9747|mz@bioaffinitytech.com|
20170725|NCT02484690|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170726|NCT03672643|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170727|NCT01067976|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20170728|NCT00589290|National Institutes of Health (NIH), National Cancer Institute (NCI)|Arun Rajan, M.D.|301-594-5322|rajana@mail.nih.gov|
20170729|NCT00976677|ECOG Statistical Office|Study Statistician|617-632-3012||
20170730|NCT00485433|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20170731|NCT01191333|Director, VISN21 MIRECC, Department of Veterans Affairs|Jerome Yesavage, MD|650-852-3287|Jerome.Yesavage@va.gov|
20170732|NCT02468232|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
20170733|NCT03509883|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20170734|NCT02024529|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
20170735|NCT00354614|ResMed|VP Medical Affairs|858 836 6782|ResmedScienceCenter@resmed.com.au|
20170736|NCT03650556|Abbott Medical|Amber Miller|(612) 413-7236|amber.miller@abbott.com|
20170737|NCT01426438|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20170738|NCT02122458|VA Pittsburgh Healthcare System|Sheila R. Pratt, Ph.D.|412-979-3157|Sheila.Pratt@va.gov|
20170739|NCT02833350|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20170740|NCT00567307|Wake Forest School of Medicine, Winston Salem, NC|Dr. Elsayed Z Soliman, Director of the Epidemiological Cardiology Research Center|336-716-8632|esoliman@wakehealth.edu|
20170741|NCT01500031|Boston Scientific|Director Clinical Trials|708-771-4737|Pamela.Grady@bsci.com|
20170742|NCT01188421|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
20170743|NCT01604408|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20170744|NCT00075218|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20170745|NCT00392860|Human Engineering Research Laboratories|Michael L Boninger|412-822-3700|boninger@upmc.edu|
20170746|NCT01102270|Brigham and Women's Hospital|Atul Malhotra|6177326488|amalhotra1@partners.org|
20170747|NCT00538291|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
20170748|NCT00694707|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
20170749|NCT01696695|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170750|NCT02640716|Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China|Dr. Yi Tang|+86 10 83199456|tangyi@xwhosp.org|
20170751|NCT04081324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20170752|NCT00739050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170753|NCT02046733|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|STIMULI@etop-eu.org|
20170754|NCT01756053|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
20170755|NCT02404220|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20170756|NCT01259596|Wake Forest School of Medicine|Gretchen A. Brenes, Ph.D.|336-716-4551|gbrenes@wakehealth.edu|
20170757|NCT02019277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170758|NCT03557853|MSD Pharmaceuticals LLC|Vladimir Achikyan|+74959167100|vladimir.achikyan@merck.com|
20170759|NCT04981392|UMass Chan Medical School|Kimberly Fisher, MD|5088561975|kimberly.fisher2@umassmed.edu|
20170760|NCT01419639|NYU Langone Medical Center|Matthias A. Karajannis|212 263 9959|matthias.karajannis@nyumc.org|
20170761|NCT00669396|University of Utah|David Turok, MD|801-581-7647|david.turok@hsc.utah.edu|
20170762|NCT01262573|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
20170763|NCT04251273|Truth Initiative|Amanda L. Graham, PhD, Principal Investigator|(202) 525-6473‬|vapestudy@truthinitiative.org|
20170764|NCT04402060|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20170765|NCT00810693|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20170766|NCT03860597|University of California, San Diego|Neal Swerdlow, M.D., Ph.D.|(619) 543-6270|nswerdlow@ucsd.edu|
20170767|NCT02507973|The R Adams Cowley Shock Trauma Center|Dr Deborah Stein|410-328-3495|dstein@umm.edu|
20170768|NCT00331422|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
20170769|NCT00989157|NRIFargo|Dr. James Roerig|701 365 4919|jroerig@nrifargo.com|
20170770|NCT03386474|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20170771|NCT02155881|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20170772|NCT04357782|Central Virginia VA Health Care System|Dr. Brian Davis|804-675-5000|Brian.Davis5@va.gov|
20170773|NCT01786148|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
20170774|NCT03780543|Assembly BioSciences Inc.|Chief Development Officer|415-855-3006|manderson@assemblybio.com|
20170775|NCT00066729|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
20170776|NCT02840721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170777|NCT01967173|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
20170778|NCT02096679|AstraZeneca|Dr Mireille Cantarini||ClinicalTrialTransparency@astrazeneca.com|
20170779|NCT02002832|Sumitomo Pharma (Suzhou) Co., Ltd.|Chief Medical Officer|+86-10-57322070|luo@dsmpharm.com.cn|
20170780|NCT03540030|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
20170781|NCT03666624|University of Washington|Karen Fredriksen Goldsen|206-543-5722|fredrikk@uw.edu|
20170782|NCT03225599|Northwell Health|Administrative Director, Clinical Research|(516) 881-7064|dcannone1@northwell.edu|
20170783|NCT02308189|Ohio University|Brian Clark, PhD|740-593-2354|clarkb2@ohio.edu|
20170784|NCT02959983|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
20170785|NCT01254630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170786|NCT00484094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170787|NCT03221270|University of North Carolina at Chapel Hill|Rachel Force, PhD|984-974-6239|rachel_force@med.unc.edu|
20170788|NCT00193258|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20170789|NCT01892865|Michael E. DeBakey VAMC|Panos Kougias MD MSc|713.794.7700|panagiotis.kougias@va.gov|
20170790|NCT03572972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170791|NCT01771952|University of Virginia, Kinesiology|Joe Hart|4349246187|jmh3zf@virginia.edu|
20170792|NCT02612129|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
20170793|NCT02557295|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
20170794|NCT03487549|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
20170795|NCT02637622|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
20170796|NCT04638400|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
20170797|NCT02160535|University of Washington|Dr. Sylvia Lucas, MD, PhD|206-598-9260|lucass@uw.edu|
20170798|NCT01826604|Saint Louis University|Dr. Katherine M. Scolari Childress|314-977-2090|scolarik@slu.edu|
20170799|NCT00320931|University of Maryland, Baltimore|Vasken Dilsizian, MD|410-328-6890|vdilsizian@umm.edu|
20170800|NCT05203289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170801|NCT00752102|Joslin Diabetes Center|Dr. Sylvia Rosas|617-309-2477|sylvia.rosas@joslin.harvard.edu|
20170802|NCT01303861|Duke University Medical Center - Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@dm.duke.edu|
20170803|NCT02234570|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
20170804|NCT00659360|Cross Cancer Institute|Dr. Margaret Von Mehren|215-214-1663|margaret.vonmehren@fccc.edu|
20170805|NCT02056639|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
20170806|NCT03270644|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20170807|NCT01868503|Stanford University|Dr. Kathleen Horst|6507360921|kateh@stanford.edu|
20170808|NCT00333177|University of California, Los Angeles|Keith H. Nuechterlein, Ph.D., Principal Investigator|(310) 825-0036|keithn@ucla.edu|
20170809|NCT02476201|Abbott Medical|Pilar Santamaria|+34 917 278 964|pilar.santamaria@abbott.com|
20170810|NCT00691301|Gynecologic Oncology Group|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
20170811|NCT02642029|McLean Hospital|Ann Shinn, MD|617-855-3053|akshinn@partners.org|
20170812|NCT01823146|University of Florida|Dr. Natalie Ebner|203 691 0371|natalie.ebner@ufl.edu|
20170813|NCT00398918|Boston University|Ofra Sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
20170814|NCT00463580|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
20170815|NCT03917459|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20170816|NCT00736944|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
20170817|NCT00676338|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20170818|NCT00412542|UT MD Anderson Cancer Center|Vinay Puduvalli, MD / Associate Professor|713-745-5769|kuhunter@mdanderson.org|
20170819|NCT02509481|Colorado State University|Dr. Brian D. Foy, Professor|970-491-3470|Brian.Foy@colostate.edu|
20170820|NCT03643575|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
20170821|NCT01189604|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20170822|NCT03626168|The University of Alabama|Dr. Amy Ellis, principal investigator|205-348-8128|aellis@ches.ua.edu|
20170823|NCT02357979|University of California at San Francisco|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
20170824|NCT05047770|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170825|NCT03758443|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
20170826|NCT00843531|University of California, San Francisco|Emily Bergsland, MD|(415) 514-6520|Emily.Bergsland@ucsf.edu|
20170827|NCT01772160|GlaxoSmithKline|GSK Response Center|866-435-7343||
20170828|NCT01573260|McGill University|Dr.Ronald B Postuma|514-934-8026|ron.postuma@mcgill.ca|
20170829|NCT00515177|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
20170830|NCT00199875|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20170831|NCT03469934|AnaptysBio, Inc|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
20170832|NCT03569033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170833|NCT05280782|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
20170834|NCT01024231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20170835|NCT01691898|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170836|NCT01013350|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20202331|NCT04689828|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20202332|NCT06105138|Colorado State University|Dr. Hollis Karoly|970-491-3677|hollis.karoly@colostate.edu|
20202333|NCT00754390|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
20202334|NCT00847613|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202335|NCT01480180|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20202336|NCT06081283|University of North Carollina at Chapel Hill|Meitra Kazemi|919-914-9579|meitra_kazemi@med.unc.edu|
20202337|NCT01885689|City of Hope|Dr. Monzi M.Al Malki, MD|626-359-8111|malmalki@coh.org|
20202338|NCT03914300|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-293-9779|bhavana.konda@osumc.edu|
20202339|NCT02280811|National Cancer Institute|Dr. Christian Hinrichs|301-435-3027|hinrichs@nih.gov|
20202340|NCT05445843|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
20202341|NCT02912364|Stanford University|Kimford Meador|650-725-6648|kmeador@stanford.edu|
20202342|NCT04090164|Mansoura University|Osama Hussein|00201099815110|osamahussein@mans.edu.eg|
20202343|NCT02625402|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@partners.org|
20202344|NCT00840463|UT Southwestern|Kelly Chin|214-645-1825|kelly.chin@utsouthwestern.edu|
20202345|NCT04884243|Cloudbreak Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
20202346|NCT03414359|UAMS|Nadir El Sharawi|5016866114|nelsharawi@uams.edu|
20202347|NCT02043574|South Texas Veterans Health Care System|Monica Serra|210-617-5300|monica.serra@va.gov|15313
20202348|NCT00770861|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
20202349|NCT03750838|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
20202350|NCT02462889|Ophthalmic Consultants of Boston|Jeffrey S. Heier, MD|617-314-2694|jsheier@eyeboston.com|
20202351|NCT01497171|Mayo Clinic|Dr. Emanuel C. Trabuco|507-284-7519|trabuco.emanuel@mayo.edu|
20202352|NCT02258412|3M Health Care Business|Clinical Research Specialist|651-736-1578|mdavid@mmm.com|
20202353|NCT03497689|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
20202354|NCT02032875|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20202355|NCT04060277|City of Hope Medical Center|Dr. Ryotaro Nakamura|6263598111|rnakamura@coh.org|
20202356|NCT01093612|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20202357|NCT04636177|Stanford University School of Medicine|Laura E Simons|(650) 736-0838|lesimons@stanford.edu|
20202358|NCT03191786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20202359|NCT05847881|Back & Pain Center Clinical Research|Afton L. Hassett, PsyD|734-763-5226|afton@med.umich.edu|
20202360|NCT07215806|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20202361|NCT02277444|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20202362|NCT05278104|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202363|NCT03439345|Nuffield Department of Population Health, University of Oxford|Associate Professor David Preiss|01865 743 743|lens@ndph.ox.ac.uk|
20202364|NCT05781542|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
20202365|NCT04974307|National Institute of Child Health and Human Development (NICHD)|Dr. An Ngoc Dang Do|301-496-8849|an.dangdo@nih.gov|
20202366|NCT01843374|AstraZeneca|Paul Stockman, MD, PhD|+44 162-523-1815|Paul.Stockman@astrazeneca.com|
20202367|NCT03704051|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
20202368|NCT02495077|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20170837|NCT04738734|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory, and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
20170838|NCT02256072|Northwestern University Feinberg School of Medicine|Dr. Lee A. Lindquist|312-503-3916|LAL425@md.northwestern.edu|
20170839|NCT03212690|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20202369|NCT01943539|Akili Interactive Labs|SVP of Medical Devices|617-456-0984|skellogg@akiliinteractive.com|
20170840|NCT02350569|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20170841|NCT01927627|Case Comprehensive Cancer Cent|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
20170842|NCT00910273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170843|NCT02215096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170844|NCT02586064|Providence VA Medical Center|Dr. Tracie Shea|401-273-7100|MaryTracie.Shea@va.gov|6248
20170845|NCT03021304|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170846|NCT03022435|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
20170847|NCT00397215|GlaxoSmithKline|GSK Response Center|866-435-7343||
20170848|NCT01433731|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|jeffrey.skolnik@tetralogicpharma.com|
20170849|NCT01361568|Cara Therapeutics|Frédérique Menzaghi, PhD; Vice President, Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
20170850|NCT02020577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20170851|NCT02728596|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|karnold@fredhutch.org|
20170852|NCT03439657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20170853|NCT00370071|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20170854|NCT00310401|Vanderbilt University|Lorraine B. Ware M.D.|615 322 8614|lorraine.ware@vanderbilt.edu|
20170855|NCT00667875|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
20170856|NCT03553927|Imperial College London|Channa Jayasena|02083833242|c.jayasena@imperial.ac.uk|
20170857|NCT03630042|Oxford University Hospital NHS Trust|Jaimal Kothari|NA|Jaimal.Kothari@ouh.nhs.uk|
20170858|NCT01759511|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20170859|NCT02569671|Institut Straumann|Mustapha El Amrani|0041619651741|mustapha.elamrani@straumann.com|
20170860|NCT01757535|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinica.Trials@bms.com|
20170861|NCT06238362|SleepRes|Bernard Hete|+1 615-921-2406|bhete@sleepres.com|
20170862|NCT04508335|Reia, LLC|Chief Medical Officer|603 715-7017|paul@reiahealth.com|
20170863|NCT01484041|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
20170864|NCT04667481|University of Washington|Dr. Kerryn Reding, Study Principal Investigator|206-221-1571|kreding@uw.edu|
20170865|NCT03689114|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Giorgia Giussani|0239014604|giorgia.giussani@marionegri.it|
20170866|NCT01313858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170867|NCT03642457|Icahn School of Medicine at Mount Sinai|Poonam Pai|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
20170868|NCT02609204|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
20170869|NCT03095885|Allena Pharmaceuticals, Inc|Allena Medical Affairs|6174674577|AllenaMedInfo@allenapharma.com|
20170870|NCT03689530|University of Michigan|Michele Heisler|(734) 845-3504|mheisler@med.umich.edu|
20170871|NCT01392443|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20170872|NCT03019575|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170873|NCT01134276|Seoul National University College of Medicine|Sun-Whe Kim|+82-2-2072-2315|sunkim@plaza.snu.ac.kr|
20170874|NCT01935791|Imperial College London|Dr Chioma Izzi-Engbeaya|02075942454|c.izzi@imperial.ac.uk|
20170875|NCT01546207|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y. Reddy|212-241-7114|vivek.reddy@mountsinai.org|
20170876|NCT01626456|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823|usmedinfo@alkermes.com|
20170877|NCT01816074|Dept of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
20170878|NCT00545766|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20170879|NCT03643796|University of Arkansas for Medical Sciences|Mohamed Abdeldayem|2244279747|Maabdeldayem@uams.edu|
20170880|NCT04075279|Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health|Dr. Tyler Quinn|412-386-4450|yhh7@cdc.gov|
20170881|NCT00608972|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
20170882|NCT00131508|St Jude Children's Research Hospital|Winfred Wang|1-866-278-5833|info@stjude.org|
20170883|NCT01330030|Stanford University|Dr Joel D Killen|650-723-5895|jkillen@stanford.edu|
20170884|NCT00845858|Evoke Pharma|Marilyn R. Carlson|858-345-1494|mcarlson@evokepharma.com|
20170885|NCT02980783|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20170886|NCT00850070|The Children's Health Council|Glen R. Elliott, Ph.D., M.D.|650.688.3649|gelliott@chconline.org|
20170887|NCT01522248|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
20170888|NCT01360593|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor, MPH, CCRP|412-647-5554|stadtermanbm@upmc.edu|
20170889|NCT03441269|Maimonides Medical Center|Sergey Motov, MD|718-283-8693|alikourezos@maimonidesmed.org|
20170890|NCT00696800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170891|NCT05294640|Moyes Eye Center|Meleha Ahmad|401-523-5911|meleha.ahmad@gmail.com|
20170892|NCT05224141|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20170893|NCT01296360|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
20170894|NCT02956070|Universidade Federal Fluminense|Dr. Luiz Augusto Poubel|55 21 981113344|luizpoubel@id.uff.br|
20170895|NCT03225573|AIn Shams University|Professor Ali Gamal Zohni|+2 01004931448|zohniali@gmail.com|
20170896|NCT01479127|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
20170897|NCT02390908|Hunter College|Dr. Tyrel J. Starks|212-772-5550|tstarks@hunter.cuny.edu|
20170898|NCT02737397|Clinilabs, Inc|Magdy Shenouda, MD|201-417-7765|Jackie@sen-jam.com|
20170899|NCT02435147|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
20170900|NCT02639546|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20170901|NCT02478372|Golden Jubilee National Hospital|David McDonald|07914861078|david.mcdonald@nhs.net|
20170902|NCT01297920|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
20170903|NCT00474760|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170904|NCT00968890|GlaxoSmithKline|GSK Response Center|866-435-7343||
20170905|NCT02362269|University of Wisconsin|Dr. Corinne D. Engleman|(608) 265-5491|cengelman@wisc.edu|
20170906|NCT04122534|Montana State University|Dr. Kelly E. Knight|303-819-6997|kelly.knight3@montana.edu|
20170907|NCT00644189|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
20170908|NCT00579878|University of Nebraska Medical Center|James O'Dell|402 559-7288|jrodell@unmc.edu|
20170909|NCT00423514|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
20170910|NCT02128932|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20170911|NCT03113916|Kaiser Permanente Center for Health Research|Nangel Lindberg|503 528 3961|Nangel.M.Lindberg@kpchr.org|
20170912|NCT04729621|Teva Pharmaceuticals|US Medical Affairs|1-888-483-8279|usmedinfo@tevapharm.com|
20170913|NCT02663908|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
20170914|NCT03308786|Case Western Reserve University|Michael M. Lederman MD|2168448786|MXL6@CASE.EDU|
20170915|NCT02004522|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
20170916|NCT01787331|University of California, San Francisco|Rahul Aggarwal, MD|877-827-3222|cancertrials@ucsf.edu|
20170917|NCT03175978|IGF Oncology, LLC|Hugh McTavish|651-207-8270|hmctavish@igfoncology.com|
20170918|NCT01999868|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20170919|NCT00761631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170920|NCT00502944|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
20170921|NCT00289016|Amgen, Inc.|Study Director|866-572-6436||
20170922|NCT00319501|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20170923|NCT00561457|Bard Peripheral Vascular|Director of Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
20170924|NCT00450255|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20170925|NCT01441180|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
20170926|NCT01402011|University of British Columbia Department of family practice|Dr. Helene Bertrand, M.D., CCFP, LM|604-985-5381|dr.hbertrand@gmail.com|
20170927|NCT00142298|Novartis Pharmaceuticals|Study Director|862-778-8300||
20170928|NCT03360747|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
20170929|NCT03366012|Columbia University|Julian Abrams, MD, MPH|212-305-1909|ja660@cumc.columbia.edu|
20157296|NCT00060944|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20157297|NCT01126957|University of Missouri-Columbia|Dr. David Henry|573/884-2582|henryda@missouri.edu|
20157298|NCT01465841|Penumbra, Inc.|Michaella Corso|415-815-8904|mcorso@penumbrainc.com|
20157299|NCT02092181|Evergreenhealth|Gowri Rajendran|425-899-5370|grajendran@evergreenhealth.com|
20170930|NCT02675114|Edwards Lifesciences|Research Director|949-250-2500|THV_CT.gov@Edwards.com|
20157300|NCT02536664|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157301|NCT03383666|Cerenovus|Michael Liao|510-770-5376|mliao7@its.jnj.com|
20157302|NCT02359903|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
20170931|NCT02027883|Wellmont CVA Heart Institute|Terrie Walker, Director of Clinical Research|423-230-5643|twalker@mycva.com|
20157303|NCT00790673|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
20157304|NCT03381989|National Heart Lung and Blood Institute|Lederman, Robert|+1 301 402 6769|lederman@nih.gov|
20157305|NCT02972996|Stratton V.A. Medical Center|Margaret M. Wilson MS, RD, LD/N, CD/N, CNSC, CDE|518 626-6889|margaret.wilson2@va.gov|
20157306|NCT03507127|Brown University|Dr. Jennifer Tidey|4018636418|jennifer_tidey@brown.edu|
20170932|NCT00531934|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20170933|NCT03948698|Elizabeth Glaser Pediatric AIDS Foundation|Shirin Kakayeva|2404377929|skakayeva@pedaids.org|
20157307|NCT01497756|uNewMexico|Mark Hauswald MD|505-269-6699|markhauswald@gmail.com|
20157308|NCT02625181|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
20170934|NCT00150709|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20157309|NCT00746811|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
20157310|NCT00867139|FHCRC|Michael Boeckh MD|206 667 6706|mboeckh@fhcrc.org|
20157311|NCT02505425|The University of Alabama at Birmingham, School of Nursing|Marie A. Bakitas, DNSc, NP-C, FAAN|(205) 934-5277|mbakitas@uab.edu|
20157312|NCT02031302|Boston Scientific Corp.|Blessie Concepcion, Director Clinical Trials|408-385-8604|Blessie.Concepcion@bsci.com|
20157313|NCT03050710|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
20157314|NCT01370551|Medinova|Doerthe Bassfeld|+41 44 306 1371|bassfeld.doerthe@medinova.ch|
20157315|NCT00833521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20170935|NCT04092582|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20157316|NCT01280942|Washington Univ Sch of Medicine|Thomas C. Bailey, MD|314-454-8293|tbailey@dom.wustl.edu|
20157317|NCT02293551|Chief Medical Officer|Eli Lilly and Company|800-545-5979||
20157318|NCT02936323|Tarveda Therapeutics, Inc.|Tarveda Clinical Information Center|(617) 923-4100|clinical.information@tarvedatx.com|
20170936|NCT01805440|Department of Psychiatry|Douglas Kondo, MD|801-583-2500|doug.kondo@hsc.utah.edu|
20170937|NCT02903355|Southern Illinois University School of Medicine|Gary Fifer, MSHI|217-545-7823|gfifer@siumed.edu|
20157319|NCT02781558|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20170938|NCT02280304|Michael E. DeBakey VA Medical Center|Dr. Mary Newsome|713-791-1414|mary.newsome@va.gov|25947
20157320|NCT02666560|University College London|Joanne Lindop|07909116145|joanne.lindop.12@ucl.ac.uk|
20157321|NCT00545779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20157322|NCT01542788|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20157323|NCT02918942|Grace Medical, Inc.|Robert Stroup|901-386-0990|robert.stroup@gracemedical.com|
20157324|NCT03586973|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
20170939|NCT00928395|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
20157325|NCT01150357|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
20170940|NCT04021771|Thomas Jefferson University|Dr. Kristin Rising|215-503-5507|Kristin.Rising@jefferson.edu|
20170941|NCT01977794|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20170942|NCT01895062|5i Sciences|Dr. Richard Rose|858-759-2205|rrose@5isciences.com|
20170943|NCT00533897|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
20170944|NCT02515825|AUM Cardiovascular|Marie Johnson, PhD|612.799.2511|mariej@aumcv.com|
20170945|NCT00713323|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20170946|NCT01925677|University of Maryland, Baltimore|Dr. Rolf Barth|4103286020|rnbarth@som.umaryland.edu|4103286020
20170947|NCT00506662|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20170948|NCT00491075|U.T. MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|guclinicaltrials@mdanderson.org|
20170949|NCT01603355|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
20170950|NCT03792191|Mansoura University|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
20170951|NCT03423082|University of Pittsburgh|Nghi C. Nguyen, MD, PhD|412-647-0104|nguyennc@upmc.edu|
20170952|NCT00246753|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20170953|NCT03921073|Moffitt Cancer Center|Dr. John Mullinax|813-745-1867|John.Mullinax@moffitt.org|
20170954|NCT00270790|University of Maryland School of Medicine|Mohan Suntharalingam|410-328-2328|msuntha@umm.edu|
20170955|NCT03019185|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20170956|NCT02764333|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner, MD|848-225-6530|konnerj@MSKCC.ORG|
20170957|NCT03355365|Tisch MS Research Center of New York|Saud Sadiq|212-265-8070|ssadiq@tischms.org|
20170958|NCT04622306|Sagami|Mr Grant R Burt|+33 607 54 52 41|grantburt@sagami-europe.com|
20170959|NCT00617851|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
20170960|NCT01200524|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
20170961|NCT02758132|University of Hawaii Cancer Center|Stacy Mercado|8084404561|smercado@cc.hawaii.edu|
20170962|NCT00723580|Child Psychopharmacology Institute|Bill J. Duke, Ph.D.|701-241-9281|bduke@ChildPsychopharmacologyInstitute.org|2
20170963|NCT00491764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20170964|NCT01601132|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20170965|NCT00354887|UT MD Anderson Cancer Center|Robert Wolff, MD / Professor|713-792-2828|mjlim@mdanderson.org|
20170966|NCT02110238|Seikagaku|Junko Takamura||junko.takamura@seikagaku.co.jp|
20170967|NCT01024335|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
20170968|NCT03273543|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
20170969|NCT01479478|Stanford University|Dr. Natali Aziz, MD|650-725-5720|mfmresearch@stanford.edu|
20170970|NCT00697788|Mass General Hospital for Children|Erik Shank, MD|6177242250|eshank@partners.org|
20170971|NCT03228433|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20170972|NCT00689078|ORA|Paul Gomes|9786858900|pgomes@oraclinical.com|
20170973|NCT03055156|Stanford University|Dr. Seiji Nishino|650-725-8602|nishino@stanford.edu|
20170974|NCT03289858|University of Massachusetts, Worcester|Eric Swart|503-880-7125|eric.swart@umassmemorial.org|
20170975|NCT04269707|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
20170976|NCT01365052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20170977|NCT00074984|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
20170978|NCT03080454|Feinstein Institute for Medical Research at Northwell Health|Bruce Volpe|516-562-3384|bvolpe1@northwell.edu|
20170979|NCT02202980|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20170980|NCT01216761|University of Michigan Health System|Laraine Washer, MD|734-936-5205|laraine@med.umich.edu|
20170981|NCT04138810|University of Pennsylvania, Department of Urogynecology|Dr. Lily Arya|215-662-4147|larya@pennmedicine.upenn.edu|
20170982|NCT01869439|WoundVision LLC|Dr. James G. Spahn, M.D.|(317) 775-6080|brett@woundvision.com|
20170983|NCT00624234|Vanderbilt University|Dr. Laurie Cutting|615-875-1054|Laurie.Cutting@Vanderbilt.Edu|
20170984|NCT00914485|Southeast Louisiana Veterans Health Care System|P. Adam Kelly, PhD, MBA|504-988-6630|peter.kelly@va.gov|
20170985|NCT02939079|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
20170986|NCT04093414|Beaumont Hospitals|Diedre Brunk|248-898-5580|Diedre.Brunk@beaumont.org|
20170987|NCT04889222|Masimo Corporation|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
20170988|NCT00116428|Biosense Webster|Melissa Schultz, Project Manager, Regulatory Affairs|800-729-9010|mschult1@its.jnj.com|8787
20170989|NCT00113087|New England Research Institute|Lynn Sleeper|617-972-3235|lsleeper@neriscience.com|
20170990|NCT03452228|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20170991|NCT00386607|Novartis Pharmaceuticals|Study Director|862-778-8300||
20170992|NCT03488355|Memorial University of Newfoundland|Dr. Peter Daley|7097772089|pkd336@mun.ca|
20157326|NCT01770743|Emergent BioSolutions|Dr. Gurdyal Kalsi|301-216-9927|kalsig@ebsi.com|
20157327|NCT01585025|Imperial College London|Prof Julian Walters|+442033132361|julian.walters@imperial.ac.uk|
20157328|NCT02336815|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20157329|NCT00952705|MedImmune, LLC|JA Sliman, MD, MPH, Director, Clinical Development|301-398-0000|SlimanJ@medimmune.com|
20157330|NCT00140140|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20157331|NCT03376516|Octapharma AG|Sylvia Werner|604-1149|sylvia.werner@octapharma.com|+1 (201)
20157332|NCT01581684|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157333|NCT00598650|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
20170993|NCT00338104|Northwestern University|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
20157334|NCT02250417|The Ohio State University|Ulysses J. Magalang|614-292-6563|magalang.1@osu.edu|
20157335|NCT01128569|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157336|NCT02941614|Kaiser Permanente Southern California Department of Research and Evaluation|Erin Hahn|626-564-3505|Erin.E.Hahn@kp.org|
20170994|NCT03476278|Derince Eğitim Ve Araştırma Hastanesi|Dr. Hande Aytuluk|5336515650|handegrbz@gmail.com|
20157337|NCT02468830|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
20157338|NCT01865487|Aeras|Dr. Dereck Tait|27214424991|dtait@aeras.org|
20157339|NCT01213082|University of California Davis|Susanna Park, MD|9167346074|sscpark@ucdavis.edu|
20157340|NCT00129285|University of Pennsylvania Treatment Research Center|Kyle Kampman|215-746-2764|kampman@mail.med.upenn.edu|
20157341|NCT01627691|Boston Scientific|Anne Cornaille|+33608863659|anne.cornaille@bsci.com|
20157342|NCT00859833|Univesity of Utah|Sheldon Litwin|801-581-7715|sheldon.litwin@hsc.utah.edu|
20157343|NCT01307449|Emory University|Rouphael, Nadine|404-712-1435|nroupha@emory.edu|
20170995|NCT00633750|Vanderbilt-Ingram Cancer Center|Carlos Arteaga, M.D.|(615) 936-1919||
20170996|NCT03000569|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20170997|NCT02298023|, Seoul National University Hospital|Dr. Sun G. Chung|+82-2-2072-2560|chung60611@gmail.com|
20157344|NCT03218917|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@Insmed.com|
20170998|NCT03320057|University of California San Francisco|Shelly Kaller|510-986-8945|shelly.kaller@ucsf.edu|
20157345|NCT00534001|Roswell Park Cancer Institute|Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
20157346|NCT03440008|VA Puget Sound Health Care System|Dr. Joseph Iaquinto|206-277-1738|Joseph.Iaquinto@va.gov|
20157347|NCT04700423|Swiss TPH|Prof. Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
20157348|NCT02958345|Tulane University|Dr. Luis Balart|504-988-3047|lbalart@tulane.edu|
20157349|NCT00760552|Iowa City VA Health Care System|Dr. Gary Rosenthal|319-338-0581|gary-rosenthal@uiowa.edu|
20157350|NCT03398330|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
20157351|NCT03261830|UMissouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
20170999|NCT02323113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20157352|NCT01918189|VA Boston Healthcare System|Diana M. Higgins, PhD|857-364-2221|diana.higgins2@va.gov|
20171000|NCT00403234|Purdue Pharma L.P.|Clinical Leader, Director of Clinical Research|800-733-1333||
20157353|NCT03323164|Wills Eye Hospital|Dr. Daniel Lee|12159283197|daniellee@willseye.org|
20157354|NCT01823289|Department of Respiratory Medicine, SHANGHAI First People's Hospital Affiliated to SHANGHAI JiaoTong University|Director of Respiratory Department|86-21-63071428|xzhou53@163.com|
20157355|NCT01736917|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20157356|NCT01259011|Emory University|Dr. Mi-Kyung Song|404-727-3134|mi-kyung.song@emory.edu|
20157357|NCT01911260|Federal University of Sao Paulo|Ana Paula Poblacion|+55 11 55391783|anapoblacion@yahoo.com.br|
20171001|NCT00316719|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157358|NCT01951391|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
20157359|NCT00956293|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
20157360|NCT01240863|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
20171002|NCT00690274|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
20202370|NCT02333331|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
20202371|NCT00728507|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
20157361|NCT02579811|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|1-866-223-8100|TaussigResearch@ccf.org|
20202372|NCT00430781|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202373|NCT05134974|Ocuphire|Drey Coleman, VP of Clinical Operations|813-404-1993|dcoleman@ocuphire.com|
20202374|NCT02158533|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
20202375|NCT01092442|CryoLife, Inc.|Scott B. Capps, MS|800-438-8285|clinicaltrialregistration@cryolife.com|
20202376|NCT00320671|Northwell|Delbert Robinson MD|718.470.8195|drobinson@nshs.edu|
20202377|NCT02037919|Family Planning Associates Medical Group , Ltd.|Allison A. Cowett, MD MPH|312-707-8988|aacowett@gmail.com|
20202378|NCT00345605|Baylor College of Medicine|Dr. Sandesh Nagamani||nagamani@bcm.edu|
20157362|NCT01816984|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
20157363|NCT05899829|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20157364|NCT00867035|Department of Orofacial Sciences, University of California, San Francisco|Milton Robert Wirthlin, DDS, MS|415-476-1731|m.robert.wirthlin@ucsf.edu; ddsmmr@att.net|
20171003|NCT02468674|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20202379|NCT01335971|Johns Hopkins University School of Medicine|Alexis Rea|(443) 287-8496|area5@jhu.edu|
20202380|NCT00384956|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
20202381|NCT03126227|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20202382|NCT04281537|Amicus Therapeutics, Inc.|Patient Advocacy|001 6096622000|clinicaltrials@amicusrx.com|
20202383|NCT03230097|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202384|NCT03056287|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
20202385|NCT05740813|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
20202386|NCT00609271|Tulane University|Dr. Lydia Bazzano|5049887323|lbazzano@tulane.edu|
20202387|NCT02439775|Medtronic|Elishea Argent, Sr. Clinical Research Specialist|(763)505-9584|elishea.n.argent@medtronic.com|
20202388|NCT04168203|BWH|Physician|6177326984|gpiazza@bwh.harvard.edu|
20202389|NCT00635102|Yale University School of Medicine|Dr John Krystal|203-785-6396|john.krystal@yale.edu|
20157365|NCT02993263|Cleveland Clinic|Daniel Sessler, MD|216-444-9400|sesslers@ccf.org|
20157366|NCT01347060|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157367|NCT01405196|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202390|NCT01241539|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202391|NCT00440401|Medical Scientific Strategy|Medical Responsible|+45 4677 1111|clinicaltrials@nycomed.com|
20202392|NCT00058370|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
20202393|NCT01238120|University of Rochester Medical Center|Michelle C. Janelsins, PhD, MPH|(585) 276-4656|Michelle_Janelsins@urmc.rochester.edu|
20202394|NCT00881205|Novartis Pharmaceuticals|Study Director|862-778-8300||
20202395|NCT02888626|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
20202396|NCT01330290|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
20202397|NCT02498652|Study Information Center AstraZeneca|Jesse Hall, MD|(877) 240-9479|information.center@astrazeneca.com|
20202398|NCT00780403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20202399|NCT00845429|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20202400|NCT01161225|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
20202401|NCT00213239|The Hospital for Sick Children, Department of Anesthesia and Pain Medicine|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
20202402|NCT00587223|Organogenesis Inc.|Director of Clinical Operations||kgiovino@organo.com|
20202403|NCT00195351|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20202404|NCT02111369|Emory University|Dr. Michael Johns|323-865-9839||
20202405|NCT01233726|Intensive Care Unit, Hospital Clínico Universitario|Alfonso Mesejo|961 97 35 00|mesejo_alf@gva.es|
20202406|NCT03959189|Expansion Therapeutics, Inc.|Chief Medical Officer|858-764-4290|info@expansionrx.com|
20202407|NCT04332419|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ram Gurajala, MD|1-866-223-8100|TaussigResearch@ccf.org|
20202408|NCT04323488|Stanford University|Jason Yeatman, PhD|(650) 321-7553|jyeatman@stanford.edu|
20202409|NCT03256539|University of California, San Francisco|Dr. Yue Leng|415 502 2949|yue.leng@ucsf.edu|
20202410|NCT00828451|Washington University|Aaron Hamvas, MD|314-454-6148|hamvas@kids.wustl.edu|
20202411|NCT02827877|City of Hope Medical Center|Dr. Joanne Mortimer|626-359-8111|jmortimer@coh.org|
20202412|NCT05755438|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20202413|NCT06027593|Children's Hospital of Philadelphia|Kathleen Chiotos|267-426-7729|chiotosk@chop.edu|
20202414|NCT01548638|University of Pennsylvania Perelman School of Medicine|Dr. Rebecca Ashare|2157465789|rlashare@mail.med.upenn.edu|
20202415|NCT05917288|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20202416|NCT03476850|Medical University of South Carolina|Eric Bolin, MD|8437921869|bolin@musc.edu|
20202417|NCT04037085|UPMC|Grace Lim, MD, MSc|412-641-1110|limkg2@upmc.edu|
20202418|NCT02049502|Emory University|Dr. Shaffer|404-778-5033|virginia.o.shaffer@emory.edu|
20202419|NCT03872427|The University of Texas MD Anderson Cancer Center|Dr. Funda Meric-Bernstam|(713) 794-1226|fmeric@mdanderson.org|
20202420|NCT01294228|Alere San Diego|Director of Clinical Affairs|1-858-805-4808|william.arnold@alere.com|
20202421|NCT01919411|Massachusetts Eye & Ear Infirmary|Dr. Eric Holbrook|617-573-3209|Eric_Holbrook@meei.harvard.edu|
20202422|NCT00144300|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202423|NCT01031095|Bursa Postgraduate Hospital|Dr.Hasan ARI|00902243605050|hasanari03@yahoo.com|1739
20202424|NCT03478683|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20202425|NCT05493280|UT Southwestern|Lead Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
20202426|NCT01332435|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202427|NCT01382186|Center of Innovation on Disability and Rehabilitation Research|Dr. Jolie Haun|813-558-7622|jolie.haun@va.gov|
20202428|NCT02742649|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20202429|NCT03348683|Icahn School of Medicine at Mount Sinai|Dr. Catherine A Bigelow|651-206-9069|cassie.bigelow@gmail.com|
20202430|NCT01709799|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
20202431|NCT04573777|UCaliforniaLA|David Liebeskind|‭(310) 963-5539‬|dliebeskind@mednet.ucla.edu|
20202432|NCT03167619|Duke Clinical Research Institute|Senior Biostatistician|919-668-8052|lilin.she@duke.edu|
20202433|NCT00678496|University of Sheffield|Daniel Hind, Assistant Director, Sheffield CTRU|+441142220707|d.hind@sheffield.ac.uk|
20202434|NCT02927223|Vanderbilt University Medical Center|Dr. Prince Kannankeril|615-322-7447|prince.kannankeril@vumc.org|
20157368|NCT01356147|Stanford University School of Medicine/Division of Neonatology|Dr. Melissa Scala|650-724-9653|mscala@stanford.edu|
20202435|NCT01348919|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20202436|NCT00812110|Akron Children's Hospital|P. Cooper White, M.D.|330-543-8530|CWhite@chmca.org|
20171004|NCT00956020|NYEEI Department of Otolaryngology|Anthony Sclafani, MD|212-979-4200|asclafani@nyee.edu|
20171005|NCT03281577|Takeda|Medical Director|+1-877-825-3327|takedadisclosures@takeda.com|
20171006|NCT01644565|Enteric Diseases Department, Naval Medical Research Center|Ramiro L. Gutierrez, MD, MPH|301-319-3193|ramiro.gutierrez@med.navy.mil|
20171007|NCT01550289|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20171008|NCT02975336|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20171009|NCT01897454|NYU Langone|Dr. Jennifer Chuy|646-501-0194|jennifer.chuy@nyulangone.org|
20171010|NCT04015336|National Cancer Institute|Dr. Scott Norberg, D.O.|301-275-9668|scott.norberg@nih.gov|
20171011|NCT00591344|Northwestern University|Daniel Corcos, PhD|708-214-5454|daniel.corcos@northwestern.edu|
20171012|NCT03779711|Mayo Clinic|Clint Hagen|(507) 577-1764|hagen.clint@mayo.edu|
20171013|NCT05981391|The University of Texas Health Science Center at San Antonio|Dr. John Moring|210-562-6716|moringj@uthscsa.edu|
20171014|NCT04460937|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
20171015|NCT04515394|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20171016|NCT00413244|Icahn School of Medicine at Mount Sinai|Dr. Mary Ann McLaughlin|(212) 241-3340|maryann.mclaughlin@mountsinai.org|
20171017|NCT02653872|AstraZeneca AB|AZD7986 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
20171018|NCT01058655|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942||
20171019|NCT03881670|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
20171020|NCT00619177|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171021|NCT01609231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171022|NCT01180647|NYU School of Medicine|Joshua D. Lee|212-263-4242|joshua.lee@nyumc.org|
20171023|NCT04873700|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20171024|NCT01044706|Kremers Urban Development Company|Bang Qian Xu, Ph.D., Director of Biopharmaceutics|812-523-5453|Bang.xu@ucb.com|
20171025|NCT01485393|MGH|Dr. Johnson-Akeju|6177247200|ojohnsonakeju@partners.org|
20171026|NCT01561378|Montefiore Medical Center|Daniel Ceusters|718-920-2956|dceuster@montefiore.org|
20171027|NCT03783975|University of Maryland Baltimore|Dr. Amber Beitelshees|410-706-0118|abeitels@som.umaryland.edu|
20171028|NCT02761733|Felton Institute & Palo Alto University|Joyce Chu (Principal Investigator)|650-814-8376|jchu@paloaltou.edu|
20171029|NCT02713204|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
20171030|NCT01222884|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
20171031|NCT03998566|Boston Scientific|Jeya Satheesh|6124490870|jeya.satheesh@bsci.com|
20171032|NCT03800173|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
20171033|NCT02572609|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171034|NCT04569253|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
20171035|NCT04206800|Boston IVF|Kristin Rooney|781-434-6470|krooney@bostonivf.com|
20171036|NCT01713608|Medicines for Malaria Venture|Dr Fiona Macintyre|+41 22 799 4078|macintyref@mmv.org|
20171037|NCT03505190|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20171038|NCT01903031|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20171039|NCT01811225|University of Minnesota|Dr. Sharon Allen|612-624-2446|allen001@umn.edu|
20171040|NCT00287365|University of North Carolina at Chapel Hill|David B. Peden, MD, MS|919-966-0768|dpeden@med.unc.edu|
20171041|NCT00569270|Arthur F Gelb MD|Arthur F Gelb MD Principal Investigator|562-633-2204|afgelb@msn.com|
20171042|NCT01811680|Tan Tock Seng Hospital|Dr Karen Chua|65 68894580|karen_chua@ttsh.com.sg|
20171043|NCT00447005|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171044|NCT00492531|Professor of Medicine: Chief, Pulmonary, Allergy and Critical Care Medicine: Director, Hemostasis and Vascular Biology Research Institute; University of Pittsburgh School of Medicine|Mark Gladwin|412-692-2117|gladwinmt@upmc.edu|
20171045|NCT01469234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20202437|NCT03215914|University of Pennsylvania|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
20202438|NCT01389128|University of São Paulo|Dr. Silvana Maria Quintana|+55(16)36022813|quintana@fmrp.usp.br|
20202439|NCT05299892|Hearts For Hearing|Sara Neumann, AuD|405-548-4300|sara.neumann@heartsforhearing.org|
20202440|NCT03180736|EMN|Sarah Lonergan, Trial lead|+44 7767565020|sarah.lonergan@emn.life|
20202441|NCT01059812|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20202442|NCT01518530|Hillel Yaffe Medical Center|Dr. Yaron River|972-523-756-446|yaronr@hy.health.gov.il|
20202443|NCT00149214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20202444|NCT00467844|GTx Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
20202445|NCT00756002|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20202446|NCT01538615|University of Minnesota School of Nursing|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
20202447|NCT00290472|University of Chicago Comprehensive Cancer Center|Dr. Sonali M. Smith|7738342895|smsmith@medicine.bsd.uchicago.edu|
20202448|NCT00174941|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20202449|NCT04329923|UPenn|Amelia Anderson|215-509-5690|amelia.anderson@pennmedicine.upenn.edu|
20202450|NCT00003820|Stanford University|Ranjana Advani, MD, Professor of Lymphoma|650-725-6456|radvani@stanford.edu|
20171046|NCT00601198|University of Cincinnati|Alison Kastl, Director of Clinical Trials|813-584-0436|kastla@ucmail.uc.edu|
20171047|NCT01682954|Ohio State University|Dr. Carla Miller|614-292-1391|miller.4453@osu.edu|
20171048|NCT00579137|Baylor|Robert Krance, MD|832-824-4661|rkrance@bcm.edu|
20171049|NCT01187433|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20171050|NCT00302107|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-2000|lori.davis@va.gov|
20171051|NCT00437983|Sourazky Tel-Aviv Medical Center|Prof. A. Korczyn|972-3-6974229|amosk@tasmc.health.gov.il|
20171052|NCT01790932|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|nlin@partners.org|
20171053|NCT00144391|Charles R. Drew University of Medicine and Science|Dr. Theodore Friedman|310-668-5197|theodorefriedman@cdrewu.edu|
20171054|NCT04223973|Medtrum France|Mrs Melanie MARMOUNIER-WILHLEM- Commercial DIrector|+33620591224|melanie.marmounier@medtrum.com|
20171055|NCT00880997|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
20171056|NCT01267045|VA Puget Sound Health Care System|David J. Kearney, MD|206-277-1445|David.Kearney@VA.gov|
20171057|NCT04721171|Medical College of Wisconsin|Thangam Venkatesan|262-226-9632|tvenkate22@gmail.com|
20171058|NCT00594659|Geisel School of Medicine at Dartmouth College|Alan J. Budney, PhD Principal Investigator|855-290-2822|Alan.J.Budney@dartmouth.edu|
20171059|NCT00300274|Novartis Pharmaceuticals|Study Director|862-778-8300||
20171060|NCT00242216|The University of Texas Health Science Center at Houston|Dr. Roberto C. Arduino, Professor of Medicine|713-500-6731|roberto.c.arduino@uth.tmc.edu|
20171061|NCT00394147|University of Maryland|Dr. Ranee Mehra|410-328-7904|rmehra@umd.edu|
20171062|NCT00678080|UT Health|Dr. Jerrie Refuerzo, M.D.|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
20171063|NCT03569618|University of California, San Francisco|Riley Bove, MD MSc|415.502.7209|riley.bove@ucsf.edu|
20171064|NCT03105479|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
20171065|NCT04439201|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
20171066|NCT00814970|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
20171067|NCT05154578|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
20171068|NCT03930680|University of Arkansas for Medical Sciences|Hui-Ming Chang, MD, MPH|501-686-7575|hchang@uams.edu|
20171069|NCT03260881|University of Miami Miller School of Medicine|Dr Gianluca Iacobellis MD PhD Professor of Medicine|3052433636|giacobellis@med.miami.edu|
20171070|NCT00894166|Duke University Medical Center|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
20171071|NCT05350410|Alzheimer's Disease Cooperative Study|Sara Moukarzel, PhD, Program Manager|(858) 432-8828|smoukarzel@health.ucsd.edu|
20171072|NCT00815698|Herlev Hospital, dept. of Surgery|Jacob Rosenberg|+45 26237323|jacob.rosenberg@regionh.dk|
20171073|NCT02432742|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20171074|NCT00142935|The Miriam Hospital/Brown University|Josiah D. Rich, MD, MPH|401-793-4770|jrich@lifespan.org|
20171075|NCT01180985|Johnson & Johnson Vision Care|John Buch, OD, MS, FAAO|1 904 443-1707|jbuch@its.jnj.com|
20171076|NCT00705289|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20171077|NCT01030536|MedImmune LLC, Milstein Building, Granta Park, Cambridge, CB21 6GH, United Kingdom|Edward Bradley, MD|+44 (0)1223 895997||
20171078|NCT00129272|The University of Tennessee|Uma Rao, MD|615-794-3351|urao@utk.edu|
20171079|NCT03473171|The University of Texas Health Science Center at Houston|James M. Stark, MD|713-500-5650|James.M.Stark@uth.tmc.edu|
20171080|NCT01550731|Veterans Administration|Dr. Rebecca Sudore|(415) 221-4810|Rebecca.Sudore@va.gov|23475
20171081|NCT02601027|Stanford University|Gordon Kwanlyp Lee, Professor of Surgery (Plastic and Reconstructive Surgery)|650-723-5824|glee@stanford.edu|
20171082|NCT01419626|Johnson & Johnson Consumer and Personal Products Worldwide|DIRECTOR ORAL HEALTH, MEDICAL AFFAIR & CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20171083|NCT01146912|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
20171084|NCT02577549|Wake Forest University|Dr. Stephen Messier|336-758-5849|messier@wfu.edu|
20171085|NCT02248701|North Florida/South Georgia Veterans Health System|Joshua Yarrow, MS, PhD|(352) 548-6477|Joshua.Yarrow@va.gov|
20171086|NCT01145625|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
20171087|NCT04289623|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
20171088|NCT01952145|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
20171089|NCT01101880|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
20171090|NCT03863197|KU Leuven|Dr. Britta Hanssen|+3216341295|britta.hanssen@kuleuven.be|
20171091|NCT01065597|Department of Psychiatry, University of Maryland School of Medicine|William T. Regenold, MDCM|410-328-6511|wregenol@psych.umaryland.edu|
20171092|NCT01622231|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171093|NCT02509767|Planned Parenthood Federation of America|Julia Kohn|2122614636|julia.kohn@ppfa.org|
20171094|NCT04545554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20171095|NCT00494299|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20171096|NCT01986907|Novartis Pharmaceuticals|Study Director|+41613241111|trialandresults.registries@novartis.com|
20171097|NCT02635776|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20171098|NCT00788073|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
20171099|NCT03608254|The University of Alabama|Dr. Amy Ellis|2053488128|aellis@ches.ua.edu|
20171100|NCT03208127|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|chung.raymond@mgh.harvard.edu|
20171101|NCT00660673|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20171102|NCT03685123|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
20171103|NCT03451578|Duke Eye Center|Dr. Sharon Fekrat|919-681-3937|sharon.fekrat@duke.edu|
20171104|NCT00400764|Hoffman-LaRoche|Medical Communications|800-821-8590||
20202451|NCT00981435|Stanford University|Clinical Research Coordinator|6507236995|mnunez1@stanford.edu|
20157369|NCT04704193|Massachusetts General Hospital|Daniel Chung, MD|617-726-8687|chung.daniel@mgh.harvard.edu|
20157370|NCT00542178|Wake Forest University School of Medicine|Dr. Walter Ambrosius, PhD|336-716-6281|wambrosi@wakehealth.edu|
20157371|NCT03449576|Rehabilitation Research & Development|Dr. Shirley Groer (Scientific Program Manager)|202-553-9899|shirley.groer@va.gov|
20157372|NCT02611037|Moffit Cancer Center|Bela Kis, MD, PhD|813-745-8425|Bela.Kis@Moffitt.org|
20157373|NCT00829998|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20157374|NCT00834197|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20157375|NCT05270863|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
20157376|NCT04712669|Sumitomo Pharma America|Ravi Grewal|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
20157377|NCT04577404|Mitsubishi Tanabe Pharma America Inc.|Clinical Trials, Information Desk|908-607-1980|information@mt-pharma-us.com|
20157378|NCT04066829|University of Michigan|Kao-Ping Chua|(734) 615-8169|chuak@med.umich.edu|
20157379|NCT00775671|Vanderbilt University|Nancy J Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
20157380|NCT00163293|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20157381|NCT02051426|Herzog Hospital|Uriel Heresco-Levy, M.D.|+972-2-5316906|urielh@ekmd.huji.ac.il|
20157382|NCT03198871|University of Pittsburgh School of Medicine / UPMC|Dr. Kathirvel Subramaniam MD MPH FASE|7247995852|subramaniamk@upmc.edu|
20157383|NCT00652743|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157384|NCT03233828|Nova Scotia Health|Principal Investigator|9024736177|carman.giacomantonio@nshealth.ca|
20157385|NCT02495285|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
20157386|NCT00503984|University of Miami|Rakesh Singal MD|305-243-9544|rsingal@med.miami.edu|
20157387|NCT01246960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20157388|NCT03430349|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
20157389|NCT02122380|Vanderbilt University Medical Center|Dr. Jessica Devin|970-875-2708|jessica.devin@vumc.org|
20157390|NCT00716820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157391|NCT04102007|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20157392|NCT05173974|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
20157393|NCT03289143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157394|NCT00730756|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157395|NCT00948688|Massachusetts General Hospital|Lawrence S. Blaszkowsky, M.D.|617-219-1230|lblaszkowsky@mgh.harvard.edu|
20157396|NCT01152307|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
20157397|NCT00524121|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20157398|NCT01840943|Xian Janssen Pharmaceutical LTD|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
20157399|NCT01446874|Washington University School of Medicine|Varun Puri, M.D.|314-362-4191|varunpuri@wustl.edu|
20157400|NCT01135992|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20157401|NCT01977898|Northwestern University|Feyce Peralta, MD|312-472-3585|f-peralta@northwestern.edu|
20157402|NCT05130593|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
20157403|NCT01453166|Instituto de Ensino e Pesquisa do Hospital do Coração|Dr. Otavio Berwanger|+ 55 11 30536677|oberwanger@hcor.com.br|8201
20157404|NCT01049373|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiss|0049/641/7960-0|klinischeforschung@pascoe.de|
20157405|NCT01693367|AO Foundation|Clinical Operations Manager of Clinical Investigation and Documentation|0041 44 200 24 67|andreas.faeh@aofoundation.org|
20157406|NCT03610048|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
20157407|NCT01155050|PenningtonBRC|Ronald Horswell|225-763-2931|Ronald.Horswell@pbrc.edu|
20157408|NCT02136914|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
20157409|NCT04136145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20157410|NCT00329030|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
20157411|NCT00325143|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157412|NCT02286895|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20157413|NCT03036852|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20157414|NCT00991809|Johns Hopkins University, School of Medicine|Dr. D. Andrew Tompkins|410-550-5953|dtompki1@jhmi.edu|
20157415|NCT00399035|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20157416|NCT01987414|University of Minnesota|Chih-Huang Yu|6126262443|yuxxx648@umn.edu|
20157417|NCT01999192|Biotest AG|Xuefei Zhou Manager Strategy & Development|+496103801|xuefei_zhou@biotest.de|1229
20157418|NCT02949011|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20157419|NCT02441218|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
20157420|NCT01541371|CDMA, Beijing|Therapeutic Area Manager|00861058218352||
20157421|NCT01131052|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20157422|NCT00163189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157423|NCT03435380|Duke University|Kevin Oeffinger, MD|919-668-2122|kevin.oeffinger@duke.edu|
20157424|NCT03338400|Cleveland Clinic Florida|Dr. David Ossin|954-659-5559|ossind@ccf.org|
20157425|NCT00383071|SAIC/National Institute of Allergy and Infectious Diseases|John Beigel, M.D.|+1 301 451 9881|jbeigel@niaid.nih.gov|
20157426|NCT01531998|University of Texas (UT) MD Anderson Cancer Center|Jatin J. Shah, MD/Associate Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
20171105|NCT04584970|University of North Carolina at Chapel Hill|Jacob Nelson|704-677-3801|jacob14@live.unc.edu|
20171106|NCT00737243|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
20171107|NCT00621959|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
20171108|NCT01758523|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
20171109|NCT01893203|Helsinki university hospital|Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
20171110|NCT00722800|MGH|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
20171111|NCT02850601|BWH|Dr. Herve Sroussi|617 5256864|hsroussi@bwh.harvard.edu|
20171112|NCT02925117|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20171113|NCT01533077|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20171114|NCT02130297|Icahn School of Medicine at Mount Sinai|Dr. Hooman Khorasani|347-574-8500|hooman.khorasani@mountsinai.org|
20171115|NCT00347360|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171116|NCT02050841|Octapharma|Michael Eppolito|2016041155|michael.eppolito@octapharma.com|
20171117|NCT01449539|University of Arkansas for Medical Science-MIRT|Sarah Waheed, MD|501-686-8230|mirt@uams.edu|
20171118|NCT05004077|University of Kentucky|Dr. Kevin Hatton|859-218-0365|kevin.hatton@uky.edu|
20171119|NCT01387789|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20171120|NCT02187744|Pfizer, Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171121|NCT02358681|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
20171122|NCT00828412|Promius Pharma|Joanne Fraser|908 429-4504|joannefraser@promiuspharma.com|
20171123|NCT00508755|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
20171124|NCT00945893|MedImmune, LLC|Raburn Mallory, MD Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
20171125|NCT03113071|Fox Chase Cancer Center|Dr. Henry Fung|215-728-2674|Henry.Fung@tuhs.temple.edu|
20171126|NCT01602120|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
20171127|NCT01540266|University Hospital Basel|Dr. med. Roland Bingisser|+41 61 265 58 30|roland.bingisser@usb.ch|
20171128|NCT00775346|Covidien|Manager, Clinical Affairs|303 305 2591|Norma.Prince@Covidien.com|
20171129|NCT02012283|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
20202452|NCT03968965|Hospital for Special Surgery|Celeste Abjornson|2127742126|AbjornsonC@HSS.edu|
20202453|NCT01120639|Stanford University|Dr. Scott Soltys (Associate Professor of Radiation Oncology)|650-724-1569|sgsoltys@stanford.edu|
20202454|NCT01844076|Fox Chase Cancer Center|Crystal Denlinger MD, FACP|215-214-1676|Crystal.Denlinger@fccc.edu|
20202455|NCT05483127|Alcon Research, LLC|Associate Director, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
20202456|NCT02951273|Rigshospitalet|Niels D. Olesen|004520262459|niels.damkjaer.olesen.01@regionh.dk|
20202457|NCT00121225|Princess Margaret Cancer Centre|Dr. David Hogg|416-946-4501|david.hogg@uhn.ca|4521
20202458|NCT00315302|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
20202459|NCT01925703|University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science|Dr. Brent N. Reed||breed@rx.umaryland.edu|
20202460|NCT01938625|Janssen Research & Development|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
20202461|NCT01937312|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
20202462|NCT05309083|Washington University School of Medicine|Dr. Kerri Rawson|813-468-8900|rawson@wustl.edu|
20202463|NCT01165229|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202464|NCT00474253|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20202465|NCT01720251|ANERGIS SA|Dr Gilles DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
20202466|NCT00550238|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
20202467|NCT03133481|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
20202468|NCT02273115|University of Massachusetts - Baystate|Dr. Corina Schoen|4137543470|Corina.SchoenMD@baystatehealth.org|413
20202469|NCT01184989|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202470|NCT01570491|Cleveland Clinic|Daniel Sessler, MD|2164444900|sessled@ccf.org|
20202471|NCT01515072|Rutgers-New Jersey Medical School|Baburao Koneru, MD, MPH|(973) 972-9599|koneruba@njms.rutgers.edu|
20202472|NCT05370157|University of Pittsburgh|Dr. Elizabeth McGuier|412-246-5895|millerea3@upmc.edu|
20202473|NCT01508676|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
20202474|NCT03700892|University of North Carolina at Chapel Hill, Center for Environmental Medicine Asthma and Lung Biology|Assistant Director of Clinical Research|919 966-5638|robinet@med.unc.edu|
20202475|NCT00609128|University of Wisconsin-Madison|Jim Stahl, PhD|608-263-6177|jlstahl@wisc.edu|
20202476|NCT00849212|Eisai Call Center|Eisai Inc.|888-422-4743||
20202477|NCT04407507|Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V|Carmen de la Rocha|523320028697|carmen.delarocha@investigacionbiomedica.com.mx|306
20202478|NCT01499576|Konyang University Hospital|Dr. Kyung Ho SONG, Assistnat Professor of Konyang University||postit2@daum.net, postit@kyuh.ac.kr|
20202479|NCT03643692|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
20202480|NCT02228499|The George Washington University|Dr. Seema Agrawal|202 699 1648|seema300@yahoo.com|
20202481|NCT00971321|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202482|NCT00519623|Altea Therapeutics|Pei-Ling Roerig, Sr. Manager Clinical Research, Altea Therapeutics|404-835-6415|proerig@alteatherapeutics.com|
20202483|NCT04222725|Tarsier Pharma|Zohar Milman|+972-50-8371319|Zohar Milman <zohar@Tarsierpharma.com>|
20171130|NCT03298867|Horizon Pharma USA, Inc.|Suzy Hammel|866-479-6742|clinicaltrials@horizontherapeutics.com|
20171131|NCT05136690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171132|NCT03730012|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20171133|NCT06956170|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171134|NCT00885846|Bastyr University|Guan-Cheng Sun, PhD|425-602-3389|gsun@bastyr.edu|
20171135|NCT01540838|University of Helsinki, Children´s Hospital, Helsinki University Hospital|Dr. Okko Savonius, PhD candidate|+358456731185|okko.savonius@helsinki.fi|
20171136|NCT02130570|Brigham and Women's Hospital|Dr. Jeffrey L Schnipper, MD, MPH, FHM|617-732-7063|jschnipper@partners.org|
20171137|NCT04424888|Pendulum Therapeutics|James Bullard, PhD, Chief Technical Officer|(844) 912-2256|james.bullard@pendulum.co|
20171138|NCT00493025|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Rosalyn Juergens, MD.|410-908-7829|rjuerge1@jhmi.edu|
20171139|NCT01457573|Houston Methodist Hosptial System|Timothy Boone, MD, PhD, Principal Investigator|713-441-6455|tboone3@houstonmethodist.org|
20171140|NCT02100579|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
20171141|NCT01440452|Johns Hopkins Hospital|Daniel Becker|4108284629|db@inirehab.com|
20171142|NCT00071396|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Assistant Professor|713-745-4613|eharriso@mdanderson.org|
20202484|NCT03819140|University of California, San Francisco|Heather Huddleston|(415) 353-7475|Heather.Huddleston@ucsf.edu|
20171143|NCT03082261|Abbott|Robyn Capobianco|+15129343941|robyn.capobianco@abbott.com|
20171144|NCT02068027|BDSI|Vice President Clinical Operations|919-582-0294|twarneke@bdsi.com|
20171145|NCT01032174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171146|NCT01281137|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
20171147|NCT01581710|CHA UNIVERSITY|Dr. HAN, MAN YONG|82-31-780-6262|drmesh@gmail.com|
20171148|NCT01961362|National Jewish Health|Dr. Jeffrey J. Swigris|303-398-1621|swigrisj@njhealth.org|
20171149|NCT01313312|Ipsen Innovation|Medical Director, Neurology.||clinical.trials@ipsen.com|
20171150|NCT04295772|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171151|NCT02846324|Global Blood Therapeutics|Nick Vlahakis|1 650 8228756|nvlahakis@gbt.com|
20171152|NCT00147212|MGH Cancer Center|M. Dror Michaelson, MD PhD|6177261594|dmichaelson1@partners.org|
20171153|NCT01761175|CHU de Québec, Département d'Anesthésie-Réanimation de l'Hôpital de l'Enfant-Jésus|Dre Marie-Josée Nadeau|418 649-5807|marie-josee.nadeau@fmed.ulaval.ca|
20171154|NCT00932126|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171155|NCT02716805|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
20171156|NCT00066365|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20171157|NCT04288752|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
20171158|NCT00467857|Kimberly-Clark Health Care|Dr. Shu-Ping Yang|770-587-7267|Shu-Ping.Yang@kcc.com|
20171159|NCT00787761|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD, Principal Investigator|404-255-1930|abashey@bmtga.com|
20171160|NCT03576495|Brigham and Women's Hospital|Dr. Douglas S. Smink|617-983-7260|dsmink@bwh.harvard.edu|
20171161|NCT02867150|Optimal Health and Weight Center|Dr. Ellyn Levine M.D.|(619) 567-6914|dr.levine@teamtsfl.com|
20202485|NCT00658333|Novartis Pharmaceuticals|Study Director|862-778-8300||
20202486|NCT03519178|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202487|NCT02426086|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
20202488|NCT00524303|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202489|NCT00499915|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
20157427|NCT02604459|University of Missouri|Dr. Quinn Johnson|573-882-2568|johnsonql@health.missouri.edu|
20157428|NCT03259295|University of Florida|Juan Carlos Roig|352-273-8985|roigjc@peds.ufl.edu|
20157429|NCT01130337|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157430|NCT03886493|Johns Hopkins University School of Medicine|Kenneth Pienta, M.D.|410-502-3137|kpienta1@jhmi.edu|
20157431|NCT00181844|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
20157432|NCT00107276|SWOG|Study statistician|206-667-4623||
20157433|NCT03179761|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
20157434|NCT04661033|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
20157435|NCT02287779|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
20157436|NCT03498716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20157437|NCT00265850|Alliance for Clinical Trials in Oncology|Alan Venook, M.D.||Venook@cc.ucsf.edu|
20157438|NCT03139448|Vanderbilt University Medical Center|Koffi Kla, MD|615-343-9419|koffi.m.kla@vumc.org|
20157439|NCT01987557|WilfridLU|Matthew Lasswell|9056992087|lass3260@mylaurier.ca|
20157440|NCT02108288|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
20157441|NCT01991860|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|Gabrielfox@acaciapharma.com|
20157442|NCT01854528|AbbVie|Global Medical Information|800-633-9110||
20157443|NCT00518180|Novartis Vaccine and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
20157444|NCT04655157|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
20157445|NCT01419119|Umea University, Umeå, Sweden|Dr Margareta Norberg|+46702618614|margareta.norberg@umu.se|
20157446|NCT04881760|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157447|NCT01061528|University of Texas at Austin|Dr. Richard A. Brown|512-471-8584|brown2@utexas.edu|
20171162|NCT04203797|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20171163|NCT01216748|University of Miami|Matthias Salathe, MD|(305)243-2568|msalathe@med.miami.edu|
20171164|NCT00579098|Mayo Clinic|Paul A. Friedman, MD|507-255-2398|friedman.paul@mayo.edu|
20171165|NCT01254331|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20171166|NCT03638622|Massachusetts General Hospital, Boston|Tayyaba Hasan|617-726-6996|thasan@mgh.harvard.edu|
20171167|NCT01589978|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
20171168|NCT00098956|The Ottawa Hospital|Dr. Glenwood Goss|613-737-7700|ggoss@ottawahospital.on.ca|56708
20171169|NCT00516074|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20171170|NCT05213481|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20171171|NCT01216631|University of Leeds|Professor Philip Conaghan|+44 113 3924884|p.conaghan@leeds.ac.uk|
20171172|NCT03822182|AHNI Orthopedics|Brian Badman|3178328800|bbadman@gmail.com|
20171173|NCT01749631|AbbVie|Global Medical Information|800-633-9110||
20171174|NCT01612858|Tufts Medical Center|Rakhi Kohli MD MS|617-636-4709|rkohli@tuftsmedicalcenter.org|
20171175|NCT01484275|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20171176|NCT03407625|University of Texas Southwestern Medical Center|Emily Adhikari, MD|214-648-7825|emily.adhikari@utsouthwestern.edu|
20171177|NCT00657358|UAB|Dr. Michael Froelich|205-975-0145|froelich@uab.edu|
20171178|NCT00515411|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
20171179|NCT03558087|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
20171180|NCT03943160|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
20171181|NCT00913380|Seoul National University Bundang Hospital|Kyoung Ho Lee|82-31-787-7607|kholeemail@gmail.com|
20171182|NCT00134030|MRC Clinical Trials Unit at UCL|Prof Matt Sydes||mrcctu.euramos@ucl.ac.uk|
20171183|NCT01788228|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171184|NCT01972568|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20171185|NCT00957580|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20171186|NCT01435603|Northwestern University|Research Project Manager|312-503-3359|emily.anderson1@northwestern.edu|
20171187|NCT02699593|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO -Sr. Principal Research Optometrist|904 443-1290|BPALL@its.jnj.com|
20171188|NCT00795145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20171189|NCT02556554|Regents of the University of Colorado|Sarit Polsky, MD, MPH|3037248575|sarit.polsky@ucdenver.edu|
20171190|NCT01696071|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171191|NCT02764697|Tampa Bay Uveitis Center, LLC|Dr. Grace Levy Clarke|855 798 8393|grace@tampabayuveitis.com|
20171192|NCT00074269|UCSD|Dr. Edward Ball, Director BMT Program|858-822-6600|tball@ucsd.edu|
20171193|NCT04547712|Medtronic Neuromodulation|Helen Berrier|763-526-8178|helen.berrier@medtronic.com|
20171194|NCT01995825|U of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
20171195|NCT01798004|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20171196|NCT04680052|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20171197|NCT01367002|Yale School of Medicine|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
20171198|NCT01516437|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171199|NCT02823431|Duke Biomedical Engineering|Warren Grill PhD|(919) 660-5276|warren.grill@duke.edu|
20171200|NCT00544466|City of Hope Medical Center|Dr. Jeffrey Wong, MD|6263598111|JWong@coh.org|
20171201|NCT01385566|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20202490|NCT01877655|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
20202491|NCT02798523|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Luis Franco|+1 240 220 4366|luis.franco@nih.gov|
20202492|NCT00095121|Gilead Sciences|John Flaherty, PharmD, Director, Clinical Research|650-522-5592|John.Flaherty@gilead.com|
20202493|NCT02677740|University of Minnesota|Silvia Mangia, Associate Professor|6126254920|mangia@umn.edu|
20202494|NCT04070378|The Feinstein Institutes for Medical Research|Marc L Gordon, MD|(516) 562-3492|mlgordon@northwell.edu|
20202495|NCT02293954|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20202496|NCT00443560|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
20202497|NCT02082184|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
20202498|NCT01197573|Cleveland Clinic|Bijan Eghtesad, MD|216 444-9898|eghtesb@ccf.org|
20202499|NCT00537940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202500|NCT05665335|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
20202501|NCT00623012|Yale University|Dr. Stuart Seropian|203-737-2477|Stuart.Seropian@yale.edu|
20202502|NCT01978912|Teijin America, Inc.|President|+1-212-308-8744|clinical-trials-safety@teijinpo.com|
20202503|NCT00416351|Memorial Sloan Kettering Cancer Center|Dr. Steven Horowitz MD|646-608-2680|horwitzs@mskcc.org|
20202504|NCT00077623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20202505|NCT00882713|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20202506|NCT04901026|Faculty of Medicine, Prince of Songkla University|Dr Pittayapon Pitathawatchai|+6674451390|pittayapon.p@psu.ac.th|
20202507|NCT00401973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171202|NCT00825682|Sheba Medical Center|Dr Dorit Gamus|+972-3-5303956|dorit.gamus@sheba.health.gov.il|
20171203|NCT01696084|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|2158709177|tom.chmielewski@jazzpharma.com|
20171204|NCT01925534|Tufts Medical Center|Dr. Nicholas Hill|(617) 636-6377|nhill@tuftsmedicalcenter.org|
20171205|NCT03811028|Sobi|Global Communication|+4686972000|info@sobi.com|
20171206|NCT00560105|VA WNY Health Care System|Dr. S. Sethy|716-862-7875|ssethi@buffalo.edu|
20171207|NCT02400333|AstraZeneca AB|Brilinta Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20171208|NCT01650844|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
20171209|NCT02785432|UT Southwestern|Jason Zafereo|146481002|jason.zafereo@utsouthwestern.edu|146481002
20171210|NCT02432729|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|christelle.haziza@pmi.com|
20171211|NCT03695250|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
20171212|NCT00539656|Johns Hopkins University School of Medicine|Allen Chen, MD,PhD,MHS|410-614-4434|chenal@jhmi.edu|
20171213|NCT00094172|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20171214|NCT01519271|University of Pennsylvania|Daniel Weintraub, MD|215-349-8207|Daniel.Weintraub@UPHS.UPENN.EDU|
20171215|NCT00993200|University of Utah|Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
20171216|NCT00289133|DePuy Orthopaedics, Inc.|Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
20171217|NCT01691339|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20171218|NCT00541931|Stanford University|Dr. Anne Chang, MD|(650)721-7151|alschang@stanford.edu|
20171219|NCT03513328|University of Florida|Biljana Horn, MD|352-273-9121|biljana.horn@ufl.edu|
20171220|NCT01947582|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
20171221|NCT00064337|SWOG Statistical Center|Study Statistician|206-667-4623||
20171222|NCT00612040|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20171223|NCT01539694|Bausch Health|Study Director||robert.steffen@bausch.com|
20171224|NCT00827502|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20171225|NCT02911857|Novartis Pharmaceuticals|Study Director|862-778-1873|Novartis.email@novartis.com|
20171226|NCT00899574|NYU Cancer Institute|Sylvia Adams, MD|212-263-6485|sylvia.adams@nyumc.org|
20171227|NCT02478632|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171228|NCT00002651|SWOG Statistical Center|Study Statistician|206-667-4623||
20171229|NCT03750955|University of Washington|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
20171230|NCT01705730|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20171231|NCT01773733|"FEDERAL STATE BUDGETARY INSTITUTION ENDOCRINOLOGY RESEARCH CENTRE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION"|Prof. Ivan I . Dedov, Director of the Endocrinology Research Centre|+7 499 124 4300|dedov@endocrincentr.ru|
20171232|NCT01315665|Riley Hospital for Children|James Chmiel|317-948-7180|jfchmiel@iu.edu|
20171233|NCT04755790|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
20171234|NCT02673138|Yale Pediatric Diabetes|Neha S. Patel, DO|203-764-6747|neha.patel@yale.edu|
20171235|NCT00880542|University of Calicornia Los Angeles (UCLA)|William Tap, MD|888-798-0719|wtap@mednet.ucla.edu|
20171236|NCT00762385|Vistakon|Kurt Moody, OD FAAO|904-443-3088||
20171237|NCT01781975|University of South Florida|Melissa Parker|8133969378|MELISSA.PARKER@EPI.USF.EDU|
20171238|NCT02329080|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
20171239|NCT04545060|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
20171240|NCT00973674|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
20171241|NCT00839852|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
20171242|NCT01704521|University of Cincinnati|Kenneth E. Sherman, MD. PhD|513-558-3918|kenneth.sherman@uc.edu|
20171243|NCT00120523|MEDA Pharma GmbH & Co. KG|Clinical Research|+49 6172 888|clinical.research@medapharma.de|01
20171244|NCT00784641|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20171245|NCT02640573|Baylor College of Medicine|Vivien Sheehan|832 824 4459|vsheehan@bcm.edu|
20171246|NCT01206166|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
20171247|NCT02605304|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20171248|NCT04010695|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
20171249|NCT03273270|Medical University of South Carolina|Gonzalo Revuelta|7927262|revuelta@musc.edu|
20171250|NCT00810355|Richard L. Roudebush VA Medical Center|Dr. Paul Lysaker|317-988-2546|paul.lysaker@va.gov|
20171251|NCT00003487|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20171252|NCT02197273|OhioHealth|Deborah Napier|614-566-5575|Deborah.Napier@ohiohealth.com|
20171253|NCT04154930|Galderma|Clinical Project Manager|817-961-5655|aestheticclinicaltrials@galderma.com|
20171254|NCT02628938|Riyadh Colleges of Dentistry and Pharmacy|Dr. Mohammad Rayyan|00966508821318|mohammadrayyan1979@gmail.com|
20171255|NCT02058693|Collaborative Behavioral Health|Michael Topel PsyD|847-922-3253|michaeltopel@gmail.com|
20171256|NCT00241358|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@wustl.edu|
20171257|NCT03855228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171258|NCT00843856|Imperial College NHS Trust|Dr Megan Griffith|02083835272|megan.griffith1@nhs.net|
20171259|NCT00590135|Cleveland Clinic|Brian Griffin MD|216-444-6812|Griffib@ccf.org|
20171260|NCT03104543|Fred Hutchinson Cancer Center|Dr. Eric Chow|206-667-7724|ericchow@uw.edu|
20171261|NCT02564497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20171262|NCT01219673|University of Texas (UT) MD Anderson Cancer Center|Dr. David Rosenthal Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
20171263|NCT03763175|MAST Program|Director of Clinical Trials|(310) 423-0617|GroupMedicineMAST@cshs.org|
20171264|NCT03698409|SUNY Upstate medical University|Assistant Profressor|3154644243|zidan@upstate.edu|
20171265|NCT00806351|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171266|NCT02059408|University of California, San Francisco|Carmen Peralta, Professor of Medicine|415-221-4810|carmenalicia.peralta@ucsf.edu|23678
20171267|NCT03351933|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
20171268|NCT01468675|Brigham and Women's Hospital|Jennifer Haas, M.D.|617-525-6652|jhaas@partners.org|
20171269|NCT01681472|Isofol Medical|Anders Rabbe|+46 (0)707 64 65 00|anders.rabbe@isofolmedical.com|
20171270|NCT01999179|Versiti|Dr Lisa Baumann Kreuziger|414-937-6826|lisakreuziger@versiti.org|
20171271|NCT01752985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
20171272|NCT05147428|UMass Chan Medical School|Jerry H. Gurwitz, MD|508-856-3085|jerry.gurwitz@umassmed.edu|
20171273|NCT01332500|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171274|NCT01687998|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20171275|NCT00443261|University of Kansas Cancer Center|Dr. Stephen Williamson|9139455059|swilliam@kumc.edu|
20171276|NCT01663532|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20171277|NCT03663816|University of Florica|Sharareh Sharififar|352-273-7410|sharareh75@phhp.ufl.edu|
20171278|NCT00871260|The University of Chicago|Dr. Amit Patel|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
20171279|NCT03539081|University of Iowa|Marshall Holland, MD|205-934-2654|mtholland@uabmc.edu|
20171280|NCT02025621|Duke Clinical Research Institute|Rajendra Mehta, MD Study Principal Investigator|919-668-8971|raj.mehta@dm.duke.edu|
20171281|NCT00739674|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20171282|NCT02373852|Gardia Medical Ltd|Dr Vardit Segal|972-52-4579178|vardit@gardiamedical.com|
20171283|NCT04805541|Akdeniz University|Prof.Dr. Ahmet Burak Bilgin|5465473336|gozdrburakbilgin@gmail.com|
20171284|NCT03243071|NYU Langoen Health|Girardin Jean-Louis, PhD|646-501-3431|Girardin.Jean-Louis@nyulangone.org|
20171285|NCT00283400|Baylor College of Medicine|Jose I Suarez, MD, Professor of Neurology|713-798-8472|jisuarez@bcm.edu|
20171286|NCT03542474|Northwestern University|Dr. Daniel Corcos|312-908-6792|daniel.corcos@northwestern.edu|
20171287|NCT00990236|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|traumare@ohsu.edu|
20171288|NCT02958293|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
20171289|NCT02195583|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171290|NCT01560403|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20171291|NCT00354744|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20171292|NCT00983437|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20171293|NCT01020981|VHA HSR&D|Marcia Valenstein, MD|7349453649|marcia.valenstein@va.gov|
20171294|NCT01337700|Montefiore Medical Center, Albert Eins|Eric Hollander, MD|7189204287|eholland@montefiore.org|
20171295|NCT01292746|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
20171296|NCT01259128|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20171297|NCT03372096|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
20171298|NCT00040365|National Cancer Institute (NCI), National Institutes of Health (NIH)|Kevin A. Camphausen|301-496-5457|camphauk@mail.nih.gov|
20171299|NCT00680017|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
20171300|NCT02840097|University of California, Davis|Daniel Nishijima, Study Co-PI|916.734.3884|dnishijima@ucdavis.edu|
20171301|NCT02555683|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20171302|NCT02614586|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20171303|NCT01397890|AstraZeneca|Nongluk Yimsuan|66 2 7397400|ClinicalTrialTransparency@astrazeneca.com|429
20171304|NCT02924571|NYU Langone Health|Themistocles Protopsaltis|646-501-7200|themistocles.protopsaltis@nyulangone.org|
20171305|NCT03783949|UZLeuven|Ellen Reynders, SC|+3216342996|ellen.reynders@uzleuven.be|
20171306|NCT00434954|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20171307|NCT00944671|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
20171308|NCT01431989|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171309|NCT03417219|VA Palo Alto Health Care System|Dr. Blake Scanlon|6504935000|blake.scanlon@va.gov|65316
20171310|NCT03345914|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
20171311|NCT02609828|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171312|NCT00319553|Sanofi Pasteur Inc.|Medical Director||RegistryContactUS@sanofipasteur.com|
20171313|NCT01896102|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
20171314|NCT00753766|VA Boston Healthcare System|Paul R. Conlin, M.D.|8572035111|paul.conlin@va.gov|
20171315|NCT01833988|Massachusetts General Hospital Diabetes Research Center|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
20171316|NCT02149719|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
20171317|NCT02805972|University of California San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
20171318|NCT02127710|AstraZeneca|Senior Medical Director, Savolitinib||ClinicalTrialTransparency@astrazeneca.com|
20171319|NCT04718961|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
20171320|NCT02727842|Cochlear Americas|Kimberly Nix, Clinical Project Manager|303-264-2340|knix@cochlear.com|
20202508|NCT01408537|Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Thailand|Dr. Pornthep Chanthavanich|6623549161|tmpct@mahidol.ac.th|
20202509|NCT01878006|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
20157448|NCT00636181|Stanford Sleep Medicine Center|Clete A. Kushida, MD, PhD|(650) 721-7560|clete@stanford.edu|
20157449|NCT03820011|Board of Trustees at University of Illinois|Dr. Mary Khetani, Associate Professor|312-996-0942|mkhetani@uic.edu|
20157450|NCT02371356|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3749|De-Kun.Li@kp.org|
20157451|NCT04549454|Loyola Marymount University|Dr. Bradley Trager, Research Scientist|3103385238|bradley.trager@lmu.edu|
20157452|NCT04336826|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20157453|NCT05076045|Baycrest Academy for Research & Education|Claude Alain|416-785-2500|calain@research.baycrest.org|3523
20157454|NCT05175014|Epicentre|Dr Matthew E Coldiron|+33 1 40 21 55 55|matthew.coldiron@epicentre.msf.org|
20157455|NCT03801993|Seattle Children's Hospital|Dr. Christopher H. Goss M.D., M.Sc.|(206) 987-5725|cgoss@uw.edu|
20157456|NCT02561962|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20157457|NCT02006108|Stanford University, Department of Radiology|Dr. Heike E. Daldrup-Link|650-497-8601|emisquez@stanford.edu|
20157458|NCT02735421|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
20157459|NCT01492426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20157460|NCT03549338|Symphogen A/S|Vice President, Global Oncology|+45 8838 2600|info@symphogen.com|
20157461|NCT00269113|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20157462|NCT01173679|Massachusetts General Hospital|Philip C. Amrein, M.D.|6177243456|pamrein@partners.org|
20157463|NCT02026011|University of California, Los Angeles|Lara Ray|310-794-5383|lararay@psych.ucla.edu|
20157464|NCT05010070|University of Michigan|Laura Saslow, Associate Professor|(734) 764-7836|saslowl@umich.edu|
20157465|NCT00939107|Back and Rehabilitation Center Copenhagen|Tom Petersen|+45 35304974|tom.petersen@suf.kk.dk|
20157466|NCT00529243|Kaiser Permanente|William Towner, MD|323-783-7855|William.J.Towner@KP.org|
20157467|NCT00639457|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
20157468|NCT03235050|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
20157469|NCT00508521|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|janis.daly@neurology.ufl.edu|6603
20157470|NCT01622296|UCSF School of Dentistry|Dr. Susan Parveen Tavana|415-476-1891|susan.tavana@ucsf.edu|
20157471|NCT00105534|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157472|NCT02935192|Institute of Virology, Vaccines and Sera, Torlak|Katarina Ilic|+381 11 3953 700|kilic@torlak.rs|214
20157473|NCT01561833|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
20157474|NCT02465931|RTI International|Dr. Don Bailey|(919) 541-6488|dbailey@rti.org|
20157475|NCT00492557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20157476|NCT01574144|Medtronic, Inc|Amy Lautenbach|7633609163|amy.a.lautenbach@medtronic.com@medtronic.com|
20157477|NCT00372957|GlaxoSmithKline|GSK Response Center|866-435-7343||
20157478|NCT03423121|Johns Hopkins University School of Medicine|Dr. Pavan Bhargava|410-614-1522|pbharga2@jhmi.edu|
20157479|NCT01354223|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|978-658-6888||151
20157480|NCT01126190|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20157481|NCT01114737|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
20157482|NCT04606927|University Medical Center Groningen|Dr. Jozine ter Maaten|0503616161|j.m.ter.maaten@umcg.nl|
20157483|NCT04563767|HealthPartners Neurology|Michael Rosenbloom, MD|651-495-6363|michael.h.rosenbloom@healthpartners.com|
20157484|NCT02660229|Mundipharma Korea Ltd.|Mrs Suyoun Yang/CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
20157485|NCT01466491|Oregon Health & Science University|Dr. Paula Bednarek|503-494-3666|whru@ohsu.edu|
20157486|NCT02727322|University of Pittsburgh|Halina Zyczynski|421-641-1440|hzyczynski@upmc.edu|
20157487|NCT02852967|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
20157488|NCT01123148|University of Michigan|Jane Huggins, PhD|734-936-7177|janeh@umich.edu|
20157489|NCT03046446|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
20157490|NCT02808897|Montreal Heart Institute|Philippe Demers|5143763330|philippe.demers@icm-mhi.org|
20157491|NCT01496287|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
20157492|NCT03012334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157493|NCT00800735|Hoffmann-La Roche|Medical Communications|800 821-8590||
20157494|NCT01103414|Mstabolic Solutions Company. LLC|Dr. Jerry Colca, President & CSO|269.343.6732|jcolca@msdrx.com|
20157495|NCT01936831|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
20157496|NCT03715790|Medtronic Cardiac Rhythm Management|CRM Clinical Research|1-800-328-2518|rs.medtronicCRMtrials@medtronic.com|
20157497|NCT00454116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20157498|NCT03085680|University of Florida|Dr. Robert Mankowski|+1 (352) 294-5055|r.mankowski@ufl.edu|
20157499|NCT02431325|Massachusetts General Hospital|Janet Lo, M.D., M.MSc.|617-724-3425|jlo@mgh.harvard.edu|
20157500|NCT01917318|University of Colorado|Michael H. Allen, M.D.|(303) 724-3300|Michael.Allen@ucdenver.edu|
20157501|NCT01008618|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
20157502|NCT01175343|Princess Margaret Cancer Centre|Dr. Amit M. Oza|416-946-2818|amit.oza@uhn.ca|
20157503|NCT03019887|Okada hospital|Dr. Ryota Ataniya|+81-4-7124-6151|ryotaataniya@pbt.nir.jp|
20157504|NCT02927795|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171321|NCT00939640|University of Michigan|Dr. Scott Hummel|734-998-7991|scothumm@med.umich.edu|
20171322|NCT00239590|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
20202510|NCT05523362|University Hospitals Cleveland Medical Center|Dr. Ian Neeland|(216)844-5965|Ian.Neeland@UHhospitals.org|
20202511|NCT03019055|Froedtert Hospital and the Medical College of Wisconsin|Dr. Nirav Shah, MD|414-805-8900|cccto@mcw.edu|
20202512|NCT01330446|University of Texas M D Anderson Cancer Center|Dr. Gary B. Gunn|(713) 563-2562|gbgunn@mdanderson.org|
20202513|NCT01588197|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
20202514|NCT03351244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202515|NCT00217438|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4933|wbensing@fhcrc.org|
20202516|NCT02437669|Columbia University College of Physicians and Surgeons|Daniel S. Tsze, MD, MPH|212-305-9825|dst2141@columbia.edu|
20202517|NCT00091793|Amgen Inc.|Study Director|866-572-6436||
20202518|NCT01025336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202519|NCT03794986|Yale University, School of Medicine|Dr. Joan Cook|203-856-2782|joan.cook@yale.edu|
20202520|NCT03000452|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
20202521|NCT02255838|University of Louisville|Rainer Lenhardt|5028523122|rainer.lenhardt@louisville.edu|
20202522|NCT05372315|Iworks Laser and Vision Center|Dr. Patrick L. Spencer|937-226-7870|iworkeye@gmail.com|
20202523|NCT00537745|PIRE|Patricia Hokanson|505-765-2325|info@bhrcs.org|
20202524|NCT01512368|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Daniel Cuevas-Ramos|525554870900|shiverqks@hotmail.com|2407
20202525|NCT01823653|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
20202526|NCT01754688|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher, MD|612-624-4586|tslusher@umn.edu|
20202527|NCT02495779|University of Pittsburgh, Graduate School of Public Health|James Egan|4126242255|jee48@pitt.edu|
20202528|NCT00748657|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
20202529|NCT01254344|Merck Sharp & Dohme (China) Ltd.|Naimi Missoum|+8621 2211 8546|naimi_missoum@merck.com|
20202530|NCT03249350|Oregon Social Learning Center|Dr. Mike McCart|541-485-2711|MikeM@oslc.org|
20202531|NCT04045912|University of California, San Francisco|Dr. Jenny Liu|1-415-502-5200|Jenny.Liu2@ucsf.edu|
20202532|NCT00513344|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
20202533|NCT00624338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20202534|NCT01476787|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20202535|NCT01591330|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20202536|NCT01450137|Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland|Prof Peter M Villiger||peter.villiger@insel.ch|
20202537|NCT02782715|University of Wisconsin School of Medicine and Public Health|Michael Bassetti, MD, PhD|608-263-8500|bassetti@humonc.wisc.edu|
20202538|NCT02986373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20202539|NCT04429932|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
20202540|NCT01662999|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
20202541|NCT05439928|Columbia University|Magdalena Bogun, MD|2128515494|mmb2263@cumc.columbia.edu|
20202542|NCT02514070|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
20202543|NCT00098059|Novartis Pharmaceuticals|Study Director|862-778-8300||
20202544|NCT01151137|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
20202545|NCT01933672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202546|NCT04125745|University of California San Francisco|Marc Simon, MD, Director of Pulmonary Vascular Disease and Pulmonary Hypertension Comprehensive Care|415-476-1325|Marc.Simon@ucsf.edu|
20202547|NCT00833859|H. Lee Moffitt Cancer Center and Research Institute|Gregory Springett, M.D., Ph.D., via Moffitt Cancer Center|813-745-6898|gregory.springett@moffitt.org|
20202548|NCT01684826|Philips|Frank Everaerts|+31630728782|frank.everaerts@philips.com|
20202549|NCT01607892|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
20202550|NCT03983941|Nationwide Children's Hospital|Julie Rice-Weimer, RN|614-355-3142|julie.rice-weimer@nationwidechildren.org|
20202551|NCT02273973|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20202552|NCT03294304|Masonic Cancer Center, University of Minnesota|Dr. Konety Badrinath|612-625-1655|brkonety@umn.edu|
20202553|NCT00957372|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
20202554|NCT04278573|Mayo Clinic|Dr. Stephen P. Merry|507-284-5180|merry.stephen@mayo.edu|
20202555|NCT01444391|Acclarent|Director Clinical|650-687-5888|lenglan1@its.jnj.com|
20202556|NCT01287117|Genentech, Inc.|Medical Communications|800 821-8590||
20202557|NCT01274897|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
20202558|NCT01769404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20202559|NCT00538733|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
20202560|NCT02378753|Centers for Disease Control and Prevention|Dr. Barbara Mahon|404-718-1157|bdm3@cdc.gov|
20202561|NCT03572634|Sr. Director Drug Development/Clinical Operations|Susan Smith|210-414-7702|s.smith@toleropharma.com|
20202562|NCT02032524|Sanofi-Aventis Recherche & Developpement|Trial Transparency Team|800-633-1610|contact-us@sanofi.com|6#
20202563|NCT03567187|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
20202564|NCT01225068|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
20202565|NCT03596645|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20202566|NCT04358458|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
20202567|NCT06046560|Mass General Brigham|Alexander Blood, MD|617-732-7144|ablood3@mgb.org|
20202568|NCT04513158|Norton Healthcare|Joseph M. Flynn, DO, MPH|502-272-5001|joseph.flynn@nortonhealthcare.org|
20202569|NCT01123889|Loma Linda University Orthopaedic Surgery|Liz Clarke|909-558-5592|eaclarke@llu.edu|
20202570|NCT04352660|UCSD Shiley Eye Institute|Dr. Jiun Do|8585346290|jiundo@ucsd.edu|
20202571|NCT01466751|Stanford University|Amit Etkin|650-725-5736|amitetkin@stanford.edu|
20202572|NCT02413255|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20202573|NCT02413398|Global Clinical Leader-Dapagliflozin AstraZeneca|Anna Maria Langkilde, MD PhD|Tel: + 46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
20202574|NCT01494038|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20202575|NCT03847337|Vanderbilt University Medical Center|Zachary Warren|615-875-3085|zachary.e.warren@vumc.org|
20202576|NCT03952546|Northwell Health System|Nancy Dengler, RN, MS Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
20202577|NCT00685178|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
20202578|NCT00249379|Virginia Commonwealth University|Michael Weaver, MD|804-828-1283|mweaver@mcvh-vcu.edu|
20202579|NCT01334125|University of Massachusetts Medical School|Benjamin U. Nwosu, MD|5083347872|Benjamin.Nwosu@umassmemorial.org|
20202580|NCT02412644|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
20202581|NCT02836886|Columbia University|Larisa Geskin, MD|2123055550|ljg2145@cumc.columbia.edu|
20202582|NCT02138110|InVivo Therapeutics Corporation|Dr. Rich Toselli|(617) 863-5540|rtoselli@invivotherapeutics.com|
20202583|NCT00844298|Asan Medical Center, University of Ulsan College of Medicine|Dr. Dae-Young Kim|82230105930|dani@amc.seoul.kr|
20202584|NCT05099991|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
20202585|NCT04075604|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20202586|NCT02760602|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
20202587|NCT03159754|University of Michigan|Steven Bruch, MD|7349368464|sbruch@umich.edu|
20202588|NCT00708877|University of Utah|Dr. Jason Schwarz|8015852708|jason.schwartz@hsc.utah.edu|
20202589|NCT01272180|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20202590|NCT03334214|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20202591|NCT03140254|Becton Dickinson|Erin Zook|201-847-5351|erin.zook@bd.com|
20202592|NCT01260181|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20202593|NCT02088034|Northwestern University|Matthew J. O'Brien, MD|312-503-5046|matthew.obrien1@northwestern.edu|
20202594|NCT05780281|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
20202595|NCT00308620|University of Minnesota|David Boulware|6126269546|boulw001@umn.edu|
20202596|NCT03002506|Texas Tech UHSC|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
20202597|NCT02102230|VA Palo Alto Health Care System|Kimberly Babson, PhD|831-325-1540|kimberly.babson@gmail.com|
20202598|NCT00637728|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
20202599|NCT01050062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202600|NCT00325572|Milton S. Hershey Medical Center|Jeanette C. Ramer MD|717 531-8414|jramer2@hmc.psu.edu|
20202601|NCT01873950|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
20202602|NCT03894540|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20202603|NCT00593112|Massachusetts General Hospital|Paul Hammerness, M.D.|617-503-1040|phammerness@partners.org|
20202604|NCT03043365|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
20202605|NCT02723630|Eisai Inc.|Eisai Medical Services|1-888-247-2378|esi-medinfo@eisai.com|
20202606|NCT00650585|PIRE|Heddy Clark|919-265-2643|hclark@pire.org|
20202607|NCT02532543|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidgetta_jenkins@unc.edu|
20202608|NCT02640612|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202609|NCT03583424|The Ohio State University Comprehensive Cancer Center|Dr. Kami Maddocks|614-293-9165|Kami.Maddocks@osumc.edu|
20202610|NCT01144637|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
20202611|NCT00906789|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
20202612|NCT02334267|Frenova Renal Research|Brigid Flanagan, MS, RN, CCRC|781-699-2970|Brigid.Flanagan@frenovarenalresearch.com|
20202613|NCT00923091|Daiichi Sankyo Europe, GmbH|Bettina Ammentorp|00498978080|bettina.ammentorp@daiichi-sankyo.eu|
20202614|NCT01889810|Queen's University, Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
20202615|NCT02460822|University of Michigan|Dr. Lawrence C. An|734-763-6099|lcan@med.umich.edu|
20202616|NCT00467649|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
20202617|NCT03240081|OHSU|Dr. Martha Goetsch|503-494-3666|goetsch@ohsu.edu|
20202618|NCT03322657|Cleveland Clinic Foundation|Dr. Ehab Farag|216 444-7550|FARAGE@ccf.org|
20157505|NCT02581891|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20157506|NCT03421886|University of Alabama at Birmingham|Chung How Kau, chair and professor|(205) 934-2782|ckau@uab.edu|
20157507|NCT01138475|William Beaumont Hospital|Kerstyn Zalesin|248-655-5900|Kerstyn.zalesin@beaumont.edu|
20157508|NCT01534481|University of Iowa|Dr. Tarah Colaizy|319-356-3508|tarah-colaizy@uiowa.edu|
20157509|NCT05525910|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20203020|NCT03152136|Cala Health|Paula Chidester|650-273-7436|paula@calahealth.com|
20171323|NCT01252147|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
20171324|NCT02121522|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171325|NCT01202565|AbbVie|Global Medical Services|800-633-9110||
20171326|NCT02169479|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20171327|NCT00892047|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
20171328|NCT05306977|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
20171329|NCT00306189|Amgen Inc.|Study Director|866-572-6436||
20171330|NCT02993757|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20171331|NCT00190671|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20171332|NCT04502433|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
20171333|NCT01234831|Massachusetts General Hospital|Dr. Erica S. Shenoy|617-726-2036|eshenoy@partners.org|
20171334|NCT00672646|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20171335|NCT00289783|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171336|NCT00660699|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@dom.wustl.edu|
20171337|NCT02963649|Medtronic|Giulia Gatta, Clinical Study Manager|+310629467793|giulia.gatta@medtronic.com|
20171338|NCT06934993|Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine|Dr. Abdulgani Orhun YENİGÜN|+90 05346214600|orhunyenigun@gmail.com|
20202619|NCT04634162|Division of Cardiology University of Florida College of Medicine - Jacksonville|Francesco Franchi, MD|1-904-244-2060|francesco.franchi@jax.ufl.edu|
20202620|NCT04925570|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
20202621|NCT05897853|Hospital of Ludwig Maximilians University, Munich|Prof. Dr. Michael Strupp|+49 894400|Michael.Strupp@med.uni-muenchen.de|76980
20202622|NCT03246074|SKCCC at Johns Hopkins|Stephanie Gaillard, MD PhD|410-955-3774|stephanie.gaillard@jhmi.edu|
20202623|NCT01039207|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
20202624|NCT00938548|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
20202625|NCT04458857|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20202626|NCT04170621|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
20202627|NCT04800315|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20202628|NCT00753922|Ethicon Endo-Surgery|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
20202629|NCT00196937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20202630|NCT01322815|Ruesch Center at Georgetown Lombardi|John L Marshall|202.444.7064|marshalj@georgetown.edu|
20202631|NCT00968344|University of Texas Medical Branch|Douglas Paddon-Jones, Professor|409-772-3073|djpaddon@utmb.edu|
20202632|NCT01526356|The University of Texas Health Science Center at Houston|Mary Kay Koenig, MD|713-500-7142|mary.k.koenig@uth.tmc.edu|
20202633|NCT03368404|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
20202634|NCT02983292|Senior Specialist-Clinical Study Management|Dr. Manvendra Saxena|+61 455 870 175|manvendra.saxena@smith-nephew.com|
20202635|NCT03949673|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20202636|NCT01328873|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
20202637|NCT00586690|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
20202638|NCT01751646|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
20202639|NCT02190591|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
20202640|NCT03022422|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
20202641|NCT01282814|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
20202642|NCT02403206|Alcon, A Novartis Division|Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
20202643|NCT01524289|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20202644|NCT01676116|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20157510|NCT02831660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20157511|NCT02918669|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
20157512|NCT01306292|Bracco Diagnostics Inc.|Dr. Maria Luigia Storto|609-514-2262|marialuigia.storto@diag.bracco.com|
20157513|NCT01812057|Duke University Medical Center|Dr Terrence K Allen|9196682024|terrence.allen@duke.edu|
20157514|NCT01180127|Columbia University Medical Center, Division of Behavioral Medicine in Psychiatry|Richard Sloan|646-774-8940|rps7@cumc.columbia.edu|
20157515|NCT01880957|Stony Brook University|Dr. Christine DeLorenzo|(631) 638-1523|Christine.Delorenzo@stonybrookmedicine.edu|
20157516|NCT02951780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20157517|NCT03060902|University of Oregon|Maureen Zalewski|541-346-7073|zalewski@uoregon.edu|
20157518|NCT02289469|SAI Interactive|Dr. Dane Boyington|(423) 521-2309|dane@thinkingmedia.com|
20157519|NCT03508050|Institut universitaire de cardiologie et de pneumologie de Québec|Dr Jean S. Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|
20157520|NCT01082614|Loma Linda University|Tonya Hamilton|909-558-9408|thamilton@llu.edu|
20157521|NCT03710889|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
20157522|NCT00421148|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20157523|NCT01538199|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
20157524|NCT02081586|University of Pittsburgh School of Nursing|Dr. Judith A. Callan PhD, RN|412-383-5321|callanja@pitt.edu|
20171339|NCT03128047|Hackensack Meridian Health|Jeanette Haugh|5519963457|Jeanette.haugh@hmhn.org|
20171340|NCT01153347|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20171341|NCT05096221|Sarepta Therapeutics Inc.|Sarepta Therapeutics Inc.|1-888-727-3782|SareptAlly@sarepta.com|
20171342|NCT02061774|TTUHSC CRI|Cathy Lovett|806-743-4222|cathy.lovett@ttuhsc.edu|
20171343|NCT04678661|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
20171344|NCT01086033|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20171345|NCT03094169|Formation Biologics|Sandra Sinclair|8326221699|sandra@forbius.com|
20171346|NCT04645953|Alexza Pharmaceuticals Inc.|Dan Myers, PhD, VP Product & R&D|(650) 210-6164|dmyers@alexza.com|
20171347|NCT00864721|Ocala Oncology, Ocala, FL, USA|Dr. Craig Reynolds|352-732-4032|Craig.Reynolds@USOncology.com|
20171348|NCT00187200|St. Jude Medical|Ashish Oza|(818) 493-3648|aoza@sjm.com|
20171349|NCT03741062|University of Manitoba|Dr. Brian Wiens|613-809-4501|wiensb3@myumanitoba.ca|
20171350|NCT00304746|McLean Hospital|Harrison G Pope Jr., M.D.|617-855-2911|hpope@mcLean.harvard.edu|
20171351|NCT02763462|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
20171352|NCT00261807|U. of Maryland Medical Systems, R Adams Cowley Shock Trauma Center|Dr. Manjari Joshi|410-328-3656|mjoshi@som.umaryland.edu|
20171353|NCT01706146|Northwestern University|Adin-Cristian Andrei, Ph.D.|312-694-0509|Adin-Cristian.Andrei@nm.org|
20171354|NCT03992014|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171355|NCT00675948|GW Pharma LTD.|Mr Richard Potts, Clinical Operations Director|00 44 1223 266 800|rp@gwpharm.com|
20171356|NCT02527161|Stryker SP|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
20171357|NCT02100514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171358|NCT00762229|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
20171359|NCT02218320|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|919 966-9998|akashuba@unc.edu|
20171360|NCT02096731|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171361|NCT01751178|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171362|NCT03719612|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
20171363|NCT05091047|Erchonia Corporation|Clinical Affairs Manager|888.242.0571|tsammons@erchonia.com|
20171364|NCT01496248|Krea University College of Medicine|Young-Hoon Ko|+82-31-412-5140|korean@chol.com|
20171365|NCT02747875|Children's National Hospital|Dr. Andrew Waberski, Assistant Professor|2024762025|awabersk@childrensnational.org|
20171366|NCT02983825|University of Pennsylvania|Nicolas Bamat, MD MSCE|2155904010|bamatn@email.chop.edu|
20171367|NCT03019783|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-5500|joshua.a.beckman@vanderbilt.edu|
20171368|NCT04891978|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20171369|NCT01776840|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20171370|NCT03641339|National Institutes of Health|Matthew J. Memoli, MD, MS|301-443-5971|memolim@niaid.nih.gov|
20171371|NCT02000583|University of Kansas Medical Center|Jeffrey M. Burns MD|913-588-0555|jburns2@kumc.edu|
20171372|NCT02589405|Galderma R&D|Stephanie Leclerc|492386706|stephanie.leclerc@galderma.com|+33
20171373|NCT03285984|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171374|NCT04208997|Vanderbilt University Medical Center|Dr Giovanni Davogustto|6159361720|giovanni.e.davogustto@vumc.org|
20171375|NCT00446251|University of Washington|Dr. Connie L. Davis|206-598-6079|cdavis@u.washington.edu|
20171376|NCT02581787|Stanford University|Maximilian Diehn, MD, PhD|(650) 721-1550|diehn@stanford.edu|
20171377|NCT00408460|University of Washington|Renato G Martins, MD|206-288-2048|rgmart@uw.edu|
20171378|NCT02264639|Apellis Pharmaceuticals, Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
20171379|NCT02506465|Medi-Tate / Olympus|Sivan Baker|+97247701839|sivan.baker@olympus.com|
20171380|NCT01117948|JSW-Lifesciences|Director of Clinical Trials|0043316 258111|office@jsw-lifesciences.com|310
20171381|NCT00381550|Sidney Kimmel Comprehensive Cancer Center|Michael McDevitt, MD PhD|410-955-9175|mmcdev1@jhmi.edu|
20171382|NCT01172522|ConnecticutSC|Edward M. Lane|2033720009|EMLMD@msn.com|
20171383|NCT02693119|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-(617) 600-6888|jim.carr@stealthbt.com|
20171384|NCT02319837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171385|NCT00702689|National Institute of Arthritis and Musculoskeletal and Skin Diseases|Edward Cowen, M.D.|301-827-2328|cowene@mail.nih.gov|
20171386|NCT03993132|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
20171387|NCT00369824|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171388|NCT02106975|Virginia Commonwealth University School of Medicine|Alpha A Fowler, III, MD|804-828-9071|alpha.fowler@vcuhealth.org|
20171389|NCT01611155|Mayo Clinic|Charles L. Loprinzi, MD|507-284-3731|cloprinzi@mayo.edu|
20171390|NCT00087607|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
20171391|NCT02015754|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
20171392|NCT02369016|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20202645|NCT02218203|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
20202646|NCT02042131|The University of Utah|Craig Bryan|801-587-7978|craig.bryan@utah.edu|
20171393|NCT02229383|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
20171394|NCT00672932|UCSF|Richard W. Price, M.D.|415-206-4487|rwprice@sfgh.ucsf.edu|
20202647|NCT02628223|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
20171395|NCT02403986|Q-Med AB|Cecilia Skoglund, Manager Study strategy and publications|46 18 474 9000|cecilia.skoglund@galderma.com|
20171396|NCT05248867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20171397|NCT05263895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171398|NCT05764408|Prisma Health|Dr. Melissa Wise|8644551600|melissa.wise2@prismahealth.org|
20171399|NCT01453361|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
20171400|NCT01594281|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@novartis.com|
20171401|NCT00289471|Durham VAMC|John W. Williams|919-286-6963|jw.williams@duke.edu|
20171402|NCT02550106|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
20171403|NCT01709513|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator||clinicaltrials@regeneron.com|
20171404|NCT01034631|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
20171405|NCT01431170|NJMS, Rutgers University|Suqin Guo, MD|973-972-2031|guos1@njms.rutgers.edu|
20171406|NCT01193530|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Medicine|713-792-6085|rdev@mdanderson.org|
20171407|NCT04218695|BIDMC|Dr. Zachary Fricker|6176321070|zfricker@bidmc.harvard.edu|
20171408|NCT01890473|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20171409|NCT03166735|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171410|NCT01543958|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
20171411|NCT04019288|M.D. Anderson Cancer Center|Amir A Jazaeri|713-745-1613|aajazaeri@mdanderson.org|
20171412|NCT01945281|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171413|NCT04538430|University of Utah|Shellie Cunningham|801-587-5488|shellie.cunningham@hsc.utah.edu|
20171414|NCT00934089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171415|NCT01112358|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
20171416|NCT00799383|Baylor College of Medicine|Chadi Calarge, MD|832-824-4764|chadi.calarge@bcm.edu|
20171417|NCT00926328|Colgate Palmolive|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
20171418|NCT00726986|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
20171419|NCT03119831|Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens, Greece|Dr. Anastasios M. Gkatzonis|6976486314|gkatzonis.tasos@gmail.com|0030
20171420|NCT02577978|Northwestern Medicine|David W Manning|3124726023|David.Manning@nm.org|
20171421|NCT01434667|Brigham and Women's Hospital|Kurt Christensen, PhD|(617) 264-5883|kchristensen@bwh.harvard.edu|
20171422|NCT02647203|University of Talca|Dr. Rodrigo Giacaman|+56712201546|giacaman@utalca.cl|2654
20171423|NCT02165215|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20171424|NCT05074667|Stanford University|Sejal Shah, MD|650-498-7351|sshah2@stanford.edu|
20171425|NCT01877265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171426|NCT02279420|USGI Medical|Senior Director of Clinical Research|9493693890|samlung@usgimedical.com|
20171427|NCT01948947|VA San Diego Healthcare System|Valerie Metzger Smith, Study Coordinator|858-750-0274|valerie.metzgersmith@va.gov|
20171428|NCT03535844|National University of Singapore|Dr. Kim Jung Eun|+6565161136|fstkje@nus.edu.sg|
20171429|NCT01803204|USP|Cristina Sousa|+5511996017972|crissousa@usp.br|
20171430|NCT00297830|Columbia University|Dr. Elizabeth Shane|2123056289|es54@columbia.edu|
20171431|NCT02835820|University of Alabama at Birmingham|Shannon Morrison|12059967841|samorris@uab.edu|
20171432|NCT03554746|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
20171433|NCT00003473|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20171434|NCT01548651|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
20171435|NCT00779701|Temple University Hospital|Dr. Nina Gentile|215-707-2000|ngentile@temple.edu|8402
20171436|NCT04613375|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171437|NCT01847274|GSK|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171438|NCT01921387|Seattle Cancer Care Alliance|Ajay Kumar Gopal, MD, Director of Clinical Research|(206) 606-2037|agopal@uw.edu.org|
20171439|NCT02114216|Seoul National University Hospital|Dr. Jinjoo Kim|82-10-6261-6483|jjkim0727@gmail.com|
20171440|NCT01439633|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
20171441|NCT00727636|Children's Hospital Boston|Dr. Athos Bousvaros|617-355-2962|athos.bousvaros@childrens.harvard.edu|
20171442|NCT00695409|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
20171443|NCT01786668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171444|NCT03570697|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20171445|NCT02989545|Shaare Zedek Medical Center|Dr. Dan Livovsky|+972525622398|danlivo@szmc.org.il|
20171446|NCT01876420|Medtronic|Terry Noel|763-526-0309||
20171447|NCT03173313|ZOLL Circulation, Inc.|Vice President of Clinical Affairs|(408) 541-2140|jcreech@zoll.com|
20171448|NCT04461210|University at Buffalo|Director of the Clinical and Translational Science Institute|7168884850|vmbarnab@buffalo.edu|
20171449|NCT05338216|Northeastern University|Dr. Erin Meier|1 (617) 373-7438|e.meier@northeastern.edu|
20171450|NCT04457336|Spruce Biosciences|Dina Ayala-Jones, Associate Director, Clinical Development Operations|424.558.1211|djones@sprucebio.com|
20171451|NCT01554683|Beth Israel Deaconess Medical Center|Dr. Daniel Press|617-667-4074|dpress@bidmc.harvard.edu|
20171452|NCT03330288|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20202648|NCT01821677|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
20171453|NCT01042678|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20171454|NCT01416272|Bausch & Lomb / Valeant Pharmaceuticals|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
20171455|NCT02284516|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20171456|NCT01719783|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
20171457|NCT01350492|William S. Middleton Memorial Veterans Hospital|Aaron J. Stegner, Ph.D.|608-262-1290|aaron.stegner@va.gov|
20171458|NCT00205881|Advanced Bionics, LLC|Kenneth Ripley|(661) 362-4572|Kenneth.Ripley@advancedbionics.com|
20171459|NCT02713373|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@RoswellPark.org|
20171460|NCT01443078|Memorial Sloan Kettering Cancer Center|Chaft, Jamie, MD|646-888-4545|ChaftJ@mskcc.org|
20171461|NCT02217878|Collegium Medicum, Nicolaus Copernicus University|Prof. Jacek Kubica|+485854023|jkubica@cm.umk.pl|
20171462|NCT00415168|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171463|NCT01706978|The Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|78377
20171464|NCT02718157|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
20171465|NCT01201785|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
20171466|NCT02151110|MedImmune LLC|David Howe, MBChB, MD, MRCOG|+44 (0) 1223 895980|information.center@astrazenea.com|
20171467|NCT01064310|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20171468|NCT02639065|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20171469|NCT01289080|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
20171470|NCT03704467|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20171471|NCT00873015|University of Virginia Medical Center|Dr. Edward Oldfield|(434) 982-0059|EHO4U@hscmail.mcc.virginia.edu|
20171472|NCT03128411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171473|NCT00345839|Amgen Inc.|Study Director|866-572-6436||
20171474|NCT01960400|Université de Sherbrooke|Dr Yannick Tousignant-Laflamme|819-821-8000|Yannick.Tousignant-Laflamme@USherbrooke.ca|72912
20171475|NCT03928353|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
20171476|NCT02989714|University of Michigan Rogel Cancer Center|Ajjai Alva, MD|734-936-0091|ajjai@umich.edu|
20171477|NCT00967668|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
20171478|NCT04096963|Boston Scientific Corperation|Associate Clinical Trial Manager|+861085742971|yifan.zhao@bsci.com|
20171479|NCT01542125|Alberta Health Services|Research Coordinator|780-492-2398|manu.saraswat@albertahealthservices.ca|
20171480|NCT01871532|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20171481|NCT01673867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20171482|NCT02048891|Rambam health Care campus|Shahar Kol Director IVF Unit|97247773232|skol@rambam.health.gov.il|
20171483|NCT00681083|Fisher & Paykel Healthcare|Hansinie Laing|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|8601
20171484|NCT01227434|University of California San Francisco|Michael Prados, MD|4154767217|pradosm@neurosurg.ucsf.edu|
20171485|NCT02767843|California Center for Sleep Disorders|Jerrold Kram, MD|510.263.3300|info@californiasleepcenters.com|
20171486|NCT01335191|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
20171487|NCT03486223|Vanderbilt University Medical Center|Dr. James M Luther|6153223353|james.luther@vumc.org|
20171488|NCT01819831|Loma Linda University Health|Gary Yang, Professor, Chair of Radiation Medicine|909 558 4444|gyang@llu.edu|
20171489|NCT01023620|UT Southwestern Medical Center|Dr. Michael Limerick|214-590-0611|Michael.Limerick@UTSouthwestern.edu|
20171490|NCT01513343|Baylor College of Medicine|Dr. Sheryl O. Hughes, Associate Professor|713-798-7017|shughes@bcm.edu|
20171491|NCT01270516|University of Kentucky|Emily Bradford, Clinical Trial Compliance Administrator|859) 323-2973|emily.bradford@uky.edu|
20171492|NCT02417831|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171493|NCT05166824|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
20171494|NCT01738321|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
20171495|NCT01468012|New York State Psychiatric Institute|Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
20171496|NCT04401423|Columbia University Irving Medical Center|Dr. Jeanine D'Armiento / Principal Investigator|212-305-3745|jmd12@cumc.columbia.edu|
20171497|NCT02193867|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
20171498|NCT01867424|National Cancer Institute|Dr. Ismail Baris Turkbey|301-443-2315|turkbey@nih.gov|
20171499|NCT02582983|Hoffmann-La Roche|Medical Communications|800-821-8590||
20171500|NCT05209360|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
20171501|NCT03416946|Orthopaedic Innovation Centre|Trevor Gascoyne|204-926-1235|tgascoyne@orthoinno.com|
20171502|NCT02569658|Rush University Medical Center|Yale Fillingham|3095310220|yale.fillingham@gmail.com|
20171503|NCT00724932|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20171504|NCT02021331|University of Michigan|Dr. Robert Eber|734-647-4023|reber@umich.edu|
20171505|NCT00469274|Vanderbilt University Medical Center|Dr. Thomas R. Talbot|615-322-2789|tom.talbot@vanderbilt.edu|
20171506|NCT01081678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20171507|NCT00900237|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
20171508|NCT01619423|PledPharma AB|Stefan Carlsson, MD, PhD, Chief Medical Officer|+46 8 679 72 10|stefan.carlsson@pledpharma.se|
20202649|NCT02768129|Butler Hospital|Benjamin Greenberg|(401) 455-6200|bgreenberg@butler.org|
20202650|NCT03461965|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Margaret Mann, MD|1-800-641-2422|CTUReferral@uhhospitals.org|
20171509|NCT01281865|Memorial Sloan-Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|keohanm@mskcc.org|
20171510|NCT03478657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171511|NCT03948581|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20171512|NCT03068455|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
20171513|NCT02498132|University of Kansas|Professor Carl Lejuez|240-535-0467|clejuez@ku.edu|
20171514|NCT04789499|Washington University in Saint Louis|Research Statistician|3143621077|kallogjerid@wustl.edu|
20171515|NCT00578383|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
20171516|NCT00005044|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
20171517|NCT00181155|Johns Hopkins University|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
20171518|NCT02572401|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
20171519|NCT01548287|AstraZeneca Pharmaceuticals LP, Neuroscience iMed|Joel Posener, MD||clinicaltrialtransparency@astrazeneca.net|
20171520|NCT01957930|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
20171521|NCT00353795|NIH|David Bluemke|301 402 1854|bluemked@nih.gov|
20171522|NCT02762578|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20171523|NCT00259610|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis,|205-934-7733|jcurtis@uab.edu|
20171524|NCT02028754|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20171525|NCT01768286|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20171526|NCT02083965|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
20171527|NCT00929383|Stryker Neurovascular|David Hess, Manager Clinical Affairs|1-510-413-2642|david.hess@stryker.com|
20171528|NCT03344796|Northwestern Univ|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
20171529|NCT00939770|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
20171530|NCT01146665|University of Alberta|Dr. Amanda Newton|780-248-5581|an6@ualberta.ca|
20171531|NCT04560998|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20171532|NCT04659928|The University of Texas Health Science Center at Houston|Claudia Ruiz Brisuela, DDS|713-486-4138|Claudia.RuizBrisuela@uth.tmc.edu|
20171533|NCT04147221|Center for Anti Infective Research and Development|Dr. Joseph L. Kuti|860-972-3612|joseph.kuti@hhchealth.org|
20171534|NCT00666029|University Hospital Southampton|Professor Christopher Byrne|+44 238120 5006|cdtb@soton.ac.uk|
20171535|NCT03749447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20171536|NCT01218113|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171537|NCT00115739|University of Michigan Comprehensive Cancer Center|Frances Worden, M.D.|(734) 615-6633|fworden@umich.edu|
20171538|NCT00259649|University of Pittsburgh|Dawn marcus|412-953-4797|marcusd@upmc.edu|
20171539|NCT01055171|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
20171540|NCT00745823|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1- 800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171541|NCT01337739|Northwestern University|Paul Fitzgerald|312-472-3539|p-fitzgerald2@northwestern.edu|
20171542|NCT00651794|University of Texas HSC-Houston|Dr. Eric Thomas|713-500-7958|Eric.Thomas@uth.tmc.edu|
20171543|NCT01633853|Peking University Internetional Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
20171544|NCT01661621|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
20171545|NCT01433991|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20171546|NCT00300391|UPittsburgh|Barb Early, RN, BSN, CCRC|(412) 647-9745|earlybj@upmc.edu|
20171547|NCT00787891|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
20171548|NCT01258582|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
20171549|NCT00290888|Pan Am Clinic|Dr. Peter MacDonald|204-925-7480|pmacdonald@panamclinic.com|
20171550|NCT00134082|Johns Hopkins University|Richard Ambinder, MD|4109558839|rambind1@jhmi.edu|
20171551|NCT01158157|Cangene Corporation|Christine Hall, Ph.D. Director Clinical|204-275-4248|chall@ebsi.com|
20171552|NCT01606007|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
20171553|NCT03758066|Dimagi, Inc.|Y. Xian Ho|617-649-2214|yho@dimagi.com|63
20171554|NCT05673889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171555|NCT02590003|Yale University|Rogerio C. Lilenbaum, MD, Professor of Medicine (Medical Oncology); Chief Medical Officer of Smilow|(203) 200-5864|rogerio.lilenbaum@yale.edu|
20171556|NCT03733470|University of Iowa|Eric Hoffman, PhD|319-365-1381|eric-hoffman@uiowa.edu|
20171557|NCT01517711|University of Cincinnati College of Medicine|Dr. Thomas Geracioti, Principle Investigator|513-748-9825|thomas.geracioti@uc.edu|
20171558|NCT01979445|The Medicines Company|Global Health Science Center, The Medicines Company|1-888-977-6326|medical.information@themedco.com|
20171559|NCT01849783|University of Iowa|Margarida Magalhaes-Silverman, MD|319-384-9156|margarida-silverman@uiowa.edu|
20171560|NCT00692341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|ClinicalTrials.gov_Inquiries@pfizer.com|
20171561|NCT03095612|University of Texas Southwestern Medical Center|Dr. David Gerber|214-648-4180|david.gerber@utsouthwestern.edu|
20171562|NCT04600375|University of Arkansas for Medical Sciences|Dr. Vivian Shi|5015266994|VYShi@uams.edu|
20171563|NCT04447794|University of Alaska Anchorage|Dr. Patrick Dulin|(907) 786-1653|pldulin@alaska.edu|
20171564|NCT03463512|Abbott|Suntje Sander|+495116750|suntje.sander@abbott.com|3254
20171565|NCT04203498|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
20171566|NCT00644657|University of Oklahoma Health Sciences Center|Eliot Schechter, MD|405-456-5378|eliot-schechter@ouhsc.edu|
20171567|NCT01235689|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
20171568|NCT01809106|Mario Negri Institution|Dr. Oscar Corli|+390239014564|oscar.corli@marionegri.it|
20171569|NCT03988088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20171570|NCT03546062|"Università degli studi della Campania luigi Vanvitelli"|Raffaele Marfella|+390815665110|raffaele.marfella@unicampania.it|
20171571|NCT00781274|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20171572|NCT01090492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171573|NCT00868608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171574|NCT02935842|University Hospital Basel|Prof. Peter Fuhr|0041 61 265|peter.fuhr@usb.ch|41 66
20171575|NCT00911547|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171576|NCT01199965|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20171577|NCT00758836|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171578|NCT00365508|University of Pennsylvania|Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
20171579|NCT00981370|Childrens Hospital Los Angeles|Thomas Coates, MD|323-361-2352|tcoates@chla.usc.edu|
20171580|NCT02538029|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
20171581|NCT02929667|University of Iowa|Dr. Rup Sainju|319-356-4337|rup-sainju@uiowa.edu|
20171582|NCT00566995|National Cancer Institute|Dr. W. Marston Linehan|301-496-6353|linehanm@mail.nih.gov|
20171583|NCT00404235|Mayo Clinic|Svetomir N. Markovic, MD, Ph.D|(507) 284-1370|markovic.svetomir@mayo.edu|
20171584|NCT00001880|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
20171585|NCT00481078|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20171586|NCT05544734|Weill Cornell Medicine|Dr Shari Lipner|6469623376|shl9032@med.cornell.edu|
20171587|NCT00228384|W. L. Gore & Associates, Inc.|Chad Badorek|800/437-8181|cbadorek@wlgore.com|
20171588|NCT02914119|Herlev Hospital, research unit, anesthesia|Dr. JLD Thomsen|004538633863|prs@demants.dk|
20171589|NCT01980940|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171590|NCT03000283|Allina Health|Dr. Jesse Corry|651-241-6550|Jesse.Corry@allina.com|
20171591|NCT03432897|Brown Oncology Research Group|BrUOG|4018633000|BrUOG@Brown.edu|
20171592|NCT04543838|UPMC|Parthasarathy Thirumala, MD|412-648-4208|thirumalapd@upmc.edu|
20171593|NCT05695209|Indiana University|Principal Investigator|317-278-3154|mmatthia@iu.edu|
20171594|NCT05358444|Johns Hopkins University Schoo of Medicine|Maya Venkataramani MD, MPH|4109559869|mvenkat2@jh.edu|
20171595|NCT05372419|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
20171596|NCT03802227|Nektar Therapeutics|Study Director|415-482-5416|medicalaffairs@nektar.com|
20171597|NCT04362072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171598|NCT04731363|Cleveland Clinic Foundation|Dr. Stanley Hazen, MD|216-444-9426|hazens@ccf.org|
20171599|NCT00595530|Connecticut Children's Medical Center|Dr. William T. Zempsky|860-837-5207|wzempsk@ConnecticutChildrens.org|
20171600|NCT01206660|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
20171601|NCT00842608|Regenstrief Institute, Inc.|Dr. Malaz Boustani|(317) 274-9235|mboustan@iu.edu|
20171602|NCT02034110|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20171603|NCT02587234|University of Kentucky|Lumy Sawaki, MD, PhD||lumy.sawaki@uky.edu|
20171604|NCT00590720|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
20171605|NCT00905151|Tufts Medical Center|Associate Professor|617-636-2569|linker@tuftsmedicalcenter.org|
20171606|NCT01001377|Amgen Inc.|Study Director|866-572-6436||
20171607|NCT01966159|Shenyang Northern Hospital (The General Hospital of Shenyang Military Region)|Dr. Hanyaling|024-28897310|hanyl@medmail.com.cn|
20171608|NCT00528788|Duke University Medical Center|Jula Inrig, MD|919-660-6882|Jula.Inrig@duke.edu|
20171609|NCT03039283|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
20171610|NCT02732119|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
20171611|NCT00964860|Procter and Gamble|Holly Eynon|513-622-2920|eynon.ha@pg.com|
20171612|NCT00867568|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
20171613|NCT01056653|University of Calgary, Faculty of Nursing|Dr. Karen Benzies|403-220-2294|benzies@ucalgary.ca|
20171614|NCT03639935|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
20171615|NCT02683161|Johns Hopkins University|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
20171616|NCT03727230|Guangzhou Blood Center|Director of Clinical Trials|+86-20 83595049|fuyongshui1969@yahoo.com|
20171617|NCT02124083|National Institute of Child Health and Human Development|Porter, Forbes|+1 301 435 4432|fdporter@mail.nih.gov|
20171618|NCT04377620|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20171619|NCT02059395|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
20171620|NCT05379231|National Centre for Audiology|Dr. Susan Scollie|519 661-2111|scollie@nca.uwo.ca|88948
20171621|NCT00764738|Retina Macula Institute|Dr. Ron Gallemore||rongallemoremd@gmail.com|
20171622|NCT00730405|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171623|NCT01004705|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
20171624|NCT01496807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Andrew Brohl|813-745-3242|andrew.brohl@moffitt.org|
20171625|NCT00959764|Tarsa Theapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
20171626|NCT01390649|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
20171627|NCT00389597|LDR Spine|Noah Bartsch, VP, Clinical,Regulatory,Quality|512-344-3319|noah.bartsch@ldrspine.com|
20171628|NCT00334958|Eisai Medical Services|Eisai Inc.|1-888-422-4743|esi_medinfo@eisai.com|
20171629|NCT04431453|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20171630|NCT00622401|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
20171631|NCT01194466|Mount Mercy University/The University of Iowa|Dr. Jen Lee|3193231623|jlee@mtmercy.edu|
20171632|NCT01323959|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171633|NCT02021773|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20171634|NCT00282984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20171635|NCT00191269|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
20171636|NCT00941005|University of Wisconsin - Madison|Jeffrey Larson, MD|(608) 417-6175|larsonjef@surgery.wisc.edu|
20171637|NCT02774954|USCalifornia|Ricky Bluthenthal|3234428236|rbluthen@usc.edu|
20171638|NCT01745133|DermResearch PLLC|leon kircik|5023965310|wedoderm@yahoo.com|
20171639|NCT00915278|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171640|NCT02168361|Center for Hepatitis C|Dr. Brian Pearlman|4042651044|brianpearlman3@hotmail.com|
20171641|NCT01804465|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
20171642|NCT02516046|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20171643|NCT02653183|Universitair Ziekenhuis Gent|Prof. Dr. Hilde Beele|+32 9 332 21 11|Hilde.Beele@uzgent.be|
20171644|NCT00674362|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
20171645|NCT00923156|Novartis Pharmaceuticals|Study Director|862-778-8300||
20171646|NCT01899261|Montefiore Medical Center and Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nohri@montefiore.org|
20171647|NCT00084383|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
20171648|NCT01201850|Children's Hospital Colorado|Margaret Macy, MD|720-777-5877|margaret.macy@childrenscolorado.org|
20171649|NCT03137537|Dana Farber Cancer Institute|Dr. Anju Nohria|6175257052|anohria@partners.org|
20171650|NCT04066023|Zosano Pharma Corporation|Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
20171651|NCT04665856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20171652|NCT01552694|Washington University School of Medicine|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
20171653|NCT00672243|The Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|(919) 668-1409|reard003@mc.duke.edu|
20171654|NCT00191139|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171655|NCT03386448|The Taub Group|Neal Taub MD|7044429805|nealtaub@gmail.com|
20171656|NCT03338010|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20171657|NCT01211730|Northwestern University Feinberg School of Medicine|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
20171658|NCT02465515|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171659|NCT02564796|UC San Diego|Dr. David Werho|(858) 966-5855|dwerho@rchsd.org|
20171660|NCT00293033|Meda Pharmaceuticals Inc.|Larry Gever, PharmD, Director, Medical Affairs|732-564-2400|larry.gever@meda.us|
20171661|NCT00816595|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
20171662|NCT03583697|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 792-756-5104|alice.huntsmanlabed@bmrn.com|
20171663|NCT00453063|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20171664|NCT01586065|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
20171665|NCT00114530|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20171666|NCT01577108|China Medical University Hospital|Ming Ho, MD|886422052121|mi.ho@msa.hinet.net|2063
20171667|NCT03724032|University of Michigan|Jacqueline Dobson|734-763-8469|contactHOPE@umich.edu|
20171668|NCT00751933|Haukeland University Hospital|Gunnar Nysæter or Solomon Tefera or Jan Hatlebakk|+47 55972900|jhat@helse-bergen.no|
20171669|NCT02450591|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
20171670|NCT01817530|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20171671|NCT00072566|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20171672|NCT00679432|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|mhuang@santarus.com|
20171673|NCT01558271|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171674|NCT01084083|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
20171675|NCT00873912|MedImmune, LLC|Elissa Malkin, DO|301-398-0000|malkine@medimmune.com|
20171676|NCT01466153|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenca.com|
20171677|NCT01213329|Northwestern University|Dr. Lorenzo Gallon|312-695-8900|l-gallon@northwestern.edu|
20171678|NCT03483740|University of Toronto|Andrew Eaton|4169788895|andrew.eaton@utoronto.ca|
20171679|NCT01703039|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
20171680|NCT03261973|Massachusetts General Hospital|Grace Ha|617-643-1697|gha2@mgh.harvard.edu|
20171681|NCT00895232|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
20171682|NCT01637935|Takeda|Head, Pharmacoepidemiology|+1-877-825-3327|trialdisclosures@takeda.com|
20171683|NCT02955602|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
20171684|NCT00872534|PLx Pharma|Ronald Zimmerman, CEO & President|1-713-842-1249|ron.zimmerman@plxpharma.com|205
20171685|NCT02501473|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171686|NCT01581931|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171687|NCT02734940|Virginia Commonwealth University|Dr. Jessica Potter|(804) 828-2755|jessica.potter@vcuhealth.org|
20171688|NCT02551757|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
20171689|NCT04160195|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
20171690|NCT01144286|Privatni gynekologicka ambulance|Vladimir Dvorak|+420 542 221 661|ssgcr@ti.cz|
20171691|NCT03068130|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20171692|NCT02643381|UT-Southwestern Medical Center|Gerald Matchett|214-648-6400|gerald.matchett@utsouthwestern.edu|
20171693|NCT05275400|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20171694|NCT02585960|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20171695|NCT06333613|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|osova@its.jnj.com|
20171696|NCT00709761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
20171697|NCT00541593|Baystate Medical Center|Dr. John R. Romanelli|(413) 794-3175|john.romanelli@bhs.org|
20171698|NCT01373242|University of North Carolina at Chapel Hill|Edwin Kim, MD; Director UNC Food Allergy Initiative|919-537-3193|edwinkim@email.unc.edu|
20171699|NCT04930965|Tulane University|Erin Peacock|504-988-1075|epeacoc@tulane.edu|
20171700|NCT05587296|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20171701|NCT02849678|University of Pittsburgh Medical Center Department of Anesthesiology|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
20171702|NCT00288054|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
20171703|NCT00289991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20171704|NCT02249585|Seoul National University Hospital|Dr Kook Hyun Lee, MD, PhD|82-2-2072-2467|leekh@snu.ac.kr|
20171705|NCT01610570|National Cancer Institute|Dr. Brigitte Widemann|301-496-7387|widemanb@mail.nih.gov|
20171706|NCT00961233|University of North Carolina School of Medicine|Evan S. Dellon, MD MPH|919-966-2511|edellon@med.unc.edu|
20171707|NCT01529502|Massachusetts General Hospital|Dr. Lorenzo Berra|617 724 1901|LBERRA@MGH.HARVARD.EDU|
20171708|NCT04159571|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
20171709|NCT00444912|Genzyme|Medical Information||medinfo@genzyme.com|
20171710|NCT00332163|Amgen Inc.|Study Director|866-572-6436||
20171711|NCT02340975|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
20171712|NCT01007812|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
20171713|NCT04353271|University of South Alabama|Office of Research Complaince|2514607573|swhite@southalabama.edu|
20171714|NCT01091974|University of Rochester Medical Center|Joseph A. Roscoe Ph.D.|(585) 275-9962|Joseph_Roscoe@URMC.Rochester.edu|
20171715|NCT02499783|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20171716|NCT02228460|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20171717|NCT01243892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20171718|NCT03675477|ReistoneBiopharma|Roger Liu, Medical Director|+8613917512446|roger.liu@reistonebio.com|
20171719|NCT01866293|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|212-639-6009|GiraltS@mskcc.org|
20171720|NCT03066804|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20171721|NCT03050554|UC San Diego Moores Cancer Center|Dr. Andrew Sharabi|858-534-4808|ansharabi@health.ucsd.edu|
20171722|NCT00555971|Cleveland Clinic|David M. Lang|216-444-6933|langd@ccf.org|
20171723|NCT03982368|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20171724|NCT00518284|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20171725|NCT03768414|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
20171726|NCT01152697|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
20171727|NCT02571777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20171728|NCT03706079|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
20171729|NCT00329238|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171730|NCT00801632|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20171731|NCT03292562|The University of Texas Health Science Center at Houston|Amir Khan, MD|713-500-5519|Amir.M.Khan@uth.tmc.edu|
20171732|NCT00000371|Freedom Clinic Trail, Massachusetts General Hospital|Dr. Donald Goff|617-921-7899|goff@psych.mgh.harvard.edu|
20171733|NCT00963937|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171734|NCT03846804|Indiana University School of Medicine|James Wood, MD|317-944-7260|woodjb@iu.edu|
20171735|NCT00824720|Vistakon|Brian Schwam MD/Director Clinical Affairs & Ocular Sciences|904-443-1482||
20171736|NCT02339584|Enter Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA, GDD|1-888-451-3937|alcon.medinfo@alcon.com|
20171737|NCT00743483|Swedish Orphan Biovitrum|Maria Öhman, TA Clinical Head Neonatology|+46 70 694 81 61|maria.ohman@sobi.com|
20171738|NCT01273597|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
20171739|NCT03100500|Novartis Pharmaceuticals|Director|862-778-8300|novartis.email@novartis.com|
20171740|NCT02352974|4Pharma AB|Åsa Carlsheimer|+4672244516|asa.carlsheimer@4pharma.com|
20171741|NCT02151383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20171742|NCT01785069|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20171743|NCT01088997|Children's Hospital of Philadelphia|Haresh Kirpalani, MD, MSc|215-590-2455|kirpalanih@email.chop.edu|
20171744|NCT02383498|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
20171745|NCT05570500|Ain Shams University|Dr. Omar Alaa Taqa|01001454416|o.a.taqa@hotmail.com|
20171746|NCT02761252|Menarini International Operations Luxembourg SA|Medical Director|+352 2649761|aconte@menarini.lu|
20171747|NCT01133522|Amgen Inc.|Study Director|866-572-6436||
20202651|NCT02680301|Seton Family of Hospitals/Ascension|Katherine Sebastian|801-598-2484|krsebastian@ascension.org|
20171748|NCT04997304|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
20171749|NCT00688753|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
20171750|NCT05996718|Georgia State University|Candace L. Kemp|404-413-5216|ckemp@gsu.edu|
20171751|NCT01713686|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
20171752|NCT00809276|SKCCC|Leo Luznik, MD|410-502-7732|lluznik2@jhmi.edu|
20171753|NCT02885012|Medical University of South Carolina|John Terrill Huggins|(843) 792-2296|hugginjt@musc.edu|
20171754|NCT03187197|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171755|NCT02385045|Imperial College London|Professor Julian Teare|02033126666|j.teare@ic.ac.uk|
20171756|NCT02200211|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
20171757|NCT00381485|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@spcorp.com|
20171758|NCT01235351|TIMI Study Group|Jessica L. Mega, MD, MPH|6172780145|jmega@partners.org|
20171759|NCT01918774|Richard L. Roudebush VA Medical Center|Marina Kukla|317-988-3330|marina.kukla2@va.gov|
20171760|NCT01606800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171761|NCT01182675|UCSF|Christopher C. Dvorak, MD|415-476-2188|dvorakc@peds.ucsf.edu|
20171762|NCT01135420|Department of Veterans Afairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|
20171763|NCT00717197|University of Florida|Erin M. Dunbar, MD|(352) 273-9000|edunbar@neurosurgery.ufl.edu|
20171764|NCT00982137|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20171765|NCT01811654|NYU Langone Health|Dennis Cardone, DO|212-460-0176|ariel.aponte@nyumc.org|
20171766|NCT00126191|DFCI|Ann LaCasce, MD|617-632-5959|ALACASCE@PARTNERS.ORG|
20171767|NCT01648101|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171768|NCT01340885|Oregon Health & Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
20171769|NCT00940225|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
20171770|NCT02469298|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171771|NCT00307294|University of Pittsburgh|Rita Johnson RN BSN CCRC|412-647-8571|johnsonr1@upmc.edu|
20171772|NCT04249583|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
20171773|NCT02519036|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
20171774|NCT03311724|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20171775|NCT02980601|Wake Forest Baptist Health|Joseph Molnar|336-716-4171|jmolnar@wakehealth.edu|
20171776|NCT01575769|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
20171777|NCT01619982|Stanford University|Chandra Ramamoothy|650-723-5728|chandrar@stanford.edu|
20171778|NCT03000439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171779|NCT02370160|Masonic Cancer Center at University of Minnesota|Dr. Veronika Bachanova|612-625-8287|pham0179@umn.edu|
20171780|NCT00634166|Mylan Pharmaceuticals Inc.|Eric Davis, M.D.|304.554.6503|eric.davis@mylan.com|
20171781|NCT01308060|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
20171782|NCT01473836|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171783|NCT01743131|Boston Children's Hospital|Dr. Leslie Kean|404-376-0187|leslie.kean@childrens.harvard.edu|
20171784|NCT02954237|Abbott|Jordan Anderson, Clinical Scientist|651-756-3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
20171785|NCT01244724|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
20171786|NCT00599924|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20171787|NCT01806298|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20171788|NCT03229278|Cancer Institute of New Jersey Rutgers|Dr. Biren Saraiya - Associate Professor of Medicine Medical Director, Office of Human Research Servi|732-235-5773|saraiybi@cinj.rutgers.edu|
20171789|NCT00980057|Medtronic, Inc|Adaptive CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|
20171790|NCT04980040|Takeda|Medical Director|+1 877-825-3327|trialdisclosures@takeda.com|
20171791|NCT01874132|University of Trás-os-Montes e Alto Douro|Professor Nelson Sousa|259350756|nelsons@utad.pt|+351
20171792|NCT00691015|Barbara Ann Karmanos Institute|Zaid Al-Kadhimi, M. D.|(404) 778-1900|zalkadh@emory.edu|
20171793|NCT02139228|Novartis Vaccines and Diagnostics Srl|Posting Director||RegistryContactVaccinesUS@novartis.com|
20171794|NCT00706823|University of Texas Medical School at Houston|Carin A. Hagberg, MD|713-500-6222|carin.a.hagberg@uth.tmc.edu|
20171795|NCT00592384|University of Washington|Dr. Jesse R. Fann|206 6854280|fann@uw.edu|
20171796|NCT03600818|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20171797|NCT02837328|University of Minnesota|Pamela Lutsey, PhD MPH|612-624-5812|lutsey@umn.edu|
20171798|NCT03355820|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171799|NCT03478930|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20171800|NCT04189081|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
20171801|NCT00044083|Office of the Clinical Director-NIMH-NIH-HHS|Jose A. Apud|3015946561|apudj@mail.nih.gov|
20171802|NCT00851747|Loyola Medical Center|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedical.org|
20171803|NCT02621060|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
20171804|NCT04003012|CAMC Institute of Academic Medicine|Dr. Stephanie Thompson|304-388-9911|stethompson@camc.org|
20171805|NCT02197520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171806|NCT00913497|Corewell Health|Esther Peariso|6164860358|esther.peariso@corewellhealth.org|
20171807|NCT03385564|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171808|NCT02933606|Bionomics Limited|VP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
20171809|NCT03087643|University of Verona|Dr. Massimo Venturelli|00390458415114|massimo.venturelli@univr.it|
20171810|NCT00183677|Massachusetts General Hospital|Dan Iosifescu, MD, MSc||diosifescu@partners.org|
20171811|NCT00113022|Experimental Therapeutics and Pathophysiology Branch, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
20171812|NCT01546883|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
20171813|NCT00223262|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146456950|sherwood.brown@utsouthwestern.edu|
20171814|NCT03834441|MGH|Margaret Samuels-Kalow|617-726-8340|msamuels-kalow@partners.org|
20171815|NCT02256631|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
20171816|NCT01427972|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171817|NCT01481376|Surgical Department of the Protestant Hospital|Docteur Dieter BIRK|06332 422120||
20171818|NCT00530946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20171819|NCT01534962|Menarini Ricerche S.p.A|Angela Capriati MD PhD, Head of Corporate Clinical Research|00390555680|acapriati@menarini-ricerche.it|9933
20171820|NCT02243696|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
20171821|NCT00622284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171822|NCT00457301|Lung transplant program, University of Alberta Hospital|Maria Jose Santana|780-441-1661|msantana@ualberta.ca|
20171823|NCT01919606|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
20171824|NCT01086761|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
20171825|NCT02094677|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
20171826|NCT03408483|UAB|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
20171827|NCT05399641|Scynexis|David Angulo|201-884-5471|david.angulo@scynexis.com|
20171828|NCT00478231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171829|NCT01300650|Virginia Commonwealth University|Benjamin Van Tassell|8049820997|bvantassell@vcu.edu|
20171830|NCT01702961|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
20171831|NCT00727220|IndianaU|Linda A DiMeglio|317-944-3889|dimeglio@iu.edu|
20171832|NCT02610725|Massachusetts General Hospital|Louisa G. Sylvia, Ph.D.|617-643-4804|lsylvia2@mgh.harvard.edu|
20171833|NCT04094883|University of North Carolina at Chapel Hill|Joseph Duncan, MD, PhD|919-966-2536|joseph_duncan@med.unc.edu|
20171834|NCT00147446|Northwestern University|David C. Mohr|312-503-3128|m.lisetteluistro@northwestern.edu|
20171835|NCT02302807|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20171836|NCT03835780|Centre for Musculoskeletal Research|Maya H Buch|+441613066000|maya.buch@manchester.ac.uk|
20171837|NCT01408485|St. Jude Medical|Nancy Ouch, Senior Clinical Project Manager|949-769-5000|NOuch@sjm.com|
20171838|NCT01397084|AstraZeneca|James Armbrust||aztrial_results_posting@astrazeneca.com|
20171839|NCT00036738|Fred Hutchinson Cancer Research Center|Dr. George Georges|206-667-6886|ggeorges@fredhutch.org|
20171840|NCT01751867|Janssen R&D US|SR DIR COMPD DEV TM LDR|1 908 704-5197||
20171841|NCT04932096|Oregon Health & Science University|Dr. Cydni Williams|5034945522|willicyd@ohsu.edu|
20171842|NCT01508650|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-2227|dkitzman@wakehealth.edu|
20171843|NCT02064894|CHU Ste-Justine Hospital|Dr. Sylvie Le May|514-343-6384|sylvie.lemay@umontreal.ca|
20171844|NCT01396148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171845|NCT02536040|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
20171846|NCT02577510|CF|Gaurav Gupta|6139451601|gaurav00gupta@gmail.com|
20171847|NCT00160693|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
20171848|NCT04566302|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
20171849|NCT05988619|Pomona College|Dr. Benjamin Rosenberg|408-458-5375|benjamin.rosenberg@pomona.edu|
20171850|NCT04538261|AdventHealth Orlando|D. Ashley Hill, MD|407-303-1444|Ashley.Hill.MD@AdventHealth.com|
20171851|NCT03616600|Hong Kong Polytechnic University|Dr. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
20171852|NCT00587054|Memorial Sloan-Kettering Cancer Center|Dr. Ann Jakubowski|212-639-5013|jakubowa@mskcc.org|
20171853|NCT03984994|University of Maryland|Dr. Steven J. Prior|301-405-2483|sprior@umd.edu|
20171854|NCT05873257|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
20171855|NCT03010176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171856|NCT01903187|St. Jude Medical, Inc.|Steven Madej|651-756-2230|smadej@sjm.com|
20171857|NCT00726232|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20171858|NCT01651039|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
20171859|NCT01488370|Loma Linda University Department of Anesthesiology|Elizabeth Ghazal, MD|909-558-4475|EGhazal@llu.edu|
20171860|NCT01471171|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
20171861|NCT01112865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171862|NCT00553644|Veterans Affairs Medical Center/University of Minnesota|Vicki Morrison, M.D.||morri002@umn.edu|
20171863|NCT00705484|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20171864|NCT00977860|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
20171865|NCT00119106|CDC|Dr. Michael Martin|662 580 0669|ZND9@CDC.GOV|
20171866|NCT01010061|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20171867|NCT00740831|PregLem SA|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
20171868|NCT03470441|Faraday Pharmaceuticals, Inc|Clinical Trials Manager|206-492-5310|info@faradaypharma.com|
20202652|NCT05635838|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20171869|NCT03652012|University of Arizona|Dr Ying-hui Chou|5206217447|yinghuichou@arizona.edu|
20171870|NCT01288235|Massachusetts General, Hospital|Torunn I. Yock, MD|6177262000|tyock@mgh.harvard.edu|
20171871|NCT01203098|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
20171872|NCT02650856|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
20202653|NCT03590457|Rush University|Dr. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
20202654|NCT03412630|ECOG-ACRIN Statistical Office|Study Statistician|4018639181|ecog-acrin@stat.brown.edu|
20202655|NCT02031146|University of Washington|Christina Marra, MD|206-744-3251|cmarra@uw.edu|
20202656|NCT05165394|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
20202657|NCT04957498|Stanford University School of Medicine|Dr. James Lock|(650) 723-6643|jimlock@stanford.edu|
20202658|NCT00001259|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
20202659|NCT03705494|The University of Hong Kong|Dr Kris LOK|39176690|krislok@hku.hk|
20202660|NCT01582282|Procter and Gamble|John McRorie, PhD|513-622-1423|mcrorie.jw@pg.com|
20202661|NCT00492622|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
20202662|NCT02629393|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
20202663|NCT03937986|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
20202664|NCT01853228|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
20202665|NCT02770287|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
20202666|NCT02786537|UF Hepatology Research at CTRB|Lauren Morelli|352-273-9508|lauren.morelli@medicine.ufl.edu|
20202667|NCT01330381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20202668|NCT03163342|Altimmune|Stephanie Holland, Clinical Project Manager|240|Sholland@altimmune.com|40
20202669|NCT02162979|Loma Linda University|Tonya Hamilton, reszearch Compliance Auditor|909-558-4908|thamilton@llu.edu|
20202670|NCT01357239|Novartis Pharmaceuticals|Study Director|862-778-8300||
20202671|NCT01542372|Massachusetts|Dr. Devon Hinton|617-620-4522|DHINTON1@mgh.harvard.edu|
20202672|NCT01673061|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Medicine|2154562313|mohiuddk@einstein.edu|
20202673|NCT03455543|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
20202674|NCT00852930|Vanderbilt University School of Nursing|Sheila H, Ridner, PHD|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
20202675|NCT00779038|Janssen-Cilag Belgium|Study Responsible Physician|003214649584||
20202676|NCT04109443|Boston University School of Public Health|Kimberly M Nelson, PhD|617-358-1482|knel@bu.edu|
20202677|NCT01221233|University of Delaware, Department of Physical Therapy|Dr. Jaclyn Megan Sions, PhD, DPT, PT|302-831-7231|megsions@udel.edu|
20171873|NCT00244010|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
20171874|NCT03851705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20171875|NCT02478775|University of Colorado School of Medicine|Dr. Alex Polotsky|303-704-8221|ALEX.POLOTSKY@CUANSCHUTZ.EDU|
20171876|NCT00621582|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20171877|NCT04672993|Coloplast|Senior Scientific Manager Marianne Raff Dambæk|004549112562|dkmr@coloplast.com|
20171878|NCT01387932|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
20171879|NCT02591290|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
20171880|NCT02571075|Womack Army Medical Center|Anthony Plunkett|910-643-2324|anthony.r.plunkett.civ@mail.mil|
20171881|NCT04092439|Pennington Biomedical Research Center|Tim Allerton, Ph.D.|225-763-2940|timothy.allerton@pbrc.edu|
20171882|NCT00864383|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
20171883|NCT01306942|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
20171884|NCT03676010|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Dr Carine Bellera|+33 (0)5 56 33 33 33|c.bellera@bordeaux.unicancer.fr|4495
20171885|NCT03190915|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
20171886|NCT04545385|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
20171887|NCT01128842|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
20171888|NCT04528732|Washington University in St. Louis|Dr. Proscovia Nabunya|3149359087|nabunyap@wustl.edu|
20171889|NCT00668707|The Centre for Health Innovation|Mark Legacy, Clinical Trial Coordinator|613-792-1222|mlegacy@thechi.ca|1
20171890|NCT02605824|UCSF Airway Clinical Research Center|Fahy Research Manager|415-514-1539|ariana.baum@ucsf.edu|
20171891|NCT00826943|Vanderbilt University|Douglas Tzanetos|615-942-7971|dtzanetos@hotmail.com|
20171892|NCT01382212|AbbVie|Global Medical Information|800-633-9110||
20171893|NCT01095731|Columbia University Irving Medical Center|E. Sander Connolly Jr., MD|212-305-0376|esc5@cumc.columbia.edu|
20202678|NCT03291197|Physical Medicine and Rehabilitation Ottawa Resident|Dr. Marc Monsour|6137377350|mmonsour051@gmail.com|
20202679|NCT01645280|Janssen Pharmaceuticals|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
20202680|NCT02723162|Medical University of South Carolina|Dr. Kevin Gray|843-792-9162|graykm@musc.edu|
20202681|NCT00234104|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
20202682|NCT01819922|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202683|NCT00546819|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20171894|NCT01446289|Novartis vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
20171895|NCT03329573|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171896|NCT00650260|University of South Florida Dept of Surgery/Anesthesiology|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
20171897|NCT02777333|University of Oxford|Mr P Garfjeld Roberts|01865 227374|patrick.garfjeldroberts@ndorms.ox.ac.uk|
20171898|NCT00837811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171899|NCT03307967|Yale University|Christina Lazar, Project Director|203-932-5711|christina.lazar@yale.edu|4833
20171900|NCT02578316|Eisai Inc.|Eisai Medical Services|888-||
20171901|NCT02065375|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20171902|NCT05243641|M D Anderson Cancer Center|Rachel M. Layman, MD|713) 745-8401|rlayman@mdanderson.org|
20171903|NCT05169437|Tempus AI, Inc|Virginia Rhodes, MD|(800) 976-5448|support@tempus.com|
20171904|NCT03268954|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20171905|NCT02159560|Beth Israel Deaconess Medical Center|Philip Hess|6176673112|phess@bidmc.harvard.edu|
20171906|NCT05438888|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202684|NCT04045613|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 76 302 53 10|manuel.haeckl@basilea.com|
20202685|NCT04276558|Recordati Rare Diseases Sarl|Beatrice Martin, Clinical study Manager|+33 1 47 73 64 58|martin.be@recordati.com|
20202686|NCT01243593|Sick Kids Hospital|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
20202687|NCT03114969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20202688|NCT01852344|University of Michigan|Dr. Chandra Sripada, MD PhD||csripada@umich.edu|
20202689|NCT01743027|Alcon Research, Ltd.|James Wheeler, Unit Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
20202690|NCT00450866|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
20202691|NCT05121103|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
20202692|NCT02111811|Crescenz VA Medical Center|David Oslin, MD|215-823-8594|dave.oslin@va.gov|
20202693|NCT02101008|Huntsman Cancer Institute|Kenneth Grossmann|801-587-4289|kenneth.grossmann@hci.utah.edu|
20202694|NCT02830165|University of California at Los Angeles, David Geffin School of Medicine, Radiation Oncology|Nicholas Nickols, MD|310 825-8278|nnickols@mednet.ucla.edu|50472
20202695|NCT02772783|Boston Children's Hospital|Belinda Lennerz|617 355 7476|belinda.lennerz@childrens.harvard.edu|
20202696|NCT03443024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20202697|NCT01359982|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|8582291062|boronsky@epicentrx.com|
20202698|NCT05593432|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
20202699|NCT03529214|Ariadne Labs|Dr. Amber Weiseth|206-786-0282|aweiseth@ariadnelabs.org|
20202700|NCT03291379|Biocompatibles UK Ltd|Sarah Cooper|07805354224|Sarah-Jane.Cooper@bsci.com|
20202701|NCT01926886|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20202702|NCT03368898|bakirkoy dr sadi konuk training and research hospital|İsmail Alay|+905462375638|dr_ismailalay@hotmail.com|
20202703|NCT02609399|Johns Hopkins University|Dr. Richard Rothman|410-735-6428|rrothma1@jhmi.edu|
20202704|NCT01065428|Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China|Dr. Haibo Qiu; Dr. Christer Sinderby|008613951965301|haiboq2000@yahoo.com.cn|
20202705|NCT04725682|FDA/CDER/OGD|Wei-Jhe Sun, Ph.D.|301-796-6176|ORSHSR@fda.hhs.gov|
20202706|NCT00964795|Regeneron|Clinical Trials Administrator|9148475385|clinicaltrials@regeneron.com|
20202707|NCT00153166|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
20202708|NCT02453841|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
20202709|NCT00857246|Perlmutter Cancer Center|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
20202710|NCT00072189|California Cancer Consortium|DCC Project Administrator|: 626-256-4673|CCCP@coh.org|60094
20202711|NCT02973815|School of Nursing, University of Minnesota|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
20202712|NCT04542291|Washington University School of Medicine|Kian-Huat Lim, M.D.|314-362-6157|kian-huat.lim@wustl.edu|
20202713|NCT03661541|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
20202714|NCT04095416|Henry Ford Hospital|Raef Ali Fadel|3139321347|rfadel2@hfhs.org|
20202715|NCT03037905|Cleveland Clinic|Christian N. Burchill, PhD, RN, CEN|216-445-9317|burchic@ccf.org|
20202716|NCT02862912|Columbia University|Dr. Allison Lee|212-305-6494|al3196@cumc.columbia.edu|
20202717|NCT01855789|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20202718|NCT01863758|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
20202719|NCT02606877|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202720|NCT00756977|Braintree Laboratories|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
20202721|NCT04952389|Mayo Clinic|Janalee K. Stokken, M.D.|507-284-1482|Stokken.Janalee@mayo.edu|
20202722|NCT00778999|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20202723|NCT00538642|University of Texas Health Science Center at San Antonio|Dr. Alexander Miller|210-567-5508|millera@uthscsa.edu|
20202724|NCT00345371|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
20202725|NCT00435539|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
20202726|NCT02839746|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202727|NCT02089737|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
20202728|NCT01300286|Duke University Medical Center|Dr. Ian Welsby|919-668-2699|ian.welsby@duke.edu|
20171907|NCT04698187|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
20171908|NCT03820986|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20171909|NCT02993146|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
20171910|NCT02284126|Columbia University Irving Medical Center|Dr. E. Sander Connolly Jr.|2123054118|esc5@cumc.columbia.edu|
20171911|NCT00607815|Cincinnati VA Medical Center|Dr. Kathleen M. Chard|859-572-6741|Kathleen.Chard@va.gov|
20171912|NCT02513394|Dana-Farber Cancer Institute|Erica L. Mayer, MD, MPH|617-632-3800|emayer@partners.org|
20171913|NCT02342327|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
20171914|NCT01700725|University of Wisconsin - Madison|David Rabago, MD|608-843-0850|david.rabago@fammed.wisc.edu|
20171915|NCT03192462|Baylor College of Medicine|Dr. Benjamin Musher|(713)798-3750|blmusher@bcm.edu|
20171916|NCT04840615|National Cancer Institute|Dr. Raffit Hassan|240760-6232|rh276q@nih.gov|
20171917|NCT03128424|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
20171918|NCT01511315|UCSF Psoriasis Center|Mio Nakamura, MD|4154764701|mio.nakamura@ucsf.edu|
20171919|NCT01898806|Columbia University|Grace Ulerio|212-305-6953|gu2102@cumc.columbia.edu|
20171920|NCT03003390|Yale University|Dr. E. Vincent S Faustino|203-785-4651|vince.faustino@yale.edu|
20171921|NCT02140372|NYU School of Medicine|Binita Shah|212-263-4235|binita.shah@nyumc.org|
20171922|NCT03576976|New York State Psychiatric Institute|Dr. Alice Medalia|646-774-8482|am2938@cumc.columbia.edu|
20171923|NCT03156543|University of Michigan Medical School|Bethany Ruffino|734 615-0768|bruffino@med.umich.edu|
20171924|NCT03364023|Medtronic Neurovascular Clinical Affairs|Medtronic Neurovascular Clinical Affairs|9498373700|rs.nvclinicalprospr-sea@medtronic.com|
20171925|NCT04666051|Menoufia Univeristy|M. Ashraf BAlbaa|+20482224216|mohamed.balbaa@med.menofia.edu.eg|
20171926|NCT02957305|Dep. of Obstetrics and Gynecology, Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brazil|Ricardo Francalacci Savaris|+5551997781966|rsavaris@hpca.edu.br|
20171927|NCT00674700|Stallergenes|Michel Roux, Medical Director|+33 1 55 59 2970|mroux@stallergenes.com|
20171928|NCT00395304|Penn State Hershey College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
20171929|NCT02356575|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao, MD, MSCE|646-888-0866|maoj@mskcc.org|
20171930|NCT00903396|Mayo Clinic|Michele Halyard, M.D.|4803014567|mhalyard@mayo.edu|
20171931|NCT01389817|Medical College of Wisconsin|Harry T. Whelan M.D.|414-266-3466|hwhelan@mcw.edu|
20171932|NCT01749137|Rhythm Pharmaceuticals, Inc|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
20171933|NCT01758432|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
20171934|NCT02871297|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
20171935|NCT02966028|Sanifit|SVP Clinical Development Operations|18582815976|Claire.Padgett@sanifit.com|
20202729|NCT00744055|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
20202730|NCT02767570|Stanford University|Julie Kolesar, PhD|614-561-1563|julie14@stanford.edu|
20202731|NCT04426630|Yale University School of Medicine|Dr. Jeremy Schwartz|2036801598|jeremy.schwartz@yale.edu|
20202732|NCT01306058|Principal Investigator|Dr. Tim Greten|301-451-4723|tim.greten@nih.hhs.gov|
20202733|NCT03842709|University of New Mexico-Dept of Neurosciences|ERIN MILLIGAN,|505-272-4411|EMilligan@salud.unm.edu|
20202734|NCT00984659|GlaxoSmithKline|GSK Response Center|866-435-7343||
20202735|NCT02757547|Philips|Pat Olsen|(303) 475-3417|pat.olsen@philips.com|
20202736|NCT02424149|Hartford Hospital|Katie Propst, MD|860-972-4338|katie.propst@hhchealth.org|
20202737|NCT03063255|Department of Anesthesiology, NF/SG Veterans Health System|Dr. Jose R. Soberon, Jr.|352-413-2317|jsoberon@anest.ufl.edu|
20202738|NCT01633060|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20202739|NCT04460027|Stanford Prevention Research Center, Department of Medicine, Stanford University|Judith J. Prochaska, PhD|650-724-3608|jpro@stanford.edu|
20202740|NCT01057121|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
20202741|NCT03633331|City of Hope Comprehensive Cancer Center|Mina S. Sedrak MD, MS|626-218-4173|msedrak@coh.org|
20202742|NCT01009294|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20202743|NCT01856673|CISALVA, Universidad del Valle|Maria Isabel Gutierrez|+57-2-5577206|maria.gutierrez@correounivalle.edu.co|103
20202744|NCT02168946|Rempex Pharmaceuticals, A Wholly Owned Subsidiary of Melinta Therapeutics, Inc.|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
20202745|NCT02457897|NIDDK|Dr. Rebecca Brown|301-594-0609|Rebecca.Brown@NIH.gov|
20202746|NCT03134963|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
20202747|NCT00138151|Rutgers Cancer Institute of New Jersey|Lorna Rodriguez, MD, PhD|732-235-8675|rodriglo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20202748|NCT02624700|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|(804) 828-0450|AskMassey@vcu.edu|
20202749|NCT02675517|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202750|NCT01950078|Huazhong University of Science and Technology|Dr. Xianwei Zhang|027 83663173|znpin@sina.cn|
20171936|NCT00621985|Children's Hospital Boston|Joseph Majzoub|617-355-7476|joseph.majzoub@childrens.harvard.edu|
20202751|NCT00301067|Northwestern University|Clinical Trials Office|312-695-1301||
20202752|NCT00149825|Stanford University, School of Medicine|Rachel Manber, PhD|650-724-2377|Rmanber@stanford.edu|
20202753|NCT00069121|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20202754|NCT00942708|UT Southwestern|Kelly Chin|214-645-5989|kelly.chin@utsouthwestern.edu|
20202755|NCT00995371|Coastal Orthopedics & Sports Medicine|Lois A. Davis|941-782-1353|ldavis@coastalorthopedics.com|
20202756|NCT00673673|Yale University|Dr. Jill Lacy|203-737-1600|jill.lacy@yale.edu|
20202757|NCT03851510|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
20202758|NCT02613572|Scheie Eye Institute; Perelman School of Medicine; University of Pennsylvania|Benjamin J. Kim, MD|215-662-8675|benjamin.kim@uphs.upenn.edu|
20202759|NCT00953121|Preston Robert Tisch Brain Tumor Center at Duke University Medical Center|Dr. Annick Desjardins|919-684-1691|annick.desjardins@duke.edu|
20171937|NCT00573469|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20171938|NCT03719885|Penn Medicine|Research Coordinator|215-662-9393|jonathan.lilley@pennmedicine.upenn.edu|
20171939|NCT01896544|Massachusetts General hospital|Tiffany M.N. Otero|4074950753|totero@partners.org|
20171940|NCT03130257|Kaiser Permanente Washington Health Research Institute|Beverly B. Green, MD, MPH|206-287-2997|Bev.B.Green@kp.org|
20171941|NCT01089062|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
20171942|NCT03095066|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20171943|NCT04592874|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
20171944|NCT01976338|Novartis|Study Director|862-778-8300||
20171945|NCT02853604|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
20171946|NCT03766581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20171947|NCT00520936|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20171948|NCT03716024|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
20171949|NCT04343261|Saint Francis Hospital and Medical Center|Latha Dulipsingh, MD|860-714-4402|Latha.Dulipsingh@trinityhealthofne.org|
20171950|NCT02123121|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
20171951|NCT02010840|The Hog Kong Polytechnic University|Vivian Ngai|2766|vivian.ngai@polyu.edu.hk|6775
20171952|NCT04182763|Oregon Health & Science University|Allison Gregory, MS CGC, Project Manager|503-494-4344|gregorya@ohsu.edu|
20171953|NCT02535312|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
20171954|NCT03739593|Aerie Pharmaceuticals, Inc|Kevin Kerr, Director of Clinical Development|(949) 526-8701|kkerr@aeriepharma.com|
20171955|NCT00370032|GlaxoSmithKline|GSK Response Center|866-435-7343||
20171956|NCT05683249|Neurocentria Inc.|Clinical Development|925-954-4868|info@neurocentria.com|
20202760|NCT01145391|University of Colorado Denver School of Medicine|Amy Huebschmann|303-724-2268|amy.huebschmann@ucdenver.edu|
20202761|NCT00970294|University of Kansas Medical Center|Patricia Kluding PT PhD|913-588-6918|pkluding@kumc.edu|
20202762|NCT01134510|Cedars-Sinai Medical Center|Stanely Jordan, MD|310-428-8186|stan.jordan@cshs.org|
20202763|NCT04579393|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Jeffrey Strich, MD|301.496.9320|jeffrey.strich@nih.gov|
20202764|NCT01333189|University of Colorado, Denver|Cory L Christiansen, PT, PhD|303-724-9101|cory.christiansen@ucdenver.edu|
20202765|NCT02312986|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
20202766|NCT00393458|Novartis Pharmaceuticals|Study Director|862 778-8300||
20202767|NCT01739595|Repros Therapeutics Inc|Jennifer Wike|2817193402|jwike@reprosrx.com|
20202768|NCT02509546|City of Hope Medical Center|Dr. Vinod Pullarkat, MD|626-359-8111|vpullarkat@coh.org|
20202769|NCT02104180|Mylan Medical SAS|Benoit LA ROCHE|+33 1 46 25 86 76|benoit.la-roche@mylan.com|
20202770|NCT01535937|NYSPI|Elias Dakwar, MD|646.774.8728|elias.dakwar@nyspi.columbia.edu|
20202771|NCT02704429|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
20202772|NCT03557372|Dana Farber Cancer Institute|Dr. Shyam Tanguturi|617-632-0000|stanguturi@partners.org|
20202773|NCT00104104|Novatis Pharmaceuticals|Study Director|862-778-8300||
20202774|NCT01326962|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
20202775|NCT00793585|1st Affiliated Hospital, Sun Yat-Sen University|Xueqing Yu , M.D. & Ph.D.|8620-87766335|yuxq@mail.sysu.edu.cn|
20202776|NCT03425656|Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.|Dr. Reza Safaei, M.D|0098-9124548684|safaiino@sina.tums.ac.ir|
20202777|NCT00035815|Mayo Clinic|Eric J. Sorenson, MD|507 538-1037|sorenson.eric@mayo.edu|
20202778|NCT02209597|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
20202779|NCT00003270|Roswell Park Comprehensive Cancer Center|Dr. Theresa Hahn|716-845-5819|theresa.hahn@roswellpark.org|
20202780|NCT02747628|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
20202781|NCT01089725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20202782|NCT01928030|Stanford University|Dr. Mark Pegram, Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
20202783|NCT02858193|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
20202784|NCT01783522|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Beth Faiman|216-444-3705|faimanb@ccf.org|
20202785|NCT00266110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20202786|NCT01266148|Novartis Pharmaceuticals|Study director|862-778-8300||
20202787|NCT01269125|Dept. of Ob/Gyn, Patra University School of Medicine, Greece|Apostolos Kaponis, M.D.|+30-2610999569|kaponisapostolos@hotmail.com|
20202788|NCT03635190|Cardio Flow, Inc.|Michael J Kallok, PhD|16512531754|mjkallok@cardioflow.net|
20202789|NCT00970203|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
20202790|NCT00417612|Yale University School of Medicine|Dr. Thomas O. Carpenter|203-785-6526|thomas.carpenter@yale.edu|
20202791|NCT03774745|University of California, Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
20202792|NCT01712438|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
20202793|NCT03216265|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20202794|NCT01539837|Imperial College London|David Dexter|+44 (0)20 7594 6665|d.dexter@imperial.ac.uk|
20202795|NCT00849693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20202796|NCT00224107|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20203021|NCT02657252|UPECLIN|Dr. Matheus Bertanha|+551438116305|matheus.fameca@ig.com.br|
20171957|NCT05393895|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
20171958|NCT00968513|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
20171959|NCT01521546|The Ohio State University|Subha V. Raman, MD|(614)293-8963|raman.1@osu.edu|
20171960|NCT01964430|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20171961|NCT02423993|Endocrinology Research Centre, Moscow|Dr. Lyudmila Ibragimova|+7 9266180811|doc_mila@mail.ru|
20171962|NCT02002091|Algiers' university -1- Benyoucef Benkhedda, Faculty of Medicine Meherzi, Algiers.|Dr Wafia- Nadia Nibouche-Hattab|+213771810932|wani16000@yahoo.fr|
20171963|NCT02846714|Huntsman Cancer Institute University of Utah|Dr. Yelena Wu|8012135653|yelena.wu@utah.edu|
20171964|NCT02467075|University of Michigan, Department of Radiology|Matthew Davenport, MD|734-232-2095|matdaven@med.umich.edu|
20171965|NCT01146834|Weill Cornell Medicine|Ruben Niesvizky, MD|646-962-9376|run9001@med.cornell.edu|
20171966|NCT02083783|Tris Pharma, Inc.|Antonio Pardo MD|732-823-4755|apardo@trispharma.com|
20171967|NCT00255125|Kansas City VA Medical Center|Dr. Peter Van Veldhuizen|816-861-4700|peter.vanveldhuizen@va.gov|
20171968|NCT04967443|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20171969|NCT01654536|Sunovion|Respiratory Medical Director|1-866-503-6351||
20171970|NCT00834171|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
20171971|NCT03943147|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
20171972|NCT00418457|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
20171973|NCT00629707|University of California, Davis|Dr. Nicole Glaser|916-734-7098|nsglaser@ucdavis.edu|
20171974|NCT02267083|Gem Pharmaceuticals, LLC|Elizabeth Moore, Regulatory Affairs Agent|8583532019|elizabethmoore109@comcast.net|
20171975|NCT00363883|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
20171976|NCT00968201|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20171977|NCT03736447|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
20171978|NCT02619175|Loewenstein Rehabilitation Hospital|Mrs. Shirley Handelzalts|972-9-7709010|peregshir@gmail.com|
20171979|NCT02657369|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20171980|NCT00361569|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
20171981|NCT04875195|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
20171982|NCT00074152|International Breast Cancer Study Goup|Barbara Ruepp|+4131 3899222|barbara.ruepp@ibcsg.org|
20171983|NCT01072331|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
20171984|NCT01594762|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
20171985|NCT03338998|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
20171986|NCT02612727|Minnesota Medical Research Foundation (now Hennepin Healthcare) and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
20171987|NCT04524689|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
20171988|NCT01354977|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einstein.yu.edu|2903
20171989|NCT00612690|University of Illinois at Chicago|Marc S. Atkins, Ph.D.|312-413-1048|atkins@uic.edu|
20171990|NCT04869644|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
20171991|NCT00680862|VHA|Henry Anaya|310-478-3711|henry.anaya@va.gov|48488
20171992|NCT04487730|Weill Cornell Medicine|Dr. Nili Solomonov|212-746-5886|nis2051@med.cornell.edu|
20171993|NCT00907777|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20171994|NCT03875885|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0677|radellin@wakehealth.edu|
20171995|NCT02674529|University of Pittsburgh|Project Research Coordinator|412-376-3913|neppacham@upmc.edu|
20171996|NCT02891850|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20171997|NCT01651195|Helsinki University Central Hospital|Prof. Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
20171998|NCT02543437|Stryker Japan|Yasuyuki Inatsugu, Associate manager of clinical affairs|81 3 6894 8394|yasuyuki.inatsugu@stryker.com|
20171999|NCT03797014|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel Chua|14107065704|jchua@ihv.umaryland.edu|
20172000|NCT01970397|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
20172001|NCT03903874|University of Alabama at Birmingham|Dr. Dori Pekmezi|205-975-8061|dpekmezi@uab.edu|
20172002|NCT03305575|Tufts Medical Center|Alaa Basura, MD|6176365000|abasura@tuftsmedicalcenter.org|6208
20172003|NCT00105469|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172004|NCT03444961|Cleveland Clinic|Dr. Aleksandra Rachitskaya|216-445-9519|rachita@ccf.org|
20172005|NCT01509950|Stanford University|Research Operations Manager|6507255720|agirsen@stanford.edu|
20172006|NCT04115839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20172007|NCT03808545|University of Alabama at Birmingham|Brooks Wingo, Associate Professor|2059345982|bcwingo@uab.edu|
20172008|NCT00790023|Sunovion|Respiratory Medical Director|1-866-503-6351||
20172009|NCT01338792|USC Norris Comprehensive Cancer Center|Jacek Pinski, MD|323-865-3900|pinski_j@ccnt.usc.edu|
20172010|NCT00618072|New York Medical College|Harriette R. Mogul MD MPH|914-594-2278|Harriette_Mogul@NYMC.edu|
20172011|NCT02151591|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Lisa Fucito|203-200-1470|Lisa.fucito@yale.edu|
20172012|NCT03644212|Maimonides Medical Center|Sara Meeder|7182837253|smeeder@maimonidesmed.org|
20172013|NCT03555591|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20202797|NCT00950352|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
20202798|NCT00098345|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20172014|NCT00684593|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172015|NCT00617773|Recepta Biopharma|Dr. Oren Smaletz, M.D., Medical Director|55 11 3709-2140|oren.smaletz@receptabiopharma.com.br|
20172016|NCT05526716|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClincalTrialsDisclosure@msd.com|
20172017|NCT01354990|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172018|NCT02170298|UC Davis|Julie B Schweitzer|916-703-0294|jschweitzer@UCDAVIS.EDU|
20172019|NCT00777608|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20172020|NCT04213079|Icahn School of Medicine at Mount Sinai|Sergei Yakushin|212-241-9349|sergei.yakushin@mssm.edu|
20172021|NCT00844714|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|phsue@medsfgh.ucsf.edu|
20172022|NCT00975650|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
20172023|NCT04220866|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172024|NCT03858309|Oregon Health & Science University (OHSU)|Selda Yildiz, PhD|(503) 494-7219|yildiz@ohsu.edu|
20172025|NCT03897465|Lohmann & Rauscher GmbH & Co. KG|Dr Daria Trofimenko, Senior Manager Clinical Regulatory Affairs|+49 (0) 2631 99 6385|Daria.Trofimenko@de.LRMed.com|
20172026|NCT02713347|VA|Dr. David Bekelman|7207236388|david.bekelman@va.gov|
20172027|NCT02197247|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
20172028|NCT05973981|RAND|William Shadel|412-683-2300|shadel@rand.org|4489
20172029|NCT00790985|Primus Pharmaceuticals|Robert Levy, MD., Director of Clinical Development|480-483-1410|Rlevy@primusrx.com|
20172030|NCT00601458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20172031|NCT05469178|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
20172032|NCT01328431|Yale University|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
20172033|NCT02158273|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
20172034|NCT03617185|University of Michigan|Brian Callaghan, MD|7349367183|Bcallagh@med.umich.edu|
20172035|NCT02801396|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
20172036|NCT02446483|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172037|NCT02899793|Yale University School of Medicine|Dr. Alessandro Santin|203-737-4450|alessandro.santin@yale.edu|
20172038|NCT01805154|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
20172039|NCT03310021|Portola Pharmaceuticals|Head of Clinical Development|6502767153|ClinicalTrials@Portola.com|
20172040|NCT04087096|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|EWYU@mgh.harvard.edu|
20172041|NCT00702923|University of Wisconsin Carbone Cancer Center|Douglas McNeel, M.D., Ph.D.|(608) 263-4198|dm3@medicine.wisc.edu|
20172042|NCT03685968|The University of Texas Health Science Center at Houston (UTHealth)|Elizabeth M. Gendel|+1 (713) 500-3587|Elizabeth.M.Gendel@uth.tmc.edu|
20172043|NCT03965039|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
20172044|NCT02771093|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20172045|NCT03322631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20202799|NCT01183858|Hoffmann-La Roche|Medical Communications|800-821-8590|genetech@druginfo.com|
20202800|NCT01048125|University of Missouri-Columbia|Dr. Anand Chockalingam|573/882-2296|chockalingama@health.missouri.edu|
20202801|NCT02046564|Otsuka Pharmaceutical Co. Ltd.|Director of Clinical Trials|+81-3-6361-7366||
20202802|NCT01419249|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
20202803|NCT01295905|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
20202804|NCT03707977|Harvard T.H. Chan School of Public Health|Molly Pretorius Holme|617-432-4377|mpretori@hsph.harvard.edu|
20202805|NCT00641147|Johns Hopkins University|Study Coordinator|410-955-3817|lhylind1@jhmi.edu|
20202806|NCT00791128|GI Dynamics, Inc.|Project Manager, Clinical and Regulatory|781.357.3263|kwoessner@gidynamics.com|
20202807|NCT01629667|MedImmune, LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20202808|NCT00353977|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
20202809|NCT05207436|VA San Diego Healthcare System|Leslie Morland|858-226-5765|leslie.morland@va.gov|
20202810|NCT03472534|Castle Creek Pharmaceuticals|Dr. Mary Spellman/Chief Medical Officer|862-286-0400|mspellman@castlecreekpharma.com|
20202811|NCT02614794|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
20202812|NCT03756012|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
20202813|NCT01731691|Institute for Human Genetics and Biochemistry|Dr. Cynthia L. Bristow|631-444-6238|cynthia.bristow@stonybrook.edu|
20202814|NCT03396471|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
20202815|NCT02796144|University of North Carolina at Chapel Hill|Lars Fredrik Jarskog, MD|919-843-7683|lars_jarskog@med.unc.edu|
20202816|NCT01319929|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20202817|NCT03237845|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
20202818|NCT04355117|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20202819|NCT03865407|Virginia Commonwealth University|Cristin Kaspar, MD|804-628-3866|cristin.kaspar@vcuhealth.org|
20202820|NCT03233048|Mayo Clinic|Dr. Imad Absah|507-266-0114|absah.imad@mayo.edu|
20202821|NCT00491530|Abbott|Medical Information Specialist|800-633-9110||
20202822|NCT00883753|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20202823|NCT02859415|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@mail.nih.gov|
20202824|NCT00691574|Oregon Health & Science University|Alfred Lewy, MD, PhD|(503) 494-7746|lewy@ohsu.edu|
20172046|NCT01646762|Mayo Clinic|Dr. Rafael Fonseca|480-301-4280|fonseca.rafael@mayo.edu|
20172047|NCT02412618|VCU Medical Center|Dr. Frances Casey|804-828-7877|frances.casey@vcuhealth.org|
20172048|NCT02378961|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
20172049|NCT01253408|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
20172050|NCT02557555|Rutgers New Jersey Medical School|Assistant Professor|4133869415|ajantoni@gmail.com|
20172051|NCT04338074|University of Alabama at Birmingham|Dr. Timothy J Ness|205-975-9643|tness@uabmc.edu|
20172052|NCT02051686|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
20172053|NCT00335478|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
20172054|NCT02405780|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|0044 1896 668 173|Clinical-Trials@fk-b.com|
20172055|NCT04502693|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
20172056|NCT00602797|University of Nebraska Medical Center|Apar Ganti|402-559-5622|aganti@unmc.edu|
20172057|NCT02494297|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
20172058|NCT01996852|Case Comprehensive Cancer Center|Dr. Amy Zhang|+1 216-368-0968|amy.zhang@case.edu|
20172059|NCT02784431|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
20172060|NCT03715530|University of Iowa|Dr. Mark Santillan|319-356-3180|mark-santillan@uiowa.edu|
20172061|NCT00382252|Institut Bergonie|Dr Françoise Bonichon||F.Bonichon@bordeaux.unicancer.fr|
20172062|NCT01600638|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
20172063|NCT00039130|Duke University Medical Center|David Rizzieri, M.D.||rizzi003@dm.duke.edu|
20172064|NCT03288129|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
20172065|NCT02657915|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
20172066|NCT00701675|Ralp H. Johnson VA Medical Center|Olga Brawman-Mintzer, MD|8437242302|mintzero@musc.edu|2834
20172067|NCT01949506|Froedtert and the Medical college of Wisconsin|Meena Bedi, MD|414-805-4400|mbedi@mcw.edu|
20172068|NCT02915016|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
20172069|NCT04292743|Lombardi Comprehensive Cancer Center|Marcus Noel|202-444-2223|Marcus.S.Noel@gunet.georgetown.edu|
20172070|NCT05766423|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
20172071|NCT01664533|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20172072|NCT00844831|University of Louisville|John M. Wo, MD|502-852-6991|johnwogi@gmail.com|
20172073|NCT05255068|The University of Iowa|Wen Liu|3193557104|wen-liu-1@uiowa.edu|
20172074|NCT00540514|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20172075|NCT03291808|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
20172076|NCT04988646|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
20172077|NCT02468414|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
20172078|NCT00004978|Division of Biostatistics, University of Minnesota|James Neaton, PhD|612-626-9040|jim@ccbr.umn.edu|
20172079|NCT01044862|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
20172080|NCT01652703|Amgen Inc.|Study Director|866-572-6436||
20172081|NCT00062374|Memorial Sloan-Kettering Cancer Center|Dr. David P. Kelsen|646-888-4179|kelsend@mskcc.org|
20172082|NCT01532414|Repros Therapeutics Inc.|Jennifer L Wike, Director of Regulatory Affairs|281-719-3402|jwike@reprosrx.com|
20172083|NCT00869349|Brigham and Women's Hospital|Nancy A. Shadick|617-732-5266|nshadick@partners.org|
20172084|NCT03633695|AcuFocus, Inc.|Magda Michna, PhD., Chief Global Clinical, Medical and Regulatory Affairs Officer|(949) 585-9511|mmichna@acufocus.com|
20172085|NCT00187486|University of California San Francisco|Michael Prados, MD|415 353 2076|PradosM@neurosurg.ucsf.edu|
20172086|NCT02728050|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
20172087|NCT01223001|The Rehabilitation Hospital of Indiana|Dr. Lance Trexler|(317)879-8940|lance.trexler@rhin.com|
20172088|NCT01438957|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172089|NCT03052725|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
20172090|NCT01448486|St. Vincent's Hospital, Sydney|Prof. Bruce Brew|61 2 8382 1111|b.brew@unsw.edu.au|4100
20172091|NCT01061177|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
20172092|NCT01539538|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
20172093|NCT00847379|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
20172094|NCT02864498|DS Biopharma|Study Director|+353 1 2933590|regulatory.dsbiopharma@DSBiopharma.com|
20172095|NCT02256189|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
20172096|NCT00378378|Merck, Sharp & Dohme Corp.|Senior Vice Presiden, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20172097|NCT00407797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172098|NCT01812174|Artivion, INC|Erica Troup , Clinical Project Manager|706-409-5974|erica.troup@artivion.com|
20172099|NCT04950998|University of Southern California|Dr. Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
20172100|NCT03250845|UZ Leuven|Datamanager|+3216346880|jonas.vanham@uzleuven.be|
20172101|NCT02019693|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
20172102|NCT03822078|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20172103|NCT01854710|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
20172104|NCT03132220|University of Colorado School of Medicine|Dr. Meredith Mealer|303-724-6857|Meredith.Mealer@cuanschutz.edu|
20172105|NCT00518986|Cephalon, Inc.|Medical monitor|1-800-896-5855||
20172106|NCT00018031|NIAID/NIH|Dr. Shyam Kottilil|301-435-036|skottilil@niaid.nih.gov|
20172107|NCT04456959|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172108|NCT01434030|University of Virginia|Boris P Kovatchev, Ph.D.|434-924-5592|bpk2u@virginia.edu|
20172109|NCT02389361|ASTES|Dr. DEFLANDRE Eric|0032477764241|eric.deflandre@gmail.com|
20172110|NCT00393029|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven Rosenberg, M.D., Ph.D.|301-496-4164|Steven.Rosenberg@nih.gov|
20172111|NCT03547583|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
20172112|NCT05853185|Liaquat University of Medical and Health Sciences|Dr. Sarang Suresh|03154044802|hotchandanisarang@gmail.com|
20172113|NCT01744197|Evergreen Hematology and Oncology|Melanie Matson, RN, BSN|5094642873|mmatson@evergreen4cure.com|
20172114|NCT04706091|Massachusetts General Hospital|John W Winkelman, MD PhD|617-724-7426|jwwinkelman@mgh.harvard.edu|
20172115|NCT01063868|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
20172116|NCT02166905|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|chong.wang@roswellpark.org|
20172117|NCT02617628|University of Pennsylvania Office of Research Services|W. Stuart Watson|215-573-6707|wswatson@upenn.edu|
20172118|NCT03278873|MeiraGTx|Program Manager|0044 (0)20 3866 4320|ocularinfo@meiragtx.com|
20172119|NCT04785677|Florida State University|Stephen Tripodi|850-645-1572|stripodi@fsu.edu|
20172120|NCT05405309|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
20172121|NCT01886794|University of Texas Medical Branch|Kathleen L. Vincent, M.D.|409-772-2610|klvincen@utmb.edu|
20172122|NCT05670236|Cleveland Clinic Foundation|Dr. Patrick Corrigan|216-618-9932|corrigd4@ccf.org|
20172123|NCT04518306|George Medicines Pty Limited|Anthony Rodgers (Principal Investigator)|+44 7983 578 290|arodgers@georgeinstitute.org|
20172124|NCT02801331|University of Pittsburgh School of Medicine|Elisabeth B Salisbury, PhD|14122465378|salisburye2@upmc.edu|
20172125|NCT02443987|Gloucestershire Hospitals NHS Foundation Trust|Dr Sharan Athwal|0300 422 2222|sharan.athwal@glos.nhs.uk|
20172126|NCT00946478|UCSD Dermatology|Dr. Tissa Hata|858-657-8390|ucsddermstudies@gmail.com|
20172127|NCT00887653|THE MIRIAM HOSPITAL|Aadia Rana|4017934680|arana@lifespan.org|
20172128|NCT03069378|Memorial Sloan Kettering Cancer Center|Dr. Ciara Kelly, MD|646-888-4312|Kellyc1@mskcc.org|
20172129|NCT01397708|Alaunos Therapeutics, Inc|Jaymes Holland Clinical Consultant|6502732627|jholland@alaunos.com|
20172130|NCT04334902|Heuron|Yoomi Kim_Clinical Research Team Leader|01035173212|yoomi_kim@iheuron.com|
20172131|NCT03480646|Constellation, Inc.|Clinical Program Lead|1-844-667-1992|medinfo@morphosys.com|
20172132|NCT01638546|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
20172133|NCT03396367|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
20172134|NCT05330702|University of Iowa|Shaoping Zhang|(319) 335-7386|shaoping-zhang@uiowa.edu|
20172135|NCT02881554|University of Washington|Dr. Smith Apisarnthanarax, Principal Investigator|+1 206 598-4100|apisarn@uw.edu|
20172136|NCT05231954|Indiana University|Katrina Coppedge|317-278-1602|kcoppedg@iu.edu|
20172137|NCT05947643|Washington University, Department of Otolaryngology - Head and Neck Surgery|Dorina Kallogjeri, Assoc.Professor of Otolaryngology|314-362-1077|kallgjerid@wustl.edu|
20172138|NCT02129725|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
20172139|NCT02397278|Stanford University|Michael Fadell II|3037241111|mfadell@stanford.edu|
20172140|NCT01304316|University of Pennsylvania|Dr. Elliot V. Hersh|215-898-9686|evhersh@pobox.upenn.edu|
20172141|NCT02820753|Northwestern University|Stephanie Batio|312-503-4684|stephanie.batio@northwestern.edu|
20172142|NCT02161731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172143|NCT02381288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20172144|NCT01315678|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
20172145|NCT02471430|Massachusetts General Hospital|Mathias Lichterfeld|617-726-2000|mlichterfeld@mgh.harvard.edu|
20172146|NCT00331682|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
20172147|NCT02155608|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
20172148|NCT02380677|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
20172149|NCT05426902|Duke University|Amanda Eudy, MSPH, Ph.D.|919-681-1811|amanda.eudy@duke.edu|
20172150|NCT02584673|The Cooper Health System|Irwin Gratz|856-968-8527|gratz-irwin@cooperhealth.edu|
20172151|NCT02599129|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
20172152|NCT02515058|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
20172153|NCT03808493|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20172154|NCT01029795|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172155|NCT03217175|MGH Diabetes Research Center|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
20172156|NCT02552199|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
20172157|NCT03487276|InflaRx N.V.|Dr. Korinna Pilz, MD, MSc|+49 89 414 189 78 00|Korinna.Pilz@InflaRx.de|
20172158|NCT05035550|Michigan State University|Dr. Jason Moser|517-355-2159|jmoser@msu.edu|
20172159|NCT01806545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20172160|NCT00429273|University of California, Los Angeles|James T. McCracken, M.D.|310-825-0470|jmccracken@mednet.ucla.edu|
20202825|NCT00949650|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172161|NCT00144963|Talon Therapeutics|VP, Regulatory Affairs|650-228-5066|ttarlow@talontx.com|
20172162|NCT00884312|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20172163|NCT00224042|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
20172164|NCT00840450|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
20172165|NCT00461045|Triphase Accelerator|Associate Director of Clinical and Regulatory Operations|858-295-4337|jennifer.ki@triphaseco.com|
20172166|NCT03814356|Massachusetts General Hospital|Brian L. Edlow, M.D.|617-724-6352|bedlow@mgh.harvard.edu|
20172167|NCT04390191|Icahn School of Medicine at Mount Sinai|Dr. Neomi Shah|212-241-6286|neomi.shah@mssm.edu|
20172168|NCT03978832|Indivior Inc|PERSERIS Medicines Development Lead and Head Global Clinical Operations and Development|804 379-1090|regan.fong@indivior.com|
20172169|NCT00003499|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20172170|NCT01744574|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
20172171|NCT01256008|Wenzhou Medical University|Director of Clinical Trials|+86 0577 55579363|hjc@wmu.edu.cn|
20172172|NCT02244606|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
20172173|NCT02248103|Faculty of Oral and Dental Medicine Cairo University|Ass. Prof. Dr. Noha Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
20172174|NCT01402492|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
20172175|NCT00730132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20172176|NCT02227758|St Jude Medical/Abbott|Clinical Study Director||rdiaz@sjm.com|
20172177|NCT02296320|MedImmune, LLC|Hasan S. Jafri|301-398-4431|information.center@astrazeneca.com|
20172178|NCT03282682|Comenius University in Bratislava|Doc. Mgr. Milan Sedliak, PhD.|+421918340671|milan.sedliak@uniba.sk|
20172179|NCT05466682|NYU Langone Health|Mia T Minen, MD|212-263-7744|mia.minen@nyulangone.org|
20172180|NCT01930123|Duke University|Brian J. Soher, Ph.D.|919-684-7350|brian.soher@duke.edu|
20172181|NCT03208244|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|Chung.Raymond@mgh.harvard.edu|
20172182|NCT02334358|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
20172183|NCT03953820|Aquestive Therapeutics|Denis Scheper, Director of Portfolio Management and Clinical Operations|(908)941-1887|denis.scheper@aquestive.com|
20172184|NCT03334539|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
20172185|NCT04974697|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
20172186|NCT03706456|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
20172187|NCT03302234|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172188|NCT03889444|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20172189|NCT02644135|UHCMC|Dr. Robert Salata|2168443293|robert.salata@uhhospitals.org|
20172190|NCT02795832|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20172191|NCT01845831|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
20172192|NCT00221403|Ohio State Medical Center/Nationwide Children's Hospital|Robert Kowatch, MD, PhD|(614) 355-2872|Robert.Kowatch@nationwidechildrens.org|
20172193|NCT00779285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
20172194|NCT02695329|Zimmer Biomet G.K.|Clinical Affairs Senior Manager|+81-6402-6777|takahito.nakai@zimmerbiomet.com|
20172195|NCT01348165|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172196|NCT01929343|UT Southwestern Medical Center|Josh Becker|2146485277|joshua.becker@utsouthwestern.edu|
20172197|NCT02417974|Boston Medical Center and BU School of Medicine|Alan Moss, MD, PhD|617-638-6116|alan.moss@bmc.org|
20172198|NCT01892293|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
20172199|NCT03602482|Pennsylvania State University College of Medicine|Dr. Amanda J. Miller|7175317676|aross1@pennstatehealth.psu.edu|
20172200|NCT02114814|The Ohio State University|Dr. Jie Hu|6146880394|hu.1348@osu.edu|
20172201|NCT02601469|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
20172202|NCT05276401|Lakewood Amedex|Dr. Adam Ruskin|941-225-2514|ARuskin@LakewoodAmedex.com|
20172203|NCT01411774|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
20172204|NCT00056316|University of Missouri-St. Louis|Ann M. Steffen, PhD, Associate Professor|314-516-5382|ann_steffen@umsl.edu|
20172205|NCT04617509|Gesynta Pharma AB|Charlotte Edenius|+46733864246|charlotte.edenius@gesynta.se|
20172206|NCT03292588|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
20172207|NCT00617123|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172208|NCT00133952|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
20172209|NCT00314093|University of Texas Southwestern Medical Center|Dr. Ellen Vitetta|214-648-1200|ELLEN.VITETTA@UTSouthwestern.edu|
20172210|NCT03809117|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
20172211|NCT05048784|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
20172212|NCT01603056|ALK-Abelló A/S|Vivian Wang, Sr. Medical Affairs Manager|86 - 10 5166 8198|Vivian.Wang@alk.net|
20172213|NCT01246401|Yale University|Dr. Sandra Springer||sandra.springer@yale.edu|
20172214|NCT03462082|University of Rochester|Karlo J Lizarraga, MD, MS / Assistant Professor of Neurology|585-341-7500|karlo.lizarraga@gmail.com|
20172215|NCT00919724|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iu.edu|
20172216|NCT00166114|University of Miami School of Medicine|Dominique Musselman, MD, MSCR|404-723-8361|dmusselman@med.miami.edu|
20172217|NCT02335294|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
20172218|NCT00545168|ParaPRO LLC|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
20172219|NCT00960778|Medical University of South Carolina|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
20172220|NCT03508921|Vanderbilt Medical Center|Melissa Kaufman, MD, PhD Professor of Urology|615-322-3807|melissa.kaufman@vumc.org|
20172221|NCT00859053|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20202826|NCT02282332|MedStar Health Research Institute|Scientific Center Adminstrator|(301) 560-7300|Research@medstar.net|
20172222|NCT04028700|University of North Carollina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.karafin@unchealth.unc.edu|
20172223|NCT01898611|University of Pennsylvania|Anne Cappola, MD|215-573-5359|acappola@mail.med.upenn.edu|
20172224|NCT02548650|University of Florida College of Medicine - Jacksonville|Dominick J Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
20172225|NCT04251169|SOLTI|Sara Cano|34 664 449 862|info@gruposolti.org|
20172226|NCT02128113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20172227|NCT00299104|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
20172228|NCT03680105|Reven Pharmaceuticals|Head, Global Clinical Affairs|13036691336|kristina.cabala@reven.com|
20172229|NCT03210376|UT MD Anderson Cancer Center|Dr. Wendell H. Williams III / Anesthesiology & Perioperative Medicine|713-563-0034|WHWilliams@mdanderson.org|
20217970|NCT00680186|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172231|NCT00521014|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
20172232|NCT04866225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172233|NCT00982878|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
20172234|NCT03722966|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|
20172235|NCT01336764|National Center for PTSD|Steven H. Woodward, PhD|650-493-5000|steve.woodward@va.gov|22111
20172236|NCT01626391|TauRx Therapeutics Ltd|Dr. Jiri Hardlund|+44 (0)1224438550|JHH@taurx.com|
20172237|NCT02573311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172238|NCT00603889|Albert B. Sabin Vaccine Institute|Dr. David Diemert, Director of Clinical Trials|202-842-5025|david.diemert@sabin.org|
20172239|NCT05537883|Wake Forest University Health Sciences|Selwan Barbat, MD|704-355-2000|Selwan.Barbat@atriumhealth.org|
20172240|NCT02099708|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20172241|NCT05229406|Center for Healthy Minds, University of Wisconsin - Madison|Simon B. Goldberg, PhD|608-265-8986|sbgoldberg@wisc.edu|
20172242|NCT04171050|University of California, Los Angeles|Tamara Grisales, MD|310-983-1023|tgrisales@mednet.ucla.edu|
20172243|NCT01370356|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172244|NCT01658072|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
20172245|NCT00040664|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172246|NCT05451225|Columbia University|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
20172247|NCT02856035|Department of Veterans Affairs, N Fl/S Georgia VA Medical Center|Dr. Janis J Daly|216 402 8940|jjd17@case.edu|
20172248|NCT01233258|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
20172249|NCT01049308|VA Loma Linda Healthcare System|Dr Helme Silvet|9095836097|helme.silvet@va.gov|
20172250|NCT03845985|UMass Chan Medical School|Melissa L. Anderson, Associate Professor of Psychiatry|508-856-5820|melissa.anderson@umassmed.edu|
20172251|NCT01318993|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172252|NCT01269463|Rhodes Pharmaceuticals L.P.|Inder Chaudhary, PhD|401-262-9272|inder.chaudhary@rhodespharma.com|
20172253|NCT00558558|UT MD Anderson Cancer Center|Ying Guo, MD - Associate Professor|713-745-2327|jaallo@mdanderson.org|
20172254|NCT01125605|Pascoe pharmazeutische Praeparate GmbH|Director of Clinical Trials|0049 641 7960100|klinische.forschung@pascoe.de|
20172255|NCT02549937|HUTCHMED Limited|Martin Benes|+1.973.306|martinb@hutch-med.com|4490
20172256|NCT00317356|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20172257|NCT03199274|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|john.eisenbrey@jefferson.edu|
20172258|NCT05980182|Virginia Commonwealth University|Dr. Maria Thomson|804-628-2640|mthomson2@vcu.edu|
20172259|NCT01352546|Plastic Surgery Professional Association|Peter T. Pacik, MD, FACS|603 387 7735|ptpacik@verizon.net|
20172260|NCT00638378|Incyte Corporation|Study Director|1-855-463-3463||
20172261|NCT00583778|MetroHealth Medical Center|Dr. Rita Cydulka|216-778-7800|rcydulka@gmail.com|
20172262|NCT00441883|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
20172263|NCT03761277|Medtronic Neuromodulation Clinical Research|Pain Therapies Clinical Research Director|763-514-4000|rs.embracetdd@medtronic.com|
20172264|NCT00684307|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20172265|NCT00543140|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
20172266|NCT00578812|NuVasive, Inc|Julie Pairamore, Sr. Manager, Clinical Affairs|858-320-5258|jpairamore@nuvasive.com|
20172267|NCT04532164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
20172268|NCT02483520|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588-1673|Kwilliams1@kumc.edu|
20172269|NCT01104493|MedImmune, LLC|Dr. Robert Gasser|301-398-0000|gasserr@medimmune.com|
20172270|NCT00846430|Corewell Health|Dr. Albert Cornelius|616-391-2086|albert.cornelius@helendevoschildrens.org|
20172271|NCT02269241|Exeltis|Dr. Enrico Colli, Chief Scientific Officer|+34917711500|enrico.colli@exeltis.com|
20172272|NCT03020160|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20172273|NCT02270957|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405 822 2336|joan-merrill@omrf.org|
20172274|NCT01513473|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
20172275|NCT03291054|Northwell|Richard Carvajal, MD|516-734-8900|rcarvajal2@northwell.edu|
20172276|NCT04166435|Yale University|Dr. Michael Cecchini|(203) 737-3472|michael.cecchini@yale.edu|
20172277|NCT01218204|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172278|NCT00743340|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20172279|NCT00489541|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
20172280|NCT05131646|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
20172281|NCT00003479|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
20172282|NCT01312272|VISN 22 Mental Illness Research, Education, and Clinical Center|Dr. Michael C. Davis|3104783711|mcdavis@mednet.ucla.edu|49234
20172283|NCT02042183|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-844-2830|clinicaltrials@mnk.com|5
20172284|NCT02254252|Mashhad University of Medical Sciences|Pouya Nezafati|00989151578421|nezafatip871@mums.ac.ir|
20172285|NCT01192516|Veterans Affairs--Ann Arbor Health Care System|Research Health Science Specialist|734-936-2123|sumurphy@umich.edu|
20172286|NCT02321800|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
20172287|NCT01051323|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20172288|NCT01193868|The University of Texas MD Anderson Cancer Center|George Blumenschein, MD / Professor|713-792-2734|CR_Study_Registration@mdanderson.org|
20172289|NCT04605484|AlloVir, Inc.|Richard Riese|617-433-2605|rriese@allovir.com|
20172290|NCT03647033|National University Hospital|Dr. David Chen|+6594550281|david_chen@nuhs.edu.sg|
20172291|NCT04171531|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
20172292|NCT00265798|University of Chicago|Dr. Hedy L. Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
20172293|NCT01401582|Geman Centr for Neurodegenerative Diseases (DZN)|PD Dr. JR Thyrian|+49383486|rene.thyrian@dzne.de|7592
20172294|NCT04862585|Ohio State University|Mike Berger, PharmD|614-366-0556|michael.berger@osumc.edu|
20172295|NCT04124757|LUMC|Martijn Boon MD PhD|003171522301|m.boon@lumc.nl|
20172296|NCT03366337|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20172297|NCT05288062|Mayo Clinic|Wilson I. Gonsalves, MD|507-266-5947|Gonsalves.Wilson@mayo.edu|
20172298|NCT00769392|Lahey Clinic|Gregory Blaha, MD|781-744-2580|christine.gould@lahey.org|
20172299|NCT01667029|Massachusetts General Hospital|Dr. Brian Wainger|617-726-8810|Brian.Wainger@mgh.harvard.edu|
20172300|NCT01025752|VA Connecticut Healthcare System|Dr. Alicia Heapy|203-932-5711|alicia.heapy@va.gov|2299
20172301|NCT04026308|UAMS|Michael Wilson|501-686-8729|MPWilson@uams.edu|
20172302|NCT01537393|CaseWestern|Dr. Jonathan Lass|2168448368|Jonathan.Lass@UHhospitals.org|
20172303|NCT01697566|M.D. Anderson Cancer Center|Karen H. Lu, MD|713-745-8902|khlu@mdanderson.org|
20172304|NCT00459953|Stanford University|Joel D Killen|(650) 723-5895|jkillen@stanford.edu|
20172305|NCT01447433|Changhai Hospital|Prof. Donglian Cai|86 21 81873168|nutrition1226@126.com|
20172306|NCT00036270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172307|NCT01578187|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
20172308|NCT04518293|George Medicines Pty Limited|Anthony Rogers (Principal Investigator)|+44-7983 578 290|arodgers@georgeinstitute.org|
20172309|NCT02516163|Stryker SP|Holly Solomon|+61 2 9467 1072|Holly.Solomon@stryker.com|
20172310|NCT03170401|University of Washingtion|Dr. Grant E O'Keefe|206-744-8016|gokeefe@uw.edu|
20172311|NCT01709162|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20172312|NCT01874054|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
20172313|NCT04746963|AsclepiX Therapeutics|Dr A Shojaei|800-572-3545|info@asclepix.com|
20172314|NCT00799422|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
20172315|NCT00880009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172316|NCT01217801|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
20172317|NCT04584645|Evidation Health|Director, Enterprise Research Design|650-389-9550|results@evidation.com|
20172318|NCT00390468|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|caperez@mdanderson.org|
20172319|NCT00545662|Columbia University|Dr. William Friedewald|212-305-3017|wtf1@columbia.edu|
20172320|NCT02457260|University of Pittsburgh|Daniel E. Forman - Chief of a section of Geriatrics Cardiology|412-864-2507|formand@pitt.edu|
20172321|NCT04112784|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
20172322|NCT00496808|UT MD Anderson Cancer Center|Raphael E Pollock,PHD/Professor Emeritus, Surgical Oncology|(713) 792-6928|CR_Study_Registration@mdanderson.org|
20172323|NCT02010775|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
20172324|NCT00256750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
20172325|NCT04659161|Karuna Therapeutics, Inc.|Inder Kaul, VP Clinical Development|1-888-783-0380|medinfo@karunatx.com|
20172326|NCT01003288|University of Bergen|Professor Rebecca Cox|+4755974668|rebecca.cox@uib.no|
20172327|NCT00901316|Texas Children's Hospital|Sheldon L. Kaplan, MD|832-824-4330|skaplan@bcm.edu|
20172328|NCT02197130|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172329|NCT02615145|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20172330|NCT02320669|Seattle Childrens hospital|Michael A Portman|206-987-1014|michael.portman@seattlechildrens.org|
20172331|NCT00592943|Massachusetts General Hospital; Harvard Medical School|Thomas J. Spencer, MD|(617) 726-1731|tspencer@partners.org|
20172332|NCT00565045|MetroHealth Medical Center|Dr. Jayme Knutson|216-778-8364|jsk12@case.edu|
20172333|NCT03648983|Montefiore Medical Center|Lisa Wiechmann||lwiechma@montefiore.org|
20172334|NCT03129178|University of Portsmouth|Dr Anthony Shepherd|02392 84|ant.shepherd@port.ac.uk|5289
20172335|NCT00456014|Stony Brook University School of Medicine|Ramin V. Parsey, MD, PhD|631-444-3084|Ramin.Parsey@stonybrookmedicine.edu|
20172336|NCT04404361|CTI BioPharma Corp.|John Volpone|206-351-7663|jvolpone@ctibiopharma.com|
20172337|NCT00217594|NHLBI, NIH|Chris Hourigan MD|301-451-0257|hourigancs@mail.nih.gov|
20172338|NCT02812160|Spatz FGIA Inc.|Jeffrey Brooks MD|1-516-303-0613|jeff@spatzmedical.net|
20172339|NCT00903695|UOklahoma Health Sciences Center|Marilee Monnot, PhD|405-456-5773|marilee-monnot@ouhsc.edu|5773
20172340|NCT04882540|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
20172341|NCT01804296|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
20172342|NCT01342796|Novartis Vaccines and Diagnostics|Posting Director||Novartis.email@novartis.com|
20172343|NCT02033694|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
20172344|NCT00786682|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
20172345|NCT03489720|Vanderbilt University Medical Center|Dr. Uma Shastri|615-936-3198|uma.shastri@vumc.org|
20172346|NCT03143894|Johns Hopkins University|Tracy Vannorsdall, PhD|410-502-3701|TVannor1@jhmi.edu|
20172347|NCT02442869|University of Nevada, Reno|Dr. Jacqueline Pistorello|775-784-4648|pistorel@unr.edu|
20172348|NCT03521934|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
20172349|NCT00727025|Dartmouth-Hitchcock|Dr. Carolyn Kerrigan|603 650-5148|carolyn.l.kerrigan@hitchcock.org|
20172350|NCT02101060|Salem VA Medical Center|Dr. Krisann Oursler|540-982-2463|krisann.oursler@va.gov|4981
20172351|NCT00038857|MDAnderson Cancer Center|Dr. Richard E. Champlin|713-792-8750|celsaenz@mdanderson.org|
20172352|NCT01391559|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
20172353|NCT03729960|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
20172354|NCT00127660|University of Minnesota|Lisa Harnack, DrPH|612-626-9398|harna001@umn.edu|
20172355|NCT01833520|UT MD Anderson Cancer Center|Vivek Subbiah,Associate Professor, Invest. Cancer Therapeutics|(713) 563-0393|vsubbiah@mdanderson.org|
20172356|NCT03266107|Relievant Medsystems Inc.|VP Clinical Affairs|(650) 368-1000|dsahr@relievant.com|280
20172357|NCT03454997|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
20172358|NCT03784729|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
20172359|NCT01191801|Sunesis Pharmaceuticals, Inc|Judy Fox, Chief Scientific Officer|(650) 266-3736|jfox@sunesis.com|
20172360|NCT00426855|Kantonsspital Aarau|Dr. Peter Moosmann|+41 62 838 60 51|peter.moosmann@ksa.ch|
20172361|NCT03348956|Dartmouth Hitchcock Medical Center|Victoria Lawson|(603) 650-5104|victoria.h.lawson@hitchcock.org|
20172362|NCT01146418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172363|NCT03926169|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20172364|NCT03789474|ALL INDIA INSTITUTE OF MEDICAL SCIENCES,RISHIKESH,UTTARAKHAND,INDIA.|Dr M KESARI|7093005219|kesyellow@yahoo.com|
20172365|NCT03708328|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20172366|NCT04523220|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
20172367|NCT00571948|Research Institute of Child Nutrition|Dortmund Intervention Trial for Optimization of Infant Nutrition|0049 231 7922100|kersting@fke-do.de|
20172368|NCT03936985|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
20172369|NCT02030041|PGIMER|Anil Bhansali|01722756583|ashuendo@gmail.com|
20172370|NCT01032837|Hoffman-LaRoche|Medical Communications|800-821-8590||
20172371|NCT00843024|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172372|NCT05201703|University of Florida - Jacksonville|Dr. Katherine Zarroli|3025615456|katherine.zarroli@jax.ufl.edu|
20172373|NCT02006719|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
20172374|NCT03123913|University of Rochester Medical Center|Chad Heatwole, MD, MS-CI|585-275-7867|dystrophy_registry@urmc.rochester.edu|
20172375|NCT02517567|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
20172376|NCT02439138|Dana-Farber Cancer Institute|Jorge J. Castillo|617-632-6045|jorgej_castillo@dfci.harvard.edu|
20172377|NCT03727347|Aerin Medical, Inc.|Anais Laborde|(650) 518-9624|alaborde@aerinmedical.com|
20172378|NCT00006237|SWOG statistical office|SWOG Melanoma Statistician|206-667-4408||
20172379|NCT00585247|University of Ccalifornia, Irvine. Beckman Laser Institute|Dr. Kristen Kelly|949.824.7997|kmkelly@uci.edu|
20172380|NCT01257087|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
20172381|NCT01846416|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
20172382|NCT00787852|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
20172383|NCT01737697|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
20172384|NCT01362205|Denver Health Medical Center|Katie Overdier RN|303 602 1479|Katie.Overdier@dhha.org|
20172385|NCT02207244|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
20172386|NCT01372462|Clinical Research Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
20172387|NCT01866930|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
20172388|NCT00750815|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
20172389|NCT02288897|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|865-769-4011|wachter@pvct.com|23
20172390|NCT02579239|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
20172391|NCT02521870|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
20172392|NCT00279305|Type 1 Diabetes TrialNet|Carla Greenbaum, MD||cjgreen@benaroyaresearch.org|
20172393|NCT02862171|International Partnership for Microbicides|Dr John Steytler|+27 21 8602300|jsteytler@ipmglobal.org|
20172394|NCT03930797|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
20172395|NCT00662012|Uniformed Services University of Health Sciences (USUHS)|Naomi Aronson, MD|(301) 295-3621|naomi.e.aronson.civ@mail.mil|
20172396|NCT01893632|NYSPI|john mariani, md|646-774-6140|john.mariani@nyspi.columbia.edu|
20172397|NCT02144012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20172398|NCT04656691|UnitedHealth Group/Optum Labs|Tracy Ziolek , Vice President, Human Research Affairs|215-868-3114|tracy_ziolek@uhg.com|
20172399|NCT03779724|Aksaray University Training and Research Hospital|The principal investigator|905555289493|mlk.aykut@gmail.com|
20172400|NCT02846779|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
20172401|NCT02959307|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
20172402|NCT00887978|United Therapeutics Corporation|Kevin Laliberte, PharmD|919-425-8350|klaliberte@unither.com|
20172403|NCT04023526|OncoVerity|Clay Smith, MD Chief Medical Officer|7204981136|csmith@oncoverity.com|
20172404|NCT02470234|Rhodes Pharmaceuticals L.P.|Dr. Akwete Adjei|401-262-9408|akwete.adjei@rhodespharma.com|
20172405|NCT00345345|National Heart Lung and Blood Institute|Stefan F Cordes, Principal Investigator, M.D., Ph.D.|+1 240 383 6460|stefan.cordes@nih.gov|
20172406|NCT02324569|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
20172407|NCT01943292|Verastem|Lou Vaickus, MD, FACP/Chief Medical Officer|781-292-4200|lvaickus@verastem.com|
20172408|NCT00996216|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172409|NCT05519540|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
20172410|NCT03825315|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
20172411|NCT01693653|NYU Langone Medical Center, Center for Musculoskeletal Care|Yusuf Yazici|646-501-7400|yusuf.yazici@nyumc.org|
20172412|NCT02038023|AUERBACH HEMATOLOGY ONCOLOGY ASSOC|Dr Michael AUERBACH|410-780-4050|MAUERBACHMD@ABHEMONC.COM|
20172413|NCT00759031|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
20172414|NCT00309387|University of Parma|Giovanni Maraini, MD|+39 0521 238527|maraini@unipr.it|
20172415|NCT00208091|Clinical Motor Physiology Laboratory|Dr. Seth Pullman|212-305-3808|sp31@columbia.edu|
20172416|NCT02113592|Kaiser Permanente Washington Health Research Institute|Lynn DeBar, PhD, MPH, Principal Investigator|206-287-2900|lynn.debar@kp.org|
20172417|NCT03684811|Forma Therapeutics, Inc.|Medical Affairs|(617) 679-1970|medicalinformation@formatherapeutics.com|
20172418|NCT01599234|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
20172419|NCT04492618|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-4256|Mangold.Aaron@mayo.edu|
20172420|NCT01148940|Albert Einstein College of Medicine|Dr. Henny Billett|718-430-2186|hbillett@montefiore.org|
20172421|NCT02495168|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
20172422|NCT00799604|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
20172423|NCT01425281|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
20172424|NCT01987505|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
20172425|NCT04677374|University of North Carolina at Chapel Hill|Mitch Matoga, MD, MS|00265 1 755056|mmatoga@email.unc.edu|
20172426|NCT04202965|Protagonist Therapeutics, Inc|Clinical Study Director|1-888-899-1543|ptgxclintrials@ptgx-inc.com|
20172427|NCT02794883|Northwestern University, Feinberg School of Medicine|Karan Dixit, MD|312-503-4724|karan.dixit@northwestern.edu|
20172428|NCT00187369|Sunnybrook Health Sciences Center|Dr Jon Barrett||jon.barrett@sunnybrook.ca|
20172429|NCT01774604|Penn State Hershey Medical Center/Dartmouth-Hitchcock Medical Center|John M. Levenick|603-667-1332|jlevenick@hmc.psu.edu|
20172430|NCT01727297|Medtronic, Inc.|Medtronic Cardiac Rhythm and Heart Failure clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
20172431|NCT00586001|Boston University Charles River Campus|Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
20172432|NCT02348606|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
20172433|NCT05374434|Lumendo|Mark Bispinghoff|+41 44 589 68 02|mark.bispinghoff@lumendo.ch|
20172434|NCT01044771|Metropolis Medical|Dr. Fritz Bredeek|415 292 5477|fritz@doctor.com|
20172435|NCT05820685|The University of Texas Health Science Center at Houston|John Harvin, MD, FACS|713-500-7244|John.Harvin@uth.tmc.edu|
20172436|NCT00420927|Abbott|Global Medical Services|1-800-633-9110||
20172437|NCT03018704|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
20172438|NCT00320411|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172439|NCT01110434|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
20172440|NCT04448171|Mayo Clinic|John Occhino, M.D., M.S.|507-538-5883|Occhino.John@mayo.edu|
20172441|NCT01115101|University of Rostock|Dr. Max Dieterich|+493814401|max.dieterich@uni-rostock.de|4500
20172442|NCT02454296|University of Hawaii|Reni Soon, MD|808-203-6548|rsoon@hawaii.edu|
20172443|NCT00211809|Icahn School of Medicine at Mount Sinai|Dr. Andrea Allen|212-241-3176|andrea.allen@mssm.edu|
20172444|NCT01417234|KCI|VP, Global Clinical Development|12102555595|jane.hart@acelity.com|
20172445|NCT00023764|Memorial Sloan-Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
20172446|NCT00823095|Loma Linda University Medical Center|Deborah Dodge|(909) 558-4000|ddodge@llu.edu|48500
20172447|NCT01525563|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
20172448|NCT01844518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
20172449|NCT03129100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20172450|NCT03725098|Biom'up|William Spotnitz, MD, MBA|351-514-5009|w.spotnitz@biomup.com|
20172451|NCT01587001|National Jewish Health|Nabeel Hamzeh|303-270-2613|hamzehn@njhealth.org|
20172452|NCT02756013|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Peter Rose|+1 216-444-6601|ROSEP@ccf.org|
20172453|NCT01197560|Celgene|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
20172454|NCT00211510|Medtronic, Inc|John Shin, PhD, MBA|818 576 4019|john.shin@medtronic.com|
20172455|NCT01487200|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
20172456|NCT01962896|University of Texas Southwestern Medical Center|Theodore Laetsch, MD|214-648-5475|ted.laetsch@utsouthwestern.edu|
20172457|NCT02837783|Ironwood Pharmaceuticals, Inc.|Lara Lane|(617) 621-7722|llane@ironwoodpharma.com|
20172458|NCT00496054|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
20172459|NCT02216591|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
20172460|NCT00680706|Baystate Medical Center|Howard Smithline|413-794-3433|howard.smithline@baystatehealth.org|
20172461|NCT01950741|Pusan National University Hospital|Ji Eun Lee, Assoicated professor|+82-51-240-7957|jlee@pusan.ac.kr|
20172462|NCT00508716|Griffin Hospital|Dr. Dorothea Wild|203 7327327|dwild@griffinhealth.org|
20172463|NCT02854631|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
20172464|NCT02233647|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
20172465|NCT03844646|Stanford University|Sun H. Kim, MD, MS|650-723-8284|sunhkim@stanford.edu|
20172466|NCT00176228|Uillinois|Dr. Mani Pavuluri|312 4130064|mpavuluri@psych.uic.edu|
20172467|NCT00621153|AstraZeneca|Gerard Lynch|+44 1509 64589|aztrial_results_posting@astrazeneca.com|4589
20172468|NCT00753415|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172469|NCT04212650|Steadman Philippon Research Institute|Suzanne Liv Page, JD|970-401-8770|spage@sprivail.org|
20172470|NCT04936256|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
20172471|NCT01753856|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172472|NCT02136810|Yale School of Medicine|Dr. Robert Schonberger, PI|203-785-2802|robert.schonberger@yale.edu|
20172473|NCT05284656|Al-Azhar University|Amira Reda Muhammad|0106 822 0389|amira.reda89@hotmail.com|
20172474|NCT00858130|University of North Carolina at Chapel Hill|Dr. Stephan Moll, Professor of Hemology/Oncology|919-966-3311|stephan_moll@med.unc.edu|
20172475|NCT00040937|SWOG|Robert Z. Orlowski, MD,PhD|(713) 792-2860|rorlowsk@mdanderson.org|
20172476|NCT00806390|UMaryland|Stephen Gottlieb|410-328-8788|sgottlie@medicine.umaryland.edu|
20172477|NCT04567225|The Cleveland Clinic Foundation|Dr. Mohammed Al-Jaghbeer|216-476-7983|ALJAGHM@ccf.org|
20172478|NCT02016560|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
20172479|NCT00911820|Dana-Farber Cancer Insitute|Peter Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
20172480|NCT02804932|University of Iowa|Dr. Darren Casey|13193841009|darren-casey@uiowa.edu|
20172481|NCT00963547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172482|NCT00279591|University of Arkansas for Medical Sciences|Dr. Michael Stroud|501-364-1861|StroudMichaelH@uams.edu|
20172483|NCT02430311|Astrazeneca|Gershon Locker|+1 773 868 0184|Gershon.Locker@astrazeneca.com|
20172484|NCT02511184|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172485|NCT02111772|University of Virginia|Dr. Peter W. Heymann|434-242-8209|pwh5a@virginia.edu|
20172486|NCT01824901|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
20172487|NCT02950025|Washington University School of Medicine|Michael C. Roach, M.D.|314-747-1786|roachm@wustl.edu|
20172488|NCT00869206|Christiana Care Health System|Andrew L. Himelstein, MD|(302) 366-1200|ahimelstein@cbg.org|
20172489|NCT00085631|Duke University Medical Center|Dr Mark Dewhirst|919 6683726|joan.cahill@dm.duke.edu|
20172490|NCT01349790|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
20172491|NCT03902574|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
20172492|NCT02376361|Albany Medical College|Loay Salman, MD|518-262-5176|SalmanL@amc.edu|
20172493|NCT00284050|Novartis Pharmaceuticals|Study Director|862 778-8300||
20172494|NCT02573350|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
20172495|NCT02708121|Department of Health Education and Behavior, College of Health and Human Performance, University of Florida|Dr. Megan McVay|(352)294-7029|megan.mcvay@ufl.edu|
20172496|NCT01111149|University of Minnesota|Dr. S. Hossein Fatemi|612-626-3633|fatem002@umn.edu|
20172497|NCT02221947|Neurotrope BioScience, Inc|Vice President, Regulatory Affairs|973-826-5109|dcrockford@neurotropebioscience.com|
20172498|NCT03857243|UTSW|Timea Hodics, M.D.|(240)-423-2741|Timea.Hodics@UTSouthwestern.edu|
20172499|NCT03765918|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
20172500|NCT04394286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
20172501|NCT01484197|Novartis Pharmaceuticals|Study Director|862-778-8300||
20172502|NCT00814164|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
20172503|NCT00299975|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
20172504|NCT03012165|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
20172505|NCT01238471|Rambam Medical Center|Professor Imad Makhoul|972-4-8542219|makhoul@rambam.health.gov.il|
20172506|NCT01169493|Duke University Medical Center|Brett D. Atwater, MD|9196848111|brett.atwater@duke.edu|
20172507|NCT05228132|Becton Dickinson|Joshua Black, Clinical Project Manager|520-599-6124|joshua.black@bd.com|
20172508|NCT03167411|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
20172509|NCT05883449|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
20172510|NCT02266225|University of Waterloo|Dr. Lora Giangregorio|519-888-4567|lora.giangregorio@uwaterloo.ca|36357
20172511|NCT00642460|Hoffman-LaRoche|Medical Communications|800-821-8590||
20172512|NCT02088047|University of Arkansas for Medical Sciences|Betholyn Gentry|(501) 603-1010|bfgenry@uams.edu|
20172513|NCT00660309|Novartis Pharmaceuticals|Study Director|862-778-8300||
20172514|NCT01191398|University of Texas Southwestern Dallas Medical Center|Craig J. Huang, MD|214-456-6371|craig.huang@utsouthwestern.edu|
20172515|NCT00589563|City of Hope Medical Center|Dr. Ryotaro Nakamura|626-256-4673|rnakamura@coh.org|65285
20172516|NCT01217814|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
20172517|NCT01218243|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@yahoo.com.cn|
20202827|NCT02278146|Skyline Urology|Fredrick Wolk, MD|+1 310.602.5005|fred.wolk@skyuro.com|
20202828|NCT02436239|Allergan|Armin Szegedi, MD, PhD, Vice President CNS Clinical Development|714-246-4500|IR-CTRegistration@allergan.com|
20202829|NCT03671369|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
20202830|NCT02235285|The Department of Plastic Surgery, Winners Clinic|Dr. Cheol Hwan Kim|.+82.2.511.9446|winners511@naver.com|
20202831|NCT02612077|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
20202832|NCT01971476|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20202833|NCT02498821|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0835|Gina.Gilbert@crbard.com|
20202834|NCT04901507|Virginia Commonwealth University School of Dentistry|Dr. Caroline Carrico|804-828-8328|ckcarrico@vcu.edu|
20202835|NCT01716169|Stanford School of Medicine|Dr. Alfred Lane|650 721 7166|atlane@stanford.edu|
20202836|NCT00466752|University of Washington / Seattle Cancer Care Alliance|Evan Yu|206-288-1152|evanyu@u.washington.edu|
20172518|NCT00830362|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
20172519|NCT02701400|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
20172520|NCT00833794|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
20172521|NCT00663169|Novartis Pharmaceuticals|Study Director|862-778-8300||
20172522|NCT00471328|Novartis Pharmaceuticals|Study Director|862-778-8300||
20172523|NCT00519831|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
20172524|NCT04051008|SUNY Buffalo|Stephanie Anzman-Frasca|17168296692|safrasca@buffalo.edu|
20172525|NCT01179568|Columbia School of Social Work|M. Katherine Shear, MD|212-851-2176|ks2394@columbia.edu|
20172526|NCT00598832|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
20172527|NCT01900704|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
20172528|NCT01414010|Beth Israel Deaconess Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
20172529|NCT02142959|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
20172530|NCT02970422|McGill University|Emilie Michalovic, Ph.D. Candidate|514-941-6450|emilie.michalovic@mail.mcgill.ca|
20172531|NCT00679302|Southern Illinois University, School of Medicine|Dr. Myto Duong, Pediatric Emergency Medicine Director|217-545-7409|myto_duong@yahoo.com|
20172532|NCT03547687|Oregon Health Science University|Dr. Julia Durrant|503-494-0353|durrantj@ohsu.edu|
20172533|NCT03898362|VA Pittsburgh Healthcare System|Dr. Brad Dicianno|412-822-3700|brad.dicianno@va.gov|
20172534|NCT05542576|Amydis, Inc.|Matthew Lehman|6463317899|matt.lehman@amydis.com|
20172535|NCT04600921|Department of Internal Medicine, Division of Cardiology, Medical University of Graz|Dr. Dirk von Lewinski|+4331638580684|dirk.von-lewinski@medunigraz.at|
20172536|NCT02700815|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172537|NCT03631472|Gala Therapeutics|James Stambaugh SVP of Clinical Affairs|4087186834|jstambaugh@galatherapeutics.com|
20172538|NCT02267811|Biolux Research, Ltd.|Dr. Peter Brawn|6046690674|p.brawn@bioluxresearch.com|
20172539|NCT02239978|Salt Lake City VA|Dr. Daniel Peterson|6028242279|daniel.peterson1@asu.edu|
20172540|NCT00602953|UT Southwestern Medical Center, Dallas, TX|Dr. ILDIKO LINGVAY|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
20172541|NCT01850550|Penn State Hershey Medical Center|Jennifer Kraschnewski|717-531-8161|jkraschnewski@hmc.psu.edu|
20172542|NCT01852110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172543|NCT02141282|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
20172544|NCT00875212|Federal University of Paraiba|Fabio Correia Sampaio (research leader)|+55 83 3216 7795|fabios@ccs.ufpb.br|
20172545|NCT01752907|Amgen Inc.|Study Director|866-572-6436||
20172546|NCT03098550|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
20172547|NCT01204853|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172548|NCT01384760|ChineseUHK|Dr Susanna S Ng|(852) 98075787|drsssng123@yahoo.com.hk|
20172549|NCT00630396|Georgia Health Sciences University|David Hess, MD|706-721-1691|dhess@georgiahealth.edu|
20172550|NCT01479517|Rock Dental Clinic|Christina Sletten, DDS|719-599-9700||
20172551|NCT02990910|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|744734170@qq.com|
20172552|NCT01206608|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
20172553|NCT00719134|Beth Israel Deacxoness Medical Center|Rami Burstein|617 735 2832|rburstei@bidmc.harvard.edu|
20172554|NCT00760578|Metabolic Solutions Development Company|Jerry Colca, PhD|269-343-6732|jcolca@msdrx.com|
20172555|NCT02989194|Visterra|Chief Medical Officer|617-498-1070|clinicaltrials@visterrainc.com|
20172556|NCT00471068|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
20172557|NCT04160091|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
20172558|NCT04113304|Wayne State University|"Dr. Kathleen Lucy McGoron"|313.664.2500|Lucy.K.McGoron@wayne.edu|
20172559|NCT04159025|Washington University School of Medicine|Alexander Chen, M.D.|314-454-8764|chenac@wustl.edu|
20172560|NCT00381095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172561|NCT02692716|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
20172562|NCT00856284|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
20172563|NCT04271605|National Taiwan University BioMedical Park Hospital Chu-Tung Campus|Chirn-Bin Chang|0972654906|G03776@hch.gov.tw|
20172564|NCT02485301|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172565|NCT01059825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172566|NCT02041286|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
20172567|NCT00106392|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
20172568|NCT03342690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172569|NCT03138889|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
20172570|NCT00411645|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
20172571|NCT04016285|University of Kentucky Department of Orthopaedic Surgery & Sports Medicine|Dr. Stephen Duncan|859-218-3084|stephen.duncan@uky.edu|
20172572|NCT02509156|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
20172573|NCT02461563|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172574|NCT01750242|Medtronic Neuromodulation|Stephanie Salisbury|763-526-8096|stephanie.salisbury@medtronic.com|
20172575|NCT00006903|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
20172576|NCT01909674|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
20217971|NCT00873119|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
20172578|NCT02969369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltraildisclosure@sunovion.com|
20172579|NCT01980992|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
20172580|NCT04380116|Yale University|Dr. Frank Buono|2037795799|frank.buono@yale.edu|
20172581|NCT01746745|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172582|NCT02627144|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20172583|NCT03284398|Fresenius Kabi Deutschland, GmbH|Prof. Dr. med. Martin Westphal|+49 6172 686-7348|martin.westphal@fresenius-kabi.com|
20172584|NCT02651922|PASCOE Pharmazeutische Präparate GmbH|Dr. Inga Trompetter and Jennifer Lebert|0049-(0)641-7960-955|Jennifer.lebert@pascoe.de|
20172585|NCT01366209|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20172586|NCT01053221|University of Wisconsin-Madison|William Burlingham, PhD|6082630119|burlingham@surgery.wisc.edu|
20172587|NCT01465997|Cares|UCB|+1844 599||2273
20172588|NCT02246660|Northwestern University|Dr. Mary McDermott|312-503-6419|mdm608@northwestern.edu|
20172589|NCT02397785|Cleveland Clinic Foundation|Erica Magelky, Principal Investigator|713-628-5357|magelke@ccf.org|
20172590|NCT02557646|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20172591|NCT01619774|University of Texas (UT) MD Anderson Cancer Center|Michael Davies, Associate Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
20172592|NCT00496470|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
20172593|NCT01369758|Hologic, Inc|Christina Mastandrea|508-263-8772|Christina.Mastandrea@Hologic.com|
20172594|NCT00729651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172595|NCT04891874|Shanghai Eastern Hepatobiliary Surgery Hospital|Dr. SHI Changying|+86-021-81887735|nona-peach@hotmail.com|
20172596|NCT01637272|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
20172597|NCT01496612|NIH/NINDS|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
20172598|NCT00291577|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
20172599|NCT03473977|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
20172600|NCT01666782|Rochester General Hospital|Saad Jamshed, MD|585-922-4020|Saad.Jamshed@rochesterregional.org|
20172601|NCT03809052|Galecto BIotech|Dr Bertil Lindmark, Chief Medical Officer|+45 70 70 52 10|info@galecto.com|
20172602|NCT02984709|Vanderbilt University Medical Center|Sarah Jaser|615-343-6775|sarah.jaser@vanderblit.edu|
20172603|NCT03200860|University Medical Center Groningen - Department of Cardiology|Prof. dr. A.A. Voors|0031503616161|a.a.voors@umcg.nl|
20172604|NCT00844896|Massachusetts General Hospital|Frederick J. Stoddard Jr., M.D.,|(617) 371-4762|fstoddard@partners.org|
20172605|NCT04774328|Concentric Analgesics|Carrie Khouri, Associate Director of Clinical Operations|1-415-484-7921|ckhouri@concentricanalgesics.com|
20172606|NCT00458211|Bronx Psychiatric Center|Nigel Bark MD|718 862 5429|Nigel.Bark@omh.ny.gov|
20172607|NCT04342897|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20172608|NCT02154243|HSS|Dr. Haskins|(212) 606-1000|HaskinsS@hss.edu|
20172609|NCT03158116|UCSF Benioff Children's Hospital Oakland|Rachna Wadia, MD|844-724-4140|rawadia@mail.cho.org|
20172610|NCT02634320|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
20172611|NCT00838578|KYOWA KIRIN PHARMA|Project Leader|6099191100|clinical.info@kyowa-kirin-pharma.com|
20172612|NCT00357968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
20172613|NCT03919799|Kadmon (A Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
20172614|NCT02044393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
20172615|NCT03734055|University of Rochester|Dr. Edith Williams|5856020802|edith_williams@urmc.rochester.edu|
20172616|NCT05425745|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
20202837|NCT00306891|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
20202838|NCT02342561|The Orthopaedic Research Unit, Department of Orthopaedic Surgery and Trauma, Odense University Hospital, Denmark|Nikolaj Milandt, Undergraduate researcher|26616611|nikolaj.rongsted.milandt@rsyd.dk|0045
20202839|NCT00231478|Hoffman-LaRoche|Medical Communications|800-821-8590||
20202840|NCT02234011|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
20202841|NCT02053246|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
20202842|NCT01399827|Massachusetts General Hospital|Craig Surman, MD|617-726-8392|csurman@partners.org|
20202843|NCT02369510|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@MountSinai.org|
20172617|NCT00998660|Medtronic, Inc.|Todd Weaver, PhD|763-526-8130|todd.weaver@medtronic.com|
20172618|NCT00793403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
20172619|NCT00218465|Center for Addiction Medicine|Sara Carlini|617-643-1990|scarlini@partners.org|
20172620|NCT00410046|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
20172621|NCT02715076|Department of outcomes research Cleveland Ohio|Dr. Daniel I. Sessler||ds@or.org|
20172622|NCT03909295|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
20172623|NCT02066740|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
20172624|NCT02566083|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
20172625|NCT03312933|Brigham and Women's Hospital|Dr. Jeremy T. Smith|(617) 983-7295|jsmith42@bwh.harvard.edu|
20172626|NCT02893514|NYU Langone Health|Jennifer McNeely, MD, MS|(646) 501-3551|Jennifer.McNeely@nyulangone.org|
20172627|NCT01549860|VP Medical Affairs|Pamela Unger|(952) 224-8755|punger@celleration.com|
20172628|NCT00660023|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
20172629|NCT04180488|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
20172630|NCT03506815|The Ottawa Hospital|Dr. Marc Carrier|613-737-8899|mcarrier@toh.ca|73034
20172631|NCT01011634|UCSF|Karen Meckstroth, MD|415 206-8713|meckstrothk@obgyn.ucsf.edu|
20172632|NCT00616200|UNC Center for Functional GI & Motility Disorders|Stephan R. Weinland, Ph.D.|9198437828|stephan_weinland@med.unc.edu|
20172633|NCT03709771|Vanderbilt University Medical Center|Emily Shardelow|615-875-8949|emily.m.shardelow@vumc.org|
20172634|NCT02899988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
20172635|NCT02000973|First Hospital of China Medical University|Jun Wang|8602483283100|wjun2000@hotmail.com|
20172636|NCT01635101|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
20172637|NCT01327885|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
20172638|NCT03232801|University of Pittsburgh|Holly Thomas|412-586-9836|thomashn@upmc.edu|
20172639|NCT03848650|Columbia University|Manish Parikh, MD|212-326-8532|map2224@cumc.columbia.edu|
20172640|NCT01577329|University of Michigan|Roxane Raffin Chan|7344780170|roxchan@comcast.net|734
20172641|NCT03991715|University of North Carolina at Chapel Hill|Kelly Evenson, PhD|(919) 966-1967|kelly_evenson@unc.edu|
20172642|NCT00844051|Children's Hospital Los Angeles|Pia Pannaraj, MD, MPH|323-361-2509|ppannaraj@chla.usc.edu|
20172643|NCT00105482|Yale School of Medicine, Department of Psychiatry|Stephanie Samples O'Malley PhD, Director, Division of Substance Abuse Research|(203) 974-7590|stephanie.omalley@yale.edu|
20172644|NCT01929460|Kaiser Permanente, Los Angeles Medical Center|Karl Kwok, MD|800-954-8000|regional-research-committee@kp.org|
20172645|NCT01749514|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172646|NCT03042533|harborview medical center|julie agel|206.744.4113|bagel@uw.edu|
20172647|NCT02547649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172648|NCT00571987|UAMS|Dr. Suzanne Klimberg|501-686-6504|klimbergsuzanne@uams.edu|
20172649|NCT02368431|VA Connecticut Healthcare System West Haven Campus, West Haven, CT|Dr Albert Arias|804-828-5793|albert.arias@vcuhealth.org|
20172650|NCT00484874|Dana-Farber Cancer Institute|Heather Jacene, MD|617-632-3767|hjacene@partners.org|
20172651|NCT00811798|GlaxoSmithKline|GSK Response Center|866-435-7343||
20172652|NCT00171730|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
20172653|NCT05025241|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
20172654|NCT02220205|Beth Israel Deaconess Medical Center|Siripanth Nippita|617-667-4165|snippita@bidmc.harvard.edu|
20172655|NCT03944954|University of Kentucky|Dr. Michael J Wesley|8593230579|michael.wesley@uky.edu|
20172656|NCT03223246|Massachusetts General Hospital|Dr. Margaret Samuels-Kalow|6177262000|msamuels-kalow@mgh.harvard.edu|
20172657|NCT02268084|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
20172658|NCT05227027|University of California, San Francisco|Dr. Justin White, Associate Professor|415-476-8045|justin.white@ucsf.edu|
20172659|NCT02911753|University of Arizona|David O. Garcia, PhD, FACSM|520-626-4641|davidogarcia@email.arizona.edu|
20172660|NCT01891695|University of Virginia|Paul Read, MD|434-924-5191|pwr3u@hscmail.mcc.virginia.edu|
20172661|NCT00855920|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
20172662|NCT00080470|Boston Scientific|Director of Clinical Operations|866-360-4747|Valerie.Lucero-Cimmarust@bsci.com|
20172663|NCT01605877|Alcon Japan, Ltd.|Hiroshi Kodama, Group Manager|81-3-6899-5000||
20172664|NCT00687323|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
20172665|NCT02132130|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
20172666|NCT02760069|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April.mil@mail.mil|
20172667|NCT02465216|IDRI|Dr. Corey Casper|2063810883|corey.casper@idri.org|
20172668|NCT04748120|Cleveland Clinic Foundation|Dr. Clayton Petro|216-444-3501|petroc@ccf.org|
20172669|NCT01593215|RegionSkane|Anders Rosengren|+4640391169|anders.rosengren@med.lu.se|
20172670|NCT00646776|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
20172671|NCT01112241|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|Dr. Giovanni Barisione, MD|+39 010 5553367|giovanni.barisione@hsanmartino.it|
20172672|NCT03305653|Children's Hospital Colorado|Dr. Calies Menard-Katcher|720-777-2318|calies.menard-katcher@childrenscolorado.org|
20172673|NCT01550302|University of Washington|Srdjan Jelacic|(206) 598-3777|sjelacic@uw.edu|
20172674|NCT00600483|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
20172675|NCT00705653|Progen Industries|Michael Fitzgerald|919-803-9988|michaelf@progen-pharma.com|
